seq_id;;swissprot;evalue;Entry name;Protein names;Gene ontology (GO);Gene ontology IDs;Gene ontology (biological process);Gene ontology (cellular component);Gene ontology (molecular function)
comp0_c2_seq1;GAXK01169722.1;P31674;1.91E-67;RS15_ORYSJ;40S ribosomal protein S15;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1_c0_seq1;GAXK01169283.1;P41042;8.44E-140;RS4_DROME;40S ribosomal protein S4;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003735; GO:0006412; GO:0019843; GO:0022626; GO:0022627";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1000036_c0_seq1;GAXK01053354.1;Q66S03;1.13E-19;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1000120_c0_seq1;GAXK01053414.1;Q9XZT6;2.32E-52;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp1000165_c0_seq1;GAXK01053382.1;Q9UBB5;6.69E-08;MBD2_HUMAN;Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2);"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"GO:0000118; GO:0000122; GO:0000183; GO:0000790; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0034622; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0043044; GO:0044030; GO:0045892; GO:0048568; GO:0070742; GO:0071407";"aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]"
comp100041_c0_seq1;GAXK01142008.1;O94876;2.61E-32;TMCC1_HUMAN;Transmembrane and coiled-coil domains protein 1;"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0016021; GO:0016197; GO:0042803; GO:0046982; GO:0051260; GO:0051291; GO:0090148; GO:0097750; GO:0140284; GO:0140285";"endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]";"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp1000629_c0_seq1;GAXK01053412.1;P15364;1.84E-09;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1000879_c0_seq1;GAXK01053355.1;O76050;9.11E-24;NEUL1_HUMAN;E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (h-neu) (h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1);"apical dendrite [GO:0097440]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]";"GO:0004842; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007420; GO:0007519; GO:0007595; GO:0008285; GO:0014069; GO:0030054; GO:0043065; GO:0043197; GO:0043204; GO:0045183; GO:0045211; GO:0045741; GO:0045746; GO:0046872; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440";"brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]";"apical dendrite [GO:0097440]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp1000921_c0_seq1;GAXK01053394.1;P36609;1.25E-34;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1000927_c0_seq1;GAXK01053389.1;Q23939;2.78E-31;TPM_DERFA;Tropomyosin (Mag44) (allergen Der f 10);;;;;
comp10009356_c0_seq1;GAXK01044924.1;P54989;1.31E-22;NTAA_AMIAI;Nitrilotriacetate monooxygenase component A (NTA monooxygenase component A) (NTA-MO A) (EC 1.14.14.10);"nitrilotriacetate monooxygenase activity [GO:0018529]; nitrilotriacetate monooxygenase activity (FMN-dependent) [GO:0102977]";"GO:0018529; GO:0102977";;;"nitrilotriacetate monooxygenase activity [GO:0018529]; nitrilotriacetate monooxygenase activity (FMN-dependent) [GO:0102977]"
comp100109_c1_seq1;GAXK01142292.1;Q9VHX7;2.98E-17;ELOVL_DROME;Elongation of very long chain fatty acids protein (EC 2.3.1.199) (Elongation of very long chain fatty acids elongase) (Very-long-chain 3-oxoacyl-CoA synthase);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0001676; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0030497; GO:0034625; GO:0034626; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp1001198_c0_seq1;GAXK01053352.1;P18715;2.01E-13;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp10012_c2_seq1;GAXK01188117.1;Q94535;9.71E-115;U2AF1_DROME;Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit);"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701";"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]";"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]"
comp1001288_c0_seq1;GAXK01053392.1;O75897;3.94E-39;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp100135_c1_seq1;GAXK01141975.1;Q3U481;7.64E-114;MFS12_MOUSE;Major facilitator superfamily domain-containing protein 12;"integral component of plasma membrane [GO:0005887]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; organic substance transport [GO:0071702]";"GO:0005887; GO:0008643; GO:0015293; GO:0071702";"carbohydrate transport [GO:0008643]; organic substance transport [GO:0071702]";integral component of plasma membrane [GO:0005887];symporter activity [GO:0015293]
comp1001370_c0_seq1;GAXK01053413.1;Q1JRP2;1.36E-32;TM11C_MOUSE;"Transmembrane protease serine 11C (EC 3.4.21.-) (Neurobin) [Cleaved into: Transmembrane protease serine 11C non-catalytic chain; Transmembrane protease serine 11C catalytic chain]";"dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0030425; GO:0043204; GO:0097264";"proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]";serine-type endopeptidase activity [GO:0004252]
comp1001629_c0_seq1;GAXK01053347.1;P10076;1.40E-54;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp10017_c0_seq1;GAXK01187726.1;P74615;1.14E-24;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp1001795_c0_seq1;GAXK01053398.1;Q8BTK5;9.49E-23;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1001859_c0_seq1;GAXK01053421.1;A8MT65;1.45E-13;ZN891_HUMAN;Zinc finger protein 891;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1002103_c0_seq1;GAXK01153991.1;D2D3B2;5.21E-51;FUMI_SPHMC;Aminopentol aminotransferase (EC 2.6.1.-);"cytoplasm [GO:0005737]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]";"GO:0005737; GO:0008483; GO:0030170";;cytoplasm [GO:0005737];"pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp100233_c6_seq1;GAXK01142151.1;Q9VMA7;1.90E-14;TGO1_DROME;Transport and Golgi organization protein 1;"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"GO:0000137; GO:0000139; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0007030; GO:0009306; GO:0012505; GO:0016021; GO:0033363; GO:0035459; GO:0051047; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp10024_c0_seq1;GAXK01188427.1;P74615;4.93E-18;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp100250_c0_seq1;GAXK01142291.1;A5HK05;8.70E-127;APBP2_RAT;Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2);"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]";"GO:0005634; GO:0005874; GO:0006886; GO:0030659";intracellular protein transport [GO:0006886];"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]";
comp100272_c1_seq1;GAXK01142350.1;Q5SRE7;5.66E-102;PHYD1_HUMAN;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp100273_c3_seq1;GAXK01142595.1;Q8IZC4;1.01E-38;RTKN2_HUMAN;Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243";"hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp1002909_c0_seq1;GAXK01154017.1;Q9GRW0;1.52E-62;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp100352_c1_seq1;GAXK01141985.1;P05661;1.09E-138;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1003587_c0_seq1;GAXK01154011.1;C0LZJ1;9.25E-25;DMRT1_BOVIN;Doublesex and mab-3 related transcription factor 1;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Sertoli cell differentiation [GO:0060008]";"GO:0000122; GO:0000987; GO:0002176; GO:0003700; GO:0005634; GO:0030238; GO:0042803; GO:0045835; GO:0045840; GO:0045944; GO:0046661; GO:0046872; GO:0046982; GO:0048599; GO:0060008; GO:0060903";"male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Sertoli cell differentiation [GO:0060008]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]"
comp100373_c0_seq1;GAXK01142497.1;Q24174;2.81E-09;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp100396_c0_seq1;GAXK01141981.1;Q2TBP8;3.86E-40;MET17_BOVIN;Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-) (Methyltransferase 11 domain-containing protein 1) (Protein RSM22 homolog, mitochondrial);"mitochondrion [GO:0005739]; ribosome [GO:0005840]; methyltransferase activity [GO:0008168]; translation [GO:0006412]";"GO:0005739; GO:0005840; GO:0006412; GO:0008168";translation [GO:0006412];"mitochondrion [GO:0005739]; ribosome [GO:0005840]";methyltransferase activity [GO:0008168]
comp100419_c0_seq1;GAXK01142219.1;Q9UKA9;1.07E-29;PTBP2_HUMAN;Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (Neurally-enriched homolog of PTB) (PTB-like protein);"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"GO:0003723; GO:0003729; GO:0005681; GO:0006376; GO:0021510; GO:0021549; GO:0030426; GO:0033119; GO:0043025; GO:2000177";"cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; spliceosomal complex [GO:0005681]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1004340_c0_seq1;GAXK01042183.1;Q99571;1.96E-77;P2RX4_HUMAN;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0006812; GO:0007165; GO:0007596; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0016021; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035381; GO:0035590; GO:0042118; GO:0042803; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904124; GO:1904141; GO:2001028";"apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]"
comp10045_c1_seq1;GAXK01187724.1;Q503P2;1.56E-106;NIP7_DANRE;60S ribosome subunit biogenesis protein NIP7 homolog;"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]";"GO:0003723; GO:0005730; GO:0030687; GO:0042255; GO:0042273";"ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]";"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";RNA binding [GO:0003723]
comp1004536_c0_seq1;GAXK01042180.1;Q0KHU5;6.23E-87;PCAT_DROME;Lysophosphatidylcholine acyltransferase (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (Acyltransferase-like 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0008654; GO:0016021; GO:0030258; GO:0047184; GO:0071617";"lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]"
comp1004568_c0_seq1;GAXK01042134.1;P17789;8.64E-20;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp10046_c0_seq1;GAXK01187728.1;B0WEV5;9.21E-173;ASNA_CULQU;ATPase ASNA1 homolog (EC 3.6.-.-) (Arsenical pump-driving ATPase homolog) (Arsenite-stimulated ATPase);"endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048]";"GO:0005524; GO:0005783; GO:0016887; GO:0045048; GO:0046872";protein insertion into ER membrane [GO:0045048];endoplasmic reticulum [GO:0005783];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp10048_c1_seq1;GAXK01188527.1;Q4JIJ3;0;METH_BOVIN;Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS);"cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0042558";pteridine-containing compound metabolic process [GO:0042558];cytosol [GO:0005829];"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp1004878_c0_seq1;GAXK01204948.1;P21266;8.66E-86;GSTM3_HUMAN;Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]";"GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458; GO:1901687";"cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]";"enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp1004881_c0_seq1;GAXK01042158.1;B9EJV3;4.03E-30;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp1004986_c0_seq1;GAXK01042138.1;Q7KRI2;1.98E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1005_c0_seq1;GAXK01169008.1;P05455;4.78E-49;LA_HUMAN;Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B);"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]";"GO:0000049; GO:0000784; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904";"histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]";"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]"
comp1005230_c0_seq1;GAXK01042179.1;P10083;4.12E-10;AST5_DROME;Achaete-scute complex protein T5 (Protein achaete);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; Malpighian tubule tip cell differentiation [GO:0061382]; nervous system development [GO:0007399]; neuroblast fate determination [GO:0007400]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419]";"GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0006963; GO:0007346; GO:0007399; GO:0007400; GO:0007417; GO:0007419; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030182; GO:0043565; GO:0045944; GO:0046982; GO:0050767; GO:0061331; GO:0061382; GO:0090575";"central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; Malpighian tubule tip cell differentiation [GO:0061382]; nervous system development [GO:0007399]; neuroblast fate determination [GO:0007400]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp1005288_c0_seq1;GAXK01042123.1;O60504;3.24E-16;VINEX_HUMAN;Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; transcription factor binding [GO:0008134]; vinculin binding [GO:0017166]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496]";"GO:0000122; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005925; GO:0006936; GO:0007015; GO:0007155; GO:0008134; GO:0017166; GO:0031589; GO:0043410; GO:0051495; GO:0051496";"actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]";"structural constituent of cytoskeleton [GO:0005200]; transcription factor binding [GO:0008134]; vinculin binding [GO:0017166]"
comp1005292_c0_seq1;GAXK01042190.1;P50429;4.35E-67;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp1005308_c0_seq1;GAXK01042175.1;P81125;5.05E-21;SNAA_BOVIN;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha);"plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005483; GO:0005774; GO:0005886; GO:0006886; GO:0010807; GO:0019905; GO:0031201; GO:0035249; GO:0035494; GO:0070044";"intracellular protein transport [GO:0006886]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]";"plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; vacuolar membrane [GO:0005774]";"soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp100552_c0_seq1;GAXK01142429.1;P52746;1.04E-13;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp100553_c0_seq1;GAXK01142367.1;P31729;1.87E-36;OV16_ONCVO;OV-16 antigen;;;;;
comp1005589_c0_seq1;GAXK01042165.1;B0JZG0;1.98E-171;S23A2_XENTR;Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; transepithelial L-ascorbic acid transport [GO:0070904]";"GO:0005737; GO:0005886; GO:0005887; GO:0008520; GO:0009925; GO:0016324; GO:0019852; GO:0070890; GO:0070904";"L-ascorbic acid metabolic process [GO:0019852]; transepithelial L-ascorbic acid transport [GO:0070904]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]"
comp1005599_c0_seq2;GAXK01042142.1;Q9UBV7;9.31E-25;B4GT7_HUMAN;Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase);"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0097435";"carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"
comp1005672_c0_seq1;GAXK01042186.1;D3Z5L6;1.27E-26;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp100578_c0_seq1;GAXK01141993.1;P56941;6.18E-29;NPC1_PIG;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103";"bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp100580_c1_seq1;GAXK01142344.1;A7RM45;1.51E-104;LMBD1_NEMVE;Probable lysosomal cobalamin transporter;"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; cobalamin binding [GO:0031419]";"GO:0005765; GO:0016021; GO:0031419";;"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";cobalamin binding [GO:0031419]
comp100585_c1_seq1;GAXK01142348.1;Q99JW2;1.91E-170;ACY1_MOUSE;Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520]";"GO:0004046; GO:0005737; GO:0006520; GO:0008237; GO:0042802; GO:0046872; GO:0070062";cellular amino acid metabolic process [GO:0006520];"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]";"aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp100588_c7_seq1;GAXK01142322.1;Q8WUA4;1.99E-26;TF3C2_HUMAN;General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta);"nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"GO:0000127; GO:0005654; GO:0006383; GO:0042791; GO:0042797";"5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]";
comp10059_c0_seq1;GAXK01188112.1;P07992;2.75E-75;ERCC1_HUMAN;DNA excision repair protein ERCC-1;"cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; transcription factor TFIID complex [GO:0005669]; damaged DNA binding [GO:0003684]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cell population proliferation [GO:0008283]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]";"GO:0000014; GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000784; GO:0001094; GO:0001302; GO:0003684; GO:0003697; GO:0005654; GO:0005669; GO:0005829; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006295; GO:0006296; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0033683; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048477; GO:0048568; GO:0061819; GO:0070522; GO:0070911; GO:0070914; GO:0090656; GO:1904431; GO:1905765";"cell population proliferation [GO:0008283]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]";"cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; transcription factor TFIID complex [GO:0005669]";"damaged DNA binding [GO:0003684]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]"
comp1005995_c0_seq1;GAXK01042147.1;P36609;1.37E-66;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1006369_c0_seq1;GAXK01050910.1;O46040;1.83E-19;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1006643_c0_seq1;GAXK01050946.1;Q9VG82;5.04E-15;CP9F2_DROME;Probable cytochrome P450 9f2 (EC 1.14.-.-) (CYPIXF2);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; wing disc development [GO:0035220]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037; GO:0035220";wing disc development [GO:0035220];endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp1006668_c0_seq1;GAXK01050902.1;Q03563;1.71E-75;SPK1_CAEEL;Serine/threonine-protein kinase spk-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009792; GO:0010468; GO:0035556; GO:0050684";"embryo development ending in birth or egg hatching [GO:0009792]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp100670_c1_seq1;GAXK01142102.1;Q9Z2A7;1.94E-101;DGAT1_MOUSE;Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0005886; GO:0010867; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0043231; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491";"diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]"
comp100675_c1_seq1;GAXK01142364.1;Q9VIP7;3.52E-86;ACASE_DROME;Alkaline ceramidase (AlkCDase) (EC 3.5.1.23) (Alkaline N-acylsphingosine amidohydrolase) (Alkaline acylsphingosine deacylase) (Protein brainwashing);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]; brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005783; GO:0006665; GO:0007420; GO:0016021; GO:0017040; GO:0019216; GO:0046514; GO:0046872; GO:0102121";"brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]"
comp10069_c1_seq1;GAXK01188277.1;P15690;0;NDUS1_BOVIN;NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-75kD) (CI-75kD);"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]";"GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045272; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593";"apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]";"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane respiratory chain complex I [GO:0045272]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp100694_c1_seq1;GAXK01142266.1;Q14643;0;ITPR1_HUMAN;Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor);"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]";"GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0030168; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050796; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:0098685; GO:0098695; GO:1903779";"calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]";"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]";"calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"
comp100713_c2_seq1;GAXK01142533.1;Q9VCA2;1.68E-42;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1007219_c0_seq1;GAXK01050921.1;P61587;1.81E-23;RND3_HUMAN;Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005925; GO:0005938; GO:0007015; GO:0007155; GO:0007266; GO:0008360; GO:0019901; GO:0030036; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp100746_c3_seq1;GAXK01141992.1;Q15477;0;SKIV2_HUMAN;Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP);"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]";"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1007893_c3_seq1;GAXK01050941.1;Q18120;1.92E-18;TWK18_CAEEL;TWiK family of potassium channels protein 18;"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0030322; GO:0040011; GO:0071805";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp1007899_c0_seq1;GAXK01050935.1;Q9NA51;4.78E-11;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1007965_c0_seq1;GAXK01050918.1;P91685;0;GRM_DROME;Metabotropic glutamate receptor (DmGluRA);"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553";"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp1008105_c0_seq1;GAXK01143453.1;Q7SGY1;1.51E-08;ALO_NEUCR;Putative D-arabinono-1,4-lactone oxidase (ALO) (EC 1.1.3.37) (L-galactono-gamma-lactone oxidase);"integral component of mitochondrial outer membrane [GO:0031307]; D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]; cellular response to oxidative stress [GO:0034599]; dehydro-D-arabinono-1,4-lactone biosynthetic process [GO:0070485]";"GO:0003885; GO:0031307; GO:0034599; GO:0070485; GO:0071949";"cellular response to oxidative stress [GO:0034599]; dehydro-D-arabinono-1,4-lactone biosynthetic process [GO:0070485]";integral component of mitochondrial outer membrane [GO:0031307];"D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]"
comp100818_c0_seq1;GAXK01142138.1;Q3ZBG5;2.61E-16;BAG2_BOVIN;BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2);"axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821]";"GO:0000774; GO:0010954; GO:0019538; GO:0030424; GO:0031072; GO:0031625; GO:0032091; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800; GO:1904667";"negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821]";"axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]";"adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]"
comp10082_c1_seq1;GAXK01188089.1;O46560;7.21E-102;PDXK_PIG;Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443]";"GO:0005524; GO:0005829; GO:0008478; GO:0009443; GO:0046872";pyridoxal 5'-phosphate salvage [GO:0009443];cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]"
comp100832_c2_seq1;GAXK01142139.1;P37662;1.25E-07;YHJX_ECOLI;Uncharacterized MFS-type transporter YhjX;"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; cellular response to nutrient levels [GO:0031669]";"GO:0005886; GO:0005887; GO:0022857; GO:0031669";cellular response to nutrient levels [GO:0031669];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp100885_c0_seq1;GAXK01142017.1;Q63060;5.97E-171;GLPK_RAT;Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP-stimulated glucocorticoid-receptor translocation promoter) (ASTP) (ATP:glycerol 3-phosphotransferase);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]";"GO:0004370; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0009409; GO:0010033; GO:0016310; GO:0019563; GO:0042393; GO:0042493; GO:0045471; GO:0046167";"glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]"
comp100888_c1_seq1;GAXK01142596.1;Q5ZLS8;2.33E-33;INT10_CHICK;Integrator complex subunit 10 (Int10);"integrator complex [GO:0032039]; snRNA processing [GO:0016180]";"GO:0016180; GO:0032039";snRNA processing [GO:0016180];integrator complex [GO:0032039];
comp1009_c0_seq1;GAXK01168375.1;Q98SN8;0;S61A2_ONCMY;Protein transport protein Sec61 subunit alpha isoform B;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0005789; GO:0015031; GO:0016021";protein transport [GO:0015031];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1009004_c0_seq1;GAXK01143427.1;O97831;6.96E-23;AGRL1_BOVIN;Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1);"axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129]";"GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007189; GO:0014069; GO:0016524; GO:0030054; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0090129";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129]";"axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]"
comp1009145_c0_seq1;GAXK01143477.1;P11118;5.62E-53;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1009233_c0_seq1;GAXK01143462.1;Q99MH9;5.57E-174;BBS2_RAT;Bardet-Biedl syndrome 2 protein homolog;"BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]";"GO:0001103; GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:1905515";"adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]";"BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]";RNA polymerase II repressing transcription factor binding [GO:0001103]
comp1009456_c0_seq1;GAXK01143485.1;O60765;2.21E-19;Z354A_HUMAN;Zinc finger protein 354A (Transcription factor 17) (TCF-17) (Zinc finger protein eZNF);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]";"GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0007605; GO:0046872";"regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp100954_c0_seq1;GAXK01141986.1;Q8AWD2;1.30E-99;MOCS3_DANRE;"Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605";"enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]"
comp100965_c0_seq1;GAXK01142071.1;Q95VA8;4.07E-35;TPM_TRISP;Tropomyosin;;;;;
comp10096618_c0_seq1;GAXK01159117.1;P13065;1.47E-25;PHSL_DESBA;Periplasmic [NiFeSe] hydrogenase large subunit (EC 1.12.99.6) (NiFeSe hydrogenlyase large chain);"periplasmic space [GO:0042597]; ferredoxin hydrogenase activity [GO:0008901]; hydrogenase (acceptor) activity [GO:0033748]; nickel cation binding [GO:0016151]";"GO:0008901; GO:0016151; GO:0033748; GO:0042597";;periplasmic space [GO:0042597];"ferredoxin hydrogenase activity [GO:0008901]; hydrogenase (acceptor) activity [GO:0033748]; nickel cation binding [GO:0016151]"
comp10097_c0_seq1;GAXK01187951.1;P38404;0;GNAO_LOCMI;Guanine nucleotide-binding protein G(o) subunit alpha;"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]";"GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872";adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1009782_c0_seq1;GAXK01143476.1;Q9NRA2;1.33E-71;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp1009920_c0_seq1;GAXK01143461.1;Q86I06;2.51E-30;NEK3_DICDI;Probable serine/threonine-protein kinase nek3 (EC 2.7.11.1) (Never in mitosis protein A-related protein kinase 3) (NimA-related protein kinase 3);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0004674; GO:0005524; GO:0005737; GO:0023014; GO:0031098; GO:0032147";"activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1009946_c0_seq1;GAXK01143455.1;O86309;1.16E-14;NAT_MYCSM;Arylamine N-acetyltransferase (NAT) (EC 2.3.1.5);arylamine N-acetyltransferase activity [GO:0004060];GO:0004060;;;arylamine N-acetyltransferase activity [GO:0004060]
comp1009961_c0_seq1;GAXK01143435.1;Q93098;5.14E-78;WNT8B_HUMAN;Protein Wnt-8b;"extracellular region [GO:0005576]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005576; GO:0005615; GO:0007165; GO:0007369; GO:0007399; GO:0016055; GO:0030182; GO:0032355; GO:0032526; GO:0045165; GO:0048018; GO:0048263; GO:0060070; GO:0071300; GO:1904886";"beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]"
comp1010042_c0_seq1;GAXK01002647.1;P17789;3.82E-12;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp10101895_c0_seq1;GAXK01063035.1;Q47452;1.79E-13;PCOA_ECOLX;Copper resistance protein A;"periplasmic space [GO:0042597]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]";"GO:0005507; GO:0016491; GO:0042597";;periplasmic space [GO:0042597];"copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]"
comp1010241_c1_seq1;GAXK01002672.1;Q98989;2.06E-09;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp10105_c0_seq1;GAXK01187988.1;Q8ML92;2.12E-23;AVE_DROME;Protein aveugle;"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0001751; GO:0001754; GO:0005737; GO:0005829; GO:0007165; GO:0007173; GO:0007601; GO:0007623; GO:0009898; GO:0042675; GO:0046579";"circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]";
comp101050_c0_seq1;GAXK01142424.1;Q0EEE2;5.09E-37;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp101053_c0_seq1;GAXK01142362.1;Q9NTM9;3.43E-61;CUTC_HUMAN;Copper homeostasis protein cutC homolog;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]";"GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070";"copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";copper ion binding [GO:0005507]
comp1010562_c0_seq1;GAXK01002687.1;Q9Z0F0;1.22E-10;B3GT4_MOUSE;Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; ganglioside galactosyltransferase activity [GO:0047915]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0001574; GO:0005783; GO:0005794; GO:0006486; GO:0008376; GO:0008499; GO:0016021; GO:0047915";"ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; ganglioside galactosyltransferase activity [GO:0047915]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp1010666_c0_seq1;GAXK01204974.1;G5E8K5;1.59E-12;ANK3_MOUSE;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp1010769_c0_seq1;GAXK01002649.1;Q64273;2.25E-87;KCNJ2_RAT;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (RBL-IRK1) (Potassium channel, inwardly rectifying subfamily J member 2);"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"GO:0005242; GO:0005546; GO:0005790; GO:0005791; GO:0005794; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0030315; GO:0030425; GO:0031224; GO:0042802; GO:0043025; GO:0043197; GO:0051289; GO:0055119; GO:0060306; GO:0071260; GO:0086002; GO:0086004; GO:0086008; GO:0086091; GO:0090076; GO:1901381; GO:1990573";"cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]";"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]"
comp101082_c1_seq1;GAXK01142070.1;Q4QQW8;3.15E-162;PLBL2_RAT;Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2);"lysosomal lumen [GO:0043202]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]";"GO:0004620; GO:0016042; GO:0043202";lipid catabolic process [GO:0016042];lysosomal lumen [GO:0043202];phospholipase activity [GO:0004620]
comp10110_c0_seq1;GAXK01187416.1;Q9W445;2.11E-78;MCTS1_DROME;Malignant T-cell-amplified sequence 1 homolog (Multiple copies in T-cell lymphoma 1 homolog) (MCT-1);"cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188]";"GO:0001731; GO:0002188; GO:0003723; GO:0022627; GO:0032991; GO:0045948";"formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188]";"cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]";RNA binding [GO:0003723]
comp1011191_c0_seq1;GAXK01002673.1;A8WQH2;1.55E-26;PXDN_CAEBR;Peroxidasin homolog (EC 1.11.1.7);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679";"embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp101121_c0_seq1;GAXK01142272.1;Q803X1;1.40E-180;CTU1_DANRE;Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (ATP-binding domain-containing protein 3) (Cytoplasmic tRNA adenylyltransferase 1);"cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";"GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0016779; GO:0032447; GO:0034227";"protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";"cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]";"nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]"
comp101129_c0_seq1;GAXK01142264.1;P57737;7.80E-111;CORO7_HUMAN;Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"GO:0000139; GO:0003779; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0015031; GO:0016020; GO:0016021; GO:0030041; GO:0031410; GO:0051015";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp1011351_c0_seq1;GAXK01002638.1;Q7KRI2;4.91E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp101137_c1_seq1;GAXK01142168.1;Q9VEG6;1.03E-137;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp1011463_c0_seq1;GAXK01002683.1;P35501;1.16E-48;ESTE_MYZPE;Esterase E4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp1011579_c0_seq1;GAXK01002678.1;P97738;3.16E-17;NPTX2_RAT;Neuronal pentraxin-2 (NP2) (Neuronal activity-regulated pentraxin) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"GO:0005576; GO:0005886; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098892; GO:0098978; GO:0099645";"neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp101193_c0_seq1;GAXK01142415.1;Q3MII6;2.91E-102;TBC25_HUMAN;TBC1 domain family member 25;"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096]";"GO:0005096; GO:0005776; GO:0006886; GO:0006914; GO:0017137; GO:0031410; GO:0090630; GO:1901096";"activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096]";"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp10120_c0_seq1;GAXK01187303.1;Q5ZJK0;5.97E-88;RGPS1_CHICK;Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (RalA exchange factor RalGPS1);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0032485";"regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp101204_c1_seq1;GAXK01141984.1;Q8WVP5;1.35E-29;TP8L1_HUMAN;Tumor necrosis factor alpha-induced protein 8-like protein 1 (TIPE1) (TNF alpha-induced protein 8-like protein 1) (TNFAIP8-like protein 1) (Oxidative stress-regulated gene-beta) (Oxy-beta);"cytoplasm [GO:0005737]; negative regulation of TOR signaling [GO:0032007]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0032007; GO:0042981";"negative regulation of TOR signaling [GO:0032007]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];
comp101205_c0_seq1;GAXK01142294.1;Q9C907;6.57E-53;GDPD5_ARATH;Glycerophosphodiester phosphodiesterase GDPD5 (EC 3.1.4.46) (Glycerophosphodiester phosphodiesterase 5) (ATGDPD5);"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]";"GO:0005576; GO:0005618; GO:0005773; GO:0005829; GO:0006071; GO:0006629; GO:0008889";"glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]";"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]";glycerophosphodiester phosphodiesterase activity [GO:0008889]
comp101206_c1_seq1;GAXK01142541.1;P58283;2.51E-33;RN216_MOUSE;E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546";"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp10122_c0_seq1;GAXK01188425.1;P35623;0;GLYC_SHEEP;Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase);"cytosol [GO:0005829]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0004372; GO:0005829; GO:0006544; GO:0006563; GO:0019264; GO:0030170; GO:0035999; GO:0046653; GO:0051289";"glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";cytosol [GO:0005829];"glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]"
comp10123_c1_seq1;GAXK01187425.1;Q9BUN8;4.33E-91;DERL1_HUMAN;Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1);"Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; ATPase binding [GO:0051117]; MHC class I protein binding [GO:0042288]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]";"GO:0000839; GO:0002020; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0016032; GO:0016567; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0032092; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0045184; GO:0051117; GO:0051260; GO:0051787; GO:0055085; GO:0071712; GO:1990381";"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]";"Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]";"ATPase binding [GO:0051117]; MHC class I protein binding [GO:0042288]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]"
comp101232_c2_seq1;GAXK01142167.1;Q9VT65;7.02E-73;CANB_DROME;"Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540";"border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp1012322_c0_seq1;GAXK01179989.1;Q9W2Q1;1.93E-49;RX_DROME;Retinal homeobox protein Rx (DRx) (DRx1);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000981; GO:0005634; GO:0006366; GO:0007275";"multicellular organism development [GO:0007275]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp101246_c3_seq1;GAXK01142293.1;Q8R2Y3;3.76E-24;DOLK_MOUSE;Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15);"integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl monophosphate biosynthetic process [GO:0043048]";"GO:0004168; GO:0030176; GO:0043048";dolichyl monophosphate biosynthetic process [GO:0043048];integral component of endoplasmic reticulum membrane [GO:0030176];dolichol kinase activity [GO:0004168]
comp10124868_c0_seq1;GAXK01150841.1;Q54KZ8;5.67E-29;EIF3M_DICDI;Eukaryotic translation initiation factor 3 subunit M (eIF3m);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0002183; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0071541";"cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]";translation initiation factor activity [GO:0003743]
comp1012649_c0_seq1;GAXK01180000.1;Q13283;1.23E-09;G3BP1_HUMAN;Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063]; type I interferon production [GO:0032606]; viral process [GO:0016032]";"GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0007265; GO:0010494; GO:0016032; GO:0032606; GO:0034063; GO:0043204; GO:0045087; GO:0051607; GO:0062029; GO:0090090; GO:1990904";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063]; type I interferon production [GO:0032606]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp10128_c0_seq1;GAXK01187376.1;Q9VKB4;4.55E-103;RPF1_DROME;Probable ribosome production factor 1 (Ribosome biogenesis protein RPF1);"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005730; GO:0006364; GO:0019843; GO:0030687; GO:0042254";"ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";"RNA binding [GO:0003723]; rRNA binding [GO:0019843]"
comp101303_c0_seq1;GAXK01142202.1;Q8TC21;1.74E-31;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp10132_c3_seq1;GAXK01187734.1;Q9VEX0;2.52E-166;SULF1_DROME;Extracellular sulfatase SULF-1 homolog (DmSulf-1) (EC 3.1.6.-);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0008045; GO:0008449; GO:0009986; GO:0016201; GO:0030202; GO:0042059; GO:0045879; GO:0045880; GO:0046872; GO:0048100; GO:0048190; GO:0090090";"heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]";"glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]"
comp101322_c1_seq1;GAXK01142534.1;Q6PH08;7.04E-34;ERC2_MOUSE;ERC protein 2 (CAZ-associated structural protein 1) (CAST1);"cell junction [GO:0030054]; cytoskeleton [GO:0005856]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; terminal bouton [GO:0043195]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; synaptic vesicle priming [GO:0016082]";"GO:0005798; GO:0005856; GO:0014069; GO:0016020; GO:0016082; GO:0030054; GO:0030165; GO:0030426; GO:0032991; GO:0042734; GO:0043025; GO:0043195; GO:0044877; GO:0045202; GO:0048786; GO:0098831; GO:0098882; GO:0098978; GO:0098982";synaptic vesicle priming [GO:0016082];"cell junction [GO:0030054]; cytoskeleton [GO:0005856]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]"
comp10134_c0_seq1;GAXK01188452.1;Q96EY1;2.58E-11;DNJA3_HUMAN;DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137";"activation-induced cell death of T cells [GO:0006924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]";"ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp101381_c2_seq1;GAXK01141994.1;Q5VU97;5.11E-159;CAHD1_HUMAN;VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);"voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]";"GO:0005245; GO:0005891";;voltage-gated calcium channel complex [GO:0005891];voltage-gated calcium channel activity [GO:0005245]
comp10139_c1_seq1;GAXK01187778.1;Q5NU14;1.78E-75;MKRN1_TAKRU;Probable E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-1);"metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0016740; GO:0046872";protein ubiquitination [GO:0016567];;"metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp1013922_c0_seq1;GAXK01180015.1;Q9JJK1;4.05E-11;GPM6B_RAT;Neuronal membrane glycoprotein M6-b (M6b) (Rhombencephalic expression protein-29 kDa) (Rhombex-29);"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893]";"GO:0001503; GO:0005886; GO:0015031; GO:0016021; GO:0030501; GO:0031175; GO:0032956; GO:0045121; GO:0051612; GO:0051893; GO:0085029; GO:2000009";"extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893]";"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";
comp1014023_c0_seq1;GAXK01151238.1;Q7M761;7.92E-21;OVCH2_MOUSE;Ovochymase-2 (EC 3.4.21.-) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1014061_c0_seq1;GAXK01151221.1;O97366;1.69E-25;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp1014267_c0_seq1;GAXK01151231.1;Q3B725;1.22E-17;ZBT24_RAT;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp101459_c0_seq1;GAXK01142075.1;Q7Z699;6.67E-23;SPRE1_HUMAN;Sprouty-related, EVH1 domain-containing protein 1 (Spred-1) (hSpred1);"caveola [GO:0005901]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of MAPK cascade [GO:0043408]; regulation of protein deacetylation [GO:0090311]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]";"GO:0000165; GO:0000188; GO:0005173; GO:0005634; GO:0005829; GO:0005886; GO:0005901; GO:0006469; GO:0008543; GO:0010801; GO:0010923; GO:0016525; GO:0019901; GO:0019902; GO:0030291; GO:0043408; GO:0043409; GO:0043517; GO:0060979; GO:0070373; GO:0090051; GO:0090311";"fibroblast growth factor receptor signaling pathway [GO:0008543]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of MAPK cascade [GO:0043408]; regulation of protein deacetylation [GO:0090311]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]";"caveola [GO:0005901]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173]"
comp101476_c16_seq1;GAXK01142226.1;Q5ZI58;6.92E-77;F214A_CHICK;Protein FAM214A;;;;;
comp1014765_c0_seq1;GAXK01151232.1;Q8JIY1;6.56E-19;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp1014998_c0_seq1;GAXK01151218.1;Q9VEG6;8.17E-113;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp1015013_c1_seq1;GAXK01151241.1;O57682;2.11E-15;PAX2B_XENLA;Paired box protein Pax-2-B (xPax-2b);"nucleus [GO:0005634]; DNA binding [GO:0003677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; segment polarity determination [GO:0007367]";"GO:0000122; GO:0003677; GO:0005634; GO:0007367; GO:0045944; GO:0048793";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; segment polarity determination [GO:0007367]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp1015043_c0_seq1;GAXK01151251.1;Q5R668;9.00E-14;ACSL3_PONAB;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391";long-chain fatty acid metabolic process [GO:0001676];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp101523_c0_seq1;GAXK01141973.1;Q7ZU13;3.22E-10;SPNS1_DANRE;Protein spinster homolog 1 (Protein not really started) (Spinster-like protein);"integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]";"GO:0005743; GO:0005887; GO:0006869; GO:0006914; GO:0055085; GO:0090398; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]";"integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]";
comp101526_c0_seq1;GAXK01142199.1;Q96S38;8.38E-36;KS6C1_HUMAN;Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein);"early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091";signal transduction [GO:0007165];"early endosome [GO:0005769]; membrane [GO:0016020]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp101533_c0_seq1;GAXK01142145.1;Q24547;1.33E-131;STX1A_DROME;Syntaxin-1A (dSynt1);"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030054; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787";"cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp101552_c1_seq1;GAXK01142073.1;Q8N6F8;1.66E-11;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp101563_c4_seq1;GAXK01142105.1;A2ANX9;1.53E-21;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp10157_c0_seq1;GAXK01188312.1;Q9U5N1;0;VATC_MANSE;V-type proton ATPase subunit C (V-ATPase subunit C) (Vacuolar proton pump subunit C);"proton-transporting V-type ATPase, V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]";"GO:0015078; GO:0033180";;proton-transporting V-type ATPase, V1 domain [GO:0033180];proton transmembrane transporter activity [GO:0015078]
comp101591_c0_seq1;GAXK01142363.1;Q9VCA2;1.40E-58;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1016_c0_seq1;GAXK01166088.1;P18238;4.23E-71;ADT3_YEAST;ADP,ATP carrier protein 3 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]; anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]";"GO:0005471; GO:0005739; GO:0005743; GO:0009061; GO:0015886; GO:0016021; GO:0042802; GO:0055085";"anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]"
comp1016070_c0_seq1;GAXK01172817.1;O43916;2.71E-19;CHST1_HUMAN;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp1016151_c0_seq1;GAXK01172777.1;Q8IN81;4.31E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1016260_c0_seq1;GAXK01172813.1;Q6XZB0;2.59E-21;LIPI_HUMAN;Lipase member I (LIPI) (EC 3.1.1.-) (Cancer/testis antigen 17) (CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta) (mPA-PLA1 beta);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"GO:0004620; GO:0005615; GO:0005886; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0052689";"lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]"
comp10164_c7_seq1;GAXK01188322.1;Q9D4D4;0;TKTL2_MOUSE;Transketolase-like protein 2 (EC 2.2.1.1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802]";"GO:0004802; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; transketolase activity [GO:0004802]"
comp101652_c5_seq1;GAXK01142564.1;Q767L8;3.26E-34;MDC1_PIG;Mediator of DNA damage checkpoint protein 1;"chromosome [GO:0005694]; nucleus [GO:0005634]; cell cycle [GO:0007049]; DNA repair [GO:0006281]";"GO:0005634; GO:0005694; GO:0006281; GO:0007049";"cell cycle [GO:0007049]; DNA repair [GO:0006281]";"chromosome [GO:0005694]; nucleus [GO:0005634]";
comp1016609_c0_seq1;GAXK01172788.1;A1ZA47;8.16E-10;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp1016785_c0_seq1;GAXK01172809.1;A0A1B8YAB1;8.52E-13;KBTB8_XENTR;Kelch repeat and BTB domain-containing protein 8;"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"GO:0005794; GO:0005819; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463";"neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]";
comp101684_c2_seq1;GAXK01142368.1;Q63060;1.56E-149;GLPK_RAT;Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP-stimulated glucocorticoid-receptor translocation promoter) (ASTP) (ATP:glycerol 3-phosphotransferase);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]";"GO:0004370; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0009409; GO:0010033; GO:0016310; GO:0019563; GO:0042393; GO:0042493; GO:0045471; GO:0046167";"glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]"
comp1016842_c0_seq1;GAXK01172792.1;P25439;1.20E-21;BRM_DROME;ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma);"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648";"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp1016861_c0_seq1;GAXK01172760.1;A0JJX5;1.81E-10;SYT4_ARATH;Synaptotagmin-4 (NTMC2T2.2) (Synaptotagmin D);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; lipid transport [GO:0006869]";"GO:0005783; GO:0006869; GO:0008289; GO:0016021; GO:0046872";lipid transport [GO:0006869];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"lipid binding [GO:0008289]; metal ion binding [GO:0046872]"
comp101697_c0_seq1;GAXK01142270.1;Q5BKS4;1.76E-74;ERI2_MOUSE;ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1);"3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]";"GO:0000175; GO:0003676; GO:0008270; GO:0008310";;;"3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"
comp1017055_c0_seq1;GAXK01172789.1;Q9H0I2;1.73E-11;ENKD1_HUMAN;Enkurin domain-containing protein 1;"cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]";"GO:0005881; GO:0015630";;"cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]";
comp1017152_c0_seq1;GAXK01172790.1;Q3ULA2;3.77E-15;FBW1A_MOUSE;F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0071407";"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]"
comp1017279_c0_seq1;GAXK01172768.1;P07463;3.01E-12;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1017282_c0_seq1;GAXK01172762.1;Q8NF91;1.81E-07;SYNE1_HUMAN;Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292";"cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp1017377_c0_seq1;GAXK01172784.1;Q9BQK8;1.24E-28;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp1017414_c0_seq1;GAXK01172810.1;Q80V23;3.56E-15;ZNF32_MOUSE;Zinc finger protein 32 (Zinc finger protein 637);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp101746_c0_seq1;GAXK01142285.1;B2D0J5;2.29E-69;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp1017469_c0_seq1;GAXK01172763.1;Q6H1V1;2.10E-27;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp101750_c1_seq1;GAXK01142436.1;Q7PD79;1.12E-162;GNAS_ANOGA;Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein);"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of smell [GO:0007608]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007188; GO:0007191; GO:0007608; GO:0031683; GO:0046872";"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of smell [GO:0007608]";heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp10175004_c0_seq1;GAXK01061998.1;P26208;8.20E-25;BGLA_CLOTH;Beta-glucosidase A (EC 3.2.1.21) (Beta-D-glucoside glucohydrolase) (Cellobiase) (Gentiobiase);"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]; cellulose catabolic process [GO:0030245]";"GO:0008422; GO:0030245; GO:0102483";cellulose catabolic process [GO:0030245];;"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]"
comp1017582_c0_seq1;GAXK01172806.1;Q8IN81;9.99E-13;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp101764_c0_seq1;GAXK01142149.1;O18973;5.27E-101;RABX5_BOVIN;Rab5 GDP/GTP exchange factor (Rabex-5);"early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]";"GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037";"endocytosis [GO:0006897]; protein transport [GO:0015031]";"early endosome [GO:0005769]; recycling endosome [GO:0055037]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp101769_c12_seq1;GAXK01142170.1;G3XA57;2.02E-25;RFIP2_MOUSE;Rab11 family-interacting protein 2 (Rab11-FIP2);"endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"GO:0001891; GO:0005654; GO:0005768; GO:0006909; GO:0017137; GO:0019901; GO:0030010; GO:0035669; GO:0035773; GO:0042802; GO:0042803; GO:0043231; GO:0043547; GO:0045055; GO:0055038; GO:1903078";"establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]"
comp1017786_c0_seq1;GAXK01172781.1;Q2HZX7;2.23E-83;FUZZY_XENTR;Protein fuzzy homolog (Xfy);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]";"GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0042995; GO:0048704; GO:0060271";"cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp10178104_c0_seq1;GAXK01024789.1;Q5B6J8;1.52E-33;EFGM_EMENI;Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1);"mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]";"GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125";mitochondrial translational elongation [GO:0070125];mitochondrion [GO:0005739];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp10180247_c0_seq1;GAXK01012841.1;Q10I26;1.31E-72;IF43B_ORYSJ;Eukaryotic initiation factor 4A-III homolog B (OseIF4AIIIb) (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (DEAD-box ATP-dependent RNA helicase 34) (OsRH34);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]";"GO:0000184; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0051028; GO:0071013";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1018125_c0_seq1;GAXK01061806.1;Q8Q0U0;7.03E-23;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp101823_c1_seq1;GAXK01142016.1;Q8TF32;8.50E-19;ZN431_HUMAN;Zinc finger protein 431;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0043433; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1018255_c1_seq1;GAXK01061891.1;Q9VZW5;3.74E-18;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1018272_c2_seq1;GAXK01061855.1;Q9ESR9;1.35E-83;ABCA2_RAT;ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2);"cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol homeostasis [GO:0042632]; lipid transport [GO:0006869]; positive regulation of amyloid-beta formation [GO:1902004]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of transcription by RNA polymerase II [GO:0006357]; response to steroid hormone [GO:0048545]; transmembrane transport [GO:0055085]";"GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0006357; GO:0006869; GO:0010008; GO:0016021; GO:0016887; GO:0031410; GO:0032383; GO:0042626; GO:0042632; GO:0043231; GO:0048545; GO:0055085; GO:1902004";"cholesterol homeostasis [GO:0042632]; lipid transport [GO:0006869]; positive regulation of amyloid-beta formation [GO:1902004]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of transcription by RNA polymerase II [GO:0006357]; response to steroid hormone [GO:0048545]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp10183_c0_seq1;GAXK01187426.1;Q9V439;3.08E-47;MED22_DROME;Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (dMED24);"chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]";"GO:0000278; GO:0000785; GO:0003712; GO:0005634; GO:0005730; GO:0006357; GO:0007406; GO:0016592; GO:1902064";"mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]";"chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]";transcription coregulator activity [GO:0003712]
comp1018555_c0_seq1;GAXK01061779.1;O14463;7.21E-30;TRX1_SCHPO;Thioredoxin-1 (TR-1) (Trx-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]";"GO:0005634; GO:0005737; GO:0005829; GO:0006662; GO:0015035; GO:0016209; GO:0019379; GO:0034614; GO:0042744; GO:0045454; GO:0061692; GO:1900409; GO:1990355";"cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]"
comp10187_c0_seq1;GAXK01187363.1;W0LYS5;0;CAMKI_MACNP;Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI);"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]";"GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404";"molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]";;"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp101879_c0_seq1;GAXK01141977.1;Q91755;1.63E-28;GRIK2_XENLA;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]";"GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]"
comp1018799_c0_seq1;GAXK01061799.1;O45539;2.91E-57;SRC2_CAEEL;Tyrosine protein-kinase src-2 (EC 2.7.10.2) (SRC oncogene related protein 2);"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; peptidyl-tyrosine autophosphorylation [GO:0038083]; pharynx development [GO:0060465]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004715; GO:0005102; GO:0005524; GO:0007169; GO:0030154; GO:0031234; GO:0038083; GO:0046872; GO:0060465";"cell differentiation [GO:0030154]; peptidyl-tyrosine autophosphorylation [GO:0038083]; pharynx development [GO:0060465]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";extrinsic component of cytoplasmic side of plasma membrane [GO:0031234];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]"
comp1019136_c0_seq1;GAXK01061889.1;Q6P1G2;1.33E-08;KDM2B_MOUSE;Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; zinc ion binding [GO:0008270]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]";"GO:0000122; GO:0000978; GO:0005634; GO:0005694; GO:0005730; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0031519; GO:0032452; GO:0035518; GO:0043524; GO:0048596; GO:0051864; GO:0070544; GO:1902459; GO:2000178";"embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; zinc ion binding [GO:0008270]"
comp1019299_c0_seq1;GAXK01061778.1;Q6GLD8;1.54E-49;CDK9_XENTR;Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle tissue regeneration [GO:0061026]; inflammatory response to wounding [GO:0090594]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0006368; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0030332; GO:0032968; GO:0044212; GO:0045944; GO:0060043; GO:0061026; GO:0070816; GO:0090594";"cardiac muscle tissue regeneration [GO:0061026]; inflammatory response to wounding [GO:0090594]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp101933_c0_seq1;GAXK01142559.1;P42577;8.61E-61;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp1019448_c1_seq1;GAXK01061789.1;Q3U2P1;1.56E-09;SC24A_MOUSE;Protein transport protein Sec24A (SEC24-related protein A);"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]";"GO:0000139; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0030127; GO:0042632; GO:0045714; GO:0050714; GO:0090110";"cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]";"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";zinc ion binding [GO:0008270]
comp1019538_c0_seq1;GAXK01061815.1;Q9VZN4;2.52E-18;DAR1_DROME;Dendritic arbor reduction protein 1;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007026; GO:0043565; GO:0045944; GO:0046872; GO:0050775; GO:1903861";"negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp101969_c0_seq1;GAXK01142143.1;Q16831;2.35E-104;UPP1_HUMAN;Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]";"GO:0004850; GO:0005634; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0009166; GO:0042149; GO:0043097; GO:0044206; GO:0046135";"cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";uridine phosphorylase activity [GO:0004850]
comp1019819_c0_seq1;GAXK01061899.1;Q9VFP2;4.18E-09;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp1019920_c0_seq1;GAXK01061909.1;Q8WTS6;5.37E-08;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp102_c0_seq1;GAXK01168677.1;O01727;1.84E-109;RS6_BRAFL;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp102020_c0_seq1;GAXK01138507.1;P13350;2.06E-42;CCNB1_XENLA;G2/mitotic-specific cyclin-B1;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; patched binding [GO:0005113]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005113; GO:0005634; GO:0005815; GO:0005829; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";patched binding [GO:0005113]
comp1020248_c0_seq1;GAXK01142652.1;A2APF3;5.53E-18;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp10202716_c0_seq1;GAXK01180298.1;Q7T3A4;4.98E-25;RAB13_DANRE;Ras-related protein Rab-13;"bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; trans-Golgi network to recycling endosome transport [GO:0044795]";"GO:0001525; GO:0003924; GO:0005525; GO:0005802; GO:0005886; GO:0005923; GO:0006886; GO:0010737; GO:0016328; GO:0030027; GO:0030139; GO:0030659; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032482; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0044795; GO:0055037; GO:0055038; GO:0070830; GO:0072659; GO:1902463";"angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; trans-Golgi network to recycling endosome transport [GO:0044795]";"bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1020310_c0_seq1;GAXK01142649.1;P36975;1.94E-47;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp102037_c2_seq1;GAXK01138180.1;P60322;2.15E-16;NANO2_MOUSE;Nanos homolog 2 (NOS-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007275; GO:0007283; GO:0008270; GO:0017148; GO:0030154; GO:0030718; GO:0045835; GO:0048471; GO:1900153";"cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]"
comp102059_c0_seq1;GAXK01138555.1;O17583;7.79E-176;LIN10_CAEEL;Protein lin-10 (Abnormal cell lineage protein 10);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]";"GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030054; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852";"chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]";Rab GTPase binding [GO:0017137]
comp1020648_c0_seq1;GAXK01142633.1;O94967;1.22E-97;WDR47_HUMAN;WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]";"GO:0005737; GO:0005874; GO:0007275";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";
comp102076_c0_seq1;GAXK01138446.1;Q6DFC0;3.00E-111;S41A2_XENLA;Solute carrier family 41 member 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]";"GO:0005886; GO:0008324; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp10208_c0_seq1;GAXK01187993.1;Q1RMJ7;3.15E-48;TSAP1_BOVIN;tRNA selenocysteine 1-associated protein 1 (tRNA selenocysteine-associated protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; selenocysteine incorporation [GO:0001514]";"GO:0001514; GO:0003723; GO:0005634; GO:0005737";selenocysteine incorporation [GO:0001514];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp102089_c0_seq1;GAXK01138252.1;Q8UWA5;2.82E-34;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp10210_c0_seq1;GAXK01187356.1;Q9VXN2;1.23E-13;SUN_DROME;Protein stunted;"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"GO:0000275; GO:0001664; GO:0005615; GO:0005743; GO:0006979; GO:0008340; GO:0015986; GO:0045745; GO:0046933; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]";"G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp102104_c1_seq1;GAXK01138265.1;Q13685;2.14E-28;AAMP_HUMAN;Angio-associated migratory cell protein;"cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]";"GO:0001525; GO:0005829; GO:0005886; GO:0008201; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0042273; GO:0045171; GO:0051082";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]";"cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; unfolded protein binding [GO:0051082]"
comp1021138_c0_seq1;GAXK01142661.1;Q9R0Q9;6.63E-25;MPU1_MOUSE;Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15);"integral component of membrane [GO:0016021]; oligosaccharide biosynthetic process [GO:0009312]";"GO:0009312; GO:0016021";oligosaccharide biosynthetic process [GO:0009312];integral component of membrane [GO:0016021];
comp1021169_c0_seq1;GAXK01142623.1;Q5R8C2;5.04E-35;LYPL1_PONAB;Lysophospholipase-like protein 1 (EC 3.1.2.-);"cytoplasm [GO:0005737]; hydrolase activity [GO:0016787]";"GO:0005737; GO:0016787";;cytoplasm [GO:0005737];hydrolase activity [GO:0016787]
comp102134_c1_seq1;GAXK01138350.1;O43913;1.18E-96;ORC5_HUMAN;Origin recognition complex subunit 5;"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]";"GO:0000082; GO:0000166; GO:0000784; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275";"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]";"ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]"
comp1021530_c1_seq1;GAXK01142631.1;Q866F1;7.95E-15;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp1021680_c0_seq1;GAXK01142621.1;Q9NQ48;1.70E-69;LZTL1_HUMAN;Leucine zipper transcription factor-like protein 1;"cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]";"GO:0005829; GO:0042802; GO:0044877; GO:1903565; GO:1903568";"negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp1021725_c0_seq1;GAXK01142622.1;Q9BXF9;3.76E-67;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp1021969_c0_seq1;GAXK01142664.1;E1BNQ4;1.27E-98;NNRD_BOVIN;ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase);"mitochondrion [GO:0005739]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; nicotinamide nucleotide metabolic process [GO:0046496]";"GO:0005524; GO:0005739; GO:0046496; GO:0047453; GO:0052855";nicotinamide nucleotide metabolic process [GO:0046496];mitochondrion [GO:0005739];"ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]"
comp1022018_c1_seq1;GAXK01184748.1;Q9XSK2;1.22E-11;CD63_BOVIN;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005765; GO:0005887; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]";
comp102208_c0_seq1;GAXK01138585.1;Q9CYF5;1.30E-57;RCC1L_MOUSE;RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein homolog);"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]";"GO:0005085; GO:0005087; GO:0005739; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613";"mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]";"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]"
comp102232_c2_seq1;GAXK01138566.1;Q7KRI2;5.76E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp102242_c1_seq1;GAXK01138400.1;P0DPW5;1.62E-07;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp102273_c0_seq1;GAXK01138445.1;Q3T126;2.70E-34;CNIH4_BOVIN;Protein cornichon homolog 4 (CNIH-4) (Cornichon family AMPA receptor auxiliary protein 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; CCR5 chemokine receptor binding [GO:0031730]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]";"GO:0005783; GO:0005793; GO:0006888; GO:0015031; GO:0016021; GO:0031730";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]";CCR5 chemokine receptor binding [GO:0031730]
comp102291_c0_seq1;GAXK01138553.1;Q9VCX1;1.95E-74;RGS_DROME;Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco);"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0014045; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857";"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]"
comp102309_c0_seq1;GAXK01138504.1;Q0EEE2;1.92E-138;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp102340_c1_seq1;GAXK01138340.1;Q4G050;3.21E-18;MKNK1_RAT;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translational initiation [GO:0006446]";"GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translational initiation [GO:0006446]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp102350_c0_seq1;GAXK01138405.1;P0CY46;0;EGFR_APIME;Epidermal growth factor receptor (Egfr) (EC 2.7.10.1);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021";"multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp102356_c1_seq1;GAXK01138290.1;P86854;3.49E-12;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1023598_c0_seq1;GAXK01184797.1;Q9W5U2;6.40E-67;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp10238_c0_seq1;GAXK01188042.1;P18915;3.08E-26;CAH6_BOVIN;Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase);"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]";"GO:0004089; GO:0005576; GO:0006730; GO:0008270";one-carbon metabolic process [GO:0006730];extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp10239_c0_seq1;GAXK01188424.1;A0LMC1;6.46E-72;PHNX_SYNFM;Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase);"magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]";"GO:0000287; GO:0019700; GO:0050194";organic phosphonate catabolic process [GO:0019700];;"magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]"
comp102396_c0_seq1;GAXK01138594.1;Q9VCR7;1.18E-114;CTNS_DROME;Cystinosin homolog;"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]; amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]";"GO:0003333; GO:0005765; GO:0005774; GO:0015171; GO:0015184; GO:0015811; GO:0016021";"amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]";"amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]"
comp1024136_c1_seq1;GAXK01150923.1;Q9VWF4;8.88E-13;DUSK4_DROME;Dual specificity protein phosphatase MPK-4 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0043508";"dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp102426_c3_seq1;GAXK01138373.1;Q8BGN2;1.04E-51;CD033_MOUSE;UPF0462 protein C4orf33 homolog;;;;;
comp102428_c0_seq1;GAXK01138330.1;Q9H4G4;9.90E-11;GAPR1_HUMAN;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374";"positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";protein homodimerization activity [GO:0042803]
comp1024296_c0_seq1;GAXK01150962.1;Q98993;1.12E-15;VTXB_SYNVE;Verrucotoxin subunit beta (VTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp10245_c0_seq1;GAXK01187686.1;Q8BTV1;2.60E-124;TUSC3_MOUSE;Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; magnesium ion transmembrane transporter activity [GO:0015095]; oligosaccharyltransferase complex binding [GO:0062062]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062";"cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]";"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]";"magnesium ion transmembrane transporter activity [GO:0015095]; oligosaccharyltransferase complex binding [GO:0062062]"
comp1024555_c0_seq1;GAXK01150932.1;Q8WV37;4.03E-28;ZN480_HUMAN;Zinc finger protein 480;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1024874_c0_seq1;GAXK01150946.1;Q09788;9.46E-11;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp10252_c11_seq1;GAXK01188428.1;Q9XTL9;0;PYG_DROME;Glycogen phosphorylase (EC 2.4.1.1);"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]";"GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499";"defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]";"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]";"glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]"
comp102541_c1_seq1;GAXK01138359.1;P91252;1.25E-18;GST6_CAEEL;Probable glutathione S-transferase 6 (EC 2.5.1.18) (GST class-sigma);"glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]";"GO:0004364; GO:0006749; GO:0045087";"glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]";;glutathione transferase activity [GO:0004364]
comp102554_c0_seq1;GAXK01138277.1;B4GAN3;3.38E-29;QVR_DROPE;Protein quiver (Protein sleepless);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"GO:0005886; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0048511; GO:1903818";"positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";GPI anchor binding [GO:0034235]
comp102559_c2_seq1;GAXK01138535.1;Q9VZX1;1.80E-12;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp1025865_c0_seq1;GAXK01150934.1;Q9VDZ3;2.02E-09;SQZ_DROME;Zinc finger protein squeeze;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; dendrite guidance [GO:0070983]; neuroblast development [GO:0014019]; neuron development [GO:0048666]";"GO:0003676; GO:0005634; GO:0014019; GO:0046872; GO:0048666; GO:0070983";"dendrite guidance [GO:0070983]; neuroblast development [GO:0014019]; neuron development [GO:0048666]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1025909_c0_seq1;GAXK01150926.1;A7Y2W8;1.05E-38;SC6A9_XENLA;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005283; GO:0005328; GO:0005887";;integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp102595_c0_seq1;GAXK01138303.1;O73787;0;GCP3_XENLA;Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule nucleation [GO:0007020]";"GO:0000922; GO:0005737; GO:0005815; GO:0005874; GO:0007020; GO:0043015";microtubule nucleation [GO:0007020];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";gamma-tubulin binding [GO:0043015]
comp10260_c0_seq1;GAXK01188471.1;Q02241;1.59E-16;KIF23_HUMAN;Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1);"centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149";"actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp1026048_c0_seq1;GAXK01148238.1;Q78PY7;5.23E-09;SND1_MOUSE;Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]";"GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172";"gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]"
comp1026170_c0_seq1;GAXK01148204.1;Q7KRI2;7.99E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp102624_c1_seq1;GAXK01138301.1;Q9HCD5;2.54E-22;NCOA5_HUMAN;Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA);"actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]";"GO:0003682; GO:0003723; GO:0005615; GO:0005634; GO:0015629; GO:0042593; GO:0046627";"glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]";"actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; RNA binding [GO:0003723]"
comp1026421_c0_seq1;GAXK01148244.1;P58215;1.68E-102;LOXL3_HUMAN;Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046";"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp102651_c0_seq1;GAXK01138393.1;Q05319;2.07E-60;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1026587_c0_seq1;GAXK01148205.1;Q8TC21;8.23E-08;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1026677_c0_seq1;GAXK01148222.1;P51590;7.05E-78;CP2J3_RAT;Cytochrome P450 2J3 (EC 1.14.14.1) (CYPIIJ3);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp102670_c1_seq1;GAXK01138286.1;Q95N00;1.70E-26;IOD1_SUNMU;Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]";"GO:0004800; GO:0005789; GO:0016021; GO:0042446";hormone biosynthetic process [GO:0042446];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";thyroxine 5'-deiodinase activity [GO:0004800]
comp1026769_c0_seq1;GAXK01148214.1;Q6RUV5;1.48E-86;RAC1_RAT;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1);"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0006935; GO:0007015; GO:0007266; GO:0008045; GO:0008283; GO:0008361; GO:0010592; GO:0016020; GO:0016477; GO:0016601; GO:0017137; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030334; GO:0031116; GO:0031410; GO:0031996; GO:0032587; GO:0032707; GO:0034446; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048012; GO:0048870; GO:0051022; GO:0051117; GO:0051496; GO:0051668; GO:0051894; GO:0055038; GO:0060263; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098978; GO:1900026; GO:1902622";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"ATPase binding [GO:0051117]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]"
comp1026781_c0_seq1;GAXK01148220.1;Q9V427;6.74E-31;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp102697_c2_seq1;GAXK01138321.1;Q93075;1.38E-45;TATD2_HUMAN;Putative deoxyribonuclease TATDN2 (EC 3.1.21.-);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]";"GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0016888; GO:0036498; GO:0046872";IRE1-mediated unfolded protein response [GO:0036498];"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
comp102705_c1_seq1;GAXK01138584.1;Q9VLS9;1.73E-101;LACB2_DROME;Beta-lactamase-like protein 2 homolog (EC 3.-.-.-);"mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; single-stranded RNA binding [GO:0003727]";"GO:0003727; GO:0004521; GO:0005759; GO:0046872";;mitochondrial matrix [GO:0005759];"endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; single-stranded RNA binding [GO:0003727]"
comp1027058_c0_seq1;GAXK01148253.1;Q9GP71;3.00E-08;YELL_DROMD;Protein yellow;"extracellular region [GO:0005576]; male mating behavior [GO:0060179]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]";"GO:0005576; GO:0007275; GO:0042438; GO:0060179";"male mating behavior [GO:0060179]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]";extracellular region [GO:0005576];
comp102710_c0_seq1;GAXK01138441.1;Q9VQX4;0;PNCB_DROME;Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]";"GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872";"NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];"metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]"
comp102713_c1_seq1;GAXK01138437.1;F1R983;1.24E-08;CTIP_DANRE;DNA endonuclease RBBP8 (EC 3.1.-.-);"nucleus [GO:0005634]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; Y-form DNA binding [GO:0000403]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]";"GO:0000014; GO:0000403; GO:0000406; GO:0000724; GO:0003684; GO:0003690; GO:0003697; GO:0005634; GO:0006289; GO:0010792; GO:0035861; GO:0051301; GO:0051321; GO:0070336";"cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]";"nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; Y-form DNA binding [GO:0000403]"
comp102727_c2_seq1;GAXK01138170.1;Q9N003;1.12E-14;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1027305_c0_seq1;GAXK01148246.1;Q0V8T4;7.80E-10;CTP5C_RAT;Contactin-associated protein like 5-3 (Cell recognition molecule Caspr5-3) (Cell recognition molecule Caspr5c) (Contactin-associated protein-like 5c);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0007155; GO:0016021";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp1027427_c0_seq1;GAXK01148233.1;Q5F3B1;1.76E-19;MTG16_CHICK;Protein CBFA2T3;"Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0030154; GO:0045892; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]";"Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp102745_c0_seq1;GAXK01138098.1;Q9NZB8;0;MOCS1_HUMAN;"Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]";"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]";"GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799";"molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]";"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp102762_c0_seq1;GAXK01138599.1;O44314;1.73E-10;ALLP_HELAM;"Helicostatins [Cleaved into: Helicostatin-1 (Helicostatin I); Helicostatin-2a (Helicostatin IIa); Helicostatin-2b (Helicostatin IIb); Helicostatin-3 (Helicostatin III); Helicostatin-4 (Helicostatin IV); Helicostatin-5 (Helicostatin V); Helicostatin-6 (Helicostatin VI); Helicostatin-7 (Helicostatin VII); Helicostatin-8 (Helicostatin VIII); Helicostatin-9 (Helicostatin IX)]";"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp102766_c0_seq1;GAXK01138601.1;Q8N2E2;1.66E-39;VWDE_HUMAN;von Willebrand factor D and EGF domain-containing protein;"cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]";"GO:0005102; GO:0005576; GO:0009986; GO:0048856";anatomical structure development [GO:0048856];"cell surface [GO:0009986]; extracellular region [GO:0005576]";signaling receptor binding [GO:0005102]
comp102782_c1_seq1;GAXK01138575.1;Q9P2Q2;8.90E-102;FRM4A_HUMAN;FERM domain-containing protein 4A;"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding, bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]";"GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162";"establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]";"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";protein binding, bridging [GO:0030674]
comp102802_c0_seq1;GAXK01138515.1;Q7KRI2;1.24E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp102808_c0_seq1;GAXK01138395.1;O15066;2.17E-150;KIF3B_HUMAN;Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed];"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115";"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"
comp1028276_c0_seq1;GAXK01127452.1;P21251;3.30E-59;CALM_STIJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1028467_c0_seq1;GAXK01127470.1;A0A0B4J2D5;3.91E-63;GAL3B_HUMAN;Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (Keio novel protein-I) (KNP-I) (Protein GT335) (Protein HES1);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp10286056_c0_seq1;GAXK01165129.1;Q80SU7;2.09E-19;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp10286979_c0_seq1;GAXK01165127.1;P57093;1.74E-31;PAHX_RAT;Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]";"GO:0001561; GO:0005739; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031418; GO:0048244; GO:0097089";"2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]"
comp1028710_c0_seq1;GAXK01127446.1;O55131;1.59E-98;SEPT7_MOUSE;Septin-7 (CDC10 protein homolog);"axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000281; GO:0000777; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030336; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043065; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046982; GO:0048668; GO:0051291; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0097730; GO:0098978; GO:0099173; GO:1902857; GO:2000134";"cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]"
comp1028802_c0_seq1;GAXK01127466.1;Q91VH2;3.36E-11;SNX9_MOUSE;Sorting nexin-9;"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032461; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045860; GO:0051044; GO:0060988; GO:0071933; GO:0097320";"cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]";"1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp102893_c0_seq1;GAXK01138329.1;Q15771;7.11E-85;RAB30_HUMAN;Ras-related protein Rab-30;"cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005795; GO:0005801; GO:0005802; GO:0006886; GO:0006888; GO:0007030; GO:0031985; GO:0032482; GO:0043231";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1028949_c0_seq1;GAXK01127460.1;Q68DY1;1.55E-53;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1029_c3_seq1;GAXK01169107.1;P0DPW5;3.71E-11;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1029060_c0_seq1;GAXK01127479.1;Q9V427;3.54E-87;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp10292_c2_seq1;GAXK01188243.1;Q9NUQ3;1.06E-14;TXLNG_HUMAN;Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription) (FIAT) (Lipopolysaccharide-specific response protein 5);"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; protein heterodimerization activity [GO:0046982]; syntaxin binding [GO:0019905]; cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]";"GO:0005829; GO:0007049; GO:0010564; GO:0019905; GO:0030500; GO:0031965; GO:0046982; GO:0051726";"cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]";"protein heterodimerization activity [GO:0046982]; syntaxin binding [GO:0019905]"
comp1029392_c0_seq1;GAXK01127447.1;Q6AXM1;1.10E-11;CHSTA_DANRE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp10295_c0_seq1;GAXK01188259.1;Q9WTX6;0;CUL1_MOUSE;Cullin-1 (CUL-1);"cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0005654; GO:0006511; GO:0006513; GO:0006915; GO:0008283; GO:0009887; GO:0016032; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0043161; GO:1990452";"animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]";ubiquitin protein ligase binding [GO:0031625]
comp1029510_c0_seq1;GAXK01127474.1;Q95KD9;3.34E-27;DIRA2_MACFA;GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1029793_c0_seq1;GAXK01127472.1;Q27433;1.56E-96;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp103_c0_seq1;GAXK01169006.1;Q8ISP0;8.64E-77;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp103003_c0_seq1;GAXK01138558.1;P02567;1.77E-17;MYO1_CAEEL;Myosin-1 (Myosin heavy chain D) (MHC D);"striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";"GO:0003774; GO:0005524; GO:0005863; GO:0006936; GO:0008307; GO:0043050; GO:0051015";"muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";striated muscle myosin thick filament [GO:0005863];"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]"
comp1030367_c0_seq1;GAXK01053000.1;Q9NQ36;3.29E-20;SCUB2_HUMAN;Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; multicellular organism development [GO:0007275]";"GO:0005509; GO:0005576; GO:0005615; GO:0007275; GO:0008289; GO:0009986";multicellular organism development [GO:0007275];"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; lipid binding [GO:0008289]"
comp10304056_c0_seq1;GAXK01158930.1;P14381;5.43E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp10305_c0_seq1;GAXK01188248.1;Q5SUE8;6.76E-29;ANR40_MOUSE;Ankyrin repeat domain-containing protein 40;;;;;
comp1030555_c0_seq1;GAXK01052981.1;Q8IUK5;6.02E-45;PLDX1_HUMAN;Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"GO:0001525; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005923; GO:0016021; GO:0021510; GO:0030425; GO:0043025; GO:0043235";"angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";
comp103065_c0_seq1;GAXK01138255.1;Q9BYW2;8.98E-94;SETD2_HUMAN;Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634";"angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"alpha-tubulin binding [GO:0043014]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1030756_c0_seq1;GAXK01052984.1;Q8N0V5;3.28E-37;GNT2A_HUMAN;N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000139; GO:0005794; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0016021; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374";"glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]
comp1030808_c0_seq1;GAXK01052959.1;Q27965;3.54E-150;HS71B_BOVIN;Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70.2);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006986; GO:0016887; GO:0031072; GO:0031625; GO:0032436; GO:0032991; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090063; GO:1901673";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp10309_c0_seq1;GAXK01188256.1;Q9BUL8;1.17E-54;PDC10_HUMAN;Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]";"GO:0000139; GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0033138; GO:0036481; GO:0042542; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0047485; GO:0050821; GO:0051683; GO:0070062; GO:0071902; GO:0090051; GO:0090168; GO:0090316; GO:1903588; GO:1990830";"angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]"
comp103104_c1_seq1;GAXK01138593.1;Q91ZH7;1.18E-91;ABHD3_MOUSE;Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3);"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568";"cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";integral component of membrane [GO:0016021];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"
comp103114_c1_seq1;GAXK01138522.1;Q8VHK7;8.35E-22;HDGF_RAT;Hepatoma-derived growth factor (HDGF);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"GO:0000122; GO:0000166; GO:0000978; GO:0001227; GO:0005615; GO:0005634; GO:0005737; GO:0008083; GO:0008201; GO:0034504; GO:0045944; GO:0051781";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1031275_c1_seq1;GAXK01052996.1;P16157;1.19E-19;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp1031367_c1_seq1;GAXK01052944.1;Q9UK10;2.48E-30;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp103160_c0_seq1;GAXK01138258.1;Q8IRW8;0;TRR_DROME;Histone-lysine N-methyltransferase trr (EC 2.1.1.43) (Lysine N-methyltransferase 2C) (Trithorax-related protein);"MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]";"GO:0003713; GO:0005102; GO:0005634; GO:0005700; GO:0005703; GO:0007458; GO:0016571; GO:0035075; GO:0042393; GO:0042800; GO:0044666; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0051568; GO:1900114";"compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]";"MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]";"histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]"
comp1031626_c0_seq1;GAXK01052983.1;P67773;6.59E-13;Y3657_MYCBO;Uncharacterized protein Mb3657;;;;;
comp1031756_c0_seq1;GAXK01053011.1;Q24174;2.19E-08;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1031761_c0_seq1;GAXK01053015.1;Q3LU40;1.42E-23;PROP1_SAPAP;Homeobox protein prophet of Pit-1 (PROP-1) (Pituitary-specific homeodomain factor);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; pituitary gland development [GO:0021983]";"GO:0000981; GO:0005634; GO:0021983; GO:0043565";pituitary gland development [GO:0021983];nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp103179_c0_seq1;GAXK01205808.1;Q9VE01;4.67E-60;C12A5_DROME;Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5);"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016491; GO:0016705; GO:0020037; GO:0031966";;mitochondrial membrane [GO:0031966];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp103186_c0_seq1;GAXK01138275.1;O09174;9.51E-154;AMACR_MOUSE;Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]";"GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008300; GO:0008410; GO:0043231";"bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]";"alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]"
comp1031908_c1_seq1;GAXK01052953.1;Q9FT72;1.20E-17;RQL3_ARATH;ATP-dependent DNA helicase Q-like 3 (EC 3.6.4.12) (RecQ-like protein 3) (AtRecQ3) (AtRecQl3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138; GO:0046872";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]"
comp103205_c0_seq1;GAXK01138246.1;Q6GQD7;2.24E-11;ARI3A_XENLA;AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (Bright homolog) (Dead ringer-like protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0005737; GO:0007275";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp103210_c0_seq1;GAXK01138511.1;P52034;0;PFKA_DROME;ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase);"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";"GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0007520; GO:0007525; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095";"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";6-phosphofructokinase complex [GO:0005945];"6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
comp103225_c0_seq1;GAXK01138545.1;P51984;3.79E-12;CREB_HYDVD;Cyclic AMP-responsive element-binding protein (cAMP-responsive element-binding protein) (cAMP response element-binding protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp1032340_c1_seq1;GAXK01015567.1;Q5BK75;1.83E-12;S46A3_RAT;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1032347_c0_seq1;GAXK01015571.1;P28563;9.85E-09;DUS1_MOUSE;Dual specificity protein phosphatase 1 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 1) (MAP kinase phosphatase 1) (MKP-1) (Protein-tyrosine phosphatase 3CH134) (Protein-tyrosine phosphatase ERP);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; growth factor binding [GO:0019838]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; cellular response to chemokine [GO:1990869]; cellular response to hormone stimulus [GO:0032870]; inactivation of MAPK activity [GO:0000188]; intracellular signal transduction [GO:0035556]; mitotic cell cycle arrest [GO:0071850]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to light stimulus [GO:0009416]; response to retinoic acid [GO:0032526]; response to testosterone [GO:0033574]";"GO:0000188; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0007162; GO:0008138; GO:0008285; GO:0008330; GO:0009416; GO:0017017; GO:0019838; GO:0032355; GO:0032526; GO:0032870; GO:0033574; GO:0035335; GO:0035556; GO:0035970; GO:0042542; GO:0043065; GO:0043066; GO:0043407; GO:0043409; GO:0051019; GO:0051384; GO:0051447; GO:0051591; GO:0051592; GO:0070262; GO:0070373; GO:0071850; GO:0090027; GO:0090266; GO:1903753; GO:1990869; GO:2000279";"cellular response to chemokine [GO:1990869]; cellular response to hormone stimulus [GO:0032870]; inactivation of MAPK activity [GO:0000188]; intracellular signal transduction [GO:0035556]; mitotic cell cycle arrest [GO:0071850]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to light stimulus [GO:0009416]; response to retinoic acid [GO:0032526]; response to testosterone [GO:0033574]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"growth factor binding [GO:0019838]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]"
comp1032437_c0_seq1;GAXK01015580.1;O97366;1.48E-16;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp1032565_c0_seq1;GAXK01015590.1;P18715;1.32E-21;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1032694_c0_seq1;GAXK01015577.1;Q8N7K0;1.58E-14;ZN433_HUMAN;Zinc finger protein 433;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp103281_c0_seq1;GAXK01138562.1;P9WIQ1;7.83E-37;GLF_MYCTU;UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) (UDP-GALP mutase) (Uridine 5-diphosphate galactopyranose mutase);"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]; Actinobacterium-type cell wall biogenesis [GO:0071766]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]";"GO:0005618; GO:0005829; GO:0005886; GO:0008767; GO:0045227; GO:0050660; GO:0071555; GO:0071766";"Actinobacterium-type cell wall biogenesis [GO:0071766]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]";"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]"
comp103282_c0_seq1;GAXK01138443.1;P52713;4.74E-50;MMSA_CAEEL;Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27);"mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";"GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859";"thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";mitochondrion [GO:0005739];"fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
comp1032900_c1_seq1;GAXK01015584.1;Q6ZMW2;3.06E-39;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp103296_c0_seq1;GAXK01138338.1;O46040;7.02E-33;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1032972_c0_seq1;GAXK01015578.1;Q10430;5.69E-13;SPC25_SCHPO;Kinetochore protein spc25;"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]";"GO:0000070; GO:0000777; GO:0000778; GO:0007059; GO:0031262; GO:0031617; GO:0051301; GO:0051455";"attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]";"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]";
comp1033_c0_seq1;GAXK01168560.1;Q9Y244;1.06E-11;POMP_HUMAN;Proteasome maturation protein (Proteassemblin) (Protein UMP1 homolog) (hUMP1) (Voltage-gated K channel beta subunit 4.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; organelle membrane [GO:0031090]; proteasome assembly [GO:0043248]";"GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0016607; GO:0031090; GO:0043248";proteasome assembly [GO:0043248];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; organelle membrane [GO:0031090]";
comp1033000_c0_seq1;GAXK01015595.1;Q9PTG8;1.63E-20;TACC3_XENLA;Transforming acidic coiled-coil-containing protein 3 (Cytoplasmic polyadenylation element-binding protein-associated factor Maskin) (CPEB-associated factor Maskin);"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148]";"GO:0000922; GO:0005737; GO:0007052; GO:0017148; GO:0031369; GO:0032991; GO:0051301";"cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148]";"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]";translation initiation factor binding [GO:0031369]
comp1033029_c0_seq1;GAXK01015561.1;P18744;6.40E-24;ZO20_XENLA;Oocyte zinc finger protein XlCOF20 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp103304_c2_seq1;GAXK01138394.1;Q9W6Z2;7.48E-26;TBPL1_XENLA;TATA box-binding protein-like protein 1 (TBP-like protein 1) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (xlTLF);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription, initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005634; GO:0005737; GO:0006352; GO:0006366; GO:0009792";"DNA-templated transcription, initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp1033065_c0_seq1;GAXK01015582.1;Q03409;5.22E-07;RS25_DICDI;40S ribosomal protein S25 (S31);"cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022627; GO:0031012";;"cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1033308_c0_seq1;GAXK01015596.1;E9Q8T2;9.17E-07;PRD15_MOUSE;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000977; GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0031490; GO:0043409; GO:0043565; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1033358_c0_seq1;GAXK01015583.1;P23416;4.29E-27;GLRA2_HUMAN;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1033395_c0_seq1;GAXK01015581.1;Q99685;6.00E-41;MGLL_HUMAN;Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0019898; GO:0036155; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124";"acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]"
comp103352_c0_seq1;GAXK01138253.1;Q9CUS9;4.95E-140;SPPL3_MOUSE;Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4);"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]";"GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0071458; GO:0071556";"membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]";"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"
comp103359_c3_seq1;GAXK01138099.1;P80646;3.79E-31;CTRB_GADMO;"Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586";digestion [GO:0007586];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp1033677_c0_seq1;GAXK01015562.1;P79779;3.14E-80;TBX6L_CHICK;T-box-containing protein TBX6L (Fragment);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000790; GO:0000977; GO:0001102; GO:0001228; GO:0001708; GO:0003007; GO:0005634; GO:0007389; GO:0045944";"cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp103382_c1_seq1;GAXK01138357.1;Q9V6L0;1.94E-158;KDM4B_DROME;Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp103395_c0_seq1;GAXK01138299.1;P36836;1.33E-121;S15A1_RABIT;Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1);"integral component of membrane [GO:0016021]; oligopeptide transmembrane transporter activity [GO:0035673]; symporter activity [GO:0015293]; protein transport [GO:0015031]";"GO:0015031; GO:0015293; GO:0016021; GO:0035673";protein transport [GO:0015031];integral component of membrane [GO:0016021];"oligopeptide transmembrane transporter activity [GO:0035673]; symporter activity [GO:0015293]"
comp1033972_c0_seq1;GAXK01015570.1;Q6ZVD7;4.91E-22;STOX1_HUMAN;Storkhead-box protein 1 (Winged-helix domain-containing protein);"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]";"GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007049; GO:0008284; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0050679; GO:0051301; GO:0051881; GO:0051897; GO:0061418; GO:0071500; GO:1901858; GO:1902882; GO:1904031; GO:1904120";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]";"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]
comp1034237_c1_seq1;GAXK01192485.1;Q94900;1.07E-149;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1034329_c0_seq1;GAXK01192460.1;Q16TM5;1.08E-35;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1034332_c1_seq1;GAXK01192466.1;O76090;2.00E-29;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp1034790_c0_seq1;GAXK01192515.1;Q9NUN7;8.33E-59;ACER3_HUMAN;Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]";"GO:0005509; GO:0005783; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030148; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121";"ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]"
comp103539_c2_seq1;GAXK01138544.1;Q6IQE9;2.76E-81;ALKB6_DANRE;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005737; GO:0046872; GO:0051213";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp10354_c0_seq1;GAXK01188275.1;Q9Y4Z0;9.11E-51;LSM4_HUMAN;U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein) (GRP);"cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cytoplasmic mRNA processing body assembly [GO:0033962]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0008380; GO:0016020; GO:0017070; GO:0032991; GO:0033962; GO:0042731; GO:0043005; GO:0043928; GO:0046540; GO:0071005; GO:0120115";"cytoplasmic mRNA processing body assembly [GO:0033962]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";"PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]"
comp1035657_c0_seq1;GAXK01192458.1;Q8ITC7;6.44E-84;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp10357_c1_seq1;GAXK01187375.1;A6H8Y1;9.27E-17;BDP1_HUMAN;Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator);"nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]; DNA binding [GO:0003677]; TFIIIC-class transcription factor complex binding [GO:0001156]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"GO:0000126; GO:0001156; GO:0003677; GO:0005654; GO:0070898";RNA polymerase III preinitiation complex assembly [GO:0070898];"nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]";"DNA binding [GO:0003677]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp1035755_c0_seq1;GAXK01192482.1;Q96IR2;2.59E-08;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp103579_c0_seq1;GAXK01138243.1;Q99NF1;9.67E-72;BCDO2_MOUSE;Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2);"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";"GO:0003834; GO:0004744; GO:0005739; GO:0010436; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0055114; GO:0102076; GO:2000377";"carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";mitochondrion [GO:0005739];"beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]"
comp1035875_c1_seq1;GAXK01192497.1;Q8BLJ3;3.14E-20;PLCX3_MOUSE;PI-PLC X domain-containing protein 3;"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202; GO:0098978";"lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]";phosphoric diester hydrolase activity [GO:0008081]
comp1035994_c0_seq1;GAXK01192484.1;Q9D3D0;2.31E-23;TTPAL_MOUSE;Alpha-tocopherol transfer protein-like;;;;;
comp1036059_c0_seq1;GAXK01076048.1;Q9VA73;0;CMC_DROME;Calcium-binding mitochondrial carrier protein Aralar1;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490";"aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]"
comp103609_c1_seq1;GAXK01138183.1;Q4V9P6;1.44E-90;ADAL_DANRE;Adenosine deaminase-like protein (EC 3.5.4.-);"adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]";"GO:0004000; GO:0006154; GO:0009117; GO:0046103; GO:0046872";"adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]";;"adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]"
comp1036257_c1_seq1;GAXK01076059.1;P11118;2.37E-59;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp10363_c4_seq1;GAXK01187478.1;Q5Y5T1;9.47E-69;ZDH20_MOUSE;Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 20) (DHHC-20);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0008270; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0030173; GO:0048471";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]"
comp103639_c1_seq1;GAXK01138560.1;Q7ZVG6;2.80E-07;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1036422_c1_seq1;GAXK01076079.1;B3EWZ6;1.11E-97;MLRP2_ACRMI;MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp103654_c0_seq1;GAXK01138245.1;P81926;4.37E-35;SODC_HALRO;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp1036540_c0_seq1;GAXK01076084.1;Q9Y2F9;8.73E-09;BTBD3_HUMAN;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp103660_c4_seq1;GAXK01138351.1;Q10L91;1.60E-07;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp103661_c1_seq1;GAXK01138397.1;P9WP50;4.75E-64;Y1077_MYCTO;Putative cystathionine beta-synthase MT1108 (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase);"cytoplasm [GO:0005737]; cystathionine beta-synthase activity [GO:0004122]; cysteine biosynthetic process via cystathionine [GO:0019343]";"GO:0004122; GO:0005737; GO:0019343";cysteine biosynthetic process via cystathionine [GO:0019343];cytoplasm [GO:0005737];cystathionine beta-synthase activity [GO:0004122]
comp103671_c0_seq1;GAXK01138328.1;Q24270;1.42E-98;CAC1D_DROME;Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]";"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp103683_c1_seq1;GAXK01138175.1;P48509;3.98E-19;CD151_HUMAN;CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151);"basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; hemidesmosome assembly [GO:0031581]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]";"GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0031581; GO:0042098; GO:0044319; GO:0045807";"cell adhesion [GO:0007155]; cell migration [GO:0016477]; hemidesmosome assembly [GO:0031581]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]";"basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";integrin binding [GO:0005178]
comp103684_c2_seq1;GAXK01138448.1;P08630;0;BTKL_DROME;Tyrosine-protein kinase Btk29A (EC 2.7.10.2) (Dsrc28C) (Dsrc29a);"apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of actin filament polymerization [GO:0030833]; regulation of imaginal disc-derived wing size [GO:0044719]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0007254; GO:0007300; GO:0007301; GO:0007349; GO:0007391; GO:0007424; GO:0007435; GO:0007485; GO:0007619; GO:0008258; GO:0008340; GO:0018108; GO:0030036; GO:0030717; GO:0030723; GO:0030833; GO:0035277; GO:0038083; GO:0042023; GO:0044719; GO:0045172; GO:0045177; GO:0046872; GO:0046960; GO:0048477; GO:0071944";"actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of actin filament polymerization [GO:0030833]; regulation of imaginal disc-derived wing size [GO:0044719]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]";"apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]"
comp1036857_c0_seq1;GAXK01076055.1;Q63515;3.78E-11;C4BPB_RAT;C4b-binding protein beta chain;"extracellular region [GO:0005576]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";"GO:0005576; GO:0006958; GO:0045087";"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp103686_c0_seq1;GAXK01138391.1;Q68CQ4;2.58E-154;DIEXF_HUMAN;Digestive organ expansion factor homolog;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; rRNA processing [GO:0006364]";"GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007275; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";"RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]"
comp10369_c0_seq1;GAXK01188119.1;P35061;9.35E-51;H2A_ACRFO;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp103694_c2_seq1;GAXK01138221.1;Q9Y4E6;0;WDR7_HUMAN;WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG);"synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244]";"GO:0002244; GO:0008021";hematopoietic progenitor cell differentiation [GO:0002244];synaptic vesicle [GO:0008021];
comp1037_c0_seq1;GAXK01169196.1;Q8VEM8;3.23E-94;MPCP_MOUSE;Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877";phosphate ion transmembrane transport [GO:0035435];"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]"
comp103707_c1_seq1;GAXK01138563.1;Q9ZR37;2.00E-12;DUS1_ARATH;Dual specificity protein phosphatase 1 (AtDsPTP1) (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005516; GO:0005634; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp10372_c2_seq1;GAXK01187345.1;Q6DCD7;8.30E-57;ZCHC4_XENLA;rRNA N6-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]";"GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0016746; GO:0031167; GO:0045727";"positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]"
comp1037281_c0_seq1;GAXK01076063.1;P0CH86;2.96E-22;PA1_VESSQ;Phospholipase A1 (EC 3.1.1.32) (allergen Ves s 1);"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0008970; GO:0016042; GO:0044179; GO:0052739; GO:0052740";"hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]"
comp103734_c0_seq1;GAXK01138348.1;Q9D2N9;0;VP33A_MOUSE;Vacuolar protein sorting-associated protein 33A;"autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006904; GO:0008333; GO:0015031; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031410; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0097352";"autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]";protein-containing complex binding [GO:0044877]
comp1037648_c1_seq1;GAXK01076072.1;Q13507;2.17E-13;TRPC3_HUMAN;Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]";"GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0030168; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp103777_c1_seq1;GAXK01138442.1;Q9VS24;2.06E-80;MELT_DROME;Protein melted;"plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]";"GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263";"cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]";plasma membrane [GO:0005886];"phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]"
comp103790_c19_seq1;GAXK01138136.1;G5ECS8;5.12E-53;ADT1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp103798_c0_seq1;GAXK01138598.1;Q8IRR5;1.50E-106;SIR4_DROME;NAD-dependent protein deacylase Sirt4 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 4);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; histone deacetylase activity [GO:0004407]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; zinc ion binding [GO:0008270]; histone deacetylation [GO:0016575]; protein ADP-ribosylation [GO:0006471]";"GO:0003950; GO:0004407; GO:0005739; GO:0005759; GO:0006471; GO:0008270; GO:0016575; GO:0034979; GO:0070403";"histone deacetylation [GO:0016575]; protein ADP-ribosylation [GO:0006471]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"histone deacetylase activity [GO:0004407]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; zinc ion binding [GO:0008270]"
comp1038176_c0_seq1;GAXK01043926.1;Q9NDM2;1.12E-36;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp1038488_c0_seq1;GAXK01043950.1;P56721;0;COLL_DROME;Transcription factor collier (Transcription factor knot);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";"GO:0001228; GO:0001700; GO:0003677; GO:0005634; GO:0006355; GO:0007350; GO:0007367; GO:0007419; GO:0007474; GO:0007476; GO:0007526; GO:0009608; GO:0010468; GO:0016204; GO:0035203; GO:0035287; GO:0035288; GO:0035289; GO:0035291; GO:0042694; GO:0045087; GO:0045944; GO:0046872; GO:0046983; GO:0048813; GO:0048814";"anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp1038625_c0_seq1;GAXK01043909.1;Q8MQW8;7.14E-23;SPRI_DROME;Protein sprint (SH2 poly-proline-containing Ras-interactor protein);"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688";"axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]"
comp103874_c0_seq1;GAXK01138173.1;Q5EAW9;4.92E-08;TAF3_XENLA;Transcription initiation factor TFIID subunit 3 (TBP-associated factor 3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]";"GO:0005634; GO:0046872";;nucleus [GO:0005634];metal ion binding [GO:0046872]
comp1039517_c0_seq1;GAXK01043921.1;Q5RD64;4.53E-30;CNTP2_PONAB;Contactin-associated protein-like 2;"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]; cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"GO:0007155; GO:0016021; GO:0033010; GO:0044224; GO:0048812; GO:0071205";"cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]";
comp1039534_c0_seq1;GAXK01043967.1;O70628;7.02E-16;PDE9A_MOUSE;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471";"cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp1039561_c0_seq1;GAXK01043964.1;Q92547;8.55E-10;TOPB1_HUMAN;DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint [GO:0033314]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]";"GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006259; GO:0006260; GO:0006281; GO:0006974; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:1901796";"cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint [GO:0033314]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]";"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]"
comp1039575_c1_seq1;GAXK01043955.1;P90519;8.02E-91;EF1A_CRYPV;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp1039671_c0_seq1;GAXK01043969.1;P16924;4.69E-51;P4HA1_CHICK;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp10397_c2_seq1;GAXK01187986.1;Q6GLD8;0;CDK9_XENTR;Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle tissue regeneration [GO:0061026]; inflammatory response to wounding [GO:0090594]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0006368; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0030332; GO:0032968; GO:0044212; GO:0045944; GO:0060043; GO:0061026; GO:0070816; GO:0090594";"cardiac muscle tissue regeneration [GO:0061026]; inflammatory response to wounding [GO:0090594]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1039739_c0_seq1;GAXK01043942.1;Q11011;4.01E-82;PSA_MOUSE;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp10398_c0_seq1;GAXK01187673.1;Q6P316;3.82E-106;S2540_XENTR;Solute carrier family 25 member 40;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp1039833_c0_seq1;GAXK01043971.1;P16292;1.95E-20;FA9_RABIT;Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Fragment);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638";"blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp103995_c0_seq1;GAXK01138259.1;Q9ULJ6;4.01E-116;ZMIZ1_HUMAN;Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]";"GO:0001085; GO:0001570; GO:0001701; GO:0003007; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007296; GO:0007569; GO:0008270; GO:0016607; GO:0016925; GO:0030374; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0048096; GO:0048146; GO:0048589; GO:0048844; GO:0061665";"artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]"
comp104004_c5_seq1;GAXK01155640.1;Q9VCA2;3.38E-81;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp104022_c0_seq1;GAXK01155453.1;Q12962;1.22E-33;TAF10_HUMAN;Transcription initiation factor TFIID subunit 10 (STAF28) (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; perinuclear region of cytoplasm [GO:0048471]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; DNA-templated transcription, initiation [GO:0006352]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; multicellular organism growth [GO:0035264]; protein deubiquitination [GO:0016579]; protein homooligomerization [GO:0051260]; regulation of DNA binding [GO:0051101]; regulation of gene expression [GO:0010468]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000082; GO:0000125; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006352; GO:0006366; GO:0006367; GO:0006915; GO:0010468; GO:0016251; GO:0016578; GO:0016579; GO:0019899; GO:0030331; GO:0030914; GO:0033276; GO:0034622; GO:0035264; GO:0043966; GO:0048471; GO:0051101; GO:0051260; GO:0070063; GO:0070365; GO:1901796";"apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; DNA-templated transcription, initiation [GO:0006352]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; multicellular organism growth [GO:0035264]; protein deubiquitination [GO:0016579]; protein homooligomerization [GO:0051260]; regulation of DNA binding [GO:0051101]; regulation of gene expression [GO:0010468]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; perinuclear region of cytoplasm [GO:0048471]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]";"DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251]"
comp104027_c0_seq1;GAXK01155678.1;Q32KJ8;6.69E-92;ARSI_RAT;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp104037_c5_seq1;GAXK01155741.1;Q9J4Z5;1.03E-08;V245_FOWPN;Putative ankyrin repeat protein FPV245;;;;;
comp1040688_c0_seq1;GAXK01081285.1;A8WQK3;3.43E-53;ACH1_CAEBR;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1040767_c0_seq1;GAXK01081290.1;O54698;4.90E-33;S29A1_RAT;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0007595; GO:0015858; GO:0015862; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794";"cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp1040927_c0_seq1;GAXK01081291.1;Q13360;7.54E-10;ZN177_HUMAN;Zinc finger protein 177;"blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0005634; GO:0046872; GO:0072562";negative regulation of transcription by RNA polymerase II [GO:0000122];"blood microparticle [GO:0072562]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp104098_c0_seq1;GAXK01155675.1;Q9VUA0;8.33E-52;GPTC1_DROME;G patch domain-containing protein 1 homolog;"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634; GO:0071011; GO:0071013";mRNA splicing, via spliceosome [GO:0000398];"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";RNA binding [GO:0003723]
comp10412_c5_seq1;GAXK01187872.1;Q96IK1;2.61E-39;BOD1_HUMAN;Biorientation of chromosomes in cell division protein 1 (Biorientation defective protein 1) (Protein FAM44B);"centrosome [GO:0005813]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein localization to chromosome, centromeric region [GO:0071459]";"GO:0000922; GO:0000940; GO:0004864; GO:0005737; GO:0005813; GO:0005876; GO:0007080; GO:0032515; GO:0051301; GO:0051721; GO:0071459; GO:0071962; GO:1990758";"cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein localization to chromosome, centromeric region [GO:0071459]";"centrosome [GO:0005813]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]";"protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]"
comp1041208_c0_seq1;GAXK01081250.1;Q9ER30;2.69E-10;KLH41_RAT;Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"GO:0001726; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014";"myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]";
comp1041673_c0_seq1;GAXK01081283.1;Q8IN81;2.84E-14;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp104171_c3_seq1;GAXK01155389.1;P9WK86;1.09E-21;NLHH_MYCTO;Carboxylesterase NlhH (EC 3.1.1.1);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp104175_c0_seq1;GAXK01155608.1;P27615;1.75E-35;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp1041760_c0_seq1;GAXK01081286.1;Q02965;1.40E-15;THB_LITCT;Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0070324";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp104182_c1_seq1;GAXK01155750.1;Q8NK02;6.86E-145;CBHB_EMENI;1,4-beta-D-glucan cellobiohydrolase B (EC 3.2.1.91) (Beta-glucancellobiohydrolase B) (Exocellobiohydrolase B) (Exoglucanase B);"extracellular region [GO:0005576]; cellulose 1,4-beta-cellobiosidase activity [GO:0016162]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]; glucan catabolic process [GO:0009251]";"GO:0005576; GO:0009251; GO:0016162; GO:0030245; GO:0030248";"cellulose catabolic process [GO:0030245]; glucan catabolic process [GO:0009251]";extracellular region [GO:0005576];"cellulose 1,4-beta-cellobiosidase activity [GO:0016162]; cellulose binding [GO:0030248]"
comp104195_c0_seq1;GAXK01155676.1;P21213;0;HUTH_RAT;Histidine ammonia-lyase (Histidase) (EC 4.3.1.3);"cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547]";"GO:0004397; GO:0005829; GO:0006547; GO:0006548; GO:0019556; GO:0019557";"histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547]";cytosol [GO:0005829];histidine ammonia-lyase activity [GO:0004397]
comp104199_c0_seq1;GAXK01155775.1;Q8SQG9;3.09E-19;NHRF2_RABIT;Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (PDZ domain-containing protein NHERF-2) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2);"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]";"GO:0005634; GO:0008022; GO:0012505; GO:0016324; GO:0060090";;"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]";"molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]"
comp1042_c1_seq1;GAXK01169989.1;P54612;0;2AAA_PIG;Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha);"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]";"GO:0000159; GO:0000775; GO:0005634; GO:0005737; GO:0006470; GO:0007059; GO:0016328; GO:0019888; GO:0030425; GO:0065003";"chromosome segregation [GO:0007059]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]";"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";protein phosphatase regulator activity [GO:0019888]
comp104212_c0_seq1;GAXK01155515.1;P56602;1.08E-59;PPOX_BOVIN;Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4);"intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004729; GO:0005739; GO:0006782; GO:0006783; GO:0016491; GO:0031304";"heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]";"oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]"
comp1042181_c0_seq1;GAXK01163945.1;Q9H3M0;4.75E-31;KCNF1_HUMAN;Potassium voltage-gated channel subfamily F member 1 (Voltage-gated potassium channel subunit Kv5.1) (kH1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]"
comp1043_c0_seq1;GAXK01169284.1;Q6PS50;8.04E-25;RS28_BOMMO;40S ribosomal protein S28;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp10430_c0_seq1;GAXK01188240.1;Q7ZWA3;7.47E-09;RBMX_DANRE;RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"GO:0000381; GO:0000398; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005719; GO:0006366; GO:0006509; GO:0007275; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347";"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]";"chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1043014_c0_seq1;GAXK01163998.1;P17970;2.83E-125;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp1043099_c0_seq1;GAXK01163953.1;Q96L94;1.39E-14;SNX22_HUMAN;Sorting nexin-22;"cytoplasmic vesicle membrane [GO:0030659]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0015031; GO:0030659; GO:0035091";protein transport [GO:0015031];cytoplasmic vesicle membrane [GO:0030659];phosphatidylinositol binding [GO:0035091]
comp10431_c3_seq1;GAXK01187427.1;P28289;1.95E-30;TMOD1_HUMAN;Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);"actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"GO:0003779; GO:0005523; GO:0005829; GO:0005865; GO:0005884; GO:0006936; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030049; GO:0030239; GO:0030863; GO:0051015; GO:0051694; GO:0070307";"adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]"
comp104311_c0_seq1;GAXK01155735.1;O18023;9.70E-60;IGDB2_CAEEL;Ig-like and fibronectin type-III domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"GO:0005886; GO:0016021; GO:0030017";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";
comp1043150_c0_seq1;GAXK01163977.1;A6QLU5;4.41E-11;ZN184_BOVIN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp104344_c3_seq1;GAXK01155662.1;Q15120;9.12E-91;PDK3_HUMAN;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp1043461_c0_seq1;GAXK01163946.1;Q66S03;2.91E-11;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1043517_c0_seq1;GAXK01164006.1;P93748;8.21E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1043610_c0_seq1;GAXK01163976.1;Q98919;3.30E-29;LSAMP_CHICK;Limbic system-associated membrane protein (CHLAMP G19-isoform) (E19S);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp10438404_c0_seq1;GAXK01171196.1;O52402;7.06E-17;ALF_EDWI9;Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase);"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; glycolytic process [GO:0006096]";"GO:0004332; GO:0006096; GO:0008270";glycolytic process [GO:0006096];;"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]"
comp104407_c0_seq1;GAXK01155392.1;Q90744;5.87E-152;NAGAB_CHICK;Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B);"cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477";"glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"cytoplasm [GO:0005737]; lysosome [GO:0005764]";"alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]"
comp1044103_c0_seq2;GAXK01145843.1;Q0VA42;1.86E-37;MINY4_XENTR;Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4);"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]";"GO:0016807; GO:0036459; GO:1990380";;;"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp104415_c0_seq1;GAXK01155552.1;Q63424;1.78E-35;S15A2_RAT;Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"GO:0005887; GO:0015031; GO:0015333; GO:0016021; GO:0035673; GO:0042938; GO:0071916; GO:1904680";"dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide:proton symporter activity [GO:0015333]; peptide transmembrane transporter activity [GO:1904680]"
comp10442_c1_seq1;GAXK01187419.1;Q922M5;1.91E-46;CDA7L_MOUSE;Cell division cycle-associated 7-like protein (Transcription factor RAM2);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001650; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0008284";"positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp1044575_c0_seq1;GAXK01145888.1;P80052;3.80E-07;CHIT_DIOJA;Acidic endochitinase (EC 3.2.1.14);"chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";;"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp1044864_c0_seq1;GAXK01145863.1;P15622;1.62E-45;ZN250_HUMAN;Zinc finger protein 250 (Zinc finger protein 647);"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0042802; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp104515_c0_seq1;GAXK01155391.1;Q9VI25;1.37E-160;NCDN_DROME;Neurochondrin homolog (dNeurochondrin);"dendrite [GO:0030425]; neuronal cell body [GO:0043025]; muscle system process [GO:0003012]";"GO:0003012; GO:0030425; GO:0043025";muscle system process [GO:0003012];"dendrite [GO:0030425]; neuronal cell body [GO:0043025]";
comp1045427_c0_seq1;GAXK01145835.1;P51414;2.09E-53;RL261_ARATH;60S ribosomal protein L26-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0009409; GO:0022625; GO:0022626; GO:0042273; GO:0042788";"cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1045509_c0_seq1;GAXK01145869.1;Q86V25;8.87E-67;VASH2_HUMAN;Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; syncytium formation by plasma membrane fusion [GO:0000768]";"GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0006508; GO:0045766; GO:0060716; GO:0140253";"cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; syncytium formation by plasma membrane fusion [GO:0000768]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]"
comp10455727_c0_seq1;GAXK01097328.1;Q43644;4.66E-38;NDUS1_SOLTU;NADH dehydrogenase [ubiquinone] iron-sulfur protein 1, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (76 kDa mitochondrial complex I subunit) (Complex I-76kD) (CI-76kD) (NADH-ubiquinone oxidoreductase 76 kDa subunit);"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773]";"GO:0005743; GO:0008137; GO:0009055; GO:0042773; GO:0046872; GO:0051537; GO:0051539; GO:0070469";ATP synthesis coupled electron transport [GO:0042773];"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp104569_c0_seq1;GAXK01155738.1;Q99LT0;8.64E-21;DPY30_MOUSE;Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L);"Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]";"GO:0005634; GO:0005654; GO:0005794; GO:0005802; GO:0016197; GO:0035097; GO:0042802; GO:0042803; GO:0044666; GO:0048188; GO:0051568";"endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]";"Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp1045842_c0_seq1;GAXK01145879.1;Q1JPJ8;1.95E-94;THOP1_BOVIN;Thimet oligopeptidase (EC 3.4.24.15);"mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";"GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0046872";"peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";mitochondrial intermembrane space [GO:0005758];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp104589_c2_seq1;GAXK01155713.1;Q91WG5;3.51E-120;AAKG2_MOUSE;5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]";"GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006469; GO:0006633; GO:0008603; GO:0008607; GO:0010800; GO:0016208; GO:0019217; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0043531; GO:0045860; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]";"ADP binding [GO:0043531]; AMP-activated protein kinase activity [GO:0004679]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]"
comp10459_c0_seq1;GAXK01187486.1;Q9BRS8;1.33E-37;LARP6_HUMAN;La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]";"GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904";"positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]"
comp104600_c1_seq1;GAXK01155570.1;Q8R1S4;1.04E-89;MTSS1_MOUSE;Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein);"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]";"GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp10465_c0_seq1;GAXK01187107.1;Q6NSN1;9.77E-42;LS12B_DANRE;Protein LSM12 homolog B;;;;;
comp104655_c0_seq1;GAXK01155669.1;Q8VHG2;7.96E-57;AMOT_MOUSE;Angiomotin;"actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]";"GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005634; GO:0005737; GO:0005884; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056";"actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]";"actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]";"angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]"
comp1046668_c0_seq1;GAXK01131856.1;Q9W6F9;1.42E-13;WIF1_DANRE;Wnt inhibitory factor 1 (WIF-1);"cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; swim bladder development [GO:0048794]; Wnt signaling pathway [GO:0016055]";"GO:0005102; GO:0005576; GO:0009986; GO:0016055; GO:0048794; GO:0048856; GO:0060828; GO:0090090";"anatomical structure development [GO:0048856]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; swim bladder development [GO:0048794]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";signaling receptor binding [GO:0005102]
comp1046888_c0_seq1;GAXK01131871.1;P41182;1.57E-10;BCL6_HUMAN;B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51);"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; cytokine-mediated signaling pathway [GO:0019221]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0000981; GO:0001161; GO:0001227; GO:0001953; GO:0002467; GO:0002634; GO:0002903; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0019221; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0042802; GO:0042981; GO:0043065; GO:0043087; GO:0043380; GO:0043565; GO:0045591; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0050776; GO:0051272; GO:1903464; GO:2000773";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; cytokine-mediated signaling pathway [GO:0019221]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp10470205_c0_seq1;GAXK01143065.1;Q7PPA5;9.13E-59;ATC1_ANOGA;Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump);"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]";"GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0033017; GO:0046872; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]";"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp10471_c5_seq1;GAXK01188056.1;Q99805;0;TM9S2_HUMAN;Transmembrane 9 superfamily member 2 (p76);"endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]";"GO:0005768; GO:0005887; GO:0010008; GO:0016020; GO:0070062; GO:0072657";protein localization to membrane [GO:0072657];"endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp1047103_c2_seq1;GAXK01131866.1;O35710;3.03E-47;NOCT_MOUSE;Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005737; GO:0005739; GO:0006397; GO:0006739; GO:0007623; GO:0009991; GO:0010629; GO:0019178; GO:0030014; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757";"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADPH phosphatase activity [GO:0102757]; NADP phosphatase activity [GO:0019178]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp1047165_c0_seq1;GAXK01131858.1;Q9BSG1;1.30E-10;ZNF2_HUMAN;Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp1047216_c0_seq1;GAXK01131880.1;A1L1J6;6.68E-19;ZN652_RAT;Zinc finger protein 652;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp104723_c1_seq1;GAXK01155555.1;Q5ZJL7;9.49E-96;DDB2_CHICK;DNA damage-binding protein 2 (Damage-specific DNA-binding protein 2);"cell junction [GO:0030054]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914]";"GO:0000209; GO:0003684; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006290; GO:0009411; GO:0030054; GO:0031465; GO:0035518; GO:0044877; GO:0051865; GO:0070914";"DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914]";"cell junction [GO:0030054]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; ubiquitin-protein transferase activity [GO:0004842]"
comp1047290_c0_seq1;GAXK01131835.1;Q8VIG1;4.32E-13;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1047404_c0_seq1;GAXK01131830.1;B1A4F7;9.48E-09;VDDP4_VESVU;Venom dipeptidyl peptidase 4 (EC 3.4.14.5) (Venom dipeptidyl peptidase IV) (allergen Ves v 3);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp1047507_c0_seq1;GAXK01131833.1;Q01238;6.27E-09;HCC2_CRYCO;Major basic nuclear protein 2 (Protein p14 alpha chain);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp1047515_c0_seq1;GAXK01131859.1;Q9QXT8;6.59E-50;CSEN_MOUSE;Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator) (DREAM) (Kv channel-interacting protein 3) (KChIP3);"axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; magnesium ion binding [GO:0000287]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; intracellular protein transport [GO:0006886]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; potassium ion transport [GO:0006813]; protein localization to plasma membrane [GO:0072659]; regulation of neuron apoptotic process [GO:0043523]; regulation of potassium ion transmembrane transport [GO:1901379]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]";"GO:0000122; GO:0000287; GO:0001046; GO:0003677; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006813; GO:0006886; GO:0006915; GO:0008022; GO:0008076; GO:0015459; GO:0019233; GO:0030424; GO:0030425; GO:0032993; GO:0042803; GO:0043523; GO:0043565; GO:0043679; GO:0044325; GO:0045892; GO:0048265; GO:0048266; GO:0048306; GO:0072659; GO:1901379";"apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; intracellular protein transport [GO:0006886]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; potassium ion transport [GO:0006813]; protein localization to plasma membrane [GO:0072659]; regulation of neuron apoptotic process [GO:0043523]; regulation of potassium ion transmembrane transport [GO:1901379]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]";"axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; magnesium ion binding [GO:0000287]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; voltage-gated ion channel activity [GO:0005244]"
comp1047552_c0_seq1;GAXK01131840.1;Q6T3U3;1.31E-17;NPCL1_RAT;NPC1-like intracellular cholesterol transporter 1 (Niemann-Pick C1-like protein 1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; spanning component of plasma membrane [GO:0044214]; drug binding [GO:0008144]; lipid transporter activity [GO:0005319]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; response to drug [GO:0042493]";"GO:0005319; GO:0006695; GO:0008144; GO:0016324; GO:0017137; GO:0030299; GO:0031489; GO:0031526; GO:0042157; GO:0042493; GO:0044214; GO:0071501";"cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; response to drug [GO:0042493]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; spanning component of plasma membrane [GO:0044214]";"drug binding [GO:0008144]; lipid transporter activity [GO:0005319]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]"
comp10478_c1_seq1;GAXK01205965.1;P52485;1.10E-103;UBCD2_DROME;Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005524; GO:0019915; GO:0061631";"lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp104782_c0_seq1;GAXK01155590.1;G5CTG7;4.42E-49;AQP10_MILTA;Aquaporin-10 (AQP-10);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]";"GO:0005886; GO:0015267; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";channel activity [GO:0015267]
comp1047847_c0_seq1;GAXK01131834.1;Q96ND8;6.05E-45;ZN583_HUMAN;Zinc finger protein 583 (Zinc finger protein L3-5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1047857_c0_seq1;GAXK01131832.1;A6QQY4;5.01E-18;HORM2_BOVIN;HORMA domain-containing protein 2;"chromosome [GO:0005694]; nucleus [GO:0005634]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]";"GO:0005634; GO:0005694; GO:0051177; GO:0051321";"meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]";"chromosome [GO:0005694]; nucleus [GO:0005634]";
comp104795_c4_seq1;GAXK01155541.1;Q5QQ53;0;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp10481_c1_seq1;GAXK01187546.1;Q3ZBD2;1.23E-111;ARP10_BOVIN;Actin-related protein 10;"axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]";"GO:0005869; GO:0007018; GO:0098958; GO:1904115";"microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]";"axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]";
comp1048111_c0_seq1;GAXK01016261.1;Q1LZC0;1.37E-26;ZNF22_BOVIN;Zinc finger protein 22;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp104819_c2_seq1;GAXK01155671.1;Q8NDZ4;4.95E-19;DIK2A_HUMAN;Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF);"COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0000139; GO:0005615; GO:0014066; GO:0030126; GO:0034392; GO:0060038";"cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";
comp104824_c0_seq1;GAXK01155556.1;Q01295;3.07E-39;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp10483_c0_seq1;GAXK01188450.1;Q05AX3;7.57E-12;PSMG1_XENLA;Proteasome assembly chaperone 1;"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; proteasome assembly [GO:0043248]";"GO:0005737; GO:0005783; GO:0043248";proteasome assembly [GO:0043248];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";
comp10484373_c0_seq1;GAXK01155025.1;Q03237;5.77E-16;MYBB_CHICK;Myb-related protein B (B-Myb) (Myb-like protein 2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000278; GO:0003677; GO:0005634; GO:0045893";"mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp104855_c0_seq1;GAXK01155737.1;Q00649;3.26E-14;HSPB1_CHICK;Heat shock protein beta-1 (HspB1) (25 kDa IAP) (Actin polymerization inhibitor) (Heat shock 25 kDa protein) (HSP 25) (Heat shock 27 kDa protein) (HSP 27);"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; intracellular [GO:0005622]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; barbed-end actin filament capping [GO:0051016]; chaperone-mediated protein folding [GO:0061077]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to heat [GO:0009408]";"GO:0005080; GO:0005622; GO:0005634; GO:0005737; GO:0005739; GO:0005819; GO:0005886; GO:0006469; GO:0008426; GO:0009408; GO:0030018; GO:0030837; GO:0032731; GO:0042535; GO:0042802; GO:0042803; GO:0043122; GO:0043292; GO:0044183; GO:0051016; GO:0061077; GO:0071901; GO:1902176; GO:2001234";"barbed-end actin filament capping [GO:0051016]; chaperone-mediated protein folding [GO:0061077]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to heat [GO:0009408]";"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; intracellular [GO:0005622]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; Z disc [GO:0030018]";"identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]"
comp1048765_c0_seq1;GAXK01016262.1;Q8JG64;5.16E-48;PDIA3_CHICK;Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0045454; GO:0098761; GO:2001238";"cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]";"identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp104881_c7_seq1;GAXK01155691.1;P36617;3.84E-153;RAD16_SCHPO;DNA repair protein rad16 (EC 3.1.-.-);"cytoplasm [GO:0005737]; mitotic spindle pole body [GO:0044732]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; double-strand break repair via single-strand annealing, removal of nonhomologous ends [GO:0000736]; gene conversion at mating-type locus [GO:0007534]; mating type switching [GO:0007533]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000014; GO:0000110; GO:0000712; GO:0000724; GO:0000736; GO:0003684; GO:0003697; GO:0005634; GO:0005737; GO:0006289; GO:0006296; GO:0007131; GO:0007533; GO:0007534; GO:0044732; GO:0045002; GO:1901255; GO:1990599";"double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; double-strand break repair via single-strand annealing, removal of nonhomologous ends [GO:0000736]; gene conversion at mating-type locus [GO:0007534]; mating type switching [GO:0007533]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]";"cytoplasm [GO:0005737]; mitotic spindle pole body [GO:0044732]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]";"3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]"
comp104890_c0_seq1;GAXK01155557.1;Q24270;0;CAC1D_DROME;Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]";"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp104922_c1_seq1;GAXK01155720.1;A5A779;8.75E-99;PGTA_PIG;Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]";"GO:0004663; GO:0005654; GO:0005737; GO:0005968; GO:0008270; GO:0017137; GO:0018344";protein geranylgeranylation [GO:0018344];"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]";"Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]"
comp1049379_c0_seq1;GAXK01016285.1;Q8BGW3;6.69E-33;BHE23_MOUSE;Class E basic helix-loop-helix protein 23 (bHLHe23) (Class B basic helix-loop-helix protein 4) (bHLHb4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; negative regulation of retinal cell programmed cell death [GO:0046671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic eye morphogenesis [GO:0048050]; retinal rod cell development [GO:0046548]";"GO:0003677; GO:0005634; GO:0045944; GO:0046548; GO:0046671; GO:0046983; GO:0048050";"negative regulation of retinal cell programmed cell death [GO:0046671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic eye morphogenesis [GO:0048050]; retinal rod cell development [GO:0046548]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp104950_c2_seq1;GAXK01155521.1;P98092;7.74E-66;HMCT_BOMMO;Hemocytin (Humoral lectin);"carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]";"GO:0007155; GO:0030246";cell adhesion [GO:0007155];;carbohydrate binding [GO:0030246]
comp104964_c1_seq1;GAXK01155696.1;Q93075;7.29E-31;TATD2_HUMAN;Putative deoxyribonuclease TATDN2 (EC 3.1.21.-);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]";"GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0016888; GO:0036498; GO:0046872";IRE1-mediated unfolded protein response [GO:0036498];"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
comp10499_c0_seq1;GAXK01187805.1;Q3U7R1;1.05E-19;ESYT1_MOUSE;Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein);"endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005783; GO:0006869; GO:0008429; GO:0030176; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0061817";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp10503_c0_seq1;GAXK01187585.1;Q9Y324;6.94E-109;FCF1_HUMAN;rRNA-processing protein FCF1 homolog;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]";"GO:0000447; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040";"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp1050327_c0_seq1;GAXK01163176.1;Q2M3R5;2.92E-17;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp10504_c0_seq1;GAXK01187992.1;P36188;1.53E-08;TNNI_DROME;Troponin I (Tn I) (Protein heldup) (Protein wings apart-A);"striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; nuclear division [GO:0000280]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]";"GO:0000280; GO:0003779; GO:0005861; GO:0005865; GO:0006936; GO:0007399; GO:0007507; GO:0007517; GO:0007519; GO:0030239; GO:0045214; GO:0046716; GO:0046872; GO:0048738; GO:0060047";"cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; nuclear division [GO:0000280]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]";"striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]";"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp105049_c1_seq1;GAXK01155487.1;O75379;1.02E-11;VAMP4_HUMAN;Vesicle-associated membrane protein 4 (VAMP-4);"cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; Golgi ribbon formation [GO:0090161]; membrane organization [GO:0061024]; microtubule cytoskeleton organization [GO:0000226]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]";"GO:0000139; GO:0000226; GO:0005764; GO:0005768; GO:0005794; GO:0005886; GO:0009986; GO:0016189; GO:0030133; GO:0030285; GO:0030665; GO:0032588; GO:0035493; GO:0061024; GO:0090161; GO:1900242";"Golgi ribbon formation [GO:0090161]; membrane organization [GO:0061024]; microtubule cytoskeleton organization [GO:0000226]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]";"cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]";
comp105062_c0_seq1;GAXK01155491.1;Q7Q9N9;1.85E-95;MTAP_ANOGA;S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]";"GO:0005634; GO:0005737; GO:0005829; GO:0006166; GO:0017061; GO:0019509";"L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]
comp1050790_c0_seq1;GAXK01163191.1;Q4P9T3;1.40E-21;CCR4_USTMA;Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]";"GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0030014; GO:0030015; GO:0046872";nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289];"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]"
comp1050894_c0_seq1;GAXK01163222.1;Q8BG95;1.39E-10;MYPT2_MOUSE;Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2);"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; signal transduction [GO:0007165]";"GO:0004857; GO:0005737; GO:0005856; GO:0007165; GO:0019208; GO:0019901; GO:0030018; GO:0031672";signal transduction [GO:0007165];"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]";"enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]"
comp1051146_c0_seq1;GAXK01163172.1;P17970;3.95E-125;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp10512_c6_seq1;GAXK01187492.1;Q02293;7.12E-157;FNTB_RAT;Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta);"protein farnesyltransferase complex [GO:0005965]; protein-containing complex [GO:0032991]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; response to cytokine [GO:0034097]; response to inorganic substance [GO:0010035]; response to organic cyclic compound [GO:0014070]; wound healing [GO:0042060]";"GO:0004311; GO:0004660; GO:0005965; GO:0008270; GO:0008284; GO:0008285; GO:0010035; GO:0014070; GO:0018342; GO:0018343; GO:0032991; GO:0034097; GO:0042060; GO:0045787; GO:0048146; GO:0051770";"negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; response to cytokine [GO:0034097]; response to inorganic substance [GO:0010035]; response to organic cyclic compound [GO:0014070]; wound healing [GO:0042060]";"protein-containing complex [GO:0032991]; protein farnesyltransferase complex [GO:0005965]";"farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]"
comp105120_c0_seq1;GAXK01155488.1;Q15643;9.26E-22;TRIPB_HUMAN;Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230);"cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]";"GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005634; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006486; GO:0016607; GO:0030133; GO:0035735; GO:0051216; GO:0060122; GO:0090161; GO:0099041";"cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]";"cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]";transcription coactivator activity [GO:0003713]
comp105128_c2_seq1;GAXK01155751.1;Q8K2J9;1.19E-20;BTBD6_MOUSE;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp10513_c1_seq1;GAXK01188263.1;Q60648;6.12E-07;SAP3_MOUSE;Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]";"GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345";"ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]";"beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]"
comp1051421_c0_seq1;GAXK01163204.1;Q07230;4.96E-16;ZSCA2_MOUSE;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1051485_c1_seq1;GAXK01163174.1;Q96AB6;1.17E-27;NTAN1_HUMAN;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418";"adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp105149_c2_seq1;GAXK01155764.1;E9Q9R9;3.91E-78;DLG5_MOUSE;Disks large homolog 5;"cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]";"GO:0001837; GO:0005737; GO:0005913; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045211; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205";"apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]";"cell-cell adherens junction [GO:0005913]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]"
comp105176_c2_seq1;GAXK01155386.1;Q8NBK3;6.46E-130;SUMF1_HUMAN;Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]";"GO:0005783; GO:0005788; GO:0006687; GO:0016491; GO:0018158; GO:0042803; GO:0043687; GO:0120147; GO:1903135";"glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]"
comp105190_c0_seq1;GAXK01155564.1;Q61967;2.83E-16;ZFP90_MOUSE;Zinc finger protein 90 (Zfp-90) (Zinc finger protein NK10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0001227; GO:0003677; GO:0005634; GO:0043392; GO:0045892; GO:0045893; GO:0046872";"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]"
comp1051947_c0_seq1;GAXK01163196.1;Q8BTI7;9.45E-10;ANR52_MOUSE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp105209_c0_seq1;GAXK01155558.1;A2RSJ4;2.37E-106;UH1BL_MOUSE;UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa);"cytosol [GO:0005829]; early endosome [GO:0005769]; GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]";"GO:0005769; GO:0005829; GO:0042803; GO:0062069";;"cytosol [GO:0005829]; early endosome [GO:0005769]";"GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]"
comp1052244_c1_seq1;GAXK01054753.1;A7SGU3;8.98E-48;DCTN6_NEMVE;Dynactin subunit 6;"cytoplasm [GO:0005737]; dynactin complex [GO:0005869]";"GO:0005737; GO:0005869";;"cytoplasm [GO:0005737]; dynactin complex [GO:0005869]";
comp105227_c0_seq1;GAXK01155604.1;Q5R9E1;1.43E-139;HMGCL_PONAB;Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase);"mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]";"GO:0004419; GO:0005759; GO:0005777; GO:0046872; GO:0046951";ketone body biosynthetic process [GO:0046951];"mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]";"hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]"
comp105228_c1_seq1;GAXK01205830.1;Q91727;6.89E-104;CDK4_XENLA;Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4);"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";;"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp105240_c0_seq1;GAXK01155579.1;Q9W734;1.86E-60;SMAD6_CHICK;Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6);"endosome [GO:0005768]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; regulation of neurogenesis [GO:0050767]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005768; GO:0007179; GO:0010693; GO:0031589; GO:0032331; GO:0044212; GO:0046872; GO:0050767; GO:1902832; GO:1902844";"cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; regulation of neurogenesis [GO:0050767]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"endosome [GO:0005768]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1052519_c0_seq1;GAXK01054693.1;P30796;1.46E-28;GASR_MASNA;Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gastrin receptor activity [GO:0015054]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0005886; GO:0007204; GO:0008284; GO:0015054; GO:0016021";"positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gastrin receptor activity [GO:0015054]
comp1052594_c0_seq1;GAXK01054739.1;Q6P720;3.18E-13;ARHGP_RAT;Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT);"myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005886; GO:0030016; GO:0030017; GO:0035023";regulation of Rho protein signal transduction [GO:0035023];"myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp1052596_c0_seq1;GAXK01054722.1;P03896;8.72E-29;NU2M_DROME;NADH-ubiquinone oxidoreductase chain 2 (EC 7.1.1.2) (NADH dehydrogenase subunit 2);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0005747; GO:0006120; GO:0008137; GO:0016021";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp105277_c3_seq1;GAXK01155562.1;Q20459;7.13E-18;NAS25_CAEEL;Zinc metalloproteinase nas-25 (EC 3.4.24.-) (Nematode astacin 25);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996";molting cycle, collagen and cuticulin-based cuticle [GO:0018996];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp105278_c2_seq1;GAXK01155739.1;P13002;2.10E-78;ELF1_DROME;Protein grainyhead (DNA-binding protein ELF-1) (Element I-binding activity) (Protein grainy-head) (Transcription factor NTF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";"GO:0003382; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007402; GO:0007419; GO:0007424; GO:0007426; GO:0007464; GO:0008362; GO:0008543; GO:0035159; GO:0040003; GO:0042052; GO:0042127; GO:0042803; GO:0043565; GO:0045944; GO:0050767; GO:0061024; GO:0061041";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp10530_c0_seq1;GAXK01187861.1;Q7KRI2;3.94E-57;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1053160_c0_seq1;GAXK01054756.1;Q60870;4.76E-09;REEP5_MOUSE;Receptor expression-enhancing protein 5 (GP106) (Polyposis locus protein 1 homolog) (Protein TB2 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp10532_c0_seq1;GAXK01187105.1;P13255;4.84E-102;GNMT_RAT;Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein);"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]; folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]";"GO:0005542; GO:0005634; GO:0005829; GO:0006111; GO:0006544; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0046655; GO:0051262; GO:0051289; GO:1901052; GO:1904047";"folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]";"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]";"folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp105322_c1_seq1;GAXK01155584.1;Q8VIG1;2.22E-07;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp105323_c0_seq1;GAXK01155607.1;Q920Q4;9.51E-162;VPS16_MOUSE;Vacuolar protein sorting-associated protein 16 homolog (mVPS16);"actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]; viral entry into host cell [GO:0046718]";"GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0032889; GO:0033263; GO:0035542; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352";"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]; viral entry into host cell [GO:0046718]";"actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp105327_c3_seq1;GAXK01155670.1;O61491;1.00E-159;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp10533_c2_seq1;GAXK01187392.1;Q9H0V9;1.25E-93;LMA2L_HUMAN;VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031]";"GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0005794; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0015031; GO:0016021; GO:0030134; GO:0046872";"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp1053330_c0_seq1;GAXK01054729.1;Q9VW51;1.08E-19;ELL_DROME;RNA polymerase II elongation factor Ell (dELL);"nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase binding [GO:0070063]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription in response to stress [GO:0043620]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0003682; GO:0005634; GO:0005700; GO:0005703; GO:0005730; GO:0006368; GO:0008023; GO:0032968; GO:0035327; GO:0042795; GO:0043620; GO:0048190; GO:0070063; GO:0097150";"neuronal stem cell population maintenance [GO:0097150]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription in response to stress [GO:0043620]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]; wing disc dorsal/ventral pattern formation [GO:0048190]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]";"chromatin binding [GO:0003682]; RNA polymerase binding [GO:0070063]"
comp105338_c2_seq1;GAXK01155633.1;B0WC46;3.00E-55;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1053389_c0_seq1;GAXK01054702.1;Q09YL6;4.69E-07;SAMD5_BOVIN;Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5);"cytoplasm [GO:0005737]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";"GO:0005737; GO:0031435; GO:0043507; GO:1901224";"positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";cytoplasm [GO:0005737];mitogen-activated protein kinase kinase kinase binding [GO:0031435]
comp10534_c0_seq1;GAXK01187854.1;O74503;1.13E-14;UAF30_SCHPO;Upstream activation factor subunit spp27 (Upstream activation factor 27 KDa subunit) (p27) (Upstream activation factor 30 KDa subunit) (p30) (Upstream activation factor subunit uaf30);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0000500; GO:0001181; GO:0005634; GO:0005829; GO:0006361";transcription initiation from RNA polymerase I promoter [GO:0006361];"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]";RNA polymerase I general transcription initiation factor activity [GO:0001181]
comp1053443_c1_seq1;GAXK01054724.1;G5ED00;2.27E-07;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp105350_c0_seq1;GAXK01155687.1;Q761V0;1.05E-101;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp1053861_c0_seq1;GAXK01054737.1;P48613;9.14E-23;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp1053897_c0_seq1;GAXK01054738.1;Q8BYF6;2.58E-102;SC5A8_MOUSE;Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"GO:0005343; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161";"apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]"
comp1053914_c0_seq1;GAXK01054703.1;Q9BYZ8;1.52E-10;REG4_HUMAN;Regenerating islet-derived protein 4 (REG-4) (Gastrointestinal secretory protein) (REG-like protein) (Regenerating islet-derived protein IV) (Reg IV);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; mannan binding [GO:2001065]; transmembrane signaling receptor activity [GO:0004888]; response to bacterium [GO:0009617]";"GO:0004888; GO:0005576; GO:0005737; GO:0008201; GO:0009617; GO:2001065";response to bacterium [GO:0009617];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"heparin binding [GO:0008201]; mannan binding [GO:2001065]; transmembrane signaling receptor activity [GO:0004888]"
comp10541_c0_seq1;GAXK01187365.1;O35345;5.58E-163;IMA7_MOUSE;Importin subunit alpha-7 (Importin alpha-S2) (Karyopherin subunit alpha-6);"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; evasion or tolerance by virus of host immune response [GO:0030683]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]";"GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0030683; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902";"entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; evasion or tolerance by virus of host immune response [GO:0030683]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]";"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]"
comp10543_c0_seq1;GAXK01187354.1;Q60899;5.87E-128;ELAV2_MOUSE;ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B) (HuB) (Nervous system-specific RNA-binding protein Mel-N1);"ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003723; GO:0045202; GO:1990830; GO:1990904";cellular response to leukemia inhibitory factor [GO:1990830];"ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]";RNA binding [GO:0003723]
comp1054424_c0_seq1;GAXK01052449.1;P51523;4.09E-30;ZNF84_HUMAN;Zinc finger protein 84 (Zinc finger protein HPF2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp1054603_c0_seq1;GAXK01052442.1;Q9VXJ0;8.19E-82;DHB4_DROME;"Peroxisomal multifunctional enzyme type 2 (DmMFE-2) [Includes: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.119)]";"peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enoyl-CoA hydratase activity [GO:0004300]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]";"GO:0003857; GO:0004300; GO:0005777; GO:0033540; GO:0042803; GO:0044594; GO:0080023";fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540];peroxisome [GO:0005777];"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enoyl-CoA hydratase activity [GO:0004300]; protein homodimerization activity [GO:0042803]"
comp1054840_c0_seq1;GAXK01052434.1;P0DPW5;6.95E-07;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1054895_c0_seq1;GAXK01052416.1;Q6DF30;1.37E-95;DHDH_XENTR;Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase);"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]";"GO:0042843; GO:0047115; GO:0047837";D-xylose catabolic process [GO:0042843];;"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
comp1054976_c0_seq1;GAXK01052438.1;A8MXY4;1.14E-21;ZNF99_HUMAN;Zinc finger protein 99;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp10550_c1_seq1;GAXK01187887.1;O89079;2.74E-116;COPE_MOUSE;Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP);"COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005198; GO:0005654; GO:0005794; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030137";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";structural molecule activity [GO:0005198]
comp1055423_c0_seq1;GAXK01052430.1;P24044;6.23E-23;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp105552_c9_seq1;GAXK01155611.1;Q8BVE8;0;NSD2_MOUSE;Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Wolf-Hirschhorn syndrome candidate 1 protein homolog);"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; histone H3-K36 methylation [GO:0010452]; histone H4-K20 methylation [GO:0034770]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0006355; GO:0010452; GO:0018024; GO:0034770; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032";"atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; histone H3-K36 methylation [GO:0010452]; histone H4-K20 methylation [GO:0034770]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1055556_c0_seq1;GAXK01052451.1;O35547;4.00E-54;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp105556_c2_seq1;GAXK01155450.1;B3TP03;9.49E-142;CTR2_CHICK;Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352]";"GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015181; GO:0015189; GO:0016021; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352";"L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]"
comp105585_c0_seq1;GAXK01155732.1;O75154;1.41E-28;RFIP3_HUMAN;Rab11 family-interacting protein 3 (FIP3-Rab11) (Rab11-FIP3) (Arfophilin-1) (EF hands-containing Rab-interacting protein) (Eferin) (MU-MB-17.148);"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005654; GO:0005768; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0016192; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0043231; GO:0045171; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0061512; GO:0070164";"cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]";"ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp105586_c0_seq1;GAXK01155486.1;O75896;3.42E-13;TUSC2_HUMAN;Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2);"mitochondrion [GO:0005739]; cell cycle [GO:0007049]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";"GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0007049; GO:0032618; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0052567; GO:0070945; GO:0071609; GO:2000377";"cell cycle [GO:0007049]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";mitochondrion [GO:0005739];
comp105587_c1_seq1;GAXK01155602.1;Q8TC92;1.11E-123;ENOX1_HUMAN;"Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]";"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]";"GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491";ultradian rhythm [GO:0007624];"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]"
comp105592_c0_seq1;GAXK01155478.1;Q3T075;2.17E-12;STX8_BOVIN;Syntaxin-8;"endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0048278";"intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp1056_c0_seq1;GAXK01168199.1;P00771;5.26E-20;COGS_LEPPG;Brachyurin (EC 3.4.21.32) (Collagenolytic protease);"serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0030574";collagen catabolic process [GO:0030574];;serine-type endopeptidase activity [GO:0004252]
comp1056003_c0_seq1;GAXK01059891.1;Q61503;7.34E-84;5NTD_MOUSE;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]";"GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0009986; GO:0016020; GO:0031225; GO:0046085; GO:0046086; GO:0050728; GO:0097060";"adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]";"5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]"
comp105620_c3_seq1;GAXK01155725.1;Q9UBJ2;0;ABCD2_HUMAN;ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]";"GO:0000038; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0055085; GO:1900016; GO:1903427; GO:1990535; GO:2001280";"fatty acid beta-oxidation [GO:0006635]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]"
comp1056301_c0_seq1;GAXK01059923.1;Q3U4G3;1.56E-30;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp1056768_c0_seq1;GAXK01059932.1;Q9H0C5;3.70E-15;BTBD1_HUMAN;BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8);"cytosol [GO:0005829]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]";"GO:0000932; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0043393; GO:0043687";"muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]";"cytosol [GO:0005829]; P-body [GO:0000932]; protein-containing complex [GO:0032991]";
comp10568_c4_seq1;GAXK01187946.1;Q6GQ82;5.22E-158;SNF5_XENLA;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1;"nuclear chromosome [GO:0000228]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]";"GO:0000228; GO:0003677; GO:0006338; GO:0007399";"chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]";nuclear chromosome [GO:0000228];DNA binding [GO:0003677]
comp1056886_c0_seq1;GAXK01059894.1;Q26492;1.01E-10;ITPL_SCHGR;Ion transport peptide-like;"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]";"GO:0005184; GO:0005576";;extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp1057_c0_seq1;GAXK01168819.1;P35979;3.12E-50;RL12_MOUSE;60S ribosomal protein L12;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp105701_c1_seq1;GAXK01155477.1;Q5E9I8;1.05E-158;DCA11_BOVIN;DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0043161; GO:0080008";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
comp1057280_c0_seq1;GAXK01059895.1;O43581;1.24E-100;SYT7_HUMAN;Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0043005; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp1057698_c0_seq1;GAXK01059938.1;B5U2W0;7.09E-59;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp105789_c0_seq1;GAXK01155661.1;Q5HLD8;6.84E-19;Y2049_STAEQ;Uncharacterized oxidoreductase SERP2049 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp105796_c1_seq1;GAXK01155753.1;Q5SSM3;4.06E-76;RHG44_MOUSE;Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2);"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]; modification of dendritic spine [GO:0098886]; modification of postsynaptic structure [GO:0099010]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]";"GO:0005096; GO:0005543; GO:0007165; GO:0014069; GO:0030054; GO:0030425; GO:0031256; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048365; GO:0048786; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099010; GO:0099152";"modification of dendritic spine [GO:0098886]; modification of postsynaptic structure [GO:0099010]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]";"GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]"
comp1057964_c0_seq1;GAXK01059908.1;Q9UII5;1.40E-42;ZN107_HUMAN;Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1058142_c0_seq1;GAXK01041742.1;Q6NT16;5.74E-43;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp105872_c0_seq1;GAXK01155637.1;Q502L2;2.46E-79;PGAM5_DANRE;Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; phosphoprotein phosphatase activity [GO:0004721]; programmed cell death [GO:0012501]";"GO:0004721; GO:0005741; GO:0012501; GO:0016021";programmed cell death [GO:0012501];"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";phosphoprotein phosphatase activity [GO:0004721]
comp105881_c0_seq1;GAXK01155722.1;Q05319;1.03E-07;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1059020_c0_seq1;GAXK01041737.1;P18173;4.97E-97;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp1059303_c0_seq1;GAXK01041739.1;O34499;8.14E-15;6PGL_BACSU;6-phosphogluconolactonase (EC 3.1.1.31);"cytosol [GO:0005829]; 6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0005829; GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";cytosol [GO:0005829];6-phosphogluconolactonase activity [GO:0017057]
comp105936_c1_seq1;GAXK01155568.1;P53369;1.83E-32;8ODP_RAT;7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]";"GO:0001669; GO:0003924; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0035539; GO:0036219; GO:0042262; GO:0046061; GO:0046686; GO:0046872; GO:0047693";"aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTPase activity [GO:0003924]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]"
comp10594_c3_seq1;GAXK01187764.1;Q9GRW0;1.51E-40;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1059417_c0_seq1;GAXK01041736.1;Q7T3S3;3.70E-29;CHSTB_DANRE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]"
comp105945_c0_seq1;GAXK01155458.1;Q9VCA2;1.45E-79;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp105959_c0_seq1;GAXK01155787.1;Q8K1S6;1.12E-45;SPIR2_MOUSE;Protein spire homolog 2 (Spir-2);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0051295; GO:0070649; GO:2000781";"actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp105981_c0_seq1;GAXK01155582.1;Q1H9T6;1.40E-12;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1059859_c0_seq1;GAXK01041732.1;Q6GNV7;6.51E-31;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp1060005_c0_seq1;GAXK01115576.1;O46040;2.88E-15;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp106025_c1_seq1;GAXK01122265.1;Q864R9;0;MRP1_MACFA;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]";"GO:0005524; GO:0005886; GO:0008559; GO:0015431; GO:0016021; GO:0016887; GO:0042493; GO:0042910; GO:0050729; GO:0071716; GO:0140359";"leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp1060426_c0_seq1;GAXK01115544.1;Q9VCA2;1.20E-71;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1060480_c0_seq1;GAXK01115580.1;P21251;3.77E-47;CALM_STIJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1060500_c1_seq1;GAXK01115581.1;Q8CHQ0;8.28E-07;FBX4_MOUSE;F-box only protein 4;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000723; GO:0004842; GO:0005737; GO:0006511; GO:0007568; GO:0010608; GO:0016567; GO:0019005; GO:0019725; GO:0031146; GO:0031398; GO:0031647; GO:0031648; GO:0032212; GO:0035726; GO:0042803; GO:0048147; GO:0061630; GO:0071479; GO:1900181; GO:1902916; GO:2000001";"aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";"protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp1060582_c0_seq1;GAXK01115524.1;Q9UGM3;1.61E-33;DMBT1_HUMAN;Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]";"GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399";"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]";"calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]"
comp1060642_c0_seq1;GAXK01115555.1;U3U715;2.94E-10;HISAT_SCOAU;Histidine N-acetyltransferase (EC 2.3.1.33);histidine N-acetyltransferase activity [GO:0047981];GO:0047981;;;histidine N-acetyltransferase activity [GO:0047981]
comp1060674_c1_seq1;GAXK01115563.1;Q9XTJ4;1.00E-14;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp106068_c1_seq1;GAXK01121896.1;Q05397;0;FAK1_HUMAN;Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; extracellular matrix organization [GO:0030198]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]";"GO:0000165; GO:0000226; GO:0001525; GO:0001570; GO:0001725; GO:0001764; GO:0001890; GO:0001932; GO:0001934; GO:0003007; GO:0003779; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007097; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010594; GO:0010613; GO:0010632; GO:0014068; GO:0016324; GO:0018108; GO:0019901; GO:0019903; GO:0021955; GO:0022408; GO:0030010; GO:0030027; GO:0030154; GO:0030155; GO:0030198; GO:0030335; GO:0033628; GO:0038007; GO:0038083; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0043087; GO:0043197; GO:0043542; GO:0043552; GO:0045667; GO:0045860; GO:0046621; GO:0046777; GO:0048010; GO:0048013; GO:0048870; GO:0050771; GO:0051493; GO:0051893; GO:0051897; GO:0051964; GO:0060396; GO:1900024; GO:2000060; GO:2000811";"angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; extracellular matrix organization [GO:0030198]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]"
comp10607525_c0_seq1;GAXK01123302.1;Q6GKT9;2.66E-25;GYRA_STAAR;DNA gyrase subunit A (EC 5.6.2.2);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; DNA topological change [GO:0006265]; DNA-dependent DNA replication [GO:0006261]; response to antibiotic [GO:0046677]";"GO:0003677; GO:0003918; GO:0005524; GO:0005694; GO:0005737; GO:0006261; GO:0006265; GO:0046677";"DNA-dependent DNA replication [GO:0006261]; DNA topological change [GO:0006265]; response to antibiotic [GO:0046677]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]"
comp106082_c0_seq1;GAXK01122203.1;Q3U0J8;1.02E-112;TBD2B_MOUSE;TBC1 domain family member 2B;"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp1061108_c0_seq1;GAXK01115571.1;Q9V576;1.16E-35;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp1061287_c0_seq1;GAXK01115579.1;P13217;0;PIPA_DROME;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase (EC 3.1.4.11) (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta) (No receptor potential A protein) (Phosphoinositide phospholipase C) (Phosphoinositide phospholipase C-beta);"inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; inositol trisphosphate biosynthetic process [GO:0032959]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0001580; GO:0002385; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0006644; GO:0006651; GO:0007601; GO:0007602; GO:0008344; GO:0008377; GO:0008654; GO:0009649; GO:0016027; GO:0016028; GO:0016042; GO:0016056; GO:0016059; GO:0019722; GO:0032959; GO:0043052; GO:0043153; GO:0045494; GO:0046488; GO:0046673; GO:0051482; GO:0071482; GO:2000370";"adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; inositol trisphosphate biosynthetic process [GO:0032959]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]";"calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]"
comp106133_c0_seq1;GAXK01121913.1;Q5R5X9;2.87E-37;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp106155_c1_seq1;GAXK01122182.1;A6QLH5;7.66E-54;ERI3_BOVIN;ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein);"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]";"GO:0000175; GO:0000467; GO:0000738; GO:0003676; GO:0046872";"DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]";;"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1061740_c0_seq1;GAXK01115547.1;Q9QYI3;6.94E-96;DNJC7_MOUSE;DnaJ homolog subfamily C member 7 (Cytoplasmic CAR retention protein) (CCRP) (MDj11) (Tetratricopeptide repeat protein 2) (TPR repeat protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]";"GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0031072; GO:0051085";chaperone cofactor-dependent protein refolding [GO:0051085];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";heat shock protein binding [GO:0031072]
comp106186_c0_seq1;GAXK01122117.1;A8WGS4;8.03E-64;TLCD2_DANRE;TLC domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1061940_c0_seq1;GAXK01115533.1;Q8TGM6;9.92E-18;TAR1_YEAST;Protein TAR1 (Transcript antisense to ribosomal RNA protein 1);"mitochondrion [GO:0005739]; regulation of cellular respiration [GO:0043457]";"GO:0005739; GO:0043457";regulation of cellular respiration [GO:0043457];mitochondrion [GO:0005739];
comp1062315_c0_seq1;GAXK01119067.1;O54963;1.50E-17;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp106240_c0_seq1;GAXK01121983.1;Q8C4B4;1.18E-86;U119B_MOUSE;Protein unc-119 homolog B;"ciliary transition zone [GO:0035869]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399]";"GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271";"cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399]";ciliary transition zone [GO:0035869];lipid binding [GO:0008289]
comp1062430_c0_seq1;GAXK01119055.1;Q01603;5.00E-94;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1062483_c0_seq1;GAXK01119072.1;Q26474;2.27E-32;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp106272_c0_seq1;GAXK01121821.1;Q8NI22;4.79E-08;MCFD2_HUMAN;Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"GO:0000139; GO:0005509; GO:0005789; GO:0006888; GO:0012507; GO:0015031; GO:0018279; GO:0033116; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]";calcium ion binding [GO:0005509]
comp106282_c3_seq1;GAXK01121988.1;Q5UR67;9.59E-22;RIBX_MIMIV;N-glycosidase R617 (EC 3.2.2.-) (Riboflavin biosynthesis intermediates N-glycosidase);"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152]";"GO:0008152; GO:0016798";metabolic process [GO:0008152];;hydrolase activity, acting on glycosyl bonds [GO:0016798]
comp1062922_c0_seq1;GAXK01119078.1;Q8N1M1;3.54E-10;BEST3_HUMAN;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0034707; GO:0043271";negative regulation of ion transport [GO:0043271];"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1062940_c0_seq1;GAXK01119089.1;Q8NET6;1.40E-16;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp10631_c0_seq2;GAXK01205936.1;A8D8P8;0;SIWI_BOMMO;Piwi-like protein Siwi (EC 3.1.26.-);"cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; PET complex [GO:1990923]";"endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]"
comp106352_c0_seq1;GAXK01122248.1;Q5ZIN2;3.59E-22;SEN2_CHICK;tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2);"tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]";"GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0006397; GO:0016829";"mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]";tRNA-intron endonuclease complex [GO:0000214];"lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]"
comp1063723_c0_seq1;GAXK01119080.1;Q7XIM0;1.42E-08;CDPKH_ORYSJ;Calcium-dependent protein kinase 17 (OsCDPK17) (OsCPK17) (EC 2.7.11.1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp1063735_c0_seq1;GAXK01119068.1;P07584;8.73E-21;ASTA_ASTAS;Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase);"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360";"cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp1063877_c0_seq1;GAXK01119051.1;Q13127;6.11E-14;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp106418_c1_seq1;GAXK01121850.1;P13007;1.29E-11;D7_XENLA;Protein D7;"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0005737; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];cytoplasm [GO:0005737];metal ion binding [GO:0046872]
comp106426_c0_seq1;GAXK01121823.1;P56389;7.54E-40;CDD_MOUSE;Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase);"cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289]";"GO:0001882; GO:0004126; GO:0005829; GO:0008270; GO:0009972; GO:0030308; GO:0042802; GO:0042803; GO:0045980; GO:0051289";"cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289]";cytosol [GO:0005829];"cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp10645619_c0_seq1;GAXK01143066.1;P22738;2.32E-51;RL32_ARATH;60S ribosomal protein L3-2;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp1064673_c0_seq1;GAXK01028242.1;O94673;9.99E-09;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp1065209_c0_seq1;GAXK01028250.1;Q8SWR3;3.85E-78;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp1065582_c0_seq1;GAXK01028253.1;Q7KRI2;1.24E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1065640_c0_seq1;GAXK01028238.1;P83088;6.51E-52;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp1065682_c0_seq1;GAXK01028259.1;Q9VZW5;5.07E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp106574_c2_seq1;GAXK01122217.1;Q9UBG0;1.36E-13;MRC2_HUMAN;C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574";"collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp106577_c0_seq1;GAXK01121860.1;A1A4L5;2.93E-144;ALKB8_BOVIN;Alkylated DNA repair protein alkB homolog 8 (EC 1.14.11.-) (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.-) (EC 2.1.1.229);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]";"GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016604; GO:0016706; GO:0030488; GO:0055114";"cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp106592_c1_seq1;GAXK01122173.1;A2AVA0;3.32E-11;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp1066133_c0_seq1;GAXK01143396.1;Q9UPW0;1.10E-07;FOXJ3_HUMAN;Forkhead box protein J3;"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0043565; GO:0045944";positive regulation of transcription by RNA polymerase II [GO:0045944];nuclear chromatin [GO:0000790];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp106615_c0_seq1;GAXK01121869.1;Q4V9F0;7.44E-85;DGAT2_DANRE;Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Diglyceride acyltransferase 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]; diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to (R)-carnitine [GO:0061959]; triglyceride biosynthetic process [GO:0019432]";"GO:0004144; GO:0005789; GO:0005811; GO:0006071; GO:0016021; GO:0019432; GO:0055088; GO:0061959; GO:1905897; GO:1990578";"glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to (R)-carnitine [GO:0061959]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]";diacylglycerol O-acyltransferase activity [GO:0004144]
comp106621_c0_seq1;GAXK01122200.1;Q8WUM0;3.05E-134;NU133_HUMAN;Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133);"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; somite development [GO:0061053]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000777; GO:0005635; GO:0005643; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0006999; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0021915; GO:0022008; GO:0031080; GO:0031081; GO:0031965; GO:0043657; GO:0048339; GO:0060964; GO:0061053; GO:0072006; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; somite development [GO:0061053]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]";structural constituent of nuclear pore [GO:0017056]
comp106633_c0_seq1;GAXK01122356.1;Q8TDX7;5.49E-167;NEK7_HUMAN;Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]";"GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355";"positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp106653_c3_seq1;GAXK01121855.1;Q7KRI2;1.02E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1066710_c0_seq1;GAXK01143400.1;Q93243;1.65E-17;NAS37_CAEEL;Zinc metalloproteinase nas-37 (EC 3.4.24.-) (Nematode astacin 37);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996; GO:0040002; GO:0042395";"collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp10668_c0_seq1;GAXK01188241.1;Q5XHA2;2.38E-116;ERD21_XENTR;ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1) (KDEL receptor 1);"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";KDEL sequence binding [GO:0005046]
comp1066960_c0_seq1;GAXK01143403.1;P08793;3.69E-144;XDH_CALVI;Xanthine dehydrogenase (XD) (EC 1.17.1.4);"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];peroxisome [GO:0005777];"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp1067035_c0_seq1;GAXK01143397.1;Q5PQ89;1.93E-07;AN34B_XENLA;Ankyrin repeat domain-containing protein 34B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp10671_c3_seq1;GAXK01188528.1;Q2UPB6;4.33E-09;ACLN_ASPOR;Aspirochlorine biosynthesis protein N;;;;;
comp106710_c0_seq1;GAXK01122251.1;B5X3B2;7.97E-50;APMAP_SALSA;Adipocyte plasma membrane-associated protein;"integral component of membrane [GO:0016021]; strictosidine synthase activity [GO:0016844]; biosynthetic process [GO:0009058]";"GO:0009058; GO:0016021; GO:0016844";biosynthetic process [GO:0009058];integral component of membrane [GO:0016021];strictosidine synthase activity [GO:0016844]
comp106716_c7_seq1;GAXK01122237.1;Q14DH7;1.71E-66;ACSS3_MOUSE;Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Propionate--CoA ligase) (EC 6.2.1.17);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]";"GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0047760; GO:0050218";;"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]"
comp1067522_c0_seq1;GAXK01143388.1;Q6R7M4;5.69E-68;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp106759_c0_seq1;GAXK01122099.1;P04755;0;ACH3_DROME;Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp10676_c0_seq1;GAXK01187586.1;Q03043;0;KGP24_DROME;cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"GO:0004691; GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0018105; GO:0030536; GO:0030553; GO:0032095; GO:0046959";"feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp1067677_c0_seq1;GAXK01143401.1;Q96IR2;1.89E-115;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp106777_c0_seq1;GAXK01122113.1;P17439;1.01E-144;GLCM_MOUSE;Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.104) (D-glucosyl-N-acylsphingosine glucohydrolase);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]";"GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0009267; GO:0009268; GO:0016787; GO:0023021; GO:0030259; GO:0032006; GO:0032268; GO:0032269; GO:0032436; GO:0032463; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0050295; GO:0051246; GO:0051247; GO:0071356; GO:0071548; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037";"autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]";"glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]"
comp1067810_c0_seq1;GAXK01143402.1;Q5SRE7;2.42E-11;PHYD1_HUMAN;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp1067859_c0_seq1;GAXK01143404.1;O46108;1.48E-17;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp106801_c1_seq1;GAXK01122311.1;Q7KRI2;6.64E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1068078_c0_seq1;GAXK01012630.1;Q8N413;9.82E-54;S2545_HUMAN;Solute carrier family 25 member 45;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; acyl carnitine transmembrane transporter activity [GO:0015227]; acyl carnitine transport [GO:0006844]";"GO:0005743; GO:0006844; GO:0015227; GO:0016021";acyl carnitine transport [GO:0006844];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp10681_c0_seq1;GAXK01187987.1;P55039;0;DRG2_HUMAN;Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]";"GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872";"cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp106819_c2_seq1;GAXK01121765.1;Q9ET61;2.13E-07;C1QR1_RAT;Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR(p)) (C1qRp) (Cell surface antigen AA4) (Complement component 1 q subcomponent receptor 1) (CD antigen CD93);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell-cell adhesion [GO:0098609]";"GO:0005509; GO:0016021; GO:0030246; GO:0098609";cell-cell adhesion [GO:0098609];integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]"
comp106845_c1_seq1;GAXK01122116.1;Q13887;6.23E-12;KLF5_HUMAN;Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0006366; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0071407; GO:0099156; GO:1901653; GO:1902895; GO:1990830";"angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp106874_c0_seq1;GAXK01122267.1;Q6PB44;4.99E-58;PTN23_MOUSE;Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643";"cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]"
comp106892_c0_seq1;GAXK01121764.1;Q95RA9;1.85E-33;GILT1_DROME;GILT-like protein 1;"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; disulfide oxidoreductase activity [GO:0015036]; immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"GO:0002376; GO:0005576; GO:0005886; GO:0015036; GO:0055114; GO:1900426";"immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]";disulfide oxidoreductase activity [GO:0015036]
comp1068961_c1_seq1;GAXK01012625.1;A0A0M4KDW1;4.71E-16;AURB_CALAK;Methyltransferase aurB (EC 2.1.1.-) (Aurovertin biosynthesis cluster protein B);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp10690_c3_seq1;GAXK01187890.1;Q80ZK9;8.54E-114;WDTC1_MOUSE;WD and tetratricopeptide repeats protein 1;"cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]";"GO:0000122; GO:0001701; GO:0004857; GO:0005634; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082";"cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]"
comp1069128_c0_seq1;GAXK01012649.1;Q80UG8;6.63E-83;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp1069137_c0_seq1;GAXK01012612.1;Q9NRG4;4.69E-18;SMYD2_HUMAN;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975; GO:1901796";"heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp1069215_c0_seq1;GAXK01012628.1;P83501;6.51E-14;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1069240_c0_seq1;GAXK01012608.1;P17032;2.99E-17;ZN37A_HUMAN;Zinc finger protein 37A (Zinc finger protein KOX21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp1069350_c0_seq1;GAXK01012627.1;Q68EA5;8.48E-13;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1069434_c0_seq1;GAXK01012647.1;Q86KC7;2.00E-11;Y4171_DICDI;Uncharacterized protein DDB_G0274171;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp106956_c1_seq1;GAXK01121880.1;O94673;2.74E-30;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp106959_c1_seq1;GAXK01121862.1;A1L3G4;7.47E-15;TM241_XENLA;Transmembrane protein 241;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1069987_c0_seq1;GAXK01012637.1;C6DKY4;1.24E-56;BETA_PECCP;Oxygen-dependent choline dehydrogenase (CDH) (CHD) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase) (BADH) (EC 1.2.1.8);"betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0008802; GO:0008812; GO:0019285; GO:0050660";glycine betaine biosynthetic process from choline [GO:0019285];;"betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]"
comp106999_c1_seq1;GAXK01122312.1;Q6NUP7;7.89E-109;PP4R4_HUMAN;Serine/threonine-protein phosphatase 4 regulatory subunit 4;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]";"GO:0001835; GO:0005737; GO:0005829; GO:0008287; GO:0019888; GO:0032515; GO:0080163";"blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]";protein phosphatase regulator activity [GO:0019888]
comp107_c4_seq1;GAXK01166605.1;P29413;1.18E-155;CALR_DROME;Calreticulin;"endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; fusome [GO:0045169]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]";"GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030968; GO:0042048; GO:0045169; GO:0051082";"endoplasmic reticulum unfolded protein response [GO:0030968]; olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]";"endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; fusome [GO:0045169]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp1070143_c0_seq1;GAXK01153207.1;Q9XYM0;1.07E-58;CRK_DROME;Adapter molecule Crk;"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013";"border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";;receptor tyrosine kinase binding [GO:0030971]
comp107041_c0_seq1;GAXK01121986.1;Q5T619;3.16E-15;ZN648_HUMAN;Zinc finger protein 648;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp107049_c1_seq1;GAXK01122078.1;Q6AYP4;8.16E-29;ZC21C_RAT;Zinc finger C2HC domain-containing protein 1C;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1070592_c0_seq1;GAXK01153218.1;G5ED00;2.37E-12;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1070791_c0_seq1;GAXK01153220.1;Q14679;1.79E-60;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp10710_c0_seq1;GAXK01187364.1;Q9D8B3;9.99E-37;CHM4B_MOUSE;Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; glutamatergic synapse [GO:0098978]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; membrane coat [GO:0030117]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; autophagy [GO:0006914]; exit from mitosis [GO:0010458]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of viral release from host cell [GO:1902188]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; regulation of autophagy [GO:0010506]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of postsynapse organization [GO:0099175]; regulation of viral process [GO:0050792]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuolar transport [GO:0007034]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]";"GO:0000281; GO:0000815; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0006620; GO:0006914; GO:0006997; GO:0007034; GO:0007080; GO:0009898; GO:0010458; GO:0010506; GO:0010824; GO:0014069; GO:0016020; GO:0030117; GO:0030496; GO:0031468; GO:0031902; GO:0031982; GO:0036438; GO:0039702; GO:0042802; GO:0042803; GO:0046755; GO:0050792; GO:0051260; GO:0060548; GO:0061952; GO:0090148; GO:0090611; GO:0098978; GO:0099175; GO:1901215; GO:1901673; GO:1902188; GO:1902902";"autophagy [GO:0006914]; exit from mitosis [GO:0010458]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of viral release from host cell [GO:1902188]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; regulation of autophagy [GO:0010506]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of postsynapse organization [GO:0099175]; regulation of viral process [GO:0050792]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuolar transport [GO:0007034]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]";"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; glutamatergic synapse [GO:0098978]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; membrane coat [GO:0030117]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; vesicle [GO:0031982]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp1071039_c0_seq1;GAXK01153221.1;P16292;1.97E-08;FA9_RABIT;Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Fragment);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638";"blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp1071133_c0_seq1;GAXK01153211.1;Q96IR7;4.86E-47;HPDL_HUMAN;4-hydroxyphenylpyruvate dioxygenase-like protein (EC 1.13.-.-) (Glyoxalase domain-containing protein 1);"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]";"GO:0003868; GO:0009072; GO:0046872";aromatic amino acid family metabolic process [GO:0009072];;"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]"
comp107128_c0_seq1;GAXK01121822.1;Q11011;0;PSA_MOUSE;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp1071342_c0_seq1;GAXK01153245.1;D3YXG0;5.37E-23;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1071874_c0_seq1;GAXK01153215.1;Q2TBP5;9.98E-24;TMM53_BOVIN;Transmembrane protein 53;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp107188_c0_seq1;GAXK01122103.1;Q16533;4.85E-11;SNPC1_HUMAN;snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Proximal sequence element-binding transcription factor subunit gamma) (PSE-binding factor subunit gamma) (PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; sequence-specific DNA binding [GO:0043565]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]";"GO:0005634; GO:0005654; GO:0005730; GO:0019185; GO:0042795; GO:0042796; GO:0043565";"snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]";sequence-specific DNA binding [GO:0043565]
comp107194_c0_seq1;GAXK01122199.1;Q7KRI2;8.74E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1072046_c0_seq1;GAXK01060561.1;Q2HJ23;7.35E-57;MLP3A_BOVIN;Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0097352";"autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]";"microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]"
comp1072382_c0_seq1;GAXK01060581.1;P42282;2.82E-16;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1072400_c0_seq1;GAXK01060593.1;A4II46;6.04E-11;ABR_XENTR;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1072627_c0_seq1;GAXK01060573.1;Q6PDB4;3.83E-12;ZN880_HUMAN;Zinc finger protein 880;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1072643_c0_seq1;GAXK01060583.1;B5U2W0;1.14E-09;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp1073049_c0_seq1;GAXK01060579.1;Q86MW9;5.00E-09;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp107311_c0_seq1;GAXK01122218.1;Q3U4G3;7.19E-27;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp107315_c1_seq1;GAXK01122190.1;Q9R226;4.20E-53;KHDR3_MOUSE;KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein Etoile) (Sam68-like mammalian protein 2) (SLM-2);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0033120; GO:0042802; GO:0048024; GO:0051259";"mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; single-stranded RNA binding [GO:0003727]"
comp107343_c0_seq1;GAXK01122075.1;O97716;4.29E-15;THA_PIG;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (c-erbA-1) (c-erbA-alpha);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0003707; GO:0004879; GO:0005634; GO:0005829; GO:0006366; GO:0007275; GO:0007420; GO:0007611; GO:0008016; GO:0008050; GO:0008134; GO:0008270; GO:0009409; GO:0009755; GO:0009887; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030374; GO:0030878; GO:0031490; GO:0033032; GO:0033993; GO:0038023; GO:0044877; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162";"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp107348_c0_seq1;GAXK01122172.1;Q9U6M0;1.06E-98;ECSIT_DROME;Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]";"GO:0005634; GO:0005737; GO:0005739; GO:0016651; GO:0045087; GO:0051341";"innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";oxidoreductase activity, acting on NAD(P)H [GO:0016651]
comp107363_c0_seq1;GAXK01122076.1;P70388;1.82E-78;RAD50_MOUSE;DNA repair protein RAD50 (mRad50) (EC 3.6.-.-);"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; protein heterooligomerization [GO:0051291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]";"GO:0000019; GO:0000722; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003690; GO:0003691; GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007346; GO:0016233; GO:0016234; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0043047; GO:0045120; GO:0046597; GO:0046872; GO:0048471; GO:0051276; GO:0051291; GO:0051880; GO:0070192; GO:0090305; GO:1904354";"cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; protein heterooligomerization [GO:0051291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]";"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]";"adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]"
comp1073775_c0_seq1;GAXK01060567.1;Q9C0G0;1.07E-07;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp1073785_c0_seq1;GAXK01060596.1;F1QJF4;8.82E-12;RORAB_DANRE;Nuclear receptor ROR-alpha B (Retinoid-related orphan receptor alpha 1) (Retinoid-related orphan receptor-alpha B);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0008270; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp107388_c3_seq1;GAXK01122072.1;Q15477;3.32E-78;SKIV2_HUMAN;Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP);"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]";"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1074055_c0_seq1;GAXK01022789.1;Q6AXF6;1.77E-26;SIDT1_MOUSE;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp107410_c1_seq1;GAXK01122401.1;Q76MY7;3.51E-123;CYH2_CHLAE;Cytohesin-2 (PH, SEC7 and coiled-coil domain-containing protein 2);"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005737; GO:0005886; GO:0008289; GO:0030426; GO:0032012; GO:0070679";regulation of ARF protein signal transduction [GO:0032012];"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"
comp1074129_c0_seq1;GAXK01022721.1;Q3MHY1;3.75E-11;CSRP1_BOVIN;Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537";"actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp107428_c3_seq1;GAXK01122108.1;P36609;6.81E-14;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1074280_c0_seq1;GAXK01022781.1;P70627;7.64E-29;FOLH1_RAT;Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]";"GO:0004180; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016805; GO:0043065; GO:0046872";"positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp107433_c0_seq1;GAXK01121769.1;Q9VSH9;6.65E-130;U183_DROME;UPF0183 protein CG7083;"trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]";"GO:0005802; GO:0043001";Golgi to plasma membrane protein transport [GO:0043001];trans-Golgi network [GO:0005802];
comp107441_c2_seq1;GAXK01122073.1;Q8VHC8;0;MA2B1_CAVPO;Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B);"lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]";"GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872";mannose metabolic process [GO:0006013];lysosome [GO:0005764];"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp107444_c0_seq1;GAXK01122104.1;Q8N806;2.31E-79;UBR7_HUMAN;Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7);"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]";"GO:0005737; GO:0008270; GO:0061630";;cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1074492_c0_seq1;GAXK01022786.1;Q99J62;2.41E-22;RFC4_MOUSE;Replication factor C subunit 4 (Activator 1 subunit 4);"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:0031391; GO:1900264";"DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]"
comp107452_c2_seq1;GAXK01121990.1;Q9D9V3;3.32E-68;ECHD1_MOUSE;Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD) (EC 7.2.4.3);"cytosol [GO:0005829]; carboxy-lyase activity [GO:0016831]; decarboxylation-driven active transmembrane transporter activity [GO:0015451]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]";"GO:0004300; GO:0005829; GO:0006635; GO:0015451; GO:0016831";fatty acid beta-oxidation [GO:0006635];cytosol [GO:0005829];"carboxy-lyase activity [GO:0016831]; decarboxylation-driven active transmembrane transporter activity [GO:0015451]; enoyl-CoA hydratase activity [GO:0004300]"
comp1074525_c0_seq1;GAXK01022740.1;Q3TTY0;2.75E-34;PLB1_MOUSE;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp107455_c1_seq1;GAXK01122141.1;Q9VCU9;0;DCR1_DROME;Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883";"apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]"
comp1074761_c0_seq1;GAXK01022739.1;Q9Z0L8;2.56E-61;GGH_MOUSE;Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (FGPH) (Folylpolyglutamate hydrolase) (GH) (Gamma-Glu-x carboxypeptidase);"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0010043; GO:0032868; GO:0034722; GO:0042470; GO:0042493; GO:0045471; GO:0046900";"response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]";gamma-glutamyl-peptidase activity [GO:0034722]
comp1074867_c0_seq1;GAXK01022787.1;Q5SVQ8;6.51E-19;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp107518_c3_seq1;GAXK01121861.1;P52746;6.93E-19;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp10752_c0_seq1;GAXK01187110.1;P48555;6.43E-104;RALA_DROME;Ras-related protein Ral-a;"cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]";"GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0007298; GO:0007464; GO:0019003; GO:0022604; GO:0030165; GO:0032154; GO:0045087; GO:0045824; GO:0046329; GO:0050829; GO:0090543";"border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]";"cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; PDZ domain binding [GO:0030165]"
comp1075233_c0_seq1;GAXK01022766.1;P50460;1.84E-38;CSRP2_CHICK;Cysteine and glycine-rich protein 2 (Beta-cysteine-rich protein) (Beta-CRP) (Cysteine-rich protein 2) (CRP2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007275; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537";"actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp107538_c0_seq1;GAXK01122184.1;Q6H1V1;2.28E-15;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp107556_c1_seq1;GAXK01122260.1;P98081;6.10E-65;DAB_DROME;Protein disabled;"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005118; GO:0005737; GO:0005829; GO:0007349; GO:0007391; GO:0008045; GO:0017124; GO:0030424; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793";"cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; presynapse [GO:0098793]";"sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]"
comp1075651_c1_seq1;GAXK01022728.1;Q7ZVG6;3.34E-07;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1075799_c0_seq1;GAXK01022733.1;Q08DK7;1.34E-45;MCATL_BOVIN;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015822; GO:0016021; GO:0089709; GO:1903400; GO:1903401; GO:1990575";"acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]"
comp107609_c5_seq1;GAXK01122086.1;Q0EEE2;1.32E-42;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp1076106_c0_seq1;GAXK01116691.1;O42409;1.63E-89;GFI1B_CHICK;Zinc finger protein Gfi-1b (Growth factor-independent protein 1B);"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001085; GO:0003677; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp107633_c0_seq1;GAXK01122221.1;Q1PRL4;1.91E-08;LIN41_CHICK;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);"P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";"GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177";"fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";P-body [GO:0000932];"miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp107644_c0_seq1;GAXK01122347.1;Q5BKR2;1.08E-97;SL9B2_MOUSE;Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:0097708; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]"
comp1076485_c0_seq1;GAXK01116727.1;Q7KRI2;1.48E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1076671_c0_seq1;GAXK01116685.1;P15364;2.15E-23;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp10767_c2_seq1;GAXK01188296.1;P41777;1.95E-16;NOLC1_RAT;Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130);"box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]";"GO:0001042; GO:0001650; GO:0003700; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006417; GO:0006970; GO:0007000; GO:0008134; GO:0008139; GO:0008284; GO:0014029; GO:0014032; GO:0015030; GO:0019904; GO:0031428; GO:0031429; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893; GO:0046982; GO:0062064; GO:0062065";"box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]";"box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]"
comp107670_c8_seq1;GAXK01122035.1;P97526;0;NF1_RAT;Neurofibromin (Neurofibromatosis-related protein NF-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]";"GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001952; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0008017; GO:0008429; GO:0008542; GO:0010976; GO:0014037; GO:0014044; GO:0014065; GO:0014069; GO:0016020; GO:0021510; GO:0021897; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030424; GO:0030425; GO:0031210; GO:0032991; GO:0042060; GO:0043005; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045685; GO:0045762; GO:0045765; GO:0048147; GO:0048485; GO:0048593; GO:0048715; GO:0048745; GO:0048844; GO:0048853; GO:0071549; GO:1990090";"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]";"GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]"
comp10768_c3_seq1;GAXK01188111.1;Q58D06;2.69E-49;WDR74_BOVIN;WD repeat-containing protein 74;"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]";"GO:0000176; GO:0001825; GO:0005634; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273";"blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]";"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]";
comp1076806_c0_seq1;GAXK01116675.1;Q5R632;1.69E-16;HPCL1_PONAB;Hippocalcin-like protein 1;"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp1076838_c0_seq1;GAXK01116709.1;Q8SWR3;2.53E-11;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp1076912_c0_seq1;GAXK01116736.1;P42768;8.18E-21;WASP_HUMAN;Wiskott-Aldrich syndrome protein (WASp);"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"GO:0000147; GO:0002625; GO:0005634; GO:0005829; GO:0005884; GO:0005911; GO:0006897; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030479; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0038096; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0048365; GO:0050852; GO:0051015; GO:0051492; GO:0051497; GO:0051666; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146; GO:2000601";"actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament-based movement [GO:0030048]; actin filament polymerization [GO:0030041]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]";"actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]"
comp1076986_c0_seq1;GAXK01116700.1;Q99PI4;1.87E-18;LPIN3_MOUSE;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3);"nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";nucleus [GO:0005634];"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp107700_c0_seq1;GAXK01121851.1;Q99J23;5.61E-58;GHDC_MOUSE;GH3 domain-containing protein;"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]; acid-amino acid ligase activity [GO:0016881]";"GO:0005635; GO:0005737; GO:0005783; GO:0016881";;"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]";acid-amino acid ligase activity [GO:0016881]
comp107701_c1_seq1;GAXK01122252.1;Q8T6B9;4.63E-108;PUF68_DROME;Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]";"GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003729; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008266; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013";"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]";"mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]"
comp1077293_c0_seq1;GAXK01116708.1;P63033;2.19E-19;RHES_RAT;GTP-binding protein Rhes (Ras homolog enriched in striatum) (SE6C);"plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0051897";"locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";plasma membrane [GO:0005886];"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp1077318_c0_seq1;GAXK01116679.1;O42409;2.53E-07;GFI1B_CHICK;Zinc finger protein Gfi-1b (Growth factor-independent protein 1B);"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001085; GO:0003677; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp107768_c0_seq1;GAXK01122314.1;Q2TBM9;2.71E-102;SRAC1_BOVIN;Protein SERAC1 (Serine active site-containing protein 1);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; phospholipid biosynthetic process [GO:0008654]";"GO:0005739; GO:0005783; GO:0008654; GO:0016021";phospholipid biosynthetic process [GO:0008654];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";
comp107778_c0_seq1;GAXK01122406.1;Q9JJZ6;6.79E-46;KLF13_MOUSE;Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Erythroid transcription factor FKLF-2) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0045944; GO:0046872";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1077855_c0_seq1;GAXK01116723.1;P50428;4.87E-110;ARSA_MOUSE;Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597";"autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]"
comp1077894_c1_seq1;GAXK01116732.1;Q5ZU30;2.04E-09;SETA_LEGPH;"Subversion of eukaryotic traffic protein A (Effector protein SetA) (Subversion of eukaryotic vesicle trafficking A) [Includes: Glucosyltransferase (EC 2.4.1.-); Phosphatidylinositol-3-phosphate-binding domain (PtdIns(3)P-binding domain)]";"extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]; pathogenesis [GO:0009405]";"GO:0005576; GO:0009405; GO:0016757";pathogenesis [GO:0009405];extracellular region [GO:0005576];transferase activity, transferring glycosyl groups [GO:0016757]
comp1077967_c0_seq1;GAXK01116742.1;Q2V2M9;1.28E-21;FHOD3_HUMAN;FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2);"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003";"actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp107853_c1_seq1;GAXK01122205.1;Q8NI22;3.31E-20;MCFD2_HUMAN;Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"GO:0000139; GO:0005509; GO:0005789; GO:0006888; GO:0012507; GO:0015031; GO:0018279; GO:0033116; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]";calcium ion binding [GO:0005509]
comp1078546_c0_seq1;GAXK01138812.1;O46040;1.12E-09;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1078571_c0_seq1;GAXK01138849.1;D3YXG0;3.28E-12;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1078997_c0_seq1;GAXK01138827.1;Q9VEN1;2.59E-109;FLNA_DROME;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1);"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495";"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp10790_c0_seq1;GAXK01187467.1;Q868N5;1.85E-35;VIT_APIME;Vitellogenin;"extracellular region [GO:0005576]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]";"GO:0005319; GO:0005576; GO:0045735";;extracellular region [GO:0005576];"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp10792_c3_seq1;GAXK01188103.1;P26779;5.08E-43;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp107920_c0_seq1;GAXK01122202.1;Q6NZN0;2.05E-27;RBM26_MOUSE;RNA-binding protein 26 (Protein expressed in male leptotene and zygotene spermatocytes 393) (MLZ-393) (RNA-binding motif protein 26);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";"GO:0003729; GO:0005634; GO:0006397; GO:0010923; GO:0046833; GO:0046872";"mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp107950_c0_seq1;GAXK01121852.1;P14533;2.85E-15;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1079534_c0_seq1;GAXK01138843.1;Q80W68;1.85E-09;KIRR1_MOUSE;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005886; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";myosin binding [GO:0017022]
comp1079736_c0_seq1;GAXK01138850.1;F1NZI4;3.09E-107;PGGHG_CHICK;Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1);"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005829; GO:0005975; GO:0047402";carbohydrate metabolic process [GO:0005975];cytosol [GO:0005829];"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]"
comp1079775_c0_seq1;GAXK01138823.1;Q8BY98;4.07E-20;SWAHD_MOUSE;Ankyrin repeat domain-containing protein SOWAHD (Ankyrin repeat domain-containing protein 58) (Protein sosondowah homolog D);;;;;
comp107979_c5_seq1;GAXK01121833.1;Q921Q3;3.21E-98;ALG1_MOUSE;Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486]";"GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]
comp108_c1_seq1;GAXK01166067.1;Q9W5R8;1.17E-132;RL5_DROME;60S ribosomal protein L5;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0008097; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp108004_c0_seq1;GAXK01036200.1;Q5C9L6;3.61E-85;CNMT_THLFG;(S)-coclaurine N-methyltransferase (TfCNMT) (EC 2.1.1.140);"cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794]";"GO:0005737; GO:0030794";;cytoplasm [GO:0005737];(S)-coclaurine-N-methyltransferase activity [GO:0030794]
comp108005_c0_seq1;GAXK01035851.1;Q75NR7;3.67E-173;RECQ4_MOUSE;ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RecQ protein-like 4);"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0001501; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0008270; GO:0008284; GO:0009378; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0043473; GO:0045875; GO:0048705; GO:0061820; GO:0061821";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]"
comp1080122_c0_seq1;GAXK01000771.1;Q5F428;6.52E-20;EIF3L_CHICK;Eukaryotic translation initiation factor 3 subunit L (eIF3l);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005852; GO:0006413; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]";translation initiation factor activity [GO:0003743]
comp108026_c0_seq1;GAXK01036087.1;Q7ZZY3;3.92E-19;TOB1B_XENLA;DNA topoisomerase 2-binding protein 1-B (DNA topoisomerase II-binding protein 1-B) (TopBP1-B) (Xmus101);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000922; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007049";"cell cycle [GO:0007049]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";DNA binding [GO:0003677]
comp1080486_c0_seq1;GAXK01000744.1;Q6V5K9;1.76E-20;ZN474_MOUSE;Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1080895_c0_seq1;GAXK01000749.1;A9NUH8;3.42E-175;METK1_PICSI;S-adenosylmethionine synthase 1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp1081_c0_seq1;GAXK01169449.1;Q13200;0;PSMD2_HUMAN;26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034515; GO:0034774; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]";enzyme regulator activity [GO:0030234]
comp108106_c0_seq1;GAXK01036205.1;Q7ZV60;3.39E-167;BCS1_DANRE;Mitochondrial chaperone BCS1 (BCS1-like protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005524; GO:0005743; GO:0016021; GO:0034551";mitochondrial respiratory chain complex III assembly [GO:0034551];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP binding [GO:0005524]
comp1081165_c0_seq1;GAXK01000775.1;O54904;6.27E-11;B3GT1_MOUSE;Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006682; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275";"galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp1081186_c0_seq1;GAXK01000760.1;Q9BQK8;1.36E-18;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp10812_c0_seq1;GAXK01187801.1;Q8BIQ5;1.71E-93;CSTF2_MOUSE;Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64);"cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0006378; GO:0016604; GO:0071920; GO:0098789; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp108138_c0_seq1;GAXK01036240.1;Q50JE5;0;ACE_MESAU;Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]";"GO:0004180; GO:0005576; GO:0005737; GO:0005886; GO:0008237; GO:0008241; GO:0016021; GO:0046872";;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]"
comp108171_c0_seq1;GAXK01035824.1;Q9VGY6;9.28E-14;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp1081786_c0_seq1;GAXK01000761.1;O89100;1.73E-07;GRAP2_MOUSE;GRB2-related adaptor protein 2 (Adapter protein GRID) (GADS protein) (GRB-2-like protein) (GRB2L) (GRB-2-related monocytic adapter protein) (MONA) (Monocytic adapter) (GRBLG) (Growth factor receptor-binding protein) (Hematopoietic cell-associated adaptor protein GrpL);"cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005768";;"cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]";
comp108189_c0_seq1;GAXK01035736.1;Q8NFU0;7.33E-106;BEST4_HUMAN;Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp10820147_c0_seq1;GAXK01127264.1;Q2RR43;1.42E-50;GMHA_RHORT;Phosphoheptose isomerase (EC 5.3.1.28) (Sedoheptulose 7-phosphate isomerase);"cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; D-sedoheptulose 7-phosphate isomerase activity [GO:0008968]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; D-glycero-D-manno-heptose 7-phosphate biosynthetic process [GO:2001061]";"GO:0005737; GO:0005975; GO:0008270; GO:0008968; GO:0097367; GO:2001061";"carbohydrate metabolic process [GO:0005975]; D-glycero-D-manno-heptose 7-phosphate biosynthetic process [GO:2001061]";cytoplasm [GO:0005737];"carbohydrate derivative binding [GO:0097367]; D-sedoheptulose 7-phosphate isomerase activity [GO:0008968]; zinc ion binding [GO:0008270]"
comp108206_c1_seq1;GAXK01036228.1;Q27433;2.57E-78;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp108208_c1_seq1;GAXK01036190.1;Q8K0H5;6.08E-23;TAF10_MOUSE;Transcription initiation factor TFIID subunit 10 (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30) (mTAFII30);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; perinuclear region of cytoplasm [GO:0048471]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; DNA-templated transcription, initiation [GO:0006352]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; liver development [GO:0001889]; multicellular organism growth [GO:0035264]; protein homooligomerization [GO:0051260]; regulation of DNA binding [GO:0051101]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000082; GO:0000125; GO:0001889; GO:0003677; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006352; GO:0006355; GO:0006367; GO:0006915; GO:0010468; GO:0016251; GO:0016578; GO:0019899; GO:0030331; GO:0030914; GO:0033276; GO:0034622; GO:0035264; GO:0043966; GO:0048471; GO:0051101; GO:0051260; GO:0070063; GO:0070365";"apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; DNA-templated transcription, initiation [GO:0006352]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; liver development [GO:0001889]; multicellular organism growth [GO:0035264]; protein homooligomerization [GO:0051260]; regulation of DNA binding [GO:0051101]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; perinuclear region of cytoplasm [GO:0048471]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]";"DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251]"
comp1082276_c1_seq1;GAXK01149603.1;Q6B9X6;3.38E-21;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp108251_c0_seq1;GAXK01035981.1;Q0IHY4;3.87E-121;TBC12_XENTR;TBC1 domain family member 12;"cell [GO:0005623]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005623; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cell [GO:0005623];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp1082613_c0_seq1;GAXK01149681.1;Q5ZLE9;1.37E-35;N4BP1_CHICK;NEDD4-binding protein 1 (N4BP1);"nucleolus [GO:0005730]; PML body [GO:0016605]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]";"GO:0005730; GO:0016605; GO:0031397; GO:0032435";"negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]";"nucleolus [GO:0005730]; PML body [GO:0016605]";
comp1082903_c0_seq1;GAXK01149642.1;Q8IN81;1.54E-11;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp108324_c1_seq1;GAXK01035887.1;O75319;3.86E-40;DUS11_HUMAN;RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1);"fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]";"GO:0001650; GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0006396; GO:0006470; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0045171; GO:0098507; GO:0098519";"polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]";"fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]"
comp10835_c1_seq1;GAXK01187808.1;Q8R1Q8;5.89E-130;DC1L1_MOUSE;Cytoplasmic dynein 1 light intermediate chain 1 (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic);"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; protein homooligomerization [GO:0051260]; regulation of centrosome cycle [GO:0046605]";"GO:0000226; GO:0000776; GO:0000777; GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0007049; GO:0019003; GO:0045504; GO:0046605; GO:0051260; GO:0051301; GO:0090267; GO:1990090";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; protein homooligomerization [GO:0051260]; regulation of centrosome cycle [GO:0046605]";"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; microtubule motor activity [GO:0003777]"
comp1083522_c0_seq1;GAXK01149669.1;A4IHR1;0;TT30A_XENTR;Tetratricopeptide repeat protein 30A (TPR repeat protein 30A);"axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]";"GO:0005879; GO:0005929; GO:0018095; GO:0030992; GO:0036064; GO:0042073; GO:0120170";"intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]";"axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]";intraciliary transport particle B binding [GO:0120170]
comp1083601_c0_seq1;GAXK01149672.1;A6H782;3.81E-81;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp1083884_c0_seq1;GAXK01149649.1;B7Z0W9;1.92E-31;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp1083935_c0_seq1;GAXK01149654.1;Q67BT3;1.72E-110;S13A5_MOUSE;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; citrate transport [GO:0015746]; succinate transport [GO:0015744]; tricarboxylic acid transport [GO:0006842]";"GO:0005343; GO:0005886; GO:0006842; GO:0015137; GO:0015141; GO:0015142; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0017153";"citrate transport [GO:0015746]; succinate transport [GO:0015744]; tricarboxylic acid transport [GO:0006842]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; tricarboxylic acid transmembrane transporter activity [GO:0015142]"
comp1084_c0_seq1;GAXK01168745.1;Q4KLN6;1.77E-175;RIR2_RAT;Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit);"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; mitotic cell cycle [GO:0000278]; positive regulation of cell population proliferation [GO:0008284]; pyrimidine nucleobase metabolic process [GO:0006206]";"GO:0000278; GO:0004748; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008284; GO:0009263; GO:0046872";"deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; mitotic cell cycle [GO:0000278]; positive regulation of cell population proliferation [GO:0008284]; pyrimidine nucleobase metabolic process [GO:0006206]";"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]";"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"
comp108410_c0_seq1;GAXK01035928.1;Q8R189;1.02E-58;PAQRA_MOUSE;Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]";"GO:0000139; GO:0004672; GO:0016021; GO:0019835; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471";"cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";protein kinase activity [GO:0004672]
comp108438_c4_seq1;GAXK01035812.1;Q8NFT6;8.03E-08;DBF4B_HUMAN;Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1);"aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]";"GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0016235; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987";"cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]";"aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]"
comp108443_c2_seq1;GAXK01036239.1;Q9EQS5;2.72E-17;SC5D_RAT;Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; lathosterol oxidase activity [GO:0050046]; cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; sterol biosynthetic process [GO:0016126]";"GO:0000248; GO:0005506; GO:0005789; GO:0006631; GO:0016021; GO:0016126; GO:0033490; GO:0043231; GO:0050046";"cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; sterol biosynthetic process [GO:0016126]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; lathosterol oxidase activity [GO:0050046]"
comp108456_c0_seq1;GAXK01035886.1;Q86YQ8;0;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp1084616_c0_seq1;GAXK01060358.1;Q96HA9;9.52E-30;PX11C_HUMAN;Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma);"integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]";"GO:0005777; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375";"peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]";"integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]";
comp1084675_c0_seq1;GAXK01060356.1;Q3ZC48;1.15E-33;DRAM2_BOVIN;DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]";"GO:0001917; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0045494";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]";
comp10848_c4_seq1;GAXK01187471.1;Q6P1S4;0;SYRC_XENTR;Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]";"GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101";arginyl-tRNA aminoacylation [GO:0006420];"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]";"arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]"
comp1084845_c0_seq1;GAXK01060343.1;P54001;2.16E-29;P4HA1_RAT;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp108492_c2_seq1;GAXK01035991.1;Q92621;0;NU205_HUMAN;Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205);"host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0005635; GO:0005643; GO:0006110; GO:0006406; GO:0006409; GO:0006913; GO:0006999; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0043657; GO:0044611; GO:0051292; GO:0060964; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]";structural constituent of nuclear pore [GO:0017056]
comp1085064_c0_seq1;GAXK01060373.1;P50429;1.78E-57;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp1085077_c0_seq1;GAXK01060344.1;P55113;1.26E-09;NAS7_CAEEL;Zinc metalloproteinase nas-7 (EC 3.4.24.-) (Nematode astacin 7);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp108548_c1_seq1;GAXK01035943.1;P60319;5.29E-09;KEN_DROYA;Probable transcription factor Ken (Protein Ken and Barbie) (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp108557_c4_seq1;GAXK01035939.1;P04069;1.72E-76;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp10856_c0_seq1;GAXK01188058.1;Q5ZLC8;1.62E-17;ANR52_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp108569_c14_seq1;GAXK01035923.1;Q8MT80;5.36E-79;PIGZ_DROME;GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol glycan anchor biosynthesis protein class Z);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]"
comp108581_c3_seq1;GAXK01035837.1;P06795;0;MDR1B_MOUSE;ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243);"apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]";"GO:0000139; GO:0005524; GO:0005739; GO:0005886; GO:0008559; GO:0014045; GO:0016021; GO:0016324; GO:0016887; GO:0042493; GO:0042626; GO:0046581; GO:0061843; GO:0090554; GO:0090555; GO:0099038; GO:0140328";"establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]";"apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]"
comp1085927_c0_seq1;GAXK01060361.1;P54727;4.52E-08;RD23B_HUMAN;UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]";"GO:0000502; GO:0000715; GO:0000717; GO:0000978; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006289; GO:0006294; GO:0006457; GO:0007283; GO:0016579; GO:0031593; GO:0032434; GO:0043130; GO:0043161; GO:0048568; GO:0070628; GO:0070911; GO:0071942; GO:0098761";"cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]";"damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]"
comp1085987_c0_seq1;GAXK01060339.1;Q27433;1.02E-25;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1086_c0_seq1;GAXK01169621.1;B4JYU5;2.65E-89;TMEDA_DROGR;Transmembrane emp24 domain-containing protein bai;"integral component of membrane [GO:0016021]; cargo receptor activity [GO:0038024]; dorsal/ventral pattern formation [GO:0009953]; regulation of post-mating oviposition [GO:0048042]; Wnt protein secretion [GO:0061355]";"GO:0009953; GO:0016021; GO:0038024; GO:0048042; GO:0061355";"dorsal/ventral pattern formation [GO:0009953]; regulation of post-mating oviposition [GO:0048042]; Wnt protein secretion [GO:0061355]";integral component of membrane [GO:0016021];cargo receptor activity [GO:0038024]
comp1086210_c0_seq1;GAXK01153704.1;Q8IN81;4.67E-07;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1086378_c0_seq1;GAXK01153687.1;P46197;2.98E-66;ANPRB_BOVIN;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0016941; GO:0017046; GO:0022414; GO:0035556; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp1086407_c0_seq1;GAXK01153694.1;Q8I6K0;3.63E-32;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1086475_c0_seq1;GAXK01153721.1;P47736;5.71E-39;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp108652_c0_seq1;GAXK01035998.1;F8U830;7.24E-16;NOTUM_SCHMD;Palmitoleoyl-protein carboxylesterase NOTUM (Smed-notum) (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0016055; GO:0030178; GO:1990697; GO:1990699";"negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp108653_c0_seq1;GAXK01036120.1;A3KPP4;1.51E-83;S2535_DANRE;Solute carrier family 25 member 35;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp108660_c0_seq1;GAXK01035938.1;O46629;3.69E-154;ECHB_BOVIN;Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)];"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; fatty acid beta-oxidation [GO:0006635]";"GO:0003988; GO:0004300; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016508; GO:0016509; GO:0050633";fatty acid beta-oxidation [GO:0006635];"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]"
comp1086735_c0_seq1;GAXK01153697.1;P56559;5.77E-50;ARL4C_HUMAN;ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-tubulin binding [GO:0043014]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0030175; GO:0032456; GO:0043014";"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"alpha-tubulin binding [GO:0043014]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp10869_c1_seq1;GAXK01187812.1;Q14019;2.02E-29;COTL1_HUMAN;Coactosin-like protein;"cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; neutrophil degranulation [GO:0043312]; regulation of actin filament polymerization [GO:0030833]";"GO:0003779; GO:0005576; GO:0005634; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0034774; GO:0043312; GO:0050832; GO:0051015; GO:0070062; GO:1904813";"defense response to fungus [GO:0050832]; neutrophil degranulation [GO:0043312]; regulation of actin filament polymerization [GO:0030833]";"cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]"
comp108723_c2_seq1;GAXK01035836.1;Q5E965;3.78E-26;C56D2_BOVIN;Cytochrome b561 domain-containing protein 2 (EC 7.2.1.3) (Putative tumor suppressor protein 101F6) (Transmembrane ascorbate ferrireductase);"cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; ferroxidase activity [GO:0004322]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0004322; GO:0005783; GO:0005789; GO:0016021; GO:0020037; GO:0030659; GO:0031982; GO:0046872";;"cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]";"ferroxidase activity [GO:0004322]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp1087330_c0_seq1;GAXK01153716.1;P55853;1.67E-13;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp108767_c0_seq1;GAXK01035997.1;Q9UMY4;9.81E-53;SNX12_HUMAN;Sorting nexin-12;"early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]";"GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0016020; GO:0019899; GO:0030100; GO:0035091; GO:0042177; GO:0051224; GO:2000642";"negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]";"early endosome [GO:0005769]; membrane [GO:0016020]";"enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]"
comp1087722_c1_seq1;GAXK01153680.1;Q7Z7L9;4.96E-30;ZSCA2_HUMAN;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp1087778_c0_seq1;GAXK01153683.1;A4IIW9;6.50E-09;LIGO1_XENTR;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]";"GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012";;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";epidermal growth factor receptor binding [GO:0005154]
comp1087951_c0_seq1;GAXK01153715.1;Q62687;5.27E-10;S6A18_RAT;Sodium-dependent neutral amino acid transporter B(0)AT3 (Renal osmotic stress-induced Na-Cl organic solute cotransporter) (ROSIT) (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; hyperosmotic response [GO:0006972]; response to osmotic stress [GO:0006970]";"GO:0005328; GO:0005886; GO:0005887; GO:0006970; GO:0006972; GO:0015175; GO:0016324";"hyperosmotic response [GO:0006972]; response to osmotic stress [GO:0006970]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp108798_c0_seq1;GAXK01035983.1;Q80T79;8.08E-24;CSMD3_MOUSE;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1088025_c1_seq1;GAXK01049626.1;P45436;2.84E-25;CED3_CAERE;"Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]";"cell junction [GO:0030054]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"GO:0004197; GO:0005739; GO:0006915; GO:0030054; GO:0031965; GO:0042981; GO:0043204; GO:0045202; GO:0048471";"apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"cell junction [GO:0030054]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]";cysteine-type endopeptidase activity [GO:0004197]
comp1088100_c0_seq1;GAXK01049658.1;O44119;1.59E-42;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp108824_c0_seq1;GAXK01035961.1;P14533;2.36E-18;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp108851_c1_seq1;GAXK01036244.1;Q9H0U3;3.34E-124;MAGT1_HUMAN;Magnesium transporter protein 1 (MagT1) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1) (Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein) (IAP);"azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; neutrophil degranulation [GO:0043312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]";"GO:0005783; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0016020; GO:0018279; GO:0035577; GO:0043312; GO:0050890; GO:0055085";"cognition [GO:0050890]; magnesium ion transport [GO:0015693]; neutrophil degranulation [GO:0043312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]";"azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]";magnesium ion transmembrane transporter activity [GO:0015095]
comp1088516_c0_seq1;GAXK01049679.1;Q28623;2.14E-19;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp1088550_c0_seq1;GAXK01049672.1;Q8Q0U0;3.67E-11;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp108864_c1_seq1;GAXK01035989.1;P48583;3.54E-60;ERD21_CAEEL;ER lumen protein-retaining receptor erd-2.1;"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]";"GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0015031; GO:0016021; GO:0046923";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";ER retention sequence binding [GO:0046923]
comp1088767_c0_seq1;GAXK01049656.1;Q7KRI2;2.53E-13;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp108880_c0_seq1;GAXK01036238.1;Q9QX29;6.26E-24;TRPC5_MOUSE;Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]";"GO:0003779; GO:0005262; GO:0005737; GO:0005887; GO:0006828; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045121; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051480; GO:0070588; GO:0070679; GO:1902630";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]";"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp108884_c0_seq1;GAXK01036121.1;P05661;3.25E-28;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1088858_c0_seq1;GAXK01049663.1;P28472;4.15E-07;GBRB3_HUMAN;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007605; GO:0022851; GO:0030054; GO:0030659; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043524; GO:0045202; GO:0045211; GO:0050877; GO:0060021; GO:0060080; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098982; GO:1902476; GO:1902711; GO:1904315; GO:1904862";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp108889_c0_seq1;GAXK01036088.1;P35038;3.96E-51;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1089075_c0_seq1;GAXK01049684.1;P41247;1.31E-40;PLPL4_HUMAN;Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Protein GS2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005739; GO:0005829; GO:0019433; GO:0050253";triglyceride catabolic process [GO:0019433];"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]"
comp108920_c1_seq1;GAXK01035971.1;Q9V427;2.36E-30;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp108925_c0_seq1;GAXK01036103.1;Q66IB8;2.21E-31;CB076_DANRE;UPF0538 protein C2orf76 homolog;;;;;
comp1089256_c0_seq1;GAXK01049668.1;Q5ZKQ3;3.74E-22;RPAP3_CHICK;RNA polymerase II-associated protein 3;;;;;
comp108949_c0_seq1;GAXK01035927.1;P0C7N9;2.10E-18;PSMG4_MOUSE;Proteasome assembly chaperone 4 (PAC-4) (mPAC4);proteasome assembly [GO:0043248];GO:0043248;proteasome assembly [GO:0043248];;
comp108952_c2_seq1;GAXK01035827.1;Q6P1R4;2.86E-148;DUS1L_HUMAN;tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 1-like);"flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]";"GO:0017150; GO:0050660";;;"flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]"
comp1089533_c0_seq1;GAXK01049641.1;P23416;2.19E-53;GLRA2_HUMAN;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp108963_c1_seq1;GAXK01036208.1;Q60739;7.00E-16;BAG1_MOUSE;BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; phosphoprotein binding [GO:0051219]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of protein phosphorylation [GO:0001933]; neuron differentiation [GO:0030182]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to mitochondrion [GO:0070585]";"GO:0000774; GO:0001933; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0014040; GO:0030182; GO:0031625; GO:0043066; GO:0043525; GO:0045944; GO:0048471; GO:0051085; GO:0051087; GO:0051219; GO:0070585; GO:2000672";"apoptotic process [GO:0006915]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of protein phosphorylation [GO:0001933]; neuron differentiation [GO:0030182]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to mitochondrion [GO:0070585]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; phosphoprotein binding [GO:0051219]; ubiquitin protein ligase binding [GO:0031625]"
comp10902460_c0_seq1;GAXK01114143.1;Q9CQS8;1.24E-10;SC61B_MOUSE;Protein transport protein Sec61 subunit beta;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005086; GO:0005783; GO:0005784; GO:0006616; GO:0016020; GO:0016021; GO:0030433; GO:0030970; GO:0031204; GO:0031205; GO:0043022; GO:0044322; GO:0048408";"posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]"
comp1090267_c0_seq1;GAXK01118733.1;P56974;1.79E-15;NRG2_MOUSE;Pro-neuregulin-2, membrane-bound isoform (Pro-NRG2) [Cleaved into: Neuregulin-2 (NRG-2) (Divergent of neuregulin 1) (DON-1)];"extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; epidermal growth factor-activated receptor activity [GO:0005006]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; regulation of synapse maturation [GO:0090128]";"GO:0005006; GO:0005102; GO:0005154; GO:0005615; GO:0005886; GO:0007173; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0043125; GO:0051963; GO:0090128; GO:0098978; GO:0098982";"epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; regulation of synapse maturation [GO:0090128]";"extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]"
comp1090559_c0_seq1;GAXK01118717.1;Q95218;2.47E-54;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp1090701_c0_seq1;GAXK01118689.1;P06213;2.65E-15;INSR_HUMAN;"Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]";"axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; anatomical structure development [GO:0048856]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transformation of host cell by virus [GO:0019087]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000187; GO:0001540; GO:0001934; GO:0003007; GO:0004713; GO:0004714; GO:0005009; GO:0005159; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0005975; GO:0006355; GO:0006468; GO:0006898; GO:0007169; GO:0007186; GO:0007612; GO:0007613; GO:0008284; GO:0008286; GO:0008544; GO:0008584; GO:0009897; GO:0010008; GO:0014068; GO:0016020; GO:0018108; GO:0019087; GO:0019904; GO:0030238; GO:0030325; GO:0030335; GO:0030424; GO:0031017; GO:0031994; GO:0031995; GO:0032147; GO:0032148; GO:0032590; GO:0032809; GO:0032869; GO:0038024; GO:0038083; GO:0042593; GO:0042802; GO:0043235; GO:0043243; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044877; GO:0045429; GO:0045725; GO:0045821; GO:0045840; GO:0045893; GO:0045995; GO:0046326; GO:0046777; GO:0048639; GO:0048856; GO:0051290; GO:0051425; GO:0051446; GO:0051897; GO:0060267; GO:0070062; GO:0071363; GO:0097062; GO:0097242; GO:1990535; GO:2000194";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; anatomical structure development [GO:0048856]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transformation of host cell by virus [GO:0019087]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp109075_c1_seq1;GAXK01036118.1;Q9CRB3;6.55E-31;HIUH_MOUSE;5-hydroxyisourate hydrolase (HIU hydrolase) (HIUHase) (EC 3.5.2.17) (Transthyretin-related protein);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";"GO:0005739; GO:0005777; GO:0006144; GO:0016787; GO:0019628; GO:0033971";"purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]"
comp109089_c0_seq1;GAXK01036193.1;A4II29;7.75E-18;NRARP_XENTR;Notch-regulated ankyrin repeat-containing protein;"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]";"GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0045746; GO:0090263";"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]";;
comp109093_c0_seq1;GAXK01036198.1;O74503;3.43E-11;UAF30_SCHPO;Upstream activation factor subunit spp27 (Upstream activation factor 27 KDa subunit) (p27) (Upstream activation factor 30 KDa subunit) (p30) (Upstream activation factor subunit uaf30);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0000500; GO:0001181; GO:0005634; GO:0005829; GO:0006361";transcription initiation from RNA polymerase I promoter [GO:0006361];"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]";RNA polymerase I general transcription initiation factor activity [GO:0001181]
comp109096_c1_seq1;GAXK01036237.1;Q07327;2.61E-134;ROP_DROME;Protein ROP;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005737; GO:0005829; GO:0006887; GO:0006904; GO:0007268; GO:0007269; GO:0007317; GO:0009416; GO:0015031; GO:0016020; GO:0016082; GO:0016192; GO:0019898; GO:0030707; GO:0032940; GO:0043195; GO:0048489; GO:1900006";"chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]";SNARE binding [GO:0000149]
comp10911_c1_seq1;GAXK01187730.1;Q66HY8;2.25E-96;PDXD1_DANRE;Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-);"endoplasmic reticulum [GO:0005783]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";"GO:0001667; GO:0005783; GO:0006665; GO:0008117; GO:0016831; GO:0019752; GO:0030149; GO:0030170";"ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";endoplasmic reticulum [GO:0005783];"carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]"
comp1091110_c0_seq1;GAXK01118721.1;Q9P2J2;2.36E-22;TUTLA_HUMAN;Protein turtle homolog A (Immunoglobulin superfamily member 9A) (IgSF9A);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]";"GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016358; GO:0030054; GO:0030424; GO:0030425; GO:0050807; GO:0060077; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp1091335_c0_seq1;GAXK01118701.1;D4A734;2.78E-27;MOT12_RAT;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1091363_c0_seq1;GAXK01118718.1;O97399;1.47E-11;TRYP_PHACE;Trypsin (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586";digestion [GO:0007586];extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp109144_c0_seq1;GAXK01035823.1;Q29FE1;8.78E-131;DBR1_DROPS;Lariat debranching enzyme (EC 3.1.-.-);"nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000375; GO:0005634; GO:0006397; GO:0008419";"mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]";nucleus [GO:0005634];RNA lariat debranching enzyme activity [GO:0008419]
comp109153_c1_seq1;GAXK01036084.1;P13590;9.12E-27;NCAM1_CHICK;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]";"GO:0005886; GO:0007156; GO:0016021; GO:0099560";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1091560_c0_seq1;GAXK01118688.1;Q92005;2.65E-61;EF1A_DANRE;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414";"translation [GO:0006412]; translational elongation [GO:0006414]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp10916_c0_seq1;GAXK01187330.1;Q91XV4;7.50E-106;DCXR_MESAU;L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h);"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]";"GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289";"D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]";"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]";"identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"
comp1091723_c0_seq1;GAXK01118704.1;Q9Y2H8;1.17E-13;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp109174_c3_seq1;GAXK01035931.1;Q8CJ19;0;MICA3_MOUSE;[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0017137; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0051301; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]";"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]"
comp1091865_c0_seq1;GAXK01118702.1;Q8N122;1.37E-11;RPTOR_HUMAN;Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cell cycle arrest [GO:0007050]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of macroautophagy [GO:0016241]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; viral process [GO:0016032]";"GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0007050; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0016032; GO:0016241; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0043025; GO:0044877; GO:0045945; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900034; GO:1900087";"cell cycle arrest [GO:0007050]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of macroautophagy [GO:0016241]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]";"14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp109190_c3_seq1;GAXK01036152.1;A4QNR8;7.15E-70;LENG8_DANRE;Leukocyte receptor cluster member 8 homolog;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp1091985_c0_seq1;GAXK01118716.1;O01404;2.24E-55;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp10920_c5_seq1;GAXK01188367.1;Q15418;0;KS6A1_HUMAN;Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]";"GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491";"cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]"
comp109225_c8_seq1;GAXK01036179.1;Q9VZZ4;5.17E-28;PXDN_DROME;Peroxidasin (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831";"basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp109248_c3_seq1;GAXK01036014.1;Q8TEP8;5.46E-19;CE192_HUMAN;Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2);"centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617]";"GO:0000086; GO:0000242; GO:0005813; GO:0005814; GO:0005829; GO:0009617; GO:0010389; GO:0010923; GO:0019902; GO:0051298; GO:0071539; GO:0090222; GO:0090307; GO:0097711";"centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617]";"centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]";phosphatase binding [GO:0019902]
comp1093143_c0_seq1;GAXK01040959.1;Q6ZMW2;1.12E-08;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1093216_c0_seq1;GAXK01040974.1;Q9JHE4;6.91E-53;G3ST1_MOUSE;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0001733; GO:0006682; GO:0007283; GO:0009247; GO:0016021; GO:0042552";"galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp1093437_c0_seq1;GAXK01040987.1;Q9XT75;5.73E-159;HEM0_DELLE;5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0030218; GO:0042541";"erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]"
comp109350_c1_seq1;GAXK01036202.1;Q8NBN7;1.64E-92;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp109408_c0_seq1;GAXK01035804.1;Q39571;1.89E-27;YPTC1_CHLRE;GTP-binding protein YPTC1;"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]";"GO:0003924; GO:0005525; GO:0005886; GO:0015031";protein transport [GO:0015031];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1094099_c0_seq1;GAXK01045844.1;Q8ITC7;1.18E-55;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp109414_c0_seq1;GAXK01035807.1;Q99JB0;1.24E-47;KLF7_MOUSE;Krueppel-like factor 7;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007409; GO:0007411; GO:0042593; GO:0045604; GO:0045893; GO:0045944; GO:0046872; GO:0048813; GO:0061179; GO:1904178";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp109419_c2_seq1;GAXK01036085.1;P25991;0;SUF_DROME;Protein suppressor of forked;"mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]";"GO:0003729; GO:0005634; GO:0005848; GO:0006397; GO:0031123; GO:1903220";"mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]";"mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]";mRNA binding [GO:0003729]
comp109448_c1_seq1;GAXK01035788.1;Q7KRI2;1.53E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1094500_c0_seq1;GAXK01045720.1;Q5RFH3;3.52E-67;NDKB_PONAB;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0003677; GO:0004550; GO:0004673; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0009142; GO:0030027; GO:0045893; GO:0045944; GO:0046872; GO:0051880; GO:0071944";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]"
comp109453_c0_seq1;GAXK01035881.1;O44119;4.95E-59;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp1095_c0_seq1;GAXK01169054.1;Q28690;1.86E-91;EI2BB_RABIT;Translation initiation factor eIF-2B subunit beta (eIF-2B GDP-GTP exchange factor subunit beta);"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"GO:0001541; GO:0003743; GO:0005524; GO:0005525; GO:0005737; GO:0005851; GO:0006413; GO:0007417; GO:0014003; GO:0042552; GO:0050852";"central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]"
comp109580_c4_seq1;GAXK01035790.1;P48607;1.88E-08;SPZ_DROME;Protein spaetzle [Cleaved into: Protein spaetzle C-106];"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0002807; GO:0005121; GO:0005125; GO:0005576; GO:0005615; GO:0006965; GO:0006967; GO:0007310; GO:0007399; GO:0007526; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0009611; GO:0009950; GO:0009953; GO:0021556; GO:0031334; GO:0031640; GO:0032991; GO:0042542; GO:0042803; GO:0045087; GO:0045752; GO:0048018; GO:0050829; GO:0050830; GO:0050832; GO:0061760";"antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp1095900_c1_seq1;GAXK01045841.1;Q9NGC3;5.55E-08;CEG1A_DROME;Centaurin-gamma-1A;"membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375";"medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp109615_c0_seq1;GAXK01036203.1;P35992;0;PTP10_DROME;Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D);"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446";"axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp10962_c0_seq1;GAXK01187547.1;Q52KN7;4.91E-134;CPE1B_XENLA;Cytoplasmic polyadenylation element-binding protein 1-B (CPE-BP1-B) (CPE-binding protein 1-B) (CPEB-1-B);"cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]";"GO:0000900; GO:0000922; GO:0005634; GO:0005737; GO:0005815; GO:0006397; GO:0016020; GO:0032869; GO:0035925; GO:0046872; GO:0071230; GO:0071456; GO:2000766";"cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp109622_c0_seq1;GAXK01036226.1;Q86WC4;8.11E-20;OSTM1_HUMAN;Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; ion transmembrane transport [GO:0034220]; osteoclast differentiation [GO:0030316]";"GO:0005765; GO:0005829; GO:0016021; GO:0030316; GO:0034220";"ion transmembrane transport [GO:0034220]; osteoclast differentiation [GO:0030316]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";
comp1096235_c0_seq1;GAXK01040014.1;Q6ZPS6;0;AKIB1_MOUSE;Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31);"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp1096267_c0_seq1;GAXK01039986.1;Q6ZN57;6.57E-30;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp109628_c1_seq1;GAXK01036090.1;Q9Z200;1.80E-71;SH2B2_RAT;SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS);"actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; identical protein binding [GO:0042802]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton organization [GO:0030036]; antigen receptor-mediated signaling pathway [GO:0050851]; B-1 B cell homeostasis [GO:0001922]; brown fat cell differentiation [GO:0050873]; cytokine-mediated signaling pathway [GO:0019221]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of metabolic process [GO:0019222]; regulation of Ras protein signal transduction [GO:0046578]";"GO:0001725; GO:0001726; GO:0001922; GO:0005068; GO:0005070; GO:0005737; GO:0005884; GO:0005886; GO:0007399; GO:0008286; GO:0019221; GO:0019222; GO:0030036; GO:0035556; GO:0042802; GO:0046578; GO:0050851; GO:0050873";"actin cytoskeleton organization [GO:0030036]; antigen receptor-mediated signaling pathway [GO:0050851]; B-1 B cell homeostasis [GO:0001922]; brown fat cell differentiation [GO:0050873]; cytokine-mediated signaling pathway [GO:0019221]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of metabolic process [GO:0019222]; regulation of Ras protein signal transduction [GO:0046578]";"actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]";"identical protein binding [GO:0042802]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]"
comp1096410_c0_seq1;GAXK01040002.1;P12544;1.76E-22;GRAA_HUMAN;Granzyme A (EC 3.4.21.78) (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor) (H factor) (HF);"extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to bacterium [GO:0009617]";"GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0006915; GO:0006955; GO:0009617; GO:0019835; GO:0032078; GO:0042803; GO:0043065; GO:0043392; GO:0051354; GO:0051603";"apoptotic process [GO:0006915]; cytolysis [GO:0019835]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to bacterium [GO:0009617]";"extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]";"protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp109649_c1_seq1;GAXK01035936.1;A0JNH9;1.18E-10;APLF_BOVIN;Aprataxin and PNK-like factor (EC 4.2.99.18) (Apurinic-apyrimidinic endonuclease APLF);"cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005829; GO:0006302; GO:0006974; GO:0008408; GO:0035861; GO:0046872; GO:0140078";"cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp1096568_c0_seq1;GAXK01039999.1;Q6ZNG1;2.71E-25;ZN600_HUMAN;Zinc finger protein 600;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1096578_c0_seq1;GAXK01040008.1;Q9UBS5;1.98E-34;GABR1_HUMAN;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]";"GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]";"G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]"
comp10968_c1_seq1;GAXK01188536.1;Q960E8;2.41E-174;TF2H1_DROME;General transcription factor IIH subunit 1 (TFIIH basal transcription factor complex subunit 1);"nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional open complex formation at RNA polymerase II promoter [GO:0001113]";"GO:0000439; GO:0001111; GO:0001113; GO:0005634; GO:0005675; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009411; GO:0070816";"nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcriptional open complex formation at RNA polymerase II promoter [GO:0001113]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]";
comp109685_c0_seq1;GAXK01035831.1;P22935;5.38E-22;RABP2_MOUSE;Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]";"GO:0001972; GO:0002138; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0042573; GO:0048385; GO:0048672";"embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]"
comp1096856_c0_seq1;GAXK01040029.1;Q0P6D2;4.41E-26;DIK1C_HUMAN;Divergent protein kinase domain 1C (Protein FAM69C);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp10970_c0_seq1;GAXK01188451.1;P80311;6.21E-84;PPIB_BOVIN;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"GO:0000413; GO:0003755; GO:0005634; GO:0005788; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070063";"bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]"
comp109702_c0_seq1;GAXK01036109.1;P30531;2.13E-100;SC6A1_HUMAN;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp109711_c0_seq1;GAXK01036010.1;A4IHY0;4.02E-61;OXND1_XENTR;Oxidoreductase NAD-binding domain-containing protein 1 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1097152_c0_seq1;GAXK01040001.1;A2ALS5;5.97E-53;RPGP1_MOUSE;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792";"cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp1097180_c0_seq1;GAXK01040017.1;Q13635;5.89E-11;PTC1_HUMAN;Protein patched homolog 1 (PTC) (PTC1);"axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]";"GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005634; GO:0005886; GO:0005901; GO:0007224; GO:0007346; GO:0007420; GO:0008158; GO:0008201; GO:0008589; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010875; GO:0014069; GO:0015485; GO:0016021; GO:0016485; GO:0021522; GO:0021532; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030666; GO:0030850; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040015; GO:0042493; GO:0042593; GO:0043231; GO:0043433; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045606; GO:0045668; GO:0045879; GO:0045893; GO:0048471; GO:0048568; GO:0050680; GO:0051782; GO:0060037; GO:0060170; GO:0060603; GO:0060644; GO:0060831; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072001; GO:0072203; GO:0072659; GO:0097108; GO:0097421";"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]";"axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]"
comp10972_c0_seq1;GAXK01187991.1;P97536;0;CAND1_RAT;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1);"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0043086; GO:0045893; GO:0045899";"cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";TBP-class protein binding [GO:0017025]
comp109735_c0_seq1;GAXK01035979.1;Q5PQS6;1.95E-61;SMG9_RAT;Protein SMG9;"identical protein binding [GO:0042802]; brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"GO:0000184; GO:0001654; GO:0001701; GO:0007420; GO:0007507; GO:0042802";"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";;identical protein binding [GO:0042802]
comp109739_c1_seq1;GAXK01035946.1;Q28E45;1.25E-79;MCM10_XENTR;Protein MCM10 homolog;"nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]";"GO:0003688; GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0031298; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]";"nucleus [GO:0005634]; replication fork protection complex [GO:0031298]";"DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]"
comp10974_c0_seq1;GAXK01188113.1;Q75QI0;1.37E-33;CFDP1_CHICK;Craniofacial development protein 1 (Bucentaur);"condensed chromosome kinetochore [GO:0000777]; multicellular organism development [GO:0007275]";"GO:0000777; GO:0007275";multicellular organism development [GO:0007275];condensed chromosome kinetochore [GO:0000777];
comp109771_c0_seq1;GAXK01036231.1;Q5R5X9;1.81E-34;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp109778_c0_seq1;GAXK01035960.1;P51547;6.69E-43;SODE_HAECO;Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005615; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp1097817_c0_seq1;GAXK01040034.1;P48180;7.11E-128;ACH1_CAEEL;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp109796_c2_seq1;GAXK01035852.1;Q7ZYA5;1.79E-13;PRKAA_XENLA;Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog A;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422]";"GO:0003725; GO:0005634; GO:0005737; GO:0008047; GO:0030422; GO:0048471";production of siRNA involved in RNA interference [GO:0030422];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]"
comp1098095_c0_seq1;GAXK01081449.1;Q9VT04;1.10E-34;PATH_DROME;Proton-coupled amino acid transporter-like protein pathetic;"axon [GO:0030424]; dendrite [GO:0030425]; endolysosome [GO:0036019]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; dendrite extension [GO:0097484]; dendrite morphogenesis [GO:0048813]; regulation of cell projection size [GO:0032536]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing size [GO:0044719]";"GO:0003333; GO:0005765; GO:0005886; GO:0015171; GO:0016021; GO:0030424; GO:0030425; GO:0031902; GO:0032536; GO:0036019; GO:0040008; GO:0043025; GO:0043204; GO:0044719; GO:0048813; GO:0097484";"amino acid transmembrane transport [GO:0003333]; dendrite extension [GO:0097484]; dendrite morphogenesis [GO:0048813]; regulation of cell projection size [GO:0032536]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing size [GO:0044719]";"axon [GO:0030424]; dendrite [GO:0030425]; endolysosome [GO:0036019]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";amino acid transmembrane transporter activity [GO:0015171]
comp1098165_c0_seq1;GAXK01081430.1;Q24270;9.20E-84;CAC1D_DROME;Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]";"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp10983_c2_seq1;GAXK01188338.1;Q02752;1.74E-10;PHPA_PLACH;Acidic phosphoprotein (50 kDa antigen);plasma membrane [GO:0005886];GO:0005886;;plasma membrane [GO:0005886];
comp109834_c0_seq1;GAXK01035806.1;Q6V5K9;1.94E-13;ZN474_MOUSE;Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1098343_c1_seq1;GAXK01081456.1;Q80UG8;1.16E-87;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp1098472_c0_seq1;GAXK01081448.1;O46040;1.76E-14;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp109893_c0_seq1;GAXK01036222.1;Q9NFP5;4.73E-21;SH3BG_DROME;SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein);SH3 domain binding [GO:0017124];GO:0017124;;;SH3 domain binding [GO:0017124]
comp109894_c0_seq1;GAXK01035896.1;O14327;6.11E-14;PAB2_SCHPO;Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Poly(A)-binding protein II) (PABII);"cytoplasm [GO:0005737]; Mmi1 nuclear focus [GO:1990251]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; poly(A) binding [GO:0008143]; mRNA catabolic process [GO:0006402]";"GO:0000790; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005844; GO:0006402; GO:0008143; GO:0016604; GO:1990251";mRNA catabolic process [GO:0006402];"cytoplasm [GO:0005737]; Mmi1 nuclear focus [GO:1990251]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]";poly(A) binding [GO:0008143]
comp109895_c0_seq1;GAXK01035941.1;Q8C3B8;1.18E-77;RFT1_MOUSE;Protein RFT1 homolog;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid transporter activity [GO:0005319]; carbohydrate transport [GO:0008643]; glycolipid translocation [GO:0034203]";"GO:0005319; GO:0005789; GO:0008643; GO:0016021; GO:0034203";"carbohydrate transport [GO:0008643]; glycolipid translocation [GO:0034203]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";lipid transporter activity [GO:0005319]
comp10991_c0_seq1;GAXK01187638.1;Q92667;1.45E-48;AKAP1_HUMAN;A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; regulation of protein kinase A signaling [GO:0010738]";"GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0007596; GO:0010738; GO:0016020; GO:0016021; GO:0034237";"blood coagulation [GO:0007596]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]"
comp109910_c0_seq1;GAXK01035777.1;Q8AVL0;3.03E-169;C19L1_XENLA;CWF19-like protein 1;;;;;
comp1099257_c0_seq1;GAXK01081431.1;Q4UMH6;1.13E-19;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp1099365_c0_seq1;GAXK01081440.1;P18729;1.47E-15;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp109952_c0_seq1;GAXK01035985.1;Q5R4L2;1.43E-34;STX1A_PONAB;Syntaxin-1A;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of norepinephrine secretion [GO:0010701]";"GO:0000149; GO:0005484; GO:0005886; GO:0006836; GO:0006886; GO:0006887; GO:0010701; GO:0016021; GO:0030054; GO:0030672; GO:0031201; GO:0033605; GO:0043005; GO:0045956";"exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of norepinephrine secretion [GO:0010701]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp10997_c0_seq1;GAXK01187460.1;Q32QL6;2.09E-68;GPX4_CALJA;Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4);"mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"GO:0004602; GO:0005739; GO:0006979; GO:0007275; GO:0007283; GO:0047066; GO:0110076";"multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";mitochondrion [GO:0005739];"glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]"
comp109970_c1_seq1;GAXK01035845.1;P40313;2.35E-21;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1099755_c0_seq1;GAXK01081437.1;Q28036;7.96E-96;SL9A1_BOVIN;Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; cellular response to acidic pH [GO:0071468]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to acidic pH [GO:0010447]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005516; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006885; GO:0010447; GO:0015385; GO:0015386; GO:0016021; GO:0036376; GO:0048306; GO:0051259; GO:0051453; GO:0071468; GO:0071805; GO:0098719";"cellular response to acidic pH [GO:0071468]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to acidic pH [GO:0010447]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp1099834_c0_seq1;GAXK01081424.1;Q9HAR2;1.10E-23;AGRL3_HUMAN;Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp109989_c0_seq1;GAXK01035885.1;O15992;2.78E-31;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp11_c0_seq1;GAXK01168702.1;P48588;5.06E-37;RS25_DROME;40S ribosomal protein S25;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp110_c1_seq1;GAXK01166608.1;P33502;1.10E-82;NU1M_ANOQU;NADH-ubiquinone oxidoreductase chain 1 (EC 7.1.1.2) (NADH dehydrogenase subunit 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]";"GO:0005743; GO:0008137; GO:0016021; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp110001_c3_seq1;GAXK01034975.1;Q9C0D7;2.58E-96;ZC12C_HUMAN;Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C);"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]";"GO:0004519; GO:0046872";;;"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp110021_c0_seq1;GAXK01034751.1;Q0VCJ7;1.08E-36;RERG_BOVIN;Ras-related and estrogen-regulated growth inhibitor;"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]";"GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308";"negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp11004_c2_seq1;GAXK01187336.1;B5EBQ4;1.55E-24;DDL_GEOBB;D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]"
comp1100567_c0_seq1;GAXK01029656.1;Q9ZRT5;4.75E-17;GSTT1_ARATH;Glutathione S-transferase T1 (AtGSTT1) (EC 2.5.1.18) (GST class-theta member 1) (Glutathione S-transferase 10);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plastid [GO:0009536]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; toxin catabolic process [GO:0009407]";"GO:0004364; GO:0004601; GO:0005634; GO:0005737; GO:0005777; GO:0009407; GO:0009536";toxin catabolic process [GO:0009407];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plastid [GO:0009536]";"glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]"
comp1100740_c0_seq1;GAXK01029651.1;O02827;6.59E-79;MYLK_SHEEP;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] (Fragment);"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp110079_c4_seq1;GAXK01035112.1;B4F7C5;1.09E-07;LRRT4_RAT;Leucine-rich repeat transmembrane neuronal protein 4;"cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; synapse organization [GO:0050808]";"GO:0005615; GO:0030054; GO:0031012; GO:0050808; GO:0098978; GO:0099061";synapse organization [GO:0050808];"cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]";
comp110081_c0_seq1;GAXK01034884.1;Q4V8K5;1.48E-117;BROX_RAT;BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein);membrane [GO:0016020];GO:0016020;;membrane [GO:0016020];
comp11009_c0_seq1;GAXK01187761.1;Q7ZVK3;3.14E-92;SIR2_DANRE;NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2);"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]";"GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777";"cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]";"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]";"histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]"
comp1101_c3_seq1;GAXK01168206.1;Q7PPA5;0;ATC1_ANOGA;Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump);"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]";"GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0033017; GO:0046872; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]";"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp1101317_c0_seq1;GAXK01029647.1;Q965X6;1.23E-07;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1101493_c0_seq1;GAXK01029634.1;Q8VIG1;1.59E-14;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp110178_c1_seq1;GAXK01034780.1;Q25074;2.67E-60;AQP_HAEIX;Aquaporin (BfWC1) (Water channel 1);"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp1101882_c0_seq1;GAXK01029635.1;Q09621;2.60E-30;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp11022_c3_seq1;GAXK01187408.1;P25071;1.06E-24;CML12_ARATH;Calmodulin-like protein 12 (Touch-induced calmodulin-related protein 3);"cytosol [GO:0005829]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; response to absence of light [GO:0009646]; response to mechanical stimulus [GO:0009612]; thigmotropism [GO:0009652]";"GO:0005509; GO:0005774; GO:0005829; GO:0009506; GO:0009612; GO:0009646; GO:0009652; GO:0019722";"calcium-mediated signaling [GO:0019722]; response to absence of light [GO:0009646]; response to mechanical stimulus [GO:0009612]; thigmotropism [GO:0009652]";"cytosol [GO:0005829]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]";calcium ion binding [GO:0005509]
comp110228_c2_seq1;GAXK01035122.1;Q8BUR4;5.29E-93;DOCK1_MOUSE;Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; hematopoietic progenitor cell differentiation [GO:0002244]; phagocytosis [GO:0006909]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; small GTPase mediated signal transduction [GO:0007264]";"GO:0002244; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0006909; GO:0006915; GO:0007264; GO:0010634; GO:0016020; GO:0016477; GO:0016607; GO:0017124; GO:0032045; GO:1900026";"apoptotic process [GO:0006915]; cell migration [GO:0016477]; hematopoietic progenitor cell differentiation [GO:0002244]; phagocytosis [GO:0006909]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; small GTPase mediated signal transduction [GO:0007264]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]"
comp110229_c2_seq1;GAXK01034988.1;O70370;1.62E-64;CATS_MOUSE;Cathepsin S (EC 3.4.22.27);"cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]";"GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0008233; GO:0008234; GO:0009986; GO:0010447; GO:0016020; GO:0016485; GO:0030574; GO:0031905; GO:0034769; GO:0043231; GO:0043236; GO:0043394; GO:0045453; GO:0048002; GO:0050729; GO:0051603; GO:0051930; GO:2001259";"antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]";"cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]"
comp110236_c0_seq1;GAXK01034960.1;Q9BTC0;5.01E-35;DIDO1_HUMAN;Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]";"GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190";"apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp1102415_c0_seq1;GAXK01082471.1;Q9Y4F4;2.35E-47;TGRM1_HUMAN;TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B);"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515";"axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]";
comp1102476_c0_seq1;GAXK01082478.1;Q98943;2.17E-40;CASP2_CHICK;"Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200";"apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp110254_c0_seq1;GAXK01034820.1;P07107;4.83E-18;ACBP_BOVIN;Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0005783; GO:0005794; GO:0008289";;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp1102549_c0_seq1;GAXK01082500.1;P49147;1.81E-94;PA24A_CHICK;"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; glycerophospholipid catabolic process [GO:0046475]";"GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0031410; GO:0046475; GO:0047498; GO:0102567; GO:0102568";glycerophospholipid catabolic process [GO:0046475];"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]";"calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp110265_c1_seq1;GAXK01205151.1;Q24537;8.93E-15;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp1102795_c0_seq1;GAXK01082475.1;Q5TP13;8.33E-07;MED15_ANOGA;Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15);"mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0005634; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];"mediator complex [GO:0016592]; nucleus [GO:0005634]";transcription coregulator activity [GO:0003712]
comp1102853_c0_seq1;GAXK01082489.1;Q9HAW7;3.35E-17;UD17_HUMAN;UDP-glucuronosyltransferase 1-7 (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G) (UDP-glucuronosyltransferase 1A7);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; retinoic acid binding [GO:0001972]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; drug metabolic process [GO:0017144]; excretion [GO:0007588]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]";"GO:0001972; GO:0004857; GO:0005080; GO:0005783; GO:0005789; GO:0006631; GO:0007588; GO:0008144; GO:0008194; GO:0009804; GO:0015020; GO:0016021; GO:0017144; GO:0019899; GO:0042573; GO:0042803; GO:0043231; GO:0045922; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:1904224; GO:2001030";"cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; drug metabolic process [GO:0017144]; excretion [GO:0007588]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"drug binding [GO:0008144]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; retinoic acid binding [GO:0001972]; UDP-glycosyltransferase activity [GO:0008194]"
comp110292_c2_seq1;GAXK01035096.1;P58283;1.49E-34;RN216_MOUSE;E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546";"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp110294_c4_seq1;GAXK01034810.1;Q90687;0;PTN11_CHICK;Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641]";"GO:0000077; GO:0000187; GO:0001784; GO:0004725; GO:0004726; GO:0005070; GO:0005158; GO:0005634; GO:0005737; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0009755; GO:0021697; GO:0030220; GO:0030971; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033629; GO:0035264; GO:0035265; GO:0035855; GO:0036302; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0061582; GO:0070374; GO:0071364";"abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organismal reproductive process [GO:0048609]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet formation [GO:0030220]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]"
comp1103_c1_seq1;GAXK01169401.1;Q960T2;1.22E-34;SAP47_DROME;Synapse-associated protein of 47 kDa;"synapse [GO:0045202]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"GO:0007268; GO:0008306; GO:0045202; GO:0048172";"associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";synapse [GO:0045202];
comp110303_c5_seq1;GAXK01034875.1;Q3U4H6;1.33E-91;HEXD_MOUSE;Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase);"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]";"GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561";carbohydrate metabolic process [GO:0005975];"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]";"beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp11031_c0_seq1;GAXK01187658.1;Q6P643;4.27E-58;THOC7_XENTR;THO complex subunit 7 homolog;"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0000445; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0016607";"mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]";RNA binding [GO:0003723]
comp110327_c0_seq1;GAXK01034763.1;P08155;5.34E-78;KRH1_DROME;Krueppel homolog 1 (Krueppel homologous protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007552; GO:0010977; GO:0035075; GO:0045316; GO:0046872";"metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp110361_c3_seq1;GAXK01034794.1;Q9Y2V0;1.28E-74;CO041_HUMAN;Protein C15orf41 (Protein HH114);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; erythrocyte differentiation [GO:0030218]";"GO:0005634; GO:0005737; GO:0030218";erythrocyte differentiation [GO:0030218];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1103898_c1_seq1;GAXK01082497.1;B3EYM8;4.98E-15;IABN_GEOSE;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp11041_c2_seq1;GAXK01187852.1;Q95M12;8.11E-120;LGMN_BOVIN;Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1);"lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624]";"GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0032801; GO:0051603; GO:1901185";"negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624]";lysosome [GO:0005764];cysteine-type endopeptidase activity [GO:0004197]
comp1104262_c1_seq1;GAXK01004848.1;Q8NDA2;1.01E-18;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp110445_c0_seq1;GAXK01034806.1;Q75WE7;3.79E-79;VWA5A_RAT;von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1);;;;;
comp11045_c0_seq1;GAXK01188535.1;Q5ZLK8;2.22E-24;CF120_CHICK;UPF0669 protein C6orf120 homolog;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1104556_c0_seq1;GAXK01004856.1;Q9P2J8;5.77E-14;ZN624_HUMAN;Zinc finger protein 624;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1104566_c0_seq1;GAXK01004857.1;P08761;1.88E-42;MSRA_DROME;Peptide methionine sulfoxide reductase (EC 1.8.4.11) (Ecdysone-induced protein 28/29 kDa) (Methionine-S-sulfoxide reductase) (Peptide-methionine (S)-S-oxide reductase);"cytoplasm [GO:0005737]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]";"GO:0000096; GO:0005737; GO:0006979; GO:0008113; GO:0008340; GO:0034599; GO:0036456";"cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]";cytoplasm [GO:0005737];"L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]"
comp11049_c0_seq1;GAXK01188041.1;Q9D531;1.14E-29;NXNL2_MOUSE;Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2);"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0007601; GO:0007608; GO:0045494";"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";;
comp110499_c2_seq1;GAXK01205141.1;P28492;1.49E-179;GLSL_RAT;Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase);"mitochondrial matrix [GO:0005759]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005759; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrial matrix [GO:0005759];glutaminase activity [GO:0004359]
comp110585_c1_seq1;GAXK01034767.1;Q7TQM3;7.01E-50;FGRL1_RAT;Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1);"cell-cell contact zone [GO:0044291]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0000139; GO:0001501; GO:0003179; GO:0005007; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030658; GO:0044291; GO:0051260; GO:0060412; GO:0060539; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]"
comp110608_c6_seq1;GAXK01034746.1;Q26474;4.21E-24;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp110634_c0_seq1;GAXK01034972.1;P70414;2.35E-10;NAC1_MOUSE;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0008092; GO:0009791; GO:0010763; GO:0010881; GO:0014704; GO:0014829; GO:0016020; GO:0016021; GO:0016323; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0035994; GO:0036376; GO:0042383; GO:0042995; GO:0043197; GO:0043198; GO:0044325; GO:0044557; GO:0045211; GO:0048747; GO:0051481; GO:0051924; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0086036; GO:0086038; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]"
comp11064_c0_seq1;GAXK01187962.1;Q8UVK2;0;SPT6H_DANRE;Transcription elongation factor SPT6 (Protein pandora);"transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0001756; GO:0003677; GO:0006368; GO:0007507; GO:0008023; GO:0031491; GO:0032968; GO:0034728; GO:0035050; GO:0035327; GO:0042393; GO:0042789; GO:0050684; GO:0061086; GO:0070827; GO:0071599";"chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]"
comp110667_c1_seq1;GAXK01034840.1;Q0EEE2;9.46E-28;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp11067_c0_seq1;GAXK01187468.1;Q27877;5.50E-21;ENO_SCHMA;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase);"phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0006096";glycolytic process [GO:0006096];phosphopyruvate hydratase complex [GO:0000015];"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp1106803_c0_seq1;GAXK01102261.1;Q08DK7;8.01E-50;MCATL_BOVIN;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015822; GO:0016021; GO:0089709; GO:1903400; GO:1903401; GO:1990575";"acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]"
comp110687_c0_seq1;GAXK01035001.1;A6QQM4;9.74E-18;ZN474_BOVIN;Zinc finger protein 474;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1106978_c0_seq1;GAXK01102263.1;Q6ZMW2;2.21E-29;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1107_c0_seq1;GAXK01166084.1;Q6WV72;5.88E-52;H4_MYTTR;Histone H4;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]";"GO:0000786; GO:0003677; GO:0005634; GO:0006352; GO:0046982";DNA-templated transcription, initiation [GO:0006352];"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp1107267_c0_seq1;GAXK01102294.1;B0FWD2;8.86E-29;NU3M_AEDAE;NADH-ubiquinone oxidoreductase chain 3 (EC 7.1.1.2) (NADH dehydrogenase subunit 3);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]";"GO:0008137; GO:0016021; GO:0031966; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp110765_c2_seq1;GAXK01034784.1;O60711;2.03E-33;LPXN_HUMAN;Leupaxin;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]";"GO:0002102; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007162; GO:0007165; GO:0016020; GO:0016607; GO:0033628; GO:0042995; GO:0046872; GO:0048471; GO:0050859; GO:0065003";"cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]"
comp1107680_c0_seq1;GAXK01102259.1;P08442;1.39E-18;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp110774_c0_seq1;GAXK01035118.1;Q802U2;1.40E-168;MIO_DANRE;GATOR complex protein MIOS;"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"GO:0005737; GO:0005765; GO:0032008; GO:0034198";"cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]";
comp1107802_c1_seq1;GAXK01102288.1;P07247;1.56E-08;KRUP_DROME;Protein krueppel;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; chromatin silencing [GO:0006342]; compound eye development [GO:0048749]; ganglion mother cell fate determination [GO:0007402]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";"GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0006342; GO:0007354; GO:0007400; GO:0007402; GO:0007411; GO:0007419; GO:0007443; GO:0007517; GO:0035206; GO:0035290; GO:0040034; GO:0043565; GO:0045892; GO:0046872; GO:0048749; GO:0050767; GO:0061332; GO:2000177";"axon guidance [GO:0007411]; chromatin silencing [GO:0006342]; compound eye development [GO:0048749]; ganglion mother cell fate determination [GO:0007402]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1107803_c0_seq1;GAXK01102281.1;Q8NB50;2.81E-30;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1107838_c0_seq1;GAXK01102276.1;G5EDN0;1.66E-14;ACC3_CAEEL;Acetylcholine-gated chloride channel subunit acc-3;"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp11080_c0_seq1;GAXK01188120.1;P40123;2.00E-129;CAP2_HUMAN;Adenylyl cyclase-associated protein 2 (CAP 2);"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0014069; GO:0030864; GO:0042802";"actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]"
comp1108018_c0_seq1;GAXK01005184.1;Q5REQ8;2.34E-74;DCP2_PONAB;m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2);"nucleus [GO:0005634]; P-body [GO:0000932]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]";"GO:0000184; GO:0000932; GO:0003723; GO:0005634; GO:0006402; GO:0030145; GO:0043488; GO:0050072; GO:0071044";"histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]";"nucleus [GO:0005634]; P-body [GO:0000932]";"m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]"
comp110816_c1_seq1;GAXK01035110.1;Q22505;6.49E-08;IMMT1_CAEEL;MICOS complex subunit MIC60-1 (Inner mitochondrial membrane protein 1) (Mitofilin homolog 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0005743; GO:0005753; GO:0016021; GO:0042407; GO:0070584";"cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; response to reactive oxygen species [GO:0000302]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]";
comp1108294_c0_seq1;GAXK01005200.1;Q8WZ42;2.54E-20;TITIN_HUMAN;Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14);"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493";"cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]"
comp1108699_c0_seq1;GAXK01005217.1;Q6IV72;2.40E-21;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1109000_c0_seq1;GAXK01005187.1;W4VS53;4.02E-08;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp11092_c0_seq1;GAXK01187341.1;Q9NVF7;1.33E-38;FBX28_HUMAN;F-box only protein 28;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";"GO:0000776; GO:0000777";;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";
comp1109250_c0_seq1;GAXK01005172.1;P05661;4.15E-87;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp110934_c0_seq1;GAXK01034822.1;Q6GQ66;3.29E-28;FAKD1_XENLA;FAST kinase domain-containing protein 1, mitochondrial;"mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]";"GO:0004672; GO:0005739";;mitochondrion [GO:0005739];protein kinase activity [GO:0004672]
comp110947_c1_seq1;GAXK01034967.1;B5X1G3;2.45E-158;GPHR_SALSA;Golgi pH regulator (Protein gpr89);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; voltage-gated ion channel activity [GO:0005244]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]";"GO:0000139; GO:0005244; GO:0015031; GO:0016021; GO:0034765";"protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";voltage-gated ion channel activity [GO:0005244]
comp110957_c0_seq1;GAXK01034987.1;Q5U4T3;8.32E-138;RHG26_XENLA;Rho GTPase-activating protein 26 (Rho-type GTPase-activating protein 26);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0005856; GO:0005925; GO:0007165; GO:0030036; GO:0051056";"actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]";GTPase activator activity [GO:0005096]
comp1109713_c0_seq1;GAXK01005215.1;Q5JVG2;1.63E-21;ZN484_HUMAN;Zinc finger protein 484;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp110982_c1_seq1;GAXK01204947.1;P28338;7.58E-53;GSTT1_MUSDO;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp1109872_c0_seq1;GAXK01005204.1;Q9QYI4;8.19E-30;DJB12_MOUSE;DnaJ homolog subfamily B member 12 (mDj10);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218";"cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]";Hsp70 protein binding [GO:0030544]
comp1109994_c0_seq1;GAXK01005175.1;Q96I24;9.38E-07;FUBP3_HUMAN;Far upstream element-binding protein 3 (FUSE-binding protein 3);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0010628; GO:0016020; GO:0045893; GO:0045944";"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp111_c2_seq1;GAXK01166584.1;Q9Y6V7;7.68E-10;DDX49_HUMAN;Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364";rRNA processing [GO:0006364];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1110159_c0_seq1;GAXK01174372.1;Q99MD8;2.75E-19;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1110200_c0_seq1;GAXK01174359.1;Q8BX90;6.50E-46;FND3A_MOUSE;Fibronectin type-III domain-containing protein 3A;"acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle membrane [GO:0012506]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"GO:0000139; GO:0001669; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016021; GO:0031410; GO:0060009; GO:0098609";"cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle membrane [GO:0012506]";
comp1110526_c0_seq1;GAXK01174369.1;Q24498;7.66E-12;RYR_DROME;Ryanodine receptor (Ryanodine receptor 44F);"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"GO:0005219; GO:0005509; GO:0005790; GO:0005886; GO:0006816; GO:0006936; GO:0007275; GO:0016021; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0035206; GO:0042383; GO:0048763; GO:0051209; GO:0060047; GO:0072347";"calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]";"calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]"
comp1110562_c0_seq1;GAXK01174331.1;Q90260;1.19E-07;ASL1B_DANRE;Achaete-scute homolog 1b (Zash-1b);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; endocrine pancreas development [GO:0031018]; hindbrain morphogenesis [GO:0021575]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]";"GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007423; GO:0008134; GO:0021575; GO:0030182; GO:0031018; GO:0043009; GO:0045666; GO:0045944; GO:0046983; GO:0050767; GO:0090575";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; endocrine pancreas development [GO:0031018]; hindbrain morphogenesis [GO:0021575]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp1110773_c0_seq1;GAXK01174380.1;P17970;6.94E-162;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp1110865_c0_seq1;GAXK01174378.1;O42329;1.28E-37;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp1110968_c0_seq1;GAXK01174396.1;Q5R5X9;3.97E-18;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp11110_c0_seq1;GAXK01187944.1;Q5XIT1;4.83E-92;MARE3_RAT;Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3);"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005815; GO:0005874; GO:0005881; GO:0008017; GO:0008022; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0045737; GO:0045893; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp1111030_c0_seq1;GAXK01174370.1;Q6ZNA1;6.05E-71;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp111106_c0_seq1;GAXK01034849.1;B2GV17;1.82E-102;CBPC5_RAT;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0045171; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp1111105_c1_seq1;GAXK01174364.1;A6H7I3;1.45E-51;ANGE2_BOVIN;Protein angel homolog 2;"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930]";"GO:0000175; GO:0003730; GO:0005737; GO:0015030; GO:0045930; GO:0070935";"3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]";"3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]"
comp1111485_c1_seq1;GAXK01174328.1;P48236;4.24E-15;YG3L_YEAST;Uncharacterized membrane protein YGR149W;"cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0005783; GO:0006656; GO:0016021; GO:0071944; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp1111540_c0_seq1;GAXK01174337.1;A8Y1P7;2.53E-29;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp111169_c4_seq1;GAXK01034759.1;Q64430;0;ATP7A_MOUSE;Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein homolog);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to copper ion [GO:0071280]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to manganese ion [GO:0010042]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]";"GO:0001568; GO:0001836; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007626; GO:0010042; GO:0010273; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0031069; GO:0031252; GO:0031410; GO:0031526; GO:0032767; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043086; GO:0043204; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0046034; GO:0046688; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0048813; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071280; GO:1903036; GO:1903136; GO:1904754; GO:1904959";"ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to copper ion [GO:0071280]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to manganese ion [GO:0010042]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]"
comp11117_c1_seq1;GAXK01188460.1;P55010;8.50E-70;IF5_HUMAN;Eukaryotic translation initiation factor 5 (eIF-5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; activation of GTPase activity [GO:0090630]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"GO:0001731; GO:0001732; GO:0003723; GO:0003743; GO:0003924; GO:0005092; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006413; GO:0006446; GO:0008135; GO:0045296; GO:0071074; GO:0090630";"activation of GTPase activity [GO:0090630]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"cadherin binding [GO:0045296]; eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp1111740_c0_seq1;GAXK01174330.1;Q5WN23;2.51E-14;GCP2_CAEBR;Glutamate carboxypeptidase 2 homolog (EC 3.4.17.21) (Glutamate carboxypeptidase II homolog);"integral component of membrane [GO:0016021]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; proteolysis [GO:0006508]";"GO:0004180; GO:0004181; GO:0006508; GO:0016021; GO:0046872";proteolysis [GO:0006508];integral component of membrane [GO:0016021];"carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]"
comp11119_c0_seq1;GAXK01188279.1;Q04451;1.74E-09;SYG_BOMMO;Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]";"GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0016740; GO:0046983";"diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]"
comp111200_c1_seq1;GAXK01035152.1;A1ZAU8;3.49E-53;PTRO_DROME;Patronin (Short spindle protein 4);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]";"GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0045167; GO:0051011; GO:0061867";"asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]";"calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]"
comp1112245_c0_seq1;GAXK01022708.1;Q8VIG1;2.23E-11;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1112265_c0_seq1;GAXK01022714.1;Q60520;5.98E-08;SIN3A_MOUSE;Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a);"chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; regulation of transcription, DNA-templated [GO:0006355]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]";"GO:0000122; GO:0000776; GO:0000785; GO:0000976; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0006476; GO:0007568; GO:0008134; GO:0010243; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030516; GO:0031937; GO:0032991; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678";"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]";"chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein-containing complex binding [GO:0044877]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1112690_c0_seq1;GAXK01022696.1;H2A0N1;2.82E-22;KCP2_PINMG;BPTI/Kunitz domain-containing protein 2 (Prism serine protease inhibitor 2) (PISP2);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp1112754_c0_seq1;GAXK01022692.1;Q9UPX0;3.31E-13;TUTLB_HUMAN;Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; kinase binding [GO:0019900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]";"GO:0007156; GO:0007399; GO:0014069; GO:0016021; GO:0019900; GO:0030054; GO:0030425; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]";"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]";kinase binding [GO:0019900]
comp1113_c8_seq2;GAXK01169043.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp111305_c0_seq2;GAXK01034978.1;P25162;0;ACH4_DROME;Acetylcholine receptor subunit beta-like 2 (Nicotinic acetylcholine receptor beta 2);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp11131_c0_seq1;GAXK01187366.1;P05661;1.13E-157;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1113114_c0_seq1;GAXK01022705.1;Q7KRI2;4.05E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1113285_c0_seq1;GAXK01022683.1;Q9NQX1;3.39E-12;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1113477_c0_seq1;GAXK01022698.1;Q50L44;1.18E-19;LIGO1_CHICK;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (cLINGO-1);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]";"GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012";;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";epidermal growth factor receptor binding [GO:0005154]
comp111373_c0_seq1;GAXK01034795.1;P02595;3.96E-43;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1114_c1_seq1;GAXK01169857.1;Q86RN8;3.15E-143;MYSP_RHIMP;Paramyosin;"myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]";"GO:0003774; GO:0030016; GO:0032982";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";motor activity [GO:0003774]
comp1114043_c0_seq1;GAXK01114285.1;Q8N695;9.26E-95;SC5A8_HUMAN;Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161";"apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]"
comp1114059_c0_seq1;GAXK01114266.1;A1L1R6;2.93E-08;ZN423_DANRE;Zinc finger protein 423;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp111406_c0_seq1;GAXK01034742.1;Q9VCA2;9.93E-81;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp11141_c1_seq1;GAXK01187418.1;P23198;2.16E-55;CBX3_MOUSE;Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (M32) (Modifier 2 protein);"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"GO:0000775; GO:0000779; GO:0000785; GO:0000976; GO:0005634; GO:0005635; GO:0005654; GO:0005719; GO:0005720; GO:0005819; GO:0006325; GO:0006974; GO:0010369; GO:0019899; GO:0019904; GO:0031618; GO:0035985; GO:0042802; GO:0045892; GO:0048511; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1114133_c0_seq1;GAXK01114267.1;Q3UHH8;1.74E-32;GXLT1_MOUSE;Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3);"integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0016021; GO:0016266; GO:0035252";O-glycan processing [GO:0016266];integral component of membrane [GO:0016021];UDP-xylosyltransferase activity [GO:0035252]
comp11143_c0_seq1;GAXK01187888.1;Q9GR88;0;ERF1_POLMI;Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1);"cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]";"GO:0003747; GO:0005737";;cytoplasm [GO:0005737];translation release factor activity [GO:0003747]
comp111444_c0_seq1;GAXK01034883.1;Q58EK3;6.05E-10;PLCX3_DANRE;PI-PLC X domain-containing protein 3;"phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"GO:0007165; GO:0008081; GO:0016042";"lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";;phosphoric diester hydrolase activity [GO:0008081]
comp11145_c0_seq1;GAXK01188310.1;O57579;0;AMPN_CHICK;Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N);"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0042277; GO:0043171; GO:0070006; GO:0070062";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp1114846_c0_seq1;GAXK01114290.1;P0C599;2.63E-38;DUPD1_TAKRU;Dual specificity phosphatase DUPD1 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1115358_c0_seq1;GAXK01114253.1;P35353;3.17E-44;CRFR1_RAT;Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1);"apical part of cell [GO:0045177]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenal gland development [GO:0030325]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to pain [GO:0048266]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; epithelial cell differentiation [GO:0030855]; fear response [GO:0042596]; feeding behavior [GO:0007631]; general adaptation syndrome, behavioral process [GO:0051867]; hypothalamus development [GO:0021854]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of neuron death [GO:1901215]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell degranulation [GO:0043306]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; regulation of corticosterone secretion [GO:2000852]; regulation of synaptic plasticity [GO:0048167]; response to electrical stimulus [GO:0051602]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; visual learning [GO:0008542]";"GO:0001666; GO:0001965; GO:0004930; GO:0005771; GO:0005802; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007200; GO:0007204; GO:0007218; GO:0007613; GO:0007631; GO:0008542; GO:0010578; GO:0015056; GO:0016020; GO:0016021; GO:0017046; GO:0021854; GO:0030325; GO:0030425; GO:0030855; GO:0031226; GO:0031982; GO:0032811; GO:0035641; GO:0035902; GO:0042277; GO:0042596; GO:0043025; GO:0043306; GO:0043404; GO:0043950; GO:0044877; GO:0045177; GO:0048148; GO:0048149; GO:0048167; GO:0048266; GO:0051424; GO:0051458; GO:0051602; GO:0051867; GO:0060291; GO:0071376; GO:1901215; GO:1901386; GO:2000252; GO:2000852";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenal gland development [GO:0030325]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to pain [GO:0048266]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; epithelial cell differentiation [GO:0030855]; fear response [GO:0042596]; feeding behavior [GO:0007631]; general adaptation syndrome, behavioral process [GO:0051867]; hypothalamus development [GO:0021854]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of neuron death [GO:1901215]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell degranulation [GO:0043306]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; regulation of corticosterone secretion [GO:2000852]; regulation of synaptic plasticity [GO:0048167]; response to electrical stimulus [GO:0051602]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; visual learning [GO:0008542]";"apical part of cell [GO:0045177]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]";"corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G-protein alpha-subunit binding [GO:0001965]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]"
comp111538_c0_seq1;GAXK01034761.1;Q642A2;8.21E-08;ATRAP_RAT;Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]";"GO:0000139; GO:0001666; GO:0004945; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005938; GO:0008217; GO:0016021; GO:0030659";"regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";angiotensin type II receptor activity [GO:0004945]
comp1115389_c0_seq1;GAXK01114305.1;Q9VZX1;2.67E-07;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp11154_c0_seq1;GAXK01187958.1;A6JUQ6;1.07E-39;CLVS2_RAT;Clavesin-2 (Retinaldehyde-binding protein 1-like 2);"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]";"GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0080025";lysosome organization [GO:0007040];"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]";phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]
comp111543_c0_seq1;GAXK01034792.1;O74369;5.01E-13;CSS1_SCHPO;Inositol phosphosphingolipids phospholipase C (IPS phospholipase C) (IPS-PLC) (EC 3.1.4.-);"cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol phosphosphingolipid phospholipase activity [GO:0052712]; mannosyl-inositol phosphorylceramide phospholipase activity [GO:0052714]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; ceramide biosynthetic process [GO:0046513]; regulation of fungal-type cell wall biogenesis [GO:0032995]; sphingoid catabolic process [GO:0046521]";"GO:0000324; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0031307; GO:0032995; GO:0046513; GO:0046521; GO:0046872; GO:0052712; GO:0052714; GO:0071555; GO:0071944";"cell wall organization [GO:0071555]; ceramide biosynthetic process [GO:0046513]; regulation of fungal-type cell wall biogenesis [GO:0032995]; sphingoid catabolic process [GO:0046521]";"cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"inositol phosphosphingolipid phospholipase activity [GO:0052712]; mannosyl-inositol phosphorylceramide phospholipase activity [GO:0052714]; metal ion binding [GO:0046872]"
comp111549_c0_seq1;GAXK01034911.1;Q9VI93;4.24E-117;RN_DROME;Zinc finger protein rotund (Zinc finger protein roughened eye);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0007480; GO:0022416; GO:0045892; GO:0046872; GO:0048749";"cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1115725_c0_seq1;GAXK01114276.1;B9EJV3;2.60E-26;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp1116264_c0_seq1;GAXK01174903.1;O76360;4.78E-26;EGL4_CAEEL;cGMP-dependent protein kinase egl-4 (EC 2.7.11.12) (Egg-laying defective protein 4);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0004691; GO:0004692; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0006935; GO:0007165; GO:0007635; GO:0008286; GO:0008340; GO:0008355; GO:0010468; GO:0010753; GO:0010754; GO:0018105; GO:0030308; GO:0030431; GO:0030512; GO:0030536; GO:0030553; GO:0040014; GO:0040015; GO:0042542; GO:0043577; GO:0046621; GO:0046662; GO:0046872; GO:0050849; GO:0050913; GO:0050921; GO:0051343; GO:0061067; GO:0070482; GO:1901046; GO:1902160; GO:1903998; GO:1905959; GO:1990335; GO:1990834";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]"
comp11164_c1_seq1;GAXK01188529.1;Q7ZVX0;4.87E-115;CCNL1_DANRE;Cyclin-L1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]";"GO:0005634; GO:0006357; GO:0006396; GO:0016538; GO:0016607";"regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]
comp1116602_c0_seq1;GAXK01174879.1;P61799;2.02E-17;APTX_DANRE;Aprataxin (EC 3.1.11.7) (EC 3.1.12.2) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0030983; GO:0033699; GO:0046872; GO:0120108; GO:1990165";"double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]"
comp111667_c0_seq1;GAXK01034848.1;O35738;2.31E-44;KLF12_MOUSE;Krueppel-like factor 12 (Transcriptional repressor AP-2rep);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1116753_c0_seq1;GAXK01174908.1;Q6A548;2.86E-20;TERT_CANLF;Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomerase RNA reverse transcriptase activity [GO:0003721]; telomeric DNA binding [GO:0042162]; telomere maintenance via telomerase [GO:0007004]";"GO:0000333; GO:0000781; GO:0003720; GO:0003721; GO:0005697; GO:0005730; GO:0005737; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034";telomere maintenance via telomerase [GO:0007004];"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]";"metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomerase RNA reverse transcriptase activity [GO:0003721]; telomeric DNA binding [GO:0042162]"
comp111682_c1_seq1;GAXK01034998.1;P12297;1.26E-35;SUWA_DROME;Protein suppressor of white apricot;"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA 5'-splice site recognition [GO:0000395]";"GO:0000395; GO:0003723; GO:0016607";mRNA 5'-splice site recognition [GO:0000395];nuclear speck [GO:0016607];RNA binding [GO:0003723]
comp1117033_c0_seq1;GAXK01174897.1;P10351;7.06E-68;XDH_DROME;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus);"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0006144; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0043546; GO:0048072; GO:0050660; GO:0051537; GO:0071949";"arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp1117191_c0_seq1;GAXK01174902.1;P15857;2.12E-29;HM17_APIME;Homeobox protein H17 (Fragment);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp111736_c0_seq1;GAXK01035101.1;Q7T076;4.88E-17;LSM11_XENLA;U7 snRNA-associated Sm-like protein LSm11;"nucleus [GO:0005634]; U7 snRNA binding [GO:0071209]; mRNA processing [GO:0006397]";"GO:0005634; GO:0006397; GO:0071209";mRNA processing [GO:0006397];nucleus [GO:0005634];U7 snRNA binding [GO:0071209]
comp1117496_c0_seq1;GAXK01174898.1;P18264;1.03E-22;ROUGH_DROVI;Homeobox protein rough;"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; establishment of ommatidial planar polarity [GO:0042067]; R2/R5 cell fate commitment [GO:0007463]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005634; GO:0006355; GO:0007463; GO:0007601; GO:0042067; GO:0043565; GO:0050896";"establishment of ommatidial planar polarity [GO:0042067]; R2/R5 cell fate commitment [GO:0007463]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp1117580_c0_seq1;GAXK01174906.1;Q1LUA6;6.05E-25;TRIO_DANRE;Triple functional domain protein (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0035023";"axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp111761_c3_seq1;GAXK01034734.1;Q9BUD6;2.43E-47;SPON2_HUMAN;Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin);"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222";"cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]";"antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]"
comp111784_c0_seq1;GAXK01034781.1;Q6DCP1;1.44E-94;FXRD1_XENLA;FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981";mitochondrial respiratory chain complex I assembly [GO:0032981];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]";oxidoreductase activity [GO:0016491]
comp111802_c0_seq1;GAXK01034882.1;P59644;1.04E-66;PI5PA_MOUSE;Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase J);"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol dephosphorylation [GO:0046856]";"GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005886; GO:0010977; GO:0017124; GO:0019898; GO:0030426; GO:0031115; GO:0033137; GO:0034485; GO:0043198; GO:0046855; GO:0046856; GO:0052658; GO:0052659";"inositol phosphate dephosphorylation [GO:0046855]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol dephosphorylation [GO:0046856]";"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]"
comp1118069_c0_seq1;GAXK01175009.1;P57071;3.79E-15;PRD15_HUMAN;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1118292_c0_seq1;GAXK01174999.1;O97341;6.26E-40;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp111832_c2_seq1;GAXK01035042.1;A2RUV0;1.13E-07;NOTC1_XENTR;"Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]";"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]";"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]"
comp1118451_c0_seq1;GAXK01174969.1;Q13332;2.25E-14;PTPRS_HUMAN;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma);"axon [GO:0030424]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]";"GO:0004721; GO:0004725; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0010977; GO:0021510; GO:0021549; GO:0021766; GO:0021987; GO:0022038; GO:0030054; GO:0030285; GO:0030424; GO:0030517; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0050804; GO:0061000; GO:0070062; GO:0090557; GO:0098685; GO:0098978; GO:0099056; GO:0099061; GO:0099151; GO:0099560";"cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]";"axon [GO:0030424]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]"
comp11185_c1_seq1;GAXK01187637.1;P79274;6.64E-171;ACADL_PIG;Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660";"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]"
comp1118698_c0_seq1;GAXK01174977.1;P26262;1.47E-14;KLKB1_MOUSE;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";"GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp111881_c0_seq1;GAXK01034985.1;Q96T21;3.03E-40;SEBP2_HUMAN;Selenocysteine insertion sequence-binding protein 2 (SECIS-binding protein 2);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; neuron development [GO:0048666]; selenocysteine incorporation [GO:0001514]; striatum development [GO:0021756]";"GO:0001514; GO:0003723; GO:0003730; GO:0005634; GO:0005739; GO:0021756; GO:0035368; GO:0043021; GO:0048666; GO:1990904; GO:2000623";"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; neuron development [GO:0048666]; selenocysteine incorporation [GO:0001514]; striatum development [GO:0021756]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]"
comp1118994_c0_seq1;GAXK01174995.1;Q7KRI2;1.92E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp11190_c0_seq1;GAXK01187469.1;Q9VAI0;1.87E-59;GNA1_DROME;Probable glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0004343; GO:0005783; GO:0005793; GO:0005794; GO:0006048; GO:0048029";UDP-N-acetylglucosamine biosynthetic process [GO:0006048];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]";"glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]"
comp111957_c0_seq1;GAXK01034829.1;O62243;1.88E-15;NAS1_CAEEL;Zinc metalloproteinase nas-1 (EC 3.4.24.-) (Nematode astacin 1);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp112014_c7_seq1;GAXK01082264.1;Q93075;9.38E-38;TATD2_HUMAN;Putative deoxyribonuclease TATDN2 (EC 3.1.21.-);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]";"GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0016888; GO:0036498; GO:0046872";IRE1-mediated unfolded protein response [GO:0036498];"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
comp112035_c2_seq1;GAXK01081979.1;Q8NDA2;4.56E-27;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp1120495_c0_seq1;GAXK01076981.1;Q8RWQ9;3.54E-09;ALEUL_ARATH;Thiol protease aleurain-like (EC 3.4.22.16);"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005829; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp112054_c1_seq1;GAXK01082081.1;P53440;2.10E-11;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp112068_c2_seq1;GAXK01082009.1;Q9V6U9;1.02E-91;MECR_DROME;Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase);"mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]";"GO:0005739; GO:0006631; GO:0006633; GO:0019166";"fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]";mitochondrion [GO:0005739];trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]
comp1120751_c0_seq1;GAXK01076969.1;O46040;5.27E-23;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp112082_c2_seq1;GAXK01082210.1;A2RU49;5.97E-65;HYKK_HUMAN;Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1);"mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]; lysine catabolic process [GO:0006554]";"GO:0005759; GO:0006554; GO:0016301; GO:0047992";lysine catabolic process [GO:0006554];mitochondrial matrix [GO:0005759];"hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]"
comp112086_c0_seq1;GAXK01082199.1;Q6Q4H1;1.53E-23;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp112096_c0_seq1;GAXK01082263.1;P13010;3.99E-85;XRCC5_HUMAN;X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining));"cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0000783; GO:0000784; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008283; GO:0016020; GO:0031625; GO:0032204; GO:0032212; GO:0032481; GO:0032991; GO:0032993; GO:0034774; GO:0042162; GO:0042493; GO:0043085; GO:0043312; GO:0043564; GO:0044212; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0075713; GO:0090734; GO:1904430; GO:1990830; GO:1990904";"activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]";"cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]";"ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]"
comp11210_c2_seq1;GAXK01187853.1;P28271;0;ACOC_MOUSE;Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]";"GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0043231; GO:0046872; GO:0048027; GO:0050892; GO:0051536; GO:0051538; GO:0051539";"cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]";"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]"
comp112100_c0_seq1;GAXK01082258.1;Q9VDH6;1.62E-104;IR93A_DROME;Ionotropic receptor 93a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005886; GO:0007610; GO:0008066; GO:0015276; GO:0016021; GO:0035249; GO:0045211; GO:0050804; GO:0050907; GO:1904315";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1121093_c0_seq1;GAXK01076991.1;A2RU67;1.62E-09;F234B_HUMAN;Protein FAM234B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1121166_c0_seq1;GAXK01076992.1;Q91XP5;1.44E-46;GLRA3_MOUSE;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp1121229_c0_seq1;GAXK01076965.1;O42606;1.39E-17;NGN1_DANRE;Neurogenin-1 (NGN-1) (Neurogenic differentiation factor 3) (NeuroD3) (Neurogenin-related protein 1);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; anterior lateral line nerve development [GO:0048909]; axon regeneration [GO:0031103]; axonal fasciculation [GO:0007413]; dorsal spinal cord development [GO:0021516]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hindbrain morphogenesis [GO:0021575]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neuromast development [GO:0048884]; olfactory bulb development [GO:0021772]; olfactory placode development [GO:0071698]; peripheral nervous system development [GO:0007422]; peripheral nervous system neuron development [GO:0048935]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line nerve development [GO:0048918]";"GO:0003682; GO:0005634; GO:0007399; GO:0007413; GO:0007422; GO:0021516; GO:0021575; GO:0021772; GO:0021884; GO:0021986; GO:0031103; GO:0045666; GO:0045944; GO:0046983; GO:0048699; GO:0048884; GO:0048909; GO:0048918; GO:0048935; GO:0050768; GO:0051091; GO:0070888; GO:0071698";"anterior lateral line nerve development [GO:0048909]; axonal fasciculation [GO:0007413]; axon regeneration [GO:0031103]; dorsal spinal cord development [GO:0021516]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hindbrain morphogenesis [GO:0021575]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neuromast development [GO:0048884]; olfactory bulb development [GO:0021772]; olfactory placode development [GO:0071698]; peripheral nervous system development [GO:0007422]; peripheral nervous system neuron development [GO:0048935]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line nerve development [GO:0048918]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]"
comp11216_c1_seq1;GAXK01187775.1;Q5RBR1;2.87E-36;SRP19_PONAB;Signal recognition particle 19 kDa protein (SRP19);"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005786; GO:0006614; GO:0008312";SRP-dependent cotranslational protein targeting to membrane [GO:0006614];signal recognition particle, endoplasmic reticulum targeting [GO:0005786];7S RNA binding [GO:0008312]
comp112179_c3_seq1;GAXK01082048.1;P09180;3.97E-136;RL4_DROME;60S ribosomal protein L4 (L1);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp1122_c8_seq1;GAXK01204964.1;P46436;3.69E-38;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp112204_c0_seq1;GAXK01205412.1;Q6CVH3;8.70E-15;NHP6_KLULA;Non-histone chromosomal protein 6;"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]";"GO:0003677; GO:0005634; GO:0005694; GO:0006281";DNA repair [GO:0006281];"chromosome [GO:0005694]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp112221_c0_seq1;GAXK01082322.1;Q80XK6;2.34E-126;ATG2B_MOUSE;Autophagy-related protein 2 homolog B;"extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]";"GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005811; GO:0019898; GO:0034045";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]";"extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]";
comp1122298_c0_seq1;GAXK01197077.1;P16912;7.20E-125;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp11223_c0_seq1;GAXK01188449.1;P82926;6.02E-20;RT33_BOVIN;28S ribosomal protein S33, mitochondrial (MRP-S33) (S33mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";"GO:0005743; GO:0005763";;"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";
comp112266_c0_seq1;GAXK01082240.1;Q8MZC4;4.02E-60;CRLS1_DROME;Probable cardiolipin synthase (CMP-forming) (CLS) (EC 2.7.8.41);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cardiolipin synthase activity [GO:0008808]; ATP biosynthetic process [GO:0006754]; cardiolipin biosynthetic process [GO:0032049]; glycerophospholipid biosynthetic process [GO:0046474]; mitochondrial membrane organization [GO:0007006]";"GO:0005739; GO:0005743; GO:0006754; GO:0007006; GO:0008808; GO:0016021; GO:0032049; GO:0046474";"ATP biosynthetic process [GO:0006754]; cardiolipin biosynthetic process [GO:0032049]; glycerophospholipid biosynthetic process [GO:0046474]; mitochondrial membrane organization [GO:0007006]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";cardiolipin synthase activity [GO:0008808]
comp112277_c0_seq1;GAXK01081939.1;P97603;0;NEO1_RAT;Neogenin (Fragment);"integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; negative regulation of neuron death [GO:1901215]; positive regulation of BMP signaling pathway [GO:0030513]";"GO:0005887; GO:0007155; GO:0007411; GO:0030513; GO:0038023; GO:0043025; GO:0055072; GO:1901215";"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; negative regulation of neuron death [GO:1901215]; positive regulation of BMP signaling pathway [GO:0030513]";"integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]";signaling receptor activity [GO:0038023]
comp112281_c2_seq1;GAXK01082260.1;Q7KRI2;3.32E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1122900_c0_seq1;GAXK01197072.1;Q5FWU8;4.72E-07;ZMY10_XENLA;Zinc finger MYND domain-containing protein 10;"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505";"inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]";metal ion binding [GO:0046872]
comp1122981_c0_seq1;GAXK01197061.1;P31227;7.92E-19;SMOD_LITCT;S-modulin (Sensitivity-modulating protein);"calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005509; GO:0007601; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";;calcium ion binding [GO:0005509]
comp1123073_c0_seq1;GAXK01197066.1;O46040;1.27E-29;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp112315_c0_seq1;GAXK01081971.1;Q922H2;3.79E-88;PDK3_MOUSE;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp112320_c0_seq1;GAXK01082194.1;Q2TB18;1.93E-54;ASTE1_HUMAN;Protein asteroid homolog 1;"nuclease activity [GO:0004518]; DNA repair [GO:0006281]";"GO:0004518; GO:0006281";DNA repair [GO:0006281];;nuclease activity [GO:0004518]
comp112339_c0_seq1;GAXK01082197.1;Q3UMT1;8.69E-08;PP12C_MOUSE;Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; signal transduction [GO:0007165]";"GO:0004857; GO:0005737; GO:0005856; GO:0007165; GO:0019208; GO:0019901";signal transduction [GO:0007165];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]"
comp1123422_c0_seq1;GAXK01197063.1;Q9W7R6;2.90E-40;SOX14_CHICK;Transcription factor SOX-14 (SRY-related protein CH60);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"GO:0000122; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0007601; GO:0009649; GO:0030154; GO:0043565; GO:0044798; GO:0045892; GO:0046982; GO:2001222";"cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"
comp1123652_c0_seq1;GAXK01197056.1;Q9YGL1;1.01E-27;SPD1B_XENLA;Speedy protein 1-B (Spy1-B) (Protein Ls27) (Rapid inducer of G2/M progression in oocytes B) (RINGO-B) (XSpy1-B) (p33 ringo-B) (xRINGO-B);"nucleus [GO:0005634]; cyclin binding [GO:0030332]; protein kinase binding [GO:0019901]; activation of MAPK activity [GO:0000187]; G2/MI transition of meiotic cell cycle [GO:0008315]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of meiotic cell cycle [GO:0051446]";"GO:0000187; GO:0001556; GO:0005634; GO:0006378; GO:0007275; GO:0008315; GO:0019901; GO:0030332; GO:0045737; GO:0051446";"activation of MAPK activity [GO:0000187]; G2/MI transition of meiotic cell cycle [GO:0008315]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of meiotic cell cycle [GO:0051446]";nucleus [GO:0005634];"cyclin binding [GO:0030332]; protein kinase binding [GO:0019901]"
comp1123791_c0_seq1;GAXK01197054.1;Q5REW7;4.81E-52;MEF2A_PONAB;Myocyte-specific enhancer factor 2A;"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ventricular cardiac myofibril assembly [GO:0055005]";"GO:0000002; GO:0000122; GO:0000165; GO:0000977; GO:0000981; GO:0003682; GO:0005634; GO:0006915; GO:0033613; GO:0035035; GO:0042826; GO:0045944; GO:0046332; GO:0046983; GO:0048311; GO:0048813; GO:0055005; GO:0061337; GO:0070375; GO:0071277";"apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ventricular cardiac myofibril assembly [GO:0055005]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]"
comp112385_c0_seq1;GAXK01081967.1;D4GWH7;2.22E-10;Y2328_HALVD;Uncharacterized isochorismatase family protein HVO_2328 (EC 3.-.-.-);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp1124147_c0_seq1;GAXK01144193.1;A7M7C7;2.08E-110;SKOR2_MOUSE;SKI family transcriptional corepressor 2 (Fussel-18 homolog) (LBX1 corepressor 1-like protein) (Ladybird homeobox corepressor 1-like protein) (Transcriptional corepressor Corl2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; cell development [GO:0048468]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellum morphogenesis [GO:0021587]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cerebellar granule cell precursor proliferation [GO:0021936]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0021587; GO:0021702; GO:0021936; GO:0030512; GO:0030514; GO:0042826; GO:0045596; GO:0045880; GO:0046332; GO:0048468; GO:0048666; GO:0048814";"cell development [GO:0048468]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellum morphogenesis [GO:0021587]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cerebellar granule cell precursor proliferation [GO:0021936]; regulation of dendrite morphogenesis [GO:0048814]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]"
comp1124334_c0_seq1;GAXK01144165.1;Q96QI5;7.90E-28;HS3S6_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) (h3-OST-6);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0001835; GO:0006024; GO:0008467; GO:0015012; GO:0016021; GO:0034483";"blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp112440_c0_seq1;GAXK01082221.1;Q4QY64;1.24E-15;ATAD5_MOUSE;ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein);"Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; B cell proliferation [GO:0042100]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]";"GO:0002377; GO:0003677; GO:0005524; GO:0005634; GO:0006974; GO:0008630; GO:0030890; GO:0031391; GO:0033260; GO:0042100; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902230; GO:1902751";"B cell proliferation [GO:0042100]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]";"Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]"
comp11245_c2_seq1;GAXK01187536.1;Q8WML3;1.71E-107;KAT6B_MACFA;Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4);"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000786; GO:0003677; GO:0004402; GO:0006334; GO:0008134; GO:0016407; GO:0016573; GO:0043966; GO:0045892; GO:0045893; GO:0046872; GO:0070776";"histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]";"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]";"acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp112451_c0_seq1;GAXK01082196.1;Q5RAQ5;1.16E-17;APC4_PONAB;Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4);"anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";"GO:0005680; GO:0007049; GO:0030071; GO:0031145; GO:0051301; GO:0070979";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";anaphase-promoting complex [GO:0005680];
comp1124541_c0_seq1;GAXK01144169.1;Q964R0;7.12E-14;CP6K1_BLAGE;Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp1124710_c0_seq1;GAXK01144191.1;Q9V427;1.36E-46;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp112473_c0_seq1;GAXK01082073.1;Q8BTK5;1.01E-27;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp112488_c0_seq1;GAXK01081965.1;Q7SXW3;6.83E-150;LRC40_DANRE;Leucine-rich repeat-containing protein 40;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp1124922_c0_seq1;GAXK01144117.1;Q9U518;9.37E-125;ASPG_DIRIM;L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase);"asparaginase activity [GO:0004067]; asparagine metabolic process [GO:0006528]";"GO:0004067; GO:0006528";asparagine metabolic process [GO:0006528];;asparaginase activity [GO:0004067]
comp112498_c0_seq1;GAXK01082261.1;Q6ZSM3;3.23E-43;MOT12_HUMAN;Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1125020_c0_seq1;GAXK01144210.1;V9ZAX6;1.14E-10;VMPA2_TITPA;Venom metalloproteinase antarease-like TpachMP_B (VMPA) (EC 3.4.24.-) (Fragment);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp112507_c1_seq1;GAXK01082256.1;Q9VH08;6.73E-114;SIR6_DROME;NAD-dependent protein deacetylase Sirt6 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6);"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"GO:0000122; GO:0004407; GO:0005634; GO:0005724; GO:0008340; GO:0016575; GO:0031937; GO:0046872; GO:0046969; GO:0070403; GO:0070932";"determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]";"histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]"
comp1125109_c0_seq1;GAXK01144209.1;Q7KRI2;4.68E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp112511_c0_seq1;GAXK01082066.1;Q9LY23;1.78E-27;IPMKA_ARATH;Inositol polyphosphate multikinase alpha (EC 2.7.1.140) (EC 2.7.1.151) (Inositol polyphosphate 6-/3-/5-kinase alpha) (AtIpk2-alpha) (AtIpk2alpha);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pollen tube [GO:0090406]; ATP binding [GO:0005524]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; embryo development ending in seed dormancy [GO:0009793]; inositol phosphate biosynthetic process [GO:0032958]; pollen development [GO:0009555]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]";"GO:0000823; GO:0000824; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0009555; GO:0009793; GO:0009846; GO:0009860; GO:0010183; GO:0032958; GO:0047326; GO:0090406; GO:0102732";"embryo development ending in seed dormancy [GO:0009793]; inositol phosphate biosynthetic process [GO:0032958]; pollen development [GO:0009555]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pollen tube [GO:0090406]";"ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]"
comp1125148_c0_seq1;GAXK01144212.1;P80944;1.27E-09;ZFX_PIG;Zinc finger X-chromosomal protein (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1125575_c0_seq1;GAXK01144198.1;Q86GF7;2.23E-34;CRUST_PANBO;Crustapain (EC 3.4.22.-) (NsCys);"extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";"GO:0005576; GO:0007586; GO:0008234; GO:0030163; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";extracellular region [GO:0005576];cysteine-type peptidase activity [GO:0008234]
comp112561_c1_seq1;GAXK01082371.1;Q9W0T1;2.24E-95;NU301_DROME;Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215);"nucleus [GO:0005634]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0005634; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0035064; GO:0035073; GO:0035076; GO:0042766; GO:0045824; GO:0046426; GO:0046872; GO:0048515; GO:0070577";"chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; NURF complex [GO:0016589]";"DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]"
comp112570_c0_seq1;GAXK01081996.1;Q8TCB0;1.38E-27;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp1125746_c0_seq1;GAXK01144171.1;Q6ZR37;1.76E-51;PKHG7_HUMAN;Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7);"Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0035023";regulation of Rho protein signal transduction [GO:0035023];;Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp1125870_c0_seq1;GAXK01144206.1;A8WGF4;0;IF122_XENTR;Intraflagellar transport protein 122 homolog;"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]";"GO:0005737; GO:0005929; GO:0007275; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0045879; GO:0060271; GO:0061512; GO:0097730; GO:1905515";"cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]";
comp1126181_c0_seq1;GAXK01140462.1;Q9NRG4;1.51E-19;SMYD2_HUMAN;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975; GO:1901796";"heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp1126270_c0_seq1;GAXK01140468.1;Q94887;1.85E-128;NRX4_DROME;Neurexin-4 (Neurexin IV);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"GO:0003015; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0007163; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016080; GO:0016081; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105";"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]";
comp1126748_c0_seq1;GAXK01140465.1;Q8T674;2.53E-105;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp1127063_c0_seq1;GAXK01140482.1;Q8IYH5;4.02E-54;ZZZ3_HUMAN;ZZ-type zinc finger-containing protein 3;"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]";"GO:0000981; GO:0003677; GO:0005634; GO:0005671; GO:0005730; GO:0008270";;"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1127315_c0_seq1;GAXK01140471.1;Q9R044;2.15E-16;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp112734_c0_seq1;GAXK01082061.1;Q8BXJ9;2.42E-64;TMM62_MOUSE;Transmembrane protein 62;"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp1127963_c0_seq1;GAXK01140459.1;Q68DY1;2.04E-14;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1128399_c0_seq1;GAXK01038553.1;Q6ZMW2;2.48E-14;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp11284_c1_seq1;GAXK01188303.1;P22935;8.36E-22;RABP2_MOUSE;Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]";"GO:0001972; GO:0002138; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0042573; GO:0048385; GO:0048672";"embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]"
comp1128589_c0_seq1;GAXK01038526.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp112859_c0_seq1;GAXK01082019.1;Q9R078;5.59E-70;AAKB1_MOUSE;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0004672; GO:0004679; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0010628; GO:0019901; GO:0031588; GO:0032991; GO:0035878; GO:0050790; GO:0051291; GO:0120162";"fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp11286_c0_seq1;GAXK01187989.1;Q924K8;9.75E-161;MTA3_MOUSE;Metastasis-associated protein MTA3;"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]";"GO:0000122; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892";"histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp11287_c0_seq1;GAXK01188278.1;P11418;1.33E-33;SODC_PRIGL;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp1128878_c0_seq1;GAXK01038560.1;A5D6V4;5.86E-30;TM17B_DANRE;Transmembrane protein 17B;"ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224]";"GO:0007224; GO:0016021; GO:0035869; GO:0036038; GO:0060170; GO:0060271; GO:1905515";"cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224]";"ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]";
comp1129018_c0_seq1;GAXK01038556.1;Q90773;7.55E-25;CEPU1_CHICK;Protein CEPU-1;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1129093_c0_seq1;GAXK01038548.1;P56823;7.21E-41;HCYG_HELPO;Hemocyanin, beta-C chain unit G (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp11291_c0_seq1;GAXK01187691.1;Q9AST1;4.02E-25;TAF15_ARATH;Transcription initiation factor TFIID subunit 15 (TBP-associated factor 15) (AtTAF15);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp112910_c0_seq1;GAXK01082373.1;Q7T0P7;2.54E-34;ATP23_XENLA;Mitochondrial inner membrane protease ATP23 homolog (EC 3.4.24.-);"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0046872";;;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp1129335_c0_seq1;GAXK01038546.1;O46107;9.29E-53;LIP1_DROME;Lipase 1 (DmLip1) (EC 3.1.1.-);"extracellular region [GO:0005576]; lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0007586; GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];lipase activity [GO:0016298]
comp112935_c6_seq1;GAXK01082303.1;O94901;4.86E-30;SUN1_HUMAN;SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1);"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0001503; GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0009612; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090286; GO:0090292";"centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]";"lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]"
comp112968_c3_seq1;GAXK01081972.1;Q9BY49;1.84E-84;PECR_HUMAN;Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (2,4-dienoyl-CoA reductase-related protein) (DCR-RP) (HPDHase) (Short chain dehydrogenase/reductase family 29C member 1) (pVI-ARL);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid alpha-oxidation [GO:0001561]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]; protein targeting to peroxisome [GO:0006625]";"GO:0001561; GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0006633; GO:0019166; GO:0033306; GO:0055114";"fatty acid alpha-oxidation [GO:0001561]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]"
comp11297_c2_seq1;GAXK01187675.1;P59110;4.91E-49;SENP1_MOUSE;Sentrin-specific protease 1 (EC 3.4.22.-) (SUMO-1 protease 2) (SuPr-2) (Sentrin/SUMO-specific protease SENP1);"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"GO:0005634; GO:0005737; GO:0005925; GO:0006919; GO:0007275; GO:0010724; GO:0016926; GO:0031965; GO:0032435; GO:0045944; GO:0070140; GO:0097190";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp112999_c1_seq1;GAXK01082254.1;P26686;1.27E-47;SRR55_DROME;Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013";"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp113001_c1_seq1;GAXK01081950.1;Q924M7;2.76E-124;MPI_MOUSE;Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI);"cytosol [GO:0005829]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; glycolytic process from mannose through fructose-6-phosphate [GO:0061619]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]";"GO:0000032; GO:0004476; GO:0005829; GO:0006486; GO:0008270; GO:0009298; GO:0061611; GO:0061619";"cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; glycolytic process from mannose through fructose-6-phosphate [GO:0061619]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]";cytosol [GO:0005829];"mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]"
comp113011_c3_seq1;GAXK01082213.1;Q9V4U9;5.00E-50;C6A13_DROME;Probable cytochrome P450 6a13 (EC 1.14.-.-) (CYPVIA13);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; defense response to bacterium [GO:0042742]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037; GO:0042742";defense response to bacterium [GO:0042742];endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp113023_c2_seq1;GAXK01082190.1;P9WK86;8.50E-16;NLHH_MYCTO;Carboxylesterase NlhH (EC 3.1.1.1);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp1130261_c0_seq1;GAXK01141153.1;Q53G44;1.02E-34;IF44L_HUMAN;Interferon-induced protein 44-like;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005525; GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp113028_c0_seq1;GAXK01082314.1;Q5SZL2;8.77E-08;CE85L_HUMAN;Centrosomal protein of 85 kDa-like (Serologically defined breast cancer antigen NY-BR-15);"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"GO:0005737; GO:0005813";;"centrosome [GO:0005813]; cytoplasm [GO:0005737]";
comp11303_c0_seq1;GAXK01187417.1;Q9Y4Y9;7.04E-41;LSM5_HUMAN;U6 snRNA-associated Sm-like protein LSm5;"cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to bacterium [GO:0009617]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0006397; GO:0009617; GO:0043928; GO:0046540; GO:0071005; GO:0120115; GO:1990726";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to bacterium [GO:0009617]";"cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";RNA binding [GO:0003723]
comp1130332_c0_seq1;GAXK01141116.1;Q9W4S1;8.94E-32;GRCR2_DROME;Glutaredoxin domain-containing cysteine-rich protein CG12206;"cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cell [GO:0005623];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp11306_c0_seq1;GAXK01187729.1;Q5XIU9;3.68E-38;PGRC2_RAT;Membrane-associated progesterone receptor component 2;"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; steroid binding [GO:0005496]";"GO:0005496; GO:0005635; GO:0016021";;"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";steroid binding [GO:0005496]
comp113087_c0_seq1;GAXK01082074.1;Q8VCX5;3.95E-41;MICU1_MOUSE;Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog);"calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]";"GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0034704; GO:0036444; GO:0042802; GO:0046982; GO:0051260; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246";"calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]";"calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]"
comp1131086_c0_seq1;GAXK01141139.1;Q9VZX1;5.48E-09;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp1131185_c0_seq1;GAXK01141156.1;P42325;2.83E-16;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp11313_c0_seq1;GAXK01187498.1;Q3UHD6;8.19E-23;SNX27_MOUSE;Sorting nexin-27;"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; retromer complex [GO:0030904]; WASH complex [GO:0071203]; ionotropic glutamate receptor binding [GO:0035255]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]";"GO:0001772; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0007165; GO:0008333; GO:0014069; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0035091; GO:0035255; GO:0061951; GO:0071203; GO:0099638; GO:1903609; GO:1904719; GO:1990126";"endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; retromer complex [GO:0030904]; WASH complex [GO:0071203]";"ionotropic glutamate receptor binding [GO:0035255]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]"
comp1131395_c0_seq1;GAXK01141118.1;P24524;8.42E-54;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp11314_c1_seq1;GAXK01187321.1;Q9UJZ1;2.16E-138;STML2_HUMAN;Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7);"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]";"GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046";"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]";"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]";"cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]"
comp113147_c0_seq1;GAXK01081949.1;Q6P3W7;0;SCYL2_HUMAN;SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa);"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370";"endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]"
comp1131568_c0_seq1;GAXK01141163.1;O75311;4.90E-08;GLRA3_HUMAN;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp113166_c0_seq1;GAXK01082021.1;P83111;5.68E-76;LACTB_HUMAN;Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]";"GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802";"lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
comp1131708_c0_seq1;GAXK01141120.1;P13667;8.96E-17;PDIA4_HUMAN;Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0045454; GO:0061077";"cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]"
comp113185_c1_seq1;GAXK01082058.1;Q6ZWR6;1.16E-53;SYNE1_MOUSE;Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1);"cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; spindle [GO:0005819]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005819; GO:0007030; GO:0007097; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090286; GO:0090292; GO:0099149; GO:1902017; GO:1903353; GO:2001054";"centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; spindle [GO:0005819]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp1131906_c0_seq1;GAXK01141162.1;Q0IIF6;3.15E-76;FAIM1_BOVIN;Fas apoptotic inhibitory molecule 1;"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769]";"GO:0005737; GO:0006915; GO:0007249; GO:0050769; GO:1902042";"apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769]";cytoplasm [GO:0005737];
comp11321_c0_seq1;GAXK01187792.1;Q9LMI7;8.40E-94;ACO32_ARATH;Putative acyl-coenzyme A oxidase 3.2, peroxisomal (EC 1.3.3.6);"peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]";"GO:0003997; GO:0005504; GO:0005777; GO:0033540; GO:0050660; GO:0055088; GO:0071949";"fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]";peroxisome [GO:0005777];"acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]"
comp1132266_c0_seq1;GAXK01077934.1;P31228;2.14E-47;OXDD_BOVIN;D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1);"cytoplasm [GO:0005737]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]";"GO:0003884; GO:0005737; GO:0005777; GO:0006531; GO:0006533; GO:0008445; GO:0019478; GO:0071949";"aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]";"cytoplasm [GO:0005737]; peroxisome [GO:0005777]";"D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]"
comp1132279_c0_seq1;GAXK01077924.1;Q9R1Y5;7.24E-09;HIC1_MOUSE;Hypermethylated in cancer 1 protein (Hic-1);"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000785; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007275; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1132393_c0_seq1;GAXK01077933.1;P84175;1.77E-20;RS12_CHICK;40S ribosomal protein S12;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp1132411_c0_seq1;GAXK01077930.1;Q6ZQ12;8.39E-12;NINL_MOUSE;Ninein-like protein;"centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454]";"GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454; GO:0045171";microtubule anchoring at centrosome [GO:0034454];"centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]";calcium ion binding [GO:0005509]
comp113250_c0_seq1;GAXK01081978.1;Q9VXH6;0;CANC_DROME;Calpain-C (Calcium-activated neutral proteinase homolog C) (CANP C);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]";"GO:0004198; GO:0005509; GO:0005737";;cytoplasm [GO:0005737];"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp1132639_c0_seq1;GAXK01077942.1;Q4TU93;1.21E-10;MRC2_RAT;C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; endocytosis [GO:0006897]";"GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp1132654_c0_seq1;GAXK01077999.1;P83501;1.14E-15;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp113302_c0_seq1;GAXK01082063.1;P48764;1.12E-163;SL9A3_HUMAN;Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0051453; GO:0070062; GO:0071805; GO:0098719";"ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp113317_c0_seq1;GAXK01081966.1;P10620;4.98E-16;MGST1_HUMAN;Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I);"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]";"GO:0004364; GO:0004602; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006749; GO:0006805; GO:0010243; GO:0016021; GO:0032496; GO:0033327; GO:0035577; GO:0042493; GO:0042803; GO:0043295; GO:0043312; GO:0045177; GO:0055114; GO:0070207; GO:0071449; GO:1901687";"cellular response to lipid hydroperoxide [GO:0071449]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]";"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]"
comp1133176_c0_seq1;GAXK01077919.1;Q64676;4.46E-12;CGT_MOUSE;2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ceramide glucosyltransferase activity [GO:0008120]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; UDP-glycosyltransferase activity [GO:0008194]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]";"GO:0002175; GO:0006682; GO:0007010; GO:0008120; GO:0008194; GO:0008489; GO:0009247; GO:0016021; GO:0030913; GO:0042552; GO:0043231; GO:0047263; GO:0048812";"cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]";"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"ceramide glucosyltransferase activity [GO:0008120]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; UDP-glycosyltransferase activity [GO:0008194]"
comp113321_c0_seq1;GAXK01082169.1;Q86YQ8;0;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp113347_c0_seq1;GAXK01082242.1;Q7Z3B3;3.77E-19;KANL1_HUMAN;KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog);"condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"GO:0000123; GO:0000777; GO:0005634; GO:0005654; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0071339";"histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";histone acetyltransferase binding [GO:0035035]
comp1133658_c0_seq1;GAXK01078006.1;Q5M8K8;1.59E-52;IFT22_XENTR;Intraflagellar transport protein 22 homolog (Rab-like protein 5);"cell [GO:0005623]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005525; GO:0005623; GO:0006886; GO:0030992; GO:0032482";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"cell [GO:0005623]; intraciliary transport particle B [GO:0030992]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp113368_c0_seq1;GAXK01082220.1;B0UXH6;3.22E-28;RGPS1_DANRE;Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (RalA exchange factor RalGPS1);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005085; GO:0005737; GO:0005886; GO:0007264";small GTPase mediated signal transduction [GO:0007264];"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp1133838_c0_seq1;GAXK01077925.1;Q869C3;0;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp1133986_c0_seq1;GAXK01077926.1;Q06495;6.19E-78;NPT2A_HUMAN;Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; protein homooligomerization [GO:0051260]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350]";"GO:0001503; GO:0001822; GO:0005436; GO:0005768; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0009100; GO:0009986; GO:0010288; GO:0015321; GO:0016324; GO:0016607; GO:0030165; GO:0030643; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035864; GO:0042431; GO:0042493; GO:0042803; GO:0044267; GO:0044341; GO:0044877; GO:0045121; GO:0045838; GO:0046686; GO:0046689; GO:0048471; GO:0051260; GO:0055062; GO:0060416; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901128; GO:1901684; GO:2000120; GO:2000187";"arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; protein homooligomerization [GO:0051260]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium-dependent phosphate transport [GO:0044341]; sodium ion import across plasma membrane [GO:0098719]; tricarboxylic acid metabolic process [GO:0072350]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]"
comp1134129_c0_seq1;GAXK01050756.1;Q6NX49;9.92E-41;ZN544_HUMAN;Zinc finger protein 544;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp113414_c0_seq1;GAXK01082327.1;Q8BID8;8.31E-153;FXL14_MOUSE;F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14);"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005737; GO:0006511; GO:0019005; GO:0031146";"SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";ubiquitin-protein transferase activity [GO:0004842]
comp1134163_c0_seq1;GAXK01050739.1;Q9V427;9.06E-46;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp113430_c0_seq1;GAXK01081970.1;Q5ZL21;2.79E-55;MMAC_CHICK;Methylmalonic aciduria and homocystinuria type C protein homolog (EC 1.16.1.-) (CblC) (Cyanocobalamin reductase (cyanide-eliminating));"cytoplasm [GO:0005737]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]";"GO:0005737; GO:0006749; GO:0009235; GO:0009236; GO:0016491; GO:0032451; GO:0033787; GO:0043295; GO:0055114; GO:0070988; GO:0071949";"cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]";cytoplasm [GO:0005737];"cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]"
comp113451_c1_seq1;GAXK01082218.1;Q9CYZ8;2.69E-54;SSBP2_MOUSE;Single-stranded DNA-binding protein 2 (Sequence-specific single-stranded-DNA-binding protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0003697; GO:0005634; GO:0005737; GO:0045944";positive regulation of transcription by RNA polymerase II [GO:0045944];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"
comp113462_c1_seq1;GAXK01082012.1;Q8IN81;1.82E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp113465_c0_seq1;GAXK01082056.1;D4ACN8;4.51E-36;PLRKT_RAT;Plasminogen receptor (KT) (Plg-R(KT));"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]";"GO:0005887; GO:0006935; GO:0006954; GO:0010756";"chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]";integral component of plasma membrane [GO:0005887];
comp1134685_c0_seq1;GAXK01050754.1;Q6ZN57;4.36E-48;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp113474_c1_seq1;GAXK01082010.1;Q32PI1;7.08E-69;VRK1_BOVIN;Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1);"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0005819; GO:0006468; GO:0007049; GO:0018105; GO:0018107; GO:0046777; GO:0051301; GO:0090166";"cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1134784_c0_seq1;GAXK01050761.1;Q9NYM4;1.09E-44;GPR83_HUMAN;Probable G-protein coupled receptor 83 (G-protein coupled receptor 72);"cilium [GO:0005929]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]; response to glucocorticoid [GO:0051384]";"GO:0004930; GO:0004983; GO:0005886; GO:0005929; GO:0007186; GO:0016021; GO:0051384; GO:0097730";"G protein-coupled receptor signaling pathway [GO:0007186]; response to glucocorticoid [GO:0051384]";"cilium [GO:0005929]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]"
comp113490_c0_seq1;GAXK01081968.1;Q9TTR7;8.71E-13;COT2_BOVIN;COUP transcription factor 2 (COUP-TF2) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; forebrain development [GO:0030900]; limb development [GO:0060173]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; placenta blood vessel development [GO:0060674]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in lymphatic endothelial cell fate commitment [GO:0060849]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000977; GO:0001764; GO:0001893; GO:0001937; GO:0001972; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007519; GO:0008270; GO:0009566; GO:0009952; GO:0009956; GO:0010596; GO:0030154; GO:0030900; GO:0042803; GO:0045736; GO:0045893; GO:0048514; GO:0048856; GO:0060173; GO:0060674; GO:0060707; GO:0060849";"anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; forebrain development [GO:0030900]; limb development [GO:0060173]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; placenta blood vessel development [GO:0060674]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in lymphatic endothelial cell fate commitment [GO:0060849]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp1134938_c0_seq1;GAXK01050731.1;Q6ZMW2;3.94E-36;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1135_c7_seq1;GAXK01169649.1;P09622;0;DLDH_HUMAN;Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein);"acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]";"GO:0004148; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006103; GO:0006120; GO:0006508; GO:0006554; GO:0007369; GO:0007568; GO:0009055; GO:0009083; GO:0009106; GO:0031514; GO:0042391; GO:0043159; GO:0043544; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0051068; GO:0051287; GO:0061732; GO:0106077";"2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]";"acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]";"dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]"
comp113513_c1_seq1;GAXK01081941.1;Q0P4U8;9.99E-170;SMAL1_XENTR;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (Sucrose nonfermenting protein 2-like 1);"nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]";"GO:0003678; GO:0005524; GO:0005634; GO:0006259; GO:0006281; GO:0006357; GO:0006974; GO:0008094; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0048478";"cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]";"nuclear replication fork [GO:0043596]; nucleus [GO:0005634]";"annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]"
comp113526_c1_seq1;GAXK01081957.1;Q26474;3.27E-24;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1135356_c0_seq1;GAXK01050763.1;A8C984;2.20E-27;MYLK3_DANRE;Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; heart morphogenesis [GO:0003007]; sarcomerogenesis [GO:0048769]; ventricular cardiac myofibril assembly [GO:0055005]";"GO:0003007; GO:0004687; GO:0005524; GO:0005737; GO:0048769; GO:0055005";"heart morphogenesis [GO:0003007]; sarcomerogenesis [GO:0048769]; ventricular cardiac myofibril assembly [GO:0055005]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]"
comp1135562_c0_seq1;GAXK01050749.1;Q6YHK3;1.52E-19;CD109_HUMAN;CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675";"hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]";"serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]"
comp1135702_c0_seq1;GAXK01050751.1;O60513;1.56E-15;B4GT4_HUMAN;Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4);"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0003945; GO:0005794; GO:0005975; GO:0006486; GO:0006643; GO:0008378; GO:0016021; GO:0018146; GO:0032580; GO:0046872";"carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486]";"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]"
comp113585_c1_seq1;GAXK01082305.1;Q8BUB4;8.37E-138;WDFY2_MOUSE;WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934]";"GO:0001934; GO:0005737; GO:0005769; GO:0031982; GO:0045600; GO:0046872";"positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]; vesicle [GO:0031982]";metal ion binding [GO:0046872]
comp113613_c0_seq1;GAXK01082075.1;P55853;1.80E-13;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp113620_c0_seq1;GAXK01082191.1;Q3IQZ9;1.79E-124;KATG_NATPD;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp113668_c5_seq1;GAXK01082249.1;Q9VE46;0;SC5A7_DROME;High-affinity choline transporter 1;"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";"GO:0003333; GO:0005307; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021; GO:0033265";"acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";integral component of membrane [GO:0016021];"amino acid transmembrane transporter activity [GO:0015171]; choline:sodium symporter activity [GO:0005307]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]"
comp11368_c0_seq1;GAXK01187497.1;Q5M8Y1;1.37E-70;SPCS2_XENTR;Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit);"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]";"GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047";"protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]";"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";peptidase activity [GO:0008233]
comp11370_c11_seq1;GAXK01187633.1;Q14974;0;IMB1_HUMAN;Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]";"GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0008536; GO:0010494; GO:0016020; GO:0019054; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0043312; GO:0043657; GO:0045184; GO:0045540; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0075733; GO:0090307; GO:1904813";"apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]";"enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1137063_c0_seq1;GAXK01102103.1;O43930;9.56E-49;PRKY_HUMAN;Putative serine/threonine-protein kinase PRKY (EC 2.7.11.1);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004674; GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0018105";"peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]"
comp11371_c3_seq1;GAXK01188274.1;Q8TF09;9.46E-45;DLRB2_HUMAN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2);"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0035735; GO:0045505; GO:0097542";"intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]"
comp1137180_c0_seq1;GAXK01102100.1;Q8BUZ1;8.70E-24;ABRA_MOUSE;Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030016; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp1137201_c0_seq1;GAXK01102112.1;Q08890;7.65E-90;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp11373_c1_seq1;GAXK01187802.1;Q9LM66;1.20E-60;XCP2_ARATH;Cysteine protease XCP2 (EC 3.4.22.-) (Xylem cysteine peptidase 2) (AtXCP2);"cell wall [GO:0005618]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; defense response to bacterium [GO:0042742]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005618; GO:0005764; GO:0005886; GO:0010623; GO:0042742; GO:0051603";"defense response to bacterium [GO:0042742]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"cell wall [GO:0005618]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";cysteine-type endopeptidase activity [GO:0004197]
comp1137351_c0_seq1;GAXK01102115.1;P08442;2.67E-16;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp113743_c1_seq1;GAXK01082072.1;Q9UJX0;1.32E-61;OSGI1_HUMAN;Oxidative stress-induced growth inhibitor 1 (Bone marrow stromal cell-derived growth inhibitor) (BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38) (huOKL38) (Pregnancy-induced growth inhibitor OKL38);"growth factor activity [GO:0008083]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]";"GO:0007275; GO:0008083; GO:0030154; GO:0030308; GO:0030334; GO:0042127; GO:0042981; GO:0043065";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]";;growth factor activity [GO:0008083]
comp1137466_c0_seq1;GAXK01102045.1;Q21701;8.04E-10;NHR12_CAEEL;Nuclear hormone receptor family member nhr-12;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1137500_c0_seq1;GAXK01102101.1;Q16960;0;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp1137558_c0_seq1;GAXK01102044.1;Q7PPU9;3.91E-22;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp113780_c5_seq1;GAXK01082173.1;P59015;0;VPS18_DANRE;Vacuolar protein sorting-associated protein 18 homolog;"endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007033; GO:0007040; GO:0007634; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0035542; GO:0043485; GO:0045176; GO:0046872; GO:0048069; GO:0048757; GO:0060036";"apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]";"endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]"
comp11380_c3_seq1;GAXK01188267.1;Q96G97;7.73E-44;BSCL2_HUMAN;Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein);"integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]";"GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0120162";"fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]";integral component of endoplasmic reticulum membrane [GO:0030176];
comp1138070_c0_seq1;GAXK01104330.1;Q9D6P8;3.20E-22;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp113809_c0_seq1;GAXK01082372.1;Q9GRW0;2.71E-55;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1138154_c1_seq1;GAXK01104333.1;P75791;3.50E-69;YBIU_ECOLI;Uncharacterized protein YbiU;;;;;
comp11383_c0_seq1;GAXK01187790.1;A6QPN6;4.56E-18;GILT_BOVIN;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (IFI30 protein);"extracellular region [GO:0005576]; lysosome [GO:0005764]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"GO:0005576; GO:0005764; GO:0016667; GO:0042590";antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590];"extracellular region [GO:0005576]; lysosome [GO:0005764]";oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]
comp113870_c0_seq1;GAXK01082024.1;Q96LD8;1.50E-43;SENP8_HUMAN;Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8);"cytosol [GO:0005829]; NEDD8-specific protease activity [GO:0019784]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]";"GO:0005829; GO:0016579; GO:0019784; GO:0043687";"post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]";cytosol [GO:0005829];NEDD8-specific protease activity [GO:0019784]
comp113891_c0_seq1;GAXK01082167.1;Q6PDG8;9.61E-129;MON1A_MOUSE;Vacuolar fusion protein MON1 homolog A;"Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular iron ion homeostasis [GO:0006879]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]";"GO:0005085; GO:0006623; GO:0006879; GO:0009306; GO:0015031; GO:0035658";"cellular iron ion homeostasis [GO:0006879]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]";Mon1-Ccz1 complex [GO:0035658];guanyl-nucleotide exchange factor activity [GO:0005085]
comp1138966_c0_seq1;GAXK01104335.1;Q5VW22;3.49E-57;AGAP6_HUMAN;Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6 (AGAP-6) (Centaurin-gamma-like family member 3);"nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]";"GO:0005096; GO:0005634; GO:0046872";;nucleus [GO:0005634];"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp1139094_c0_seq1;GAXK01104319.1;P41116;1.86E-95;RL8_XENLA;60S ribosomal protein L8;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1139109_c0_seq1;GAXK01104323.1;Q9PVG3;3.42E-07;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp11392_c0_seq1;GAXK01187860.1;Q16740;2.56E-107;CLPP_HUMAN;ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp);"endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006515; GO:0008233; GO:0009368; GO:0042802; GO:0051117; GO:0051260; GO:0051603";"protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATPase binding [GO:0051117]; ATP-dependent peptidase activity [GO:0004176]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp1139223_c0_seq1;GAXK01205494.1;P89116;5.38E-64;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp1139286_c0_seq1;GAXK01104325.1;Q7PEV7;9.47E-27;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp113935_c5_seq1;GAXK01082331.1;P20482;6.59E-19;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp113977_c0_seq1;GAXK01081936.1;Q0IHH9;3.47E-26;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp114_c0_seq1;GAXK01166142.1;Q498T4;3.36E-41;RM02_RAT;39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005762; GO:0032543";mitochondrial translation [GO:0032543];mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp1140206_c0_seq1;GAXK01061977.1;Q9CXE0;7.64E-09;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1140288_c0_seq1;GAXK01061966.1;P15619;3.57E-09;SRYC_DROME;Serendipity locus protein H-1 (Protein pourquoi-pas) (Protein wings-down);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp114031_c1_seq1;GAXK01023553.1;Q6PD31;2.27E-53;TRAK1_MOUSE;Trafficking kinesin-binding protein 1 (Protein Milton);"axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]; anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496]";"GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006605; GO:0008089; GO:0008104; GO:0008333; GO:0017022; GO:0019896; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:0098957; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496]";"axonal growth cone [GO:0044295]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]"
comp114046_c1_seq1;GAXK01023617.1;Q99728;1.61E-35;BARD1_HUMAN;BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1);"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]; tissue homeostasis [GO:0001894]";"GO:0000151; GO:0000729; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006303; GO:0006974; GO:0007050; GO:0016567; GO:0016579; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0045732; GO:0046826; GO:0046872; GO:0046982; GO:0070531; GO:0085020; GO:1901796";"cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]; tissue homeostasis [GO:0001894]";"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]"
comp114047_c0_seq1;GAXK01023379.1;Q6P1C1;7.24E-26;IPPK_MOUSE;Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]";"GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0032958; GO:0035299; GO:0052746; GO:0060090; GO:1901838";"inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]"
comp11405_c0_seq1;GAXK01204918.1;Q6RUV5;5.19E-120;RAC1_RAT;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1);"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0006935; GO:0007015; GO:0007266; GO:0008045; GO:0008283; GO:0008361; GO:0010592; GO:0016020; GO:0016477; GO:0016601; GO:0017137; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030334; GO:0031116; GO:0031410; GO:0031996; GO:0032587; GO:0032707; GO:0034446; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048012; GO:0048870; GO:0051022; GO:0051117; GO:0051496; GO:0051668; GO:0051894; GO:0055038; GO:0060263; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098978; GO:1900026; GO:1902622";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"ATPase binding [GO:0051117]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]"
comp114078_c5_seq1;GAXK01023471.1;Q8IN81;9.33E-18;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp114080_c3_seq1;GAXK01023283.1;Q14CB8;1.55E-26;RHG19_HUMAN;Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0043231; GO:0051056";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp1141_c1_seq1;GAXK01168755.1;Q6NW59;6.27E-08;ATF4_DANRE;Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0048511";"regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1141050_c0_seq1;GAXK01061937.1;Q6P4K1;2.60E-07;HDGR2_XENTR;Hepatoma-derived growth factor-related protein 2 (HRP-2);;;;;
comp1141108_c1_seq1;GAXK01061967.1;O54963;1.97E-10;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1141200_c0_seq1;GAXK01061964.1;Q09103;0;DGK2_DROME;Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein);"membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872";"deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";membrane [GO:0016020];"ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp1141253_c0_seq1;GAXK01061954.1;Q9NGC3;1.95E-19;CEG1A_DROME;Centaurin-gamma-1A;"membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375";"medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp114134_c0_seq1;GAXK01023251.1;Q6PLK3;1.28E-21;AOFB_PIG;Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]";"GO:0005741; GO:0016021; GO:0016491";;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";oxidoreductase activity [GO:0016491]
comp1141398_c0_seq1;GAXK01061975.1;Q8BKG4;1.26E-64;FZD10_MOUSE;Frizzled-10 (Fz-10) (CD antigen CD350);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; negative regulation of GTPase activity [GO:0034260]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055]";"GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0007275; GO:0009986; GO:0016021; GO:0016055; GO:0017147; GO:0032956; GO:0034260; GO:0035567; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070";"canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; negative regulation of GTPase activity [GO:0034260]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp11415_c0_seq1;GAXK01187473.1;P45594;2.10E-44;CADF_DROME;Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0050714; GO:0051299";"actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]";actin binding [GO:0003779]
comp1141547_c0_seq1;GAXK01061956.1;Q96JL9;2.43E-15;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp114169_c0_seq1;GAXK01205112.1;B1H369;8.95E-97;HDAC8_XENTR;Histone deacetylase 8 (HD8) (EC 3.5.1.98);"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000118; GO:0004407; GO:0005737; GO:0032041; GO:0045944; GO:0046872; GO:0070932; GO:0070933";"histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]";"histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]"
comp1141712_c0_seq1;GAXK01061946.1;B4QBN3;3.87E-43;TRE12_DROSI;Facilitated trehalose transporter Tret1-2 homolog;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015771; GO:0016021; GO:0022857";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp114181_c2_seq1;GAXK01023493.1;P30281;8.79E-50;CCND3_HUMAN;G1/S-specific cyclin-D3;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]";"GO:0000079; GO:0000122; GO:0000307; GO:0001934; GO:0004693; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0016020; GO:0016538; GO:0019901; GO:0042098; GO:0042127; GO:0044772; GO:0045737; GO:0046626; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp114182_c0_seq1;GAXK01023424.1;B9EJ86;0;OSBL8_MOUSE;Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8);"cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]";"GO:0001786; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343";"activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]";"cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp1142008_c0_seq1;GAXK01000041.1;O46040;1.68E-17;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp114238_c1_seq1;GAXK01023692.1;Q21701;1.96E-11;NHR12_CAEEL;Nuclear hormone receptor family member nhr-12;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1142863_c0_seq1;GAXK01000019.1;P91953;7.41E-33;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1142963_c0_seq1;GAXK01000037.1;O09160;4.47E-20;FUT1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp1142965_c0_seq1;GAXK01000022.1;P17970;3.39E-85;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp1143175_c0_seq1;GAXK01000014.1;Q7SYC9;8.14E-119;CTL2_DANRE;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp114322_c4_seq1;GAXK01023198.1;P36956;2.26E-98;SRBP1_HUMAN;Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]";"GO:0000122; GO:0000139; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009749; GO:0010867; GO:0012507; GO:0016021; GO:0019217; GO:0019901; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032991; GO:0033762; GO:0033993; GO:0042789; GO:0044877; GO:0045444; GO:0045540; GO:0045542; GO:0045944; GO:0046676; GO:0046983; GO:0051591; GO:0071398; GO:1902895; GO:1903146; GO:1903214";"aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]"
comp1143286_c0_seq1;GAXK01000016.1;Q9P243;9.63E-11;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1143292_c2_seq1;GAXK01000029.1;Q26491;2.53E-08;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp1143304_c0_seq1;GAXK01000070.1;Q8IVL1;8.02E-79;NAV2_HUMAN;Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2);"interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]";"GO:0003025; GO:0003678; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0021554; GO:0021563; GO:0021564; GO:0022008";"glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]";"interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]"
comp1143359_c0_seq1;GAXK01000052.1;P13608;1.32E-28;PGCA_BOVIN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp114347_c2_seq1;GAXK01023381.1;Q3ZCX4;3.97E-10;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp114377_c1_seq1;GAXK01023333.1;G4RK44;1.75E-107;TPSP_THETK;"Bifunctional trehalose-6-phosphate synthase/phosphatase [Includes: Alpha,alpha-trehalose-phosphate synthase [UDP-forming] (EC 2.4.1.15) (Trehalose-6-phosphate synthase); Trehalose-6-phosphate phosphatase (EC 3.1.3.12)]";"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]; trehalose biosynthetic process [GO:0005992]";"GO:0003825; GO:0004805; GO:0005992; GO:0046872";trehalose biosynthetic process [GO:0005992];;"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]"
comp114383_c0_seq1;GAXK01023658.1;Q96FI4;4.12E-08;NEIL1_HUMAN;Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1) (NEH1) (Nei-like protein 1);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]";"GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006284; GO:0006289; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0019104; GO:0032074; GO:0045008; GO:0140078";"base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]"
comp1143845_c0_seq1;GAXK01000059.1;Q26474;2.22E-34;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp11439_c0_seq1;GAXK01187322.1;Q9VQG2;4.60E-59;APH1_DROME;Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor);"endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]";"GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0034205; GO:0035333; GO:0043085; GO:0055037; GO:0070765";"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]";"endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]";endopeptidase activity [GO:0004175]
comp1144_c1_seq1;GAXK01169775.1;P11951;2.03E-13;CX6C2_RAT;Cytochrome c oxidase subunit 6C-2 (Cytochrome c oxidase polypeptide VIc-2);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005751; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]";cytochrome-c oxidase activity [GO:0004129]
comp114408_c0_seq1;GAXK01023103.1;Q9BXW4;2.66E-32;MLP3C_HUMAN;Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]";"GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0035973; GO:0036464; GO:0097352";"aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]";"microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]"
comp114418_c1_seq1;GAXK01023158.1;Q9Y4G8;0;RPGF2_HUMAN;Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1);"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591]";"GO:0000165; GO:0001568; GO:0001764; GO:0005088; GO:0005096; GO:0005509; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007186; GO:0007218; GO:0007264; GO:0008285; GO:0010976; GO:0016020; GO:0016324; GO:0017034; GO:0019933; GO:0019992; GO:0021591; GO:0021884; GO:0030033; GO:0030139; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0035556; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070300; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:0072659; GO:0090557; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591]";"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]";"beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]"
comp11447_c0_seq1;GAXK01187399.1;Q9ET77;6.20E-123;JPH3_MOUSE;Junctophilin-3 (JP-3) (Junctophilin type 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; calcium-release channel activity [GO:0015278]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]";"GO:0005783; GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0015278; GO:0016021; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314";"exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]";calcium-release channel activity [GO:0015278]
comp1144723_c0_seq1;GAXK01154565.1;P41731;6.36E-29;CD63_MOUSE;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0034613; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigmentation [GO:0043473]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";protein-containing complex binding [GO:0044877]
comp114480_c3_seq1;GAXK01023335.1;P42260;0;GRIK2_RAT;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp1144893_c0_seq1;GAXK01154563.1;P58526;2.57E-14;MTOX_YERPE;N-methyl-L-tryptophan oxidase (MTOX) (EC 1.5.3.-);"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; N-methyl-L-amino-acid oxidase activity [GO:0050131]; sarcosine oxidase activity [GO:0008115]";"GO:0005829; GO:0008115; GO:0050131; GO:0050660";;cytosol [GO:0005829];"flavin adenine dinucleotide binding [GO:0050660]; N-methyl-L-amino-acid oxidase activity [GO:0050131]; sarcosine oxidase activity [GO:0008115]"
comp1144972_c0_seq1;GAXK01154562.1;A2VEI2;5.65E-129;MICU1_DROME;Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1);"mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051561; GO:0072375; GO:1990246";"anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]";calcium ion binding [GO:0005509]
comp114500_c0_seq1;GAXK01023386.1;Q5VT66;9.12E-37;MARC1_HUMAN;Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005739; GO:0005741; GO:0006805; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0055114";"detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]"
comp114503_c0_seq1;GAXK01023465.1;Q6IV72;4.52E-13;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1145096_c0_seq1;GAXK01154534.1;P28039;3.74E-100;AOAH_HUMAN;"Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]";"GO:0005509; GO:0005576; GO:0006631; GO:0009104; GO:0031410; GO:0050528";"fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]";"acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]"
comp114514_c2_seq1;GAXK01023175.1;P10090;0;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp114515_c4_seq1;GAXK01023197.1;P11475;5.59E-98;ERR2_RAT;Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2);"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]";"GO:0000793; GO:0000978; GO:0000980; GO:0000981; GO:0000993; GO:0001158; GO:0001228; GO:0003700; GO:0003707; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:2000035; GO:2000737";"cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]";"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp1145236_c1_seq1;GAXK01154553.1;Q5ZLK5;1.19E-33;P4HA2_CHICK;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp11453_c0_seq1;GAXK01187430.1;Q7SXP0;6.85E-87;S22BB_DANRE;Vesicle-trafficking protein SEC22b-B (SEC22 vesicle-trafficking protein homolog B-B);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]";"GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0012507; GO:0015031; GO:0016021; GO:0031201; GO:0033116; GO:0042470; GO:0048280";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]";SNAP receptor activity [GO:0005484]
comp114536_c1_seq1;GAXK01023620.1;Q32NT4;6.19E-71;LRC58_XENLA;Leucine-rich repeat-containing protein 58;;;;;
comp114537_c0_seq1;GAXK01023419.1;A1Z6W3;5.93E-150;PRIC1_DROME;Protein prickle (Protein spiny legs);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; axonal transport [GO:0098930]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; maintenance of protein location [GO:0045185]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0001736; GO:0001737; GO:0001738; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0007164; GO:0008270; GO:0009948; GO:0016020; GO:0030424; GO:0030951; GO:0042067; GO:0045184; GO:0045185; GO:0045773; GO:0060071; GO:0098930; GO:1902669";"anterior/posterior axis specification [GO:0009948]; axonal transport [GO:0098930]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; maintenance of protein location [GO:0045185]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]";zinc ion binding [GO:0008270]
comp1145411_c0_seq1;GAXK01154547.1;Q86MW9;4.17E-09;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1145461_c0_seq1;GAXK01154559.1;Q54WS6;1.75E-20;TGDS_DICDI;dTDP-D-glucose 4,6-dehydratase (EC 4.2.1.46);"dTDP-glucose 4,6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]";"GO:0008460; GO:0009225";nucleotide-sugar metabolic process [GO:0009225];;dTDP-glucose 4,6-dehydratase activity [GO:0008460]
comp114594_c0_seq1;GAXK01023105.1;Q8TDY2;1.21E-87;RBCC1_HUMAN;RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200);"Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; macroautophagy [GO:0016236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of macroautophagy [GO:0016241]; reticulophagy [GO:0061709]";"GO:0000045; GO:0000407; GO:0000422; GO:0001889; GO:0001934; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007049; GO:0007507; GO:0016236; GO:0016241; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0045793; GO:0046330; GO:0061709; GO:0061723; GO:1990316; GO:2001237";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; macroautophagy [GO:0016236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of macroautophagy [GO:0016241]; reticulophagy [GO:0061709]";"Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]";protein kinase binding [GO:0019901]
comp114596_c0_seq1;GAXK01023663.1;P24799;2.78E-08;GNAS_XENLA;Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein);"plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0003924; GO:0005525; GO:0005886; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];plasma membrane [GO:0005886];"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp114599_c0_seq1;GAXK01023555.1;P19538;1.22E-95;CI_DROME;Transcriptional activator cubitus interruptus (Transcriptional activator ci) (ci form of 155 kDa) (ci-155) (ci full-length protein) (ciFL) [Cleaved into: Transcriptional repressor cubitus interruptus (Transcriptional repressor ci) (ci C-terminally truncated form) (ci form of 75 kDa) (ci-75)];"cytosol [GO:0005829]; Hedgehog signaling complex [GO:0035301]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; blastoderm segmentation [GO:0007350]; cuticle pattern formation [GO:0035017]; dendrite morphogenesis [GO:0048813]; eye morphogenesis [GO:0048592]; genital disc anterior/posterior pattern formation [GO:0035224]; heart formation [GO:0060914]; labial disc development [GO:0035217]; mucosal immune response [GO:0002385]; ovarian follicle cell development [GO:0030707]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0000977; GO:0000981; GO:0001228; GO:0002385; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007224; GO:0007346; GO:0007350; GO:0007367; GO:0016020; GO:0030707; GO:0030858; GO:0032991; GO:0035017; GO:0035217; GO:0035224; GO:0035277; GO:0035301; GO:0042802; GO:0042803; GO:0043565; GO:0044212; GO:0045944; GO:0046872; GO:0048100; GO:0048592; GO:0048813; GO:0060914; GO:1900087; GO:1904263";"blastoderm segmentation [GO:0007350]; cuticle pattern formation [GO:0035017]; dendrite morphogenesis [GO:0048813]; eye morphogenesis [GO:0048592]; genital disc anterior/posterior pattern formation [GO:0035224]; heart formation [GO:0060914]; labial disc development [GO:0035217]; mucosal immune response [GO:0002385]; ovarian follicle cell development [GO:0030707]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; Hedgehog signaling complex [GO:0035301]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp114604_c2_seq1;GAXK01205110.1;P29294;3.73E-91;MYLK_RABIT;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp11467_c1_seq1;GAXK01187415.1;O00410;0;IPO5_HUMAN;Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032]";"GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0016020; GO:0016032; GO:0042307; GO:0045736; GO:0061608; GO:0071230";"cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]"
comp1146733_c1_seq1;GAXK01000390.1;P81018;1.85E-07;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp1146782_c0_seq1;GAXK01000413.1;Q05481;5.52E-54;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1146911_c0_seq1;GAXK01000378.1;B2RRE4;1.48E-13;Z518B_MOUSE;Zinc finger protein 518B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp114738_c0_seq1;GAXK01023677.1;Q9NYT6;6.09E-41;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1147625_c0_seq1;GAXK01000402.1;Q810T5;1.95E-80;KAT7_RAT;Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2);"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000123; GO:0000790; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0008270; GO:0010485; GO:0018393; GO:0042393; GO:0043161; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045892; GO:0045944";"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]"
comp114763_c6_seq1;GAXK01023528.1;O08662;2.07E-102;PI4KA_RAT;Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67);"cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]";"GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0030660; GO:0046854; GO:0048015";"phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]";"cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]"
comp114772_c0_seq1;GAXK01023410.1;P29052;1.65E-68;TF2B_DROME;Transcription initiation factor IIB (General transcription factor TFIIB);"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]";"GO:0000979; GO:0001139; GO:0001174; GO:0005634; GO:0006352; GO:0006357; GO:0006367; GO:0008134; GO:0017025; GO:0046872; GO:0051101; GO:0051123; GO:0097550";"DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]";"metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp1147890_c0_seq1;GAXK01000384.1;Q6H1V1;8.71E-11;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1148062_c0_seq1;GAXK01032684.1;O55131;2.59E-97;SEPT7_MOUSE;Septin-7 (CDC10 protein homolog);"axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000281; GO:0000777; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030336; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043065; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046982; GO:0048668; GO:0051291; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0097730; GO:0098978; GO:0099173; GO:1902857; GO:2000134";"cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]"
comp1148071_c0_seq1;GAXK01032667.1;P24733;2.88E-43;MYS_ARGIR;Myosin heavy chain, striated muscle;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp114817_c1_seq1;GAXK01023452.1;Q7JQ32;0;GC76C_DROME;Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]"
comp11483_c0_seq1;GAXK01188306.1;P35668;1.83E-123;GSHB_XENLA;Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase);"ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]";"GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295";;;"ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
comp114831_c0_seq1;GAXK01023243.1;P60321;1.18E-18;NANO2_HUMAN;Nanos homolog 2 (NOS-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007275; GO:0007283; GO:0008270; GO:0017148; GO:0030154; GO:0030718; GO:0045835; GO:0048471; GO:1900153";"cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]"
comp1148402_c0_seq1;GAXK01032675.1;Q80XN0;5.07E-36;BDH_MOUSE;D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH);"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]";"GO:0003858; GO:0005543; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0099617";;"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]"
comp1148666_c0_seq1;GAXK01032654.1;Q539E5;5.17E-12;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp1148832_c0_seq1;GAXK01032714.1;Q16983;8.11E-39;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp1149042_c0_seq1;GAXK01032706.1;O88609;1.06E-68;LMX1B_MOUSE;LIM homeobox transcription factor 1-beta (LIM/homeobox protein 1.2) (LMX-1.2) (LIM/homeobox protein LMX1B);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; central nervous system neuron development [GO:0021954]; cerebellum morphogenesis [GO:0021587]; collagen fibril organization [GO:0030199]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midbrain development [GO:0030901]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory behavior [GO:0042048]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression [GO:0010468]; regulation of intracellular transport [GO:0032386]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse organization [GO:0050808]; trabecular meshwork development [GO:0002930]";"GO:0000977; GO:0000981; GO:0001228; GO:0001764; GO:0002930; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007613; GO:0007626; GO:0008283; GO:0009953; GO:0010468; GO:0010506; GO:0021587; GO:0021954; GO:0030182; GO:0030199; GO:0030326; GO:0030901; GO:0032386; GO:0035108; GO:0035265; GO:0042048; GO:0043010; GO:0045944; GO:0046872; GO:0050808; GO:0071542";"camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; central nervous system neuron development [GO:0021954]; cerebellum morphogenesis [GO:0021587]; collagen fibril organization [GO:0030199]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midbrain development [GO:0030901]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory behavior [GO:0042048]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression [GO:0010468]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808]; trabecular meshwork development [GO:0002930]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp114906_c1_seq1;GAXK01023474.1;Q1LVQ7;9.82E-20;ALX1_DANRE;ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0001228; GO:0001755; GO:0005634; GO:0010718; GO:0045892; GO:0045893; GO:0045944; GO:0048701; GO:0048704";"embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp114924_c3_seq1;GAXK01023571.1;E1BMP7;8.33E-60;DNA2_BOVIN;"DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)]";"cytoplasm [GO:0005737]; gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]";"GO:0000076; GO:0000729; GO:0000784; GO:0003677; GO:0003678; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005760; GO:0006260; GO:0006264; GO:0006284; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0042645; GO:0043137; GO:0043139; GO:0043504; GO:0045740; GO:0046872; GO:0051539; GO:0071932; GO:1902990";"base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; DNA replication checkpoint [GO:0000076]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]";"cytoplasm [GO:0005737]; gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]"
comp1149290_c0_seq1;GAXK01032689.1;P84615;2.53E-10;DCAL1_DRONO;Dromaiocalcin-1 (DCA-1);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1149351_c0_seq1;GAXK01032677.1;Q8K1C7;2.41E-09;MOT14_MOUSE;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp114939_c0_seq1;GAXK01023312.1;P15364;4.92E-18;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp114951_c2_seq1;GAXK01023582.1;Q5W0V3;1.16E-30;F16B1_HUMAN;Protein FAM160B1;;;;;
comp114955_c0_seq1;GAXK01023109.1;Q28017;1.85E-61;PAFA_BOVIN;Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase);"extracellular space [GO:0005615]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]";"GO:0003847; GO:0005615; GO:0016042";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]
comp1149875_c0_seq1;GAXK01032659.1;Q86AD7;3.89E-26;MYLKB_DICDI;Probable myosin light chain kinase DDB_G0271550 (EC 2.7.11.18);"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0004687; GO:0005524";;;"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]"
comp1150276_c0_seq1;GAXK01157461.1;Q9VN45;1.14E-10;SPART_DROME;Protein spartin;"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030054; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301";"cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";Rab GTPase binding [GO:0017137]
comp115043_c0_seq1;GAXK01023656.1;Q9UBI4;3.92E-28;STML1_HUMAN;Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869]";"GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121";lipid transport [GO:0006869];"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";
comp115071_c0_seq1;GAXK01023678.1;Q24371;2.42E-82;L2DTL_DROME;Protein lethal(2)denticleless (Protein DTL83);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005737; GO:0007049; GO:0016567";"cell cycle [GO:0007049]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp115076_c0_seq1;GAXK01023540.1;Q9VQU9;5.77E-94;BOWEL_DROME;Protein bowel (Brother of odd with entrails limited);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619";"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1150839_c0_seq1;GAXK01157481.1;P09243;1.00E-66;TBA2_STYLE;Tubulin alpha-2 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp115089_c1_seq1;GAXK01023242.1;P10076;6.62E-60;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp115100_c0_seq1;GAXK01023396.1;P49415;2.36E-08;SDC_DROME;Syndecan;"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; synapse [GO:0045202]; axon guidance [GO:0007411]; cell migration [GO:0016477]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell development [GO:0021782]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]";"GO:0005886; GO:0007411; GO:0007427; GO:0007517; GO:0008045; GO:0009986; GO:0016021; GO:0016477; GO:0021782; GO:0031594; GO:0045202; GO:0045887; GO:0098595; GO:2000637";"axon guidance [GO:0007411]; cell migration [GO:0016477]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell development [GO:0021782]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; synapse [GO:0045202]";
comp11512_c0_seq1;GAXK01188249.1;Q9CRG1;2.70E-38;TM7S3_MOUSE;Transmembrane 7 superfamily member 3 (NARP1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024]";"GO:0005886; GO:0016021; GO:0032024; GO:0034620; GO:0043069";"cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1151212_c0_seq1;GAXK01157463.1;P16236;7.13E-09;REL_CHICK;Proto-oncogene c-Rel (p68);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic DNA fragmentation [GO:0006309]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]";"GO:0000122; GO:0000977; GO:0000981; GO:0003677; GO:0003682; GO:0003700; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006954; GO:0007249; GO:0034097; GO:0038061; GO:0042803; GO:0045944; GO:0046982";"apoptotic DNA fragmentation [GO:0006309]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1151454_c1_seq1;GAXK01157471.1;Q9N294;2.31E-20;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp1151522_c0_seq1;GAXK01157472.1;Q5UE96;4.11E-37;KCNK1_RABIT;Potassium channel subfamily K member 1;"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"GO:0005267; GO:0005272; GO:0005887; GO:0016021; GO:0016324; GO:0022841; GO:0030054; GO:0030425; GO:0034705; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0045202; GO:0055037; GO:0060075; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]";"identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]"
comp115153_c5_seq1;GAXK01023318.1;A2SWM2;4.96E-07;SPNS2_DANRE;Protein spinster homolog 2 (Protein two of hearts);"integral component of plasma membrane [GO:0005887]; branching involved in blood vessel morphogenesis [GO:0001569]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; lipid transport [GO:0006869]; regulation of cartilage development [GO:0061035]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane transport [GO:0055085]; vasculature development [GO:0001944]";"GO:0001569; GO:0001944; GO:0003143; GO:0003319; GO:0003376; GO:0005887; GO:0006869; GO:0048703; GO:0055085; GO:0061035";"branching involved in blood vessel morphogenesis [GO:0001569]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; lipid transport [GO:0006869]; regulation of cartilage development [GO:0061035]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane transport [GO:0055085]; vasculature development [GO:0001944]";integral component of plasma membrane [GO:0005887];
comp115178_c0_seq1;GAXK01023134.1;Q9CWL8;1.62E-163;CTBL1_MOUSE;Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]";"GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0006915; GO:0016445; GO:0019899; GO:0043065";"apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]";enzyme binding [GO:0019899]
comp1151976_c0_seq1;GAXK01157456.1;Q2UPB6;1.76E-08;ACLN_ASPOR;Aspirochlorine biosynthesis protein N;;;;;
comp115207_c0_seq1;GAXK01023402.1;Q5R7D1;0;DDX42_PONAB;ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42);"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008104; GO:0015030; GO:0016607; GO:0042981";"protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp115215_c1_seq1;GAXK01023298.1;Q5EBL2;4.32E-16;ZN628_HUMAN;Zinc finger protein 628;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp115229_c0_seq1;GAXK01023213.1;Q60821;2.58E-11;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp1152315_c0_seq1;GAXK01115110.1;P42325;3.54E-17;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp1152395_c0_seq1;GAXK01115107.1;Q9P2E3;4.85E-38;ZNFX1_HUMAN;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1152518_c0_seq1;GAXK01115092.1;P51814;1.02E-30;ZNF41_HUMAN;Zinc finger protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp115253_c9_seq1;GAXK01023482.1;Q6IUU3;5.67E-70;QSOX1_RAT;Sulfhydryl oxidase 1 (rQSOX) (rSOx) (EC 1.8.3.2) (FAD-dependent sulfhydryl oxidase-2) (SOx-2) (Quiescin Q6);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]; FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]";"GO:0000139; GO:0003756; GO:0005615; GO:0016242; GO:0016971; GO:0030173; GO:0045171; GO:0045454; GO:0070062; GO:0071949; GO:0085029";"cell redox homeostasis [GO:0045454]; extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]";"FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]"
comp115261_c0_seq1;GAXK01023653.1;P0DPW5;7.01E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1152792_c2_seq1;GAXK01115106.1;A2ASQ1;2.48E-31;AGRIN_MOUSE;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]";"acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp115289_c1_seq1;GAXK01023433.1;G5ECB1;6.91E-12;ZIG4_CAEEL;Zwei Ig domain protein zig-4 (2 Ig domain protein zig-4);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]";"GO:0005576; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0048666; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]";"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp1152919_c0_seq1;GAXK01115094.1;Q26474;3.04E-28;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1153204_c0_seq1;GAXK01115117.1;P10076;1.72E-34;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp115336_c0_seq1;GAXK01023240.1;Q9HAR2;2.05E-57;AGRL3_HUMAN;Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp115340_c0_seq1;GAXK01023073.1;P23359;1.41E-100;BMP7_MOUSE;Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; vesicle [GO:0031982]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; transforming growth factor beta receptor binding [GO:0005160]; allantois development [GO:1905069]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of MAPK cascade [GO:0043408]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of phosphorylation [GO:0042325]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657]";"GO:0001503; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005160; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0010800; GO:0010862; GO:0010942; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0034504; GO:0035239; GO:0042325; GO:0042326; GO:0042475; GO:0042981; GO:0043065; GO:0043401; GO:0043407; GO:0043408; GO:0043434; GO:0045597; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060393; GO:0060395; GO:0060411; GO:0060445; GO:0060485; GO:0060548; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0062023; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:1900006; GO:1900106; GO:1905069; GO:1905312";"allantois development [GO:1905069]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of MAPK cascade [GO:0043408]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of phosphorylation [GO:0042325]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; vesicle [GO:0031982]";"BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; transforming growth factor beta receptor binding [GO:0005160]"
comp1153511_c0_seq1;GAXK01205602.1;Q94527;6.92E-21;NFKB1_DROME;"Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]";"GO:0000981; GO:0001228; GO:0002230; GO:0003677; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0043565; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:0061059; GO:1901224; GO:2000647";"cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]"
comp11537_c1_seq1;GAXK01187488.1;Q5I030;1.51E-11;SELS_XENTR;Selenoprotein S (SelS) (VCP-interacting membrane protein);"cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; integral component of endoplasmic reticulum membrane [GO:0030176]; endoplasmic reticulum unfolded protein response [GO:0030968]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005881; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0036502; GO:0036513";"endoplasmic reticulum unfolded protein response [GO:0030968]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp115374_c3_seq1;GAXK01023408.1;O94760;9.97E-61;DDAH1_HUMAN;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]";"GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038";"arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]"
comp1153765_c0_seq1;GAXK01115111.1;Q25604;1.66E-19;NHR1_ONCVO;Nuclear hormone receptor-like 1;"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0004879; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp115378_c4_seq1;GAXK01023651.1;Q9VGY6;4.45E-07;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp115383_c0_seq1;GAXK01023208.1;Q8BSF4;1.14E-98;PISD_MOUSE;"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0016540; GO:0031305";"phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";phosphatidylserine decarboxylase activity [GO:0004609]
comp1153863_c0_seq1;GAXK01115098.1;P34885;1.55E-148;KPC1B_CAEEL;Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005623; GO:0005737; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008306; GO:0016020; GO:0016079; GO:0018105; GO:0035556; GO:0040012; GO:0040024; GO:0046872; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:1902074; GO:1990504; GO:2001024";"associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp115405_c3_seq1;GAXK01023091.1;O88572;1.44E-51;LRP6_MOUSE;Low-density lipoprotein receptor-related protein 6 (LRP-6);"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168";"anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell-cell adhesion [GO:0098609]; cell migration involved in gastrulation [GO:0042074]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]";"apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp1154094_c0_seq1;GAXK01123969.1;Q08180;1.67E-91;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp1154127_c0_seq1;GAXK01123959.1;Q63184;6.22E-22;E2AK2_RAT;Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; activation of MAPKK activity [GO:0000186]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to exogenous dsRNA [GO:0043330]; response to interferon-alpha [GO:0035455]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin E [GO:0033197]";"GO:0000186; GO:0001819; GO:0003723; GO:0004672; GO:0004694; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009612; GO:0009615; GO:0009636; GO:0010033; GO:0017148; GO:0022626; GO:0032496; GO:0032722; GO:0032874; GO:0033197; GO:0033689; GO:0035455; GO:0043065; GO:0043330; GO:0045071; GO:0045087; GO:0046777; GO:0048471; GO:0051092; GO:0051607; GO:1900225; GO:1901224; GO:1901532; GO:1902033; GO:1902036";"activation of MAPKK activity [GO:0000186]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to exogenous dsRNA [GO:0043330]; response to interferon-alpha [GO:0035455]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin E [GO:0033197]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]"
comp1154160_c0_seq1;GAXK01123962.1;P51688;2.27E-128;SPHM_HUMAN;N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase);"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]";"GO:0005764; GO:0006027; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062";"glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]"
comp115432_c0_seq1;GAXK01023543.1;P39447;1.75E-108;ZO1_MOUSE;Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; I band [GO:0031674]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; calmodulin binding [GO:0005516]; connexin binding [GO:0071253]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; blastocyst formation [GO:0001825]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of vascular permeability [GO:0043116]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; sensory perception of sound [GO:0007605]";"GO:0001825; GO:0005516; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005921; GO:0005923; GO:0007605; GO:0008022; GO:0009986; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030054; GO:0031674; GO:0032496; GO:0032991; GO:0043116; GO:0043296; GO:0045177; GO:0045471; GO:0046581; GO:0070160; GO:0071000; GO:0071253; GO:0071333; GO:0090557";"blastocyst formation [GO:0001825]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of vascular permeability [GO:0043116]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; sensory perception of sound [GO:0007605]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; I band [GO:0031674]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]";"calmodulin binding [GO:0005516]; connexin binding [GO:0071253]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]"
comp1154371_c0_seq1;GAXK01124016.1;P19634;9.26E-93;SL9A1_HUMAN;Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein binding, bridging [GO:0030674]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; hyaluronan catabolic process [GO:0030214]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005516; GO:0005546; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006811; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014704; GO:0015299; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0016477; GO:0030011; GO:0030027; GO:0030214; GO:0030307; GO:0030315; GO:0030346; GO:0030674; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051492; GO:0051893; GO:0051930; GO:0055007; GO:0060090; GO:0070062; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071260; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086036; GO:0086040; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902600; GO:1903281";"cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; hyaluronan catabolic process [GO:0030214]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]";"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein binding, bridging [GO:0030674]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]"
comp115446_c0_seq1;GAXK01023108.1;P33085;3.61E-20;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp115456_c0_seq1;GAXK01023397.1;Q62824;0;EXOC4_RAT;Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8);"cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522]";"GO:0000145; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0043005; GO:0043025; GO:0043198; GO:0043209; GO:0044091; GO:0044877; GO:0045202; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0090522; GO:0090543";"chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522]";"cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]";"PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]"
comp115466_c2_seq1;GAXK01023210.1;Q7KRI2;3.54E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp115488_c0_seq1;GAXK01023467.1;P36609;3.26E-76;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp115489_c1_seq1;GAXK01023388.1;Q23551;4.85E-129;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp1154958_c0_seq1;GAXK01124022.1;Q00871;2.46E-61;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp1155049_c0_seq1;GAXK01123964.1;P14940;3.76E-28;ADH_CUPNE;Alcohol dehydrogenase (EC 1.1.1.1) (EC 1.1.1.4) (EC 1.2.1.3);"(R,R)-butanediol dehydrogenase activity [GO:0000721]; alcohol dehydrogenase (NAD) activity [GO:0004022]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; zinc ion binding [GO:0008270]";"GO:0000721; GO:0004022; GO:0004029; GO:0008270; GO:0043878";;;"(R,R)-butanediol dehydrogenase activity [GO:0000721]; alcohol dehydrogenase (NAD) activity [GO:0004022]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; zinc ion binding [GO:0008270]"
comp1155253_c0_seq1;GAXK01123975.1;P11247;4.34E-68;PERM_MOUSE;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268";"aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]";"heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1155261_c0_seq1;GAXK01124017.1;P80109;3.33E-19;PHLD_BOVIN;Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]";"GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0005615; GO:0005737; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0034364; GO:0035690; GO:0035774; GO:0043065; GO:0043231; GO:0045919; GO:0046470; GO:0051044; GO:0051047; GO:0070633; GO:0071277; GO:0071397; GO:0071401; GO:0071467; GO:1900076";"cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]";"glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]"
comp1155280_c0_seq1;GAXK01124014.1;Q5RBF2;6.31E-29;NED4L_PONAB;E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L);"Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005771; GO:0005794; GO:0006511; GO:0030154; GO:0061630";"cell differentiation [GO:0030154]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]";ubiquitin protein ligase activity [GO:0061630]
comp1155382_c0_seq1;GAXK01123967.1;P41183;1.20E-09;BCL6_MOUSE;B-cell lymphoma 6 protein homolog;"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0001161; GO:0001227; GO:0001953; GO:0002467; GO:0002829; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005657; GO:0005794; GO:0006357; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0042802; GO:0043065; GO:0043066; GO:0043087; GO:0043380; GO:0043565; GO:0045591; GO:0045596; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0051272; GO:2000773";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1155422_c0_seq1;GAXK01123985.1;Q8GUD7;7.49E-41;CHIL_HEVBR;Probable inactive chitinase-like protein LaCIC (Leaf class I chitinase) (LaCIC) (allergen Hev b 11) (Fragment);"chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]";"GO:0004568; GO:0005975; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"carbohydrate metabolic process [GO:0005975]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]";;"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp115547_c5_seq1;GAXK01023337.1;Q6P0B1;2.34E-81;CELF2_DANRE;CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (RNA-binding protein BRUNOL-3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904";"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1155625_c0_seq1;GAXK01124013.1;Q98943;1.78E-26;CASP2_CHICK;"Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200";"apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp1155826_c0_seq1;GAXK01123960.1;B0S6R1;7.64E-11;NCKP1_DANRE;Nck-associated protein 1 (NAP 1);"integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; SCAR complex [GO:0031209]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]";"GO:0000902; GO:0016021; GO:0016477; GO:0030031; GO:0030866; GO:0031209; GO:0031258; GO:0048812";"cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]";"integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; SCAR complex [GO:0031209]";
comp115609_c1_seq1;GAXK01023299.1;Q923W1;7.25E-88;TGS1_MOUSE;Trimethylguanosine synthase (EC 2.1.1.-) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT);"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]";"GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0009452; GO:0015030; GO:0036261; GO:0071164";"7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA trimethylguanosine synthase activity [GO:0071164]
comp1156365_c0_seq1;GAXK01064635.1;Q7KRI2;1.20E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp115639_c1_seq1;GAXK01023257.1;Q29IM7;8.05E-16;CASP8_DROPS;"Caspase-8 (EC 3.4.22.61) (Death-related ced-3/NEDD2-like protein) [Cleaved into: Caspase-8 subunit p15; Caspase-8 subunit p10]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]";"GO:0004197; GO:0005737; GO:0006915; GO:0008656; GO:0045087; GO:0050829";"apoptotic process [GO:0006915]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]"
comp1156505_c0_seq1;GAXK01064669.1;Q95KD9;1.10E-26;DIRA2_MACFA;GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp115661_c0_seq1;GAXK01023691.1;P83501;2.12E-28;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp11567_c0_seq1;GAXK01187358.1;Q5RAZ5;3.14E-16;NSE1_PONAB;Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]";"GO:0000781; GO:0004842; GO:0005634; GO:0006281; GO:0006310; GO:0030915; GO:0035556; GO:0046872; GO:0046983; GO:2001022";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]";"metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]"
comp115677_c0_seq1;GAXK01023297.1;A8MXY4;3.58E-17;ZNF99_HUMAN;Zinc finger protein 99;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp115680_c1_seq1;GAXK01023308.1;Q6AZW8;1.13E-37;ZN660_HUMAN;Zinc finger protein 660;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp115694_c3_seq1;GAXK01023418.1;Q6P6J0;8.06E-43;ADAT2_MOUSE;tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2);"tRNA-specific adenosine-34 deaminase complex [GO:0052718]; tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270]; tRNA wobble adenosine to inosine editing [GO:0002100]";"GO:0002100; GO:0008270; GO:0052717; GO:0052718";tRNA wobble adenosine to inosine editing [GO:0002100];tRNA-specific adenosine-34 deaminase complex [GO:0052718];"tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270]"
comp11570_c1_seq1;GAXK01187639.1;Q0VCC1;2.61E-78;S66A2_BOVIN;Solute carrier family 66 member 2 (PQ-loop repeat-containing protein 1);"cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; phospholipid translocation [GO:0045332]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005768; GO:0005802; GO:0005829; GO:0016021; GO:0042147; GO:0045332";"phospholipid translocation [GO:0045332]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";
comp1157098_c0_seq1;GAXK01064664.1;Q6C2P2;6.27E-08;MRS2_YARLI;Mitochondrial inner membrane magnesium transporter MRS2 (RNA-splicing protein MRS2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";magnesium ion transmembrane transporter activity [GO:0015095]
comp1157350_c0_seq1;GAXK01064668.1;Q9V8K2;4.82E-175;EXOC3_DROME;Exocyst complex component 3 (Exocyst complex component Sec6);"cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; SNARE binding [GO:0000149]; border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793";"border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]";SNARE binding [GO:0000149]
comp115737_c0_seq1;GAXK01023655.1;Q24247;0;ITA1_DROME;"Integrin alpha-PS1 (Position-specific antigen subunit alpha-1) (Protein multiple edematous wings) [Cleaved into: Integrin alpha-PS1 heavy chain; Integrin alpha-PS1 light chain]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; cell adhesion molecule binding [GO:0050839]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; ectodermal digestive tract morphogenesis [GO:0048567]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; salivary gland boundary specification [GO:0007432]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005887; GO:0005925; GO:0007015; GO:0007155; GO:0007157; GO:0007229; GO:0007411; GO:0007414; GO:0007431; GO:0007432; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0030154; GO:0033627; GO:0034446; GO:0035160; GO:0046982; GO:0048567; GO:0050839; GO:0050840; GO:0098609";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; ectodermal digestive tract morphogenesis [GO:0048567]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; salivary gland boundary specification [GO:0007432]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]";"cell adhesion molecule binding [GO:0050839]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]"
comp115749_c0_seq1;GAXK01023258.1;Q7KRI2;2.46E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp115753_c4_seq1;GAXK01023664.1;Q8TAQ5;1.95E-23;ZN420_HUMAN;Zinc finger protein 420;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0042981; GO:0046872";"regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]";nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1157671_c0_seq1;GAXK01064655.1;Q62640;2.42E-16;GRID1_RAT;Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035176; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp115777_c4_seq1;GAXK01023183.1;Q9P792;6.78E-21;YN8B_SCHPO;ZZ-type zinc finger-containing protein P35G2.11c;"fungal-type vacuole lumen [GO:0000328]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; NVT complex [GO:0061957]; zinc ion binding [GO:0008270]; macroautophagy [GO:0016236]; protein localization by the NVT pathway [GO:0120113]";"GO:0000328; GO:0005771; GO:0005794; GO:0008270; GO:0016236; GO:0061957; GO:0120113";"macroautophagy [GO:0016236]; protein localization by the NVT pathway [GO:0120113]";"fungal-type vacuole lumen [GO:0000328]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; NVT complex [GO:0061957]";zinc ion binding [GO:0008270]
comp1157888_c0_seq1;GAXK01064631.1;Q29G54;1.47E-75;WSCD_DROPS;WSCD family member GA21586;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1158272_c0_seq1;GAXK01015646.1;P17038;3.07E-07;ZNF43_HUMAN;Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp115838_c0_seq1;GAXK01023203.1;Q15654;2.69E-35;TRIP6_HUMAN;Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0001725; GO:0003723; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007165; GO:0019900; GO:0030335; GO:0046872; GO:0046966; GO:0048041; GO:1901224";"focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]"
comp1158681_c0_seq1;GAXK01015631.1;Q7Z0G7;1.60E-61;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1158967_c0_seq1;GAXK01015633.1;Q8IN81;1.73E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1158980_c0_seq1;GAXK01015608.1;Q7Z2K6;6.78E-119;ERMP1_HUMAN;Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0005789; GO:0006508; GO:0008237; GO:0016020; GO:0016021; GO:0046872";proteolysis [GO:0006508];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1159029_c0_seq1;GAXK01015645.1;Q8VIG1;3.94E-15;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1159193_c0_seq1;GAXK01015636.1;Q9BQK8;3.26E-29;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp115920_c0_seq1;GAXK01023676.1;P16066;7.31E-55;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp1159853_c0_seq1;GAXK01015635.1;A2AGA4;9.27E-58;RHBL2_MOUSE;"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp11599_c2_seq1;GAXK01188040.1;O13016;9.49E-92;PTN1_CHICK;Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (CPTP1) (Protein-tyrosine phosphatase 1B) (PTP-1B);"early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966]";"GO:0004725; GO:0005769; GO:0005789; GO:0009966; GO:0030100; GO:0030968; GO:0031532; GO:0035335";"actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966]";"early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]";protein tyrosine phosphatase activity [GO:0004725]
comp116_c2_seq1;GAXK01205880.1;Q9U639;0;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp116012_c3_seq1;GAXK01030962.1;Q9IAB2;1.26E-22;MTG8R_XENLA;Protein CBFA2T2 (MTG8-like protein) (MTG8-related protein 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0003714; GO:0005634; GO:0010977; GO:0045892; GO:0046872; GO:0050768";"negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp116048_c1_seq1;GAXK01031023.1;Q7KRI2;1.54E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp116056_c0_seq1;GAXK01030720.1;P52898;1.13E-44;DDBX_BOVIN;Dihydrodiol dehydrogenase 3 (EC 1.-.-.-) (Prostaglandin F synthase);"cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]";"GO:0004032; GO:0005829; GO:0006693; GO:0008106; GO:0008202; GO:0016229; GO:0016491; GO:0042448; GO:0044597; GO:0044598; GO:0047023; GO:0047086";"daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]";cytosol [GO:0005829];"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]"
comp116069_c1_seq1;GAXK01030616.1;Q869N6;3.19E-75;CRTL_DICDI;3-hydroxybutyryl-CoA dehydratase-like protein, mitochondrial (EC 4.2.1.-);"mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]";"GO:0004300; GO:0005739; GO:0006635";fatty acid beta-oxidation [GO:0006635];mitochondrion [GO:0005739];enoyl-CoA hydratase activity [GO:0004300]
comp1160725_c0_seq1;GAXK01001593.1;Q7TS63;4.37E-10;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1160760_c0_seq1;GAXK01001554.1;Q01603;7.38E-103;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1160941_c0_seq1;GAXK01001544.1;Q01842;5.07E-11;POK_DROME;Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000980; GO:0000981; GO:0001012; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090175; GO:1903688; GO:2000051";"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp116115_c1_seq1;GAXK01030686.1;A9X4T1;0;CHD1_BOMMO;Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1);"chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]";"GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0006325";chromatin organization [GO:0006325];"chromosome [GO:0005694]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp1161155_c0_seq1;GAXK01001559.1;Q9QZW0;2.96E-39;AT11C_MOUSE;Phospholipid-transporting ATPase 11C (EC 7.6.2.1) (ATPase class VI type 11C) (P4-ATPase flippase complex alpha subunit ATP11C);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]; positive regulation of B cell differentiation [GO:0045579]; pre-B cell differentiation [GO:0002329]";"GO:0000287; GO:0002329; GO:0005524; GO:0005783; GO:0005789; GO:0005802; GO:0005886; GO:0016021; GO:0045332; GO:0045579; GO:0055037; GO:0140326";"phospholipid translocation [GO:0045332]; positive regulation of B cell differentiation [GO:0045579]; pre-B cell differentiation [GO:0002329]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp1161287_c0_seq1;GAXK01001543.1;Q9QWG7;1.32E-33;ST1B1_MOUSE;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (DOPA/tyrosine sulfotransferase);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";"GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp116149_c3_seq1;GAXK01204943.1;P46436;2.26E-31;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp116162_c0_seq1;GAXK01030802.1;Q86GC8;0;ACES_CULPI;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp1161636_c0_seq1;GAXK01001578.1;Q8W0Z9;3.82E-07;CCR4A_ARATH;Carbon catabolite repressor protein 4 homolog 1 (CCR4 homolog 1) (EC 3.1.13.4);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; starch biosynthetic process [GO:0019252]; sucrose biosynthetic process [GO:0005986]";"GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006397; GO:0019252; GO:0030014; GO:0046872";"mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; starch biosynthetic process [GO:0019252]; sucrose biosynthetic process [GO:0005986]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]"
comp1161647_c0_seq1;GAXK01001581.1;Q8STF0;2.76E-50;CALM_STRIE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1161825_c0_seq1;GAXK01001566.1;Q64273;2.37E-31;KCNJ2_RAT;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (RBL-IRK1) (Potassium channel, inwardly rectifying subfamily J member 2);"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"GO:0005242; GO:0005546; GO:0005790; GO:0005791; GO:0005794; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0030315; GO:0030425; GO:0031224; GO:0042802; GO:0043025; GO:0043197; GO:0051289; GO:0055119; GO:0060306; GO:0071260; GO:0086002; GO:0086004; GO:0086008; GO:0086091; GO:0090076; GO:1901381; GO:1990573";"cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]";"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]"
comp116210_c0_seq1;GAXK01030770.1;Q8K3A2;3.51E-54;TRPT1_MOUSE;tRNA 2'-phosphotransferase 1 (mTPT1) (EC 2.7.1.160);"tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"GO:0000215; GO:0006388; GO:0045859";"regulation of protein kinase activity [GO:0045859]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";;tRNA 2'-phosphotransferase activity [GO:0000215]
comp116215_c2_seq1;GAXK01030810.1;Q5F361;7.01E-170;TBCK_CHICK;TBC domain-containing protein kinase-like protein;"cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0005819; GO:0006886; GO:0017137; GO:0030496; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]";"ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; Rab GTPase binding [GO:0017137]"
comp1162527_c0_seq1;GAXK01173829.1;Q7KRI2;1.47E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp116257_c0_seq1;GAXK01030627.1;Q28DB5;3.04E-08;ALAT2_XENTR;Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";"GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";;"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
comp116271_c1_seq1;GAXK01030842.1;Q292F9;2.34E-62;GDAP2_DROPS;Protein GDAP2 homolog;;;;;
comp116278_c1_seq1;GAXK01030582.1;Q9QX01;1.93E-12;TRPC1_RAT;Short transient receptor potential channel 1 (TrpC1) (Transient receptor protein 1) (TRP-1);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005887; GO:0006828; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679; GO:0071456";"calcium ion transmembrane transport [GO:0070588]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp1163077_c0_seq1;GAXK01173845.1;Q9VJJ7;0;TRPG_DROME;Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635";"adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"
comp116313_c3_seq1;GAXK01030580.1;Q9UBS8;3.36E-68;RNF14_HUMAN;E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630";"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]"
comp1163651_c0_seq1;GAXK01173800.1;P10076;5.36E-52;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp11637_c7_seq1;GAXK01187205.1;P52948;2.40E-49;NUP98_HUMAN;"Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]";"cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016032; GO:0016604; GO:0016925; GO:0017056; GO:0019083; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0043231; GO:0043657; GO:0044614; GO:0044615; GO:0048026; GO:0051292; GO:0060964; GO:0075733; GO:1900034; GO:1990841; GO:1990904";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]"
comp1163782_c0_seq1;GAXK01173815.1;Q08180;2.68E-66;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp1164114_c0_seq1;GAXK01162766.1;Q14588;5.74E-51;ZN234_HUMAN;Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1164261_c0_seq1;GAXK01162785.1;P15330;1.18E-57;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp116436_c0_seq1;GAXK01030833.1;Q6P2D0;3.50E-15;ZFP1_HUMAN;Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp116462_c3_seq1;GAXK01030567.1;P08953;1.03E-102;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp116480_c0_seq1;GAXK01030633.1;P0DKX0;3.55E-18;ZN728_HUMAN;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp116481_c0_seq1;GAXK01030925.1;Q298E0;2.29E-39;RU1C_DROPS;U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C);"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000243; GO:0000387; GO:0000395; GO:0003729; GO:0005685; GO:0008270; GO:0030619; GO:0071004";"mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]";"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";"mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]"
comp1164968_c0_seq1;GAXK01162777.1;P42325;1.97E-22;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp1165286_c0_seq1;GAXK01162779.1;P70684;3.18E-29;PGDH_CAVPO;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp11657_c0_seq1;GAXK01187429.1;Q9SXE1;2.14E-35;GSOX3_ARATH;Flavin-containing monooxygenase FMO GS-OX3 (EC 1.14.13.237) (Flavin-monooxygenase glucosinolate S-oxygenase 3);"integral component of membrane [GO:0016021]; 3-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080102]; 4-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080103]; 5-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080104]; 6-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080105]; 7-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080106]; 8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]";"GO:0004497; GO:0004499; GO:0016021; GO:0019761; GO:0050660; GO:0050661; GO:0080102; GO:0080103; GO:0080104; GO:0080105; GO:0080106; GO:0080107";glucosinolate biosynthetic process [GO:0019761];integral component of membrane [GO:0016021];"3-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080102]; 4-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080103]; 5-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080104]; 6-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080105]; 7-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080106]; 8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp116580_c0_seq1;GAXK01030651.1;Q70CQ4;6.15E-147;UBP31_HUMAN;Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31);"nucleus [GO:0005634]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004843; GO:0005634; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];thiol-dependent ubiquitin-specific protease activity [GO:0004843]
comp1165885_c0_seq1;GAXK01162770.1;Q5U5R9;0;HECD2_HUMAN;Probable E3 ubiquitin-protein ligase HECTD2 (EC 2.3.2.26) (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2);"cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005829";protein polyubiquitination [GO:0000209];cytosol [GO:0005829];ubiquitin-protein transferase activity [GO:0004842]
comp1166272_c0_seq1;GAXK01180256.1;Q80SU7;9.71E-101;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp116630_c0_seq1;GAXK01030566.1;Q29RL0;1.62E-12;TBC31_BOVIN;TBC1 domain family member 31 (WD repeat-containing protein 67);centrosome [GO:0005813];GO:0005813;;centrosome [GO:0005813];
comp116644_c0_seq1;GAXK01031016.1;Q9P0R6;2.49E-08;GSKIP_HUMAN;GSK3B-interacting protein (GSKIP) (GSK3beta interaction protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of Wnt signaling pathway [GO:0030111]";"GO:0004860; GO:0005634; GO:0005737; GO:0006469; GO:0008631; GO:0019901; GO:0030111; GO:0034237; GO:0051018; GO:0090263";"intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of Wnt signaling pathway [GO:0030111]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]"
comp1166583_c0_seq1;GAXK01180209.1;Q80SU7;1.77E-79;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp1166634_c0_seq1;GAXK01180215.1;Q5RCX4;3.03E-19;ZN547_PONAB;Zinc finger protein 547;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1166890_c0_seq1;GAXK01180216.1;Q292N4;5.69E-12;LPHN_DROPS;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1167083_c0_seq1;GAXK01180248.1;P18732;2.16E-10;ZG64_XENLA;Gastrula zinc finger protein XlCGF64.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp11671_c0_seq1;GAXK01187428.1;O97162;3.45E-08;TPM_RHIMP;Tropomyosin;;;;;
comp1167144_c0_seq1;GAXK01180207.1;Q94128;1.62E-15;WRT1_CAEEL;"Warthog protein 1 [Cleaved into: Warthog protein 1 N-product; Warthog protein 1 C-product]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"GO:0005576; GO:0005615; GO:0005886; GO:0007267; GO:0007367; GO:0008233; GO:0009986; GO:0016539; GO:0016540";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";peptidase activity [GO:0008233]
comp116717_c2_seq1;GAXK01030645.1;I6V1W0;2.98E-09;BMBL_DANRE;Protein brambleberry;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; karyomere membrane fusion [GO:0061472]; pronuclear fusion [GO:0007344]";"GO:0007344; GO:0016021; GO:0031965; GO:0061472";"karyomere membrane fusion [GO:0061472]; pronuclear fusion [GO:0007344]";"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";
comp1167293_c0_seq1;GAXK01180212.1;O55171;1.36E-49;ACOT2_RAT;Acyl-coenzyme A thioesterase 2, mitochondrial (Acyl-CoA thioesterase 2) (EC 3.1.2.2) (ARTISt/p43) (Acyl coenzyme A thioester hydrolase) (MTE-I) (Very-long-chain acyl-CoA thioesterase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; response to drug [GO:0042493]; response to epidermal growth factor [GO:0070849]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; very long-chain fatty acid catabolic process [GO:0042760]";"GO:0001666; GO:0005739; GO:0005759; GO:0006631; GO:0006637; GO:0009725; GO:0016290; GO:0031667; GO:0042493; GO:0042760; GO:0047617; GO:0052689; GO:0070849; GO:0102991";"acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; response to drug [GO:0042493]; response to epidermal growth factor [GO:0070849]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; very long-chain fatty acid catabolic process [GO:0042760]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp1167728_c0_seq1;GAXK01180251.1;P28698;5.63E-19;MZF1_HUMAN;Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0042803; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp1168144_c0_seq1;GAXK01136340.1;O35867;4.48E-60;NEB1_RAT;Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (PP1bp175) (Protein phosphatase 1 regulatory subunit 9A) (p180);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"GO:0005737; GO:0005829; GO:0005856; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0010976; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030027; GO:0030054; GO:0030175; GO:0030425; GO:0030426; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0044325; GO:0044326; GO:0044877; GO:0045202; GO:0045860; GO:0048666; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761";"actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]";"actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]"
comp1168228_c0_seq1;GAXK01136322.1;Q8C827;4.64E-13;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp116840_c0_seq1;GAXK01030704.1;P56941;9.06E-18;NPC1_PIG;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103";"bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp1168518_c0_seq1;GAXK01136362.1;Q8TC29;8.70E-33;ENKUR_HUMAN;Enkurin;"acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124]";"GO:0001669; GO:0005516; GO:0017124; GO:0097228";;"acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]";"calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124]"
comp1169158_c0_seq1;GAXK01136326.1;Q8X187;1.96E-18;CALM_PAXIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp116942_c0_seq1;GAXK01030678.1;Q5F415;2.98E-112;TBC23_CHICK;TBC1 domain family member 23;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; embryonic brain development [GO:1990403]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005794; GO:0005829; GO:0042147; GO:1990403";"embryonic brain development [GO:1990403]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";
comp116965_c5_seq1;GAXK01030622.1;Q9XSC3;0;WDR44_BOVIN;WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11);"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]";"GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471";;"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";Rab GTPase binding [GO:0017137]
comp11697_c0_seq1;GAXK01205932.1;Q91233;0;HSP70_ONCTS;Heat shock 70 kDa protein (HSP70);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp116983_c0_seq1;GAXK01030847.1;P95607;6.55E-09;CATA_RHOOP;Catechol 1,2-dioxygenase (EC 1.13.11.1) (1,2-CTD) (Fragment);"catechol 1,2-dioxygenase activity [GO:0018576]; chlorocatechol 1,2-dioxygenase activity [GO:0018575]; ferric iron binding [GO:0008199]; aromatic compound catabolic process [GO:0019439]; catechol-containing compound metabolic process [GO:0009712]";"GO:0008199; GO:0009712; GO:0018575; GO:0018576; GO:0019439";"aromatic compound catabolic process [GO:0019439]; catechol-containing compound metabolic process [GO:0009712]";;"catechol 1,2-dioxygenase activity [GO:0018576]; chlorocatechol 1,2-dioxygenase activity [GO:0018575]; ferric iron binding [GO:0008199]"
comp117032_c3_seq1;GAXK01030608.1;Q9U8W7;1.37E-52;TL5B_TACTR;Techylectin-5B;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp117038_c1_seq1;GAXK01030732.1;Q9XYN1;3.92E-34;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp1170418_c0_seq1;GAXK01103892.1;Q8BKE9;1.77E-119;IFT74_MOUSE;Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2);"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0008544; GO:0030992; GO:0031410; GO:0033630; GO:0035735; GO:0042073; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:1905515";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]";"beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]"
comp1170790_c0_seq1;GAXK01103919.1;Q9CQC9;5.38E-52;SAR1B_MOUSE;GTP-binding protein SAR1b;"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1170904_c0_seq1;GAXK01103910.1;O54750;4.05E-33;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp1170948_c0_seq1;GAXK01103911.1;Q7TNC8;1.69E-32;GLRA2_MOUSE;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp117116_c4_seq1;GAXK01030631.1;O00311;1.02E-43;CDC7_HUMAN;Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1);"cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]";"GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0018107; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686";"cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]";"cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp11713_c0_seq1;GAXK01187723.1;Q2TBX5;5.73E-28;SSRD_BOVIN;Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp117150_c0_seq1;GAXK01030869.1;Q6AYU1;3.89E-61;MO4L1_RAT;Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Transcription factor-like protein MRG15);"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; cell population proliferation [GO:0008283]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"GO:0000123; GO:0000724; GO:0003682; GO:0006342; GO:0008283; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0047485";"cell population proliferation [GO:0008283]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]";"chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]"
comp1171884_c0_seq1;GAXK01103898.1;A2ANX9;1.84E-11;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1172_c1_seq1;GAXK01169999.1;Q7T2P6;4.20E-22;TIM23_DANRE;Mitochondrial import inner membrane translocase subunit Tim23;"integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; intracellular protein transport [GO:0006886]; multicellular organism development [GO:0007275]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]";"GO:0005744; GO:0006886; GO:0007275; GO:0008320; GO:0015450; GO:0016021; GO:0030150; GO:0031305; GO:0042719; GO:0045039";"intracellular protein transport [GO:0006886]; multicellular organism development [GO:0007275]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]";"integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";"P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]"
comp1172113_c0_seq1;GAXK01087412.1;P43510;1.17E-15;CPR6_CAEEL;Cathepsin B-like cysteine proteinase 6 (EC 3.4.22.-) (Cysteine protease-related 6);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp117214_c1_seq1;GAXK01030674.1;Q9VGH7;8.75E-48;CLCN2_DROME;Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]";"GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]";"chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]"
comp1172192_c0_seq1;GAXK01087387.1;Q9VZH2;2.14E-12;MAS_DROME;Protein masquerade;"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007417; GO:0007422; GO:0010976; GO:0016203; GO:0030424; GO:0043025; GO:0061564; GO:0106030";"axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";
comp1172276_c0_seq1;GAXK01087372.1;B3EWZ3;1.19E-19;CADN_ACRMI;Coadhesin (Fragment);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1172402_c0_seq1;GAXK01087383.1;Q6DGZ1;1.94E-75;B9D2_DANRE;B9 domain-containing protein 2;"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; gamma-tubulin binding [GO:0043015]; cilium assembly [GO:0060271]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; opsin transport [GO:0036372]";"GO:0001736; GO:0005737; GO:0005813; GO:0005929; GO:0007163; GO:0036038; GO:0036064; GO:0036372; GO:0043015; GO:0060271";"cilium assembly [GO:0060271]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; opsin transport [GO:0036372]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]";gamma-tubulin binding [GO:0043015]
comp117246_c0_seq1;GAXK01030564.1;Q7KRI2;1.88E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp117250_c3_seq1;GAXK01030628.1;P90893;7.69E-89;YM9I_CAEEL;Putative serine protease F56F10.1 (EC 3.4.-.-);"membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0006508; GO:0008236; GO:0008239; GO:0045087; GO:0045121";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";membrane raft [GO:0045121];"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]"
comp11726_c0_seq1;GAXK01187678.1;Q0IEG8;3.80E-124;ARP8_AEDAE;Actin-related protein 8;"Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0005524; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0006355; GO:0031011";"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";Ino80 complex [GO:0031011];ATP binding [GO:0005524]
comp1172742_c0_seq1;GAXK01087409.1;O61369;2.15E-42;PICO_DROAN;Putative inorganic phosphate cotransporter;"integral component of plasma membrane [GO:0005887]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0015114; GO:0015293";sodium ion transport [GO:0006814];integral component of plasma membrane [GO:0005887];"phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]"
comp1173_c3_seq1;GAXK01205878.1;P12613;0;TCPA_DROME;T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1);"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]";"GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0030707; GO:0051082";"ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]";"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp1173115_c0_seq1;GAXK01087373.1;Q27433;1.05E-14;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1173151_c0_seq1;GAXK01087398.1;P90884;1.30E-31;MADD4_CAEEL;Protein madd-4 (Punctin);"axon [GO:0030424]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; dorsal/ventral axon guidance [GO:0033563]; synapse organization [GO:0050808]";"GO:0005102; GO:0005615; GO:0008233; GO:0030054; GO:0030424; GO:0033563; GO:0045202; GO:0050808";"dorsal/ventral axon guidance [GO:0033563]; synapse organization [GO:0050808]";"axon [GO:0030424]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";"peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp1173254_c0_seq1;GAXK01087420.1;Q26474;1.89E-26;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1173479_c0_seq1;GAXK01087397.1;P26714;2.09E-11;GBRB_LYMST;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]";"GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1173509_c0_seq1;GAXK01087378.1;Q8MIP0;3.60E-07;FRIH_HORSE;Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) [Cleaved into: Ferritin heavy chain, N-terminally processed];"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]";"GO:0004322; GO:0005506; GO:0005737; GO:0006826; GO:0006880; GO:0006955; GO:0008198; GO:0008199; GO:0008285; GO:0042802";"immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]"
comp1173609_c0_seq1;GAXK01087363.1;G5ED00;4.63E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp117365_c0_seq1;GAXK01030666.1;Q9BX70;4.32E-10;BTBD2_HUMAN;BTB/POZ domain-containing protein 2;"cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]";"GO:0000932; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; P-body [GO:0000932]";
comp1173725_c0_seq1;GAXK01087406.1;P10180;3.92E-08;CUT_DROME;Homeobox protein cut;"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0030713; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983";"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp117403_c2_seq1;GAXK01031047.1;Q9HBE1;2.83E-16;PATZ1_HUMAN;POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872";"male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp117439_c1_seq1;GAXK01031043.1;Q95V25;0;SLO1_CAEEL;Calcium-activated potassium channel slo-1 (BK channel) (Maxi K channel) (MaxiK) (Slo homolog) (Slowpoke protein 1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"GO:0005249; GO:0005886; GO:0006813; GO:0015269; GO:0015271; GO:0016021; GO:0030054; GO:0031430; GO:0034765; GO:0040011; GO:0042391; GO:0042493; GO:0043050; GO:0045202; GO:0045211; GO:0045214; GO:0046928; GO:0048149; GO:0050804; GO:0055120; GO:0060072";"behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]"
comp117443_c1_seq1;GAXK01030641.1;Q0IHH9;4.52E-37;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp11745_c3_seq1;GAXK01187857.1;Q9Y3C6;3.25E-79;PPIL1_HUMAN;Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1);"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718";"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]";"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";"cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp1174500_c0_seq1;GAXK01159544.1;Q9VZX1;5.50E-08;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp117451_c1_seq1;GAXK01030872.1;Q05481;1.22E-30;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp117494_c2_seq1;GAXK01030573.1;O75191;0;XYLB_HUMAN;Xylulose kinase (Xylulokinase) (EC 2.7.1.17);"cytosol [GO:0005829]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]";"GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0016310; GO:0019640; GO:0042732";"carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]";cytosol [GO:0005829];"ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]"
comp117512_c0_seq1;GAXK01030721.1;Q95T19;1.86E-24;SLIMP_DROME;Serine--tRNA synthetase-like protein Slimp (Seryl-tRNA synthetase-like insect mitochondrial protein);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; tRNA binding [GO:0000049]; seryl-tRNA aminoacylation [GO:0006434]";"GO:0000049; GO:0000166; GO:0005737; GO:0005739; GO:0006434";seryl-tRNA aminoacylation [GO:0006434];"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"nucleotide binding [GO:0000166]; tRNA binding [GO:0000049]"
comp117515_c0_seq1;GAXK01030878.1;Q9VD44;5.81E-59;GLD2A_DROME;Poly(A) RNA polymerase gld-2 homolog A (DmGLD2) (EC 2.7.7.19);"cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; long-term memory [GO:0007616]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]";"GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005737; GO:0006397; GO:0007616; GO:0043005; GO:0043631; GO:0046872";"long-term memory [GO:0007616]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]";"cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]"
comp117525_c1_seq1;GAXK01031001.1;Q80T11;1.93E-61;USH1G_MOUSE;Usher syndrome type-1G protein homolog (Jackson shaker protein) (Scaffold protein containing ankyrin repeats and SAM domain);"actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"GO:0001917; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0015629; GO:0016020; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0042803; GO:0045494; GO:0050953; GO:0050957; GO:0060113; GO:0060122";"equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]"
comp1175328_c0_seq1;GAXK01159559.1;Q5XIT1;3.71E-14;MARE3_RAT;Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3);"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005815; GO:0005874; GO:0005881; GO:0008017; GO:0008022; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0045737; GO:0045893; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp117533_c0_seq1;GAXK01030841.1;P35992;0;PTP10_DROME;Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D);"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446";"axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp1175418_c0_seq1;GAXK01159546.1;Q69ZN7;8.94E-10;MYOF_MOUSE;Myoferlin (Fer-1-like protein 3);"caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]";"GO:0001778; GO:0005543; GO:0005886; GO:0005901; GO:0006071; GO:0007520; GO:0016021; GO:0030659; GO:0030947; GO:0031410; GO:0031965; GO:0033292; GO:0034605; GO:0043231; GO:0048747";"cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]";"caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]";phospholipid binding [GO:0005543]
comp1175430_c0_seq1;GAXK01159564.1;Q95VA8;4.93E-49;TPM_TRISP;Tropomyosin;;;;;
comp1175664_c0_seq1;GAXK01159542.1;P83088;1.81E-54;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp117580_c1_seq1;GAXK01030563.1;P57721;9.85E-89;PCBP3_HUMAN;Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]";"GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829";mRNA metabolic process [GO:0016071];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp117588_c0_seq1;GAXK01030635.1;P44292;1.61E-09;Y1701_HAEIN;Uncharacterized protein HI_1701;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Gram-negative-bacterium-type cell wall biogenesis [GO:0043164]; peptidoglycan metabolic process [GO:0000270]";"GO:0000270; GO:0005886; GO:0016021; GO:0043164";"Gram-negative-bacterium-type cell wall biogenesis [GO:0043164]; peptidoglycan metabolic process [GO:0000270]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp117602_c1_seq1;GAXK01030835.1;Q2KHK3;2.07E-25;AMPQ_MOUSE;Aminopeptidase Q (AP-Q) (APQ) (EC 3.4.11.-) (Laeverin);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp1176275_c0_seq1;GAXK01179507.1;B4MYA4;3.86E-35;TRET1_DROWI;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1176406_c0_seq1;GAXK01179519.1;D3YXG0;4.74E-20;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1176466_c0_seq1;GAXK01179509.1;Q9BYZ6;5.83E-131;RHBT2_HUMAN;Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"GO:0000902; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007266; GO:0016477; GO:0019901; GO:0030036; GO:0030838; GO:0043652; GO:0051056";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp117671_c0_seq1;GAXK01031017.1;Q6DCE3;3.62E-118;ZNT9_XENLA;Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9);"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cation transmembrane transporter activity [GO:0008324]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transport [GO:0006829]";"GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0008324; GO:0016021; GO:0031410";"cellular zinc ion homeostasis [GO:0006882]; zinc ion transport [GO:0006829]";"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";cation transmembrane transporter activity [GO:0008324]
comp1176775_c0_seq1;GAXK01179527.1;Q6NUT3;3.80E-56;MFS12_HUMAN;Major facilitator superfamily domain-containing protein 12;"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; organic substance transport [GO:0071702]";"GO:0005765; GO:0005887; GO:0008643; GO:0015293; GO:0071702";"carbohydrate transport [GO:0008643]; organic substance transport [GO:0071702]";"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";symporter activity [GO:0015293]
comp117681_c4_seq1;GAXK01030882.1;Q99828;3.43E-42;CIB1_HUMAN;Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28);"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein membrane anchor [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]";"GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]";"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]";"calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein membrane anchor [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]"
comp1177175_c0_seq1;GAXK01179511.1;Q6GNS1;2.94E-13;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp1177386_c1_seq1;GAXK01179514.1;Q8I6K0;3.19E-24;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1177611_c0_seq1;GAXK01179529.1;O75762;1.68E-14;TRPA1_HUMAN;Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"GO:0005886; GO:0005887; GO:0006811; GO:0007166; GO:0009409; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070588; GO:0097604";"calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]";"calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]"
comp117773_c0_seq1;GAXK01030836.1;Q9VLV7;2.64E-11;SPZ3_DROME;Protein spaetzle 3 (Protein spatzle 3);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp11779_c12_seq1;GAXK01188023.1;Q9JIP7;2.66E-31;S15A1_MOUSE;Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) (Proton-coupled dipeptide cotransporter);"brush border [GO:0005903]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"GO:0005427; GO:0005887; GO:0005903; GO:0006857; GO:0015031; GO:0015333; GO:0016020; GO:0016021; GO:0016248; GO:0035673; GO:0051956; GO:0071916; GO:1904680";"negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"brush border [GO:0005903]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide:proton symporter activity [GO:0015333]; peptide transmembrane transporter activity [GO:1904680]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]"
comp117790_c1_seq1;GAXK01030956.1;Q9H2B2;3.00E-99;SYT4_HUMAN;Synaptotagmin-4 (Synaptotagmin IV) (SytIV);"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; integral component of Golgi membrane [GO:0030173]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; microvesicle [GO:1990742]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; secretory granule maturation [GO:0061792]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007420; GO:0007613; GO:0014049; GO:0014059; GO:0016192; GO:0017075; GO:0017156; GO:0017158; GO:0030054; GO:0030100; GO:0030173; GO:0030276; GO:0030285; GO:0030348; GO:0030424; GO:0030425; GO:0031339; GO:0032127; GO:0033604; GO:0042803; GO:0043005; GO:0043025; GO:0043231; GO:0044306; GO:0045955; GO:0045956; GO:0046982; GO:0048174; GO:0048471; GO:0048791; GO:0050709; GO:0061782; GO:0061792; GO:0070382; GO:0071277; GO:0097449; GO:0098978; GO:0099066; GO:0099161; GO:0099183; GO:1903861; GO:1905414; GO:1905415; GO:1905433; GO:1990742; GO:2000301";"brain development [GO:0007420]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; secretory granule maturation [GO:0061792]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; integral component of Golgi membrane [GO:0030173]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]"
comp1178019_c0_seq1;GAXK01038977.1;P47742;2.14E-30;GBRR2_RAT;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp117814_c1_seq1;GAXK01030604.1;Q9CXL1;2.62E-24;TM50A_MOUSE;Transmembrane protein 50A (Small membrane protein 1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]";"GO:0005737; GO:0005783; GO:0016021; GO:0032511; GO:0043025; GO:0097386";late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";
comp1178746_c0_seq1;GAXK01039001.1;Q9I3H5;3.25E-50;BVMO_PSEAE;Baeyer-Villiger monooxygenase (BVMO) (EC 1.14.13.-);"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidation-reduction process [GO:0055114]";"GO:0004499; GO:0016709; GO:0050660; GO:0050661; GO:0055114";oxidation-reduction process [GO:0055114];;"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp1178754_c0_seq1;GAXK01039019.1;Q29IM7;2.40E-26;CASP8_DROPS;"Caspase-8 (EC 3.4.22.61) (Death-related ced-3/NEDD2-like protein) [Cleaved into: Caspase-8 subunit p15; Caspase-8 subunit p10]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]";"GO:0004197; GO:0005737; GO:0006915; GO:0008656; GO:0045087; GO:0050829";"apoptotic process [GO:0006915]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]"
comp1178845_c0_seq1;GAXK01039037.1;Q9CXE0;3.27E-07;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1178872_c0_seq1;GAXK01039042.1;Q80ZA4;2.84E-124;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp1179120_c0_seq1;GAXK01038969.1;P48168;1.68E-11;GLRB_MOUSE;Glycine receptor subunit beta (Glycine receptor 58 kDa subunit);"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; drug binding [GO:0008144]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuropeptide signaling pathway [GO:0007218]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001964; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0008144; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0050905; GO:0051291; GO:0060012; GO:0060013; GO:0097112; GO:0098690; GO:0098982; GO:1902476; GO:1904315";"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuropeptide signaling pathway [GO:0007218]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"drug binding [GO:0008144]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1179273_c0_seq1;GAXK01039036.1;Q9VWP4;5.58E-148;SUOX_DROME;Probable sulfite oxidase, mitochondrial (EC 1.8.3.1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";"GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0042128; GO:0043546";"nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]"
comp117962_c0_seq1;GAXK01030606.1;Q96GA7;8.82E-61;SDSL_HUMAN;Serine dehydratase-like (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) (EC 4.3.1.17);"cytosol [GO:0005829]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; L-serine catabolic process [GO:0006565]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]";"GO:0003941; GO:0004794; GO:0005829; GO:0006565; GO:0006567; GO:0019518; GO:0030170; GO:0042802";"L-serine catabolic process [GO:0006565]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]"
comp1179801_c0_seq1;GAXK01039014.1;O15403;1.66E-07;MOT7_HUMAN;Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020";monocarboxylic acid transport [GO:0015718];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1179965_c0_seq1;GAXK01039026.1;Q8NDA2;3.37E-22;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp118_c5_seq1;GAXK01169275.1;Q1HPS0;1.76E-39;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp11800_c2_seq1;GAXK01188260.1;Q9P7T8;2.00E-121;YIW2_SCHPO;Uncharacterized helicase C694.02 (EC 3.6.4.-);"cytosol [GO:0005829]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]";"GO:0003676; GO:0003724; GO:0005524; GO:0005829";;cytosol [GO:0005829];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp11803_c0_seq1;GAXK01188461.1;D3ZSI8;6.78E-158;PI51A_RAT;Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha);"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"GO:0005524; GO:0005829; GO:0005847; GO:0006661; GO:0010761; GO:0016308; GO:0016607; GO:0019900; GO:0030027; GO:0031532; GO:0032587; GO:0048041; GO:0060326; GO:0072659; GO:0090630; GO:0097178";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]"
comp1180369_c0_seq1;GAXK01204631.1;Q2QL92;6.95E-17;TES_MICMU;Testin;"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]";"GO:0005737; GO:0005925; GO:0008270; GO:0008285";negative regulation of cell population proliferation [GO:0008285];"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]";zinc ion binding [GO:0008270]
comp118046_c0_seq1;GAXK01106574.1;Q5VV41;6.21E-85;ARHGG_HUMAN;Rho guanine nucleotide exchange factor 16 (Ephexin-4);"cytosol [GO:0005829]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005829; GO:0007186; GO:0017048; GO:0030165; GO:0030971; GO:0035023; GO:0043065; GO:0045296; GO:0051056; GO:0060326; GO:0090630; GO:1903078";"activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";cytosol [GO:0005829];"cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1180831_c0_seq1;GAXK01204639.1;Q6CJK6;6.44E-29;APTH1_KLULA;Acyl-protein thioesterase 1 (EC 3.1.2.-);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein deacylation [GO:0035601]";"GO:0005737; GO:0006631; GO:0008474; GO:0035601; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein deacylation [GO:0035601]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp11809_c0_seq1;GAXK01188448.1;P02689;7.23E-18;MYP2_HUMAN;Myelin P2 protein (Peripheral myelin protein 2);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; membrane organization [GO:0061024]";"GO:0005504; GO:0005737; GO:0015485; GO:0043209; GO:0061024; GO:0070062";membrane organization [GO:0061024];"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]";"cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]"
comp118109_c0_seq1;GAXK01106492.1;B5X4H8;9.23E-40;RFT2_SALSA;Riboflavin transporter 2 (RFT2);"integral component of plasma membrane [GO:0005887]; riboflavin transmembrane transporter activity [GO:0032217]";"GO:0005887; GO:0032217";;integral component of plasma membrane [GO:0005887];riboflavin transmembrane transporter activity [GO:0032217]
comp1181127_c0_seq1;GAXK01204641.1;Q9VUL9;2.04E-114;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp118134_c0_seq1;GAXK01106481.1;O95835;0;LATS1_HUMAN;Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]";"GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058";"cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]"
comp1181344_c0_seq1;GAXK01204633.1;O46040;3.76E-25;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1181566_c0_seq1;GAXK01204642.1;Q9VXE5;9.03E-144;PAKM_DROME;Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein);"adherens junction [GO:0005912]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000187; GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0016477; GO:0017048; GO:0018105; GO:0023014; GO:0031098; GO:0032147; GO:0043408; GO:0045315; GO:0045792; GO:0048365; GO:0048749; GO:2000047";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"adherens junction [GO:0005912]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]"
comp118171_c1_seq1;GAXK01106274.1;P34552;2.33E-44;ALXA_CAEEL;Apoptosis-linked gene 2-interacting protein X 1 (Prion-like-(Q/N-rich) domain-bearing protein 58) (Protein YNK1);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]; Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"GO:0005112; GO:0005771; GO:0007032; GO:0008022; GO:0016323; GO:0031410; GO:0032456; GO:0033365; GO:0042176; GO:0043226; GO:0055037";"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]";"Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]"
comp1181877_c0_seq1;GAXK01204618.1;Q91WK7;6.94E-13;ANR54_MOUSE;Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein);"cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]";"GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531";"nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]";"cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]";"protein-containing complex binding [GO:0044877]; protein kinase regulator activity [GO:0019887]"
comp1181969_c0_seq1;GAXK01204634.1;P0C7T6;3.39E-32;ATX1L_MOUSE;Ataxin-1-like (Brother of ataxin-1);"dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]";"GO:0000122; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0035176; GO:0048286; GO:0048856; GO:1902035";"anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]";"dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp118199_c1_seq1;GAXK01106456.1;Q08BG7;1.21E-25;SCOCA_DANRE;Short coiled-coil protein A;"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635]";"GO:0000139; GO:0005829; GO:0016239; GO:0061635";"positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]";
comp1182_c0_seq1;GAXK01168752.1;P55935;4.19E-105;RS9_DROME;40S ribosomal protein S9;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]";"GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0019843; GO:0022626; GO:0022627; GO:0045903";"cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp11820_c0_seq1;GAXK01187960.1;P16254;1.32E-27;SRP14_MOUSE;Signal recognition particle 14 kDa protein (SRP14);"nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005634; GO:0005786; GO:0006614; GO:0008312; GO:0030942; GO:0042493; GO:0045047";"protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]";"7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]"
comp1182096_c0_seq1;GAXK01179640.1;P10090;0;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp118211_c2_seq1;GAXK01106423.1;Q86BJ3;9.14E-76;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp118214_c1_seq1;GAXK01106105.1;Q9LGZ2;2.13E-35;LCYD1_ORYSJ;Putative L-cysteine desulfhydrase 1 (EC 4.4.1.28) (OsL-CDes1) (L-CDes1);lyase activity [GO:0016829];GO:0016829;;;lyase activity [GO:0016829]
comp11824_c4_seq1;GAXK01187470.1;Q7ZX06;5.53E-40;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp1182445_c0_seq1;GAXK01179641.1;Q80UG8;9.11E-62;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp1182770_c0_seq1;GAXK01179647.1;Q9UQC9;4.90E-26;CLCA2_HUMAN;"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872";"cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1183_c1_seq1;GAXK01168240.1;Q9VYB7;2.26E-164;TPST_DROME;Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase) (TPST);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0009306; GO:0016021";"peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp11830_c2_seq1;GAXK01188060.1;Q9H1P3;5.30E-122;OSBL2_HUMAN;Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]";"GO:0005546; GO:0005811; GO:0005829; GO:0006699; GO:0007009; GO:0008289; GO:0008526; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0031234; GO:0032367; GO:0032934; GO:0043231; GO:0051289; GO:0120020";"bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol transfer activity [GO:0008526]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp118308_c0_seq1;GAXK01106116.1;Q7M4F0;6.82E-11;CUD9_SCHGR;Endocuticle structural glycoprotein SgAbd-9;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1183080_c0_seq1;GAXK01179643.1;P35668;4.61E-37;GSHB_XENLA;Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase);"ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]";"GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295";;;"ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
comp1183422_c0_seq1;GAXK01179626.1;O01803;5.84E-50;RB11A_CAEEL;Ras-related protein rab-11.1 (Rab GTPase rab-11.1);"apical plasma membrane [GO:0016324]; cortical granule [GO:0060473]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; positive regulation of cytokinesis [GO:0032467]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]";"GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0006887; GO:0006898; GO:0009792; GO:0016324; GO:0030133; GO:0030703; GO:0032467; GO:0032482; GO:0055037; GO:0055038; GO:0060471; GO:0060473";"cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; positive regulation of cytokinesis [GO:0032467]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]";"apical plasma membrane [GO:0016324]; cortical granule [GO:0060473]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; transport vesicle [GO:0030133]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp118347_c2_seq1;GAXK01106557.1;Q17328;6.59E-18;GLUCB_CAEEL;Glutamate-gated chloride channel subunit beta (Glu-Cl subunit beta) (Avermectin-sensitive glutamate-gated chloride channel subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp118368_c0_seq1;GAXK01106241.1;Q5U3Y5;5.17E-54;SFT2A_RAT;Vesicle transport protein SFT2A (SFT2 domain-containing protein 1);"integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0015031; GO:0016021; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";integral component of membrane [GO:0016021];
comp118387_c1_seq1;GAXK01106476.1;Q5LJZ2;2.22E-36;SET1_DROME;Histone-lysine N-methyltransferase SETD1 (EC 2.1.1.43);"euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"GO:0000791; GO:0003723; GO:0005700; GO:0035327; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0080182";"histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]";"histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]"
comp118390_c1_seq1;GAXK01106139.1;Q9NA75;2.09E-54;T38B1_CAEEL;Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";potassium channel activity [GO:0005267]
comp118408_c0_seq1;GAXK01106104.1;Q9H8M5;2.66E-83;CNNM2_HUMAN;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231";magnesium ion homeostasis [GO:0010960];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp118419_c1_seq1;GAXK01106250.1;P82963;5.62E-45;CHAO_TRICA;Chaoptin (Photoreceptor cell-specific membrane protein) (Fragment);"plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005886; GO:0007155; GO:0007601; GO:0050896";"cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";plasma membrane [GO:0005886];
comp118425_c1_seq1;GAXK01106114.1;P51522;8.20E-24;ZNF83_HUMAN;Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1184314_c0_seq1;GAXK01012232.1;Q8N184;3.68E-16;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1184749_c0_seq1;GAXK01012214.1;Q8WVB3;1.20E-78;HEXD_HUMAN;Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase);"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]";"GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561";carbohydrate metabolic process [GO:0005975];"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]";"beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp1185_c3_seq1;GAXK01166211.1;Q9VF87;0;CYFIP_DROME;Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]";"GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0050807; GO:0051491; GO:0060269";"axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]";RNA 7-methylguanosine cap binding [GO:0000340]
comp11850_c0_seq1;GAXK01187996.1;Q5U2T8;3.34E-33;CIR1_RAT;Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]";"GO:0001701; GO:0003714; GO:0005737; GO:0005813; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0044877; GO:0045892";"in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]";"protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]"
comp1185087_c0_seq1;GAXK01012226.1;P26187;5.46E-26;MGMT_MOUSE;Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]";"GO:0003677; GO:0003908; GO:0005509; GO:0005634; GO:0005654; GO:0006281; GO:0006307; GO:0006974; GO:0008168; GO:0034599; GO:0043066; GO:0043281; GO:0045471; GO:0045739; GO:0051593; GO:0060548; GO:0060644; GO:0071407; GO:0071479; GO:2000781";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]"
comp1185304_c0_seq2;GAXK01012224.1;Q9P243;2.78E-10;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1185388_c0_seq1;GAXK01012257.1;O74467;8.77E-23;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1185436_c1_seq1;GAXK01012256.1;Q9I840;1.65E-15;SLYB_CALRH;Snaclec rhodocytin subunit beta (Aggretin beta chain) (Rhodoaggretin subunit beta);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]";"GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1185457_c0_seq1;GAXK01012231.1;O44252;4.95E-11;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp118547_c0_seq1;GAXK01106503.1;A1Z7G7;4.70E-63;LPHN_DROME;Latrophilin Cirl;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurotransmitter secretion [GO:0007269]; vesicle-mediated transport [GO:0016192]";"GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007269; GO:0008021; GO:0008344; GO:0016021; GO:0016192; GO:0016524; GO:0030246";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurotransmitter secretion [GO:0007269]; vesicle-mediated transport [GO:0016192]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]"
comp118565_c0_seq1;GAXK01106077.1;O70572;3.26E-11;NSMA_MOUSE;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0006685; GO:0009612; GO:0016020; GO:0016021; GO:0035556; GO:0043065; GO:0046513; GO:0046872";"ceramide biosynthetic process [GO:0046513]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"caveola [GO:0005901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp1185660_c0_seq1;GAXK01012242.1;Q96ND8;7.03E-78;ZN583_HUMAN;Zinc finger protein 583 (Zinc finger protein L3-5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp11857_c0_seq1;GAXK01188255.1;Q9LQU4;3.82E-11;PCR2_ARATH;Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to oxidative stress [GO:0006979]";"GO:0005886; GO:0006979; GO:0016021";response to oxidative stress [GO:0006979];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1185756_c0_seq1;GAXK01012218.1;Q11126;2.86E-39;FUT3_BOVIN;Galactoside 3(4)-L-fucosyltransferase (EC 2.4.1.65) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (FUTB) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]"
comp1185831_c0_seq1;GAXK01012222.1;Q5TYP8;1.03E-10;STUM_DANRE;Protein stum homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1185901_c0_seq1;GAXK01012259.1;O02485;3.44E-60;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp118593_c2_seq1;GAXK01106329.1;P20107;3.45E-08;ZRC1_YEAST;Zinc/cadmium resistance protein;"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; response to cadmium ion [GO:0046686]";"GO:0000324; GO:0000329; GO:0005385; GO:0006882; GO:0016021; GO:0031966; GO:0046686";"cellular zinc ion homeostasis [GO:0006882]; response to cadmium ion [GO:0046686]";"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]";zinc ion transmembrane transporter activity [GO:0005385]
comp118638_c0_seq1;GAXK01106623.1;Q9Z2D8;1.16E-61;MBD3_MOUSE;Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]; aging [GO:0007568]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; in utero embryonic development [GO:0001701]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]";"GO:0000122; GO:0000785; GO:0000792; GO:0001701; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006346; GO:0007420; GO:0007507; GO:0007568; GO:0008327; GO:0009888; GO:0016573; GO:0016581; GO:0031667; GO:0032355; GO:0032991; GO:0044030; GO:0048568";"aging [GO:0007568]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; in utero embryonic development [GO:0001701]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]"
comp1186442_c0_seq1;GAXK01091704.1;Q94B65;5.07E-45;UTR7_ARATH;UDP-galactose/UDP-glucose transporter 7 (AtUTr7);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]";"GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0008643; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0048527; GO:0072334; GO:0080147";"carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]"
comp118676_c1_seq1;GAXK01106460.1;P35778;1.83E-41;VA3_SOLIN;Venom allergen 3 (Allergen Sol i III) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol i 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp118679_c0_seq1;GAXK01106507.1;Q99NI4;5.63E-35;IPMK_RAT;Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]";"GO:0000823; GO:0000825; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0008440; GO:0032957; GO:0032958; GO:0046872; GO:0046934; GO:0047326; GO:0052812; GO:0070266; GO:0097243; GO:0102732";"inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"
comp118732_c2_seq1;GAXK01106202.1;Q08180;1.77E-61;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp1187575_c0_seq1;GAXK01091665.1;Q8R151;1.11E-38;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1187665_c0_seq1;GAXK01091715.1;P25123;2.98E-132;GBRB_DROME;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (Protein cyclodiene resistance);"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0002121; GO:0004890; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0009612; GO:0016021; GO:0022851; GO:0030054; GO:0030424; GO:0030425; GO:0030431; GO:0030594; GO:0032589; GO:0032809; GO:0034220; GO:0034707; GO:0042048; GO:0042391; GO:0042493; GO:0042749; GO:0043005; GO:0045202; GO:0045211; GO:0050805; GO:0050877; GO:0090328";"chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]"
comp118778_c0_seq1;GAXK01106491.1;Q8CFK2;8.08E-09;TF3B_MOUSE;Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1);"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898";"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]";"metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp118824_c0_seq1;GAXK01106577.1;Q5HLD8;6.43E-30;Y2049_STAEQ;Uncharacterized oxidoreductase SERP2049 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1188331_c0_seq1;GAXK01150349.1;Q9NPF2;5.17E-09;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp118839_c1_seq1;GAXK01106587.1;Q61334;9.47E-17;BAP29_MOUSE;B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29);"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"GO:0005789; GO:0005887; GO:0006886; GO:0006888; GO:0006915; GO:0070973";"apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]";
comp118847_c0_seq1;GAXK01106249.1;Q5ZEQ8;5.84E-38;FJX1_XIPMA;Four-jointed box protein 1 (Four-jointed protein homolog);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp118849_c6_seq1;GAXK01106342.1;L7YAI7;8.07E-31;B4GA1_DANRE;Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]";"GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0035269; GO:0046872; GO:0048747";"muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp1188517_c0_seq1;GAXK01150345.1;O18141;4.48E-14;NHR79_CAEEL;Nuclear hormone receptor family member nhr-79;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1188632_c0_seq1;GAXK01150378.1;Q05481;7.20E-13;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1188792_c0_seq1;GAXK01150341.1;Q3SYX0;6.47E-48;NDRG1_BOVIN;Protein NDRG1 (N-myc downstream-regulated gene 1 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mast cell activation [GO:0045576]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0005886; GO:0007165; GO:0032287; GO:0042127; GO:0045576";"mast cell activation [GO:0045576]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp1188964_c0_seq1;GAXK01150368.1;Q6NL02;6.76E-07;FK131_ARATH;F-box/kelch-repeat protein At5g39560;chloroplast [GO:0009507];GO:0009507;;chloroplast [GO:0009507];
comp11890_c3_seq1;GAXK01188253.1;Q9Y6N5;1.59E-145;SQOR_HUMAN;Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase);"mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";"GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949";"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";mitochondrial inner membrane [GO:0005743];"FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]"
comp118901_c0_seq1;GAXK01106287.1;Q32PH0;2.54E-162;TPPC9_BOVIN;Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein);"endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; cell differentiation [GO:0030154]";"GO:0005783; GO:0005802; GO:0030154";cell differentiation [GO:0030154];"endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]";
comp118902_c0_seq1;GAXK01106071.1;Q9H008;1.67E-84;LHPP_HUMAN;Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (hLHPP) (EC 3.1.3.-) (EC 3.6.1.1);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0000287; GO:0004427; GO:0005634; GO:0005829; GO:0006470; GO:0006796; GO:0009168; GO:0016311; GO:0016607; GO:0016791; GO:0042803; GO:0101006";"dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; protein homodimerization activity [GO:0042803]"
comp1189108_c0_seq1;GAXK01150369.1;A6NK75;2.67E-19;ZNF98_HUMAN;Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp118972_c3_seq1;GAXK01106583.1;B4SLL0;9.47E-15;ASPN_STRM5;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp118973_c0_seq1;GAXK01106334.1;Q4R5V1;2.13E-90;TEKT2_MACFA;Tektin-2;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]";"GO:0005737; GO:0005815; GO:0005874; GO:0031514";;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]";
comp118993_c1_seq1;GAXK01106248.1;Q9R1A8;0;COP1_MOUSE;E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2);"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]";"GO:0000139; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp119_c2_seq1;GAXK01165539.1;Q6F482;1.80E-24;RL39_PLUXY;60S ribosomal protein L39;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp119015_c0_seq1;GAXK01106478.1;Q66J91;4.49E-51;SAMTR_XENLA;S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-);"methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]";"GO:0008168; GO:0034198; GO:1904047; GO:1904262";"cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]";;"methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]"
comp1190212_c0_seq1;GAXK01164796.1;O70628;7.40E-41;PDE9A_MOUSE;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471";"cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp1190347_c0_seq1;GAXK01164797.1;Q8BLY2;3.77E-09;SYTC2_MOUSE;Threonine--tRNA ligase 2, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]";"GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435";threonyl-tRNA aminoacylation [GO:0006435];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]"
comp119035_c1_seq1;GAXK01106564.1;Q20765;7.23E-17;NHR7_CAEEL;Nuclear hormone receptor family member nhr-7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp119064_c2_seq1;GAXK01106579.1;Q9TXD8;3.18E-15;ISOHC_AGEAP;Venom peptide isomerase heavy chain (EC 5.-.-.-);"extracellular region [GO:0005576]; isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0016853";;extracellular region [GO:0005576];"isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]"
comp119072_c6_seq1;GAXK01106190.1;P49847;1.69E-87;TAF6_DROME;Transcription initiation factor TFIID subunit 6 (TAFII-60) (TAFII-62) (Transcription initiation factor TFIID 62 kDa subunit) (p62);"nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000124; GO:0005634; GO:0005669; GO:0006325; GO:0006357; GO:0006366; GO:0006367; GO:0046695; GO:0046982; GO:0051123";"chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]";protein heterodimerization activity [GO:0046982]
comp1190855_c0_seq1;GAXK01164814.1;Q6DKC0;3.08E-42;ERL2B_XENLA;Erlin-2-B (Endoplasmic reticulum lipid raft-associated protein 2-B) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2-B) (SPFH domain-containing protein 2-B);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]";"GO:0005789; GO:0008203; GO:0016021; GO:0031625";cholesterol metabolic process [GO:0008203];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";ubiquitin protein ligase binding [GO:0031625]
comp119087_c5_seq1;GAXK01106541.1;O70277;5.89E-07;TRIM3_RAT;Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]";"GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp119092_c1_seq1;GAXK01106468.1;P02595;6.16E-10;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1191_c3_seq1;GAXK01166598.1;Q6WV72;1.04E-44;H4_MYTTR;Histone H4;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]";"GO:0000786; GO:0003677; GO:0005634; GO:0006352; GO:0046982";DNA-templated transcription, initiation [GO:0006352];"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp1191036_c0_seq1;GAXK01164826.1;Q8CFJ7;1.80E-68;S2545_MOUSE;Solute carrier family 25 member 45;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; acyl carnitine transport [GO:0006844]";"GO:0005739; GO:0005743; GO:0006844; GO:0015227; GO:0016021";acyl carnitine transport [GO:0006844];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp1191177_c0_seq1;GAXK01164822.1;A6QL70;4.91E-31;PED1B_BOVIN;PC-esterase domain-containing protein 1B (Protein FAM113B);;;;;
comp1191263_c0_seq1;GAXK01164818.1;Q90812;4.65E-31;CRFR1_CHICK;Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1);"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]";"GO:0007166; GO:0007189; GO:0015056; GO:0016021; GO:0017046; GO:0031226; GO:0043404; GO:0051424; GO:0051458; GO:0071376; GO:2000852";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]";"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]";"corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; peptide hormone binding [GO:0017046]"
comp119128_c0_seq1;GAXK01106083.1;Q17CE7;2.76E-127;S35B3_AEDAE;Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]";"GO:0000139; GO:0005794; GO:0007275; GO:0016021; GO:0046963; GO:0046964";"3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]
comp11919_c2_seq1;GAXK01187684.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp11921_c2_seq1;GAXK01188080.1;O00629;1.61E-87;IMA3_HUMAN;Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4);"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]";"GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0019054; GO:0031965; GO:0042542; GO:0061608";"modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";nuclear import signal receptor activity [GO:0061608]
comp1192223_c0_seq1;GAXK01194087.1;F6Z5C0;3.52E-27;UBP15_XENTR;Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389";"BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp1192277_c0_seq1;GAXK01194079.1;Q5U3U0;1.83E-08;PHYD1_DANRE;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp1192689_c0_seq1;GAXK01194082.1;P0DPU3;2.66E-152;TX14A_SCOSD;"Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]";"extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729";"glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]"
comp1193_c185_seq1;GAXK01167875.1;Q9V498;1.48E-165;CSTN1_DROME;Calsyntenin-1 (Cadherin-102F);"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]";"GO:0005509; GO:0005576; GO:0005887; GO:0007156; GO:0009986; GO:0016339; GO:0044331; GO:0045211; GO:0050806; GO:0051965";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]";calcium ion binding [GO:0005509]
comp1193223_c1_seq1;GAXK01194065.1;Q26474;6.08E-32;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp119360_c6_seq1;GAXK01106148.1;Q8BTN6;1.61E-32;LENG9_MOUSE;Leukocyte receptor cluster member 9;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1193877_c1_seq1;GAXK01194071.1;A4IGH2;9.74E-74;RSAD1_DANRE;Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone);"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]";"GO:0004109; GO:0005739; GO:0006779; GO:0046872; GO:0051539";porphyrin-containing compound biosynthetic process [GO:0006779];mitochondrion [GO:0005739];"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]"
comp11940_c0_seq1;GAXK01187745.1;P57722;7.67E-32;PCBP3_MOUSE;Poly(rC)-binding protein 3 (Alpha-CP3);"cytoplasm [GO:0005737]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001227; GO:0003690; GO:0003723; GO:0005737; GO:1990829";negative regulation of transcription by RNA polymerase II [GO:0000122];cytoplasm [GO:0005737];"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp1194030_c0_seq1;GAXK01089451.1;Q6ZNH5;2.42E-27;ZN497_HUMAN;Zinc finger protein 497;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1194096_c0_seq1;GAXK01089427.1;Q9NRA2;2.32E-78;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp119420_c0_seq1;GAXK01106362.1;P47970;4.67E-16;NPTX2_CAVPO;Neuronal pentraxin-2 (NP2) (Acrosomal pentaxin-like protein p50) (AM50) (Neuronal pentraxin II) (Apexin) (NP-II);"acrosomal lumen [GO:0043160]; metal ion binding [GO:0046872]";"GO:0043160; GO:0046872";;acrosomal lumen [GO:0043160];metal ion binding [GO:0046872]
comp1194572_c1_seq1;GAXK01089476.1;Q54DV3;1.91E-18;Y2016_DICDI;von Willebrand factor A domain-containing protein DDB_G0292016;;;;;
comp1194639_c0_seq1;GAXK01089425.1;Q92834;3.24E-105;RPGR_HUMAN;X-linked retinitis pigmentosa GTPase regulator;"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271";"cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]";"guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]"
comp1194655_c0_seq1;GAXK01089415.1;P27615;1.40E-52;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp119468_c2_seq1;GAXK01106414.1;O43741;1.17E-08;AAKB2_HUMAN;5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0006853; GO:0007050; GO:0007165; GO:0016236; GO:0016241; GO:0019901; GO:0031588; GO:0042304; GO:0042802; GO:0050790; GO:0120162; GO:1901796";"carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]"
comp11948_c0_seq1;GAXK01187886.1;Q6PAK3;1.63E-33;ANM8_MOUSE;Protein arginine N-methyltransferase 8 (EC 2.1.1.319) (EC 2.1.1.321) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4);"anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005829; GO:0005886; GO:0006355; GO:0006479; GO:0008469; GO:0008757; GO:0016571; GO:0018216; GO:0019919; GO:0034969; GO:0035241; GO:0035242; GO:0042802; GO:0042803; GO:0046982; GO:0051260; GO:0098753; GO:1904047";"histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of transcription, DNA-templated [GO:0006355]";"anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp119491_c0_seq1;GAXK01106094.1;P36609;1.80E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1194981_c0_seq1;GAXK01089421.1;O46040;3.99E-18;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp119513_c0_seq1;GAXK01106348.1;Q8CJ96;3.90E-30;RASF8_MOUSE;Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1 homolog);"adherens junction maintenance [GO:0034334]; signal transduction [GO:0007165]";"GO:0007165; GO:0034334";"adherens junction maintenance [GO:0034334]; signal transduction [GO:0007165]";;
comp11952_c1_seq1;GAXK01187759.1;Q9JHS4;0;CLPX_MOUSE;ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial;"cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006457; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0030163; GO:0042645; GO:0046034; GO:0046872; GO:0051082; GO:0051603";"ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]"
comp1195297_c0_seq1;GAXK01089417.1;Q8RBH4;9.72E-12;HUTH_CALS4;Histidine ammonia-lyase (Histidase) (EC 4.3.1.3);"cytoplasm [GO:0005737]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";"GO:0004397; GO:0005737; GO:0019556; GO:0019557";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";cytoplasm [GO:0005737];histidine ammonia-lyase activity [GO:0004397]
comp119531_c0_seq1;GAXK01106106.1;Q09225;7.33E-39;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp1195323_c0_seq1;GAXK01089423.1;Q5EA06;5.69E-33;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp119534_c0_seq1;GAXK01106488.1;P08047;1.20E-38;SP1_HUMAN;Transcription factor Sp1;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcriptional repressor complex [GO:0017053]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of phenotypic switching by transcription from RNA polymerase II promoter [GO:0100057]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]; snRNA transcription by RNA polymerase II [GO:0042795]; viral process [GO:0016032]";"GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001103; GO:0001228; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0008134; GO:0010628; GO:0016032; GO:0017053; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0042795; GO:0042803; GO:0042826; GO:0043425; GO:0043536; GO:0043565; GO:0043923; GO:0044212; GO:0045540; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0070491; GO:0071837; GO:0100057; GO:1904828; GO:1905564";"cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of phenotypic switching by transcription from RNA polymerase II promoter [GO:0100057]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]; snRNA transcription by RNA polymerase II [GO:0042795]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcriptional repressor complex [GO:0017053]";"bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1195373_c1_seq1;GAXK01089480.1;Q14CN2;1.20E-23;CLCA4_HUMAN;"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872";ion transmembrane transport [GO:0034220];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1195465_c0_seq1;GAXK01089468.1;Q3B725;3.82E-09;ZBT24_RAT;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1195854_c0_seq1;GAXK01089477.1;Q8K4Q0;5.22E-16;RPTOR_MOUSE;Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]";"GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087";"cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]";"14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp11959_c2_seq1;GAXK01187571.1;Q8K4Z5;6.95E-14;SF3A1_MOUSE;Splicing factor 3A subunit 1 (SF3a120);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]";"GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241";"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]";RNA binding [GO:0003723]
comp119590_c0_seq1;GAXK01106418.1;O95263;0;PDE8B_HUMAN;High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004115; GO:0005829; GO:0006198; GO:0007186; GO:0046872";"cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]"
comp1195951_c0_seq1;GAXK01089430.1;Q39757;4.52E-107;1433_FUCVE;14-3-3-like protein;protein domain specific binding [GO:0019904];GO:0019904;;;protein domain specific binding [GO:0019904]
comp1196091_c0_seq1;GAXK01038234.1;Q5XM24;1.06E-54;APRA_DICDI;Autocrine proliferation repressor protein A (PhoPQ-activated pathogenicity-related protein);"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005096; GO:0005102; GO:0005576; GO:0007049; GO:0008233; GO:0030435; GO:0031157; GO:0032991; GO:0045499; GO:0050919; GO:0072659; GO:0090630; GO:1903665";"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]";"chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp1196132_c1_seq1;GAXK01038208.1;Q8ITC7;5.11E-65;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp119614_c1_seq1;GAXK01106619.1;Q58FA4;3.24E-39;E2F8_MOUSE;Transcription factor E2F8 (E2F-8);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001890; GO:0002040; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005730; GO:0005829; GO:0008134; GO:0008283; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0042803; GO:0043565; GO:0045944; GO:0051726; GO:0060707; GO:0060718; GO:0070365; GO:0090575";"cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp119615_c1_seq1;GAXK01106243.1;Q6AX23;5.45E-87;QSOX2_XENLA;Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1);"cell [GO:0005623]; integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0016021; GO:0016971; GO:0045454";cell redox homeostasis [GO:0045454];"cell [GO:0005623]; integral component of membrane [GO:0016021]";flavin-linked sulfhydryl oxidase activity [GO:0016971]
comp11966_c0_seq1;GAXK01188309.1;O42130;0;TOP2A_CHICK;DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme);"chromosome [GO:0005694]; condensed chromosome [GO:0000793]; DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; drug binding [GO:0008144]; magnesium ion binding [GO:0000287]; apoptotic chromosome condensation [GO:0030263]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]";"GO:0000287; GO:0000712; GO:0000792; GO:0000793; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0008094; GO:0008144; GO:0008283; GO:0008301; GO:0009330; GO:0030263; GO:0030332; GO:0043065; GO:0044774; GO:0048511; GO:1905463; GO:1990904";"apoptotic chromosome condensation [GO:0030263]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]";"chromosome [GO:0005694]; condensed chromosome [GO:0000793]; DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; drug binding [GO:0008144]; magnesium ion binding [GO:0000287]"
comp119666_c0_seq1;GAXK01106477.1;Q9Z2G9;3.58E-60;HTAI2_MOUSE;Oxidoreductase HTATIP2 (EC 1.1.1.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]";"GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170; GO:0051287";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]";"NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]"
comp1196671_c0_seq1;GAXK01038232.1;Q9VJJ7;1.12E-35;TRPG_DROME;Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635";"adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"
comp1196811_c0_seq1;GAXK01038246.1;A7MBC0;1.97E-115;NAGA_BOVIN;N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25) (Amidohydrolase domain-containing protein 2);"metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]";"GO:0005975; GO:0006046; GO:0008448; GO:0019262; GO:0046872; GO:0047419";"carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]";;"metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]"
comp119688_c0_seq1;GAXK01106549.1;Q62009;2.51E-18;POSTN_MOUSE;Periostin (PN) (Osteoblast-specific factor 2) (OSF-2);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]";"GO:0001666; GO:0001953; GO:0003073; GO:0005615; GO:0005737; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0050839; GO:0062023; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523";"bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]"
comp1196903_c0_seq1;GAXK01038209.1;Q6GNS1;5.48E-19;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp119693_c0_seq1;GAXK01106324.1;Q9VVW3;2.97E-121;SFXN2_DROME;Sideroflexin-2;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"GO:0005739; GO:0006730; GO:0016021; GO:0022889; GO:0031966; GO:0140300; GO:1990542";"mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";serine transmembrane transporter activity [GO:0022889]
comp1196940_c0_seq1;GAXK01038211.1;Q5FWI3;1.47E-23;CEIP2_MOUSE;Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2);"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";"GO:0001525; GO:0004415; GO:0005509; GO:0005887; GO:0030214; GO:1903670";"angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";integral component of plasma membrane [GO:0005887];"calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]"
comp11970_c0_seq1;GAXK01187108.1;A8DYP0;2.00E-100;OBSCN_DROME;Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89);"M band [GO:0031430]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]";"GO:0005089; GO:0005523; GO:0005524; GO:0006468; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0035023; GO:0036309; GO:0045214; GO:0046872";"adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]";"M band [GO:0031430]; sarcomere [GO:0030017]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; tropomyosin binding [GO:0005523]"
comp11971_c1_seq1;GAXK01188311.1;O01159;7.10E-49;RSP7_CAEEL;Probable splicing factor, arginine/serine-rich 7 (p54);"nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005654";mRNA splicing, via spliceosome [GO:0000398];nucleoplasm [GO:0005654];RNA binding [GO:0003723]
comp119725_c1_seq1;GAXK01106571.1;P0DQA0;9.06E-18;TXB5A_SCOMO;U-scoloptoxin(11)-Sm5a (U-SLPTX(11)-Sm5a) (Fragment);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp119778_c0_seq1;GAXK01106417.1;Q3BCR8;7.25E-30;TPMT_PANTR;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase);"cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144]";"GO:0005737; GO:0008119; GO:0017144; GO:1904047";drug metabolic process [GO:0017144];cytoplasm [GO:0005737];"S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]"
comp119779_c0_seq1;GAXK01106145.1;Q80YA7;0;DPP8_MOUSE;Dipeptidyl peptidase 8 (DP8) (EC 3.4.14.5) (Dipeptidyl peptidase VIII) (DPP VIII);"cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005829; GO:0008236";;cytosol [GO:0005829];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp1197962_c0_seq1;GAXK01038242.1;Q1LUA6;2.71E-19;TRIO_DANRE;Triple functional domain protein (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0035023";"axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1198015_c0_seq1;GAXK01121634.1;Q24756;8.59E-10;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp119824_c0_seq1;GAXK01106551.1;Q4R7V3;1.25E-22;FR1OP_MACFA;FGFR1 oncogene partner;"cell projection [GO:0042995]; centriole [GO:0005814]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]";"GO:0005814; GO:0030030; GO:0034453; GO:0042995";"cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]";"cell projection [GO:0042995]; centriole [GO:0005814]";
comp119848_c0_seq1;GAXK01106553.1;Q9VCA2;1.25E-77;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1198524_c1_seq1;GAXK01121625.1;Q866F0;1.94E-16;FUT1_SAIBB;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp119862_c0_seq1;GAXK01106201.1;Q5PPZ9;5.80E-18;GDS1B_XENLA;Rap1 GTPase-GDP dissociation stimulator 1-B (Rap1gds1-B protein) (RalB-binding protein B) (XsmgGDS-B) (smgGDS-B);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0005737; GO:0005856; GO:0007264; GO:0017160; GO:0043547";"positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]"
comp119917_c0_seq1;GAXK01106156.1;Q5TYP8;5.69E-08;STUM_DANRE;Protein stum homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp119946_c5_seq1;GAXK01106539.1;Q94900;8.76E-49;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1199533_c0_seq1;GAXK01121626.1;P70617;4.32E-19;NINJ1_RAT;Ninjurin-1 (Nerve injury-induced protein 1);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]";"GO:0001954; GO:0007155; GO:0016021; GO:0042246; GO:1990384";"cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]";integral component of membrane [GO:0016021];
comp11996_c0_seq1;GAXK01187727.1;Q19749;4.29E-150;ODP2_CAEEL;Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2);"mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096]";"GO:0004742; GO:0005759; GO:0006096; GO:0045254";glycolytic process [GO:0006096];"mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]";dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]
comp1199836_c0_seq1;GAXK01121624.1;P86810;1.78E-51;OXLA_SIGCA;L-amino-acid oxidase (EC 1.4.3.2) (Antiparasitic protein) (APP) (Serum L-amino-acid oxidase) (SR-LAAO);"extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";"GO:0001716; GO:0005576; GO:0042742; GO:0045087";"defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";extracellular region [GO:0005576];L-amino-acid oxidase activity [GO:0001716]
comp12_c1_seq1;GAXK01168365.1;O49923;3.06E-123;ADK_PHYPA;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase);"cytosol [GO:0005829]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";"GO:0004001; GO:0005524; GO:0005634; GO:0005829; GO:0006166; GO:0044209";"AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]"
comp120_c0_seq1;GAXK01169776.1;Q9VXX8;7.20E-38;RL371_DROME;Probable 60S ribosomal protein L37-A;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0046872";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp120002_c1_seq1;GAXK01199473.1;Q25452;0;CAC1M_MUSDO;Muscle calcium channel subunit alpha-1 (MDL-alpha-1);"voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0034765; GO:0046872";regulation of ion transmembrane transport [GO:0034765];voltage-gated calcium channel complex [GO:0005891];"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp12001_c0_seq1;GAXK01020078.1;Q9H6U8;6.17E-174;ALG9_HUMAN;Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]";"GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926";dolichol-linked oligosaccharide biosynthetic process [GO:0006488];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]"
comp1200135_c0_seq1;GAXK01101804.1;P17789;7.49E-10;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp120023_c4_seq1;GAXK01199458.1;Q9MZD2;1.23E-15;FLNB_RABIT;Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]";"GO:0003779; GO:0005856; GO:0005938; GO:0030036; GO:0030154";"actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp1200325_c0_seq1;GAXK01101805.1;Q9H8E8;7.04E-72;CSR2B_HUMAN;Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; LIM domain binding [GO:0030274]; G2/M transition of mitotic cell cycle [GO:0000086]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]";"GO:0000086; GO:0004402; GO:0005634; GO:0005671; GO:0005737; GO:0016573; GO:0030274; GO:0043966";"G2/M transition of mitotic cell cycle [GO:0000086]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"histone acetyltransferase activity [GO:0004402]; LIM domain binding [GO:0030274]"
comp120037_c2_seq1;GAXK01199200.1;Q3V080;3.95E-26;ZN583_MOUSE;Zinc finger protein 583;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1201_c0_seq1;GAXK01168586.1;P57103;0;NAC3_HUMAN;Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]";"GO:0002244; GO:0005432; GO:0005516; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1903779; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]";"cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]"
comp1201124_c0_seq1;GAXK01101799.1;Q7KRI2;7.29E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1201384_c0_seq1;GAXK01101808.1;O60235;1.65E-33;TM11D_HUMAN;"Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007585; GO:0008233; GO:0070062";"proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";"peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp120171_c0_seq1;GAXK01199007.1;Q26474;4.70E-131;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1201715_c0_seq1;GAXK01101803.1;Q84MN0;2.55E-11;CML4_ORYSJ;Calmodulin-like protein 4;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1201854_c0_seq1;GAXK01101819.1;Q5W252;1.44E-54;PIGC_SERMA;Prodigiosin synthesizing transferase PigC (EC 6.4.-.-) (Prodigiosin synthetase PigC);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; ligase activity [GO:0016874]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]";"GO:0005524; GO:0016301; GO:0016740; GO:0016874; GO:0017000";antibiotic biosynthetic process [GO:0017000];;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; ligase activity [GO:0016874]; transferase activity [GO:0016740]"
comp120189_c1_seq1;GAXK01199056.1;Q8BYK4;2.17E-42;RDH12_MOUSE;Retinol dehydrogenase 12 (EC 1.1.1.300);"photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";photoreceptor inner segment [GO:0001917];"NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]"
comp1201961_c0_seq1;GAXK01101828.1;Q55EH8;1.35E-84;ABCGN_DICDI;ABC transporter G family member 23 (ABC transporter ABCG.23);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016021; GO:0016887";;integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp1202191_c0_seq1;GAXK01037998.1;Q61624;2.95E-11;ZN148_MOUSE;Zinc finger protein 148 (Beta enolase repressor factor 1) (G-rich box-binding protein) (Transcription factor BFCOL1) (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89);"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]";"GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0007276; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045944; GO:0046872; GO:0065003";"gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1202617_c0_seq1;GAXK01037977.1;Q95NT6;5.22E-32;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp12028_c2_seq1;GAXK01020823.1;Q8I1F6;3.23E-77;PPO3_DROER;Phenoloxidase 3 (EC 1.14.18.1) (Diphenoloxidase subunit A3) (Tyrosinase A3);"extracellular region [GO:0005576]; dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";"GO:0004503; GO:0005576; GO:0035011; GO:0036263; GO:0036264; GO:0042438; GO:0046872";"melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";extracellular region [GO:0005576];"dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]"
comp120281_c0_seq1;GAXK01198878.1;Q91309;8.34E-71;F26_LITCT;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";"GO:0003873; GO:0004331; GO:0005524; GO:0006000; GO:0006003";"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";;"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp120289_c2_seq1;GAXK01199402.1;O00400;2.04E-144;ACATN_HUMAN;Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395";"BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]"
comp1202920_c0_seq1;GAXK01037981.1;O46040;1.12E-27;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1202966_c0_seq1;GAXK01037967.1;O77633;1.27E-29;ADA10_PIG;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005798; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030307; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945";"cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp1203110_c0_seq1;GAXK01037966.1;P34461;1.36E-33;SODE_CAEEL;Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801]";"GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0006801; GO:0016020; GO:0019430";"removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]"
comp120354_c0_seq1;GAXK01198864.1;P27816;5.59E-23;MAP4_HUMAN;Microtubule-associated protein 4 (MAP-4);"axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]";"GO:0000226; GO:0003723; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0007052; GO:0008017; GO:0014069; GO:0015630; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856";"cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]";"axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]"
comp120365_c1_seq1;GAXK01199328.1;Q28620;1.16E-118;NPT2A_RABIT;Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-6) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; symporter activity [GO:0015293]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; response to mercury ion [GO:0046689]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0006817; GO:0010288; GO:0015293; GO:0015321; GO:0016021; GO:0016324; GO:0016607; GO:0046686; GO:0046689; GO:0055062; GO:0072686";"phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; response to mercury ion [GO:0046689]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]";"sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; symporter activity [GO:0015293]"
comp1203830_c0_seq1;GAXK01037991.1;Q9V427;4.46E-43;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp1203893_c0_seq1;GAXK01037969.1;G5ED00;6.70E-09;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1204049_c0_seq1;GAXK01170672.1;Q4V348;4.14E-11;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp120405_c5_seq1;GAXK01199316.1;Q9W0T5;5.13E-09;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp120409_c0_seq1;GAXK01199162.1;B0X0K1;9.29E-07;KEN2_CULQU;Transcription factor Ken 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0030539; GO:0030540; GO:0045496; GO:0045497; GO:0046872";"female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp120436_c0_seq1;GAXK01198868.1;Q9NVH2;4.09E-168;INT7_HUMAN;Integrator complex subunit 7 (Int7);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0042795; GO:0071479";"cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp120463_c3_seq1;GAXK01199369.1;Q91W86;0;VPS11_MOUSE;Vacuolar protein sorting-associated protein 11 homolog;"actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:0048786; GO:1901998; GO:1902115; GO:1903364; GO:2000643";"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]";"actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786]";"metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]"
comp12047_c1_seq1;GAXK01020463.1;P15646;1.20E-14;FBRL_YEAST;rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase) (U3 small nucleolar RNA-associated protein NOP1) (Nucleolar protein 1) (U3 snoRNA-associated protein NOP1);"90S preribosome [GO:0030686]; box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; histone-glutamine methyltransferase activity [GO:1990259]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; regulation of transcription by RNA polymerase I [GO:0006356]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA processing [GO:0043144]";"GO:0000451; GO:0000494; GO:0003723; GO:0005654; GO:0005730; GO:0006356; GO:0006364; GO:0008171; GO:0008649; GO:0015030; GO:0030686; GO:0031167; GO:0031428; GO:0032040; GO:0043144; GO:1990258; GO:1990259";"box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; regulation of transcription by RNA polymerase I [GO:0006356]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA processing [GO:0043144]";"90S preribosome [GO:0030686]; box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";"histone-glutamine methyltransferase activity [GO:1990259]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]"
comp1205065_c0_seq1;GAXK01170677.1;Q32KY0;1.81E-12;APOD_BOVIN;Apolipoprotein D (Apo-D) (ApoD);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";cholesterol binding [GO:0015485]
comp120518_c5_seq1;GAXK01199334.1;P33085;8.80E-148;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp1205214_c0_seq1;GAXK01170675.1;Q32LG5;1.86E-31;REEP6_BOVIN;Receptor expression-enhancing protein 6;"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp120535_c3_seq1;GAXK01199395.1;P43352;1.25E-76;RAD52_MOUSE;DNA repair protein RAD52 homolog;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; protein homooligomerization [GO:0051260]; regulation of nucleotide-excision repair [GO:2000819]";"GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0006310; GO:0006312; GO:0006974; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:0051260; GO:2000819";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; protein homooligomerization [GO:0051260]; regulation of nucleotide-excision repair [GO:2000819]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]"
comp120540_c0_seq1;GAXK01199399.1;Q7T0L7;1.55E-63;BN3D2_XENLA;Pre-miRNA 5'-monophosphate methyltransferase (EC 2.1.1.-) (BCDIN3 domain-containing protein);"cytoplasm [GO:0005737]; O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]";"GO:0001510; GO:0005737; GO:0008171; GO:0008173; GO:0010586; GO:2000632";"miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]";cytoplasm [GO:0005737];"O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]"
comp12057_c6_seq1;GAXK01020340.1;Q5BKR2;1.06E-78;SL9B2_MOUSE;Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:0097708; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]"
comp1205781_c0_seq1;GAXK01170696.1;P31597;2.57E-43;EAA3_RABIT;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476";"chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp120603_c0_seq1;GAXK01199160.1;B4LNA8;3.00E-39;LPHN_DROVI;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1206076_c0_seq1;GAXK01142830.1;Q01295;3.43E-15;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp120612_c0_seq1;GAXK01199164.1;Q13591;0;SEM5A_HUMAN;Semaphorin-5A (Semaphorin-F) (Sema F);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]";"GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:0097485; GO:1990256; GO:2000352; GO:2001028";"axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]"
comp1206284_c0_seq1;GAXK01142820.1;P20482;1.28E-15;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp1206416_c0_seq1;GAXK01142819.1;A0A0E3D8N0;2.90E-08;JANO_PENJA;FAD-linked oxidoreductase janO (EC 1.1.1.-) (Janthitremanes biosynthesis cluster protein O);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0071949";;;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp1206650_c0_seq1;GAXK01142835.1;P41351;0;TBA_TETTH;Tubulin alpha chain (Alpha-tubulin) [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp120693_c1_seq1;GAXK01199425.1;Q8K2J9;2.91E-09;BTBD6_MOUSE;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp12070_c5_seq1;GAXK01020726.1;Q21974;7.15E-13;UNC8_CAEEL;Degenerin unc-8 (Uncoordinated protein 8);"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; cation transport [GO:0006812]; locomotion [GO:0040011]";"GO:0005261; GO:0005272; GO:0005886; GO:0006812; GO:0016021; GO:0040011; GO:0043025";"cation transport [GO:0006812]; locomotion [GO:0040011]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]"
comp120720_c0_seq1;GAXK01199076.1;Q14997;0;PSME4_HUMAN;Proteasome activator complex subunit 4 (Proteasome activator PA200);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006521; GO:0006974; GO:0007275; GO:0010499; GO:0010972; GO:0016504; GO:0016579; GO:0016607; GO:0031145; GO:0031146; GO:0033209; GO:0035093; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070577; GO:0070628; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1990111";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]";"lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]"
comp1207388_c0_seq1;GAXK01142834.1;Q9QYI4;1.32E-20;DJB12_MOUSE;DnaJ homolog subfamily B member 12 (mDj10);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218";"cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]";Hsp70 protein binding [GO:0030544]
comp1207399_c0_seq1;GAXK01142799.1;P62749;1.43E-27;HPCL1_RAT;Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3);"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp120742_c1_seq1;GAXK01199370.1;P27465;3.88E-59;PISD_CRIGR;"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]";"integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305";"phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]";phosphatidylserine decarboxylase activity [GO:0004609]
comp120779_c0_seq1;GAXK01199495.1;Q8IS64;3.63E-96;ECE_LOCMI;Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1208_c0_seq1;GAXK01168377.1;P80971;3.32E-28;COX42_THUOB;Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (EC 1.9.3.1) (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2);"mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005743";;mitochondrial inner membrane [GO:0005743];cytochrome-c oxidase activity [GO:0004129]
comp120802_c0_seq1;GAXK01199120.1;Q01973;0;ROR1_HUMAN;Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1);"axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007605; GO:0009986; GO:0014002; GO:0017147; GO:0030424; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0048856; GO:0051092; GO:1904929";"anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]";"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp1208072_c0_seq1;GAXK01122721.1;Q25410;9.08E-39;MIPR_LYMST;"Putative molluscan insulin-related peptide(s) receptor (EC 2.7.10.1) [Cleaved into: Putative molluscan insulin-related peptide(s) receptor alpha chain; Putative molluscan insulin-related peptide(s) receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0046872";transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1208087_c0_seq1;GAXK01122696.1;Q61503;1.47E-10;5NTD_MOUSE;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]";"GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0009986; GO:0016020; GO:0031225; GO:0046085; GO:0046086; GO:0050728; GO:0097060";"adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]";"5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]"
comp120815_c0_seq1;GAXK01198872.1;P80387;1.06E-08;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp1208307_c0_seq1;GAXK01122718.1;P61859;3.65E-16;CALM_NEUCR;Calmodulin (CaM);"central plaque of spindle pole body [GO:0005823]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";"GO:0005509; GO:0005823; GO:0019722; GO:0051300";"calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";central plaque of spindle pole body [GO:0005823];calcium ion binding [GO:0005509]
comp120838_c0_seq1;GAXK01199527.1;O81884;5.70E-81;GALDH_ARATH;L-galactose dehydrogenase (At-GalDH) (L-GalDH) (EC 1.1.1.316);"cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0005829; GO:0006012; GO:0010349; GO:0016491; GO:0019853";"galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853]";cytosol [GO:0005829];"L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]"
comp1208487_c0_seq1;GAXK01122702.1;P97292;1.81E-26;HRH2_MOUSE;Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004930; GO:0004969; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998";"chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
comp12088_c0_seq1;GAXK01020317.1;Q3MHE8;2.58E-166;SRPRA_BOVIN;Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha);"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047";"protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]"
comp1209_c0_seq1;GAXK01169484.1;P18203;4.47E-45;FKB1A_BOVIN;Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase);"cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; chaperone-mediated protein folding [GO:0061077]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"GO:0000413; GO:0001933; GO:0003007; GO:0003755; GO:0005528; GO:0005737; GO:0005829; GO:0006936; GO:0007183; GO:0008144; GO:0016020; GO:0016529; GO:0019221; GO:0019855; GO:0030018; GO:0031000; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0033017; GO:0042098; GO:0042110; GO:0042803; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0051209; GO:0051280; GO:0055010; GO:0060314; GO:0060315; GO:0060347; GO:0061077; GO:0070062; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425";"amyloid fibril formation [GO:1990000]; chaperone-mediated protein folding [GO:0061077]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]";"activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]"
comp120915_c0_seq1;GAXK01199426.1;Q5ZIX8;8.24E-40;KDM3A_CHICK;Lysine-specific demethylase 3A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]";"GO:0000785; GO:0000976; GO:0005634; GO:0005737; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213";histone H3-K9 demethylation [GO:0033169];"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1209191_c1_seq1;GAXK01122697.1;A2A6H3;2.18E-09;FBX47_MOUSE;F-box only protein 47;;;;;
comp12094_c3_seq1;GAXK01020920.1;Q9V9U4;6.29E-114;DOHH_DROME;Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase);"endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; deoxyhypusine monooxygenase activity [GO:0019135]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of autophagy [GO:0010508]";"GO:0005789; GO:0008283; GO:0008612; GO:0010508; GO:0019135; GO:0042406; GO:0046872";"cell population proliferation [GO:0008283]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of autophagy [GO:0010508]";"endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]";"deoxyhypusine monooxygenase activity [GO:0019135]; metal ion binding [GO:0046872]"
comp1209514_c0_seq1;GAXK01122686.1;Q9XU98;1.86E-17;EVA1_CAEEL;Protein eva-1 (Enhancer of ventral-axon guidance defects of unc-40 mutants);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; carbohydrate binding [GO:0030246]";"GO:0005886; GO:0016021; GO:0030054; GO:0030246; GO:0031430; GO:0055120";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";carbohydrate binding [GO:0030246]
comp1209534_c0_seq1;GAXK01122690.1;Q9Y2H8;1.42E-24;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp120960_c3_seq1;GAXK01199462.1;Q6GPD0;7.80E-167;RHG32_XENLA;Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0014069; GO:1901981";signal transduction [GO:0007165];"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]"
comp1209717_c0_seq1;GAXK01122693.1;Q99PV8;2.76E-07;BC11B_MOUSE;B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (mRit1);"neuron projection [GO:0043005]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006355; GO:0007409; GO:0008285; GO:0009791; GO:0010468; GO:0010837; GO:0019216; GO:0021773; GO:0021902; GO:0021953; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043066; GO:0043368; GO:0043565; GO:0043588; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0071678; GO:0097535";"alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"neuron projection [GO:0043005]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp121_c0_seq1;GAXK01169004.1;O00567;0;NOP56_HUMAN;Nucleolar protein 56 (Nucleolar protein 5A);"box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]";"GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226";rRNA processing [GO:0006364];"box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]";"cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]"
comp121000_c0_seq1;GAXK01205999.1;P15330;8.02E-22;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp121028_c0_seq1;GAXK01199006.1;Q5ZID5;3.44E-112;UBP28_CHICK;Ubiquitin carboxyl-terminal hydrolase 28 (EC 3.4.19.12) (Deubiquitinating enzyme 28) (Ubiquitin thioesterase 28) (Ubiquitin-specific-processing protease 28);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; protein deubiquitination [GO:0016579]; Ras protein signal transduction [GO:0007265]; regulation of protein stability [GO:0031647]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000077; GO:0004197; GO:0004843; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0007265; GO:0008283; GO:0010212; GO:0016579; GO:0031647; GO:0036459; GO:0042771";"cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; protein deubiquitination [GO:0016579]; Ras protein signal transduction [GO:0007265]; regulation of protein stability [GO:0031647]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp1210291_c0_seq1;GAXK01143037.1;Q95LI3;8.85E-15;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp121041_c0_seq1;GAXK01199397.1;O75030;9.59E-32;MITF_HUMAN;Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0010628; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141";"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1210416_c0_seq1;GAXK01143055.1;O54963;7.44E-12;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp121072_c0_seq1;GAXK01199503.1;Q7YZH1;1.73E-172;RNO_DROME;PHD finger protein rhinoceros;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";"GO:0005634; GO:0042051; GO:0042059; GO:0046872";"compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";nucleus [GO:0005634];metal ion binding [GO:0046872]
comp121091_c2_seq1;GAXK01199205.1;Q2EI21;1.17E-14;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp121096_c0_seq1;GAXK01198867.1;Q8T3B9;2.49E-31;SEM2_CAEEL;Transcription factor sem-2 (Sex muscle abnormal protein 2);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; myoblast fate specification [GO:0048626]; positive regulation of embryonic development [GO:0040019]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of oviposition [GO:1901046]; positive regulation of post-embryonic development [GO:0048582]; positive regulation of vulval development [GO:0040026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007501; GO:0030154; GO:0040019; GO:0040026; GO:0044798; GO:0048337; GO:0048582; GO:0048626; GO:1901046";"cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; myoblast fate specification [GO:0048626]; positive regulation of embryonic development [GO:0040019]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of oviposition [GO:1901046]; positive regulation of post-embryonic development [GO:0048582]; positive regulation of vulval development [GO:0040026]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp121098_c3_seq1;GAXK01199388.1;P21369;8.10E-35;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp121119_c1_seq1;GAXK01199057.1;G5EBQ8;8.59E-89;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp1211282_c0_seq1;GAXK01143059.1;P10076;1.98E-21;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1211335_c0_seq1;GAXK01143057.1;Q8IN81;2.49E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1211379_c0_seq1;GAXK01143033.1;Q9DBI0;3.22E-13;TMPS6_MOUSE;Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016021; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264";"cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1211426_c0_seq1;GAXK01143052.1;A6NCF5;3.84E-11;KLH33_HUMAN;Kelch-like protein 33;;;;;
comp121174_c0_seq1;GAXK01205995.1;P07548;1.54E-46;DFD_DROME;Homeotic protein deformed;"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; embryonic brain development [GO:1990403]; head development [GO:0060322]; head morphogenesis [GO:0060323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; specification of segmental identity, head [GO:0007380]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0007380; GO:0009952; GO:0010468; GO:0033613; GO:0035289; GO:0043565; GO:0045944; GO:0060322; GO:0060323; GO:1902339; GO:1990403";"anterior/posterior pattern specification [GO:0009952]; embryonic brain development [GO:1990403]; head development [GO:0060322]; head morphogenesis [GO:0060323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; specification of segmental identity, head [GO:0007380]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1212026_c0_seq1;GAXK01197758.1;P33085;2.53E-32;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp12123_c2_seq1;GAXK01020113.1;Q3ULA2;0;FBW1A_MOUSE;F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0071407";"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]"
comp121231_c0_seq1;GAXK01205997.1;Q8T940;1.74E-48;UBX_JUNCO;Homeotic protein ultrabithorax (JcUbx);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp12128_c3_seq1;GAXK01019989.1;Q2LAE1;8.04E-27;ASHH2_ARATH;Histone-lysine N-methyltransferase ASHH2 (EC 2.1.1.43) (ASH1 homolog 2) (H3-K4-HMTase) (Histone H3-K36 methyltransferase 8) (H3-K36-HMTase 8) (Protein EARLY FLOWERING IN SHORT DAYS) (Protein LAZARUS 2) (Protein SET DOMAIN GROUP 8);"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; anther development [GO:0048653]; carotenoid metabolic process [GO:0016116]; embryo sac development [GO:0009553]; histone H3-K36 methylation [GO:0010452]; negative regulation of flower development [GO:0009910]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; positive regulation of histone methylation [GO:0031062]; regulation of gene expression, epigenetic [GO:0040029]; regulation of plant-type hypersensitive response [GO:0010363]; regulation of programmed cell death [GO:0043067]; regulation of transcription, DNA-templated [GO:0006355]; secondary shoot formation [GO:0010223]";"GO:0000775; GO:0000785; GO:0005634; GO:0006355; GO:0008270; GO:0009553; GO:0009555; GO:0009910; GO:0010223; GO:0010363; GO:0010452; GO:0016116; GO:0031062; GO:0040029; GO:0042800; GO:0043067; GO:0046975; GO:0048481; GO:0048653";"anther development [GO:0048653]; carotenoid metabolic process [GO:0016116]; embryo sac development [GO:0009553]; histone H3-K36 methylation [GO:0010452]; negative regulation of flower development [GO:0009910]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; positive regulation of histone methylation [GO:0031062]; regulation of gene expression, epigenetic [GO:0040029]; regulation of plant-type hypersensitive response [GO:0010363]; regulation of programmed cell death [GO:0043067]; regulation of transcription, DNA-templated [GO:0006355]; secondary shoot formation [GO:0010223]";"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]"
comp1212947_c0_seq1;GAXK01197756.1;Q9I928;1.26E-09;FUCL4_ANGJA;Fucolectin-4;"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";"GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088";"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
comp1213_c0_seq1;GAXK01166085.1;P48597;1.75E-72;IF4E_XENLA;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417]";"GO:0003743; GO:0005845; GO:0006417; GO:0016281; GO:0032991";regulation of translation [GO:0006417];"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]";translation initiation factor activity [GO:0003743]
comp1213172_c0_seq1;GAXK01197766.1;Q08470;0;L2GL_DROPS;Protein lethal(2) giant larvae (p127);"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; exocytosis [GO:0006887]";"GO:0005576; GO:0005886; GO:0006887; GO:0007049";"cell cycle [GO:0007049]; exocytosis [GO:0006887]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp12133_c0_seq1;GAXK01019901.1;Q71KT5;2.84E-52;ERG24_MOUSE;Delta(14)-sterol reductase TM7SF2 (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; organelle membrane [GO:0031090]; receptor complex [GO:0043235]; delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"GO:0005637; GO:0005783; GO:0005789; GO:0006695; GO:0016126; GO:0030176; GO:0031090; GO:0043231; GO:0043235; GO:0050613; GO:0050661";"cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; organelle membrane [GO:0031090]; receptor complex [GO:0043235]";"delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]"
comp1213326_c0_seq1;GAXK01197762.1;P48427;6.74E-09;TBCA_BOVIN;Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA);"cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"GO:0005730; GO:0005829; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487";"post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]";"beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]"
comp1213372_c0_seq1;GAXK01197772.1;Q8BIK6;3.45E-22;TMPS7_MOUSE;Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0016021";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1213432_c0_seq1;GAXK01197739.1;P19218;2.98E-08;GP2_RAT;Pancreatic secretory granule membrane major glycoprotein GP2 (Glycoprotein 80) (gp80) (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"GO:0005576; GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp12138_c0_seq1;GAXK01020504.1;B3M1H7;1.08E-45;CISD2_DROAN;CDGSH iron-sulfur domain-containing protein 2 homolog;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]";"GO:0005789; GO:0016021; GO:0046872; GO:0051537";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"
comp1214_c0_seq1;GAXK01205903.1;P25153;7.86E-92;UBCD6_DROME;Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 6) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; centrosome cycle [GO:0007098]; centrosome separation [GO:0051299]; DNA repair [GO:0006281]; endocytic recycling [GO:0032456]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0000422; GO:0000790; GO:0002039; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0006511; GO:0007098; GO:0007507; GO:0019904; GO:0032436; GO:0032456; GO:0033503; GO:0043066; GO:0043161; GO:0043518; GO:0051299; GO:0061631; GO:1902166";"autophagy of mitochondrion [GO:0000422]; centrosome cycle [GO:0007098]; centrosome separation [GO:0051299]; DNA repair [GO:0006281]; endocytic recycling [GO:0032456]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp1214026_c0_seq1;GAXK01189364.1;Q03923;1.65E-16;ZNF85_HUMAN;Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]";"GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp1214127_c0_seq1;GAXK01189346.1;Q9V3Z2;7.40E-20;SER7_DROME;Serine protease 7 (EC 3.4.21.-) (Melanization protease 2);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0035006; GO:0035008; GO:0046872";"melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp121421_c1_seq1;GAXK01199496.1;Q7ZX22;0;WDR24_XENLA;GATOR complex protein WDR24;"lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]";"GO:0005765; GO:0006914; GO:0032008";"autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]";lysosomal membrane [GO:0005765];
comp1214303_c0_seq1;GAXK01189339.1;Q9BUG6;3.81E-14;ZSA5A_HUMAN;Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1214424_c0_seq1;GAXK01189347.1;Q01603;1.61E-13;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1214724_c0_seq1;GAXK01189362.1;P0DJJ2;5.39E-07;ASTL_CHICK;Astacin-like metalloendopeptidase (EC 3.4.-.-);"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0030133; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360";"cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp121505_c0_seq1;GAXK01199400.1;P26779;4.90E-07;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp1215075_c0_seq1;GAXK01189341.1;Q9FR62;3.85E-15;P23A_BRANA;Co-chaperone protein p23-1 (Bnp23-1);"chaperone complex [GO:0101031]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]";"GO:0009408; GO:0051085; GO:0051087; GO:0051879; GO:0101031";"chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]";chaperone complex [GO:0101031];"chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]"
comp12151_c0_seq1;GAXK01020913.1;Q6PHE8;9.35E-32;CC124_DANRE;Coiled-coil domain-containing protein 124;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005737; GO:0005815; GO:0007049; GO:0030496; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]";
comp121535_c0_seq1;GAXK01199498.1;Q22398;5.98E-10;NAS22_CAEEL;Zinc metalloproteinase nas-22 (EC 3.4.24.-) (Nematode astacin 22);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996";molting cycle, collagen and cuticulin-based cuticle [GO:0018996];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1215459_c0_seq1;GAXK01189359.1;B4SLL0;3.10E-07;ASPN_STRM5;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1215487_c0_seq1;GAXK01189353.1;Q9P2J8;2.34E-24;ZN624_HUMAN;Zinc finger protein 624;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1215649_c0_seq1;GAXK01189358.1;P05661;4.52E-38;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp121581_c0_seq1;GAXK01198871.1;P09478;0;ACH1_DROME;Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1216223_c0_seq1;GAXK01058668.1;P20693;8.29E-14;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp121626_c0_seq1;GAXK01199005.1;O46040;2.67E-26;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1216374_c0_seq1;GAXK01058660.1;Q5MCW4;2.28E-23;ZN569_HUMAN;Zinc finger protein 569;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1216383_c0_seq1;GAXK01058691.1;Q22X38;2.07E-22;RL36A_TETTS;60S ribosomal protein L36a (60S ribosomal protein L44);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1216411_c1_seq1;GAXK01058697.1;O00151;1.56E-09;PDLI1_HUMAN;PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36);"cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; stress fiber [GO:0001725]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]";"GO:0001666; GO:0001725; GO:0003713; GO:0003779; GO:0005667; GO:0005913; GO:0005925; GO:0006355; GO:0006979; GO:0007507; GO:0030018; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0061061; GO:0098641";"actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]";"cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; stress fiber [GO:0001725]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]";"actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; transcription coactivator activity [GO:0003713]"
comp1216725_c0_seq1;GAXK01058683.1;A9ZSY3;1.47E-35;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1216750_c0_seq1;GAXK01058659.1;P42787;2.79E-60;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp1216881_c0_seq1;GAXK01058696.1;Q9BPW5;2.25E-25;RSLBB_HUMAN;Ras-like protein family member 11B;"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transforming growth factor beta receptor binding [GO:0005160]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; signal transduction [GO:0007165]";"GO:0003924; GO:0005160; GO:0005525; GO:0007165; GO:0016020; GO:0030512";"negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; signal transduction [GO:0007165]";membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; transforming growth factor beta receptor binding [GO:0005160]"
comp121709_c1_seq1;GAXK01199122.1;P05661;1.43E-35;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1217104_c0_seq1;GAXK01058674.1;Q01484;6.82E-22;ANK2_HUMAN;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp12172_c0_seq1;GAXK01205096.1;Q24537;1.18E-70;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp121728_c3_seq1;GAXK01199201.1;Q7KRI2;2.37E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1217391_c0_seq1;GAXK01058692.1;Q5F4B8;3.86E-11;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1217471_c0_seq1;GAXK01058663.1;Q9GUM2;1.99E-75;BRE4_CAEEL;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";"GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872";"carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";integral component of membrane [GO:0016021];"acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"
comp1217500_c0_seq1;GAXK01058667.1;Q6JEL2;1.69E-66;KLH10_HUMAN;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp1217540_c1_seq1;GAXK01058723.1;Q8N1M1;9.48E-37;BEST3_HUMAN;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0034707; GO:0043271";negative regulation of ion transport [GO:0043271];"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1217785_c0_seq1;GAXK01058665.1;Q20191;3.52E-68;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1218060_c0_seq1;GAXK01113849.1;Q24372;4.40E-07;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp1218078_c0_seq1;GAXK01113830.1;Q504C1;1.19E-24;LRIT2_DANRE;Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp121819_c0_seq1;GAXK01198885.1;Q9W3Y4;3.61E-42;GA2PE_DROME;GAS2-like protein pickled eggs;"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; microtubule binding [GO:0008017]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"GO:0005856; GO:0005938; GO:0008017; GO:0030707; GO:0030713";"ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]";microtubule binding [GO:0008017]
comp1218199_c0_seq1;GAXK01113858.1;P08442;7.03E-13;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp1218238_c0_seq1;GAXK01113829.1;P08953;2.59E-78;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp1218256_c0_seq1;GAXK01113836.1;P36609;3.53E-27;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1218260_c0_seq1;GAXK01113820.1;Q59KL6;3.69E-11;TF3A_CANAL;Transcription factor IIIA (TFIIIA);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1218335_c0_seq1;GAXK01113794.1;Q90935;2.27E-37;NEUS_CHICK;Neuroserpin (Axonin-2) (Peptidase inhibitor 12) (PI-12) (Serpin I1);"cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0010951; GO:0034774; GO:0043025; GO:0043204; GO:0060205";negative regulation of endopeptidase activity [GO:0010951];"cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp1218611_c0_seq1;GAXK01113851.1;D3ZKX9;2.09E-42;LOXE3_RAT;Hydroperoxide isomerase ALOXE3 (EC 5.4.4.7) (Epidermis-type lipoxygenase 3) (Epidermal LOX-3) (e-LOX-3) (eLOX-3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152);"cytoplasm [GO:0005737]; hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]";"GO:0005506; GO:0005737; GO:0006665; GO:0016702; GO:0016829; GO:0019233; GO:0019369; GO:0019372; GO:0035357; GO:0043651; GO:0045444; GO:0046513; GO:0051120; GO:0051122; GO:0061436";"arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]";cytoplasm [GO:0005737];"hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp121870_c1_seq1;GAXK01199124.1;Q17DK5;1.93E-24;CRY1_AEDAE;Cryptochrome-1;"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660";"negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]"
comp1218751_c0_seq1;GAXK01113835.1;P13418;2.53E-24;POLS_CRPVC;"Structural polyprotein [Cleaved into: Capsid protein 1 (CP1); Capsid protein 4 (CP4); Capsid protein 2 (CP2); Capsid protein 3 (CP3)]";"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028; GO:0030430";;"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]";structural molecule activity [GO:0005198]
comp1218957_c0_seq1;GAXK01113845.1;Q3B8H0;1.10E-49;TM107_XENLA;Transmembrane protein 107;"integral component of membrane [GO:0016021]; cell projection organization [GO:0030030]; multicellular organism development [GO:0007275]";"GO:0007275; GO:0016021; GO:0030030";"cell projection organization [GO:0030030]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];
comp12192_c0_seq1;GAXK01020513.1;O73888;3.77E-40;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp121942_c1_seq1;GAXK01198970.1;Q9W0A0;0;DRPR_DROME;Protein draper;"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396";"apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]";"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]";phosphatidylserine binding [GO:0001786]
comp1219499_c0_seq1;GAXK01113810.1;O35312;2.16E-47;GDF8_RAT;Growth/differentiation factor 8 (GDF-8) (Myostatin);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta receptor binding [GO:0005160]; cell development [GO:0048468]; cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; skeletal muscle tissue regeneration [GO:0043403]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005125; GO:0005160; GO:0005615; GO:0005737; GO:0007179; GO:0008083; GO:0008201; GO:0009408; GO:0009629; GO:0010592; GO:0010759; GO:0010862; GO:0014732; GO:0014741; GO:0014839; GO:0014850; GO:0022602; GO:0033574; GO:0033673; GO:0042802; GO:0042803; GO:0042981; GO:0043403; GO:0043408; GO:0043627; GO:0045471; GO:0045662; GO:0045893; GO:0046627; GO:0046716; GO:0048468; GO:0048632; GO:0051384; GO:0051602; GO:0051898; GO:0060395; GO:0071549; GO:1902723; GO:1902725; GO:2000818";"cell development [GO:0048468]; cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; skeletal muscle tissue regeneration [GO:0043403]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta receptor binding [GO:0005160]"
comp1219521_c0_seq1;GAXK01113800.1;Q98ST7;1.50E-13;MOXD1_CHICK;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp1219663_c0_seq1;GAXK01113814.1;Q7Z4L5;0;TT21B_HUMAN;Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog);"ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]";"GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0021591; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0061512; GO:0097542; GO:1905799";"forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]";"ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]";
comp121972_c0_seq1;GAXK01199466.1;C0HKT3;8.91E-14;DIUX_AGRIP;Diuretic hormone class 2 (DH(31)) (Diuretic peptide) (DP);"extracellular region [GO:0005576]; diuretic hormone activity [GO:0008613]; body fluid secretion [GO:0007589]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218; GO:0007589; GO:0008613";"body fluid secretion [GO:0007589]; neuropeptide signaling pathway [GO:0007218]";extracellular region [GO:0005576];diuretic hormone activity [GO:0008613]
comp12198_c0_seq1;GAXK01020916.1;Q9WTV5;1.21E-45;PSMD9_RAT;26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27) (Transactivating protein Bridge-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; bHLH transcription factor binding [GO:0043425]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome regulatory particle assembly [GO:0070682]; type B pancreatic cell apoptotic process [GO:0097050]";"GO:0003713; GO:0005634; GO:0005737; GO:0008022; GO:0008540; GO:0032024; GO:0043425; GO:0045893; GO:0045944; GO:0046676; GO:0070682; GO:0097050";"negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome regulatory particle assembly [GO:0070682]; type B pancreatic cell apoptotic process [GO:0097050]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]";"bHLH transcription factor binding [GO:0043425]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]"
comp1219859_c0_seq1;GAXK01113828.1;Q9NNZ3;3.55E-11;DNJC4_HUMAN;DnaJ homolog subfamily C member 4 (DnaJ-like protein HSPF2) (Multiple endocrine neoplasia type 1 candidate protein number 18);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]";"GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0051082";"protein folding [GO:0006457]; response to unfolded protein [GO:0006986]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";unfolded protein binding [GO:0051082]
comp1219919_c0_seq1;GAXK01113848.1;Q5F4B8;2.98E-14;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp122_c0_seq1;GAXK01169625.1;Q00871;7.99E-71;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp122023_c2_seq1;GAXK01074243.1;P11536;1.06E-56;E74EB_DROME;Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]";"GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0008219; GO:0030154; GO:0035071; GO:0040034; GO:0043565; GO:0045944; GO:0048477";"autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp1220322_c0_seq1;GAXK01150189.1;P79782;2.91E-24;TCF15_CHICK;Transcription factor 15 (TCF-15) (Paraxis) (Protein bHLH-EC2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046983";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp1220349_c0_seq1;GAXK01150230.1;Q8CGM1;2.22E-18;AGRB2_MOUSE;Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2);"centrosome [GO:0005813]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965]";"GO:0004930; GO:0005813; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016525; GO:0033173; GO:0051965";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965]";"centrosome [GO:0005813]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp122040_c2_seq1;GAXK01074315.1;Q13887;1.42E-44;KLF5_HUMAN;Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0006366; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0071407; GO:0099156; GO:1901653; GO:1902895; GO:1990830";"angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1220514_c0_seq1;GAXK01150247.1;Q0III3;1.02E-168;DC1I2_BOVIN;Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2);"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0031982; GO:0045503; GO:0045504";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp1220823_c0_seq1;GAXK01150211.1;P29508;5.65E-27;SPB3_HUMAN;Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1) (SCCA-1);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; vesicle [GO:0031982]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; virus receptor activity [GO:0001618]; autocrine signaling [GO:0035425]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; neutrophil degranulation [GO:0043312]; paracrine signaling [GO:0038001]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of epithelial to mesenchymal transition [GO:0010718]";"GO:0001618; GO:0002020; GO:0004867; GO:0004869; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008284; GO:0010466; GO:0010718; GO:0010950; GO:0010951; GO:0030335; GO:0031410; GO:0031982; GO:0035425; GO:0035578; GO:0038001; GO:0043086; GO:0043312; GO:0043508; GO:0045861; GO:0070062";"autocrine signaling [GO:0035425]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; neutrophil degranulation [GO:0043312]; paracrine signaling [GO:0038001]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of epithelial to mesenchymal transition [GO:0010718]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; vesicle [GO:0031982]";"cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; virus receptor activity [GO:0001618]"
comp1220877_c0_seq1;GAXK01150261.1;Q922K9;2.57E-67;FRK_MOUSE;Tyrosine-protein kinase FRK (EC 2.7.10.2) (Beta-cell Src-homology tyrosine kinase) (BSK) (FYN-related kinase) (Intestine tyrosine kinase);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine autophosphorylation [GO:0038083]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000122; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0030154; GO:0031234; GO:0038083";"cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine autophosphorylation [GO:0038083]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]"
comp1220929_c0_seq1;GAXK01150232.1;Q60560;2.88E-132;SMBP2_MESAU;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Immunoglobulin mu-binding protein 2) (Insulin II gene enhancer-binding protein) (RIPE3B-binding complex 3B2 p110 subunit) (RIP-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; protein homooligomerization [GO:0051260]";"GO:0000049; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0030424; GO:0032574; GO:0043022; GO:0043139; GO:0043621; GO:0051260";protein homooligomerization [GO:0051260];"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp1221081_c0_seq1;GAXK01150237.1;Q8IN81;6.05E-10;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1221267_c0_seq1;GAXK01150227.1;Q61096;4.10E-18;PRTN3_MOUSE;Myeloblastin (EC 3.4.21.76) (Proteinase 3) (PR-3);"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; enzyme binding [GO:0019899]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; cell-cell junction maintenance [GO:0045217]; collagen catabolic process [GO:0030574]; mature conventional dendritic cell differentiation [GO:0097029]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of phagocytosis [GO:0050765]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; proteolysis [GO:0006508]";"GO:0004252; GO:0005102; GO:0005615; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0006909; GO:0019899; GO:0030574; GO:0035578; GO:0043547; GO:0044853; GO:0045217; GO:0050765; GO:0072672; GO:0097029";"cell-cell junction maintenance [GO:0045217]; collagen catabolic process [GO:0030574]; mature conventional dendritic cell differentiation [GO:0097029]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of phagocytosis [GO:0050765]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; proteolysis [GO:0006508]";"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]";"enzyme binding [GO:0019899]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]"
comp1221273_c0_seq1;GAXK01150201.1;Q9D8T3;4.20E-13;REBL1_MOUSE;GTPase RhebL1 (Ras homolog enriched in brain-like protein 1) (Rheb-like protein 1);"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929]";"GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0007264; GO:0012505; GO:0019003; GO:0031929; GO:0046872; GO:0051092";"positive regulation of NF-kappaB transcription factor activity [GO:0051092]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp12215_c0_seq1;GAXK01020302.1;O01479;5.95E-53;TMOD_CAEEL;Tropomodulin (Tmod-like protein) (cTmd1) (Uncoordinated protein 94);"cytoplasm [GO:0005737]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; terminal web [GO:1990357]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; negative regulation of actin filament depolymerization [GO:0030835]; nematode larval development [GO:0002119]; pointed-end actin filament capping [GO:0051694]; sarcomere organization [GO:0045214]";"GO:0002119; GO:0005523; GO:0005737; GO:0005865; GO:0009792; GO:0030016; GO:0030239; GO:0030835; GO:0040011; GO:0045214; GO:0051015; GO:0051694; GO:0071689; GO:1990357";"embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; negative regulation of actin filament depolymerization [GO:0030835]; nematode larval development [GO:0002119]; pointed-end actin filament capping [GO:0051694]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; terminal web [GO:1990357]";"actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]"
comp122165_c0_seq1;GAXK01074346.1;O88480;1.71E-25;CABIN_RAT;Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase inhibitor activity [GO:0004864]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]";"GO:0004864; GO:0005634; GO:0005737; GO:0006336; GO:0014823; GO:0019904; GO:0030346; GO:0060548";"DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"protein domain specific binding [GO:0019904]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase inhibitor activity [GO:0004864]"
comp1221983_c0_seq1;GAXK01150231.1;Q1RK13;3.47E-12;Y220_RICBR;Putative ankyrin repeat protein RBE_0220;;;;;
comp1222071_c0_seq1;GAXK01069933.1;Q52V16;5.15E-20;ZFY_GORGO;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp122215_c0_seq1;GAXK01074312.1;Q62059;2.34E-17;CSPG2_MOUSE;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Large fibroblast proteoglycan) (PG-M);"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"GO:0001501; GO:0001657; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0008347; GO:0009986; GO:0019903; GO:0030246; GO:0031012; GO:0043666; GO:0045202; GO:0062023; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]"
comp122219_c12_seq1;GAXK01074278.1;P0C6B8;6.72E-12;SVEP1_RAT;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";calcium ion binding [GO:0005509]
comp1222293_c0_seq1;GAXK01069912.1;Q9NRA2;4.11E-33;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp1222344_c0_seq1;GAXK01069902.1;Q7ZYC4;1.26E-56;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp122269_c0_seq1;GAXK01074060.1;Q9UIF8;2.32E-58;BAZ2B_HUMAN;Bromodomain adjacent to zinc finger domain protein 2B (hWALp4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872";"chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1222694_c0_seq1;GAXK01069904.1;Q7PEV7;2.75E-09;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp1222736_c0_seq1;GAXK01069877.1;Q96SU4;8.46E-28;OSBL9_HUMAN;Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]";"GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231";bile acid biosynthetic process [GO:0006699];"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]";"lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp122289_c0_seq1;GAXK01074162.1;Q8BYK4;2.27E-58;RDH12_MOUSE;Retinol dehydrogenase 12 (EC 1.1.1.300);"photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";photoreceptor inner segment [GO:0001917];"NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]"
comp1223_c0_seq1;GAXK01170173.1;Q6WV72;9.30E-52;H4_MYTTR;Histone H4;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]";"GO:0000786; GO:0003677; GO:0005634; GO:0006352; GO:0046982";DNA-templated transcription, initiation [GO:0006352];"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp122313_c1_seq1;GAXK01074230.1;P35041;1.29E-35;TRY7_ANOGA;Trypsin-7 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp122315_c0_seq1;GAXK01074073.1;P40692;0;MLH1_HUMAN;DNA mismatch repair protein Mlh1 (MutL protein homolog 1);"chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257";"double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]"
comp122317_c0_seq1;GAXK01074264.1;Q9HC21;3.04E-67;TPC_HUMAN;Mitochondrial thiamine pyrophosphate carrier (Mitochondrial uncoupling protein 1) (Solute carrier family 25 member 19);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; deoxynucleotide transmembrane transporter activity [GO:0030233]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; thiamine transmembrane transporter activity [GO:0015234]; deoxynucleotide transport [GO:0030302]; thiamine pyrophosphate transmembrane transport [GO:0030974]; thiamine-containing compound metabolic process [GO:0042723]";"GO:0005634; GO:0005743; GO:0015234; GO:0030233; GO:0030302; GO:0030974; GO:0031305; GO:0042723; GO:0090422";"deoxynucleotide transport [GO:0030302]; thiamine-containing compound metabolic process [GO:0042723]; thiamine pyrophosphate transmembrane transport [GO:0030974]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";"deoxynucleotide transmembrane transporter activity [GO:0030233]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; thiamine transmembrane transporter activity [GO:0015234]"
comp1223242_c0_seq1;GAXK01069905.1;Q6Z2J1;3.49E-13;CML20_ORYSJ;Probable calcium-binding protein CML20 (Calmodulin-like protein 20);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp12234_c0_seq1;GAXK01020615.1;P14599;6.90E-65;A4_DROME;Amyloid-beta-like protein;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of neuron death [GO:1901215]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; short-term memory [GO:0007614]; synapse organization [GO:0050808]";"GO:0005576; GO:0005886; GO:0007422; GO:0007611; GO:0007614; GO:0007616; GO:0008201; GO:0016021; GO:0016319; GO:0046914; GO:0048678; GO:0048812; GO:0050808; GO:0051602; GO:1901215";"learning or memory [GO:0007611]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of neuron death [GO:1901215]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; short-term memory [GO:0007614]; synapse organization [GO:0050808]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]"
comp122348_c2_seq1;GAXK01074259.1;P0CP96;1.42E-22;FKBP2_CRYNJ;FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0005783; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp122393_c0_seq1;GAXK01074187.1;O42643;9.20E-158;PRP22_SCHPO;Pre-mRNA-splicing factor ATP-dependent RNA helicase prp22 (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; spliceosomal complex disassembly [GO:0000390]";"GO:0000390; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005684; GO:0034458; GO:0071013; GO:0071014";spliceosomal complex disassembly [GO:0000390];"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1224_c1_seq1;GAXK01168672.1;Q94519;2.30E-38;ACPM_DROME;Acyl carrier protein, mitochondrial (ACP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit) (NADH-ubiquinone oxidoreductase acyl-carrier subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0000035; GO:0000036; GO:0005739; GO:0005747; GO:0006120; GO:0006633; GO:0031177";"fatty acid biosynthetic process [GO:0006633]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]"
comp122402_c1_seq1;GAXK01074022.1;Q00558;6.33E-27;F8I2_MOUSE;Factor VIII intron 22 protein (CpG island protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1224049_c0_seq1;GAXK01018782.1;Q52KB5;7.22E-08;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1224083_c0_seq1;GAXK01018780.1;O88898;8.33E-40;P63_MOUSE;Tumor protein 63 (p63) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; multicellular organism aging [GO:0010259]; multicellular organism development [GO:0007275]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"GO:0000122; GO:0000790; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0001738; GO:0001942; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007275; GO:0007283; GO:0007389; GO:0007499; GO:0007569; GO:0008283; GO:0008544; GO:0009887; GO:0009913; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0019904; GO:0030154; GO:0030216; GO:0030326; GO:0030425; GO:0030850; GO:0030855; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043005; GO:0043281; GO:0043565; GO:0043589; GO:0043616; GO:0044212; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048646; GO:0048807; GO:0050699; GO:0051289; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:0098773; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773; GO:2001235";"anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; multicellular organism aging [GO:0010259]; multicellular organism development [GO:0007275]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]";"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]"
comp122438_c0_seq1;GAXK01074314.1;Q9W3Y4;6.61E-45;GA2PE_DROME;GAS2-like protein pickled eggs;"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; microtubule binding [GO:0008017]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"GO:0005856; GO:0005938; GO:0008017; GO:0030707; GO:0030713";"ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]";microtubule binding [GO:0008017]
comp12245_c0_seq1;GAXK01205094.1;Q9VS59;1.81E-23;AKIRN_DROME;Akirin (Protein bhringi);"nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription coregulator activity [GO:0003712]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]";"GO:0003712; GO:0005634; GO:0005700; GO:0005719; GO:0007526; GO:0045087; GO:0045088; GO:0045089; GO:0045944; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]";"nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";transcription coregulator activity [GO:0003712]
comp12246_c1_seq1;GAXK01020123.1;P82119;1.66E-07;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1224707_c1_seq1;GAXK01018765.1;Q8NFT8;4.28E-14;DNER_HUMAN;Delta and Notch-like epidermal growth factor-related receptor;"dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741";"central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]";"dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]"
comp1224737_c0_seq1;GAXK01018783.1;Q8WTS6;4.67E-28;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1224850_c1_seq1;GAXK01018804.1;Q9BXF9;1.97E-70;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp122486_c0_seq1;GAXK01074081.1;P31646;5.00E-75;S6A13_RAT;Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13);"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836]";"GO:0005332; GO:0005886; GO:0005887; GO:0006836; GO:0042165; GO:0043005";neurotransmitter transport [GO:0006836];"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]"
comp12249_c0_seq1;GAXK01020946.1;A3KP48;4.38E-11;F162B_DANRE;Protein FAM162B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp122514_c0_seq1;GAXK01074234.1;Q717B2;6.91E-38;TDPZ2_MOUSE;TD and POZ domain-containing protein 2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp12254_c0_seq1;GAXK01020539.1;Q5R1W5;1.94E-33;SRSF2_PANTR;Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp1225661_c0_seq1;GAXK01018786.1;P27619;1.56E-34;DYN_DROME;Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]; vesicle-mediated transport [GO:0016192]";"GO:0001661; GO:0001738; GO:0001933; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0016020; GO:0016185; GO:0016192; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475";"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]"
comp122579_c1_seq1;GAXK01074133.1;Q7KHG2;2.57E-45;JING_DROME;Zinc finger protein jing (Zinc finger protein rhumba);"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]";"GO:0000122; GO:0003676; GO:0005634; GO:0006325; GO:0007298; GO:0007382; GO:0007411; GO:0007417; GO:0007418; GO:0007424; GO:0007474; GO:0007479; GO:0008347; GO:0035098; GO:0042246; GO:0045944; GO:0046872";"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]";"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1226054_c0_seq1;GAXK01204951.1;O18598;8.42E-30;GST1_BLAGE;Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma) (Major allergen Bla g 5) (allergen Bla g 5);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp1226061_c0_seq1;GAXK01088539.1;P21521;1.15E-19;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp122628_c1_seq1;GAXK01074084.1;Q8TJK1;3.47E-28;ARSM_METAC;Arsenite methyltransferase (EC 2.1.1.137) (As(III) methyltransferase);"arsenite methyltransferase activity [GO:0030791]; response to arsenic-containing substance [GO:0046685]";"GO:0030791; GO:0046685";response to arsenic-containing substance [GO:0046685];;arsenite methyltransferase activity [GO:0030791]
comp1226302_c0_seq1;GAXK01088491.1;P11584;4.02E-51;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp12266_c0_seq1;GAXK01020454.1;Q178A5;1.26E-101;UFC1_AEDAE;Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1);;;;;
comp122683_c0_seq1;GAXK01074325.1;Q5R670;1.68E-10;ZKSC1_PONAB;Zinc finger protein with KRAB and SCAN domains 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1227_c0_seq1;GAXK01168568.1;Q94519;1.22E-31;ACPM_DROME;Acyl carrier protein, mitochondrial (ACP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit) (NADH-ubiquinone oxidoreductase acyl-carrier subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0000035; GO:0000036; GO:0005739; GO:0005747; GO:0006120; GO:0006633; GO:0031177";"fatty acid biosynthetic process [GO:0006633]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]"
comp12270_c0_seq1;GAXK01020369.1;P62744;1.91E-92;AP2S1_RAT;AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma-adaptin 3b) (Sigma2-adaptin);"AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005886; GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583";"clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";clathrin adaptor activity [GO:0035615]
comp122700_c0_seq1;GAXK01074129.1;Q5M824;2.26E-97;SHC1_RAT;SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]";"GO:0000187; GO:0001525; GO:0001666; GO:0001784; GO:0005154; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006940; GO:0007173; GO:0007568; GO:0008284; GO:0008286; GO:0009636; GO:0010008; GO:0014070; GO:0030036; GO:0030182; GO:0030971; GO:0031100; GO:0031175; GO:0032868; GO:0032869; GO:0035094; GO:0035556; GO:0040008; GO:0042542; GO:0044877; GO:0045907; GO:0048661; GO:0051219; GO:0051384; GO:0051721; GO:0070435; GO:0071363; GO:1990839";"actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]";"epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; receptor tyrosine kinase binding [GO:0030971]"
comp122747_c0_seq1;GAXK01074389.1;Q80TE4;0;SI1L2_MOUSE;Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2);"GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0051056";regulation of small GTPase mediated signal transduction [GO:0051056];;GTPase activator activity [GO:0005096]
comp1227473_c0_seq1;GAXK01088520.1;B0ZTE1;5.59E-42;SOX21_XENLA;Transcription factor Sox-21 (SRY (sex determining region Y)-box 21);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]";"GO:0000122; GO:0005634; GO:0007399; GO:0043565; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp1227810_c0_seq1;GAXK01088532.1;Q29RM3;6.58E-24;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp12279_c0_seq1;GAXK01020244.1;Q9UJX2;0;CDC23_HUMAN;Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8);"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000278; GO:0004842; GO:0005622; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007080; GO:0007091; GO:0007096; GO:0030071; GO:0031145; GO:0051301; GO:0070979; GO:1901990";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]";"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]";ubiquitin-protein transferase activity [GO:0004842]
comp122813_c0_seq1;GAXK01074287.1;Q1LVC2;3.63E-60;JARD2_DANRE;Protein Jumonji (Jumonji/ARID domain-containing protein 2);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; multicellular organism development [GO:0007275]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; stem cell differentiation [GO:0048863]";"GO:0003677; GO:0003682; GO:0005634; GO:0006338; GO:0007275; GO:0031061; GO:0032452; GO:0034721; GO:0035097; GO:0045892; GO:0048863; GO:0051574";"chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; multicellular organism development [GO:0007275]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; stem cell differentiation [GO:0048863]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]"
comp12286_c0_seq1;GAXK01020331.1;O73723;0;ARP3_TAKRU;Actin-related protein 3 (Actin-like protein 3);"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995; GO:0045944";"Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"actin binding [GO:0003779]; ATP binding [GO:0005524]"
comp1228663_c2_seq1;GAXK01188842.1;Q9QUP4;2.00E-15;CHST5_MOUSE;Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4) (GST4) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (mIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0018146";"carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]
comp12287_c1_seq1;GAXK01020243.1;Q9BXS5;0;AP1M1_HUMAN;AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin);"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690]";"GO:0000139; GO:0005765; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0019886; GO:0030131; GO:0030659; GO:0030665; GO:0032438; GO:0032588; GO:0035579; GO:0035646; GO:0043312; GO:0050690; GO:0070062";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690]";"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]";
comp12289_c0_seq1;GAXK01020301.1;Q01105;2.15E-71;SET_HUMAN;Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]";"GO:0003677; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0016032; GO:0019888; GO:0032991; GO:0035067; GO:0042393; GO:0043488; GO:0043524; GO:0045892; GO:0048471";"DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]"
comp122905_c0_seq1;GAXK01074288.1;Q6DJT9;1.22E-24;PLAG1_HUMAN;Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0045944; GO:0046872; GO:0060252; GO:0060736";"gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp12291_c0_seq1;GAXK01020170.1;O17445;1.51E-31;RL15_DROME;60S ribosomal protein L15;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp122912_c1_seq1;GAXK01074148.1;O46689;1.61E-29;STAR_HORSE;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005758; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020";"cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp122926_c1_seq1;GAXK01074255.1;Q01611;2.29E-13;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1229560_c0_seq1;GAXK01188823.1;Q9U3P2;1.16E-14;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp1229768_c0_seq1;GAXK01188830.1;Q876A6;2.51E-08;AKR1_NAUCC;Palmitoyltransferase AKR1 (EC 2.3.1.225) (Ankyrin repeat-containing protein AKR1);"early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; G-protein beta/gamma-subunit complex binding [GO:0031683]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion [GO:0090029]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of endocytosis [GO:0030100]";"GO:0000139; GO:0006612; GO:0016021; GO:0018345; GO:0019706; GO:0030100; GO:0031683; GO:0031901; GO:0090029";"negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion [GO:0090029]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of endocytosis [GO:0030100]";"early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"G-protein beta/gamma-subunit complex binding [GO:0031683]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp123021_c0_seq1;GAXK01074080.1;Q9GLP2;5.29E-25;PROC_PIG;"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]";"GO:0004252; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0007596; GO:0030195; GO:0043066; GO:0050728; GO:0050819; GO:1903142";"blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp1230507_c0_seq1;GAXK01079832.1;Q6IVV8;4.88E-13;PKD2_DANRE;Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738";"atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp123058_c3_seq1;GAXK01074390.1;Q640B4;1.43E-62;MUS81_XENTR;Crossover junction endonuclease MUS81 (EC 3.1.22.-);"Holliday junction resolvase complex [GO:0048476]; nucleus [GO:0005634]; 3'-flap endonuclease activity [GO:0048257]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0000727; GO:0003677; GO:0005634; GO:0031573; GO:0046872; GO:0048257; GO:0048476";"double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; resolution of meiotic recombination intermediates [GO:0000712]";"Holliday junction resolvase complex [GO:0048476]; nucleus [GO:0005634]";"3'-flap endonuclease activity [GO:0048257]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1230651_c0_seq1;GAXK01079841.1;P86854;1.50E-14;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1230736_c0_seq1;GAXK01079835.1;O08648;1.05E-08;M3K4_MOUSE;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp123079_c0_seq1;GAXK01074263.1;Q96AE7;5.65E-12;TTC17_HUMAN;Tetratricopeptide repeat protein 17 (TPR repeat protein 17);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]";"GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782";"actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp1230953_c0_seq1;GAXK01079745.1;Q9LE22;7.81E-07;CML27_ARATH;Probable calcium-binding protein CML27 (Calmodulin-like protein 27);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005634; GO:0005773; GO:0005829; GO:0005886";;"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";calcium ion binding [GO:0005509]
comp123099_c0_seq1;GAXK01074136.1;Q6NZQ4;4.73E-40;PAXI1_MOUSE;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein);"chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; cellular response to DNA damage stimulus [GO:0006974]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]";"GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006974; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022";"adipose tissue development [GO:0060612]; cellular response to DNA damage stimulus [GO:0006974]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]";"chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1231264_c0_seq1;GAXK01079749.1;Q8VIG1;3.05E-20;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp123133_c1_seq1;GAXK01074297.1;Q6DIY8;9.62E-30;M17L2_XENTR;Mpv17-like protein 2;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome assembly [GO:0061668]";"GO:0005737; GO:0005743; GO:0016021; GO:0061668";mitochondrial ribosome assembly [GO:0061668];"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp1231408_c0_seq1;GAXK01079750.1;Q8C525;1.53E-07;M21D2_MOUSE;Protein MB21D2 (Mab-21 domain-containing protein 2);protein-containing complex binding [GO:0044877];GO:0044877;;;protein-containing complex binding [GO:0044877]
comp12315_c0_seq1;GAXK01020052.1;Q28XE2;1.21E-30;AN32A_DROPS;Acidic leucine-rich nuclear phosphoprotein 32 family member A;"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913]";"GO:0005634; GO:0005737; GO:0005783; GO:0006913; GO:0048471";nucleocytoplasmic transport [GO:0006913];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp123163_c1_seq1;GAXK01074139.1;P86854;9.67E-17;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1231750_c0_seq1;GAXK01079840.1;P02595;5.37E-35;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1231845_c0_seq1;GAXK01079837.1;Q9V7U0;4.59E-10;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp123202_c0_seq1;GAXK01074261.1;Q9VCA2;5.23E-74;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1232282_c0_seq1;GAXK01162176.1;Q5RCU4;3.99E-33;SOX6_PONAB;Transcription factor SOX-6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp12324_c1_seq1;GAXK01020945.1;P52655;1.38E-22;TF2AA_HUMAN;"Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001103; GO:0003677; GO:0003713; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0008134; GO:0016251; GO:0017025; GO:0042795; GO:0046982";"snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp123265_c1_seq1;GAXK01074149.1;P19572;1.98E-41;DCDA_PSEAE;Diaminopimelate decarboxylase (DAP decarboxylase) (DAPDC) (EC 4.1.1.20);"diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170]; lysine biosynthetic process via diaminopimelate [GO:0009089]";"GO:0008836; GO:0009089; GO:0030170";lysine biosynthetic process via diaminopimelate [GO:0009089];;"diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170]"
comp1232935_c0_seq1;GAXK01162154.1;Q5HZL5;7.12E-18;B3G5A_XENLA;Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021; GO:0047256";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]"
comp1233532_c0_seq1;GAXK01162181.1;P18173;4.03E-94;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp1233588_c0_seq1;GAXK01162182.1;Q8BM89;1.06E-71;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp1234_c0_seq1;GAXK01168990.1;Q21735;3.74E-32;NTF2_CAEEL;Probable nuclear transport factor 2 (NTF-2);"cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]";"GO:0005737; GO:0006606; GO:0006913; GO:0044613";"nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]";"cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]";
comp1234091_c0_seq1;GAXK01063429.1;B4GD14;6.21E-22;LPHN_DROPE;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1234152_c0_seq1;GAXK01063411.1;Q80UG8;1.09E-61;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp123438_c0_seq1;GAXK01074018.1;Q91Z79;0;LIPA3_RAT;Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3) (PTPRF-interacting protein alpha-3);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; epididymosome [GO:0098875]; presynaptic active zone [GO:0048786]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"GO:0001669; GO:0005737; GO:0007269; GO:0048172; GO:0048786; GO:0098875";"neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; epididymosome [GO:0098875]; presynaptic active zone [GO:0048786]";
comp123452_c2_seq1;GAXK01074198.1;Q5R4S2;4.51E-42;B4GA1_PONAB;Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein O-linked mannosylation [GO:0035269]";"GO:0000139; GO:0005794; GO:0015020; GO:0016021; GO:0035269; GO:0046872";protein O-linked mannosylation [GO:0035269];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp1234871_c0_seq1;GAXK01063398.1;P51521;2.45E-07;OVO_DROME;Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)];"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896";"adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp123488_c0_seq1;GAXK01074114.1;P05661;6.61E-29;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp123538_c1_seq1;GAXK01074233.1;Q5ZMG1;1.17E-116;UFL1_CHICK;E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; UFM1 transferase activity [GO:0071568]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0005783; GO:0005789; GO:0032088; GO:0032434; GO:0034976; GO:0071568; GO:0071569; GO:1990592";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]";UFM1 transferase activity [GO:0071568]
comp1235426_c0_seq1;GAXK01063405.1;Q18297;5.42E-23;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp1235926_c0_seq1;GAXK01063401.1;A7Y2W8;2.69E-69;SC6A9_XENLA;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005283; GO:0005328; GO:0005887";;integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp123625_c0_seq1;GAXK01074206.1;Q55GQ5;5.14E-09;SODC1_DICDI;Superoxide dismutase [Cu-Zn] 1 (EC 1.15.1.1);"cytosol [GO:0005829]; extracellular matrix [GO:0031012]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; aggregation involved in sorocarp development [GO:0031152]; removal of superoxide radicals [GO:0019430]; response to bacterium [GO:0009617]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]";"GO:0004784; GO:0005507; GO:0005634; GO:0005829; GO:0006801; GO:0006979; GO:0009617; GO:0019430; GO:0031012; GO:0031152; GO:0042542; GO:0045335; GO:1904643";"aggregation involved in sorocarp development [GO:0031152]; removal of superoxide radicals [GO:0019430]; response to bacterium [GO:0009617]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]";"cytosol [GO:0005829]; extracellular matrix [GO:0031012]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]";"copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]"
comp123658_c6_seq1;GAXK01074209.1;A6H730;3.10E-86;PPAP_BOVIN;Prostatic acid phosphatase (EC 3.1.3.2);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"GO:0003993; GO:0005615; GO:0005886; GO:0006772; GO:0008253; GO:0012506; GO:0016311; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168";"adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]"
comp12366_c1_seq1;GAXK01205100.1;Q90593;0;BIP_CHICK;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein);"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090074; GO:1903895";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp123668_c0_seq1;GAXK01074305.1;B2RZ50;8.77E-46;CDKN3_RAT;Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Kinase-associated phosphatase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cell cycle arrest [GO:0007050]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0007050; GO:0048471";cell cycle arrest [GO:0007050];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp1236834_c0_seq1;GAXK01117751.1;Q9Z0X2;5.90E-19;SL9A5_RAT;Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5) (NHE-5) (Solute carrier family 9 member 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719; GO:1902600";"potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp1236927_c0_seq1;GAXK01117754.1;Q500Z2;4.59E-12;ZDH20_ARATH;Probable protein S-acyltransferase 15 (EC 2.3.1.225) (Probable palmitoyltransferase At5g04270) (Zinc finger DHHC domain-containing protein At5g04270);"cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706; GO:0030659";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp1237_c0_seq1;GAXK01168678.1;Q24046;3.74E-32;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp123702_c0_seq1;GAXK01074301.1;P51650;0;SSDH_RAT;Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase);"mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105]";"GO:0004777; GO:0005739; GO:0006105; GO:0007417; GO:0009013; GO:0009450; GO:0031406; GO:0051287; GO:0055114";"central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105]";mitochondrion [GO:0005739];"carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]"
comp1237358_c0_seq1;GAXK01117760.1;Q9C0G0;4.08E-14;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp123742_c7_seq1;GAXK01074273.1;Q8MKW7;7.75E-118;RNZ_DROME;Ribonuclease Z, mitochondrial (RNase Z) (EC 3.1.26.11) (Juvenile hormone-inducible protein 1) (dRNAse Z) (tRNA 3 endonuclease) (DmeZ) (tRNase Z);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]";"GO:0001558; GO:0005634; GO:0005739; GO:0005829; GO:0006388; GO:0007419; GO:0016891; GO:0030307; GO:0034414; GO:0036093; GO:0042780; GO:0042781; GO:0045727; GO:0046872; GO:0072684; GO:0140040; GO:1902375";"germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]"
comp123745_c1_seq1;GAXK01074150.1;Q9VVA0;3.90E-23;Y9705_DROME;Cold shock domain-containing protein CG9705;"cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]";"GO:0003730; GO:0005737; GO:0043488; GO:0048813";"dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]";cytoplasm [GO:0005737];mRNA 3'-UTR binding [GO:0003730]
comp1237583_c0_seq1;GAXK01117769.1;P23607;1.08E-09;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1237635_c0_seq1;GAXK01117755.1;Q6GL68;9.48E-12;TF7L1_XENTR;Transcription factor 7-like 1 (HMG box transcription factor 3) (TCF-3);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007275; GO:0008013; GO:0008134; GO:0043565; GO:0044212; GO:0060070";"canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp123816_c2_seq1;GAXK01074142.1;Q7L3S4;2.61E-30;ZN771_HUMAN;Zinc finger protein 771 (Mesenchymal stem cell protein DSC43);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0005730; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp123838_c0_seq1;GAXK01074300.1;O75356;7.03E-48;ENTP5_HUMAN;Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0008283; GO:0014066; GO:0034656; GO:0045134; GO:0045821; GO:0046034; GO:0051084";"'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]"
comp12386_c0_seq1;GAXK01020124.1;P14599;2.74E-87;A4_DROME;Amyloid-beta-like protein;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of neuron death [GO:1901215]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; short-term memory [GO:0007614]; synapse organization [GO:0050808]";"GO:0005576; GO:0005886; GO:0007422; GO:0007611; GO:0007614; GO:0007616; GO:0008201; GO:0016021; GO:0016319; GO:0046914; GO:0048678; GO:0048812; GO:0050808; GO:0051602; GO:1901215";"learning or memory [GO:0007611]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of neuron death [GO:1901215]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; short-term memory [GO:0007614]; synapse organization [GO:0050808]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]"
comp1238769_c0_seq1;GAXK01162820.1;Q9Y6N5;4.09E-29;SQOR_HUMAN;Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase);"mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";"GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949";"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";mitochondrial inner membrane [GO:0005743];"FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]"
comp123879_c2_seq1;GAXK01074303.1;Q6P3S1;4.87E-118;DEN1B_HUMAN;DENN domain-containing protein 1B (Connecdenn 2) (Protein FAM31B);"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745]";"GO:0005829; GO:0006897; GO:0015031; GO:0016607; GO:0017112; GO:0017137; GO:0030136; GO:0032456; GO:0035745; GO:0043231; GO:0043547; GO:0050776; GO:0050852; GO:1901981";"endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745]";"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]";"phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp1238927_c0_seq1;GAXK01162797.1;Q9W056;1.52E-32;C1139_DROME;Proton-coupled amino acid transporter-like protein CG1139;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; regulation of growth [GO:0040008]";"GO:0003333; GO:0005886; GO:0015171; GO:0016021; GO:0040008";"amino acid transmembrane transport [GO:0003333]; regulation of growth [GO:0040008]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";amino acid transmembrane transporter activity [GO:0015171]
comp123905_c0_seq1;GAXK01074344.1;Q8VD04;5.74E-52;GRAP1_MOUSE;GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)];"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]";"GO:0005654; GO:0005829; GO:0030054; GO:0030424; GO:0030425; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244";"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]";"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]";
comp1239219_c0_seq1;GAXK01162815.1;Q6PJP8;8.72E-18;DCR1A_HUMAN;DNA cross-link repair 1A protein (SNM1 homolog A) (hSNM1) (hSNM1A);"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"GO:0000784; GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0031848; GO:0035312; GO:0036297; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]";"5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]"
comp123958_c3_seq1;GAXK01074291.1;Q7L273;1.54E-116;KCTD9_HUMAN;BTB/POZ domain-containing protein KCTD9;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602";"intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]"
comp1239661_c0_seq1;GAXK01162826.1;Q27218;1.61E-30;ACH7_CAEEL;Acetylcholine receptor subunit beta-type lev-1 (Levamisole-resistant protein 1);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of locomotion [GO:0040012]; regulation of membrane potential [GO:0042391]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0040012; GO:0042391; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0046662; GO:0050877; GO:0098662";"chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of locomotion [GO:0040012]; regulation of membrane potential [GO:0042391]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1239826_c1_seq1;GAXK01162822.1;Q63ZI0;4.28E-10;KCNK9_XENLA;Potassium channel subfamily K member 9;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";potassium channel activity [GO:0005267]
comp124_c0_seq1;GAXK01170072.1;Q5ZLK1;0;DCA13_CHICK;DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1);"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]";"GO:0000462; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0032040; GO:0080008";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]";"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";
comp124010_c0_seq1;GAXK01118272.1;Q8R5K6;1.33E-45;TOB1_RAT;Protein Tob1 (Transducer of erbB-2 1);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; receptor tyrosine kinase binding [GO:0030971]; transcription corepressor activity [GO:0003714]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]";"GO:0003714; GO:0005634; GO:0005737; GO:0008285; GO:0010468; GO:0017148; GO:0030014; GO:0030971; GO:0060212; GO:0060213; GO:1900153";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"receptor tyrosine kinase binding [GO:0030971]; transcription corepressor activity [GO:0003714]"
comp124012_c2_seq1;GAXK01118256.1;B0WAE3;5.51E-106;GATA_CULQU;Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"GO:0004040; GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp12403_c3_seq1;GAXK01020218.1;Q6ZPJ3;1.48E-30;UBE2O_MOUSE;(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534";"positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp1240348_c0_seq1;GAXK01156533.1;Q54HW1;4.90E-12;PSD10_DICDI;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28);"cytoplasm [GO:0005737]; proteasome regulatory particle assembly [GO:0070682]";"GO:0005737; GO:0070682";proteasome regulatory particle assembly [GO:0070682];cytoplasm [GO:0005737];
comp124054_c0_seq1;GAXK01118193.1;Q16TM5;7.66E-133;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1240641_c0_seq1;GAXK01156567.1;O46040;9.21E-24;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp124084_c0_seq1;GAXK01118463.1;P27080;1.05E-117;ADT_CHLRE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp1240921_c0_seq1;GAXK01156540.1;Q1EHB3;6.90E-26;ATS7_RAT;A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004222; GO:0005576; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773";"cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis involved in cellular protein catabolic process [GO:0051603]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp1241087_c0_seq1;GAXK01156574.1;Q6KHP5;1.73E-07;GLGC_MYCMO;Glucose-1-phosphate adenylyltransferase (EC 2.7.7.27) (ADP-glucose pyrophosphorylase) (ADPGlc PPase) (ADP-glucose synthase);"ATP binding [GO:0005524]; glucose-1-phosphate adenylyltransferase activity [GO:0008878]; glycogen biosynthetic process [GO:0005978]";"GO:0005524; GO:0005978; GO:0008878";glycogen biosynthetic process [GO:0005978];;"ATP binding [GO:0005524]; glucose-1-phosphate adenylyltransferase activity [GO:0008878]"
comp1241350_c0_seq1;GAXK01156561.1;O08574;6.46E-09;MESP2_MOUSE;Mesoderm posterior protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; heart morphogenesis [GO:0003007]; mesoderm formation [GO:0001707]; mesodermal cell migration [GO:0008078]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";"GO:0000978; GO:0001228; GO:0001707; GO:0001756; GO:0003007; GO:0003677; GO:0003700; GO:0005634; GO:0007219; GO:0008078; GO:0023019; GO:0032525; GO:0045944; GO:0046983";"heart morphogenesis [GO:0003007]; mesodermal cell migration [GO:0008078]; mesoderm formation [GO:0001707]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp124140_c0_seq1;GAXK01118271.1;Q4UMH6;3.86E-09;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp1241418_c0_seq1;GAXK01156532.1;Q6B4Z5;1.96E-11;ZFY_PANTR;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1241443_c0_seq1;GAXK01156575.1;P27325;2.29E-40;H2A_URECA;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp124147_c2_seq1;GAXK01118245.1;Q5XHZ9;8.25E-128;PCH2_RAT;Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13);"chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint [GO:0051598]; mitotic spindle assembly checkpoint [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0001556; GO:0001673; GO:0005524; GO:0005694; GO:0006302; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0042802; GO:0048477; GO:0051598";"double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint [GO:0051598]; mitotic spindle assembly checkpoint [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]"
comp1241973_c0_seq1;GAXK01156571.1;Q9XYN1;1.00E-12;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp1242153_c0_seq1;GAXK01009651.1;P42519;1.52E-09;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp1242178_c0_seq1;GAXK01009640.1;Q8IZ52;4.02E-24;CHSS2_HUMAN;Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2);"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206]";"GO:0000139; GO:0005759; GO:0005829; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510";chondroitin sulfate biosynthetic process [GO:0030206];"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]";"glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]"
comp1242588_c0_seq1;GAXK01009621.1;Q27433;4.48E-10;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1242717_c0_seq1;GAXK01009622.1;Q9BLY8;3.83E-12;GBRB_DROSI;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor) (Protein cyclodiene resistance);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; ion transport [GO:0006811]";"GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0030054; GO:0030594; GO:0034707; GO:0045211";ion transport [GO:0006811];"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]"
comp124279_c1_seq1;GAXK01118241.1;Q9WVR8;1.46E-135;MEN1_RAT;Menin;"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein binding, bridging [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region DNA binding [GO:0044212]; Y-form DNA binding [GO:0000403]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; decidualization [GO:0046697]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]";"GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000785; GO:0000790; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005829; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0018024; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0035097; GO:0043433; GO:0044212; GO:0045668; GO:0045736; GO:0045786; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071375; GO:0071559; GO:1902807";"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; decidualization [GO:0046697]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]";"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein binding, bridging [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region DNA binding [GO:0044212]; Y-form DNA binding [GO:0000403]"
comp1243024_c0_seq1;GAXK01009645.1;Q7CS13;4.13E-46;DEACT_AGRFC;Deacetylase Atu3266 (EC 3.1.1.-);"deacetylase activity [GO:0019213]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872]";"GO:0016810; GO:0019213; GO:0046872";;;"deacetylase activity [GO:0019213]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872]"
comp124327_c0_seq1;GAXK01118255.1;B1WBS3;4.74E-16;ZBT42_RAT;Zinc finger and BTB domain-containing protein 42;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006974; GO:0007517; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp124328_c3_seq1;GAXK01117999.1;Q27504;1.84E-51;CAH3_CAEEL;Putative carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase 3);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0008270";;;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp124371_c2_seq1;GAXK01118401.1;P15620;7.70E-65;ZN271_MOUSE;Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";"GO:0000976; GO:0002437; GO:0002829; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872";"cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1243841_c0_seq1;GAXK01009634.1;Q96PE6;7.21E-07;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp124406_c1_seq1;GAXK01118491.1;B1WAR9;2.67E-65;GWL_XENTR;Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L);"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]";"GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721";"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]"
comp124419_c0_seq1;GAXK01118505.1;A0A1L8EXB5;3.55E-134;AR1AB_XENLA;Actin-related protein 2/3 complex subunit 1A-B;"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp12444_c1_seq1;GAXK01020948.1;Q9FKM5;6.88E-19;XRCC3_ARATH;DNA repair protein XRCC3 homolog (X-ray repair cross-complementing protein 3 homolog) (AtXRCC3);"Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; single-stranded DNA binding [GO:0003697]; double-strand break repair [GO:0006302]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; resolution of mitotic recombination intermediates [GO:0071140]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0003697; GO:0005524; GO:0005657; GO:0006302; GO:0008094; GO:0033065; GO:0045003; GO:0051321; GO:0071140; GO:0090656";"double-strand break repair [GO:0006302]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; resolution of mitotic recombination intermediates [GO:0071140]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]";"Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]";"ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; single-stranded DNA binding [GO:0003697]"
comp1244407_c0_seq1;GAXK01140955.1;Q8R4D5;2.85E-82;TRPM8_MOUSE;Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; protein homotrimerization [GO:0070207]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266]; thermoception [GO:0050955]";"GO:0005216; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0009266; GO:0009409; GO:0009897; GO:0016020; GO:0016021; GO:0016048; GO:0042803; GO:0045121; GO:0050955; GO:0051289; GO:0070207; GO:0120162";"calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; protein homotrimerization [GO:0070207]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266]; thermoception [GO:0050955]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]"
comp1244488_c0_seq1;GAXK01140937.1;Q94900;5.05E-13;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1244580_c0_seq1;GAXK01140971.1;Q20065;3.77E-31;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp1244626_c0_seq1;GAXK01140928.1;G5EBK1;8.14E-59;PBO4_CAEEL;Na(+)/H(+) exchanger protein 7 (Na(+)/H(+) antiporter nhx-7) (PBoc defective protein pbo-4);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; defecation [GO:0030421]; lipid transport involved in lipid storage [GO:0010877]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion transmembrane transport [GO:0071805]; regulation of cellular pH [GO:0030641]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005516; GO:0005886; GO:0010877; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0030421; GO:0030641; GO:0045989; GO:0051453; GO:0071805; GO:0098719; GO:1904731";"defecation [GO:0030421]; lipid transport involved in lipid storage [GO:0010877]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion transmembrane transport [GO:0071805]; regulation of cellular pH [GO:0030641]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp1244860_c0_seq1;GAXK01140944.1;Q9JME2;3.00E-16;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp12449_c1_seq1;GAXK01205090.1;P68036;3.03E-66;UB2L3_HUMAN;Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0003713; GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006464; GO:0006511; GO:0008283; GO:0016567; GO:0019899; GO:0031398; GO:0031625; GO:0044770; GO:0051443; GO:0061631; GO:0070979; GO:0071383; GO:0071385; GO:0097027; GO:1903955";"cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]"
comp1245388_c0_seq1;GAXK01140930.1;O97366;1.64E-30;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp124558_c0_seq1;GAXK01118079.1;P10959;2.09E-10;EST1C_RAT;Carboxylesterase 1C (EC 3.1.1.1) (Carboxyesterase ES-1) (E1) (ES-THET) (Esterase-2) (Liver carboxylesterase 1) (Neutral retinyl ester hydrolase) (NREH) (Retinyl ester hydrolase) (REH);"endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0016042; GO:0052689; GO:0080030";lipid catabolic process [GO:0016042];"endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]";"carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"
comp1245861_c0_seq1;GAXK01140959.1;O14792;4.79E-42;HS3S1_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0034483";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp124597_c2_seq1;GAXK01117988.1;O15504;3.53E-13;NUP42_HUMAN;Nucleoporin NUP42 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1) (Nucleoporin-42) (Nucleoporin-like protein 2);"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0003723; GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006611; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043657; GO:0046872; GO:0060964; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]"
comp1246_c1_seq1;GAXK01166122.1;Q6YS30;2.44E-154;RH5_ORYSJ;DEAD-box ATP-dependent RNA helicase 5 (EC 3.6.4.13);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1246149_c0_seq1;GAXK01004678.1;B9EJV3;3.56E-09;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp1246162_c0_seq1;GAXK01004660.1;P14834;1.65E-88;HSP70_LEIMA;Heat shock 70 kDa protein (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp12467_c0_seq1;GAXK01020693.1;Q60809;1.06E-141;CNOT7_MOUSE;CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"GO:0000122; GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0008134; GO:0008284; GO:0008285; GO:0010629; GO:0016604; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0061014; GO:0075341; GO:1900153";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]";"3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp124687_c0_seq1;GAXK01118433.1;A5PK00;5.34E-115;VPS36_BOVIN;Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36);"endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]";"GO:0000814; GO:0005634; GO:0005768; GO:0031902; GO:0032266; GO:0043130; GO:0043328";protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328];"endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]"
comp1246917_c0_seq1;GAXK01004676.1;Q9UJV9;2.24E-08;DDX41_HUMAN;Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of type I interferon production [GO:0032481]";"GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0030154; GO:0032481; GO:0046872; GO:0071013";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of type I interferon production [GO:0032481]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp124699_c0_seq1;GAXK01118254.1;Q3KQ62;1.05E-111;WDR83_XENLA;WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp1247117_c0_seq1;GAXK01004664.1;Q9NV72;8.16E-15;ZN701_HUMAN;Zinc finger protein 701;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp124719_c1_seq1;GAXK01118010.1;Q02386;1.97E-24;ZNF45_HUMAN;Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006367; GO:0007275; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp124765_c0_seq1;GAXK01118478.1;O01814;6.75E-20;FABP5_CAEEL;Fatty acid-binding protein homolog 5;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504]";"GO:0005504; GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";fatty acid binding [GO:0005504]
comp1247716_c0_seq1;GAXK01004666.1;Q7M758;3.38E-51;NALDL_MOUSE;Aminopeptidase NAALADL1 (EC 3.4.11.-) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004180; GO:0005509; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171";peptide catabolic process [GO:0043171];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp1247786_c0_seq1;GAXK01004674.1;Q8R4H4;3.21E-56;CBPA5_MOUSE;Carboxypeptidase A5 (EC 3.4.17.-);"extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0005615; GO:0006508; GO:0008233; GO:0008270";proteolysis [GO:0006508];extracellular space [GO:0005615];"metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp12478_c0_seq1;GAXK01020743.1;O15155;2.79E-15;BET1_HUMAN;BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle fusion with Golgi apparatus [GO:0048280]";"GO:0000138; GO:0000139; GO:0005484; GO:0005789; GO:0006888; GO:0015031; GO:0016020; GO:0030133; GO:0030173; GO:0031201; GO:0033116; GO:0048208; GO:0048280";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle fusion with Golgi apparatus [GO:0048280]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]";SNAP receptor activity [GO:0005484]
comp124785_c0_seq1;GAXK01118326.1;A7X409;5.16E-07;LECM2_PHIOL;C-type lectin lectoxin-Phi2 (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp1248_c1_seq1;GAXK01169735.1;Q9CWX9;0;DDX47_MOUSE;Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47);"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625";"extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1248082_c0_seq1;GAXK01009483.1;Q8VIG1;2.84E-11;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1248236_c0_seq1;GAXK01009471.1;Q52L45;4.95E-41;ILEU_XENLA;Leukocyte elastase inhibitor (Serpin B1);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005615; GO:0005737";;"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp1248247_c0_seq1;GAXK01009478.1;Q3UVX5;0;GRM5_MOUSE;Metabotropic glutamate receptor 5 (mGluR5);"astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; A2A adenosine receptor binding [GO:0031687]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; protein tyrosine kinase binding [GO:1990782]; activation of MAPKKK activity [GO:0000185]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]";"GO:0000185; GO:0001639; GO:0001932; GO:0002029; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006448; GO:0006468; GO:0007205; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0014069; GO:0016020; GO:0031687; GO:0035584; GO:0040013; GO:0043005; GO:0043197; GO:0043198; GO:0048169; GO:0048170; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0090647; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782";"activation of MAPKKK activity [GO:0000185]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]";"astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]";"A2A adenosine receptor binding [GO:0031687]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; protein tyrosine kinase binding [GO:1990782]"
comp124827_c1_seq1;GAXK01118342.1;Q8BV66;5.86E-14;IFI44_MOUSE;Interferon-induced protein 44 (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp124854_c0_seq1;GAXK01204961.1;P46436;1.76E-30;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp124879_c0_seq1;GAXK01118372.1;O43345;3.91E-21;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp124880_c0_seq1;GAXK01118492.1;Q839G8;4.71E-34;EFTU_ENTFA;Elongation factor Tu (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp124894_c0_seq1;GAXK01117987.1;Q9GZT4;1.94E-78;SRR_HUMAN;Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]";"GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006563; GO:0006564; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0051289; GO:0070178; GO:0070179";"aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]"
comp124941_c2_seq1;GAXK01118086.1;Q9VX32;0;RG190_DROME;Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa);"cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770";"defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]"
comp124956_c1_seq1;GAXK01118022.1;Q5PQ53;4.70E-47;PEF1_XENLA;Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1);"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]";"GO:0000139; GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0048208; GO:0060090; GO:1902527";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]";"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]";"calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]"
comp1249795_c0_seq1;GAXK01009473.1;Q05481;3.55E-31;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp124988_c0_seq1;GAXK01118469.1;Q7ZYC4;1.48E-165;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp125_c0_seq1;GAXK01166145.1;Q95KV7;7.05E-15;NDUAD_BOVIN;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]";"GO:0005654; GO:0005737; GO:0005739; GO:0005746; GO:0005747; GO:0008137; GO:0016021; GO:0030308; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243";"apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp125017_c4_seq1;GAXK01118308.1;P66900;6.00E-101;DPAL_ECOL6;Diaminopropionate ammonia-lyase (DAPAL) (EC 4.3.1.15) (2,3-diaminopropionate ammonia-lyase) (Alpha,beta-diaminopropionate ammonia-lyase);"diaminopropionate ammonia-lyase activity [GO:0008838]; pyridoxal phosphate binding [GO:0030170]";"GO:0008838; GO:0030170";;;"diaminopropionate ammonia-lyase activity [GO:0008838]; pyridoxal phosphate binding [GO:0030170]"
comp1250245_c0_seq1;GAXK01172703.1;P40797;1.91E-72;PNUT_DROME;Protein peanut;"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"GO:0000281; GO:0003779; GO:0003924; GO:0005525; GO:0005739; GO:0005886; GO:0005940; GO:0006915; GO:0007349; GO:0008017; GO:0015630; GO:0016324; GO:0031105; GO:0031625; GO:0032154; GO:0042803; GO:0043065; GO:0045171; GO:0045572; GO:0060271; GO:0061640; GO:0070938";"apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp12504_c1_seq1;GAXK01020847.1;Q6DHU1;1.03E-168;CLP1L_DANRE;Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein);"integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]";"GO:0006915; GO:0016021";apoptotic process [GO:0006915];integral component of membrane [GO:0016021];
comp1250581_c0_seq1;GAXK01172715.1;Q9GZM7;8.99E-48;TINAL_HUMAN;Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cysteine-type peptidase activity [GO:0008234]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; endosomal transport [GO:0016197]; immune response [GO:0006955]";"GO:0005044; GO:0005201; GO:0005576; GO:0005615; GO:0005737; GO:0006955; GO:0007155; GO:0008234; GO:0016197; GO:0030247; GO:0043236; GO:0062023; GO:0070062";"cell adhesion [GO:0007155]; endosomal transport [GO:0016197]; immune response [GO:0006955]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"cysteine-type peptidase activity [GO:0008234]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp125073_c4_seq1;GAXK01118210.1;P10076;3.17E-51;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1250951_c0_seq1;GAXK01172723.1;Q90481;2.46E-36;NX22A_DANRE;Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000978; GO:0003700; GO:0005634; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0043565; GO:0045944";"cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1251_c0_seq1;GAXK01169033.1;Q6DKE1;2.16E-52;CYC2_XENLA;Cytochrome c, testis-specific;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp1251171_c0_seq1;GAXK01172731.1;A4IH61;9.62E-08;NMNA2_XENTR;Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 (NMN/NaMN adenylyltransferase 2) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 2) (NMN adenylyltransferase 2) (Nicotinate-nucleotide adenylyltransferase 2) (NaMN adenylyltransferase 2);"Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]";"GO:0000309; GO:0004515; GO:0005524; GO:0005794; GO:0009435";NAD biosynthetic process [GO:0009435];Golgi apparatus [GO:0005794];"ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]"
comp125131_c0_seq1;GAXK01118335.1;Q90629;1.58E-28;TRY3_CHICK;Trypsin II-P29 (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872";"digestion [GO:0007586]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp125134_c0_seq1;GAXK01118371.1;Q29NG1;9.50E-08;GLYR1_DROPS;Putative oxidoreductase GLYR1 homolog (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60 homolog);"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0050661; GO:0051287";;;"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]"
comp125136_c0_seq1;GAXK01118015.1;Q5T2R2;1.96E-101;DPS1_HUMAN;Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1);"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234";"isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]"
comp125148_c1_seq1;GAXK01118498.1;Q91YL3;0;UCKL1_MOUSE;Uridine-cytidine kinase-like 1 (EC 2.7.1.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206";"nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp125165_c0_seq1;GAXK01118161.1;O64425;8.99E-10;RMA1_ARATH;E3 ubiquitin-protein ligase RMA1 (EC 2.3.2.27) (Protein RING membrane-anchor 1) (RING-type E3 ubiquitin transferase RMA1);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0032527; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp1251764_c0_seq1;GAXK01172732.1;P20693;2.21E-14;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp125192_c2_seq1;GAXK01118368.1;P05661;1.65E-74;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp12520_c2_seq1;GAXK01020728.1;Q9VUV9;0;U520_DROME;Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]";"GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003676; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005681; GO:0005682; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0046540; GO:0071011; GO:0071013; GO:0071014";"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";"ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp125255_c0_seq1;GAXK01118442.1;C0IN03;1.44E-48;HENMT_XENTR;Small RNA 2'-O-methyltransferase (EC 2.1.1.n8) (HEN1 methyltransferase homolog 1) (piRNA methyltransferase 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]";"GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872";"piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]";"metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]"
comp1252660_c0_seq1;GAXK01193391.1;Q7X809;1.87E-10;PAO3_ORYSJ;Polyamine oxidase 3 (OsPAO3) (EC 1.5.3.-);"peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602]";"GO:0005777; GO:0006598; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0050660; GO:0052894; GO:0052901; GO:0052903; GO:1903602";"polyamine catabolic process [GO:0006598]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602]";peroxisome [GO:0005777];"flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp125299_c0_seq1;GAXK01118494.1;Q58D65;4.65E-90;TYW2_BOVIN;tRNA wybutosine-synthesizing protein 2 homolog (tRNA-yW-synthesizing protein 2) (EC 2.5.1.114) (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase);"cytoplasm [GO:0005737]; tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]";"GO:0005737; GO:0008175; GO:0030488; GO:0031591; GO:0102522";"tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]";cytoplasm [GO:0005737];"tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]"
comp1253119_c0_seq1;GAXK01193386.1;Q8AVC3;7.89E-98;G6PT3_XENLA;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp125326_c2_seq1;GAXK01118192.1;P00765;1.60E-26;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1253580_c0_seq1;GAXK01193382.1;Q9LE22;5.29E-11;CML27_ARATH;Probable calcium-binding protein CML27 (Calmodulin-like protein 27);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005634; GO:0005773; GO:0005829; GO:0005886";;"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";calcium ion binding [GO:0005509]
comp125360_c0_seq1;GAXK01118456.1;Q599T9;4.37E-17;MYD88_BOVIN;Myeloid differentiation primary response protein MyD88;"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TIR domain binding [GO:0070976]; Toll-like receptor binding [GO:0035325]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to Gram-positive bacterium [GO:0050830]; establishment of endothelial intestinal barrier [GO:0090557]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; phagocytosis [GO:0006909]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of neutrophil migration [GO:1902622]; response to molecule of fungal origin [GO:0002238]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615]; Toll signaling pathway [GO:0008063]; type I interferon biosynthetic process [GO:0045351]";"GO:0002238; GO:0002755; GO:0005634; GO:0005829; GO:0005886; GO:0006909; GO:0006954; GO:0008063; GO:0009615; GO:0009682; GO:0010628; GO:0016064; GO:0031663; GO:0032494; GO:0032740; GO:0032747; GO:0032755; GO:0032760; GO:0035325; GO:0043123; GO:0045080; GO:0045087; GO:0045351; GO:0046330; GO:0050671; GO:0050830; GO:0051092; GO:0070976; GO:0090557; GO:0140052; GO:1900017; GO:1902622; GO:2000338; GO:2000341";"cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to Gram-positive bacterium [GO:0050830]; establishment of endothelial intestinal barrier [GO:0090557]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; phagocytosis [GO:0006909]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of neutrophil migration [GO:1902622]; response to molecule of fungal origin [GO:0002238]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615]; Toll signaling pathway [GO:0008063]; type I interferon biosynthetic process [GO:0045351]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"TIR domain binding [GO:0070976]; Toll-like receptor binding [GO:0035325]"
comp1253645_c0_seq1;GAXK01193396.1;P42787;9.12E-10;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp125375_c0_seq1;GAXK01118166.1;Q9BYN7;1.72E-07;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1253764_c0_seq1;GAXK01193384.1;B0FYY4;5.86E-32;ITB1_SHEEP;Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29);"cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710]";"GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0010710; GO:0016020; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0038023; GO:0042470; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0071438; GO:1903078";"cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710]";"cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]"
comp12539_c0_seq1;GAXK01020181.1;P15278;3.58E-16;FAS3_DROME;Fasciclin-3 (Fasciclin III) (FAS III);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ovarian follicle cell development [GO:0030707]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]";"GO:0005737; GO:0005829; GO:0005886; GO:0005918; GO:0005920; GO:0007156; GO:0007411; GO:0007413; GO:0008039; GO:0016021; GO:0016200; GO:0016323; GO:0016328; GO:0030707; GO:0031594; GO:0031965; GO:0055037";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ovarian follicle cell development [GO:0030707]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]";
comp125391_c0_seq1;GAXK01118077.1;O12947;1.33E-69;ICMT_XENLA;Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Farnesyl cysteine carboxyl methyltransferase) (FCMT) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]";"GO:0004671; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]
comp1253959_c0_seq1;GAXK01193404.1;Q8VHL1;7.04E-32;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1254182_c0_seq1;GAXK01048041.1;Q5R1P3;2.56E-135;NMDE2_CANLF;Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"GO:0004972; GO:0005886; GO:0005887; GO:0008270; GO:0014069; GO:0016595; GO:0017146; GO:0022849; GO:0030054; GO:0051290; GO:0060079; GO:0060291; GO:0097553; GO:0098839";"calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]";"glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]"
comp1254512_c0_seq1;GAXK01048016.1;P08962;1.19E-14;CD63_HUMAN;CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63);"azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0002576; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0015031; GO:0016477; GO:0031088; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0034613; GO:0035577; GO:0035646; GO:0042470; GO:0043312; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]";
comp1254551_c0_seq1;GAXK01048009.1;Q25158;6.96E-63;OPSC2_HEMSA;Compound eye opsin BCRH2;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp1254779_c0_seq1;GAXK01048044.1;D3ZEN0;2.26E-32;MILK2_RAT;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp1254892_c0_seq1;GAXK01048038.1;O35136;2.37E-16;NCAM2_MOUSE;Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);"anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]";"GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802";"axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]";identical protein binding [GO:0042802]
comp125490_c0_seq1;GAXK01118373.1;A1ZA47;1.25E-18;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp125509_c1_seq1;GAXK01118496.1;D7A0Y2;1.12E-132;C3HPD_STAND;Cis-3-hydroxy-L-proline dehydratase (c3LHyp dehydratase) (c3LHypD) (EC 4.2.1.171);"hydro-lyase activity [GO:0016836]; metal ion binding [GO:0046872]; alpha-amino acid metabolic process [GO:1901605]";"GO:0016836; GO:0046872; GO:1901605";alpha-amino acid metabolic process [GO:1901605];;"hydro-lyase activity [GO:0016836]; metal ion binding [GO:0046872]"
comp12554_c0_seq1;GAXK01020082.1;Q641G7;3.10E-96;ARPC4_XENLA;Actin-related protein 2/3 complex subunit 4;"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995";"actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp1255426_c0_seq1;GAXK01048017.1;P31390;8.05E-51;HRH1_RAT;Histamine H1 receptor (H1R) (HH1R);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine binding [GO:0051381]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of steroid biosynthetic process [GO:0010894]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vasoconstriction [GO:0045907]; regulation of vascular permeability [GO:0043114]; response to gravity [GO:0009629]";"GO:0004930; GO:0004969; GO:0004993; GO:0005887; GO:0007186; GO:0007187; GO:0007199; GO:0007268; GO:0009629; GO:0010894; GO:0030425; GO:0030594; GO:0043114; GO:0045429; GO:0045907; GO:0048245; GO:0051381; GO:0071420";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; negative regulation of steroid biosynthetic process [GO:0010894]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vasoconstriction [GO:0045907]; regulation of vascular permeability [GO:0043114]; response to gravity [GO:0009629]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine binding [GO:0051381]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
comp1255462_c0_seq1;GAXK01048015.1;Q9BYN7;2.63E-117;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp125547_c0_seq1;GAXK01118472.1;Q9D119;2.82E-30;PPR27_MOUSE;Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1);"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]";"GO:0004864; GO:0010923; GO:0019902";negative regulation of phosphatase activity [GO:0010923];;"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]"
comp125548_c3_seq1;GAXK01118250.1;E1BNG3;0;ASCC3_BOVIN;Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12);"activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]";"GO:0003676; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053";"cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]";"activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]"
comp125568_c0_seq1;GAXK01118011.1;S4X0Q8;2.94E-75;AGRA3_DANRE;Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; convergent extension involved in gastrulation [GO:0060027]; motor neuron migration [GO:0097475]; planar cell polarity pathway involved in axis elongation [GO:0003402]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]";"GO:0003402; GO:0004930; GO:0005886; GO:0016021; GO:0060027; GO:0097475; GO:2000095";"convergent extension involved in gastrulation [GO:0060027]; motor neuron migration [GO:0097475]; planar cell polarity pathway involved in axis elongation [GO:0003402]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp125569_c0_seq1;GAXK01118495.1;O13991;3.27E-08;YEG9_SCHPO;Uncharacterized oxidoreductase C26H5.09c (EC 1.-.-.-);"nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]";"GO:0005634; GO:0006740; GO:0016491";NADPH regeneration [GO:0006740];nucleus [GO:0005634];oxidoreductase activity [GO:0016491]
comp12557_c0_seq1;GAXK01020021.1;Q6PG31;7.29E-33;RNPS1_DANRE;RNA-binding protein with serine-rich domain 1;"ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0008380; GO:0016607; GO:0061574";"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";RNA binding [GO:0003723]
comp1255768_c0_seq1;GAXK01048014.1;Q12797;3.87E-40;ASPH_HUMAN;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]"
comp125584_c2_seq1;GAXK01118329.1;P00520;0;ABL1_MOUSE;Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150);"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; B cell proliferation [GO:0042100]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; integrin-mediated signaling pathway [GO:0007229]; microspike assembly [GO:0030035]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of extracellular matrix organization [GO:1903053]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]";"GO:0000287; GO:0000400; GO:0000405; GO:0001726; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006468; GO:0006897; GO:0006909; GO:0006914; GO:0006915; GO:0006974; GO:0006975; GO:0006979; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0009791; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019901; GO:0019904; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030145; GO:0030154; GO:0030182; GO:0030425; GO:0030426; GO:0030514; GO:0030516; GO:0031113; GO:0031252; GO:0032489; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0035791; GO:0038083; GO:0038189; GO:0038191; GO:0042100; GO:0042127; GO:0042169; GO:0042770; GO:0043005; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043542; GO:0045184; GO:0045202; GO:0045580; GO:0045930; GO:0045931; GO:0046632; GO:0046777; GO:0046875; GO:0048008; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051726; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070097; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071901; GO:0072358; GO:0090050; GO:0090135; GO:1900026; GO:1900042; GO:1900272; GO:1900275; GO:1901216; GO:1902715; GO:1903053; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000251; GO:2000352; GO:2000772; GO:2000773; GO:2001020";"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; B-1 B cell homeostasis [GO:0001922]; B cell proliferation [GO:0042100]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; integrin-mediated signaling pathway [GO:0007229]; microspike assembly [GO:0030035]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of extracellular matrix organization [GO:1903053]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]";"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]"
comp125588_c4_seq1;GAXK01118289.1;Q9Y4G2;2.64E-32;PKHM1_HUMAN;Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162);"endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031]";"GO:0005730; GO:0005765; GO:0006914; GO:0010008; GO:0015031; GO:0032418; GO:0035556; GO:0043231; GO:0045780; GO:0046872; GO:1900029";"autophagy [GO:0006914]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031]";"endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]";metal ion binding [GO:0046872]
comp125615_c0_seq1;GAXK01118399.1;P09480;2.50E-62;ACHA2_CHICK;Neuronal acetylcholine receptor subunit alpha-2;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp12563_c0_seq1;GAXK01020308.1;D7UQM5;1.87E-72;AURK_PATPE;Aurora kinase (EC 2.7.11.1) (ApAurora);"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]";"GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0007275; GO:0030496; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]";"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp125646_c2_seq1;GAXK01118063.1;Q9H7F0;3.20E-105;AT133_HUMAN;Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1);"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"GO:0005524; GO:0005623; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872";"cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp125664_c0_seq1;GAXK01118276.1;P18583;1.31E-20;SON_HUMAN;Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726";"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]"
comp125680_c0_seq1;GAXK01118325.1;Q00059;2.68E-10;TFAM_HUMAN;Transcription factor A, mitochondrial (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from mitochondrial promoter [GO:0006391]";"GO:0001018; GO:0001223; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006390; GO:0006391; GO:0007005; GO:0008301; GO:0031072; GO:0032991; GO:0033108; GO:0042645; GO:0043565; GO:0045893";"mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from mitochondrial promoter [GO:0006391]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]"
comp125700_c1_seq1;GAXK01118316.1;O13097;5.77E-16;EFNB1_XENLA;Ephrin-B1 (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) (XlERK);"integral component of membrane [GO:0016021]; ephrin receptor binding [GO:0046875]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0046875; GO:0048013";"cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];ephrin receptor binding [GO:0046875]
comp12571_c0_seq1;GAXK01020180.1;Q9NUJ3;2.15E-82;T11L1_HUMAN;T-complex protein 11-like protein 1;microtubule [GO:0005874];GO:0005874;;microtubule [GO:0005874];
comp1257153_c0_seq1;GAXK01041321.1;P35789;2.54E-29;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp1257272_c0_seq1;GAXK01041328.1;Q00PJ1;6.11E-09;CTTB2_ATEAB;Cortactin-binding protein 2 (CortBP2);"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";"GO:0005938; GO:0043197";;"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";
comp125737_c0_seq1;GAXK01118493.1;D8VNS6;1.10E-07;LECM_CERRY;C-type lectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]";"GO:0005576; GO:0030246; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1257421_c0_seq1;GAXK01041323.1;Q13002;9.98E-22;GRIK2_HUMAN;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6);"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp125784_c0_seq1;GAXK01118014.1;Q5ZLN1;2.58E-128;PGAM1_CHICK;Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1);"cell [GO:0005623]; cytosol [GO:0005829]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004082; GO:0004619; GO:0005623; GO:0005829; GO:0006094; GO:0006096; GO:0016787";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cell [GO:0005623]; cytosol [GO:0005829]";"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]"
comp125796_c0_seq1;GAXK01118431.1;Q505D1;0;ANR28_MOUSE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp1258099_c0_seq1;GAXK01154309.1;Q8CJ78;8.12E-10;ZN628_MOUSE;Zinc finger protein 628 (Zinc finger protein expressed in embryonal cells and certain adult organs);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp125814_c0_seq1;GAXK01118278.1;P18722;6.39E-07;ZG46_XENLA;Gastrula zinc finger protein XlCGF46.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1258251_c0_seq1;GAXK01154326.1;Q9NXS3;1.71E-09;KLH28_HUMAN;Kelch-like protein 28 (BTB/POZ domain-containing protein 5);;;;;
comp1258448_c0_seq1;GAXK01154316.1;Q67EQ0;2.92E-12;CLC4A_RAT;C-type lectin domain family 4 member A (C-type lectin superfamily member 6) (Dendritic cell inhibitory receptor) (CD antigen CD367);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]";"GO:0001818; GO:0002250; GO:0002470; GO:0005509; GO:0005537; GO:0005886; GO:0016021; GO:0030246; GO:0032720; GO:0036037; GO:0042590; GO:0045087";"adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]"
comp125846_c3_seq1;GAXK01118178.1;Q9NVM9;2.26E-47;INT13_HUMAN;Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795]";"GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0030317; GO:0042795; GO:0051301; GO:0051642; GO:0080154; GO:0090435";"cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1258559_c0_seq1;GAXK01154306.1;P41731;2.67E-23;CD63_MOUSE;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0034613; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigmentation [GO:0043473]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";protein-containing complex binding [GO:0044877]
comp125859_c0_seq1;GAXK01118506.1;Q8NB50;3.15E-26;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp125886_c0_seq1;GAXK01118187.1;Q9NFT7;2.15E-103;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp125906_c1_seq1;GAXK01118309.1;P00918;5.08E-70;CAH2_HUMAN;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0015701; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070062; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp125908_c0_seq1;GAXK01118269.1;C3XVM1;1.41E-29;GATC_BRAFL;Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]";"GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp1259203_c0_seq1;GAXK01154314.1;O88818;4.03E-28;PLST_CRIGR;Plastin-3 (T-plastin);"cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]";"GO:0005509; GO:0005737; GO:0051015; GO:0051017";actin filament bundle assembly [GO:0051017];cytoplasm [GO:0005737];"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp1259220_c0_seq1;GAXK01154303.1;Q06389;5.46E-18;NCS1_YEAST;Calcium-binding protein NCS-1;"cellular bud membrane [GO:0033101]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; enzyme activator activity [GO:0008047]; positive regulation of 1-phosphatidylinositol 4-kinase activity [GO:0043128]; regulation of signal transduction [GO:0009966]";"GO:0000139; GO:0005509; GO:0005829; GO:0008047; GO:0009966; GO:0033101; GO:0043128";"positive regulation of 1-phosphatidylinositol 4-kinase activity [GO:0043128]; regulation of signal transduction [GO:0009966]";"cellular bud membrane [GO:0033101]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]";"calcium ion binding [GO:0005509]; enzyme activator activity [GO:0008047]"
comp125927_c0_seq1;GAXK01118400.1;Q9R087;3.43E-151;GPC6_MOUSE;Glypican-6 [Cleaved into: Secreted glypican-6];"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]";"GO:0005576; GO:0005615; GO:0005796; GO:0005887; GO:0009966; GO:0009986; GO:0016477; GO:0045202; GO:0046658; GO:0062023; GO:0098696; GO:0098978; GO:1905475";"cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]";"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";
comp1259859_c0_seq1;GAXK01154304.1;P14533;1.93E-20;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp125986_c1_seq1;GAXK01118147.1;P00920;3.04E-30;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp125994_c1_seq1;GAXK01118504.1;P16554;5.72E-101;NUMB_DROME;Protein numb;"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007400; GO:0007405; GO:0007406; GO:0007417; GO:0007507; GO:0007622; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045165; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692";"asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; Notch binding [GO:0005112]"
comp1260_c1_seq1;GAXK01168241.1;Q9GYZ9;4.44E-26;HEMTM_THETS;Myohemerythrin (MHr);"cytoplasm [GO:0005737]; iron ion binding [GO:0005506]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005506; GO:0005737";;cytoplasm [GO:0005737];"iron ion binding [GO:0005506]; oxygen carrier activity [GO:0005344]"
comp12600_c2_seq1;GAXK01020954.1;Q91WG0;5.40E-55;EST2C_MOUSE;Acylcarnitine hydrolase (ACH M1) (EC 3.1.1.28) (Carboxylesterase 2) (CES 2) (Peroxisome proliferator-inducible acylcarnitine hydrolase);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]";"GO:0005615; GO:0005783; GO:0043231; GO:0047619; GO:0052689";;"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]";"acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]"
comp126028_c0_seq1;GAXK01058991.1;G5E8P0;2.83E-50;GCP6_MOUSE;Gamma-tubulin complex component 6 (GCP-6);"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]";"GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415";"cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]";"gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]"
comp126033_c5_seq1;GAXK01058925.1;B3A0N5;3.93E-124;APY_TABYA;Apyrase (EC 3.6.1.5) (ATP-diphosphatase) (ADPase) (ATP-diphosphohydrolase) (Adenosine diphosphatase) (allergen Tab y 1);"extracellular region [GO:0005576]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; nucleotide catabolic process [GO:0009166]";"GO:0005524; GO:0005576; GO:0009166; GO:0016788; GO:0046872; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491";nucleotide catabolic process [GO:0009166];extracellular region [GO:0005576];"8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]"
comp1260414_c0_seq1;GAXK01149897.1;P07949;3.20E-31;RET_HUMAN;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007399; GO:0007411; GO:0007497; GO:0010008; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1260550_c0_seq1;GAXK01149910.1;Q9H902;1.02E-22;REEP1_HUMAN;Receptor expression-enhancing protein 1 (Spastic paraplegia 31 protein);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; microtubule binding [GO:0008017]; olfactory receptor binding [GO:0031849]; endoplasmic reticulum tubular network organization [GO:0071786]; protein insertion into membrane [GO:0051205]; regulation of intracellular transport [GO:0032386]";"GO:0005737; GO:0005783; GO:0005789; GO:0008017; GO:0016020; GO:0016021; GO:0031849; GO:0031966; GO:0032386; GO:0051205; GO:0071782; GO:0071786";"endoplasmic reticulum tubular network organization [GO:0071786]; protein insertion into membrane [GO:0051205]; regulation of intracellular transport [GO:0032386]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]";"microtubule binding [GO:0008017]; olfactory receptor binding [GO:0031849]"
comp126056_c0_seq1;GAXK01058798.1;Q9GTD4;3.14E-14;NHR71_CAEEL;Nuclear hormone receptor family member nhr-71;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp126065_c4_seq1;GAXK01058923.1;D3ZAT9;3.26E-41;FAXC_RAT;Failed axon connections homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1260689_c0_seq1;GAXK01149907.1;Q14679;4.44E-12;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp12607_c0_seq1;GAXK01020889.1;Q9VSS2;2.06E-148;SRP68_DROME;Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein);"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; signal recognition particle binding [GO:0005047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005047; GO:0005786; GO:0006614; GO:0008312; GO:0030942";SRP-dependent cotranslational protein targeting to membrane [GO:0006614];signal recognition particle, endoplasmic reticulum targeting [GO:0005786];"7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; signal recognition particle binding [GO:0005047]"
comp126071_c4_seq1;GAXK01058916.1;P35220;0;CTNA_DROME;Catenin alpha;"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323";"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp126072_c0_seq1;GAXK01058807.1;Q5I0E6;1.19E-26;RPAP2_RAT;RNA polymerase II subunit B1 CTD phosphatase Rpap2 (EC 3.1.3.16) (Putative RNA polymerase II-associated protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]";"GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008420; GO:0009301; GO:0016591; GO:0043175; GO:0046872; GO:0070940";"dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]";"metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]"
comp126074_c1_seq1;GAXK01058809.1;Q5U2P0;0;DI3L1_RAT;DIS3-like exonuclease 1 (EC 3.1.13.-);"centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; plasma membrane [GO:0005886]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; rRNA catabolic process [GO:0016075]";"GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005813; GO:0005829; GO:0005886; GO:0016075; GO:0019899";rRNA catabolic process [GO:0016075];"centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; plasma membrane [GO:0005886]";"3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]"
comp1260846_c0_seq1;GAXK01149915.1;O46040;1.14E-14;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp126098_c0_seq1;GAXK01058929.1;Q9VKM6;3.06E-59;VPS72_DROME;Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1);"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0010629; GO:0016573; GO:0035267; GO:0043486";"histone acetylation [GO:0016573]; histone exchange [GO:0043486]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]";"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp1261_c0_seq1;GAXK01169014.1;P82995;0;HS90A_RAT;Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; GTP binding [GO:0005525]; ion channel binding [GO:0044325]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein phosphatase binding [GO:0019903]; Rho GDP-dissociation inhibitor binding [GO:0051022]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; skeletal muscle contraction [GO:0003009]";"GO:0001764; GO:0002134; GO:0002135; GO:0003009; GO:0003729; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006457; GO:0009408; GO:0009409; GO:0009651; GO:0009986; GO:0010592; GO:0010659; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019903; GO:0030235; GO:0030911; GO:0031526; GO:0032564; GO:0032991; GO:0034605; GO:0036126; GO:0042220; GO:0042470; GO:0042493; GO:0043005; GO:0043025; GO:0043209; GO:0043627; GO:0044325; GO:0045429; GO:0045793; GO:0046677; GO:0048156; GO:0048471; GO:0050821; GO:0051022; GO:0051082; GO:0060452; GO:0061635; GO:0061684; GO:0061741; GO:0062023; GO:0097226; GO:0097524; GO:0097718";"cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; skeletal muscle contraction [GO:0003009]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; GTP binding [GO:0005525]; ion channel binding [GO:0044325]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein phosphatase binding [GO:0019903]; Rho GDP-dissociation inhibitor binding [GO:0051022]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]"
comp126103_c3_seq1;GAXK01058828.1;Q5BP74;3.45E-172;KC1D_XENLA;Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016055";Wnt signaling pathway [GO:0016055];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp126118_c3_seq1;GAXK01058904.1;P61592;2.44E-11;MCPH1_HYLLA;Microcephalin;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; cerebral cortex development [GO:0021987]";"GO:0005737; GO:0005815; GO:0021987";cerebral cortex development [GO:0021987];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]";
comp1261246_c0_seq1;GAXK01149893.1;Q14973;1.41E-23;NTCP_HUMAN;Sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618]; bile acid and bile salt transport [GO:0015721]";"GO:0001618; GO:0005886; GO:0005887; GO:0008508; GO:0015721; GO:0016323";bile acid and bile salt transport [GO:0015721];"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618]"
comp126137_c1_seq1;GAXK01059123.1;Q6DHN0;8.93E-20;TMM53_DANRE;Transmembrane protein 53;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1261754_c0_seq1;GAXK01149867.1;Q9W0T5;5.93E-10;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp126177_c0_seq1;GAXK01058894.1;Q9VZS6;1.74E-25;NSMA_DROME;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp126190_c0_seq1;GAXK01058783.1;Q6NZQ8;9.51E-77;MARH1_MOUSE;E3 ubiquitin-protein ligase MARCH1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING-type E3 ubiquitin transferase MARCH1);"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0002495; GO:0004842; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0005886; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0061630";"antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]";"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]";"MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1261914_c0_seq1;GAXK01149918.1;Q7TNC8;8.22E-26;GLRA2_MOUSE;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1262006_c0_seq1;GAXK01069084.1;Q8W257;5.80E-12;PFI_PTIFI;Polyenoic fatty acid isomerase (PFI) (EC 5.3.3.13);"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]";"GO:0016491; GO:0034016";;;"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]"
comp126227_c3_seq1;GAXK01059048.1;Q27433;1.35E-14;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1262281_c0_seq1;GAXK01069097.1;Q6P560;3.03E-07;ZN182_MOUSE;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1262339_c0_seq1;GAXK01069082.1;Q8VIG1;8.93E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp126250_c1_seq1;GAXK01059077.1;Q7KRI2;3.85E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp126285_c0_seq1;GAXK01058835.1;Q9CQA9;9.45E-39;NTPCR_MOUSE;Cancer-related nucleoside-triphosphatase homolog (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase);"ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]";"GO:0005524; GO:0017111; GO:0098519";;;"ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]"
comp1262944_c1_seq1;GAXK01069095.1;Q9CQ46;4.66E-51;DRC8_MOUSE;Dynein regulatory complex protein 8 (EF-hand calcium-binding domain-containing protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005737; GO:0005856; GO:0031514";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp1262990_c0_seq1;GAXK01069092.1;A2A9G7;1.97E-08;SHL2A_MOUSE;Protein shisa-like-2A;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1263273_c0_seq1;GAXK01069089.1;Q6ZSB9;3.29E-15;ZBT49_HUMAN;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp126333_c0_seq1;GAXK01058919.1;Q9CQI9;6.86E-39;MED30_MOUSE;Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25);"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000151; GO:0003712; GO:0005634; GO:0005654; GO:0006367; GO:0016567; GO:0016592; GO:0019827; GO:0045893; GO:0046966; GO:0061630";"positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]"
comp1263706_c0_seq1;GAXK01069091.1;Q9FPH3;1.47E-93;THA2_ARATH;Probable low-specificity L-threonine aldolase 2 (EC 4.1.2.48) (Threonine aldolase 2);"cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]";"GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732";"glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]";cytosol [GO:0005829];"L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]"
comp1264_c0_seq1;GAXK01169725.1;Q9V3J1;0;VATH_DROME;V-type proton ATPase subunit H (V-ATPase subunit H) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD);"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]";"GO:0000221; GO:0008340; GO:0033181; GO:0033227; GO:0046961; GO:1902600";"determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]";"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp12642_c1_seq1;GAXK01020327.1;P16100;0;IDH_AZOVI;Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (Oxalosuccinate decarboxylase);"cytoplasm [GO:0005737]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004450; GO:0005737; GO:0006097; GO:0006099; GO:0046872";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";cytoplasm [GO:0005737];"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]"
comp1264200_c0_seq1;GAXK01131395.1;Q91W90;6.56E-91;TXND5_MOUSE;Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46);"endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]";"GO:0005788; GO:0016853; GO:0043277; GO:0045454";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]";endoplasmic reticulum lumen [GO:0005788];isomerase activity [GO:0016853]
comp1264209_c0_seq1;GAXK01131368.1;Q99685;2.20E-50;MGLL_HUMAN;Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0019898; GO:0036155; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124";"acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]"
comp126438_c1_seq1;GAXK01058943.1;Q28824;2.00E-80;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp1264994_c0_seq1;GAXK01131388.1;O75311;4.46E-98;GLRA3_HUMAN;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp126535_c0_seq1;GAXK01058960.1;Q08821;6.84E-30;HXA1_XENLA;Homeobox protein Hox-A1 (Hox.lab2) (Fragment);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp12655_c0_seq1;GAXK01020025.1;P05661;2.08E-27;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1265530_c0_seq1;GAXK01131399.1;G5ED00;2.24E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1265660_c0_seq1;GAXK01131376.1;O59952;2.21E-09;LIP_THELA;Lipase (EC 3.1.1.3) (Triacylglycerol lipase);"triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0016042";lipid catabolic process [GO:0016042];;triglyceride lipase activity [GO:0004806]
comp1265849_c0_seq1;GAXK01131371.1;O15525;6.23E-16;MAFG_HUMAN;Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult behavior [GO:0030534]; blood coagulation [GO:0007596]; in utero embryonic development [GO:0001701]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]";"GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0007596; GO:0030534; GO:0030641; GO:0042127; GO:0043565; GO:0045604; GO:0046982";"adult behavior [GO:0030534]; blood coagulation [GO:0007596]; in utero embryonic development [GO:0001701]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp126605_c0_seq1;GAXK01059014.1;P59171;1.88E-07;PA2A5_ECHOC;Acidic phospholipase A2 5 (svPLA2) (EC 3.1.1.4) (PLA2-Eoc79) (Phosphatidylcholine 2-acylhydrolase);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0050482; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp12662_c0_seq1;GAXK01020334.1;P06603;0;TBA1_DROME;Tubulin alpha-1 chain;"astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0019730; GO:0032418; GO:0048471";"antimicrobial humoral response [GO:0019730]; lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1266605_c0_seq1;GAXK01143258.1;Q7PEV7;6.83E-38;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp126667_c2_seq1;GAXK01058972.1;Q3UR85;4.46E-30;MYRF_MOUSE;"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]; central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016021; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0042802; GO:0043565; GO:0045893; GO:0048709";"central nervous system myelination [GO:0022010]; central nervous system myelin maintenance [GO:0032286]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]"
comp12667_c2_seq1;GAXK01020602.1;Q6P1J6;1.21E-17;PLB1_HUMAN;"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"GO:0001523; GO:0004622; GO:0004623; GO:0005886; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0036151; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp1266875_c0_seq1;GAXK01143274.1;Q5F364;1.47E-114;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp1266964_c0_seq1;GAXK01143238.1;P17972;1.25E-74;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp126709_c0_seq1;GAXK01058918.1;O35887;3.99E-58;CALU_MOUSE;Calumenin (Crocalbin);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]";"GO:0004857; GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0019899; GO:0033018; GO:0042470; GO:0043231";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";"calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]"
comp126731_c1_seq1;GAXK01058985.1;Q8TAT5;7.81E-69;NEIL3_HUMAN;Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078";"base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"
comp1267312_c0_seq1;GAXK01143283.1;P35035;2.90E-34;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1267357_c0_seq1;GAXK01143217.1;Q5DTI8;1.08E-58;ESYT3_MOUSE;Extended synaptotagmin-3 (E-Syt3);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp126745_c1_seq1;GAXK01059013.1;Q9R207;6.73E-29;NBN_MOUSE;Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1 homolog);"Mre11 complex [GO:0030870]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of fibroblast proliferation [GO:0048145]; signal transduction in response to DNA damage [GO:0042770]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]";"GO:0000077; GO:0000723; GO:0000724; GO:0000784; GO:0001701; GO:0001832; GO:0003678; GO:0003684; GO:0005634; GO:0005657; GO:0005730; GO:0006302; GO:0007093; GO:0007095; GO:0008134; GO:0008283; GO:0008284; GO:0016233; GO:0016605; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042405; GO:0042770; GO:0045190; GO:0045665; GO:0046597; GO:0047485; GO:0048145; GO:0050885; GO:0051321; GO:0090656; GO:0090737; GO:0097193; GO:1904354";"blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of fibroblast proliferation [GO:0048145]; signal transduction in response to DNA damage [GO:0042770]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]";"Mre11 complex [GO:0030870]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]";"damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]"
comp1267543_c0_seq1;GAXK01143260.1;P47742;1.62E-07;GBRR2_RAT;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp12677_c0_seq1;GAXK01205097.1;Q293F6;5.25E-175;SSRP1_DROPS;FACT complex subunit Ssrp1 (Facilitates chromatin transcription complex subunit Ssrp1) (Recombination signal sequence recognition protein) (Single-strand recognition protein);"chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0003677; GO:0003723; GO:0005694; GO:0005730; GO:0006260; GO:0006281";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";"chromosome [GO:0005694]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp126800_c1_seq1;GAXK01058913.1;Q9WTR6;3.54E-31;XCT_MOUSE;Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (xCT);"astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; organic substance transport [GO:0071702]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0016020; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0043231; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0071702; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1900407; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211";"adult behavior [GO:0030534]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; lens fiber cell differentiation [GO:0070306]; L-glutamate import across plasma membrane [GO:0098712]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; organic substance transport [GO:0071702]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]";L-amino acid transmembrane transporter activity [GO:0015179]
comp126825_c0_seq1;GAXK01058806.1;Q8CGV7;4.31E-10;THTPA_RAT;Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772]";"GO:0000287; GO:0005737; GO:0006772; GO:0016311; GO:0042357; GO:0050333";"dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772]";cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]"
comp126831_c0_seq1;GAXK01058955.1;Q6P9I7;7.79E-74;SMC6_XENLA;Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398";"cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp126871_c0_seq1;GAXK01058790.1;P40617;1.31E-46;ARL4A_HUMAN;ADP-ribosylation factor-like protein 4A;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873";"brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp126921_c0_seq1;GAXK01058951.1;Q2VPA6;0;HELQ_MOUSE;Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase);"single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]; DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0000724; GO:0003677; GO:0005524; GO:0006259; GO:0017116; GO:0017117";"DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; resolution of meiotic recombination intermediates [GO:0000712]";single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]"
comp126927_c0_seq1;GAXK01058781.1;P00731;4.73E-60;CBPA1_RAT;Carboxypeptidase A1 (EC 3.4.17.1);"extracellular space [GO:0005615]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004181; GO:0005615; GO:0006508; GO:0008238; GO:0008270; GO:0051603";"proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";extracellular space [GO:0005615];"exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp12693_c8_seq1;GAXK01020365.1;Q80ZA4;0;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp126941_c0_seq1;GAXK01059003.1;Q96GD3;5.39E-103;SCMH1_HUMAN;Polycomb protein SCMH1 (Sex comb on midleg homolog 1);"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]";"GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0045892";"anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]";"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]";
comp12697_c1_seq1;GAXK01020709.1;O60678;4.03E-117;ANM3_HUMAN;Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006479; GO:0008168; GO:0008469; GO:0016274; GO:0019919; GO:0031397; GO:0034969; GO:0035242; GO:0043022; GO:0046872";"histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]"
comp127008_c0_seq1;GAXK01059039.1;Q5ZLG9;1.08E-155;WDR59_CHICK;GATOR complex protein WDR59;"GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"GO:0005765; GO:0032008; GO:0034198; GO:0061700";"cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]";
comp1270197_c0_seq1;GAXK01146260.1;P0C1S9;1.64E-11;DGLB_RAT;Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-);"integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0016021; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp12702_c0_seq1;GAXK01020692.1;B6Q1K5;1.93E-07;STS1_TALMQ;Tethering factor for nuclear proteasome sts1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; proteasome localization [GO:0031144]; protein transport [GO:0015031]";"GO:0005634; GO:0005737; GO:0015031; GO:0031144; GO:0071630";"nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; proteasome localization [GO:0031144]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp127030_c0_seq1;GAXK01058826.1;Q20140;3.88E-49;KAD1_CAEEL;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase);"cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0006172; GO:0009142; GO:0046033; GO:0046034";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";cytoplasm [GO:0005737];"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp127037_c0_seq1;GAXK01058838.1;Q24120;3.50E-79;CAPU_DROME;Protein cappuccino;"actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin filament organization [GO:0007015]; actin filament-based process [GO:0030029]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; positive regulation of actin nucleation [GO:0051127]; protein transport [GO:0015031]";"GO:0003779; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007015; GO:0007304; GO:0007315; GO:0007316; GO:0008017; GO:0015031; GO:0030029; GO:0030659; GO:0045010; GO:0045451; GO:0048477; GO:0051127";"actin filament-based process [GO:0030029]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; positive regulation of actin nucleation [GO:0051127]; protein transport [GO:0015031]";"actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]"
comp127047_c0_seq1;GAXK01058825.1;A0JM12;1.32E-33;MEG10_XENTR;Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]";"GO:0005112; GO:0005886; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0030239; GO:0043277";"apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";Notch binding [GO:0005112]
comp1270590_c0_seq1;GAXK01146266.1;P05661;1.62E-33;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp127073_c1_seq1;GAXK01058989.1;P37137;4.45E-85;LHX5_XENLA;LIM/homeobox protein Lhx5 (LIM homeobox protein 5) (Homeobox protein LIM-5) (xLIM-5) (xLIM-2A);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1270819_c0_seq1;GAXK01146313.1;Q9U3F4;1.97E-26;ZYX_CAEEL;Zyxin;"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]; DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"GO:0000003; GO:0001725; GO:0005634; GO:0005925; GO:0007399; GO:0015629; GO:0017151; GO:0030424; GO:0031430; GO:0046872; GO:0055120; GO:0098609; GO:0099558";"cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]";"DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]"
comp1270909_c0_seq1;GAXK01146306.1;Q94900;7.44E-33;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1271_c0_seq1;GAXK01169026.1;P48601;0;PRS4_DROME;26S proteasome regulatory subunit 4 (P26s4);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]";"GO:0005524; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008540; GO:0016887; GO:0017025; GO:0036402; GO:0043161";"circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]"
comp12710_c1_seq1;GAXK01020952.1;Q9VKX7;2.29E-138;ALG6_DROME;Probable dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase) (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; glucosyltransferase activity [GO:0046527]; chitin-based cuticle development [GO:0040003]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]";"GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0040003; GO:0042281; GO:0046527";"chitin-based cuticle development [GO:0040003]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; glucosyltransferase activity [GO:0046527]"
comp127102_c0_seq1;GAXK01059025.1;Q9NWW6;4.15E-25;NRK1_HUMAN;Nicotinamide riboside kinase 1 (NRK 1) (NmR-K 1) (EC 2.7.1.22) (Nicotinic acid riboside kinase 1) (EC 2.7.1.173) (Ribosylnicotinamide kinase 1) (RNK 1) (Ribosylnicotinic acid kinase 1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]";"GO:0005524; GO:0005829; GO:0009435; GO:0016301; GO:0019674; GO:0046872; GO:0050262; GO:0061769";"NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]"
comp1271112_c0_seq1;GAXK01146264.1;Q63151;1.60E-118;ACSL3_RAT;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Brain acyl-CoA synthetase II) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp127132_c0_seq1;GAXK01058936.1;Q804T6;3.72E-50;DIX1A_DANRE;Dixin-A (Coiled-coil protein DIX1-A) (Coiled-coil-DIX1-A) (DIX domain-containing protein 1-A);"cytosol [GO:0005829]; focal adhesion [GO:0005925]; protein homodimerization activity [GO:0042803]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; forebrain development [GO:0030900]";"GO:0005829; GO:0005925; GO:0030900; GO:0042803; GO:0043010; GO:0060070";"camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; forebrain development [GO:0030900]";"cytosol [GO:0005829]; focal adhesion [GO:0005925]";protein homodimerization activity [GO:0042803]
comp127141_c2_seq1;GAXK01059027.1;Q9NYT6;4.27E-20;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1271531_c0_seq1;GAXK01146261.1;Q96RW7;7.99E-11;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1271765_c1_seq1;GAXK01146299.1;F1NY98;6.03E-107;DSCAM_CHICK;Down syndrome cell adhesion molecule homolog;"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030017; GO:0030054; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]";"netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]"
comp127191_c0_seq1;GAXK01058987.1;A0A096ZEC9;1.24E-13;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp127194_c0_seq1;GAXK01058792.1;O46101;1.72E-12;TSN2A_DROME;Tetraspanin-2A;"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; smooth septate junction [GO:0005920]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; smooth septate junction assembly [GO:0090528]";"GO:0005887; GO:0005920; GO:0016021; GO:0016327; GO:0061028; GO:0090528; GO:0090557";"establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; smooth septate junction assembly [GO:0090528]";"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; smooth septate junction [GO:0005920]";
comp1272003_c0_seq1;GAXK01114732.1;Q9VB68;1.96E-25;GRASS_DROME;Serine protease grass (EC 3.4.21.-) (Gram-positive specific serine protease);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]";"GO:0002804; GO:0004252; GO:0005509; GO:0005576; GO:0006508; GO:0006963; GO:0045087; GO:0045752; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp127201_c0_seq1;GAXK01058958.1;Q8CDF7;6.85E-30;EXD1_MOUSE;piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1);"P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]";"GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:0090305; GO:1990923";"gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]";"PET complex [GO:1990923]; P granule [GO:0043186]";"protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp127217_c2_seq1;GAXK01058939.1;Q9VW71;3.38E-18;FAT2_DROME;Fat-like cadherin-related tumor suppressor homolog (Protein kugelei);"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]"
comp1272247_c0_seq1;GAXK01114714.1;Q9Z175;1.11E-09;LOXL3_MOUSE;Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3) (Lysyl oxidase-related protein 2);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046";"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp127251_c1_seq1;GAXK01058841.1;F1MAD2;7.22E-106;INADL_RAT;InaD-like protein (Inadl protein) (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions);"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"GO:0005923; GO:0016324; GO:0032991; GO:0048471";;"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";
comp127265_c0_seq1;GAXK01059007.1;Q8IY67;1.32E-40;RAVR1_HUMAN;Ribonucleoprotein PTB-binding 1 (Protein raver-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp1272743_c0_seq1;GAXK01114715.1;Q99571;1.92E-65;P2RX4_HUMAN;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0006812; GO:0007165; GO:0007596; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0016021; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035381; GO:0035590; GO:0042118; GO:0042803; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904124; GO:1904141; GO:2001028";"apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]"
comp127275_c0_seq1;GAXK01058834.1;Q9VZZ9;1.46E-16;DOS_DROME;Protein daughter of sevenless;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification, embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293]";"GO:0005737; GO:0005886; GO:0007465; GO:0008293; GO:0008595; GO:0019730; GO:0042169; GO:0042461; GO:0045500; GO:0046578";"anterior/posterior axis specification, embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";SH2 domain binding [GO:0042169]
comp127282_c1_seq1;GAXK01058886.1;Q9V7S5;1.36E-79;PICO_DROME;Putative inorganic phosphate cotransporter;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0015114; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]"
comp1273103_c0_seq1;GAXK01114702.1;P08045;2.80E-09;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp127341_c4_seq1;GAXK01059129.1;F1M386;0;RPGF2_RAT;Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; cAMP binding [GO:0030552]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; ventricular system development [GO:0021591]";"GO:0001568; GO:0001764; GO:0005088; GO:0005096; GO:0005737; GO:0005770; GO:0005886; GO:0005911; GO:0007186; GO:0007218; GO:0008285; GO:0010976; GO:0017034; GO:0019901; GO:0019933; GO:0021591; GO:0021884; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; ventricular system development [GO:0021591]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]";"beta-1 adrenergic receptor binding [GO:0031697]; cAMP binding [GO:0030552]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]"
comp1273509_c0_seq1;GAXK01114679.1;Q99PI5;1.19E-47;LPIN2_MOUSE;Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp1273613_c0_seq1;GAXK01114759.1;O13263;1.81E-30;SCNNH_XENLA;Amiloride-sensitive sodium channel subunit gamma-2 (Epithelial Na(+) channel subunit gamma-2) (Gamma-2-ENaC) (Gamma-2-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma-2) (SCNEG2);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transport [GO:0035725]";"GO:0015280; GO:0016021; GO:0016324; GO:0035725";sodium ion transmembrane transport [GO:0035725];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";ligand-gated sodium channel activity [GO:0015280]
comp1273821_c0_seq1;GAXK01114764.1;P86854;1.19E-09;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp12739_c1_seq1;GAXK01020116.1;Q7SZE5;0;SC23A_DANRE;Protein transport protein Sec23A (SEC23-related protein A);"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; COPII-coated vesicle cargo loading [GO:0090110]; embryonic neurocranium morphogenesis [GO:0048702]; intracellular protein transport [GO:0006886]; pectoral fin morphogenesis [GO:0035138]";"GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0035138; GO:0048702; GO:0051216; GO:0070971; GO:0090110";"cartilage development [GO:0051216]; COPII-coated vesicle cargo loading [GO:0090110]; embryonic neurocranium morphogenesis [GO:0048702]; intracellular protein transport [GO:0006886]; pectoral fin morphogenesis [GO:0035138]";"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]";"GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]"
comp1273944_c0_seq1;GAXK01114685.1;Q8N988;8.00E-21;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1274013_c0_seq1;GAXK01080055.1;Q4V348;2.19E-63;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1274016_c0_seq1;GAXK01080044.1;Q9V4U9;2.99E-30;C6A13_DROME;Probable cytochrome P450 6a13 (EC 1.14.-.-) (CYPVIA13);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; defense response to bacterium [GO:0042742]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037; GO:0042742";defense response to bacterium [GO:0042742];endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp1274875_c0_seq1;GAXK01080076.1;Q0CT27;2.21E-20;CCR4_ASPTN;Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase);"CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]";"GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0030015; GO:0046872";nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289];"CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]";"metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]"
comp1274939_c0_seq1;GAXK01080080.1;Q9R1S0;4.65E-94;B9D1_MOUSE;B9 domain-containing protein 1 (Endothelial precursor cells protein B9);"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; hedgehog receptor activity [GO:0008158]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]";"GO:0001701; GO:0001944; GO:0005737; GO:0005813; GO:0007224; GO:0008158; GO:0016020; GO:0032880; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0043010; GO:0060271; GO:0060563";"camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]";hedgehog receptor activity [GO:0008158]
comp1274995_c0_seq1;GAXK01080083.1;Q5F478;2.31E-24;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp127533_c1_seq1;GAXK01059083.1;G5EBQ8;4.83E-19;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp127544_c0_seq1;GAXK01058952.1;P93748;4.55E-12;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp127575_c0_seq1;GAXK01058910.1;Q8K190;2.23E-09;SMDC1_MOUSE;SAYSvFN domain-containing protein 1;"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"GO:0016021; GO:0030659; GO:0043231";;"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";
comp127583_c0_seq1;GAXK01058820.1;Q8SXT3;1.98E-17;HFW2_DROME;Protein singed wings 2;"intracellular signal transduction [GO:0035556]; pupariation [GO:0035073]; response to ecdysone [GO:0035075]";"GO:0035073; GO:0035075; GO:0035556";"intracellular signal transduction [GO:0035556]; pupariation [GO:0035073]; response to ecdysone [GO:0035075]";;
comp127589_c1_seq1;GAXK01058954.1;Q9BUU2;1.28E-26;MET22_HUMAN;Methyltransferase-like protein 22 (EC 2.1.1.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; protein methylation [GO:0006479]";"GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991";protein methylation [GO:0006479];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"heat shock protein binding [GO:0031072]; protein-lysine N-methyltransferase activity [GO:0016279]; protein methyltransferase activity [GO:0008276]"
comp127591_c0_seq1;GAXK01058782.1;Q5G271;3.11E-76;NETR_PANTR;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp127604_c0_seq1;GAXK01058911.1;P40656;7.75E-27;SOX14_DROME;Putative transcription factor SOX-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0016322; GO:0030154; GO:0043565; GO:0044798; GO:0048813; GO:1904799; GO:1904801";"cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp1276109_c0_seq1;GAXK01138906.1;Q7KRI2;2.75E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp127632_c2_seq1;GAXK01058900.1;P41938;8.87E-97;HCDH2_CAEEL;Probable 3-hydroxyacyl-CoA dehydrogenase B0272.3 (EC 1.1.1.35);"mitochondrial matrix [GO:0005759]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]";"GO:0003857; GO:0005759; GO:0006635; GO:0070403";fatty acid beta-oxidation [GO:0006635];mitochondrial matrix [GO:0005759];"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]"
comp127644_c1_seq1;GAXK01058788.1;Q9H8H3;9.18E-37;MET7A_HUMAN;Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0043312; GO:1904724";neutrophil degranulation [GO:0043312];"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]";methyltransferase activity [GO:0008168]
comp127684_c0_seq1;GAXK01058953.1;B5U2W0;4.16E-57;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp1277_c0_seq1;GAXK01168979.1;P50882;5.23E-96;RL9_DROME;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp127703_c0_seq1;GAXK01058959.1;Q9D0S9;4.60E-51;HINT2_MOUSE;Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3);"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]";"GO:0000166; GO:0005730; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757";"apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]";"mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]"
comp127718_c1_seq1;GAXK01058930.1;Q9D531;2.32E-28;NXNL2_MOUSE;Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2);"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0007601; GO:0007608; GO:0045494";"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";;
comp1277272_c0_seq1;GAXK01138898.1;P10076;5.73E-27;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1277280_c1_seq1;GAXK01138889.1;Q9WTK8;3.92E-41;SPO11_MOUSE;Meiotic recombination protein SPO11 (EC 5.6.2.2);"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 3'-phosphomonoesters [GO:0016889]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair involved in meiotic recombination [GO:1990918]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic DNA double-strand break processing [GO:0000706]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synapsis [GO:0007129]; synaptonemal complex assembly [GO:0007130]";"GO:0000706; GO:0000737; GO:0000781; GO:0001541; GO:0003677; GO:0005524; GO:0005654; GO:0007129; GO:0007130; GO:0007131; GO:0007141; GO:0007286; GO:0016853; GO:0016889; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918";"DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair involved in meiotic recombination [GO:1990918]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic DNA double-strand break processing [GO:0000706]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synapsis [GO:0007129]; synaptonemal complex assembly [GO:0007130]";"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 3'-phosphomonoesters [GO:0016889]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]"
comp12773_c0_seq1;GAXK01020907.1;Q9VXN2;3.38E-09;SUN_DROME;Protein stunted;"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"GO:0000275; GO:0001664; GO:0005615; GO:0005743; GO:0006979; GO:0008340; GO:0015986; GO:0045745; GO:0046933; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]";"G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp127761_c3_seq1;GAXK01058997.1;Q80ZD3;4.94E-22;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp1277979_c0_seq1;GAXK01138903.1;Q0IIY2;2.41E-34;WSCD1_XENTR;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp12780_c11_seq1;GAXK01020677.1;Q4WF54;2.09E-29;SIDH_ASPFU;Mevalonyl-coenzyme A hydratase sidH (EC 4.2.1.-) (Siderophore biosynthesis protein H);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to iron ion starvation [GO:0010106]; ergosterol biosynthetic process [GO:0006696]; fatty acid beta-oxidation [GO:0006635]; N',N'',N'''-triacetylfusarinine C biosynthetic process [GO:1900551]; pathogenesis [GO:0009405]";"GO:0004300; GO:0005739; GO:0005777; GO:0006635; GO:0006696; GO:0009405; GO:0010106; GO:0016853; GO:0070301; GO:1900551";"cellular response to hydrogen peroxide [GO:0070301]; cellular response to iron ion starvation [GO:0010106]; ergosterol biosynthetic process [GO:0006696]; fatty acid beta-oxidation [GO:0006635]; N',N'',N'''-triacetylfusarinine C biosynthetic process [GO:1900551]; pathogenesis [GO:0009405]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]"
comp1278000_c0_seq1;GAXK01030384.1;Q9NYT6;6.03E-15;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp127814_c0_seq1;GAXK01058892.1;Q8NCC3;3.29E-111;PAG15_HUMAN;Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006672; GO:0008374; GO:0009062; GO:0016020; GO:0034638; GO:0043231; GO:0046338; GO:0047499; GO:0070062";"ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]"
comp12782_c2_seq1;GAXK01020040.1;Q7TPV4;4.96E-07;MBB1A_MOUSE;Myb-binding protein 1A (Myb-binding protein of 160 kDa);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]; E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]";"GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0008134; GO:0008270; GO:0022904; GO:0032922; GO:0042149; GO:0042254; GO:0042564; GO:0043231; GO:0043565; GO:0045892; GO:0070888; GO:0071158; GO:0072332; GO:2000210";"cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp127838_c0_seq1;GAXK01058808.1;Q3ZBX1;5.73E-27;PIGC_BOVIN;Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C);"glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000506; GO:0006506; GO:0016021; GO:0017176";GPI anchor biosynthetic process [GO:0006506];"glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]";phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]
comp127839_c0_seq1;GAXK01058837.1;Q8IYR2;5.77E-19;SMYD4_HUMAN;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1278519_c1_seq1;GAXK01030376.1;Q9GRW0;2.24E-81;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1278667_c0_seq1;GAXK01030364.1;O02388;1.05E-14;CU22_BOMMO;Larval cuticle protein LCP-22;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1278697_c0_seq1;GAXK01030381.1;Q17QE5;4.64E-45;CIB1_BOVIN;Calcium and integrin-binding protein 1 (Calmyrin);"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]";"GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005737; GO:0005813; GO:0005886; GO:0006915; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008284; GO:0008285; GO:0010977; GO:0016324; GO:0030027; GO:0030220; GO:0030307; GO:0030335; GO:0030426; GO:0031122; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070374; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:1900026; GO:1990090; GO:2000256";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]";"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";calcium ion binding [GO:0005509]
comp1278919_c0_seq1;GAXK01030365.1;Q80WQ9;5.78E-09;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp12791_c1_seq1;GAXK01020026.1;Q9VU68;0;WDR1_DROME;Actin-interacting protein 1 (AIP1) (Protein flare);"actomyosin, actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]";"GO:0001736; GO:0005856; GO:0007298; GO:0030042; GO:0030833; GO:0030834; GO:0030836; GO:0030864; GO:0034316; GO:0035317; GO:0040011; GO:0042643; GO:0045214; GO:0051015";"actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]";"actomyosin, actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]";actin filament binding [GO:0051015]
comp127939_c0_seq1;GAXK01058819.1;P0C1J5;1.60E-33;FKB2B_RHIO9;FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0016021";;integral component of membrane [GO:0016021];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp1279470_c0_seq1;GAXK01030387.1;Q14679;4.27E-125;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp1279691_c0_seq1;GAXK01030382.1;A9ZSY2;5.28E-30;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp127988_c0_seq1;GAXK01059026.1;Q24322;0;SEM1A_DROME;Semaphorin-1A (Semaphorin-I) (Sema I);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell size [GO:0045792]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance [GO:2000305]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]";"GO:0001755; GO:0005615; GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016021; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0048843; GO:0050919; GO:0071526; GO:2000305";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell size [GO:0045792]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance [GO:2000305]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215]"
comp1280341_c0_seq1;GAXK01198641.1;B0WC46;1.26E-09;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1280486_c0_seq1;GAXK01198618.1;O15156;8.55E-07;ZBT7B_HUMAN;Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 secretion [GO:0072615]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001865; GO:0005634; GO:0005654; GO:0006366; GO:0007398; GO:0007595; GO:0010628; GO:0010629; GO:0031065; GO:0032868; GO:0042803; GO:0042826; GO:0043372; GO:0043377; GO:0046628; GO:0046872; GO:0051141; GO:0060850; GO:0072615; GO:0090336; GO:0120162; GO:1990845; GO:2000320; GO:2000640";"adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 secretion [GO:0072615]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp12813_c2_seq1;GAXK01020722.1;P00920;1.85E-69;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp128132_c0_seq1;GAXK01181553.1;P20009;9.19E-49;DLL_DROME;Homeotic protein distal-less (Protein brista);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; analia development [GO:0007487]; antennal development [GO:0007469]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; olfactory behavior [GO:0042048]; olfactory nerve development [GO:0021553]; positive regulation of transcription, DNA-templated [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]";"GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0021553; GO:0035114; GO:0035215; GO:0042048; GO:0043565; GO:0045893; GO:0048264; GO:0048728";"analia development [GO:0007487]; antennal development [GO:0007469]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; olfactory behavior [GO:0042048]; olfactory nerve development [GO:0021553]; positive regulation of transcription, DNA-templated [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1281463_c0_seq1;GAXK01198619.1;Q11002;2.31E-160;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp1281531_c0_seq1;GAXK01198640.1;P19218;4.37E-10;GP2_RAT;Pancreatic secretory granule membrane major glycoprotein GP2 (Glycoprotein 80) (gp80) (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"GO:0005576; GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp12818_c0_seq1;GAXK01020458.1;P06754;1.54E-31;TPM1_DROME;Tropomyosin-1, isoforms 9A/A/B (Cytoskeletal tropomyosin) (Tropomyosin II);"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019901; GO:0030017; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865";"actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]"
comp1281862_c0_seq1;GAXK01198625.1;Q7KRI2;1.78E-07;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1281873_c0_seq1;GAXK01198621.1;Q5QQ50;1.13E-28;XYLT2_CANLF;Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 2) (Xylosyltransferase II);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]";"GO:0000139; GO:0000287; GO:0005615; GO:0008375; GO:0015012; GO:0016021; GO:0030145; GO:0030158; GO:0030206; GO:0030210; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]";"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]"
comp128203_c0_seq1;GAXK01181623.1;Q4R4N7;1.58E-24;GANAB_MACFA;Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha);"glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]";"GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599";"carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]";"glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]";"alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]"
comp1282231_c0_seq1;GAXK01101997.1;Q16WU7;6.40E-13;WSCD_AEDAE;WSCD family member AAEL009094;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp128225_c0_seq1;GAXK01181616.1;P34528;3.11E-87;YM67_CAEEL;Putative serine protease K12H4.7 (EC 3.4.-.-);"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0006508; GO:0008236; GO:0008239; GO:0045087";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";;"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]"
comp1282281_c0_seq1;GAXK01102022.1;Q9D826;6.63E-88;SOX_MOUSE;Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase);"peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114";"L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]";peroxisome [GO:0005777];"L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]"
comp12824_c1_seq1;GAXK01020891.1;Q7T3H1;4.37E-20;DCTN2_DANRE;Dynactin subunit 2;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; motor activity [GO:0003774]; auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494]";"GO:0001754; GO:0003774; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0007097; GO:0010001; GO:0016020; GO:0030286; GO:0030719; GO:0031982; GO:0035088; GO:0045494; GO:0060117";"auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]";motor activity [GO:0003774]
comp1282815_c0_seq1;GAXK01102001.1;Q5R5X9;2.62E-19;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1283045_c0_seq1;GAXK01102013.1;Q8N8E2;3.43E-18;ZN513_HUMAN;Zinc finger protein 513;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";"GO:0000979; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0044212; GO:0046872; GO:0050896; GO:0060041";"regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp128335_c1_seq1;GAXK01181464.1;Q99N34;8.83E-51;DFFB_RAT;DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (DNA fragmentation factor 40 kDa subunit) (DFF-40);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; deoxyribonuclease activity [GO:0004536]; apoptotic DNA fragmentation [GO:0006309]; brain development [GO:0007420]";"GO:0000790; GO:0004536; GO:0005634; GO:0005737; GO:0006309; GO:0007420";"apoptotic DNA fragmentation [GO:0006309]; brain development [GO:0007420]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";deoxyribonuclease activity [GO:0004536]
comp128357_c2_seq1;GAXK01181629.1;A8XV95;6.69E-56;GELS1_CAEBR;Gelsolin-like protein 1;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament depolymerization [GO:0030042]; actin filament severing [GO:0051014]; barbed-end actin filament capping [GO:0051016]; positive regulation of synapse pruning [GO:1905808]";"GO:0003785; GO:0005546; GO:0005737; GO:0005856; GO:0030042; GO:0051014; GO:0051015; GO:0051016; GO:1905808";"actin filament depolymerization [GO:0030042]; actin filament severing [GO:0051014]; barbed-end actin filament capping [GO:0051016]; positive regulation of synapse pruning [GO:1905808]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp128361_c1_seq1;GAXK01181680.1;Q91YX5;2.11E-76;LGAT1_MOUSE;Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; positive regulation of fatty acid biosynthetic process [GO:0045723]";"GO:0003841; GO:0005737; GO:0005789; GO:0006644; GO:0008654; GO:0016021; GO:0016746; GO:0045723";"phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; positive regulation of fatty acid biosynthetic process [GO:0045723]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp128370_c6_seq1;GAXK01181634.1;Q925F4;6.02E-34;RNF37_MOUSE;RING finger protein 37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5);"focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0005634; GO:0005654; GO:0005925; GO:0016604; GO:0031625; GO:0034450; GO:0046872; GO:0061630";protein polyubiquitination [GO:0000209];"focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]"
comp1283729_c0_seq1;GAXK01102017.1;Q32KH5;0;GALNS_CANLF;N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase);"lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]";"GO:0004065; GO:0005764; GO:0043890; GO:0046872";;lysosome [GO:0005764];"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]"
comp1284_c0_seq1;GAXK01168239.1;P26686;3.71E-67;SRR55_DROME;Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013";"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp128420_c0_seq1;GAXK01181592.1;P40791;3.88E-68;MEF2_DROME;Myocyte-specific enhancer factor 2 (D-mef2) (MADS domain transcription factor);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior midgut development [GO:0007496]; antimicrobial humoral response [GO:0019730]; carbohydrate storage [GO:0052576]; heart development [GO:0007507]; lipid storage [GO:0019915]; locomotor rhythm [GO:0045475]; mesoderm development [GO:0007498]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of gene expression [GO:0010468]; regulation of striated muscle tissue development [GO:0016202]; skeletal muscle tissue development [GO:0007519]";"GO:0000977; GO:0001158; GO:0001228; GO:0003677; GO:0005634; GO:0007496; GO:0007498; GO:0007507; GO:0007517; GO:0007519; GO:0007520; GO:0010468; GO:0016202; GO:0019730; GO:0019915; GO:0030707; GO:0032968; GO:0045475; GO:0045944; GO:0046983; GO:0048747; GO:0052576";"anterior midgut development [GO:0007496]; antimicrobial humoral response [GO:0019730]; carbohydrate storage [GO:0052576]; heart development [GO:0007507]; lipid storage [GO:0019915]; locomotor rhythm [GO:0045475]; mesoderm development [GO:0007498]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of gene expression [GO:0010468]; regulation of striated muscle tissue development [GO:0016202]; skeletal muscle tissue development [GO:0007519]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1284366_c0_seq1;GAXK01042797.1;B8N0F1;1.86E-07;ASAE_ASPFN;MFS transporter asaE (Aspergillic acid biosynthesis cluster protein E);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp128440_c2_seq1;GAXK01181499.1;Q9QYI7;4.87E-25;DNJB8_MOUSE;DnaJ homolog subfamily B member 8 (mDj6);"cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]";"GO:0005634; GO:0005829; GO:0044183; GO:0051082; GO:0051087; GO:0061077; GO:0090084";"chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp128453_c0_seq1;GAXK01181380.1;Q7KRI2;1.85E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1284595_c0_seq1;GAXK01042832.1;Q9V427;3.11E-19;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp12847_c0_seq1;GAXK01020595.1;O97397;4.81E-60;CATLL_PHACE;Cathepsin L-like proteinase (EC 3.4.22.-);"cysteine-type peptidase activity [GO:0008234]; digestion [GO:0007586]";"GO:0007586; GO:0008234";digestion [GO:0007586];;cysteine-type peptidase activity [GO:0008234]
comp12848_c2_seq1;GAXK01020122.1;Q9VPQ2;2.24E-148;DJSHV_DROME;DnaJ homolog shv (Protein shriveled);"extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]";"GO:0005178; GO:0005615; GO:0005634; GO:0005886; GO:0006457; GO:0007155; GO:0031594; GO:0036098; GO:0051082; GO:0060250; GO:0090129; GO:2001046";"cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]";"extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]"
comp128480_c1_seq1;GAXK01181722.1;A8C750;4.40E-123;THADA_CANLF;Thyroid adenoma-associated protein homolog;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]";"GO:0005783; GO:0005829; GO:0030488; GO:0032471; GO:0055088";"lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";
comp1284951_c0_seq1;GAXK01042801.1;B4P641;1.45E-34;QVR_DROYA;Protein quiver (Protein sleepless);"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818";"negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]";GPI anchor binding [GO:0034235]
comp12850_c0_seq1;GAXK01020893.1;Q9UMX0;2.47E-109;UBQL1_HUMAN;Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1);"aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071";"aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]";"identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]"
comp128505_c0_seq1;GAXK01181326.1;Q9VYY9;0;EVI5_DROME;Ecotropic viral integration site 5 ortholog;"cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]";"GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0007298; GO:0017137; GO:0030334; GO:0031982; GO:0032880; GO:0043087; GO:0090630";"activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp12853_c2_seq1;GAXK01020202.1;Q9VA73;0;CMC_DROME;Calcium-binding mitochondrial carrier protein Aralar1;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490";"aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]"
comp12859_c0_seq1;GAXK01205098.1;P52486;1.35E-81;UBCD4_DROME;Ubiquitin-conjugating enzyme E2-22 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0031625; GO:0061631; GO:0070628";protein polyubiquitination [GO:0000209];nucleus [GO:0005634];"ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp12861_c2_seq1;GAXK01020931.1;P12265;0;BGLR_MOUSE;Beta-glucuronidase (EC 3.2.1.31);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]";"GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0005783; GO:0005975; GO:0016787; GO:0019391; GO:0019904; GO:0030246; GO:0043231";"carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]";"beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]"
comp1286110_c0_seq1;GAXK01061682.1;Q68DY1;1.15E-17;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp128618_c0_seq1;GAXK01181489.1;Q10L91;5.63E-09;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp128636_c0_seq1;GAXK01181486.1;Q8CGN4;2.26E-26;BCOR_MOUSE;BCL-6 corepressor (BCoR);"BCOR complex [GO:0140261]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]";"GO:0000122; GO:0000415; GO:0000977; GO:0001835; GO:0003714; GO:0004842; GO:0005634; GO:0007507; GO:0008134; GO:0030502; GO:0031072; GO:0035518; GO:0042476; GO:0042826; GO:0044212; GO:0045892; GO:0051572; GO:0060021; GO:0065001; GO:0070171; GO:0140261";"blastocyst hatching [GO:0001835]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]";"BCOR complex [GO:0140261]; nucleus [GO:0005634]";"heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]"
comp128642_c0_seq1;GAXK01181626.1;Q924A5;7.06E-80;S36A1_RAT;Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (Lysosomal amino acid transporter 1) (LYAAT-1) (Neutral amino acid/proton symporter) (Solute carrier family 36 member 1);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; neutral amino acid transmembrane transporter activity [GO:0015175]; proton transmembrane transporter activity [GO:0015078]; amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"GO:0003333; GO:0005280; GO:0005764; GO:0005765; GO:0005783; GO:0005886; GO:0015078; GO:0015171; GO:0015175; GO:0015180; GO:0015187; GO:0015193; GO:0015804; GO:0015808; GO:0015816; GO:0016021; GO:0035524; GO:1902600";"amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"amino acid:proton symporter activity [GO:0005280]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; neutral amino acid transmembrane transporter activity [GO:0015175]; proton transmembrane transporter activity [GO:0015078]"
comp1286512_c0_seq1;GAXK01061698.1;Q7PPU9;3.66E-19;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp128686_c0_seq1;GAXK01181675.1;Q9CR16;5.34E-100;PPID_MOUSE;Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]";"GO:0000122; GO:0000413; GO:0003755; GO:0005528; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019899; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0042026; GO:0043065; GO:0045070; GO:0050714; GO:0051082; GO:0051879; GO:0061077; GO:0065003; GO:0071492";"apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp1286900_c0_seq1;GAXK01061696.1;P52746;3.77E-12;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp128701_c1_seq1;GAXK01181598.1;Q6INU7;2.93E-08;FRRS1_XENLA;Putative ferric-chelate reductase 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491";;integral component of membrane [GO:0016021];oxidoreductase activity [GO:0016491]
comp128728_c2_seq1;GAXK01181493.1;Q66L58;0;VAC14_DANRE;Protein VAC14 homolog;"endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000306; GO:0006661; GO:0010008; GO:0070772";phosphatidylinositol biosynthetic process [GO:0006661];"endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]";
comp12873_c0_seq1;GAXK01020922.1;O15995;1.70E-97;CCNE_HEMPU;G1/S-specific cyclin-E;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp128759_c0_seq1;GAXK01181381.1;Q7T2H2;2.78E-58;FGRL1_CHICK;Fibroblast growth factor receptor-like 1;"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030133; GO:0044291; GO:0051260; GO:0060412; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]"
comp1287695_c0_seq1;GAXK01061688.1;Q9UDV7;3.73E-11;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp128798_c0_seq1;GAXK01205921.1;P02512;2.62E-19;CRYAB_SQUAC;Alpha-crystallin B chain (Alpha(B)-crystallin);"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]";"GO:0005212; GO:0042803; GO:0046872";;;"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]"
comp1288280_c0_seq1;GAXK01071865.1;Q9U3S9;6.80E-18;NAS6_CAEEL;Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp128838_c0_seq1;GAXK01181714.1;Q8C547;0;HTR5B_MOUSE;HEAT repeat-containing protein 5B;"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147";"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]";
comp128867_c0_seq1;GAXK01181664.1;Q60738;9.81E-37;ZNT1_MOUSE;Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829]";"GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0099061";"cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]";"calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]"
comp128878_c0_seq1;GAXK01181600.1;Q9W391;1.57E-110;KPBA_DROME;Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha);"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"GO:0003824; GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468";"glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]"
comp1289002_c0_seq1;GAXK01071873.1;Q3SYV7;1.00E-24;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1289018_c0_seq1;GAXK01071862.1;P10076;7.47E-18;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp128919_c0_seq1;GAXK01181632.1;Q9UJ83;0;HACL1_HUMAN;2-hydroxyacyl-CoA lyase 1 (EC 4.1.-.-) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2);"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625]";"GO:0000287; GO:0001561; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016830; GO:0030976; GO:0042802; GO:0048037; GO:0051259";"fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]"
comp1289191_c0_seq1;GAXK01071870.1;A9JTH1;5.50E-20;NCLDA_DANRE;Neurocalcin-delta A;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp128958_c1_seq1;GAXK01181646.1;Q9UEG4;1.36E-09;ZN629_HUMAN;Zinc finger protein 629 (Zinc finger protein 65);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1289660_c0_seq1;GAXK01071871.1;P41041;1.50E-31;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp128969_c0_seq1;GAXK01181679.1;P46976;2.80E-89;GLYG_HUMAN;Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186);"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005829; GO:0005978; GO:0008466; GO:0016020; GO:0030145; GO:0034774; GO:0042803; GO:0043202; GO:0043312; GO:0102751; GO:1904813";"glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]";"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]";"glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]"
comp128973_c2_seq1;GAXK01181718.1;Q60676;3.32E-09;PPP5_MOUSE;Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PPT);"cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]";"GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0008017; GO:0010288; GO:0016576; GO:0016791; GO:0031072; GO:0032991; GO:0042802; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0051259; GO:0051291; GO:0051879; GO:0060548; GO:0070301; GO:0071276; GO:0071944; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324";"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]";"cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]"
comp1289844_c0_seq1;GAXK01071869.1;Q9VNM1;1.16E-24;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp1290154_c0_seq1;GAXK01063360.1;Q09621;5.38E-08;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1290704_c0_seq1;GAXK01063382.1;P36609;6.73E-28;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1290953_c0_seq1;GAXK01063355.1;P0DPA6;4.41E-38;PSID_PSICU;L-tryptophan decarboxylase (EC 4.1.1.105) (Psilocybin biosynthesis decarboxylase);"phosphatidylserine decarboxylase activity [GO:0004609]; phospholipid biosynthetic process [GO:0008654]";"GO:0004609; GO:0008654";phospholipid biosynthetic process [GO:0008654];;phosphatidylserine decarboxylase activity [GO:0004609]
comp12910_c0_seq1;GAXK01019902.1;P36872;0;2ABA_DROME;Protein phosphatase PP2A 55 kDa regulatory subunit (PR55) (Protein phosphatase PP2A regulatory subunit B) (Protein twins);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; circadian rhythm [GO:0007623]; imaginal disc pattern formation [GO:0007447]; maintenance of neuroblast polarity [GO:0045201]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; sensory organ development [GO:0007423]";"GO:0000159; GO:0000278; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007091; GO:0007098; GO:0007099; GO:0007406; GO:0007423; GO:0007447; GO:0007623; GO:0019888; GO:0030071; GO:0045201; GO:0045880; GO:0050821; GO:0070262; GO:0090263";"centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; circadian rhythm [GO:0007623]; imaginal disc pattern formation [GO:0007447]; maintenance of neuroblast polarity [GO:0045201]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; sensory organ development [GO:0007423]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";"protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]"
comp1291145_c0_seq1;GAXK01063377.1;Q8TBR7;3.76E-12;TLC3A_HUMAN;TLC domain-containing protein 3A (Protein CT120) (Protein FAM57A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1291418_c0_seq1;GAXK01063364.1;A6H737;8.20E-101;LOXL2_BOVIN;Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2);"basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]";"GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0006464; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0046688; GO:0070492; GO:0070828; GO:1902455";"cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]";"basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp12920_c0_seq1;GAXK01020077.1;P04184;1.89E-71;KITH_MOUSE;Thymidine kinase, cytosolic (EC 2.7.1.21);"cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; DNA metabolic process [GO:0006259]; protein homotetramerization [GO:0051289]; thymidine metabolic process [GO:0046104]";"GO:0004797; GO:0005524; GO:0005829; GO:0006259; GO:0008270; GO:0042802; GO:0046104; GO:0051289; GO:0071897";"DNA biosynthetic process [GO:0071897]; DNA metabolic process [GO:0006259]; protein homotetramerization [GO:0051289]; thymidine metabolic process [GO:0046104]";cytosol [GO:0005829];"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]"
comp1292134_c0_seq1;GAXK01000480.1;Q24174;2.48E-25;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp12922_c3_seq1;GAXK01020353.1;Q5RBM1;4.06E-83;RPN2_PONAB;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (Ribophorin II) (RPN-II) (Ribophorin-2);"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487]";"GO:0006487; GO:0008250; GO:0016021";protein N-linked glycosylation [GO:0006487];"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]";
comp1292295_c0_seq1;GAXK01000465.1;Q92539;9.88E-07;LPIN2_HUMAN;Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp1292309_c0_seq1;GAXK01000494.1;Q3V1H9;3.25E-14;SAMD5_MOUSE;Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5);"cytoplasm [GO:0005737]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";"GO:0005737; GO:0031435; GO:0043507; GO:1901224";"positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";cytoplasm [GO:0005737];mitogen-activated protein kinase kinase kinase binding [GO:0031435]
comp1292331_c0_seq1;GAXK01000487.1;Q9MYW0;1.43E-10;TRPC6_BOVIN;Short transient receptor potential channel 6 (TrpC6);"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005261; GO:0005737; GO:0005886; GO:0005887; GO:0006828; GO:0007204; GO:0007338; GO:0015279; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0051480; GO:0051928; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";"cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]"
comp1292406_c0_seq1;GAXK01000472.1;Q7KRI2;2.85E-11;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1292732_c0_seq1;GAXK01000463.1;P52192;2.92E-18;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp1292977_c0_seq1;GAXK01000492.1;Q0VC71;0;TTLL1_BOVIN;Probable tubulin polyglutamylase TTLL1 (EC 6.-.-.-) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]";"GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0007288; GO:0016874; GO:0018095; GO:1905419";"epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp129301_c0_seq1;GAXK01181390.1;Q43007;0;PLDA1_ORYSJ;Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1);"membrane [GO:0016020]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004630; GO:0005509; GO:0016020; GO:0016042; GO:0046470; GO:0070290";"lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";membrane [GO:0016020];"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]"
comp1293021_c0_seq1;GAXK01000493.1;P93748;1.28E-11;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1293143_c0_seq1;GAXK01000504.1;Q9VCA2;2.15E-30;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp129347_c0_seq1;GAXK01181610.1;P41366;2.45E-32;VMO1_CHICK;Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI);"cell [GO:0005623]; extracellular space [GO:0005615]";"GO:0005615; GO:0005623";;"cell [GO:0005623]; extracellular space [GO:0005615]";
comp1293528_c0_seq1;GAXK01000476.1;A7Y7X5;3.92E-18;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp129353_c0_seq1;GAXK01181554.1;Q9ULD9;6.14E-26;ZN608_HUMAN;Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36);"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003676; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp129426_c0_seq1;GAXK01181717.1;Q8VDM6;7.63E-98;HNRL1_MOUSE;Heterogeneous nuclear ribonucleoprotein U-like protein 1;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]";"GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899";"response to virus [GO:0009615]; RNA processing [GO:0006396]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; RNA binding [GO:0003723]"
comp12943_c1_seq1;GAXK01020460.1;Q63699;1.44E-140;CDK2_RAT;Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2);"Cajal body [GO:0015030]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; meiotic cell cycle [GO:0051321]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to cadmium ion [GO:0046686]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]";"GO:0000082; GO:0000307; GO:0002088; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005815; GO:0005829; GO:0006281; GO:0006468; GO:0008284; GO:0009636; GO:0010389; GO:0015030; GO:0030332; GO:0031100; GO:0032355; GO:0032869; GO:0042493; GO:0043231; GO:0044877; GO:0045471; GO:0046686; GO:0046872; GO:0051301; GO:0051321; GO:0051591; GO:0051602";"animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; meiotic cell cycle [GO:0051321]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to cadmium ion [GO:0046686]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]";"Cajal body [GO:0015030]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]"
comp1294333_c0_seq1;GAXK01157523.1;Q5ZMV8;1.17E-35;RPGP2_CHICK;Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4);"cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005737; GO:0051056";regulation of small GTPase mediated signal transduction [GO:0051056];cytoplasm [GO:0005737];GTPase activator activity [GO:0005096]
comp1294367_c0_seq1;GAXK01157513.1;Q27972;1.15E-23;CHAD_BOVIN;Chondroadherin (38 kDa bone protein) (Cartilage leucine-rich protein) [Cleaved into: Chondroadherin minor form];extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1294685_c0_seq1;GAXK01157509.1;O94892;1.79E-17;ZN432_HUMAN;Zinc finger protein 432;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp129486_c0_seq1;GAXK01181589.1;Q86SQ0;5.63E-55;PHLB2_HUMAN;Pleckstrin homology-like domain family B member 2 (Protein LL5-beta);"basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]";"GO:0000226; GO:0005829; GO:0005886; GO:0010470; GO:0010717; GO:0031252; GO:0045111; GO:0045180; GO:0045184; GO:0045296; GO:0051497; GO:0051895; GO:0070507; GO:1903690; GO:1904261";"establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]";"basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]";cadherin binding [GO:0045296]
comp129501_c0_seq1;GAXK01181631.1;Q15024;3.81E-83;EXOS7_HUMAN;Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8);"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006401; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]"
comp1295246_c0_seq1;GAXK01157514.1;P29844;1.32E-86;BIP_DROME;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein homolog) (GRP-78 homolog) (Binding-immunoglobulin protein homolog) (BiP) (Heat shock 70 kDa protein cognate 3) (Heat shock protein cognate 72);"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006986; GO:0012505; GO:0016020; GO:0016246; GO:0016887; GO:0030431; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0034976; GO:0036335; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp1295258_c0_seq1;GAXK01157500.1;Q28FF3;5.36E-25;S49A3_XENTR;Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1295299_c0_seq1;GAXK01157498.1;Q1H9T6;1.91E-18;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp12954_c34_seq1;GAXK01020787.1;Q922B2;0;SYDC_MOUSE;Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]";"GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202";aspartyl-tRNA aminoacylation [GO:0006422];"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]";"aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp129544_c2_seq1;GAXK01181663.1;Q23551;2.47E-53;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp1295512_c0_seq1;GAXK01157519.1;P52746;2.62E-18;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp129566_c0_seq1;GAXK01181556.1;Q9W0K4;1.25E-25;BAB2_DROME;Protein bric-a-brac 2;"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736";"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp1295822_c0_seq1;GAXK01157502.1;Q04634;1.19E-180;EF1A_TETPY;Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp1296147_c0_seq1;GAXK01016780.1;O08648;5.66E-18;M3K4_MOUSE;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp1296319_c0_seq1;GAXK01016782.1;Q6C8H7;8.25E-23;LPE10_YARLI;Mitochondrial inner membrane magnesium transporter LPE10;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";magnesium ion transmembrane transporter activity [GO:0015095]
comp129639_c0_seq1;GAXK01181471.1;Q9Y6X8;1.44E-07;ZHX2_HUMAN;Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1) (AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000790; GO:0000981; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0035019; GO:0042802; GO:0042803; GO:0045665; GO:0045892; GO:0046872; GO:0046982; GO:0060040";"mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]"
comp1296630_c0_seq1;GAXK01016771.1;A0JNB1;4.68E-14;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1296668_c0_seq1;GAXK01016779.1;Q05941;8.75E-103;ACHA7_RAT;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0007165; GO:0007268; GO:0007271; GO:0007613; GO:0008144; GO:0008179; GO:0014069; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032279; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042416; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0050877; GO:0050893; GO:0051117; GO:0070373; GO:0070374; GO:0095500; GO:0097110; GO:0098690; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:1904315; GO:1905144; GO:2000300";"acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp129677_c3_seq1;GAXK01181466.1;O89114;9.97E-34;DNJB5_MOUSE;DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40);"cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"GO:0000122; GO:0005634; GO:0005829; GO:0006986; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp129695_c0_seq1;GAXK01181453.1;Q24342;1.91E-102;FNG_DROME;Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0001745; GO:0005737; GO:0005783; GO:0005794; GO:0005795; GO:0005797; GO:0006493; GO:0007293; GO:0007450; GO:0007476; GO:0008375; GO:0008587; GO:0008593; GO:0030173; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]"
comp1296991_c0_seq1;GAXK01016770.1;C6JUN9;2.44E-25;LEC1_MICCO;C-type lectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp12970_c2_seq1;GAXK01020381.1;Q91821;3.35E-153;MELK_XENLA;Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]";"GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]"
comp129712_c1_seq1;GAXK01181618.1;Q9W358;4.96E-61;RIC8_DROME;Synembryn (Protein Ric-8);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; asymmetric cell division [GO:0008356]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation involving germ band extension [GO:0010004]; neuroblast division [GO:0055057]; protein localization [GO:0008104]; protein stabilization [GO:0050821]";"GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005938; GO:0007163; GO:0007186; GO:0008104; GO:0008356; GO:0010004; GO:0040001; GO:0050821; GO:0055057";"asymmetric cell division [GO:0008356]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation involving germ band extension [GO:0010004]; G protein-coupled receptor signaling pathway [GO:0007186]; neuroblast division [GO:0055057]; protein localization [GO:0008104]; protein stabilization [GO:0050821]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]"
comp1297402_c0_seq1;GAXK01016759.1;P25169;5.89E-48;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp1297504_c0_seq1;GAXK01016797.1;Q94900;1.80E-15;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1297718_c0_seq1;GAXK01016802.1;D3YXG0;1.61E-26;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1297834_c0_seq1;GAXK01016773.1;Q9R1T9;6.66E-96;KCNH4_RAT;Potassium voltage-gated channel subfamily H member 4 (Brain-specific eag-like channel 2) (BEC2) (Ether-a-go-go-like potassium channel 1) (ELK channel 1) (rElk1) (Voltage-gated potassium channel subunit Kv12.3);"integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005249; GO:0005887; GO:0034765; GO:0042391; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";integral component of plasma membrane [GO:0005887];voltage-gated potassium channel activity [GO:0005249]
comp1298099_c0_seq1;GAXK01061707.1;P50257;2.31E-88;EF1AS_PORPU;Elongation factor 1-alpha S (EF-1-alpha S) (Sporophyte-specific EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp129820_c5_seq1;GAXK01181428.1;P17970;0;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp129834_c0_seq1;GAXK01181615.1;P27615;7.10E-12;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp129854_c0_seq1;GAXK01181361.1;Q95L11;2.13E-80;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp1298603_c0_seq1;GAXK01204827.1;P18172;7.28E-39;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp1299_c1_seq1;GAXK01169235.1;O01666;4.00E-112;ATPG_DROME;ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit);"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"GO:0000275; GO:0005739; GO:0006754; GO:0015986; GO:0046933; GO:1902600";"ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]";proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]
comp12990_c0_seq1;GAXK01020963.1;Q9Y3B4;3.19E-71;SF3B6_HUMAN;Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa);"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005686; GO:0005689; GO:0071013";"blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]";"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1299359_c0_seq1;GAXK01061730.1;P52746;1.33E-21;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1299364_c0_seq1;GAXK01061755.1;Q5SVQ8;9.77E-18;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp12994_c0_seq1;GAXK01020047.1;P29775;2.43E-41;ETS4_DROME;DNA-binding protein D-ETS-4;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565";"cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp129949_c0_seq1;GAXK01181485.1;Q0VCH3;4.17E-21;CDPF1_BOVIN;Cysteine-rich DPF motif domain-containing protein 1;;;;;
comp129967_c5_seq1;GAXK01181490.1;O43426;0;SYNJ1_HUMAN;Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1);"clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]";"GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0034595; GO:0043195; GO:0043647; GO:0043812; GO:0046488; GO:0046855; GO:0046856; GO:0048471; GO:0048488; GO:0048489; GO:0061024; GO:0097060; GO:0098793; GO:1904980";"brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]";"clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]";"phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp12997_c0_seq1;GAXK01020246.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp13_c0_seq1;GAXK01169093.1;P07797;2.95E-07;FRI3_LITCT;Ferritin, lower subunit (Ferritin L);"cell [GO:0005623]; ferric iron binding [GO:0008199]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0005623; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cell [GO:0005623];ferric iron binding [GO:0008199]
comp130_c1_seq1;GAXK01165542.1;P61270;7.70E-73;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp130025_c0_seq1;GAXK01044328.1;Q9VHH9;4.38E-09;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp1300355_c0_seq1;GAXK01151831.1;A2CG49;1.72E-19;KALRN_MOUSE;Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274";"adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp130044_c0_seq1;GAXK01044197.1;Q539E5;6.03E-11;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp130068_c0_seq1;GAXK01044342.1;Q8T498;2.02E-129;GAP2_DROME;Probable Ras GTPase-activating protein;"apical cortex [GO:0045179]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]";"GO:0005096; GO:0007165; GO:0045179; GO:0046580";"negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]";apical cortex [GO:0045179];GTPase activator activity [GO:0005096]
comp13009_c0_seq1;GAXK01020044.1;A2VE47;3.30E-53;ADPGK_BOVIN;ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872]"
comp1301244_c0_seq1;GAXK01151825.1;Q25452;1.96E-09;CAC1M_MUSDO;Muscle calcium channel subunit alpha-1 (MDL-alpha-1);"voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0034765; GO:0046872";regulation of ion transmembrane transport [GO:0034765];voltage-gated calcium channel complex [GO:0005891];"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp1301291_c0_seq1;GAXK01151838.1;Q6DHG0;9.83E-48;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1301475_c0_seq1;GAXK01151819.1;Q54VV7;8.50E-07;Y0111_DICDI;Probable serine/threonine-protein kinase DDB_G0280111 (EC 2.7.11.1);"ATP binding [GO:0005524]; phospholipid binding [GO:0005543]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0005524; GO:0005543; GO:0006468";protein phosphorylation [GO:0006468];;"ATP binding [GO:0005524]; phospholipid binding [GO:0005543]; protein serine/threonine kinase activity [GO:0004674]"
comp13015_c0_seq1;GAXK01020720.1;Q9CWP6;4.56E-33;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp130197_c0_seq1;GAXK01044118.1;Q9C6H2;4.62E-10;SINL3_ARATH;E3 ubiquitin-protein ligase SINA-like 3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 3) (Seven in absentia-like protein 3);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1302097_c0_seq1;GAXK01145660.1;Q6ZNA1;1.36E-10;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp130243_c0_seq1;GAXK01044317.1;Q8AVG0;1.05E-149;ABR_XENLA;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1302499_c0_seq1;GAXK01145645.1;Q8C8R3;1.57E-09;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp1302880_c0_seq1;GAXK01145650.1;O15442;1.52E-34;MPPD1_HUMAN;Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp130302_c0_seq1;GAXK01044006.1;Q26473;1.36E-177;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp130311_c0_seq1;GAXK01044279.1;P52429;6.31E-118;DGKE_HUMAN;Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid biosynthetic process [GO:0008654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]";"GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0008654; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050804; GO:0098978";"diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid biosynthetic process [GO:0008654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp130330_c0_seq1;GAXK01044016.1;Q91502;4.95E-45;SC6A8_TORMA;Creatine transporter;"integral component of membrane [GO:0016021]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0016021";;integral component of membrane [GO:0016021];neurotransmitter:sodium symporter activity [GO:0005328]
comp13034_c0_seq1;GAXK01020849.1;Q6UX98;1.51E-20;ZDH24_HUMAN;Probable palmitoyltransferase ZDHHC24 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 24) (DHHC-24);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp130377_c0_seq1;GAXK01044357.1;A0JMY5;0;NFXL1_XENLA;NF-X1-type zinc finger protein NFXL1;"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0016021";;"integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp1303779_c0_seq1;GAXK01145663.1;Q96PQ6;3.86E-22;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp130392_c0_seq1;GAXK01044324.1;P18714;1.16E-15;ZG20_XENLA;Gastrula zinc finger protein xFG20-1 (XlCGF20.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1304_c3_seq1;GAXK01168197.1;Q5R1W5;9.50E-28;SRSF2_PANTR;Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp130410_c0_seq1;GAXK01044155.1;P20456;5.32E-68;IMPA1_BOVIN;Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1);"cytoplasm [GO:0005737]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";"GO:0000287; GO:0005737; GO:0006021; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834";"inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]"
comp1304325_c0_seq1;GAXK01046233.1;A2ANX9;1.03E-10;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp130438_c0_seq1;GAXK01044117.1;O75581;2.80E-144;LRP6_HUMAN;Low-density lipoprotein receptor-related protein 6 (LRP-6);"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909";"anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]";"apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp130451_c0_seq1;GAXK01044305.1;Q24025;2.93E-146;SOG_DROME;Dorsal-ventral patterning protein Sog (Short gastrulation protein);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; amnioserosa formation [GO:0007378]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]; sequestering of BMP from receptor via BMP binding [GO:0038098]";"GO:0000139; GO:0005518; GO:0005615; GO:0005886; GO:0007313; GO:0007378; GO:0008083; GO:0008586; GO:0016021; GO:0030513; GO:0030514; GO:0035271; GO:0035592; GO:0036122; GO:0038098; GO:0040008; GO:0061328; GO:0110107";"amnioserosa formation [GO:0007378]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]; sequestering of BMP from receptor via BMP binding [GO:0038098]";"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"BMP binding [GO:0036122]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]"
comp130453_c0_seq1;GAXK01044322.1;Q96CD2;7.33E-40;COAC_HUMAN;Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC);"cytosol [GO:0005829]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]";"GO:0004633; GO:0005829; GO:0009108; GO:0015937; GO:0042802";"coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]"
comp1304694_c0_seq1;GAXK01046235.1;P81133;3.05E-165;SIM1_HUMAN;Single-minded homolog 1 (Class E basic helix-loop-helix protein 14) (bHLHe14);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]";"GO:0000790; GO:0000981; GO:0001657; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0046982";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]"
comp1304831_c0_seq1;GAXK01046262.1;Q58DR5;1.57E-33;SCAM3_BOVIN;Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; protein transport [GO:0015031]";"GO:0000139; GO:0005794; GO:0015031; GO:0016021; GO:0032588; GO:0055038";protein transport [GO:0015031];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]";
comp130504_c0_seq1;GAXK01044304.1;O96081;9.64E-26;CALMB_HALRO;Calmodulin-B (CaM B);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1305735_c0_seq1;GAXK01046253.1;Q9Y6R4;5.89E-78;M3K4_HUMAN;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp1306104_c0_seq1;GAXK01107640.1;Q66H07;2.48E-12;FANK1_RAT;Fibronectin type 3 and ankyrin repeat domains 1 protein;"chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005929; GO:0036064; GO:0043065; GO:0043066; GO:0045893; GO:0051091";"negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]";"chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1306223_c0_seq1;GAXK01107606.1;Q27294;3.12E-27;CAZ_DROME;RNA-binding protein cabeza (P19) (Sarcoma-associated RNA-binding fly homolog);"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000398; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006367; GO:0008344; GO:0008345; GO:0045887; GO:0046872; GO:0048749; GO:0051124; GO:0071013";"adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp1306488_c1_seq1;GAXK01107598.1;Q4R882;3.21E-13;ZN561_MACFA;Zinc finger protein 561;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp130652_c0_seq1;GAXK01044115.1;Q3Y8M6;6.57E-43;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp130660_c11_seq1;GAXK01044052.1;Q91YR9;1.26E-91;PTGR1_MOUSE;Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74);"cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]; response to antineoplastic agent [GO:0097327]";"GO:0005737; GO:0032440; GO:0036132; GO:0047522; GO:0097327";response to antineoplastic agent [GO:0097327];cytoplasm [GO:0005737];"13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]"
comp13067_c2_seq1;GAXK01020313.1;Q28ID3;6.09E-134;GLRX3_XENTR;Glutaredoxin-3 (Thioredoxin-like protein 2);"cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"GO:0005634; GO:0005829; GO:0006879; GO:0009055; GO:0015035; GO:0015038; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0097428";"[2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"
comp1306839_c0_seq1;GAXK01107649.1;Q9R0S3;1.11E-20;MMP17_MOUSE;Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]";"GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0042756";"collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp13069_c0_seq1;GAXK01020020.1;Q9QZH3;2.81E-141;PPIE_MOUSE;Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; unfolded protein binding [GO:0051082]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000398; GO:0000413; GO:0003729; GO:0003755; GO:0005634; GO:0005829; GO:0006355; GO:0008143; GO:0016018; GO:0016607; GO:0042026; GO:0045070; GO:0051082; GO:0071007; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of transcription, DNA-templated [GO:0006355]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";"cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; unfolded protein binding [GO:0051082]"
comp130728_c1_seq1;GAXK01044282.1;B0WC46;8.14E-96;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1307334_c0_seq1;GAXK01107629.1;Q9W0T5;3.51E-12;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp1307462_c0_seq1;GAXK01107607.1;Q25074;2.19E-24;AQP_HAEIX;Aquaporin (BfWC1) (Water channel 1);"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp1307525_c0_seq1;GAXK01107631.1;P48059;9.80E-131;LIMS1_HUMAN;LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051291; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046";"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]"
comp1307589_c0_seq1;GAXK01107609.1;O35548;3.08E-13;MMP16_RAT;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; response to odorant [GO:1990834]; skeletal system development [GO:0001501]";"GO:0001501; GO:0004222; GO:0005615; GO:0005887; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:1990834";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; response to odorant [GO:1990834]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1307697_c0_seq1;GAXK01107604.1;Q5R8J8;4.44E-08;DNJB4_PONAB;DnaJ homolog subfamily B member 4;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0001671; GO:0005737; GO:0005886; GO:0006457; GO:0051082";protein folding [GO:0006457];"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATPase activator activity [GO:0001671]; unfolded protein binding [GO:0051082]"
comp130801_c0_seq1;GAXK01044017.1;Q5R6I6;1.18E-66;S39AD_PONAB;Zinc transporter ZIP13 (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]";"GO:0000139; GO:0006829; GO:0016021; GO:0046873";zinc ion transport [GO:0006829];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";metal ion transmembrane transporter activity [GO:0046873]
comp1308053_c0_seq1;GAXK01173418.1;Q9W6V2;1.79E-24;NEGR1_CHICK;Neuronal growth regulator 1 (Neurotractin);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp130871_c0_seq1;GAXK01044157.1;Q5R7K0;6.92E-62;HSDL1_PONAB;Inactive hydroxysteroid dehydrogenase-like protein 1;"mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0055114";oxidation-reduction process [GO:0055114];mitochondrion [GO:0005739];
comp130887_c2_seq1;GAXK01044005.1;Q7KRI2;9.40E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1308961_c0_seq1;GAXK01173397.1;Q9JHE8;5.64E-17;NINJ2_RAT;Ninjurin-2 (Nerve injury-induced protein 2);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";"GO:0007155; GO:0016021; GO:0042246";"cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";integral component of membrane [GO:0016021];
comp1309849_c0_seq1;GAXK01173413.1;Q7Z6K4;1.25E-07;NRARP_HUMAN;Notch-regulated ankyrin repeat-containing protein;"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";"GO:0000122; GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:1902367";"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";;
comp1309944_c0_seq1;GAXK01173400.1;Q9VZW5;8.38E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1309961_c0_seq1;GAXK01173417.1;Q9H8M5;3.03E-86;CNNM2_HUMAN;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231";magnesium ion homeostasis [GO:0010960];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp1309973_c0_seq1;GAXK01173401.1;Q6MG71;7.56E-14;CTL4_RAT;Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]"
comp131008_c2_seq1;GAXK01044311.1;O02485;4.40E-57;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp1310299_c0_seq1;GAXK01129120.1;Q8VHX6;7.70E-21;FLNC_MOUSE;Filamin-C (FLN-C) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament-based process [GO:0030029]; muscle fiber development [GO:0048747]";"GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0008092; GO:0015629; GO:0016528; GO:0030018; GO:0030029; GO:0030506; GO:0042383; GO:0042802; GO:0048747";"actin filament-based process [GO:0030029]; muscle fiber development [GO:0048747]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]";"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]"
comp131032_c2_seq1;GAXK01044012.1;Q9JMD3;1.26E-61;STA10_MOUSE;START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10);"cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]";"GO:0005548; GO:0005829; GO:0005902; GO:0008289; GO:0015914; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581";"bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]";"cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]";"lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]"
comp1310419_c0_seq1;GAXK01129088.1;P55112;8.62E-21;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1310760_c0_seq1;GAXK01129102.1;Q15119;2.52E-37;PDK2_HUMAN;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]";"GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005967; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0050848; GO:0072332";"cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp131085_c1_seq1;GAXK01044296.1;P41214;2.55E-103;EIF2D_HUMAN;Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]";"GO:0001731; GO:0003743; GO:0005737; GO:0005829; GO:0006886; GO:0016604; GO:0032790; GO:0038023; GO:0075522";"formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]";"signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]"
comp131092_c0_seq1;GAXK01044214.1;O64943;1.66E-17;POLC2_JUNOX;Polcalcin Jun o 2 (Calcium-binding pollen allergen Jun o 2) (allergen Jun o 2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1310926_c0_seq1;GAXK01129100.1;Q62283;1.49E-10;TSN7_MOUSE;Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp131101_c0_seq1;GAXK01044355.1;P37747;5.24E-24;GLF_ECOLI;UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) (UDP-GALP mutase) (Uridine 5-diphosphate galactopyranose mutase);"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]; lipopolysaccharide biosynthetic process [GO:0009103]";"GO:0005829; GO:0008767; GO:0009103; GO:0050660";lipopolysaccharide biosynthetic process [GO:0009103];cytosol [GO:0005829];"flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]"
comp131106_c2_seq1;GAXK01044281.1;Q6YP21;1.03E-117;KAT3_HUMAN;Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]";"GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]"
comp131112_c1_seq1;GAXK01043972.1;Q9DBY8;6.85E-41;NVL_MOUSE;Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein);"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275";"positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]"
comp1311149_c0_seq1;GAXK01129075.1;P35832;1.43E-91;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp13113_c0_seq1;GAXK01020136.1;P56873;1.04E-30;ZNRD2_MOUSE;Protein ZNRD2 (Autoantigen p27 homolog) (Protein C184L) (Sjoegren syndrome/scleroderma autoantigen 1 homolog) (Zinc ribbon domain-containing protein 2);identical protein binding [GO:0042802];GO:0042802;;;identical protein binding [GO:0042802]
comp1311335_c0_seq1;GAXK01129091.1;Q3TN34;5.05E-33;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp13114_c2_seq1;GAXK01020950.1;P49321;1.25E-26;NASP_HUMAN;Nuclear autoantigenic sperm protein (NASP);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell population proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]";"GO:0000082; GO:0000790; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0006336; GO:0008283; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0043486; GO:0044877";"blastocyst development [GO:0001824]; cell population proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]"
comp1311434_c0_seq1;GAXK01129107.1;Q7MND7;1.50E-44;DADA_VIBVY;D-amino acid dehydrogenase (EC 1.4.99.-);"D-amino-acid dehydrogenase activity [GO:0008718]; D-amino acid catabolic process [GO:0019478]";"GO:0008718; GO:0019478";D-amino acid catabolic process [GO:0019478];;D-amino-acid dehydrogenase activity [GO:0008718]
comp131151_c3_seq1;GAXK01044309.1;O17795;5.40E-21;STDH2_CAEEL;Putative steroid dehydrogenase 2 (EC 1.1.1.-);"endoplasmic reticulum [GO:0005783]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"GO:0005783; GO:0006694; GO:0016491; GO:0030497";"fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";endoplasmic reticulum [GO:0005783];oxidoreductase activity [GO:0016491]
comp1311538_c0_seq1;GAXK01129069.1;Q4GZT3;3.24E-92;PKD2_BOVIN;Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738";"calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp1311542_c0_seq1;GAXK01129078.1;Q9W6A8;3.27E-09;OP1S2_DANRE;Opsin-1, short-wave-sensitive 2 (Blue cone photoreceptor pigment) (Blue-sensitive opsin) (Opsin SWS-2);"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; blue light photoreceptor activity [GO:0009882]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0001750; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009882; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]";"blue light photoreceptor activity [GO:0009882]; G protein-coupled photoreceptor activity [GO:0008020]"
comp131159_c0_seq1;GAXK01043988.1;A6NCF5;1.61E-10;KLH33_HUMAN;Kelch-like protein 33;;;;;
comp131175_c0_seq1;GAXK01044044.1;Q5T2R2;8.68E-102;DPS1_HUMAN;Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1);"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234";"isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]"
comp1312_c0_seq1;GAXK01169974.1;Q8CEF1;1.05E-84;FEM1C_MOUSE;Protein fem-1 homolog C (FEM1c) (FEM1-gamma);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]";"GO:0005654; GO:0005829; GO:0016567";protein ubiquitination [GO:0016567];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp13120_c2_seq1;GAXK01020318.1;Q5F339;2.62E-96;CCHL_CHICK;Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]";"GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872";cytochrome c-heme linkage [GO:0018063];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]"
comp1312002_c0_seq1;GAXK01087441.1;Q3T191;3.22E-09;CIDEB_BOVIN;Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B);"lipid droplet [GO:0005811]; apoptotic process [GO:0006915]";"GO:0005811; GO:0006915";apoptotic process [GO:0006915];lipid droplet [GO:0005811];
comp1312098_c0_seq1;GAXK01087452.1;Q8ITC7;4.91E-56;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp1312309_c0_seq1;GAXK01087468.1;O35956;2.92E-07;S22A6_RAT;Solute carrier family 22 member 6 (Organic anion transporter 1) (rOAT1) (renal organic anion transporter 1) (rROAT1);"basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]";"GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042803; GO:0043252; GO:0051260; GO:0097254";"alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]";"basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]"
comp13124_c1_seq1;GAXK01020316.1;Q9JJK4;2.57E-46;PEX3_RAT;Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]; lipid binding [GO:0008289]; protein binding, bridging [GO:0030674]; protein dimerization activity [GO:0046983]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]";"GO:0005654; GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0005829; GO:0007031; GO:0008289; GO:0016021; GO:0016557; GO:0030674; GO:0032994; GO:0045046; GO:0046983";"peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]";"lipid binding [GO:0008289]; protein binding, bridging [GO:0030674]; protein dimerization activity [GO:0046983]"
comp1312421_c0_seq1;GAXK01087469.1;D3Z5L6;2.92E-35;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp131255_c1_seq1;GAXK01044116.1;P45882;1.01E-24;ACBP_ANAPL;Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0005783; GO:0005794; GO:0008289";;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp131266_c0_seq1;GAXK01044004.1;Q5DHJ5;1.13E-77;IFT46_SCHJA;Intraflagellar transport protein 46 homolog;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport [GO:0042073]";"GO:0005737; GO:0005856; GO:0005929; GO:0042073";intraciliary transport [GO:0042073];"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp1312735_c0_seq1;GAXK01087474.1;P55786;7.66E-26;PSA_HUMAN;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp131295_c0_seq1;GAXK01044019.1;P22288;6.67E-86;GCH1_RAT;GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein-containing complex assembly [GO:0065003]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]";"GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042803; GO:0045776; GO:0046654; GO:0048265; GO:0050662; GO:0050884; GO:0051000; GO:0051019; GO:0051066; GO:0051260; GO:0051291; GO:0065003; GO:2000121";"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]"
comp1313024_c0_seq1;GAXK01087451.1;Q9Y2H8;5.65E-08;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1313089_c0_seq1;GAXK01087478.1;Q9HFY6;1.12E-36;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1313379_c0_seq1;GAXK01087447.1;Q1RJR6;1.25E-18;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp131347_c2_seq1;GAXK01044350.1;Q9VSL7;1.76E-53;FOI_DROME;Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007280; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030154; GO:0035147; GO:0035262; GO:0071578";"branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp131351_c0_seq1;GAXK01044349.1;Q3UPH1;1.89E-58;PRRC1_MOUSE;Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199]";"GO:0005737; GO:0005794; GO:0034199; GO:0034237";activation of protein kinase A activity [GO:0034199];"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";protein kinase A regulatory subunit binding [GO:0034237]
comp1313661_c0_seq1;GAXK01087459.1;Q9JME2;1.14E-18;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp131376_c2_seq1;GAXK01044318.1;Q10L91;1.22E-08;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1313984_c0_seq1;GAXK01087477.1;Q9WVR6;1.49E-12;LAT2_RAT;Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; neutral amino acid transport [GO:0015804]";"GO:0005737; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0016021; GO:0016323; GO:0019534; GO:0042605";neutral amino acid transport [GO:0015804];"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]"
comp1314011_c0_seq1;GAXK01000280.1;Q80VW5;4.86E-26;WHRN_MOUSE;Whirlin;"actin filament [GO:0005884]; axon [GO:0030424]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0016020; GO:0019904; GO:0021694; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042803; GO:0043025; GO:0043198; GO:0045184; GO:0045202; GO:0046982; GO:0050910; GO:0050953; GO:0060088; GO:0060122; GO:1990075; GO:1990227; GO:1990696";"auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"actin filament [GO:0005884]; axon [GO:0030424]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]";"protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp13141_c2_seq1;GAXK01020836.1;Q8BGH2;5.02E-91;SAM50_MOUSE;Sorting and assembly machinery component 50 homolog;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]";"GO:0001401; GO:0005739; GO:0005741; GO:0005743; GO:0016021; GO:0033108; GO:0034622; GO:0042407; GO:0045040";"cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]";
comp13143_c0_seq1;GAXK01020045.1;O88828;1.11E-39;RPAB2_RAT;DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog);"nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383";"transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp13148_c2_seq1;GAXK01020240.1;Q9Y5A7;3.14E-64;NUB1_HUMAN;NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18);"cytosol [GO:0005829]; nucleus [GO:0005634]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:0043687";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp131493_c0_seq1;GAXK01044137.1;B3MLI0;1.99E-80;U518_DROAN;UPF0518 protein GF15501;;;;;
comp1315_c0_seq1;GAXK01169970.1;Q8R1R3;7.18E-34;STAR7_MOUSE;StAR-related lipid transfer protein 7, mitochondrial (START domain-containing protein 7) (StARD7);"mitochondrion [GO:0005739]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914]";"GO:0005548; GO:0005739; GO:0008289; GO:0015914";phospholipid transport [GO:0015914];mitochondrion [GO:0005739];"lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]"
comp131530_c2_seq1;GAXK01043997.1;Q7KRI2;1.33E-13;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1315557_c1_seq1;GAXK01000253.1;Q9NPG2;3.36E-15;NGB_HUMAN;Neuroglobin;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; apoptotic process [GO:0006915]; oxygen transport [GO:0015671]";"GO:0005344; GO:0005739; GO:0005829; GO:0006915; GO:0015671; GO:0019825; GO:0020037; GO:0043204; GO:0046872";"apoptotic process [GO:0006915]; oxygen transport [GO:0015671]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp131565_c0_seq1;GAXK01044020.1;Q5SSK3;2.30E-09;TEFM_MOUSE;Transcription elongation factor, mitochondrial;"mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; DNA polymerase processivity factor activity [GO:0030337]; nucleic acid binding [GO:0003676]; mitochondrial transcription [GO:0006390]; oxidative phosphorylation [GO:0006119]; transcription elongation from mitochondrial promoter [GO:0006392]";"GO:0003676; GO:0005739; GO:0005759; GO:0006119; GO:0006390; GO:0006392; GO:0030337; GO:0042645; GO:1990904";"mitochondrial transcription [GO:0006390]; oxidative phosphorylation [GO:0006119]; transcription elongation from mitochondrial promoter [GO:0006392]";"mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]";"DNA polymerase processivity factor activity [GO:0030337]; nucleic acid binding [GO:0003676]"
comp1315703_c0_seq1;GAXK01000268.1;Q9UBX3;2.27E-25;DIC_HUMAN;Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0070221; GO:0071422; GO:0071423";"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]"
comp131608_c0_seq1;GAXK01044209.1;P24156;6.42E-61;L2CC_DROME;Protein l(2)37Cc;"membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"GO:0005739; GO:0007275; GO:0016020; GO:0071456";"cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"membrane [GO:0016020]; mitochondrion [GO:0005739]";
comp131654_c2_seq1;GAXK01044023.1;P48728;6.94E-144;GCST_HUMAN;Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0006546; GO:0008483; GO:0019464";"glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]"
comp13166_c0_seq1;GAXK01020333.1;Q9VJ26;9.08E-50;EFHD2_DROME;EF-hand domain-containing protein D2 homolog (Swiprosin-1 homolog);"muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005886; GO:0005927; GO:0007498";mesoderm development [GO:0007498];"muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp131678_c0_seq1;GAXK01044153.1;Q9UJT9;2.16E-17;FBXL7_HUMAN;F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7);"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0004842; GO:0005813; GO:0005829; GO:0006511; GO:0008283; GO:0010265; GO:0010972; GO:0016567; GO:0019005; GO:0031146; GO:0043687; GO:0051301";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";ubiquitin-protein transferase activity [GO:0004842]
comp1316856_c0_seq1;GAXK01042899.1;Q01528;7.81E-10;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1316925_c0_seq1;GAXK01042911.1;P48284;2.11E-31;CAH4_RAT;Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV);"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; animal organ development [GO:0048513]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]";"GO:0004089; GO:0008270; GO:0016324; GO:0016529; GO:0031225; GO:0042383; GO:0042493; GO:0048513; GO:0048545";"animal organ development [GO:0048513]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]";"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp13170_c1_seq1;GAXK01020376.1;P83871;5.43E-69;PHF5A_RAT;PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b);"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000398; GO:0003677; GO:0003700; GO:0003723; GO:0005686; GO:0005689; GO:0016363; GO:0016607; GO:0045893; GO:0046872; GO:0071005";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]";"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp1317000_c0_seq1;GAXK01042920.1;P0DOC8;1.17E-27;CH037_DANRE;Protein C8orf37 homolog;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; photoreceptor cell morphogenesis [GO:0008594]";"GO:0001917; GO:0005737; GO:0005829; GO:0008594; GO:0032402; GO:0070121";"Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; photoreceptor cell morphogenesis [GO:0008594]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]";
comp131710_c1_seq1;GAXK01044189.1;Q7KRI2;8.17E-12;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1317209_c0_seq1;GAXK01042909.1;P28476;7.19E-21;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp131732_c3_seq1;GAXK01044024.1;P41476;8.30E-10;RNL1_NPVAC;"Putative bifunctional polynucleotide kinase/RNA ligase [Includes: Polynucleotide kinase (PNK) (EC 2.7.1.78) (Polynucleotide 5'-hydroxy-kinase); RNA ligase (EC 6.5.1.3)]";"ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; RNA ligase (ATP) activity [GO:0003972]; RNA repair [GO:0042245]";"GO:0003972; GO:0005524; GO:0042245; GO:0046404";RNA repair [GO:0042245];;"ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; RNA ligase (ATP) activity [GO:0003972]"
comp1317375_c0_seq1;GAXK01042918.1;Q01070;1.03E-38;ESMC_DROME;Enhancer of split mgamma protein (E(spl)mgamma) (Split locus enhancer protein mB);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0008134; GO:0009952; GO:0030154; GO:0035326; GO:0043565; GO:0046983; GO:0048190; GO:0050767; GO:0097150; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"
comp13174_c3_seq1;GAXK01020547.1;D3ZVM4;3.30E-136;LIN41_RAT;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);"P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";"GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637";"3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";P-body [GO:0000932];"miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1317402_c0_seq1;GAXK01042903.1;Q9VZW5;1.30E-20;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1317496_c0_seq1;GAXK01042887.1;B7Z0W9;3.01E-119;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp131759_c0_seq1;GAXK01044287.1;Q7KRI2;5.33E-30;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp131769_c0_seq1;GAXK01044150.1;P16157;3.99E-32;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp1317762_c0_seq1;GAXK01042888.1;A1L253;6.47E-08;F149B_DANRE;Protein FAM149B1;;;;;
comp131782_c0_seq1;GAXK01044001.1;Q8IN81;6.86E-11;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1318039_c0_seq1;GAXK01136238.1;P86854;2.25E-12;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1318294_c0_seq1;GAXK01136232.1;Q9VZW5;7.23E-15;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1318403_c0_seq1;GAXK01136228.1;Q75NR7;3.01E-09;RECQ4_MOUSE;ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RecQ protein-like 4);"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0001501; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0008270; GO:0008284; GO:0009378; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0043473; GO:0045875; GO:0048705; GO:0061820; GO:0061821";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]"
comp13185_c0_seq1;GAXK01020499.1;Q9VVE5;8.70E-88;MSIR6_DROME;RNA-binding protein Musashi homolog Rbp6;"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]";"GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904";stem cell development [GO:0048864];"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp1318806_c0_seq1;GAXK01136213.1;O01382;2.38E-34;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp131888_c0_seq1;GAXK01044144.1;Q9VWB0;0;TECPR_DROME;Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein);"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]";"GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266";peroxisome organization [GO:0007031];"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp1318885_c0_seq1;GAXK01136240.1;O35678;4.20E-32;MGLL_MOUSE;Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL);"axon [GO:0030424]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0005654; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0097756; GO:2000124";"acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"axon [GO:0030424]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; varicosity [GO:0043196]";"acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]"
comp1319072_c0_seq1;GAXK01136242.1;B5X3W7;2.30E-09;CTL2_SALSA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp131942_c0_seq1;GAXK01043998.1;Q8BL66;2.71E-41;EEA1_MOUSE;Early endosome antigen 1;"axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]";"GO:0003676; GO:0005545; GO:0005768; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0019897; GO:0030742; GO:0031410; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0046872; GO:0055037";"endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]";"axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]";"1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp1319765_c0_seq1;GAXK01136229.1;O95436;1.38E-30;NPT2B_HUMAN;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]";"GO:0001701; GO:0005436; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0015321; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031526; GO:0031982; GO:0042301; GO:0043627; GO:0044267; GO:0044341";"cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"phosphate ion binding [GO:0042301]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium ion binding [GO:0031402]"
comp1319766_c0_seq1;GAXK01136226.1;P49275;9.33E-49;DERF3_DERFA;Mite allergen Der f 3 (EC 3.4.21.-) (Allergen Der f III) (allergen Der f 3);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp13199_c0_seq1;GAXK01020844.1;Q9VMM6;1.78E-12;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp131998_c0_seq1;GAXK01044002.1;Q1RM03;1.09E-09;TCHP_DANRE;Trichoplein keratin filament-binding protein (Protein TCHP);"cytoplasm [GO:0005737]; keratin filament [GO:0045095]; apoptotic process [GO:0006915]";"GO:0005737; GO:0006915; GO:0045095";apoptotic process [GO:0006915];"cytoplasm [GO:0005737]; keratin filament [GO:0045095]";
comp13202_c0_seq1;GAXK01019910.1;Q6PC64;7.03E-71;ELOV6_DANRE;Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp1320275_c0_seq1;GAXK01136662.1;P02707;5.87E-13;LECH_CHICK;Hepatic lectin;"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]";"GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];integral component of membrane [GO:0016021];carbohydrate binding [GO:0030246]
comp1320449_c0_seq1;GAXK01136636.1;Q9VCA2;1.27E-54;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp13207_c0_seq1;GAXK01020665.1;Q3T174;5.61E-43;TAF12_BOVIN;Transcription initiation factor TFIID subunit 12 (Transcription initiation factor TFIID 20/15 kDa subunits) (TAFII-20/TAFII-15) (TAFII20/TAFII15);"SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; RNA polymerase II preinitiation complex assembly [GO:0051123]";"GO:0000124; GO:0003677; GO:0005669; GO:0017025; GO:0043966; GO:0046695; GO:0046982; GO:0051123";"histone H3 acetylation [GO:0043966]; RNA polymerase II preinitiation complex assembly [GO:0051123]";"SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]"
comp132107_c0_seq1;GAXK01173204.1;C4N147;7.66E-08;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp132139_c1_seq1;GAXK01172885.1;Q96CB9;9.17E-65;NSUN4_HUMAN;5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]; mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; rRNA methylation [GO:0031167]";"GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0031167; GO:0042256; GO:0070131; GO:0070181";"mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; rRNA methylation [GO:0031167]";"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]";"methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]"
comp1321535_c0_seq1;GAXK01136634.1;P83088;2.84E-60;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp13216_c0_seq1;GAXK01020917.1;P11960;0;ODBA_RAT;2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha) (Fragment);"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 2-oxoisovalerate dehydrogenase (acylating) activity [GO:0047101]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; branched-chain amino acid catabolic process [GO:0009083]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]";"GO:0003826; GO:0003863; GO:0005739; GO:0005947; GO:0007584; GO:0009083; GO:0044877; GO:0046872; GO:0047101; GO:0051384; GO:0051591";"branched-chain amino acid catabolic process [GO:0009083]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]";"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]";"2-oxoisovalerate dehydrogenase (acylating) activity [GO:0047101]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]"
comp1321759_c0_seq1;GAXK01136631.1;Q1RJR6;4.23E-10;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp132179_c1_seq1;GAXK01173038.1;P10242;6.02E-83;MYB_HUMAN;Transcriptional activator Myb (Proto-oncogene c-Myb);"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]";"GO:0000122; GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0005654; GO:0006338; GO:0006355; GO:0016363; GO:0032967; GO:0043525; GO:0045624; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0051571; GO:0051574; GO:0060252; GO:0070301; GO:0071300; GO:0071636; GO:1902036; GO:1904899; GO:2000491; GO:2000845";"cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]";"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1321820_c0_seq1;GAXK01136654.1;Q9W707;3.94E-58;FXF1B_XENLA;Forkhead box protein F1-B (FoxF1-B) (FoxF1b) (Fork head domain-related protein 13') (xFD-13');"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; embryonic digestive tract development [GO:0048566]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; smooth muscle tissue development [GO:0048745]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0008283; GO:0030154; GO:0030509; GO:0043565; GO:0045893; GO:0048566; GO:0048745";"BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; embryonic digestive tract development [GO:0048566]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; smooth muscle tissue development [GO:0048745]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp1322130_c0_seq1;GAXK01090282.1;B3MFV7;3.68E-18;LPHN_DROAN;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1322244_c0_seq1;GAXK01090262.1;Q90632;3.85E-28;MOT3_CHICK;Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);"integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1322377_c0_seq1;GAXK01090308.1;Q14590;1.35E-08;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp132239_c0_seq1;GAXK01173258.1;Q9N2M8;4.94E-19;HDC_DROME;Headcase protein [Cleaved into: Headcase short protein];"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"GO:0002165; GO:0005737; GO:0007430; GO:0016246; GO:0030424; GO:0030425; GO:0035071; GO:0048471; GO:0048675; GO:0050768; GO:1904799";"axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]";
comp132241_c1_seq1;GAXK01172886.1;Q3UQ28;2.78E-121;PXDN_MOUSE;Peroxidasin homolog (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023";"collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1322549_c0_seq1;GAXK01090300.1;Q86YE8;1.13E-11;ZN573_HUMAN;Zinc finger protein 573;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp132257_c2_seq1;GAXK01173273.1;P31430;1.90E-42;DPEP1_RAT;Dipeptidase 1 (EC 3.4.13.19) (Microsomal dipeptidase) (Renal dipeptidase);"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; homocysteine metabolic process [GO:0050667]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]";"GO:0005615; GO:0005634; GO:0005886; GO:0008239; GO:0008270; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070573; GO:0071277; GO:0071732; GO:0072341";"antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; homocysteine metabolic process [GO:0050667]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]"
comp132268_c3_seq1;GAXK01173285.1;B2D0J5;6.77E-66;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp1323_c5_seq1;GAXK01168404.1;O61463;2.77E-15;RLA2_CRYST;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1323282_c0_seq1;GAXK01090302.1;Q0VG99;5.74E-09;MESP2_HUMAN;Mesoderm posterior protein 2 (Class C basic helix-loop-helix protein 6) (bHLHc6);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; heart morphogenesis [GO:0003007]; mesoderm formation [GO:0001707]; Notch signaling pathway [GO:0007219]; somitogenesis [GO:0001756]";"GO:0000790; GO:0000978; GO:0000981; GO:0001707; GO:0001756; GO:0003007; GO:0005634; GO:0007219; GO:0046983";"heart morphogenesis [GO:0003007]; mesoderm formation [GO:0001707]; Notch signaling pathway [GO:0007219]; somitogenesis [GO:0001756]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp132361_c2_seq1;GAXK01173154.1;Q9TXQ1;1.19E-83;TNKS1_CAEEL;Poly [ADP-ribose] polymerase tankyrase (EC 2.4.2.30) (Poly ADP-ribose metabolism enzyme 5) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-);"chromosome [GO:0005694]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; protein ADP-ribosylation [GO:0006471]; response to gamma radiation [GO:0010332]";"GO:0003950; GO:0005634; GO:0005694; GO:0006281; GO:0006471; GO:0006974; GO:0008630; GO:0010332; GO:0043069";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; protein ADP-ribosylation [GO:0006471]; response to gamma radiation [GO:0010332]";"chromosome [GO:0005694]; nucleus [GO:0005634]";NAD+ ADP-ribosyltransferase activity [GO:0003950]
comp1323722_c0_seq1;GAXK01090299.1;Q14BT6;1.32E-15;A4GCT_MOUSE;Alpha-1,4-N-acetylglucosaminyltransferase (Alpha4GnT) (EC 2.4.1.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0006493; GO:0008375; GO:0009101; GO:0016021; GO:0050680";"glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; protein O-linked glycosylation [GO:0006493]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";acetylglucosaminyltransferase activity [GO:0008375]
comp1323803_c0_seq1;GAXK01090284.1;Q5R5X9;4.47E-35;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1324002_c0_seq1;GAXK01157070.1;Q8TCX5;1.12E-11;RHPN1_HUMAN;Rhophilin-1 (GTP-Rho-binding protein 1);"cytosol [GO:0005829]; signal transduction [GO:0007165]";"GO:0005829; GO:0007165";signal transduction [GO:0007165];cytosol [GO:0005829];
comp1324043_c0_seq1;GAXK01157075.1;Q80X44;1.94E-12;ZBT24_MOUSE;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Brain-specific protein 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp132406_c0_seq1;GAXK01172965.1;Q16534;6.77E-38;HLF_HUMAN;Hepatic leukemia factor;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp132428_c0_seq1;GAXK01173268.1;F7D3V9;1.09E-108;LGR5_XENTR;Leucine-rich repeat-containing G-protein coupled receptor 5;"integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]";"GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0008528; GO:0009755; GO:0016500; GO:0032588; GO:0090263";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]";"integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]"
comp132443_c0_seq1;GAXK01173132.1;Q61603;3.37E-33;GLRA4_MOUSE;Glycine receptor subunit alpha-4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0050877; GO:0060012; GO:0098690; GO:0099060; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]"
comp13248_c2_seq1;GAXK01020874.1;O77460;2.76E-106;IPYR_DROME;Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; regulation of hemocyte proliferation [GO:0035206]; transcription, DNA-templated [GO:0006351]";"GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0006338; GO:0006351; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766";"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; regulation of hemocyte proliferation [GO:0035206]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NURF complex [GO:0016589]";"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp1324807_c0_seq1;GAXK01157081.1;O97716;2.09E-07;THA_PIG;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (c-erbA-1) (c-erbA-alpha);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0003707; GO:0004879; GO:0005634; GO:0005829; GO:0006366; GO:0007275; GO:0007420; GO:0007611; GO:0008016; GO:0008050; GO:0008134; GO:0008270; GO:0009409; GO:0009755; GO:0009887; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030374; GO:0030878; GO:0031490; GO:0033032; GO:0033993; GO:0038023; GO:0044877; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162";"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp1325237_c0_seq1;GAXK01157079.1;O97366;8.87E-36;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp13254_c0_seq1;GAXK01020706.1;Q14554;3.62E-71;PDIA5_HUMAN;Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein);"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; IRE1-mediated unfolded protein response [GO:0036498]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]";"GO:0003756; GO:0005788; GO:0005789; GO:0006457; GO:0015037; GO:0016491; GO:0036498; GO:0045454; GO:0055114";"cell redox homeostasis [GO:0045454]; IRE1-mediated unfolded protein response [GO:0036498]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]";"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]";"oxidoreductase activity [GO:0016491]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp132541_c1_seq1;GAXK01173135.1;Q9VQM4;1.37E-52;TYDP1_DROME;Probable tyrosyl-DNA phosphodiesterase (Tyr-DNA phosphodiesterase) (EC 3.1.4.-) (Protein glaikit);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]; central nervous system development [GO:0007417]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; single strand break repair [GO:0000012]";"GO:0000012; GO:0003690; GO:0003697; GO:0004527; GO:0005634; GO:0005737; GO:0006281; GO:0006302; GO:0007417; GO:0017005; GO:0045197";"central nervous system development [GO:0007417]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; single strand break repair [GO:0000012]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]"
comp132548_c0_seq1;GAXK01172938.1;Q5ZHN9;9.28E-117;PGPS1_CHICK;CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]";"GO:0005524; GO:0005739; GO:0008444; GO:0032049";cardiolipin biosynthetic process [GO:0032049];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]"
comp13255_c1_seq1;GAXK01020961.1;Q5IS99;8.89E-20;CASP3_SAIBB;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytosol [GO:0005829]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; anterior neural tube closure [GO:0061713]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]";"GO:0001782; GO:0004190; GO:0004861; GO:0005634; GO:0005829; GO:0006508; GO:0006974; GO:0007507; GO:0007605; GO:0008627; GO:0009411; GO:0009611; GO:0016485; GO:0030216; GO:0030218; GO:0030889; GO:0031647; GO:0034349; GO:0043029; GO:0043065; GO:0043066; GO:0045165; GO:0046007; GO:0048011; GO:0051402; GO:0061713; GO:0072734; GO:0097199; GO:0097200; GO:1902004";"anterior neural tube closure [GO:0061713]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp132564_c0_seq1;GAXK01173272.1;Q14982;1.04E-28;OPCM_HUMAN;Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp1325784_c0_seq1;GAXK01157095.1;Q9Y6K8;4.01E-29;KAD5_HUMAN;Adenylate kinase isoenzyme 5 (AK 5) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 5);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]";"GO:0004017; GO:0004550; GO:0005524; GO:0005815; GO:0005829; GO:0006165; GO:0006172; GO:0006173; GO:0009142; GO:0009220; GO:0015949; GO:0046034";"ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp132600_c0_seq1;GAXK01173071.1;Q09225;1.05E-60;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp1326641_c0_seq1;GAXK01159434.1;Q9VZW5;3.91E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp13267_c1_seq1;GAXK01020914.1;Q6JWW5;6.64E-14;RL5_OIKDI;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp132675_c3_seq1;GAXK01173070.1;Q4R495;3.02E-105;MFS11_MACFA;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp132678_c1_seq1;GAXK01172839.1;Q9CZP5;7.89E-27;BCS1_MOUSE;Mitochondrial chaperone BCS1 (BCS1-like protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; mitochondrion organization [GO:0007005]";"GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0016021; GO:0032981; GO:0033617; GO:0034551";"mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; mitochondrion organization [GO:0007005]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";ATP binding [GO:0005524]
comp132691_c2_seq1;GAXK01172936.1;O44342;2.18E-40;WBL_DROME;Protein windbeutel (Erp29 homolog);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein homodimerization activity [GO:0042803]; dorsal/ventral axis specification [GO:0009950]; embryo development ending in birth or egg hatching [GO:0009792]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; regulation of multicellular organism growth [GO:0040014]";"GO:0005783; GO:0005788; GO:0007313; GO:0009306; GO:0009792; GO:0009950; GO:0012505; GO:0034975; GO:0040014; GO:0042803";"dorsal/ventral axis specification [GO:0009950]; embryo development ending in birth or egg hatching [GO:0009792]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; regulation of multicellular organism growth [GO:0040014]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein homodimerization activity [GO:0042803]
comp132750_c1_seq1;GAXK01173206.1;Q9VQU9;2.78E-63;BOWEL_DROME;Protein bowel (Brother of odd with entrails limited);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619";"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp132775_c3_seq1;GAXK01173068.1;P55859;3.69E-96;PNPH_BOVIN;Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; purine-nucleoside phosphorylase activity [GO:0004731]; nucleoside metabolic process [GO:0009116]";"GO:0004731; GO:0005737; GO:0005856; GO:0009116";nucleoside metabolic process [GO:0009116];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";purine-nucleoside phosphorylase activity [GO:0004731]
comp1327812_c0_seq1;GAXK01159447.1;E2AZE8;1.27E-11;DIUX_CAMFO;Diuretic hormone class 2 (DH(31)) (Diuretic peptide) (DP);"extracellular region [GO:0005576]; diuretic hormone activity [GO:0008613]; body fluid secretion [GO:0007589]";"GO:0005576; GO:0007589; GO:0008613";body fluid secretion [GO:0007589];extracellular region [GO:0005576];diuretic hormone activity [GO:0008613]
comp1327942_c0_seq1;GAXK01159440.1;Q9NXZ2;1.14E-81;DDX43_HUMAN;Probable ATP-dependent RNA helicase DDX43 (EC 3.6.4.13) (Cancer/testis antigen 13) (CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen);"intracellular [GO:0005622]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]";"GO:0003723; GO:0003724; GO:0005524; GO:0005622";;intracellular [GO:0005622];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp132795_c2_seq1;GAXK01173011.1;Q9Y485;7.20E-68;DMXL1_HUMAN;DmX-like protein 1 (X-like 1 protein);"RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]";"GO:0007035; GO:0043291";vacuolar acidification [GO:0007035];RAVE complex [GO:0043291];
comp1328050_c0_seq1;GAXK01114380.1;Q9W0T5;2.35E-90;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp132807_c3_seq1;GAXK01173195.1;Q765P7;7.61E-24;MTSS2_HUMAN;Protein MTSS 2 (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1) (MTSS1-like protein);"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"GO:0003785; GO:0005096; GO:0005546; GO:0007009; GO:0030027; GO:0030864; GO:0032587; GO:0036120; GO:0048365; GO:0090630; GO:0097178; GO:0097581";"activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]";"actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]"
comp1328172_c0_seq1;GAXK01114361.1;Q5U4E2;4.87E-12;REPI1_MOUSE;Replication initiator 1 (Zinc finger protein 464) (Zfp-464);"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; lipid droplet [GO:0005811]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; positive regulation of glucose import [GO:0046326]; regulation of fatty acid transport [GO:2000191]";"GO:0003677; GO:0005634; GO:0005811; GO:0005829; GO:0006260; GO:0022626; GO:0031965; GO:0046326; GO:0046872; GO:2000191";"DNA replication [GO:0006260]; positive regulation of glucose import [GO:0046326]; regulation of fatty acid transport [GO:2000191]";"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; lipid droplet [GO:0005811]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp13285_c0_seq1;GAXK01020464.1;O95372;1.09E-11;LYPA2_HUMAN;Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0007411; GO:0008474; GO:0045296; GO:0052689; GO:0070062";"axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]";"cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp132857_c1_seq1;GAXK01205909.1;Q6GNY1;0;MIB1_XENLA;E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase mib1);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]";"GO:0004842; GO:0005737; GO:0005815; GO:0007219; GO:0008270";Notch signaling pathway [GO:0007219];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1328793_c0_seq1;GAXK01204870.1;Q5U2T6;1.02E-11;PLAG1_RAT;Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0046872; GO:0060252; GO:0060736";"gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp132882_c1_seq1;GAXK01173283.1;Q9UBH6;0;XPR1_HUMAN;Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]";"GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023";"cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]";"efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp13289_c0_seq1;GAXK01020088.1;Q5XGM3;0;BHMT1_XENLA;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";"GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0047150";"amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";cytoplasm [GO:0005737];"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp132893_c0_seq1;GAXK01172964.1;Q0II68;2.32E-167;ACMSD_BOVIN;2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; protein complex oligomerization [GO:0051259]; secondary metabolic process [GO:0019748]";"GO:0001760; GO:0005737; GO:0005829; GO:0008270; GO:0016787; GO:0019748; GO:0051259; GO:1904985";"negative regulation of quinolinate biosynthetic process [GO:1904985]; protein complex oligomerization [GO:0051259]; secondary metabolic process [GO:0019748]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]"
comp1329034_c0_seq1;GAXK01114349.1;Q9Y462;4.39E-11;ZN711_HUMAN;Zinc finger protein 711 (Zinc finger protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0031490; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1329168_c0_seq1;GAXK01114378.1;P49747;3.64E-10;COMP_HUMAN;Cartilage oligomeric matrix protein (COMP) (Thrombospondin-5) (TSP5);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394]; animal organ morphogenesis [GO:0009887]; animal organ senescence [GO:0010260]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle fiber development [GO:0048747]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; neuromuscular process [GO:0050905]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular smooth muscle cell development [GO:0097084]; vascular smooth muscle contraction [GO:0014829]";"GO:0001501; GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0009887; GO:0010259; GO:0010260; GO:0014829; GO:0016485; GO:0030198; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043394; GO:0043395; GO:0043588; GO:0048747; GO:0048844; GO:0050881; GO:0050905; GO:0060173; GO:0062023; GO:0070062; GO:0070527; GO:0097084; GO:1900047; GO:1902732";"animal organ morphogenesis [GO:0009887]; animal organ senescence [GO:0010260]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle fiber development [GO:0048747]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; neuromuscular process [GO:0050905]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular smooth muscle cell development [GO:0097084]; vascular smooth muscle contraction [GO:0014829]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394]"
comp1329283_c0_seq1;GAXK01114341.1;P29290;1.39E-32;TNNCA_HOMAM;Troponin C, isoform 2A;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp132956_c1_seq1;GAXK01172853.1;Q640G7;6.43E-108;ATG4B_XENLA;Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related protein 4 homolog B);"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein transport [GO:0015031]";"GO:0004197; GO:0005737; GO:0006914; GO:0015031";"autophagy [GO:0006914]; protein transport [GO:0015031]";cytoplasm [GO:0005737];cysteine-type endopeptidase activity [GO:0004197]
comp1329588_c0_seq2;GAXK01114363.1;Q96MH6;1.61E-51;TMM68_HUMAN;Transmembrane protein 68;"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]";"GO:0016021; GO:0016746";;integral component of membrane [GO:0016021];transferase activity, transferring acyl groups [GO:0016746]
comp13296_c2_seq1;GAXK01020731.1;Q8VDM6;2.53E-93;HNRL1_MOUSE;Heterogeneous nuclear ribonucleoprotein U-like protein 1;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]";"GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899";"response to virus [GO:0009615]; RNA processing [GO:0006396]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; RNA binding [GO:0003723]"
comp132966_c0_seq1;GAXK01172878.1;P48053;8.79E-121;YPD1_CAEEL;Uncharacterized protein C05D11.1;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0046872";;;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp1329717_c0_seq1;GAXK01114355.1;P32429;8.99E-11;RL7A_CHICK;60S ribosomal protein L7a;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp132989_c1_seq1;GAXK01173036.1;Q6PAY6;2.09E-91;HYPDH_XENLA;Hydroxyproline dehydrogenase (HYPDH) (EC 1.5.5.3) (Probable proline dehydrogenase 2) (EC 1.5.5.2) (Probable proline oxidase 2);"oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133]";"GO:0004657; GO:0010133; GO:0016645";proline catabolic process to glutamate [GO:0010133];;"oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]"
comp1330011_c1_seq1;GAXK01153930.1;Q1LZH7;3.48E-07;KANK2_BOVIN;KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0000122; GO:0005737; GO:0005739; GO:0006915; GO:0008285; GO:0033147; GO:0035023; GO:0043069; GO:0070563; GO:0072073; GO:0090521; GO:2000134";"apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";
comp133007_c0_seq1;GAXK01172950.1;O43586;2.74E-54;PPIP1_HUMAN;Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP);"actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165]";"GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0008092; GO:0016020; GO:0030027; GO:0030041; GO:0032154; GO:0042802; GO:0045087; GO:0048471; GO:0051015";"actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165]";"actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]";"actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]"
comp1330119_c0_seq1;GAXK01153919.1;Q3E6S9;9.34E-34;CNIF3_ARATH;Probable L-cysteine desulfhydrase, chloroplastic (EC 4.4.1.-) (Chloroplastic cysteine desulfurase-like protein 3) (NIFS-like protein 3) (CpNifS3);"chloroplast [GO:0009507]; lyase activity [GO:0016829]";"GO:0009507; GO:0016829";;chloroplast [GO:0009507];lyase activity [GO:0016829]
comp1330149_c0_seq1;GAXK01153920.1;P17019;3.63E-23;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp1330287_c0_seq1;GAXK01153909.1;O74467;1.27E-11;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp13307_c0_seq1;GAXK01020540.1;Q921G7;0;ETFD_MOUSE;Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase);"integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]";"GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051536; GO:0051539";"electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]";"integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]"
comp1330738_c0_seq1;GAXK01153907.1;Q5ZM39;3.90E-13;BCL6_CHICK;B-cell lymphoma 6 protein homolog;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001953; GO:0002467; GO:0002829; GO:0003677; GO:0003682; GO:0005634; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043087; GO:0043380; GO:0043565; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0051272";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp13309_c0_seq1;GAXK01020146.1;P18173;4.30E-142;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp1330968_c0_seq1;GAXK01153932.1;Q66IF1;2.91E-20;REEP6_DANRE;Receptor expression-enhancing protein 6;"clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]";"GO:0005789; GO:0010842; GO:0016021; GO:0030665; GO:0060059";"embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]";"clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1331_c0_seq1;GAXK01169855.1;Q5ZMD6;1.88E-64;H2AZ_CHICK;Histone H2A.Z (H2A/z);"nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to estradiol stimulus [GO:0071392]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000786; GO:0000790; GO:0000978; GO:0000979; GO:0000980; GO:0003677; GO:0005719; GO:0005720; GO:0006325; GO:0031492; GO:0045944; GO:0046982; GO:0071392";"cellular response to estradiol stimulus [GO:0071392]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nucleosome [GO:0000786]";"DNA binding [GO:0003677]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1331342_c0_seq1;GAXK01153925.1;P11118;1.95E-60;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp133145_c0_seq1;GAXK01173032.1;O35115;1.85E-44;FHL2_RAT;Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3);"M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000122; GO:0001649; GO:0005634; GO:0008134; GO:0030018; GO:0031430; GO:0043066; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885";"atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp1331761_c0_seq1;GAXK01153915.1;Q5ZLK5;1.66E-28;P4HA2_CHICK;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp1332_c2_seq1;GAXK01169231.1;O35490;2.81E-117;BHMT1_MOUSE;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267";"amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]";"betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]"
comp133200_c0_seq1;GAXK01173219.1;Q10L91;2.80E-08;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp133223_c0_seq1;GAXK01172967.1;P69478;1.77E-22;CHSTB_RAT;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp133274_c2_seq1;GAXK01173263.1;Q8VCB1;3.38E-15;NDC1_MOUSE;Nucleoporin NDC1 (Transmembrane protein 48);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0005643; GO:0005737; GO:0005886; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0015629; GO:0016021; GO:0017056; GO:0031081; GO:0031965; GO:0051028; GO:0051292; GO:0070762";"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]";structural constituent of nuclear pore [GO:0017056]
comp1332819_c0_seq1;GAXK01133374.1;Q8KWT4;2.35E-47;BACC_BACIU;Dihydroanticapsin 7-dehydrogenase (EC 1.1.1.385) (Bacilysin biosynthesis oxidoreductase BacC);"oxidoreductase activity [GO:0016491]; antibiotic biosynthetic process [GO:0017000]";"GO:0016491; GO:0017000";antibiotic biosynthetic process [GO:0017000];;oxidoreductase activity [GO:0016491]
comp1332830_c0_seq1;GAXK01133372.1;Q7ZSX3;1.93E-26;PTF1A_DANRE;Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]";"GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048699";"amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]"
comp133289_c2_seq1;GAXK01173048.1;Q6DFB8;1.53E-104;TTC37_XENLA;Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (Thespin homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401]";"GO:0005634; GO:0005737; GO:0006401; GO:0035327; GO:0055087";RNA catabolic process [GO:0006401];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]";
comp13329_c0_seq1;GAXK01020349.1;P82968;1.41E-08;MCPI_MELCP;Four-domain proteases inhibitor (McaPI);serine-type endopeptidase inhibitor activity [GO:0004867];GO:0004867;;;serine-type endopeptidase inhibitor activity [GO:0004867]
comp1333072_c0_seq1;GAXK01133393.1;Q9W534;3.60E-08;MOODY_DROME;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp13331_c1_seq1;GAXK01019897.1;Q9CQT7;5.12E-16;DESI1_MOUSE;Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]";"GO:0005634; GO:0005737; GO:0008233; GO:0042802";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
comp133310_c0_seq1;GAXK01172880.1;Q9GRW0;5.79E-25;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp133323_c0_seq1;GAXK01173176.1;Q9JM76;1.77E-57;ARPC3_MOUSE;Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC);"Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]";"GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090";"Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]";"Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]"
comp133338_c0_seq1;GAXK01172901.1;Q24206;3.34E-37;BRC4_DROME;Broad-complex core protein isoform 6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp133348_c0_seq1;GAXK01172951.1;Q9DC26;1.55E-18;S46A3_MOUSE;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp133352_c0_seq1;GAXK01172840.1;P38935;0;SMBP2_HUMAN;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2);"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homooligomerization [GO:0051260]; translation [GO:0006412]";"GO:0000049; GO:0000122; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0016020; GO:0030424; GO:0030426; GO:0032574; GO:0043022; GO:0043139; GO:0051260; GO:1990904";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homooligomerization [GO:0051260]; translation [GO:0006412]";"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp1333531_c0_seq1;GAXK01133379.1;P81656;1.07E-12;VA5_POLDO;Venom allergen 5 (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (allergen Pol d 5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1333758_c1_seq1;GAXK01133389.1;Q9NQX1;7.47E-15;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp133388_c0_seq1;GAXK01173210.1;Q5VXM1;2.94E-21;CDCP2_HUMAN;CUB domain-containing protein 2;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp133394_c0_seq1;GAXK01172952.1;P30432;0;FUR2_DROME;Furin-like protease 2 (Furin-2) (EC 3.4.21.75);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048";"negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp1334049_c0_seq1;GAXK01078993.1;P35785;1.40E-23;VA5_VESPE;Venom allergen 5 (Allergen Ves p V) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (allergen Ves p 5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp133407_c0_seq1;GAXK01173097.1;Q5REX5;1.08E-35;ABHDA_PONAB;Mycophenolic acid acyl-glucuronide esterase, mitochondrial (EC 3.1.1.93) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10);"mitochondrion [GO:0005739]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]";"GO:0005739; GO:0102390";;mitochondrion [GO:0005739];mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]
comp133410_c0_seq1;GAXK01173128.1;Q6IDD9;4.23E-69;SARM1_DROME;Sterile alpha and TIR motif-containing protein 1 (Tir-1 homolog) (dSarm);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214";"innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";signaling adaptor activity [GO:0035591]
comp1334157_c0_seq1;GAXK01078987.1;O46040;7.80E-24;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1334489_c0_seq1;GAXK01079004.1;Q9V7U0;3.16E-09;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp13348_c1_seq1;GAXK01020737.1;O08901;5.46E-30;BUB1_MOUSE;Mitotic checkpoint serine/threonine-protein kinase BUB1 (mBUB1) (EC 2.7.11.1) (BUB1A);"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000780; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0051301; GO:0051754; GO:0051983; GO:2001244";"apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp133492_c0_seq1;GAXK01172920.1;Q7KRI2;3.76E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp133520_c0_seq1;GAXK01173110.1;Q8N859;7.35E-08;ZN713_HUMAN;Zinc finger protein 713;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1335209_c0_seq1;GAXK01079005.1;P55210;4.42E-19;CASP7_HUMAN;"Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008233; GO:0008234; GO:0072734; GO:0097153; GO:0097194; GO:0097200";"apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]"
comp133560_c0_seq1;GAXK01172966.1;P35122;3.46E-21;UCHL_DROME;Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) (Ubiquitin thioesterase);"cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004843; GO:0005737; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytoplasm [GO:0005737];thiol-dependent ubiquitin-specific protease activity [GO:0004843]
comp1335621_c0_seq1;GAXK01079009.1;Q8BHW2;9.38E-88;OSCP1_MOUSE;Protein OSCP1;"basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; transmembrane transporter activity [GO:0022857]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]";"GO:0005737; GO:0009925; GO:0022857; GO:1990961";xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961];"basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]";transmembrane transporter activity [GO:0022857]
comp1335659_c1_seq1;GAXK01079000.1;Q9N003;4.00E-19;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp133569_c0_seq1;GAXK01173222.1;P91791;9.12E-57;PPIA_HEMPU;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp133575_c0_seq1;GAXK01173188.1;P33085;1.26E-112;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp1336066_c0_seq1;GAXK01174768.1;F4JBP3;2.47E-27;ATG1B_ARATH;Serine/threonine-protein kinase ATG1b (EC 2.7.11.-) (Autophagy-related protein 1b) (AtAPG1b);"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagosome assembly [GO:0000045]; protein autophosphorylation [GO:0046777]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]";"GO:0000045; GO:0000407; GO:0004674; GO:0005524; GO:0005776; GO:0005829; GO:0010506; GO:0015031; GO:0016020; GO:0031410; GO:0046777";"autophagosome assembly [GO:0000045]; protein autophosphorylation [GO:0046777]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]";"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp133615_c2_seq1;GAXK01172968.1;G5EBQ8;0;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp133623_c1_seq1;GAXK01172940.1;P34925;3.85E-104;RYK_HUMAN;Tyrosine-protein kinase RYK (EC 2.7.10.1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp133645_c0_seq1;GAXK01173098.1;Q61555;0;FBN2_MOUSE;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
comp1336501_c0_seq1;GAXK01174740.1;Q9CZQ9;4.53E-164;BBS5_MOUSE;Bardet-Biedl syndrome 5 protein homolog;"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; intracellular transport [GO:0046907]; protein transport [GO:0015031]";"GO:0001103; GO:0005929; GO:0005930; GO:0015031; GO:0032266; GO:0034451; GO:0034464; GO:0036064; GO:0046907; GO:0060170; GO:0060271";"cilium assembly [GO:0060271]; intracellular transport [GO:0046907]; protein transport [GO:0015031]";"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]"
comp1336709_c0_seq1;GAXK01174743.1;Q3U4G3;3.84E-26;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp1336722_c0_seq1;GAXK01174777.1;P24524;1.33E-11;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp133673_c0_seq1;GAXK01173035.1;Q9Y259;2.11E-93;CHKB_HUMAN;Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB);"cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656; GO:0007517";"muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]";cytosol [GO:0005829];"ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]"
comp13369_c2_seq1;GAXK01019905.1;Q80XI3;3.50E-148;IF4G3_MOUSE;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";"GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903";"positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";eukaryotic translation initiation factor 4F complex [GO:0016281];"mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]"
comp1337017_c0_seq1;GAXK01174751.1;Q8JZZ7;5.65E-17;AGRL2_MOUSE;Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin-2);"glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of synapse assembly [GO:0051965]; response to bacterium [GO:0009617]; synapse organization [GO:0050808]";"GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0007420; GO:0009617; GO:0030165; GO:0030246; GO:0043005; GO:0050808; GO:0051965; GO:0098978; GO:0099055";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of synapse assembly [GO:0051965]; response to bacterium [GO:0009617]; synapse organization [GO:0050808]";"glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]"
comp133707_c1_seq1;GAXK01173164.1;Q05B92;5.19E-39;TFE3_BOVIN;Transcription factor E3;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]";"GO:0000978; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006959; GO:0044212; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983";"adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of osteoclast differentiation [GO:0045670]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp1337102_c0_seq1;GAXK01174757.1;Q5HZQ9;7.07E-109;PCX4_XENLA;Pecanex-like protein 4 (Pecanex homolog protein 4);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp133715_c0_seq1;GAXK01173218.1;Q8H191;5.22E-12;PAO4_ARATH;Probable polyamine oxidase 4 (AtPAO4) (EC 1.5.3.16) (Amine oxidase 2);"peroxisome [GO:0005777]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";"GO:0005777; GO:0006598; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901";"polyamine catabolic process [GO:0006598]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";peroxisome [GO:0005777];"N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp133734_c3_seq1;GAXK01173225.1;Q6Y685;5.77E-26;TACC1_MOUSE;Transforming acidic coiled-coil-containing protein 1;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0007052; GO:0008283; GO:0016922; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301; GO:2000327";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]";"estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]"
comp1337441_c0_seq1;GAXK01174745.1;Q6WRH9;8.59E-22;IGS10_RAT;Immunoglobulin superfamily member 10 (IgSF10) (Calvaria mechanical force protein 608) (CMF608);"extracellular region [GO:0005576]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]";"GO:0001503; GO:0005576; GO:0042246; GO:2001222";"ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]";extracellular region [GO:0005576];
comp1337597_c0_seq1;GAXK01174762.1;Q13231;2.71E-40;CHIT1_HUMAN;Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]";"GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724";"chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp1337665_c0_seq1;GAXK01174770.1;Q92051;3.85E-26;CAHZ_DANRE;Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";"GO:0004089; GO:0008270; GO:0015670; GO:0042539";"carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp13377_c2_seq1;GAXK01020368.1;B2LU20;1.82E-119;SFXN1_SHEEP;Sideroflexin-1;"integral component of mitochondrial inner membrane [GO:0031305]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; D-serine transport [GO:0042942]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"GO:0006730; GO:0015194; GO:0015825; GO:0031305; GO:0042942; GO:0042945; GO:0140300";"D-serine transport [GO:0042942]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";integral component of mitochondrial inner membrane [GO:0031305];"D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]"
comp1337816_c0_seq1;GAXK01174778.1;Q8N8E2;4.65E-27;ZN513_HUMAN;Zinc finger protein 513;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";"GO:0000979; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0044212; GO:0046872; GO:0050896; GO:0060041";"regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp1337859_c0_seq1;GAXK01174746.1;A1L1R6;3.83E-07;ZN423_DANRE;Zinc finger protein 423;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp133809_c2_seq1;GAXK01172873.1;O43572;1.38E-79;AKA10_HUMAN;A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; blood coagulation [GO:0007596]; protein localization [GO:0008104]; signal transduction [GO:0007165]";"GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0007596; GO:0008104; GO:0032991; GO:0051018";"blood coagulation [GO:0007596]; protein localization [GO:0008104]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";protein kinase A binding [GO:0051018]
comp1338116_c0_seq1;GAXK01027321.1;Q8MRC9;7.01E-135;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp1338151_c0_seq1;GAXK01027295.1;Q9VZW5;4.04E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1338202_c0_seq1;GAXK01027308.1;Q9NGC3;8.65E-42;CEG1A_DROME;Centaurin-gamma-1A;"membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375";"medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1338286_c0_seq1;GAXK01027313.1;P54131;4.48E-103;ACHA7_BOVIN;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp133881_c0_seq1;GAXK01173031.1;Q64425;1.41E-27;LIPP_MYOCO;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp1338891_c0_seq1;GAXK01027312.1;Q5T5D7;5.57E-16;ZN684_HUMAN;Zinc finger protein 684;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp133900_c0_seq1;GAXK01173178.1;E9PYK3;1.86E-25;PARP4_MOUSE;Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]";"GO:0003950; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006464; GO:0006954; GO:0008219; GO:0019899; GO:0051972; GO:0140289; GO:1990404";"cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]";"enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]"
comp1339228_c0_seq1;GAXK01027304.1;P07630;2.61E-65;CAH2_CHICK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to carbon dioxide [GO:0071244]; morphogenesis of an epithelium [GO:0002009]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; secretion [GO:0046903]";"GO:0002009; GO:0004064; GO:0004089; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0045177; GO:0046903; GO:0071244; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to carbon dioxide [GO:0071244]; morphogenesis of an epithelium [GO:0002009]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp1339262_c0_seq1;GAXK01027320.1;Q6DE37;3.30E-27;GXLT2_XENLA;Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4);"integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0016021; GO:0016266; GO:0035252";O-glycan processing [GO:0016266];integral component of membrane [GO:0016021];UDP-xylosyltransferase activity [GO:0035252]
comp133932_c1_seq1;GAXK01173166.1;Q964R0;2.46E-85;CP6K1_BLAGE;Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp133979_c3_seq1;GAXK01173034.1;Q9M883;7.63E-07;SC5D2_ARATH;Putative Delta(7)-sterol-C5(6)-desaturase 2 (EC 1.14.19.20) (Delta(7)-sterol-C5-desaturase 2) (Delta-7-C-5 sterol desaturase 2) (Homolog of DWF7 protein);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000248; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]"
comp13398_c0_seq1;GAXK01019992.1;Q08BI9;1.73E-105;MCU_DANRE;Calcium uniporter protein, mitochondrial;"calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]";"GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0031305; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0051259; GO:0051560; GO:0051561; GO:0060027; GO:1990246";"actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]";"calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]";"calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]"
comp13399_c1_seq1;GAXK01020843.1;Q6AZD1;1.61E-32;T179A_DANRE;Transmembrane protein 179;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp134_c0_seq1;GAXK01169994.1;P48149;1.07E-87;RS15A_DROME;40S ribosomal protein S15Aa;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp134002_c1_seq1;GAXK01184199.1;Q15392;0;DHC24_HUMAN;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214";"amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]";"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"
comp134041_c1_seq1;GAXK01184346.1;Q16FT5;1.46E-83;COQ4_AEDAE;Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog);"extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744]";"GO:0006744; GO:0031314";ubiquinone biosynthetic process [GO:0006744];extrinsic component of mitochondrial inner membrane [GO:0031314];
comp1340509_c0_seq1;GAXK01063526.1;Q25158;5.83E-62;OPSC2_HEMSA;Compound eye opsin BCRH2;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp134052_c0_seq1;GAXK01184392.1;Q9V427;3.74E-50;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp1340710_c0_seq1;GAXK01063534.1;Q17938;5.16E-89;DAF36_CAEEL;Cholesterol 7-desaturase (EC 1.14.19.21) (Cholesterol desaturase daf-36);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]";"GO:0005737; GO:0008203; GO:0016021; GO:0016491; GO:0046872; GO:0051537";cholesterol metabolic process [GO:0008203];"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp1340834_c0_seq1;GAXK01063510.1;P41823;1.03E-24;SY65_APLCA;Synaptotagmin-1 (Synaptotagmin I) (p65);"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000149; GO:0005509; GO:0005544; GO:0016079; GO:0030054; GO:0030285; GO:0045955";"negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; SNARE binding [GO:0000149]"
comp13413_c0_seq1;GAXK01019921.1;Q921N6;8.42E-175;DDX27_MOUSE;Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27);"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364";rRNA processing [GO:0006364];"chromosome [GO:0005694]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1341420_c0_seq1;GAXK01063505.1;Q9TU53;6.74E-19;CUBN_CANLF;Cubilin;"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"GO:0005509; GO:0005765; GO:0008144; GO:0008203; GO:0010008; GO:0015031; GO:0016324; GO:0031419; GO:0031526";"cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]";"calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]"
comp13415_c2_seq1;GAXK01020133.1;P17210;0;KINH_DROME;Kinesin heavy chain;"actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]; actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; microtubule-based movement [GO:0007018]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; skeletal muscle fiber development [GO:0048741]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]";"GO:0001754; GO:0003774; GO:0003777; GO:0005523; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007097; GO:0007303; GO:0007310; GO:0007315; GO:0007317; GO:0007409; GO:0007411; GO:0008017; GO:0008088; GO:0008103; GO:0008345; GO:0008574; GO:0010970; GO:0016887; GO:0030478; GO:0032839; GO:0035371; GO:0035617; GO:0045451; GO:0046785; GO:0046843; GO:0048311; GO:0048312; GO:0048489; GO:0048741; GO:0048813; GO:0051012; GO:0051299; GO:0061572; GO:0070868; GO:0098937; GO:0098957; GO:0098971; GO:1904115";"actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; microtubule-based movement [GO:0007018]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; skeletal muscle fiber development [GO:0048741]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]";"actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]"
comp1341684_c0_seq1;GAXK01063525.1;P87149;2.74E-10;MRS2_SCHPO;Mitochondrial inner membrane magnesium transporter mrs2 (RNA-splicing protein mrs2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005739; GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";magnesium ion transmembrane transporter activity [GO:0015095]
comp1341710_c0_seq1;GAXK01063520.1;Q23551;3.61E-14;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp1342641_c0_seq1;GAXK01086084.1;Q71SG7;6.88E-37;GCNT4_DANRE;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0003829; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp1342684_c0_seq1;GAXK01086113.1;P55216;1.54E-94;CGL2_CAEEL;Putative cystathionine gamma-lyase 2 (EC 4.4.1.1) (Gamma-cystathionase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]";"GO:0004123; GO:0005737; GO:0005783; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146";"cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";"carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]"
comp134270_c5_seq1;GAXK01184291.1;O97562;2.72E-79;UCP2_PIG;Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]";"GO:0005743; GO:0009409; GO:0016021; GO:0017077; GO:1990542; GO:1990845";"adaptive thermogenesis [GO:1990845]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";oxidative phosphorylation uncoupler activity [GO:0017077]
comp134279_c0_seq1;GAXK01184605.1;O95822;1.28E-110;DCMC_HUMAN;Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]";"GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006625; GO:0006633; GO:0006637; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294";"acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]"
comp13429_c0_seq1;GAXK01020455.1;P54145;2.12E-81;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp13433_c0_seq1;GAXK01020319.1;O00170;1.33E-78;AIP_HUMAN;AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9);"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]";"GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0008134; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0035722; GO:0036004; GO:0051082; GO:0051344";"interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]";"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp1343545_c0_seq1;GAXK01086106.1;Q6TXF1;8.13E-20;ARRD3_RAT;Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048);"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"GO:0001659; GO:0005764; GO:0005769; GO:0005886; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163";"fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";beta-3 adrenergic receptor binding [GO:0031699]
comp1343557_c0_seq1;GAXK01086103.1;Q86V86;1.51E-14;PIM3_HUMAN;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1343749_c0_seq1;GAXK01086115.1;Q9VEG6;2.26E-75;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp1343811_c0_seq1;GAXK01086095.1;Q9HCD6;0;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp1343814_c0_seq1;GAXK01086090.1;E2AX35;1.49E-74;PROH4_CAMFO;IDLSRF-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp1343967_c0_seq1;GAXK01086136.1;P30975;3.29E-107;TLR2_DROME;Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058";"detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp13440_c0_seq1;GAXK01020892.1;Q5R4S3;2.67E-08;RM42_PONAB;39S ribosomal protein L42, mitochondrial (L42mt) (MRP-L42) (28S ribosomal protein S32, mitochondrial) (MRP-S32) (S32mt);mitochondrial large ribosomal subunit [GO:0005762];GO:0005762;;mitochondrial large ribosomal subunit [GO:0005762];
comp1344020_c0_seq1;GAXK01108394.1;P25304;3.20E-23;AGRIN_RAT;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030054; GO:0031012; GO:0033691; GO:0035374; GO:0036122; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0045202; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0070507; GO:0071340; GO:0098978; GO:1902667";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp1344221_c0_seq1;GAXK01108399.1;Q80ZA4;2.19E-46;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp134451_c7_seq1;GAXK01184607.1;B2D0J5;6.00E-64;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp134486_c1_seq1;GAXK01184305.1;P80601;1.83E-46;RIDA_CAPHI;2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.3 kDa perchloric acid soluble protein) (Translation inhibitor L-PSP ribonuclease) (EC 3.1.-.-) (UK114 antigen);"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; mRNA binding [GO:0003729]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]";"GO:0003729; GO:0005634; GO:0005759; GO:0005777; GO:0006402; GO:0016892; GO:0017148; GO:0019239; GO:0061157; GO:1901565";"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]";"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; mRNA binding [GO:0003729]"
comp1345033_c0_seq1;GAXK01108393.1;P54680;2.09E-36;FIMB_DICDI;Fimbrin;"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; sexual reproduction [GO:0019953]";"GO:0001891; GO:0005509; GO:0005737; GO:0005884; GO:0019953; GO:0030027; GO:0031252; GO:0032432; GO:0045335; GO:0051015; GO:0051017; GO:0051639";"actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; sexual reproduction [GO:0019953]";"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp1345092_c0_seq1;GAXK01108395.1;Q8R151;6.93E-77;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1345377_c0_seq1;GAXK01108403.1;Q5U3S1;5.85E-141;KATL1_DANRE;Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031122";"cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp1345468_c0_seq1;GAXK01108417.1;B0JZV4;1.88E-19;CBPC5_XENTR;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp1345687_c0_seq1;GAXK01108404.1;Q9ULI0;8.11E-08;ATD2B_HUMAN;ATPase family AAA domain-containing protein 2B;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0031936; GO:0042393; GO:0045944; GO:0070577";"negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]"
comp13458_c2_seq1;GAXK01020152.1;Q9W5E0;1.44E-97;SUV42_DROME;Histone-lysine N-methyltransferase Suv4-20 (EC 2.1.1.43) (Suppressor of variegation 4-20) (Su(var)4-20);"nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0005634; GO:0005700; GO:0005720; GO:0006342; GO:0016571; GO:0034770; GO:0034772; GO:0034773; GO:0040029; GO:0042799";"chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]";"nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";histone methyltransferase activity (H4-K20 specific) [GO:0042799]
comp1345877_c0_seq1;GAXK01108392.1;O15335;2.76E-09;CHAD_HUMAN;Chondroadherin (Cartilage leucine-rich protein);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]";"GO:0005615; GO:0031012; GO:0060348; GO:1900155";"bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";
comp134616_c0_seq1;GAXK01184276.1;Q96AB6;2.13E-53;NTAN1_HUMAN;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418";"adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp1346209_c0_seq1;GAXK01062814.1;P18915;1.99E-25;CAH6_BOVIN;Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase);"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]";"GO:0004089; GO:0005576; GO:0006730; GO:0008270";one-carbon metabolic process [GO:0006730];extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp134624_c0_seq1;GAXK01184256.1;Q9UII5;3.28E-35;ZN107_HUMAN;Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1346243_c0_seq1;GAXK01062822.1;Q5R633;2.60E-14;TZAP_PONAB;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005634; GO:0010833; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]";"double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp13464_c0_seq1;GAXK01020330.1;Q4VC12;1.75E-22;MSS51_HUMAN;Putative protein MSS51 homolog, mitochondrial (Zinc finger MYND domain-containing protein 17);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp134651_c0_seq1;GAXK01184676.1;Q9N2D1;4.60E-20;TRYT_PIG;Tryptase (EC 3.4.21.59);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508";proteolysis [GO:0006508];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp13466_c0_seq1;GAXK01205099.1;Q64261;3.34E-121;CDK6_MOUSE;Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE);"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0007219; GO:0009615; GO:0010468; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000773";"cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]"
comp1346663_c0_seq1;GAXK01062795.1;P04069;3.56E-80;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp13468_c0_seq1;GAXK01020446.1;Q60809;1.65E-103;CNOT7_MOUSE;CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"GO:0000122; GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0008134; GO:0008284; GO:0008285; GO:0010629; GO:0016604; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0061014; GO:0075341; GO:1900153";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]";"3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp1346816_c0_seq2;GAXK01062807.1;Q9D733;7.95E-16;GP2_MOUSE;Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]";"GO:0002412; GO:0003823; GO:0005576; GO:0016324; GO:0031225";antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412];"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]";antigen binding [GO:0003823]
comp134687_c0_seq1;GAXK01184192.1;P84022;0;SMAD3_HUMAN;Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001228; GO:0001657; GO:0001666; GO:0001701; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0003712; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008013; GO:0008134; GO:0008270; GO:0009880; GO:0010628; GO:0010694; GO:0010718; GO:0016202; GO:0016579; GO:0017015; GO:0017151; GO:0019049; GO:0019901; GO:0019902; GO:0023019; GO:0030308; GO:0030325; GO:0030335; GO:0030501; GO:0030512; GO:0030618; GO:0030878; GO:0031053; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032731; GO:0032909; GO:0032916; GO:0032924; GO:0033689; GO:0035259; GO:0035326; GO:0038092; GO:0042060; GO:0042110; GO:0042177; GO:0042307; GO:0042802; GO:0042803; GO:0043066; GO:0043130; GO:0043235; GO:0043425; GO:0043565; GO:0044212; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045893; GO:0045930; GO:0045944; GO:0046982; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0050821; GO:0050927; GO:0051091; GO:0051098; GO:0051481; GO:0051496; GO:0051894; GO:0060039; GO:0060290; GO:0060395; GO:0061045; GO:0061767; GO:0070306; GO:0070410; GO:0070412; GO:0070878; GO:0071141; GO:0071144; GO:0071345; GO:0071560; GO:0090263; GO:0097191; GO:0097296; GO:1901203; GO:1902895; GO:1903243";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp1346997_c0_seq1;GAXK01062815.1;Q94900;5.83E-15;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp1347202_c0_seq1;GAXK01062811.1;O35547;5.47E-40;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp1347592_c0_seq1;GAXK01062780.1;Q61164;2.80E-07;CTCF_MOUSE;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006355; GO:0007059; GO:0008285; GO:0009048; GO:0010216; GO:0010628; GO:0010629; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0046872; GO:0071459; GO:1902895";"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp13476_c0_seq1;GAXK01020017.1;Q8WR63;2.25E-20;TPM_TRIPS;Tropomyosin;;;;;
comp134764_c0_seq1;GAXK01184126.1;P13538;1.48E-71;MYSS_CHICK;Myosin heavy chain, skeletal muscle, adult;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp1347772_c0_seq1;GAXK01062816.1;Q9VHN9;1.65E-20;HPS5_DROME;Hermansky-Pudlak syndrome 5 protein homolog (Protein pink) (dHPS5);"BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; pigment binding [GO:0031409]; compound eye pigmentation [GO:0048072]; eye pigment biosynthetic process [GO:0006726]; negative regulation of gene silencing by RNA [GO:0060967]; ommochrome biosynthetic process [GO:0006727]; protein targeting to lysosome [GO:0006622]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005737; GO:0006622; GO:0006726; GO:0006727; GO:0007601; GO:0031084; GO:0031409; GO:0048072; GO:0050896; GO:0060967";"compound eye pigmentation [GO:0048072]; eye pigment biosynthetic process [GO:0006726]; negative regulation of gene silencing by RNA [GO:0060967]; ommochrome biosynthetic process [GO:0006727]; protein targeting to lysosome [GO:0006622]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]";pigment binding [GO:0031409]
comp13478_c0_seq1;GAXK01020617.1;O77210;7.28E-36;IF4E_APLCA;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);"cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0005737";;cytoplasm [GO:0005737];translation initiation factor activity [GO:0003743]
comp1347881_c0_seq1;GAXK01062801.1;Q3V1M1;8.36E-10;IGS10_MOUSE;Immunoglobulin superfamily member 10 (IgSF10);"extracellular region [GO:0005576]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]";"GO:0001503; GO:0005576; GO:0042246; GO:2001222";"ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]";extracellular region [GO:0005576];
comp1348072_c0_seq1;GAXK01198692.1;O97366;5.50E-41;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp1348129_c0_seq1;GAXK01198674.1;O16259;3.86E-18;STIP1_CAEEL;Stress-induced-phosphoprotein 1 (CeSTI1) (STI1) (Hsc70/Hsp90-organizing protein) (CeHop) (Hop);"cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";"GO:0000003; GO:0005737; GO:0008340; GO:0009408; GO:0030544; GO:0032780; GO:0042030; GO:0051879";"determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]"
comp13483_c2_seq1;GAXK01020523.1;Q13619;0;CUL4A_HUMAN;Cullin-4A (CUL-4A);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819";"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]";ubiquitin protein ligase binding [GO:0031625]
comp134846_c0_seq1;GAXK01184306.1;B0W2W6;1.21E-28;MAEL_CULQU;Protein maelstrom homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"GO:0003677; GO:0005634; GO:0005737; GO:0007275; GO:0030154; GO:0031047; GO:0051321; GO:0060964";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp134866_c1_seq1;GAXK01184681.1;Q9USQ7;1.11E-106;DPH6_SCHPO;Diphthine--ammonia ligase (EC 6.3.1.14) (Diphthamide synthase) (Diphthamide synthetase);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; meiotic cell cycle [GO:0051321]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]";"GO:0005524; GO:0005634; GO:0005829; GO:0017178; GO:0017183; GO:0051321";"meiotic cell cycle [GO:0051321]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]"
comp134876_c0_seq1;GAXK01184584.1;Q9H9Q4;4.71E-12;NHEJ1_HUMAN;Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor);"DNA ligase IV complex [GO:0032807]; fibrillar center [GO:0001650]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA end binding [GO:0045027]; B cell differentiation [GO:0030183]; central nervous system development [GO:0007417]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of ligase activity [GO:0051351]; response to ionizing radiation [GO:0010212]; T cell differentiation [GO:0030217]";"GO:0001650; GO:0005634; GO:0005654; GO:0006303; GO:0007417; GO:0010212; GO:0030183; GO:0030217; GO:0032807; GO:0045027; GO:0051351; GO:0070419";"B cell differentiation [GO:0030183]; central nervous system development [GO:0007417]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of ligase activity [GO:0051351]; response to ionizing radiation [GO:0010212]; T cell differentiation [GO:0030217]";"DNA ligase IV complex [GO:0032807]; fibrillar center [GO:0001650]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";DNA end binding [GO:0045027]
comp1348764_c0_seq1;GAXK01198696.1;G5EBF1;6.52E-11;SAX3_CAEEL;Protein sax-3 (Sensory axon guidance 3);"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; axon guidance receptor activity [GO:0008046]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374]";"GO:0001764; GO:0005829; GO:0005887; GO:0008046; GO:0033563; GO:0035385; GO:0097374; GO:1905489";"dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374]";"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]";axon guidance receptor activity [GO:0008046]
comp13489_c0_seq1;GAXK01020691.1;Q0VFP5;1.82E-53;CWC15_XENTR;Protein CWC15 homolog;"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634; GO:0045292; GO:0071007; GO:0071013";"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";RNA binding [GO:0003723]
comp1348936_c0_seq1;GAXK01198700.1;Q7RTY0;1.32E-34;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1348968_c0_seq1;GAXK01198690.1;E1C8P7;8.06E-15;DSCL1_CHICK;Down syndrome cell adhesion molecule-like protein 1 homolog;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0007156; GO:0007416; GO:0007417; GO:0010842; GO:0016021; GO:0030017; GO:0030054; GO:0045202; GO:0060219";"camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]";
comp134941_c2_seq1;GAXK01184286.1;P49291;2.42E-11;LAZA_SCHAM;Lazarillo protein;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; pigment binding [GO:0031409]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005886; GO:0007399; GO:0030154; GO:0031225; GO:0031409";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";pigment binding [GO:0031409]
comp1349466_c0_seq1;GAXK01198676.1;Q08180;5.80E-22;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp134947_c15_seq1;GAXK01184637.1;Q14585;3.57E-27;ZN345_HUMAN;Zinc finger protein 345 (Zinc finger protein HZF10);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0000122; GO:0003700; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1349601_c0_seq1;GAXK01198667.1;G5EBR3;1.59E-19;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp1349751_c0_seq1;GAXK01198682.1;Q96BH3;1.51E-08;ESPB1_HUMAN;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12);"cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";heparin binding [GO:0008201]
comp134984_c1_seq1;GAXK01184309.1;Q9Z1N9;0;UN13B_MOUSE;Protein unc-13 homolog B (Munc13-2) (munc13);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytosol [GO:0005829]; early phagosome [GO:0032009]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; non-kinase phorbol ester receptor activity [GO:0001566]; phospholipid binding [GO:0005543]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; phagosome maturation [GO:0090382]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of exocytosis [GO:0045921]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]";"GO:0001566; GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016020; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019905; GO:0019992; GO:0030054; GO:0030672; GO:0030742; GO:0031594; GO:0031914; GO:0032009; GO:0035249; GO:0035556; GO:0042734; GO:0043065; GO:0043195; GO:0044305; GO:0045921; GO:0048172; GO:0048786; GO:0050714; GO:0060384; GO:0060478; GO:0061669; GO:0061789; GO:0071333; GO:0090382; GO:0097060; GO:0097151; GO:0097470; GO:0098686; GO:0098793; GO:0098831; GO:0098978; GO:0099525; GO:1900426";"acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; phagosome maturation [GO:0090382]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of exocytosis [GO:0045921]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytosol [GO:0005829]; early phagosome [GO:0032009]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; non-kinase phorbol ester receptor activity [GO:0001566]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; syntaxin binding [GO:0019905]"
comp135_c0_seq1;GAXK01165949.1;Q6XHI1;7.27E-38;THIO2_DROYA;Thioredoxin-2 (Trx-2);"cell [GO:0005623]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"GO:0005623; GO:0006662; GO:0015035; GO:0045454";"cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";cell [GO:0005623];protein disulfide oxidoreductase activity [GO:0015035]
comp135005_c1_seq1;GAXK01184171.1;A6QR20;6.67E-12;SLF1_BOVIN;SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleosome [GO:0000786]; site of double-strand break [GO:0035861]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]";"GO:0000786; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:0042405; GO:0044877; GO:1990166; GO:2000781";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleosome [GO:0000786]; site of double-strand break [GO:0035861]";"protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]"
comp135016_c0_seq1;GAXK01184680.1;B2RR83;0;YTDC2_MOUSE;3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]";"GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247";"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]"
comp1350226_c0_seq1;GAXK01172576.1;Q9VFP2;1.77E-20;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp1350237_c0_seq1;GAXK01172589.1;Q25410;4.36E-52;MIPR_LYMST;"Putative molluscan insulin-related peptide(s) receptor (EC 2.7.10.1) [Cleaved into: Putative molluscan insulin-related peptide(s) receptor alpha chain; Putative molluscan insulin-related peptide(s) receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0046872";transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp135051_c0_seq1;GAXK01184572.1;Q9VXB0;1.55E-56;NECAP_DROME;NECAP-like protein CG9132;"clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; endocytosis [GO:0006897]; protein transport [GO:0015031]";"GO:0005905; GO:0006897; GO:0015031; GO:0030125";"endocytosis [GO:0006897]; protein transport [GO:0015031]";"clathrin-coated pit [GO:0005905]; clathrin vesicle coat [GO:0030125]";
comp135167_c1_seq1;GAXK01184601.1;P51547;3.05E-35;SODE_HAECO;Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005615; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp135172_c0_seq1;GAXK01184275.1;Q9Z2Y8;1.33E-79;PLPHP_MOUSE;Pyridoxal phosphate homeostasis protein (PLP homeostasis protein) (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein);"mitochondrion [GO:0005739]; pyridoxal phosphate binding [GO:0030170]";"GO:0005739; GO:0030170";;mitochondrion [GO:0005739];pyridoxal phosphate binding [GO:0030170]
comp135188_c0_seq1;GAXK01184585.1;Q13118;4.99E-35;KLF10_HUMAN;Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1901653";"bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp13520_c1_seq1;GAXK01020906.1;Q24020;0;FLII_DROME;Protein flightless-1 (Flightless-I);"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament severing [GO:0051014]; adult somatic muscle development [GO:0007527]; gastrulation involving germ band extension [GO:0010004]; myofibril assembly [GO:0030239]";"GO:0003779; GO:0005509; GO:0007527; GO:0010004; GO:0030239; GO:0051014; GO:0051015";"actin filament severing [GO:0051014]; adult somatic muscle development [GO:0007527]; gastrulation involving germ band extension [GO:0010004]; myofibril assembly [GO:0030239]";;"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp1352353_c0_seq1;GAXK01198122.1;Q90889;1.18E-13;MAFG_CHICK;Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult behavior [GO:0030534]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0030534; GO:0042127; GO:0043565; GO:0045604; GO:0046982";"adult behavior [GO:0030534]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp13524_c1_seq1;GAXK01020616.1;P35761;4.55E-53;TTK_MOUSE;Dual specificity protein kinase TTK (EC 2.7.12.1) (ESK) (PYT);"cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein localization to chromosome [GO:0034502]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]";"GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007059; GO:0007094; GO:0016020; GO:0016321; GO:0018105; GO:0018107; GO:0018108; GO:0033316; GO:0034501; GO:0034502; GO:0042803; GO:0043515; GO:0046777; GO:0051304; GO:1903096";"chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein localization to chromosome [GO:0034502]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]";"cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp135256_c3_seq1;GAXK01184197.1;Q56YP2;1.13E-22;PI5K1_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 1 (AtPIP5K1) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 1) (Diphosphoinositide kinase 1) (PtdIns(4)P-5-kinase 1);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]";"GO:0003785; GO:0005524; GO:0005886; GO:0016307; GO:0016308; GO:0051015";;plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]"
comp1352806_c0_seq1;GAXK01198119.1;P19334;0;TRP_DROME;Transient receptor potential protein;"cation channel complex [GO:0034703]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in sensory perception [GO:0050962]; detection of light stimulus involved in visual perception [GO:0050908]; inorganic cation transmembrane transport [GO:0098662]; light-induced release of internally sequestered calcium ion [GO:0008377]; manganese ion transport [GO:0006828]; mitochondrion organization [GO:0007005]; olfactory learning [GO:0008355]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; protein localization [GO:0008104]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]";"GO:0001895; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007005; GO:0007602; GO:0007603; GO:0007605; GO:0007608; GO:0008104; GO:0008355; GO:0008377; GO:0009416; GO:0010461; GO:0015279; GO:0016021; GO:0016027; GO:0016028; GO:0034703; GO:0035997; GO:0042802; GO:0042803; GO:0046982; GO:0050908; GO:0050962; GO:0051480; GO:0070588; GO:0070679; GO:0071454; GO:0098662";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in sensory perception [GO:0050962]; detection of light stimulus involved in visual perception [GO:0050908]; inorganic cation transmembrane transport [GO:0098662]; light-induced release of internally sequestered calcium ion [GO:0008377]; manganese ion transport [GO:0006828]; mitochondrion organization [GO:0007005]; olfactory learning [GO:0008355]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; protein localization [GO:0008104]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]";"cation channel complex [GO:0034703]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]"
comp1353163_c0_seq1;GAXK01198150.1;O76828;9.51E-14;NHR42_CAEEL;Nuclear hormone receptor family member nhr-42;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp135319_c0_seq1;GAXK01184333.1;Q6NZN0;1.41E-23;RBM26_MOUSE;RNA-binding protein 26 (Protein expressed in male leptotene and zygotene spermatocytes 393) (MLZ-393) (RNA-binding motif protein 26);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";"GO:0003729; GO:0005634; GO:0006397; GO:0010923; GO:0046833; GO:0046872";"mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp13532_c1_seq1;GAXK01020842.1;Q5E9K3;7.15E-83;PNPO_BOVIN;Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";"GO:0004733; GO:0005654; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823";"pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]"
comp135331_c0_seq1;GAXK01184497.1;P21158;1.46E-19;CSGA_MYXXA;C-factor (C signal);"extracellular region [GO:0005576]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005576; GO:0030435";sporulation resulting in formation of a cellular spore [GO:0030435];extracellular region [GO:0005576];
comp135340_c0_seq1;GAXK01184294.1;Q9QY39;3.01E-23;PDZD4_MOUSE;PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein);"cell cortex [GO:0005938]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]";"GO:0005938; GO:0016567; GO:0061630";protein ubiquitination [GO:0016567];cell cortex [GO:0005938];ubiquitin protein ligase activity [GO:0061630]
comp1353538_c0_seq1;GAXK01198145.1;Q5RHP9;9.20E-19;ERIC3_HUMAN;Glutamate-rich protein 3;;;;;
comp1353751_c0_seq1;GAXK01198148.1;Q3SZA5;1.81E-40;SPSY_BOVIN;Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase);"spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]";"GO:0006597; GO:0016768";spermine biosynthetic process [GO:0006597];;spermine synthase activity [GO:0016768]
comp135388_c0_seq1;GAXK01184593.1;Q9VAH9;0;INT11_DROME;Integrator complex subunit 11 (EC 3.1.27.-);"cytoplasm [GO:0005737]; integrator complex [GO:0032039]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; mRNA polyadenylation [GO:0006378]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"GO:0005634; GO:0005737; GO:0005847; GO:0006378; GO:0016180; GO:0016787; GO:0032039; GO:0034472";"mRNA polyadenylation [GO:0006378]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"cytoplasm [GO:0005737]; integrator complex [GO:0032039]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]";hydrolase activity [GO:0016787]
comp1354097_c0_seq1;GAXK01133598.1;Q9Y6N5;1.31E-105;SQOR_HUMAN;Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase);"mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";"GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949";"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";mitochondrial inner membrane [GO:0005743];"FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]"
comp1354118_c0_seq1;GAXK01133583.1;Q05941;1.45E-54;ACHA7_RAT;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0007165; GO:0007268; GO:0007271; GO:0007613; GO:0008144; GO:0008179; GO:0014069; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032279; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042416; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0050877; GO:0050893; GO:0051117; GO:0070373; GO:0070374; GO:0095500; GO:0097110; GO:0098690; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:1904315; GO:1905144; GO:2000300";"acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp135437_c2_seq1;GAXK01184559.1;Q13002;0;GRIK2_HUMAN;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6);"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp1354555_c0_seq1;GAXK01133609.1;O09452;0;G3PA_GUITH;Glyceraldehyde-3-phosphate dehydrogenase, chloroplastic (EC 1.2.1.59) (NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase);"chloroplast [GO:0009507]; glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0006006; GO:0009507; GO:0019253; GO:0043891; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp1354621_c0_seq1;GAXK01133611.1;O00468;2.90E-09;AGRIN_HUMAN;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]";"GO:0001523; GO:0002162; GO:0005200; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005829; GO:0005886; GO:0006024; GO:0006027; GO:0007165; GO:0007213; GO:0007411; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030054; GO:0030198; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]"
comp135468_c0_seq1;GAXK01184505.1;P11584;2.09E-08;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp1354930_c0_seq1;GAXK01133594.1;P41224;5.31E-08;TEF_RAT;Thyrotroph embryonic factor;"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]";"GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0042803; GO:0043565; GO:0045944; GO:0046982; GO:0048511";"positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1355055_c0_seq1;GAXK01133591.1;Q8NDA2;9.51E-46;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp1355132_c0_seq1;GAXK01133584.1;B4LNA8;1.98E-16;LPHN_DROVI;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1355198_c1_seq1;GAXK01133571.1;Q5RB30;1.16E-09;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp135528_c0_seq1;GAXK01184122.1;Q803E0;1.88E-22;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp13554_c1_seq1;GAXK01019909.1;P05661;4.11E-74;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp135558_c2_seq1;GAXK01184188.1;P35324;3.17E-07;SPRR1_RABIT;Cornifin alpha (Small proline-rich protein I) (SPR-I);"cytoplasm [GO:0005737]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]";"GO:0005737; GO:0018149; GO:0031424";"keratinization [GO:0031424]; peptide cross-linking [GO:0018149]";cytoplasm [GO:0005737];
comp135572_c0_seq1;GAXK01184301.1;Q6GLW8;1.44E-39;AIFM2_XENLA;Apoptosis-inducing factor 2 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; DNA binding [GO:0003677]; oxidoreductase activity [GO:0016491]; apoptotic process [GO:0006915]";"GO:0003677; GO:0005741; GO:0006915; GO:0016021; GO:0016491";apoptotic process [GO:0006915];"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"DNA binding [GO:0003677]; oxidoreductase activity [GO:0016491]"
comp135599_c1_seq1;GAXK01184424.1;Q96EG3;1.14E-25;ZN837_HUMAN;Zinc finger protein 837;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp135624_c2_seq1;GAXK01184127.1;P60889;2.25E-20;CBX7_RAT;Chromobox protein homolog 7;"cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to drug [GO:0042493]; sebaceous gland development [GO:0048733]";"GO:0000122; GO:0000790; GO:0000792; GO:0003006; GO:0003682; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0031519; GO:0032968; GO:0035064; GO:0035102; GO:0042493; GO:0048733";"chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to drug [GO:0042493]; sebaceous gland development [GO:0048733]";"cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]";"chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]"
comp135640_c0_seq1;GAXK01184191.1;Q4R6X5;6.86E-70;STRAA_MACFA;STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]";"GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0006611; GO:0007049; GO:0030295; GO:0032147";"activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]"
comp135736_c4_seq1;GAXK01184367.1;Q8BKX6;7.80E-98;SMG1_MOUSE;Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]";"GO:0000184; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0018105; GO:0032204; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020";"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]"
comp1357388_c0_seq1;GAXK01197251.1;Q80UG8;1.05E-69;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp1357597_c0_seq1;GAXK01197265.1;B3EYM8;1.41E-16;IABN_GEOSE;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp135763_c0_seq1;GAXK01184604.1;Q5RCD9;4.70E-36;ZSCA2_PONAB;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp135779_c1_seq1;GAXK01184613.1;P21521;3.40E-30;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp135783_c3_seq1;GAXK01184173.1;Q8N4W9;1.95E-13;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp135806_c0_seq1;GAXK01184552.1;Q20191;1.06E-73;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp135814_c3_seq1;GAXK01184336.1;Q6GPQ3;3.08E-80;MFSD8_XENLA;Major facilitator superfamily domain-containing protein 8;"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp1358307_c0_seq1;GAXK01022043.1;A9ZSY3;8.43E-26;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp135846_c1_seq1;GAXK01184588.1;Q64430;0;ATP7A_MOUSE;Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein homolog);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to copper ion [GO:0071280]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to manganese ion [GO:0010042]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]";"GO:0001568; GO:0001836; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007626; GO:0010042; GO:0010273; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0031069; GO:0031252; GO:0031410; GO:0031526; GO:0032767; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043086; GO:0043204; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0046034; GO:0046688; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0048813; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071280; GO:1903036; GO:1903136; GO:1904754; GO:1904959";"ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to copper ion [GO:0071280]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to manganese ion [GO:0010042]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]"
comp135864_c1_seq1;GAXK01184269.1;Q6ING4;3.12E-47;DEP1A_XENLA;DEP domain-containing protein 1A;"GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556]";"GO:0005096; GO:0035556";intracellular signal transduction [GO:0035556];;GTPase activator activity [GO:0005096]
comp135872_c2_seq1;GAXK01184167.1;O43432;1.64E-33;IF4G3_HUMAN;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]";"GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016281";regulation of translational initiation [GO:0006446];"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp1358778_c0_seq1;GAXK01022052.1;P05661;4.62E-57;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp135901_c1_seq1;GAXK01184200.1;Q80YV3;0;TRRAP_MOUSE;Transformation/transcription domain-associated protein (Tra1 homolog);"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor complex [GO:0005667]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000123; GO:0000124; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006281; GO:0006355; GO:0007093; GO:0016578; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968";"DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]";"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor complex [GO:0005667]; transcription factor TFTC complex [GO:0033276]";"chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp135926_c1_seq1;GAXK01184602.1;O97394;0;SDK_DROME;Protein sidekick;"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]";"GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595";"compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]";
comp1359288_c0_seq1;GAXK01022040.1;P51842;4.91E-41;GUC2F_RAT;Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0016020; GO:0016021; GO:0019934; GO:0042803; GO:0046982; GO:0050908";"cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]"
comp13595_c0_seq1;GAXK01020587.1;O73612;6.02E-14;EFNB1_CHICK;Ephrin-B1 (CEK5 ligand) (CEK5-L);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]";"GO:0005829; GO:0005886; GO:0007411; GO:0016021; GO:0046875; GO:0048013";"axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp1359954_c0_seq1;GAXK01022036.1;Q9W534;3.54E-18;MOODY_DROME;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp136_c0_seq1;GAXK01166400.1;Q9D3D9;2.01E-34;ATPD_MOUSE;ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit);"mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATPase activity [GO:0016887]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton transmembrane transport [GO:1902600]";"GO:0000275; GO:0005739; GO:0005740; GO:0005743; GO:0005753; GO:0009060; GO:0015078; GO:0015986; GO:0016887; GO:0033615; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1902600";"aerobic respiration [GO:0009060]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton transmembrane transport [GO:1902600]";"mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATPase activity [GO:0016887]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp13600_c0_seq1;GAXK01020247.1;Q61771;1.65E-46;KIF3B_MOUSE;Kinesin-like protein KIF3B (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed];"axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]";"GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0015630; GO:0016887; GO:0016939; GO:0017048; GO:0030424; GO:0030496; GO:0032467; GO:0090307; GO:0120170";"microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]";"axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"
comp13603_c0_seq1;GAXK01020314.1;Q28IG8;2.88E-67;TPPC2_XENTR;Trafficking protein particle complex subunit 2;"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]";"GO:0005634; GO:0005793; GO:0006888; GO:0048471";endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888];"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp1360322_c0_seq1;GAXK01143132.1;Q3B7N9;3.91E-21;MYNN_BOVIN;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp136043_c0_seq1;GAXK01007986.1;Q9PWA1;5.41E-54;RGS20_CHICK;Regulator of G-protein signaling 20 (RGS20) (Gz-selective GTPase-activating protein) (G(z)GAP) (Gz-GAP);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968]";"GO:0005634; GO:0005737; GO:0009968; GO:0016020";negative regulation of signal transduction [GO:0009968];"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";
comp136080_c2_seq1;GAXK01007974.1;Q9V5N8;0;STAN_DROME;Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night);"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0001736; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007367; GO:0007409; GO:0007411; GO:0007464; GO:0016021; GO:0016318; GO:0016319; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0060071; GO:0070593; GO:0090175; GO:0098609; GO:1902669";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]"
comp1361_c2_seq1;GAXK01169289.1;Q94920;2.46E-100;VDAC_DROME;Voltage-dependent anion-selective channel (DmVDAC) (Porin);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]";"GO:0005739; GO:0005741; GO:0006811; GO:0006839; GO:0007005; GO:0007291; GO:0007602; GO:0008308; GO:0015288; GO:0016006; GO:0030382; GO:0046930";"ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]";"porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]"
comp1361024_c0_seq1;GAXK01143140.1;Q5E9H5;2.03E-69;BCS1_BOVIN;Mitochondrial chaperone BCS1 (BCS1-like protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"GO:0005524; GO:0005743; GO:0016021; GO:0032981; GO:0033617; GO:0034551";"mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP binding [GO:0005524]
comp136118_c0_seq1;GAXK01008222.1;Q5ZMM3;3.92E-61;RHG15_CHICK;Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15);"cytoplasm [GO:0005737]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0007165; GO:0016020; GO:0043087";"regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";GTPase activator activity [GO:0005096]
comp136142_c3_seq1;GAXK01008160.1;O95502;1.84E-08;NPTXR_HUMAN;Neuronal pentraxin receptor;"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005886; GO:0009898; GO:0016021; GO:0030175; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098962; GO:0098978";"neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp1361579_c0_seq1;GAXK01143118.1;Q9N294;3.36E-08;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp1361753_c0_seq1;GAXK01143123.1;Q05319;6.19E-60;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp136193_c6_seq1;GAXK01008180.1;P55214;8.12E-23;CASP7_MESAU;"Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (ICE-like apoptotic protease 3) (ICE-LAP3) (SREBP cleavage activity 2) (SCA-2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0005737; GO:0006915";apoptotic process [GO:0006915];cytoplasm [GO:0005737];cysteine-type endopeptidase activity [GO:0004197]
comp1361944_c0_seq1;GAXK01143136.1;Q9BQ50;1.01E-22;TREX2_HUMAN;Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2);"nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";"GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803";"DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";nucleus [GO:0005634];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp136195_c0_seq1;GAXK01008203.1;P61023;1.08E-72;CHP1_RAT;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015630; GO:0017156; GO:0019722; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071468; GO:0090314; GO:1901214";"calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]"
comp136236_c4_seq1;GAXK01007927.1;Q6ZT07;0;TBCD9_HUMAN;TBC1 domain family member 9 (TBC1 domain family member 9A);"cell [GO:0005623]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005509; GO:0005623; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cell [GO:0005623];"calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp1362501_c0_seq1;GAXK01193796.1;Q5NC05;6.86E-127;TTF2_MOUSE;Transcription termination factor 2 (EC 3.6.4.-) (RNA polymerase II termination factor) (Transcription release factor 2);"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003677; GO:0004386; GO:0005524; GO:0005681; GO:0005829; GO:0006353; GO:0006397; GO:0008270; GO:0008380";"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]"
comp136335_c4_seq1;GAXK01007980.1;F1ND48;6.17E-70;FBH1_CHICK;F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18);"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]";"GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042";"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]";"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]"
comp136344_c1_seq1;GAXK01007976.1;Q07113;3.40E-85;MPRI_MOUSE;Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222);"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0042981; GO:0043065; GO:0044794; GO:0048471; GO:0051219";"animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]";"enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]"
comp1363560_c0_seq1;GAXK01193799.1;Q08493;3.44E-32;PDE4C_HUMAN;cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004115; GO:0005615; GO:0005829; GO:0005929; GO:0006198; GO:0007186; GO:0046872";"cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]";"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]"
comp136357_c0_seq1;GAXK01008227.1;Q9CW46;3.57E-27;RAVR1_MOUSE;Ribonucleoprotein PTB-binding 1 (Protein raver-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp136376_c1_seq1;GAXK01008191.1;Q8N8R7;7.46E-18;AL14E_HUMAN;ARL14 effector protein (ARF7 effector protein);"cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231";;"cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp1363776_c0_seq1;GAXK01193819.1;Q6ZNA1;8.58E-16;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1363807_c0_seq1;GAXK01193795.1;Q8C827;4.49E-23;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1363845_c0_seq1;GAXK01193810.1;Q7PPU9;5.26E-56;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1364101_c0_seq1;GAXK01171180.1;Q3U4G3;1.04E-26;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp13642_c2_seq1;GAXK01020305.1;Q9D1L0;2.89E-10;CHCH2_MOUSE;Coiled-coil-helix-coiled-coil-helix domain-containing protein 2;"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]";"GO:0005634; GO:0005739; GO:0005758; GO:0007005; GO:0008134; GO:0043565; GO:0045944; GO:1900037";"mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp136421_c0_seq1;GAXK01007970.1;Q63HQ2;2.95E-138;EGFLA_HUMAN;Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein);"basement membrane [GO:0005604]; cell junction [GO:0030054]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009887; GO:0009888; GO:0010811; GO:0016477; GO:0019800; GO:0030054; GO:0030198; GO:0034446; GO:0045202";"animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; interstitial matrix [GO:0005614]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]"
comp136493_c1_seq1;GAXK01007994.1;D3Z7P3;1.17E-165;GLSK_MOUSE;"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]";"GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0051289; GO:0090461";"chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]"
comp1365179_c0_seq1;GAXK01171182.1;A2ASQ1;4.83E-15;AGRIN_MOUSE;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]";"acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp1365402_c0_seq1;GAXK01171174.1;Q9VCG3;4.05E-16;OPA32_DROME;Putative OPA3-like protein CG13603;"mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]";"GO:0005739; GO:0019216";regulation of lipid metabolic process [GO:0019216];mitochondrion [GO:0005739];
comp1365709_c0_seq1;GAXK01171165.1;O43791;8.55E-15;SPOP_HUMAN;Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp1366_c1_seq1;GAXK01169511.1;P97379;4.26E-59;G3BP2_MOUSE;Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063]";"GO:0003729; GO:0005829; GO:0007264; GO:0010494; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029; GO:1990904";"innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";mRNA binding [GO:0003729]
comp1366048_c0_seq1;GAXK01010475.1;Q2PZL6;1.03E-12;FAT4_MOUSE;Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]";"GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609";"branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]";"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp1366100_c0_seq1;GAXK01010465.1;P22770;1.02E-59;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp136640_c0_seq1;GAXK01008193.1;Q8WVB3;4.83E-84;HEXD_HUMAN;Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase);"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]";"GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561";carbohydrate metabolic process [GO:0005975];"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]";"beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp136656_c0_seq1;GAXK01008178.1;Q61575;2.92E-45;FOXN1_MOUSE;Forkhead box protein N1 (Hepatocyte nuclear factor 3 forkhead homolog 11) (HFH-11) (HNF-3/forkhead homolog 11) (Winged-helix transcription factor nude);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific DNA binding [GO:0043565]; blood vessel morphogenesis [GO:0048514]; cell population proliferation [GO:0008283]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hemopoiesis [GO:0030097]; keratinocyte differentiation [GO:0030216]; lymphocyte homeostasis [GO:0002260]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of positive thymic T cell selection [GO:1902232]; regulation of T cell differentiation in thymus [GO:0033081]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus development [GO:0048538]; thymus epithelium morphogenesis [GO:0097536]";"GO:0001228; GO:0001942; GO:0002260; GO:0002360; GO:0005634; GO:0008283; GO:0008544; GO:0010468; GO:0030097; GO:0030216; GO:0030858; GO:0033081; GO:0035878; GO:0043029; GO:0043565; GO:0045944; GO:0048514; GO:0048538; GO:0050673; GO:0051798; GO:0097535; GO:0097536; GO:1902232";"blood vessel morphogenesis [GO:0048514]; cell population proliferation [GO:0008283]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hemopoiesis [GO:0030097]; keratinocyte differentiation [GO:0030216]; lymphocyte homeostasis [GO:0002260]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of positive thymic T cell selection [GO:1902232]; regulation of T cell differentiation in thymus [GO:0033081]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus development [GO:0048538]; thymus epithelium morphogenesis [GO:0097536]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific DNA binding [GO:0043565]"
comp1366767_c0_seq1;GAXK01010446.1;Q0EEE2;1.30E-16;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp136699_c0_seq1;GAXK01008316.1;Q8R821;9.72E-10;PPAX_CALS4;Putative pyrophosphatase PpaX (EC 3.6.1.1);"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]";"GO:0000287; GO:0004427";;;"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp1367255_c0_seq1;GAXK01010450.1;O54968;6.53E-23;NF2L2_RAT;Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; inflammatory response [GO:0006954]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription from RNA polymerase II promoter in response to copper ion [GO:0061396]";"GO:0000785; GO:0000976; GO:0000980; GO:0001102; GO:0001221; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006954; GO:0007568; GO:0010499; GO:0010667; GO:0010976; GO:0016567; GO:0019904; GO:0030194; GO:0032993; GO:0034599; GO:0036091; GO:0036499; GO:0042149; GO:0043161; GO:0043536; GO:0043565; GO:0045454; GO:0045766; GO:0045893; GO:0045944; GO:0045995; GO:0046223; GO:0046326; GO:0060548; GO:0061396; GO:0061419; GO:0070301; GO:0071356; GO:0071456; GO:0071498; GO:0071499; GO:1902037; GO:1902176; GO:1903206; GO:1903788; GO:1904385; GO:1904753; GO:2000121; GO:2000352; GO:2000379";"aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; inflammatory response [GO:0006954]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription from RNA polymerase II promoter in response to copper ion [GO:0061396]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp136731_c0_seq1;GAXK01008010.1;Q05108;5.15E-34;VA5_DOLAR;Venom allergen 5 (Allergen Dol a V) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (allergen Dol a 5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp136800_c0_seq1;GAXK01008029.1;Q9CR50;3.06E-81;ZN363_MOUSE;RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0002039; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp136801_c0_seq1;GAXK01008019.1;Q8L7K9;3.88E-154;MAO2_ARATH;NAD-dependent malic enzyme 2, mitochondrial (AtNAD-ME2) (NAD-malic enzyme 2) (EC 1.1.1.39);"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"GO:0004470; GO:0004471; GO:0005524; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008270; GO:0009507; GO:0042803; GO:0050897; GO:0051287";"malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp13681_c0_seq1;GAXK01020050.1;Q03751;3.98E-34;DNJC5_DROME;DnaJ homolog subfamily C member 5 homolog (Cysteine string protein);"plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; exocytosis [GO:0006887]; negative regulation of response to wounding [GO:1903035]; neuron cellular homeostasis [GO:0070050]; protein folding [GO:0006457]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005886; GO:0006457; GO:0006887; GO:0008021; GO:0016079; GO:0043195; GO:0061176; GO:0061177; GO:0070050; GO:0098693; GO:1900073; GO:1903035";"exocytosis [GO:0006887]; negative regulation of response to wounding [GO:1903035]; neuron cellular homeostasis [GO:0070050]; protein folding [GO:0006457]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]";"plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]";
comp1368124_c0_seq1;GAXK01042609.1;P13596;1.24E-13;NCAM1_RAT;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56);"glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]";"GO:0005104; GO:0005886; GO:0007155; GO:0007413; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0014823; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048666; GO:0050804; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241; GO:0098685; GO:0098978; GO:0099055; GO:0099056";"aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]";"glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]"
comp1368167_c0_seq1;GAXK01042602.1;Q9NQX1;1.81E-19;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp136823_c1_seq1;GAXK01008177.1;Q8BMG8;8.44E-90;MFTC_MOUSE;Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; glycine metabolic process [GO:0006544]";"GO:0005739; GO:0005743; GO:0006544; GO:0008517; GO:0015230; GO:0016021";glycine metabolic process [GO:0006544];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]"
comp1368445_c0_seq1;GAXK01042618.1;P00765;3.58E-30;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp13688_c0_seq1;GAXK01019900.1;Q24368;0;ISWI_DROME;Chromatin-remodeling complex ATPase chain Iswi (EC 3.6.4.-) (CHRAC 140 kDa subunit) (Nucleosome-remodeling factor 140 kDa subunit) (NURF-140) (Protein imitation swi);"ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription factor complex [GO:0005667]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]";"GO:0000166; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005667; GO:0005700; GO:0006325; GO:0006333; GO:0006334; GO:0006338; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008094; GO:0008134; GO:0008623; GO:0016584; GO:0016589; GO:0016590; GO:0031010; GO:0031213; GO:0031491; GO:0035041; GO:0035063; GO:0035076; GO:0035092; GO:0042752; GO:0042766; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0070615";"ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]; transcription, DNA-templated [GO:0006351]";"ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription factor complex [GO:0005667]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]"
comp136880_c1_seq1;GAXK01008257.1;Q59022;1.67E-16;Y1628_METJA;Uncharacterized protein MJ1628;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp13689_c1_seq1;GAXK01020741.1;O73888;4.32E-23;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp136892_c3_seq1;GAXK01008200.1;A6QLE1;4.47E-15;TDRD7_BOVIN;Tudor domain-containing protein 7;"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0005737; GO:0007283; GO:0010608; GO:0035770; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]";mRNA binding [GO:0003729]
comp136897_c0_seq1;GAXK01008284.1;Q5REP8;1.61E-134;MGT4A_PONAB;Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form];"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005576; GO:0006486; GO:0008454; GO:0016021; GO:0046872";protein glycosylation [GO:0006486];"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]"
comp136904_c0_seq1;GAXK01008229.1;Q8JIY1;2.03E-29;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp136906_c1_seq1;GAXK01007942.1;Q7ZYC4;0;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp136910_c0_seq1;GAXK01008306.1;Q7SXT7;1.92E-07;ZC21A_DANRE;Zinc finger C2HC domain-containing protein 1A;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp136923_c1_seq1;GAXK01007971.1;Q01973;0;ROR1_HUMAN;Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1);"axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007605; GO:0009986; GO:0014002; GO:0017147; GO:0030424; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0048856; GO:0051092; GO:1904929";"anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]";"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp13696_c0_seq1;GAXK01020668.1;Q9V464;4.17E-71;ASF1_DROME;Histone chaperone asf1 (Anti-silencing function protein 1) (Replication-coupling assembly factor subunit ASF1) (RCAF subunit ASF1) (dASF1);"polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcriptional repressor complex [GO:0017053]; RNA polymerase II repressing transcription factor binding [GO:0001103]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0000122; GO:0001103; GO:0005700; GO:0006325; GO:0006334; GO:0017053; GO:0035059; GO:0048024";"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcriptional repressor complex [GO:0017053]";RNA polymerase II repressing transcription factor binding [GO:0001103]
comp1369742_c0_seq1;GAXK01042592.1;Q2EI21;4.85E-09;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp136988_c0_seq1;GAXK01008234.1;Q9UMN6;8.21E-08;KMT2B_HUMAN;Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; chromatin-mediated maintenance of transcription [GO:0048096]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of megakaryocyte differentiation [GO:0045652]";"GO:0001541; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0030728; GO:0035097; GO:0042800; GO:0045652; GO:0045893; GO:0048096; GO:0051568; GO:0051569; GO:0080182";"chromatin-mediated maintenance of transcription [GO:0048096]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of megakaryocyte differentiation [GO:0045652]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]"
comp137040_c0_seq1;GAXK01008198.1;P50174;5.42E-156;THIL_RHIME;Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase);"cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]";"GO:0003985; GO:0005737; GO:0042619";poly-hydroxybutyrate biosynthetic process [GO:0042619];cytoplasm [GO:0005737];acetyl-CoA C-acetyltransferase activity [GO:0003985]
comp137052_c4_seq1;GAXK01008324.1;Q9VN14;0;CONT_DROME;Contactin;"anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632";"axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";cell-cell adhesion mediator activity [GO:0098632]
comp137059_c2_seq1;GAXK01008235.1;Q9Y6L7;0;TLL2_HUMAN;Tolloid-like protein 2 (EC 3.4.24.-);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0022617; GO:0030154; GO:0048632";"cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp13708_c0_seq1;GAXK01020895.1;Q6IFY7;6.76E-16;RTN1A_XENLA;Reticulon-1-A (RTN1.1) (xRTN1) (XRTN1-C.1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"GO:0005634; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp1370973_c0_seq1;GAXK01156833.1;Q4ZJM9;8.81E-10;C1QL4_MOUSE;Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11);"collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]";"GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373";"negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]";"collagen trimer [GO:0005581]; extracellular space [GO:0005615]";identical protein binding [GO:0042802]
comp1371036_c0_seq1;GAXK01156821.1;Q9VWF4;2.73E-62;DUSK4_DROME;Dual specificity protein phosphatase MPK-4 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0043508";"dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp137115_c0_seq1;GAXK01007985.1;Q9VD09;2.64E-43;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp1371186_c0_seq1;GAXK01156818.1;Q8N883;2.68E-10;ZN614_HUMAN;Zinc finger protein 614;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1371337_c0_seq1;GAXK01156847.1;A9JTH1;8.46E-22;NCLDA_DANRE;Neurocalcin-delta A;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1371432_c0_seq1;GAXK01156829.1;P0DJ60;2.90E-69;RL19_TETTS;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1371449_c0_seq1;GAXK01156825.1;Q7KRI2;6.22E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp13716_c0_seq1;GAXK01020233.1;Q54BM8;3.37E-158;U652_DICDI;UPF0652 protein;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp137160_c3_seq1;GAXK01007969.1;Q9Z0P7;8.22E-111;SUFU_MOUSE;Suppressor of fused homolog;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of left/right symmetry [GO:0007368]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0001843; GO:0001947; GO:0003281; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0007368; GO:0008013; GO:0008134; GO:0019901; GO:0021513; GO:0021775; GO:0021776; GO:0035904; GO:0042994; GO:0043433; GO:0043588; GO:0045879; GO:0060976; GO:1901621; GO:2000059";"aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of left/right symmetry [GO:0007368]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; ventricular septum development [GO:0003281]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]"
comp1371603_c0_seq1;GAXK01156830.1;Q96RK4;1.34E-175;BBS4_HUMAN;Bardet-Biedl syndrome 4 protein;"BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"GO:0000226; GO:0000242; GO:0000281; GO:0001103; GO:0001750; GO:0001764; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0003777; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010629; GO:0015031; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034260; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0071539; GO:0097730; GO:1902855; GO:1903546; GO:1905515";"adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]"
comp137219_c0_seq1;GAXK01007943.1;Q8N531;4.77E-40;FBXL6_HUMAN;F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A);"SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0004842; GO:0006508; GO:0019005; GO:0031146";"proteolysis [GO:0006508]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";SCF ubiquitin ligase complex [GO:0019005];ubiquitin-protein transferase activity [GO:0004842]
comp1372208_c0_seq1;GAXK01035643.1;B7ZRM8;1.78E-07;EVI1B_XENLA;MDS1 and EVI1 complex locus protein EVI1-B (Ecotropic virus integration site 1 protein homolog-B);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";"GO:0003677; GO:0016607; GO:0039013; GO:0039022; GO:0046872; GO:0072196";"pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1372329_c0_seq1;GAXK01035632.1;Q91453;1.39E-27;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp1372440_c0_seq1;GAXK01035642.1;Q9ULL8;1.21E-17;SHRM4_HUMAN;Protein Shroom4 (Second homolog of apical protein);"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"GO:0001725; GO:0005737; GO:0005884; GO:0005912; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0045159; GO:0050890; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; myosin II binding [GO:0045159]"
comp1372577_c0_seq1;GAXK01035618.1;A2A761;1.73E-11;ZFP69_MOUSE;Zinc finger protein 69 (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1372655_c0_seq1;GAXK01035647.1;Q9VZW5;9.33E-23;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp13730_c1_seq1;GAXK01020719.1;O75828;4.15E-36;CBR3_HUMAN;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Short chain dehydrogenase/reductase family 21C member 2);"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"GO:0000253; GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0042376; GO:0050890; GO:0070402";"cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]"
comp137305_c0_seq1;GAXK01008302.1;Q9VXD1;3.20E-34;SINGL_DROME;Protein singles bar;"integral component of membrane [GO:0016021]; adult somatic muscle development [GO:0007527]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]";"GO:0007517; GO:0007520; GO:0007527; GO:0016021";"adult somatic muscle development [GO:0007527]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]";integral component of membrane [GO:0016021];
comp1373690_c0_seq1;GAXK01035631.1;O35690;4.94E-35;PHX2B_MOUSE;Paired mesoderm homeobox protein 2B (Neuroblastoma Phox) (NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell development [GO:0048468]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory system development [GO:0060541]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]";"GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002087; GO:0003357; GO:0003358; GO:0003360; GO:0005634; GO:0005654; GO:0007399; GO:0008285; GO:0010001; GO:0010468; GO:0021533; GO:0021723; GO:0021934; GO:0030182; GO:0035914; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0048483; GO:0048484; GO:0048485; GO:0048486; GO:0048839; GO:0048894; GO:0060541; GO:0061452; GO:0061549; GO:0071542; GO:0071773; GO:0120162; GO:1901166";"autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell development [GO:0048468]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory system development [GO:0060541]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp13739_c10_seq1;GAXK01019931.1;Q3L1C9;1.10E-99;STAUH_APLCA;Double-stranded RNA-binding protein Staufen homolog;"neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880]";"GO:0003729; GO:0032880; GO:0043005; GO:0043025; GO:0043204";regulation of protein localization [GO:0032880];"neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";mRNA binding [GO:0003729]
comp137413_c1_seq1;GAXK01008195.1;A1ZAI5;1.08E-127;FACR1_DROME;Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965";"ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]"
comp137439_c2_seq1;GAXK01008015.1;Q4UKL7;1.61E-08;GLRX1_RICFE;Glutaredoxin 1;"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp13746_c0_seq1;GAXK01020148.1;Q9U1N0;4.58E-123;HRP65_CHITE;Hrp65 protein (Ct-Hrp65);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]";"GO:0003723; GO:0005634; GO:0005737; GO:0005856; GO:0006406";mRNA export from nucleus [GO:0006406];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp13750_c0_seq1;GAXK01020597.1;Q6X4M3;2.07E-21;LIN52_ONCMY;Protein lin-52 homolog (12.5 kDa retinal tissue protein) (Rtp12.5);"DRM complex [GO:0070176]; multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]";"GO:0006351; GO:0007275; GO:0070176";"multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]";DRM complex [GO:0070176];
comp137509_c0_seq1;GAXK01007925.1;P48809;1.12E-17;RB27C_DROME;Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]";"GO:0003697; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0007411; GO:0008266; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904";"axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp13751_c0_seq1;GAXK01020923.1;Q6P5I8;1.16E-67;YIPF5_DANRE;Protein YIPF5 (YIP1 family member 5);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005789; GO:0005794; GO:0015031; GO:0016021; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";
comp1375191_c0_seq1;GAXK01192897.1;Q8NB50;1.07E-08;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1375225_c0_seq1;GAXK01192880.1;Q6PFM1;4.23E-15;S20AB_DANRE;Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp1375445_c0_seq1;GAXK01192906.1;Q3ZBG9;6.66E-43;PLS2_BOVIN;Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]";"GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872";plasma membrane phospholipid scrambling [GO:0017121];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]"
comp1375534_c0_seq1;GAXK01192900.1;Q06732;1.85E-25;ZN33B_HUMAN;Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp137556_c1_seq1;GAXK01007939.1;Q9W0T5;4.18E-36;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp137558_c1_seq1;GAXK01008006.1;Q9VVE5;1.15E-59;MSIR6_DROME;RNA-binding protein Musashi homolog Rbp6;"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]";"GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904";stem cell development [GO:0048864];"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp1375882_c0_seq1;GAXK01192881.1;Q5XI33;2.81E-12;CIDEC_RAT;Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27);"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; apoptotic process [GO:0006915]";"GO:0005634; GO:0005783; GO:0005811; GO:0006915";apoptotic process [GO:0006915];"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";
comp1375961_c0_seq1;GAXK01192907.1;Q23387;2.69E-07;TM151_CAEEL;Transmembrane protein 151 homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp137600_c0_seq1;GAXK01007945.1;P51400;5.87E-170;RED1_RAT;Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]";"GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0030336; GO:0042803; GO:0044387; GO:0045070; GO:0046872; GO:0050685; GO:0051726";"adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp137620_c0_seq1;GAXK01008008.1;Q9Y6X2;5.04E-10;PIAS3_HUMAN;E3 SUMO-protein ligase PIAS3 (EC 2.3.2.-) (E3 SUMO-protein transferase PIAS3) (Protein inhibitor of activated STAT protein 3);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"GO:0000122; GO:0001085; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008022; GO:0008270; GO:0009725; GO:0010628; GO:0015459; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0030425; GO:0033234; GO:0033235; GO:0045202; GO:0045671; GO:0045838; GO:0047485; GO:0061665; GO:0071847";"negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]";"enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]"
comp1376289_c0_seq1;GAXK01049327.1;Q0VAW7;9.08E-10;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp137634_c0_seq1;GAXK01008216.1;Q92804;3.62E-13;RBP56_HUMAN;TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0006367; GO:0045893; GO:0046872; GO:1901796";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp137641_c2_seq1;GAXK01008220.1;Q9H845;8.98E-95;ACAD9_HUMAN;Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-);"dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991";"long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]"
comp1376461_c0_seq1;GAXK01049339.1;Q1QBB9;3.36E-25;DHMA_PSYCK;Haloalkane dehalogenase (EC 3.8.1.5);haloalkane dehalogenase activity [GO:0018786];GO:0018786;;;haloalkane dehalogenase activity [GO:0018786]
comp1376735_c0_seq1;GAXK01049350.1;Q495B1;3.40E-07;AKD1A_HUMAN;Ankyrin repeat and death domain-containing protein 1A;signal transduction [GO:0007165];GO:0007165;signal transduction [GO:0007165];;
comp1376774_c0_seq1;GAXK01049320.1;Q12766;1.05E-12;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp137688_c0_seq1;GAXK01008318.1;O60669;5.54E-13;MOT2_HUMAN;Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]";"GO:0005477; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035873; GO:0050833; GO:1901475";"lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]"
comp1377_c0_seq1;GAXK01170095.1;Q99LE6;0;ABCF2_MOUSE;ATP-binding cassette sub-family F member 2;"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0005739; GO:0016887";;mitochondrion [GO:0005739];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp137734_c0_seq1;GAXK01008214.1;Q6N075;7.95E-28;MFSD5_HUMAN;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp137740_c0_seq1;GAXK01008221.1;Q9XZT6;5.19E-81;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp13775_c0_seq1;GAXK01020162.1;Q5R7S6;2.01E-30;ZFAN6_PONAB;AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]";"GO:0003677; GO:0005737; GO:0006625; GO:0006915; GO:0008270; GO:0031593; GO:0043066; GO:0043122; GO:0071356";"apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]";cytoplasm [GO:0005737];"DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]"
comp13778_c0_seq1;GAXK01020343.1;A6QL88;0;SAC1_BOVIN;Phosphatidylinositide phosphatase SAC1 (EC 3.1.3.-) (Suppressor of actin mutations 1-like protein);"AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856]";"GO:0005783; GO:0005789; GO:0005794; GO:0016791; GO:0032281; GO:0043812; GO:0046856";phosphatidylinositol dephosphorylation [GO:0046856];"AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]";"phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]"
comp1377805_c0_seq1;GAXK01049347.1;P26258;9.21E-10;TETN_CARPZ;Tetranectin-like protein;carbohydrate binding [GO:0030246];GO:0030246;;;carbohydrate binding [GO:0030246]
comp137807_c0_seq1;GAXK01008285.1;Q4V8C3;0;EMAL1_RAT;Echinoderm microtubule-associated protein-like 1 (EMAP-1);"cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405]";"GO:0000226; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015631; GO:0048471";"brain development [GO:0007420]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405]";"cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]";"microtubule binding [GO:0008017]; tubulin binding [GO:0015631]"
comp137811_c4_seq1;GAXK01007988.1;P52746;1.31E-25;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp137813_c0_seq1;GAXK01008039.1;Q9VSL7;1.56E-73;FOI_DROME;Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007280; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030154; GO:0035147; GO:0035262; GO:0071578";"branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp13783_c0_seq1;GAXK01019891.1;O60046;8.43E-20;FKBP2_NEUCR;FK506-binding protein 2 (FKBP2) (EC 5.2.1.8) (FK506-resistance protein 5) (NcFKBP22) (Peptidyl-prolyl cis-trans isomerase fkr-5) (PPIase fkr-5);"endoplasmic reticulum lumen [GO:0005788]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp137877_c0_seq1;GAXK01008024.1;Q811F1;1.12E-25;ZBT41_MOUSE;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp13789_c0_seq1;GAXK01020329.1;A5PJG7;2.31E-78;CCHL_BOVIN;Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]";"GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872";cytochrome c-heme linkage [GO:0018063];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]"
comp137910_c0_seq1;GAXK01007992.1;Q7Z0Q2;7.17E-21;RNKB_CERCA;Ribonuclease kappa-B (RNase K-B) (RNase kappa-B) (EC 3.1.-.-) (Cc RNase);"integral component of membrane [GO:0016021]; endoribonuclease activity [GO:0004521]";"GO:0004521; GO:0016021";;integral component of membrane [GO:0016021];endoribonuclease activity [GO:0004521]
comp137912_c1_seq1;GAXK01008217.1;Q5VT66;5.46E-49;MARC1_HUMAN;Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005739; GO:0005741; GO:0006805; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0055114";"detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]"
comp1379233_c0_seq1;GAXK01071254.1;Q0VAW7;1.03E-12;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1379256_c1_seq1;GAXK01071243.1;P34101;4.26E-35;FHKC_DICDI;Probable serine/threonine-protein kinase fhkC (EC 2.7.11.1) (Forkhead-associated protein kinase C) (Protein kinase 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; mitotic DNA damage checkpoint [GO:0044773]; signal transduction in response to DNA damage [GO:0042770]";"GO:0000077; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0042770; GO:0044773";"cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; mitotic DNA damage checkpoint [GO:0044773]; signal transduction in response to DNA damage [GO:0042770]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp13797_c0_seq1;GAXK01020120.1;Q9U639;6.55E-124;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp137991_c0_seq1;GAXK01008287.1;Q9QZP2;3.55E-17;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1380007_c0_seq1;GAXK01192333.1;Q6DCW1;1.44E-07;GFI1B_XENLA;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0006325; GO:0007275; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1380199_c0_seq1;GAXK01192340.1;Q9VQ56;8.46E-07;ERM_DROME;Fez family zinc finger protein erm (Earmuff);"axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; axon target recognition [GO:0007412]; axonogenesis involved in innervation [GO:0060385]; cell dedifferentiation [GO:0043697]; medulla oblongata morphogenesis [GO:0021579]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; stem cell population maintenance [GO:0019827]";"GO:0005634; GO:0007406; GO:0007412; GO:0010628; GO:0010629; GO:0019827; GO:0021579; GO:0043025; GO:0043565; GO:0043697; GO:0044212; GO:0044295; GO:0045666; GO:0045892; GO:0046872; GO:0050767; GO:0060385; GO:0072499; GO:1902692; GO:1902843";"axonogenesis involved in innervation [GO:0060385]; axon target recognition [GO:0007412]; cell dedifferentiation [GO:0043697]; medulla oblongata morphogenesis [GO:0021579]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; stem cell population maintenance [GO:0019827]";"axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp138022_c0_seq1;GAXK01046721.1;Q9BJK5;5.02E-10;NHR97_CAEEL;Nuclear hormone receptor family member nhr-97;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp138024_c1_seq1;GAXK01046874.1;Q8CHL0;2.86E-53;FZD5_RAT;Frizzled-5 (Fz-5);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; presynapse assembly [GO:0099054]";"GO:0000139; GO:0004930; GO:0005886; GO:0008289; GO:0016021; GO:0017147; GO:0030054; GO:0030424; GO:0030425; GO:0035567; GO:0042813; GO:0043204; GO:0045202; GO:0060070; GO:0098978; GO:0099054";"canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; presynapse assembly [GO:0099054]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp13803_c3_seq1;GAXK01020593.1;Q15637;1.71E-126;SF01_HUMAN;Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0016604; GO:0030238; GO:0030575; GO:0033327; GO:0042802; GO:0045131; GO:0048662; GO:0050810";"Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]";"identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp138030_c0_seq1;GAXK01046889.1;Q6R032;1.84E-09;MB3R5_ARATH;Transcription factor MYB3R-5 (Myb-related protein 3R-5);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; response to ethylene [GO:0009723]; response to salicylic acid [GO:0009751]";"GO:0003700; GO:0005634; GO:0008285; GO:0009723; GO:0009751; GO:0043565; GO:0045892";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; response to ethylene [GO:0009723]; response to salicylic acid [GO:0009751]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp1380698_c0_seq1;GAXK01192337.1;Q5R573;1.05E-90;RBL2A_PONAB;Rab-like protein 2A;"GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525";;;"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp138077_c1_seq1;GAXK01046673.1;Q5PQ71;1.79E-67;ISOC2_XENLA;Isochorismatase domain-containing protein 2;catalytic activity [GO:0003824];GO:0003824;;;catalytic activity [GO:0003824]
comp138090_c0_seq1;GAXK01047053.1;Q5FWP2;8.65E-22;SMAG1_XENLA;Protein Smaug homolog 1 (Smaug 1) (Sterile alpha motif domain-containing protein 4A);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; synapse [GO:0045202]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; regulation of mRNA stability [GO:0043488]";"GO:0003723; GO:0005737; GO:0030054; GO:0030371; GO:0030425; GO:0043488; GO:0045202";regulation of mRNA stability [GO:0043488];"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; synapse [GO:0045202]";"RNA binding [GO:0003723]; translation repressor activity [GO:0030371]"
comp1381005_c0_seq1;GAXK01192360.1;Q52KB5;5.58E-13;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp138102_c0_seq1;GAXK01046938.1;P28191;5.23E-153;PTP1_CAEEL;Tyrosine-protein phosphatase 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1);"cytoskeleton [GO:0005856]; sarcoplasmic reticulum [GO:0016529]; cytoskeletal protein binding [GO:0008092]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004725; GO:0005856; GO:0008092; GO:0016529";;"cytoskeleton [GO:0005856]; sarcoplasmic reticulum [GO:0016529]";"cytoskeletal protein binding [GO:0008092]; protein tyrosine phosphatase activity [GO:0004725]"
comp1381198_c0_seq1;GAXK01192353.1;Q6PFM1;4.43E-29;S20AB_DANRE;Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp1381513_c0_seq1;GAXK01192334.1;Q8MSU3;4.57E-69;FRRS1_DROME;Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-);"integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]";"GO:0000293; GO:0016021; GO:0055114";oxidation-reduction process [GO:0055114];integral component of membrane [GO:0016021];ferric-chelate reductase activity [GO:0000293]
comp138154_c2_seq1;GAXK01047169.1;P54350;1.56E-68;WEE1_DROME;Wee1-like protein kinase (Dwee1) (EC 2.7.10.2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";"GO:0000287; GO:0001700; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0006468; GO:0007093; GO:0018108; GO:0045736; GO:0051225; GO:0051299; GO:0051301; GO:0051642";"cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp1381659_c1_seq1;GAXK01192343.1;P59511;0;ATS20_MOUSE;A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-);"extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]";"GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0008270; GO:0009967; GO:0030198; GO:0043066; GO:0045636; GO:0048070";"extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]";extracellular space [GO:0005615];"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1381970_c0_seq1;GAXK01192352.1;Q96RW7;9.47E-20;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1382_c1_seq1;GAXK01170557.1;Q9Z2U1;3.06E-135;PSA5_MOUSE;Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp1382129_c0_seq1;GAXK01114974.1;P18749;3.01E-08;ZO6_XENLA;Oocyte zinc finger protein XlCOF6 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp138237_c0_seq1;GAXK01046996.1;P48607;3.87E-13;SPZ_DROME;Protein spaetzle [Cleaved into: Protein spaetzle C-106];"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0002807; GO:0005121; GO:0005125; GO:0005576; GO:0005615; GO:0006965; GO:0006967; GO:0007310; GO:0007399; GO:0007526; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0009611; GO:0009950; GO:0009953; GO:0021556; GO:0031334; GO:0031640; GO:0032991; GO:0042542; GO:0042803; GO:0045087; GO:0045752; GO:0048018; GO:0050829; GO:0050830; GO:0050832; GO:0061760";"antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp138241_c0_seq1;GAXK01046957.1;P70403;7.05E-120;CASP_MOUSE;Protein CASP;"cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; neuron projection [GO:0043005]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; Golgi vesicle transport [GO:0048193]; inner ear auditory receptor cell differentiation [GO:0042491]; intra-Golgi vesicle-mediated transport [GO:0006891]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000139; GO:0000977; GO:0000980; GO:0001822; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006891; GO:0030173; GO:0030324; GO:0042491; GO:0043005; GO:0043565; GO:0048193";"Golgi vesicle transport [GO:0048193]; inner ear auditory receptor cell differentiation [GO:0042491]; intra-Golgi vesicle-mediated transport [GO:0006891]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; neuron projection [GO:0043005]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1382554_c0_seq1;GAXK01114948.1;G5ED00;3.01E-08;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp138256_c0_seq1;GAXK01046671.1;Q9U2M7;4.60E-33;AP4A_CAEEL;Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.-) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nudix hydrolase 4);"5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity [GO:0043135]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; ADP biosynthetic process [GO:0006172]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; diadenosine tetraphosphate catabolic process [GO:0015967]; ribose phosphate metabolic process [GO:0019693]";"GO:0004081; GO:0005524; GO:0006167; GO:0006172; GO:0006754; GO:0006915; GO:0015967; GO:0019693; GO:0043135";"ADP biosynthetic process [GO:0006172]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; diadenosine tetraphosphate catabolic process [GO:0015967]; ribose phosphate metabolic process [GO:0019693]";;"5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity [GO:0043135]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]"
comp13826_c0_seq1;GAXK01020445.1;Q9CZX5;4.07E-44;PINX1_MOUSE;PIN2/TERF1-interacting telomerase inhibitor 1 (67-11-3 protein) (LPTS1) (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (TRF1-interacting protein 1);"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]";"GO:0000228; GO:0000776; GO:0000777; GO:0000781; GO:0000784; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0051974; GO:0070034; GO:0070198; GO:1902570; GO:1904744; GO:1904751";"mitotic metaphase plate congression [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]";"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]";"protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]"
comp1382689_c1_seq1;GAXK01114957.1;Q7Z410;7.46E-14;TMPS9_HUMAN;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp13829_c1_seq1;GAXK01020051.1;Q5ZKM1;5.31E-120;SPB1_CHICK;pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3);"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]";"GO:0000453; GO:0000463; GO:0000466; GO:0001510; GO:0005730; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105";"enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]";"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]";"RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]"
comp138301_c8_seq1;GAXK01047055.1;B2RXH2;1.21E-106;KDM4E_HUMAN;Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K9 demethylation [GO:0033169]";"GO:0005634; GO:0006338; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0046872; GO:0051213";"chromatin remodeling [GO:0006338]; histone H3-K9 demethylation [GO:0033169]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp1383116_c0_seq1;GAXK01114949.1;P70052;1.30E-90;NR2E1_XENLA;Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (xTLL);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0003707; GO:0005634; GO:0007275; GO:0008270; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp138326_c1_seq1;GAXK01046904.1;Q8VCH6;2.95E-114;DHC24_MOUSE;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; tissue development [GO:0009888]";"GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006979; GO:0007265; GO:0008104; GO:0008202; GO:0008203; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016125; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949";"amyloid precursor protein catabolic process [GO:0042987]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]";"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"
comp138339_c2_seq1;GAXK01047166.1;G4RK44;2.30E-119;TPSP_THETK;"Bifunctional trehalose-6-phosphate synthase/phosphatase [Includes: Alpha,alpha-trehalose-phosphate synthase [UDP-forming] (EC 2.4.1.15) (Trehalose-6-phosphate synthase); Trehalose-6-phosphate phosphatase (EC 3.1.3.12)]";"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]; trehalose biosynthetic process [GO:0005992]";"GO:0003825; GO:0004805; GO:0005992; GO:0046872";trehalose biosynthetic process [GO:0005992];;"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]"
comp138344_c1_seq1;GAXK01046748.1;O15360;1.03E-33;FANCA_HUMAN;Fanconi anemia group A protein (Protein FACA);"cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]";"GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348";"DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]";"cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1383575_c0_seq1;GAXK01114952.1;Q5FWI3;9.13E-85;CEIP2_MOUSE;Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2);"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";"GO:0001525; GO:0004415; GO:0005509; GO:0005887; GO:0030214; GO:1903670";"angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";integral component of plasma membrane [GO:0005887];"calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]"
comp1383698_c0_seq1;GAXK01114987.1;A7T1N0;7.11E-29;TMP2L_NEMVE;Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"GO:0005886; GO:0015280; GO:0016021; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604";"calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]"
comp138394_c1_seq1;GAXK01046961.1;O70273;3.21E-23;EHF_MOUSE;ETS homologous factor (ETS domain-containing transcription factor);"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0045893; GO:0045944; GO:0050673";"cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp13841_c0_seq1;GAXK01020053.1;Q7YR70;2.66E-33;AAMP_CANLF;Angio-associated migratory cell protein;"cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]";"GO:0001525; GO:0005829; GO:0005886; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0042273; GO:0045171; GO:0051082";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]";"cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]";unfolded protein binding [GO:0051082]
comp138422_c1_seq1;GAXK01047054.1;P23258;3.46E-30;TBG1_HUMAN;Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1);"apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730";"ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]"
comp1384247_c0_seq1;GAXK01108934.1;Q6GNS1;3.39E-11;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp1384540_c1_seq1;GAXK01108960.1;Q96EK7;1.44E-41;F120B_HUMAN;Constitutive coactivator of peroxisome proliferator-activated receptor gamma (Constitutive coactivator of PPAR-gamma) (Constitutive coactivator of PPARG) (PPARG constitutive coactivator 1) (PGCC1) (Protein FAM120B);"nucleus [GO:0005634]; fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]";"GO:0005634; GO:0035357; GO:0045444";"fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]";nucleus [GO:0005634];
comp1384711_c0_seq1;GAXK01108930.1;Q63515;5.63E-08;C4BPB_RAT;C4b-binding protein beta chain;"extracellular region [GO:0005576]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";"GO:0005576; GO:0006958; GO:0045087";"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp1384832_c0_seq1;GAXK01108964.1;P52746;2.78E-09;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp13850_c0_seq1;GAXK01020448.1;Q5ZMC0;1.87E-43;EDF1_CHICK;Endothelial differentiation-related factor 1 homolog (EDF-1);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; positive regulation of DNA binding [GO:0043388]";"GO:0001094; GO:0003677; GO:0003713; GO:0005634; GO:0005730; GO:0005829; GO:0043388";positive regulation of DNA binding [GO:0043388];"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]"
comp138504_c0_seq1;GAXK01046823.1;Q7K0F0;5.98E-103;CC130_DROME;Coiled-coil domain-containing protein 130 homolog;;;;;
comp13852_c1_seq1;GAXK01020049.1;O61492;0;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp1385205_c0_seq1;GAXK01108938.1;Q8N6D5;8.74E-64;ANR29_HUMAN;Ankyrin repeat domain-containing protein 29;;;;;
comp138526_c1_seq1;GAXK01046727.1;B7YZU2;4.95E-105;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1385584_c0_seq1;GAXK01108933.1;O46040;1.05E-31;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1385831_c0_seq1;GAXK01108918.1;Q5SRE7;5.69E-12;PHYD1_HUMAN;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp138586_c0_seq1;GAXK01046722.1;Q9H0R3;4.49E-80;TM222_HUMAN;Transmembrane protein 222;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1385909_c0_seq1;GAXK01108919.1;P83501;3.57E-11;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1386_c0_seq1;GAXK01170562.1;Q28C98;8.57E-60;MESH1_XENTR;Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase);"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]; guanosine tetraphosphate catabolic process [GO:0015971]";"GO:0008893; GO:0015971; GO:0046872";guanosine tetraphosphate catabolic process [GO:0015971];;"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"
comp1386071_c0_seq1;GAXK01154091.1;P55112;6.94E-56;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp138625_c1_seq1;GAXK01046729.1;Q7KRI2;1.34E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1386597_c0_seq1;GAXK01154123.1;Q9TUP7;4.87E-15;OX2R_CANLF;Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2);"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0022410; GO:0051480";"circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]"
comp1386809_c0_seq1;GAXK01154131.1;Q9VCA2;4.24E-74;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1387141_c0_seq1;GAXK01154117.1;Q9Y2G3;0;AT11B_HUMAN;Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B);"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326";"aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]"
comp1387178_c0_seq1;GAXK01154099.1;Q19791;1.47E-53;GON1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1);"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]";"GO:0004222; GO:0005604; GO:0005783; GO:0005794; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0048644; GO:1905607";"cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]";"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp1387388_c1_seq1;GAXK01154087.1;O35929;6.74E-13;REM1_MOUSE;GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1387490_c1_seq1;GAXK01154120.1;Q5RFU0;2.40E-77;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp138768_c0_seq1;GAXK01046665.1;Q8GAV9;1.57E-32;CPNA_COMS9;Cyclopentanol dehydrogenase (EC 1.1.1.163);"cyclopentanol dehydrogenase activity [GO:0055041]; cyclopentanol catabolic process [GO:0033022]";"GO:0033022; GO:0055041";cyclopentanol catabolic process [GO:0033022];;cyclopentanol dehydrogenase activity [GO:0055041]
comp13879_c0_seq1;GAXK01020022.1;Q96AE4;2.32E-31;FUBP1_HUMAN;Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; transcription by RNA polymerase II [GO:0006366]";"GO:0003697; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0006366; GO:0010628";"positive regulation of gene expression [GO:0010628]; transcription by RNA polymerase II [GO:0006366]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp138792_c3_seq1;GAXK01046905.1;Q7Z6B7;4.75E-91;SRGP1_HUMAN;SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056";"negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]"
comp1388178_c0_seq1;GAXK01007185.1;P34442;2.74E-18;PTP5_CAEEL;Probable tyrosine-protein phosphatase F54C8.4 (EC 3.1.3.48);"nucleus [GO:0005634]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]";"GO:0004651; GO:0004725; GO:0005634; GO:0008138";;nucleus [GO:0005634];"polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1388269_c0_seq1;GAXK01007230.1;Q7M4I5;6.36E-26;PA2_APIDO;Phospholipase A2 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (allergen Api d 1);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp138832_c3_seq1;GAXK01046710.1;O88576;4.00E-139;S6A18_MOUSE;Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]";"GO:0003333; GO:0005328; GO:0005886; GO:0005887; GO:0015175; GO:0016324; GO:0031526";amino acid transmembrane transport [GO:0003333];"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp138837_c0_seq1;GAXK01047190.1;Q8WVT3;6.53E-84;TPC12_HUMAN;Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15) (Trafficking of membranes and mitosis);"cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234]";"GO:0000776; GO:0004175; GO:0005634; GO:0005793; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0051259; GO:0051310; GO:0090234; GO:1905342";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234]";"cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]";endopeptidase activity [GO:0004175]
comp1389_c1_seq1;GAXK01168741.1;P30736;1.99E-55;RL15_CHITE;60S ribosomal protein L15 (YL10);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1389184_c0_seq1;GAXK01007237.1;Q9NQZ8;3.43E-48;ZNF71_HUMAN;Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1389204_c0_seq1;GAXK01007181.1;O02466;2.71E-13;ILPR_BRALA;"Insulin-like peptide receptor (ILP receptor) (EC 2.7.10.1) [Cleaved into: Insulin-like peptide receptor alpha chain; Insulin-like peptide receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0043548; GO:0043560; GO:0046777; GO:0046872";"protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp138922_c0_seq1;GAXK01047188.1;Q9I7F7;0;ACKL_DROME;Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468]";"GO:0004713; GO:0004715; GO:0005524; GO:0006468; GO:0008258; GO:0031034; GO:0046664";"dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468]";;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]"
comp138950_c0_seq1;GAXK01047029.1;P49283;2.01E-150;MVL_DROME;Protein Malvolio;"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838";"copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]"
comp1389569_c0_seq1;GAXK01007175.1;Q8CHN8;2.14E-26;MASP1_RAT;"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]";"GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0006956; GO:0042803; GO:0048306";"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]";extracellular space [GO:0005615];"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp139_c0_seq1;GAXK01166087.1;Q95WA0;1.58E-73;RL26_LITLI;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp1390_c0_seq1;GAXK01168997.1;Q94516;2.81E-48;AT5F1_DROME;ATP synthase subunit b, mitochondrial (ATPase subunit b) (FO-ATP synthase subunit b);"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"GO:0000276; GO:0005739; GO:0015078; GO:0015986; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";proton transmembrane transporter activity [GO:0015078]
comp139002_c0_seq1;GAXK01046803.1;Q9D844;2.26E-16;DNJC4_MOUSE;DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"GO:0005739; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";
comp139018_c0_seq1;GAXK01046960.1;Q5E9P6;1.07E-08;BSCL2_BOVIN;Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog);"integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]";"GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995";"fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]";integral component of endoplasmic reticulum membrane [GO:0030176];
comp13903_c0_seq1;GAXK01020858.1;P54357;3.50E-36;MLC2_DROME;Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]";"GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036";actin filament-based movement [GO:0030048];"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]";"calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
comp13904_c0_seq1;GAXK01020546.1;Q2IBC1;2.94E-25;CAV1_RHIFE;Caveolin-1;"caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]";"GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836";"caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]";"caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]";
comp1390459_c0_seq1;GAXK01195299.1;Q9Y530;6.09E-19;OARD1_HUMAN;ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]"
comp139046_c1_seq1;GAXK01046951.1;P27701;1.75E-08;CD82_HUMAN;CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"GO:0005886; GO:0005887; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";
comp1391007_c0_seq1;GAXK01195285.1;O02151;1.94E-17;NHR14_CAEEL;Nuclear hormone receptor family member nhr-14;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp139102_c0_seq1;GAXK01046705.1;Q9PU85;1.86E-112;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp139122_c3_seq1;GAXK01046997.1;Q7KRI2;5.37E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp139123_c0_seq1;GAXK01046935.1;E9Q394;1.81E-71;AKP13_MOUSE;A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc);"cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]";"GO:0004691; GO:0005078; GO:0005089; GO:0005634; GO:0005829; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0017048; GO:0030864; GO:0035025; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023; GO:1900169";"adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]";"cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp139131_c4_seq1;GAXK01046942.1;P85084;1.29E-38;CHIT_CARPA;Endochitinase (EC 3.2.1.14);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp139156_c0_seq1;GAXK01046970.1;Q8INB9;1.03E-166;AKT1_DROME;RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB);"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008284; GO:0008286; GO:0008362; GO:0010884; GO:0010897; GO:0018105; GO:0030307; GO:0031104; GO:0032869; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215; GO:1904262; GO:1904263";"apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp1391600_c0_seq1;GAXK01195291.1;A9YME1;5.90E-24;VA5_MICHY;Venom allergen 5 (Antigen 5) (Cysteine-rich venom protein) (CRVP) (Venom protein 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1391809_c0_seq1;GAXK01195312.1;G5EFD9;5.14E-17;ADA10_CAEEL;Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]";"GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667";"cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp139247_c0_seq1;GAXK01047051.1;P07247;3.32E-63;KRUP_DROME;Protein krueppel;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; chromatin silencing [GO:0006342]; compound eye development [GO:0048749]; ganglion mother cell fate determination [GO:0007402]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";"GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0006342; GO:0007354; GO:0007400; GO:0007402; GO:0007411; GO:0007419; GO:0007443; GO:0007517; GO:0035206; GO:0035290; GO:0040034; GO:0043565; GO:0045892; GO:0046872; GO:0048749; GO:0050767; GO:0061332; GO:2000177";"axon guidance [GO:0007411]; chromatin silencing [GO:0006342]; compound eye development [GO:0048749]; ganglion mother cell fate determination [GO:0007402]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp139271_c7_seq1;GAXK01046839.1;Q05927;4.61E-90;5NTD_BOVIN;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; AMP catabolic process [GO:0006196]";"GO:0000166; GO:0005886; GO:0006196; GO:0008253; GO:0031225; GO:0046872";AMP catabolic process [GO:0006196];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp1392922_c0_seq1;GAXK01017684.1;O14966;3.54E-55;RAB7L_HUMAN;Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29);"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0032482; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1903441; GO:1905279; GO:1990967";"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]";"dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]"
comp13930_c1_seq1;GAXK01020189.1;O18733;1.13E-08;MMP9_CANLF;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp139320_c3_seq1;GAXK01047012.1;Q5RJY2;6.19E-63;G2E3_MOUSE;G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0001824; GO:0005730; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243";"apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp139333_c0_seq1;GAXK01046822.1;Q5R668;2.12E-31;ACSL3_PONAB;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391";long-chain fatty acid metabolic process [GO:0001676];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp1393516_c0_seq1;GAXK01017677.1;Q80UG8;2.87E-64;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp139370_c0_seq1;GAXK01046953.1;B3EWZ6;1.61E-87;MLRP2_ACRMI;MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp1393791_c0_seq1;GAXK01017688.1;P86704;5.15E-15;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp139385_c0_seq1;GAXK01046838.1;C4N147;1.46E-22;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp1393911_c0_seq1;GAXK01017685.1;P38040;1.70E-23;GBG1_DROME;Guanine nucleotide-binding protein subunit gamma-1;"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343";"apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]"
comp139427_c2_seq1;GAXK01046723.1;O00160;0;MYO1F_HUMAN;Unconventional myosin-If (Myosin-Ie);"unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0016461";;unconventional myosin complex [GO:0016461];"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp139444_c0_seq1;GAXK01046999.1;Q7KRI2;1.09E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1394662_c0_seq1;GAXK01095296.1;Q8I6K0;4.21E-22;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1395_c0_seq1;GAXK01168974.1;Q7KVQ0;9.24E-45;GAR1_DROME;Probable H/ACA ribonucleoprotein complex subunit 1 (GCR 101 snRNP) (Nucleolar protein family A member 1);"box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]";"GO:0000454; GO:0005654; GO:0005730; GO:0005732; GO:0031118; GO:0031429; GO:0034513";"rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]";"box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]";box H/ACA snoRNA binding [GO:0034513]
comp13951_c0_seq1;GAXK01020150.1;G4WAW9;5.17E-12;SELM_ERISI;Selenoprotein M;endoplasmic reticulum [GO:0005783];GO:0005783;;endoplasmic reticulum [GO:0005783];
comp139521_c0_seq1;GAXK01047004.1;Q9VHX7;1.77E-66;ELOVL_DROME;Elongation of very long chain fatty acids protein (EC 2.3.1.199) (Elongation of very long chain fatty acids elongase) (Very-long-chain 3-oxoacyl-CoA synthase);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0001676; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0030497; GO:0034625; GO:0034626; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp13953_c0_seq1;GAXK01020705.1;A1L2P2;1.91E-11;SI12A_XENLA;Small integral membrane protein 12-A;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp139544_c0_seq1;GAXK01046933.1;P15846;2.49E-16;TPMM_TRICO;Tropomyosin, muscle;;;;;
comp1395496_c0_seq1;GAXK01095302.1;D2KBH9;4.14E-31;NAS8_STECR;Zinc metalloproteinase nas-8 (EC 3.4.24.21) (Nematode astacin 8) (Sc-AST);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1395556_c0_seq1;GAXK01095309.1;Q7PPU9;4.23E-35;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp139559_c0_seq1;GAXK01046811.1;Q5NVS7;6.80E-14;CAN1_PONAB;Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Micromolar-calpain) (muCANP);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; self proteolysis [GO:0097264]";"GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0006508; GO:0050790; GO:0097264";"proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; self proteolysis [GO:0097264]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp1395846_c0_seq1;GAXK01095303.1;Q7Z2H8;4.98E-54;S36A1_HUMAN;Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"GO:0003333; GO:0005280; GO:0005765; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015078; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015808; GO:0015816; GO:0016021; GO:0035524; GO:1902600";"amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"amino acid:proton symporter activity [GO:0005280]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]"
comp1395888_c0_seq1;GAXK01095279.1;Q9VRX6;2.53E-10;INX4_DROME;Innexin inx4 (Innexin-4) (Protein zero population growth);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; germ cell development [GO:0007281]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007281; GO:0007283; GO:0010496; GO:0016021; GO:0036098; GO:0055077";"germ cell development [GO:0007281]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; spermatogenesis [GO:0007283]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]"
comp13961_c2_seq1;GAXK01020925.1;Q5ZKQ3;8.40E-39;RPAP3_CHICK;RNA polymerase II-associated protein 3;;;;;
comp13965_c2_seq1;GAXK01020903.1;O14753;3.12E-11;OVOL1_HUMAN;Putative transcription factor Ovo-like 1 (hOvo1);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; skin development [GO:0043588]; spermatogenesis [GO:0007283]";"GO:0000978; GO:0001227; GO:0001228; GO:0001822; GO:0005634; GO:0007283; GO:0007498; GO:0009913; GO:0043565; GO:0043588; GO:0045892; GO:0046872; GO:0051729; GO:1901994; GO:2000647";"epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; skin development [GO:0043588]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1396581_c0_seq1;GAXK01197999.1;Q8I6K0;4.72E-23;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1396617_c0_seq1;GAXK01197994.1;P32114;1.29E-58;PAX2_MOUSE;Paired box protein Pax-2;"centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]";"GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001656; GO:0001657; GO:0001658; GO:0001709; GO:0001822; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005730; GO:0005764; GO:0005794; GO:0005815; GO:0006351; GO:0007417; GO:0007501; GO:0008134; GO:0008284; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031016; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0042981; GO:0043010; GO:0043066; GO:0043067; GO:0043069; GO:0043154; GO:0043491; GO:0044212; GO:0045892; GO:0045893; GO:0045918; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061205; GO:0061360; GO:0070301; GO:0070742; GO:0071260; GO:0071300; GO:0071333; GO:0071542; GO:0072075; GO:0072108; GO:0072162; GO:0072164; GO:0072172; GO:0072177; GO:0072179; GO:0072189; GO:0072197; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0072593; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:2000378; GO:2000594; GO:2000597";"brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]";"centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]";"C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1396710_c0_seq1;GAXK01197987.1;Q86WZ6;1.32E-17;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp139675_c2_seq1;GAXK01046700.1;Q9V576;1.51E-51;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp139694_c1_seq1;GAXK01046979.1;Q13796;4.30E-17;SHRM2_HUMAN;Protein Shroom2 (Apical-like protein) (Protein APXL);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"GO:0002089; GO:0003779; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005913; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0030036; GO:0030864; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]"
comp1397_c0_seq1;GAXK01169312.1;O16797;1.82E-43;RL3_DROME;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp13970_c0_seq1;GAXK01020605.1;Q9V464;8.96E-86;ASF1_DROME;Histone chaperone asf1 (Anti-silencing function protein 1) (Replication-coupling assembly factor subunit ASF1) (RCAF subunit ASF1) (dASF1);"polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcriptional repressor complex [GO:0017053]; RNA polymerase II repressing transcription factor binding [GO:0001103]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0000122; GO:0001103; GO:0005700; GO:0006325; GO:0006334; GO:0017053; GO:0035059; GO:0048024";"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcriptional repressor complex [GO:0017053]";RNA polymerase II repressing transcription factor binding [GO:0001103]
comp1397193_c0_seq1;GAXK01198002.1;P36579;3.24E-72;ARF1_SCHPO;ADP-ribosylation factor 1;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0006893; GO:0016192";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp139739_c0_seq1;GAXK01046804.1;Q1HRV8;2.60E-26;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp139740_c3_seq1;GAXK01046934.1;Q9Y2Q3;1.67E-41;GSTK1_HUMAN;Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]";"GO:0004364; GO:0004602; GO:0005622; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006749; GO:0015035; GO:0016020; GO:0030855; GO:0070062; GO:1901687";"epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]"
comp139765_c0_seq1;GAXK01046666.1;Q9H2A2;0;AL8A1_HUMAN;2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase 12) (Aldehyde dehydrogenase family 8 member A1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]";"GO:0001758; GO:0005829; GO:0042573; GO:0042574; GO:0042904; GO:0047102; GO:0070062; GO:0097053";"9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]"
comp1397946_c0_seq1;GAXK01197989.1;P20918;1.58E-09;PLMN_MOUSE;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; other organism cell membrane [GO:0044218]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; proteasome core complex binding [GO:1904854]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; interaction with symbiont [GO:0051702]; interaction with symbiont via secreted substance [GO:0052213]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]";"GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0009986; GO:0010812; GO:0016525; GO:0019897; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031232; GO:0034185; GO:0042246; GO:0042730; GO:0043231; GO:0044218; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0052213; GO:0060707; GO:0060716; GO:0062023; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1904854; GO:1990405";"blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; interaction with symbiont [GO:0051702]; interaction with symbiont via secreted substance [GO:0052213]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; other organism cell membrane [GO:0044218]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; proteasome core complex binding [GO:1904854]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]"
comp139813_c1_seq1;GAXK01046981.1;Q1HRV8;1.00E-42;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp139814_c3_seq1;GAXK01046826.1;Q99NI4;3.84E-27;IPMK_RAT;Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]";"GO:0000823; GO:0000825; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0008440; GO:0032957; GO:0032958; GO:0046872; GO:0046934; GO:0047326; GO:0052812; GO:0070266; GO:0097243; GO:0102732";"inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"
comp1398413_c1_seq1;GAXK01203644.1;O93430;3.87E-34;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp139848_c2_seq1;GAXK01047165.1;Q05319;4.13E-35;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp139864_c0_seq1;GAXK01047194.1;Q76KX8;1.24E-36;ZN534_HUMAN;Zinc finger protein 534 (KRAB domain only protein 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp139872_c0_seq1;GAXK01046835.1;P80457;0;XDH_BOVIN;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp1398923_c0_seq1;GAXK01203646.1;Q964T2;2.45E-38;CP9E2_BLAGE;Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp1399060_c0_seq1;GAXK01203652.1;Q9R044;1.16E-14;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp13992_c0_seq1;GAXK01020142.1;O77784;6.25E-130;IDH3B_BOVIN;Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-isocitrate dehydrogenase subunit 1) (IDH1) (NAD(+)-specific ICDH subunit beta);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp13994_c0_seq1;GAXK01020694.1;P54671;9.49E-14;H1_DICDI;Histone H1;"extracellular matrix [GO:0031012]; nucleosome [GO:0000786]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000786; GO:0003690; GO:0005516; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031012; GO:0031492; GO:0031936; GO:0045910";"chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"extracellular matrix [GO:0031012]; nucleosome [GO:0000786]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]"
comp1399459_c0_seq1;GAXK01203611.1;Q5USV6;4.56E-11;GDF8_SYLGR;Growth/differentiation factor 8 (GDF-8) (Myostatin);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]";"GO:0005125; GO:0005615; GO:0008083; GO:0008201; GO:0010592; GO:0010759; GO:0014839; GO:0042802";"myoblast migration involved in skeletal muscle regeneration [GO:0014839]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]";extracellular space [GO:0005615];"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]"
comp13995_c0_seq1;GAXK01020594.1;Q921Y2;4.80E-84;IMP3_MOUSE;U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3);"Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]";"GO:0005634; GO:0005730; GO:0006364; GO:0019843; GO:0030515; GO:0030684; GO:0032040; GO:0034457";rRNA processing [GO:0006364];"Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]";"rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]"
comp1399547_c0_seq1;GAXK01203655.1;Q8N0X7;1.35E-07;SPART_HUMAN;Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ubiquitin protein ligase binding [GO:0031625]; abscission [GO:0009838]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881]";"GO:0005737; GO:0005741; GO:0005811; GO:0005829; GO:0005886; GO:0009838; GO:0030496; GO:0030514; GO:0031625; GO:0034389; GO:0045202; GO:0048698; GO:0050905; GO:0051301; GO:0051881; GO:0060612";"abscission [GO:0009838]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202]";ubiquitin protein ligase binding [GO:0031625]
comp139956_c0_seq1;GAXK01046815.1;B6ZLK2;2.77E-78;CHD1_CHICK;Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1);"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]";"GO:0000775; GO:0003677; GO:0003678; GO:0005524; GO:0005634";;"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp13998_c0_seq1;GAXK01020457.1;Q6B857;2.16E-134;CFA20_BOVIN;Cilia- and flagella-associated protein 20;"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]";"GO:0005634; GO:0005814; GO:0005874; GO:0005929; GO:0018095; GO:0031514; GO:0036064; GO:0060271; GO:0060296; GO:2000147; GO:2000253";"cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; motile cilium [GO:0031514]; nucleus [GO:0005634]";
comp1399864_c0_seq1;GAXK01203618.1;Q7KRI2;8.44E-11;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1399979_c0_seq1;GAXK01203610.1;A2ZVI7;1.35E-10;CDPK1_ORYSJ;Calcium-dependent protein kinase 1 (OsCDPK1) (OsCPK1) (EC 2.7.11.1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp14_c0_seq1;GAXK01169617.1;Q6PS50;1.13E-22;RS28_BOMMO;40S ribosomal protein S28;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp140_c0_seq1;GAXK01168707.1;Q9D8V0;4.17E-155;HM13_MOUSE;Minor histocompatibility antigen H13 (EC 3.4.23.-) (Presenilin-like protein 3) (Signal peptide peptidase);"cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]";"GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0071458; GO:0071556; GO:1904211";"in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]";"cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]";"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp140030_c2_seq1;GAXK01177137.1;P51512;1.11E-88;MMP16_HUMAN;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0019538; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094";"chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp140066_c1_seq1;GAXK01177096.1;Q9DAG9;5.02E-44;PHF7_MOUSE;PHD finger protein 7 (Testis development protein NYD-SP6);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]";"GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872";;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp1400690_c0_seq1;GAXK01123303.1;Q6ZNA1;9.69E-40;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1401464_c0_seq1;GAXK01123327.1;P22465;1.74E-17;ANX10_DROME;Annexin B10 (Annexin X) (Annexin-10);"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]";"GO:0005509; GO:0005544; GO:0016020";;membrane [GO:0016020];"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]"
comp1401563_c0_seq1;GAXK01123305.1;Q6ZMW2;2.78E-18;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp140171_c0_seq1;GAXK01177173.1;Q29RM3;7.19E-24;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp140180_c0_seq1;GAXK01177159.1;Q8BX51;3.01E-16;SGCZ_MOUSE;Zeta-sarcoglycan (Zeta-SG) (ZSG1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; membrane organization [GO:0061024]";"GO:0005737; GO:0005856; GO:0005886; GO:0016012; GO:0016021; GO:0042383; GO:0048738; GO:0060047; GO:0061024";"cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; membrane organization [GO:0061024]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]";
comp140195_c0_seq1;GAXK01177217.1;Q15326;2.00E-73;ZMY11_HUMAN;Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]";"GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0016032; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237";"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp140202_c2_seq1;GAXK01177276.1;Q28955;2.05E-46;NTAN1_PIG;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0008418";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp14023_c0_seq1;GAXK01178750.1;Q28IU1;2.53E-54;DHB12_XENTR;Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342";"estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]"
comp140282_c3_seq1;GAXK01177019.1;Q8R3B7;4.02E-29;BRD8_MOUSE;Bromodomain-containing protein 8;"mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]";"GO:0000812; GO:0005654; GO:0005739; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]";"mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]";
comp140298_c1_seq1;GAXK01177053.1;A6NAF9;5.18E-13;TRD7A_DANRE;Tudor domain-containing protein 7A;"P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0007283; GO:0010608; GO:0030719; GO:0035770; GO:0043186; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]";mRNA binding [GO:0003729]
comp1403_c1_seq1;GAXK01166056.1;Q11002;0;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp1403141_c0_seq1;GAXK01165479.1;P26221;3.12E-100;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp140328_c1_seq1;GAXK01177202.1;P21521;1.70E-81;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp1403382_c0_seq1;GAXK01165489.1;Q8N7K0;4.88E-10;ZN433_HUMAN;Zinc finger protein 433;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp140341_c0_seq1;GAXK01177218.1;Q1HRV8;9.55E-81;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp140371_c0_seq1;GAXK01177286.1;Q7KRI2;9.07E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp140383_c2_seq1;GAXK01177046.1;P26967;4.44E-08;CU20_TENMO;Adult-specific cuticular protein ACP-20;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1403867_c0_seq1;GAXK01165486.1;Q8BG22;3.62E-07;CLCA2_MOUSE;Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 5) (mCLCA5);"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006821; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0046872";"cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp140389_c0_seq1;GAXK01177121.1;Q920M9;2.41E-08;SIAH1_RAT;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244";"cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]";"disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1403891_c0_seq1;GAXK01165491.1;Q7TSH4;2.05E-09;CP110_MOUSE;Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (Cep110) (Cp110);"centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; microtubule organizing center [GO:0005815]; protein-containing complex [GO:0032991]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465]";"GO:0005813; GO:0005814; GO:0005815; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018";"centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465]";"centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; microtubule organizing center [GO:0005815]; protein-containing complex [GO:0032991]";
comp1403893_c0_seq1;GAXK01165503.1;H2A0N1;1.03E-17;KCP2_PINMG;BPTI/Kunitz domain-containing protein 2 (Prism serine protease inhibitor 2) (PISP2);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp1404055_c0_seq1;GAXK01107995.1;P17970;1.48E-59;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp140409_c2_seq1;GAXK01177038.1;Q13042;4.32E-176;CDC16_HUMAN;Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6);"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007049; GO:0031145; GO:0051301; GO:0070979; GO:1901990";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]";
comp14041_c1_seq1;GAXK01177825.1;P18106;0;FER_DROME;Tyrosine-protein kinase Fer (EC 2.7.10.2);"adherens junction [GO:0005912]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein tyrosine kinase activity [GO:0004713]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; regulation of cell population proliferation [GO:0042127]";"GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005886; GO:0005912; GO:0007391; GO:0007394; GO:0007411; GO:0019898; GO:0031234; GO:0042127; GO:0046664; GO:0051017";"actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; regulation of cell population proliferation [GO:0042127]";"adherens junction [GO:0005912]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein tyrosine kinase activity [GO:0004713]"
comp1404198_c0_seq1;GAXK01108017.1;E1BZ85;9.12E-33;MARF1_CHICK;Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog);"peroxisome [GO:0005777]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"GO:0003723; GO:0005777; GO:0010468; GO:0048477; GO:0051321";"meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";peroxisome [GO:0005777];RNA binding [GO:0003723]
comp14043_c0_seq1;GAXK01178385.1;Q16698;1.44E-103;DECR_HUMAN;2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]";"GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0051289; GO:0070402; GO:0120162";"fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]"
comp1404352_c0_seq1;GAXK01107984.1;Q8IT98;2.47E-49;RS18_ARGIR;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp14044_c2_seq1;GAXK01178014.1;Q6Q7J2;1.42E-09;GDIB_PIG;Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2);"cytoplasm [GO:0005737]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"GO:0005093; GO:0005096; GO:0005737; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137";"protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]"
comp140463_c0_seq1;GAXK01177280.1;P05661;1.49E-81;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1405084_c0_seq1;GAXK01108018.1;Q8MKK4;2.66E-25;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp140536_c0_seq1;GAXK01177083.1;Q9D853;2.18E-60;EFMT2_MOUSE;EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase Mettl10);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]";"GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1405598_c0_seq1;GAXK01108013.1;Q99N48;1.18E-10;SYTL3_MOUSE;Synaptotagmin-like protein 3 (Exophilin-6);"exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; calcium-dependent phospholipid binding [GO:0005544]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]";"GO:0005543; GO:0005544; GO:0006886; GO:0006887; GO:0008270; GO:0016020; GO:0017137; GO:0019897; GO:0042043; GO:0070382";"exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]";"exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]";"calcium-dependent phospholipid binding [GO:0005544]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]"
comp1405889_c0_seq1;GAXK01107991.1;Q9N003;2.99E-14;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp140614_c0_seq1;GAXK01177016.1;O60906;2.33E-17;NSMA_HUMAN;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase);"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005886; GO:0005887; GO:0005901; GO:0006684; GO:0006685; GO:0006687; GO:0009612; GO:0035556; GO:0046513; GO:0046872; GO:2000304";"ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp1406356_c0_seq1;GAXK01133765.1;Q64520;4.43E-78;KGUA_MOUSE;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939";"ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp1406489_c0_seq1;GAXK01133751.1;Q8VCV9;1.45E-46;MF4B1_MOUSE;Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp1406592_c0_seq1;GAXK01133763.1;Q8MRC9;0;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp1406634_c0_seq1;GAXK01133758.1;P86810;6.99E-44;OXLA_SIGCA;L-amino-acid oxidase (EC 1.4.3.2) (Antiparasitic protein) (APP) (Serum L-amino-acid oxidase) (SR-LAAO);"extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";"GO:0001716; GO:0005576; GO:0042742; GO:0045087";"defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";extracellular region [GO:0005576];L-amino-acid oxidase activity [GO:0001716]
comp1406637_c0_seq1;GAXK01133771.1;P54802;5.09E-120;ANAG_HUMAN;"Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]";"GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062";"cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";alpha-N-acetylglucosaminidase activity [GO:0004561]
comp14068_c2_seq1;GAXK01177930.1;Q9YHY6;0;CND1_XENLA;Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp140695_c0_seq1;GAXK01177084.1;P27080;3.22E-119;ADT_CHLRE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp140696_c1_seq1;GAXK01177181.1;Q91ZT5;2.30E-107;FGD4_MOUSE;FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of JUN kinase activity [GO:0007257]; lamellipodium assembly [GO:0030032]; microspike assembly [GO:0030035]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0003779; GO:0005089; GO:0005737; GO:0005856; GO:0007257; GO:0008360; GO:0030027; GO:0030032; GO:0030035; GO:0030175; GO:0035023; GO:0046872; GO:0051015";"activation of JUN kinase activity [GO:0007257]; lamellipodium assembly [GO:0030032]; microspike assembly [GO:0030035]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp140713_c0_seq1;GAXK01176921.1;P39413;1.76E-24;AEF1_DROME;Adult enhancer factor 1 (AEF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1407153_c0_seq1;GAXK01133757.1;P68370;6.80E-09;TBA1A_RAT;Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain];"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0019904; GO:0031594; GO:0036464; GO:0043209; GO:0045121; GO:0046982; GO:0050807; GO:0055037";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]";"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]"
comp1407168_c0_seq1;GAXK01133752.1;Q9WV18;1.93E-15;GABR1_MOUSE;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);"axolemma [GO:0030673]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]";"GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005887; GO:0007193; GO:0007194; GO:0007214; GO:0008021; GO:0008134; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030054; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0038037; GO:0038039; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043231; GO:0045121; GO:0045211; GO:0046982; GO:0050805; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099579; GO:0150099; GO:1902710; GO:1990430";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]";"axolemma [GO:0030673]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; GABA receptor complex [GO:1902710]; glutamatergic synapse [GO:0098978]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]";"extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp14073_c3_seq1;GAXK01178506.1;P15870;6.15E-09;H1D_STRPU;Histone H1-delta;"nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031492; GO:0031936; GO:0045910";"chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"nucleosome [GO:0000786]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]"
comp140738_c1_seq1;GAXK01177124.1;Q3B725;2.69E-10;ZBT24_RAT;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp140796_c3_seq1;GAXK01177047.1;Q8K4F5;1.11E-60;ABHDB_MOUSE;Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog);"mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]";"GO:0005739; GO:0016787";;mitochondrion [GO:0005739];hydrolase activity [GO:0016787]
comp1407975_c0_seq1;GAXK01133741.1;Q9JME2;3.38E-12;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp14082_c0_seq1;GAXK01177945.1;Q2KJ14;2.79E-136;PAF1_BOVIN;RNA polymerase II-associated factor 1 homolog;"Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000993; GO:0001711; GO:0003682; GO:0005737; GO:0006368; GO:0006378; GO:0010390; GO:0016020; GO:0016055; GO:0016584; GO:0016593; GO:0019827; GO:0030054; GO:0031062; GO:0031442; GO:0032968; GO:0033523; GO:0034504; GO:0035327; GO:0045638; GO:0045944; GO:0071222; GO:1902808";"cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]";"chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]"
comp140834_c0_seq1;GAXK01177010.1;P42282;3.55E-24;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1408876_c0_seq1;GAXK01062524.1;Q9DAX2;3.12E-26;PLPP2_MOUSE;Phospholipid phosphatase 2 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c);"integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";"GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0042577; GO:0046839";"phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";integral component of plasma membrane [GO:0005887];"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]"
comp1409033_c0_seq1;GAXK01062539.1;P28476;4.80E-11;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp140904_c1_seq1;GAXK01177278.1;Q9UH90;8.21E-10;FBX40_HUMAN;F-box only protein 40 (Muscle disease-related protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; muscle cell differentiation [GO:0042692]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0005737; GO:0005829; GO:0008270; GO:0042692; GO:0043687; GO:0061630";"muscle cell differentiation [GO:0042692]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1409239_c0_seq1;GAXK01062519.1;Q5BKN4;6.76E-26;SEP2A_XENTR;Septin-2A;"ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224]";"GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0015630; GO:0030496; GO:0031105; GO:0032154; GO:0060170; GO:0060271; GO:0061640";"cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224]";"ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1409452_c0_seq1;GAXK01062516.1;Q6UY18;1.54E-19;LIGO4_HUMAN;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"GO:0005615; GO:0016021; GO:0031012";;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp140958_c2_seq1;GAXK01177304.1;Q94521;8.94E-08;DNAT_DROME;Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase);"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";"GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066";"catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";cytoplasm [GO:0005737];"aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]"
comp1409702_c0_seq1;GAXK01062536.1;Q6UX71;2.61E-39;PXDC2_HUMAN;Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1409742_c0_seq1;GAXK01062533.1;O01382;1.07E-25;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp1409743_c0_seq1;GAXK01062520.1;Q5RC69;4.01E-77;DCTD_PONAB;Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase);"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";"GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802";"nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";;"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]"
comp140996_c0_seq1;GAXK01177055.1;Q8CC12;1.15E-92;CDAN1_MOUSE;Codanin-1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; nuclear envelope organization [GO:0006998]; protein localization [GO:0008104]";"GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497";"chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; nuclear envelope organization [GO:0006998]; protein localization [GO:0008104]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp1410_c0_seq1;GAXK01170054.1;Q80Y44;0;DDX10_MOUSE;Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10);"nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0097065";"anterior head development [GO:0097065]; rRNA processing [GO:0006364]";nucleus [GO:0005634];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1410128_c0_seq1;GAXK01172350.1;Q8N4W9;1.38E-14;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp141014_c1_seq1;GAXK01177186.1;Q14591;3.07E-28;ZN271_HUMAN;Deleted.;;;;;
comp1410195_c0_seq1;GAXK01172339.1;O46040;1.24E-20;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1410198_c0_seq1;GAXK01172309.1;Q76KB1;1.47E-30;HS2ST_CHICK;Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]";"GO:0000139; GO:0004394; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030202; GO:0042802; GO:0060676";"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]"
comp1410289_c0_seq1;GAXK01172311.1;O96900;5.18E-14;VSP1_SCOSU;Serine protease SSP1 (EC 3.4.21.-) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp141048_c1_seq1;GAXK01177189.1;P9WK86;8.29E-16;NLHH_MYCTO;Carboxylesterase NlhH (EC 3.1.1.1);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp1410567_c0_seq1;GAXK01172312.1;Q9LZG0;4.32E-12;ADK2_ARATH;Adenosine kinase 2 (AK 2) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032]";"GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006169; GO:0016032; GO:0019900; GO:0044209";"adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]"
comp141063_c0_seq1;GAXK01176869.1;Q14CM0;1.20E-135;FRPD4_HUMAN;FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso);"cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]; postsynaptic actin cytoskeleton organization [GO:0098974]";"GO:0005546; GO:0005856; GO:0014069; GO:0032991; GO:0043197; GO:0051835; GO:0098974; GO:0098978";"positive regulation of synapse structural plasticity [GO:0051835]; postsynaptic actin cytoskeleton organization [GO:0098974]";"cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]";phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]
comp1410668_c0_seq1;GAXK01172329.1;Q7TS63;2.78E-11;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1410815_c0_seq1;GAXK01172326.1;Q9NUA8;5.50E-07;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14109_c1_seq1;GAXK01178488.1;Q9H3N1;3.91E-63;TMX1_HUMAN;Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0005789; GO:0015036; GO:0016021; GO:0034976; GO:0045454";"cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";disulfide oxidoreductase activity [GO:0015036]
comp1411209_c0_seq1;GAXK01172321.1;Q95NI4;3.71E-35;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp14114_c0_seq1;GAXK01178705.1;Q08DW2;4.29E-134;KPRA_BOVIN;Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]";"GO:0000287; GO:0002189; GO:0004749; GO:0005737; GO:0006015; GO:0006164; GO:0009165; GO:0042802";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp141144_c0_seq1;GAXK01177297.1;Q6DFF6;1.56E-46;KLH20_XENLA;Kelch-like protein 20;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390";"Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]";"interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]"
comp1411513_c0_seq1;GAXK01172344.1;Q5EA01;1.52E-34;B4GA1_BOVIN;Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein O-linked mannosylation [GO:0035269]";"GO:0000139; GO:0005794; GO:0015020; GO:0016021; GO:0035269; GO:0046872";protein O-linked mannosylation [GO:0035269];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp1411519_c0_seq1;GAXK01172322.1;Q866F1;2.36E-21;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp141166_c0_seq1;GAXK01177143.1;P52746;8.35E-18;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp141174_c2_seq1;GAXK01177236.1;Q9H8N7;2.13E-18;ZN395_HUMAN;Zinc finger protein 395 (HD-regulating factor 2) (HDRF-2) (Huntington disease gene regulatory region-binding protein 2) (HD gene regulatory region-binding protein 2) (HDBP-2) (Papillomavirus regulatory factor 1) (PRF-1) (Papillomavirus-binding factor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0000981; GO:0001158; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1412339_c0_seq1;GAXK01009042.1;Q90850;3.91E-10;HIC1_CHICK;Hypermethylated in cancer 1 protein (Hic-1) (GammaFBP) (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0008630; GO:0046872";"intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp141253_c1_seq1;GAXK01177287.1;A6H7I3;6.60E-64;ANGE2_BOVIN;Protein angel homolog 2;"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930]";"GO:0000175; GO:0003730; GO:0005737; GO:0015030; GO:0045930; GO:0070935";"3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]";"3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]"
comp1412537_c0_seq1;GAXK01009090.1;Q05589;1.25E-27;UROK_BOVIN;"Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]; regulation of cell adhesion mediated by integrin [GO:0033628]";"GO:0004252; GO:0005615; GO:0006508; GO:0031639; GO:0033628; GO:0042730";"fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]; regulation of cell adhesion mediated by integrin [GO:0033628]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp141276_c0_seq1;GAXK01177087.1;Q01887;2.70E-23;RYK_MOUSE;Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R);"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"GO:0004672; GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0007409; GO:0007411; GO:0016020; GO:0016055; GO:0017147; GO:0018108; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0050919; GO:0061643; GO:0071679; GO:1904938; GO:1904948; GO:1904953";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp141307_c0_seq1;GAXK01177302.1;Q2EI21;3.27E-19;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp141322_c1_seq1;GAXK01177226.1;O60602;4.87E-10;TLR5_HUMAN;Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-1 receptor binding [GO:0005149]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 5 signaling pathway [GO:0034146]";"GO:0002755; GO:0004888; GO:0005149; GO:0005886; GO:0006954; GO:0016021; GO:0032757; GO:0034123; GO:0034146; GO:0042742; GO:0045087; GO:0050707; GO:0071260";"cellular response to mechanical stimulus [GO:0071260]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 5 signaling pathway [GO:0034146]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"interleukin-1 receptor binding [GO:0005149]; transmembrane signaling receptor activity [GO:0004888]"
comp141341_c4_seq1;GAXK01177059.1;Q8K1R3;1.58E-146;PNPT1_MOUSE;Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]";"GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772";"cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]";"3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]"
comp1413441_c0_seq1;GAXK01009060.1;Q21355;3.30E-22;GST4_CAEEL;Glutathione S-transferase 4 (EC 2.5.1.18) (CeGST1) (GST class-sigma);"contractile fiber [GO:0043292]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749; GO:0043292";glutathione metabolic process [GO:0006749];contractile fiber [GO:0043292];glutathione transferase activity [GO:0004364]
comp1413525_c0_seq1;GAXK01009068.1;Q61555;2.54E-14;FBN2_MOUSE;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
comp1413539_c0_seq1;GAXK01009041.1;Q0VAW7;7.56E-11;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp141367_c0_seq1;GAXK01176906.1;Q9W0K4;1.51E-25;BAB2_DROME;Protein bric-a-brac 2;"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736";"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp1413685_c0_seq1;GAXK01009065.1;Q99JB7;1.81E-24;AMNLS_MOUSE;Protein amnionless [Cleaved into: Soluble protein amnionless];"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; signaling receptor binding [GO:0005102]; cobalamin transport [GO:0015889]; excretion [GO:0007588]; Golgi to plasma membrane protein transport [GO:0043001]; multicellular organism development [GO:0007275]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]";"GO:0005102; GO:0005615; GO:0005768; GO:0005905; GO:0006898; GO:0007275; GO:0007588; GO:0008104; GO:0015889; GO:0016021; GO:0016324; GO:0030139; GO:0031526; GO:0032991; GO:0043001; GO:0045177";"cobalamin transport [GO:0015889]; excretion [GO:0007588]; Golgi to plasma membrane protein transport [GO:0043001]; multicellular organism development [GO:0007275]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";signaling receptor binding [GO:0005102]
comp1413774_c0_seq1;GAXK01009030.1;Q965X6;2.38E-07;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1413821_c1_seq1;GAXK01009073.1;P01126;6.28E-25;REL_AVIRE;"Transforming protein rel polyprotein (p58 V-rel) [Cleaved into: Env polyprotein N-terminal; Transforming protein rel; Env polyprotein C-terminal]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003677; GO:0003700; GO:0007249; GO:0030430; GO:0042025; GO:0045893";"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of transcription, DNA-templated [GO:0045893]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp141390_c1_seq1;GAXK01176995.1;Q9VW71;0;FAT2_DROME;Fat-like cadherin-related tumor suppressor homolog (Protein kugelei);"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]"
comp141417_c0_seq1;GAXK01177135.1;Q26491;3.28E-21;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp141421_c2_seq1;GAXK01177163.1;Q9NZI7;3.99E-92;UBIP1_HUMAN;Upstream-binding protein 1 (Transcription factor LBP-1);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]";"GO:0000790; GO:0000981; GO:0001525; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0019079; GO:0043565; GO:0045892";"angiogenesis [GO:0001525]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]"
comp141444_c0_seq1;GAXK01177015.1;Q6DG85;3.42E-38;URIC_DANRE;Uricase (EC 1.7.3.3) (Urate oxidase);"peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; protein homotetramerization [GO:0051289]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";"GO:0004846; GO:0005777; GO:0006144; GO:0019628; GO:0051289";"protein homotetramerization [GO:0051289]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";peroxisome [GO:0005777];urate oxidase activity [GO:0004846]
comp1414570_c0_seq1;GAXK01177341.1;Q08473;2.78E-25;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp14146_c0_seq1;GAXK01179246.1;Q13825;1.00E-109;AUHM_HUMAN;Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]";"GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0009083; GO:0050011";"branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]"
comp141486_c0_seq1;GAXK01176877.1;Q86X10;0;RLGPB_HUMAN;Ral GTPase-activating protein subunit beta (p170);"GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0046982; GO:0051056; GO:0090630";"activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]";;"GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]"
comp14149_c1_seq1;GAXK01178817.1;Q27245;1.88E-124;YH24_CAEEL;Putative aminopeptidase W07G4.4 (EC 3.4.11.-);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]";"GO:0004177; GO:0005737; GO:0008235; GO:0030145";;cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]"
comp141492_c1_seq1;GAXK01176986.1;Q86T29;4.53E-33;ZN605_HUMAN;Zinc finger protein 605;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000976; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1415_c0_seq1;GAXK01169233.1;P23709;6.90E-112;NDUS3_BOVIN;NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit);"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]";"GO:0003954; GO:0005747; GO:0008137; GO:0030308; GO:0031966; GO:0072593; GO:2001243";"negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]";"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]";"NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]"
comp14152_c1_seq1;GAXK01178489.1;Q00277;3.92E-40;GPX1_SCHMA;Glutathione peroxidase (GPX) (EC 1.11.1.9);"glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0006979";response to oxidative stress [GO:0006979];;glutathione peroxidase activity [GO:0004602]
comp141542_c1_seq1;GAXK01177085.1;Q8N5Z0;5.98E-131;AADAT_HUMAN;Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Kynurenine aminotransferase II) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II);"mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]";"GO:0005759; GO:0006103; GO:0006536; GO:0006554; GO:0006569; GO:0008483; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0042803; GO:0047536; GO:0070189; GO:1901605";"2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]";mitochondrial matrix [GO:0005759];"2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp141553_c0_seq1;GAXK01177301.1;O35613;3.75E-19;DAXX_MOUSE;Death domain-associated protein 6 (Daxx);"cell body [GO:0044297]; cell cortex [GO:0005938]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]; androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; androgen receptor signaling pathway [GO:0030521]; apoptotic signaling pathway [GO:0097190]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; chromatin remodeling [GO:0006338]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; PML body organization [GO:0030578]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron death [GO:1901216]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromatin [GO:0071168]; regulation of apoptotic process [GO:0042981]; regulation of multicellular organism growth [GO:0040014]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000281; GO:0000775; GO:0000792; GO:0001741; GO:0001934; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005874; GO:0005938; GO:0006334; GO:0006338; GO:0006355; GO:0008134; GO:0008432; GO:0010832; GO:0016604; GO:0016605; GO:0019894; GO:0019899; GO:0019901; GO:0030295; GO:0030521; GO:0030578; GO:0031396; GO:0031625; GO:0032183; GO:0033129; GO:0034605; GO:0034620; GO:0040014; GO:0042393; GO:0042803; GO:0042981; GO:0043005; GO:0043065; GO:0043066; GO:0044297; GO:0045860; GO:0045892; GO:0045944; GO:0046982; GO:0047485; GO:0050681; GO:0071168; GO:0071276; GO:0071280; GO:0072738; GO:0097190; GO:1901216; GO:1903936; GO:2001235";"androgen receptor signaling pathway [GO:0030521]; apoptotic signaling pathway [GO:0097190]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; chromatin remodeling [GO:0006338]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; PML body organization [GO:0030578]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron death [GO:1901216]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromatin [GO:0071168]; regulation of apoptotic process [GO:0042981]; regulation of multicellular organism growth [GO:0040014]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]";"cell body [GO:0044297]; cell cortex [GO:0005938]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]";"androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"
comp141578_c5_seq1;GAXK01177193.1;Q9BSV6;7.48E-32;SEN34_HUMAN;tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]";"GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005634; GO:0005654; GO:0005730; GO:0006388; GO:0006397; GO:0016829";"mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]";"lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]"
comp141585_c0_seq1;GAXK01177164.1;B0DOB5;2.81E-165;DAA1A_XENLA;Disheveled-associated activator of morphogenesis 1-A;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway [GO:0016055]";"GO:0003779; GO:0005737; GO:0005856; GO:0016055; GO:0017048; GO:0030036; GO:0042995";"actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway [GO:0016055]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]"
comp141594_c3_seq1;GAXK01177175.1;Q9VW71;6.67E-07;FAT2_DROME;Fat-like cadherin-related tumor suppressor homolog (Protein kugelei);"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]";"actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]"
comp1415995_c0_seq1;GAXK01177336.1;Q9JHE4;5.54E-39;G3ST1_MOUSE;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0001733; GO:0006682; GO:0007283; GO:0009247; GO:0016021; GO:0042552";"galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp141608_c1_seq1;GAXK01177172.1;Q8BH60;4.81E-51;GOPC_MOUSE;Golgi-associated PDZ and coiled-coil motif-containing protein (PDZ protein interacting specifically with TC10) (PIST);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]";"GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0008022; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030054; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042803; GO:0043004; GO:0044325; GO:0045202; GO:0045211; GO:0051260; GO:2000009";"autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]";"frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]"
comp1416144_c0_seq1;GAXK01089182.1;O60825;3.72E-176;F262_HUMAN;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]";"GO:0003873; GO:0004331; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006007; GO:0006089; GO:0006096; GO:0009749; GO:0019901; GO:0032024; GO:0033133; GO:0045821";"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]"
comp1416236_c0_seq1;GAXK01089153.1;Q20561;4.39E-20;HLH13_CAEEL;Helix-loop-helix protein 13 (Fer3-like protein) (Nephew of atonal 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; dauer exit [GO:0043054]; insulin receptor signaling pathway [GO:0008286]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0005634; GO:0005737; GO:0006979; GO:0008134; GO:0008286; GO:0030154; GO:0043054; GO:0046983";"cell differentiation [GO:0030154]; dauer exit [GO:0043054]; insulin receptor signaling pathway [GO:0008286]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]"
comp1416411_c0_seq1;GAXK01089178.1;P0C548;5.14E-66;PLPL2_RAT;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0055088";"lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp14166_c1_seq1;GAXK01179197.1;Q6NYV9;1.61E-96;LEO1_DANRE;RNA polymerase-associated protein LEO1;"Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936]";"GO:0005634; GO:0006368; GO:0007507; GO:0014032; GO:0016570; GO:0016593; GO:0021529; GO:0021782; GO:0030318; GO:0032968; GO:0045944; GO:0048701; GO:0050936; GO:1990269";"embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936]";"Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]";RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]
comp141676_c2_seq1;GAXK01176886.1;A2ANX9;1.73E-17;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1416869_c0_seq1;GAXK01089179.1;P52404;1.32E-26;CHI2_SOLTU;Endochitinase 2 (EC 3.2.1.14) (Fragment);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp1417_c0_seq1;GAXK01168784.1;P50247;3.12E-41;SAHH_MOUSE;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (CUBP) (Liver copper-binding protein) (S-adenosyl-L-homocysteine hydrolase);"cytosol [GO:0005829]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; protein self-association [GO:0043621]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]";"GO:0002439; GO:0004013; GO:0005507; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0043621; GO:0051287";"chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]";"cytosol [GO:0005829]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]";"adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; protein self-association [GO:0043621]"
comp14170_c3_seq1;GAXK01177893.1;Q5ZMP6;0;AP2M1_CHICK;AP-2 complex subunit mu (AP-2 mu chain) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein);"AP-2 adaptor complex [GO:0030122]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]";"GO:0006886; GO:0008289; GO:0030122; GO:0072583; GO:0097718; GO:0098794; GO:0098884; GO:0098978";"clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]";"AP-2 adaptor complex [GO:0030122]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]";"disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]"
comp1417125_c0_seq1;GAXK01089162.1;P0DN67;1.88E-12;ACTP1_TERSU;Tereporin-Ts1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp1417217_c0_seq1;GAXK01089157.1;Q94521;1.39E-16;DNAT_DROME;Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase);"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";"GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066";"catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";cytoplasm [GO:0005737];"aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]"
comp141722_c2_seq1;GAXK01177204.1;Q964R0;5.48E-69;CP6K1_BLAGE;Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp1417296_c0_seq1;GAXK01089185.1;Q6ZMW2;2.68E-27;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14173_c1_seq1;GAXK01178378.1;Q9H0A0;0;NAT10_HUMAN;RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP);"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]";"GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0008080; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883";"negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]";"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]";"ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]"
comp141739_c0_seq1;GAXK01177162.1;Q66H45;6.86E-44;TTC36_RAT;Tetratricopeptide repeat protein 36 (TPR repeat protein 36);cilium assembly [GO:0060271];GO:0060271;cilium assembly [GO:0060271];;
comp1417460_c0_seq1;GAXK01089174.1;Q1H9T6;1.06E-14;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp14175_c1_seq1;GAXK01178142.1;Q7SY23;0;AL4A1_DANRE;Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase);"mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; proline catabolic process to glutamate [GO:0010133]";"GO:0003842; GO:0005759; GO:0010133; GO:0016620";proline catabolic process to glutamate [GO:0010133];mitochondrial matrix [GO:0005759];"1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"
comp141770_c0_seq1;GAXK01176871.1;A6NEL2;7.39E-25;SWAHB_HUMAN;Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B);;;;;
comp1417825_c0_seq1;GAXK01089172.1;Q8ITC7;6.19E-68;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp14180_c0_seq1;GAXK01178005.1;O97159;1.09E-108;CHDM_DROME;Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2);"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0035327; GO:0042766; GO:0043044; GO:0045892; GO:0051276; GO:0051312; GO:0070615; GO:0071923";"ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]"
comp141810_c1_seq1;GAXK01177018.1;Q5VYX0;5.97E-96;RNLS_HUMAN;Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]";"GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074";"NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"
comp1418109_c0_seq1;GAXK01081131.1;Q9JFG1;1.42E-07;VC02_VACCT;Kelch repeat protein C2;;;;;
comp14188_c2_seq1;GAXK01178427.1;P25155;5.68E-07;FA10_CHICK;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp1418916_c0_seq1;GAXK01081128.1;P18716;1.56E-17;ZG28_XENLA;Gastrula zinc finger protein XlCGF28.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1418938_c0_seq1;GAXK01081129.1;Q4ZHA6;3.36E-29;KCNB2_BOVIN;Potassium voltage-gated channel subfamily B member 2;"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp1419082_c0_seq1;GAXK01081137.1;Q16TM5;8.96E-39;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp141948_c0_seq1;GAXK01177036.1;Q7Z0G7;3.34E-57;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp141950_c1_seq1;GAXK01177141.1;Q9QZ67;5.32E-92;PPM1D_MOUSE;Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; response to bacterium [GO:0009617]";"GO:0000086; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006306; GO:0006342; GO:0009267; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019";"cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; response to bacterium [GO:0009617]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]"
comp141961_c1_seq1;GAXK01177013.1;A6NKF1;8.91E-18;SAC31_HUMAN;SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]";"GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0051225; GO:0051298; GO:0051301";"cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";
comp14198_c0_seq1;GAXK01177916.1;Q5ISW3;1.61E-10;MED29_BOMMO;Mediator of RNA polymerase II transcription subunit 29 (Mediator complex subunit 29) (Protein intersex);mediator complex [GO:0016592];GO:0016592;;mediator complex [GO:0016592];
comp142_c0_seq1;GAXK01165946.1;P17704;4.51E-69;RS17_DROME;40S ribosomal protein S17;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp142001_c0_seq1;GAXK01160524.1;P02747;7.90E-09;C1QC_HUMAN;Complement C1q subcomponent subunit C;"blood microparticle [GO:0072562]; cell [GO:0005623]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; postsynapse [GO:0098794]; synapse [GO:0045202]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; regulation of complement activation [GO:0030449]; synapse pruning [GO:0098883]";"GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0006955; GO:0006956; GO:0006958; GO:0030449; GO:0030853; GO:0045087; GO:0045202; GO:0045650; GO:0062023; GO:0072562; GO:0098794; GO:0098883";"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; regulation of complement activation [GO:0030449]; synapse pruning [GO:0098883]";"blood microparticle [GO:0072562]; cell [GO:0005623]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; postsynapse [GO:0098794]; synapse [GO:0045202]";
comp1420573_c0_seq1;GAXK01159607.1;P42282;2.91E-22;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1420694_c0_seq1;GAXK01159625.1;Q95NQ0;7.39E-22;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp142093_c0_seq1;GAXK01160528.1;A4ZGQ8;7.58E-48;HMT1_BRAOT;Homocysteine S-methyltransferase 1 (BoHMT1) (EC 2.1.1.10);"betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]";"GO:0008270; GO:0008898; GO:0009086; GO:0032259; GO:0047150";"methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]";;"betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]"
comp1421250_c0_seq1;GAXK01159629.1;P36537;1.36E-25;UDB10_HUMAN;UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]";"GO:0005789; GO:0006629; GO:0008194; GO:0016021; GO:0016758; GO:0043231";lipid metabolic process [GO:0006629];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]"
comp14214_c0_seq1;GAXK01179159.1;A8NJZ7;1.01E-10;SCOC_BRUMA;Short coiled-coil protein homolog;"cytosol [GO:0005829]; Golgi membrane [GO:0000139]";"GO:0000139; GO:0005829";;"cytosol [GO:0005829]; Golgi membrane [GO:0000139]";
comp1421528_c0_seq1;GAXK01159603.1;P97794;1.00E-43;KCNJ8_MOUSE;ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1);"intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; defense response to virus [GO:0051607]; heart development [GO:0007507]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]";"GO:0001822; GO:0005242; GO:0005524; GO:0005739; GO:0006813; GO:0007507; GO:0008282; GO:0015272; GO:0016020; GO:0017098; GO:0030016; GO:0032496; GO:0034765; GO:0042383; GO:0043231; GO:0043330; GO:0051607; GO:0098915; GO:1902282; GO:1990573";"defense response to virus [GO:0051607]; heart development [GO:0007507]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]";"intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; sarcolemma [GO:0042383]";"ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATP binding [GO:0005524]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp14217_c0_seq1;GAXK01178514.1;Q5R4V3;0;KC1G3_PONAB;Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005737; GO:0016055";Wnt signaling pathway [GO:0016055];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp142177_c0_seq1;GAXK01160227.1;A2AWA9;0;RBGP1_MOUSE;Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]";"GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630";"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp1422346_c0_seq1;GAXK01075351.1;Q6PD29;7.70E-07;ZN513_MOUSE;Zinc finger protein 513;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0044212; GO:0046872; GO:0060041";"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1422635_c0_seq1;GAXK01075358.1;O14628;4.34E-08;ZN195_HUMAN;Zinc finger protein 195;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp142271_c0_seq1;GAXK01160274.1;Q7PHR1;0;KIF1A_ANOGA;Kinesin-like protein unc-104;"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]";"GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489";"cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]";"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp1422951_c0_seq1;GAXK01075337.1;P02599;1.66E-21;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp14230_c1_seq1;GAXK01178417.1;P00503;4.31E-156;AATC_PIG;Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384]";"GO:0004069; GO:0004609; GO:0005654; GO:0005829; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0019550; GO:0019551; GO:0030170; GO:0032869; GO:0047801; GO:0051384; GO:0055089";"2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]"
comp1423135_c0_seq1;GAXK01075316.1;Q8WWW0;4.36E-07;RASF5_HUMAN;Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]";"GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0008285; GO:0017016; GO:0031398; GO:0035556; GO:0042802; GO:0042981; GO:0046872; GO:1900180";"apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; Ras GTPase binding [GO:0017016]"
comp14233_c2_seq1;GAXK01178754.1;P0DPW5;3.01E-10;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1423315_c0_seq1;GAXK01075357.1;Q9VEG6;9.90E-11;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp1423330_c0_seq1;GAXK01075336.1;Q01063;8.85E-77;PDE4D_MOUSE;cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3);"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]";"GO:0002027; GO:0004115; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0006939; GO:0007568; GO:0008144; GO:0010880; GO:0016324; GO:0030552; GO:0030593; GO:0031965; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0050852; GO:0050900; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071872; GO:0086004; GO:0097110; GO:1901844; GO:1901898";"aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]";"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]";"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]"
comp1423400_c0_seq1;GAXK01075325.1;Q5R5U3;1.50E-96;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp14240_c1_seq1;GAXK01178372.1;Q9CXE0;5.74E-17;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp142410_c1_seq1;GAXK01160527.1;Q5R533;3.89E-15;SERC3_PONAB;Serine incorporator 3;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016021; GO:0045087; GO:0051607; GO:1902237";"defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp142413_c0_seq1;GAXK01160159.1;Q498J9;7.14E-46;MBLC1_XENLA;Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp142428_c2_seq1;GAXK01160468.1;Q5ZJG8;6.54E-38;HSDL1_CHICK;Hydroxysteroid dehydrogenase-like protein 1 (EC 1.1.1.-);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005783; GO:0006694; GO:0016491; GO:0030497";"fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp1424612_c0_seq1;GAXK01081330.1;Q4R6K2;4.01E-13;ZNT1_MACFA;Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]";"GO:0005886; GO:0006829; GO:0008324; GO:0016021";zinc ion transport [GO:0006829];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp1424642_c0_seq1;GAXK01081341.1;B0WC46;2.54E-46;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1424922_c0_seq1;GAXK01081348.1;P77316;2.76E-17;YBDR_ECOLI;Uncharacterized zinc-type alcohol dehydrogenase-like protein YbdR (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016491";;;"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]"
comp142534_c0_seq1;GAXK01160466.1;O77503;3.30E-62;AGO2_RABIT;Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer) (Fragment);"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000340; GO:0000932; GO:0005634; GO:0005844; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153; GO:1990904";"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"
comp142537_c0_seq1;GAXK01160282.1;Q8JZN5;1.37E-90;ACAD9_MOUSE;Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-);"dendrite [GO:0030425]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991";"long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"dendrite [GO:0030425]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]"
comp1425379_c0_seq1;GAXK01081355.1;A8Y1P7;5.54E-21;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp1425443_c0_seq1;GAXK01081323.1;Q2LE78;4.44E-09;BTBD6_XENLA;BTB/POZ domain-containing protein 6;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp142554_c0_seq1;GAXK01160143.1;B6MFW3;1.01E-34;HOOK_BRAFL;Protein Hook homolog;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]";"GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0015031; GO:0030705; GO:0031122; GO:0051959";"cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]"
comp1425634_c0_seq1;GAXK01081331.1;Q8N0X7;2.14E-12;SPART_HUMAN;Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ubiquitin protein ligase binding [GO:0031625]; abscission [GO:0009838]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881]";"GO:0005737; GO:0005741; GO:0005811; GO:0005829; GO:0005886; GO:0009838; GO:0030496; GO:0030514; GO:0031625; GO:0034389; GO:0045202; GO:0048698; GO:0050905; GO:0051301; GO:0051881; GO:0060612";"abscission [GO:0009838]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202]";ubiquitin protein ligase binding [GO:0031625]
comp1425749_c0_seq1;GAXK01081333.1;O96269;1.80E-10;RS30_PLAF7;40S ribosomal protein S30;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp14258_c2_seq1;GAXK01177801.1;O57328;0;FZD1_CHICK;Frizzled-1 (Fz-1) (cFz-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; non-canonical Wnt signaling pathway [GO:0035567]";"GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0017147; GO:0035567; GO:0042813; GO:0060070";"canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; non-canonical Wnt signaling pathway [GO:0035567]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp14265_c0_seq1;GAXK01178161.1;P52899;2.34E-146;ODPA_CAEEL;Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096";"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]
comp1426676_c0_seq1;GAXK01127251.1;Q8N3Y7;2.39E-51;RDHE2_HUMAN;Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0008134; GO:0016021; GO:0017053; GO:0031065; GO:0033613; GO:0035067; GO:0042572; GO:0042574; GO:0043616";"keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp142695_c0_seq1;GAXK01160149.1;P0DSI3;4.64E-44;VA3_DINQU;Venom allergen 3 homolog (Cysteine-rich venom protein) (CRVP);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp1427414_c0_seq1;GAXK01127249.1;Q68EK2;1.52E-37;CALRL_DANRE;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064";"angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcitonin receptor activity [GO:0004948]
comp142754_c1_seq1;GAXK01160212.1;Q8MRC9;3.85E-99;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp14277_c0_seq1;GAXK01179160.1;P42207;0;SEPT1_DROME;Septin-1 (DIFF6 protein homolog) (Protein innocent bystander);"microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]";"GO:0003924; GO:0005525; GO:0005940; GO:0007349; GO:0015630; GO:0031105; GO:0031625; GO:0042803; GO:0043065; GO:0061640";"cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]";"microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp142785_c0_seq1;GAXK01160465.1;P08171;9.06E-15;EST6_DROME;Esterase-6 (Est-6) (EC 3.1.1.1) (Carboxylic-ester hydrolase 6) (Carboxylesterase-6);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; courtship behavior [GO:0007619]; mating [GO:0007618]; multicellular organism reproduction [GO:0032504]; organic substance catabolic process [GO:1901575]; ovulation [GO:0030728]; pheromone biosynthetic process [GO:0042811]; regulation of female receptivity, post-mating [GO:0046008]; regulation of oviposition [GO:0046662]; sperm storage [GO:0046693]";"GO:0005576; GO:0005615; GO:0007618; GO:0007619; GO:0030728; GO:0032504; GO:0034338; GO:0042811; GO:0046008; GO:0046662; GO:0046693; GO:0052689; GO:0080030; GO:1901575";"courtship behavior [GO:0007619]; mating [GO:0007618]; multicellular organism reproduction [GO:0032504]; organic substance catabolic process [GO:1901575]; ovulation [GO:0030728]; pheromone biosynthetic process [GO:0042811]; regulation of female receptivity, post-mating [GO:0046008]; regulation of oviposition [GO:0046662]; sperm storage [GO:0046693]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]"
comp1427982_c0_seq1;GAXK01127244.1;P18729;4.11E-21;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14282_c0_seq1;GAXK01178515.1;P15651;0;ACADS_RAT;Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]";"GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0046359; GO:0050660; GO:0051289; GO:0051384";"butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]"
comp142820_c2_seq1;GAXK01160312.1;Q5E9R3;1.01E-178;EHD1_BOVIN;EH domain-containing protein 1;"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]"
comp142827_c0_seq1;GAXK01160232.1;O15118;0;NPC1_HUMAN;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp1428681_c0_seq1;GAXK01101521.1;Q9WV72;2.61E-10;ASB3_MOUSE;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp142893_c1_seq1;GAXK01160157.1;Q9V7S5;3.73E-124;PICO_DROME;Putative inorganic phosphate cotransporter;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0015114; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]"
comp142895_c0_seq1;GAXK01160216.1;Q65AC2;2.73E-85;S26A2_HORSE;Sulfate transporter (Solute carrier family 26 member 2);"integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]";"GO:0001503; GO:0005887; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531; GO:1902358";"ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]";integral component of plasma membrane [GO:0005887];"anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp1429211_c0_seq1;GAXK01101551.1;Q9NPF2;1.96E-24;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp142924_c0_seq1;GAXK01160036.1;Q7KN62;8.18E-24;TERA_DROME;Transitional endoplasmic reticulum ATPase TER94 (EC 3.6.4.6) (Valosin-containing protein homolog);"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fusome [GO:0045169]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; ER-associated misfolded protein catabolic process [GO:0071712]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000226; GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006511; GO:0007029; GO:0007030; GO:0007040; GO:0007279; GO:0007317; GO:0016236; GO:0016320; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0031965; GO:0032436; GO:0034098; GO:0035096; GO:0043186; GO:0043523; GO:0043525; GO:0044754; GO:0045169; GO:0046598; GO:0046716; GO:0048477; GO:0048813; GO:0051228; GO:0071712; GO:0090090; GO:0097352; GO:0098586";"autophagosome maturation [GO:0097352]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; ER-associated misfolded protein catabolic process [GO:0071712]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fusome [GO:0045169]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]"
comp142929_c0_seq1;GAXK01160237.1;P24463;3.07E-79;CP3AC_CANLF;Cytochrome P450 3A12 (EC 1.14.14.1) (CYPIIIA12) (Cytochrome P450-PBD-1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on CH or CH2 groups [GO:0016725]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; hormone metabolic process [GO:0042445]; organic hydroxy compound metabolic process [GO:1901615]; oxidative demethylation [GO:0070989]; progesterone metabolic process [GO:0042448]; steroid metabolic process [GO:0008202]";"GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0016725; GO:0020037; GO:0042445; GO:0042448; GO:0050649; GO:0070330; GO:0070989; GO:1901615";"hormone metabolic process [GO:0042445]; organic hydroxy compound metabolic process [GO:1901615]; oxidative demethylation [GO:0070989]; progesterone metabolic process [GO:0042448]; steroid metabolic process [GO:0008202]";endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on CH or CH2 groups [GO:0016725]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]"
comp142941_c1_seq1;GAXK01160150.1;Q9BQP7;4.33E-33;MGME1_HUMAN;Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-);"mitochondrion [GO:0005739]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]";"GO:0000002; GO:0005739; GO:0006264; GO:0008297; GO:0043504";"mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]";mitochondrion [GO:0005739];single-stranded DNA exodeoxyribonuclease activity [GO:0008297]
comp1429433_c0_seq1;GAXK01101529.1;Q5RFP4;8.99E-24;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1429538_c0_seq1;GAXK01101523.1;Q63207;5.74E-25;FA10_RAT;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0005783; GO:0007596; GO:0016020; GO:0043231";blood coagulation [GO:0007596];"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp142974_c2_seq1;GAXK01160272.1;Q5F3V0;5.57E-29;SMYD4_CHICK;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp142975_c0_seq1;GAXK01160464.1;P83099;4.46E-153;KPC4_DROME;Putative protein kinase C delta type homolog (EC 2.7.11.13);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]";"GO:0004674; GO:0004697; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp143_c0_seq1;GAXK01169090.1;Q5R7P2;8.14E-70;TSN_PONAB;Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; RNA metabolic process [GO:0016070]";"GO:0003697; GO:0003723; GO:0004519; GO:0005634; GO:0005737; GO:0016070; GO:0043565";RNA metabolic process [GO:0016070];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]"
comp143002_c0_seq1;GAXK01160108.1;Q91YR9;5.10E-84;PTGR1_MOUSE;Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74);"cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]; response to antineoplastic agent [GO:0097327]";"GO:0005737; GO:0032440; GO:0036132; GO:0047522; GO:0097327";response to antineoplastic agent [GO:0097327];cytoplasm [GO:0005737];"13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]"
comp14301_c3_seq1;GAXK01177915.1;O61305;0;DDX19_DROME;DEAD-box helicase Dbp80 (EC 3.6.4.13);"cytoplasmic stress granule [GO:0010494]; nuclear membrane [GO:0031965]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0010494; GO:0016973; GO:0031965; GO:0044614";poly(A)+ mRNA export from nucleus [GO:0016973];"cytoplasmic stress granule [GO:0010494]; nuclear membrane [GO:0031965]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp143058_c3_seq1;GAXK01160513.1;Q27746;2.68E-08;DNMT1_PARLI;DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp1430665_c0_seq1;GAXK01035412.1;P97292;4.62E-19;HRH2_MOUSE;Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004930; GO:0004969; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998";"chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
comp1430694_c0_seq1;GAXK01035373.1;Q8N608;5.43E-55;DPP10_HUMAN;Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2);"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078";"positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp14310_c0_seq1;GAXK01178114.1;B7TB45;1.12E-11;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp143108_c7_seq1;GAXK01160375.1;Q80XC3;1.11E-125;US6NL_MOUSE;USP6 N-terminal-like protein;"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]";"GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358";"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]";"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp1431374_c0_seq1;GAXK01035397.1;Q8NBH2;2.73E-28;KY_HUMAN;Kyphoscoliosis peptidase (EC 3.4.-.-);"cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]";"GO:0005856; GO:0008233; GO:0030018";;"cytoskeleton [GO:0005856]; Z disc [GO:0030018]";peptidase activity [GO:0008233]
comp1431384_c0_seq1;GAXK01035405.1;Q99676;1.85E-13;ZN184_HUMAN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp1431427_c0_seq1;GAXK01035407.1;O73693;5.02E-42;EGR1_TAEGU;Early growth response protein 1 (EGR-1) (Zinc finger protein ZENK) (Fragment);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein sumoylation [GO:0033233]; response to auditory stimulus [GO:0010996]; transcription by RNA polymerase II [GO:0006366]";"GO:0000976; GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0008270; GO:0010385; GO:0010996; GO:0032922; GO:0033233; GO:0035035; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0070498; GO:0098759; GO:1990841";"cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein sumoylation [GO:0033233]; response to auditory stimulus [GO:0010996]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp143165_c4_seq1;GAXK01160083.1;Q9J5H8;5.90E-07;V023_FOWPN;Putative ankyrin repeat protein FPV023;;;;;
comp1431881_c0_seq1;GAXK01035379.1;Q8MV48;1.22E-171;GALT7_DROME;N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp1432_c0_seq1;GAXK01165942.1;Q9DCF9;2.57E-65;SSRG_MOUSE;Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005783; GO:0005789; GO:0006614; GO:0016021";SRP-dependent cotranslational protein targeting to membrane [GO:0006614];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1432045_c0_seq1;GAXK01003906.1;Q68EY9;8.73E-167;GMPBA_XENLA;Mannose-1-phosphate guanyltransferase beta-A (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B-A) (GTP-mannose-1-phosphate guanylyltransferase beta-A);"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]";"GO:0004475; GO:0005525; GO:0009298";GDP-mannose biosynthetic process [GO:0009298];;"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]"
comp143220_c8_seq1;GAXK01160668.1;A7E2Y6;3.99E-16;MROH1_BOVIN;Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A);;;;;
comp143237_c2_seq1;GAXK01160214.1;Q9VW47;2.57E-70;MED12_DROME;Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Mediator complex subunit Kohtalo) (dTRAP230);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]";"GO:0003712; GO:0003713; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0016592; GO:0022416; GO:0035072; GO:0036011; GO:0045498; GO:0048749; GO:0070847; GO:0090263";"chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp143260_c1_seq1;GAXK01160506.1;Q95RI5;2.49E-48;FAXC_DROME;Failed axon connections;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"GO:0005737; GO:0005886; GO:0007409; GO:0036099";"axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";
comp1432616_c0_seq1;GAXK01003925.1;Q64640;9.65E-55;ADK_RAT;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenosine metabolic process [GO:0046085]; AMP salvage [GO:0044209]; circadian regulation of gene expression [GO:0032922]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; type B pancreatic cell proliferation [GO:0044342]";"GO:0004001; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006166; GO:0010613; GO:0032922; GO:0042102; GO:0044209; GO:0044342; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; AMP salvage [GO:0044209]; circadian regulation of gene expression [GO:0032922]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; type B pancreatic cell proliferation [GO:0044342]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp1432935_c0_seq1;GAXK01003907.1;G5ED00;6.81E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1432946_c0_seq1;GAXK01003904.1;B0WC46;3.00E-41;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp143335_c1_seq1;GAXK01160440.1;P10076;1.76E-25;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp143359_c7_seq1;GAXK01160199.1;Q9BX63;5.93E-99;FANCJ_HUMAN;Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1);"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]";"GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918";"cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]";"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"
comp143374_c0_seq1;GAXK01160456.1;Q8N357;1.07E-91;S35F6_HUMAN;Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029";"negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";transmembrane transporter activity [GO:0022857]
comp1433984_c0_seq1;GAXK01003909.1;Q96KB5;3.45E-07;TOPK_HUMAN;Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase);"nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]";"GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0032435; GO:0032873; GO:0034644; GO:0050728";"cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]";nucleus [GO:0005634];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp143410_c0_seq1;GAXK01160026.1;Q9R087;3.02E-113;GPC6_MOUSE;Glypican-6 [Cleaved into: Secreted glypican-6];"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]";"GO:0005576; GO:0005615; GO:0005796; GO:0005887; GO:0009966; GO:0009986; GO:0016477; GO:0045202; GO:0046658; GO:0062023; GO:0098696; GO:0098978; GO:1905475";"cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]";"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";
comp1434180_c0_seq1;GAXK01057919.1;P25490;6.61E-30;TYY1_HUMAN;Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1);"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0000400; GO:0000724; GO:0000790; GO:0000978; GO:0000980; GO:0000981; GO:0000987; GO:0001158; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010629; GO:0016363; GO:0016579; GO:0030154; GO:0031011; GO:0031519; GO:0032688; GO:0034644; GO:0034696; GO:0043565; GO:0044212; GO:0045944; GO:0046332; GO:0048593; GO:0051276; GO:0061052; GO:0071347; GO:1902894";"anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp14342_c1_seq1;GAXK01178180.1;Q9W719;1.81E-89;HPRT_CHICK;Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; guanine binding [GO:0002057]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine nucleobase binding [GO:0002060]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]";"GO:0000166; GO:0000287; GO:0002057; GO:0002060; GO:0004422; GO:0005694; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042803; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0051289; GO:0052657";"adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]";"guanine binding [GO:0002057]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine nucleobase binding [GO:0002060]"
comp14349_c1_seq1;GAXK01179177.1;P36609;1.23E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1435058_c0_seq1;GAXK01057921.1;A7X3Y2;7.77E-07;LECM6_PSEPL;C-type lectin lectoxin-Enh6 (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]";"GO:0005576; GO:0030246; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp143540_c0_seq1;GAXK01160508.1;Q3V080;5.97E-30;ZN583_MOUSE;Zinc finger protein 583;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp143563_c0_seq1;GAXK01160215.1;Q8VD65;0;PI3R4_MOUSE;Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1);"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]";"GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561";"autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]";"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp143570_c0_seq1;GAXK01160530.1;Q8NDF8;2.43E-98;PAPD5_HUMAN;Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050]";"GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870";"carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]"
comp14358_c1_seq1;GAXK01178178.1;Q96QK1;0;VPS35_HUMAN;Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35);"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]";"GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0007416; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016032; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:1990126; GO:2000331";"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]";D1 dopamine receptor binding [GO:0031748]
comp1435834_c0_seq1;GAXK01057917.1;Q6IP59;2.99E-77;CTL2_XENLA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp14359_c0_seq1;GAXK01178265.1;O43447;4.23E-98;PPIH_HUMAN;Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003]";"GO:0000398; GO:0000413; GO:0001525; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0006457; GO:0016018; GO:0016607; GO:0042026; GO:0043021; GO:0045070; GO:0046540; GO:0051082; GO:0065003; GO:0071001";"angiogenesis [GO:0001525]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]"
comp1436_c0_seq1;GAXK01170555.1;Q9VXK0;2.33E-56;NIPSN_DROME;Protein NipSnap;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp14364_c0_seq1;GAXK01178435.1;Q9UKV8;0;AGO2_HUMAN;Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904";"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"
comp1436624_c0_seq1;GAXK01193752.1;B2D0J5;3.53E-35;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp143680_c0_seq1;GAXK01160505.1;P55786;2.74E-19;PSA_HUMAN;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp143686_c0_seq1;GAXK01160027.1;Q8VCC1;1.04E-08;PGDH_MOUSE;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]"
comp1436870_c0_seq1;GAXK01193745.1;Q6UWL6;6.01E-16;KIRR2_HUMAN;Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3);"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"GO:0001933; GO:0005886; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0098609";"cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";identical protein binding [GO:0042802]
comp14369_c1_seq1;GAXK01178410.1;Q498T3;9.00E-50;ING3_RAT;Inhibitor of growth protein 3;"NuA4 histone acetyltransferase complex [GO:0035267]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]";"GO:0000812; GO:0004402; GO:0032777; GO:0035064; GO:0035267; GO:0040008; GO:0043065; GO:0043967; GO:0043968; GO:0046872";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]";"NuA4 histone acetyltransferase complex [GO:0035267]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]";"histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp143703_c0_seq1;GAXK01160284.1;P17789;2.23E-34;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1437174_c0_seq1;GAXK01193729.1;P48985;2.38E-07;ATOH1_MOUSE;Protein atonal homolog 1 (Helix-loop-helix protein mATH-1) (mATH1);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; auditory receptor cell fate determination [GO:0042668]; auditory receptor cell fate specification [GO:0042667]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; Notch signaling pathway [GO:0007219]; positive regulation of inner ear auditory receptor cell differentiation [GO:0045609]; positive regulation of inner ear receptor cell differentiation [GO:2000982]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]";"GO:0000978; GO:0001228; GO:0001764; GO:0003677; GO:0005634; GO:0007219; GO:0007411; GO:0007420; GO:0021987; GO:0030154; GO:0030182; GO:0031490; GO:0042472; GO:0042491; GO:0042667; GO:0042668; GO:0043066; GO:0043565; GO:0045609; GO:0045664; GO:0045666; GO:0045944; GO:0046983; GO:0048839; GO:2000982";"auditory receptor cell fate determination [GO:0042668]; auditory receptor cell fate specification [GO:0042667]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; Notch signaling pathway [GO:0007219]; positive regulation of inner ear auditory receptor cell differentiation [GO:0045609]; positive regulation of inner ear receptor cell differentiation [GO:2000982]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]";nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp143731_c2_seq1;GAXK01160371.1;Q9VBY8;4.85E-169;UN13B_DROME;Protein unc-13 homolog 4B (Protein Staccato);"cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]; branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082]";"GO:0005764; GO:0005770; GO:0005856; GO:0007269; GO:0008021; GO:0016082; GO:0030175; GO:0035147; GO:0099503";"branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082]";"cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]";
comp14374_c0_seq1;GAXK01178574.1;A1L1F0;3.04E-38;NR2CA_XENTR;Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog);nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp143740_c1_seq1;GAXK01160335.1;Q8TDJ6;0;DMXL2_HUMAN;DmX-like protein 2 (Rabconnectin-3);"cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035]";"GO:0005615; GO:0007035; GO:0008021; GO:0017137; GO:0030054; GO:0030672; GO:0043291";vacuolar acidification [GO:0007035];"cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";Rab GTPase binding [GO:0017137]
comp1437740_c0_seq1;GAXK01193741.1;Q7ZY36;4.72E-08;SCM1A_XENLA;Calcium-binding mitochondrial carrier protein SCaMC-1-A (Small calcium-binding mitochondrial carrier protein 1-A) (Solute carrier family 25 member 24-A);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]";"GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015867; GO:0016021; GO:0034599; GO:0071277";"ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]"
comp1437759_c0_seq1;GAXK01193726.1;Q08DY9;5.54E-18;CASP3_BOVIN;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp143792_c2_seq1;GAXK01160288.1;Q9AV39;1.59E-07;GLO1A_ORYSJ;Very-long-chain aldehyde decarbonylase GL1-10 (EC 4.1.99.5) (Protein GLOSSY 1-10);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; aldehyde oxygenase (deformylating) activity [GO:1990465]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; octadecanal decarbonylase activity [GO:0009924]; sterol biosynthetic process [GO:0016126]";"GO:0000254; GO:0005506; GO:0005789; GO:0009924; GO:0016021; GO:0016126; GO:1990465";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"aldehyde oxygenase (deformylating) activity [GO:1990465]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; octadecanal decarbonylase activity [GO:0009924]"
comp143807_c4_seq1;GAXK01160178.1;Q8L7K9;4.31E-58;MAO2_ARATH;NAD-dependent malic enzyme 2, mitochondrial (AtNAD-ME2) (NAD-malic enzyme 2) (EC 1.1.1.39);"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"GO:0004470; GO:0004471; GO:0005524; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008270; GO:0009507; GO:0042803; GO:0050897; GO:0051287";"malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp1438117_c0_seq1;GAXK01173563.1;Q7K237;1.24E-54;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp1438206_c0_seq1;GAXK01173538.1;A2ALS5;8.97E-102;RPGP1_MOUSE;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792";"cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp1438354_c0_seq1;GAXK01173584.1;Q9UHH9;3.86E-25;IP6K2_HUMAN;Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (InsP6K2) (EC 2.7.4.-) (P(i)-uptake stimulator) (PiUS);"cell junction [GO:0030054]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]; type I interferon signaling pathway [GO:0060337]";"GO:0000828; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0006817; GO:0030054; GO:0030308; GO:0032958; GO:0043065; GO:0043647; GO:0046854; GO:0060337; GO:0097243; GO:1905396";"cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]; type I interferon signaling pathway [GO:0060337]";"cell junction [GO:0030054]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"
comp143838_c0_seq1;GAXK01160492.1;Q96H86;6.51E-43;ZN764_HUMAN;Zinc finger protein 764;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14384_c0_seq1;GAXK01179097.1;P05661;3.13E-108;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1438645_c0_seq1;GAXK01173544.1;Q8WTS6;1.15E-25;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1438790_c0_seq1;GAXK01173556.1;Q4N3P0;2.14E-68;RS8_THEPA;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp143884_c0_seq1;GAXK01160213.1;A7X3Z7;2.27E-07;LECM2_ERYPO;C-type lectin lectoxin-Lio2 (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp143893_c0_seq1;GAXK01160211.1;P49813;1.03E-28;TMOD1_MOUSE;Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);"actin filament [GO:0005884]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"GO:0003779; GO:0005523; GO:0005634; GO:0005737; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0008180; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051015; GO:0051694; GO:0070307";"adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"actin filament [GO:0005884]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]"
comp1438985_c0_seq1;GAXK01173534.1;P24456;1.56E-61;CP2DA_MOUSE;Cytochrome P450 2D10 (EC 1.14.14.1) (CYPIID10) (Cytochrome P450-16-alpha) (Cytochrome P450CB) (Testosterone 16-alpha hydroxylase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0019369; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp143926_c0_seq1;GAXK01160165.1;Q9Y6L7;7.87E-08;TLL2_HUMAN;Tolloid-like protein 2 (EC 3.4.24.-);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0022617; GO:0030154; GO:0048632";"cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp14393_c0_seq1;GAXK01177999.1;Q5ZIY4;5.65E-90;SBDS_CHICK;Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell population proliferation [GO:0008283]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]";"GO:0000922; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0008283; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539";"bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell population proliferation [GO:0008283]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]";"microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]"
comp143939_c2_seq1;GAXK01160231.1;Q7JYV2;1.63E-48;SNG_DROME;Synaptogyrin;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]";"GO:0006897; GO:0016021; GO:0016079; GO:0030054; GO:0030672; GO:0031594; GO:0048489; GO:0098693";"endocytosis [GO:0006897]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]";
comp1439701_c0_seq1;GAXK01173557.1;P19109;2.22E-12;DDX17_DROME;ATP-dependent RNA helicase p62 (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005700; GO:0005703; GO:0005730; GO:0005737; GO:0005829; GO:0006417; GO:0016246; GO:0019730; GO:0050688; GO:0051607; GO:0071011; GO:0071013; GO:1990904";"antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp143976_c0_seq1;GAXK01160301.1;Q9VIP0;1.97E-14;NESD_DROME;Protein nessun dorma;"female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]; carbohydrate binding [GO:0030246]; female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]";"GO:0007112; GO:0007283; GO:0008335; GO:0030246; GO:0030496; GO:0035323; GO:0035324; GO:0045169; GO:0045171";"female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]";"female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]";carbohydrate binding [GO:0030246]
comp1439888_c0_seq1;GAXK01173543.1;P31018;5.64E-63;EF1A_ENTHI;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp144_c87_seq1;GAXK01165612.1;Q612F5;0;PCCA_CAEBR;Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]";"GO:0004658; GO:0005524; GO:0005759; GO:0046872";;mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]"
comp1440092_c0_seq1;GAXK01021105.1;Q63276;1.98E-60;BAAT_RAT;Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Kan-1) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2);"cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glycine N-choloyltransferase activity [GO:0047963]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]";"GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052817; GO:0102991";"acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glycine N-choloyltransferase activity [GO:0047963]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]"
comp1440383_c0_seq1;GAXK01021055.1;Q3ZCB2;2.83E-08;PLAC8_BOVIN;Placenta-specific gene 8 protein;;;;;
comp14405_c0_seq1;GAXK01179250.1;O75116;0;ROCK2_HUMAN;Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]";"GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145";"actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]"
comp1440604_c1_seq1;GAXK01021091.1;P11247;1.76E-75;PERM_MOUSE;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268";"aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]";"heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp144062_c0_seq1;GAXK01201071.1;Q5M872;9.48E-56;DPEP2_RAT;Dipeptidase 2 (EC 3.4.13.19);"anchored component of membrane [GO:0031225]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]";"GO:0008235; GO:0008239; GO:0016805; GO:0031225; GO:0046872";;anchored component of membrane [GO:0031225];"dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]"
comp144075_c2_seq1;GAXK01201069.1;A7MIZ2;1.34E-22;6PGL_CROS8;6-phosphogluconolactonase (6-P-gluconolactonase) (EC 3.1.1.31);"6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";;6-phosphogluconolactonase activity [GO:0017057]
comp144097_c1_seq1;GAXK01201387.1;A1L1W9;1.07E-87;MOT10_DANRE;Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10);"integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]";"GO:0005887; GO:0015173; GO:0015349";;integral component of plasma membrane [GO:0005887];"aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp1441030_c0_seq1;GAXK01021117.1;O73874;7.04E-12;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp1441051_c0_seq1;GAXK01021115.1;P51029;1.85E-37;WNT8B_DANRE;Protein Wnt-8b;"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]";"GO:0001654; GO:0005109; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679";"canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp1441081_c0_seq1;GAXK01021065.1;B4GD14;6.87E-21;LPHN_DROPE;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1441171_c0_seq1;GAXK01021113.1;O96774;1.76E-162;RL3_TETTH;Ribosomal protein L3;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1441218_c0_seq1;GAXK01021053.1;Q0IIY2;1.71E-13;WSCD1_XENTR;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp1441345_c0_seq1;GAXK01021062.1;Q803E0;1.98E-15;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp144188_c1_seq1;GAXK01201094.1;Q3URE1;2.69E-173;ACSF3_MOUSE;Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3);"mitochondrion [GO:0005739]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; malonate catabolic process [GO:0090410]";"GO:0005524; GO:0005739; GO:0006631; GO:0006633; GO:0016878; GO:0031957; GO:0090409; GO:0090410";"fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; malonate catabolic process [GO:0090410]";mitochondrion [GO:0005739];"acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp1441897_c0_seq1;GAXK01021067.1;P69478;4.32E-24;CHSTB_RAT;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp1442245_c0_seq1;GAXK01061438.1;Q80ZA4;0;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp1442647_c0_seq1;GAXK01061449.1;Q86BJ3;1.46E-10;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp14427_c4_seq1;GAXK01178658.1;Q5ZJN4;1.32E-54;UBP10_CHICK;Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0036459; GO:0043124; GO:0044325; GO:0071347";"autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp144270_c0_seq1;GAXK01201105.1;Q9H040;3.93E-86;SPRTN_HUMAN;SprT-like domain-containing protein Spartan (DNA damage protein targeting VCP) (DVC1) (Protein with SprT-like domain at the N terminus) (Spartan);"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; error-free translesion synthesis [GO:0070987]; positive regulation of protein ubiquitination [GO:0031398]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0009411; GO:0016607; GO:0019985; GO:0031398; GO:0043130; GO:0046872; GO:0070530; GO:0070987";"cellular response to DNA damage stimulus [GO:0006974]; error-free translesion synthesis [GO:0070987]; positive regulation of protein ubiquitination [GO:0031398]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]"
comp1442976_c0_seq1;GAXK01061457.1;Q9VR07;0;INE_DROME;Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891";"glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]"
comp144323_c0_seq1;GAXK01201339.1;P46871;5.74E-38;KRP95_STRPU;Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit);"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp144361_c4_seq1;GAXK01201149.1;P82450;4.32E-76;SIAE_RAT;"Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]";"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp144374_c1_seq1;GAXK01201063.1;Q24040;1.68E-46;BGB_DROME;Protein big brother;"core-binding factor complex [GO:0016513]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0008134; GO:0016513; GO:0035206; GO:0046982";"regulation of hemocyte proliferation [GO:0035206]; regulation of transcription by RNA polymerase II [GO:0006357]";"core-binding factor complex [GO:0016513]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]"
comp1443803_c0_seq1;GAXK01061451.1;Q19200;5.72E-44;STO1_CAEEL;Stomatin-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1443874_c0_seq1;GAXK01061435.1;Q92629;7.67E-23;SGCD_HUMAN;Delta-sarcoglycan (Delta-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG);"cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue development [GO:0048738]; cell death [GO:0008219]; cellular protein-containing complex localization [GO:0034629]; coronary vasculature morphogenesis [GO:0060977]; heart contraction [GO:0060047]; muscle organ development [GO:0007517]";"GO:0005856; GO:0005886; GO:0007517; GO:0008219; GO:0016010; GO:0016012; GO:0016021; GO:0016529; GO:0019722; GO:0034629; GO:0042383; GO:0048738; GO:0048739; GO:0055074; GO:0060047; GO:0060977; GO:0086003";"calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue development [GO:0048738]; cell death [GO:0008219]; cellular protein-containing complex localization [GO:0034629]; coronary vasculature morphogenesis [GO:0060977]; heart contraction [GO:0060047]; muscle organ development [GO:0007517]";"cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]";
comp14440_c15_seq1;GAXK01178630.1;Q6PHQ8;3.49E-158;NAA35_MOUSE;N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein) (Protein MAK10 homolog);"cytoplasm [GO:0005737]; NatC complex [GO:0031417]; polysome [GO:0005844]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]";"GO:0004596; GO:0005737; GO:0005844; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659";"negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; smooth muscle cell proliferation [GO:0048659]";"cytoplasm [GO:0005737]; NatC complex [GO:0031417]; polysome [GO:0005844]";peptide alpha-N-acetyltransferase activity [GO:0004596]
comp144433_c0_seq1;GAXK01201167.1;P87064;1.09E-33;DODA_AMAMU;DOPA 4,5-dioxygenase (EC 1.14.99.-);"cytoplasm [GO:0005737]; dioxygenase activity [GO:0051213]";"GO:0005737; GO:0051213";;cytoplasm [GO:0005737];dioxygenase activity [GO:0051213]
comp1444770_c0_seq1;GAXK01069770.1;Q8Q0U0;9.82E-08;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp144540_c1_seq1;GAXK01201065.1;Q12849;8.63E-24;GRSF1_HUMAN;G-rich sequence factor 1 (GRSF-1);"cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; anterior/posterior pattern specification [GO:0009952]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA polyadenylation [GO:0006378]; tRNA processing [GO:0008033]";"GO:0003723; GO:0003729; GO:0005737; GO:0005739; GO:0006378; GO:0008033; GO:0009952; GO:0016331; GO:0035770; GO:0042645";"anterior/posterior pattern specification [GO:0009952]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA polyadenylation [GO:0006378]; tRNA processing [GO:0008033]";"cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1445439_c0_seq1;GAXK01069808.1;Q9FKD5;9.90E-08;SINL9_ARATH;Putative E3 ubiquitin-protein ligase SINA-like 9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 9) (Seven in absentia-like protein 9);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1445600_c0_seq1;GAXK01069778.1;Q20065;8.48E-53;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp1445774_c0_seq1;GAXK01069809.1;Q99MD8;5.46E-15;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1446125_c0_seq1;GAXK01133870.1;Q8VIG1;8.35E-09;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp144680_c0_seq1;GAXK01201152.1;P29503;3.23E-108;NEUR_DROME;Protein neuralized;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007398; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030707; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981";"asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp144691_c2_seq1;GAXK01201443.1;P0C026;4.10E-46;NUD24_ARATH;Nudix hydrolase 24, chloroplastic (AtNUDT24) (EC 3.6.1.-);"chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872]";"GO:0009507; GO:0044715; GO:0046872";;chloroplast [GO:0009507];"8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872]"
comp1446957_c0_seq1;GAXK01133878.1;P0DJ24;4.23E-39;RL37_TETTS;60S ribosomal protein L37;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp144734_c2_seq1;GAXK01201147.1;Q9Z1N4;1.13E-31;BPNT1_RAT;3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP) (scHAL2 analogous 3);"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0000287; GO:0004441; GO:0008441; GO:0046854";phosphatidylinositol phosphorylation [GO:0046854];;"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]"
comp14475_c10_seq1;GAXK01178548.1;O18048;6.53E-09;NH213_CAEEL;Nuclear hormone receptor family member nhr-213;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp144755_c2_seq1;GAXK01201134.1;Q9VXE5;5.93E-168;PAKM_DROME;Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein);"adherens junction [GO:0005912]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000187; GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0016477; GO:0017048; GO:0018105; GO:0023014; GO:0031098; GO:0032147; GO:0043408; GO:0045315; GO:0045792; GO:0048365; GO:0048749; GO:2000047";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"adherens junction [GO:0005912]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]"
comp1447863_c0_seq1;GAXK01133885.1;Q6GN21;1.18E-12;N2C1A_XENLA;Nuclear receptor subfamily 2 group C member 1-A (Developmental orphan receptor 2-A) (DOR2-A) (xDOR2-A) (Orphan nuclear receptor TR2-A) (Testicular receptor 2-A);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp1447936_c0_seq1;GAXK01133903.1;B1AS42;1.81E-43;NB5R5_MOUSE;NADH-cytochrome b5 reductase-like (EC 1.6.2.2);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]";"GO:0004128; GO:0005634; GO:0005654";;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]
comp144804_c0_seq1;GAXK01201382.1;P31521;2.79E-61;P47K_PSECL;47 kDa protein (P47K);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp144822_c0_seq1;GAXK01201338.1;O00571;0;DDX3X_HUMAN;ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P granule [GO:0043186]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005741; GO:0005829; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016607; GO:0016887; GO:0017111; GO:0017148; GO:0030154; GO:0030307; GO:0030308; GO:0031333; GO:0031369; GO:0032728; GO:0033592; GO:0034063; GO:0034774; GO:0035556; GO:0035613; GO:0042256; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0090263; GO:0097193; GO:1900087; GO:1903608; GO:1904813; GO:2001243";"cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P granule [GO:0043186]; secretory granule lumen [GO:0034774]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]"
comp144823_c0_seq1;GAXK01201313.1;Q9WTN5;2.40E-100;TPC1_RAT;Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005765; GO:0010008; GO:0016021; GO:0034765; GO:0072345";regulation of ion transmembrane transport [GO:0034765];"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]"
comp14485_c0_seq1;GAXK01179076.1;P53352;1.05E-16;INCE_CHICK;Inner centromere protein;"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]";"GO:0000070; GO:0000281; GO:0000775; GO:0000777; GO:0005634; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0030496; GO:0032991; GO:1902412";"chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]";"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]";
comp1448511_c0_seq1;GAXK01170596.1;Q8NET6;3.47E-16;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp1448729_c0_seq1;GAXK01170594.1;Q9NUA8;3.41E-08;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp144878_c0_seq1;GAXK01201312.1;Q8NDA2;2.82E-77;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp1449_c0_seq1;GAXK01169104.1;Q8SPI1;6.66E-11;COX7C_MACFA;Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp1449014_c0_seq1;GAXK01170598.1;P05140;1.19E-13;ISP2_HEMAM;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1449281_c0_seq1;GAXK01170614.1;A6H730;5.47E-79;PPAP_BOVIN;Prostatic acid phosphatase (EC 3.1.3.2);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"GO:0003993; GO:0005615; GO:0005886; GO:0006772; GO:0008253; GO:0012506; GO:0016311; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168";"adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]"
comp144932_c1_seq1;GAXK01201347.1;P36975;9.67E-35;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp1449375_c0_seq1;GAXK01170607.1;O94889;7.93E-10;KLH18_HUMAN;Kelch-like protein 18;;;;;
comp144938_c0_seq1;GAXK01201064.1;Q9W0Y6;1.13E-17;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp144942_c1_seq1;GAXK01201383.1;Q86X67;1.98E-60;NUD13_HUMAN;Nucleoside diphosphate-linked moiety X motif 13 (Nudix motif 13) (EC 3.-.-.-) (Protein KiSS-16);"mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; nucleobase-containing small molecule interconversion [GO:0015949]";"GO:0005759; GO:0015949; GO:0016462; GO:0046872";nucleobase-containing small molecule interconversion [GO:0015949];mitochondrial matrix [GO:0005759];"metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]"
comp1449824_c0_seq1;GAXK01170612.1;Q640C5;3.05E-08;DOPDB_XENLA;D-dopachrome decarboxylase-B (EC 4.1.1.84) (D-dopachrome tautomerase-B);"cytoplasm [GO:0005737]; D-dopachrome decarboxylase activity [GO:0033981]; melanin biosynthetic process [GO:0042438]";"GO:0005737; GO:0033981; GO:0042438";melanin biosynthetic process [GO:0042438];cytoplasm [GO:0005737];D-dopachrome decarboxylase activity [GO:0033981]
comp144986_c0_seq1;GAXK01201431.1;E7FDB3;1.73E-18;NANO1_DANRE;Nanos homolog 1;"cytoplasm [GO:0005737]; germ plasm [GO:0060293]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]";"GO:0003723; GO:0005737; GO:0007281; GO:0008270; GO:0008354; GO:0030371; GO:0048471; GO:0060293";"germ cell development [GO:0007281]; germ cell migration [GO:0008354]";"cytoplasm [GO:0005737]; germ plasm [GO:0060293]; perinuclear region of cytoplasm [GO:0048471]";"RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]"
comp1449874_c0_seq1;GAXK01170602.1;Q7Z4N8;9.21E-32;P4HA3_HUMAN;Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp1449879_c0_seq1;GAXK01170616.1;Q96RW7;3.98E-24;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp1449950_c0_seq1;GAXK01170606.1;P34568;2.99E-11;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp1449955_c0_seq1;GAXK01170622.1;O96006;1.52E-07;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp144997_c0_seq1;GAXK01201415.1;Q5ZLD7;0;VPS53_CHICK;Vacuolar protein sorting-associated protein 53 homolog;"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000938; GO:0005802; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0032456; GO:0042147; GO:0048471; GO:0055037; GO:1990745";"endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";
comp145_c0_seq1;GAXK01169190.1;P55833;3.89E-49;RS27_HOMAM;40S ribosomal protein S27;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp1450077_c0_seq1;GAXK01139385.1;Q16TM5;5.62E-34;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1450167_c0_seq1;GAXK01139382.1;Q0WW40;2.59E-08;FBK5_ARATH;F-box/kelch-repeat protein At1g16250;;;;;
comp1450585_c0_seq1;GAXK01139388.1;P10758;2.15E-10;LITH_RAT;Lithostathine (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP);"basal part of cell [GO:0045178]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium ion homeostasis [GO:0055074]; cell wall disruption in other organism [GO:0044278]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell population proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]";"GO:0001666; GO:0004888; GO:0005102; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008284; GO:0008285; GO:0010628; GO:0014070; GO:0019902; GO:0019903; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0032991; GO:0042060; GO:0042588; GO:0042802; GO:0042803; GO:0042834; GO:0043434; GO:0044278; GO:0045178; GO:0048471; GO:0051260; GO:0051289; GO:0055074; GO:0061844; GO:0070492; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990867; GO:1990869; GO:1990878";"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium ion homeostasis [GO:0055074]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; cell wall disruption in other organism [GO:0044278]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell population proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to gastrin [GO:1990867]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]";"basal part of cell [GO:0045178]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]";"growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]"
comp145079_c2_seq1;GAXK01201423.1;Q8IZ73;1.65E-17;RUSD2_HUMAN;RNA pseudouridylate synthase domain-containing protein 2;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]";"GO:0000455; GO:0003723; GO:0009982";enzyme-directed rRNA pseudouridine synthesis [GO:0000455];;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp145084_c1_seq1;GAXK01201406.1;Q14183;3.84E-17;DOC2A_HUMAN;Double C2-like domain-containing protein alpha (Doc2) (Doc2-alpha);"cell junction [GO:0030054]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005544; GO:0005634; GO:0005730; GO:0005764; GO:0007268; GO:0007399; GO:0016079; GO:0017158; GO:0030054; GO:0043005; GO:0061669; GO:0098850";"chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle exocytosis [GO:0016079]";"cell junction [GO:0030054]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]"
comp145090_c1_seq1;GAXK01201390.1;O46040;1.18E-23;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1450908_c0_seq1;GAXK01139362.1;P0DPW4;3.52E-09;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp145101_c0_seq1;GAXK01201088.1;O42412;8.19E-35;IOD3_CHICK;Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]";"GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0042403; GO:0042446";"hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]";"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";thyroxine 5'-deiodinase activity [GO:0004800]
comp145108_c0_seq1;GAXK01201068.1;F6PTN1;3.84E-132;TIKI1_XENTR;Metalloprotease TIKI1 (EC 3.4.-.-) (TRAB domain-containing protein 2A);"integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]";"GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0046872; GO:0060322";"head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]";"integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]"
comp145109_c4_seq1;GAXK01201107.1;P58545;5.57E-08;BTBD3_MOUSE;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp14511_c2_seq1;GAXK01177973.1;Q6PN98;1.86E-73;CATZ_ONCVO;Cathepsin Z (EC 3.4.18.1) (L3 cysteine protease) (LOVCP);"extracellular space [GO:0005615]; secretory vesicle [GO:0099503]; transport vesicle [GO:0030133]; cysteine-type peptidase activity [GO:0008234]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]";"GO:0005615; GO:0008234; GO:0030133; GO:0042395; GO:0099503";ecdysis, collagen and cuticulin-based cuticle [GO:0042395];"extracellular space [GO:0005615]; secretory vesicle [GO:0099503]; transport vesicle [GO:0030133]";cysteine-type peptidase activity [GO:0008234]
comp145120_c1_seq2;GAXK01201308.1;A6NCF5;9.29E-12;KLH33_HUMAN;Kelch-like protein 33;;;;;
comp1451281_c2_seq1;GAXK01139390.1;Q99PV8;2.83E-29;BC11B_MOUSE;B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (mRit1);"neuron projection [GO:0043005]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006355; GO:0007409; GO:0008285; GO:0009791; GO:0010468; GO:0010837; GO:0019216; GO:0021773; GO:0021902; GO:0021953; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043066; GO:0043368; GO:0043565; GO:0043588; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0071678; GO:0097535";"alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"neuron projection [GO:0043005]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1451304_c0_seq1;GAXK01139384.1;Q8N988;7.05E-24;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1451388_c0_seq1;GAXK01139352.1;Q3URE9;1.45E-18;LIGO2_MOUSE;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp1451433_c0_seq1;GAXK01139386.1;Q5RFP4;6.94E-42;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1451476_c0_seq1;GAXK01139354.1;P17970;5.51E-80;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp145176_c0_seq1;GAXK01201146.1;A5D6U8;3.00E-139;ACP7_DANRE;Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form);"extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]";"GO:0003993; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]"
comp1451843_c0_seq1;GAXK01139357.1;Q3U4G3;7.01E-31;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp14525_c2_seq1;GAXK01178704.1;Q54MF3;6.58E-07;CANB2_DICDI;Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2);"calcium ion binding [GO:0005509]; protein dephosphorylation [GO:0006470]";"GO:0005509; GO:0006470";protein dephosphorylation [GO:0006470];;calcium ion binding [GO:0005509]
comp1452582_c0_seq1;GAXK01086573.1;Q03923;1.13E-83;ZNF85_HUMAN;Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]";"GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp1452680_c0_seq1;GAXK01086581.1;Q6P560;2.35E-08;ZN182_MOUSE;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1452786_c0_seq1;GAXK01086545.1;Q8BTH6;1.55E-09;SCRT2_MOUSE;Transcriptional repressor scratch 2 (Scratch homolog 2 zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp145279_c6_seq1;GAXK01201082.1;Q9VCY8;9.39E-88;ADRL_DROME;Adiponectin receptor protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]"
comp145312_c1_seq1;GAXK01201188.1;Q28BL6;0;AACS_XENTR;Acetoacetyl-CoA synthetase (EC 6.2.1.16);"cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0005829; GO:0006631; GO:0030729";fatty acid metabolic process [GO:0006631];cytosol [GO:0005829];"acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]"
comp145327_c2_seq1;GAXK01201090.1;Q9XZ43;1.68E-89;5NTD_LUTLO;"Protein 5NUC [Includes: UDP-sugar hydrolase (EC 3.6.1.45) (UDP-sugar diphosphatase) (UDP-sugar pyrophosphatase); 5'-nucleotidase (5'-NT) (EC 3.1.3.5)]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0008253; GO:0008768; GO:0009166; GO:0046872";nucleotide catabolic process [GO:0009166];;"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]"
comp1453459_c0_seq1;GAXK01086556.1;P35444;2.33E-90;COMP_RAT;Cartilage oligomeric matrix protein (COMP);"collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; vitamin D binding [GO:0005499]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; positive regulation of chondrocyte proliferation [GO:1902732]";"GO:0001968; GO:0005201; GO:0005499; GO:0005509; GO:0006915; GO:0007155; GO:0008201; GO:0062023; GO:1902732";"apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; positive regulation of chondrocyte proliferation [GO:1902732]";collagen-containing extracellular matrix [GO:0062023];"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; vitamin D binding [GO:0005499]"
comp1453588_c0_seq1;GAXK01086571.1;P23919;3.30E-58;KTHY_HUMAN;Thymidylate kinase (EC 2.7.4.9) (dTMP kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627]; thymidine biosynthetic process [GO:0046105]";"GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0015949; GO:0043627; GO:0045445; GO:0046105; GO:0046686; GO:0071363";"cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627]; thymidine biosynthetic process [GO:0046105]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]"
comp1453614_c0_seq1;GAXK01086561.1;Q7XXL2;1.18E-28;4CLL9_ORYSJ;4-coumarate--CoA ligase-like 9 (EC 6.2.1.-);"endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty-acyl-CoA biosynthetic process [GO:0046949]; sporopollenin biosynthetic process [GO:0080110]";"GO:0004467; GO:0005524; GO:0005783; GO:0031956; GO:0046949; GO:0080110";"fatty-acyl-CoA biosynthetic process [GO:0046949]; sporopollenin biosynthetic process [GO:0080110]";endoplasmic reticulum [GO:0005783];"ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]"
comp14541_c0_seq1;GAXK01178751.1;Q7JW12;1.81E-91;TMX2_DROME;Thioredoxin-related transmembrane protein 2 homolog (Thioredoxin domain-containing protein 14 homolog);"cell [GO:0005623]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0016021; GO:0045454";cell redox homeostasis [GO:0045454];"cell [GO:0005623]; integral component of membrane [GO:0016021]";
comp1454104_c0_seq1;GAXK01140033.1;Q2V2K5;1.20E-19;GNRHR_OCTVU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (oct-GnRHR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp1454158_c0_seq1;GAXK01140007.1;B4LZT9;2.23E-11;HH_DROVI;"Protein hedgehog [Cleaved into: Protein hedgehog N-product; Protein hedgehog C-product]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; morphogen activity [GO:0016015]; peptidase activity [GO:0008233]; anatomical structure morphogenesis [GO:0009653]; cell-cell signaling involved in cell fate commitment [GO:0045168]; intein-mediated protein splicing [GO:0016539]; segment polarity determination [GO:0007367]";"GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007367; GO:0008233; GO:0009653; GO:0016015; GO:0016539; GO:0045168; GO:0046872";"anatomical structure morphogenesis [GO:0009653]; cell-cell signaling involved in cell fate commitment [GO:0045168]; intein-mediated protein splicing [GO:0016539]; segment polarity determination [GO:0007367]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; morphogen activity [GO:0016015]; peptidase activity [GO:0008233]"
comp145435_c4_seq1;GAXK01201334.1;Q6TNR1;1.19E-177;RHPN2_DANRE;Rhophilin-2 (GTP-Rho-binding protein 2);"cytoplasm [GO:0005737]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165";signal transduction [GO:0007165];cytoplasm [GO:0005737];
comp145449_c0_seq1;GAXK01201410.1;O77215;6.34E-48;UNC4_DROME;Homeobox protein unc-4 (Paired-like homeodomain protein unc-4) (DPHD-1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0043565";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp14545_c0_seq1;GAXK01179253.1;Q27245;1.58E-123;YH24_CAEEL;Putative aminopeptidase W07G4.4 (EC 3.4.11.-);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]";"GO:0004177; GO:0005737; GO:0008235; GO:0030145";;cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]"
comp1454744_c0_seq1;GAXK01140031.1;K7FQW8;1.07E-27;SCNNB_PELSI;Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB);"apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; multicellular organismal water homeostasis [GO:0050891]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]";"GO:0005887; GO:0009897; GO:0015280; GO:0016324; GO:0030659; GO:0034706; GO:0035725; GO:0050699; GO:0050891; GO:0055078; GO:0070062";"multicellular organismal water homeostasis [GO:0050891]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]";"apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; sodium channel complex [GO:0034706]";"ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]"
comp1455217_c0_seq1;GAXK01140023.1;Q8BZ34;2.62E-18;ZN641_MOUSE;Zinc finger protein 641;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1455276_c0_seq1;GAXK01140016.1;P41041;4.06E-21;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp14554_c1_seq1;GAXK01178106.1;Q5E951;3.02E-73;TBCB_BOVIN;Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]";
comp145542_c3_seq1;GAXK01201403.1;Q5T160;8.60E-131;SYRM_HUMAN;Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0003723; GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006420; GO:0032543";"arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp1455819_c0_seq1;GAXK01140001.1;Q1ENI8;1.46E-70;PXDN_CAEEL;Peroxidasin homolog (EC 1.11.1.7);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679";"embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1456_c0_seq1;GAXK01169286.1;Q9U3Z7;4.26E-59;NH2L1_DROME;NHP2-like protein 1 homolog (Protein hoi-polloi);"box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; mRNA splicing, via spliceosome [GO:0000398]; muscle tissue morphogenesis [GO:0060415]; positive regulation of translation [GO:0045727]; posttranscriptional regulation of gene expression [GO:0010608]";"GO:0000398; GO:0000470; GO:0003723; GO:0010608; GO:0030532; GO:0031428; GO:0032040; GO:0045727; GO:0046540; GO:0060415; GO:0071011";"maturation of LSU-rRNA [GO:0000470]; mRNA splicing, via spliceosome [GO:0000398]; muscle tissue morphogenesis [GO:0060415]; positive regulation of translation [GO:0045727]; posttranscriptional regulation of gene expression [GO:0010608]";"box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";RNA binding [GO:0003723]
comp145603_c1_seq1;GAXK01201095.1;P29594;8.27E-36;CASP2_MOUSE;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]";"GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0016020; GO:0016485; GO:0019904; GO:0035234; GO:0042802; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp1456085_c0_seq1;GAXK01003535.1;Q9Z1E9;8.15E-99;GSLG1_CRIGR;Golgi apparatus protein 1 (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160) (Latent TGF-beta complexed protein 1) (LTCP-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"GO:0000139; GO:0016021";;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp1456280_c0_seq1;GAXK01003524.1;A8K7I4;1.13E-37;CLCA1_HUMAN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0034220; GO:0042589; GO:0046872; GO:0071456";"calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp145630_c0_seq1;GAXK01201400.1;Q8C5N5;5.25E-21;PDD2L_MOUSE;Programmed cell death protein 2-like;"cytoplasm [GO:0005737]; cell cycle [GO:0007049]";"GO:0005737; GO:0007049";cell cycle [GO:0007049];cytoplasm [GO:0005737];
comp14565_c1_seq1;GAXK01178095.1;Q8NBN7;3.59E-67;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp1456540_c0_seq1;GAXK01003546.1;Q8C166;8.10E-16;CPNE1_MOUSE;Copine-1 (Copine I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; cellular response to calcium ion [GO:0071277]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]";"GO:0001786; GO:0004175; GO:0005509; GO:0005544; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0010629; GO:0016020; GO:0031965; GO:0042803; GO:0043122; GO:0043392; GO:0045666; GO:0051059; GO:0051897; GO:0071277; GO:1901223; GO:1903265; GO:1990138";"cellular response to calcium ion [GO:0071277]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]"
comp145655_c0_seq1;GAXK01201302.1;B5DE09;6.93E-39;NCOA2_XENTR;Nuclear receptor coactivator 2 (NCoA-2) (Transcriptional intermediary factor 2);"nucleus [GO:0005634]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; cellular response to hormone stimulus [GO:0032870]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular signal transduction [GO:0035556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0005634; GO:0006355; GO:0009792; GO:0016922; GO:0030374; GO:0030375; GO:0032870; GO:0035257; GO:0035556; GO:0045944; GO:0046966; GO:0046983; GO:0048511";"cellular response to hormone stimulus [GO:0032870]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular signal transduction [GO:0035556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";nucleus [GO:0005634];"nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]"
comp1456582_c0_seq1;GAXK01003541.1;A2A935;4.21E-12;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp1456610_c0_seq1;GAXK01003528.1;P16912;3.79E-34;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp1457266_c0_seq1;GAXK01003529.1;P41041;3.32E-48;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp14576_c1_seq1;GAXK01178701.1;P50568;6.29E-22;RABP2_XENLA;Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein) (CRABP) (xCRABP) (xCRABP-b);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; regulation of retinoic acid receptor signaling pathway [GO:0048385]";"GO:0001972; GO:0005634; GO:0005737; GO:0016918; GO:0019841; GO:0048385";regulation of retinoic acid receptor signaling pathway [GO:0048385];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]"
comp145767_c0_seq1;GAXK01201194.1;Q290X1;1.25E-32;SWET1_DROPS;Sugar transporter SWEET1 (Protein saliva);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; salivary gland development [GO:0007431]";"GO:0000139; GO:0005886; GO:0007431; GO:0016021; GO:0051119";salivary gland development [GO:0007431];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sugar transmembrane transporter activity [GO:0051119]
comp145778_c0_seq1;GAXK01201072.1;Q8BRH4;4.53E-13;KMT2C_MOUSE;Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog);"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338]";"GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0007338; GO:0010468; GO:0016571; GO:0016746; GO:0035097; GO:0035264; GO:0042393; GO:0042800; GO:0044666; GO:0045944; GO:0046872; GO:0048146; GO:0061029";"eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338]";"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"
comp14579_c0_seq1;GAXK01178329.1;Q05B83;0;RFC2_BOVIN;Replication factor C subunit 2 (Activator 1 subunit 2);"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:1900264";"DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]"
comp145798_c0_seq1;GAXK01201187.1;Q96RW7;1.45E-08;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp14582_c0_seq1;GAXK01178480.1;Q23551;0;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp145820_c7_seq1;GAXK01201444.1;B5U2W0;3.91E-30;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp145824_c1_seq1;GAXK01201182.1;Q8R2K4;4.36E-29;TAF6L_MOUSE;TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (PCAF-associated factor 65-alpha) (PAF65-alpha);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]";"GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006325; GO:0006357; GO:0006366; GO:0030914; GO:0043966; GO:0046695; GO:0046982; GO:0051123";"chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]";"protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]"
comp1458397_c0_seq1;GAXK01143503.1;Q25390;7.47E-07;SCRA_LIMPO;Alpha-scruin;;;;;
comp14587_c0_seq1;GAXK01177998.1;Q9UQW9;5.99E-30;DCOR_SCHPO;Ornithine decarboxylase (ODC) (EC 4.1.1.17);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ornithine decarboxylase activity [GO:0004586]; pantothenate biosynthetic process [GO:0015940]; putrescine biosynthetic process from ornithine [GO:0033387]";"GO:0004586; GO:0005634; GO:0005737; GO:0005829; GO:0015940; GO:0033387";"pantothenate biosynthetic process [GO:0015940]; putrescine biosynthetic process from ornithine [GO:0033387]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";ornithine decarboxylase activity [GO:0004586]
comp145871_c1_seq1;GAXK01201136.1;Q62975;7.67E-21;ZPI_RAT;Protein Z-dependent protease inhibitor (PZ-dependent protease inhibitor) (PZI) (Regeneration-associated serpin 1) (RASP-1) (Serpin A10);"extracellular space [GO:0005615]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0007596; GO:0008201; GO:0010951; GO:0097421";"blood coagulation [GO:0007596]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951]";extracellular space [GO:0005615];"heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp1459_c0_seq1;GAXK01166397.1;P50143;0;TCPG_XENLA;T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp145913_c1_seq1;GAXK01201380.1;F4JML5;6.75E-51;ECH2M_ARATH;Probable enoyl-CoA hydratase 2, mitochondrial (EC 4.2.1.17);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; methylglutaconyl-CoA hydratase activity [GO:0004490]; peptidase activity [GO:0008233]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]";"GO:0004300; GO:0004490; GO:0005739; GO:0005829; GO:0006635; GO:0008233; GO:0009083";"branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"enoyl-CoA hydratase activity [GO:0004300]; methylglutaconyl-CoA hydratase activity [GO:0004490]; peptidase activity [GO:0008233]"
comp1459196_c0_seq1;GAXK01143496.1;Q91WB4;3.49E-43;PKHF2_MOUSE;Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0005783; GO:0015031; GO:0030133; GO:0031901; GO:0035091; GO:0046872";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]"
comp1459710_c0_seq1;GAXK01143502.1;P04070;5.89E-14;PROC_HUMAN;"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; post-translational protein modification [GO:0043687]; proteolysis [GO:0006508]";"GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005794; GO:0005796; GO:0006508; GO:0006888; GO:0007596; GO:0030195; GO:0043066; GO:0043687; GO:0044267; GO:0050728; GO:0050819; GO:1903142";"blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; post-translational protein modification [GO:0043687]; proteolysis [GO:0006508]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp145980_c0_seq1;GAXK01201480.1;Q9BXW7;1.18E-106;HDHD5_HUMAN;Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5);"mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]";"GO:0005739; GO:0046474";glycerophospholipid biosynthetic process [GO:0046474];mitochondrion [GO:0005739];
comp145995_c0_seq1;GAXK01201385.1;Q499U6;3.76E-14;NSE1_RAT;Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]";"GO:0000724; GO:0000781; GO:0004842; GO:0005634; GO:0006301; GO:0030915; GO:0035556; GO:0046872; GO:0046983; GO:2001022";"double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]";"metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]"
comp146009_c0_seq1;GAXK01040211.1;Q6P7Q4;1.07E-87;LGUL_RAT;Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]";"GO:0004462; GO:0005634; GO:0005829; GO:0005886; GO:0005975; GO:0006749; GO:0008270; GO:0009438; GO:0043066";"carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]"
comp14601_c0_seq1;GAXK01178330.1;Q29503;1.10E-103;UB2R2_RABIT;Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2);"ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]";"GO:0004842; GO:0005524; GO:0006513; GO:0070936";"protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]";;"ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]"
comp1461_c2_seq1;GAXK01170061.1;A1L2T6;4.43E-23;ZCHC7_XENLA;Zinc finger CCHC domain-containing protein 7 (TRAMP-like complex RNA-binding factor ZCCHC7);"nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]";"GO:0003676; GO:0005730; GO:0008270";;nucleolus [GO:0005730];"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp14610_c1_seq1;GAXK01205917.1;P46436;9.42E-46;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp146100_c0_seq1;GAXK01040320.1;Q86V71;3.01E-24;ZN429_HUMAN;Zinc finger protein 429;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1461162_c0_seq1;GAXK01119247.1;O42266;1.11E-28;OPSP_ICTPU;Parapinopsin;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp146123_c0_seq1;GAXK01040441.1;Q8MSU3;4.31E-40;FRRS1_DROME;Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-);"integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]";"GO:0000293; GO:0016021; GO:0055114";oxidation-reduction process [GO:0055114];integral component of membrane [GO:0016021];ferric-chelate reductase activity [GO:0000293]
comp1461358_c0_seq1;GAXK01119248.1;G5ED00;6.70E-11;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp146145_c1_seq1;GAXK01040317.1;P69526;7.91E-65;TMPS9_RAT;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp14615_c1_seq1;GAXK01178326.1;Q24756;1.04E-28;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp146195_c0_seq1;GAXK01040240.1;P19236;1.58E-41;TRYM_CANLF;Mastin (EC 3.4.21.-) (Mast cell protease 3) (DMP) (MCP-3) (dMCP-3) (Mastocytoma protease);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0005737; GO:0006508";proteolysis [GO:0006508];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp146200_c3_seq1;GAXK01205163.1;Q26240;0;NOS_RHOPR;Nitric oxide synthase, salivary gland (NOS) (EC 1.14.13.39);"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric oxide biosynthetic process [GO:0006809]";"GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0046872; GO:0050660; GO:0050661";nitric oxide biosynthetic process [GO:0006809];;"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]"
comp1462731_c0_seq1;GAXK01105185.1;Q5JVG2;6.70E-26;ZN484_HUMAN;Zinc finger protein 484;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp146293_c0_seq1;GAXK01040263.1;Q1NZ26;1.10E-80;YSMU_CAEEL;Uncharacterized protein F13E9.13, mitochondrial;"mitochondrion [GO:0005739]; catalytic activity [GO:0003824]";"GO:0003824; GO:0005739";;mitochondrion [GO:0005739];catalytic activity [GO:0003824]
comp1463084_c0_seq1;GAXK01105127.1;Q3UR97;5.24E-14;SNX21_MOUSE;Sorting nexin-21;"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein transport [GO:0015031]";"GO:0005546; GO:0015031; GO:0030659; GO:0031901; GO:0032266";protein transport [GO:0015031];"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp14633_c3_seq1;GAXK01179095.1;Q8TEX9;1.11E-150;IPO4_HUMAN;Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; protein import into nucleus [GO:0006606]";"GO:0000790; GO:0005634; GO:0005737; GO:0006335; GO:0006336; GO:0006606; GO:0008139; GO:0008536; GO:0016020; GO:0032991; GO:0061608";"DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; protein import into nucleus [GO:0006606]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]"
comp1463460_c0_seq1;GAXK01105181.1;Q9D4V0;6.78E-67;EKI1_MOUSE;Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646";phosphatidylethanolamine biosynthetic process [GO:0006646];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]"
comp146354_c0_seq1;GAXK01040488.1;Q7YZA2;3.26E-17;Y7065_DROME;Uncharacterized protein CG7065;;;;;
comp1463580_c0_seq1;GAXK01105170.1;A2BID7;2.07E-09;PRD10_DANRE;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp1463691_c1_seq1;GAXK01105145.1;P27671;1.13E-32;RGRF1_MOUSE;Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (CDC25Mm) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25);"apical dendrite [GO:0097440]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; glutamate receptor binding [GO:0035254]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor tyrosine kinase binding [GO:0030971]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; neuron projection development [GO:0031175]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005088; GO:0005089; GO:0005737; GO:0005829; GO:0007264; GO:0008022; GO:0008283; GO:0016323; GO:0016327; GO:0017016; GO:0019901; GO:0030426; GO:0030971; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043025; GO:0043547; GO:0046578; GO:0046579; GO:0048146; GO:0048167; GO:0048168; GO:0090630; GO:0097440; GO:2000310";"activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; neuron projection development [GO:0031175]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; small GTPase mediated signal transduction [GO:0007264]";"apical dendrite [GO:0097440]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]";"glutamate receptor binding [GO:0035254]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor tyrosine kinase binding [GO:0030971]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1463791_c0_seq1;GAXK01105182.1;P17035;1.04E-18;ZNF28_HUMAN;Zinc finger protein 28 (Zinc finger protein KOX24);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp14638_c0_seq1;GAXK01179086.1;Q08288;9.44E-32;LYAR_MOUSE;Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364]";"GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0046872; GO:0048821; GO:0050766";"erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp146384_c3_seq1;GAXK01040219.1;P16621;0;LAR_DROME;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);"axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]";"GO:0004725; GO:0005001; GO:0005925; GO:0006470; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0016021; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0035335; GO:0045467; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0120034; GO:1903386";"axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]";"axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]";"heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp146413_c4_seq1;GAXK01040152.1;Q9UHB4;8.92E-116;NDOR1_HUMAN;NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]";"GO:0003958; GO:0005634; GO:0005737; GO:0005829; GO:0008219; GO:0010181; GO:0016226; GO:0016491; GO:0036245; GO:0045111; GO:0048471; GO:0050660; GO:0050661; GO:0055114";"cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]"
comp146454_c2_seq1;GAXK01040520.1;P48613;9.69E-14;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp14646_c0_seq1;GAXK01177946.1;Q9VDD7;1.21E-110;S35B1_DROME;Solute carrier family 35 member B1 homolog (Protein medial glomeruli);"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; axon guidance [GO:0007411]; carbohydrate transport [GO:0008643]; dendrite guidance [GO:0070983]; protein N-linked glycosylation [GO:0006487]; response to endoplasmic reticulum stress [GO:0034976]; UDP-galactose transmembrane transport [GO:0072334]";"GO:0005459; GO:0005460; GO:0005789; GO:0006487; GO:0007411; GO:0008643; GO:0022857; GO:0030173; GO:0030176; GO:0034976; GO:0070983; GO:0072334";"axon guidance [GO:0007411]; carbohydrate transport [GO:0008643]; dendrite guidance [GO:0070983]; protein N-linked glycosylation [GO:0006487]; response to endoplasmic reticulum stress [GO:0034976]; UDP-galactose transmembrane transport [GO:0072334]";"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]";"transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]"
comp1464676_c0_seq1;GAXK01120976.1;A2ASS6;9.16E-15;TITIN_MOUSE;Titin (EC 2.7.11.1) (Connectin);"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897";"adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp146479_c1_seq1;GAXK01040242.1;Q9W0Y6;2.22E-15;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp1465_c0_seq1;GAXK01169628.1;Q9VXN2;6.92E-10;SUN_DROME;Protein stunted;"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"GO:0000275; GO:0001664; GO:0005615; GO:0005743; GO:0006979; GO:0008340; GO:0015986; GO:0045745; GO:0046933; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]";"G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp146583_c3_seq1;GAXK01040292.1;Q15929;8.06E-14;ZNF56_HUMAN;Putative zinc finger protein 56 (Putative zinc finger protein 742);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14659_c0_seq1;GAXK01178100.1;Q96GG9;3.83E-128;DCNL1_HUMAN;DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";"GO:0000151; GO:0005634; GO:0005829; GO:0031624; GO:0032182; GO:0043687; GO:0045116; GO:0051443; GO:0097602; GO:2000436";"positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]"
comp1466241_c0_seq1;GAXK01009565.1;Q86UE3;4.24E-50;ZN546_HUMAN;Zinc finger protein 546 (Zinc finger protein 49);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp146626_c0_seq1;GAXK01040501.1;Q8BKK5;3.43E-10;ZN689_MOUSE;Zinc finger protein 689;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";"GO:0003677; GO:0005634; GO:0006355; GO:0035914; GO:0046872";"regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp146636_c2_seq1;GAXK01040449.1;Q5R9A7;8.52E-111;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp1466365_c0_seq1;GAXK01009543.1;Q8UUG8;4.11E-60;5HT2B_TETFL;5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; Gq/11-coupled serotonin receptor activity [GO:0001587]; neurotransmitter receptor activity [GO:0030594]; behavior [GO:0007610]; embryonic morphogenesis [GO:0048598]; heart development [GO:0007507]; regulation of behavior [GO:0050795]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]";"GO:0001587; GO:0005887; GO:0006939; GO:0007507; GO:0007610; GO:0030054; GO:0030594; GO:0042310; GO:0043005; GO:0045202; GO:0048598; GO:0050795";"behavior [GO:0007610]; embryonic morphogenesis [GO:0048598]; heart development [GO:0007507]; regulation of behavior [GO:0050795]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"Gq/11-coupled serotonin receptor activity [GO:0001587]; neurotransmitter receptor activity [GO:0030594]"
comp146638_c0_seq1;GAXK01040325.1;Q9VFP2;6.43E-24;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp1466590_c0_seq1;GAXK01009567.1;P52167;4.72E-12;GATAB_BOMMO;Transcription factor BCFI (BmGATA-beta) (GATA-beta);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp14666_c0_seq1;GAXK01178271.1;Q16594;2.09E-48;TAF9_HUMAN;Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32);"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cell growth [GO:0030307]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000124; GO:0000125; GO:0000492; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0006974; GO:0008134; GO:0030307; GO:0030914; GO:0032435; GO:0033276; GO:0033613; GO:0042795; GO:0043066; GO:0043966; GO:0044212; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:1901796; GO:1902166";"box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cell growth [GO:0030307]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]";"activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp146662_c0_seq1;GAXK01040353.1;O22527;4.04E-10;CLH1_ARATH;Chlorophyllase-1 (AtCLH1) (EC 3.1.1.14) (Chlorophyll-chlorophyllido hydrolase 1) (Chlase 1) (Coronatine-induced protein 1) (CORI1);"nucleus [GO:0005634]; vacuole [GO:0005773]; chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]; chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"GO:0005634; GO:0005773; GO:0015996; GO:0042742; GO:0047746; GO:0050832; GO:0102293";"chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"nucleus [GO:0005634]; vacuole [GO:0005773]";"chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]"
comp14668_c0_seq1;GAXK01178409.1;Q96AT9;2.39E-99;RPE_HUMAN;Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]";"GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0019323; GO:0042802; GO:0042803; GO:0044262; GO:0046872; GO:0070062";"carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]"
comp1466961_c0_seq1;GAXK01009564.1;Q66S03;6.12E-17;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp146701_c1_seq1;GAXK01040512.1;Q5ZK44;1.90E-61;F172A_CHICK;Cotranscriptional regulator FAM172A homolog (Protein FAM172A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0031048";"chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp146726_c1_seq1;GAXK01040269.1;Q7KRI2;2.91E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp14674_c0_seq1;GAXK01177812.1;A9ULE9;5.18E-24;DJC22_XENTR;DnaJ homolog subfamily C member 22;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp146748_c0_seq1;GAXK01040314.1;Q00422;1.01E-66;GABPA_MOUSE;GA-binding protein alpha chain (GABP subunit alpha);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0001825; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0033613; GO:0044212; GO:0045653; GO:0045944; GO:0046982; GO:1903351";"blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp1467486_c0_seq1;GAXK01009584.1;Q9VJ79;8.16E-90;PDE11_DROME;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp1467607_c0_seq1;GAXK01009579.1;P81178;1.19E-16;ALDH2_MESAU;Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1);"mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]";"GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287";ethanol catabolic process [GO:0006068];mitochondrial matrix [GO:0005759];"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]"
comp1467693_c0_seq1;GAXK01009570.1;O82018;4.31E-16;CALM_MOUSC;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1467835_c0_seq1;GAXK01009582.1;P13264;1.00E-175;GLSK_RAT;"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]";"GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0051289";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";glutaminase activity [GO:0004359]
comp14681_c2_seq1;GAXK01178820.1;Q8C8T8;9.78E-22;TSR2_MOUSE;Pre-rRNA-processing protein TSR2 homolog;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];GO:0000462;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];;
comp146816_c0_seq1;GAXK01040495.1;Q3Y8M6;3.22E-47;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp1468303_c1_seq1;GAXK01012117.1;W4VS53;1.18E-29;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp146856_c0_seq1;GAXK01040330.1;Q5XJN2;9.15E-25;GILT_DANRE;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376]";"GO:0002376; GO:0005576; GO:0005764; GO:0047134";immune system process [GO:0002376];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp14687_c0_seq1;GAXK01178572.1;Q8MQJ9;1.39E-163;BRAT_DROME;Brain tumor protein;"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007411; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0043161; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061630; GO:0099738; GO:1900242; GO:1902692";"asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]";"mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp146872_c2_seq1;GAXK01040183.1;Q9VH19;1.89E-173;LMLN_DROME;Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin);"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0004222; GO:0005737; GO:0006338; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0031252; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:1902769";"brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]"
comp1468858_c0_seq1;GAXK01012098.1;Q7Z460;1.77E-27;CLAP1_HUMAN;CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1);"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]";"GO:0000086; GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010389; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0090091; GO:0090162; GO:0090307; GO:0097711; GO:1903690; GO:1904261";"astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]";"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]";"dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]"
comp146887_c0_seq1;GAXK01040333.1;P30279;6.68E-44;CCND2_HUMAN;G1/S-specific cyclin-D2;"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp14689_c4_seq1;GAXK01178146.1;Q91WF7;0;FIG4_MOUSE;Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3);"endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]";"GO:0004438; GO:0005783; GO:0005794; GO:0005811; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0032288; GO:0034593; GO:0043231; GO:0043473; GO:0043812; GO:0046488; GO:0048666; GO:0055037";"locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]";"endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]";"phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]"
comp146916_c2_seq1;GAXK01040331.1;Q8BMI4;1.59E-81;GEN_MOUSE;Flap endonuclease GEN homolog 1 (EC 3.1.-.-);"centrosome [GO:0005813]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; flap endonuclease activity [GO:0048256]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]";"GO:0000287; GO:0000400; GO:0000724; GO:0005634; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0035312; GO:0042803; GO:0048256; GO:0071139; GO:0071140; GO:0090267";"double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]";"centrosome [GO:0005813]; nucleus [GO:0005634]";"5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; flap endonuclease activity [GO:0048256]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
comp14693_c6_seq1;GAXK01178044.1;D3Z5L6;2.56E-34;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp146951_c0_seq1;GAXK01040315.1;P05661;5.57E-44;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp14696_c0_seq1;GAXK01179096.1;Q9D287;1.59E-82;SPF27_MOUSE;Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2 homolog) (DNA amplified in mammary carcinoma 1 protein);"centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0000974; GO:0005634; GO:0005662; GO:0005681; GO:0005730; GO:0005813; GO:0016607; GO:0071007";mRNA splicing, via spliceosome [GO:0000398];"centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]";
comp1469625_c0_seq1;GAXK01012130.1;Q9V818;1.76E-12;MTH3_DROME;Probable G-protein coupled receptor Mth-like 3 (Protein methuselah-like 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp1469809_c0_seq1;GAXK01012125.1;Q14246;1.14E-09;AGRE1_HUMAN;Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor);"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0002250; GO:0004930; GO:0005509; GO:0005887; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0009897";"adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]"
comp1469906_c0_seq1;GAXK01012145.1;Q6YCH1;4.52E-16;TDPZ5_MOUSE;TD and POZ domain-containing protein 5;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp147_c0_seq1;GAXK01165527.1;P84175;9.11E-60;RS12_CHICK;40S ribosomal protein S12;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp1470_c0_seq1;GAXK01165937.1;Q9VMV6;6.75E-56;SELT_DROME;Thioredoxin reductase-like selenoprotein T homolog CG3887 (EC 1.8.1.9);"endomembrane system [GO:0012505]; thioredoxin-disulfide reductase activity [GO:0004791]";"GO:0004791; GO:0012505";;endomembrane system [GO:0012505];thioredoxin-disulfide reductase activity [GO:0004791]
comp1470014_c0_seq1;GAXK01049383.1;Q96GC6;1.47E-10;ZN274_HUMAN;Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2) (Zf2);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003682; GO:0003700; GO:0003714; GO:0005730; GO:0005737; GO:0006355; GO:0043565; GO:0046872; GO:1900112";"regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]"
comp1470128_c0_seq1;GAXK01049384.1;P36609;4.17E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp147019_c0_seq1;GAXK01040181.1;Q8JIY1;1.32E-115;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp1470323_c0_seq1;GAXK01049361.1;Q20191;2.48E-23;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1470505_c0_seq1;GAXK01049390.1;Q3SZK8;1.47E-18;NHRF1_BOVIN;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0003096; GO:0005737; GO:0005902; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0043621; GO:0044062; GO:0045198; GO:0045859; GO:0045930; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0060088; GO:0060090; GO:0060158; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0097225; GO:0097291; GO:2000146; GO:2001244";"actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]";"beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]"
comp147052_c1_seq1;GAXK01040043.1;Q8K1K9;1.08E-10;HINFP_MOUSE;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp1470523_c0_seq1;GAXK01049379.1;Q95R48;7.10E-37;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp147056_c2_seq1;GAXK01040468.1;Q9VD09;3.93E-36;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp1471_c0_seq1;GAXK01166210.1;P00129;6.82E-32;QCR7_BOVIN;Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein);"mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005750; GO:0006122; GO:0009060; GO:0034551";"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";mitochondrial respiratory chain complex III [GO:0005750];
comp1471207_c0_seq1;GAXK01049386.1;P11121;1.49E-56;CALM_PYUSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp147142_c0_seq1;GAXK01040487.1;Q9VZZ4;1.86E-79;PXDN_DROME;Peroxidasin (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831";"basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp147152_c0_seq1;GAXK01040502.1;A0JNI5;7.84E-46;CLASR_BOVIN;CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16);"nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0005634; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";nucleus [GO:0005634];
comp1471540_c0_seq1;GAXK01049393.1;Q05319;5.49E-61;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1471643_c0_seq1;GAXK01049354.1;P28494;5.97E-24;MA2A1_RAT;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp147165_c0_seq1;GAXK01040484.1;Q54MF3;4.10E-08;CANB2_DICDI;Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2);"calcium ion binding [GO:0005509]; protein dephosphorylation [GO:0006470]";"GO:0005509; GO:0006470";protein dephosphorylation [GO:0006470];;calcium ion binding [GO:0005509]
comp1471773_c0_seq1;GAXK01049391.1;Q29043;6.48E-20;FUT1_PIG;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp147217_c0_seq1;GAXK01040510.1;P93748;1.27E-09;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1472434_c0_seq1;GAXK01078298.1;Q5EA06;2.58E-24;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1472546_c0_seq1;GAXK01078263.1;P54611;3.34E-55;VATE_DROME;V-type proton ATPase subunit E (V-ATPase subunit E) (V-ATPase 26 kDa subunit) (Vacuolar proton pump subunit E);"plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]";"GO:0000221; GO:0005886; GO:0007430; GO:0033181; GO:0035002; GO:0045176; GO:0046961; GO:1902600";"apical protein localization [GO:0045176]; liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]";"plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp1472601_c0_seq1;GAXK01078301.1;P42519;7.25E-07;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp147283_c1_seq1;GAXK01040527.1;O94830;0;DDHD2_HUMAN;Phospholipase DDHD2 (EC 3.1.1.-) (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipid droplet organization [GO:0034389]; locomotory behavior [GO:0007626]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of mitochondrial fission [GO:0090141]; triglyceride catabolic process [GO:0019433]; visual learning [GO:0008542]";"GO:0004620; GO:0004806; GO:0005793; GO:0005794; GO:0005815; GO:0005829; GO:0006654; GO:0006888; GO:0007626; GO:0008542; GO:0016020; GO:0019433; GO:0030134; GO:0034389; GO:0046872; GO:0090141";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipid droplet organization [GO:0034389]; locomotory behavior [GO:0007626]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of mitochondrial fission [GO:0090141]; triglyceride catabolic process [GO:0019433]; visual learning [GO:0008542]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]";"metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]"
comp147293_c1_seq1;GAXK01040475.1;Q08CI8;1.12E-75;S238A_DANRE;Mitochondrial glycine transporter A (Solute carrier family 25 member 38-A);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; glycine transmembrane transporter activity [GO:0015187]; erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]; hemoglobin biosynthetic process [GO:0042541]; hemoglobin metabolic process [GO:0020027]";"GO:0005739; GO:0005743; GO:0015187; GO:0016021; GO:0020027; GO:0030218; GO:0042541; GO:1904983";"erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]; hemoglobin biosynthetic process [GO:0042541]; hemoglobin metabolic process [GO:0020027]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";glycine transmembrane transporter activity [GO:0015187]
comp1473069_c0_seq1;GAXK01078272.1;P13608;4.46E-27;PGCA_BOVIN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp1473242_c0_seq1;GAXK01078292.1;Q75NA5;1.34E-56;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1473425_c0_seq1;GAXK01078266.1;Q11002;1.04E-46;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp147350_c0_seq1;GAXK01040326.1;O08747;2.13E-91;UNC5C_MOUSE;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C) (Rostral cerebellar malformation protein);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030054; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0033564; GO:0038007; GO:0043025; GO:0043065; GO:0045202; GO:0061643; GO:1990791";"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"
comp1473689_c0_seq1;GAXK01078299.1;P21783;1.57E-14;NOTC1_XENLA;"Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]"
comp147374_c0_seq1;GAXK01040271.1;Q9R044;1.67E-77;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp147376_c0_seq1;GAXK01040042.1;Q9VC27;2.10E-65;NICA_DROME;Nicastrin;"gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta formation [GO:0034205]; lateral inhibition [GO:0046331]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of compound eye photoreceptor development [GO:0045314]";"GO:0005770; GO:0005886; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0034205; GO:0035333; GO:0045314; GO:0046331; GO:0055037; GO:0070765";"amyloid-beta formation [GO:0034205]; lateral inhibition [GO:0046331]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of compound eye photoreceptor development [GO:0045314]";"gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";
comp1474_c2_seq1;GAXK01168769.1;P20478;0;GLNA2_DROME;Glutamine synthetase 2 cytoplasmic (EC 6.3.1.2) (Glutamate--ammonia ligase 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";"GO:0004356; GO:0005524; GO:0005737; GO:0006538; GO:0006542; GO:0007416; GO:0045213";"glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]"
comp147405_c0_seq1;GAXK01040517.1;Q9GQQ0;6.13E-111;SPIN_DROME;Protein spinster (Protein benchwarmer) (Protein diphthong);"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0055085; GO:0098793";"cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]";
comp14745_c0_seq1;GAXK01177947.1;P18754;1.95E-62;RCC1_HUMAN;Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1);"chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]";"GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0016032; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051290; GO:0051301";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]";"chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]"
comp1474640_c0_seq1;GAXK01194485.1;A7E379;9.92E-97;PTPC1_BOVIN;Protein tyrosine phosphatase domain-containing protein 1 (EC 3.1.3.-);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]";"GO:0004725; GO:0005737; GO:0008138; GO:0060271";cilium assembly [GO:0060271];cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1474701_c0_seq1;GAXK01194480.1;A0A126GUP6;7.26E-20;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp147473_c1_seq1;GAXK01040507.1;Q26473;0;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp14748_c1_seq1;GAXK01178278.1;P45594;3.75E-53;CADF_DROME;Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0050714; GO:0051299";"actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]";actin binding [GO:0003779]
comp147489_c4_seq1;GAXK01040147.1;Q92542;8.79E-81;NICA_HUMAN;Nicastrin;"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; endopeptidase activity [GO:0004175]; adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular protein metabolic process [GO:0044267]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; dopamine receptor signaling pathway [GO:0007212]; ephrin receptor signaling pathway [GO:0048013]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; neutrophil degranulation [GO:0043312]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098]";"GO:0002262; GO:0004175; GO:0005739; GO:0005765; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016021; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0031293; GO:0034205; GO:0035333; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0043065; GO:0043085; GO:0043312; GO:0044267; GO:0048013; GO:0050673; GO:0051402; GO:0070062; GO:0070765; GO:0071277; GO:0099056; GO:1900271; GO:1990926";"adult behavior [GO:0030534]; amyloid-beta formation [GO:0034205]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; cellular protein metabolic process [GO:0044267]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; dopamine receptor signaling pathway [GO:0007212]; ephrin receptor signaling pathway [GO:0048013]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; neutrophil degranulation [GO:0043312]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098]";"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]";endopeptidase activity [GO:0004175]
comp1475_c0_seq1;GAXK01166387.1;Q5JVF3;6.75E-179;PCID2_HUMAN;PCI domain-containing protein 2 (CSN12-like protein);"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117";"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]";"double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp14750_c5_seq1;GAXK01179271.1;A3KPN8;7.72E-80;TTC38_DANRE;Tetratricopeptide repeat protein 38 (TPR repeat protein 38);;;;;
comp1475114_c0_seq1;GAXK01194510.1;Q8VHE6;0;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp1475264_c0_seq1;GAXK01194519.1;Q8CHD8;3.40E-12;RFIP3_MOUSE;Rab11 family-interacting protein 3 (FIP3-Rab11) (Rab11-FIP3);"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]";"GO:0005509; GO:0005654; GO:0005768; GO:0005813; GO:0005815; GO:0007049; GO:0016020; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0043231; GO:0045171; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0061512; GO:0070164";"cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]";"ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp1475369_c0_seq1;GAXK01194475.1;Q6L5F4;3.03E-09;CML14_ORYSJ;Probable calcium-binding protein CML14 (Calmodulin-like protein 14);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp147594_c0_seq1;GAXK01040491.1;Q9NA73;9.28E-18;T38B2_CAEEL;Trimeric intracellular cation channel type 1B.2 (TRIC-1B.2) (TRIC-B2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";potassium channel activity [GO:0005267]
comp147601_c0_seq1;GAXK01040044.1;P08548;2.81E-39;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp1476156_c0_seq1;GAXK01174313.1;E7F6F9;1.14E-19;KLHL3_DANRE;Kelch-like protein 3;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0003779; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156";"distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";actin binding [GO:0003779]
comp147634_c1_seq1;GAXK01040480.1;Q5KR61;8.34E-83;PIGV_RAT;GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity [GO:0004584]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000030; GO:0004584; GO:0005789; GO:0006506; GO:0016021; GO:0031501";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]";"dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity [GO:0004584]; mannosyltransferase activity [GO:0000030]"
comp1476562_c0_seq1;GAXK01174312.1;Q63421;4.40E-13;PDE1C_RAT;Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (3',5'-cyclic-AMP phosphodiesterase) (EC 3.1.4.-) (3',5'-cyclic-GMP phosphodiesterase) (EC 3.1.4.35);"neuronal cell body [GO:0043025]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]";"GO:0004117; GO:0005516; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0048101; GO:0051592; GO:0061179";"negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]";neuronal cell body [GO:0043025];"calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]"
comp147659_c5_seq1;GAXK01040531.1;Q7T3H9;2.54E-59;HYI_DANRE;Putative hydroxypyruvate isomerase (EC 5.3.1.22);"hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]";"GO:0008903; GO:0016857";;;"hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]"
comp14769_c1_seq1;GAXK01178653.1;Q3T0H0;3.80E-91;LCMT1_BOVIN;Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1);"cytosol [GO:0005829]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; C-terminal protein methylation [GO:0006481]; negative regulation of protein complex assembly [GO:0031333]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"GO:0005829; GO:0006481; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266";"C-terminal protein methylation [GO:0006481]; negative regulation of protein complex assembly [GO:0031333]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";cytosol [GO:0005829];protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]
comp147715_c1_seq1;GAXK01040189.1;B3DHU2;1.18E-41;TMM65_DANRE;Transmembrane protein 65;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]";"GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779";"cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]";
comp1477276_c0_seq1;GAXK01174304.1;P40145;7.84E-132;ADCY8_HUMAN;Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]";"GO:0003091; GO:0003779; GO:0004016; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006171; GO:0007165; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0007204; GO:0007611; GO:0007613; GO:0007616; GO:0007626; GO:0008294; GO:0010255; GO:0014069; GO:0016020; GO:0016323; GO:0016324; GO:0030054; GO:0030424; GO:0030425; GO:0030665; GO:0031915; GO:0032793; GO:0032809; GO:0034199; GO:0035774; GO:0038003; GO:0042593; GO:0042803; GO:0044853; GO:0045121; GO:0045211; GO:0046872; GO:0046982; GO:0046983; GO:0048786; GO:0051259; GO:0051260; GO:0051480; GO:0051721; GO:0060076; GO:0071277; GO:0071315; GO:0071333; GO:0071377; GO:0080135; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0150076; GO:1900273; GO:1900454; GO:1904322";"activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]";"actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]"
comp147750_c0_seq1;GAXK01040334.1;Q5ZKR7;2.41E-131;ACBG2_CHICK;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp147761_c0_seq1;GAXK01040286.1;Q96MH6;1.13E-75;TMM68_HUMAN;Transmembrane protein 68;"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]";"GO:0016021; GO:0016746";;integral component of membrane [GO:0016021];transferase activity, transferring acyl groups [GO:0016746]
comp1477646_c1_seq1;GAXK01174298.1;P34672;2.81E-31;BST24_CAEEL;Bestrophin homolog 24;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp147779_c1_seq1;GAXK01040492.1;P55789;1.13E-50;ALR_HUMAN;FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin);"cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein disulfide oxidoreductase activity [GO:0015035]";"GO:0005576; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0050660";;"cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein disulfide oxidoreductase activity [GO:0015035]"
comp147783_c0_seq1;GAXK01040477.1;Q5SRX1;6.70E-60;TM1L2_MOUSE;TOM1-like protein 2 (Target of Myb-like protein 2);"cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]";"GO:0005623; GO:0006886; GO:0007165; GO:0019901; GO:0030276; GO:0045839";"intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]";cell [GO:0005623];"clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]"
comp147788_c0_seq1;GAXK01040513.1;P34672;3.86E-09;BST24_CAEEL;Bestrophin homolog 24;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1478227_c0_seq1;GAXK01191157.1;B8V7S0;1.13E-33;CPP1_ACRMI;CUB and peptidase domain-containing protein 1 (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp1478254_c0_seq1;GAXK01191160.1;P05661;2.01E-51;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp14784_c1_seq1;GAXK01179094.1;Q8SZA8;9.22E-31;ADXH2_DROME;Adrenodoxin-like protein 2, mitochondrial (Ferredoxin-2);"mitochondrial matrix [GO:0005759]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]";"GO:0005759; GO:0006694; GO:0009055; GO:0045998; GO:0046872; GO:0051537";"positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]";mitochondrial matrix [GO:0005759];"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"
comp147844_c1_seq1;GAXK01040241.1;P0DN66;1.80E-19;ACTP1_CINAN;Tereporin-Ca1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp147860_c0_seq1;GAXK01040489.1;Q32PP1;8.50E-17;MRNIP_DANRE;MRN complex-interacting protein (MRN-interacting protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]";"GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp147878_c2_seq1;GAXK01040469.1;Q6ETN3;3.91E-111;4CL3_ORYSJ;Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp1478934_c0_seq1;GAXK01191148.1;Q9VUI3;0;EMAL_DROME;Echinoderm microtubule-associated protein-like CG42247;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]; microtubule binding [GO:0008017]; adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]";"GO:0000226; GO:0005737; GO:0005874; GO:0007605; GO:0008017; GO:0008344; GO:0035011; GO:0035556; GO:0071683";"adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]";microtubule binding [GO:0008017]
comp1479228_c0_seq1;GAXK01191154.1;Q9Y613;1.75E-56;FHOD1_HUMAN;FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1);"bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleus [GO:0005634]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492]";"GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007097; GO:0014704; GO:0016020; GO:0019904; GO:0032059; GO:0042802; GO:0043621; GO:0045944; GO:0051492; GO:0051496; GO:0051660";"establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492]";"bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleus [GO:0005634]";"actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]"
comp14793_c0_seq1;GAXK01178001.1;P50396;3.30E-40;GDIA_MOUSE;Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]";"GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043005; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051592; GO:0090315";"negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; protein-containing complex [GO:0032991]";"GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]"
comp147970_c2_seq1;GAXK01040146.1;Q9I0H4;1.25E-85;HMP_PSEAE;Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17);"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; cellular response to nitrosative stress [GO:0071500]; nitric oxide catabolic process [GO:0046210]; response to toxic substance [GO:0009636]";"GO:0005344; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046210; GO:0046872; GO:0071500; GO:0071949";"cellular response to nitrosative stress [GO:0071500]; nitric oxide catabolic process [GO:0046210]; response to toxic substance [GO:0009636]";;"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp1480200_c0_seq1;GAXK01110166.1;Q6AYF9;1.16E-34;IIGP5_RAT;Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1);"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525; GO:0016020";;membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1480213_c0_seq1;GAXK01110169.1;P40313;1.11E-36;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1480229_c0_seq1;GAXK01110183.1;Q28IM6;6.48E-15;HPCL1_XENTR;Hippocalcin-like protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1480339_c0_seq1;GAXK01110180.1;Q62761;1.00E-112;KC1G1_RAT;Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006897; GO:0016055; GO:0018105; GO:0018107; GO:0046777; GO:0090263";"endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp148056_c0_seq1;GAXK01073469.1;Q7ZZ00;5.24E-27;ZN511_DANRE;Zinc finger protein 511;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp148061_c1_seq1;GAXK01073133.1;Q75NA5;5.69E-169;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1480813_c0_seq1;GAXK01110175.1;Q8WZ42;7.34E-19;TITIN_HUMAN;Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14);"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493";"cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]"
comp148085_c1_seq1;GAXK01073170.1;Q19AV6;7.40E-20;ZSWM7_HUMAN;Zinc finger SWIM domain-containing protein 7 (SWIM domain-containing and Srs2-interacting protein 1 homolog) (SWIM-type zinc finger domain-containing protein 7);"nucleus [GO:0005634]; Shu complex [GO:0097196]; zinc ion binding [GO:0008270]; double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821]";"GO:0000724; GO:0005634; GO:0008270; GO:0050821; GO:0097196";"double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821]";"nucleus [GO:0005634]; Shu complex [GO:0097196]";zinc ion binding [GO:0008270]
comp1480912_c0_seq1;GAXK01110185.1;P24524;1.73E-21;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp1481199_c0_seq1;GAXK01110176.1;Q7PPU9;9.87E-50;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp14812_c1_seq1;GAXK01178120.1;Q99N95;7.94E-65;RM03_MOUSE;39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp148142_c0_seq1;GAXK01073248.1;P45447;1.93E-11;E78C_DROME;Ecdysone-induced protein 78C (DR-78) (Nuclear receptor subfamily 1 group E member 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565; GO:0045892";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp148143_c3_seq1;GAXK01073434.1;Q26304;4.83E-28;LUCI_LUCMI;Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7);"peroxisome [GO:0005777]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]; bioluminescence [GO:0008218]";"GO:0000287; GO:0005524; GO:0005777; GO:0008218; GO:0047077";bioluminescence [GO:0008218];peroxisome [GO:0005777];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]"
comp148189_c0_seq1;GAXK01073331.1;Q9ULM2;8.10E-21;ZN490_HUMAN;Zinc finger protein 490;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp14826_c1_seq1;GAXK01179184.1;Q93009;0;UBP7_HUMAN;Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7);"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006511; GO:0007275; GO:0008022; GO:0008134; GO:0010216; GO:0016032; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0036459; GO:0042752; GO:0048511; GO:0050821; GO:0051090; GO:0101005; GO:1901537; GO:1904353; GO:1990380";"histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]"
comp148261_c0_seq1;GAXK01073203.1;Q4R4U1;0;PANK4_MACFA;"Pantothenate kinase 4 (Pantothenic acid kinase) [Includes: Pantothenate kinase (EC 2.7.1.33); 4'-phosphopantetheine phosphatase (EC 3.1.3.-)]";"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]";"GO:0004594; GO:0005524; GO:0005737; GO:0015937; GO:0016787; GO:0046872";coenzyme A biosynthetic process [GO:0015937];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]"
comp148289_c0_seq1;GAXK01073420.1;P40656;1.08E-35;SOX14_DROME;Putative transcription factor SOX-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0016322; GO:0030154; GO:0043565; GO:0044798; GO:0048813; GO:1904799; GO:1904801";"cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp148294_c2_seq1;GAXK01073177.1;Q8C3Y4;2.16E-48;KNTC1_MOUSE;Kinetochore-associated protein 1;"actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]";"GO:0000777; GO:0000922; GO:0005634; GO:0005828; GO:0005829; GO:0005886; GO:0007093; GO:0015629; GO:0051301; GO:1990423";"cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]";"actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]";
comp148341_c10_seq1;GAXK01073391.1;Q9W0Y6;2.07E-33;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp148345_c0_seq1;GAXK01073468.1;P28338;6.14E-39;GSTT1_MUSDO;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp1483659_c0_seq1;GAXK01135009.1;B8VIV4;7.01E-19;CPP2_ACRMI;CUB and peptidase domain-containing protein 2 (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp1484_c1_seq1;GAXK01165933.1;O97159;0;CHDM_DROME;Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2);"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0035327; GO:0042766; GO:0043044; GO:0045892; GO:0051276; GO:0051312; GO:0070615; GO:0071923";"ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]"
comp148446_c0_seq1;GAXK01073376.1;Q27052;1.42E-20;FCA1_TRYRA;Flagellar calcium-binding protein;"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp148449_c0_seq1;GAXK01205400.1;P56520;0;HDAC3_CHICK;Histone deacetylase 3 (HD3) (EC 3.5.1.98);"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]";"GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0008134; GO:0017053; GO:0032041; GO:0032922; GO:0042752; GO:0045944; GO:0070491; GO:0070932; GO:0070933";"chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]";"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp1485_c1_seq1;GAXK01170083.1;Q7KRI2;1.75E-73;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp148500_c0_seq1;GAXK01073167.1;Q5RD93;2.37E-132;MANEA_PONAB;Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (EC 3.2.1.130);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]";"GO:0000139; GO:0004569; GO:0016021";;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]
comp148505_c6_seq1;GAXK01073158.1;Q7KRI2;5.54E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp148507_c0_seq1;GAXK01073180.1;Q684M2;6.05E-73;ATG4D_PIG;Cysteine protease ATG4D (EC 3.4.22.-) (Autophagin-4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial];"mitochondrial matrix [GO:0005759]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]";"GO:0005759; GO:0006914; GO:0006915; GO:0008234; GO:0015031";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]";mitochondrial matrix [GO:0005759];cysteine-type peptidase activity [GO:0008234]
comp148519_c0_seq1;GAXK01073494.1;Q9C0G0;1.34E-11;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp148539_c2_seq1;GAXK01073419.1;B9X187;1.09E-30;NMP1A_XENLA;Nuclear envelope integral membrane protein 1a;"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein self-association [GO:0043621]; eye development [GO:0001654]";"GO:0001654; GO:0005635; GO:0005637; GO:0016021; GO:0043621";eye development [GO:0001654];"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]";protein self-association [GO:0043621]
comp1485394_c0_seq1;GAXK01155136.1;Q3ZBH3;5.20E-13;CD151_BOVIN;CD151 antigen (CD antigen CD151);"integral component of plasma membrane [GO:0005887]; integrin binding [GO:0005178]; cell migration [GO:0016477]";"GO:0005178; GO:0005887; GO:0016477";cell migration [GO:0016477];integral component of plasma membrane [GO:0005887];integrin binding [GO:0005178]
comp14855_c1_seq1;GAXK01178373.1;P52583;1.26E-57;VGFR2_COTJA;Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1);"cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]"
comp1485599_c0_seq1;GAXK01155072.1;P01125;1.13E-24;REL_MELGA;Proto-oncogene c-Rel (p68) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007249; GO:0045893";"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp1485637_c0_seq1;GAXK01155141.1;O42329;2.67E-13;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp1486232_c0_seq1;GAXK01039201.1;Q802Y8;8.71E-08;ZB16A_DANRE;Zinc finger and BTB domain-containing protein 16-A (Promyelocytic leukemia zinc finger protein-A) (Zinc finger protein PLZF-A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"GO:0003677; GO:0005634; GO:0005737; GO:0016567; GO:0032481; GO:0046872; GO:0050767";"positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1486317_c0_seq1;GAXK01039220.1;P91953;1.57E-42;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp148637_c0_seq1;GAXK01073417.1;Q9UI40;8.43E-122;NCKX2_HUMAN;Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; protein dimerization activity [GO:0046983]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007601; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0034220; GO:0046983; GO:0050896; GO:0060291; GO:0060292; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; protein dimerization activity [GO:0046983]; symporter activity [GO:0015293]"
comp1486412_c0_seq1;GAXK01039218.1;Q5M9G0;1.69E-42;DCTD_RAT;Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase);"cytoplasm [GO:0005737]; dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]";"GO:0004132; GO:0005737; GO:0006226; GO:0006231; GO:0008270";"dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]";cytoplasm [GO:0005737];"dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]"
comp1486437_c0_seq1;GAXK01039200.1;Q8T3Y0;4.58E-08;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp14865_c4_seq1;GAXK01178369.1;Q80Z70;0;SE1L1_RAT;Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L);"endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein ubiquitination [GO:0016567]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000839; GO:0005783; GO:0006641; GO:0007219; GO:0009306; GO:0016021; GO:0016567; GO:0030433; GO:0036503";"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein ubiquitination [GO:0016567]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]";
comp1486584_c0_seq1;GAXK01039212.1;Q9H3W5;1.38E-17;LRRN3_HUMAN;Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3) (NLRR-3);"integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0016021; GO:0051965";positive regulation of synapse assembly [GO:0051965];integral component of membrane [GO:0016021];
comp1487483_c0_seq1;GAXK01039183.1;Q9NQA5;7.44E-33;TRPV5_HUMAN;Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035809; GO:0046872; GO:0051262; GO:0051289; GO:0055074; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp1487720_c0_seq1;GAXK01039192.1;Q9NR82;5.19E-129;KCNQ5_HUMAN;Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5);"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]";"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp14879_c1_seq1;GAXK01178073.1;Q9BPX3;3.83E-155;CND3_HUMAN;Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog);"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0000779; GO:0000793; GO:0000796; GO:0005634; GO:0005737; GO:0005829; GO:0007076; GO:0016020; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";
comp1488187_c0_seq1;GAXK01127524.1;Q9NXL6;2.71E-66;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp1488419_c0_seq1;GAXK01127528.1;Q9WVC5;2.41E-08;TRPC7_MOUSE;Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (mTRP7);"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005262; GO:0005635; GO:0005801; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0015279; GO:0016021; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp1488494_c1_seq1;GAXK01127517.1;Q9EPW1;6.47E-29;BMAL1_RAT;Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Brain and muscle ARNT-like 1) (Tic);"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]";"GO:0000976; GO:0000980; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007283; GO:0007623; GO:0016605; GO:0032007; GO:0032922; GO:0033391; GO:0042634; GO:0042753; GO:0043161; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:1901985; GO:2000074; GO:2000323; GO:2000772; GO:2001016";"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp14885_c0_seq1;GAXK01178263.1;Q7JZM8;1.77E-43;RM41_DROME;39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41);"mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0032543; GO:1990904";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";"mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]";structural constituent of ribosome [GO:0003735]
comp1488504_c0_seq1;GAXK01127525.1;Q9PVZ4;6.99E-08;INSR_XENLA;"Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; insulin receptor signaling pathway [GO:0008286]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";"GO:0004713; GO:0004714; GO:0005009; GO:0005524; GO:0005886; GO:0005887; GO:0007275; GO:0008286; GO:0016020; GO:0042169; GO:0043548; GO:0043559; GO:0043560; GO:0046777; GO:0051290; GO:0051425";"insulin receptor signaling pathway [GO:0008286]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1488519_c0_seq1;GAXK01127518.1;Q3U4G3;9.85E-27;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp148881_c1_seq1;GAXK01073327.1;Q980A9;1.06E-13;METE_SACS2;Methionine synthase (EC 2.1.1.-) (Homocysteine methyltransferase);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp148909_c0_seq1;GAXK01073153.1;Q10574;1.95E-15;LIN32_CAEEL;Protein lin-32 (Abnormal cell lineage protein 32);"nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";"GO:0005634; GO:0009792; GO:0042803; GO:0043565; GO:0045138; GO:0046982; GO:0048666; GO:0051179";"embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";nucleus [GO:0005634];"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp148949_c0_seq1;GAXK01073467.1;Q16518;3.39E-27;RPE65_HUMAN;Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase);"cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of rhodopsin gene expression [GO:0007468]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]; zeaxanthin biosynthetic process [GO:1901827]";"GO:0001523; GO:0001786; GO:0001895; GO:0003407; GO:0004744; GO:0005789; GO:0005886; GO:0006776; GO:0007468; GO:0007601; GO:0007623; GO:0008286; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0042574; GO:0044297; GO:0046872; GO:0050251; GO:0050908; GO:0052884; GO:0052885; GO:0060042; GO:0071257; GO:1901612; GO:1901827";"cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of rhodopsin gene expression [GO:0007468]; retina homeostasis [GO:0001895]; retinal metabolic process [GO:0042574]; retina morphogenesis in camera-type eye [GO:0060042]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]; zeaxanthin biosynthetic process [GO:1901827]";"cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]"
comp1489933_c0_seq1;GAXK01127493.1;O73810;1.62E-26;DRD2_MELGA;D(2) dopamine receptor (Dopamine D2 receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of peptide hormone secretion [GO:0090278]";"GO:0004930; GO:0004952; GO:0005886; GO:0007195; GO:0010523; GO:0016021; GO:0035240; GO:0038023; GO:0090278";"adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of peptide hormone secretion [GO:0090278]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]"
comp1489946_c0_seq1;GAXK01127495.1;A2A935;6.61E-07;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp149_c0_seq1;GAXK01166147.1;Q9W6H5;1.54E-81;UBC9A_DANRE;SUMO-conjugating enzyme UBC9-A (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9-A) (SUMO-protein ligase A) (Ubiquitin carrier protein 9-A) (Ubiquitin carrier protein I-A) (Ubiquitin-conjugating enzyme E2 I-A) (Ubiquitin-protein ligase I-A);"nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]; regeneration [GO:0031099]; regulation of mitotic nuclear division [GO:0007088]";"GO:0001947; GO:0005524; GO:0005634; GO:0007049; GO:0007059; GO:0007088; GO:0016925; GO:0019789; GO:0031099; GO:0036306; GO:0051301; GO:0060216; GO:0061484; GO:0061656";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]; regeneration [GO:0031099]; regulation of mitotic nuclear division [GO:0007088]";nucleus [GO:0005634];"ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]"
comp149005_c0_seq1;GAXK01073496.1;Q66S03;2.83E-22;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1490126_c0_seq1;GAXK01144261.1;P49816;1.75E-08;TSC2_RAT;Tuberin (Tuberous sclerosis 2 protein homolog);"caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]";"GO:0001933; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005901; GO:0007165; GO:0007568; GO:0008285; GO:0010719; GO:0010763; GO:0010976; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030178; GO:0030425; GO:0030426; GO:0032007; GO:0032991; GO:0033596; GO:0034394; GO:0035176; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043407; GO:0045121; GO:0045184; GO:0045785; GO:0045792; GO:0046627; GO:0046982; GO:0047485; GO:0048147; GO:0048471; GO:0048550; GO:0050680; GO:0050771; GO:0051056; GO:0051260; GO:0051291; GO:0051726; GO:0051898; GO:0060999; GO:0098978; GO:0099175; GO:1905563";"aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]";"caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]";"GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"
comp149030_c0_seq1;GAXK01073472.1;Q86UW9;7.79E-50;DTX2_HUMAN;Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2);"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0016740; GO:0031965";"Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1490399_c0_seq1;GAXK01144272.1;Q63099;4.17E-38;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp149053_c0_seq1;GAXK01073440.1;B0W2W6;3.62E-34;MAEL_CULQU;Protein maelstrom homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"GO:0003677; GO:0005634; GO:0005737; GO:0007275; GO:0030154; GO:0031047; GO:0051321; GO:0060964";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp1490538_c0_seq1;GAXK01144288.1;Q9P2J8;2.73E-11;ZN624_HUMAN;Zinc finger protein 624;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1490550_c0_seq1;GAXK01144283.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp149064_c1_seq1;GAXK01073130.1;P54145;8.29E-62;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp149085_c0_seq1;GAXK01073168.1;Q7ZXP0;7.72E-127;TWF2A_XENLA;Twinfilin-2-A;"cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; negative regulation of actin filament polymerization [GO:0030837]";"GO:0003779; GO:0005856; GO:0030837; GO:0048471";negative regulation of actin filament polymerization [GO:0030837];"cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]";actin binding [GO:0003779]
comp1490876_c0_seq1;GAXK01144263.1;Q20459;7.55E-17;NAS25_CAEEL;Zinc metalloproteinase nas-25 (EC 3.4.24.-) (Nematode astacin 25);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996";molting cycle, collagen and cuticulin-based cuticle [GO:0018996];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1491227_c0_seq1;GAXK01144280.1;Q6DFL0;4.32E-15;C102A_XENLA;Coiled-coil domain-containing protein 102A;"myosin complex [GO:0016459]; motor activity [GO:0003774]";"GO:0003774; GO:0016459";;myosin complex [GO:0016459];motor activity [GO:0003774]
comp1491343_c0_seq1;GAXK01144275.1;Q8MQS8;1.34E-15;SP34_APIME;Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp149142_c0_seq1;GAXK01073188.1;Q6R7M4;2.06E-97;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp149164_c0_seq1;GAXK01073189.1;Q91YJ5;1.50E-148;IF2M_MOUSE;Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt));"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]";"GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0008135; GO:0032790; GO:0043024; GO:0070124";"mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp1491674_c0_seq1;GAXK01144268.1;Q5XM24;2.34E-07;APRA_DICDI;Autocrine proliferation repressor protein A (PhoPQ-activated pathogenicity-related protein);"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005096; GO:0005102; GO:0005576; GO:0007049; GO:0008233; GO:0030435; GO:0031157; GO:0032991; GO:0045499; GO:0050919; GO:0072659; GO:0090630; GO:1903665";"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]";"chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp1491692_c0_seq1;GAXK01144271.1;Q8IXU6;4.68E-20;S35F2_HUMAN;Solute carrier family 35 member F2;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]";"GO:0016021; GO:0022857";;integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp14917_c0_seq1;GAXK01179098.1;Q9GRW0;2.63E-68;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1491891_c0_seq1;GAXK01144282.1;Q26491;6.04E-13;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp1491929_c0_seq1;GAXK01144270.1;Q6PG37;3.89E-07;ZN790_HUMAN;Zinc finger protein 790;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1492010_c0_seq1;GAXK01190390.1;Q9NFP5;4.50E-23;SH3BG_DROME;SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein);SH3 domain binding [GO:0017124];GO:0017124;;;SH3 domain binding [GO:0017124]
comp149227_c0_seq1;GAXK01073329.1;Q9H706;1.18E-08;GARE1_HUMAN;GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1);"plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364";"cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";plasma membrane [GO:0005886];proline-rich region binding [GO:0070064]
comp1492330_c0_seq1;GAXK01190365.1;P17972;2.54E-47;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp14924_c0_seq1;GAXK01178377.1;P11915;0;NLTP_RAT;Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; lipid binding [GO:0008289]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylethanolamine transfer activity [GO:1904121]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular response to cholesterol [GO:0071397]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]";"GO:0003988; GO:0005634; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006694; GO:0007568; GO:0008289; GO:0008525; GO:0010893; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032355; GO:0032385; GO:0033814; GO:0034699; GO:0042803; GO:0043065; GO:0045542; GO:0046982; GO:0071397; GO:1904109; GO:1904121";"aging [GO:0007568]; cellular response to cholesterol [GO:0071397]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"acetyl-CoA C-acyltransferase activity [GO:0003988]; lipid binding [GO:0008289]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylethanolamine transfer activity [GO:1904121]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp149251_c0_seq1;GAXK01073240.1;Q58DR2;2.59E-21;DJB12_BOVIN;DnaJ homolog subfamily B member 12;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218";"cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]";Hsp70 protein binding [GO:0030544]
comp1492517_c0_seq1;GAXK01190429.1;Q8BYF6;2.25E-109;SC5A8_MOUSE;Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"GO:0005343; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161";"apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]"
comp1492529_c0_seq1;GAXK01190415.1;P21461;8.71E-08;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp14926_c0_seq1;GAXK01178371.1;Q7PVQ9;2.20E-65;RPB11_ANOGA;DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II subunit J);"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]";"GO:0001055; GO:0003677; GO:0005665; GO:0046983";;RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]"
comp1492693_c0_seq1;GAXK01190427.1;B0VXV1;1.18E-09;SL2_SISCA;Snaclec 2 (C-type lectin isoform 2);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp14928_c0_seq1;GAXK01178709.1;Q8VHZ7;2.55E-125;IMP4_MOUSE;U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4);"fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]";"GO:0001650; GO:0005730; GO:0006364; GO:0030515; GO:0030684; GO:0032040; GO:0034457";rRNA processing [GO:0006364];"fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]";snoRNA binding [GO:0030515]
comp1492829_c0_seq1;GAXK01190400.1;Q86YT5;1.40E-134;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp1492993_c0_seq1;GAXK01190397.1;P14381;4.53E-10;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp1493202_c2_seq1;GAXK01190367.1;Q9W0T5;5.38E-13;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp1493210_c0_seq1;GAXK01190412.1;O73874;3.94E-17;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp1493432_c0_seq1;GAXK01190364.1;P52746;4.25E-25;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1493484_c0_seq1;GAXK01190362.1;Q7KRI2;1.19E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp149365_c1_seq1;GAXK01073210.1;O42287;1.69E-19;ITSN1_XENLA;Intersectin-1;"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0030054; GO:0035023; GO:0035556; GO:0043005; GO:0045202; GO:0055037";"endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of Rho protein signal transduction [GO:0035023]";"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp149413_c0_seq1;GAXK01073493.1;Q8N184;8.28E-23;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp149433_c0_seq1;GAXK01073586.1;P07746;5.08E-10;HMGT_ONCMY;High mobility group-T protein (HMG-T) (HMG-T1) (HMG-1);"nuclear chromatin [GO:0000790]; double-stranded DNA binding [GO:0003690]";"GO:0000790; GO:0003690";;nuclear chromatin [GO:0000790];double-stranded DNA binding [GO:0003690]
comp1494562_c0_seq1;GAXK01134697.1;P53041;5.03E-59;PPP5_HUMAN;Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT);"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]";"GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051291; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324";"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]";"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]"
comp14948_c0_seq1;GAXK01178264.1;P10620;5.41E-41;MGST1_HUMAN;Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I);"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]";"GO:0004364; GO:0004602; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006749; GO:0006805; GO:0010243; GO:0016021; GO:0032496; GO:0033327; GO:0035577; GO:0042493; GO:0042803; GO:0043295; GO:0043312; GO:0045177; GO:0055114; GO:0070207; GO:0071449; GO:1901687";"cellular response to lipid hydroperoxide [GO:0071449]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]";"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]"
comp1495_c1_seq1;GAXK01168751.1;P91753;1.17E-10;MP62_LYTPI;Mitotic apparatus protein p62;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp149513_c0_seq1;GAXK01073449.1;O01382;9.57E-39;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp149540_c1_seq1;GAXK01073408.1;Q9CWH5;2.85E-125;TRM11_MOUSE;tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog);"cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]";"GO:0000049; GO:0004809; GO:0005737; GO:0008168";;cytoplasm [GO:0005737];"methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]"
comp1495543_c0_seq1;GAXK01134686.1;B7Z0W9;2.41E-08;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp14956_c2_seq1;GAXK01178575.1;Q9VVU5;0;CSN1_DROME;COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b);"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; multicellular organism development [GO:0007275]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]";"GO:0000338; GO:0005737; GO:0007275; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821";"female germ-line stem cell population maintenance [GO:0036099]; germarium-derived cystoblast division [GO:0048142]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; multicellular organism development [GO:0007275]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]";"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]";
comp1495869_c0_seq1;GAXK01134676.1;P17970;6.17E-79;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp149600_c1_seq1;GAXK01073105.1;Q4R4U9;0;SYSC_MACFA;Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"GO:0000122; GO:0000978; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0006434; GO:0016525; GO:0097056; GO:1904046";"negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]"
comp1496263_c0_seq1;GAXK01104289.1;P45723;2.33E-21;PLC_STAAE;1-phosphatidylinositol phosphodiesterase (EC 4.6.1.13) (Phosphatidylinositol diacylglycerol-lyase) (Phosphatidylinositol-specific phospholipase C) (PI-PLC);"extracellular region [GO:0005576]; phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"GO:0004436; GO:0005576; GO:0008081; GO:0009405; GO:0016042";"lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";extracellular region [GO:0005576];"phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]"
comp149662_c1_seq1;GAXK01073191.1;Q99L90;5.20E-129;MCRS1_MOUSE;Microspherule protein 1 (58 kDa microspherule protein);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045944; GO:0046972; GO:0051974; GO:0071339; GO:1904357; GO:1904751";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]";"G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]"
comp149697_c2_seq1;GAXK01073116.1;Q6ETN3;1.13E-96;4CL3_ORYSJ;Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp1497297_c0_seq1;GAXK01104284.1;Q9ZR37;1.28E-21;DUS1_ARATH;Dual specificity protein phosphatase 1 (AtDsPTP1) (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005516; GO:0005634; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1497333_c0_seq1;GAXK01104278.1;Q16832;3.43E-09;DDR2_HUMAN;Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001503; GO:0001952; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007160; GO:0007165; GO:0007169; GO:0008284; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030154; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091; GO:1903053";"biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1497949_c0_seq1;GAXK01104300.1;P42282;2.47E-14;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1497983_c0_seq1;GAXK01104304.1;B3EYM8;1.12E-13;IABN_GEOSE;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp1498196_c0_seq1;GAXK01159011.1;Q6YCH2;4.42E-15;TDPZ4_MOUSE;TD and POZ domain-containing protein 4;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp1498337_c0_seq1;GAXK01158991.1;Q8Q0U0;3.27E-23;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp14988_c0_seq1;GAXK01177971.1;Q6NZ22;2.30E-164;MET14_DANRE;N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14);"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]";"GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157; GO:0080009";"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]";"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";"mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]"
comp149883_c4_seq1;GAXK01073231.1;P46940;1.91E-52;IQGA1_HUMAN;Ras GTPase-activating-like protein IQGAP1 (p195);"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]";"GO:0001726; GO:0001817; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0016032; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0031234; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043539; GO:0044548; GO:0044877; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776";"cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]";"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]";"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"
comp1498921_c0_seq1;GAXK01159004.1;Q6P1L6;6.98E-26;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1499_c2_seq1;GAXK01168228.1;P19039;2.70E-40;EF1A_APIME;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp1499157_c0_seq1;GAXK01158994.1;P08442;3.35E-13;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp1499736_c0_seq1;GAXK01159009.1;P17326;2.18E-09;AT1A_ARTSF;Sodium/potassium-transporting ATPase subunit alpha-A (Na(+)/K(+) ATPase alpha-A subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp1499850_c0_seq1;GAXK01159012.1;Q9UKP5;8.60E-97;ATS6_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]";"GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976";"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp15_c0_seq1;GAXK01169648.1;Q962Q6;1.21E-33;RS24_SPOFR;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1500317_c0_seq1;GAXK01019863.1;Q7Z0G7;2.61E-57;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1500585_c0_seq1;GAXK01019859.1;Q9NTW7;1.24E-09;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1501_c0_seq1;GAXK01169092.1;Q7ZWA3;1.42E-09;RBMX_DANRE;RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"GO:0000381; GO:0000398; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005719; GO:0006366; GO:0006509; GO:0007275; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347";"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]";"chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp150120_c0_seq1;GAXK01029337.1;B7PXE3;1.40E-121;SPAST_IXOSC;Spastin (EC 5.6.1.1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]";"GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0016021; GO:0016853; GO:0016887; GO:0031117; GO:0031122; GO:0034214; GO:0051013";"cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp15013_c1_seq1;GAXK01178002.1;Q9DCG9;1.27E-40;TR112_MOUSE;Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog);"nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488]";"GO:0005654; GO:0008276; GO:0016435; GO:0018364; GO:0030488; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234";"peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488]";"nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]"
comp150135_c0_seq1;GAXK01029370.1;Q9PVG3;2.41E-18;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp150154_c5_seq1;GAXK01029541.1;Q9V6X7;1.95E-143;OFUT1_DROME;GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1);"endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]";"GO:0005112; GO:0005783; GO:0006004; GO:0006493; GO:0007219; GO:0008417; GO:0016266; GO:0045747; GO:0045807; GO:0046922";"fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]";endoplasmic reticulum [GO:0005783];"fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]"
comp150168_c0_seq1;GAXK01029339.1;A2AQW0;3.07E-19;M3K15_MOUSE;Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15);"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]";"GO:0000186; GO:0004672; GO:0004709; GO:0005524; GO:0046872";activation of MAPKK activity [GO:0000186];;"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]"
comp150176_c1_seq1;GAXK01029512.1;O14512;3.99E-48;SOCS7_HUMAN;Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4);"cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935";"intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]";"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]"
comp1502_c0_seq1;GAXK01168775.1;Q9CQ69;1.18E-09;QCR8_MOUSE;Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C);"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]";"GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901";"cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]";"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]";ubiquinol-cytochrome-c reductase activity [GO:0008121]
comp1502043_c0_seq1;GAXK01054941.1;Q8VIG3;1.54E-19;RSPH1_MOUSE;Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein);"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]";"GO:0000794; GO:0001520; GO:0005737; GO:0007286; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687";"axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]";"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]";
comp15022_c2_seq1;GAXK01177900.1;A4IHB9;3.60E-77;SL9B2_XENTR;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]";"GO:0005886; GO:0010008; GO:0015385; GO:0016021; GO:0030054; GO:0030317; GO:0030672; GO:0031966";flagellated sperm motility [GO:0030317];"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";sodium:proton antiporter activity [GO:0015385]
comp1502340_c0_seq1;GAXK01054972.1;Q7KRI2;2.65E-09;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1502361_c0_seq1;GAXK01054940.1;O95466;1.95E-10;FMNL1_HUMAN;Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin);"bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; actin filament severing [GO:0051014]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"GO:0005522; GO:0005829; GO:0005886; GO:0005938; GO:0006929; GO:0008360; GO:0016020; GO:0030866; GO:0032059; GO:0032794; GO:0045335; GO:0048365; GO:0051014; GO:0051015; GO:0070062";"actin filament severing [GO:0051014]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]"
comp1502465_c0_seq1;GAXK01054968.1;P23607;1.21E-08;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1502542_c0_seq1;GAXK01054938.1;O76360;3.74E-21;EGL4_CAEEL;cGMP-dependent protein kinase egl-4 (EC 2.7.11.12) (Egg-laying defective protein 4);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0004691; GO:0004692; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0006935; GO:0007165; GO:0007635; GO:0008286; GO:0008340; GO:0008355; GO:0010468; GO:0010753; GO:0010754; GO:0018105; GO:0030308; GO:0030431; GO:0030512; GO:0030536; GO:0030553; GO:0040014; GO:0040015; GO:0042542; GO:0043577; GO:0046621; GO:0046662; GO:0046872; GO:0050849; GO:0050913; GO:0050921; GO:0051343; GO:0061067; GO:0070482; GO:1901046; GO:1902160; GO:1903998; GO:1905959; GO:1990335; GO:1990834";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]"
comp150266_c0_seq1;GAXK01029389.1;Q2S3D8;3.38E-15;MOAC_SALRD;Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C);"cyclic pyranopterin monophosphate synthase activity [GO:0061799]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]";"GO:0006777; GO:0061799";Mo-molybdopterin cofactor biosynthetic process [GO:0006777];;cyclic pyranopterin monophosphate synthase activity [GO:0061799]
comp15028_c1_seq1;GAXK01177811.1;Q8AVK1;6.47E-29;TI13B_XENLA;Mitochondrial import inner membrane translocase subunit Tim13-B;"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321]";"GO:0005743; GO:0005758; GO:0046872; GO:0072321";chaperone-mediated protein transport [GO:0072321];"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]";metal ion binding [GO:0046872]
comp150286_c1_seq1;GAXK01029378.1;Q05481;2.26E-37;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1502868_c0_seq1;GAXK01054935.1;O54689;1.93E-09;CCR6_MOUSE;C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (KY411) (CD antigen CD196);"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524]; sperm principal piece [GO:0097228]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine binding [GO:0019956]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; DN2 thymocyte differentiation [GO:1904155]; DN3 thymocyte differentiation [GO:1904156]; immune response [GO:0006955]; isotype switching to IgA isotypes [GO:0048290]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration [GO:0072676]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; regulation of T cell migration [GO:2000404]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679]";"GO:0002523; GO:0006935; GO:0006955; GO:0007204; GO:0009897; GO:0009986; GO:0010634; GO:0016021; GO:0016493; GO:0019722; GO:0019956; GO:0019957; GO:0036126; GO:0048290; GO:0060326; GO:0060474; GO:0072676; GO:0072678; GO:0072679; GO:0097225; GO:0097228; GO:0097524; GO:1904155; GO:1904156; GO:2000404; GO:2000510";"calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; DN2 thymocyte differentiation [GO:1904155]; DN3 thymocyte differentiation [GO:1904156]; immune response [GO:0006955]; isotype switching to IgA isotypes [GO:0048290]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration [GO:0072676]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; regulation of T cell migration [GO:2000404]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679]";"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524]; sperm principal piece [GO:0097228]";"C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine binding [GO:0019956]"
comp1502952_c0_seq1;GAXK01054947.1;B4F6U4;8.40E-09;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp150301_c2_seq1;GAXK01029292.1;Q68DY1;6.96E-46;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1503394_c0_seq1;GAXK01054945.1;P36609;4.92E-17;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1503597_c0_seq1;GAXK01054956.1;Q0VFX8;5.62E-13;CRIP2_BOVIN;Cysteine-rich protein 2 (CRP-2);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1503948_c0_seq1;GAXK01054966.1;Q92597;8.93E-63;NDRG1_HUMAN;Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42);"cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005913; GO:0007165; GO:0008017; GO:0008285; GO:0010038; GO:0015630; GO:0017137; GO:0030330; GO:0032287; GO:0042981; GO:0043015; GO:0045296; GO:0045576; GO:0048471; GO:0055038; GO:0070062; GO:0071456; GO:0098978; GO:0099173";"cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]";"cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]"
comp15040_c2_seq1;GAXK01179256.1;P51572;1.49E-26;BAP31_HUMAN;B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28);"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cisterna membrane [GO:0032580]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum [GO:0097038]; MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; apoptotic process [GO:0006915]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein localization to endoplasmic reticulum exit site [GO:0070973]; spermatogenesis [GO:0007283]; viral process [GO:0016032]";"GO:0002474; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0005887; GO:0006886; GO:0006888; GO:0006915; GO:0007204; GO:0007283; GO:0016020; GO:0016032; GO:0030136; GO:0032471; GO:0032580; GO:0033116; GO:0035584; GO:0042288; GO:0043280; GO:0044877; GO:0051561; GO:0070973; GO:0071556; GO:0097038; GO:1903071; GO:1904154; GO:2001244";"antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; apoptotic process [GO:0006915]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein localization to endoplasmic reticulum exit site [GO:0070973]; spermatogenesis [GO:0007283]; viral process [GO:0016032]";"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum [GO:0097038]";"MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877]"
comp1504067_c0_seq1;GAXK01186804.1;Q8AYA4;3.05E-07;SLB1_DEIAC;Snaclec agglucetin subunit beta-1;"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp1504146_c0_seq1;GAXK01186806.1;Q575T0;9.05E-13;CYGB1_ORYLA;Cytoglobin-1;"cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037";;cytoplasm [GO:0005737];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp15042_c1_seq1;GAXK01177929.1;Q9W3T5;4.11E-12;SMIM4_DROME;Small integral membrane protein 4;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1504594_c0_seq1;GAXK01186832.1;O43312;1.32E-30;MTSS1_HUMAN;Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]";"actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp1504600_c0_seq1;GAXK01186830.1;Q1XG89;2.44E-09;TDR12_BOMMO;Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (RNA helicase-like protein) (Tudor domain-containing protein 12) (BmTdrd12);"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; P granule [GO:0043186]; PET complex [GO:1990923]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003676; GO:0003724; GO:0005524; GO:0005694; GO:0005829; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0031965; GO:0043186; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; PET complex [GO:1990923]; P granule [GO:0043186]";"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp150463_c0_seq1;GAXK01029410.1;Q3SZU0;4.25E-07;GTSF1_BOVIN;Gametocyte-specific factor 1 (Protein FAM112B);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";cytoplasm [GO:0005737];metal ion binding [GO:0046872]
comp150484_c0_seq1;GAXK01029544.1;Q8BGY4;7.63E-71;KLH26_MOUSE;Kelch-like protein 26;;;;;
comp1504958_c0_seq1;GAXK01186821.1;B4QBN3;4.83E-151;TRE12_DROSI;Facilitated trehalose transporter Tret1-2 homolog;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015771; GO:0016021; GO:0022857";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp1505289_c0_seq1;GAXK01186811.1;P00920;6.36E-65;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp1505574_c0_seq1;GAXK01186828.1;P80561;4.34E-08;APX_STRGG;Aminopeptidase S (EC 3.4.11.24) (API) (SGAP);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004177; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp150558_c0_seq1;GAXK01029492.1;O15118;1.47E-36;NPC1_HUMAN;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp15058_c2_seq1;GAXK01179244.1;Q24133;6.41E-112;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp1505837_c0_seq1;GAXK01186820.1;P06604;2.65E-43;TBA2_DROME;Tubulin alpha-2 chain;"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005876; GO:0005881; GO:0007017; GO:0009826";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]";"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp150591_c0_seq1;GAXK01029374.1;Q6P4R8;2.90E-52;NFRKB_HUMAN;Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G);"Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]";"GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006366; GO:0006954; GO:0016579; GO:0031011";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]";"Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protease binding [GO:0002020]"
comp1506062_c0_seq1;GAXK01128660.1;Q9HAE3;2.26E-57;EFCB1_HUMAN;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp15061_c1_seq1;GAXK01178262.1;P11387;0;TOP1_HUMAN;DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I);"DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032]";"GO:0000932; GO:0000978; GO:0001650; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0009330; GO:0012501; GO:0016032; GO:0016310; GO:0018105; GO:0019904; GO:0031298; GO:0032922; GO:0032993; GO:0040016; GO:0042493; GO:0043204; GO:0097100";"chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032]";"DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]"
comp1506122_c0_seq1;GAXK01128661.1;Q9XGL4;5.42E-56;RL31_CYAPA;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1506275_c0_seq1;GAXK01128663.1;Q96IR2;6.95E-30;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15063_c0_seq1;GAXK01178433.1;Q12874;0;SF3A3_HUMAN;Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]";"GO:0000375; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241";"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]";"RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1506324_c0_seq1;GAXK01128692.1;Q12797;7.05E-28;ASPH_HUMAN;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]"
comp150634_c0_seq1;GAXK01029438.1;Q24573;1.19E-66;DRI_DROME;Protein dead ringer (Protein retained);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of female receptivity [GO:0045924]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]";"GO:0000122; GO:0000976; GO:0000977; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0007411; GO:0007431; GO:0007435; GO:0007517; GO:0008049; GO:0009880; GO:0009952; GO:0042063; GO:0045893; GO:0045924; GO:0048477; GO:0048813; GO:0070491";"anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of female receptivity [GO:0045924]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1506438_c1_seq1;GAXK01128685.1;Q14108;8.81E-17;SCRB2_HUMAN;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]";"GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005548; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0030666; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671";"aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]";"clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp150644_c0_seq1;GAXK01029376.1;Q9V0D5;1.66E-52;MDH_PYRAB;Malate dehydrogenase (EC 1.1.1.37);"cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]";"GO:0005737; GO:0006099; GO:0030060";tricarboxylic acid cycle [GO:0006099];cytoplasm [GO:0005737];L-malate dehydrogenase activity [GO:0030060]
comp1506483_c0_seq1;GAXK01128691.1;Q7T103;3.61E-20;P5F11_XENLA;POU domain, class 5, transcription factor 1.1 (POU class V protein oct-25) (XOct-25);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; gastrulation [GO:0007369]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]";"GO:0003700; GO:0005634; GO:0005667; GO:0007369; GO:0008134; GO:0030514; GO:0032926; GO:0043565; GO:0044212; GO:0045605; GO:0045892; GO:0045893; GO:0046332; GO:0050767";"gastrulation [GO:0007369]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1506512_c0_seq1;GAXK01128686.1;Q3B7N9;3.42E-12;MYNN_BOVIN;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1506693_c0_seq1;GAXK01128668.1;Q9NJP2;4.10E-13;NACH_DROVI;Sodium channel protein Nach (Fragment);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp1507268_c0_seq1;GAXK01128681.1;O15403;7.58E-23;MOT7_HUMAN;Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020";monocarboxylic acid transport [GO:0015718];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp150743_c0_seq1;GAXK01029514.1;Q09621;2.09E-36;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp150745_c1_seq1;GAXK01029515.1;Q8MUJ1;4.45E-12;EIGER_DROME;"Protein eiger [Cleaved into: Protein eiger, membrane form; Protein eiger, soluble form]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006955; GO:0007254; GO:0014009; GO:0032813; GO:0035006; GO:0043652; GO:0044214; GO:0045087; GO:0045167; GO:0045176; GO:0050829; GO:0070050; GO:0097191; GO:1900074; GO:1904058";"apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]";"cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]"
comp1507511_c0_seq1;GAXK01128689.1;D3JZP7;8.82E-09;HTP1_SAPPC;RxLR effector protein Htp1 (Host targeting protein 1);"extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]";"GO:0005576; GO:0009405; GO:0043657";pathogenesis [GO:0009405];"extracellular region [GO:0005576]; host cell [GO:0043657]";
comp15077_c0_seq1;GAXK01179090.1;Q2EN76;3.49E-74;NDKB_PIG;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0003677; GO:0004550; GO:0004673; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0009142; GO:0030027; GO:0045893; GO:0045944; GO:0046872; GO:0051880; GO:0071944";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]"
comp150770_c0_seq1;GAXK01029368.1;P46782;6.20E-58;RS5_HUMAN;40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000028; GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005654; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006450; GO:0006614; GO:0016020; GO:0019083; GO:0019843; GO:0022627; GO:0070062; GO:1990904";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1507767_c0_seq1;GAXK01128664.1;D4AK17;1.71E-08;PLCX1_ARTBC;PI-PLC X domain-containing protein 1;"extracellular region [GO:0005576]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"GO:0005576; GO:0007165; GO:0008081; GO:0016042";"lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";extracellular region [GO:0005576];phosphoric diester hydrolase activity [GO:0008081]
comp1507847_c0_seq1;GAXK01128665.1;Q23TC8;2.25E-43;RL21_TETTS;60S ribosomal protein L21;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp150790_c0_seq1;GAXK01029328.1;Q17QJ3;3.64E-19;DUS26_BOVIN;Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48);"Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]";"GO:0004725; GO:0005634; GO:0005794; GO:0008138";;"Golgi apparatus [GO:0005794]; nucleus [GO:0005634]";"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1508118_c0_seq1;GAXK01021749.1;P18735;1.60E-20;ZG7_XENLA;Gastrula zinc finger protein XlCGF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1508152_c0_seq1;GAXK01021737.1;Q8ITC7;2.90E-49;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp1508157_c0_seq1;GAXK01021748.1;P42282;2.78E-17;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1508605_c0_seq1;GAXK01021769.1;P34024;4.41E-13;PLC_LISMO;1-phosphatidylinositol phosphodiesterase (EC 4.6.1.13) (Phosphatidylinositol diacylglycerol-lyase) (Phosphatidylinositol-specific phospholipase C) (PI-PLC);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"GO:0004436; GO:0005576; GO:0005737; GO:0008081; GO:0009405; GO:0016042";"lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]"
comp15087_c0_seq1;GAXK01177921.1;Q95RA8;8.83E-138;MOB1_DROME;MOB kinase activator-like 1 (Mob as tumor suppressor protein 1) (Dmob1) (Mps one binder kinase activator-like 1);"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165]";"GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0007059; GO:0007165; GO:0007275; GO:0008283; GO:0019901; GO:0030295; GO:0030707; GO:0035329; GO:0046872";"apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165]";"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]"
comp150873_c0_seq1;GAXK01029399.1;Q9VZI3;0;UN112_DROME;Unc-112-related protein (Fermitin-1);"cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]";"GO:0005737; GO:0007160; GO:0007229; GO:0048738; GO:0050829; GO:0050839";"cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]";cytoplasm [GO:0005737];cell adhesion molecule binding [GO:0050839]
comp1509_c0_seq1;GAXK01165997.1;Q28IU1;1.61E-79;DHB12_XENTR;Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342";"estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]"
comp1509096_c0_seq1;GAXK01021763.1;P70031;8.79E-40;CCKAR_XENLA;Cholecystokinin receptor (CCK-XLR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp150921_c0_seq1;GAXK01029382.1;P13002;3.60E-32;ELF1_DROME;Protein grainyhead (DNA-binding protein ELF-1) (Element I-binding activity) (Protein grainy-head) (Transcription factor NTF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";"GO:0003382; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007402; GO:0007419; GO:0007424; GO:0007426; GO:0007464; GO:0008362; GO:0008543; GO:0035159; GO:0040003; GO:0042052; GO:0042127; GO:0042803; GO:0043565; GO:0045944; GO:0050767; GO:0061024; GO:0061041";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp1509292_c0_seq1;GAXK01021752.1;Q52KB5;3.31E-07;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp15093_c0_seq1;GAXK01178591.1;P08760;2.66E-85;KAD3_BOVIN;GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]";"GO:0004017; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0006172; GO:0046033; GO:0046039; GO:0046041; GO:0046899";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]"
comp15095_c1_seq1;GAXK01178170.1;Q5ZK10;8.03E-77;NSF1C_CHICK;NSFL1 cofactor p47 (p97 cofactor p47);"cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000045; GO:0000132; GO:0005654; GO:0005795; GO:0005815; GO:0005829; GO:0005886; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0045111; GO:0046604; GO:0061025; GO:1904780";"autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"lipid binding [GO:0008289]; ubiquitin binding [GO:0043130]"
comp1509652_c0_seq1;GAXK01021776.1;Q9BI40;1.30E-09;GATC_CAEEL;Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]";"GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp150970_c2_seq1;GAXK01029488.1;P26358;1.69E-09;DNMT1_HUMAN;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]";"GO:0000122; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006325; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010424; GO:0010628; GO:0010629; GO:0016458; GO:0043045; GO:0045814; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1904707; GO:1905460; GO:1905931; GO:1990841";"cellular response to amino acid stimulus [GO:0071230]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]";"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp150972_c1_seq1;GAXK01029500.1;Q09621;1.88E-41;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1509798_c0_seq1;GAXK01021743.1;Q640N2;2.67E-48;AR13B_MOUSE;ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein hennin);"axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]";"GO:0001947; GO:0005525; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]";"axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]";GTP binding [GO:0005525]
comp150995_c2_seq1;GAXK01029421.1;Q9EPX5;1.01E-10;FXL12_MOUSE;F-box/LRR-repeat protein 12 (F-box and leucine-rich repeat protein 12) (F-box protein FBL12);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; G2/M transition of mitotic cell cycle [GO:0000086]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0051726";"G2/M transition of mitotic cell cycle [GO:0000086]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";
comp151_c0_seq1;GAXK01168978.1;P46222;6.01E-111;RL11_DROME;60S ribosomal protein L11;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1510504_c0_seq1;GAXK01116627.1;P21797;2.37E-33;TNNC1_BALNU;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp151057_c0_seq1;GAXK01029379.1;O18405;2.98E-13;SURF4_DROME;Surfeit locus protein 4 homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0012505; GO:0016021; GO:0045169";;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";
comp1510704_c0_seq1;GAXK01116618.1;P93748;2.47E-08;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp151072_c1_seq1;GAXK01029400.1;Q9VZW5;1.94E-26;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1511_c5_seq1;GAXK01170080.1;B9RAJ0;5.06E-151;DNPEP_RICCO;Probable aspartyl aminopeptidase (EC 3.4.11.21);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]";"GO:0004177; GO:0005737; GO:0008237; GO:0008270";;cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp151103_c0_seq1;GAXK01029477.1;O35114;1.02E-18;SCRB2_MOUSE;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp151123_c1_seq1;GAXK01029470.1;Q5XHM7;1.64E-17;CHSTC_XENLA;Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0016021; GO:0016051; GO:0047756";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";chondroitin 4-sulfotransferase activity [GO:0047756]
comp15113_c0_seq1;GAXK01178756.1;Q147X3;1.31E-86;NAA30_HUMAN;N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]";"GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417";N-terminal peptidyl-methionine acetylation [GO:0017196];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]";peptide alpha-N-acetyltransferase activity [GO:0004596]
comp1511334_c0_seq1;GAXK01116622.1;Q7WHJ0;5.54E-10;ECTD_BORBR;Ectoine dioxygenase (EC 1.14.11.55) (Ectoine hydroxylase);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; ectoine catabolic process [GO:0042400]";"GO:0005506; GO:0016706; GO:0042400";ectoine catabolic process [GO:0042400];;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]"
comp1511379_c0_seq1;GAXK01116602.1;Q9Y115;3.33E-24;UN93L_DROME;UNC93-like protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120";"regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";potassium channel regulator activity [GO:0015459]
comp151141_c0_seq1;GAXK01029461.1;Q7Z6K4;3.02E-16;NRARP_HUMAN;Notch-regulated ankyrin repeat-containing protein;"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";"GO:0000122; GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:1902367";"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";;
comp151145_c0_seq1;GAXK01029423.1;Q9HBF4;0;ZFYV1_HUMAN;Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1);"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]";"GO:0000407; GO:0005545; GO:0005547; GO:0005776; GO:0005783; GO:0005795; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:1990462";"cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]";"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]";"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; zinc ion binding [GO:0008270]"
comp1511475_c0_seq1;GAXK01116600.1;Q01842;2.03E-08;POK_DROME;Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000980; GO:0000981; GO:0001012; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090175; GO:1903688; GO:2000051";"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp1511506_c0_seq1;GAXK01116621.1;P17970;1.45E-123;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp15116_c1_seq1;GAXK01178442.1;Q24093;7.50E-61;ABHD2_DROME;Abhydrolase domain-containing protein 2 (EC 3.1.1.-);"integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]";"GO:0006629; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524";"acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]";"integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]";"acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]"
comp1511759_c0_seq1;GAXK01116591.1;P50757;8.74E-09;MMP2_RABIT;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) [Cleaved into: PEX];"extracellular matrix [GO:0031012]; membrane [GO:0016020]; nucleus [GO:0005634]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]";"GO:0001525; GO:0004222; GO:0005634; GO:0008270; GO:0016020; GO:0030574; GO:0031012";"angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]";"extracellular matrix [GO:0031012]; membrane [GO:0016020]; nucleus [GO:0005634]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1512275_c0_seq1;GAXK01136179.1;P83088;3.87E-40;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp1512534_c0_seq1;GAXK01136169.1;Q23F79;3.86E-47;RL26_TETTS;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp1512813_c0_seq1;GAXK01136185.1;P30531;9.74E-19;SC6A1_HUMAN;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp151307_c0_seq1;GAXK01029425.1;Q9QZS7;2.27E-114;NPHN_MOUSE;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0000165; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015";"cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp151320_c0_seq1;GAXK01029440.1;O70472;0;TM131_MOUSE;Transmembrane protein 131 (Protein RW1);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1513269_c0_seq1;GAXK01136194.1;Q5LWJ5;1.34E-08;DNAJ_RUEPO;Chaperone protein DnaJ;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082";"DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp1513406_c0_seq1;GAXK01136173.1;Q13106;4.00E-21;ZN154_HUMAN;Zinc finger protein 154;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1513484_c0_seq1;GAXK01136175.1;P35779;5.29E-42;VA3_SOLRI;Venom allergen 3 (Allergen Sol r III) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol r 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp15136_c2_seq1;GAXK01178394.1;P11733;3.03E-08;CU07_LOCMI;Cuticle protein 7 (LM-ACP 7) (LM-7);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1514240_c0_seq1;GAXK01012339.1;Q9BDB7;3.80E-07;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp151434_c0_seq1;GAXK01029441.1;Q8C8Y5;9.06E-08;SAMD7_MOUSE;Sterile alpha motif domain-containing protein 7 (SAM domain-containing protein 7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of gene expression [GO:0010629]";"GO:0005634; GO:0005737; GO:0010629";negative regulation of gene expression [GO:0010629];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp151458_c0_seq1;GAXK01029390.1;Q9NHP7;3.11E-64;TF2B_DROVI;Transcription initiation factor IIB (General transcription factor TFIIB);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; TBP-class protein binding [GO:0017025]; regulation of transcription, DNA-templated [GO:0006355]; transcription preinitiation complex assembly [GO:0070897]";"GO:0005634; GO:0006355; GO:0017025; GO:0046872; GO:0070897";"regulation of transcription, DNA-templated [GO:0006355]; transcription preinitiation complex assembly [GO:0070897]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; TBP-class protein binding [GO:0017025]"
comp15147_c0_seq1;GAXK01179161.1;Q24276;2.81E-113;CDC37_DROME;Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (Protein enhancer of sevenless 3B);"cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; unfolded protein binding [GO:0051082]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005737; GO:0006457; GO:0007059; GO:0007275; GO:0019901; GO:0030296; GO:0031072; GO:0035556; GO:0050821; GO:0051082; GO:0051087; GO:0051301; GO:0051321; GO:0070374";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";cytoplasm [GO:0005737];"chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; unfolded protein binding [GO:0051082]"
comp1515004_c0_seq1;GAXK01012317.1;Q9XSR1;4.14E-07;ZN252_CANLF;Zinc finger protein 252;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1515238_c0_seq1;GAXK01012319.1;P97292;5.90E-21;HRH2_MOUSE;Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004930; GO:0004969; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998";"chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
comp151531_c1_seq1;GAXK01029385.1;O76082;2.29E-68;S22A5_HUMAN;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0005886; GO:0006814; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0015893; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0052106; GO:0060731; GO:0070062; GO:0070715; GO:1902603";"carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp151548_c0_seq1;GAXK01029411.1;D4A1F2;4.78E-145;MICA2_RAT;[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";"GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp151568_c0_seq1;GAXK01029398.1;Q0P5C0;0;LMF1_BOVIN;Lipase maturation factor 1 (Transmembrane protein 112);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein maturation [GO:0051604]; triglyceride metabolic process [GO:0006641]";"GO:0005789; GO:0006641; GO:0016021; GO:0051604";"protein maturation [GO:0051604]; triglyceride metabolic process [GO:0006641]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp151572_c2_seq2;GAXK01029495.1;Q9VLV7;1.12E-13;SPZ3_DROME;Protein spaetzle 3 (Protein spatzle 3);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp151583_c2_seq1;GAXK01029478.1;Q8L5J1;6.45E-19;MAN4_SOLLC;Mannan endo-1,4-beta-mannosidase 4 (EC 3.2.1.78) (Beta-mannanase 4) (Endo-beta-1,4-mannanase 4) (LeMAN4a) (LeMAN4i);"extracellular region [GO:0005576]; mannan endo-1,4-beta-mannosidase activity [GO:0016985]; mannan catabolic process [GO:0046355]";"GO:0005576; GO:0016985; GO:0046355";mannan catabolic process [GO:0046355];extracellular region [GO:0005576];mannan endo-1,4-beta-mannosidase activity [GO:0016985]
comp1516019_c0_seq1;GAXK01035265.1;Q0EEE2;3.68E-17;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp151647_c0_seq1;GAXK01029295.1;P51815;1.99E-14;ZN75D_HUMAN;Zinc finger protein 75D (Zinc finger protein 75) (Zinc finger protein 82);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp1516525_c0_seq1;GAXK01035258.1;Q6J329;1.23E-11;S2547_RAT;Solute carrier family 25 member 47 (Hepatocellular carcinoma down-regulated mitochondrial carrier homolog);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; acyl carnitine transmembrane transporter activity [GO:0015227]; acyl carnitine transport [GO:0006844]";"GO:0005743; GO:0006844; GO:0015227; GO:0016021";acyl carnitine transport [GO:0006844];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp1516601_c0_seq1;GAXK01035255.1;H9GBX2;4.98E-30;SCNNA_ANOCA;Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);"acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; multicellular organismal water homeostasis [GO:0050891]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]";"GO:0001669; GO:0005737; GO:0005887; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725; GO:0050699; GO:0050891; GO:0055078; GO:0060170; GO:0070062";"multicellular organismal water homeostasis [GO:0050891]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]";"acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]";"ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]"
comp1516767_c0_seq1;GAXK01035220.1;P0C6Y7;4.73E-19;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp151713_c1_seq1;GAXK01029401.1;Q6DJT9;1.36E-60;PLAG1_HUMAN;Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0045944; GO:0046872; GO:0060252; GO:0060736";"gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1517154_c0_seq1;GAXK01035243.1;Q6DEW6;5.04E-09;REXO4_XENTR;RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein);"nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364]";"GO:0000726; GO:0000737; GO:0000738; GO:0003676; GO:0004527; GO:0005634; GO:0006364; GO:0008408; GO:0045944";"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364]";nucleus [GO:0005634];"3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]"
comp1517167_c0_seq1;GAXK01035224.1;Q9DBI0;1.40E-30;TMPS6_MOUSE;Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016021; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264";"cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp151721_c3_seq1;GAXK01029436.1;E6ZIJ1;2.60E-83;HOIL1_DICLA;RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog);"LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein linear polyubiquitination [GO:0097039]";"GO:0016740; GO:0043123; GO:0043130; GO:0046872; GO:0071797; GO:0097039";"positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein linear polyubiquitination [GO:0097039]";LUBAC complex [GO:0071797];"metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]"
comp1517722_c0_seq1;GAXK01035230.1;Q9VR07;1.44E-50;INE_DROME;Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891";"glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]"
comp1517733_c0_seq1;GAXK01035233.1;O76217;2.38E-09;PE1_ANOGA;Peritrophin-1 (AgAper-1) (Peritrophic matrix protein 1) (Peritrophin A);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];chitin binding [GO:0008061]
comp1517862_c0_seq1;GAXK01035263.1;Q9GPJ1;5.85E-12;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp1517886_c0_seq1;GAXK01035253.1;B0WC46;8.05E-22;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp151792_c1_seq1;GAXK01029369.1;Q8C8M1;4.39E-53;SHCAF_MOUSE;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp1517956_c1_seq1;GAXK01035219.1;B4F753;4.91E-10;ABD12_XENTR;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0016021; GO:0046464; GO:0047372; GO:0052651";"acylglycerol catabolic process [GO:0046464]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp151802_c0_seq1;GAXK01029299.1;O94892;3.99E-14;ZN432_HUMAN;Zinc finger protein 432;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1518030_c0_seq1;GAXK01029594.1;P02707;5.11E-09;LECH_CHICK;Hepatic lectin;"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]";"GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];integral component of membrane [GO:0016021];carbohydrate binding [GO:0030246]
comp1518125_c0_seq1;GAXK01029602.1;G5ED00;1.75E-14;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1518590_c0_seq1;GAXK01029604.1;Q9JMH9;3.31E-11;MY18A_MOUSE;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]"
comp151924_c1_seq1;GAXK01029298.1;Q9UGU0;9.79E-13;TCF20_HUMAN;Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016604; GO:0044212; GO:0045944; GO:0046872";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp151946_c0_seq1;GAXK01029384.1;P02595;1.26E-14;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp15197_c2_seq1;GAXK01178327.1;Q8JI28;7.20E-07;TLL1_XENLA;Tolloid-like protein 1 (EC 3.4.24.-) (Metalloprotease xolloid-like) (Xenopus tolloid-like protein 1) (Xlr);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1519812_c0_seq1;GAXK01029611.1;Q5G267;3.87E-17;NETR_MACMU;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp152035_c0_seq1;GAXK01135929.1;Q6PF93;9.35E-136;PK3C3_MOUSE;Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3);"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]";"GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0006468; GO:0006497; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0009267; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035004; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0045335; GO:0046854; GO:0048015; GO:0050708; GO:0051301";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]";"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]";"1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; protein kinase activity [GO:0004672]"
comp152068_c0_seq1;GAXK01135775.1;Q16983;1.01E-65;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp152080_c0_seq1;GAXK01135755.1;Q8BGN2;3.12E-38;CD033_MOUSE;UPF0462 protein C4orf33 homolog;;;;;
comp1520931_c0_seq1;GAXK01090801.1;Q9NPF2;2.47E-27;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp1520992_c0_seq1;GAXK01090805.1;P51993;6.95E-38;FUT6_HUMAN;Alpha-(1,3)-fucosyltransferase 6 (EC 2.4.1.65) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase);"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"GO:0005794; GO:0006486; GO:0006672; GO:0008417; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0042355; GO:0046920; GO:0070062";"ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp1521_c0_seq1;GAXK01168367.1;Q9YHT1;0;SDHA_CHICK;Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp);"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; plasma membrane succinate dehydrogenase complex [GO:0045282]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0045282; GO:0050660";"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; plasma membrane succinate dehydrogenase complex [GO:0045282]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]"
comp152103_c9_seq1;GAXK01135558.1;Q01063;3.60E-100;PDE4D_MOUSE;cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3);"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]";"GO:0002027; GO:0004115; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0006939; GO:0007568; GO:0008144; GO:0010880; GO:0016324; GO:0030552; GO:0030593; GO:0031965; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0050852; GO:0050900; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071872; GO:0086004; GO:0097110; GO:1901844; GO:1901898";"aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]";"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]";"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]"
comp1521117_c0_seq1;GAXK01090769.1;Q9H305;7.10E-12;CDIP1_HUMAN;Cell death-inducing p53-target protein 1 (Cell death involved p53-target) (Cell death-inducing protein) (LITAF-like protein) (Lipopolysaccharide-induced tumor necrosis factor-alpha-like protein) (Transmembrane protein I1);"cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0005634; GO:0006915; GO:0033209; GO:0042771; GO:0046872; GO:0098560; GO:0098574";"apoptotic process [GO:0006915]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp1521437_c0_seq1;GAXK01090772.1;O46040;7.87E-26;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp15217_c0_seq1;GAXK01178382.1;D4A734;1.50E-31;MOT12_RAT;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1521822_c0_seq1;GAXK01090779.1;Q80V53;2.36E-16;CHSTE_MOUSE;Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0050655";"carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp1521893_c0_seq1;GAXK01090781.1;O02235;1.40E-12;NHR89_CAEEL;Nuclear hormone receptor family member nhr-89;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1521956_c0_seq1;GAXK01090785.1;Q02525;2.42E-13;ZFP39_MOUSE;Zinc finger protein 39 (Zfp-39) (CtFIN33);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp152198_c1_seq1;GAXK01135722.1;Q9FT97;9.76E-76;AGAL1_ARATH;Alpha-galactosidase 1 (AtAGAL1) (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase 1) (Melibiase 1);"apoplast [GO:0048046]; cell wall [GO:0005618]; plant-type cell wall [GO:0009505]; secretory vesicle [GO:0099503]; raffinose alpha-galactosidase activity [GO:0052692]; carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]";"GO:0005618; GO:0005975; GO:0009505; GO:0048046; GO:0052692; GO:0071555; GO:0099503";"carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]";"apoplast [GO:0048046]; cell wall [GO:0005618]; plant-type cell wall [GO:0009505]; secretory vesicle [GO:0099503]";raffinose alpha-galactosidase activity [GO:0052692]
comp15222_c1_seq1;GAXK01178020.1;Q03001;0;DYST_HUMAN;Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein);"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]";"GO:0000226; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031122; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115";"cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]";"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; H zone [GO:0031673]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]"
comp152228_c0_seq1;GAXK01135843.1;Q8WXR4;4.93E-131;MYO3B_HUMAN;Myosin-IIIb (EC 2.7.11.1);"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0003774; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103";"cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]"
comp15223_c0_seq1;GAXK01178389.1;Q6NV26;0;SDA1_DANRE;Protein SDA1 homolog (SDA1 domain-containing protein 1);"nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]";"GO:0000055; GO:0005634; GO:0005730; GO:0030036; GO:0042273";"actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp152265_c0_seq1;GAXK01205804.1;P56523;4.26E-96;CLR3_SCHPO;Histone deacetylase clr3 (EC 3.5.1.98) (Cryptic loci regulator 3);"chromosome, telomeric region [GO:0000781]; mating-type region heterochromatin [GO:0031934]; nuclear chromatin [GO:0000790]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; nucleolar chromatin [GO:0030874]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]; SHREC complex [GO:0070824]; SHREC2 complex [GO:0110129]; histone deacetylase activity [GO:0004407]; histone deacetylase activity (H3-K14 specific) [GO:0031078]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; chromatin organization [GO:0006325]; chromatin silencing at centromere [GO:0030702]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at silent mating-type cassette [GO:0030466]; chromatin silencing at telomere [GO:0006348]; chromatin silencing by small RNA [GO:0031048]; histone deacetylation [GO:0016575]; histone H3-K14 acetylation [GO:0044154]; maintenance of chromatin silencing at silent mating-type cassette [GO:0035391]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]";"GO:0000122; GO:0000183; GO:0000781; GO:0000790; GO:0004407; GO:0005634; GO:0006325; GO:0006348; GO:0016575; GO:0016584; GO:0030466; GO:0030702; GO:0030874; GO:0031048; GO:0031078; GO:0031618; GO:0031934; GO:0032041; GO:0033553; GO:0035391; GO:0044154; GO:0070824; GO:0110129; GO:1990707";"chromatin organization [GO:0006325]; chromatin silencing at centromere [GO:0030702]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at silent mating-type cassette [GO:0030466]; chromatin silencing at telomere [GO:0006348]; chromatin silencing by small RNA [GO:0031048]; histone deacetylation [GO:0016575]; histone H3-K14 acetylation [GO:0044154]; maintenance of chromatin silencing at silent mating-type cassette [GO:0035391]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]";"chromosome, telomeric region [GO:0000781]; mating-type region heterochromatin [GO:0031934]; nuclear chromatin [GO:0000790]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; nucleolar chromatin [GO:0030874]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]; SHREC2 complex [GO:0110129]; SHREC complex [GO:0070824]";"histone deacetylase activity [GO:0004407]; histone deacetylase activity (H3-K14 specific) [GO:0031078]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]"
comp1522713_c0_seq1;GAXK01045176.1;Q9VZW5;1.76E-23;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1522852_c0_seq1;GAXK01045154.1;Q9D4B2;1.51E-17;TTC25_MOUSE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp1522943_c0_seq1;GAXK01045179.1;Q99PV0;2.02E-48;PRP8_MOUSE;Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000386; GO:0000398; GO:0005634; GO:0005682; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157";"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]"
comp152296_c0_seq1;GAXK01135756.1;Q9Y2M2;1.14E-41;SSUH2_HUMAN;Protein SSUH2 homolog (Protein ssu-2 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; odontogenesis [GO:0042476]";"GO:0005634; GO:0005737; GO:0042476";odontogenesis [GO:0042476];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1523054_c0_seq1;GAXK01045158.1;Q9NR64;1.44E-09;KLHL1_HUMAN;Kelch-like protein 1;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]";"GO:0003779; GO:0005737; GO:0005856; GO:0007628; GO:0016358; GO:0021680; GO:0030036; GO:0030425; GO:0043025";"actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]";actin binding [GO:0003779]
comp152319_c1_seq1;GAXK01135690.1;Q91W36;3.46E-128;UBP3_MOUSE;Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000122; GO:0000278; GO:0000790; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0008270; GO:0016578; GO:0031647; GO:0036464; GO:0042393; GO:0090543; GO:1990841";"DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]"
comp152357_c0_seq1;GAXK01135769.1;Q5U3Q6;2.29E-45;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp152371_c0_seq1;GAXK01135515.1;Q6ING7;1.63E-139;FLAD1_XENLA;"FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region]";"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; FAD biosynthetic process [GO:0006747]";"GO:0003919; GO:0005524; GO:0005737; GO:0006747";FAD biosynthetic process [GO:0006747];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]"
comp1524_c0_seq1;GAXK01168699.1;Q02370;2.65E-29;NDUA2_BOVIN;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit);"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"GO:0005747; GO:0031966; GO:0032981; GO:0055114";"mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]";
comp15240_c0_seq1;GAXK01179248.1;Q80U96;0;XPO1_RAT;Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog);"annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]";"GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0034504; GO:0042176; GO:0042493; GO:0046825; GO:0051028; GO:1990904";"mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]";"annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]"
comp1524170_c0_seq1;GAXK01009408.1;Q7Z0G7;3.77E-63;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1524463_c0_seq1;GAXK01009405.1;Q96BA8;9.56E-13;CR3L1_HUMAN;Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; SMAD binding [GO:0046332]; transcription regulatory region DNA binding [GO:0044212]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; multicellular organism development [GO:0007275]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]";"GO:0000790; GO:0000981; GO:0001227; GO:0001228; GO:0001649; GO:0003682; GO:0005634; GO:0005783; GO:0005789; GO:0007275; GO:0010629; GO:0016020; GO:0016021; GO:0030968; GO:0032967; GO:0035497; GO:0040037; GO:0044212; GO:0045892; GO:0046332; GO:0070278; GO:1902236; GO:1903671; GO:1990440";"endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; multicellular organism development [GO:0007275]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; SMAD binding [GO:0046332]; transcription regulatory region DNA binding [GO:0044212]"
comp152457_c0_seq1;GAXK01135829.1;P18715;4.12E-28;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp152469_c2_seq1;GAXK01135880.1;Q9VGY5;6.71E-28;MET15_DROME;Probable methyltransferase-like protein 15 homolog (EC 2.1.1.-);"rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475]";"GO:0070475; GO:0071424";rRNA base methylation [GO:0070475];;rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]
comp152510_c0_seq1;GAXK01135513.1;Q9QZB1;6.78E-35;RGS20_MOUSE;Regulator of G-protein signaling 20 (RGS20) (Regulator of G-protein signaling Z1);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]";"GO:0005096; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0007186; GO:0009968; GO:0016020";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]";GTPase activator activity [GO:0005096]
comp152553_c0_seq1;GAXK01135831.1;Q8T6L5;3.87E-13;TPM_PERFU;Tropomyosin;;;;;
comp1525669_c0_seq1;GAXK01009404.1;P35500;1.61E-55;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp152571_c0_seq1;GAXK01135771.1;Q86TJ5;4.20E-15;ZN554_HUMAN;Zinc finger protein 554;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1525949_c0_seq1;GAXK01009413.1;Q8N184;4.08E-18;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15261_c1_seq1;GAXK01178105.1;Q96JC9;6.29E-24;EAF1_HUMAN;ELL-associated factor 1;"Cajal body [GO:0015030]; ELL-EAF complex [GO:0032783]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0008023; GO:0015030; GO:0016604; GO:0016607; GO:0032783; GO:0043231; GO:0045171";"regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"Cajal body [GO:0015030]; ELL-EAF complex [GO:0032783]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]";
comp15263_c0_seq1;GAXK01178272.1;Q6DFJ3;3.12E-13;FUD1B_XENLA;FUN14 domain-containing protein 1B;"integral component of mitochondrial outer membrane [GO:0031307]; autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]";"GO:0000422; GO:0001666; GO:0031307";"autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]";integral component of mitochondrial outer membrane [GO:0031307];
comp1526514_c0_seq1;GAXK01004780.1;Q6ZQW0;1.13E-75;I23O2_HUMAN;Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0002376; GO:0004833; GO:0005737; GO:0005829; GO:0006569; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872";"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]"
comp1526922_c0_seq1;GAXK01004798.1;Q2IBC2;1.15E-25;CAV2_RHIFE;Caveolin-2;"caveola [GO:0005901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; D1 dopamine receptor binding [GO:0031748]; caveola assembly [GO:0070836]; endoplasmic reticulum organization [GO:0007029]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; skeletal muscle fiber development [GO:0048741]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000139; GO:0001937; GO:0005634; GO:0005901; GO:0006906; GO:0007005; GO:0007029; GO:0031234; GO:0031748; GO:0048278; GO:0048471; GO:0048741; GO:0060161; GO:0070836";"caveola assembly [GO:0070836]; endoplasmic reticulum organization [GO:0007029]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; skeletal muscle fiber development [GO:0048741]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"caveola [GO:0005901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";D1 dopamine receptor binding [GO:0031748]
comp1527317_c0_seq1;GAXK01004768.1;P36609;1.18E-41;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp152735_c0_seq1;GAXK01135900.1;Q6UB98;7.14E-12;ANR12_HUMAN;Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp1527361_c0_seq1;GAXK01004793.1;O00482;1.92E-13;NR5A2_HUMAN;Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell differentiation [GO:0030855]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000790; GO:0000976; GO:0000978; GO:0000980; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0003707; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0030855; GO:0042127; GO:0042592; GO:0042632; GO:0043565; GO:0044212; GO:0045070; GO:0045893; GO:0045944; GO:0061113; GO:0090575; GO:0097720; GO:1990830";"bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell differentiation [GO:0030855]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp1527460_c0_seq1;GAXK01004785.1;Q28824;8.74E-33;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp15276_c0_seq1;GAXK01177997.1;P42325;1.88E-14;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp15277_c0_seq1;GAXK01178053.1;Q08012;3.99E-127;DRK_DROME;Protein enhancer of sevenless 2B (Protein E(sev)2B) (Downstream of receptor kinase) (SH2-SH3 adapter protein drk);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; sevenless binding [GO:0005118]; SH3/SH2 adaptor activity [GO:0005070]; associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001784; GO:0005070; GO:0005118; GO:0005154; GO:0005654; GO:0005737; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007465; GO:0007476; GO:0007614; GO:0008293; GO:0008306; GO:0008355; GO:0008543; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:1904263";"associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; sevenless binding [GO:0005118]; SH3/SH2 adaptor activity [GO:0005070]"
comp15278_c0_seq1;GAXK01204967.1;Q9CPU4;2.08E-30;MGST3_MOUSE;Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0043231";"leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]"
comp1527856_c0_seq1;GAXK01004767.1;O04036;1.42E-15;ERD6_ARATH;Sugar transporter ERD6 (Early-responsive to dehydration protein 6) (Sugar transporter-like protein 1);"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]; sugar transmembrane transporter activity [GO:0051119]; response to abscisic acid [GO:0009737]; response to chitin [GO:0010200]; response to cold [GO:0009409]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"GO:0005351; GO:0005783; GO:0005887; GO:0009409; GO:0009414; GO:0009651; GO:0009737; GO:0010200; GO:0051119";"response to abscisic acid [GO:0009737]; response to chitin [GO:0010200]; response to cold [GO:0009409]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]";"carbohydrate:proton symporter activity [GO:0005351]; sugar transmembrane transporter activity [GO:0051119]"
comp1528670_c0_seq1;GAXK01005150.1;Q8I6K0;1.65E-41;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp15288_c0_seq1;GAXK01177966.1;P45974;1.16E-99;UBP5_HUMAN;Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5);"cytosol [GO:0005829]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0036459; GO:0043130; GO:0071108";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; lysosome [GO:0005764]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp15290_c3_seq1;GAXK01177934.1;Q9UMS4;0;PRP19_HUMAN;Pre-mRNA-processing factor 19 (EC 2.3.2.27) (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (hPso4) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neuron differentiation [GO:0045666]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000209; GO:0000244; GO:0000245; GO:0000349; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005811; GO:0005819; GO:0006283; GO:0006303; GO:0008610; GO:0010498; GO:0016020; GO:0016607; GO:0034450; GO:0034613; GO:0035861; GO:0042802; GO:0045666; GO:0048026; GO:0048711; GO:0061630; GO:0070534; GO:0071006; GO:0071007; GO:0071013; GO:0072422";"cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neuron differentiation [GO:0045666]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]; transcription-coupled nucleotide-excision repair [GO:0006283]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]";"identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]"
comp1529200_c0_seq1;GAXK01005140.1;Q78JN3;2.61E-24;ECI3_MOUSE;Enoyl-CoA delta isomerase 3, peroxisomal (EC 5.3.3.8) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase);"peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]";"GO:0000062; GO:0004165; GO:0005777; GO:0006635";fatty acid beta-oxidation [GO:0006635];peroxisome [GO:0005777];"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]"
comp15293_c0_seq1;GAXK01177972.1;Q5ZHN3;4.49E-148;WIPI2_CHICK;WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2);"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0061739; GO:0080025; GO:0098792";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]";"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp152937_c1_seq1;GAXK01135886.1;Q8IZ81;8.99E-85;ELMD2_HUMAN;ELMO domain-containing protein 2;"membrane [GO:0016020]; GTPase activator activity [GO:0005096]; defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]";"GO:0005096; GO:0016020; GO:0050688; GO:0051607";"defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]";membrane [GO:0016020];GTPase activator activity [GO:0005096]
comp1529451_c0_seq1;GAXK01005149.1;Q7Z0G7;9.36E-47;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1529655_c0_seq1;GAXK01005137.1;Q8SWR3;6.09E-28;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp1529749_c0_seq1;GAXK01005122.1;P05661;2.41E-122;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp153_c0_seq1;GAXK01168184.1;Q24251;3.29E-17;ATP5H_DROME;ATP synthase subunit d, mitochondrial (ATPase subunit d);"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]";"GO:0000274; GO:0000276; GO:0005739; GO:0006979; GO:0008340; GO:0015078; GO:0015986; GO:0032007; GO:0046034; GO:0051881; GO:0070373; GO:1902600";"ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]";"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";proton transmembrane transporter activity [GO:0015078]
comp153000_c0_seq1;GAXK01135830.1;P27816;2.74E-24;MAP4_HUMAN;Microtubule-associated protein 4 (MAP-4);"axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]";"GO:0000226; GO:0003723; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0007052; GO:0008017; GO:0014069; GO:0015630; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856";"cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]";"axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]"
comp15301_c1_seq1;GAXK01177802.1;Q1L987;4.12E-45;ATPF1_DANRE;ATP synthase mitochondrial F1 complex assembly factor 1;"mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]";"GO:0005739; GO:0033615";mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615];mitochondrion [GO:0005739];
comp153022_c0_seq1;GAXK01135723.1;Q9H165;3.79E-37;BC11A_HUMAN;B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173";"cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1530263_c0_seq1;GAXK01137833.1;P09871;1.12E-14;C1S_HUMAN;"Complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain]";"blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]";"GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006956; GO:0006958; GO:0030449; GO:0042802; GO:0045087; GO:0072562";"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]";"blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]"
comp153036_c6_seq1;GAXK01135738.1;A8BQB4;0;GDE_HORSE;"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]";"cytoplasm [GO:0005737]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]";"GO:0004134; GO:0004135; GO:0005737; GO:0005978; GO:0005980; GO:0102500";"glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]";cytoplasm [GO:0005737];"4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]"
comp153117_c1_seq1;GAXK01135883.1;Q41142;3.49E-174;PLDA1_RICCO;Phospholipase D alpha 1 (PLD 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1);"endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; plastid [GO:0009536]; vacuole [GO:0005773]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004630; GO:0005509; GO:0005773; GO:0005783; GO:0005886; GO:0009536; GO:0016042; GO:0046470; GO:0070290";"lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; plastid [GO:0009536]; vacuole [GO:0005773]";"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]"
comp153119_c4_seq1;GAXK01135765.1;Q54LN4;5.64E-53;GGHA_DICDI;Gamma-glutamyl hydrolase A (EC 3.4.19.9) (Conjugase A) (GH A) (Gamma-Glu-X carboxypeptidase A);"cell wall [GO:0005618]; extracellular space [GO:0005615]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"GO:0005615; GO:0005618; GO:0005773; GO:0008242; GO:0034722; GO:0046900";tetrahydrofolylpolyglutamate metabolic process [GO:0046900];"cell wall [GO:0005618]; extracellular space [GO:0005615]; vacuole [GO:0005773]";"gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]"
comp1531202_c0_seq1;GAXK01137845.1;P49258;2.07E-07;CALL_DROME;Calmodulin-related protein 97A (Protein androcam);"cytoplasm [GO:0005737]; investment cone [GO:0070865]; myosin VI complex [GO:0031476]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; myosin VI head/neck binding [GO:0070855]; actin filament-based movement [GO:0030048]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005634; GO:0005737; GO:0019722; GO:0030048; GO:0031476; GO:0070855; GO:0070865";"actin filament-based movement [GO:0030048]; calcium-mediated signaling [GO:0019722]";"cytoplasm [GO:0005737]; investment cone [GO:0070865]; myosin VI complex [GO:0031476]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; myosin VI head/neck binding [GO:0070855]"
comp1531236_c0_seq1;GAXK01137816.1;P48180;3.55E-121;ACH1_CAEEL;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1531287_c0_seq1;GAXK01137829.1;P23342;6.62E-09;MSOX_BACSN;Monomeric sarcosine oxidase (MSOX) (EC 1.5.3.1);"cytoplasm [GO:0005737]; sarcosine oxidase activity [GO:0008115]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005737; GO:0008115; GO:0046653";tetrahydrofolate metabolic process [GO:0046653];cytoplasm [GO:0005737];sarcosine oxidase activity [GO:0008115]
comp1531530_c0_seq1;GAXK01137835.1;Q10469;2.89E-07;MGAT2_HUMAN;Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0000139; GO:0005794; GO:0005795; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803";"oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"
comp153161_c2_seq1;GAXK01135698.1;Q09YN8;2.75E-59;TES_RABIT;Testin;"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]";"GO:0005737; GO:0005925; GO:0008270; GO:0008285";negative regulation of cell population proliferation [GO:0008285];"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]";zinc ion binding [GO:0008270]
comp15317_c0_seq1;GAXK01177805.1;Q11011;0;PSA_MOUSE;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp153170_c2_seq1;GAXK01135597.1;Q95LI3;7.91E-24;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15319_c2_seq1;GAXK01177871.1;P35035;2.69E-47;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1531901_c0_seq1;GAXK01137839.1;Q86GF7;4.01E-29;CRUST_PANBO;Crustapain (EC 3.4.22.-) (NsCys);"extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";"GO:0005576; GO:0007586; GO:0008234; GO:0030163; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";extracellular region [GO:0005576];cysteine-type peptidase activity [GO:0008234]
comp15320_c0_seq1;GAXK01177996.1;Q15582;4.80E-58;BGH3_HUMAN;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0044267; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]"
comp153224_c3_seq1;GAXK01135593.1;P54281;3.20E-96;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp153261_c1_seq1;GAXK01135762.1;F1MN90;4.52E-13;CIDEC_BOVIN;Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0034389; GO:0097194";"execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";
comp1532853_c0_seq1;GAXK01127213.1;Q96SZ4;3.63E-13;ZSC10_HUMAN;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; somatic stem cell population maintenance [GO:0035019]";"GO:0003700; GO:0005634; GO:0005654; GO:0035019; GO:0043565; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1533_c0_seq1;GAXK01169311.1;P62312;4.47E-48;LSM6_HUMAN;U6 snRNA-associated Sm-like protein LSm6;"cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]";"GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005829; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0043928; GO:0046540; GO:0071005; GO:0120115";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]";"cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";RNA binding [GO:0003723]
comp15333_c0_seq1;GAXK01177899.1;O44119;4.73E-20;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp1533519_c0_seq1;GAXK01127218.1;P15442;2.26E-22;GCN2_YEAST;eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (General control non-derepressible protein 2) (Serine/threonine-protein kinase GCN2);"cytosolic ribosome [GO:0022626]; large ribosomal subunit [GO:0015934]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to histidine [GO:0071232]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; chronological cell aging [GO:0001300]; DNA damage checkpoint [GO:0000077]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of cellular response to amino acid starvation [GO:1903833]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"GO:0000049; GO:0000077; GO:0001300; GO:0003725; GO:0004672; GO:0004694; GO:0005524; GO:0006412; GO:0006446; GO:0006468; GO:0015934; GO:0015935; GO:0016239; GO:0022626; GO:0031369; GO:0034198; GO:0042788; GO:0042803; GO:0043022; GO:0043023; GO:0043621; GO:0046777; GO:0060733; GO:0070301; GO:0071232; GO:0071264; GO:0072755; GO:0100002; GO:1903833; GO:1904262; GO:1990451";"cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to histidine [GO:0071232]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; chronological cell aging [GO:0001300]; DNA damage checkpoint [GO:0000077]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of cellular response to amino acid starvation [GO:1903833]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"cytosolic ribosome [GO:0022626]; large ribosomal subunit [GO:0015934]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]";"ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]; tRNA binding [GO:0000049]"
comp15337_c0_seq1;GAXK01179173.1;Q803V5;1.23E-155;LST8_DANRE;Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog);"cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]";"GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956";"regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]";
comp1533741_c0_seq1;GAXK01127215.1;P24044;2.55E-12;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1533970_c0_seq1;GAXK01127214.1;Q8C0X2;2.46E-25;SL9B1_MOUSE;Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9 subfamily B member 1) (Testis specific sodium-hydrogen exchanger) (MtsNHE);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0016021; GO:0030317; GO:0051453; GO:0097228";"flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]";solute:proton antiporter activity [GO:0015299]
comp1533977_c0_seq1;GAXK01127219.1;Q7TS63;8.49E-10;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1533990_c0_seq1;GAXK01127199.1;Q8R151;0;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1534012_c0_seq1;GAXK01155293.1;D4ACX8;3.09E-30;PCD16_RAT;Protocadherin-16 (Protein dachsous homolog 1);"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]";"GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016021; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102";"branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]";"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp153406_c11_seq1;GAXK01135814.1;O02485;1.02E-50;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp153408_c0_seq1;GAXK01135803.1;P36609;5.35E-29;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp15342_c1_seq1;GAXK01178279.1;P53395;1.71E-171;ODB2_MOUSE;Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase);"cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]";"GO:0005737; GO:0005739; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754";;"cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]";"acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]"
comp153456_c0_seq1;GAXK01135675.1;Q13148;2.10E-56;TADBP_HUMAN;TAR DNA-binding protein 43 (TDP-43);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"GO:0000980; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003727; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0070935; GO:0071765; GO:1990904";"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]";"DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]"
comp15348_c1_seq1;GAXK01178280.1;O60671;3.33E-92;RAD1_HUMAN;Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein);"checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]";"GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479; GO:1901796";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]";"checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]"
comp1535_c0_seq1;GAXK01169418.1;Q1HPS0;6.26E-29;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp153505_c1_seq1;GAXK01135874.1;Q9CXE0;3.64E-12;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1535158_c0_seq1;GAXK01155296.1;Q96Q07;1.91E-07;BTBD9_HUMAN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";"GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050951; GO:0060586; GO:1900242";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";;
comp1535252_c0_seq1;GAXK01155288.1;P0DPW5;7.44E-07;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp153526_c0_seq1;GAXK01135724.1;Q96G03;0;PGM2_HUMAN;Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]";"GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006098; GO:0008973; GO:0019388; GO:0034774; GO:0043312; GO:0046386; GO:0070062; GO:1904813";"deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]";"magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]"
comp1535367_c0_seq1;GAXK01155286.1;A9ZSY2;1.60E-09;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1535706_c0_seq1;GAXK01155287.1;Q5R8K2;3.44E-52;CSTF1_PONAB;Cleavage stimulation factor subunit 1 (Cleavage stimulation factor 50 kDa subunit) (CSTF 50 kDa subunit) (CstF-50);"nucleus [GO:0005634]; mRNA processing [GO:0006397]";"GO:0005634; GO:0006397";mRNA processing [GO:0006397];nucleus [GO:0005634];
comp1535865_c0_seq1;GAXK01155297.1;P28682;1.38E-16;OPSB_CHICK;Blue-sensitive opsin (Blue cone photoreceptor pigment);"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; absorption of visible light [GO:0016038]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0001750; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016038; GO:0018298; GO:0071482";"absorption of visible light [GO:0016038]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]";G protein-coupled photoreceptor activity [GO:0008020]
comp1535957_c0_seq1;GAXK01155292.1;Q5ZKW5;1.10E-27;AR2BP_CHICK;ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein);"cilium [GO:0005929]; microtubule organizing center [GO:0005815]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription coactivator activity [GO:0003713]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]";"GO:0003713; GO:0005634; GO:0005758; GO:0005815; GO:0005819; GO:0005929; GO:0042531; GO:0051457";"maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]";"cilium [GO:0005929]; microtubule organizing center [GO:0005815]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; spindle [GO:0005819]";transcription coactivator activity [GO:0003713]
comp1536_c0_seq1;GAXK01166582.1;Q93104;1.10E-62;ERH_AEDAE;Enhancer of rudimentary homolog;cell cycle [GO:0007049];GO:0007049;cell cycle [GO:0007049];;
comp1536092_c0_seq1;GAXK01027133.1;A7Y7X5;5.96E-12;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1536182_c0_seq1;GAXK01027160.1;Q9CR40;9.65E-29;KLH28_MOUSE;Kelch-like protein 28 (BTB/POZ domain-containing protein 5);;;;;
comp153626_c0_seq1;GAXK01135717.1;Q8MJ50;1.82E-34;OSTF1_BOVIN;Osteoclast-stimulating factor 1;"cytoplasm [GO:0005737]; SH3 domain binding [GO:0017124]";"GO:0005737; GO:0017124";;cytoplasm [GO:0005737];SH3 domain binding [GO:0017124]
comp153668_c2_seq1;GAXK01135642.1;Q8K370;0;ACD10_MOUSE;Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-);"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]";"GO:0005739; GO:0016627; GO:0016787; GO:0050660";;mitochondrion [GO:0005739];"flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp1536840_c0_seq1;GAXK01027171.1;Q9FT72;1.09E-11;RQL3_ARATH;ATP-dependent DNA helicase Q-like 3 (EC 3.6.4.12) (RecQ-like protein 3) (AtRecQ3) (AtRecQl3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138; GO:0046872";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]"
comp1537_c0_seq1;GAXK01168256.1;P29845;1.26E-74;HSP7E_DROME;Heat shock 70 kDa protein cognate 5;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; autophagy of mitochondrion [GO:0000422]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mitochondrion morphogenesis [GO:0070584]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0000422; GO:0005524; GO:0005737; GO:0005739; GO:0006457; GO:0006986; GO:0010918; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070584";"autophagy of mitochondrion [GO:0000422]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mitochondrion morphogenesis [GO:0070584]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp15372_c0_seq1;GAXK01177799.1;Q26516;1.35E-63;PPIE_SCHJA;Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Rotamase E) (Fragment);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp1537393_c0_seq1;GAXK01027149.1;P38040;1.09E-15;GBG1_DROME;Guanine nucleotide-binding protein subunit gamma-1;"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343";"apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]"
comp1537583_c0_seq1;GAXK01027132.1;A2AN08;4.32E-07;UBR4_MOUSE;E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Zinc finger UBR1-type protein 1) (p600);"centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016021";ubiquitin-dependent protein catabolic process [GO:0006511];"centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";"calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1537610_c0_seq1;GAXK01027163.1;P19579;1.47E-16;CAPA_BACAN;Capsule biosynthesis protein CapA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; capsule polysaccharide biosynthetic process [GO:0045227]; pathogenesis [GO:0009405]";"GO:0005886; GO:0009405; GO:0016021; GO:0045227";"capsule polysaccharide biosynthetic process [GO:0045227]; pathogenesis [GO:0009405]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1537656_c0_seq1;GAXK01027164.1;P50429;8.61E-45;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp153779_c0_seq1;GAXK01135867.1;Q9W261;5.17E-82;RTF1_DROME;RNA polymerase-associated protein Rtf1 (dRtf1);"Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; histone H3-K4 methylation [GO:0051568]; Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003677; GO:0005634; GO:0007219; GO:0016593; GO:0035327; GO:0042800; GO:0045893; GO:0051568; GO:0051571; GO:1990269";"histone H3-K4 methylation [GO:0051568]; Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]";"Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]"
comp1537932_c0_seq1;GAXK01027165.1;Q29RM3;7.83E-23;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp1538187_c0_seq1;GAXK01061488.1;P16374;2.90E-12;ZFP60_MOUSE;Zinc finger protein 60 (Zfp-60) (Zinc finger protein Mfg-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15387_c0_seq1;GAXK01178062.1;Q5R5H4;5.54E-67;PARL_PONAB;Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005634; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";serine-type endopeptidase activity [GO:0004252]
comp153888_c3_seq1;GAXK01135689.1;Q5R9S8;2.48E-71;TMM43_PONAB;Transmembrane protein 43 (Protein LUMA);"endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; protein self-association [GO:0043621]; nuclear membrane organization [GO:0071763]";"GO:0005639; GO:0005788; GO:0005794; GO:0043621; GO:0071763";nuclear membrane organization [GO:0071763];"endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]";protein self-association [GO:0043621]
comp153891_c3_seq1;GAXK01135594.1;Q09990;3.29E-14;LIN23_CAEEL;F-box/WD repeat-containing protein lin-23 (Abnormal cell lineage protein 23);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007049; GO:0008013; GO:0008285; GO:0010826; GO:0019902; GO:0031647; GO:0046983; GO:0048812; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]"
comp1539149_c0_seq1;GAXK01061485.1;Q8N157;8.91E-124;AHI1_HUMAN;Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1);"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]";"GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097711; GO:0097730";"cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]";"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]";identical protein binding [GO:0042802]
comp15392_c0_seq1;GAXK01177957.1;Q6AX45;3.56E-52;VPS25_XENLA;Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25);"ESCRT II complex [GO:0000814]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]";"GO:0000814; GO:0015031; GO:0071985";"multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]";ESCRT II complex [GO:0000814];
comp153937_c0_seq1;GAXK01135842.1;A3KGF7;0;PLCB2_MOUSE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2) (PLC-beta-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]; sensory perception of bitter taste [GO:0050913]";"GO:0001580; GO:0004435; GO:0004629; GO:0005509; GO:0005543; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007200; GO:0016042; GO:0031680; GO:0031683; GO:0032959; GO:0048015; GO:0050913; GO:0051209";"detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]; sensory perception of bitter taste [GO:0050913]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; G-protein beta/gamma-subunit complex [GO:0031680]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]"
comp15396_c5_seq1;GAXK01178504.1;Q9W4M9;0;NSUN2_DROME;tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (NOP2/Sun domain family member 2 ortholog);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]";"GO:0000049; GO:0001510; GO:0005634; GO:0005730; GO:0005737; GO:0007614; GO:0008168; GO:0016428; GO:0030488";"RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]"
comp153968_c0_seq1;GAXK01135763.1;Q49AA0;1.10E-08;ZFP69_HUMAN;Zinc finger protein 69 homolog (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15398_c0_seq1;GAXK01178185.1;Q9Y2S2;9.43E-103;CRYL1_HUMAN;Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]";"GO:0003857; GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403";"fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]"
comp153985_c0_seq1;GAXK01135601.1;Q01295;1.10E-21;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp153993_c1_seq1;GAXK01135901.1;Q96JC1;0;VPS39_HUMAN;Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p);"AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192]";"GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016192; GO:0030123; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126";"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192]";"AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";
comp154_c1_seq1;GAXK01168682.1;Q01519;3.64E-27;COX12_YEAST;Cytochrome c oxidase subunit 6B (EC 1.9.3.1) (Cytochrome c oxidase polypeptide VIb);"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; oxidative phosphorylation [GO:0006119]";"GO:0004129; GO:0005739; GO:0005751; GO:0005758; GO:0006119; GO:0033617";"mitochondrial respiratory chain complex IV assembly [GO:0033617]; oxidative phosphorylation [GO:0006119]";"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";cytochrome-c oxidase activity [GO:0004129]
comp154002_c1_seq1;GAXK01150658.1;Q18163;2.95E-24;DDRA_CAEEL;Discoidin domain-containing receptor A;"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"GO:0004672; GO:0005524; GO:0005886; GO:0008045; GO:0016021; GO:0030424; GO:0043204; GO:0048680";"motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp154018_c0_seq1;GAXK01150553.1;Q24046;3.13E-42;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp1540453_c0_seq1;GAXK01111288.1;Q622X0;4.52E-12;UNC58_CAEBR;Uncoordinated protein 58;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; parturition [GO:0007567]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0006936; GO:0007567; GO:0022841; GO:0030322; GO:0040011; GO:0071805";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; parturition [GO:0007567]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp154047_c0_seq1;GAXK01150563.1;P52189;3.59E-95;KCNJ4_MOUSE;Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0016021; GO:0016323; GO:0030054; GO:0030165; GO:0030425; GO:0030659; GO:0034765; GO:0043025; GO:0045211; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]";"inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165]"
comp1540482_c0_seq1;GAXK01111284.1;Q8NDX2;1.73E-101;VGLU3_HUMAN;Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8);"apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0003407; GO:0005313; GO:0005326; GO:0005771; GO:0005887; GO:0006811; GO:0006814; GO:0007420; GO:0007605; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043204; GO:0043679; GO:0050803; GO:0060076; GO:0090102; GO:0097440; GO:0097441; GO:0097451; GO:0098700; GO:1990030";"brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp15405_c2_seq1;GAXK01178101.1;P55853;2.16E-41;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp15406_c0_seq1;GAXK01178283.1;Q5R4Y2;2.39E-41;RANB3_PONAB;Ran-binding protein 3 (RanBP3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031]";"GO:0005634; GO:0005737; GO:0015031; GO:0046907";"intracellular transport [GO:0046907]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp154065_c5_seq1;GAXK01150807.1;Q6P1L6;3.51E-16;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1540722_c0_seq1;GAXK01111266.1;P30677;3.47E-102;GNA14_MOUSE;Guanine nucleotide-binding protein subunit alpha-14 (G alpha-14) (G-protein subunit alpha-14);"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0007188; GO:0031683; GO:0046872; GO:0060158";"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]";heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1540920_c0_seq1;GAXK01111271.1;Q945U1;9.11E-34;RS15_ELAOL;40S ribosomal protein S15;"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1541078_c0_seq1;GAXK01111252.1;O54963;5.05E-11;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1541201_c0_seq1;GAXK01111255.1;O94739;3.34E-26;CALM_PLEOS;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1541357_c0_seq1;GAXK01111270.1;P0DN66;8.03E-18;ACTP1_CINAN;Tereporin-Ca1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp1541484_c0_seq1;GAXK01111259.1;Q2JR73;3.15E-23;RS15_SYNJA;30S ribosomal protein S15;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1541663_c0_seq1;GAXK01111281.1;P22771;3.06E-08;GLRA2_RAT;Glycine receptor subunit alpha-2 (Glycine receptor strychnine-binding subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0007416; GO:0016594; GO:0016934; GO:0021510; GO:0022824; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]"
comp15420_c0_seq1;GAXK01178392.1;P81018;3.05E-13;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp154231_c2_seq1;GAXK01150742.1;Q8C8M1;1.50E-50;SHCAF_MOUSE;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp1542320_c0_seq1;GAXK01088439.1;O62621;1.36E-08;COPB2_DROME;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005198; GO:0005795; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0010883; GO:0030126";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]";structural molecule activity [GO:0005198]
comp15426_c0_seq1;GAXK01178706.1;Q1KKT4;1.01E-31;LNPA_TAKRU;Endoplasmic reticulum junction formation protein lunapark-A (ER junction formation factor lunapark);"endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; endoplasmic reticulum tubular network maintenance [GO:0071788]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]";"GO:0030176; GO:0042802; GO:0046872; GO:0071788; GO:0098826; GO:1903373";"endoplasmic reticulum tubular network maintenance [GO:0071788]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]";"endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp1542678_c0_seq1;GAXK01088447.1;Q5U239;1.43E-118;TM145_XENLA;Transmembrane protein 145;"integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]";"GO:0007186; GO:0016021; GO:0019236";"G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]";integral component of membrane [GO:0016021];
comp1542780_c0_seq1;GAXK01088434.1;P58659;6.56E-11;EVA1C_MOUSE;Protein eva-1 homolog C (Protein FAM176C);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]";"GO:0005576; GO:0005886; GO:0008201; GO:0016021; GO:0030246";;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]"
comp1542860_c0_seq1;GAXK01088433.1;A6NFI3;9.18E-16;ZN316_HUMAN;Zinc finger protein 316;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15429_c1_seq1;GAXK01179048.1;Q08E13;5.80E-82;RNF10_BOVIN;RING finger protein 10;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]";"GO:0004842; GO:0005634; GO:0005737; GO:0031643; GO:0044212; GO:0045944; GO:0046872; GO:0051865";"positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]"
comp1543_c0_seq1;GAXK01168522.1;Q7PKQ5;0;ACTN_ANOGA;Alpha-actinin, sarcomeric (F-actin cross-linking protein);"actin binding [GO:0003779]; calcium ion binding [GO:0005509]";"GO:0003779; GO:0005509";;;"actin binding [GO:0003779]; calcium ion binding [GO:0005509]"
comp1543291_c0_seq1;GAXK01088458.1;Q06455;8.43E-08;MTG8_HUMAN;Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2);"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; generation of precursor metabolites and energy [GO:0006091]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006091; GO:0016363; GO:0045599; GO:0045892; GO:0046872";"generation of precursor metabolites and energy [GO:0006091]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]";"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp1543458_c0_seq1;GAXK01088454.1;P29788;4.16E-35;VTNC_MOUSE;Vitronectin (VN) (S-protein) (Serum-spreading factor);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; rough endoplasmic reticulum lumen [GO:0048237]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; protein polymerization [GO:0051258]; smooth muscle cell-matrix adhesion [GO:0061302]";"GO:0005044; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005737; GO:0005783; GO:0005796; GO:0006955; GO:0007160; GO:0008201; GO:0008283; GO:0010811; GO:0010951; GO:0014911; GO:0016477; GO:0030198; GO:0030247; GO:0031012; GO:0032092; GO:0033627; GO:0035987; GO:0042802; GO:0043231; GO:0048237; GO:0048260; GO:0048709; GO:0050731; GO:0050840; GO:0051258; GO:0061302; GO:0062023; GO:0097421";"cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; protein polymerization [GO:0051258]; smooth muscle cell-matrix adhesion [GO:0061302]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; rough endoplasmic reticulum lumen [GO:0048237]";"collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp154379_c0_seq1;GAXK01150812.1;A8X765;3.76E-07;EGG1_CAEBR;LDL receptor repeat-containing protein egg-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"GO:0005886; GO:0007275; GO:0007338; GO:0016021";"multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1544_c1_seq1;GAXK01169451.1;O15992;2.89E-121;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp1544111_c0_seq1;GAXK01054424.1;P34568;3.56E-17;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp154426_c1_seq1;GAXK01150711.1;B0WC46;9.58E-09;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp154427_c0_seq1;GAXK01150537.1;E9PV86;7.91E-20;MCTP1_MOUSE;Multiple C2 and transmembrane domain-containing protein 1;"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"GO:0005509; GO:0005789; GO:0016021; GO:0030054; GO:0030336; GO:0030672; GO:0045806; GO:0055037; GO:1902883";"negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp154438_c0_seq1;GAXK01150728.1;Q9Y5Z4;6.10E-30;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp1544408_c0_seq1;GAXK01054449.1;Q9UEG4;3.56E-19;ZN629_HUMAN;Zinc finger protein 629 (Zinc finger protein 65);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp154455_c5_seq1;GAXK01150708.1;O43156;2.38E-19;TTI1_HUMAN;TELO2-interacting protein 1 homolog (Protein SMG10);"ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]";"GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209";regulation of TOR signaling [GO:0032006];"ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]";
comp1544967_c0_seq1;GAXK01054441.1;Q5MD89;6.82E-12;VGFR3_DANRE;Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1);"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; selective angioblast sprouting [GO:0035474]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; venous endothelial cell migration involved in lymph vessel development [GO:0060855]";"GO:0001525; GO:0001570; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0004714; GO:0005021; GO:0005524; GO:0005634; GO:0005737; GO:0005887; GO:0007169; GO:0008045; GO:0008284; GO:0014068; GO:0030947; GO:0035474; GO:0036303; GO:0036328; GO:0038084; GO:0038085; GO:0042803; GO:0043235; GO:0043410; GO:0046777; GO:0048010; GO:0060836; GO:0060841; GO:0060855; GO:0070374; GO:1900746";"angiogenesis [GO:0001525]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; selective angioblast sprouting [GO:0035474]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; venous endothelial cell migration involved in lymph vessel development [GO:0060855]";"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]; VEGF-C-activated receptor activity [GO:0036328]"
comp15450_c0_seq1;GAXK01178446.1;Q5RA77;0;COPD_PONAB;Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0006890; GO:0015031; GO:0030126";"protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]";
comp154519_c0_seq1;GAXK01150743.1;Q566L8;4.10E-66;MAT2B_XENTR;Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta);"methionine adenosyltransferase complex [GO:0048269]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0006556; GO:0006730; GO:0048269; GO:0048270";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";methionine adenosyltransferase complex [GO:0048269];methionine adenosyltransferase regulator activity [GO:0048270]
comp154553_c1_seq1;GAXK01150549.1;Q24595;2.25E-110;XPC_DROME;DNA repair protein complementing XP-C cells homolog (Mutagen-sensitive 209 protein) (XPCDM) (Xeroderma pigmentosum group C-complementing protein homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; meiotic mismatch repair involved in reciprocal meiotic recombination [GO:0010777]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]";"GO:0000111; GO:0003684; GO:0003697; GO:0005634; GO:0005737; GO:0005829; GO:0006289; GO:0006298; GO:0010777; GO:0071942";"meiotic mismatch repair involved in reciprocal meiotic recombination [GO:0010777]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; XPC complex [GO:0071942]";"damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]"
comp15456_c0_seq1;GAXK01179158.1;P94425;7.53E-07;YCNE_BACSU;Putative monooxygenase YcnE (EC 1.-.-.-);"monooxygenase activity [GO:0004497]; aromatic compound catabolic process [GO:0019439]; response to toxic substance [GO:0009636]";"GO:0004497; GO:0009636; GO:0019439";"aromatic compound catabolic process [GO:0019439]; response to toxic substance [GO:0009636]";;monooxygenase activity [GO:0004497]
comp1545640_c0_seq1;GAXK01054456.1;Q8TD57;0;DYH3_HUMAN;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp1545728_c0_seq1;GAXK01054423.1;Q5RAH1;4.65E-11;NCALD_PONAB;Neurocalcin-delta;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp154576_c0_seq1;GAXK01150755.1;Q68CP4;3.67E-100;HGNAT_HUMAN;Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821";"glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"
comp15460_c3_seq1;GAXK01179175.1;Q2KI54;0;ARMC8_BOVIN;Armadillo repeat-containing protein 8;"cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000151; GO:0005634; GO:0005737; GO:0034657; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";
comp154615_c0_seq1;GAXK01150536.1;P33450;0;FAT_DROME;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000904; GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008283; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0018149; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090176; GO:0090251; GO:0098609";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
comp1546162_c0_seq1;GAXK01090654.1;Q6NT16;1.19E-30;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp15469_c0_seq1;GAXK01178573.1;Q9UGU5;2.27E-23;HMGX4_HUMAN;HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG);"NURF complex [GO:0016589]; DNA binding [GO:0003677]; endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178";"endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";NURF complex [GO:0016589];DNA binding [GO:0003677]
comp154714_c9_seq1;GAXK01150777.1;Q6P7W0;2.22E-11;SENP6_MOUSE;Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234";"protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp154720_c1_seq1;GAXK01150709.1;Q3EC11;3.77E-64;ZDHC2_ARATH;Probable protein S-acyltransferase 23 (EC 2.3.1.225) (Probable palmitoyltransferase At2g14255) (Zinc finger DHHC domain-containing protein At2g14255);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp1547242_c0_seq1;GAXK01090634.1;Q54KA7;3.01E-31;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp154726_c0_seq1;GAXK01150830.1;Q6P9V9;5.56E-91;TBA1B_RAT;Tubulin alpha-1B chain (Alpha-tubulin 2) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain];"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; ubiquitin protein ligase binding [GO:0031625]; cellular response to interleukin-4 [GO:0071353]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0031625; GO:0045121; GO:0071353";"cellular response to interleukin-4 [GO:0071353]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]";"double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; ubiquitin protein ligase binding [GO:0031625]"
comp154765_c2_seq1;GAXK01150802.1;Q8MRC9;0;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp1547854_c1_seq1;GAXK01090643.1;Q0EEE2;6.52E-15;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp1547998_c0_seq1;GAXK01090657.1;Q6GM59;1.67E-11;MOT12_XENLA;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]";"GO:0005308; GO:0005887; GO:0015293; GO:0015881";creatine transmembrane transport [GO:0015881];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]"
comp154843_c0_seq1;GAXK01150550.1;Q5ZLY5;9.20E-57;PKHF2_CHICK;Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]"
comp1548577_c0_seq1;GAXK01070070.1;Q3ZCX4;2.89E-61;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp154862_c2_seq1;GAXK01150759.1;Q9VVH9;4.11E-75;SO74D_DROME;Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D);"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702";"ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";"active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]"
comp15487_c0_seq1;GAXK01177918.1;Q8SWX0;2.83E-18;ASTRX_DROME;Gametocyte-specific factor 1 homolog (Protein asterix);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; gene silencing by RNA [GO:0031047]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]";"GO:0005634; GO:0031047; GO:0045892; GO:0046872; GO:0048477";"gene silencing by RNA [GO:0031047]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]";nucleus [GO:0005634];metal ion binding [GO:0046872]
comp154890_c1_seq1;GAXK01150672.1;O97490;2.96E-105;TRFM_RABIT;Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]";"GO:0005615; GO:0005886; GO:0006811; GO:0031225; GO:0046872; GO:0055072";"ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp1548994_c0_seq1;GAXK01070060.1;O62640;4.21E-15;PIAP_PIG;Putative inhibitor of apoptosis;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]";"GO:0005634; GO:0005737; GO:0031398; GO:0043027; GO:0043154; GO:0046872; GO:0060546; GO:0061630; GO:1990001";"inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp1549192_c0_seq1;GAXK01070074.1;Q84MN0;2.72E-16;CML4_ORYSJ;Calmodulin-like protein 4;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp154921_c2_seq1;GAXK01150526.1;Q9V7S5;7.96E-93;PICO_DROME;Putative inorganic phosphate cotransporter;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0015114; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]"
comp154950_c0_seq1;GAXK01150801.1;Q9BUT9;4.21E-09;MCRI2_HUMAN;MAPK regulated corepressor interacting protein 2 (Protein FAM195A);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0010494";;"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";
comp154955_c0_seq1;GAXK01205827.1;A9ULZ2;4.60E-24;BIR7B_XENLA;Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B);"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";"GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865";"multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";cytoplasm [GO:0005737];"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp154982_c0_seq1;GAXK01150822.1;Q9Z2D6;1.07E-21;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp15499_c0_seq1;GAXK01178282.1;Q9WTK0;1.63E-11;NUPR1_MOUSE;Nuclear protein 1 (Protein p8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; acetyltransferase activator activity [GO:0010698]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; acute inflammatory response [GO:0002526]; cell population proliferation [GO:0008283]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein modification process [GO:0031401]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; regulation of autophagy [GO:0010506]; regulation of female gonad development [GO:2000194]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to toxic substance [GO:0009636]; skeletal muscle cell differentiation [GO:0035914]";"GO:0002526; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006473; GO:0008283; GO:0008285; GO:0008584; GO:0009636; GO:0010506; GO:0010507; GO:0010667; GO:0010698; GO:0031401; GO:0032993; GO:0035914; GO:0042771; GO:0043065; GO:0043066; GO:0043433; GO:0043525; GO:0045786; GO:0045820; GO:0048147; GO:0048471; GO:0050680; GO:0062099; GO:0065003; GO:0150078; GO:1901800; GO:1902902; GO:1903862; GO:1904036; GO:1904691; GO:1905897; GO:2000194; GO:2001244";"acute inflammatory response [GO:0002526]; cell population proliferation [GO:0008283]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein modification process [GO:0031401]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; regulation of autophagy [GO:0010506]; regulation of female gonad development [GO:2000194]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to toxic substance [GO:0009636]; skeletal muscle cell differentiation [GO:0035914]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]";"acetyltransferase activator activity [GO:0010698]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp154995_c1_seq1;GAXK01150557.1;D3YXG0;3.60E-28;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp155_c0_seq1;GAXK01168242.1;O75828;8.58E-32;CBR3_HUMAN;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Short chain dehydrogenase/reductase family 21C member 2);"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"GO:0000253; GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0042376; GO:0050890; GO:0070402";"cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]"
comp1550184_c0_seq1;GAXK01053585.1;Q9SLX0;1.51E-07;IMA1B_ORYSJ;Importin subunit alpha-1b;"cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]";"GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0048471; GO:0061608";NLS-bearing protein import into nucleus [GO:0006607];"cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]"
comp155029_c0_seq1;GAXK01150499.1;Q9ULJ7;4.67E-14;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp155033_c0_seq1;GAXK01150539.1;Q96QF7;5.37E-39;ACRC_HUMAN;Acidic repeat-containing protein (Germ cell nuclear antigen);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp1550343_c0_seq1;GAXK01053521.1;Q3U4G3;5.78E-29;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp15504_c0_seq1;GAXK01178268.1;Q0IHH9;1.06E-67;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp1550402_c0_seq1;GAXK01053568.1;Q4V348;6.02E-76;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp15505_c0_seq1;GAXK01178072.1;Q8R323;0;RFC3_MOUSE;Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38);"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]";"GO:0003689; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0017116; GO:0031390; GO:0046683; GO:1900264";"DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]";"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]";"DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]"
comp155055_c0_seq1;GAXK01150651.1;Q05481;1.14E-25;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1550618_c0_seq1;GAXK01053520.1;Q86T26;7.93E-15;TM11B_HUMAN;Transmembrane protease serine 11B (EC 3.4.21.-) (Airway trypsin-like protease 5);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]";"GO:0004252; GO:0005886; GO:0005887; GO:0008236; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1550754_c0_seq1;GAXK01053552.1;Q8MJY8;3.47E-09;PGDH_MACFA;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp155123_c4_seq1;GAXK01150573.1;Q9ES63;3.83E-14;UBP29_MOUSE;Ubiquitin carboxyl-terminal hydrolase 29 (EC 3.4.19.12) (Deubiquitinating enzyme 29) (Ubiquitin thioesterase 29) (Ubiquitin-specific-processing protease 29);"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp15514_c0_seq1;GAXK01178273.1;P61024;9.35E-43;CKS1_HUMAN;Cyclin-dependent kinases regulatory subunit 1 (CKS-1);"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000307; GO:0005654; GO:0007049; GO:0007346; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0051301; GO:0061575";"cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]";"cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]"
comp1551714_c0_seq1;GAXK01053579.1;Q9U8W8;6.74E-26;TL5A_TACTR;Techylectin-5A;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp155187_c1_seq1;GAXK01150523.1;Q623D4;5.58E-31;VAB15_CAEBR;Homeobox protein vab-15 (Variable abnormal morphology protein 15);"nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryonic morphogenesis [GO:0048598]; locomotory behavior [GO:0007626]; parturition [GO:0007567]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000977; GO:0005634; GO:0006355; GO:0007567; GO:0007626; GO:0048598";"embryonic morphogenesis [GO:0048598]; locomotory behavior [GO:0007626]; parturition [GO:0007567]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]
comp1552310_c0_seq1;GAXK01152949.1;P82120;4.93E-19;CUO7_BLACR;Cuticle protein 7 (BcNCP15.0);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1552385_c0_seq1;GAXK01152944.1;P55853;3.75E-24;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp155273_c1_seq1;GAXK01150811.1;P48052;5.53E-86;CBPA2_HUMAN;Carboxypeptidase A2 (EC 3.4.17.15);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]";"GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270";"protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp155286_c0_seq1;GAXK01150631.1;P30279;2.47E-57;CCND2_HUMAN;G1/S-specific cyclin-D2;"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp1552887_c0_seq1;GAXK01152954.1;Q9VZW5;4.08E-15;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1552998_c0_seq1;GAXK01152936.1;Q9SFB8;1.02E-20;PI5K6_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 6 (AtPIP5K6) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 6) (Diphosphoinositide kinase 6) (PtdIns(4)P-5-kinase 6);"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005524; GO:0016308; GO:0016324; GO:0072583; GO:0090406";clathrin-dependent endocytosis [GO:0072583];"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp155300_c2_seq1;GAXK01150791.1;P69149;1.91E-24;H31_TETPY;Histone H3 (H3S) (Major histone H3) [Cleaved into: H3F];"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp155306_c3_seq1;GAXK01150737.1;Q7SYN5;4.12E-16;RXRBA_DANRE;Retinoic acid receptor RXR-beta-A (Nuclear receptor subfamily 2 group B member 2-A) (Retinoid X receptor beta-A);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]";"GO:0000977; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0006357; GO:0008270; GO:0030154; GO:0032526; GO:0044323; GO:0045892; GO:0045944; GO:0048384; GO:0048856; GO:0090575";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp155309_c2_seq1;GAXK01150624.1;Q6IA86;1.13E-28;ELP2_HUMAN;Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0033588";"regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]";
comp155313_c2_seq1;GAXK01150715.1;B0WAU8;3.19E-113;PLK4_CULQU;Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase SAK);"centriole [GO:0005814]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]";"GO:0004674; GO:0005524; GO:0005814; GO:0007099";centriole replication [GO:0007099];centriole [GO:0005814];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp155413_c0_seq1;GAXK01150831.1;Q5CZQ0;3.07E-22;CR19B_DANRE;Uncharacterized protein C18orf19 homolog B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1554192_c0_seq1;GAXK01174036.1;Q9HCX4;8.26E-29;TRPC7_HUMAN;Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (hTRP7);"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0030168; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp15542_c2_seq1;GAXK01178484.1;Q5RBU7;3.20E-158;PCP_PONAB;Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP);"lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; serine-type peptidase activity [GO:0008236]";"GO:0004180; GO:0005764; GO:0008236";;lysosome [GO:0005764];"carboxypeptidase activity [GO:0004180]; serine-type peptidase activity [GO:0008236]"
comp155422_c1_seq1;GAXK01150524.1;Q9Y6I9;2.36E-41;TX264_HUMAN;Testis-expressed protein 264 (Putative secreted protein Zsig11);"autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; platelet degranulation [GO:0002576]; reticulophagy [GO:0061709]";"GO:0000421; GO:0002576; GO:0005576; GO:0005789; GO:0031093; GO:0061709";"platelet degranulation [GO:0002576]; reticulophagy [GO:0061709]";"autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]";
comp1554347_c0_seq1;GAXK01174043.1;Q7ZYC4;7.75E-117;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp1554402_c0_seq1;GAXK01174058.1;P62932;1.44E-28;FBX40_MOUSE;F-box only protein 40;"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; muscle cell differentiation [GO:0042692]";"GO:0005737; GO:0008270; GO:0042692; GO:0061630";muscle cell differentiation [GO:0042692];cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp15545_c0_seq1;GAXK01178380.1;Q24048;1.02E-75;ATPB2_DROME;Sodium/potassium-transporting ATPase subunit beta-2 (Protein nervana 2) (Sodium/potassium-dependent ATPase subunit beta-2);"axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cell adhesion involved in heart morphogenesis [GO:0061343]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; open tracheal system development [GO:0007424]; potassium ion import across plasma membrane [GO:1990573]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; regulation of tube size, open tracheal system [GO:0035151]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007424; GO:0007605; GO:0010248; GO:0019991; GO:0030007; GO:0030424; GO:0035151; GO:0035158; GO:0035159; GO:0036376; GO:0060857; GO:0061343; GO:1990573";"cation transport [GO:0006812]; cell adhesion involved in heart morphogenesis [GO:0061343]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; open tracheal system development [GO:0007424]; potassium ion import across plasma membrane [GO:1990573]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; regulation of tube size, open tracheal system [GO:0035151]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]";"axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp1554502_c0_seq1;GAXK01174039.1;Q01812;8.50E-13;GRIK4_RAT;Glutamate receptor ionotropic, kainate 4 (GluK4) (Glutamate receptor KA-1) (KA1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; modulation of chemical synaptic transmission [GO:0050804]; response to corticosteroid [GO:0031960]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005634; GO:0005886; GO:0006811; GO:0007268; GO:0008066; GO:0008328; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0031960; GO:0032983; GO:0035249; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0098978; GO:0099056; GO:1904315";"chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; modulation of chemical synaptic transmission [GO:0050804]; response to corticosteroid [GO:0031960]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp155452_c1_seq1;GAXK01150688.1;Q9VWE0;7.11E-19;DOME_DROME;Cytokine receptor (Protein domeless);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"GO:0001745; GO:0004896; GO:0005886; GO:0006955; GO:0007259; GO:0007298; GO:0007350; GO:0007424; GO:0007442; GO:0007472; GO:0007616; GO:0008284; GO:0016021; GO:0016324; GO:0016327; GO:0019221; GO:0045475; GO:0046982; GO:0050829; GO:0097677; GO:0097678; GO:1990782";"blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]"
comp1554584_c0_seq1;GAXK01174046.1;Q9NYT6;2.18E-23;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1554635_c0_seq1;GAXK01174038.1;Q7ZX53;1.08E-36;S22FL_XENLA;Solute carrier family 22 member 15-like;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1555665_c1_seq1;GAXK01174057.1;P17019;1.32E-21;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp155577_c1_seq1;GAXK01150714.1;Q60821;4.15E-22;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp1555821_c0_seq1;GAXK01174033.1;P30974;3.07E-20;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp1555834_c0_seq1;GAXK01174053.1;Q8AXC6;1.22E-68;KIT_TAKRU;Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Tyrosine-protein kinase kit);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Fc receptor signaling pathway [GO:0038093]; Kit signaling pathway [GO:0038109]";"GO:0004714; GO:0005524; GO:0005886; GO:0016021; GO:0019955; GO:0038093; GO:0038109; GO:0046872";"Fc receptor signaling pathway [GO:0038093]; Kit signaling pathway [GO:0038109]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp15559_c0_seq1;GAXK01178428.1;Q1HG43;5.36E-37;DOXA1_HUMAN;Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein);"cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]";"GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609";"cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]";"cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";enzyme binding [GO:0019899]
comp15560_c2_seq1;GAXK01179052.1;Q96EL3;2.43E-08;RM53_HUMAN;39S ribosomal protein L53, mitochondrial (L53mt) (MRP-L53) (Mitochondrial large ribosomal subunit protein mL53);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126";"mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";
comp155615_c1_seq1;GAXK01150572.1;Q6YHK3;2.15E-37;CD109_HUMAN;CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675";"hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]";"serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]"
comp1556153_c0_seq1;GAXK01015162.1;P93748;7.32E-08;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp155618_c0_seq1;GAXK01205828.1;P20228;0;DCE_DROME;Glutamate decarboxylase (GAD) (EC 4.1.1.15);"cytosol [GO:0005829]; glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]";"GO:0004351; GO:0005829; GO:0006538; GO:0007416; GO:0007528; GO:0008345; GO:0008355; GO:0009449; GO:0009612; GO:0030170; GO:0045213";"gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]";cytosol [GO:0005829];"glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]"
comp155642_c0_seq1;GAXK01150816.1;Q14686;1.04E-10;NCOA6_HUMAN;Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein);"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription, initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]";"GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019216; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0030520; GO:0035097; GO:0042921; GO:0043231; GO:0045893; GO:0045944; GO:0046965; GO:0046966";"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription, initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]";"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]"
comp15566_c2_seq1;GAXK01178116.1;Q3TAS6;4.92E-23;EMC10_MOUSE;ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1);"ER membrane protein complex [GO:0072546]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]";"GO:0001525; GO:0001938; GO:0005576; GO:0010595; GO:0016021; GO:0045766; GO:0072546; GO:1900745";"angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]";"ER membrane protein complex [GO:0072546]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]";
comp155676_c0_seq1;GAXK01150665.1;Q5R9A7;1.05E-76;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp1556826_c0_seq1;GAXK01015159.1;Q8LHH9;2.96E-83;SHL2_ORYSJ;Probable RNA-dependent RNA polymerase SHL2 (EC 2.7.7.48) (Protein SHOOTLESS 2);"nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; carpel development [GO:0048440]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; production of siRNA involved in chromatin silencing by small RNA [GO:0070919]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; recognition of pollen [GO:0048544]; RNA interference [GO:0016246]; virus induced gene silencing [GO:0009616]";"GO:0003723; GO:0003968; GO:0005634; GO:0009616; GO:0010267; GO:0010492; GO:0016246; GO:0030422; GO:0031380; GO:0048366; GO:0048440; GO:0048544; GO:0070919";"carpel development [GO:0048440]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; production of siRNA involved in chromatin silencing by small RNA [GO:0070919]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; recognition of pollen [GO:0048544]; RNA interference [GO:0016246]; virus induced gene silencing [GO:0009616]";"nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]"
comp1556889_c0_seq1;GAXK01015150.1;O16305;2.92E-88;CALM_CAEEL;Calmodulin (CaM);"cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]";"GO:0005509; GO:0005813; GO:0009792; GO:0016477; GO:0019722; GO:0031965; GO:0032880; GO:0042981; GO:0043277; GO:0051296; GO:0051726; GO:0071944; GO:0072686";"apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]";"cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]";calcium ion binding [GO:0005509]
comp155702_c1_seq1;GAXK01150515.1;Q99JW2;1.74E-169;ACY1_MOUSE;Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520]";"GO:0004046; GO:0005737; GO:0006520; GO:0008237; GO:0042802; GO:0046872; GO:0070062";cellular amino acid metabolic process [GO:0006520];"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]";"aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1557023_c0_seq1;GAXK01015149.1;Q5QJ74;1.06E-22;TBCEL_HUMAN;Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014";"microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";alpha-tubulin binding [GO:0043014]
comp1557027_c0_seq1;GAXK01015151.1;Q9VNM1;1.35E-48;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp155735_c1_seq1;GAXK01150735.1;P34275;1.51E-63;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp1557600_c0_seq1;GAXK01015154.1;B8M9K5;1.34E-22;TROPC_TALSN;2-oxoglutarate-dependent dioxygenase tropC (EC 1.14.-.-) (Tropolone synthesis protein C);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp155802_c2_seq1;GAXK01150633.1;Q60649;0;CLPB_MOUSE;Caseinolytic peptidase B protein homolog (EC 3.6.1.3) (Suppressor of potassium transport defect 3);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605]";"GO:0005524; GO:0005739; GO:0016887; GO:0034605";cellular response to heat [GO:0034605];mitochondrion [GO:0005739];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp1558035_c0_seq1;GAXK01050713.1;Q5ZLK5;1.41E-18;P4HA2_CHICK;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp155806_c0_seq1;GAXK01150482.1;Q12912;6.85E-29;LRMP_HUMAN;Lymphoid-restricted membrane protein (Protein Jaw1) [Cleaved into: Processed lymphoid-restricted membrane protein];"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"GO:0000922; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0007338; GO:0016020; GO:0016021; GO:0035577; GO:0043312";"neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]";
comp155821_c1_seq1;GAXK01150635.1;Q7KRI2;2.00E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1558240_c0_seq1;GAXK01050716.1;P15159;1.50E-18;TNNC_TACTR;Troponin C;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp155853_c0_seq1;GAXK01150829.1;P11362;1.36E-50;FGFR1_HUMAN;Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; cell migration [GO:0016477]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]";"GO:0000122; GO:0000165; GO:0001501; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001764; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005730; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0007399; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010518; GO:0010863; GO:0010966; GO:0010976; GO:0014068; GO:0016021; GO:0016477; GO:0017134; GO:0018108; GO:0021847; GO:0030326; GO:0030901; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048339; GO:0048378; GO:0048469; GO:0048705; GO:0048762; GO:0051897; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1905564; GO:2000546; GO:2000830; GO:2001239";"angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; cell migration [GO:0016477]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp155874_c0_seq1;GAXK01150825.1;P05661;1.31E-98;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1558951_c0_seq1;GAXK01050699.1;Q6DHG0;3.12E-16;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp15590_c0_seq1;GAXK01178387.1;Q8NFZ3;1.22E-40;NLGNY_HUMAN;Neuroligin-4, Y-linked (Neuroligin Y);"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0014069; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054";"learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp155931_c4_seq1;GAXK01150533.1;Q3T0C2;1.06E-51;PGDH_BOVIN;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp155940_c0_seq1;GAXK01150522.1;Q9XSR3;1.86E-50;RBM47_CANLF;RNA-binding protein 47 (RNA-binding motif protein 47);"nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]";"GO:0003723; GO:0003729; GO:0005634; GO:0016554";cytidine to uridine editing [GO:0016554];nucleus [GO:0005634];"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1559532_c0_seq1;GAXK01050705.1;Q3U288;5.08E-15;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp155964_c1_seq1;GAXK01150625.1;Q99P55;4.05E-56;SGPP1_RAT;Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]";"GO:0005789; GO:0005886; GO:0016021; GO:0035621; GO:0042392; GO:0045616; GO:0045682";"ER to Golgi ceramide transport [GO:0035621]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sphingosine-1-phosphate phosphatase activity [GO:0042392]
comp1559746_c0_seq1;GAXK01050722.1;Q6P9S0;1.97E-23;MTSS2_MOUSE;Protein MTSS 2 (MTSS1-like protein);"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"GO:0001726; GO:0003785; GO:0005096; GO:0005546; GO:0005886; GO:0007009; GO:0030027; GO:0030864; GO:0032587; GO:0036120; GO:0048365; GO:0061024; GO:0090630; GO:0097178; GO:0097581";"activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]"
comp15599_c0_seq1;GAXK01178431.1;P23258;0;TBG1_HUMAN;Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1);"apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730";"ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]"
comp156_c1_seq1;GAXK01170055.1;P00765;6.39E-57;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp156000_c0_seq1;GAXK01104710.1;Q6PJF5;7.52E-151;RHDF2_HUMAN;Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]";"GO:0005789; GO:0005886; GO:0006508; GO:0015031; GO:0016021; GO:0019838; GO:0042058; GO:0050708; GO:0050709";"negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";growth factor binding [GO:0019838]
comp156007_c1_seq1;GAXK01104769.1;Q23551;2.49E-130;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp156018_c1_seq1;GAXK01104853.1;Q9JLB0;1.21E-111;MPP6_MOUSE;MAGUK p55 subfamily member 6 (Dlgh4 protein) (P55T protein) (Protein associated with Lin-7 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; guanylate kinase activity [GO:0004385]";"GO:0004385; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";guanylate kinase activity [GO:0004385]
comp156037_c0_seq1;GAXK01104742.1;Q9EQ15;7.76E-14;GNB1L_MOUSE;Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF);"cytoplasm [GO:0005737]; social behavior [GO:0035176]";"GO:0005737; GO:0035176";social behavior [GO:0035176];cytoplasm [GO:0005737];
comp156057_c2_seq1;GAXK01104809.1;Q9BU70;3.06E-54;TRMO_HUMAN;tRNA (adenine(37)-N6)-methyltransferase (EC 2.1.1.-) (tRNA methyltransferase O);"tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]; tRNA methylation [GO:0030488]";"GO:0016430; GO:0030488";tRNA methylation [GO:0030488];;tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]
comp156076_c1_seq1;GAXK01104982.1;Q96F15;8.15E-07;GIMA5_HUMAN;GTPase IMAP family member 5 (Immune-associated nucleotide-binding protein 5) (Immunity-associated nucleotide 4-like 1 protein) (Immunity-associated nucleotide 5 protein) (IAN-5) (hIAN5) (Immunity-associated protein 3);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; GTP binding [GO:0005525]";"GO:0005525; GO:0005765; GO:0005783; GO:0016021; GO:0032585";;"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]";GTP binding [GO:0005525]
comp156091_c1_seq1;GAXK01104914.1;Q9VEG6;1.69E-122;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp1560992_c0_seq1;GAXK01035354.1;Q9NUA8;2.41E-08;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1561_c0_seq1;GAXK01169195.1;P80566;7.32E-71;SODC_CHICK;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cell [GO:0005623]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; removal of superoxide radicals [GO:0019430]";"GO:0004784; GO:0005507; GO:0005623; GO:0005634; GO:0005739; GO:0005829; GO:0019430";removal of superoxide radicals [GO:0019430];"cell [GO:0005623]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]"
comp1561142_c0_seq1;GAXK01035353.1;P10876;1.93E-86;TBB_TETPY;Tubulin beta chain (Beta-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1561403_c0_seq1;GAXK01035352.1;Q5T9C9;7.13E-46;PI5L1_HUMAN;Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (EC 2.7.1.68);"cell projection [GO:0042995]; cytosol [GO:0005829]; membrane [GO:0016020]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of apoptotic process [GO:0043065]";"GO:0001933; GO:0005524; GO:0005829; GO:0010917; GO:0016020; GO:0016308; GO:0030336; GO:0042995; GO:0043065";"negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of apoptotic process [GO:0043065]";"cell projection [GO:0042995]; cytosol [GO:0005829]; membrane [GO:0016020]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp1561406_c0_seq1;GAXK01035365.1;Q6TFL4;1.81E-10;KLH24_HUMAN;Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1);"adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]";"GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312";"intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]";"adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]";
comp156162_c0_seq1;GAXK01104870.1;Q8C8M1;3.59E-45;SHCAF_MOUSE;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp156184_c3_seq1;GAXK01104965.1;Q8CHT3;1.34E-33;INT5_MOUSE;Integrator complex subunit 5 (Int5);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"GO:0005634; GO:0005737; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472";"snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";
comp15619_c1_seq1;GAXK01179092.1;P54813;2.64E-173;YME1_CAEEL;ATP-dependent zinc metalloprotease YME1 homolog (EC 3.4.24.-);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]";"GO:0004222; GO:0005524; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872";"cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp1562047_c0_seq1;GAXK01007155.1;Q9XYN1;3.92E-75;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp15621_c0_seq1;GAXK01178576.1;P55258;2.03E-40;RAB8A_MOUSE;Ras-related protein Rab-8A (Oncogene c-mel);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]";"GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017137; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032482; GO:0032869; GO:0032880; GO:0036064; GO:0043025; GO:0043197; GO:0045202; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060271; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003";"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]"
comp156231_c0_seq1;GAXK01104712.1;Q1DH70;3.05E-30;SHAKB_AEDAE;Innexin shaking-B;"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; gap junction assembly [GO:0016264]; ion transport [GO:0006811]; response to light stimulus [GO:0009416]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0009416; GO:0009881; GO:0016021; GO:0016264";"gap junction assembly [GO:0016264]; ion transport [GO:0006811]; response to light stimulus [GO:0009416]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp15624_c3_seq1;GAXK01179247.1;A4FUW8;3.94E-15;TXD11_BOVIN;Thioredoxin domain-containing protein 11;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]";"GO:0005789; GO:0016021; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1562427_c0_seq1;GAXK01007157.1;G5ECX0;3.43E-09;LPLT2_CAEEL;Latrophilin-like protein LAT-2;"integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";"GO:0004175; GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0030246; GO:0097264";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";integral component of plasma membrane [GO:0005887];"carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]"
comp156257_c0_seq1;GAXK01104663.1;Q8BJL1;1.70E-28;FBX30_MOUSE;F-box only protein 30 (Muscle ubiquitin ligase of SCF complex in atrophy-1) (MUSA1);"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0061630";;;"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp156274_c0_seq1;GAXK01104980.1;Q9ULU4;1.94E-46;PKCB1_HUMAN;Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8);"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003714; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952";"modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; nucleus [GO:0005634]";"lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp1562929_c0_seq1;GAXK01007153.1;Q96SE7;9.73E-15;ZN347_HUMAN;Zinc finger protein 347 (Zinc finger protein 1111);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1563_c0_seq1;GAXK01170196.1;Q96T23;3.58E-36;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp1563223_c0_seq1;GAXK01007174.1;O43934;1.14E-69;MFS11_HUMAN;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1563669_c0_seq1;GAXK01007165.1;O35929;1.68E-20;REM1_MOUSE;GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp156397_c0_seq1;GAXK01104974.1;Q86YQ8;5.74E-101;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp1564114_c0_seq1;GAXK01071275.1;Q5REU2;1.70E-55;RL23_PONAB;60S ribosomal protein L23;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp15642_c1_seq1;GAXK01178711.1;Q8K268;0;ABCF3_MOUSE;ATP-binding cassette sub-family F member 3;"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607]";"GO:0005524; GO:0016887; GO:0051607";defense response to virus [GO:0051607];;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp156424_c4_seq1;GAXK01104577.1;Q8IN94;4.05E-38;OSA_DROME;Trithorax group protein osa (Protein eyelid);"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190";"chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";DNA binding [GO:0003677]
comp1564364_c0_seq1;GAXK01071315.1;Q91VH2;5.24E-10;SNX9_MOUSE;Sorting nexin-9;"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032461; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045860; GO:0051044; GO:0060988; GO:0071933; GO:0097320";"cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]";"1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp156448_c2_seq1;GAXK01104748.1;O61307;0;TENM_DROME;Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0030054; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331";"cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp1564630_c0_seq1;GAXK01071281.1;Q3ECP7;1.40E-24;ERDL5_ARATH;Sugar transporter ERD6-like 5;"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp156499_c1_seq1;GAXK01104944.1;Q2KHX3;9.89E-22;PRAF2_BOVIN;PRA1 family protein 2;"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0010008; GO:0015031; GO:0016021";protein transport [GO:0015031];"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]";
comp15650_c1_seq1;GAXK01179269.1;B2D0J5;2.60E-54;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp1565045_c0_seq1;GAXK01071300.1;Q0VAW7;1.09E-25;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1565270_c0_seq1;GAXK01071316.1;Q8N8A2;2.55E-15;ANR44_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp156537_c2_seq1;GAXK01104955.1;G5EFD5;6.25E-80;UNC71_CAEEL;Disintegrin and metalloproteinase domain-containing protein unc-71 (Uncoordinated protein 71);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell-cell adhesion [GO:0098609]; plasma membrane fusion [GO:0045026]; proteolysis [GO:0006508]";"GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0016021; GO:0045026; GO:0098609";"cell-cell adhesion [GO:0098609]; plasma membrane fusion [GO:0045026]; proteolysis [GO:0006508]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp15655_c2_seq1;GAXK01178183.1;Q9JK81;1.97E-131;MYG1_MOUSE;UPF0160 protein MYG1, mitochondrial (Protein Gamm1);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641]";"GO:0005634; GO:0005654; GO:0005739; GO:0035641";locomotory exploration behavior [GO:0035641];"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp156552_c0_seq1;GAXK01104852.1;Q9CZE3;2.42E-80;RAB32_MOUSE;Ras-related protein Rab-32;"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0006886; GO:0007005; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032482; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232";"antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]";"AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]"
comp1565587_c0_seq1;GAXK01071299.1;Q9Y575;3.76E-10;ASB3_HUMAN;Ankyrin repeat and SOCS box protein 3 (ASB-3);"cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005829; GO:0016567; GO:0035556; GO:0043687";"intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";cytosol [GO:0005829];
comp1565656_c0_seq1;GAXK01071324.1;Q5R5Y7;3.42E-28;ZN436_PONAB;Zinc finger protein 436;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1565762_c0_seq1;GAXK01071312.1;Q26630;1.74E-102;IDLC_STRPU;33 kDa inner dynein arm light chain, axonemal (p33);"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504";inner dynein arm assembly [GO:0036159];"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp1565771_c0_seq1;GAXK01071295.1;E9QAT4;7.23E-11;SC16A_MOUSE;Protein transport protein Sec16A (SEC16 homolog A) (p250);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0007029; GO:0007030; GO:0012507; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]";
comp156600_c0_seq1;GAXK01104850.1;P18253;1.25E-16;CYPH_SCHPO;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (CPH) (Cyclosporin A-binding protein) (Rotamase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]";"GO:0003755; GO:0005634; GO:0005739; GO:0005829; GO:0016018; GO:0042026; GO:0051082";protein refolding [GO:0042026];"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp156604_c2_seq1;GAXK01104745.1;Q3URR7;5.56E-16;ZSC10_MOUSE;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863";"negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp156605_c0_seq1;GAXK01104838.1;P26016;0;FUR11_DROME;Furin-like protease 1, isoforms 1/1-X/2 (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688";"glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp1566268_c0_seq1;GAXK01090335.1;Q5ZM14;1.30E-26;NHRF1_CHICK;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0005737; GO:0005902; GO:0010642; GO:0012505; GO:0014067; GO:0016055; GO:0017081; GO:0030175; GO:0031528; GO:0032782; GO:0034635; GO:0045859; GO:0051898; GO:0060090; GO:0070293; GO:0071944; GO:2000146";"bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; Wnt signaling pathway [GO:0016055]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]";"chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]"
comp156630_c0_seq1;GAXK01104820.1;P05748;8.51E-49;RL15A_YEAST;60S ribosomal protein L15-A (L13) (Large ribosomal subunit protein eL15-A) (RP15R) (YL10) (YP18);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1566528_c0_seq1;GAXK01090358.1;D3Z5L6;7.03E-30;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1566540_c0_seq1;GAXK01090347.1;Q5RB30;6.50E-29;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp15666_c0_seq1;GAXK01179174.1;Q9D1Q6;3.41E-116;ERP44_MOUSE;Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4);"cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454";"cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]";protein disulfide isomerase activity [GO:0003756]
comp1566639_c0_seq1;GAXK01090357.1;Q9SFB8;1.07E-20;PI5K6_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 6 (AtPIP5K6) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 6) (Diphosphoinositide kinase 6) (PtdIns(4)P-5-kinase 6);"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005524; GO:0016308; GO:0016324; GO:0072583; GO:0090406";clathrin-dependent endocytosis [GO:0072583];"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp1566796_c0_seq1;GAXK01090345.1;P20237;4.45E-101;GBRA4_BOVIN;Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp156680_c1_seq1;GAXK01105032.1;A2VDQ7;1.25E-62;ZN420_BOVIN;Zinc finger protein 420;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp156690_c0_seq1;GAXK01104884.1;Q3UHD1;4.24E-26;AGRB1_MOUSE;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]"
comp15670_c0_seq1;GAXK01178434.1;Q0IHF9;9.46E-36;SARAF_XENLA;Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (Transmembrane protein 66);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]";"GO:0006816; GO:0030176; GO:0140268; GO:2001256";"calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp1567089_c0_seq1;GAXK01090329.1;P11120;2.69E-09;CALM_PLECO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1567107_c0_seq1;GAXK01090360.1;Q5F4B3;8.48E-66;TMLH_CHICK;Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]";"GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353";carnitine biosynthetic process [GO:0045329];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"
comp156713_c0_seq1;GAXK01104923.1;Q05209;4.60E-49;PTN12_HUMAN;Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]";"GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0038128; GO:0042058; GO:0042246; GO:0042995; GO:0071345; GO:0071364; GO:1901185; GO:2000587";"cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]";"non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]"
comp156717_c2_seq1;GAXK01104787.1;O46432;0;MA2B1_FELCA;Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B);"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"GO:0004559; GO:0005764; GO:0005774; GO:0006013; GO:0006517; GO:0030246; GO:0046872";"mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp1567203_c0_seq1;GAXK01090356.1;Q2KJ63;2.27E-31;KLKB1_BOVIN;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";"GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";extracellular space [GO:0005615];"protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp156753_c1_seq1;GAXK01104821.1;Q17LW0;0;MYO7A_AEDAE;Myosin-VIIa (Protein crinkled);"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015";"actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; myosin complex [GO:0016459]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp156770_c8_seq1;GAXK01104949.1;Q9W0Y6;1.33E-20;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp156793_c0_seq1;GAXK01104971.1;P18714;1.87E-10;ZG20_XENLA;Gastrula zinc finger protein xFG20-1 (XlCGF20.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp156809_c1_seq1;GAXK01104918.1;Q4R7U0;7.53E-59;TMC7_MACFA;Transmembrane channel-like protein 7;"integral component of plasma membrane [GO:0005887]; ion transport [GO:0006811]";"GO:0005887; GO:0006811";ion transport [GO:0006811];integral component of plasma membrane [GO:0005887];
comp15683_c7_seq1;GAXK01178595.1;Q96JT2;2.38E-50;S45A3_HUMAN;Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]";"GO:0005886; GO:0005887; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0045723; GO:0048713; GO:0051119";"hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]"
comp156832_c1_seq1;GAXK01104780.1;Q38931;1.89E-13;FKB62_ARATH;Peptidyl-prolyl cis-trans isomerase FKBP62 (PPIase FKBP62) (EC 5.2.1.8) (70 kDa peptidyl-prolyl isomerase) (FK506-binding protein 62) (AtFKBP62) (Immunophilin FKBP62) (Peptidylprolyl isomerase ROF1) (Protein ROTAMASE FKBP 1) (Rotamase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; cellular heat acclimation [GO:0070370]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005516; GO:0005634; GO:0005737; GO:0061077; GO:0070370";"cellular heat acclimation [GO:0070370]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp1568892_c0_seq1;GAXK01203567.1;G3MWR8;4.16E-46;MICA3_BOVIN;[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0017137; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]";"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]"
comp15689_c0_seq1;GAXK01178821.1;Q9NYZ2;2.75E-96;MFRN1_HUMAN;Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]";"GO:0005381; GO:0005743; GO:0016021; GO:0048250; GO:0055072";"iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";iron ion transmembrane transporter activity [GO:0005381]
comp1569003_c0_seq1;GAXK01203564.1;P33727;1.18E-34;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp156904_c1_seq1;GAXK01104986.1;O88582;4.59E-10;SOCS2_RAT;Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2);"cytoplasm [GO:0005737]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; response to peptide hormone [GO:0043434]";"GO:0001558; GO:0005159; GO:0005737; GO:0005942; GO:0007568; GO:0008269; GO:0016567; GO:0035556; GO:0043434; GO:0046426; GO:0046627; GO:0046854; GO:0046935";"aging [GO:0007568]; intracellular signal transduction [GO:0035556]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; response to peptide hormone [GO:0043434]";"cytoplasm [GO:0005737]; phosphatidylinositol 3-kinase complex [GO:0005942]";"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]"
comp15692_c2_seq1;GAXK01178068.1;Q99L48;0;NMD3_MOUSE;60S ribosomal export protein NMD3;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding, bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]";"GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751";"positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"protein binding, bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]"
comp1569343_c1_seq1;GAXK01203579.1;P07463;3.48E-17;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1569692_c0_seq1;GAXK01203570.1;Q5QJC2;6.33E-41;DCR1C_CHICK;Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein) (SNM1 homolog C) (chSNM1C) (SNM1-like protein);"Golgi apparatus [GO:0005794]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; response to ionizing radiation [GO:0010212]; V(D)J recombination [GO:0033151]";"GO:0000014; GO:0000784; GO:0002250; GO:0003684; GO:0005654; GO:0005794; GO:0006303; GO:0010212; GO:0030183; GO:0031848; GO:0033151; GO:0035312; GO:0036297; GO:0070419";"adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; response to ionizing radiation [GO:0010212]; V(D)J recombination [GO:0033151]";"Golgi apparatus [GO:0005794]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]";"5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]"
comp156976_c0_seq1;GAXK01104981.1;O08585;6.81E-26;CLCA_MOUSE;Clathrin light chain A (Lca);"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631";"cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]";"clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]"
comp1569785_c0_seq1;GAXK01203603.1;Q804S5;4.54E-07;MIB1_DANRE;E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Protein mind bomb) (RING-type E3 ubiquitin transferase mib1);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]";"GO:0000151; GO:0001568; GO:0001570; GO:0001756; GO:0001885; GO:0002040; GO:0002064; GO:0002090; GO:0002244; GO:0003407; GO:0003408; GO:0004842; GO:0005737; GO:0005815; GO:0005886; GO:0006897; GO:0007219; GO:0007368; GO:0007417; GO:0007420; GO:0007507; GO:0008270; GO:0008284; GO:0008593; GO:0009880; GO:0010001; GO:0016567; GO:0021508; GO:0021510; GO:0021514; GO:0021519; GO:0021520; GO:0021521; GO:0021536; GO:0021546; GO:0021654; GO:0021986; GO:0022008; GO:0030097; GO:0030139; GO:0030182; GO:0030318; GO:0030902; GO:0030903; GO:0031076; GO:0031398; GO:0031410; GO:0032991; GO:0035315; GO:0039022; GO:0042803; GO:0045664; GO:0045685; GO:0045747; GO:0048066; GO:0048259; GO:0048471; GO:0048514; GO:0048546; GO:0048663; GO:0048665; GO:0048666; GO:0048699; GO:0048793; GO:0048859; GO:0048892; GO:0048899; GO:0048916; GO:0048920; GO:0050931; GO:0051865; GO:0060035; GO:0060113; GO:0060216; GO:0060218; GO:0061195; GO:0061551; GO:0070086; GO:0071599";"anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]";"protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1569869_c1_seq1;GAXK01203606.1;P17041;1.89E-12;ZNF32_HUMAN;Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp1569929_c0_seq1;GAXK01203600.1;P04052;1.23E-34;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp1570159_c0_seq1;GAXK01001239.1;Q4KME6;1.54E-09;GGYF2_DANRE;GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein);;;;;
comp1570220_c0_seq1;GAXK01001233.1;Q0DHL5;1.94E-24;LAC11_ORYSJ;Putative laccase-11 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 11) (Diphenol oxidase 11) (Urishiol oxidase 11);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp15703_c1_seq1;GAXK01177969.1;O18405;4.93E-113;SURF4_DROME;Surfeit locus protein 4 homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0012505; GO:0016021; GO:0045169";;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";
comp1570609_c0_seq1;GAXK01001226.1;Q9UPW0;1.55E-26;FOXJ3_HUMAN;Forkhead box protein J3;"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0043565; GO:0045944";positive regulation of transcription by RNA polymerase II [GO:0045944];nuclear chromatin [GO:0000790];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp157066_c1_seq1;GAXK01104953.1;Q7KRI2;2.53E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1570742_c0_seq1;GAXK01001241.1;P33188;4.11E-176;TBB1_PARTE;Tubulin beta chain (Beta-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp157081_c0_seq1;GAXK01104756.1;Q9NZL3;1.50E-22;ZN224_HUMAN;Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22);"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0001227; GO:0005634; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1570914_c0_seq1;GAXK01001254.1;Q9M7R0;5.52E-08;ALL8_OLEEU;Calcium-binding allergen Ole e 8 (PCA18/PCA23) (allergen Ole e 8);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1571_c0_seq2;GAXK01165991.1;P06754;7.05E-55;TPM1_DROME;Tropomyosin-1, isoforms 9A/A/B (Cytoskeletal tropomyosin) (Tropomyosin II);"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019901; GO:0030017; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865";"actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]"
comp157129_c0_seq1;GAXK01104867.1;D3Z5L6;2.95E-31;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1571418_c0_seq1;GAXK01001229.1;Q92010;2.29E-07;ZBT14_CHICK;Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 5) (ZF5);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0005634; GO:0043565; GO:0044212; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1571631_c0_seq1;GAXK01001252.1;Q27433;7.96E-07;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1571805_c1_seq1;GAXK01001221.1;Q99056;3.19E-18;LAC5_TRAVI;Laccase-5 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 5) (Diphenol oxidase 5) (Urishiol oxidase 5);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp157182_c0_seq1;GAXK01104859.1;P34465;2.71E-15;CY561_CAEEL;Putative cytochrome b561 (Cytochrome b-561);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0005765; GO:0016021; GO:0016491; GO:0031902; GO:0046872";;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp1572033_c0_seq1;GAXK01054243.1;Q20065;8.90E-28;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp15724_c3_seq2;GAXK01177817.1;Q17LW0;0;MYO7A_AEDAE;Myosin-VIIa (Protein crinkled);"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015";"actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; myosin complex [GO:0016459]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp1572433_c0_seq1;GAXK01054236.1;Q19269;5.99E-19;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp157244_c1_seq1;GAXK01105028.1;B5XF11;7.10E-85;KDM8_SALSA;Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0070544";"circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]"
comp1572522_c1_seq1;GAXK01054247.1;Q9XYN1;7.80E-21;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp157255_c0_seq1;GAXK01104910.1;O35491;8.11E-100;CLK2_MOUSE;Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2);"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]";"GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010033; GO:0010212; GO:0016604; GO:0016607; GO:0018108; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777";"negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]";"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp157259_c0_seq1;GAXK01104972.1;Q557E7;3.53E-09;CBLA_DICDI;E3 ubiquitin-protein ligase cblA (EC 2.3.2.27) (Cbl-like protein A) (RING finger protein cblA) (RING-type E3 ubiquitin transferase cblA);"cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; transferase activity [GO:0016740]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]; sorocarp development [GO:0030587]";"GO:0001784; GO:0005509; GO:0005634; GO:0005829; GO:0016567; GO:0016740; GO:0030587; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]; sorocarp development [GO:0030587]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; transferase activity [GO:0016740]"
comp15726_c1_seq1;GAXK01179162.1;Q71R50;1.20E-76;DHR11_CHICK;Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1);"extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]";"GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582";estrogen biosynthetic process [GO:0006703];extracellular region [GO:0005576];"17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]"
comp157267_c0_seq1;GAXK01104942.1;Q5XIA9;8.40E-10;KLD8B_RAT;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp1572761_c0_seq1;GAXK01054241.1;A6QNK1;8.75E-44;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp1572815_c0_seq1;GAXK01054245.1;P47989;0;XDH_HUMAN;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115]";"GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006195; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010629; GO:0016529; GO:0042803; GO:0043546; GO:0045602; GO:0050660; GO:0051537; GO:0051898; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp157283_c0_seq1;GAXK01104844.1;Q9ESP5;7.15E-21;FEZF2_MOUSE;Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex neuron differentiation [GO:0021895]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain development [GO:0030900]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axon guidance [GO:1902667]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; telencephalon development [GO:0021537]";"GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0007413; GO:0007626; GO:0008285; GO:0016358; GO:0021537; GO:0021542; GO:0021797; GO:0021853; GO:0021895; GO:0021902; GO:0030900; GO:0043565; GO:0043697; GO:0044212; GO:0045665; GO:0045666; GO:0045893; GO:0046872; GO:0048664; GO:0050767; GO:1902667";"axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex neuron differentiation [GO:0021895]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain development [GO:0030900]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axon guidance [GO:1902667]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; telencephalon development [GO:0021537]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp15729_c1_seq1;GAXK01178285.1;P56192;0;SYMC_HUMAN;Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838";"cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]"
comp157290_c1_seq1;GAXK01104597.1;Q6IRE4;5.87E-30;TS101_RAT;Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]";"GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0045892; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0090543; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397";"cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]"
comp1573979_c0_seq1;GAXK01054242.1;A6H782;1.46E-65;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp15741_c1_seq1;GAXK01178655.1;Q9GRC0;2.18E-46;MOS_PATPE;Serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos);"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]";"GO:0004709; GO:0005524; GO:0007147; GO:0007292; GO:0045930";"female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]";;"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]"
comp157452_c1_seq1;GAXK01104896.1;Q8BZG5;1.18E-17;RRNAD_MOUSE;Protein RRNAD1;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1574679_c0_seq1;GAXK01137196.1;Q07120;1.75E-07;GFI1_RAT;Zinc finger protein Gfi-1 (Growth factor independent protein 1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0000122; GO:0001227; GO:0003700; GO:0005654; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0044212; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp15747_c0_seq1;GAXK01178112.1;Q7SXW4;8.42E-131;EMC3_DANRE;ER membrane protein complex subunit 3 (Protein pob) (Transmembrane protein 111);"ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network transport vesicle [GO:0030140]; photoreceptor cell maintenance [GO:0045494]; protein folding in endoplasmic reticulum [GO:0034975]; retina development in camera-type eye [GO:0060041]";"GO:0005794; GO:0016021; GO:0030140; GO:0034975; GO:0045494; GO:0060041; GO:0072546";"photoreceptor cell maintenance [GO:0045494]; protein folding in endoplasmic reticulum [GO:0034975]; retina development in camera-type eye [GO:0060041]";"ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network transport vesicle [GO:0030140]";
comp157470_c0_seq1;GAXK01104902.1;O70628;0;PDE9A_MOUSE;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471";"cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp157471_c0_seq1;GAXK01104572.1;P25228;9.68E-129;RAB3_DROME;Ras-related protein Rab-3;"cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0017157; GO:0030054; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0048172; GO:0048786; GO:0048789; GO:0048790; GO:0072659";"cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1574797_c0_seq1;GAXK01137208.1;A9ZSY3;3.55E-14;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1575_c1_seq1;GAXK01169020.1;Q94920;5.53E-101;VDAC_DROME;Voltage-dependent anion-selective channel (DmVDAC) (Porin);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]";"GO:0005739; GO:0005741; GO:0006811; GO:0006839; GO:0007005; GO:0007291; GO:0007602; GO:0008308; GO:0015288; GO:0016006; GO:0030382; GO:0046930";"ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]";"porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]"
comp157523_c0_seq1;GAXK01104576.1;P20350;8.46E-35;RHOM_DROME;Protein rhomboid (EC 3.4.21.105) (Protein veinlet);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0006508; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0038005; GO:0042058; GO:0042327; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317; GO:0098609";"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]";serine-type endopeptidase activity [GO:0004252]
comp15753_c1_seq1;GAXK01179245.1;P23776;4.15E-51;EXG1_YEAST;Glucan 1,3-beta-glucosidase I/II (EC 3.2.1.58) (Exo-1,3-beta-glucanase I/II) (Soluble cell wall protein 6);"cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole [GO:0000324]; glucan exo-1,3-beta-glucosidase activity [GO:0004338]; cellular glucan metabolic process [GO:0006073]; fungal-type cell wall organization [GO:0031505]; glucan catabolic process [GO:0009251]";"GO:0000324; GO:0004338; GO:0005576; GO:0006073; GO:0009251; GO:0009277; GO:0009986; GO:0031505";"cellular glucan metabolic process [GO:0006073]; fungal-type cell wall organization [GO:0031505]; glucan catabolic process [GO:0009251]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole [GO:0000324]";glucan exo-1,3-beta-glucosidase activity [GO:0004338]
comp157537_c0_seq1;GAXK01104916.1;Q02446;6.70E-62;SP4_HUMAN;Transcription factor Sp4 (SPR-1);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000981; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0043565; GO:0046872";regulation of transcription by RNA polymerase II [GO:0006357];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]"
comp157541_c1_seq1;GAXK01204957.1;P42860;1.71E-35;GSTT1_LUCCU;Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp157559_c1_seq1;GAXK01104786.1;Q1H9T6;1.95E-12;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp157565_c0_seq1;GAXK01104755.1;Q8NAG6;6.52E-40;ANKL1_HUMAN;Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; DNA repair [GO:0006281]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]";"GO:0004519; GO:0005634; GO:0005737; GO:0006281; GO:0006611; GO:0090305; GO:2001022";"DNA repair [GO:0006281]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";endonuclease activity [GO:0004519]
comp1575743_c0_seq1;GAXK01137191.1;A6NM28;2.09E-11;ZFP92_HUMAN;Zinc finger protein 92 homolog (Zfp-92);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1575827_c0_seq1;GAXK01137192.1;P09052;4.12E-28;VASA1_DROME;ATP-dependent RNA helicase vasa (EC 3.6.4.13) (Antigen Mab46F11);"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007275; GO:0007276; GO:0008104; GO:0030154; GO:0043073; GO:0043186; GO:0048477; GO:0061803";"cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1575898_c0_seq1;GAXK01137199.1;Q18321;1.05E-11;DAF37_CAEEL;G-protein coupled receptor daf-37 (Abnormal dauer formation protein 37);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"GO:0005794; GO:0005886; GO:0008528; GO:0016021; GO:0042803; GO:0046982; GO:0097730; GO:1904066; GO:1904067; GO:1904068";"G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp1575904_c0_seq1;GAXK01137197.1;Q62283;2.47E-14;TSN7_MOUSE;Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp1575920_c0_seq1;GAXK01137188.1;Q6L4D4;7.02E-07;CML15_ORYSJ;Probable calcium-binding protein CML15 (Calmodulin-like protein 15);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp157600_c2_seq1;GAXK01104766.1;Q8KZT5;5.89E-67;GBH_ARTS8;Guanidinobutyrase (GBase) (EC 3.5.3.7) (D-arginase) (EC 3.5.3.10);"D-arginase activity [GO:0047817]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]";"GO:0046872; GO:0047817; GO:0047971";;;"D-arginase activity [GO:0047817]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]"
comp157611_c0_seq1;GAXK01105026.1;Q60HD0;9.91E-72;SUOX_MACFA;Sulfite oxidase, mitochondrial (EC 1.8.3.1);"mitochondrial intermembrane space [GO:0005758]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";"GO:0005758; GO:0006790; GO:0008482; GO:0030151; GO:0042128; GO:0043546";"nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";mitochondrial intermembrane space [GO:0005758];"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]"
comp157686_c1_seq1;GAXK01104673.1;P25391;0;LAMA1_HUMAN;Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);"basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]";"GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030155; GO:0030198; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045995; GO:0048514; GO:0060441; GO:0060445; GO:0061304; GO:0062023";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]";"extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]"
comp157721_c1_seq1;GAXK01104851.1;Q9VZX1;2.89E-10;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp157761_c3_seq1;GAXK01104768.1;Q24046;9.48E-14;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp1577911_c1_seq1;GAXK01108453.1;O60749;6.90E-32;SNX2_HUMAN;Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042803; GO:0045296; GO:0046982; GO:0051259; GO:0072673; GO:1990459; GO:1990460";"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]";"cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]"
comp157793_c2_seq1;GAXK01104741.1;Q9W0Y6;1.70E-25;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp1578036_c0_seq1;GAXK01022998.1;P35500;1.98E-127;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp1578134_c0_seq1;GAXK01022926.1;P23607;2.70E-10;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1578210_c0_seq1;GAXK01022918.1;Q7KRI2;1.67E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp157838_c0_seq1;GAXK01104574.1;Q9BVJ7;2.06E-12;DUS23_HUMAN;Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]";"GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0016311; GO:0016791";dephosphorylation [GO:0016311];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1578411_c0_seq1;GAXK01022969.1;P14617;4.94E-15;INSRR_CAVPO;"Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain]";"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton reorganization [GO:0031532]; cellular response to alkaline pH [GO:0071469]; male sex determination [GO:0030238]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0030238; GO:0031532; GO:0043235; GO:0043548; GO:0043560; GO:0046777; GO:0071469";"actin cytoskeleton reorganization [GO:0031532]; cellular response to alkaline pH [GO:0071469]; male sex determination [GO:0030238]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp157854_c7_seq1;GAXK01104925.1;Q9VE34;1.12E-79;EPG5_DROME;Ectopic P granules protein 5 homolog;"cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";"GO:0005737; GO:0005764; GO:0006914; GO:0048471; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";"cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]";
comp1578673_c1_seq1;GAXK01022951.1;Q9Y4F3;3.44E-12;MARF1_HUMAN;Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0016020; GO:0043231; GO:0048477";"double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]";RNA binding [GO:0003723]
comp157868_c1_seq1;GAXK01205495.1;Q3U1V8;2.20E-153;M3K9_MOUSE;Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25);"ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; cell death [GO:0008219]; MAPK cascade [GO:0000165]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0000165; GO:0004674; GO:0004706; GO:0005524; GO:0006468; GO:0006915; GO:0007257; GO:0008219; GO:0043065; GO:0046777";"activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; cell death [GO:0008219]; MAPK cascade [GO:0000165]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";;"ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein serine/threonine kinase activity [GO:0004674]"
comp157872_c1_seq1;GAXK01104842.1;Q5UR59;7.58E-13;YL803_MIMIV;Uncharacterized protein L803;;;;;
comp1578767_c0_seq1;GAXK01022983.1;A2ARV4;4.84E-18;LRP2_MOUSE;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0140058; GO:0140077; GO:1904447";"aorta development [GO:0035904]; cell population proliferation [GO:0008283]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]"
comp1578890_c0_seq1;GAXK01022990.1;Q63151;9.61E-52;ACSL3_RAT;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Brain acyl-CoA synthetase II) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp15792_c1_seq1;GAXK01177870.1;Q9VN93;6.97E-94;CPR1_DROME;Putative cysteine proteinase CG12163 (EC 3.4.22.-);"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0045169; GO:0051603; GO:0098595";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]";cysteine-type endopeptidase activity [GO:0004197]
comp1579307_c0_seq1;GAXK01022927.1;P17646;2.11E-36;OPS4_DROVI;Opsin Rh4 (Inner R7 photoreceptor cells opsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp15794_c1_seq1;GAXK01179089.1;Q9Z2V5;4.01E-30;HDAC6_MOUSE;Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2);"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dynein complex [GO:0030286]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000118; GO:0000209; GO:0000978; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006511; GO:0006515; GO:0006886; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0009636; GO:0009967; GO:0010033; GO:0010469; GO:0010634; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019213; GO:0030286; GO:0030424; GO:0030425; GO:0031252; GO:0031593; GO:0031625; GO:0031647; GO:0032041; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0044297; GO:0045598; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090035; GO:0090042; GO:0098779; GO:1901300";"aggresome assembly [GO:0070842]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dynein complex [GO:0030286]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp1579460_c0_seq1;GAXK01022921.1;Q8X187;1.16E-14;CALM_PAXIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1579993_c0_seq1;GAXK01023001.1;A6NM28;1.55E-08;ZFP92_HUMAN;Zinc finger protein 92 homolog (Zfp-92);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1580154_c0_seq1;GAXK01159293.1;Q7Z7L9;7.48E-30;ZSCA2_HUMAN;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp158023_c2_seq1;GAXK01088264.1;Q15678;5.26E-35;PTN14_HUMAN;Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]; cellular response to cytokine stimulus [GO:0071345]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825]";"GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006470; GO:0008285; GO:0030971; GO:0046825; GO:0071345";"cellular response to cytokine stimulus [GO:0071345]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]"
comp1580332_c0_seq1;GAXK01159276.1;Q5I0B9;1.26E-18;ATG16_XENTR;Autophagy-related protein 16 (APG16-like 1);"autophagosome membrane [GO:0000421]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]";"GO:0000045; GO:0000421; GO:0015031; GO:0034045; GO:0039689";"autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]";"autophagosome membrane [GO:0000421]; phagophore assembly site membrane [GO:0034045]";
comp158077_c0_seq1;GAXK01088012.1;Q6GNP2;3.97E-11;Z652A_XENLA;Zinc finger protein 652-A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1580839_c0_seq1;GAXK01159275.1;Q4R4I8;2.23E-16;COPB2_MACFA;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP);"COPI-coated vesicle membrane [GO:0030663]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane coat [GO:0030117]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663";"intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"COPI-coated vesicle membrane [GO:0030663]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane coat [GO:0030117]";structural molecule activity [GO:0005198]
comp158085_c0_seq1;GAXK01088233.1;O77792;1.50E-29;UCP3_BOVIN;Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; fatty acid metabolic process [GO:0006631]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]; response to superoxide [GO:0000303]";"GO:0000303; GO:0005743; GO:0006631; GO:0009409; GO:0016021; GO:0017077; GO:1990542; GO:1990845";"adaptive thermogenesis [GO:1990845]; fatty acid metabolic process [GO:0006631]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]; response to superoxide [GO:0000303]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";oxidative phosphorylation uncoupler activity [GO:0017077]
comp1580960_c0_seq1;GAXK01159277.1;Q9W747;7.05E-12;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp158133_c1_seq1;GAXK01088045.1;Q14147;0;DHX34_HUMAN;Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34);"membrane [GO:0016020]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"GO:0000184; GO:0000956; GO:0003723; GO:0005524; GO:0016020; GO:0034458; GO:2000623";"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";membrane [GO:0016020];"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp1581394_c0_seq1;GAXK01159292.1;P59759;2.19E-17;MRTFB_MOUSE;Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; DNA-binding transcription factor activity [GO:0003700]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cardiac muscle tissue development [GO:0048738]; embryonic organ development [GO:0048568]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; muscle organ development [GO:0007517]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; smooth muscle cell differentiation [GO:0051145]";"GO:0001701; GO:0001764; GO:0001889; GO:0003007; GO:0003700; GO:0003713; GO:0003779; GO:0005634; GO:0005737; GO:0007507; GO:0007517; GO:0010467; GO:0010468; GO:0030036; GO:0030900; GO:0031175; GO:0045844; GO:0045893; GO:0045944; GO:0048514; GO:0048568; GO:0048738; GO:0051145";"actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cardiac muscle tissue development [GO:0048738]; embryonic organ development [GO:0048568]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; muscle organ development [GO:0007517]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; smooth muscle cell differentiation [GO:0051145]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"actin binding [GO:0003779]; DNA-binding transcription factor activity [GO:0003700]; transcription coactivator activity [GO:0003713]"
comp158141_c2_seq1;GAXK01088073.1;O18783;6.50E-12;PLMN_MACEU;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]";"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp15816_c1_seq1;GAXK01177956.1;Q96EQ9;2.03E-17;PRDM9_MOUSE;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0007283; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0043565; GO:0044212; GO:0045944; GO:0046872; GO:0060903";"histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp158174_c2_seq1;GAXK01205423.1;P52826;9.40E-154;CACP_COLLI;Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT);"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; fatty acid metabolic process [GO:0006631]";"GO:0004092; GO:0005743; GO:0005777; GO:0005783; GO:0006631";fatty acid metabolic process [GO:0006631];"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]";carnitine O-acetyltransferase activity [GO:0004092]
comp1582162_c0_seq1;GAXK01099420.1;Q9VZW5;2.90E-13;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1582312_c0_seq1;GAXK01099383.1;Q86WZ6;3.41E-25;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1582320_c0_seq1;GAXK01099371.1;Q90Z00;4.20E-24;FGR1A_DANRE;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; negative regulation of endodermal cell fate specification [GO:0042664]; nervous system development [GO:0007399]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001889; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0010863; GO:0017134; GO:0018108; GO:0021628; GO:0031101; GO:0031410; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0048738; GO:0048916; GO:0060249; GO:0071699";"anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; negative regulation of endodermal cell fate specification [GO:0042664]; nervous system development [GO:0007399]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1582638_c0_seq1;GAXK01099390.1;Q9V3Y3;3.90E-13;DFP_DROME;Defense protein l(2)34Fc;"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; negative regulation of immune response [GO:0050777]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087; GO:0050777";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; negative regulation of immune response [GO:0050777]";extracellular region [GO:0005576];
comp1582767_c0_seq1;GAXK01099374.1;Q23DE3;1.19E-83;RS3A_TETTS;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp1582959_c0_seq1;GAXK01099397.1;P17970;6.05E-98;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp158297_c0_seq1;GAXK01088241.1;Q61908;1.06E-07;CMC4_MOUSE;Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein) (Mature T-cell proliferation-1 type A) (MTCP-1 type A) (Protein p8 MTCP-1) (p8MTCP1);mitochondrial intermembrane space [GO:0005758];GO:0005758;;mitochondrial intermembrane space [GO:0005758];
comp158300_c2_seq1;GAXK01088041.1;Q7KRI2;2.48E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1583305_c0_seq1;GAXK01099380.1;Q3U4G3;1.04E-32;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp158332_c0_seq1;GAXK01088094.1;Q9PU85;1.36E-112;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1583348_c0_seq1;GAXK01099377.1;O96102;2.60E-11;CALM_PHYPO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp158345_c0_seq1;GAXK01088089.1;Q62981;1.92E-19;ZN260_RAT;Zinc finger protein 260 (Zfp-260) (Pancreas-only zinc finger protein 1) (POZF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1583540_c0_seq1;GAXK01099373.1;O88553;7.61E-11;ZFP37_RAT;Zinc finger protein 37 (Zfp-37);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp158427_c1_seq1;GAXK01088358.1;Q9H583;2.79E-10;HEAT1_HUMAN;HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed];"90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006364; GO:0016020; GO:0030686; GO:0032040; GO:0034455; GO:0045943; GO:2000234";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]";RNA binding [GO:0003723]
comp1584648_c0_seq1;GAXK01095207.1;P41245;1.07E-13;MMP9_MOUSE;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"GO:0001501; GO:0001934; GO:0001968; GO:0002687; GO:0004175; GO:0004222; GO:0004252; GO:0005615; GO:0006508; GO:0006979; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0019087; GO:0030198; GO:0030335; GO:0030574; GO:0031915; GO:0032991; GO:0034614; GO:0035987; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0044877; GO:0045742; GO:0045766; GO:0048147; GO:0048771; GO:0051259; GO:0051549; GO:0062023; GO:0071276; GO:0071460; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp15847_c9_seq1;GAXK01179132.1;Q8NEZ4;8.83E-55;KMT2C_HUMAN;Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3);"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]";"GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]";"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"
comp1584732_c0_seq1;GAXK01095205.1;Q8WXS5;1.88E-09;CCG8_HUMAN;Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8) (TARP gamma-8);"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cardiac conduction [GO:0061337]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]";"GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:0014069; GO:0016247; GO:0019226; GO:0030054; GO:0030666; GO:0032281; GO:0051968; GO:0061337; GO:0098839; GO:0098943; GO:0098970; GO:0099590; GO:1990454; GO:2000311";"calcium ion transport [GO:0006816]; cardiac conduction [GO:0061337]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]";"calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]"
comp1585067_c0_seq1;GAXK01095224.1;P86221;4.54E-70;TBB4B_MESAU;Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1585411_c0_seq1;GAXK01095245.1;Q9P2K1;0;C2D2A_HUMAN;Coiled-coil and C2 domain-containing protein 2A;"ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]; axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]";"GO:0001843; GO:0005829; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:0097711; GO:1904491; GO:1905515; GO:1990403";"axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]";"ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]";
comp158569_c0_seq1;GAXK01088297.1;O14717;2.48E-67;TRDMT_HUMAN;tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog HsaIIP) (DNA MTase homolog HsaIIP) (M.HsaIIP) (PuMet);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175]; response to amphetamine [GO:0001975]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]";"GO:0001975; GO:0003723; GO:0005654; GO:0005737; GO:0006400; GO:0008175; GO:0016428; GO:0030488";"response to amphetamine [GO:0001975]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175]"
comp1586212_c0_seq1;GAXK01078341.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp1586654_c0_seq1;GAXK01078346.1;Q92051;3.17E-37;CAHZ_DANRE;Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";"GO:0004089; GO:0008270; GO:0015670; GO:0042539";"carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp1586746_c0_seq1;GAXK01078344.1;Q13105;2.42E-07;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp158707_c1_seq1;GAXK01088360.1;Q63398;5.89E-123;COE1_RAT;Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor) (Olf-1) (Olfactory neuronal transcription factor);"nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001228; GO:0003677; GO:0005634; GO:0007275; GO:0045944; GO:0046872; GO:0046983; GO:0070742";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp158728_c2_seq1;GAXK01088212.1;Q9VQB7;4.95E-135;EOGT_DROME;EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase);"endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]";"GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0097363; GO:0097370";"larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]";endoplasmic reticulum lumen [GO:0005788];"protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"
comp158738_c1_seq1;GAXK01088096.1;Q6GN29;1.24E-112;ATLA2_XENLA;Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]";"GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0007029; GO:0007030; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809";"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp158740_c0_seq1;GAXK01088308.1;Q96IV6;1.19E-43;FXDC2_HUMAN;Fatty acid hydroxylase domain-containing protein 2;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000254; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]"
comp158755_c0_seq1;GAXK01088218.1;Q61555;6.02E-13;FBN2_MOUSE;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
comp158764_c1_seq1;GAXK01088293.1;Q3TWI9;1.22E-133;CSCL2_MOUSE;CSC1-like protein 2 (Transmembrane protein 63B);"actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]";"GO:0005227; GO:0005886; GO:0015629; GO:0016021";;"actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium activated cation channel activity [GO:0005227]
comp1588324_c0_seq1;GAXK01059192.1;Q9U6D3;6.09E-15;CALM_MYXGL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1588458_c0_seq1;GAXK01059205.1;Q24C27;5.51E-28;RL14_TETTS;60S ribosomal protein L14;"ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1588756_c0_seq1;GAXK01059212.1;Q9P243;7.98E-07;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1588931_c0_seq1;GAXK01059202.1;A0A126GUP6;1.41E-26;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1588956_c0_seq1;GAXK01059201.1;P86221;5.09E-55;TBB4B_MESAU;Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp158907_c0_seq1;GAXK01088302.1;O61491;0;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp158930_c5_seq1;GAXK01088092.1;P98169;2.44E-08;ZXDB_HUMAN;Zinc finger X-linked protein ZXDB;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1589502_c0_seq1;GAXK01059222.1;Q86WI1;4.04E-44;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp158952_c1_seq1;GAXK01088065.1;Q8IN81;1.15E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1589750_c0_seq1;GAXK01059261.1;P13395;8.80E-13;SPTCA_DROME;Spectrin alpha chain;"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693";"actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]"
comp1589988_c0_seq1;GAXK01059210.1;Q9Z336;2.61E-52;DYLT1_RAT;Dynein light chain Tctex-type 1 (Activator of G-protein signaling 2) (AGS2) (T-complex testis-specific protein 1 homolog);"axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]";"GO:0000132; GO:0003774; GO:0005739; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0006886; GO:0008022; GO:0008277; GO:0010976; GO:0016358; GO:0019060; GO:0030027; GO:0035022; GO:0035795; GO:0042802; GO:0043025; GO:0043087; GO:0043657; GO:0044295; GO:0048812; GO:0050768; GO:0051301; GO:0051493; GO:0060548; GO:0061564; GO:0099503";"axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]";"axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]"
comp159_c0_seq1;GAXK01165943.1;Q96T23;3.40E-22;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp1590366_c0_seq1;GAXK01150160.1;Q9Y115;6.48E-42;UN93L_DROME;UNC93-like protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120";"regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";potassium channel regulator activity [GO:0015459]
comp15904_c1_seq1;GAXK01178171.1;O43824;3.07E-87;GTPB6_HUMAN;Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]";"GO:0005525; GO:0005737; GO:0043022; GO:0046872";;cytoplasm [GO:0005737];"GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]"
comp1590536_c0_seq1;GAXK01150164.1;P17276;3.56E-69;PH4H_DROME;Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase);"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";"GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427";"eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";;"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]"
comp1590773_c0_seq1;GAXK01150166.1;Q01717;1.51E-63;TRFR_RAT;Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein homodimerization activity [GO:0090073]";"GO:0004997; GO:0005886; GO:0007200; GO:0007204; GO:0009986; GO:0016021; GO:0042803; GO:0090073";"phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein homodimerization activity [GO:0090073]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein homodimerization activity [GO:0042803]; thyrotropin-releasing hormone receptor activity [GO:0004997]"
comp159080_c0_seq1;GAXK01088300.1;Q9VCU5;2.55E-89;MTG1_DROME;Mitochondrial ribosome-associated GTPase 1 (Mitochondrial GTPase 1);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525; GO:0005739; GO:0005743";;"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp15909_c5_seq1;GAXK01178584.1;Q9H4G4;9.08E-25;GAPR1_HUMAN;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374";"positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";protein homodimerization activity [GO:0042803]
comp1591229_c0_seq1;GAXK01150150.1;Q03720;1.35E-142;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp1591345_c0_seq1;GAXK01150162.1;Q15075;2.41E-30;EEA1_HUMAN;Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2);"axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]";"GO:0003676; GO:0005516; GO:0005545; GO:0005737; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0008270; GO:0016020; GO:0016189; GO:0019897; GO:0030742; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0045022; GO:0055037; GO:0070062";"early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]";"axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]";"1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp1591373_c0_seq1;GAXK01150168.1;P17130;5.33E-21;ROA1_XENLA;Heterogeneous nuclear ribonucleoproteins A1 homolog (hnRNP A1) (Helix-destabilizing protein) (Single-strand-binding protein) (hnRNP core protein A1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp1591422_c0_seq1;GAXK01150145.1;P89116;5.59E-66;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp1591505_c0_seq1;GAXK01150188.1;A2CEA7;6.92E-52;RGRF2_DANRE;Ras-specific guanine nucleotide-releasing factor 2 (Ras-GRF2) (Ras guanine nucleotide exchange factor 2);"endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005089; GO:0005516; GO:0005789; GO:0005886; GO:0007264; GO:0035023";"regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]";"endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1591530_c0_seq1;GAXK01150177.1;Q9XU98;5.76E-11;EVA1_CAEEL;Protein eva-1 (Enhancer of ventral-axon guidance defects of unc-40 mutants);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; carbohydrate binding [GO:0030246]";"GO:0005886; GO:0016021; GO:0030054; GO:0030246; GO:0031430; GO:0055120";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";carbohydrate binding [GO:0030246]
comp159156_c0_seq1;GAXK01088081.1;Q05915;6.48E-97;GCH1_MOUSE;GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; cellular response to lipopolysaccharide [GO:0071222]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; regulation of serotonin biosynthetic process [GO:1905627]; response to interferon-gamma [GO:0034341]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]";"GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042803; GO:0045776; GO:0046654; GO:0048265; GO:0050662; GO:0050884; GO:0051000; GO:0051019; GO:0051066; GO:0051260; GO:0051291; GO:0065003; GO:0071222; GO:1905627; GO:2000121";"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; cellular response to lipopolysaccharide [GO:0071222]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; regulation of serotonin biosynthetic process [GO:1905627]; response to interferon-gamma [GO:0034341]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]"
comp15916_c0_seq1;GAXK01178654.1;Q8IVN8;1.03E-16;SBSPO_HUMAN;Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin);"collagen-containing extracellular matrix [GO:0062023]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]";"GO:0005044; GO:0006955; GO:0030247; GO:0062023";immune response [GO:0006955];collagen-containing extracellular matrix [GO:0062023];"polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp159164_c0_seq1;GAXK01088237.1;Q9NHW7;4.63E-51;AQP_AEDAE;Aquaporin AQPAe.a;"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp1591687_c0_seq1;GAXK01150148.1;Q8WPA2;1.36E-62;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp159214_c1_seq1;GAXK01088066.1;P61859;3.12E-26;CALM_NEUCR;Calmodulin (CaM);"central plaque of spindle pole body [GO:0005823]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";"GO:0005509; GO:0005823; GO:0019722; GO:0051300";"calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";central plaque of spindle pole body [GO:0005823];calcium ion binding [GO:0005509]
comp1592259_c0_seq1;GAXK01111242.1;P30974;2.50E-84;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp159227_c0_seq1;GAXK01088359.1;Q96DX4;0;RSPRY_HUMAN;RING finger and SPRY domain-containing protein 1;"extracellular region [GO:0005576]; metal ion binding [GO:0046872]";"GO:0005576; GO:0046872";;extracellular region [GO:0005576];metal ion binding [GO:0046872]
comp159272_c1_seq1;GAXK01088048.1;Q9D818;1.11E-43;SAPC2_MOUSE;Suppressor APC domain-containing protein 2 (Protein Ang);"apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725]";"GO:0000132; GO:0005634; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777";"establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725]";"apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp15929_c0_seq1;GAXK01177824.1;Q2KJF9;7.30E-69;T2EB_BOVIN;General transcription factor IIE subunit 2 (Transcription initiation factor IIE subunit beta) (TFIIE-beta);"transcription factor TFIIE complex [GO:0005673]; DNA binding [GO:0003677]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003677; GO:0005673; GO:0006367";transcription initiation from RNA polymerase II promoter [GO:0006367];transcription factor TFIIE complex [GO:0005673];DNA binding [GO:0003677]
comp1593_c2_seq1;GAXK01170215.1;Q8C261;3.79E-85;NCKX5_MOUSE;Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5);"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"GO:0005262; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0034220; GO:0042470; GO:0048022; GO:0050896; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp159309_c1_seq1;GAXK01088024.1;Q9NWZ5;1.78E-32;UCKL1_HUMAN;Uridine-cytidine kinase-like 1 (EC 2.7.1.48);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]";"GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0016032; GO:0016301; GO:0043097; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp1593161_c0_seq1;GAXK01111196.1;Q32NH8;3.93E-97;PLCD4_XENLA;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4);"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0007340; GO:0016020; GO:0016042; GO:0035556; GO:0046488";"acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp15932_c0_seq1;GAXK01178269.1;Q9UIJ5;1.72E-92;ZDHC2_HUMAN;Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; cellular protein metabolic process [GO:0044267]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0044267; GO:0055038";"cellular protein metabolic process [GO:0044267]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp1593207_c0_seq1;GAXK01111209.1;Q7KRI2;3.47E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp159360_c3_seq1;GAXK01088309.1;Q8TEB9;6.35E-41;RHBL4_HUMAN;Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]";"GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211";"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]";"endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp159413_c1_seq1;GAXK01088206.1;P98160;9.34E-13;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp159430_c0_seq1;GAXK01088047.1;Q6P9H4;9.35E-50;CNKR3_HUMAN;Connector enhancer of kinase suppressor of ras 3 (Connector enhancer of KSR 3) (CNK homolog protein 3) (CNK3) (CNKSR family member 3) (Maguin-like protein);"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]";"GO:0005737; GO:0010765; GO:0016324; GO:0033137; GO:0070373; GO:2000651";"negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]";"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]";
comp1594394_c0_seq1;GAXK01039625.1;Q26614;4.68E-42;FGFR_STRPU;Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1);"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; positive regulation of cell population proliferation [GO:0008284]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005007; GO:0005524; GO:0005887; GO:0007169; GO:0008284; GO:0017134; GO:0043235";"positive regulation of cell population proliferation [GO:0008284]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp159459_c0_seq1;GAXK01088151.1;Q5TZE1;7.27E-09;BTB6B_DANRE;BTB/POZ domain-containing protein 6-B;"cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp159474_c0_seq1;GAXK01088296.1;Q7KRI2;1.43E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp159482_c1_seq1;GAXK01088307.1;Q08924;8.19E-12;WDR6_YEAST;Regulator of Ty1 transposition protein 10 (Endosomal recycling protein 2) (tRNA (guanosine(34)-2'-O)-methyltransferase non-catalytic subunit TRM734);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endocytic recycling [GO:0032456]; wobble position ribose methylation [GO:0002130]";"GO:0002130; GO:0005737; GO:0005768; GO:0032456";"endocytic recycling [GO:0032456]; wobble position ribose methylation [GO:0002130]";"cytoplasm [GO:0005737]; endosome [GO:0005768]";
comp159499_c0_seq1;GAXK01088046.1;Q6NYU2;0;HELZ_DANRE;Probable helicase with zinc finger domain (EC 3.6.4.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194]";"GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0035194; GO:0043186; GO:0046872";posttranscriptional gene silencing by RNA [GO:0035194];"cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp1595_c0_seq1;GAXK01168569.1;Q9VXE0;1.07E-34;RUXG_DROME;Probable small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0030532; GO:0034719; GO:0043186; GO:0071004; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]";RNA binding [GO:0003723]
comp15950_c0_seq1;GAXK01177806.1;P16554;9.48E-104;NUMB_DROME;Protein numb;"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007400; GO:0007405; GO:0007406; GO:0007417; GO:0007507; GO:0007622; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045165; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692";"asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; Notch binding [GO:0005112]"
comp159546_c1_seq1;GAXK01088075.1;O00060;7.34E-17;CYPH_UROFA;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Planta-induced rust protein 28) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp159554_c0_seq1;GAXK01088020.1;P78362;3.43E-106;SRPK2_HUMAN;"SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000287; GO:0001525; GO:0003723; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0071889";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]"
comp15956_c0_seq1;GAXK01177906.1;Q8CDN6;8.52E-32;TXNL1_MOUSE;Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]";"GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036; GO:0045454";cell redox homeostasis [GO:0045454];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";disulfide oxidoreductase activity [GO:0015036]
comp1595989_c0_seq1;GAXK01039643.1;Q9NDM2;2.03E-20;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp159648_c4_seq1;GAXK01088246.1;P80003;1.72E-24;PA2A2_HELSU;Acidic phospholipase A2 PA4 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) [Cleaved into: Acidic phospholipase A2 PA2];"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp15966_c0_seq1;GAXK01178070.1;Q7T3C6;8.90E-124;CPSF5_DANRE;Cleavage and polyadenylation specificity factor subunit 5 (Nudix hydrolase 21);"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290]";"GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0030154; GO:0031439; GO:0035925; GO:0042382; GO:0042802; GO:0051290; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975";"cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290]";"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]";"AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]"
comp1596942_c0_seq1;GAXK01075521.1;Q8SRF5;6.07E-23;Y823_ENCCU;Probable cell division protein kinase ECU08_0230 (EC 2.7.11.22);"nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp1597307_c0_seq1;GAXK01075509.1;Q05481;1.67E-24;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp159738_c0_seq1;GAXK01088295.1;P22444;8.04E-27;BMP3_BOVIN;Bone morphogenetic protein 3 (BMP-3) (Osteogenin);"extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; cartilage development [GO:0051216]; cell development [GO:0048468]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]";"GO:0001649; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0010862; GO:0042981; GO:0043408; GO:0048468; GO:0051216; GO:0060395; GO:0070700";"cartilage development [GO:0051216]; cell development [GO:0048468]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]";extracellular space [GO:0005615];"BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]"
comp15975_c0_seq1;GAXK01205915.1;Q58H57;0;CBS_MACFA;Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]";"GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0006563; GO:0019343; GO:0030170; GO:0042803; GO:0043418; GO:0046872; GO:0050667; GO:0070814";"cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cystathionine beta-synthase activity [GO:0004122]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]"
comp159761_c0_seq1;GAXK01088330.1;Q9P2F6;1.12E-73;RHG20_HUMAN;Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20);"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005829; GO:0007165; GO:0051056";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";cytosol [GO:0005829];GTPase activator activity [GO:0005096]
comp1597712_c0_seq1;GAXK01075507.1;Q8NDA2;1.37E-11;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp1597737_c0_seq1;GAXK01075526.1;Q09788;3.52E-10;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp159774_c0_seq1;GAXK01088283.1;Q9H334;4.52E-66;FOXP1_HUMAN;Forkhead box protein P1 (Mac-1-regulated forkhead) (MFH);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; interleukin-21 secretion [GO:0072619]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta secretion [GO:0050706]; regulation of interleukin-12 secretion [GO:2001182]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; somatic stem cell population maintenance [GO:0035019]; T follicular helper cell differentiation [GO:0061470]";"GO:0000790; GO:0000981; GO:0002903; GO:0005634; GO:0005654; GO:0006974; GO:0010595; GO:0010629; GO:0030316; GO:0032496; GO:0032680; GO:0035019; GO:0035926; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042802; GO:0043565; GO:0043621; GO:0045655; GO:0045892; GO:0046872; GO:0048661; GO:0050681; GO:0050706; GO:0050727; GO:0050861; GO:0060766; GO:0061470; GO:0072619; GO:1900424; GO:1901256; GO:1901509; GO:2001182";"cellular response to DNA damage stimulus [GO:0006974]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; interleukin-21 secretion [GO:0072619]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-12 secretion [GO:2001182]; regulation of interleukin-1 beta secretion [GO:0050706]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; somatic stem cell population maintenance [GO:0035019]; T follicular helper cell differentiation [GO:0061470]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"androgen receptor binding [GO:0050681]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; sequence-specific DNA binding [GO:0043565]"
comp159782_c0_seq1;GAXK01088083.1;Q8R409;1.01E-17;HEXI1_MOUSE;Protein HEXIM1 (Cardiac lineage protein 1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; snRNA binding [GO:0017069]; activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of signal transduction by p53 class mediator [GO:1901798]";"GO:0000122; GO:0002218; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0007507; GO:0017069; GO:0045087; GO:0045736; GO:0045892; GO:0097322; GO:1901798";"activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; snRNA binding [GO:0017069]"
comp1597838_c0_seq1;GAXK01075505.1;Q68G31;3.85E-34;PBLD_RAT;Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-);"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]";"GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394";"biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]";cytoplasm [GO:0005737];"identical protein binding [GO:0042802]; isomerase activity [GO:0016853]"
comp1597869_c0_seq1;GAXK01204834.1;Q811G0;0;PTHB1_MOUSE;Protein PTHB1 (Bardet-Biedl syndrome 9 protein homolog) (Parathyroid hormone-responsive B1 gene protein homolog);"BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; membrane [GO:0016020]; pericentriolar material [GO:0000242]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]";"GO:0000242; GO:0005929; GO:0015031; GO:0016020; GO:0034451; GO:0034464; GO:0035869; GO:0036064; GO:0045444; GO:0060170; GO:0060271; GO:0061512";"cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]";"BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; membrane [GO:0016020]; pericentriolar material [GO:0000242]";
comp159790_c0_seq1;GAXK01088019.1;P0CH36;5.67E-37;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp159827_c0_seq1;GAXK01088239.1;Q9VQH2;0;DUOX_DROME;Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1);"endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]";"GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593";"adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]";"endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp15983_c1_seq1;GAXK01178055.1;P80311;2.10E-75;PPIB_BOVIN;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"GO:0000413; GO:0003755; GO:0005634; GO:0005788; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070063";"bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]"
comp159872_c1_seq1;GAXK01088234.1;Q16651;1.48E-36;PRSS8_HUMAN;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]; cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0008236; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0046658; GO:0070062; GO:0070268";"cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]"
comp159873_c0_seq1;GAXK01088205.1;Q9V3P0;1.18E-08;PRDX1_DROME;Peroxiredoxin 1 (EC 1.11.1.15) (Cytosolic thioredoxin peroxidase) (DPx-4783) (DmTPx-1) (Thioredoxin peroxidase);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]";"GO:0005829; GO:0006979; GO:0007155; GO:0007281; GO:0008340; GO:0008354; GO:0008379; GO:0019430; GO:0042594; GO:0042744; GO:0045321; GO:0045454";"cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp159884_c1_seq1;GAXK01088064.1;Q9H777;5.65E-74;RNZ1_HUMAN;Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005829; GO:0042781; GO:0046872";;"cytosol [GO:0005829]; nucleus [GO:0005634]";"3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]"
comp1598964_c0_seq1;GAXK01159333.1;A8K7I4;2.47E-77;CLCA1_HUMAN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0034220; GO:0042589; GO:0046872; GO:0071456";"calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp159903_c1_seq1;GAXK01088232.1;Q04205;1.87E-84;TENS_CHICK;Tensin;"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856; GO:0005912; GO:0009986";;"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp1599294_c0_seq1;GAXK01159329.1;Q552Z6;1.74E-07;GTPA_DICDI;GTP-binding protein A;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp159951_c1_seq1;GAXK01088185.1;M9NDE3;0;BARK_DROME;Protein bark beetle (Protein anakonda);"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]";"GO:0005044; GO:0005886; GO:0005912; GO:0005918; GO:0005923; GO:0016021; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:0090557; GO:1904274";"cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]";"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]";"carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]"
comp159954_c0_seq1;GAXK01088087.1;Q5RE08;3.98E-34;FBX22_PONAB;F-box only protein 22;Z disc [GO:0030018];GO:0030018;;Z disc [GO:0030018];
comp1599649_c0_seq1;GAXK01159340.1;Q9Y613;1.78E-30;FHOD1_HUMAN;FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1);"bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleus [GO:0005634]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492]";"GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007097; GO:0014704; GO:0016020; GO:0019904; GO:0032059; GO:0042802; GO:0043621; GO:0045944; GO:0051492; GO:0051496; GO:0051660";"establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492]";"bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleus [GO:0005634]";"actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]"
comp159970_c1_seq1;GAXK01088069.1;Q6PA06;2.47E-165;ATLA2_MOUSE;Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]";"GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0007029; GO:0007030; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809";"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp1600_c0_seq1;GAXK01168692.1;Q9CY21;7.62E-114;BUD23_MOUSE;Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog) (rRNA methyltransferase and ribosome maturation factor);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]";"GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234";"chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]"
comp160000_c0_seq1;GAXK01131617.1;Q5DW34;2.35E-178;EHMT1_MOUSE;Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Lysine N-methyltransferase 1D);"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0060992; GO:0070742; GO:0120162";"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]"
comp160021_c0_seq1;GAXK01131754.1;O70260;2.17E-111;PIAS3_RAT;E3 SUMO-protein ligase PIAS3 (EC 2.3.2.-) (E3 SUMO-protein transferase PIAS3) (KChAP) (Potassium channel-associated protein) (Protein inhibitor of activated STAT protein 3);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; synapse [GO:0045202]; enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"GO:0000122; GO:0001085; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0008022; GO:0008270; GO:0009725; GO:0010628; GO:0015459; GO:0016607; GO:0016925; GO:0019899; GO:0030425; GO:0033234; GO:0033235; GO:0045202; GO:0045671; GO:0045838; GO:0047485; GO:0061665; GO:0071847";"negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; synapse [GO:0045202]";"enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]"
comp160031_c0_seq1;GAXK01131561.1;O94901;3.22E-67;SUN1_HUMAN;SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1);"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0001503; GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0009612; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090286; GO:0090292";"centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]";"lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]"
comp1600408_c0_seq1;GAXK01197099.1;P18735;6.17E-19;ZG7_XENLA;Gastrula zinc finger protein XlCGF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp160048_c1_seq1;GAXK01131789.1;Q6GL42;1.00E-69;TM39A_XENTR;Transmembrane protein 39A;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1600504_c0_seq1;GAXK01197093.1;Q9UMX6;2.87E-14;GUC1B_HUMAN;Guanylyl cyclase-activating protein 2 (GCAP 2) (Guanylate cyclase activator 1B);"photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; body fluid secretion [GO:0007589]; cell-cell signaling [GO:0007267]; phototransduction [GO:0007602]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; visual perception [GO:0007601]";"GO:0001917; GO:0005509; GO:0005886; GO:0007168; GO:0007267; GO:0007589; GO:0007601; GO:0007602; GO:0008048; GO:0022400; GO:0097381";"body fluid secretion [GO:0007589]; cell-cell signaling [GO:0007267]; phototransduction [GO:0007602]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; visual perception [GO:0007601]";"photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp1600665_c0_seq1;GAXK01197101.1;Q10741;1.02E-72;ADA10_BOVIN;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp160069_c0_seq1;GAXK01131615.1;Q9US35;6.92E-55;DSD1_SCHPO;D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase) (DSD);"cytosol [GO:0005829]; nucleus [GO:0005634]; D-serine ammonia-lyase activity [GO:0008721]; D-serine catabolic process [GO:0036088]";"GO:0005634; GO:0005829; GO:0008721; GO:0036088";D-serine catabolic process [GO:0036088];"cytosol [GO:0005829]; nucleus [GO:0005634]";D-serine ammonia-lyase activity [GO:0008721]
comp1600854_c0_seq1;GAXK01197108.1;P52746;9.12E-23;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp160087_c2_seq1;GAXK01131517.1;Q7KRW1;1.05E-133;TRC8_DROME;Protein TRC8 homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ERAD pathway [GO:0036503]; negative regulation of growth [GO:0045926]; protein ubiquitination [GO:0016567]; ventral midline development [GO:0007418]";"GO:0004842; GO:0005783; GO:0005789; GO:0007418; GO:0008270; GO:0012505; GO:0016021; GO:0016567; GO:0036503; GO:0045926; GO:0061630";"ERAD pathway [GO:0036503]; negative regulation of growth [GO:0045926]; protein ubiquitination [GO:0016567]; ventral midline development [GO:0007418]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp160096_c0_seq1;GAXK01131539.1;Q8NAT2;1.16E-17;TDRD5_HUMAN;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp160098_c0_seq1;GAXK01131481.1;D2YVH7;2.34E-09;LECM_OXYSU;C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose-binding isoform 1);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp160129_c0_seq1;GAXK01131791.1;Q6N069;0;NAA16_HUMAN;N-alpha-acetyltransferase 16, NatA auxiliary subunit (NMDA receptor-regulated 1-like protein) (NARG1-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";"GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0017196; GO:0031415; GO:0043022; GO:0043066; GO:0045893; GO:0050821; GO:0070062";"negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";ribosome binding [GO:0043022]
comp160130_c3_seq1;GAXK01131765.1;Q9V427;7.14E-90;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp160136_c6_seq1;GAXK01131610.1;P55262;6.11E-08;ADK_CRIGR;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase);"nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";"GO:0004001; GO:0005524; GO:0005634; GO:0006166; GO:0044209; GO:0046872";"AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";nucleus [GO:0005634];"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp160147_c1_seq1;GAXK01131774.1;Q9Y305;2.83E-126;ACOT9_HUMAN;Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]";"GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689";acyl-CoA metabolic process [GO:0006637];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]"
comp160152_c1_seq1;GAXK01131792.1;Q9UJU3;1.13E-20;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1601528_c0_seq1;GAXK01197096.1;Q26474;1.24E-18;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp160212_c1_seq1;GAXK01131800.1;O45035;2.33E-16;FABP_SCHJA;Fatty acid-binding protein (Sj-FABPc) (Sj14FABP);"cytoplasm [GO:0005737]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289";;cytoplasm [GO:0005737];lipid binding [GO:0008289]
comp160218_c1_seq1;GAXK01131822.1;Q6VUP9;5.53E-101;AP2E_MOUSE;Transcription factor AP-2-epsilon (AP2-epsilon) (Activating enhancer-binding protein 2-epsilon);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0042803; GO:0045944; GO:0046982";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp160223_c0_seq1;GAXK01131620.1;Q6DIV4;1.19E-40;RBM38_XENTR;RNA-binding protein 38 (RNA-binding motif protein 38);"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";"GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0006397; GO:0007275; GO:0008380; GO:0030154; GO:1990904";"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1602316_c0_seq1;GAXK01112818.1;P40313;1.96E-29;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp16025_c0_seq1;GAXK01068390.1;Q9V3H8;5.13E-32;NXT1_DROME;NTF2-related export protein (p15);"cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]";"GO:0005635; GO:0005654; GO:0005737; GO:0006606; GO:0006913; GO:0016973; GO:0044613; GO:0045824; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]";"cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]";
comp160259_c0_seq1;GAXK01131804.1;Q8BHN5;1.63E-30;RBM45_MOUSE;RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:1990904";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp160274_c4_seq1;GAXK01131651.1;Q8R4F0;1.43E-110;MCLN3_MOUSE;Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3);"autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]";"GO:0000421; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016021; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345";"inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]";"autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171]";"lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]"
comp1603007_c0_seq1;GAXK01112807.1;Q6H8Q1;2.28E-07;ABLM2_HUMAN;Actin-binding LIM protein 2 (abLIM-2) (Actin-binding LIM protein family member 2);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]";"GO:0005737; GO:0006351; GO:0015629; GO:0030032; GO:0030036; GO:0046872; GO:0051015";"actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp1603071_c0_seq1;GAXK01112815.1;Q8IS44;4.80E-69;DRD2L_DROME;Dopamine D2-like receptor (DD2R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001591; GO:0004930; GO:0004935; GO:0005887; GO:0007186; GO:0007188; GO:0007212; GO:0007615; GO:0008227; GO:0016021; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]"
comp1603177_c0_seq1;GAXK01112794.1;E9QBI7;4.16E-57;OMA1_DANRE;Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0046872; GO:0097009";"diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp1603279_c0_seq1;GAXK01112796.1;Q3MHE8;1.58E-07;SRPRA_BOVIN;Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha);"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047";"protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]"
comp160336_c0_seq1;GAXK01131616.1;P24091;6.66E-31;CHI2_TOBAC;Endochitinase B (CHN-B) (EC 3.2.1.14);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; plant-type hypersensitive response [GO:0009626]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0008061; GO:0009626; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; plant-type hypersensitive response [GO:0009626]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp160342_c2_seq1;GAXK01131814.1;Q9GRW0;6.80E-53;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1604155_c0_seq1;GAXK01122725.1;Q5I2J3;1.19E-09;TBA_GIBZE;Tubulin alpha chain (Alpha-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1604281_c0_seq1;GAXK01122723.1;P35953;8.00E-27;VLDLR_RABIT;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"GO:0005509; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038025; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006";"cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp1604288_c0_seq1;GAXK01122749.1;P42787;4.14E-25;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp160450_c1_seq1;GAXK01131477.1;Q9CQI3;2.08E-43;GMFB_MOUSE;Glia maturation factor beta (GMF-beta);"actin cortical patch [GO:0030479]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; actin filament debranching [GO:0071846]; learning [GO:0007612]; locomotory behavior [GO:0007626]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]";"GO:0003779; GO:0007612; GO:0007626; GO:0008083; GO:0030479; GO:0034316; GO:0071846; GO:0071933";"actin filament debranching [GO:0071846]; learning [GO:0007612]; locomotory behavior [GO:0007626]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]";actin cortical patch [GO:0030479];"actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]"
comp16046_c0_seq1;GAXK01068085.1;Q08257;1.00E-102;QOR_HUMAN;Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]";"GO:0003730; GO:0003960; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0051289; GO:0070062; GO:0070402";"protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"mRNA 3'-UTR binding [GO:0003730]; NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; zinc ion binding [GO:0008270]"
comp1604663_c0_seq1;GAXK01122757.1;P45436;2.82E-27;CED3_CAERE;"Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]";"cell junction [GO:0030054]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"GO:0004197; GO:0005739; GO:0006915; GO:0030054; GO:0031965; GO:0042981; GO:0043204; GO:0045202; GO:0048471";"apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"cell junction [GO:0030054]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]";cysteine-type endopeptidase activity [GO:0004197]
comp1604784_c0_seq1;GAXK01122751.1;Q8BYM5;3.32E-90;NLGN3_MOUSE;Neuroligin-3 (Gliotactin homolog);"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]";"GO:0002087; GO:0005887; GO:0006898; GO:0007158; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030054; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0043025; GO:0045202; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051966; GO:0051968; GO:0060024; GO:0060076; GO:0060077; GO:0060079; GO:0060080; GO:0060291; GO:0060999; GO:0061001; GO:0061002; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0097151; GO:0098698; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099060; GO:1900271; GO:1902474; GO:2000310; GO:2000311; GO:2000331; GO:2000463; GO:2000809; GO:2000969";"adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]";"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp16048_c2_seq1;GAXK01068251.1;P46436;3.15E-41;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp160482_c0_seq1;GAXK01131751.1;Q91YA9;5.39E-150;BMAL1_NANGA;Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1);"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; circadian regulation of gene expression [GO:0032922]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]";"GO:0000980; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007283; GO:0016605; GO:0032007; GO:0032922; GO:0033391; GO:0042634; GO:0042753; GO:0043161; GO:0045599; GO:0045893; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0070888; GO:0090263; GO:0090403; GO:1901985; GO:2000074; GO:2000772; GO:2001016";"circadian regulation of gene expression [GO:0032922]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]"
comp1604825_c0_seq1;GAXK01122752.1;Q55EH8;2.04E-78;ABCGN_DICDI;ABC transporter G family member 23 (ABC transporter ABCG.23);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016021; GO:0016887";;integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp1605003_c0_seq1;GAXK01122738.1;Q80WC3;7.03E-11;TNC18_MOUSE;Trinucleotide repeat-containing gene 18 protein (Zinc finger protein 469);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]";"GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0031965";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp1605343_c0_seq1;GAXK01122740.1;Q7ZV84;7.56E-63;DAAF1_DANRE;Dynein assembly factor 1, axonemal (Leucine-rich repeat-containing protein 50);"axoneme [GO:0005930]; dynein complex binding [GO:0070840]; axoneme assembly [GO:0035082]; cell migration involved in heart jogging [GO:0003305]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; gastrulation [GO:0007369]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart rudiment morphogenesis [GO:0003314]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; spermatogenesis [GO:0007283]";"GO:0001947; GO:0003143; GO:0003146; GO:0003305; GO:0003314; GO:0005930; GO:0007283; GO:0007368; GO:0007369; GO:0035082; GO:0044458; GO:0048793; GO:0060027; GO:0060271; GO:0061371; GO:0070840";"axoneme assembly [GO:0035082]; cell migration involved in heart jogging [GO:0003305]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; gastrulation [GO:0007369]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart rudiment morphogenesis [GO:0003314]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; spermatogenesis [GO:0007283]";axoneme [GO:0005930];dynein complex binding [GO:0070840]
comp160546_c0_seq1;GAXK01131484.1;Q3SZP8;4.67E-55;TAD2A_BOVIN;Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; positive regulation of histone acetylation [GO:0035066]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]";"GO:0000278; GO:0001932; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0005694; GO:0006338; GO:0006357; GO:0016573; GO:0031063; GO:0031647; GO:0035066; GO:0070461; GO:0072686; GO:0090043";"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; positive regulation of histone acetylation [GO:0035066]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp1605495_c0_seq1;GAXK01122737.1;Q8MUJ1;4.33E-13;EIGER_DROME;"Protein eiger [Cleaved into: Protein eiger, membrane form; Protein eiger, soluble form]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006955; GO:0007254; GO:0014009; GO:0032813; GO:0035006; GO:0043652; GO:0044214; GO:0045087; GO:0045167; GO:0045176; GO:0050829; GO:0070050; GO:0097191; GO:1900074; GO:1904058";"apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]";"cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]"
comp160551_c0_seq1;GAXK01131499.1;Q8K1C7;8.78E-40;MOT14_MOUSE;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1605733_c0_seq1;GAXK01122724.1;Q6DDV0;4.93E-08;MYNN_XENLA;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16058_c0_seq1;GAXK01068032.1;P54385;0;DHE3_DROME;Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0019551; GO:0042802";"glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp16059_c0_seq1;GAXK01067455.1;Q9S725;1.19E-111;4CL2_ARATH;4-coumarate--CoA ligase 2 (4CL 2) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 2) (At4CL2) (4-coumaroyl-CoA synthase 2);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp160597_c1_seq1;GAXK01131536.1;A7Y2X0;8.64E-136;SC6A5_XENLA;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp16062_c0_seq1;GAXK01068227.1;Q8WR63;4.12E-21;TPM_TRIPS;Tropomyosin;;;;;
comp1606274_c0_seq1;GAXK01021348.1;A6H782;1.21E-79;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp1606532_c0_seq1;GAXK01021359.1;Q29013;2.75E-71;PO2F2_PIG;POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2) (Oct-2) (Octamer-binding transcription factor 2) (OTF-2);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0005634; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp1606542_c0_seq1;GAXK01021381.1;Q8BJ90;9.11E-25;ZN771_MOUSE;Zinc finger protein 771;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1606633_c0_seq1;GAXK01021349.1;Q1H9T6;4.32E-07;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1606668_c0_seq1;GAXK01021340.1;B4SLL0;5.81E-08;ASPN_STRM5;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1606894_c0_seq1;GAXK01021365.1;Q7K237;9.84E-07;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp16072_c1_seq1;GAXK01068231.1;Q15428;2.04E-112;SF3A2_HUMAN;Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]";"GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241";"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]";"RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1607541_c0_seq1;GAXK01021360.1;P98073;7.35E-13;ENTK_HUMAN;"Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]";"brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021";;"brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp160759_c1_seq1;GAXK01131503.1;P05187;4.01E-52;PPB1_HUMAN;Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]";"GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0031225";;"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]"
comp160762_c1_seq1;GAXK01131749.1;Q5RAQ5;1.08E-59;APC4_PONAB;Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4);"anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";"GO:0005680; GO:0007049; GO:0030071; GO:0031145; GO:0051301; GO:0070979";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";anaphase-promoting complex [GO:0005680];
comp1607736_c0_seq1;GAXK01021374.1;Q95RJ9;1.58E-10;EBI_DROME;F-box-like/WD repeat-containing protein ebi;"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cellular response to light stimulus [GO:0071482]; chaeta development [GO:0022416]; histone deacetylation [GO:0016575]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; photoreceptor cell development [GO:0042461]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of Notch signaling pathway [GO:0045747]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]; visual perception [GO:0007601]; wing disc development [GO:0035220]";"GO:0000118; GO:0003682; GO:0003714; GO:0005634; GO:0005700; GO:0006357; GO:0006979; GO:0007049; GO:0007601; GO:0008587; GO:0016575; GO:0017053; GO:0022416; GO:0031065; GO:0035220; GO:0042058; GO:0042461; GO:0043161; GO:0043524; GO:0045572; GO:0045747; GO:0045892; GO:0046329; GO:0070050; GO:0070491; GO:0071482";"cell cycle [GO:0007049]; cellular response to light stimulus [GO:0071482]; chaeta development [GO:0022416]; histone deacetylation [GO:0016575]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; photoreceptor cell development [GO:0042461]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of Notch signaling pathway [GO:0045747]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]; visual perception [GO:0007601]; wing disc development [GO:0035220]";"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]"
comp160795_c3_seq1;GAXK01131526.1;Q68EJ0;1.98E-97;NB5R4_RAT;Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R);"endoplasmic reticulum [GO:0005783]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADPH-hemoprotein reductase activity [GO:0003958]; generation of precursor metabolites and energy [GO:0006091]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]";"GO:0003958; GO:0004128; GO:0005783; GO:0006091; GO:0006739; GO:0006801; GO:0020037; GO:0046872; GO:0050660; GO:0055114";"generation of precursor metabolites and energy [GO:0006091]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]";endoplasmic reticulum [GO:0005783];"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADPH-hemoprotein reductase activity [GO:0003958]"
comp160858_c1_seq1;GAXK01131614.1;Q03427;1.42E-44;LAMC_DROME;Lamin-C (pG-IF);"lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]; structural constituent of cytoskeleton [GO:0005200]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear pore distribution [GO:0031081]; regulation of actin filament polymerization [GO:0030833]; tendon development [GO:0035989]";"GO:0005200; GO:0005638; GO:0005652; GO:0006325; GO:0006342; GO:0007112; GO:0016020; GO:0030833; GO:0031081; GO:0034399; GO:0035989; GO:0060415; GO:0070732";"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear pore distribution [GO:0031081]; regulation of actin filament polymerization [GO:0030833]; tendon development [GO:0035989]";"lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]";structural constituent of cytoskeleton [GO:0005200]
comp1608949_c0_seq1;GAXK01001432.1;Q16534;3.37E-13;HLF_HUMAN;Hepatic leukemia factor;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp160907_c0_seq1;GAXK01131479.1;Q24292;0;DS_DROME;Protein dachsous (Adherin);"apicolateral plasma membrane [GO:0016327]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000904; GO:0001736; GO:0005509; GO:0005886; GO:0007156; GO:0008283; GO:0016021; GO:0016327; GO:0018149; GO:0030054; GO:0035331; GO:0035332; GO:0042067; GO:0060071; GO:0090251";"cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"apicolateral plasma membrane [GO:0016327]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp1609316_c0_seq1;GAXK01001452.1;Q7K4Y6;4.55E-26;DAT_DROME;Sodium-dependent dopamine transporter (Protein fumin);"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]";"GO:0005328; GO:0005330; GO:0005886; GO:0005887; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834";"adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]";"integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp160970_c0_seq1;GAXK01131794.1;Q8BYM5;3.28E-63;NLGN3_MOUSE;Neuroligin-3 (Gliotactin homolog);"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]";"GO:0002087; GO:0005887; GO:0006898; GO:0007158; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030054; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0043025; GO:0045202; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051966; GO:0051968; GO:0060024; GO:0060076; GO:0060077; GO:0060079; GO:0060080; GO:0060291; GO:0060999; GO:0061001; GO:0061002; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0097151; GO:0098698; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099060; GO:1900271; GO:1902474; GO:2000310; GO:2000311; GO:2000331; GO:2000463; GO:2000809; GO:2000969";"adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]";"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp160979_c0_seq1;GAXK01131718.1;Q9M2P4;1.60E-12;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp161005_c2_seq1;GAXK01131722.1;O97341;9.99E-55;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1610097_c0_seq1;GAXK01028154.1;Q9VZS6;5.71E-14;NSMA_DROME;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp16102_c0_seq1;GAXK01067379.1;Q8BS40;2.91E-40;CPTP_MOUSE;Ceramide-1-phosphate transfer protein (CPTP) (Glycolipid transfer protein domain-containing protein 1);"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]";"GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0010008; GO:0010507; GO:0035627; GO:0050713; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389";"ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]";"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]";"ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]"
comp1610495_c0_seq1;GAXK01028155.1;Q7KRI2;2.31E-07;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp161063_c0_seq1;GAXK01131655.1;Q4V8V2;7.12E-71;NUD17_DANRE;Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-);"cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]";"GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872";"NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]"
comp1610910_c0_seq1;GAXK01028165.1;P47861;9.21E-09;SYT5_RAT;Synaptotagmin-5 (Synaptotagmin IX) (Synaptotagmin V) (SytV);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0014059; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0043025; GO:0046982; GO:0048471; GO:0048488; GO:0048791; GO:0055038; GO:0070382; GO:0071277; GO:0099066; GO:1990769";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp1611_c1_seq1;GAXK01168785.1;Q9W4J5;1.09E-90;NEP1_DROME;Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine-N1)-methyltransferase) (Ribosome biogenesis protein NEP1);"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; defense response to bacterium [GO:0042742]; rRNA base methylation [GO:0070475]; rRNA methylation [GO:0031167]";"GO:0005730; GO:0019843; GO:0031167; GO:0032040; GO:0042742; GO:0070037; GO:0070475";"defense response to bacterium [GO:0042742]; rRNA base methylation [GO:0070475]; rRNA methylation [GO:0031167]";"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";"rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]"
comp16111_c1_seq1;GAXK01067377.1;Q24046;4.90E-39;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp16112_c10_seq1;GAXK01068042.1;Q72HI4;3.25E-11;MENG_THET2;Demethylmenaquinone methyltransferase (EC 2.1.1.163);"S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]";"GO:0009234; GO:0102955";menaquinone biosynthetic process [GO:0009234];;S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]
comp161160_c0_seq1;GAXK01131627.1;Q19269;1.17E-19;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp161168_c0_seq1;GAXK01131524.1;Q6PHF0;5.24E-43;CHM1A_DANRE;Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a);"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0007076; GO:0015031; GO:0016363; GO:0021549; GO:0032509; GO:0045324";"cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]";
comp1611739_c0_seq1;GAXK01028157.1;Q8NFU0;3.52E-84;BEST4_HUMAN;Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp161183_c0_seq1;GAXK01131790.1;Q9VVW3;9.78E-55;SFXN2_DROME;Sideroflexin-2;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"GO:0005739; GO:0006730; GO:0016021; GO:0022889; GO:0031966; GO:0140300; GO:1990542";"mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";serine transmembrane transporter activity [GO:0022889]
comp1611960_c0_seq1;GAXK01028152.1;Q9JK45;1.08E-23;KCNQ5_MOUSE;Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5);"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005516; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp161237_c0_seq1;GAXK01131588.1;Q8TCB0;5.87E-19;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp1612549_c0_seq1;GAXK01114791.1;Q6WQJ1;2.24E-41;DGLA_MOUSE;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp16126_c2_seq1;GAXK01068346.1;O76878;9.05E-61;RIPL_DROME;RILP-like protein homolog (Rab-interacting lysosomal protein-like);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; dynein light intermediate chain binding [GO:0051959]; GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; lysosome localization [GO:0032418]";"GO:0005737; GO:0005765; GO:0030742; GO:0031267; GO:0032418; GO:0036064; GO:0048471; GO:0051959; GO:0060271";"cilium assembly [GO:0060271]; lysosome localization [GO:0032418]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]";"dynein light intermediate chain binding [GO:0051959]; GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]"
comp16131_c0_seq1;GAXK01068403.1;P36609;7.57E-26;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1613143_c0_seq1;GAXK01114772.1;Q60779;8.24E-89;DRC4_MOUSE;Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526]";"GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005874; GO:0005929; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0015630; GO:0017137; GO:0030317; GO:0031514; GO:0034613; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0060294; GO:0097729; GO:1903566; GO:1904526";"axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]";"microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]"
comp16132_c0_seq1;GAXK01068538.1;Q8WYH8;5.83E-60;ING5_HUMAN;Inhibitor of growth protein 5 (p28ING5);"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006473; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0045893; GO:0045926; GO:0046872; GO:0070776; GO:1901796; GO:2001235";"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]";"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp161328_c0_seq1;GAXK01205694.1;Q9Z2V5;0;HDAC6_MOUSE;Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2);"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dynein complex [GO:0030286]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000118; GO:0000209; GO:0000978; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006511; GO:0006515; GO:0006886; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0009636; GO:0009967; GO:0010033; GO:0010469; GO:0010634; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019213; GO:0030286; GO:0030424; GO:0030425; GO:0031252; GO:0031593; GO:0031625; GO:0031647; GO:0032041; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0044297; GO:0045598; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090035; GO:0090042; GO:0098779; GO:1901300";"aggresome assembly [GO:0070842]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dynein complex [GO:0030286]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp161338_c0_seq1;GAXK01131784.1;P37137;1.29E-47;LHX5_XENLA;LIM/homeobox protein Lhx5 (LIM homeobox protein 5) (Homeobox protein LIM-5) (xLIM-5) (xLIM-2A);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp161364_c0_seq1;GAXK01131771.1;Q5K2P9;2.14E-16;POLS2_RAT;Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]";"GO:0004252; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp1613742_c0_seq1;GAXK01114781.1;P41366;2.64E-23;VMO1_CHICK;Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI);"cell [GO:0005623]; extracellular space [GO:0005615]";"GO:0005615; GO:0005623";;"cell [GO:0005623]; extracellular space [GO:0005615]";
comp1613913_c0_seq1;GAXK01114788.1;Q6P1L6;1.36E-28;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1613988_c0_seq1;GAXK01114785.1;P0DN67;1.19E-15;ACTP1_TERSU;Tereporin-Ts1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp161399_c0_seq1;GAXK01131566.1;Q8R0T2;1.74E-18;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp161409_c0_seq1;GAXK01131486.1;Q7ZX06;2.54E-18;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp161410_c0_seq1;GAXK01131538.1;Q9EPN1;0;NBEA_MOUSE;Neurobeachin (Lysosomal-trafficking regulator 2);"cell junction [GO:0030054]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; trans-Golgi network [GO:0005802]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization [GO:0008104]; protein targeting [GO:0006605]";"GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006892; GO:0008104; GO:0012505; GO:0019901; GO:0030054; GO:0045211; GO:0051018";"post-Golgi vesicle-mediated transport [GO:0006892]; protein localization [GO:0008104]; protein targeting [GO:0006605]";"cell junction [GO:0030054]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; trans-Golgi network [GO:0005802]";"protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]"
comp161449_c0_seq1;GAXK01131807.1;O74259;1.55E-47;GPA1_SPOS1;Guanine nucleotide-binding protein subunit alpha;"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1614527_c0_seq1;GAXK01037137.1;Q86UD5;2.67E-52;SL9B2_HUMAN;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]"
comp16146_c0_seq1;GAXK01068333.1;Q9H4M9;0;EHD1_HUMAN;EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin);"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0007596; GO:0010008; GO:0010886; GO:0016020; GO:0017137; GO:0020018; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0045296; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:1901741; GO:1990090; GO:2001137";"blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]"
comp161460_c0_seq1;GAXK01131493.1;Q7KRI2;1.96E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1615_c3_seq1;GAXK01166371.1;Q5ZHZ0;0;DX39B_CHICK;Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56);"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]";"GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0016607; GO:0032786; GO:0051028; GO:2000002";"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]";"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp16150_c0_seq1;GAXK01067449.1;Q9V3D2;5.61E-167;HEM6_DROME;Oxygen-dependent coproporphyrinogen-III oxidase (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004109; GO:0005737; GO:0005739; GO:0006782; GO:0006783; GO:0042803";"heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]"
comp1615068_c0_seq1;GAXK01037146.1;Q16TM5;2.19E-36;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp16151_c1_seq1;GAXK01067516.1;O35426;4.26E-15;XBP1_MOUSE;"X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; presynapse [GO:0098793]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation [GO:0002070]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001085; GO:0001158; GO:0001525; GO:0001558; GO:0001889; GO:0001934; GO:0001935; GO:0002020; GO:0002070; GO:0002639; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006357; GO:0006366; GO:0006511; GO:0006629; GO:0006914; GO:0006990; GO:0007517; GO:0008284; GO:0010506; GO:0010508; GO:0010832; GO:0014065; GO:0015031; GO:0019901; GO:0030176; GO:0030335; GO:0030512; GO:0030968; GO:0031017; GO:0031062; GO:0031490; GO:0031625; GO:0031647; GO:0031648; GO:0031670; GO:0032008; GO:0032869; GO:0034599; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036312; GO:0042149; GO:0042307; GO:0042493; GO:0042593; GO:0042632; GO:0042826; GO:0043066; GO:0043565; GO:0044212; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048010; GO:0048666; GO:0051024; GO:0051602; GO:0055089; GO:0055092; GO:0060096; GO:0060394; GO:0060612; GO:0060691; GO:0070059; GO:0070373; GO:0071222; GO:0071230; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0098793; GO:1900100; GO:1900102; GO:1900103; GO:1901800; GO:1901985; GO:1902236; GO:1903489; GO:1990418; GO:1990830; GO:2000347; GO:2000353; GO:2000778";"adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation [GO:0002070]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; presynapse [GO:0098793]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]"
comp161518_c1_seq1;GAXK01131515.1;P32717;3.56E-54;YJCS_ECOLI;Putative alkyl/aryl-sulfatase YjcS (EC 3.1.6.-);"outer membrane-bounded periplasmic space [GO:0030288]; alkyl sulfatase activity [GO:0018741]; protein dimerization activity [GO:0046983]; dodecyl sulfate metabolic process [GO:0018909]";"GO:0018741; GO:0018909; GO:0030288; GO:0046983";dodecyl sulfate metabolic process [GO:0018909];outer membrane-bounded periplasmic space [GO:0030288];"alkyl sulfatase activity [GO:0018741]; protein dimerization activity [GO:0046983]"
comp1615262_c0_seq1;GAXK01037147.1;P0DJ52;1.92E-115;RL8_TETTS;60S ribosomal protein L8;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp161544_c0_seq1;GAXK01131501.1;P08159;5.62E-13;HDNO_PSEOX;6-hydroxy-D-nicotine oxidase (6-HDNO) (EC 1.5.3.6);"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]; nicotine catabolic process [GO:0019608]";"GO:0018530; GO:0019608; GO:0071949";nicotine catabolic process [GO:0019608];;"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]"
comp1615451_c0_seq1;GAXK01037148.1;G3V893;1.59E-07;ZN335_RAT;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000979; GO:0002052; GO:0005634; GO:0007420; GO:0010468; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0050671; GO:0050769; GO:0080182; GO:2000327";"brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp1615715_c0_seq1;GAXK01037141.1;Q505J3;1.18E-19;WSCD1_RAT;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp1615977_c1_seq1;GAXK01037144.1;Q09466;7.67E-12;WHT3_CAEEL;ABC transporter ATP-binding protein/permease wht-3 (White related ABC transporter 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp1615999_c0_seq1;GAXK01037125.1;Q80W68;8.13E-16;KIRR1_MOUSE;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005886; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";myosin binding [GO:0017022]
comp16160_c1_seq1;GAXK01067504.1;P0CJ14;6.22E-10;VP302_LYCMC;Venom protein 302;"extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; regulation of cell growth [GO:0001558]";"GO:0001558; GO:0005520; GO:0005576";regulation of cell growth [GO:0001558];extracellular region [GO:0005576];insulin-like growth factor binding [GO:0005520]
comp161635_c0_seq1;GAXK01131759.1;Q26474;7.00E-21;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp16169_c0_seq1;GAXK01068401.1;A5HII1;9.13E-23;ACTN_ACTDE;Actinidain (Actinidin) (EC 3.4.22.14) (Allergen Act d 1) (allergen Act d 1);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp161703_c1_seq1;GAXK01131720.1;A0R665;1.30E-86;ETHA_MYCS2;FAD-containing monooxygenase EthA (EC 1.14.13.-) (Baeyer-Villiger monooxygenase) (BVMO) (Prodrug activator EtaA);"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]";"GO:0004499; GO:0005886; GO:0050660; GO:0050661";;plasma membrane [GO:0005886];"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp161710_c1_seq1;GAXK01131626.1;P46575;1.62E-14;RL40_EIMBO;"Ubiquitin-60S ribosomal protein L40 (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52) (CEP53)]";"nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp1617309_c0_seq1;GAXK01098335.1;O94469;8.66E-31;DUR31_SCHPO;Probable urea active transporter 1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918";"putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]"
comp1617485_c0_seq1;GAXK01098339.1;P62144;1.23E-51;CALM_ANAPL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp161752_c1_seq1;GAXK01131535.1;Q8VHI3;2.04E-123;OFUT2_MOUSE;GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]";"GO:0001707; GO:0005783; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036065; GO:0036066; GO:0046922; GO:0051046";"fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]"
comp161763_c0_seq1;GAXK01131778.1;P41933;1.02E-10;ODR7_CAEEL;Nuclear hormone receptor family member odr-7 (Odorant response abnormal protein 7);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative adaptation of signaling pathway [GO:0022401]; positive chemotaxis [GO:0050918]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of smell [GO:0007608]";"GO:0001228; GO:0005634; GO:0007608; GO:0008270; GO:0022401; GO:0043565; GO:0045944; GO:0048471; GO:0050918";"negative adaptation of signaling pathway [GO:0022401]; positive chemotaxis [GO:0050918]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of smell [GO:0007608]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1617743_c0_seq1;GAXK01098327.1;Q09788;1.07E-09;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp1618036_c0_seq1;GAXK01009101.1;Q6P6Z0;4.83E-11;DDB1_XENLA;DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008";"DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp161827_c0_seq1;GAXK01131516.1;Q8UWJ4;2.67E-159;DLLD_DANRE;Delta-like protein D (DeltaD) (After eight protein);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract morphogenesis [GO:0048546]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; lateral inhibition [GO:0046331]; Notch signaling pathway [GO:0007219]; regulation of hematopoietic stem cell differentiation [GO:1902036]; sclerotome development [GO:0061056]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0001756; GO:0002244; GO:0003140; GO:0005112; GO:0005509; GO:0005737; GO:0005886; GO:0007219; GO:0007368; GO:0009952; GO:0016020; GO:0016021; GO:0021514; GO:0021523; GO:0030165; GO:0035469; GO:0046331; GO:0048471; GO:0048546; GO:0060218; GO:0060271; GO:0061056; GO:0071910; GO:1902036";"anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract morphogenesis [GO:0048546]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; lateral inhibition [GO:0046331]; Notch signaling pathway [GO:0007219]; regulation of hematopoietic stem cell differentiation [GO:1902036]; sclerotome development [GO:0061056]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]"
comp161957_c0_seq1;GAXK01131482.1;P09480;8.91E-33;ACHA2_CHICK;Neuronal acetylcholine receptor subunit alpha-2;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1619613_c0_seq1;GAXK01009112.1;Q866E1;4.72E-19;FUT1_ALOBE;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp161968_c1_seq1;GAXK01131783.1;Q28658;4.65E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp1619696_c0_seq1;GAXK01009109.1;P25776;2.37E-42;ORYA_ORYSJ;Oryzain alpha chain (EC 3.4.22.-);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp1619868_c0_seq1;GAXK01009105.1;P0DM39;1.02E-07;SLDB_TRIAB;Snaclec alboaggregin-D subunit beta;"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp161993_c3_seq1;GAXK01131591.1;P42519;3.22E-13;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp1620286_c0_seq1;GAXK01007805.1;Q28IU1;1.05E-60;DHB12_XENTR;Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342";"estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]"
comp1620295_c0_seq1;GAXK01007771.1;Q8ITC7;9.47E-44;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp162030_c0_seq1;GAXK01120610.1;P11049;6.90E-10;CD37_HUMAN;Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37);"extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"GO:0001772; GO:0005887; GO:0016020; GO:0070062";;"extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp162039_c1_seq1;GAXK01120734.1;P07902;3.66E-161;GALT_HUMAN;Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]";"GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499";"galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]"
comp162052_c0_seq1;GAXK01120717.1;P11420;8.16E-26;DA_DROME;Protein daughterless;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0061101; GO:0061382";"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp1621_c11_seq1;GAXK01166080.1;Q27527;0;ENO_CAEEL;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase);"cytoplasm [GO:0005737]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0005737; GO:0006096";glycolytic process [GO:0006096];"cytoplasm [GO:0005737]; phosphopyruvate hydratase complex [GO:0000015]";"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp162109_c0_seq1;GAXK01120794.1;Q05319;2.79E-52;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp162154_c0_seq1;GAXK01120811.1;Q5SYL3;0;K0100_MOUSE;Protein KIAA0100;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp162176_c2_seq1;GAXK01120830.1;Q96EP0;2.28E-85;RNF31_HUMAN;E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein);"CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]";"GO:0000209; GO:0004842; GO:0005829; GO:0007249; GO:0009898; GO:0010803; GO:0023035; GO:0031625; GO:0035631; GO:0043123; GO:0043130; GO:0046872; GO:0050852; GO:0051092; GO:0071797; GO:0097039; GO:1903955";"CD40 signaling pathway [GO:0023035]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]";"CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]";"metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp1621897_c0_seq1;GAXK01007802.1;Q9JI93;5.12E-09;A4GAT_RAT;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp1622_c0_seq1;GAXK01168225.1;P48149;9.72E-63;RS15A_DROME;40S ribosomal protein S15Aa;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp1622108_c0_seq1;GAXK01190330.1;Q9JJ57;1.27E-51;KCIP1_MOUSE;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]; positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0034705; GO:0043025; GO:0044325; GO:0045760; GO:0046982; GO:0047485; GO:1901379";"positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]"
comp1622359_c0_seq1;GAXK01190313.1;Q8VIG1;3.31E-17;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp162244_c0_seq1;GAXK01120817.1;P10076;6.48E-31;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp162255_c1_seq1;GAXK01120588.1;Q94900;4.32E-25;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp162260_c1_seq1;GAXK01120790.1;Q9VRJ2;5.38E-82;FITM_DROME;Fat storage-inducing transmembrane protein;"integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730]";"GO:0007605; GO:0008344; GO:0008654; GO:0019915; GO:0030176; GO:0030730; GO:0034389; GO:0050773";"adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730]";integral component of endoplasmic reticulum membrane [GO:0030176];
comp162275_c3_seq1;GAXK01120619.1;Q17449;3.25E-64;FAAH1_CAEEL;Fatty acid amide hydrolase 1 (EC 3.5.1.99);"amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; fatty acid catabolic process [GO:0009062]; positive regulation of axon regeneration [GO:0048680]";"GO:0004040; GO:0009062; GO:0017064; GO:0048680; GO:0102077; GO:0103073";"fatty acid catabolic process [GO:0009062]; positive regulation of axon regeneration [GO:0048680]";;"amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]"
comp162296_c0_seq1;GAXK01120764.1;P14533;9.14E-12;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp162330_c1_seq1;GAXK01120843.1;Q94890;4.59E-90;H15_DROME;T-box protein H15;"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cardioblast cell fate commitment [GO:0042684]; cell fate specification [GO:0001708]; chorion-containing eggshell pattern formation [GO:0030381]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; heart process [GO:0003015]; leg disc pattern formation [GO:0035223]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]";"GO:0000122; GO:0000977; GO:0001102; GO:0001228; GO:0001708; GO:0003015; GO:0005634; GO:0007507; GO:0030381; GO:0035050; GO:0035223; GO:0042659; GO:0042684; GO:0045944";"cardioblast cell fate commitment [GO:0042684]; cell fate specification [GO:0001708]; chorion-containing eggshell pattern formation [GO:0030381]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; heart process [GO:0003015]; leg disc pattern formation [GO:0035223]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell fate specification [GO:0042659]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1623396_c0_seq1;GAXK01190325.1;P50430;1.14E-27;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp162365_c0_seq1;GAXK01120738.1;Q7KVA1;4.88E-12;XYLT_DROME;Xylosyltransferase oxt (EC 2.4.2.26) (Imaginal disk type I) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030201; GO:0030204; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp162378_c0_seq1;GAXK01120507.1;Q7T3C7;1.64E-32;RT4I1_DANRE;Reticulon-4-interacting protein 1 homolog, mitochondrial;"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"GO:0005739; GO:0005741; GO:0010842; GO:0016491; GO:0042462; GO:0050773";"eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp1624_c1_seq1;GAXK01169399.1;Q32N70;3.89E-75;YKT6B_XENLA;Synaptobrevin homolog YKT6-B (EC 2.3.1.-);"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]";"GO:0000139; GO:0005783; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]";"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp16240_c3_seq1;GAXK01067553.1;Q6GPF3;0;CUL3B_XENLA;Cullin-3-B (CUL-3-B);"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]";"GO:0000139; GO:0005634; GO:0005827; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208";"cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]";ubiquitin protein ligase binding [GO:0031625]
comp1624198_c0_seq1;GAXK01180933.1;P27590;6.66E-10;UROM_RAT;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; response to organic substance [GO:0010033]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0010033; GO:0016323; GO:0016324; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0060170";response to organic substance [GO:0010033];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";calcium ion binding [GO:0005509]
comp1624561_c0_seq1;GAXK01180947.1;Q8IN81;1.84E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp162457_c1_seq1;GAXK01120758.1;O35657;4.60E-17;NEUR1_MOUSE;Sialidase-1 (EC 3.2.1.18) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1);"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313]; positive regulation of neuron projection development [GO:0010976]; regulation of myoblast proliferation [GO:2000291]";"GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0009986; GO:0010976; GO:0016020; GO:0016997; GO:0030054; GO:0031410; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796; GO:2000291";"ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313]; positive regulation of neuron projection development [GO:0010976]; regulation of myoblast proliferation [GO:2000291]";"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]"
comp1624587_c0_seq1;GAXK01180962.1;Q0V8T0;2.42E-18;CNTP5_CANLF;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp162460_c2_seq1;GAXK01120849.1;Q02157;1.53E-44;LIPP_RABIT;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp162498_c1_seq1;GAXK01120795.1;O95185;4.73E-142;UNC5C_HUMAN;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030054; GO:0030175; GO:0030334; GO:0030425; GO:0030426; GO:0033564; GO:0043025; GO:0043065; GO:0045202; GO:0061643; GO:1990791";"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"
comp1625_c0_seq1;GAXK01168773.1;C4N147;4.75E-28;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp162504_c3_seq1;GAXK01120601.1;Q08180;7.82E-88;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp1625177_c0_seq1;GAXK01180939.1;G5ED00;5.28E-11;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp162530_c1_seq1;GAXK01120513.1;P30044;5.02E-59;PRDX5_HUMAN;Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]";"GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]"
comp1625377_c0_seq1;GAXK01180949.1;Q63481;5.45E-37;RAB7L_RAT;Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29);"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0032482; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0048471; GO:0050862; GO:0055037; GO:0070840; GO:0072657; GO:0090316; GO:1901214; GO:1905279; GO:1990967";"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]";"dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]"
comp1625858_c0_seq1;GAXK01180944.1;P08048;4.94E-14;ZFY_HUMAN;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005654; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp162590_c0_seq1;GAXK01120829.1;Q14591;4.96E-25;ZN271_HUMAN;Deleted.;;;;;
comp1626085_c0_seq1;GAXK01057102.1;Q8MJ44;7.25E-71;KAPCA_CANLF;cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11);"acrosomal vesicle [GO:0001669]; cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; peptidyl-serine phosphorylation [GO:0018105]; protein kinase A signaling [GO:0010737]; signal transduction [GO:0007165]";"GO:0001669; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005952; GO:0007165; GO:0010737; GO:0018105; GO:0034237; GO:0034605; GO:0036126; GO:0048471; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; peptidyl-serine phosphorylation [GO:0018105]; protein kinase A signaling [GO:0010737]; signal transduction [GO:0007165]";"acrosomal vesicle [GO:0001669]; cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]"
comp162615_c0_seq1;GAXK01120599.1;Q6DGA6;9.08E-129;ALLC_DANRE;Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase);"allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]";"GO:0000256; GO:0004037; GO:0006144";"allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]";;allantoicase activity [GO:0004037]
comp162627_c0_seq1;GAXK01120828.1;Q9UKT5;9.05E-19;FBX4_HUMAN;F-box only protein 4;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-translational protein modification [GO:0043687]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000723; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007568; GO:0010608; GO:0016567; GO:0019005; GO:0019725; GO:0031146; GO:0031398; GO:0031647; GO:0031648; GO:0032212; GO:0035726; GO:0042803; GO:0043687; GO:0048147; GO:0061630; GO:0071479; GO:1900181; GO:1902916; GO:2000001";"aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; post-translational protein modification [GO:0043687]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";"protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp162650_c0_seq1;GAXK01120623.1;Q2T9K2;1.10E-109;AP2E_XENLA;Transcription factor AP-2-epsilon (AP-2-epsilon);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp1626579_c0_seq1;GAXK01057112.1;Q9UJN7;2.90E-20;ZN391_HUMAN;Zinc finger protein 391;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1626889_c0_seq1;GAXK01057108.1;Q90YK5;1.66E-81;HPSE_CHICK;Heparanase (EC 3.2.1.166);"extracellular matrix [GO:0031012]; membrane [GO:0016020]; heparanase activity [GO:0030305]; angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; heparan sulfate proteoglycan catabolic process [GO:0030200]";"GO:0007160; GO:0016020; GO:0030200; GO:0030305; GO:0031012; GO:0060055";"angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; heparan sulfate proteoglycan catabolic process [GO:0030200]";"extracellular matrix [GO:0031012]; membrane [GO:0016020]";heparanase activity [GO:0030305]
comp1626925_c0_seq1;GAXK01057105.1;Q80V03;7.28E-18;ADCK5_MOUSE;Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005739; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";protein serine/threonine kinase activity [GO:0004674]
comp16271_c0_seq1;GAXK01068477.1;Q5E9Z8;1.11E-50;LSM1_BOVIN;U6 snRNA-associated Sm-like protein LSm1;"Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]";"GO:0000290; GO:0000339; GO:0000932; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726";"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]";"Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]";"RNA binding [GO:0003723]; RNA cap binding [GO:0000339]"
comp1627282_c0_seq1;GAXK01057107.1;D7GXF9;4.96E-20;PORB_ZOBGA;Beta-porphyranase B (EC 3.2.1.178);"periplasmic space [GO:0042597]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005975; GO:0042597";carbohydrate metabolic process [GO:0005975];periplasmic space [GO:0042597];hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp16273_c0_seq1;GAXK01068098.1;A8NFF0;5.75E-116;TRMB_BRUMA;tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase);"nucleus [GO:0005634]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]";"GO:0000049; GO:0005634; GO:0008176";;nucleus [GO:0005634];"tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]"
comp16275_c0_seq1;GAXK01068402.1;Q4AEI0;1.42E-61;GPX2_PONPY;Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI);"cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0005737; GO:0006979";response to oxidative stress [GO:0006979];cytoplasm [GO:0005737];glutathione peroxidase activity [GO:0004602]
comp162769_c0_seq1;GAXK01120564.1;Q8BJ51;3.08E-101;MFS11_MOUSE;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1627953_c0_seq1;GAXK01057087.1;P18737;5.20E-12;ZG8_XENLA;Gastrula zinc finger protein XlCGF8.2DB (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp162800_c0_seq1;GAXK01120624.1;O13082;3.62E-20;COX6A_CYPCA;Cytochrome c oxidase subunit 6A, mitochondrial (Cytochrome c oxidase polypeptide VIa);"mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005751";;mitochondrial respiratory chain complex IV [GO:0005751];cytochrome-c oxidase activity [GO:0004129]
comp1628002_c0_seq1;GAXK01007356.1;Q07553;0;GCY3E_DROME;Guanylate cyclase 32E (EC 4.6.1.2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0019934; GO:0038023";"cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]"
comp162813_c1_seq1;GAXK01120808.1;Q8BLR7;2.33E-20;RND1_MOUSE;Rho-related GTP-binding protein Rho6 (Rho family GTPase 1) (Rnd1);"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005102; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005938; GO:0007015; GO:0007162; GO:0007266; GO:0008360; GO:0015629; GO:0016322; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]"
comp162824_c3_seq1;GAXK01120742.1;Q9WUU9;3.41E-91;GANP_MOUSE;Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390";"mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]";"chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]"
comp1628524_c0_seq1;GAXK01007353.1;P17970;1.19E-73;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp16287_c0_seq1;GAXK01068237.1;P05661;3.00E-49;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp162901_c0_seq1;GAXK01120719.1;Q18297;8.61E-59;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp162909_c0_seq1;GAXK01120757.1;P50342;1.32E-54;TRYT_MERUN;Mast cell tryptase (EC 3.4.21.59);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp162921_c2_seq1;GAXK01120748.1;P33727;2.98E-104;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp16294_c0_seq1;GAXK01067849.1;P25208;6.76E-54;NFYB_HUMAN;Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB);"CCAAT-binding factor complex [GO:0016602]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000790; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0016602; GO:0032993; GO:0043565; GO:0044212; GO:0044877; GO:0045540; GO:0045893; GO:0046982; GO:0070491; GO:0090575; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of transcription, DNA-templated [GO:0006355]";"CCAAT-binding factor complex [GO:0016602]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp162956_c0_seq1;GAXK01120605.1;Q5BLK4;1.68E-29;TUT7_MOUSE;Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]";"GO:0001556; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074";"miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]"
comp162957_c1_seq1;GAXK01120816.1;Q9GRW0;1.63E-54;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1629570_c0_seq1;GAXK01007359.1;P36609;8.32E-51;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1629574_c0_seq1;GAXK01007378.1;Q29J90;2.45E-19;MOODY_DROPS;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp1629588_c0_seq1;GAXK01007385.1;Q4KMQ2;5.25E-180;ANO6_HUMAN;Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F);"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]";"GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035630; GO:0035725; GO:0042803; GO:0043065; GO:0043312; GO:0045794; GO:0046931; GO:0060100; GO:0061589; GO:0061590; GO:0061591; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353";"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]";"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]"
comp16297_c0_seq1;GAXK01068532.1;Q8BIX3;3.09E-25;AL14E_MOUSE;ARL14 effector protein (ARF7 effector protein);"cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231";;"cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp162997_c2_seq1;GAXK01120557.1;Q64392;6.79E-23;AT12A_CAVPO;Potassium-transporting ATPase alpha chain 2 (EC 7.2.2.19) (Non-gastric H(+)/K(+) ATPase subunit alpha) (Proton pump);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; potassium transmembrane transporter activity, phosphorylative mechanism [GO:0008556]";"GO:0005524; GO:0008556; GO:0016021; GO:0046872";;integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; potassium transmembrane transporter activity, phosphorylative mechanism [GO:0008556]"
comp1630_c0_seq1;GAXK01169618.1;P05661;2.93E-27;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1630118_c0_seq1;GAXK01063079.1;B9EJV3;3.41E-17;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp163015_c0_seq1;GAXK01120740.1;Q8IMC6;5.01E-159;ASATR_DROME;Tau-tubulin kinase homolog Asator (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0018105; GO:0018107";"peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1630261_c0_seq1;GAXK01063077.1;Q8BGM5;1.26E-67;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp16304_c0_seq1;GAXK01068476.1;Q98TA4;6.15E-15;MBL_CHICK;Mannose-binding protein (MBP) (Mannan-binding protein);"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; mannose binding [GO:0005537]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]";"GO:0001867; GO:0005537; GO:0005576; GO:0005581; GO:0006956; GO:0006958";"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]";"collagen trimer [GO:0005581]; extracellular region [GO:0005576]";mannose binding [GO:0005537]
comp1630722_c0_seq1;GAXK01063090.1;Q28615;9.61E-46;S13A2_RABIT;Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter);"integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];integral component of membrane [GO:0016021];symporter activity [GO:0015293]
comp163103_c0_seq1;GAXK01120609.1;Q5ZLX5;8.95E-09;ZRAB2_CHICK;Zinc finger Ran-binding domain-containing protein 2;"nucleoplasm [GO:0005654]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]";"GO:0001530; GO:0003723; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp163113_c2_seq1;GAXK01120826.1;Q5RET3;3.95E-08;AAGAB_PONAB;Alpha- and gamma-adaptin-binding protein p34;"cytosol [GO:0005829]; protein transport [GO:0015031]";"GO:0005829; GO:0015031";protein transport [GO:0015031];cytosol [GO:0005829];
comp1631162_c0_seq1;GAXK01063098.1;A2AUC9;7.50E-10;KLH41_MOUSE;Kelch-like protein 41 (Kelch repeat and BTB domain-containing protein 10);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"GO:0001726; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014";"myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]";
comp1631510_c0_seq1;GAXK01063099.1;O08762;4.47E-19;NETR_MOUSE;Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202";"exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp1631668_c0_seq1;GAXK01063102.1;Q11073;1.19E-08;YT45_CAEEL;Uncharacterized protein B0416.5;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp16317_c0_seq1;GAXK01067376.1;P05547;1.29E-08;TNNI_ASTLP;Troponin I (TnI);"troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]";"GO:0003779; GO:0005861; GO:0046872";;troponin complex [GO:0005861];"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp163170_c1_seq1;GAXK01120803.1;Q6ZW49;4.57E-54;PAXI1_HUMAN;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein);"chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]";"GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022";"adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]";"chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp163179_c0_seq1;GAXK01120508.1;Q7KRI2;2.30E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1632039_c0_seq1;GAXK01180369.1;Q9VZW5;3.05E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1632100_c0_seq1;GAXK01180375.1;Q8TCX5;1.42E-33;RHPN1_HUMAN;Rhophilin-1 (GTP-Rho-binding protein 1);"cytosol [GO:0005829]; signal transduction [GO:0007165]";"GO:0005829; GO:0007165";signal transduction [GO:0007165];cytosol [GO:0005829];
comp1632208_c0_seq1;GAXK01180366.1;P0CH86;4.56E-27;PA1_VESSQ;Phospholipase A1 (EC 3.1.1.32) (allergen Ves s 1);"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0008970; GO:0016042; GO:0044179; GO:0052739; GO:0052740";"hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]"
comp1632327_c0_seq1;GAXK01180358.1;Q8WV37;2.33E-34;ZN480_HUMAN;Zinc finger protein 480;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1632509_c0_seq1;GAXK01180368.1;Q6NT16;1.22E-07;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp163282_c0_seq1;GAXK01120625.1;Q3SZF3;2.31E-53;HNRH2_BOVIN;Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed];"nucleoplasm [GO:0005654]; RNA binding [GO:0003723]";"GO:0003723; GO:0005654";;nucleoplasm [GO:0005654];RNA binding [GO:0003723]
comp1632999_c0_seq1;GAXK01180341.1;P25723;7.14E-15;TLD_DROME;Dorsal-ventral patterning protein tolloid (EC 3.4.24.-);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amnioserosa formation [GO:0007378]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]";"GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0016485; GO:0030513; GO:0032927; GO:0045464";"amnioserosa formation [GO:0007378]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp163300_c0_seq1;GAXK01120857.1;C5H5C4;2.10E-23;NOT1A_DANRE;Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0006507; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp1633083_c0_seq1;GAXK01180356.1;O80582;5.46E-07;FBK46_ARATH;F-box/kelch-repeat protein At2g44130;"cytosol [GO:0005829]; regulation of phenylpropanoid metabolic process [GO:2000762]";"GO:0005829; GO:2000762";regulation of phenylpropanoid metabolic process [GO:2000762];cytosol [GO:0005829];
comp1633188_c0_seq1;GAXK01180374.1;Q7KRI2;1.08E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1633361_c0_seq1;GAXK01180344.1;Q9VCA2;3.45E-80;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1633419_c1_seq1;GAXK01180339.1;Q32PL8;7.07E-53;PRIPO_DANRE;DNA-directed primase/polymerase protein (EC 2.7.7.-) (Coiled-coil domain-containing protein 111 homolog);"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0031297";"mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA primase activity [GO:0003896]"
comp1633459_c0_seq1;GAXK01180322.1;Q3V080;1.27E-23;ZN583_MOUSE;Zinc finger protein 583;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp163398_c1_seq1;GAXK01120759.1;Q2UPC2;9.13E-08;ACLK_ASPOR;Gamma-glutamyl cyclotransferase aclK (GGCT aclK) (EC 4.3.2.9) (Aspirochlorine biosynthesis protein K);gamma-glutamylcyclotransferase activity [GO:0003839];GO:0003839;;;gamma-glutamylcyclotransferase activity [GO:0003839]
comp1634297_c0_seq1;GAXK01038128.1;O45782;2.36E-10;ARD17_CAEEL;Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1);"protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]";"GO:0007610; GO:0030346";behavior [GO:0007610];;protein phosphatase 2B binding [GO:0030346]
comp1634492_c0_seq1;GAXK01038120.1;Q8TCB0;8.19E-19;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp1634532_c0_seq1;GAXK01038121.1;Q5VIY5;2.04E-09;ZN468_HUMAN;Zinc finger protein 468;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp163462_c1_seq1;GAXK01120812.1;O74507;5.17E-35;YJD4_SCHPO;Uncharacterized protein C594.04c;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; steroid dehydrogenase activity [GO:0016229]; steroid metabolic process [GO:0008202]";"GO:0005783; GO:0005789; GO:0008202; GO:0016021; GO:0016229; GO:0016627";steroid metabolic process [GO:0008202];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; steroid dehydrogenase activity [GO:0016229]"
comp1634687_c0_seq1;GAXK01038113.1;K0DZA0;1.31E-26;HTYE_ASPRU;2-oxoglutarate-dependent dioxygenase htyE (EC 1.14.-.-) (L-homotyrosine biosynthetic cluster protein E);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp16347_c0_seq1;GAXK01068196.1;Q4FZX7;1.09E-08;SRPRB_RAT;Signal recognition particle receptor subunit beta (SR-beta);"cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]";"GO:0005525; GO:0005789; GO:0005881; GO:0016021; GO:0031625";;"cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]"
comp1634923_c1_seq1;GAXK01038139.1;P83088;8.03E-33;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp16353_c1_seq1;GAXK01067393.1;Q7K556;4.91E-151;TTD14_DROME;TRPL translocation defect protein 14;"cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";"GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300";"photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";cytosol [GO:0005829];"GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]"
comp163534_c0_seq1;GAXK01120792.1;Q7T3P8;8.64E-70;FEM1C_DANRE;Protein fem-1 homolog C (FEM1c) (FEM1-gamma);"cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0016567";protein ubiquitination [GO:0016567];cytoplasm [GO:0005737];
comp1635697_c0_seq1;GAXK01038137.1;O46040;1.77E-27;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp163576_c2_seq1;GAXK01120850.1;Q8NCG7;3.42E-75;DGLB_HUMAN;Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-) (KCCR13L);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0005634; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0016021; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp16359_c2_seq1;GAXK01068361.1;P79955;1.10E-19;CTK2_XENLA;Carboxy-terminal kinesin 2 (XCTK2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp163598_c0_seq1;GAXK01120611.1;Q5R766;7.04E-19;LTOR1_PONAB;Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1);"late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]";"GO:0001558; GO:0001919; GO:0005085; GO:0005764; GO:0005765; GO:0005886; GO:0007032; GO:0007040; GO:0010872; GO:0010874; GO:0016197; GO:0031902; GO:0032008; GO:0032418; GO:0034613; GO:0042632; GO:0043410; GO:0045121; GO:0060090; GO:0060620; GO:0071230; GO:0071986";"cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]";"late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]";"guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]"
comp1636358_c0_seq1;GAXK01022813.1;P11247;1.33E-54;PERM_MOUSE;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268";"aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]";"heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp16367_c0_seq1;GAXK01067517.1;Q6TGZ5;0;HPPD_DANRE;4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0000139; GO:0003868; GO:0004462; GO:0005789; GO:0006559; GO:0006572; GO:0046872";"L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]"
comp163682_c0_seq1;GAXK01120752.1;Q9BTE0;3.45E-51;NAT9_HUMAN;N-acetyltransferase 9 (EC 2.3.1.-) (Embryo brain-specific protein);"protein-containing complex [GO:0032991]; N-acetyltransferase activity [GO:0008080]; protein acetylation [GO:0006473]";"GO:0006473; GO:0008080; GO:0032991";protein acetylation [GO:0006473];protein-containing complex [GO:0032991];N-acetyltransferase activity [GO:0008080]
comp1637017_c0_seq1;GAXK01022823.1;O15078;0;CE290_HUMAN;Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2);"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000086; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010389; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043312; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711";"ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]";identical protein binding [GO:0042802]
comp1637137_c0_seq1;GAXK01022818.1;Q08431;1.51E-28;MFGM_HUMAN;"Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; post-translational protein modification [GO:0043687]; single fertilization [GO:0007338]";"GO:0001525; GO:0001786; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0016020; GO:0019897; GO:0043277; GO:0043687; GO:0044267; GO:0050766; GO:0062023; GO:0070062; GO:1903561";"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; post-translational protein modification [GO:0043687]; single fertilization [GO:0007338]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]";"integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]"
comp16372_c0_seq1;GAXK01067562.1;O43402;1.27E-32;EMC8_HUMAN;ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0016020; GO:0072546";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";
comp1637349_c0_seq1;GAXK01022806.1;Q8CBY1;3.67E-26;SMAG1_MOUSE;Protein Smaug homolog 1 (Smaug 1) (mSmaug 1) (Sterile alpha motif domain-containing protein 4A);"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; P-body [GO:0000932]; synapse [GO:0045202]; mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]";"GO:0000289; GO:0000932; GO:0001650; GO:0003729; GO:0005829; GO:0017148; GO:0030054; GO:0030371; GO:0030425; GO:0043488; GO:0045202; GO:0045727";"negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]";"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; P-body [GO:0000932]; synapse [GO:0045202]";"mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]"
comp16376_c0_seq1;GAXK01067686.1;B3NU52;0;NCBP1_DROER;Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit);"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]";"GO:0000339; GO:0005634; GO:0005846; GO:0006370; GO:0030422; GO:0031053; GO:0045071; GO:0045292; GO:0051028";"7-methylguanosine mRNA capping [GO:0006370]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]";"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]";RNA cap binding [GO:0000339]
comp163804_c0_seq1;GAXK01120784.1;P36394;1.20E-13;SRY_RAT;Sex-determining region Y protein (Testis-determining factor) (Fragment);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]";"GO:0000122; GO:0000981; GO:0005516; GO:0005634; GO:0005737; GO:0006355; GO:0007417; GO:0007548; GO:0016607; GO:0019899; GO:0030154; GO:0030182; GO:0030238; GO:0043565; GO:0044798; GO:0045944";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; sequence-specific DNA binding [GO:0043565]"
comp163825_c0_seq1;GAXK01120793.1;Q27593;1.24E-11;CP6A8_DROME;Cytochrome P450 6a8 (EC 1.14.-.-) (CYPVIA8);"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; alkane 1-monooxygenase activity [GO:0018685]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; insecticide metabolic process [GO:0017143]; lauric acid metabolic process [GO:0048252]; response to caffeine [GO:0031000]";"GO:0005506; GO:0005789; GO:0009055; GO:0012505; GO:0017143; GO:0018685; GO:0020037; GO:0031000; GO:0048252";"insecticide metabolic process [GO:0017143]; lauric acid metabolic process [GO:0048252]; response to caffeine [GO:0031000]";"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]";"alkane 1-monooxygenase activity [GO:0018685]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp1638405_c0_seq1;GAXK01054363.1;F1NVK6;2.10E-19;TM237_CHICK;Transmembrane protein 237;"ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]";"GO:0016021; GO:0030111; GO:0035869; GO:0060271";"cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]";"ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]";
comp163844_c0_seq1;GAXK01120750.1;Q6DHG0;9.29E-52;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp163868_c4_seq1;GAXK01120562.1;C3YWU0;2.42E-177;FUCO_BRAFL;Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase);"extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139";"fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"extracellular region [GO:0005576]; lysosome [GO:0005764]";alpha-L-fucosidase activity [GO:0004560]
comp1638786_c0_seq1;GAXK01054371.1;Q8ISP0;1.70E-70;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1638808_c0_seq1;GAXK01054348.1;P18729;1.20E-16;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1638868_c0_seq1;GAXK01054364.1;Q6DFF6;1.61E-09;KLH20_XENLA;Kelch-like protein 20;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390";"Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]";"interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]"
comp1638875_c0_seq1;GAXK01054358.1;Q8VIG1;1.47E-07;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1638953_c0_seq1;GAXK01054345.1;O02367;6.67E-37;CALM_CIOIN;Calmodulin (CaM) (Ci-CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp163900_c0_seq1;GAXK01120755.1;Q27319;6.13E-26;GELS_HOMAM;Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]";"GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693";actin filament capping [GO:0051693];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp163962_c7_seq1;GAXK01120630.1;Q96RW7;2.24E-13;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp163987_c0_seq1;GAXK01120749.1;Q9CZ42;5.57E-98;NNRD_MOUSE;ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; nicotinamide nucleotide metabolic process [GO:0046496]";"GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0046496; GO:0047453; GO:0052855";nicotinamide nucleotide metabolic process [GO:0046496];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";"ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]"
comp164_c0_seq1;GAXK01168824.1;Q90Z10;3.89E-78;RL13_DANRE;60S ribosomal protein L13;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0051726";"regulation of cell cycle [GO:0051726]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp16400_c0_seq1;GAXK01068335.1;P48508;1.07E-24;GSH0_RAT;Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit);"glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]";"GO:0004357; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0046982; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237";"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]";glutamate-cysteine ligase complex [GO:0017109];"enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]"
comp1640274_c0_seq1;GAXK01034123.1;P36609;7.38E-15;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1641050_c0_seq1;GAXK01034136.1;Q6GM59;1.78E-16;MOT12_XENLA;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]";"GO:0005308; GO:0005887; GO:0015293; GO:0015881";creatine transmembrane transport [GO:0015881];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]"
comp1641236_c0_seq1;GAXK01034140.1;P41596;7.13E-84;DOPR1_DROME;Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542]";"GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005887; GO:0007187; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016021; GO:0030425; GO:0030594; GO:0040040; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834";"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]";"dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]"
comp164146_c0_seq1;GAXK01137535.1;Q9JJ09;3.03E-108;NPT2B_RAT;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; aging [GO:0007568]; cellular phosphate ion homeostasis [GO:0030643]; response to estradiol [GO:0032355]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341]";"GO:0005436; GO:0005886; GO:0005903; GO:0007568; GO:0009750; GO:0015321; GO:0016021; GO:0016324; GO:0019904; GO:0030643; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0044341";"aging [GO:0007568]; cellular phosphate ion homeostasis [GO:0030643]; response to estradiol [GO:0032355]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"protein domain specific binding [GO:0019904]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]"
comp164172_c4_seq1;GAXK01137287.1;Q9S777;2.39E-100;4CL3_ARATH;4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 3) (At4CL3) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]; pollen exine formation [GO:0010584]";"GO:0005524; GO:0009698; GO:0010584; GO:0016207";"phenylpropanoid metabolic process [GO:0009698]; pollen exine formation [GO:0010584]";;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp1642_c0_seq1;GAXK01170170.1;O59950;1.05E-49;RS4_YARLI;40S ribosomal protein S4 (S7);"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp16420_c2_seq1;GAXK01067585.1;Q3UYR4;9.88E-08;ESPNL_MOUSE;Espin-like protein;"cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605]";"GO:0005737; GO:0007605; GO:0032426; GO:0051015; GO:0051017";"actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]";actin filament binding [GO:0051015]
comp1642043_c0_seq1;GAXK01071764.1;O75626;8.72E-08;PRDM1_HUMAN;PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001763; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0031490; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841";"adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp164255_c1_seq1;GAXK01137324.1;Q24342;7.28E-91;FNG_DROME;Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0001745; GO:0005737; GO:0005783; GO:0005794; GO:0005795; GO:0005797; GO:0006493; GO:0007293; GO:0007450; GO:0007476; GO:0008375; GO:0008587; GO:0008593; GO:0030173; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]"
comp1642640_c0_seq1;GAXK01071766.1;Q9V7U0;5.47E-07;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp164276_c0_seq1;GAXK01137262.1;Q6NSI4;2.86E-09;RADX_HUMAN;RPA-related protein RADX (RPA-related and RAD51-antagonist, X-chromosome);"replication fork [GO:0005657]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]";"GO:0003697; GO:0003723; GO:0005657; GO:2000042";negative regulation of double-strand break repair via homologous recombination [GO:2000042];replication fork [GO:0005657];"RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp164293_c0_seq1;GAXK01137340.1;Q90718;2.29E-55;SRF_CHICK;Serum response factor (SRF) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; serum response element binding [GO:0010736]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; positive regulation of transcription via serum response element binding [GO:0010735]";"GO:0000981; GO:0003700; GO:0005634; GO:0007275; GO:0008134; GO:0010735; GO:0010736; GO:0030036; GO:0043565; GO:0044212; GO:0046983";"actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; positive regulation of transcription via serum response element binding [GO:0010735]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; serum response element binding [GO:0010736]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1643295_c0_seq1;GAXK01071765.1;P08736;2.92E-160;EF1A1_DROME;Elongation factor 1-alpha 1 (EF-1-alpha-1) (50 kDa female-specific protein);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp164336_c1_seq1;GAXK01137312.1;Q9VVH9;3.16E-59;SO74D_DROME;Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D);"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702";"ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";"active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]"
comp16437_c0_seq1;GAXK01067533.1;Q5ZJX1;1.26E-150;AB17C_CHICK;Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein palmitoylation [GO:0018345]";"GO:0002084; GO:0008474; GO:0014069; GO:0018345; GO:0030054; GO:0043197; GO:0045211; GO:0055038; GO:1902817; GO:1905668";"negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein palmitoylation [GO:0018345]";"cell junction [GO:0030054]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]";palmitoyl-(protein) hydrolase activity [GO:0008474]
comp1643742_c0_seq1;GAXK01071754.1;Q4V920;1.45E-57;PACN1_DANRE;Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]";"GO:0005543; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0007010; GO:0007015; GO:0008092; GO:0030054; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0097320; GO:1900006";"actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]";"cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]"
comp164384_c2_seq1;GAXK01137213.1;Q9H7F0;0;AT133_HUMAN;Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1);"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"GO:0005524; GO:0005623; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872";"cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp16439_c0_seq1;GAXK01067519.1;P26885;7.74E-55;FKBP2_HUMAN;Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005528; GO:0005783; GO:0005789";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]";"FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp164397_c0_seq1;GAXK01137271.1;J3SDX8;9.52E-52;LICH_CROAD;Putative lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase);"extracellular region [GO:0005576]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0004806; GO:0005576; GO:0016042";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"
comp1644065_c0_seq1;GAXK01119450.1;Q8GX78;2.23E-39;ANTR2_ARATH;"Ascorbate transporter, chloroplastic (Phosphate transporter PHT4;4) (AtPHT4;4) (Probable anion transporter 2)";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plastid [GO:0009536]; inorganic phosphate transmembrane transporter activity [GO:0005315]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; L-ascorbic acid transmembrane transport [GO:0015882]; xanthophyll cycle [GO:0010028]";"GO:0005315; GO:0005887; GO:0009507; GO:0009536; GO:0009706; GO:0009941; GO:0010028; GO:0015229; GO:0015882; GO:0016021";"L-ascorbic acid transmembrane transport [GO:0015882]; xanthophyll cycle [GO:0010028]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plastid [GO:0009536]";"inorganic phosphate transmembrane transporter activity [GO:0005315]; L-ascorbic acid transmembrane transporter activity [GO:0015229]"
comp164432_c0_seq1;GAXK01137552.1;Q9NX65;3.37E-07;ZSC32_HUMAN;Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp164440_c0_seq1;GAXK01137502.1;Q7Q968;1.30E-78;NTAQ1_ANOGA;Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (Protein tungus);"cytosol [GO:0005829]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]; cellular protein modification process [GO:0006464]";"GO:0005634; GO:0005829; GO:0006464; GO:0008418; GO:0070773";cellular protein modification process [GO:0006464];"cytosol [GO:0005829]; nucleus [GO:0005634]";"protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]"
comp1644419_c0_seq1;GAXK01119425.1;Q99999;2.10E-38;G3ST1_HUMAN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0001733; GO:0005887; GO:0006487; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552";"galactosylceramide biosynthetic process [GO:0006682]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]";"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]"
comp164465_c1_seq1;GAXK01137408.1;Q6INV8;1.30E-20;Z652B_XENLA;Zinc finger protein 652-B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16447_c1_seq1;GAXK01068206.1;P18262;1.11E-92;RAS_ARTSA;Ras-like protein (Fragment);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp164483_c3_seq1;GAXK01137389.1;Q61554;1.18E-48;FBN1_MOUSE;Fibrillin-1 [Cleaved into: Asprosin];"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001527; GO:0001656; GO:0001822; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205";"activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]"
comp1644838_c0_seq1;GAXK01119430.1;Q6PD03;1.07E-100;2A5A_MOUSE;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha);"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]";"GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007165; GO:0016020; GO:0019900; GO:0030018; GO:0031430; GO:0031952; GO:0035307; GO:0072542; GO:0090219; GO:1903077";"negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]";"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]";"kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]"
comp1645_c0_seq1;GAXK01169315.1;Q9VH95;4.23E-22;YC17_DROME;Uncharacterized protein CG16817;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; chaperone-mediated protein complex assembly [GO:0051131]; Golgi organization [GO:0007030]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0007030; GO:0031965; GO:0050220; GO:0051087; GO:0051131; GO:0051879; GO:0106161";"chaperone-mediated protein complex assembly [GO:0051131]; Golgi organization [GO:0007030]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]"
comp1645095_c0_seq1;GAXK01119421.1;O14594;5.27E-11;NCAN_HUMAN;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0043202";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp164519_c2_seq1;GAXK01137343.1;Q9UPT9;0;UBP22_HUMAN;Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000124; GO:0003713; GO:0004843; GO:0005654; GO:0006511; GO:0007049; GO:0008270; GO:0009792; GO:0016574; GO:0016578; GO:0016579; GO:0016607; GO:0019899; GO:0030374; GO:0043967; GO:0045893; GO:0045931";"cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]";"enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]"
comp1645204_c0_seq1;GAXK01119428.1;P10925;1.08E-08;ZFY1_MOUSE;Zinc finger Y-chromosomal protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1645292_c0_seq1;GAXK01119429.1;D3Z3C6;2.08E-52;ZFAN4_MOUSE;AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1);zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp1645590_c0_seq1;GAXK01119422.1;Q8NDA2;2.49E-24;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp16456_c0_seq1;GAXK01068217.1;Q5HZY0;4.00E-32;UBXN4_RAT;UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005635; GO:0005789; GO:0005829; GO:0006986; GO:0030433";"response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]";
comp164580_c0_seq1;GAXK01137516.1;B7Z0W9;2.83E-66;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp16459_c0_seq1;GAXK01068126.1;P21521;3.40E-25;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp1646107_c0_seq1;GAXK01028173.1;Q5SVQ0;4.35E-17;KAT7_MOUSE;Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2);"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA replication origin binding [GO:0003688]; DNA-binding transcription factor activity [GO:0003700]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000123; GO:0000790; GO:0003688; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0008270; GO:0010485; GO:0018393; GO:0031098; GO:0042393; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0044212; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:1900182";"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA replication origin binding [GO:0003688]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp164615_c0_seq1;GAXK01137322.1;Q13395;6.55E-86;TARB1_HUMAN;Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185);"nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]";"GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488";"regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]";nucleus [GO:0005634];"RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]"
comp1646590_c0_seq1;GAXK01028200.1;Q16983;2.16E-09;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp164676_c0_seq1;GAXK01137551.1;Q91ZQ5;5.14E-24;RPE65_MOUSE;Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase);"cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of rhodopsin gene expression [GO:0007468]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]";"GO:0001523; GO:0001786; GO:0001895; GO:0003407; GO:0004744; GO:0005789; GO:0005886; GO:0007468; GO:0007601; GO:0007623; GO:0008286; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0042572; GO:0042574; GO:0044297; GO:0046872; GO:0050251; GO:0050908; GO:0052884; GO:0052885; GO:0060041; GO:0060042; GO:0071257; GO:1901612; GO:1901827";"cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of rhodopsin gene expression [GO:0007468]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; retinal metabolic process [GO:0042574]; retina morphogenesis in camera-type eye [GO:0060042]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]";"cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]"
comp1647426_c0_seq1;GAXK01028184.1;Q8I6K0;1.32E-17;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp164744_c0_seq1;GAXK01137362.1;Q9BXF3;1.37E-37;CECR2_HUMAN;Cat eye syndrome critical region protein 2;"CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; vesicle-mediated transport [GO:0016192]";"GO:0005634; GO:0006309; GO:0007010; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194";"apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; vesicle-mediated transport [GO:0016192]";"CERF complex [GO:0090537]; nucleus [GO:0005634]";
comp164745_c0_seq1;GAXK01137412.1;Q0VA40;5.02E-84;SP9_XENTR;Transcription factor Sp9;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0030326; GO:0035118; GO:0045743; GO:0046872";"embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp16475_c0_seq1;GAXK01067509.1;P17343;0;GBB1_CAEEL;Guanine nucleotide-binding protein subunit beta-1;"heterotrimeric G-protein complex [GO:0005834]; cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of locomotion [GO:0040013]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165]";"GO:0000132; GO:0005834; GO:0007165; GO:0009792; GO:0040013; GO:0046662; GO:0051301";"cell division [GO:0051301]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of locomotion [GO:0040013]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165]";heterotrimeric G-protein complex [GO:0005834];
comp164787_c0_seq1;GAXK01137265.1;Q7KRI2;2.53E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1647989_c0_seq1;GAXK01028179.1;Q08705;4.04E-17;CTCF_CHICK;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16481_c2_seq1;GAXK01067444.1;Q80U78;5.16E-10;PUM1_MOUSE;Pumilio homolog 1;"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]";"GO:0000932; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0016607; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0061157; GO:1900246; GO:2000637";"adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]"
comp1648556_c0_seq1;GAXK01080914.1;O02367;2.62E-30;CALM_CIOIN;Calmodulin (CaM) (Ci-CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1648689_c1_seq1;GAXK01080919.1;Q8BGM5;2.36E-16;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1648841_c0_seq1;GAXK01080939.1;Q0Q028;4.45E-11;DFP3_ANTMY;Putative defense protein 3 (DFP-3);"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp1648886_c0_seq1;GAXK01080938.1;Q5R949;9.80E-29;ACM1_PONAB;Muscarinic acetylcholine receptor M1;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; G protein-coupled acetylcholine receptor activity [GO:0016907]; cognition [GO:0050890]; regulation of locomotion [GO:0040012]; saliva secretion [GO:0046541]";"GO:0005887; GO:0016907; GO:0030054; GO:0040012; GO:0045211; GO:0046541; GO:0050890";"cognition [GO:0050890]; regulation of locomotion [GO:0040012]; saliva secretion [GO:0046541]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]";G protein-coupled acetylcholine receptor activity [GO:0016907]
comp164890_c1_seq1;GAXK01137245.1;Q6DUZ9;3.79E-101;EIPR1_GEKJA;EARP-interacting protein homolog;;;;;
comp164925_c4_seq1;GAXK01137368.1;Q5E960;3.25E-12;S39A3_BOVIN;Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]";"GO:0005385; GO:0005886; GO:0016021; GO:0071577";zinc ion transmembrane transport [GO:0071577];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp164970_c0_seq1;GAXK01137212.1;Q556K3;3.38E-24;AOFB_DICDI;Probable flavin-containing monoamine oxidase B (EC 1.4.3.4);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1649949_c0_seq1;GAXK01080917.1;Q68CZ1;5.26E-95;FTM_HUMAN;Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein);"axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]";"GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0090102; GO:0097711; GO:1905515";"camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]";"axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]";thromboxane A2 receptor binding [GO:0031870]
comp164997_c0_seq1;GAXK01137553.1;Q5T619;2.55E-16;ZN648_HUMAN;Zinc finger protein 648;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp164999_c0_seq1;GAXK01137315.1;Q3BSE3;2.29E-131;SELO_XANC5;Protein adenylyltransferase SelO (EC 2.7.7.-) (EC 2.7.7.n1);"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]";"GO:0000287; GO:0005524; GO:0016779";;;"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]"
comp165020_c0_seq1;GAXK01137215.1;P50748;6.34E-78;KNTC1_HUMAN;Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod);"actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]";"GO:0000777; GO:0000922; GO:0005634; GO:0005828; GO:0005829; GO:0005886; GO:0007093; GO:0007096; GO:0015629; GO:0051301; GO:0065003; GO:1990423";"cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]";"actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]";
comp165066_c0_seq1;GAXK01137441.1;P35559;5.96E-121;IDE_RAT;Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"GO:0001540; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008233; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0031597; GO:0031626; GO:0032461; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045861; GO:0050435; GO:0051289; GO:0051291; GO:0051603; GO:0097242; GO:0140036; GO:0150094; GO:1901143; GO:1903715";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]";"amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]"
comp165093_c0_seq1;GAXK01137244.1;Q6DG32;8.24E-86;S2536_DANRE;Solute carrier family 25 member 36-A;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; pyrimidine nucleotide import into mitochondrion [GO:1990519]";"GO:0005743; GO:0015218; GO:0016021; GO:1990519";pyrimidine nucleotide import into mitochondrion [GO:1990519];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";pyrimidine nucleotide transmembrane transporter activity [GO:0015218]
comp1651_c0_seq1;GAXK01168203.1;Q6DFC6;3.91E-29;WDR75_XENLA;WD repeat-containing protein 75;"nucleolus [GO:0005730]; rRNA processing [GO:0006364]";"GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];
comp165103_c0_seq1;GAXK01137247.1;Q9UJA3;0;MCM8_HUMAN;DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8);"chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; G1/S transition of mitotic cell cycle [GO:0000082]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]";"GO:0000082; GO:0000724; GO:0003678; GO:0003682; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006974; GO:0007292; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; G1/S transition of mitotic cell cycle [GO:0000082]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]";"chromosome [GO:0005694]; MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]"
comp1651057_c0_seq1;GAXK01115694.1;Q9NZI2;4.71E-10;KCIP1_HUMAN;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0061337; GO:1901379";"cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp165140_c0_seq1;GAXK01137571.1;Q3LHL9;2.82E-36;WGE_DROME;Protein winged eye;"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"GO:0000785; GO:0003682; GO:0005634; GO:0007560; GO:0030154";"cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"chromatin [GO:0000785]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp165153_c0_seq1;GAXK01137576.1;P91621;0;SIF1_DROME;Protein still life, isoform SIF type 1;"cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; eye development [GO:0001654]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803]; visual perception [GO:0007601]";"GO:0001654; GO:0007601; GO:0030036; GO:0030054; GO:0030676; GO:0035023; GO:0035556; GO:0043087; GO:0045202; GO:0050770; GO:0050803; GO:0051491";"actin cytoskeleton organization [GO:0030036]; eye development [GO:0001654]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803]; visual perception [GO:0007601]";"cell junction [GO:0030054]; synapse [GO:0045202]";Rac guanyl-nucleotide exchange factor activity [GO:0030676]
comp165163_c0_seq1;GAXK01137261.1;Q6P1C6;4.79E-167;LRIG3_MOUSE;Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]";"GO:0005886; GO:0016021; GO:0030659; GO:0032474";otolith morphogenesis [GO:0032474];"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp16517_c2_seq1;GAXK01068341.1;Q6DRD9;3.74E-41;ABHDB_DANRE;Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog);"mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]";"GO:0005739; GO:0016787";;mitochondrion [GO:0005739];hydrolase activity [GO:0016787]
comp165170_c0_seq1;GAXK01137339.1;Q8K368;5.19E-88;FANCI_MOUSE;Fanconi anemia group I protein homolog (Protein FACI);"cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; DNA polymerase binding [GO:0070182]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]";"GO:0005654; GO:0005829; GO:0006281; GO:0007049; GO:0031398; GO:0043240; GO:0070182";"cell cycle [GO:0007049]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]";"cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]";DNA polymerase binding [GO:0070182]
comp1652109_c0_seq1;GAXK01165050.1;A0JNB1;1.30E-32;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp165212_c0_seq1;GAXK01137330.1;Q7KRI2;4.26E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1652168_c0_seq1;GAXK01165072.1;Q9Z1Y4;6.81E-31;TRIP6_MOUSE;Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Zyxin-related protein 1) (ZRP-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0001725; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0019900; GO:0030335; GO:0046872; GO:1901224";"cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]"
comp165238_c0_seq1;GAXK01137243.1;P18729;6.95E-38;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp165241_c3_seq1;GAXK01137317.1;Q8BYR1;1.27E-63;TYW4_MOUSE;tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase);"protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]";"GO:0003880; GO:0006481; GO:0008175; GO:0030488; GO:0031591";"C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]";;"protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175]"
comp165272_c0_seq1;GAXK01137241.1;Q5RB30;1.55E-31;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp165296_c0_seq1;GAXK01137456.1;Q99575;7.76E-45;POP1_HUMAN;Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5);"extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease MRP activity [GO:0000171]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]";"GO:0000171; GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204";"tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]";"extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]";"ribonuclease MRP activity [GO:0000171]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]"
comp1652964_c0_seq1;GAXK01165043.1;Q76EC5;1.34E-09;CHST9_MOUSE;Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp1653_c1_seq1;GAXK01165526.1;Q14061;1.39E-19;COX17_HUMAN;Cytochrome c oxidase copper chaperone;"cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; brain development [GO:0007420]; copper ion transport [GO:0006825]; generation of precursor metabolites and energy [GO:0006091]; heart development [GO:0007507]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytochrome-c oxidase activity [GO:1904960]";"GO:0005507; GO:0005737; GO:0005758; GO:0006091; GO:0006825; GO:0007420; GO:0007507; GO:0008284; GO:0016531; GO:0033617; GO:1903136; GO:1904960";"brain development [GO:0007420]; copper ion transport [GO:0006825]; generation of precursor metabolites and energy [GO:0006091]; heart development [GO:0007507]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytochrome-c oxidase activity [GO:1904960]";"cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]";"copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]"
comp16530_c2_seq1;GAXK01068508.1;P40927;0;MAOX_COLLI;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40);"cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287";;cytoplasm [GO:0005737];"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp1653050_c1_seq1;GAXK01165077.1;O00591;1.29E-08;GBRP_HUMAN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp165312_c0_seq1;GAXK01137522.1;O61577;1.15E-88;KTNA1_STRPU;Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (p60 katanin);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]";"GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0030496; GO:0031122; GO:0051301; GO:0097431";"cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp165323_c0_seq1;GAXK01137617.1;Q15311;9.57E-75;RBP1_HUMAN;RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1);"cytosol [GO:0005829]; membrane [GO:0016020]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]";"GO:0005096; GO:0005829; GO:0006897; GO:0006935; GO:0007264; GO:0016020; GO:0017160; GO:0022857; GO:0042626; GO:0042910; GO:0043087; GO:0043547; GO:0048365; GO:0051056; GO:0055085; GO:1900753; GO:1990961";"chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]";"cytosol [GO:0005829]; membrane [GO:0016020]";"ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp1653488_c0_seq1;GAXK01165064.1;Q4V348;1.37E-19;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp165360_c1_seq1;GAXK01137455.1;Q24133;3.63E-54;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp1653832_c1_seq1;GAXK01165075.1;Q9VZW5;4.38E-15;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp165387_c0_seq1;GAXK01137568.1;P52597;4.71E-15;HNRPF_HUMAN;Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed];"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]";"GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013";"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]"
comp165403_c0_seq1;GAXK01137521.1;Q6IV72;1.85E-11;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1654149_c0_seq1;GAXK01029662.1;P20905;3.73E-20;5HT1R_DROME;5-hydroxytryptamine receptor 1 (5-HT receptor) (5HT-dro) (Serotonin receptor 1);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; female mating behavior [GO:0060180]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, proboscis-mediated licking [GO:0016546]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; serotonin receptor signaling pathway [GO:0007210]";"GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007192; GO:0007210; GO:0007268; GO:0007619; GO:0008227; GO:0016021; GO:0016543; GO:0016545; GO:0016546; GO:0030425; GO:0030594; GO:0060179; GO:0060180";"adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; female mating behavior [GO:0060180]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, proboscis-mediated licking [GO:0016546]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; serotonin receptor signaling pathway [GO:0007210]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]"
comp16543_c0_seq1;GAXK01068123.1;Q6IP52;3.31E-86;CHM2A_XENLA;Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a);"late endosome membrane [GO:0031902]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]";"GO:0005635; GO:0007034; GO:0010458; GO:0015031; GO:0031468; GO:0031902";"exit from mitosis [GO:0010458]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]";"late endosome membrane [GO:0031902]; nuclear envelope [GO:0005635]";
comp165445_c1_seq1;GAXK01137227.1;O88956;7.27E-31;PLPP1_CAVPO;Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidate phosphatase activity [GO:0008195]; lipid metabolic process [GO:0006629]";"GO:0005886; GO:0006629; GO:0008195; GO:0016020; GO:0016021";lipid metabolic process [GO:0006629];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";phosphatidate phosphatase activity [GO:0008195]
comp165487_c1_seq1;GAXK01137548.1;Q04164;1.80E-50;SAS_DROME;Putative epidermal cell surface receptor (Stranded at second protein);"apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]";"GO:0002168; GO:0005178; GO:0005887; GO:0007155; GO:0007411; GO:0008201; GO:0016324; GO:0031012; GO:0038023; GO:0060548";"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]";"apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]";"heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]"
comp165550_c1_seq1;GAXK01137299.1;P30531;7.25E-165;SC6A1_HUMAN;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp165551_c1_seq1;GAXK01137255.1;Q8BH44;6.14E-160;COR2B_MOUSE;Coronin-2B;"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; talin binding [GO:1990147]; vinculin binding [GO:0017166]; actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of establishment of protein localization [GO:1904950]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of protein localization [GO:1904951]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cellular response to stress [GO:0080135]; regulation of glomerular filtration [GO:0003093]";"GO:0001725; GO:0003093; GO:0005737; GO:0005925; GO:0010812; GO:0016020; GO:0017166; GO:0030036; GO:0032956; GO:0048041; GO:0051015; GO:0051497; GO:0080135; GO:1904950; GO:1904951; GO:1990147";"actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of establishment of protein localization [GO:1904950]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of protein localization [GO:1904951]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cellular response to stress [GO:0080135]; regulation of glomerular filtration [GO:0003093]";"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; talin binding [GO:1990147]; vinculin binding [GO:0017166]"
comp165576_c1_seq1;GAXK01137574.1;Q9UBQ7;1.59E-110;GRHPR_HUMAN;Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]";"GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402";"cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]";"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"
comp1656050_c0_seq1;GAXK01146661.1;Q96SE7;8.01E-15;ZN347_HUMAN;Zinc finger protein 347 (Zinc finger protein 1111);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1656263_c0_seq1;GAXK01146675.1;E9Q555;3.87E-60;RN213_MOUSE;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp16563_c0_seq1;GAXK01068342.1;Q86SX6;4.50E-41;GLRX5_HUMAN;Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5);"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]";"GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0015038; GO:0030097; GO:0030425; GO:0043025; GO:0044281; GO:0045454; GO:0046872; GO:0051537";"cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]";"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"
comp165632_c1_seq1;GAXK01137621.1;Q9VCA2;1.10E-77;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp16568_c0_seq1;GAXK01067690.1;Q6DEL1;5.39E-86;S38A7_DANRE;Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp165688_c0_seq1;GAXK01137250.1;Q22707;2.83E-20;DUS11_CAEEL;RNA/RNP complex-1-interacting phosphatase homolog (EC 3.1.3.-) (Dual specificity protein phosphatase 11 homolog) (Phosphatase interacting with RNA/RNP complex-1);"nucleus [GO:0005634]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]";"GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0008138; GO:0031047";gene silencing by RNA [GO:0031047];nucleus [GO:0005634];"polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]"
comp16569_c0_seq1;GAXK01067697.1;Q5ZMM5;1.41E-12;ZN706_CHICK;Zinc finger protein 706;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455";"negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp165747_c0_seq1;GAXK01137406.1;P38412;2.49E-81;GNAQ_LOLFO;Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q);"G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp1657575_c0_seq1;GAXK01146687.1;P13360;6.78E-09;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp165762_c5_seq1;GAXK01137354.1;Q9R1X5;0;MRP5_MOUSE;Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; organic anion transmembrane transporter activity [GO:0008514]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0008514; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0048471; GO:0055085";transmembrane transport [GO:0055085];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]"
comp165780_c1_seq1;GAXK01137260.1;P22324;2.59E-35;A1AF_CAVPO;Alpha-1-antiproteinase F (APF) (Alpha-1-antitrypsin) (Alpha-1-proteinase inhibitor) (Fragment);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]";"GO:0004867; GO:0005615; GO:0006953";acute-phase response [GO:0006953];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp1657911_c0_seq1;GAXK01146688.1;P29774;4.34E-61;ETS3_DROME;DNA-binding protein D-ETS-3;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0030154; GO:0043565";"cell differentiation [GO:0030154]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp1657954_c1_seq1;GAXK01146682.1;Q86GV3;9.87E-21;GCY28_CAEEL;Receptor-type guanylate cyclase gcy-28 (EC 4.6.1.2) (GCY-X1);"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; receptor guanylyl cyclase signaling pathway [GO:0007168]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007606; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0042048; GO:0043005; GO:0043204; GO:0044297; GO:0046872; GO:0050893";"cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; receptor guanylyl cyclase signaling pathway [GO:0007168]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp16581_c2_seq1;GAXK01067513.1;Q7Q2B7;0;CARM1_ANOGA;Histone-arginine methyltransferase CARMER (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (AgCARM1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0008469; GO:0019919; GO:0034969; GO:0035241; GO:0035242; GO:0042054";"chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]"
comp1658134_c0_seq1;GAXK01015024.1;Q0DJV6;4.16E-08;CML18_ORYSJ;Probable calcium-binding protein CML18 (Calmodulin-like protein 18);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp165830_c0_seq1;GAXK01137267.1;P21108;1.94E-93;PRPS3_HUMAN;Ribose-phosphate pyrophosphokinase 3 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 1-like 1) (PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III) (PRS-III);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp1658729_c0_seq1;GAXK01015019.1;P0DJ19;2.99E-41;RL27_TETTH;60S ribosomal protein L27;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp16588_c0_seq1;GAXK01067689.1;Q9V359;7.59E-97;VPS28_DROME;Vacuolar protein sorting-associated protein 28 homolog (ESCRT-I complex subunit VPS28);"ESCRT I complex [GO:0000813]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; compound eye development [GO:0048749]; embryo development ending in birth or egg hatching [GO:0009792]; endosome transport via multivesicular body sorting pathway [GO:0032509]; neuron remodeling [GO:0016322]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of multivesicular body size [GO:0010796]; sperm individualization [GO:0007291]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000813; GO:0006914; GO:0007291; GO:0009792; GO:0010796; GO:0016322; GO:0030036; GO:0032509; GO:0043162; GO:0043328; GO:0044877; GO:0048749; GO:0097352";"actin cytoskeleton organization [GO:0030036]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; compound eye development [GO:0048749]; embryo development ending in birth or egg hatching [GO:0009792]; endosome transport via multivesicular body sorting pathway [GO:0032509]; neuron remodeling [GO:0016322]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of multivesicular body size [GO:0010796]; sperm individualization [GO:0007291]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";ESCRT I complex [GO:0000813];protein-containing complex binding [GO:0044877]
comp16590_c1_seq1;GAXK01068343.1;Q9XYN1;1.09E-53;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp165915_c0_seq1;GAXK01137519.1;A4IP64;2.15E-53;ADH1_GEOTN;Long-chain-alcohol dehydrogenase 1 (EC 1.1.1.192) (Alcohol dehydrogenase 1) (ADH1) (Fatty alcohol oxidoreductase 1) (Glycerol dehydrogenase) (EC 1.1.1.6);"glycerol dehydrogenase [NAD+] activity [GO:0008888]; long-chain-alcohol dehydrogenase activity [GO:0050060]; metal ion binding [GO:0046872]";"GO:0008888; GO:0046872; GO:0050060";;;"glycerol dehydrogenase [NAD+] activity [GO:0008888]; long-chain-alcohol dehydrogenase activity [GO:0050060]; metal ion binding [GO:0046872]"
comp1659386_c0_seq1;GAXK01015026.1;C0SPF7;7.08E-47;C15C1_BOMMO;Farnesoate epoxidase (EC 1.14.14.128) (Cytochrome P450 15C1) (Protein dimolting) (mod);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]; metamorphosis [GO:0007552]";"GO:0005506; GO:0006718; GO:0007552; GO:0016709; GO:0020037";"juvenile hormone biosynthetic process [GO:0006718]; metamorphosis [GO:0007552]";;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp16594_c3_seq1;GAXK01067497.1;Q8N3Y7;4.63E-86;RDHE2_HUMAN;Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0008134; GO:0016021; GO:0017053; GO:0031065; GO:0033613; GO:0035067; GO:0042572; GO:0042574; GO:0043616";"keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp1659524_c0_seq1;GAXK01015020.1;Q2TBW8;7.69E-82;RL10L_BOVIN;60S ribosomal protein L10-like;"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; polysome [GO:0005844]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0005783; GO:0005844; GO:0006412; GO:0007283; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; polysome [GO:0005844]";structural constituent of ribosome [GO:0003735]
comp165969_c0_seq1;GAXK01137342.1;P26651;7.36E-14;TTP_HUMAN;mRNA decay activator protein ZFP36 (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Tristetraprolin) (Zinc finger protein 36) (Zfp-36);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; 14-3-3 protein binding [GO:0071889]; C-C chemokine binding [GO:0019957]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; MAPK cascade [GO:0000165]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; mRNA transport [GO:0051028]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of polynucleotide adenylyltransferase activity [GO:1904246]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; p38MAPK cascade [GO:0038066]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to starvation [GO:0042594]; response to wounding [GO:0009611]";"GO:0000122; GO:0000165; GO:0000288; GO:0000289; GO:0000932; GO:0003677; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0009611; GO:0010494; GO:0010837; GO:0019899; GO:0019901; GO:0019957; GO:0031072; GO:0031086; GO:0032680; GO:0032897; GO:0035278; GO:0035925; GO:0038066; GO:0042594; GO:0043488; GO:0044344; GO:0045085; GO:0045600; GO:0045616; GO:0045647; GO:0046872; GO:0051028; GO:0060213; GO:0061158; GO:0070063; GO:0070935; GO:0071222; GO:0071356; GO:0071364; GO:0071385; GO:0071889; GO:0097011; GO:1900153; GO:1901835; GO:1902172; GO:1904246; GO:1904582; GO:1990904; GO:2000637";"3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; MAPK cascade [GO:0000165]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; mRNA transport [GO:0051028]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of polynucleotide adenylyltransferase activity [GO:1904246]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; p38MAPK cascade [GO:0038066]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to starvation [GO:0042594]; response to wounding [GO:0009611]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]";"14-3-3 protein binding [GO:0071889]; C-C chemokine binding [GO:0019957]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]"
comp1659836_c0_seq1;GAXK01015015.1;B5AJT4;4.92E-20;VMP03_EULPE;Venom metalloproteinase 3 (EpMP3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp166_c0_seq1;GAXK01166062.1;P91914;3.28E-49;RL27_CAEEL;60S ribosomal protein L27;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0098556";translation [GO:0006412];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp1660348_c0_seq1;GAXK01113917.1;Q80ST9;3.33E-16;LCA5_MOUSE;Lebercilin (Leber congenital amaurosis 5 protein homolog);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]";"GO:0005929; GO:0005930; GO:0032391; GO:0036064; GO:0042073; GO:0044877; GO:0045494";"intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]";protein-containing complex binding [GO:0044877]
comp1660355_c0_seq1;GAXK01113914.1;Q8N6V9;2.72E-26;TEX9_HUMAN;Testis-expressed protein 9;;;;;
comp166043_c0_seq1;GAXK01103735.1;Q8K284;1.96E-120;TF3C1_MOUSE;General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha);"nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"GO:0000127; GO:0001002; GO:0001003; GO:0005634; GO:0005730; GO:0006384; GO:0042791; GO:1990904";"5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]";"RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]"
comp1660433_c0_seq1;GAXK01113923.1;P10675;7.52E-71;FAS1_SCHAM;Fasciclin-1 (Fasciclin I) (FAS I) (FCN);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp1660791_c0_seq1;GAXK01113926.1;Q9VCJ8;3.74E-16;SPE_DROME;"Spaetzle-processing enzyme (EC 3.4.21.-) (Spatzle-processing enzyme) [Cleaved into: Spaetzle-processing enzyme light chain; Spaetzle-processing enzyme heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; regulation of Toll signaling pathway [GO:0008592]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0004252; GO:0005576; GO:0006508; GO:0006965; GO:0008063; GO:0008592; GO:0009620; GO:0045087; GO:0045752; GO:0046872; GO:0050829; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; regulation of Toll signaling pathway [GO:0008592]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp16608_c4_seq1;GAXK01068479.1;P42325;2.66E-109;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp1660910_c0_seq1;GAXK01113913.1;P86933;3.72E-86;EF1A_TRYBB;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mRNA binding [GO:0003729]; translation elongation factor activity [GO:0003746]; calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017]";"GO:0003729; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005737; GO:0007017; GO:0019722";"calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017]";cytoplasm [GO:0005737];"calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; mRNA binding [GO:0003729]; translation elongation factor activity [GO:0003746]"
comp166105_c0_seq1;GAXK01103675.1;Q9JJS6;4.53E-20;BCDO1_MOUSE;Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1);"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";"GO:0001523; GO:0003834; GO:0004744; GO:0010436; GO:0016121; GO:0042572; GO:0042574; GO:0046872; GO:1901810";"beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";;"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]"
comp1661346_c0_seq1;GAXK01113933.1;P86854;4.72E-10;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1661472_c0_seq1;GAXK01113942.1;P36609;1.49E-49;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1661821_c0_seq1;GAXK01113932.1;P53440;8.83E-14;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp1662004_c0_seq1;GAXK01081032.1;P52746;7.05E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp166208_c0_seq1;GAXK01103766.1;P36609;6.82E-36;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp166218_c1_seq1;GAXK01103710.1;Q8HXG8;4.57E-14;BCDO2_MACFA;Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2);"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; carotene metabolic process [GO:0016119]";"GO:0005739; GO:0016119; GO:0016702; GO:0046872; GO:0102076";carotene metabolic process [GO:0016119];mitochondrion [GO:0005739];"beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp1662243_c0_seq1;GAXK01081029.1;A6NGD5;5.01E-16;ZSA5C_HUMAN;Zinc finger and SCAN domain-containing protein 5C (Zinc finger and SCAN domain-containing protein 5C pseudogene);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp166240_c0_seq1;GAXK01103619.1;P28493;1.70E-53;PR5_ARATH;Pathogenesis-related protein 5 (PR-5);"apoplast [GO:0048046]; cell wall [GO:0005618]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]; defense response [GO:0006952]; regulation of anthocyanin biosynthetic process [GO:0031540]; response to cadmium ion [GO:0046686]; response to UV-B [GO:0010224]; response to virus [GO:0009615]; systemic acquired resistance [GO:0009627]";"GO:0005576; GO:0005618; GO:0005739; GO:0005773; GO:0006952; GO:0009615; GO:0009627; GO:0010224; GO:0031540; GO:0046686; GO:0048046; GO:0099503";"defense response [GO:0006952]; regulation of anthocyanin biosynthetic process [GO:0031540]; response to cadmium ion [GO:0046686]; response to UV-B [GO:0010224]; response to virus [GO:0009615]; systemic acquired resistance [GO:0009627]";"apoplast [GO:0048046]; cell wall [GO:0005618]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]";
comp166242_c1_seq1;GAXK01103686.1;Q8CG71;2.82E-93;P3H2_MOUSE;Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1);"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; sarcoplasmic reticulum [GO:0016529]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]";"GO:0005506; GO:0005604; GO:0005783; GO:0005794; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963";"collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]";"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; sarcoplasmic reticulum [GO:0016529]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]"
comp1662829_c0_seq1;GAXK01081031.1;P58462;8.62E-10;FOXP1_MOUSE;Forkhead box protein P1 (Forkhead-related transcription factor 1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle cell differentiation [GO:0055007]; cardiovascular system development [GO:0072358]; cellular response to ionomycin [GO:1904637]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; innate vocalization behavior [GO:0098582]; interleukin-21 secretion [GO:0072619]; lung development [GO:0030324]; lung secretory cell differentiation [GO:0061140]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; motor neuron axon guidance [GO:0008045]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of lung goblet cell differentiation [GO:1901250]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pre-B cell differentiation [GO:0002329]; regulation of action potential [GO:0098900]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of defense response to bacterium [GO:1900424]; regulation of lung goblet cell differentiation [GO:1901249]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]; ventral spinal cord development [GO:0021517]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001701; GO:0002053; GO:0002329; GO:0002639; GO:0002903; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007507; GO:0007519; GO:0008045; GO:0008134; GO:0010595; GO:0021517; GO:0021756; GO:0030316; GO:0030324; GO:0032496; GO:0032680; GO:0033152; GO:0033574; GO:0035926; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042803; GO:0043621; GO:0044212; GO:0045214; GO:0045655; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046982; GO:0048661; GO:0048745; GO:0050679; GO:0055007; GO:0060043; GO:0060766; GO:0061052; GO:0061140; GO:0061470; GO:0071356; GO:0072358; GO:0072619; GO:0098582; GO:0098900; GO:1900424; GO:1901249; GO:1901250; GO:1901256; GO:1904637; GO:1905206";"cardiac muscle cell differentiation [GO:0055007]; cardiovascular system development [GO:0072358]; cellular response to ionomycin [GO:1904637]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate vocalization behavior [GO:0098582]; interleukin-21 secretion [GO:0072619]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lung secretory cell differentiation [GO:0061140]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; motor neuron axon guidance [GO:0008045]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of lung goblet cell differentiation [GO:1901250]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-B cell differentiation [GO:0002329]; regulation of action potential [GO:0098900]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of defense response to bacterium [GO:1900424]; regulation of lung goblet cell differentiation [GO:1901249]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]; ventral spinal cord development [GO:0021517]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp166321_c0_seq1;GAXK01103777.1;P41240;9.41E-14;CSK_HUMAN;Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]";"GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375";"adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]"
comp166349_c1_seq1;GAXK01103856.1;Q91WG0;1.03E-55;EST2C_MOUSE;Acylcarnitine hydrolase (ACH M1) (EC 3.1.1.28) (Carboxylesterase 2) (CES 2) (Peroxisome proliferator-inducible acylcarnitine hydrolase);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]";"GO:0005615; GO:0005783; GO:0043231; GO:0047619; GO:0052689";;"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]";"acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]"
comp166360_c0_seq1;GAXK01103824.1;Q8BFR4;2.79E-140;GNS_MOUSE;N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S);"lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan metabolic process [GO:0030203]";"GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030203; GO:0043199; GO:0046872";glycosaminoglycan metabolic process [GO:0030203];lysosome [GO:0005764];"glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]"
comp1663710_c0_seq1;GAXK01081054.1;P15159;9.18E-08;TNNC_TACTR;Troponin C;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp166378_c0_seq1;GAXK01103618.1;O95573;2.27E-24;ACSL3_HUMAN;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp166407_c1_seq1;GAXK01103638.1;Q9Y0Y7;7.32E-60;LANC3_DROME;LanC-like protein 3 homolog;"plasma membrane [GO:0005886]; catalytic activity [GO:0003824]";"GO:0003824; GO:0005886";;plasma membrane [GO:0005886];catalytic activity [GO:0003824]
comp1664159_c1_seq1;GAXK01049156.1;Q9W0T5;8.38E-25;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp1664198_c0_seq1;GAXK01205184.1;Q9VWR5;3.32E-54;CP306_DROME;Cytochrome P450 306a1 (CYPCCCVIA1) (EC 1.14.-.-) (Protein phantom) (Dmphm);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; ecdysteroid 25-hydroxylase activity [GO:0035302]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; border follicle cell migration [GO:0007298]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; exogenous drug catabolic process [GO:0042738]; oogenesis [GO:0048477]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0001700; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006697; GO:0006805; GO:0007298; GO:0008395; GO:0016712; GO:0020037; GO:0035302; GO:0042738; GO:0043231; GO:0048477; GO:0055114";"border follicle cell migration [GO:0007298]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; exogenous drug catabolic process [GO:0042738]; oogenesis [GO:0048477]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"ecdysteroid 25-hydroxylase activity [GO:0035302]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp166471_c0_seq1;GAXK01103825.1;Q5SVQ8;3.98E-07;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16649_c0_seq1;GAXK01068345.1;Q13148;1.61E-113;TADBP_HUMAN;TAR DNA-binding protein 43 (TDP-43);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"GO:0000980; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003727; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0070935; GO:0071765; GO:1990904";"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]";"DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]"
comp166495_c0_seq1;GAXK01103857.1;Q9Y5B6;2.01E-71;PAXB1_HUMAN;PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]";"GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0005829; GO:0007517; GO:0008134; GO:0014842; GO:0031062; GO:0045944; GO:2000288";"muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"
comp1664979_c0_seq1;GAXK01049183.1;Q27433;1.31E-78;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp166504_c0_seq1;GAXK01103679.1;P22845;5.30E-11;H10A_XENLA;Histone H1.0-A (H1-SB) (H1E) (Histone H1(0)-1) (Histone H5B) (XlH5B);"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0030261";"chromosome condensation [GO:0030261]; nucleosome assembly [GO:0006334]";"nucleosome [GO:0000786]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp1665294_c1_seq1;GAXK01049178.1;Q22SV3;9.67E-14;RL38_TETTS;60S ribosomal protein L38;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp166533_c1_seq1;GAXK01103743.1;Q8VCZ8;3.25E-63;RUSD1_MOUSE;RNA pseudouridylate synthase domain-containing protein 1 (Ribosomal large subunit pseudouridine synthase C-like protein);"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]";"GO:0001522; GO:0003723; GO:0009982";pseudouridine synthesis [GO:0001522];;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp1665673_c0_seq1;GAXK01049203.1;Q9VZW5;1.04E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp1665834_c0_seq1;GAXK01049159.1;Q8BXA0;4.24E-17;LRFN5_MOUSE;Leucine-rich repeat and fibronectin type-III domain-containing protein 5;"cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]";"GO:0009986; GO:0043031; GO:0050728; GO:0098978; GO:0098982; GO:0099061; GO:0099560; GO:1905606";"negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]";"cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]";
comp1665901_c0_seq1;GAXK01049174.1;P02599;5.99E-25;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp1665917_c0_seq1;GAXK01049168.1;Q02280;0;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp166607_c0_seq1;GAXK01103602.1;P64918;7.06E-96;Y2023_MYCBO;Uncharacterized protein Mb2023;;;;;
comp166663_c0_seq1;GAXK01103772.1;Q84K34;2.24E-10;SIL10_ARATH;E3 ubiquitin-protein ligase SINA-like 10 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 10) (Seven in absentia-like protein 10);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp166686_c0_seq1;GAXK01103733.1;Q6R7M4;2.33E-80;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp166695_c0_seq1;GAXK01103644.1;Q09621;2.56E-32;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp166715_c0_seq1;GAXK01103663.1;P53624;5.81E-173;MA1A1_DROME;Mannosyl-oligosaccharide alpha-1,2-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Mannosidase-1);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]";"GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0006486; GO:0006491; GO:0008340; GO:0012505; GO:0016021; GO:0035010; GO:0072347";"determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
comp1667219_c0_seq1;GAXK01063962.1;O43345;9.08E-27;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp1667303_c0_seq1;GAXK01063959.1;A6QR55;4.65E-70;UBP4_BOVIN;Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872";"negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp16677_c0_seq1;GAXK01068236.1;Q6DV01;3.86E-64;SYF2_GEKJA;Pre-mRNA-splicing factor syf2;"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0071007";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";
comp166773_c4_seq1;GAXK01103632.1;Q9W0Y6;1.59E-47;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp166842_c0_seq1;GAXK01103559.1;P60889;9.12E-23;CBX7_RAT;Chromobox protein homolog 7;"cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to drug [GO:0042493]; sebaceous gland development [GO:0048733]";"GO:0000122; GO:0000790; GO:0000792; GO:0003006; GO:0003682; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0031519; GO:0032968; GO:0035064; GO:0035102; GO:0042493; GO:0048733";"chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to drug [GO:0042493]; sebaceous gland development [GO:0048733]";"cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]";"chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]"
comp166907_c0_seq1;GAXK01103668.1;A8WQK3;3.73E-132;ACH1_CAEBR;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp16692_c1_seq1;GAXK01067679.1;P23381;0;SYWC_HUMAN;"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062";"angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]"
comp1669332_c0_seq1;GAXK01097027.1;P30279;1.65E-07;CCND2_HUMAN;G1/S-specific cyclin-D2;"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp1669490_c0_seq1;GAXK01097034.1;O60711;1.16E-32;LPXN_HUMAN;Leupaxin;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]";"GO:0002102; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007162; GO:0007165; GO:0016020; GO:0016607; GO:0033628; GO:0042995; GO:0046872; GO:0048471; GO:0050859; GO:0065003";"cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]"
comp166960_c1_seq1;GAXK01103685.1;O43808;3.72E-54;PM34_HUMAN;Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17);"integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]";"GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122";"ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]";"integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]"
comp166983_c0_seq1;GAXK01103779.1;A2BD66;1.50E-29;BRK1B_XENLA;Probable protein BRICK1-B;"cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]";"GO:0005856; GO:0007015; GO:0031209; GO:0044877";actin filament organization [GO:0007015];"cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]";protein-containing complex binding [GO:0044877]
comp167_c0_seq1;GAXK01169784.1;Q8HXB8;2.90E-19;RL29_MACFA;60S ribosomal protein L29;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1670237_c0_seq1;GAXK01008656.1;Q6UY87;6.13E-08;BEST1_MACFA;Bestrophin-1 (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; response to stimulus [GO:0050896]";"GO:0005254; GO:0016323; GO:0034707; GO:0050896";response to stimulus [GO:0050896];"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";chloride channel activity [GO:0005254]
comp167034_c1_seq1;GAXK01103677.1;Q7KRI2;1.09E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1670409_c0_seq1;GAXK01008661.1;Q8T9B6;3.31E-24;MESD_DROME;LDLR chaperone boca;"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";identical protein binding [GO:0042802]
comp167043_c0_seq1;GAXK01103740.1;Q60439;2.01E-07;CDN1B_CRIGR;Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1);"endosome [GO:0005768]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; regulation of cell population proliferation [GO:0042127]";"GO:0004861; GO:0005634; GO:0005768; GO:0007050; GO:0042127; GO:0045736";"cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; regulation of cell population proliferation [GO:0042127]";"endosome [GO:0005768]; nucleus [GO:0005634]";cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]
comp1670447_c0_seq1;GAXK01008650.1;Q3U4H6;4.71E-99;HEXD_MOUSE;Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase);"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]";"GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561";carbohydrate metabolic process [GO:0005975];"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]";"beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp1670454_c0_seq1;GAXK01008658.1;P0DJ58;1.16E-50;RL13_TETTS;60S ribosomal protein L13;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp167047_c1_seq1;GAXK01103890.1;P42787;1.86E-105;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp16708_c0_seq1;GAXK01068270.1;Q8R0J7;7.31E-18;VP37B_MOUSE;Vacuolar protein sorting-associated protein 37B (Vps37B) (ESCRT-I complex subunit VPS37B);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosome transport via multivesicular body sorting pathway [GO:0032509]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0030496; GO:0031902; GO:0032509; GO:0043162; GO:0043231; GO:0048306; GO:1902188; GO:1903774";"endosome transport via multivesicular body sorting pathway [GO:0032509]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]";calcium-dependent protein binding [GO:0048306]
comp1670842_c0_seq1;GAXK01008659.1;P41995;3.49E-10;ODD1_CAEEL;Protein odd-skipped-related 1;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0005634; GO:0007275; GO:0045944; GO:0046872";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp167109_c0_seq1;GAXK01103636.1;P69327;1.15E-49;AMYG_ASPAW;Glucoamylase (EC 3.2.1.3) (1,4-alpha-D-glucan glucohydrolase) (Glucan 1,4-alpha-glucosidase);"glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004339; GO:2001070";polysaccharide catabolic process [GO:0000272];;"glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]"
comp1671206_c0_seq1;GAXK01008649.1;Q02427;9.95E-21;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1671247_c0_seq1;GAXK01008652.1;Q94900;5.31E-07;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp167137_c1_seq1;GAXK01103676.1;P45376;4.16E-69;ALDR_MOUSE;Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldo-keto reductase family 1 member B3) (Aldose reductase) (AR) (EC 1.1.1.21);"cytosol [GO:0005829]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; monosaccharide metabolic process [GO:0005996]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to organic substance [GO:0010033]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]";"GO:0001523; GO:0001758; GO:0001894; GO:0003091; GO:0004032; GO:0005615; GO:0005654; GO:0005829; GO:0005996; GO:0006061; GO:0008106; GO:0009414; GO:0010033; GO:0016491; GO:0018931; GO:0031098; GO:0032838; GO:0033010; GO:0035809; GO:0042415; GO:0042629; GO:0043066; GO:0043220; GO:0043795; GO:0044597; GO:0044598; GO:0046427; GO:0047655; GO:0048471; GO:0048661; GO:0052650; GO:0055114; GO:0060135; GO:0070301; GO:0071475; GO:0072061; GO:0072205; GO:0097066; GO:0097238; GO:0097454; GO:1901653";"cellular hyperosmotic salinity response [GO:0071475]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; monosaccharide metabolic process [GO:0005996]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to organic substance [GO:0010033]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]"
comp167181_c0_seq1;GAXK01103776.1;Q28CK1;3.87E-81;NR2C1_XENTR;Nuclear receptor subfamily 2 group C member 1 (Developmental orphan receptor 2) (DOR2) (Orphan nuclear receptor TR2) (Testicular receptor 2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045892; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp167196_c0_seq1;GAXK01103658.1;O74467;5.16E-12;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1672149_c0_seq1;GAXK01121754.1;Q7ZX06;3.50E-08;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp1672658_c1_seq1;GAXK01121757.1;Q68DY1;6.13E-14;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp167302_c2_seq1;GAXK01103882.1;Q80U93;2.25E-32;NU214_MOUSE;Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214);"cytoplasmic side of nuclear pore [GO:1990876]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]";"GO:0000278; GO:0005049; GO:0005634; GO:0005635; GO:0005643; GO:0005925; GO:0006406; GO:0006606; GO:0006611; GO:0008139; GO:0017056; GO:0043231; GO:0046822; GO:0051726; GO:1990876";"mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]";"cytoplasmic side of nuclear pore [GO:1990876]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]";"nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]"
comp16732_c2_seq1;GAXK01067542.1;Q803A6;8.26E-102;MCMBP_DANRE;Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]";"GO:0000790; GO:0003682; GO:0005634; GO:0006261; GO:0007062; GO:0051301";"cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp167329_c0_seq1;GAXK01103713.1;Q6DN90;1.18E-80;IQEC1_HUMAN;IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005730; GO:0005737; GO:0008289; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0043547; GO:0051549; GO:1903393";"actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]"
comp167338_c0_seq1;GAXK01103774.1;Q8N957;2.71E-80;ANKF1_HUMAN;Ankyrin repeat and fibronectin type-III domain-containing protein 1;;;;;
comp16734_c1_seq1;GAXK01068234.1;Q7ZV03;7.12E-179;VP26B_DANRE;Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B);"cytosol [GO:0005829]; endosome [GO:0005768]; retromer complex [GO:0030904]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005768; GO:0005829; GO:0006886; GO:0030904; GO:0042147";"intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; endosome [GO:0005768]; retromer complex [GO:0030904]";
comp1673426_c1_seq1;GAXK01121750.1;Q0IHH9;5.86E-13;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp1673433_c0_seq1;GAXK01121749.1;Q8IZU9;2.02E-17;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1673845_c0_seq1;GAXK01121756.1;Q86MW9;5.41E-08;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1673846_c0_seq1;GAXK01121739.1;Q18515;2.58E-50;C1GLT_CAEEL;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; O-glycan processing, core 1 [GO:0016267]";"GO:0016021; GO:0016263; GO:0016267; GO:0046872";O-glycan processing, core 1 [GO:0016267];integral component of membrane [GO:0016021];"glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp167391_c0_seq1;GAXK01103560.1;B7YZU2;2.66E-12;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1673981_c0_seq1;GAXK01121753.1;P34410;3.12E-21;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp1674231_c0_seq1;GAXK01076928.1;O60242;1.75E-07;AGRB3_HUMAN;Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]";"G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]"
comp1674240_c0_seq1;GAXK01076916.1;Q8BIQ3;1.86E-22;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16743_c0_seq1;GAXK01068255.1;O73888;9.71E-10;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp167432_c1_seq1;GAXK01103767.1;Q62283;6.64E-22;TSN7_MOUSE;Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp1674324_c0_seq1;GAXK01076950.1;Q9ES83;1.88E-23;POPD1_MOUSE;Blood vessel epicardial substance (mBVES) (Popeye domain-containing protein 1) (Popeye protein 1);"bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]; cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]";"GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007519; GO:0008360; GO:0016020; GO:0016021; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135";"cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]";"bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]"
comp16745_c0_seq1;GAXK01068528.1;O73888;2.55E-37;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp1674639_c0_seq1;GAXK01076944.1;P21329;3.42E-28;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp16755_c2_seq1;GAXK01067681.1;O18373;2.59E-158;SPS1_DROME;Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";"GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0007049; GO:0007275; GO:0010637; GO:0016260; GO:0070329; GO:2000378";"cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]"
comp16756_c1_seq1;GAXK01068132.1;Q9H0U6;1.04E-25;RM18_HUMAN;39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18) (Mitochondrial large ribosomal subunit protein uL18m);"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412]";"GO:0003735; GO:0005615; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0008097; GO:0035928; GO:0070125; GO:0070126";"mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp167576_c0_seq1;GAXK01103886.1;Q9W0K7;7.88E-15;BAB1_DROME;Protein bric-a-brac 1;"nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092";"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp1675789_c0_seq1;GAXK01076953.1;O14649;4.33E-11;KCNK3_HUMAN;Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0022841; GO:0030322; GO:0034220; GO:0042493; GO:0044548; GO:0051481; GO:0061337; GO:0071294; GO:0071456; GO:0071805; GO:0090102";"brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]"
comp1675871_c0_seq1;GAXK01076947.1;Q14590;1.12E-12;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp167595_c0_seq1;GAXK01103678.1;Q7LBC6;1.79E-120;KDM3B_HUMAN;Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA);"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718";"histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp167599_c0_seq1;GAXK01103708.1;Q29P71;0;MYO7A_DROPS;Myosin-VIIa (Protein crinkled);"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0005524; GO:0005737; GO:0005902; GO:0007015; GO:0007605; GO:0008407; GO:0008586; GO:0030048; GO:0030898; GO:0031477; GO:0032027; GO:0032529; GO:0035182; GO:0035293; GO:0035317; GO:0045179; GO:0045180; GO:0045296; GO:0048800; GO:0051015; GO:0070825";"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp1676_c0_seq1;GAXK01169396.1;Q9W602;1.63E-07;SSRP1_XENLA;FACT complex subunit SSRP1 (DNA unwinding factor 87 kDa subunit) (DUF87) (Facilitates chromatin transcription complex subunit ssrp1) (Structure-specific recognition protein 1);"chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0003677; GO:0005694; GO:0005730; GO:0006260; GO:0006281";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";"chromosome [GO:0005694]; nucleolus [GO:0005730]";DNA binding [GO:0003677]
comp1676284_c0_seq1;GAXK01147003.1;O82018;8.92E-14;CALM_MOUSC;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp16763_c0_seq1;GAXK01067998.1;Q5R8B1;3.05E-20;DPM3_PONAB;Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol synthase subunit 3) (MPD synthase subunit 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein glycosylation [GO:0006486]";"GO:0005789; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp167659_c0_seq1;GAXK01103655.1;Q7PEV7;4.10E-41;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp167666_c0_seq1;GAXK01103656.1;Q920N5;1.71E-153;PEX5_CRIGR;Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1);"cell [GO:0005623]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome matrix targeting signal-1 binding [GO:0005052]; protein C-terminus binding [GO:0008022]; cell development [GO:0048468]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]";"GO:0000038; GO:0001764; GO:0005052; GO:0005623; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007006; GO:0007029; GO:0008022; GO:0016558; GO:0016561; GO:0021795; GO:0021895; GO:0040018; GO:0048468; GO:0050905; GO:0051262";"cell development [GO:0048468]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]";"cell [GO:0005623]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"peroxisome matrix targeting signal-1 binding [GO:0005052]; protein C-terminus binding [GO:0008022]"
comp1676750_c0_seq1;GAXK01146991.1;P17970;2.47E-87;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp1676783_c0_seq1;GAXK01146999.1;Q96PE6;1.37E-19;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1676914_c0_seq1;GAXK01146998.1;Q8R431;9.17E-48;MGLL_RAT;Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0097756";"acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]";"acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]"
comp167726_c0_seq1;GAXK01103809.1;P06800;2.20E-50;PTPRC_MOUSE;Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (Lymphocyte antigen 5) (Ly-5) (T200) (CD antigen CD45);"bleb [GO:0032059]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002711; GO:0002923; GO:0002925; GO:0004725; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016021; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045085; GO:0045086; GO:0045121; GO:0045582; GO:0045588; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050732; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070373; GO:0070374; GO:0071944; GO:0098857; GO:1903615; GO:1905451; GO:2000473; GO:2000648; GO:2001236; GO:2001238";"activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"bleb [GO:0032059]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]"
comp167740_c1_seq1;GAXK01103871.1;Q3UQ28;2.08E-105;PXDN_MOUSE;Peroxidasin homolog (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023";"collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp167742_c5_seq1;GAXK01103561.1;Q8TF45;2.32E-41;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp167748_c1_seq1;GAXK01103680.1;Q9CXI3;2.77E-84;MOXD1_MOUSE;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016020; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp167844_c0_seq1;GAXK01103609.1;E7F0Z8;3.12E-22;NOTU2_DANRE;Carboxylesterase notum2 (EC 3.1.1.-);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]";"GO:0005576; GO:0008045; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp167879_c0_seq1;GAXK01103596.1;P40798;0;STC_DROME;Protein shuttle craft;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0000981; GO:0003700; GO:0003723; GO:0005634; GO:0006355; GO:0008270";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"
comp167909_c0_seq1;GAXK01103642.1;Q9NPB8;1.61E-107;GPCP1_HUMAN;Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5);"cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]";"GO:0005829; GO:0007519; GO:0046475; GO:0047389; GO:2001070";"glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]";cytosol [GO:0005829];"glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]"
comp167933_c0_seq1;GAXK01103696.1;Q8VD72;0;TTC8_MOUSE;Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein homolog);"BBSome [GO:0034464]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; RNA polymerase II repressing transcription factor binding [GO:0001103]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]";"GO:0001103; GO:0001736; GO:0005813; GO:0005814; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0016020; GO:0021772; GO:0032391; GO:0032880; GO:0034260; GO:0034464; GO:0035264; GO:0036064; GO:0045444; GO:0048560; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0072659; GO:0097730; GO:1903251; GO:1905515";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multicellular organism growth [GO:0035264]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]";"BBSome [GO:0034464]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]";RNA polymerase II repressing transcription factor binding [GO:0001103]
comp1679379_c0_seq1;GAXK01157046.1;Q9Y4D2;5.02E-13;DGLA_HUMAN;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp1679533_c0_seq1;GAXK01157055.1;P69526;1.14E-59;TMPS9_RAT;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp1679534_c0_seq1;GAXK01157050.1;Q8KQN8;1.61E-54;CPHE_PSEAG;Cyanophycinase (EC 3.4.15.6) (Extracellular CGPase) (CPHEpa) (Extracellular cyanophycinase);"extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236]; cellular macromolecule metabolic process [GO:0044260]";"GO:0005576; GO:0008236; GO:0044260";cellular macromolecule metabolic process [GO:0044260];extracellular region [GO:0005576];serine-type peptidase activity [GO:0008236]
comp1679621_c0_seq1;GAXK01157061.1;Q8IYD2;5.78E-07;KLD8A_HUMAN;Kelch domain-containing protein 8A (Substitute for delta-EGFR expression 1) (S-delta-E1);;;;;
comp167963_c0_seq1;GAXK01103887.1;Q4V8B2;2.61E-73;DCNL3_RAT;DCN1-like protein 3 (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3);"perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]";"GO:0000151; GO:0005886; GO:0010225; GO:0010332; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0051443; GO:0097602; GO:2000134";"negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]";"perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]";"cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]"
comp167970_c1_seq1;GAXK01103601.1;Q08623;1.63E-65;HDHD1_HUMAN;Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase);"cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]";"GO:0000287; GO:0005829; GO:0009117; GO:0043097; GO:1990738";"nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]";cytosol [GO:0005829];"magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]"
comp1679816_c0_seq1;GAXK01157043.1;Q7RTX9;3.89E-08;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1679851_c0_seq1;GAXK01157064.1;Q8N4W9;3.08E-23;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16800_c0_seq1;GAXK01068522.1;P21522;8.73E-65;ROA1_SCHAM;Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog;"nucleus [GO:0005634]; mRNA binding [GO:0003729]";"GO:0003729; GO:0005634";;nucleus [GO:0005634];mRNA binding [GO:0003729]
comp168005_c0_seq1;GAXK01115988.1;Q9H2C1;1.26E-56;LHX5_HUMAN;LIM/homeobox protein Lhx5 (LIM homeobox protein 5);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";"GO:0000790; GO:0000977; GO:0000981; GO:0005634; GO:0021527; GO:0021702; GO:0021766; GO:0021846; GO:0021879; GO:0021937; GO:0030182; GO:0045944; GO:0046872";"cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp168009_c0_seq1;GAXK01116042.1;Q3ZBN4;1.24E-28;CUED2_BOVIN;CUE domain-containing protein 2;"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936]";"GO:0005654; GO:0005829; GO:0010936; GO:0031965; GO:1900016";"negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";
comp1680496_c0_seq1;GAXK01146809.1;Q9LXG1;5.21E-64;RS91_ARATH;40S ribosomal protein S9-1;"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0006412; GO:0009506; GO:0009507; GO:0009536; GO:0019843; GO:0022626; GO:0022627; GO:0042788; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1680518_c0_seq1;GAXK01146804.1;Q95NQ0;4.09E-14;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp168083_c0_seq1;GAXK01115919.1;Q2KJ64;2.87E-86;ARGI1_BOVIN;Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; arginine catabolic process to ornithine [GO:0019547]; defense response to protozoan [GO:0042832]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; urea cycle [GO:0000050]";"GO:0000050; GO:0004053; GO:0005615; GO:0005737; GO:0005829; GO:0019547; GO:0030145; GO:0042832; GO:0046007; GO:0060336; GO:0070965; GO:2000552";"arginine catabolic process to ornithine [GO:0019547]; defense response to protozoan [GO:0042832]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; urea cycle [GO:0000050]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]";"arginase activity [GO:0004053]; manganese ion binding [GO:0030145]"
comp168093_c2_seq1;GAXK01116208.1;Q6F7T9;3.05E-63;ALMA_ACIAD;Probable FAD-binding monooxygenase AlmA (EC 1.14.13.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; alkane catabolic process [GO:0043448]";"GO:0004499; GO:0005886; GO:0016021; GO:0043448; GO:0050660; GO:0050661";alkane catabolic process [GO:0043448];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp1681500_c0_seq1;GAXK01146839.1;P24119;5.28E-74;RL11_TETTH;60S ribosomal protein L11 (L21);"nucleus [GO:0005634]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp168154_c0_seq1;GAXK01115952.1;Q8BID8;7.91E-133;FXL14_MOUSE;F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14);"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005737; GO:0006511; GO:0019005; GO:0031146";"SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";ubiquitin-protein transferase activity [GO:0004842]
comp168167_c1_seq1;GAXK01115945.1;Q7KRI2;1.07E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp168175_c1_seq1;GAXK01116212.1;Q8I6K0;3.77E-36;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp168194_c0_seq1;GAXK01116221.1;Q5JWR5;6.53E-163;DOP1_HUMAN;Protein dopey-1;"cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031";"Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]";
comp1682169_c0_seq1;GAXK01146594.1;Q24174;2.11E-14;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp168237_c0_seq1;GAXK01205604.1;Q9VJK8;1.39E-52;JHAMT_DROME;Juvenile hormone acid O-methyltransferase (EC 2.1.1.325) (Juvenile hormone acid methyltransferase) (DmJHAMT);"farnesoic acid O-methyltransferase activity [GO:0019010]; juvenile hormone acid methyltransferase activity [GO:0035049]; juvenile hormone biosynthetic process [GO:0006718]; male courtship behavior [GO:0008049]";"GO:0006718; GO:0008049; GO:0019010; GO:0035049";"juvenile hormone biosynthetic process [GO:0006718]; male courtship behavior [GO:0008049]";;"farnesoic acid O-methyltransferase activity [GO:0019010]; juvenile hormone acid methyltransferase activity [GO:0035049]"
comp168246_c2_seq1;GAXK01116260.1;Q3Y416;1.03E-122;KKCC_CAEEL;Calcium/calmodulin-dependent protein kinase kinase (CaM-KK) (CaM-kinase kinase) (EC 2.7.11.17);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; calcium-mediated signaling [GO:0019722]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; transcription, DNA-templated [GO:0006351]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006351; GO:0006468; GO:0019722; GO:0032793; GO:0045860; GO:0046872";"calcium-mediated signaling [GO:0019722]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp1682536_c0_seq1;GAXK01146615.1;Q91WD2;3.82E-19;TRPV6_MOUSE;Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016021; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp16828_c1_seq1;GAXK01067696.1;O95164;9.29E-51;UBL3_HUMAN;Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1);"extracellular exosome [GO:0070062]; intracellular [GO:0005622]; plasma membrane [GO:0005886]";"GO:0005622; GO:0005886; GO:0070062";;"extracellular exosome [GO:0070062]; intracellular [GO:0005622]; plasma membrane [GO:0005886]";
comp168293_c1_seq1;GAXK01116243.1;Q9CPW9;4.37E-13;MAP12_MOUSE;Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D);"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]";"GO:0005739; GO:0043231; GO:0046872; GO:0070006; GO:0070084";protein initiator methionine removal [GO:0070084];"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp1683259_c0_seq1;GAXK01146611.1;Q9JL89;7.44E-08;NINJ2_MOUSE;Ninjurin-2 (Nerve injury-induced protein 2);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";"GO:0007155; GO:0016021; GO:0042246";"cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";integral component of membrane [GO:0016021];
comp16837_c0_seq1;GAXK01068188.1;Q0P4C4;4.06E-60;DCAKD_DANRE;Dephospho-CoA kinase domain-containing protein;"ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]";"GO:0004140; GO:0005524; GO:0015937";coenzyme A biosynthetic process [GO:0015937];;"ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]"
comp16840_c0_seq1;GAXK01068519.1;Q9D7S9;6.98E-97;CHMP5_MOUSE;Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2);"cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755]";"GO:0001919; GO:0005634; GO:0005829; GO:0006997; GO:0007040; GO:0007080; GO:0008333; GO:0010008; GO:0010824; GO:0015031; GO:0046755; GO:0061763; GO:0061952; GO:0071222; GO:0071225; GO:0071985; GO:1901673";"cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body-lysosome fusion [GO:0061763]; multivesicular body sorting pathway [GO:0071985]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755]";"cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]";
comp168407_c3_seq1;GAXK01115916.1;B0BNC9;1.18E-28;QORL2_RAT;Quinone oxidoreductase-like protein 2 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1684282_c0_seq1;GAXK01005273.1;Q5ZJI0;4.48E-75;TPST2_CHICK;Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0016021";peptidyl-tyrosine sulfation [GO:0006478];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp168430_c0_seq1;GAXK01116271.1;Q24564;0;MERH_DROME;Moesin/ezrin/radixin homolog 2 (Ezrin-moesin-radixin 2) (Merlin) (dMerlin);"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; Kibra-Ex-Mer complex [GO:0036375]; membrane [GO:0016020]; Nebenkern [GO:0016006]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; axis specification [GO:0009798]; cell-cell signaling [GO:0007267]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; male meiosis cytokinesis [GO:0007112]; meiotic chromosome separation [GO:0051307]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; pole plasm mRNA localization [GO:0019094]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; regulation of signal transduction [GO:0009966]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]";"GO:0001558; GO:0001745; GO:0001751; GO:0001934; GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005938; GO:0006897; GO:0007112; GO:0007267; GO:0007283; GO:0007291; GO:0008285; GO:0009798; GO:0009966; GO:0016006; GO:0016020; GO:0016324; GO:0019094; GO:0032456; GO:0035332; GO:0036375; GO:0042127; GO:0042802; GO:0043065; GO:0045179; GO:0045595; GO:0046621; GO:0046669; GO:0051307; GO:0060253; GO:0072659; GO:0098592";"axis specification [GO:0009798]; cell-cell signaling [GO:0007267]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; male meiosis cytokinesis [GO:0007112]; meiotic chromosome separation [GO:0051307]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of organ growth [GO:0046621]; pole plasm mRNA localization [GO:0019094]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of compound eye retinal cell programmed cell death [GO:0046669]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]";"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; Kibra-Ex-Mer complex [GO:0036375]; membrane [GO:0016020]; Nebenkern [GO:0016006]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; identical protein binding [GO:0042802]"
comp168434_c0_seq1;GAXK01116065.1;O60299;9.28E-30;LZTS3_HUMAN;Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1) (ProSAPiP1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; regulation of dendritic spine morphogenesis [GO:0061001]";"GO:0005737; GO:0005856; GO:0014069; GO:0030054; GO:0045202; GO:0045211; GO:0061001";regulation of dendritic spine morphogenesis [GO:0061001];"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";
comp1684428_c0_seq1;GAXK01005262.1;Q5RE33;1.57E-16;REEP5_PONAB;Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp1684859_c0_seq1;GAXK01005271.1;Q12805;1.94E-21;FBLN3_HUMAN;EGF-containing fibulin-like extracellular matrix protein 1 (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; epidermal growth factor-activated receptor activity [GO:0005006]; growth factor activity [GO:0008083]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; post-embryonic eye morphogenesis [GO:0048050]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"GO:0005006; GO:0005154; GO:0005509; GO:0005576; GO:0005615; GO:0006355; GO:0007173; GO:0007601; GO:0008083; GO:0018108; GO:0031012; GO:0032331; GO:0043010; GO:0048048; GO:0048050; GO:0062023; GO:0070062";"camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; post-embryonic eye morphogenesis [GO:0048050]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]"
comp1684926_c0_seq1;GAXK01005283.1;O88488;1.29E-33;PTPRQ_RAT;Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; regulation of fat cell differentiation [GO:0045598]";"GO:0004725; GO:0005886; GO:0016021; GO:0045598";regulation of fat cell differentiation [GO:0045598];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";protein tyrosine phosphatase activity [GO:0004725]
comp1685006_c0_seq1;GAXK01005277.1;Q27433;1.71E-12;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1685050_c0_seq1;GAXK01005266.1;P30974;3.01E-59;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp168507_c0_seq1;GAXK01116309.1;P36609;3.04E-25;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp168525_c0_seq1;GAXK01115909.1;Q27664;3.15E-80;CP6B2_HELAM;Cytochrome P450 6B2 (EC 1.14.14.1) (CYPVIB2);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp168599_c0_seq1;GAXK01116134.1;Q07969;3.49E-36;CD36_RAT;Platelet glycoprotein 4 (Adipocyte membrane protein) (Fatty acid translocase) (Fatty acid transport protein) (Glycoprotein IIIb) (GPIIIB) (PAS IV) (PAS-4) (Platelet glycoprotein IV) (GPIV) (CD antigen CD36);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; oleic acid binding [GO:0070538]; scavenger receptor activity [GO:0005044]; thrombospondin receptor activity [GO:0070053]; transforming growth factor beta binding [GO:0050431]; amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol import [GO:0070508]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; fatty acid oxidation [GO:0019395]; fatty acid transport [GO:0015908]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; maternal placenta development [GO:0001893]; negative regulation of angiogenesis [GO:0016525]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of triglyceride metabolic process [GO:0090208]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to growth hormone [GO:0060416]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; sensory perception of taste [GO:0050909]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]";"GO:0001676; GO:0001893; GO:0003085; GO:0005044; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0005901; GO:0006631; GO:0006641; GO:0006898; GO:0006955; GO:0007166; GO:0007204; GO:0007584; GO:0009612; GO:0009986; GO:0014823; GO:0015908; GO:0015909; GO:0016021; GO:0016324; GO:0016525; GO:0019395; GO:0030299; GO:0031526; GO:0031623; GO:0032355; GO:0032869; GO:0032991; GO:0033993; GO:0034197; GO:0042383; GO:0042493; GO:0042593; GO:0042755; GO:0043231; GO:0044539; GO:0045177; GO:0048565; GO:0050431; GO:0050702; GO:0050715; GO:0050766; GO:0050892; GO:0050909; GO:0060416; GO:0070053; GO:0070508; GO:0070538; GO:0070542; GO:0070543; GO:0071404; GO:0071726; GO:0090208; GO:0097009; GO:0098742; GO:0120162; GO:0150094; GO:1900227; GO:1990000";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid fibril formation [GO:1990000]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol import [GO:0070508]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; fatty acid oxidation [GO:0019395]; fatty acid transport [GO:0015908]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; maternal placenta development [GO:0001893]; negative regulation of angiogenesis [GO:0016525]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of triglyceride metabolic process [GO:0090208]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to growth hormone [GO:0060416]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; sensory perception of taste [GO:0050909]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]";"oleic acid binding [GO:0070538]; scavenger receptor activity [GO:0005044]; thrombospondin receptor activity [GO:0070053]; transforming growth factor beta binding [GO:0050431]"
comp1686288_c0_seq1;GAXK01072563.1;Q7T070;1.87E-43;RHBG_DANRE;Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonia homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]";"GO:0005887; GO:0008519; GO:0015696; GO:0016323; GO:0030659; GO:0072488; GO:0097272";"ammonia homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]";ammonium transmembrane transporter activity [GO:0008519]
comp1686475_c0_seq1;GAXK01072586.1;Q9D6F4;3.60E-12;GBRA4_MOUSE;Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of response to drug [GO:2001023]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007417; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315; GO:2001023";"central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of response to drug [GO:2001023]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp168658_c0_seq1;GAXK01116203.1;Q7SYL3;4.49E-08;SIAH2_DANRE;E3 ubiquitin-protein ligase Siah2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2-like) (Siah-2);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007093; GO:0007275; GO:0008270; GO:0031624; GO:0042752; GO:0043161; GO:0048511; GO:0061630";"mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1686627_c0_seq1;GAXK01072584.1;Q8C7V3;9.00E-09;UTP15_MOUSE;U3 small nucleolar RNA-associated protein 15 homolog (Src-associated protein SAW);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"GO:0001650; GO:0005730; GO:0005737; GO:0005783; GO:0006364; GO:0045943; GO:2000234";"positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]";
comp168693_c0_seq1;GAXK01116290.1;Q9U3V5;4.32E-59;TIPT_DROME;Protein tiptop;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]";"GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007380; GO:0046872; GO:0048730; GO:0048749; GO:0061330";"compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp168708_c0_seq1;GAXK01116030.1;Q95LI3;1.88E-17;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1687114_c0_seq1;GAXK01072587.1;Q9D7L8;1.19E-09;TMIG1_MOUSE;Transmembrane and immunoglobulin domain-containing protein 1;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of apoptotic process [GO:0043066]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of membrane permeability [GO:0090559]";"GO:0005737; GO:0005886; GO:0016021; GO:0030334; GO:0042127; GO:0043066; GO:0090559";"negative regulation of apoptotic process [GO:0043066]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of membrane permeability [GO:0090559]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp168748_c0_seq1;GAXK01116039.1;P86854;2.78E-12;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp168769_c2_seq1;GAXK01115982.1;E2RDZ6;9.36E-146;SIR5_CANLF;NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5);"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]";"GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0008270; GO:0010566; GO:0034979; GO:0036046; GO:0036048; GO:0036054; GO:0036055; GO:0061697; GO:0070403; GO:2000378";"negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]"
comp1687851_c0_seq1;GAXK01072573.1;Q6P1J6;3.49E-40;PLB1_HUMAN;"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"GO:0001523; GO:0004622; GO:0004623; GO:0005886; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0036151; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp1688_c0_seq1;GAXK01169691.1;Q0MQJ3;6.82E-07;NDUBB_PONPY;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"GO:0005747; GO:0016021; GO:0032981; GO:0055114";"mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]";
comp168804_c2_seq1;GAXK01116057.1;Q8IN81;4.98E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp168864_c1_seq1;GAXK01116102.1;Q07342;1.34E-66;FOXA2_DANRE;Forkhead box protein A2 (Axial protein);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; axial mesoderm morphogenesis [GO:0048319]; cell differentiation [GO:0030154]; central nervous system myelin formation [GO:0032289]; endoderm development [GO:0007492]; floor plate development [GO:0033504]; oligodendrocyte cell fate commitment [GO:0021779]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";"GO:0000976; GO:0000981; GO:0005634; GO:0006357; GO:0007418; GO:0007492; GO:0008134; GO:0009653; GO:0019904; GO:0021779; GO:0030154; GO:0032289; GO:0033504; GO:0043565; GO:0048319";"anatomical structure morphogenesis [GO:0009653]; axial mesoderm morphogenesis [GO:0048319]; cell differentiation [GO:0030154]; central nervous system myelin formation [GO:0032289]; endoderm development [GO:0007492]; floor plate development [GO:0033504]; oligodendrocyte cell fate commitment [GO:0021779]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp168934_c0_seq1;GAXK01116013.1;Q7Z0G7;4.35E-56;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp168963_c2_seq1;GAXK01115989.1;A2APF3;1.32E-18;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1689699_c0_seq1;GAXK01123146.1;P17972;1.07E-38;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp169044_c1_seq1;GAXK01116063.1;Q7TT18;3.92E-19;MCAF1_MOUSE;Activating transcription factor 7-interacting protein 1 (ATFa-associated modulator) (mAM) (MBD1-containing chromatin-associated factor 1);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]";"GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309";"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]"
comp169107_c0_seq1;GAXK01116232.1;Q95Q89;4.37E-08;SIR24_CAEEL;NAD-dependent protein deacetylase sir-2.4 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4);"cytoplasmic stress granule [GO:0010494]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]; P granule [GO:0043186]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; P granule assembly [GO:1903863]; protein deacetylation [GO:0006476]; response to heat [GO:0009408]";"GO:0000122; GO:0004407; GO:0005634; GO:0005635; GO:0005643; GO:0005724; GO:0006476; GO:0008134; GO:0009408; GO:0010494; GO:0034979; GO:0043186; GO:0046872; GO:0046969; GO:0070403; GO:0070932; GO:1903863";"histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; P granule assembly [GO:1903863]; protein deacetylation [GO:0006476]; response to heat [GO:0009408]";"cytoplasmic stress granule [GO:0010494]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]; P granule [GO:0043186]";"histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]"
comp1691453_c0_seq1;GAXK01034663.1;Q0A4U4;1.80E-64;MSBA_ALKEH;Lipid A export ATP-binding/permease protein MsbA (EC 7.5.2.6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]"
comp169166_c0_seq1;GAXK01116252.1;Q9W0K4;3.01E-30;BAB2_DROME;Protein bric-a-brac 2;"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736";"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp16921_c0_seq1;GAXK01068215.1;Q05722;5.30E-31;CO9A1_MOUSE;Collagen alpha-1(IX) chain;"collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte proliferation [GO:0035988]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]";"GO:0001501; GO:0001894; GO:0003417; GO:0005201; GO:0005594; GO:0005615; GO:0030198; GO:0031012; GO:0035988; GO:0046872; GO:0051216; GO:0060349";"bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte proliferation [GO:0035988]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]";"collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]"
comp169215_c1_seq1;GAXK01115873.1;Q8C033;7.80E-104;ARHGA_MOUSE;Rho guanine nucleotide exchange factor 10;"centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005085; GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630";"actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]";"centrosome [GO:0005813]; cytosol [GO:0005829]";"guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1692336_c0_seq1;GAXK01154274.1;Q9R210;2.86E-09;TFEB_MOUSE;Transcription factor EB;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response to Gram-negative bacterium [GO:0050829]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of defense response to bacterium, incompatible interaction [GO:1902477]";"GO:0000978; GO:0001228; GO:0001892; GO:0002250; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006914; GO:0006959; GO:0007040; GO:0010508; GO:0032418; GO:0044212; GO:0045893; GO:0045944; GO:0046982; GO:0050829; GO:1902477";"adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response to Gram-negative bacterium [GO:0050829]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of defense response to bacterium, incompatible interaction [GO:1902477]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp1692665_c0_seq1;GAXK01154281.1;Q28039;6.59E-78;SC6A9_BOVIN;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; regulation of synaptic transmission, glycinergic [GO:0060092]";"GO:0005283; GO:0005328; GO:0005886; GO:0005887; GO:0015187; GO:0060092; GO:0061537; GO:0098793";"glycine secretion, neurotransmission [GO:0061537]; regulation of synaptic transmission, glycinergic [GO:0060092]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp1692670_c0_seq1;GAXK01154290.1;Q6ZN57;5.49E-29;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp16930_c3_seq1;GAXK01067676.1;P28755;7.91E-69;SODC_CERCA;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp1693524_c0_seq1;GAXK01154261.1;Q8T3Y0;3.58E-09;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp169375_c0_seq1;GAXK01116028.1;Q4A054;1.35E-26;Y0419_STAS1;Uncharacterized oxidoreductase SSP0419 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1693841_c0_seq1;GAXK01154278.1;Q92010;4.12E-07;ZBT14_CHICK;Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 5) (ZF5);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0005634; GO:0043565; GO:0044212; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1694_c0_seq1;GAXK01165881.1;Q94518;1.48E-58;NACA_DROME;Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC);"nascent polypeptide-associated complex [GO:0005854]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005854; GO:0007275; GO:0015031";"multicellular organism development [GO:0007275]; protein transport [GO:0015031]";nascent polypeptide-associated complex [GO:0005854];
comp1694094_c0_seq1;GAXK01195766.1;P25970;9.06E-18;Y5909_MYXXD;Uncharacterized oxidoreductase MXAN_5909 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp169418_c2_seq1;GAXK01116032.1;Q86TJ5;5.92E-34;ZN554_HUMAN;Zinc finger protein 554;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp169419_c0_seq1;GAXK01115947.1;Q02401;3.79E-141;LPH_RAT;"Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; transferase activity [GO:0016740]; carbohydrate metabolic process [GO:0005975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]";"GO:0000016; GO:0001666; GO:0005903; GO:0005975; GO:0007584; GO:0008422; GO:0009725; GO:0009744; GO:0010033; GO:0010040; GO:0010045; GO:0010288; GO:0016021; GO:0016324; GO:0016740; GO:0017042; GO:0042493; GO:0042594; GO:0043627; GO:0045471";"carbohydrate metabolic process [GO:0005975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]";"beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; transferase activity [GO:0016740]"
comp169431_c1_seq1;GAXK01116193.1;P29829;4.03E-131;GBB2_DROME;Guanine nucleotide-binding protein subunit beta-2;"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; deactivation of rhodopsin mediated signaling [GO:0016059]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway [GO:0045879]; phototransduction [GO:0007602]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601]";"GO:0005737; GO:0005834; GO:0007186; GO:0007202; GO:0007601; GO:0007602; GO:0016028; GO:0016056; GO:0016059; GO:0045879; GO:0046982";"activation of phospholipase C activity [GO:0007202]; deactivation of rhodopsin mediated signaling [GO:0016059]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway [GO:0045879]; phototransduction [GO:0007602]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]";protein heterodimerization activity [GO:0046982]
comp169483_c0_seq1;GAXK01116258.1;Q9NBK5;2.98E-16;TRC_DROME;Serine/threonine-protein kinase tricorner (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like);"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0007476; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0070451; GO:0070593; GO:0071944";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp1695_c0_seq1;GAXK01168221.1;Q9T053;3.54E-174;PLDG1_ARATH;Phospholipase D gamma 1 (AtPLDgamma1) (PLD gamma 1) (EC 3.1.4.4) (Choline phosphatase) (Lecithinase D) (Lipophosphodiesterase II);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]; embryo development ending in seed dormancy [GO:0009793]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]";"GO:0004630; GO:0005509; GO:0005546; GO:0005829; GO:0005886; GO:0006643; GO:0006979; GO:0009793; GO:0010044; GO:0016042; GO:0046470; GO:0070290";"embryo development ending in seed dormancy [GO:0009793]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]"
comp1695037_c0_seq1;GAXK01195759.1;P35464;1.38E-25;DIHR_MANSE;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp1695168_c0_seq1;GAXK01195737.1;Q9VS29;5.45E-09;DSCL_DROME;Down syndrome cell adhesion molecule-like protein Dscam2;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]"
comp16953_c0_seq1;GAXK01068100.1;Q5U4Q0;1.13E-21;WAC_XENTR;WW domain-containing adapter protein with coiled-coil;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894";"cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]"
comp1695636_c1_seq1;GAXK01195746.1;Q17232;6.73E-70;OAR_BOMMO;Octopamine receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp1695652_c0_seq1;GAXK01195740.1;Q9GKN7;2.69E-13;RHAG_BOVIN;Ammonium transporter Rh type A (Erythrocyte membrane glycoprotein Rh50) (Rhesus blood group family type A glycoprotein) (Rh family type A glycoprotein) (Rh type A glycoprotein) (CD antigen CD241);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; leak channel activity [GO:0022840]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]; cellular ion homeostasis [GO:0006873]; monovalent inorganic cation transport [GO:0015672]";"GO:0005886; GO:0005887; GO:0006873; GO:0008519; GO:0015672; GO:0015696; GO:0016020; GO:0022840; GO:0072488";"ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]; cellular ion homeostasis [GO:0006873]; monovalent inorganic cation transport [GO:0015672]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ammonium transmembrane transporter activity [GO:0008519]; leak channel activity [GO:0022840]"
comp169573_c7_seq1;GAXK01115904.1;Q9JME2;3.65E-23;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp169588_c2_seq1;GAXK01116014.1;Q8NDA8;2.52E-137;MROH1_HUMAN;Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A);;;;;
comp169630_c5_seq1;GAXK01115858.1;Q9VS24;2.30E-73;MELT_DROME;Protein melted;"plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]";"GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263";"cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]";plasma membrane [GO:0005886];"phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]"
comp16964_c0_seq1;GAXK01068202.1;Q68EK7;3.79E-115;RAB4B_DANRE;Ras-related protein Rab-4B;"endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0030100; GO:0032482; GO:0032593";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp169643_c1_seq1;GAXK01115912.1;Q1LWH4;1.20E-114;FAN1_DANRE;Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15);"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]";"GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008409; GO:0017108; GO:0033683; GO:0036297; GO:0046872; GO:0070336; GO:0140036";"DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]";nucleus [GO:0005634];"5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]"
comp1696544_c0_seq1;GAXK01123175.1;Q06985;2.97E-09;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp169696_c1_seq1;GAXK01116261.1;Q9VHH9;2.21E-09;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp1697129_c0_seq1;GAXK01123190.1;Q5SXM1;2.14E-62;ZN678_HUMAN;Zinc finger protein 678;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1697133_c0_seq1;GAXK01123177.1;A0JNB1;6.08E-19;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1697167_c0_seq1;GAXK01123166.1;Q6PFX9;2.85E-16;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp169730_c1_seq1;GAXK01116311.1;Q8N441;7.33E-61;FGRL1_HUMAN;Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0008543; GO:0016021; GO:0017134; GO:0030133; GO:0044291; GO:0051260; GO:0060412; GO:0060539; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]"
comp1697345_c0_seq1;GAXK01123163.1;O49995;1.00E-56;1433B_TOBAC;14-3-3-like protein B;protein domain specific binding [GO:0019904];GO:0019904;;;protein domain specific binding [GO:0019904]
comp1697391_c0_seq1;GAXK01123169.1;A9JTH1;6.44E-14;NCLDA_DANRE;Neurocalcin-delta A;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp16974_c0_seq1;GAXK01068121.1;B5X5U9;9.02E-17;LYM4A_SALSA;LYR motif-containing protein 4A;;;;;
comp169760_c0_seq1;GAXK01116245.1;Q9JKB5;5.34E-65;ARI4B_RAT;AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1);"nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006325; GO:0006357; GO:0044212";"chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];transcription regulatory region DNA binding [GO:0044212]
comp169770_c7_seq1;GAXK01116123.1;Q8N4W9;9.36E-07;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp169792_c0_seq1;GAXK01115953.1;Q9UKM9;3.08E-31;RALY_HUMAN;RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; cholesterol homeostasis [GO:0042632]; mRNA splicing, via spliceosome [GO:0000398]; regulation of nucleic acid-templated transcription [GO:1903506]";"GO:0000398; GO:0003712; GO:0003723; GO:0005634; GO:0042632; GO:0071013; GO:1903506";"cholesterol homeostasis [GO:0042632]; mRNA splicing, via spliceosome [GO:0000398]; regulation of nucleic acid-templated transcription [GO:1903506]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]"
comp1698282_c0_seq1;GAXK01164059.1;A0A096ZEC9;5.19E-13;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp1698464_c0_seq1;GAXK01164050.1;P47736;3.53E-70;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp1698846_c0_seq1;GAXK01164055.1;Q6Y288;2.71E-08;B3GLT_HUMAN;Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066";"fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp169891_c2_seq1;GAXK01116281.1;Q9D6Y9;1.22E-171;GLGB_MOUSE;1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme);"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]";"GO:0003844; GO:0004553; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0102752";"carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]";;"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp169913_c0_seq1;GAXK01116312.1;Q9V7Y2;1.45E-156;SGPL_DROME;Sphingosine-1-phosphate lyase (S1PL) (SP-lyase) (SPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";"GO:0001667; GO:0005783; GO:0005789; GO:0006665; GO:0007275; GO:0007527; GO:0008117; GO:0016021; GO:0016831; GO:0019752; GO:0030149; GO:0030170";"adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]"
comp169932_c1_seq1;GAXK01116109.1;Q52KB5;1.00E-22;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp169956_c0_seq1;GAXK01116310.1;P0DPB4;5.00E-09;SCHI1_MOUSE;Schwannomin-interacting protein 1 (SCHIP-1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]";"GO:0001553; GO:0001822; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006807; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016604; GO:0030054; GO:0042802; GO:0042803; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325";"estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp169960_c0_seq1;GAXK01116047.1;Q5R1M5;2.82E-21;CELA1_FELCA;Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0046872";proteolysis [GO:0006508];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp169976_c0_seq1;GAXK01116044.1;Q86UY8;1.60E-141;NT5D3_HUMAN;5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase);"receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]";"GO:0008253; GO:0043235; GO:0046872";;receptor complex [GO:0043235];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]"
comp16999_c0_seq2;GAXK01068230.1;Q9N2R3;1.01E-08;TPM_CHAFE;Tropomyosin (Allergen Cha f I) (allergen Cha f 1) (Fragment);;;;;
comp169996_c0_seq1;GAXK01116237.1;O94808;0;GFPT2_HUMAN;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2);"cytosol [GO:0005829]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0097367; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";cytosol [GO:0005829];"carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]"
comp17_c0_seq1;GAXK01165951.1;Q5G5C4;2.84E-140;RS3A_PERAM;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp170_c1_seq1;GAXK01168584.1;P55841;4.90E-42;RL14_DROME;60S ribosomal protein L14;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; negative regulation of neuron apoptotic process [GO:0043524]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626; GO:0042273; GO:0043524";"cytoplasmic translation [GO:0002181]; negative regulation of neuron apoptotic process [GO:0043524]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1700387_c0_seq1;GAXK01062295.1;Q5R6S2;1.19E-75;DIRA2_PONAB;GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp170050_c0_seq1;GAXK01127656.1;P80311;5.55E-35;PPIB_BOVIN;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"GO:0000413; GO:0003755; GO:0005634; GO:0005788; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070063";"bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]"
comp1700509_c0_seq1;GAXK01062285.1;Q9D1G3;1.02E-09;HHATL_MOUSE;Protein-cysteine N-palmitoyltransferase HHAT-like protein (Glycerol uptake/transporter homolog) (Hedgehog acyltransferase-like protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; transferase activity, transferring acyl groups [GO:0016746]; negative regulation of N-terminal protein palmitoylation [GO:0060262]";"GO:0005783; GO:0005789; GO:0016021; GO:0016746; GO:0048471; GO:0060262";negative regulation of N-terminal protein palmitoylation [GO:0060262];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";transferase activity, transferring acyl groups [GO:0016746]
comp1701_c0_seq1;GAXK01165995.1;Q5E9K0;6.84E-77;PSB2_BOVIN;Proteasome subunit beta type-2 (EC 3.4.25.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp1701002_c1_seq1;GAXK01062284.1;P08953;4.75E-62;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp1701222_c0_seq1;GAXK01062270.1;Q9FMH8;1.01E-55;RD21B_ARATH;Probable cysteine protease RD21B (EC 3.4.22.-);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0051603; GO:0099503";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]";cysteine-type endopeptidase activity [GO:0004197]
comp1701287_c0_seq1;GAXK01062274.1;B7Z031;1.85E-12;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1701508_c0_seq1;GAXK01062272.1;P55263;2.42E-36;ADK_HUMAN;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; AMP salvage [GO:0044209]; dATP biosynthetic process [GO:0006175]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0003723; GO:0004001; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006166; GO:0006175; GO:0009156; GO:0043101; GO:0044209; GO:0046872";"AMP salvage [GO:0044209]; dATP biosynthetic process [GO:0006175]; purine-containing compound salvage [GO:0043101]; purine ribonucleoside salvage [GO:0006166]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp1701584_c0_seq1;GAXK01062263.1;Q91770;1.99E-26;NOT2_XENLA;Homeobox protein not2 (Xnot-2) (Xnot2);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; notochord formation [GO:0014028]";"GO:0005634; GO:0014028; GO:0043565; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; notochord formation [GO:0014028]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp1701765_c0_seq1;GAXK01062294.1;Q6R5N8;1.04E-32;TLR13_MOUSE;Toll-like receptor 13;"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; rRNA binding [GO:0019843]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002755; GO:0005737; GO:0005768; GO:0005887; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0042803; GO:0043408; GO:0045087";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]; toll-like receptor signaling pathway [GO:0002224]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; rRNA binding [GO:0019843]"
comp1701880_c0_seq1;GAXK01062239.1;Q05319;2.91E-74;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1701945_c0_seq1;GAXK01062241.1;P83088;3.72E-46;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp1702_c2_seq1;GAXK01165929.1;Q28EB4;2.61E-96;NP1L1_XENTR;Nucleosome assembly protein 1-like 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030154; GO:0030332; GO:0042393; GO:0045944; GO:0051260; GO:0060215";"cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; histone binding [GO:0042393]"
comp1702040_c0_seq1;GAXK01038719.1;Q12986;5.44E-17;NFX1_HUMAN;Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006366; GO:0006954; GO:0008270; GO:0016032; GO:0016567; GO:0045347; GO:0061630";"inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp170218_c0_seq1;GAXK01127798.1;P00765;7.14E-33;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp170232_c1_seq1;GAXK01127709.1;Q6NYV5;5.34E-62;SP30L_DANRE;Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like);"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0004407; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273";"heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]"
comp1703_c0_seq1;GAXK01168257.1;Q921U8;3.31E-23;SMTN_MOUSE;Smoothelin;"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cardiac muscle contraction [GO:0060452]";"GO:0003085; GO:0003779; GO:0005737; GO:0005815; GO:0030036; GO:0031941; GO:0060452";"actin cytoskeleton organization [GO:0030036]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cardiac muscle contraction [GO:0060452]";"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]";actin binding [GO:0003779]
comp1703189_c0_seq1;GAXK01038739.1;Q0R4E4;3.40E-28;RGS4_RABIT;Regulator of G-protein signaling 4 (RGS4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]";"GO:0005096; GO:0005634; GO:0005737; GO:0007186; GO:0009968";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";GTPase activator activity [GO:0005096]
comp17032_c1_seq1;GAXK01068000.1;Q24400;5.20E-127;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp1703722_c0_seq1;GAXK01038723.1;Q9XYN1;1.48E-14;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp170377_c4_seq1;GAXK01127553.1;Q09225;8.73E-49;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp1704121_c0_seq1;GAXK01182333.1;P41366;4.12E-14;VMO1_CHICK;Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI);"cell [GO:0005623]; extracellular space [GO:0005615]";"GO:0005615; GO:0005623";;"cell [GO:0005623]; extracellular space [GO:0005615]";
comp1704421_c0_seq1;GAXK01182325.1;Q92982;6.47E-12;NINJ1_HUMAN;Ninjurin-1 (Nerve injury-induced protein 1);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]";"GO:0001954; GO:0007155; GO:0007399; GO:0016021; GO:0042246; GO:1990384";"cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]";integral component of membrane [GO:0016021];
comp170489_c2_seq1;GAXK01127594.1;A9C3R8;2.11E-12;RP65C_DANRE;Retinal Mueller cells isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl ester 13-cis isomerohydrolase C) (EC 3.1.1.90) (All-trans-retinylester 11-cis isomerohydrolase C) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein homolog C) (RPE56c);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; zeaxanthin biosynthetic process [GO:1901827]";"GO:0001523; GO:0004744; GO:0005789; GO:0005829; GO:0005886; GO:0016020; GO:0016702; GO:0042574; GO:0046872; GO:0050251; GO:0052884; GO:0052885; GO:1901827";"retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; zeaxanthin biosynthetic process [GO:1901827]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]"
comp170503_c1_seq1;GAXK01127796.1;Q7QEI1;2.26E-178;RTEL1_ANOGA;Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12);"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]";"GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]";nucleus [GO:0005634];"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"
comp1705402_c0_seq1;GAXK01182329.1;Q9U539;1.22E-58;OCT1_CAEEL;Organic cation transporter 1 (CeOCT1);"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";"GO:0008340; GO:0015101; GO:0015695; GO:0016021";"determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp1705673_c0_seq1;GAXK01182322.1;B3N8M1;9.26E-15;LPHN_DROER;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp17057_c0_seq1;GAXK01068256.1;Q13257;2.44E-66;MD2L1_HUMAN;Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1);"chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006511; GO:0007093; GO:0007094; GO:0008022; GO:0031145; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1901990; GO:1904667";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]";"identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]"
comp1705854_c0_seq1;GAXK01182316.1;Q91453;8.06E-37;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp1705903_c0_seq1;GAXK01182324.1;Q19187;9.04E-07;GCY12_CAEEL;Receptor-type guanylate cyclase gcy-12 (EC 4.6.1.2);"cilium [GO:0005929]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of multicellular organism growth [GO:0040014]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005929; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0030425; GO:0035556; GO:0040014; GO:0040015; GO:0043204; GO:0046872; GO:0061067; GO:0090325; GO:0097730";"cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of multicellular organism growth [GO:0040014]; signal transduction [GO:0007165]";"cilium [GO:0005929]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp1706121_c0_seq1;GAXK01119731.1;Q8K1C7;1.77E-26;MOT14_MOUSE;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp1706559_c0_seq1;GAXK01119726.1;Q91060;1.15E-14;TBA_NOTVI;Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1706588_c0_seq1;GAXK01119728.1;O43390;1.16E-85;HNRPR_HUMAN;Heterogeneous nuclear ribonucleoprotein R (hnRNP R);"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904";"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp170678_c0_seq1;GAXK01127641.1;Q9UGJ1;4.16E-114;GCP4_HUMAN;Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76);"centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]";"GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008274; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0055037; GO:0065003";"cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]";"gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]"
comp170714_c0_seq1;GAXK01127665.1;P48067;5.25E-30;SC6A9_HUMAN;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9);"hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine secretion, neurotransmission [GO:0061537]; neurotransmitter uptake [GO:0001504]; regulation of synaptic transmission, glycinergic [GO:0060092]";"GO:0001504; GO:0005886; GO:0005887; GO:0014069; GO:0015187; GO:0015375; GO:0016020; GO:0030285; GO:0060092; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056";"glycine secretion, neurotransmission [GO:0061537]; neurotransmitter uptake [GO:0001504]; regulation of synaptic transmission, glycinergic [GO:0060092]";"hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]"
comp17074_c0_seq1;GAXK01068520.1;O43390;5.59E-159;HNRPR_HUMAN;Heterogeneous nuclear ribonucleoprotein R (hnRNP R);"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904";"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1707426_c0_seq1;GAXK01119730.1;Q8BY79;4.82E-14;S35G1_MOUSE;Solute carrier family 35 member G1 (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp170792_c0_seq1;GAXK01204962.1;Q9CPU4;3.75E-37;MGST3_MOUSE;Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0043231";"leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]"
comp170807_c0_seq1;GAXK01127817.1;C5H5C4;8.52E-25;NOT1A_DANRE;Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0006507; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp170893_c1_seq1;GAXK01127614.1;Q68EA5;3.71E-33;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp170897_c1_seq1;GAXK01127540.1;Q80ZF8;2.19E-10;AGRB3_MOUSE;Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0007520; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]";"G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]"
comp170910_c2_seq1;GAXK01127592.1;O75529;9.48E-20;TAF5L_HUMAN;TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (PCAF-associated factor 65 beta) (PAF65-beta);"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; transcription by RNA polymerase II [GO:0006366]";"GO:0003713; GO:0005634; GO:0006366; GO:0016607; GO:0030914; GO:0033276; GO:0036464; GO:0043966";"histone H3 acetylation [GO:0043966]; transcription by RNA polymerase II [GO:0006366]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]";transcription coactivator activity [GO:0003713]
comp170923_c2_seq1;GAXK01127623.1;P52746;2.20E-24;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp170970_c2_seq1;GAXK01127565.1;P07692;7.64E-55;ACES_TORMA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; acetylcholine catabolic process in synaptic cleft [GO:0001507]";"GO:0001507; GO:0003990; GO:0005886; GO:0030054; GO:0031225; GO:0043083";acetylcholine catabolic process in synaptic cleft [GO:0001507];"anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]";acetylcholinesterase activity [GO:0003990]
comp1709930_c0_seq1;GAXK01072911.1;P63033;4.65E-32;RHES_RAT;GTP-binding protein Rhes (Ras homolog enriched in striatum) (SE6C);"plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0051897";"locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";plasma membrane [GO:0005886];"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp1710375_c0_seq1;GAXK01123538.1;Q95218;3.13E-14;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp171071_c4_seq1;GAXK01127652.1;Q5R9R1;1.38E-26;EDRF1_PONAB;Erythroid differentiation-related factor 1;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp171096_c1_seq1;GAXK01127683.1;Q800K6;3.19E-23;TOB1A_XENLA;DNA topoisomerase 2-binding protein 1-A (Cut5 protein) (DNA topoisomerase II-binding protein 1-A) (TopBP1-A) (XtopBP);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"GO:0000076; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0005815; GO:0006270; GO:0006281; GO:0006974; GO:0019900; GO:0030174; GO:0033138; GO:0035563; GO:0045860; GO:0071163; GO:0071165; GO:0071168";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]"
comp1710996_c0_seq1;GAXK01123535.1;Q9CXE0;1.06E-08;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp171118_c1_seq1;GAXK01127597.1;Q7ZVG6;1.67E-07;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1711944_c0_seq1;GAXK01123551.1;Q95135;1.01E-66;EAA3_BOVIN;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Renal high affinity glutamate transporter EAAC1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0098712; GO:0140009; GO:1902476";"chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp171200_c2_seq1;GAXK01127560.1;Q96JG6;0;VPS50_HUMAN;Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50);"cytosol [GO:0005829]; EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]";"GO:0000149; GO:0005829; GO:0015031; GO:0016020; GO:0032456; GO:0055037; GO:0070062; GO:1990745";"endocytic recycling [GO:0032456]; protein transport [GO:0015031]";"cytosol [GO:0005829]; EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; recycling endosome [GO:0055037]";SNARE binding [GO:0000149]
comp17121_c15_seq1;GAXK01068458.1;Q8NCN5;0;PDPR_HUMAN;Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]";"GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491";regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510];"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp171214_c0_seq1;GAXK01127710.1;Q25637;4.23E-96;PER_PERAM;Period circadian protein;"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0005634; GO:0006355; GO:0048511";"regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";nucleus [GO:0005634];
comp1712329_c0_seq1;GAXK01013047.1;Q90703;9.65E-34;NOS2_CHICK;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (Macrophage NOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0031284; GO:0032310; GO:0032496; GO:0042742; GO:0045776; GO:0046872; GO:0050660; GO:0050661; GO:0072604; GO:0072606; GO:1900015";"arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp1712349_c0_seq1;GAXK01013037.1;Q9UC06;7.07E-07;ZNF70_HUMAN;Zinc finger protein 70 (Zinc finger protein N27C7-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1712384_c0_seq1;GAXK01013075.1;Q9UPV0;3.12E-09;CE164_HUMAN;Centrosomal protein of 164 kDa (Cep164);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000086; GO:0005615; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0010389; GO:0043231; GO:0051301; GO:0060271; GO:0097539; GO:0097711";"cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";
comp1712880_c0_seq1;GAXK01013082.1;Q5MCW4;8.65E-14;ZN569_HUMAN;Zinc finger protein 569;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp17129_c0_seq1;GAXK01067380.1;P59837;2.77E-66;RDH12_BOVIN;Retinol dehydrogenase 12 (EC 1.1.1.300) (Double substrate specificity short-chain dehydrogenase/reductase 2);"photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";photoreceptor inner segment [GO:0001917];"NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]"
comp17132_c0_seq1;GAXK01068324.1;Q4U0G1;1.35E-40;CLA1A_XENLA;CLIP-associating protein 1-A (Cytoplasmic linker-associated protein 1-A) (XCLASP1);"condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]";"GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005881; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0043515; GO:0051010; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]";"condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]";"kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]"
comp1713207_c0_seq1;GAXK01013080.1;P49754;2.04E-07;VPS41_HUMAN;Vacuolar protein sorting-associated protein 41 homolog (S53);"AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]";"GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006886; GO:0006914; GO:0008017; GO:0008333; GO:0010008; GO:0015630; GO:0016020; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042144; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774";"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]";"AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]"
comp1713283_c0_seq1;GAXK01013064.1;Q22A30;1.80E-70;RL15_TETTS;60S ribosomal protein L15;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1713375_c0_seq1;GAXK01013062.1;P08183;0;MDR1_HUMAN;ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085]";"GO:0000086; GO:0005215; GO:0005524; GO:0005886; GO:0008559; GO:0009986; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0042493; GO:0042626; GO:0045332; GO:0047484; GO:0055085; GO:0070062; GO:0072089; GO:0090554; GO:0090555; GO:0099038; GO:0099040; GO:0140328; GO:1901529; GO:2001225";"ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]"
comp1713610_c0_seq1;GAXK01013060.1;Q5R5N5;8.00E-13;MYNN_PONAB;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp171369_c2_seq1;GAXK01127532.1;Q15276;1.69E-21;RABE1_HUMAN;Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17);"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025; GO:1903441";"apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]";"growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]"
comp1713723_c0_seq1;GAXK01013046.1;Q7Z6R9;9.72E-106;AP2D_HUMAN;Transcription factor AP-2-delta (AP2-delta) (Activating enhancer-binding protein 2-delta) (Transcription factor AP-2-beta-like 1);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; inferior colliculus development [GO:0061379]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000977; GO:0000981; GO:0005634; GO:0005667; GO:0006357; GO:0043524; GO:0045944; GO:0061379";"inferior colliculus development [GO:0061379]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1713895_c0_seq1;GAXK01013081.1;Q69ZK5;5.24E-08;KLH14_MOUSE;Kelch-like protein 14 (Protein interactor of Torsin-1A) (Printor) (Protein interactor of torsinA);"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]";"GO:0005783; GO:0005789; GO:0005829; GO:0015629; GO:0016235; GO:0043005; GO:0043025";;"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";
comp171396_c1_seq1;GAXK01127806.1;P06795;0;MDR1B_MOUSE;ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243);"apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]";"GO:0000139; GO:0005524; GO:0005739; GO:0005886; GO:0008559; GO:0014045; GO:0016021; GO:0016324; GO:0016887; GO:0042493; GO:0042626; GO:0046581; GO:0061843; GO:0090554; GO:0090555; GO:0099038; GO:0140328";"establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]";"apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]"
comp171404_c0_seq1;GAXK01127657.1;P30279;1.95E-60;CCND2_HUMAN;G1/S-specific cyclin-D2;"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp171425_c0_seq1;GAXK01127544.1;Q01295;7.13E-24;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp171446_c0_seq1;GAXK01127680.1;Q96EY1;4.16E-15;DNJA3_HUMAN;DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137";"activation-induced cell death of T cells [GO:0006924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]";"ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp1714550_c0_seq1;GAXK01093336.1;Q9DAJ5;4.76E-33;DLRB2_MOUSE;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505";microtubule-based movement [GO:0007018];"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp171496_c0_seq1;GAXK01127535.1;P58005;2.84E-113;SESN3_HUMAN;Sestrin-3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]";"GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0031932; GO:0032868; GO:0034198; GO:0038203; GO:0042149; GO:0042593; GO:0046626; GO:0051896; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253";"cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]";"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]"
comp1715014_c0_seq1;GAXK01093352.1;P36639;4.85E-20;8ODP_HUMAN;7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; nucleobase-containing small molecule catabolic process [GO:0034656]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]";"GO:0001669; GO:0003924; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0006979; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0034656; GO:0035539; GO:0036219; GO:0042262; GO:0046061; GO:0046686; GO:0046872; GO:0047693";"aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; nucleobase-containing small molecule catabolic process [GO:0034656]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTPase activity [GO:0003924]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]"
comp1715040_c0_seq1;GAXK01093341.1;Q8NHP8;3.58E-33;PLBL2_HUMAN;"Putative phospholipase B-like 2 (EC 3.1.1.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form; Putative phospholipase B-like 2 45 kDa form]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]";"GO:0004620; GO:0016042; GO:0043202; GO:0070062";lipid catabolic process [GO:0016042];"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]";phospholipase activity [GO:0004620]
comp171526_c0_seq1;GAXK01127666.1;Q92010;7.30E-07;ZBT14_CHICK;Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 5) (ZF5);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0005634; GO:0043565; GO:0044212; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp171538_c1_seq1;GAXK01127793.1;Q05319;3.69E-40;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp1715558_c0_seq1;GAXK01093356.1;Q7RTY7;2.61E-24;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp171610_c1_seq1;GAXK01127711.1;Q9WX57;7.46E-07;MAIA_GEOSE;Maleate isomerase (EC 5.2.1.1) (Maleate cis-trans isomerase);"maleate isomerase activity [GO:0050076]; protein homotetramerization [GO:0051289]";"GO:0050076; GO:0051289";protein homotetramerization [GO:0051289];;maleate isomerase activity [GO:0050076]
comp1716111_c0_seq1;GAXK01090393.1;Q9CZW4;3.33E-93;ACSL3_MOUSE;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp171625_c2_seq1;GAXK01127703.1;Q0P651;2.31E-81;ABD18_HUMAN;Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp171637_c4_seq1;GAXK01127822.1;Q8K370;0;ACD10_MOUSE;Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-);"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]";"GO:0005739; GO:0016627; GO:0016787; GO:0050660";;mitochondrion [GO:0005739];"flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp171706_c1_seq1;GAXK01127580.1;Q5R5P3;2.89E-158;THNS1_PONAB;Threonine synthase-like 1 (TSH1);;;;;
comp1717189_c0_seq1;GAXK01090387.1;B8JKP6;1.09E-17;GRB1L_DANRE;GREB1-like protein;"integral component of membrane [GO:0016021]; kidney development [GO:0001822]; pronephros development [GO:0048793]";"GO:0001822; GO:0016021; GO:0048793";"kidney development [GO:0001822]; pronephros development [GO:0048793]";integral component of membrane [GO:0016021];
comp1717417_c0_seq1;GAXK01090423.1;O89094;5.01E-23;CASPE_MOUSE;"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008233; GO:0008630; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]"
comp1717670_c0_seq1;GAXK01090419.1;P18699;2.31E-13;TBB_LYMST;Tubulin beta chain (Beta-tubulin) (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp171806_c0_seq1;GAXK01127660.1;P36609;2.02E-66;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1718063_c0_seq1;GAXK01087031.1;Q9J569;1.73E-15;V162_FOWPN;Putative ankyrin repeat protein FPV162;;;;;
comp1718171_c0_seq1;GAXK01087052.1;Q8BYH0;1.11E-35;DRGX_MOUSE;Dorsal root ganglia homeobox protein (Dorsal root ganglion 11) (Homeobox protein DRG11) (Paired-related homeobox protein-like 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]";"GO:0000977; GO:0000981; GO:0001764; GO:0003677; GO:0003700; GO:0005634; GO:0007399; GO:0007409; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0030182; GO:0050954";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp17182_c1_seq1;GAXK01067510.1;P08928;3.83E-88;LAM0_DROME;Lamin Dm0;"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433";"adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp171820_c0_seq1;GAXK01127636.1;Q9W539;1.01E-66;HR4_DROME;Hormone receptor 4 (dHR4) (Nuclear receptor subfamily 6 group A member 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor-mediated signaling pathway [GO:0120143]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]";"GO:0000978; GO:0003707; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0040018; GO:0045892; GO:0048638; GO:0071456; GO:0106023; GO:0120143";"cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor-mediated signaling pathway [GO:0120143]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp171823_c0_seq1;GAXK01127684.1;Q9HAW8;4.93E-65;UD110_HUMAN;UDP-glucuronosyltransferase 1-10 (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J) (UDP-glucuronosyltransferase 1A10);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic glucuronidation [GO:0052697]";"GO:0005080; GO:0005783; GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0043231; GO:0045922; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:1904224; GO:2001030";"cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic glucuronidation [GO:0052697]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; UDP-glycosyltransferase activity [GO:0008194]"
comp171831_c1_seq1;GAXK01127640.1;Q9VMM6;4.94E-23;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp171849_c5_seq1;GAXK01127671.1;Q8BTK5;1.88E-59;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1718560_c0_seq1;GAXK01087051.1;P36609;3.99E-24;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1718569_c0_seq1;GAXK01087028.1;Q9HAZ2;4.33E-07;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp1718763_c0_seq1;GAXK01087043.1;Q8BZ39;1.83E-10;NMUR2_MOUSE;Neuromedin-U receptor 2 (NMU-R2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]";"GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0006816; GO:0007200; GO:0007204; GO:0007218; GO:0007417; GO:0007625; GO:0008188; GO:0016021; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930";"activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp171894_c1_seq1;GAXK01127825.1;Q24K02;7.42E-172;IDE_BOVIN;Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin);"basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein homooligomerization [GO:0051260]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008270; GO:0008340; GO:0009897; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0032461; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0050435; GO:0051260; GO:0051603; GO:0140036; GO:0150094; GO:1901143; GO:1903715";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein homooligomerization [GO:0051260]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]";"ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]"
comp1718984_c0_seq1;GAXK01087027.1;P0DPW4;5.77E-08;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1719319_c0_seq1;GAXK01087073.1;P42575;7.34E-35;CASP2_HUMAN;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0008630; GO:0016020; GO:0016485; GO:0019899; GO:0019904; GO:0035234; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097194; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp17194_c0_seq1;GAXK01067518.1;F1NLH9;2.57E-87;ITPA_CHICK;Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase);"cytosol [GO:0005829]; dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]";"GO:0000166; GO:0005829; GO:0006193; GO:0009143; GO:0009204; GO:0035529; GO:0035870; GO:0042802; GO:0046872; GO:0047429; GO:0051276";"chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]";cytosol [GO:0005829];"dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]"
comp1719859_c0_seq1;GAXK01087069.1;Q8K4K7;1.11E-14;ABRA_RAT;Actin-binding Rho-activating protein (MS1) (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp172_c16_seq1;GAXK01165985.1;P18238;1.13E-114;ADT3_YEAST;ADP,ATP carrier protein 3 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]; anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]";"GO:0005471; GO:0005739; GO:0005743; GO:0009061; GO:0015886; GO:0016021; GO:0042802; GO:0055085";"anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]"
comp1720040_c0_seq1;GAXK01004577.1;Q9H2X3;2.05E-09;CLC4M_HUMAN;C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0006897; GO:0007159; GO:0009988; GO:0016020; GO:0019048; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046790; GO:0046872; GO:0046968; GO:0048306; GO:0075733";"adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]"
comp172077_c1_seq1;GAXK01060893.1;Q8BIG4;2.47E-70;FBX28_MOUSE;F-box only protein 28;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";"GO:0000776; GO:0000777";;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";
comp172117_c1_seq1;GAXK01060971.1;Q9VDY1;0;INO80_DROME;Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-);"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region DNA binding [GO:0044212]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]";"GO:0000790; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0044212; GO:0045892";"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]";"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region DNA binding [GO:0044212]"
comp1721270_c0_seq1;GAXK01004576.1;Q32LQ4;8.34E-11;BHMT1_DANRE;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; digestive system development [GO:0055123]; methionine biosynthetic process [GO:0009086]; type B pancreatic cell development [GO:0003323]";"GO:0003323; GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0047150; GO:0055123";"amino-acid betaine catabolic process [GO:0006579]; digestive system development [GO:0055123]; methionine biosynthetic process [GO:0009086]; type B pancreatic cell development [GO:0003323]";cytoplasm [GO:0005737];"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp17213_c1_seq1;GAXK01068228.1;O55096;0;DPP3_RAT;Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0005829; GO:0005886; GO:0006508; GO:0008237; GO:0008239; GO:0008270; GO:0016607";proteolysis [GO:0006508];"cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]";"dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp1721450_c0_seq1;GAXK01004569.1;Q9JI93;5.43E-13;A4GAT_RAT;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp1721495_c0_seq1;GAXK01004587.1;Q6GM59;3.59E-12;MOT12_XENLA;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]";"GO:0005308; GO:0005887; GO:0015293; GO:0015881";creatine transmembrane transport [GO:0015881];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]"
comp1722258_c0_seq1;GAXK01173619.1;Q0V9W6;9.01E-11;BTBD6_XENTR;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp172230_c0_seq1;GAXK01060841.1;P91943;1.74E-69;PANG1_DROME;Protein pangolin, isoforms A/H/I/S (dTCF);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055]";"GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007367; GO:0007435; GO:0007476; GO:0007500; GO:0007507; GO:0008013; GO:0009880; GO:0010628; GO:0016055; GO:0019900; GO:0035277; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0060070; GO:0070491; GO:0072091";"canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp172234_c0_seq1;GAXK01060862.1;Q9H511;2.33E-09;KLH31_HUMAN;Kelch-like protein 31 (BTB and kelch domain-containing protein 6) (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein KLHL);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein phosphorylation [GO:0001933]";"GO:0001933; GO:0005634; GO:0005737; GO:0046329";"negative regulation of JNK cascade [GO:0046329]; negative regulation of protein phosphorylation [GO:0001933]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1722669_c0_seq1;GAXK01173631.1;O43312;1.37E-20;MTSS1_HUMAN;Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]";"actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp172280_c0_seq1;GAXK01060902.1;O54728;3.23E-39;PLB1_RAT;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp17230_c1_seq1;GAXK01068298.1;Q9P2D1;4.94E-35;CHD7_HUMAN;Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"GO:0000978; GO:0001501; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0006364; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010880; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042472; GO:0043584; GO:0045944; GO:0048752; GO:0048806; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:1990841";"adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp172305_c3_seq1;GAXK01060906.1;Q7ZYC4;7.61E-50;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp1723055_c0_seq1;GAXK01173623.1;Q8CG09;0;MRP1_RAT;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; positive regulation of xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005324; GO:0005524; GO:0005737; GO:0005774; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0046618; GO:0046624; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0071716; GO:0140359; GO:1901215; GO:1905701";"cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; positive regulation of xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp1723314_c0_seq1;GAXK01173635.1;Q8ITC9;6.96E-29;PK1R_DROME;Pyrokinin-1 receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]"
comp172372_c1_seq1;GAXK01060973.1;Q84H44;0;XSC_CASDE;Sulfoacetaldehyde acetyltransferase (EC 2.3.3.15);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; sulfoacetaldehyde acetyltransferase activity [GO:0050487]; thiamine pyrophosphate binding [GO:0030976]; taurine catabolic process [GO:0019529]";"GO:0000287; GO:0005737; GO:0019529; GO:0030976; GO:0050487";taurine catabolic process [GO:0019529];cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; sulfoacetaldehyde acetyltransferase activity [GO:0050487]; thiamine pyrophosphate binding [GO:0030976]"
comp17238_c0_seq1;GAXK01067570.1;Q8TF32;2.06E-19;ZN431_HUMAN;Zinc finger protein 431;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0043433; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1724230_c0_seq1;GAXK01146895.1;P0DJ16;8.58E-55;RL17_TETTS;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp1724641_c0_seq1;GAXK01146901.1;Q9BTX7;2.61E-20;TTPAL_HUMAN;Alpha-tocopherol transfer protein-like;membrane [GO:0016020];GO:0016020;;membrane [GO:0016020];
comp1724716_c0_seq1;GAXK01146894.1;Q9XZ71;1.83E-58;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp17248_c0_seq1;GAXK01068388.1;Q65169;2.09E-10;VF602_ASFB7;Protein B602L (pB602L);host cell cytoplasm [GO:0030430];GO:0030430;;host cell cytoplasm [GO:0030430];
comp1724835_c0_seq1;GAXK01146904.1;B0BMZ3;1.55E-08;GIMD1_RAT;GTPase IMAP family member GIMD1 (GIMAP family P-loop NTPase domain-containing protein 1);GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp1724885_c1_seq1;GAXK01146918.1;Q8C827;3.99E-10;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1724943_c0_seq1;GAXK01146919.1;Q13507;3.28E-10;TRPC3_HUMAN;Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]";"GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0030168; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp1724976_c0_seq1;GAXK01146909.1;Q9NAS9;4.57E-16;CLP15_ANOGA;CLIP domain-containing serine protease B15 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0042832; GO:0045087; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp17250_c0_seq1;GAXK01067457.1;Q9JI85;1.37E-57;NUCB2_RAT;Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]; insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]";"GO:0003677; GO:0005164; GO:0005509; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0005797; GO:0009749; GO:0016020; GO:0032099; GO:0042594; GO:0043951; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:1901142; GO:1990680; GO:2000845";"insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]";"calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]"
comp17253_c1_seq1;GAXK01068259.1;G7CFI3;2.12E-13;EGTB_MYCT3;Hercynine oxygenase (EC 1.14.99.50) (Gamma-glutamyl hercynylcysteine S-oxide synthase) (Sulfoxide synthase EgtB);"iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ergothioneine biosynthetic process [GO:0052699]";"GO:0004497; GO:0005506; GO:0016705; GO:0052699";ergothioneine biosynthetic process [GO:0052699];;"iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp17257_c0_seq1;GAXK01068258.1;Q9VCA9;2.36E-38;SPCS3_DROME;Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit);"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0019089; GO:0045047";"protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";peptidase activity [GO:0008233]
comp172587_c0_seq1;GAXK01060848.1;P0DPW5;4.73E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp172601_c3_seq1;GAXK01060904.1;Q66S03;2.51E-12;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp172625_c0_seq1;GAXK01060854.1;Q8WZ60;1.21E-12;KLHL6_HUMAN;Kelch-like protein 6;"B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]";"GO:0002467; GO:0009617; GO:0050853";"B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]";;
comp1726253_c0_seq1;GAXK01190136.1;Q9W2E1;1.17E-13;STUM_DROME;Protein stum;"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; sensory dendrite [GO:0071683]; proprioception [GO:0019230]; sensory perception of mechanical stimulus [GO:0050954]; taxis [GO:0042330]";"GO:0016021; GO:0019230; GO:0030425; GO:0042330; GO:0050954; GO:0071683";"proprioception [GO:0019230]; sensory perception of mechanical stimulus [GO:0050954]; taxis [GO:0042330]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; sensory dendrite [GO:0071683]";
comp1726302_c0_seq1;GAXK01190173.1;Q9UJU3;2.55E-13;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp172641_c0_seq1;GAXK01060786.1;Q9ULL8;6.94E-16;SHRM4_HUMAN;Protein Shroom4 (Second homolog of apical protein);"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"GO:0001725; GO:0005737; GO:0005884; GO:0005912; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0045159; GO:0050890; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; myosin II binding [GO:0045159]"
comp172662_c0_seq1;GAXK01060827.1;Q8VCC1;5.13E-42;PGDH_MOUSE;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]"
comp172672_c0_seq1;GAXK01060918.1;Q14919;1.04E-37;NC2A_HUMAN;Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0003700; GO:0003712; GO:0003714; GO:0005634; GO:0042802; GO:0046982";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]"
comp172697_c0_seq1;GAXK01060824.1;Q91WW7;4.72E-53;PLPL3_MOUSE;1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 (EC 2.3.1.51) (Acylglycerol transacylase) (Adiponutrin) (ADPN) (Calcium-independent phospholipase A2-epsilon) (iPLA2-epsilon) (Lysophosphatidic acid acyltransferase) (Patatin-like phospholipase domain-containing protein 3) (EC 3.1.1.3);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]; glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"GO:0001676; GO:0002021; GO:0003841; GO:0004623; GO:0004806; GO:0005737; GO:0005811; GO:0006650; GO:0006654; GO:0016020; GO:0016021; GO:0019432; GO:0019433; GO:0034389; GO:0035727; GO:0036042; GO:0036153; GO:0042171; GO:0051264; GO:0051265; GO:0055088";"glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]"
comp1726972_c0_seq1;GAXK01190169.1;Q9UDV7;8.21E-12;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp1727100_c0_seq1;GAXK01190168.1;P30191;8.84E-78;GBRA6_RAT;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008144; GO:0016020; GO:0022851; GO:0030054; GO:0030425; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0042391; GO:0042734; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0051932; GO:0060078; GO:0098686; GO:0098794; GO:0098982; GO:0099060; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1727245_c0_seq1;GAXK01190144.1;B5DEL1;8.44E-11;KCTD5_RAT;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp1727377_c0_seq1;GAXK01190141.1;Q26473;7.36E-168;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp1727549_c0_seq1;GAXK01190170.1;Q5RBZ6;5.33E-10;CHSTA_PONAB;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp1727869_c0_seq1;GAXK01190152.1;Q9V438;3.08E-42;PDIA6_DROME;Protein disulfide-isomerase A6 homolog (EC 5.3.4.1) (Calcium-binding protein 1) (DmCaBP1);"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]";"GO:0003756; GO:0005783; GO:0005788; GO:0006909; GO:0009986; GO:0012505; GO:0015037; GO:0045454; GO:2000427";"cell redox homeostasis [GO:0045454]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]";"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp1727905_c0_seq1;GAXK01190137.1;A6QQM4;2.08E-14;ZN474_BOVIN;Zinc finger protein 474;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp1727953_c0_seq1;GAXK01190143.1;Q26630;1.65E-70;IDLC_STRPU;33 kDa inner dynein arm light chain, axonemal (p33);"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504";inner dynein arm assembly [GO:0036159];"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp1728163_c0_seq1;GAXK01203184.1;Q38902;4.04E-23;RAC1_ARATH;Rac-like GTP-binding protein ARAC1 (GTPase protein ROP3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; abscisic acid-activated signaling pathway [GO:0009738]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; auxin-activated signaling pathway [GO:0009734]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"GO:0000902; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007015; GO:0007266; GO:0009524; GO:0009734; GO:0009738; GO:0016477; GO:0019901; GO:0030036; GO:0030838";"abscisic acid-activated signaling pathway [GO:0009738]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; auxin-activated signaling pathway [GO:0009734]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp1728227_c0_seq1;GAXK01203175.1;P21369;7.02E-29;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp17283_c0_seq1;GAXK01067392.1;Q9Z336;2.77E-62;DYLT1_RAT;Dynein light chain Tctex-type 1 (Activator of G-protein signaling 2) (AGS2) (T-complex testis-specific protein 1 homolog);"axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]";"GO:0000132; GO:0003774; GO:0005739; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0006886; GO:0008022; GO:0008277; GO:0010976; GO:0016358; GO:0019060; GO:0030027; GO:0035022; GO:0035795; GO:0042802; GO:0043025; GO:0043087; GO:0043657; GO:0044295; GO:0048812; GO:0050768; GO:0051301; GO:0051493; GO:0060548; GO:0061564; GO:0099503";"axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]";"axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]"
comp1728330_c0_seq1;GAXK01203183.1;Q0IIY2;2.11E-29;WSCD1_XENTR;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp1728351_c0_seq1;GAXK01203163.1;Q13003;2.09E-14;GRIK3_HUMAN;Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315";"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp1728546_c0_seq1;GAXK01203178.1;Q66S03;9.56E-14;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp1728750_c0_seq1;GAXK01203193.1;Q6BXH8;2.42E-66;RS6_DEBHA;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1728754_c0_seq1;GAXK01203198.1;P24468;1.58E-45;COT2_HUMAN;COUP transcription factor 2 (COUP-TF2) (Apolipoprotein A-I regulatory protein 1) (ARP-1) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; forebrain development [GO:0030900]; limb development [GO:0060173]; lipid metabolic process [GO:0006629]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron migration [GO:0001764]; placenta blood vessel development [GO:0060674]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in lymphatic endothelial cell fate commitment [GO:0060849]; response to estradiol [GO:0032355]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000977; GO:0000981; GO:0001764; GO:0001893; GO:0001937; GO:0001972; GO:0003084; GO:0003700; GO:0003707; GO:0003714; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006629; GO:0007165; GO:0007519; GO:0008270; GO:0009566; GO:0009952; GO:0009956; GO:0010596; GO:0030154; GO:0030900; GO:0032355; GO:0042803; GO:0043565; GO:0045736; GO:0045892; GO:0045893; GO:0048514; GO:0048856; GO:0060173; GO:0060674; GO:0060707; GO:0060849";"anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; forebrain development [GO:0030900]; limb development [GO:0060173]; lipid metabolic process [GO:0006629]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; placenta blood vessel development [GO:0060674]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in lymphatic endothelial cell fate commitment [GO:0060849]; response to estradiol [GO:0032355]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp1728871_c0_seq1;GAXK01203186.1;Q16534;6.02E-17;HLF_HUMAN;Hepatic leukemia factor;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1729319_c0_seq1;GAXK01203188.1;Q94521;9.68E-15;DNAT_DROME;Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase);"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";"GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066";"catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";cytoplasm [GO:0005737];"aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]"
comp1729491_c0_seq1;GAXK01203157.1;P31009;9.88E-92;RS2_DROME;40S ribosomal protein S2 (Protein strings of pearls);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";"GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0007275; GO:0022626; GO:0022627; GO:0048477";"cytoplasmic translation [GO:0002181]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp17295_c0_seq1;GAXK01068006.1;Q60WU2;2.89E-20;SYB1_CAEBR;Synaptobrevin-1 (Synaptobrevin-related protein 1);"axon [GO:0030424]; cell junction [GO:0030054]; cortical granule [GO:0060473]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]; defecation [GO:0030421]; nematode larval development [GO:0002119]; regulation of hindgut contraction [GO:0043134]; regulation of pharyngeal pumping [GO:0043051]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle exocytosis [GO:0016079]";"GO:0002119; GO:0005886; GO:0007271; GO:0016021; GO:0016079; GO:0030054; GO:0030421; GO:0030424; GO:0030672; GO:0043051; GO:0043134; GO:0048786; GO:0060473";"defecation [GO:0030421]; nematode larval development [GO:0002119]; regulation of hindgut contraction [GO:0043134]; regulation of pharyngeal pumping [GO:0043051]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle exocytosis [GO:0016079]";"axon [GO:0030424]; cell junction [GO:0030054]; cortical granule [GO:0060473]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]";
comp1729904_c0_seq1;GAXK01203172.1;Q9W4Y2;3.15E-53;PDFR_DROME;PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; calcitonin receptor activity [GO:0004948]; neuropeptide receptor activity [GO:0008188]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]";"GO:0004948; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0016021; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0055070; GO:0060086";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";"calcitonin receptor activity [GO:0004948]; neuropeptide receptor activity [GO:0008188]"
comp172995_c4_seq1;GAXK01060752.1;P84022;3.62E-74;SMAD3_HUMAN;Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001228; GO:0001657; GO:0001666; GO:0001701; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0003712; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008013; GO:0008134; GO:0008270; GO:0009880; GO:0010628; GO:0010694; GO:0010718; GO:0016202; GO:0016579; GO:0017015; GO:0017151; GO:0019049; GO:0019901; GO:0019902; GO:0023019; GO:0030308; GO:0030325; GO:0030335; GO:0030501; GO:0030512; GO:0030618; GO:0030878; GO:0031053; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032731; GO:0032909; GO:0032916; GO:0032924; GO:0033689; GO:0035259; GO:0035326; GO:0038092; GO:0042060; GO:0042110; GO:0042177; GO:0042307; GO:0042802; GO:0042803; GO:0043066; GO:0043130; GO:0043235; GO:0043425; GO:0043565; GO:0044212; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045893; GO:0045930; GO:0045944; GO:0046982; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0050821; GO:0050927; GO:0051091; GO:0051098; GO:0051481; GO:0051496; GO:0051894; GO:0060039; GO:0060290; GO:0060395; GO:0061045; GO:0061767; GO:0070306; GO:0070410; GO:0070412; GO:0070878; GO:0071141; GO:0071144; GO:0071345; GO:0071560; GO:0090263; GO:0097191; GO:0097296; GO:1901203; GO:1902895; GO:1903243";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp173_c0_seq1;GAXK01168698.1;P63208;8.28E-80;SKP1_HUMAN;S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1);"centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; protein domain specific binding [GO:0019904]; ubiquitin-protein transferase activity [GO:0004842]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H2A monoubiquitination [GO:0035518]; interleukin-1-mediated signaling pathway [GO:0070498]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0008013; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0035518; GO:0038061; GO:0038095; GO:0043687; GO:0050852; GO:0051403; GO:0051457; GO:0070498; GO:0097602; GO:1901990";"cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H2A monoubiquitination [GO:0035518]; interleukin-1-mediated signaling pathway [GO:0070498]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; protein domain specific binding [GO:0019904]; ubiquitin-protein transferase activity [GO:0004842]"
comp173003_c1_seq1;GAXK01060935.1;A6NNF4;1.27E-31;ZN726_HUMAN;Zinc finger protein 726;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1730254_c0_seq1;GAXK01084169.1;Q9VCA2;1.11E-09;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp173029_c0_seq1;GAXK01060901.1;Q53FA7;1.48E-34;QORX_HUMAN;Quinone oxidoreductase PIG3 (EC 1.-.-.-) (Tumor protein p53-inducible protein 3) (p53-induced gene 3 protein);"cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]";"GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0042981; GO:0048038; GO:0070402";"NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]";cytosol [GO:0005829];"NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]"
comp173105_c0_seq1;GAXK01060815.1;O44390;1.21E-29;ACO11_TRINI;Acyl-CoA Delta(11) desaturase (EC 1.14.19.5) (Acyl-CoA Delta-11 desaturase) (Delta(11)-desaturase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acyl-CoA delta11-desaturase activity [GO:0017105]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]";"GO:0005789; GO:0006633; GO:0016021; GO:0017105; GO:0046872";fatty acid biosynthetic process [GO:0006633];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acyl-CoA delta11-desaturase activity [GO:0017105]; metal ion binding [GO:0046872]"
comp173120_c0_seq1;GAXK01060881.1;Q6GR09;3.10E-07;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp17314_c3_seq1;GAXK01068396.1;O77503;4.14E-158;AGO2_RABIT;Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer) (Fragment);"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000340; GO:0000932; GO:0005634; GO:0005844; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153; GO:1990904";"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"
comp1731638_c0_seq1;GAXK01084164.1;O77475;4.48E-27;CPESY_DROME;Ceramide phosphoethanolamine synthase (CPE synthase) (EC 2.7.8.n3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0005886; GO:0006665; GO:0016021; GO:0016740";sphingolipid metabolic process [GO:0006665];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transferase activity [GO:0016740]
comp173165_c0_seq1;GAXK01060745.1;Q96MU6;4.05E-31;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp173190_c3_seq1;GAXK01060940.1;Q9EQQ9;1.33E-81;OGA_MOUSE;Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]";"GO:0004402; GO:0005634; GO:0005739; GO:0005829; GO:0006044; GO:0006517; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571";"dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]"
comp17321_c0_seq1;GAXK01067515.1;Q8K1C7;9.49E-22;MOT14_MOUSE;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp173211_c1_seq1;GAXK01060899.1;O46040;7.93E-18;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp173270_c0_seq1;GAXK01060836.1;Q502G2;1.19E-60;T41AA_DANRE;Transmembrane protein 41A-A;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1732789_c0_seq1;GAXK01052640.1;Q94HW2;1.53E-27;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp173325_c2_seq1;GAXK01060863.1;Q9VJ79;1.65E-17;PDE11_DROME;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp173368_c0_seq1;GAXK01060965.1;F1NHE9;9.79E-34;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp17337_c9_seq1;GAXK01067704.1;Q23551;0;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp173373_c0_seq1;GAXK01060857.1;C0HBT3;8.74E-28;RN146_SALSA;E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146);"cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1733805_c0_seq1;GAXK01052625.1;Q9NW07;2.70E-13;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1734_c55_seq1;GAXK01168948.1;Q24756;8.98E-31;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp173443_c1_seq1;GAXK01060800.1;Q7PPU9;9.89E-54;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp173467_c0_seq1;GAXK01060944.1;Q3UHD1;3.21E-21;AGRB1_MOUSE;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]"
comp1734769_c0_seq1;GAXK01039230.1;P49582;3.63E-29;ACHA7_MOUSE;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"GO:0000187; GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008144; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0014069; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032222; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0045471; GO:0045766; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051823; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098793; GO:0098815; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:1905923; GO:2000300; GO:2000463";"acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp173542_c0_seq1;GAXK01060842.1;P47990;0;XDH_CHICK;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949";"urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp17356_c1_seq1;GAXK01068109.1;Q5U4T7;9.66E-103;BIC1B_XENLA;Protein bicaudal C homolog 1-B (Bic-C-B);"RNA binding [GO:0003723]; multicellular organism development [GO:0007275]";"GO:0003723; GO:0007275";multicellular organism development [GO:0007275];;RNA binding [GO:0003723]
comp1735675_c0_seq1;GAXK01205162.1;Q09390;2.11E-12;HMG12_CAEEL;High mobility group protein 1.2;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell fate specification [GO:0001708]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vulval development [GO:0040025]; Wnt signaling pathway [GO:0016055]";"GO:0000790; GO:0001708; GO:0005634; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0008406; GO:0016055; GO:0040025; GO:0044212; GO:0045089; GO:0045944";"cell fate specification [GO:0001708]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vulval development [GO:0040025]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1735715_c0_seq1;GAXK01039244.1;P89116;5.25E-23;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp173615_c0_seq1;GAXK01060976.1;P70399;6.43E-18;TP53B_MOUSE;TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1);"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II activating transcription factor binding [GO:0001102]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000077; GO:0000776; GO:0000777; GO:0000784; GO:0001102; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0008134; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0042393; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061649; GO:0071481; GO:1990391; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription, DNA-templated [GO:0006355]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]";"damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II activating transcription factor binding [GO:0001102]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin modification-dependent histone binding [GO:0061649]"
comp17362_c3_seq1;GAXK01067682.1;P10351;5.00E-173;XDH_DROME;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus);"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0006144; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0043546; GO:0048072; GO:0050660; GO:0051537; GO:0071949";"arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp173633_c1_seq1;GAXK01060889.1;Q17528;4.04E-35;BEST1_CAEEL;Bestrophin homolog 1;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp173639_c2_seq1;GAXK01060837.1;P56499;3.22E-35;UCP3_RAT;Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; mitochondrial transmembrane transport [GO:1990542]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to superoxide [GO:0000303]";"GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006631; GO:0007568; GO:0007584; GO:0009409; GO:0014823; GO:0015078; GO:0016021; GO:0017077; GO:0032868; GO:0032870; GO:0048545; GO:0051384; GO:1990542; GO:1990845";"adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; mitochondrial transmembrane transport [GO:1990542]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to superoxide [GO:0000303]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]"
comp173687_c0_seq1;GAXK01060980.1;Q52KB5;8.97E-08;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1736933_c0_seq1;GAXK01122922.1;Q28181;9.77E-68;CNGB1_BOVIN;Cyclic nucleotide-gated cation channel beta-1 (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0005737; GO:0007601; GO:0007608; GO:0010628; GO:0016021; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0050896; GO:0051289";"positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]"
comp1737_c1_seq1;GAXK01205872.1;P35128;7.01E-95;UBE2N_DROME;Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Protein bendless) (Ubiquitin carrier protein N) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase D3) (Ubiquitin-protein ligase N);"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; UBC13-UEV1A complex [GO:0035370]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; axon target recognition [GO:0007412]; axonogenesis [GO:0007409]; flight behavior [GO:0007629]; grooming behavior [GO:0007625]; jump response [GO:0007630]; peptidoglycan recognition protein signaling pathway [GO:0061057]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of cell death [GO:0010942]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of protein polyubiquitination [GO:1902916]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; response to anesthetic [GO:0072347]; response to oxidative stress [GO:0006979]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]";"GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0006301; GO:0006979; GO:0007409; GO:0007412; GO:0007625; GO:0007629; GO:0007630; GO:0008594; GO:0010942; GO:0031624; GO:0031625; GO:0035370; GO:0045977; GO:0046330; GO:0048471; GO:0051124; GO:0060074; GO:0061057; GO:0061631; GO:0070534; GO:0072347; GO:1902916";"axonogenesis [GO:0007409]; axon target recognition [GO:0007412]; flight behavior [GO:0007629]; grooming behavior [GO:0007625]; jump response [GO:0007630]; peptidoglycan recognition protein signaling pathway [GO:0061057]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of cell death [GO:0010942]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of protein polyubiquitination [GO:1902916]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; response to anesthetic [GO:0072347]; response to oxidative stress [GO:0006979]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]";"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; UBC13-UEV1A complex [GO:0035370]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp17371_c1_seq1;GAXK01068475.1;O42254;6.69E-62;IF2B1_CHICK;Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1);"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]";"GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150";"CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]";"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]"
comp1737322_c0_seq1;GAXK01122904.1;Q8ITC9;1.19E-08;PK1R_DROME;Pyrokinin-1 receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]"
comp173740_c0_seq1;GAXK01060784.1;Q8T4E1;4.97E-172;GPI8_DROME;Putative GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol glycan anchor biosynthesis protein class K);"GPI-anchor transamidase complex [GO:0042765]; cysteine-type peptidase activity [GO:0008234]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]";"GO:0003923; GO:0008234; GO:0016255; GO:0034394; GO:0042765";"attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]";GPI-anchor transamidase complex [GO:0042765];"cysteine-type peptidase activity [GO:0008234]; GPI-anchor transamidase activity [GO:0003923]"
comp173743_c0_seq1;GAXK01060970.1;O76202;1.41E-15;USP_CHOFU;Protein ultraspiracle homolog (Nuclear receptor subfamily 2 group B member 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp173744_c0_seq1;GAXK01060942.1;Q6ZS10;7.07E-08;CL17A_HUMAN;C-type lectin domain family 17, member A (Prolectin);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]";"GO:0005537; GO:0009986; GO:0016021; GO:0042806; GO:0046872";;"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";"fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp173770_c0_seq1;GAXK01060769.1;Q9BQT8;3.67E-122;ODC_HUMAN;Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; lysine catabolic process [GO:0006554]";"GO:0005743; GO:0006554; GO:0015139; GO:0016021";lysine catabolic process [GO:0006554];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";alpha-ketoglutarate transmembrane transporter activity [GO:0015139]
comp173774_c0_seq1;GAXK01060969.1;Q5R542;4.88E-20;MFSD5_PONAB;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp173807_c0_seq1;GAXK01060930.1;Q07130;4.76E-169;UGPA_BOVIN;UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]";"GO:0003983; GO:0005737; GO:0005977; GO:0006011; GO:0046872";"glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]"
comp1738076_c0_seq1;GAXK01071374.1;Q6IMN8;8.52E-35;ALRA_DICDI;Aldose reductase A (ARA) (EC 1.1.1.21) (Aldehyde reductase A);"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; response to bacterium [GO:0009617]; response to oxidative stress [GO:0006979]";"GO:0004032; GO:0005829; GO:0006979; GO:0008106; GO:0009617; GO:0016491; GO:0031158; GO:0042593; GO:0045335; GO:0048870";"cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; response to bacterium [GO:0009617]; response to oxidative stress [GO:0006979]";"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"
comp1738150_c0_seq1;GAXK01071370.1;P80561;5.83E-08;APX_STRGG;Aminopeptidase S (EC 3.4.11.24) (API) (SGAP);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004177; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp173819_c1_seq1;GAXK01060828.1;P59722;6.27E-64;EGLN1_RAT;Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (Fragment);"cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline dioxygenase activity [GO:0031543]; negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron death [GO:1901216]; regulation of angiogenesis [GO:0045765]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]";"GO:0001666; GO:0005634; GO:0005829; GO:0008198; GO:0019899; GO:0031418; GO:0031543; GO:0043065; GO:0043433; GO:0045765; GO:0051344; GO:0071731; GO:1901216; GO:1905290";"negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron death [GO:1901216]; regulation of angiogenesis [GO:0045765]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline dioxygenase activity [GO:0031543]"
comp173830_c1_seq1;GAXK01060802.1;P70673;7.27E-86;KCJ11_RAT;ATP-sensitive inward rectifier potassium channel 11 (BIR) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11);"acrosomal vesicle [GO:0001669]; axolemma [GO:0030673]; cell body fiber [GO:0070852]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; heat shock protein binding [GO:0031072]; inward rectifier potassium channel activity [GO:0005242]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; cellular response to glucose stimulus [GO:0071333]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; glucose metabolic process [GO:0006006]; negative regulation of insulin secretion [GO:0046676]; nervous system process [GO:0050877]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to testosterone [GO:0033574]";"GO:0001669; GO:0002931; GO:0005242; GO:0005524; GO:0005635; GO:0005739; GO:0005768; GO:0005783; GO:0005829; GO:0005886; GO:0006006; GO:0006813; GO:0008022; GO:0008282; GO:0014704; GO:0015272; GO:0030315; GO:0030506; GO:0030673; GO:0031072; GO:0032355; GO:0033198; GO:0033574; GO:0042383; GO:0042391; GO:0042493; GO:0043025; GO:0043209; GO:0043231; GO:0044325; GO:0046676; GO:0050877; GO:0070852; GO:0071316; GO:0071333; GO:0071356; GO:1903078; GO:1990573; GO:2001259";"cellular response to glucose stimulus [GO:0071333]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; glucose metabolic process [GO:0006006]; negative regulation of insulin secretion [GO:0046676]; nervous system process [GO:0050877]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to testosterone [GO:0033574]";"acrosomal vesicle [GO:0001669]; axolemma [GO:0030673]; cell body fiber [GO:0070852]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]";"ankyrin binding [GO:0030506]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; inward rectifier potassium channel activity [GO:0005242]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]"
comp1738569_c0_seq1;GAXK01071350.1;Q9BSG1;2.20E-21;ZNF2_HUMAN;Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp17386_c0_seq1;GAXK01068001.1;P21797;5.20E-26;TNNC1_BALNU;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1739599_c0_seq1;GAXK01071340.1;P55040;7.25E-23;GEM_HUMAN;GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR);"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842";"cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp1740_c1_seq1;GAXK01168771.1;Q9GV27;1.86E-142;EIF3H_BOMMO;Eukaryotic translation initiation factor 3 subunit H (eIF3h);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp1740075_c0_seq1;GAXK01129028.1;Q7KRI2;1.58E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp174015_c0_seq1;GAXK01114598.1;Q8CEG5;1.30E-10;CC28B_MOUSE;Coiled-coil domain-containing protein 28B;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]";"GO:0005737; GO:0005813; GO:0060271";cilium assembly [GO:0060271];"centrosome [GO:0005813]; cytoplasm [GO:0005737]";
comp1740262_c0_seq1;GAXK01129067.1;Q8VDJ3;1.66E-25;VIGLN_MOUSE;Vigilin (High density lipoprotein-binding protein) (HDL-binding protein);"cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]";"GO:0003723; GO:0005634; GO:0005829; GO:0006869; GO:0008203; GO:0034364";"cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]";"cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp174046_c0_seq1;GAXK01114421.1;Q9R1R4;2.30E-14;TDRD7_RAT;Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap);"mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0005759; GO:0007283; GO:0010608; GO:0035770; GO:0047485; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]";"mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]"
comp174074_c1_seq1;GAXK01114574.1;Q96NN9;1.17E-139;AIFM3_HUMAN;Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]";"GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194";execution phase of apoptosis [GO:0097194];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp1740876_c0_seq1;GAXK01129062.1;Q0PMG2;2.03E-19;MDGA1_MOUSE;MAM domain-containing glycosylphosphatidylinositol anchor protein 1;"anchored component of plasma membrane [GO:0046658]; GABA-ergic synapse [GO:0098982]; membrane raft [GO:0045121]; cerebral cortex radially oriented cell migration [GO:0021799]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]";"GO:0001764; GO:0021799; GO:0045121; GO:0046658; GO:0051964; GO:0098982; GO:0099179; GO:1905606";"cerebral cortex radially oriented cell migration [GO:0021799]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]";"anchored component of plasma membrane [GO:0046658]; GABA-ergic synapse [GO:0098982]; membrane raft [GO:0045121]";
comp1740883_c0_seq1;GAXK01129026.1;P0DN18;1.06E-10;VKTE_ANEVI;U-actitoxin-Avd3q (U-AITX-Avd3q) (AsKC14);"extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]";"GO:0004867; GO:0005576; GO:0042151; GO:0090729";;"extracellular region [GO:0005576]; nematocyst [GO:0042151]";"serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]"
comp1740983_c0_seq1;GAXK01129041.1;Q7Z3E5;4.47E-38;ARMC9_HUMAN;LisH domain-containing protein ARMC9 (Armadillo repeat-containing protein 9) (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]";"GO:0005737; GO:0036064; GO:0060271; GO:0070062";cilium assembly [GO:0060271];"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]";
comp174103_c1_seq1;GAXK01114474.1;Q9H221;2.25E-35;ABCG8_HUMAN;ATP-binding cassette sub-family G member 8 (EC 7.6.2.-) (Sterolin-2);"apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0007588; GO:0010949; GO:0015914; GO:0015918; GO:0016324; GO:0016887; GO:0030299; GO:0033344; GO:0042493; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0120020";"cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]";"apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]"
comp174129_c0_seq1;GAXK01114551.1;Q9VEV4;0;CL16A_DROME;Protein CLEC16A homolog (Endosomal maturation defective protein);"autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]";"GO:0000139; GO:0000421; GO:0005770; GO:0005794; GO:0006914; GO:0008333; GO:0016021; GO:0016197; GO:0017137; GO:0031902; GO:0036020";"autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]";"autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]";Rab GTPase binding [GO:0017137]
comp1741326_c0_seq1;GAXK01129039.1;Q96PE6;8.99E-07;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp174172_c1_seq1;GAXK01114550.1;Q5RCT4;9.86E-08;CSRP1_PONAB;Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]";"GO:0005634; GO:0046872";;nucleus [GO:0005634];metal ion binding [GO:0046872]
comp1741895_c0_seq1;GAXK01129065.1;P41216;2.49E-129;ACSL1_MOUSE;Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0014070; GO:0015908; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0042493; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]"
comp1742447_c0_seq1;GAXK01060603.1;P21329;4.77E-35;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp1742502_c0_seq1;GAXK01060639.1;P41115;2.14E-86;RS11_XENLA;40S ribosomal protein S11;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp174251_c0_seq1;GAXK01114627.1;Q6UWM7;2.87E-120;LCTL_HUMAN;Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein);"brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0002089; GO:0005783; GO:0005789; GO:0005903; GO:0005975; GO:0007601; GO:0008422; GO:0016021; GO:0050896";"carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";beta-glucosidase activity [GO:0008422]
comp1742568_c0_seq1;GAXK01060626.1;A0ZSK4;2.26E-37;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp174284_c1_seq1;GAXK01114527.1;P42519;6.52E-09;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp1742994_c0_seq1;GAXK01060628.1;Q9TU53;5.28E-09;CUBN_CANLF;Cubilin;"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"GO:0005509; GO:0005765; GO:0008144; GO:0008203; GO:0010008; GO:0015031; GO:0016324; GO:0031419; GO:0031526";"cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]";"calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]"
comp174309_c0_seq1;GAXK01114670.1;Q8IVH2;9.73E-55;FOXP4_HUMAN;Forkhead box protein P4 (Fork head-related protein-like A);"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]";"GO:0000790; GO:0000981; GO:0043565; GO:0046872";;nuclear chromatin [GO:0000790];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp17432_c2_seq1;GAXK01068527.1;P42337;0;PK3CA_MOUSE;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; liver development [GO:0001889]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]";"GO:0001525; GO:0001889; GO:0001932; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006006; GO:0006909; GO:0010468; GO:0010629; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030027; GO:0030295; GO:0033138; GO:0035005; GO:0036092; GO:0040014; GO:0043457; GO:0043491; GO:0043524; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048661; GO:0052812; GO:0060612; GO:0071333; GO:0097009; GO:2000270; GO:2000653; GO:2000811";"adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; liver development [GO:0001889]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]";"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]"
comp17436_c0_seq1;GAXK01067694.1;Q91YW3;3.54E-121;DNJC3_MOUSE;DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]; cellular response to cold [GO:0070417]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0004860; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006469; GO:0019901; GO:0030968; GO:0034975; GO:0034976; GO:0036494; GO:0043066; GO:0051082; GO:0051087; GO:0051603; GO:0051787; GO:0070417; GO:1903912";"cellular response to cold [GO:0070417]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to endoplasmic reticulum stress [GO:0034976]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; smooth endoplasmic reticulum [GO:0005790]";"chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]"
comp174364_c0_seq1;GAXK01114410.1;Q5DQR4;0;STB5L_MOUSE;Syntaxin-binding protein 5-like (Lethal(2) giant larvae protein homolog 4) (Tomosyn-2);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; negative regulation of insulin secretion [GO:0046676]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]";"GO:0005096; GO:0005737; GO:0005886; GO:0006887; GO:0015031; GO:0016021; GO:0017137; GO:0017157; GO:0019905; GO:0031201; GO:0031594; GO:0042593; GO:0045159; GO:0046676; GO:0050714; GO:0098992; GO:2000300";"exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; negative regulation of insulin secretion [GO:0046676]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]";"GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]"
comp1743657_c0_seq1;GAXK01060624.1;Q9HCD6;5.93E-88;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp17437_c0_seq1;GAXK01067403.1;P62078;3.07E-23;TIM8B_RAT;Mitochondrial import inner membrane translocase subunit Tim8 B (Deafness dystonia protein 2 homolog);"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321]";"GO:0005743; GO:0005758; GO:0046872; GO:0072321";chaperone-mediated protein transport [GO:0072321];"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]";metal ion binding [GO:0046872]
comp1744002_c0_seq1;GAXK01148132.1;Q6AYK2;1.80E-20;JMJD6_RAT;Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]";"GO:0001822; GO:0002040; GO:0003713; GO:0003727; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006397; GO:0006482; GO:0007166; GO:0007507; GO:0008380; GO:0018395; GO:0030324; GO:0032451; GO:0032452; GO:0033077; GO:0033746; GO:0033749; GO:0035513; GO:0035515; GO:0038023; GO:0042116; GO:0042803; GO:0043654; GO:0045893; GO:0045944; GO:0048024; GO:0048821; GO:0051260; GO:0060041; GO:0070079; GO:0070815; GO:0106140; GO:1990904";"cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]";"demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; protein homodimerization activity [GO:0042803]; P-TEFb complex binding [GO:0106140]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]"
comp174409_c0_seq1;GAXK01114582.1;Q6DE73;7.08E-116;OGFD1_XENLA;Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase);"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]";"GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063";"cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]";"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]"
comp174428_c0_seq1;GAXK01114519.1;Q9DAK2;1.31E-85;PACRG_MOUSE;Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein);"cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]";"GO:0001664; GO:0003779; GO:0005739; GO:0005829; GO:0005929; GO:0007286; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225";"cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]";"cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]"
comp174455_c0_seq1;GAXK01114634.1;Q8IN81;1.03E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp174487_c3_seq1;GAXK01114568.1;Q18297;5.05E-28;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp174490_c0_seq1;GAXK01114575.1;P91766;0;ACH1_MANSE;Acetylcholine receptor subunit alpha-like (MARA1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp1745_c0_seq1;GAXK01166066.1;P53461;1.29E-46;ACTC_HALRO;Actin, nonmuscle [Cleaved into: Actin, nonmuscle, intermediate form];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp174549_c0_seq1;GAXK01114654.1;Q7KRI2;2.62E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1745546_c0_seq1;GAXK01148136.1;Q9Y575;6.02E-08;ASB3_HUMAN;Ankyrin repeat and SOCS box protein 3 (ASB-3);"cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005829; GO:0016567; GO:0035556; GO:0043687";"intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";cytosol [GO:0005829];
comp174620_c3_seq1;GAXK01114416.1;Q1XG89;3.04E-51;TDR12_BOMMO;Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (RNA helicase-like protein) (Tudor domain-containing protein 12) (BmTdrd12);"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; P granule [GO:0043186]; PET complex [GO:1990923]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003676; GO:0003724; GO:0005524; GO:0005694; GO:0005829; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0031965; GO:0043186; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; PET complex [GO:1990923]; P granule [GO:0043186]";"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp1746701_c0_seq1;GAXK01093311.1;Q5QJ74;8.26E-13;TBCEL_HUMAN;Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014";"microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";alpha-tubulin binding [GO:0043014]
comp174685_c0_seq1;GAXK01114663.1;Q9NV88;0;INT9_HUMAN;Integrator complex subunit 9 (Int9) (Protein related to CPSF subunits of 74 kDa) (RC-74);"cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"GO:0005634; GO:0005654; GO:0005829; GO:0016180; GO:0032039; GO:0042795";"snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1746865_c0_seq1;GAXK01093319.1;Q9VV72;2.22E-41;MINP1_DROME;Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase);"anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; dephosphorylation [GO:0016311]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]";"GO:0003993; GO:0005886; GO:0007424; GO:0016311; GO:0016323; GO:0016324; GO:0030054; GO:0030175; GO:0031362; GO:0034417; GO:0051491; GO:0052745; GO:0052826; GO:0070062";"dephosphorylation [GO:0016311]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]";"anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; plasma membrane [GO:0005886]";"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]"
comp174697_c1_seq1;GAXK01114651.1;Q9NP59;1.14E-82;S40A1_HUMAN;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988";"cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp1746975_c0_seq1;GAXK01093307.1;Q9FRL3;2.09E-34;ERDL6_ARATH;Sugar transporter ERD6-like 6;"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; carbohydrate:proton symporter activity [GO:0005351]; glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"GO:0005351; GO:0005739; GO:0005774; GO:0005794; GO:0005887; GO:0009705; GO:0010030; GO:0042593";"glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]";carbohydrate:proton symporter activity [GO:0005351]
comp1747141_c0_seq1;GAXK01093308.1;Q8IN81;1.76E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1747195_c0_seq1;GAXK01093312.1;Q91610;4.83E-20;DHHA_XENLA;"Desert hedgehog protein A (Cephalic hedgehog protein) (Desert hedgehog protein 1) (DHH-1) (X-CHH) [Cleaved into: Desert hedgehog protein A N-product; Desert hedgehog protein A C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0016539; GO:0046872";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp174759_c0_seq1;GAXK01114429.1;Q86MW9;7.24E-14;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp174766_c0_seq1;GAXK01114423.1;Q9BRR8;3.96E-19;GPTC1_HUMAN;G patch domain-containing protein 1 (Evolutionarily conserved G-patch domain-containing protein);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634; GO:0071013";mRNA splicing, via spliceosome [GO:0000398];"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp174775_c0_seq1;GAXK01114649.1;Q15392;0;DHC24_HUMAN;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214";"amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]";"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"
comp1747784_c0_seq1;GAXK01093318.1;O42387;8.61E-27;RS24_TAKRU;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp174784_c2_seq1;GAXK01114465.1;P10076;7.45E-26;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp174802_c0_seq1;GAXK01114556.1;Q21642;2.19E-10;HRG1_CAEEL;Heme transporter hrg-1 (Heme-responsive gene 1 protein) (CeHRG-1);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; heme transport [GO:0015886]";"GO:0005765; GO:0005886; GO:0010008; GO:0015232; GO:0015886; GO:0016021; GO:0020037";heme transport [GO:0015886];"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"heme binding [GO:0020037]; heme transporter activity [GO:0015232]"
comp1748099_c0_seq1;GAXK01061091.1;Q9VNL4;5.96E-51;GRCR1_DROME;Glutaredoxin domain-containing cysteine-rich protein CG31559;"cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cell [GO:0005623];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp17481_c11_seq1;GAXK01067391.1;D3YXG0;3.01E-25;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp174864_c0_seq1;GAXK01114408.1;Q60LV4;1.51E-27;MYO3_CAEBR;Myosin-3 (Myosin heavy chain A) (MHC A);"A band [GO:0031672]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; locomotory behavior [GO:0007626]";"GO:0003774; GO:0005524; GO:0007626; GO:0031672; GO:0032982; GO:0051015";locomotory behavior [GO:0007626];"A band [GO:0031672]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp174879_c0_seq1;GAXK01114600.1;P26967;7.85E-10;CU20_TENMO;Adult-specific cuticular protein ACP-20;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp174910_c0_seq1;GAXK01114437.1;Q6AY62;1.60E-69;NEUFC_RAT;Neuferricin (Cytochrome b5 domain-containing protein 2);"extracellular region [GO:0005576]; heme binding [GO:0020037]; positive regulation of neuron differentiation [GO:0045666]";"GO:0005576; GO:0020037; GO:0045666";positive regulation of neuron differentiation [GO:0045666];extracellular region [GO:0005576];heme binding [GO:0020037]
comp174924_c0_seq1;GAXK01114435.1;Q6DHF7;6.83E-92;GTPBA_DANRE;GTP-binding protein 10;"nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254]";"GO:0005525; GO:0005730; GO:0042254";ribosome biogenesis [GO:0042254];nucleolus [GO:0005730];GTP binding [GO:0005525]
comp1749315_c0_seq1;GAXK01061116.1;O46040;1.82E-20;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1749471_c0_seq1;GAXK01061090.1;P0C233;1.60E-104;RS4_TETTH;40S ribosomal protein S4 (40S ribosomal protein S7);"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp174965_c1_seq1;GAXK01114554.1;Q9WYP5;3.04E-57;IOLG_THEMA;Myo-inositol 2-dehydrogenase (EC 1.1.1.18);"inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]";"GO:0006020; GO:0006740; GO:0016491; GO:0050112";"inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]";;"inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]"
comp175_c19_seq1;GAXK01170230.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1750219_c0_seq1;GAXK01140643.1;Q61670;1.73E-30;HLX_MOUSE;H2.0-like homeobox protein (Homeobox protein HLX1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; animal organ development [GO:0048513]; cell differentiation [GO:0030154]; embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle tissue development [GO:0007519]";"GO:0001889; GO:0005634; GO:0006355; GO:0007519; GO:0008284; GO:0030154; GO:0043565; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048513; GO:0048557";"animal organ development [GO:0048513]; cell differentiation [GO:0030154]; embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle tissue development [GO:0007519]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp175027_c0_seq1;GAXK01114514.1;Q4V847;4.82E-47;INT8_XENLA;Integrator complex subunit 8 (Int8);"nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]";"GO:0005634; GO:0034472";snRNA 3'-end processing [GO:0034472];nucleus [GO:0005634];
comp1750330_c1_seq1;GAXK01140649.1;Q9VYV5;2.71E-64;FUT8_DROME;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]"
comp17504_c0_seq1;GAXK01068124.1;Q99LZ3;1.67E-55;SLD5_MOUSE;DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed];"cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]";"GO:0000727; GO:0000811; GO:0001833; GO:0005634; GO:0005737; GO:0006261; GO:0031298; GO:0032508";"DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]";"cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]";
comp17505_c1_seq1;GAXK01067668.1;Q8IYB3;9.53E-48;SRRM1_HUMAN;Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0008380; GO:0016363; GO:0016607; GO:0031124; GO:0071013";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp1750563_c0_seq1;GAXK01140644.1;Q10979;2.45E-16;FUT1_RABIT;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp1750685_c0_seq1;GAXK01140651.1;B7Z6K7;7.70E-12;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1750991_c0_seq1;GAXK01140631.1;A0FKN6;1.83E-23;VMPA_LOXIN;Astacin-like metalloprotease toxin 1 (EC 3.4.24.-) (Loxosceles astacin-like protease 1) (LALP) (LALP1);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270; GO:0090729";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]"
comp1751_c1_seq1;GAXK01169509.1;Q8BHL6;8.35E-22;FAP24_MOUSE;Fanconi anemia core complex-associated protein 24 (Fanconi anemia-associated protein of 24 kDa);"Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]";"GO:0003677; GO:0003682; GO:0005654; GO:0036297; GO:0043231; GO:0043240";interstrand cross-link repair [GO:0036297];"Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]"
comp175119_c1_seq1;GAXK01114538.1;P05205;3.37E-08;HP1_DROME;Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen);"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]; polytene chromosome, telomeric region [GO:0035012]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; chromatin silencing [GO:0006342]; chromatin silencing at centromere [GO:0030702]; chromosome organization [GO:0051276]; establishment of chromatin silencing [GO:0006343]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]";"GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000780; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005704; GO:0005720; GO:0005721; GO:0006342; GO:0006343; GO:0006355; GO:0010629; GO:0016458; GO:0030544; GO:0030674; GO:0030702; GO:0031060; GO:0031507; GO:0033697; GO:0034773; GO:0035012; GO:0035064; GO:0042393; GO:0042981; GO:0044877; GO:0045892; GO:0045893; GO:0051276; GO:0061408; GO:0070063; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646";"chromatin silencing [GO:0006342]; chromatin silencing at centromere [GO:0030702]; chromosome organization [GO:0051276]; establishment of chromatin silencing [GO:0006343]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]";"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome, telomeric region [GO:0035012]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]"
comp175150_c0_seq1;GAXK01114576.1;A0A0R4IKJ1;0;CAPAM_DANRE;mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (zCAPAM) (Phosphorylated CTD-interacting factor 1);"nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]";"GO:0005634; GO:0016422; GO:0045727; GO:0080009; GO:0099122; GO:1904047";"mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]";nucleus [GO:0005634];"mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]"
comp1751640_c0_seq1;GAXK01140645.1;A6NDV4;2.35E-16;TMM8B_HUMAN;Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]";"GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007160; GO:0007346; GO:0009986; GO:0016021; GO:0040008";"cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp175169_c1_seq1;GAXK01114631.1;P0DMR6;6.89E-48;TDP1L_MOUSE;TD and POZ domain-containing protein 1-like;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp175199_c1_seq1;GAXK01114529.1;Q5ZI89;2.27E-161;TPC11_CHICK;Trafficking protein particle complex subunit 11;"Golgi apparatus [GO:0005794]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0016192";vesicle-mediated transport [GO:0016192];Golgi apparatus [GO:0005794];
comp175216_c0_seq1;GAXK01114517.1;P05661;1.79E-32;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1752227_c0_seq1;GAXK01117895.1;Q6GNS1;6.18E-21;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp175225_c1_seq1;GAXK01114552.1;Q9VWB0;6.87E-08;TECPR_DROME;Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein);"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]";"GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266";peroxisome organization [GO:0007031];"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp1752693_c0_seq1;GAXK01117919.1;Q9VJJ7;3.21E-22;TRPG_DROME;Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635";"adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"
comp175272_c1_seq1;GAXK01114495.1;P80229;2.93E-38;ILEU_PIG;Leukocyte elastase inhibitor (LEI) (Leukocyte neutral proteinase inhibitor) (LNPI) (Serpin B1);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0005737; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp175323_c3_seq1;GAXK01114641.1;P17970;6.45E-67;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp175332_c5_seq1;GAXK01114501.1;Q98931;4.37E-08;LRP8_CHICK;Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) (Protein LR8B);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]";"GO:0005509; GO:0006897; GO:0016021; GO:0021517";"endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]";integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp175348_c2_seq1;GAXK01114396.1;E2QTD3;4.27E-15;TDRD5_CANLF;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp1753779_c0_seq1;GAXK01117917.1;Q86LG1;8.60E-10;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp1753815_c0_seq1;GAXK01117927.1;P50914;9.79E-32;RL14_HUMAN;60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0045296; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]";"cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp175390_c0_seq1;GAXK01114413.1;Q05733;0;DCHS_DROME;Histidine decarboxylase (HDC) (EC 4.1.1.22);"histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]";"GO:0004398; GO:0006520; GO:0030170; GO:0042423; GO:0043052";"catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]";;"histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]"
comp1753941_c0_seq1;GAXK01117929.1;P59511;2.02E-46;ATS20_MOUSE;A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-);"extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]";"GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0008270; GO:0009967; GO:0030198; GO:0043066; GO:0045636; GO:0048070";"extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]";extracellular space [GO:0005615];"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp175417_c0_seq1;GAXK01114520.1;P18172;7.95E-106;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp175428_c0_seq1;GAXK01114436.1;Q9NW38;1.12E-55;FANCL_HUMAN;E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL);"cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]";"GO:0004842; GO:0005635; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]";"cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp17544_c0_seq1;GAXK01067577.1;Q24562;0;U2AF2_DROME;Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit);"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701";"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; U2-type prespliceosome [GO:0071004]";"mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]"
comp1755662_c0_seq1;GAXK01005316.1;Q6NVP8;1.40E-81;FUT8_XENTR;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]"
comp175610_c1_seq1;GAXK01114635.1;P33270;8.78E-71;CP6A2_DROME;Cytochrome P450 6a2 (EC 1.14.-.-) (CYPVIA2) (Cytochrome P450-B1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; response to caffeine [GO:0031000]; response to DDT [GO:0046680]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037; GO:0031000; GO:0046680";"response to caffeine [GO:0031000]; response to DDT [GO:0046680]";endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp175677_c1_seq1;GAXK01114603.1;Q01295;9.57E-37;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1756908_c0_seq1;GAXK01033059.1;O62621;1.05E-10;COPB2_DROME;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005198; GO:0005795; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0010883; GO:0030126";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]";structural molecule activity [GO:0005198]
comp1757018_c0_seq1;GAXK01033083.1;Q62396;3.57E-09;ZFP92_MOUSE;Zinc finger protein 92 (Zfp-92);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp175718_c4_seq1;GAXK01114597.1;Q9H5Z1;0;DHX35_HUMAN;Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35);"catalytic step 2 spliceosome [GO:0071013]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0001701; GO:0003723; GO:0005524; GO:0034458; GO:0071013";"in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]";catalytic step 2 spliceosome [GO:0071013];"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp17578_c0_seq1;GAXK01068197.1;Q9NFZ3;3.32E-27;GBGE_DROME;Guanine nucleotide-binding protein subunit gamma-e (Ggamma(e));"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]; GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]; cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"GO:0003924; GO:0005737; GO:0005834; GO:0007186; GO:0007200; GO:0007601; GO:0007602; GO:0016028; GO:0046982; GO:0050909; GO:0071244";"cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]";"GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]"
comp175800_c0_seq1;GAXK01114434.1;Q5TZ24;1.39E-105;MOXD1_DANRE;DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp1758006_c0_seq1;GAXK01154606.1;Q24174;7.88E-10;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp175825_c0_seq1;GAXK01114427.1;Q6DCX5;5.62E-17;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp1758341_c0_seq1;GAXK01154603.1;A2ANX9;1.39E-15;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp17584_c0_seq1;GAXK01067999.1;Q9D1M4;1.76E-26;MCA3_MOUSE;Eukaryotic translation elongation factor 1 epsilon-1 (Elongation factor p18) (Multisynthase complex auxiliary component p18);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]";"GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235";"cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp175841_c0_seq1;GAXK01114530.1;P18061;1.20E-20;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp17585_c0_seq1;GAXK01068205.1;Q95KE5;7.64E-26;RM43_BOVIN;39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Retina-specific 15.7 kDa protein);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005743; GO:0005762; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp17588_c0_seq1;GAXK01068334.1;Q9V4N3;6.86E-37;CYB5_DROME;Cytochrome b5 (CYTB5);"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]; regulation of hemocyte differentiation [GO:0045610]; regulation of hemocyte proliferation [GO:0035206]";"GO:0005789; GO:0012505; GO:0016021; GO:0020037; GO:0035206; GO:0045610; GO:0046872; GO:0055114";"oxidation-reduction process [GO:0055114]; regulation of hemocyte differentiation [GO:0045610]; regulation of hemocyte proliferation [GO:0035206]";"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp175903_c2_seq1;GAXK01114441.1;Q6NVF4;5.04E-17;HELB_MOUSE;DNA helicase B (EC 3.6.4.12);"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA-dependent DNA replication [GO:0006261]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005662; GO:0005737; GO:0006260; GO:0006261; GO:0006269; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp175953_c1_seq1;GAXK01114533.1;Q9WVH3;3.91E-42;FOXO4_MOUSE;Forkhead box protein O4 (Afxh) (Fork head domain transcription factor AFX1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; aging [GO:0007568]; cell cycle arrest [GO:0007050]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007050; GO:0007095; GO:0007517; GO:0007568; GO:0008013; GO:0008134; GO:0008285; GO:0008286; GO:0014911; GO:0016525; GO:0016607; GO:0019899; GO:0031667; GO:0042593; GO:0042802; GO:0043565; GO:0045893; GO:0045944; GO:0048863; GO:0051151; GO:0070317; GO:0071158; GO:1990785; GO:1990841";"aging [GO:0007568]; cell cycle arrest [GO:0007050]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp1759633_c0_seq1;GAXK01154601.1;Q6INV8;1.74E-11;Z652B_XENLA;Zinc finger protein 652-B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp17597_c1_seq1;GAXK01067648.1;Q9XYN1;1.03E-19;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp176_c7_seq2;GAXK01170005.1;O15992;3.51E-96;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp1760086_c0_seq1;GAXK01039602.1;Q658P3;1.37E-24;STEA3_HUMAN;Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]";"GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0033572; GO:0042802; GO:0042981; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0098706";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp1760439_c0_seq1;GAXK01039615.1;P83553;2.85E-10;DERM_BIOGL;Dermatopontin (Tyrosine-rich acidic matrix protein) (TRAMP);"extracellular region [GO:0005576]; cell adhesion [GO:0007155]";"GO:0005576; GO:0007155";cell adhesion [GO:0007155];extracellular region [GO:0005576];
comp176062_c1_seq1;GAXK01083802.1;Q6P988;1.62E-25;NOTUM_HUMAN;Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]; cellular protein metabolic process [GO:0044267]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; post-translational protein modification [GO:0043687]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0043687; GO:0044267; GO:0090090; GO:1990697; GO:1990699";"cellular protein metabolic process [GO:0044267]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; post-translational protein modification [GO:0043687]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]"
comp176079_c0_seq1;GAXK01083627.1;Q8T062;0;NEP4_DROME;Neprilysin-4 (EC 3.4.24.11);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016529; GO:0046872";proteolysis [GO:0006508];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp176094_c0_seq1;GAXK01083556.1;P16375;0;7UP1_DROME;Steroid receptor seven-up, isoforms B/C (Nuclear receptor subfamily 2 group F member 3, isoforms B/C);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0000977; GO:0001227; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0007270; GO:0007419; GO:0007462; GO:0007464; GO:0007503; GO:0007507; GO:0007510; GO:0007601; GO:0008270; GO:0014019; GO:0021782; GO:0030154; GO:0042331; GO:0042803; GO:0046530; GO:0046982; GO:0048856; GO:0061331";"anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp176096_c4_seq1;GAXK01083538.1;Q05192;1.84E-131;FTF1B_DROME;Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"GO:0000976; GO:0000978; GO:0003682; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0009755; GO:0009888; GO:0035211; GO:0045944; GO:0060968; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp176100_c0_seq1;GAXK01083805.1;Q08C93;3.39E-21;ABD12_DANRE;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651";"acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp1761373_c0_seq1;GAXK01039608.1;Q8N4S7;9.55E-20;PAQR4_HUMAN;Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV);"integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]";"GO:0016021; GO:0038023";;integral component of membrane [GO:0016021];signaling receptor activity [GO:0038023]
comp17614_c0_seq1;GAXK01068238.1;P25439;0;BRM_DROME;ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma);"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648";"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp176144_c0_seq1;GAXK01083890.1;Q24212;9.31E-77;STNB_DROME;Protein stoned-B (Stn-B) (StonedB);"cell junction [GO:0030054]; endocytic vesicle [GO:0030139]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; regulation of endocytosis [GO:0030100]; regulation of synaptic vesicle endocytosis [GO:1900242]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]";"GO:0007268; GO:0008021; GO:0030054; GO:0030100; GO:0030139; GO:0048488; GO:0048489; GO:0048786; GO:0097110; GO:0099504; GO:1900242";"chemical synaptic transmission [GO:0007268]; regulation of endocytosis [GO:0030100]; regulation of synaptic vesicle endocytosis [GO:1900242]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]";"cell junction [GO:0030054]; endocytic vesicle [GO:0030139]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]";scaffold protein binding [GO:0097110]
comp176150_c0_seq1;GAXK01083583.1;Q08DJ7;3.14E-96;AAR2_BOVIN;Protein AAR2 homolog (AAR2 splicing factor homolog);"spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0005681";spliceosomal tri-snRNP complex assembly [GO:0000244];spliceosomal complex [GO:0005681];
comp17617_c0_seq1;GAXK01067646.1;P86854;1.28E-10;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp176179_c0_seq1;GAXK01083931.1;Q13449;2.00E-29;LSAMP_HUMAN;Limbic system-associated membrane protein (LSAMP) (IgLON family member 3);"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; nervous system development [GO:0007399]";"GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225";"cell adhesion [GO:0007155]; nervous system development [GO:0007399]";"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp17618_c1_seq1;GAXK01067381.1;Q96LJ7;1.49E-100;DHRS1_HUMAN;Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 19C member 1);"endoplasmic reticulum [GO:0005783]; oxidoreductase activity [GO:0016491]";"GO:0005783; GO:0016491";;endoplasmic reticulum [GO:0005783];oxidoreductase activity [GO:0016491]
comp1761860_c0_seq1;GAXK01039607.1;Q66S03;2.80E-19;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp176220_c1_seq1;GAXK01083514.1;Q96MZ0;2.14E-14;GD1L1_HUMAN;Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1-L1);;;;;
comp1762416_c0_seq1;GAXK01001081.1;O74467;1.04E-07;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1762493_c0_seq1;GAXK01001099.1;Q06518;1.13E-12;NOS2_RAT;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; glycoside metabolic process [GO:0016137]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"GO:0001935; GO:0001974; GO:0003779; GO:0003958; GO:0004517; GO:0005516; GO:0005615; GO:0005634; GO:0005737; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0007165; GO:0007199; GO:0007263; GO:0007568; GO:0008013; GO:0008016; GO:0008217; GO:0008603; GO:0009612; GO:0009725; GO:0010181; GO:0012506; GO:0014823; GO:0016137; GO:0016491; GO:0018119; GO:0019901; GO:0019934; GO:0020037; GO:0031284; GO:0032310; GO:0032355; GO:0032496; GO:0034612; GO:0035556; GO:0035902; GO:0042060; GO:0042742; GO:0042803; GO:0043065; GO:0045296; GO:0045776; GO:0046872; GO:0048384; GO:0048471; GO:0050660; GO:0050661; GO:0050829; GO:0050998; GO:0051879; GO:0071222; GO:0071285; GO:0071305; GO:0071345; GO:0071347; GO:0071356; GO:0071407; GO:0071461; GO:0071548; GO:0072604; GO:0072606; GO:1900015";"aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; glycoside metabolic process [GO:0016137]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"
comp1762539_c0_seq1;GAXK01001114.1;O64425;3.58E-15;RMA1_ARATH;E3 ubiquitin-protein ligase RMA1 (EC 2.3.2.27) (Protein RING membrane-anchor 1) (RING-type E3 ubiquitin transferase RMA1);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0032527; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp176255_c1_seq1;GAXK01083792.1;P34714;2.68E-39;SPRC_CAEEL;SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; multicellular organism development [GO:0007275]";"GO:0005509; GO:0005518; GO:0005604; GO:0005615; GO:0007275; GO:0050840";multicellular organism development [GO:0007275];"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]"
comp176263_c0_seq1;GAXK01083798.1;P05661;2.78E-89;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1762731_c0_seq1;GAXK01001103.1;Q5R5X9;6.28E-37;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp1762764_c0_seq1;GAXK01001116.1;P98063;1.50E-30;BMP1_MOUSE;Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]";"GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023";"cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]";"calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp1763070_c0_seq1;GAXK01001088.1;Q6X5S5;1.15E-11;SL27_ECHOC;Snaclec 27 (C-type lectin 27) (CTL-27) (Fragment);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp176324_c3_seq1;GAXK01083941.1;Q6XPS3;2.91E-110;TPTE2_HUMAN;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314";phosphatidylinositol biosynthetic process [GO:0006661];"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp176356_c0_seq1;GAXK01083558.1;P42638;3.70E-14;TPM2_SCHMA;Tropomyosin-2 (Tropomyosin II) (SmTMII) (TMII);;;;;
comp176370_c0_seq1;GAXK01083516.1;Q3SZ16;3.51E-47;IAH1_BOVIN;Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-);"hydrolase activity, acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016788";lipid catabolic process [GO:0016042];;hydrolase activity, acting on ester bonds [GO:0016788]
comp1763717_c0_seq1;GAXK01001097.1;Q1H9T6;1.03E-10;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1763981_c0_seq1;GAXK01001100.1;Q09621;4.12E-29;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1764684_c0_seq1;GAXK01012921.1;Q7M4I3;1.81E-19;SP4_BOMPE;Venom protease (EC 3.4.21.-) (allergen Bom p 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp1764788_c0_seq1;GAXK01012938.1;P04069;6.31E-95;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp1765185_c0_seq1;GAXK01012943.1;Q9D0B5;7.03E-16;TSTD3_MOUSE;Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3);thiosulfate sulfurtransferase activity [GO:0004792];GO:0004792;;;thiosulfate sulfurtransferase activity [GO:0004792]
comp176527_c0_seq1;GAXK01083913.1;B4GD14;8.35E-86;LPHN_DROPE;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1766100_c0_seq1;GAXK01054867.1;P10076;8.08E-38;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp17665_c1_seq1;GAXK01068083.1;Q9R1B1;1.07E-19;T10B_RAT;Mitochondrial import inner membrane translocase subunit Tim10 B (Fracture callus protein 1) (FxC1) (Mitochondrial import inner membrane translocase subunit Tim9 B) (TIMM10B) (Tim10b);"mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; metal ion binding [GO:0046872]; protein transport [GO:0015031]";"GO:0015031; GO:0042719; GO:0042721; GO:0046872";protein transport [GO:0015031];"mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]";metal ion binding [GO:0046872]
comp176678_c0_seq1;GAXK01083582.1;Q6Q7X9;2.30E-13;KLH31_DANRE;Kelch-like protein 31 (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein Klhl);negative regulation of protein phosphorylation [GO:0001933];GO:0001933;negative regulation of protein phosphorylation [GO:0001933];;
comp1767005_c0_seq1;GAXK01054852.1;O43520;6.15E-15;AT8B1_HUMAN;Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; aminophospholipid flippase activity [GO:0015247]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; drug transmembrane transport [GO:0006855]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of microvillus assembly [GO:0032534]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006855; GO:0007030; GO:0007605; GO:0008206; GO:0015247; GO:0015721; GO:0016324; GO:0021650; GO:0031526; GO:0032420; GO:0032534; GO:0034220; GO:0045332; GO:0045892; GO:0060119; GO:0140326; GO:1901612";"bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; drug transmembrane transport [GO:0006855]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of microvillus assembly [GO:0032534]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]";"aminophospholipid flippase activity [GO:0015247]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]"
comp176722_c0_seq1;GAXK01083638.1;Q5HZH2;1.58E-73;TSR3_MOUSE;Ribosome biogenesis protein TSR3 homolog;"transferase activity [GO:0016740]; maturation of SSU-rRNA [GO:0030490]";"GO:0016740; GO:0030490";maturation of SSU-rRNA [GO:0030490];;transferase activity [GO:0016740]
comp176749_c1_seq1;GAXK01083949.1;Q8BS90;3.09E-08;BORA_MOUSE;Protein aurora borealis;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein localization [GO:0032880]";"GO:0005634; GO:0005737; GO:0007049; GO:0007088; GO:0019901; GO:0032147; GO:0032880; GO:0051301; GO:0060236";"activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein localization [GO:0032880]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp1767523_c0_seq1;GAXK01054842.1;P36609;5.15E-48;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1768035_c0_seq1;GAXK01154749.1;P36609;5.34E-19;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp176812_c1_seq1;GAXK01083791.1;Q29451;3.38E-13;MA2B1_BOVIN;"Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]";"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"GO:0004559; GO:0005764; GO:0005774; GO:0006013; GO:0006517; GO:0030246; GO:0046872";"mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp176825_c2_seq1;GAXK01083806.1;Q8CAQ8;3.52E-57;MIC60_MOUSE;MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin);"MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]";"GO:0005739; GO:0005743; GO:0042407; GO:0043209; GO:0051560; GO:0061617";"cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]";"MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";
comp1768267_c0_seq1;GAXK01154725.1;Q869C3;2.33E-65;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp1768349_c0_seq1;GAXK01154746.1;Q24563;6.02E-81;DOPR2_DROME;Dopamine receptor 2 (Dopamine 1-like receptor 2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled amine receptor activity [GO:0008227]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; age-dependent response to oxidative stress [GO:0001306]; cellular response to dopamine [GO:1903351]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]";"GO:0001306; GO:0001588; GO:0004935; GO:0004952; GO:0005886; GO:0005887; GO:0007186; GO:0007188; GO:0007191; GO:0007212; GO:0008226; GO:0008227; GO:0016021; GO:0030285; GO:0042321; GO:0071880; GO:0099509; GO:1903223; GO:1903351; GO:1990834";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; age-dependent response to oxidative stress [GO:0001306]; cellular response to dopamine [GO:1903351]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]";"adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled amine receptor activity [GO:0008227]; tyramine receptor activity [GO:0008226]"
comp1768475_c0_seq1;GAXK01154737.1;Q6NS09;4.77E-34;TM45B_XENLA;Transmembrane protein 45B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp17685_c0_seq1;GAXK01067683.1;Q8WR63;1.83E-61;TPM_TRIPS;Tropomyosin;;;;;
comp176852_c1_seq1;GAXK01083938.1;Q84P21;1.24E-45;4CLL5_ARATH;4-coumarate--CoA ligase-like 5 (EC 6.2.1.-) (4-coumarate--CoA ligase isoform 9) (At4CL9) (Peroxisomal OPC-8:0-CoA ligase 1);"peroxisome [GO:0005777]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; jasmonic acid biosynthetic process [GO:0009695]; response to wounding [GO:0009611]";"GO:0005524; GO:0005777; GO:0009611; GO:0009695; GO:0016874";"jasmonic acid biosynthetic process [GO:0009695]; response to wounding [GO:0009611]";peroxisome [GO:0005777];"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp1768547_c0_seq1;GAXK01154733.1;Q99M85;1.07E-80;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1768607_c0_seq1;GAXK01154745.1;Q8R1F6;3.08E-27;HID1_MOUSE;Protein HID1 (HID1 domain-containing protein) (Protein hid-1 homolog);"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]";"GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0006886; GO:0016020; GO:0090498";intracellular protein transport [GO:0006886];"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]";
comp1768718_c0_seq1;GAXK01154732.1;Q16975;7.53E-100;KPC2_APLCA;Calcium-independent protein kinase C (EC 2.7.11.13) (APL II);"membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556]";"GO:0004697; GO:0005524; GO:0016020; GO:0035556; GO:0046872";intracellular signal transduction [GO:0035556];membrane [GO:0016020];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp176884_c0_seq1;GAXK01204950.1;Q93113;3.36E-37;GST1D_ANOGA;Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749; GO:0018833";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp176897_c0_seq1;GAXK01083797.1;P19388;2.35E-31;RPAB1_HUMAN;DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]";"GO:0000398; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006283; GO:0006351; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006383; GO:0008543; GO:0016032; GO:0016070; GO:0032481; GO:0035019; GO:0042795; GO:0045815; GO:0050434; GO:0060964";"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp1769137_c0_seq1;GAXK01154739.1;A6H782;6.85E-70;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp176952_c2_seq1;GAXK01083952.1;Q24119;3.62E-161;TRH_DROME;Protein trachealess;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; epithelial cell fate determination, open tracheal system [GO:0007425]; epithelial tube formation [GO:0072175]; limb development [GO:0060173]; Malpighian tubule morphogenesis [GO:0007443]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]";"GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007424; GO:0007425; GO:0007431; GO:0007435; GO:0007443; GO:0035202; GO:0035277; GO:0043565; GO:0045944; GO:0046982; GO:0060173; GO:0072175";"epithelial cell fate determination, open tracheal system [GO:0007425]; epithelial tube formation [GO:0072175]; limb development [GO:0060173]; Malpighian tubule morphogenesis [GO:0007443]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"
comp1769557_c0_seq1;GAXK01154720.1;P58659;1.19E-13;EVA1C_MOUSE;Protein eva-1 homolog C (Protein FAM176C);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]";"GO:0005576; GO:0005886; GO:0008201; GO:0016021; GO:0030246";;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]"
comp1769738_c0_seq1;GAXK01154729.1;Q149M0;1.84E-08;CL12B_MOUSE;C-type lectin domain family 12 member B;"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; receptor inhibitor activity [GO:0030547]; natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of signaling receptor activity [GO:2000272]";"GO:0002769; GO:0009897; GO:0016021; GO:0019903; GO:0030246; GO:0030547; GO:0032991; GO:0045953; GO:2000272";"natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of signaling receptor activity [GO:2000272]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";"carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; receptor inhibitor activity [GO:0030547]"
comp1769994_c0_seq1;GAXK01154721.1;Q9U1K1;1.23E-17;SPIR_DROME;Protein spire;"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; actin filament-based process [GO:0030029]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; protein transport [GO:0015031]; regulation of cytoskeleton organization [GO:0051493]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007304; GO:0007315; GO:0007316; GO:0008017; GO:0015031; GO:0016192; GO:0030029; GO:0030036; GO:0030659; GO:0030717; GO:0045010; GO:0045451; GO:0048471; GO:0048477; GO:0051493; GO:0051639";"actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; protein transport [GO:0015031]; regulation of cytoskeleton organization [GO:0051493]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]"
comp1770468_c0_seq1;GAXK01112884.1;O75581;1.06E-13;LRP6_HUMAN;Low-density lipoprotein receptor-related protein 6 (LRP-6);"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909";"anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]";"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]";"apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp1770484_c0_seq1;GAXK01112868.1;P35687;9.47E-22;RS21_ORYSJ;40S ribosomal protein S21;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]; translation [GO:0006412]";"GO:0000447; GO:0000461; GO:0003735; GO:0006412; GO:0022627";"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp17705_c0_seq1;GAXK01067512.1;Q1LXS2;9.52E-46;PSMG2_DANRE;Proteasome assembly chaperone 2 (Tumor necrosis factor superfamily member 5-induced protein 1 homolog);"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248]";"GO:0005634; GO:0005829; GO:0043248";proteasome assembly [GO:0043248];"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp17706_c0_seq1;GAXK01205387.1;Q9H2X6;0;HIPK2_HUMAN;Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription factor complex [GO:0090575]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II activating transcription factor binding [GO:0001102]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]; adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]";"GO:0000122; GO:0001102; GO:0001654; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008284; GO:0009952; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0019048; GO:0030182; GO:0030218; GO:0030511; GO:0030514; GO:0030578; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0071456; GO:0090575; GO:0097193; GO:1901796; GO:2000059";"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription factor complex [GO:0090575]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II activating transcription factor binding [GO:0001102]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]"
comp17707_c1_seq1;GAXK01067511.1;Q15438;1.62E-125;CYH1_HUMAN;Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1);"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005086; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0016192; GO:0030155; GO:0031234; GO:0032012; GO:0090162";"establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192]";"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]"
comp1770734_c0_seq1;GAXK01112887.1;Q0V9W6;1.64E-08;BTBD6_XENTR;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp177087_c0_seq1;GAXK01083989.1;Q8IXV7;3.90E-12;KLD8B_HUMAN;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp177135_c1_seq1;GAXK01083960.1;P09470;4.01E-167;ACE_MOUSE;Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form];"basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]";"GO:0001822; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0008144; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008239; GO:0008240; GO:0008241; GO:0008270; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019233; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031711; GO:0031982; GO:0032091; GO:0032092; GO:0032496; GO:0035814; GO:0042310; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071838; GO:0090281; GO:0097225; GO:0097756; GO:1900086; GO:1902033; GO:1903597; GO:2000170";"amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]";"basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]";"actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]"
comp17715_c3_seq1;GAXK01068269.1;P16092;1.12E-113;FGFR1_MOUSE;Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]";"GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0050839; GO:0051174; GO:0051930; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1905564; GO:2000546; GO:2000830; GO:2001239";"angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp1771503_c0_seq1;GAXK01112866.1;P51874;2.02E-34;PCP_SYMSP;Peridinin-chlorophyll a-binding protein, chloroplastic (PCP);"chloroplast [GO:0009507]; light-harvesting complex [GO:0030076]; chlorophyll binding [GO:0016168]; protein-chromophore linkage [GO:0018298]";"GO:0009507; GO:0016168; GO:0018298; GO:0030076";protein-chromophore linkage [GO:0018298];"chloroplast [GO:0009507]; light-harvesting complex [GO:0030076]";chlorophyll binding [GO:0016168]
comp1771563_c0_seq1;GAXK01112888.1;Q80SU7;3.25E-107;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp177176_c0_seq1;GAXK01083868.1;P42003;1.97E-72;MAD_DROME;Protein mothers against dpp;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0000122; GO:0000977; GO:0000980; GO:0000981; GO:0001012; GO:0001102; GO:0001227; GO:0001228; GO:0001745; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0007391; GO:0007419; GO:0007476; GO:0007480; GO:0007488; GO:0007507; GO:0007560; GO:0008586; GO:0030509; GO:0030707; GO:0030718; GO:0032924; GO:0035019; GO:0035290; GO:0042078; GO:0043565; GO:0045464; GO:0045595; GO:0045705; GO:0045887; GO:0045944; GO:0046872; GO:0048100; GO:0060395; GO:0060799; GO:0071144; GO:0090571; GO:1904398; GO:2000134";"activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc morphogenesis [GO:0007560]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]"
comp1771856_c0_seq1;GAXK01112892.1;E9PV86;8.13E-95;MCTP1_MOUSE;Multiple C2 and transmembrane domain-containing protein 1;"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"GO:0005509; GO:0005789; GO:0016021; GO:0030054; GO:0030336; GO:0030672; GO:0045806; GO:0055037; GO:1902883";"negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp177190_c0_seq2;GAXK01083629.1;Q6GR09;7.58E-21;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp177211_c1_seq1;GAXK01083518.1;E0CZ16;8.56E-78;KLHL3_MOUSE;Kelch-like protein 3;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; catalytic activity [GO:0003824]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0003779; GO:0003824; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156";"distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";"actin binding [GO:0003779]; catalytic activity [GO:0003824]"
comp177220_c1_seq1;GAXK01083557.1;Q6GNV7;3.42E-36;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp1772406_c0_seq1;GAXK01128100.1;O01382;3.00E-38;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp1772923_c0_seq1;GAXK01128095.1;Q52KB5;1.06E-25;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp177304_c0_seq1;GAXK01083804.1;Q6PBU5;2.12E-96;GRT1A_DANRE;Growth hormone-regulated TBC protein 1-A;"cell [GO:0005623]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005623; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cell [GO:0005623];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp177306_c0_seq1;GAXK01083950.1;P97531;4.09E-12;CIP4_RAT;Cdc42-interacting protein 4 (Salt tolerant protein) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; phagocytic cup [GO:0001891]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; epithelial to mesenchymal transition [GO:0001837]; hyperosmotic salinity response [GO:0042538]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; response to food [GO:0032094]";"GO:0001837; GO:0001891; GO:0005764; GO:0005794; GO:0005856; GO:0005938; GO:0006897; GO:0008289; GO:0010667; GO:0030036; GO:0032094; GO:0042538; GO:0042995; GO:0061051";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; epithelial to mesenchymal transition [GO:0001837]; hyperosmotic salinity response [GO:0042538]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; response to food [GO:0032094]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; phagocytic cup [GO:0001891]";lipid binding [GO:0008289]
comp177322_c3_seq1;GAXK01083861.1;P97738;1.40E-13;NPTX2_RAT;Neuronal pentraxin-2 (NP2) (Neuronal activity-regulated pentraxin) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"GO:0005576; GO:0005886; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098892; GO:0098978; GO:0099645";"neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp1773398_c0_seq1;GAXK01128094.1;A2AIG8;5.93E-80;1A1L1_MOUSE;1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1);"catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]";"GO:0003824; GO:0009058; GO:0030170; GO:0042802";biosynthetic process [GO:0009058];;"catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]"
comp17736_c0_seq1;GAXK01068539.1;Q9ES53;8.26E-116;UFD1_RAT;Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1 homolog) (UB fusion protein 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005102; GO:0005634; GO:0005829; GO:0006511; GO:0030970; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0043161; GO:0044877; GO:0051117; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]"
comp177367_c0_seq1;GAXK01083553.1;Q497V6;1.14E-41;BAHD1_MOUSE;Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1);"chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892";"heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]";"chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]";chromatin binding [GO:0003682]
comp1773713_c0_seq1;GAXK01128104.1;P0DPW4;9.70E-11;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp177378_c0_seq1;GAXK01083519.1;Q2KIY1;1.87E-32;PXMP2_BOVIN;Peroxisomal membrane protein 2;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991]";"GO:0005737; GO:0005778; GO:0016021; GO:0032991";;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991]";
comp17743_c1_seq1;GAXK01067423.1;A8WYE4;7.48E-53;PAR1_CAEBR;Serine/threonine-protein kinase par-1 (EC 2.7.11.1);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]";"GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005938; GO:0007275; GO:0035556; GO:0046872; GO:0050321";"intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp177438_c1_seq1;GAXK01083796.1;Q86VZ4;3.64E-07;LRP11_HUMAN;Low-density lipoprotein receptor-related protein 11 (LRP-11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]";"GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219";"multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";phosphoprotein binding [GO:0051219]
comp177481_c0_seq1;GAXK01083959.1;Q9NZQ9;3.07E-31;TMOD4_HUMAN;Tropomodulin-4 (Skeletal muscle tropomodulin) (Sk-Tmod);"myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"GO:0005523; GO:0005865; GO:0006936; GO:0030016; GO:0030239; GO:0051015; GO:0051694";"muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]";"myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]";"actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]"
comp17750_c0_seq1;GAXK01067456.1;Q7ZYA5;2.24E-45;PRKAA_XENLA;Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog A;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422]";"GO:0003725; GO:0005634; GO:0005737; GO:0008047; GO:0030422; GO:0048471";production of siRNA involved in RNA interference [GO:0030422];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]"
comp1775108_c1_seq1;GAXK01190827.1;P52746;5.43E-13;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp177527_c0_seq1;GAXK01083945.1;Q9VAC5;0;ADA17_DROME;ADAM 17-like protease (EC 3.4.24.-);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";"GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp177536_c10_seq1;GAXK01083866.1;Q969X1;2.77E-08;LFG3_HUMAN;Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1);"endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; death receptor binding [GO:0005123]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; neutrophil degranulation [GO:0043312]; positive regulation of blood vessel remodeling [GO:2000504]";"GO:0005123; GO:0005765; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0035579; GO:0043086; GO:0043231; GO:0043312; GO:0070062; GO:1902042; GO:1902045; GO:1903077; GO:2000504";"negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; neutrophil degranulation [GO:0043312]; positive regulation of blood vessel remodeling [GO:2000504]";"endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]";death receptor binding [GO:0005123]
comp177581_c0_seq1;GAXK01083836.1;Q8C827;5.81E-53;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp177592_c1_seq1;GAXK01083996.1;P21108;1.88E-77;PRPS3_HUMAN;Ribose-phosphate pyrophosphokinase 3 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 1-like 1) (PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III) (PRS-III);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp1776026_c0_seq1;GAXK01075534.1;Q9N294;6.82E-19;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp177633_c1_seq1;GAXK01083962.1;Q25604;2.67E-13;NHR1_ONCVO;Nuclear hormone receptor-like 1;"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0004879; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp17764_c0_seq1;GAXK01067492.1;B7PS00;0;LIS1_IXOSC;Lissencephaly-1 homolog;"axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]";"GO:0000132; GO:0000776; GO:0005635; GO:0005815; GO:0005875; GO:0005881; GO:0007097; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115; GO:2000574";"brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]";"axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]";"dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]"
comp177688_c1_seq1;GAXK01083940.1;Q05187;0;TGMH_TACTR;Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase);"membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]";"GO:0003810; GO:0016020; GO:0018149; GO:0046872";peptide cross-linking [GO:0018149];membrane [GO:0016020];"metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
comp1777_c2_seq1;GAXK01168366.1;Q20140;2.61E-80;KAD1_CAEEL;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase);"cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0006172; GO:0009142; GO:0046033; GO:0046034";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";cytoplasm [GO:0005737];"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp1777009_c0_seq1;GAXK01075536.1;B3E099;1.84E-120;KATG_METI4;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp17774_c0_seq1;GAXK01068061.1;Q95TJ9;1.10E-51;CYCG_DROME;Cyclin G;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; meiotic DNA repair synthesis [GO:0000711]; mitotic cell cycle phase transition [GO:0044772]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000711; GO:0003677; GO:0004864; GO:0005634; GO:0005700; GO:0005737; GO:0006302; GO:0006468; GO:0007143; GO:0007275; GO:0016538; GO:0019901; GO:0044772; GO:0045746; GO:0045927; GO:0046628; GO:0051301; GO:0051897; GO:0060429; GO:2000134";"cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; meiotic DNA repair synthesis [GO:0000711]; mitotic cell cycle phase transition [GO:0044772]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]"
comp1777503_c0_seq1;GAXK01075549.1;O91250;2.85E-13;REP7_FBNY2;Para-Rep C7 (Rep7) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3) (ATP-dependent helicase C7) (Replication-associated protein of non-essential DNA C7);"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";"GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872";"DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";host cell nucleus [GO:0042025];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp177756_c3_seq1;GAXK01083574.1;P84339;3.84E-47;CALM_AGABI;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1778016_c0_seq1;GAXK01180297.1;Q9HAZ2;2.55E-14;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp1778032_c0_seq1;GAXK01180287.1;Q6DCG4;6.23E-58;RHBGB_XENLA;Ammonium transporter Rh type B-B (Rhesus blood group family type B glycoprotein B) (Rh family type B glycoprotein B) (Rh type B glycoprotein B);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]";"GO:0008519; GO:0016021; GO:0016323; GO:0030659";;"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";ammonium transmembrane transporter activity [GO:0008519]
comp177816_c0_seq1;GAXK01083555.1;P90543;5.12E-29;H3_EUPCR;Histone H3;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp177832_c1_seq1;GAXK01083862.1;Q9VCA2;2.79E-74;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1778587_c0_seq1;GAXK01180288.1;Q1H9T6;3.26E-21;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1779072_c0_seq1;GAXK01180276.1;Q02527;3.50E-67;MGAT3_RAT;Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]; amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"GO:0000139; GO:0003830; GO:0006044; GO:0006487; GO:0008104; GO:0016021; GO:0016757; GO:0030334; GO:0034599; GO:0050435; GO:0050890; GO:1902966; GO:1905166";"amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp17791_c2_seq1;GAXK01068514.1;Q9XZ71;1.09E-49;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp1779157_c0_seq1;GAXK01180273.1;P05933;2.74E-14;CALM_SCHPO;Calmodulin (CaM);"cell division site [GO:0032153]; central plaque of mitotic spindle pole body [GO:0061493]; central plaque of spindle pole body [GO:0005823]; cytosol [GO:0005829]; division septum [GO:0000935]; growing cell tip [GO:0035838]; mating projection tip [GO:0043332]; meiotic spindle pole body [GO:0035974]; mitotic spindle pole body [GO:0044732]; myosin I complex [GO:0045160]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; calcium ion binding [GO:0005509]; ascospore formation [GO:0030437]; ascospore-type prospore-specific spindle pole body remodeling [GO:0031322]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to meiotic spindle pole body [GO:1990954]; mitotic spindle assembly [GO:0090307]; spindle pole body organization [GO:0051300]";"GO:0000935; GO:0005509; GO:0005634; GO:0005823; GO:0005829; GO:0019722; GO:0030437; GO:0031322; GO:0032153; GO:0035838; GO:0035840; GO:0035841; GO:0035974; GO:0043332; GO:0044732; GO:0045160; GO:0051300; GO:0061493; GO:0090307; GO:1990954";"ascospore formation [GO:0030437]; ascospore-type prospore-specific spindle pole body remodeling [GO:0031322]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to meiotic spindle pole body [GO:1990954]; mitotic spindle assembly [GO:0090307]; spindle pole body organization [GO:0051300]";"cell division site [GO:0032153]; central plaque of mitotic spindle pole body [GO:0061493]; central plaque of spindle pole body [GO:0005823]; cytosol [GO:0005829]; division septum [GO:0000935]; growing cell tip [GO:0035838]; mating projection tip [GO:0043332]; meiotic spindle pole body [GO:0035974]; mitotic spindle pole body [GO:0044732]; myosin I complex [GO:0045160]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]";calcium ion binding [GO:0005509]
comp1779808_c0_seq1;GAXK01180275.1;O15266;1.02E-34;SHOX_HUMAN;Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein);"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000981; GO:0001228; GO:0001501; GO:0003700; GO:0005654; GO:0006366; GO:0043231; GO:0043565; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]";"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp177984_c1_seq1;GAXK01083961.1;Q8C7H1;2.71E-111;MMAA_MOUSE;Methylmalonic aciduria type A homolog, mitochondrial (EC 3.6.-.-);"mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin biosynthetic process [GO:0009236]";"GO:0003924; GO:0005525; GO:0005739; GO:0009236; GO:0042802; GO:0042803";cobalamin biosynthetic process [GO:0009236];mitochondrion [GO:0005739];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp178_c0_seq1;GAXK01169220.1;O01802;1.41E-113;RL7_CAEEL;60S ribosomal protein L7;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003723; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1780120_c0_seq1;GAXK01010431.1;Q67PR5;3.14E-26;DEF_SYMTH;Peptide deformylase (PDF) (EC 3.5.1.88) (Polypeptide deformylase);"metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; translation [GO:0006412]";"GO:0006412; GO:0042586; GO:0046872";translation [GO:0006412];;"metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]"
comp1780178_c0_seq1;GAXK01010417.1;O28972;2.77E-24;Y1297_ARCFU;Cell division cycle protein 48 homolog AF_1297;"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]";"GO:0005524; GO:0016787";;;"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp178018_c0_seq1;GAXK01130619.1;P23034;1.00E-34;AAT_BACY2;Aspartate aminotransferase (AspAT) (EC 2.6.1.1) (Transaminase A);"cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]";"GO:0004069; GO:0005737; GO:0009058; GO:0030170";biosynthetic process [GO:0009058];cytoplasm [GO:0005737];"L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]"
comp178044_c0_seq1;GAXK01130896.1;O18391;9.90E-50;KRAK_DROME;Probable serine hydrolase (EC 3.1.-.-) (Kraken protein);"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]; digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";"GO:0007275; GO:0007586; GO:0009636; GO:0017171; GO:0052689";"digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";;"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]"
comp1780804_c0_seq1;GAXK01010435.1;Q93560;2.10E-21;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1780904_c0_seq1;GAXK01010421.1;P42519;1.59E-10;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp1780950_c0_seq1;GAXK01010429.1;Q8WPA2;5.68E-77;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp178135_c0_seq1;GAXK01130592.1;O60462;6.03E-09;NRP2_HUMAN;Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2);"axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral process [GO:0016032]";"GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0016021; GO:0016032; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0046872; GO:0048010; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099175; GO:1901166; GO:1902285; GO:1903375; GO:1904835; GO:1990830";"angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral process [GO:0016032]";"axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]";"cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor-activated receptor activity [GO:0005021]"
comp1781552_c0_seq1;GAXK01010432.1;O16259;1.24E-25;STIP1_CAEEL;Stress-induced-phosphoprotein 1 (CeSTI1) (STI1) (Hsc70/Hsp90-organizing protein) (CeHop) (Hop);"cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";"GO:0000003; GO:0005737; GO:0008340; GO:0009408; GO:0030544; GO:0032780; GO:0042030; GO:0051879";"determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]"
comp1781791_c0_seq1;GAXK01010407.1;P17019;9.46E-28;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp178184_c2_seq1;GAXK01130569.1;Q9LJX4;9.05E-10;PUM5_ARATH;Pumilio homolog 5 (APUM-5) (AtPUM5);"cytosol [GO:0005829]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; drought recovery [GO:0009819]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]";"GO:0003727; GO:0003729; GO:0005773; GO:0005829; GO:0006970; GO:0009651; GO:0009819; GO:0051607; GO:0061158";"3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; drought recovery [GO:0009819]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]";"cytosol [GO:0005829]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]"
comp17819_c0_seq1;GAXK01067647.1;Q962X9;2.90E-85;BUD31_BRABE;Protein BUD31 homolog (Protein G10 homolog);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp17820_c4_seq1;GAXK01067535.1;G5ECB1;2.19E-23;ZIG4_CAEEL;Zwei Ig domain protein zig-4 (2 Ig domain protein zig-4);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]";"GO:0005576; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0048666; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]";"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp1782111_c0_seq1;GAXK01203473.1;Q9SQZ1;1.95E-42;RS173_ARATH;40S ribosomal protein S17-3;"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022626; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp17823_c0_seq1;GAXK01067378.1;Q7Z429;2.16E-57;LFG1_HUMAN;Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]";"GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236";"endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";ion channel binding [GO:0044325]
comp1783_c5_seq1;GAXK01165831.1;Q9VVE5;1.00E-66;MSIR6_DROME;RNA-binding protein Musashi homolog Rbp6;"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]";"GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904";stem cell development [GO:0048864];"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp1783113_c0_seq1;GAXK01203467.1;P25155;2.55E-30;FA10_CHICK;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp178313_c0_seq1;GAXK01130930.1;O97341;1.44E-56;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1783236_c0_seq1;GAXK01203470.1;Q9UQC9;3.69E-21;CLCA2_HUMAN;"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872";"cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp178400_c1_seq1;GAXK01130937.1;Q9W0Y6;2.51E-17;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp1784207_c0_seq1;GAXK01079613.1;C0SPF7;1.43E-74;C15C1_BOMMO;Farnesoate epoxidase (EC 1.14.14.128) (Cytochrome P450 15C1) (Protein dimolting) (mod);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]; metamorphosis [GO:0007552]";"GO:0005506; GO:0006718; GO:0007552; GO:0016709; GO:0020037";"juvenile hormone biosynthetic process [GO:0006718]; metamorphosis [GO:0007552]";;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp1784228_c0_seq1;GAXK01079586.1;O18023;6.16E-34;IGDB2_CAEEL;Ig-like and fibronectin type-III domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"GO:0005886; GO:0016021; GO:0030017";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";
comp178423_c0_seq1;GAXK01130853.1;Q0P424;1.93E-23;ELP6_DANRE;Elongator complex protein 6 (Protein TMEM103);"Elongator holoenzyme complex [GO:0033588]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0030335; GO:0033588";"positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]";Elongator holoenzyme complex [GO:0033588];
comp1784263_c0_seq1;GAXK01079605.1;Q19269;2.67E-30;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp178455_c0_seq1;GAXK01130499.1;Q91VA6;1.30E-48;PDIP2_MOUSE;Polymerase delta-interacting protein 2;"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584";"mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]"
comp1784572_c0_seq1;GAXK01079603.1;Q90WJ3;7.32E-27;PAXI1_XENLA;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) (SMAD wing for transcriptional activation) (Protein Swift);"nucleus [GO:0005634]; DNA repair [GO:0006281]";"GO:0005634; GO:0006281";DNA repair [GO:0006281];nucleus [GO:0005634];
comp17846_c0_seq1;GAXK01068478.1;Q13231;8.85E-14;CHIT1_HUMAN;Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]";"GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724";"chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp1784660_c0_seq1;GAXK01079596.1;Q9NR99;1.00E-07;MXRA5_HUMAN;Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; response to transforming growth factor beta [GO:0071559]";"GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559";response to transforming growth factor beta [GO:0071559];"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]";extracellular matrix structural constituent [GO:0005201]
comp1784927_c0_seq1;GAXK01079594.1;Q8X5L7;7.64E-31;BCSA_ECO57;Cellulose synthase catalytic subunit [UDP-forming] (EC 2.4.1.12);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose synthase (UDP-forming) activity [GO:0016760]; cyclic-di-GMP binding [GO:0035438]; cellulose biosynthetic process [GO:0030244]; UDP-glucose metabolic process [GO:0006011]";"GO:0005886; GO:0006011; GO:0016021; GO:0016760; GO:0030244; GO:0035438";"cellulose biosynthetic process [GO:0030244]; UDP-glucose metabolic process [GO:0006011]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cellulose synthase (UDP-forming) activity [GO:0016760]; cyclic-di-GMP binding [GO:0035438]"
comp178505_c0_seq1;GAXK01130664.1;A8KBE0;6.13E-33;OXR1_XENTR;Oxidation resistance protein 1;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp1785112_c0_seq1;GAXK01079611.1;Q51330;1.18E-14;OXLT_OXAFO;Oxalate:formate antiporter (OFA) (Oxalate:formate antiport protein) (Oxalate:formate exchange protein);"integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]";"GO:0005887; GO:0015297; GO:0019531";;integral component of plasma membrane [GO:0005887];"antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]"
comp1785193_c0_seq1;GAXK01079593.1;O54963;3.41E-16;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp178540_c0_seq1;GAXK01130925.1;Q9P055;6.27E-84;JKAMP_HUMAN;JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625";"response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";ubiquitin protein ligase binding [GO:0031625]
comp178567_c1_seq1;GAXK01130514.1;Q8NFU1;8.73E-85;BEST2_HUMAN;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0034707; GO:0051899";"membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1785826_c0_seq1;GAXK01079607.1;Q6AW86;2.58E-18;Z324B_HUMAN;Zinc finger protein 324B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1786031_c0_seq1;GAXK01016468.1;P11118;3.79E-54;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp17861_c1_seq1;GAXK01068262.1;Q174D3;1.41E-45;MED19_AEDAE;Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp1786294_c0_seq1;GAXK01016491.1;P18445;7.93E-66;RL27A_RAT;60S ribosomal protein L27a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp1786355_c0_seq1;GAXK01016487.1;Q8TF45;1.45E-24;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1786754_c0_seq1;GAXK01016482.1;P82600;1.22E-15;PERC_AEDAE;Chorion peroxidase (EC 1.11.1.7);"extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0020037; GO:0042743; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]";extracellular region [GO:0005576];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp17868_c0_seq1;GAXK01068536.1;Q7ZWL6;8.12E-66;MAF1_XENLA;Repressor of RNA polymerase III transcription MAF1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase III [GO:0016480]";"GO:0005634; GO:0005737; GO:0016480";negative regulation of transcription by RNA polymerase III [GO:0016480];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp178684_c0_seq1;GAXK01130501.1;P21108;1.37E-89;PRPS3_HUMAN;Ribose-phosphate pyrophosphokinase 3 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 1-like 1) (PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III) (PRS-III);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp17870_c0_seq1;GAXK01067466.1;P10735;4.22E-41;RT12_DROME;40S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Protein technical knockout locus);"mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; courtship behavior [GO:0007619]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; mitochondrial translation [GO:0032543]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; translation [GO:0006412]";"GO:0001666; GO:0003735; GO:0005763; GO:0006412; GO:0007605; GO:0007619; GO:0007638; GO:0008049; GO:0009612; GO:0032543";"courtship behavior [GO:0007619]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; mitochondrial translation [GO:0032543]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];structural constituent of ribosome [GO:0003735]
comp178709_c0_seq1;GAXK01130933.1;P17019;1.39E-15;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp1787470_c0_seq1;GAXK01016469.1;Q5RA57;5.05E-40;PLCC_PONAB;1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0003841; GO:0005635; GO:0005789; GO:0016021; GO:0016024";CDP-diacylglycerol biosynthetic process [GO:0016024];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp178754_c0_seq1;GAXK01130636.1;A8WHP3;3.35E-172;SC5A9_DANRE;Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]";"GO:0005412; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";glucose:sodium symporter activity [GO:0005412]
comp1787601_c0_seq1;GAXK01016494.1;B0CM36;5.63E-10;LCA5L_PAPAN;Lebercilin-like protein (Leber congenital amaurosis 5-like protein);;;;;
comp1787713_c0_seq1;GAXK01016472.1;B5X3W7;1.55E-12;CTL2_SALSA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1787754_c0_seq1;GAXK01016493.1;Q16983;3.19E-59;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp178789_c0_seq1;GAXK01130826.1;Q8CJ78;4.82E-25;ZN628_MOUSE;Zinc finger protein 628 (Zinc finger protein expressed in embryonal cells and certain adult organs);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp178793_c1_seq1;GAXK01130502.1;O34722;2.74E-12;YFMG_BACSU;Uncharacterized protein YfmG;;;;;
comp1787952_c0_seq1;GAXK01016495.1;Q03043;8.27E-52;KGP24_DROME;cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"GO:0004691; GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0018105; GO:0030536; GO:0030553; GO:0032095; GO:0046959";"feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp1788_c0_seq1;GAXK01169620.1;Q2M2S5;1.08E-13;COA6_BOVIN;Cytochrome c oxidase assembly factor 6 homolog;"host cell mitochondrial intermembrane space [GO:0072492]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535]";"GO:0005507; GO:0005739; GO:0005758; GO:0005886; GO:0008535; GO:0042774; GO:0072492";"plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535]";"host cell mitochondrial intermembrane space [GO:0072492]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";copper ion binding [GO:0005507]
comp178803_c3_seq1;GAXK01130854.1;Q7ZVT3;6.25E-73;SAS6_DANRE;Spindle assembly abnormal protein 6 homolog;"centriole [GO:0005814]; centrosome [GO:0005813]; deuterosome [GO:0098536]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; embryonic cleavage [GO:0040016]; mitotic spindle organization [GO:0007052]; nuclear division [GO:0000280]; spermatogenesis [GO:0007283]";"GO:0000280; GO:0005813; GO:0005814; GO:0007052; GO:0007099; GO:0007283; GO:0040016; GO:0051298; GO:0098536";"centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; embryonic cleavage [GO:0040016]; mitotic spindle organization [GO:0007052]; nuclear division [GO:0000280]; spermatogenesis [GO:0007283]";"centriole [GO:0005814]; centrosome [GO:0005813]; deuterosome [GO:0098536]";
comp1788147_c0_seq1;GAXK01093043.1;P35464;3.24E-13;DIHR_MANSE;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp178851_c13_seq1;GAXK01130694.1;Q3LHL9;1.00E-39;WGE_DROME;Protein winged eye;"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"GO:0000785; GO:0003682; GO:0005634; GO:0007560; GO:0030154";"cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"chromatin [GO:0000785]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp1788760_c0_seq1;GAXK01093051.1;Q7K237;8.39E-14;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp178886_c0_seq1;GAXK01130620.1;G5EBR3;8.91E-17;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp1788870_c0_seq1;GAXK01093048.1;P25123;1.35E-115;GBRB_DROME;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (Protein cyclodiene resistance);"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0002121; GO:0004890; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0009612; GO:0016021; GO:0022851; GO:0030054; GO:0030424; GO:0030425; GO:0030431; GO:0030594; GO:0032589; GO:0032809; GO:0034220; GO:0034707; GO:0042048; GO:0042391; GO:0042493; GO:0042749; GO:0043005; GO:0045202; GO:0045211; GO:0050805; GO:0050877; GO:0090328";"chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]"
comp17890_c0_seq1;GAXK01068464.1;Q642A0;2.70E-22;PDRG1_RAT;p53 and DNA damage-regulated protein 1;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp1789048_c0_seq1;GAXK01093060.1;Q99N37;5.80E-32;RHG17_RAT;Rho GTPase-activating protein 17 (Neuron-associated developmentally-regulated protein) (Nadrin) (Rho-type GTPase-activating protein 17);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; signal transduction [GO:0007165]";"GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005923; GO:0007015; GO:0007165; GO:0016020; GO:0017124; GO:0017156; GO:0032956; GO:0048365";"actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; signal transduction [GO:0007165]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]"
comp1789578_c0_seq1;GAXK01093073.1;P27323;1.03E-171;HS901_ARATH;Heat shock protein 90-1 (AtHSP90.1) (AtHsp90-1) (Heat shock protein 81-1) (Hsp81-1) (Heat shock protein 83);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";"GO:0005524; GO:0005737; GO:0009816; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp178982_c0_seq1;GAXK01205656.1;Q8NB50;1.11E-21;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp179_c2_seq1;GAXK01169627.1;Q8VEM8;2.28E-153;MPCP_MOUSE;Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877";phosphate ion transmembrane transport [GO:0035435];"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]"
comp179012_c1_seq1;GAXK01130902.1;Q96QE2;5.11E-82;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp1790572_c0_seq1;GAXK01205113.1;Q62210;2.27E-12;BIRC2_MOUSE;Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (Inhibitor of apoptosis protein 2) (mIAP2) (RING-type E3 ubiquitin transferase BIRC2);"CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]";"GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0045121; GO:0045471; GO:0047485; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1902916; GO:1990001; GO:2000377";"cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]";"CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]";"chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp179060_c0_seq1;GAXK01130858.1;P90992;3.95E-32;M2OM_CAEEL;Mitochondrial 2-oxoglutarate/malate carrier protein (Mitochondrial solute carrier 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367]";"GO:0005739; GO:0005743; GO:0015367; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";oxoglutarate:malate antiporter activity [GO:0015367]
comp1791066_c0_seq1;GAXK01023711.1;P93051;8.60E-13;ERDL7_ARATH;Sugar transporter ERD6-like 7;"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; carbohydrate:proton symporter activity [GO:0005351]; zinc ion transport [GO:0006829]";"GO:0005351; GO:0005773; GO:0005774; GO:0005829; GO:0005887; GO:0006829; GO:0009705";zinc ion transport [GO:0006829];"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";carbohydrate:proton symporter activity [GO:0005351]
comp1791072_c0_seq1;GAXK01023702.1;O74467;1.18E-16;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp17912_c0_seq1;GAXK01067383.1;Q6PB66;4.43E-48;LPPRC_MOUSE;Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130);"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; beta-tubulin binding [GO:0048487]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]";"GO:0000794; GO:0000961; GO:0003697; GO:0003723; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005856; GO:0005874; GO:0031625; GO:0042645; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904";"mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]";"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]";"beta-tubulin binding [GO:0048487]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]"
comp1791448_c0_seq1;GAXK01023710.1;P16912;1.10E-11;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp179161_c5_seq1;GAXK01130865.1;Q86UD5;1.53E-77;SL9B2_HUMAN;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]"
comp17920_c1_seq1;GAXK01067576.1;Q99L20;5.70E-16;GSTT3_MOUSE;Glutathione S-transferase theta-3 (EC 2.5.1.18);"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];glutathione transferase activity [GO:0004364]
comp17922_c0_seq1;GAXK01067669.1;Q7JWG9;1.07E-10;RM52_DROME;39S ribosomal protein L52, mitochondrial (L52mt) (MRP-L52);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp179246_c4_seq1;GAXK01130954.1;Q8BS35;9.50E-94;ALKMO_MOUSE;Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]";"GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479";"ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]"
comp17930_c1_seq1;GAXK01067698.1;Q5R6J3;3.00E-86;S35F5_PONAB;Solute carrier family 35 member F5;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp179335_c0_seq1;GAXK01130622.1;Q8VHI6;1.80E-11;WASF3_MOUSE;Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]";"GO:0003779; GO:0005737; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031643; GO:0098794; GO:0098885; GO:0098978";"actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]";actin binding [GO:0003779]
comp179340_c3_seq1;GAXK01130887.1;P49916;0;DNLI3_HUMAN;DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3);"cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair, DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006281; GO:0006283; GO:0006288; GO:0006297; GO:0006302; GO:0007005; GO:0007049; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681";"base-excision repair, DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283]";"cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]"
comp1793885_c0_seq1;GAXK01164179.1;Q9VCA8;1.69E-10;ANKHM_DROME;Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; regulation of establishment of blood-brain barrier [GO:0090210]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019730; GO:0019901; GO:0030018; GO:0031430; GO:0043066; GO:0045214; GO:0060361; GO:0090210; GO:1903147";"antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; regulation of establishment of blood-brain barrier [GO:0090210]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]";"protein kinase binding [GO:0019901]; RNA binding [GO:0003723]"
comp179394_c1_seq1;GAXK01205654.1;Q26240;0;NOS_RHOPR;Nitric oxide synthase, salivary gland (NOS) (EC 1.14.13.39);"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric oxide biosynthetic process [GO:0006809]";"GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0046872; GO:0050660; GO:0050661";nitric oxide biosynthetic process [GO:0006809];;"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]"
comp1794_c0_seq1;GAXK01168378.1;O16087;7.59E-45;HSP83_DROMI;Heat shock protein 83 (HSP 82) (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp1794167_c0_seq1;GAXK01145704.1;Q8IYU8;4.84E-51;MICU2_HUMAN;Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1);"calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:1990246";"calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]";"calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]"
comp179422_c1_seq1;GAXK01130626.1;P48763;2.13E-106;SL9A2_RAT;Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0051453; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp1794398_c0_seq1;GAXK01145686.1;A3KNI7;1.72E-09;CCDB1_DANRE;Cyclin-D1-binding protein 1 homolog (Zebrafish homolog of Maid);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]";"GO:0005634; GO:0005737; GO:0007049; GO:0051726";"cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1794454_c0_seq1;GAXK01145690.1;Q5BL35;2.45E-11;SPOLA_DANRE;Speckle-type POZ protein-like A (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp1794461_c0_seq1;GAXK01145687.1;P28515;3.47E-17;ELT1_CAEEL;Transcription factor elt-1;"axon [GO:0030424]; nucleus [GO:0005634]; perikaryon [GO:0043204]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; epidermal cell fate specification [GO:0009957]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]";"GO:0000122; GO:0000978; GO:0000981; GO:0001162; GO:0005634; GO:0007275; GO:0007286; GO:0008270; GO:0009957; GO:0019827; GO:0030424; GO:0043204; GO:0045944";"epidermal cell fate specification [GO:0009957]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286]; stem cell population maintenance [GO:0019827]";"axon [GO:0030424]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp1794519_c0_seq1;GAXK01145694.1;Q5HYK9;7.41E-13;ZN667_HUMAN;Zinc finger protein 667;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1794967_c0_seq1;GAXK01145692.1;Q9UFB7;1.55E-11;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp179511_c0_seq1;GAXK01130907.1;Q9NX07;2.82E-39;TSAP1_HUMAN;tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; selenocysteine incorporation [GO:0001514]";"GO:0001514; GO:0003723; GO:0005634; GO:0005737";selenocysteine incorporation [GO:0001514];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp179516_c1_seq1;GAXK01130841.1;A2AKX3;6.65E-23;SETX_MOUSE;Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog);"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]";"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]"
comp179525_c0_seq1;GAXK01130899.1;Q8N5I4;2.78E-15;DHRSX_HUMAN;Dehydrogenase/reductase SDR family member on chromosome X (EC 1.1.-.-) (DHRSXY) (Short chain dehydrogenase/reductase family 46C member 1) (Short chain dehydrogenase/reductase family 7C member 6);"extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]; positive regulation of autophagy [GO:0010508]";"GO:0005576; GO:0010508; GO:0016491";positive regulation of autophagy [GO:0010508];extracellular region [GO:0005576];oxidoreductase activity [GO:0016491]
comp1795254_c0_seq1;GAXK01145698.1;P56823;4.19E-39;HCYG_HELPO;Hemocyanin, beta-C chain unit G (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp1795581_c0_seq1;GAXK01145701.1;Q9Y2H8;8.76E-52;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1795977_c0_seq1;GAXK01145680.1;P10076;2.56E-21;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp179616_c0_seq1;GAXK01130510.1;Q07230;9.23E-27;ZSCA2_MOUSE;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1796584_c0_seq1;GAXK01022373.1;Q9VZU2;1.51E-24;HHAT_DROME;Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0046843; GO:0048100";"dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp17969_c0_seq1;GAXK01205386.1;P68036;1.02E-71;UB2L3_HUMAN;Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0003713; GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006464; GO:0006511; GO:0008283; GO:0016567; GO:0019899; GO:0031398; GO:0031625; GO:0044770; GO:0051443; GO:0061631; GO:0070979; GO:0071383; GO:0071385; GO:0097027; GO:1903955";"cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]"
comp1796956_c0_seq1;GAXK01022428.1;Q04841;4.61E-55;3MG_MOUSE;DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase);"mitochondrial nucleoid [GO:0042645]; nucleus [GO:0005634]; alkylbase DNA N-glycosylase activity [GO:0003905]; DNA binding [GO:0003677]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]";"GO:0003677; GO:0003905; GO:0005634; GO:0006284; GO:0008725; GO:0042645; GO:0043916; GO:0052821; GO:0052822";base-excision repair [GO:0006284];"mitochondrial nucleoid [GO:0042645]; nucleus [GO:0005634]";"alkylbase DNA N-glycosylase activity [GO:0003905]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA binding [GO:0003677]"
comp1797_c12_seq1;GAXK01169875.1;Q9VYS3;0;RENT1_DROME;Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-);"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuronal ribonucleoprotein granule [GO:0071598]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000624]";"GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0008270; GO:0071456; GO:0071598; GO:1990124; GO:2000624";"cellular response to hypoxia [GO:0071456]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000624]";"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuronal ribonucleoprotein granule [GO:0071598]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]"
comp179713_c1_seq1;GAXK01130898.1;Q6TNU3;3.39E-12;INT10_DANRE;Integrator complex subunit 10 (Int10);"integrator complex [GO:0032039]; snRNA processing [GO:0016180]";"GO:0016180; GO:0032039";snRNA processing [GO:0016180];integrator complex [GO:0032039];
comp1797859_c0_seq1;GAXK01022379.1;Q99MV7;2.07E-23;RNF17_MOUSE;RING finger protein 17 (Mad member-interacting protein 2) (Mmip-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]";"GO:0005634; GO:0005737; GO:0007275; GO:0007286; GO:0042803; GO:0046872";"multicellular organism development [GO:0007275]; spermatid development [GO:0007286]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
comp179789_c0_seq1;GAXK01130895.1;P81018;1.12E-15;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp17979_c0_seq1;GAXK01067578.1;Q9CRD2;6.53E-65;EMC2_MOUSE;ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein folding in endoplasmic reticulum [GO:0034975]";"GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0034975; GO:0072546";protein folding in endoplasmic reticulum [GO:0034975];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";
comp1798179_c0_seq1;GAXK01110011.1;P15330;3.91E-25;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp17982_c0_seq1;GAXK01067525.1;Q02427;1.03E-21;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1798290_c0_seq1;GAXK01110001.1;P10379;1.85E-14;UZIP_DROME;Protein unzipped (Protein zipper);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]";"GO:0005886; GO:0007411; GO:0007413; GO:0016021";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1798443_c0_seq1;GAXK01110005.1;P56079;3.55E-13;CDSA_DROME;Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016021; GO:0016024; GO:0016056; GO:0043052";"CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";phosphatidate cytidylyltransferase activity [GO:0004605]
comp179854_c0_seq1;GAXK01130852.1;Q9VAF5;0;CAD99_DROME;Cadherin-99C;"apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305]";"GO:0002385; GO:0005509; GO:0005887; GO:0005902; GO:0005913; GO:0007156; GO:0007304; GO:0007305; GO:0010008; GO:0016324; GO:0016339; GO:0017022; GO:0019722; GO:0031528; GO:0032529; GO:0032533; GO:0035239; GO:0044331; GO:0045176; GO:0098609; GO:2000370";"apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305]";"apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]";"calcium ion binding [GO:0005509]; myosin binding [GO:0017022]"
comp17989_c0_seq1;GAXK01068249.1;P62489;4.04E-114;RPB7_RAT;DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G);"nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000291; GO:0000932; GO:0003697; GO:0003727; GO:0003899; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0006915; GO:0031369; GO:0045948; GO:0060213";"apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]"
comp1798999_c0_seq1;GAXK01110010.1;Q5M821;1.29E-83;PPM1H_RAT;Protein phosphatase 1H (EC 3.1.3.16);"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]";"GO:0004721; GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005737; GO:0098978";;"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]"
comp1799127_c0_seq1;GAXK01110004.1;P28188;1.23E-45;RAD2A_ARATH;Ras-related protein RABD2a (AtRABD2a) (Ras-related protein Ara-5) (Ras-related protein Rab1B) (AtRab1B);"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vacuole [GO:0005773]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; response to cadmium ion [GO:0046686]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005773; GO:0005789; GO:0005886; GO:0006886; GO:0006888; GO:0032482; GO:0032588; GO:0046686";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; response to cadmium ion [GO:0046686]";"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vacuole [GO:0005773]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp17993_c0_seq1;GAXK01068531.1;G5CTG8;1.18E-18;AQP11_MILTA;Aquaporin-11 (AQP-11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp17994_c2_seq1;GAXK01067700.1;Q9D2V8;8.76E-98;MFS10_MOUSE;Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein);"brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nuclear inner membrane [GO:0005637]; organic anion transmembrane transporter activity [GO:0008514]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]";"GO:0005637; GO:0005887; GO:0006915; GO:0008514; GO:0030659; GO:0031526; GO:0043252";"apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]";"brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nuclear inner membrane [GO:0005637]";organic anion transmembrane transporter activity [GO:0008514]
comp179948_c1_seq1;GAXK01130942.1;P26221;1.01E-110;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp179954_c0_seq1;GAXK01130818.1;Q8R1K4;7.89E-88;AT2L2_MOUSE;5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2);"mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]";"GO:0005739; GO:0008483; GO:0016829; GO:0030170; GO:0042802";;mitochondrion [GO:0005739];"identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp18_c0_seq1;GAXK01168994.1;Q6DF30;3.72E-83;DHDH_XENTR;Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase);"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]";"GO:0042843; GO:0047115; GO:0047837";D-xylose catabolic process [GO:0042843];;"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
comp1800250_c0_seq1;GAXK01107753.1;Q7ZUB2;3.89E-58;RS17_COTJA;40S ribosomal protein S17;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp18007_c0_seq1;GAXK01026786.1;A2VDF0;4.26E-59;FUCM_HUMAN;Fucose mutarotase (EC 5.1.3.29);"cytosol [GO:0005829]; fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665]";"GO:0005829; GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806; GO:0045665; GO:0060180";"female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665]";cytosol [GO:0005829];"fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]"
comp1801081_c0_seq1;GAXK01107754.1;Q27433;2.11E-14;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp1801180_c0_seq1;GAXK01107757.1;Q9Z125;3.39E-10;CR3L1_MOUSE;Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1 (Oasis N-terminal fragment) (OA-N)];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; SMAD binding [GO:0046332]; transcription regulatory region DNA binding [GO:0044212]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; multicellular organism development [GO:0007275]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of ossification [GO:0030278]";"GO:0000139; GO:0000790; GO:0001227; GO:0001228; GO:0001649; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0007275; GO:0010629; GO:0016020; GO:0030176; GO:0030278; GO:0030968; GO:0032967; GO:0035497; GO:0040037; GO:0044212; GO:0045892; GO:0046332; GO:0070278; GO:1902236; GO:1903671; GO:1990440";"endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; multicellular organism development [GO:0007275]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of ossification [GO:0030278]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; SMAD binding [GO:0046332]; transcription regulatory region DNA binding [GO:0044212]"
comp1801212_c0_seq1;GAXK01107772.1;Q91ZD4;2.63E-28;VANG2_MOUSE;Vang-like protein 2 (Loop-tail protein 1) (Loop-tail-associated protein) (Van Gogh-like protein 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell pole [GO:0060187]; cell-cell junction [GO:0005911]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell migration involved in kidney development [GO:0035787]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; convergent extension involved in organogenesis [GO:0060029]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron axon guidance [GO:0036514]; epicardial cell to mesenchymal cell transition [GO:0003347]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell polarity [GO:0090162]; establishment of planar polarity [GO:0001736]; establishment of planar polarity involved in neural tube closure [GO:0090177]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glomerulus development [GO:0032835]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney morphogenesis [GO:0060993]; lateral sprouting involved in lung morphogenesis [GO:0060490]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; outflow tract septum morphogenesis [GO:0003148]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in heart morphogenesis [GO:0061346]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; positive regulation of JUN kinase activity [GO:0043507]; post-anal tail morphogenesis [GO:0036342]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of planar polarity [GO:0090175]; regulation of Wnt signaling pathway [GO:0030111]; Rho protein signal transduction [GO:0007266]; serotonergic neuron axon guidance [GO:0036515]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]";"GO:0001569; GO:0001725; GO:0001736; GO:0001843; GO:0001942; GO:0001947; GO:0003148; GO:0003149; GO:0003150; GO:0003347; GO:0003402; GO:0005886; GO:0005911; GO:0007266; GO:0009952; GO:0015012; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0022007; GO:0030111; GO:0030134; GO:0032835; GO:0032956; GO:0035019; GO:0035567; GO:0035787; GO:0036342; GO:0036514; GO:0036515; GO:0042060; GO:0043507; GO:0045176; GO:0045197; GO:0048103; GO:0048105; GO:0048546; GO:0060028; GO:0060029; GO:0060071; GO:0060119; GO:0060122; GO:0060187; GO:0060488; GO:0060489; GO:0060490; GO:0060947; GO:0060993; GO:0061346; GO:0071944; GO:0090102; GO:0090103; GO:0090162; GO:0090175; GO:0090177; GO:0090179; GO:1904938; GO:1905515";"anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell migration involved in kidney development [GO:0035787]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; convergent extension involved in organogenesis [GO:0060029]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron axon guidance [GO:0036514]; epicardial cell to mesenchymal cell transition [GO:0003347]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell polarity [GO:0090162]; establishment of planar polarity [GO:0001736]; establishment of planar polarity involved in neural tube closure [GO:0090177]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glomerulus development [GO:0032835]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney morphogenesis [GO:0060993]; lateral sprouting involved in lung morphogenesis [GO:0060490]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; outflow tract septum morphogenesis [GO:0003148]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in heart morphogenesis [GO:0061346]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; positive regulation of JUN kinase activity [GO:0043507]; post-anal tail morphogenesis [GO:0036342]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of planar polarity [GO:0090175]; regulation of Wnt signaling pathway [GO:0030111]; Rho protein signal transduction [GO:0007266]; serotonergic neuron axon guidance [GO:0036515]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell periphery [GO:0071944]; cell pole [GO:0060187]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";
comp1801467_c0_seq1;GAXK01107759.1;P52746;2.19E-21;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp180148_c1_seq1;GAXK01199704.1;Q9D1D1;7.34E-43;TSN11_MOUSE;Tetraspanin-11 (Tspan-11);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp1801482_c0_seq1;GAXK01107763.1;Q91453;3.13E-40;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp1801520_c0_seq1;GAXK01107765.1;P36609;1.01E-54;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1801532_c0_seq1;GAXK01107780.1;Q6GN21;2.28E-13;N2C1A_XENLA;Nuclear receptor subfamily 2 group C member 1-A (Developmental orphan receptor 2-A) (DOR2-A) (xDOR2-A) (Orphan nuclear receptor TR2-A) (Testicular receptor 2-A);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp180209_c0_seq1;GAXK01199643.1;O31474;1.97E-11;YCGJ_BACSU;Uncharacterized methyltransferase YcgJ (EC 2.1.1.-);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp180212_c0_seq1;GAXK01199735.1;Q19013;2.24E-26;GLS2_CAEEL;Putative glutaminase 2 (GLS) (EC 3.5.1.2) (L-glutamine amidohydrolase);"mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005739; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrion [GO:0005739];glutaminase activity [GO:0004359]
comp1802496_c0_seq1;GAXK01091874.1;Q9C102;3.04E-13;GLT1_SCHPO;Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; iron ion binding [GO:0005506]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]";"GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054";"ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; iron ion binding [GO:0005506]"
comp1802734_c0_seq1;GAXK01091891.1;Q7KM13;2.74E-43;HEY_DROME;Hairy/enhancer-of-split related with YRPW motif protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0046983; GO:0048664; GO:0050767";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1802944_c0_seq1;GAXK01091889.1;P87149;2.93E-17;MRS2_SCHPO;Mitochondrial inner membrane magnesium transporter mrs2 (RNA-splicing protein mrs2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005739; GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";magnesium ion transmembrane transporter activity [GO:0015095]
comp180356_c0_seq1;GAXK01199571.1;D4PHA7;1.05E-31;WSCD2_MOUSE;WSC domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp180366_c3_seq1;GAXK01199929.1;P70665;2.24E-77;SIAE_MOUSE;"Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]";"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"GO:0001681; GO:0002682; GO:0005764; GO:0005975";"carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp180370_c1_seq1;GAXK01199599.1;P51906;9.44E-54;EAA3_MOUSE;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transmembrane transport [GO:1903712]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; positive regulation of heart rate [GO:0010460]; protein homooligomerization [GO:0051260]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0010460; GO:0015108; GO:0015501; GO:0015813; GO:0016020; GO:0016324; GO:0016595; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0051260; GO:0051938; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476; GO:1903712";"chloride transmembrane transport [GO:1902476]; cysteine transmembrane transport [GO:1903712]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; positive regulation of heart rate [GO:0010460]; protein homooligomerization [GO:0051260]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; glutamate binding [GO:0016595]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp18048_c0_seq1;GAXK01026409.1;O95628;1.27E-120;CNOT4_HUMAN;CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4);"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0006977; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865";"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]";"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]"
comp18050_c0_seq1;GAXK01026064.1;Q5RC80;3.67E-165;RBM39_PONAB;RNA-binding protein 39 (RNA-binding motif protein 39);"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0006397; GO:0008380; GO:0016607";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];RNA binding [GO:0003723]
comp1805433_c0_seq1;GAXK01143763.1;O74467;3.42E-14;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp180544_c0_seq1;GAXK01199677.1;P02636;4.66E-08;SCPA_PENSP;Sarcoplasmic calcium-binding protein, alpha-B and -A chains (SCP alpha chain);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp18056_c1_seq1;GAXK01026032.1;Q22544;1.07E-14;YAE7_CAEEL;Uncharacterized protein T18D3.7;DNA-binding transcription factor activity [GO:0003700];GO:0003700;;;DNA-binding transcription factor activity [GO:0003700]
comp180561_c0_seq1;GAXK01199911.1;P86704;1.80E-31;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp180564_c2_seq1;GAXK01199697.1;Q24400;4.55E-07;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp180567_c0_seq1;GAXK01199604.1;Q86UP3;2.50E-10;ZFHX4_HUMAN;Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0008270; GO:0044212; GO:0045893";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp1805712_c0_seq1;GAXK01143758.1;Q12719;3.38E-18;LAC4_TRAVE;Laccase-4 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 4) (Diphenol oxidase 4) (Urishiol oxidase 4);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp180697_c1_seq1;GAXK01199624.1;Q0E908;0;HIL_DROME;Hillarin (D-Hillarin) (D-hil);"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]";"GO:0005938; GO:0032154; GO:0046872";;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]";metal ion binding [GO:0046872]
comp180707_c0_seq1;GAXK01199684.1;Q6AXW7;1.16E-07;DUS18_RAT;Dual specificity protein phosphatase 18 (EC 3.1.3.16) (EC 3.1.3.48);"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]";"GO:0004725; GO:0005634; GO:0005758; GO:0008138; GO:0016311; GO:0016791; GO:0017017; GO:0031314; GO:0035335; GO:0035970";"dephosphorylation [GO:0016311]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]";"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]";"MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp1807413_c0_seq1;GAXK01092869.1;Q6PFM1;3.65E-35;S20AB_DANRE;Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp1807462_c0_seq1;GAXK01092887.1;Q9VKY2;4.54E-09;CAND1_DROME;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1);"nucleus [GO:0005634]; negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";"GO:0005634; GO:0010265; GO:0016567; GO:0031647; GO:2000435";"negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";nucleus [GO:0005634];
comp180772_c0_seq1;GAXK01199749.1;Q9VDR1;4.11E-39;MED25_DROME;Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) (dmPTOV2);"mediator complex [GO:0016592]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; transcription coregulator activity [GO:0003712]; nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0005654; GO:0006357; GO:0006963; GO:0007399; GO:0016592; GO:0044798; GO:0045944";"nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"mediator complex [GO:0016592]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]";transcription coregulator activity [GO:0003712]
comp180785_c1_seq1;GAXK01199620.1;P57721;6.39E-21;PCBP3_HUMAN;Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]";"GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829";mRNA metabolic process [GO:0016071];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp1807949_c0_seq1;GAXK01092873.1;Q9NTW7;4.78E-08;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp180842_c1_seq1;GAXK01199693.1;Q9Y2I1;6.04E-67;NISCH_HUMAN;Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]";"GO:0005178; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037";"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]"
comp1808605_c0_seq1;GAXK01164584.1;P27473;1.82E-42;IFI44_PANTR;Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp180868_c2_seq1;GAXK01199631.1;Q10L91;4.78E-09;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp180880_c0_seq1;GAXK01199645.1;Q9W5U2;5.41E-26;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp180883_c1_seq1;GAXK01199732.1;H1UBN0;2.39E-12;CPNE7_RAT;Copine-7 (Copine VII);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0071277";cellular response to calcium ion [GO:0071277];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp1808855_c0_seq1;GAXK01164574.1;P25291;9.69E-08;GP2_CANLF;Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"GO:0005576; GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp1809050_c0_seq1;GAXK01164596.1;B1AS29;5.27E-129;GRIK3_MOUSE;Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315";"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp180921_c0_seq1;GAXK01199674.1;Q9VCA2;1.20E-82;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1809381_c0_seq1;GAXK01164590.1;Q58DS9;3.61E-81;RAB5C_BOVIN;Ras-related protein Rab-5C;"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0032482; GO:0042470";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; melanosome [GO:0042470]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1809807_c0_seq1;GAXK01164582.1;O94761;4.50E-10;RECQ4_HUMAN;ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4);"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]"
comp1809821_c0_seq1;GAXK01164583.1;Q1H9T6;2.72E-08;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp180983_c0_seq1;GAXK01199673.1;Q9DEE9;1.88E-150;ARP6_CHICK;Actin-related protein 6 (gArp6) (gARPX);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]";"GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486";histone exchange [GO:0043486];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]";nucleosome binding [GO:0031491]
comp181008_c1_seq1;GAXK01199640.1;Q9VHH9;2.09E-11;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp1810233_c0_seq1;GAXK01196376.1;Q96RE9;4.58E-45;ZN300_HUMAN;Zinc finger protein 300;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001228; GO:0005634; GO:0005730; GO:0043565; GO:0045944; GO:0046872";positive regulation of transcription by RNA polymerase II [GO:0045944];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp181031_c0_seq1;GAXK01199644.1;O13737;8.23E-20;YDR2_SCHPO;Uncharacterized endoplasmic reticulum membrane protein C16E8.02;"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid alpha-oxygenase activity [GO:0102672]; sphingoid catabolic process [GO:0046521]";"GO:0005783; GO:0030176; GO:0046521; GO:0102672";sphingoid catabolic process [GO:0046521];"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";fatty acid alpha-oxygenase activity [GO:0102672]
comp181040_c0_seq1;GAXK01199700.1;P00765;3.43E-37;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp181053_c0_seq1;GAXK01199825.1;P05661;2.13E-107;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp18106_c0_seq1;GAXK01026104.1;Q5HZF2;5.11E-13;WBP4_RAT;WW domain-binding protein 4 (WBP-4) (Formin-binding protein 21) (WW domain-containing-binding protein 4);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; proline-rich region binding [GO:0070064]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003676; GO:0005634; GO:0008270; GO:0016607; GO:0045292; GO:0070064; GO:0071005";"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]";"nucleic acid binding [GO:0003676]; proline-rich region binding [GO:0070064]; zinc ion binding [GO:0008270]"
comp181086_c0_seq1;GAXK01199686.1;P21271;1.15E-80;MYO5B_MOUSE;Unconventional myosin-Vb;"apical cortex [GO:0045179]; brush border [GO:0005903]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; motor activity [GO:0003774]; Rab GTPase binding [GO:0017137]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]";"GO:0003774; GO:0005516; GO:0005524; GO:0005903; GO:0015031; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098871; GO:0098944; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543";"dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]";"apical cortex [GO:0045179]; brush border [GO:0005903]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]";"actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; motor activity [GO:0003774]; Rab GTPase binding [GO:0017137]"
comp18112_c0_seq1;GAXK01026334.1;Q05858;3.34E-07;FMN_CHICK;Formin (Limb deformity protein);"actin filament [GO:0005884]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]; positive regulation of actin nucleation [GO:0051127]";"GO:0003779; GO:0005634; GO:0005737; GO:0005789; GO:0005884; GO:0007275; GO:0008017; GO:0045010; GO:0051127";"actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]; positive regulation of actin nucleation [GO:0051127]";"actin filament [GO:0005884]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]"
comp1811280_c0_seq1;GAXK01196370.1;Q866F1;2.31E-16;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp1811783_c0_seq1;GAXK01196366.1;Q8VYR2;2.88E-08;NUDT9_ARATH;Nudix hydrolase 9 (AtNUDT9) (EC 3.6.1.-);"cytosol [GO:0005829]; GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; cellular response to ammonium ion [GO:0071242]";"GO:0005829; GO:0046872; GO:0052751; GO:0071242";cellular response to ammonium ion [GO:0071242];cytosol [GO:0005829];"GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]"
comp181194_c0_seq1;GAXK01199621.1;Q96MF6;3.88E-39;CQ10A_HUMAN;Coenzyme Q-binding protein COQ10 homolog A, mitochondrial;"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039";"cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";ubiquinone binding [GO:0048039]
comp1812_c0_seq1;GAXK01166402.1;P54357;2.81E-70;MLC2_DROME;Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]";"GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036";actin filament-based movement [GO:0030048];"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]";"calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
comp1812021_c0_seq1;GAXK01172663.1;P93748;6.98E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp181228_c0_seq1;GAXK01199702.1;Q9VSK8;1.79E-41;ZC3H3_DROME;Zinc finger CCCH domain-containing protein 3 (dZC3H3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear export [GO:0051168]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA polyadenylation [GO:1900363]";"GO:0003723; GO:0005634; GO:0006397; GO:0010793; GO:0046872; GO:0051028; GO:0051168; GO:1900363";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear export [GO:0051168]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA polyadenylation [GO:1900363]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp1812382_c0_seq1;GAXK01172684.1;Q20765;1.37E-10;NHR7_CAEEL;Nuclear hormone receptor family member nhr-7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp1812412_c0_seq1;GAXK01172665.1;Q8MKK4;7.28E-93;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp181266_c1_seq1;GAXK01199647.1;P93748;2.01E-10;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp18128_c0_seq1;GAXK01026512.1;A4IFF3;2.23E-23;TTC9C_BOVIN;Tetratricopeptide repeat protein 9C (TPR repeat protein 9C);;;;;
comp181286_c0_seq1;GAXK01199779.1;P10073;4.79E-32;ZSC22_HUMAN;Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1813005_c0_seq1;GAXK01172680.1;O97951;3.39E-21;UDB18_MACFA;UDP-glucuronosyltransferase 2B18 (UDPGT 2B18) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp1813035_c0_seq1;GAXK01172673.1;Q02575;1.27E-27;HEN1_HUMAN;Helix-loop-helix protein 1 (HEN-1) (Class A basic helix-loop-helix protein 35) (bHLHa35) (Nescient helix loop helix 1) (NSCL-1);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007417; GO:0030154; GO:0045944; GO:0046983";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1813203_c0_seq1;GAXK01172657.1;Q9P109;3.48E-51;GCNT4_HUMAN;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993";"carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp181328_c0_seq1;GAXK01199676.1;Q8QG61;0;CRY1_CHICK;Cryptochrome-1;"cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0031398; GO:0042622; GO:0045721; GO:0097381";"circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]";"nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]"
comp1813378_c0_seq1;GAXK01172687.1;P18729;2.01E-14;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp181347_c0_seq1;GAXK01199945.1;Q6DHG0;1.42E-15;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1813674_c0_seq1;GAXK01172691.1;Q8WXR4;1.34E-11;MYO3B_HUMAN;Myosin-IIIb (EC 2.7.11.1);"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0003774; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103";"cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]"
comp1813682_c0_seq1;GAXK01172675.1;P37164;2.53E-09;RS27A_CAEBR;"Ubiquitin-like protein 1-40S ribosomal protein S27a [Cleaved into: Ubiquitin-like protein 1; 40S ribosomal protein S27a]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0046872";"modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]";"metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]"
comp1813695_c0_seq1;GAXK01172696.1;Q14593;2.72E-19;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp181392_c2_seq1;GAXK01199754.1;Q02965;2.61E-16;THB_LITCT;Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0070324";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp1814041_c0_seq1;GAXK01194237.1;Q4VSI4;1.26E-15;UBP7_RAT;Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (rHAUSP) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription factor binding [GO:0008134]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006283; GO:0006511; GO:0007275; GO:0008134; GO:0010216; GO:0016579; GO:0016605; GO:0031647; GO:0035616; GO:0042752; GO:0042803; GO:0043065; GO:0048511; GO:0050821; GO:0051090; GO:0101005; GO:1901537; GO:1990380";"histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]";"cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription factor binding [GO:0008134]; ubiquitinyl hydrolase activity [GO:0101005]"
comp1814292_c0_seq1;GAXK01194261.1;Q9VZW5;4.97E-55;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp181437_c0_seq1;GAXK01199760.1;Q02525;4.21E-14;ZFP39_MOUSE;Zinc finger protein 39 (Zfp-39) (CtFIN33);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp18144_c0_seq1;GAXK01026939.1;Q9D0G0;2.39E-14;RT30_MOUSE;28S ribosomal protein S30, mitochondrial (MRP-S30) (S30mt);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp1814444_c0_seq2;GAXK01194273.1;Q80WV3;2.20E-17;CHST2_MOUSE;Carbohydrate sulfotransferase 2 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2) (GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1) (GlcNAc6ST-1) (Gn6st-1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021";"carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp1814584_c0_seq1;GAXK01194247.1;Q62059;6.01E-11;CSPG2_MOUSE;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Large fibroblast proteoglycan) (PG-M);"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"GO:0001501; GO:0001657; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0008347; GO:0009986; GO:0019903; GO:0030246; GO:0031012; GO:0043666; GO:0045202; GO:0062023; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]"
comp1814749_c0_seq1;GAXK01194252.1;Q05006;4.00E-26;CDC22_MEDSA;Cell division control protein 2 homolog 2 (EC 2.7.11.22);"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";;"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp1815_c2_seq1;GAXK01168671.1;P43024;1.42E-19;CX6A1_MOUSE;Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver);"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005739; GO:0005751; GO:0006123; GO:0009060; GO:0030234; GO:0043209";"aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]"
comp1815182_c0_seq1;GAXK01194241.1;P53184;6.58E-13;PNC1_YEAST;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; replicative cell aging [GO:0001302]";"GO:0000183; GO:0000781; GO:0001302; GO:0005634; GO:0005737; GO:0005777; GO:0006348; GO:0008936; GO:0019358; GO:0046872; GO:1904524";"chromatin silencing at rDNA [GO:0000183]; chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; replicative cell aging [GO:0001302]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp18154_c0_seq1;GAXK01026100.1;P70236;5.42E-142;MP2K6_MOUSE;Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (SAPKK3);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000165; GO:0000187; GO:0001934; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006915; GO:0019901; GO:0022602; GO:0023014; GO:0031098; GO:0032147; GO:0032308; GO:0042493; GO:0042802; GO:0043065; GO:0051770; GO:0060048; GO:0072709; GO:0120163";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp181543_c0_seq1;GAXK01199609.1;Q24742;3.42E-99;TRX_DROVI;Histone-lysine N-methyltransferase trithorax (EC 2.1.1.43);"histone methyltransferase complex [GO:0035097]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0007275; GO:0008270; GO:0035097; GO:0042800; GO:0043565";multicellular organism development [GO:0007275];histone methyltransferase complex [GO:0035097];"DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp181551_c1_seq1;GAXK01199650.1;O74503;4.32E-13;UAF30_SCHPO;Upstream activation factor subunit spp27 (Upstream activation factor 27 KDa subunit) (p27) (Upstream activation factor 30 KDa subunit) (p30) (Upstream activation factor subunit uaf30);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0000500; GO:0001181; GO:0005634; GO:0005829; GO:0006361";transcription initiation from RNA polymerase I promoter [GO:0006361];"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]";RNA polymerase I general transcription initiation factor activity [GO:0001181]
comp181575_c1_seq1;GAXK01199590.1;Q3TZI6;7.22E-10;CCNJ_MOUSE;Cyclin-J;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0016538; GO:0019901; GO:0044772";"mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp18158_c6_seq1;GAXK01026192.1;Q8TAG9;0;EXOC6_HUMAN;Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1);"cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000145; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0030426; GO:0048471; GO:0090543";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]";"cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";
comp181594_c2_seq1;GAXK01199576.1;P37111;1.13E-147;ACY1_PIG;Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase);"cytoplasm [GO:0005737]; aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520]";"GO:0004046; GO:0005737; GO:0006520; GO:0008237; GO:0046872";cellular amino acid metabolic process [GO:0006520];cytoplasm [GO:0005737];"aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp1816205_c0_seq1;GAXK01131116.1;Q7ZVG6;2.76E-14;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1816444_c0_seq1;GAXK01131133.1;O65731;3.70E-80;RS5_CICAR;40S ribosomal protein S5 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp18166_c0_seq1;GAXK01026726.1;Q16537;0;2A5E_HUMAN;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B'-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]";"GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0019888; GO:0031952; GO:0072542";"protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";"protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]"
comp1816796_c0_seq1;GAXK01131139.1;P21902;2.32E-43;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1816839_c0_seq1;GAXK01131135.1;Q9VZW5;2.93E-24;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp181691_c7_seq1;GAXK01199781.1;Q8T3Y0;7.91E-08;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp181785_c5_seq1;GAXK01199786.1;Q5F371;4.66E-135;SBNO1_CHICK;Protein strawberry notch homolog 1;"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];
comp181791_c1_seq1;GAXK01199598.1;B4F785;3.34E-17;EGFLA_RAT;Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein);"basement membrane [GO:0005604]; cell junction [GO:0030054]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005509; GO:0005604; GO:0009887; GO:0009888; GO:0016477; GO:0030054; GO:0034446; GO:0045202";"animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; synapse [GO:0045202]";calcium ion binding [GO:0005509]
comp1817970_c0_seq1;GAXK01131114.1;Q7PPU9;6.49E-75;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1818397_c0_seq1;GAXK01008506.1;Q14BI2;7.72E-21;GRM2_MOUSE;Metabotropic glutamate receptor 2 (mGluR2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0051966; GO:0090461; GO:0099055";"chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]";"calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp18186_c0_seq1;GAXK01026473.1;P48758;2.57E-31;CBR1_MOUSE;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0016655; GO:0017144; GO:0042373; GO:0043231; GO:0047021; GO:0050221; GO:0055114";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"
comp1818600_c0_seq1;GAXK01008490.1;Q86WA9;4.54E-12;S2611_HUMAN;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062";"ion transport [GO:0006811]; sulfate transport [GO:0008272]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp181886_c0_seq1;GAXK01199637.1;Q28824;1.18E-86;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp1818982_c0_seq1;GAXK01008502.1;O73874;7.93E-14;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp1819089_c0_seq1;GAXK01008498.1;Q9SRU2;1.40E-10;BIG_ARATH;Auxin transport protein BIG (Protein ATTENUATED SHADE AVOIDANCE 1) (Protein CORYMBOSA1) (Protein DARK OVER-EXPRESSION OF CAB 1) (Protein LOW PHOSPHATE-RESISTANT ROOT 1) (Protein TRANSPORT INHIBITOR RESPONSE 3) (Protein UMBRELLA 1);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasmodesma [GO:0009506]; zinc ion binding [GO:0008270]; auxin polar transport [GO:0009926]; auxin-activated signaling pathway [GO:0009734]; inflorescence morphogenesis [GO:0048281]; lateral root formation [GO:0010311]; photomorphogenesis [GO:0009640]; response to auxin [GO:0009733]; response to fungus [GO:0009620]; root development [GO:0048364]; unidimensional cell growth [GO:0009826]";"GO:0005829; GO:0008270; GO:0009506; GO:0009620; GO:0009640; GO:0009733; GO:0009734; GO:0009826; GO:0009926; GO:0010311; GO:0016020; GO:0016021; GO:0048281; GO:0048364";"auxin-activated signaling pathway [GO:0009734]; auxin polar transport [GO:0009926]; inflorescence morphogenesis [GO:0048281]; lateral root formation [GO:0010311]; photomorphogenesis [GO:0009640]; response to auxin [GO:0009733]; response to fungus [GO:0009620]; root development [GO:0048364]; unidimensional cell growth [GO:0009826]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasmodesma [GO:0009506]";zinc ion binding [GO:0008270]
comp1819354_c0_seq1;GAXK01008504.1;Q0IUU4;4.43E-18;CML2_ORYSJ;Putative calmodulin-like protein 2;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp181966_c2_seq1;GAXK01199641.1;Q96LW9;1.13E-12;ZSC31_HUMAN;Zinc finger and SCAN domain-containing protein 31 (Zinc finger protein 323);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1819706_c0_seq1;GAXK01008507.1;Q65XV7;3.35E-10;RFA1C_ORYSJ;Replication protein A 70 kDa DNA-binding subunit C (OsRPA70c) (Replication factor A protein 1C) (Replication protein A 1C);"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; damaged DNA binding [GO:0003684]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005662; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0008270; GO:0043047; GO:0043565; GO:0051321";"DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]";"damaged DNA binding [GO:0003684]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; zinc ion binding [GO:0008270]"
comp18198_c0_seq1;GAXK01026893.1;Q66JF3;1.79E-104;MKNK1_XENTR;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp182002_c1_seq1;GAXK01064024.1;Q68EA5;3.44E-24;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1820132_c0_seq1;GAXK01205137.1;Q9VGH1;8.62E-59;CP315_DROME;Cytochrome P450 315a1, mitochondrial (EC 1.14.99.-) (CYPCCCXVA1) (Protein shadow);"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ecdysteroid 2-hydroxylase activity [GO:0042768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]; motor neuron axon guidance [GO:0008045]";"GO:0005506; GO:0005739; GO:0006697; GO:0007391; GO:0007417; GO:0007494; GO:0008045; GO:0008258; GO:0016705; GO:0020037; GO:0031966; GO:0042768";"central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]; motor neuron axon guidance [GO:0008045]";"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"ecdysteroid 2-hydroxylase activity [GO:0042768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp182035_c1_seq1;GAXK01064129.1;P45478;6.00E-80;PPT1_BOVIN;Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1);"axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; brain development [GO:0007420]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007399; GO:0007420; GO:0008021; GO:0008474; GO:0015031; GO:0016042; GO:0016290; GO:0030308; GO:0030424; GO:0031579; GO:0043066; GO:0043524; GO:0045121; GO:0048260; GO:0048549; GO:0051181; GO:0051186";"brain development [GO:0007420]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]";"palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp1820398_c0_seq1;GAXK01034037.1;Q8JZL0;5.13E-09;ZN467_MOUSE;Zinc finger protein 467 (Endothelial cell-derived zinc finger protein) (EZI);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1820574_c0_seq1;GAXK01034035.1;O60669;1.98E-14;MOT2_HUMAN;Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]";"GO:0005477; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035873; GO:0050833; GO:1901475";"lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]"
comp182065_c0_seq1;GAXK01064323.1;Q6ETN3;2.32E-14;4CL3_ORYSJ;Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp18208_c0_seq1;GAXK01027032.1;P57721;1.05E-55;PCBP3_HUMAN;Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]";"GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829";mRNA metabolic process [GO:0016071];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp182097_c5_seq1;GAXK01064154.1;Q14590;1.39E-11;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp182098_c0_seq1;GAXK01064074.1;P35038;8.32E-32;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp182106_c0_seq1;GAXK01064288.1;Q4TU93;5.47E-13;MRC2_RAT;C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; endocytosis [GO:0006897]";"GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp182160_c0_seq1;GAXK01064134.1;Q9UBB5;9.53E-07;MBD2_HUMAN;Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2);"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"GO:0000118; GO:0000122; GO:0000183; GO:0000790; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0034622; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0043044; GO:0044030; GO:0045892; GO:0048568; GO:0070742; GO:0071407";"aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]"
comp1821699_c0_seq1;GAXK01034055.1;Q02357;5.20E-08;ANK1_MOUSE;Ankyrin-1 (ANK-1) (Erythrocyte ankyrin);"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0043194; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]"
comp1821729_c0_seq1;GAXK01034034.1;Q7SY29;8.04E-84;G6PT3_DANRE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp18219_c0_seq1;GAXK01026355.1;Q9VAU9;1.60E-124;ZN330_DROME;Zinc finger protein 330 homolog (Nucleolar autoantigen 36 homolog);"chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]; larval lymph gland hemopoiesis [GO:0035167]";"GO:0000775; GO:0005730; GO:0008270; GO:0030496; GO:0035167";larval lymph gland hemopoiesis [GO:0035167];"chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]";zinc ion binding [GO:0008270]
comp1822_c0_seq1;GAXK01166365.1;O18373;0;SPS1_DROME;Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";"GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0007049; GO:0007275; GO:0010637; GO:0016260; GO:0070329; GO:2000378";"cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]"
comp182227_c0_seq1;GAXK01064263.1;Q5RCB7;5.00E-44;SHCAF_PONAB;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp1822279_c0_seq1;GAXK01069296.1;Q9BSG1;1.23E-21;ZNF2_HUMAN;Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp1822381_c0_seq1;GAXK01069295.1;Q8I7D9;1.26E-21;SC61G_CIOIN;Protein transport protein Sec61 subunit gamma;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein targeting [GO:0006605]";"GO:0005789; GO:0006605; GO:0015450; GO:0016021";protein targeting [GO:0006605];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]
comp1822650_c0_seq1;GAXK01069287.1;B3N8M1;7.32E-13;LPHN_DROER;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp18227_c0_seq1;GAXK01027027.1;A4QNF3;7.01E-19;ROMO1_XENTR;Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]";"GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379";"cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]";"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";
comp182272_c0_seq1;GAXK01064094.1;Q9CZJ0;1.54E-32;MPPD2_MOUSE;Metallophosphoesterase MPPED2 (EC 3.1.-.-) (Metallophosphoesterase domain-containing protein 2);"AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]";"GO:0008081; GO:0016208; GO:0019002; GO:0030145";;;"AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]"
comp1823071_c0_seq1;GAXK01069299.1;B2RY50;8.55E-136;ARMC4_MOUSE;Armadillo repeat-containing protein 4;"axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]";"GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]";"axoneme [GO:0005930]; ciliary base [GO:0097546]";
comp1823289_c0_seq1;GAXK01069290.1;P18735;1.72E-19;ZG7_XENLA;Gastrula zinc finger protein XlCGF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp182332_c2_seq1;GAXK01064014.1;Q7LBC6;3.35E-45;KDM3B_HUMAN;Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA);"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718";"histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1823706_c0_seq1;GAXK01069283.1;Q4R495;9.22E-11;MFS11_MACFA;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1823720_c0_seq1;GAXK01069285.1;Q96JL9;4.21E-18;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1824019_c0_seq1;GAXK01152591.1;Q9UDV7;3.48E-14;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp182402_c1_seq1;GAXK01064261.1;Q5EBP3;1.27E-25;ARMC5_MOUSE;Armadillo repeat-containing protein 5;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005737; GO:0005829; GO:0005925";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]";
comp182407_c2_seq1;GAXK01064292.1;P52013;4.86E-19;CYP5_CAEEL;Peptidyl-prolyl cis-trans isomerase 5 (PPIase 5) (EC 5.2.1.8) (Cyclophilin-5) (Rotamase 5);"cytoplasm [GO:0005737]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"GO:0000413; GO:0003755; GO:0005737; GO:0016018; GO:0042026; GO:0051082";"protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";cytoplasm [GO:0005737];"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp182411_c1_seq1;GAXK01064149.1;Q9DBT9;0;M2GD_MOUSE;Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]";"GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0035999; GO:0042426; GO:0047865; GO:0050660";"amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]"
comp18245_c1_seq1;GAXK01026879.1;P27541;2.01E-92;HSP70_BRUMA;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp1824586_c0_seq1;GAXK01152595.1;C3RZA1;1.17E-09;SMYD2_PIG;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp1824792_c0_seq1;GAXK01152603.1;Q28824;5.01E-15;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp182480_c0_seq1;GAXK01064131.1;P94409;1.84E-22;YCLG_BACSU;Uncharacterized protein YclG;;;;;
comp182488_c1_seq1;GAXK01064098.1;P54315;7.21E-67;LIPR1_HUMAN;Inactive pancreatic lipase-related protein 1 (PL-RP1);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]";"GO:0004806; GO:0005509; GO:0005576; GO:0006629";lipid metabolic process [GO:0006629];extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; triglyceride lipase activity [GO:0004806]"
comp1824975_c0_seq2;GAXK01152598.1;G5EEY6;1.82E-10;ZIG3_CAEEL;Zwei Ig domain protein zig-3 (2 Ig domain protein zig-3);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0005576; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp1825016_c0_seq1;GAXK01152607.1;Q235M8;7.33E-107;RL10_TETTS;60S ribosomal protein L10;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1825017_c0_seq1;GAXK01152592.1;B4M9A8;2.27E-12;RAD54_DROVI;DNA repair and recombination protein RAD54-like (EC 3.6.4.-) (Protein okra);"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic DNA repair synthesis [GO:0000711]; oocyte fate determination [GO:0030716]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";"GO:0000711; GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006338; GO:0007131; GO:0010212; GO:0030716; GO:0043150; GO:0045003; GO:0048477; GO:0051301";"cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic DNA repair synthesis [GO:0000711]; oocyte fate determination [GO:0030716]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]"
comp182512_c0_seq1;GAXK01064109.1;Q6ZUJ8;6.83E-09;BCAP_HUMAN;Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1);"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]";"GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727; GO:0051897";"positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]";"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]"
comp18252_c0_seq1;GAXK01026194.1;Q9Y333;7.19E-61;LSM2_HUMAN;U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0017070; GO:0017160; GO:0043928; GO:0046540; GO:0071005; GO:0071013; GO:0120115; GO:1990726";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";"Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]"
comp1825529_c0_seq1;GAXK01152609.1;Q23G98;2.39E-40;RL37A_TETTS;60S ribosomal protein L37a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1825665_c0_seq1;GAXK01152600.1;Q01650;1.27E-20;LAT1_HUMAN;Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter);"amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; peptide antigen binding [GO:0042605]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-tryptophan transmembrane transport [GO:1904556]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]";"GO:0005765; GO:0005829; GO:0005886; GO:0015171; GO:0015179; GO:0015190; GO:0015196; GO:0015804; GO:0016020; GO:0016021; GO:0016324; GO:0042605; GO:0043231; GO:0050900; GO:0070062; GO:1902475; GO:1904556; GO:1990184";"L-alpha-amino acid transmembrane transport [GO:1902475]; leukocyte migration [GO:0050900]; L-tryptophan transmembrane transport [GO:1904556]; neutral amino acid transport [GO:0015804]";"amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; peptide antigen binding [GO:0042605]"
comp1825834_c0_seq1;GAXK01152589.1;Q14679;8.75E-77;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp182598_c2_seq1;GAXK01064123.1;Q9Y2I7;1.05E-85;FYV1_HUMAN;1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase);"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000139; GO:0000285; GO:0005524; GO:0005829; GO:0005911; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0031901; GO:0031902; GO:0032288; GO:0034504; GO:0035556; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:1904562; GO:2000785";"intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]";"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]";"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; zinc ion binding [GO:0008270]"
comp1826008_c0_seq1;GAXK01142741.1;Q5R5L7;1.23E-29;ARRD3_PONAB;Arrestin domain-containing protein 3;"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"GO:0005764; GO:0005769; GO:0005886";;"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";
comp182628_c0_seq1;GAXK01064322.1;Q9VAS7;4.22E-09;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp1826372_c0_seq1;GAXK01142740.1;Q7RTU5;1.07E-12;ASCL5_HUMAN;Achaete-scute homolog 5 (ASH-5) (hASH5) (Class A basic helix-loop-helix protein 47) (bHLHa47);"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0008134; GO:0045944; GO:0046983; GO:0090575";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp182645_c0_seq1;GAXK01064330.1;P39769;3.10E-10;PHP_DROME;Polyhomeotic-proximal chromatin protein;"nucleolus [GO:0005730]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; central nervous system neuron development [GO:0021954]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell stalk formation [GO:0030713]; response to ecdysone [GO:0035075]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"GO:0000070; GO:0003677; GO:0003682; GO:0005634; GO:0005730; GO:0008270; GO:0016458; GO:0021954; GO:0030708; GO:0030713; GO:0035075; GO:0035102; GO:0035186; GO:0043565; GO:0044547; GO:0045892; GO:0051087";"central nervous system neuron development [GO:0021954]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell stalk formation [GO:0030713]; response to ecdysone [GO:0035075]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]";"chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp182671_c0_seq1;GAXK01064132.1;Q20140;8.37E-41;KAD1_CAEEL;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase);"cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0006172; GO:0009142; GO:0046033; GO:0046034";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside triphosphate biosynthetic process [GO:0009142]";cytoplasm [GO:0005737];"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp182686_c0_seq1;GAXK01064304.1;A2RT62;3.07E-143;FXL16_MOUSE;F-box/LRR-repeat protein 16 (F-box and leucine-rich repeat protein 16);"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005737; GO:0006511; GO:0016567; GO:0019005; GO:0031146";"protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp18269_c2_seq1;GAXK01026627.1;Q54TR1;3.66E-50;CFAD_DICDI;Counting factor associated protein D;"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0030435; GO:0031288; GO:0031410; GO:0051603; GO:0072659; GO:1903665; GO:1903669";"negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp1826992_c0_seq1;GAXK01142761.1;Q80W49;3.03E-07;CRBG3_MOUSE;Beta/gamma crystallin domain-containing protein 3;"protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]";"GO:0002088; GO:0005212; GO:0007601; GO:0030246; GO:0032991; GO:0051018";"lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]";protein-containing complex [GO:0032991];"carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]"
comp1827022_c0_seq1;GAXK01142747.1;Q7PEV7;3.56E-43;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp1827681_c0_seq1;GAXK01142759.1;Q6CJK6;8.71E-24;APTH1_KLULA;Acyl-protein thioesterase 1 (EC 3.1.2.-);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein deacylation [GO:0035601]";"GO:0005737; GO:0006631; GO:0008474; GO:0035601; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein deacylation [GO:0035601]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp182795_c0_seq1;GAXK01064283.1;A7X3Y2;4.68E-09;LECM6_PSEPL;C-type lectin lectoxin-Enh6 (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]";"GO:0005576; GO:0030246; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp18280_c1_seq1;GAXK01026163.1;B1H2N3;2.36E-37;MICU1_XENTR;Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog);"integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0051560; GO:0051561; GO:0070509; GO:1990246";"calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]";calcium ion binding [GO:0005509]
comp1828004_c0_seq1;GAXK01068555.1;P33124;2.37E-47;ACSL6_RAT;Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6) (Long-chain-fatty-acid--CoA ligase, brain isozyme);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein homodimerization activity [GO:0042803]; cellular response to insulin stimulus [GO:0032869]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuron development [GO:0048666]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; triglyceride biosynthetic process [GO:0019432]";"GO:0001666; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005634; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0007584; GO:0008654; GO:0009629; GO:0010747; GO:0010976; GO:0015908; GO:0016021; GO:0019432; GO:0032869; GO:0035338; GO:0042803; GO:0047676; GO:0048545; GO:0048666; GO:0102391";"cellular response to insulin stimulus [GO:0032869]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuron development [GO:0048666]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein homodimerization activity [GO:0042803]"
comp1828007_c0_seq1;GAXK01068567.1;Q29NC4;1.04E-26;CBPA1_DROPS;Zinc carboxypeptidase A 1 (EC 3.4.17.-);"extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005615; GO:0008270";;extracellular space [GO:0005615];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp182803_c4_seq1;GAXK01064282.1;B2D0J5;3.64E-75;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp182821_c0_seq1;GAXK01064112.1;P18756;4.77E-59;ETS1B_XENLA;Protein c-ets-1-B (C-ets-1B) (XE1-B) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";"GO:0003700; GO:0005634; GO:0010595; GO:0043565; GO:0045765";"positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp18285_c0_seq1;GAXK01026724.1;Q4FZQ0;6.99E-56;YF1BB_XENLA;Protein YIF1B-B (YIP1-interacting factor homolog B-B);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]";"GO:0005789; GO:0006888; GO:0016021";endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1828630_c0_seq1;GAXK01068562.1;Q06496;2.49E-119;NPT2A_RAT;Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; protein homooligomerization [GO:0051260]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to parathyroid hormone [GO:0071107]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350]";"GO:0001503; GO:0001822; GO:0005436; GO:0005768; GO:0005886; GO:0005903; GO:0007584; GO:0009100; GO:0009986; GO:0010288; GO:0015321; GO:0016021; GO:0016324; GO:0016607; GO:0030165; GO:0030643; GO:0031226; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035435; GO:0035864; GO:0042431; GO:0042493; GO:0042803; GO:0043434; GO:0044341; GO:0044877; GO:0045121; GO:0045838; GO:0046686; GO:0046689; GO:0048471; GO:0051260; GO:0060416; GO:0071107; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901128; GO:1901652; GO:1901684; GO:2000120; GO:2000187";"arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; protein homooligomerization [GO:0051260]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to parathyroid hormone [GO:0071107]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium-dependent phosphate transport [GO:0044341]; sodium ion import across plasma membrane [GO:0098719]; tricarboxylic acid metabolic process [GO:0072350]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]"
comp182870_c1_seq1;GAXK01064022.1;Q9GLG2;6.63E-122;CAN1_MACFA;Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Micromolar-calpain) (muCANP);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0005886; GO:0006508";proteolysis [GO:0006508];"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp182878_c0_seq1;GAXK01064091.1;Q4VBS4;4.79E-56;MAP12_DANRE;Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D);"mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]";"GO:0005739; GO:0046872; GO:0070006; GO:0070084";protein initiator methionine removal [GO:0070084];mitochondrion [GO:0005739];"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp1829044_c1_seq1;GAXK01068552.1;Q9WWW2;1.55E-64;ALKJ_PSEPU;Alcohol dehydrogenase [acceptor] (EC 1.1.99.-);"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005886; GO:0016614; GO:0050660";;plasma membrane [GO:0005886];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp1829121_c0_seq1;GAXK01068572.1;P42324;1.96E-33;HPCL1_CHICK;Hippocalcin-like protein 1 (Protein Rem-1);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp182935_c0_seq1;GAXK01064026.1;P21461;3.73E-08;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp182968_c1_seq1;GAXK01064255.1;O95342;0;ABCBB_HUMAN;Bile salt export pump (EC 7.6.2.-) (ATP-binding cassette sub-family B member 11);"apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; canalicular bile acid transport [GO:0015722]";"GO:0005215; GO:0005524; GO:0005886; GO:0005887; GO:0006699; GO:0008554; GO:0015126; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0045177; GO:0046581; GO:0070062";"bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; canalicular bile acid transport [GO:0015722]";"apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]"
comp182992_c1_seq1;GAXK01064270.1;Q7KRI2;2.39E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp183_c0_seq1;GAXK01166367.1;Q9VZS5;1.65E-36;RL28_DROME;60S ribosomal protein L28;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp1830_c0_seq1;GAXK01166144.1;Q8R066;1.53E-07;C1QT4_MOUSE;Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]";"GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778";"positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]";extracellular space [GO:0005615];cytokine activity [GO:0005125]
comp183005_c0_seq1;GAXK01064305.1;Q5RDY7;4.07E-165;GNB5_PONAB;Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5);"membrane [GO:0016020]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]";"GO:0007212; GO:0016020; GO:0031682; GO:0051087; GO:1901386";"dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]";membrane [GO:0016020];"chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]"
comp18301_c2_seq1;GAXK01026066.1;P49453;2.58E-07;CENPC_SHEEP;Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Fragment);"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]";"GO:0000278; GO:0000776; GO:0000777; GO:0005634; GO:0005721; GO:0007059; GO:0019237; GO:0051301; GO:0051382";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]";"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]";centromeric DNA binding [GO:0019237]
comp1830172_c0_seq1;GAXK01080801.1;P83118;1.72E-08;MTH11_DROME;Probable G-protein coupled receptor Mth-like 11 (Protein methuselah-like 11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp18304_c5_seq1;GAXK01026956.1;Q02440;0;MYO5A_CHICK;Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain p190) (Myosin-V);"filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0000146; GO:0005516; GO:0005524; GO:0016192; GO:0016459; GO:0031941; GO:0032593; GO:0032869; GO:0051015; GO:0060001; GO:0072659";"cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]";"filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]"
comp18305_c0_seq1;GAXK01026307.1;O08658;1.64E-58;NUP88_RAT;Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup84) (Nucleoporin Nup88);"nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]";"GO:0000055; GO:0000056; GO:0000278; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056";"mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]";"nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";structural constituent of nuclear pore [GO:0017056]
comp183056_c0_seq1;GAXK01064285.1;Q17QH8;3.51E-39;D39U1_BOVIN;Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1);"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0050662";;;"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]"
comp1830695_c0_seq1;GAXK01080806.1;Q93WD2;1.72E-17;CB29_CHLRE;Chlorophyll a-b binding protein CP29 (Lhcbm4);"integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; thylakoid light-harvesting complex [GO:0009503]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009503; GO:0009522; GO:0009523; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; thylakoid light-harvesting complex [GO:0009503]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp183077_c0_seq1;GAXK01064003.1;Q5T619;5.01E-18;ZN648_HUMAN;Zinc finger protein 648;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp183118_c1_seq1;GAXK01064268.1;P59055;4.17E-22;CSRN3_MOUSE;Cysteine/serine-rich nuclear protein 3 (CSRNP-3) (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2) (TAIP-2);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0043065; GO:0043565; GO:0045944";"apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp183121_c2_seq1;GAXK01064117.1;Q6GWX0;8.38E-14;DDX4_PIG;Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog) (Vasa-like protein);"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp1831363_c0_seq1;GAXK01080800.1;B2GV17;8.40E-24;CBPC5_RAT;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0045171; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp183139_c0_seq1;GAXK01064118.1;P18173;1.92E-155;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp18321_c0_seq1;GAXK01026736.1;P62958;1.18E-51;HINT1_BOVIN;Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (17 kDa inhibitor of protein kinase C) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1);"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000118; GO:0000166; GO:0005737; GO:0006355; GO:0009154; GO:0016787; GO:0072332";"intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]";"hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]"
comp183219_c0_seq1;GAXK01064284.1;Q05193;0;DYN1_HUMAN;Dynamin-1 (EC 3.6.5.5);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"GO:0001917; GO:0002031; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0006898; GO:0007032; GO:0008017; GO:0008021; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0017124; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0031749; GO:0042802; GO:0043196; GO:0043197; GO:0044327; GO:0044877; GO:0045202; GO:0045211; GO:0048013; GO:0050803; GO:0050804; GO:0050998; GO:0070062; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1900244; GO:1901998; GO:1904645";"endocytosis [GO:0006897]; endosome organization [GO:0007032]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]";"D2 dopamine receptor binding [GO:0031749]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp1832205_c0_seq1;GAXK01180026.1;P42787;4.26E-43;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp1832417_c0_seq2;GAXK01180021.1;P0DJ23;2.34E-32;RL34_TETTS;60S ribosomal protein L34;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp18328_c0_seq1;GAXK01026940.1;Q6PFL6;5.74E-11;CCD43_DANRE;Coiled-coil domain-containing protein 43;;;;;
comp1832915_c0_seq1;GAXK01180044.1;Q8WPA2;1.02E-35;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp183317_c2_seq1;GAXK01064287.1;Q99NB1;0;ACS2L_MOUSE;Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]";"GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218";"acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]"
comp1833407_c0_seq1;GAXK01180025.1;Q9Y232;8.83E-09;CDYL_HUMAN;Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-);"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0007283; GO:0007286; GO:0016607; GO:0030674; GO:0035064; GO:0060816; GO:0120092; GO:0120094";"negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]"
comp183343_c0_seq1;GAXK01064289.1;Q8VIG1;1.87E-07;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp183378_c0_seq1;GAXK01064113.1;Q01295;2.76E-24;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp183381_c0_seq1;GAXK01064081.1;Q5D1D6;1.51E-96;GBP1_CHLAE;Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607";"defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp183394_c0_seq1;GAXK01064130.1;Q9PWH2;3.11E-95;FZD10_CHICK;Frizzled-10 (Fz-10) (cFz-10);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; non-canonical Wnt signaling pathway [GO:0035567]";"GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0017147; GO:0035567; GO:0042813; GO:0060070";"canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; non-canonical Wnt signaling pathway [GO:0035567]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp183444_c1_seq1;GAXK01064110.1;Q9EPR2;1.30E-14;PG12A_MOUSE;Group XIIA secretory phospholipase A2 (GXII sPLA2) (sPLA2-XII) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 12A);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005509; GO:0005576; GO:0005737; GO:0005783; GO:0005794; GO:0006644; GO:0016042; GO:0050482; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp183445_c0_seq1;GAXK01064025.1;Q0VD59;3.71E-12;MARH8_BOVIN;E3 ubiquitin-protein ligase MARCH8 (EC 2.3.2.27) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING-type E3 ubiquitin transferase MARCH8);"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]";"GO:0002250; GO:0004842; GO:0005764; GO:0005765; GO:0005768; GO:0008270; GO:0016021; GO:0030659; GO:0031901";adaptive immune response [GO:0002250];"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp183446_c0_seq1;GAXK01064096.1;B2D0J5;3.13E-73;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp18347_c2_seq1;GAXK01027110.1;Q9Z1G4;0;VPP1_MOUSE;V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]";"GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998";"regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp1834728_c0_seq1;GAXK01075644.1;P20693;3.10E-10;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp183517_c1_seq1;GAXK01205370.1;Q24537;2.86E-13;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp1835315_c0_seq1;GAXK01075655.1;Q9ULL8;3.91E-22;SHRM4_HUMAN;Protein Shroom4 (Second homolog of apical protein);"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"GO:0001725; GO:0005737; GO:0005884; GO:0005912; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0045159; GO:0050890; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; myosin II binding [GO:0045159]"
comp18355_c0_seq1;GAXK01027051.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp1835597_c0_seq1;GAXK01075654.1;A8MPY1;5.12E-15;GBRR3_HUMAN;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]"
comp18356_c1_seq1;GAXK01026931.1;Q7SYL3;1.62E-08;SIAH2_DANRE;E3 ubiquitin-protein ligase Siah2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2-like) (Siah-2);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007093; GO:0007275; GO:0008270; GO:0031624; GO:0042752; GO:0043161; GO:0048511; GO:0061630";"mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp1835721_c0_seq1;GAXK01075639.1;B7Z031;5.51E-44;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp18361_c0_seq1;GAXK01026475.1;Q7Z7K0;1.95E-13;COXM1_HUMAN;COX assembly mitochondrial protein homolog (Cmc1p);"mitochondrion [GO:0005739]; metal ion binding [GO:0046872]";"GO:0005739; GO:0046872";;mitochondrion [GO:0005739];metal ion binding [GO:0046872]
comp1836364_c0_seq1;GAXK01000625.1;Q60716;3.77E-28;P4HA2_MOUSE;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; procollagen-proline 4-dioxygenase complex [GO:0016222]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0016222; GO:0016702; GO:0018401; GO:0031418; GO:0043231";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp183642_c2_seq1;GAXK01064325.1;P41181;1.46E-57;AQP2_HUMAN;Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lumenal side of membrane [GO:0098576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transport vesicle membrane [GO:0030658]; glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; glycerol transport [GO:0015793]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; water transport [GO:0006833]";"GO:0003091; GO:0003097; GO:0005372; GO:0005794; GO:0005886; GO:0005887; GO:0006833; GO:0015168; GO:0015250; GO:0015793; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030658; GO:0042631; GO:0051289; GO:0055037; GO:0070062; GO:0071280; GO:0071288; GO:0072205; GO:0098576";"cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; glycerol transport [GO:0015793]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; water transport [GO:0006833]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lumenal side of membrane [GO:0098576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transport vesicle membrane [GO:0030658]";"glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]"
comp183686_c1_seq1;GAXK01064138.1;O96017;3.56E-76;CHK2_HUMAN;Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"GO:0000077; GO:0000086; GO:0001302; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:0090399; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210";"cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]"
comp183693_c0_seq1;GAXK01064274.1;Q9NRF9;2.54E-32;DPOE3_HUMAN;DNA polymerase epsilon subunit 3 (EC 2.7.7.7) (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone H3 acetylation [GO:0043966]; nucleosome mobilization [GO:0042766]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005671; GO:0006260; GO:0006270; GO:0006974; GO:0008622; GO:0032201; GO:0034080; GO:0042766; GO:0043966; GO:0046982; GO:0070869; GO:0071480";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone H3 acetylation [GO:0043966]; nucleosome mobilization [GO:0042766]; telomere maintenance via semi-conservative replication [GO:0032201]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]"
comp1837225_c0_seq1;GAXK01000640.1;Q4R4R6;2.11E-64;CDC42_MACFA;Cell division control protein 42 homolog (EC 3.6.5.2);"cytoplasm [GO:0005737]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle midzone [GO:0051233]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin filament organization [GO:0007015]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0006911; GO:0007015; GO:0007264; GO:0007399; GO:0016020; GO:0030154; GO:0030496; GO:0031258; GO:0032467; GO:0051233; GO:0051489; GO:0051988; GO:0072686; GO:1900026";"actin filament organization [GO:0007015]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; small GTPase mediated signal transduction [GO:0007264]";"cytoplasm [GO:0005737]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle midzone [GO:0051233]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp18373_c0_seq1;GAXK01026518.1;Q28719;2.53E-82;PTGR1_RABIT;Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (ADRAB-F) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74);"cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]";"GO:0005737; GO:0032440; GO:0036132; GO:0047522";;cytoplasm [GO:0005737];"13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]"
comp1837540_c0_seq1;GAXK01000654.1;A6QLM0;1.06E-94;TM189_BOVIN;Transmembrane protein 189;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp1837611_c0_seq1;GAXK01000649.1;P52746;1.14E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp183763_c0_seq1;GAXK01064115.1;Q8NBN7;1.73E-85;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp183781_c2_seq1;GAXK01064106.1;Q6P4H8;3.23E-60;ACKMT_HUMAN;ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (hFAM173B);"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]";"GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706";"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]";"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]";protein-lysine N-methyltransferase activity [GO:0016279]
comp183830_c2_seq1;GAXK01064141.1;Q0VBY7;2.80E-16;DJC24_BOVIN;DnaJ homolog subfamily C member 24 (CSL-type zinc finger-containing protein 3) (Diphthamide biosynthesis protein 4);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATPase activator activity [GO:0001671]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270]; oxidation-reduction process [GO:0055114]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; positive regulation of ATPase activity [GO:0032781]";"GO:0001671; GO:0005737; GO:0005856; GO:0008198; GO:0008270; GO:0017183; GO:0032781; GO:0055114";"oxidation-reduction process [GO:0055114]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; positive regulation of ATPase activity [GO:0032781]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"ATPase activator activity [GO:0001671]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270]"
comp183855_c0_seq1;GAXK01064097.1;Q5FWN8;1.85E-28;DNJ6A_XENLA;DnaJ homolog subfamily B member 6-A;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp1838571_c0_seq1;GAXK01058497.1;Q96GW7;5.07E-14;PGCB_HUMAN;Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0098978";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp1838596_c0_seq1;GAXK01058470.1;P50428;1.01E-100;ARSA_MOUSE;Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597";"autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]"
comp1839_c0_seq1;GAXK01166146.1;P25788;1.36E-127;PSA3_HUMAN;Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]"
comp183900_c0_seq1;GAXK01064137.1;Q6GQD5;3.77E-34;RN146_XENLA;E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146);"cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp18393_c0_seq1;GAXK01026666.1;Q01406;4.31E-19;SRC8_CHICK;Src substrate protein p85 (Cortactin) (p80);"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]";"GO:0001726; GO:0002102; GO:0005783; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097581";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]";"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]";actin filament binding [GO:0051015]
comp1839499_c0_seq1;GAXK01058483.1;A2BGU9;7.38E-09;SERHL_DANRE;Serine hydrolase-like protein (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]";"GO:0004377; GO:0005789; GO:0016787";;endoplasmic reticulum membrane [GO:0005789];"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]"
comp183962_c0_seq1;GAXK01064128.1;Q8GZ43;3.64E-07;YZR3_ARATH;RanBP2-type zinc finger protein At1g67325;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]";"GO:0003729; GO:0046872";;;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp183977_c0_seq1;GAXK01064099.1;Q5M8Z0;4.40E-117;BHMT1_XENTR;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";"GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0047150";"amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";cytoplasm [GO:0005737];"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp18398_c1_seq1;GAXK01026480.1;P22674;2.05E-32;CCNO_HUMAN;Cyclin-O;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cilium assembly [GO:0060271]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; multi-ciliated epithelial cell differentiation [GO:1903251]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to drug [GO:0042493]";"GO:0000079; GO:0000278; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0016538; GO:0019901; GO:0042493; GO:0044772; GO:0051301; GO:0060271; GO:1903251";"cell division [GO:0051301]; cilium assembly [GO:0060271]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; multi-ciliated epithelial cell differentiation [GO:1903251]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to drug [GO:0042493]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp184010_c3_seq1;GAXK01105328.1;O75521;4.56E-81;ECI2_HUMAN;Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]";"GO:0000062; GO:0004165; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0009062; GO:0016020; GO:0033540; GO:0043231";"fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]"
comp1840378_c0_seq1;GAXK01200953.1;P42519;1.72E-11;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp18405_c3_seq1;GAXK01027120.1;Q9XYN1;1.86E-100;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp184052_c1_seq1;GAXK01105570.1;P57695;8.34E-28;GLRA1_BOVIN;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp184058_c0_seq1;GAXK01105686.1;P23792;6.18E-32;DISC_DROME;Protein disconnected;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; antennal development [GO:0007469]; brain development [GO:0007420]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; leg disc proximal/distal pattern formation [GO:0007479]; locomotor rhythm [GO:0045475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0000977; GO:0003677; GO:0005634; GO:0007420; GO:0007469; GO:0007479; GO:0007601; GO:0007623; GO:0008062; GO:0010468; GO:0045475; GO:0045494; GO:0045893; GO:0045944; GO:0046872; GO:0050896";"antennal development [GO:0007469]; brain development [GO:0007420]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; leg disc proximal/distal pattern formation [GO:0007479]; locomotor rhythm [GO:0045475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp184100_c0_seq1;GAXK01105425.1;B0ZTE2;2.65E-46;SOX14_XENLA;Transcription factor Sox-14 (SRY (sex determining region Y)-box 14);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]";"GO:0000122; GO:0005634; GO:0007399; GO:0043565; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp1841032_c0_seq1;GAXK01200943.1;W4VS53;8.56E-31;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp184153_c2_seq1;GAXK01105431.1;Q1QBB9;1.67E-73;DHMA_PSYCK;Haloalkane dehalogenase (EC 3.8.1.5);haloalkane dehalogenase activity [GO:0018786];GO:0018786;;;haloalkane dehalogenase activity [GO:0018786]
comp184154_c0_seq1;GAXK01105553.1;Q5ND34;5.93E-86;WDR81_MOUSE;WD repeat-containing protein 81;"autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010923; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530";"aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]";"autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]"
comp18417_c0_seq1;GAXK01026359.1;Q7PPU9;5.58E-98;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1842_c0_seq1;GAXK01169211.1;Q17770;0;PDI2_CAEEL;Protein disulfide-isomerase 2 (EC 5.3.4.1) (PDI 1) (Prolyl 4-hydroxylase subunit beta-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; cell redox homeostasis [GO:0045454]; endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0003810; GO:0005783; GO:0005788; GO:0006457; GO:0016222; GO:0018401; GO:0030968; GO:0034976; GO:0043412; GO:0045454; GO:0055114; GO:0080058";"cell redox homeostasis [GO:0045454]; endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
comp184234_c2_seq1;GAXK01105350.1;Q9BE52;2.38E-13;CK5P2_MACFA;CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; neurogenesis [GO:0022008]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007420; GO:0019901; GO:0022008; GO:0031023; GO:0035371; GO:0044212; GO:0045893; GO:0046600; GO:0048471; GO:0090266";"brain development [GO:0007420]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; neurogenesis [GO:0022008]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]";"calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]"
comp18426_c1_seq1;GAXK01026550.1;Q5BK46;1.54E-35;RNH1_RAT;Ribonuclease H1 (RNase H1) (EC 3.1.26.4);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";"GO:0000287; GO:0003676; GO:0004523; GO:0005737; GO:0043137; GO:0090502";"DNA replication, removal of RNA primer [GO:0043137]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp1842723_c0_seq1;GAXK01136407.1;Q6K1J1;5.91E-69;UDB31_CANLF;UDP-glucuronosyltransferase 2B31 (UDPGT 2B31) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]";"GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0043231";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]"
comp1843016_c0_seq1;GAXK01136413.1;Q2TBF2;6.59E-15;WSCD2_HUMAN;WSC domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp1843447_c0_seq1;GAXK01136412.1;Q95V58;5.77E-41;KARG_ARTSF;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp1843609_c0_seq1;GAXK01136426.1;Q9N003;2.16E-18;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp184365_c3_seq1;GAXK01105438.1;Q53G44;3.53E-37;IF44L_HUMAN;Interferon-induced protein 44-like;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005525; GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp184390_c1_seq1;GAXK01105767.1;Q7KRI2;1.57E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp184403_c0_seq1;GAXK01105523.1;Q5FW37;2.41E-25;MTNB_XENTR;Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog);"cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";"GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570";"apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";cytoplasm [GO:0005737];"methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]"
comp184431_c0_seq1;GAXK01105736.1;Q9YH16;7.79E-66;LMO3_XENLA;LIM domain only protein 3 (LMO-3) (LIM domain only protein 1) (LMO-1) (xLMO1);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp184494_c0_seq1;GAXK01105785.1;Q8C3X4;8.81E-66;GUF1_MOUSE;Translation factor Guf1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase Guf1) (Ribosomal back-translocase);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; positive regulation of translation [GO:0045727]; translation [GO:0006412]";"GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727";"positive regulation of translation [GO:0045727]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]"
comp184510_c2_seq1;GAXK01105568.1;Q9V427;1.62E-106;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp1845543_c0_seq1;GAXK01033874.1;Q05481;1.99E-17;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp184557_c0_seq1;GAXK01105745.1;Q9UJU3;3.16E-08;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp184564_c0_seq1;GAXK01105781.1;Q7KRI2;4.75E-35;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1845792_c0_seq1;GAXK01033882.1;O42490;3.25E-22;OPSP_PETMA;Pineal opsin (Pineal gland-specific opsin) (P-opsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp184596_c0_seq1;GAXK01105761.1;Q8WZA0;3.04E-41;LZIC_HUMAN;Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein);"beta-catenin binding [GO:0008013]; response to ionizing radiation [GO:0010212]";"GO:0008013; GO:0010212";response to ionizing radiation [GO:0010212];;beta-catenin binding [GO:0008013]
comp184618_c1_seq1;GAXK01105743.1;Q6DIV6;6.29E-122;VIAAT_XENTR;Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter);"dendrite terminus [GO:0044292]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection terminus [GO:0044306]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; amino acid transmembrane transport [GO:0003333]; neurotransmitter loading into synaptic vesicle [GO:0098700]";"GO:0003333; GO:0015171; GO:0015495; GO:0030285; GO:0044292; GO:0044306; GO:0098700";"amino acid transmembrane transport [GO:0003333]; neurotransmitter loading into synaptic vesicle [GO:0098700]";"dendrite terminus [GO:0044292]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection terminus [GO:0044306]";"amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]"
comp184628_c0_seq1;GAXK01105804.1;Q6DCX5;6.30E-10;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp184658_c2_seq1;GAXK01105307.1;O88554;1.12E-129;PARP2_MOUSE;Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212]";"GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404";"base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]"
comp1846693_c0_seq1;GAXK01199554.1;Q3UQ28;2.23E-08;PXDN_MOUSE;Peroxidasin homolog (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023";"collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1846794_c0_seq1;GAXK01199548.1;P13214;7.78E-19;ANXA4_BOVIN;Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; epithelial cell differentiation [GO:0030855]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007219; GO:0008201; GO:0009986; GO:0016020; GO:0016324; GO:0030246; GO:0030855; GO:0031965; GO:0032088; GO:0035374; GO:0042584; GO:0042802; GO:0048306; GO:0048471; GO:0051059; GO:2000483";"epithelial cell differentiation [GO:0030855]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]"
comp1846838_c0_seq1;GAXK01199547.1;P62263;4.16E-64;RS14_HUMAN;40S ribosomal protein S14 (Small ribosomal subunit protein uS11);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000028; GO:0000122; GO:0000184; GO:0000462; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181";"erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]";"mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]"
comp1846972_c0_seq1;GAXK01199568.1;Q9V576;4.39E-21;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp1847032_c0_seq1;GAXK01199533.1;Q7T019;1.17E-18;DZIP1_DANRE;Zinc finger protein Dzip1 (DAZ-interacting protein 1 homolog) (Iguana protein);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; adenohypophysis development [GO:0021984]; axoneme assembly [GO:0035082]; blood vessel development [GO:0001568]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; heart looping [GO:0001947]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; regulation of smoothened signaling pathway [GO:0008589]; retinal ganglion cell axon guidance [GO:0031290]";"GO:0001568; GO:0001947; GO:0003143; GO:0003676; GO:0005634; GO:0005737; GO:0005814; GO:0006607; GO:0007368; GO:0008589; GO:0021984; GO:0031290; GO:0035082; GO:0036064; GO:0046872; GO:0060271; GO:0061371; GO:0097730; GO:2000223";"adenohypophysis development [GO:0021984]; axoneme assembly [GO:0035082]; blood vessel development [GO:0001568]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; heart looping [GO:0001947]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; regulation of smoothened signaling pathway [GO:0008589]; retinal ganglion cell axon guidance [GO:0031290]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp184707_c0_seq1;GAXK01105764.1;A1ZAY1;7.45E-50;DLISH_DROME;SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains);"apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cadherin binding [GO:0045296]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; protein localization involved in establishment of planar polarity [GO:0090251]";"GO:0001736; GO:0005737; GO:0016327; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251";"establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; protein localization involved in establishment of planar polarity [GO:0090251]";"apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]";cadherin binding [GO:0045296]
comp1847078_c0_seq1;GAXK01199536.1;Q9VYV3;2.05E-17;TXND5_DROME;Thioredoxin domain-containing protein 5 homolog (Protein pretaporter);"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; positive regulation of apoptotic cell clearance [GO:2000427]";"GO:0005783; GO:0009986; GO:0012505; GO:0016853; GO:0043277; GO:0045454; GO:2000427";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; positive regulation of apoptotic cell clearance [GO:2000427]";"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]";isomerase activity [GO:0016853]
comp184748_c0_seq1;GAXK01105665.1;Q6IR42;2.07E-18;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp1847538_c0_seq1;GAXK01199565.1;P51817;3.58E-43;PRKX_HUMAN;cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]";"GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:2000696";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp184754_c0_seq1;GAXK01105744.1;Q86TP1;3.39E-43;PRUN1_HUMAN;Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]";"GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006798; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767";"polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]";"exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]"
comp184767_c0_seq1;GAXK01105810.1;Q5R9B8;6.92E-110;DCAF6_PONAB;DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]";
comp1847852_c0_seq1;GAXK01206000.1;Q3BAI2;1.16E-15;YCX91_PHAAO;Uncharacterized protein ORF91;chloroplast [GO:0009507];GO:0009507;;chloroplast [GO:0009507];
comp18483_c4_seq1;GAXK01026765.1;P42325;4.36E-72;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp1848351_c0_seq1;GAXK01087712.1;P10076;3.75E-16;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1848990_c0_seq1;GAXK01087690.1;P42519;1.24E-07;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp1849130_c0_seq1;GAXK01087702.1;Q8TBZ8;1.18E-10;ZN564_HUMAN;Zinc finger protein 564;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1849236_c0_seq1;GAXK01087684.1;Q96JE7;9.91E-07;SC16B_HUMAN;Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117) (RGPR-p117) (SEC16 homolog B);"cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031]";"GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0007029; GO:0007030; GO:0007031; GO:0010628; GO:0012507; GO:0015031; GO:0016559; GO:0043231; GO:0048208; GO:0070863; GO:0070971; GO:0070973";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031]";"cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]";
comp1849487_c0_seq1;GAXK01087686.1;Q9ULC3;2.97E-37;RAB23_HUMAN;Ras-related protein Rab-23;"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp184968_c0_seq1;GAXK01105747.1;Q9QZD8;3.62E-44;DIC_MOUSE;Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate ion transmembrane transporter activity [GO:0015114]; secondary active transmembrane transporter activity [GO:0015291]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; malate transport [GO:0015743]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]";"GO:0005654; GO:0005739; GO:0005743; GO:0006817; GO:0006839; GO:0008272; GO:0015114; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015291; GO:0015297; GO:0015709; GO:0015729; GO:0015743; GO:0015744; GO:0016021; GO:0035435; GO:0071422; GO:0071423";"malate transmembrane transport [GO:0071423]; malate transport [GO:0015743]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate ion transmembrane transporter activity [GO:0015114]; secondary active transmembrane transporter activity [GO:0015291]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]"
comp1850_c6_seq1;GAXK01205870.1;Q9NB32;0;TCPD_OCHTR;T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp1850204_c0_seq1;GAXK01136141.1;Q03720;1.66E-79;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp1850261_c0_seq1;GAXK01136154.1;Q96LW4;8.09E-11;PRIPO_HUMAN;DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.-) (Coiled-coil domain-containing protein 111);"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0030145; GO:0031297";"mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA primase activity [GO:0003896]; manganese ion binding [GO:0030145]"
comp1850440_c0_seq1;GAXK01136137.1;Q9U6A1;7.93E-20;PROS_DROVI;Homeobox protein prospero;"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp1850796_c0_seq1;GAXK01136149.1;Q9SCW7;6.78E-10;ERDL1_ARATH;Sugar transporter ERD6-like 1 (Sugar transporter-like protein 4);"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp1850809_c0_seq1;GAXK01136143.1;Q8N695;2.83E-135;SC5A8_HUMAN;Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161";"apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]"
comp18514_c0_seq1;GAXK01026170.1;Q9Y5Z4;1.84E-18;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp185151_c0_seq1;GAXK01105780.1;Q26473;0;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp185164_c0_seq1;GAXK01105806.1;Q32LB9;1.92E-48;NOA1_BOVIN;Nitric oxide-associated protein 1;"mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; regulation of cell death [GO:0010941]; regulation of cellular respiration [GO:0043457]";"GO:0005525; GO:0005743; GO:0006915; GO:0010941; GO:0032543; GO:0043457";"apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; regulation of cell death [GO:0010941]; regulation of cellular respiration [GO:0043457]";mitochondrial inner membrane [GO:0005743];GTP binding [GO:0005525]
comp1851699_c0_seq1;GAXK01136146.1;P28698;4.78E-18;MZF1_HUMAN;Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0042803; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp18517_c0_seq1;GAXK01026339.1;Q9BVS4;2.15E-153;RIOK2_HUMAN;Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234";"cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp185198_c0_seq1;GAXK01105759.1;P42325;8.63E-24;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp1852005_c0_seq1;GAXK01200431.1;Q9HBH5;3.30E-43;RDH14_HUMAN;Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650";osteoblast differentiation [GO:0001649];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]";NADP-retinol dehydrogenase activity [GO:0052650]
comp1852077_c0_seq1;GAXK01200427.1;P17970;1.10E-153;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp185225_c0_seq1;GAXK01105326.1;Q2VG86;1.76E-58;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp185226_c12_seq1;GAXK01105360.1;Q5THJ4;0;VP13D_HUMAN;Vacuolar protein sorting-associated protein 13D;"cell [GO:0005623]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]";"GO:0005623; GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526";"mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]";"cell [GO:0005623]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]";
comp185233_c1_seq1;GAXK01105559.1;P30622;7.77E-76;CLIP1_HUMAN;CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin);"centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]";"GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005635; GO:0005768; GO:0005813; GO:0005829; GO:0005874; GO:0005881; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0035371; GO:0042802; GO:0042803; GO:0044861; GO:0046872; GO:0051010";"microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]";"centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp1852428_c0_seq1;GAXK01200428.1;P09086;5.55E-75;PO2F2_HUMAN;POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2) (Oct-2) (Octamer-binding transcription factor 2) (OTF-2);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell maturation [GO:0048469]; humoral immune response [GO:0006959]; immunoglobulin secretion involved in immune response [GO:0002380]; mature B cell differentiation [GO:0002335]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0002335; GO:0002380; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0006959; GO:0019904; GO:0042795; GO:0043231; GO:0043565; GO:0048469";"cell maturation [GO:0048469]; humoral immune response [GO:0006959]; immunoglobulin secretion involved in immune response [GO:0002380]; mature B cell differentiation [GO:0002335]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp1853045_c0_seq1;GAXK01200419.1;Q8R481;7.71E-67;PERL_MESAU;Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; thiocyanate peroxidase activity [GO:0036393]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979]";"GO:0001580; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872";"defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; thiocyanate peroxidase activity [GO:0036393]"
comp1853056_c1_seq1;GAXK01200426.1;Q9VDR1;1.29E-33;MED25_DROME;Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) (dmPTOV2);"mediator complex [GO:0016592]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; transcription coregulator activity [GO:0003712]; nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0005654; GO:0006357; GO:0006963; GO:0007399; GO:0016592; GO:0044798; GO:0045944";"nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"mediator complex [GO:0016592]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]";transcription coregulator activity [GO:0003712]
comp185311_c0_seq1;GAXK01105687.1;P20481;1.67E-17;BUCC_APLCA;"Buccalin [Cleaved into: Buccalin-D; Buccalin-E; Buccalin-F; Buccalin-G; Buccalin-H; Buccalin-A; Buccalin-I; Buccalin-J; Buccalin-K; Buccalin-L; Buccalin-B (BUCb); Buccalin-M; Buccalin gene-predicted acidic peptide A (BGPAP A); Buccalin-N; Buccalin-O; Buccalin-P; Buccalin-Q; Buccalin-R; Buccalin-C; Buccalin-S; Buccalin gene-predicted acidic peptide B (BGPAP B)]";"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp185376_c1_seq1;GAXK01105774.1;Q7RPB4;2.52E-40;ACT2_PLAYO;Actin-2 (Actin II);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp1853782_c0_seq1;GAXK01200410.1;Q7KRI2;2.37E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1853801_c0_seq1;GAXK01200411.1;Q6P9Z4;5.27E-09;FEM1A_DANRE;Protein fem-1 homolog A (FEM1a) (FEM1-alpha);"cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438]";"GO:0004842; GO:0005737; GO:0051438";regulation of ubiquitin-protein transferase activity [GO:0051438];cytoplasm [GO:0005737];ubiquitin-protein transferase activity [GO:0004842]
comp1853880_c0_seq1;GAXK01200421.1;P0CB50;1.45E-10;PRDX1_CHICK;Peroxiredoxin-1 (EC 1.11.1.15);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]";"GO:0005829; GO:0006979; GO:0008379; GO:0019430; GO:0042744; GO:0045321; GO:0045454";"cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp1854046_c0_seq1;GAXK01154774.1;P18715;2.19E-19;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1854051_c0_seq1;GAXK01154772.1;Q5R615;5.32E-17;RB33B_PONAB;Ras-related protein Rab-33B;"Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]";"GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005796; GO:0006891; GO:0015031; GO:0032482; GO:0034067; GO:0048705; GO:1903358; GO:1903434; GO:2000156";"autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]";"Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp1854110_c0_seq1;GAXK01154775.1;Q5SSG5;4.36E-37;RSLAB_MOUSE;Ras-like protein family member 10B;"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";"GO:0003050; GO:0003924; GO:0005525; GO:0005886; GO:0090277";"positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp18544_c0_seq1;GAXK01026851.1;Q6DGQ0;1.69E-55;SPT4H_DANRE;Transcription elongation factor SPT4 (DRB sensitivity-inducing factor small subunit) (DSIF small subunit);"DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription, elongation [GO:0032786]";"GO:0000993; GO:0003727; GO:0006325; GO:0008270; GO:0032044; GO:0032786";"chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription, elongation [GO:0032786]";DSIF complex [GO:0032044];"RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]"
comp1854491_c0_seq1;GAXK01154758.1;Q9W2S3;3.72E-14;BTBD9_DROME;BTB/POZ domain-containing protein 9;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; protein binding, bridging [GO:0030674]; adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of synaptic transmission, dopaminergic [GO:0032225]";"GO:0005737; GO:0008344; GO:0030674; GO:0031463; GO:0032225; GO:0045938; GO:0048512";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of synaptic transmission, dopaminergic [GO:0032225]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]";protein binding, bridging [GO:0030674]
comp185528_c1_seq1;GAXK01105569.1;Q9HDD0;1.11E-14;PLAT1_HUMAN;Phospholipase A and acyltransferase 1 (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (HRAS-like suppressor 1) (HRSL1) (Phospholipid-metabolizing enzyme A-C1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; O-acyltransferase activity [GO:0008374]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004623; GO:0005634; GO:0005641; GO:0005737; GO:0008374; GO:0008970; GO:0016021; GO:0016042; GO:0016410; GO:0046470; GO:0052739; GO:0052740; GO:0070292; GO:0102567; GO:0102568";"lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylcholine metabolic process [GO:0046470]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]";"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; O-acyltransferase activity [GO:0008374]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp18553_c0_seq1;GAXK01026514.1;Q9NSB8;1.74E-73;HOME2_HUMAN;Homer protein homolog 2 (Homer-2) (Cupidin);"apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]";"GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019904; GO:0030054; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035256; GO:0035584; GO:0042803; GO:0043005; GO:0043025; GO:0045177; GO:0045211; GO:0046982; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256";"behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]";"apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; G protein-coupled glutamate receptor binding [GO:0035256]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp18562_c1_seq1;GAXK01027116.1;P00766;7.52E-35;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp185634_c0_seq1;GAXK01105433.1;Q8TAQ5;2.65E-47;ZN420_HUMAN;Zinc finger protein 420;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0042981; GO:0046872";"regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]";nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp185648_c1_seq1;GAXK01105554.1;A4IHB9;2.72E-12;SL9B2_XENTR;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]";"GO:0005886; GO:0010008; GO:0015385; GO:0016021; GO:0030054; GO:0030317; GO:0030672; GO:0031966";flagellated sperm motility [GO:0030317];"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";sodium:proton antiporter activity [GO:0015385]
comp185664_c0_seq1;GAXK01105688.1;O73612;1.21E-18;EFNB1_CHICK;Ephrin-B1 (CEK5 ligand) (CEK5-L);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]";"GO:0005829; GO:0005886; GO:0007411; GO:0016021; GO:0046875; GO:0048013";"axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp1856883_c0_seq1;GAXK01071616.1;O55029;4.64E-22;COPB2_MOUSE;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102);"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]";"protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]"
comp18569_c1_seq1;GAXK01026602.1;Q05913;4.12E-23;T2FA_DROME;General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha);"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006367; GO:0006368; GO:0016740; GO:0032968; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]";"DNA binding [GO:0003677]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]"
comp185706_c0_seq1;GAXK01105521.1;Q7KRI2;1.19E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp185711_c0_seq1;GAXK01105520.1;A2I8Z7;9.70E-64;LHX9_ASTFA;LIM/homeobox protein Lhx9 (LIM homeobox protein 9);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003714; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0097380";"dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of transcription, DNA-templated [GO:0045892]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]"
comp185722_c0_seq1;GAXK01105522.1;Q8IN81;6.41E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1857409_c0_seq1;GAXK01071630.1;Q7ZVG6;6.83E-10;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp18575_c1_seq1;GAXK01026358.1;Q8SPI1;2.40E-14;COX7C_MACFA;Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp18578_c0_seq1;GAXK01026095.1;P22127;1.02E-106;RAB10_DIPOM;Ras-related protein Rab-10 (ORA1);"cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006893; GO:0007409; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361";"axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]";"cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp185798_c2_seq1;GAXK01105557.1;Q9R1D1;4.62E-20;CTCF_RAT;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"GO:0000775; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0008285; GO:0044212; GO:0045944; GO:0046872; GO:0071459; GO:1902895";"chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp185812_c0_seq1;GAXK01105684.1;P98068;4.18E-08;SPAN_STRPU;Protein SpAN (EC 3.4.24.-);"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];;"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1858181_c0_seq1;GAXK01180540.1;Q1JPB9;2.27E-27;PA2G3_BOVIN;Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3);"centriole [GO:0005814]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005576; GO:0005814; GO:0005886; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0060271; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"centriole [GO:0005814]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp185866_c0_seq1;GAXK01105327.1;Q7ZWN0;1.87E-139;LMF2_XENLA;Lipase maturation factor 2;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp185873_c0_seq1;GAXK01105807.1;Q96IR2;2.44E-16;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp185875_c1_seq1;GAXK01105760.1;Q6XPS3;2.20E-39;TPTE2_HUMAN;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314";phosphatidylinositol biosynthetic process [GO:0006661];"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp185913_c1_seq1;GAXK01105322.1;Q6ZNE5;1.40E-42;BAKOR_HUMAN;Beclin 1-associated autophagy-related key regulator (Barkor) (Autophagy-related protein 14-like protein) (Atg14L);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; GTPase binding [GO:0051020]; autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of protein complex stability [GO:0061635]; regulation of protein phosphorylation [GO:0001932]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780]";"GO:0000045; GO:0000421; GO:0000423; GO:0001932; GO:0001933; GO:0001934; GO:0005776; GO:0005789; GO:0005829; GO:0005930; GO:0008333; GO:0009267; GO:0010608; GO:0016236; GO:0016240; GO:0034045; GO:0035032; GO:0042149; GO:0043552; GO:0044233; GO:0045335; GO:0051020; GO:0061635; GO:0090207; GO:0097629; GO:0097632; GO:0098780";"autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of protein complex stability [GO:0061635]; regulation of protein phosphorylation [GO:0001932]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]";GTPase binding [GO:0051020]
comp185921_c0_seq1;GAXK01105770.1;Q96RV3;0;PCX1_HUMAN;Pecanex-like protein 1 (Pecanex homolog protein 1);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp18594_c0_seq1;GAXK01205115.1;Q24537;1.54E-52;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp1859478_c0_seq1;GAXK01180547.1;Q5REK1;2.72E-08;ZN136_PONAB;Zinc finger protein 136;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp185961_c0_seq1;GAXK01105329.1;Q9EQ60;0;CAC1H_RAT;Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]";"GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0019233; GO:0030425; GO:0032342; GO:0034651; GO:0034765; GO:0043204; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0106134";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]"
comp18598_c3_seq1;GAXK01026404.1;Q8IW92;3.52E-115;GLBL2_HUMAN;Beta-galactosidase-1-like protein 2 (EC 3.2.1.-);"extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]";"GO:0004565; GO:0005576; GO:0005773; GO:0005975";carbohydrate metabolic process [GO:0005975];"extracellular region [GO:0005576]; vacuole [GO:0005773]";beta-galactosidase activity [GO:0004565]
comp18603_c1_seq1;GAXK01027019.1;Q9VAS7;3.47E-17;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp18608_c0_seq1;GAXK01026352.1;Q9EPS3;4.69E-131;GLCE_MOUSE;D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]";"GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379";"heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]"
comp186157_c1_seq1;GAXK01003311.1;Q62773;4.15E-104;S28A2_RAT;Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (rCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside cotransporter) (SPNT) (Solute carrier family 28 member 2);"integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleoside transmembrane transporter activity [GO:0015211]; nucleoside transmembrane transport [GO:1901642]; protein localization to cell surface [GO:0034394]; retina homeostasis [GO:0001895]";"GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015211; GO:0034394; GO:1901642";"nucleoside transmembrane transport [GO:1901642]; protein localization to cell surface [GO:0034394]; retina homeostasis [GO:0001895]";integral component of plasma membrane [GO:0005887];"nucleoside:sodium symporter activity [GO:0005415]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]"
comp186180_c0_seq1;GAXK01003436.1;B4NFR1;2.81E-43;FOXO_DROWI;Forkhead box protein O;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627";"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp186223_c1_seq1;GAXK01003163.1;Q6IR42;1.82E-24;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp186230_c0_seq1;GAXK01003423.1;Q8JJC0;1.90E-92;ZIC1_CHICK;Zinc finger protein ZIC 1 (Zinc finger protein of the cerebellum 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]";"GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0007389; GO:0007417; GO:0008589; GO:0021510; GO:0030154; GO:0042472; GO:0046872";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1862521_c0_seq1;GAXK01105036.1;Q5ZM44;2.36E-70;CHP1_CHICK;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071468; GO:0090314; GO:1901214";"cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]"
comp186274_c0_seq1;GAXK01003115.1;O15442;1.99E-34;MPPD1_HUMAN;Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp186303_c1_seq1;GAXK01003351.1;P13667;2.48E-07;PDIA4_HUMAN;Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0045454; GO:0061077";"cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]"
comp186328_c2_seq1;GAXK01003159.1;Q9GKK8;5.13E-13;BRCA1_PANTR;Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1);"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of centriole replication [GO:0046600]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]";"GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0005886; GO:0006357; GO:0006359; GO:0006633; GO:0006915; GO:0006978; GO:0007049; GO:0008270; GO:0008274; GO:0009048; GO:0015631; GO:0031436; GO:0035066; GO:0035067; GO:0042127; GO:0042981; GO:0043009; GO:0045717; GO:0045739; GO:0045893; GO:0045944; GO:0046600; GO:0051865; GO:0070063; GO:0070531; GO:0071158; GO:0085020";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of centriole replication [GO:0046600]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]";"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1863511_c0_seq1;GAXK01105067.1;G5ECD6;5.04E-83;CHS1_CAEEL;Chitin synthase chs-1 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-1);"cell cortex [GO:0005938]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]";"GO:0004100; GO:0005886; GO:0005938; GO:0006031; GO:0006038; GO:0016021; GO:0030428; GO:0030703; GO:1904778";"cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]";"cell cortex [GO:0005938]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp186374_c0_seq1;GAXK01003222.1;Q9W5D0;1.32E-155;Y34F_DROME;Uncharacterized protein CG43867;cytoskeleton [GO:0005856];GO:0005856;;cytoskeleton [GO:0005856];
comp1863826_c0_seq1;GAXK01105041.1;P10076;1.81E-25;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1863961_c0_seq1;GAXK01105059.1;Q8IUK5;1.12E-09;PLDX1_HUMAN;Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"GO:0001525; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005923; GO:0016021; GO:0021510; GO:0030425; GO:0043025; GO:0043235";"angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";
comp1864_c5_seq1;GAXK01169946.1;Q9EPL8;0;IPO7_MOUSE;Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7);"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; innate immune response [GO:0045087]; protein import into nucleus [GO:0006606]";"GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0008536; GO:0042393; GO:0045087; GO:0046332";"innate immune response [GO:0045087]; protein import into nucleus [GO:0006606]";"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]";"histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]"
comp186489_c1_seq1;GAXK01003117.1;Q6PEY2;1.30E-120;TBA3E_HUMAN;Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017; GO:0015630";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1865176_c0_seq1;GAXK01102342.1;Q8NB50;3.65E-12;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp186542_c0_seq1;GAXK01003358.1;Q75NA5;4.75E-136;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1865635_c0_seq1;GAXK01102341.1;Q93105;4.21E-40;INSR_AEDAE;"Insulin-like receptor (MIR) (EC 2.7.10.1) [Cleaved into: Insulin-like receptor alpha chain; Insulin-like receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; insulin receptor signaling pathway [GO:0008286]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";"GO:0005009; GO:0005524; GO:0008286; GO:0016021; GO:0043548; GO:0043559; GO:0043560; GO:0046777; GO:0046872; GO:0051290";"insulin receptor signaling pathway [GO:0008286]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]"
comp186580_c1_seq1;GAXK01003401.1;Q66J74;0;TFP11_XENLA;Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1);"spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003676; GO:0005681; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";spliceosomal complex [GO:0005681];nucleic acid binding [GO:0003676]
comp186622_c0_seq1;GAXK01003157.1;Q5EA03;2.92E-22;TM186_BOVIN;Transmembrane protein 186;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"GO:0005739; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";
comp1866682_c0_seq1;GAXK01001635.1;P39087;0;GRIK2_MOUSE;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp18668_c0_seq1;GAXK01026022.1;O35857;1.95E-131;TIM44_MOUSE;Mitochondrial import inner membrane translocase subunit TIM44;"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]";"GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006886; GO:0019899; GO:0030150; GO:0051087";"intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]"
comp18669_c4_seq1;GAXK01026077.1;P46978;0;STT3A_MOUSE;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0004579; GO:0016020; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0046872";"co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase III complex [GO:0035000]";"dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]"
comp1867010_c0_seq1;GAXK01001621.1;Q52M93;7.88E-18;Z585B_HUMAN;Zinc finger protein 585B (zinc finger protein 41-like protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1867087_c0_seq1;GAXK01001636.1;Q9TTF0;4.32E-40;NR2E3_BOVIN;Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp186710_c0_seq1;GAXK01003195.1;A3DH97;4.36E-66;RSGI6_CLOTH;Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0005886; GO:0016021; GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";endo-1,4-beta-xylanase activity [GO:0031176]
comp18672_c0_seq1;GAXK01026568.1;Q6Y7W8;3.90E-15;GGYF2_MOUSE;GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982]; proline-rich region binding [GO:0070064]; adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]";"GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016021; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0031982; GO:0032991; GO:0035264; GO:0043204; GO:0044267; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635";"adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982]";proline-rich region binding [GO:0070064]
comp186723_c0_seq1;GAXK01003421.1;Q9EQN9;5.02E-74;S19A2_MOUSE;Thiamine transporter 1 (ThTr-1) (Solute carrier family 19 member 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; transmembrane transport [GO:0055085]";"GO:0005886; GO:0015234; GO:0015888; GO:0016021; GO:0055085; GO:0071934";"thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";thiamine transmembrane transporter activity [GO:0015234]
comp1867442_c0_seq1;GAXK01001630.1;Q5R621;6.77E-16;HS2ST_PONAB;Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0000139; GO:0008146; GO:0016021";;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp186790_c0_seq1;GAXK01003437.1;Q28824;1.66E-56;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp1868035_c0_seq1;GAXK01075935.1;P33527;1.84E-85;MRP1_HUMAN;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005524; GO:0005774; GO:0005886; GO:0005887; GO:0006691; GO:0006855; GO:0008559; GO:0009235; GO:0015420; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0071716; GO:0099039; GO:0140359";"cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp1868178_c0_seq1;GAXK01075922.1;Q9HAZ2;1.20E-10;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp186833_c0_seq1;GAXK01003383.1;Q59E55;6.34E-38;NAB_DROME;NGFI-A-binding protein homolog (dNAB);"nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell population proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription, DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222]";"GO:0003712; GO:0005634; GO:0006355; GO:0007626; GO:0008283; GO:0014019; GO:0035222; GO:0045892; GO:0048666";"cell population proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription, DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222]";nucleus [GO:0005634];transcription coregulator activity [GO:0003712]
comp186836_c0_seq1;GAXK01003155.1;Q9UK10;1.95E-33;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp186841_c0_seq1;GAXK01003434.1;Q9GRW0;1.55E-69;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1868467_c0_seq1;GAXK01075928.1;Q27677;0;ACES_LEPDE;Acetylcholinesterase (AChE) (EC 3.1.1.7);"anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; acetylcholine catabolic process in synaptic cleft [GO:0001507]";"GO:0001507; GO:0003990; GO:0005886; GO:0030054; GO:0031225; GO:0043083";acetylcholine catabolic process in synaptic cleft [GO:0001507];"anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]";acetylcholinesterase activity [GO:0003990]
comp186849_c0_seq1;GAXK01003112.1;Q9V6L0;7.63E-101;KDM4B_DROME;Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp18687_c2_seq1;GAXK01026510.1;O46504;2.25E-92;PDPR_BOVIN;Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]";"GO:0005737; GO:0005739; GO:0005759; GO:0016491";;"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp1868892_c0_seq1;GAXK01075919.1;P35288;4.06E-18;RAB23_MOUSE;Ras-related protein Rab-23 (Protein open brain) (Rab-15);"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic digit morphogenesis [GO:0042733]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of proteolysis [GO:0045861]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; Rab protein signal transduction [GO:0032482]; regulation of smoothened signaling pathway [GO:0008589]; signal transduction [GO:0007165]; spinal cord dorsal/ventral patterning [GO:0021513]";"GO:0000045; GO:0001843; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0007165; GO:0007399; GO:0008589; GO:0010008; GO:0021513; GO:0021904; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0042733; GO:0045335; GO:0045861; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic digit morphogenesis [GO:0042733]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of proteolysis [GO:0045861]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; Rab protein signal transduction [GO:0032482]; regulation of smoothened signaling pathway [GO:0008589]; signal transduction [GO:0007165]; spinal cord dorsal/ventral patterning [GO:0021513]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp186914_c2_seq1;GAXK01003211.1;O95477;0;ABCA1_HUMAN;Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein);"endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]";"GO:0005102; GO:0005319; GO:0005524; GO:0005543; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008509; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016887; GO:0019216; GO:0019905; GO:0030139; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071397; GO:0071404; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140328";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]";"endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]"
comp1869148_c0_seq1;GAXK01075914.1;B4HS00;1.17E-11;LPHN_DROSE;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1869302_c0_seq1;GAXK01075910.1;Q66TN7;1.26E-20;OVCH2_RHIAE;Ovochymase-2 (EC 3.4.21.120) (Oviductal protease) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp1869394_c0_seq1;GAXK01075936.1;Q8BHY3;0;ANO1_MOUSE;Anoctamin-1 (Transmembrane protein 16A);"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]";"GO:0005227; GO:0005229; GO:0005247; GO:0005254; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007200; GO:0009897; GO:0015111; GO:0015705; GO:0016324; GO:0034605; GO:0034707; GO:0035774; GO:0042391; GO:0042803; GO:0046982; GO:0050965; GO:0060438; GO:1902476";"cation transport [GO:0006812]; cellular response to heat [GO:0034605]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]";"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]"
comp1869554_c0_seq1;GAXK01075929.1;Q9FKU8;2.59E-15;BBE26_ARATH;Berberine bridge enzyme-like 26 (AtBBE-like 26) (EC 1.1.1.-);"cell wall [GO:0005618]; extracellular region [GO:0005576]; plasmodesma [GO:0009506]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0005576; GO:0005618; GO:0009506; GO:0016491; GO:0071949";;"cell wall [GO:0005618]; extracellular region [GO:0005576]; plasmodesma [GO:0009506]";"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp18696_c0_seq1;GAXK01026469.1;Q9ZRJ4;1.11E-109;TBA_CHLVU;Tubulin alpha chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1869944_c0_seq1;GAXK01075918.1;Q6AYC5;4.11E-22;RHG15_RAT;Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15);"cytoplasm [GO:0005737]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0007165; GO:0008360; GO:0016020; GO:0043087";"regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";GTPase activator activity [GO:0005096]
comp187_c0_seq1;GAXK01170207.1;O17445;1.96E-111;RL15_DROME;60S ribosomal protein L15;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1870_c2_seq1;GAXK01168818.1;Q24572;0;CAF1_DROME;Probable histone-binding protein Caf1 (Chromatin assembly factor 1 p55 subunit) (CAF-1 p55 subunit) (Nucleosome-remodeling factor 55 kDa subunit) (NURF-55) (dCAF-1);"CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription factor complex [GO:0005667]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region DNA binding [GO:0044212]; chromatin assembly [GO:0031497]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000281; GO:0005634; GO:0005667; GO:0005700; GO:0006281; GO:0006334; GO:0006342; GO:0006351; GO:0007307; GO:0007346; GO:0007379; GO:0008284; GO:0010468; GO:0016571; GO:0016573; GO:0016581; GO:0016584; GO:0016589; GO:0031497; GO:0031523; GO:0033186; GO:0034968; GO:0035097; GO:0035098; GO:0042393; GO:0042766; GO:0042803; GO:0042826; GO:0044212; GO:0051567; GO:0070734; GO:0070822";"chromatin assembly [GO:0031497]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]";"CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription factor complex [GO:0005667]";"histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region DNA binding [GO:0044212]"
comp1870045_c0_seq1;GAXK01165324.1;B4P3A0;1.93E-07;LPHN_DROYA;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp1870081_c0_seq1;GAXK01165318.1;Q5EB47;4.44E-29;LN28A_XENTR;Protein lin-28 homolog A (Lin-28A);"cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; positive regulation of cytoplasmic translation [GO:2000767]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]";"GO:0000932; GO:0003723; GO:0005634; GO:0005730; GO:0005791; GO:0005844; GO:0008270; GO:0010494; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:1905538; GO:1990904; GO:2000767";"miRNA catabolic process [GO:0010587]; positive regulation of cytoplasmic translation [GO:2000767]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]";"cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]";"polysome binding [GO:1905538]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp187013_c1_seq1;GAXK01003435.1;P42324;2.54E-59;HPCL1_CHICK;Hippocalcin-like protein 1 (Protein Rem-1);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp18702_c1_seq1;GAXK01026485.1;Q2KI95;3.46E-120;FHL2_BOVIN;Four and a half LIM domains protein 2 (FHL-2);"nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000122; GO:0001649; GO:0005634; GO:0008134; GO:0030018; GO:0043066; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885";"atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"nucleus [GO:0005634]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp1870250_c0_seq1;GAXK01165327.1;Q09101;1.58E-64;HIG_DROME;Locomotion-related protein Hikaru genki;"neuronal cell body [GO:0043025]; synaptic cleft [GO:0043083]; synaptic target recognition [GO:0008039]";"GO:0008039; GO:0043025; GO:0043083";synaptic target recognition [GO:0008039];"neuronal cell body [GO:0043025]; synaptic cleft [GO:0043083]";
comp1870383_c0_seq1;GAXK01165344.1;P52404;2.58E-29;CHI2_SOLTU;Endochitinase 2 (EC 3.2.1.14) (Fragment);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp1870523_c0_seq1;GAXK01165317.1;O42409;4.80E-08;GFI1B_CHICK;Zinc finger protein Gfi-1b (Growth factor-independent protein 1B);"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001085; GO:0003677; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp1870859_c0_seq1;GAXK01165342.1;Q12766;8.96E-08;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp187091_c1_seq1;GAXK01003110.1;Q6DFJ6;5.71E-150;TBK1_XENLA;Serine/threonine-protein kinase TBK1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]";"GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087";"innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp187135_c0_seq1;GAXK01003260.1;P07768;0;SUIS_RABIT;"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; carbohydrate metabolic process [GO:0005975]";"GO:0004574; GO:0004575; GO:0005975; GO:0016021; GO:0016324; GO:0030246";carbohydrate metabolic process [GO:0005975];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"
comp187153_c0_seq1;GAXK01003393.1;P24156;1.08E-42;L2CC_DROME;Protein l(2)37Cc;"membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"GO:0005739; GO:0007275; GO:0016020; GO:0071456";"cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"membrane [GO:0016020]; mitochondrion [GO:0005739]";
comp1871536_c0_seq1;GAXK01165326.1;Q8NB50;4.28E-20;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1871563_c0_seq1;GAXK01165332.1;O70595;0;ABCB6_RAT;ATP-binding cassette sub-family B member 6, mitochondrial (Ubiquitously-expressed mammalian ABC half transporter);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]; brain development [GO:0007420]; porphyrin-containing compound biosynthetic process [GO:0006779]; skin development [GO:0043588]";"GO:0005524; GO:0005654; GO:0005739; GO:0005768; GO:0005774; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006779; GO:0007420; GO:0015439; GO:0015562; GO:0016021; GO:0016887; GO:0020037; GO:0031307; GO:0042626; GO:0043588";"brain development [GO:0007420]; porphyrin-containing compound biosynthetic process [GO:0006779]; skin development [GO:0043588]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]"
comp187179_c0_seq1;GAXK01003202.1;Q80Z96;6.43E-76;VANG1_MOUSE;Vang-like protein 1 (Loop-tail protein 2) (Van Gogh-like protein 1);"integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473]";"GO:0005886; GO:0007275; GO:0016021; GO:0016328; GO:0043473";"multicellular organism development [GO:0007275]; pigmentation [GO:0043473]";"integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";
comp187234_c1_seq1;GAXK01003205.1;Q6NSJ0;1.59E-66;MYORG_HUMAN;Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]";"GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897";"carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp187236_c0_seq1;GAXK01003389.1;Q8C6E0;1.76E-35;CFA36_MOUSE;Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104);"ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein N-terminus binding [GO:0047485]";"GO:0005634; GO:0005737; GO:0031514; GO:0035869; GO:0047485; GO:0097546";;"ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]";protein N-terminus binding [GO:0047485]
comp1872457_c0_seq1;GAXK01045239.1;P00637;5.05E-24;F16P1_RABIT;Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]";"GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0051289; GO:0071286";"cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
comp1872733_c0_seq1;GAXK01045244.1;Q43362;6.68E-54;VATL_CHRCT;V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit);"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]";"GO:0005774; GO:0015078; GO:0016021; GO:0033179";;"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";proton transmembrane transporter activity [GO:0015078]
comp1873175_c0_seq1;GAXK01045243.1;Q9NHV9;2.61E-11;VAV_DROME;Protein vav (DroVav) (dVAV);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035023; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";cytosol [GO:0005829];"metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]"
comp187345_c0_seq1;GAXK01003353.1;O70589;0;CSKP_MOUSE;Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase);"apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; calcium ion import [GO:0070509]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001953; GO:0004674; GO:0005516; GO:0005524; GO:0005604; GO:0005634; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006357; GO:0008022; GO:0010839; GO:0014069; GO:0016020; GO:0016323; GO:0016363; GO:0030165; GO:0030425; GO:0031982; GO:0032024; GO:0032991; GO:0042043; GO:0042734; GO:0043025; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0060170; GO:0061003; GO:0061045; GO:0070509; GO:0072659; GO:0090280; GO:0090288; GO:0097060; GO:0097440; GO:0098685; GO:0098846; GO:2000300";"calcium ion import [GO:0070509]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]";"apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]"
comp1873590_c0_seq1;GAXK01045240.1;Q6DHG0;3.71E-41;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp1873600_c0_seq1;GAXK01045250.1;Q9UIH9;4.48E-19;KLF15_HUMAN;Krueppel-like factor 15 (Kidney-enriched krueppel-like factor);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0005634; GO:0006357; GO:0010001; GO:0014898; GO:0032868; GO:0044212; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:2000757";"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp1873789_c0_seq1;GAXK01045249.1;Q96P65;1.47E-11;QRFPR_HUMAN;Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016021";G protein-coupled receptor signaling pathway [GO:0007186];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]"
comp1873891_c0_seq1;GAXK01045242.1;Q5RBA5;3.93E-09;SQSTM_PONAB;Sequestosome-1 (Ubiquitin-binding protein p62);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"GO:0000932; GO:0002376; GO:0005080; GO:0005764; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0035973; GO:0042169; GO:0043122; GO:0043130; GO:0061912; GO:0070530; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp1874_c0_seq1;GAXK01166360.1;Q9N2J2;1.68E-65;GPX4_BOVIN;Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"GO:0004601; GO:0004602; GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0005829; GO:0006325; GO:0006979; GO:0007275; GO:0007283; GO:0032991; GO:0042802; GO:0047066; GO:0051258; GO:0110076";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]"
comp18741_c15_seq1;GAXK01026037.1;O94469;3.33E-69;DUR31_SCHPO;Probable urea active transporter 1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918";"putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]"
comp1874123_c0_seq1;GAXK01064699.1;P02594;4.95E-41;CALM_ELEEL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1874391_c0_seq1;GAXK01064707.1;G4WMX4;9.50E-28;RYAR_TRICA;RYamide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]";"GO:0004983; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";neuropeptide Y receptor activity [GO:0004983]
comp18745_c1_seq1;GAXK01026937.1;Q5REY3;1.58E-104;PRDX3_PONAB;Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Peroxiredoxin-3);"cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]";"GO:0001893; GO:0005739; GO:0005769; GO:0005829; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0018171; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0045454; GO:0051092; GO:0051881";"cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]"
comp187467_c0_seq1;GAXK01003417.1;Q7T330;3.47E-21;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp18751_c1_seq1;GAXK01026584.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp187524_c4_seq1;GAXK01003114.1;Q4U2R1;0;HERC2_MOUSE;E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2);"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";"SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1875328_c0_seq1;GAXK01064696.1;O34736;7.35E-31;YJMC_BACSU;Uncharacterized oxidoreductase YjmC (EC 1.1.1.-);"cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]";"GO:0005737; GO:0016491";;cytoplasm [GO:0005737];oxidoreductase activity [GO:0016491]
comp1875359_c0_seq1;GAXK01064689.1;P50246;0;SAHH_MEDSA;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp18756_c1_seq1;GAXK01026166.1;Q03168;0;ASPP_AEDAE;Lysosomal aspartic protease (EC 3.4.23.-);"lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]";"GO:0004190; GO:0005764";;lysosome [GO:0005764];aspartic-type endopeptidase activity [GO:0004190]
comp187573_c1_seq1;GAXK01003382.1;P13182;2.11E-10;CX6A1_BOVIN;Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit SSG);"mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005751; GO:0006123; GO:0009060; GO:0030234";"aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";mitochondrial respiratory chain complex IV [GO:0005751];"cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]"
comp1875786_c0_seq1;GAXK01064688.1;Q6ZNG1;5.00E-21;ZN600_HUMAN;Zinc finger protein 600;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1875788_c0_seq1;GAXK01064708.1;Q9D9S1;2.01E-12;EVG1_MOUSE;UPF0193 protein EVG1 homolog;;;;;
comp187588_c0_seq1;GAXK01003198.1;Q5RJQ0;6.34E-30;CHST1_RAT;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0016021; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]"
comp1876029_c0_seq1;GAXK01133835.1;Q6IR42;1.23E-07;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp187622_c1_seq1;GAXK01003408.1;Q68CP4;2.29E-120;HGNAT_HUMAN;Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821";"glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"
comp187628_c0_seq1;GAXK01003318.1;Q9VFP2;5.16E-19;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp1876347_c0_seq1;GAXK01133854.1;A6H8H5;3.00E-33;KCNB2_MOUSE;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp187665_c2_seq1;GAXK01003273.1;Q80TI1;1.77E-34;PKHH1_MOUSE;Pleckstrin homology domain-containing family H member 1 (PH domain-containing family H member 1);cytoskeleton [GO:0005856];GO:0005856;;cytoskeleton [GO:0005856];
comp18768_c0_seq1;GAXK01026896.1;P35604;3.65E-78;COPZ1_BOVIN;Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"GO:0000139; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:1901998";"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]";
comp187718_c0_seq1;GAXK01003207.1;Q8C0Y1;2.80E-23;TGIF2_MOUSE;Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2) (TGFB-induced factor 2);"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; retina development in camera-type eye [GO:0060041]";"GO:0000122; GO:0003677; GO:0005654; GO:0010470; GO:0038092; GO:0045666; GO:0060041";"negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; retina development in camera-type eye [GO:0060041]";nucleoplasm [GO:0005654];DNA binding [GO:0003677]
comp1877392_c0_seq1;GAXK01133856.1;Q99NE5;6.63E-10;RIMS1_MOUSE;Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1) (RIM 1) (Rab-3-interacting protein 1);"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; structural constituent of presynaptic active zone [GO:0098882]; acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synaptic vesicle priming [GO:0010808]; protein-containing complex assembly [GO:0065003]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]";"GO:0005886; GO:0006886; GO:0007269; GO:0010628; GO:0010808; GO:0014069; GO:0016081; GO:0016082; GO:0017124; GO:0017137; GO:0019901; GO:0030054; GO:0031982; GO:0042391; GO:0042734; GO:0044325; GO:0045202; GO:0046872; GO:0048167; GO:0048169; GO:0048788; GO:0048791; GO:0050806; GO:0060077; GO:0060291; GO:0060478; GO:0061669; GO:0065003; GO:0097151; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:1903861; GO:2000300; GO:2000463";"acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synaptic vesicle priming [GO:0010808]; protein-containing complex assembly [GO:0065003]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]";"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982]";"ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; structural constituent of presynaptic active zone [GO:0098882]"
comp187748_c1_seq1;GAXK01003263.1;Q6AY65;2.11E-90;ARFP2_RAT;Arfaptin-2 (ADP-ribosylation factor-interacting protein 2);"cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886]";"GO:0005543; GO:0005737; GO:0006886; GO:0019904; GO:0032588";intracellular protein transport [GO:0006886];"cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]";"phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]"
comp187769_c0_seq1;GAXK01003208.1;Q00805;1.19E-48;GIL_DROME;Protein giant-lens (Protein argos) (Protein strawberry);"extracellular space [GO:0005615]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; receptor antagonist activity [GO:0048019]; anterior/posterior axis specification [GO:0009948]; dorsal/ventral axis specification [GO:0009950]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; genital disc development [GO:0035215]; haltere development [GO:0007482]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neurogenesis [GO:0050768]; negative regulation of stem cell differentiation [GO:2000737]; oenocyte delamination [GO:0060233]; ommatidial rotation [GO:0016318]; positive regulation of apoptotic process [GO:0043065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]; wing disc morphogenesis [GO:0007472]";"GO:0001654; GO:0005154; GO:0005615; GO:0007175; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007482; GO:0007601; GO:0009948; GO:0009950; GO:0016318; GO:0035215; GO:0042059; GO:0042802; GO:0043065; GO:0048019; GO:0050768; GO:0050896; GO:0060233; GO:0070373; GO:2000737";"anterior/posterior axis specification [GO:0009948]; dorsal/ventral axis specification [GO:0009950]; eye-antennal disc morphogenesis [GO:0007455]; eye development [GO:0001654]; genital disc development [GO:0035215]; haltere development [GO:0007482]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neurogenesis [GO:0050768]; negative regulation of stem cell differentiation [GO:2000737]; oenocyte delamination [GO:0060233]; ommatidial rotation [GO:0016318]; positive regulation of apoptotic process [GO:0043065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]; wing disc morphogenesis [GO:0007472]";extracellular space [GO:0005615];"epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; receptor antagonist activity [GO:0048019]"
comp187783_c0_seq1;GAXK01003144.1;Q28996;4.07E-22;STAR_PIG;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005758; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020";"cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp1878087_c0_seq1;GAXK01062847.1;A2ANX9;4.47E-11;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp1878302_c0_seq1;GAXK01062867.1;Q5SPC5;0;OTOF_DANRE;Otoferlin (Fer-1-like protein 2);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; neuromuscular process controlling balance [GO:0050885]; response to auditory stimulus [GO:0010996]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005789; GO:0010996; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0050885";"neuromuscular process controlling balance [GO:0050885]; response to auditory stimulus [GO:0010996]; synaptic vesicle exocytosis [GO:0016079]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp1878405_c0_seq2;GAXK01062852.1;P54254;8.61E-10;ATX1_MOUSE;Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]";"GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0032991; GO:0034046; GO:0035176; GO:0042326; GO:0042405; GO:0042802; GO:0043569; GO:0043621; GO:0045892; GO:0045944; GO:0048286; GO:0048856; GO:0051168; GO:0060079; GO:0060252; GO:0098794";"adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]"
comp187885_c0_seq1;GAXK01003133.1;Q9NW07;3.01E-07;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1878885_c0_seq1;GAXK01062866.1;P49016;2.86E-09;MENG_LACLA;Demethylmenaquinone methyltransferase (EC 2.1.1.163);"S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]";"GO:0009234; GO:0102955";menaquinone biosynthetic process [GO:0009234];;S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]
comp1878989_c0_seq1;GAXK01062850.1;P35789;4.66E-19;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp187929_c1_seq1;GAXK01003143.1;Q8K078;3.51E-136;SO4A1_MOUSE;Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12);"integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";"GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252";"organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";integral component of plasma membrane [GO:0005887];"organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp1879851_c0_seq1;GAXK01062841.1;P79371;3.95E-12;SOX_RABIT;Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase);"peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114";"L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]";peroxisome [GO:0005777];"L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]"
comp188_c0_seq1;GAXK01169206.1;P42766;1.30E-56;RL35_HUMAN;60S ribosomal protein L35 (Large ribosomal subunit protein uL29);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0000463; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp188027_c1_seq1;GAXK01025073.1;Q502L1;3.59E-37;ACB5A_DANRE;Acyl-CoA-binding domain-containing protein 5A;"integral component of membrane [GO:0016021]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]";"GO:0000062; GO:0008289; GO:0016021; GO:0030242";autophagy of peroxisome [GO:0030242];integral component of membrane [GO:0016021];"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp1880324_c0_seq1;GAXK01093453.1;Q3AC47;1.64E-116;ACKA_CARHZ;Acetate kinase (EC 2.7.2.1) (Acetokinase);"cytoplasm [GO:0005737]; acetate kinase activity [GO:0008776]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; acetyl-CoA biosynthetic process [GO:0006085]; organic acid metabolic process [GO:0006082]";"GO:0000287; GO:0005524; GO:0005737; GO:0006082; GO:0006085; GO:0008776";"acetyl-CoA biosynthetic process [GO:0006085]; organic acid metabolic process [GO:0006082]";cytoplasm [GO:0005737];"acetate kinase activity [GO:0008776]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp1880352_c0_seq1;GAXK01093444.1;Q95LI3;2.19E-20;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp188069_c0_seq1;GAXK01025498.1;P47990;0;XDH_CHICK;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949";"urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp1880733_c0_seq1;GAXK01093452.1;Q6AXM1;7.38E-09;CHSTA_DANRE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp18809_c1_seq1;GAXK01026282.1;Q4KLN7;5.89E-75;ARFG3_RAT;ADP-ribosylation factor GTPase-activating protein 3 (ARF GAP 3);"Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005096; GO:0005802; GO:0006888; GO:0006890; GO:0015031; GO:0046872; GO:0048205";"COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp188098_c2_seq1;GAXK01025087.1;Q9UA35;7.77E-131;S28A3_EPTST;Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT);"integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005887";;integral component of plasma membrane [GO:0005887];nucleoside transmembrane transporter activity [GO:0005337]
comp18816_c1_seq1;GAXK01026103.1;Q9VMM6;3.73E-22;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp1881735_c0_seq1;GAXK01093469.1;P25152;7.60E-08;BSAP_BACSU;Aminopeptidase YwaD (Arginyl aminopeptidase) (EC 3.4.11.6) (BSAP) (Leucyl aminopeptidase) (EC 3.4.11.10);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004177; GO:0005576; GO:0006508; GO:0008237; GO:0046872";proteolysis [GO:0006508];extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp18823_c0_seq1;GAXK01026344.1;P29702;1.19E-109;FNTA_BOVIN;Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha);"CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; protein farnesyltransferase complex [GO:0005965]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]";"GO:0004660; GO:0004661; GO:0004662; GO:0005737; GO:0005953; GO:0005965; GO:0018343; GO:0018344";"protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]";"CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; protein farnesyltransferase complex [GO:0005965]";"CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]"
comp188251_c0_seq1;GAXK01025108.1;Q02337;1.18E-48;BDH_BOVIN;D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH);"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]";"GO:0003858; GO:0005654; GO:0005759; GO:0099617";;"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]";3-hydroxybutyrate dehydrogenase activity [GO:0003858]
comp18827_c0_seq1;GAXK01026586.1;P83094;2.95E-106;STIM_DROME;Stromal interaction molecule homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]";"GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016021; GO:0022416; GO:0032237; GO:0048763; GO:0051924";"activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium channel regulator activity [GO:0005246]; calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]"
comp188270_c2_seq1;GAXK01025489.1;Q9NIV1;1.34E-19;E2AK3_DROME;Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK);"cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330";"PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]"
comp188282_c2_seq1;GAXK01025382.1;P32261;1.18E-45;ANT3_MOUSE;Antithrombin-III (ATIII) (Serpin C1);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute inflammatory response to antigenic stimulus [GO:0002438]; blood coagulation [GO:0007596]; lactation [GO:0007595]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]; response to nutrient [GO:0007584]";"GO:0002020; GO:0002438; GO:0004867; GO:0005615; GO:0007584; GO:0007595; GO:0007596; GO:0008201; GO:0010951; GO:0042802; GO:0062023; GO:2000266";"acute inflammatory response to antigenic stimulus [GO:0002438]; blood coagulation [GO:0007596]; lactation [GO:0007595]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]; response to nutrient [GO:0007584]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]";"heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp188288_c0_seq1;GAXK01025177.1;Q9VLS1;0;KPBB_DROME;Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta);"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"GO:0003824; GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468";"glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]"
comp1883180_c0_seq1;GAXK01062194.1;Q67FQ3;6.69E-42;ARHB_XENLA;Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta);"cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]";"GO:0005737; GO:0006897; GO:0008203";"cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]";cytoplasm [GO:0005737];
comp1883250_c0_seq1;GAXK01062193.1;Q3S4T7;1.06E-83;BIP_ICTTR;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; posttranslational protein targeting to membrane, translocation [GO:0031204]";"GO:0005524; GO:0005737; GO:0005739; GO:0005788; GO:0005829; GO:0016887; GO:0030335; GO:0031204; GO:0035437; GO:0043231; GO:0090074; GO:1903895";"maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; posttranslational protein targeting to membrane, translocation [GO:0031204]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp1883320_c0_seq1;GAXK01062205.1;Q63ZU0;7.31E-74;ADA_XENTR;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]";"GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205";"adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]";"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]";"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp188336_c0_seq1;GAXK01025169.1;Q7KRI2;8.67E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp188338_c0_seq1;GAXK01025460.1;Q7KRI2;2.73E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1883479_c0_seq1;GAXK01062213.1;P34672;1.02E-31;BST24_CAEEL;Bestrophin homolog 24;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp18835_c0_seq1;GAXK01026119.1;Q9H9Q2;2.42E-69;CSN7B_HUMAN;COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) (JAB1-containing signalosome subunit 7b);"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]";"GO:0000338; GO:0000715; GO:0005654; GO:0005829; GO:0006283; GO:0008180; GO:0010387; GO:0016032; GO:0043687";"COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]";"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp18836_c3_seq1;GAXK01026316.1;P46824;0;KLC_DROME;Kinesin light chain (KLC);"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777]; dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0046843";"dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";microtubule motor activity [GO:0003777]
comp1884086_c0_seq1;GAXK01039746.1;Q5EA06;4.03E-29;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp18842_c1_seq1;GAXK01205116.1;P54864;7.81E-40;JUN_SERCA;Transcription factor AP-1 (Proto-oncogene c-Jun);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265]";"GO:0003700; GO:0005634; GO:0007265; GO:0044212";Ras protein signal transduction [GO:0007265];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]"
comp188423_c0_seq1;GAXK01025082.1;Q3TWI9;5.69E-104;CSCL2_MOUSE;CSC1-like protein 2 (Transmembrane protein 63B);"actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]";"GO:0005227; GO:0005886; GO:0015629; GO:0016021";;"actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium activated cation channel activity [GO:0005227]
comp188440_c1_seq1;GAXK01025438.1;Q9U5P1;6.43E-11;FABP_LEPDS;Fatty acid-binding protein (allergen Lep d 13);"cytoplasm [GO:0005737]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289";;cytoplasm [GO:0005737];lipid binding [GO:0008289]
comp188443_c2_seq1;GAXK01025388.1;A4IHT0;4.07E-124;FIGL1_XENTR;Fidgetin-like protein 1 (EC 3.6.4.-);"nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cytoplasmic microtubule organization [GO:0031122]; regulation of double-strand break repair via homologous recombination [GO:0010569]";"GO:0000228; GO:0000287; GO:0005524; GO:0005634; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0031122; GO:0046034; GO:0048471";"ATP metabolic process [GO:0046034]; cytoplasmic microtubule organization [GO:0031122]; regulation of double-strand break repair via homologous recombination [GO:0010569]";"nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]"
comp188444_c2_seq1;GAXK01025376.1;Q8TE73;1.35E-123;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp1884551_c0_seq1;GAXK01039751.1;Q9Y4E8;1.86E-16;UBP15_HUMAN;Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0036459; GO:0042802; GO:0046332; GO:0060389; GO:0061649";"BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]"
comp1884996_c0_seq1;GAXK01039750.1;Q9ERC5;1.10E-153;OTOF_RAT;Otoferlin (Fer-1-like protein 2);"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007605; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0044877; GO:0045177; GO:0045178; GO:0090102";"cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]"
comp1886061_c0_seq1;GAXK01095381.1;Q54KA7;1.79E-20;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp188647_c13_seq1;GAXK01025334.1;O60500;4.02E-08;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp18866_c1_seq1;GAXK01026323.1;P53396;0;ACLY_HUMAN;ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme);"azurophil granule lumen [GO:0035578]; citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]";"GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0009346; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0048037; GO:0070062; GO:1904813";"acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]";"azurophil granule lumen [GO:0035578]; citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]"
comp1886694_c0_seq1;GAXK01095380.1;Q8BY79;4.42E-11;S35G1_MOUSE;Solute carrier family 35 member G1 (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp1886935_c0_seq1;GAXK01095379.1;P39057;2.71E-164;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp1887013_c0_seq1;GAXK01095384.1;Q8IN81;7.65E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1887202_c0_seq1;GAXK01095401.1;P27615;5.63E-26;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp1887272_c0_seq1;GAXK01095403.1;P30274;1.41E-56;CCNA2_BOVIN;Cyclin-A2 (Cyclin-A);"cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]";"GO:0000079; GO:0000086; GO:0000307; GO:0005634; GO:0005737; GO:0006275; GO:0006468; GO:0016538; GO:0019901; GO:0044772; GO:0044843; GO:0051301; GO:0097124";"cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]";"cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp1887347_c0_seq1;GAXK01095408.1;P16562;4.67E-39;CRIS2_HUMAN;Cysteine-rich secretory protein 2 (CRISP-2) (Cancer/testis antigen 36) (CT36) (Testis-specific protein TPX-1);"extracellular space [GO:0005615]; cell-cell adhesion [GO:0098609]";"GO:0005615; GO:0098609";cell-cell adhesion [GO:0098609];extracellular space [GO:0005615];
comp188775_c0_seq1;GAXK01025093.1;Q96P48;1.97E-53;ARAP1_HUMAN;Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; type 1 angiotensin receptor binding [GO:0031702]; actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0001921; GO:0005096; GO:0005547; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008360; GO:0030037; GO:0031410; GO:0031702; GO:0032580; GO:0043231; GO:0043547; GO:0045742; GO:0046872; GO:0051056; GO:0051270; GO:0051491; GO:0051497";"actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; type 1 angiotensin receptor binding [GO:0031702]"
comp1887988_c0_seq1;GAXK01095388.1;B0WC46;5.97E-19;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1887993_c0_seq1;GAXK01095404.1;Q8MQS8;5.32E-34;SP34_APIME;Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp1888505_c0_seq1;GAXK01030441.1;Q8VCV9;4.33E-07;MF4B1_MOUSE;Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp1888605_c0_seq1;GAXK01030420.1;Q8BMG8;1.44E-81;MFTC_MOUSE;Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; glycine metabolic process [GO:0006544]";"GO:0005739; GO:0005743; GO:0006544; GO:0008517; GO:0015230; GO:0016021";glycine metabolic process [GO:0006544];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]"
comp188865_c0_seq1;GAXK01025118.1;O44252;3.84E-14;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp18887_c0_seq1;GAXK01026899.1;Q9VIW7;0;RTCB_DROME;tRNA-splicing ligase RtcB homolog (EC 6.5.1.3);"nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"GO:0000971; GO:0003972; GO:0005524; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:2000237";"positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]"
comp1888910_c0_seq1;GAXK01030445.1;Q6X936;1.44E-11;KIRR1_RAT;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]";myosin binding [GO:0017022]
comp1888971_c0_seq1;GAXK01030431.1;P0DJ54;1.36E-28;RL24_TETTS;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp188900_c1_seq1;GAXK01025425.1;O95625;4.12E-09;ZBT11_HUMAN;Zinc finger and BTB domain-containing protein 11;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1889507_c0_seq1;GAXK01030426.1;Q11073;9.57E-32;YT45_CAEEL;Uncharacterized protein B0416.5;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1889585_c0_seq1;GAXK01030448.1;Q05481;3.23E-31;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp18897_c0_seq1;GAXK01026412.1;Q2T9K6;0;FEM1C_XENLA;Protein fem-1 homolog C (FEM1c) (FEM1-gamma);"cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0016567";protein ubiquitination [GO:0016567];cytoplasm [GO:0005737];
comp1889733_c0_seq1;GAXK01030427.1;Q3V1N1;5.64E-16;MFHA1_MOUSE;Malignant fibrous histiocytoma-amplified sequence 1 homolog;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; defense response [GO:0006952]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0005525; GO:0005737; GO:0006952; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035308; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745";"defense response [GO:0006952]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121]";cytoplasm [GO:0005737];"GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]"
comp188976_c0_seq1;GAXK01025172.1;O95848;4.18E-29;NUD14_HUMAN;Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14);"cytosol [GO:0005829]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; protein N-linked glycosylation via asparagine [GO:0018279]; ribose phosphate metabolic process [GO:0019693]";"GO:0005829; GO:0006753; GO:0008768; GO:0018279; GO:0019693; GO:0042802; GO:0046872; GO:0047631";"nucleoside phosphate metabolic process [GO:0006753]; protein N-linked glycosylation via asparagine [GO:0018279]; ribose phosphate metabolic process [GO:0019693]";cytosol [GO:0005829];"ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]"
comp18898_c0_seq1;GAXK01026330.1;Q24747;7.66E-36;EXU_DROVI;Maternal protein exuperantia;"protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; bicoid mRNA localization [GO:0045450]";"GO:0003723; GO:0042803; GO:0045450";bicoid mRNA localization [GO:0045450];;"protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp1889872_c0_seq1;GAXK01030434.1;Q95NQ0;1.47E-07;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp18899_c1_seq1;GAXK01026513.1;C4N147;5.41E-19;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp188997_c0_seq1;GAXK01025185.1;Q9Y140;4.16E-73;DHRS7_DROME;Dehydrogenase/reductase SDR family protein 7-like (EC 1.1.-.-);"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; oxidoreductase activity [GO:0016491]";"GO:0005778; GO:0016021; GO:0016491";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";oxidoreductase activity [GO:0016491]
comp189_c33_seq1;GAXK01168304.1;Q13367;0;AP3B2_HUMAN;AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP);"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:0097708; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]";
comp18901_c0_seq1;GAXK01026603.1;P61209;4.94E-120;ARF1_DROME;ADP-ribosylation factor 1;"apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0006893; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386";"ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp18902_c1_seq1;GAXK01026848.1;O11780;1.40E-49;BGH3_PIG;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]";"GO:0005178; GO:0005518; GO:0005615; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840";"cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp18903_c0_seq1;GAXK01026117.1;Q8R344;1.25E-28;CCD12_MOUSE;Coiled-coil domain-containing protein 12;"post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]";"GO:0005684; GO:0071014";;"post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]";
comp1890459_c0_seq1;GAXK01194197.1;P83501;2.24E-20;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp189050_c0_seq1;GAXK01025052.1;Q9JHW4;0;SELB_MOUSE;Selenocysteine-specific elongation factor (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific) (mSelB);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414]";"GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005739; GO:0005829; GO:0006414; GO:0035368; GO:0043021; GO:1990904";"selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]"
comp1890696_c0_seq1;GAXK01194162.1;Q96SR6;6.21E-08;ZN382_HUMAN;Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1) (KS1) (Multiple zinc finger and krueppel-associated box protein KS1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp18907_c0_seq1;GAXK01027122.1;Q1XHY1;1.84E-29;RT18B_PANTR;28S ribosomal protein S18b, mitochondrial (MRP-S18-b) (Mrps18-b) (S18mt-b) (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2);"cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005654; GO:0005739; GO:0005763; GO:0030054; GO:0032543";mitochondrial translation [GO:0032543];"cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";structural constituent of ribosome [GO:0003735]
comp1891367_c0_seq1;GAXK01194190.1;P17608;2.75E-22;RYH1_SCHPO;GTP-binding protein ryh1;"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; positive regulation of TORC2 signaling [GO:1904515]; protein localization to phagophore assembly site [GO:0034497]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0007264; GO:0010008; GO:0032482; GO:0034497; GO:0042147; GO:1904515";"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; positive regulation of TORC2 signaling [GO:1904515]; protein localization to phagophore assembly site [GO:0034497]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; small GTPase mediated signal transduction [GO:0007264]";"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp189141_c0_seq1;GAXK01025500.1;P42325;4.38E-78;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp189145_c0_seq1;GAXK01025145.1;A1ZA47;2.54E-11;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp1891503_c0_seq1;GAXK01194175.1;O75311;1.06E-33;GLRA3_HUMAN;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp18917_c4_seq1;GAXK01027052.1;Q27638;0;G6PD_DROYA;Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) (Fragment);"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";"GO:0004345; GO:0006006; GO:0006098; GO:0006739; GO:0050661; GO:0051156";"glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";;"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]"
comp189224_c2_seq1;GAXK01025175.1;Q8BM14;4.42E-70;LIPK_MOUSE;Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2);"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0016042; GO:0016298; GO:0043231; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]";lipase activity [GO:0016298]
comp189278_c0_seq1;GAXK01025101.1;Q17BA4;3.89E-07;MED15_AEDAE;Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp1893_c4_seq1;GAXK01205897.1;Q9NQX3;1.59E-135;GEPH_HUMAN;"Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038]";"GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007529; GO:0008940; GO:0010038; GO:0014069; GO:0018315; GO:0030054; GO:0030425; GO:0032324; GO:0043546; GO:0045211; GO:0046872; GO:0061598; GO:0061599; GO:0072579; GO:0097112; GO:0098970; GO:0099572; GO:0099634";"establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]"
comp1893019_c0_seq1;GAXK01060715.1;Q95NT6;1.67E-08;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp189318_c0_seq1;GAXK01025423.1;Q8K078;1.22E-116;SO4A1_MOUSE;Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12);"integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";"GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252";"organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";integral component of plasma membrane [GO:0005887];"organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp18933_c0_seq1;GAXK01026318.1;O15514;1.91E-71;RPB4_HUMAN;DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000166; GO:0000288; GO:0000398; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0035019; GO:0042795; GO:0045948; GO:0050434; GO:0060964";"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]"
comp1893306_c0_seq1;GAXK01060716.1;Q32PH1;9.59E-25;CDCA7_BOVIN;Cell division cycle-associated protein 7;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006915; GO:0042127";"apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp1893738_c0_seq1;GAXK01060742.1;Q8JIY1;2.13E-32;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp18940_c4_seq1;GAXK01026138.1;Q9I7U4;0;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp1894297_c0_seq1;GAXK01204313.1;Q8BIQ3;1.80E-18;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp189439_c1_seq1;GAXK01025424.1;P91622;2.16E-139;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp18945_c0_seq1;GAXK01027042.1;Q9UK45;3.76E-51;LSM7_HUMAN;U6 snRNA-associated Sm-like protein LSm7;"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; U6 snRNA binding [GO:0017070]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0005654; GO:0005688; GO:0005689; GO:0005829; GO:0017070; GO:0043928; GO:0046540; GO:0071004; GO:0071005; GO:0071013; GO:0120115; GO:1990726";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA splicing, via spliceosome [GO:0000398]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";U6 snRNA binding [GO:0017070]
comp1894592_c0_seq1;GAXK01204316.1;Q9QY31;1.43E-09;SNAI3_MOUSE;Zinc finger protein SNAI3 (Protein snail homolog 3) (Snail-related gene from muscle cells) (Zinc finger protein 293);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp1894656_c0_seq1;GAXK01204314.1;Q13127;6.62E-07;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1894763_c0_seq1;GAXK01204310.1;Q0V8S9;8.65E-22;CNTP5_CHICK;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]";"GO:0007155; GO:0016021";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];
comp189479_c0_seq1;GAXK01025375.1;Q8LE52;2.90E-13;DHAR3_ARATH;Glutathione S-transferase DHAR3, chloroplastic (EC 2.5.1.18) (Chloride intracellular channel homolog 3) (CLIC homolog 3) (Glutathione-dependent dehydroascorbate reductase 3) (AtDHAR3) (ChlDHAR) (GSH-dependent dehydroascorbate reductase 3) (EC 1.8.5.1);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein glutathionylation [GO:0010731]";"GO:0004364; GO:0009507; GO:0009536; GO:0009570; GO:0009941; GO:0010731; GO:0045174";protein glutathionylation [GO:0010731];"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]";"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]"
comp189508_c2_seq1;GAXK01025181.1;Q70JS2;6.04E-14;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp1895140_c0_seq1;GAXK01204325.1;P0DPW5;3.03E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp189541_c0_seq1;GAXK01025168.1;B7TB45;2.60E-43;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp189599_c3_seq1;GAXK01025100.1;Q6DJM2;8.00E-97;TAM41_XENLA;Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41);"extrinsic component of mitochondrial inner membrane [GO:0031314]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0004605; GO:0016024; GO:0031314; GO:0032049";"cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]";extrinsic component of mitochondrial inner membrane [GO:0031314];phosphatidate cytidylyltransferase activity [GO:0004605]
comp18961_c1_seq1;GAXK01027036.1;Q9NRF9;1.72E-32;DPOE3_HUMAN;DNA polymerase epsilon subunit 3 (EC 2.7.7.7) (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone H3 acetylation [GO:0043966]; nucleosome mobilization [GO:0042766]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005671; GO:0006260; GO:0006270; GO:0006974; GO:0008622; GO:0032201; GO:0034080; GO:0042766; GO:0043966; GO:0046982; GO:0070869; GO:0071480";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone H3 acetylation [GO:0043966]; nucleosome mobilization [GO:0042766]; telomere maintenance via semi-conservative replication [GO:0032201]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]"
comp1896393_c0_seq1;GAXK01163499.1;Q9VWA2;1.40E-27;DCTD_DROME;Probable deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase);"cytoplasm [GO:0005737]; dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]";"GO:0004132; GO:0005737; GO:0006226; GO:0006231; GO:0008270";"dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]";cytoplasm [GO:0005737];"dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]"
comp18964_c0_seq1;GAXK01026898.1;Q7K556;0;TTD14_DROME;TRPL translocation defect protein 14;"cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";"GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300";"photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";cytosol [GO:0005829];"GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]"
comp1896540_c0_seq1;GAXK01163479.1;O43505;7.22E-38;B4GA1_HUMAN;Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1);"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; keratan sulfate biosynthetic process [GO:0018146]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]";"GO:0000139; GO:0005794; GO:0006493; GO:0015020; GO:0018146; GO:0030173; GO:0035269; GO:0046872; GO:0070062";"keratan sulfate biosynthetic process [GO:0018146]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]";"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]";"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp189664_c0_seq1;GAXK01025078.1;Q8CF82;0;ABCA5_RAT;ATP-binding cassette sub-family A member 5;"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol transport [GO:0030301]; lipid transport [GO:0006869]; sterol transport [GO:0015918]";"GO:0000139; GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005794; GO:0006869; GO:0015918; GO:0016021; GO:0016887; GO:0030301; GO:0031902; GO:0042626; GO:0043231";"cholesterol transport [GO:0030301]; lipid transport [GO:0006869]; sterol transport [GO:0015918]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp1897_c9_seq1;GAXK01169541.1;Q3MHL7;0;TCPZ_BOVIN;T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta) (CCT-zeta-1);"chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0032212; GO:0050821; GO:0051082; GO:0071987; GO:1904851";"positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]"
comp189721_c0_seq1;GAXK01025507.1;P82295;3.62E-48;PROML_DROME;Prominin-like protein;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp189769_c0_seq1;GAXK01025119.1;Q80UN1;3.74E-15;KCTD9_MOUSE;BTB/POZ domain-containing protein KCTD9;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602";"intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]"
comp189813_c0_seq1;GAXK01025116.1;Q5RFV4;3.41E-80;R1441_DANRE;Probable E3 ubiquitin-protein ligase RNF144A-A (EC 2.3.2.31) (RING finger protein 144A-A);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp1898184_c0_seq1;GAXK01196917.1;P26714;1.33E-07;GBRB_LYMST;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]";"GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp1898263_c0_seq1;GAXK01196908.1;P51281;2.82E-67;YCF45_PORPU;Uncharacterized protein ycf45 (ORF565);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005524; GO:0009507";;chloroplast [GO:0009507];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]"
comp18983_c0_seq1;GAXK01026357.1;Q175F8;5.06E-154;GLYR1_AEDAE;Putative oxidoreductase GLYR1 homolog (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60 homolog);"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0050661; GO:0051287";;;"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]"
comp189850_c0_seq1;GAXK01025170.1;Q96PQ7;0;KLHL5_HUMAN;Kelch-like protein 5;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]";"GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687";post-translational protein modification [GO:0043687];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";actin binding [GO:0003779]
comp1898604_c0_seq1;GAXK01196915.1;Q8BZK4;1.84E-50;S35F4_MOUSE;Solute carrier family 35 member F4;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]";"GO:0016021; GO:0022857";;integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp1898663_c0_seq1;GAXK01196904.1;P57071;1.19E-09;PRD15_HUMAN;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp18988_c0_seq1;GAXK01026517.1;P05090;4.36E-33;APOD_HUMAN;Apolipoprotein D (Apo-D) (ApoD);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp1898841_c0_seq1;GAXK01196921.1;Q8NFU0;7.66E-76;BEST4_HUMAN;Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp189917_c0_seq1;GAXK01025090.1;O97366;4.69E-37;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp189918_c1_seq1;GAXK01025187.1;Q7Z6E9;2.53E-11;RBBP6_HUMAN;E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis);"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001701; GO:0003723; GO:0004842; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]";"protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1899289_c0_seq1;GAXK01196916.1;P0CK98;5.79E-38;CCD39_DANRE;Coiled-coil domain-containing protein 39;"axoneme [GO:0005930]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159]";"GO:0003341; GO:0005576; GO:0005930; GO:0007368; GO:0036159; GO:0060285; GO:0060287; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159]";"axoneme [GO:0005930]; extracellular region [GO:0005576]";
comp189932_c2_seq1;GAXK01025115.1;D2YVH7;3.86E-14;LECM_OXYSU;C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose-binding isoform 1);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp189951_c1_seq1;GAXK01025088.1;Q8TBR7;4.43E-36;TLC3A_HUMAN;TLC domain-containing protein 3A (Protein CT120) (Protein FAM57A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp189959_c0_seq1;GAXK01025081.1;P58772;6.01E-22;TPM1_RABIT;Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1);"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]";"GO:0005737; GO:0005884; GO:0015629; GO:0031013; GO:0042802; GO:0042803; GO:0046982; GO:0051015";;"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]"
comp189976_c4_seq1;GAXK01025148.1;P38571;3.64E-74;LICH_HUMAN;Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase);"fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]";"GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0044255; GO:0048771; GO:0048873";"cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]";"fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";"lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]"
comp19_c1_seq1;GAXK01165892.1;P34838;0;COX1_ANOGA;Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide I);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005751; GO:0006123; GO:0009060; GO:0015990; GO:0016021; GO:0020037; GO:0046872";"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]";"cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp190028_c1_seq1;GAXK01141399.1;Q8IWB9;9.82E-22;TEX2_HUMAN;Testis-expressed protein 2 (Transmembrane protein 96);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]";"GO:0005783; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021";"lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";lipid binding [GO:0008289]
comp190057_c0_seq1;GAXK01141667.1;Q9D7X8;1.26E-36;GGCT_MOUSE;Gamma-glutamylcyclotransferase (EC 4.3.2.9);"cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836]";"GO:0001836; GO:0003839; GO:0005829; GO:0042803";release of cytochrome c from mitochondria [GO:0001836];cytosol [GO:0005829];"gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]"
comp1900704_c0_seq1;GAXK01075706.1;Q6P9T8;2.23E-15;TBB4B_RAT;Tubulin beta-4B chain (Tubulin beta-2C chain);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp190075_c1_seq1;GAXK01141577.1;Q1H9T6;1.40E-21;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp1900916_c0_seq1;GAXK01075695.1;Q5G872;1.93E-16;SCUB2_DANRE;Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein You);"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; blood circulation [GO:0008015]; muscle cell fate specification [GO:0042694]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; striated muscle cell differentiation [GO:0051146]";"GO:0001756; GO:0005509; GO:0005576; GO:0005615; GO:0007224; GO:0007517; GO:0008015; GO:0009897; GO:0009986; GO:0030141; GO:0042694; GO:0048747; GO:0051146";"blood circulation [GO:0008015]; muscle cell fate specification [GO:0042694]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; striated muscle cell differentiation [GO:0051146]";"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]";calcium ion binding [GO:0005509]
comp1901_c0_seq1;GAXK01168585.1;P62752;1.86E-49;RL23A_RAT;60S ribosomal protein L23a;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0022625; GO:0070180; GO:1904841";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]"
comp1901479_c0_seq1;GAXK01075712.1;Q9W534;6.18E-15;MOODY_DROME;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp1901672_c0_seq1;GAXK01075681.1;Q9HFV1;1.19E-11;CYB5_RHIST;Cytochrome b5;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005789; GO:0016021; GO:0020037; GO:0046872; GO:0055114";oxidation-reduction process [GO:0055114];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp1901739_c0_seq1;GAXK01075722.1;Q9WTJ4;5.24E-09;FIZ1_MOUSE;Flt3-interacting zinc finger protein 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; receptor tyrosine kinase binding [GO:0030971]; positive regulation of protein phosphorylation [GO:0001934]";"GO:0001934; GO:0003676; GO:0005634; GO:0005737; GO:0030971; GO:0046872";positive regulation of protein phosphorylation [GO:0001934];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; receptor tyrosine kinase binding [GO:0030971]"
comp190201_c1_seq1;GAXK01141546.1;O00548;1.10E-10;DLL1_HUMAN;Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957]; astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; nephron development [GO:0072006]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323]";"GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030154; GO:0030155; GO:0030857; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0048839; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726";"astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; nephron development [GO:0072006]; neuronal stem cell population maintenance [GO:0097150]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; proximal tubule development [GO:0072014]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957]"
comp1902027_c0_seq1;GAXK01108508.1;Q14593;2.12E-10;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp190212_c2_seq1;GAXK01141329.1;Q6PCN7;3.40E-120;HLTF_MOUSE;Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (P113) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3) (TNF-response element-binding protein);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; helicase activity [GO:0004386]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0001228; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0006357; GO:0008270; GO:0016887; GO:0031625; GO:0045944; GO:0061630";"chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; helicase activity [GO:0004386]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp19022_c0_seq1;GAXK01026346.1;Q9VMM6;5.09E-20;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp1902327_c0_seq1;GAXK01108509.1;O14771;2.53E-18;ZN213_HUMAN;Zinc finger protein 213 (Putative transcription factor CR53) (Zinc finger protein with KRAB and SCAN domains 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp190253_c0_seq1;GAXK01141327.1;B7Z031;1.93E-64;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp190282_c0_seq1;GAXK01205812.1;P09077;9.05E-51;SCR_DROME;Homeotic protein Sex combs reduced;"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland boundary specification [GO:0007432]; sex comb development [GO:0045498]; sex differentiation [GO:0007548]";"GO:0000977; GO:0001228; GO:0005634; GO:0007432; GO:0007494; GO:0007548; GO:0009952; GO:0033613; GO:0042803; GO:0043565; GO:0045498; GO:0045944";"anterior/posterior pattern specification [GO:0009952]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland boundary specification [GO:0007432]; sex comb development [GO:0045498]; sex differentiation [GO:0007548]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp1902858_c0_seq1;GAXK01108515.1;Q9FN19;2.45E-07;HOS15_ARATH;WD40 repeat-containing protein HOS15 (HIGH OSMOTIC STRESS GENE EXPRESSION 15);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]";"GO:0000118; GO:0003714; GO:0005634; GO:0006357; GO:0009409; GO:0016575; GO:0080008";"histone deacetylation [GO:0016575]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]";transcription corepressor activity [GO:0003714]
comp190291_c0_seq1;GAXK01141708.1;Q5ZI51;5.88E-73;ARHL2_CHICK;ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]";"GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0061463; GO:0090734; GO:0140290; GO:0140292";"DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]";"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"
comp190308_c4_seq1;GAXK01141632.1;Q99PV3;0;MKLN1_RAT;Muskelin;"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytosol [GO:0005829]; ruffle [GO:0001726]; synapse [GO:0045202]; protein homodimerization activity [GO:0042803]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]";"GO:0001726; GO:0002090; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030054; GO:0031532; GO:0042803; GO:0045202";"actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]";"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytosol [GO:0005829]; ruffle [GO:0001726]; synapse [GO:0045202]";protein homodimerization activity [GO:0042803]
comp1903094_c0_seq1;GAXK01108511.1;Q4KL91;2.40E-28;S36A4_XENLA;Proton-coupled amino acid transporter 4 (Proton/amino acid transporter 4) (Solute carrier family 36 member 4);"integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]";"GO:0006865; GO:0015293; GO:0016021";amino acid transport [GO:0006865];integral component of membrane [GO:0016021];symporter activity [GO:0015293]
comp190310_c0_seq1;GAXK01141359.1;P29503;5.66E-10;NEUR_DROME;Protein neuralized;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007398; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030707; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981";"asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp19033_c0_seq1;GAXK01026583.1;Q4G012;7.04E-19;FMC1_RAT;Protein FMC1 homolog (Formation of mitochondrial complex V assembly factor 1 homolog);"mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; negative regulation of lipid catabolic process [GO:0050995]; regulation of type B pancreatic cell proliferation [GO:0061469]";"GO:0005739; GO:0033615; GO:0050995; GO:0061469";"mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; negative regulation of lipid catabolic process [GO:0050995]; regulation of type B pancreatic cell proliferation [GO:0061469]";mitochondrion [GO:0005739];
comp190373_c0_seq1;GAXK01141547.1;P59889;6.97E-25;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp1903876_c0_seq1;GAXK01108502.1;Q7XJS0;6.50E-14;ASHR1_ARATH;Histone-lysine N-methyltransferase ASHR1 (EC 2.1.1.43) (ASH1-related protein 1) (Protein SET DOMAIN GROUP 37);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005694; GO:0018024; GO:0046872";;"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]"
comp19039_c1_seq1;GAXK01026672.1;Q9CPV4;8.88E-116;GLOD4_MOUSE;Glyoxalase domain-containing protein 4;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp190398_c7_seq1;GAXK01141312.1;A8C756;4.00E-24;THADA_MOUSE;Thyroid adenoma-associated protein homolog;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]";"GO:0005783; GO:0005829; GO:0030488; GO:0032471; GO:0055088";"lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";
comp1904079_c0_seq1;GAXK01068894.1;P91685;0;GRM_DROME;Metabotropic glutamate receptor (DmGluRA);"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553";"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp190429_c0_seq1;GAXK01141478.1;Q0DZP5;4.73E-14;CML17_ORYSJ;Probable calcium-binding protein CML17 (Calmodulin-like protein 17);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1904501_c0_seq1;GAXK01068881.1;A6QNK1;7.85E-26;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp1904784_c0_seq1;GAXK01068886.1;P83088;5.58E-39;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp190482_c0_seq1;GAXK01141360.1;P30281;1.90E-48;CCND3_HUMAN;G1/S-specific cyclin-D3;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]";"GO:0000079; GO:0000122; GO:0000307; GO:0001934; GO:0004693; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0016020; GO:0016538; GO:0019901; GO:0042098; GO:0042127; GO:0044772; GO:0045737; GO:0046626; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp1905093_c0_seq1;GAXK01068882.1;Q95NT6;1.36E-15;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp1905329_c0_seq1;GAXK01068896.1;Q6DHG0;4.46E-09;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp190555_c0_seq1;GAXK01141318.1;Q66S03;5.55E-27;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp190593_c0_seq1;GAXK01141549.1;Q02290;2.03E-10;XYNB_NEOPA;Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B);"extracellular region [GO:0005576]; cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0005576; GO:0030248; GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];extracellular region [GO:0005576];"cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]"
comp1906256_c0_seq1;GAXK01136497.1;Q9ULL8;3.54E-11;SHRM4_HUMAN;Protein Shroom4 (Second homolog of apical protein);"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"GO:0001725; GO:0005737; GO:0005884; GO:0005912; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0045159; GO:0050890; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; myosin II binding [GO:0045159]"
comp190635_c0_seq1;GAXK01141637.1;Q91428;1.21E-42;GATA3_DANRE;Transcription factor GATA-3 (GATA-binding factor 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000978; GO:0000981; GO:0002520; GO:0005634; GO:0008270; GO:0008284; GO:0008543; GO:0021514; GO:0030856; GO:0031101; GO:0042246; GO:0043049; GO:0045582; GO:0048568; GO:0048702; GO:0050769; GO:0060788; GO:0061026; GO:0071696; GO:2001224";"cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp1906599_c0_seq1;GAXK01136470.1;P08537;1.99E-85;TBA_XENLA;Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp1906654_c0_seq1;GAXK01136506.1;Q96GW7;1.89E-10;PGCB_HUMAN;Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0098978";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp1906969_c0_seq1;GAXK01136499.1;Q866F1;2.67E-22;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp19070_c0_seq1;GAXK01026165.1;Q5ZL00;3.66E-103;EMC1_CHICK;ER membrane protein complex subunit 1;"ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975]";"GO:0016021; GO:0034975; GO:0072546";protein folding in endoplasmic reticulum [GO:0034975];"ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]";
comp190704_c0_seq1;GAXK01141598.1;P42260;0;GRIK2_RAT;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp190709_c2_seq1;GAXK01141662.1;Q66JF3;4.60E-123;MKNK1_XENTR;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp1907670_c0_seq1;GAXK01136466.1;Q6GL52;1.64E-10;ZN574_XENTR;Zinc finger protein 574;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp190771_c0_seq1;GAXK01141328.1;P35831;1.00E-29;PTN12_MOUSE;Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (MPTP-PEST) (Protein-tyrosine phosphatase P19) (P19-PTP);"cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; podosome [GO:0002102]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to epidermal growth factor stimulus [GO:0071364]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]";"GO:0002102; GO:0004721; GO:0004725; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0042995; GO:0071364";"cellular response to epidermal growth factor stimulus [GO:0071364]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]";"cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; podosome [GO:0002102]";"phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]"
comp19079_c1_seq1;GAXK01026918.1;Q7K4Q5;6.30E-81;Y0417_DROME;Probable protein phosphatase CG10417 (EC 3.1.3.16);"cytoplasm [GO:0005737]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]";"GO:0004722; GO:0004724; GO:0005737; GO:0006470; GO:0046872";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp190814_c7_seq1;GAXK01141580.1;Q32KI9;2.52E-98;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp1908145_c0_seq1;GAXK01075877.1;Q7NBW0;2.47E-14;DNAJ_MYCGA;Chaperone protein DnaJ;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082";"DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp19082_c0_seq1;GAXK01026553.1;P56182;3.39E-48;RRP1_HUMAN;Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein);"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0030687; GO:0030688";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]";RNA binding [GO:0003723]
comp1908334_c0_seq1;GAXK01075871.1;B2RY50;8.66E-78;ARMC4_MOUSE;Armadillo repeat-containing protein 4;"axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]";"GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]";"axoneme [GO:0005930]; ciliary base [GO:0097546]";
comp190848_c0_seq1;GAXK01141739.1;Q27712;7.23E-88;CP2L1_PANAR;Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp19086_c1_seq1;GAXK01026444.1;A4IGH4;1.54E-31;WDR4_DANRE;tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit wdr4 (WD repeat-containing protein 4);"cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]";"GO:0005634; GO:0005829; GO:0006400; GO:0043527; GO:0106004";"tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]";"cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]";
comp1908790_c0_seq1;GAXK01075876.1;Q20065;7.03E-56;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp19090_c3_seq1;GAXK01026534.1;P54622;3.04E-30;SSBP_DROME;Single-stranded DNA-binding protein, mitochondrial (Dm mtSSB) (Mt-SSB) (MtSSB) (Protein low power);"mitochondrial chromosome [GO:0000262]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; single-stranded DNA binding [GO:0003697]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]; positive regulation of helicase activity [GO:0051096]";"GO:0000002; GO:0000262; GO:0003697; GO:0005739; GO:0006264; GO:0042645; GO:0051096";"mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]; positive regulation of helicase activity [GO:0051096]";"mitochondrial chromosome [GO:0000262]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]";single-stranded DNA binding [GO:0003697]
comp190901_c1_seq1;GAXK01141695.1;Q99758;0;ABCA3_HUMAN;ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3);"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233";"cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp190907_c0_seq1;GAXK01141559.1;P82186;2.69E-26;GUN_MYTED;Endoglucanase (EC 3.2.1.4) (CMCase) (Cellulase) (Endo-1,4-beta-glucanase);"cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245";cellulose catabolic process [GO:0030245];;cellulase activity [GO:0008810]
comp190931_c0_seq1;GAXK01141557.1;Q99615;1.25E-90;DNJC7_HUMAN;DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";heat shock protein binding [GO:0031072]
comp1909406_c0_seq1;GAXK01075864.1;A9ZSY3;6.97E-26;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp19097_c0_seq1;GAXK01026592.1;P62997;2.12E-29;TRA2B_RAT;Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0048026; GO:0048471; GO:1990904";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp190976_c1_seq1;GAXK01141527.1;Q80XQ2;1.98E-82;TBCD5_MOUSE;TBC1 domain family member 5;"AP-2 adaptor complex [GO:0030122]; Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0010008; GO:0016236; GO:0017137; GO:0030122; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0090630; GO:1905394; GO:1990316";"activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]";"AP-2 adaptor complex [GO:0030122]; Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]";"AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]"
comp190998_c1_seq1;GAXK01141597.1;Q9N294;2.51E-08;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp191010_c0_seq1;GAXK01141737.1;Q7UM18;2.99E-13;Y9128_RHOBA;UPF0314 protein RB9128;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp191024_c1_seq1;GAXK01141678.1;A2AH22;3.94E-55;AMRA1_MOUSE;Activating molecule in BECN1-regulated autophagy protein 1;"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; GTPase binding [GO:0051020]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to mitochondrial depolarisation [GO:0098780]";"GO:0000045; GO:0000422; GO:0000423; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0005930; GO:0006914; GO:0008285; GO:0009267; GO:0010508; GO:0010667; GO:0021915; GO:0030154; GO:0031625; GO:0043524; GO:0043552; GO:0045335; GO:0051020; GO:0098780";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to mitochondrial depolarisation [GO:0098780]";"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]";"GTPase binding [GO:0051020]; ubiquitin protein ligase binding [GO:0031625]"
comp1910287_c0_seq1;GAXK01024222.1;Q6H1V1;9.91E-18;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp1910824_c0_seq1;GAXK01024206.1;Q5SVQ8;2.07E-18;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp191092_c4_seq1;GAXK01141571.1;Q8BTY2;6.12E-100;S4A7_MOUSE;Sodium bicarbonate cotransporter 3 (Solute carrier family 4 member 7);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cochlear nucleus development [GO:0021747]; regulation of intracellular pH [GO:0051453]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal cell programmed cell death [GO:0046666]; visual perception [GO:0007601]";"GO:0005452; GO:0005737; GO:0005886; GO:0005887; GO:0007601; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0021747; GO:0031410; GO:0032420; GO:0045202; GO:0046666; GO:0051453; GO:0060117; GO:0060219; GO:0061299";"auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cochlear nucleus development [GO:0021747]; regulation of intracellular pH [GO:0051453]; retinal cell programmed cell death [GO:0046666]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]";"inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]"
comp1911029_c0_seq1;GAXK01024221.1;P23607;8.10E-09;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1911038_c0_seq1;GAXK01024210.1;Q5U206;5.43E-18;CALL3_RAT;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp191139_c0_seq1;GAXK01141515.1;A6QP15;0;HOT_BOVIN;Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1);"mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]";"GO:0004022; GO:0005739; GO:0006539; GO:0046872; GO:0047988";glutamate catabolic process via 2-oxoglutarate [GO:0006539];mitochondrion [GO:0005739];"alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]"
comp19118_c1_seq1;GAXK01027028.1;Q7KRI2;2.43E-37;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp1912_c0_seq1;GAXK01170186.1;P32429;8.79E-48;RL7A_CHICK;60S ribosomal protein L7a;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp1912232_c0_seq1;GAXK01037730.1;Q8BKK5;9.38E-13;ZN689_MOUSE;Zinc finger protein 689;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";"GO:0003677; GO:0005634; GO:0006355; GO:0035914; GO:0046872";"regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1912296_c0_seq1;GAXK01037724.1;Q236T0;7.08E-51;RL32_TETTS;60S ribosomal protein L32;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp19123_c0_seq1;GAXK01026101.1;Q804H7;2.12E-36;BI52B_XENLA;Baculoviral IAP repeat-containing protein 5.2-B (Survivin in Xenopus) (SIX) (Survivin2-B) (XSurvivin2B);"chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944]";"GO:0000777; GO:0001944; GO:0005634; GO:0005737; GO:0005819; GO:0006468; GO:0007049; GO:0007059; GO:0030496; GO:0032133; GO:0043066; GO:0045892; GO:0046872; GO:0046965; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944]";"chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]";"metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]"
comp1913343_c0_seq1;GAXK01037749.1;A2A2Z9;2.81E-08;AN18B_HUMAN;Ankyrin repeat domain-containing protein 18B;;;;;
comp1913548_c0_seq1;GAXK01037752.1;Q5F478;4.75E-08;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp191386_c2_seq1;GAXK01141709.1;Q14591;1.28E-24;ZN271_HUMAN;Deleted.;;;;;
comp1914_c1_seq1;GAXK01165885.1;O95757;8.17E-177;HS74L_HUMAN;Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986";"protein folding [GO:0006457]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp19140_c0_seq1;GAXK01026938.1;P38401;2.55E-115;GNAI1_CAVPO;Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein);"cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]";"GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005886; GO:0007049; GO:0007186; GO:0007188; GO:0019003; GO:0030496; GO:0031683; GO:0043949; GO:0051301; GO:0060236; GO:0099738; GO:1904322; GO:1904778";"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]";"cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp191422_c0_seq1;GAXK01141517.1;Q9UI36;1.08E-45;DACH1_HUMAN;Dachshund homolog 1 (Dach1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279";"cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp19143_c0_seq1;GAXK01026587.1;Q7L5D6;4.46E-88;GET4_HUMAN;Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35);"BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]";"GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378";"cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]";"BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";chaperone binding [GO:0051087]
comp1915110_c0_seq1;GAXK01015387.1;Q5RES8;9.12E-21;ZN334_PONAB;Zinc finger protein 334;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1915277_c0_seq1;GAXK01015393.1;P00765;1.60E-34;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp191548_c0_seq1;GAXK01141319.1;P51163;1.82E-27;HEM4_MOUSE;Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; cofactor binding [GO:0048037]; uroporphyrinogen-III synthase activity [GO:0004852]; cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to antibiotic [GO:0046677]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780]";"GO:0004852; GO:0005739; GO:0005829; GO:0006779; GO:0006780; GO:0006782; GO:0006783; GO:0046677; GO:0048037; GO:0070541; GO:0071243; GO:0071418";"cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to antibiotic [GO:0046677]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"cofactor binding [GO:0048037]; uroporphyrinogen-III synthase activity [GO:0004852]"
comp1915799_c0_seq1;GAXK01015401.1;Q9TUD4;1.88E-10;FUT1_GORGO;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp191589_c3_seq1;GAXK01141663.1;P54583;5.62E-48;GUN1_ACIC1;Endoglucanase E1 (EC 3.2.1.4) (Cellulase E1) (Endo-1,4-beta-glucanase E1) (Endocellulase E1);"cellulase activity [GO:0008810]; polysaccharide binding [GO:0030247]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030247";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; polysaccharide binding [GO:0030247]"
comp1916106_c0_seq1;GAXK01196899.1;Q5SUV1;9.04E-12;RSAD1_MOUSE;Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone);"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]";"GO:0004109; GO:0005739; GO:0006779; GO:0046872; GO:0051539";porphyrin-containing compound biosynthetic process [GO:0006779];mitochondrion [GO:0005739];"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]"
comp1916480_c0_seq1;GAXK01196900.1;Q0Q028;1.90E-26;DFP3_ANTMY;Putative defense protein 3 (DFP-3);"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp19165_c1_seq1;GAXK01026464.1;B8XY56;1.99E-30;RNT2_DANRE;Ribonuclease T2 (EC 3.1.27.-) (RNase Dre2);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; endoribonuclease activity [GO:0004521]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]";"GO:0003723; GO:0004521; GO:0005576; GO:0005788; GO:0006401; GO:0016075; GO:0033897; GO:0043202";"RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]";"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]";"endoribonuclease activity [GO:0004521]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]"
comp191674_c0_seq1;GAXK01141317.1;Q9GV16;1.36E-43;EGCSE_CYANO;Endoglycoceramidase (EGCase) (EC 3.2.1.123) (Glycosphingolipid-specific enzyme) (GSL-specific enzyme);"extracellular region [GO:0005576]; nematocyst [GO:0042151]; endoglycosylceramidase activity [GO:0047876]; cellulose catabolic process [GO:0030245]";"GO:0005576; GO:0030245; GO:0042151; GO:0047876";cellulose catabolic process [GO:0030245];"extracellular region [GO:0005576]; nematocyst [GO:0042151]";endoglycosylceramidase activity [GO:0047876]
comp191686_c2_seq1;GAXK01141397.1;Q7KRI2;1.36E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp191693_c1_seq1;GAXK01141593.1;Q6NY74;4.10E-158;RFA1_DANRE;Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1);"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0007507; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321";"DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]";"damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]"
comp1917218_c0_seq1;GAXK01196891.1;Q22AX5;2.01E-69;RL9_TETTS;60S ribosomal protein L9;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp191727_c0_seq1;GAXK01141676.1;Q8VCX6;1.40E-65;KPTN_MOUSE;KICSTOR complex protein kaptin;"KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262";"actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]";actin filament binding [GO:0051015]
comp19175_c0_seq1;GAXK01026604.1;P16332;0;MUTA_MOUSE;Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]";"GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009791; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341";"homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]"
comp191763_c1_seq1;GAXK01141579.1;Q9CXG9;7.14E-33;PHF19_MOUSE;PHD finger protein 19 (Polycomb-like protein 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]";"GO:0000122; GO:0003700; GO:0005634; GO:0006325; GO:0019827; GO:0035064; GO:0043565; GO:0045893; GO:0046872; GO:0048863; GO:0061087";"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; sequence-specific DNA binding [GO:0043565]"
comp191772_c0_seq1;GAXK01141701.1;Q5RBN8;1.25E-63;LIN54_PONAB;Protein lin-54 homolog;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]";"GO:0003677; GO:0005634; GO:0007049; GO:0046872";cell cycle [GO:0007049];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1917908_c0_seq1;GAXK01196880.1;P08159;9.23E-14;HDNO_PSEOX;6-hydroxy-D-nicotine oxidase (6-HDNO) (EC 1.5.3.6);"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]; nicotine catabolic process [GO:0019608]";"GO:0018530; GO:0019608; GO:0071949";nicotine catabolic process [GO:0019608];;"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]"
comp1918077_c0_seq1;GAXK01163511.1;Q2T9W3;5.73E-37;CCD63_BOVIN;Coiled-coil domain-containing protein 63;"axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]";"GO:0003341; GO:0005930; GO:0007286; GO:0036158";"cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]";axoneme [GO:0005930];
comp191846_c0_seq1;GAXK01141548.1;Q6X936;4.54E-23;KIRR1_RAT;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]";myosin binding [GO:0017022]
comp1918649_c0_seq1;GAXK01163546.1;O35904;1.87E-166;PK3CD_MOUSE;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell homeostasis [GO:0001782]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; defense response to fungus [GO:0050832]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]";"GO:0001782; GO:0002250; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006935; GO:0006954; GO:0007166; GO:0010628; GO:0010629; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030154; GO:0030335; GO:0033031; GO:0035005; GO:0036092; GO:0042113; GO:0045087; GO:0046854; GO:0046934; GO:0048015; GO:0048872; GO:0050832; GO:0052812";"adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell homeostasis [GO:0001782]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; defense response to fungus [GO:0050832]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]";"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"
comp1918784_c0_seq1;GAXK01163539.1;P0DPW4;1.49E-10;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp1919_c0_seq1;GAXK01169483.1;Q68EW1;4.93E-26;RTN3B_XENLA;Reticulon-3-B (RTN3.2);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005789; GO:0016021; GO:0016192";vesicle-mediated transport [GO:0016192];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp1919023_c0_seq1;GAXK01163540.1;B5BLW5;1.50E-16;ARE_SACSO;Arylesterase (A-esterase) (EC 3.1.1.2) (Paraoxonase) (EC 3.1.8.1);"aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; aromatic compound catabolic process [GO:0019439]";"GO:0004063; GO:0004064; GO:0019439";aromatic compound catabolic process [GO:0019439];;"aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]"
comp1919144_c0_seq1;GAXK01163561.1;Q9VA73;0;CMC_DROME;Calcium-binding mitochondrial carrier protein Aralar1;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490";"aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]"
comp1919243_c0_seq1;GAXK01163534.1;Q6JQN1;3.76E-15;ACD10_HUMAN;Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; fatty acid beta-oxidation [GO:0006635]";"GO:0003995; GO:0005739; GO:0005759; GO:0006635; GO:0016787; GO:0050660";fatty acid beta-oxidation [GO:0006635];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]"
comp19193_c1_seq1;GAXK01026589.1;Q24298;0;CADE_DROME;DE-cadherin (Protein shotgun);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; determination of digestive tract left/right asymmetry [GO:0071907]; establishment or maintenance of cell polarity [GO:0007163]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of an epithelium [GO:0002009]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; optic lobe placode development [GO:0001748]; outflow tract morphogenesis [GO:0003151]; ovarian follicle cell migration [GO:0007297]; pole cell migration [GO:0007280]; positive regulation of border follicle cell migration [GO:1903688]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]";"GO:0000902; GO:0001738; GO:0001745; GO:0001748; GO:0002009; GO:0003151; GO:0005509; GO:0005886; GO:0005887; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0005938; GO:0007155; GO:0007156; GO:0007163; GO:0007280; GO:0007281; GO:0007297; GO:0007298; GO:0007314; GO:0007370; GO:0007379; GO:0007399; GO:0007409; GO:0007411; GO:0007420; GO:0007424; GO:0007435; GO:0007506; GO:0007507; GO:0008013; GO:0008258; GO:0008354; GO:0008356; GO:0008406; GO:0010004; GO:0016318; GO:0016339; GO:0016342; GO:0017022; GO:0030031; GO:0030175; GO:0030708; GO:0030720; GO:0035019; GO:0035099; GO:0035147; GO:0035160; GO:0035212; GO:0035262; GO:0036099; GO:0042060; GO:0042803; GO:0043296; GO:0044331; GO:0045176; GO:0045186; GO:0048477; GO:0050832; GO:0055037; GO:0071907; GO:0090254; GO:0098609; GO:0098730; GO:1903688";"apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; determination of digestive tract left/right asymmetry [GO:0071907]; establishment or maintenance of cell polarity [GO:0007163]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of a polarized epithelium [GO:0001738]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; optic lobe placode development [GO:0001748]; outflow tract morphogenesis [GO:0003151]; ovarian follicle cell migration [GO:0007297]; pole cell migration [GO:0007280]; positive regulation of border follicle cell migration [GO:1903688]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]";"beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]"
comp191941_c0_seq1;GAXK01141594.1;Q91ZE0;9.39E-73;TMLH_MOUSE;Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]";"GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353; GO:0051354";"carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"
comp19202_c0_seq1;GAXK01026537.1;P26640;0;SYVC_HUMAN;Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS);"cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438";"tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]";cytosol [GO:0005829];"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]"
comp1920325_c0_seq1;GAXK01001951.1;Q4LBB6;2.02E-34;OCTB3_DROME;Octopamine receptor beta-3R (DmOct-beta-3R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004989; GO:0005887; GO:0007186; GO:0007189; GO:0008227; GO:0016021";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]"
comp192084_c0_seq1;GAXK01118891.1;Q5NU14;8.97E-32;MKRN1_TAKRU;Probable E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-1);"metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0016740; GO:0046872";protein ubiquitination [GO:0016567];;"metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp19222_c2_seq1;GAXK01026674.1;Q9UJW0;1.69E-123;DCTN4_HUMAN;Dynactin subunit 4 (Dyn4) (Dynactin subunit p62);"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097]";"GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005925; GO:0005938; GO:0006888; GO:0007097; GO:0019886; GO:0030017; GO:0047485";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097]";"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]";protein N-terminus binding [GO:0047485]
comp19223_c0_seq1;GAXK01026016.1;P20481;6.78E-17;BUCC_APLCA;"Buccalin [Cleaved into: Buccalin-D; Buccalin-E; Buccalin-F; Buccalin-G; Buccalin-H; Buccalin-A; Buccalin-I; Buccalin-J; Buccalin-K; Buccalin-L; Buccalin-B (BUCb); Buccalin-M; Buccalin gene-predicted acidic peptide A (BGPAP A); Buccalin-N; Buccalin-O; Buccalin-P; Buccalin-Q; Buccalin-R; Buccalin-C; Buccalin-S; Buccalin gene-predicted acidic peptide B (BGPAP B)]";"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp1922568_c0_seq1;GAXK01009133.1;Q8VIG1;8.15E-23;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp1922919_c0_seq1;GAXK01009132.1;Q9W0T5;5.66E-18;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp1922920_c0_seq1;GAXK01009150.1;A6H730;1.21E-60;PPAP_BOVIN;Prostatic acid phosphatase (EC 3.1.3.2);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"GO:0003993; GO:0005615; GO:0005886; GO:0006772; GO:0008253; GO:0012506; GO:0016311; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168";"adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]"
comp19231_c0_seq1;GAXK01026333.1;Q6TNS2;7.22E-73;PK1IP_DANRE;p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like);"nucleolus [GO:0005730]; negative regulation of signal transduction [GO:0009968]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0005730; GO:0009968; GO:0042273";"negative regulation of signal transduction [GO:0009968]; ribosomal large subunit biogenesis [GO:0042273]";nucleolus [GO:0005730];
comp1923130_c1_seq1;GAXK01009141.1;O75636;1.35E-10;FCN3_HUMAN;Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (Hakata antigen);"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; recognition of apoptotic cell [GO:0043654]";"GO:0001867; GO:0003823; GO:0005576; GO:0005581; GO:0006956; GO:0030246; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:1902679";"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; recognition of apoptotic cell [GO:0043654]";"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]";"antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp192330_c0_seq1;GAXK01118828.1;Q17771;1.02E-13;NHR35_CAEEL;Nuclear hormone receptor family member nhr-35;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp192334_c0_seq1;GAXK01118915.1;Q803E0;2.38E-32;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp1923363_c0_seq1;GAXK01009148.1;Q3MJ62;3.51E-07;ZSC23_HUMAN;Zinc finger and SCAN domain-containing protein 23 (Zinc finger protein 390) (Zinc finger protein 453);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp19234_c0_seq1;GAXK01026415.1;O75792;2.16E-99;RNH2A_HUMAN;Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]";"GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872";"DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]";"metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp1923483_c0_seq1;GAXK01009145.1;Q16KI5;1.26E-100;TULP1_AEDAE;Protein king tubby 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp1923819_c0_seq1;GAXK01009134.1;Q5SPC5;1.23E-71;OTOF_DANRE;Otoferlin (Fer-1-like protein 2);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; neuromuscular process controlling balance [GO:0050885]; response to auditory stimulus [GO:0010996]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005789; GO:0010996; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0050885";"neuromuscular process controlling balance [GO:0050885]; response to auditory stimulus [GO:0010996]; synaptic vesicle exocytosis [GO:0016079]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp1924_c2_seq1;GAXK01168233.1;Q6NY74;5.55E-167;RFA1_DANRE;Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1);"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0007507; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321";"DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]";"damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]"
comp19245_c0_seq1;GAXK01026097.1;Q90972;4.04E-47;RNF13_CHICK;E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (C-RZF) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005654; GO:0005765; GO:0005829; GO:0006511; GO:0016021; GO:0031902; GO:0046872; GO:0051865; GO:0061630";"protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp192483_c0_seq1;GAXK01118929.1;Q8UWA5;1.85E-24;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp1924851_c0_seq1;GAXK01042861.1;P91829;2.49E-15;NHR69_CAEEL;Nuclear hormone receptor family member nhr-69;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0046332; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp1925049_c0_seq1;GAXK01042866.1;O15973;4.81E-11;OPSD1_MIZYE;Rhodopsin, GQ-coupled (GQ-rhodopsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp19251_c0_seq1;GAXK01027039.1;P79733;2.67E-169;RIR2_DANRE;Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit);"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]";"GO:0004748; GO:0005829; GO:0005971; GO:0006260; GO:0009263; GO:0046872";"deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]";"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]";"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"
comp1925851_c0_seq1;GAXK01042869.1;Q03720;4.32E-11;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp192602_c1_seq1;GAXK01119016.1;A4IGL7;3.72E-106;PXDN_XENTR;Peroxidasin (EC 1.11.1.7);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp1926152_c0_seq1;GAXK01190583.1;Q5R7I8;9.58E-11;ZNF19_PONAB;Zinc finger protein 19;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp192620_c0_seq1;GAXK01118969.1;Q8BGX0;0;TRI23_MOUSE;E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0003676; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006471; GO:0006886; GO:0006893; GO:0008270; GO:0016192; GO:0016567; GO:0019003; GO:0042802";"Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp192670_c0_seq1;GAXK01118819.1;P15370;1.01E-46;EGON_DROME;Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp192676_c3_seq1;GAXK01118926.1;Q9Z2D6;3.39E-08;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp1926978_c0_seq1;GAXK01190587.1;Q6ZMG9;3.85E-40;CERS6_HUMAN;Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"GO:0000981; GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0050291";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]"
comp1927_c0_seq1;GAXK01169194.1;Q805B4;4.88E-34;TISDB_XENLA;mRNA decay activator protein ZFP36L2-B (CCCH zinc finger protein 3-B) (XC3H-3b) (Zinc finger protein 36, C3H1 type-like 2-B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; definitive hemopoiesis [GO:0060216]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; MAPK cascade [GO:0000165]; mRNA catabolic process [GO:0006402]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; negative regulation of stem cell differentiation [GO:2000737]; nephron tubule development [GO:0072080]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; pronephric nephron tubule development [GO:0039020]; pronephros development [GO:0048793]; regulation of B cell differentiation [GO:0045577]; regulation of mRNA stability [GO:0043488]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]";"GO:0000165; GO:0000288; GO:0003677; GO:0005634; GO:0005737; GO:0006402; GO:0030097; GO:0031086; GO:0035019; GO:0035925; GO:0039020; GO:0043488; GO:0044344; GO:0045577; GO:0045599; GO:0046872; GO:0048103; GO:0048793; GO:0060216; GO:0061158; GO:0070371; GO:0071356; GO:0071364; GO:0071385; GO:0071560; GO:0072080; GO:0097011; GO:1900153; GO:1901991; GO:2000737";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; definitive hemopoiesis [GO:0060216]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; MAPK cascade [GO:0000165]; mRNA catabolic process [GO:0006402]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; negative regulation of stem cell differentiation [GO:2000737]; nephron tubule development [GO:0072080]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; pronephric nephron tubule development [GO:0039020]; pronephros development [GO:0048793]; regulation of B cell differentiation [GO:0045577]; regulation of mRNA stability [GO:0043488]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]"
comp1927089_c0_seq1;GAXK01190577.1;Q9YHZ5;1.30E-84;PIM2_DANRE;Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Kinase pim-1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007346; GO:0030097; GO:0043066; GO:0046777";"apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1927222_c0_seq1;GAXK01190588.1;A4UHC0;4.45E-10;CALM_ALEFU;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp19278_c0_seq1;GAXK01027113.1;P10158;3.37E-13;FOSL1_RAT;Fos-related antigen 1 (FRA-1);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to extracellular stimulus [GO:0031668]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; vitellogenesis [GO:0007296]";"GO:0000978; GO:0001228; GO:0001701; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0007296; GO:0007565; GO:0007612; GO:0008285; GO:0009612; GO:0009629; GO:0014070; GO:0031668; GO:0032570; GO:0034097; GO:0042493; GO:0042542; GO:0042734; GO:0043005; GO:0043065; GO:0043231; GO:0045787; GO:0045944; GO:0051091; GO:0051412; GO:0051591; GO:0060674; GO:0061614; GO:2000144";"cellular response to extracellular stimulus [GO:0031668]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; vitellogenesis [GO:0007296]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1927882_c0_seq1;GAXK01190592.1;Q1HPS0;2.21E-55;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp19282_c0_seq1;GAXK01026348.1;P09661;4.55E-89;RU2A_HUMAN;U2 small nuclear ribonucleoprotein A' (U2 snRNP A');"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0035722; GO:0071005; GO:0071007; GO:0071013";"interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]";"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]";"RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]"
comp19287_c2_seq1;GAXK01027021.1;P49915;0;GUAA_HUMAN;GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462";"glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";cytosol [GO:0005829];"ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]"
comp1928754_c0_seq1;GAXK01025716.1;P00766;5.92E-24;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp1928922_c0_seq1;GAXK01025739.1;Q2YX69;1.06E-08;MNTH_STAAB;Divalent metal cation transporter MntH;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]";"GO:0005886; GO:0015293; GO:0016021; GO:0046872; GO:0046873";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]"
comp1928951_c0_seq1;GAXK01025723.1;P51486;3.61E-40;ARR1_CALVI;Phosrestin-2 (Arrestin-1) (Arrestin-A) (Phosrestin II);"signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0007165; GO:0007601";"signal transduction [GO:0007165]; visual perception [GO:0007601]";;
comp192951_c0_seq1;GAXK01118887.1;P10180;2.89E-63;CUT_DROME;Homeobox protein cut;"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0030713; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983";"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp192978_c0_seq1;GAXK01118888.1;Q86YT5;1.15E-100;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp19299_c0_seq1;GAXK01026118.1;Q91WK0;1.44E-52;LRRF2_MOUSE;Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2);"MyD88-dependent toll-like receptor 4 signaling pathway [GO:0035660]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tumor necrosis factor secretion [GO:1904469]; Wnt signaling pathway [GO:0016055]";"GO:0002756; GO:0016055; GO:0035660; GO:0051092; GO:1904469";"MyD88-dependent toll-like receptor 4 signaling pathway [GO:0035660]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tumor necrosis factor secretion [GO:1904469]; Wnt signaling pathway [GO:0016055]";;
comp193_c0_seq1;GAXK01168686.1;P42577;3.81E-65;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp19304_c0_seq1;GAXK01026483.1;Q9JI92;7.86E-104;SDCB1_RAT;Syntenin-1 (Syndecan-binding protein 1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"GO:0002091; GO:0005137; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0008289; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042470; GO:0042803; GO:0045121; GO:0045545; GO:0046875; GO:0046982; GO:0050839; GO:0070062; GO:0099054";"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]"
comp1930419_c0_seq1;GAXK01164997.1;P48166;1.31E-47;RL36A_CAEEL;Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp1930502_c0_seq1;GAXK01165004.1;O57382;4.63E-15;TLL2_XENLA;Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1930753_c0_seq1;GAXK01164990.1;Q9H4Z2;3.44E-15;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp1931036_c0_seq1;GAXK01165022.1;Q91ZW7;2.42E-11;C209E_MOUSE;CD209 antigen-like protein E (DC-SIGN-related protein 4) (DC-SIGNR4) (CD antigen CD209);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"GO:0005537; GO:0005886; GO:0006897; GO:0009897; GO:0016021; GO:0042102; GO:0097323";"B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";mannose binding [GO:0005537]
comp1931113_c0_seq1;GAXK01165003.1;Q75NA5;2.75E-104;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp193118_c0_seq1;GAXK01119000.1;Q8N201;0;INT1_HUMAN;Integrator complex subunit 1 (Int1);"integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]; U2 snRNA 3'-end processing [GO:0034474]";"GO:0005654; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0042795";"snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]; U2 snRNA 3'-end processing [GO:0034474]";"integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";
comp193128_c0_seq1;GAXK01118968.1;Q869C3;3.80E-85;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp1931363_c0_seq1;GAXK01165021.1;P0DKQ8;1.20E-14;ACTP_CONCN;Conoporin-Cn1;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp1931751_c0_seq1;GAXK01165013.1;Q3U4G3;4.22E-30;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp1931764_c0_seq1;GAXK01165012.1;Q9N294;2.79E-31;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp1931801_c0_seq1;GAXK01165007.1;B0G124;6.96E-09;Y9043_DICDI;Ankyrin repeat-containing protein DDB_G0279043;;;;;
comp1931850_c0_seq1;GAXK01165016.1;P34477;3.35E-16;UBC7_CAEEL;Probable ubiquitin-conjugating enzyme E2 7 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 7) (Ubiquitin carrier protein 7) (Ubiquitin-protein ligase 7);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0005524; GO:0006511; GO:0043161; GO:0061631";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]"
comp1931905_c1_seq1;GAXK01164996.1;Q5VTD9;8.17E-15;GFI1B_HUMAN;Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000981; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872; GO:2000134";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp193199_c0_seq1;GAXK01118916.1;Q804H7;8.70E-37;BI52B_XENLA;Baculoviral IAP repeat-containing protein 5.2-B (Survivin in Xenopus) (SIX) (Survivin2-B) (XSurvivin2B);"chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944]";"GO:0000777; GO:0001944; GO:0005634; GO:0005737; GO:0005819; GO:0006468; GO:0007049; GO:0007059; GO:0030496; GO:0032133; GO:0043066; GO:0045892; GO:0046872; GO:0046965; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944]";"chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]";"metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]"
comp1932105_c0_seq1;GAXK01015932.1;Q96IR2;6.92E-36;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1932253_c0_seq1;GAXK01015928.1;Q6B4Z5;2.68E-12;ZFY_PANTR;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1933072_c0_seq1;GAXK01015942.1;Q149C3;1.70E-13;LIGO4_MOUSE;Leucine-rich repeat and immunoglobulin-like domain containing-NOGO receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp1933543_c0_seq1;GAXK01015934.1;Q5F4B8;4.57E-19;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1933634_c0_seq1;GAXK01015940.1;Q6PFX9;3.24E-08;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp193394_c0_seq1;GAXK01118924.1;Q5R6L1;4.63E-36;PKNX2_PONAB;Homeobox protein PKNOX2 (PBX/knotted homeobox 2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];DNA binding [GO:0003677]
comp1934_c0_seq1;GAXK01169099.1;Q29HY3;1.89E-131;CDC42_DROPS;Cdc42 homolog (EC 3.6.5.2);"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0005912; GO:0005938; GO:0006909; GO:0007266; GO:0007274; GO:0007286; GO:0007391; GO:0008045; GO:0008360; GO:0008582; GO:0010592; GO:0016028; GO:0016318; GO:0019901; GO:0030011; GO:0030027; GO:0030031; GO:0030041; GO:0030426; GO:0030833; GO:0030866; GO:0031532; GO:0032794; GO:0035011; GO:0035099; GO:0035318; GO:0042060; GO:0045177; GO:0045185; GO:0045200; GO:0045860; GO:0046330; GO:0046843; GO:0048010; GO:0048675; GO:0048813; GO:0050770; GO:0050975; GO:0051491; GO:0051601; GO:0060446; GO:0072659; GO:0090303; GO:0097206";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp19341_c7_seq1;GAXK01026253.1;Q60280;5.59E-09;Y3520_METJA;Uncharacterized protein MJECL20;"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004725; GO:0005737";;cytoplasm [GO:0005737];protein tyrosine phosphatase activity [GO:0004725]
comp193411_c0_seq1;GAXK01118833.1;Q9N293;7.83E-20;B3GT5_GORGO;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp1934186_c0_seq1;GAXK01005419.1;Q9H3E2;1.49E-90;SNX25_HUMAN;Sorting nexin-25;"endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]";"GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091; GO:0043231; GO:0060394";"negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]";"endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]";"phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]"
comp19344_c2_seq1;GAXK01026632.1;Q9CX00;2.73E-88;IST1_MOUSE;IST1 homolog;"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]";"GO:0000785; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0031410; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543";"abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]";"identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]"
comp1934415_c0_seq1;GAXK01005416.1;Q9NTI2;0;AT8A2_HUMAN;Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2);"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; aminophospholipid flippase activity [GO:0015247]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; aging [GO:0007568]; axonogenesis [GO:0007409]; detection of light stimulus involved in visual perception [GO:0050908]; eating behavior [GO:0042755]; inner ear morphogenesis [GO:0042472]; involuntary skeletal muscle contraction [GO:0003011]; negative regulation of cell population proliferation [GO:0008285]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling posture [GO:0050884]; neuron development [GO:0048666]; phospholipid translocation [GO:0045332]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; response to auditory stimulus [GO:0010996]; retina layer formation [GO:0010842]; skin development [GO:0043588]";"GO:0000287; GO:0001750; GO:0003011; GO:0005524; GO:0005654; GO:0005768; GO:0005794; GO:0005886; GO:0007409; GO:0007568; GO:0008285; GO:0010842; GO:0010976; GO:0010996; GO:0015247; GO:0016021; GO:0040018; GO:0042472; GO:0042755; GO:0043588; GO:0045332; GO:0048666; GO:0050884; GO:0050908; GO:0060052; GO:0061092; GO:0140326";"aging [GO:0007568]; axonogenesis [GO:0007409]; detection of light stimulus involved in visual perception [GO:0050908]; eating behavior [GO:0042755]; inner ear morphogenesis [GO:0042472]; involuntary skeletal muscle contraction [GO:0003011]; negative regulation of cell population proliferation [GO:0008285]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling posture [GO:0050884]; neuron development [GO:0048666]; phospholipid translocation [GO:0045332]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; response to auditory stimulus [GO:0010996]; retina layer formation [GO:0010842]; skin development [GO:0043588]";"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]";"aminophospholipid flippase activity [GO:0015247]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp1934916_c1_seq1;GAXK01005414.1;P32183;1.20E-13;FOXA3_RAT;Hepatocyte nuclear factor 3-gamma (HNF-3-gamma) (HNF-3G) (Forkhead box protein A3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]";"GO:0000981; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0006325; GO:0006355; GO:0006357; GO:0007275; GO:0008134; GO:0008285; GO:0009653; GO:0019904; GO:0030154; GO:0031667; GO:0043565; GO:0045944; GO:0070368";"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp1935_c0_seq1;GAXK01170171.1;Q9PTW9;4.32E-131;PSA7_CARAU;Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit alpha 4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]";threonine-type endopeptidase activity [GO:0004298]
comp19352_c0_seq1;GAXK01026846.1;Q5ZKV8;0;KIF2A_CHICK;Kinesin-like protein KIF2A;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301";"cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp193524_c8_seq1;GAXK01118866.1;Q05B79;1.34E-176;DHX36_BOVIN;ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein);"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]";"GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0034458; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1902741; GO:1903843; GO:1904358; GO:1904582; GO:2000767";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]";"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]"
comp193539_c0_seq1;GAXK01118812.1;Q96SQ7;2.80E-12;ATOH8_HUMAN;Protein atonal homolog 8 (Class A basic helix-loop-helix protein 21) (bHLHa21) (Helix-loop-helix protein hATH-6) (hATH6);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]";"GO:0000790; GO:0000981; GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0010595; GO:0010629; GO:0016607; GO:0030154; GO:0033613; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060395; GO:0070888; GO:1902895";"cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]"
comp193581_c0_seq1;GAXK01119011.1;Q5VV43;3.63E-145;K0319_HUMAN;Dyslexia-associated protein KIAA0319;"clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; response to auditory stimulus [GO:0010996]";"GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0061024; GO:2000171";"membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; response to auditory stimulus [GO:0010996]";"clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";
comp1935918_c0_seq1;GAXK01005406.1;Q6L4F8;5.98E-07;GBLPB_ORYSJ;Guanine nucleotide-binding protein subunit beta-like protein B (GPB-LR) (Receptor for activated C kinase 1B);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]";"GO:0001934; GO:0005080; GO:0005634; GO:0005829; GO:0007165; GO:0019899; GO:0022627; GO:0043022; GO:0072344";"positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp19360_c6_seq1;GAXK01026567.1;Q5RBZ2;6.33E-23;MEP50_PONAB;Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]";"GO:0005634; GO:0005737; GO:0005829; GO:0008327; GO:0034709";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]";methyl-CpG binding [GO:0008327]
comp1936082_c0_seq1;GAXK01172273.1;Q62513;9.27E-14;ZN260_MOUSE;Zinc finger protein 260 (Zfp-260);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005654; GO:0005829; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1936120_c0_seq1;GAXK01172299.1;Q9JM99;1.81E-07;PRG4_MOUSE;Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part];"extracellular space [GO:0005615]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; hematopoietic stem cell proliferation [GO:0071425]; immune response [GO:0006955]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; regulation of cell population proliferation [GO:0042127]";"GO:0005044; GO:0005615; GO:0006955; GO:0030247; GO:0042127; GO:0045409; GO:0071425";"hematopoietic stem cell proliferation [GO:0071425]; immune response [GO:0006955]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; regulation of cell population proliferation [GO:0042127]";extracellular space [GO:0005615];"polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp193689_c2_seq1;GAXK01118817.1;Q9NQW7;1.49E-129;XPP1_HUMAN;Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]";"GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062";"bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]"
comp193694_c0_seq1;GAXK01118913.1;Q6R7M4;1.28E-76;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp1937_c1_seq1;GAXK01168363.1;Q9XYU1;0;MCM3_DROME;DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3);"MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]";"GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0007049; GO:0042555";"cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]";"MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp1937041_c0_seq1;GAXK01172279.1;Q0VGE8;3.30E-38;ZN816_HUMAN;Zinc finger protein 816;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1937690_c0_seq1;GAXK01172276.1;A9ULY7;1.88E-72;IFT57_XENLA;Intraflagellar transport protein 57 homolog;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0006919; GO:0030992; GO:0036064; GO:0042981";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]";
comp1937753_c0_seq1;GAXK01172291.1;Q9ES88;1.65E-19;S13A2_MOUSE;Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter);"integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];integral component of membrane [GO:0016021];symporter activity [GO:0015293]
comp1937935_c0_seq1;GAXK01172286.1;Q9M2P4;1.74E-11;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp1938150_c0_seq1;GAXK01034347.1;Q66IG8;8.26E-35;FXJ12_XENTR;Forkhead box protein J1.2 (FoxJ1.2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cilium assembly [GO:0060271]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000976; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0060271";"cilium assembly [GO:0060271]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp19388_c0_seq1;GAXK01205117.1;Q24307;8.00E-37;DIAP2_DROME;Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001";"chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp1938839_c0_seq1;GAXK01034342.1;P25931;9.28E-50;RYAR_DROME;RYamide receptor (Neuropeptide Y-like receptor) (NPY-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021";"cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]"
comp193888_c0_seq1;GAXK01118980.1;P46692;2.57E-38;HMD1_CHICK;Homeobox protein CHOX-CAD;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior axis specification [GO:0009948]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0009948; GO:0030154";"anterior/posterior axis specification [GO:0009948]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp193895_c1_seq1;GAXK01118952.1;P18502;1.41E-164;PTC_DROME;Protein patched (Hedgehog receptor);"basal plasma membrane [GO:0009925]; cilium [GO:0005929]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; lipoprotein particle receptor activity [GO:0030228]; phosphatidylinositol-4-phosphate binding [GO:0070273]; smoothened binding [GO:0005119]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; Bolwig's organ morphogenesis [GO:0001746]; determination of genital disc primordium [GO:0035225]; eye-antennal disc morphogenesis [GO:0007455]; gonad development [GO:0008406]; imaginal disc-derived wing morphogenesis [GO:0007476]; lipid homeostasis [GO:0055088]; negative regulation of smoothened signaling pathway [GO:0045879]; ovarian follicle cell development [GO:0030707]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0001746; GO:0005119; GO:0005886; GO:0005887; GO:0005929; GO:0007224; GO:0007346; GO:0007367; GO:0007411; GO:0007455; GO:0007476; GO:0008158; GO:0008406; GO:0009925; GO:0030139; GO:0030228; GO:0030707; GO:0035225; GO:0042981; GO:0045879; GO:0048099; GO:0048100; GO:0055088; GO:0070273; GO:0097108; GO:2000274";"anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; Bolwig's organ morphogenesis [GO:0001746]; determination of genital disc primordium [GO:0035225]; eye-antennal disc morphogenesis [GO:0007455]; gonad development [GO:0008406]; imaginal disc-derived wing morphogenesis [GO:0007476]; lipid homeostasis [GO:0055088]; negative regulation of smoothened signaling pathway [GO:0045879]; ovarian follicle cell development [GO:0030707]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"basal plasma membrane [GO:0009925]; cilium [GO:0005929]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; lipoprotein particle receptor activity [GO:0030228]; phosphatidylinositol-4-phosphate binding [GO:0070273]; smoothened binding [GO:0005119]"
comp19391_c6_seq1;GAXK01026731.1;Q96BP3;0;PPWD1_HUMAN;Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8) (Spliceosome-associated cyclophilin);"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]";"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp1939119_c0_seq1;GAXK01034346.1;P05132;2.25E-45;KAPCA_MOUSE;cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11);"acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cellular respiration [GO:0043457]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; sperm capacitation [GO:0048240]";"GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0004672; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005930; GO:0005952; GO:0006397; GO:0006468; GO:0007165; GO:0008284; GO:0010737; GO:0016020; GO:0016607; GO:0017137; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032991; GO:0034237; GO:0034605; GO:0036126; GO:0043005; GO:0043197; GO:0043457; GO:0044853; GO:0044877; GO:0045171; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051447; GO:0051966; GO:0061136; GO:0070613; GO:0071158; GO:0071333; GO:0071374; GO:0097225; GO:0097546; GO:1901621; GO:2000810";"cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cellular respiration [GO:0043457]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; sperm capacitation [GO:0048240]";"acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]"
comp193942_c0_seq1;GAXK01118820.1;Q28623;4.76E-42;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp193958_c0_seq1;GAXK01119013.1;O15350;3.91E-38;P73_HUMAN;Tumor protein p73 (p53-like transcription factor) (p53-related protein);"cell junction [GO:0030054]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; activation of MAPK activity [GO:0000187]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; mismatch repair [GO:0006298]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein tetramerization [GO:0051262]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle [GO:0007346]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]; viral process [GO:0016032]";"GO:0000187; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0002039; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0005794; GO:0005829; GO:0006298; GO:0006974; GO:0007050; GO:0007346; GO:0008134; GO:0008285; GO:0008630; GO:0010243; GO:0010468; GO:0016032; GO:0019901; GO:0030054; GO:0042493; GO:0042771; GO:0042802; GO:0042981; GO:0043231; GO:0044212; GO:0045665; GO:0045893; GO:0045944; GO:0046872; GO:0048714; GO:0051262; GO:0060044; GO:0071158; GO:0097371; GO:1900740; GO:1901796; GO:1902036";"activation of MAPK activity [GO:0000187]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; mismatch repair [GO:0006298]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle [GO:0007346]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]; viral process [GO:0016032]";"cell junction [GO:0030054]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp1939734_c0_seq1;GAXK01034321.1;P98158;2.59E-08;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp194_c1_seq1;GAXK01168867.1;P19804;2.01E-84;NDKB_RAT;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0008144; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051259; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
comp1940422_c0_seq1;GAXK01034157.1;P91931;2.69E-119;DCAM_DROME;"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]";"cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";"GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";cytosol [GO:0005829];adenosylmethionine decarboxylase activity [GO:0004014]
comp1940506_c0_seq1;GAXK01034163.1;P08044;2.01E-12;SNAI_DROME;Protein snail;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; adherens junction organization [GO:0034332]; asymmetric neuroblast division [GO:0055059]; central nervous system development [GO:0007417]; compound eye development [GO:0048749]; ectoderm and mesoderm interaction [GO:0007499]; gastrulation involving germ band extension [GO:0010004]; Malpighian tubule morphogenesis [GO:0007443]; mesoderm development [GO:0007498]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription, DNA-templated [GO:0006355]; ventral furrow formation [GO:0007370]";"GO:0000122; GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007370; GO:0007417; GO:0007443; GO:0007498; GO:0007499; GO:0007500; GO:0010004; GO:0031065; GO:0034332; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0055059; GO:0070491; GO:2000177";"adherens junction organization [GO:0034332]; asymmetric neuroblast division [GO:0055059]; central nervous system development [GO:0007417]; compound eye development [GO:0048749]; ectoderm and mesoderm interaction [GO:0007499]; gastrulation involving germ band extension [GO:0010004]; Malpighian tubule morphogenesis [GO:0007443]; mesodermal cell fate determination [GO:0007500]; mesoderm development [GO:0007498]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription, DNA-templated [GO:0006355]; ventral furrow formation [GO:0007370]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp1940794_c0_seq1;GAXK01034154.1;Q9VXE0;1.06E-16;RUXG_DROME;Probable small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0030532; GO:0034719; GO:0043186; GO:0071004; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]";RNA binding [GO:0003723]
comp1941_c0_seq1;GAXK01169098.1;P54357;3.81E-58;MLC2_DROME;Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]";"GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036";actin filament-based movement [GO:0030048];"cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]";"calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
comp194116_c1_seq1;GAXK01138987.1;O35242;1.33E-154;FAN_MOUSE;Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation);"death receptor binding [GO:0005123]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; positive regulation of apoptotic process [GO:0043065]";"GO:0005123; GO:0016230; GO:0043065";positive regulation of apoptotic process [GO:0043065];;"death receptor binding [GO:0005123]; sphingomyelin phosphodiesterase activator activity [GO:0016230]"
comp194150_c0_seq1;GAXK01139119.1;Q91WK7;1.07E-36;ANR54_MOUSE;Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein);"cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]";"GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531";"nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]";"cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]";"protein-containing complex binding [GO:0044877]; protein kinase regulator activity [GO:0019887]"
comp194157_c0_seq1;GAXK01139217.1;P08045;1.25E-23;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp194170_c0_seq1;GAXK01139157.1;A7M7B9;3.70E-101;NTH_CHICK;Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]";"GO:0000703; GO:0003690; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006296; GO:0046872; GO:0051539; GO:0140078";"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]"
comp194202_c0_seq1;GAXK01139259.1;P0CH36;8.13E-32;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp194207_c3_seq1;GAXK01139160.1;Q8VCD6;4.50E-40;REEP2_MOUSE;Receptor expression-enhancing protein 2;"cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; taste receptor binding [GO:0031883]; endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]";"GO:0005783; GO:0005789; GO:0005881; GO:0005887; GO:0031883; GO:0032386; GO:0032596; GO:0050913; GO:0050916; GO:0071786";"endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]";"cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]";taste receptor binding [GO:0031883]
comp1942475_c0_seq1;GAXK01180395.1;Q9NP59;3.12E-39;S40A1_HUMAN;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988";"cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp1942622_c0_seq1;GAXK01180414.1;Q9Y2C2;2.04E-15;UST_HUMAN;Uronyl 2-sulfotransferase (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770";"dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp19429_c0_seq1;GAXK01026996.1;Q9VZX9;0;SAHH2_DROME;Adenosylhomocysteinase-like 1 (dAhcyL1) (Inactive S-adenosyl-L-homocysteine hydrolase) (S-adenosylhomocysteine hydrolase-like protein 1);"cytosol [GO:0005829]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]";"GO:0005829; GO:0006730; GO:0019510; GO:0033353";"one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]";cytosol [GO:0005829];
comp194319_c1_seq1;GAXK01139038.1;P49291;1.45E-15;LAZA_SCHAM;Lazarillo protein;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; pigment binding [GO:0031409]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005886; GO:0007399; GO:0030154; GO:0031225; GO:0031409";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";pigment binding [GO:0031409]
comp1943345_c0_seq1;GAXK01180401.1;Q6XDT6;3.58E-07;IKZF_MYXGL;Ikaros family zinc finger protein (Ikaros-like transcription factor) (HIL);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp19442_c0_seq1;GAXK01026325.1;Q3T0V9;1.89E-144;DEOC_BOVIN;Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]";"GO:0004139; GO:0005634; GO:0005737; GO:0009264; GO:0016052; GO:0046121; GO:0046386";"carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";deoxyribose-phosphate aldolase activity [GO:0004139]
comp1944426_c0_seq1;GAXK01182381.1;O76090;2.49E-53;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp1944448_c0_seq1;GAXK01182383.1;P35500;1.75E-61;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp1944762_c0_seq1;GAXK01182380.1;P59889;3.98E-14;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp194494_c0_seq1;GAXK01139042.1;Q3MI00;2.30E-78;DNJB1_BOVIN;DnaJ homolog subfamily B member 1;"cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"GO:0000122; GO:0001671; GO:0003714; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]"
comp19450_c6_seq1;GAXK01026255.1;Q80WR1;6.59E-10;TSN18_MOUSE;Tetraspanin-18 (Tspan-18);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp1945027_c0_seq1;GAXK01182386.1;Q8VCR8;4.54E-31;MYLK2_MOUSE;Myosin light chain kinase 2, skeletal/cardiac muscle (MLCK2) (EC 2.7.11.18);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of MAPK cascade [GO:0043408]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding [GO:0032971]; regulation of neuronal synaptic plasticity [GO:0048168]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941]; synaptic vesicle transport [GO:0048489]; water transport [GO:0006833]";"GO:0004687; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006833; GO:0006937; GO:0006941; GO:0007274; GO:0008021; GO:0010628; GO:0014069; GO:0014816; GO:0018107; GO:0030425; GO:0031448; GO:0032027; GO:0032971; GO:0035914; GO:0043025; GO:0043195; GO:0043197; GO:0043408; GO:0046777; GO:0048168; GO:0048489; GO:0051726; GO:0055007; GO:0055008";"cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of MAPK cascade [GO:0043408]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding [GO:0032971]; regulation of neuronal synaptic plasticity [GO:0048168]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941]; synaptic vesicle transport [GO:0048489]; water transport [GO:0006833]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]"
comp1945085_c0_seq1;GAXK01182377.1;P49582;5.55E-40;ACHA7_MOUSE;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"GO:0000187; GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008144; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0014069; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032222; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0045471; GO:0045766; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051823; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098793; GO:0098815; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:1905923; GO:2000300; GO:2000463";"acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp194527_c0_seq1;GAXK01139245.1;Q13868;5.20E-18;EXOS2_HUMAN;Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4);"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0008312; GO:0030307; GO:0034427; GO:0034475; GO:0043488; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051";"CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]"
comp1945388_c0_seq1;GAXK01182384.1;Q9QXW2;8.30E-31;FBXW5_MOUSE;F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";protein kinase binding [GO:0019901]
comp1945589_c0_seq1;GAXK01182382.1;Q8I7Z8;3.13E-07;HAM_DROME;Transcription factor hamlet;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007219; GO:0008285; GO:0014017; GO:0046872; GO:0046974; GO:0048813; GO:0050773";"dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]"
comp194579_c0_seq1;GAXK01139078.1;O46040;2.42E-23;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp1945914_c0_seq1;GAXK01182372.1;D3ZJP6;5.29E-49;MYO10_RAT;Unconventional myosin-X (Unconventional myosin-10);"cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]";"GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005938; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030507; GO:0030705; GO:0030898; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002";"cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; ruffle [GO:0001726]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]"
comp1946088_c0_seq1;GAXK01134042.1;P86854;2.41E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp1946104_c0_seq1;GAXK01134019.1;F4KD71;1.03E-57;DUR3_ARATH;Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]";"GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918";"cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]"
comp1946267_c0_seq1;GAXK01134032.1;Q94900;4.15E-164;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp194634_c1_seq1;GAXK01139049.1;P51814;4.60E-07;ZNF41_HUMAN;Zinc finger protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp194681_c0_seq1;GAXK01139001.1;P10076;1.08E-32;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1946979_c0_seq1;GAXK01134036.1;Q9HCD6;3.38E-140;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp1947_c0_seq1;GAXK01170098.1;Q9D8W5;0;PSD12_MOUSE;26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55);"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624; GO:0031595; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]";
comp194717_c3_seq1;GAXK01139225.1;P97767;2.77E-125;EYA1_MOUSE;Eyes absent homolog 1 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; histone dephosphorylation [GO:0016576]; inner ear morphogenesis [GO:0042472]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; striated muscle tissue development [GO:0014706]; ureteric bud development [GO:0001657]";"GO:0001656; GO:0001657; GO:0001658; GO:0003151; GO:0003723; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006470; GO:0007389; GO:0007501; GO:0009887; GO:0010212; GO:0014706; GO:0016576; GO:0016604; GO:0016925; GO:0032991; GO:0032993; GO:0035909; GO:0042472; GO:0042473; GO:0042474; GO:0045165; GO:0045664; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0048665; GO:0048704; GO:0048752; GO:0048856; GO:0050679; GO:0060037; GO:0071599; GO:0071600; GO:0072513; GO:0090103; GO:2001240";"anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; histone dephosphorylation [GO:0016576]; inner ear morphogenesis [GO:0042472]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; striated muscle tissue development [GO:0014706]; ureteric bud development [GO:0001657]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]"
comp1948008_c0_seq1;GAXK01086627.1;Q90XC2;5.48E-123;NEK8_DANRE;Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8);"cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326]";"GO:0001947; GO:0004674; GO:0005524; GO:0005737; GO:0005929; GO:0007049; GO:0009887; GO:0046872; GO:0048793; GO:0051301; GO:0060271; GO:0061326; GO:0061371; GO:0072116";"animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326]";"cilium [GO:0005929]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp1948209_c0_seq1;GAXK01086668.1;Q86W56;9.35E-12;PARG_HUMAN;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:0043231; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";poly(ADP-ribose) glycohydrolase activity [GO:0004649]
comp1948540_c0_seq1;GAXK01086654.1;Q8K4Q0;1.15E-22;RPTOR_MOUSE;Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]";"GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087";"cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]";"14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp1948767_c0_seq1;GAXK01086669.1;Q5RB30;5.26E-13;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1949002_c0_seq1;GAXK01086631.1;P17970;1.66E-39;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp1949366_c0_seq1;GAXK01086671.1;Q3BCR8;3.98E-08;TPMT_PANTR;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase);"cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144]";"GO:0005737; GO:0008119; GO:0017144; GO:1904047";drug metabolic process [GO:0017144];cytoplasm [GO:0005737];"S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]"
comp194975_c4_seq1;GAXK01139289.1;W4VSJ0;9.24E-31;ACES_TRILK;Acetylcholinesterase-1 (AChE) (EC 3.1.1.7);"extracellular region [GO:0005576]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0042135";neurotransmitter catabolic process [GO:0042135];extracellular region [GO:0005576];acetylcholinesterase activity [GO:0003990]
comp19498_c4_seq1;GAXK01026788.1;Q9Y345;6.92E-150;SC6A5_HUMAN;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804";"chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]"
comp194994_c0_seq1;GAXK01139133.1;P23508;9.29E-46;CRCM_HUMAN;Colorectal mutant cancer protein (Protein MCC);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090";"establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";signaling receptor activity [GO:0038023]
comp195_c0_seq1;GAXK01170209.1;P50882;4.93E-97;RL9_DROME;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp1950247_c0_seq1;GAXK01069282.1;O08648;3.56E-49;M3K4_MOUSE;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp1950590_c0_seq1;GAXK01069271.1;Q86WI1;2.45E-26;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp1950759_c0_seq1;GAXK01069256.1;Q9ULI1;9.47E-11;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp1950822_c0_seq1;GAXK01069272.1;P0DJ51;1.56E-31;RL35_TETTS;60S ribosomal protein L35;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp1950994_c0_seq1;GAXK01069280.1;P21329;2.00E-15;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp195132_c0_seq1;GAXK01139223.1;Q9Y234;8.13E-74;LIPT_HUMAN;Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; transferase activity, transferring acyl groups [GO:0016746]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein modification process [GO:0006464]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]";"GO:0005739; GO:0005759; GO:0006464; GO:0006629; GO:0009249; GO:0016746; GO:0034641";"cellular nitrogen compound metabolic process [GO:0034641]; cellular protein modification process [GO:0006464]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";transferase activity, transferring acyl groups [GO:0016746]
comp195144_c1_seq1;GAXK01139208.1;P61587;2.11E-17;RND3_HUMAN;Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005925; GO:0005938; GO:0007015; GO:0007155; GO:0007266; GO:0008360; GO:0019901; GO:0030036; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp1951494_c0_seq1;GAXK01069254.1;P42787;2.57E-46;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp19515_c0_seq1;GAXK01026897.1;P02556;5.99E-18;TBB_LYTPI;Tubulin beta chain (Beta-tubulin) (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp195156_c1_seq1;GAXK01139174.1;Q2JVA4;6.93E-23;GLMU_SYNJA;"Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)]";"cytoplasm [GO:0005737]; glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; lipopolysaccharide biosynthetic process [GO:0009103]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009103; GO:0009245; GO:0009252; GO:0019134; GO:0071555";"cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; lipopolysaccharide biosynthetic process [GO:0009103]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";cytoplasm [GO:0005737];"glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]"
comp1951640_c0_seq1;GAXK01069265.1;Q3T0Y3;8.62E-36;ST1B1_BOVIN;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";"GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";cytoplasm [GO:0005737];aryl sulfotransferase activity [GO:0004062]
comp1951720_c0_seq1;GAXK01069276.1;P36609;1.18E-25;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp19518_c7_seq1;GAXK01026888.1;Q99PV0;0;PRP8_MOUSE;Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000386; GO:0000398; GO:0005634; GO:0005682; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157";"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]"
comp19520_c0_seq1;GAXK01026735.1;Q7QJW7;0;CLP1_ANOGA;Protein CLP1 homolog;"mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; ATP binding [GO:0005524]; mRNA polyadenylation [GO:0006378]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"GO:0005524; GO:0005634; GO:0005849; GO:0006378; GO:0006388";"mRNA polyadenylation [GO:0006378]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp1952161_c0_seq1;GAXK01181172.1;Q95K49;2.34E-14;ZN614_MACFA;Zinc finger protein 614;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp195243_c3_seq1;GAXK01138973.1;Q9VSL3;1.16E-25;SEPIA_DROME;Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia);"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";"GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114";"eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";cytoplasm [GO:0005737];"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"
comp195245_c0_seq1;GAXK01139123.1;Q9NQX1;3.40E-10;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp19526_c0_seq1;GAXK01026091.1;Q6AZG6;0;SYFAA_XENLA;Phenylalanine--tRNA ligase alpha subunit A (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit A) (PheRS);"cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]";"GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328; GO:0051290";"phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]";"cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]";"ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]"
comp195301_c3_seq1;GAXK01139092.1;P36609;3.30E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp1953296_c0_seq1;GAXK01181168.1;Q8BHT6;1.74E-20;B3GLT_MOUSE;Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486]";"GO:0005789; GO:0006004; GO:0006486; GO:0008375; GO:0016021";"fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";acetylglucosaminyltransferase activity [GO:0008375]
comp19534_c0_seq1;GAXK01026327.1;Q5I0E3;8.36E-13;CG050_RAT;Uncharacterized protein C7orf50 homolog;;;;;
comp19535_c2_seq1;GAXK01026617.1;P04052;0;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp1953573_c0_seq1;GAXK01181160.1;O62243;6.83E-24;NAS1_CAEEL;Zinc metalloproteinase nas-1 (EC 3.4.24.-) (Nematode astacin 1);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1954235_c0_seq1;GAXK01122958.1;Q9JHU0;1.55E-13;DPYL5_RAT;Dihydropyrimidinase-related protein 5 (DRP-5) (UNC33-like phosphoprotein 6) (ULIP-6);"cytosol [GO:0005829]; protein-containing complex [GO:0032991]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; microtubule binding [GO:0008017]; axon guidance [GO:0007411]; neuron differentiation [GO:0030182]";"GO:0005829; GO:0007411; GO:0008017; GO:0016810; GO:0030182; GO:0032991";"axon guidance [GO:0007411]; neuron differentiation [GO:0030182]";"cytosol [GO:0005829]; protein-containing complex [GO:0032991]";"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; microtubule binding [GO:0008017]"
comp195463_c3_seq1;GAXK01139210.1;Q8BG94;9.39E-07;COMD7_MOUSE;COMM domain-containing protein 7;"cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0031410; GO:0032088; GO:0033209; GO:0043231; GO:0045892; GO:0051059";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]";NF-kappaB binding [GO:0051059]
comp195498_c0_seq1;GAXK01139209.1;P05549;3.77E-111;AP2A_HUMAN;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0003404; GO:0003409; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0006357; GO:0007605; GO:0008285; GO:0010628; GO:0010842; GO:0010944; GO:0021559; GO:0021623; GO:0030501; GO:0035115; GO:0042472; GO:0042803; GO:0043066; GO:0043231; GO:0043525; GO:0043565; GO:0044212; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048701; GO:0060021; GO:0060349; GO:0061029; GO:0070172; GO:0071281; GO:2000378";"bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp195512_c1_seq1;GAXK01139184.1;P25976;3.89E-45;UBF1_MOUSE;Nucleolar transcription factor 1 (Upstream-binding factor 1) (UBF-1);"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]; scaffold protein binding [GO:0097110]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at rDNA [GO:0000183]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription elongation from RNA polymerase I promoter [GO:0006362]";"GO:0000183; GO:0001164; GO:0001165; GO:0001650; GO:0003682; GO:0005634; GO:0005730; GO:0006360; GO:0006362; GO:0045943; GO:0097110; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at rDNA [GO:0000183]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription elongation from RNA polymerase I promoter [GO:0006362]";"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]; scaffold protein binding [GO:0097110]"
comp195517_c0_seq1;GAXK01139131.1;Q4A054;5.52E-26;Y0419_STAS1;Uncharacterized oxidoreductase SSP0419 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp1955243_c0_seq1;GAXK01122966.1;Q8VIG1;1.18E-12;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp19555_c4_seq1;GAXK01026705.1;Q4QQS1;7.68E-35;T184A_RAT;Transmembrane protein 184A;"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; heparin binding [GO:0008201]";"GO:0005768; GO:0005886; GO:0008201; GO:0016021; GO:0030658; GO:0030659; GO:0030667; GO:0031901; GO:0048471";;"cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]";heparin binding [GO:0008201]
comp1955899_c0_seq1;GAXK01122956.1;Q923U9;2.25E-57;S40A1_RAT;Solute carrier family 40 member 1 (CAR1) (Cell adhesion regulator) (Ferroportin-1);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]";"GO:0005381; GO:0006826; GO:0016021; GO:0016323; GO:0017046; GO:0034755; GO:0055072";"iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp19561_c2_seq1;GAXK01026609.1;Q99P31;1.18E-29;HPBP1_MOUSE;Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]";"GO:0000774; GO:0005737; GO:0005783; GO:0031398; GO:0031625; GO:0032436";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";"adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]"
comp195628_c0_seq1;GAXK01139177.1;Q9H2F5;4.06E-91;EPC1_HUMAN;Enhancer of polycomb homolog 1;"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]";"GO:0000122; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0031965; GO:0032777; GO:0035267; GO:0035886; GO:0040008; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0070317";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]";"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]";
comp1956739_c0_seq1;GAXK01071210.1;P49540;1.20E-45;YCF45_TRICV;Uncharacterized protein ycf45 (ORF455);"chloroplast [GO:0009507]; ATP binding [GO:0005524]";"GO:0005524; GO:0009507";;chloroplast [GO:0009507];ATP binding [GO:0005524]
comp1956980_c0_seq1;GAXK01071199.1;Q96PQ6;8.79E-11;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1957_c0_seq1;GAXK01169105.1;P38542;2.03E-94;RAN_BRUMA;GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4);"nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]";"GO:0003924; GO:0005525; GO:0005634; GO:0006913; GO:0015031";"nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]";nucleus [GO:0005634];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp195721_c0_seq1;GAXK01139185.1;Q9Z2Z6;5.39E-50;MCAT_MOUSE;Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0015227; GO:0016021; GO:1902603";"carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp1957547_c0_seq1;GAXK01071207.1;Q9EQB9;3.29E-22;ZN287_MOUSE;Zinc finger protein 287 (Zfp-287) (Zinc finger protein SKAT-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";"GO:0003677; GO:0003700; GO:0005634; GO:0042035; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp195787_c0_seq1;GAXK01139191.1;Q9BWF3;7.71E-10;RBM4_HUMAN;RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]";"GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0008270; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0030332; GO:0032055; GO:0035198; GO:0035278; GO:0043153; GO:0045292; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0097157; GO:0097158; GO:0097167";"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp1958077_c0_seq1;GAXK01110210.1;B4HEM4;2.90E-20;PDE6_DROSE;cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35);"membrane [GO:0016020]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0005886; GO:0007165; GO:0016020; GO:0046068; GO:0046872; GO:0047555";"cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"membrane [GO:0016020]; plasma membrane [GO:0005886]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp195832_c1_seq1;GAXK01138936.1;Q6DF30;1.40E-48;DHDH_XENTR;Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase);"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]";"GO:0042843; GO:0047115; GO:0047837";D-xylose catabolic process [GO:0042843];;"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
comp195852_c0_seq1;GAXK01139282.1;Q9BXB4;5.10E-34;OSB11_HUMAN;Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"GO:0005654; GO:0005794; GO:0005829; GO:0008289; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444";"fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp1958575_c0_seq1;GAXK01110207.1;P10074;6.66E-09;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp19588_c0_seq1;GAXK01027043.1;Q0P3X7;3.24E-14;CV039_DANRE;UPF0545 protein C22orf39 homolog;;;;;
comp1959081_c0_seq1;GAXK01110205.1;Q8WPA2;1.84E-13;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp19591_c0_seq1;GAXK01027115.1;Q2TBS2;7.07E-24;RM21_BOVIN;39S ribosomal protein L21, mitochondrial (L21mt) (MRP-L21);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005743; GO:0005762";;"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp195918_c4_seq1;GAXK01139129.1;Q6P9S0;6.71E-34;MTSS2_MOUSE;Protein MTSS 2 (MTSS1-like protein);"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"GO:0001726; GO:0003785; GO:0005096; GO:0005546; GO:0005886; GO:0007009; GO:0030027; GO:0030864; GO:0032587; GO:0036120; GO:0048365; GO:0061024; GO:0090630; GO:0097178; GO:0097581";"activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]"
comp19593_c0_seq1;GAXK01027040.1;Q9Y5V0;1.84E-16;ZN706_HUMAN;Zinc finger protein 706;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455";"negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp195931_c4_seq1;GAXK01138992.1;P18887;2.91E-31;XRCC1_HUMAN;DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1);"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]";"GO:0000012; GO:0000724; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006283; GO:0006284; GO:0006288; GO:0006297; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599";"base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]";"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]"
comp195953_c0_seq1;GAXK01139260.1;P12080;1.87E-143;ITA2_DROME;"Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]";"GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609";"apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]"
comp196_c0_seq1;GAXK01169622.1;Q9Y3U8;1.89E-38;RL36_HUMAN;60S ribosomal protein L36 (Large ribosomal subunit protein eL36);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042788";"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp196013_c0_seq1;GAXK01112729.1;Q9NBK5;0;TRC_DROME;Serine/threonine-protein kinase tricorner (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like);"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0007476; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0070451; GO:0070593; GO:0071944";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp1960766_c0_seq2;GAXK01088734.1;F7J220;1.25E-57;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp1961036_c0_seq1;GAXK01088754.1;Q0VC22;3.52E-10;NAR5_BOVIN;Ecto-ADP-ribosyltransferase 5 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 5) (ARTC5) (Mono(ADP-ribosyl)transferase 5) (NAD(P)(+)--arginine ADP-ribosyltransferase 5);"extracellular region [GO:0005576]; membrane [GO:0016020]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471]";"GO:0003950; GO:0003956; GO:0005576; GO:0006471; GO:0016020; GO:0018120";"peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471]";"extracellular region [GO:0005576]; membrane [GO:0016020]";"NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ ADP-ribosyltransferase activity [GO:0003950]"
comp1961365_c0_seq1;GAXK01088729.1;Q9NPF2;6.48E-25;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp196145_c1_seq1;GAXK01112664.1;O95153;2.29E-65;RIMB1_HUMAN;Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1);"calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; C21-steroid hormone biosynthetic process [GO:0006700]; glutamate secretion [GO:0014047]; neurotransmitter secretion [GO:0007269]";"GO:0005737; GO:0005739; GO:0005829; GO:0006700; GO:0007269; GO:0014047; GO:0030156; GO:0044305; GO:0098978; GO:0099626";"C21-steroid hormone biosynthetic process [GO:0006700]; glutamate secretion [GO:0014047]; neurotransmitter secretion [GO:0007269]";"calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]";"benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]"
comp1961676_c0_seq1;GAXK01088746.1;O60494;0;CUBN_HUMAN;Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062";"cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp196186_c1_seq1;GAXK01112470.1;P04069;3.89E-85;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp1962477_c0_seq1;GAXK01047288.1;C5FP68;1.31E-07;SCONB_ARTOC;Probable E3 ubiquitin ligase complex SCF subunit sconB (Sulfur controller B) (Sulfur metabolite repression control protein B);protein ubiquitination [GO:0016567];GO:0016567;protein ubiquitination [GO:0016567];;
comp1962508_c1_seq1;GAXK01047307.1;Q6ZN57;3.72E-65;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp19626_c1_seq1;GAXK01026542.1;P53992;0;SC24C_HUMAN;Protein transport protein Sec24C (SEC24-related protein C);"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"GO:0000139; GO:0000149; GO:0002474; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0030127; GO:0048208; GO:0090110";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]";"SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]"
comp19627_c0_seq1;GAXK01026941.1;P26686;6.19E-57;SRR55_DROME;Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013";"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp1962765_c0_seq1;GAXK01047291.1;A6QNK1;1.78E-20;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp1963518_c0_seq1;GAXK01047301.1;Q9W7R6;8.81E-41;SOX14_CHICK;Transcription factor SOX-14 (SRY-related protein CH60);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"GO:0000122; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0007601; GO:0009649; GO:0030154; GO:0043565; GO:0044798; GO:0045892; GO:0046982; GO:2001222";"cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"
comp196379_c2_seq1;GAXK01112641.1;O74747;2.42E-21;RAD18_SCHPO;Postreplication repair E3 ubiquitin-protein ligase rad18 (EC 2.3.2.27) (RAD18 homolog) (RING-type E3 ubiquitin transferase rad18);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; ubiquitin protein ligase activity [GO:0061630]; interstrand cross-link repair [GO:0036297]; postreplication repair [GO:0006301]; proteasome localization to nuclear periphery [GO:1990920]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]";"GO:0000790; GO:0003697; GO:0005634; GO:0006301; GO:0006513; GO:0009411; GO:0017116; GO:0036297; GO:0043161; GO:0046872; GO:0061630; GO:0097505; GO:1990920";"interstrand cross-link repair [GO:0036297]; postreplication repair [GO:0006301]; proteasome localization to nuclear periphery [GO:1990920]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]";"metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; ubiquitin protein ligase activity [GO:0061630]"
comp1964416_c0_seq1;GAXK01204882.1;Q24143;9.20E-08;HR96_DROME;Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]";"GO:0000976; GO:0000977; GO:0000981; GO:0004879; GO:0005634; GO:0006357; GO:0007275; GO:0008134; GO:0008270; GO:0030154; GO:0030374; GO:0038023; GO:0042594; GO:0042632; GO:0045944; GO:0070328; GO:0070873; GO:0090575";"cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp1964431_c0_seq1;GAXK01141915.1;Q5XTS1;8.13E-48;PLPL8_RABIT;Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]";"GO:0000139; GO:0004622; GO:0005789; GO:0016021; GO:0016042; GO:0048471";lipid catabolic process [GO:0016042];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";lysophospholipase activity [GO:0004622]
comp196448_c2_seq1;GAXK01112552.1;Q76B49;3.80E-20;CD63_FELCA;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005765; GO:0005887; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]";
comp196458_c0_seq1;GAXK01112681.1;P00766;1.39E-62;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp196460_c0_seq1;GAXK01112727.1;Q8C827;1.31E-35;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1965085_c0_seq1;GAXK01141936.1;A9ZSY3;6.16E-29;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp1965146_c0_seq1;GAXK01141938.1;Q08890;1.65E-151;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp1965305_c0_seq1;GAXK01141919.1;Q14721;6.02E-26;KCNB1_HUMAN;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0050796; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp1965422_c0_seq2;GAXK01141935.1;Q8N6D5;3.17E-28;ANR29_HUMAN;Ankyrin repeat domain-containing protein 29;;;;;
comp196548_c1_seq1;GAXK01112467.1;B5DEQ3;2.57E-106;XPP3_RAT;Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3);"mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]";"GO:0004177; GO:0005739; GO:0030145";;mitochondrion [GO:0005739];"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]"
comp1965500_c0_seq1;GAXK01141929.1;P27105;2.33E-32;STOM_HUMAN;Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin);"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0051260; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585";"neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]";"protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]"
comp196573_c0_seq1;GAXK01112511.1;A2ALS5;3.30E-123;RPGP1_MOUSE;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792";"cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp196588_c0_seq1;GAXK01112471.1;Q9I3S3;5.44E-138;GBUA_PSEAE;Guanidinobutyrase (EC 3.5.3.7);"agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]";"GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971";"arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]";;"agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]"
comp196642_c0_seq1;GAXK01112496.1;Q8BTK5;1.63E-10;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp19666_c0_seq1;GAXK01026502.1;Q5RD81;1.04E-112;GHC1_PONAB;Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; symporter activity [GO:0015293]";"GO:0005743; GO:0015293; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";symporter activity [GO:0015293]
comp1966693_c0_seq1;GAXK01083354.1;Q8C827;1.94E-28;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp196679_c0_seq1;GAXK01112588.1;Q76IQ7;8.99E-31;TOX2_RAT;TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698]";"GO:0001085; GO:0003677; GO:0005634; GO:0008585; GO:0034698; GO:0045944";"female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698]";nucleus [GO:0005634];"DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]"
comp196702_c0_seq1;GAXK01112578.1;Q9K7A0;4.21E-43;CSD_BACHD;Probable cysteine desulfurase (EC 2.8.1.7);"cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]";"GO:0006534; GO:0030170; GO:0031071";cysteine metabolic process [GO:0006534];;"cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]"
comp1967148_c0_seq1;GAXK01083353.1;Q28FF3;4.02E-14;S49A3_XENTR;Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp1967458_c0_seq1;GAXK01083352.1;P91953;7.29E-48;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp196855_c0_seq1;GAXK01112674.1;Q2KIT4;7.38E-26;DNJB4_BOVIN;DnaJ homolog subfamily B member 4;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp196890_c0_seq1;GAXK01112469.1;Q9WTK3;1.66E-95;GPAA1_MOUSE;Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (mGAA1);"GPI-anchor transamidase complex [GO:0042765]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein-containing complex assembly [GO:0065003]";"GO:0003923; GO:0005887; GO:0006506; GO:0016021; GO:0016255; GO:0034235; GO:0042765; GO:0065003";"attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein-containing complex assembly [GO:0065003]";"GPI-anchor transamidase complex [GO:0042765]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]"
comp1969329_c0_seq1;GAXK01055855.1;Q94984;3.39E-13;CU15_MANSE;Cuticle protein CP14.6 (MSCP14.6);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp1969402_c0_seq1;GAXK01055848.1;P48148;2.03E-63;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp1969467_c0_seq1;GAXK01055851.1;Q9BWP8;1.43E-08;COL11_HUMAN;Collectin-11 (Collectin kidney protein 1) (CL-K1);"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent carbohydrate binding [GO:0120153]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; monosaccharide binding [GO:0048029]; oligosaccharide binding [GO:0070492]; antimicrobial humoral response [GO:0019730]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; receptor-mediated endocytosis [GO:0006898]";"GO:0001867; GO:0003677; GO:0005509; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0006898; GO:0006956; GO:0007275; GO:0019730; GO:0032502; GO:0042806; GO:0048029; GO:0070492; GO:0097194; GO:0120153";"antimicrobial humoral response [GO:0019730]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; receptor-mediated endocytosis [GO:0006898]";"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium-dependent carbohydrate binding [GO:0120153]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; monosaccharide binding [GO:0048029]; oligosaccharide binding [GO:0070492]"
comp1969822_c0_seq1;GAXK01055829.1;O97162;7.73E-42;TPM_RHIMP;Tropomyosin;;;;;
comp197_c0_seq1;GAXK01165989.1;P27952;2.72E-133;RS2_RAT;40S ribosomal protein S2;"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; formation of translation preinitiation complex [GO:0001731]; response to ethanol [GO:0045471]; ribosomal small subunit assembly [GO:0000028]";"GO:0000028; GO:0001731; GO:0003723; GO:0003735; GO:0022627; GO:0044877; GO:0045202; GO:0045471; GO:0071353; GO:1990904";"cellular response to interleukin-4 [GO:0071353]; formation of translation preinitiation complex [GO:0001731]; response to ethanol [GO:0045471]; ribosomal small subunit assembly [GO:0000028]";"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]";"protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp197023_c2_seq1;GAXK01112503.1;P51905;1.96E-121;SC6A4_DROME;Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1);"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"GO:0005261; GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610";"monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; serotonin binding [GO:0051378]"
comp1970789_c0_seq1;GAXK01150064.1;O55071;7.31E-69;CP2BJ_MOUSE;Cytochrome P450 2B19 (EC 1.14.14.1) (CYPIIB19);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp1970926_c0_seq1;GAXK01150074.1;P62907;3.97E-57;RL10A_RAT;60S ribosomal protein L10a;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0006412; GO:0014069; GO:0022625; GO:0042788; GO:0045471";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp1971003_c0_seq1;GAXK01150066.1;Q5ZJZ5;2.15E-28;BDH_CHICK;D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH);"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]";"GO:0003858; GO:0005759; GO:0099617";;"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]";3-hydroxybutyrate dehydrogenase activity [GO:0003858]
comp197149_c0_seq1;GAXK01112761.1;P21461;8.15E-20;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp19717_c2_seq1;GAXK01026927.1;A1L2I9;4.57E-54;T214B_XENLA;Transmembrane protein 214-B;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]";"GO:0005789; GO:0006915; GO:0016021";apoptotic process [GO:0006915];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp197179_c0_seq1;GAXK01112720.1;O43345;4.19E-41;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp197204_c1_seq1;GAXK01112532.1;Q9BYN7;4.45E-07;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp19721_c0_seq1;GAXK01026169.1;Q2TBR6;4.41E-26;PFD4_BOVIN;Prefoldin subunit 4;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082";protein folding [GO:0006457];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]";unfolded protein binding [GO:0051082]
comp197246_c0_seq1;GAXK01112691.1;Q8N2R8;9.09E-39;FA43A_HUMAN;Protein FAM43A;;;;;
comp197262_c0_seq1;GAXK01112730.1;Q24372;5.09E-31;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp197269_c0_seq1;GAXK01112726.1;Q5XGI3;4.89E-44;FBXL5_XENTR;F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5);"perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; iron ion binding [GO:0005506]; iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005506; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072";"iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]";iron ion binding [GO:0005506]
comp1973068_c0_seq1;GAXK01045339.1;Q9W092;3.03E-50;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp197308_c0_seq1;GAXK01112643.1;Q91309;1.70E-180;F26_LITCT;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";"GO:0003873; GO:0004331; GO:0005524; GO:0006000; GO:0006003";"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";;"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp19735_c0_seq1;GAXK01027121.1;Q641B9;8.12E-33;APC5C_XENLA;Actin-related protein 2/3 complex subunit 5-C;"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp1973518_c0_seq1;GAXK01045341.1;P35500;7.53E-32;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp1973696_c0_seq1;GAXK01045332.1;P52746;8.09E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp197414_c0_seq1;GAXK01112584.1;Q6IN38;1.25E-31;WIF1_RAT;Wnt inhibitory factor 1 (WIF-1);"cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]; positive regulation of fat cell differentiation [GO:0045600]; Wnt signaling pathway [GO:0016055]";"GO:0005102; GO:0005576; GO:0007275; GO:0009986; GO:0016055; GO:0045600; GO:0048856";"anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]; positive regulation of fat cell differentiation [GO:0045600]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";signaling receptor binding [GO:0005102]
comp197466_c0_seq1;GAXK01112760.1;Q3B7D5;8.80E-32;RASF2_RAT;Ras association domain-containing protein 2;"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]";"GO:0000776; GO:0000777; GO:0005634; GO:0005737; GO:0007049; GO:0007165; GO:0042981";"cell cycle [GO:0007049]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]";
comp197523_c2_seq1;GAXK01112652.1;Q08C93;6.65E-101;ABD12_DANRE;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651";"acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp1975405_c0_seq1;GAXK01095018.1;P83088;3.75E-60;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp1975792_c0_seq1;GAXK01095032.1;Q26565;1.45E-15;PPIA_SCHMA;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase) (Smp17.7) (p17.7);"peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0006457";protein folding [GO:0006457];;peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp19760_c0_seq1;GAXK01026516.1;Q9D4H8;0;CUL2_MOUSE;Cullin-2 (CUL-2);"Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005654; GO:0005730; GO:0006511; GO:0016567; GO:0019005; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0044877";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]";"protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]"
comp197622_c0_seq1;GAXK01112687.1;G5EBU4;2.50E-28;ZAG1_CAEEL;Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";"GO:0000122; GO:0005634; GO:0007411; GO:0043565; GO:0045773; GO:0046872";"axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp197626_c0_seq1;GAXK01112662.1;Q9NUQ9;3.10E-33;FA49B_HUMAN;Protein FAM49B (L1);"cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]";"GO:0001916; GO:0002576; GO:0005576; GO:0005929; GO:0016020; GO:0023030; GO:0031093; GO:0032729; GO:0050870; GO:0070062; GO:2000568";"platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]";"cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]";MHC class Ib protein binding, via antigen binding groove [GO:0023030]
comp197644_c2_seq1;GAXK01112661.1;Q4KMD7;5.90E-56;STPAP_DANRE;Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52);"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180]";"GO:0003723; GO:0003730; GO:0004652; GO:0005524; GO:0005730; GO:0006378; GO:0008270; GO:0016180; GO:0016607; GO:0050265; GO:0098789";"mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180]";"nuclear speck [GO:0016607]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]"
comp197699_c1_seq1;GAXK01112482.1;B1WB06;3.76E-09;MET24_XENTR;Methyltransferase-like protein 24 (EC 2.1.1.-);"extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]";"GO:0005576; GO:0008168";;extracellular region [GO:0005576];methyltransferase activity [GO:0008168]
comp1977064_c0_seq1;GAXK01059445.1;Q8VCN9;9.27E-17;TBCC_MOUSE;Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"GO:0000902; GO:0003924; GO:0005737; GO:0005829; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391";"cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]";"GTPase activity [GO:0003924]; tubulin binding [GO:0015631]"
comp19771_c1_seq1;GAXK01026688.1;Q96MG7;2.77E-17;NSE3_HUMAN;Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]";"GO:0000781; GO:0005654; GO:0005737; GO:0006281; GO:0006310; GO:0030915; GO:0031398; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711";"cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Smc5-Smc6 complex [GO:0030915]";protein dimerization activity [GO:0046983]
comp197715_c1_seq1;GAXK01112521.1;Q5F4B2;4.24E-20;SWP70_CHICK;Switch-associated protein 70 (SWAP-70);"cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0030027";;"cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";DNA binding [GO:0003677]
comp197736_c0_seq1;GAXK01112678.1;Q3U4G3;5.40E-11;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp197741_c0_seq1;GAXK01112689.1;P04352;3.39E-47;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp1977636_c0_seq1;GAXK01059452.1;P83088;9.51E-60;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp197805_c0_seq1;GAXK01112610.1;P05661;5.35E-66;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp197812_c0_seq1;GAXK01112718.1;P46218;9.77E-15;Y1674_SULAC;Uncharacterized protein Saci_1674;;;;;
comp197827_c2_seq1;GAXK01112599.1;O57460;9.72E-07;TLL1_DANRE;Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";"GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264";"blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp197834_c0_seq1;GAXK01112686.1;Q5XIY8;1.98E-12;PAXI1_DANRE;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein);"nucleus [GO:0005634]; DNA repair [GO:0006281]";"GO:0005634; GO:0006281";DNA repair [GO:0006281];nucleus [GO:0005634];
comp1978412_c0_seq1;GAXK01077090.1;E1BBG2;2.76E-17;MILK1_BOVIN;MICAL-like protein 1;"extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; slow endocytic recycling [GO:0032458]";"GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0017137; GO:0019898; GO:0031175; GO:0031902; GO:0032458; GO:0036010; GO:0042802; GO:0046872; GO:0055038; GO:0070300; GO:0097320; GO:1990126";"endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; slow endocytic recycling [GO:0032458]";"extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; Rab GTPase binding [GO:0017137]"
comp197872_c0_seq1;GAXK01112644.1;Q9VGG8;5.71E-32;MTH5_DROME;Probable G-protein coupled receptor Mth-like 5 (Protein methuselah-like 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; heart morphogenesis [GO:0003007]; response to starvation [GO:0042594]";"GO:0003007; GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; heart morphogenesis [GO:0003007]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp1978768_c0_seq1;GAXK01077062.1;Q6Q4H1;2.44E-07;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp19791_c1_seq1;GAXK01026341.1;Q5RF00;0;ALDH2_PONAB;Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2);"mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]";"GO:0004029; GO:0005759; GO:0043878";;mitochondrial matrix [GO:0005759];"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]"
comp197910_c1_seq1;GAXK01112535.1;A0JMI9;4.15E-177;RRF2M_DANRE;Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2);"mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]";"GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0032543; GO:0032790";"mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]";mitochondrion [GO:0005739];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp19793_c1_seq1;GAXK01026408.1;Q7ZV80;2.03E-32;SPF30_DANRE;Survival of motor neuron-related-splicing factor 30 (Survival motor neuron domain-containing protein 1);"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0015030; GO:0016607";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp1979528_c0_seq1;GAXK01077079.1;P18751;8.75E-11;ZO71_XENLA;Oocyte zinc finger protein XlCOF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp197956_c0_seq1;GAXK01112733.1;O46108;2.83E-28;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp197994_c0_seq1;GAXK01112683.1;A4FUH1;1.71E-09;TOR2A_BOVIN;Torsin-2A (Torsin family 2 member A);"endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260]";"GO:0005524; GO:0005635; GO:0005788; GO:0016887; GO:0051085; GO:0051260";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260]";"endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp1979994_c0_seq1;GAXK01077064.1;Q01345;2.24E-21;NHEB_ONCMY;Na(+)/H(+) exchanger beta (Beta-NHE) (Na(+)/H(+) antiporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]";"GO:0006885; GO:0015385; GO:0016021; GO:0016323";regulation of pH [GO:0006885];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";sodium:proton antiporter activity [GO:0015385]
comp198_c0_seq1;GAXK01169632.1;P62333;0;PRS10_HUMAN;26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42);"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0022624; GO:0030433; GO:0030674; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0045899; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]"
comp1980017_c0_seq1;GAXK01073794.1;A1U3K1;3.89E-11;UBIG_MARHV;Ubiquinone biosynthesis O-methyltransferase (2-polyprenyl-6-hydroxyphenol methylase) (EC 2.1.1.222) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.64);"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; ubiquinone biosynthetic process [GO:0006744]";"GO:0006744; GO:0008425; GO:0008689";ubiquinone biosynthetic process [GO:0006744];;"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]"
comp198003_c1_seq1;GAXK01046112.1;A6NN14;6.45E-39;ZN729_HUMAN;Zinc finger protein 729;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1980039_c0_seq1;GAXK01073767.1;Q9YGL3;1.48E-08;NR2E1_ORYLA;Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0007275; GO:0008270; GO:0030154; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp1980242_c0_seq1;GAXK01073783.1;P14133;8.89E-49;ASO_CUCSA;L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]";"GO:0005507; GO:0005576; GO:0008447";;extracellular region [GO:0005576];"copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]"
comp198025_c1_seq1;GAXK01046073.1;P54281;3.71E-88;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp198044_c1_seq1;GAXK01045890.1;O14649;2.35E-23;KCNK3_HUMAN;Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0022841; GO:0030322; GO:0034220; GO:0042493; GO:0044548; GO:0051481; GO:0061337; GO:0071294; GO:0071456; GO:0071805; GO:0090102";"brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]"
comp198078_c3_seq1;GAXK01045966.1;Q9PU85;1.85E-104;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp1981_c0_seq1;GAXK01168520.1;P83916;1.34E-40;CBX1_HUMAN;Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta);"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000775; GO:0000784; GO:0000785; GO:0001939; GO:0001940; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005819; GO:0006974; GO:0010369; GO:0019899; GO:0042803; GO:0045892; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]"
comp1981287_c0_seq1;GAXK01073778.1;Q28658;3.32E-10;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp198137_c2_seq1;GAXK01046126.1;Q8IZ69;1.92E-89;TRM2A_HUMAN;tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein);"RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]";"GO:0003723; GO:0006396; GO:0008173";RNA processing [GO:0006396];;"RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]"
comp1981448_c0_seq1;GAXK01073769.1;Q9JLQ2;4.17E-09;GIT2_MOUSE;ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2);"calyx of Held [GO:0044305]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic vesicle exocytosis [GO:2000300]";"GO:0005096; GO:0005654; GO:0044305; GO:0044877; GO:0046872; GO:0048266; GO:0099171; GO:2000300";"behavioral response to pain [GO:0048266]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic vesicle exocytosis [GO:2000300]";"calyx of Held [GO:0044305]; nucleoplasm [GO:0005654]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]"
comp1981888_c0_seq1;GAXK01073787.1;Q0DJV6;5.30E-08;CML18_ORYSJ;Probable calcium-binding protein CML18 (Calmodulin-like protein 18);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp198192_c0_seq1;GAXK01046114.1;P08442;7.88E-15;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp198197_c3_seq1;GAXK01046087.1;P06623;7.27E-41;CN37_BOVIN;2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; oligodendrocyte differentiation [GO:0048709]; response to toxic substance [GO:0009636]";"GO:0003723; GO:0004113; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0042470; GO:0043209; GO:0048709";"adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; oligodendrocyte differentiation [GO:0048709]; response to toxic substance [GO:0009636]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]";"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; RNA binding [GO:0003723]"
comp1982_c1_seq1;GAXK01169208.1;Q68F62;1.21E-14;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp198207_c0_seq1;GAXK01046167.1;P0C026;3.62E-45;NUD24_ARATH;Nudix hydrolase 24, chloroplastic (AtNUDT24) (EC 3.6.1.-);"chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872]";"GO:0009507; GO:0044715; GO:0046872";;chloroplast [GO:0009507];"8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872]"
comp19822_c0_seq1;GAXK01026416.1;Q96MG7;2.08E-26;NSE3_HUMAN;Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]";"GO:0000781; GO:0005654; GO:0005737; GO:0006281; GO:0006310; GO:0030915; GO:0031398; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711";"cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Smc5-Smc6 complex [GO:0030915]";protein dimerization activity [GO:0046983]
comp198263_c0_seq1;GAXK01046111.1;W4VS53;1.49E-39;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp19827_c3_seq1;GAXK01026418.1;Q5R614;0;SYLC_PONAB;Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS);"cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]";"GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429";leucyl-tRNA aminoacylation [GO:0006429];cytoplasm [GO:0005737];"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]"
comp1982980_c0_seq1;GAXK01117692.1;D4ACX8;1.38E-29;PCD16_RAT;Protocadherin-16 (Protein dachsous homolog 1);"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]";"GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016021; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102";"branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]";"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp1983240_c0_seq1;GAXK01117686.1;Q12955;1.18E-23;ANK3_HUMAN;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp1983336_c0_seq1;GAXK01117677.1;Q96IV6;6.05E-09;FXDC2_HUMAN;Fatty acid hydroxylase domain-containing protein 2;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000254; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]"
comp198352_c0_seq1;GAXK01046045.1;P36609;2.00E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp198353_c1_seq1;GAXK01045891.1;Q19958;1.54E-108;STO2_CAEEL;Stomatin-2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp198361_c0_seq1;GAXK01046160.1;Q8IZF6;3.48E-11;AGRG4_HUMAN;Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";G protein-coupled receptor activity [GO:0004930]
comp1983617_c0_seq1;GAXK01117691.1;Q75NA5;3.35E-09;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp19840_c0_seq1;GAXK01026063.1;Q6DKM1;2.91E-102;UN50A_XENLA;Protein unc-50 homolog A;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; RNA binding [GO:0003723]; protein transport [GO:0015031]";"GO:0000139; GO:0003723; GO:0005637; GO:0015031; GO:0016021";protein transport [GO:0015031];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]";RNA binding [GO:0003723]
comp1984419_c0_seq1;GAXK01159649.1;Q7Z2Y8;3.26E-09;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp1984790_c0_seq1;GAXK01159651.1;B4F6U4;9.43E-08;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp198481_c0_seq1;GAXK01045964.1;Q7ZWN6;1.28E-08;Z703A_XENLA;Zinc finger protein 703-A;"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; adherens junction assembly [GO:0034333]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]";"GO:0003676; GO:0005634; GO:0005737; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0046872; GO:0051726; GO:0060828";"adherens junction assembly [GO:0034333]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]";"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp198505_c0_seq1;GAXK01046118.1;Q008X1;3.70E-19;DFP_BOMMO;Putative defense protein;"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp1985607_c1_seq1;GAXK01159644.1;P55213;7.72E-08;CASP3_RAT;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]";"GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004861; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008234; GO:0008627; GO:0009411; GO:0009749; GO:0010033; GO:0010038; GO:0010165; GO:0014070; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0035556; GO:0042060; GO:0042493; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044877; GO:0045121; GO:0045165; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071407; GO:0071887; GO:0072734; GO:0097153; GO:0097199; GO:0097200; GO:1902004";"anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]"
comp198599_c0_seq1;GAXK01046140.1;Q9JHR7;3.88E-37;IDE_MOUSE;Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032461; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045861; GO:0050435; GO:0051260; GO:0051289; GO:0051291; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]"
comp19861_c0_seq1;GAXK01026115.1;Q16G71;8.61E-58;MED10_AEDAE;Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp198620_c0_seq1;GAXK01046139.1;P52198;7.12E-36;RND2_HUMAN;Rho-related GTP-binding protein RhoN (Rho family GTPase 2) (Rho-related GTP-binding protein Rho7) (Rnd2);"acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]";"GO:0002080; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005938; GO:0007015; GO:0007165; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0047485; GO:0048672; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]";"acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]"
comp198644_c0_seq1;GAXK01046161.1;A2CG49;3.96E-70;KALRN_MOUSE;Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274";"adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp1986445_c0_seq1;GAXK01173477.1;Q91XB0;7.02E-23;TREX1_MOUSE;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; activation of immune response [GO:0002253]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to type I interferon [GO:0071357]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response [GO:0006955]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organ or tissue specific immune response [GO:0002251]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular metabolic process [GO:0031323]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; response to UV [GO:0009411]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"GO:0000287; GO:0001568; GO:0001822; GO:0002250; GO:0002251; GO:0002253; GO:0002281; GO:0002320; GO:0002379; GO:0002383; GO:0002437; GO:0002457; GO:0002637; GO:0003007; GO:0003015; GO:0003228; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006091; GO:0006110; GO:0006259; GO:0006260; GO:0006304; GO:0006308; GO:0006954; GO:0006955; GO:0006974; GO:0008250; GO:0008296; GO:0008301; GO:0008340; GO:0008408; GO:0008853; GO:0009411; GO:0010468; GO:0019217; GO:0031323; GO:0032197; GO:0032405; GO:0032407; GO:0032479; GO:0032508; GO:0032558; GO:0032607; GO:0032680; GO:0032993; GO:0034599; GO:0034614; GO:0034644; GO:0035458; GO:0035781; GO:0042803; GO:0043277; GO:0043457; GO:0043596; GO:0045087; GO:0045088; GO:0045184; GO:0046890; GO:0050699; GO:0050727; GO:0050790; GO:0050821; GO:0050863; GO:0051607; GO:0060337; GO:0060339; GO:0061635; GO:0071310; GO:0071357; GO:0071480; GO:0072394; GO:0072421; GO:0072422; GO:0072711; GO:0097281; GO:1904161; GO:1905671";"activation of immune response [GO:0002253]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to type I interferon [GO:0071357]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response [GO:0006955]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organ or tissue specific immune response [GO:0002251]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular metabolic process [GO:0031323]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; response to UV [GO:0009411]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]"
comp198685_c0_seq1;GAXK01046150.1;Q14591;1.14E-25;ZN271_HUMAN;Deleted.;;;;;
comp198701_c1_seq1;GAXK01046131.1;Q24270;0;CAC1D_DROME;Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]";"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp1987388_c0_seq1;GAXK01173494.1;O43312;1.55E-23;MTSS1_HUMAN;Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]";"actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp19876_c0_seq1;GAXK01026023.1;A9ZSZ2;0;AGO3_BOMMO;Piwi-like protein Ago3 (BmAGO3) (EC 3.1.26.-);"cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0004519; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0046872; GO:0051321";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";cytoplasm [GO:0005737];"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp198761_c4_seq1;GAXK01045916.1;P42787;3.12E-77;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp1987798_c0_seq1;GAXK01173516.1;Q6ZL17;2.35E-07;CSTR2_ORYSJ;CMP-sialic acid transporter 2 (CMP-SA-Tr 2) (CMP-Sia-Tr 2) (CMP-sialic acid transporter-like protein 2) (OsCSTLP2);"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; sialic acid transmembrane transporter activity [GO:0015136]; carbohydrate transport [GO:0008643]";"GO:0005794; GO:0008643; GO:0015136; GO:0015165; GO:0030173";carbohydrate transport [GO:0008643];"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]";"pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; sialic acid transmembrane transporter activity [GO:0015136]"
comp198782_c1_seq1;GAXK01046023.1;P61023;3.87E-52;CHP1_RAT;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015630; GO:0017156; GO:0019722; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071468; GO:0090314; GO:1901214";"calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]"
comp1988136_c0_seq1;GAXK01143988.1;Q5XIA0;1.59E-22;DZI1L_RAT;Zinc finger protein DZIP1L (DAZ-interacting protein 1-like protein);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cilium assembly [GO:0060271]; regulation of protein localization [GO:0032880]";"GO:0003676; GO:0005737; GO:0005814; GO:0032880; GO:0036064; GO:0046872; GO:0060271";"cilium assembly [GO:0060271]; regulation of protein localization [GO:0032880]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp1988141_c0_seq1;GAXK01144004.1;Q8N1V2;2.36E-68;CFA52_HUMAN;Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]";"GO:0005930; GO:0031514; GO:0036064; GO:0060271";cilium assembly [GO:0060271];"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]";
comp1988233_c0_seq1;GAXK01143989.1;Q9V3Y3;1.26E-08;DFP_DROME;Defense protein l(2)34Fc;"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; negative regulation of immune response [GO:0050777]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087; GO:0050777";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; negative regulation of immune response [GO:0050777]";extracellular region [GO:0005576];
comp1988307_c0_seq1;GAXK01144005.1;P24044;4.71E-14;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp1988648_c0_seq1;GAXK01144003.1;Q9GLE5;4.80E-07;MMP2_BOVIN;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Matrix metalloproteinase-2) (MMP-2) [Cleaved into: PEX];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"GO:0001525; GO:0001666; GO:0004222; GO:0005615; GO:0005634; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0048771";"angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1988744_c0_seq1;GAXK01144006.1;B4DU55;8.13E-09;ZN879_HUMAN;Zinc finger protein 879;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp198940_c0_seq1;GAXK01046046.1;Q9PVG3;2.88E-15;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp198963_c0_seq1;GAXK01045925.1;Q9CZJ2;7.17E-155;HS12B_MOUSE;Heat shock 70 kDa protein 12B;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp198980_c0_seq1;GAXK01045970.1;Q20191;2.34E-20;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp1990066_c0_seq1;GAXK01128635.1;G5ED00;3.77E-09;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp1990433_c0_seq1;GAXK01128649.1;P04052;6.91E-23;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp1991090_c0_seq1;GAXK01128650.1;Q5U3Q6;7.77E-30;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp1991384_c0_seq1;GAXK01128620.1;Q9W0T5;9.21E-10;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp1991627_c0_seq1;GAXK01128614.1;G5EBR3;2.62E-12;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp199170_c4_seq1;GAXK01045903.1;O46040;2.56E-28;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp199174_c0_seq1;GAXK01046090.1;O88746;6.84E-62;TOM1_MOUSE;Target of Myb protein 1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; membrane [GO:0016020]; clathrin binding [GO:0030276]; intracellular protein transport [GO:0006886]";"GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0016020; GO:0030276";intracellular protein transport [GO:0006886];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; membrane [GO:0016020]";clathrin binding [GO:0030276]
comp1991765_c0_seq1;GAXK01128615.1;Q2KNE5;1.42E-11;OPN4A_DANRE;Melanopsin-A (Mammalian-like melanopsin) (Melanopsin-M) (Opsin-4-A) (Opsin-4M);"integral component of plasma membrane [GO:0005887]; G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of plasma membrane [GO:0005887];"G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881]"
comp19918_c0_seq1;GAXK01026468.1;P79274;1.05E-170;ACADL_PIG;Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660";"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]"
comp1991881_c0_seq1;GAXK01128619.1;P32839;4.10E-10;BCS1_YEAST;Mitochondrial chaperone BCS1;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein transmembrane transporter activity [GO:0008320]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]";"GO:0005524; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0008320; GO:0016021; GO:0032979; GO:0034551; GO:0042626; GO:0051131";"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]"
comp1991954_c0_seq1;GAXK01128639.1;Q8N988;2.29E-16;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1992045_c0_seq1;GAXK01119288.1;Q0VA42;9.65E-19;MINY4_XENTR;Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4);"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]";"GO:0016807; GO:0036459; GO:1990380";;;"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp1992159_c0_seq1;GAXK01119273.1;Q95218;4.78E-53;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp1992705_c0_seq1;GAXK01119270.1;Q62261;4.91E-12;SPTB2_MOUSE;Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain);"axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]";"GO:0000281; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0007009; GO:0007182; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0030506; GO:0030673; GO:0030863; GO:0031430; GO:0032437; GO:0032991; GO:0043001; GO:0044877; GO:0051020; GO:0051693; GO:0060390; GO:0071709; GO:0072659; GO:0098794; GO:0098978; GO:1900042; GO:1903076; GO:1903078";"actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]";"axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]";"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]"
comp1993142_c0_seq1;GAXK01119287.1;P0DJ14;9.41E-87;RL7A_TETTH;60S ribosomal protein L7a;"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp1993494_c0_seq1;GAXK01119285.1;Q01277;8.98E-07;SCONB_NEUCR;Probable E3 ubiquitin ligase complex SCF subunit scon-2 (Sulfur controller 2) (SCON2) (Sulfur metabolite repression control protein 2);"nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0005634; GO:0043130; GO:0043224";protein polyubiquitination [GO:0000209];"nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]";ubiquitin binding [GO:0043130]
comp199359_c0_seq1;GAXK01045968.1;Q14005;3.01E-15;IL16_HUMAN;Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)];"cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]";"GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006955; GO:0016032; GO:0016607; GO:0019221; GO:0030595; GO:0042609; GO:0050930; GO:0051924";"cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]";"cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]";"CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]"
comp199402_c0_seq1;GAXK01046026.1;Q8IN81;3.23E-20;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp1994222_c0_seq1;GAXK01150888.1;Q8N427;4.10E-10;TXND3_HUMAN;Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2);"outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0007275; GO:0007283; GO:0008017; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0045454; GO:0060271; GO:0097228; GO:0097598";"cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm principal piece [GO:0097228]";microtubule binding [GO:0008017]
comp1994444_c0_seq1;GAXK01150880.1;B0BM24;8.54E-09;F161A_XENTR;Protein FAM161A;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782]";"GO:0005737; GO:0005856; GO:0032391; GO:0044782";cilium organization [GO:0044782];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]";
comp199507_c1_seq1;GAXK01046075.1;Q96B97;7.10E-43;SH3K1_HUMAN;SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360]";"GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0007411; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0042059; GO:0043005; GO:0045202; GO:0061024";"actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]";SH3 domain binding [GO:0017124]
comp1995099_c0_seq1;GAXK01150901.1;Q68US5;1.43E-12;EVA1C_PANTR;Protein eva-1 homolog C (Protein FAM176C);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]";"GO:0005886; GO:0008201; GO:0016021; GO:0030246";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]"
comp199518_c1_seq1;GAXK01046010.1;Q2XWK0;6.92E-165;SVOP_XENLA;Synaptic vesicle 2-related protein (SV2-related protein);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]";"GO:0005887; GO:0022857; GO:0030054; GO:0030672";;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]";transmembrane transporter activity [GO:0022857]
comp199533_c0_seq1;GAXK01046151.1;P58802;7.01E-119;TB10A_MOUSE;TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein);"cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0005902; GO:0006886; GO:0017137; GO:0030165; GO:0042147; GO:0045862; GO:0090630; GO:0097202";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]"
comp199544_c1_seq1;GAXK01046162.1;Q61824;1.14E-121;ADA12_MOUSE;Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]";"GO:0004222; GO:0005615; GO:0005654; GO:0005886; GO:0007155; GO:0016021; GO:0017124; GO:0045766; GO:0046872";"cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]"
comp1995587_c0_seq1;GAXK01150871.1;P10076;5.30E-07;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp1995972_c0_seq1;GAXK01150895.1;Q63099;2.49E-75;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp19961_c0_seq1;GAXK01026852.1;Q7Z3K3;5.49E-13;POGZ_HUMAN;Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468]";"GO:0000790; GO:0000979; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0010468; GO:0046872; GO:0051301; GO:0051382";"cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp199610_c3_seq1;GAXK01046071.1;Q9VEG6;7.12E-109;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp199632_c1_seq1;GAXK01046171.1;P80387;7.04E-07;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp199677_c0_seq1;GAXK01046229.1;Q8CJG0;2.00E-44;AGO2_MOUSE;Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005844; GO:0005845; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0016442; GO:0030054; GO:0030154; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]"
comp199681_c0_seq1;GAXK01046109.1;P49010;3.39E-140;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp199707_c0_seq1;GAXK01045963.1;Q7PWV1;5.67E-66;AQP_ANOGA;Aquaporin AQPAn.G;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]";"GO:0005886; GO:0015250; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";water channel activity [GO:0015250]
comp19971_c1_seq1;GAXK01026611.1;Q6GYQ0;0;RGPA1_HUMAN;Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630";"activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]"
comp199712_c0_seq1;GAXK01046110.1;Q01070;1.58E-40;ESMC_DROME;Enhancer of split mgamma protein (E(spl)mgamma) (Split locus enhancer protein mB);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0008134; GO:0009952; GO:0030154; GO:0035326; GO:0043565; GO:0046983; GO:0048190; GO:0050767; GO:0097150; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"
comp199728_c0_seq1;GAXK01046043.1;Q1JPA0;2.03E-151;AL3B1_BOVIN;Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7);"plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";"GO:0004028; GO:0004030; GO:0005886; GO:0006068; GO:0006081; GO:0018477; GO:0018479";"cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";plasma membrane [GO:0005886];"3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]"
comp1997289_c0_seq1;GAXK01115664.1;Q8AYA3;3.19E-07;SLB2_DEIAC;Snaclec agglucetin subunit beta-2 (Antithrombin 1 chain B);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp199736_c1_seq1;GAXK01046227.1;A7Y2W8;7.14E-157;SC6A9_XENLA;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005283; GO:0005328; GO:0005887";;integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp1997379_c0_seq1;GAXK01115658.1;P59326;2.01E-59;YTHD1_MOUSE;YTH domain-containing family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1 homolog) (DACA-1 homolog);"cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]";"GO:0002376; GO:0002577; GO:0005737; GO:0007612; GO:0007613; GO:0043022; GO:0045727; GO:0045948; GO:1900271; GO:1902667; GO:1990247";"immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]";cytoplasm [GO:0005737];"N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]"
comp199746_c0_seq1;GAXK01045888.1;Q16600;1.66E-54;ZN239_HUMAN;Zinc finger protein 239 (Zinc finger protein HOK-2) (Zinc finger protein MOK-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003723; GO:0005634; GO:0006357; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp1997468_c0_seq1;GAXK01115652.1;O74467;1.62E-11;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp199779_c0_seq1;GAXK01046076.1;P42325;3.39E-20;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp199822_c0_seq1;GAXK01046141.1;O08730;7.26E-15;GLYG_RAT;Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186);"glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]";"GO:0005536; GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751";glycogen biosynthetic process [GO:0005978];;"glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]"
comp19988_c1_seq1;GAXK01027041.1;Q0IH86;4.11E-73;SLX1_XENLA;Structure-specific endonuclease subunit slx1 (EC 3.1.-.-) (GIY-YIG domain-containing protein 1);"Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0006281; GO:0006310; GO:0017108; GO:0033557; GO:0046872";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]";Slx1-Slx4 complex [GO:0033557];"5'-flap endonuclease activity [GO:0017108]; metal ion binding [GO:0046872]"
comp199918_c1_seq1;GAXK01046127.1;Q64729;1.20E-163;TGFR1_MOUSE;TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I);"activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"GO:0000186; GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005623; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007389; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019838; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0035556; GO:0042118; GO:0043065; GO:0043066; GO:0043231; GO:0043235; GO:0043393; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046777; GO:0046872; GO:0046982; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070411; GO:0070723; GO:0071560; GO:1902894; GO:1902895; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237";"activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]"
comp1999296_c0_seq1;GAXK01090479.1;F7J220;1.91E-21;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp1999550_c0_seq1;GAXK01090469.1;P51829;2.30E-38;ADCY7_MOUSE;Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]";"GO:0002819; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007190; GO:0016020; GO:0016021; GO:0046872; GO:0060135; GO:0071285; GO:0071361; GO:1900016";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp199969_c3_seq1;GAXK01046144.1;Q92539;3.60E-38;LPIN2_HUMAN;Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp1999835_c0_seq1;GAXK01090473.1;Q04310;1.44E-42;Y4629_STRCO;Uncharacterized protein SCO4629;"plasma membrane [GO:0005886]; DNA binding [GO:0003677]";"GO:0003677; GO:0005886";;plasma membrane [GO:0005886];DNA binding [GO:0003677]
comp20_c0_seq1;GAXK01169000.1;Q9VZE6;2.22E-107;BRX1_DROME;Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2 homolog);"nucleolus [GO:0005730]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0005730; GO:0019843";ribosomal large subunit assembly [GO:0000027];nucleolus [GO:0005730];rRNA binding [GO:0019843]
comp2000194_c0_seq1;GAXK01041911.1;Q5ZJR8;4.33E-79;ELOV6_CHICK;Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp200027_c0_seq1;GAXK01095529.1;P50027;1.77E-14;DNAJH_SYNY3;DnAJ-like protein slr0093;"cytosol [GO:0005829]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]";"GO:0005829; GO:0051082; GO:0051085; GO:0051087";chaperone cofactor-dependent protein refolding [GO:0051085];cytosol [GO:0005829];"chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp200048_c0_seq1;GAXK01095670.1;Q96K58;2.42E-26;ZN668_HUMAN;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]";"GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp20006_c1_seq1;GAXK01031687.1;A6NE02;1.01E-35;BTBDH_HUMAN;BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like);"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]";"GO:0005576; GO:0005886; GO:0009615; GO:0045071";"negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp2000629_c0_seq1;GAXK01041904.1;Q98ST7;7.77E-13;MOXD1_CHICK;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp2000780_c0_seq1;GAXK01041910.1;Q61488;8.69E-16;DHH_MOUSE;"Desert hedgehog protein (DHH) (HHG-3) [Cleaved into: Desert hedgehog protein N-product; Desert hedgehog protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]";"GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007286; GO:0008233; GO:0008270; GO:0010468; GO:0016539; GO:0030238; GO:0032355; GO:0033327; GO:0042552; GO:0043627; GO:0050810";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; intein-mediated protein splicing [GO:0016539]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp200082_c2_seq1;GAXK01095752.1;P35969;7.15E-48;VGFR1_MOUSE;Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT);"actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]";"GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0030949; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0038085; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:0070374; GO:1901534; GO:1905563";"angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]"
comp2000962_c0_seq1;GAXK01041927.1;Q9XSM3;7.88E-08;TRPV5_RABIT;Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"GO:0005262; GO:0005516; GO:0005887; GO:0006816; GO:0016324; GO:0035809; GO:0046872; GO:0051262; GO:0051289; GO:0055074; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp2001_c2_seq1;GAXK01176586.1;P00428;4.56E-18;COX5B_BOVIN;Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide VIa) (Cytochrome c oxidase polypeptide Vb);"mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005743; GO:0006123; GO:0042776; GO:0045277; GO:0046872";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]";"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp200118_c0_seq1;GAXK01095618.1;P33507;1.50E-64;ATP6_ANOQU;ATP synthase subunit a (F-ATPase protein 6);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005743; GO:0015078; GO:0015986; GO:0016021; GO:0045263";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";proton transmembrane transporter activity [GO:0015078]
comp20012_c0_seq1;GAXK01031384.1;Q6NYG8;0;DPYD_DANRE;Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]";"GO:0002058; GO:0005737; GO:0005829; GO:0006210; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0046872; GO:0050661; GO:0051536; GO:0051539";"beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; uracil binding [GO:0002058]"
comp200132_c4_seq1;GAXK01095504.1;Q5XJ56;7.04E-34;DTWD1_DANRE;DTW domain-containing protein 1;;;;;
comp20014_c0_seq1;GAXK01031630.1;Q9D7J4;9.18E-07;COX20_MOUSE;Cytochrome c oxidase assembly protein COX20, mitochondrial;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"GO:0005739; GO:0005743; GO:0016021; GO:0033617";mitochondrial respiratory chain complex IV assembly [GO:0033617];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp2001444_c0_seq1;GAXK01041915.1;Q90Z04;3.96E-08;CDON_XENLA;Cell adhesion molecule-related/down-regulated by oncogenes;"integral component of plasma membrane [GO:0005887]; cell adhesion [GO:0007155]; embryonic morphogenesis [GO:0048598]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224]";"GO:0005887; GO:0007155; GO:0007224; GO:0045663; GO:0045664; GO:0048598";"cell adhesion [GO:0007155]; embryonic morphogenesis [GO:0048598]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224]";integral component of plasma membrane [GO:0005887];
comp2001656_c0_seq1;GAXK01041903.1;Q9XSR1;9.09E-79;ZN252_CANLF;Zinc finger protein 252;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2001806_c0_seq1;GAXK01041902.1;P08953;2.01E-59;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp200197_c0_seq1;GAXK01095530.1;Q01603;1.95E-116;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp2002039_c0_seq1;GAXK01153807.1;B1WBM3;1.32E-34;TM138_RAT;Transmembrane protein 138;"cilium [GO:0005929]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; cilium assembly [GO:0060271]";"GO:0005774; GO:0005929; GO:0016021; GO:0060271";cilium assembly [GO:0060271];"cilium [GO:0005929]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";
comp200209_c0_seq1;GAXK01095563.1;A2BID7;4.21E-14;PRD10_DANRE;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp2002129_c0_seq1;GAXK01153809.1;Q0V8T4;9.95E-19;CTP5C_RAT;Contactin-associated protein like 5-3 (Cell recognition molecule Caspr5-3) (Cell recognition molecule Caspr5c) (Contactin-associated protein-like 5c);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0007155; GO:0016021";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp200221_c0_seq1;GAXK01095566.1;Q8K5B3;1.13E-10;MCFD2_RAT;Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0007420; GO:0015031; GO:0016192; GO:0019752; GO:0060548";"brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]";calcium ion binding [GO:0005509]
comp20024_c0_seq1;GAXK01031851.1;P81018;8.55E-14;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp200251_c0_seq2;GAXK01095620.1;Q7KRI2;4.78E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp200254_c1_seq1;GAXK01095420.1;O17798;1.92E-98;FKPC1_CAEEL;Furin-like protease kpc-1 (EC 3.4.21.-) (CelfurPC protein);"axon [GO:0030424]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; gene expression [GO:0010467]; insulin processing [GO:0030070]; negative regulation of dauer entry [GO:1905910]; negative regulation of protein localization to cell surface [GO:2000009]; peptide hormone processing [GO:0016486]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization to endosome [GO:0036010]; protein processing [GO:0016485]; regulation of dendrite extension [GO:1903859]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron migration [GO:2001222]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005102; GO:0005802; GO:0005886; GO:0010467; GO:0016020; GO:0016485; GO:0016486; GO:0030070; GO:0030173; GO:0030424; GO:0031638; GO:0036010; GO:0043025; GO:0043204; GO:0045887; GO:0046872; GO:0048813; GO:0048814; GO:0050775; GO:0070593; GO:1900006; GO:1903859; GO:1903861; GO:1905910; GO:2000009; GO:2001222";"dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; gene expression [GO:0010467]; insulin processing [GO:0030070]; negative regulation of dauer entry [GO:1905910]; negative regulation of protein localization to cell surface [GO:2000009]; peptide hormone processing [GO:0016486]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization to endosome [GO:0036010]; protein processing [GO:0016485]; regulation of dendrite extension [GO:1903859]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron migration [GO:2001222]; zymogen activation [GO:0031638]";"axon [GO:0030424]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]"
comp2002905_c0_seq1;GAXK01153795.1;A2ASQ1;7.43E-08;AGRIN_MOUSE;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]";"acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp200297_c0_seq1;GAXK01095488.1;P70684;1.30E-47;PGDH_CAVPO;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp2003180_c0_seq1;GAXK01153786.1;Q90384;1.68E-69;TDX_CYNPY;Peroxiredoxin (EC 1.11.1.15) (Animal blastomere protein, 25 kDa) (ABP-25) (Thioredoxin peroxidase) (Thioredoxin-dependent peroxide reductase);"cell [GO:0005623]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005623; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];cell [GO:0005623];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp200334_c1_seq1;GAXK01095599.1;P11951;2.34E-11;CX6C2_RAT;Cytochrome c oxidase subunit 6C-2 (Cytochrome c oxidase polypeptide VIc-2);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005751; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]";cytochrome-c oxidase activity [GO:0004129]
comp20036_c1_seq1;GAXK01031407.1;Q9W3M3;0;UBR3_DROME;E3 ubiquitin-protein ligase Ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase Ubr3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0043066; GO:0045880; GO:0051865; GO:0061630; GO:0070936; GO:0071596";"negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2003846_c0_seq1;GAXK01153791.1;Q76LL6;5.85E-18;FHOD3_MOUSE;FH1/FH2 domain-containing protein 3 (Formin homolog overexpressed in spleen 2) (mFHOS2);"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030017; GO:0030018; GO:0030837; GO:0045214; GO:0051639; GO:0055003";"actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp2004093_c0_seq1;GAXK01109925.1;Q8WXX0;9.19E-70;DYH7_HUMAN;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2);"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp20042_c2_seq1;GAXK01032521.1;Q4LDE5;2.05E-17;SVEP1_HUMAN;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp2004439_c0_seq1;GAXK01109919.1;P10076;4.67E-09;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp200447_c3_seq1;GAXK01095476.1;Q9NXL6;1.97E-65;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp20045_c0_seq1;GAXK01031403.1;Q803E0;2.08E-24;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp20046_c2_seq1;GAXK01031845.1;Q96I24;2.75E-21;FUBP3_HUMAN;Far upstream element-binding protein 3 (FUSE-binding protein 3);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0010628; GO:0016020; GO:0045893; GO:0045944";"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2004784_c0_seq1;GAXK01109926.1;B4SLL0;1.50E-22;ASPN_STRM5;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp200484_c0_seq1;GAXK01095602.1;Q8VHC8;0;MA2B1_CAVPO;Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B);"lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]";"GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872";mannose metabolic process [GO:0006013];lysosome [GO:0005764];"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp2004876_c0_seq1;GAXK01109949.1;Q24F59;9.43E-22;RL36_TETTS;60S ribosomal protein L36;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp20053_c0_seq1;GAXK01032135.1;Q9VPT8;7.59E-116;CPSF4_DROME;Cleavage and polyadenylation specificity factor subunit 4 (EC 3.1.-.-) (Cleavage and polyadenylation specificity factor 30 kDa subunit) (Protein clipper);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0007275; GO:0008270; GO:0098789";"mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";mRNA cleavage and polyadenylation specificity factor complex [GO:0005847];"endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp200531_c3_seq1;GAXK01095687.1;Q6ETN3;4.85E-48;4CL3_ORYSJ;Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp2005382_c0_seq1;GAXK01109941.1;Q96BH3;4.68E-11;ESPB1_HUMAN;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12);"cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";heparin binding [GO:0008201]
comp20055_c0_seq1;GAXK01031994.1;Q9VHI7;9.63E-34;IRU_DROME;E3 ubiquitin-protein ligase Iruka (EC 2.3.2.27);"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0051865; GO:0061630; GO:2000637";"positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2005784_c0_seq1;GAXK01109960.1;Q16TM5;3.71E-26;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp200604_c4_seq1;GAXK01095603.1;Q54KF6;2.84E-84;Y7365_DICDI;Protein DDB_G0287365;"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152]";"GO:0008152; GO:0016798";metabolic process [GO:0008152];;hydrolase activity, acting on glycosyl bonds [GO:0016798]
comp2006233_c0_seq1;GAXK01082950.1;Q86YE8;8.38E-12;ZN573_HUMAN;Zinc finger protein 573;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp20064_c0_seq1;GAXK01031247.1;B7P877;4.15E-88;NCBP2_IXOSC;Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20);"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000339; GO:0000398; GO:0005634; GO:0005846; GO:0031047; GO:0045292";"gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]";RNA cap binding [GO:0000339]
comp20065_c0_seq1;GAXK01032524.1;Q7ZYC4;4.84E-174;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp200717_c0_seq1;GAXK01095598.1;O95466;3.21E-13;FMNL1_HUMAN;Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin);"bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; actin filament severing [GO:0051014]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"GO:0005522; GO:0005829; GO:0005886; GO:0005938; GO:0006929; GO:0008360; GO:0016020; GO:0030866; GO:0032059; GO:0032794; GO:0045335; GO:0048365; GO:0051014; GO:0051015; GO:0070062";"actin filament severing [GO:0051014]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]"
comp2007346_c0_seq1;GAXK01082934.1;Q29HZ1;4.26E-93;LANC3_DROPS;LanC-like protein 3 homolog;catalytic activity [GO:0003824];GO:0003824;;;catalytic activity [GO:0003824]
comp20075_c0_seq1;GAXK01031783.1;P41041;3.33E-51;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp200754_c0_seq1;GAXK01095668.1;Q17529;5.18E-47;BEST2_CAEEL;Bestrophin homolog 2;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2007790_c0_seq1;GAXK01082939.1;A6NCF5;5.07E-07;KLH33_HUMAN;Kelch-like protein 33;;;;;
comp200787_c2_seq1;GAXK01095626.1;Q6PFX9;5.31E-11;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp200800_c1_seq1;GAXK01095511.1;Q96T23;8.56E-24;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp2008601_c0_seq1;GAXK01175069.1;B2D0J5;4.02E-21;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp2008855_c0_seq1;GAXK01175042.1;P52746;1.61E-11;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp200954_c2_seq1;GAXK01095572.1;A4Q9E8;6.52E-22;TTLL6_MOUSE;Tubulin polyglutamylase TTLL6 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 6);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]";"GO:0001578; GO:0003353; GO:0005524; GO:0005737; GO:0005874; GO:0015631; GO:0018095; GO:0036064; GO:0051013; GO:0070739";"microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp200984_c3_seq1;GAXK01095417.1;P08218;2.46E-22;CEL2B_HUMAN;Chymotrypsin-like elastase family member 2B (EC 3.4.21.71) (Elastase-2B);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508";proteolysis [GO:0006508];"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp2010_c5_seq1;GAXK01175503.1;P07463;4.07E-33;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2010075_c0_seq1;GAXK01101962.1;P0DJ18;1.04E-73;RL18A_TETTH;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2010541_c0_seq1;GAXK01101954.1;Q569L8;6.09E-44;CENPJ_MOUSE;Centromere protein J (CENP-J);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]";"GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005886; GO:0007099; GO:0007224; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046785; GO:0051298; GO:0051301; GO:0061511; GO:0098534; GO:1902857; GO:1903087; GO:1903724; GO:1904951; GO:1905515";"astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]"
comp201069_c1_seq1;GAXK01095489.1;Q9NPC3;9.14E-12;CIP1_HUMAN;E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1);"synaptonemal complex [GO:0000795]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]";"GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0046872; GO:0051026; GO:0061630";"blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]";synaptonemal complex [GO:0000795];"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp2011_c0_seq1;GAXK01175639.1;Q6AYD3;6.93E-151;PA2G4_RAT;Proliferation-associated protein 2G4;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"GO:0003676; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0043066; GO:0045597";"negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]"
comp2011077_c0_seq1;GAXK01101944.1;Q539E5;9.81E-09;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp2011301_c0_seq1;GAXK01101945.1;Q03238;7.12E-13;GRAM_RAT;Granzyme M (EC 3.4.21.-) (Met-ase) (Natural killer cell granular protease) (RNK-Met-1) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0006915; GO:0008236; GO:0019835; GO:0045087";"apoptotic process [GO:0006915]; cytolysis [GO:0019835]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp2011374_c0_seq1;GAXK01101961.1;P55828;2.01E-29;RS20_DROME;40S ribosomal protein S20;"cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp20117_c0_seq1;GAXK01031988.1;Q8IN78;8.61E-27;TIM22_DROME;Mitochondrial import inner membrane translocase subunit Tim22;"integral component of membrane [GO:0016021]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]";"GO:0005744; GO:0006626; GO:0008320; GO:0015450; GO:0016021; GO:0030943; GO:0042721; GO:0045039";"protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]";"integral component of membrane [GO:0016021]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";"mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]"
comp201171_c0_seq1;GAXK01095533.1;Q1RJR6;4.07E-07;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp201194_c0_seq1;GAXK01095506.1;Q8BGM5;4.32E-24;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp201200_c1_seq1;GAXK01095422.1;P43025;1.21E-08;TETN_MOUSE;Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; granular component [GO:0001652]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]; kringle domain binding [GO:0036143]; bone mineralization [GO:0030282]; ossification [GO:0001503]; positive regulation of plasminogen activation [GO:0010756]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001503; GO:0001652; GO:0005509; GO:0005615; GO:0005737; GO:0008201; GO:0010756; GO:0030246; GO:0030282; GO:0031012; GO:0036143";"bone mineralization [GO:0030282]; ossification [GO:0001503]; positive regulation of plasminogen activation [GO:0010756]; skeletal system development [GO:0001501]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; granular component [GO:0001652]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]; kringle domain binding [GO:0036143]"
comp201251_c1_seq1;GAXK01095582.1;Q8K2C7;3.42E-39;OS9_MOUSE;Protein OS-9;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"carbohydrate binding [GO:0030246]; protease binding [GO:0002020]"
comp201290_c1_seq1;GAXK01095750.1;P02595;5.90E-14;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp201297_c2_seq1;GAXK01095546.1;Q9JMI9;2.19E-10;TRPC3_RAT;Short transient receptor potential channel 3 (TrpC3) (Trp-related protein 3);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; calcium activated cation channel activity [GO:0005227]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005227; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]";"calcium activated cation channel activity [GO:0005227]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp201315_c1_seq1;GAXK01095505.1;Q29499;2.93E-07;ACES_RABIT;Acetylcholinesterase (AChE) (EC 3.1.1.7) (Fragment);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp201331_c0_seq1;GAXK01095485.1;Q8C8M1;1.72E-43;SHCAF_MOUSE;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp2013393_c0_seq1;GAXK01069453.1;Q80VN0;9.91E-27;CP100_MOUSE;Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37);"axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574]";"GO:0003341; GO:0031514; GO:0036159; GO:0070840; GO:0097545; GO:2000574";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574]";"axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]";dynein complex binding [GO:0070840]
comp2013431_c0_seq1;GAXK01069433.1;Q5R541;7.77E-24;GEM_PONAB;GTP-binding protein GEM;"plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp201347_c3_seq1;GAXK01095414.1;P41245;4.28E-09;MMP9_MOUSE;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"GO:0001501; GO:0001934; GO:0001968; GO:0002687; GO:0004175; GO:0004222; GO:0004252; GO:0005615; GO:0006508; GO:0006979; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0019087; GO:0030198; GO:0030335; GO:0030574; GO:0031915; GO:0032991; GO:0034614; GO:0035987; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0044877; GO:0045742; GO:0045766; GO:0048147; GO:0048771; GO:0051259; GO:0051549; GO:0062023; GO:0071276; GO:0071460; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp201360_c1_seq1;GAXK01095621.1;Q27052;2.10E-20;FCA1_TRYRA;Flagellar calcium-binding protein;"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp2013723_c0_seq1;GAXK01069439.1;Q5ZLY5;1.74E-48;PKHF2_CHICK;Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]"
comp2013906_c0_seq1;GAXK01069449.1;Q4R6X9;3.23E-40;DRC3_MACFA;Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";"GO:0005737; GO:0005856; GO:0031514";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";
comp2014315_c0_seq1;GAXK01123695.1;P57727;6.25E-19;TMPS3_HUMAN;Transmembrane protease serine 3 (EC 3.4.21.-) (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"GO:0004252; GO:0005044; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0016021; GO:0017080; GO:0043025";"cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]"
comp2014330_c0_seq1;GAXK01123689.1;P33085;2.25E-158;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp201443_c0_seq1;GAXK01095748.1;Q9YHB5;1.69E-12;CND3_XENLA;Condensin complex subunit 3 (Chromosome assembly protein xCAP-G) (Chromosome-associated protein G) (Condensin subunit CAP-G) (Non-SMC condensin I complex subunit G);"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0000796; GO:0005634; GO:0005829; GO:0007076; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp2014441_c0_seq1;GAXK01123698.1;Q09453;7.62E-12;GLRB4_CAEEL;Glycine receptor subunit beta-type 4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp2014660_c0_seq1;GAXK01123688.1;Q8IZ73;8.13E-118;RUSD2_HUMAN;RNA pseudouridylate synthase domain-containing protein 2;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]";"GO:0000455; GO:0003723; GO:0009982";enzyme-directed rRNA pseudouridine synthesis [GO:0000455];;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp2014882_c0_seq1;GAXK01123702.1;P17970;1.80E-70;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp201490_c1_seq1;GAXK01095648.1;P0DPW5;8.61E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp201557_c1_seq1;GAXK01095622.1;Q9W0E8;0;ZER1_DROME;Protein zer-1 homolog (Zyg-11 homolog B-like protein);Cul2-RING ubiquitin ligase complex [GO:0031462];GO:0031462;;Cul2-RING ubiquitin ligase complex [GO:0031462];
comp2015716_c0_seq1;GAXK01123699.1;Q7KRI2;7.25E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2015741_c0_seq1;GAXK01123713.1;Q66S03;1.38E-19;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp201599_c4_seq1;GAXK01095611.1;Q8TEQ6;1.37E-83;GEMI5_HUMAN;Gem-associated protein 5 (Gemin5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]";"GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0051170; GO:0065003; GO:0097504";"import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]";"mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]"
comp201600_c0_seq1;GAXK01095486.1;Q7KRI2;9.01E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2016041_c0_seq1;GAXK01012594.1;Q9VZW5;6.20E-21;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2016146_c0_seq1;GAXK01012592.1;P35500;1.30E-41;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp20164_c1_seq1;GAXK01031250.1;Q6GR25;4.64E-80;PPTC7_XENLA;Protein phosphatase PTC7 homolog (EC 3.1.3.16);"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]";"GO:0004721; GO:0046872";;;"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]"
comp201640_c1_seq1;GAXK01095745.1;Q20765;2.94E-18;NHR7_CAEEL;Nuclear hormone receptor family member nhr-7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp2016570_c0_seq1;GAXK01012577.1;Q3U4G3;2.58E-25;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp2017001_c0_seq1;GAXK01012590.1;A0A096ZEC9;1.48E-11;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp201710_c6_seq1;GAXK01095458.1;P14057;3.53E-81;NFIL_PIG;Nuclear factor 1 (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I) (NF-I) (TGGCA-binding protein) (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0006260; GO:0045944";"DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp2017384_c0_seq1;GAXK01012602.1;Q22165;5.27E-90;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp201743_c1_seq1;GAXK01095749.1;Q5ZKG2;3.76E-22;BRD7_CHICK;Bromodomain-containing protein 7;"nucleus [GO:0005634]; cell cycle [GO:0007049]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0007049; GO:0016055";"cell cycle [GO:0007049]; Wnt signaling pathway [GO:0016055]";nucleus [GO:0005634];
comp2017757_c0_seq1;GAXK01012600.1;Q8AVY1;1.44E-39;ODF3A_XENLA;Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp20178_c0_seq1;GAXK01031967.1;Q7TPM1;1.49E-13;PRC2B_MOUSE;Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B);in utero embryonic development [GO:0001701];GO:0001701;in utero embryonic development [GO:0001701];;
comp2017894_c0_seq1;GAXK01012580.1;Q80XI3;2.82E-10;IF4G3_MOUSE;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";"GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903";"positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";eukaryotic translation initiation factor 4F complex [GO:0016281];"mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]"
comp201811_c0_seq1;GAXK01095685.1;F1N476;1.41E-30;ECE2_BOVIN;Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71);"cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]";"GO:0000139; GO:0004222; GO:0007420; GO:0007507; GO:0010002; GO:0016021; GO:0016486; GO:0030658; GO:0030659; GO:0046872";"brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]";"cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp201818_c2_seq1;GAXK01095578.1;Q84MB6;6.03E-25;DIOX2_ARATH;Probable 2-oxoglutarate-dependent dioxygenase At3g50210 (EC 1.14.11.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp2018187_c0_seq1;GAXK01151134.1;Q8SQG9;8.72E-26;NHRF2_RABIT;Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (PDZ domain-containing protein NHERF-2) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2);"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]";"GO:0005634; GO:0008022; GO:0012505; GO:0016324; GO:0060090";;"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]";"molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]"
comp201830_c0_seq1;GAXK01095557.1;Q9NDM2;2.78E-59;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2018322_c1_seq1;GAXK01151130.1;Q05516;6.58E-22;ZBT16_HUMAN;Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"GO:0000122; GO:0000980; GO:0001227; GO:0001823; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007417; GO:0008022; GO:0008285; GO:0009880; GO:0009952; GO:0016567; GO:0016604; GO:0016605; GO:0016607; GO:0017053; GO:0019904; GO:0030097; GO:0030099; GO:0032332; GO:0032991; GO:0034504; GO:0035116; GO:0035136; GO:0042733; GO:0042802; GO:0042803; GO:0043065; GO:0043565; GO:0043687; GO:0045600; GO:0045638; GO:0045778; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048133; GO:0051138; GO:0051216; GO:0061036";"anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp2018384_c0_seq1;GAXK01151149.1;Q9QXW9;8.93E-07;LAT2_MOUSE;Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]";"GO:0005275; GO:0005737; GO:0005886; GO:0006865; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0015807; GO:0016021; GO:0016323; GO:0019534";"amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]"
comp201844_c0_seq1;GAXK01095661.1;P48607;8.26E-18;SPZ_DROME;Protein spaetzle [Cleaved into: Protein spaetzle C-106];"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0002807; GO:0005121; GO:0005125; GO:0005576; GO:0005615; GO:0006965; GO:0006967; GO:0007310; GO:0007399; GO:0007526; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0009611; GO:0009950; GO:0009953; GO:0021556; GO:0031334; GO:0031640; GO:0032991; GO:0042542; GO:0042803; GO:0045087; GO:0045752; GO:0048018; GO:0050829; GO:0050830; GO:0050832; GO:0061760";"antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp20187_c0_seq1;GAXK01031282.1;P16409;3.05E-12;MYL3_RAT;Myosin light chain 3 (Myosin alkali light chain 1, ventricular) (MLClV) (Myosin light chain 1, slow-twitch muscle B/ventricular isoform) (MLC1SB) (Ventricular myosin light chain 1) (rVMLC1);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; skeletal muscle tissue development [GO:0007519]";"GO:0003774; GO:0005509; GO:0006936; GO:0007519; GO:0016459; GO:0060048";"cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; skeletal muscle tissue development [GO:0007519]";myosin complex [GO:0016459];"calcium ion binding [GO:0005509]; motor activity [GO:0003774]"
comp2019054_c0_seq1;GAXK01151148.1;Q52M93;8.24E-08;Z585B_HUMAN;Zinc finger protein 585B (zinc finger protein 41-like protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp20192_c1_seq1;GAXK01031649.1;P47980;3.12E-22;TIS11_DROME;Protein TIS11 (dTIS11);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; RNA interference [GO:0016246]";"GO:0003677; GO:0003730; GO:0005634; GO:0005829; GO:0010629; GO:0016246; GO:0035925; GO:0046872; GO:0061158; GO:1900153";"3'-UTR-mediated mRNA destabilization [GO:0061158]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; RNA interference [GO:0016246]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]"
comp2019427_c0_seq1;GAXK01151155.1;P21328;1.58E-10;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp201956_c0_seq1;GAXK01095686.1;Q8R5M0;5.39E-50;GIPC3_MOUSE;PDZ domain-containing protein GIPC3 (Regulator of G-protein signaling 19-interacting protein 3);;;;;
comp20199_c0_seq1;GAXK01031577.1;Q9NQQ7;3.90E-94;S35C2_HUMAN;Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein);"cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]";"GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0033116; GO:0036066; GO:0045747";"negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";"antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]"
comp202000_c0_seq1;GAXK01157768.1;B2FQP3;6.61E-08;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2020272_c0_seq1;GAXK01119145.1;Q68CP4;2.05E-83;HGNAT_HUMAN;Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821";"glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"
comp2020280_c0_seq1;GAXK01119137.1;Q5RFP4;6.53E-08;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2020322_c0_seq1;GAXK01119138.1;Q941X2;3.89E-34;LAC3_ORYSJ;Laccase-3 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 3) (Diphenol oxidase 3) (Urishiol oxidase 3);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp20205_c1_seq1;GAXK01031966.1;O54842;2.35E-10;NUPR1_RAT;Nuclear protein 1 (Protein p8);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506]; regulation of response to endoplasmic reticulum stress [GO:1905897]";"GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0008285; GO:0010506; GO:0010507; GO:0010667; GO:0010698; GO:0043066; GO:0043433; GO:0043525; GO:0045786; GO:0045820; GO:0048471; GO:0050680; GO:0062099; GO:0150078; GO:1901800; GO:1902902; GO:1903862; GO:1904036; GO:1904691; GO:1905897; GO:2001244";"negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506]; regulation of response to endoplasmic reticulum stress [GO:1905897]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp20206_c2_seq1;GAXK01031968.1;Q5ZME8;0;SMU1_CHICK;WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005";"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]";
comp2021081_c0_seq1;GAXK01119130.1;P63026;3.58E-11;VAMP2_BOVIN;Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2);"caveola [GO:0005901]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589]; calmodulin binding [GO:0005516]; phospholipid binding [GO:0005543]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; cytochrome complex assembly [GO:0017004]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; membrane raft distribution [GO:0031580]; positive regulation of intracellular protein transport [GO:0090316]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]; synaptic vesicle docking [GO:0016081]; vasodilation [GO:0042311]; vesicle fusion [GO:0006906]";"GO:0000322; GO:0005516; GO:0005543; GO:0005765; GO:0005802; GO:0005901; GO:0006906; GO:0007165; GO:0016021; GO:0016081; GO:0017004; GO:0017075; GO:0017156; GO:0017157; GO:0019905; GO:0030054; GO:0030672; GO:0031201; GO:0031580; GO:0031982; GO:0032869; GO:0042311; GO:0042589; GO:0043001; GO:0043005; GO:0046879; GO:0048471; GO:0060291; GO:0070044; GO:0090316; GO:0098967; GO:1902259";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; cytochrome complex assembly [GO:0017004]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; membrane raft distribution [GO:0031580]; positive regulation of intracellular protein transport [GO:0090316]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]; synaptic vesicle docking [GO:0016081]; vasodilation [GO:0042311]; vesicle fusion [GO:0006906]";"caveola [GO:0005901]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589]";"calmodulin binding [GO:0005516]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; syntaxin binding [GO:0019905]"
comp202113_c1_seq1;GAXK01157974.1;A9JS71;1.70E-75;ECHD3_XENLA;Enoyl-CoA hydratase domain-containing protein 3, mitochondrial;"mitochondrion [GO:0005739]; catalytic activity [GO:0003824]";"GO:0003824; GO:0005739";;mitochondrion [GO:0005739];catalytic activity [GO:0003824]
comp202171_c0_seq1;GAXK01157784.1;Q9NRZ7;5.69E-63;PLCC_HUMAN;1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"GO:0000139; GO:0003841; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006644; GO:0006654; GO:0008654; GO:0016020; GO:0016021; GO:0016024; GO:0016746";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp202173_c0_seq1;GAXK01157996.1;Q9BWH6;3.28E-52;RPAP1_HUMAN;RNA polymerase II-associated protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0006366";transcription by RNA polymerase II [GO:0006366];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp202180_c2_seq1;GAXK01157895.1;O60260;8.80E-107;PRKN_HUMAN;E3 ubiquitin-protein ligase parkin (Parkin) (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2);"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]";"GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0000976; GO:0001227; GO:0001664; GO:0001933; GO:0001964; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044267; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378";"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]";"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]";"actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]"
comp202201_c0_seq1;GAXK01157995.1;Q8BRM2;4.23E-38;GORAB_MOUSE;RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (mNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901622]";"GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0031069; GO:1901622; GO:1905515";"hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901622]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp202219_c0_seq1;GAXK01157775.1;Q8JG30;3.65E-51;ST1B1_CHICK;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]";"GO:0005737; GO:0008146; GO:0008202";steroid metabolic process [GO:0008202];cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp2022274_c0_seq1;GAXK01160772.1;P70059;4.82E-26;TRY2_XENLA;Trypsin (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2022399_c0_seq1;GAXK01160785.1;P23467;2.16E-16;PTPRB_HUMAN;Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; neutrophil degranulation [GO:0043312]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]";"GO:0001525; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0016311; GO:0035579; GO:0043235; GO:0043312; GO:0045296; GO:0070821";"angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; neutrophil degranulation [GO:0043312]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp20224_c1_seq1;GAXK01031862.1;Q22165;8.86E-103;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp202247_c0_seq1;GAXK01157799.1;Q8K389;1.69E-12;CK5P2_MOUSE;CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48);"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431";"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]";"calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]"
comp202273_c0_seq1;GAXK01157956.1;Q8N465;1.43E-79;D2HDH_HUMAN;D-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.-);"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; 2-oxoglutarate metabolic process [GO:0006103]; cellular protein metabolic process [GO:0044267]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]";"GO:0004458; GO:0005739; GO:0005759; GO:0006103; GO:0010042; GO:0010043; GO:0019516; GO:0022904; GO:0031234; GO:0032025; GO:0044267; GO:0051990; GO:0071949";"2-oxoglutarate metabolic process [GO:0006103]; cellular protein metabolic process [GO:0044267]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]";"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"(R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]"
comp202277_c1_seq1;GAXK01157806.1;Q9PTU6;3.56E-59;ENDOU_PAROL;Poly(U)-specific endoribonuclease (EC 3.1.-.-) (Pancreatic protein with two somatomedin-B domains) (Protein endoU) (Uridylate-specific endoribonuclease);"extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]";"GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0006955; GO:0030247; GO:0046872";immune response [GO:0006955];extracellular region [GO:0005576];"endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]"
comp202341_c0_seq1;GAXK01157988.1;Q9NHD5;1.26E-15;SAN_DROME;Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0016573; GO:0031248; GO:0031415";"histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]";"N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]"
comp202352_c0_seq1;GAXK01157977.1;Q91ZH7;7.15E-93;ABHD3_MOUSE;Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3);"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568";"cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";integral component of membrane [GO:0016021];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"
comp2023766_c0_seq1;GAXK01160777.1;Q11002;1.35E-110;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp20238_c0_seq1;GAXK01031726.1;P25160;9.98E-109;ARL1_DROME;ADP-ribosylation factor-like protein 1;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; dsRNA transport [GO:0033227]; endoplasmic reticulum membrane organization [GO:0090158]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; regulation of cell migration [GO:0030334]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; salivary gland development [GO:0007431]; secretory granule organization [GO:0033363]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]";"GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0006886; GO:0007030; GO:0007269; GO:0007431; GO:0016192; GO:0019904; GO:0030334; GO:0033227; GO:0033363; GO:0034067; GO:0035220; GO:0048488; GO:0060628; GO:0070861; GO:0090158; GO:0098793; GO:1903292";"dsRNA transport [GO:0033227]; endoplasmic reticulum membrane organization [GO:0090158]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; regulation of cell migration [GO:0030334]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; salivary gland development [GO:0007431]; secretory granule organization [GO:0033363]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein domain specific binding [GO:0019904]"
comp2023929_c0_seq1;GAXK01160788.1;P18583;5.33E-08;SON_HUMAN;Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726";"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]"
comp2023958_c0_seq1;GAXK01160770.1;Q14CN2;5.20E-27;CLCA4_HUMAN;"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872";ion transmembrane transport [GO:0034220];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp20243_c0_seq1;GAXK01031222.1;Q8ND76;9.75E-126;CCNY_HUMAN;Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X);"cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000308; GO:0005634; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0051301; GO:0060828";"cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]";"cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp20244_c0_seq1;GAXK01031276.1;B0JZ65;2.20E-41;LRWD1_XENTR;Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein);"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; telomeric heterochromatin [GO:0031933]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000776; GO:0000777; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0006342; GO:0008327; GO:0031933; GO:0035064; GO:0035098; GO:0070734; GO:0071169";"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; telomeric heterochromatin [GO:0031933]";"chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]"
comp202447_c1_seq1;GAXK01157978.1;Q7KRI2;1.66E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2024512_c0_seq1;GAXK01029263.1;Q810K9;4.27E-40;GXLT2_MOUSE;Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4);"integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0016021; GO:0016266; GO:0035252";O-glycan processing [GO:0016266];integral component of membrane [GO:0016021];UDP-xylosyltransferase activity [GO:0035252]
comp2025_c0_seq1;GAXK01175685.1;Q9VX98;4.37E-25;DENR_DROME;Density-regulated protein homolog;"protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188]";"GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0008284; GO:0032991; GO:0045948; GO:0046628; GO:0120142";"formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188]";protein-containing complex [GO:0032991];"mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]"
comp202592_c0_seq1;GAXK01157994.1;O86042;3.70E-43;NAGK_RALSP;Fumarylpyruvate hydrolase (EC 3.7.1.20) (Naphthalene degradation protein K);"fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances [GO:0016823]; metal ion binding [GO:0046872]; aromatic compound catabolic process [GO:0019439]";"GO:0016823; GO:0019439; GO:0034545; GO:0046872";aromatic compound catabolic process [GO:0019439];;"fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances [GO:0016823]; metal ion binding [GO:0046872]"
comp202595_c0_seq1;GAXK01157923.1;P18117;3.19E-14;THBA_XENLA;Thyroid hormone receptor beta-A (TRbetaA) (xTR) (Nuclear receptor subfamily 1 group A member 2-A);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0070324";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp20261_c0_seq1;GAXK01031224.1;Q8N6R1;6.29E-27;SERP2_HUMAN;Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]";"GO:0005789; GO:0006486; GO:0015031; GO:0016021; GO:0030968";"endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp2026622_c0_seq1;GAXK01054396.1;P50573;1.29E-19;GBRR3_RAT;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]"
comp20268_c3_seq1;GAXK01031621.1;Q91YT7;2.43E-101;YTHD2_MOUSE;YTH domain-containing family protein 2;"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; P-body [GO:0000932]; N6-methyladenosine-containing RNA binding [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]";"GO:0000932; GO:0001556; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0006402; GO:0036464; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247";"embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; P-body [GO:0000932]";N6-methyladenosine-containing RNA binding [GO:1990247]
comp2027001_c0_seq1;GAXK01054393.1;Q9GRJ3;1.52E-54;RS23_LUMRU;40S ribosomal protein S23;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";structural constituent of ribosome [GO:0003735]
comp2028042_c0_seq1;GAXK01182211.1;P25364;3.42E-16;HCM1_YEAST;Forkhead transcription factor HCM1 (High-copy suppressor of calmodulin protein 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle pole body organization [GO:0051300]";"GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007005; GO:0034599; GO:0043565; GO:0045944; GO:0051300";"cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle pole body organization [GO:0051300]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp202816_c1_seq1;GAXK01157790.1;Q9UPM8;1.64E-50;AP4E1_HUMAN;AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin);"AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network membrane [GO:0032588]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]";"GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588";"protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]";"AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network membrane [GO:0032588]";
comp2028288_c0_seq1;GAXK01182213.1;Q32KH7;4.72E-75;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp20292_c0_seq1;GAXK01031790.1;Q3B726;1.68E-28;RPA43_HUMAN;DNA-directed RNA polymerase I subunit RPA43 (Twist neighbor protein);"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0003899; GO:0005654; GO:0005736; GO:0006361; GO:0006362; GO:0006363; GO:0045815; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]";DNA-directed 5'-3' RNA polymerase activity [GO:0003899]
comp2029472_c0_seq1;GAXK01182224.1;P18748;1.30E-10;ZO29_XENLA;Oocyte zinc finger protein XlCOF29;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp202971_c0_seq1;GAXK01157894.1;Q5ZK92;1.22E-137;SPAST_CHICK;Spastin (EC 5.6.1.1);"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]";"GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031122; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0090148; GO:1904115";"anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]";"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]";"alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp2029758_c0_seq1;GAXK01182221.1;Q9NUN7;7.71E-51;ACER3_HUMAN;Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]";"GO:0005509; GO:0005783; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030148; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121";"ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]"
comp203_c0_seq1;GAXK01165987.1;P62277;1.75E-96;RS13_HUMAN;40S ribosomal protein S13 (Small ribosomal subunit protein uS15);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022627; GO:0033119; GO:0048027; GO:0070062; GO:0070181";"negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]";"mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp2030_c0_seq1;GAXK01176458.1;Q58EM4;2.69E-118;ARMT1_DANRE;Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1);"metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]";"GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:2001020";"methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]";;"metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp203017_c1_seq1;GAXK01157898.1;Q5TYW1;5.03E-26;ZN658_HUMAN;Zinc finger protein 658;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";"GO:0000976; GO:0003677; GO:0005634; GO:0042254; GO:0045892; GO:0046872; GO:0071294";"cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp203048_c1_seq1;GAXK01157787.1;Q02127;1.14E-125;PYRD_HUMAN;Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]";"GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0009220; GO:0010181; GO:0016021; GO:0031000; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0046134; GO:0048039; GO:0090140; GO:1903576";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]";"dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]"
comp2030492_c0_seq1;GAXK01107879.1;Q5NSW5;9.77E-24;DBX1_RAT;Homeobox protein DBX1 (Developing brain homeobox protein 1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell differentiation in spinal cord [GO:0021515]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral spinal cord interneuron specification [GO:0021521]";"GO:0005634; GO:0006357; GO:0021515; GO:0021521; GO:0043565";"cell differentiation in spinal cord [GO:0021515]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral spinal cord interneuron specification [GO:0021521]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp203055_c1_seq1;GAXK01157976.1;P16375;0;7UP1_DROME;Steroid receptor seven-up, isoforms B/C (Nuclear receptor subfamily 2 group F member 3, isoforms B/C);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0000977; GO:0001227; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0007270; GO:0007419; GO:0007462; GO:0007464; GO:0007503; GO:0007507; GO:0007510; GO:0007601; GO:0008270; GO:0014019; GO:0021782; GO:0030154; GO:0042331; GO:0042803; GO:0046530; GO:0046982; GO:0048856; GO:0061331";"anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp203065_c0_seq1;GAXK01157924.1;Q26474;5.27E-13;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp203076_c0_seq1;GAXK01157763.1;B2RRL2;2.11E-13;JERKL_MOUSE;Jerky protein homolog-like;"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp203101_c0_seq1;GAXK01157801.1;Q9VGY6;3.99E-68;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp203104_c1_seq1;GAXK01157762.1;Q96F63;7.18E-14;CCD97_HUMAN;Coiled-coil domain-containing protein 97;;;;;
comp203120_c0_seq1;GAXK01158023.1;Q9ERI6;1.56E-43;RDH14_MOUSE;Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]";"GO:0005739; GO:0005783; GO:0008106; GO:0042572; GO:0052650";retinol metabolic process [GO:0042572];"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; NADP-retinol dehydrogenase activity [GO:0052650]"
comp2031308_c0_seq1;GAXK01107880.1;Q9HBT8;1.78E-13;Z286A_HUMAN;Zinc finger protein 286A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp203135_c0_seq1;GAXK01157767.1;Q68FH4;3.12E-135;GALK2_MOUSE;N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose catabolic process via UDP-galactose [GO:0033499]";"GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0033499; GO:0033858";galactose catabolic process via UDP-galactose [GO:0033499];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]"
comp20314_c0_seq1;GAXK01031730.1;P53621;0;COPA_HUMAN;"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]";"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0070062";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]";"hormone activity [GO:0005179]; structural molecule activity [GO:0005198]"
comp20317_c0_seq1;GAXK01032363.1;A1Z6E0;4.95E-115;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp203219_c0_seq1;GAXK01157744.1;P13055;1.13E-08;E75BB_DROME;Ecdysone-induced protein 75B, isoform B (E75-C) (Nuclear receptor subfamily 1 group D member 3, isoform B);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0007553; GO:0007591; GO:0008134; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0019730; GO:0020037; GO:0030154; GO:0030374; GO:0033993; GO:0035075; GO:0038023; GO:0045944; GO:0048477; GO:0090575";"antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp203269_c0_seq1;GAXK01157760.1;Q90WJ8;2.78E-10;AJL2_ANGJA;Lactose-binding lectin l-2 (Ajl-2);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; defense response to Gram-negative bacterium [GO:0050829]; induction of bacterial agglutination [GO:0043152]";"GO:0005576; GO:0030246; GO:0043152; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; induction of bacterial agglutination [GO:0043152]";extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp203270_c1_seq1;GAXK01157981.1;Q9Y5Q5;2.24E-39;CORIN_HUMAN;"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment]";"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";"GO:0003050; GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016021; GO:0016486; GO:0016604; GO:0035813; GO:1903779";"female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp20328_c1_seq1;GAXK01031688.1;Q9PTS2;4.30E-150;DCUP_DANRE;Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37);"cytosol [GO:0005829]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004853; GO:0005829; GO:0006778; GO:0006782; GO:0006783";"heme biosynthetic process [GO:0006783]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]";cytosol [GO:0005829];uroporphyrinogen decarboxylase activity [GO:0004853]
comp2033_c0_seq1;GAXK01176599.1;Q29RL9;7.12E-79;TCEA1_BOVIN;Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0005634; GO:0006351; GO:0008270; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp203315_c0_seq1;GAXK01157812.1;Q01345;3.91E-98;NHEB_ONCMY;Na(+)/H(+) exchanger beta (Beta-NHE) (Na(+)/H(+) antiporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]";"GO:0006885; GO:0015385; GO:0016021; GO:0016323";regulation of pH [GO:0006885];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";sodium:proton antiporter activity [GO:0015385]
comp2033748_c0_seq1;GAXK01195322.1;Q9VUL9;2.16E-53;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp2034_c1_seq1;GAXK01175477.1;Q9Z1P6;2.18E-09;NDUA7_MOUSE;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005739; GO:0005747; GO:0005761; GO:0006120; GO:0008137; GO:0032543";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";"NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]"
comp2034241_c0_seq1;GAXK01119753.1;Q9VQ30;2.18E-07;CHNMO_DROME;Zinc finger protein chinmo (Protein chronologically inappropriate morphogenesis);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]";"GO:0001933; GO:0003676; GO:0005634; GO:0006357; GO:0007548; GO:0016319; GO:0019102; GO:0030838; GO:0035214; GO:0046872; GO:0048666; GO:0051170; GO:2000035";"eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp203426_c2_seq1;GAXK01157729.1;Q5PXQ6;5.94E-10;CHQB_NOCSI;Hydroxyquinol 1,2-dioxygenase (EC 1.13.11.37) (1,2-HQD);"catechol 1,2-dioxygenase activity [GO:0018576]; ferric iron binding [GO:0008199]; hydroxyquinol 1,2-dioxygenase activity [GO:0018581]; beta-ketoadipate pathway [GO:0042952]; catechol-containing compound metabolic process [GO:0009712]";"GO:0008199; GO:0009712; GO:0018576; GO:0018581; GO:0042952";"beta-ketoadipate pathway [GO:0042952]; catechol-containing compound metabolic process [GO:0009712]";;"catechol 1,2-dioxygenase activity [GO:0018576]; ferric iron binding [GO:0008199]; hydroxyquinol 1,2-dioxygenase activity [GO:0018581]"
comp2034303_c0_seq1;GAXK01119762.1;P47791;1.45E-82;GSHR_MOUSE;Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7);"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"GO:0004362; GO:0005739; GO:0005829; GO:0006749; GO:0007283; GO:0009055; GO:0009897; GO:0034599; GO:0042803; GO:0043295; GO:0045454; GO:0050660; GO:0050661";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]"
comp203457_c0_seq1;GAXK01157987.1;Q96GM8;2.62E-92;TOE1_HUMAN;Target of EGR1 protein 1;"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]";"GO:0000175; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503";"RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069]"
comp2034644_c0_seq1;GAXK01119765.1;Q8MJU1;3.75E-14;CASP3_FELCA;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp20350_c0_seq1;GAXK01032143.1;Q803I4;1.10E-81;RING2_DANRE;E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING-type E3 ubiquitin transferase RING2);"chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; embryonic cranial skeleton morphogenesis [GO:0048701]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; regulation of chondrocyte differentiation [GO:0032330]; retina morphogenesis in camera-type eye [GO:0060042]";"GO:0000122; GO:0000151; GO:0003682; GO:0005694; GO:0031519; GO:0032330; GO:0033339; GO:0035102; GO:0035518; GO:0036353; GO:0046872; GO:0048701; GO:0060042; GO:0061630; GO:0071339; GO:1902254";"embryonic cranial skeleton morphogenesis [GO:0048701]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; regulation of chondrocyte differentiation [GO:0032330]; retina morphogenesis in camera-type eye [GO:0060042]";"chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp2035184_c0_seq1;GAXK01119770.1;Q5YLM1;7.73E-36;DGLA_RAT;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp20361_c1_seq1;GAXK01031165.1;P23687;0;PPCE_PIG;Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]";"GO:0004175; GO:0004252; GO:0005737; GO:0005829; GO:0070008; GO:0070012";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]"
comp203617_c3_seq1;GAXK01157942.1;Q6GNV7;6.40E-24;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp203645_c0_seq1;GAXK01157986.1;A0AK43;3.60E-10;MENG_LISW6;Demethylmenaquinone methyltransferase (EC 2.1.1.163);"S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]";"GO:0009234; GO:0102955";menaquinone biosynthetic process [GO:0009234];;S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]
comp2036947_c0_seq1;GAXK01071169.1;Q8I6K0;4.29E-08;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2037083_c0_seq1;GAXK01071181.1;Q622X0;9.57E-08;UNC58_CAEBR;Uncoordinated protein 58;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; parturition [GO:0007567]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0006936; GO:0007567; GO:0022841; GO:0030322; GO:0040011; GO:0071805";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; parturition [GO:0007567]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp20371_c0_seq1;GAXK01031226.1;Q62381;1.44E-12;TLL1_MOUSE;Tolloid-like protein 1 (mTll) (EC 3.4.24.-);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0007275; GO:0008270; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp203752_c0_seq1;GAXK01157804.1;Q96MU6;6.69E-11;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2037655_c0_seq1;GAXK01071164.1;Q8T3Y0;3.74E-09;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp203785_c1_seq1;GAXK01157918.1;Q503C8;1.29E-33;NUDC1_DANRE;NudC domain-containing protein 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2037997_c0_seq1;GAXK01071163.1;Q9DCM4;1.39E-17;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp203826_c1_seq1;GAXK01157774.1;O35114;5.82E-84;SCRB2_MOUSE;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp2038368_c0_seq1;GAXK01091055.1;Q9JLB4;1.27E-18;CUBN_MOUSE;Cubilin (Intrinsic factor-cobalamin receptor);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2038624_c0_seq1;GAXK01091058.1;P08159;2.97E-08;HDNO_PSEOX;6-hydroxy-D-nicotine oxidase (6-HDNO) (EC 1.5.3.6);"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]; nicotine catabolic process [GO:0019608]";"GO:0018530; GO:0019608; GO:0071949";nicotine catabolic process [GO:0019608];;"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]"
comp203911_c0_seq1;GAXK01157788.1;Q8TEJ3;4.81E-20;SH3R3_HUMAN;E3 ubiquitin-protein ligase SH3RF3 (EC 2.3.2.27) (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4);"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]";"GO:0006915; GO:0046330; GO:0046872; GO:0051865; GO:0061630";"apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]";;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp203954_c0_seq1;GAXK01157778.1;Q767K7;1.59E-57;ATAT_PIG;Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog);"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; spindle [GO:0005819]; coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]";"GO:0004468; GO:0005737; GO:0005819; GO:0005874; GO:0005905; GO:0005925; GO:0019799; GO:0030424; GO:0048666; GO:0050662; GO:0070507; GO:0071929";"alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]";"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; spindle [GO:0005819]";"coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]"
comp203961_c1_seq1;GAXK01157792.1;Q9D700;1.57E-41;DUS26_MOUSE;Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP3);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA polymerase II activating transcription factor binding [GO:0001102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; protein dephosphorylation [GO:0006470]";"GO:0000122; GO:0001102; GO:0002039; GO:0004647; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0006470; GO:0008138; GO:0044387; GO:0045785; GO:0070373; GO:1902310";"negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA polymerase II activating transcription factor binding [GO:0001102]"
comp203999_c3_seq1;GAXK01157999.1;Q8CH02;3.09E-39;SUGP1_MOUSE;SURP and G-patch domain-containing protein 1 (Splicing factor 4);"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp204_c0_seq1;GAXK01169189.1;Q9WU83;4.57E-146;DPM1_CRIGR;Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1);"endoplasmic reticulum [GO:0005783]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; protein glycosylation [GO:0006486]";"GO:0004582; GO:0005783; GO:0006486";protein glycosylation [GO:0006486];endoplasmic reticulum [GO:0005783];dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]
comp2040033_c0_seq1;GAXK01062000.1;Q9YH16;2.19E-61;LMO3_XENLA;LIM domain only protein 3 (LMO-3) (LIM domain only protein 1) (LMO-1) (xLMO1);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp2040094_c0_seq1;GAXK01062007.1;O15457;4.52E-38;MSH4_HUMAN;MutS protein homolog 4 (hMSH4);"mismatch repair complex [GO:0032300]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0000228; GO:0000712; GO:0000795; GO:0001541; GO:0003677; GO:0005524; GO:0005634; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0008094; GO:0030983; GO:0032300";"female gamete generation [GO:0007292]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"mismatch repair complex [GO:0032300]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]"
comp2040237_c0_seq1;GAXK01062019.1;Q8BGD8;8.17E-13;COA6_MOUSE;Cytochrome c oxidase assembly factor 6 homolog;"host cell mitochondrial intermembrane space [GO:0072492]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535]";"GO:0005507; GO:0005739; GO:0005758; GO:0005886; GO:0008535; GO:0042774; GO:0072492";"plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535]";"host cell mitochondrial intermembrane space [GO:0072492]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";copper ion binding [GO:0005507]
comp20412_c1_seq1;GAXK01031746.1;A8D8P8;4.57E-48;SIWI_BOMMO;Piwi-like protein Siwi (EC 3.1.26.-);"cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; PET complex [GO:1990923]";"endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]"
comp2041445_c0_seq1;GAXK01062008.1;Q9STN8;3.90E-12;SINA4_ARATH;E3 ubiquitin-protein ligase SINAT4 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT4) (Seven in absentia homolog 4);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2041683_c0_seq1;GAXK01062016.1;Q9FJE8;3.64E-14;H2A7_ARATH;Probable histone H2A.7 (HTA6);"heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; plasmodesma [GO:0009506]; plastid [GO:0009536]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]";"GO:0000786; GO:0000790; GO:0000792; GO:0003677; GO:0003682; GO:0005721; GO:0005730; GO:0006325; GO:0009506; GO:0009536; GO:0046982; GO:0070828";"chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]";"heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp20418_c11_seq1;GAXK01031241.1;Q91955;7.70E-33;MTPN_CHICK;Myotrophin (Granule cell differentiation protein) (Protein V-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]";"GO:0005634; GO:0005737; GO:0005829; GO:0008290; GO:0008361; GO:0010557; GO:0010613; GO:0030307; GO:0030424; GO:0048471; GO:0051092; GO:0051247; GO:2000812";"positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp204190_c0_seq1;GAXK01016126.1;Q7KRW8;7.33E-20;PRP39_DROME;Pre-mRNA-processing factor 39 (PRP39 homolog);"commitment complex [GO:0000243]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000243; GO:0000381; GO:0000395; GO:0000398; GO:0005634; GO:0005685; GO:0071004";"mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"commitment complex [GO:0000243]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";
comp2042273_c0_seq1;GAXK01137025.1;Q94900;1.28E-105;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp204228_c2_seq1;GAXK01016050.1;O57579;1.53E-72;AMPN_CHICK;Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N);"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0042277; GO:0043171; GO:0070006; GO:0070062";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp20424_c2_seq1;GAXK01032518.1;A6H730;1.74E-90;PPAP_BOVIN;Prostatic acid phosphatase (EC 3.1.3.2);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"GO:0003993; GO:0005615; GO:0005886; GO:0006772; GO:0008253; GO:0012506; GO:0016311; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168";"adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]"
comp204243_c0_seq1;GAXK01016025.1;P33727;1.37E-110;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp2042557_c0_seq1;GAXK01137050.1;Q8WXW3;1.66E-09;PIBF1_HUMAN;Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90);"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539]";"GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515";"activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539]";"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";interleukin-4 receptor binding [GO:0005136]
comp2042899_c0_seq1;GAXK01137043.1;Q9HCN3;5.18E-08;TMM8A_HUMAN;Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]";"GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0070062; GO:0102567; GO:0102568";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp2042901_c0_seq1;GAXK01137022.1;P34545;1.04E-08;CBP1_CAEEL;Protein cbp-1 (EC 2.3.1.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; embryo development ending in birth or egg hatching [GO:0009792]; histone acetylation [GO:0016573]; internal peptidyl-lysine acetylation [GO:0018393]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron projection development [GO:0010975]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003712; GO:0004402; GO:0004468; GO:0005634; GO:0005737; GO:0006355; GO:0006915; GO:0007283; GO:0008134; GO:0008270; GO:0009792; GO:0010975; GO:0016573; GO:0018393; GO:0043065; GO:0045944; GO:0061629; GO:0061733";"apoptotic process [GO:0006915]; embryo development ending in birth or egg hatching [GO:0009792]; histone acetylation [GO:0016573]; internal peptidyl-lysine acetylation [GO:0018393]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron projection development [GO:0010975]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"histone acetyltransferase activity [GO:0004402]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp204332_c0_seq1;GAXK01016008.1;Q9BVQ7;4.62E-61;SPA5L_HUMAN;Spermatogenesis-associated protein 5-like protein 1;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0005737; GO:0016887";;cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp2043518_c0_seq1;GAXK01137024.1;Q8A1F3;1.68E-30;DDL_BACTN;D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]"
comp2043704_c0_seq1;GAXK01137030.1;A0A0R4IBK5;3.81E-07;R213A_DANRE;E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872";"blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp2044068_c0_seq1;GAXK01158855.1;Q658P3;7.83E-19;STEA3_HUMAN;Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]";"GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0033572; GO:0042802; GO:0042981; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0098706";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp20442_c0_seq1;GAXK01032019.1;Q5BJI9;1.92E-72;SPCS2_DANRE;Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit);"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]";"GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047";"protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]";"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";peptidase activity [GO:0008233]
comp2044626_c0_seq1;GAXK01158860.1;P23645;5.90E-23;BIB_DROME;Neurogenic protein big brain;"adherens junction [GO:0005912]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; channel activity [GO:0015267]; cell-cell adhesion [GO:0098609]; ectoderm development [GO:0007398]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; neuron fate specification [GO:0048665]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of imaginal disc-derived wing size [GO:0044719]; transmembrane transport [GO:0055085]; water transport [GO:0006833]";"GO:0005261; GO:0005886; GO:0005912; GO:0006833; GO:0007398; GO:0007498; GO:0015267; GO:0016021; GO:0030707; GO:0031410; GO:0044719; GO:0045747; GO:0046331; GO:0048665; GO:0055085; GO:0098609";"cell-cell adhesion [GO:0098609]; ectoderm development [GO:0007398]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; neuron fate specification [GO:0048665]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of imaginal disc-derived wing size [GO:0044719]; transmembrane transport [GO:0055085]; water transport [GO:0006833]";"adherens junction [GO:0005912]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; channel activity [GO:0015267]"
comp204464_c2_seq1;GAXK01016172.1;P49010;3.10E-111;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp204465_c2_seq1;GAXK01016156.1;P80387;3.45E-09;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp20447_c0_seq1;GAXK01031929.1;Q9BXF3;2.69E-20;CECR2_HUMAN;Cat eye syndrome critical region protein 2;"CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; vesicle-mediated transport [GO:0016192]";"GO:0005634; GO:0006309; GO:0007010; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194";"apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; vesicle-mediated transport [GO:0016192]";"CERF complex [GO:0090537]; nucleus [GO:0005634]";
comp204474_c0_seq1;GAXK01016160.1;Q9JM76;9.51E-56;ARPC3_MOUSE;Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC);"Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]";"GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090";"Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]";"Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]"
comp2044829_c0_seq1;GAXK01158873.1;Q96H40;1.25E-10;ZN486_HUMAN;Zinc finger protein 486 (KRAB domain only protein 2);"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0070062";regulation of transcription, DNA-templated [GO:0006355];"extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp204494_c0_seq1;GAXK01016033.1;Q5W5U4;1.03E-78;DDX4_BOVIN;Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4);"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp2045049_c0_seq1;GAXK01158877.1;G4SLH0;1.86E-07;TTN1_CAEEL;Titin homolog (EC 2.7.11.1);"A band [GO:0031672]; I band [GO:0031674]; M band [GO:0031430]; nuclear membrane [GO:0031965]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0017022; GO:0030017; GO:0031430; GO:0031672; GO:0031674; GO:0031965; GO:0046872; GO:0051015";;"A band [GO:0031672]; I band [GO:0031674]; M band [GO:0031430]; nuclear membrane [GO:0031965]; sarcomere [GO:0030017]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]"
comp2045082_c0_seq1;GAXK01158872.1;Q14591;4.25E-17;ZN271_HUMAN;Deleted.;;;;;
comp2045913_c0_seq1;GAXK01158870.1;Q21701;1.17E-09;NHR12_CAEEL;Nuclear hormone receptor family member nhr-12;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp2046_c0_seq1;GAXK01175382.1;Q95RI5;4.78E-99;FAXC_DROME;Failed axon connections;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"GO:0005737; GO:0005886; GO:0007409; GO:0036099";"axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";
comp204660_c3_seq1;GAXK01015983.1;Q9VHH9;4.25E-65;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp2046608_c0_seq1;GAXK01004599.1;P51613;3.15E-13;CHIB_VITVI;Basic endochitinase (EC 3.2.1.14);"chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";;"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp2046786_c0_seq1;GAXK01004612.1;O62729;9.73E-16;NPY5R_CANLF;Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; chemical synaptic transmission [GO:0007268]";"GO:0001601; GO:0001602; GO:0005886; GO:0007268; GO:0016020; GO:0016021; GO:0043005";chemical synaptic transmission [GO:0007268];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]"
comp20470_c0_seq1;GAXK01031689.1;Q5F3X8;0;SC31A_CHICK;Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A);"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"GO:0000139; GO:0005198; GO:0005789; GO:0006886; GO:0006888; GO:0007029; GO:0030127; GO:0030134; GO:0070971; GO:0090110; GO:0090114";"COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";structural molecule activity [GO:0005198]
comp2047341_c0_seq1;GAXK01004596.1;Q8ITC7;4.76E-52;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp20483_c0_seq1;GAXK01031760.1;P62997;1.41E-51;TRA2B_RAT;Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0048026; GO:0048471; GO:1990904";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp20484_c2_seq1;GAXK01032627.1;Q4V838;1.35E-81;LTV1_XENLA;Protein LTV1 homolog;ribosomal small subunit biogenesis [GO:0042274];GO:0042274;ribosomal small subunit biogenesis [GO:0042274];;
comp2048445_c0_seq1;GAXK01116844.1;Q8BHI9;5.70E-119;NIM1_MOUSE;Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0031588; GO:0032007; GO:0035556; GO:0042149";"cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp204851_c0_seq1;GAXK01016043.1;O43657;3.67E-14;TSN6_HUMAN;Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"GO:0005887; GO:0039532; GO:0043123; GO:0070062; GO:1901223";"negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]";
comp204856_c1_seq1;GAXK01016000.1;A8WHR0;6.86E-23;DCA17_DANRE;DDB1- and CUL4-associated factor 17;"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; protein ubiquitination [GO:0016567]";"GO:0005730; GO:0016021; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]";
comp204909_c1_seq1;GAXK01015953.1;P58283;1.54E-37;RN216_MOUSE;E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546";"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp2049259_c0_seq1;GAXK01116842.1;P28891;1.21E-11;VM1F_AGKCO;Snake venom metalloproteinase fibrolase (SVMP) (EC 3.4.24.72) (Fibrinolytic metalloproteinase) (Fibrinolytic proteinase) (Alfimeprase);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp204928_c0_seq1;GAXK01016122.1;A1ZA47;4.48E-08;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp20496_c3_seq1;GAXK01032197.1;P10711;4.02E-10;TCEA1_MOUSE;Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006351; GO:0008270; GO:0030218; GO:0045893; GO:0045944";"erythrocyte differentiation [GO:0030218]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp204985_c0_seq1;GAXK01016139.1;P18061;3.19E-48;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp20500_c0_seq1;GAXK01031479.1;Q9VKQ9;2.46E-11;DPY30_DROME;Protein dpy-30 homolog (Dpy-30-like protein 1);"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]";"GO:0044665; GO:0044666; GO:0048188; GO:0051568";histone H3-K4 methylation [GO:0051568];"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]";
comp205001_c0_seq1;GAXK01015979.1;Q8NCC3;2.17E-107;PAG15_HUMAN;Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006672; GO:0008374; GO:0009062; GO:0016020; GO:0034638; GO:0043231; GO:0046338; GO:0047499; GO:0070062";"ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]"
comp2050051_c0_seq1;GAXK01204098.1;A2A935;3.63E-07;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp2050109_c0_seq1;GAXK01204096.1;Q8MRC9;1.84E-64;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp2050139_c0_seq1;GAXK01204083.1;Q8TE73;1.35E-82;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp20505_c1_seq1;GAXK01031926.1;O44424;1.53E-71;ESS2_DROME;Splicing factor ESS-2 homolog (Protein Es2) (dEs2);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]";"GO:0000398; GO:0005634; GO:0007399; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]";
comp20508_c1_seq1;GAXK01032163.1;P61964;0;WDR5_HUMAN;WD repeat-containing protein 5 (BMP2-induced 3-kb gene protein);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; neuron projection development [GO:0031175]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; skeletal system development [GO:0001501]";"GO:0000123; GO:0001501; GO:0005634; GO:0005654; GO:0005671; GO:0031175; GO:0035064; GO:0035097; GO:0035948; GO:0042393; GO:0043687; GO:0043966; GO:0043981; GO:0043982; GO:0043984; GO:0044666; GO:0045652; GO:0048188; GO:0051568; GO:0071339";"histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; neuron projection development [GO:0031175]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; skeletal system development [GO:0001501]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]";"histone binding [GO:0042393]; methylated histone binding [GO:0035064]"
comp205100_c1_seq1;GAXK01016127.1;Q5SXM1;4.91E-49;ZN678_HUMAN;Zinc finger protein 678;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2051890_c0_seq1;GAXK01204106.1;Q28BQ6;3.03E-10;TMED1_XENTR;Transmembrane emp24 domain-containing protein 1 (p24 family protein gamma-1) (p24gamma1);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2051894_c0_seq1;GAXK01204101.1;Q9VZW5;2.42E-09;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp205215_c0_seq1;GAXK01015947.1;Q25637;1.53E-85;PER_PERAM;Period circadian protein;"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0005634; GO:0006355; GO:0048511";"regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";nucleus [GO:0005634];
comp205219_c0_seq1;GAXK01016153.1;Q9NQ79;0;CRAC1_HUMAN;Cartilage acidic protein 1 (68 kDa chondrocyte-expressed protein) (CEP-68) (ASPIC);"extracellular exosome [GO:0070062]; growth cone [GO:0030426]; calcium ion binding [GO:0005509]; axonal fasciculation [GO:0007413]; negative regulation of receptor binding [GO:1900121]; olfactory bulb development [GO:0021772]";"GO:0005509; GO:0007413; GO:0021772; GO:0030426; GO:0070062; GO:1900121";"axonal fasciculation [GO:0007413]; negative regulation of receptor binding [GO:1900121]; olfactory bulb development [GO:0021772]";"extracellular exosome [GO:0070062]; growth cone [GO:0030426]";calcium ion binding [GO:0005509]
comp205222_c7_seq1;GAXK01016085.1;Q6VNB8;0;WDFY3_MOUSE;WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1);"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]";"GO:0003831; GO:0005545; GO:0005634; GO:0005635; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635";"aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]";"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]";"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"
comp205264_c0_seq1;GAXK01015997.1;Q8MVS5;7.14E-170;GLT35_DROME;Polypeptide N-acetylgalactosaminyltransferase 35A (EC 2.4.1.41) (Protein l(2)35Aa) (Protein-UDP acetylgalactosaminyltransferase 35A) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 35A) (pp-GaNTase 35A) (dGalNAc-T1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; open tracheal system development [GO:0007424]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]";"GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0005795; GO:0006486; GO:0007424; GO:0008593; GO:0009312; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; open tracheal system development [GO:0007424]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp20528_c0_seq1;GAXK01032298.1;P12370;0;KAPC1_DROME;cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0);"cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; signal transduction [GO:0007165]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]";"GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0018105; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0040040; GO:0042981; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048149; GO:0048477; GO:0048682; GO:0048749; GO:0050804; GO:0071361; GO:2000249";"anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; signal transduction [GO:0007165]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]";"cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]"
comp20533_c0_seq1;GAXK01032115.1;O88874;7.11E-121;CCNK_MOUSE;Cyclin-K;"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001701; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0016538; GO:0019901; GO:0032786; GO:0044828; GO:0051301; GO:0061575; GO:0071157; GO:2000737; GO:2001165";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357]";"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp2053543_c0_seq1;GAXK01179771.1;O54981;7.51E-18;STIP1_CRIGR;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp205355_c1_seq1;GAXK01016053.1;Q8MHY7;6.21E-35;UROK_RABIT;"Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B]";"cell surface [GO:0009986]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]";"GO:0001666; GO:0004252; GO:0005615; GO:0009986; GO:0010469; GO:0014909; GO:0014910; GO:0030335; GO:0031639; GO:0033628; GO:0042127; GO:0042730; GO:2000097";"fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; regulation of smooth muscle cell migration [GO:0014910]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]";"cell surface [GO:0009986]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp2053685_c0_seq1;GAXK01179775.1;P63079;3.15E-24;GBRB3_RAT;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0030659; GO:0034220; GO:0034707; GO:0035612; GO:0042391; GO:0043005; GO:0043195; GO:0045202; GO:0050877; GO:0051932; GO:0060021; GO:0060077; GO:0071420; GO:0098982; GO:0099055; GO:0099060; GO:1902711; GO:1904862";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp20538_c8_seq1;GAXK01031833.1;A2AVA0;1.74E-26;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp205392_c6_seq1;GAXK01016007.1;P50451;6.00E-28;CBG_SAISC;Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin);"extracellular space [GO:0005615]; steroid binding [GO:0005496]";"GO:0005496; GO:0005615";;extracellular space [GO:0005615];steroid binding [GO:0005496]
comp205430_c1_seq1;GAXK01016039.1;O08760;9.14E-91;OGG1_MOUSE;"N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]";"mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; microtubule binding [GO:0008017]; oxidized base lesion DNA N-glycosylase activity [GO:0000702]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]";"GO:0000702; GO:0002526; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006355; GO:0006974; GO:0006979; GO:0007568; GO:0008017; GO:0008534; GO:0009314; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0032355; GO:0032357; GO:0032991; GO:0033683; GO:0034039; GO:0043066; GO:0045471; GO:0051593; GO:0071276; GO:0140078; GO:1901291";"acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]";"mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; microtubule binding [GO:0008017]; oxidized base lesion DNA N-glycosylase activity [GO:0000702]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]"
comp2054517_c0_seq1;GAXK01196956.1;P05661;8.76E-53;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2054975_c0_seq1;GAXK01196946.1;Q9VZW5;3.28E-19;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2054994_c0_seq1;GAXK01196947.1;P11118;1.55E-32;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2055250_c0_seq1;GAXK01196945.1;Q17320;2.89E-96;WHITE_CERCA;Protein white;"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pigment binding [GO:0031409]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0055085";transmembrane transport [GO:0055085];integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; pigment binding [GO:0031409]"
comp2055365_c0_seq1;GAXK01196937.1;A8ERX9;2.86E-56;PAND_ARCB4;"Aspartate 1-decarboxylase (EC 4.1.1.11) (Aspartate alpha-decarboxylase) [Cleaved into: Aspartate 1-decarboxylase beta chain; Aspartate 1-decarboxylase alpha chain]";"cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; alanine biosynthetic process [GO:0006523]; pantothenate biosynthetic process [GO:0015940]";"GO:0004068; GO:0005737; GO:0006523; GO:0015940";"alanine biosynthetic process [GO:0006523]; pantothenate biosynthetic process [GO:0015940]";cytoplasm [GO:0005737];aspartate 1-decarboxylase activity [GO:0004068]
comp20554_c1_seq1;GAXK01031818.1;Q9VMM6;3.88E-16;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp2055586_c0_seq1;GAXK01196936.1;Q27173;2.35E-13;T2A_PARTE;"Trichocyst matrix protein T2-A (Secretory granule protein T2-A) (TMP 2-A) [Cleaved into: Trichocyst matrix protein T2-A 1; Trichocyst matrix protein T2-A 2]";trichocyst [GO:0055039];GO:0055039;;trichocyst [GO:0055039];
comp20557_c0_seq1;GAXK01032195.1;P56966;3.46E-120;GGPPS_BOVIN;Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10);"cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]";"GO:0004161; GO:0004311; GO:0004337; GO:0005737; GO:0006720; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872";"farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]";cytoplasm [GO:0005737];"dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp205572_c1_seq1;GAXK01015980.1;Q9HH99;1.31E-50;P5CR_METAC;Pyrroline-5-carboxylate reductase (P5C reductase) (P5CR) (EC 1.5.1.2) (PCA reductase);"cytoplasm [GO:0005737]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]";"GO:0004735; GO:0005737; GO:0055129";L-proline biosynthetic process [GO:0055129];cytoplasm [GO:0005737];pyrroline-5-carboxylate reductase activity [GO:0004735]
comp2056272_c0_seq1;GAXK01179969.1;A6NJL1;6.19E-09;ZSA5B_HUMAN;Zinc finger and SCAN domain-containing protein 5B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2056471_c0_seq1;GAXK01179973.1;P56561;6.82E-07;CUD5_LOCMI;Endocuticle structural glycoprotein ABD-5;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp20565_c0_seq1;GAXK01031265.1;A1Z6E0;6.13E-128;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp205669_c1_seq1;GAXK01015945.1;Q9R078;8.58E-37;AAKB1_MOUSE;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0004672; GO:0004679; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0010628; GO:0019901; GO:0031588; GO:0032991; GO:0035878; GO:0050790; GO:0051291; GO:0120162";"fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp20575_c0_seq1;GAXK01031398.1;Q6NZ07;4.39E-123;NCLN_DANRE;Nicalin-1 (Nicastrin-like protein 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enteric nervous system development [GO:0048484]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; regulation of signal transduction [GO:0009966]";"GO:0005789; GO:0005886; GO:0009966; GO:0016021; GO:0048484; GO:1900176";"enteric nervous system development [GO:0048484]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; regulation of signal transduction [GO:0009966]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp205757_c0_seq1;GAXK01016013.1;Q9NVG8;6.02E-146;TBC13_HUMAN;TBC1 domain family member 13;"cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0016020; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"cytosol [GO:0005829]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp20577_c0_seq1;GAXK01031727.1;Q99J62;1.07E-155;RFC4_MOUSE;Replication factor C subunit 4 (Activator 1 subunit 4);"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:0031391; GO:1900264";"DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]"
comp2058190_c0_seq1;GAXK01159889.1;Q9JKA7;2.37E-159;HCN4_RAT;Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cAMP binding [GO:0030552]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated potassium channel activity [GO:0005249]; cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; modulation of chemical synaptic transmission [GO:0050804]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; response to cisplatin [GO:0072718]";"GO:0002027; GO:0005222; GO:0005249; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0016323; GO:0030552; GO:0031226; GO:0034765; GO:0043005; GO:0043025; GO:0043195; GO:0050804; GO:0071320; GO:0071805; GO:0072718; GO:1904045";"cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; modulation of chemical synaptic transmission [GO:0050804]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; response to cisplatin [GO:0072718]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]";"cAMP binding [GO:0030552]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated potassium channel activity [GO:0005249]"
comp2058373_c0_seq1;GAXK01159897.1;Q99PE9;5.14E-24;ARL4D_MOUSE;ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0016192";"intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp205849_c2_seq1;GAXK01015949.1;Q05319;3.84E-46;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp2058524_c0_seq1;GAXK01159904.1;Q9D119;2.19E-11;PPR27_MOUSE;Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1);"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]";"GO:0004864; GO:0010923; GO:0019902";negative regulation of phosphatase activity [GO:0010923];;"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]"
comp205857_c0_seq1;GAXK01015952.1;Q9C0G0;1.19E-19;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp205873_c4_seq1;GAXK01016100.1;P55112;6.91E-36;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2059412_c0_seq1;GAXK01159902.1;Q6GN42;5.83E-21;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp206029_c0_seq1;GAXK01204616.1;Q3URR7;5.36E-18;ZSC10_MOUSE;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863";"negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp206089_c2_seq1;GAXK01204547.1;Q0E908;5.57E-118;HIL_DROME;Hillarin (D-Hillarin) (D-hil);"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]";"GO:0005938; GO:0032154; GO:0046872";;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]";metal ion binding [GO:0046872]
comp2061156_c0_seq1;GAXK01041439.1;Q94900;1.36E-17;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp206147_c0_seq1;GAXK01204475.1;O88907;3.89E-58;PIAS1_MOUSE;E3 SUMO-protein ligase PIAS1 (EC 2.3.2.27) (DEAD/H box-binding protein 1) (Protein inhibitor of activated STAT protein 1) (RING-type E3 ubiquitin transferase PIAS1);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]";"GO:0000082; GO:0000122; GO:0001085; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0007259; GO:0007283; GO:0008022; GO:0008134; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0019904; GO:0031625; GO:0032436; GO:0033235; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0051152; GO:0061665; GO:0065004";"fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex assembly [GO:0065004]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp2062120_c0_seq1;GAXK01114093.1;Q00871;6.92E-57;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp206215_c0_seq1;GAXK01204418.1;Q9V427;2.64E-77;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp2062186_c0_seq1;GAXK01114113.1;Q60821;6.50E-11;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp2062359_c0_seq1;GAXK01114107.1;O17449;1.10E-131;TBB1_MANSE;Tubulin beta-1 chain (Beta-1-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp20624_c1_seq1;GAXK01032624.1;Q961C9;1.04E-26;TNG11_DROME;Transport and Golgi organization protein 11 (Tango-11);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; protein secretion [GO:0009306]";"GO:0005737; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0009306; GO:0016021";protein secretion [GO:0009306];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]";
comp2062569_c0_seq1;GAXK01114134.1;Q54KF6;1.46E-33;Y7365_DICDI;Protein DDB_G0287365;"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152]";"GO:0008152; GO:0016798";metabolic process [GO:0008152];;hydrolase activity, acting on glycosyl bonds [GO:0016798]
comp2063083_c0_seq1;GAXK01114100.1;P40313;8.54E-32;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp206325_c3_seq1;GAXK01204536.1;Q6DCP6;5.59E-35;DYM_XENLA;Dymeclin;Golgi apparatus [GO:0005794];GO:0005794;;Golgi apparatus [GO:0005794];
comp2063362_c0_seq1;GAXK01114095.1;Q9NPC7;2.48E-08;MYNN_HUMAN;Myoneurin (Zinc finger and BTB domain-containing protein 31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp20634_c0_seq1;GAXK01032198.1;Q561T9;4.99E-40;OBRG_DANRE;Leptin receptor gene-related protein (Endospanin-1) (OB-R gene-related protein) (OB-RGRP);"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of protein localization to cell surface [GO:2000009]";"GO:0000139; GO:0005768; GO:0010008; GO:0016021; GO:0032511; GO:2000009";"late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of protein localization to cell surface [GO:2000009]";"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp2063488_c0_seq1;GAXK01114108.1;O88280;4.73E-08;SLIT3_RAT;Slit homolog 3 protein (Slit-3) (Multiple epidermal growth factor-like domains protein 5) (Multiple EGF-like domains protein 5);"extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; brain development [GO:0007420]; negative chemotaxis [GO:0050919]; spinal cord development [GO:0021510]";"GO:0005509; GO:0005615; GO:0007411; GO:0007420; GO:0008201; GO:0016020; GO:0021510; GO:0048495; GO:0050919";"axon guidance [GO:0007411]; brain development [GO:0007420]; negative chemotaxis [GO:0050919]; spinal cord development [GO:0021510]";"extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]"
comp2063549_c0_seq1;GAXK01114109.1;Q68Y21;1.34E-29;GRID2_DANRE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2063705_c0_seq1;GAXK01114090.1;P70677;2.27E-11;CASP3_MOUSE;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]";"GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0008627; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0035556; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044877; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0070059; GO:0071310; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097199; GO:0097200; GO:1902004";"anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]"
comp206380_c0_seq1;GAXK01204600.1;Q8TB37;1.66E-93;NUBPL_HUMAN;Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]";"GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584";"iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp206384_c1_seq1;GAXK01204412.1;P27615;9.04E-66;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp2063969_c0_seq1;GAXK01114131.1;Q8BIG4;1.28E-44;FBX28_MOUSE;F-box only protein 28;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";"GO:0000776; GO:0000777";;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";
comp2064047_c0_seq1;GAXK01055589.1;P10078;6.41E-13;ZFP28_MOUSE;Zinc finger protein 28 (Zfp-28) (Protein mKR5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2064179_c0_seq1;GAXK01055602.1;Q9MZ19;4.80E-32;KCNB1_RABIT;Potassium voltage-gated channel subfamily B member 1 (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005251; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp206435_c0_seq1;GAXK01204377.1;Q6ZS10;8.12E-09;CL17A_HUMAN;C-type lectin domain family 17, member A (Prolectin);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]";"GO:0005537; GO:0009986; GO:0016021; GO:0042806; GO:0046872";;"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";"fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp206484_c0_seq1;GAXK01204414.1;P82861;5.59E-107;ADRO_SALFO;NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203]";"GO:0005739; GO:0005743; GO:0008203; GO:0015039";cholesterol metabolic process [GO:0008203];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";NADPH-adrenodoxin reductase activity [GO:0015039]
comp206495_c0_seq1;GAXK01204394.1;Q8WR63;2.46E-70;TPM_TRIPS;Tropomyosin;;;;;
comp206497_c1_seq1;GAXK01204518.1;P10351;0;XDH_DROME;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus);"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0006144; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0043546; GO:0048072; GO:0050660; GO:0051537; GO:0071949";"arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp2064978_c0_seq1;GAXK01055612.1;Q3USY0;8.57E-91;S38AB_MOUSE;Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp2065017_c0_seq1;GAXK01055585.1;Q8I6K0;1.34E-28;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2065211_c0_seq1;GAXK01055587.1;Q10981;3.57E-09;FUT2_HUMAN;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (SE2) (Secretor blood group alpha-2-fucosyltransferase) (Secretor factor) (Se);"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"GO:0005794; GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0042355; GO:0070062";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp2065267_c0_seq1;GAXK01055594.1;Q80Z29;3.38E-128;NAMPT_RAT;Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]";"GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042803; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773";"aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cytokine activity [GO:0005125]; drug binding [GO:0008144]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]"
comp206605_c4_seq1;GAXK01204597.1;Q8BGM5;3.18E-89;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2066290_c0_seq1;GAXK01000296.1;Q86LG1;2.64E-17;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp2066385_c0_seq1;GAXK01000314.1;Q9BDB7;1.72E-24;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp20666_c0_seq1;GAXK01032175.1;Q9SFB8;8.59E-18;PI5K6_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 6 (AtPIP5K6) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 6) (Diphosphoinositide kinase 6) (PtdIns(4)P-5-kinase 6);"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005524; GO:0016308; GO:0016324; GO:0072583; GO:0090406";clathrin-dependent endocytosis [GO:0072583];"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp2066768_c0_seq1;GAXK01000315.1;Q9FYK2;6.19E-10;CML25_ARATH;Probable calcium-binding protein CML25 (Calmodulin-like protein 25);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; response to cold [GO:0009409]; root hair elongation [GO:0048767]";"GO:0005509; GO:0005634; GO:0005737; GO:0009409; GO:0048767";"response to cold [GO:0009409]; root hair elongation [GO:0048767]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";calcium ion binding [GO:0005509]
comp2067392_c0_seq1;GAXK01000316.1;Q8W257;1.12E-10;PFI_PTIFI;Polyenoic fatty acid isomerase (PFI) (EC 5.3.3.13);"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]";"GO:0016491; GO:0034016";;;"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]"
comp2067519_c0_seq1;GAXK01000309.1;A2APF3;9.14E-07;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2068164_c0_seq1;GAXK01041791.1;Q8VHL1;1.89E-18;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2068331_c0_seq1;GAXK01041826.1;Q9VZW5;1.47E-19;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp206836_c0_seq1;GAXK01204477.1;P98160;4.44E-24;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp2068442_c0_seq1;GAXK01041808.1;Q2PC93;4.74E-179;SSPO_CHICK;SCO-spondin;"extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005615; GO:0007155; GO:0007399; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";extracellular space [GO:0005615];
comp2068745_c0_seq1;GAXK01041799.1;A2RRH5;4.77E-34;WDR27_HUMAN;WD repeat-containing protein 27;nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp2069019_c0_seq1;GAXK01041796.1;Q76KX8;3.63E-07;ZN534_HUMAN;Zinc finger protein 534 (KRAB domain only protein 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp206907_c0_seq1;GAXK01204424.1;P61374;7.69E-117;ISL1_RAT;Insulin gene enhancer protein ISL-1 (Islet-1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]";"GO:0000122; GO:0000978; GO:0000981; GO:0001102; GO:0001158; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003203; GO:0003215; GO:0003266; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0007409; GO:0007507; GO:0008284; GO:0010575; GO:0010718; GO:0016922; GO:0021520; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0043565; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0046872; GO:0048665; GO:0048880; GO:0048936; GO:0050680; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0071385; GO:0071657; GO:0090074; GO:0090090; GO:1990841";"atrial septum morphogenesis [GO:0060413]; axonogenesis [GO:0007409]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]"
comp2069216_c0_seq1;GAXK01041807.1;P69097;1.68E-43;CALM_TRYBB;Calmodulin (CaM);"axoneme [GO:0005930]; cilium [GO:0005929]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005929; GO:0005930; GO:0019722";calcium-mediated signaling [GO:0019722];"axoneme [GO:0005930]; cilium [GO:0005929]";calcium ion binding [GO:0005509]
comp2069411_c0_seq1;GAXK01041814.1;P86854;1.18E-09;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp2069501_c0_seq1;GAXK01041798.1;Q9NXV2;1.07E-13;KCTD5_HUMAN;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; viral process [GO:0016032]";"GO:0005634; GO:0005737; GO:0005829; GO:0016032; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; viral process [GO:0016032]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp2069634_c0_seq1;GAXK01041820.1;P30430;8.09E-175;FUR1C_DROME;Furin-like protease 1, isoform 1-CRR (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688";"glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp2069636_c0_seq1;GAXK01041821.1;Q8T3Y0;1.33E-07;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp206997_c0_seq1;GAXK01204496.1;Q26473;2.44E-21;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp2070042_c0_seq1;GAXK01057777.1;Q9JLB4;1.07E-39;CUBN_MOUSE;Cubilin (Intrinsic factor-cobalamin receptor);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp207054_c0_seq1;GAXK01204549.1;Q4KLV6;3.79E-81;AGO4_XENLA;Protein argonaute-4 (Argonaute4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4);"P-body [GO:0000932]; RISC complex [GO:0016442]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"GO:0000932; GO:0006402; GO:0016442; GO:0035198; GO:0035278";"miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"P-body [GO:0000932]; RISC complex [GO:0016442]";miRNA binding [GO:0035198]
comp2070818_c0_seq1;GAXK01057783.1;Q9XYM0;8.86E-28;CRK_DROME;Adapter molecule Crk;"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013";"border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";;receptor tyrosine kinase binding [GO:0030971]
comp2070922_c0_seq1;GAXK01057776.1;Q17528;2.00E-18;BEST1_CAEEL;Bestrophin homolog 1;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2070983_c0_seq1;GAXK01057784.1;Q9Y115;1.89E-13;UN93L_DROME;UNC93-like protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120";"regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";potassium channel regulator activity [GO:0015459]
comp20713_c0_seq1;GAXK01031997.1;P0C7P0;1.36E-12;CISD3_HUMAN;CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2) (Miner2) (Mitochondrial inner NEET protein) (MiNT);"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]";"GO:0005739; GO:0046872; GO:0051537; GO:0106034";protein maturation by [2Fe-2S] cluster transfer [GO:0106034];mitochondrion [GO:0005739];"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"
comp2071455_c0_seq1;GAXK01057749.1;Q6DHG0;7.38E-22;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2071546_c0_seq1;GAXK01057768.1;P81282;1.77E-15;CSPG2_BOVIN;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp207173_c0_seq1;GAXK01204544.1;Q9N293;4.62E-21;B3GT5_GORGO;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp207176_c2_seq1;GAXK01204539.1;Q92636;3.17E-37;FAN_HUMAN;Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165]";"GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065; GO:2000304";"ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";sphingomyelin phosphodiesterase activator activity [GO:0016230]
comp2071839_c0_seq1;GAXK01057779.1;Q94HW2;2.31E-21;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp2072_c1_seq1;GAXK01176488.1;P91753;5.95E-10;MP62_LYTPI;Mitotic apparatus protein p62;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp2072420_c0_seq1;GAXK01090595.1;O42409;1.28E-07;GFI1B_CHICK;Zinc finger protein Gfi-1b (Growth factor-independent protein 1B);"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001085; GO:0003677; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp207249_c1_seq1;GAXK01204596.1;Q9UJU3;1.46E-23;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2072602_c0_seq1;GAXK01090582.1;Q3Z8V9;2.63E-48;PDXT_DEHM1;Pyridoxal 5'-phosphate synthase subunit PdxT (EC 4.3.3.6) (Pdx2) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2);"glutaminase activity [GO:0004359]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; glutamine catabolic process [GO:0006543]; pyridoxal phosphate biosynthetic process [GO:0042823]";"GO:0004359; GO:0006543; GO:0036381; GO:0042823";"glutamine catabolic process [GO:0006543]; pyridoxal phosphate biosynthetic process [GO:0042823]";;"glutaminase activity [GO:0004359]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]"
comp20729_c0_seq1;GAXK01031217.1;Q15022;1.61E-41;SUZ12_HUMAN;Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog);"ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RSC-type complex [GO:0016586]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000122; GO:0000978; GO:0001739; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0008284; GO:0016574; GO:0016586; GO:0016604; GO:0031490; GO:0032993; GO:0035064; GO:0035098; GO:0042054; GO:0045596; GO:0045814; GO:0046872; GO:0070317; GO:0070734; GO:1990841";"histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]";"ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RSC-type complex [GO:0016586]; sex chromatin [GO:0001739]";"chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp207306_c0_seq1;GAXK01204381.1;Q5XIN7;0;PMGT1_RAT;Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-);"integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]";"GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223";"O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]";"integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]"
comp2073128_c0_seq1;GAXK01090591.1;P61023;4.78E-11;CHP1_RAT;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015630; GO:0017156; GO:0019722; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071468; GO:0090314; GO:1901214";"calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]"
comp2073234_c0_seq1;GAXK01090588.1;Q86MW9;6.15E-08;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2073445_c0_seq1;GAXK01090579.1;Q02156;1.64E-32;KPCE_HUMAN;Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"GO:0002281; GO:0003785; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030168; GO:0030546; GO:0030838; GO:0031397; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043278; GO:0043410; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:1903078; GO:2000650; GO:2001031";"apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]"
comp2073474_c0_seq1;GAXK01090593.1;Q5ZI33;2.83E-09;KLHL7_CHICK;Kelch-like protein 7;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031463; GO:0042803; GO:0048471";protein ubiquitination [GO:0016567];"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";protein homodimerization activity [GO:0042803]
comp207351_c1_seq1;GAXK01204385.1;Q5U3S1;8.15E-138;KATL1_DANRE;Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031122";"cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp20738_c0_seq1;GAXK01031477.1;P41996;2.54E-11;CPG2_CAEEL;Chondroitin proteoglycan-2 (Cytokinesis protein B0280.5);"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"GO:0000281; GO:0006030; GO:0008061; GO:0009792; GO:0030312; GO:0030703; GO:0032465; GO:0098595";"chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]";chitin binding [GO:0008061]
comp2074_c2_seq1;GAXK01176560.1;Q5ZLF0;1.04E-70;F10A1_CHICK;Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog);"cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085]";"GO:0005737; GO:0046983; GO:0051085";chaperone cofactor-dependent protein refolding [GO:0051085];cytoplasm [GO:0005737];protein dimerization activity [GO:0046983]
comp20745_c3_seq1;GAXK01031167.1;Q8N6T3;1.01E-56;ARFG1_HUMAN;ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005096; GO:0005829; GO:0006888; GO:0006890; GO:0014069; GO:0015031; GO:0030100; GO:0032012; GO:0036498; GO:0045202; GO:0046872";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp207466_c1_seq1;GAXK01204442.1;P34465;3.03E-24;CY561_CAEEL;Putative cytochrome b561 (Cytochrome b-561);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0005765; GO:0016021; GO:0016491; GO:0031902; GO:0046872";;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp2074833_c0_seq1;GAXK01084149.1;P05994;3.30E-31;PAPA4_CARPA;Papaya proteinase 4 (EC 3.4.22.25) (Glycyl endopeptidase) (Papaya peptidase B) (Papaya proteinase IV) (PPIV);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp207488_c0_seq1;GAXK01204504.1;Q9XY07;5.51E-42;KARG_STIJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp207525_c0_seq1;GAXK01204548.1;Q924D0;2.04E-07;RT4I1_MOUSE;Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; regulation of dendrite development [GO:0050773]";"GO:0005739; GO:0005741; GO:0008270; GO:0016491; GO:0050773";regulation of dendrite development [GO:0050773];"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]"
comp2075256_c0_seq1;GAXK01084145.1;P17025;9.14E-12;ZN182_HUMAN;Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp207580_c0_seq1;GAXK01204445.1;Q9NRA2;6.44E-52;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp2076013_c0_seq1;GAXK01088387.1;Q95NI4;4.07E-33;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp207602_c1_seq1;GAXK01204415.1;Q6DDH2;7.08E-30;RMI1_XENLA;RecQ-mediated genome instability protein 1;"nucleus [GO:0005634]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]";"GO:0000166; GO:0005634; GO:0006260";DNA replication [GO:0006260];nucleus [GO:0005634];nucleotide binding [GO:0000166]
comp207610_c0_seq1;GAXK01204603.1;Q66IJ4;6.31E-103;PIGM_XENTR;GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity, transferring hexosyl groups [GO:0016758]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005789; GO:0006506; GO:0016021; GO:0016758";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";transferase activity, transferring hexosyl groups [GO:0016758]
comp2076166_c0_seq1;GAXK01088406.1;P00971;1.44E-07;RLIG_BPT4;T4 RNA ligase 1 (EC 6.5.1.3) (Gene product 63) (gp63) (Rnl1);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; RNA repair [GO:0042245]; virus tail fiber assembly [GO:0098004]";"GO:0003972; GO:0005524; GO:0042245; GO:0046872; GO:0098004";"RNA repair [GO:0042245]; virus tail fiber assembly [GO:0098004]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]"
comp207619_c2_seq1;GAXK01204397.1;Q5TZ80;1.70E-24;HOOK1_DANRE;Protein Hook homolog 1;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031]";"GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0045022; GO:0051959; GO:0070695";"cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]";"dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]"
comp2076475_c0_seq1;GAXK01088410.1;P08045;2.49E-17;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp2076561_c0_seq1;GAXK01088385.1;P11118;1.05E-17;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp207672_c0_seq1;GAXK01204440.1;Q9U539;1.27E-133;OCT1_CAEEL;Organic cation transporter 1 (CeOCT1);"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";"GO:0008340; GO:0015101; GO:0015695; GO:0016021";"determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp20772_c0_seq1;GAXK01031729.1;Q7K4Q5;2.95E-38;Y0417_DROME;Probable protein phosphatase CG10417 (EC 3.1.3.16);"cytoplasm [GO:0005737]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]";"GO:0004722; GO:0004724; GO:0005737; GO:0006470; GO:0046872";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp2077353_c0_seq1;GAXK01088418.1;Q80ZD3;3.62E-55;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp2077771_c0_seq1;GAXK01088403.1;P14381;1.98E-09;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp207838_c2_seq1;GAXK01204527.1;Q8K2J9;0;BTBD6_MOUSE;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp2078499_c0_seq1;GAXK01073705.1;P27615;2.55E-43;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp2078570_c0_seq1;GAXK01073682.1;O35244;1.42E-42;PRDX6_RAT;Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Non-selenium glutathione peroxidase) (NSGPx) (Thiol-specific antioxidant protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]";"GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0031625; GO:0034599; GO:0042744; GO:0042803; GO:0045454; GO:0046475; GO:0047499; GO:0048026; GO:0048471; GO:0051920; GO:0102567; GO:0102568";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp2078733_c0_seq1;GAXK01073693.1;Q9QUL7;4.72E-26;TRYG1_MOUSE;"Tryptase gamma (EC 3.4.21.-) (Transmembrane tryptase) [Cleaved into: Tryptase gamma light chain; Tryptase gamma heavy chain]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0016021";proteolysis [GO:0006508];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp20792_c0_seq1;GAXK01032628.1;Q99ND9;1.03E-30;RWDD1_RAT;RWD domain-containing protein 1 (Small androgen receptor-interacting protein);"cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]";"GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825";"androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]";"cytoplasm [GO:0005737]; polysome [GO:0005844]";
comp207957_c0_seq1;GAXK01204451.1;Q13127;6.40E-20;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp207971_c1_seq1;GAXK01204393.1;Q9DBQ9;1.59E-18;SWT1_MOUSE;Transcriptional protein SWT1;"nucleus [GO:0005634]; transcription, DNA-templated [GO:0006351]";"GO:0005634; GO:0006351";transcription, DNA-templated [GO:0006351];nucleus [GO:0005634];
comp208000_c1_seq1;GAXK01078466.1;O75521;1.46E-30;ECI2_HUMAN;Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]";"GO:0000062; GO:0004165; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0009062; GO:0016020; GO:0033540; GO:0043231";"fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]"
comp2080298_c0_seq1;GAXK01198822.1;Q575T0;5.16E-15;CYGB1_ORYLA;Cytoglobin-1;"cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037";;cytoplasm [GO:0005737];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp2080807_c0_seq1;GAXK01198832.1;Q9VSL7;2.14E-16;FOI_DROME;Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007280; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030154; GO:0035147; GO:0035262; GO:0071578";"branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp20810_c0_seq1;GAXK01031467.1;P91622;9.06E-87;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp2081036_c0_seq1;GAXK01198831.1;Q9W092;1.25E-47;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp2081170_c0_seq1;GAXK01198839.1;Q9V427;9.89E-88;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp208122_c1_seq1;GAXK01078527.1;Q8QFX1;1.14E-54;RIMB2_CHICK;RIMS-binding protein 2 (RIM-BP2);"cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274]";"GO:0005886; GO:0007274; GO:0010923; GO:0030054; GO:0045202";"negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274]";"cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]";
comp208144_c0_seq1;GAXK01078496.1;Q6DCP1;4.59E-139;FXRD1_XENLA;FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981";mitochondrial respiratory chain complex I assembly [GO:0032981];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]";oxidoreductase activity [GO:0016491]
comp2081632_c0_seq1;GAXK01198835.1;P48034;9.76E-18;AOXA_BOVIN;Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-);"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]";"GO:0004031; GO:0004854; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0017144; GO:0042803; GO:0043546; GO:0050250; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0071949; GO:0102797; GO:0102798";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]";cytosol [GO:0005829];"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]"
comp2081725_c0_seq1;GAXK01198813.1;Q10904;4.41E-11;YWO1_CAEEL;Probable G-protein coupled receptor AH9.1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2081750_c0_seq1;GAXK01198830.1;Q6NVP8;5.18E-65;FUT8_XENTR;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]"
comp208176_c0_seq1;GAXK01078445.1;Q96I34;2.95E-95;PP16A_HUMAN;Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3);"plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888]";"GO:0005886; GO:0019888";;plasma membrane [GO:0005886];protein phosphatase regulator activity [GO:0019888]
comp208201_c0_seq1;GAXK01078467.1;P05661;2.39E-52;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2082107_c0_seq1;GAXK01129254.1;Q9ULE6;4.50E-22;PALD_HUMAN;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp208225_c1_seq1;GAXK01078625.1;Q9ZD54;3.58E-15;Y493_RICPR;Putative aldolase class 2 protein RP493;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp2082313_c0_seq1;GAXK01129252.1;O55737;2.52E-08;123R_IIV6;Putative tyrosine phosphatase 123R (EC 3.1.3.-);"protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]";"GO:0004725; GO:0008138";;;"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp208232_c0_seq1;GAXK01078613.1;Q9D1J3;2.00E-09;SARNP_MOUSE;SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1);"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417]";"GO:0000122; GO:0000346; GO:0000978; GO:0001227; GO:0003723; GO:0005634; GO:0006406; GO:0006417; GO:0008022; GO:0016607; GO:0036464; GO:0050733";"mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]"
comp208247_c0_seq1;GAXK01078538.1;H3BPM6;9.55E-28;MKROS_HUMAN;MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1);;;;;
comp2083_c0_seq1;GAXK01175359.1;P12717;9.12E-34;ACTM_PISOC;Actin, muscle;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp2083570_c0_seq1;GAXK01129279.1;Q23BV5;2.14E-24;RL22_TETTS;60S ribosomal protein L22;"ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2083906_c0_seq1;GAXK01129275.1;Q80XI3;3.17E-13;IF4G3_MOUSE;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";"GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903";"positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";eukaryotic translation initiation factor 4F complex [GO:0016281];"mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]"
comp2084256_c0_seq1;GAXK01095249.1;Q9BXF9;2.49E-44;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp208432_c0_seq1;GAXK01078557.1;Q8AXY6;0;MUSK_CHICK;Muscle, skeletal receptor tyrosine protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008582; GO:0017147; GO:0030054; GO:0030154; GO:0043235; GO:0045211; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]"
comp20847_c0_seq1;GAXK01032149.1;Q0IFL2;0;RUVB1_AEDAE;RuvB-like helicase 1 (EC 3.6.4.12) (Pontin);"Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]";"GO:0003713; GO:0005524; GO:0005634; GO:0006281; GO:0006310; GO:0006325; GO:0007049; GO:0031011; GO:0035267; GO:0042127; GO:0043139; GO:0051301; GO:0090263; GO:0097255";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]";"Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]"
comp208483_c0_seq1;GAXK01078490.1;Q8IN81;8.72E-18;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp20852_c0_seq1;GAXK01031632.1;Q9CZW4;0;ACSL3_MOUSE;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp20855_c10_seq1;GAXK01031892.1;P20740;2.15E-41;OVOS_CHICK;Ovostatin (Ovomacroglobulin);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp20863_c3_seq1;GAXK01031576.1;Q8VE11;0;MTMR6_MOUSE;Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; ruffle membrane [GO:0032587]; calcium-activated potassium channel activity [GO:0015269]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; endocytosis [GO:0006897]; phosphatidylinositol dephosphorylation [GO:0046856]";"GO:0004438; GO:0004725; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0006897; GO:0015269; GO:0032587; GO:0046856; GO:0106018";"endocytosis [GO:0006897]; phosphatidylinositol dephosphorylation [GO:0046856]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; ruffle membrane [GO:0032587]";"calcium-activated potassium channel activity [GO:0015269]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"
comp208675_c0_seq1;GAXK01078542.1;P74615;8.67E-17;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp2086929_c0_seq1;GAXK01205908.1;P09450;7.25E-16;JUNB_MOUSE;Transcription factor jun-B (MyD21);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]";"GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001701; GO:0001829; GO:0003677; GO:0003690; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006366; GO:0008134; GO:0009314; GO:0009612; GO:0009987; GO:0010033; GO:0030316; GO:0032496; GO:0032870; GO:0033687; GO:0034097; GO:0035976; GO:0042493; GO:0043565; GO:0045597; GO:0045944; GO:0046697; GO:0051591; GO:0051726; GO:0060136; GO:0060716; GO:0071277";"cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp2087038_c0_seq1;GAXK01172393.1;D3ZBE5;2.05E-24;NEK7_RAT;Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]";"GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0006468; GO:0046872";protein phosphorylation [GO:0006468];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp208716_c3_seq1;GAXK01078650.1;Q8T3Y0;3.53E-14;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2087804_c0_seq1;GAXK01172378.1;P39021;1.60E-28;MEOX2_XENLA;Homeobox protein MOX-2;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0005634; GO:0007275; GO:0016607; GO:0043565";multicellular organism development [GO:0007275];"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp2087977_c0_seq1;GAXK01172383.1;Q76KB1;1.97E-15;HS2ST_CHICK;Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]";"GO:0000139; GO:0004394; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030202; GO:0042802; GO:0060676";"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]"
comp208821_c2_seq1;GAXK01205403.1;Q9V4X2;1.52E-42;PGSC2_DROME;Peptidoglycan-recognition protein SC2 (EC 3.5.1.28);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]";"GO:0005576; GO:0005615; GO:0006955; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0019730; GO:0032827; GO:0042834; GO:0045087; GO:0045824; GO:0050830";"antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]"
comp208845_c0_seq1;GAXK01078478.1;Q9U969;0;SWS_DROME;Neuropathy target esterase sws (Swiss cheese) (DSWS) (EC 3.1.1.5);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; protein kinase A catalytic subunit binding [GO:0034236]; ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]";"GO:0004622; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006643; GO:0006644; GO:0007272; GO:0007608; GO:0016021; GO:0016042; GO:0034236; GO:0034349; GO:0045494; GO:0046470; GO:0051402; GO:0061024; GO:0072657; GO:2000480";"ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lysophospholipase activity [GO:0004622]; protein kinase A catalytic subunit binding [GO:0034236]"
comp208870_c0_seq1;GAXK01078624.1;Q8K174;4.48E-20;TMM60_MOUSE;Transmembrane protein 60;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp20888_c0_seq1;GAXK01031280.1;Q9VHN6;1.78E-73;RM19_DROME;39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp20890_c0_seq1;GAXK01032522.1;Q8R2L5;6.58E-17;RT18C_MOUSE;28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1);"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0070181";translation [GO:0006412];"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp208922_c0_seq1;GAXK01078652.1;Q08DX0;6.89E-85;SNX29_BOVIN;Sorting nexin-29;phosphatidylinositol binding [GO:0035091];GO:0035091;;;phosphatidylinositol binding [GO:0035091]
comp20896_c5_seq1;GAXK01032015.1;Q7ZYQ3;5.87E-126;CEPT1_XENLA;Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0016021; GO:0031965; GO:0046872";phosphatidylethanolamine biosynthetic process [GO:0006646];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";"diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]"
comp2089661_c0_seq1;GAXK01089965.1;Q9HCF6;5.21E-50;TRPM3_HUMAN;Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951]";"GO:0005227; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0016021; GO:0016048; GO:0050951; GO:0051262; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp209040_c0_seq1;GAXK01078635.1;Q6IWH7;0;ANO7_HUMAN;Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);"cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0030054; GO:0034220; GO:0046983; GO:0061589; GO:0061590; GO:0061591";"calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]"
comp2090555_c0_seq1;GAXK01205369.1;Q9V5L3;7.62E-64;C49A1_DROME;Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016491; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp20908_c0_seq1;GAXK01032023.1;Q5ZKH4;1.52E-65;NDEL1_CHICK;Nuclear distribution protein nudE-like 1;"axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]";"GO:0000132; GO:0000776; GO:0001764; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0047496; GO:0048487; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0090630; GO:1900029; GO:1904115; GO:1990138; GO:2000574";"activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]";"axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]"
comp2090946_c0_seq1;GAXK01061006.1;Q54S90;2.51E-60;RS11_DICDI;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp20913_c0_seq1;GAXK01031259.1;Q9CQI7;1.81E-98;RU2B_MOUSE;U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'');"catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0001650; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030532; GO:0030619; GO:0070990; GO:0071005; GO:0071007; GO:0071013";mRNA splicing, via spliceosome [GO:0000398];"catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]";"snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]"
comp209136_c0_seq1;GAXK01078653.1;P07463;8.50E-22;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2091491_c0_seq1;GAXK01060996.1;Q02UU0;3.05E-12;AHPC_PSEAB;Alkyl hydroperoxide reductase C (EC 1.11.1.15) (Peroxiredoxin) (Thioredoxin peroxidase);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0005737; GO:0006979; GO:0045454; GO:0051920";"cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp2092_c1_seq1;GAXK01175362.1;Q92162;7.02E-88;CCNB1_CARAU;G2/mitotic-specific cyclin-B1;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp20920_c0_seq1;GAXK01031675.1;Q7ZVB1;1.91E-78;CHM1B_DANRE;Charged multivesicular body protein 1b (Chromatin-modifying protein 1b) (CHMP1b);"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324";"endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]";
comp2092614_c0_seq1;GAXK01003841.1;Q99P61;2.87E-11;FABPH_ICTTR;Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP);"cytoplasm [GO:0005737]; lipid binding [GO:0008289]; hibernation [GO:0042750]";"GO:0005737; GO:0008289; GO:0042750";hibernation [GO:0042750];cytoplasm [GO:0005737];lipid binding [GO:0008289]
comp2092882_c0_seq1;GAXK01003856.1;P06867;2.27E-16;PLMN_PIG;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]";"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance [GO:0052213]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771; GO:0052213";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance [GO:0052213]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp2092889_c0_seq1;GAXK01003831.1;O54963;4.57E-14;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp209289_c5_seq1;GAXK01078647.1;Q5RCJ1;1.04E-08;CIP4_PONAB;Cdc42-interacting protein 4 (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; phagocytic cup [GO:0001891]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0001891; GO:0005764; GO:0005794; GO:0005856; GO:0005938; GO:0006897; GO:0008289; GO:0030036; GO:0042995";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; phagocytic cup [GO:0001891]";lipid binding [GO:0008289]
comp2093128_c0_seq1;GAXK01003849.1;P0CJ14;4.61E-10;VP302_LYCMC;Venom protein 302;"extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; regulation of cell growth [GO:0001558]";"GO:0001558; GO:0005520; GO:0005576";regulation of cell growth [GO:0001558];extracellular region [GO:0005576];insulin-like growth factor binding [GO:0005520]
comp2093281_c0_seq1;GAXK01003839.1;Q27294;6.63E-07;CAZ_DROME;RNA-binding protein cabeza (P19) (Sarcoma-associated RNA-binding fly homolog);"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000398; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006367; GO:0008344; GO:0008345; GO:0045887; GO:0046872; GO:0048749; GO:0051124; GO:0071013";"adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp20933_c1_seq1;GAXK01204944.1;Q9BEA9;1.59E-86;GSTM3_MACFU;Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3);"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];glutathione transferase activity [GO:0004364]
comp2093373_c0_seq1;GAXK01003844.1;Q1LYM6;2.83E-08;KLH38_DANRE;Kelch-like protein 38;;;;;
comp2093481_c1_seq1;GAXK01003858.1;P55112;4.28E-15;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp209361_c2_seq1;GAXK01078629.1;Q63068;2.75E-10;PHAX_RAT;Phosphorylated adapter RNA export protein (26 kDa resiniferatoxin-binding protein) (RBP-26) (RNA U small nuclear RNA export adapter protein) (RTX-42) (Resiniferatoxin-binding protein 2) (RBP-2);"Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"GO:0003723; GO:0005634; GO:0005737; GO:0005813; GO:0006408; GO:0015030; GO:0015031; GO:0015643; GO:0043025";"protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; toxic substance binding [GO:0015643]"
comp2093893_c0_seq1;GAXK01003833.1;P46293;4.91E-52;RS16_GOSHI;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp20940_c1_seq1;GAXK01031959.1;P82925;1.81E-30;RT31_BOVIN;28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005730; GO:0005743; GO:0005763; GO:0019904";;"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; nucleolus [GO:0005730]";"protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]"
comp2094278_c0_seq1;GAXK01052492.1;Q64273;9.45E-86;KCNJ2_RAT;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (RBL-IRK1) (Potassium channel, inwardly rectifying subfamily J member 2);"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"GO:0005242; GO:0005546; GO:0005790; GO:0005791; GO:0005794; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0030315; GO:0030425; GO:0031224; GO:0042802; GO:0043025; GO:0043197; GO:0051289; GO:0055119; GO:0060306; GO:0071260; GO:0086002; GO:0086004; GO:0086008; GO:0086091; GO:0090076; GO:1901381; GO:1990573";"cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]";"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]"
comp2094414_c1_seq1;GAXK01052489.1;O75762;9.31E-11;TRPA1_HUMAN;Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"GO:0005886; GO:0005887; GO:0006811; GO:0007166; GO:0009409; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070588; GO:0097604";"calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]";"calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]"
comp2094497_c0_seq1;GAXK01052525.1;Q5U4F6;2.87E-32;WDR34_MOUSE;WD repeat-containing protein 34;"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]";"GO:0005814; GO:0005829; GO:0005868; GO:0005930; GO:0007018; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014";"cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]";"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]"
comp2094757_c0_seq1;GAXK01052487.1;Q40401;2.60E-137;CALR_NICPL;Calreticulin;"endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082";protein folding [GO:0006457];endoplasmic reticulum lumen [GO:0005788];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp209484_c4_seq1;GAXK01078572.1;O43312;9.30E-40;MTSS1_HUMAN;Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]";"actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp2094902_c0_seq1;GAXK01052479.1;Q8JG30;1.17E-30;ST1B1_CHICK;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]";"GO:0005737; GO:0008146; GO:0008202";steroid metabolic process [GO:0008202];cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp2094960_c0_seq1;GAXK01052491.1;Q21432;2.80E-17;NAS11_CAEEL;Zinc metalloproteinase nas-11 (EC 3.4.24.-) (Nematode astacin 11);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp209512_c7_seq1;GAXK01078517.1;Q28BX9;3.97E-16;C2CD5_XENTR;C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]";"GO:0005509; GO:0005544; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0038028; GO:0065002; GO:0090314";"cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]"
comp20956_c2_seq1;GAXK01031820.1;P29373;4.37E-25;RABP2_HUMAN;Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]";"GO:0001972; GO:0002138; GO:0005501; GO:0005654; GO:0005783; GO:0005829; GO:0006355; GO:0007165; GO:0008544; GO:0016918; GO:0019841; GO:0035115; GO:0048385; GO:0048672; GO:0070062";"embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]";"retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp2095649_c0_seq1;GAXK01052486.1;P16149;3.64E-39;RS16_LUPPO;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp20957_c5_seq1;GAXK01031786.1;P82166;2.61E-19;CU198_LOCMI;Cuticle protein 19.8 (LmNCP19.8);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp2095877_c1_seq1;GAXK01052514.1;B7Z0W9;1.01E-33;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp209610_c1_seq1;GAXK01078672.1;B4F6U4;5.63E-62;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp209613_c0_seq1;GAXK01078611.1;Q9VUN0;0;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp20964_c0_seq1;GAXK01031728.1;Q7Z3D4;3.82E-10;LYSM3_HUMAN;LysM and putative peptidoglycan-binding domain-containing protein 3;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp209681_c1_seq1;GAXK01078483.1;Q9W0Y6;5.73E-19;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp2096942_c0_seq1;GAXK01054762.1;Q9UNY4;1.58E-22;TTF2_HUMAN;Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2);"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0003677; GO:0004386; GO:0005524; GO:0005681; GO:0005829; GO:0006353; GO:0006369; GO:0006397; GO:0008023; GO:0008094; GO:0008270; GO:0008380";"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]";"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]"
comp2097014_c0_seq1;GAXK01054769.1;A7Y7X5;4.68E-12;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2097190_c0_seq1;GAXK01054772.1;Q9XYN1;1.96E-60;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp2097595_c0_seq1;GAXK01054759.1;Q25604;3.87E-13;NHR1_ONCVO;Nuclear hormone receptor-like 1;"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0004879; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp209763_c0_seq1;GAXK01078444.1;Q9ULD9;1.03E-18;ZN608_HUMAN;Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36);"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003676; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp209813_c0_seq1;GAXK01078623.1;Q54HW1;8.40E-08;PSD10_DICDI;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28);"cytoplasm [GO:0005737]; proteasome regulatory particle assembly [GO:0070682]";"GO:0005737; GO:0070682";proteasome regulatory particle assembly [GO:0070682];cytoplasm [GO:0005737];
comp2098233_c0_seq1;GAXK01135941.1;Q149M0;1.12E-07;CL12B_MOUSE;C-type lectin domain family 12 member B;"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; receptor inhibitor activity [GO:0030547]; natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of signaling receptor activity [GO:2000272]";"GO:0002769; GO:0009897; GO:0016021; GO:0019903; GO:0030246; GO:0030547; GO:0032991; GO:0045953; GO:2000272";"natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of signaling receptor activity [GO:2000272]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";"carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; receptor inhibitor activity [GO:0030547]"
comp209826_c0_seq1;GAXK01078549.1;Q9P243;8.86E-11;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp209828_c3_seq1;GAXK01078661.1;O43313;4.42E-14;ATMIN_HUMAN;ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein) (ASCIZ) (Zinc finger protein 822);"nuclear body [GO:0016604]; dynein complex binding [GO:0070840]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to DNA damage stimulus [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0006974; GO:0016604; GO:0044212; GO:0044458; GO:0045893; GO:0046872; GO:0070840; GO:1902857";"cellular response to DNA damage stimulus [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription, DNA-templated [GO:0045893]";nuclear body [GO:0016604];"dynein complex binding [GO:0070840]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp20983_c0_seq1;GAXK01032357.1;O88600;9.14E-104;HSP74_RAT;Heat shock 70 kDa protein 4 (Ischemia responsive 94 kDa protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; response to heat [GO:0009408]";"GO:0001085; GO:0001822; GO:0001933; GO:0005524; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0009408; GO:0010628; GO:0010629; GO:0032092; GO:0033613; GO:0043066; GO:0043392; GO:0044877; GO:0045766; GO:0060548";"kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; response to heat [GO:0009408]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";"activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]"
comp209846_c0_seq1;GAXK01078541.1;Q27319;2.98E-38;GELS_HOMAM;Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]";"GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693";actin filament capping [GO:0051693];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp209869_c0_seq1;GAXK01078610.1;Q642M9;3.85E-80;DHDH_DANRE;Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase);"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]";"GO:0047115; GO:0047837";;;"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
comp209879_c1_seq1;GAXK01078476.1;Q5XJK1;3.53E-25;SCOCB_DANRE;Short coiled-coil protein B;"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635]";"GO:0000139; GO:0005829; GO:0016239; GO:0061635";"positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]";
comp209885_c0_seq1;GAXK01078615.1;Q7KRI2;3.13E-32;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp209888_c0_seq1;GAXK01078612.1;Q0P6H9;4.29E-101;TMM62_HUMAN;Transmembrane protein 62;"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp20992_c0_seq1;GAXK01032137.1;O60543;2.52E-14;CIDEA_HUMAN;Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell death [GO:0008219]; lipid droplet organization [GO:0034389]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]";"GO:0001659; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0005829; GO:0006629; GO:0006915; GO:0008219; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0034389; GO:0035634; GO:0042803; GO:0050710; GO:0050995; GO:0120163; GO:1900118; GO:1902510";"apoptotic process [GO:0006915]; cell death [GO:0008219]; lipid droplet organization [GO:0034389]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";protein homodimerization activity [GO:0042803]
comp209934_c0_seq1;GAXK01078547.1;A2AG06;1.42E-34;MEIOC_MOUSE;Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192";"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2099481_c0_seq1;GAXK01135936.1;Q5T2R2;1.31E-14;DPS1_HUMAN;Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1);"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234";"isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]"
comp2099745_c0_seq1;GAXK01135949.1;Q8K2R5;2.22E-22;ZN668_MOUSE;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2099786_c0_seq1;GAXK01135954.1;Q8NHV1;1.22E-09;GIMA7_HUMAN;GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein) (IAN-7);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039]";"GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0042802; GO:0042803; GO:0043231; GO:0046039";GTP metabolic process [GO:0046039];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp20998_c1_seq1;GAXK01031849.1;P09884;0;DPOLA_HUMAN;DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180);"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; G1/S transition of mitotic cell cycle [GO:0000082]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]";"GO:0000082; GO:0000083; GO:0000166; GO:0000731; GO:0001882; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008283; GO:0016032; GO:0016363; GO:0017076; GO:0019103; GO:0019901; GO:0032201; GO:0046872; GO:0051539; GO:1902975";"cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; G1/S transition of mitotic cell cycle [GO:0000082]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]";"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]"
comp2099840_c0_seq1;GAXK01135943.1;Q17895;1.87E-07;MNM2_CAEEL;Zinc finger protein mnm-2;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; positive regulation of axon guidance [GO:1902669]";"GO:0003676; GO:0005634; GO:0046872; GO:1902669";positive regulation of axon guidance [GO:1902669];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp210_c0_seq1;GAXK01165829.1;Q9VS34;1.16E-92;RL18_DROME;60S ribosomal protein L18;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp210055_c2_seq1;GAXK01030116.1;Q91653;6.21E-33;CRHBP_XENLA;Corticotropin-releasing factor-binding protein (CRF-BP) (CRF-binding protein) (Corticotropin-releasing hormone-binding protein) (CRH-BP);"extracellular region [GO:0005576]; corticotropin-releasing hormone binding [GO:0051424]";"GO:0005576; GO:0051424";;extracellular region [GO:0005576];corticotropin-releasing hormone binding [GO:0051424]
comp2101324_c0_seq1;GAXK01084943.1;P52808;2.14E-50;RL30A_SCHPO;60S ribosomal protein L30-1 (L32);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; rRNA processing [GO:0006364]";"GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0022625";"cytoplasmic translation [GO:0002181]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp210141_c0_seq1;GAXK01029977.1;Q61188;1.48E-46;EZH2_MOUSE;Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.43) (ENX-1) (Enhancer of zeste homolog 2);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]";"GO:0000122; GO:0000781; GO:0000790; GO:0000978; GO:0000979; GO:0001932; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006348; GO:0006357; GO:0008284; GO:0010468; GO:0010629; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0031490; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042127; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0043565; GO:0044212; GO:0045120; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0050767; GO:0051154; GO:0070301; GO:0070314; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1902808; GO:1904772; GO:1990841; GO:2000134";"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp2101423_c0_seq1;GAXK01084970.1;Q8NG08;8.31E-47;HELB_HUMAN;DNA helicase B (hDHB) (EC 3.6.4.12);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp210155_c1_seq1;GAXK01030221.1;Q10L91;3.39E-09;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp210158_c0_seq1;GAXK01030163.1;P09057;9.67E-152;DCOR_RAT;Ornithine decarboxylase (ODC) (EC 4.1.1.17);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]";"GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471";"kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]"
comp210180_c0_seq1;GAXK01030326.1;P0DPW5;1.69E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp2102033_c0_seq1;GAXK01000809.1;P17789;8.37E-11;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp210207_c0_seq1;GAXK01030246.1;P15364;2.01E-37;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp2102370_c0_seq1;GAXK01000808.1;Q9FRL3;1.04E-34;ERDL6_ARATH;Sugar transporter ERD6-like 6;"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; carbohydrate:proton symporter activity [GO:0005351]; glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"GO:0005351; GO:0005739; GO:0005774; GO:0005794; GO:0005887; GO:0009705; GO:0010030; GO:0042593";"glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]";carbohydrate:proton symporter activity [GO:0005351]
comp210307_c2_seq2;GAXK01030203.1;Q9NUA8;1.47E-13;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp210354_c0_seq1;GAXK01030110.1;P12252;1.05E-35;PDE4B_DROME;cAMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce);"nucleus [GO:0005634]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; reproduction [GO:0000003]; short-term memory [GO:0007614]; thermosensory behavior [GO:0040040]";"GO:0000003; GO:0001661; GO:0004115; GO:0005634; GO:0006198; GO:0007268; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045475; GO:0046872; GO:0046958; GO:0048149; GO:0048675";"anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; reproduction [GO:0000003]; short-term memory [GO:0007614]; thermosensory behavior [GO:0040040]";nucleus [GO:0005634];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]"
comp210374_c1_seq1;GAXK01030086.1;Q8IS64;0;ECE_LOCMI;Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2103901_c0_seq1;GAXK01000817.1;Q90YH9;3.98E-25;TES_CHICK;Testin;"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; regulation of cell population proliferation [GO:0042127]";"GO:0005737; GO:0005925; GO:0008270; GO:0042127";regulation of cell population proliferation [GO:0042127];"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]";zinc ion binding [GO:0008270]
comp210400_c0_seq1;GAXK01204803.1;Q9NWM0;1.50E-76;SMOX_HUMAN;Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901";"polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp210406_c2_seq1;GAXK01030150.1;Q5RAS0;2.06E-133;ACADS_PONAB;Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase);"mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid metabolic process [GO:0006631]";"GO:0003995; GO:0004085; GO:0005759; GO:0006631; GO:0050660";fatty acid metabolic process [GO:0006631];mitochondrial matrix [GO:0005759];"acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]"
comp210425_c0_seq1;GAXK01029980.1;Q9VUN0;3.09E-10;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp210434_c0_seq1;GAXK01030295.1;B2RZ37;1.02E-37;REEP5_RAT;Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp2104510_c0_seq1;GAXK01005243.1;P16912;7.90E-53;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp2104526_c0_seq1;GAXK01005246.1;P79197;3.32E-23;KCNA5_MUSPF;Potassium voltage-gated channel subfamily A member 5 (Voltage-gated potassium channel subunit Kv1.5);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; Notch signaling pathway [GO:0007219]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]";"GO:0005251; GO:0005887; GO:0007219; GO:0008076; GO:0009986; GO:0014704; GO:0015271; GO:0019229; GO:0019901; GO:0034705; GO:0043266; GO:0045121; GO:0051260; GO:0051393; GO:0060081; GO:0060372; GO:0071805; GO:0086087; GO:0086089; GO:0086090; GO:0086091; GO:0097110; GO:0097623; GO:0098914";"membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; Notch signaling pathway [GO:0007219]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]"
comp2104626_c0_seq1;GAXK01005250.1;Q9VZW5;4.66E-23;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp210475_c1_seq1;GAXK01030317.1;Q9VQX4;0;PNCB_DROME;Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]";"GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872";"NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];"metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]"
comp210483_c0_seq1;GAXK01030006.1;Q99NF3;3.17E-33;CEP41_MOUSE;Centrosomal protein of 41 kDa (Cep41) (Testis-specific gene A14 protein);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031]";"GO:0005813; GO:0005814; GO:0005929; GO:0015031; GO:0018095; GO:0036064; GO:0060271";"cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]";
comp2104882_c0_seq1;GAXK01005245.1;Q9CXS4;4.53E-46;CENPV_MOUSE;Centromere protein V (CENP-V) (Proline-rich protein 6);"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]";"GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005737; GO:0007049; GO:0015630; GO:0016846; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301";"ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]";"carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]"
comp2105_c1_seq1;GAXK01175797.1;P25843;1.85E-47;PROF_DROME;Profilin (Protein chickadee);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007411; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]";actin monomer binding [GO:0003785]
comp210504_c0_seq1;GAXK01029984.1;P13607;6.86E-99;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp210547_c0_seq1;GAXK01030318.1;Q62661;3.25E-51;HBP1_RAT;HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1);"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of potassium ion transport [GO:0043268]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000978; GO:0001227; GO:0003723; GO:0005634; GO:0006355; GO:0016055; GO:0043268";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of potassium ion transport [GO:0043268]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]";nucleus [GO:0005634];"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2105717_c0_seq1;GAXK01005235.1;Q29RZ4;2.14E-18;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp210598_c0_seq1;GAXK01030084.1;Q32KX7;1.41E-73;BMI1_BOVIN;Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4);"cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]";"GO:0000122; GO:0000151; GO:0005737; GO:0006342; GO:0008270; GO:0031519; GO:0035102; GO:0036353; GO:0045814; GO:0051443; GO:1990841";"chromatin silencing [GO:0006342]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]";"cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]";"promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp210599_c1_seq1;GAXK01030282.1;Q9UBI4;5.70E-31;STML1_HUMAN;Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869]";"GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121";lipid transport [GO:0006869];"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";
comp2106188_c0_seq1;GAXK01079637.1;Q7KRI2;4.30E-09;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp21065_c0_seq1;GAXK01031574.1;P05661;4.35E-38;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2106504_c0_seq1;GAXK01079618.1;Q09614;2.52E-18;PTC1_CAEEL;Protein patched homolog 1;"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell cycle [GO:0007049]; cell division [GO:0051301]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; smoothened signaling pathway [GO:0007224]";"GO:0005119; GO:0005886; GO:0005887; GO:0007049; GO:0007224; GO:0008158; GO:0018996; GO:0051301; GO:0097108";"cell cycle [GO:0007049]; cell division [GO:0051301]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]; smoothened signaling pathway [GO:0007224]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp210729_c2_seq1;GAXK01030083.1;Q9VY99;4.97E-114;NNAD_DROME;Cytosolic carboxypeptidase Nna1 (EC 3.4.17.-) (Nervous system nuclear protein induced by axotomy protein 1 homolog);"mitochondrion [GO:0005739]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";"GO:0002164; GO:0003407; GO:0004181; GO:0005739; GO:0007005; GO:0008270";"larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";mitochondrion [GO:0005739];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp2107510_c0_seq1;GAXK01079630.1;P20693;5.82E-13;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp2107612_c0_seq1;GAXK01079622.1;P0DKK8;8.20E-35;RS10A_ORYSJ;40S ribosomal protein S10-1;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]";"GO:0000028; GO:0003735; GO:0022627";ribosomal small subunit assembly [GO:0000028];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp210779_c0_seq1;GAXK01030259.1;Q01295;2.51E-13;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp210807_c0_seq1;GAXK01030211.1;Q15776;2.28E-25;ZKSC8_HUMAN;Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2108162_c0_seq1;GAXK01095000.1;Q8C0X2;1.88E-12;SL9B1_MOUSE;Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9 subfamily B member 1) (Testis specific sodium-hydrogen exchanger) (MtsNHE);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0016021; GO:0030317; GO:0051453; GO:0097228";"flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]";solute:proton antiporter activity [GO:0015299]
comp210821_c0_seq1;GAXK01030315.1;Q60821;1.98E-09;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp2108352_c0_seq1;GAXK01095013.1;O48557;2.49E-17;RL17_MAIZE;60S ribosomal protein L17;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp210874_c1_seq1;GAXK01030283.1;O16099;5.97E-157;MAL2_DROVI;Maltase 2 (EC 3.2.1.20);"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]";"GO:0004558; GO:0032450";;;"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]"
comp210889_c0_seq1;GAXK01030294.1;Q13530;3.40E-20;SERC3_HUMAN;Serine incorporator 3 (Tumor differentially expressed protein 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0009597; GO:0016021; GO:0045087; GO:0048471; GO:0051607; GO:1902237";"defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";
comp2109145_c0_seq1;GAXK01095008.1;Q06732;1.27E-19;ZN33B_HUMAN;Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2109263_c0_seq1;GAXK01095012.1;P42787;1.61E-80;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp21093_c0_seq1;GAXK01031573.1;Q29NV5;1.43E-17;RM10_DROPS;39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10);"mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0042254; GO:1990904";"ribosome biogenesis [GO:0042254]; translation [GO:0006412]";"mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]";structural constituent of ribosome [GO:0003735]
comp210950_c0_seq1;GAXK01030146.1;Q16932;3.00E-12;STX_APLCA;Syntaxin;"cell [GO:0005623]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005623; GO:0006836; GO:0006886; GO:0016021; GO:0016192; GO:0017157";"intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; integral component of membrane [GO:0016021]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp211_c12_seq1;GAXK01166006.1;P09052;1.42E-161;VASA1_DROME;ATP-dependent RNA helicase vasa (EC 3.6.4.13) (Antigen Mab46F11);"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007275; GO:0007276; GO:0008104; GO:0030154; GO:0043073; GO:0043186; GO:0048477; GO:0061803";"cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp2110061_c0_seq1;GAXK01145831.1;P06147;1.18E-78;RS12_TETTH;40S ribosomal protein S12;"small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];structural constituent of ribosome [GO:0003735]
comp211038_c0_seq1;GAXK01030200.1;Q9XYN1;1.47E-49;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp211047_c4_seq1;GAXK01030157.1;Q502K2;3.39E-10;SAMH1_DANRE;Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-);"nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]"
comp211065_c0_seq1;GAXK01030258.1;Q767L8;3.20E-19;MDC1_PIG;Mediator of DNA damage checkpoint protein 1;"chromosome [GO:0005694]; nucleus [GO:0005634]; cell cycle [GO:0007049]; DNA repair [GO:0006281]";"GO:0005634; GO:0005694; GO:0006281; GO:0007049";"cell cycle [GO:0007049]; DNA repair [GO:0006281]";"chromosome [GO:0005694]; nucleus [GO:0005634]";
comp2111468_c0_seq1;GAXK01145833.1;P10716;3.34E-07;CLC4F_RAT;C-type lectin domain family 4 member F (C-type lectin superfamily member 13) (C-type lectin 13) (Kupffer cell receptor);"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]";"GO:0006897; GO:0016021; GO:0030246; GO:0038023";endocytosis [GO:0006897];integral component of membrane [GO:0016021];"carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]"
comp2111849_c0_seq1;GAXK01145826.1;Q22DH9;3.48E-25;RL31_TETTS;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2112_c1_seq1;GAXK01175980.1;Q94522;3.07E-138;SUCA_DROME;Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (Succinyl-coenzyme A synthetase alpha subunit 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA hydrolase activity [GO:0004778]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000166; GO:0004550; GO:0004775; GO:0004776; GO:0004778; GO:0005739; GO:0005829; GO:0006099; GO:0006104; GO:0006105; GO:0009142; GO:0045244; GO:0048037";"nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]";"cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA hydrolase activity [GO:0004778]"
comp211215_c1_seq1;GAXK01029978.1;P02567;2.40E-58;MYO1_CAEEL;Myosin-1 (Myosin heavy chain D) (MHC D);"striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";"GO:0003774; GO:0005524; GO:0005863; GO:0006936; GO:0008307; GO:0043050; GO:0051015";"muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";striated muscle myosin thick filament [GO:0005863];"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]"
comp21124_c0_seq1;GAXK01031393.1;T1SH39;4.38E-32;TXD17_EPICO;Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14);"cytosol [GO:0005829]; peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]; oxidation-reduction process [GO:0055114]";"GO:0004601; GO:0005829; GO:0047134; GO:0055114";oxidation-reduction process [GO:0055114];cytosol [GO:0005829];"peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]"
comp21125_c2_seq1;GAXK01031608.1;Q7ZXH2;2.15E-10;NSE2_XENLA;E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000724; GO:0000781; GO:0007049; GO:0008270; GO:0016605; GO:0019789; GO:0030915; GO:0034184; GO:0045842; GO:0051301; GO:0090398";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";"SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]"
comp21138_c1_seq1;GAXK01032625.1;Q6AYB3;3.88E-82;ISY1_RAT;Pre-mRNA-splicing factor ISY1 homolog;"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0005634; GO:0071006; GO:0071013; GO:0071014; GO:0071020";"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]";
comp211392_c2_seq1;GAXK01030223.1;A9CPT4;3.11E-07;TDRD1_ORYLA;Tudor domain-containing protein 1;"P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"P granule [GO:0043186]; pi-body [GO:0071546]";metal ion binding [GO:0046872]
comp2114_c0_seq1;GAXK01176485.1;Q6GR45;2.25E-148;IF6_XENLA;Eukaryotic translation initiation factor 6 (eIF-6);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0003743; GO:0005730; GO:0005737; GO:0042256; GO:0042273; GO:0043022; GO:0043023";"mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]"
comp2114132_c0_seq1;GAXK01075634.1;Q0P5L8;8.12E-104;KBL_BOVIN;2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]";"GO:0005634; GO:0005739; GO:0008890; GO:0009058; GO:0019518; GO:0030170";"biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]"
comp2114191_c0_seq1;GAXK01075628.1;Q13002;5.78E-166;GRIK2_HUMAN;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6);"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp211429_c1_seq1;GAXK01030230.1;Q09575;3.76E-27;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp21144_c19_seq1;GAXK01032047.1;P21787;2.07E-07;P320_TRYBB;Microtubule-associated protein P320 (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule binding [GO:0008017]";"GO:0005737; GO:0005874; GO:0008017";;"cytoplasm [GO:0005737]; microtubule [GO:0005874]";microtubule binding [GO:0008017]
comp211446_c0_seq1;GAXK01030160.1;B6RSP1;3.29E-36;PKHA7_DANRE;Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) (Heart adapter protein 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218]";"GO:0005737; GO:0005813; GO:0005915; GO:0008016; GO:0045218; GO:0055007; GO:0070097; GO:0090136";"cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]";delta-catenin binding [GO:0070097]
comp2115_c0_seq1;GAXK01175305.1;Q7ZTZ2;9.09E-55;RLP24_DANRE;Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1);"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp21150_c0_seq1;GAXK01032523.1;P83876;5.52E-97;TXN4A_HUMAN;Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD);"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005";"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";
comp211552_c1_seq1;GAXK01030262.1;Q5U303;2.26E-09;TAB2_RAT;TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2);"cytosol [GO:0005829]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496]";"GO:0005634; GO:0005829; GO:0007507; GO:0032496; GO:0043123; GO:0045860; GO:0046872; GO:0070530";"heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]"
comp2115735_c0_seq1;GAXK01075636.1;Q8VIJ8;5.91E-109;NPRL3_MOUSE;GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein);"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagosome assembly [GO:2000785]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]";"GO:0003281; GO:0005096; GO:0005765; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1990130; GO:2000785";"aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagosome assembly [GO:2000785]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]";"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]";GTPase activator activity [GO:0005096]
comp211584_c3_seq1;GAXK01030007.1;Q08431;1.30E-42;MFGM_HUMAN;"Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; post-translational protein modification [GO:0043687]; single fertilization [GO:0007338]";"GO:0001525; GO:0001786; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0016020; GO:0019897; GO:0043277; GO:0043687; GO:0044267; GO:0050766; GO:0062023; GO:0070062; GO:1903561";"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; post-translational protein modification [GO:0043687]; single fertilization [GO:0007338]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]";"integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]"
comp2115940_c0_seq1;GAXK01075627.1;Q8ITC9;2.30E-22;PK1R_DROME;Pyrokinin-1 receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]"
comp2116086_c0_seq1;GAXK01113989.1;C3YWU0;3.44E-09;FUCO_BRAFL;Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase);"extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139";"fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"extracellular region [GO:0005576]; lysosome [GO:0005764]";alpha-L-fucosidase activity [GO:0004560]
comp2116190_c0_seq1;GAXK01113988.1;Q5U3Q6;2.00E-33;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp211635_c0_seq1;GAXK01029999.1;Q9D2J7;2.40E-09;ANKE1_MOUSE;Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5);;;;;
comp211674_c3_seq1;GAXK01030329.1;Q4A054;1.68E-21;Y0419_STAS1;Uncharacterized oxidoreductase SSP0419 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp2116830_c0_seq1;GAXK01114010.1;Q9FT72;1.02E-15;RQL3_ARATH;ATP-dependent DNA helicase Q-like 3 (EC 3.6.4.12) (RecQ-like protein 3) (AtRecQ3) (AtRecQl3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138; GO:0046872";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]"
comp2116884_c0_seq1;GAXK01114003.1;Q9VZW5;1.58E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2117_c4_seq1;GAXK01175739.1;P70583;3.62E-68;DUT_RAT;Deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) (EC 3.6.1.23) (PPAR-interacting protein 4) (PIP4) (dUTP pyrophosphatase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070]";"GO:0000287; GO:0001889; GO:0004170; GO:0005634; GO:0005737; GO:0005829; GO:0006226; GO:0014070; GO:0030547; GO:0032556; GO:0042975; GO:0043497; GO:0046081; GO:0070207";"dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]"
comp2117472_c0_seq1;GAXK01113993.1;Q3U4G3;1.79E-17;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp2117692_c0_seq1;GAXK01113986.1;Q9BYN7;7.95E-08;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp21179_c1_seq1;GAXK01031214.1;Q8TAC1;1.04E-09;RFESD_HUMAN;Rieske domain-containing protein;"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0046872; GO:0051537";;;"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp21181_c0_seq1;GAXK01031969.1;P40423;8.06E-108;SQH_DROME;Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash);"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]";"GO:0000281; GO:0001736; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0030707; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144";"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]";"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]"
comp21184_c0_seq1;GAXK01031995.1;P02553;4.08E-28;TBA_LYTPI;Tubulin alpha chain (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp211854_c0_seq1;GAXK01030289.1;Q9V427;1.25E-32;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp21188_c0_seq1;GAXK01031800.1;Q8BIZ6;1.07E-77;SNIP1_MOUSE;Smad nuclear-interacting protein 1;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA binding [GO:0003729]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mRNA splicing, via spliceosome [GO:0000398]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007249; GO:0035196; GO:0071005";"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mRNA splicing, via spliceosome [GO:0000398]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]";mRNA binding [GO:0003729]
comp211898_c1_seq1;GAXK01029997.1;P45478;9.13E-63;PPT1_BOVIN;Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1);"axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; brain development [GO:0007420]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007399; GO:0007420; GO:0008021; GO:0008474; GO:0015031; GO:0016042; GO:0016290; GO:0030308; GO:0030424; GO:0031579; GO:0043066; GO:0043524; GO:0045121; GO:0048260; GO:0048549; GO:0051181; GO:0051186";"brain development [GO:0007420]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]";"palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp2119034_c0_seq1;GAXK01024144.1;P10592;8.59E-69;HSP72_YEAST;Heat shock protein SSA2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole membrane [GO:0000329]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tRNA binding [GO:0000049]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of cell aging [GO:0090344]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; tRNA import into nucleus [GO:0035719]; vesicle-mediated transport [GO:0016192]";"GO:0000049; GO:0000329; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005844; GO:0005886; GO:0006457; GO:0006616; GO:0006986; GO:0009277; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0035719; GO:0042026; GO:0042623; GO:0043161; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090344";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of cell aging [GO:0090344]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; tRNA import into nucleus [GO:0035719]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole membrane [GO:0000329]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tRNA binding [GO:0000049]; unfolded protein binding [GO:0051082]"
comp2119254_c0_seq1;GAXK01024140.1;Q3UVU3;2.57E-09;ZNT10_MOUSE;Zinc transporter 10 (ZnT-10) (Solute carrier family 30 member 10);"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; cation transmembrane transporter activity [GO:0008324]; cellular response to angiotensin [GO:1904385]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transport [GO:0006829]";"GO:0005769; GO:0005794; GO:0005886; GO:0006828; GO:0006829; GO:0007173; GO:0008324; GO:0016021; GO:0043524; GO:0055037; GO:0070374; GO:0071421; GO:0071579; GO:1903427; GO:1904385; GO:1905802; GO:2000773";"cellular response to angiotensin [GO:1904385]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transport [GO:0006829]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";cation transmembrane transporter activity [GO:0008324]
comp21194_c2_seq1;GAXK01031763.1;Q04726;0;TLE3_HUMAN;Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3);"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; beta-catenin-TCF complex assembly [GO:1904837]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0007165; GO:0009887; GO:0016055; GO:0070491; GO:0090090; GO:0120163; GO:1904837; GO:1990907";"animal organ morphogenesis [GO:0009887]; beta-catenin-TCF complex assembly [GO:1904837]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]"
comp21201_c4_seq2;GAXK01031285.1;P27619;0;DYN_DROME;Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]; vesicle-mediated transport [GO:0016192]";"GO:0001661; GO:0001738; GO:0001933; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0016020; GO:0016185; GO:0016192; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475";"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; memory [GO:0007613]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]"
comp2120183_c0_seq1;GAXK01052723.1;Q80W68;1.15E-09;KIRR1_MOUSE;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005886; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";myosin binding [GO:0017022]
comp2120737_c0_seq1;GAXK01052724.1;Q8VIG1;5.45E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2121_c0_seq1;GAXK01175384.1;Q9Y5Z4;4.83E-12;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp212154_c0_seq1;GAXK01042459.1;Q9W698;8.39E-64;1A1L1_TAKRU;1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1);"catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]; 1-aminocyclopropane-1-carboxylate biosynthetic process [GO:0042218]";"GO:0003824; GO:0030170; GO:0042218";1-aminocyclopropane-1-carboxylate biosynthetic process [GO:0042218];;"catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]"
comp2121753_c0_seq1;GAXK01052719.1;Q9P2G3;2.80E-08;KLH14_HUMAN;Kelch-like protein 14 (Protein interactor of Torsin-1A) (Printor) (Protein interactor of torsinA);"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]";"GO:0005783; GO:0005789; GO:0005829; GO:0015629; GO:0016235; GO:0043005; GO:0043025";;"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";
comp2122_c0_seq1;GAXK01176030.1;P26779;5.92E-09;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp2122433_c0_seq1;GAXK01059874.1;Q6NX49;7.17E-15;ZN544_HUMAN;Zinc finger protein 544;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp212255_c2_seq1;GAXK01042411.1;Q86NH1;4.25E-67;SYD1_CAEEL;Rho GTPase-activating protein syd-1 (Axon identity specification protein syd-1) (Synapse defective protein 1);"cell junction [GO:0030054]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; axo-dendritic transport [GO:0008088]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; cellular protein localization [GO:0034613]; locomotion [GO:0040011]; nervous system development [GO:0007399]; signal transduction [GO:0007165]";"GO:0005096; GO:0005102; GO:0007165; GO:0007399; GO:0008088; GO:0017048; GO:0030030; GO:0030054; GO:0030154; GO:0034613; GO:0040011; GO:0042734; GO:0043005; GO:0045202; GO:0048495; GO:0090630";"activation of GTPase activity [GO:0090630]; axo-dendritic transport [GO:0008088]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; cellular protein localization [GO:0034613]; locomotion [GO:0040011]; nervous system development [GO:0007399]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]"
comp2122556_c0_seq1;GAXK01059873.1;E9PY46;0;IF140_MOUSE;Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2);"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705]";"GO:0001750; GO:0005813; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0048705; GO:0060041; GO:0060271; GO:0061512; GO:0072001; GO:0097730; GO:1902017; GO:1905515; GO:1990403";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705]";"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]";
comp21229_c0_seq1;GAXK01031931.1;Q3ZBV8;0;SYTC_BOVIN;Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]";"GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006435; GO:0015629";threonyl-tRNA aminoacylation [GO:0006435];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]"
comp212292_c0_seq1;GAXK01042524.1;D3KVM6;9.88E-09;HBQR_BURSP;2-hydroxy-1,4-benzoquinone reductase (EC 1.6.5.7) (Benzoquinone reductase) (Hydroxybenzoquinone reductase);2-hydroxy-1,4-benzoquinone reductase activity [GO:0050625];GO:0050625;;;2-hydroxy-1,4-benzoquinone reductase activity [GO:0050625]
comp2123666_c0_seq1;GAXK01059851.1;O43390;1.08E-25;HNRPR_HUMAN;Heterogeneous nuclear ribonucleoprotein R (hnRNP R);"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904";"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]";"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp212397_c0_seq1;GAXK01042417.1;Q9SZJ2;1.97E-50;GRDP2_ARATH;Glycine-rich domain-containing protein 2 (AtGRDP2);"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";"GO:0009734; GO:0010928; GO:0071470; GO:2000028";"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";;
comp2124_c1_seq1;GAXK01176092.1;O65493;3.06E-47;XCP1_ARATH;Cysteine protease XCP1 (EC 3.4.22.-) (Xylem cysteine peptidase 1) (AtXCP1);"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0000325; GO:0004197; GO:0005615; GO:0005634; GO:0005764; GO:0005886; GO:0010623; GO:0051603";"programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]";cysteine-type endopeptidase activity [GO:0004197]
comp2124416_c0_seq1;GAXK01012368.1;P13418;1.86E-22;POLS_CRPVC;"Structural polyprotein [Cleaved into: Capsid protein 1 (CP1); Capsid protein 4 (CP4); Capsid protein 2 (CP2); Capsid protein 3 (CP3)]";"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028; GO:0030430";;"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]";structural molecule activity [GO:0005198]
comp2124689_c0_seq1;GAXK01012348.1;Q6NT16;8.94E-08;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp2124805_c0_seq1;GAXK01012363.1;B1H2T2;1.26E-46;DIK2A_XENTR;Divergent protein kinase domain 2A (Deleted in autism protein 1 homolog);"COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; cardiac muscle cell proliferation [GO:0060038]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0005615; GO:0014066; GO:0030126; GO:0060038";"cardiac muscle cell proliferation [GO:0060038]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]";
comp212487_c2_seq1;GAXK01042538.1;P53995;2.90E-11;APC1_MOUSE;Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein);"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]";"GO:0005634; GO:0005680; GO:0007091; GO:0031145; GO:0051301; GO:0070979";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]";"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]";
comp21249_c0_seq1;GAXK01031744.1;O96102;2.73E-62;CALM_PHYPO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2125097_c0_seq1;GAXK01012369.1;P08418;1.32E-39;HSP70_SCHMA;Heat shock 70 kDa protein homolog (HSP70) (Major surface antigen);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp212512_c0_seq1;GAXK01042586.1;Q7KRI2;8.12E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2125128_c0_seq1;GAXK01012365.1;P29240;2.94E-10;5NTD_DIPOM;5'-nucleotidase (EC 3.1.3.5) (Ecto-nucleotidase);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005886; GO:0008253; GO:0009166; GO:0031225; GO:0046872";nucleotide catabolic process [GO:0009166];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp212524_c0_seq1;GAXK01042413.1;Q2TU62;3.63E-18;CLCA1_HORSE;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2125260_c0_seq1;GAXK01012353.1;B0S5A7;3.89E-20;CTL5B_DANRE;Choline transporter-like protein 5-B (Solute carrier family 44 member 5-B) (Fragment);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2125458_c0_seq1;GAXK01012355.1;Q9LYK9;5.53E-25;RS263_ARATH;40S ribosomal protein S26-3;"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005829; GO:0006412; GO:0022626; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp212586_c1_seq1;GAXK01042460.1;Q5ZIJ9;1.44E-154;MIB2_CHICK;E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2);"cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567";"Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp212589_c1_seq1;GAXK01042533.1;P82120;3.17E-24;CUO7_BLACR;Cuticle protein 7 (BcNCP15.0);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp2126002_c0_seq1;GAXK01004701.1;Q6DCX5;2.39E-13;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp212603_c0_seq1;GAXK01042568.1;Q9HAZ2;3.58E-14;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp21263_c0_seq1;GAXK01031847.1;Q8MS27;1.06E-12;RM35_DROME;39S ribosomal protein L35, mitochondrial (L35mt) (MRP-L35);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005739; GO:0005762; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp212631_c2_seq1;GAXK01042528.1;B2RX12;0;MRP3_MOUSE;Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0005887; GO:0006855; GO:0015722; GO:0015893; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0055085";"canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; transmembrane transport [GO:0055085]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp2126404_c0_seq1;GAXK01004698.1;P49196;2.77E-21;RS12_CAEEL;40S ribosomal protein S12;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp212667_c2_seq1;GAXK01042444.1;Q15262;3.04E-79;PTPRK_HUMAN;Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48);"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041";"cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"adherens junction [GO:0005912]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]";"beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp212712_c1_seq1;GAXK01042492.1;P37221;4.82E-60;MAOM_SOLTU;NAD-dependent malic enzyme 62 kDa isoform, mitochondrial (NAD-ME) (EC 1.1.1.39);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; malate metabolic process [GO:0006108]";"GO:0004471; GO:0005524; GO:0005759; GO:0006108; GO:0008270; GO:0042803; GO:0050897; GO:0051287";malate metabolic process [GO:0006108];mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp21273_c4_seq1;GAXK01031735.1;P49881;9.25E-26;ECR_BOMMO;Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1);"nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565";ecdysone receptor-mediated signaling pathway [GO:0035076];nucleus [GO:0005634];"ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp21275_c0_seq1;GAXK01032194.1;Q05913;1.83E-27;T2FA_DROME;General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha);"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006367; GO:0006368; GO:0016740; GO:0032968; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]";"DNA binding [GO:0003677]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]"
comp2127562_c0_seq1;GAXK01004689.1;Q16959;6.07E-173;DYI2_HELCR;Dynein intermediate chain 2, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp2128_c0_seq1;GAXK01175785.1;Q9HB97;5.03E-144;PARVA_RAT;Alpha-parvin (Actopaxin);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; actin binding [GO:0003779]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein heterooligomerization [GO:0051291]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0002040; GO:0003148; GO:0003779; GO:0005737; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0019904; GO:0030018; GO:0030031; GO:0030036; GO:0031532; GO:0032991; GO:0034113; GO:0034446; GO:0051291; GO:0060271; GO:0070252; GO:0071670";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein heterooligomerization [GO:0051291]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]";"actin binding [GO:0003779]; protein domain specific binding [GO:0019904]"
comp212805_c0_seq1;GAXK01042518.1;Q8N371;1.62E-31;KDM8_HUMAN;Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.-) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]";"GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544";"circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp2128137_c0_seq1;GAXK01052331.1;Q94128;3.31E-12;WRT1_CAEEL;"Warthog protein 1 [Cleaved into: Warthog protein 1 N-product; Warthog protein 1 C-product]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"GO:0005576; GO:0005615; GO:0005886; GO:0007267; GO:0007367; GO:0008233; GO:0009986; GO:0016539; GO:0016540";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";peptidase activity [GO:0008233]
comp212849_c1_seq1;GAXK01042408.1;P86854;2.34E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp21288_c0_seq1;GAXK01031852.1;Q7ZVC2;9.29E-118;CLUA1_DANRE;Clusterin-associated protein 1 homolog (Qilin);"centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; kidney development [GO:0001822]; photoreceptor cell maintenance [GO:0045494]";"GO:0001822; GO:0005634; GO:0005813; GO:0005929; GO:0030992; GO:0045494; GO:0060271";"cilium assembly [GO:0060271]; kidney development [GO:0001822]; photoreceptor cell maintenance [GO:0045494]";"centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]";
comp21292_c0_seq1;GAXK01031215.1;Q9VSH4;6.51E-45;CPSF6_DROME;Cleavage and polyadenylation specificity factor subunit CG7185;"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]";"GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0010508; GO:0043484";"mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]";nucleus [GO:0005634];mRNA binding [GO:0003729]
comp2129580_c0_seq1;GAXK01052319.1;Q9NQV6;3.29E-09;PRD10_HUMAN;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10) (Tristanin);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp2129615_c0_seq1;GAXK01052322.1;Q8T3Y0;1.37E-07;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp212964_c0_seq1;GAXK01042521.1;Q1H9T6;9.44E-26;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp212969_c1_seq1;GAXK01042582.1;P21902;3.76E-52;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2130186_c0_seq1;GAXK01193289.1;Q9SDL7;2.75E-08;HMT1_ARATH;Homocysteine S-methyltransferase 1 (EC 2.1.1.10) (S-methylmethionine:homocysteine methyltransferase 1) (AtHMT-1) (SMM:Hcy S-methyltransferase 1);"betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; S-methylmethionine cycle [GO:0033528]";"GO:0008270; GO:0008898; GO:0009086; GO:0033528; GO:0047150";"methionine biosynthetic process [GO:0009086]; S-methylmethionine cycle [GO:0033528]";;"betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]"
comp213033_c0_seq1;GAXK01042491.1;Q6IMM1;2.87E-88;DJC27_CHICK;DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein);"nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; Rab protein signal transduction [GO:0032482]; regulation of MAPK export from nucleus [GO:0071701]";"GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0032482; GO:0070374; GO:0071701";"intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; Rab protein signal transduction [GO:0032482]; regulation of MAPK export from nucleus [GO:0071701]";nucleus [GO:0005634];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2130367_c0_seq1;GAXK01193288.1;P0DJ17;1.47E-76;RL18_TETTH;60S ribosomal protein L18;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp21305_c2_seq1;GAXK01032121.1;Q17335;1.10E-158;ADHX_CAEEL;Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; alcohol metabolic process [GO:0006066]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]";"GO:0004024; GO:0005737; GO:0005829; GO:0006066; GO:0006069; GO:0008270; GO:0046294; GO:0051903";"alcohol metabolic process [GO:0006066]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"
comp2130599_c0_seq1;GAXK01193278.1;Q9BHU1;1.55E-28;RS26_STENO;40S ribosomal protein S26;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2131_c0_seq1;GAXK01175879.1;Q7PVX8;1.79E-144;ARPC2_ANOGA;Probable actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC);"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0005200; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0051015";"actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]"
comp213105_c0_seq1;GAXK01042577.1;Q6UPE0;0;CHDH_RAT;Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1);"mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005743; GO:0008812; GO:0019285; GO:0050660";glycine betaine biosynthetic process from choline [GO:0019285];mitochondrial inner membrane [GO:0005743];"choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]"
comp21311_c0_seq1;GAXK01031989.1;O83041;5.68E-125;PIP_LEPBY;Probable proline iminopeptidase (PIP) (EC 3.4.11.5) (Prolyl aminopeptidase) (PAP);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]";"GO:0004177; GO:0005737";;cytoplasm [GO:0005737];aminopeptidase activity [GO:0004177]
comp2131207_c0_seq1;GAXK01193297.1;Q93VD5;3.10E-16;CCD8A_ORYSJ;Carotenoid cleavage dioxygenase 8 homolog A, chloroplastic (OsCCD8a) (EC 1.13.11.-) (Protein D10-like);"chloroplast [GO:0009507]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; carotene catabolic process [GO:0016121]";"GO:0009507; GO:0010436; GO:0016121; GO:0046872";carotene catabolic process [GO:0016121];chloroplast [GO:0009507];"carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]"
comp213127_c0_seq1;GAXK01042504.1;Q96RR4;2.92E-124;KKCC2_HUMAN;Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta);"cell projection [GO:0042995]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein tyrosine kinase activity [GO:0004713]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]";"GO:0000165; GO:0001934; GO:0004683; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0042995; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:1903599";"calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]";"cell projection [GO:0042995]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein tyrosine kinase activity [GO:0004713]"
comp2131476_c0_seq1;GAXK01193311.1;Q3U0J8;1.99E-99;TBD2B_MOUSE;TBC1 domain family member 2B;"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp21315_c1_seq1;GAXK01031992.1;Q5S1U6;5.77E-38;IFRD1_PIG;Interferon-related developmental regulator 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"GO:0005634; GO:0005737; GO:0014706; GO:0030517; GO:0042692; GO:0043403; GO:0048671";"muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp21316_c1_seq1;GAXK01031646.1;P35032;2.95E-12;TRY2_SALSA;Trypsin-2 (EC 3.4.21.4) (Trypsin II) (Fragment);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp213164_c0_seq1;GAXK01042565.1;Q7KRI2;3.32E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2131894_c0_seq1;GAXK01193312.1;Q2RAV0;7.54E-14;CDPKP_ORYSJ;Calcium-dependent protein kinase 25 (OsCDPK25) (OsCPK25) (EC 2.7.11.1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp213275_c0_seq1;GAXK01042537.1;P62286;1.62E-07;ASPM_CANLF;Abnormal spindle-like microcephaly-associated protein homolog;"cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle assembly involved in meiosis [GO:0090306]; spindle localization [GO:0051653]";"GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0007283; GO:0008584; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431";"cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuronal stem cell population maintenance [GO:0097150]; neuron migration [GO:0001764]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle assembly involved in meiosis [GO:0090306]; spindle localization [GO:0051653]";"cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]";calmodulin binding [GO:0005516]
comp2132842_c0_seq1;GAXK01197222.1;A8WE67;1.15E-21;KBP_DANRE;KIF1-binding protein homolog;"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]";"GO:0000226; GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0021952; GO:0048484; GO:0048929; GO:1990535";"central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]";"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]";
comp213300_c0_seq1;GAXK01042509.1;Q39249;2.07E-12;VDE_ARATH;Violaxanthin de-epoxidase, chloroplastic (AtVxDE) (EC 1.23.5.1) (Protein NON-PHOTOCHEMICAL QUENCHING 1);"chloroplast [GO:0009507]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; extracellular region [GO:0005576]; thylakoid lumen [GO:0031977]; protein domain specific binding [GO:0019904]; violaxanthin de-epoxidase activity [GO:0046422]; chlorophyll metabolic process [GO:0015994]; fatty acid metabolic process [GO:0006631]; response to heat [GO:0009408]; xanthophyll cycle [GO:0010028]";"GO:0005576; GO:0005829; GO:0006631; GO:0009408; GO:0009507; GO:0009534; GO:0009535; GO:0010028; GO:0015994; GO:0019904; GO:0031977; GO:0046422";"chlorophyll metabolic process [GO:0015994]; fatty acid metabolic process [GO:0006631]; response to heat [GO:0009408]; xanthophyll cycle [GO:0010028]";"chloroplast [GO:0009507]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; extracellular region [GO:0005576]; thylakoid lumen [GO:0031977]";"protein domain specific binding [GO:0019904]; violaxanthin de-epoxidase activity [GO:0046422]"
comp2133064_c0_seq1;GAXK01197228.1;P15119;6.05E-07;MCPT2_MOUSE;Mast cell protease 2 (mMCP-2) (EC 3.4.21.-);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615; GO:0005737";;"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp2133341_c0_seq1;GAXK01197216.1;Q80V63;2.42E-11;PRDM4_MOUSE;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005123; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0035097; GO:0043565; GO:0045944; GO:0046872; GO:1990226; GO:2000177; GO:2000736";"negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2133426_c0_seq1;GAXK01197204.1;Q15935;5.72E-11;ZNF77_HUMAN;Zinc finger protein 77 (ZNFpT1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2133505_c0_seq1;GAXK01197226.1;Q9U280;9.69E-29;TAT1_CAEEL;Phospholipid-transporting ATPase tat-1 (EC 7.6.2.1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"GO:0000287; GO:0005524; GO:0005737; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006897; GO:0007040; GO:0015914; GO:0016323; GO:0016324; GO:0031901; GO:0045332; GO:0055038; GO:0060100; GO:0060101; GO:0140326";"endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp2133647_c0_seq1;GAXK01197206.1;P54779;1.27E-12;USP_MANSE;Protein ultraspiracle homolog (Nuclear receptor subfamily 2 group B member 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp213377_c2_seq1;GAXK01042495.1;Q7KRI2;1.03E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2133949_c0_seq1;GAXK01197213.1;Q9W3Y4;7.48E-33;GA2PE_DROME;GAS2-like protein pickled eggs;"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; microtubule binding [GO:0008017]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"GO:0005856; GO:0005938; GO:0008017; GO:0030707; GO:0030713";"ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]";microtubule binding [GO:0008017]
comp2133976_c0_seq1;GAXK01197229.1;Q8N1W2;8.74E-08;ZN710_HUMAN;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp213438_c1_seq1;GAXK01042519.1;Q9UNA4;8.96E-11;POLI_HUMAN;DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B);"cytoplasmic ribonucleoprotein granule [GO:0036464]; intracellular [GO:0005622]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985]";"GO:0003684; GO:0003887; GO:0005622; GO:0005654; GO:0006260; GO:0006281; GO:0016607; GO:0019985; GO:0036464; GO:0042276; GO:0046872";"DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; intracellular [GO:0005622]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]"
comp2134730_c0_seq1;GAXK01155375.1;Q96S79;1.24E-32;RSLAB_HUMAN;Ras-like protein family member 10B (Ras-like protein VTS58635) (Ras-related protein 17) (RRP17);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]; signal transduction [GO:0007165]";"GO:0003050; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0090277";"positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp213493_c0_seq1;GAXK01042451.1;C6KSS5;2.22E-09;LRR2_PLAF7;Protein PFF0380w;;;;;
comp2135376_c0_seq1;GAXK01155356.1;Q7KRI2;3.66E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp21355_c0_seq1;GAXK01031980.1;Q58CY6;1.23E-31;PXL2B_BOVIN;Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]; oxidation-reduction process [GO:0055114]; prostaglandin biosynthetic process [GO:0001516]";"GO:0001516; GO:0005737; GO:0005783; GO:0005829; GO:0016209; GO:0016616; GO:0043209; GO:0047017; GO:0055114";"oxidation-reduction process [GO:0055114]; prostaglandin biosynthetic process [GO:0001516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; myelin sheath [GO:0043209]";"antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]"
comp2135660_c0_seq1;GAXK01155365.1;Q3SYV7;3.36E-54;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2135844_c0_seq1;GAXK01155355.1;Q9VH08;1.12E-15;SIR6_DROME;NAD-dependent protein deacetylase Sirt6 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6);"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"GO:0000122; GO:0004407; GO:0005634; GO:0005724; GO:0008340; GO:0016575; GO:0031937; GO:0046872; GO:0046969; GO:0070403; GO:0070932";"determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]";"histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]"
comp2135882_c0_seq1;GAXK01155373.1;G5ED00;2.42E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp213598_c1_seq1;GAXK01042516.1;Q8VXZ9;6.97E-19;R47BP_ARATH;Polyadenylate-binding protein RBP47B' (Poly(A)-binding protein RBP47B') (RNA-binding protein 47B') (AtRBP47B prime) (AtRBP47B');"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; cellular response to heat [GO:0034605]; mRNA processing [GO:0006397]";"GO:0003729; GO:0005634; GO:0005829; GO:0006397; GO:0008143; GO:0010494; GO:0034605";"cellular response to heat [GO:0034605]; mRNA processing [GO:0006397]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]"
comp2136013_c0_seq1;GAXK01142919.1;P23469;5.14E-20;PTPRE_HUMAN;Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0016021; GO:0046627";"negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp213607_c0_seq1;GAXK01042440.1;Q15392;6.48E-118;DHC24_HUMAN;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214";"amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]";"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"
comp2136162_c0_seq1;GAXK01142927.1;B4MYI5;5.05E-25;BOP1_DROWI;Ribosome biogenesis protein BOP1 homolog;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0043021";"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]";ribonucleoprotein complex binding [GO:0043021]
comp2136433_c0_seq1;GAXK01142928.1;Q8GXK5;3.89E-12;EDL14_ARATH;Sugar transporter ERD6-like 14;"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp2136652_c0_seq1;GAXK01142920.1;Q5R5U3;6.23E-36;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2136723_c0_seq1;GAXK01142910.1;P0DJ56;1.66E-42;RL6_TETTS;60S ribosomal protein L6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp21369_c0_seq1;GAXK01032353.1;Q9H553;7.33E-128;ALG2_HUMAN;Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]";"GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704";"dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"
comp213696_c0_seq1;GAXK01042488.1;Q70E73;1.39E-71;RAPH1_HUMAN;Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; axon extension [GO:0048675]; signal transduction [GO:0007165]";"GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675";"axon extension [GO:0048675]; signal transduction [GO:0007165]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]";
comp2136999_c0_seq1;GAXK01142895.1;Q04896;7.12E-39;HME1A_DANRE;Homeobox protein engrailed-1a (Homeobox protein en-1a);"nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016586; GO:0030182; GO:0043565; GO:0060385";"axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RSC-type complex [GO:0016586]";sequence-specific DNA binding [GO:0043565]
comp2137385_c0_seq1;GAXK01142930.1;Q80WQ9;2.10E-13;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp213764_c0_seq1;GAXK01042536.1;Q68ED7;6.90E-07;CRTC1_MOUSE;CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1 homolog) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0014069; GO:0016604; GO:0030425; GO:0032793; GO:0043025; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:0098978; GO:0099527; GO:1900006; GO:1900273; GO:1902631";"energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";cAMP response element binding protein binding [GO:0008140]
comp213805_c1_seq1;GAXK01042493.1;Q6NYV5;1.56E-60;SP30L_DANRE;Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like);"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0004407; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273";"heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]"
comp2138083_c0_seq1;GAXK01108563.1;Q9PSX7;4.69E-13;RHOC_CHICK;Rho-related GTP-binding protein RhoC;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stereocilium [GO:0032420]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; mitotic cytokinesis [GO:0000281]; positive regulation of protein homooligomerization [GO:0032464]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]";"GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0016477; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032154; GO:0032420; GO:0032464; GO:0032956; GO:0043231; GO:0043297; GO:0044319; GO:0051017; GO:1902766";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; mitotic cytokinesis [GO:0000281]; positive regulation of protein homooligomerization [GO:0032464]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stereocilium [GO:0032420]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp2138487_c0_seq1;GAXK01108580.1;C7EXK4;5.17E-12;AT8A2_BOVIN;Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (P4-ATPase flippase complex alpha subunit ATP8A2);"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]; neuron development [GO:0048666]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005768; GO:0005794; GO:0005886; GO:0016021; GO:0045332; GO:0048666; GO:0090556; GO:0097381; GO:0140326";"neuron development [GO:0048666]; phospholipid translocation [GO:0045332]";"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]"
comp2138504_c0_seq1;GAXK01108573.1;C9WMM5;5.84E-64;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp2138581_c0_seq1;GAXK01108562.1;Q9UDV7;9.28E-09;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp2138871_c0_seq1;GAXK01108560.1;Q8T635;3.51E-17;CU20_MANSE;Pupal cuticle protein 20 (MS-PCP20) (MsCP20);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp213922_c0_seq1;GAXK01042489.1;Q8TC84;1.59E-09;FANK1_HUMAN;Fibronectin type 3 and ankyrin repeat domains protein 1;"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0043065; GO:0043066; GO:0045893; GO:0051091";"negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp213937_c2_seq1;GAXK01042469.1;P59889;2.53E-30;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp2140497_c0_seq1;GAXK01071417.1;O74467;2.53E-21;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2140530_c0_seq1;GAXK01071398.1;P40749;4.82E-07;SYT4_MOUSE;Synaptotagmin-4 (Synaptotagmin IV) (SytIV);"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of neuronal dense core vesicle membrane [GO:0099066]; intracellular membrane-bounded organelle [GO:0043231]; microvesicle [GO:1990742]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; secretory granule membrane [GO:0030667]; somatodendritic compartment [GO:0036477]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; secretory granule maturation [GO:0061792]; synaptic vesicle transport [GO:0048489]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005794; GO:0005886; GO:0007269; GO:0007420; GO:0007613; GO:0014049; GO:0014059; GO:0016021; GO:0016192; GO:0017075; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030100; GO:0030276; GO:0030348; GO:0030424; GO:0030425; GO:0030667; GO:0031045; GO:0031338; GO:0031339; GO:0031982; GO:0033604; GO:0036477; GO:0042803; GO:0043005; GO:0043025; GO:0043231; GO:0044306; GO:0045955; GO:0046929; GO:0046982; GO:0048174; GO:0048471; GO:0048489; GO:0048791; GO:0050709; GO:0061782; GO:0061792; GO:0070382; GO:0071277; GO:0097449; GO:0098793; GO:0098794; GO:0098978; GO:0099066; GO:0099161; GO:0099183; GO:1903861; GO:1905414; GO:1905415; GO:1905433; GO:1990742; GO:2000301";"brain development [GO:0007420]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; secretory granule maturation [GO:0061792]; synaptic vesicle transport [GO:0048489]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of neuronal dense core vesicle membrane [GO:0099066]; intracellular membrane-bounded organelle [GO:0043231]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; secretory granule membrane [GO:0030667]; somatodendritic compartment [GO:0036477]; vesicle [GO:0031982]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; syntaxin binding [GO:0019905]"
comp214071_c1_seq1;GAXK01070313.1;P04630;4.99E-17;CALL_CAEEL;Calmodulin-like protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp214084_c5_seq1;GAXK01070700.1;P52403;7.92E-26;CHI1_SOLTU;Endochitinase 1 (EC 3.2.1.14) (Fragment);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp2140863_c0_seq1;GAXK01071429.1;Q8WPA2;9.55E-44;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp2140879_c0_seq1;GAXK01071413.1;Q9UL40;9.54E-10;ZN346_HUMAN;Zinc finger protein 346 (Just another zinc finger protein);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; positive regulation of apoptotic process [GO:0043065]";"GO:0003723; GO:0003725; GO:0005634; GO:0005730; GO:0005737; GO:0008270; GO:0019899; GO:0035198; GO:0043065";positive regulation of apoptotic process [GO:0043065];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp21410_c0_seq1;GAXK01031981.1;Q8K1A0;3.62E-87;METL5_MOUSE;Methyltransferase-like protein 5 (EC 2.1.1.-);"methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0008168";;;"methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]"
comp2141300_c0_seq1;GAXK01071410.1;Q867X2;1.22E-36;ACES_CULQU;Acetylcholinesterase (AChE) (EC 3.1.1.7) (Fragment);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp214159_c1_seq1;GAXK01070655.1;O14594;7.64E-12;NCAN_HUMAN;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0043202";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp214167_c0_seq1;GAXK01070331.1;P29880;1.61E-100;COX2_SYMST;Cytochrome c oxidase subunit 2 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide II);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005507; GO:0005743; GO:0016021; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";"copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]"
comp2141802_c0_seq1;GAXK01071427.1;B9EY52;4.52E-17;KN13B_ORYSJ;Kinesin-like protein KIN-13B;"kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887";microtubule-based movement [GO:0007018];"kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp214214_c1_seq1;GAXK01070562.1;Q9CZP0;7.15E-42;UFSP1_MOUSE;Ufm1-specific protease 1 (UfSP1) (EC 3.4.22.-);"thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]";"GO:0016790; GO:0071567";;;"thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]"
comp2142243_c0_seq1;GAXK01105982.1;A2AP18;1.46E-21;PLCH2_MOUSE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209]";"GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0032959; GO:0046488; GO:0048015; GO:0051209";"inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; release of sequestered calcium ion into cytosol [GO:0051209]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]"
comp214262_c1_seq1;GAXK01070560.1;Q641B9;2.56E-31;APC5C_XENLA;Actin-related protein 2/3 complex subunit 5-C;"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp2143_c0_seq1;GAXK01176099.1;P62305;7.00E-46;RUXE_MOUSE;Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE);"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0042633; GO:0046540; GO:0071005; GO:0071007; GO:1990446";"hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]";"RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]"
comp21434_c9_seq1;GAXK01032514.1;Q27597;0;NCPR_DROME;NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4);"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cuticle hydrocarbon biosynthetic process [GO:0006723]; response to hormone [GO:0009725]";"GO:0003958; GO:0005789; GO:0005829; GO:0006723; GO:0009725; GO:0010181; GO:0012505; GO:0016021; GO:0016491; GO:0050660; GO:0050661";"cuticle hydrocarbon biosynthetic process [GO:0006723]; response to hormone [GO:0009725]";"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]"
comp214377_c10_seq1;GAXK01070380.1;Q9BXW9;5.30E-27;FACD2_HUMAN;Fanconi anemia group D2 protein (Protein FACD2);"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]; synapsis [GO:0007129]";"GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:2000348";"brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]; synapsis [GO:0007129]";"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";DNA polymerase binding [GO:0070182]
comp214390_c1_seq1;GAXK01070543.1;Q8IVH2;2.37E-39;FOXP4_HUMAN;Forkhead box protein P4 (Fork head-related protein-like A);"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]";"GO:0000790; GO:0000981; GO:0043565; GO:0046872";;nuclear chromatin [GO:0000790];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2143979_c0_seq1;GAXK01105995.1;Q91453;2.04E-33;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp214402_c0_seq1;GAXK01070726.1;Q55C09;1.25E-23;SGMA_DICDI;Sphingomyelin phosphodiesterase A (EC 3.1.4.-) (Acid sphingomyelinase A) (aSMase A);"extracellular space [GO:0005615]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005615; GO:0006685; GO:0008081; GO:0016798; GO:0046513; GO:0046872";"ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]";extracellular space [GO:0005615];"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp214428_c0_seq1;GAXK01070297.1;P11707;1.55E-30;CP3A6_RABIT;Cytochrome P450 3A6 (EC 1.14.14.1) (CYPIIIA6) (Cytochrome P450-3C);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]";"GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]"
comp2144401_c0_seq1;GAXK01010370.1;Q8CIM1;1.21E-67;LRC45_MOUSE;Leucine-rich repeat-containing protein 45;"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"GO:0005654; GO:0005813; GO:0005829; GO:0005886";;"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";
comp2144679_c0_seq1;GAXK01010364.1;Q08745;1.00E-17;RS10A_YEAST;40S ribosomal protein S10-A (Small ribosomal subunit protein eS10-A);"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cellular response to amino acid starvation [GO:0034198]; cytoplasmic translation [GO:0002181]; positive regulation of protein kinase activity [GO:0045860]; ribosomal small subunit assembly [GO:0000028]; rRNA export from nucleus [GO:0006407]";"GO:0000028; GO:0002181; GO:0003735; GO:0006407; GO:0022627; GO:0034198; GO:0045860";"cellular response to amino acid starvation [GO:0034198]; cytoplasmic translation [GO:0002181]; positive regulation of protein kinase activity [GO:0045860]; ribosomal small subunit assembly [GO:0000028]; rRNA export from nucleus [GO:0006407]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp2144891_c0_seq1;GAXK01010347.1;Q8NET6;4.95E-13;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp2145_c2_seq1;GAXK01175199.1;Q16P20;0;CISY2_AEDAE;Probable citrate synthase 2, mitochondrial (EC 2.3.3.16);"mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";"GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101";"carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];citrate (Si)-synthase activity [GO:0004108]
comp2145002_c0_seq1;GAXK01010374.1;Q8N1W2;5.04E-09;ZN710_HUMAN;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2145086_c0_seq1;GAXK01010329.1;Q80T91;1.10E-11;MEG11_MOUSE;Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]";"GO:0010842; GO:0016021; GO:0016323; GO:0034109";"homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";
comp21452_c1_seq1;GAXK01031865.1;O01367;1.92E-94;HOW_DROME;Protein held out wings (KH domain protein KH93F) (Protein muscle-specific) (Protein struthio) (Protein wings held out) (Putative RNA-binding protein) (Quaking-related 93F);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284]";"GO:0000381; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0007155; GO:0007284; GO:0007438; GO:0007475; GO:0007498; GO:0007517; GO:0007521; GO:0007525; GO:0008016; GO:0008078; GO:0008347; GO:0008366; GO:0016203; GO:0016477; GO:0030154; GO:0030718; GO:0045214; GO:0045995";"apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesodermal cell migration [GO:0008078]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp2145440_c0_seq1;GAXK01010345.1;O77487;4.75E-07;FUT2_PONPY;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp214552_c0_seq1;GAXK01070495.1;B2GV17;1.66E-79;CBPC5_RAT;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0045171; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp214556_c0_seq1;GAXK01205388.1;Q9VE01;2.06E-59;C12A5_DROME;Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5);"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016491; GO:0016705; GO:0020037; GO:0031966";;mitochondrial membrane [GO:0031966];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp214561_c3_seq1;GAXK01070649.1;Q0V8E4;4.23E-110;ASND1_BOVIN;Asparagine synthetase domain-containing protein 1;"asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]";"GO:0004066; GO:0006529; GO:0006541";"asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]";;asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]
comp2145726_c0_seq1;GAXK01010353.1;P55040;1.40E-21;GEM_HUMAN;GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR);"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842";"cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp2145896_c0_seq1;GAXK01010326.1;Q14593;6.13E-64;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp214643_c4_seq1;GAXK01070601.1;Q80ZD3;4.02E-104;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp2146495_c0_seq1;GAXK01143313.1;P17789;6.56E-08;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp21471_c0_seq1;GAXK01031762.1;Q63151;0;ACSL3_RAT;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Brain acyl-CoA synthetase II) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp214711_c0_seq1;GAXK01070496.1;Q6DDH6;1.88E-21;SP13A_XENLA;Histone deacetylase complex subunit SAP130-A (130 kDa Sin3-associated polypeptide A) (Sin3-associated polypeptide p130 A);"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];
comp214733_c2_seq1;GAXK01070299.1;Q19165;2.46E-07;FLP06_CAEEL;"FMRFamide-like neuropeptides 6 [Cleaved into: QQDSEVEREMM; KSAYMRF-amide 1 (AF8 1) (PF3 1); KSAYMRF-amide 2 (AF8 2) (PF3 2); KSAYMRF-amide 3 (AF8 3) (PF3 3); KSAYMRF-amide 4 (AF8 4) (PF3 4); KSAYMRF-amide 5 (AF8 5) (PF3 5); KSAYMRF-amide 6 (AF8 6) (PF3 6)]";"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp2147508_c0_seq1;GAXK01143316.1;P26367;1.14E-86;PAX6_HUMAN;Paired box protein Pax-6 (Aniridia type II protein) (Oculorhombin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; blood vessel development [GO:0001568]; cell fate determination [GO:0001709]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; establishment of mitotic spindle orientation [GO:0000132]; eye development [GO:0001654]; eye photoreceptor cell development [GO:0042462]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; oligodendrocyte cell fate specification [GO:0021778]; pancreatic A cell development [GO:0003322]; pituitary gland development [GO:0021983]; positive regulation of core promoter binding [GO:1904798]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to organelle [GO:0033365]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [GO:0021918]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; salivary gland morphogenesis [GO:0007435]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; visual perception [GO:0007601]";"GO:0000132; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001568; GO:0001654; GO:0001709; GO:0001764; GO:0001933; GO:0002052; GO:0002088; GO:0003309; GO:0003322; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007224; GO:0007411; GO:0007417; GO:0007435; GO:0007601; GO:0008134; GO:0009611; GO:0009786; GO:0009887; GO:0009950; GO:0010628; GO:0019901; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021912; GO:0021913; GO:0021918; GO:0021983; GO:0021986; GO:0023019; GO:0030216; GO:0030334; GO:0030858; GO:0031625; GO:0032808; GO:0033365; GO:0035035; GO:0042462; GO:0042593; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048663; GO:0048708; GO:0050680; GO:0050768; GO:0060041; GO:0061072; GO:0061303; GO:0070410; GO:0070412; GO:0071837; GO:1904798; GO:1990830; GO:2000178";"animal organ morphogenesis [GO:0009887]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; blood vessel development [GO:0001568]; cell fate determination [GO:0001709]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; establishment of mitotic spindle orientation [GO:0000132]; eye development [GO:0001654]; eye photoreceptor cell development [GO:0042462]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; oligodendrocyte cell fate specification [GO:0021778]; pancreatic A cell development [GO:0003322]; pituitary gland development [GO:0021983]; positive regulation of core promoter binding [GO:1904798]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to organelle [GO:0033365]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [GO:0021918]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; salivary gland morphogenesis [GO:0007435]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; protein kinase binding [GO:0019901]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"
comp214760_c1_seq1;GAXK01070352.1;P93748;9.39E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2147626_c0_seq1;GAXK01143317.1;P46436;8.28E-16;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp214784_c0_seq1;GAXK01070632.1;P34024;6.40E-21;PLC_LISMO;1-phosphatidylinositol phosphodiesterase (EC 4.6.1.13) (Phosphatidylinositol diacylglycerol-lyase) (Phosphatidylinositol-specific phospholipase C) (PI-PLC);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"GO:0004436; GO:0005576; GO:0005737; GO:0008081; GO:0009405; GO:0016042";"lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]"
comp2148073_c0_seq1;GAXK01025662.1;D0VWY5;8.97E-43;GASHR_MARGR;Glutathione amide reductase (GAR) (EC 1.8.1.16);"cell [GO:0005623]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]";"GO:0004362; GO:0005623; GO:0006749; GO:0009055; GO:0045454; GO:0046872; GO:0050660; GO:0050661";"cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]";cell [GO:0005623];"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]"
comp21483_c1_seq1;GAXK01204945.1;O73888;1.48E-35;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp214836_c0_seq1;GAXK01070398.1;P00765;1.59E-35;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2149_c1_seq1;GAXK01175128.1;P49321;9.12E-30;NASP_HUMAN;Nuclear autoantigenic sperm protein (NASP);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell population proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]";"GO:0000082; GO:0000790; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0006336; GO:0008283; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0043486; GO:0044877";"blastocyst development [GO:0001824]; cell population proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]"
comp214946_c1_seq1;GAXK01070691.1;Q3T052;2.28E-95;ITIH4_BOVIN;Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";"GO:0004867; GO:0005576; GO:0006953; GO:0030212";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp215_c0_seq1;GAXK01169631.1;Q2F637;3.34E-150;1433Z_BOMMO;14-3-3 protein zeta;"cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]";"GO:0005737; GO:0019904";;cytoplasm [GO:0005737];protein domain specific binding [GO:0019904]
comp2150178_c0_seq1;GAXK01108174.1;P69526;7.64E-09;TMPS9_RAT;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp215022_c0_seq1;GAXK01070635.1;Q53G44;1.85E-32;IF44L_HUMAN;Interferon-induced protein 44-like;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005525; GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp2150292_c0_seq1;GAXK01108175.1;P07463;3.52E-10;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp21509_c1_seq1;GAXK01031254.1;Q7YU24;0;MARF_DROME;Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin);"axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003924; GO:0005525; GO:0005740; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115";"adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]";"axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp215095_c0_seq1;GAXK01070302.1;P41041;1.92E-27;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2151_c0_seq1;GAXK01176638.1;Q91YT0;0;NDUV1_MOUSE;NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit);"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0005739; GO:0005743; GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0042775; GO:0045333; GO:0046872; GO:0051287; GO:0051539";"cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp2151391_c0_seq1;GAXK01108159.1;Q7XWK5;5.82E-66;SAG39_ORYSJ;Senescence-specific cysteine protease SAG39 (EC 3.4.22.-) (Cysteine proteinase SAG39) (Protein SENESCENCE-ASSOCIATED GENE 39);"extracellular space [GO:0005615]; lysosome [GO:0005764]; senescence-associated vacuole [GO:0010282]; cysteine-type endopeptidase activity [GO:0004197]; aging [GO:0007568]; leaf senescence [GO:0010150]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to abscisic acid [GO:0009737]; response to ethylene [GO:0009723]; response to gibberellin [GO:0009739]";"GO:0004197; GO:0005615; GO:0005764; GO:0007568; GO:0009723; GO:0009737; GO:0009739; GO:0010150; GO:0010282; GO:0010623; GO:0051603";"aging [GO:0007568]; leaf senescence [GO:0010150]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to abscisic acid [GO:0009737]; response to ethylene [GO:0009723]; response to gibberellin [GO:0009739]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; senescence-associated vacuole [GO:0010282]";cysteine-type endopeptidase activity [GO:0004197]
comp215159_c0_seq1;GAXK01070295.1;Q0IES8;0;MAB21_AEDAE;Protein mab-21;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp21516_c0_seq1;GAXK01031979.1;P21521;1.03E-92;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp215172_c0_seq1;GAXK01070357.1;Q7PEV7;1.75E-25;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp21524_c0_seq1;GAXK01031999.1;P48059;9.94E-158;LIMS1_HUMAN;LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051291; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046";"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]"
comp2152602_c0_seq1;GAXK01078314.1;Q231U7;5.48E-101;RL5_TETTS;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp215265_c0_seq1;GAXK01070363.1;P42282;3.21E-23;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp215290_c4_seq1;GAXK01070622.1;Q1R0J2;1.02E-38;LLDD_CHRSD;L-lactate dehydrogenase (EC 1.1.-.-);"plasma membrane [GO:0005886]; FMN binding [GO:0010181]; lactate dehydrogenase activity [GO:0004457]; lactate oxidation [GO:0019516]";"GO:0004457; GO:0005886; GO:0010181; GO:0019516";lactate oxidation [GO:0019516];plasma membrane [GO:0005886];"FMN binding [GO:0010181]; lactate dehydrogenase activity [GO:0004457]"
comp2153_c0_seq1;GAXK01175224.1;P48451;4.62E-90;CANB1_DROME;Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1);"calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calmodulin binding [GO:0005516]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005516; GO:0005955; GO:0006470; GO:0007269; GO:0008021; GO:0008597; GO:0016192; GO:0030431";"neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]";"calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]";"calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]"
comp215357_c7_seq1;GAXK01070710.1;Q92482;2.63E-27;AQP3_HUMAN;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"GO:0002684; GO:0003091; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323; GO:0032526; GO:0033280; GO:0042476; GO:0045616; GO:0051592; GO:0070295; GO:0071456; GO:0090650";"cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp2153687_c0_seq1;GAXK01078302.1;Q1RJR6;4.21E-10;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp21540_c0_seq1;GAXK01031225.1;Q6ZQ58;1.45E-144;LARP1_MOUSE;La-related protein 1 (La ribonucleoprotein domain family member 1);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysomal ribosome [GO:0042788]; TORC1 complex [GO:0031931]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413]";"GO:0000339; GO:0000340; GO:0003730; GO:0005737; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0031931; GO:0038202; GO:0042788; GO:0043024; GO:0045070; GO:0045947; GO:0048027; GO:0048255; GO:0072752; GO:1990928";"cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysomal ribosome [GO:0042788]; TORC1 complex [GO:0031931]";"eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]"
comp215410_c0_seq1;GAXK01070609.1;O08738;5.77E-09;CASP6_MOUSE;"Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; acute inflammatory response to non-antigenic stimulus [GO:0002525]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of retinal cell programmed cell death [GO:0046670]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]";"GO:0002525; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007413; GO:0009749; GO:0010039; GO:0030424; GO:0030855; GO:0034097; GO:0042542; GO:0042802; GO:0043025; GO:0043065; GO:0043525; GO:0046670; GO:0072734; GO:0097153; GO:0097200";"acute inflammatory response to non-antigenic stimulus [GO:0002525]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of retinal cell programmed cell death [GO:0046670]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]"
comp2154227_c0_seq1;GAXK01003518.1;Q802Y8;2.89E-09;ZB16A_DANRE;Zinc finger and BTB domain-containing protein 16-A (Promyelocytic leukemia zinc finger protein-A) (Zinc finger protein PLZF-A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"GO:0003677; GO:0005634; GO:0005737; GO:0016567; GO:0032481; GO:0046872; GO:0050767";"positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2154520_c0_seq1;GAXK01003492.1;Q96HP0;5.38E-43;DOCK6_HUMAN;Dedicator of cytokinesis protein 6;"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0048471";"blood coagulation [GO:0007596]; small GTPase mediated signal transduction [GO:0007264]";"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp215454_c5_seq1;GAXK01070694.1;A8WGE3;1.93E-152;COR2B_XENTR;Coronin-2B;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]";"GO:0005737; GO:0005856; GO:0016020; GO:0030036; GO:0051015";actin cytoskeleton organization [GO:0030036];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]";actin filament binding [GO:0051015]
comp2154601_c0_seq1;GAXK01003514.1;Q2M3R5;2.81E-11;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp215463_c0_seq1;GAXK01070630.1;P50947;3.50E-08;PHO23_YEAST;Transcriptional regulatory protein PHO23;"histone deacetylase complex [GO:0000118]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Rpd3L complex [GO:0033698]; Rpd3L-Expanded complex [GO:0070210]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; negative regulation of autophagy [GO:0010507]; negative regulation of chromatin silencing at rDNA [GO:0061188]; negative regulation of chromatin silencing at silent mating-type cassette [GO:0061186]; negative regulation of chromatin silencing at telomere [GO:0031939]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of invasive growth in response to glucose limitation [GO:2000219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of protein localization by the Cvt pathway [GO:2001159]";"GO:0000118; GO:0000122; GO:0005634; GO:0006325; GO:0010507; GO:0016479; GO:0016573; GO:0031939; GO:0033698; GO:0035064; GO:0035267; GO:0045944; GO:0046872; GO:0061186; GO:0061188; GO:0061408; GO:0070210; GO:2000219; GO:2001159";"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; negative regulation of autophagy [GO:0010507]; negative regulation of chromatin silencing at rDNA [GO:0061188]; negative regulation of chromatin silencing at silent mating-type cassette [GO:0061186]; negative regulation of chromatin silencing at telomere [GO:0031939]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of invasive growth in response to glucose limitation [GO:2000219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of protein localization by the Cvt pathway [GO:2001159]";"histone deacetylase complex [GO:0000118]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Rpd3L complex [GO:0033698]; Rpd3L-Expanded complex [GO:0070210]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp215488_c2_seq1;GAXK01070626.1;O43345;4.51E-30;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp2155084_c0_seq1;GAXK01003500.1;O61366;9.67E-139;GPRS_DROME;Serine-enriched protein;;;;;
comp2155099_c0_seq1;GAXK01003503.1;P18910;0;ANPRA_RAT;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662";"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp2155496_c0_seq1;GAXK01003517.1;P85831;1.45E-71;PROH4_APIME;"Prohormone-4 [Cleaved into: Brain peptide IDLSRFYGHFNT; Brain peptide IDLSRFYGHFN; Brain peptide IDLSRFYGHF; Brain peptide DLSRFYGHFNT; Brain peptide DLSRFYGHFN; Brain peptide DLSRFYGHF]";extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp21558_c0_seq1;GAXK01031275.1;Q24246;0;DYIN_DROME;Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing);"cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]";"GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642";"axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]";"cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]";"dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp215580_c0_seq1;GAXK01070591.1;Q6UXY8;5.85E-33;TMC5_HUMAN;Transmembrane channel-like protein 5;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]";"GO:0005216; GO:0005887; GO:0008381; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]";"ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]"
comp2155902_c0_seq1;GAXK01003519.1;P18061;4.62E-27;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2156013_c0_seq1;GAXK01091720.1;Q9QZ85;1.97E-23;IIGP1_MOUSE;Interferon-inducible GTPase 1 (EC 3.6.5.-);"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829";"cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp215621_c0_seq1;GAXK01070604.1;P46541;1.18E-26;PIP_BACCO;Proline iminopeptidase (PIP) (EC 3.4.11.5) (Prolyl aminopeptidase) (PAP);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]";"GO:0004177; GO:0005737";;cytoplasm [GO:0005737];aminopeptidase activity [GO:0004177]
comp2156396_c0_seq1;GAXK01091737.1;P82968;9.88E-13;MCPI_MELCP;Four-domain proteases inhibitor (McaPI);serine-type endopeptidase inhibitor activity [GO:0004867];GO:0004867;;;serine-type endopeptidase inhibitor activity [GO:0004867]
comp215724_c0_seq1;GAXK01070607.1;Q24207;3.11E-37;BOULE_DROME;Protein boule;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0007275; GO:0007283; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935";"3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]"
comp2157377_c0_seq1;GAXK01091741.1;Q6P1H1;5.36E-10;CYAC3_MOUSE;Cytochrome b ascorbate-dependent protein 3 (EC 1.-.-.-) (Cytochrome b561 family member A3) (Lysosomal cytochrome b) (LCytb);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0005764; GO:0005765; GO:0016021; GO:0016491; GO:0031902; GO:0046872";;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp2157396_c0_seq1;GAXK01091722.1;Q96L93;1.22E-08;KI16B_HUMAN;Kinesin-like protein KIF16B (Sorting nexin-23);"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]";"GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0017137; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0071346; GO:0080025";"cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]";"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]"
comp2157404_c0_seq1;GAXK01091740.1;P52746;6.35E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2157467_c0_seq1;GAXK01091743.1;P20023;2.24E-07;CR2_HUMAN;Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; complement binding [GO:0001848]; complement receptor activity [GO:0004875]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]";"GO:0001618; GO:0001848; GO:0003677; GO:0004875; GO:0004888; GO:0005886; GO:0006955; GO:0006958; GO:0016021; GO:0030183; GO:0030449; GO:0042100; GO:0042803; GO:0043235; GO:0045087; GO:0070062";"B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"complement binding [GO:0001848]; complement receptor activity [GO:0004875]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp2157638_c0_seq1;GAXK01091724.1;P0DPW5;6.00E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp215810_c0_seq1;GAXK01070534.1;O08755;5.08E-44;HNF6_MOUSE;Hepatocyte nuclear factor 6 (HNF-6) (One cut domain family member 1) (One cut homeobox 1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; endoderm development [GO:0007492]; epithelial cell development [GO:0002064]; glucose metabolic process [GO:0006006]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]";"GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006006; GO:0006357; GO:0007219; GO:0007492; GO:0009653; GO:0030154; GO:0030183; GO:0030335; GO:0030512; GO:0031016; GO:0031018; GO:0045165; GO:0045944; GO:0048536; GO:0060271";"anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; endoderm development [GO:0007492]; epithelial cell development [GO:0002064]; glucose metabolic process [GO:0006006]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp215899_c1_seq1;GAXK01070595.1;Q17P71;4.83E-144;T23O_AEDAE;Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase);"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; ommochrome biosynthetic process [GO:0006727]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0004833; GO:0006727; GO:0019441; GO:0020037; GO:0046872";"ommochrome biosynthetic process [GO:0006727]; tryptophan catabolic process to kynurenine [GO:0019441]";;"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]"
comp21590_c30_seq1;GAXK01031491.1;Q01295;3.30E-23;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2159100_c0_seq1;GAXK01015113.1;Q14AK4;4.00E-36;ZDH11_MOUSE;Probable palmitoyltransferase ZDHHC11 (EC 2.3.1.225) (DHHC-containing protein 10) (Zinc finger DHHC domain-containing protein 11) (DHHC-11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp2159112_c0_seq1;GAXK01015129.1;P12327;7.31E-21;CB21_EUGGR;Chlorophyll a-b binding protein of LHCII type 1 (Chlorophyll a-b binding protein of LHCII type I) (CAB) (LHCP) (Fragment);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009522; GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp2159249_c0_seq1;GAXK01015127.1;Q23312;8.58E-34;RS7_CAEEL;40S ribosomal protein S7;"cytosolic small ribosomal subunit [GO:0022627]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]";"GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274";"ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; small-subunit processome [GO:0032040]";structural constituent of ribosome [GO:0003735]
comp21594_c1_seq1;GAXK01032297.1;P42577;3.96E-41;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp215961_c1_seq1;GAXK01070638.1;Q8NDC4;1.27E-10;MORN4_HUMAN;MORN repeat-containing protein 4 (Protein 44050) (Retinophilin);"cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678]";"GO:0005737; GO:0032426; GO:0032433; GO:0048678";response to axon injury [GO:0048678];"cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]";
comp2159932_c0_seq1;GAXK01015123.1;Q9DBI0;2.11E-16;TMPS6_MOUSE;Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016021; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264";"cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp216_c1_seq1;GAXK01168170.1;Q963B6;1.84E-100;RL10A_SPOFR;60S ribosomal protein L10a;"large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp216017_c1_seq1;GAXK01087353.1;Q3SZL0;2.76E-20;NR1H4_BOVIN;Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]";"GO:0003707; GO:0004879; GO:0005634; GO:0006954; GO:0008270; GO:0043565; GO:0045087";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2160235_c0_seq1;GAXK01024855.1;Q6P402;3.99E-09;CEP89_DANRE;Centrosomal protein of 89 kDa (Cep89) (Coiled-coil domain-containing protein 123);"centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]";"GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0007005; GO:0007268; GO:0060271";"chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]";"centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; spindle pole [GO:0000922]";
comp2160324_c0_seq1;GAXK01024853.1;P51957;1.93E-24;NEK4_HUMAN;Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2);"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0031098; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020";"activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]"
comp216083_c0_seq1;GAXK01087193.1;P19397;1.54E-08;CD53_HUMAN;Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25) (Tspan-25) (CD antigen CD53);"cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; neutrophil degranulation [GO:0043312]; positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165]";"GO:0001772; GO:0005886; GO:0005887; GO:0005911; GO:0007165; GO:0009986; GO:0035579; GO:0043312; GO:0070062; GO:0070821; GO:1901741";"neutrophil degranulation [GO:0043312]; positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165]";"cell-cell junction [GO:0005911]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";
comp216100_c0_seq1;GAXK01087167.1;Q8VID5;7.73E-109;RECQ5_MOUSE;ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RECQL5beta) (RecQ protein-like 5);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0035690; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042";"cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]"
comp216167_c1_seq1;GAXK01087186.1;Q7KHG2;6.97E-28;JING_DROME;Zinc finger protein jing (Zinc finger protein rhumba);"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]";"GO:0000122; GO:0003676; GO:0005634; GO:0006325; GO:0007298; GO:0007382; GO:0007411; GO:0007417; GO:0007418; GO:0007424; GO:0007474; GO:0007479; GO:0008347; GO:0035098; GO:0042246; GO:0045944; GO:0046872";"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]";"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2161921_c0_seq1;GAXK01024865.1;P09482;2.37E-29;ACHA4_CHICK;Neuronal acetylcholine receptor subunit alpha-4;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; exploration behavior [GO:0035640]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0001508; GO:0001666; GO:0005887; GO:0005892; GO:0006281; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007585; GO:0007626; GO:0009897; GO:0014059; GO:0015464; GO:0019233; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0035640; GO:0042113; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500; GO:0098691; GO:0099056; GO:2000300";"acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; exploration behavior [GO:0035640]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]"
comp2161953_c0_seq1;GAXK01024867.1;P0DJ15;5.69E-77;RL13A_TETTS;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp216199_c1_seq1;GAXK01087329.1;Q9ULU4;8.95E-50;PKCB1_HUMAN;Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8);"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003714; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952";"modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; nucleus [GO:0005634]";"lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp2162253_c0_seq1;GAXK01093771.1;P07548;2.57E-09;DFD_DROME;Homeotic protein deformed;"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; embryonic brain development [GO:1990403]; head development [GO:0060322]; head morphogenesis [GO:0060323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; specification of segmental identity, head [GO:0007380]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0007380; GO:0009952; GO:0010468; GO:0033613; GO:0035289; GO:0043565; GO:0045944; GO:0060322; GO:0060323; GO:1902339; GO:1990403";"anterior/posterior pattern specification [GO:0009952]; embryonic brain development [GO:1990403]; head development [GO:0060322]; head morphogenesis [GO:0060323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; specification of segmental identity, head [GO:0007380]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2162265_c0_seq1;GAXK01093746.1;P0DJ20;2.14E-09;RL28_TETTH;60S ribosomal protein L28;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp21623_c1_seq1;GAXK01032199.1;Q7ZXA8;2.61E-108;THO5B_XENLA;THO complex subunit 5 homolog B;"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0030154; GO:0051028";"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";RNA binding [GO:0003723]
comp21628_c1_seq1;GAXK01031725.1;Q00871;6.66E-85;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp216284_c0_seq1;GAXK01087339.1;P55567;3.18E-20;Y4MH_SINFN;Uncharacterized protein y4mH;hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp216289_c3_seq1;GAXK01087194.1;E1BZ85;3.20E-45;MARF1_CHICK;Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog);"peroxisome [GO:0005777]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"GO:0003723; GO:0005777; GO:0010468; GO:0048477; GO:0051321";"meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";peroxisome [GO:0005777];RNA binding [GO:0003723]
comp2162955_c0_seq1;GAXK01093751.1;Q7T3Q7;8.22E-22;OPSO_RUTRU;Opsin-VA (Vertebrate ancient opsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0004930; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp2163476_c0_seq1;GAXK01093747.1;Q8VHE6;0;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp21636_c0_seq1;GAXK01032022.1;Q5SSI6;5.83E-74;UTP18_MOUSE;U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50);"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]";"GO:0005634; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388";rRNA processing [GO:0006364];"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]";
comp2165676_c0_seq1;GAXK01081830.1;Q9Y2L5;1.02E-12;TPPC8_HUMAN;Trafficking protein particle complex subunit 8 (Protein TRS85 homolog);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497]";"GO:0000045; GO:0000407; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0030242; GO:0031410; GO:0032258; GO:0034497; GO:1990072";"autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]";
comp2165786_c0_seq1;GAXK01081846.1;O35929;8.16E-26;REM1_MOUSE;GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp216579_c0_seq1;GAXK01087170.1;Q9NFT7;4.70E-43;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp2166014_c0_seq1;GAXK01142734.1;P17970;2.01E-27;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp216602_c1_seq1;GAXK01087191.1;Q6UXP7;1.06E-36;F151B_HUMAN;Protein FAM151B;;;;;
comp216610_c0_seq1;GAXK01087273.1;B4K9L4;0;PDE6_DROMO;cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35);"membrane [GO:0016020]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0005886; GO:0007165; GO:0016020; GO:0046068; GO:0046872; GO:0047555";"cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"membrane [GO:0016020]; plasma membrane [GO:0005886]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp2166273_c0_seq1;GAXK01142722.1;Q10010;3.53E-24;YSV4_CAEEL;Uncharacterized protein T19C3.4;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2166371_c0_seq1;GAXK01142710.1;Q99PJ7;6.66E-08;ZN689_RAT;Zinc finger protein 689 (Transcription factor HIT-39);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2166542_c0_seq1;GAXK01142718.1;E1BE02;4.73E-10;E2F7_BOVIN;Transcription factor E2F7 (E2F-7);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001890; GO:0002040; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0008134; GO:0008285; GO:0016607; GO:0030330; GO:0032466; GO:0032877; GO:0042802; GO:0043565; GO:0045944; GO:0051726; GO:0060707; GO:0060718; GO:0070365; GO:0071930; GO:0090575; GO:2000134";"chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp2166630_c0_seq1;GAXK01142733.1;Q5YLM1;9.20E-11;DGLA_RAT;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp216682_c4_seq1;GAXK01087237.1;P13914;8.18E-41;ARY2_CHICK;Arylamine N-acetyltransferase, pineal gland isozyme NAT-3 (Arylamine acetylase) (EC 2.3.1.5);arylamine N-acetyltransferase activity [GO:0004060];GO:0004060;;;arylamine N-acetyltransferase activity [GO:0004060]
comp216690_c1_seq1;GAXK01087314.1;P34275;3.31E-68;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp21670_c0_seq1;GAXK01205133.1;Q969M7;4.23E-76;UBE2F_HUMAN;NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F);"cytosol [GO:0005829]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";"GO:0005524; GO:0005829; GO:0019788; GO:0043687; GO:0045116; GO:0061654";"post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";cytosol [GO:0005829];"ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]"
comp21677_c6_seq1;GAXK01032007.1;Q56A18;4.95E-82;SMCE1_RAT;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57);"nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]";"GO:0003677; GO:0005634; GO:0007286; GO:0007420; GO:0016514; GO:0016922; GO:0043044; GO:0045892; GO:0047485";"ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]";"nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";"DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]"
comp2167847_c0_seq1;GAXK01142711.1;Q7TN88;8.14E-61;PK1L2_MOUSE;Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]";"GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982";detection of mechanical stimulus [GO:0050982];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]"
comp2168091_c0_seq1;GAXK01159867.1;P31944;2.46E-29;CASPE_HUMAN;"Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008544; GO:0008630; GO:0031424; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]"
comp216813_c0_seq1;GAXK01087302.1;Q86YQ8;3.62E-180;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp2168591_c0_seq1;GAXK01159881.1;O35379;5.55E-72;MRP1_MOUSE;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005324; GO:0005524; GO:0005737; GO:0005774; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0046618; GO:0046624; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215";"cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp2168735_c0_seq1;GAXK01159874.1;A2A935;5.44E-07;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp216943_c1_seq1;GAXK01087247.1;Q96SB3;7.64E-62;NEB2_HUMAN;Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin);"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]";"GO:0000164; GO:0001560; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007050; GO:0007096; GO:0008157; GO:0008380; GO:0014069; GO:0015629; GO:0016477; GO:0019722; GO:0030027; GO:0030175; GO:0030308; GO:0030425; GO:0031175; GO:0032587; GO:0042127; GO:0043197; GO:0046847; GO:0050804; GO:0051015; GO:0071315; GO:2000474";"actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]";"actin filament binding [GO:0051015]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]"
comp2169609_c0_seq1;GAXK01159884.1;P24140;1.24E-09;GPT_CRIGR;UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein complex oligomerization [GO:0051259]";"GO:0003975; GO:0003976; GO:0005789; GO:0006488; GO:0008963; GO:0016021; GO:0016757; GO:0019408; GO:0030176; GO:0046872; GO:0051259";"dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein complex oligomerization [GO:0051259]";"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"
comp2170137_c0_seq1;GAXK01123028.1;Q4LBB6;1.06E-56;OCTB3_DROME;Octopamine receptor beta-3R (DmOct-beta-3R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004989; GO:0005887; GO:0007186; GO:0007189; GO:0008227; GO:0016021";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]"
comp2170421_c0_seq1;GAXK01123040.1;A0A0R4IMY7;9.30E-45;TRPM2_DANRE;Transient receptor potential cation channel subfamily M member 2;"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; ligand-gated calcium channel activity [GO:0099604]; mono-ADP-D-ribose binding [GO:0072571]; calcium ion transmembrane transport [GO:0070588]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]";"GO:0005509; GO:0005887; GO:0006979; GO:0016787; GO:0051289; GO:0070588; GO:0072571; GO:0099604";"calcium ion transmembrane transport [GO:0070588]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]";integral component of plasma membrane [GO:0005887];"calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; ligand-gated calcium channel activity [GO:0099604]; mono-ADP-D-ribose binding [GO:0072571]"
comp2170865_c0_seq1;GAXK01123026.1;Q9NPC2;3.26E-22;KCNK9_HUMAN;Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0008021; GO:0022841; GO:0030322; GO:0071805; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]"
comp2170871_c0_seq1;GAXK01123042.1;O42329;4.90E-29;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp2171_c0_seq1;GAXK01175640.1;Q8N6R1;7.77E-17;SERP2_HUMAN;Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]";"GO:0005789; GO:0006486; GO:0015031; GO:0016021; GO:0030968";"endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp2171143_c0_seq1;GAXK01123043.1;Q6IV72;6.45E-18;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2171226_c0_seq1;GAXK01123038.1;Q7K237;4.31E-20;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp2171248_c0_seq1;GAXK01205616.1;P37899;0;HSP70_PYRSA;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp2171494_c0_seq1;GAXK01123030.1;Q8C0X2;8.08E-32;SL9B1_MOUSE;Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9 subfamily B member 1) (Testis specific sodium-hydrogen exchanger) (MtsNHE);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0016021; GO:0030317; GO:0051453; GO:0097228";"flagellated sperm motility [GO:0030317]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]";solute:proton antiporter activity [GO:0015299]
comp217187_c0_seq1;GAXK01087153.1;Q28E61;3.98E-102;NSUN2_XENTR;tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (NOL1/NOP2/Sun domain family member 2);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; tRNA methylation [GO:0030488]";"GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0008168; GO:0016428; GO:0030488";tRNA methylation [GO:0030488];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]"
comp2172724_c0_seq1;GAXK01191035.1;Q0BUV2;5.26E-20;DADA_GRABC;D-amino acid dehydrogenase (EC 1.4.99.-);"D-amino-acid dehydrogenase activity [GO:0008718]; D-alanine catabolic process [GO:0055130]";"GO:0008718; GO:0055130";D-alanine catabolic process [GO:0055130];;D-amino-acid dehydrogenase activity [GO:0008718]
comp217279_c0_seq1;GAXK01087275.1;Q25604;4.10E-15;NHR1_ONCVO;Nuclear hormone receptor-like 1;"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0004879; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp2172861_c0_seq1;GAXK01191027.1;Q6XD76;1.57E-07;ASCL4_HUMAN;Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44);"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]";"GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0008134; GO:0043588; GO:0045944; GO:0046983; GO:0090575";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]";"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp2172992_c0_seq1;GAXK01191021.1;Q9N294;3.68E-20;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp217306_c0_seq1;GAXK01087175.1;Q8IVI9;2.13E-38;NOSTN_HUMAN;Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer);"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]";"GO:0003677; GO:0005856; GO:0005886; GO:0006897; GO:0016607; GO:0030666; GO:0045892; GO:0050999";"endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]";"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]";DNA binding [GO:0003677]
comp2173084_c0_seq1;GAXK01191014.1;P36609;2.22E-10;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp21731_c3_seq1;GAXK01032340.1;Q868Z9;4.46E-44;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp2173643_c0_seq1;GAXK01191025.1;Q9UDV7;9.74E-11;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp2173662_c0_seq1;GAXK01191045.1;P24014;1.64E-13;SLIT_DROME;"Protein slit (dSlit) [Cleaved into: Protein slit N-product; Protein slit C-product]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell migration [GO:0008078]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"GO:0001764; GO:0003151; GO:0005509; GO:0005576; GO:0005886; GO:0007411; GO:0007427; GO:0007432; GO:0007502; GO:0007509; GO:0008078; GO:0008201; GO:0008347; GO:0008406; GO:0010632; GO:0016199; GO:0016201; GO:0022409; GO:0030182; GO:0030335; GO:0035050; GO:0035385; GO:0048495; GO:0048813; GO:0050929; GO:0071666; GO:2000274";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesodermal cell migration [GO:0008078]; mesoderm migration involved in gastrulation [GO:0007509]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell migration [GO:0030335]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]"
comp2174_c1_seq1;GAXK01176590.1;Q9QUM9;2.00E-138;PSA6_MOUSE;Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]";"GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0007519; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603";"positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]";"endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]"
comp21740_c0_seq1;GAXK01031982.1;Q9ULC8;3.64E-87;ZDHC8_HUMAN;Probable palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378);"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; protein palmitoylation [GO:0018345]";"GO:0005739; GO:0005794; GO:0005829; GO:0007626; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030659; GO:0034380";"high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; protein palmitoylation [GO:0018345]";"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp2174098_c0_seq1;GAXK01159035.1;Q1LYM6;4.09E-10;KLH38_DANRE;Kelch-like protein 38;;;;;
comp2174284_c0_seq1;GAXK01159039.1;P79008;1.13E-08;TBB_COPC7;Tubulin beta chain (Beta-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2174294_c0_seq1;GAXK01159028.1;Q99PX1;2.50E-18;DEAA_VIBAL;Chitin disaccharide deacetylase (EC 3.5.1.105) (Chitin oligosaccharide deacetylase);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; chitin deacetylase activity [GO:0004099]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004099; GO:0004553; GO:0005576; GO:0006032; GO:0030246";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; chitin deacetylase activity [GO:0004099]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp2174461_c0_seq1;GAXK01159037.1;P0DJ59;7.85E-43;RL30_TETTS;60S ribosomal protein L30;"ribosome [GO:0005840]; RNA binding [GO:0003723]";"GO:0003723; GO:0005840";;ribosome [GO:0005840];RNA binding [GO:0003723]
comp217452_c0_seq1;GAXK01087148.1;Q95333;2.98E-126;XPP2_PIG;Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2);"anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]";"GO:0005737; GO:0005886; GO:0031225; GO:0046872; GO:0070006";;"anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp2174564_c0_seq1;GAXK01159043.1;P42519;1.58E-09;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp2175_c0_seq1;GAXK01176654.1;Q46N53;6.00E-143;HPSN_CUPNJ;Sulfopropanediol 3-dehydrogenase (EC 1.1.1.308) (2,3-dihydroxypropane-1-sulfonate 3-dehydrogenase (sulfolactate forming)) (DHPS 3-dehydrogenase (sulfolactate forming));"histidinol dehydrogenase activity [GO:0004399]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; histidine biosynthetic process [GO:0000105]";"GO:0000105; GO:0004399; GO:0008270; GO:0051287";histidine biosynthetic process [GO:0000105];;"histidinol dehydrogenase activity [GO:0004399]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]"
comp217519_c0_seq1;GAXK01087171.1;Q6DGV7;2.21E-36;M17L2_DANRE;Mpv17-like protein 2;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome assembly [GO:0061668]";"GO:0005737; GO:0005743; GO:0016021; GO:0061668";mitochondrial ribosome assembly [GO:0061668];"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp21752_c0_seq1;GAXK01031998.1;Q68EL3;2.73E-19;BET1L_DANRE;BET1-like protein;"cytosol [GO:0005829]; Golgi trans cisterna [GO:0000138]; integral component of Golgi membrane [GO:0030173]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000138; GO:0005484; GO:0005829; GO:0015031; GO:0030173; GO:0031201; GO:0042147; GO:2000156";"protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; Golgi trans cisterna [GO:0000138]; integral component of Golgi membrane [GO:0030173]; SNARE complex [GO:0031201]";SNAP receptor activity [GO:0005484]
comp217574_c2_seq1;GAXK01087176.1;Q8N8Q3;2.04E-55;ENDOV_HUMAN;Endonuclease V (hEndoV) (EC 3.1.26.-) (Inosine-specific endoribonuclease);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; magnesium ion binding [GO:0000287]; single-stranded RNA binding [GO:0003727]; DNA repair [GO:0006281]";"GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0016888; GO:0016891";DNA repair [GO:0006281];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; magnesium ion binding [GO:0000287]; single-stranded RNA binding [GO:0003727]"
comp2175842_c0_seq1;GAXK01159020.1;Q09JY9;4.85E-08;SHRM2_XENTR;Protein Shroom2 (Protein Apxl);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"GO:0002089; GO:0003779; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0007015; GO:0007420; GO:0008057; GO:0016324; GO:0016477; GO:0030036; GO:0030864; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp2176213_c0_seq1;GAXK01073039.1;Q8BQN6;3.18E-15;OZF_MOUSE;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2176326_c0_seq1;GAXK01073029.1;O89114;8.09E-21;DNJB5_MOUSE;DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40);"cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"GO:0000122; GO:0005634; GO:0005829; GO:0006986; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp217658_c1_seq1;GAXK01087238.1;Q7KRI2;2.13E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp217689_c1_seq1;GAXK01087243.1;Q23985;1.30E-48;DTX_DROME;Protein deltex (Probable E3 ubiquitin-protein ligase deltex) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase deltex);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]";"GO:0005112; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007220; GO:0008270; GO:0016567; GO:0017124; GO:0035220; GO:0045746; GO:0045747; GO:0061630";"endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp217704_c0_seq1;GAXK01087147.1;P02588;4.01E-10;TNNC2_CHICK;Troponin C, skeletal muscle;"troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005509; GO:0005861; GO:0006937; GO:0048306; GO:0051015";"regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";troponin complex [GO:0005861];"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]"
comp217707_c0_seq1;GAXK01087340.1;Q24206;6.83E-07;BRC4_DROME;Broad-complex core protein isoform 6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp217742_c1_seq1;GAXK01087274.1;B7TB45;2.72E-10;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp217786_c2_seq1;GAXK01087154.1;Q5RFT1;4.24E-76;S35F6_PONAB;Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005739; GO:0005765; GO:0008284; GO:0016021; GO:0022857; GO:1901029";"negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]";transmembrane transporter activity [GO:0022857]
comp2178208_c0_seq1;GAXK01063441.1;P47971;1.37E-13;NPTX1_RAT;Neuronal pentraxin-1 (NP1) (47 kDa taipoxin-binding protein) (Neuronal pentraxin I) (NP-I);"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]";"GO:0005737; GO:0005739; GO:0005886; GO:0006839; GO:0030133; GO:0035865; GO:0043005; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0098978; GO:0099151; GO:0099645";"axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]";"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]";metal ion binding [GO:0046872]
comp21785_c2_seq1;GAXK01031279.1;Q922V4;0;PLRG1_MOUSE;Pleiotropic regulator 1;"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]";"GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]";"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]";
comp217887_c0_seq1;GAXK01087293.1;Q6AY85;8.56E-38;ALG14_RAT;UDP-N-acetylglucosamine transferase subunit ALG14 homolog;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]";"GO:0006488; GO:0016021; GO:0031965; GO:0043541";dolichol-linked oligosaccharide biosynthetic process [GO:0006488];"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]";
comp2178893_c0_seq1;GAXK01204828.1;Q7JVE7;1.90E-39;SWET1_DROME;Sugar transporter SWEET1 (Protein saliva);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"GO:0000139; GO:0005886; GO:0007431; GO:0008643; GO:0016021; GO:0051119";"carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sugar transmembrane transporter activity [GO:0051119]
comp217902_c0_seq1;GAXK01087179.1;Q7K556;6.06E-15;TTD14_DROME;TRPL translocation defect protein 14;"cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";"GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300";"photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]";cytosol [GO:0005829];"GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]"
comp2179180_c0_seq1;GAXK01063478.1;O08901;1.53E-17;BUB1_MOUSE;Mitotic checkpoint serine/threonine-protein kinase BUB1 (mBUB1) (EC 2.7.11.1) (BUB1A);"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000780; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0051301; GO:0051754; GO:0051983; GO:2001244";"apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp2179244_c0_seq1;GAXK01063450.1;Q8K2C8;2.76E-16;GPAT4_MOUSE;Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420";"acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";"glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]"
comp2179334_c0_seq2;GAXK01063475.1;P27105;3.26E-44;STOM_HUMAN;Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin);"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0051260; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585";"neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]";"protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]"
comp217946_c0_seq1;GAXK01087124.1;P83501;1.89E-23;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp217976_c1_seq1;GAXK01087342.1;B7YZV4;8.11E-135;PDE1_DROME;Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1) (EC 3.1.4.17);"extracellular space [GO:0005615]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]";"GO:0004115; GO:0005516; GO:0005615; GO:0007165; GO:0032504; GO:0046058; GO:0046068; GO:0046872; GO:0047555; GO:0048101; GO:0060179";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]";extracellular space [GO:0005615];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp2179777_c0_seq1;GAXK01063451.1;Q12099;4.39E-14;FAL1_YEAST;ATP-dependent RNA helicase FAL1 (EC 3.6.4.13) (Translation initiation factor four A-like protein 1);"catalytic step 2 spliceosome [GO:0071013]; FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0030688; GO:0071013; GO:0097078";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"catalytic step 2 spliceosome [GO:0071013]; FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp218_c0_seq1;GAXK01166123.1;P46436;2.79E-34;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp2180428_c0_seq1;GAXK01128942.1;P07439;2.95E-13;LEC3_MEGRO;Lectin BRA-3;carbohydrate binding [GO:0030246];GO:0030246;;;carbohydrate binding [GO:0030246]
comp2180554_c0_seq1;GAXK01128947.1;Q70JS2;1.29E-55;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp21807_c0_seq1;GAXK01031575.1;Q6IFY7;1.98E-33;RTN1A_XENLA;Reticulon-1-A (RTN1.1) (xRTN1) (XRTN1-C.1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"GO:0005634; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp2180877_c0_seq1;GAXK01128955.1;Q92260;5.32E-117;HSP70_PENCI;Heat shock 70 kDa protein (allergen Pen c 19) (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp21810_c0_seq1;GAXK01031408.1;O02466;6.58E-79;ILPR_BRALA;"Insulin-like peptide receptor (ILP receptor) (EC 2.7.10.1) [Cleaved into: Insulin-like peptide receptor alpha chain; Insulin-like peptide receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0043548; GO:0043560; GO:0046777; GO:0046872";"protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp2181455_c0_seq1;GAXK01128946.1;Q80W31;5.82E-14;ZN569_MOUSE;Zinc finger protein 569 (Mszf21) (Zinc finger protein 74) (Zfp-74);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2182174_c0_seq1;GAXK01071151.1;Q8VIG1;5.54E-12;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp218222_c0_seq1;GAXK01163458.1;Q92045;1.64E-15;CP11A_HYPAM;Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc)) (Fragment);"mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]";"GO:0005506; GO:0005743; GO:0006700; GO:0008203; GO:0008386; GO:0020037";"C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]";mitochondrial inner membrane [GO:0005743];"cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp2182497_c0_seq1;GAXK01071141.1;Q27960;7.47E-22;NPT2B_BOVIN;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341]";"GO:0005436; GO:0005886; GO:0005903; GO:0006817; GO:0015321; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341";"cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"phosphate ion binding [GO:0042301]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium ion binding [GO:0031402]"
comp2182575_c0_seq1;GAXK01071145.1;Q2UH35;2.32E-18;DPP4_ASPOR;Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (DppIV);"extracellular region [GO:0005576]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0005576; GO:0006508; GO:0008236; GO:0008239; GO:0051603";"proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";extracellular region [GO:0005576];"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]"
comp2182608_c0_seq1;GAXK01071147.1;Q9NZJ4;2.86E-20;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp218270_c1_seq1;GAXK01163453.1;A4IF63;3.58E-43;TRIM2_BOVIN;Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";"GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp218272_c0_seq1;GAXK01163279.1;Q14590;1.20E-36;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp218306_c1_seq1;GAXK01163420.1;Q9V3L1;0;NDST_DROME;"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]";"GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0016055; GO:0019213; GO:0030210; GO:0034483; GO:0042328; GO:0045570";"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp2183293_c0_seq1;GAXK01071154.1;Q16651;5.99E-16;PRSS8_HUMAN;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]; cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0008236; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0046658; GO:0070062; GO:0070268";"cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]"
comp2183633_c0_seq1;GAXK01071153.1;Q98993;1.45E-07;VTXB_SYNVE;Verrucotoxin subunit beta (VTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp218384_c0_seq1;GAXK01163294.1;Q9VPF0;3.12E-49;ATK_DROME;Protein artichoke;"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271";"cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]";
comp218412_c0_seq1;GAXK01163430.1;Q05B79;0;DHX36_BOVIN;ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein);"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]";"GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0034458; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1902741; GO:1903843; GO:1904358; GO:1904582; GO:2000767";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]";"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]"
comp2184758_c0_seq1;GAXK01072539.1;F7J220;2.74E-12;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp2184832_c0_seq1;GAXK01072555.1;Q17QN9;1.03E-39;S22AG_BOVIN;Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; organic cation transmembrane transporter activity [GO:0015101]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]";"GO:0005886; GO:0007275; GO:0007283; GO:0015101; GO:0015695; GO:0016021; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";organic cation transmembrane transporter activity [GO:0015101]
comp2184867_c0_seq1;GAXK01072550.1;P07463;2.39E-38;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2185100_c0_seq1;GAXK01072548.1;P07727;2.06E-33;GLRA1_RAT;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp218516_c0_seq1;GAXK01163432.1;P0DMB4;4.71E-23;PA11_VESAF;Phospholipase A1 1 (EC 3.1.1.32) (Allergen Ves a 1.01) (Vespapase) (allergen Vesp a 1);"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0008970; GO:0016042; GO:0044179; GO:0052739; GO:0052740; GO:0090729";"hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; toxin activity [GO:0090729]"
comp218549_c1_seq1;GAXK01163292.1;Q3U145;2.63E-47;TMM64_MOUSE;Transmembrane protein 64;"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of ATPase activity [GO:0043462]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005783; GO:0016021; GO:0043462; GO:0045600; GO:0045668; GO:0045672; GO:0045780; GO:0051480; GO:0090090";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of ATPase activity [GO:0043462]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";
comp21855_c0_seq1;GAXK01031231.1;O35345;5.58E-80;IMA7_MOUSE;Importin subunit alpha-7 (Importin alpha-S2) (Karyopherin subunit alpha-6);"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; evasion or tolerance by virus of host immune response [GO:0030683]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]";"GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0030683; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902";"entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; evasion or tolerance by virus of host immune response [GO:0030683]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]";"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]"
comp2185530_c0_seq1;GAXK01072546.1;Q6JEL2;3.29E-07;KLH10_HUMAN;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp218561_c2_seq1;GAXK01163461.1;Q18297;4.77E-114;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp2185621_c0_seq1;GAXK01072543.1;B3EWZ3;5.78E-33;CADN_ACRMI;Coadhesin (Fragment);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2187044_c0_seq1;GAXK01088696.1;Q7SY29;1.68E-111;G6PT3_DANRE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp218731_c0_seq1;GAXK01163429.1;Q568H3;6.64E-15;MD2L2_DANRE;Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0005819; GO:0007049; GO:0016035; GO:0033138; GO:0042177; GO:0042772; GO:0045893; GO:0051301; GO:1904667";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]";
comp2188_c0_seq1;GAXK01175644.1;Q7SXG4;0;SAE2_DANRE;SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2);"cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]";"GO:0005524; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032446; GO:0046872";"protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]";"cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]"
comp218816_c0_seq1;GAXK01163333.1;Q7KRI2;7.47E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2188203_c0_seq1;GAXK01189184.1;P01011;1.82E-10;AACT_HUMAN;Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less];"azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of endopeptidase activity [GO:0010951]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; regulation of lipid metabolic process [GO:0019216]";"GO:0002576; GO:0003677; GO:0004867; GO:0005576; GO:0005615; GO:0005634; GO:0006953; GO:0006954; GO:0010951; GO:0019216; GO:0030277; GO:0031093; GO:0034774; GO:0035578; GO:0043312; GO:0062023; GO:0070062; GO:0072562";"acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of endopeptidase activity [GO:0010951]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; regulation of lipid metabolic process [GO:0019216]";"azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]";"DNA binding [GO:0003677]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp2188287_c0_seq1;GAXK01189171.1;U3NEE3;2.05E-14;HNMTL_CHICK;Carnosine N-methyltransferase 2 (EC 2.1.1.22) (Histamine N-methyltransferase-like) (HNMT-like);"neuron projection [GO:0043005]; carnosine N-methyltransferase activity [GO:0030735]; histamine N-methyltransferase activity [GO:0046539]; brain development [GO:0007420]; carnosine metabolic process [GO:0035498]; methylation [GO:0032259]";"GO:0007420; GO:0030735; GO:0032259; GO:0035498; GO:0043005; GO:0046539";"brain development [GO:0007420]; carnosine metabolic process [GO:0035498]; methylation [GO:0032259]";neuron projection [GO:0043005];"carnosine N-methyltransferase activity [GO:0030735]; histamine N-methyltransferase activity [GO:0046539]"
comp2188322_c0_seq1;GAXK01189180.1;Q5R8S4;6.26E-25;ERLEC_PONAB;Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin);"endoplasmic reticulum lumen [GO:0005788]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005788; GO:0030433";ubiquitin-dependent ERAD pathway [GO:0030433];endoplasmic reticulum lumen [GO:0005788];
comp218936_c3_seq1;GAXK01163285.1;P10076;4.25E-37;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp21894_c0_seq1;GAXK01031788.1;P06754;8.02E-21;TPM1_DROME;Tropomyosin-1, isoforms 9A/A/B (Cytoskeletal tropomyosin) (Tropomyosin II);"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019901; GO:0030017; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865";"actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]";"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]"
comp2189648_c0_seq1;GAXK01189170.1;Q8MQS8;8.75E-12;SP34_APIME;Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp218974_c1_seq1;GAXK01163397.1;Q9FKD5;1.38E-07;SINL9_ARATH;Putative E3 ubiquitin-protein ligase SINA-like 9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 9) (Seven in absentia-like protein 9);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2189800_c0_seq1;GAXK01189166.1;O35929;2.42E-13;REM1_MOUSE;GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2190141_c0_seq1;GAXK01055572.1;Q11186;4.14E-56;PLPL2_CAEEL;Patanin-like phospholipase domain-containing protein (EC 3.1.1.3) (Adipose triglyceride lipase 1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0016020; GO:0016021; GO:0019433; GO:0055088";"lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp219040_c0_seq1;GAXK01163295.1;Q3V2Q8;6.25E-40;N42L1_MOUSE;NEDD4-binding protein 2-like 1;;;;;
comp2190472_c0_seq1;GAXK01055573.1;Q9Y466;5.25E-13;NR2E1_HUMAN;Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (hTll);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367]; visual perception [GO:0007601]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0003700; GO:0003707; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0007399; GO:0007601; GO:0008270; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0048856; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:2000178; GO:2000179; GO:2000648";"aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367]; visual perception [GO:0007601]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2190841_c0_seq1;GAXK01055574.1;Q8SWD4;6.58E-15;UBIQ_ENCCU;Ubiquitin;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp219087_c0_seq1;GAXK01163444.1;P0DPW5;1.04E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp2190993_c0_seq1;GAXK01055578.1;Q9W1M8;3.31E-27;ITA5_DROME;Integrin alpha-PS5 (Position-specific antigen subunit alpha-5);"integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; protein heterodimerization activity [GO:0046982]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; oocyte growth [GO:0001555]";"GO:0001555; GO:0007157; GO:0007160; GO:0007229; GO:0008305; GO:0016021; GO:0033627; GO:0046982";"cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; oocyte growth [GO:0001555]";"integral component of membrane [GO:0016021]; integrin complex [GO:0008305]";protein heterodimerization activity [GO:0046982]
comp2191297_c0_seq1;GAXK01055575.1;P0DJ22;9.48E-28;RL35A_TETTS;60S ribosomal protein L35a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]";"GO:0000049; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp21916_c0_seq1;GAXK01031816.1;P52899;3.52E-151;ODPA_CAEEL;Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096";"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]
comp2191988_c0_seq1;GAXK01055570.1;O74467;1.12E-08;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2192255_c1_seq1;GAXK01158846.1;Q4UMH6;2.92E-22;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp219234_c0_seq1;GAXK01163366.1;Q9EQZ7;2.72E-59;RIMS2_MOUSE;Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2);"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]";"GO:0006886; GO:0007269; GO:0010628; GO:0016081; GO:0016082; GO:0017137; GO:0017156; GO:0017157; GO:0019904; GO:0019933; GO:0030054; GO:0030073; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0045202; GO:0046872; GO:0046982; GO:0048167; GO:0048788; GO:0048791; GO:0050806; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:1903861; GO:2000300; GO:2000463";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cAMP-mediated signaling [GO:0019933]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]";"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]";"ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]"
comp2192534_c0_seq1;GAXK01158839.1;Q3E813;1.84E-07;YL154_YEAST;Uncharacterized protein YLR154C-G;;;;;
comp2192569_c0_seq1;GAXK01158840.1;Q6DHG0;4.29E-39;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2192599_c0_seq1;GAXK01158838.1;O01404;1.55E-40;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp219260_c0_seq1;GAXK01163428.1;Q8C6G1;1.48E-51;CF410_MOUSE;Cilia- and flagella-associated protein 410;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"GO:0001750; GO:0005737; GO:0005739; GO:0005886; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0042769; GO:0060271; GO:0097733";"cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]";
comp21929_c2_seq1;GAXK01031390.1;Q9VCP0;2.82E-40;ELOA1_DROME;Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA);"elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449";"imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]";
comp219295_c0_seq1;GAXK01163408.1;Q9H867;1.48E-33;MT21D_HUMAN;Protein-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";"GO:0005737; GO:0005829; GO:0006479; GO:0016279; GO:0018022; GO:0018023; GO:0032780; GO:0032991; GO:0051117";"negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]";"ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp219316_c0_seq1;GAXK01163384.1;P05549;7.89E-110;AP2A_HUMAN;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0003404; GO:0003409; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0006357; GO:0007605; GO:0008285; GO:0010628; GO:0010842; GO:0010944; GO:0021559; GO:0021623; GO:0030501; GO:0035115; GO:0042472; GO:0042803; GO:0043066; GO:0043231; GO:0043525; GO:0043565; GO:0044212; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048701; GO:0060021; GO:0060349; GO:0061029; GO:0070172; GO:0071281; GO:2000378";"bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp219334_c1_seq1;GAXK01163274.1;D4A770;1.01E-121;CL004_RAT;Protein C12orf4 homolog;"cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304]";"GO:0005737; GO:0043304";regulation of mast cell degranulation [GO:0043304];cytoplasm [GO:0005737];
comp219397_c1_seq1;GAXK01163407.1;E9QAG8;7.40E-11;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp219420_c1_seq1;GAXK01163401.1;A1ZAI5;2.34E-144;FACR1_DROME;Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965";"ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]"
comp219443_c0_seq1;GAXK01163362.1;A0NLY7;2.42E-15;ISAHY_LABAI;Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b);"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0004061; GO:0016812; GO:0019441; GO:0030145";tryptophan catabolic process to kynurenine [GO:0019441];;"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]"
comp21948_c1_seq1;GAXK01032156.1;Q28623;5.18E-45;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp219490_c0_seq1;GAXK01163404.1;Q3UKY7;2.00E-22;PRS38_MOUSE;Serine protease 38 (EC 3.4.21.-) (Marapsin-2);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp219507_c0_seq1;GAXK01163447.1;Q80UG8;3.95E-82;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp2195313_c0_seq1;GAXK01049248.1;Q9X248;1.52E-18;FABG_THEMA;3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase);"3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]";"GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132";fatty acid elongation [GO:0030497];;"3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp219538_c0_seq1;GAXK01163441.1;Q08180;5.21E-79;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp21955_c1_seq1;GAXK01031396.1;O94952;1.55E-12;FBX21_HUMAN;F-box only protein 21;"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0003677; GO:0004842; GO:0005829; GO:0006511; GO:0043687";"post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]";"DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]"
comp219562_c2_seq1;GAXK01163335.1;Q6ZNW5;3.63E-50;GDPP1_HUMAN;GDP-D-glucose phosphorylase 1 (EC 2.7.7.78);"cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]";"GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048";glucose metabolic process [GO:0006006];cytoplasm [GO:0005737];"GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]"
comp2195853_c0_seq1;GAXK01049252.1;O88870;5.07E-15;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp2195888_c0_seq1;GAXK01049243.1;P14133;9.92E-19;ASO_CUCSA;L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]";"GO:0005507; GO:0005576; GO:0008447";;extracellular region [GO:0005576];"copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]"
comp219604_c0_seq1;GAXK01163426.1;Q5RAA9;2.60E-25;NPS3A_PONAB;Protein NipSnap homolog 3A (NipSnap3A);cytosol [GO:0005829];GO:0005829;;cytosol [GO:0005829];
comp219612_c1_seq1;GAXK01163406.1;Q5ZKE5;1.57E-27;CAB45_CHICK;45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4);"endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; calcium ion binding [GO:0005509]; calcium-ion regulated exocytosis [GO:0017156]; fat cell differentiation [GO:0045444]";"GO:0005509; GO:0005770; GO:0005783; GO:0005796; GO:0017156; GO:0045444";"calcium-ion regulated exocytosis [GO:0017156]; fat cell differentiation [GO:0045444]";"endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]";calcium ion binding [GO:0005509]
comp21962_c0_seq1;GAXK01032120.1;Q96NC0;5.26E-61;ZMAT2_HUMAN;Zinc finger matrin-type protein 2;"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003677; GO:0005634; GO:0008270; GO:0046540; GO:0071005";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp21971_c0_seq1;GAXK01031395.1;Q28GD9;1.62E-34;RNH2B_XENTR;Ribonuclease H2 subunit B (RNase H2 subunit B) (Ribonuclease HI subunit B);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; ribonucleotide metabolic process [GO:0009259]; RNA catabolic process [GO:0006401]";"GO:0004523; GO:0005634; GO:0005654; GO:0006401; GO:0009259; GO:0032299";"ribonucleotide metabolic process [GO:0009259]; RNA catabolic process [GO:0006401]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]";RNA-DNA hybrid ribonuclease activity [GO:0004523]
comp2197536_c0_seq1;GAXK01194365.1;Q3TN34;1.17E-27;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp219830_c5_seq1;GAXK01163423.1;Q3B7T1;6.27E-54;EDRF1_HUMAN;Erythroid differentiation-related factor 1;"nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0045893";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];
comp2198314_c0_seq1;GAXK01170789.1;P45856;3.90E-19;HBD_BACSU;Probable 3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD);"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]; butyrate metabolic process [GO:0019605]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0003857; GO:0008691; GO:0019605; GO:0030435; GO:0070403";"butyrate metabolic process [GO:0019605]; sporulation resulting in formation of a cellular spore [GO:0030435]";;"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]"
comp21989_c0_seq1;GAXK01031996.1;P05661;3.54E-86;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2199218_c0_seq1;GAXK01170769.1;Q23369;8.29E-07;BST22_CAEEL;Bestrophin homolog 22;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp219954_c2_seq1;GAXK01163438.1;Q9VZS6;1.99E-61;NSMA_DROME;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp2199751_c0_seq1;GAXK01170785.1;Q14CZ7;7.46E-22;FAKD3_HUMAN;FAST kinase domain-containing protein 3, mitochondrial;"mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]";"GO:0003723; GO:0004672; GO:0005634; GO:0005739; GO:0033617; GO:0044528; GO:0070131";"mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"protein kinase activity [GO:0004672]; RNA binding [GO:0003723]"
comp22_c0_seq1;GAXK01168565.1;O70622;8.77E-20;RTN2_MOUSE;Reticulon-2 (Neuroendocrine-specific protein-like 1) (NSP-like protein 1) (Neuroendocrine-specific protein-like I) (NSP-like protein I) (NSPLI);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; intracellular protein transmembrane transport [GO:0065002]; regulation of glucose import [GO:0046324]";"GO:0005783; GO:0005789; GO:0014802; GO:0016021; GO:0030315; GO:0046324; GO:0065002";"intracellular protein transmembrane transport [GO:0065002]; regulation of glucose import [GO:0046324]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; terminal cisterna [GO:0014802]; T-tubule [GO:0030315]";
comp220022_c0_seq1;GAXK01110482.1;Q7SY29;4.54E-103;G6PT3_DANRE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp22007_c2_seq1;GAXK01011435.1;Q9VYV5;4.08E-173;FUT8_DROME;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]"
comp22008_c0_seq1;GAXK01011956.1;A1Z9X0;0;APKC_DROME;Atypical protein kinase C (EC 2.7.11.13);"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]";"GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0006468; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0018105; GO:0030011; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035556; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0046667; GO:0046872; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:1904580";"adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]";"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp2201196_c0_seq1;GAXK01179718.1;Q00519;1.53E-98;XDH_MOUSE;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]";"GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006150; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010044; GO:0010629; GO:0016491; GO:0016529; GO:0030151; GO:0030856; GO:0042803; GO:0043546; GO:0045602; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0055114; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp22014_c0_seq1;GAXK01012056.1;Q90ZA1;5.71E-161;PARN_XENLA;Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) (parn-A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402]";"GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006402; GO:0043169; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]"
comp2201625_c0_seq1;GAXK01179738.1;P24494;2.29E-20;RS19G_ASCSU;40S ribosomal protein S19G (Eliminated protein NO. 1);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp220168_c2_seq1;GAXK01110509.1;Q8BFR4;1.10E-107;GNS_MOUSE;N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S);"lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan metabolic process [GO:0030203]";"GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030203; GO:0043199; GO:0046872";glycosaminoglycan metabolic process [GO:0030203];lysosome [GO:0005764];"glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]"
comp220181_c0_seq1;GAXK01110312.1;Q9TW28;3.46E-19;MYOM_DICDI;Myosin-M heavy chain (RhoGEF domain-containing protein myoM);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microfilament motor activity [GO:0000146]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; pseudopodium organization [GO:0031268]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0000146; GO:0005524; GO:0005737; GO:0006971; GO:0006972; GO:0016461; GO:0016887; GO:0030676; GO:0031268; GO:0035020; GO:0035023; GO:0042995; GO:0051015";"hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; pseudopodium organization [GO:0031268]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Rho protein signal transduction [GO:0035023]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; unconventional myosin complex [GO:0016461]";"actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]"
comp22021_c1_seq1;GAXK01012071.1;Q9Y305;8.28E-83;ACOT9_HUMAN;Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]";"GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689";acyl-CoA metabolic process [GO:0006637];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]"
comp220248_c0_seq1;GAXK01110244.1;Q9VCA2;4.64E-74;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp2202529_c0_seq1;GAXK01189749.1;O15027;9.48E-15;SC16A_HUMAN;Protein transport protein Sec16A (SEC16 homolog A) (p250);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]";
comp2202575_c0_seq1;GAXK01189750.1;Q9ER10;2.32E-08;BSSP4_MOUSE;Brain-specific serine protease 4 (BSSP-4) (EC 3.4.21.-) (Serine protease 22) (Serine protease 26) (Tryptase epsilon);"anchored component of plasma membrane [GO:0046658]; extrinsic component of plasma membrane [GO:0019897]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0019897; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extrinsic component of plasma membrane [GO:0019897]";serine-type endopeptidase activity [GO:0004252]
comp2202822_c0_seq1;GAXK01189735.1;Q22566;6.77E-22;BST17_CAEEL;Bestrophin homolog 17;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2203281_c0_seq1;GAXK01189744.1;P18061;9.05E-34;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp22035_c0_seq1;GAXK01011221.1;Q7ZVX6;0;UBA3_DANRE;NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.-) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]";"GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0032446; GO:0045116";"protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]"
comp2203625_c0_seq1;GAXK01189746.1;B3EYM8;3.47E-13;IABN_GEOSE;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp2203876_c0_seq1;GAXK01189745.1;P07307;1.77E-15;ASGR2_HUMAN;Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2);"endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; bone mineralization [GO:0030282]; cell surface receptor signaling pathway [GO:0007166]; lipid homeostasis [GO:0055088]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; viral process [GO:0016032]";"GO:0004873; GO:0005886; GO:0007166; GO:0016021; GO:0016032; GO:0018279; GO:0030246; GO:0030282; GO:0031647; GO:0044322; GO:0048471; GO:0055088";"bone mineralization [GO:0030282]; cell surface receptor signaling pathway [GO:0007166]; lipid homeostasis [GO:0055088]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; viral process [GO:0016032]";"endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]"
comp2204174_c0_seq1;GAXK01104448.1;R4ZGN4;2.15E-37;XDH_BLAAD;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Xanthine oxidoreductase) (Axorp) (XOR);"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; cellular response to ammonium ion [GO:0071242]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to iron ion [GO:0071281]; cellular response to nitrate [GO:0071249]; cellular response to zinc ion [GO:0071294]; guanine catabolic process [GO:0006147]; hypoxanthine oxidation [GO:0006150]; purine nucleobase catabolic process [GO:0006145]; xanthine oxidation [GO:0006151]";"GO:0004854; GO:0005506; GO:0005737; GO:0006145; GO:0006147; GO:0006150; GO:0006151; GO:0009055; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071242; GO:0071249; GO:0071276; GO:0071280; GO:0071281; GO:0071294; GO:0071949";"cellular response to ammonium ion [GO:0071242]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to iron ion [GO:0071281]; cellular response to nitrate [GO:0071249]; cellular response to zinc ion [GO:0071294]; guanine catabolic process [GO:0006147]; hypoxanthine oxidation [GO:0006150]; purine nucleobase catabolic process [GO:0006145]; xanthine oxidation [GO:0006151]";cytoplasm [GO:0005737];"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]"
comp220444_c1_seq1;GAXK01110496.1;P41636;7.46E-56;4CL_PINTA;4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp22045_c1_seq1;GAXK01011924.1;Q9Y2L5;3.60E-131;TPPC8_HUMAN;Trafficking protein particle complex subunit 8 (Protein TRS85 homolog);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497]";"GO:0000045; GO:0000407; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0030242; GO:0031410; GO:0032258; GO:0034497; GO:1990072";"autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]";
comp2204536_c0_seq1;GAXK01104441.1;O96647;6.73E-100;RL10_BOMMA;60S ribosomal protein L10 (QM protein homolog);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp220465_c1_seq1;GAXK01110302.1;Q0KHU5;3.27E-47;PCAT_DROME;Lysophosphatidylcholine acyltransferase (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (Acyltransferase-like 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0008654; GO:0016021; GO:0030258; GO:0047184; GO:0071617";"lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]"
comp2204771_c0_seq1;GAXK01104466.1;P60204;2.69E-07;CALM_EMENI;Calmodulin (CaM);"central plaque of spindle pole body [GO:0005823]; hyphal tip [GO:0001411]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; regulation of cell cycle [GO:0051726]; spindle pole body organization [GO:0051300]; spore germination [GO:0009847]";"GO:0001411; GO:0005509; GO:0005823; GO:0009847; GO:0019722; GO:0051300; GO:0051726";"calcium-mediated signaling [GO:0019722]; regulation of cell cycle [GO:0051726]; spindle pole body organization [GO:0051300]; spore germination [GO:0009847]";"central plaque of spindle pole body [GO:0005823]; hyphal tip [GO:0001411]";calcium ion binding [GO:0005509]
comp2204954_c1_seq1;GAXK01104456.1;P42264;1.54E-22;GRIK3_RAT;Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0007268; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:1904315";"chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp220496_c0_seq1;GAXK01110286.1;Q9JM83;1.74E-07;CALM4_MOUSE;Calmodulin-4 (Calcium-binding protein Dd112);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0005509; GO:0019722; GO:1990830";"calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]";;calcium ion binding [GO:0005509]
comp2205033_c0_seq1;GAXK01104468.1;Q80XH4;2.01E-15;WSCD1_MOUSE;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp220511_c1_seq1;GAXK01110248.1;Q5PNP1;6.02E-45;SNX14_DANRE;Sorting nexin-14;"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902]";"GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0016021; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0080025; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]
comp2205142_c0_seq1;GAXK01104459.1;Q27963;1.50E-92;VMAT2_BOVIN;Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2);"chromaffin granule [GO:0042583]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; monoamine transmembrane transporter activity [GO:0008504]; organic cyclic compound binding [GO:0097159]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; neurotransmitter transport [GO:0006836]; response to potassium ion [GO:0035864]";"GO:0005335; GO:0005887; GO:0006836; GO:0008504; GO:0015842; GO:0030672; GO:0035864; GO:0042583; GO:0042910; GO:0043195; GO:0097159";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; neurotransmitter transport [GO:0006836]; response to potassium ion [GO:0035864]";"chromaffin granule [GO:0042583]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"monoamine transmembrane transporter activity [GO:0008504]; organic cyclic compound binding [GO:0097159]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp2205765_c0_seq1;GAXK01104469.1;Q8BY79;4.20E-15;S35G1_MOUSE;Solute carrier family 35 member G1 (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp22058_c2_seq1;GAXK01011995.1;Q15582;9.53E-35;BGH3_HUMAN;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0044267; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]"
comp220589_c5_seq1;GAXK01110342.1;P98157;0;LRP1_CHICK;Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005905; GO:0016021; GO:0016964";;"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]";"alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]"
comp220592_c0_seq1;GAXK01110472.1;Q9Y2G3;0;AT11B_HUMAN;Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B);"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326";"aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]"
comp2206058_c0_seq1;GAXK01156590.1;P0C548;8.86E-61;PLPL2_RAT;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0055088";"lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp2206160_c0_seq1;GAXK01156597.1;Q9SMI3;7.26E-54;RS12_CYAPA;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2206693_c0_seq1;GAXK01156587.1;Q28181;2.11E-81;CNGB1_BOVIN;Cyclic nucleotide-gated cation channel beta-1 (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0005737; GO:0007601; GO:0007608; GO:0010628; GO:0016021; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0050896; GO:0051289";"positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]"
comp22071_c4_seq1;GAXK01011252.1;P37225;1.48E-107;MAON_SOLTU;NAD-dependent malic enzyme 59 kDa isoform, mitochondrial (NAD-ME) (EC 1.1.1.39);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; malate metabolic process [GO:0006108]";"GO:0004471; GO:0005524; GO:0005759; GO:0006108; GO:0008270; GO:0042803; GO:0050897; GO:0051287";malate metabolic process [GO:0006108];mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp2207153_c0_seq1;GAXK01156605.1;E9Q555;1.82E-25;RN213_MOUSE;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp2207299_c0_seq1;GAXK01156588.1;A5D8V7;1.01E-07;CC151_HUMAN;Coiled-coil domain-containing protein 151;"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]";"GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0036064; GO:0036158; GO:1902017";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]";"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]";
comp220768_c0_seq1;GAXK01110287.1;O34313;5.66E-35;NTPES_BACSU;"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]";"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005576; GO:0005618; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872";nucleotide catabolic process [GO:0009166];"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]";"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp220777_c0_seq1;GAXK01110515.1;W4VS53;1.26E-52;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp220789_c0_seq1;GAXK01110303.1;Q27433;1.10E-114;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp220795_c1_seq1;GAXK01110543.1;P36898;3.22E-157;BMR1B_MOUSE;Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (Activin receptor-like kinase 6) (ALK-6) (Serine/threonine-protein kinase receptor R6) (SKR6) (CD antigen CDw293);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"GO:0001501; GO:0001502; GO:0001550; GO:0001654; GO:0002062; GO:0002063; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0006703; GO:0006954; GO:0007178; GO:0007179; GO:0007389; GO:0009953; GO:0019838; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0035108; GO:0042698; GO:0043010; GO:0043025; GO:0043235; GO:0045597; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:1902043; GO:1902731";"BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"
comp220817_c0_seq1;GAXK01110305.1;Q8T8R1;1.06E-21;Y3800_DROME;CCHC-type zinc finger protein CG3800;"cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]";"GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767";positive regulation of cytoplasmic translation [GO:2000767];cytoplasm [GO:0005737];"mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]"
comp22082_c0_seq1;GAXK01011958.1;Q4H2R2;1.46E-11;SSRP1_CIOIN;FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Structure-specific recognition protein 1);"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]"
comp220850_c0_seq1;GAXK01110522.1;Q9FM14;1.24E-08;SIL11_ARATH;E3 ubiquitin-protein ligase SINA-like 11 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 11) (Seven in absentia-like protein 11);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp220852_c0_seq1;GAXK01110479.1;Q6IV72;2.40E-16;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2208990_c0_seq1;GAXK01138912.1;P02594;1.25E-55;CALM_ELEEL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp220900_c1_seq1;GAXK01110512.1;Q9DAK9;3.32E-08;PHP14_MOUSE;14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP);"cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249]";"GO:0005829; GO:0006470; GO:0019855; GO:0035774; GO:0035971; GO:0044325; GO:0050860; GO:0051350; GO:0101006; GO:2000147; GO:2000249; GO:2000984";"negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249]";cytosol [GO:0005829];"calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]"
comp2209189_c0_seq1;GAXK01138911.1;Q9C4Z6;1.09E-07;GPLPB_ARATH;Receptor for activated C kinase 1B (Guanine nucleotide-binding protein subunit beta-like protein B);"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; enzyme binding [GO:0019899]; MAP-kinase scaffold activity [GO:0005078]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cellular response to abscisic acid stimulus [GO:0071215]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome biogenesis [GO:0042254]; root development [GO:0048364]; seed germination [GO:0009845]; shoot system development [GO:0048367]; signal transduction [GO:0007165]";"GO:0001934; GO:0003735; GO:0005078; GO:0005080; GO:0005634; GO:0005829; GO:0006417; GO:0007165; GO:0009845; GO:0009967; GO:0019899; GO:0022626; GO:0022627; GO:0042254; GO:0042788; GO:0043022; GO:0048364; GO:0048367; GO:0071215; GO:0072344";"cellular response to abscisic acid stimulus [GO:0071215]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome biogenesis [GO:0042254]; root development [GO:0048364]; seed germination [GO:0009845]; shoot system development [GO:0048367]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]";"enzyme binding [GO:0019899]; MAP-kinase scaffold activity [GO:0005078]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]"
comp220922_c2_seq1;GAXK01110431.1;Q96PH1;3.18E-73;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp220932_c1_seq1;GAXK01110271.1;Q86WU2;0;LDHD_HUMAN;Probable D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.2.4);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457]";"GO:0004458; GO:0005739; GO:0005743; GO:0008720; GO:0050660; GO:0071949; GO:1903457";lactate catabolic process [GO:1903457];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]"
comp220935_c1_seq1;GAXK01110304.1;P40797;4.14E-125;PNUT_DROME;Protein peanut;"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"GO:0000281; GO:0003779; GO:0003924; GO:0005525; GO:0005739; GO:0005886; GO:0005940; GO:0006915; GO:0007349; GO:0008017; GO:0015630; GO:0016324; GO:0031105; GO:0031625; GO:0032154; GO:0042803; GO:0043065; GO:0045171; GO:0045572; GO:0060271; GO:0061640; GO:0070938";"apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp22094_c0_seq1;GAXK01011486.1;Q9ERG2;5.20E-151;STRN3_MOUSE;Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]";"GO:0000122; GO:0003700; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0017048; GO:0030425; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443";"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; Rho GTPase binding [GO:0017048]"
comp220943_c2_seq1;GAXK01110261.1;Q9NUV9;2.96E-07;GIMA4_HUMAN;GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4);"cytosol [GO:0005829]; GTP binding [GO:0005525]";"GO:0005525; GO:0005829";;cytosol [GO:0005829];GTP binding [GO:0005525]
comp2209744_c0_seq1;GAXK01138930.1;P83088;9.82E-36;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp2209777_c0_seq1;GAXK01138918.1;P52905;1.83E-07;TRYI_DROME;Trypsin iota (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0008236";proteolysis [GO:0006508];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp22098_c1_seq1;GAXK01011783.1;Q9VC99;3.24E-98;UCK_DROME;Uridine-cytidine kinase (UCK) (EC 2.7.1.48) (Cytidine monophosphokinase) (Uridine monophosphokinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp2209877_c0_seq1;GAXK01138916.1;Q6GNS1;1.88E-16;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp2209911_c0_seq1;GAXK01138927.1;Q6DHG0;6.51E-28;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp221_c4_seq1;GAXK01169538.1;P09180;2.58E-171;RL4_DROME;60S ribosomal protein L4 (L1);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp2210094_c0_seq1;GAXK01090459.1;Q25074;6.16E-15;AQP_HAEIX;Aquaporin (BfWC1) (Water channel 1);"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp221029_c0_seq1;GAXK01110444.1;Q06985;3.12E-08;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp221041_c0_seq1;GAXK01110256.1;O75525;2.01E-49;KHDR3_HUMAN;KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2) (SLM-2) (Sam68-like phosphotyrosine protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0042802; GO:0048024; GO:0051259";"mRNA processing [GO:0006397]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp22107_c8_seq1;GAXK01011192.1;Q8BJ34;3.84E-137;MARF1_MOUSE;Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0043231; GO:0048477";"double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777]";RNA binding [GO:0003723]
comp2210769_c0_seq1;GAXK01090464.1;Q5U3U0;2.31E-11;PHYD1_DANRE;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp2210868_c0_seq1;GAXK01090443.1;Q7ZX06;6.60E-23;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp221091_c0_seq1;GAXK01110544.1;Q8R081;1.57E-66;HNRPL_MOUSE;Heterogeneous nuclear ribonucleoprotein L (hnRNP L);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0034198; GO:0035770; GO:0044212; GO:0045120; GO:0045727; GO:0048025; GO:0048471; GO:0097157; GO:1902416; GO:1990715; GO:1990904";"cellular response to amino acid starvation [GO:0034198]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]";"mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]"
comp2210947_c0_seq1;GAXK01090440.1;Q80YN4;8.30E-27;CORIN_RAT;"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Pro-ANP-converting enzyme) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";"GO:0003050; GO:0004252; GO:0005044; GO:0005576; GO:0005887; GO:0007565; GO:0008217; GO:0016486; GO:0031410; GO:0035813";"female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp22111_c2_seq1;GAXK01011484.1;Q28F39;3.18E-22;CC134_XENTR;Coiled-coil domain-containing protein 134;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]";"GO:0005576; GO:0005634; GO:0005783";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]";
comp2211447_c0_seq1;GAXK01090458.1;P70398;9.50E-08;USP9X_MOUSE;Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets homolog) (Fat facets protein-related, X-linked) (Ubiquitin carboxyl-terminal hydrolase FAM) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001701; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0009791; GO:0016579; GO:0021698; GO:0021766; GO:0030426; GO:0030509; GO:0031625; GO:0036459; GO:0042752; GO:0045177; GO:0048511; GO:0048675; GO:0050821; GO:0050856; GO:0051301; GO:0070410; GO:0071560; GO:0071947; GO:0101005; GO:1901537; GO:1990138; GO:1990380";"axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]";"co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]"
comp2211608_c0_seq1;GAXK01090455.1;Q7KRI2;1.46E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2211773_c0_seq1;GAXK01090444.1;Q6P6Z0;6.32E-25;DDB1_XENLA;DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008";"DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp2211846_c0_seq1;GAXK01090446.1;G5CTG8;1.26E-11;AQP11_MILTA;Aquaporin-11 (AQP-11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp221185_c0_seq1;GAXK01110265.1;Q9D529;1.04E-07;WBP2L_MOUSE;Postacrosomal sheath WW domain-binding protein (WW domain-binding protein 2-like);"nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]; egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]";"GO:0003713; GO:0005634; GO:0007343; GO:0031490; GO:0033011; GO:0035038; GO:0035039; GO:0036126; GO:0050699; GO:0061827";"egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]";"nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]";"chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]"
comp2212114_c0_seq1;GAXK01137005.1;Q9VZW5;5.38E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp221223_c1_seq1;GAXK01110306.1;Q96IG2;3.61E-176;FXL20_HUMAN;F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001662; GO:0005829; GO:0006511; GO:0019005; GO:0031146; GO:0043687; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300";"behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]";
comp2212240_c0_seq1;GAXK01136982.1;Q868Z9;1.63E-16;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp2212598_c0_seq1;GAXK01136979.1;Q68CL5;2.49E-49;TPGS2_HUMAN;Tubulin polyglutamylase complex subunit 2 (PGs2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; protein polyglutamylation [GO:0018095]";"GO:0005737; GO:0005874; GO:0018095";protein polyglutamylation [GO:0018095];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";
comp22126_c0_seq1;GAXK01011882.1;P54359;0;SEPT2_DROME;Septin-2;"microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]";"GO:0000281; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0042803; GO:0051726; GO:0061640";"cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]";"microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803]"
comp2212687_c0_seq1;GAXK01136976.1;Q8C761;8.55E-75;WDR60_MOUSE;WD repeat-containing protein 60;"centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018]";"GO:0000242; GO:0000922; GO:0005813; GO:0005868; GO:0005929; GO:0007018; GO:0031021; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097546";"cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018]";"centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]"
comp2213066_c0_seq1;GAXK01136966.1;Q07014;9.21E-52;LYN_RAT;Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn);"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; mast cell granule [GO:0042629]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001782; GO:0001817; GO:0001933; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002902; GO:0004713; GO:0004715; GO:0005102; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005794; GO:0005886; GO:0005913; GO:0006974; GO:0006991; GO:0007169; GO:0008284; GO:0008285; GO:0009636; GO:0009725; GO:0009743; GO:0010976; GO:0014003; GO:0014069; GO:0014070; GO:0016020; GO:0016301; GO:0017124; GO:0019899; GO:0030061; GO:0030154; GO:0030218; GO:0030335; GO:0030889; GO:0031175; GO:0031234; GO:0031625; GO:0031663; GO:0031668; GO:0031966; GO:0032868; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038083; GO:0042327; GO:0042493; GO:0042531; GO:0042629; GO:0043015; GO:0043200; GO:0043208; GO:0043304; GO:0043407; GO:0043434; GO:0043552; GO:0044325; GO:0044877; GO:0045087; GO:0045121; GO:0045646; GO:0046875; GO:0048471; GO:0048678; GO:0050663; GO:0050707; GO:0050727; GO:0050853; GO:0050855; GO:0051219; GO:0051279; GO:0060252; GO:0060369; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0098978; GO:0099091; GO:0140031; GO:1902532; GO:1902961; GO:2000670";"adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; mast cell granule [GO:0042629]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]"
comp2213146_c0_seq1;GAXK01136987.1;P05095;4.57E-18;ACTNA_DICDI;Alpha-actinin A (Actin-binding protein A) (F-actin cross-linking protein);"actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; contractile vacuole [GO:0000331]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; macropinocytic cup [GO:0070685]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; protein binding, bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cell motility [GO:0048870]; cellular response to starvation [GO:0009267]; hyperosmotic response [GO:0006972]; multicellular organism development [GO:0007275]; phagocytosis [GO:0006909]; sorocarp development [GO:0030587]";"GO:0000331; GO:0005200; GO:0005509; GO:0005829; GO:0005884; GO:0005938; GO:0006909; GO:0006972; GO:0007275; GO:0009267; GO:0030587; GO:0030674; GO:0031012; GO:0031143; GO:0031252; GO:0045335; GO:0048870; GO:0051015; GO:0051017; GO:0051764; GO:0070685";"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cell motility [GO:0048870]; cellular response to starvation [GO:0009267]; hyperosmotic response [GO:0006972]; multicellular organism development [GO:0007275]; phagocytosis [GO:0006909]; sorocarp development [GO:0030587]";"actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; contractile vacuole [GO:0000331]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; macropinocytic cup [GO:0070685]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; protein binding, bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]"
comp2213481_c0_seq1;GAXK01136992.1;Q9ESV0;3.37E-09;DDX24_MOUSE;ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp221352_c0_seq1;GAXK01110445.1;Q24040;4.29E-63;BGB_DROME;Protein big brother;"core-binding factor complex [GO:0016513]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0008134; GO:0016513; GO:0035206; GO:0046982";"regulation of hemocyte proliferation [GO:0035206]; regulation of transcription by RNA polymerase II [GO:0006357]";"core-binding factor complex [GO:0016513]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]"
comp2213705_c0_seq1;GAXK01137006.1;P48613;1.20E-18;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp2214035_c0_seq1;GAXK01021453.1;Q7M4E9;6.01E-17;CUD3_SCHGR;Endocuticle structural glycoprotein SgAbd-3;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp221442_c0_seq1;GAXK01110277.1;Q13247;5.60E-15;SRSF6_HUMAN;Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]";"GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006376; GO:0006405; GO:0006406; GO:0010837; GO:0016607; GO:0031124; GO:0032868; GO:0036002; GO:0045292; GO:0045617; GO:0048025; GO:0060501; GO:0060548; GO:0061041; GO:2000675";"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]"
comp22146_c1_seq1;GAXK01012070.1;Q99PD4;8.41E-143;ARC1A_RAT;Actin-related protein 2/3 complex subunit 1A;"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0051015";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin filament binding [GO:0051015]
comp2214795_c0_seq1;GAXK01021446.1;O88178;2.53E-13;B3GT4_RAT;Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; ganglioside galactosyltransferase activity [GO:0047915]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0008376; GO:0016021; GO:0047915";protein glycosylation [GO:0006486];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; ganglioside galactosyltransferase activity [GO:0047915]"
comp2214944_c0_seq1;GAXK01021474.1;Q08BJ2;6.82E-43;KHDR2_DANRE;KH domain-containing, RNA-binding, signal transduction-associated protein 2;"nucleus [GO:0005634]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0005634; GO:0006397; GO:0008143; GO:0017124; GO:0048024";"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]";nucleus [GO:0005634];"poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp2214989_c0_seq1;GAXK01205109.1;Q6R7M4;3.27E-87;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp2215218_c0_seq1;GAXK01021476.1;Q27367;5.24E-19;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp2215557_c0_seq1;GAXK01021460.1;Q9DE09;1.01E-34;HMX1_CHICK;Homeobox protein HMX1 (GH6) (Homeobox protein H6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0007275; GO:0043565; GO:0045892";"multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";nucleus [GO:0005634];"DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565]"
comp2215600_c0_seq1;GAXK01021452.1;Q08180;3.24E-76;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp221576_c2_seq1;GAXK01110492.1;B2D0J5;1.23E-65;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp2215983_c0_seq1;GAXK01021463.1;Q8IYR2;3.87E-11;SMYD4_HUMAN;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp221601_c0_seq1;GAXK01110282.1;Q501J6;0;DDX17_MOUSE;Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]";"GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010586; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:1990904; GO:2001014";"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]"
comp2216064_c0_seq1;GAXK01101572.1;Q86XH1;6.07E-100;DRC11_HUMAN;Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1);"axoneme [GO:0005930]; motile cilium [GO:0031514]; ATP binding [GO:0005524]";"GO:0005524; GO:0005930; GO:0031514";;"axoneme [GO:0005930]; motile cilium [GO:0031514]";ATP binding [GO:0005524]
comp2216307_c0_seq1;GAXK01101581.1;Q8CFE4;2.98E-87;SCYL2_MOUSE;SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa);"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370";"endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]"
comp221683_c2_seq1;GAXK01110478.1;O17040;2.21E-48;HACD_CAEEL;Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase hpo-8 (EC 4.2.1.134) (Probable 3-hydroxyacyl-CoA dehydratase);"integral component of membrane [GO:0016021]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0016021; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345";"fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of membrane [GO:0016021];"3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]"
comp221687_c2_seq1;GAXK01110548.1;O76463;2.69E-129;NFT1_CAEEL;"Nitrilase and fragile histidine triad fusion protein NitFhit [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]";"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]";"GO:0000166; GO:0006139; GO:0016810; GO:0047710";nucleobase-containing compound metabolic process [GO:0006139];;"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]"
comp221703_c0_seq1;GAXK01110429.1;Q7TS68;8.83E-98;NSUN6_MOUSE;Putative methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6);"cytoplasm [GO:0005737]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]";"GO:0000049; GO:0005737; GO:0016428";;cytoplasm [GO:0005737];"tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]"
comp221733_c1_seq1;GAXK01110464.1;Q27960;2.42E-25;NPT2B_BOVIN;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341]";"GO:0005436; GO:0005886; GO:0005903; GO:0006817; GO:0015321; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341";"cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"phosphate ion binding [GO:0042301]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium ion binding [GO:0031402]"
comp22176_c0_seq1;GAXK01011575.1;Q9H3K6;3.21E-24;BOLA2_HUMAN;BolA-like protein 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; [2Fe-2S] cluster assembly [GO:0044571]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"GO:0005634; GO:0005737; GO:0005829; GO:0035722; GO:0044571; GO:0097428";"[2Fe-2S] cluster assembly [GO:0044571]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp2217619_c0_seq1;GAXK01101569.1;Q86UD5;2.05E-23;SL9B2_HUMAN;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]"
comp2218091_c0_seq1;GAXK01011065.1;Q9HAZ2;1.72E-09;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp221815_c0_seq1;GAXK01110539.1;A1Z6E0;5.02E-92;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp2218198_c0_seq1;GAXK01011044.1;Q4V8C9;2.27E-15;LRC56_RAT;Leucine-rich repeat-containing protein 56;"cilium [GO:0005929]; cell projection organization [GO:0030030]";"GO:0005929; GO:0030030";cell projection organization [GO:0030030];cilium [GO:0005929];
comp2218211_c0_seq1;GAXK01011055.1;Q9FF52;1.03E-44;RL123_ARATH;60S ribosomal protein L12-3;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plastid [GO:0009536]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005829; GO:0006412; GO:0009536; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plastid [GO:0009536]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2218248_c0_seq1;GAXK01011054.1;B0WC46;2.59E-37;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2218327_c0_seq1;GAXK01011057.1;Q8NE01;2.12E-20;CNNM3_HUMAN;Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0005886; GO:0006811; GO:0016020; GO:0016021; GO:0022857";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp22184_c2_seq1;GAXK01011312.1;Q16S14;0;EFGM_AEDAE;Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1);"mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]";"GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125";mitochondrial translational elongation [GO:0070125];mitochondrion [GO:0005739];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp221868_c1_seq1;GAXK01110311.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp2218744_c0_seq1;GAXK01011047.1;Q9QUQ5;8.30E-23;TRPC4_MOUSE;Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4);"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005911; GO:0006816; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034703; GO:0034704; GO:0045121; GO:0045296; GO:0048709; GO:0051480; GO:0051924; GO:0070509; GO:0070588; GO:0070679";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480]";"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp221878_c0_seq1;GAXK01110341.1;P55011;0;S12A2_HUMAN;Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transport [GO:0015696]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; ion transport [GO:0006811]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]";"GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0010818; GO:0015081; GO:0015378; GO:0015379; GO:0015696; GO:0016020; GO:0016324; GO:0019901; GO:0030321; GO:0035725; GO:0045795; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:0070634; GO:1902476; GO:1903561; GO:1990573; GO:1990869";"aging [GO:0007568]; ammonium transport [GO:0015696]; cellular response to chemokine [GO:1990869]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; ion transport [GO:0006811]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp2218782_c0_seq1;GAXK01011063.1;P22933;2.04E-26;GBRD_MOUSE;Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098978; GO:0098982; GO:0099055; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp22188_c2_seq1;GAXK01011160.1;P37198;5.46E-64;NUP62_HUMAN;Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62);"annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; host cell [GO:0043657]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex adaptor activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; hormone-mediated signaling pathway [GO:0009755]; intracellular transport of virus [GO:0075733]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000922; GO:0003682; GO:0005543; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005813; GO:0006110; GO:0006351; GO:0006406; GO:0006409; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0007569; GO:0008219; GO:0008285; GO:0009755; GO:0009966; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0043657; GO:0044613; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0046966; GO:0051425; GO:0051879; GO:0060236; GO:0060964; GO:0070208; GO:0072686; GO:0075733; GO:0090543; GO:0098534; GO:1900034; GO:1903438; GO:1904781; GO:1990904";"cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; hormone-mediated signaling pathway [GO:0009755]; intracellular transport of virus [GO:0075733]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; host cell [GO:0043657]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex adaptor activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]"
comp2218809_c0_seq1;GAXK01011060.1;Q1RJR6;1.73E-15;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp221910_c0_seq1;GAXK01110447.1;P78563;9.01E-32;RED1_HUMAN;Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0044387; GO:0045070; GO:0045087; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049";"adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp221930_c0_seq1;GAXK01110300.1;P33085;1.95E-34;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp222_c0_seq1;GAXK01166208.1;P36188;5.98E-09;TNNI_DROME;Troponin I (Tn I) (Protein heldup) (Protein wings apart-A);"striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; nuclear division [GO:0000280]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]";"GO:0000280; GO:0003779; GO:0005861; GO:0005865; GO:0006936; GO:0007399; GO:0007507; GO:0007517; GO:0007519; GO:0030239; GO:0045214; GO:0046716; GO:0046872; GO:0048738; GO:0060047";"cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; nuclear division [GO:0000280]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]";"striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]";"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp2220392_c0_seq1;GAXK01156811.1;Q16983;1.21E-42;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp222069_c3_seq1;GAXK01152418.1;Q4W930;9.53E-07;ABNC_ASPFU;Probable arabinan endo-1,5-alpha-L-arabinosidase C (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase C) (ABN C);"extracellular region [GO:0005576]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493]";"GO:0005576; GO:0031222; GO:0045493; GO:0046558";"arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493]";extracellular region [GO:0005576];arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]
comp22209_c0_seq1;GAXK01012027.1;B4J672;7.74E-108;KAD2_DROGR;Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase);"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]";"GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]";"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]"
comp2221193_c0_seq1;GAXK01156786.1;Q5EA06;1.26E-11;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp22215_c2_seq1;GAXK01011925.1;Q502K2;1.21E-76;SAMH1_DANRE;Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-);"nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]"
comp2221978_c0_seq1;GAXK01156802.1;Q9BLY8;5.46E-16;GBRB_DROSI;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor) (Protein cyclodiene resistance);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; ion transport [GO:0006811]";"GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0030054; GO:0030594; GO:0034707; GO:0045211";ion transport [GO:0006811];"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]"
comp222210_c1_seq1;GAXK01152466.1;P53621;4.67E-173;COPA_HUMAN;"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]";"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0070062";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]";"hormone activity [GO:0005179]; structural molecule activity [GO:0005198]"
comp2222126_c0_seq1;GAXK01131078.1;Q8TBJ5;2.38E-07;FEZF2_HUMAN;Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]";"GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0007413; GO:0007626; GO:0008285; GO:0016358; GO:0021542; GO:0021797; GO:0021853; GO:0021902; GO:0031490; GO:0043565; GO:0043697; GO:0045665; GO:0045666; GO:0046872; GO:0048664; GO:1902667";"axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]";nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2222801_c0_seq1;GAXK01131089.1;Q9CXE0;9.12E-27;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp222326_c1_seq1;GAXK01152412.1;O15439;3.84E-172;MRP4_HUMAN;Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0048661; GO:0055085; GO:0060271";"cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]"
comp2223500_c0_seq1;GAXK01131071.1;Q9VI93;2.41E-13;RN_DROME;Zinc finger protein rotund (Zinc finger protein roughened eye);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0007480; GO:0022416; GO:0045892; GO:0046872; GO:0048749";"cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2223805_c0_seq1;GAXK01131085.1;Q3UTA9;3.18E-29;I4E1B_MOUSE;Eukaryotic translation initiation factor 4E type 1B (Oocyte-specific eukaryotic translation initiation factor 4E-like);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]";"GO:0000340; GO:0003743; GO:0005845; GO:0016281";;"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]";"RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]"
comp2224215_c0_seq1;GAXK01164441.1;Q3U288;1.59E-18;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2224289_c0_seq1;GAXK01164436.1;P16305;2.58E-93;GBRA6_MOUSE;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008144; GO:0016020; GO:0022851; GO:0030054; GO:0030425; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0042391; GO:0042734; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0051932; GO:0060078; GO:0098686; GO:0098794; GO:0098982; GO:0099060; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp22245_c4_seq1;GAXK01011210.1;O88379;1.12E-46;BAZ1A_MOUSE;Bromodomain adjacent to zinc finger domain protein 1A (Cbp146);"CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]";"GO:0000228; GO:0006261; GO:0006338; GO:0008623; GO:0046872";"chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]";"CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]";metal ion binding [GO:0046872]
comp22249_c1_seq1;GAXK01011425.1;Q4V8Y6;8.73E-96;ERGI1_DANRE;Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0016021; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp2225447_c0_seq1;GAXK01164438.1;Q6GNS1;9.28E-10;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp222607_c0_seq1;GAXK01152407.1;Q7KRI2;8.28E-33;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp22261_c0_seq1;GAXK01011356.1;P11584;0;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp222636_c0_seq1;GAXK01152411.1;Q99PE8;2.64E-60;ABCG5_MOUSE;ATP-binding cassette sub-family G member 5 (EC 7.6.2.-) (Sterolin-1);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0007588; GO:0010212; GO:0010949; GO:0015918; GO:0016020; GO:0016324; GO:0016887; GO:0030299; GO:0033344; GO:0042493; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045177; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0120020";"cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]"
comp222647_c0_seq1;GAXK01152510.1;Q6PBV4;1.25E-21;RWDD3_DANRE;RWD domain-containing protein 3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902073]; positive regulation of protein sumoylation [GO:0033235]";"GO:0005634; GO:0005737; GO:0032088; GO:0033235; GO:1902073";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902073]; positive regulation of protein sumoylation [GO:0033235]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp22265_c1_seq1;GAXK01011355.1;Q9VFC8;0;GYS_DROME;Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase);"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]";"GO:0004373; GO:0005737; GO:0005776; GO:0005977; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0045819; GO:0061723; GO:0071329";"cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]";"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]";glycogen (starch) synthase activity [GO:0004373]
comp222686_c4_seq1;GAXK01152494.1;Q9H0W9;2.07E-82;CK054_HUMAN;Ester hydrolase C11orf54 (EC 3.1.-.-);"extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]";"GO:0005634; GO:0005654; GO:0008270; GO:0016604; GO:0016788; GO:0070062";;"extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
comp2227106_c0_seq1;GAXK01120501.1;Q6GP70;3.69E-32;ADA_XENLA;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0046103; GO:0060205";"adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp2227756_c0_seq1;GAXK01120500.1;Q869C3;1.63E-07;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp2227791_c0_seq1;GAXK01120496.1;P27541;3.30E-55;HSP70_BRUMA;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp22281_c0_seq1;GAXK01011432.1;P15846;1.85E-18;TPMM_TRICO;Tropomyosin, muscle;;;;;
comp222813_c0_seq1;GAXK01152349.1;Q99M85;1.18E-57;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2228244_c0_seq1;GAXK01065188.1;Q9VMM6;3.75E-08;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp22283_c4_seq1;GAXK01011785.1;A1A4Q2;1.30E-29;PRXD1_BOVIN;Prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1);aminoacyl-tRNA editing activity [GO:0002161];GO:0002161;;;aminoacyl-tRNA editing activity [GO:0002161]
comp2228317_c0_seq1;GAXK01065195.1;Q05319;1.97E-37;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp2229_c2_seq1;GAXK01175167.1;Q24799;1.52E-50;MYPH_ECHGR;Myophilin;;;;;
comp22292_c3_seq1;GAXK01011318.1;Q9VZI3;0;UN112_DROME;Unc-112-related protein (Fermitin-1);"cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]";"GO:0005737; GO:0007160; GO:0007229; GO:0048738; GO:0050829; GO:0050839";"cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]";cytoplasm [GO:0005737];cell adhesion molecule binding [GO:0050839]
comp2229222_c0_seq1;GAXK01065182.1;Q8SQ01;2.98E-07;NR1I2_MACMU;Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; drug export [GO:0046618]; exogenous drug catabolic process [GO:0042738]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]";"GO:0000976; GO:0000977; GO:0000981; GO:0003707; GO:0004879; GO:0005634; GO:0006805; GO:0007275; GO:0008134; GO:0008144; GO:0008270; GO:0030154; GO:0030374; GO:0038023; GO:0042738; GO:0042908; GO:0045893; GO:0045944; GO:0046618; GO:0090575";"cell differentiation [GO:0030154]; drug export [GO:0046618]; exogenous drug catabolic process [GO:0042738]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp2229439_c0_seq1;GAXK01065197.1;B7YZU2;7.55E-32;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp222958_c8_seq1;GAXK01152441.1;Q5EBF1;1.26E-105;5NTC_XENTR;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";"GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp2229642_c0_seq1;GAXK01065191.1;Q03413;2.13E-13;MEF2D_XENLA;Myocyte-specific enhancer factor 2D homolog (Serum response factor-like protein 1) (SL-1);"nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000977; GO:0005634; GO:0045944; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];nucleus [GO:0005634];"protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2229771_c0_seq1;GAXK01065194.1;Q21038;3.94E-21;VER3_CAEEL;Tyrosine-protein kinase receptor ver-3 (EC 2.7.10.1) (Vascular endothelial growth factor receptor related 3);"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of cell population proliferation [GO:0008284]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0008284; GO:0043235; GO:0045138";"nematode male tail tip morphogenesis [GO:0045138]; positive regulation of cell population proliferation [GO:0008284]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp2229783_c0_seq1;GAXK01065198.1;Q9Y2C3;2.17E-22;B3GT5_HUMAN;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp222993_c0_seq1;GAXK01152306.1;P35500;0;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp222998_c0_seq1;GAXK01152460.1;D3YXS5;1.50E-161;KIF28_MOUSE;Kinesin-like protein KIF28P (Kinesin-like protein 6);"kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]";"GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384";"cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]";"kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp2230586_c0_seq1;GAXK01025608.1;Q9VFP2;3.90E-21;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp223067_c2_seq1;GAXK01152455.1;P63100;2.05E-07;CANB1_RAT;Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1);"cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470]";"GO:0004721; GO:0005509; GO:0005829; GO:0006470; GO:0042383";protein dephosphorylation [GO:0006470];"cytosol [GO:0005829]; sarcolemma [GO:0042383]";"calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]"
comp223114_c0_seq1;GAXK01152408.1;Q7PVQ9;6.20E-48;RPB11_ANOGA;DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II subunit J);"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]";"GO:0001055; GO:0003677; GO:0005665; GO:0046983";;RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]"
comp223164_c1_seq1;GAXK01152459.1;Q96KE9;6.14E-55;BTBD6_HUMAN;BTB/POZ domain-containing protein 6 (Lens BTB domain protein);"cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";"GO:0005829; GO:0022008; GO:0043687";"neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";cytosol [GO:0005829];
comp2231892_c0_seq1;GAXK01025601.1;Q09453;1.51E-17;GLRB4_CAEEL;Glycine receptor subunit beta-type 4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp223206_c2_seq1;GAXK01152422.1;P91953;1.69E-34;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp223244_c7_seq1;GAXK01152476.1;P91953;8.84E-57;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2232564_c0_seq1;GAXK01191142.1;Q8TD57;0;DYH3_HUMAN;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp2232617_c0_seq1;GAXK01191145.1;Q9HAZ2;9.96E-17;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp223275_c1_seq1;GAXK01152410.1;Q13625;8.73E-28;ASPP2_HUMAN;Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"GO:0002039; GO:0005070; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007165; GO:0017124; GO:0030054; GO:0042802; GO:0042981; GO:0045786; GO:0048471; GO:0051059; GO:0072332; GO:1900119; GO:1900740; GO:1901216; GO:1901796";"cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3/SH2 adaptor activity [GO:0005070]; SH3 domain binding [GO:0017124]"
comp2232801_c0_seq1;GAXK01191126.1;O73925;1.84E-123;KCNQ1_SQUAC;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp2232917_c0_seq1;GAXK01191122.1;Q9VGY6;1.19E-07;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp2233087_c0_seq1;GAXK01191120.1;Q14CN2;1.04E-83;CLCA4_HUMAN;"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872";ion transmembrane transport [GO:0034220];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2233552_c0_seq1;GAXK01191119.1;Q84MN0;1.06E-07;CML4_ORYSJ;Calmodulin-like protein 4;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2233557_c0_seq1;GAXK01191137.1;Q99MS4;5.44E-11;PRS29_MOUSE;Serine protease 29 (EC 3.4.21.-) (Implantation serine proteinase 2) (ISP-2) (Strypsin-2) (Strypsin-related protein) (Tryptase-like proteinase);"extracellular space [GO:0005615]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"GO:0001835; GO:0004252; GO:0005615; GO:0006508; GO:0007566; GO:0008236; GO:0046982";"blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp223360_c0_seq1;GAXK01152497.1;Q9WTN6;2.98E-65;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp2233919_c0_seq1;GAXK01191117.1;P49701;5.81E-14;VDR_COTJA;Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0008270; GO:0043565; GO:0070561";vitamin D receptor signaling pathway [GO:0070561];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2233941_c0_seq1;GAXK01205972.1;P50901;2.02E-32;HOX3_BRAFL;Homeobox protein HOX3;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0005634; GO:0007275; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp223396_c0_seq1;GAXK01152366.1;O60941;1.96E-113;DTNB_HUMAN;Dystrobrevin beta (DTN-B) (Beta-dystrobrevin);"cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]";"GO:0005737; GO:0008270";;cytoplasm [GO:0005737];zinc ion binding [GO:0008270]
comp223429_c1_seq1;GAXK01152394.1;A5PKL7;2.27E-19;LZTS2_BOVIN;Leucine zipper putative tumor suppressor 2 (Protein LAPSER1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of Wnt signaling pathway [GO:0030178]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055]";"GO:0000281; GO:0005737; GO:0005813; GO:0005874; GO:0016055; GO:0030178; GO:0030496; GO:0051013; GO:0051168; GO:0051255";"microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of Wnt signaling pathway [GO:0030178]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]";
comp2234410_c0_seq1;GAXK01077350.1;Q86BJ3;2.51E-26;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp22345_c0_seq1;GAXK01011464.1;Q6P011;7.35E-45;EMC4_DANRE;ER membrane protein complex subunit 4 (Transmembrane protein 85);"ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975]";"GO:0016021; GO:0034975; GO:0072546";protein folding in endoplasmic reticulum [GO:0034975];"ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]";
comp2234933_c0_seq1;GAXK01077332.1;Q6R520;1.36E-32;CALM_OREMO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2234963_c0_seq1;GAXK01077351.1;Q09453;1.16E-07;GLRB4_CAEEL;Glycine receptor subunit beta-type 4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp2235198_c0_seq1;GAXK01077348.1;Q9UR07;8.12E-11;TF211_SCHPO;Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp2235548_c0_seq1;GAXK01077344.1;Q91880;2.11E-68;SUH_XENLA;Suppressor of hairless protein homolog (X-Su(H));"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]";"GO:0000978; GO:0001228; GO:0005634; GO:0005737; GO:0007221; GO:0007275; GO:0043565; GO:0061419";"multicellular organism development [GO:0007275]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp22356_c0_seq1;GAXK01011912.1;Q8K2A1;1.19E-20;GULP1_MOUSE;PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP);"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";"GO:0005737; GO:0006869; GO:0006911; GO:0006915";"apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";cytoplasm [GO:0005737];
comp2235764_c0_seq1;GAXK01077325.1;Q8K2A6;2.07E-33;LIPM_MOUSE;Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3);"extracellular region [GO:0005576]; lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];lipase activity [GO:0016298]
comp2236025_c0_seq1;GAXK01107906.1;Q9NPF2;5.85E-20;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp2236046_c0_seq1;GAXK01107907.1;P23416;6.82E-21;GLRA2_HUMAN;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2236091_c0_seq1;GAXK01107922.1;P51522;1.22E-46;ZNF83_HUMAN;Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp22362_c0_seq1;GAXK01012093.1;Q49P94;3.77E-55;GAAP_VACCL;Golgi anti-apoptotic protein (GAAP);"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0044178";;"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]";
comp2236281_c0_seq1;GAXK01107896.1;P39101;8.77E-11;CAJ1_YEAST;Protein CAJ1;"cytosol [GO:0005829]; nucleus [GO:0005634]; protein folding [GO:0006457]; protein import into peroxisome matrix [GO:0016558]";"GO:0005634; GO:0005829; GO:0006457; GO:0016558";"protein folding [GO:0006457]; protein import into peroxisome matrix [GO:0016558]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp22364_c1_seq1;GAXK01012054.1;Q24547;8.74E-38;STX1A_DROME;Syntaxin-1A (dSynt1);"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030054; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787";"cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp223644_c0_seq1;GAXK01152293.1;Q86W92;1.18E-94;LIPB1_HUMAN;Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2);"cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]";"GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0045296";cell adhesion [GO:0007155];"cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]";cadherin binding [GO:0045296]
comp2236455_c0_seq1;GAXK01107898.1;P07093;3.08E-36;GDN_HUMAN;Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2);"collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of external side of plasma membrane [GO:0031232]; neuromuscular junction [GO:0031594]; platelet alpha granule [GO:0031091]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; cerebellar granular layer morphogenesis [GO:0021683]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; mating plug formation [GO:0042628]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of proteolysis [GO:0045861]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of timing of cell differentiation [GO:0048505]; secretion by cell [GO:0032940]; secretory granule organization [GO:0033363]; seminal vesicle epithelium development [GO:0061108]";"GO:0004867; GO:0005102; GO:0005539; GO:0005576; GO:0005615; GO:0005829; GO:0007596; GO:0008201; GO:0008285; GO:0010757; GO:0010766; GO:0010951; GO:0010955; GO:0014067; GO:0021683; GO:0030195; GO:0030308; GO:0030334; GO:0031091; GO:0031232; GO:0031594; GO:0032940; GO:0033363; GO:0042177; GO:0042628; GO:0045861; GO:0045879; GO:0048505; GO:0048711; GO:0050974; GO:0051966; GO:0060291; GO:0060384; GO:0061108; GO:0062023; GO:0090331; GO:1903561";"blood coagulation [GO:0007596]; cerebellar granular layer morphogenesis [GO:0021683]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; mating plug formation [GO:0042628]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of proteolysis [GO:0045861]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of timing of cell differentiation [GO:0048505]; secretion by cell [GO:0032940]; secretory granule organization [GO:0033363]; seminal vesicle epithelium development [GO:0061108]";"collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of external side of plasma membrane [GO:0031232]; neuromuscular junction [GO:0031594]; platelet alpha granule [GO:0031091]";"glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]"
comp2236470_c0_seq1;GAXK01107910.1;P82963;1.47E-13;CHAO_TRICA;Chaoptin (Photoreceptor cell-specific membrane protein) (Fragment);"plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005886; GO:0007155; GO:0007601; GO:0050896";"cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";plasma membrane [GO:0005886];
comp2236929_c0_seq1;GAXK01107897.1;Q52V16;3.91E-11;ZFY_GORGO;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2236978_c0_seq1;GAXK01107900.1;B4P624;5.10E-09;TRET1_DROYA;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2237239_c0_seq1;GAXK01107904.1;Q7Z2Y8;5.88E-53;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp223726_c0_seq1;GAXK01152348.1;P05661;6.52E-16;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2237399_c0_seq1;GAXK01107913.1;Q9NZJ4;9.68E-31;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp22374_c0_seq1;GAXK01011421.1;Q90X38;5.84E-84;GPKOW_DANRE;G-patch domain and KOW motifs-containing protein (Protein T54-like);"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634; GO:0005681";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp223810_c4_seq1;GAXK01152544.1;O15118;6.86E-30;NPC1_HUMAN;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp223812_c0_seq1;GAXK01152415.1;P35953;2.02E-160;VLDLR_RABIT;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"GO:0005509; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038025; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006";"cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp2238236_c0_seq1;GAXK01024164.1;Q86B91;1.60E-12;TINC_DROME;Protein tincar;"integral component of membrane [GO:0016021]; regulation of eye photoreceptor cell development [GO:0042478]";"GO:0016021; GO:0042478";regulation of eye photoreceptor cell development [GO:0042478];integral component of membrane [GO:0016021];
comp223837_c0_seq1;GAXK01152406.1;Q8TDF5;7.80E-57;NETO1_HUMAN;Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1);"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; ionotropic glutamate receptor binding [GO:0035255]; memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542]";"GO:0005576; GO:0007613; GO:0008542; GO:0014069; GO:0030054; GO:0035255; GO:0048169; GO:0060076; GO:0097120; GO:0098839; GO:0098978; GO:0099061; GO:2000312; GO:2000463";"memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542]";"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]";ionotropic glutamate receptor binding [GO:0035255]
comp2238635_c0_seq1;GAXK01024179.1;Q9BMK3;1.98E-12;FABP2_ECHGR;Fatty acid-binding protein homolog 2;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp2238873_c0_seq1;GAXK01024163.1;Q83CJ2;5.50E-16;CBPA_COXBU;Curved DNA-binding protein;"cytoplasm [GO:0005737]; nucleoid [GO:0009295]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]";"GO:0003677; GO:0003681; GO:0005737; GO:0009295; GO:0042026; GO:0051082; GO:0051085";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]";"cytoplasm [GO:0005737]; nucleoid [GO:0009295]";"bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]"
comp223890_c0_seq1;GAXK01152496.1;Q66HR2;1.99E-80;MARE1_RAT;Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1);"cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005794; GO:0005813; GO:0005815; GO:0005874; GO:0005881; GO:0005925; GO:0008017; GO:0016477; GO:0019901; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0042802; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]"
comp223896_c1_seq1;GAXK01152450.1;P52736;1.42E-13;ZN133_HUMAN;Zinc finger protein 133 (Zinc finger protein 150);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp22390_c0_seq1;GAXK01204996.1;Q9NPD8;9.06E-70;UBE2T_HUMAN;Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]";"GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006513; GO:0006974; GO:0016567; GO:0031625; GO:0035519; GO:0036297; GO:0044314; GO:0051865; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:0085020";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp2239169_c0_seq1;GAXK01024178.1;G5EBI4;7.08E-08;CEEH1_CAEEL;Epoxide hydrolase 1 (EC 3.3.2.10);"integral component of membrane [GO:0016021]; epoxide hydrolase activity [GO:0004301]; cellular lipid metabolic process [GO:0044255]";"GO:0004301; GO:0016021; GO:0044255";cellular lipid metabolic process [GO:0044255];integral component of membrane [GO:0016021];epoxide hydrolase activity [GO:0004301]
comp2239528_c0_seq1;GAXK01024187.1;Q9CXE0;1.41E-07;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2239675_c0_seq2;GAXK01024190.1;Q20026;1.01E-07;CTL1L_CAEEL;Choline transporter-like protein 1;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp224001_c0_seq1;GAXK01109838.1;Q7SZ07;4.46E-52;CP52B_XENLA;Uncharacterized protein C16orf52 homolog B;;;;;
comp224009_c0_seq1;GAXK01109742.1;Q8IY33;2.80E-29;MILK2_HUMAN;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0001725; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:1903955";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp224031_c0_seq1;GAXK01109601.1;P98160;1.13E-27;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp224070_c0_seq1;GAXK01109763.1;Q9NJG9;6.08E-10;SUZ12_DROME;Polycomb protein Su(z)12 (Suppressor 12 of zeste protein);"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"GO:0000790; GO:0003677; GO:0005634; GO:0016458; GO:0016571; GO:0016586; GO:0022008; GO:0031490; GO:0034968; GO:0035097; GO:0035098; GO:0045892; GO:0046872; GO:0070734; GO:2001229";"gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]";"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp224122_c1_seq1;GAXK01205516.1;Q04864;2.82E-12;REL_HUMAN;Proto-oncogene c-Rel;"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]";"GO:0000122; GO:0000790; GO:0000977; GO:0000980; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006954; GO:0007249; GO:0010629; GO:0032688; GO:0034097; GO:0038061; GO:0043123; GO:0045944; GO:1901215";"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2241359_c0_seq1;GAXK01128852.1;Q4V348;5.37E-54;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp224153_c0_seq1;GAXK01109743.1;Q8R071;3.33E-68;IP3KA_MOUSE;Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A);"dendritic spine [GO:0043197]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]";"GO:0004683; GO:0005516; GO:0005524; GO:0006020; GO:0008440; GO:0030036; GO:0032958; GO:0043197; GO:0048167; GO:0048365; GO:0061003; GO:0097062";"actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]";dendritic spine [GO:0043197];"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]"
comp2241668_c0_seq1;GAXK01128864.1;Q18297;1.18E-62;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp2241923_c0_seq1;GAXK01128862.1;Q6PJG9;1.17E-17;LRFN4_HUMAN;Leucine-rich repeat and fibronectin type-III domain-containing protein 4;"cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]";"GO:0005886; GO:0009986; GO:0098978; GO:0098982; GO:0099061; GO:0099151; GO:0099560; GO:1905606";"regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]";"cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]";
comp2242322_c0_seq1;GAXK01131197.1;Q922K9;1.48E-52;FRK_MOUSE;Tyrosine-protein kinase FRK (EC 2.7.10.2) (Beta-cell Src-homology tyrosine kinase) (BSK) (FYN-related kinase) (Intestine tyrosine kinase);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine autophosphorylation [GO:0038083]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000122; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0030154; GO:0031234; GO:0038083";"cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine autophosphorylation [GO:0038083]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]"
comp22427_c0_seq1;GAXK01011220.1;P78312;2.98E-24;F193A_HUMAN;Protein FAM193A (Protein IT14);;;;;
comp2243_c0_seq1;GAXK01176075.1;O46036;0;CTBP_DROME;C-terminal-binding protein (CtBP protein) (dCtBP);"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]";"GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263";"ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]";"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp224311_c0_seq1;GAXK01109813.1;Q13351;7.77E-44;KLF1_HUMAN;Krueppel-like factor 1 (Erythroid krueppel-like transcription factor) (EKLF);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0030218; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0060135; GO:1901653";"cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp2243553_c0_seq1;GAXK01131203.1;P51658;1.91E-20;DHB2_MOUSE;Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]";"GO:0001701; GO:0001890; GO:0004303; GO:0006702; GO:0006703; GO:0016021; GO:0032526; GO:0043231; GO:0047035";"androgen biosynthetic process [GO:0006702]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]";"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"
comp224385_c0_seq1;GAXK01109787.1;Q6ME97;8.03E-59;Y378_PARUW;UPF0176 protein pc0378;;;;;
comp2244115_c0_seq1;GAXK01141289.1;Q60LV4;1.94E-11;MYO3_CAEBR;Myosin-3 (Myosin heavy chain A) (MHC A);"A band [GO:0031672]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; locomotory behavior [GO:0007626]";"GO:0003774; GO:0005524; GO:0007626; GO:0031672; GO:0032982; GO:0051015";locomotory behavior [GO:0007626];"A band [GO:0031672]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp2244171_c0_seq1;GAXK01141282.1;Q9D6P8;2.04E-20;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp224441_c1_seq1;GAXK01109627.1;A2RRD8;1.05E-07;ZN320_HUMAN;Zinc finger protein 320;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2244500_c1_seq1;GAXK01141271.1;Q5HYA8;5.11E-156;MKS3_HUMAN;Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67);"centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005789; GO:0005813; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035869; GO:0036038; GO:0051082; GO:0060170; GO:0060271; GO:0097711";"ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433]";"centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]";"filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]"
comp2244591_c0_seq1;GAXK01141291.1;Q9ULH0;6.22E-12;KDIS_HUMAN;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090";"activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]"
comp22446_c0_seq1;GAXK01012030.1;Q8UVD9;1.76E-31;FUBP2_CHICK;Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (Zipcode-binding protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; intracellular mRNA localization [GO:0008298]; miRNA metabolic process [GO:0010586]; mRNA transport [GO:0051028]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003730; GO:0005634; GO:0005737; GO:0006355; GO:0008298; GO:0010586; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; intracellular mRNA localization [GO:0008298]; miRNA metabolic process [GO:0010586]; mRNA transport [GO:0051028]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]"
comp224497_c2_seq1;GAXK01109695.1;P53440;1.48E-44;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp2245019_c0_seq1;GAXK01141290.1;Q94HW2;8.28E-27;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp2245388_c0_seq1;GAXK01141277.1;P07934;1.84E-08;PHKG1_MOUSE;Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26);"phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"GO:0004683; GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005977; GO:0005978; GO:0006468; GO:0019899; GO:0050321";"glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";phosphorylase kinase complex [GO:0005964];"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]"
comp22457_c1_seq1;GAXK01011440.1;Q9CQ18;3.71E-08;RNH2C_MOUSE;Ribonuclease H2 subunit C (RNase H2 subunit C) (Ribonuclease HI subunit C);"nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401]";"GO:0005634; GO:0006401; GO:0032299";RNA catabolic process [GO:0006401];"nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]";
comp2245950_c0_seq1;GAXK01141280.1;Q7Z0G7;3.84E-19;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp224613_c0_seq1;GAXK01109836.1;Q7PYU6;9.93E-09;ZGPAT_ANOGA;Zinc finger CCCH-type with G patch domain-containing protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2246383_c0_seq1;GAXK01143080.1;Q9UMS6;2.05E-09;SYNP2_HUMAN;Synaptopodin-2 (Genethonin-2) (Myopodin);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein binding, bridging [GO:0030674]; autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]";"GO:0000045; GO:0001725; GO:0003779; GO:0005634; GO:0005829; GO:0005925; GO:0015629; GO:0030018; GO:0030335; GO:0030674; GO:0031005; GO:0032233; GO:0043231; GO:0051371; GO:0051393; GO:0061684; GO:0071889; GO:0099023; GO:2000298";"autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]";"14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein binding, bridging [GO:0030674]"
comp2246387_c0_seq1;GAXK01143072.1;O46040;1.89E-25;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp2246829_c0_seq1;GAXK01143076.1;Q92616;5.36E-08;GCN1_HUMAN;eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]";"GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253";"cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]";"cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]"
comp2247378_c0_seq1;GAXK01143094.1;Q8BZ25;1.00E-13;ANKK1_MOUSE;Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995";regulation of cell cycle process [GO:0010564];"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp2247457_c0_seq1;GAXK01143097.1;Q9QUI0;1.67E-32;RHOA_MOUSE;Transforming protein RhoA (EC 3.6.5.2);"apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell periphery [GO:0071944]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; integrin-mediated signaling pathway [GO:0007229]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of modification of synaptic structure [GO:1905244]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]";"GO:0000902; GO:0001666; GO:0001998; GO:0002363; GO:0003100; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005739; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006357; GO:0007010; GO:0007015; GO:0007155; GO:0007160; GO:0007229; GO:0007266; GO:0007519; GO:0008360; GO:0009612; GO:0009749; GO:0010812; GO:0010975; GO:0010977; GO:0016020; GO:0016477; GO:0017022; GO:0019003; GO:0019901; GO:0019904; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030154; GO:0030307; GO:0030334; GO:0030424; GO:0030496; GO:0030521; GO:0030838; GO:0030950; GO:0031098; GO:0031234; GO:0031532; GO:0031982; GO:0032153; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0042493; GO:0043123; GO:0043124; GO:0043149; GO:0043197; GO:0043200; GO:0043231; GO:0043280; GO:0043296; GO:0043297; GO:0043366; GO:0043524; GO:0043525; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045471; GO:0045665; GO:0045666; GO:0045727; GO:0045792; GO:0045987; GO:0046039; GO:0046638; GO:0048812; GO:0050773; GO:0050919; GO:0051017; GO:0051022; GO:0051384; GO:0051496; GO:0051924; GO:0060193; GO:0060548; GO:0061383; GO:0070507; GO:0071222; GO:0071345; GO:0071803; GO:0071902; GO:0071944; GO:0090051; GO:0090307; GO:0090324; GO:0097498; GO:0098794; GO:0098978; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904996; GO:1905244; GO:1905274; GO:1990869; GO:2000177; GO:2000406";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; integrin-mediated signaling pathway [GO:0007229]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of modification of synaptic structure [GO:1905244]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress-activated protein kinase signaling cascade [GO:0031098]; stress fiber assembly [GO:0043149]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]";"apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell periphery [GO:0071944]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]"
comp224771_c1_seq1;GAXK01109814.1;P54619;1.51E-90;AAKG1_HUMAN;5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; macroautophagy [GO:0016236]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of glycolytic process [GO:0006110]; regulation of macroautophagy [GO:0016241]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]";"GO:0004672; GO:0004691; GO:0005524; GO:0005654; GO:0005829; GO:0006110; GO:0006468; GO:0006633; GO:0007050; GO:0007165; GO:0007283; GO:0008603; GO:0010628; GO:0016020; GO:0016208; GO:0016236; GO:0016241; GO:0019901; GO:0031588; GO:0043531; GO:0045860; GO:0051170; GO:0071900; GO:1901796";"cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; macroautophagy [GO:0016236]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of glycolytic process [GO:0006110]; regulation of macroautophagy [GO:0016241]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]";"ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp224775_c1_seq1;GAXK01109631.1;Q9VZW5;1.80E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp22479_c1_seq1;GAXK01012068.1;Q8WVK2;1.29E-22;SNR27_HUMAN;U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein (U4/U6.U5 snRNP 27 kDa protein) (U4/U6.U5-27K) (Nucleic acid-binding protein RY-1) (U4/U6.U5 tri-snRNP-associated 27 kDa protein) (27K) (U4/U6.U5 tri-snRNP-associated protein 3);"nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003676; GO:0005654";mRNA splicing, via spliceosome [GO:0000398];nucleoplasm [GO:0005654];nucleic acid binding [GO:0003676]
comp2248_c0_seq1;GAXK01176486.1;P17844;0;DDX5_HUMAN;Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]";"GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0009299; GO:0016020; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014";"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]"
comp2248050_c0_seq1;GAXK01105879.1;Q9JJ57;2.39E-15;KCIP1_MOUSE;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]; positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0034705; GO:0043025; GO:0044325; GO:0045760; GO:0046982; GO:0047485; GO:1901379";"positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]"
comp2248358_c0_seq1;GAXK01105871.1;Q26630;1.29E-88;IDLC_STRPU;33 kDa inner dynein arm light chain, axonemal (p33);"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504";inner dynein arm assembly [GO:0036159];"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp2248573_c0_seq1;GAXK01105880.1;Q4U2R1;7.93E-07;HERC2_MOUSE;E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2);"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";"SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2248690_c0_seq1;GAXK01105859.1;Q01603;1.96E-19;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp2249124_c0_seq1;GAXK01105852.1;Q03720;4.20E-24;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp2249235_c0_seq1;GAXK01105860.1;P51881;9.36E-48;ADT2_MOUSE;ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed];"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005471; GO:0005739; GO:0005743; GO:0007059; GO:0008284; GO:0016021; GO:0031625; GO:0042645; GO:0043209; GO:0045121; GO:0071817; GO:1901029; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]";"ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]"
comp2249525_c0_seq1;GAXK01105878.1;Q5H8A4;4.26E-98;PIGG_HUMAN;GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]";"GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267";"GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
comp2249727_c0_seq1;GAXK01105873.1;B0WC46;1.24E-50;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2250109_c0_seq1;GAXK01010489.1;P11678;6.04E-30;PERE_HUMAN;"Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]";"GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0043312; GO:0046872; GO:0070062; GO:0072677";"defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp2250269_c0_seq1;GAXK01010504.1;Q95029;2.17E-26;CATL_DROME;"Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]";"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; digestion [GO:0007586]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0007275; GO:0007586; GO:0008233; GO:0045169; GO:0051603";"digestion [GO:0007586]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]";"cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]"
comp2250297_c0_seq1;GAXK01010491.1;O60242;2.90E-16;AGRB3_HUMAN;Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]";"G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]"
comp2250972_c0_seq1;GAXK01010496.1;Q6GNY1;1.39E-09;MIB1_XENLA;E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase mib1);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]";"GO:0004842; GO:0005737; GO:0005815; GO:0007219; GO:0008270";Notch signaling pathway [GO:0007219];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp225128_c0_seq1;GAXK01109776.1;Q9JME2;2.84E-19;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp2251651_c0_seq1;GAXK01010494.1;Q9V7U0;3.81E-07;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp2251938_c0_seq1;GAXK01010484.1;P29773;6.04E-61;ETS2_LYTVA;Protein C-ets-2 (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0005634; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp225208_c5_seq1;GAXK01109756.1;Q5PQ50;8.91E-71;NUD19_XENLA;Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-);"peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0005777; GO:0016787; GO:0046872";;peroxisome [GO:0005777];"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp2252984_c0_seq1;GAXK01015103.1;Q9FNE2;3.26E-24;GRXC2_ARATH;Glutaredoxin-C2 (AtGrxC2);"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";"GO:0004362; GO:0005737; GO:0009055; GO:0015035; GO:0034599; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]"
comp2253_c0_seq1;GAXK01175740.1;Q8SWU7;0;OLA1_DROME;Obg-like ATPase 1;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]";"GO:0005524; GO:0005525; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872";;cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]"
comp22532_c1_seq1;GAXK01011690.1;Q27746;0;DNMT1_PARLI;DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp225331_c0_seq1;GAXK01109830.1;Q9NAS9;2.84E-46;CLP15_ANOGA;CLIP domain-containing serine protease B15 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0042832; GO:0045087; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp2254_c0_seq1;GAXK01175647.1;Q8I7D9;2.20E-25;SC61G_CIOIN;Protein transport protein Sec61 subunit gamma;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein targeting [GO:0006605]";"GO:0005789; GO:0006605; GO:0015450; GO:0016021";protein targeting [GO:0006605];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]
comp225400_c0_seq1;GAXK01109716.1;Q9JHJ7;4.79E-08;TEST_MOUSE;Testisin (EC 3.4.21.-) (Serine protease 21) (Tryptase 4);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]";"GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0007283; GO:0008236; GO:0016020; GO:0031225";"proteolysis [GO:0006508]; spermatogenesis [GO:0007283]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp225416_c0_seq1;GAXK01109773.1;Q7KRI2;8.27E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2254273_c0_seq1;GAXK01126184.1;B3EWZ8;4.95E-08;ECT_ACRMI;Ectin (Fragment);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp225467_c0_seq1;GAXK01109708.1;Q9H7Z3;7.89E-52;NRDE2_HUMAN;Protein NRDE2 homolog;"chromatin silencing by small RNA [GO:0031048]; RNA interference [GO:0016246]";"GO:0016246; GO:0031048";"chromatin silencing by small RNA [GO:0031048]; RNA interference [GO:0016246]";;
comp2255_c2_seq1;GAXK01175370.1;Q6P7W0;3.46E-21;SENP6_MOUSE;Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234";"protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp22552_c0_seq1;GAXK01011463.1;Q17FR9;4.27E-160;SRRT_AEDAE;Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog);"nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";"GO:0003676; GO:0005654; GO:0006397; GO:0031053";"mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";nucleoplasm [GO:0005654];nucleic acid binding [GO:0003676]
comp2255418_c0_seq1;GAXK01126170.1;Q9VZW5;7.76E-13;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp22557_c0_seq1;GAXK01011953.1;Q9HD33;5.82E-39;RM47_HUMAN;39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47) (Mitochondrial large ribosomal subunit protein uL29m) (Nasopharyngeal carcinoma metastasis-related protein 1);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543; GO:0070125; GO:0070126";"mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp225580_c7_seq1;GAXK01109660.1;P10076;1.50E-18;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2255874_c0_seq1;GAXK01126197.1;Q86WI1;1.96E-104;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp2255899_c0_seq1;GAXK01126172.1;P61587;5.26E-14;RND3_HUMAN;Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005925; GO:0005938; GO:0007015; GO:0007155; GO:0007266; GO:0008360; GO:0019901; GO:0030036; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp2256_c4_seq1;GAXK01175959.1;P07154;9.91E-120;CATL1_RAT;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Cyclic protein 2) (CP-2) (Major excreted protein) (MEP) [Cleaved into: Procathepsin L; Cathepsin L1 heavy chain; Cathepsin L1 light chain]";"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"GO:0004177; GO:0004197; GO:0005615; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0014070; GO:0021675; GO:0030984; GO:0034698; GO:0042277; GO:0043005; GO:0043204; GO:0044877; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:1990834";"autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; vacuole [GO:0005773]";"aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]"
comp2256005_c0_seq1;GAXK01064748.1;P20662;2.98E-07;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp22561_c0_seq1;GAXK01011154.1;Q5RC69;1.84E-78;DCTD_PONAB;Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase);"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";"GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802";"nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";;"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]"
comp22562_c4_seq1;GAXK01011982.1;Q9Y4X0;9.14E-84;AMMR1_HUMAN;AMME syndrome candidate gene 1 protein;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp22564_c0_seq1;GAXK01011394.1;O55013;2.81E-83;TPPC3_MOUSE;Trafficking protein particle complex subunit 3 (BET3 homolog);"cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]";"GO:0000139; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]";"cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]";
comp2256563_c0_seq1;GAXK01064768.1;Q61830;1.72E-30;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp225658_c2_seq1;GAXK01109630.1;P58108;3.21E-99;AAKG1_BOVIN;5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg);"nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of protein serine/threonine kinase activity [GO:0071900]";"GO:0005524; GO:0005634; GO:0006468; GO:0006633; GO:0016208; GO:0031588; GO:0043531; GO:0071900";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of protein serine/threonine kinase activity [GO:0071900]";"nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]"
comp22566_c0_seq1;GAXK01011920.1;Q7PMT1;7.29E-116;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp2257243_c0_seq1;GAXK01064749.1;P81732;4.25E-39;HC2C_MEGCR;Hemocyanin 2-c chain (KLH2-c);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005615; GO:0016491; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp225749_c2_seq1;GAXK01109839.1;Q5VV41;5.93E-92;ARHGG_HUMAN;Rho guanine nucleotide exchange factor 16 (Ephexin-4);"cytosol [GO:0005829]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005829; GO:0007186; GO:0017048; GO:0030165; GO:0030971; GO:0035023; GO:0043065; GO:0045296; GO:0051056; GO:0060326; GO:0090630; GO:1903078";"activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";cytosol [GO:0005829];"cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp225788_c0_seq1;GAXK01109762.1;P05661;1.54E-28;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp225802_c1_seq1;GAXK01109717.1;O15226;8.35E-36;NKRF_HUMAN;NF-kappa-B-repressing factor (NFkB-repressing factor) (Protein ITBA4) (Transcription factor NRF);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp22585_c0_seq1;GAXK01012096.1;Q9NRH2;2.38E-173;SNRK_HUMAN;SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556";"intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp225855_c0_seq1;GAXK01109694.1;Q04831;0;GLNA_PANAR;Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]";"GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872";glutamine biosynthetic process [GO:0006542];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]"
comp225879_c0_seq1;GAXK01109801.1;O60500;7.80E-134;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp2258793_c0_seq1;GAXK01027565.1;Q9JME2;9.86E-08;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp22589_c1_seq1;GAXK01011488.1;Q9HD20;0;AT131_HUMAN;Manganese-transporting ATPase 13A1 (EC 3.6.3.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]";"GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872";"cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"
comp2259304_c0_seq1;GAXK01027560.1;Q9SKC4;3.58E-19;ARI10_ARATH;Probable E3 ubiquitin-protein ligase ARI10 (EC 2.3.2.31) (ARIADNE-like protein ARI10) (Protein ariadne homolog 10) (RING-type E3 ubiquitin transferase ARI10);"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp225987_c0_seq1;GAXK01109710.1;Q9W625;7.52E-61;IMPCT_XENLA;Protein IMPACT (Imprinted and ancient gene protein homolog) (Ximpact);"cytoplasm [GO:0005737]; polysome [GO:0005844]; cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]";"GO:0000122; GO:0001933; GO:0005737; GO:0005844; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0045666; GO:0060548; GO:0060733; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:1990138; GO:1990253";"cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]";"cytoplasm [GO:0005737]; polysome [GO:0005844]";
comp2260219_c0_seq1;GAXK01098590.1;Q03720;3.27E-79;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp226044_c0_seq1;GAXK01151419.1;Q92597;4.19E-64;NDRG1_HUMAN;Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42);"cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005913; GO:0007165; GO:0008017; GO:0008285; GO:0010038; GO:0015630; GO:0017137; GO:0030330; GO:0032287; GO:0042981; GO:0043015; GO:0045296; GO:0045576; GO:0048471; GO:0055038; GO:0070062; GO:0071456; GO:0098978; GO:0099173";"cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]";"cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]"
comp226050_c0_seq1;GAXK01151796.1;Q64323;1.38E-152;PIGA_MOUSE;N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A);"endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000506; GO:0005789; GO:0006506; GO:0016021; GO:0017176; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]";"endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]";phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]
comp2260563_c0_seq1;GAXK01098588.1;Q9NTW7;1.06E-07;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2260617_c0_seq1;GAXK01098599.1;Q8TGM5;7.93E-19;ART3_YEAST;Putative uncharacterized protein ART3 (Antisense to ribosomal RNA transcript protein 3);;;;;
comp2261_c0_seq1;GAXK01175312.1;Q9DCJ5;2.06E-31;NDUA8_MOUSE;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit);"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; protein-containing complex binding [GO:0044877]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0032981; GO:0044877";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";protein-containing complex binding [GO:0044877]
comp22610_c0_seq1;GAXK01011416.1;Q7SY75;1.49E-29;NCALD_XENLA;Neurocalcin-delta;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2261094_c0_seq1;GAXK01098602.1;O76090;3.96E-97;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp22613_c2_seq1;GAXK01011874.1;P34552;5.87E-153;ALXA_CAEEL;Apoptosis-linked gene 2-interacting protein X 1 (Prion-like-(Q/N-rich) domain-bearing protein 58) (Protein YNK1);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]; Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"GO:0005112; GO:0005771; GO:0007032; GO:0008022; GO:0016323; GO:0031410; GO:0032456; GO:0033365; GO:0042176; GO:0043226; GO:0055037";"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]";"Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]"
comp226148_c0_seq1;GAXK01151541.1;Q9Y6Y1;3.34E-66;CMTA1_HUMAN;Calmodulin-binding transcription activator 1;"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000981; GO:0005634; GO:0005730; GO:0005829; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886";"neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp2261480_c0_seq1;GAXK01098597.1;Q8TF68;1.85E-16;ZN384_HUMAN;Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2261814_c0_seq1;GAXK01098592.1;Q96PE6;8.06E-07;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2262022_c0_seq1;GAXK01003639.1;Q91233;1.69E-52;HSP70_ONCTS;Heat shock 70 kDa protein (HSP70);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp22621_c0_seq1;GAXK01011250.1;Q9H2H8;3.30E-83;PPIL3_HUMAN;Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3);"catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000398; GO:0000413; GO:0003755; GO:0006457; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]";catalytic step 2 spliceosome [GO:0071013];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp2262234_c0_seq1;GAXK01003620.1;P58545;7.14E-07;BTBD3_MOUSE;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp22626_c3_seq1;GAXK01011262.1;P02545;3.97E-10;LMNA_HUMAN;Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)];"cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; IRE1-mediated unfolded protein response [GO:0036498]; mitotic nuclear envelope reassembly [GO:0007084]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0005198; GO:0005634; GO:0005635; GO:0005638; GO:0005652; GO:0005654; GO:0005829; GO:0005882; GO:0006606; GO:0006998; GO:0007084; GO:0007517; GO:0008285; GO:0010628; GO:0016607; GO:0030334; GO:0030951; GO:0031647; GO:0031965; GO:0032204; GO:0034504; GO:0034613; GO:0036498; GO:0042802; GO:0048471; GO:0055015; GO:0071456; GO:0072201; GO:0090201; GO:0090343; GO:1900114; GO:1900180; GO:1903243; GO:2001237";"cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; IRE1-mediated unfolded protein response [GO:0036498]; mitotic nuclear envelope reassembly [GO:0007084]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015]";"cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp226288_c0_seq1;GAXK01151582.1;Q14AI6;4.13E-08;RUSD3_MOUSE;Mitochondrial mRNA pseudouridine synthase Rpusd3 (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 3);"mitochondrial matrix [GO:0005759]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]";"GO:0001522; GO:0003723; GO:0005759; GO:0006397; GO:0009982; GO:0070131";"mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]";mitochondrial matrix [GO:0005759];"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp2263431_c0_seq1;GAXK01003637.1;P21902;2.46E-16;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2263615_c0_seq1;GAXK01003621.1;Q7PPU9;1.95E-32;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp226412_c0_seq1;GAXK01151479.1;Q9U518;3.43E-19;ASPG_DIRIM;L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase);"asparaginase activity [GO:0004067]; asparagine metabolic process [GO:0006528]";"GO:0004067; GO:0006528";asparagine metabolic process [GO:0006528];;asparaginase activity [GO:0004067]
comp226414_c0_seq1;GAXK01151465.1;P05661;1.19E-08;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp22646_c0_seq1;GAXK01011973.1;Q5ZIQ3;1.18E-24;HNRPK_CHICK;Heterogeneous nuclear ribonucleoprotein K (hnRNP K);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]";"GO:0003677; GO:0003723; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp226475_c0_seq1;GAXK01151687.1;P15588;1.90E-17;G6PD_DIDVI;Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) (Fragments);"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";"GO:0004345; GO:0006006; GO:0006098; GO:0006739; GO:0050661; GO:0051156";"glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";;"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]"
comp2264753_c0_seq1;GAXK01088004.1;P18715;2.09E-09;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2264903_c0_seq1;GAXK01087997.1;Q8TMP0;6.52E-08;Y2613_METAC;Uncharacterized serpin-like protein MA_2613/MA_2612;"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp2264935_c0_seq1;GAXK01087999.1;Q805E5;4.62E-17;CHSTE_DANRE;Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0050655";"carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp226499_c2_seq1;GAXK01151797.1;Q96LT4;3.41E-81;SAMD8_HUMAN;Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303";"ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]"
comp22650_c0_seq1;GAXK01011433.1;P29052;3.65E-136;TF2B_DROME;Transcription initiation factor IIB (General transcription factor TFIIB);"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]";"GO:0000979; GO:0001139; GO:0001174; GO:0005634; GO:0006352; GO:0006357; GO:0006367; GO:0008134; GO:0017025; GO:0046872; GO:0051101; GO:0051123; GO:0097550";"DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]";"metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp226516_c4_seq1;GAXK01151719.1;Q9NFL5;5.49E-75;HCYF_APHSP;Hemocyanin F chain (HcF);"extracellular space [GO:0005615]; chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005507; GO:0005615; GO:0016491; GO:0031404";;extracellular space [GO:0005615];"chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp2265569_c0_seq1;GAXK01087986.1;P16066;7.39E-44;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp2265589_c0_seq1;GAXK01087987.1;Q7PPU9;5.90E-62;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp226584_c0_seq1;GAXK01151413.1;P36537;1.45E-65;UDB10_HUMAN;UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]";"GO:0005789; GO:0006629; GO:0008194; GO:0016021; GO:0016758; GO:0043231";lipid metabolic process [GO:0006629];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]"
comp2265880_c0_seq1;GAXK01087990.1;Q99LI5;2.22E-07;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp226626_c0_seq1;GAXK01151475.1;Q9Y573;2.71E-121;IPP_HUMAN;Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0015629";;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";actin binding [GO:0003779]
comp2266553_c0_seq1;GAXK01075610.1;Q7Z2Q7;5.48E-14;LRR70_HUMAN;Leucine-rich repeat-containing protein 70 (Synleurin);"integral component of plasma membrane [GO:0005887]; positive regulation of response to cytokine stimulus [GO:0060760]";"GO:0005887; GO:0060760";positive regulation of response to cytokine stimulus [GO:0060760];integral component of plasma membrane [GO:0005887];
comp2266554_c0_seq1;GAXK01075612.1;Q6PFX9;1.99E-09;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp2266978_c0_seq1;GAXK01075614.1;Q75NA5;8.34E-09;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp226713_c0_seq1;GAXK01151404.1;Q08180;1.58E-25;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp2267372_c0_seq1;GAXK01075600.1;Q5XI60;2.10E-17;REEP6_RAT;Receptor expression-enhancing protein 6 (Polyposis locus protein 1-like 1);"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp22674_c0_seq1;GAXK01011919.1;Q6GLM9;0;CSN5_XENLA;COP9 signalosome complex subunit 5 (Signalosome subunit 5) (EC 3.4.-.-);"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]";"GO:0004222; GO:0005634; GO:0005829; GO:0008021; GO:0008180; GO:0030054; GO:0043066; GO:0046872; GO:0048471; GO:0051091";"negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]";"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp226774_c1_seq1;GAXK01151660.1;P56941;1.03E-17;NPC1_PIG;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103";"bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp22678_c0_seq1;GAXK01011888.1;Q93353;2.59E-132;IDH3B_CAEEL;Probable isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp226815_c0_seq1;GAXK01151686.1;Q791F6;9.57E-44;TPRA1_RAT;Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (TPRA40) (Transmembrane domain protein of 40 kDa regulated in adipocytes);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp226821_c0_seq1;GAXK01151436.1;Q8BGM5;1.31E-81;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp226838_c0_seq1;GAXK01151618.1;O16305;4.33E-47;CALM_CAEEL;Calmodulin (CaM);"cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]";"GO:0005509; GO:0005813; GO:0009792; GO:0016477; GO:0019722; GO:0031965; GO:0032880; GO:0042981; GO:0043277; GO:0051296; GO:0051726; GO:0071944; GO:0072686";"apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]";"cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]";calcium ion binding [GO:0005509]
comp226852_c0_seq1;GAXK01151616.1;P40986;3.39E-10;CDC1_YEAST;Cell division control protein 1 (EC 3.1.-.-);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005783; GO:0006281; GO:0006506; GO:0007049; GO:0016021; GO:0016787; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; GPI anchor biosynthetic process [GO:0006506]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp226855_c3_seq1;GAXK01151689.1;A1ZAI5;2.69E-155;FACR1_DROME;Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965";"ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]"
comp226886_c0_seq1;GAXK01151642.1;Q7Z407;3.58E-23;CSMD3_HUMAN;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp22690_c3_seq1;GAXK01011717.1;Q8INB9;0;AKT1_DROME;RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB);"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008284; GO:0008286; GO:0008362; GO:0010884; GO:0010897; GO:0018105; GO:0030307; GO:0031104; GO:0032869; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215; GO:1904262; GO:1904263";"apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp2269521_c0_seq1;GAXK01037009.1;P51452;3.90E-14;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp22700_c0_seq1;GAXK01011405.1;Q9Z2D6;8.42E-10;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp2270170_c0_seq1;GAXK01116332.1;Q01345;3.26E-09;NHEB_ONCMY;Na(+)/H(+) exchanger beta (Beta-NHE) (Na(+)/H(+) antiporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]";"GO:0006885; GO:0015385; GO:0016021; GO:0016323";regulation of pH [GO:0006885];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";sodium:proton antiporter activity [GO:0015385]
comp2270176_c0_seq1;GAXK01116340.1;B7TB45;1.26E-14;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp227021_c0_seq1;GAXK01151666.1;Q6CQE5;5.34E-12;TAR1_KLULA;Protein TAR1;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp2270272_c0_seq1;GAXK01116333.1;Q94900;3.75E-27;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp2270348_c0_seq1;GAXK01116346.1;P98204;1.57E-126;ALA1_ARATH;Phospholipid-transporting ATPase 1 (AtALA1) (EC 7.6.2.1) (Aminophospholipid flippase 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005789; GO:0005886; GO:0016020; GO:0016021; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp227041_c0_seq1;GAXK01151684.1;Q22038;1.41E-33;RHO1_CAEEL;Ras-like GTP-binding protein rhoA;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actomyosin contractile ring assembly [GO:0000915]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; multicellular organism development [GO:0007275]; myosin filament assembly [GO:0031034]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of locomotion [GO:0040017]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0000915; GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007266; GO:0007275; GO:0008360; GO:0014057; GO:0016477; GO:0019901; GO:0030241; GO:0030334; GO:0030950; GO:0031034; GO:0032153; GO:0032154; GO:0032794; GO:0032956; GO:0032970; GO:0040017; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actomyosin contractile ring assembly [GO:0000915]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; multicellular organism development [GO:0007275]; myosin filament assembly [GO:0031034]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of locomotion [GO:0040017]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle myosin thick filament assembly [GO:0030241]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp227078_c1_seq1;GAXK01151815.1;Q8MUC1;3.16E-15;FABP_CLOSI;Fatty acid-binding protein;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp22708_c0_seq1;GAXK01011792.1;P41224;5.96E-27;TEF_RAT;Thyrotroph embryonic factor;"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]";"GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0042803; GO:0043565; GO:0045944; GO:0046982; GO:0048511";"positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp227101_c1_seq1;GAXK01151412.1;A0JPN4;5.36E-48;ZC12A_RAT;Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]";"GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003729; GO:0003730; GO:0004518; GO:0004521; GO:0004532; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006954; GO:0006974; GO:0007399; GO:0010508; GO:0010595; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050713; GO:0050852; GO:0051259; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900165; GO:1900745; GO:1901223; GO:1902714; GO:1903003; GO:1903799; GO:1903936; GO:1904468; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627";"3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp2271041_c0_seq1;GAXK01116345.1;Q8NDL9;2.47E-20;CBPC5_HUMAN;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0045171; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp227133_c0_seq1;GAXK01151454.1;Q9FMN2;4.42E-34;PAH2_ARATH;Phosphatidate phosphatase PAH2 (EC 3.1.3.4) (Phosphatidic acid phosphohydrolase 2) (AtPAH2);"apoplast [GO:0048046]; cytosol [GO:0005829]; phosphatidate phosphatase activity [GO:0008195]; cellular response to phosphate starvation [GO:0016036]; galactolipid biosynthetic process [GO:0019375]; lipid metabolic process [GO:0006629]; phospholipid biosynthetic process [GO:0008654]";"GO:0005829; GO:0006629; GO:0008195; GO:0008654; GO:0016036; GO:0019375; GO:0048046";"cellular response to phosphate starvation [GO:0016036]; galactolipid biosynthetic process [GO:0019375]; lipid metabolic process [GO:0006629]; phospholipid biosynthetic process [GO:0008654]";"apoplast [GO:0048046]; cytosol [GO:0005829]";phosphatidate phosphatase activity [GO:0008195]
comp22721_c0_seq1;GAXK01011354.1;Q9VLN1;1.85E-156;WDR82_DROME;WD repeat-containing protein 82;"histone methyltransferase complex [GO:0035097]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"GO:0003682; GO:0035097; GO:0048188; GO:0051568; GO:0080182";"histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"histone methyltransferase complex [GO:0035097]; Set1C/COMPASS complex [GO:0048188]";chromatin binding [GO:0003682]
comp227218_c3_seq1;GAXK01151511.1;Q6QI06;3.58E-159;RICTR_MOUSE;Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo);"TORC2 complex [GO:0031932]; enzyme activator activity [GO:0008047]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; actin cytoskeleton reorganization [GO:0031532]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of cell polarity [GO:0030010]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of phosphorylation [GO:0042325]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";"GO:0001932; GO:0001938; GO:0008047; GO:0009792; GO:0010468; GO:0018105; GO:0019901; GO:0030010; GO:0030838; GO:0030950; GO:0031532; GO:0031929; GO:0031932; GO:0032008; GO:0032956; GO:0033135; GO:0042325; GO:0043022; GO:0043087; GO:0050727; GO:0050731; GO:0051896; GO:0051897; GO:2000114";"actin cytoskeleton reorganization [GO:0031532]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of cell polarity [GO:0030010]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of phosphorylation [GO:0042325]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";TORC2 complex [GO:0031932];"enzyme activator activity [GO:0008047]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]"
comp22724_c0_seq1;GAXK01011713.1;Q9VC49;4.65E-42;RPAB5_DROME;DNA-directed RNA polymerases I, II, and III subunit RPABC5 (RNA polymerases I, II, and III subunit ABC5) (RPB10 homolog);"RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797]";"GO:0003677; GO:0003899; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0008270; GO:0042797";"transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797]";"RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]"
comp2272539_c0_seq1;GAXK01158893.1;P29594;4.17E-34;CASP2_MOUSE;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]";"GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0016020; GO:0016485; GO:0019904; GO:0035234; GO:0042802; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp227254_c0_seq1;GAXK01151522.1;Q7KRI2;6.42E-31;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2273470_c0_seq1;GAXK01158894.1;Q9XYN1;1.44E-34;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp227350_c0_seq1;GAXK01151501.1;O43345;1.61E-38;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp22738_c0_seq1;GAXK01012081.1;P0DPW5;2.96E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp227393_c0_seq1;GAXK01151637.1;Q80Z96;6.00E-138;VANG1_MOUSE;Vang-like protein 1 (Loop-tail protein 2) (Van Gogh-like protein 1);"integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473]";"GO:0005886; GO:0007275; GO:0016021; GO:0016328; GO:0043473";"multicellular organism development [GO:0007275]; pigmentation [GO:0043473]";"integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";
comp22743_c0_seq1;GAXK01011710.1;Q402E2;6.38E-37;H33A_LILLO;Histone H3.3a (Histone soH3-2) (Somatic-like histone H3-2);"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp22744_c1_seq1;GAXK01011883.1;Q8N3R9;1.64E-163;MPP5_HUMAN;MAGUK p55 subfamily member 5;"apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]";"GO:0002011; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005886; GO:0005913; GO:0005923; GO:0016324; GO:0019904; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0043204; GO:0043219; GO:0043220; GO:0070062; GO:0070830; GO:0072659; GO:0090162";"bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]";"ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]"
comp22745_c0_seq1;GAXK01011974.1;Q17QG5;2.47E-85;UB2G2_BOVIN;Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005829; GO:0006511; GO:0018279; GO:0030433; GO:0035458; GO:0042802; GO:0061631; GO:0070936; GO:1904153";"cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp2274663_c0_seq1;GAXK01119219.1;Q8MKK4;1.44E-52;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp227629_c0_seq1;GAXK01151663.1;B3N8M1;4.36E-65;LPHN_DROER;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp2276369_c0_seq1;GAXK01186780.1;Q27433;1.02E-14;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp2276463_c0_seq1;GAXK01186776.1;A6H603;2.44E-26;NWD1_MOUSE;NACHT domain- and WD repeat-containing protein 1;"cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";"GO:0005524; GO:0005829; GO:0010628; GO:0032088";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";cytosol [GO:0005829];ATP binding [GO:0005524]
comp227654_c1_seq1;GAXK01151675.1;Q5EAX4;8.45E-13;SMO1B_XENLA;Small ubiquitin-related modifier 1-B (SUMO-1-B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor binding [GO:0008134]; protein sumoylation [GO:0016925]";"GO:0005634; GO:0005737; GO:0005886; GO:0008134; GO:0016925";protein sumoylation [GO:0016925];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";transcription factor binding [GO:0008134]
comp227655_c0_seq1;GAXK01151437.1;Q9HCK5;4.06E-148;AGO4_HUMAN;Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; single-stranded RNA binding [GO:0003727]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell morphogenesis [GO:0022604]; regulation of megakaryocyte differentiation [GO:0045652]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"GO:0000932; GO:0003725; GO:0003727; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0007130; GO:0007140; GO:0007223; GO:0008584; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0016604; GO:0022604; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0043066; GO:0045652; GO:0070578";"male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell morphogenesis [GO:0022604]; regulation of megakaryocyte differentiation [GO:0045652]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; single-stranded RNA binding [GO:0003727]"
comp227713_c0_seq1;GAXK01151497.1;Q6ZS30;0;NBEL1_HUMAN;Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein);;;;;
comp22776_c0_seq1;GAXK01011455.1;P52434;4.25E-85;RPAB3_HUMAN;DNA-directed RNA polymerases I, II, and III subunit RPABC3 (RNA polymerases I, II, and III subunit ABC3) (DNA-directed RNA polymerase II subunit H) (DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide) (RPB17) (RPB8 homolog) (hRPB8);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000398; GO:0003697; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006283; GO:0006351; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006383; GO:0008543; GO:0016070; GO:0032481; GO:0032993; GO:0035019; GO:0042795; GO:0045815; GO:0050434; GO:0060964";"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]"
comp227768_c0_seq1;GAXK01151716.1;Q2UPZ7;1.18E-76;DNPEP_ASPOR;Aspartyl aminopeptidase (DAP) (EC 3.4.11.21);"aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]";"GO:0004177; GO:0008237; GO:0008270";;;"aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp227789_c2_seq1;GAXK01151792.1;Q04448;9.92E-71;MTDC_DROME;"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial (DNMDMC) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]";"mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; 10-formyltetrahydrofolate metabolic process [GO:0009256]; carbohydrate metabolic process [GO:0005975]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0005975; GO:0009256; GO:0035999; GO:0042301; GO:0046653";"10-formyltetrahydrofolate metabolic process [GO:0009256]; carbohydrate metabolic process [GO:0005975]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";mitochondrion [GO:0005739];"magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]"
comp2278188_c0_seq1;GAXK01120397.1;P20662;1.07E-09;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp22783_c1_seq1;GAXK01011780.1;Q6AXY7;1.17E-75;PR38B_RAT;Pre-mRNA-splicing factor 38B;"precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0006397; GO:0008380; GO:0071011";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";precatalytic spliceosome [GO:0071011];
comp2278523_c0_seq1;GAXK01120398.1;P70057;1.56E-33;KCNQ1_XENLA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha xKvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp2278536_c0_seq1;GAXK01120401.1;Q25479;7.47E-43;NKCL_MANSE;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter);"integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0006813; GO:0006814; GO:0015377; GO:0016021";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];cation:chloride symporter activity [GO:0015377]
comp227907_c1_seq1;GAXK01151793.1;Q868Z9;2.78E-100;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp2279111_c0_seq1;GAXK01120407.1;P47194;2.44E-15;SYB_DORPE;Synaptobrevin;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192]";"GO:0016021; GO:0016192; GO:0030054; GO:0030672; GO:0043005";vesicle-mediated transport [GO:0016192];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]";
comp227938_c0_seq1;GAXK01204889.1;Q94900;0;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp227992_c1_seq1;GAXK01151453.1;Q5JH51;4.49E-25;METE_THEKO;Methionine synthase (EC 2.1.1.-) (Homocysteine methyltransferase);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp228002_c3_seq1;GAXK01148642.1;Q60HC5;1.78E-117;DHC24_MACFA;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]; cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"GO:0000139; GO:0005634; GO:0005783; GO:0005789; GO:0006695; GO:0006979; GO:0009888; GO:0016021; GO:0019899; GO:0042605; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0071949";"cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]"
comp2280343_c0_seq1;GAXK01005336.1;Q9C3Z5;1.55E-20;RLA2_PODAS;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp228064_c2_seq1;GAXK01148507.1;Q6XP49;6.60E-39;GLIS3_MOUSE;Zinc finger protein GLIS3 (GLI-similar 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp228084_c0_seq1;GAXK01148292.1;Q28F51;3.89E-41;TADBP_XENTR;TAR DNA-binding protein 43 (TDP-43);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]";"GO:0003690; GO:0003723; GO:0003727; GO:0003730; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0031647; GO:0042752; GO:0048511; GO:0070935; GO:1990904";"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp228092_c2_seq1;GAXK01148500.1;Q7KRI2;4.67E-11;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2280963_c0_seq1;GAXK01005323.1;F1M5M3;3.79E-14;TEX14_RAT;Inactive serine/threonine-protein kinase TEX14 (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein);"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]";"GO:0000776; GO:0000777; GO:0004672; GO:0005524; GO:0005623; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0030496; GO:0043063; GO:0045171; GO:0051301; GO:0051306";"attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]";"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp228100_c0_seq1;GAXK01148293.1;Q3SIB2;1.83E-12;RNH_THIDA;Ribonuclease H (RNase H) (EC 3.1.26.4);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; RNA catabolic process [GO:0006401]";"GO:0000287; GO:0003676; GO:0004523; GO:0005737; GO:0006401";RNA catabolic process [GO:0006401];cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp22814_c4_seq1;GAXK01011364.1;P40798;0;STC_DROME;Protein shuttle craft;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0000981; GO:0003700; GO:0003723; GO:0005634; GO:0006355; GO:0008270";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"
comp228400_c1_seq1;GAXK01148283.1;Q5E9G1;0;P2R3C_BOVIN;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma;"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]";"GO:0000226; GO:0001782; GO:0002759; GO:0005634; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900";"activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]";"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; spindle [GO:0005819]";metal ion binding [GO:0046872]
comp2284130_c0_seq1;GAXK01074629.1;Q9QYF9;3.55E-29;NDRG3_MOUSE;Protein NDRG3 (N-myc downstream-regulated gene 3 protein) (Protein Ndr3);"cytoplasm [GO:0005737]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165";signal transduction [GO:0007165];cytoplasm [GO:0005737];
comp228429_c2_seq1;GAXK01148369.1;Q9U3S9;4.64E-28;NAS6_CAEEL;Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp22843_c0_seq1;GAXK01012028.1;Q5S1U1;1.08E-13;HSPB1_PIG;Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27);"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932]";"GO:0001932; GO:0005634; GO:0005737; GO:0005819; GO:0042802; GO:0042803; GO:0044183; GO:0061077; GO:0099641; GO:1904115";"anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932]";"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]"
comp228433_c0_seq1;GAXK01148611.1;P9WLR0;4.94E-30;LIPZ_MYCTO;Putative hydrolase LipZ (EC 3.-.-.-);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp228439_c0_seq1;GAXK01148556.1;Q28BL7;1.58E-65;PO2F1_XENTR;POU domain, class 2, transcription factor 1 (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007219; GO:0042981; GO:0043565; GO:0045893; GO:0045944; GO:0060019";"Notch signaling pathway [GO:0007219]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp2284647_c0_seq1;GAXK01074630.1;Q504C1;1.29E-13;LRIT2_DANRE;Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2285554_c0_seq1;GAXK01074650.1;Q6RI85;1.69E-16;PGK2_PIG;Phosphoglycerate kinase 2 (EC 2.7.2.3) (Phosphoglycerate kinase, testis specific);"cytosol [GO:0005829]; sperm fibrous sheath [GO:0035686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of oxidative phosphorylation [GO:1903862]";"GO:0004618; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0030317; GO:0035686; GO:0043531; GO:1903862";"flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of oxidative phosphorylation [GO:1903862]";"cytosol [GO:0005829]; sperm fibrous sheath [GO:0035686]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]"
comp228558_c0_seq1;GAXK01148497.1;Q9EQ06;4.00E-57;DHB11_MOUSE;Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Dehydrogenase/reductase SDR family member 8);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]";"GO:0004303; GO:0005737; GO:0005783; GO:0005811; GO:0006694; GO:0006710; GO:0016229";"androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]";"estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]"
comp2285858_c0_seq1;GAXK01074647.1;Q8IN81;8.94E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2286377_c0_seq1;GAXK01097042.1;O15020;2.45E-39;SPTN2_HUMAN;Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192]";"GO:0000165; GO:0003779; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0006888; GO:0007411; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0019886; GO:0021692; GO:0030054; GO:0030534; GO:0035264; GO:0043025; GO:0045296; GO:0051693; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099173; GO:0099189";"actin filament capping [GO:0051693]; adult behavior [GO:0030534]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]";"actin binding [GO:0003779]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]"
comp2286515_c0_seq1;GAXK01097044.1;P18746;1.42E-22;ZO26_XENLA;Oocyte zinc finger protein XlCOF26 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2286571_c0_seq1;GAXK01097043.1;A8Y1P7;1.28E-90;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp2287000_c0_seq1;GAXK01097047.1;P48593;1.24E-13;E631_DROME;Calcium-binding protein E63-1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005634; GO:0005737; GO:0005886; GO:0019722";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp22871_c0_seq1;GAXK01011222.1;Q6P2U9;6.79E-144;CSN3_DANRE;COP9 signalosome complex subunit 3 (Signalosome subunit 3);"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005737; GO:0006511; GO:0008180";ubiquitin-dependent protein catabolic process [GO:0006511];"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]";
comp228711_c0_seq1;GAXK01148311.1;B7YZU2;7.58E-45;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp228756_c1_seq1;GAXK01148295.1;O96790;6.29E-12;DPGN_DIPMA;Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]";"GO:0004867; GO:0005576; GO:0050819";negative regulation of coagulation [GO:0050819];extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp2287733_c0_seq1;GAXK01097052.1;Q09811;2.02E-10;HUS2_SCHPO;ATP-dependent DNA helicase hus2/rqh1 (EC 3.6.4.12);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ helicase-Topo III complex [GO:0031422]; site of double-strand break [GO:0035861]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; intra-S DNA damage checkpoint [GO:0031573]; maintenance of rDNA [GO:0043007]; mitotic recombination-dependent replication fork processing [GO:1990426]; postreplication repair [GO:0006301]; recombinational repair [GO:0000725]; regulation of mitotic recombination involved in replication fork processing [GO:1903221]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; UV-damage excision repair [GO:0070914]";"GO:0000228; GO:0000724; GO:0000725; GO:0000729; GO:0003677; GO:0005524; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0006268; GO:0006281; GO:0006301; GO:0006310; GO:0006974; GO:0009378; GO:0031297; GO:0031422; GO:0031573; GO:0032508; GO:0035861; GO:0043007; GO:0043138; GO:0043596; GO:0070914; GO:0071140; GO:1903221; GO:1990426";"cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; intra-S DNA damage checkpoint [GO:0031573]; maintenance of rDNA [GO:0043007]; mitotic recombination-dependent replication fork processing [GO:1990426]; postreplication repair [GO:0006301]; recombinational repair [GO:0000725]; regulation of mitotic recombination involved in replication fork processing [GO:1903221]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; UV-damage excision repair [GO:0070914]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ helicase-Topo III complex [GO:0031422]; site of double-strand break [GO:0035861]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp2287766_c0_seq1;GAXK01097054.1;P0DJ55;1.19E-115;RL4_TETTS;60S ribosomal protein L4;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp228785_c0_seq1;GAXK01148287.1;Q9P2K8;0;E2AK4_HUMAN;eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein);"cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]";"GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005844; GO:0006446; GO:0006468; GO:0007050; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0036492; GO:0039520; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0060733; GO:0070417; GO:0071264; GO:1900273; GO:1990138; GO:1990253";"adaptive immune response [GO:0002250]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]";"cytosolic ribosome [GO:0022626]; polysome [GO:0005844]";"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]"
comp228801_c1_seq1;GAXK01148286.1;P52746;3.83E-15;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2288019_c0_seq1;GAXK01079395.1;Q9D733;1.83E-10;GP2_MOUSE;Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]";"GO:0002412; GO:0003823; GO:0005576; GO:0016324; GO:0031225";antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412];"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]";antigen binding [GO:0003823]
comp22881_c3_seq1;GAXK01011552.1;Q8BHN3;0;GANAB_MOUSE;Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha);"endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; glucosidase activity [GO:0015926]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]";"GO:0005783; GO:0005794; GO:0005975; GO:0006491; GO:0015926; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599";"carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]";"endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]";"alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; glucosidase activity [GO:0015926]"
comp2288320_c0_seq1;GAXK01079400.1;Q86WI1;3.21E-49;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp2288688_c0_seq1;GAXK01079397.1;M0R8U1;0;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp228962_c5_seq1;GAXK01148622.1;Q20176;3.49E-19;NAS39_CAEEL;Zinc metalloproteinase nas-39 (EC 3.4.24.-) (Nematode astacin 39);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005509; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp228978_c2_seq1;GAXK01148312.1;B2D0J5;8.14E-66;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp228989_c0_seq1;GAXK01148640.1;Q99M87;2.29E-22;DNJA3_MOUSE;DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog);"actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006469; GO:0006915; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137";"activation-induced cell death of T cells [GO:0006924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp229_c0_seq1;GAXK01170558.1;Q5NVI9;5.98E-155;DNJA1_PONAB;DnaJ homolog subfamily A member 1;"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]";"GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585";"negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]";"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp2290025_c0_seq1;GAXK01070774.1;Q9ULI1;3.76E-71;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp2290032_c0_seq1;GAXK01070757.1;Q2KJ63;3.39E-21;KLKB1_BOVIN;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";"GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";extracellular space [GO:0005615];"protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp22901_c7_seq1;GAXK01011340.1;E1B7L7;3.18E-14;UBN2_BOVIN;Ubinuclein-2;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp2290521_c0_seq1;GAXK01070753.1;P08953;2.95E-54;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp2291_c0_seq1;GAXK01175259.1;Q2HJ98;1.75E-79;FAHD1_BOVIN;Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0005654; GO:0005739; GO:0005829; GO:0008948; GO:0016787; GO:0018773; GO:0034545; GO:0046872; GO:0047621";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]"
comp22916_c0_seq1;GAXK01011952.1;Q9U639;7.41E-97;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp229202_c0_seq1;GAXK01148557.1;P16375;8.48E-70;7UP1_DROME;Steroid receptor seven-up, isoforms B/C (Nuclear receptor subfamily 2 group F member 3, isoforms B/C);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0000977; GO:0001227; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0007270; GO:0007419; GO:0007462; GO:0007464; GO:0007503; GO:0007507; GO:0007510; GO:0007601; GO:0008270; GO:0014019; GO:0021782; GO:0030154; GO:0042331; GO:0042803; GO:0046530; GO:0046982; GO:0048856; GO:0061331";"anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp229214_c0_seq1;GAXK01148641.1;P27398;0;CAND_DROME;Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein);"cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896";"nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";cytoplasm [GO:0005737];"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]"
comp229236_c0_seq1;GAXK01148555.1;Q539E5;2.33E-36;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp2292512_c0_seq1;GAXK01004402.1;P31421;1.45E-162;GRM2_RAT;Metabotropic glutamate receptor 2 (mGluR2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0046928; GO:0051966; GO:0090461; GO:0099055";"chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; presynaptic membrane [GO:0042734]";"calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp2292713_c0_seq1;GAXK01004407.1;Q9P109;4.79E-34;GCNT4_HUMAN;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993";"carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp229278_c3_seq1;GAXK01148371.1;Q9W0T5;5.63E-23;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp229291_c0_seq1;GAXK01148612.1;Q6P1C6;1.29E-17;LRIG3_MOUSE;Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]";"GO:0005886; GO:0016021; GO:0030659; GO:0032474";otolith morphogenesis [GO:0032474];"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp229314_c0_seq1;GAXK01148510.1;Q64709;3.64E-38;HLF_RAT;Hepatic leukemia factor;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0048511";"regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp229347_c0_seq1;GAXK01148506.1;Q6GPI1;7.08E-28;CTRB2_HUMAN;"Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp2293554_c0_seq1;GAXK01004399.1;P05661;5.50E-24;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2293632_c0_seq1;GAXK01004394.1;P36609;6.08E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp229369_c0_seq1;GAXK01148421.1;Q9FPH3;1.83E-111;THA2_ARATH;Probable low-specificity L-threonine aldolase 2 (EC 4.1.2.48) (Threonine aldolase 2);"cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]";"GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732";"glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]";cytosol [GO:0005829];"L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]"
comp2294473_c0_seq1;GAXK01121112.1;Q9QYJ6;2.93E-21;PDE10_RAT;cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35);"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]";"GO:0004112; GO:0004114; GO:0004118; GO:0005737; GO:0006198; GO:0007165; GO:0010738; GO:0010754; GO:0016020; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0043951; GO:0046069; GO:0046872; GO:0047555";"cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"
comp2294657_c0_seq1;GAXK01121089.1;P98073;4.39E-23;ENTK_HUMAN;"Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]";"brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021";;"brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp229476_c0_seq1;GAXK01148354.1;Q5F3N5;1.89E-08;KLH14_CHICK;Kelch-like protein 14;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]";"GO:0005783; GO:0005789; GO:0005829; GO:0043005; GO:0043025";;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";
comp2294888_c0_seq1;GAXK01121107.1;Q29G54;2.60E-24;WSCD_DROPS;WSCD family member GA21586;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2294918_c0_seq1;GAXK01121121.1;E1C8P7;4.85E-15;DSCL1_CHICK;Down syndrome cell adhesion molecule-like protein 1 homolog;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0007156; GO:0007416; GO:0007417; GO:0010842; GO:0016021; GO:0030017; GO:0030054; GO:0045202; GO:0060219";"camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]";
comp2295355_c0_seq1;GAXK01121118.1;Q86XH1;4.07E-81;DRC11_HUMAN;Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1);"axoneme [GO:0005930]; motile cilium [GO:0031514]; ATP binding [GO:0005524]";"GO:0005524; GO:0005930; GO:0031514";;"axoneme [GO:0005930]; motile cilium [GO:0031514]";ATP binding [GO:0005524]
comp22956_c0_seq1;GAXK01012094.1;Q89PW2;1.32E-21;AZOR1_BRADU;FMN-dependent NADH-azoreductase 1 (EC 1.7.1.17) (Azo-dye reductase 1) (FMN-dependent NADH-azo compound oxidoreductase 1);"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor [GO:0016652]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]";"GO:0009055; GO:0010181; GO:0016652; GO:0016661";;;"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor [GO:0016652]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]"
comp2295644_c0_seq1;GAXK01121092.1;Q9UPV0;1.62E-14;CE164_HUMAN;Centrosomal protein of 164 kDa (Cep164);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000086; GO:0005615; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0010389; GO:0043231; GO:0051301; GO:0060271; GO:0097539; GO:0097711";"cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";
comp2295656_c0_seq1;GAXK01121104.1;Q9GNN8;1.84E-08;CTXA_CARAL;Toxin CaTX-A (Toxin A) (CAT-1);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nematocyst [GO:0042151]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0042151; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nematocyst [GO:0042151]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp229568_c0_seq1;GAXK01148505.1;A7SLZ2;6.35E-09;STING_NEMVE;Stimulator of interferon genes protein (NvSTING) (STING);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; autophagy [GO:0006914]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]";"GO:0002230; GO:0005789; GO:0006914; GO:0016021; GO:0016239; GO:0032481; GO:0032608; GO:0035438; GO:0039528; GO:0045087; GO:0051607; GO:0061507; GO:0071360";"autophagy [GO:0006914]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]"
comp2295696_c0_seq1;GAXK01121095.1;P55115;5.27E-15;NAS15_CAEEL;Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp22959_c1_seq1;GAXK01011316.1;D2YVH7;1.64E-14;LECM_OXYSU;C-type lectin mannose-binding isoform (CTL) (Venom C-type lectin mannose-binding isoform 1);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]";"GO:0005576; GO:0030246; GO:0046872";;extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp229593_c1_seq1;GAXK01148619.1;Q09621;2.01E-32;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2296323_c0_seq1;GAXK01056079.1;P55861;9.03E-13;MCM2_XENLA;DNA replication licensing factor mcm2 (EC 3.6.4.12) (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112);"chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872; GO:1905775";"cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"
comp229648_c0_seq1;GAXK01148344.1;Q08DD7;1.31E-07;SNX11_BOVIN;Sorting nexin-11;"endosome [GO:0005768]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]";"GO:0005768; GO:0006886; GO:0016020; GO:0016050; GO:1901981";"intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]";"endosome [GO:0005768]; membrane [GO:0016020]";phosphatidylinositol phosphate binding [GO:1901981]
comp229695_c0_seq1;GAXK01148656.1;O35347;3.00E-32;DGCR6_MOUSE;Protein DGCR6 (DiGeorge syndrome critical region 6 homolog);;;;;
comp229710_c1_seq1;GAXK01148571.1;Q03445;3.37E-107;GLR1_DROME;Glutamate receptor 1 (Glutamate receptor I) (dGLUR-I) (Kainate-selective glutamate receptor);"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; kainate selective glutamate receptor activity [GO:0015277]; cation transport [GO:0006812]";"GO:0004971; GO:0005886; GO:0006812; GO:0008328; GO:0015277; GO:0030054; GO:0032281; GO:0045211";cation transport [GO:0006812];"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"AMPA glutamate receptor activity [GO:0004971]; kainate selective glutamate receptor activity [GO:0015277]"
comp2297344_c0_seq1;GAXK01056086.1;Q494W8;2.50E-32;CRFM7_HUMAN;CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10);"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005230; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp2297372_c0_seq1;GAXK01056080.1;Q6GNV5;9.66E-12;FNBP1_XENLA;Formin-binding protein 1 homolog;"cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0008289; GO:0031410";endocytosis [GO:0006897];"cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp2297548_c0_seq1;GAXK01056078.1;Q9M9H7;3.97E-29;SOL1_ARATH;Carboxypeptidase SOL1 (EC 3.4.17.-) (Protein SUPPRESSOR OF LLP1 1);"endosome membrane [GO:0010008]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]";"GO:0004181; GO:0004185; GO:0005615; GO:0006518; GO:0008270; GO:0010008; GO:0016021; GO:0016485";"peptide metabolic process [GO:0006518]; protein processing [GO:0016485]";"endosome membrane [GO:0010008]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]"
comp229764_c1_seq1;GAXK01148524.1;Q9Y253;7.14E-113;POLH_HUMAN;DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]; translesion synthesis [GO:0019985]";"GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0019985; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494";"cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]; translesion synthesis [GO:0019985]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]";"damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]"
comp229768_c1_seq1;GAXK01148291.1;P86854;2.60E-23;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp229805_c1_seq1;GAXK01148423.1;Q68DY1;2.17E-23;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2298502_c1_seq1;GAXK01195913.1;P34885;4.39E-28;KPC1B_CAEEL;Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005623; GO:0005737; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008306; GO:0016020; GO:0016079; GO:0018105; GO:0035556; GO:0040012; GO:0040024; GO:0046872; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:1902074; GO:1990504; GO:2001024";"associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp2298550_c0_seq1;GAXK01195915.1;P12007;9.88E-10;IVD_RAT;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; protein homooligomerization [GO:0051260]";"GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0008470; GO:0031966; GO:0033539; GO:0050660; GO:0051260";"fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; protein homooligomerization [GO:0051260]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]"
comp229858_c0_seq1;GAXK01148341.1;Q9Y4A8;8.89E-08;NF2L3_HUMAN;Nuclear factor erythroid 2-related factor 3 (NF-E2-related factor 3) (NFE2-related factor 3) (Nuclear factor, erythroid derived 2, like 3);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0003713; GO:0005634; GO:0005737; GO:0006366; GO:0045893";"positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp229864_c1_seq1;GAXK01148284.1;Q6A085;4.90E-12;ZN629_MOUSE;Zinc finger protein 629;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2298935_c0_seq1;GAXK01195911.1;Q7ZVC2;4.50E-10;CLUA1_DANRE;Clusterin-associated protein 1 homolog (Qilin);"centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; kidney development [GO:0001822]; photoreceptor cell maintenance [GO:0045494]";"GO:0001822; GO:0005634; GO:0005813; GO:0005929; GO:0030992; GO:0045494; GO:0060271";"cilium assembly [GO:0060271]; kidney development [GO:0001822]; photoreceptor cell maintenance [GO:0045494]";"centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]";
comp229895_c0_seq1;GAXK01148503.1;Q5RFR0;6.57E-24;TTPAL_PONAB;Alpha-tocopherol transfer protein-like;;;;;
comp22991_c1_seq1;GAXK01011695.1;P07192;3.92E-60;MAL3_DROME;Maltase A3 (EC 3.2.1.20) (Larval visceral protein L);"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]";"GO:0004558; GO:0032450";;;"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]"
comp2299341_c0_seq1;GAXK01195908.1;P9WLL8;9.39E-10;Y2067_MYCTO;Uncharacterized protein MT2127;;;;;
comp229949_c3_seq1;GAXK01148343.1;O14981;0;BTAF1_HUMAN;TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172);"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0004386; GO:0005524; GO:0005654; GO:0035562; GO:0043231; GO:0045892";"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]";"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]"
comp229966_c0_seq1;GAXK01148644.1;Q9H2F5;1.90E-22;EPC1_HUMAN;Enhancer of polycomb homolog 1;"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]";"GO:0000122; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0031965; GO:0032777; GO:0035267; GO:0035886; GO:0040008; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0070317";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]";"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]";
comp229973_c1_seq1;GAXK01148592.1;Q925Q3;4.25E-119;NCLX_MOUSE;Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1);"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]";"GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006851; GO:0030061; GO:0032592; GO:0035725; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0070588; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256";"calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]";"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp23_c0_seq1;GAXK01169217.1;P58375;5.08E-66;RL30_SPOFR;60S ribosomal protein L30;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022625";;cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2300415_c0_seq1;GAXK01147084.1;Q2VG86;6.11E-11;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2300426_c0_seq1;GAXK01147056.1;Q9VHJ6;1.83E-08;ICH_DROME;Ichor;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";"GO:0000122; GO:0003677; GO:0005634; GO:0010628; GO:0035149; GO:0045944; GO:0046872; GO:0060439; GO:1901148";"gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2300439_c0_seq1;GAXK01147058.1;Q02753;5.78E-62;RL21A_YEAST;60S ribosomal protein L21-A (Large ribosomal subunit protein eL21-A);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp2300616_c0_seq1;GAXK01147071.1;Q27571;3.38E-66;NOS_DROME;Nitric oxide synthase (EC 1.14.13.39) (dNOS);"cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]";"GO:0002027; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0007399; GO:0007416; GO:0007444; GO:0008156; GO:0008285; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0020037; GO:0031284; GO:0032496; GO:0046620; GO:0046872; GO:0050660; GO:0050661";"arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]";"cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp230126_c1_seq1;GAXK01174135.1;O35459;1.23E-97;ECH1_MOUSE;Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]";"GO:0005739; GO:0005777; GO:0006635; GO:0051750";fatty acid beta-oxidation [GO:0006635];"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]
comp23014_c3_seq1;GAXK01011216.1;Q5M818;1.08E-24;RM16_RAT;39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005762; GO:0005763; GO:0019843; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2301614_c0_seq1;GAXK01147060.1;Q6TH47;7.36E-20;STBPA_DANRE;STAM-binding protein-like A (EC 3.4.19.-);"cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"GO:0004843; GO:0005768; GO:0008237; GO:0016020; GO:0016579; GO:0032154; GO:0046872; GO:0061578; GO:0070536";"protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]";"Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp230216_c1_seq1;GAXK01174272.1;Q29RU6;2.08E-54;G6PC_BOVIN;Glucose-6-phosphatase (G-6-Pase) (G6Pase) (EC 3.1.3.9);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose-6-phosphate transport [GO:0015760]; glycogen catabolic process [GO:0005980]; multicellular organism growth [GO:0035264]; regulation of gene expression [GO:0010468]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415]";"GO:0004346; GO:0005789; GO:0005980; GO:0006094; GO:0006641; GO:0008202; GO:0010468; GO:0015760; GO:0016021; GO:0016773; GO:0035264; GO:0042301; GO:0042593; GO:0042632; GO:0046415; GO:0051156";"cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; multicellular organism growth [GO:0035264]; regulation of gene expression [GO:0010468]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"
comp230270_c3_seq1;GAXK01174291.1;Q9Y2G4;3.44E-12;ANKR6_HUMAN;Ankyrin repeat domain-containing protein 6 (Diversin);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";
comp2302751_c0_seq1;GAXK01099607.1;O17645;1.66E-11;HST2_CAEEL;Heparan sulfate 2-O-sulfotransferase hst-2 (Heparan sulfotransferase 2) (EC 2.8.2.-) (HS2ST1 homolog);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; positive regulation of multicellular organism growth [GO:0040018]; regulation of axon guidance [GO:1902667]; regulation of cell migration [GO:0030334]";"GO:0000139; GO:0004394; GO:0005794; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030334; GO:0040018; GO:1902667";"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; positive regulation of multicellular organism growth [GO:0040018]; regulation of axon guidance [GO:1902667]; regulation of cell migration [GO:0030334]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]"
comp2302841_c0_seq1;GAXK01099586.1;Q96DD7;1.40E-07;SHSA4_HUMAN;Protein shisa-4 (Transmembrane protein 58);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp23030_c0_seq1;GAXK01011198.1;Q17G75;0;PURA_AEDAE;Adenylosuccinate synthetase (AMPSase) (AdSS) (EC 6.3.4.4) (IMP--aspartate ligase);"cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]";"GO:0000287; GO:0004019; GO:0005525; GO:0005737; GO:0044208";'de novo' AMP biosynthetic process [GO:0044208];cytoplasm [GO:0005737];"adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp2303374_c0_seq1;GAXK01099583.1;Q8BQN6;1.65E-13;OZF_MOUSE;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2303658_c0_seq1;GAXK01099587.1;P0CT41;3.42E-22;TF212_SCHPO;Transposon Tf2-12 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp23041_c1_seq1;GAXK01011200.1;P41996;5.86E-07;CPG2_CAEEL;Chondroitin proteoglycan-2 (Cytokinesis protein B0280.5);"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"GO:0000281; GO:0006030; GO:0008061; GO:0009792; GO:0030312; GO:0030703; GO:0032465; GO:0098595";"chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]";chitin binding [GO:0008061]
comp230443_c12_seq1;GAXK01174157.1;Q5SGD2;4.01E-50;PPM1L_HUMAN;Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon);"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; MAPK cascade [GO:0000165]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"GO:0000165; GO:0004722; GO:0004724; GO:0005789; GO:0007178; GO:0016021; GO:0030148; GO:0046872; GO:0070062";"MAPK cascade [GO:0000165]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp230457_c0_seq1;GAXK01174184.1;Q9NTW7;2.28E-24;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp230466_c1_seq1;GAXK01174145.1;Q0VCM5;1.86E-17;ITIH1_BOVIN;Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]";"GO:0004867; GO:0005576; GO:0030212";hyaluronan metabolic process [GO:0030212];extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp2304877_c0_seq1;GAXK01115817.1;Q15120;2.32E-09;PDK3_HUMAN;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp2304915_c0_seq1;GAXK01115818.1;P06734;1.48E-11;FCER2_HUMAN;"Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0005178; GO:0005886; GO:0005887; GO:0007219; GO:0009897; GO:0019221; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062";"cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]"
comp23053_c1_seq1;GAXK01011249.1;Q6NZF1;1.67E-26;ZC11A_MOUSE;Zinc finger CCCH domain-containing protein 11A;"cell [GO:0005623]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]";"GO:0003729; GO:0005623; GO:0016973; GO:0046872";poly(A)+ mRNA export from nucleus [GO:0016973];cell [GO:0005623];"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp2305331_c0_seq1;GAXK01115801.1;Q9V817;3.44E-12;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2305759_c0_seq1;GAXK01115806.1;O54702;1.12E-10;CHSTA_RAT;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST) (RaHNK-1ST) (Sul-T);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0016232; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]"
comp230576_c1_seq1;GAXK01174171.1;Q7Z6B7;4.75E-104;SRGP1_HUMAN;SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056";"negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]"
comp230577_c0_seq1;GAXK01174244.1;Q80X72;1.07E-30;LRC15_MOUSE;Leucine-rich repeat-containing protein 15;"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]";"GO:0001968; GO:0005518; GO:0005615; GO:0009986; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0062023; GO:1903077";"negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]"
comp2306217_c0_seq1;GAXK01129297.1;P36609;2.27E-47;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2306253_c0_seq1;GAXK01129299.1;Q86LG1;3.67E-24;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp2306312_c0_seq1;GAXK01129298.1;Q91482;2.78E-07;PRVB1_SALSA;Parvalbumin beta 1 (Major allergen Sal s 1) (allergen Sal s 1);"cell [GO:0005623]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005623";;cell [GO:0005623];calcium ion binding [GO:0005509]
comp2307_c0_seq1;GAXK01176079.1;P55853;4.31E-42;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp2307196_c0_seq1;GAXK01129294.1;P31579;2.58E-26;LCE_ORYLA;Low choriolytic enzyme (EC 3.4.24.66) (Choriolysin L) (Hatching enzyme zinc-protease subunit LCE);"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005886; GO:0008270; GO:0030133; GO:0060468; GO:0060473; GO:2000360";"negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp23072_c0_seq1;GAXK01011457.1;P41900;1.82E-84;T2FB_DROME;General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP-dependent helicase TfIIF-beta) (Transcription initiation factor IIF subunit beta) (TFIIF-beta);"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; TFIIF-class transcription factor complex binding [GO:0001096]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001096; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0032968";"positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; TFIIF-class transcription factor complex binding [GO:0001096]"
comp23075_c1_seq1;GAXK01011461.1;Q9VSF4;1.61E-167;DHYS_DROME;Probable deoxyhypusine synthase (DHS) (EC 2.5.1.46);"cytoplasm [GO:0005737]; deoxyhypusine synthase activity [GO:0034038]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]";"GO:0005737; GO:0008612; GO:0034038";peptidyl-lysine modification to peptidyl-hypusine [GO:0008612];cytoplasm [GO:0005737];deoxyhypusine synthase activity [GO:0034038]
comp2307525_c0_seq1;GAXK01129308.1;Q6GNV7;5.03E-35;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp2308066_c0_seq1;GAXK01106051.1;U3JAG9;5.11E-64;CP131_DANRE;Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1);"centriolar satellite [GO:0034451]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; extracellular region [GO:0005576]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]";"GO:0000775; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]";"centriolar satellite [GO:0034451]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; extracellular region [GO:0005576]";
comp2308371_c0_seq1;GAXK01106047.1;Q32LZ8;1.63E-07;PLPL5_MOUSE;Patatin-like phospholipase domain-containing protein 5 (EC 3.1.1.-);"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005737; GO:0005811; GO:0016020; GO:0019433; GO:0055088";"lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]";triglyceride lipase activity [GO:0004806]
comp2308388_c0_seq1;GAXK01106058.1;Q9NXB0;1.26E-89;MKS1_HUMAN;Meckel syndrome type 1 protein;"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]";"GO:0001843; GO:0003271; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:0097711; GO:1901620; GO:1905515; GO:1990403; GO:2000095";"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]";
comp2308502_c0_seq1;GAXK01106055.1;P17970;2.41E-60;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp230855_c0_seq1;GAXK01174194.1;Q8R1Q9;8.67E-67;RBSK_MOUSE;Ribokinase (RK) (EC 2.7.1.15);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]";"GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0019303; GO:0046835; GO:0046872";"carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]"
comp2308691_c0_seq1;GAXK01106041.1;P86854;3.71E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp23089_c0_seq1;GAXK01011313.1;Q503V0;6.39E-54;CHMP6_DANRE;Charged multivesicular body protein 6 (Chromatin-modifying protein 6);"late endosome membrane [GO:0031902]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]";"GO:0007034; GO:0015031; GO:0031902";"protein transport [GO:0015031]; vacuolar transport [GO:0007034]";late endosome membrane [GO:0031902];
comp230894_c0_seq1;GAXK01174179.1;Q05360;0;WHITE_LUCCU;Protein white;"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pigment binding [GO:0031409]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0055085";transmembrane transport [GO:0055085];integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; pigment binding [GO:0031409]"
comp230942_c3_seq1;GAXK01174199.1;Q5R5U3;1.18E-32;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2309444_c0_seq1;GAXK01106039.1;B4HS00;1.64E-20;LPHN_DROSE;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp230951_c0_seq1;GAXK01174143.1;P59889;3.51E-16;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp23097_c0_seq1;GAXK01011610.1;Q3T168;1.99E-34;CYBP_BOVIN;Calcyclin-binding protein (CacyBP);"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]";"GO:0005634; GO:0005641; GO:0005654; GO:0005829; GO:0007507; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0044548; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]";"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]"
comp230979_c0_seq1;GAXK01174273.1;O35595;2.72E-07;PTC2_MOUSE;Protein patched homolog 2 (PTC2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0008544; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0097108";"cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp2309920_c0_seq1;GAXK01106036.1;O65731;1.89E-68;RS5_CICAR;40S ribosomal protein S5 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp231_c0_seq1;GAXK01166363.1;P62866;2.82E-18;RS30_BOVIN;40S ribosomal protein S30;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp2310_c2_seq1;GAXK01175482.1;P26779;9.62E-09;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp23106_c2_seq1;GAXK01011458.1;Q5TGZ0;1.83E-12;MIC10_HUMAN;MICOS complex subunit MIC10 (Mitochondrial inner membrane organizing system protein 1);"MICOS complex [GO:0061617]; mitochondrion [GO:0005739]";"GO:0005739; GO:0061617";;"MICOS complex [GO:0061617]; mitochondrion [GO:0005739]";
comp2311230_c0_seq1;GAXK01102041.1;Q09327;4.61E-07;MGAT3_HUMAN;Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]; amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"GO:0000139; GO:0003830; GO:0006044; GO:0006487; GO:0008104; GO:0016021; GO:0016757; GO:0030334; GO:0034599; GO:0050435; GO:0050890; GO:1902966; GO:1905166";"amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp2311497_c0_seq1;GAXK01102040.1;Q9GKT2;3.06E-08;FXDC2_MACFA;Fatty acid hydroxylase domain-containing protein 2;"integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]";"GO:0005506; GO:0008610; GO:0016021; GO:0016491";lipid biosynthetic process [GO:0008610];integral component of membrane [GO:0016021];"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"
comp231153_c0_seq1;GAXK01174160.1;Q8BMG8;1.69E-93;MFTC_MOUSE;Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; glycine metabolic process [GO:0006544]";"GO:0005739; GO:0005743; GO:0006544; GO:0008517; GO:0015230; GO:0016021";glycine metabolic process [GO:0006544];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]"
comp2311840_c0_seq1;GAXK01102035.1;Q9VMX1;8.06E-10;KBP_DROME;Protein KBP homolog;"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; mitochondrial transport [GO:0006839]";"GO:0005739; GO:0005856; GO:0006839";mitochondrial transport [GO:0006839];"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]";
comp2311873_c0_seq1;GAXK01102033.1;Q94900;5.64E-13;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp231201_c1_seq1;GAXK01174154.1;P09398;1.02E-14;STRG_STRGR;Streptomycin biosynthesis protein StrG;streptomycin biosynthetic process [GO:0019872];GO:0019872;streptomycin biosynthetic process [GO:0019872];;
comp231206_c0_seq1;GAXK01174202.1;Q9W107;1.48E-162;SYYM_DROME;Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]";"GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184";"mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]"
comp2312308_c0_seq1;GAXK01104419.1;Q8NET6;1.76E-18;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp231274_c0_seq1;GAXK01174189.1;P54350;2.31E-70;WEE1_DROME;Wee1-like protein kinase (Dwee1) (EC 2.7.10.2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";"GO:0000287; GO:0001700; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0006468; GO:0007093; GO:0018108; GO:0045736; GO:0051225; GO:0051299; GO:0051301; GO:0051642";"cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp231293_c1_seq1;GAXK01174259.1;Q03442;2.88E-25;CRJ1A_TRICY;Crystallin J1A;structural constituent of eye lens [GO:0005212];GO:0005212;;;structural constituent of eye lens [GO:0005212]
comp231295_c1_seq1;GAXK01174203.1;Q5RG82;2.89E-13;NS1BA_DANRE;Influenza virus NS1A-binding protein homolog A (NS1-BP homolog A) (NS1-binding protein homolog A);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";
comp231301_c0_seq1;GAXK01174281.1;O02373;0;UGDH_DROME;UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper);"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]";"GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287";"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]"
comp231303_c0_seq1;GAXK01174287.1;Q26366;1.17E-08;VG_DROME;Protein vestigial;"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compound eye morphogenesis [GO:0001745]; determination of muscle attachment site [GO:0016204]; DNA replication [GO:0006260]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; haltere development [GO:0007482]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of mitotic cell cycle [GO:0007346]; somatic muscle development [GO:0007525]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc proximal/distal pattern formation [GO:0007473]";"GO:0001745; GO:0003677; GO:0005634; GO:0006260; GO:0007049; GO:0007346; GO:0007451; GO:0007472; GO:0007473; GO:0007476; GO:0007480; GO:0007482; GO:0007525; GO:0008022; GO:0016204; GO:0035220; GO:0042127; GO:0044719; GO:0045944; GO:0048190; GO:0090254";"cell cycle [GO:0007049]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compound eye morphogenesis [GO:0001745]; determination of muscle attachment site [GO:0016204]; DNA replication [GO:0006260]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; haltere development [GO:0007482]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of mitotic cell cycle [GO:0007346]; somatic muscle development [GO:0007525]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc proximal/distal pattern formation [GO:0007473]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]"
comp23132_c2_seq1;GAXK01011430.1;Q5ZK84;2.97E-117;AK1A1_CHICK;Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019853; GO:0042840; GO:0046185; GO:0110095";"aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; L-ascorbic acid biosynthetic process [GO:0019853]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"
comp2313382_c0_seq1;GAXK01104413.1;Q61941;5.43E-09;NNTM_MOUSE;NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]";"GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600";"NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp2313567_c0_seq1;GAXK01104410.1;A5E8F3;2.62E-23;Y150_BRASB;UPF0314 protein BBta_0150;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp23136_c0_seq1;GAXK01011158.1;Q5EBF1;6.92E-104;5NTC_XENTR;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";"GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp231425_c0_seq1;GAXK01174170.1;P22978;5.35E-19;CG445_DROME;Rhodanese domain-containing protein CG4456 (Heat shock protein 67B2);;;;;
comp23145_c3_seq1;GAXK01011894.1;P33587;1.08E-39;PROC_MOUSE;"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; oligopeptidase activity [GO:0070012]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508]; regulation of circulating fibrinogen levels [GO:0044537]";"GO:0001889; GO:0004252; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0007596; GO:0008233; GO:0030195; GO:0043066; GO:0043621; GO:0044537; GO:0050728; GO:0050819; GO:0070012; GO:1903142";"blood coagulation [GO:0007596]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508]; regulation of circulating fibrinogen levels [GO:0044537]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; oligopeptidase activity [GO:0070012]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]"
comp2314568_c0_seq1;GAXK01193821.1;Q9BYN7;2.14E-11;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp231499_c1_seq1;GAXK01174249.1;P21902;2.03E-49;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2315244_c0_seq1;GAXK01193822.1;Q9UJL9;1.11E-30;ZF69B_HUMAN;Zinc finger protein 69 homolog B (Zinc finger protein 643);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2315841_c0_seq1;GAXK01193829.1;Q5RBP9;2.30E-52;MPEG1_PONAB;Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2);"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; pore formation in membrane of other organism [GO:0035915]";"GO:0016021; GO:0030659; GO:0031410; GO:0035915; GO:0045087; GO:0045335; GO:0050829; GO:0050830";"defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; pore formation in membrane of other organism [GO:0035915]";"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]";
comp231606_c1_seq1;GAXK01174270.1;P35041;4.85E-51;TRY7_ANOGA;Trypsin-7 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp231617_c0_seq1;GAXK01174271.1;Q9H1A4;1.27E-22;APC1_HUMAN;Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein);"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007091; GO:0031145; GO:0051301; GO:0070979; GO:1901990";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp2316187_c0_seq1;GAXK01164949.1;Q5RA57;7.25E-14;PLCC_PONAB;1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0003841; GO:0005635; GO:0005789; GO:0016021; GO:0016024";CDP-diacylglycerol biosynthetic process [GO:0016024];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp231620_c0_seq1;GAXK01174238.1;Q95R48;1.34E-69;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp2316386_c0_seq1;GAXK01164947.1;Q17QQ2;1.67E-13;TPMT_BOVIN;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase);"cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144]";"GO:0005737; GO:0008119; GO:0017144; GO:1904047";drug metabolic process [GO:0017144];cytoplasm [GO:0005737];"S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]"
comp23166_c3_seq1;GAXK01011201.1;O16810;2.02E-124;ORC1_DROME;Origin recognition complex subunit 1 (DmORC1);"nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283]; DNA amplification [GO:0006277]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]";"GO:0000278; GO:0000784; GO:0003682; GO:0003688; GO:0005524; GO:0005664; GO:0006270; GO:0006277; GO:0008283; GO:0033314; GO:0046872";"cell population proliferation [GO:0008283]; DNA amplification [GO:0006277]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]";"nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]"
comp23168_c0_seq1;GAXK01012064.1;O18733;4.80E-11;MMP9_CANLF;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2316936_c0_seq1;GAXK01164936.1;P91711;1.99E-46;XDH_DROSU;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus);"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];peroxisome [GO:0005777];"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp2317_c0_seq1;GAXK01176652.1;P45594;2.45E-60;CADF_DROME;Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0050714; GO:0051299";"actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]";actin binding [GO:0003779]
comp231729_c0_seq1;GAXK01174284.1;Q55EX9;8.88E-17;Y8948_DICDI;Putative methyltransferase DDB_G0268948 (EC 2.1.1.-);"phagocytic vesicle [GO:0045335]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]";"GO:0008757; GO:0045335";;phagocytic vesicle [GO:0045335];S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]
comp23176_c0_seq1;GAXK01011966.1;Q9D1B9;9.43E-25;RM28_MOUSE;39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28);"cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005739; GO:0005761; GO:0005762; GO:0005829";;"cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp231781_c0_seq1;GAXK01174256.1;Q6P158;0;DHX57_HUMAN;Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57);"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]";"GO:0003723; GO:0005524; GO:0034458; GO:0046872";;;"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp2318_c2_seq1;GAXK01176141.1;Q18688;0;HSP90_CAEEL;Heat shock protein 90 (Abnormal dauer formation protein 21);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein phosphatase 5 binding [GO:1990634]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; dauer larval development [GO:0040024]; detection of chemical stimulus [GO:0009593]; determination of adult lifespan [GO:0008340]; nematode larval development [GO:0002119]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of chemotaxis [GO:0050920]; response to biotin [GO:0070781]; response to inorganic substance [GO:0010035]";"GO:0002119; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0006470; GO:0006611; GO:0006935; GO:0007049; GO:0008340; GO:0009593; GO:0009986; GO:0010035; GO:0016887; GO:0032516; GO:0032991; GO:0034605; GO:0035259; GO:0040024; GO:0042802; GO:0043327; GO:0045121; GO:0048471; GO:0050821; GO:0050920; GO:0051082; GO:0061077; GO:0070781; GO:0097718; GO:1990634";"cell cycle [GO:0007049]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; dauer larval development [GO:0040024]; detection of chemical stimulus [GO:0009593]; determination of adult lifespan [GO:0008340]; nematode larval development [GO:0002119]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of chemotaxis [GO:0050920]; response to biotin [GO:0070781]; response to inorganic substance [GO:0010035]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein phosphatase 5 binding [GO:1990634]; unfolded protein binding [GO:0051082]"
comp231802_c1_seq1;GAXK01174243.1;Q6GPQ3;6.03E-48;MFSD8_XENLA;Major facilitator superfamily domain-containing protein 8;"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp231838_c5_seq1;GAXK01174204.1;Q22328;5.52E-117;LEV9_CAEEL;Protein lev-9;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase inhibitor activity [GO:0030414]";"GO:0005615; GO:0030054; GO:0030414; GO:0045202";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";peptidase inhibitor activity [GO:0030414]
comp231881_c0_seq1;GAXK01174241.1;P42573;1.41E-39;CED3_CAEEL;"Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"GO:0004175; GO:0004197; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006919; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0012501; GO:0016020; GO:0016540; GO:0030042; GO:0030054; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043025; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050807; GO:0050829; GO:0097153; GO:0097194; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845";"actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]";"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]"
comp2319569_c0_seq1;GAXK01065274.1;Q5H8A4;1.46E-20;PIGG_HUMAN;GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]";"GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267";"GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
comp232062_c0_seq1;GAXK01121490.1;Q9W0Y6;5.70E-44;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp23208_c0_seq1;GAXK01011487.1;Q7PR68;8.21E-79;MED7_ANOGA;Mediator of RNA polymerase II transcription subunit 7 (Mediator complex subunit 7);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592; GO:0070847";regulation of transcription by RNA polymerase II [GO:0006357];"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";transcription coregulator activity [GO:0003712]
comp2320822_c0_seq1;GAXK01184837.1;Q8BV66;6.68E-22;IFI44_MOUSE;Interferon-induced protein 44 (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp232210_c0_seq1;GAXK01121499.1;Q6ZMP0;6.57E-61;THSD4_HUMAN;Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]";"GO:0001527; GO:0008233; GO:0048251; GO:0062023; GO:0070062";elastic fiber assembly [GO:0048251];"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]";peptidase activity [GO:0008233]
comp2322268_c0_seq1;GAXK01139542.1;O61366;9.68E-67;GPRS_DROME;Serine-enriched protein;;;;;
comp23227_c0_seq1;GAXK01011420.1;Q28658;1.32E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp232279_c1_seq1;GAXK01121584.1;Q7PXN1;1.15E-115;SHAKB_ANOGA;Innexin shaking-B;"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; gap junction assembly [GO:0016264]; ion transport [GO:0006811]; response to light stimulus [GO:0009416]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0009416; GO:0009881; GO:0016021; GO:0016264";"gap junction assembly [GO:0016264]; ion transport [GO:0006811]; response to light stimulus [GO:0009416]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp2322842_c0_seq1;GAXK01139540.1;P17970;3.52E-07;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp2322957_c0_seq1;GAXK01139541.1;Q25338;7.29E-22;LITD_LATTR;Delta-latroinsectotoxin-Lt1a (Delta-LIT-Lt1a) (Delta-latroinsectotoxin) (Delta-LIT);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; exocytosis [GO:0006887]";"GO:0005576; GO:0006887; GO:0016021; GO:0044218; GO:0090729";exocytosis [GO:0006887];"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp23232_c0_seq1;GAXK01012069.1;Q0P678;4.58E-19;ZCH18_MOUSE;Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1);"nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]";"GO:0016607; GO:0032991; GO:0046872";;"nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]";metal ion binding [GO:0046872]
comp2323364_c0_seq1;GAXK01139533.1;Q7KRI2;3.92E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2323710_c0_seq1;GAXK01139553.1;O35052;4.28E-23;CDS1_RAT;Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0004605; GO:0005789; GO:0006661; GO:0016021; GO:0016024";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidylinositol biosynthetic process [GO:0006661]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";phosphatidate cytidylyltransferase activity [GO:0004605]
comp23238_c1_seq1;GAXK01011886.1;Q66H76;7.01E-155;PAXI_RAT;Paxillin;"cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of stress fiber assembly [GO:0051496]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001725; GO:0003712; GO:0005178; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007179; GO:0008013; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0031625; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0044877; GO:0046872; GO:0051496; GO:0060396; GO:1901652";"cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of stress fiber assembly [GO:0051496]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]"
comp23241_c2_seq1;GAXK01011898.1;Q66H20;1.02E-171;PTBP2_RAT;Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (PTB-like protein);"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"GO:0003729; GO:0005634; GO:0005681; GO:0006376; GO:0021510; GO:0021549; GO:0030426; GO:0033119; GO:0043025; GO:2000177";"cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";mRNA binding [GO:0003729]
comp232446_c1_seq1;GAXK01121489.1;Q7ZYC4;5.86E-59;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp232468_c2_seq1;GAXK01121498.1;Q7KRI2;5.91E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2324702_c0_seq1;GAXK01040905.1;Q6P9U1;3.93E-22;NUD22_RAT;Uridine diphosphate glucose pyrophosphatase NUDT22 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 22) (Nudix motif 22);"nucleoplasm [GO:0005654]; GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]";"GO:0005654; GO:0008768; GO:0046872; GO:0052751";;nucleoplasm [GO:0005654];"GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]"
comp232625_c2_seq1;GAXK01121481.1;Q9JLY7;1.59E-19;DUS14_MOUSE;Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004725; GO:0005634; GO:0005737; GO:0017017";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]"
comp2326478_c0_seq1;GAXK01099334.1;Q5BKN4;1.21E-30;SEP2A_XENTR;Septin-2A;"ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224]";"GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0015630; GO:0030496; GO:0031105; GO:0032154; GO:0060170; GO:0060271; GO:0061640";"cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224]";"ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2326523_c0_seq1;GAXK01099331.1;Q24488;5.90E-08;ROR1_DROME;Tyrosine-protein kinase transmembrane receptor Ror (dRor) (EC 2.7.10.1);"axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0007417; GO:0016021; GO:0017147; GO:0030424; GO:0043235; GO:0048856";"anatomical structure development [GO:0048856]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]"
comp2327_c3_seq1;GAXK01176040.1;Q9NDM2;5.09E-44;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp23273_c19_seq1;GAXK01011740.1;Q70BM6;1.06E-24;S22A8_PIG;Solute carrier family 22 member 8 (Organic anion transporter 3) (pOAT3);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; response to toxic substance [GO:0009636]";"GO:0005886; GO:0006811; GO:0009636; GO:0016021; GO:0016323; GO:0022857";"ion transport [GO:0006811]; response to toxic substance [GO:0009636]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp232751_c1_seq1;GAXK01121551.1;Q7RTX9;1.90E-35;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp23277_c0_seq1;GAXK01011456.1;Q8K2M0;2.38E-51;RM38_MOUSE;39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005761; GO:0005762";;"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";
comp23279_c3_seq1;GAXK01011476.1;Q9P289;8.95E-46;STK26_HUMAN;Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK);"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000139; GO:0000165; GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0006468; GO:0006915; GO:0009267; GO:0012506; GO:0016020; GO:0016324; GO:0023014; GO:0030033; GO:0030336; GO:0031098; GO:0032147; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0046777; GO:0048471; GO:0048812; GO:0070062; GO:0071944; GO:1903205";"activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp2327937_c0_seq1;GAXK01099348.1;P86221;1.06E-66;TBB4B_MESAU;Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp23280_c1_seq1;GAXK01011541.1;Q9U516;8.20E-45;ASTER_MANSE;Protein Asterix;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp232813_c0_seq1;GAXK01121403.1;Q8R0T2;3.03E-16;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2328653_c0_seq1;GAXK01059277.1;Q3U4G3;1.23E-19;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp232902_c1_seq1;GAXK01121563.1;Q3T0C2;7.47E-25;PGDH_BOVIN;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp2329154_c0_seq1;GAXK01059282.1;Q7KRI2;2.10E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2329388_c0_seq1;GAXK01059284.1;Q7Z020;6.70E-10;TRPA1_DROME;Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1);"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016021; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]"
comp2329605_c0_seq1;GAXK01059283.1;Q5G267;1.89E-23;NETR_MACMU;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp232967_c0_seq1;GAXK01121557.1;Q3UFF7;1.49E-37;LYPL1_MOUSE;Lysophospholipase-like protein 1 (EC 3.1.2.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0005829; GO:0008474; GO:0042997; GO:0052689";"negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp232976_c2_seq1;GAXK01121588.1;Q8TF45;6.89E-23;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp233_c1_seq1;GAXK01168218.1;P61209;2.55E-128;ARF1_DROME;ADP-ribosylation factor 1;"apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0006893; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386";"ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp233017_c0_seq1;GAXK01121271.1;P28698;4.40E-15;MZF1_HUMAN;Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0042803; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp23303_c0_seq1;GAXK01012083.1;B0LT89;5.66E-79;STK24_RAT;"Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (MST3b) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 35 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]";"cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000139; GO:0000165; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008631; GO:0009267; GO:0023014; GO:0030336; GO:0031098; GO:0032147; GO:0046777; GO:0046872; GO:0048680; GO:0048812";"activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp23305_c0_seq1;GAXK01204998.1;P62256;3.14E-87;UBE2H_HUMAN;Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H);"cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0016567; GO:0043161; GO:0061631; GO:0070936; GO:0070979";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp2330639_c0_seq1;GAXK01191083.1;Q86LG1;2.62E-66;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp233065_c0_seq1;GAXK01121406.1;Q9DCM4;2.97E-42;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp23308_c1_seq1;GAXK01011993.1;Q66JG3;7.56E-151;SYEM_XENTR;Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]";"GO:0000049; GO:0004818; GO:0005524; GO:0005759; GO:0006424; GO:0008270";glutamyl-tRNA aminoacylation [GO:0006424];mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp2330858_c0_seq1;GAXK01191082.1;P48441;5.65E-101;IDUA_MOUSE;Alpha-L-iduronidase (EC 3.2.1.76);"coated vesicle [GO:0030135]; extracellular space [GO:0005615]; lysosome [GO:0005764]; L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparin catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542]";"GO:0000902; GO:0003940; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030135; GO:0030198; GO:0030209; GO:0030211; GO:0035108; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079";"adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparin catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542]";"coated vesicle [GO:0030135]; extracellular space [GO:0005615]; lysosome [GO:0005764]";"L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102]"
comp2331531_c0_seq1;GAXK01191113.1;O74467;6.50E-15;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp23320_c0_seq1;GAXK01011572.1;Q6PFM0;1.69E-153;JMJD6_DANRE;Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]";"GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815";"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]"
comp2332161_c0_seq1;GAXK01122673.1;Q99KQ4;3.73E-165;NAMPT_MOUSE;Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]";"GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0042803; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773";"aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]"
comp23324_c7_seq1;GAXK01011809.1;G5E8K5;0;ANK3_MOUSE;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp233275_c2_seq1;GAXK01121468.1;O54963;1.66E-16;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp233282_c0_seq1;GAXK01121494.1;Q24174;1.94E-15;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp233305_c1_seq1;GAXK01121269.1;Q8C0R0;2.07E-16;UBP37_MOUSE;Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37);"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0051301; GO:0071108";"cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp2333278_c0_seq1;GAXK01122666.1;Q28658;3.98E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp2333316_c0_seq1;GAXK01122664.1;P15848;7.94E-51;ARSB_HUMAN;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp23334_c1_seq1;GAXK01011954.1;Q0VGW6;0;S12A9_XENLA;Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0005886; GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp2333488_c0_seq1;GAXK01122684.1;O43772;4.70E-17;MCAT_HUMAN;Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine shuttle [GO:0006853]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0006853; GO:0015227; GO:0016021";"carnitine shuttle [GO:0006853]; in utero embryonic development [GO:0001701]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp2333601_c0_seq1;GAXK01122663.1;Q9GRW0;5.40E-37;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2333795_c0_seq1;GAXK01122671.1;P31646;9.50E-135;S6A13_RAT;Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13);"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836]";"GO:0005332; GO:0005886; GO:0005887; GO:0006836; GO:0042165; GO:0043005";neurotransmitter transport [GO:0006836];"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]"
comp2333985_c0_seq1;GAXK01122674.1;Q68DL7;2.32E-23;CR063_HUMAN;Uncharacterized protein C18orf63;;;;;
comp233416_c0_seq1;GAXK01121492.1;O57415;2.99E-30;RREB1_CHICK;Ras-responsive element-binding protein 1 (RREB-1);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2334443_c0_seq1;GAXK01173420.1;Q7M4I3;1.61E-18;SP4_BOMPE;Venom protease (EC 3.4.21.-) (allergen Bom p 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp233549_c0_seq1;GAXK01121267.1;Q9VHH9;2.13E-59;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp2335495_c0_seq1;GAXK01173431.1;Q24352;4.37E-20;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp23356_c0_seq1;GAXK01011955.1;P0ABQ3;5.51E-36;GARR_ECOL6;2-hydroxy-3-oxopropionate reductase (EC 1.1.1.60) (Tartronate semialdehyde reductase) (TSAR);"2-hydroxy-3-oxopropionate reductase activity [GO:0008679]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; galactarate catabolic process [GO:0046392]; glyoxylate metabolic process [GO:0046487]";"GO:0008679; GO:0046392; GO:0046487; GO:0050661; GO:0051287";"galactarate catabolic process [GO:0046392]; glyoxylate metabolic process [GO:0046487]";;"2-hydroxy-3-oxopropionate reductase activity [GO:0008679]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp233566_c0_seq1;GAXK01121576.1;Q7KRI2;2.11E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2336_c0_seq1;GAXK01176024.1;P62997;8.79E-45;TRA2B_RAT;Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0048026; GO:0048471; GO:1990904";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp2336459_c0_seq1;GAXK01185317.1;P13608;9.67E-21;PGCA_BOVIN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp233660_c0_seq1;GAXK01121420.1;Q965X6;9.69E-09;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp233709_c0_seq1;GAXK01121451.1;Q62293;7.38E-38;TGTP1_MOUSE;T-cell-specific guanine nucleotide triphosphate-binding protein 1 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb5);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to interferon-alpha [GO:0035455]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]";"GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0006955; GO:0009615; GO:0009617; GO:0034341; GO:0035455; GO:0035458";"cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to interferon-alpha [GO:0035455]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2337221_c0_seq1;GAXK01185312.1;Q9I9R3;4.20E-39;S40A1_DANRE;Solute carrier family 40 member 1 (Ferroportin-1);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]";"GO:0005381; GO:0006826; GO:0006879; GO:0010039; GO:0016021; GO:0016323; GO:0017046; GO:0030282; GO:0034755; GO:0035162; GO:0042541; GO:0043362; GO:0046688; GO:0055072";"bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp2337228_c0_seq1;GAXK01185328.1;Q15181;5.19E-57;IPYR_HUMAN;Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000287; GO:0004427; GO:0005737; GO:0005829; GO:0006418; GO:0006796; GO:0070062; GO:0071344";"diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; tRNA aminoacylation for protein translation [GO:0006418]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp233757_c0_seq1;GAXK01121270.1;Q3Y8M6;8.45E-83;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp2337661_c0_seq1;GAXK01185325.1;Q24174;1.37E-07;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2337799_c0_seq1;GAXK01185323.1;Q96JM2;2.43E-08;ZN462_HUMAN;Zinc finger protein 462 (Zinc finger PBX1-interacting protein) (ZFPIP);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872";"chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp2337887_c0_seq1;GAXK01185327.1;Q6A070;4.82E-28;TGRM1_MOUSE;TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B);"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515";"axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]";
comp233801_c1_seq1;GAXK01121427.1;Q5E980;2.19E-12;CP20A_BOVIN;Cytochrome P450 20A1 (EC 1.14.-.-);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037";;integral component of membrane [GO:0016021];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp233807_c0_seq1;GAXK01121434.1;P35500;1.01E-151;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp23382_c0_seq1;GAXK01011715.1;P91622;3.47E-149;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp2338367_c0_seq1;GAXK01056118.1;Q27746;2.44E-10;DNMT1_PARLI;DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp2338936_c0_seq1;GAXK01056114.1;Q67BJ4;1.03E-18;A4GAT_MOUSE;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp2339074_c0_seq1;GAXK01056100.1;P17972;6.78E-46;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp2339919_c0_seq1;GAXK01056112.1;Q8TF09;2.33E-38;DLRB2_HUMAN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2);"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0035735; GO:0045505; GO:0097542";"intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]"
comp2339933_c0_seq1;GAXK01056108.1;Q9VZW5;1.58E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp233996_c1_seq1;GAXK01121580.1;Q91428;2.94E-52;GATA3_DANRE;Transcription factor GATA-3 (GATA-binding factor 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000978; GO:0000981; GO:0002520; GO:0005634; GO:0008270; GO:0008284; GO:0008543; GO:0021514; GO:0030856; GO:0031101; GO:0042246; GO:0043049; GO:0045582; GO:0048568; GO:0048702; GO:0050769; GO:0060788; GO:0061026; GO:0071696; GO:2001224";"cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp234_c0_seq1;GAXK01168255.1;P40622;2.63E-10;HMG1A_CHITE;Mobility group protein 1A;"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634; GO:0005694";;"chromosome [GO:0005694]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp23403_c1_seq1;GAXK01011961.1;Q8CGY8;0;OGT1_MOUSE;UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0070207; GO:0070208; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428";"apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]";"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"
comp234038_c1_seq1;GAXK01005553.1;A2ALK8;8.26E-11;PTN3_MOUSE;Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080]; liver regeneration [GO:0097421]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649]";"GO:0001784; GO:0004725; GO:0005737; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0017080; GO:0045930; GO:0051045; GO:0051117; GO:0097421; GO:0098902; GO:2000649";"liver regeneration [GO:0097421]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649]";"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]";"ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080]"
comp234051_c1_seq1;GAXK01005712.1;P15370;2.37E-44;EGON_DROME;Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp2340628_c1_seq1;GAXK01099634.1;P23758;1.86E-68;POXN_DROME;Paired box pox-neuro protein (Paired box neuronal protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; adult feeding behavior [GO:0008343]; antennal morphogenesis [GO:0048800]; cell differentiation [GO:0030154]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; male courtship behavior [GO:0008049]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; response to water [GO:0009415]; sensory organ development [GO:0007423]";"GO:0003677; GO:0005634; GO:0006355; GO:0007399; GO:0007423; GO:0007476; GO:0007480; GO:0008049; GO:0008343; GO:0009415; GO:0030154; GO:0048800";"adult feeding behavior [GO:0008343]; antennal morphogenesis [GO:0048800]; cell differentiation [GO:0030154]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; male courtship behavior [GO:0008049]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; response to water [GO:0009415]; sensory organ development [GO:0007423]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp234065_c0_seq1;GAXK01005470.1;Q9ZCN4;1.58E-21;Y689_RICPR;Uncharacterized protein RP689;"integral component of membrane [GO:0016021]; transferase activity [GO:0016740]";"GO:0016021; GO:0016740";;integral component of membrane [GO:0016021];transferase activity [GO:0016740]
comp234103_c0_seq1;GAXK01005439.1;Q5E9R3;1.16E-86;EHD1_BOVIN;EH domain-containing protein 1;"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]"
comp2341041_c0_seq1;GAXK01099643.1;Q03683;1.26E-29;BIP3_TOBAC;Luminal-binding protein 3 (BiP 3) (78 kDa glucose-regulated protein homolog 3) (GRP-78-3) (Fragment);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp234109_c0_seq1;GAXK01005456.1;Q8W485;1.41E-38;Y5010_ARATH;Uncharacterized protein At5g50100, chloroplastic;"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; protein disulfide oxidoreductase activity [GO:0015035]; tissue regeneration [GO:0042246]";"GO:0005739; GO:0009507; GO:0015035; GO:0042246";tissue regeneration [GO:0042246];"chloroplast [GO:0009507]; mitochondrion [GO:0005739]";protein disulfide oxidoreductase activity [GO:0015035]
comp234145_c0_seq1;GAXK01005550.1;Q8KWT4;6.29E-10;BACC_BACIU;Dihydroanticapsin 7-dehydrogenase (EC 1.1.1.385) (Bacilysin biosynthesis oxidoreductase BacC);"oxidoreductase activity [GO:0016491]; antibiotic biosynthetic process [GO:0017000]";"GO:0016491; GO:0017000";antibiotic biosynthetic process [GO:0017000];;oxidoreductase activity [GO:0016491]
comp23415_c1_seq1;GAXK01012037.1;Q8AXV1;6.04E-24;SH3G2_CHICK;Endophilin-A1 (Endophilin-1) (SH3 domain-containing GRB2-like protein 1) (SH3p4);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]; endocytosis [GO:0006897]";"GO:0005737; GO:0006897; GO:0008289; GO:0016020";endocytosis [GO:0006897];"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp23420_c2_seq1;GAXK01011408.1;P51984;1.22E-26;CREB_HYDVD;Cyclic AMP-responsive element-binding protein (cAMP-responsive element-binding protein) (cAMP response element-binding protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp234232_c0_seq1;GAXK01005471.1;P08928;9.52E-16;LAM0_DROME;Lamin Dm0;"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433";"adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp2342482_c0_seq1;GAXK01045405.1;P08418;8.43E-78;HSP70_SCHMA;Heat shock 70 kDa protein homolog (HSP70) (Major surface antigen);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp234255_c0_seq1;GAXK01005604.1;Q24157;9.00E-66;BRN_DROME;Beta-1,3-galactosyltransferase brn (EC 2.4.1.62) (Brainiac protein) (Neurogenic secreted-signaling protein brn);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0001744; GO:0005576; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0006688; GO:0007219; GO:0007275; GO:0007293; GO:0007298; GO:0007299; GO:0008375; GO:0008376; GO:0008532; GO:0016021; GO:0016333; GO:0030311; GO:0030707; GO:0042248; GO:0046981; GO:0047915; GO:0048477";"border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell-cell adhesion [GO:0007299]; ovarian follicle cell development [GO:0030707]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]"
comp234261_c0_seq1;GAXK01005588.1;Q8JG30;2.16E-21;ST1B1_CHICK;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]";"GO:0005737; GO:0008146; GO:0008202";steroid metabolic process [GO:0008202];cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp234302_c0_seq1;GAXK01005601.1;Q8IN81;2.22E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2343054_c0_seq1;GAXK01045399.1;Q19013;3.13E-33;GLS2_CAEEL;Putative glutaminase 2 (GLS) (EC 3.5.1.2) (L-glutamine amidohydrolase);"mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005739; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrion [GO:0005739];glutaminase activity [GO:0004359]
comp2343174_c0_seq1;GAXK01045406.1;F1QZ88;3.89E-07;E2F8_DANRE;Transcription factor E2F8 (E2F-8);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; lymphangiogenesis [GO:0001946]; motor neuron axon guidance [GO:0008045]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]";"GO:0000122; GO:0000981; GO:0001946; GO:0002040; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0008045; GO:0008134; GO:0032466; GO:0032877; GO:0033301; GO:0043565; GO:0045892; GO:0045944; GO:0051726; GO:0060718; GO:0070365; GO:0090575";"cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; lymphangiogenesis [GO:0001946]; motor neuron axon guidance [GO:0008045]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp2343270_c0_seq1;GAXK01045398.1;Q4UMH6;1.01E-37;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp2343348_c0_seq1;GAXK01045408.1;P41386;8.21E-43;TBB_HALDI;Tubulin beta chain (Beta-tubulin) (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2343379_c0_seq1;GAXK01045387.1;Q9W5R8;2.96E-104;RL5_DROME;60S ribosomal protein L5;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0008097; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp23438_c0_seq1;GAXK01011429.1;Q8MKK4;1.85E-51;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp2343824_c0_seq1;GAXK01045397.1;Q8K4Q0;1.32E-11;RPTOR_MOUSE;Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]";"GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087";"cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]";"14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp2344032_c0_seq1;GAXK01021284.1;Q22165;6.99E-24;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2344526_c0_seq1;GAXK01021293.1;Q6Q473;3.41E-28;CLA4A_MOUSE;"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872";chloride transport [GO:0006821];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2344889_c0_seq1;GAXK01021283.1;Q57146;1.70E-31;PAT_STRVT;Phosphinothricin N-acetyltransferase (PPT N-acetyltransferase) (EC 2.3.1.183) (Phosphinothricin-resistance protein);"N-acetyltransferase activity [GO:0008080]; phosphinothricin N-acetyltransferase activity [GO:0102971]; response to antibiotic [GO:0046677]; response to herbicide [GO:0009635]";"GO:0008080; GO:0009635; GO:0046677; GO:0102971";"response to antibiotic [GO:0046677]; response to herbicide [GO:0009635]";;"N-acetyltransferase activity [GO:0008080]; phosphinothricin N-acetyltransferase activity [GO:0102971]"
comp234514_c1_seq1;GAXK01005459.1;Q9PTU6;5.73E-65;ENDOU_PAROL;Poly(U)-specific endoribonuclease (EC 3.1.-.-) (Pancreatic protein with two somatomedin-B domains) (Protein endoU) (Uridylate-specific endoribonuclease);"extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]";"GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0006955; GO:0030247; GO:0046872";immune response [GO:0006955];extracellular region [GO:0005576];"endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]"
comp234555_c0_seq1;GAXK01005473.1;Q96C28;8.14E-07;ZN707_HUMAN;Zinc finger protein 707;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2345782_c0_seq1;GAXK01021291.1;Q8ITC7;2.87E-22;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp23458_c1_seq1;GAXK01204995.1;Q9UNN5;6.85E-104;FAF1_HUMAN;FAS-associated factor 1 (hFAF1) (UBX domain-containing protein 12) (UBX domain-containing protein 3A);"CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176]";"GO:0005634; GO:0005635; GO:0005829; GO:0006915; GO:0007253; GO:0008219; GO:0010942; GO:0019887; GO:0019901; GO:0019904; GO:0030155; GO:0031072; GO:0031265; GO:0031334; GO:0031625; GO:0034098; GO:0042176; GO:0043065; GO:0043130; GO:0043161; GO:0045740; GO:0048471; GO:0051059; GO:1902043; GO:1903364";"apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176]";"CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
comp2346354_c0_seq1;GAXK01136837.1;Q29043;7.59E-08;FUT1_PIG;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp2346707_c0_seq1;GAXK01136840.1;Q24372;1.17E-09;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp234672_c1_seq1;GAXK01005720.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp2347_c1_seq1;GAXK01176562.1;O44119;1.57E-49;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp23473_c0_seq1;GAXK01011418.1;Q17902;2.38E-44;EGAL1_CAEEL;Egalitarian protein homolog;"nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005635; GO:0008408";;nuclear envelope [GO:0005635];"3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]"
comp234747_c0_seq1;GAXK01005598.1;P52953;1.37E-39;MSX2_RAT;Homeobox protein MSX-2 (Homeobox protein Hox-8-1) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cartilage development [GO:0051216]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001649; GO:0002076; GO:0005634; GO:0006366; GO:0010942; GO:0043065; GO:0044212; GO:0045892; GO:0048598; GO:0051216";"cartilage development [GO:0051216]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp2347521_c0_seq1;GAXK01136867.1;Q9BXF9;5.96E-19;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp2347534_c0_seq1;GAXK01136828.1;O08747;1.70E-12;UNC5C_MOUSE;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C) (Rostral cerebellar malformation protein);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030054; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0033564; GO:0038007; GO:0043025; GO:0043065; GO:0045202; GO:0061643; GO:1990791";"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"
comp234783_c0_seq1;GAXK01005745.1;O55028;3.08E-139;BCKD_MOUSE;[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN);"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; phosphorylation [GO:0016310]";"GO:0004672; GO:0004674; GO:0005524; GO:0005739; GO:0005947; GO:0009083; GO:0016310; GO:0047323";"branched-chain amino acid catabolic process [GO:0009083]; phosphorylation [GO:0016310]";"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]";"[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp234792_c0_seq1;GAXK01005469.1;Q3KNW5;1.22E-20;SOAT_HUMAN;Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085]";"GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251; GO:0055085";"bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]"
comp2347950_c0_seq1;GAXK01136854.1;O00476;1.08E-22;NPT4_HUMAN;Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]";"GO:0005436; GO:0005737; GO:0005764; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0008308; GO:0008514; GO:0015136; GO:0015143; GO:0015562; GO:0015711; GO:0015739; GO:0015747; GO:0015760; GO:0016021; GO:0016324; GO:0019534; GO:0031526; GO:0034220; GO:0042910; GO:0046415; GO:0048471; GO:1990961";"glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp2348186_c0_seq1;GAXK01042716.1;Q13106;4.35E-19;ZN154_HUMAN;Zinc finger protein 154;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp234849_c1_seq1;GAXK01005462.1;Q9QXL2;0;KI21A_MOUSE;Kinesin-like protein KIF21A;"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425";microtubule-based movement [GO:0007018];"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp234856_c0_seq1;GAXK01005494.1;Q9NHE5;0;CAPS_DROME;Calcium-dependent secretion activator (Calcium-activated protein for secretion);"cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030054; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504";"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]";"calcium ion binding [GO:0005509]; lipid binding [GO:0008289]"
comp234867_c3_seq1;GAXK01005615.1;Q9P260;5.95E-87;RELCH_HUMAN;RAB11-binding protein RELCH (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing) (RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats);"recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367]";"GO:0005802; GO:0032367; GO:0055037";intracellular cholesterol transport [GO:0032367];"recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";
comp2348951_c0_seq1;GAXK01042718.1;Q4LDE5;7.87E-08;SVEP1_HUMAN;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp2348984_c0_seq1;GAXK01042729.1;Q8WR63;9.69E-26;TPM_TRIPS;Tropomyosin;;;;;
comp23493_c1_seq1;GAXK01011976.1;Q5NCF2;3.22E-39;TPPC1_MOUSE;Trafficking protein particle complex subunit 1;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]";"GO:0005783; GO:0005794; GO:0006888; GO:0017112; GO:0030008";endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]";Rab guanyl-nucleotide exchange factor activity [GO:0017112]
comp234949_c1_seq1;GAXK01005715.1;Q9U637;5.68E-48;PITX_BRABE;Pituitary homeobox x (Bicoid type transcription factor Pitx) (BbPtx) (Homeobox protein Ptx) (Paired-like homeodomain transcription factor x);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0005634; GO:0007275; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp234969_c0_seq1;GAXK01005551.1;P09653;2.57E-07;TBB5_CHICK;Tubulin beta-5 chain (Beta-tubulin class-V);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2349745_c0_seq1;GAXK01042723.1;Q3TTY0;1.34E-23;PLB1_MOUSE;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp23499_c0_seq1;GAXK01011417.1;Q9NVV5;5.60E-36;AIG1_HUMAN;Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; long-chain fatty acid catabolic process [GO:0042758]";"GO:0016020; GO:0016021; GO:0016787; GO:0042758";long-chain fatty acid catabolic process [GO:0042758];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";hydrolase activity [GO:0016787]
comp2350_c0_seq1;GAXK01175705.1;P42678;3.58E-57;ETIF1_ANOGA;Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog);"eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]";"GO:0003723; GO:0003743; GO:0016282; GO:0043024";;eukaryotic 43S preinitiation complex [GO:0016282];"ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
comp2350280_c0_seq2;GAXK01090512.1;Q8BXX2;2.88E-09;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp235033_c1_seq1;GAXK01005563.1;Q92482;5.90E-64;AQP3_HUMAN;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"GO:0002684; GO:0003091; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323; GO:0032526; GO:0033280; GO:0042476; GO:0045616; GO:0051592; GO:0070295; GO:0071456; GO:0090650";"cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp23508_c0_seq2;GAXK01011315.1;Q5U395;1.49E-113;CNEPA_DANRE;CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]";"GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0006470; GO:0006998; GO:0010867; GO:0016021; GO:0031965; GO:0071595";"nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]";"phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]"
comp2350821_c0_seq1;GAXK01090513.1;Q41093;2.03E-27;FCPE_PHATR;Fucoxanthin-chlorophyll a-c binding protein E, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp2351386_c0_seq1;GAXK01090502.1;A7MBJ2;5.32E-15;SENP7_BOVIN;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp23514_c0_seq1;GAXK01011203.1;Q24400;1.24E-11;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp235162_c0_seq1;GAXK01005710.1;O35789;2.22E-08;B3GA1_RAT;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P);"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; cellular response to hypoxia [GO:0071456]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005576; GO:0005789; GO:0005796; GO:0006486; GO:0008499; GO:0015018; GO:0016021; GO:0046872; GO:0050650; GO:0071456";"cellular response to hypoxia [GO:0071456]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486]";"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp235204_c4_seq1;GAXK01005487.1;Q7KRI2;2.53E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp235207_c1_seq1;GAXK01005449.1;O94431;3.16E-43;EGT2_SCHPO;Hercynylcysteine sulfoxide lyase (EC 4.4.1.-) (Ergothioneine biosynthesis protein 2) (PLP-binding cysteine desulfurase) (PLP-dependent C-S lyase);"cytosol [GO:0005829]; nucleus [GO:0005634]; hercynylcysteine sulfoxide lyase activity (ergothioneine-forming) [GO:1990411]; hercynylselenocysteine lyase activity (selenoneine-forming) [GO:1990412]; ergothioneine biosynthetic process [GO:0052699]; selenoneine biosynthetic process [GO:1903257]";"GO:0005634; GO:0005829; GO:0052699; GO:1903257; GO:1990411; GO:1990412";"ergothioneine biosynthetic process [GO:0052699]; selenoneine biosynthetic process [GO:1903257]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"hercynylcysteine sulfoxide lyase activity (ergothioneine-forming) [GO:1990411]; hercynylselenocysteine lyase activity (selenoneine-forming) [GO:1990412]"
comp235209_c0_seq1;GAXK01005716.1;Q8C0L6;2.73E-16;PAOX_MOUSE;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase);"peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";"GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307";"polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";peroxisomal matrix [GO:0005782];"N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp2352317_c0_seq1;GAXK01051022.1;A6QPT6;1.01E-16;ZN274_BOVIN;Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of histone H3-K9 trimethylation [GO:1900112]";"GO:0003677; GO:0003682; GO:0003700; GO:0005730; GO:0005737; GO:0046872; GO:1900112";regulation of histone H3-K9 trimethylation [GO:1900112];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp23530_c0_seq1;GAXK01011921.1;Q96I24;3.92E-14;FUBP3_HUMAN;Far upstream element-binding protein 3 (FUSE-binding protein 3);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0010628; GO:0016020; GO:0045893; GO:0045944";"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2353233_c0_seq1;GAXK01051030.1;P24014;4.55E-10;SLIT_DROME;"Protein slit (dSlit) [Cleaved into: Protein slit N-product; Protein slit C-product]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell migration [GO:0008078]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"GO:0001764; GO:0003151; GO:0005509; GO:0005576; GO:0005886; GO:0007411; GO:0007427; GO:0007432; GO:0007502; GO:0007509; GO:0008078; GO:0008201; GO:0008347; GO:0008406; GO:0010632; GO:0016199; GO:0016201; GO:0022409; GO:0030182; GO:0030335; GO:0035050; GO:0035385; GO:0048495; GO:0048813; GO:0050929; GO:0071666; GO:2000274";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesodermal cell migration [GO:0008078]; mesoderm migration involved in gastrulation [GO:0007509]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell migration [GO:0030335]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]"
comp235338_c0_seq1;GAXK01005595.1;Q96SW2;1.25E-84;CRBN_HUMAN;Protein cereblon;"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of protein homodimerization activity [GO:0090073]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005730; GO:0005737; GO:0016020; GO:0016567; GO:0031464; GO:0032463; GO:0034766; GO:0043161; GO:0046872; GO:0090073";"negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of protein homodimerization activity [GO:0090073]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp23539_c0_seq1;GAXK01011712.1;P30536;3.04E-32;TSPO_HUMAN;Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; ion channel binding [GO:0044325]; adrenal gland development [GO:0030325]; aging [GO:0007568]; anion transport [GO:0006820]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; lipid transport [GO:0006869]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; steroid metabolic process [GO:0008202]";"GO:0005497; GO:0005741; GO:0005783; GO:0006626; GO:0006700; GO:0006783; GO:0006820; GO:0006821; GO:0006869; GO:0007568; GO:0008202; GO:0008347; GO:0008503; GO:0010042; GO:0010266; GO:0010940; GO:0014012; GO:0015485; GO:0016021; GO:0030325; GO:0031397; GO:0032374; GO:0032570; GO:0032720; GO:0033574; GO:0042127; GO:0043065; GO:0044325; GO:0045019; GO:0048266; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0070062; GO:0071222; GO:0071294; GO:0071476; GO:0072656; GO:1903147; GO:1903579; GO:2000379";"adrenal gland development [GO:0030325]; aging [GO:0007568]; anion transport [GO:0006820]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; lipid transport [GO:0006869]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; steroid metabolic process [GO:0008202]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; ion channel binding [GO:0044325]"
comp2354172_c0_seq1;GAXK01119325.1;Q5R5U3;4.02E-10;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp235447_c0_seq1;GAXK01005746.1;P98160;1.10E-33;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp235449_c0_seq1;GAXK01005454.1;Q7KRI2;9.44E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2354793_c0_seq1;GAXK01119323.1;P42325;3.54E-09;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp235538_c2_seq1;GAXK01005468.1;Q9VZN4;1.14E-49;DAR1_DROME;Dendritic arbor reduction protein 1;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007026; GO:0043565; GO:0045944; GO:0046872; GO:0050775; GO:1903861";"negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp23554_c1_seq1;GAXK01011900.1;O76357;5.31E-07;ILYS3_CAEEL;Invertebrate-type lysozyme 3 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase);"extracellular space [GO:0005615]; late endosome lumen [GO:0031906]; lysosomal lumen [GO:0043202]; recycling endosome lumen [GO:0034777]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; digestion [GO:0007586]; metabolic process [GO:0008152]";"GO:0003796; GO:0005615; GO:0007586; GO:0008152; GO:0008340; GO:0019835; GO:0031906; GO:0034777; GO:0042742; GO:0043202; GO:0050830";"cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; digestion [GO:0007586]; metabolic process [GO:0008152]";"extracellular space [GO:0005615]; late endosome lumen [GO:0031906]; lysosomal lumen [GO:0043202]; recycling endosome lumen [GO:0034777]";lysozyme activity [GO:0003796]
comp235550_c0_seq1;GAXK01005737.1;O35806;1.16E-41;LTBP2_RAT;Latent-transforming growth factor beta-binding protein 2 (LTBP-2);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]; supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005509; GO:0005576; GO:0007179; GO:0008201; GO:0019838; GO:0050436; GO:0097435";"supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]"
comp23564_c3_seq1;GAXK01011228.1;Q03188;5.75E-07;CENPC_HUMAN;Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7);"cleavage furrow [GO:0032154]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]";"GO:0000278; GO:0000776; GO:0000778; GO:0000780; GO:0003677; GO:0005654; GO:0005721; GO:0005829; GO:0007059; GO:0016604; GO:0019237; GO:0030496; GO:0031618; GO:0032154; GO:0034080; GO:0042802; GO:0045171; GO:0051301; GO:0051315; GO:0051382; GO:0051455; GO:0090543";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]";"cleavage furrow [GO:0032154]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]";"centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]"
comp2356504_c0_seq1;GAXK01088812.1;Q9U280;1.67E-16;TAT1_CAEEL;Phospholipid-transporting ATPase tat-1 (EC 7.6.2.1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"GO:0000287; GO:0005524; GO:0005737; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006897; GO:0007040; GO:0015914; GO:0016323; GO:0016324; GO:0031901; GO:0045332; GO:0055038; GO:0060100; GO:0060101; GO:0140326";"endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp2356670_c0_seq1;GAXK01088807.1;Q8BQ86;5.90E-17;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp235709_c0_seq1;GAXK01005452.1;Q99087;2.40E-11;LDLR1_XENLA;Low-density lipoprotein receptor 1 (LDL receptor 1);"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]";"GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362";"cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]";"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp23573_c6_seq1;GAXK01011551.1;P14314;1.43E-52;GLU2B_HUMAN;Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]";"GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219";"cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]"
comp2357398_c0_seq1;GAXK01088814.1;P63079;4.13E-38;GBRB3_RAT;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0030659; GO:0034220; GO:0034707; GO:0035612; GO:0042391; GO:0043005; GO:0043195; GO:0045202; GO:0050877; GO:0051932; GO:0060021; GO:0060077; GO:0071420; GO:0098982; GO:0099055; GO:0099060; GO:1902711; GO:1904862";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp235749_c2_seq1;GAXK01005461.1;O18964;1.36E-108;SYNJ1_BOVIN;Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1) (p150) (Fragment);"perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; phosphatidylinositol dephosphorylation [GO:0046856]; synaptic vesicle endocytosis [GO:0048488]";"GO:0003723; GO:0004439; GO:0007420; GO:0007612; GO:0017124; GO:0046855; GO:0046856; GO:0048471; GO:0048488; GO:0098793";"brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; phosphatidylinositol dephosphorylation [GO:0046856]; synaptic vesicle endocytosis [GO:0048488]";"perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]";"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp2357848_c0_seq1;GAXK01088809.1;P11120;3.20E-34;CALM_PLECO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp23583_c0_seq1;GAXK01011889.1;Q8INX3;2.59E-23;TIPIN_DROME;Protein TIPIN homolog (CSM3 homolog);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]";"GO:0000076; GO:0000790; GO:0003677; GO:0005634; GO:0005737; GO:0008284; GO:0031298; GO:0031573; GO:0043111; GO:0044770; GO:0048478; GO:0051301";"cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]";DNA binding [GO:0003677]
comp2358428_c0_seq1;GAXK01009384.1;P40313;6.80E-29;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp23587_c0_seq1;GAXK01011449.1;Q4FZQ6;1.10E-109;PR38A_XENLA;Pre-mRNA-splicing factor 38A;"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0071005";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]";
comp235888_c0_seq1;GAXK01005599.1;P07451;3.17E-34;CAH3_HUMAN;Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III);"cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]";"GO:0004089; GO:0005829; GO:0006979; GO:0008270; GO:0009617; GO:0015701; GO:0016151; GO:0016791; GO:0045471";"bicarbonate transport [GO:0015701]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];"carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270]"
comp23589_c1_seq1;GAXK01011159.1;Q15427;1.08E-138;SF3B4_HUMAN;Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990904";"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]";RNA binding [GO:0003723]
comp2358990_c0_seq1;GAXK01204991.1;P42575;5.73E-31;CASP2_HUMAN;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0008630; GO:0016020; GO:0016485; GO:0019899; GO:0019904; GO:0035234; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097194; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp2359_c0_seq1;GAXK01176489.1;P42678;1.28E-57;ETIF1_ANOGA;Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog);"eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]";"GO:0003723; GO:0003743; GO:0016282; GO:0043024";;eukaryotic 43S preinitiation complex [GO:0016282];"ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
comp235905_c1_seq1;GAXK01005558.1;P41436;2.54E-15;IAP_GVCPM;Apoptosis inhibitor IAP;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp235921_c0_seq1;GAXK01005714.1;Q6ZMV8;2.81E-17;ZN730_HUMAN;Putative zinc finger protein 730;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp235947_c0_seq1;GAXK01005451.1;Q04896;5.33E-51;HME1A_DANRE;Homeobox protein engrailed-1a (Homeobox protein en-1a);"nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016586; GO:0030182; GO:0043565; GO:0060385";"axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RSC-type complex [GO:0016586]";sequence-specific DNA binding [GO:0043565]
comp2359678_c0_seq1;GAXK01009375.1;Q86WA9;1.15E-29;S2611_HUMAN;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062";"ion transport [GO:0006811]; sulfate transport [GO:0008272]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp2359977_c0_seq1;GAXK01009381.1;O18927;8.12E-30;MMP13_HORSE;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]";"GO:0001958; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349";"bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp236001_c4_seq1;GAXK01129606.1;P08953;5.37E-27;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp23601_c0_seq1;GAXK01011427.1;Q5F413;9.73E-56;SMAP2_CHICK;Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like);"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]";"GO:0005096; GO:0046872";;;"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp236129_c0_seq1;GAXK01129359.1;Q9P217;0;ZSWM5_HUMAN;Zinc finger SWIM domain-containing protein 5;"Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]";"GO:0005615; GO:0008270; GO:0031462; GO:1902667";regulation of axon guidance [GO:1902667];"Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615]";zinc ion binding [GO:0008270]
comp236138_c2_seq1;GAXK01129626.1;Q9H0M4;1.30E-10;ZCPW1_HUMAN;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp2361532_c0_seq1;GAXK01104554.1;P18061;1.53E-31;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2361664_c0_seq1;GAXK01104551.1;Q6IP59;3.40E-38;CTL2_XENLA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp236167_c0_seq1;GAXK01129410.1;O01761;1.08E-56;UNC89_CAEEL;Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89);"A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0035023; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905";"cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]";"ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp2362299_c0_seq1;GAXK01092994.1;P21439;1.53E-33;MDR3_HUMAN;Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; ceramide translocation [GO:0099040]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; regulation of lipid metabolic process [GO:0019216]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0019216; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0099040; GO:1901557; GO:1903413; GO:2001140";"bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; ceramide translocation [GO:0099040]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; regulation of lipid metabolic process [GO:0019216]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid transporter activity [GO:0005548]"
comp2362566_c0_seq1;GAXK01092987.1;Q02427;2.46E-16;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp236278_c0_seq1;GAXK01129417.1;Q9QXW2;6.20E-42;FBXW5_MOUSE;F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";protein kinase binding [GO:0019901]
comp2362836_c0_seq1;GAXK01092983.1;Q6ZMW2;1.75E-23;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp23629_c0_seq1;GAXK01011319.1;Q9VGY6;3.19E-17;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp2363507_c0_seq1;GAXK01092982.1;Q8VHK8;4.37E-17;TM11D_MOUSE;"Transmembrane protease serine 11D (EC 3.4.21.-) (Adrenal secretory serine protease) (AsP) (Airway trypsin-like protease) (AT) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; proteolysis in other organism [GO:0035897]; regulation of growth [GO:0040008]; viral entry into host cell [GO:0046718]";"GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0008236; GO:0009986; GO:0035897; GO:0040008; GO:0046718";"proteolysis [GO:0006508]; proteolysis in other organism [GO:0035897]; regulation of growth [GO:0040008]; viral entry into host cell [GO:0046718]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp236478_c6_seq1;GAXK01129442.1;Q32LQ0;7.65E-33;AMPE_BOVIN;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006";"cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp2364964_c0_seq1;GAXK01153646.1;P49582;7.39E-12;ACHA7_MOUSE;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"GO:0000187; GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008144; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0014069; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032222; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0045471; GO:0045766; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051823; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098793; GO:0098815; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:1905923; GO:2000300; GO:2000463";"acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of acetylcholine biosynthetic process [GO:1905923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, cholinergic [GO:0032222]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]";"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp236532_c0_seq1;GAXK01129614.1;Q05481;1.83E-27;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp23655_c0_seq1;GAXK01012087.1;P53610;3.14E-119;PGTB1_RAT;Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta);"CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; response to cytokine [GO:0034097]";"GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0008284; GO:0018342; GO:0018344; GO:0034097; GO:0045787; GO:0051771";"negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; response to cytokine [GO:0034097]";CAAX-protein geranylgeranyltransferase complex [GO:0005953];"CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]"
comp236554_c0_seq1;GAXK01129431.1;Q9VTY4;3.08E-26;KXDL1_DROME;KxDL motif-containing protein CG10681;"BORC complex [GO:0099078]; lysosome localization [GO:0032418]";"GO:0032418; GO:0099078";lysosome localization [GO:0032418];BORC complex [GO:0099078];
comp23656_c6_seq1;GAXK01011288.1;Q96BM9;6.86E-115;ARL8A_HUMAN;ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2);"axon cytoplasm [GO:1904115]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]";"GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005774; GO:0005886; GO:0007049; GO:0007059; GO:0008089; GO:0015031; GO:0016020; GO:0030054; GO:0030496; GO:0031902; GO:0035577; GO:0043014; GO:0043312; GO:0045202; GO:0048487; GO:0051233; GO:0051301; GO:0070062; GO:0101003; GO:1904115";"anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]";"axon cytoplasm [GO:1904115]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2365613_c0_seq1;GAXK01153644.1;Q8BLR2;2.90E-19;CPNE4_MOUSE;Copine-4 (Copine IV);"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0071277";cellular response to calcium ion [GO:0071277];plasma membrane [GO:0005886];calcium-dependent phospholipid binding [GO:0005544]
comp23658_c0_seq1;GAXK01012095.1;Q8VEG6;0;CNO6L_MOUSE;CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]";"GO:0000175; GO:0000288; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157";"gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp236583_c0_seq1;GAXK01129414.1;Q99KE8;4.50E-23;ZFP64_MOUSE;Zinc finger protein 64 (Zfp-64);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0007275; GO:0010468; GO:0032728; GO:0032755; GO:0032760; GO:0046872; GO:0048026";"multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp236595_c2_seq1;GAXK01129629.1;P42892;1.37E-70;ECE1_HUMAN;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);"early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814]";"GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0070062";"bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814]";"early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]";"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp2366_c0_seq1;GAXK01175732.1;Q4H2R2;9.56E-15;SSRP1_CIOIN;FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Structure-specific recognition protein 1);"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]"
comp2366327_c0_seq1;GAXK01051059.1;Q8K1Q0;4.86E-13;NMT1_RAT;Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]";"GO:0001701; GO:0004379; GO:0005737; GO:0005829; GO:0005886; GO:0018008; GO:0019107; GO:0019898; GO:0042180";"cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]";"glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]"
comp236654_c0_seq1;GAXK01129455.1;Q7PPU9;4.21E-21;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp236656_c0_seq1;GAXK01129437.1;Q969T9;2.62E-32;WBP2_HUMAN;WW domain-binding protein 2 (WBP-2);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]";"GO:0000790; GO:0000978; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045944; GO:0050847; GO:0071391; GO:0071442";"cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]"
comp2366749_c0_seq1;GAXK01051071.1;P27163;6.99E-17;CALM2_PETHY;Calmodulin-2 (CaM-2);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2366784_c0_seq1;GAXK01205251.1;P12981;2.56E-13;JUN_COTJA;Transcription factor AP-1 (Proto-oncogene c-Jun);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265]";"GO:0003700; GO:0005634; GO:0007265; GO:0044212";Ras protein signal transduction [GO:0007265];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]"
comp2366956_c0_seq1;GAXK01051063.1;Q8BG95;3.69E-08;MYPT2_MOUSE;Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2);"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; signal transduction [GO:0007165]";"GO:0004857; GO:0005737; GO:0005856; GO:0007165; GO:0019208; GO:0019901; GO:0030018; GO:0031672";signal transduction [GO:0007165];"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]";"enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]"
comp236699_c0_seq1;GAXK01129449.1;Q9BX95;5.70E-68;SGPP1_HUMAN;Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]";"GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0006668; GO:0006670; GO:0016021; GO:0030148; GO:0035621; GO:0042392; GO:0045616; GO:0045682; GO:0097191; GO:0097193";"ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";sphingosine-1-phosphate phosphatase activity [GO:0042392]
comp236722_c0_seq1;GAXK01129407.1;Q7M3Y8;5.61E-12;TPM_TURCO;Tropomyosin (Major allergen Tur c 1) (allergen Tur c 1) (Fragments);;;;;
comp2367234_c0_seq1;GAXK01051067.1;Q02525;1.63E-13;ZFP39_MOUSE;Zinc finger protein 39 (Zfp-39) (CtFIN33);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp236765_c0_seq1;GAXK01129374.1;Q6NYJ3;1.58E-07;TE2IP_DANRE;Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog) (RAP1 homolog);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; DNA binding [GO:0003677]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000723; GO:0000781; GO:0003677; GO:0005634; GO:0005737; GO:0006355; GO:0010569; GO:0010833; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187";"negative regulation of DNA recombination at telomere [GO:0048239]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; shelterin complex [GO:0070187]";"DNA binding [GO:0003677]; telomeric DNA binding [GO:0042162]"
comp23679_c1_seq1;GAXK01011428.1;Q6DGE9;0;UN45B_DANRE;Protein unc-45 homolog B (Unc-45B) (UNC45-related protein);"A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]";"GO:0002088; GO:0005737; GO:0007519; GO:0030018; GO:0030239; GO:0031672; GO:0048471; GO:0048738; GO:0048747; GO:0051879; GO:0060538; GO:0061077";"cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]";"A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";Hsp90 protein binding [GO:0051879]
comp236803_c0_seq1;GAXK01129495.1;Q8IYB9;1.83E-27;ZN595_HUMAN;Zinc finger protein 595;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2368152_c0_seq1;GAXK01008331.1;Q7K237;2.24E-39;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp23682_c5_seq1;GAXK01011397.1;Q1RMU4;2.12E-28;ERLN2_BOVIN;Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0031625; GO:0032933";"cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp2369340_c0_seq1;GAXK01008351.1;Q95V25;2.18E-56;SLO1_CAEEL;Calcium-activated potassium channel slo-1 (BK channel) (Maxi K channel) (MaxiK) (Slo homolog) (Slowpoke protein 1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"GO:0005249; GO:0005886; GO:0006813; GO:0015269; GO:0015271; GO:0016021; GO:0030054; GO:0031430; GO:0034765; GO:0040011; GO:0042391; GO:0042493; GO:0043050; GO:0045202; GO:0045211; GO:0045214; GO:0046928; GO:0048149; GO:0050804; GO:0055120; GO:0060072";"behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]"
comp2369366_c0_seq1;GAXK01008333.1;Q32KJ8;5.15E-11;ARSI_RAT;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp23700_c1_seq1;GAXK01011251.1;Q9BSF4;1.28E-22;TIM29_HUMAN;Mitochondrial import inner membrane translocase subunit Tim29 (TIM29);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein insertion into mitochondrial inner membrane [GO:0045039]";"GO:0005743; GO:0005758; GO:0016021; GO:0042721; GO:0045039";protein insertion into mitochondrial inner membrane [GO:0045039];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]";
comp2370686_c0_seq1;GAXK01182053.1;Q29RZ4;1.69E-08;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2371215_c0_seq1;GAXK01182063.1;P24505;2.44E-15;SY61_DIPOM;Synaptotagmin-A (Synaptic vesicle protein O-p65-A);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269]";"GO:0005544; GO:0007269; GO:0016021; GO:0030054; GO:0030672; GO:0046872";neurotransmitter secretion [GO:0007269];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]"
comp237147_c0_seq1;GAXK01129454.1;P97260;2.03E-116;SCAP_CRIGR;Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]; protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]; cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]";"GO:0000139; GO:0005783; GO:0005789; GO:0006606; GO:0008022; GO:0008203; GO:0012507; GO:0016020; GO:0030120; GO:0032933; GO:0032934; GO:0032936; GO:0032937; GO:0036315; GO:0090110";"cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]";"protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]"
comp2372113_c0_seq1;GAXK01092717.1;P0C6Y7;4.49E-15;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2372201_c0_seq1;GAXK01092729.1;Q9MYW6;1.99E-41;XDH_FELCA;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp2373052_c0_seq1;GAXK01092726.1;Q7Z7L9;8.76E-14;ZSCA2_HUMAN;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp237348_c0_seq1;GAXK01129628.1;Q9QUI1;3.21E-11;LRA25_MOUSE;Leucine repeat adapter protein 25 (C184L ORF2 protein) (C184M protein) (MMTV receptor);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; transcription corepressor binding [GO:0001222]; establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]";"GO:0001222; GO:0005737; GO:0009986; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392";"establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]";transcription corepressor binding [GO:0001222]
comp2373499_c0_seq1;GAXK01092732.1;O46108;3.55E-33;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp23735_c0_seq1;GAXK01011573.1;A8D8P8;5.33E-83;SIWI_BOMMO;Piwi-like protein Siwi (EC 3.1.26.-);"cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; PET complex [GO:1990923]";"endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]"
comp2374058_c0_seq1;GAXK01095346.1;Q55EH8;7.00E-28;ABCGN_DICDI;ABC transporter G family member 23 (ABC transporter ABCG.23);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016021; GO:0016887";;integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp2374126_c0_seq1;GAXK01095337.1;P41239;1.76E-45;CSK_CHICK;Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]";"GO:0002250; GO:0004715; GO:0005524; GO:0005737; GO:0034332; GO:0046872; GO:0060368";"adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp2374405_c0_seq1;GAXK01095343.1;Q10980;6.58E-25;FUT1_RAT;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha 1,2-fucosyltransferase A) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp23745_c0_seq1;GAXK01011217.1;Q29PG4;3.44E-26;RM51_DROPS;39S ribosomal protein L51, mitochondrial (L51mt) (MRP-L51);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412";translation [GO:0006412];mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp237465_c4_seq1;GAXK01129408.1;P15684;0;AMPN_RAT;Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13);"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0001525; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0031526; GO:0035814; GO:0042277; GO:0043171; GO:0070006";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp2374761_c0_seq1;GAXK01095326.1;A6QLE6;1.07E-137;ANO4_BOVIN;Anoctamin-4 (Transmembrane protein 16D);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]";"GO:0005886; GO:0016021; GO:0046983; GO:0061588";calcium activated phospholipid scrambling [GO:0061588];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";protein dimerization activity [GO:0046983]
comp2374786_c0_seq1;GAXK01095341.1;Q4PB04;4.33E-26;H32_USTMA;Histone H3.2;"nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0005634; GO:0031492; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]"
comp2375_c3_seq1;GAXK01175363.1;P82119;2.73E-12;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp237578_c0_seq1;GAXK01129639.1;Q7ZYC4;4.90E-13;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp2376385_c0_seq1;GAXK01075588.1;O54698;1.41E-31;S29A1_RAT;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0007595; GO:0015858; GO:0015862; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794";"cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp237678_c1_seq1;GAXK01129421.1;Q13105;8.29E-30;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp23769_c0_seq1;GAXK01012076.1;Q91YU8;3.52E-89;SSF1_MOUSE;Suppressor of SWI4 1 homolog (Ssf-1) (Peter Pan homolog);"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; regulation of cell growth by extracellular stimulus [GO:0001560]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0001560; GO:0005634; GO:0005730; GO:0030687";"regulation of cell growth by extracellular stimulus [GO:0001560]; ribosomal large subunit assembly [GO:0000027]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]";
comp23771_c2_seq1;GAXK01011199.1;Q9VN93;3.27E-114;CPR1_DROME;Putative cysteine proteinase CG12163 (EC 3.4.22.-);"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0045169; GO:0051603; GO:0098595";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]";cysteine-type endopeptidase activity [GO:0004197]
comp2377349_c0_seq1;GAXK01075572.1;Q9VS77;4.68E-07;MTH6_DROME;Probable G-protein coupled receptor Mth-like 6 (Protein methuselah-like 6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2377458_c0_seq1;GAXK01075583.1;M0R8U1;4.80E-116;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp237748_c3_seq1;GAXK01129518.1;Q96RT1;4.43E-143;ERBIN_HUMAN;Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2);"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]";"GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0038128; GO:0045104; GO:0045175; GO:0045197; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072";"basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]";"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]";"ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp237789_c1_seq1;GAXK01129493.1;P29773;1.45E-61;ETS2_LYTVA;Protein C-ets-2 (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0005634; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp237792_c0_seq1;GAXK01129625.1;Q91V76;8.54E-24;CK054_MOUSE;Ester hydrolase C11orf54 homolog (EC 3.1.-.-);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]";"GO:0005634; GO:0005654; GO:0008270; GO:0016604; GO:0016788";;"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
comp2378_c0_seq1;GAXK01175888.1;Q803E0;1.82E-28;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp2378224_c0_seq1;GAXK01072095.1;P10911;3.07E-47;MCF2_HUMAN;"Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005829; GO:0005856; GO:0007186; GO:0016020; GO:0016358; GO:0035023; GO:0035556; GO:0043065; GO:0050771; GO:0051056; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]";Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp237847_c0_seq1;GAXK01129436.1;Q9ULC3;9.33E-81;RAB23_HUMAN;Ras-related protein Rab-23;"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2378602_c0_seq1;GAXK01072093.1;Q7ZYC4;2.43E-77;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp237875_c0_seq1;GAXK01129638.1;Q6AYU1;2.19E-76;MO4L1_RAT;Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Transcription factor-like protein MRG15);"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; cell population proliferation [GO:0008283]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"GO:0000123; GO:0000724; GO:0003682; GO:0006342; GO:0008283; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0047485";"cell population proliferation [GO:0008283]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]";"chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]"
comp237878_c1_seq1;GAXK01129580.1;P49021;2.39E-11;TIM_DROME;Protein timeless;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; protein import into nucleus [GO:0006606]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]; sleep [GO:0030431]";"GO:0000076; GO:0000122; GO:0000790; GO:0003053; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006606; GO:0007617; GO:0007620; GO:0007622; GO:0007623; GO:0008062; GO:0008134; GO:0009648; GO:0009649; GO:0030431; GO:0031298; GO:0032991; GO:0042306; GO:0042749; GO:0043111; GO:0045187; GO:0045475; GO:0046957; GO:0046982; GO:0048471; GO:0048478; GO:0048512; GO:0050764; GO:0050766; GO:0060086; GO:0071482; GO:2000678";"cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; protein import into nucleus [GO:0006606]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]; sleep [GO:0030431]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; replication fork protection complex [GO:0031298]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp2378818_c0_seq1;GAXK01072101.1;Q80ZD3;2.43E-19;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp2379075_c0_seq1;GAXK01072084.1;Q99315;5.79E-08;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp2379194_c0_seq1;GAXK01072099.1;Q8SWR3;1.32E-22;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp237929_c0_seq1;GAXK01129630.1;Q9D2D9;6.78E-08;KLD8B_MOUSE;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp2379293_c0_seq1;GAXK01072073.1;P02597;6.94E-07;CALMS_CHICK;Calmodulin, striated muscle;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2379611_c0_seq1;GAXK01072096.1;P10077;2.15E-16;ZFP27_MOUSE;Zinc finger protein 27 (Zfp-27) (Protein mKR4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2379961_c0_seq1;GAXK01072097.1;Q9WTV8;1.87E-08;V1AR_MICMA;Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vasopressin receptor activity [GO:0005000]; male mating behavior [GO:0060179]";"GO:0005000; GO:0005886; GO:0016021; GO:0060179";male mating behavior [GO:0060179];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";vasopressin receptor activity [GO:0005000]
comp23801_c4_seq1;GAXK01011594.1;Q9CQN1;0;TRAP1_MOUSE;Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1);"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]";"GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751";"negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]";"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]"
comp2380121_c0_seq1;GAXK01128066.1;F1NHE9;2.15E-59;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp2380256_c0_seq1;GAXK01128065.1;Q9ERC5;7.48E-128;OTOF_RAT;Otoferlin (Fer-1-like protein 2);"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007605; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0044877; GO:0045177; GO:0045178; GO:0090102";"cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]"
comp2380441_c0_seq1;GAXK01128059.1;Q66S03;4.31E-13;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp23807_c6_seq2;GAXK01011494.1;P35658;8.47E-16;NU214_HUMAN;Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN);"cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000278; GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0005925; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0006611; GO:0008139; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0043231; GO:0043488; GO:0043657; GO:0046822; GO:0051726; GO:0060964; GO:0075733; GO:1900034; GO:1990876";"intracellular transport of virus [GO:0075733]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]"
comp238092_c0_seq1;GAXK01099200.1;Q7KRI2;3.34E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2381212_c0_seq1;GAXK01128063.1;P93748;1.42E-13;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2381239_c0_seq1;GAXK01128075.1;Q66S17;4.81E-07;NATT3_THANI;Natterin-3 (EC 3.4.-.-);"extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; toxin activity [GO:0090729]";"GO:0005576; GO:0016787; GO:0090729";;extracellular region [GO:0005576];"hydrolase activity [GO:0016787]; toxin activity [GO:0090729]"
comp238145_c2_seq1;GAXK01099048.1;P69526;9.39E-62;TMPS9_RAT;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp2382_c1_seq1;GAXK01175723.1;P86854;1.60E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp2382602_c0_seq1;GAXK01173305.1;Q8VI56;2.43E-09;LRP4_MOUSE;Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan);"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp2382824_c0_seq1;GAXK01173304.1;Q96K62;6.77E-08;ZBT45_HUMAN;Zinc finger and BTB domain-containing protein 45 (Zinc finger protein 499);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]";"GO:0003677; GO:0005634; GO:0007399; GO:0046872";nervous system development [GO:0007399];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2383511_c0_seq1;GAXK01173295.1;P61356;1.96E-39;RL27_BOVIN;60S ribosomal protein L27;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; rRNA processing [GO:0006364]; translation [GO:0006412]";"GO:0003735; GO:0006364; GO:0006412; GO:0015934; GO:0022625; GO:0098556";"rRNA processing [GO:0006364]; translation [GO:0006412]";"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp238359_c0_seq1;GAXK01099101.1;Q5ZLY5;3.53E-09;PKHF2_CHICK;Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]"
comp2383764_c0_seq1;GAXK01173298.1;Q9HAR2;5.02E-26;AGRL3_HUMAN;Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp23842_c0_seq1;GAXK01011407.1;Q92734;1.43E-31;TFG_HUMAN;Protein TFG (TRK-fused gene protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0048208; GO:0070971";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]";identical protein binding [GO:0042802]
comp2384221_c0_seq1;GAXK01015513.1;Q5U3Z0;5.00E-68;CF298_RAT;Cilia- and flagella-associated protein 298 (Protein kurly homolog);"cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; regulation of cilium movement [GO:0003352]";"GO:0003352; GO:0005829; GO:0005856; GO:0005929";regulation of cilium movement [GO:0003352];"cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";
comp238424_c1_seq1;GAXK01099096.1;Q16739;7.53E-131;CEGT_HUMAN;Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769]; cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid metabolic process [GO:0006687]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966]";"GO:0000139; GO:0006497; GO:0006679; GO:0006687; GO:0008120; GO:0008544; GO:0009966; GO:0016021; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:0102769; GO:1903575";"cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid metabolic process [GO:0006687]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769]"
comp238428_c0_seq1;GAXK01099103.1;Q22067;3.50E-125;AATC_CAEEL;Aspartate aminotransferase, cytoplasmic (EC 2.6.1.1) (Glutamate oxaloacetate transaminase 1.2) (Transaminase A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]; positive regulation of glutamate metabolic process [GO:2000213]";"GO:0004069; GO:0005737; GO:0005829; GO:0006103; GO:0006531; GO:0006532; GO:0006536; GO:0030170; GO:2000213";"2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]; positive regulation of glutamate metabolic process [GO:2000213]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]"
comp238437_c2_seq1;GAXK01099190.1;Q9VH78;4.65E-118;ALG12_DROME;Probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0016021; GO:0052824; GO:0052917";"dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; mannosyltransferase activity [GO:0000030]"
comp2384405_c0_seq1;GAXK01015506.1;P24666;3.98E-08;PPAC_HUMAN;Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0003993; GO:0004725; GO:0004726; GO:0005737; GO:0009898; GO:0070062";;"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]";"acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]"
comp2384512_c0_seq1;GAXK01015493.1;Q96MR6;1.78E-79;CFA57_HUMAN;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp2384744_c0_seq1;GAXK01015512.1;E9Q7R9;1.51E-63;CFA43_MOUSE;Cilia- and flagella-associated protein 43;"axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]";"GO:0005930; GO:0007288; GO:0031514; GO:1905419";"sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]";"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp2385_c10_seq1;GAXK01176134.1;Q8TAQ2;6.09E-146;SMRC2_HUMAN;SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2);"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0003677; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565";"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]";"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]"
comp238511_c0_seq1;GAXK01099086.1;Q7KRI2;1.25E-43;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp23853_c1_seq1;GAXK01011320.1;Q15853;1.10E-44;USF2_HUMAN;Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12) (bHLHb12) (FOS-interacting protein) (FIP) (Major late transcription factor 2) (Upstream transcription factor 2);"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366]";"GO:0000430; GO:0000432; GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006366; GO:0007595; GO:0019086; GO:0042803; GO:0043231; GO:0043425; GO:0043565; GO:0045944; GO:0046982; GO:0055088";"lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366]";"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp2385680_c0_seq1;GAXK01015511.1;Q91ZS8;9.77E-136;RED1_MOUSE;Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042803; GO:0044387; GO:0045070; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049";"adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp2385816_c0_seq1;GAXK01015503.1;Q16445;8.94E-74;GBRA6_HUMAN;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2386196_c0_seq1;GAXK01027493.1;Q8VIG1;6.17E-11;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp238643_c1_seq1;GAXK01099115.1;Q9J504;7.42E-07;V231_FOWPN;Putative ankyrin repeat protein FPV231;;;;;
comp238661_c0_seq1;GAXK01099140.1;Q05158;3.34E-18;CSRP2_COTJA;Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2);"nucleus [GO:0005634]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005634; GO:0007275; GO:0008270; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";nucleus [GO:0005634];zinc ion binding [GO:0008270]
comp2386699_c0_seq1;GAXK01027501.1;Q8CG85;2.25E-08;MAMC2_MOUSE;MAM domain-containing protein 2 (MAM domain-containing proteoglycan) (Mamcan);"endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; glycosaminoglycan binding [GO:0005539]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]";"GO:0005539; GO:0005614; GO:0005783; GO:0016020; GO:0019800; GO:0031012";peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800];"endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; interstitial matrix [GO:0005614]; membrane [GO:0016020]";glycosaminoglycan binding [GO:0005539]
comp23869_c0_seq1;GAXK01012080.1;Q0VD32;2.24E-20;CRBL2_BOVIN;cAMP-responsive element-binding protein-like 2;"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]";"GO:0003677; GO:0003700; GO:0005634; GO:0016032; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821";"cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp238732_c0_seq1;GAXK01099102.1;Q9UL36;4.05E-17;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp23881_c0_seq1;GAXK01011994.1;Q5TUE9;1.31E-43;RM23_ANOGA;Probable 39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005762; GO:0032543";mitochondrial translation [GO:0032543];mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp2388423_c0_seq1;GAXK01159093.1;Q8BP00;7.00E-09;IQCB1_MOUSE;IQ calmodulin-binding motif-containing protein 1;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]";"GO:0001750; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0072686";"cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]";"calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]"
comp2388914_c0_seq1;GAXK01159081.1;Q5UR45;7.39E-22;YL572_MIMIV;Putative AAA family ATPase L572;"ATP binding [GO:0005524]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005524; GO:0034551";mitochondrial respiratory chain complex III assembly [GO:0034551];;ATP binding [GO:0005524]
comp2389100_c0_seq1;GAXK01159097.1;Q96QE2;4.24E-36;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp2389591_c0_seq1;GAXK01159094.1;P63185;2.86E-20;SRC_RSVSE;Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524";;;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp2389824_c0_seq1;GAXK01159088.1;P26714;1.52E-15;GBRB_LYMST;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]";"GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp2389841_c0_seq1;GAXK01159083.1;O02019;3.45E-48;SUH_HALRO;Suppressor of hairless homolog (RBP-Jkappa);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]";"GO:0000978; GO:0001228; GO:0005634; GO:0007219; GO:0007275";"multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp238988_c0_seq1;GAXK01099017.1;Q9VY77;7.35E-128;AJUBA_DROME;LIM domain-containing protein jub;"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0007010; GO:0030707; GO:0035331; GO:0045177; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:2000637";"cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]";"metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp239003_c0_seq1;GAXK01099150.1;P36220;2.13E-137;TBA_TORMA;Tubulin alpha chain (Alpha T6) [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2390106_c0_seq1;GAXK01194149.1;A7T1N0;3.13E-32;TMP2L_NEMVE;Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"GO:0005886; GO:0015280; GO:0016021; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604";"calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]"
comp239060_c0_seq1;GAXK01099082.1;Q9VVI3;0;NEDD4_DROME;E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:1905062; GO:1905306; GO:2000650";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp2390700_c0_seq1;GAXK01194148.1;Q8MPF7;8.41E-66;RSSA_TOXGO;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp239154_c0_seq1;GAXK01099143.1;Q8WXB4;4.50E-27;ZN606_HUMAN;Zinc finger protein 606 (Zinc finger protein 328);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2391541_c0_seq1;GAXK01194140.1;Q9V817;9.20E-08;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp23918_c0_seq1;GAXK01011485.1;Q3SZZ5;2.44E-19;TM208_BOVIN;Transmembrane protein 208;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vacuole [GO:0005773]; autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]";"GO:0005773; GO:0005789; GO:0006624; GO:0006914; GO:0016021";"autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vacuole [GO:0005773]";
comp239186_c0_seq1;GAXK01099047.1;P26779;1.78E-09;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp2391884_c0_seq1;GAXK01194159.1;Q3UHK1;3.33E-33;MYCT_MOUSE;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];integral component of plasma membrane [GO:0005887];myo-inositol:proton symporter activity [GO:0005366]
comp2391938_c0_seq1;GAXK01194146.1;O54898;5.46E-23;CAC1G_RAT;Voltage-dependent T-type calcium channel subunit alpha-1G (Voltage-gated calcium channel subunit alpha Cav3.1);"cell body [GO:0044297]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; artery smooth muscle contraction [GO:0014824]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to dexamethasone stimulus [GO:0071549]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"GO:0005886; GO:0005891; GO:0007204; GO:0008332; GO:0014824; GO:0016020; GO:0019228; GO:0030425; GO:0034765; GO:0043025; GO:0044297; GO:0045956; GO:0048471; GO:0051924; GO:0060402; GO:0070509; GO:0071549; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091";"artery smooth muscle contraction [GO:0014824]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to dexamethasone stimulus [GO:0071549]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"cell body [GO:0044297]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]"
comp2392_c15_seq1;GAXK01175584.1;P98069;4.49E-10;BMPH_STRPU;Bone morphogenetic protein 1 homolog (EC 3.4.24.-) (SUBMP);"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];;"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2392039_c0_seq1;GAXK01062916.1;P34410;7.09E-09;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp239226_c0_seq1;GAXK01099023.1;P05661;1.17E-70;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2392593_c0_seq1;GAXK01062924.1;Q13796;4.96E-17;SHRM2_HUMAN;Protein Shroom2 (Apical-like protein) (Protein APXL);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"GO:0002089; GO:0003779; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005913; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0030036; GO:0030864; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]"
comp23927_c0_seq1;GAXK01011353.1;Q9VP61;0;ACSA_DROME;Acetyl-coenzyme A synthetase (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-activating enzyme);"cytoplasm [GO:0005737]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; short-chain fatty acid-CoA ligase activity [GO:0031955]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; behavioral response to ethanol [GO:0048149]; fatty acid biosynthetic process [GO:0006633]";"GO:0003987; GO:0005524; GO:0005737; GO:0006633; GO:0016208; GO:0019427; GO:0031955; GO:0048149";"acetyl-CoA biosynthetic process from acetate [GO:0019427]; behavioral response to ethanol [GO:0048149]; fatty acid biosynthetic process [GO:0006633]";cytoplasm [GO:0005737];"acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; short-chain fatty acid-CoA ligase activity [GO:0031955]"
comp239276_c0_seq1;GAXK01099051.1;A0JPA0;3.03E-106;CNNM4_XENTR;Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]";"GO:0005886; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0022857";"magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]"
comp239289_c0_seq1;GAXK01099105.1;Q32PP9;4.87E-44;SOX14_DANRE;Transcription factor Sox-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation [GO:0030154]; hypothalamus development [GO:0021854]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0021854; GO:0030154; GO:0044798";"cell differentiation [GO:0030154]; hypothalamus development [GO:0021854]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp23931_c2_seq1;GAXK01011327.1;O17732;0;PYC1_CAEEL;Pyruvate carboxylase 1 (EC 6.4.1.1) (Pyruvic carboxylase 1) (PCB 1);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]";"GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0006090; GO:0006094; GO:0009374; GO:0046872";"gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]"
comp239326_c0_seq1;GAXK01099107.1;Q8IN81;1.41E-20;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp23934_c1_seq1;GAXK01011346.1;Q4R8M9;7.86E-16;GTSF1_MACFA;Gametocyte-specific factor 1 (Protein FAM112B);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";cytoplasm [GO:0005737];metal ion binding [GO:0046872]
comp2393950_c0_seq1;GAXK01062912.1;Q10056;9.12E-24;SHK2_SCHPO;Serine/threonine-protein kinase shk2 (EC 2.7.11.1);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; MAPK cascade [GO:0000165]; plasma membrane fusion involved in cytogamy [GO:0032220]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000165; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0016477; GO:0023014; GO:0031098; GO:0032147; GO:0032220; GO:0043408; GO:0048365";"activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; MAPK cascade [GO:0000165]; plasma membrane fusion involved in cytogamy [GO:0032220]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]"
comp239403_c0_seq1;GAXK01099025.1;Q8N9R8;0;SCAI_HUMAN;Protein SCAI (Suppressor of cancer cell invasion protein);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]";"GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016021; GO:0030336; GO:0031965; GO:0035024";"negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";transcription corepressor activity [GO:0003714]
comp2395273_c0_seq1;GAXK01059613.1;Q05481;2.71E-07;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp2395384_c0_seq1;GAXK01059602.1;Q8BLD9;1.44E-26;DRD5_MOUSE;D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor);"axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of protein kinase activity [GO:0006469]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; synaptic transmission, dopaminergic [GO:0001963]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060]";"GO:0001588; GO:0001963; GO:0001965; GO:0001975; GO:0001992; GO:0001994; GO:0004930; GO:0004952; GO:0005886; GO:0005929; GO:0006469; GO:0007189; GO:0007191; GO:0007212; GO:0007617; GO:0008144; GO:0008306; GO:0008542; GO:0019226; GO:0030336; GO:0030424; GO:0030425; GO:0031526; GO:0033861; GO:0035240; GO:0042060; GO:0042220; GO:0043025; GO:0043197; GO:0045776; GO:0045924; GO:0046960; GO:0048169; GO:0060170; GO:0060292; GO:0071870; GO:0072593; GO:0097730; GO:0098978; GO:0099061; GO:0099072";"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of protein kinase activity [GO:0006469]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; synaptic transmission, dopaminergic [GO:0001963]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060]";"axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; drug binding [GO:0008144]; G-protein alpha-subunit binding [GO:0001965]; G protein-coupled receptor activity [GO:0004930]"
comp239560_c1_seq1;GAXK01099018.1;P10925;1.64E-25;ZFY1_MOUSE;Zinc finger Y-chromosomal protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2395803_c0_seq1;GAXK01059608.1;Q9ULH0;4.69E-21;KDIS_HUMAN;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090";"activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]"
comp239594_c1_seq1;GAXK01099153.1;G5ECX0;3.53E-28;LPLT2_CAEEL;Latrophilin-like protein LAT-2;"integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";"GO:0004175; GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0030246; GO:0097264";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";integral component of plasma membrane [GO:0005887];"carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]"
comp2396037_c0_seq1;GAXK01054684.1;Q9PPI9;0;DPO3A_CAMJE;DNA polymerase III subunit alpha (EC 2.7.7.7);"cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]";"GO:0003887; GO:0005737; GO:0006260; GO:0008408";DNA replication [GO:0006260];cytoplasm [GO:0005737];"3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]"
comp2396452_c0_seq1;GAXK01054678.1;Q1RLL3;4.00E-13;CPNE9_MOUSE;Copine-9 (Copine IX);"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]";"GO:0005544; GO:0005886; GO:0071277; GO:1903861";"cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]";plasma membrane [GO:0005886];calcium-dependent phospholipid binding [GO:0005544]
comp2396466_c0_seq1;GAXK01054681.1;Q94HW2;2.42E-20;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp23967_c1_seq1;GAXK01011957.1;Q502L2;2.78E-79;PGAM5_DANRE;Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; phosphoprotein phosphatase activity [GO:0004721]; programmed cell death [GO:0012501]";"GO:0004721; GO:0005741; GO:0012501; GO:0016021";programmed cell death [GO:0012501];"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";phosphoprotein phosphatase activity [GO:0004721]
comp239743_c1_seq1;GAXK01099131.1;Q9Y289;9.30E-20;SC5A6_HUMAN;Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6);"brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; transmembrane transport [GO:0055085]";"GO:0005886; GO:0005887; GO:0006768; GO:0008523; GO:0012506; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0031526; GO:0055085";"biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; transmembrane transport [GO:0055085]";"brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]
comp2397658_c0_seq1;GAXK01054686.1;Q9WTJ2;2.63E-08;OVOL1_MOUSE;Putative transcription factor Ovo-like 1 (mOvo1) (mOvo1a);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; skin development [GO:0043588]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0001822; GO:0003700; GO:0005634; GO:0007283; GO:0007498; GO:0008544; GO:0009913; GO:0043565; GO:0043588; GO:0045892; GO:0046872; GO:0051729; GO:1901994; GO:2000647";"epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; skin development [GO:0043588]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp23977_c3_seq1;GAXK01011909.1;Q9EQ20;0;MMSA_MOUSE;Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thiolester hydrolase activity [GO:0016790]; beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";"GO:0004491; GO:0005654; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0016790; GO:0018478; GO:0019484; GO:0019859; GO:0050873";"beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thiolester hydrolase activity [GO:0016790]"
comp239790_c0_seq1;GAXK01099108.1;Q9P2U8;5.76E-121;VGLU2_HUMAN;Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6);"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005313; GO:0005326; GO:0005887; GO:0006811; GO:0006814; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0050803; GO:0060076; GO:0098700";"ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp2398046_c0_seq1;GAXK01082919.1;Q9H3Q3;8.88E-22;G3ST2_HUMAN;Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2) (Glycoprotein beta-Gal 3'-sulfotransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]";"GO:0001733; GO:0008146; GO:0009247; GO:0016020; GO:0016021; GO:0032580";glycolipid biosynthetic process [GO:0009247];"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]"
comp2398069_c0_seq1;GAXK01082929.1;O89110;7.45E-09;CASP8_MOUSE;"Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]";"CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; Noc1p-Noc2p complex [GO:0030690]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of thymocyte apoptotic process [GO:0070243]; response to ethanol [GO:0045471]; response to tumor necrosis factor [GO:0034612]; TRAIL-activated apoptotic signaling pathway [GO:0036462]";"GO:0001525; GO:0001841; GO:0004175; GO:0004197; GO:0005123; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006919; GO:0007507; GO:0008233; GO:0008625; GO:0030225; GO:0030690; GO:0031264; GO:0031265; GO:0031625; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0046982; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097202; GO:0097284; GO:0097342; GO:1901216; GO:2001233; GO:2001238";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of thymocyte apoptotic process [GO:0070243]; response to ethanol [GO:0045471]; response to tumor necrosis factor [GO:0034612]; TRAIL-activated apoptotic signaling pathway [GO:0036462]";"CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; Noc1p-Noc2p complex [GO:0030690]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]"
comp2398107_c0_seq1;GAXK01082905.1;A6NDX5;8.42E-08;ZN840_HUMAN;Putative zinc finger protein 840 (Zinc finger protein 840 pseudogene);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp239882_c5_seq1;GAXK01099160.1;O35710;7.64E-70;NOCT_MOUSE;Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005737; GO:0005739; GO:0006397; GO:0006739; GO:0007623; GO:0009991; GO:0010629; GO:0019178; GO:0030014; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757";"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADPH phosphatase activity [GO:0102757]; NADP phosphatase activity [GO:0019178]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp2399176_c0_seq1;GAXK01082903.1;Q27433;2.43E-43;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp239927_c1_seq1;GAXK01099055.1;Q9V5L3;1.49E-67;C49A1_DROME;Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016491; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp23994_c0_seq1;GAXK01011438.1;P00568;5.35E-51;KAD1_HUMAN;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004017; GO:0004550; GO:0005524; GO:0005829; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0070062";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp2399544_c0_seq1;GAXK01082901.1;P42519;1.02E-10;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp2399620_c0_seq1;GAXK01082895.1;Q869C3;4.60E-72;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp2399712_c0_seq1;GAXK01082910.1;A2AS55;3.33E-14;ANR16_MOUSE;Ankyrin repeat domain-containing protein 16;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA modification [GO:0006400]";"GO:0005634; GO:0005737; GO:0006400";tRNA modification [GO:0006400];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2399944_c0_seq1;GAXK01082902.1;Q14721;4.94E-79;KCNB1_HUMAN;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0050796; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp24_c0_seq1;GAXK01166065.1;P05765;1.60E-43;RS21_RAT;40S ribosomal protein S21;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]";"GO:0000447; GO:0000461; GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788; GO:0043022";"cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]";"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";"ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]"
comp2400058_c0_seq1;GAXK01021190.1;Q14CN2;3.51E-18;CLCA4_HUMAN;"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872";ion transmembrane transport [GO:0034220];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2400210_c0_seq1;GAXK01021206.1;O15457;4.22E-51;MSH4_HUMAN;MutS protein homolog 4 (hMSH4);"mismatch repair complex [GO:0032300]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"GO:0000228; GO:0000712; GO:0000795; GO:0001541; GO:0003677; GO:0005524; GO:0005634; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0008094; GO:0030983; GO:0032300";"female gamete generation [GO:0007292]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]";"mismatch repair complex [GO:0032300]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]"
comp2400223_c0_seq1;GAXK01021194.1;Q17NV8;1.37E-14;TRET1_AEDAE;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2400321_c0_seq1;GAXK01021186.1;O62836;4.94E-08;ZFX_BOVIN;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746";"fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2400835_c0_seq1;GAXK01021204.1;Q86FP7;3.44E-77;RS23_DERVA;40S ribosomal protein S23;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";structural constituent of ribosome [GO:0003735]
comp2401013_c0_seq1;GAXK01021185.1;Q54MF3;2.40E-10;CANB2_DICDI;Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2);"calcium ion binding [GO:0005509]; protein dephosphorylation [GO:0006470]";"GO:0005509; GO:0006470";protein dephosphorylation [GO:0006470];;calcium ion binding [GO:0005509]
comp24013_c0_seq1;GAXK01124696.1;Q3Y8M6;5.47E-83;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp2401314_c0_seq1;GAXK01021200.1;Q20065;9.47E-24;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp2401601_c0_seq1;GAXK01021196.1;Q6GN42;8.88E-11;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp2401844_c0_seq1;GAXK01021184.1;P93748;4.40E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp24019_c0_seq1;GAXK01125513.1;P16303;6.38E-77;CES1D_RAT;Carboxylesterase 1D (Carboxyesterase ES-10) (Carboxylesterase 3) (EC 3.1.1.1) (EC 3.1.1.67) (ES-HVEL) (Fatty acid ethyl ester synthase) (FAEE synthase) (Liver carboxylesterase 10) (pI 6.1 esterase);"cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acylglycerol catabolic process [GO:0046464]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0005811; GO:0005829; GO:0016042; GO:0030339; GO:0046464; GO:0052689; GO:0080030";"acylglycerol catabolic process [GO:0046464]; lipid catabolic process [GO:0016042]";"cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]";"carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"
comp240199_c0_seq1;GAXK01135333.1;O54963;9.27E-07;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2402417_c0_seq1;GAXK01063043.1;Q2KJG8;7.45E-134;BCKD_BOVIN;[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN);"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; phosphorylation [GO:0016310]";"GO:0004674; GO:0005524; GO:0005947; GO:0009083; GO:0016310; GO:0047323";"branched-chain amino acid catabolic process [GO:0009083]; phosphorylation [GO:0016310]";mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947];"[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp240255_c1_seq1;GAXK01135146.1;Q9NHV9;9.16E-28;VAV_DROME;Protein vav (DroVav) (dVAV);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035023; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";cytosol [GO:0005829];"metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]"
comp2402611_c0_seq1;GAXK01063040.1;P35440;6.17E-33;TSP2_CHICK;Thrombospondin-2;"collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]";"GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023";"cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]";collagen-containing extracellular matrix [GO:0062023];"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp24030_c2_seq1;GAXK01125638.1;P54687;2.80E-131;BCAT1_HUMAN;Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid catabolic process [GO:0009083]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"GO:0000082; GO:0004084; GO:0005739; GO:0005829; GO:0009082; GO:0009083; GO:0009098; GO:0009099; GO:0042802; GO:0052654; GO:0052655; GO:0052656";"branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid catabolic process [GO:0009083]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]"
comp2403088_c0_seq1;GAXK01063050.1;Q9NXL6;4.79E-09;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp240320_c0_seq1;GAXK01135109.1;Q6ZMS4;1.07E-23;ZN852_HUMAN;Zinc finger protein 852;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp240330_c0_seq1;GAXK01135155.1;Q8UW76;3.28E-64;TBX20_CHICK;T-box transcription factor TBX20 (T-box protein 20) (cTbx20);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"GO:0000122; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010991; GO:0021524; GO:0030335; GO:0035922; GO:0036306; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0060973; GO:2000793";"aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]"
comp240332_c0_seq1;GAXK01135074.1;Q7TNC6;4.35E-85;KI26B_MOUSE;Kinesin-like protein KIF26B;"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]";"GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0022409; GO:0030010; GO:0072092";"establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]";"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp24043_c1_seq1;GAXK01125210.1;Q9ULI1;1.57E-114;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp240454_c0_seq1;GAXK01135401.1;Q96MU6;1.16E-15;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp240490_c1_seq1;GAXK01135381.1;O61307;0;TENM_DROME;Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0030054; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331";"cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp24050_c0_seq1;GAXK01125391.1;Q8NF91;1.08E-07;SYNE1_HUMAN;Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292";"cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp240555_c3_seq1;GAXK01135402.1;Q92072;1.97E-09;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp24057_c2_seq1;GAXK01125606.1;Q27128;0;PAPSS_URECA;"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]";"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103]";"GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779";sulfate assimilation [GO:0000103];;"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]"
comp24058_c0_seq1;GAXK01125042.1;H2LBU8;9.17E-50;YAP1_ORYLA;Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0035329; GO:0045944";"hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp2406_c1_seq1;GAXK01175287.1;Q1JQA3;3.63E-104;AP3S2_BOVIN;AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b);"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030659; GO:0043231; GO:0048490; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]";
comp2406119_c0_seq1;GAXK01154359.1;P54001;1.15E-14;P4HA1_RAT;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp2406159_c0_seq1;GAXK01154376.1;Q7RVN0;1.54E-75;RL11_NEUCR;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp240626_c0_seq1;GAXK01135435.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp24063_c2_seq1;GAXK01125488.1;Q3T105;8.25E-142;GALE_BOVIN;UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase);"cytosol [GO:0005829]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]";"GO:0003974; GO:0003978; GO:0005829; GO:0019388; GO:0033499; GO:0042803";"galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]";cytosol [GO:0005829];"protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]"
comp2406437_c0_seq1;GAXK01154371.1;Q9V818;3.04E-10;MTH3_DROME;Probable G-protein coupled receptor Mth-like 3 (Protein methuselah-like 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp240672_c6_seq1;GAXK01135404.1;Q8NDA2;3.77E-39;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp240687_c1_seq1;GAXK01135082.1;Q7KRI2;2.38E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp240720_c0_seq1;GAXK01135123.1;Q68DU8;5.16E-44;KCD16_HUMAN;BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16);"cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein homooligomerization [GO:0051260]";"GO:0030054; GO:0042734; GO:0045211; GO:0051260";protein homooligomerization [GO:0051260];"cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";
comp2407218_c0_seq1;GAXK01154367.1;Q8SWR3;1.38E-07;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp240735_c1_seq1;GAXK01205798.1;Q6NZM9;2.87E-114;HDAC4_MOUSE;Histone deacetylase 4 (HD4) (EC 3.5.1.98);"A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]";"GO:0000118; GO:0000122; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003677; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010592; GO:0010832; GO:0010882; GO:0014894; GO:0014911; GO:0016575; GO:0017053; GO:0019789; GO:0019901; GO:0030017; GO:0030018; GO:0030955; GO:0031594; GO:0031672; GO:0032041; GO:0032991; GO:0033235; GO:0033558; GO:0033613; GO:0034983; GO:0040029; GO:0042493; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0043525; GO:0045668; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0048742; GO:0051091; GO:0051153; GO:0070491; GO:0070555; GO:0070932; GO:0070933; GO:0071260; GO:0071356; GO:0071374; GO:1902437; GO:1902894; GO:1903428; GO:1990841";"cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]";"A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]";"activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp2407350_c0_seq1;GAXK01154357.1;Q62600;4.27E-53;NOS3_RAT;Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII);"apical part of cell [GO:0045177]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; bone development [GO:0060348]; cellular response to cAMP [GO:0071320]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to magnesium ion [GO:0071286]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to rotenone [GO:1904648]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; female pregnancy [GO:0007565]; negative regulation of blood pressure [GO:0045776]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to candesartan [GO:1901556]; response to carbohydrate [GO:0009743]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to erythropoietin [GO:0036017]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to hormone [GO:0009725]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to ketone [GO:1901654]; response to L-arginine [GO:1903576]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to mechanical stimulus [GO:0009612]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to metformin [GO:1901558]; response to nicotine [GO:0035094]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to salt [GO:1902074]; response to ultrasound [GO:1990478]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]";"GO:0001666; GO:0003779; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0007165; GO:0007263; GO:0007565; GO:0007568; GO:0008013; GO:0009612; GO:0009725; GO:0009743; GO:0009750; GO:0010038; GO:0010181; GO:0010288; GO:0012506; GO:0014070; GO:0014823; GO:0016491; GO:0020037; GO:0031284; GO:0031667; GO:0032355; GO:0032496; GO:0032869; GO:0034097; GO:0034605; GO:0035094; GO:0036017; GO:0042383; GO:0042493; GO:0043065; GO:0043200; GO:0043434; GO:0045121; GO:0045177; GO:0045296; GO:0045471; GO:0045776; GO:0046689; GO:0046872; GO:0048662; GO:0048678; GO:0050660; GO:0050661; GO:0050998; GO:0051412; GO:0051879; GO:0055093; GO:0060041; GO:0060348; GO:0071000; GO:0071260; GO:0071286; GO:0071320; GO:0071356; GO:0071363; GO:0071403; GO:0071404; GO:0071407; GO:0071560; GO:0097110; GO:1901556; GO:1901558; GO:1901652; GO:1901654; GO:1902074; GO:1903576; GO:1904648; GO:1990478";"aging [GO:0007568]; arginine catabolic process [GO:0006527]; bone development [GO:0060348]; cellular response to cAMP [GO:0071320]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to magnesium ion [GO:0071286]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to rotenone [GO:1904648]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; female pregnancy [GO:0007565]; negative regulation of blood pressure [GO:0045776]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to candesartan [GO:1901556]; response to carbohydrate [GO:0009743]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to erythropoietin [GO:0036017]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to hormone [GO:0009725]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to ketone [GO:1901654]; response to L-arginine [GO:1903576]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to mechanical stimulus [GO:0009612]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to metformin [GO:1901558]; response to nicotine [GO:0035094]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to salt [GO:1902074]; response to ultrasound [GO:1990478]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]";"apical part of cell [GO:0045177]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]"
comp240752_c1_seq1;GAXK01135086.1;A6QLU6;5.29E-18;AGRD1_BOVIN;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2408214_c0_seq1;GAXK01060154.1;Q86GC8;9.69E-37;ACES_CULPI;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp24083_c0_seq1;GAXK01124833.1;Q5ZHV7;4.33E-50;SPRY7_CHICK;SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein homolog) (CLL deletion region gene 6 protein homolog);;;;;
comp240908_c0_seq1;GAXK01135107.1;Q7K237;1.64E-135;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp2409388_c0_seq1;GAXK01060137.1;Q9JL26;3.10E-12;FMNL1_MOUSE;Formin-like protein 1 (Formin-related protein);"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; actin filament severing [GO:0051014]; cellular process [GO:0009987]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"GO:0005522; GO:0005829; GO:0005886; GO:0006929; GO:0008360; GO:0009987; GO:0030866; GO:0032794; GO:0045335; GO:0048365; GO:0051014; GO:0051015";"actin filament severing [GO:0051014]; cellular process [GO:0009987]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]";"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]"
comp240939_c0_seq1;GAXK01135338.1;Q9LDU6;3.66E-89;ST7R_ARATH;7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Protein DWARF 5) (Sterol Delta(7)-reductase);"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 7-dehydrocholesterol reductase activity [GO:0047598]; sterol delta7 reductase activity [GO:0009918]; brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"GO:0005634; GO:0005794; GO:0005886; GO:0006695; GO:0009918; GO:0016126; GO:0016132; GO:0030176; GO:0047598";"brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"7-dehydrocholesterol reductase activity [GO:0047598]; sterol delta7 reductase activity [GO:0009918]"
comp2409747_c0_seq1;GAXK01060141.1;Q9ES03;7.14E-93;TBX20_MOUSE;T-box transcription factor TBX20 (T-box protein 20);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve development [GO:0003176]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic heart tube elongation [GO:0036306]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of epithelial to mesenchymal transition [GO:0010717]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003143; GO:0003148; GO:0003151; GO:0003175; GO:0003176; GO:0003180; GO:0003193; GO:0003203; GO:0003207; GO:0003215; GO:0003272; GO:0003279; GO:0003344; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0008283; GO:0009953; GO:0010717; GO:0010991; GO:0021524; GO:0035050; GO:0035922; GO:0036306; GO:0045892; GO:0045893; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577";"aortic valve development [GO:0003176]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic heart tube elongation [GO:0036306]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of epithelial to mesenchymal transition [GO:0010717]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]"
comp2409935_c0_seq1;GAXK01060147.1;A2A935;2.01E-13;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp2410167_c1_seq1;GAXK01139794.1;O75437;9.62E-10;ZN254_HUMAN;Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2410243_c0_seq1;GAXK01139776.1;Q5XIJ8;8.35E-41;DRC2_RAT;Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]";"GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0060285; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp2410496_c0_seq1;GAXK01139795.1;Q18297;1.18E-88;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp2410560_c0_seq1;GAXK01139798.1;P13678;4.98E-90;KPC3_DROME;Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";"GO:0004674; GO:0004697; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872";"dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp24106_c0_seq1;GAXK01125604.1;P59923;2.42E-07;ZN445_HUMAN;Zinc finger protein 445 (ZFP445) (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2410724_c0_seq1;GAXK01139781.1;Q9LT35;6.72E-30;NEK6_ARATH;Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (NimA-related protein kinase 6) (AtNek6);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cortical microtubule organization [GO:0043622]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0005524; GO:0006468; GO:0010311; GO:0010366; GO:0043622";"cortical microtubule organization [GO:0043622]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein phosphorylation [GO:0006468]";;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp2411081_c0_seq1;GAXK01139797.1;P79015;1.68E-23;RL32A_SCHPO;60S ribosomal protein L32-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp24112_c0_seq1;GAXK01124482.1;Q86B79;2.22E-138;UNK_DROME;RING finger protein unkempt;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; chaeta morphogenesis [GO:0008407]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval development [GO:0002164]; neuron differentiation [GO:0030182]; regulation of neurogenesis [GO:0050767]";"GO:0002164; GO:0003677; GO:0005737; GO:0007476; GO:0008270; GO:0008407; GO:0030182; GO:0048749; GO:0050767";"chaeta morphogenesis [GO:0008407]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval development [GO:0002164]; neuron differentiation [GO:0030182]; regulation of neurogenesis [GO:0050767]";cytoplasm [GO:0005737];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp24113_c0_seq1;GAXK01124867.1;Q14202;1.27E-80;ZMYM3_HUMAN;Zinc finger MYM-type protein 3 (Zinc finger protein 261);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007010; GO:0007275; GO:0008270; GO:0022604";"cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp2411358_c0_seq1;GAXK01139796.1;Q925Q3;4.87E-42;NCLX_MOUSE;Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1);"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]";"GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006851; GO:0030061; GO:0032592; GO:0035725; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0070588; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256";"calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]";"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp2411487_c0_seq1;GAXK01139770.1;O35814;2.79E-24;STIP1_RAT;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop);"chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; cellular response to interleukin-7 [GO:0098761]";"GO:0005634; GO:0005737; GO:0008022; GO:0030544; GO:0032991; GO:0051087; GO:0051879; GO:0098761; GO:0101031";cellular response to interleukin-7 [GO:0098761];"chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]"
comp2411824_c0_seq1;GAXK01139789.1;A8MPY1;2.34E-07;GBRR3_HUMAN;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]"
comp24123_c1_seq1;GAXK01125396.1;Q7KRI2;9.33E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp241235_c0_seq1;GAXK01135363.1;Q14318;2.47E-16;FKBP8_HUMAN;Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]";"GO:0001708; GO:0001933; GO:0003755; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0097718";"apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp241263_c2_seq1;GAXK01135296.1;P31579;1.34E-24;LCE_ORYLA;Low choriolytic enzyme (EC 3.4.24.66) (Choriolysin L) (Hatching enzyme zinc-protease subunit LCE);"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005886; GO:0008270; GO:0030133; GO:0060468; GO:0060473; GO:2000360";"negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp241276_c0_seq1;GAXK01135372.1;P29503;6.16E-110;NEUR_DROME;Protein neuralized;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007398; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030707; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981";"asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2413074_c0_seq1;GAXK01195916.1;Q9Y2D9;2.39E-07;ZN652_HUMAN;Zinc finger protein 652;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2413840_c0_seq1;GAXK01195922.1;Q32KL9;2.99E-14;BAP29_BOVIN;B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29);"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"GO:0005789; GO:0005887; GO:0006886; GO:0006888; GO:0006915; GO:0070973";"apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]";
comp241387_c1_seq1;GAXK01135369.1;D2Z030;1.53E-13;DCSG_STRLA;Cycloserine biosynthesis protein DcsG (EC 6.3.3.5);"ATP binding [GO:0005524]; cyclo-ligase activity [GO:0016882]; metal ion binding [GO:0046872]; antibiotic biosynthetic process [GO:0017000]";"GO:0005524; GO:0016882; GO:0017000; GO:0046872";antibiotic biosynthetic process [GO:0017000];;"ATP binding [GO:0005524]; cyclo-ligase activity [GO:0016882]; metal ion binding [GO:0046872]"
comp2414054_c0_seq1;GAXK01122629.1;P36609;7.61E-17;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp241418_c0_seq1;GAXK01135115.1;Q66KB0;6.42E-91;UBE2Z_XENTR;Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006915; GO:0043066; GO:0061631";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]"
comp241433_c0_seq1;GAXK01135152.1;O61491;1.43E-160;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp24146_c0_seq1;GAXK01125057.1;Q28658;1.32E-10;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp2414812_c0_seq1;GAXK01122628.1;Q9Y2C2;2.20E-19;UST_HUMAN;Uronyl 2-sulfotransferase (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770";"dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp24152_c1_seq1;GAXK01125567.1;Q8R2Y8;1.76E-51;PTH2_MOUSE;Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]";"GO:0004045; GO:0005739; GO:0005829; GO:0010629; GO:2000210; GO:2000811";"negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";aminoacyl-tRNA hydrolase activity [GO:0004045]
comp2415380_c0_seq1;GAXK01122622.1;P34885;1.92E-50;KPC1B_CAEEL;Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005623; GO:0005737; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008306; GO:0016020; GO:0016079; GO:0018105; GO:0035556; GO:0040012; GO:0040024; GO:0046872; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:1902074; GO:1990504; GO:2001024";"associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp2415630_c0_seq1;GAXK01122626.1;P02588;1.78E-07;TNNC2_CHICK;Troponin C, skeletal muscle;"troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005509; GO:0005861; GO:0006937; GO:0048306; GO:0051015";"regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";troponin complex [GO:0005861];"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]"
comp2416_c0_seq1;GAXK01176558.1;Q9UHV9;2.98E-36;PFD2_HUMAN;Prefoldin subunit 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495";"positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]";"protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp2416323_c0_seq1;GAXK01045021.1;Q8N695;2.35E-95;SC5A8_HUMAN;Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161";"apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]"
comp2416537_c0_seq1;GAXK01045038.1;Q54TR1;4.00E-16;CFAD_DICDI;Counting factor associated protein D;"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0030435; GO:0031288; GO:0031410; GO:0051603; GO:0072659; GO:1903665; GO:1903669";"negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp241727_c1_seq1;GAXK01135132.1;Q95JD5;3.90E-49;ST1B1_CANLF;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (cSULT1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";"GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";cytoplasm [GO:0005737];aryl sulfotransferase activity [GO:0004062]
comp241747_c1_seq1;GAXK01135362.1;Q86MW9;7.41E-09;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2417552_c0_seq1;GAXK01045024.1;A1ZBD6;4.79E-45;MCTP_DROME;Multiple C2 and transmembrane domain-containing protein;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0005789; GO:0016021; GO:0046928; GO:0048168";"regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";calcium ion binding [GO:0005509]
comp24176_c1_seq1;GAXK01125460.1;Q9VMM6;4.20E-22;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp241809_c1_seq1;GAXK01135367.1;Q1L981;5.10E-10;TDRD5_DANRE;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp2418283_c0_seq1;GAXK01157242.1;Q84RR2;1.18E-07;ARI2_ARATH;Probable E3 ubiquitin-protein ligase ARI2 (EC 2.3.2.31) (ARIADNE-like protein ARI2) (Protein ariadne homolog 2) (RING-type E3 ubiquitin transferase ARI2);"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp2418402_c0_seq1;GAXK01157238.1;Q42064;1.63E-53;RL83_ARATH;60S ribosomal protein L8-3;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0005773; GO:0005886; GO:0022625; GO:0022626; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp24187_c0_seq1;GAXK01124563.1;Q49GP5;0;P4K2B_DANRE;Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta);"endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0007030; GO:0007032; GO:0033339; GO:0046854";"endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854]";"endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]"
comp241900_c0_seq1;GAXK01135160.1;Q7N3U5;2.67E-26;SUFS_PHOLL;Cysteine desulfurase (EC 2.8.1.7) (Selenocysteine beta-lyase) (SCL) (Selenocysteine lyase) (EC 4.4.1.16) (Selenocysteine reductase);"cytoplasm [GO:0005737]; cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; selenocysteine lyase activity [GO:0009000]; cysteine metabolic process [GO:0006534]";"GO:0005737; GO:0006534; GO:0009000; GO:0030170; GO:0031071";cysteine metabolic process [GO:0006534];cytoplasm [GO:0005737];"cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; selenocysteine lyase activity [GO:0009000]"
comp241917_c2_seq1;GAXK01135430.1;Q26710;5.36E-80;AOX_TRYBB;Alternative oxidase, mitochondrial (EC 1.-.-.-);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; alternative oxidase activity [GO:0009916]; ferric iron binding [GO:0008199]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0005743; GO:0008199; GO:0009916; GO:0016021; GO:0016491; GO:0055114; GO:0070469";oxidation-reduction process [GO:0055114];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]";"alternative oxidase activity [GO:0009916]; ferric iron binding [GO:0008199]; oxidoreductase activity [GO:0016491]"
comp2420240_c0_seq1;GAXK01089258.1;B3VSC2;1.51E-08;TSN9_SHEEP;Tetraspanin-9 (Tspan-9) (Tetraspan NET-5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp242050_c0_seq1;GAXK01044542.1;Q3URD3;9.32E-31;SLMAP_MOUSE;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; Rho GTPase binding [GO:0017048]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]";"GO:0005615; GO:0005815; GO:0006936; GO:0016021; GO:0017048; GO:0030018; GO:0031430; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150";"muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; Z disc [GO:0030018]";Rho GTPase binding [GO:0017048]
comp242073_c0_seq1;GAXK01044456.1;Q9NPC2;1.98E-17;KCNK9_HUMAN;Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0008021; GO:0022841; GO:0030322; GO:0071805; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]"
comp242085_c0_seq1;GAXK01044450.1;P41216;0;ACSL1_MOUSE;Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0014070; GO:0015908; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0042493; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]"
comp242096_c2_seq1;GAXK01044536.1;A9ZSY2;3.95E-69;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2421_c3_seq1;GAXK01176540.1;P31729;2.95E-11;OV16_ONCVO;OV-16 antigen;;;;;
comp2421253_c0_seq1;GAXK01089259.1;Q05B81;1.47E-08;PCFT_BOVIN;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Retinal pigment epithelium transporter) (Solute carrier family 46 member 1);"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; proton transmembrane transporter activity [GO:0015078]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; heme transport [GO:0015886]; methotrexate transport [GO:0051958]";"GO:0005542; GO:0005737; GO:0005887; GO:0008517; GO:0015078; GO:0015232; GO:0015884; GO:0015886; GO:0016324; GO:0051958; GO:1904447";"folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; heme transport [GO:0015886]; methotrexate transport [GO:0051958]";"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]";"folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; proton transmembrane transporter activity [GO:0015078]"
comp2421412_c0_seq1;GAXK01089252.1;D3ZTE0;3.05E-08;FA12_RAT;"Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain]";"extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]";"GO:0004252; GO:0005509; GO:0005615; GO:0005791; GO:0006508; GO:0007596; GO:0042730";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]";"extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp242172_c2_seq1;GAXK01044581.1;P95470;1.73E-34;ARBA_CELJU;Extracellular exo-alpha-(1->5)-L-arabinofuranosidase ArbA (ABF) (EC 3.2.1.55) (Extracellular arabinan exo-alpha-(1->5)-L-arabinosidase ArbA) (Arabinosidase);"extracellular region [GO:0005576]; alpha-L-arabinofuranosidase activity [GO:0046556]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005576; GO:0031222; GO:0046556; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];extracellular region [GO:0005576];"alpha-L-arabinofuranosidase activity [GO:0046556]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp2421971_c0_seq1;GAXK01089242.1;Q9NP59;1.69E-31;S40A1_HUMAN;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988";"cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp2422168_c0_seq1;GAXK01176715.1;Q62073;3.60E-21;M3K7_MOUSE;Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000165; GO:0000287; GO:0001525; GO:0001841; GO:0004674; GO:0004708; GO:0004709; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007179; GO:0007252; GO:0007254; GO:0014069; GO:0016239; GO:0018107; GO:0030971; GO:0043123; GO:0043276; GO:0043507; GO:0046330; GO:0060546; GO:0097110; GO:1902443; GO:2000377; GO:2000378; GO:2001234";"angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp2422253_c0_seq1;GAXK01176703.1;P81708;5.12E-30;LYSC1_CANLF;Lysozyme C, milk isozyme (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C);"lysozyme activity [GO:0003796]; metal ion binding [GO:0046872]; cytolysis [GO:0019835]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; metabolic process [GO:0008152]";"GO:0003796; GO:0008152; GO:0019835; GO:0046872; GO:0050829; GO:0050830";"cytolysis [GO:0019835]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; metabolic process [GO:0008152]";;"lysozyme activity [GO:0003796]; metal ion binding [GO:0046872]"
comp242234_c0_seq2;GAXK01044559.1;Q6PB70;9.80E-113;ANO8_MOUSE;Anoctamin-8 (Transmembrane protein 16H);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transport [GO:0006821]";"GO:0005229; GO:0005886; GO:0006821; GO:0016021";chloride transport [GO:0006821];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";intracellular calcium activated chloride channel activity [GO:0005229]
comp2422382_c0_seq1;GAXK01176696.1;Q9C0D5;9.85E-13;TANC1_HUMAN;Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1);"axon terminus [GO:0043679]; cell junction [GO:0030054]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]";"GO:0007520; GO:0008542; GO:0014069; GO:0030054; GO:0030425; GO:0043025; GO:0043679; GO:0045211; GO:0097062";"dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]";"axon terminus [GO:0043679]; cell junction [GO:0030054]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";
comp2422616_c0_seq1;GAXK01176700.1;Q8CHB8;1.45E-157;TTLL5_MOUSE;Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 5);"centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]";"GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0016874; GO:0018095; GO:0030317; GO:0060041";"fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]; spermatogenesis [GO:0007283]; sperm axoneme assembly [GO:0007288]";"centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp2423179_c0_seq1;GAXK01176693.1;Q9VZW5;4.11E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2423209_c0_seq1;GAXK01176717.1;Q9FN03;3.97E-38;UVR8_ARATH;Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8);"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536]; chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803]; entrainment of circadian clock [GO:0009649]; protein-chromophore linkage [GO:0018298]; response to UV [GO:0009411]; response to UV-B [GO:0010224]";"GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0018298; GO:0042802; GO:0042803";"entrainment of circadian clock [GO:0009649]; protein-chromophore linkage [GO:0018298]; response to UV [GO:0009411]; response to UV-B [GO:0010224]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536]";"chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803]"
comp24236_c0_seq1;GAXK01125583.1;Q8WXX5;1.72E-64;DNJC9_HUMAN;DnaJ homolog subfamily C member 9 (HDJC9) (DnaJ protein SB73);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]";"GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031072; GO:0032781";positive regulation of ATPase activity [GO:0032781];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";heat shock protein binding [GO:0031072]
comp2423636_c0_seq1;GAXK01176692.1;Q80V53;2.55E-08;CHSTE_MOUSE;Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0050655";"carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp2423794_c0_seq1;GAXK01176713.1;P0DPW5;7.13E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp24238_c2_seq1;GAXK01124357.1;Q24174;6.79E-26;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2424196_c0_seq1;GAXK01010900.1;Q9VJJ7;1.60E-08;TRPG_DROME;Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635";"adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"
comp2424472_c0_seq1;GAXK01010898.1;P05140;4.96E-08;ISP2_HEMAM;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp242485_c0_seq1;GAXK01044555.1;Q9XYN1;4.65E-31;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp242567_c1_seq1;GAXK01044453.1;Q9WU63;2.10E-08;HEBP2_MOUSE;Heme-binding protein 2 (Protein SOUL);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035794";"negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp242597_c0_seq1;GAXK01044452.1;Q8BSY0;4.47E-30;ASPH_MOUSE;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]"
comp2426_c0_seq1;GAXK01176090.1;Q92541;2.15E-81;RTF1_HUMAN;RNA polymerase-associated protein RTF1 homolog;"Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0006368; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0032968; GO:0045944; GO:0051571; GO:0080182; GO:1990269";"blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]"
comp2426389_c0_seq1;GAXK01091524.1;Q6PGK7;1.62E-15;CHSTA_MOUSE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0007612; GO:0007616; GO:0008146; GO:0016021; GO:0016051; GO:0016232; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]"
comp2426531_c0_seq1;GAXK01091520.1;Q9QZ15;3.93E-08;CLC4A_MOUSE;C-type lectin domain family 4 member A (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (CD antigen CD367);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]";"GO:0001818; GO:0002250; GO:0002470; GO:0005509; GO:0005537; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0032720; GO:0036037; GO:0042590; GO:0045087";"adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]"
comp24268_c0_seq1;GAXK01124333.1;C4N147;1.05E-13;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp242776_c0_seq1;GAXK01044592.1;Q96RW7;3.29E-15;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp242799_c0_seq1;GAXK01044573.1;Q9DCW2;3.05E-34;PLS2_MOUSE;Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; cellular response to lipopolysaccharide [GO:0071222]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]";"GO:0005634; GO:0005737; GO:0005886; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0046872; GO:0070782; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]"
comp242834_c0_seq1;GAXK01044529.1;Q62059;8.15E-19;CSPG2_MOUSE;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Large fibroblast proteoglycan) (PG-M);"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"GO:0001501; GO:0001657; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0008347; GO:0009986; GO:0019903; GO:0030246; GO:0031012; GO:0043666; GO:0045202; GO:0062023; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; heart development [GO:0007507]; regulation of phosphoprotein phosphatase activity [GO:0043666]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; protein phosphatase binding [GO:0019903]"
comp242848_c0_seq1;GAXK01044548.1;O77564;9.42E-51;FOLH1_PIG;Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0004180; GO:0005886; GO:0008237; GO:0016021; GO:0016805; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2428560_c0_seq1;GAXK01109530.1;Q5M8H5;1.59E-10;MOGT2_XENTR;2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Monoacylglycerol O-acyltransferase 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"GO:0003846; GO:0005789; GO:0006071; GO:0016021; GO:0019432; GO:1990578";"glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]";2-acylglycerol O-acyltransferase activity [GO:0003846]
comp2428650_c0_seq1;GAXK01109521.1;P20662;1.49E-08;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2428699_c0_seq1;GAXK01109516.1;P48994;4.61E-10;TRPL_DROME;Transient-receptor-potential-like protein;"cation channel complex [GO:0034703]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]; body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]";"GO:0005261; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006812; GO:0006816; GO:0006828; GO:0007589; GO:0007603; GO:0007605; GO:0009416; GO:0010461; GO:0015075; GO:0015279; GO:0016021; GO:0016027; GO:0016028; GO:0019722; GO:0030425; GO:0034703; GO:0035997; GO:0042802; GO:0046982; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:0071454";"body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]";"cation channel complex [GO:0034703]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]"
comp2428790_c0_seq1;GAXK01109519.1;P21369;1.08E-11;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp24291_c3_seq1;GAXK01125112.1;Q5R411;1.01E-120;PACN1_PONAB;Protein kinase C and casein kinase substrate in neurons protein 1;"axon terminus [GO:0043679]; cell junction [GO:0030054]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; photoreceptor ribbon synapse [GO:0098684]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; negative regulation of endocytosis [GO:0045806]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; protein localization to membrane [GO:0072657]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005543; GO:0005737; GO:0005829; GO:0007015; GO:0008092; GO:0030054; GO:0030137; GO:0030659; GO:0032587; GO:0042802; GO:0043679; GO:0045806; GO:0048488; GO:0048812; GO:0072657; GO:0097320; GO:0098684; GO:0098833";"actin filament organization [GO:0007015]; negative regulation of endocytosis [GO:0045806]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; protein localization to membrane [GO:0072657]; synaptic vesicle endocytosis [GO:0048488]";"axon terminus [GO:0043679]; cell junction [GO:0030054]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; photoreceptor ribbon synapse [GO:0098684]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]";"cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]"
comp2429191_c0_seq1;GAXK01109518.1;P35500;9.35E-34;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp2429320_c0_seq1;GAXK01109522.1;Q5PRF9;1.13E-10;SMAG2_HUMAN;Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B);"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of mRNA stability [GO:0043488]";"GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0017148; GO:0030371; GO:0043488";"negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of mRNA stability [GO:0043488]";"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]"
comp2429452_c0_seq1;GAXK01109517.1;Q99315;6.79E-10;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp242947_c0_seq1;GAXK01044549.1;Q9W0K7;2.93E-61;BAB1_DROME;Protein bric-a-brac 1;"nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092";"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp242954_c1_seq1;GAXK01044585.1;A4IJ05;4.82E-14;SYT17_XENTR;Synaptotagmin-17 (Synaptotagmin XVII) (SytXVII);"exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0048488; GO:0048791; GO:0070382; GO:0071277; GO:0098793";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp2429560_c0_seq1;GAXK01109531.1;P24005;1.51E-12;ACTB_DICDI;Calcium-regulated actin-bundling protein (34 kDa actin-binding protein);"cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; intranuclear rod [GO:0061836]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; parallel actin filament bundle assembly [GO:0030046]";"GO:0005509; GO:0005737; GO:0030046; GO:0030175; GO:0030863; GO:0031143; GO:0045335; GO:0051015; GO:0051017; GO:0051764; GO:0061836";"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; parallel actin filament bundle assembly [GO:0030046]";"cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; intranuclear rod [GO:0061836]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp2429657_c0_seq1;GAXK01109525.1;P36609;1.82E-43;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp242966_c0_seq1;GAXK01044546.1;P26686;3.99E-15;SRR55_DROME;Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013";"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp2430_c0_seq1;GAXK01176593.1;Q6DGW9;3.41E-84;TMCO1_DANRE;Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1);"Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]";"GO:0000139; GO:0005262; GO:0006983; GO:0030176; GO:0032469; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]";"Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]";calcium channel activity [GO:0005262]
comp2430001_c0_seq1;GAXK01153574.1;P06734;6.54E-12;FCER2_HUMAN;"Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0005178; GO:0005886; GO:0005887; GO:0007219; GO:0009897; GO:0019221; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062";"cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]"
comp243016_c0_seq1;GAXK01044553.1;Q28151;1.15E-33;OZF_BOVIN;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp24303_c2_seq1;GAXK01124344.1;O94805;0;ACL6B_HUMAN;Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B);"nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]";"GO:0003682; GO:0003713; GO:0005200; GO:0005634; GO:0005730; GO:0006325; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0021510; GO:0035267; GO:0043044; GO:0043967; GO:0071565";"ATP-dependent chromatin remodeling [GO:0043044]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]";"nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";"chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]"
comp243048_c0_seq1;GAXK01044535.1;D3ZEN0;4.51E-34;MILK2_RAT;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp24306_c3_seq1;GAXK01125193.1;O70172;2.03E-13;PI42A_MOUSE;Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(5)P-4-kinase isoform 2-alpha);"autophagosome [GO:0005776]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; megakaryocyte development [GO:0035855]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]";"GO:0005524; GO:0005634; GO:0005776; GO:0005886; GO:0010506; GO:0016309; GO:0035855; GO:2000786";"megakaryocyte development [GO:0035855]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]";"autophagosome [GO:0005776]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]"
comp24307_c0_seq1;GAXK01125106.1;O15992;1.11E-17;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp2430798_c0_seq1;GAXK01153568.1;P05932;3.65E-09;CALMB_ARBPU;Calmodulin-beta (Cam B) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp243083_c0_seq1;GAXK01044433.1;E1BE02;3.13E-10;E2F7_BOVIN;Transcription factor E2F7 (E2F-7);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001890; GO:0002040; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0008134; GO:0008285; GO:0016607; GO:0030330; GO:0032466; GO:0032877; GO:0042802; GO:0043565; GO:0045944; GO:0051726; GO:0060707; GO:0060718; GO:0070365; GO:0071930; GO:0090575; GO:2000134";"chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp2430915_c0_seq1;GAXK01153590.1;O60308;5.37E-14;CE104_HUMAN;Centrosomal protein of 104 kDa (Cep104);"centriole [GO:0005814]; cilium [GO:0005929]; spindle pole [GO:0000922]; glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]";"GO:0000922; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596";;"centriole [GO:0005814]; cilium [GO:0005929]; spindle pole [GO:0000922]";"glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]"
comp24312_c0_seq1;GAXK01124959.1;Q9Z2Q5;1.19E-09;RM40_MOUSE;39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome homolog);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005761; GO:0005762";;"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";
comp243143_c0_seq1;GAXK01044547.1;Q6TEN1;2.93E-27;RAP1B_DANRE;Ras-related protein Rap-1b;"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; MAP kinase kinase activity [GO:0004708]; cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; small GTPase mediated signal transduction [GO:0007264]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";"GO:0001756; GO:0003428; GO:0003924; GO:0004708; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0007264; GO:0007507; GO:0019003; GO:0032486; GO:0032525; GO:0060026; GO:0060536; GO:0071320; GO:2000301";"cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; small GTPase mediated signal transduction [GO:0007264]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; MAP kinase kinase activity [GO:0004708]"
comp2431784_c0_seq1;GAXK01153577.1;Q9NYT6;4.79E-21;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp243216_c0_seq1;GAXK01044498.1;Q4V8B0;1.34E-56;OXR1_RAT;Oxidation resistance protein 1 (Protein C7);"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; response to oxidative stress [GO:0006979]";"GO:0005730; GO:0005739; GO:0006979";response to oxidative stress [GO:0006979];"mitochondrion [GO:0005739]; nucleolus [GO:0005730]";
comp24322_c2_seq1;GAXK01124446.1;Q9VVE5;2.26E-100;MSIR6_DROME;RNA-binding protein Musashi homolog Rbp6;"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]";"GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904";stem cell development [GO:0048864];"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp2432374_c0_seq1;GAXK01059943.1;P50549;6.80E-56;ETV1_HUMAN;ETS translocation variant 1 (Ets-related protein 81);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935";"axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2432610_c0_seq1;GAXK01059960.1;Q8BWP5;2.92E-07;TTPA_MOUSE;Alpha-tocopherol transfer protein (Alpha-TTP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome [GO:0005770]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; vitamin binding [GO:0019842]; vitamin E binding [GO:0008431]; embryonic placenta development [GO:0001892]; intermembrane lipid transfer [GO:0120009]; intracellular pH reduction [GO:0051452]; negative regulation of cell death [GO:0060548]; negative regulation of establishment of blood-brain barrier [GO:0090212]; placenta development [GO:0001890]; response to nutrient [GO:0007584]; response to pH [GO:0009268]; response to toxic substance [GO:0009636]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180]";"GO:0001890; GO:0001892; GO:0005546; GO:0005737; GO:0005770; GO:0005829; GO:0007584; GO:0008431; GO:0009268; GO:0009636; GO:0019842; GO:0042360; GO:0043325; GO:0051180; GO:0051452; GO:0060548; GO:0090212; GO:0120009; GO:0120013";"embryonic placenta development [GO:0001892]; intermembrane lipid transfer [GO:0120009]; intracellular pH reduction [GO:0051452]; negative regulation of cell death [GO:0060548]; negative regulation of establishment of blood-brain barrier [GO:0090212]; placenta development [GO:0001890]; response to nutrient [GO:0007584]; response to pH [GO:0009268]; response to toxic substance [GO:0009636]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome [GO:0005770]";"lipid transfer activity [GO:0120013]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; vitamin binding [GO:0019842]; vitamin E binding [GO:0008431]"
comp243262_c2_seq1;GAXK01044460.1;A4IIM3;1.47E-68;SIN1_XENTR;Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; TORC2 signaling [GO:0038203]";"GO:0005546; GO:0005737; GO:0005886; GO:0030950; GO:0031932; GO:0038203";"establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; TORC2 signaling [GO:0038203]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]";phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]
comp243414_c0_seq1;GAXK01044541.1;Q78ZA7;2.21E-31;NP1L4_MOUSE;Nucleosome assembly protein 1-like 4;"cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; nucleosome assembly [GO:0006334]";"GO:0005634; GO:0005737; GO:0006334; GO:0030425; GO:0031491; GO:0043025";nucleosome assembly [GO:0006334];"cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";nucleosome binding [GO:0031491]
comp2434266_c0_seq1;GAXK01060497.1;Q63170;0;DYH7_RAT;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005509; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp2434449_c0_seq1;GAXK01060496.1;Q17529;7.71E-08;BEST2_CAEEL;Bestrophin homolog 2;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp24349_c0_seq1;GAXK01124871.1;P35037;2.49E-40;TRY3_ANOGA;Trypsin-3 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp24353_c7_seq1;GAXK01125004.1;Q99K43;1.81E-16;PRC1_MOUSE;Protein regulator of cytokinesis 1;"contractile ring [GO:0070938]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]";"GO:0000922; GO:0001578; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008284; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0051301; GO:0070938";"cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]";"contractile ring [GO:0070938]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]";"identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"
comp2435798_c0_seq1;GAXK01060478.1;Q7Z3F1;5.60E-14;GP155_HUMAN;Integral membrane protein GPR155 (G-protein coupled receptor PGR22);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062";"cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";
comp243591_c3_seq1;GAXK01044477.1;Q75NA5;1.13E-11;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp243597_c1_seq1;GAXK01044512.1;Q3U435;6.88E-102;MMP25_MOUSE;Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016021; GO:0016504; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0060022";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; proteolysis [GO:0006508]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270]"
comp243610_c1_seq1;GAXK01044515.1;O14792;4.28E-73;HS3S1_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0034483";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp24363_c1_seq1;GAXK01125501.1;Q9I7T7;7.29E-70;LAR4_DROME;La-related protein Larp4B (La ribonucleoprotein domain family member Larp4B);RNA binding [GO:0003723];GO:0003723;;;RNA binding [GO:0003723]
comp2436477_c0_seq1;GAXK01102215.1;Q3TZZ7;1.14E-33;ESYT2_MOUSE;Extended synaptotagmin-2 (E-Syt2);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268";"endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp2436478_c0_seq1;GAXK01102205.1;Q9ATF5;9.32E-60;RL18A_CASSA;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp243711_c0_seq1;GAXK01044591.1;O15439;0;MRP4_HUMAN;Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0048661; GO:0055085; GO:0060271";"cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]"
comp243827_c0_seq1;GAXK01044580.1;Q9NQX1;1.31E-14;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp24388_c3_seq1;GAXK01124977.1;Q7TSG2;4.99E-90;CTDP1_MOUSE;RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]";"GO:0000922; GO:0001096; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940";"cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]";"RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]"
comp2439056_c0_seq1;GAXK01193878.1;Q9VJ79;1.66E-97;PDE11_DROME;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp24391_c0_seq1;GAXK01125639.1;Q32N93;1.57E-16;INCEB_XENLA;Inner centromere protein B;"chromosome [GO:0005694]; chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]; spindle assembly [GO:0051225]";"GO:0000070; GO:0000777; GO:0005634; GO:0005694; GO:0005737; GO:0005819; GO:0005874; GO:0019901; GO:0030496; GO:0032133; GO:0051225; GO:0051301; GO:1902412";"cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]; spindle assembly [GO:0051225]";"chromosome [GO:0005694]; chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]";protein kinase binding [GO:0019901]
comp2439116_c0_seq1;GAXK01193864.1;Q9V3G1;5.03E-90;RL8_DROME;60S ribosomal protein L8;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp24393_c3_seq1;GAXK01125105.1;O88870;3.37E-58;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp2439351_c0_seq1;GAXK01193880.1;Q1MX18;4.18E-09;INSC_HUMAN;Protein inscuteable homolog;"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp24394_c0_seq1;GAXK01124657.1;G5EBQ8;0;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp2439416_c0_seq1;GAXK01193858.1;Q0V9U2;2.79E-18;S35F2_XENTR;Solute carrier family 35 member F2;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]";"GO:0016021; GO:0022857";;integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp2439623_c0_seq1;GAXK01193883.1;P36609;1.82E-43;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2439640_c0_seq1;GAXK01193862.1;P11118;7.93E-25;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp243977_c2_seq1;GAXK01044514.1;Q11073;2.11E-42;YT45_CAEEL;Uncharacterized protein B0416.5;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp244_c0_seq1;GAXK01168993.1;Q1HPK6;0;EF2_BOMMO;Translation elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp244001_c1_seq1;GAXK01024069.1;O35595;1.77E-28;PTC2_MOUSE;Protein patched homolog 2 (PTC2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0008544; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0097108";"cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp24407_c1_seq1;GAXK01124375.1;Q9W596;1.37E-60;FUTSC_DROME;"Microtubule-associated protein futsch (MAP1B homolog) [Cleaved into: Futsch heavy chain; Futsch light chain LC(f)]";"axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0000226; GO:0003779; GO:0005829; GO:0005874; GO:0005875; GO:0007399; GO:0007409; GO:0007528; GO:0008017; GO:0008088; GO:0008355; GO:0008582; GO:0015630; GO:0015631; GO:0016358; GO:0019900; GO:0030424; GO:0030425; GO:0031114; GO:0042995; GO:0043025; GO:0043524; GO:0045202; GO:0048749; GO:0048813; GO:0060052; GO:1901215";"axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]";"actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]"
comp2440827_c0_seq1;GAXK01037095.1;P00731;2.71E-32;CBPA1_RAT;Carboxypeptidase A1 (EC 3.4.17.1);"extracellular space [GO:0005615]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004181; GO:0005615; GO:0006508; GO:0008238; GO:0008270; GO:0051603";"proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";extracellular space [GO:0005615];"exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp244092_c0_seq1;GAXK01024098.1;Q5ZIX8;1.23E-31;KDM3A_CHICK;Lysine-specific demethylase 3A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]";"GO:0000785; GO:0000976; GO:0005634; GO:0005737; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213";histone H3-K9 demethylation [GO:0033169];"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp244093_c1_seq1;GAXK01023842.1;Q965X6;2.27E-08;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2441598_c0_seq1;GAXK01037088.1;Q32LG5;2.75E-16;REEP6_BOVIN;Receptor expression-enhancing protein 6;"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp2442399_c0_seq1;GAXK01061288.1;Q2M1K9;2.83E-07;ZN423_HUMAN;Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0045892; GO:0045893; GO:0046872; GO:0120163";"cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2442418_c0_seq1;GAXK01061275.1;Q5RES1;9.58E-29;MMP14_PONAB;Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80);"extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of myotube differentiation [GO:0010831]";"GO:0004222; GO:0008270; GO:0010831; GO:0016021; GO:0031012; GO:0042470; GO:0045579; GO:0045746";"negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of myotube differentiation [GO:0010831]";"extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp24428_c0_seq1;GAXK01124986.1;A9X4T1;0;CHD1_BOMMO;Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1);"chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]";"GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0006325";chromatin organization [GO:0006325];"chromosome [GO:0005694]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp2442963_c0_seq1;GAXK01061274.1;G5EBU4;5.02E-09;ZAG1_CAEEL;Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";"GO:0000122; GO:0005634; GO:0007411; GO:0043565; GO:0045773; GO:0046872";"axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2443_c8_seq1;GAXK01175859.1;P34455;0;ACON_CAEEL;Probable aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; metal ion binding [GO:0046872]; tricarboxylic acid cycle [GO:0006099]";"GO:0003994; GO:0005739; GO:0005829; GO:0006099; GO:0046872; GO:0051539";tricarboxylic acid cycle [GO:0006099];"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; metal ion binding [GO:0046872]"
comp244315_c7_seq1;GAXK01024050.1;Q9NSN8;2.49E-71;SNTG1_HUMAN;Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]; cell communication [GO:0007154]";"GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0008022; GO:0016010; GO:0016013; GO:0032587";cell communication [GO:0007154];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]";"actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]"
comp24435_c0_seq1;GAXK01125605.1;Q5R454;5.11E-18;AR6P1_PONAB;ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]";"GO:0002038; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006613; GO:0006915; GO:0030176; GO:0043066; GO:0043154; GO:0071787; GO:1990809";"apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]";
comp2443535_c0_seq1;GAXK01061277.1;P16373;7.52E-07;ZFP59_MOUSE;Zinc finger protein 59 (Zfp-59) (Zinc finger protein Mfg-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2443776_c0_seq1;GAXK01061282.1;Q6GNV7;2.30E-28;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp244379_c0_seq1;GAXK01024106.1;B3MFV7;1.12E-61;LPHN_DROAN;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp24439_c0_seq1;GAXK01125231.1;O46689;4.74E-22;STAR_HORSE;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005758; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020";"cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp2444072_c0_seq1;GAXK01161084.1;Q9D9T8;3.23E-102;EFHC1_MOUSE;EF-hand domain-containing protein 1 (Myoclonin-1);"axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cellular calcium ion homeostasis [GO:0006874]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; positive regulation of apoptotic process [GO:0043065]; regulation of cell division [GO:0051302]";"GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005929; GO:0005930; GO:0006874; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0043065; GO:0051302; GO:0060285; GO:0072686";"cellular calcium ion homeostasis [GO:0006874]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; positive regulation of apoptotic process [GO:0043065]; regulation of cell division [GO:0051302]";"axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]";"alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]"
comp244440_c3_seq1;GAXK01023817.1;P80311;4.45E-54;PPIB_BOVIN;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"GO:0000413; GO:0003755; GO:0005634; GO:0005788; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070063";"bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]";"endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]"
comp244457_c0_seq1;GAXK01024037.1;P55326;2.53E-08;YZG1_CAEEL;Uncharacterized protein F13E6.1;;;;;
comp2444702_c0_seq1;GAXK01161064.1;Q96RW7;2.99E-38;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2445_c0_seq1;GAXK01175360.1;Q99615;2.43E-136;DNJC7_HUMAN;DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";heat shock protein binding [GO:0031072]
comp244512_c1_seq1;GAXK01024077.1;Q8C033;3.76E-113;ARHGA_MOUSE;Rho guanine nucleotide exchange factor 10;"centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005085; GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630";"actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]";"centrosome [GO:0005813]; cytosol [GO:0005829]";"guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp2445195_c0_seq1;GAXK01161082.1;O77487;4.86E-18;FUT2_PONPY;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp244559_c0_seq1;GAXK01024026.1;Q28955;2.63E-13;NTAN1_PIG;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0008418";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp244565_c2_seq1;GAXK01023938.1;P23636;1.89E-44;PP2A2_SCHPO;Major serine/threonine-protein phosphatase PP2A-2 catalytic subunit (EC 3.1.3.16);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signaling [GO:0023052]";"GO:0004721; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0010389; GO:0010515; GO:0010972; GO:0023052; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signaling [GO:0023052]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]"
comp2446057_c0_seq1;GAXK01170791.1;P33727;1.26E-43;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp244654_c0_seq1;GAXK01023955.1;Q66I46;2.47E-15;MKNK2_XENTR;MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp2446932_c0_seq1;GAXK01170800.1;O57379;1.61E-16;S22A6_PSEAM;Solute carrier family 22 member 6 (Organic anion transporter 1) (Renal organic anion transporter 1) (ROAT1) (fROAT1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]";"GO:0005886; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp244738_c0_seq1;GAXK01024020.1;Q68EL2;5.02E-33;DTD2_DANRE;D-aminoacyl-tRNA deacylase 2 (EC 3.1.1.96) (Animalia-specific tRNA deacylase) (ATD) (D-tyrosyl-tRNA deacylase 2) (L-alanyl-tRNA deacylase) (EC 3.1.1.-);"cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399]";"GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500; GO:0106074; GO:0106105";"aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399]";cytoplasm [GO:0005737];"Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]"
comp244755_c1_seq1;GAXK01024087.1;Q16TM5;5.23E-117;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2448466_c0_seq1;GAXK01076214.1;P55066;1.22E-13;NCAN_MOUSE;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp24487_c1_seq1;GAXK01124464.1;Q91955;4.06E-11;MTPN_CHICK;Myotrophin (Granule cell differentiation protein) (Protein V-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]";"GO:0005634; GO:0005737; GO:0005829; GO:0008290; GO:0008361; GO:0010557; GO:0010613; GO:0030307; GO:0030424; GO:0048471; GO:0051092; GO:0051247; GO:2000812";"positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp244947_c0_seq1;GAXK01023806.1;O14981;0;BTAF1_HUMAN;TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172);"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0004386; GO:0005524; GO:0005654; GO:0035562; GO:0043231; GO:0045892";"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]";"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]"
comp244988_c0_seq1;GAXK01024003.1;Q9BWF3;1.45E-29;RBM4_HUMAN;RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]";"GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0008270; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0030332; GO:0032055; GO:0035198; GO:0035278; GO:0043153; GO:0045292; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0097157; GO:0097158; GO:0097167";"cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translation in response to stress [GO:0032055]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp245_c0_seq1;GAXK01169371.1;P61759;2.29E-58;PFD3_MOUSE;Prefoldin subunit 3 (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; tubulin binding [GO:0015631]; microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231";"microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]";tubulin binding [GO:0015631]
comp24501_c0_seq1;GAXK01124440.1;O00566;1.71E-63;MPP10_HUMAN;U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10);"chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]";"GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0010923; GO:0032040; GO:0034457";"negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]";"chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp245031_c0_seq1;GAXK01024056.1;Q9D3D0;5.78E-37;TTPAL_MOUSE;Alpha-tocopherol transfer protein-like;;;;;
comp245045_c0_seq1;GAXK01023974.1;Q8CG80;1.09E-30;SHF_MOUSE;SH2 domain-containing adapter protein F;"phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915]";"GO:0001784; GO:0006915";apoptotic process [GO:0006915];;phosphotyrosine residue binding [GO:0001784]
comp245074_c0_seq1;GAXK01024105.1;Q8K4T5;1.48E-32;DUS19_MOUSE;Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1);"cytoplasm [GO:0005737]; JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; regulation of MAP kinase activity [GO:0043405]";"GO:0000188; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0006469; GO:0006470; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043405; GO:0043410; GO:0043507; GO:0043508; GO:0045860; GO:0046329; GO:0046330";"inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; regulation of MAP kinase activity [GO:0043405]";cytoplasm [GO:0005737];"JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]"
comp24511_c0_seq1;GAXK01125059.1;Q7YR75;4.53E-35;RM12_BOVIN;39S ribosomal protein L12, mitochondrial (L12mt) (MRP-L12);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; positive regulation of transcription, DNA-templated [GO:0045893]; translation [GO:0006412]";"GO:0003735; GO:0005743; GO:0005762; GO:0006390; GO:0006412; GO:0045893";"mitochondrial transcription [GO:0006390]; positive regulation of transcription, DNA-templated [GO:0045893]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp24512_c4_seq1;GAXK01124715.1;Q64560;2.91E-149;TPP2_RAT;Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II);"cytosol [GO:0005829]; nuclear body [GO:0016604]; aminopeptidase activity [GO:0004177]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; proteolysis [GO:0006508]";"GO:0004177; GO:0004252; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042277";proteolysis [GO:0006508];"cytosol [GO:0005829]; nuclear body [GO:0016604]";"aminopeptidase activity [GO:0004177]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]"
comp24521_c0_seq1;GAXK01125520.1;A0A1I8M2I8;0;CWC22_MUSDO;Pre-mRNA-splicing factor CWC22 homolog (Nucampholin);"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0006397; GO:0008380; GO:0016607";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];RNA binding [GO:0003723]
comp2452275_c0_seq1;GAXK01098504.1;A8MT65;2.29E-16;ZN891_HUMAN;Zinc finger protein 891;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp245276_c1_seq1;GAXK01024006.1;Q9NTG7;3.79E-90;SIR3_HUMAN;NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]";"GO:0003950; GO:0005654; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0007005; GO:0007568; GO:0008270; GO:0009060; GO:0017136; GO:0019899; GO:0032024; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070373; GO:0070403; GO:2000304; GO:2000378";"aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp24531_c0_seq1;GAXK01125620.1;Q5BKL1;7.93E-74;CG025_XENTR;UPF0415 protein C7orf25 homolog;;;;;
comp2453632_c0_seq1;GAXK01098506.1;P21812;5.39E-09;MCPT4_MOUSE;Mast cell protease 4 (mMCP-4) (EC 3.4.21.-) (MSMCP) (Myonase) (Serosal mast cell protease);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; regulation of angiotensin levels in blood [GO:0002002]";"GO:0002002; GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0008233";"proteolysis [GO:0006508]; regulation of angiotensin levels in blood [GO:0002002]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";"peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp245383_c0_seq1;GAXK01024078.1;Q9I922;3.00E-15;RGN_XENLA;Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30) (xSMP-30);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]";"GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848";"cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]"
comp245444_c1_seq1;GAXK01023855.1;Q9VVH9;9.83E-64;SO74D_DROME;Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D);"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702";"ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";"active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]"
comp2454609_c0_seq1;GAXK01123674.1;Q9VTG7;8.11E-65;B3G2P_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0005794; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695";"cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"
comp245484_c1_seq1;GAXK01024025.1;Q9CXR1;5.93E-71;DHRS7_MOUSE;Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp24549_c0_seq1;GAXK01125103.1;Q01603;1.47E-108;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp2455_c1_seq1;GAXK01175289.1;Q963B6;1.88E-41;RL10A_SPOFR;60S ribosomal protein L10a;"large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp24551_c0_seq1;GAXK01125399.1;P25183;9.78E-115;RCC1_XENLA;Regulator of chromosome condensation;"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005085; GO:0005634; GO:0005694; GO:0005737; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp245568_c5_seq1;GAXK01023945.1;Q8IN81;1.04E-24;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp245583_c2_seq1;GAXK01024071.1;P10379;3.98E-11;UZIP_DROME;Protein unzipped (Protein zipper);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]";"GO:0005886; GO:0007411; GO:0007413; GO:0016021";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2456_c0_seq1;GAXK01176052.1;A1ZBT5;4.50E-60;MED8_DROME;Mediator of RNA polymerase II transcription subunit 8 (Mediator complex subunit 8);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0003712; GO:0006357; GO:0006366; GO:0016592; GO:0070847";"regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";"RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]"
comp245622_c0_seq1;GAXK01023977.1;D3YXG0;2.45E-25;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2456850_c0_seq1;GAXK01159414.1;Q6ZWL3;1.52E-78;CP4V2_HUMAN;Cytochrome P450 4V2 (EC 1.14.14.-) (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]";"GO:0001523; GO:0004497; GO:0005506; GO:0005789; GO:0007601; GO:0010430; GO:0016021; GO:0016125; GO:0016705; GO:0020037; GO:0050896";"fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp245698_c0_seq1;GAXK01024024.1;Q2HJ86;7.78E-07;TBA1D_BOVIN;Tubulin alpha-1D chain [Cleaved into: Detyrosinated tubulin alpha-1D chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp245703_c2_seq1;GAXK01024042.1;Q7ZVE3;1.87E-23;TIGRB_DANRE;Fructose-2,6-bisphosphatase TIGAR B (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator B);"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; bisphosphoglycerate 2-phosphatase activity [GO:0004083]; catalytic activity [GO:0003824]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]";"GO:0003824; GO:0004083; GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006003; GO:0006914; GO:0006915; GO:0030388";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]";"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"bisphosphoglycerate 2-phosphatase activity [GO:0004083]; catalytic activity [GO:0003824]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp2457089_c0_seq1;GAXK01159420.1;Q09323;3.24E-25;BAGT_LYMST;Beta-N-acetyl-D-glucosaminide beta-1,4-N-acetylglucosaminyl-transferase (EC 2.4.1.-) (Beta-1,4-GlcNAcT) (UDP-GlcNAc:GlcNAc beta-R beta-1,4-N-acetylglucosaminyl-transferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005975; GO:0006486; GO:0016021; GO:0016757";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";transferase activity, transferring glycosyl groups [GO:0016757]
comp2457115_c0_seq1;GAXK01159412.1;Q95L11;6.14E-83;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp2457197_c0_seq1;GAXK01159410.1;Q9GKL2;1.54E-13;STF1_HORSE;Steroidogenic factor 1 (SF-1) (STF-1) (Nuclear receptor subfamily 5 group A member 1);"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; female gonad development [GO:0008585]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sex determination [GO:0007530]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0003707; GO:0004879; GO:0007530; GO:0008270; GO:0008289; GO:0008584; GO:0008585; GO:0009755; GO:0009888; GO:0010628; GO:0045944; GO:0090575";"female gonad development [GO:0008585]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sex determination [GO:0007530]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp2457809_c0_seq1;GAXK01159425.1;P10076;4.87E-15;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2458939_c0_seq1;GAXK01055814.1;Q99PJ0;1.36E-31;NTRI_MOUSE;Neurotrimin;"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"GO:0005615; GO:0005886; GO:0007155; GO:0009986; GO:0010977; GO:0030424; GO:0031225; GO:0048471; GO:0060076";"cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";
comp2459_c0_seq1;GAXK01176015.1;Q8WQG1;5.55E-35;YLC1_CAEEL;ER membrane protein complex subunit 7 homolog;ER membrane protein complex [GO:0072546];GO:0072546;;ER membrane protein complex [GO:0072546];
comp245907_c0_seq1;GAXK01023956.1;P10076;1.76E-18;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp24592_c0_seq1;GAXK01124963.1;Q9V9Z1;2.89E-17;RM32_DROME;39S ribosomal protein L32, mitochondrial (L32mt) (MRP-L32);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp245926_c0_seq1;GAXK01024104.1;D3YXG0;3.49E-24;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp245936_c1_seq1;GAXK01024041.1;O00400;5.63E-148;ACATN_HUMAN;Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395";"BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]"
comp2459366_c0_seq1;GAXK01055824.1;P02993;1.22E-64;EF1A_ARTSA;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp2459378_c0_seq1;GAXK01055816.1;Q8R151;5.61E-35;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp245950_c0_seq1;GAXK01024046.1;Q40593;2.50E-13;VDE_TOBAC;Violaxanthin de-epoxidase, chloroplastic (EC 1.23.5.1);"chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422]";"GO:0009535; GO:0046422";;chloroplast thylakoid membrane [GO:0009535];violaxanthin de-epoxidase activity [GO:0046422]
comp24596_c0_seq1;GAXK01124445.1;Q8K2A1;9.65E-34;GULP1_MOUSE;PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP);"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";"GO:0005737; GO:0006869; GO:0006911; GO:0006915";"apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";cytoplasm [GO:0005737];
comp245983_c1_seq1;GAXK01024068.1;Q95NT6;2.63E-13;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp245999_c0_seq1;GAXK01023934.1;Q08E40;2.10E-41;S39AC_BOVIN;Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12);"integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]";"GO:0005385; GO:0005887; GO:0006882; GO:0007165; GO:0010975; GO:0031113; GO:0048471; GO:0071578";"cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]";"integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]";zinc ion transmembrane transporter activity [GO:0005385]
comp246_c1_seq1;GAXK01166091.1;Q99JI4;2.49E-174;PSMD6_MOUSE;26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A);"proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0005838; GO:0022624; GO:0030234; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]";enzyme regulator activity [GO:0030234]
comp246038_c1_seq1;GAXK01027811.1;O46040;3.16E-24;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp2460475_c0_seq1;GAXK01050999.1;Q8SWR3;3.55E-82;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp246056_c3_seq1;GAXK01027727.1;Q8IY45;4.75E-30;AMN1_HUMAN;Protein AMN1 homolog;"SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0006511; GO:0016567; GO:0019005; GO:0031146";"protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";SCF ubiquitin ligase complex [GO:0019005];
comp246095_c0_seq1;GAXK01027718.1;E2JA28;3.51E-33;DDAC_ENTAG;Dapdiamide synthesis protein DdaC (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; antibiotic biosynthetic process [GO:0017000]";"GO:0016491; GO:0017000";antibiotic biosynthetic process [GO:0017000];;oxidoreductase activity [GO:0016491]
comp2461_c0_seq1;GAXK01175333.1;O35547;0;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp2461178_c0_seq1;GAXK01050998.1;Q4A054;4.58E-30;Y0419_STAS1;Uncharacterized oxidoreductase SSP0419 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp2461436_c0_seq1;GAXK01050991.1;O88819;9.76E-08;FUT9_MOUSE;Alpha-(1,3)-fucosyltransferase 9 (EC 2.4.1.-) (Fucosyltransferase 9) (Fucosyltransferase IX) (Fuc-TIX) (FucT-IX) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0007399; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";alpha-(1->3)-fucosyltransferase activity [GO:0046920]
comp2461786_c0_seq1;GAXK01050990.1;P33749;7.76E-09;MSN4_YEAST;Zinc finger protein MSN4 (Multicopy suppressor of SNF1 protein 4);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; cellular response to acidic pH [GO:0071468]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to a hypotonic environment [GO:0061401]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; positive regulation of transcription from RNA polymerase II promoter in response to alkaline pH [GO:0061422]; positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation [GO:0061412]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to cold [GO:0061411]; positive regulation of transcription from RNA polymerase II promoter in response to ethanol [GO:0061410]; positive regulation of transcription from RNA polymerase II promoter in response to freezing [GO:0061409]; positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation [GO:0061406]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide [GO:0061407]; positive regulation of transcription from RNA polymerase II promoter in response to hydrostatic pressure [GO:0061405]; positive regulation of transcription from RNA polymerase II promoter in response to increased salt [GO:0061404]; positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation [GO:0036278]; positive regulation of transcription from RNA polymerase II promoter in response to nitrosative stress [GO:0061403]; positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation [GO:0097236]; regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction [GO:0061434]; replicative cell aging [GO:0001302]";"GO:0000981; GO:0000987; GO:0001302; GO:0001324; GO:0005634; GO:0005829; GO:0006338; GO:0036278; GO:0045944; GO:0046872; GO:0061395; GO:0061401; GO:0061402; GO:0061403; GO:0061404; GO:0061405; GO:0061406; GO:0061407; GO:0061408; GO:0061409; GO:0061410; GO:0061411; GO:0061412; GO:0061422; GO:0061434; GO:0071468; GO:0097236";"age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; cellular response to acidic pH [GO:0071468]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; positive regulation of transcription from RNA polymerase II promoter in response to a hypotonic environment [GO:0061401]; positive regulation of transcription from RNA polymerase II promoter in response to alkaline pH [GO:0061422]; positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation [GO:0061412]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to cold [GO:0061411]; positive regulation of transcription from RNA polymerase II promoter in response to ethanol [GO:0061410]; positive regulation of transcription from RNA polymerase II promoter in response to freezing [GO:0061409]; positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation [GO:0061406]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide [GO:0061407]; positive regulation of transcription from RNA polymerase II promoter in response to hydrostatic pressure [GO:0061405]; positive regulation of transcription from RNA polymerase II promoter in response to increased salt [GO:0061404]; positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation [GO:0036278]; positive regulation of transcription from RNA polymerase II promoter in response to nitrosative stress [GO:0061403]; positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation [GO:0097236]; regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction [GO:0061434]; replicative cell aging [GO:0001302]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]"
comp246179_c1_seq1;GAXK01027644.1;Q6ZMW2;2.93E-33;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp246193_c0_seq1;GAXK01027740.1;O60494;5.21E-12;CUBN_HUMAN;Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062";"cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp24622_c0_seq1;GAXK01124330.1;Q9DAK9;1.02E-43;PHP14_MOUSE;14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP);"cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249]";"GO:0005829; GO:0006470; GO:0019855; GO:0035774; GO:0035971; GO:0044325; GO:0050860; GO:0051350; GO:0101006; GO:2000147; GO:2000249; GO:2000984";"negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249]";cytosol [GO:0005829];"calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]"
comp24624_c0_seq1;GAXK01205640.1;Q5RKH1;6.84E-137;PRP4B_RAT;Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog);"catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]";"GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005694; GO:0006397; GO:0006468; GO:0008380; GO:0016607; GO:0071013";"mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp2462470_c0_seq1;GAXK01038622.1;O97531;2.65E-158;KCNQ1_FELCA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) (Fragment);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005769; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016021; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0071805; GO:0086009; GO:0086089; GO:0097623; GO:1902282";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp24628_c0_seq1;GAXK01125508.1;O15145;3.64E-77;ARPC3_HUMAN;Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC);"actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024]";"GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0005925; GO:0015629; GO:0016020; GO:0030027; GO:0031941; GO:0034314; GO:0035861; GO:0038096; GO:0048013; GO:0061024; GO:0061850; GO:0070062; GO:0070358; GO:1990090";"actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024]";"actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]"
comp246291_c0_seq1;GAXK01027677.1;Q4R3Y4;6.17E-171;S27A4_MACFA;Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]";"GO:0000166; GO:0004467; GO:0005789; GO:0015908; GO:0016021; GO:0031957";fatty acid transport [GO:0015908];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp2463_c0_seq1;GAXK01175336.1;Q8BJW6;8.71E-160;EIF2A_MOUSE;Eukaryotic translation initiation factor 2A (eIF-2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed];"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of signal transduction [GO:0009967]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to amino acid starvation [GO:1990928]; ribosome assembly [GO:0042255]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]";"GO:0000049; GO:0003743; GO:0005737; GO:0005850; GO:0006412; GO:0006417; GO:0006468; GO:0009967; GO:0022627; GO:0030968; GO:0032933; GO:0042255; GO:0043022; GO:1990928";"endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of signal transduction [GO:0009967]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to amino acid starvation [GO:1990928]; ribosome assembly [GO:0042255]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]";"ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]"
comp24633_c0_seq1;GAXK01125087.1;Q9UL36;4.74E-18;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2463491_c0_seq1;GAXK01038618.1;P21461;1.12E-07;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp246365_c0_seq1;GAXK01027742.1;O08585;1.07E-09;CLCA_MOUSE;Clathrin light chain A (Lca);"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631";"cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]";"clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]"
comp2463713_c0_seq1;GAXK01038623.1;Q6ZMW2;5.55E-20;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp24643_c0_seq1;GAXK01125514.1;Q8BZA9;1.21E-10;TIGAR_MOUSE;Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator) (TP53-induced glycolysis regulatory phosphatase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to cobalt ion [GO:0071279]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; intestinal epithelial cell development [GO:0060576]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of glycolytic process [GO:0045820]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron death [GO:1901215]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]";"GO:0002931; GO:0004083; GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006003; GO:0006914; GO:0006915; GO:0006974; GO:0009410; GO:0010332; GO:0010666; GO:0030388; GO:0033673; GO:0043069; GO:0043456; GO:0045739; GO:0045820; GO:0060576; GO:0071279; GO:0071456; GO:1901215; GO:1901525; GO:1902153; GO:1903301; GO:1904024; GO:2000378";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to cobalt ion [GO:0071279]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; intestinal epithelial cell development [GO:0060576]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of glycolytic process [GO:0045820]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron death [GO:1901215]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp2464513_c0_seq1;GAXK01000095.1;Q9EQC0;3.85E-17;CHST1_MOUSE;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp246556_c0_seq1;GAXK01027679.1;Q9RKB5;4.72E-96;BVMO2_STRCO;Baeyer-Villiger monooxygenase (BVMO) (EC 1.14.13.-);"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidation-reduction process [GO:0055114]";"GO:0004499; GO:0016709; GO:0050660; GO:0050661; GO:0055114";oxidation-reduction process [GO:0055114];;"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp246604_c0_seq1;GAXK01027642.1;B2RYI0;5.69E-59;WDR91_RAT;WD repeat-containing protein 91;"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]";"GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022; GO:1903362";"early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]";phosphatidylinositol 3-kinase regulator activity [GO:0035014]
comp2466094_c0_seq1;GAXK01012448.1;Q8W257;2.98E-11;PFI_PTIFI;Polyenoic fatty acid isomerase (PFI) (EC 5.3.3.13);"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]";"GO:0016491; GO:0034016";;;"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]"
comp246627_c0_seq1;GAXK01027817.1;D3YXG0;4.06E-42;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2466923_c0_seq1;GAXK01012451.1;Q5VXM1;3.08E-31;CDCP2_HUMAN;CUB domain-containing protein 2;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp2467054_c0_seq1;GAXK01012453.1;P13360;7.46E-09;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp246714_c0_seq1;GAXK01027643.1;Q5UE96;8.47E-46;KCNK1_RABIT;Potassium channel subfamily K member 1;"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"GO:0005267; GO:0005272; GO:0005887; GO:0016021; GO:0016324; GO:0022841; GO:0030054; GO:0030425; GO:0034705; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0045202; GO:0055037; GO:0060075; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]";"identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]"
comp2468_c0_seq1;GAXK01175782.1;Q2TBP7;3.22E-16;MYCBP_BOVIN;c-Myc-binding protein (Associate of Myc 1) (AMY-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003713; GO:0005634; GO:0005737; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";transcription coactivator activity [GO:0003713]
comp2468154_c0_seq1;GAXK01173587.1;O74467;1.19E-10;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2469107_c0_seq1;GAXK01173591.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp2469337_c0_seq1;GAXK01173604.1;Q8K4K7;7.14E-23;ABRA_RAT;Actin-binding Rho-activating protein (MS1) (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp2469408_c0_seq1;GAXK01173590.1;Q4G0X9;4.09E-22;CCD40_HUMAN;Coiled-coil domain-containing protein 40;"axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356]";"GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0035469; GO:0036159; GO:0044458; GO:0060271; GO:0060287; GO:0070286; GO:0071907; GO:0071910";"axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356]";"axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]";
comp246959_c0_seq1;GAXK01027731.1;O35490;2.29E-128;BHMT1_MOUSE;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267";"amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]";"betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]"
comp24697_c0_seq1;GAXK01125674.1;O94888;1.50E-93;UBXN7_HUMAN;UBX domain-containing protein 7;"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; post-translational protein modification [GO:0043687]";"GO:0005654; GO:0005829; GO:0008134; GO:0016604; GO:0031625; GO:0034098; GO:0043130; GO:0043687";post-translational protein modification [GO:0043687];"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
comp247013_c0_seq1;GAXK01027665.1;Q09YL6;8.92E-19;SAMD5_BOVIN;Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5);"cytoplasm [GO:0005737]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";"GO:0005737; GO:0031435; GO:0043507; GO:1901224";"positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]";cytoplasm [GO:0005737];mitogen-activated protein kinase kinase kinase binding [GO:0031435]
comp247027_c0_seq1;GAXK01204942.1;P46436;3.08E-37;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp247045_c1_seq1;GAXK01027842.1;Q28658;8.89E-07;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp247055_c0_seq1;GAXK01027729.1;P47193;4.83E-14;VAMP2_XENLA;Vesicle-associated membrane protein 2 (VAMP-2) (SYBII) (Synaptobrevin-2);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192]";"GO:0005886; GO:0016021; GO:0016192; GO:0030054; GO:0030672; GO:0043005";vesicle-mediated transport [GO:0016192];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";
comp247071_c0_seq1;GAXK01027739.1;P26221;6.21E-42;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp2470879_c0_seq1;GAXK01105956.1;Q91453;3.46E-32;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp247122_c0_seq1;GAXK01027678.1;Q642A5;3.12E-20;DPOE3_RAT;DNA polymerase epsilon subunit 3 (EC 2.7.7.7) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone acetylation [GO:0016573]; nucleosome mobilization [GO:0042766]";"GO:0003677; GO:0003887; GO:0005671; GO:0006974; GO:0008622; GO:0016573; GO:0034080; GO:0042766; GO:0046982; GO:0070869; GO:0071480";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone acetylation [GO:0016573]; nucleosome mobilization [GO:0042766]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]"
comp2471280_c0_seq1;GAXK01105967.1;Q9C401;1.34E-81;TPIS_ZYGBA;Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase);"triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004807; GO:0006094; GO:0006096";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";;triose-phosphate isomerase activity [GO:0004807]
comp247151_c1_seq1;GAXK01027743.1;Q5JNZ3;1.28E-15;ZN311_HUMAN;Zinc finger protein 311 (Zinc finger protein zfp-31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2471780_c0_seq1;GAXK01105980.1;Q6C5V7;1.30E-14;YNG2_YARLI;Chromatin modification-related protein YNG2 (ING1 homolog 2);"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; meiotic cell cycle [GO:0051321]";"GO:0005634; GO:0006281; GO:0016573; GO:0035064; GO:0035267; GO:0046872; GO:0051321";"DNA repair [GO:0006281]; histone acetylation [GO:0016573]; meiotic cell cycle [GO:0051321]";"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp2471854_c0_seq1;GAXK01105959.1;P02595;3.41E-11;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2471896_c0_seq1;GAXK01105960.1;P0DJ13;1.28E-88;RL7_TETTH;60S ribosomal protein L7;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003723; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2471960_c0_seq1;GAXK01105979.1;Q9NPA2;8.38E-35;MMP25_HUMAN;Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0016021; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0035579; GO:0043312; GO:0060022";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2472_c2_seq1;GAXK01175308.1;P28075;1.78E-98;PSB5_RAT;Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit X);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp2472151_c0_seq1;GAXK01003043.1;B0WC46;1.35E-32;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp247221_c0_seq1;GAXK01027836.1;Q9VDW6;0;DMDA_DROME;Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699";"establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp24730_c0_seq1;GAXK01124925.1;O60749;4.90E-126;SNX2_HUMAN;Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042803; GO:0045296; GO:0046982; GO:0051259; GO:0072673; GO:1990459; GO:1990460";"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]";"cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]"
comp2473269_c0_seq1;GAXK01003060.1;Q29463;2.68E-19;TRY2_BOVIN;Anionic trypsin (EC 3.4.21.4);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp24736_c0_seq1;GAXK01124811.1;Q08DG6;4.99E-104;COX15_BOVIN;Cytochrome c oxidase assembly protein COX15 homolog;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; heme a biosynthetic process [GO:0006784]";"GO:0005743; GO:0006784; GO:0016021; GO:0016627; GO:0016653";heme a biosynthetic process [GO:0006784];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp247384_c1_seq1;GAXK01027746.1;Q58EK5;6.78E-31;TDRD1_DANRE;Tudor domain-containing protein 1;"cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0007281; GO:0007283; GO:0030719; GO:0031047; GO:0034584; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]";"metal ion binding [GO:0046872]; piRNA binding [GO:0034584]"
comp2474116_c0_seq1;GAXK01099566.1;Q7RVN0;1.57E-64;RL11_NEUCR;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2474490_c0_seq1;GAXK01099561.1;P60868;1.63E-45;RS20_RAT;40S ribosomal protein S20;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2474532_c0_seq1;GAXK01099567.1;P24721;1.04E-11;ASGR2_MOUSE;Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (Hepatic lectin 2) (HL-2) (mHL-2);"endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; bone mineralization [GO:0030282]; endocytosis [GO:0006897]; glycoprotein metabolic process [GO:0009100]; lipid homeostasis [GO:0055088]; regulation of protein stability [GO:0031647]";"GO:0006897; GO:0009100; GO:0016021; GO:0030246; GO:0030282; GO:0031647; GO:0044322; GO:0048471; GO:0055088";"bone mineralization [GO:0030282]; endocytosis [GO:0006897]; glycoprotein metabolic process [GO:0009100]; lipid homeostasis [GO:0055088]; regulation of protein stability [GO:0031647]";"endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";carbohydrate binding [GO:0030246]
comp247539_c4_seq1;GAXK01027661.1;Q8NEP9;2.10E-24;ZN555_HUMAN;Zinc finger protein 555;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2475613_c0_seq1;GAXK01099581.1;O14628;6.80E-10;ZN195_HUMAN;Zinc finger protein 195;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp2475690_c0_seq1;GAXK01099572.1;Q06559;1.09E-63;RS3_DROME;40S ribosomal protein S3;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]";"GO:0000278; GO:0002181; GO:0003684; GO:0003723; GO:0003735; GO:0003906; GO:0004519; GO:0005634; GO:0006281; GO:0008534; GO:0016363; GO:0022626; GO:0022627; GO:0032357; GO:0043524; GO:0045739; GO:0140078; GO:2001235";"cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]";"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp247587_c0_seq1;GAXK01027675.1;Q17DK5;1.23E-10;CRY1_AEDAE;Cryptochrome-1;"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660";"negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]"
comp2475872_c0_seq1;GAXK01099573.1;Q9JKS4;2.92E-08;LDB3_MOUSE;LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein);"cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]";"GO:0001725; GO:0003779; GO:0005080; GO:0005856; GO:0005913; GO:0007507; GO:0008092; GO:0030018; GO:0030036; GO:0031143; GO:0031941; GO:0045214; GO:0046872; GO:0048471; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]";"cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]"
comp2476_c1_seq1;GAXK01176032.1;Q98TX3;3.85E-100;PDCD4_CHICK;Programmed cell death protein 4 (Protein I11/6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell aging [GO:0007569]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007569; GO:0043508; GO:0045892";"cell aging [GO:0007569]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of transcription, DNA-templated [GO:0045892]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp2476392_c0_seq1;GAXK01116822.1;Q86WC6;2.77E-11;PPR27_HUMAN;Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1) (Toonin);"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]";"GO:0004864; GO:0010923; GO:0019902";negative regulation of phosphatase activity [GO:0010923];;"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]"
comp2476562_c0_seq1;GAXK01116817.1;Q16TM5;2.81E-18;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp247666_c0_seq1;GAXK01027682.1;A8XNK6;3.67E-14;NHR28_CAEBR;Nuclear hormone receptor family member nhr-28;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp247697_c0_seq1;GAXK01027850.1;Q96IR2;5.12E-26;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2477353_c0_seq1;GAXK01116811.1;Q5P9U8;3.10E-07;RNC_ANAMM;Ribonuclease 3 (EC 3.1.26.3) (Ribonuclease III) (RNase III);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; rRNA binding [GO:0019843]; mRNA processing [GO:0006397]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033]";"GO:0004525; GO:0005737; GO:0006364; GO:0006397; GO:0008033; GO:0016075; GO:0019843; GO:0046872";"mRNA processing [GO:0006397]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; rRNA binding [GO:0019843]"
comp2477994_c0_seq1;GAXK01116818.1;P0DSI3;1.98E-10;VA3_DINQU;Venom allergen 3 homolog (Cysteine-rich venom protein) (CRVP);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp247816_c0_seq1;GAXK01027687.1;Q99KZ6;2.07E-07;ZN639_MOUSE;Zinc finger protein 639 (Zinc finger protein ZASC1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; viral entry into host cell [GO:0046718]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0030307; GO:0043621; GO:0043922; GO:0043923; GO:0044212; GO:0045892; GO:0045944; GO:0046718; GO:0046872";"negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; viral entry into host cell [GO:0046718]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp2478278_c0_seq1;GAXK01015044.1;P10751;1.03E-20;ZFP11_MOUSE;Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp24792_c1_seq1;GAXK01125240.1;Q7JZB4;0;GMPPB_DROME;Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta);"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167]";"GO:0004475; GO:0005525; GO:0009298; GO:0035167";"GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167]";;"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]"
comp247923_c0_seq1;GAXK01027657.1;Q6DFC0;8.99E-99;S41A2_XENLA;Solute carrier family 41 member 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]";"GO:0005886; GO:0008324; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp2479421_c0_seq1;GAXK01015061.1;Q9X1E2;7.70E-14;MCP4_THEMA;Methyl-accepting chemotaxis protein 4;"integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0006935; GO:0007165";"chemotaxis [GO:0006935]; signal transduction [GO:0007165]";integral component of plasma membrane [GO:0005887];transmembrane signaling receptor activity [GO:0004888]
comp2479569_c0_seq1;GAXK01015057.1;Q93560;1.01E-07;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp24805_c0_seq1;GAXK01124529.1;P41515;0;TOP2A_CRIGR;DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme);"centriole [GO:0005814]; condensed chromosome [GO:0000793]; DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0000228; GO:0000287; GO:0000793; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005654; GO:0005730; GO:0005814; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008301; GO:0009330; GO:0019035; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904";"apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"centriole [GO:0005814]; condensed chromosome [GO:0000793]; DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]"
comp2480523_c0_seq1;GAXK01203344.1;Q7RTU5;6.80E-11;ASCL5_HUMAN;Achaete-scute homolog 5 (ASH-5) (hASH5) (Class A basic helix-loop-helix protein 47) (bHLHa47);"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0008134; GO:0045944; GO:0046983; GO:0090575";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp24806_c0_seq1;GAXK01125264.1;Q2HU68;7.35E-41;H2A1_MEDTR;Probable histone H2A.1;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp248139_c1_seq1;GAXK01196671.1;Q961J5;1.97E-44;BALAT_DROME;Beta-alanine transporter (BalaT);"integral component of plasma membrane [GO:0005887]; beta-alanine transmembrane transporter activity [GO:0001761]; beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]";"GO:0001694; GO:0001761; GO:0001762; GO:0005887";"beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]";integral component of plasma membrane [GO:0005887];beta-alanine transmembrane transporter activity [GO:0001761]
comp24815_c2_seq1;GAXK01125268.1;Q2KJI7;0;AFG32_BOVIN;AFG3-like protein 2 (EC 3.4.24.-);"m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]";"GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013";"axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]";"m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]";"ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp2481896_c1_seq1;GAXK01203324.1;A6H6T1;2.57E-13;PRS40_MOUSE;Serine protease 40 (EC 3.4.21.-) (Testicular serine protease 2);"acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0001669; GO:0004252; GO:0005615; GO:0006508";proteolysis [GO:0006508];"acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp2481905_c0_seq1;GAXK01203337.1;Q29043;1.50E-19;FUT1_PIG;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp2482_c0_seq1;GAXK01175976.1;Q25532;1.30E-46;VATG_MANSE;V-type proton ATPase subunit G (V-ATPase subunit G) (V-ATPase 13 kDa subunit) (Vacuolar proton pump subunit G);"apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase-coupled transmembrane transporter activity [GO:0042626]; proton transmembrane transport [GO:1902600]";"GO:0016324; GO:0016471; GO:0042626; GO:1902600";proton transmembrane transport [GO:1902600];"apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";ATPase-coupled transmembrane transporter activity [GO:0042626]
comp24820_c1_seq1;GAXK01125098.1;O60508;0;PRP17_HUMAN;Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";RNA binding [GO:0003723]
comp24821_c0_seq1;GAXK01125229.1;O13918;8.15E-66;ZHF1_SCHPO;Zinc homeostasis factor 1;"endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; zinc ion transmembrane transporter activity [GO:0005385]; cellular cobalt ion homeostasis [GO:0006877]; cellular detoxification of cadmium ion [GO:0098849]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import into endoplasmic reticulum [GO:0140209]; zinc ion import into organelle [GO:0062111]";"GO:0000324; GO:0000329; GO:0005385; GO:0005789; GO:0005794; GO:0006877; GO:0006882; GO:0016021; GO:0031965; GO:0062111; GO:0098849; GO:0140209";"cellular cobalt ion homeostasis [GO:0006877]; cellular detoxification of cadmium ion [GO:0098849]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import into endoplasmic reticulum [GO:0140209]; zinc ion import into organelle [GO:0062111]";"endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";zinc ion transmembrane transporter activity [GO:0005385]
comp2482242_c0_seq1;GAXK01038631.1;O28852;2.18E-32;Y1420_ARCFU;Uncharacterized protein AF_1420;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp248233_c0_seq1;GAXK01196701.1;Q6DK99;1.10E-10;CNFNB_XENLA;Cornifelin homolog B;;;;;
comp248238_c1_seq1;GAXK01196689.1;Q53EU6;2.63E-130;GPAT3_HUMAN;Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]";"GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006654; GO:0016021; GO:0016024; GO:0019432; GO:0032006; GO:0102420";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]"
comp2482671_c0_seq1;GAXK01038637.1;Q9R078;1.06E-12;AAKB1_MOUSE;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0004672; GO:0004679; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0010628; GO:0019901; GO:0031588; GO:0032991; GO:0035878; GO:0050790; GO:0051291; GO:0120162";"fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"AMP-activated protein kinase activity [GO:0004679]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp24832_c0_seq1;GAXK01125058.1;Q29IK4;2.89E-55;RM22_DROPS;39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp248334_c0_seq1;GAXK01196644.1;O62621;6.01E-09;COPB2_DROME;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005198; GO:0005795; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0010883; GO:0030126";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]";structural molecule activity [GO:0005198]
comp2483724_c0_seq1;GAXK01038638.1;P16157;4.47E-08;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp2483862_c0_seq1;GAXK01038653.1;O54963;2.95E-11;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2484_c0_seq1;GAXK01175781.1;Q8K4R9;5.17E-33;DLGP5_MOUSE;Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; phosphoprotein phosphatase activity [GO:0004721]; cell cycle [GO:0007049]; signaling [GO:0023052]";"GO:0004721; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0007049; GO:0023052; GO:0031616";"cell cycle [GO:0007049]; signaling [GO:0023052]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]";phosphoprotein phosphatase activity [GO:0004721]
comp2484089_c0_seq1;GAXK01101590.1;P91119;5.33E-76;PDE5_CAEEL;Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17);"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";"GO:0004114; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";;"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"
comp2484129_c0_seq1;GAXK01101593.1;P49643;1.91E-20;PRI2_HUMAN;DNA primase large subunit (EC 2.7.7.-) (DNA primase 58 kDa subunit) (p58);"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539";"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]";"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"
comp2484322_c0_seq1;GAXK01101612.1;P52307;2.83E-51;5NTD_RHIMP;"Protein 5NUC [Includes: UDP-sugar hydrolase (EC 3.6.1.45) (UDP-sugar diphosphatase) (UDP-sugar pyrophosphatase); 5'-nucleotidase (5'-NT) (EC 3.1.3.5)] (Fragment)";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005886; GO:0008253; GO:0008768; GO:0009166; GO:0031225; GO:0046872";nucleotide catabolic process [GO:0009166];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]"
comp2485048_c0_seq1;GAXK01101594.1;Q9XYN1;2.26E-09;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp2485100_c0_seq1;GAXK01101609.1;B4P624;1.11E-25;TRET1_DROYA;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp248520_c0_seq1;GAXK01196698.1;P24524;8.01E-53;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp2485220_c0_seq1;GAXK01101621.1;Q9ERC5;6.69E-41;OTOF_RAT;Otoferlin (Fer-1-like protein 2);"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007605; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0044877; GO:0045177; GO:0045178; GO:0090102";"cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]"
comp248526_c0_seq1;GAXK01196710.1;P02595;1.96E-11;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2485380_c0_seq1;GAXK01101616.1;Q9NP59;7.04E-15;S40A1_HUMAN;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988";"cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp2486061_c0_seq1;GAXK01156982.1;P46218;9.09E-13;Y1674_SULAC;Uncharacterized protein Saci_1674;;;;;
comp2486072_c0_seq1;GAXK01156972.1;Q9R0S3;6.33E-33;MMP17_MOUSE;Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]";"GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0042756";"collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp24866_c0_seq1;GAXK01124337.1;O61491;1.22E-158;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp2486775_c0_seq1;GAXK01156973.1;B4HNS0;2.08E-22;TRE11_DROSE;Facilitated trehalose transporter Tret1-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2486814_c0_seq1;GAXK01156974.1;P18173;1.09E-46;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp248688_c6_seq1;GAXK01196647.1;Q9Y3Z3;9.41E-31;SAMH1_HUMAN;Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337; GO:0060339; GO:0097197; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]";"dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]"
comp24869_c0_seq1;GAXK01124569.1;Q99JX3;4.23E-113;GORS2_MOUSE;Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925";"cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]";
comp248698_c0_seq1;GAXK01196703.1;P51512;1.36E-26;MMP16_HUMAN;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0019538; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094";"chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp248752_c0_seq1;GAXK01196632.1;Q7KRI2;1.51E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2487612_c0_seq1;GAXK01156958.1;Q80XJ2;9.90E-28;RN168_MOUSE;E3 ubiquitin-protein ligase RNF168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168);"cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cellular protein localization [GO:1903827]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0031491; GO:0032991; GO:0034244; GO:0034644; GO:0035518; GO:0035861; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535; GO:1903827; GO:1990391";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; double-strand break repair [GO:0006302]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cellular protein localization [GO:1903827]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]"
comp2487648_c0_seq1;GAXK01156961.1;P23415;4.64E-15;GLRA1_HUMAN;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp2488_c3_seq1;GAXK01175717.1;P04069;2.44E-104;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp2488249_c0_seq1;GAXK01089991.1;P10076;2.88E-18;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2488276_c0_seq1;GAXK01089997.1;P35704;2.14E-76;PRDX2_RAT;Peroxiredoxin-2 (EC 1.11.1.15) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of neuron apoptotic process [GO:0043524]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]";"GO:0005829; GO:0006979; GO:0008379; GO:0019430; GO:0042744; GO:0043524; GO:0045321; GO:0045454";"cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of neuron apoptotic process [GO:0043524]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp2488506_c0_seq1;GAXK01089989.1;Q29HY3;2.49E-23;CDC42_DROPS;Cdc42 homolog (EC 3.6.5.2);"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0005912; GO:0005938; GO:0006909; GO:0007266; GO:0007274; GO:0007286; GO:0007391; GO:0008045; GO:0008360; GO:0008582; GO:0010592; GO:0016028; GO:0016318; GO:0019901; GO:0030011; GO:0030027; GO:0030031; GO:0030041; GO:0030426; GO:0030833; GO:0030866; GO:0031532; GO:0032794; GO:0035011; GO:0035099; GO:0035318; GO:0042060; GO:0045177; GO:0045185; GO:0045200; GO:0045860; GO:0046330; GO:0046843; GO:0048010; GO:0048675; GO:0048813; GO:0050770; GO:0050975; GO:0051491; GO:0051601; GO:0060446; GO:0072659; GO:0090303; GO:0097206";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp2488733_c0_seq1;GAXK01090013.1;Q5R5U3;1.55E-16;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2489267_c0_seq1;GAXK01089999.1;P03957;1.00E-46;MMP3_RAT;Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (PTR1 protein) (Transin-1);"cell body [GO:0044297]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to interleukin-1 [GO:0071347]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; response to amino acid [GO:0043200]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; wound healing [GO:0042060]";"GO:0001666; GO:0004222; GO:0005615; GO:0005634; GO:0007565; GO:0008270; GO:0009612; GO:0030198; GO:0030335; GO:0030425; GO:0030574; GO:0031012; GO:0032355; GO:0032496; GO:0032991; GO:0034097; GO:0034612; GO:0042060; GO:0043200; GO:0044297; GO:0044877; GO:0070555; GO:0071347; GO:0071460";"cellular response to cell-matrix adhesion [GO:0071460]; cellular response to interleukin-1 [GO:0071347]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; response to amino acid [GO:0043200]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; wound healing [GO:0042060]";"cell body [GO:0044297]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]"
comp2489270_c0_seq1;GAXK01089981.1;Q5R9Y9;2.99E-12;KIF2A_PONAB;Kinesin-like protein KIF2A;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0030154; GO:0051301; GO:0090307";"cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp2489452_c0_seq1;GAXK01090005.1;P27164;6.21E-07;CALM3_PETHY;Calmodulin-related protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2489720_c0_seq1;GAXK01090018.1;Q5R5U3;3.05E-17;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2489733_c0_seq1;GAXK01089990.1;Q7SZP9;1.57E-07;APJA_DANRE;Apelin receptor A (Angiotensin II receptor-like 1a) (Angiotensin receptor-like 1a) (G-protein coupled receptor APJ A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]; angioblast cell migration from lateral mesoderm to midline [GO:0035479]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; endodermal cell differentiation [GO:0035987]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; lymph vessel development [GO:0001945]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of nodal signaling pathway [GO:1900107]; vasculogenesis [GO:0001570]";"GO:0001525; GO:0001568; GO:0001570; GO:0001702; GO:0001945; GO:0004930; GO:0005886; GO:0007186; GO:0007507; GO:0016021; GO:0016477; GO:0035479; GO:0035987; GO:0042074; GO:0043951; GO:0045766; GO:0048738; GO:0051281; GO:0055113; GO:0060182; GO:0060976; GO:1900107; GO:1903589; GO:1904325";"angioblast cell migration from lateral mesoderm to midline [GO:0035479]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; endodermal cell differentiation [GO:0035987]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; gastrulation with mouth forming second [GO:0001702]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lymph vessel development [GO:0001945]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of nodal signaling pathway [GO:1900107]; vasculogenesis [GO:0001570]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]"
comp24898_c2_seq1;GAXK01124437.1;Q32M00;1.15E-18;CRBL2_MOUSE;cAMP-responsive element-binding protein-like 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";"GO:0003677; GO:0003700; GO:0005634; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821";"cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp2489989_c0_seq1;GAXK01090015.1;Q09621;6.11E-27;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp249036_c0_seq1;GAXK01196816.1;Q99816;5.38E-55;TS101_HUMAN;Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]";"GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0045892; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397";"autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]";"calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]"
comp249041_c4_seq1;GAXK01196759.1;Q0IHA5;1.84E-31;MPPE1_XENLA;Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5);"cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; GPI anchor binding [GO:0034235]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0008081; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]";"GPI anchor binding [GO:0034235]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]"
comp2490483_c0_seq1;GAXK01013098.1;O44001;1.30E-154;HSP90_EIMTE;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp2490525_c0_seq1;GAXK01013094.1;Q5ZJ60;5.05E-31;HIBCH_CHICK;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp249055_c0_seq1;GAXK01196686.1;E9QHE3;2.28E-119;RN207_DANRE;RING finger protein 207;"cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]";"GO:0005737; GO:0008270; GO:0030544; GO:0055117; GO:0086019; GO:1901207; GO:1903762; GO:1903954";"cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]";cytoplasm [GO:0005737];"Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]"
comp249058_c0_seq1;GAXK01196665.1;Q9D7X8;8.64E-40;GGCT_MOUSE;Gamma-glutamylcyclotransferase (EC 4.3.2.9);"cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836]";"GO:0001836; GO:0003839; GO:0005829; GO:0042803";release of cytochrome c from mitochondria [GO:0001836];cytosol [GO:0005829];"gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]"
comp249072_c0_seq1;GAXK01196761.1;Q6ZN08;8.46E-36;ZNF66_HUMAN;Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2491288_c0_seq1;GAXK01013088.1;O96006;2.46E-28;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp24914_c1_seq1;GAXK01125509.1;Q6MG08;0;ABCF1_RAT;ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50);"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]";"GO:0005524; GO:0005635; GO:0005654; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0008494; GO:0016887; GO:0042788; GO:0043022; GO:0045727";"positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]";"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]"
comp24916_c0_seq1;GAXK01125122.1;Q04499;0;PROD_DROME;Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Protein sluggish-A);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"GO:0004657; GO:0005739; GO:0005759; GO:0006537; GO:0006562; GO:0007626; GO:0010133; GO:0042331; GO:0071949";"glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]"
comp249190_c0_seq1;GAXK01196673.1;Q6IP59;9.08E-154;CTL2_XENLA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2491998_c0_seq1;GAXK01013095.1;Q96QS3;5.49E-26;ARX_HUMAN;Homeobox protein ARX (Aristaless-related homeobox);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; neuron development [GO:0048666]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; regulation of cell population proliferation [GO:0042127]";"GO:0000790; GO:0000977; GO:0000980; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0007411; GO:0010628; GO:0021759; GO:0021800; GO:0021831; GO:0021846; GO:0021853; GO:0042127; GO:0044241; GO:0046622; GO:0048666; GO:0072148";"axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; neuron development [GO:0048666]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; regulation of cell population proliferation [GO:0042127]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp249239_c1_seq1;GAXK01196679.1;Q8BQC8;4.93E-11;RBAK_MOUSE;RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0005654; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp249241_c1_seq1;GAXK01196717.1;Q7KRI2;1.27E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2493734_c0_seq1;GAXK01162987.1;Q9LX30;7.15E-20;GCN2_ARATH;eIF-2-alpha kinase GCN2 (serine/threonine-protein kinase GCN2) (EC 2.7.11.1);"cytosolic ribosome [GO:0022626]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; translation [GO:0006412]";"GO:0000049; GO:0004672; GO:0004694; GO:0005524; GO:0006412; GO:0022626; GO:0034198; GO:0070301; GO:0072755; GO:1990451";"cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; translation [GO:0006412]";cytosolic ribosome [GO:0022626];"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]"
comp249387_c0_seq1;GAXK01196791.1;O08762;3.04E-51;NETR_MOUSE;Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202";"exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp24942_c0_seq1;GAXK01124348.1;Q9Y2Z0;9.87E-64;SGT1_HUMAN;Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog);"cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; mitotic cell cycle [GO:0000278]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]";"GO:0000151; GO:0000278; GO:0000776; GO:0005634; GO:0005829; GO:0031647; GO:0032991; GO:0043947; GO:0050821";"mitotic cell cycle [GO:0000278]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]";"cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]";
comp249423_c0_seq1;GAXK01196680.1;P00765;2.62E-43;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2494347_c0_seq1;GAXK01033028.1;P55042;1.70E-19;RAD_HUMAN;GTP-binding protein RAD (RAD1) (Ras associated with diabetes);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007264; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2494352_c0_seq1;GAXK01033027.1;P05661;3.07E-52;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp24946_c0_seq1;GAXK01124875.1;P82922;1.61E-63;RT29_BOVIN;28S ribosomal protein S29, mitochondrial (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006915; GO:0032543";"apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]";"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp2494764_c0_seq1;GAXK01033019.1;Q8SWR2;8.27E-14;BICRD_DROME;Bicaudal D-related protein homolog (BICD-related protein homolog);;;;;
comp2495068_c0_seq1;GAXK01033016.1;Q61171;2.10E-14;PRDX2_MOUSE;Peroxiredoxin-2 (EC 1.11.1.15) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"GO:0000187; GO:0002536; GO:0004601; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0008430; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042743; GO:0042744; GO:0042981; GO:0043209; GO:0043524; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001237; GO:2001240";"activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]"
comp249537_c0_seq1;GAXK01196754.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp249564_c0_seq1;GAXK01196682.1;D3ZGB1;1.15E-70;NFAT5_RAT;Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0001228; GO:0001816; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006366; GO:0006970; GO:0008134; GO:0033173; GO:0044798; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996";"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"
comp2495739_c0_seq1;GAXK01033014.1;Q9U3P2;1.49E-21;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp249575_c0_seq1;GAXK01196707.1;P00766;2.04E-33;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp249582_c0_seq1;GAXK01196808.1;Q8MIS5;1.45E-11;209L2_MACMU;CD209 antigen-like protein 2 (CD antigen CD209);"integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]";"GO:0002250; GO:0005537; GO:0006897; GO:0016021; GO:0045087; GO:0046872";"adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]";integral component of membrane [GO:0016021];"mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp24960_c1_seq1;GAXK01125032.1;Q8NFZ0;1.96E-114;FBH1_HUMAN;F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18);"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]";"GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042";"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]";"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]"
comp249643_c0_seq1;GAXK01196666.1;O15018;2.59E-19;PDZD2_HUMAN;PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2];"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155]";"GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005911; GO:0007155";cell adhesion [GO:0007155];"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]";
comp249658_c1_seq1;GAXK01196750.1;Q14139;7.03E-124;UBE4A_HUMAN;Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0030433; GO:0034450";"protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";ubiquitin-ubiquitin ligase activity [GO:0034450]
comp249703_c0_seq1;GAXK01196798.1;Q8BQ86;3.07E-27;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp249707_c0_seq1;GAXK01196656.1;P50428;6.70E-90;ARSA_MOUSE;Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597";"autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]"
comp2497073_c0_seq1;GAXK01069053.1;Q3UQ41;1.58E-13;TM11A_MOUSE;Transmembrane protease serine 11A (EC 3.4.21.-) (Airway trypsin-like protease 1) (Serine protease DESC3) (DESC-3);"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cell cycle [GO:0007049]; proteolysis in other organism [GO:0035897]; viral entry into host cell [GO:0046718]";"GO:0004252; GO:0005576; GO:0005887; GO:0007049; GO:0008236; GO:0035897; GO:0046718";"cell cycle [GO:0007049]; proteolysis in other organism [GO:0035897]; viral entry into host cell [GO:0046718]";"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp24978_c0_seq1;GAXK01125398.1;O95394;1.58E-166;AGM1_HUMAN;Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3);"cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0000287; GO:0004610; GO:0004614; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097";"carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";cytosol [GO:0005829];"magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]"
comp249812_c0_seq1;GAXK01196706.1;P05661;4.35E-33;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2498354_c0_seq1;GAXK01119396.1;Q9VQG4;5.11E-20;COLT_DROME;Congested-like trachea protein;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; carnitine:acyl carnitine antiporter activity [GO:0005476]; acyl carnitine transport [GO:0006844]; carnitine transport [GO:0015879]; epithelial cell morphogenesis [GO:0003382]; liquid clearance, open tracheal system [GO:0035002]; mitochondrial transport [GO:0006839]";"GO:0003382; GO:0005476; GO:0005743; GO:0006839; GO:0006844; GO:0015879; GO:0016021; GO:0035002";"acyl carnitine transport [GO:0006844]; carnitine transport [GO:0015879]; epithelial cell morphogenesis [GO:0003382]; liquid clearance, open tracheal system [GO:0035002]; mitochondrial transport [GO:0006839]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";carnitine:acyl carnitine antiporter activity [GO:0005476]
comp24986_c8_seq1;GAXK01124589.1;E9QAT4;3.49E-102;SC16A_MOUSE;Protein transport protein Sec16A (SEC16 homolog A) (p250);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0007029; GO:0007030; GO:0012507; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]";
comp24987_c0_seq1;GAXK01125510.1;Q7ZUZ0;3.18E-22;CSN8_DANRE;COP9 signalosome complex subunit 8 (Signalosome subunit 8);"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]";"GO:0000338; GO:0005737; GO:0008180; GO:0010387";"COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]";"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]";
comp2498830_c0_seq1;GAXK01119391.1;A5A4K9;9.99E-22;GHSR_RABIT;Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]";"GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963";"actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"growth hormone-releasing hormone receptor activity [GO:0016520]; growth hormone secretagogue receptor activity [GO:0001616]"
comp24990_c0_seq1;GAXK01124349.1;Q60809;1.24E-141;CNOT7_MOUSE;CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"GO:0000122; GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0008134; GO:0008284; GO:0008285; GO:0010629; GO:0016604; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0061014; GO:0075341; GO:1900153";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]";"3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp249902_c0_seq1;GAXK01196676.1;Q26473;1.33E-157;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp2499349_c0_seq1;GAXK01119379.1;Q8N3I7;6.66E-151;BBS5_HUMAN;Bardet-Biedl syndrome 5 protein;"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; intracellular [GO:0005622]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0001103; GO:0001947; GO:0005622; GO:0005829; GO:0005930; GO:0007601; GO:0015031; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0044458; GO:0046907; GO:0050896; GO:0060170; GO:0060271";"cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; intracellular [GO:0005622]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]"
comp249960_c1_seq1;GAXK01196634.1;P50430;1.68E-108;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp24997_c0_seq1;GAXK01124476.1;Q9GZU8;6.75E-13;PIP30_HUMAN;PSME3-interacting protein (NEFA-interacting nuclear protein NIP30) (PA28G-interacting protein);"nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091]";"GO:0005634; GO:0032091; GO:1901799";"negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091]";nucleus [GO:0005634];
comp25_c4_seq1;GAXK01166051.1;P10987;0;ACT1_DROME;Actin-5C;"actin cytoskeleton [GO:0015629]; brahma complex [GO:0035060]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]";"GO:0000281; GO:0005524; GO:0005737; GO:0006338; GO:0007291; GO:0015629; GO:0031011; GO:0032507; GO:0035060; GO:0035148";"chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]";"actin cytoskeleton [GO:0015629]; brahma complex [GO:0035060]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]";ATP binding [GO:0005524]
comp25004_c3_seq1;GAXK01124480.1;Q6GR09;7.27E-54;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp250083_c1_seq1;GAXK01132106.1;Q96I99;7.97E-16;SUCB2_HUMAN;Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0019003; GO:0042709; GO:0045244; GO:0046982";"succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]";"ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]"
comp250116_c0_seq1;GAXK01132026.1;Q96C23;1.09E-65;GALM_HUMAN;Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]";"GO:0004034; GO:0005737; GO:0006006; GO:0006012; GO:0030246; GO:0033499; GO:0070062";"galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]";"aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]"
comp2501329_c0_seq1;GAXK01137080.1;P19515;1.76E-07;LIP_RHIMI;Lipase (EC 3.1.1.3) (Triacylglycerol lipase);"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];;"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp2501336_c0_seq1;GAXK01137057.1;Q19791;3.06E-75;GON1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1);"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]";"GO:0004222; GO:0005604; GO:0005783; GO:0005794; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0048644; GO:1905607";"cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]";"basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp25014_c6_seq1;GAXK01125625.1;Q14703;0;MBTP1_HUMAN;Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1);"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540";"ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";serine-type endopeptidase activity [GO:0004252]
comp2501993_c0_seq1;GAXK01137053.1;O62739;9.39E-128;RS4Y1_MONDO;40S ribosomal protein S4, Y isoform 1;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2502284_c0_seq1;GAXK01062098.1;A6QNK1;7.83E-18;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp2502365_c0_seq1;GAXK01062120.1;O43526;4.75E-35;KCNQ2_HUMAN;Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2);"axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0071805";"chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]";"axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp25030_c0_seq1;GAXK01125601.1;Q4R372;5.07E-38;FBX25_MACFA;F-box only protein 25;"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; actin binding [GO:0003779]; protein ubiquitination [GO:0016567]";"GO:0003779; GO:0005634; GO:0016567; GO:0019005";protein ubiquitination [GO:0016567];"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";actin binding [GO:0003779]
comp2503259_c0_seq1;GAXK01062103.1;Q0IUU4;4.48E-16;CML2_ORYSJ;Putative calmodulin-like protein 2;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp25034_c2_seq1;GAXK01124935.1;Q94899;0;CSN2_DROME;COP9 signalosome complex subunit 2 (Dch2) (Signalosome subunit 2) (Alien protein);"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; repressor ecdysone receptor complex [GO:0008231]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]";"GO:0000338; GO:0003714; GO:0005737; GO:0007275; GO:0007281; GO:0008180; GO:0008231; GO:0016922; GO:0035257; GO:0036099; GO:0042803; GO:0045892; GO:0048140; GO:0048142; GO:0050821";"female germ-line stem cell population maintenance [GO:0036099]; germarium-derived cystoblast division [GO:0048142]; germ cell development [GO:0007281]; male germ-line cyst encapsulation [GO:0048140]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]";"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; repressor ecdysone receptor complex [GO:0008231]";"nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]"
comp25035_c3_seq1;GAXK01124528.1;Q91VA6;2.89E-157;PDIP2_MOUSE;Polymerase delta-interacting protein 2;"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584";"mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]"
comp25038_c0_seq1;GAXK01125635.1;P55258;1.10E-74;RAB8A_MOUSE;Ras-related protein Rab-8A (Oncogene c-mel);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]";"GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017137; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032482; GO:0032869; GO:0032880; GO:0036064; GO:0043025; GO:0043197; GO:0045202; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060271; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003";"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]"
comp2504356_c0_seq1;GAXK01008734.1;Q9P202;3.86E-30;WHRN_HUMAN;Whirlin (Autosomal recessive deafness type 31 protein);"actin filament [GO:0005884]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0007605; GO:0010628; GO:0021694; GO:0030054; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042803; GO:0045184; GO:0045202; GO:0046982; GO:0050910; GO:0050953; GO:0060088; GO:0060122; GO:1990075; GO:1990227; GO:1990696";"auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"actin filament [GO:0005884]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]";"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp2504559_c0_seq1;GAXK01008743.1;P29474;1.12E-32;NOS3_HUMAN;Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cell redox homeostasis [GO:0045454]; cofactor metabolic process [GO:0051186]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of platelet activation [GO:0010544]; negative regulation of potassium ion transport [GO:0043267]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of nervous system process [GO:0031644]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412]";"GO:0000139; GO:0001525; GO:0001542; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003785; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0007005; GO:0007263; GO:0008217; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010544; GO:0010628; GO:0012506; GO:0014740; GO:0014806; GO:0016491; GO:0019430; GO:0020037; GO:0030324; GO:0030666; GO:0031284; GO:0031644; GO:0031663; GO:0032496; GO:0034405; GO:0034617; GO:0034618; GO:0042311; GO:0043267; GO:0043536; GO:0043542; GO:0045454; GO:0045747; GO:0045766; GO:0045776; GO:0046870; GO:0048873; GO:0050660; GO:0050661; GO:0050999; GO:0051186; GO:0051346; GO:0051926; GO:0060412; GO:0070168; GO:0097110; GO:0097746; GO:1902042";"angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cell redox homeostasis [GO:0045454]; cofactor metabolic process [GO:0051186]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of platelet activation [GO:0010544]; negative regulation of potassium ion transport [GO:0043267]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of nervous system process [GO:0031644]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]"
comp250459_c0_seq1;GAXK01132043.1;Q6PBA8;9.64E-35;MNS1_DANRE;Meiosis-specific nuclear structural protein 1;"motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321]";"GO:0005634; GO:0031514; GO:0044782; GO:0051321";"cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321]";"motile cilium [GO:0031514]; nucleus [GO:0005634]";
comp250466_c0_seq1;GAXK01131917.1;Q26636;4.98E-81;CATL_SARPE;"Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]";"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005764; GO:0007275; GO:0008234; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp250470_c2_seq1;GAXK01131934.1;Q90419;6.85E-15;TWHH_DANRE;"Tiggy-winkle hedgehog protein (TWHH) (Sonic hedgehog protein B) (SHHB) [Cleaved into: Tiggy-winkle hedgehog protein N-product; Tiggy-winkle hedgehog protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0030182; GO:0030900; GO:0042063; GO:0048663; GO:0048702; GO:0048703; GO:0048709; GO:0055002; GO:0060956";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp2504712_c0_seq1;GAXK01008756.1;Q05025;7.68E-155;G3P_COTJA;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; lipid droplet [GO:0005811]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interferon-gamma [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction [GO:0052501]; positive regulation of cytokine secretion [GO:0050715]; protein stabilization [GO:0050821]";"GO:0000226; GO:0004365; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006006; GO:0006096; GO:0008017; GO:0015630; GO:0017148; GO:0019828; GO:0031965; GO:0035605; GO:0035606; GO:0042802; GO:0050661; GO:0050715; GO:0050821; GO:0050832; GO:0051287; GO:0051402; GO:0051873; GO:0052501; GO:0061844; GO:0071346; GO:0097452; GO:0097718; GO:1990904";"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interferon-gamma [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction [GO:0052501]; positive regulation of cytokine secretion [GO:0050715]; protein stabilization [GO:0050821]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; lipid droplet [GO:0005811]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]";"aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]"
comp2504962_c0_seq1;GAXK01008744.1;Q8BKC5;3.97E-11;IPO5_MOUSE;Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]";"GO:0005634; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0042307; GO:0061608; GO:0071230";"cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]"
comp2504983_c0_seq1;GAXK01008736.1;B5U2W0;1.22E-20;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp25053_c1_seq1;GAXK01125239.1;Q5ZLG1;1.72E-93;RAB18_CHICK;Ras-related protein Rab-18;"endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";"GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007420; GO:0019003; GO:0032482; GO:0034389; GO:0071782; GO:0071786";"brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";"endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2506564_c0_seq1;GAXK01203106.1;O42329;1.19E-28;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp2506645_c0_seq1;GAXK01203098.1;P30974;3.96E-28;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp2506849_c0_seq1;GAXK01203117.1;A8PXY6;4.84E-83;RSSA_MALGO;40S ribosomal protein S0;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp250688_c0_seq1;GAXK01132027.1;O35547;3.68E-52;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp2507274_c0_seq1;GAXK01203118.1;Q9N2R3;3.88E-07;TPM_CHAFE;Tropomyosin (Allergen Cha f I) (allergen Cha f 1) (Fragment);;;;;
comp2507311_c0_seq1;GAXK01203105.1;P55012;2.63E-77;S12A2_MOUSE;Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hyperosmotic response [GO:0006972]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]";"GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006884; GO:0006972; GO:0008511; GO:0008519; GO:0010818; GO:0015081; GO:0015378; GO:0015379; GO:0015696; GO:0016021; GO:0016323; GO:0016324; GO:0019901; GO:0030321; GO:0035264; GO:0035725; GO:0045795; GO:0050910; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0070634; GO:1902476; GO:1990573; GO:1990869";"ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to chemokine [GO:1990869]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hyperosmotic response [GO:0006972]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp250761_c0_seq1;GAXK01132081.1;D4A734;1.95E-29;MOT12_RAT;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp2507812_c0_seq1;GAXK01203119.1;Q9D7Z6;2.42E-13;CLCA1_MOUSE;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0006821; GO:0008237; GO:0016021; GO:0030141; GO:0042589; GO:0046872; GO:0071456";"calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp250784_c0_seq1;GAXK01131993.1;Q9VCA2;1.79E-71;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp25081_c1_seq1;GAXK01124475.1;P13667;3.88E-138;PDIA4_HUMAN;Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0045454; GO:0061077";"cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]"
comp2508106_c0_seq1;GAXK01110993.1;Q9VZW5;4.01E-14;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2508222_c0_seq1;GAXK01110978.1;Q92766;1.81E-07;RREB1_HUMAN;Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006366; GO:0007265; GO:0007275; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:1900026; GO:1903691; GO:2000394";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp250825_c2_seq1;GAXK01131949.1;F8U830;4.35E-17;NOTUM_SCHMD;Palmitoleoyl-protein carboxylesterase NOTUM (Smed-notum) (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0016055; GO:0030178; GO:1990697; GO:1990699";"negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp2508366_c0_seq1;GAXK01110967.1;Q5VIY5;9.87E-08;ZN468_HUMAN;Zinc finger protein 468;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp250851_c2_seq1;GAXK01131961.1;P10379;8.93E-12;UZIP_DROME;Protein unzipped (Protein zipper);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]";"GO:0005886; GO:0007411; GO:0007413; GO:0016021";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2508652_c0_seq1;GAXK01110968.1;Q9UFB7;4.57E-27;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2508881_c0_seq1;GAXK01110987.1;Q5ZJG8;3.88E-32;HSDL1_CHICK;Hydroxysteroid dehydrogenase-like protein 1 (EC 1.1.1.-);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005783; GO:0006694; GO:0016491; GO:0030497";"fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp2508942_c0_seq1;GAXK01110969.1;O42387;1.11E-34;RS24_TAKRU;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp250899_c0_seq1;GAXK01131998.1;P42577;3.29E-62;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp250912_c0_seq1;GAXK01131978.1;Q70E73;6.61E-62;RAPH1_HUMAN;Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; axon extension [GO:0048675]; signal transduction [GO:0007165]";"GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675";"axon extension [GO:0048675]; signal transduction [GO:0007165]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]";
comp250916_c0_seq1;GAXK01132025.1;Q7KRI2;3.23E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2509202_c0_seq1;GAXK01110966.1;Q8BTH6;8.37E-59;SCRT2_MOUSE;Transcriptional repressor scratch 2 (Scratch homolog 2 zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2509403_c0_seq1;GAXK01110989.1;Q17R89;6.61E-35;RHG44_HUMAN;Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2);"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]; exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005543; GO:0005829; GO:0006887; GO:0007165; GO:0014069; GO:0030054; GO:0030425; GO:0031256; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048365; GO:0048786; GO:0051056; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099152";"exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]";"GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]"
comp250959_c0_seq1;GAXK01131951.1;Q9W092;1.13E-122;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp250995_c0_seq1;GAXK01132112.1;Q6K1J1;8.76E-57;UDB31_CANLF;UDP-glucuronosyltransferase 2B31 (UDPGT 2B31) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]";"GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0043231";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]"
comp2509973_c0_seq1;GAXK01110979.1;A9ZSY2;3.77E-17;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp251_c0_seq1;GAXK01169856.1;Q8JZQ9;0;EIF3B_MOUSE;Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; synapse [GO:0045202]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]";"GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0071541; GO:0075522; GO:0075525";"formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; synapse [GO:0045202]";"RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp251013_c1_seq1;GAXK01132028.1;Q9H330;4.45E-60;TM245_HUMAN;Transmembrane protein 245 (Protein CG-2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp251135_c1_seq1;GAXK01131979.1;Q6P3D0;6.00E-39;NUD16_MOUSE;U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]";"GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0008284; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0098519; GO:1901639; GO:1901640; GO:1901641; GO:1990174; GO:2000233; GO:2000781";"adenosine to inosine editing [GO:0006382]; chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]"
comp2511389_c0_seq1;GAXK01022140.1;Q8TD84;3.99E-08;DSCL1_HUMAN;Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030054; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]"
comp251151_c0_seq1;GAXK01132064.1;Q80X44;2.58E-12;ZBT24_MOUSE;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Brain-specific protein 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2511561_c0_seq1;GAXK01022137.1;Q6TDP4;2.90E-11;KLH17_HUMAN;Kelch-like protein 17 (Actinfilin);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"GO:0005615; GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0030054; GO:0031208; GO:0032839; GO:0043025; GO:0045211; GO:0051015; GO:0060090";"actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]"
comp25120_c0_seq1;GAXK01125634.1;Q8R2M2;9.85E-34;TDIF2_MOUSE;Deoxynucleotidyltransferase terminal-interacting protein 2;"nucleolus [GO:0005730]; nucleus [GO:0005634]";"GO:0005634; GO:0005730";;"nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp251223_c0_seq1;GAXK01131986.1;Q96QE2;2.01E-25;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp251242_c2_seq1;GAXK01132065.1;P41041;4.26E-19;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp251268_c1_seq1;GAXK01131946.1;Q5R5X9;3.34E-12;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp251272_c1_seq1;GAXK01131981.1;P34319;1.48E-29;BEST5_CAEEL;Bestrophin homolog 5;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2513_c0_seq1;GAXK01175521.1;Q9NWM8;1.24E-44;FKB14_HUMAN;Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase);"endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; IRE1-mediated unfolded protein response [GO:0036498]";"GO:0003755; GO:0005509; GO:0005788; GO:0036498";IRE1-mediated unfolded protein response [GO:0036498];endoplasmic reticulum lumen [GO:0005788];"calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp2513591_c0_seq1;GAXK01198849.1;Q86UC2;3.38E-11;RSPH3_HUMAN;Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp251425_c0_seq1;GAXK01132120.1;Q5RDW1;1.46E-69;MTG2_PONAB;Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254]";"GO:0000287; GO:0003924; GO:0005525; GO:0005743; GO:0005759; GO:0005761; GO:0042254; GO:0044065; GO:0070129";"regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp251435_c0_seq1;GAXK01131984.1;Q6XPS3;1.92E-37;TPTE2_HUMAN;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314";phosphatidylinositol biosynthetic process [GO:0006661];"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp25147_c1_seq1;GAXK01125453.1;Q1HPQ0;5.05E-17;TPM2_BOMMO;Tropomyosin-2;;;;;
comp251483_c0_seq1;GAXK01132080.1;Q8IN81;1.37E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2515_c0_seq1;GAXK01176022.1;O49923;3.68E-115;ADK_PHYPA;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase);"cytosol [GO:0005829]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";"GO:0004001; GO:0005524; GO:0005634; GO:0005829; GO:0006166; GO:0044209";"AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]"
comp2515008_c0_seq1;GAXK01010875.1;Q5R5U3;3.72E-26;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp251525_c0_seq1;GAXK01131977.1;O57685;2.48E-73;PAX2A_XENLA;Paired box protein Pax-2-A (xPax-2a);"nucleus [GO:0005634]; DNA binding [GO:0003677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]";"GO:0000122; GO:0003677; GO:0005634; GO:0007367; GO:0045944";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp2515367_c0_seq1;GAXK01010863.1;O96081;2.15E-41;CALMB_HALRO;Calmodulin-B (CaM B);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp25157_c0_seq1;GAXK01125573.1;Q6P9I7;1.49E-119;SMC6_XENLA;Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398";"cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp2516578_c0_seq1;GAXK01198011.1;O01382;1.93E-61;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp2516600_c0_seq1;GAXK01198018.1;Q9LUQ6;2.04E-78;RL192_ARATH;60S ribosomal protein L19-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp251673_c1_seq1;GAXK01132115.1;Q8HYW2;1.09E-103;SO3A1_BOVIN;Solute carrier organic anion transporter family member 3A1 (Organic anion-transporting polypeptide D) (OATP-D);"integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]";"GO:0005887; GO:0015347; GO:0015732; GO:0043252";"prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]";integral component of plasma membrane [GO:0005887];sodium-independent organic anion transmembrane transporter activity [GO:0015347]
comp251696_c1_seq1;GAXK01131994.1;O15484;1.05E-174;CAN5_HUMAN;Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]";"GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062";"proteolysis [GO:0006508]; signal transduction [GO:0007165]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]";calcium-dependent cysteine-type endopeptidase activity [GO:0004198]
comp2517112_c0_seq1;GAXK01198017.1;G5EDR5;1.02E-38;FUTA_CAEEL;Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1);"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872]; carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0036065; GO:0046872; GO:0046920";"carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872]"
comp251746_c0_seq1;GAXK01132114.1;P58545;6.11E-07;BTBD3_MOUSE;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp251763_c0_seq1;GAXK01205696.1;Q95078;4.42E-150;CP18A_DROME;Cytochrome P450 18a1 (EC 1.14.-.-) (CYPXVIIIA1);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; chorion-containing eggshell formation [GO:0007304]; ecdysteroid catabolic process [GO:0046344]; exogenous drug catabolic process [GO:0042738]; imaginal disc-derived leg morphogenesis [GO:0007480]; metamorphosis [GO:0007552]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; prepupal development [GO:0035210]; pupation [GO:0035074]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0007304; GO:0007480; GO:0007552; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0035074; GO:0035210; GO:0042738; GO:0043231; GO:0046344; GO:0055114";"chorion-containing eggshell formation [GO:0007304]; ecdysteroid catabolic process [GO:0046344]; exogenous drug catabolic process [GO:0042738]; imaginal disc-derived leg morphogenesis [GO:0007480]; metamorphosis [GO:0007552]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; prepupal development [GO:0035210]; pupation [GO:0035074]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp251775_c0_seq1;GAXK01131972.1;Q00657;0;CSPG4_RAT;Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (HSN tumor-specific antigen);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; angiogenesis [GO:0001525]; inflammatory response [GO:0006954]; negative regulation of neuron projection development [GO:0010977]; neuron remodeling [GO:0016322]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]";"GO:0001525; GO:0005518; GO:0005886; GO:0005887; GO:0006954; GO:0007165; GO:0009986; GO:0010226; GO:0010977; GO:0016322; GO:0016324; GO:0031258; GO:0048771";"angiogenesis [GO:0001525]; inflammatory response [GO:0006954]; negative regulation of neuron projection development [GO:0010977]; neuron remodeling [GO:0016322]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]";collagen binding [GO:0005518]
comp2518388_c0_seq1;GAXK01090553.1;P34319;1.56E-15;BEST5_CAEEL;Bestrophin homolog 5;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp251849_c0_seq1;GAXK01131914.1;Q0EEE2;5.19E-53;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp251938_c1_seq1;GAXK01132039.1;P21461;5.57E-11;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp251940_c1_seq1;GAXK01131987.1;Q9C0K0;9.72E-33;BC11B_HUMAN;B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1);"neuron projection [GO:0043005]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"GO:0000978; GO:0000981; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006355; GO:0008285; GO:0010837; GO:0019216; GO:0021773; GO:0021902; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043066; GO:0043368; GO:0043565; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0071678; GO:0097535";"alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"neuron projection [GO:0043005]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp251957_c0_seq1;GAXK01132066.1;Q96MF6;1.71E-38;CQ10A_HUMAN;Coenzyme Q-binding protein COQ10 homolog A, mitochondrial;"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039";"cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";ubiquinone binding [GO:0048039]
comp2520_c1_seq1;GAXK01176001.1;P25789;3.54E-140;PSA4_HUMAN;Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043231; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp2520064_c0_seq1;GAXK01162195.1;P34672;1.35E-18;BST24_CAEEL;Bestrophin homolog 24;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp252035_c0_seq1;GAXK01099937.1;Q7T2H2;1.65E-51;FGRL1_CHICK;Fibroblast growth factor receptor-like 1;"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030133; GO:0044291; GO:0051260; GO:0060412; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]"
comp2520433_c0_seq1;GAXK01162197.1;O91250;1.86E-11;REP7_FBNY2;Para-Rep C7 (Rep7) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3) (ATP-dependent helicase C7) (Replication-associated protein of non-essential DNA C7);"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";"GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872";"DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";host cell nucleus [GO:0042025];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp2521395_c0_seq1;GAXK01162198.1;Q8TAS1;1.86E-16;UHMK1_HUMAN;Serine/threonine-protein kinase Kist (EC 2.7.11.1) (Kinase interacting with stathmin) (PAM COOH-terminal interactor protein 2) (P-CIP2) (U2AF homology motif kinase 1);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; Golgi apparatus [GO:0005794]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; cell cycle arrest [GO:0007050]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein autophosphorylation [GO:0046777]; regulation of protein export from nucleus [GO:0046825]";"GO:0003723; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007050; GO:0016740; GO:0018105; GO:0030424; GO:0031175; GO:0032839; GO:0043021; GO:0045948; GO:0046777; GO:0046825; GO:0071598";"cell cycle arrest [GO:0007050]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein autophosphorylation [GO:0046777]; regulation of protein export from nucleus [GO:0046825]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; Golgi apparatus [GO:0005794]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transferase activity [GO:0016740]"
comp25216_c4_seq1;GAXK01125091.1;O76924;0;ARI2_DROME;Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (Ari-2) (RING-type E3 ubiquitin transferase ariadne-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0032436; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2521623_c0_seq1;GAXK01162193.1;P36609;2.88E-18;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp25219_c1_seq1;GAXK01125448.1;Q00277;1.49E-14;GPX1_SCHMA;Glutathione peroxidase (GPX) (EC 1.11.1.9);"glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0006979";response to oxidative stress [GO:0006979];;glutathione peroxidase activity [GO:0004602]
comp2522065_c0_seq1;GAXK01025541.1;Q9CWR2;2.00E-10;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp252216_c1_seq1;GAXK01099865.1;Q9VRJ1;1.21E-167;SYAM_DROME;Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS);"mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA modification [GO:0006400]";"GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597";"alanyl-tRNA aminoacylation [GO:0006419]; tRNA modification [GO:0006400]";mitochondrion [GO:0005739];"alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp25224_c2_seq1;GAXK01125130.1;Q9D753;1.47E-88;EXOS8_MOUSE;Exosome complex component RRP43 (Exosome component 8) (Ribosomal RNA-processing protein 43);"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0005634; GO:0005730; GO:0005737; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]"
comp252260_c0_seq1;GAXK01099903.1;Q9UNX9;9.85E-27;KCJ14_HUMAN;ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4) (IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14);"dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; cardiac conduction [GO:0061337]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0008076; GO:0030425; GO:0034765; GO:0043025; GO:0061337; GO:1990573";"cardiac conduction [GO:0061337]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";inward rectifier potassium channel activity [GO:0005242]
comp2522602_c0_seq1;GAXK01025535.1;P33450;7.09E-24;FAT_DROME;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000904; GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008283; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0018149; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090176; GO:0090251; GO:0098609";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
comp25227_c2_seq1;GAXK01125516.1;Q9XZ71;3.89E-10;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp25231_c2_seq1;GAXK01125636.1;P0DJ50;3.00E-08;VKT31_MESMA;Kunitz-type serine protease inhibitor BmKTT-2 (Delta-KTx 3.1);"extracellular region [GO:0005576]; host cell membrane [GO:0033644]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]; envenomation resulting in negative regulation of voltage-gated potassium channel activity in other organism [GO:0044562]";"GO:0004867; GO:0005576; GO:0033644; GO:0044562; GO:0090729";envenomation resulting in negative regulation of voltage-gated potassium channel activity in other organism [GO:0044562];"extracellular region [GO:0005576]; host cell membrane [GO:0033644]";"serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]"
comp2523702_c0_seq1;GAXK01025536.1;Q7Z6Z7;8.32E-10;HUWE1_HUMAN;E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043312; GO:0061630; GO:0070062; GO:1903955; GO:1904813";"base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp2523744_c0_seq1;GAXK01025534.1;O74467;2.24E-11;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2523976_c0_seq1;GAXK01025537.1;Q60431;4.00E-30;CASP3_MESAU;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0031647; GO:0097199; GO:1902004";"positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]
comp252426_c0_seq1;GAXK01099947.1;O57409;2.55E-31;DLLB_DANRE;Delta-like protein B (DeltaB);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell differentiation [GO:0030154]; diencephalon development [GO:0021536]; midbrain development [GO:0030901]; Notch signaling pathway [GO:0007219]";"GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0016021; GO:0021536; GO:0030154; GO:0030901";"cell differentiation [GO:0030154]; diencephalon development [GO:0021536]; midbrain development [GO:0030901]; Notch signaling pathway [GO:0007219]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]"
comp25248_c0_seq1;GAXK01125267.1;Q28653;0;2A5D_RABIT;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta);"nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; signal transduction [GO:0007165]";"GO:0000159; GO:0005634; GO:0007165; GO:0019888";signal transduction [GO:0007165];"nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";protein phosphatase regulator activity [GO:0019888]
comp2525280_c0_seq1;GAXK01119183.1;Q0P5N6;4.17E-19;ARL16_HUMAN;ADP-ribosylation factor-like protein 16;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp25253_c0_seq1;GAXK01125025.1;B5DPF1;3.33E-114;TRM5_DROPS;tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog);"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]";"GO:0005634; GO:0005759; GO:0052906";;"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]";tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]
comp25255_c1_seq1;GAXK01124965.1;Q6NYY9;3.81E-127;VMP1_DANRE;Vacuole membrane protein 1 (Transmembrane protein 49);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; autophagy [GO:0006914]; Golgi organization [GO:0007030]";"GO:0005774; GO:0005783; GO:0005886; GO:0006914; GO:0007030; GO:0016021; GO:0033116";"autophagy [GO:0006914]; Golgi organization [GO:0007030]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";
comp2525524_c0_seq1;GAXK01119172.1;P97435;7.73E-17;ENTK_MOUSE;"Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005044; GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp2525911_c0_seq1;GAXK01119176.1;Q5EBL2;3.45E-12;ZN628_HUMAN;Zinc finger protein 628;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2526_c1_seq1;GAXK01176553.1;B4JG34;2.02E-116;TMEDE_DROGR;Transmembrane emp24 domain-containing protein eca;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]";"GO:0005789; GO:0009953; GO:0016021";dorsal/ventral pattern formation [GO:0009953];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp252614_c0_seq1;GAXK01099922.1;Q8I6K1;2.43E-50;PPO1_HOLDI;Phenoloxidase 1 (EC 1.14.18.-) (Prophenoloxidase-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";"GO:0004497; GO:0005576; GO:0042438; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
comp252632_c0_seq1;GAXK01100007.1;P54886;1.86E-13;P5CS_HUMAN;"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]";"GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0005829; GO:0006536; GO:0006561; GO:0006592; GO:0008652; GO:0019240; GO:0042802; GO:0055129";"cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]"
comp2526363_c0_seq1;GAXK01108099.1;P83088;1.73E-09;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp25264_c1_seq1;GAXK01124329.1;Q6GLT8;1.15E-113;FAHD2_XENLA;Fumarylacetoacetate hydrolase domain-containing protein 2 (EC 3.-.-.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp2526606_c0_seq1;GAXK01108089.1;P55112;2.94E-16;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp252664_c0_seq1;GAXK01099912.1;Q7PEV7;2.08E-32;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp252669_c1_seq1;GAXK01099787.1;G5EBQ8;4.69E-84;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp2526830_c0_seq1;GAXK01108100.1;Q9U280;6.74E-23;TAT1_CAEEL;Phospholipid-transporting ATPase tat-1 (EC 7.6.2.1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"GO:0000287; GO:0005524; GO:0005737; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006897; GO:0007040; GO:0015914; GO:0016323; GO:0016324; GO:0031901; GO:0045332; GO:0055038; GO:0060100; GO:0060101; GO:0140326";"endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp252697_c0_seq1;GAXK01099970.1;Q2VG86;2.58E-43;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2527119_c0_seq1;GAXK01108097.1;P25784;3.85E-20;CYSP3_HOMAM;Digestive cysteine proteinase 3 (EC 3.4.22.-);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp25272_c1_seq1;GAXK01124462.1;Q64520;1.01E-70;KGUA_MOUSE;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939";"ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp2527776_c0_seq1;GAXK01108091.1;Q7T2Z5;1.93E-11;UNC5C_CHICK;Netrin receptor UNC5C (Protein unc-5 homolog 3) (cUNC-5H3) (Protein unc-5 homolog C);"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791]";"GO:0005042; GO:0005886; GO:0007411; GO:0009986; GO:0016021; GO:0030027; GO:0030054; GO:0030175; GO:0030425; GO:0030426; GO:0045202; GO:1990791";"axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791]";"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]";netrin receptor activity [GO:0005042]
comp252832_c1_seq1;GAXK01099858.1;B4F7C4;4.63E-08;TDRD5_RAT;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp25288_c0_seq1;GAXK01124566.1;Q6TLE4;8.14E-22;MMGT1_DANRE;Membrane magnesium transporter 1 (ER membrane protein complex subunit 5) (Transmembrane protein 32);"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]";"GO:0000139; GO:0005769; GO:0005794; GO:0005886; GO:0015095; GO:0015693; GO:0016021; GO:0022890; GO:0031901; GO:0072546";magnesium ion transport [GO:0015693];"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]"
comp2528834_c0_seq1;GAXK01008547.1;P28699;5.78E-13;RARG_XENLA;Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0048384";retinoic acid receptor signaling pathway [GO:0048384];nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp252920_c0_seq1;GAXK01099788.1;Q28FF3;4.28E-71;S49A3_XENTR;Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp2529231_c0_seq1;GAXK01008542.1;O97399;4.69E-09;TRYP_PHACE;Trypsin (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586";digestion [GO:0007586];extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp2529256_c0_seq1;GAXK01008567.1;Q8N184;1.51E-11;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2529336_c0_seq1;GAXK01008560.1;Q9VZW5;8.35E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp252968_c0_seq1;GAXK01099917.1;Q8CA03;5.42E-08;TSCOT_MOUSE;Thymic stromal cotransporter protein (Solute carrier family 46 member 2);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]; negative regulation of T cell apoptotic process [GO:0070233]; regulation of T cell differentiation [GO:0045580]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]";"GO:0005887; GO:0009986; GO:0022857; GO:0043029; GO:0045580; GO:0048538; GO:0070233";"negative regulation of T cell apoptotic process [GO:0070233]; regulation of T cell differentiation [GO:0045580]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]";transmembrane transporter activity [GO:0022857]
comp25297_c0_seq1;GAXK01124970.1;Q99943;2.53E-41;PLCA_HUMAN;1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cellular metabolic process [GO:0031325]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]";"GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0016024; GO:0031325";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cellular metabolic process [GO:0031325]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of cytokine production [GO:0001819]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp2529957_c0_seq1;GAXK01008561.1;Q91610;2.42E-21;DHHA_XENLA;"Desert hedgehog protein A (Cephalic hedgehog protein) (Desert hedgehog protein 1) (DHH-1) (X-CHH) [Cleaved into: Desert hedgehog protein A N-product; Desert hedgehog protein A C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0016539; GO:0046872";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp252998_c0_seq1;GAXK01099950.1;Q9U8B8;1.74E-20;DYR_HELVI;Dihydrofolate reductase (EC 1.5.1.3);"dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]";"GO:0004146; GO:0006545; GO:0006730; GO:0046654; GO:0050661";"glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]";;"dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]"
comp2529994_c0_seq1;GAXK01008546.1;P02993;2.08E-70;EF1A_ARTSA;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp253_c3_seq1;GAXK01169967.1;O18640;0;GBLP_DROME;Guanine nucleotide-binding protein subunit beta-like protein (Receptor of activated protein kinase C homolog);"autophagosome [GO:0005776]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein phosphorylation [GO:0001934]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]";"GO:0000398; GO:0001933; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0007626; GO:0009267; GO:0016243; GO:0018991; GO:0019899; GO:0022627; GO:0030838; GO:0035220; GO:0042335; GO:0043022; GO:0044829; GO:0045725; GO:0046716; GO:0048477; GO:0071011; GO:0071013; GO:0072344; GO:0075522";"cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein phosphorylation [GO:0001934]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]";"autophagosome [GO:0005776]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp253007_c3_seq1;GAXK01099952.1;Q8BLE7;1.05E-23;VGLU2_MOUSE;Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6);"cell junction [GO:0030054]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; pericellular basket [GO:1990030]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001504; GO:0005313; GO:0005326; GO:0005769; GO:0005887; GO:0006814; GO:0008021; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0050803; GO:0060076; GO:0098700; GO:0098793; GO:1990030";"neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; pericellular basket [GO:1990030]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp2530489_c0_seq1;GAXK01037296.1;Q96JB1;0;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp25307_c4_seq1;GAXK01124755.1;Q5EAJ7;0;MVP_STRPU;Major vault protein (MVP);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2530790_c0_seq1;GAXK01037306.1;Q19204;6.61E-39;ADT2_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-2 (ADAMTS adt-2) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";"GO:0004222; GO:0005576; GO:0008340; GO:0008361; GO:0030199; GO:0040018; GO:0046872";"collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp253085_c1_seq1;GAXK01099862.1;Q95NM6;2.92E-88;NUCG_CAEEL;Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; exodeoxyribonuclease activity [GO:0004529]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; apoptotic process [GO:0006915]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]";"GO:0000014; GO:0000737; GO:0004519; GO:0004520; GO:0004521; GO:0004529; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0006401; GO:0006915; GO:0042803; GO:0043565; GO:0046872";"apoptotic DNA fragmentation [GO:0006309]; apoptotic process [GO:0006915]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; exodeoxyribonuclease activity [GO:0004529]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]"
comp253114_c0_seq1;GAXK01099907.1;Q64709;1.56E-30;HLF_RAT;Hepatic leukemia factor;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0048511";"regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2531281_c0_seq1;GAXK01037293.1;Q6GNP2;5.99E-08;Z652A_XENLA;Zinc finger protein 652-A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp253158_c0_seq1;GAXK01099946.1;Q99685;2.46E-56;MGLL_HUMAN;Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0019898; GO:0036155; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124";"acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]"
comp2532267_c0_seq1;GAXK01010220.1;Q9VY99;0;NNAD_DROME;Cytosolic carboxypeptidase Nna1 (EC 3.4.17.-) (Nervous system nuclear protein induced by axotomy protein 1 homolog);"mitochondrion [GO:0005739]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";"GO:0002164; GO:0003407; GO:0004181; GO:0005739; GO:0007005; GO:0008270";"larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";mitochondrion [GO:0005739];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp253228_c0_seq1;GAXK01099905.1;A0A0N6WHT4;1.91E-15;MTP_MEGAM;Microsomal triglyceride transfer protein;"endoplasmic reticulum [GO:0005783]; ceramide 1-phosphate transfer activity [GO:1902388]; protein heterodimerization activity [GO:0046982]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; triglyceride transport [GO:0034197]";"GO:0005783; GO:0015914; GO:0034197; GO:0034377; GO:0046982; GO:1902388";"phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; triglyceride transport [GO:0034197]";endoplasmic reticulum [GO:0005783];"ceramide 1-phosphate transfer activity [GO:1902388]; protein heterodimerization activity [GO:0046982]"
comp2532573_c0_seq1;GAXK01010223.1;P21956;2.00E-07;MFGM_MOUSE;Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47);"collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]";"GO:0001525; GO:0001786; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0050766; GO:0062023";"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]";"collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]";"integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]"
comp25326_c1_seq1;GAXK01125125.1;O96005;0;CLPT1_HUMAN;Cleft lip and palate transmembrane protein 1;"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp253281_c4_seq1;GAXK01099825.1;Q3TN34;1.18E-33;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp2533234_c0_seq1;GAXK01010231.1;Q92051;4.85E-42;CAHZ_DANRE;Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";"GO:0004089; GO:0008270; GO:0015670; GO:0042539";"carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp253347_c0_seq1;GAXK01099786.1;Q9GZX5;1.14E-10;ZN350_HUMAN;Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0001162; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0016363; GO:0016604; GO:0017053; GO:0044212; GO:0045892; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription regulatory region DNA binding [GO:0044212]"
comp253358_c0_seq1;GAXK01099918.1;Q9ER04;1.00E-11;TMPS5_MOUSE;Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin);"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0008233; GO:0016021; GO:0043025";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp25340_c1_seq1;GAXK01125086.1;Q95SS8;5.03E-41;TMM70_DROME;Transmembrane protein 70 homolog, mitochondrial;"integral component of mitochondrial membrane [GO:0032592]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]";"GO:0032592; GO:0033615";mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615];integral component of mitochondrial membrane [GO:0032592];
comp2534251_c0_seq1;GAXK01033938.1;A3QK16;4.47E-16;ERLN2_DANRE;Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0031625; GO:0032933";"cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp2534587_c0_seq1;GAXK01033934.1;Q8BZ25;5.46E-10;ANKK1_MOUSE;Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995";regulation of cell cycle process [GO:0010564];"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp2534615_c0_seq1;GAXK01033922.1;C6KSS5;3.09E-13;LRR2_PLAF7;Protein PFF0380w;;;;;
comp253471_c0_seq1;GAXK01100005.1;Q9NDM2;3.45E-88;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp253537_c2_seq1;GAXK01099793.1;P41830;2.25E-15;CNR14_CAEEL;Steroid hormone receptor family member cnr14 (Nuclear receptor subfamily 1 group G member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; dosage compensation by hypoactivation of X chromosome [GO:0042464]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary sex determination [GO:0007538]; response to lipid [GO:0033993]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003700; GO:0003707; GO:0005634; GO:0007275; GO:0007538; GO:0008134; GO:0008270; GO:0009755; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042464; GO:0045944; GO:0090575";"cell differentiation [GO:0030154]; dosage compensation by hypoactivation of X chromosome [GO:0042464]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary sex determination [GO:0007538]; response to lipid [GO:0033993]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp2535423_c0_seq1;GAXK01033920.1;P04352;4.14E-17;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp2535492_c0_seq1;GAXK01033929.1;Q7KRI2;7.54E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp253646_c0_seq1;GAXK01100000.1;P38040;8.44E-22;GBG1_DROME;Guanine nucleotide-binding protein subunit gamma-1;"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343";"apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]"
comp253657_c1_seq1;GAXK01099792.1;Q99K70;2.75E-141;RRAGC_MOUSE;Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929);"cytoplasm [GO:0005737]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0009267; GO:0010506; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131";"cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]";"cytoplasm [GO:0005737]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; protein heterodimerization activity [GO:0046982]"
comp2536753_c0_seq1;GAXK01156868.1;Q7ZVG6;8.33E-08;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp25368_c2_seq1;GAXK01124441.1;Q5ZKG2;1.07E-69;BRD7_CHICK;Bromodomain-containing protein 7;"nucleus [GO:0005634]; cell cycle [GO:0007049]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0007049; GO:0016055";"cell cycle [GO:0007049]; Wnt signaling pathway [GO:0016055]";nucleus [GO:0005634];
comp2536803_c0_seq1;GAXK01156874.1;Q27433;2.05E-26;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp253694_c1_seq1;GAXK01100002.1;Q5T3U5;0;MRP7_HUMAN;Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp2537163_c0_seq1;GAXK01156865.1;Q9VZW5;1.27E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2538_c0_seq1;GAXK01175736.1;Q02369;1.21E-27;NDUB9_BOVIN;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005747; GO:0006120; GO:0032981";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";mitochondrial respiratory chain complex I [GO:0005747];
comp253824_c3_seq1;GAXK01204953.1;P42860;3.86E-40;GSTT1_LUCCU;Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp2538429_c0_seq1;GAXK01156522.1;Q6DET9;2.42E-15;EF1B_XENTR;Elongation factor 1-beta (EF-1-beta);"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414";translational elongation [GO:0006414];"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]";"guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]"
comp2538539_c0_seq1;GAXK01156512.1;P25439;2.32E-24;BRM_DROME;ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma);"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648";"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]";"brahma complex [GO:0035060]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp2538691_c0_seq1;GAXK01156510.1;B2RZ55;2.29E-15;SIR7_RAT;NAD-dependent protein deacetylase sirtuin-7 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7);"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"GO:0000122; GO:0003682; GO:0004407; GO:0005634; GO:0005724; GO:0005731; GO:0005737; GO:0007072; GO:0009303; GO:0046872; GO:0070403; GO:0070932; GO:0097372";"histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]"
comp2538974_c0_seq1;GAXK01156506.1;Q8UWA5;6.62E-13;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp253899_c0_seq1;GAXK01099923.1;Q5F3G7;7.25E-33;C1GLT_CHICK;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]";"GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872";"angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]";integral component of membrane [GO:0016021];"glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp2539_c3_seq1;GAXK01175874.1;Q9DE27;0;RUVB2_XENLA;RuvB-like 2 (EC 3.6.4.12) (Reptin);"Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]"
comp253923_c0_seq1;GAXK01099863.1;P52746;4.96E-15;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp25393_c1_seq1;GAXK01125503.1;Q9VZF4;0;FBXW7_DROME;F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago);"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]; axon guidance [GO:0007411]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]";"GO:0005634; GO:0007088; GO:0007096; GO:0007411; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381";"axon guidance [GO:0007411]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]";"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]"
comp253937_c1_seq1;GAXK01099829.1;G5ED00;4.72E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp2539497_c0_seq1;GAXK01156504.1;B3EWY9;1.23E-09;MLP_ACRMI;Mucin-like protein (Fragment);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]";"GO:0005509; GO:0007160; GO:0016021";cell-matrix adhesion [GO:0007160];integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp25397_c0_seq1;GAXK01125512.1;Q2KJC9;0;AL7A1_BOVIN;Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0043878";glycine betaine biosynthetic process from choline [GO:0019285];"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]"
comp2540130_c0_seq1;GAXK01138753.1;Q8I6K0;7.57E-18;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp254042_c1_seq1;GAXK01004082.1;Q8WV41;4.18E-72;SNX33_HUMAN;Sorting nexin-33 (SH3 and PX domain-containing protein 3);"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]";"GO:0000281; GO:0005829; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0019898; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010";"cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]";"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]";"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]"
comp2540434_c0_seq1;GAXK01138771.1;Q26630;2.59E-29;IDLC_STRPU;33 kDa inner dynein arm light chain, axonemal (p33);"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504";inner dynein arm assembly [GO:0036159];"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp254108_c0_seq1;GAXK01004075.1;P46941;3.70E-29;TG325_CAEEL;WW domain-containing protein tag-325;"cytoplasm [GO:0005737]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0043087";"regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];
comp254119_c1_seq1;GAXK01004196.1;Q54P77;1.18E-94;4CL1_DICDI;Probable 4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp2541865_c0_seq1;GAXK01138774.1;P36609;2.17E-27;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2542258_c0_seq1;GAXK01131152.1;Q9XYN0;9.33E-07;INX1_SCHAM;Innexin inx1 (Innexin-1) (G-Inx1);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp2542980_c0_seq1;GAXK01131154.1;Q6ZN57;4.42E-28;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2543111_c0_seq1;GAXK01131155.1;Q6Q4H1;1.39E-22;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp2543265_c0_seq1;GAXK01131158.1;O74467;1.33E-09;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp254348_c0_seq1;GAXK01204976.1;Q3U3Q1;1.13E-117;ULK3_MOUSE;Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagosome assembly [GO:0000045]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]";"GO:0000045; GO:0000407; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0010506; GO:0016020; GO:0045879; GO:0045880; GO:0046777";"autophagosome assembly [GO:0000045]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp254359_c0_seq1;GAXK01004017.1;P90884;1.02E-81;MADD4_CAEEL;Protein madd-4 (Punctin);"axon [GO:0030424]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; dorsal/ventral axon guidance [GO:0033563]; synapse organization [GO:0050808]";"GO:0005102; GO:0005615; GO:0008233; GO:0030054; GO:0030424; GO:0033563; GO:0045202; GO:0050808";"dorsal/ventral axon guidance [GO:0033563]; synapse organization [GO:0050808]";"axon [GO:0030424]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";"peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp2543785_c0_seq1;GAXK01131151.1;P11118;1.30E-49;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2543848_c0_seq1;GAXK01131162.1;Q2M1K9;1.72E-13;ZN423_HUMAN;Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0045892; GO:0045893; GO:0046872; GO:0120163";"cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2544260_c0_seq1;GAXK01111066.1;Q5W8I8;1.65E-16;VGL2A_DANRE;Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A);"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; chemical synaptic transmission [GO:0007268]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]";"GO:0005313; GO:0005326; GO:0005887; GO:0006814; GO:0007268; GO:0007601; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0050803; GO:0060076; GO:0098700";"chemical synaptic transmission [GO:0007268]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]";"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp25450_c0_seq1;GAXK01124753.1;A1Z6E0;4.14E-67;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp25454_c0_seq1;GAXK01205639.1;P35129;9.94E-89;UBC2_CAEEL;Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2);"chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0004842; GO:0005524; GO:0005634; GO:0005694; GO:0006511; GO:0016567; GO:0031625; GO:0061631";"protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp2546965_c0_seq1;GAXK01164842.1;Q2EI21;3.01E-11;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2547234_c0_seq1;GAXK01164836.1;Q8BVU5;3.76E-58;NUDT9_MOUSE;ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9);"mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]";"GO:0005739; GO:0043262; GO:0046032; GO:0046709; GO:0047631";"ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]";mitochondrion [GO:0005739];"adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]"
comp2547243_c0_seq1;GAXK01164833.1;Q18192;3.81E-12;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp254725_c0_seq1;GAXK01204791.1;Q5ZLN1;5.68E-119;PGAM1_CHICK;Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1);"cell [GO:0005623]; cytosol [GO:0005829]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004082; GO:0004619; GO:0005623; GO:0005829; GO:0006094; GO:0006096; GO:0016787";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cell [GO:0005623]; cytosol [GO:0005829]";"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]"
comp254754_c0_seq1;GAXK01004046.1;Q5VIY5;5.01E-16;ZN468_HUMAN;Zinc finger protein 468;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2547568_c0_seq1;GAXK01164850.1;Q8Q0U0;6.13E-12;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp2547574_c0_seq1;GAXK01164847.1;P41753;2.07E-59;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp2547999_c0_seq1;GAXK01164848.1;Q61171;9.43E-17;PRDX2_MOUSE;Peroxiredoxin-2 (EC 1.11.1.15) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"GO:0000187; GO:0002536; GO:0004601; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0008430; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042743; GO:0042744; GO:0042981; GO:0043209; GO:0043524; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001237; GO:2001240";"activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]"
comp2548383_c0_seq1;GAXK01162342.1;O16116;5.82E-20;GST3_CAEEL;Glutathione S-transferase 3 (EC 2.5.1.18) (CeGST3) (GST class-sigma);"glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749";glutathione metabolic process [GO:0006749];;glutathione transferase activity [GO:0004364]
comp254924_c2_seq1;GAXK01003992.1;Q8IYD8;1.00E-180;FANCM_HUMAN;Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog);"FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0003677; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0031297; GO:0036297; GO:0043240; GO:0071821; GO:1902527";"interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]";"FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]"
comp254962_c2_seq1;GAXK01003997.1;Q5R633;6.39E-13;TZAP_PONAB;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005634; GO:0010833; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]";"double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp254973_c0_seq1;GAXK01004124.1;P06803;3.54E-68;PIM1_MOUSE;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0008283; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp2549887_c0_seq1;GAXK01162338.1;Q09FC8;8.39E-19;ZN415_HUMAN;Zinc finger protein 415;"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0001650; GO:0003677; GO:0005634; GO:0005737; GO:0015630; GO:0046872";;"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2549922_c0_seq1;GAXK01162347.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp2549975_c0_seq1;GAXK01162336.1;Q8TE73;2.40E-36;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp255036_c0_seq1;GAXK01004172.1;P35502;7.85E-63;ESTF_MYZPE;Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp2550510_c0_seq1;GAXK01108471.1;Q5U3U0;2.58E-12;PHYD1_DANRE;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp25508_c0_seq1;GAXK01124754.1;Q9VTJ8;5.39E-51;TIM14_DROME;Mitochondrial import inner membrane translocase subunit TIM14;"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150]";"GO:0001405; GO:0001671; GO:0005744; GO:0016021; GO:0030150";protein import into mitochondrial matrix [GO:0030150];"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";ATPase activator activity [GO:0001671]
comp25510_c0_seq1;GAXK01124353.1;Q5R5C9;9.75E-116;SCPDL_PONAB;Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp255162_c1_seq1;GAXK01004063.1;Q8NHP8;2.51E-93;PLBL2_HUMAN;"Putative phospholipase B-like 2 (EC 3.1.1.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form; Putative phospholipase B-like 2 45 kDa form]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]";"GO:0004620; GO:0016042; GO:0043202; GO:0070062";lipid catabolic process [GO:0016042];"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]";phospholipase activity [GO:0004620]
comp255184_c0_seq1;GAXK01004054.1;P22293;9.03E-22;SUS_DROME;Protein suppressor of sable;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear RNA surveillance [GO:0071027]";"GO:0001162; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005700; GO:0045892; GO:0046872; GO:0071027";"negative regulation of transcription, DNA-templated [GO:0045892]; nuclear RNA surveillance [GO:0071027]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"
comp2552569_c0_seq1;GAXK01127862.1;O43581;4.34E-52;SYT7_HUMAN;Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0043005; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp255375_c0_seq1;GAXK01004121.1;O97827;9.59E-22;AGRL3_BOVIN;Adhesion G protein-coupled receptor L3 (Latrophilin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp2554_c0_seq1;GAXK01175330.1;Q05AY2;0;EI3EA_XENLA;Eukaryotic translation initiation factor 3 subunit E-A (eIF3e-A) (Eukaryotic translation initiation factor 3 subunit 6-A);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]";translation initiation factor activity [GO:0003743]
comp25543_c3_seq1;GAXK01125571.1;Q8VDT9;9.35E-10;RM50_MOUSE;39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005762";;"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";
comp2554325_c0_seq1;GAXK01055864.1;Q9DG25;1.21E-39;POPD3_CHICK;Popeye domain-containing protein 3 (Popeye protein 3);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; heart development [GO:0007507]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]";"GO:0007507; GO:0007519; GO:0016020; GO:0016021; GO:0030552; GO:0042383; GO:0042391; GO:0051146";"heart development [GO:0007507]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcolemma [GO:0042383]";cAMP binding [GO:0030552]
comp25544_c0_seq1;GAXK01124465.1;B4N0P7;5.79E-147;KRR1_DROWI;KRR1 small subunit processome component homolog (KRR-R motif-containing protein 1) (Protein dribble);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007275; GO:1990904";"multicellular organism development [GO:0007275]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp2554999_c0_seq1;GAXK01055878.1;X2JAU8;2.48E-71;NWK_DROME;Protein nervous wreck (Nwk);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030054; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601";"multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]";"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"
comp255538_c0_seq1;GAXK01004076.1;Q86YT5;1.47E-112;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp25554_c0_seq1;GAXK01125208.1;Q7Z5Y7;4.56E-130;KCD20_HUMAN;BTB/POZ domain-containing protein KCTD20 (Potassium channel tetramerization domain containing 20);"cytoplasm [GO:0005737]; positive regulation of phosphorylation [GO:0042327]";"GO:0005737; GO:0042327";positive regulation of phosphorylation [GO:0042327];cytoplasm [GO:0005737];
comp255602_c0_seq1;GAXK01004136.1;Q9PU47;2.98E-09;PDLI3_CHICK;PDZ and LIM domain protein 3 (Alpha-actinin-associated LIM protein);"actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]";"GO:0001725; GO:0003779; GO:0005623; GO:0005913; GO:0005925; GO:0007507; GO:0015629; GO:0030018; GO:0030027; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0051393; GO:0061061";"actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]";"actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp255614_c0_seq1;GAXK01004093.1;Q9VUN0;1.17E-07;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp2556319_c0_seq1;GAXK01021238.1;P16157;8.79E-12;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp2556720_c0_seq1;GAXK01021251.1;Q9TU53;1.84E-11;CUBN_CANLF;Cubilin;"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"GO:0005509; GO:0005765; GO:0008144; GO:0008203; GO:0010008; GO:0015031; GO:0016324; GO:0031419; GO:0031526";"cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]";"calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]"
comp2556882_c0_seq1;GAXK01021259.1;P18730;4.50E-17;ZG58_XENLA;Gastrula zinc finger protein XlCGF58.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp255715_c0_seq1;GAXK01004150.1;Q0P485;1.35E-27;C85CA_DANRE;Coiled-coil domain-containing protein 85C-A;multicellular organism development [GO:0007275];GO:0007275;multicellular organism development [GO:0007275];;
comp2557295_c0_seq1;GAXK01021263.1;Q5G268;1.16E-14;NETR_NOMLE;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424";exocytosis [GO:0006887];"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp25573_c4_seq1;GAXK01124828.1;Q90673;3.15E-42;PRLD1_CHICK;PRELI domain-containing protein 1, mitochondrial (Px19-like protein);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; apoptotic process [GO:0006915]; phospholipid transport [GO:0015914]";"GO:0005739; GO:0005758; GO:0006915; GO:0015914; GO:1990050";"apoptotic process [GO:0006915]; phospholipid transport [GO:0015914]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";phosphatidic acid transfer activity [GO:1990050]
comp2557393_c0_seq1;GAXK01021256.1;Q9VZW5;2.59E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp25575_c0_seq1;GAXK01125230.1;Q9BSB4;1.64E-84;ATGA1_HUMAN;Autophagy-related protein 101;"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; macroautophagy [GO:0016236]; regulation of macroautophagy [GO:0016241]";"GO:0000045; GO:0000407; GO:0005789; GO:0005829; GO:0016236; GO:0016241; GO:0042802; GO:0044877";"autophagosome assembly [GO:0000045]; macroautophagy [GO:0016236]; regulation of macroautophagy [GO:0016241]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]";"identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp255808_c1_seq1;GAXK01004206.1;Q18PE0;2.39E-34;DOK7_MOUSE;Protein Dok-7 (Downstream of tyrosine kinase 7);"cell junction [GO:0030054]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; neuromuscular junction development [GO:0007528]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]";"GO:0001934; GO:0005634; GO:0005654; GO:0005739; GO:0005886; GO:0007528; GO:0019901; GO:0030054; GO:0031594; GO:0035091; GO:0043113; GO:0061098";"neuromuscular junction development [GO:0007528]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]";"cell junction [GO:0030054]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]"
comp255811_c0_seq1;GAXK01004044.1;Q04791;3.27E-49;SASB_ANAPL;Fatty acyl-CoA hydrolase precursor, medium chain (EC 3.1.2.-) (Thioesterase B);"hydrolase activity [GO:0016787]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0016787";fatty acid biosynthetic process [GO:0006633];;hydrolase activity [GO:0016787]
comp25584_c6_seq1;GAXK01125472.1;Q95KI0;9.39E-28;RFOX1_MACFA;RNA binding protein fox-1 homolog 1 (Ataxin-2-binding protein 1) (Fox-1 homolog A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0043484";"mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp2558962_c0_seq1;GAXK01196603.1;P17970;6.60E-100;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp2559_c0_seq1;GAXK01176038.1;O61703;1.72E-57;MPCP_CHOFU;Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp255931_c0_seq1;GAXK01004098.1;Q3MI00;1.28E-28;DNJB1_BOVIN;DnaJ homolog subfamily B member 1;"cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"GO:0000122; GO:0001671; GO:0003714; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]"
comp2559318_c0_seq1;GAXK01196609.1;P48149;1.92E-55;RS15A_DROME;40S ribosomal protein S15Aa;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp2559403_c0_seq1;GAXK01196616.1;P52176;3.01E-13;MMP9_BOVIN;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001934; GO:0004222; GO:0005615; GO:0006508; GO:0007566; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0034614; GO:0035987; GO:0042802; GO:0043388; GO:0045742; GO:0051549; GO:0071276; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2559822_c0_seq1;GAXK01196607.1;Q8BGM5;3.81E-32;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp256_c0_seq1;GAXK01169193.1;P09527;6.61E-123;RAB7A_RAT;Ras-related protein Rab-7a (Ras-related protein BRL-RAS) (Ras-related protein p23);"alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]";"GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005774; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0008333; GO:0016042; GO:0019003; GO:0030670; GO:0031410; GO:0031902; GO:0032419; GO:0032482; GO:0033162; GO:0034045; GO:0043195; GO:0045022; GO:0045335; GO:0045453; GO:0048365; GO:0061724; GO:0090383; GO:0090385; GO:0097208; GO:0098993";"bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]";"alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; Rac GTPase binding [GO:0048365]"
comp25600_c1_seq1;GAXK01125504.1;Q8MRC9;0;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp2560307_c0_seq1;GAXK01086141.1;P83501;1.98E-11;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp2560771_c0_seq1;GAXK01086145.1;Q6JEL2;4.73E-13;KLH10_HUMAN;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp2560833_c0_seq1;GAXK01205421.1;Q09390;7.91E-09;HMG12_CAEEL;High mobility group protein 1.2;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell fate specification [GO:0001708]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vulval development [GO:0040025]; Wnt signaling pathway [GO:0016055]";"GO:0000790; GO:0001708; GO:0005634; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0008406; GO:0016055; GO:0040025; GO:0044212; GO:0045089; GO:0045944";"cell fate specification [GO:0001708]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vulval development [GO:0040025]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp256119_c0_seq1;GAXK01124152.1;P17971;0;KCNAL_DROME;Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016021; GO:0030425; GO:0034765; GO:0043204; GO:0051260; GO:0071805";"associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249]"
comp25612_c1_seq1;GAXK01124971.1;Q9I0K4;0;ACEA_PSEAE;Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase);"isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]; glyoxylate cycle [GO:0006097]; negative regulation of single-species biofilm formation on inanimate substrate [GO:1900232]; pathogenesis [GO:0009405]; tricarboxylic acid cycle [GO:0006099]";"GO:0004451; GO:0006097; GO:0006099; GO:0009405; GO:0046872; GO:1900232";"glyoxylate cycle [GO:0006097]; negative regulation of single-species biofilm formation on inanimate substrate [GO:1900232]; pathogenesis [GO:0009405]; tricarboxylic acid cycle [GO:0006099]";;"isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]"
comp2561306_c0_seq1;GAXK01086146.1;P36609;6.37E-24;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp25615_c2_seq1;GAXK01125499.1;Q7JUX9;1.27E-24;MRRP1_DROME;Mitochondrial ribonuclease P protein 1 homolog (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C);"mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";"GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0009019; GO:0030678; GO:0090502; GO:0090646";"mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";"mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]"
comp2561558_c0_seq1;GAXK01086149.1;Q75EV6;0;EF3_ASHGO;Elongation factor 3 (EF-3);"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0005524; GO:0016887";;;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; translation elongation factor activity [GO:0003746]"
comp2561573_c0_seq1;GAXK01086155.1;Q9ULI1;8.26E-70;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp25616_c1_seq1;GAXK01125393.1;O35867;1.37E-21;NEB1_RAT;Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (PP1bp175) (Protein phosphatase 1 regulatory subunit 9A) (p180);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"GO:0005737; GO:0005829; GO:0005856; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0010976; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030027; GO:0030054; GO:0030175; GO:0030425; GO:0030426; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0044325; GO:0044326; GO:0044877; GO:0045202; GO:0045860; GO:0048666; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761";"actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]";"actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]"
comp2561725_c0_seq1;GAXK01086157.1;P27949;2.79E-20;UBC_ASFB7;Ubiquitin-conjugating enzyme E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) (pI215L);"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]";"GO:0005524; GO:0016567; GO:0016740; GO:0030430; GO:0042025";protein ubiquitination [GO:0016567];"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]";"ATP binding [GO:0005524]; transferase activity [GO:0016740]"
comp2562439_c0_seq1;GAXK01182263.1;Q8L7M4;8.55E-30;SDN5_ARATH;Small RNA degrading nuclease 5 (EC 3.1.-.-);"nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0004527; GO:0005634";;nucleus [GO:0005634];"exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]"
comp25625_c0_seq1;GAXK01125089.1;P49867;7.01E-169;FTZF1_BOMMO;Nuclear hormone receptor FTZ-F1 (BmFTZ-F1) (Nuclear receptor subfamily 5 group A member 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2563451_c0_seq1;GAXK01182266.1;P79263;2.45E-08;ITIH4_PIG;Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Major acute phase protein) (MAP);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097]";"GO:0004867; GO:0005576; GO:0006953; GO:0030212; GO:0034097";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097]";extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp25636_c0_seq1;GAXK01125395.1;Q9UBV8;2.62E-49;PEF1_HUMAN;Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1);"COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]";"GO:0000139; GO:0003723; GO:0005509; GO:0005737; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0060090; GO:0070062; GO:1902527";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]";"COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]"
comp2563616_c0_seq1;GAXK01182256.1;P80457;6.30E-52;XDH_BOVIN;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp25639_c1_seq1;GAXK01124352.1;Q5BJZ6;4.08E-119;CARME_RAT;Carnosine N-methyltransferase (EC 2.1.1.22) (Anserine-producing methyltransferase);"cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498]";"GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0035498";carnosine metabolic process [GO:0035498];"cytosol [GO:0005829]; nucleus [GO:0005634]";"carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp256396_c0_seq1;GAXK01124276.1;Q96QE2;1.72E-95;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp2564_c0_seq1;GAXK01175650.1;P07749;7.57E-20;FCA1_TRYCR;Flagellar calcium-binding protein (FCABP) (1F8 protein) (24 kDa antigen) (29 kDa flagella protein) (ALC-1 antigen) (F29) (P24);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp256401_c0_seq1;GAXK01124142.1;Q9LT35;1.58E-26;NEK6_ARATH;Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (NimA-related protein kinase 6) (AtNek6);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cortical microtubule organization [GO:0043622]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0005524; GO:0006468; GO:0010311; GO:0010366; GO:0043622";"cortical microtubule organization [GO:0043622]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein phosphorylation [GO:0006468]";;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp256430_c0_seq1;GAXK01124085.1;Q6PHZ8;1.84E-54;KCIP4_MOUSE;Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0030425; GO:0043025; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp2564335_c0_seq1;GAXK01149129.1;Q61116;8.45E-12;ZN235_MOUSE;Zinc finger protein 235 (Zinc finger protein 93) (Zfp-93);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp256437_c0_seq1;GAXK01124140.1;Q9VUN0;0;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp256471_c1_seq1;GAXK01124251.1;Q96HH4;2.89E-43;TM169_HUMAN;Transmembrane protein 169;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2564794_c0_seq1;GAXK01149127.1;Q9QZ85;1.30E-24;IIGP1_MOUSE;Interferon-inducible GTPase 1 (EC 3.6.5.-);"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829";"cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp256481_c4_seq1;GAXK01124146.1;Q7KRI2;2.00E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2565657_c0_seq1;GAXK01149108.1;Q9ESD1;1.96E-18;PRSS8_MOUSE;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]";"anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633]";"GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0045121; GO:0046658; GO:0070633; GO:1902307";"positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633]";"anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]"
comp2565758_c0_seq1;GAXK01149134.1;Q9VZW5;3.07E-12;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp256595_c0_seq1;GAXK01205637.1;P05627;1.07E-10;JUN_MOUSE;Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; aging [GO:0007568]; angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular process [GO:0009987]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion starvation [GO:0051365]; cellular response to reactive oxygen species [GO:0034614]; circadian rhythm [GO:0007623]; eyelid development in camera-type eye [GO:0061029]; leading edge cell differentiation [GO:0035026]; learning [GO:0007612]; liver development [GO:0001889]; membrane depolarization [GO:0051899]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000980; GO:0000981; GO:0001102; GO:0001228; GO:0001525; GO:0001774; GO:0001836; GO:0001889; GO:0001938; GO:0003151; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0005096; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005829; GO:0006351; GO:0006355; GO:0006366; GO:0007179; GO:0007265; GO:0007568; GO:0007612; GO:0007623; GO:0008134; GO:0008284; GO:0008285; GO:0009314; GO:0009612; GO:0009987; GO:0010033; GO:0010634; GO:0017053; GO:0019899; GO:0030224; GO:0031103; GO:0031625; GO:0031953; GO:0032496; GO:0032870; GO:0033613; GO:0034097; GO:0034614; GO:0035026; GO:0035497; GO:0035976; GO:0035994; GO:0042493; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043392; GO:0043524; GO:0043525; GO:0043565; GO:0043922; GO:0043923; GO:0044212; GO:0044389; GO:0045597; GO:0045657; GO:0045740; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048146; GO:0048661; GO:0051365; GO:0051591; GO:0051726; GO:0051899; GO:0060395; GO:0061029; GO:0070374; GO:0070412; GO:0071276; GO:0071277; GO:0071837; GO:1902895; GO:1904707; GO:1990441; GO:2000144";"aging [GO:0007568]; angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular process [GO:0009987]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion starvation [GO:0051365]; cellular response to reactive oxygen species [GO:0034614]; circadian rhythm [GO:0007623]; eyelid development in camera-type eye [GO:0061029]; leading edge cell differentiation [GO:0035026]; learning [GO:0007612]; liver development [GO:0001889]; membrane depolarization [GO:0051899]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; SMAD protein signal transduction [GO:0060395]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]";"activating transcription factor binding [GO:0033613]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]"
comp256608_c0_seq1;GAXK01124298.1;Q9I9R3;9.79E-100;S40A1_DANRE;Solute carrier family 40 member 1 (Ferroportin-1);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]";"GO:0005381; GO:0006826; GO:0006879; GO:0010039; GO:0016021; GO:0016323; GO:0017046; GO:0030282; GO:0034755; GO:0035162; GO:0042541; GO:0043362; GO:0046688; GO:0055072";"bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp25667_c5_seq1;GAXK01125236.1;Q06609;0;RAD51_HUMAN;DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A);"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA ligation [GO:0051106]; protein homooligomerization [GO:0051260]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000785; GO:0000790; GO:0000793; GO:0000794; GO:0000800; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005815; GO:0005829; GO:0006268; GO:0006281; GO:0006310; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051106; GO:0051260; GO:0051321; GO:0070182; GO:0070192; GO:0070317; GO:0071479; GO:0072757; GO:1990426";"cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA ligation [GO:0051106]; protein homooligomerization [GO:0051260]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]";"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]"
comp256671_c1_seq1;GAXK01124118.1;Q62431;5.21E-26;ARI3A_MOUSE;AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000977; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0042803; GO:0043231; GO:0045121; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp25668_c1_seq1;GAXK01125088.1;O46108;1.85E-87;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp25673_c2_seq1;GAXK01124951.1;P62184;1.39E-21;CALM_RENRE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2567536_c0_seq1;GAXK01048276.1;Q54KA7;7.63E-34;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp2567549_c0_seq1;GAXK01048280.1;Q94900;1.32E-15;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp2568_c1_seq1;GAXK01175753.1;Q503I8;1.98E-134;NGLY1_DANRE;Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872";"glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]"
comp2568046_c0_seq1;GAXK01095116.1;Q2XSV9;7.27E-35;GNA11_PIG;Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11);"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]";"GO:0001508; GO:0001664; GO:0001750; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0007188; GO:0007213; GO:0007603; GO:0009649; GO:0016020; GO:0031683; GO:0031826; GO:0046872; GO:0060158";"action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]";"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]"
comp256833_c0_seq1;GAXK01124153.1;Q9N1Q4;1.13E-141;LAT2_RABIT;Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; neutral amino acid transport [GO:0015804]";"GO:0005737; GO:0015101; GO:0015171; GO:0015179; GO:0015804; GO:0016021; GO:0016323; GO:0019534; GO:0042605";neutral amino acid transport [GO:0015804];"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]"
comp256851_c0_seq1;GAXK01124284.1;O74467;2.50E-19;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp256946_c0_seq1;GAXK01124111.1;Q9TTV2;2.10E-31;ROA2_SAGOE;Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1) (Vitamin D response element-binding protein 2) (VDRE-BP 2);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006406; GO:0031053; GO:0035198; GO:0043047; GO:0070062; GO:1990247; GO:1990428; GO:1990904";"miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]"
comp256975_c0_seq1;GAXK01124235.1;Q5SP46;9.14E-51;GXLT1_DANRE;Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3);"integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0016021; GO:0016266; GO:0035252";O-glycan processing [GO:0016266];integral component of membrane [GO:0016021];UDP-xylosyltransferase activity [GO:0035252]
comp257_c0_seq1;GAXK01168783.1;P97461;4.04E-135;RS5_MOUSE;40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed];"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0006412; GO:0006450; GO:0019843; GO:0022627; GO:1990904";"regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2570061_c0_seq1;GAXK01005167.1;P35464;2.71E-07;DIHR_MANSE;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp25703_c0_seq1;GAXK01125390.1;P05547;5.20E-08;TNNI_ASTLP;Troponin I (TnI);"troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]";"GO:0003779; GO:0005861; GO:0046872";;troponin complex [GO:0005861];"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp257034_c1_seq1;GAXK01124261.1;P61214;5.63E-57;ARL4A_RAT;ADP-ribosylation factor-like protein 4A;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873";"brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp257090_c0_seq1;GAXK01124281.1;Q3UVK0;4.40E-137;ERMP1_MOUSE;Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508]";"GO:0001541; GO:0005783; GO:0005789; GO:0006508; GO:0008237; GO:0016021; GO:0046872";"ovarian follicle development [GO:0001541]; proteolysis [GO:0006508]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp257099_c1_seq1;GAXK01124130.1;Q868Z9;3.59E-45;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp257116_c1_seq1;GAXK01124136.1;Q24372;9.18E-32;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp257172_c0_seq1;GAXK01124250.1;Q9Y297;3.41E-18;FBW1A_HUMAN;F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000209; GO:0000462; GO:0002223; GO:0005654; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016032; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0032040; GO:0033598; GO:0034388; GO:0038061; GO:0038095; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0043433; GO:0043687; GO:0045309; GO:0045862; GO:0045879; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0051403; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070498; GO:0071407; GO:1901990";"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]";"beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]"
comp257258_c0_seq1;GAXK01124092.1;Q8CHG5;4.55E-117;AREL1_MOUSE;Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0045732; GO:0061630";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp25729_c1_seq1;GAXK01124567.1;Q1HRV8;1.88E-61;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp257307_c0_seq1;GAXK01124105.1;Q95RA9;2.70E-31;GILT1_DROME;GILT-like protein 1;"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; disulfide oxidoreductase activity [GO:0015036]; immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"GO:0002376; GO:0005576; GO:0005886; GO:0015036; GO:0055114; GO:1900426";"immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]";disulfide oxidoreductase activity [GO:0015036]
comp257314_c0_seq1;GAXK01124087.1;P30872;9.08E-62;SSR1_HUMAN;Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SRIF-2);"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]";"GO:0004930; GO:0004994; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007215; GO:0007218; GO:0007283; GO:0008285; GO:0021549; GO:0030900; GO:0042277; GO:0042594; GO:0071392; GO:1990830";"cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; glutamate receptor signaling pathway [GO:0007215]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]"
comp257389_c0_seq1;GAXK01124295.1;Q868Z9;2.43E-119;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp25739_c0_seq1;GAXK01124932.1;P36609;2.70E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2574311_c0_seq1;GAXK01091593.1;O61365;1.14E-14;NACH_DROME;Sodium channel protein Nach (Pickpocket protein 4);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0006814; GO:0016021; GO:0035002";"liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp257466_c2_seq1;GAXK01205618.1;Q62073;4.44E-122;M3K7_MOUSE;Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000165; GO:0000287; GO:0001525; GO:0001841; GO:0004674; GO:0004708; GO:0004709; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007179; GO:0007252; GO:0007254; GO:0014069; GO:0016239; GO:0018107; GO:0030971; GO:0043123; GO:0043276; GO:0043507; GO:0046330; GO:0060546; GO:0097110; GO:1902443; GO:2000377; GO:2000378; GO:2001234";"angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp2574775_c0_seq1;GAXK01091576.1;Q7KRI2;9.71E-12;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2574980_c0_seq1;GAXK01091591.1;F7J220;7.42E-32;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp2575014_c0_seq1;GAXK01091584.1;Q7K237;3.56E-53;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp25753_c0_seq1;GAXK01125209.1;Q8VHK7;2.92E-18;HDGF_RAT;Hepatoma-derived growth factor (HDGF);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"GO:0000122; GO:0000166; GO:0000978; GO:0001227; GO:0005615; GO:0005634; GO:0005737; GO:0008083; GO:0008201; GO:0034504; GO:0045944; GO:0051781";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp25756_c2_seq1;GAXK01124371.1;Q9H4I3;2.27E-79;TRABD_HUMAN;TraB domain-containing protein (Protein TTG2);;;;;
comp2575806_c0_seq1;GAXK01091589.1;Q95NI4;1.80E-46;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2575814_c0_seq1;GAXK01091579.1;Q9VUL9;4.43E-14;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp257613_c1_seq1;GAXK01124199.1;Q9HCD6;3.12E-142;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp257622_c0_seq1;GAXK01124233.1;Q7KRI2;5.54E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp257626_c1_seq1;GAXK01124050.1;Q0EEE2;4.96E-37;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp2576564_c0_seq1;GAXK01156453.1;Q7ZZY3;3.03E-18;TOB1B_XENLA;DNA topoisomerase 2-binding protein 1-B (DNA topoisomerase II-binding protein 1-B) (TopBP1-B) (Xmus101);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000922; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007049";"cell cycle [GO:0007049]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";DNA binding [GO:0003677]
comp257662_c7_seq1;GAXK01124171.1;Q5R826;9.44E-100;CSCL1_PONAB;CSC1-like protein 1 (Transmembrane protein 63A);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleic acid binding [GO:0003676]; ion transport [GO:0006811]";"GO:0003676; GO:0005765; GO:0006811; GO:0016021";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";nucleic acid binding [GO:0003676]
comp2576754_c0_seq1;GAXK01156465.1;H3BMG3;5.45E-09;SMKR1_HUMAN;Small lysine-rich protein 1;;;;;
comp257690_c0_seq1;GAXK01124121.1;P27323;1.86E-80;HS901_ARATH;Heat shock protein 90-1 (AtHSP90.1) (AtHsp90-1) (Heat shock protein 81-1) (Hsp81-1) (Heat shock protein 83);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";"GO:0005524; GO:0005737; GO:0009816; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp25770_c8_seq1;GAXK01125083.1;Q14232;3.36E-62;EI2BA_HUMAN;Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0005886; GO:0006413; GO:0006446; GO:0009408; GO:0009749; GO:0014003; GO:0016020; GO:0042802; GO:0043434; GO:0050852";"oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]"
comp257707_c1_seq1;GAXK01124143.1;Q9D7X3;5.90E-35;DUS3_MOUSE;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001701; GO:0001772; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp2577516_c0_seq1;GAXK01156463.1;Q99LI5;8.21E-07;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp257770_c1_seq1;GAXK01124077.1;Q0V9J0;8.45E-20;TMM69_XENTR;Transmembrane protein 69;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp257791_c0_seq1;GAXK01124154.1;Q70JS2;1.29E-71;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp25781_c0_seq1;GAXK01124749.1;Q6GLE1;7.10E-72;CCD25_XENTR;Coiled-coil domain-containing protein 25;;;;;
comp257851_c0_seq1;GAXK01124283.1;Q1H9T6;6.20E-18;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp2578659_c0_seq1;GAXK01162726.1;Q659X0;1.88E-77;FUT8_CANLF;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]"
comp2578661_c0_seq1;GAXK01162721.1;P17970;2.63E-118;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp25787_c0_seq1;GAXK01124751.1;O54963;1.11E-12;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp257904_c0_seq1;GAXK01124120.1;Q9CZV8;1.04E-51;FXL20_MOUSE;F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like);"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; behavioral fear response [GO:0001662]; protein ubiquitination [GO:0016567]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001662; GO:0005737; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300";"behavioral fear response [GO:0001662]; protein ubiquitination [GO:0016567]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]";
comp25792_c1_seq1;GAXK01124507.1;Q7ZXR3;3.65E-88;NAA20_XENLA;N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]";"GO:0005634; GO:0005737; GO:0008080";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";N-acetyltransferase activity [GO:0008080]
comp2579587_c0_seq1;GAXK01162716.1;Q6RYS3;6.41E-130;RL8_MAMBR;60S ribosomal protein L8;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2579675_c0_seq1;GAXK01162705.1;Q90YS3;2.62E-112;RS2_ICTPU;40S ribosomal protein S2;"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp257969_c0_seq1;GAXK01124292.1;Q8BM89;7.79E-95;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp257984_c3_seq1;GAXK01124061.1;Q9VLA1;2.99E-88;B3G2S_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase S (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase S) (Glucuronosyltransferase S) (GlcAT-S) (UDP-glucuronosyltransferase S) (DmGlcAT-BSI);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0006486; GO:0006688; GO:0009101; GO:0015018; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650";"chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"
comp2580198_c0_seq1;GAXK01115322.1;Q920M9;7.94E-10;SIAH1_RAT;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244";"cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]";"disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2580326_c0_seq1;GAXK01115292.1;Q5YLM1;5.66E-12;DGLA_RAT;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp2580381_c0_seq1;GAXK01115296.1;Q9VUL9;3.08E-48;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp258056_c0_seq1;GAXK01053794.1;P30432;1.30E-16;FUR2_DROME;Furin-like protease 2 (Furin-2) (EC 3.4.21.75);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048";"negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp2580693_c0_seq1;GAXK01115310.1;Q8BGC3;1.59E-13;MOT12_MOUSE;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp25810_c2_seq1;GAXK01125222.1;O13134;0;S4A4_AMBTI;Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005452; GO:0006814; GO:0015293; GO:0016021; GO:0016323";sodium ion transport [GO:0006814];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]"
comp2581262_c0_seq1;GAXK01115286.1;P81115;1.98E-08;SLBA_TRIAB;Snaclec alboaggregin-B subunit alpha (AL-B subunit alpha) (25-kDa alboaggregin);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp2581349_c0_seq1;GAXK01115317.1;Q8TE73;6.22E-129;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp258207_c0_seq1;GAXK01053914.1;A1A4L6;3.55E-90;ETS2_BOVIN;Protein C-ets-2;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0000981; GO:0001227; GO:0001712; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0045893; GO:0090009";"cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp258231_c0_seq1;GAXK01053608.1;Q7KRI2;1.20E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2582384_c0_seq1;GAXK01013242.1;Q7Q297;2.96E-13;WSCD_ANOGA;WSCD family member AGAP003962;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp258273_c0_seq1;GAXK01053856.1;Q5RFI0;1.49E-29;PX11B_PONAB;Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta);"integral component of peroxisomal membrane [GO:0005779]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; signal transduction [GO:0007165]";"GO:0005779; GO:0007031; GO:0007165; GO:0016559";"peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; signal transduction [GO:0007165]";integral component of peroxisomal membrane [GO:0005779];
comp258274_c0_seq1;GAXK01053793.1;Q9AST1;9.52E-15;TAF15_ARATH;Transcription initiation factor TFIID subunit 15 (TBP-associated factor 15) (AtTAF15);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp2582807_c0_seq1;GAXK01013236.1;Q9H2X3;3.94E-08;CLC4M_HUMAN;C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0006897; GO:0007159; GO:0009988; GO:0016020; GO:0019048; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046790; GO:0046872; GO:0046968; GO:0048306; GO:0075733";"adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]"
comp258349_c0_seq1;GAXK01053789.1;Q3MHI4;1.26E-16;PHAX_BOVIN;Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein);"Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"GO:0003723; GO:0005634; GO:0005737; GO:0005813; GO:0006408; GO:0015030; GO:0015031";"protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp2584090_c0_seq1;GAXK01182235.1;Q91206;2.11E-07;MYOD2_ONCMY;Myoblast determination protein 1 homolog 2 (Myogenic factor 1-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]";"GO:0003677; GO:0005634; GO:0007517; GO:0030154; GO:0046983; GO:1905382; GO:1990841";"cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]";nucleus [GO:0005634];"DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]"
comp258422_c0_seq1;GAXK01053664.1;Q07120;7.56E-10;GFI1_RAT;Zinc finger protein Gfi-1 (Growth factor independent protein 1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0000122; GO:0001227; GO:0003700; GO:0005654; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0044212; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp2584273_c0_seq1;GAXK01182233.1;Q9XYP7;5.43E-15;GCP2_DROME;Gamma-tubulin complex component 2 homolog (Gamma-ring complex protein 84 kDa) (d84p) (dGrip84);"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]";"GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0007020; GO:0007098; GO:0007283; GO:0008275; GO:0030953; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0051726";"astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]";gamma-tubulin binding [GO:0043015]
comp2584294_c0_seq1;GAXK01182242.1;Q5R6L5;3.14E-47;CAND1_PONAB;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1);"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"GO:0005634; GO:0005737; GO:0010265; GO:0016567; GO:0031461";"protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2584307_c0_seq1;GAXK01182228.1;P31692;5.82E-134;ADT_PARKE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp2584565_c0_seq1;GAXK01182227.1;P55113;9.79E-21;NAS7_CAEEL;Zinc metalloproteinase nas-7 (EC 3.4.24.-) (Nematode astacin 7);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2584703_c0_seq1;GAXK01182241.1;Q9U3S9;1.94E-07;NAS6_CAEEL;Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp258515_c2_seq1;GAXK01053847.1;Q5ZMB2;7.78E-11;HEBP1_CHICK;Heme-binding protein 1;"cytoplasm [GO:0005737]; heme binding [GO:0020037]";"GO:0005737; GO:0020037";;cytoplasm [GO:0005737];heme binding [GO:0020037]
comp258521_c0_seq1;GAXK01053741.1;Q9V427;2.13E-57;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp25856_c0_seq1;GAXK01125380.1;Q24214;1.06E-100;CANB2_DROME;Calcineurin subunit B type 2 (Protein phosphatase 2B regulatory subunit 2) (dCNB2);"calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calmodulin binding [GO:0005516]; meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005516; GO:0005955; GO:0006470; GO:0007269; GO:0008021; GO:0008597; GO:0016192; GO:0030241; GO:0030431; GO:0045214; GO:0051321";"meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]";"calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]";"calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]"
comp258576_c0_seq1;GAXK01053675.1;Q9P2S5;2.99E-83;WRP73_HUMAN;WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]";"GO:0005813; GO:0005814; GO:0030030; GO:0036064; GO:0090307; GO:1902857";"cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]";
comp2585863_c0_seq1;GAXK01204914.1;P53440;3.94E-11;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp2586025_c0_seq1;GAXK01162615.1;Q50KB1;4.86E-39;SEP2_EMIHU;Protein disulfide-isomerase-like protein EhSep2;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein disulfide isomerase activity [GO:0003756]
comp258644_c3_seq1;GAXK01053606.1;P51452;3.77E-37;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp258725_c4_seq1;GAXK01053736.1;Q8MQJ9;7.04E-35;BRAT_DROME;Brain tumor protein;"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007411; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0043161; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061630; GO:0099738; GO:1900242; GO:1902692";"asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]";"mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2587356_c0_seq1;GAXK01162622.1;Q866F1;3.51E-22;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp258754_c0_seq1;GAXK01053818.1;Q3KR37;8.42E-24;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp2588094_c0_seq1;GAXK01022246.1;P18729;9.14E-14;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2588125_c0_seq1;GAXK01022233.1;P00766;2.01E-10;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp258813_c0_seq1;GAXK01053614.1;Q9UBG0;9.94E-15;MRC2_HUMAN;C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574";"collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp2588340_c0_seq1;GAXK01022252.1;Q9UI46;7.04E-82;DNAI1_HUMAN;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003774; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp2588430_c0_seq1;GAXK01022238.1;Q06908;7.30E-129;ATPG_TRICV;ATP synthase gamma chain, chloroplastic (F-ATPase gamma subunit);"chloroplast thylakoid membrane [GO:0009535]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0009535; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"chloroplast thylakoid membrane [GO:0009535]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]
comp2588720_c0_seq1;GAXK01022243.1;B3MRS1;1.30E-59;NAAT1_DROAN;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp258905_c0_seq1;GAXK01053871.1;P22648;3.44E-158;FAS2_SCHAM;Fasciclin-2 (Fasciclin II) (FAS II);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007155; GO:0007399; GO:0016021; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];
comp2589545_c0_seq1;GAXK01022261.1;Q9JME2;3.27E-09;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp258958_c0_seq1;GAXK01053862.1;Q6UB98;8.07E-14;ANR12_HUMAN;Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp2589583_c0_seq1;GAXK01022255.1;O60241;5.36E-18;AGRB2_HUMAN;Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2);"centrosome [GO:0005813]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965]";"GO:0004930; GO:0005813; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016021; GO:0016525; GO:0033173; GO:0051965";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965]";"centrosome [GO:0005813]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2589686_c0_seq1;GAXK01022235.1;Q9R0Y1;1.84E-07;ASIC5_MOUSE;Acid-sensing ion channel 5 (ASIC5) (Amiloride-sensitive cation channel 5) (Brain-liver-intestine amiloride-sensitive Na(+) channel) (BLINaC);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; sodium ion transmembrane transport [GO:0035725]";"GO:0005272; GO:0005886; GO:0015252; GO:0015280; GO:0016020; GO:0016021; GO:0035725";sodium ion transmembrane transport [GO:0035725];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]"
comp25897_c0_seq1;GAXK01124356.1;Q96EE3;1.34E-171;SEH1_HUMAN;Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein);"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000777; GO:0002534; GO:0005198; GO:0005635; GO:0005765; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006999; GO:0007080; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0043657; GO:0050830; GO:0051301; GO:0051315; GO:0060964; GO:0061700; GO:0075733; GO:1900034; GO:1904263";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]";structural molecule activity [GO:0005198]
comp2589813_c0_seq1;GAXK01022237.1;Q5RB30;2.35E-17;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp259_c2_seq1;GAXK01169221.1;Q9Z2I8;1.26E-160;SUCB2_MOUSE;Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG);"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004775; GO:0004776; GO:0004777; GO:0005524; GO:0005525; GO:0005739; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0019003; GO:0032991; GO:0042709; GO:0045244; GO:0046982";"succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]";"ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]"
comp2590186_c0_seq1;GAXK01037528.1;P11503;6.84E-71;HSP70_ONCVO;Heat shock 70 kDa protein (HSP70) (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp2590527_c0_seq1;GAXK01037531.1;Q9VZW5;3.40E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp259077_c0_seq1;GAXK01053728.1;A6H751;3.12E-130;FOLC_BOVIN;Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolate synthase) (Tetrahydrofolylpolyglutamate synthase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; folic acid-containing compound biosynthetic process [GO:0009396]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]";"GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006730; GO:0009396; GO:0046872; GO:0046901";"folic acid-containing compound biosynthetic process [GO:0009396]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]"
comp259085_c0_seq1;GAXK01053732.1;Q96EG3;3.93E-09;ZN837_HUMAN;Zinc finger protein 837;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp259128_c0_seq1;GAXK01053681.1;Q1H9T6;1.81E-11;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp259147_c1_seq1;GAXK01053678.1;O77475;3.21E-21;CPESY_DROME;Ceramide phosphoethanolamine synthase (CPE synthase) (EC 2.7.8.n3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0005886; GO:0006665; GO:0016021; GO:0016740";sphingolipid metabolic process [GO:0006665];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transferase activity [GO:0016740]
comp2592041_c0_seq1;GAXK01164162.1;P35500;8.03E-56;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp259250_c0_seq1;GAXK01053807.1;Q5U374;7.80E-09;KLH12_DANRE;Kelch-like protein 12;"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028";"anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]";
comp259257_c1_seq1;GAXK01053878.1;Q4GZT3;2.82E-177;PKD2_BOVIN;Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738";"calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp259259_c0_seq1;GAXK01053820.1;Q801S4;9.38E-60;K0930_XENLA;Uncharacterized protein KIAA0930 homolog;;;;;
comp2592953_c0_seq1;GAXK01164155.1;B2RW38;2.38E-119;CFA58_MOUSE;Cilia- and flagella-associated protein 58;cilium [GO:0005929];GO:0005929;;cilium [GO:0005929];
comp259347_c0_seq1;GAXK01053733.1;Q920N2;1.11E-49;BPL1_MOUSE;"Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]";"GO:0000785; GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0008283; GO:0009305; GO:0009374; GO:0016363; GO:0016570; GO:0018271; GO:0019899; GO:0042803; GO:0070781; GO:0071110";"cell population proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]";"ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin binding [GO:0009374]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]"
comp2593487_c0_seq1;GAXK01164154.1;Q99MD8;5.63E-07;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp259349_c0_seq1;GAXK01053824.1;P61859;2.75E-34;CALM_NEUCR;Calmodulin (CaM);"central plaque of spindle pole body [GO:0005823]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";"GO:0005509; GO:0005823; GO:0019722; GO:0051300";"calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300]";central plaque of spindle pole body [GO:0005823];calcium ion binding [GO:0005509]
comp2593656_c0_seq1;GAXK01164168.1;O74467;1.73E-12;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp259368_c0_seq1;GAXK01053836.1;O23791;3.76E-52;BROM1_ANACO;Fruit bromelain (EC 3.4.22.33) (allergen Ana c 2);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp259375_c0_seq1;GAXK01053817.1;P17030;4.55E-17;ZNF25_HUMAN;Zinc finger protein 25 (Zinc finger protein KOX19);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp25939_c0_seq1;GAXK01125056.1;P41942;6.39E-31;YKB4_CAEEL;Uncharacterized protein B0272.4;"peroxisome [GO:0005777]; isomerase activity [GO:0016853]";"GO:0005777; GO:0016853";;peroxisome [GO:0005777];isomerase activity [GO:0016853]
comp2593977_c1_seq1;GAXK01164150.1;Q28955;3.84E-21;NTAN1_PIG;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0008418";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp259418_c5_seq1;GAXK01053803.1;A9CPT4;1.52E-23;TDRD1_ORYLA;Tudor domain-containing protein 1;"P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"P granule [GO:0043186]; pi-body [GO:0071546]";metal ion binding [GO:0046872]
comp259466_c0_seq1;GAXK01053834.1;Q8BIQ3;5.75E-23;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp25947_c0_seq1;GAXK01125521.1;Q95VA8;1.56E-78;TPM_TRISP;Tropomyosin;;;;;
comp259504_c0_seq1;GAXK01053744.1;Q9VI93;4.71E-11;RN_DROME;Zinc finger protein rotund (Zinc finger protein roughened eye);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0007480; GO:0022416; GO:0045892; GO:0046872; GO:0048749";"cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp25951_c0_seq1;GAXK01124810.1;C6DCH7;1.89E-18;6PGL_PECCP;6-phosphogluconolactonase (6-P-gluconolactonase) (EC 3.1.1.31);"6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";;6-phosphogluconolactonase activity [GO:0017057]
comp2595180_c0_seq1;GAXK01180822.1;Q8BGM5;2.71E-12;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2596128_c0_seq1;GAXK01092918.1;F1RWC3;8.17E-40;CUBN_PIG;Cubilin (Intrinsic factor-cobalamin receptor);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006898; GO:0009617; GO:0016324; GO:0030139; GO:0042803; GO:0042953; GO:0070062";"lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]"
comp2596684_c0_seq1;GAXK01092925.1;Q9UJU3;9.56E-14;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2596956_c0_seq1;GAXK01092917.1;Q9NPC7;2.62E-07;MYNN_HUMAN;Myoneurin (Zinc finger and BTB domain-containing protein 31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp2596978_c0_seq1;GAXK01092912.1;Q09453;7.30E-33;GLRB4_CAEEL;Glycine receptor subunit beta-type 4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp25974_c1_seq1;GAXK01125220.1;Q23983;4.94E-121;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp25975_c0_seq1;GAXK01125632.1;B5X5L2;4.34E-21;LYRM1_SALSA;LYR motif-containing protein 1;;;;;
comp259752_c0_seq1;GAXK01053788.1;Q66S03;5.08E-14;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp259769_c0_seq1;GAXK01053731.1;Q9N003;8.01E-17;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp259781_c3_seq1;GAXK01053697.1;Q9VMA7;1.96E-16;TGO1_DROME;Transport and Golgi organization protein 1;"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"GO:0000137; GO:0000139; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0007030; GO:0009306; GO:0012505; GO:0016021; GO:0033363; GO:0035459; GO:0051047; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp259789_c1_seq1;GAXK01053779.1;P02595;1.43E-16;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp259809_c0_seq1;GAXK01053740.1;A9ZSY2;2.60E-54;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2598662_c0_seq1;GAXK01063807.1;Q5EA06;7.43E-22;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp259911_c0_seq1;GAXK01053835.1;P05661;1.08E-07;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp259941_c3_seq1;GAXK01053827.1;Q8I6K1;3.16E-74;PPO1_HOLDI;Phenoloxidase 1 (EC 1.14.18.-) (Prophenoloxidase-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";"GO:0004497; GO:0005576; GO:0042438; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
comp2599558_c0_seq1;GAXK01063830.1;Q13813;1.15E-07;SPTN1_HUMAN;Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]";"GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724";"actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]";"actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]"
comp26_c0_seq1;GAXK01169644.1;P47813;1.22E-54;IF1AX_HUMAN;Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C);"cytosol [GO:0005829]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]";"GO:0003723; GO:0003743; GO:0005829; GO:0006413; GO:0008135";translational initiation [GO:0006413];cytosol [GO:0005829];"RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp2600054_c0_seq1;GAXK01076181.1;Q4R495;1.26E-39;MFS11_MACFA;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp26003_c1_seq1;GAXK01132911.1;Q9BTC8;2.82E-142;MTA3_HUMAN;Metastasis-associated protein MTA3;"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]";"GO:0000122; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892";"histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp260069_c2_seq1;GAXK01091225.1;Q91VT4;6.80E-16;CBR4_MOUSE;Carbonyl reductase family member 4 (EC 1.-.-.-) (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit) (KAR beta subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Quinone reductase CBR4);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]";"GO:0003955; GO:0005739; GO:0005759; GO:0006633; GO:0008753; GO:0016616; GO:0044597; GO:0044598; GO:0047025; GO:0048038; GO:0051289; GO:0051290; GO:0055114; GO:0070402; GO:1990204";"daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]";"3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]"
comp260070_c0_seq1;GAXK01091353.1;F4HU58;9.09E-11;TAD1_ARATH;tRNA-specific adenosine deaminase TAD1 (AtTAD1) (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase TAD1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA modification [GO:0006400]";"GO:0003723; GO:0005634; GO:0006400; GO:0008251; GO:0042803; GO:0046872";tRNA modification [GO:0006400];nucleus [GO:0005634];"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp2601002_c0_seq1;GAXK01076203.1;Q920Q8;8.21E-10;NS1BP_MOUSE;Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]";"GO:0005634; GO:0005829; GO:0005856; GO:0008380; GO:0009615; GO:0031397; GO:2001243";"negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp26013_c0_seq1;GAXK01132902.1;Q28DE6;1.47E-119;RSBNL_XENTR;Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like);"nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0005634; GO:0046872; GO:0051213";;nucleus [GO:0005634];"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp260142_c0_seq1;GAXK01091397.1;O75897;4.03E-51;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp260158_c0_seq1;GAXK01091230.1;Q8T3Y0;9.28E-09;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2601660_c0_seq1;GAXK01076182.1;P59769;7.44E-11;BIP_ASPAW;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (Immunoglobulin heavy chain-binding protein homolog) (BiP);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005788; GO:0006986; GO:0016787";response to unfolded protein [GO:0006986];endoplasmic reticulum lumen [GO:0005788];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp2601686_c0_seq1;GAXK01076198.1;Q54MG6;2.99E-31;RL37_DICDI;60S ribosomal protein L37;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022625; GO:0046872";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp26019_c0_seq1;GAXK01132816.1;Q9VXB0;1.08E-66;NECAP_DROME;NECAP-like protein CG9132;"clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; endocytosis [GO:0006897]; protein transport [GO:0015031]";"GO:0005905; GO:0006897; GO:0015031; GO:0030125";"endocytosis [GO:0006897]; protein transport [GO:0015031]";"clathrin-coated pit [GO:0005905]; clathrin vesicle coat [GO:0030125]";
comp260210_c0_seq1;GAXK01091169.1;C9D7C2;0;CAC1A_APIME;Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);"voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005509; GO:0005891; GO:0034765";regulation of ion transmembrane transport [GO:0034765];voltage-gated calcium channel complex [GO:0005891];"calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]"
comp2602185_c0_seq1;GAXK01157263.1;Q9Y4D2;1.24E-13;DGLA_HUMAN;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp2602446_c0_seq1;GAXK01157247.1;Q9VZW5;9.47E-33;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp260327_c0_seq1;GAXK01091101.1;P22978;1.37E-14;CG445_DROME;Rhodanese domain-containing protein CG4456 (Heat shock protein 67B2);;;;;
comp2603784_c0_seq1;GAXK01157267.1;Q8TBH0;1.34E-09;ARRD2_HUMAN;Arrestin domain-containing protein 2;"cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031410";;"cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]";
comp2604612_c0_seq1;GAXK01037700.1;Q8QZS1;3.39E-08;HIBCH_MOUSE;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp260470_c1_seq1;GAXK01091469.1;A8WQK3;3.24E-53;ACH1_CAEBR;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp2604727_c0_seq1;GAXK01037682.1;B5U2W0;1.28E-29;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp260497_c0_seq1;GAXK01091497.1;P42678;1.55E-25;ETIF1_ANOGA;Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog);"eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]";"GO:0003723; GO:0003743; GO:0016282; GO:0043024";;eukaryotic 43S preinitiation complex [GO:0016282];"ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
comp2604974_c0_seq1;GAXK01037688.1;O42248;4.77E-70;GBLP_DANRE;Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543";"angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp2605_c1_seq1;GAXK01175711.1;P43296;6.49E-60;RD19A_ARATH;Cysteine protease RD19A (EC 3.4.22.-) (Protein RESPONSIVE TO DEHYDRATION 19) (RD19);"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; defense response to bacterium [GO:0042742]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]";"GO:0000323; GO:0004197; GO:0005615; GO:0005634; GO:0005764; GO:0005773; GO:0005886; GO:0006970; GO:0009651; GO:0042742; GO:0051603";"defense response to bacterium [GO:0042742]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";cysteine-type endopeptidase activity [GO:0004197]
comp2605148_c0_seq1;GAXK01037683.1;Q9DCM4;2.31E-36;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp2605523_c0_seq1;GAXK01037678.1;P35789;2.37E-17;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp2605682_c0_seq1;GAXK01037690.1;P48168;1.70E-13;GLRB_MOUSE;Glycine receptor subunit beta (Glycine receptor 58 kDa subunit);"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; drug binding [GO:0008144]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuropeptide signaling pathway [GO:0007218]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001964; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0008144; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0050905; GO:0051291; GO:0060012; GO:0060013; GO:0097112; GO:0098690; GO:0098982; GO:1902476; GO:1904315";"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuropeptide signaling pathway [GO:0007218]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"drug binding [GO:0008144]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2606216_c0_seq1;GAXK01057498.1;Q0IIL1;4.33E-39;MICU1_BOVIN;Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog);"calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]";"GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246";"calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]";"calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]";"calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]"
comp2606280_c0_seq1;GAXK01057479.1;Q8SWR2;4.48E-07;BICRD_DROME;Bicaudal D-related protein homolog (BICD-related protein homolog);;;;;
comp2606384_c0_seq1;GAXK01057478.1;Q63065;1.44E-08;PDK1_RAT;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of glucose metabolic process [GO:0010906]";"GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0006006; GO:0006468; GO:0007166; GO:0008283; GO:0008631; GO:0010906; GO:0018105; GO:0042803; GO:0044877; GO:0045254; GO:0046982; GO:0097411";"cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of glucose metabolic process [GO:0010906]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]";"ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp2606390_c0_seq1;GAXK01057473.1;Q2M3R5;5.60E-12;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp26064_c2_seq1;GAXK01132589.1;Q10713;0;MPPA_HUMAN;Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (P-55);"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005739; GO:0005743; GO:0006508; GO:0006627; GO:0006851; GO:0017087; GO:0046872";"mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp260670_c7_seq1;GAXK01091237.1;Q9VUN0;7.20E-110;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp2607_c0_seq1;GAXK01176468.1;O70593;1.30E-77;SGTA_RAT;Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 1);"cytosol [GO:0005829]; extrinsic component of synaptic vesicle membrane [GO:0098850]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; TRC complex [GO:0072380]; BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; chaperone-mediated protein folding [GO:0061077]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of chaperone-mediated protein folding [GO:1903646]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005634; GO:0005829; GO:0006620; GO:0016020; GO:0030433; GO:0042802; GO:0043621; GO:0061077; GO:0071816; GO:0072380; GO:0098793; GO:0098850; GO:1903070; GO:1903071; GO:1903646; GO:1904288; GO:2000059";"chaperone-mediated protein folding [GO:0061077]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of chaperone-mediated protein folding [GO:1903646]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytosol [GO:0005829]; extrinsic component of synaptic vesicle membrane [GO:0098850]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; TRC complex [GO:0072380]";"BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]"
comp260701_c1_seq1;GAXK01091410.1;A6QLU6;2.74E-12;AGRD1_BOVIN;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp260724_c1_seq1;GAXK01091468.1;O18824;1.33E-51;SCRB1_BOVIN;Scavenger receptor class B member 1 (SRB1) (SR-BI);"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508";"adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]";"amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]"
comp2607509_c0_seq1;GAXK01057480.1;Q61171;1.94E-32;PRDX2_MOUSE;Peroxiredoxin-2 (EC 1.11.1.15) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"GO:0000187; GO:0002536; GO:0004601; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0008430; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042743; GO:0042744; GO:0042981; GO:0043209; GO:0043524; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001237; GO:2001240";"activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]"
comp2607644_c0_seq1;GAXK01057476.1;X2JAU8;1.21E-26;NWK_DROME;Protein nervous wreck (Nwk);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030054; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601";"multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]";"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"
comp2607773_c0_seq1;GAXK01057492.1;Q67BJ4;1.10E-16;A4GAT_MOUSE;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp2607817_c0_seq1;GAXK01057487.1;A6QNK1;2.07E-17;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp260845_c1_seq1;GAXK01205429.1;O01382;3.10E-60;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp2608840_c0_seq1;GAXK01159184.1;Q6DHG0;7.95E-08;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2609002_c0_seq1;GAXK01159172.1;Q9VD09;1.63E-13;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp260922_c0_seq1;GAXK01091152.1;Q96AY4;0;TTC28_HUMAN;Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686";"cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]";kinase binding [GO:0019900]
comp2609334_c0_seq1;GAXK01159194.1;P31944;2.03E-21;CASPE_HUMAN;"Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008544; GO:0008630; GO:0031424; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]"
comp26094_c2_seq1;GAXK01133099.1;Q8WVN8;1.37E-121;UB2Q2_HUMAN;Ubiquitin-conjugating enzyme E2 Q2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2);"cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005524; GO:0005829; GO:0016567; GO:0061631; GO:0070936";"protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]";cytosol [GO:0005829];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp26096_c1_seq1;GAXK01132245.1;Q148G7;4.23E-72;DCTN6_BOVIN;Dynactin subunit 6;"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]";"GO:0000777; GO:0005737; GO:0005813; GO:0005869";;"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]";
comp261067_c1_seq1;GAXK01091323.1;Q28062;2.16E-09;PGCB_BOVIN;Brevican core protein;"extracellular matrix [GO:0031012]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp261078_c2_seq1;GAXK01091220.1;Q9R152;2.00E-35;PARP1_CRIGR;Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-);"nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]";"GO:0003677; GO:0003950; GO:0005730; GO:0006302; GO:0006471; GO:0006974; GO:0008270; GO:0010613; GO:0018312; GO:0018424; GO:0030592; GO:0051287; GO:0070212; GO:0070213; GO:0090734; GO:1905168; GO:1990404; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]";"nucleolus [GO:0005730]; site of DNA damage [GO:0090734]";"DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp2611_c0_seq1;GAXK01175960.1;P36178;1.02E-72;CTRB2_PENVA;Chymotrypsin BII (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp26111_c0_seq1;GAXK01133109.1;Q503Y4;3.94E-56;OVCA2_DANRE;Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526]";"GO:0005634; GO:0005737; GO:0016787; GO:0032526";response to retinoic acid [GO:0032526];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";hydrolase activity [GO:0016787]
comp261132_c2_seq1;GAXK01091409.1;Q9WTN5;1.01E-172;TPC1_RAT;Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005765; GO:0010008; GO:0016021; GO:0034765; GO:0072345";regulation of ion transmembrane transport [GO:0034765];"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]"
comp2611760_c0_seq1;GAXK01108108.1;Q3V3N7;6.71E-46;BBS1_MOUSE;Bardet-Biedl syndrome 1 protein homolog;"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515";"adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]";"patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]"
comp2611821_c0_seq1;GAXK01108110.1;Q96QE2;1.64E-11;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp2611826_c0_seq1;GAXK01108114.1;Q9FIF3;9.62E-78;RS82_ARATH;40S ribosomal protein S8-2;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"GO:0000462; GO:0003735; GO:0006412; GO:0022626; GO:0022627";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp26120_c2_seq1;GAXK01132925.1;P93748;7.69E-11;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2612104_c0_seq1;GAXK01163567.1;Q9W4S1;4.19E-42;GRCR2_DROME;Glutaredoxin domain-containing cysteine-rich protein CG12206;"cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cell [GO:0005623];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp261232_c3_seq1;GAXK01091151.1;O62389;6.63E-14;NHR61_CAEEL;Nuclear hormone receptor family member nhr-61;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp261250_c1_seq1;GAXK01091317.1;Q16534;2.20E-17;HLF_HUMAN;Hepatic leukemia factor;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp26127_c4_seq1;GAXK01132221.1;O70422;6.24E-166;TF2H4_MOUSE;General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit);"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]";"GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0008094; GO:0008353; GO:0016251; GO:0016607; GO:0070816";"nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]";"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]";"ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II general transcription initiation factor activity [GO:0016251]"
comp2613_c1_seq1;GAXK01175877.1;P15927;9.05E-23;RFA2_HUMAN;Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34);"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]";"GO:0000082; GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006283; GO:0006284; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006297; GO:0006298; GO:0010569; GO:0016604; GO:0016605; GO:0019899; GO:0019903; GO:0019985; GO:0031571; GO:0031625; GO:0032201; GO:0033683; GO:0034502; GO:0035861; GO:0036297; GO:0042276; GO:0042769; GO:0047485; GO:0070987; GO:0098505; GO:1900034; GO:1901796; GO:2000001";"base-excision repair [GO:0006284]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]";"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]";"damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]"
comp261355_c0_seq1;GAXK01091228.1;Q05A13;1.15E-31;S16C6_MOUSE;Short-chain dehydrogenase/reductase family 16C member 6 (EC 1.1.1.-);"lipid droplet [GO:0005811]; oxidoreductase activity [GO:0016491]";"GO:0005811; GO:0016491";;lipid droplet [GO:0005811];oxidoreductase activity [GO:0016491]
comp261377_c0_seq1;GAXK01091316.1;P36609;3.02E-63;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2613778_c0_seq1;GAXK01163594.1;P12412;9.15E-19;CYSEP_VIGMU;"Vignain (EC 3.4.22.-) (Bean endopeptidase) (Cysteine proteinase) (Sulfhydryl-endopeptidase) (SH-EP) [Cleaved into: Vignain-1; Vignain-2]";"aleurone grain [GO:0033095]; endoplasmic reticulum lumen [GO:0005788]; vacuole [GO:0005773]; cysteine-type peptidase activity [GO:0008234]";"GO:0005773; GO:0005788; GO:0008234; GO:0033095";;"aleurone grain [GO:0033095]; endoplasmic reticulum lumen [GO:0005788]; vacuole [GO:0005773]";cysteine-type peptidase activity [GO:0008234]
comp2613816_c0_seq1;GAXK01163586.1;P11424;1.38E-07;IMAP_DROFU;Male accessory gland serine protease inhibitor (Acrosin inhibitor) (Paragonial peptide D);serine-type endopeptidase inhibitor activity [GO:0004867];GO:0004867;;;serine-type endopeptidase inhibitor activity [GO:0004867]
comp261384_c1_seq1;GAXK01091322.1;P0CB42;1.80E-56;ALKB1_MOUSE;Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-);"mitochondrion [GO:0005739]; nuclear euchromatin [GO:0005719]; 1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; dioxygenase activity [GO:0051213]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984]; cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; placenta development [GO:0001890]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101]";"GO:0000049; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005719; GO:0005739; GO:0006281; GO:0006307; GO:0006446; GO:0006448; GO:0008198; GO:0010468; GO:0016706; GO:0030154; GO:0031175; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0051213; GO:0070129; GO:0070579; GO:0070989; GO:0080111; GO:0103053; GO:0140078; GO:1990983; GO:1990984";"cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; placenta development [GO:0001890]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101]";"mitochondrion [GO:0005739]; nuclear euchromatin [GO:0005719]";"1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; dioxygenase activity [GO:0051213]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984]"
comp26139_c0_seq1;GAXK01132914.1;Q8N6M9;7.48E-45;ZFN2A_HUMAN;AN1-type zinc finger protein 2A;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; zinc ion binding [GO:0008270]; cellular response to arsenic-containing substance [GO:0071243]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]";"GO:0000502; GO:0005634; GO:0005737; GO:0008270; GO:0032436; GO:0071243";"cellular response to arsenic-containing substance [GO:0071243]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";zinc ion binding [GO:0008270]
comp2614_c1_seq1;GAXK01175999.1;Q6NVR1;8.43E-16;ENSA_XENTR;Alpha-endosulfine;"cytoplasm [GO:0005737]; phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]";"GO:0000086; GO:0000278; GO:0004864; GO:0005737; GO:0019212; GO:0019888; GO:0035308; GO:0051301; GO:0051721";"cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]";cytoplasm [GO:0005737];"phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]"
comp2614566_c0_seq1;GAXK01052800.1;P69097;2.61E-37;CALM_TRYBB;Calmodulin (CaM);"axoneme [GO:0005930]; cilium [GO:0005929]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005929; GO:0005930; GO:0019722";calcium-mediated signaling [GO:0019722];"axoneme [GO:0005930]; cilium [GO:0005929]";calcium ion binding [GO:0005509]
comp2614969_c1_seq1;GAXK01052811.1;Q3TTY0;1.45E-16;PLB1_MOUSE;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp261518_c0_seq1;GAXK01091312.1;Q84JL3;5.60E-16;SINA3_ARATH;E3 ubiquitin-protein ligase SINAT3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT3) (Seven in absentia homolog 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2615208_c0_seq1;GAXK01052802.1;Q8TE73;1.13E-36;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp261569_c1_seq1;GAXK01091154.1;Q99P21;9.81E-86;MUTYH_MOUSE;Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (mMYH);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; response to oxidative stress [GO:0006979]";"GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0006979; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0046872; GO:0051539";"base-excision repair [GO:0006284]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; response to oxidative stress [GO:0006979]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]"
comp2616142_c0_seq1;GAXK01064979.1;P16295;8.91E-08;FA9_CAVPO;Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Fragment);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638";"blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp26163_c1_seq1;GAXK01132535.1;Q9V7S5;1.06E-123;PICO_DROME;Putative inorganic phosphate cotransporter;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0015114; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]"
comp2616365_c0_seq1;GAXK01065002.1;Q862Z3;3.24E-13;UROM_CANLF;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]";"GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016323; GO:0016324; GO:0031225; GO:0060170";;"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]";calcium ion binding [GO:0005509]
comp2616755_c0_seq1;GAXK01065004.1;Q06985;5.90E-07;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp261697_c0_seq1;GAXK01091327.1;Q56A10;1.18E-09;ZN608_MOUSE;Zinc finger protein 608;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003676; GO:0033085; GO:0046872";"negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2617081_c0_seq1;GAXK01064988.1;P42787;3.56E-61;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp2617202_c0_seq1;GAXK01064977.1;P56823;3.20E-48;HCYG_HELPO;Hemocyanin, beta-C chain unit G (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp26175_c0_seq1;GAXK01132922.1;P54385;6.53E-70;DHE3_DROME;Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0019551; GO:0042802";"glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp26177_c0_seq1;GAXK01133213.1;Q58D20;0;NLE1_BOVIN;Notchless protein homolog 1;"nucleolus [GO:0005730]; Notch signaling pathway [GO:0007219]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0005730; GO:0007219";"Notch signaling pathway [GO:0007219]; ribosomal large subunit assembly [GO:0000027]";nucleolus [GO:0005730];
comp2617725_c0_seq1;GAXK01064994.1;Q9SCC7;0;CBBX_GUITH;Protein cbbX homolog, chloroplastic;"chloroplast [GO:0009507]; ATP binding [GO:0005524]";"GO:0005524; GO:0009507";;chloroplast [GO:0009507];ATP binding [GO:0005524]
comp261793_c0_seq1;GAXK01091227.1;Q9VC56;3.59E-106;PUF_DROME;Ubiquitin carboxyl-terminal hydrolase puf (EC 3.4.19.12) (Protein puffyeye);"nucleus [GO:0005634]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of innate immune response [GO:0045824]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of cell growth [GO:0030307]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; regulation of gene silencing [GO:0060968]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc development [GO:0035220]";"GO:0002785; GO:0004843; GO:0005634; GO:0006511; GO:0016579; GO:0030307; GO:0031647; GO:0035220; GO:0043687; GO:0045751; GO:0045824; GO:0060968; GO:0061060";"negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of innate immune response [GO:0045824]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of cell growth [GO:0030307]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; regulation of gene silencing [GO:0060968]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc development [GO:0035220]";nucleus [GO:0005634];thiol-dependent ubiquitin-specific protease activity [GO:0004843]
comp2618282_c0_seq1;GAXK01024728.1;Q8N427;1.89E-17;TXND3_HUMAN;Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2);"outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0007275; GO:0007283; GO:0008017; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0045454; GO:0060271; GO:0097228; GO:0097598";"cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm principal piece [GO:0097228]";microtubule binding [GO:0008017]
comp2618354_c0_seq1;GAXK01024733.1;O97018;1.21E-09;SXL_CHRRU;Sex-lethal homolog;"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]";"GO:0000380; GO:0003723; GO:0005634; GO:0007530; GO:1990904";"alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]";"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp26184_c0_seq1;GAXK01133249.1;Q9BW72;6.80E-18;HIG2A_HUMAN;HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]";"GO:0005743; GO:0016021; GO:0043066; GO:0055114; GO:0070469";"negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";
comp2618463_c0_seq1;GAXK01024730.1;P55202;4.15E-110;ANPRB_ANGJA;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]";"GO:0001503; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0007168; GO:0016941; GO:0035556";"intracellular signal transduction [GO:0035556]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; protein kinase activity [GO:0004672]"
comp261857_c0_seq1;GAXK01091318.1;A3DH97;9.68E-48;RSGI6_CLOTH;Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0005886; GO:0016021; GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";endo-1,4-beta-xylanase activity [GO:0031176]
comp2619118_c0_seq1;GAXK01024749.1;Q9R1Y5;3.76E-09;HIC1_MOUSE;Hypermethylated in cancer 1 protein (Hic-1);"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000785; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007275; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2619166_c0_seq1;GAXK01024737.1;Q5BL35;6.64E-21;SPOLA_DANRE;Speckle-type POZ protein-like A (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp2619513_c0_seq1;GAXK01024725.1;Q9N003;1.47E-12;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2619730_c0_seq1;GAXK01024748.1;Q7ZU45;6.32E-17;TTC25_DANRE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371";"cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp262_c0_seq1;GAXK01205877.1;Q5ZJK8;0;TCPH_CHICK;T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta);"chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005832; GO:0006457; GO:0051082";protein folding [GO:0006457];chaperonin-containing T-complex [GO:0005832];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp2620_c0_seq1;GAXK01205914.1;P11142;0;HSP7C_HUMAN;Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1);"autophagosome [GO:0005776]; axon [GO:0030424]; blood microparticle [GO:0072562]; chaperone complex [GO:0101031]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lumenal side of lysosomal membrane [GO:0098575]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; MHC class II protein complex binding [GO:0023026]; misfolded protein binding [GO:0051787]; protein binding, bridging [GO:0030674]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; axo-dendritic transport [GO:0008088]; cellular response to heat [GO:0034605]; cellular response to starvation [GO:0009267]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; cytokine-mediated signaling pathway [GO:0019221]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of supramolecular fiber organization [GO:1902904]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of cellular response to heat [GO:1900034]; regulation of mRNA stability [GO:0043488]; regulation of protein complex assembly [GO:0043254]; regulation of protein complex stability [GO:0061635]; regulation of protein import [GO:1904589]; regulation of protein stability [GO:0031647]; response to unfolded protein [GO:0006986]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]";"GO:0000398; GO:0000974; GO:0001664; GO:0003723; GO:0005524; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005765; GO:0005776; GO:0005829; GO:0005886; GO:0005925; GO:0006457; GO:0006986; GO:0007269; GO:0008088; GO:0009267; GO:0016020; GO:0016032; GO:0016192; GO:0016887; GO:0019221; GO:0019899; GO:0023026; GO:0030424; GO:0030425; GO:0030674; GO:0031072; GO:0031625; GO:0031647; GO:0034605; GO:0034620; GO:0034774; GO:0042026; GO:0042470; GO:0042623; GO:0043195; GO:0043202; GO:0043254; GO:0043312; GO:0043488; GO:0044183; GO:0045296; GO:0045892; GO:0046034; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0055131; GO:0061024; GO:0061202; GO:0061635; GO:0061684; GO:0061738; GO:0061740; GO:0061741; GO:0070062; GO:0072562; GO:0098575; GO:0099523; GO:0099524; GO:0101031; GO:1900034; GO:1902904; GO:1904589; GO:1904764; GO:1904813; GO:1990832; GO:1990833; GO:1990904";"ATP metabolic process [GO:0046034]; axo-dendritic transport [GO:0008088]; cellular response to heat [GO:0034605]; cellular response to starvation [GO:0009267]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; cytokine-mediated signaling pathway [GO:0019221]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of supramolecular fiber organization [GO:1902904]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of cellular response to heat [GO:1900034]; regulation of mRNA stability [GO:0043488]; regulation of protein complex assembly [GO:0043254]; regulation of protein complex stability [GO:0061635]; regulation of protein import [GO:1904589]; regulation of protein stability [GO:0031647]; response to unfolded protein [GO:0006986]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]";"autophagosome [GO:0005776]; axon [GO:0030424]; blood microparticle [GO:0072562]; chaperone complex [GO:0101031]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lumenal side of lysosomal membrane [GO:0098575]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; MHC class II protein complex binding [GO:0023026]; misfolded protein binding [GO:0051787]; protein binding, bridging [GO:0030674]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp262025_c1_seq1;GAXK01189988.1;P15857;4.24E-28;HM17_APIME;Homeobox protein H17 (Fragment);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp262033_c0_seq1;GAXK01190130.1;P29523;1.27E-124;PPB_BOMMO;Membrane-bound alkaline phosphatase (M-ALP) (EC 3.1.3.1);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]";"GO:0004035; GO:0005886; GO:0031225; GO:0046872";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]"
comp262224_c1_seq1;GAXK01189877.1;Q2LE78;9.43E-07;BTBD6_XENLA;BTB/POZ domain-containing protein 6;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp26228_c0_seq1;GAXK01133315.1;Q96I24;1.06E-08;FUBP3_HUMAN;Far upstream element-binding protein 3 (FUSE-binding protein 3);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0010628; GO:0016020; GO:0045893; GO:0045944";"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp262292_c1_seq1;GAXK01190027.1;P54190;2.36E-08;TES26_TOXCA;26 kDa secreted antigen (Toxocara excretory-secretory antigen 26) (TES-26);"extracellular region [GO:0005576]; lipid binding [GO:0008289]";"GO:0005576; GO:0008289";;extracellular region [GO:0005576];lipid binding [GO:0008289]
comp26232_c2_seq1;GAXK01133238.1;Q18066;1.51E-19;DIM_CAEEL;Disorganized muscle protein 1 (2D-page protein spot 8);sarcomere [GO:0030017];GO:0030017;;sarcomere [GO:0030017];
comp2623254_c0_seq1;GAXK01152217.1;P04630;1.20E-14;CALL_CAEEL;Calmodulin-like protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp262335_c0_seq1;GAXK01189999.1;Q6JEL3;3.93E-15;KLH10_RAT;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp2623473_c0_seq1;GAXK01152214.1;Q14872;1.91E-15;MTF1_HUMAN;Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]";"GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006979; GO:0007417; GO:0010038; GO:0035035; GO:0045944; GO:0046686; GO:0046872";"central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]"
comp262371_c1_seq1;GAXK01190034.1;Q8IRR1;4.92E-44;VNNL2_DROME;Vanin-like protein 2;"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; nitrogen compound metabolic process [GO:0006807]";"GO:0006807; GO:0016811";nitrogen compound metabolic process [GO:0006807];;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]
comp2623820_c0_seq1;GAXK01152209.1;Q5RE88;5.12E-57;CF251_PONAB;Cilia- and flagella-associated protein 251 (CFAP251) (WD repeat-containing protein 66);"axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126";"cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]";
comp2623960_c0_seq1;GAXK01152215.1;Q8SWD4;6.52E-18;UBIQ_ENCCU;Ubiquitin;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2624589_c0_seq1;GAXK01138084.1;Q5JXM2;4.81E-09;MET24_HUMAN;Methyltransferase-like protein 24 (EC 2.1.1.-);"extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]";"GO:0005576; GO:0008168";;extracellular region [GO:0005576];methyltransferase activity [GO:0008168]
comp26248_c1_seq1;GAXK01133065.1;P97821;5.79E-129;CATC_MOUSE;"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]";"centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]";"GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235";"aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]";"centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]";"chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]"
comp26249_c0_seq1;GAXK01132229.1;Q9NXW2;4.72E-84;DJB12_HUMAN;DnaJ homolog subfamily B member 12;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0016020; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218";"cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";Hsp70 protein binding [GO:0030544]
comp2625128_c0_seq1;GAXK01138086.1;Q86LG1;1.64E-17;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp262540_c0_seq1;GAXK01190088.1;P36609;1.60E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2625836_c0_seq1;GAXK01138080.1;P07727;3.08E-31;GLRA1_RAT;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp2626_c0_seq1;GAXK01175783.1;Q9U639;2.71E-25;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp2626519_c0_seq1;GAXK01182627.1;P25685;5.05E-17;DNJB1_HUMAN;DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; sperm head [GO:0061827]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]";"GO:0000122; GO:0001671; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006986; GO:0014069; GO:0030544; GO:0030900; GO:0032781; GO:0043025; GO:0043197; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0061827; GO:0070062; GO:0090084; GO:0097201; GO:0098978; GO:1900034";"chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; sperm head [GO:0061827]";"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]"
comp26266_c3_seq1;GAXK01133078.1;P51987;3.22E-09;CCNB_HYDVD;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp262664_c0_seq1;GAXK01189917.1;Q9VAS7;1.04E-20;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp2626729_c0_seq1;GAXK01182618.1;Q5R9A7;2.16E-66;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp262691_c1_seq1;GAXK01190103.1;Q1H9T6;7.54E-21;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp262733_c1_seq1;GAXK01190032.1;Q8N8U9;1.72E-122;BMPER_HUMAN;BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2);"extracellular space [GO:0005615]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]";"GO:0001657; GO:0002043; GO:0005615; GO:0010594; GO:0030514; GO:0042118; GO:0048839; GO:0060393; GO:0070374; GO:1903672";"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]";extracellular space [GO:0005615];
comp2627390_c0_seq1;GAXK01182623.1;P46863;7.20E-07;KL61_DROME;Kinesin-like protein Klp61F (Bipolar kinesin KRP-130);"aster [GO:0005818]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; cell division [GO:0051301]; centrosome separation [GO:0051299]; fusome organization [GO:0045478]; Golgi organization [GO:0007030]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end directed microtubule sliding [GO:0031535]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; protein secretion [GO:0009306]";"GO:0000278; GO:0001578; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005818; GO:0005819; GO:0005871; GO:0005874; GO:0005875; GO:0005876; GO:0007018; GO:0007030; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0009306; GO:0016887; GO:0031535; GO:0042998; GO:0045169; GO:0045478; GO:0051299; GO:0051301; GO:0072686; GO:0090307; GO:0097431; GO:1990498";"cell division [GO:0051301]; centrosome separation [GO:0051299]; fusome organization [GO:0045478]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end directed microtubule sliding [GO:0031535]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; protein secretion [GO:0009306]";"aster [GO:0005818]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]"
comp2627401_c0_seq1;GAXK01182638.1;Q7M761;2.65E-15;OVCH2_MOUSE;Ovochymase-2 (EC 3.4.21.-) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp262774_c0_seq1;GAXK01190001.1;O15550;0;KDM6A_HUMAN;Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein);"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]";"GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358";"canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]";"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp26279_c2_seq1;GAXK01132936.1;P58242;5.92E-52;ASM3B_MOUSE;Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0045824; GO:0046466; GO:0050728";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp26283_c3_seq1;GAXK01132456.1;Q5ZI34;1.63E-48;PXL2A_CHICK;Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A);"cytoplasm [GO:0005737]; antioxidant activity [GO:0016209]; oxidation-reduction process [GO:0055114]";"GO:0005737; GO:0016209; GO:0055114";oxidation-reduction process [GO:0055114];cytoplasm [GO:0005737];antioxidant activity [GO:0016209]
comp2628334_c0_seq1;GAXK01140882.1;Q9DDN6;6.17E-37;NPY2R_CHICK;Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]";"GO:0004983; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";neuropeptide Y receptor activity [GO:0004983]
comp262834_c0_seq1;GAXK01190108.1;Q7KRI2;2.67E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp26285_c2_seq1;GAXK01133270.1;Q9WVF8;1.18E-17;TUSC2_MOUSE;Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2);"mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";"GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0032618; GO:0032700; GO:0032733; GO:0048469; GO:0050829; GO:0051881; GO:0052567; GO:0070945; GO:0071609; GO:2000377";"cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";mitochondrion [GO:0005739];
comp262868_c1_seq1;GAXK01189991.1;Q58CQ9;2.04E-82;VNN1_BOVIN;Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; pantothenate metabolic process [GO:0015939]";"GO:0005886; GO:0015939; GO:0017159; GO:0031225";pantothenate metabolic process [GO:0015939];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";pantetheine hydrolase activity [GO:0017159]
comp262902_c0_seq1;GAXK01190123.1;Q6GLQ4;3.43E-16;PP1RA_XENLA;Serine/threonine-protein phosphatase 1 regulatory subunit 10;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]";"GO:0004864; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]"
comp262908_c5_seq1;GAXK01190038.1;Q61164;1.42E-18;CTCF_MOUSE;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006355; GO:0007059; GO:0008285; GO:0009048; GO:0010216; GO:0010628; GO:0010629; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0046872; GO:0071459; GO:1902895";"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2629214_c0_seq1;GAXK01140917.1;Q8TE73;0;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp262966_c4_seq1;GAXK01190071.1;Q9VN45;2.29E-25;SPART_DROME;Protein spartin;"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030054; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301";"cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";Rab GTPase binding [GO:0017137]
comp2629784_c0_seq1;GAXK01140911.1;Q5RG49;9.00E-08;ACSF4_DANRE;Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4);"acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0006631; GO:0016878";fatty acid metabolic process [GO:0006631];;"acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]"
comp2630352_c0_seq1;GAXK01153733.1;O60500;1.97E-116;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp26304_c0_seq1;GAXK01132258.1;P87498;1.83E-09;VIT1_CHICK;"Vitellogenin-1 (Minor vitellogenin) (Vitellogenin I) [Cleaved into: Lipovitellin-1 (Lipovitellin I) (LVI); Phosvitin (PV); Lipovitellin-2 (Lipovitellin II) (LVII); YGP42 (allergen Gal d 6)]";"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; cellular response to estrogen stimulus [GO:0071391]; response to estradiol [GO:0032355]";"GO:0005319; GO:0032355; GO:0045735; GO:0071391";"cellular response to estrogen stimulus [GO:0071391]; response to estradiol [GO:0032355]";;"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp26307_c1_seq1;GAXK01133185.1;Q8NBM4;1.99E-25;UBAC2_HUMAN;Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]";"GO:0005783; GO:0005789; GO:0016021; GO:0070972; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp263083_c0_seq1;GAXK01189876.1;P05549;4.42E-97;AP2A_HUMAN;Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0003404; GO:0003409; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0006357; GO:0007605; GO:0008285; GO:0010628; GO:0010842; GO:0010944; GO:0021559; GO:0021623; GO:0030501; GO:0035115; GO:0042472; GO:0042803; GO:0043066; GO:0043231; GO:0043525; GO:0043565; GO:0044212; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048701; GO:0060021; GO:0060349; GO:0061029; GO:0070172; GO:0071281; GO:2000378";"bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559]";"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2630843_c0_seq1;GAXK01153751.1;O69060;5.95E-09;HTXA_PSEST;Probable alpha-ketoglutarate-dependent hypophosphite dioxygenase (EC 1.-.-.-);dioxygenase activity [GO:0051213];GO:0051213;;;dioxygenase activity [GO:0051213]
comp263099_c0_seq1;GAXK01189878.1;Q96KQ7;1.44E-07;EHMT2_HUMAN;Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a);"nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000122; GO:0000790; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0008270; GO:0009267; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0046974; GO:0046976; GO:0070317; GO:0070742; GO:1901796; GO:1990841";"cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]; regulation of signal transduction by p53 class mediator [GO:1901796]";"nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]"
comp26310_c0_seq1;GAXK01133237.1;O00400;3.94E-162;ACATN_HUMAN;Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395";"BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]"
comp263102_c0_seq1;GAXK01190128.1;Q99K70;1.51E-34;RRAGC_MOUSE;Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929);"cytoplasm [GO:0005737]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0009267; GO:0010506; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131";"cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]";"cytoplasm [GO:0005737]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; protein heterodimerization activity [GO:0046982]"
comp263115_c5_seq1;GAXK01190013.1;Q9Y6R4;5.52E-33;M3K4_HUMAN;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp263120_c0_seq1;GAXK01189921.1;O94827;7.86E-109;PKHG5_HUMAN;Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0030027; GO:0030139; GO:0035023; GO:0035767; GO:0043065; GO:0043123; GO:0048471; GO:0051056; GO:0098793; GO:0099575";"endothelial cell chemotaxis [GO:0035767]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp26314_c0_seq1;GAXK01132171.1;Q0P5B9;2.56E-38;ANR39_BOVIN;Ankyrin repeat domain-containing protein 39;;;;;
comp2631681_c0_seq1;GAXK01153747.1;Q8IWZ3;1.35E-09;ANKH1_HUMAN;Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK);"cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]";"GO:0003723; GO:0005737; GO:0045087";innate immune response [GO:0045087];cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp263214_c1_seq1;GAXK01189969.1;O75897;4.38E-52;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp263322_c1_seq1;GAXK01189882.1;Q7KRI2;1.77E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2633373_c0_seq1;GAXK01120335.1;Q16TM5;1.10E-11;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp26334_c6_seq1;GAXK01133259.1;Q8C6G1;1.63E-48;CF410_MOUSE;Cilia- and flagella-associated protein 410;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"GO:0001750; GO:0005737; GO:0005739; GO:0005886; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0042769; GO:0060271; GO:0097733";"cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]";
comp263343_c0_seq1;GAXK01189888.1;Q9QXL7;8.97E-110;NDK7_RAT;Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-R7);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"GO:0004550; GO:0005524; GO:0006183; GO:0006228; GO:0006241; GO:0046872";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]"
comp2633906_c0_seq1;GAXK01120327.1;Q9C9U8;1.18E-12;CML26_ARATH;Probable calcium-binding protein CML26 (Calmodulin-like protein 26);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005737";;cytoplasm [GO:0005737];calcium ion binding [GO:0005509]
comp26341_c0_seq1;GAXK01132599.1;Q9N5X6;2.09E-10;ODD2_CAEEL;Protein odd-skipped-related 2;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0005634; GO:0007275; GO:0045944; GO:0046872";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp263413_c1_seq1;GAXK01189873.1;Q9P0M2;9.60E-16;AKA7G_HUMAN;A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma);"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686";"modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]"
comp2634259_c0_seq1;GAXK01038691.1;Q9V7U0;2.66E-09;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp263526_c2_seq1;GAXK01189884.1;P22814;7.80E-66;RUNT_DROME;Segmentation protein Runt;"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";"GO:0003700; GO:0005524; GO:0005634; GO:0007366; GO:0007367; GO:0007377; GO:0007400; GO:0007411; GO:0007419; GO:0007540; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048592";"axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp263537_c0_seq1;GAXK01189954.1;Q61382;8.99E-120;TRAF4_MOUSE;TNF receptor-associated factor 4 (Cysteine-rich motif associated to RING and Traf domains protein 1);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]";"GO:0005164; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0032991; GO:0042802; GO:0042981; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0090073";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp26355_c0_seq1;GAXK01133183.1;P31007;0;DLG1_DROME;Disks large 1 tumor suppressor protein;"apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; subsynaptic reticulum [GO:0071212]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tricellular tight junction [GO:0061689]; type I terminal bouton [GO:0061174]; type Ib terminal bouton [GO:0061176]; epidermal growth factor receptor binding [GO:0005154]; guanylate kinase activity [GO:0004385]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization [GO:0008104]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of border follicle cell delamination [GO:0030710]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic growth at neuromuscular junction [GO:0051124]";"GO:0000122; GO:0000132; GO:0001708; GO:0001738; GO:0004385; GO:0005154; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0005938; GO:0007165; GO:0007268; GO:0007318; GO:0007391; GO:0007399; GO:0007617; GO:0008049; GO:0008104; GO:0008593; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030707; GO:0030710; GO:0030714; GO:0031594; GO:0035255; GO:0042058; GO:0042127; GO:0042332; GO:0043005; GO:0043113; GO:0043195; GO:0045167; GO:0045175; GO:0045179; GO:0045197; GO:0045202; GO:0045211; GO:0045475; GO:0045571; GO:0045887; GO:0046425; GO:0046956; GO:0048149; GO:0048471; GO:0051124; GO:0051294; GO:0060581; GO:0061174; GO:0061176; GO:0061689; GO:0071212; GO:0097120; GO:0098609; GO:0098839";"anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization [GO:0008104]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of border follicle cell delamination [GO:0030710]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic growth at neuromuscular junction [GO:0051124]";"apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; subsynaptic reticulum [GO:0071212]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tricellular tight junction [GO:0061689]; type Ib terminal bouton [GO:0061176]; type I terminal bouton [GO:0061174]";"epidermal growth factor receptor binding [GO:0005154]; guanylate kinase activity [GO:0004385]; ionotropic glutamate receptor binding [GO:0035255]"
comp263557_c0_seq1;GAXK01190066.1;Q9VUN0;0;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp263596_c0_seq1;GAXK01189928.1;Q8SQC1;1.20E-25;SCRB1_PIG;Scavenger receptor class B member 1 (SRB1) (High density lipoprotein receptor SR-BI) (SR-BI);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; transcytosis [GO:0045056]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0016323; GO:0016324; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0045056; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508";"adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; transcytosis [GO:0045056]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]"
comp2636191_c0_seq1;GAXK01118598.1;P19476;5.12E-13;CR29_ENTHI;Putative peroxiredoxin (EC 1.11.1.15) (29 kDa cysteine-rich surface antigen) (Thioredoxin peroxidase);"plasma membrane [GO:0005886]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005886; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];plasma membrane [GO:0005886];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp26364_c0_seq1;GAXK01132918.1;P82916;6.26E-14;RT17_BOVIN;28S ribosomal protein S17, mitochondrial (MRP-S17) (S17mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843";translation [GO:0006412];"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2636973_c0_seq1;GAXK01118596.1;A1L4W5;4.71E-07;BPM6_ARATH;BTB/POZ and MATH domain-containing protein 6 (Protein BTB-POZ AND MATH DOMAIN 6) (AtBPM6);"cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to salt stress [GO:0071472]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0005829; GO:0006970; GO:0016567; GO:0071472";"cellular response to salt stress [GO:0071472]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp263698_c1_seq1;GAXK01189918.1;O96790;4.43E-13;DPGN_DIPMA;Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]";"GO:0004867; GO:0005576; GO:0050819";negative regulation of coagulation [GO:0050819];extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp26375_c4_seq1;GAXK01133287.1;P28494;1.57E-126;MA2A1_RAT;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp2637812_c0_seq1;GAXK01118586.1;P36609;8.27E-17;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp263820_c0_seq1;GAXK01190029.1;P61799;1.54E-68;APTX_DANRE;Aprataxin (EC 3.1.11.7) (EC 3.1.12.2) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0030983; GO:0033699; GO:0046872; GO:0120108; GO:1990165";"double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]"
comp2638438_c0_seq1;GAXK01197026.1;Q14028;9.74E-12;CNGB1_HUMAN;Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"ciliary membrane [GO:0060170]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0000139; GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0007608; GO:0015276; GO:0016056; GO:0017071; GO:0022400; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0043195; GO:0045494; GO:0050908; GO:0051290; GO:0051480; GO:0060170; GO:1902495";"cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]"
comp26386_c0_seq1;GAXK01132345.1;Q91VA6;8.42E-81;PDIP2_MOUSE;Polymerase delta-interacting protein 2;"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584";"mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]";"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]"
comp263872_c0_seq1;GAXK01190107.1;Q19425;2.86E-112;S38A9_CAEEL;Sodium-coupled neutral amino acid transporter 9 homolog;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]";"GO:0003333; GO:0005765; GO:0015171; GO:0016021; GO:0031902; GO:0046872";amino acid transmembrane transport [GO:0003333];"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]"
comp26389_c1_seq1;GAXK01132538.1;Q9JLC3;1.60E-35;MSRB1_MOUSE;Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein R) (SelR) (Selenoprotein X) (SelX);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; methionine-R-sulfoxide reductase activity [GO:0070191]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]";"GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0008270; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0070191";"actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; methionine-R-sulfoxide reductase activity [GO:0070191]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]"
comp263902_c0_seq1;GAXK01189927.1;Q7SZM9;2.36E-114;TB1RA_XENLA;F-box-like/WD repeat-containing protein TBL1XR1-A (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1-A) (TBL1-related protein 1-A) (xTBLR1) (Transducin beta-like 1X-related protein 1-A);"nucleus [GO:0005634]; chromatin organization [GO:0006325]";"GO:0005634; GO:0006325";chromatin organization [GO:0006325];nucleus [GO:0005634];
comp263949_c0_seq1;GAXK01190094.1;Q9V817;5.03E-14;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2639531_c0_seq1;GAXK01197036.1;P35038;1.41E-26;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp263965_c0_seq1;GAXK01189930.1;P40144;6.27E-42;ADCY5_RABIT;Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5);"cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]";"GO:0004016; GO:0005524; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007204; GO:0016021; GO:0046872; GO:0061178; GO:1904322";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]";"cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp2639837_c0_seq1;GAXK01197034.1;Q9BYT9;7.30E-24;ANO3_HUMAN;Anoctamin-3 (Transmembrane protein 16C);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]";"GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0061590; GO:0061591";"calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]"
comp26399_c3_seq1;GAXK01133155.1;P68512;1.30E-16;FEL_CYPCA;Fish-egg lectin (FEL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp264_c0_seq1;GAXK01205873.1;Q3ZBH0;0;TCPB_BOVIN;T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta);"cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]";"GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0007339; GO:0031625; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874";"binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]";"cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]";"ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp2640309_c0_seq1;GAXK01003089.1;F1RWC3;6.98E-117;CUBN_PIG;Cubilin (Intrinsic factor-cobalamin receptor);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006898; GO:0009617; GO:0016324; GO:0030139; GO:0042803; GO:0042953; GO:0070062";"lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]"
comp2640557_c0_seq1;GAXK01003070.1;Q22165;3.66E-41;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2640583_c0_seq1;GAXK01003088.1;Q61699;6.63E-23;HS105_MOUSE;Heat shock protein 105 kDa (42 degrees C-HSP) (Heat shock 110 kDa protein) (Heat shock-related 100 kDa protein E7I) (HSP-E7I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to unfolded protein [GO:0006986]";"GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006986; GO:0032991; GO:0043014; GO:0043524; GO:0045345; GO:0045944; GO:0051085; GO:0051135; GO:0061098; GO:0070507; GO:1903748; GO:1903751; GO:1903753; GO:2001234";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]"
comp2640606_c0_seq1;GAXK01003081.1;Q99NF1;2.62E-20;BCDO2_MOUSE;Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2);"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";"GO:0003834; GO:0004744; GO:0005739; GO:0010436; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0055114; GO:0102076; GO:2000377";"carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";mitochondrion [GO:0005739];"beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]"
comp2640694_c0_seq1;GAXK01003084.1;Q9ULJ7;8.59E-32;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp2640754_c0_seq1;GAXK01003083.1;Q05A62;7.38E-70;DNAL1_MOUSE;Dynein light chain 1, axonemal;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]";"GO:0003774; GO:0005737; GO:0005874; GO:0036157; GO:0036158; GO:0043014; GO:0045504";outer dynein arm assembly [GO:0036158];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp2640969_c0_seq1;GAXK01003077.1;Q5U2P1;1.30E-31;CNNM2_RAT;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231";magnesium ion homeostasis [GO:0010960];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp2641021_c0_seq1;GAXK01003068.1;Q3KQV3;3.08E-13;ZN792_HUMAN;Zinc finger protein 792;"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0042802; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp2641049_c0_seq1;GAXK01003078.1;Q11002;5.36E-25;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp264110_c0_seq1;GAXK01054210.1;Q0P595;4.83E-118;SIR7_BOVIN;NAD-dependent protein deacetylase sirtuin-7 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7);"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"GO:0000122; GO:0003682; GO:0004407; GO:0005634; GO:0005724; GO:0005730; GO:0005731; GO:0005737; GO:0007072; GO:0009303; GO:0046872; GO:0070403; GO:0070932; GO:0097372";"histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]"
comp26413_c0_seq1;GAXK01133232.1;Q9Y4B6;0;DCAF1_HUMAN;DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]";"GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005737; GO:0016032; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0080008; GO:1990244; GO:1990245";"B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]"
comp264139_c0_seq1;GAXK01054090.1;Q01611;2.17E-19;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp264194_c3_seq1;GAXK01054032.1;Q61164;1.95E-19;CTCF_MOUSE;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006355; GO:0007059; GO:0008285; GO:0009048; GO:0010216; GO:0010628; GO:0010629; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0046872; GO:0071459; GO:1902895";"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2642392_c0_seq1;GAXK01010690.1;Q2M3R5;2.49E-09;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2642506_c0_seq1;GAXK01010695.1;Q04499;1.51E-137;PROD_DROME;Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Protein sluggish-A);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"GO:0004657; GO:0005739; GO:0005759; GO:0006537; GO:0006562; GO:0007626; GO:0010133; GO:0042331; GO:0071949";"glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]"
comp264276_c2_seq1;GAXK01054202.1;O34371;1.23E-17;YTET_BACSU;Putative oxidoreductase YteT (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp264317_c2_seq1;GAXK01054080.1;Q6WKZ4;2.75E-26;RFIP1_HUMAN;Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; Rab GTPase binding [GO:0017137]; negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]";"GO:0005829; GO:0015031; GO:0017137; GO:0030670; GO:0043231; GO:0045055; GO:0055037; GO:0070164";"negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]";Rab GTPase binding [GO:0017137]
comp264364_c0_seq1;GAXK01054211.1;Q95NQ0;5.45E-17;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp264375_c0_seq1;GAXK01054172.1;Q8TB69;8.05E-25;ZN519_HUMAN;Zinc finger protein 519;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp264450_c2_seq1;GAXK01053968.1;Q9U3F4;4.32E-38;ZYX_CAEEL;Zyxin;"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]; DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"GO:0000003; GO:0001725; GO:0005634; GO:0005925; GO:0007399; GO:0015629; GO:0017151; GO:0030424; GO:0031430; GO:0046872; GO:0055120; GO:0098609; GO:0099558";"cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]";"DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]"
comp264452_c3_seq1;GAXK01054040.1;Q496Z2;1.62E-17;TRIL_RAT;TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644 homolog);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142]";"GO:0001530; GO:0002718; GO:0005615; GO:0006954; GO:0031012; GO:0034142; GO:0045087; GO:0046696";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]";lipopolysaccharide binding [GO:0001530]
comp2644672_c0_seq1;GAXK01005344.1;Q7T2B0;1.00E-38;CTL4_DANRE;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0048840; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp264592_c3_seq1;GAXK01054171.1;Q8R0T2;4.67E-07;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp264596_c0_seq1;GAXK01054212.1;Q2NKQ1;0;SGSM1_HUMAN;Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2);"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0006886; GO:0017137; GO:0030659; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp2646154_c0_seq1;GAXK01084684.1;Q3U4G3;1.26E-11;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp264631_c0_seq1;GAXK01054107.1;Q9VJ34;8.38E-23;GSTCD_DROME;Glutathione S-transferase C-terminal domain-containing protein homolog;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp264715_c2_seq1;GAXK01054205.1;Q92614;6.90E-50;MY18A_HUMAN;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp2647614_c0_seq1;GAXK01084689.1;A8MTY0;3.70E-16;ZN724_HUMAN;Zinc finger protein 724;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2647751_c0_seq1;GAXK01084685.1;Q6IQ16;3.31E-08;SPOPL_HUMAN;Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp2647818_c0_seq1;GAXK01084673.1;Q40301;5.07E-09;FCPE_MACPY;Fucoxanthin-chlorophyll a-c binding protein E, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp2647990_c0_seq1;GAXK01084680.1;Q6PB70;7.14E-63;ANO8_MOUSE;Anoctamin-8 (Transmembrane protein 16H);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transport [GO:0006821]";"GO:0005229; GO:0005886; GO:0006821; GO:0016021";chloride transport [GO:0006821];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";intracellular calcium activated chloride channel activity [GO:0005229]
comp264806_c1_seq1;GAXK01054007.1;Q9D5V2;1.06E-08;KLH10_MOUSE;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp26484_c0_seq1;GAXK01133055.1;Q505F5;2.61E-58;LRC47_MOUSE;Leucine-rich repeat-containing protein 47;"phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]";"GO:0003723; GO:0004826";;;"phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]"
comp264855_c8_seq1;GAXK01053922.1;Q9DEI1;1.88E-93;PRKDC_XENLA;DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1);"nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]";"GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0070419; GO:0072431";"double-strand break repair via nonhomologous end joining [GO:0006303]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]";"nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]"
comp264864_c0_seq1;GAXK01053983.1;P00767;3.33E-11;CTRB_BOVIN;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586";digestion [GO:0007586];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp2648642_c0_seq1;GAXK01103953.1;A8WGS4;1.57E-18;TLCD2_DANRE;TLC domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp264875_c5_seq1;GAXK01054019.1;Q9LP11;1.68E-11;AATP1_ARATH;AAA-ATPase At1g43910 (EC 3.6.1.3);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to potassium ion starvation [GO:0051365]; response to abscisic acid [GO:0009737]";"GO:0005524; GO:0005783; GO:0005794; GO:0009506; GO:0009737; GO:0016021; GO:0016887; GO:0051365";"cellular response to potassium ion starvation [GO:0051365]; response to abscisic acid [GO:0009737]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasmodesma [GO:0009506]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp2648821_c0_seq1;GAXK01103965.1;Q5F364;3.55E-89;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp2648937_c0_seq1;GAXK01103950.1;P30191;4.02E-69;GBRA6_RAT;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008144; GO:0016020; GO:0022851; GO:0030054; GO:0030425; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0042391; GO:0042734; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0051932; GO:0060078; GO:0098686; GO:0098794; GO:0098982; GO:0099060; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; drug binding [GO:0008144]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp264940_c0_seq1;GAXK01054199.1;Q9D0B5;5.87E-21;TSTD3_MOUSE;Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3);thiosulfate sulfurtransferase activity [GO:0004792];GO:0004792;;;thiosulfate sulfurtransferase activity [GO:0004792]
comp2650_c0_seq1;GAXK01176142.1;P41236;8.23E-26;IPP2_HUMAN;Protein phosphatase inhibitor 2 (IPP-2);"protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966]";"GO:0004864; GO:0004865; GO:0005977; GO:0006091; GO:0009966; GO:0043666";"generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966]";;"protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]"
comp2650140_c0_seq1;GAXK01115712.1;Q6H1V1;3.86E-42;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2650850_c0_seq1;GAXK01115704.1;Q9XYP7;1.41E-14;GCP2_DROME;Gamma-tubulin complex component 2 homolog (Gamma-ring complex protein 84 kDa) (d84p) (dGrip84);"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]";"GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0007020; GO:0007098; GO:0007283; GO:0008275; GO:0030953; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0051726";"astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]";gamma-tubulin binding [GO:0043015]
comp265098_c2_seq1;GAXK01054197.1;P34043;6.64E-09;GPA5_DICDI;Guanine nucleotide-binding protein alpha-5 subunit (G alpha-5);"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sorocarp development [GO:0030587]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0007188; GO:0030587; GO:0031157; GO:0031683; GO:0043326; GO:0046872";"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sorocarp development [GO:0030587]";heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp265099_c0_seq1;GAXK01054099.1;Q7KRI2;1.30E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp265104_c4_seq1;GAXK01054185.1;Q8IYB9;1.03E-18;ZN595_HUMAN;Zinc finger protein 595;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2651064_c0_seq1;GAXK01115716.1;Q5RE88;7.20E-47;CF251_PONAB;Cilia- and flagella-associated protein 251 (CFAP251) (WD repeat-containing protein 66);"axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126";"cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]";
comp26516_c0_seq1;GAXK01133122.1;Q2HJ21;5.24E-10;MDM4_BOVIN;Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]";"GO:0005634; GO:0043066; GO:0046872; GO:0071157";"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]";nucleus [GO:0005634];metal ion binding [GO:0046872]
comp26521_c0_seq1;GAXK01132597.1;Q5ZK28;5.47E-19;DPOD3_CHICK;DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66);"cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; DNA-directed DNA polymerase activity [GO:0003887]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; nucleotide-excision repair, DNA gap filling [GO:0006297]";"GO:0003887; GO:0005654; GO:0005737; GO:0006271; GO:0006297; GO:0043625; GO:1904161";"DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; nucleotide-excision repair, DNA gap filling [GO:0006297]";"cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]";DNA-directed DNA polymerase activity [GO:0003887]
comp2652310_c0_seq1;GAXK01041269.1;P60204;7.43E-21;CALM_EMENI;Calmodulin (CaM);"central plaque of spindle pole body [GO:0005823]; hyphal tip [GO:0001411]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; regulation of cell cycle [GO:0051726]; spindle pole body organization [GO:0051300]; spore germination [GO:0009847]";"GO:0001411; GO:0005509; GO:0005823; GO:0009847; GO:0019722; GO:0051300; GO:0051726";"calcium-mediated signaling [GO:0019722]; regulation of cell cycle [GO:0051726]; spindle pole body organization [GO:0051300]; spore germination [GO:0009847]";"central plaque of spindle pole body [GO:0005823]; hyphal tip [GO:0001411]";calcium ion binding [GO:0005509]
comp26525_c0_seq1;GAXK01133214.1;Q2F5J3;5.00E-15;PYM_BOMMO;Partner of Y14 and mago (Protein wibg homolog);"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"GO:0000184; GO:0005737; GO:0035145; GO:1903259";"exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]";
comp26538_c0_seq1;GAXK01132343.1;Q9VCE1;2.40E-145;BECN1_DROME;Beclin-1-like protein (Autophagy protein 6-like) (APG6-like);"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein localization by the Cvt pathway [GO:0032258]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]";"GO:0000045; GO:0000407; GO:0006897; GO:0006914; GO:0006979; GO:0006995; GO:0009267; GO:0009306; GO:0016322; GO:0019898; GO:0030097; GO:0032258; GO:0032465; GO:0034271; GO:0034272; GO:0035096; GO:0045324; GO:0045824; GO:0050829; GO:0061723";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein localization by the Cvt pathway [GO:0032258]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]";"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]";
comp2653993_c0_seq1;GAXK01041270.1;Q9ES07;1.13E-96;S15A2_MOUSE;Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; dipeptide transmembrane transporter activity [GO:0071916]; high-affinity oligopeptide transmembrane transporter activity [GO:0015334]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; dipeptide transport [GO:0042938]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"GO:0005887; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0016020; GO:0016021; GO:0035673; GO:0042938; GO:0071916; GO:1904680";"dipeptide transport [GO:0042938]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"dipeptide transmembrane transporter activity [GO:0071916]; high-affinity oligopeptide transmembrane transporter activity [GO:0015334]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide:proton symporter activity [GO:0015333]; peptide transmembrane transporter activity [GO:1904680]"
comp2654_c0_seq1;GAXK01175522.1;B5DGI7;3.98E-08;RBM8A_SALSA;RNA-binding protein 8A (RNA-binding motif protein 8A) (Ribonucleoprotein RBM8A);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA binding [GO:0003729]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]";"GO:0000184; GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0016607; GO:0051028; GO:0071006";"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]";mRNA binding [GO:0003729]
comp2654338_c0_seq1;GAXK01170950.1;Q27140;1.51E-37;EF1A2_EUPCR;Elongation factor 1-alpha 2 (EF-1-alpha-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp265554_c0_seq1;GAXK01054193.1;A6H782;7.94E-127;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp265674_c5_seq1;GAXK01054022.1;Q9HC77;1.10E-46;CENPJ_HUMAN;Centromere protein J (CENP-J) (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; smoothened signaling pathway [GO:0007224]";"GO:0000086; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005886; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0010389; GO:0015631; GO:0019901; GO:0019904; GO:0036064; GO:0042802; GO:0044458; GO:0046599; GO:0046785; GO:0051301; GO:0061511; GO:0097711; GO:1902857; GO:1903724; GO:1904951; GO:1905515";"cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; smoothened signaling pathway [GO:0007224]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]"
comp2656783_c0_seq1;GAXK01016804.1;P89116;2.96E-65;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp265691_c0_seq1;GAXK01054027.1;Q96JL9;4.10E-28;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2657102_c0_seq1;GAXK01016812.1;Q8N988;1.97E-12;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2657237_c0_seq1;GAXK01016809.1;P30796;6.31E-17;GASR_MASNA;Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gastrin receptor activity [GO:0015054]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0005886; GO:0007204; GO:0008284; GO:0015054; GO:0016021";"positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gastrin receptor activity [GO:0015054]
comp265766_c2_seq1;GAXK01054030.1;B3DIY3;2.89E-12;MMS22_DANRE;Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like);"nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]";"GO:0000724; GO:0031297; GO:0043596";"double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]";nuclear replication fork [GO:0043596];
comp2657882_c0_seq1;GAXK01016821.1;Q01630;1.54E-10;UNC33_CAEEL;Protein unc-33 (Uncoordinated protein 33);"cytosol [GO:0005829]; neuron projection [GO:0043005]; dihydropyrimidinase activity [GO:0004157]; filamin binding [GO:0031005]; axon guidance [GO:0007411]; pyrimidine nucleobase catabolic process [GO:0006208]";"GO:0004157; GO:0005829; GO:0006208; GO:0007411; GO:0031005; GO:0043005";"axon guidance [GO:0007411]; pyrimidine nucleobase catabolic process [GO:0006208]";"cytosol [GO:0005829]; neuron projection [GO:0043005]";"dihydropyrimidinase activity [GO:0004157]; filamin binding [GO:0031005]"
comp2658574_c0_seq1;GAXK01120380.1;P55112;4.42E-21;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp26587_c24_seq1;GAXK01205722.1;O02002;3.91E-41;CASP1_DROME;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p22; Caspase-1 subunit p13]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"GO:0004197; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007275; GO:0007300; GO:0007303; GO:0009267; GO:0010508; GO:0010623; GO:0012501; GO:0016239; GO:0016322; GO:0043025; GO:0045476; GO:0048477; GO:0071598; GO:0097153; GO:0097194; GO:0097200; GO:1900074; GO:1990124; GO:1990525";"apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]";"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp265885_c7_seq1;GAXK01054110.1;O97716;1.17E-14;THA_PIG;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (c-erbA-1) (c-erbA-alpha);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0003707; GO:0004879; GO:0005634; GO:0005829; GO:0006366; GO:0007275; GO:0007420; GO:0007611; GO:0008016; GO:0008050; GO:0008134; GO:0008270; GO:0009409; GO:0009755; GO:0009887; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030374; GO:0030878; GO:0031490; GO:0033032; GO:0033993; GO:0038023; GO:0044877; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162";"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to cold [GO:0009409]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]";"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp26589_c0_seq1;GAXK01133056.1;Q9CX11;1.58E-45;UTP23_MOUSE;rRNA-processing protein UTP23 homolog;"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]";"GO:0000480; GO:0003730; GO:0005730; GO:0032040; GO:0048027; GO:0070181";endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480];"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]"
comp2658965_c0_seq1;GAXK01120372.1;Q6NSI8;4.35E-44;K1841_HUMAN;Uncharacterized protein KIAA1841;;;;;
comp26592_c0_seq1;GAXK01132319.1;P50613;5.26E-160;CDK7_HUMAN;Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit);"cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; 7-methylguanosine mRNA capping [GO:0006370]; androgen receptor signaling pathway [GO:0030521]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000079; GO:0000082; GO:0000086; GO:0003713; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0006283; GO:0006294; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006468; GO:0007050; GO:0008022; GO:0008094; GO:0008353; GO:0016301; GO:0019907; GO:0030521; GO:0042795; GO:0045893; GO:0045944; GO:0048471; GO:0050681; GO:0050821; GO:0051301; GO:0070985";"7-methylguanosine mRNA capping [GO:0006370]; androgen receptor signaling pathway [GO:0030521]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]";"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]"
comp26594_c0_seq1;GAXK01132225.1;Q6VAB6;3.46E-94;KSR2_HUMAN;Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; Ras protein signal transduction [GO:0007265]";"GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0007265; GO:0019722; GO:0046872; GO:0120162";"calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; Ras protein signal transduction [GO:0007265]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp26596_c0_seq1;GAXK01132536.1;A1CE97;6.48E-177;CBHA_ASPCL;Probable 1,4-beta-D-glucan cellobiohydrolase A (EC 3.2.1.91) (Beta-glucancellobiohydrolase A) (Cellobiohydrolase D) (Exocellobiohydrolase A) (Exoglucanase A);"extracellular region [GO:0005576]; cellulose 1,4-beta-cellobiosidase activity [GO:0016162]; cellulose catabolic process [GO:0030245]";"GO:0005576; GO:0016162; GO:0030245";cellulose catabolic process [GO:0030245];extracellular region [GO:0005576];cellulose 1,4-beta-cellobiosidase activity [GO:0016162]
comp2659645_c0_seq1;GAXK01120386.1;Q5E9R2;3.62E-21;PLCD_BOVIN;1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phospholipid metabolic process [GO:0006644]";"GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006644; GO:0016021; GO:0016024; GO:0016746";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phospholipid metabolic process [GO:0006644]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp2659959_c0_seq1;GAXK01120383.1;O76360;9.04E-54;EGL4_CAEEL;cGMP-dependent protein kinase egl-4 (EC 2.7.11.12) (Egg-laying defective protein 4);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0004691; GO:0004692; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0006935; GO:0007165; GO:0007635; GO:0008286; GO:0008340; GO:0008355; GO:0010468; GO:0010753; GO:0010754; GO:0018105; GO:0030308; GO:0030431; GO:0030512; GO:0030536; GO:0030553; GO:0040014; GO:0040015; GO:0042542; GO:0043577; GO:0046621; GO:0046662; GO:0046872; GO:0050849; GO:0050913; GO:0050921; GO:0051343; GO:0061067; GO:0070482; GO:1901046; GO:1902160; GO:1903998; GO:1905959; GO:1990335; GO:1990834";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]"
comp266_c0_seq1;GAXK01168987.1;B0FWD3;1.31E-125;NU5M_AEDAE;NADH-ubiquinone oxidoreductase chain 5 (EC 7.1.1.2) (NADH dehydrogenase subunit 5);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773]";"GO:0005743; GO:0008137; GO:0016021; GO:0042773; GO:0070469";ATP synthesis coupled electron transport [GO:0042773];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp2660027_c0_seq1;GAXK01195704.1;Q3SYV7;5.19E-15;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2660146_c0_seq1;GAXK01195686.1;Q28658;2.93E-07;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp266024_c0_seq1;GAXK01079301.1;Q12529;1.57E-07;SET6_YEAST;Potential protein lysine methyltransferase SET6 (EC 2.1.1.-) (SET domain-containing protein 6);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp266035_c2_seq1;GAXK01079239.1;Q7KRI2;1.01E-13;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2660365_c0_seq1;GAXK01195693.1;O46040;1.45E-32;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp2660423_c0_seq1;GAXK01195703.1;Q90XC2;1.98E-146;NEK8_DANRE;Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8);"cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326]";"GO:0001947; GO:0004674; GO:0005524; GO:0005737; GO:0005929; GO:0007049; GO:0009887; GO:0046872; GO:0048793; GO:0051301; GO:0060271; GO:0061326; GO:0061371; GO:0072116";"animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326]";"cilium [GO:0005929]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp2660567_c0_seq1;GAXK01195698.1;Q9V9L1;1.62E-29;CP6W1_DROME;Probable cytochrome P450 6w1 (EC 1.14.-.-) (CYPVIW1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; insecticide catabolic process [GO:0046701]; response to DDT [GO:0046680]; sensory perception of smell [GO:0007608]";"GO:0004497; GO:0005506; GO:0005789; GO:0007608; GO:0016705; GO:0020037; GO:0046680; GO:0046701";"insecticide catabolic process [GO:0046701]; response to DDT [GO:0046680]; sensory perception of smell [GO:0007608]";endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp266121_c0_seq1;GAXK01079310.1;Q4AC94;9.36E-16;C2CD3_HUMAN;C2 domain-containing protein 3;"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]";"GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0061511; GO:0071539; GO:0097711; GO:1905515";"brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]";"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]";
comp266163_c0_seq1;GAXK01079210.1;Q5R839;4.76E-128;S41A1_PONAB;Solute carrier family 41 member 1;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]";"GO:0010961; GO:0015095; GO:0016021; GO:0016323; GO:0032991; GO:0061768; GO:0071286; GO:0072509";"cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";"divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium:sodium antiporter activity [GO:0061768]; magnesium ion transmembrane transporter activity [GO:0015095]"
comp266175_c0_seq1;GAXK01079347.1;Q8BHJ5;4.17E-139;TBL1R_MOUSE;F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1);"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"GO:0000118; GO:0000122; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263";"adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp26618_c0_seq1;GAXK01133152.1;Q8BNJ2;8.05E-07;ATS4_MOUSE;A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (Aggrecanase-1);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protease binding [GO:0002020]; defense response to bacterium [GO:0042742]; proteolysis [GO:0006508]";"GO:0002020; GO:0004222; GO:0005615; GO:0006508; GO:0008237; GO:0016607; GO:0042742; GO:0046872; GO:0062023";"defense response to bacterium [GO:0042742]; proteolysis [GO:0006508]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protease binding [GO:0002020]"
comp2661988_c0_seq1;GAXK01195694.1;Q27433;1.77E-67;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp2662181_c0_seq1;GAXK01144230.1;Q9XYN1;5.76E-11;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp26627_c2_seq1;GAXK01133236.1;P49256;2.69E-88;LMAN2_CANLF;Vesicular integral-membrane protein VIP36 (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36);"COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031]";"GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0015031; GO:0016021; GO:0030134; GO:0030137; GO:0031410; GO:0046872; GO:0048471; GO:0070382";"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031]";"COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp2663224_c0_seq1;GAXK01144239.1;Q94900;2.27E-51;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp26633_c2_seq1;GAXK01132280.1;Q7KMJ6;8.51E-30;NITO_DROME;RNA-binding protein spenito;"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737";"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";RNA binding [GO:0003723]
comp26639_c0_seq1;GAXK01133088.1;P54288;1.92E-149;CACB2_RABIT;Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2);"L-type voltage-gated calcium channel complex [GO:1990454]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0034765; GO:1990454";regulation of ion transmembrane transport [GO:0034765];L-type voltage-gated calcium channel complex [GO:1990454];voltage-gated calcium channel activity [GO:0005245]
comp2663986_c0_seq1;GAXK01144228.1;A7T1N0;2.96E-20;TMP2L_NEMVE;Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"GO:0005886; GO:0015280; GO:0016021; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604";"calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]"
comp266440_c0_seq1;GAXK01079309.1;P36958;5.97E-69;RPB9_DROME;DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II 15.1 kDa polypeptide);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mitotic cell cycle [GO:0000278]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000278; GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0006379; GO:0008270";"maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mitotic cell cycle [GO:0000278]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp26646_c1_seq1;GAXK01133063.1;Q9HC07;5.63E-23;TM165_HUMAN;Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL);"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0016021; GO:0031901; GO:0031902; GO:0032472; GO:0032588; GO:0035751; GO:0043231";"cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]";
comp2664837_c0_seq1;GAXK01027214.1;Q9VZW5;1.58E-18;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp26653_c0_seq1;GAXK01133084.1;O46339;1.12E-86;HTH_DROME;Homeobox protein homothorax (Homeobox protein dorsotonals);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; enhancer sequence-specific DNA binding [GO:0001158]; protein heterodimerization activity [GO:0046982]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; compound eye development [GO:0048749]; compound eye photoreceptor fate commitment [GO:0001752]; eye development [GO:0001654]; haltere morphogenesis [GO:0048735]; head morphogenesis [GO:0060323]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; Malpighian tubule development [GO:0072002]; oenocyte differentiation [GO:0001742]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation involved in compound eye morphogenesis [GO:2000497]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; proximal/distal pattern formation [GO:0009954]; regulation of cell fate specification [GO:0042659]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland boundary specification [GO:0007432]; segmentation [GO:0035282]; somatic muscle development [GO:0007525]; specification of animal organ identity [GO:0010092]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, head [GO:0007380]";"GO:0000981; GO:0001158; GO:0001223; GO:0001654; GO:0001742; GO:0001752; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0007380; GO:0007383; GO:0007420; GO:0007422; GO:0007432; GO:0007476; GO:0007479; GO:0007480; GO:0007525; GO:0008134; GO:0009954; GO:0010092; GO:0032993; GO:0034504; GO:0035282; GO:0035326; GO:0042659; GO:0045664; GO:0045944; GO:0046982; GO:0048735; GO:0048749; GO:0060323; GO:0072002; GO:0090575; GO:2000497";"brain development [GO:0007420]; compound eye development [GO:0048749]; compound eye photoreceptor fate commitment [GO:0001752]; eye development [GO:0001654]; haltere morphogenesis [GO:0048735]; head morphogenesis [GO:0060323]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; Malpighian tubule development [GO:0072002]; oenocyte differentiation [GO:0001742]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation involved in compound eye morphogenesis [GO:2000497]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; proximal/distal pattern formation [GO:0009954]; regulation of cell fate specification [GO:0042659]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland boundary specification [GO:0007432]; segmentation [GO:0035282]; somatic muscle development [GO:0007525]; specification of animal organ identity [GO:0010092]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, head [GO:0007380]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; enhancer sequence-specific DNA binding [GO:0001158]; protein heterodimerization activity [GO:0046982]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp26654_c16_seq1;GAXK01132206.1;Q769K2;1.62E-105;NAPEP_RAT;N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54);"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase activity [GO:0004620]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659]";"GO:0000139; GO:0001659; GO:0004620; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0006644; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999";"aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659]";"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]";"identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase activity [GO:0004620]; zinc ion binding [GO:0008270]"
comp26655_c2_seq1;GAXK01133071.1;Q3TZX8;6.76E-36;NOL9_MOUSE;Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9);"intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]";"GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005730; GO:0045111; GO:0051731";"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]";"intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]"
comp2666000_c0_seq1;GAXK01007534.1;Q5G265;2.82E-12;NETR_SAGLB;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424";exocytosis [GO:0006887];"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp2666273_c0_seq1;GAXK01007539.1;P02588;4.52E-12;TNNC2_CHICK;Troponin C, skeletal muscle;"troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005509; GO:0005861; GO:0006937; GO:0048306; GO:0051015";"regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]";troponin complex [GO:0005861];"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]"
comp2666529_c0_seq1;GAXK01007555.1;A6NCF5;1.66E-08;KLH33_HUMAN;Kelch-like protein 33;;;;;
comp2666656_c0_seq1;GAXK01007541.1;Q86GV3;4.17E-22;GCY28_CAEEL;Receptor-type guanylate cyclase gcy-28 (EC 4.6.1.2) (GCY-X1);"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; receptor guanylyl cyclase signaling pathway [GO:0007168]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007606; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0042048; GO:0043005; GO:0043204; GO:0044297; GO:0046872; GO:0050893";"cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; receptor guanylyl cyclase signaling pathway [GO:0007168]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp266667_c1_seq1;GAXK01079306.1;Q7SBB6;5.20E-07;ERG3_NEUCR;Probable Delta(7)-sterol 5(6)-desaturase (EC 1.14.19.20) (C-5 sterol desaturase) (Ergosterol Delta(5,6) desaturase) (Sterol-C5-desaturase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000248; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]"
comp266684_c1_seq1;GAXK01079379.1;Q9QZU7;2.67E-71;BODG_RAT;Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase);"mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]";"GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0016702; GO:0045329";carnitine biosynthetic process [GO:0045329];mitochondrion [GO:0005739];"gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; zinc ion binding [GO:0008270]"
comp2666897_c0_seq1;GAXK01007556.1;P68172;0;SAHH_NICSY;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (Cytokinin-binding protein CBP57) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp266699_c0_seq1;GAXK01079264.1;Q5ICW4;9.22E-15;GRB14_BOVIN;Growth factor receptor-bound protein 14 (GRB14 adapter protein);"cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]";"GO:0005070; GO:0005737; GO:0005886; GO:0008286; GO:0010008; GO:0046627";"insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]";"cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]";SH3/SH2 adaptor activity [GO:0005070]
comp2667111_c0_seq1;GAXK01007559.1;Q5G267;5.90E-32;NETR_MACMU;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp266730_c4_seq1;GAXK01079368.1;Q99020;1.20E-18;ROAA_MOUSE;Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0001837; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0043565; GO:0045893; GO:0090575; GO:0099523; GO:1990837; GO:1990904";"epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]";"RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp26676_c1_seq1;GAXK01133057.1;Q9XT75;0;HEM0_DELLE;5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0030218; GO:0042541";"erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]"
comp26681_c1_seq1;GAXK01132179.1;Q9NUL3;2.62E-21;STAU2_HUMAN;Double-stranded RNA-binding protein Staufen homolog 2;"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]";"GO:0003723; GO:0003725; GO:0005730; GO:0005783; GO:0005874; GO:0016020";;"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleolus [GO:0005730]";"double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]"
comp26686_c0_seq1;GAXK01132322.1;O77245;1.24E-132;E75_METEN;Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp266932_c0_seq1;GAXK01079208.1;Q17N72;2.61E-119;CALYP_AEDAE;Ubiquitin carboxyl-terminal hydrolase calypso (EC 3.4.19.12) (BAP1 homolog);"nuclear chromatin [GO:0000790]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; chromatin silencing [GO:0006342]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000790; GO:0003682; GO:0004843; GO:0006342; GO:0006511; GO:0035517; GO:0035522; GO:0036459";"chromatin silencing [GO:0006342]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; ubiquitin-dependent protein catabolic process [GO:0006511]";"nuclear chromatin [GO:0000790]; PR-DUB complex [GO:0035517]";"chromatin binding [GO:0003682]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp26697_c0_seq1;GAXK01132173.1;Q7ZYC4;7.55E-150;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp2669909_c0_seq1;GAXK01159359.1;Q149M9;7.09E-27;NWD1_HUMAN;NACHT domain- and WD repeat-containing protein 1;"cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";"GO:0005524; GO:0005829; GO:0010628; GO:0032088";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";cytosol [GO:0005829];ATP binding [GO:0005524]
comp267028_c0_seq1;GAXK01079381.1;Q8K354;1.14E-78;CBR3_MOUSE;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]";"GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0042376; GO:0050890; GO:0070402";"cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]"
comp2670698_c0_seq1;GAXK01140878.1;P36609;3.60E-45;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2670707_c0_seq1;GAXK01140863.1;P47825;3.11E-11;TAF4_DROME;Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110);"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001092; GO:0003677; GO:0003700; GO:0005634; GO:0005669; GO:0006355; GO:0006366; GO:0006367; GO:0008134; GO:0045944; GO:0046982";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]"
comp267073_c0_seq1;GAXK01079377.1;Q5FW48;5.44E-77;ASPD_XENTR;Putative L-aspartate dehydrogenase (EC 1.4.1.21) (Aspartate dehydrogenase domain-containing protein);"aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]";"GO:0009435; GO:0033735; GO:0050661";NAD biosynthetic process [GO:0009435];;"aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]"
comp26721_c0_seq1;GAXK01132578.1;Q23356;0;MIG15_CAEEL;Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0031098; GO:0032147; GO:0032228; GO:0033563; GO:0048812";"activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp2672574_c0_seq1;GAXK01171214.1;Q9R0N3;1.93E-26;SYT11_MOUSE;Synaptotagmin-11 (Synaptotagmin XI) (SytXI);"axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; beta-tubulin binding [GO:0048487]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of membrane invagination [GO:1905154]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; protein homotetramerization [GO:0051289]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; response to wounding [GO:0009611]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001778; GO:0001786; GO:0001891; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0008021; GO:0009611; GO:0014059; GO:0014069; GO:0016192; GO:0017156; GO:0017158; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0031369; GO:0031625; GO:0031982; GO:0032009; GO:0042803; GO:0043005; GO:0043195; GO:0043197; GO:0044297; GO:0045335; GO:0046872; GO:0048471; GO:0048487; GO:0048787; GO:0048791; GO:0050765; GO:0051289; GO:0055037; GO:0060076; GO:0060077; GO:0070382; GO:0071277; GO:0098685; GO:0098793; GO:0098794; GO:0099059; GO:1900165; GO:1900186; GO:1900243; GO:1900424; GO:1904468; GO:1905154; GO:1905162; GO:1905171; GO:1905469; GO:1990927";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of membrane invagination [GO:1905154]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; protein homotetramerization [GO:0051289]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; response to wounding [GO:0009611]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; vesicle [GO:0031982]";"beta-tubulin binding [GO:0048487]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]"
comp2672586_c0_seq1;GAXK01171211.1;Q5ZJU0;5.37E-12;MOT9_CHICK;Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp267263_c1_seq1;GAXK01079241.1;P52746;1.43E-15;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2673983_c0_seq2;GAXK01171209.1;P35035;1.08E-54;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp267410_c4_seq1;GAXK01079233.1;P15169;2.69E-82;CBPN_HUMAN;Carboxypeptidase N catalytic chain (CPN) (EC 3.4.17.3) (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N) (SCPN);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; regulation of complement activation [GO:0030449]; response to glucocorticoid [GO:0051384]";"GO:0004181; GO:0005576; GO:0005615; GO:0006518; GO:0008270; GO:0010815; GO:0016485; GO:0030449; GO:0051384";"bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; regulation of complement activation [GO:0030449]; response to glucocorticoid [GO:0051384]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp2674499_c0_seq1;GAXK01037119.1;Q9BQS2;2.88E-21;SYT15_HUMAN;Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV);"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]"
comp2674553_c0_seq1;GAXK01037109.1;Q6PDB4;1.23E-07;ZN880_HUMAN;Zinc finger protein 880;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp267500_c0_seq1;GAXK01079247.1;Q9R1S3;6.18E-155;PIGN_MOUSE;GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016021; GO:0016780; GO:0051377";GPI anchor biosynthetic process [GO:0006506];"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"mannose-ethanolamine phosphotransferase activity [GO:0051377]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
comp267512_c0_seq1;GAXK01079303.1;P55016;0;S12A1_RAT;Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) (BSC1) (Kidney-specific Na-K-Cl symporter);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006884; GO:0008511; GO:0009986; GO:0015081; GO:0015378; GO:0015379; GO:0016021; GO:0016101; GO:0016324; GO:0032978; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070294; GO:1902476; GO:1990573";"cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:chloride symporter activity [GO:0015379]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp26754_c0_seq1;GAXK01133251.1;Q7KRI2;3.20E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2675902_c0_seq1;GAXK01037113.1;O00505;2.08E-09;IMA4_HUMAN;Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma);"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]";"GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008022; GO:0008139; GO:0019054; GO:0043657; GO:0046718; GO:0061608; GO:0065003; GO:0075732";"modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]";"cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]"
comp267632_c0_seq1;GAXK01079294.1;Q4A054;1.61E-35;Y0419_STAS1;Uncharacterized oxidoreductase SSP0419 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp267635_c1_seq1;GAXK01079230.1;P50729;1.49E-12;RECS_BACSU;Probable ATP-dependent DNA helicase RecS (EC 3.6.4.12) (Recombination protein S);"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006281; GO:0006310; GO:0009378; GO:0030894; GO:0032508; GO:0043138; GO:0043590";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp267657_c2_seq1;GAXK01079307.1;Q9D0U1;3.03E-38;DTWD2_MOUSE;DTW domain-containing protein 2;;;;;
comp267658_c0_seq1;GAXK01079363.1;Q9Y3B3;1.12E-10;TMED7_HUMAN;Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27);"COPI vesicle coat [GO:0030126]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]";
comp2676617_c0_seq1;GAXK01180787.1;P51840;3.92E-39;GUC2E_RAT;Guanylyl cyclase GC-E (EC 4.6.1.2) (Guanylate cyclase 2E);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0016021; GO:0019934; GO:0042803; GO:0046982";"cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]"
comp267685_c0_seq1;GAXK01079209.1;P49869;1.71E-129;HR38_DROME;Probable nuclear hormone receptor HR38 (dHR38) (Nuclear receptor subfamily 4 group A member 4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; core promoter binding [GO:0001047]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]";"GO:0000977; GO:0000978; GO:0001047; GO:0003707; GO:0004879; GO:0005102; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0035259; GO:0042335; GO:0043565; GO:0045944; GO:0046982; GO:0048082; GO:0071376";"cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"core promoter binding [GO:0001047]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2677054_c0_seq1;GAXK01180791.1;P18713;2.66E-09;ZG17_XENLA;Gastrula zinc finger protein XlCGF17.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp26772_c0_seq1;GAXK01132337.1;Q568K5;8.51E-60;NAA40_DANRE;N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187]";"GO:0005634; GO:0005737; GO:0006474; GO:0010485; GO:0043967; GO:0043968; GO:0043998; GO:0061187; GO:1990189";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]"
comp2678_c0_seq2;GAXK01175488.1;P63331;0;PP2AA_RAT;Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16);"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; spindle pole [GO:0000922]; terminal bouton [GO:0043195]; beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cellular response to cytokine stimulus [GO:0071345]; cellular response to ethanol [GO:0071361]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to steroid hormone stimulus [GO:0071383]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of microtubule binding [GO:1904528]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; protein heterotrimerization [GO:0070208]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein catabolic process [GO:0042176]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; response to lead ion [GO:0010288]";"GO:0000122; GO:0000775; GO:0000922; GO:0001932; GO:0001933; GO:0003231; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0007507; GO:0008022; GO:0010288; GO:0010469; GO:0014069; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0031698; GO:0031952; GO:0032516; GO:0032869; GO:0035307; GO:0042176; GO:0042308; GO:0043005; GO:0043065; GO:0043195; GO:0043280; GO:0043422; GO:0044325; GO:0044877; GO:0045121; GO:0046872; GO:0046982; GO:0046983; GO:0048156; GO:0051321; GO:0051721; GO:0070208; GO:0071277; GO:0071333; GO:0071345; GO:0071361; GO:0071372; GO:0071383; GO:1901020; GO:1904528; GO:1990405";"cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cellular response to cytokine stimulus [GO:0071345]; cellular response to ethanol [GO:0071361]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to steroid hormone stimulus [GO:0071383]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of microtubule binding [GO:1904528]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; protein heterotrimerization [GO:0070208]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein catabolic process [GO:0042176]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; response to lead ion [GO:0010288]";"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; spindle pole [GO:0000922]; terminal bouton [GO:0043195]";"beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; tau protein binding [GO:0048156]"
comp267814_c0_seq1;GAXK01079213.1;P50482;2.96E-89;SL9A2_RABIT;Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2);"integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]";"GO:0006885; GO:0015385; GO:0016021";regulation of pH [GO:0006885];integral component of membrane [GO:0016021];sodium:proton antiporter activity [GO:0015385]
comp2678471_c0_seq1;GAXK01200862.1;Q03685;3.82E-41;BIP5_TOBAC;Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp267866_c0_seq1;GAXK01079196.1;P49442;1.62E-77;INPP_MOUSE;Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57);"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0004441; GO:0046854; GO:0046855; GO:0046872";"inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]";;"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]"
comp267890_c0_seq1;GAXK01079240.1;O57457;1.23E-110;E41L4_DANRE;Band 4.1-like protein 4 (Protein Nbl4);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]";"GO:0005516; GO:0005737; GO:0005856; GO:0031032";actomyosin structure organization [GO:0031032];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";calmodulin binding [GO:0005516]
comp267943_c0_seq1;GAXK01079278.1;Q9SZJ2;3.59E-45;GRDP2_ARATH;Glycine-rich domain-containing protein 2 (AtGRDP2);"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";"GO:0009734; GO:0010928; GO:0071470; GO:2000028";"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";;
comp2680_c0_seq1;GAXK01175501.1;Q13442;9.36E-09;HAP28_HUMAN;28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1);"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]";"GO:0003723; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:0043312; GO:1904813";"neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]";RNA binding [GO:0003723]
comp268021_c0_seq1;GAXK01019043.1;O94760;5.22E-48;DDAH1_HUMAN;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]";"GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038";"arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]"
comp268189_c0_seq1;GAXK01019027.1;Q0VA77;2.58E-35;ENPP4_XENTR;Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]";"GO:0005886; GO:0007596; GO:0016021; GO:0030194; GO:0046872; GO:0047710";"blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]"
comp2682396_c0_seq1;GAXK01024121.1;Q9JME2;2.40E-17;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp268249_c0_seq1;GAXK01018852.1;P02310;5.13E-08;H41_TETPY;Histone H4, major;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp2682626_c0_seq1;GAXK01024123.1;Q7Z7K2;1.30E-12;ZN467_HUMAN;Zinc finger protein 467;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp26828_c0_seq1;GAXK01133149.1;Q90577;5.58E-113;SRCA_CHICK;Sarcalumenin;"sarcoplasmic reticulum lumen [GO:0033018]; GTP binding [GO:0005525]";"GO:0005525; GO:0033018";;sarcoplasmic reticulum lumen [GO:0033018];GTP binding [GO:0005525]
comp26845_c0_seq1;GAXK01132253.1;F0NBH8;1.07E-22;KMT_SULIR;Protein-lysine N-methyltransferase (EC 2.1.1.-) (Archaeal protein lysine methyltransferase) (aKMT);protein-lysine N-methyltransferase activity [GO:0016279];GO:0016279;;;protein-lysine N-methyltransferase activity [GO:0016279]
comp26849_c0_seq1;GAXK01132814.1;A7MCB7;1.59E-25;TMA16_DANRE;Translation machinery-associated protein 16;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp268494_c1_seq1;GAXK01018992.1;Q11002;9.75E-177;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp2685836_c0_seq1;GAXK01040914.1;Q7SYC9;4.04E-36;CTL2_DANRE;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp2686259_c0_seq1;GAXK01071118.1;Q54DL6;4.99E-07;Y2140_DICDI;SET and MYND domain-containing protein DDB_G0292140 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp268683_c1_seq1;GAXK01019037.1;B4RYN2;7.70E-18;SFSA_ALTMD;Sugar fermentation stimulation protein homolog;DNA binding [GO:0003677];GO:0003677;;;DNA binding [GO:0003677]
comp268685_c0_seq1;GAXK01019025.1;Q9NFT7;2.12E-140;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp26877_c1_seq1;GAXK01133199.1;Q9XZT6;4.64E-51;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp268781_c0_seq1;GAXK01018969.1;P04069;4.37E-70;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp268790_c0_seq1;GAXK01018995.1;Q9NUA8;3.08E-07;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2687996_c0_seq1;GAXK01071130.1;P17927;6.21E-09;CR1_HUMAN;Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of serine-type endopeptidase activity [GO:1900004]; neutrophil degranulation [GO:0043312]; positive regulation of serine-type endopeptidase activity [GO:1900005]; regulation of complement activation [GO:0030449]; regulation of regulatory T cell differentiation [GO:0045589]";"GO:0001618; GO:0001851; GO:0001855; GO:0001861; GO:0004877; GO:0005886; GO:0005887; GO:0006958; GO:0009986; GO:0030449; GO:0030667; GO:0043312; GO:0045087; GO:0045589; GO:0045957; GO:0045959; GO:0070062; GO:0101003; GO:1900004; GO:1900005";"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of serine-type endopeptidase activity [GO:1900004]; neutrophil degranulation [GO:0043312]; positive regulation of serine-type endopeptidase activity [GO:1900005]; regulation of complement activation [GO:0030449]; regulation of regulatory T cell differentiation [GO:0045589]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]";"complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]"
comp2688059_c0_seq1;GAXK01112860.1;Q9GRW0;2.78E-61;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp268824_c1_seq1;GAXK01019001.1;Q96EG3;5.31E-22;ZN837_HUMAN;Zinc finger protein 837;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp268838_c0_seq1;GAXK01019029.1;Q9DAG9;4.50E-63;PHF7_MOUSE;PHD finger protein 7 (Testis development protein NYD-SP6);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]";"GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872";;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp26889_c2_seq1;GAXK01133241.1;Q5E9H5;2.25E-25;BCS1_BOVIN;Mitochondrial chaperone BCS1 (BCS1-like protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"GO:0005524; GO:0005743; GO:0016021; GO:0032981; GO:0033617; GO:0034551";"mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP binding [GO:0005524]
comp268890_c4_seq1;GAXK01018978.1;P0C5Y8;1.79E-119;ALS2_RAT;Alsin (Amyotrophic lateral sclerosis 2 protein homolog);"axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035023; GO:0035249; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036";"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]";"protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]"
comp26892_c2_seq1;GAXK01132441.1;Q5ZIQ3;2.34E-14;HNRPK_CHICK;Heterogeneous nuclear ribonucleoprotein K (hnRNP K);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]";"GO:0003677; GO:0003723; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp2689217_c0_seq1;GAXK01112850.1;Q6IV72;7.99E-11;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp268974_c1_seq1;GAXK01019000.1;Q9W1L5;4.68E-70;PAL2_DROME;Peptidyl-alpha-hydroxyglycine alpha-amidating lyase 2 (EC 4.3.2.5) (Peptidylamidoglycolate lyase 2) (dPAL2);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; cellular metabolic process [GO:0044237]; peptide amidation [GO:0001519]";"GO:0001519; GO:0004504; GO:0004598; GO:0005576; GO:0044237; GO:0046872";"cellular metabolic process [GO:0044237]; peptide amidation [GO:0001519]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp2689803_c0_seq1;GAXK01112854.1;Q8VIG1;2.17E-10;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2689927_c0_seq1;GAXK01112845.1;Q9M2P4;2.25E-12;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp268995_c6_seq1;GAXK01018835.1;Q12767;4.74E-112;TMM94_HUMAN;Transmembrane protein 94;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp268997_c0_seq1;GAXK01018863.1;P05661;2.56E-37;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp26902_c1_seq1;GAXK01133086.1;P08266;0;RPB2_DROME;DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide);"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0032549; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]"
comp2690371_c0_seq1;GAXK01101654.1;Q96EQ9;1.31E-20;PRDM9_MOUSE;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0007283; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0043565; GO:0044212; GO:0045944; GO:0046872; GO:0060903";"histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2690402_c0_seq1;GAXK01101655.1;Q96RW7;2.96E-17;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2691445_c0_seq1;GAXK01101662.1;A8C984;5.66E-44;MYLK3_DANRE;Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; heart morphogenesis [GO:0003007]; sarcomerogenesis [GO:0048769]; ventricular cardiac myofibril assembly [GO:0055005]";"GO:0003007; GO:0004687; GO:0005524; GO:0005737; GO:0048769; GO:0055005";"heart morphogenesis [GO:0003007]; sarcomerogenesis [GO:0048769]; ventricular cardiac myofibril assembly [GO:0055005]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]"
comp269169_c0_seq1;GAXK01018854.1;P23435;1.93E-07;CBLN1_HUMAN;"Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin (CER); [des-Ser1]-cerebellin]";"cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synaptic cleft [GO:0043083]; protein homodimerization activity [GO:0042803]; cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of excitatory postsynaptic potential [GO:0090394]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]";"GO:0007157; GO:0007268; GO:0007399; GO:0009306; GO:0021707; GO:0030054; GO:0042803; GO:0043083; GO:0045211; GO:0051965; GO:0062023; GO:0090394; GO:0098688; GO:0098978; GO:0099151; GO:1900454; GO:1905606";"cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of excitatory postsynaptic potential [GO:0090394]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]";"cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synaptic cleft [GO:0043083]";protein homodimerization activity [GO:0042803]
comp269195_c0_seq1;GAXK01019031.1;Q91YL3;6.26E-44;UCKL1_MOUSE;Uridine-cytidine kinase-like 1 (EC 2.7.1.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206";"nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp2692316_c0_seq1;GAXK01200029.1;Q6F482;8.96E-08;RL39_PLUXY;60S ribosomal protein L39;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2692446_c0_seq1;GAXK01200047.1;P17789;3.13E-08;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp269255_c0_seq1;GAXK01018971.1;Q96JL9;7.14E-10;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp269293_c0_seq1;GAXK01019063.1;P34568;6.04E-26;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp269318_c1_seq1;GAXK01018976.1;P39806;8.57E-53;SALM_DROVI;Homeotic protein spalt-major;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2693352_c0_seq1;GAXK01200033.1;Q8VCV9;1.04E-12;MF4B1_MOUSE;Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp2693458_c0_seq1;GAXK01200034.1;P17970;7.94E-41;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp2693477_c0_seq1;GAXK01200027.1;Q8BQ86;7.38E-13;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp269358_c0_seq1;GAXK01018998.1;O94818;1.36E-37;NOL4_HUMAN;Nucleolar protein 4 (Nucleolar-localized protein);"nucleolus [GO:0005730]; RNA binding [GO:0003723]";"GO:0003723; GO:0005730";;nucleolus [GO:0005730];RNA binding [GO:0003723]
comp269371_c0_seq1;GAXK01018996.1;Q9GRW0;3.54E-62;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2693984_c0_seq1;GAXK01200026.1;Q9N295;2.24E-30;B3GT5_PANTR;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp269408_c0_seq1;GAXK01018955.1;Q6ZQM8;1.62E-17;UD17C_MOUSE;UDP-glucuronosyltransferase 1-7C (UDPGT 1-7C) (UGT1*7C) (UGT1-07C) (UGT1.7C) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1A7C) (UGT1A10);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; aromatic compound catabolic process [GO:0019439]; coumarin catabolic process [GO:0046226]; estrogen catabolic process [GO:0006711]; flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]";"GO:0005789; GO:0006711; GO:0008194; GO:0015020; GO:0016020; GO:0016021; GO:0019439; GO:0043231; GO:0046226; GO:0052696; GO:0052697";"aromatic compound catabolic process [GO:0019439]; coumarin catabolic process [GO:0046226]; estrogen catabolic process [GO:0006711]; flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]";"glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]"
comp2694166_c0_seq1;GAXK01134014.1;Q9Y6N7;7.41E-13;ROBO1_HUMAN;Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1);"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]"
comp269448_c0_seq1;GAXK01019047.1;P23792;2.10E-37;DISC_DROME;Protein disconnected;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; antennal development [GO:0007469]; brain development [GO:0007420]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; leg disc proximal/distal pattern formation [GO:0007479]; locomotor rhythm [GO:0045475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0000977; GO:0003677; GO:0005634; GO:0007420; GO:0007469; GO:0007479; GO:0007601; GO:0007623; GO:0008062; GO:0010468; GO:0045475; GO:0045494; GO:0045893; GO:0045944; GO:0046872; GO:0050896";"antennal development [GO:0007469]; brain development [GO:0007420]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; leg disc proximal/distal pattern formation [GO:0007479]; locomotor rhythm [GO:0045475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp26945_c7_seq1;GAXK01133246.1;Q14690;1.06E-70;RRP5_HUMAN;Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0008134; GO:0032040";"mRNA processing [GO:0006397]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]";"RNA binding [GO:0003723]; transcription factor binding [GO:0008134]"
comp26951_c0_seq1;GAXK01132336.1;Q8NI22;3.21E-18;MCFD2_HUMAN;Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"GO:0000139; GO:0005509; GO:0005789; GO:0006888; GO:0012507; GO:0015031; GO:0018279; GO:0033116; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]";calcium ion binding [GO:0005509]
comp26953_c1_seq1;GAXK01133107.1;P33174;0;KIF4_MOUSE;Chromosome-associated kinesin KIF4 (Chromokinesin);"chromosome [GO:0005694]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]";"GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005694; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016887; GO:0030496; GO:0045171; GO:0051256";"microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]";"chromosome [GO:0005694]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp26956_c0_seq1;GAXK01133274.1;Q24133;8.67E-127;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp2695686_c0_seq1;GAXK01134008.1;P14381;4.19E-16;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp2695827_c0_seq1;GAXK01134010.1;Q9P2G3;1.10E-08;KLH14_HUMAN;Kelch-like protein 14 (Protein interactor of Torsin-1A) (Printor) (Protein interactor of torsinA);"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]";"GO:0005783; GO:0005789; GO:0005829; GO:0015629; GO:0016235; GO:0043005; GO:0043025";;"actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";
comp2695913_c0_seq1;GAXK01134003.1;O97531;1.55E-18;KCNQ1_FELCA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) (Fragment);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005769; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016021; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0071805; GO:0086009; GO:0086089; GO:0097623; GO:1902282";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp2696042_c0_seq1;GAXK01191315.1;O57460;3.47E-24;TLL1_DANRE;Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";"GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264";"blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp269657_c1_seq1;GAXK01018943.1;Q8TEQ8;1.25E-98;PIGO_HUMAN;GPI ethanolamine phosphate transferase 3 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class O protein) (PIG-O);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005789; GO:0006506; GO:0016020; GO:0016021; GO:0051377";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";mannose-ethanolamine phosphotransferase activity [GO:0051377]
comp26970_c1_seq1;GAXK01133121.1;Q39769;1.49E-60;G3PC_GINBI;Glyceraldehyde-3-phosphate dehydrogenase, cytosolic (EC 1.2.1.12);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp269752_c1_seq1;GAXK01018846.1;Q08AE8;3.47E-62;SPIR1_HUMAN;Protein spire homolog 1 (Spir-1);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048471; GO:0051295; GO:0070649; GO:2000781";"actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp2697551_c0_seq1;GAXK01191340.1;Q69UI2;4.68E-56;RS131_ORYSJ;40S ribosomal protein S13-1;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp2697849_c0_seq1;GAXK01191341.1;B4QBN3;1.74E-14;TRE12_DROSI;Facilitated trehalose transporter Tret1-2 homolog;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015771; GO:0016021; GO:0022857";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp2698181_c0_seq1;GAXK01022174.1;P18910;1.56E-75;ANPRA_RAT;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662";"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp269827_c0_seq1;GAXK01018947.1;Q05319;3.06E-50;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp269833_c1_seq1;GAXK01018999.1;Q9CWK8;7.00E-112;SNX2_MOUSE;Sorting nexin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042803; GO:0046982; GO:0051259; GO:0072673; GO:1990459; GO:1990460";"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]";"epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]"
comp269923_c0_seq1;GAXK01019038.1;Q05319;2.56E-20;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp2699923_c0_seq1;GAXK01022181.1;Q91X17;2.29E-14;UROM_MOUSE;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266";"chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";"calcium ion binding [GO:0005509]; IgG binding [GO:0019864]"
comp27_c0_seq1;GAXK01169619.1;Q8WQI5;6.84E-123;RS8_SPOFR;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp270_c0_seq1;GAXK01168976.1;Q7KRI2;7.24E-72;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp27001_c0_seq1;GAXK01132172.1;O94826;6.59E-168;TOM70_HUMAN;Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; macroautophagy [GO:0016236]; protein targeting to mitochondrion [GO:0006626]";"GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016020; GO:0016021; GO:0016236; GO:0070062";"macroautophagy [GO:0016236]; protein targeting to mitochondrion [GO:0006626]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]";protein transmembrane transporter activity [GO:0008320]
comp270020_c2_seq1;GAXK01104138.1;Q6NSR3;9.03E-79;ADCK2_MOUSE;Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0005739; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp2700302_c0_seq1;GAXK01179746.1;E9Q555;5.48E-08;RN213_MOUSE;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp2700588_c0_seq1;GAXK01179754.1;Q28181;1.31E-19;CNGB1_BOVIN;Cyclic nucleotide-gated cation channel beta-1 (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0005737; GO:0007601; GO:0007608; GO:0010628; GO:0016021; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0050896; GO:0051289";"positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]"
comp270076_c0_seq1;GAXK01104053.1;Q9H116;1.51E-23;GZF1_HUMAN;GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0001658; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0046872";"branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp270084_c0_seq1;GAXK01104092.1;B1A193;6.32E-18;RASFA_XENLA;Ras association domain-containing protein 10;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0050769; GO:2000179";"positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";
comp2701132_c0_seq1;GAXK01179751.1;Q86WI1;3.22E-08;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp27012_c0_seq1;GAXK01133154.1;Q9Z206;6.52E-80;ARHG8_MOUSE;Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005634; GO:0005737; GO:0005886; GO:0017049; GO:0035023; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026";"cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTP-Rho binding [GO:0017049]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp270120_c1_seq1;GAXK01104250.1;Q96S16;1.95E-72;JMJD8_HUMAN;JmjC domain-containing protein 8 (Jumonji domain-containing protein 8);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]";"GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672";"positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]";
comp270148_c0_seq1;GAXK01104028.1;Q66H68;1.84E-75;RBM47_RAT;RNA-binding protein 47 (RNA-binding motif protein 47);"nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244]";"GO:0002244; GO:0003723; GO:0003729; GO:0005634; GO:0016554";"cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244]";nucleus [GO:0005634];"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp27018_c0_seq1;GAXK01205697.1;O73688;1.46E-08;HMOX_TAKRU;Heme oxygenase (HO) (EC 1.14.14.18);"endoplasmic reticulum [GO:0005783]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; heme oxidation [GO:0006788]";"GO:0004392; GO:0005783; GO:0006788; GO:0046872";heme oxidation [GO:0006788];endoplasmic reticulum [GO:0005783];"heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]"
comp2702_c0_seq1;GAXK01176544.1;Q92193;1.34E-69;ACT_CRAVI;Actin (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp2702736_c0_seq1;GAXK01138015.1;Q9VMM6;2.23E-07;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp270326_c2_seq1;GAXK01104009.1;P22814;1.81E-61;RUNT_DROME;Segmentation protein Runt;"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";"GO:0003700; GO:0005524; GO:0005634; GO:0007366; GO:0007367; GO:0007377; GO:0007400; GO:0007411; GO:0007419; GO:0007540; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048592";"axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp270362_c1_seq1;GAXK01104253.1;Q9Y606;8.52E-99;TRUA_HUMAN;tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]";"GO:0000049; GO:0002153; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0009982; GO:0031119; GO:0070902; GO:0106029; GO:1990481";"mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]"
comp2703722_c0_seq1;GAXK01138031.1;Q93VP3;2.80E-46;IF5A2_ARATH;Eukaryotic translation initiation factor 5A-2 (AtELF5A-2) (eIF-5A-2) (Protein FUMONISIN B1-RESISTANT 12);"cytosol [GO:0005829]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; defense response to bacterium [GO:0042742]; host programmed cell death induced by symbiont [GO:0034050]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; programmed cell death [GO:0012501]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to wounding [GO:0009611]; translational frameshifting [GO:0006452]; translational initiation [GO:0006413]";"GO:0003743; GO:0003746; GO:0005634; GO:0005829; GO:0006413; GO:0006452; GO:0009611; GO:0009617; GO:0012501; GO:0034050; GO:0042742; GO:0043022; GO:0045901; GO:0045905; GO:0046686";"defense response to bacterium [GO:0042742]; host programmed cell death induced by symbiont [GO:0034050]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; programmed cell death [GO:0012501]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to wounding [GO:0009611]; translational frameshifting [GO:0006452]; translational initiation [GO:0006413]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp2703796_c0_seq1;GAXK01138017.1;P19363;1.88E-15;GLB1_ARTSX;Extracellular globin-E1 (Fragment);"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0019825; GO:0020037; GO:0046872";;;"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp270380_c0_seq1;GAXK01104068.1;Q4FZY0;3.03E-58;EFHD2_RAT;EF-hand domain-containing protein D2 (Swiprosin-1);"membrane raft [GO:0045121]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0045121";;membrane raft [GO:0045121];calcium ion binding [GO:0005509]
comp2704294_c0_seq1;GAXK01001513.1;Q9D099;5.61E-10;ACER3_MOUSE;Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512]";"GO:0005509; GO:0005783; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121";"ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]"
comp270441_c1_seq1;GAXK01104217.1;Q20561;6.49E-25;HLH13_CAEEL;Helix-loop-helix protein 13 (Fer3-like protein) (Nephew of atonal 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; dauer exit [GO:0043054]; insulin receptor signaling pathway [GO:0008286]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0005634; GO:0005737; GO:0006979; GO:0008134; GO:0008286; GO:0030154; GO:0043054; GO:0046983";"cell differentiation [GO:0030154]; dauer exit [GO:0043054]; insulin receptor signaling pathway [GO:0008286]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]"
comp2704445_c0_seq1;GAXK01001519.1;P04004;6.52E-27;VTNC_HUMAN;"Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]";"alphav-beta3 integrin-vitronectin complex [GO:0071062]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; rough endoplasmic reticulum lumen [GO:0048237]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endopeptidase activity [GO:0010951]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of wound healing [GO:0090303]; protein polymerization [GO:0051258]; regulation of complement activation [GO:0030449]; smooth muscle cell-matrix adhesion [GO:0061302]";"GO:0005044; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0005796; GO:0006955; GO:0007155; GO:0007160; GO:0008201; GO:0008283; GO:0010811; GO:0010951; GO:0014911; GO:0016477; GO:0030195; GO:0030198; GO:0030247; GO:0030449; GO:0030949; GO:0032092; GO:0033627; GO:0035987; GO:0042802; GO:0043231; GO:0048237; GO:0048260; GO:0048709; GO:0050731; GO:0050840; GO:0051258; GO:0061302; GO:0062023; GO:0070062; GO:0071062; GO:0072562; GO:0090303; GO:0097421";"cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endopeptidase activity [GO:0010951]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of wound healing [GO:0090303]; protein polymerization [GO:0051258]; regulation of complement activation [GO:0030449]; smooth muscle cell-matrix adhesion [GO:0061302]";"alphav-beta3 integrin-vitronectin complex [GO:0071062]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; rough endoplasmic reticulum lumen [GO:0048237]";"collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp27047_c0_seq1;GAXK01132920.1;Q29L50;7.17E-168;SMBT_DROPS;Polycomb protein Sfmbt (Scm-like with four MBT domain-containing protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]";"GO:0003677; GO:0005634; GO:0006342; GO:0007446; GO:0008270; GO:0035064";"chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]";nucleus [GO:0005634];"DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]"
comp270512_c1_seq1;GAXK01104135.1;Q8C456;4.42E-69;FRITZ_MOUSE;WD repeat-containing and planar cell polarity effector protein fritz homolog (mFrtz) (Homolog-13) (WD repeat-containing and planar cell polarity effector protein);"axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; plasma membrane [GO:0005886]; auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cardiovascular system development [GO:0072358]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; kidney development [GO:0001822]; nervous system development [GO:0007399]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]";"GO:0001822; GO:0002093; GO:0005886; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0032185; GO:0032880; GO:0042733; GO:0043010; GO:0044782; GO:0045184; GO:0048568; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072358; GO:0090521; GO:0097541; GO:1900027; GO:2000114";"auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cardiovascular system development [GO:0072358]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; kidney development [GO:0001822]; nervous system development [GO:0007399]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]";"axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; plasma membrane [GO:0005886]";
comp2705133_c0_seq1;GAXK01001521.1;P25155;6.04E-20;FA10_CHICK;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp2705900_c0_seq1;GAXK01001511.1;P52917;2.29E-33;VPS4_YEAST;Vacuolar protein sorting-associated protein 4 (DOA4-independent degradation protein 6) (Protein END13) (Vacuolar protein-targeting protein 10);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033]";"GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0007033; GO:0015031; GO:0016020; GO:0016125; GO:0016236; GO:0016887; GO:0032511; GO:0042802; GO:0042803; GO:0045053; GO:0045324; GO:0070676; GO:1990621";"intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp27060_c0_seq1;GAXK01132183.1;Q9H920;2.83E-139;RN121_HUMAN;RING finger protein 121;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0030968; GO:0046872; GO:0061630";"endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp2706118_c0_seq1;GAXK01025860.1;Q53G44;3.14E-10;IF44L_HUMAN;Interferon-induced protein 44-like;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005525; GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp270619_c3_seq1;GAXK01104204.1;Q9U3D4;1.06E-10;SMS1_CAEEL;Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Sphingomyelin synthase 1);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0005887; GO:0006686; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]"
comp2706286_c0_seq1;GAXK01025843.1;A4QNP7;1.37E-24;DMTA2_XENTR;Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0005634; GO:0042803; GO:0043565; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp27068_c3_seq1;GAXK01133148.1;Q9CZU3;0;MTREX_MOUSE;Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase);"catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]";"GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0008380; GO:0031499; GO:0071013";"maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]";"catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp2706827_c0_seq1;GAXK01025856.1;A7RRJ0;5.93E-58;FEN1_NEMVE;Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1);"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]";"GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137; GO:0048256";"base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]";"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp2706980_c0_seq1;GAXK01025841.1;Q9C912;1.25E-28;R35A3_ARATH;60S ribosomal protein L35a-3;"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005739; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp2707093_c0_seq1;GAXK01025861.1;Q6UX71;1.52E-14;PXDC2_HUMAN;Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp270710_c0_seq1;GAXK01104054.1;Q8T6L5;6.14E-12;TPM_PERFU;Tropomyosin;;;;;
comp270712_c0_seq1;GAXK01104063.1;P40797;2.59E-116;PNUT_DROME;Protein peanut;"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"GO:0000281; GO:0003779; GO:0003924; GO:0005525; GO:0005739; GO:0005886; GO:0005940; GO:0006915; GO:0007349; GO:0008017; GO:0015630; GO:0016324; GO:0031105; GO:0031625; GO:0032154; GO:0042803; GO:0043065; GO:0045171; GO:0045572; GO:0060271; GO:0061640; GO:0070938";"apoptotic process [GO:0006915]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]";"apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp270762_c0_seq1;GAXK01204956.1;Q9BEA9;5.69E-85;GSTM3_MACFU;Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3);"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];glutathione transferase activity [GO:0004364]
comp27077_c0_seq1;GAXK01132539.1;Q5U317;9.90E-21;FIP1_RAT;Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"GO:0003723; GO:0005847; GO:0006378; GO:0098789";"mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";mRNA cleavage and polyadenylation specificity factor complex [GO:0005847];RNA binding [GO:0003723]
comp2707965_c0_seq1;GAXK01025829.1;Q9I8X5;2.57E-09;SIAH2_XENLA;E3 ubiquitin-protein ligase siah2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2) (Xsiah-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0042752; GO:0048511; GO:0061630";"multicellular organism development [GO:0007275]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp270836_c12_seq1;GAXK01104114.1;Q76CA2;2.13E-11;ACTP2_MONPT;Echotoxin-2 (Echt 2);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp27087_c0_seq1;GAXK01133104.1;P16580;3.64E-70;GLNA_CHICK;Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) (p42);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate decarboxylase activity [GO:0004351]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]";"GO:0004351; GO:0004356; GO:0005524; GO:0005739; GO:0006542; GO:0046872";glutamine biosynthetic process [GO:0006542];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate decarboxylase activity [GO:0004351]; metal ion binding [GO:0046872]"
comp2708741_c0_seq1;GAXK01127365.1;Q5WR10;1.60E-09;DX39B_CANLF;Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]";"GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0010501; GO:0016607; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002";"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]";"ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]"
comp2709076_c0_seq1;GAXK01127354.1;P08976;1.96E-08;LH18_EUGGR;"Light-harvesting complex I LH38 proteins [Cleaved into: LH38 protein 1; LH38 protein 2; LH38 protein 3] (Fragment)";"chloroplast [GO:0009507]; photosystem I [GO:0009522]; photosynthesis, light harvesting [GO:0009765]";"GO:0009507; GO:0009522; GO:0009765";photosynthesis, light harvesting [GO:0009765];"chloroplast [GO:0009507]; photosystem I [GO:0009522]";
comp270917_c0_seq1;GAXK01103976.1;P25123;3.22E-36;GBRB_DROME;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (Protein cyclodiene resistance);"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0002121; GO:0004890; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0009612; GO:0016021; GO:0022851; GO:0030054; GO:0030424; GO:0030425; GO:0030431; GO:0030594; GO:0032589; GO:0032809; GO:0034220; GO:0034707; GO:0042048; GO:0042391; GO:0042493; GO:0042749; GO:0043005; GO:0045202; GO:0045211; GO:0050805; GO:0050877; GO:0090328";"chemical synaptic transmission [GO:0007268]; inter-male aggressive behavior [GO:0002121]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of synaptic transmission [GO:0050805]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of membrane potential [GO:0042391]; regulation of olfactory learning [GO:0090328]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; sleep [GO:0030431]";"axon [GO:0030424]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]"
comp270925_c0_seq1;GAXK01104243.1;P82147;5.24E-31;L2EFL_DROME;Protein lethal(2)essential for life (Protein Efl21);"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";unfolded protein binding [GO:0051082]
comp2709479_c0_seq1;GAXK01127350.1;Q23716;0;EF2_CRYPV;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp270956_c11_seq1;GAXK01104159.1;P35832;1.61E-52;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp271_c0_seq1;GAXK01169055.1;P55277;4.15E-55;VATL_HELVI;V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit);"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]";"GO:0005774; GO:0015078; GO:0016021; GO:0033179";;"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";proton transmembrane transporter activity [GO:0015078]
comp2710056_c0_seq1;GAXK01075565.1;P14381;1.18E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp2710101_c0_seq1;GAXK01075558.1;P25387;5.72E-81;GBLP_CHLRE;Guanine nucleotide-binding protein subunit beta-like protein;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp271039_c0_seq1;GAXK01103999.1;Q99JT1;2.98E-141;GATB_MOUSE;Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp2710435_c0_seq1;GAXK01075556.1;Q6AYF9;2.87E-35;IIGP5_RAT;Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1);"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525; GO:0016020";;membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2710772_c0_seq1;GAXK01075568.1;P0DPU2;2.12E-29;VA543_SCOSD;Scoloptoxin SSD43 (Cysteine-rich venom protein) (CRVP);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp2711075_c0_seq1;GAXK01075553.1;O95502;1.08E-11;NPTXR_HUMAN;Neuronal pentraxin receptor;"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005886; GO:0009898; GO:0016021; GO:0030175; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098962; GO:0098978";"neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp271176_c0_seq1;GAXK01104108.1;Q1LYM3;7.62E-46;SPIR1_DANRE;Protein spire homolog 1;"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0015031; GO:0016192; GO:0030659; GO:0032154; GO:0045010; GO:0048471; GO:0070649; GO:2000781";"actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";actin binding [GO:0003779]
comp27118_c0_seq1;GAXK01132247.1;P90689;7.41E-10;ACT_BRUMA;Actin;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp271192_c0_seq1;GAXK01104093.1;Q6DHF9;5.95E-114;SIX1A_DANRE;Homeobox protein six1a (Homeobox protein six1b) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of inner ear receptor cell differentiation [GO:2000980]; regulation of skeletal muscle cell proliferation [GO:0014857]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]";"GO:0000976; GO:0000981; GO:0005634; GO:0005667; GO:0005737; GO:0006915; GO:0007519; GO:0014857; GO:0045892; GO:0048741; GO:0048856; GO:2000980";"anatomical structure development [GO:0048856]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of inner ear receptor cell differentiation [GO:2000980]; regulation of skeletal muscle cell proliferation [GO:0014857]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2712413_c0_seq1;GAXK01108991.1;P40145;1.32E-27;ADCY8_HUMAN;Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]";"GO:0003091; GO:0003779; GO:0004016; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006171; GO:0007165; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0007204; GO:0007611; GO:0007613; GO:0007616; GO:0007626; GO:0008294; GO:0010255; GO:0014069; GO:0016020; GO:0016323; GO:0016324; GO:0030054; GO:0030424; GO:0030425; GO:0030665; GO:0031915; GO:0032793; GO:0032809; GO:0034199; GO:0035774; GO:0038003; GO:0042593; GO:0042803; GO:0044853; GO:0045121; GO:0045211; GO:0046872; GO:0046982; GO:0046983; GO:0048786; GO:0051259; GO:0051260; GO:0051480; GO:0051721; GO:0060076; GO:0071277; GO:0071315; GO:0071333; GO:0071377; GO:0080135; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0150076; GO:1900273; GO:1900454; GO:1904322";"activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]";"actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]"
comp271278_c0_seq1;GAXK01104201.1;B4HY03;2.92E-57;IHOG_DROSE;Interference hedgehog;"cell surface [GO:0009986]; cytoneme [GO:0035230]; integral component of membrane [GO:0016021]; coreceptor activity [GO:0015026]; hedgehog family protein binding [GO:0097108]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein homodimerization activity [GO:0042803]; compound eye development [GO:0048749]; cuticle pattern formation [GO:0035017]; maintenance of protein location in extracellular region [GO:0071694]; segment specification [GO:0007379]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]";"GO:0005113; GO:0007224; GO:0007379; GO:0008201; GO:0009986; GO:0015026; GO:0016021; GO:0035017; GO:0035222; GO:0035230; GO:0042803; GO:0048749; GO:0071694; GO:0097108";"compound eye development [GO:0048749]; cuticle pattern formation [GO:0035017]; maintenance of protein location in extracellular region [GO:0071694]; segment specification [GO:0007379]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]";"cell surface [GO:0009986]; cytoneme [GO:0035230]; integral component of membrane [GO:0016021]";"coreceptor activity [GO:0015026]; hedgehog family protein binding [GO:0097108]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein homodimerization activity [GO:0042803]"
comp271293_c0_seq1;GAXK01104098.1;A5DQS0;5.88E-104;DED1_PICGU;ATP-dependent RNA helicase DED1 (EC 3.6.4.13);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]";"GO:0003724; GO:0003743; GO:0005524; GO:0005737";;cytoplasm [GO:0005737];"ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp2713400_c0_seq1;GAXK01108985.1;M0R8U1;0;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp271374_c2_seq1;GAXK01104074.1;Q9C8V2;6.91E-07;IAN7_ARATH;Immune-associated nucleotide-binding protein 7 (AtIAN7) (AIG1-like protein);GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp2714_c4_seq1;GAXK01175981.1;P26638;0;SYSC_MOUSE;Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"GO:0000122; GO:0000978; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006434; GO:0016525; GO:0042803; GO:0097056; GO:1904046";"negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]"
comp2714096_c0_seq1;GAXK01069117.1;Q9SCW7;1.77E-11;ERDL1_ARATH;Sugar transporter ERD6-like 1 (Sugar transporter-like protein 4);"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp2714754_c0_seq1;GAXK01069136.1;C7E3T4;3.02E-51;KARG_PENMO;Arginine kinase (AK) (EC 2.7.3.3) (allergen Pen m 2);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]";"GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0046314";"phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]";;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp27148_c0_seq1;GAXK01132820.1;Q5S1U6;1.65E-35;IFRD1_PIG;Interferon-related developmental regulator 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"GO:0005634; GO:0005737; GO:0014706; GO:0030517; GO:0042692; GO:0043403; GO:0048671";"muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2715106_c0_seq1;GAXK01069119.1;Q6N075;2.44E-16;MFSD5_HUMAN;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp27153_c1_seq1;GAXK01133247.1;Q9VN45;1.65E-30;SPART_DROME;Protein spartin;"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030054; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301";"cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";Rab GTPase binding [GO:0017137]
comp2715683_c0_seq1;GAXK01069120.1;A0A0R4IBK5;1.11E-33;R213A_DANRE;E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872";"blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp271595_c0_seq1;GAXK01104137.1;Q91428;2.45E-65;GATA3_DANRE;Transcription factor GATA-3 (GATA-binding factor 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000978; GO:0000981; GO:0002520; GO:0005634; GO:0008270; GO:0008284; GO:0008543; GO:0021514; GO:0030856; GO:0031101; GO:0042246; GO:0043049; GO:0045582; GO:0048568; GO:0048702; GO:0050769; GO:0060788; GO:0061026; GO:0071696; GO:2001224";"cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp2716_c0_seq1;GAXK01175306.1;P00021;1.45E-49;CYC_COLLI;Cytochrome c;"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0005829; GO:0020037; GO:0045155; GO:0046872; GO:0070469";;"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp271635_c2_seq1;GAXK01104220.1;Q9DC53;6.51E-142;CPNE8_MOUSE;Copine-8 (Copine VIII);"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0071277";cellular response to calcium ion [GO:0071277];plasma membrane [GO:0005886];calcium-dependent phospholipid binding [GO:0005544]
comp2716648_c0_seq1;GAXK01162948.1;Q9YHB5;1.59E-13;CND3_XENLA;Condensin complex subunit 3 (Chromosome assembly protein xCAP-G) (Chromosome-associated protein G) (Condensin subunit CAP-G) (Non-SMC condensin I complex subunit G);"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0000796; GO:0005634; GO:0005829; GO:0007076; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp2716987_c0_seq1;GAXK01162946.1;Q9VW60;8.38E-35;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp27170_c0_seq1;GAXK01133119.1;F4ISQ7;2.75E-136;TOP3B_ARATH;DNA topoisomerase 3-beta (EC 5.6.2.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; DNA topological change [GO:0006265]";"GO:0003677; GO:0003729; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0046872";DNA topological change [GO:0006265];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp27175_c0_seq1;GAXK01132832.1;Q8VXV4;1.84E-45;DNJ16_ARATH;Chaperone protein dnaJ 16 (AtDjB16) (AtJ16) (Protein ARG1-LIKE 1) (AtARL1);"membrane [GO:0016020]; response to abscisic acid [GO:0009737]";"GO:0009737; GO:0016020";response to abscisic acid [GO:0009737];membrane [GO:0016020];
comp271763_c1_seq1;GAXK01104140.1;P02597;8.64E-16;CALMS_CHICK;Calmodulin, striated muscle;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp271766_c1_seq1;GAXK01104078.1;Q7KRI2;5.59E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2718167_c0_seq1;GAXK01062385.1;P51910;1.59E-20;APOD_MOUSE;Apolipoprotein D (Apo-D) (ApoD);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";cholesterol binding [GO:0015485]
comp27186_c2_seq1;GAXK01132576.1;E2RYF8;8.08E-48;TPX2_PATPE;Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]";"GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236";"activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]";
comp271872_c0_seq1;GAXK01104230.1;Q6P2P2;5.09E-48;ANM9_HUMAN;Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; histone arginine methylation [GO:0034969]; mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005737; GO:0005829; GO:0006355; GO:0006397; GO:0008469; GO:0016274; GO:0034969; GO:0035241; GO:0035242; GO:0035243";"histone arginine methylation [GO:0034969]; mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]"
comp2718772_c0_seq1;GAXK01062372.1;Q9N289;3.72E-15;A4GAT_PONPY;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase) (Fragment);"Golgi membrane [GO:0000139]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; lipid metabolic process [GO:0006629]";"GO:0000139; GO:0006629; GO:0050512";lipid metabolic process [GO:0006629];Golgi membrane [GO:0000139];lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]
comp271886_c5_seq1;GAXK01104209.1;Q6AXF6;1.18E-87;SIDT1_MOUSE;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp2719007_c0_seq1;GAXK01062383.1;P13360;5.69E-12;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2719008_c0_seq1;GAXK01062368.1;Q9H2U2;3.97E-31;IPYR2_HUMAN;Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2);"mitochondrial matrix [GO:0005759]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000287; GO:0004427; GO:0004722; GO:0005759; GO:0006418; GO:0006796; GO:0051881; GO:0071344";"diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]";mitochondrial matrix [GO:0005759];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]"
comp27192_c0_seq1;GAXK01132540.1;O18373;0;SPS1_DROME;Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";"GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0007049; GO:0007275; GO:0010637; GO:0016260; GO:0070329; GO:2000378";"cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]"
comp271928_c0_seq1;GAXK01104034.1;Q61830;1.28E-10;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp271940_c0_seq1;GAXK01104001.1;Q9H4Z2;2.77E-14;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp2719454_c0_seq1;GAXK01062387.1;Q9V427;7.38E-07;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp27196_c0_seq1;GAXK01132923.1;Q9Z0L0;1.45E-12;TPBG_MOUSE;Trophoblast glycoprotein (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (Wnt-activated inhibitory factor 1) (WAIF1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of synapse assembly [GO:0051965]";"GO:0005737; GO:0005783; GO:0005886; GO:0016021; GO:0051965";positive regulation of synapse assembly [GO:0051965];"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2719685_c0_seq1;GAXK01062366.1;P26714;7.85E-27;GBRB_LYMST;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]";"GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp272_c1_seq1;GAXK01169010.1;O44119;7.01E-96;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp272002_c1_seq1;GAXK01039835.1;P25703;3.37E-77;BMP2A_XENLA;Bone morphogenetic protein 2-A (BMP-2-I);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]";"GO:0001503; GO:0005125; GO:0005615; GO:0008083; GO:0030154; GO:0051216";"cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]";extracellular space [GO:0005615];"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]"
comp27203_c1_seq1;GAXK01133302.1;Q86UA1;3.60E-131;PRP39_HUMAN;Pre-mRNA-processing factor 39 (PRP39 homolog);"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]";"GO:0000243; GO:0000395; GO:0005685; GO:0071004";mRNA 5'-splice site recognition [GO:0000395];"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";
comp2720550_c0_seq1;GAXK01028844.1;Q6Q3F5;3.11E-15;SIDT1_RAT;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp272067_c1_seq1;GAXK01039943.1;Q9I7U4;3.04E-53;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp2720881_c0_seq1;GAXK01028842.1;A6QR55;4.66E-34;UBP4_BOVIN;Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872";"negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp2721_c0_seq1;GAXK01175223.1;P54578;0;UBP14_HUMAN;Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14);"cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0004197; GO:0004843; GO:0004866; GO:0005829; GO:0005886; GO:0006511; GO:0007268; GO:0009986; GO:0016579; GO:0031410; GO:0036459; GO:0045087; GO:0045202; GO:0050920; GO:0061136; GO:0070062; GO:0070628; GO:1903070";"chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]";"cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp272166_c1_seq1;GAXK01039852.1;Q8BGE5;2.22E-23;FANCM_MOUSE;Fanconi anemia group M protein homolog (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM);"FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; DNA repair [GO:0006281]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0003677; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0006281; GO:0031297; GO:0043240; GO:0071821; GO:1902527";"DNA repair [GO:0006281]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]";"FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]"
comp272173_c0_seq1;GAXK01039966.1;Q90744;2.41E-147;NAGAB_CHICK;Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B);"cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477";"glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"cytoplasm [GO:0005737]; lysosome [GO:0005764]";"alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]"
comp272175_c1_seq1;GAXK01039922.1;Q6AZW2;6.28E-74;A1A1A_DANRE;Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]";"GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0110095";cellular detoxification of aldehyde [GO:0110095];"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"
comp272226_c0_seq1;GAXK01039902.1;Q8CBE3;8.61E-149;WDR37_MOUSE;WD repeat-containing protein 37;"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]";"GO:0030687; GO:0070545";;"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]";
comp2722720_c0_seq1;GAXK01159994.1;Q3UWA6;4.92E-39;GUC2C_MOUSE;Heat-stable enterotoxin receptor (STA receptor) (EC 4.6.1.2) (Guanylyl cyclase C) (GC-C) (Intestinal guanylate cyclase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0009636; GO:0015643; GO:0016021; GO:0035556; GO:0042127";"cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]"
comp2722721_c0_seq1;GAXK01159989.1;Q8N883;2.14E-13;ZN614_HUMAN;Zinc finger protein 614;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2723383_c0_seq1;GAXK01159997.1;P23098;1.62E-45;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp272372_c1_seq1;GAXK01039914.1;P43125;0;RDGB_DROME;Protein retinal degeneration B (Probable calcium transporter rdgB);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0005388; GO:0005737; GO:0005886; GO:0005887; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050";"cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]";"calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]"
comp2723880_c0_seq1;GAXK01160006.1;Q9EPU0;6.85E-12;RENT1_MOUSE;Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006449; GO:0008270; GO:0009048; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]"
comp2724633_c0_seq1;GAXK01112937.1;Q7Z0G7;7.18E-11;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2724743_c0_seq1;GAXK01112938.1;Q9VS29;4.40E-15;DSCL_DROME;Down syndrome cell adhesion molecule-like protein Dscam2;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]"
comp2725017_c0_seq1;GAXK01112933.1;Q5MGQ0;1.12E-11;DFP1_LONON;Putative defense protein 1 (DFP-1);"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp272533_c0_seq1;GAXK01039901.1;P28661;1.74E-129;SEPT4_MOUSE;Septin-4 (Brain protein H5) (Peanut-like protein 2);"cell projection [GO:0042995]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein homooligomerization [GO:0051260]; regulation of exocytosis [GO:0017157]; sperm capacitation [GO:0048240]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]";"GO:0000287; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005940; GO:0007286; GO:0007420; GO:0008021; GO:0015630; GO:0017157; GO:0030382; GO:0031105; GO:0031398; GO:0031514; GO:0036126; GO:0042803; GO:0042995; GO:0043065; GO:0043209; GO:0048240; GO:0051260; GO:0061640; GO:0097227; GO:2001244";"brain development [GO:0007420]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein homooligomerization [GO:0051260]; regulation of exocytosis [GO:0017157]; spermatid development [GO:0007286]; sperm capacitation [GO:0048240]; sperm mitochondrion organization [GO:0030382]";"cell projection [GO:0042995]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; synaptic vesicle [GO:0008021]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
comp272540_c0_seq1;GAXK01039983.1;O14733;2.74E-147;MP2K7_HUMAN;Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000187; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0034612; GO:0038095; GO:0045893; GO:0051403; GO:0051973; GO:0070374; GO:1904355";"activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp2725476_c0_seq1;GAXK01112939.1;Q9D180;6.16E-21;CFA57_MOUSE;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp272581_c0_seq1;GAXK01039815.1;Q7TNC6;2.47E-102;KI26B_MOUSE;Kinesin-like protein KIF26B;"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]";"GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0022409; GO:0030010; GO:0072092";"establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]";"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp27259_c1_seq1;GAXK01132888.1;Q8VBT9;1.72E-13;ASPC1_MOUSE;Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein homolog);"cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]";"GO:0005654; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0019898; GO:0030659; GO:0031401; GO:0033116; GO:0042593; GO:0043231; GO:0046324; GO:0048471";"glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]";"cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";
comp2726516_c0_seq1;GAXK01164114.1;Q9VNM1;2.99E-21;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp27266_c0_seq1;GAXK01132175.1;Q8TCD6;2.26E-48;PHOP2_HUMAN;Pyridoxal phosphate phosphatase PHOSPHO2 (EC 3.1.3.74);"metal ion binding [GO:0046872]; pyridoxal phosphatase activity [GO:0033883]";"GO:0033883; GO:0046872";;;"metal ion binding [GO:0046872]; pyridoxal phosphatase activity [GO:0033883]"
comp272682_c0_seq1;GAXK01039891.1;Q17237;2.61E-88;SGF3_BOMMO;Silk gland factor 3 (SGF-3) (POU domain protein M1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0030154; GO:0043565";"brain development [GO:0007420]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp27269_c8_seq1;GAXK01132596.1;J3S9D9;5.53E-57;RCN2V_CROAD;Reticulocalbin-2 (Taipoxin-associated calcium-binding protein 49 homolog);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576";;extracellular region [GO:0005576];calcium ion binding [GO:0005509]
comp272704_c1_seq1;GAXK01039982.1;Q9VLP9;2.08E-36;PORED_DROME;Polyprenol reductase (EC 1.3.1.94);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; polyprenol catabolic process [GO:0016095]";"GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0016021; GO:0016095; GO:0019348; GO:0019408; GO:0102389";"dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; polyprenol catabolic process [GO:0016095]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]"
comp2727092_c0_seq1;GAXK01164120.1;P36609;4.83E-25;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2727607_c0_seq1;GAXK01164119.1;P48348;1.12E-32;14338_ARATH;14-3-3-like protein GF14 kappa (General regulatory factor 8);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; regulation of metabolic process [GO:0019222]; response to freezing [GO:0050826]";"GO:0005634; GO:0005737; GO:0019222; GO:0019904; GO:0050826";"regulation of metabolic process [GO:0019222]; response to freezing [GO:0050826]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein domain specific binding [GO:0019904]
comp272771_c0_seq1;GAXK01039774.1;P33628;3.37E-16;TBA_PICAB;Tubulin alpha chain (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp272773_c0_seq1;GAXK01039899.1;O18823;3.09E-150;AOAH_RABIT;"Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]";"GO:0005509; GO:0005576; GO:0006631; GO:0009104; GO:0031410; GO:0050528";"fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]";"acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]"
comp27278_c1_seq1;GAXK01133201.1;Q9UPN6;5.54E-57;SCAF8_HUMAN;SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16);"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805";"mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]";"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]"
comp272819_c2_seq1;GAXK01039904.1;Q6IDD9;1.98E-64;SARM1_DROME;Sterile alpha and TIR motif-containing protein 1 (Tir-1 homolog) (dSarm);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214";"innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";signaling adaptor activity [GO:0035591]
comp2728288_c0_seq1;GAXK01024282.1;Q13127;3.51E-15;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp272829_c0_seq1;GAXK01039871.1;Q9H7B4;1.25E-36;SMYD3_HUMAN;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp27291_c0_seq1;GAXK01132821.1;Q9PTU6;1.51E-74;ENDOU_PAROL;Poly(U)-specific endoribonuclease (EC 3.1.-.-) (Pancreatic protein with two somatomedin-B domains) (Protein endoU) (Uridylate-specific endoribonuclease);"extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]";"GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0006955; GO:0030247; GO:0046872";immune response [GO:0006955];extracellular region [GO:0005576];"endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]"
comp2729184_c0_seq1;GAXK01024296.1;Q9Y2H8;6.90E-20;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp272926_c1_seq2;GAXK01039909.1;Q9VKJ1;3.01E-89;MPND_DROME;MPN domain-containing protein CG4751 (EC 3.4.-.-);"SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ATP-dependent chromatin remodeling [GO:0043044]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0008237; GO:0016514; GO:0042393; GO:0043044; GO:0045893; GO:0046872";"ATP-dependent chromatin remodeling [GO:0043044]; positive regulation of transcription, DNA-templated [GO:0045893]";SWI/SNF complex [GO:0016514];"histone binding [GO:0042393]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2729295_c0_seq1;GAXK01024290.1;P96789;2.59E-58;6PGD_LACLM;6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]";"GO:0004616; GO:0006098; GO:0019521; GO:0050661";"D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]";;"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]"
comp2729320_c0_seq1;GAXK01024265.1;Q6ZMW2;7.67E-19;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2729457_c0_seq1;GAXK01024284.1;A2ARI4;3.19E-11;LGR4_MOUSE;Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]";"GO:0001649; GO:0001942; GO:0004888; GO:0005615; GO:0005887; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050710; GO:0050919; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013";"axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]";"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888]"
comp27299_c0_seq1;GAXK01133197.1;P05408;5.35E-09;7B2_HUMAN;"Neuroendocrine protein 7B2 (Pituitary polypeptide) (Secretogranin V) (Secretogranin-5) (Secretory granule endocrine protein I) [Cleaved into: N-terminal peptide; C-terminal peptide]";"extracellular region [GO:0005576]; secretory granule [GO:0030141]; enzyme inhibitor activity [GO:0004857]; GTP binding [GO:0005525]; unfolded protein binding [GO:0051082]; intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883]";"GO:0004857; GO:0005525; GO:0005576; GO:0006886; GO:0007218; GO:0016486; GO:0030141; GO:0046883; GO:0051082";"intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883]";"extracellular region [GO:0005576]; secretory granule [GO:0030141]";"enzyme inhibitor activity [GO:0004857]; GTP binding [GO:0005525]; unfolded protein binding [GO:0051082]"
comp2729918_c1_seq1;GAXK01024294.1;Q5VIY5;5.82E-18;ZN468_HUMAN;Zinc finger protein 468;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp272992_c1_seq1;GAXK01039917.1;Q9HAT2;2.83E-96;SIAE_HUMAN;Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062";"carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]";sialate O-acetylesterase activity [GO:0001681]
comp27300_c0_seq1;GAXK01132919.1;P53569;1.28E-160;CEBPZ_MOUSE;CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254]";"GO:0000978; GO:0001228; GO:0005634; GO:0042254; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp27306_c0_seq1;GAXK01132934.1;P61376;1.69E-44;LHX5_RAT;LIM/homeobox protein Lhx5 (LIM homeobox protein 5) (Homeobox protein LIM-2);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";"GO:0000977; GO:0000981; GO:0005634; GO:0021527; GO:0021702; GO:0021766; GO:0021846; GO:0021879; GO:0021937; GO:0030182; GO:0045944; GO:0046872";"cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2730640_c0_seq1;GAXK01150015.1;Q07230;1.53E-13;ZSCA2_MOUSE;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2730689_c0_seq1;GAXK01149995.1;Q68Y21;5.28E-19;GRID2_DANRE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp273073_c0_seq1;GAXK01039939.1;P15370;1.65E-47;EGON_DROME;Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp273080_c0_seq1;GAXK01039940.1;Q7TT28;1.31E-38;REXO1_MOUSE;RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604";;"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]"
comp2730924_c0_seq1;GAXK01149998.1;A5D7B7;1.30E-24;SEPR_BOVIN;Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) (Z-Pro-prolinal insensitive peptidase) (ZIP) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)];"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]";"GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0007155; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030054; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]";"dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp2731220_c0_seq1;GAXK01150003.1;Q69L99;9.76E-15;LAC14_ORYSJ;Laccase-14 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 14) (Diphenol oxidase 14) (Urishiol oxidase 14);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp2731429_c0_seq1;GAXK01150014.1;P20693;1.14E-12;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp2731735_c0_seq1;GAXK01150004.1;F1QRC1;6.48E-14;DRC1_DANRE;Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]";"GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0060285; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp273236_c2_seq1;GAXK01039907.1;A6H8Z2;2.88E-28;F221B_HUMAN;Protein FAM221B;;;;;
comp2732390_c0_seq1;GAXK01064958.1;Q8MXQ2;8.80E-29;RB32C_DICDI;Ras-related protein Rab-32C;"melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0032482; GO:0042470";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"melanosome [GO:0042470]; trans-Golgi network [GO:0005802]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2732740_c0_seq1;GAXK01064965.1;P21328;1.35E-22;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp2732982_c0_seq1;GAXK01064963.1;B6EWW8;1.15E-21;V5NTD_GLOBR;Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase);"anchored component of membrane [GO:0031225]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0008253; GO:0009166; GO:0031225; GO:0046872";nucleotide catabolic process [GO:0009166];anchored component of membrane [GO:0031225];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp2733189_c0_seq1;GAXK01064955.1;Q09575;1.30E-08;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp27333_c0_seq1;GAXK01132339.1;Q9VPH8;0;RBBP5_DROME;Retinoblastoma-binding protein 5 homolog;"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]";"GO:0044665; GO:0044666; GO:0048188; GO:0051568";histone H3-K4 methylation [GO:0051568];"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]";
comp2733562_c0_seq1;GAXK01064960.1;Q91453;6.59E-30;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp2734_c0_seq1;GAXK01175251.1;Q9VMM6;1.66E-28;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp273472_c0_seq1;GAXK01039836.1;Q9HCK4;1.07E-131;ROBO2_HUMAN;Roundabout homolog 2;"axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]";"GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021510; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062";"aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]";"axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]"
comp273522_c2_seq1;GAXK01039944.1;Q9UT27;2.51E-08;PVG1_SCHPO;Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]";"GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555";"4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";pyruvyltransferase activity [GO:0046919]
comp2735411_c0_seq1;GAXK01061024.1;P26358;2.09E-22;DNMT1_HUMAN;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]";"GO:0000122; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006325; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010424; GO:0010628; GO:0010629; GO:0016458; GO:0043045; GO:0045814; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1904707; GO:1905460; GO:1905931; GO:1990841";"cellular response to amino acid stimulus [GO:0071230]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]";"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp2735468_c0_seq1;GAXK01061021.1;Q95RN0;2.94E-39;F172A_DROME;FAM172 family protein homolog CG10038;"nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]";"GO:0005634; GO:0031048";chromatin silencing by small RNA [GO:0031048];nucleus [GO:0005634];
comp273572_c0_seq1;GAXK01039921.1;Q8N2H3;0;PYRD2_HUMAN;Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp273613_c0_seq1;GAXK01039869.1;P42519;2.86E-10;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp273618_c1_seq1;GAXK01039937.1;A5IED7;1.72E-69;RF1_LEGPC;Peptide chain release factor 1 (RF-1);"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]";"GO:0005737; GO:0016149";;cytoplasm [GO:0005737];translation release factor activity, codon specific [GO:0016149]
comp27365_c1_seq1;GAXK01132929.1;Q9QX47;7.75E-10;SON_MOUSE;Protein SON (Negative regulatory element-binding protein) (NRE-binding protein);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726";"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]"
comp2736526_c0_seq1;GAXK01156914.1;Q9HFY6;2.61E-40;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2736858_c0_seq1;GAXK01156922.1;B0BN95;1.85E-12;HARB1_RAT;Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]";"GO:0004518; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
comp2737_c0_seq1;GAXK01175646.1;Q9CPQ8;2.31E-22;ATP5L_MOUSE;ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g);"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0008553; GO:0015986; GO:0046034";"ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]";"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]
comp27371_c0_seq1;GAXK01132600.1;Q9NFZ3;1.59E-26;GBGE_DROME;Guanine nucleotide-binding protein subunit gamma-e (Ggamma(e));"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]; GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]; cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"GO:0003924; GO:0005737; GO:0005834; GO:0007186; GO:0007200; GO:0007601; GO:0007602; GO:0016028; GO:0046982; GO:0050909; GO:0071244";"cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]";"GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]"
comp273721_c1_seq1;GAXK01039927.1;Q9UJU3;1.42E-34;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2737388_c0_seq1;GAXK01156919.1;Q9NBK4;3.63E-140;RL3_CAEBR;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp2737537_c0_seq1;GAXK01156910.1;Q9PT61;6.40E-12;OTX5B_XENLA;Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0009952; GO:0042706; GO:0043565; GO:0045872; GO:0045893; GO:0045944";"anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp27380_c3_seq1;GAXK01132858.1;Q9GQQ0;2.05E-120;SPIN_DROME;Protein spinster (Protein benchwarmer) (Protein diphthong);"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0055085; GO:0098793";"cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]";
comp2738319_c0_seq1;GAXK01032737.1;F1NY98;3.29E-11;DSCAM_CHICK;Down syndrome cell adhesion molecule homolog;"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030017; GO:0030054; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]";"netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]"
comp27384_c3_seq1;GAXK01133299.1;Q91W43;0;GCSP_MOUSE;Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring));"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]";"GO:0004375; GO:0005634; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0046983; GO:0070280; GO:1903442; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]";"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]"
comp2738427_c0_seq1;GAXK01032743.1;P34815;3.84E-09;UNC18_CAEEL;Putative acetylcholine regulator unc-18 (Uncoordinated protein 18);"axon [GO:0030424]; presynapse [GO:0098793]; syntaxin binding [GO:0019905]; positive regulation of neurotransmitter secretion [GO:0001956]; protein transport [GO:0015031]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle docking [GO:0016081]";"GO:0001956; GO:0007271; GO:0015031; GO:0016081; GO:0019905; GO:0030424; GO:0098793";"positive regulation of neurotransmitter secretion [GO:0001956]; protein transport [GO:0015031]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle docking [GO:0016081]";"axon [GO:0030424]; presynapse [GO:0098793]";syntaxin binding [GO:0019905]
comp273851_c4_seq1;GAXK01039872.1;O94462;2.89E-11;PUF3_SCHPO;mRNA-binding protein puf3 (Pumilio homology domain family member 3);"cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; CCR4-NOT complex binding [GO:1905762]; exoribonuclease activator activity [GO:0044692]; mRNA binding [GO:0003729]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]";"GO:0003729; GO:0005741; GO:0005829; GO:0044692; GO:0060213; GO:1905762";positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213];"cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]";"CCR4-NOT complex binding [GO:1905762]; exoribonuclease activator activity [GO:0044692]; mRNA binding [GO:0003729]"
comp2738716_c0_seq1;GAXK01032725.1;O88446;1.44E-38;S22A3_RAT;Solute carrier family 22 member 3 (Organic cation transporter 3);"integral component of membrane [GO:0016021]; dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; dopamine transport [GO:0015872]; histamine uptake [GO:0051615]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";"GO:0005330; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015872; GO:0016021; GO:0019534; GO:0032098; GO:0051615";"dopamine transport [GO:0015872]; histamine uptake [GO:0051615]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";integral component of membrane [GO:0016021];"dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]"
comp2738866_c0_seq1;GAXK01032732.1;P30736;3.67E-68;RL15_CHITE;60S ribosomal protein L15 (YL10);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp273918_c0_seq1;GAXK01039853.1;P27165;5.98E-64;CALM_PHYIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2739244_c0_seq1;GAXK01032729.1;Q9DFQ7;1.13E-32;RL24_GILMI;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp27394_c0_seq1;GAXK01132224.1;P00357;2.07E-48;G3P_HOMAM;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp27395_c3_seq1;GAXK01133082.1;Q3SZH7;0;LKHA4_BOVIN;Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0019370; GO:0043171; GO:0044255; GO:0044267; GO:0070006";"cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]"
comp2740_c0_seq1;GAXK01175495.1;Q9V535;2.21E-60;RBM8A_DROME;RNA-binding protein 8A (Protein tsunagi);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition, DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380]";"GO:0000184; GO:0000226; GO:0000335; GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0007294; GO:0007310; GO:0007314; GO:0007317; GO:0008380; GO:0035145; GO:0045451; GO:0046595; GO:0051028; GO:0051663; GO:0071013";"establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition, DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]";mRNA binding [GO:0003729]
comp2740023_c0_seq1;GAXK01204705.1;P34586;1.35E-19;TRPL_CAEEL;Transient-receptor-potential-like protein (TRP homologous cation channel protein 1);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp274028_c0_seq1;GAXK01074840.1;Q8JFQ4;7.17E-21;RDM1_CHICK;RAD52 motif-containing protein 1;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723]";"GO:0003677; GO:0003723; GO:0005730; GO:0005737";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp274040_c2_seq1;GAXK01075012.1;Q7TNG5;8.64E-131;EMAL2_MOUSE;Echinoderm microtubule-associated protein-like 2 (EMAP-2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]";"GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115";"negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]";"microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]"
comp2740492_c0_seq1;GAXK01204700.1;P21902;9.91E-42;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp274059_c1_seq1;GAXK01074866.1;Q61493;0;REV3L_MOUSE;DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4);"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305";"DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]";"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp27406_c0_seq1;GAXK01133313.1;Q0JNL7;5.16E-22;CALM3_ORYSJ;Calmodulin-3 (CaM-3);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp27407_c0_seq1;GAXK01132579.1;Q9R1K5;0;FZR1_MOUSE;Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog);"anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin-protein transferase activator activity [GO:0097027]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"GO:0005654; GO:0005680; GO:0006281; GO:0007049; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0072425; GO:0090344; GO:0097027; GO:1904668";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"anaphase-promoting complex binding [GO:0010997]; ubiquitin-protein transferase activator activity [GO:0097027]"
comp2740900_c0_seq1;GAXK01204678.1;Q8IZT8;1.79E-10;HS3S5_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (3-OST-5) (Heparan sulfate 3-O-sulfotransferase 5) (h3-OST-5);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]";"GO:0000139; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0016021; GO:0034483; GO:0046596; GO:0050656; GO:0050819";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp2741115_c0_seq1;GAXK01204701.1;Q9XTR1;4.03E-22;CDK4_CAEEL;Cyclin-dependent kinase 4 homolog (CDK4/6) (EC 2.7.11.22) (Cell division protein kinase 4);"nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";"GO:0002119; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007530; GO:0008584; GO:0009791; GO:0018105; GO:0018107; GO:0032877; GO:0040035; GO:0044843; GO:0046872; GO:0051301; GO:0090727; GO:1900087";"cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";nucleus [GO:0005634];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp2741503_c0_seq1;GAXK01204692.1;P86854;5.89E-11;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp2741598_c0_seq1;GAXK01204702.1;Q96BH3;1.71E-08;ESPB1_HUMAN;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12);"cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";heparin binding [GO:0008201]
comp27421_c1_seq1;GAXK01132495.1;P54187;1.20E-07;D2_ONCVO;Protein D2 (Fragment);;;;;
comp2742547_c0_seq1;GAXK01007269.1;B9EJR8;5.69E-104;DAAF5_MOUSE;Dynein assembly factor 5, axonemal (HEAT repeat-containing protein 2);"cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005737; GO:0036158; GO:0036159; GO:0045505";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]";cytoplasm [GO:0005737];dynein intermediate chain binding [GO:0045505]
comp2743_c0_seq1;GAXK01176490.1;K7IM66;0;EIF3D_NASVI;Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0098808";"cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";"mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]"
comp2743067_c0_seq1;GAXK01007267.1;P18910;4.76E-25;ANPRA_RAT;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662";"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp274311_c4_seq1;GAXK01074859.1;Q5VW36;1.97E-33;FOCAD_HUMAN;Focadhesin;"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]";"GO:0005925; GO:0016021";;"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]";
comp2743231_c0_seq1;GAXK01007249.1;P30974;1.65E-29;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp2743280_c0_seq1;GAXK01007245.1;O88622;3.29E-12;PARG_MOUSE;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; detection of bacterium [GO:0016045]; nucleotide-sugar metabolic process [GO:0009225]; positive regulation of DNA repair [GO:0045739]; regulation of DNA repair [GO:0006282]";"GO:0000785; GO:0003682; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:0016045; GO:0043231; GO:0045739; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; detection of bacterium [GO:0016045]; nucleotide-sugar metabolic process [GO:0009225]; positive regulation of DNA repair [GO:0045739]; regulation of DNA repair [GO:0006282]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"
comp2743426_c0_seq1;GAXK01007261.1;Q7Z2Y8;5.25E-100;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp2743552_c0_seq1;GAXK01007272.1;P62244;4.30E-76;RS15A_HUMAN;40S ribosomal protein S15a (Small ribosomal subunit protein uS8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0008284; GO:0009615; GO:0016020; GO:0019083; GO:0022627; GO:0045787; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp27439_c0_seq1;GAXK01133275.1;Q9VL63;1.48E-10;U430_DROME;UPF0430 protein CG31712;"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005739";;"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";
comp2743931_c0_seq1;GAXK01007252.1;P18292;9.76E-09;THRB_RAT;"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; cellular response to mechanical stimulus [GO:0071260]; positive regulation of blood coagulation [GO:0030194]; response to inactivity [GO:0014854]; response to Thyroglobulin triiodothyronine [GO:1904016]; response to thyrotropin-releasing hormone [GO:1905225]; response to thyroxine [GO:0097068]";"GO:0004252; GO:0005509; GO:0005615; GO:0006953; GO:0007596; GO:0014854; GO:0030194; GO:0062023; GO:0071260; GO:0097068; GO:1904016; GO:1905225";"acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; cellular response to mechanical stimulus [GO:0071260]; positive regulation of blood coagulation [GO:0030194]; response to inactivity [GO:0014854]; response to Thyroglobulin triiodothyronine [GO:1904016]; response to thyrotropin-releasing hormone [GO:1905225]; response to thyroxine [GO:0097068]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp274399_c2_seq1;GAXK01074891.1;Q4V8X0;6.58E-24;TPRA1_DANRE;Transmembrane protein adipocyte-associated 1 homolog (Integral membrane protein GPR175);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp27441_c1_seq1;GAXK01133087.1;Q99615;8.51E-53;DNJC7_HUMAN;DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";heat shock protein binding [GO:0031072]
comp27442_c0_seq1;GAXK01132236.1;P51823;6.39E-83;ARF2_ORYSJ;ADP-ribosylation factor 2;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005737; GO:0005794; GO:0006471; GO:0006886; GO:0016192";"intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";GTP binding [GO:0005525]
comp274476_c0_seq1;GAXK01074979.1;Q9NXL6;2.71E-50;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp2744957_c0_seq1;GAXK01073617.1;Q9VNM1;6.58E-17;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp27456_c0_seq1;GAXK01132240.1;Q9D1X9;2.03E-44;TM50B_MOUSE;Transmembrane protein 50B;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]";"GO:0000139; GO:0005783; GO:0005789; GO:0016021; GO:0032511";late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp27457_c0_seq1;GAXK01132493.1;Q8R4A1;2.32E-100;ERO1A_RAT;ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase alpha) (Endoplasmic reticulum oxidoreductin-1-like protein) (Global ischemia-induced protein 11) (Oxidoreductin-1-L-alpha);"dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005789; GO:0010260; GO:0015035; GO:0016671; GO:0019471; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034975; GO:0034976; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456";"4-hydroxyproline metabolic process [GO:0019471]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]";"dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]";"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"
comp27459_c0_seq1;GAXK01133060.1;Q9U616;5.37E-42;GCSH_DROME;Glycine cleavage system H protein, mitochondrial (Protein pumpless);"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"GO:0005739; GO:0005960; GO:0006546; GO:0019464";"glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]";
comp27461_c0_seq1;GAXK01132228.1;Q6P135;1.07E-16;TMUB1_DANRE;Transmembrane and ubiquitin-like domain-containing protein 1;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005634; GO:0005737; GO:0016021; GO:0030433";ubiquitin-dependent ERAD pathway [GO:0030433];"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp27467_c1_seq1;GAXK01132334.1;Q9Y0Y6;1.07E-166;NRBP_DROME;Nuclear receptor-binding protein homolog (MLF1-adaptor molecule);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]";"GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005938; GO:0006468; GO:0006888; GO:0008361; GO:0009306; GO:0012505; GO:0035556; GO:0036335; GO:0042127; GO:0042803";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]";"ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]"
comp27468_c0_seq1;GAXK01205795.1;P52485;2.83E-80;UBCD2_DROME;Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005524; GO:0019915; GO:0061631";"lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp2746815_c0_seq1;GAXK01170727.1;Q04206;2.20E-42;TF65_HUMAN;Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; NF-kappaB p50/p65 complex [GO:0035525]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; actinin binding [GO:0042805]; activating transcription factor binding [GO:0033613]; ankyrin repeat binding [GO:0071532]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phosphate ion binding [GO:0042301]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription coactivator binding [GO:0001225]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; acetaldehyde metabolic process [GO:0006117]; aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; cellular defense response [GO:0006968]; cellular response to angiotensin [GO:1904385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to nicotine [GO:0071316]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; liver development [GO:0001889]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; postsynapse to nucleus signaling pathway [GO:0099527]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of inflammatory response [GO:0050727]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of transcription, DNA-templated [GO:0006355]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to cobalamin [GO:0033590]; response to cytokine [GO:0034097]; response to insulin [GO:0032868]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to progesterone [GO:0032570]; response to UV-B [GO:0010224]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]";"GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001225; GO:0001227; GO:0001228; GO:0001889; GO:0001942; GO:0002223; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006117; GO:0006325; GO:0006355; GO:0006954; GO:0006968; GO:0007249; GO:0007568; GO:0008134; GO:0008284; GO:0009887; GO:0010033; GO:0010224; GO:0014040; GO:0016032; GO:0019221; GO:0019899; GO:0019901; GO:0031293; GO:0031490; GO:0031625; GO:0032332; GO:0032481; GO:0032495; GO:0032570; GO:0032868; GO:0033209; GO:0033234; GO:0033590; GO:0033613; GO:0034097; GO:0035525; GO:0035729; GO:0035924; GO:0035994; GO:0038061; GO:0038095; GO:0042177; GO:0042301; GO:0042802; GO:0042803; GO:0042805; GO:0042826; GO:0043066; GO:0043123; GO:0043200; GO:0043278; GO:0043620; GO:0044212; GO:0044877; GO:0045084; GO:0045892; GO:0045893; GO:0045944; GO:0046627; GO:0046982; GO:0047485; GO:0050727; GO:0050852; GO:0050862; GO:0051059; GO:0051092; GO:0051591; GO:0051607; GO:0061614; GO:0070301; GO:0070431; GO:0070491; GO:0070498; GO:0070555; GO:0071222; GO:0071223; GO:0071224; GO:0071316; GO:0071347; GO:0071354; GO:0071356; GO:0071532; GO:0098978; GO:0099527; GO:1901222; GO:1901223; GO:1901224; GO:1901522; GO:1902894; GO:1902895; GO:1904385; GO:1904996; GO:2000630; GO:2001237";"acetaldehyde metabolic process [GO:0006117]; aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; cellular defense response [GO:0006968]; cellular response to angiotensin [GO:1904385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to nicotine [GO:0071316]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; liver development [GO:0001889]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of type I interferon production [GO:0032481]; postsynapse to nucleus signaling pathway [GO:0099527]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of inflammatory response [GO:0050727]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of transcription, DNA-templated [GO:0006355]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to cobalamin [GO:0033590]; response to cytokine [GO:0034097]; response to insulin [GO:0032868]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to progesterone [GO:0032570]; response to UV-B [GO:0010224]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; NF-kappaB p50/p65 complex [GO:0035525]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"actinin binding [GO:0042805]; activating transcription factor binding [GO:0033613]; ankyrin repeat binding [GO:0071532]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phosphate ion binding [GO:0042301]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription coactivator binding [GO:0001225]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]"
comp274683_c0_seq1;GAXK01074903.1;P50429;7.63E-97;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp2747_c0_seq1;GAXK01176561.1;Q3SZ71;0;MPPB_BOVIN;Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP);"mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]";"GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872";protein processing involved in protein targeting to mitochondrion [GO:0006627];"mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp2747233_c1_seq1;GAXK01170742.1;Q06068;2.44E-08;HSP97_STRPU;97 kDa heat shock protein (Egg sperm receptor);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp274766_c2_seq1;GAXK01075009.1;K4BW79;2.89E-14;ENOX_SOLLC;2-methylene-furan-3-one reductase (EC 1.3.1.105) (Enone oxidoreductase) (SlEO);"chloroplast [GO:0009507]; furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0009507; GO:0102978";;chloroplast [GO:0009507];"furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]"
comp2747830_c0_seq1;GAXK01170749.1;Q8R431;1.10E-15;MGLL_RAT;Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0097756";"acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]";"acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]"
comp2748506_c0_seq1;GAXK01072046.1;P06803;9.81E-25;PIM1_MOUSE;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0008283; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp2748627_c0_seq1;GAXK01072036.1;P18061;4.72E-10;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp274871_c0_seq1;GAXK01074933.1;Q9W6N4;5.01E-17;THA_HIPHI;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0070324";;nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp2748781_c0_seq1;GAXK01072040.1;O96185;2.85E-07;YPF08_PLAF7;Uncharacterized protein PFB0460c;;;;;
comp274930_c1_seq1;GAXK01074918.1;P84329;4.92E-26;HFW1_DROPS;Protein halfway (Protein singed wings);"intracellular signal transduction [GO:0035556]; pupariation [GO:0035073]; response to ecdysone [GO:0035075]";"GO:0035073; GO:0035075; GO:0035556";"intracellular signal transduction [GO:0035556]; pupariation [GO:0035073]; response to ecdysone [GO:0035075]";;
comp2749449_c0_seq1;GAXK01072047.1;O61365;8.10E-17;NACH_DROME;Sodium channel protein Nach (Pickpocket protein 4);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0006814; GO:0016021; GO:0035002";"liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp27504_c0_seq1;GAXK01132937.1;P00020;2.24E-38;CYC_ANAPL;Cytochrome c;"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0005829; GO:0020037; GO:0045155; GO:0046872; GO:0070469";;"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp27514_c2_seq1;GAXK01133103.1;Q01528;2.10E-15;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp2751742_c0_seq1;GAXK01089375.1;P00873;1.82E-50;RBS1_CHLRE;Ribulose bisphosphate carboxylase small chain 1, chloroplastic (RuBisCO small subunit 1) (EC 4.1.1.39);"chloroplast [GO:0009507]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]; carbon fixation [GO:0015977]; photorespiration [GO:0009853]; photosynthesis [GO:0015979]";"GO:0004497; GO:0009507; GO:0009853; GO:0015977; GO:0015979; GO:0016984";"carbon fixation [GO:0015977]; photorespiration [GO:0009853]; photosynthesis [GO:0015979]";chloroplast [GO:0009507];"monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]"
comp2751845_c0_seq1;GAXK01089387.1;B7Z0W9;2.92E-23;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp2752584_c0_seq1;GAXK01141898.1;Q94900;3.56E-08;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp275273_c1_seq1;GAXK01074892.1;B2RYJ8;9.79E-18;ESRP2_RAT;Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B);"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0003729; GO:0005634; GO:0006397; GO:0008380; GO:0043484";"mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nucleus [GO:0005634];mRNA binding [GO:0003729]
comp2753032_c0_seq1;GAXK01141904.1;Q09575;5.18E-19;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp27538_c0_seq1;GAXK01133195.1;Q9VLU6;5.91E-23;SDHF4_DROME;Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) (Starvation-upregulated protein);"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; cellular respiration [GO:0045333]; cellular response to reactive oxygen species [GO:0034614]; mitochondrial respiratory chain complex II assembly [GO:0034553]; neural retina development [GO:0003407]";"GO:0003407; GO:0005749; GO:0005759; GO:0034553; GO:0034614; GO:0045333";"cellular respiration [GO:0045333]; cellular response to reactive oxygen species [GO:0034614]; mitochondrial respiratory chain complex II assembly [GO:0034553]; neural retina development [GO:0003407]";"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";
comp27542_c0_seq1;GAXK01132176.1;O54774;0;AP3D1_MOUSE;AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1);"AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]";"GO:0000139; GO:0005802; GO:0006623; GO:0006829; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0033365; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0099003; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]";"AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]";
comp2754200_c0_seq1;GAXK01094937.1;P05932;1.00E-21;CALMB_ARBPU;Calmodulin-beta (Cam B) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp27548_c2_seq1;GAXK01133193.1;P53042;0;PPP5_RAT;Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PPT);"cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]";"GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0008017; GO:0010288; GO:0016576; GO:0031072; GO:0042802; GO:0043005; GO:0043025; GO:0043204; GO:0043278; GO:0043531; GO:0046872; GO:0051259; GO:0051291; GO:0051879; GO:0060548; GO:0070301; GO:0071276; GO:0071944; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324";"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]";"cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]"
comp2755207_c0_seq1;GAXK01094905.1;P17970;4.93E-64;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp27553_c0_seq1;GAXK01132519.1;Q66S03;1.10E-17;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp2755387_c0_seq1;GAXK01094925.1;Q08832;3.12E-14;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp27554_c0_seq1;GAXK01132598.1;Q7YRA3;7.15E-116;EXOS4_BOVIN;Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41);"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; intermediate filament cytoskeleton [GO:0045111]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; transcriptionally active chromatin [GO:0035327]; exonuclease activity [GO:0004527]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000176; GO:0000177; GO:0000178; GO:0000460; GO:0004527; GO:0005730; GO:0005829; GO:0016075; GO:0030307; GO:0034427; GO:0034475; GO:0035327; GO:0035925; GO:0045006; GO:0045111; GO:0051607; GO:0071028; GO:0071044; GO:0071051";"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; intermediate filament cytoskeleton [GO:0045111]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; transcriptionally active chromatin [GO:0035327]";"exonuclease activity [GO:0004527]; mRNA 3'-UTR AU-rich region binding [GO:0035925]"
comp2755684_c0_seq1;GAXK01094924.1;Q07230;1.25E-18;ZSCA2_MOUSE;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp275572_c0_seq1;GAXK01074904.1;Q61545;1.30E-10;EWS_MOUSE;RNA-binding protein EWS;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006355; GO:0042802; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp2755984_c0_seq1;GAXK01094932.1;B6CZ61;1.11E-14;LRC51_RAT;Leucine-rich repeat-containing protein 51 (Protein LRTOMT1);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp27568_c0_seq1;GAXK01132227.1;E9PVX6;4.27E-23;KI67_MOUSE;Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]";"GO:0000775; GO:0000793; GO:0003677; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007088; GO:0008022; GO:0008283; GO:0016604; GO:0051321; GO:0051983; GO:0072574; GO:1902275; GO:1990705";"cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]"
comp275690_c0_seq1;GAXK01074942.1;Q5QQ53;7.80E-19;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp2757764_c0_seq1;GAXK01152132.1;Q02280;4.84E-08;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp275789_c3_seq1;GAXK01074874.1;Q9JJ09;8.96E-118;NPT2B_RAT;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; aging [GO:0007568]; cellular phosphate ion homeostasis [GO:0030643]; response to estradiol [GO:0032355]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341]";"GO:0005436; GO:0005886; GO:0005903; GO:0007568; GO:0009750; GO:0015321; GO:0016021; GO:0016324; GO:0019904; GO:0030643; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0044341";"aging [GO:0007568]; cellular phosphate ion homeostasis [GO:0030643]; response to estradiol [GO:0032355]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"protein domain specific binding [GO:0019904]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]"
comp2758_c0_seq1;GAXK01175491.1;Q9P2T1;0;GMPR2_HUMAN;GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2);"cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]; purine-containing compound salvage [GO:0043101]";"GO:0003920; GO:0005829; GO:0006144; GO:0015951; GO:0043101; GO:0046037; GO:0046872; GO:1902560";"GMP metabolic process [GO:0046037]; purine-containing compound salvage [GO:0043101]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]";"cytosol [GO:0005829]; GMP reductase complex [GO:1902560]";"GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]"
comp27583_c3_seq1;GAXK01132279.1;Q9W6K1;2.35E-140;MRE11_XENLA;Double-strand break repair protein MRE11 (EC 3.1.-.-);"Mre11 complex [GO:0030870]; replication fork [GO:0005657]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; manganese ion binding [GO:0030145]; cellular response to DNA damage stimulus [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]";"GO:0000724; GO:0004519; GO:0005657; GO:0006974; GO:0008408; GO:0008409; GO:0030145; GO:0030870; GO:0051321; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]";"Mre11 complex [GO:0030870]; replication fork [GO:0005657]";"3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; manganese ion binding [GO:0030145]"
comp27586_c1_seq1;GAXK01132583.1;P14576;0;SRP54_MOUSE;Signal recognition particle 54 kDa protein (SRP54);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0008144; GO:0008312; GO:0016607; GO:0019003; GO:0030942; GO:0043021";"SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]";"7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]"
comp275935_c4_seq1;GAXK01074828.1;Q8IZU9;4.39E-28;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp276039_c0_seq1;GAXK01098754.1;Q5RBA5;7.98E-13;SQSTM_PONAB;Sequestosome-1 (Ubiquitin-binding protein p62);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"GO:0000932; GO:0002376; GO:0005080; GO:0005764; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0035973; GO:0042169; GO:0043122; GO:0043130; GO:0061912; GO:0070530; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp276072_c0_seq1;GAXK01098857.1;Q91ZH7;7.12E-31;ABHD3_MOUSE;Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3);"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568";"cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";integral component of membrane [GO:0016021];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"
comp276091_c2_seq1;GAXK01098783.1;Q9UBG0;1.73E-39;MRC2_HUMAN;C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574";"collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]";"focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp2761267_c0_seq1;GAXK01115337.1;Q86BJ3;9.32E-13;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp27617_c0_seq1;GAXK01133150.1;Q8K4L0;0;DDX54_MOUSE;ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54);"Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]";"GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0030331";"RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]";"Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]"
comp2762_c0_seq1;GAXK01175707.1;O35244;2.13E-100;PRDX6_RAT;Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Non-selenium glutathione peroxidase) (NSGPx) (Thiol-specific antioxidant protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]";"GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0031625; GO:0034599; GO:0042744; GO:0042803; GO:0045454; GO:0046475; GO:0047499; GO:0048026; GO:0048471; GO:0051920; GO:0102567; GO:0102568";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp2762292_c0_seq1;GAXK01086233.1;Q80WQ9;3.45E-37;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp2762462_c0_seq1;GAXK01086229.1;P06871;9.40E-07;TRY1_CANLF;Cationic trypsin (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872";"digestion [GO:0007586]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2762471_c0_seq1;GAXK01086224.1;P0DJJ2;1.17E-22;ASTL_CHICK;Astacin-like metalloendopeptidase (EC 3.4.-.-);"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0030133; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360";"cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp276339_c0_seq1;GAXK01098815.1;Q8TGM6;1.55E-08;TAR1_YEAST;Protein TAR1 (Transcript antisense to ribosomal RNA protein 1);"mitochondrion [GO:0005739]; regulation of cellular respiration [GO:0043457]";"GO:0005739; GO:0043457";regulation of cellular respiration [GO:0043457];mitochondrion [GO:0005739];
comp276370_c0_seq1;GAXK01098759.1;Q6ZQF0;3.04E-10;TOPB1_MOUSE;DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint [GO:0033314]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";"GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint [GO:0033314]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]"
comp276416_c0_seq1;GAXK01098817.1;A6LJM7;1.17E-87;MTNA_THEM4;Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase);"S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";"GO:0019284; GO:0019509; GO:0046523";"L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";;S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]
comp2764462_c0_seq1;GAXK01106022.1;P03952;1.08E-21;KLKB1_HUMAN;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007597; GO:0022617; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062";"blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp2764658_c0_seq1;GAXK01106020.1;A2VE36;5.46E-09;PRS45_BOVIN;Serine protease 45 (EC 3.4.21.-) (Testis serine protease 5);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508";proteolysis [GO:0006508];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp27650_c0_seq1;GAXK01133316.1;Q60597;8.65E-59;ODO1_MOUSE;2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]";"GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077";"2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]";"chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]"
comp2765789_c0_seq1;GAXK01106026.1;P29289;1.32E-31;TNNC1_HOMAM;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2765837_c0_seq1;GAXK01106013.1;P15036;5.08E-16;ETS2_HUMAN;Protein C-ets-2;"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0001712; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0035259; GO:0045893; GO:0045944; GO:0090009";"cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2766074_c0_seq1;GAXK01196864.1;Q9P243;5.92E-07;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp27664_c2_seq1;GAXK01133207.1;O43683;4.86E-60;BUB1_HUMAN;Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A);"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]; viral process [GO:0016032]";"GO:0000776; GO:0000777; GO:0000778; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007093; GO:0007094; GO:0008283; GO:0016020; GO:0016032; GO:0051301; GO:0051754; GO:0051983";"apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]; viral process [GO:0016032]";"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp2766613_c0_seq1;GAXK01196865.1;P10978;9.57E-08;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp27672_c1_seq1;GAXK01133061.1;Q9VEX9;6.08E-37;SAP18_DROME;Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Bicoid-interacting protein 1) (dSAP18);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011]; Sin3 complex [GO:0016580]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000398; GO:0003714; GO:0005737; GO:0006342; GO:0007275; GO:0008134; GO:0016580; GO:0045892; GO:0071011; GO:0071013";"chromatin silencing [GO:0006342]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011]; Sin3 complex [GO:0016580]";"transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp276747_c0_seq1;GAXK01098870.1;B4G4S8;9.43E-60;FOXO_DROPE;Forkhead box protein O;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627";"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp2767684_c0_seq1;GAXK01196863.1;P30974;1.41E-42;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp2767746_c0_seq1;GAXK01196869.1;Q9Y3M9;1.22E-09;ZN337_HUMAN;Zinc finger protein 337;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp27679_c1_seq1;GAXK01132348.1;Q3ZBR5;6.78E-54;TTC1_BOVIN;Tetratricopeptide repeat protein 1 (TPR repeat protein 1);cytosol [GO:0005829];GO:0005829;;cytosol [GO:0005829];
comp276811_c1_seq1;GAXK01098966.1;Q8IZ52;9.74E-46;CHSS2_HUMAN;Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2);"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206]";"GO:0000139; GO:0005759; GO:0005829; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510";chondroitin sulfate biosynthetic process [GO:0030206];"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]";"glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]"
comp2768403_c0_seq1;GAXK01133800.1;Q3V0Q7;9.11E-14;TMPSC_MOUSE;Transmembrane protease serine 12 (EC 3.4.21.-);"integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0016021";;integral component of membrane [GO:0016021];serine-type endopeptidase activity [GO:0004252]
comp276848_c3_seq1;GAXK01098980.1;Q6DDZ9;4.18E-66;MEAK7_XENLA;MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1);"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]";"GO:0005737; GO:0005765; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032";"positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]";
comp276849_c0_seq1;GAXK01098757.1;A8X6H4;3.34E-89;CMK1_CAEBR;Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp276887_c0_seq1;GAXK01098959.1;P35501;8.69E-53;ESTE_MYZPE;Esterase E4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp276896_c1_seq1;GAXK01098768.1;A8MXY4;6.25E-38;ZNF99_HUMAN;Zinc finger protein 99;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp27691_c1_seq1;GAXK01132489.1;D3ZDK7;3.05E-70;PGP_RAT;Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]";"GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0005829; GO:0006114; GO:0006650; GO:0008967; GO:0016311; GO:0016791; GO:0043136; GO:0045721; GO:0098519";"dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]"
comp27694_c1_seq1;GAXK01132585.1;Q5R5D5;3.71E-85;AK1A1_PONAB;Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; cellular detoxification of aldehyde [GO:0110095]";"GO:0005829; GO:0008106; GO:0016324; GO:0019726; GO:0047655; GO:0047939; GO:0047941; GO:0110095";cellular detoxification of aldehyde [GO:0110095];"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]"
comp27696_c0_seq1;GAXK01133317.1;Q5XI06;0;KAT8_RAT;Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1);"histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]";"GO:0000123; GO:0000776; GO:0000790; GO:0004402; GO:0005634; GO:0008134; GO:0010506; GO:0016363; GO:0019899; GO:0030099; GO:0035064; GO:0042393; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0071339; GO:0072487";"histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]";"histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]"
comp2770013_c0_seq1;GAXK01155153.1;Q9NZI2;4.01E-19;KCIP1_HUMAN;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0061337; GO:1901379";"cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp27701_c1_seq1;GAXK01132903.1;Q9XUE6;1.36E-98;PMM_CAEEL;Probable phosphomannomutase (PMM) (EC 5.4.2.8);"cytosol [GO:0005829]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]";"GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0045047";"GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]";cytosol [GO:0005829];phosphomannomutase activity [GO:0004615]
comp277012_c0_seq1;GAXK01098879.1;Q61143;1.67E-13;TRPC6_MOUSE;Short transient receptor potential channel 6 (TrpC6) (Calcium entry channel) (Transient receptor protein 6) (TRP-6);"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; aging [GO:0007568]; calcium ion transmembrane transport [GO:0070588]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0003779; GO:0005216; GO:0005261; GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0006828; GO:0007204; GO:0007338; GO:0007568; GO:0010800; GO:0015279; GO:0016020; GO:0030182; GO:0030276; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0042805; GO:0045666; GO:0050774; GO:0051117; GO:0051480; GO:0051928; GO:0070301; GO:0070588; GO:0070679; GO:0071456";"aging [GO:0007568]; calcium ion transmembrane transport [GO:0070588]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]"
comp27702_c2_seq1;GAXK01132533.1;Q9W4V8;2.10E-78;TI50C_DROME;Mitochondrial import inner membrane translocase subunit TIM50-C (Tiny tim 50);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]";"GO:0004721; GO:0004722; GO:0004725; GO:0005739; GO:0005743; GO:0005744; GO:0006470; GO:0007005; GO:0007006; GO:0016021; GO:0030150";"mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";"phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp2770210_c0_seq1;GAXK01155161.1;Q8I6K0;2.35E-30;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp27705_c0_seq1;GAXK01132910.1;Q8BHJ5;0;TBL1R_MOUSE;F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1);"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"GO:0000118; GO:0000122; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263";"adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp277070_c0_seq1;GAXK01098977.1;Q9NUA8;2.31E-10;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2771_c1_seq1;GAXK01175517.1;Q9R257;6.75E-18;HEBP1_MOUSE;Heme-binding protein 1 (p22HBP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; heme metabolic process [GO:0042168]";"GO:0005737; GO:0005739; GO:0005829; GO:0020037; GO:0042168";heme metabolic process [GO:0042168];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp27715_c1_seq1;GAXK01132350.1;P48597;7.89E-40;IF4E_XENLA;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417]";"GO:0003743; GO:0005845; GO:0006417; GO:0016281; GO:0032991";regulation of translation [GO:0006417];"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]";translation initiation factor activity [GO:0003743]
comp2771509_c0_seq1;GAXK01155157.1;Q94051;2.19E-14;CAV1_CAEEL;Caveolin-1;"caveola [GO:0005901]; cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; caveola assembly [GO:0070836]; meiotic cell cycle [GO:0051321]; Ras protein signal transduction [GO:0007265]; regulation of oviposition [GO:0046662]";"GO:0000139; GO:0005198; GO:0005887; GO:0005901; GO:0005938; GO:0007265; GO:0009898; GO:0030133; GO:0045121; GO:0046662; GO:0048471; GO:0051321; GO:0060090; GO:0060473; GO:0070836";"caveola assembly [GO:0070836]; meiotic cell cycle [GO:0051321]; Ras protein signal transduction [GO:0007265]; regulation of oviposition [GO:0046662]";"caveola [GO:0005901]; cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]";"molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]"
comp27723_c0_seq1;GAXK01132896.1;Q9UHI5;2.30E-129;LAT2_HUMAN;Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; amino acid transport [GO:0006865]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; response to toxic substance [GO:0009636]";"GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0016323; GO:0019534; GO:0042605; GO:0050900; GO:0055065";"amino acid transport [GO:0006865]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; response to toxic substance [GO:0009636]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]"
comp2772557_c0_seq1;GAXK01151872.1;Q9Z265;6.28E-21;CHK2_MOUSE;Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210";"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]"
comp277259_c0_seq1;GAXK01098799.1;Q14591;2.13E-12;ZN271_HUMAN;Deleted.;;;;;
comp2772843_c0_seq1;GAXK01151868.1;P48613;7.76E-11;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp2772939_c0_seq1;GAXK01151879.1;P55066;4.78E-16;NCAN_MOUSE;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp277345_c0_seq1;GAXK01098831.1;Q6WV17;0;GALT5_DROME;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp27735_c0_seq1;GAXK01133198.1;Q92667;1.20E-18;AKAP1_HUMAN;A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; regulation of protein kinase A signaling [GO:0010738]";"GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0007596; GO:0010738; GO:0016020; GO:0016021; GO:0034237";"blood coagulation [GO:0007596]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]"
comp27737_c0_seq1;GAXK01132259.1;Q9VLV7;1.00E-60;SPZ3_DROME;Protein spaetzle 3 (Protein spatzle 3);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp277447_c1_seq1;GAXK01098884.1;O46101;3.07E-21;TSN2A_DROME;Tetraspanin-2A;"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; smooth septate junction [GO:0005920]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; smooth septate junction assembly [GO:0090528]";"GO:0005887; GO:0005920; GO:0016021; GO:0016327; GO:0061028; GO:0090528; GO:0090557";"establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; smooth septate junction assembly [GO:0090528]";"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; smooth septate junction [GO:0005920]";
comp277451_c1_seq1;GAXK01098779.1;Q99M85;3.95E-51;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp277463_c0_seq1;GAXK01098753.1;Q08890;1.13E-95;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp27749_c0_seq1;GAXK01132450.1;Q9CYX7;2.15E-27;RRP15_MOUSE;RRP15-like protein (Ribosomal RNA-processing protein 15);"preribosome, large subunit precursor [GO:0030687]; rRNA processing [GO:0006364]";"GO:0006364; GO:0030687";rRNA processing [GO:0006364];preribosome, large subunit precursor [GO:0030687];
comp2775043_c0_seq1;GAXK01034258.1;O02836;9.31E-09;NPY2R_PIG;Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]";"GO:0004983; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";neuropeptide Y receptor activity [GO:0004983]
comp2775879_c0_seq1;GAXK01034261.1;P35789;6.29E-15;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp27760_c0_seq1;GAXK01132220.1;Q61827;2.23E-13;MAFK_MOUSE;Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000976; GO:0000978; GO:0001221; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007399; GO:0043565; GO:0071535";"negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp277718_c1_seq1;GAXK01098964.1;Q7TT00;2.42E-43;SP20H_MOUSE;Transcription factor SPT20 homolog (p38-interacting protein) (p38IP);"fibrillar center [GO:0001650]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; gastrulation [GO:0007369]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000124; GO:0001650; GO:0003712; GO:0006357; GO:0007369; GO:0035948";"gastrulation [GO:0007369]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; regulation of transcription by RNA polymerase II [GO:0006357]";"fibrillar center [GO:0001650]; SAGA complex [GO:0000124]";transcription coregulator activity [GO:0003712]
comp2777209_c0_seq1;GAXK01049313.1;O01404;4.42E-48;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp277735_c0_seq1;GAXK01098781.1;Q5R476;3.33E-14;RN111_PONAB;E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (RING-type E3 ubiquitin transferase Arkadia);"cytoplasm [GO:0005737]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0006281; GO:0007275; GO:0016567; GO:0016605; GO:0016740; GO:0032184; GO:0046872";"DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; PML body [GO:0016605]";"metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]"
comp27774_c2_seq1;GAXK01132554.1;A1ZA47;4.03E-53;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp27778_c0_seq1;GAXK01132452.1;Q9Z0S9;3.35E-39;PRAF1_MOUSE;Prenylated Rab acceptor protein 1 (PRA1 family protein 1) (Prenylin);"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]";"GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016021; GO:0030054; GO:0042802; GO:0070064";;"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]"
comp277793_c0_seq1;GAXK01098782.1;P49010;4.44E-29;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp27780_c3_seq1;GAXK01132230.1;Q9Z2A7;1.48E-46;DGAT1_MOUSE;Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0005886; GO:0010867; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0043231; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491";"diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]"
comp2778034_c0_seq1;GAXK01062063.1;P14381;1.09E-11;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp2778609_c0_seq1;GAXK01062058.1;P20693;1.97E-18;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp2778677_c0_seq1;GAXK01062044.1;Q6DGN0;1.26E-22;RERGL_DANRE;Ras-related and estrogen-regulated growth inhibitor-like protein (RERG/Ras-like protein);"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0007165; GO:0016020";signal transduction [GO:0007165];membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp277878_c0_seq1;GAXK01098776.1;Q9R9I9;1.07E-66;MYCC_BACIU;"Mycosubtilin synthase subunit C (EC 2.3.1.-) [Includes: ATP-dependent serine adenylase (SerA) (Serine activase); ATP-dependent asparagine adenylase 3 (AsnA 3) (Asparagine activase 3)]";"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]";"GO:0016740; GO:0016788; GO:0017000";antibiotic biosynthetic process [GO:0017000];;"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]"
comp2779276_c0_seq1;GAXK01062060.1;P35346;1.38E-13;SSR5_HUMAN;Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]";"GO:0004930; GO:0004994; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007218; GO:0008285; GO:0032467; GO:0042277; GO:0042593; GO:0050796; GO:0071385";"cellular response to glucocorticoid stimulus [GO:0071385]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]"
comp277974_c0_seq1;GAXK01098958.1;Q5RHD1;4.10E-79;KDM7A_DANRE;Lysine-specific demethylase 7A (DrKDM7a) (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D-A);"nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]";"GO:0005634; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035574; GO:0035575; GO:0046872; GO:0051864; GO:0070544; GO:0071557; GO:0071558";"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]";nucleus [GO:0005634];"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]"
comp2780060_c0_seq1;GAXK01146961.1;P34737;2.08E-39;RS15_PODAS;40S ribosomal protein S15 (S12);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2780590_c0_seq1;GAXK01146969.1;Q91XP5;1.04E-33;GLRA3_MOUSE;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp278080_c0_seq1;GAXK01177619.1;Q6JDV7;1.22E-111;POLK_ARATH;DNA polymerase kappa (AtPOLK) (EC 2.7.7.7);"nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985]";"GO:0003684; GO:0003697; GO:0003887; GO:0005634; GO:0006260; GO:0006281; GO:0019985; GO:0042276; GO:0046872";"DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985]";nucleus [GO:0005634];"damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]"
comp278086_c1_seq1;GAXK01177627.1;O00625;6.91E-117;PIR_HUMAN;Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366]";"GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007586; GO:0008127; GO:0030224; GO:0046872";"digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]"
comp278088_c4_seq1;GAXK01177533.1;D3YXG0;1.27E-16;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp2781065_c0_seq1;GAXK01146951.1;F7J220;6.80E-20;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp2781160_c0_seq1;GAXK01146977.1;A9JTH1;7.18E-13;NCLDA_DANRE;Neurocalcin-delta A;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2781186_c0_seq1;GAXK01146967.1;Q63273;1.26E-21;GRIK5_RAT;Glutamate receptor ionotropic, kainate 5 (GluK5) (Glutamate receptor KA-2) (KA2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005634; GO:0005783; GO:0005886; GO:0006621; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0017124; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031630; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043525; GO:0045211; GO:0050804; GO:0051649; GO:0060079; GO:0071333; GO:0098686; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:1904315";"cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2781288_c0_seq1;GAXK01146976.1;Q9ULF5;1.10E-45;S39AA_HUMAN;Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10);"integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]";"GO:0002903; GO:0005385; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615";"cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]";integral component of plasma membrane [GO:0005887];zinc ion transmembrane transporter activity [GO:0005385]
comp2781354_c0_seq1;GAXK01146962.1;Q5QQ53;2.83E-16;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp2781393_c0_seq1;GAXK01146943.1;D4PHA7;6.69E-19;WSCD2_MOUSE;WSC domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp278141_c0_seq1;GAXK01177566.1;B2D0J5;3.40E-60;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp2781878_c0_seq1;GAXK01146968.1;G3V893;1.67E-07;ZN335_RAT;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000979; GO:0002052; GO:0005634; GO:0007420; GO:0010468; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0050671; GO:0050769; GO:0080182; GO:2000327";"brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp278201_c1_seq1;GAXK01177695.1;Q6ZMW2;2.89E-25;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp278210_c1_seq1;GAXK01177576.1;Q66TN7;4.69E-13;OVCH2_RHIAE;Ovochymase-2 (EC 3.4.21.120) (Oviductal protease) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2782610_c0_seq1;GAXK01034231.1;P20107;8.58E-21;ZRC1_YEAST;Zinc/cadmium resistance protein;"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; response to cadmium ion [GO:0046686]";"GO:0000324; GO:0000329; GO:0005385; GO:0006882; GO:0016021; GO:0031966; GO:0046686";"cellular zinc ion homeostasis [GO:0006882]; response to cadmium ion [GO:0046686]";"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]";zinc ion transmembrane transporter activity [GO:0005385]
comp2783_c1_seq1;GAXK01176091.1;Q3ZBG9;7.56E-88;PLS2_BOVIN;Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]";"GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872";plasma membrane phospholipid scrambling [GO:0017121];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]"
comp278347_c1_seq1;GAXK01177577.1;Q4R684;2.24E-23;AMZ2_MACFA;Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2783965_c0_seq1;GAXK01034230.1;P28476;4.85E-08;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp2784_c1_seq1;GAXK01175662.1;P07764;1.40E-170;ALF_DROME;Fructose-bisphosphate aldolase (EC 4.1.2.13);"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]";"GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]";"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]";fructose-bisphosphate aldolase activity [GO:0004332]
comp278450_c1_seq1;GAXK01177702.1;Q14590;8.67E-20;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp2784554_c0_seq1;GAXK01148979.1;Q0IP28;6.87E-13;LAC25_ORYSJ;Laccase-25 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 25) (Diphenol oxidase 25) (Urishiol oxidase 25);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp278572_c0_seq1;GAXK01177629.1;Q6VV64;1.60E-25;KCNKI_MOUSE;Potassium channel subfamily K member 18 (Two-pore-domain potassium channel TRESK);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623";"cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp2785795_c0_seq1;GAXK01148969.1;Q9W1C9;1.13E-13;PEB3_DROME;Ejaculatory bulb-specific protein 3 (Ejaculatory bulb-specific protein III) (PEB-meIII) (PEBmelIII);"extracellular region [GO:0005576]; metamorphosis [GO:0007552]; post-mating behavior [GO:0045297]; response to virus [GO:0009615]";"GO:0005576; GO:0007552; GO:0009615; GO:0045297";"metamorphosis [GO:0007552]; post-mating behavior [GO:0045297]; response to virus [GO:0009615]";extracellular region [GO:0005576];
comp278583_c1_seq1;GAXK01177531.1;Q7Z020;1.53E-16;TRPA1_DROME;Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1);"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016021; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]"
comp2785904_c0_seq1;GAXK01148974.1;B4L1Z2;3.24E-46;RTEL1_DROMO;Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12);"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]";nucleus [GO:0005634];"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"
comp27861_c1_seq1;GAXK01133101.1;Q9BY77;1.24E-24;PDIP3_HUMAN;Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]";"GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016607; GO:0016973; GO:0031124; GO:0036464; GO:0044877; GO:0045727";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]"
comp278649_c0_seq1;GAXK01177631.1;Q8IUN9;2.57E-10;CLC10_HUMAN;C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"GO:0002223; GO:0002250; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0045087";"adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";carbohydrate binding [GO:0030246]
comp2786702_c0_seq1;GAXK01121026.1;Q32P85;6.92E-34;DLRB2_BOVIN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505";microtubule-based movement [GO:0007018];"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp278693_c1_seq1;GAXK01177521.1;Q8N184;2.82E-17;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp278718_c0_seq1;GAXK01177542.1;Q5R633;7.75E-11;TZAP_PONAB;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005634; GO:0010833; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]";"double-stranded telomeric DNA binding [GO:0003691]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp278732_c2_seq1;GAXK01177700.1;P25169;3.22E-75;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp2787567_c0_seq1;GAXK01121011.1;Q13127;3.50E-08;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp278815_c0_seq1;GAXK01177661.1;P18756;4.06E-68;ETS1B_XENLA;Protein c-ets-1-B (C-ets-1B) (XE1-B) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";"GO:0003700; GO:0005634; GO:0010595; GO:0043565; GO:0045765";"positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp278826_c3_seq1;GAXK01177583.1;Q5RDX1;5.64E-20;Z585A_PONAB;Zinc finger protein 585A;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2788477_c0_seq1;GAXK01193468.1;P05661;1.92E-11;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp27886_c1_seq1;GAXK01132947.1;Q6ZQ08;0;CNOT1_MOUSE;CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"GO:0000122; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0010606; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036";"gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]";"armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]"
comp2789_c0_seq1;GAXK01175204.1;Q95VA8;7.73E-76;TPM_TRISP;Tropomyosin;;;;;
comp278925_c1_seq1;GAXK01177588.1;P13527;2.04E-44;CP6A1_MUSDO;Cytochrome P450 6A1 (EC 1.14.14.1) (CYPVIA1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp278926_c1_seq1;GAXK01177567.1;Q9DE14;2.47E-42;ATR_XENLA;Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein);"PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]";"GO:0003677; GO:0004674; GO:0005524; GO:0006281; GO:0016605; GO:0018105; GO:0046982";"DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]";PML body [GO:0016605];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]"
comp2789352_c0_seq1;GAXK01193472.1;Q7KRI2;1.50E-12;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp279_c0_seq1;GAXK01169409.1;Q6EE31;0;TCPQ_CHICK;T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta);"cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005815; GO:0005832; GO:0006457; GO:0042995; GO:0051082";protein folding [GO:0006457];"cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp2790685_c0_seq1;GAXK01019848.1;B2D0J5;3.17E-40;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp279072_c2_seq1;GAXK01177636.1;Q14591;2.43E-26;ZN271_HUMAN;Deleted.;;;;;
comp2791_c4_seq1;GAXK01175730.1;Q173M7;0;EIF3A_AEDAE;Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp27910_c0_seq1;GAXK01132217.1;Q5F362;1.21E-99;CC50A_CHICK;Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A);"apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; phospholipid translocation [GO:0045332]";"GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0016324; GO:0030658; GO:0045332";phospholipid translocation [GO:0045332];"apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]";
comp27914_c0_seq1;GAXK01133301.1;Q02427;1.24E-24;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp2791412_c0_seq1;GAXK01019846.1;Q9T043;5.25E-29;RL142_ARATH;60S ribosomal protein L14-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005773; GO:0005774; GO:0005783; GO:0005829; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042273; GO:0042788";"ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp279172_c0_seq1;GAXK01177601.1;Q9DC26;1.24E-12;S46A3_MOUSE;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp2792074_c0_seq1;GAXK01078726.1;P26432;6.61E-07;SL9A3_RABIT;Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0005903; GO:0006885; GO:0009986; GO:0015385; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0098719";"regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"PDZ domain binding [GO:0030165]; sodium:proton antiporter activity [GO:0015385]"
comp27922_c0_seq1;GAXK01132174.1;P49858;3.19E-47;CNI_DROME;Protein cornichon;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005789; GO:0006888; GO:0007310; GO:0007350; GO:0009952; GO:0015031; GO:0016021; GO:0016192; GO:0046843";"anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp2792943_c0_seq1;GAXK01078735.1;Q09990;1.32E-13;LIN23_CAEEL;F-box/WD repeat-containing protein lin-23 (Abnormal cell lineage protein 23);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007049; GO:0008013; GO:0008285; GO:0010826; GO:0019902; GO:0031647; GO:0046983; GO:0048812; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]"
comp279336_c0_seq1;GAXK01177703.1;Q9UL36;7.57E-13;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp279345_c0_seq1;GAXK01177568.1;Q9NP71;2.65E-42;MLXPL_HUMAN;Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]";"GO:0000790; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008284; GO:0009653; GO:0010255; GO:0033137; GO:0035538; GO:0035556; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0070328; GO:0071157; GO:0090324; GO:0097009";"anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp279348_c2_seq1;GAXK01177527.1;Q8WUH2;6.38E-150;TGFA1_HUMAN;Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1);"CORVET complex [GO:0033263]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005160; GO:0005769; GO:0006355; GO:0006886; GO:0007165; GO:0007179; GO:0008333; GO:0016020; GO:0033263; GO:0034058; GO:0043231; GO:0046332";"endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"CORVET complex [GO:0033263]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]";"SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]"
comp2793683_c0_seq1;GAXK01078723.1;Q5F4B8;3.05E-15;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp2794908_c0_seq1;GAXK01009659.1;P62244;8.58E-77;RS15A_HUMAN;40S ribosomal protein S15a (Small ribosomal subunit protein uS8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0008284; GO:0009615; GO:0016020; GO:0019083; GO:0022627; GO:0045787; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2795483_c0_seq1;GAXK01009662.1;P26794;6.77E-29;PIM1_RAT;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0008283; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp279585_c4_seq1;GAXK01177640.1;Q28864;2.40E-25;TFPI1_MACMU;Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]";"GO:0004867; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp2795877_c0_seq1;GAXK01009657.1;Q16181;4.09E-67;SEPT7_HUMAN;Septin-7 (CDC10 protein homolog);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]";"cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp2795885_c0_seq1;GAXK01009668.1;Q5RC69;3.02E-13;DCTD_PONAB;Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase);"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";"GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802";"nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]";;"dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]"
comp279635_c0_seq1;GAXK01177634.1;Q9SLI8;1.76E-28;2AB2D_ARATH;Probable serine/threonine protein phosphatase 2A regulatory subunit B''delta (AtB''delta);"protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]";"GO:0000159; GO:0005509; GO:0006470; GO:0019888";protein dephosphorylation [GO:0006470];protein phosphatase type 2A complex [GO:0000159];"calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]"
comp2796363_c0_seq1;GAXK01004421.1;Q80ZD3;1.43E-30;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp2796392_c0_seq1;GAXK01004423.1;Q53EU6;6.47E-35;GPAT3_HUMAN;Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]";"GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006654; GO:0016021; GO:0016024; GO:0019432; GO:0032006; GO:0102420";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]"
comp27968_c0_seq1;GAXK01133203.1;A4FUY7;9.96E-52;MOC2B_BOVIN;Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B);"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]";"GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366; GO:0032324";"molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]";"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]";molybdopterin synthase activity [GO:0030366]
comp2797524_c0_seq1;GAXK01004411.1;Q6R7M4;2.07E-35;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp279760_c0_seq1;GAXK01177532.1;P86854;8.58E-20;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp2797666_c0_seq1;GAXK01004418.1;P08570;2.97E-28;RLA1_DROME;60S acidic ribosomal protein P1 (Acidic ribosomal protein RPA2) (RP21C);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0043021";"cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp27978_c0_seq1;GAXK01133227.1;P80404;5.31E-169;GABT_HUMAN;4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT);"4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]";"GO:0001666; GO:0003867; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042803; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450";"aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]";"4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]";"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; 4-aminobutyrate transaminase activity [GO:0003867]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]"
comp2797876_c0_seq1;GAXK01004420.1;P48613;2.78E-27;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp279825_c2_seq1;GAXK01177693.1;Q5F4B8;1.07E-26;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp2799_c0_seq1;GAXK01175704.1;Q8N6F8;1.31E-11;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp279906_c0_seq1;GAXK01177620.1;Q8IN81;9.17E-28;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp279907_c6_seq1;GAXK01177654.1;O44252;1.74E-11;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp279950_c1_seq1;GAXK01177660.1;Q96PH1;3.65E-129;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp2799734_c0_seq1;GAXK01174473.1;O35142;5.15E-13;COPB2_RAT;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102);"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]";"protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]"
comp28_c0_seq1;GAXK01166117.1;Q90YT7;4.40E-54;RL31_ICTPU;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp280_c0_seq1;GAXK01166216.1;P30151;5.84E-77;EF1B_XENLA;Elongation factor 1-beta (EF-1-beta) (p30);"eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0005853";;eukaryotic translation elongation factor 1 complex [GO:0005853];translation elongation factor activity [GO:0003746]
comp2800064_c0_seq1;GAXK01098617.1;Q2EI21;1.33E-13;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2800653_c0_seq1;GAXK01098615.1;Q29RM3;2.48E-19;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp280070_c0_seq1;GAXK01028672.1;A6H779;6.52E-110;FBXL2_BOVIN;F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2);"membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; calmodulin binding [GO:0005516]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005516; GO:0006511; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0031146";"protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]";calmodulin binding [GO:0005516]
comp280092_c0_seq1;GAXK01028727.1;Q2TAR3;1.63E-27;FEZF2_XENLA;Fez family zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0003677; GO:0005634; GO:0007399; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp28010_c0_seq1;GAXK01051803.1;Q7T2G1;1.98E-23;I2B2B_DANRE;Interferon regulatory factor 2-binding protein 2-B (IRF-2-binding protein 2-B) (IRF-2BP2-B);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]";"GO:0000977; GO:0001228; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp280100_c1_seq1;GAXK01028703.1;P70414;4.17E-07;NAC1_MOUSE;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0008092; GO:0009791; GO:0010763; GO:0010881; GO:0014704; GO:0014829; GO:0016020; GO:0016021; GO:0016323; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0035994; GO:0036376; GO:0042383; GO:0042995; GO:0043197; GO:0043198; GO:0044325; GO:0044557; GO:0045211; GO:0048747; GO:0051481; GO:0051924; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0086036; GO:0086038; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]"
comp280130_c2_seq1;GAXK01028825.1;O16264;3.59E-08;PEBPH_CAEEL;Phosphatidylethanolamine-binding protein homolog F40A3.3;"mitochondrion [GO:0005739]; lipid binding [GO:0008289]";"GO:0005739; GO:0008289";;mitochondrion [GO:0005739];lipid binding [GO:0008289]
comp280136_c0_seq1;GAXK01028725.1;Q08180;4.38E-127;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp2801620_c0_seq1;GAXK01098613.1;Q03681;4.56E-61;BIP1_TOBAC;Luminal-binding protein 1 (BiP 1) (78 kDa glucose-regulated protein homolog 1) (GRP-78-1) (Fragment);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp2802020_c0_seq1;GAXK01127879.1;P49455;3.63E-10;TPM4_DROME;Tropomyosin-1, isoforms 33/34 (Tropomyosin II);"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; P granule [GO:0043186]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; kinesin binding [GO:0019894]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]";"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019894; GO:0030017; GO:0043149; GO:0043186; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865";"actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]";"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; P granule [GO:0043186]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; kinesin binding [GO:0019894]"
comp280220_c0_seq1;GAXK01028740.1;P35778;1.94E-38;VA3_SOLIN;Venom allergen 3 (Allergen Sol i III) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol i 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp2802297_c0_seq1;GAXK01127883.1;Q74MI6;2.97E-14;EF1A_NANEQ;Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp280265_c5_seq1;GAXK01028749.1;P0DKQ8;4.67E-13;ACTP_CONCN;Conoporin-Cn1;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp2803392_c0_seq1;GAXK01127884.1;Q7PPU9;2.15E-18;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp280381_c0_seq1;GAXK01028694.1;Q9LIS2;1.28E-08;RBG4_ARATH;Glycine-rich RNA-binding protein 4, mitochondrial (AtGR-RBP4) (AtRBG4) (Glycine-rich protein 4) (AtGRP4) (Mitochondrial RNA-binding protein 1b) (At-mRBP1b);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mitochondrial mRNA modification [GO:0080156]; mitochondrial RNA modification [GO:1900864]; response to cold [GO:0009409]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"GO:0003690; GO:0003697; GO:0003723; GO:0005739; GO:0005829; GO:0006970; GO:0009409; GO:0009414; GO:0009651; GO:0080156; GO:1900864; GO:1990904";"mitochondrial mRNA modification [GO:0080156]; mitochondrial RNA modification [GO:1900864]; response to cold [GO:0009409]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]";"double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp280386_c0_seq1;GAXK01028711.1;Q9EQJ4;1.66E-16;ZN384_RAT;Zinc finger protein 384 (Cas-associated zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4);"focal adhesion [GO:0005925]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0001228; GO:0005634; GO:0005925; GO:0006913; GO:0017124; GO:0043565; GO:0045944; GO:0046872; GO:0050714";"nucleocytoplasmic transport [GO:0006913]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"focal adhesion [GO:0005925]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]"
comp2804867_c0_seq1;GAXK01117628.1;P18761;2.43E-10;CAH6_MOUSE;Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730]";"GO:0001580; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0006730; GO:0008270";"detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp2805223_c0_seq1;GAXK01117625.1;P38433;2.36E-16;ACE1_CAEEL;Acetylcholinesterase 1 (AChE 1) (EC 3.1.1.7);"cell junction [GO:0030054]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; regulation of locomotion [GO:0040012]";"GO:0001507; GO:0003990; GO:0005615; GO:0005886; GO:0006581; GO:0030054; GO:0040012; GO:0042802; GO:0043083";"acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; regulation of locomotion [GO:0040012]";"cell junction [GO:0030054]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]";"acetylcholinesterase activity [GO:0003990]; identical protein binding [GO:0042802]"
comp28053_c0_seq1;GAXK01051424.1;O75419;8.21E-168;CDC45_HUMAN;Cell division control protein 45 homolog (PORC-PI-1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; 3'-5' DNA helicase activity [GO:0043138]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication preinitiation complex assembly [GO:1902977]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin silencing at telomere [GO:0031938]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]";"GO:0000076; GO:0000082; GO:0000083; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0005813; GO:0006260; GO:0006270; GO:0031261; GO:0031298; GO:0031938; GO:0043138; GO:1900087; GO:1902977";"DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication preinitiation complex assembly [GO:1902977]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin silencing at telomere [GO:0031938]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]";"3'-5' DNA helicase activity [GO:0043138]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp280538_c0_seq2;GAXK01028663.1;Q8BQ86;2.65E-22;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp280570_c0_seq1;GAXK01028726.1;P31629;2.41E-45;ZEP2_HUMAN;Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2);"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2806332_c0_seq1;GAXK01049531.1;Q7SXB3;2.93E-07;P3IP1_DANRE;Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]";"GO:0004252; GO:0005886; GO:0016021; GO:0043553";negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp28069_c4_seq1;GAXK01052014.1;P33731;7.85E-108;SRP72_CANLF;Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0042493; GO:0043022";"response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]";"7S RNA binding [GO:0008312]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]"
comp2807_c3_seq1;GAXK01175355.1;P45433;2.23E-48;SSRA_ONCMY;Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp28070_c0_seq1;GAXK01051626.1;Q9VTC4;1.77E-72;GALL2_DROME;MIP18 family protein galla-2;"CIA complex [GO:0097361]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]";"GO:0007049; GO:0007059; GO:0016226; GO:0051301; GO:0097361; GO:0106035";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]";CIA complex [GO:0097361];
comp28071_c0_seq1;GAXK01051634.1;Q92051;1.67E-37;CAHZ_DANRE;Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";"GO:0004089; GO:0008270; GO:0015670; GO:0042539";"carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp2807396_c0_seq1;GAXK01049518.1;Q8ITC7;6.99E-19;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp2807501_c0_seq1;GAXK01049519.1;Q9P2N4;2.55E-81;ATS9_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]";"GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671";"aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp280759_c2_seq1;GAXK01028797.1;O96015;4.49E-27;DNAL4_HUMAN;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp2807806_c0_seq1;GAXK01049522.1;O75325;2.28E-17;LRRN2_HUMAN;Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023";"cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp280843_c1_seq1;GAXK01028655.1;Q7TSH9;1.90E-37;ZN184_MOUSE;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2808500_c0_seq1;GAXK01005767.1;Q7T330;6.17E-12;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp28087_c0_seq1;GAXK01052069.1;P20478;1.78E-53;GLNA2_DROME;Glutamine synthetase 2 cytoplasmic (EC 6.3.1.2) (Glutamate--ammonia ligase 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";"GO:0004356; GO:0005524; GO:0005737; GO:0006538; GO:0006542; GO:0007416; GO:0045213";"glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]"
comp280887_c0_seq1;GAXK01028710.1;Q7KRI2;2.61E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2809_c2_seq1;GAXK01175212.1;Q9STX5;0;ENPL_ARATH;Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog) (Heat shock protein 90-7) (AtHSP90.7) (AtHsp90-7) (Protein SHEPHERD);"chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"GO:0005524; GO:0005634; GO:0005739; GO:0005773; GO:0005774; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0051082; GO:0099503";"protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp2809312_c0_seq1;GAXK01005766.1;P35035;8.81E-17;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp280950_c3_seq1;GAXK01028829.1;Q17529;2.79E-23;BEST2_CAEEL;Bestrophin homolog 2;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp280955_c1_seq1;GAXK01028738.1;P53814;7.54E-18;SMTN_HUMAN;Smoothelin;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939]";"GO:0003779; GO:0005737; GO:0005815; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629; GO:0030036; GO:0031941";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp28098_c0_seq1;GAXK01052166.1;Q5RKH3;2.18E-09;K1143_RAT;Uncharacterized protein KIAA1143 homolog;;;;;
comp281_c5_seq1;GAXK01169237.1;P54399;0;PDI_DROME;Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1);"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0006457; GO:0012505; GO:0015037; GO:0034976; GO:0043025; GO:0045169; GO:0045454; GO:0048471; GO:0060187; GO:0070732";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp2810160_c0_seq1;GAXK01038510.1;Q1MX18;1.77E-11;INSC_HUMAN;Protein inscuteable homolog;"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp28103_c3_seq1;GAXK01052168.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2810301_c0_seq1;GAXK01038516.1;Q8BV66;2.97E-25;IFI44_MOUSE;Interferon-induced protein 44 (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp2810337_c0_seq1;GAXK01038502.1;P12545;9.14E-20;PLMN_MACMU;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]";"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp2810385_c0_seq1;GAXK01038519.1;Q42262;1.69E-60;RS3A2_ARATH;40S ribosomal protein S3a-2;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp28108_c4_seq1;GAXK01051901.1;P07751;1.33E-146;SPTN1_CHICK;Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain);"cell cortex [GO:0005938]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; actin filament capping [GO:0051693]";"GO:0003779; GO:0005509; GO:0005516; GO:0005856; GO:0005938; GO:0043034; GO:0051693";actin filament capping [GO:0051693];"cell cortex [GO:0005938]; costamere [GO:0043034]; cytoskeleton [GO:0005856]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]"
comp2810986_c0_seq1;GAXK01038512.1;Q8JG69;9.42E-23;AA2DB_DANRE;Alpha-2Db adrenergic receptor (Alpha-2Db adrenoceptor) (Alpha(2Db)AR) (Alpha-2Db adrenoreceptor);"integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]";"GO:0004935; GO:0004938; GO:0005887; GO:0006940; GO:0007188; GO:0019229; GO:0030168; GO:0071880; GO:0071881";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]";integral component of plasma membrane [GO:0005887];"adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]"
comp28114_c2_seq1;GAXK01052015.1;P55016;6.45E-87;S12A1_RAT;Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) (BSC1) (Kidney-specific Na-K-Cl symporter);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006884; GO:0008511; GO:0009986; GO:0015081; GO:0015378; GO:0015379; GO:0016021; GO:0016101; GO:0016324; GO:0032978; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070294; GO:1902476; GO:1990573";"cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:chloride symporter activity [GO:0015379]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp2811413_c0_seq1;GAXK01038521.1;O35379;4.98E-42;MRP1_MOUSE;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005324; GO:0005524; GO:0005737; GO:0005774; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0046618; GO:0046624; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215";"cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp28115_c0_seq1;GAXK01052305.1;P11147;4.61E-23;HSP7D_DROME;Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"GO:0000398; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0016887; GO:0030707; GO:0031072; GO:0034605; GO:0034620; GO:0035967; GO:0042026; GO:0042623; GO:0044183; GO:0048471; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0097753; GO:0098793; GO:0106161";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp28117_c0_seq1;GAXK01051578.1;P45517;7.66E-12;YDHY_CITFR;Uncharacterized 15.0 kDa protein in dhaT-dhaS intergenic region (ORFY);;;;;
comp28119_c0_seq1;GAXK01052110.1;Q24524;1.63E-142;SING_DROME;Protein singed;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein binding, bridging [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]";"GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017";"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein binding, bridging [GO:0030674]"
comp2812105_c0_seq1;GAXK01034192.1;O18405;9.33E-75;SURF4_DROME;Surfeit locus protein 4 homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0012505; GO:0016021; GO:0045169";;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";
comp2812442_c0_seq1;GAXK01034181.1;Q3SZ90;1.54E-61;RL13A_BOVIN;60S ribosomal protein L13a;"cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194";"negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp28127_c0_seq1;GAXK01051945.1;Q8LBN7;7.33E-08;COSA_ARATH;Costars family protein At4g33640;"cytosol [GO:0005829]; regulation of actin filament-based process [GO:0032970]";"GO:0005829; GO:0032970";regulation of actin filament-based process [GO:0032970];cytosol [GO:0005829];
comp281287_c0_seq1;GAXK01028652.1;F1NPQ2;4.11E-38;MINP1_CHICK;Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Band 17) (Histidine phosphatase of the endoplasmic reticulum 1) (HiPER1);"endoplasmic reticulum lumen [GO:0005788]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]";"GO:0003993; GO:0005788; GO:0034417; GO:0052745; GO:0052826";;endoplasmic reticulum lumen [GO:0005788];"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]"
comp2813_c2_seq1;GAXK01176661.1;P52170;0;IMA5_XENLA;Importin subunit alpha-5 (Karyopherin subunit alpha-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606]";"GO:0005634; GO:0005737; GO:0006606; GO:0061608";protein import into nucleus [GO:0006606];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";nuclear import signal receptor activity [GO:0061608]
comp28135_c0_seq1;GAXK01052059.1;P30533;8.66E-33;AMRP_HUMAN;Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP);"cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]";"GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0008201; GO:0009986; GO:0010916; GO:0031904; GO:0032091; GO:0035473; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223";"amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]";"cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]";"amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]"
comp2813682_c0_seq1;GAXK01034185.1;A9ZSY3;6.43E-12;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp281393_c2_seq1;GAXK01028758.1;Q9QZE3;2.36E-47;CATQ_RAT;Cathepsin Q (EC 3.4.22.-);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp2814_c0_seq1;GAXK01175670.1;Q15369;2.56E-56;ELOC_HUMAN;Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1);"cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0006368; GO:0006511; GO:0016032; GO:0016567; GO:0032968; GO:0043687; GO:0061418; GO:0070449";"positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]";
comp28141_c2_seq1;GAXK01052007.1;P49338;4.33E-106;WNT4_XENLA;Protein Wnt-4 (XWnt-4);"extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]";"GO:0005102; GO:0005576; GO:0009880; GO:0016055; GO:0039018; GO:0039020; GO:0072013";"embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];signaling receptor binding [GO:0005102]
comp28144_c0_seq1;GAXK01051976.1;Q7SYJ9;7.10E-42;SPAG7_DANRE;Sperm-associated antigen 7 homolog;nucleic acid binding [GO:0003676];GO:0003676;;;nucleic acid binding [GO:0003676]
comp281440_c1_seq1;GAXK01028746.1;Q9M883;3.50E-08;SC5D2_ARATH;Putative Delta(7)-sterol-C5(6)-desaturase 2 (EC 1.14.19.20) (Delta(7)-sterol-C5-desaturase 2) (Delta-7-C-5 sterol desaturase 2) (Homolog of DWF7 protein);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000248; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]"
comp2814470_c0_seq1;GAXK01114174.1;Q29043;7.01E-16;FUT1_PIG;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp28155_c0_seq1;GAXK01051862.1;P82119;1.40E-14;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp281571_c4_seq1;GAXK01028705.1;Q9XTJ4;3.77E-10;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp281584_c1_seq1;GAXK01028818.1;P36609;4.11E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp281592_c2_seq1;GAXK01028653.1;Q9H0D2;8.92E-29;ZN541_HUMAN;Zinc finger protein 541;"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0000118; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0007275; GO:0007283; GO:0008134; GO:0030154; GO:0044212; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp28172_c0_seq1;GAXK01051556.1;Q9NV56;2.62E-16;MRGBP_HUMAN;MRG/MORF4L-binding protein (MRG-binding protein) (Up-regulated in colon cancer 4) (Urcc4);"NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0005654; GO:0006357; GO:0016573; GO:0035267; GO:0040008";"histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp2817258_c0_seq1;GAXK01016749.1;O96006;5.42E-29;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp28173_c0_seq1;GAXK01051938.1;Q28619;2.40E-19;NHRF1_RABIT;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0005737; GO:0005902; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0030175; GO:0031528; GO:0032782; GO:0034635; GO:0045859; GO:0051898; GO:0060090; GO:0070293; GO:0071944; GO:0097225; GO:0097291; GO:2000146";"bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]";"chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]"
comp2817397_c0_seq1;GAXK01016752.1;O18868;8.19E-75;KCNB1_PIG;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp28174_c0_seq1;GAXK01052127.1;Q58EA0;6.31E-19;FUD1A_XENLA;FUN14 domain-containing protein 1A;"integral component of mitochondrial outer membrane [GO:0031307]; autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]";"GO:0000422; GO:0001666; GO:0031307";"autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]";integral component of mitochondrial outer membrane [GO:0031307];
comp281749_c2_seq1;GAXK01028692.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp28175_c1_seq1;GAXK01051218.1;P27601;3.19E-131;GNA13_MOUSE;Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13);"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0001525; GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0035556; GO:0042470; GO:0046872";"activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp281798_c0_seq1;GAXK01028802.1;Q9MYW6;0;XDH_FELCA;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp28187_c0_seq1;GAXK01051219.1;Q1IAY6;9.68E-120;KATG_PSEE4;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp281873_c0_seq1;GAXK01028803.1;P39806;3.84E-23;SALM_DROVI;Homeotic protein spalt-major;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2818757_c0_seq1;GAXK01133941.1;Q8CE94;1.58E-14;MOT13_MOUSE;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp2819087_c0_seq1;GAXK01133960.1;Q75NA5;6.81E-13;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp2819185_c0_seq1;GAXK01133945.1;Q93560;1.82E-11;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp28195_c1_seq1;GAXK01051813.1;P54960;0;HMDH_BLAGE;3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADP binding [GO:0050661]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]";"GO:0004420; GO:0005789; GO:0008299; GO:0015936; GO:0016021; GO:0050661";"coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADP binding [GO:0050661]"
comp2819581_c0_seq1;GAXK01133944.1;Q9HFV1;2.60E-15;CYB5_RHIST;Cytochrome b5;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005789; GO:0016021; GO:0020037; GO:0046872; GO:0055114";oxidation-reduction process [GO:0055114];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp2819683_c0_seq1;GAXK01133950.1;Q60821;3.60E-20;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp281969_c1_seq1;GAXK01028729.1;Q99N69;2.06E-29;LPXN_MOUSE;Leupaxin;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; regulation of cell adhesion mediated by integrin [GO:0033628]";"GO:0002102; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007162; GO:0016607; GO:0033628; GO:0042995; GO:0046872; GO:0048471; GO:0050859";"cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; regulation of cell adhesion mediated by integrin [GO:0033628]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]"
comp2819725_c0_seq1;GAXK01133948.1;P97924;5.61E-17;KALRN_RAT;Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (PAM COOH-terminal interactor protein 10) (P-CIP10) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);"cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axonogenesis [GO:0007409]; intracellular signal transduction [GO:0035556]; modification of postsynaptic actin cytoskeleton [GO:0098885]; nervous system development [GO:0007399]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005856; GO:0007399; GO:0007409; GO:0014069; GO:0019899; GO:0035023; GO:0035556; GO:0043005; GO:0043025; GO:0046872; GO:0048471; GO:0050773; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274";"axonogenesis [GO:0007409]; intracellular signal transduction [GO:0035556]; modification of postsynaptic actin cytoskeleton [GO:0098885]; nervous system development [GO:0007399]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]";"cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp282_c0_seq1;GAXK01169777.1;P62752;4.67E-63;RL23A_RAT;60S ribosomal protein L23a;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0022625; GO:0070180; GO:1904841";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]"
comp2820090_c0_seq1;GAXK01193951.1;P25490;6.19E-37;TYY1_HUMAN;Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1);"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0000400; GO:0000724; GO:0000790; GO:0000978; GO:0000980; GO:0000981; GO:0000987; GO:0001158; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010629; GO:0016363; GO:0016579; GO:0030154; GO:0031011; GO:0031519; GO:0032688; GO:0034644; GO:0034696; GO:0043565; GO:0044212; GO:0045944; GO:0046332; GO:0048593; GO:0051276; GO:0061052; GO:0071347; GO:1902894";"anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp282054_c2_seq1;GAXK01205009.1;P22813;1.89E-66;HSF_DROME;Heat shock factor protein (HSF) (Heat shock transcription factor) (HSTF);"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to heat [GO:0034605]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]";"GO:0000785; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0009408; GO:0034605; GO:0042742; GO:0042802; GO:0043388; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0050832; GO:0061408";"cellular response to heat [GO:0034605]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; response to heat [GO:0009408]";"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp2820804_c0_seq1;GAXK01193931.1;O23755;8.57E-136;EF2_BETVU;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp2820900_c0_seq1;GAXK01193944.1;Q96JB3;3.60E-16;HIC2_HUMAN;Hypermethylated in cancer 2 protein (Hic-2) (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0008022; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp282142_c0_seq1;GAXK01016585.1;Q6DJT9;1.87E-16;PLAG1_HUMAN;Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0045944; GO:0046872; GO:0060252; GO:0060736";"gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2821492_c0_seq1;GAXK01193927.1;Q9C505;1.30E-47;IF5A3_ARATH;Eukaryotic translation initiation factor 5A-3 (AtELF5A-3) (eIF-5A-3);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003743; GO:0003746; GO:0005739; GO:0005829; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp2821918_c0_seq1;GAXK01193939.1;Q6GP70;9.10E-46;ADA_XENLA;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0046103; GO:0060205";"adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp2822_c0_seq1;GAXK01176633.1;Q8MT06;1.47E-128;GNL3_DROME;Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin 1) (Nucleostemin homolog);"granular component [GO:0001652]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitotic spindle assembly [GO:0090307]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0001652; GO:0003924; GO:0005525; GO:0005730; GO:0016887; GO:0040014; GO:0042127; GO:0042273; GO:0090307";"mitotic spindle assembly [GO:0090307]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; ribosomal large subunit biogenesis [GO:0042273]";"granular component [GO:0001652]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2822013_c0_seq1;GAXK01052361.1;P17970;3.01E-17;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp2822415_c0_seq1;GAXK01052364.1;A5PKG7;2.10E-08;KCTD5_BOVIN;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0043161; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";cullin family protein binding [GO:0097602]
comp2822443_c0_seq1;GAXK01052369.1;Q7ZVG6;9.67E-09;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp282313_c1_seq1;GAXK01016598.1;Q80SU7;2.79E-80;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp282327_c0_seq1;GAXK01016666.1;Q1KKR9;4.28E-33;LNPB_TAKRU;Endoplasmic reticulum junction formation protein lunapark-B (ER junction formation factor lunapark);"endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; endoplasmic reticulum tubular network maintenance [GO:0071788]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]";"GO:0030176; GO:0042802; GO:0046872; GO:0071788; GO:0098826; GO:1903373";"endoplasmic reticulum tubular network maintenance [GO:0071788]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]";"endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp28233_c0_seq1;GAXK01051915.1;P36404;5.45E-94;ARL2_HUMAN;ADP-ribosylation factor-like protein 2;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]";"GO:0003924; GO:0005095; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005758; GO:0005759; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0007021; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0050796; GO:0051457; GO:0070830";"bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; GTP binding [GO:0005525]"
comp2823435_c0_seq1;GAXK01052367.1;Q7KRI2;1.04E-11;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp282376_c1_seq1;GAXK01016723.1;O74467;1.15E-10;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2824667_c0_seq1;GAXK01180900.1;Q27245;7.62E-17;YH24_CAEEL;Putative aminopeptidase W07G4.4 (EC 3.4.11.-);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]";"GO:0004177; GO:0005737; GO:0008235; GO:0030145";;cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]"
comp2824698_c0_seq1;GAXK01180930.1;P54685;2.52E-19;CDK7_DICDI;Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (CDK-activating kinase) (CAK) (Cell division protein kinase 7) (MO15 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]";"GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008353; GO:0045944; GO:0051301; GO:0051321; GO:0070985";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor TFIIK complex [GO:0070985]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp2825142_c0_seq1;GAXK01180902.1;Q5R6L5;1.64E-13;CAND1_PONAB;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1);"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"GO:0005634; GO:0005737; GO:0010265; GO:0016567; GO:0031461";"protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp282534_c1_seq1;GAXK01016626.1;Q0VCR6;8.04E-57;TMM68_BOVIN;Transmembrane protein 68;"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]";"GO:0016021; GO:0016746";;integral component of membrane [GO:0016021];transferase activity, transferring acyl groups [GO:0016746]
comp2825369_c0_seq1;GAXK01180919.1;F7J220;9.25E-32;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp2825979_c0_seq1;GAXK01180913.1;B6K180;2.86E-100;RSSA1_SCHJY;40S ribosomal protein S0-A;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp28263_c0_seq1;GAXK01051864.1;Q8C1A5;0;THOP1_MOUSE;Thimet oligopeptidase (EC 3.4.24.15);"mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";"GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0046872";"intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";mitochondrial intermembrane space [GO:0005758];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]"
comp2826377_c0_seq1;GAXK01054310.1;Q9Y2C3;7.75E-32;B3GT5_HUMAN;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp2826678_c0_seq1;GAXK01054323.1;P50232;2.05E-43;SYT4_RAT;Synaptotagmin-4 (Synaptotagmin IV) (SytIV);"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of neuronal dense core vesicle membrane [GO:0099066]; microvesicle [GO:1990742]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; secretory granule maturation [GO:0061792]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005794; GO:0005886; GO:0007269; GO:0007420; GO:0007613; GO:0008021; GO:0014049; GO:0014059; GO:0016021; GO:0016192; GO:0017075; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030100; GO:0030276; GO:0030348; GO:0030424; GO:0030425; GO:0030667; GO:0030672; GO:0031045; GO:0031338; GO:0031339; GO:0033604; GO:0042803; GO:0043005; GO:0043025; GO:0044306; GO:0045955; GO:0046872; GO:0046929; GO:0046982; GO:0048174; GO:0048471; GO:0048791; GO:0050709; GO:0061782; GO:0061792; GO:0070382; GO:0071277; GO:0097449; GO:0098978; GO:0099066; GO:0099161; GO:0099183; GO:1903861; GO:1905414; GO:1905415; GO:1905433; GO:1990742; GO:2000301";"brain development [GO:0007420]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; secretory granule maturation [GO:0061792]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]";"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of neuronal dense core vesicle membrane [GO:0099066]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";"clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; syntaxin binding [GO:0019905]"
comp282672_c2_seq1;GAXK01016689.1;P53365;9.13E-98;ARFP2_HUMAN;Arfaptin-2 (ADP-ribosylation factor-interacting protein 2) (Partner of RAC1) (Protein POR1);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; intracellular protein transport [GO:0006886]; lamellipodium assembly [GO:0030032]; ruffle organization [GO:0031529]; small GTPase mediated signal transduction [GO:0007264]";"GO:0001726; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0007264; GO:0019904; GO:0030032; GO:0030036; GO:0030742; GO:0031529; GO:0032588; GO:0042802; GO:0045296; GO:0048365; GO:0070273";"actin cytoskeleton organization [GO:0030036]; intracellular protein transport [GO:0006886]; lamellipodium assembly [GO:0030032]; ruffle organization [GO:0031529]; small GTPase mediated signal transduction [GO:0007264]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; Rac GTPase binding [GO:0048365]"
comp2826895_c0_seq1;GAXK01054308.1;Q86XW9;1.44E-25;TXND6_HUMAN;Thioredoxin domain-containing protein 6 (Thioredoxin-like protein 2) (Txl-2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoside diphosphate kinase activity [GO:0004550]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"GO:0004550; GO:0005737; GO:0005856; GO:0006183; GO:0006228; GO:0006241; GO:0045454";"cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";nucleoside diphosphate kinase activity [GO:0004550]
comp2827777_c0_seq1;GAXK01054317.1;Q62925;3.15E-32;M3K1_RAT;Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000165; GO:0000186; GO:0000209; GO:0004674; GO:0004706; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0006468; GO:0006511; GO:0006970; GO:0007256; GO:0008270; GO:0008432; GO:0016020; GO:0018105; GO:0023014; GO:0031098; GO:0031434; GO:0032147; GO:0032232; GO:0043065; GO:0043406; GO:0043507; GO:0045944; GO:0046625; GO:0046777; GO:0050434; GO:0051019; GO:0051259";"activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp282796_c1_seq1;GAXK01016553.1;Q7KRI2;1.27E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp28280_c1_seq1;GAXK01051518.1;Q94CF0;8.31E-09;EHD1_ARATH;EH domain-containing protein 1 (AtEHD1) (EC 3.6.5.2);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; hyperosmotic salinity response [GO:0042538]; protein homooligomerization [GO:0051260]";"GO:0005509; GO:0005525; GO:0005737; GO:0005768; GO:0005886; GO:0006897; GO:0009506; GO:0010008; GO:0016020; GO:0016787; GO:0032456; GO:0042538; GO:0043231; GO:0051260";"endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; hyperosmotic salinity response [GO:0042538]; protein homooligomerization [GO:0051260]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]"
comp282802_c3_seq1;GAXK01016634.1;Q7KRI2;5.44E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp28283_c2_seq1;GAXK01051373.1;Q5R988;7.71E-79;RAP2A_PONAB;Ras-related protein Rap-2a;"midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]";"GO:0003924; GO:0005525; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0034613; GO:0046328; GO:0048814; GO:0055038";"actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]";"midbody [GO:0030496]; recycling endosome membrane [GO:0055038]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2828379_c0_seq1;GAXK01003015.1;P06205;2.26E-09;CRP1_LIMPO;C-reactive protein 1.1;"extracellular region [GO:0005576]; metal ion binding [GO:0046872]";"GO:0005576; GO:0046872";;extracellular region [GO:0005576];metal ion binding [GO:0046872]
comp282874_c0_seq1;GAXK01016570.1;Q9UJU3;1.28E-21;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2828758_c0_seq1;GAXK01003033.1;Q8BIQ3;2.70E-15;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp282882_c0_seq1;GAXK01016628.1;Q8IYB9;6.38E-23;ZN595_HUMAN;Zinc finger protein 595;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2829000_c0_seq1;GAXK01003021.1;Q90629;1.64E-37;TRY3_CHICK;Trypsin II-P29 (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872";"digestion [GO:0007586]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp282906_c1_seq1;GAXK01016642.1;Q7KRI2;1.35E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2829737_c0_seq1;GAXK01003023.1;P35033;1.86E-25;TRY3_SALSA;Trypsin-3 (EC 3.4.21.4) (Trypsin III) (Fragment);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp282978_c0_seq1;GAXK01016595.1;Q96IR7;1.65E-51;HPDL_HUMAN;4-hydroxyphenylpyruvate dioxygenase-like protein (EC 1.13.-.-) (Glyoxalase domain-containing protein 1);"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]";"GO:0003868; GO:0009072; GO:0046872";aromatic amino acid family metabolic process [GO:0009072];;"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]"
comp2829850_c0_seq1;GAXK01003036.1;O35490;5.06E-80;BHMT1_MOUSE;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267";"amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]";"betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]"
comp2830111_c0_seq1;GAXK01090029.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp2830172_c0_seq1;GAXK01090026.1;Q5R9A7;1.32E-57;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp28302_c0_seq1;GAXK01051982.1;A4IFH4;7.15E-61;PSF1_BOVIN;DNA replication complex GINS protein PSF1 (GINS complex subunit 1);"GINS complex [GO:0000811]; 3'-5' DNA helicase activity [GO:0043138]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]";"GO:0000811; GO:0043138; GO:1902983";DNA strand elongation involved in mitotic DNA replication [GO:1902983];GINS complex [GO:0000811];3'-5' DNA helicase activity [GO:0043138]
comp2830494_c0_seq1;GAXK01090039.1;O94892;4.74E-14;ZN432_HUMAN;Zinc finger protein 432;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2830704_c0_seq1;GAXK01090043.1;O42329;8.32E-23;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp2830742_c0_seq1;GAXK01090050.1;O02387;8.22E-17;CU17_BOMMO;Larval cuticle protein LCP-17;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp283100_c5_seq1;GAXK01016671.1;P10076;3.30E-31;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp28311_c0_seq1;GAXK01052126.1;Q9P1U0;3.47E-28;RPA12_HUMAN;DNA-directed RNA polymerase I subunit RPA12 (Zinc ribbon domain-containing protein 1);"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0003676; GO:0003899; GO:0005654; GO:0005736; GO:0006139; GO:0006361; GO:0006362; GO:0006363; GO:0006379; GO:0008270; GO:0045815";"mRNA cleavage [GO:0006379]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp2831211_c0_seq1;GAXK01090047.1;O70237;4.29E-09;GFI1B_MOUSE;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"GO:0000122; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0007275; GO:0016363; GO:0030854; GO:0045646; GO:0046872; GO:0051572; GO:0051574";"multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp283170_c4_seq1;GAXK01016555.1;P56721;0;COLL_DROME;Transcription factor collier (Transcription factor knot);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";"GO:0001228; GO:0001700; GO:0003677; GO:0005634; GO:0006355; GO:0007350; GO:0007367; GO:0007419; GO:0007474; GO:0007476; GO:0007526; GO:0009608; GO:0010468; GO:0016204; GO:0035203; GO:0035287; GO:0035288; GO:0035289; GO:0035291; GO:0042694; GO:0045087; GO:0045944; GO:0046872; GO:0046983; GO:0048813; GO:0048814";"anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp2831770_c0_seq1;GAXK01090051.1;Q6P0F9;5.18E-08;INS1A_DANRE;Insulinoma-associated protein 1a (Insulinoma-associated 1-like protein a) (Zinc finger protein IA-1a);"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell dedifferentiation [GO:0043697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]";"GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0010564; GO:0017053; GO:0021522; GO:0030182; GO:0031490; GO:0035677; GO:0042670; GO:0043565; GO:0043697; GO:0045892; GO:0046872; GO:0048920; GO:0060221; GO:0060290; GO:0070654";"cell dedifferentiation [GO:0043697]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]";"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp28323_c0_seq1;GAXK01051869.1;P02826;1.19E-43;HSP7A_DROSI;Heat shock 70 kDa protein cognate 1 (Heat shock 70 kDa protein 70C) (Fragments);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp2832352_c0_seq1;GAXK01068606.1;A1VYV7;7.44E-117;ALF_CAMJJ;Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase);"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; glycolytic process [GO:0006096]";"GO:0004332; GO:0006096; GO:0008270";glycolytic process [GO:0006096];;"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]"
comp2832542_c0_seq1;GAXK01068603.1;Q09274;1.52E-19;UN105_CAEEL;Degenerin-like protein unc-105 (Uncoordinated protein 105);"integral component of membrane [GO:0016021]; ion channel activity [GO:0005216]; sodium channel activity [GO:0005272]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; magnesium ion transport [GO:0015693]; muscle organ development [GO:0007517]";"GO:0005216; GO:0005272; GO:0006816; GO:0007517; GO:0015693; GO:0016021; GO:0030154";"calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; magnesium ion transport [GO:0015693]; muscle organ development [GO:0007517]";integral component of membrane [GO:0016021];"ion channel activity [GO:0005216]; sodium channel activity [GO:0005272]"
comp2833028_c0_seq1;GAXK01068618.1;P55040;1.46E-21;GEM_HUMAN;GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR);"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842";"cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp2833095_c0_seq1;GAXK01068613.1;P35684;1.22E-168;RL3_ORYSJ;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp283325_c0_seq1;GAXK01016724.1;Q9I8X5;2.27E-08;SIAH2_XENLA;E3 ubiquitin-protein ligase siah2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2) (Xsiah-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0042752; GO:0048511; GO:0061630";"multicellular organism development [GO:0007275]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp283378_c1_seq1;GAXK01016596.1;P05661;9.50E-96;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2833919_c0_seq1;GAXK01068608.1;A0JNB1;4.23E-36;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2833986_c0_seq1;GAXK01068602.1;Q6V291;2.39E-38;MARE1_COTCO;Microtubule-associated protein RP/EB family member 1;"cortical microtubule cytoskeleton [GO:0030981]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of microtubule polymerization [GO:0031115]; protein localization to microtubule [GO:0035372]";"GO:0005815; GO:0005874; GO:0007049; GO:0030981; GO:0031115; GO:0035372; GO:0051010; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of microtubule polymerization [GO:0031115]; protein localization to microtubule [GO:0035372]";"cortical microtubule cytoskeleton [GO:0030981]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]";microtubule plus-end binding [GO:0051010]
comp283420_c0_seq1;GAXK01016637.1;O64943;1.93E-11;POLC2_JUNOX;Polcalcin Jun o 2 (Calcium-binding pollen allergen Jun o 2) (allergen Jun o 2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp28344_c0_seq1;GAXK01052139.1;Q01617;1.81E-59;CPO_DROME;Protein couch potato;"nucleus [GO:0005634]; mRNA binding [GO:0003729]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206]";"GO:0003729; GO:0005634; GO:0007268; GO:0007275; GO:0022611; GO:0035206";"chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206]";nucleus [GO:0005634];mRNA binding [GO:0003729]
comp2834591_c0_seq1;GAXK01009761.1;Q9VZW5;3.79E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2834863_c0_seq1;GAXK01009763.1;O13769;1.74E-20;ULP2_SCHPO;Ubiquitin-like-specific protease 2 (EC 3.4.22.-);"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"GO:0005634; GO:0010494; GO:0016926; GO:0070140; GO:0070647; GO:2000765";"protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp283489_c0_seq1;GAXK01016567.1;Q5F3V0;1.09E-26;SMYD4_CHICK;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp28351_c0_seq1;GAXK01052057.1;Q00537;0;CDK17_HUMAN;Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]";"GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468";protein phosphorylation [GO:0006468];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp283535_c1_seq1;GAXK01016685.1;Q9UM73;3.71E-133;ALK_HUMAN;ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; cell population proliferation [GO:0008283]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000187; GO:0004704; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0008283; GO:0016310; GO:0021766; GO:0030534; GO:0032991; GO:0036269; GO:0042127; GO:0042802; GO:0042981; GO:0043235; GO:0045664; GO:0046777; GO:0048666; GO:0051092; GO:0060159; GO:0070062; GO:0090648; GO:1900006";"activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; cell population proliferation [GO:0008283]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp2835491_c0_seq1;GAXK01009764.1;Q9CZD0;3.83E-15;MMAC_MOUSE;Methylmalonic aciduria and homocystinuria type C protein homolog (EC 1.16.1.-) (CblC) (Cyanocobalamin reductase (cyanide-eliminating));"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]";"GO:0005737; GO:0005739; GO:0006749; GO:0009235; GO:0009236; GO:0016491; GO:0031419; GO:0032451; GO:0033787; GO:0042803; GO:0043295; GO:0055114; GO:0070988; GO:0071949";"cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]"
comp2835511_c0_seq1;GAXK01009767.1;Q7K4Y6;2.25E-76;DAT_DROME;Sodium-dependent dopamine transporter (Protein fumin);"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]";"GO:0005328; GO:0005330; GO:0005886; GO:0005887; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834";"adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]";"integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp2836109_c0_seq1;GAXK01130970.1;Q03112;1.24E-10;MECOM_HUMAN;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0016607; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0070828; GO:0071425";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
comp283634_c0_seq1;GAXK01016627.1;O95461;0;LARG1_HUMAN;"LARGE xylosyl- and glucuronyltransferase 1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) [Includes: Xylosyltransferase LARGE (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE (EC 2.4.1.-)]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]";"GO:0000139; GO:0005794; GO:0006044; GO:0006486; GO:0006493; GO:0006688; GO:0008375; GO:0009101; GO:0015020; GO:0016757; GO:0030145; GO:0030173; GO:0035252; GO:0035269; GO:0042285; GO:0043403; GO:0046716; GO:0060538";"glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]";"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]"
comp2836386_c0_seq1;GAXK01130994.1;P52741;7.51E-22;ZN134_HUMAN;Zinc finger protein 134;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp28367_c0_seq1;GAXK01052010.1;Q9V460;0;SPT5H_DROME;Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (dSpt5);"DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000122; GO:0000993; GO:0003682; GO:0003729; GO:0005700; GO:0005703; GO:0005705; GO:0006357; GO:0006368; GO:0007549; GO:0008023; GO:0032044; GO:0032785; GO:0032786; GO:0044877; GO:0045944; GO:0046982";"dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]";"chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]"
comp28370_c3_seq1;GAXK01052306.1;Q9VRJ8;1.32E-42;ASTER_DROME;Protein Asterix;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp283710_c0_seq1;GAXK01016629.1;P51452;3.43E-26;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp283737_c2_seq1;GAXK01016716.1;Q95NI4;6.73E-37;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2837717_c0_seq1;GAXK01130974.1;G5EBR3;3.99E-13;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp283773_c0_seq1;GAXK01016721.1;P18488;1.31E-27;EMS_DROME;Homeotic protein empty spiracles;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]";"GO:0000977; GO:0000978; GO:0000980; GO:0001700; GO:0003700; GO:0005634; GO:0007389; GO:0007409; GO:0007419; GO:0007420; GO:0007424; GO:0010468; GO:0014019; GO:0030154; GO:0035277; GO:0035284; GO:0035288; GO:0043565; GO:0045944; GO:0048813";"anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2837798_c0_seq1;GAXK01130969.1;Q95L11;2.63E-70;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp2837817_c0_seq1;GAXK01130993.1;Q90703;1.41E-37;NOS2_CHICK;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (Macrophage NOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0031284; GO:0032310; GO:0032496; GO:0042742; GO:0045776; GO:0046872; GO:0050660; GO:0050661; GO:0072604; GO:0072606; GO:1900015";"arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp2838_c0_seq1;GAXK01175671.1;Q6P5E4;0;UGGG1_MOUSE;UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0051082; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; protein-containing complex [GO:0032991]";"UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]"
comp2838419_c0_seq1;GAXK01021404.1;Q8NFZ3;3.59E-20;NLGNY_HUMAN;Neuroligin-4, Y-linked (Neuroligin Y);"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0014069; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054";"learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp28390_c0_seq1;GAXK01051735.1;Q3T1J8;1.15E-46;RTF2_RAT;Replication termination factor 2 (RTF2) (Replication termination factor 2 domain-containing protein 1);"nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]";"GO:0003677; GO:0005634; GO:0005657; GO:0071171; GO:0072711; GO:0097752; GO:1902979";"cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]";"nucleus [GO:0005634]; replication fork [GO:0005657]";DNA binding [GO:0003677]
comp283944_c2_seq1;GAXK01016662.1;O75629;3.69E-39;CREG1_HUMAN;Protein CREG1 (Cellular repressor of E1A-stimulated genes 1);"azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription factor complex [GO:0005667]; cofactor binding [GO:0048037]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003714; GO:0005576; GO:0005615; GO:0005667; GO:0006357; GO:0007275; GO:0008134; GO:0035578; GO:0040008; GO:0043312; GO:0048037; GO:0070062";"multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription factor complex [GO:0005667]";"cofactor binding [GO:0048037]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp2840_c1_seq1;GAXK01175494.1;Q0VFM0;2.88E-61;ZFPL1_XENTR;Zinc finger protein-like 1;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0016021; GO:0016192; GO:0046872";vesicle-mediated transport [GO:0016192];"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";metal ion binding [GO:0046872]
comp2840050_c0_seq1;GAXK01002590.1;O35956;8.47E-33;S22A6_RAT;Solute carrier family 22 member 6 (Organic anion transporter 1) (rOAT1) (renal organic anion transporter 1) (rROAT1);"basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]";"GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042803; GO:0043252; GO:0051260; GO:0097254";"alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]";"basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]"
comp2840128_c0_seq1;GAXK01002587.1;Q6PAV8;8.30E-58;MACD2_XENLA;ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-);"nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]";"GO:0005634; GO:0006974; GO:0016798; GO:0051725; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]";nucleus [GO:0005634];"ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]"
comp284061_c5_seq1;GAXK01156046.1;Q14590;5.77E-16;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp284081_c1_seq1;GAXK01156055.1;Q9ULJ7;9.93E-08;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp2841281_c0_seq1;GAXK01002595.1;Q23983;2.30E-09;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp284179_c0_seq1;GAXK01156038.1;Q8N9F8;4.97E-45;ZN454_HUMAN;Zinc finger protein 454;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp284185_c0_seq1;GAXK01156084.1;Q9JJ57;4.37E-38;KCIP1_MOUSE;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]; positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0034705; GO:0043025; GO:0044325; GO:0045760; GO:0046982; GO:0047485; GO:1901379";"positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]"
comp284209_c0_seq1;GAXK01156156.1;Q7ZVG6;2.65E-10;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp284226_c1_seq1;GAXK01156203.1;Q28Z18;1.30E-90;SETB1_DROPS;Histone-lysine N-methyltransferase eggless (EC 2.1.1.43) (SETDB1 homolog);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038";"multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]"
comp284249_c0_seq1;GAXK01156165.1;O97951;9.77E-52;UDB18_MACFA;UDP-glucuronosyltransferase 2B18 (UDPGT 2B18) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp2843103_c0_seq1;GAXK01035683.1;Q866F0;4.68E-17;FUT1_SAIBB;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp284362_c0_seq1;GAXK01156190.1;P93748;5.99E-12;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp2843804_c0_seq1;GAXK01035685.1;A0JMG1;3.36E-16;SPOLB_DANRE;Speckle-type POZ protein-like B (HIB homolog 3);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp2844_c1_seq1;GAXK01175651.1;Q9CX56;6.80E-92;PSMD8_MOUSE;26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14);"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0005829; GO:0008541; GO:0022624; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]";
comp284426_c1_seq1;GAXK01156060.1;Q54DV3;6.78E-70;Y2016_DICDI;von Willebrand factor A domain-containing protein DDB_G0292016;;;;;
comp28443_c0_seq1;GAXK01051790.1;Q8T9B6;2.77E-49;MESD_DROME;LDLR chaperone boca;"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";identical protein binding [GO:0042802]
comp284459_c1_seq1;GAXK01156179.1;A0FKN6;3.16E-28;VMPA_LOXIN;Astacin-like metalloprotease toxin 1 (EC 3.4.24.-) (Loxosceles astacin-like protease 1) (LALP) (LALP1);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270; GO:0090729";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]"
comp284467_c0_seq1;GAXK01156100.1;G5EGM1;7.16E-11;MMPA_CAEEL;Matrix metalloproteinase-A (MMP-A) (MMP-Y19) (EC 3.4.24.-) (Zinc metalloprotease 1);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; basement membrane disassembly [GO:0034769]; collagen catabolic process [GO:0030574]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]";"GO:0004222; GO:0007368; GO:0008237; GO:0008270; GO:0009986; GO:0016021; GO:0016323; GO:0030198; GO:0030574; GO:0031012; GO:0034769";"basement membrane disassembly [GO:0034769]; collagen catabolic process [GO:0030574]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp28447_c0_seq1;GAXK01051835.1;O08908;2.00E-113;P85B_MOUSE;Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta);"focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0001678; GO:0001784; GO:0005634; GO:0005925; GO:0005942; GO:0008134; GO:0008286; GO:0010506; GO:0014065; GO:0015031; GO:0019903; GO:0030833; GO:0030971; GO:0032869; GO:0034976; GO:0036312; GO:0042307; GO:0043409; GO:0043551; GO:0045785; GO:0045944; GO:0046854; GO:0046935; GO:0046982; GO:0051492; GO:0090051; GO:1903076";"cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]";"focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]";"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]"
comp2844883_c0_seq1;GAXK01109158.1;P41753;2.98E-34;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp2845775_c0_seq1;GAXK01109138.1;P81908;2.36E-15;CHLE_HORSE;Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase);"extracellular region [GO:0005576]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]";"GO:0003990; GO:0004104; GO:0005576";;extracellular region [GO:0005576];"acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]"
comp2846_c0_seq1;GAXK01175733.1;Q4R4F8;4.18E-10;SMN_MACFA;Survival motor neuron protein;"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006353; GO:0007399; GO:0015030; GO:0030018; GO:0032797; GO:0034719; GO:0036464; GO:0043005; GO:0043204; GO:0097504";"DNA-templated transcription, termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal snRNP assembly [GO:0000387]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018]";RNA binding [GO:0003723]
comp2846473_c0_seq1;GAXK01077621.1;P10076;1.49E-37;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2846920_c0_seq1;GAXK01077628.1;Q8TF40;2.96E-10;FNIP1_HUMAN;Folliculin-interacting protein 1;"cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";"GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0009267; GO:0010823; GO:0031334; GO:0031929; GO:0032007; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:1904262; GO:2000973";"cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";cytoplasm [GO:0005737];"ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; guanyl-nucleotide exchange factor activity [GO:0005085]"
comp28470_c0_seq1;GAXK01051382.1;Q9JI92;2.21E-107;SDCB1_RAT;Syntenin-1 (Syndecan-binding protein 1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"GO:0002091; GO:0005137; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0008289; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042470; GO:0042803; GO:0045121; GO:0045545; GO:0046875; GO:0046982; GO:0050839; GO:0070062; GO:0099054";"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]"
comp28471_c2_seq1;GAXK01051512.1;Q7PZ25;4.57E-58;DCTN2_ANOGA;Dynactin subunit 2 (Dynactin 2 p50 subunit);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; motor activity [GO:0003774]; cell population proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]";"GO:0000278; GO:0003774; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0008283; GO:0016020; GO:0030286; GO:0031982";"cell population proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]";motor activity [GO:0003774]
comp2847283_c0_seq1;GAXK01077623.1;Q9FLF0;3.07E-73;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp28473_c0_seq1;GAXK01051370.1;Q24134;0;NELFD_DROME;Negative elongation factor D;"NELF complex [GO:0032021]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]";"GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244";"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]";"NELF complex [GO:0032021]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcriptional repressor complex [GO:0017053]; transcription elongation factor complex [GO:0008023]";RNA binding [GO:0003723]
comp2847636_c0_seq1;GAXK01077633.1;O35595;8.04E-18;PTC2_MOUSE;Protein patched homolog 2 (PTC2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0008544; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0097108";"cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp28480_c2_seq1;GAXK01051288.1;Q66S03;8.61E-14;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp284839_c0_seq1;GAXK01156178.1;Q2M3R5;3.96E-12;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp28489_c0_seq1;GAXK01051874.1;Q8K158;1.85E-47;CNPD1_MOUSE;Protein CNPPD1;"integral component of membrane [GO:0016021]; protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0016021; GO:0019901";regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079];integral component of membrane [GO:0016021];protein kinase binding [GO:0019901]
comp2849072_c0_seq1;GAXK01009791.1;Q6GPI1;4.45E-09;CTRB2_HUMAN;"Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp28494_c0_seq1;GAXK01051624.1;Q32LG5;5.86E-25;REEP6_BOVIN;Receptor expression-enhancing protein 6;"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp2849872_c0_seq1;GAXK01009785.1;Q5R5M1;1.01E-08;PRDM4_PONAB;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005634; GO:0006366; GO:0008168; GO:0046872; GO:1990226";transcription by RNA polymerase II [GO:0006366];nucleus [GO:0005634];"DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp285_c0_seq1;GAXK01166217.1;Q5R9I9;1.27E-58;NACA_PONAB;Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC);"nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein transport [GO:0015031]";"GO:0003677; GO:0005634; GO:0005854; GO:0015031";protein transport [GO:0015031];"nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp28501_c0_seq1;GAXK01052128.1;P36362;6.53E-18;CHIT_MANSE;Endochitinase (EC 3.2.1.14);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp285028_c5_seq1;GAXK01156211.1;Q9VXD9;5.36E-15;MTH1_DROME;Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252";"actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp28504_c2_seq1;GAXK01051737.1;Q4R6P2;6.75E-52;RWD2A_MACFA;RWD domain-containing protein 2A;;;;;
comp28505_c3_seq1;GAXK01052212.1;Q27433;1.13E-87;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp285055_c1_seq1;GAXK01156071.1;Q15036;6.05E-134;SNX17_HUMAN;Sorting nexin-17;"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]";"GO:0003279; GO:0005102; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006707; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0016020; GO:0016197; GO:0030100; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976; GO:1990126";"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]";"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]";"low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]"
comp2850662_c0_seq1;GAXK01135991.1;Q7KRI2;2.88E-35;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2850726_c0_seq1;GAXK01135988.1;Q28658;7.06E-13;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp285094_c2_seq1;GAXK01156198.1;B9EJR8;9.08E-62;DAAF5_MOUSE;Dynein assembly factor 5, axonemal (HEAT repeat-containing protein 2);"cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005737; GO:0036158; GO:0036159; GO:0045505";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]";cytoplasm [GO:0005737];dynein intermediate chain binding [GO:0045505]
comp2851050_c0_seq1;GAXK01135989.1;Q7ZV82;2.35E-48;RL27_DANRE;60S ribosomal protein L27;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; erythrocyte differentiation [GO:0030218]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0030218; GO:0098556";"erythrocyte differentiation [GO:0030218]; translation [GO:0006412]";"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp285176_c0_seq1;GAXK01156109.1;Q66S03;4.33E-08;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp28518_c0_seq1;GAXK01051870.1;Q9Y4G6;0;TLN2_HUMAN;Talin-2;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"GO:0001726; GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007016; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015";"cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp2851986_c0_seq1;GAXK01135990.1;P62318;1.52E-07;SMD3_HUMAN;Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3);"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U7 snRNA binding [GO:0071209]; histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0006369; GO:0006479; GO:0008334; GO:0008380; GO:0016604; GO:0019899; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0051170; GO:0070034; GO:0071005; GO:0071007; GO:0071013; GO:0071208; GO:0071209; GO:1990446";"histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]";"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]";"enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U7 snRNA binding [GO:0071209]"
comp2852061_c1_seq1;GAXK01101775.1;Q5R5X9;2.60E-16;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp2852346_c0_seq1;GAXK01101778.1;O13769;7.53E-21;ULP2_SCHPO;Ubiquitin-like-specific protease 2 (EC 3.4.22.-);"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"GO:0005634; GO:0010494; GO:0016926; GO:0070140; GO:0070647; GO:2000765";"protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp28528_c1_seq1;GAXK01051746.1;P41241;1.66E-152;CSK_MOUSE;Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase MPK-2) (p50CSK);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863]";"GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008285; GO:0010989; GO:0016740; GO:0019903; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050863; GO:0060368; GO:0070064; GO:0070373; GO:0071375";"adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]"
comp2852831_c0_seq1;GAXK01101766.1;Q91YK0;5.80E-52;LRC49_MOUSE;Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4) (p79);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; outer dynein arm assembly [GO:0036158]; protein polyglutamylation [GO:0018095]";"GO:0005737; GO:0005829; GO:0005874; GO:0018095; GO:0036158";"outer dynein arm assembly [GO:0036158]; protein polyglutamylation [GO:0018095]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]";
comp28535_c1_seq1;GAXK01051949.1;B4MYI5;0;BOP1_DROWI;Ribosome biogenesis protein BOP1 homolog;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0043021";"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]";ribonucleoprotein complex binding [GO:0043021]
comp28537_c2_seq1;GAXK01051576.1;Q9HCN4;7.78E-47;GPN1_HUMAN;GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp2853833_c0_seq1;GAXK01101786.1;P29563;7.46E-14;BACR2_HALS2;Archaerhodopsin-2 (AR 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005216; GO:0005886; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]"
comp2854000_c0_seq1;GAXK01154646.1;Q6NWH0;2.77E-33;CK068_DANRE;UPF0696 protein C11orf68 homolog;;;;;
comp285440_c1_seq1;GAXK01156166.1;Q9ULJ7;0;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp285505_c0_seq1;GAXK01156125.1;Q6AXF6;2.04E-43;SIDT1_MOUSE;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp2855079_c0_seq1;GAXK01154657.1;A0A0R4I9Y1;1.66E-09;R213B_DANRE;E3 ubiquitin-protein ligase rnf213-beta (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-B) (Mysterin-beta) (RING finger protein 213-B) (RING finger protein 213-beta) (RING-type E3 ubiquitin transferase rnf213-beta);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005829; GO:0006511; GO:0016887; GO:0046872";ubiquitin-dependent protein catabolic process [GO:0006511];cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp285540_c2_seq1;GAXK01156144.1;Q5JVG8;7.74E-07;ZN506_HUMAN;Zinc finger protein 506;"nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleolus [GO:0005730];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp28555_c3_seq1;GAXK01051962.1;Q0V9J5;2.08E-35;EIF1A_XENTR;Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein);"nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0005634";;nucleus [GO:0005634];translation initiation factor activity [GO:0003743]
comp285564_c0_seq1;GAXK01156110.1;Q94051;1.32E-14;CAV1_CAEEL;Caveolin-1;"caveola [GO:0005901]; cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; caveola assembly [GO:0070836]; meiotic cell cycle [GO:0051321]; Ras protein signal transduction [GO:0007265]; regulation of oviposition [GO:0046662]";"GO:0000139; GO:0005198; GO:0005887; GO:0005901; GO:0005938; GO:0007265; GO:0009898; GO:0030133; GO:0045121; GO:0046662; GO:0048471; GO:0051321; GO:0060090; GO:0060473; GO:0070836";"caveola assembly [GO:0070836]; meiotic cell cycle [GO:0051321]; Ras protein signal transduction [GO:0007265]; regulation of oviposition [GO:0046662]";"caveola [GO:0005901]; cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]";"molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]"
comp2856_c0_seq1;GAXK01175690.1;P24862;4.94E-98;CCNB_PATVU;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp285618_c1_seq1;GAXK01156098.1;P64918;9.12E-81;Y2023_MYCBO;Uncharacterized protein Mb2023;;;;;
comp2856209_c0_seq1;GAXK01064401.1;P0C6B8;5.44E-07;SVEP1_RAT;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";calcium ion binding [GO:0005509]
comp285637_c0_seq1;GAXK01156205.1;P0CY33;2.62E-23;CDC42_CANAL;Cell division control protein 42 homolog;"cell cortex [GO:0005938]; cell projection [GO:0042995]; cell septum [GO:0030428]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytoplasm [GO:0005737]; hyphal tip [GO:0001411]; hyphal tip polarisome [GO:0031562]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spitzenkorper [GO:0031521]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell budding [GO:0007114]; cell cycle [GO:0007049]; cell growth mode switching, budding to filamentous [GO:0036187]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; hyphal growth [GO:0030448]; pathogenesis [GO:0009405]; positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:1900445]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; septum digestion after cytokinesis [GO:0000920]";"GO:0000902; GO:0000920; GO:0001411; GO:0001558; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005934; GO:0005935; GO:0005938; GO:0006897; GO:0007015; GO:0007049; GO:0007114; GO:0007163; GO:0007266; GO:0008360; GO:0009405; GO:0016020; GO:0019901; GO:0030010; GO:0030031; GO:0030036; GO:0030428; GO:0030447; GO:0030448; GO:0031521; GO:0031562; GO:0032488; GO:0032956; GO:0036180; GO:0036187; GO:0042995; GO:0044182; GO:1900445";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell budding [GO:0007114]; cell cycle [GO:0007049]; cell growth mode switching, budding to filamentous [GO:0036187]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; hyphal growth [GO:0030448]; pathogenesis [GO:0009405]; positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:1900445]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; septum digestion after cytokinesis [GO:0000920]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cell septum [GO:0030428]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytoplasm [GO:0005737]; hyphal tip [GO:0001411]; hyphal tip polarisome [GO:0031562]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spitzenkorper [GO:0031521]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp28565_c1_seq1;GAXK01051638.1;Q56WF8;2.53E-105;SCP48_ARATH;Serine carboxypeptidase-like 48 (EC 3.4.16.-);"extracellular region [GO:0005576]; vacuole [GO:0005773]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004185; GO:0005576; GO:0005773; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular region [GO:0005576]; vacuole [GO:0005773]";serine-type carboxypeptidase activity [GO:0004185]
comp2856828_c0_seq1;GAXK01064400.1;P13418;1.31E-21;POLS_CRPVC;"Structural polyprotein [Cleaved into: Capsid protein 1 (CP1); Capsid protein 4 (CP4); Capsid protein 2 (CP2); Capsid protein 3 (CP3)]";"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028; GO:0030430";;"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]";structural molecule activity [GO:0005198]
comp2857005_c0_seq1;GAXK01064374.1;P17031;2.27E-11;ZNF26_HUMAN;Zinc finger protein 26 (Zinc finger protein KOX20);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp2857029_c0_seq1;GAXK01064395.1;P00918;3.40E-23;CAH2_HUMAN;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0015701; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070062; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp2857158_c0_seq1;GAXK01064370.1;P41436;3.54E-26;IAP_GVCPM;Apoptosis inhibitor IAP;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp2857784_c0_seq1;GAXK01064403.1;Q9NUQ8;0;ABCF3_HUMAN;ATP-binding cassette sub-family F member 3;"membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]";"GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607";defense response to virus [GO:0051607];membrane [GO:0016020];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]"
comp2857887_c0_seq1;GAXK01064377.1;Q3UPC7;5.77E-27;K0825_MOUSE;Uncharacterized protein KIAA0825 homolog;;;;;
comp285808_c0_seq1;GAXK01156122.1;Q5WRU0;3.02E-21;OIG4_CAEEL;Immunoglobulin domain-containing protein oig-4;"cell junction [GO:0030054]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]";"GO:0005615; GO:0030054; GO:0031594";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]";
comp2858133_c0_seq1;GAXK01108633.1;Q9JME2;4.46E-13;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp285833_c1_seq1;GAXK01156097.1;F2T1C4;4.92E-40;MDR2_TRIRC;ABC multidrug transporter MDR2 (Multidrug resistance protein 2);"fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]";"GO:0000324; GO:0005524; GO:0005886; GO:0006855; GO:0016021; GO:0016887; GO:0042626; GO:0140115";"drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]";"fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp285845_c2_seq1;GAXK01156051.1;Q9QX15;1.86E-89;CA3A1_MOUSE;Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-);"integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]";"GO:0005229; GO:0005887; GO:0006821; GO:0008237; GO:0046872";chloride transport [GO:0006821];integral component of plasma membrane [GO:0005887];"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2858815_c0_seq1;GAXK01108652.1;Q8VHL1;1.48E-55;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp2858894_c0_seq1;GAXK01108650.1;A8Y9I2;7.19E-07;NINAB_GALME;Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B);"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]";"GO:0004497; GO:0016702; GO:0042572; GO:0046872";retinol metabolic process [GO:0042572];;"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp285921_c0_seq1;GAXK01156102.1;Q6DCZ7;4.28E-36;FBP1L_XENLA;Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1);"cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; autophagy [GO:0006914]; endocytosis [GO:0006897]";"GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006914; GO:0008289; GO:0031410";"autophagy [GO:0006914]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp285931_c1_seq1;GAXK01156153.1;P20456;1.36E-51;IMPA1_BOVIN;Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1);"cytoplasm [GO:0005737]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";"GO:0000287; GO:0005737; GO:0006021; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834";"inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]"
comp286_c0_seq1;GAXK01166118.1;Q9XZ71;1.75E-48;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp2860011_c0_seq1;GAXK01189611.1;Q14028;1.56E-41;CNGB1_HUMAN;Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"ciliary membrane [GO:0060170]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0000139; GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0007608; GO:0015276; GO:0016056; GO:0017071; GO:0022400; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0043195; GO:0045494; GO:0050908; GO:0051290; GO:0051480; GO:0060170; GO:1902495";"cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]"
comp2860136_c0_seq1;GAXK01189584.1;Q19038;1.92E-07;DEL1_CAEEL;Degenerin del-1;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]";"GO:0005272; GO:0016021";;integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp286055_c0_seq1;GAXK01058167.1;P18488;1.53E-31;EMS_DROME;Homeotic protein empty spiracles;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]";"GO:0000977; GO:0000978; GO:0000980; GO:0001700; GO:0003700; GO:0005634; GO:0007389; GO:0007409; GO:0007419; GO:0007420; GO:0007424; GO:0010468; GO:0014019; GO:0030154; GO:0035277; GO:0035284; GO:0035288; GO:0043565; GO:0045944; GO:0048813";"anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2860775_c0_seq1;GAXK01189588.1;P39057;3.25E-109;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp286107_c0_seq1;GAXK01058129.1;Q8GYS4;7.37E-21;AVT1D_ARATH;Amino acid transporter AVT1D (AtAvt1D);"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]";"GO:0003333; GO:0005774; GO:0015171; GO:0016021";amino acid transmembrane transport [GO:0003333];"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";amino acid transmembrane transporter activity [GO:0015171]
comp2861423_c0_seq1;GAXK01189597.1;P81018;1.59E-14;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp2861496_c0_seq1;GAXK01189585.1;Q6IP59;7.36E-09;CTL2_XENLA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp286151_c0_seq1;GAXK01058052.1;Q24174;1.25E-15;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp28618_c1_seq1;GAXK01051402.1;Q90ZK6;1.24E-109;ACVR1_CHICK;Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor);"activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]";"GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003203; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005524; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007389; GO:0007498; GO:0007507; GO:0009968; GO:0010694; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0043235; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060389; GO:0060412; GO:0060923; GO:0061312; GO:0061445; GO:0071773; GO:0098821; GO:1905007; GO:2000017; GO:2001237";"activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]";"activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235]";"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"
comp286202_c0_seq1;GAXK01058114.1;Q25008;2.33E-85;TBA1_HOMAM;Tubulin alpha-1 chain (Alpha-I tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2862360_c0_seq1;GAXK01063551.1;Q90953;1.51E-29;CSPG2_CHICK;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Large fibroblast proteoglycan) (PG-M);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp286245_c0_seq1;GAXK01058091.1;Q810T5;8.76E-161;KAT7_RAT;Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2);"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000123; GO:0000790; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0008270; GO:0010485; GO:0018393; GO:0042393; GO:0043161; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045892; GO:0045944";"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]"
comp2862672_c0_seq1;GAXK01063554.1;Q9N003;2.05E-11;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp286306_c0_seq1;GAXK01058191.1;Q3KR37;3.44E-23;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp286332_c0_seq1;GAXK01058101.1;O45782;1.39E-47;ARD17_CAEEL;Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1);"protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]";"GO:0007610; GO:0030346";behavior [GO:0007610];;protein phosphatase 2B binding [GO:0030346]
comp2863346_c0_seq1;GAXK01063557.1;Q63HQ2;2.64E-15;EGFLA_HUMAN;Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein);"basement membrane [GO:0005604]; cell junction [GO:0030054]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009887; GO:0009888; GO:0010811; GO:0016477; GO:0019800; GO:0030054; GO:0030198; GO:0034446; GO:0045202";"animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; interstitial matrix [GO:0005614]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]"
comp28634_c0_seq1;GAXK01052183.1;Q8IZ83;1.19E-127;A16A1_HUMAN;Aldehyde dehydrogenase family 16 member A1;"membrane [GO:0016020]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]";"GO:0016020; GO:0016620";;membrane [GO:0016020];oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]
comp28635_c0_seq1;GAXK01051832.1;Q7K0E3;1.20E-128;MOB4_DROME;MOB kinase activator-like 4 (Mob as tumor suppressor protein 4) (Dmob4) (Mps one binder kinase activator-like 4);"cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; terminal bouton [GO:0043195]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; axo-dendritic transport [GO:0008088]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron projection morphogenesis [GO:0048812]; positive regulation of Ras protein signal transduction [GO:0046579]";"GO:0000226; GO:0005829; GO:0008088; GO:0019901; GO:0035331; GO:0043195; GO:0045886; GO:0046579; GO:0046872; GO:0048812; GO:0090307; GO:0090443";"axo-dendritic transport [GO:0008088]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron projection morphogenesis [GO:0048812]; positive regulation of Ras protein signal transduction [GO:0046579]";"cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; terminal bouton [GO:0043195]";"metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]"
comp2863519_c0_seq1;GAXK01063556.1;P16066;9.97E-16;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp2863606_c0_seq1;GAXK01063566.1;Q96MR6;4.58E-40;CFA57_HUMAN;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp2864_c1_seq1;GAXK01176021.1;Q7KRI2;3.07E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp28643_c0_seq1;GAXK01051582.1;P15215;0;LAMC1_DROME;Laminin subunit gamma-1 (Laminin B2 chain);"basement membrane [GO:0005604]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005604; GO:0007435; GO:0007494; GO:0009887; GO:0009888; GO:0016477; GO:0033627; GO:0034446; GO:0061031; GO:0070831; GO:0071711; GO:0085029";"animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";basement membrane [GO:0005604];
comp286437_c0_seq1;GAXK01058085.1;P04630;1.07E-09;CALL_CAEEL;Calmodulin-like protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp286505_c0_seq1;GAXK01058195.1;P79143;2.19E-26;AMPN_CANLF;Aminopeptidase N (AP-N) (cAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13);"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0001525; GO:0001618; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006; GO:0070062";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"
comp2866662_c0_seq1;GAXK01198749.1;P35992;8.88E-139;PTP10_DROME;Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D);"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446";"axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]";"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp2866716_c0_seq1;GAXK01198731.1;P57695;2.04E-25;GLRA1_BOVIN;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp2866927_c0_seq1;GAXK01198743.1;P52186;8.05E-31;KCNJ2_CHICK;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]";inward rectifier potassium channel activity [GO:0005242]
comp286724_c0_seq1;GAXK01058087.1;Q6Q473;1.41E-52;CLA4A_MOUSE;"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]";"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872";chloride transport [GO:0006821];"apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp286736_c2_seq1;GAXK01058161.1;A0ZSK4;2.16E-13;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp2867518_c0_seq1;GAXK01198751.1;P0A2X3;6.77E-08;EXOA_STRPN;Exodeoxyribonuclease (EC 3.1.11.2);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]";"GO:0003677; GO:0004519; GO:0005737; GO:0006281; GO:0008853; GO:0046872";DNA repair [GO:0006281];cytoplasm [GO:0005737];"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]"
comp286764_c0_seq1;GAXK01058111.1;P05933;1.70E-36;CALM_SCHPO;Calmodulin (CaM);"cell division site [GO:0032153]; central plaque of mitotic spindle pole body [GO:0061493]; central plaque of spindle pole body [GO:0005823]; cytosol [GO:0005829]; division septum [GO:0000935]; growing cell tip [GO:0035838]; mating projection tip [GO:0043332]; meiotic spindle pole body [GO:0035974]; mitotic spindle pole body [GO:0044732]; myosin I complex [GO:0045160]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; calcium ion binding [GO:0005509]; ascospore formation [GO:0030437]; ascospore-type prospore-specific spindle pole body remodeling [GO:0031322]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to meiotic spindle pole body [GO:1990954]; mitotic spindle assembly [GO:0090307]; spindle pole body organization [GO:0051300]";"GO:0000935; GO:0005509; GO:0005634; GO:0005823; GO:0005829; GO:0019722; GO:0030437; GO:0031322; GO:0032153; GO:0035838; GO:0035840; GO:0035841; GO:0035974; GO:0043332; GO:0044732; GO:0045160; GO:0051300; GO:0061493; GO:0090307; GO:1990954";"ascospore formation [GO:0030437]; ascospore-type prospore-specific spindle pole body remodeling [GO:0031322]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to meiotic spindle pole body [GO:1990954]; mitotic spindle assembly [GO:0090307]; spindle pole body organization [GO:0051300]";"cell division site [GO:0032153]; central plaque of mitotic spindle pole body [GO:0061493]; central plaque of spindle pole body [GO:0005823]; cytosol [GO:0005829]; division septum [GO:0000935]; growing cell tip [GO:0035838]; mating projection tip [GO:0043332]; meiotic spindle pole body [GO:0035974]; mitotic spindle pole body [GO:0044732]; myosin I complex [GO:0045160]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]";calcium ion binding [GO:0005509]
comp2867735_c0_seq1;GAXK01198745.1;Q9Z1Y4;3.41E-21;TRIP6_MOUSE;Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Zyxin-related protein 1) (ZRP-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0001725; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0019900; GO:0030335; GO:0046872; GO:1901224";"cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]"
comp286784_c0_seq1;GAXK01058106.1;Q96N64;4.23E-16;PWP2A_HUMAN;PWWP domain-containing protein 2A;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]";"GO:0003682; GO:0005634; GO:0042393";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone binding [GO:0042393]"
comp28679_c0_seq1;GAXK01051628.1;Q8AVS8;1.06E-24;LRC59_XENLA;Leucine-rich repeat-containing protein 59;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";"GO:0005635; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";
comp286793_c0_seq1;GAXK01058145.1;Q8S3N1;4.19E-11;SINA5_ARATH;E3 ubiquitin-protein ligase SINAT5 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT5) (Seven in absentia homolog 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp28680_c0_seq1;GAXK01051877.1;Q14151;3.71E-35;SAFB2_HUMAN;Scaffold attachment factor B2 (SAF-B2);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]";"GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062";"regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]"
comp28685_c1_seq1;GAXK01051239.1;Q8MJ14;5.84E-51;GPX1_PIG;Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; glutathione metabolic process [GO:0006749]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]; response to selenium ion [GO:0010269]";"GO:0004601; GO:0004602; GO:0005739; GO:0005829; GO:0006749; GO:0010269; GO:0042542; GO:0042744";"glutathione metabolic process [GO:0006749]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]; response to selenium ion [GO:0010269]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]"
comp286854_c0_seq1;GAXK01058105.1;Q9VZN4;5.41E-57;DAR1_DROME;Dendritic arbor reduction protein 1;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007026; GO:0043565; GO:0045944; GO:0046872; GO:0050775; GO:1903861";"negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp28688_c9_seq1;GAXK01051283.1;Q5T4S7;0;UBR4_HUMAN;E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1);"centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0070821; GO:0101003";"neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2869013_c0_seq1;GAXK01087078.1;Q18297;1.12E-12;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp286908_c1_seq1;GAXK01058174.1;Q9VU84;1.53E-14;DBNL_DROME;Drebrin-like protein (Actin binding protein 1);"axon [GO:0030424]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; terminal button organization [GO:0072553]";"GO:0001786; GO:0003779; GO:0005546; GO:0005547; GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0022416; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030864; GO:0031594; GO:0045211; GO:0045773; GO:0045887; GO:0048812; GO:0051015; GO:0061003; GO:0061176; GO:0061177; GO:0072553; GO:0098974";"chaeta development [GO:0022416]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; terminal button organization [GO:0072553]";"axon [GO:0030424]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]"
comp2869128_c0_seq1;GAXK01087077.1;Q8IWZ3;3.11E-10;ANKH1_HUMAN;Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK);"cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]";"GO:0003723; GO:0005737; GO:0045087";innate immune response [GO:0045087];cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp2869517_c0_seq1;GAXK01087087.1;P28166;1.58E-10;ZFH1_DROME;Zinc finger protein 1 (Zinc finger homeodomain protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; antimicrobial humoral response [GO:0019730]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; heart development [GO:0007507]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pole cell migration [GO:0007280]; somatic stem cell division [GO:0048103]";"GO:0000122; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0007280; GO:0007399; GO:0007498; GO:0007507; GO:0007516; GO:0008045; GO:0008354; GO:0008406; GO:0019730; GO:0046716; GO:0046872; GO:0048103; GO:0048542; GO:0051148; GO:0061321";"antimicrobial humoral response [GO:0019730]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; heart development [GO:0007507]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pole cell migration [GO:0007280]; somatic stem cell division [GO:0048103]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp287_c0_seq1;GAXK01166218.1;Q17Q06;0;EIF3C_AEDAE;Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";"translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp2870_c0_seq1;GAXK01175724.1;Q5NVR2;5.72E-153;MDHM_PONAB;Malate dehydrogenase, mitochondrial (EC 1.1.1.37);"mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0005759; GO:0005975; GO:0006099; GO:0006108; GO:0006475; GO:0009060; GO:0030060; GO:0042803";"aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];"L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]"
comp287000_c2_seq1;GAXK01058028.1;Q9TUB5;3.09E-46;CLCA1_PIG;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (pCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp287002_c0_seq1;GAXK01058248.1;B3MFV7;3.17E-73;LPHN_DROAN;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp2870497_c0_seq1;GAXK01094976.1;Q99KE8;4.74E-12;ZFP64_MOUSE;Zinc finger protein 64 (Zfp-64);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0007275; GO:0010468; GO:0032728; GO:0032755; GO:0032760; GO:0046872; GO:0048026";"multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp287066_c0_seq1;GAXK01058179.1;Q17232;2.59E-59;OAR_BOMMO;Octopamine receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp2870917_c0_seq1;GAXK01094975.1;Q6DHG0;3.51E-09;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp287095_c1_seq1;GAXK01058131.1;Q9IA88;5.02E-114;SIK2_CHICK;Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0031588; GO:0032007; GO:0035556; GO:0042149; GO:0046626";"cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp28711_c0_seq1;GAXK01051822.1;Q03042;0;KGP1_DROME;cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; larval somatic muscle development [GO:0007526]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007526; GO:0018105; GO:0030553";"larval somatic muscle development [GO:0007526]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp2871842_c0_seq1;GAXK01094965.1;Q6ZMT1;6.34E-09;STAC2_HUMAN;SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005829; GO:0031234; GO:0035556; GO:0042383; GO:0046872; GO:1901387; GO:1903078";"intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]";metal ion binding [GO:0046872]
comp2872239_c0_seq1;GAXK01154882.1;P70665;1.50E-77;SIAE_MOUSE;"Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]";"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"GO:0001681; GO:0002682; GO:0005764; GO:0005975";"carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp2872374_c0_seq1;GAXK01154877.1;Q93560;1.93E-22;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp2872512_c0_seq1;GAXK01154868.1;Q32PL8;1.68E-07;PRIPO_DANRE;DNA-directed primase/polymerase protein (EC 2.7.7.-) (Coiled-coil domain-containing protein 111 homolog);"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0031297";"mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA primase activity [GO:0003896]"
comp287271_c0_seq1;GAXK01058088.1;Q9D1G2;7.03E-65;PMVK_MOUSE;Phosphomevalonate kinase (PMKase) (EC 2.7.4.2);"cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]";"GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0016126; GO:0019287; GO:0070723";"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]"
comp2872849_c0_seq1;GAXK01154864.1;Q9VW60;1.50E-107;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp287306_c0_seq1;GAXK01058230.1;B5DEL3;6.04E-59;TTC17_RAT;Tetratricopeptide repeat protein 17 (TPR repeat protein 17);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]";"GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782";"actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp2873458_c0_seq1;GAXK01154881.1;Q5ZKI6;3.19E-34;GXLT1_CHICK;Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3);"integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0016021; GO:0016266; GO:0035252";O-glycan processing [GO:0016266];integral component of membrane [GO:0016021];UDP-xylosyltransferase activity [GO:0035252]
comp2873574_c0_seq1;GAXK01154867.1;Q03963;2.31E-17;E2AK2_MOUSE;Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]; cellular response to amino acid starvation [GO:0034198]; defense response to virus [GO:0051607]; endoplasmic reticulum unfolded protein response [GO:0030968]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to interferon-alpha [GO:0035455]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin E [GO:0033197]; translation [GO:0006412]";"GO:0000186; GO:0001819; GO:0003725; GO:0004672; GO:0004694; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006468; GO:0009615; GO:0009636; GO:0017148; GO:0022626; GO:0030968; GO:0032496; GO:0032722; GO:0032874; GO:0033197; GO:0033689; GO:0034198; GO:0035455; GO:0042802; GO:0043065; GO:0043066; GO:0045071; GO:0045087; GO:0046777; GO:0048471; GO:0051092; GO:0051607; GO:1900225; GO:1901224; GO:1901532; GO:1902033; GO:1902036";"activation of MAPKK activity [GO:0000186]; cellular response to amino acid starvation [GO:0034198]; defense response to virus [GO:0051607]; endoplasmic reticulum unfolded protein response [GO:0030968]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to interferon-alpha [GO:0035455]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin E [GO:0033197]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]"
comp2873576_c0_seq1;GAXK01154863.1;Q94900;2.93E-24;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp2873599_c0_seq1;GAXK01154872.1;Q01082;1.08E-23;SPTB2_HUMAN;Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1);"axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]";"GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032991; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1900042; GO:1903076; GO:1903078";"actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]";"axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]";"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]"
comp2873910_c0_seq1;GAXK01154879.1;Q9VEN1;2.81E-62;FLNA_DROME;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1);"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495";"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp2874029_c0_seq1;GAXK01018834.1;Q5M7E1;1.44E-33;CLVS1_XENLA;Clavesin-1 (Retinaldehyde-binding protein 1-like 1);"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]";"GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0080025";lysosome organization [GO:0007040];"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]";phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]
comp2874113_c0_seq1;GAXK01018824.1;B8V7S0;2.26E-24;CPP1_ACRMI;CUB and peptidase domain-containing protein 1 (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp2874191_c0_seq1;GAXK01018830.1;O14718;3.52E-16;OPSX_HUMAN;Visual pigment-like receptor peropsin;"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0001750; GO:0004930; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]";"G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]"
comp2874516_c0_seq1;GAXK01018819.1;P23286;1.59E-19;CALM_CANAX;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp2874632_c0_seq1;GAXK01018832.1;Q86TJ5;9.90E-17;ZN554_HUMAN;Zinc finger protein 554;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2875326_c0_seq1;GAXK01018816.1;O01382;8.31E-13;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp2875367_c0_seq1;GAXK01018815.1;Q24JV9;7.57E-15;L3BPA_DANRE;Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A);"extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]";"GO:0005044; GO:0005576; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"extracellular region [GO:0005576]; membrane [GO:0016020]";scavenger receptor activity [GO:0005044]
comp2875468_c0_seq1;GAXK01018822.1;Q9VZW5;4.70E-22;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp2875490_c0_seq1;GAXK01018825.1;M0R8U1;2.59E-59;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp287620_c0_seq1;GAXK01058095.1;Q1MX18;1.23E-30;INSC_HUMAN;Protein inscuteable homolog;"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp2876325_c0_seq1;GAXK01180302.1;Q8INI8;1.00E-67;HSP72_DROME;Major heat shock 70 kDa protein Ba (Heat shock protein 70Ba) (HSP70-87C1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; heat shock-mediated polytene chromosome puffing [GO:0035080]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to unfolded protein [GO:0006986]";"GO:0001666; GO:0005524; GO:0005737; GO:0005829; GO:0006986; GO:0009408; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0035080; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; heat shock-mediated polytene chromosome puffing [GO:0035080]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp28777_c0_seq1;GAXK01051511.1;Q9VJQ4;3.74E-102;MCES_DROME;mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (mRNA (guanine-N(7)-)-methyltransferase);"nucleus [GO:0005634]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]";"GO:0003723; GO:0004482; GO:0005634; GO:0006370";7-methylguanosine mRNA capping [GO:0006370];nucleus [GO:0005634];"mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]"
comp287790_c0_seq1;GAXK01058150.1;Q9UBX3;2.54E-62;DIC_HUMAN;Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0070221; GO:0071422; GO:0071423";"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]"
comp287818_c0_seq1;GAXK01058168.1;P20350;1.99E-51;RHOM_DROME;Protein rhomboid (EC 3.4.21.105) (Protein veinlet);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0006508; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0038005; GO:0042058; GO:0042327; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317; GO:0098609";"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]";serine-type endopeptidase activity [GO:0004252]
comp287860_c1_seq1;GAXK01058171.1;Q90889;3.39E-13;MAFG_CHICK;Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult behavior [GO:0030534]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0030534; GO:0042127; GO:0043565; GO:0045604; GO:0046982";"adult behavior [GO:0030534]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp287893_c0_seq1;GAXK01058125.1;Q9BR84;3.27E-29;ZN559_HUMAN;Zinc finger protein 559;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2879_c0_seq1;GAXK01175882.1;Q8K4R4;2.14E-119;PITC1_MOUSE;Cytoplasmic phosphatidylinositol transfer protein 1 (Mammalian rdgB homolog beta) (M-rdgB beta) (MrdgBbeta) (mM-rdgBbeta) (Retinal degeneration B homolog beta) (RdgBbeta);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol metabolic process [GO:0046488]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0007165; GO:0008526; GO:0035091; GO:0046488";"phosphatidylinositol metabolic process [GO:0046488]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]"
comp287903_c0_seq1;GAXK01058175.1;Q8K1K9;3.57E-54;HINFP_MOUSE;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp2879214_c0_seq1;GAXK01165372.1;Q9HAZ2;1.11E-12;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp288_c0_seq1;GAXK01169945.1;P21531;0;RL3_RAT;60S ribosomal protein L3 (L4);"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005730; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0045202; GO:0071353";"cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; ribosome [GO:0005840]; synapse [GO:0045202]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp28803_c0_seq1;GAXK01052181.1;D4A1F2;3.42E-143;MICA2_RAT;[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";"GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp28805_c3_seq1;GAXK01052148.1;Q5R4R2;1.01E-151;SYHC_PONAB;Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; histidyl-tRNA aminoacylation [GO:0006427]";"GO:0004821; GO:0005524; GO:0005737; GO:0006427";histidyl-tRNA aminoacylation [GO:0006427];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]"
comp2880533_c0_seq1;GAXK01172220.1;Q502M6;3.09E-09;ANR29_DANRE;Ankyrin repeat domain-containing protein 29;;;;;
comp28806_c0_seq1;GAXK01051881.1;Q0VFD6;9.24E-20;MZT1_XENTR;Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1);"centrosome [GO:0005813]; gamma-tubulin ring complex [GO:0008274]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819]; gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307]";"GO:0005813; GO:0005819; GO:0008274; GO:0031021; GO:0033566; GO:0051415; GO:0090307";"gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307]";"centrosome [GO:0005813]; gamma-tubulin ring complex [GO:0008274]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819]";
comp2880603_c0_seq1;GAXK01172217.1;P16066;5.15E-62;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp2881096_c0_seq1;GAXK01172248.1;Q20657;7.69E-34;STO3_CAEEL;Stomatin-3;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2882012_c0_seq1;GAXK01036301.1;P35500;1.57E-40;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp288202_c3_seq1;GAXK01183006.1;Q08DV6;4.05E-29;ASB3_BOVIN;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp288209_c2_seq1;GAXK01182922.1;Q9VEG6;5.26E-137;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp288219_c1_seq1;GAXK01182906.1;Q8CFD4;9.42E-70;SNX8_MOUSE;Sorting nexin-8;"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]";"GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231";"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]";"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]"
comp28822_c3_seq1;GAXK01205339.1;O75179;0;ANR17_HUMAN;Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]";"GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246";"blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; RNA binding [GO:0003723]"
comp288222_c0_seq1;GAXK01182942.1;Q8I6K0;7.66E-47;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2882447_c0_seq1;GAXK01036292.1;Q6MG71;7.12E-25;CTL4_RAT;Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]"
comp28825_c0_seq1;GAXK01051745.1;P33610;1.22E-114;PRI2_MOUSE;DNA primase large subunit (EC 2.7.7.-) (DNA primase 58 kDa subunit) (p58);"alpha DNA polymerase:primase complex [GO:0005658]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003896; GO:0005658; GO:0046872; GO:0051539";;alpha DNA polymerase:primase complex [GO:0005658];"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"
comp288278_c2_seq1;GAXK01182889.1;Q54BM8;4.70E-39;U652_DICDI;UPF0652 protein;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp2882911_c0_seq1;GAXK01036282.1;Q06547;1.19E-08;GABP1_HUMAN;GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2) (Nuclear respiratory factor 2) (Transcription factor E4TF1-47) (Transcription factor E4TF1-53);"cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007005; GO:0036464; GO:0044212; GO:0045944; GO:0046982";"mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]"
comp2882923_c0_seq1;GAXK01036284.1;Q8VHZ8;1.05E-08;DSCAM_RAT;Down syndrome cell adhesion molecule homolog;"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0010842; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0038007; GO:0042327; GO:0043025; GO:0045202; GO:0048842; GO:0060219; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";cell-cell adhesion mediator activity [GO:0098632]
comp2883_c0_seq1;GAXK01175771.1;Q8R1I1;7.13E-16;QCR9_MOUSE;Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein);"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0009060; GO:0034551";"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]";
comp288326_c1_seq1;GAXK01182921.1;Q3U4G3;2.11E-37;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp28835_c0_seq1;GAXK01051557.1;Q9D1Q6;5.79E-24;ERP44_MOUSE;Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4);"cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454";"cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]";protein disulfide isomerase activity [GO:0003756]
comp2883784_c0_seq1;GAXK01036297.1;Q9Y2C2;3.26E-08;UST_HUMAN;Uronyl 2-sulfotransferase (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770";"dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp2884468_c0_seq1;GAXK01022304.1;Q8BW94;2.48E-35;DYH3_MOUSE;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp288574_c0_seq1;GAXK01182800.1;Q6NRH1;6.40E-78;DCAF8_XENLA;DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp2886015_c0_seq1;GAXK01056806.1;P21251;4.47E-42;CALM_STIJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp28861_c1_seq1;GAXK01051855.1;Q5XGY1;0;TSR1_XENLA;Pre-rRNA-processing protein TSR1 homolog;"nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]";"GO:0005730; GO:0042254";ribosome biogenesis [GO:0042254];nucleolus [GO:0005730];
comp288613_c2_seq1;GAXK01182977.1;Q28BZ2;7.04E-17;HINT3_XENTR;Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]";"GO:0000166; GO:0005634; GO:0005737; GO:0016787";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]"
comp2886244_c0_seq1;GAXK01056808.1;P20393;8.28E-09;NR1D1_HUMAN;Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of receptor biosynthetic process [GO:0010871]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]; response to lipid [GO:0033993]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003707; GO:0003714; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005978; GO:0006367; GO:0007275; GO:0007623; GO:0008134; GO:0008270; GO:0009755; GO:0010498; GO:0010871; GO:0016604; GO:0019216; GO:0020037; GO:0030154; GO:0030374; GO:0030425; GO:0031648; GO:0032922; GO:0033993; GO:0034144; GO:0035947; GO:0038023; GO:0042632; GO:0042749; GO:0042752; GO:0043124; GO:0043197; GO:0044212; GO:0044321; GO:0045598; GO:0045892; GO:0045893; GO:0045944; GO:0050728; GO:0060086; GO:0061178; GO:0061469; GO:0061889; GO:0070859; GO:0070888; GO:0071222; GO:0071347; GO:0071356; GO:0090575; GO:0120163; GO:0150079; GO:1903979";"cell differentiation [GO:0030154]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of receptor biosynthetic process [GO:0010871]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]; response to lipid [GO:0033993]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp28864_c0_seq1;GAXK01051221.1;Q965W1;4.85E-08;FABP9_CAEEL;Fatty acid-binding protein homolog 9;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp288664_c0_seq1;GAXK01182982.1;P51799;5.18E-91;CLCN7_RAT;H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7);"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]";"GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0031410; GO:0043231";response to pH [GO:0009268];"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]";"antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]"
comp2887115_c0_seq1;GAXK01056810.1;Q8MKK4;9.06E-17;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp28873_c2_seq1;GAXK01051884.1;Q805F9;0;DDB1_CHICK;DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008";"DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";damaged DNA binding [GO:0003684]
comp2887969_c0_seq1;GAXK01056807.1;P83501;2.25E-18;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp28880_c0_seq1;GAXK01052129.1;Q921L7;1.31E-51;HEMK1_MOUSE;MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1);"mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]";"GO:0003676; GO:0005739; GO:0008276; GO:0102559";;mitochondrion [GO:0005739];"nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]"
comp2888421_c0_seq1;GAXK01052666.1;Q9XYN1;7.88E-15;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp2888562_c0_seq1;GAXK01052654.1;Q80ZA4;9.51E-28;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp2888938_c1_seq1;GAXK01052665.1;P50429;1.82E-29;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp28892_c0_seq1;GAXK01052172.1;Q9VBP9;0;NPL4_DROME;Nuclear protein localization protein 4 homolog;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0046872; GO:0098586";"cellular response to virus [GO:0098586]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
comp2889295_c0_seq1;GAXK01052669.1;Q9NQX1;8.05E-07;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp2889566_c0_seq1;GAXK01052668.1;Q6P5U7;6.04E-07;NWD2_MOUSE;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp2889666_c0_seq1;GAXK01052656.1;Q9D2J7;3.24E-09;ANKE1_MOUSE;Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5);;;;;
comp2890199_c0_seq1;GAXK01204079.1;Q7KQZ4;2.22E-07;LOLA3_DROME;Longitudinals lacking protein, isoforms A/B/D/L;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp28905_c0_seq1;GAXK01051625.1;Q86VP3;1.52E-145;PACS2_HUMAN;Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032]";"GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0016032; GO:0034497; GO:0044325; GO:0072659";"apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032]";"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";ion channel binding [GO:0044325]
comp289086_c0_seq1;GAXK01182935.1;P91931;9.57E-46;DCAM_DROME;"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]";"cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";"GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";cytosol [GO:0005829];adenosylmethionine decarboxylase activity [GO:0004014]
comp2891180_c0_seq1;GAXK01204071.1;Q9IZK2;1.19E-18;GCNT3_BHV4V;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (BORFF3-4) (C2GnT-mucin type) (C2GnT-M);"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; protein glycosylation [GO:0006486]";"GO:0003829; GO:0006486; GO:0008109; GO:0016021; GO:0044178; GO:0047225";protein glycosylation [GO:0006486];"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]";"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp2891604_c0_seq1;GAXK01204057.1;Q10984;3.86E-23;FUT2_RAT;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha 1,2-fucosyltransferase) (Alpha 1,2-fucosyltransferase B) (Alpha 1-2 fucosyltransferase) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (Secretor blood group alpha-2-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp289174_c0_seq1;GAXK01182976.1;Q96MU6;1.30E-13;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp289195_c0_seq1;GAXK01182946.1;X2JAU8;2.43E-117;NWK_DROME;Protein nervous wreck (Nwk);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030054; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601";"multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]";"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"
comp2892600_c0_seq1;GAXK01162911.1;Q01611;7.13E-08;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp289280_c2_seq1;GAXK01183020.1;Q6WKZ4;1.81E-27;RFIP1_HUMAN;Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; Rab GTPase binding [GO:0017137]; negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]";"GO:0005829; GO:0015031; GO:0017137; GO:0030670; GO:0043231; GO:0045055; GO:0055037; GO:0070164";"negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]";Rab GTPase binding [GO:0017137]
comp289283_c1_seq1;GAXK01182871.1;Q7QH73;2.10E-100;PERC_ANOGA;Chorion peroxidase (EC 1.11.1.7);"extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477";"hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";extracellular region [GO:0005576];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp2893123_c0_seq1;GAXK01162909.1;Q5ZJ56;1.22E-27;RL7_CHICK;60S ribosomal protein L7;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003723; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp289324_c2_seq1;GAXK01182799.1;Q66HF8;0;AL1B1_RAT;Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase family 1 member B1);"mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; ethanol catabolic process [GO:0006068]";"GO:0004029; GO:0005759; GO:0006068; GO:0043878";ethanol catabolic process [GO:0006068];mitochondrial matrix [GO:0005759];"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]"
comp28934_c0_seq1;GAXK01051501.1;Q9VJ38;6.22E-68;RM13_DROME;39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005739; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0032543";"mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribosome [GO:0005840]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp2893521_c0_seq1;GAXK01162905.1;Q16983;4.34E-26;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp28937_c2_seq1;GAXK01051478.1;Q03924;6.60E-15;ZN117_HUMAN;Zinc finger protein 117 (Provirus-linked krueppel) (h-PLK) (Zinc finger protein HPF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp2893956_c0_seq1;GAXK01162903.1;Q9SF85;4.29E-62;ADK1_ARATH;Adenosine kinase 1 (AK 1) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 1);"apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]";"GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006169; GO:0009506; GO:0016032; GO:0044209; GO:0046686; GO:0048046; GO:0080094";"adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]";"apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]"
comp28941_c4_seq1;GAXK01051854.1;Q9NRG9;6.21E-55;AAAS_HUMAN;Aladin (Adracalin);"centrosome [GO:0005813]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; fertilization [GO:0009566]; intracellular transport of virus [GO:0075733]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of nucleocytoplasmic transport [GO:0046822]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006913; GO:0007612; GO:0009566; GO:0016020; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043657; GO:0046822; GO:0060964; GO:0072686; GO:0075733; GO:0090307; GO:1900034";"fertilization [GO:0009566]; intracellular transport of virus [GO:0075733]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of nucleocytoplasmic transport [GO:0046822]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"centrosome [GO:0005813]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]";
comp2894281_c0_seq1;GAXK01070235.1;P17972;1.43E-56;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp289435_c1_seq1;GAXK01182998.1;O02151;8.57E-15;NHR14_CAEEL;Nuclear hormone receptor family member nhr-14;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp2894661_c0_seq1;GAXK01070242.1;Q86B91;6.29E-15;TINC_DROME;Protein tincar;"integral component of membrane [GO:0016021]; regulation of eye photoreceptor cell development [GO:0042478]";"GO:0016021; GO:0042478";regulation of eye photoreceptor cell development [GO:0042478];integral component of membrane [GO:0016021];
comp289506_c0_seq1;GAXK01183003.1;P12024;5.64E-70;CHAO_DROME;Chaoptin (Photoreceptor cell-specific membrane protein);"anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus [GO:0035996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microvillus organization [GO:0032528]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"GO:0005886; GO:0007156; GO:0007601; GO:0016028; GO:0032528; GO:0035996; GO:0042052; GO:0046658; GO:0050896";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microvillus organization [GO:0032528]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus [GO:0035996]";
comp289524_c0_seq1;GAXK01182941.1;Q9H5H4;5.77E-11;ZN768_HUMAN;Zinc finger protein 768;"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003723; GO:0005634; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp28956_c2_seq1;GAXK01051998.1;Q9VB25;0;KL98A_DROME;Kinesin-like protein Klp98A;"cytosol [GO:0005829]; early endosome [GO:0005769]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagy [GO:0006914]; early endosome to late endosome transport [GO:0045022]; microtubule-based movement [GO:0007018]; plus-end-directed endosome transport along mitotic spindle midzone microtubule [GO:0140024]";"GO:0003777; GO:0005524; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006914; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0032266; GO:0045022; GO:0045167; GO:0140024; GO:1901981";"asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagy [GO:0006914]; early endosome to late endosome transport [GO:0045022]; microtubule-based movement [GO:0007018]; plus-end-directed endosome transport along mitotic spindle midzone microtubule [GO:0140024]";"cytosol [GO:0005829]; early endosome [GO:0005769]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]"
comp2895617_c0_seq1;GAXK01070225.1;Q6VVW5;6.66E-79;ANPRB_MOUSE;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp289569_c2_seq1;GAXK01182926.1;C5H5C4;2.26E-19;NOT1A_DANRE;Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0006507; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp289606_c0_seq1;GAXK01183005.1;O54826;2.48E-97;AF10_MOUSE;Protein AF-10;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872";positive regulation of transcription by RNA polymerase II [GO:0045944];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]"
comp2896290_c0_seq1;GAXK01083467.1;Q9NZT1;1.50E-07;CALL5_HUMAN;Calmodulin-like protein 5 (Calmodulin-like skin protein);"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; epidermis development [GO:0008544]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]";"GO:0005509; GO:0005576; GO:0007165; GO:0008544; GO:0019722; GO:0043312; GO:1904813";"calcium-mediated signaling [GO:0019722]; epidermis development [GO:0008544]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]";"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]";calcium ion binding [GO:0005509]
comp2896346_c0_seq1;GAXK01083469.1;Q9WVG5;2.97E-14;LIPE_MOUSE;Endothelial lipase (EC 3.1.1.3) (Endothelial cell-derived lipase) (EDL);"cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; cell population proliferation [GO:0008283]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; lipid catabolic process [GO:0016042]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; regulation of lipoprotein metabolic process [GO:0050746]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]";"GO:0004465; GO:0004620; GO:0005615; GO:0005769; GO:0005794; GO:0006633; GO:0007584; GO:0008201; GO:0008283; GO:0008970; GO:0009986; GO:0010983; GO:0016042; GO:0016298; GO:0019433; GO:0032376; GO:0034372; GO:0034375; GO:0042632; GO:0043691; GO:0050746; GO:0055091; GO:0070328";"cell population proliferation [GO:0008283]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; lipid catabolic process [GO:0016042]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; regulation of lipoprotein metabolic process [GO:0050746]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]";"cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]";"heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]"
comp28971_c0_seq1;GAXK01051639.1;P52746;1.34E-20;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp289740_c0_seq1;GAXK01182984.1;Q9W1K5;3.54E-34;SESN_DROME;Sestrin homolog (dSesn);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]";"GO:0000422; GO:0005634; GO:0005737; GO:0010259; GO:0016239; GO:0016684; GO:0030308; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253; GO:2000377";"autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]"
comp2898067_c0_seq1;GAXK01077054.1;P83088;1.43E-43;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp2898086_c0_seq1;GAXK01077048.1;Q9I8C7;2.49E-111;ACH10_CHICK;Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005262; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]"
comp289809_c0_seq1;GAXK01182805.1;Q9R0S2;4.92E-91;MMP24_MOUSE;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp2898116_c0_seq1;GAXK01077053.1;P18061;1.51E-30;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp28988_c2_seq1;GAXK01051878.1;Q26474;2.21E-96;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp2898888_c0_seq1;GAXK01077038.1;Q6P1J6;4.17E-12;PLB1_HUMAN;"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"GO:0001523; GO:0004622; GO:0004623; GO:0005886; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0036151; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp2899002_c0_seq1;GAXK01077043.1;Q1HPS0;1.34E-09;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp289922_c0_seq1;GAXK01182925.1;Q5REI6;4.43E-09;ZN791_PONAB;Zinc finger protein 791;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp289939_c6_seq1;GAXK01182901.1;P41044;7.50E-93;CAB32_DROME;Calbindin-32;"cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]";"GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043005; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271; GO:1903035";"negative regulation of response to wounding [GO:1903035]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]";"cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type III terminal bouton [GO:0097467]; type II terminal bouton [GO:0061175]";calcium ion binding [GO:0005509]
comp289972_c0_seq1;GAXK01183010.1;Q5ZIR1;2.92E-67;SHLB1_CHICK;Endophilin-B1 (SH3 domain-containing GRB2-like protein B1);"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915]";"GO:0000139; GO:0005741; GO:0006915; GO:0008289";apoptotic process [GO:0006915];"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]";lipid binding [GO:0008289]
comp2899827_c0_seq1;GAXK01077041.1;Q8BLK3;7.36E-08;LSAMP_MOUSE;Limbic system-associated membrane protein (LSAMP);"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]";"GO:0005829; GO:0005886; GO:0007155; GO:0031225; GO:0035641";"cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]";"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp29_c1_seq1;GAXK01169200.1;O96647;5.95E-111;RL10_BOMMA;60S ribosomal protein L10 (QM protein homolog);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2900571_c0_seq1;GAXK01082382.1;Q7T3S3;5.16E-07;CHSTB_DANRE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]"
comp2901_c2_seq1;GAXK01175481.1;P41374;5.07E-120;IF2A_DROME;Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha);"cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; multi-eIF complex [GO:0043614]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]";"GO:0003743; GO:0005829; GO:0005850; GO:0005851; GO:0006413; GO:0033290; GO:0043022; GO:0043614";translational initiation [GO:0006413];"cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; multi-eIF complex [GO:0043614]";"ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]"
comp29011_c10_seq1;GAXK01051509.1;Q6PFJ7;3.51E-79;NSMA3_DANRE;Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685]";"GO:0000139; GO:0004767; GO:0005635; GO:0005789; GO:0006685; GO:0016021; GO:0046475; GO:0046513; GO:0046872; GO:0050290";"ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]"
comp2901242_c0_seq1;GAXK01082379.1;P25387;8.16E-47;GBLP_CHLRE;Guanine nucleotide-binding protein subunit beta-like protein;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp2901584_c0_seq1;GAXK01082392.1;Q6YND2;2.73E-07;ZN653_MOUSE;Zinc finger protein 653 (67 kDa zinc finger protein) (Zinc finger protein Zip67);"extracellular region [GO:0005576]; nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]";"GO:0003677; GO:0003714; GO:0005576; GO:0005634; GO:0008134; GO:0046872; GO:0048019; GO:0050682; GO:1900116; GO:1903507";"extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]";"extracellular region [GO:0005576]; nucleus [GO:0005634]";"AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp29016_c0_seq1;GAXK01051728.1;E9QAG8;8.78E-32;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp290187_c0_seq1;GAXK01179438.1;Q92482;9.87E-62;AQP3_HUMAN;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"GO:0002684; GO:0003091; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323; GO:0032526; GO:0033280; GO:0042476; GO:0045616; GO:0051592; GO:0070295; GO:0071456; GO:0090650";"cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp29019_c1_seq1;GAXK01051398.1;Q9U1H8;4.31E-81;FACE2_DROME;CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (Protein severas);"integral component of endoplasmic reticulum membrane [GO:0030176]; cysteine-type endopeptidase activity [GO:0004197]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]";"GO:0004197; GO:0004222; GO:0030176; GO:0071586";CAAX-box protein processing [GO:0071586];integral component of endoplasmic reticulum membrane [GO:0030176];"cysteine-type endopeptidase activity [GO:0004197]; metalloendopeptidase activity [GO:0004222]"
comp290197_c1_seq1;GAXK01179434.1;Q9NUJ7;5.76E-21;PLCX1_HUMAN;PI-PLC X domain-containing protein 1;"cytoplasm [GO:0005737]; phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629]";"GO:0005737; GO:0006629; GO:0008081";lipid metabolic process [GO:0006629];cytoplasm [GO:0005737];phosphoric diester hydrolase activity [GO:0008081]
comp2902_c0_seq1;GAXK01175796.1;Q5XIF3;2.57E-47;NDUS4_RAT;NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (NADH-ubiquinone oxidoreductase 18 kDa subunit);"mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]";"GO:0001932; GO:0005747; GO:0007420; GO:0008137; GO:0019933; GO:0022900; GO:0032981; GO:0045333; GO:0048146; GO:0051591; GO:0072593";"brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]";mitochondrial respiratory chain complex I [GO:0005747];NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp290215_c4_seq1;GAXK01179338.1;O01404;5.18E-72;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp290233_c0_seq1;GAXK01179362.1;Q86MW9;7.60E-09;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp290252_c0_seq1;GAXK01179405.1;O02485;4.38E-39;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp2902539_c0_seq1;GAXK01180570.1;Q96JB1;0;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp290281_c0_seq1;GAXK01179425.1;Q8N7N5;1.67E-71;DCAF8_MOUSE;DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp290341_c1_seq1;GAXK01179350.1;Q0VCB0;5.09E-21;ZN350_BOVIN;Zinc finger protein 350;"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005634; GO:0005654; GO:0016363; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp2903457_c0_seq1;GAXK01180574.1;Q6H1V1;1.61E-07;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp2904245_c0_seq1;GAXK01198061.1;Q8AVC3;7.46E-70;G6PT3_XENLA;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp2904310_c0_seq1;GAXK01198070.1;D4A734;3.54E-28;MOT12_RAT;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp290441_c5_seq1;GAXK01179308.1;Q03601;1.23E-18;NHL1_CAEEL;RING finger protein nhl-1;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0004842; GO:0016567; GO:0043161; GO:0046872; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp290459_c0_seq1;GAXK01179333.1;O54904;3.18E-46;B3GT1_MOUSE;Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006682; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275";"galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp2904651_c0_seq1;GAXK01198052.1;P17970;4.68E-09;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp290487_c2_seq1;GAXK01179409.1;A8WHP3;6.57E-168;SC5A9_DANRE;Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]";"GO:0005412; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";glucose:sodium symporter activity [GO:0005412]
comp2905007_c0_seq1;GAXK01198073.1;Q5F201;1.54E-21;CFA52_MOUSE;Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]";"GO:0005930; GO:0031514; GO:0036064; GO:0060271";cilium assembly [GO:0060271];"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]";
comp290506_c1_seq1;GAXK01179298.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp2905274_c0_seq1;GAXK01198068.1;P41245;3.47E-15;MMP9_MOUSE;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"GO:0001501; GO:0001934; GO:0001968; GO:0002687; GO:0004175; GO:0004222; GO:0004252; GO:0005615; GO:0006508; GO:0006979; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0019087; GO:0030198; GO:0030335; GO:0030574; GO:0031915; GO:0032991; GO:0034614; GO:0035987; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0044877; GO:0045742; GO:0045766; GO:0048147; GO:0048771; GO:0051259; GO:0051549; GO:0062023; GO:0071276; GO:0071460; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp290655_c5_seq1;GAXK01179361.1;Q8BHI4;2.97E-11;KBTB3_MOUSE;Kelch repeat and BTB domain-containing protein 3 (BTB and kelch domain-containing protein 3);;;;;
comp29070_c0_seq1;GAXK01051482.1;P49596;2.60E-125;PP2C2_CAEEL;Probable protein phosphatase 2C T23F11.1 (PP2C) (EC 3.1.3.16);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0004722; GO:0004724; GO:0005634; GO:0005737; GO:0030517; GO:0031625; GO:0032873; GO:0046872; GO:0048786; GO:0051965; GO:0071470; GO:1990439";"cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]"
comp290715_c1_seq1;GAXK01179304.1;Q9D0K1;1.92E-54;PEX13_MOUSE;Peroxisomal membrane protein PEX13 (Peroxin-13);"integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome targeting sequence binding [GO:0000268]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]";"GO:0000268; GO:0001561; GO:0001764; GO:0001967; GO:0005777; GO:0005778; GO:0005779; GO:0007626; GO:0016560; GO:0021795; GO:0043231; GO:0060152; GO:1990429";"cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]";"integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";peroxisome targeting sequence binding [GO:0000268]
comp29074_c0_seq1;GAXK01051537.1;Q3ZBT2;2.59E-68;FBX9_BOVIN;F-box only protein 9;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0045087; GO:0045444";"fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp2907645_c0_seq1;GAXK01194123.1;Q94660;1.95E-41;RLA0_PLAF8;60S acidic ribosomal protein P0;"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp29080_c0_seq1;GAXK01052164.1;Q9UBX3;2.25E-111;DIC_HUMAN;Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0070221; GO:0071422; GO:0071423";"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]"
comp290801_c0_seq1;GAXK01179299.1;Q5UQN4;4.47E-29;YL432_MIMIV;Uncharacterized protein L432;hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp290812_c0_seq1;GAXK01179300.1;Q06985;9.30E-09;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2908152_c0_seq1;GAXK01054418.1;Q9VZW5;1.99E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp290844_c1_seq1;GAXK01179380.1;Q7KRI2;2.57E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2908867_c0_seq1;GAXK01054409.1;A8MT65;2.25E-07;ZN891_HUMAN;Zinc finger protein 891;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp290926_c1_seq1;GAXK01179305.1;Q80T85;8.67E-146;DCAF5_MOUSE;DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739]; protein ubiquitination [GO:0016567]";"GO:0005739; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739]";
comp290951_c0_seq1;GAXK01179411.1;Q55EH8;3.65E-80;ABCGN_DICDI;ABC transporter G family member 23 (ABC transporter ABCG.23);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016021; GO:0016887";;integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp290969_c1_seq1;GAXK01179347.1;Q0P523;1.01E-40;CIB3_MOUSE;Calcium and integrin-binding family member 3;"calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]";"GO:0000287; GO:0005509";;;"calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]"
comp2909818_c0_seq1;GAXK01054420.1;O08726;6.12E-07;GALR2_RAT;Galanin receptor type 2 (GAL2-R) (GALR-2);"cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0004966; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0008528; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; galanin-activated signaling pathway [GO:0090663]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"galanin receptor activity [GO:0004966]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]"
comp2910214_c0_seq1;GAXK01012304.1;Q8BMN3;1.80E-29;ACHB3_MOUSE;Neuronal acetylcholine receptor subunit beta-3;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0098691; GO:2000300";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]"
comp291058_c2_seq1;GAXK01179432.1;P89116;1.71E-63;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp2910649_c0_seq1;GAXK01012314.1;P70338;5.65E-08;GFI1_MOUSE;Zinc finger protein Gfi-1 (Growth factor independent protein 1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell fate specification [GO:0009996]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0007638; GO:0009996; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0042472; GO:0042491; GO:0042660; GO:0044212; GO:0045165; GO:0045892; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell fate specification [GO:0009996]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp2910688_c0_seq1;GAXK01012298.1;Q2V2K5;2.69E-11;GNRHR_OCTVU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (oct-GnRHR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp2910728_c0_seq1;GAXK01012301.1;Q8INF0;7.17E-51;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp29113_c0_seq1;GAXK01051558.1;P20007;0;PCKG_DROME;Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]";"GO:0004613; GO:0005525; GO:0005739; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0033993; GO:0042594; GO:0046327; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]"
comp2911489_c0_seq1;GAXK01012305.1;P27105;3.77E-11;STOM_HUMAN;Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin);"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0051260; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585";"neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]";"azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]";"protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]"
comp291164_c1_seq1;GAXK01179382.1;Q24206;1.79E-21;BRC4_DROME;Broad-complex core protein isoform 6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp29119_c5_seq1;GAXK01051697.1;Q96RQ3;0;MCCA_HUMAN;Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha);"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]";"GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:0051291; GO:1905202";"biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]";"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]"
comp29124_c0_seq1;GAXK01051827.1;Q6GM44;5.34E-88;MARH5_XENLA;E3 ubiquitin-protein ligase MARCH5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCH5);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; protein autoubiquitination [GO:0051865]; regulation of mitochondrial fission [GO:0090140]";"GO:0004842; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051865; GO:0090140; GO:0090344";"negative regulation of cell aging [GO:0090344]; protein autoubiquitination [GO:0051865]; regulation of mitochondrial fission [GO:0090140]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2912422_c0_seq1;GAXK01061246.1;P93030;6.83E-08;RMA2_ARATH;E3 ubiquitin-protein ligase RMA2 (EC 2.3.2.27) (Protein RING membrane-anchor 2) (RING-type E3 ubiquitin transferase RMA2);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016021; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp29126_c1_seq1;GAXK01051787.1;Q20263;6.38E-22;GOT1_CAEEL;Probable Golgi transport protein 1 (Enlarged amphid sheath glia protein 1);"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005783; GO:0015031; GO:0016021; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp291401_c1_seq1;GAXK01179424.1;O43280;1.37E-153;TREA_HUMAN;Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase);"anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; alpha,alpha-trehalase activity [GO:0004555]; animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]";"GO:0004555; GO:0005991; GO:0005993; GO:0009887; GO:0031225; GO:0046658; GO:0070062";"animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]";"anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]";alpha,alpha-trehalase activity [GO:0004555]
comp2914621_c0_seq1;GAXK01057025.1;Q8BYF6;4.66E-35;SC5A8_MOUSE;Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"GO:0005343; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161";"apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]"
comp29148_c0_seq1;GAXK01051627.1;Q9U1M2;3.93E-122;TM120_DROME;Transmembrane protein 120 homolog;"integral component of membrane [GO:0016021]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]";"GO:0016021; GO:0045089; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]";integral component of membrane [GO:0016021];
comp291490_c0_seq1;GAXK01179415.1;B7Z6K7;5.50E-30;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2915_c2_seq1;GAXK01176487.1;Q9BQ67;3.69E-134;GRWD1_HUMAN;Glutamate-rich WD repeat-containing protein 1;"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]";"GO:0003682; GO:0003688; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0032991; GO:0042393";"DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; RNA binding [GO:0003723]"
comp2915626_c0_seq1;GAXK01057016.1;Q04896;2.78E-55;HME1A_DANRE;Homeobox protein engrailed-1a (Homeobox protein en-1a);"nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016586; GO:0030182; GO:0043565; GO:0060385";"axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RSC-type complex [GO:0016586]";sequence-specific DNA binding [GO:0043565]
comp291575_c2_seq1;GAXK01179423.1;Q9BYZ6;4.73E-162;RHBT2_HUMAN;Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"GO:0000902; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007266; GO:0016477; GO:0019901; GO:0030036; GO:0030838; GO:0043652; GO:0051056";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp2915789_c0_seq1;GAXK01057026.1;P55067;1.26E-20;NCAN_RAT;Neurocan core protein (245 kDa early postnatal core glycoprotein) (Chondroitin sulfate proteoglycan 3) [Cleaved into: 150 kDa adult core glycoprotein];"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp2915866_c0_seq1;GAXK01057015.1;Q22070;1.82E-39;PLCG_CAEEL;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma plc-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma plc-3) (Phospholipase C-gamma plc-3) (PLC-gamma plc-3);"cell [GO:0005623]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; release of sequestered calcium ion into cytosol [GO:0051209]; sleep [GO:0030431]";"GO:0004435; GO:0005623; GO:0009395; GO:0010634; GO:0030431; GO:0032959; GO:0046872; GO:0048015; GO:0051209";"inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; release of sequestered calcium ion into cytosol [GO:0051209]; sleep [GO:0030431]";cell [GO:0005623];"metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp2915893_c0_seq1;GAXK01057023.1;O75832;1.00E-08;PSD10_HUMAN;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK));"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";transcription factor binding [GO:0008134]
comp291618_c0_seq1;GAXK01179289.1;Q2TU62;1.27E-16;CLCA1_HORSE;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2917145_c0_seq1;GAXK01084212.1;O60312;1.04E-47;AT10A_HUMAN;Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]";"GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0008360; GO:0016021; GO:0034220; GO:0045332; GO:0140326";"ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp29173_c2_seq1;GAXK01052103.1;Q90YA8;3.92E-76;QPCT_GLOBL;Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);"extracellular region [GO:0005576]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]";"GO:0005576; GO:0008270; GO:0016603; GO:0017186";peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186];extracellular region [GO:0005576];"glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]"
comp291746_c1_seq1;GAXK01179346.1;Q02974;1.95E-68;KHK_RAT;Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; ketohexokinase activity [GO:0004454]; carbohydrate catabolic process [GO:0016052]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]";"GO:0004454; GO:0005524; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0016052; GO:0019200; GO:0032868; GO:0070873";"carbohydrate catabolic process [GO:0016052]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; ketohexokinase activity [GO:0004454]"
comp2917568_c0_seq1;GAXK01084206.1;Q8NBS9;1.77E-15;TXND5_HUMAN;Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46);"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005783; GO:0005788; GO:0016853; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0045454; GO:0070062";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]";isomerase activity [GO:0016853]
comp29178_c1_seq1;GAXK01051540.1;Q95M17;7.98E-89;CHIA_BOVIN;Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197";"apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp291801_c0_seq1;GAXK01179302.1;Q8IN81;5.71E-10;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp291819_c0_seq1;GAXK01179414.1;Q86B91;9.59E-37;TINC_DROME;Protein tincar;"integral component of membrane [GO:0016021]; regulation of eye photoreceptor cell development [GO:0042478]";"GO:0016021; GO:0042478";regulation of eye photoreceptor cell development [GO:0042478];integral component of membrane [GO:0016021];
comp2919444_c0_seq1;GAXK01060180.1;Q9W332;1.83E-131;CUBN_DROME;Cubilin homolog;"plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]";"GO:0005509; GO:0005886; GO:0015031; GO:0097017; GO:0097206";"nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]";plasma membrane [GO:0005886];calcium ion binding [GO:0005509]
comp2919522_c0_seq1;GAXK01060174.1;Q27180;2.07E-17;T1B_PARTE;"Trichocyst matrix protein T1-B (Secretory granule protein T1-B) (TMP 1-B) [Cleaved into: Trichocyst matrix protein T1-B 1; Trichocyst matrix protein T1-B 2]";trichocyst [GO:0055039];GO:0055039;;trichocyst [GO:0055039];
comp29198_c2_seq1;GAXK01051284.1;Q3KR37;1.59E-91;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp29199_c0_seq1;GAXK01052041.1;Q8N357;1.24E-120;S35F6_HUMAN;Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029";"negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";transmembrane transporter activity [GO:0022857]
comp29201_c0_seq1;GAXK01051699.1;Q8CGF7;3.75E-58;TCRG1_MOUSE;Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0001103; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0042802; GO:0070064";"negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]"
comp2920272_c0_seq1;GAXK01114080.1;Q9VZW5;5.93E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp292095_c0_seq1;GAXK01200758.1;Q9BDJ5;3.24E-58;VNN1_PIG;Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; pantothenate metabolic process [GO:0015939]";"GO:0005886; GO:0015939; GO:0017159; GO:0031225";pantothenate metabolic process [GO:0015939];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";pantetheine hydrolase activity [GO:0017159]
comp292145_c1_seq1;GAXK01200849.1;Q19204;4.34E-34;ADT2_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-2 (ADAMTS adt-2) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";"GO:0004222; GO:0005576; GO:0008340; GO:0008361; GO:0030199; GO:0040018; GO:0046872";"collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp29216_c2_seq1;GAXK01051559.1;Q4KLL4;0;TM9S4_RAT;Transmembrane 9 superfamily member 4;"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010";"cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp29218_c1_seq1;GAXK01051734.1;P79101;0;CPSF3_BOVIN;Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]";"GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872";"mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]";mRNA cleavage and polyadenylation specificity factor complex [GO:0005847];"5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp29219_c0_seq1;GAXK01052011.1;G4WAW9;1.73E-13;SELM_ERISI;Selenoprotein M;endoplasmic reticulum [GO:0005783];GO:0005783;;endoplasmic reticulum [GO:0005783];
comp292256_c0_seq1;GAXK01200829.1;G3V8T1;9.94E-07;MPP8_RAT;M-phase phosphoprotein 8;"nuclear heterochromatin [GO:0005720]; nuclear nucleosome [GO:0000788]; methylated histone binding [GO:0035064]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; regulation of DNA methylation [GO:0044030]";"GO:0000788; GO:0005720; GO:0035064; GO:0044030; GO:0045814; GO:0045869; GO:0045892; GO:0090309";"negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; regulation of DNA methylation [GO:0044030]";"nuclear heterochromatin [GO:0005720]; nuclear nucleosome [GO:0000788]";methylated histone binding [GO:0035064]
comp2922981_c0_seq1;GAXK01015437.1;Q9N658;2.12E-07;GFI1_DROME;Zinc finger protein sens (Protein senseless);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; visual perception [GO:0007601]";"GO:0000122; GO:0000981; GO:0005634; GO:0005700; GO:0007219; GO:0007411; GO:0007422; GO:0007423; GO:0007601; GO:0008407; GO:0008594; GO:0016360; GO:0042051; GO:0043066; GO:0043425; GO:0043565; GO:0045872; GO:0045944; GO:0046530; GO:0046872";"axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; visual perception [GO:0007601]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2923090_c0_seq1;GAXK01015423.1;Q95NQ0;5.18E-13;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp292363_c0_seq1;GAXK01200754.1;Q9UBV7;3.30E-75;B4GT7_HUMAN;Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase);"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0097435";"carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"
comp29237_c2_seq1;GAXK01051602.1;Q9N285;8.08E-51;MTCH2_BOVIN;Mitochondrial carrier homolog 2;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065]";"GO:0005739; GO:0005743; GO:0016021; GO:0043065";positive regulation of apoptotic process [GO:0043065];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp2923731_c0_seq1;GAXK01015427.1;Q9QWN8;1.94E-20;SPTN2_RAT;Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; synaptic vesicle [GO:0008021]; actin binding [GO:0003779]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; cellular response to ethanol [GO:0071361]; regulation of calcium ion-dependent exocytosis [GO:0017158]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000139; GO:0003779; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016363; GO:0017158; GO:0048471; GO:0051693; GO:0071361";"actin filament capping [GO:0051693]; cellular response to ethanol [GO:0071361]; regulation of calcium ion-dependent exocytosis [GO:0017158]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; synaptic vesicle [GO:0008021]";"actin binding [GO:0003779]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]"
comp2923863_c0_seq1;GAXK01015439.1;Q28658;3.40E-14;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp292417_c1_seq1;GAXK01200780.1;Q9V576;2.64E-40;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp292504_c2_seq1;GAXK01200681.1;Q54DY9;1.72E-20;BCS1B_DICDI;Probable mitochondrial chaperone BCS1-B (BCS1-like protein 2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005524; GO:0005739; GO:0005743; GO:0008320; GO:0016021; GO:0034551; GO:0051131";"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]"
comp29251_c0_seq1;GAXK01051541.1;Q2HJ46;4.78E-20;RNF8_BOVIN;E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0042393; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070535; GO:0070936";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2925417_c0_seq1;GAXK01099015.1;P14381;1.56E-09;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp292589_c2_seq1;GAXK01200781.1;P15364;2.16E-17;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp29259_c1_seq1;GAXK01051425.1;Q6PB44;2.73E-94;PTN23_MOUSE;Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643";"cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]"
comp2926320_c0_seq1;GAXK01141806.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp29265_c0_seq1;GAXK01051927.1;Q9CZV5;1.10E-14;ST65G_MOUSE;STAGA complex 65 subunit gamma (SPTF-associated factor 65 gamma) (STAF65gamma) (Suppressor of Ty 7-like);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; histone acetyltransferase activity [GO:0004402]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; maintenance of protein location in nucleus [GO:0051457]";"GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0030914; GO:0043966; GO:0046982; GO:0051457";"histone H3 acetylation [GO:0043966]; maintenance of protein location in nucleus [GO:0051457]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]";"histone acetyltransferase activity [GO:0004402]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]"
comp29266_c8_seq1;GAXK01051331.1;Q80ZA4;1.56E-105;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp292672_c0_seq1;GAXK01200802.1;Q6TXF1;4.50E-22;ARRD3_RAT;Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048);"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"GO:0001659; GO:0005764; GO:0005769; GO:0005886; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163";"fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";beta-3 adrenergic receptor binding [GO:0031699]
comp292679_c0_seq1;GAXK01200803.1;A8X679;3.21E-08;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2927_c1_seq1;GAXK01176502.1;Q94521;2.41E-08;DNAT_DROME;Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase);"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";"GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066";"catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";cytoplasm [GO:0005737];"aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]"
comp292706_c1_seq1;GAXK01200692.1;P17970;3.44E-168;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp29271_c0_seq1;GAXK01051868.1;Q3T0Z7;4.05E-66;DHPR_BOVIN;Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase);"cytoplasm [GO:0005737]; 6,7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"GO:0004155; GO:0005737; GO:0006559; GO:0006729; GO:0070402; GO:0070404";"L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]";cytoplasm [GO:0005737];"6,7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]"
comp2927268_c0_seq1;GAXK01141813.1;Q9GRW0;4.02E-54;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp29274_c0_seq1;GAXK01051942.1;P91950;0;GNAQ_HOMAM;Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q);"G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp292761_c0_seq1;GAXK01200810.1;Q96T23;1.19E-17;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp29279_c1_seq1;GAXK01051863.1;Q8AYS7;1.26E-24;CENPI_CHICK;Centromere protein I (CENP-I);"kinetochore [GO:0000776]; nucleus [GO:0005634]; centromere complex assembly [GO:0034508]";"GO:0000776; GO:0005634; GO:0034508";centromere complex assembly [GO:0034508];"kinetochore [GO:0000776]; nucleus [GO:0005634]";
comp292797_c0_seq1;GAXK01200815.1;Q9Y6H5;2.13E-27;SNCAP_HUMAN;Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; cell death [GO:0008219]; cellular protein metabolic process [GO:0044267]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0044267; GO:0046928; GO:0090083";"cell death [GO:0008219]; cellular protein metabolic process [GO:0044267]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]";"identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]"
comp2928404_c0_seq1;GAXK01151908.1;P04630;1.02E-14;CALL_CAEEL;Calmodulin-like protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp29287_c1_seq1;GAXK01051830.1;Q9BV81;4.29E-23;EMC6_HUMAN;ER membrane protein complex subunit 6 (Transmembrane protein 93);"ER membrane protein complex [GO:0072546]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of omegasome membrane [GO:0097631]; autophagosome assembly [GO:0000045]; protein folding in endoplasmic reticulum [GO:0034975]";"GO:0000045; GO:0016021; GO:0030176; GO:0034975; GO:0072546; GO:0097631";"autophagosome assembly [GO:0000045]; protein folding in endoplasmic reticulum [GO:0034975]";"ER membrane protein complex [GO:0072546]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of omegasome membrane [GO:0097631]";
comp2928782_c0_seq1;GAXK01151914.1;Q5R5J6;1.29E-14;GCP2_PONAB;Gamma-tubulin complex component 2 (GCP-2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule nucleation [GO:0007020]";"GO:0000922; GO:0005737; GO:0005815; GO:0005874; GO:0007020; GO:0043015";microtubule nucleation [GO:0007020];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";gamma-tubulin binding [GO:0043015]
comp29292_c0_seq1;GAXK01051381.1;Q5BJD5;5.29E-93;TM41B_HUMAN;Transmembrane protein 41B;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; autophagosome assembly [GO:0000045]; nervous system development [GO:0007399]";"GO:0000045; GO:0005789; GO:0007399; GO:0016021";"autophagosome assembly [GO:0000045]; nervous system development [GO:0007399]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp29295_c2_seq1;GAXK01052180.1;O93310;1.91E-79;RAD21_XENLA;Double-strand-break repair protein rad21 homolog (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)];"chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062]";"GO:0000775; GO:0000922; GO:0005829; GO:0006281; GO:0006915; GO:0007062; GO:0007275; GO:0008278; GO:0016363; GO:0051301; GO:0071168";"apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062]";"chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; spindle pole [GO:0000922]";
comp2929976_c0_seq1;GAXK01151916.1;Q9VYB7;3.09E-124;TPST_DROME;Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase) (TPST);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0009306; GO:0016021";"peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp293_c1_seq1;GAXK01168572.1;Q9U505;1.06E-16;AT5G_MANSE;ATP synthase lipid-binding protein, mitochondrial (ATPase protein 9) (ATPase subunit c);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0008289; GO:0015078; GO:0015986; GO:0016021; GO:0031966; GO:0045263";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";"lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078]"
comp2930050_c0_seq1;GAXK01081726.1;Q2V2K5;1.31E-20;GNRHR_OCTVU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (oct-GnRHR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp29305_c1_seq1;GAXK01205257.1;Q28DV3;0;HDAC3_XENTR;Histone deacetylase 3 (HD3) (EC 3.5.1.98);"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]";"GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0017053; GO:0032041; GO:0032922; GO:0042752; GO:0045944; GO:0070932; GO:0070933";"circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]";"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]"
comp2930990_c0_seq1;GAXK01081717.1;P18745;4.23E-08;ZO22_XENLA;Oocyte zinc finger protein XlCOF22;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2931476_c0_seq1;GAXK01081723.1;A2BID7;1.14E-10;PRD10_DANRE;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp293196_c2_seq1;GAXK01200828.1;Q965X6;7.08E-11;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp293239_c2_seq1;GAXK01200835.1;B4QBN3;7.23E-65;TRE12_DROSI;Facilitated trehalose transporter Tret1-2 homolog;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015771; GO:0016021; GO:0022857";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp2933301_c0_seq1;GAXK01141953.1;P35779;2.32E-19;VA3_SOLRI;Venom allergen 3 (Allergen Sol r III) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol r 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp293333_c0_seq1;GAXK01200776.1;Q9VYY9;1.48E-175;EVI5_DROME;Ecotropic viral integration site 5 ortholog;"cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]";"GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0007298; GO:0017137; GO:0030334; GO:0031982; GO:0032880; GO:0043087; GO:0090630";"activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp2933673_c0_seq1;GAXK01141950.1;P34091;1.23E-69;RL6_MESCR;60S ribosomal protein L6 (YL16-like);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp2934073_c0_seq1;GAXK01060262.1;P08045;5.81E-07;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp293417_c0_seq1;GAXK01200854.1;O46040;3.36E-26;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp2934175_c0_seq1;GAXK01060257.1;O02002;1.59E-59;CASP1_DROME;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p22; Caspase-1 subunit p13]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"GO:0004197; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007275; GO:0007300; GO:0007303; GO:0009267; GO:0010508; GO:0010623; GO:0012501; GO:0016239; GO:0016322; GO:0043025; GO:0045476; GO:0048477; GO:0071598; GO:0097153; GO:0097194; GO:0097200; GO:1900074; GO:1990124; GO:1990525";"apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]";"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp293430_c0_seq1;GAXK01200806.1;Q60J38;2.33E-11;ANKHM_CAEBR;Ankyrin repeat and KH domain-containing protein CBG24701;"cytoplasm [GO:0005737]; RNA binding [GO:0003723]";"GO:0003723; GO:0005737";;cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp29344_c0_seq1;GAXK01052307.1;Q91819;1.77E-67;AURAB_XENLA;Aurora kinase A-B (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-B) (Serine/threonine-protein kinase Eg2-B) (Serine/threonine-protein kinase aurora-A) (p46XlEg22);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0000212; GO:0000922; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005876; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0046777; GO:0051301; GO:0090307";"cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp293484_c0_seq1;GAXK01200778.1;Q8C7K6;6.25E-51;PCYXL_MOUSE;Prenylcysteine oxidase-like (EC 1.8.3.-);"extracellular region [GO:0005576]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]";"GO:0001735; GO:0005576; GO:0030327; GO:0030328";"prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]";extracellular region [GO:0005576];prenylcysteine oxidase activity [GO:0001735]
comp29355_c0_seq1;GAXK01051819.1;P08397;1.09E-105;HEM3_HUMAN;Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004418; GO:0005737; GO:0005829; GO:0006782; GO:0006783; GO:0018160";"heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";hydroxymethylbilane synthase activity [GO:0004418]
comp293552_c7_seq1;GAXK01200816.1;Q5W1J5;2.20E-20;FOXP1_XENLA;Forkhead box protein P1 (XlFoxP1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0042803; GO:0043565; GO:0045892; GO:0046872; GO:0046982";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp2936062_c0_seq1;GAXK01035215.1;Q95218;2.03E-21;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp293702_c2_seq1;GAXK01200823.1;B9EKR1;9.94E-80;PTPRZ_MOUSE;Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]";"GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045202; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224";"axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]";"fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]"
comp29374_c0_seq1;GAXK01052107.1;Q8AY73;0;XPO2_ORENI;Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886]";"GO:0005634; GO:0005737; GO:0006886; GO:0007589; GO:0008536";"body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";Ran GTPase binding [GO:0008536]
comp293788_c0_seq1;GAXK01200674.1;P70684;8.80E-25;PGDH_CAVPO;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp2938135_c0_seq1;GAXK01184701.1;P51427;3.64E-55;RS52_ARATH;40S ribosomal protein S5-2 (AtRPS5A) (Protein ARABIDOPSIS MINUTE-LIKE 1);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0005618; GO:0005773; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0019843; GO:0022626; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2938730_c0_seq1;GAXK01184687.1;Q4WK03;1.69E-116;PABP_ASPFU;Polyadenylate-binding protein, cytoplasmic and nuclear (PABP) (Poly(A)-binding protein) (Polyadenylate tail-binding protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]";"GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0008143; GO:0008266; GO:0010494; GO:0051028; GO:1990904";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]"
comp293878_c0_seq1;GAXK01200848.1;Q9VVW3;2.46E-66;SFXN2_DROME;Sideroflexin-2;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"GO:0005739; GO:0006730; GO:0016021; GO:0022889; GO:0031966; GO:0140300; GO:1990542";"mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";serine transmembrane transporter activity [GO:0022889]
comp2938884_c0_seq1;GAXK01184695.1;P51281;1.14E-58;YCF45_PORPU;Uncharacterized protein ycf45 (ORF565);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005524; GO:0009507";;chloroplast [GO:0009507];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]"
comp293902_c0_seq1;GAXK01200691.1;Q21738;4.12E-08;PAXT1_CAEEL;Partner of xrn-2 protein 1;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]";"GO:0005634; GO:0005654; GO:0005730; GO:0006397";mRNA processing [GO:0006397];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp2939104_c0_seq1;GAXK01184685.1;Q8T3Y0;1.67E-16;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp2939254_c0_seq1;GAXK01184688.1;P0CX23;2.78E-65;RL20A_YEAST;60S ribosomal protein L20-A (L18a) (Large ribosomal subunit protein eL20-A);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp293935_c0_seq1;GAXK01200784.1;Q9W332;3.34E-09;CUBN_DROME;Cubilin homolog;"plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]";"GO:0005509; GO:0005886; GO:0015031; GO:0097017; GO:0097206";"nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]";plasma membrane [GO:0005886];calcium ion binding [GO:0005509]
comp293978_c0_seq1;GAXK01200796.1;P61295;3.60E-35;HAND2_RAT;Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; heart development [GO:0007507]";"GO:0000981; GO:0001525; GO:0003677; GO:0005634; GO:0007507; GO:0008134; GO:0030154; GO:0033613; GO:0046983; GO:0071300; GO:0071407";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; heart development [GO:0007507]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]"
comp29398_c0_seq1;GAXK01205255.1;P89116;8.19E-107;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp293997_c0_seq1;GAXK01200855.1;Q27052;1.47E-10;FCA1_TRYRA;Flagellar calcium-binding protein;"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp293999_c0_seq1;GAXK01200702.1;P12309;1.40E-18;GLRX1_PIG;Glutaredoxin-1 (Thioltransferase-1) (TTase-1);"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp2940197_c0_seq1;GAXK01193196.1;Q66S03;1.11E-19;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp29402_c0_seq1;GAXK01051476.1;Q66HL2;2.58E-57;SRC8_RAT;Src substrate cortactin;"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; proline-rich region binding [GO:0070064]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]";"GO:0001726; GO:0002102; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0007420; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0070064; GO:0071933; GO:0097581; GO:0098871; GO:0098885; GO:0098978";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]";"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]";"actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; proline-rich region binding [GO:0070064]"
comp29403_c1_seq1;GAXK01052108.1;Q9VCC0;4.04E-120;CHRD1_DROME;Cysteine and histidine-rich domain-containing protein (Morgana);"metal ion binding [GO:0046872]; centrosome duplication [GO:0051298]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]";"GO:0008361; GO:0046872; GO:0050773; GO:0051298";"centrosome duplication [GO:0051298]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]";;metal ion binding [GO:0046872]
comp29404_c1_seq1;GAXK01051802.1;D3Z5L6;9.31E-20;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp294119_c1_seq1;GAXK01116567.1;Q5ZIR1;9.34E-65;SHLB1_CHICK;Endophilin-B1 (SH3 domain-containing GRB2-like protein B1);"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915]";"GO:0000139; GO:0005741; GO:0006915; GO:0008289";apoptotic process [GO:0006915];"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]";lipid binding [GO:0008289]
comp294143_c0_seq1;GAXK01116569.1;Q5RGJ6;1.33E-28;WASC3_DANRE;WASH complex subunit 3 (Coiled-coil domain-containing protein 53);"WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]";"GO:0006887; GO:0030041; GO:0071203";"actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]";WASH complex [GO:0071203];
comp294156_c0_seq1;GAXK01116572.1;Q7KRI2;1.84E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2942187_c0_seq1;GAXK01051207.1;P83088;1.10E-55;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp29423_c1_seq1;GAXK01052093.1;Q29S14;8.10E-63;TV23B_BOVIN;Golgi apparatus membrane protein TVP23 homolog B;"integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]";"GO:0009306; GO:0016192; GO:0030173";"protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]";integral component of Golgi membrane [GO:0030173];
comp2942722_c0_seq1;GAXK01051196.1;Q8NET6;5.37E-21;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp2943512_c0_seq1;GAXK01051208.1;Q27238;4.02E-119;ADT1_ANOGA;ADP,ATP carrier protein 1 (ADP/ATP translocase 1) (Adenine nucleotide translocator 1) (ANT 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]";"GO:0005471; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP:ADP antiporter activity [GO:0005471]
comp29438_c0_seq1;GAXK01051815.1;Q9Z1L5;4.40E-145;CA2D3_MOUSE;"Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]";"voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0006816; GO:0034765; GO:0046872";"calcium ion transport [GO:0006816]; regulation of ion transmembrane transport [GO:0034765]";voltage-gated calcium channel complex [GO:0005891];"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp2944047_c0_seq1;GAXK01095155.1;Q8BSY0;8.76E-37;ASPH_MOUSE;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]"
comp29442_c0_seq1;GAXK01051788.1;Q6NU91;2.61E-106;NOC4B_XENLA;Nucleolar complex protein 4 homolog B (NOC4 protein homolog B) (NOC4-like protein B) (Nucleolar complex-associated protein 4-like protein B);"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]";"GO:0005730; GO:0016021; GO:0031965; GO:0042254";ribosome biogenesis [GO:0042254];"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]";
comp2944299_c0_seq1;GAXK01095163.1;Q03720;2.97E-32;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp29443_c0_seq1;GAXK01052171.1;Q7T0Q5;0;NOL10_XENLA;Nucleolar protein 10;nucleolus [GO:0005730];GO:0005730;;nucleolus [GO:0005730];
comp2944504_c0_seq1;GAXK01095164.1;Q8ISP0;1.81E-68;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp294468_c5_seq1;GAXK01116465.1;Q9BVK2;9.55E-156;ALG8_HUMAN;Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0000033; GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0018279; GO:0042281; GO:0042283";"dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]"
comp2944757_c0_seq1;GAXK01095178.1;Q8TF09;3.51E-27;DLRB2_HUMAN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2);"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0035735; GO:0045505; GO:0097542";"intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]"
comp2944878_c0_seq1;GAXK01095160.1;Q08832;7.41E-16;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp2944977_c0_seq1;GAXK01095177.1;Q6PFM1;6.98E-37;S20AB_DANRE;Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp294560_c0_seq1;GAXK01116563.1;Q6ZQF0;9.08E-12;TOPB1_MOUSE;DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint [GO:0033314]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";"GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint [GO:0033314]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]";"actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle pole [GO:0000922]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]"
comp294584_c2_seq1;GAXK01116531.1;A0AVT1;1.16E-58;UBA6_HUMAN;Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004839; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996";"amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]"
comp2945842_c0_seq1;GAXK01095175.1;P14635;3.34E-39;CCNB1_HUMAN;G2/mitotic-specific cyclin-B1;"centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; histone kinase activity [GO:0035173]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000079; GO:0000086; GO:0000307; GO:0000922; GO:0000942; GO:0001556; GO:0001701; GO:0001933; GO:0005113; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006367; GO:0006977; GO:0007052; GO:0007077; GO:0007080; GO:0007283; GO:0009612; GO:0010629; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0031145; GO:0031442; GO:0033129; GO:0035173; GO:0042246; GO:0044389; GO:0044772; GO:0045931; GO:0046680; GO:0048146; GO:0048565; GO:0051301; GO:0051726; GO:0051987; GO:0055015; GO:0060045; GO:0060623; GO:0061575; GO:0065003; GO:0071283; GO:0071398; GO:0071407; GO:0071456; GO:0090266; GO:0097125; GO:1901990; GO:1905448; GO:2000775";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]";"centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; histone kinase activity [GO:0035173]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]"
comp294588_c0_seq1;GAXK01116557.1;Q6AXJ9;1.77E-159;CDKL1_DANRE;Cyclin-dependent kinase-like 1 (EC 2.7.11.22);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]";"GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468";protein phosphorylation [GO:0006468];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp294627_c0_seq1;GAXK01116380.1;Q4JAI4;6.29E-26;METE_SULAC;Methionine synthase (EC 2.1.1.-) (Homocysteine methyltransferase);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp29471_c0_seq1;GAXK01051826.1;Q5BKN8;4.15E-180;THIL_XENTR;Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase);"mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]";"GO:0003985; GO:0003988; GO:0005739; GO:0006635; GO:0046872";fatty acid beta-oxidation [GO:0006635];mitochondrion [GO:0005739];"acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]"
comp29473_c1_seq1;GAXK01052060.1;Q8WQA4;1.61E-47;EXC4_CAEEL;Chloride intracellular channel exc-4 (Excretory canal abnormal protein 4);"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150]";"GO:0002064; GO:0005244; GO:0005254; GO:0005634; GO:0005764; GO:0005887; GO:0016324; GO:0034707; GO:0034765; GO:0035150; GO:0043296";"epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150]";"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]";"chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]"
comp2947805_c0_seq1;GAXK01012201.1;P38666;1.90E-23;RL242_ARATH;60S ribosomal protein L24-2 (Protein SHORT VALVE 1);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; auxin-activated signaling pathway [GO:0009734]; gynoecium development [GO:0048467]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0009734; GO:0022625; GO:0048467; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; auxin-activated signaling pathway [GO:0009734]; gynoecium development [GO:0048467]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2947828_c0_seq1;GAXK01012200.1;Q99KE8;3.07E-08;ZFP64_MOUSE;Zinc finger protein 64 (Zfp-64);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0007275; GO:0010468; GO:0032728; GO:0032755; GO:0032760; GO:0046872; GO:0048026";"multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp2948248_c0_seq1;GAXK01061403.1;Q4V8A1;3.13E-34;PCT2B_RAT;Lysophosphatidylcholine acyltransferase 2B (EC 2.3.1.-) (Acyltransferase-like 1-B);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]";"GO:0005509; GO:0008654; GO:0016021; GO:0016746";phospholipid biosynthetic process [GO:0008654];integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; transferase activity, transferring acyl groups [GO:0016746]"
comp2948261_c0_seq1;GAXK01061393.1;Q24352;6.96E-53;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp2948380_c0_seq1;GAXK01061397.1;P33190;2.04E-08;RL40_TETPY;"Ubiquitin-60S ribosomal protein L40 [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52) (CEP53)]";"nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp29484_c0_seq1;GAXK01051944.1;Q8GYM3;8.00E-14;AUG4_ARATH;AUGMIN subunit 4;"HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]";"GO:0005876; GO:0007098; GO:0009524; GO:0051011; GO:0051225; GO:0051301; GO:0070652";"cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]";"HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]";microtubule minus-end binding [GO:0051011]
comp294870_c0_seq1;GAXK01116562.1;G5EDN6;2.44E-13;CANB_CAEEL;Protein phosphatase 2B regulatory subunit cnb-1 (Calcineurin subunit B);"endoplasmic reticulum [GO:0005783]; sarcomere [GO:0030017]; striated muscle dense body [GO:0055120]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]";"GO:0005509; GO:0005783; GO:0006897; GO:0030017; GO:0055120";endocytosis [GO:0006897];"endoplasmic reticulum [GO:0005783]; sarcomere [GO:0030017]; striated muscle dense body [GO:0055120]";calcium ion binding [GO:0005509]
comp29490_c0_seq1;GAXK01051488.1;Q6WV20;4.51E-157;GALT1_DROME;Polypeptide N-acetylgalactosaminyltransferase 1 (pp-GaNTase 1) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp294905_c3_seq1;GAXK01116454.1;Q9V4M2;1.22E-08;WECH_DROME;Protein wech (Protein dappled);"muscle tendon junction [GO:0005927]; protein binding, bridging [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; instar larval development [GO:0002168]; muscle attachment [GO:0016203]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]";"GO:0000209; GO:0002168; GO:0005927; GO:0008270; GO:0016203; GO:0030154; GO:0030674; GO:0033632; GO:0043161; GO:0061630";"cell differentiation [GO:0030154]; instar larval development [GO:0002168]; muscle attachment [GO:0016203]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]";muscle tendon junction [GO:0005927];"protein binding, bridging [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp2949759_c0_seq1;GAXK01061401.1;P46940;1.84E-07;IQGA1_HUMAN;Ras GTPase-activating-like protein IQGAP1 (p195);"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]";"GO:0001726; GO:0001817; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0016032; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0031234; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043539; GO:0044548; GO:0044877; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776";"cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]";"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]";"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"
comp2949845_c0_seq1;GAXK01061392.1;Q8VIK2;3.98E-16;M17L2_MOUSE;Mpv17-like protein 2;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]";"GO:0005737; GO:0005739; GO:0005743; GO:0005762; GO:0016021; GO:0061668; GO:0070131";"mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";
comp294988_c1_seq1;GAXK01116463.1;P0DPB5;3.30E-08;RPC22_HUMAN;Protein POLR1D, isoform 2;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0005654; GO:0005829; GO:0006361; GO:0006362; GO:0006363; GO:0032481; GO:0045815";"positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp295005_c3_seq1;GAXK01116533.1;Q7KRI2;1.26E-32;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2950728_c0_seq1;GAXK01004524.1;Q01528;2.24E-12;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp2951053_c0_seq1;GAXK01004543.1;Q9SCM3;4.21E-77;RS24_ARATH;40S ribosomal protein S2-4;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp2951265_c0_seq1;GAXK01004542.1;Q32TG3;5.06E-23;EFHC2_CHICK;EF-hand domain-containing family member C2;"cell [GO:0005623]; regulation of neuron projection development [GO:0010975]";"GO:0005623; GO:0010975";regulation of neuron projection development [GO:0010975];cell [GO:0005623];
comp2951510_c0_seq1;GAXK01004534.1;Q8L765;1.71E-07;BPM1_ARATH;BTB/POZ and MATH domain-containing protein 1 (Protein BTB-POZ AND MATH DOMAIN 1) (AtBPM1);"nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0006970; GO:0016567; GO:0042631; GO:0042802; GO:0071472";"cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];identical protein binding [GO:0042802]
comp29516_c0_seq1;GAXK01051947.1;Q28EW0;7.76E-118;TM87A_XENTR;Transmembrane protein 87A;"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0032580";;"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";
comp2952_c0_seq1;GAXK01175710.1;P70097;3.62E-38;C560_CRIGR;Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0009055; GO:0016021; GO:0020037; GO:0046872";tricarboxylic acid cycle [GO:0006099];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]"
comp29523_c0_seq1;GAXK01051397.1;P27779;1.63E-08;CUP7_DROME;Pupal cuticle protein Edg-78E;"extracellular matrix [GO:0031012]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin-based cuticle development [GO:0040003]";"GO:0008010; GO:0008011; GO:0031012; GO:0040003";chitin-based cuticle development [GO:0040003];extracellular matrix [GO:0031012];"structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp29529_c1_seq1;GAXK01051928.1;Q9V7Y2;9.92E-176;SGPL_DROME;Sphingosine-1-phosphate lyase (S1PL) (SP-lyase) (SPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";"GO:0001667; GO:0005783; GO:0005789; GO:0006665; GO:0007275; GO:0007527; GO:0008117; GO:0016021; GO:0016831; GO:0019752; GO:0030149; GO:0030170";"adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]"
comp2952904_c0_seq1;GAXK01140660.1;Q9VZW5;6.42E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp295510_c0_seq1;GAXK01116448.1;Q02356;0;AMPD2_RAT;AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L);"cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]";"GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0046033; GO:0046872; GO:0052652";"AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]";cytosol [GO:0005829];"AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]"
comp2955399_c0_seq1;GAXK01078201.1;Q9NRA2;1.01E-14;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp2955449_c0_seq1;GAXK01078195.1;Q9D572;2.52E-13;UBX11_MOUSE;UBX domain-containing protein 11 (Socius) (UBX domain-containing protein 5);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ubiquitin binding [GO:0043130]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0005737; GO:0005856; GO:0043130; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ubiquitin binding [GO:0043130]
comp2955722_c0_seq1;GAXK01078192.1;P64918;2.13E-81;Y2023_MYCBO;Uncharacterized protein Mb2023;;;;;
comp2956165_c0_seq1;GAXK01024455.1;Q7Z460;5.74E-14;CLAP1_HUMAN;CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1);"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]";"GO:0000086; GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010389; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0090091; GO:0090162; GO:0090307; GO:0097711; GO:1903690; GO:1904261";"astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]";"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]";"dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]"
comp295633_c0_seq1;GAXK01116452.1;P18729;4.42E-38;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2956381_c0_seq1;GAXK01024442.1;A6UQ14;5.91E-35;EF1A_METVS;Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp2956402_c0_seq1;GAXK01024454.1;Q9NZJ4;1.59E-21;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp2956902_c0_seq1;GAXK01024444.1;O75832;3.65E-16;PSD10_HUMAN;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK));"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";transcription factor binding [GO:0008134]
comp2957076_c0_seq1;GAXK01024443.1;P41353;7.18E-73;H33_TETTS;Histone H3.3 (Minor histone H3 variant) (hv2);"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp29571_c0_seq1;GAXK01051393.1;P16930;0;FAAA_HUMAN;Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0004334; GO:0005829; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:0070062; GO:1902000";"arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]"
comp2957237_c0_seq1;GAXK01024441.1;Q8BMT9;1.01E-14;HHAT_MOUSE;Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; multicellular organism development [GO:0007275]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]";"GO:0005525; GO:0005783; GO:0005789; GO:0007224; GO:0007275; GO:0016021; GO:0016409; GO:0016746; GO:0018345";"multicellular organism development [GO:0007275]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp29574_c0_seq1;GAXK01051617.1;P06865;1.95E-160;HEXA_HUMAN;Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha);"azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]";"GO:0004563; GO:0005975; GO:0006024; GO:0006687; GO:0008375; GO:0016020; GO:0030207; GO:0030214; GO:0042340; GO:0042582; GO:0043202; GO:0046982; GO:0070062; GO:0102148";"carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]";"azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]";"acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]"
comp295779_c0_seq1;GAXK01116566.1;Q9VGZ5;8.72E-31;CWO_DROME;Transcription factor cwo (Protein clockwork orange);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007623; GO:0009952; GO:0030154; GO:0032922; GO:0042752; GO:0046983; GO:0048813; GO:0050767";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp2958062_c0_seq1;GAXK01016189.1;Q7PPU9;7.63E-33;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp2958885_c0_seq1;GAXK01016190.1;P48613;2.92E-13;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp29589_c0_seq1;GAXK01051981.1;Q5RFE4;6.84E-15;CPVL_PONAB;Probable serine carboxypeptidase CPVL (EC 3.4.16.-);serine-type carboxypeptidase activity [GO:0004185];GO:0004185;;;serine-type carboxypeptidase activity [GO:0004185]
comp29594_c1_seq1;GAXK01052056.1;Q9Y2H8;3.27E-23;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2959904_c0_seq1;GAXK01016199.1;Q6Q4H1;1.25E-27;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp29603_c0_seq1;GAXK01052142.1;P43487;6.00E-53;RANG_HUMAN;Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032]";"GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0007165; GO:0008536; GO:0016032; GO:0045296; GO:0046604; GO:0046907";"intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]";"cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]"
comp296156_c4_seq1;GAXK01108900.1;A0JMU5;5.18E-08;ANM9_XENLA;Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320);"cytoplasm [GO:0005737]; protein-arginine N-methyltransferase activity [GO:0016274]; mRNA processing [GO:0006397]";"GO:0005737; GO:0006397; GO:0016274";mRNA processing [GO:0006397];cytoplasm [GO:0005737];protein-arginine N-methyltransferase activity [GO:0016274]
comp29616_c0_seq1;GAXK01051979.1;Q2T9S7;2.11E-26;FBX7_BOVIN;F-box only protein 7;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein kinase binding [GO:0019901]; autophagy of mitochondrion [GO:0000422]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]";"GO:0000151; GO:0000422; GO:0005634; GO:0005739; GO:0005829; GO:0006626; GO:0016567; GO:0019901; GO:1903204; GO:1903599";"autophagy of mitochondrion [GO:0000422]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";protein kinase binding [GO:0019901]
comp2962080_c0_seq1;GAXK01081195.1;P27482;5.05E-09;CALL3_HUMAN;Calmodulin-like protein 3 (CaM-like protein) (CLP) (Calmodulin-related protein NB-1);"extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0070062";calcium-mediated signaling [GO:0019722];extracellular exosome [GO:0070062];calcium ion binding [GO:0005509]
comp2962397_c0_seq1;GAXK01081212.1;P51881;1.00E-49;ADT2_MOUSE;ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed];"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005471; GO:0005739; GO:0005743; GO:0007059; GO:0008284; GO:0016021; GO:0031625; GO:0042645; GO:0043209; GO:0045121; GO:0071817; GO:1901029; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]";"ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]"
comp29625_c0_seq1;GAXK01051481.1;Q6RUV5;2.80E-101;RAC1_RAT;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1);"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0006935; GO:0007015; GO:0007266; GO:0008045; GO:0008283; GO:0008361; GO:0010592; GO:0016020; GO:0016477; GO:0016601; GO:0017137; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030334; GO:0031116; GO:0031410; GO:0031996; GO:0032587; GO:0032707; GO:0034446; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048012; GO:0048870; GO:0051022; GO:0051117; GO:0051496; GO:0051668; GO:0051894; GO:0055038; GO:0060263; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098978; GO:1900026; GO:1902622";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"ATPase binding [GO:0051117]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]"
comp2962502_c0_seq1;GAXK01081225.1;Q86UD5;5.83E-43;SL9B2_HUMAN;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]"
comp2962505_c0_seq1;GAXK01081191.1;Q8PC00;8.76E-14;ASPN_XANCP;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp2963030_c0_seq1;GAXK01081193.1;O22860;1.76E-29;RL38_ARATH;60S ribosomal protein L38;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022625; GO:0022626";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp2963055_c0_seq1;GAXK01081220.1;Q6NP60;2.46E-08;MOX12_DROME;MOXD1 homolog 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005829; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp2963121_c0_seq1;GAXK01081208.1;B0WC46;1.34E-15;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp29633_c0_seq1;GAXK01205256.1;P62255;1.70E-51;UB2G1_RAT;Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0043161; GO:0061631; GO:0070534; GO:0070936";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp296359_c2_seq1;GAXK01108864.1;P32242;3.50E-11;OTX1_HUMAN;Homeobox protein OTX1 (Orthodenticle homolog 1);"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0009952; GO:0022037; GO:0030901; GO:0042472; GO:0045944; GO:0048852";"anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nuclear chromatin [GO:0000790];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp296378_c0_seq1;GAXK01108821.1;Q3UGF1;0;WDR19_MOUSE;WD repeat-containing protein 19 (Intraflagellar transport 144 homolog);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"GO:0000902; GO:0001701; GO:0001750; GO:0005654; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0008406; GO:0016604; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060830; GO:0060831; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441";"cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; intraciliary retrograde transport [GO:0035721]; in utero embryonic development [GO:0001701]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein-containing complex assembly [GO:0065003]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]";
comp2964_c0_seq1;GAXK01175372.1;P05661;1.18E-52;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp29641_c0_seq1;GAXK01051930.1;Q9R099;2.65E-105;TBL2_MOUSE;Transducin beta-like protein 2;"endoplasmic reticulum [GO:0005783]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]";"GO:0005783; GO:0019901; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456";"cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]";endoplasmic reticulum [GO:0005783];"phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; translation initiation factor binding [GO:0031369]"
comp29650_c0_seq1;GAXK01051823.1;Q9VE11;5.74E-15;U488_DROME;UPF0488 protein CG14286;;;;;
comp296585_c0_seq1;GAXK01108775.1;P25364;6.72E-14;HCM1_YEAST;Forkhead transcription factor HCM1 (High-copy suppressor of calmodulin protein 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle pole body organization [GO:0051300]";"GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007005; GO:0034599; GO:0043565; GO:0045944; GO:0051300";"cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle pole body organization [GO:0051300]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp296625_c0_seq1;GAXK01108752.1;Q6DN90;5.44E-95;IQEC1_HUMAN;IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005730; GO:0005737; GO:0008289; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0043547; GO:0051549; GO:1903393";"actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]"
comp2966293_c0_seq1;GAXK01034608.1;P23768;4.59E-14;GAT1B_XENLA;GATA-binding factor 1-B (Transcription factor xGATA-1B);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp2966658_c0_seq1;GAXK01034597.1;Q7ZX06;6.43E-19;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp2966747_c0_seq1;GAXK01034616.1;Q7RTY7;1.33E-21;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp296676_c2_seq1;GAXK01108800.1;A9Y006;1.42E-09;AQP3_PIG;Aquaporin-3 (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transport [GO:0015793]; water transport [GO:0006833]";"GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323";"glycerol transport [GO:0015793]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp2967708_c0_seq1;GAXK01034615.1;Q502M6;3.14E-20;ANR29_DANRE;Ankyrin repeat domain-containing protein 29;;;;;
comp2967899_c0_seq1;GAXK01034602.1;Q07230;4.16E-18;ZSCA2_MOUSE;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp2968_c2_seq1;GAXK01176493.1;C9WMM5;1.47E-98;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp29682_c10_seq1;GAXK01052071.1;O18737;2.71E-17;CACO2_BOVIN;Calcium-binding and coiled-coil domain-containing protein 2 (Antigen nuclear dot 52 kDa protein) (Nuclear domain 10 protein NDP52) (Nuclear domain 10 protein 52) (Nuclear dot protein 52);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; positive regulation of autophagosome maturation [GO:1901098]; response to interferon-gamma [GO:0034341]; xenophagy [GO:0098792]";"GO:0000421; GO:0005776; GO:0005829; GO:0005856; GO:0031410; GO:0034341; GO:0042803; GO:0048471; GO:0098792; GO:1901098";"positive regulation of autophagosome maturation [GO:1901098]; response to interferon-gamma [GO:0034341]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";protein homodimerization activity [GO:0042803]
comp29684_c2_seq1;GAXK01051848.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp296852_c1_seq1;GAXK01108807.1;Q1LYM3;1.49E-08;SPIR1_DANRE;Protein spire homolog 1;"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0015031; GO:0016192; GO:0030659; GO:0032154; GO:0045010; GO:0048471; GO:0070649; GO:2000781";"actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";actin binding [GO:0003779]
comp296905_c0_seq1;GAXK01108812.1;Q9EQC4;2.28E-86;ELOV4_MOUSE;Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]";"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp2969317_c0_seq1;GAXK01117726.1;Q7ZYS8;6.75E-17;RL10A_XENLA;60S ribosomal protein L10a;"large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp29697_c0_seq1;GAXK01052130.1;Q92664;2.79E-47;TF3A_HUMAN;Transcription factor IIIA (TFIIIA);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0005634; GO:0005654; GO:0006383; GO:0008097; GO:0009303; GO:0042273; GO:0046872";"ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp297022_c1_seq1;GAXK01108836.1;A6NLW8;4.36E-16;DUXA_HUMAN;Double homeobox protein A;"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]";"GO:0000790; GO:0000981; GO:0003677";;nuclear chromatin [GO:0000790];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp2970605_c0_seq1;GAXK01042694.1;Q86LG1;1.24E-14;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp2971158_c0_seq1;GAXK01042689.1;P0DJ57;7.28E-37;RL23A_TETTS;60S ribosomal protein L23A;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2971295_c0_seq1;GAXK01042704.1;Q8CCB5;1.44E-09;MET24_MOUSE;Methyltransferase-like protein 24 (EC 2.1.1.-);"extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]";"GO:0005576; GO:0008168";;extracellular region [GO:0005576];methyltransferase activity [GO:0008168]
comp297134_c1_seq1;GAXK01108692.1;Q6ZNG1;3.12E-29;ZN600_HUMAN;Zinc finger protein 600;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp29714_c2_seq1;GAXK01052143.1;E2ADG2;2.96E-40;PROH3_CAMFO;ITG-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp29717_c0_seq1;GAXK01051727.1;Q9CZJ1;2.55E-53;UTP11_MOUSE;Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]";"GO:0005615; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0043065";"nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";
comp2971762_c0_seq1;GAXK01042710.1;Q60431;2.54E-33;CASP3_MESAU;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0031647; GO:0097199; GO:1902004";"positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]
comp2971779_c0_seq1;GAXK01042706.1;Q86WZ6;5.96E-10;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2972047_c0_seq1;GAXK01180768.1;P17970;1.66E-23;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp2972083_c0_seq1;GAXK01180761.1;Q5R476;5.08E-15;RN111_PONAB;E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (RING-type E3 ubiquitin transferase Arkadia);"cytoplasm [GO:0005737]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0006281; GO:0007275; GO:0016567; GO:0016605; GO:0016740; GO:0032184; GO:0046872";"DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; PML body [GO:0016605]";"metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]"
comp297220_c1_seq1;GAXK01108809.1;Q8VIG1;3.43E-07;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp2972220_c0_seq1;GAXK01180746.1;Q96RW7;2.60E-10;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp297331_c0_seq1;GAXK01108778.1;Q9UBS5;0;GABR1_HUMAN;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]";"GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]";"G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]"
comp297344_c0_seq1;GAXK01108871.1;Q26622;7.97E-47;SHR2_STRPU;Orphan steroid hormone receptor 2 (SpSHR2);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp297381_c0_seq1;GAXK01108715.1;Q9BQK8;6.12E-55;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp297393_c2_seq1;GAXK01108757.1;Q5RBA5;8.60E-17;SQSTM_PONAB;Sequestosome-1 (Ubiquitin-binding protein p62);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"GO:0000932; GO:0002376; GO:0005080; GO:0005764; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0035973; GO:0042169; GO:0043122; GO:0043130; GO:0061912; GO:0070530; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp29743_c0_seq1;GAXK01051383.1;Q61249;1.37E-53;IGBP1_MOUSE;Immunoglobulin-binding protein 1 (Alpha4 phosphoprotein) (CD79a-binding protein 1) (Lymphocyte signal transduction molecule alpha 4) (Protein phosphatase 2/4/6 regulatory subunit) (p52);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877]; B cell activation [GO:0042113]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]";"GO:0000122; GO:0005737; GO:0005829; GO:0005874; GO:0019888; GO:0019904; GO:0031434; GO:0032873; GO:0034612; GO:0035306; GO:0035308; GO:0042113; GO:0043154; GO:0044877; GO:0045944; GO:0051721; GO:0060632; GO:0070555; GO:2001234";"B cell activation [GO:0042113]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]";"mitogen-activated protein kinase kinase binding [GO:0031434]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]"
comp2974511_c0_seq1;GAXK01028361.1;P61270;2.17E-63;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp2975_c1_seq1;GAXK01175878.1;Q9CY62;9.17E-34;RN181_MOUSE;E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0061630";"protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp297500_c0_seq1;GAXK01108843.1;P35778;1.45E-38;VA3_SOLIN;Venom allergen 3 (Allergen Sol i III) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol i 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp2975279_c0_seq1;GAXK01028365.1;Q6ZUK4;2.38E-15;TMM26_HUMAN;Transmembrane protein 26;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp297561_c0_seq1;GAXK01108674.1;Q8K007;2.80E-19;SULF1_MOUSE;Extracellular sulfatase Sulf-1 (mSulf-1) (EC 3.1.6.-);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; limb joint morphogenesis [GO:0036022]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; sulfur compound metabolic process [GO:0006790]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001502; GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0005886; GO:0006790; GO:0006915; GO:0007155; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0036022; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048661; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686";"apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; limb joint morphogenesis [GO:0036022]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; sulfur compound metabolic process [GO:0006790]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]"
comp2975740_c0_seq1;GAXK01028341.1;P35546;7.27E-97;RET_MOUSE;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp2975872_c0_seq1;GAXK01028360.1;Q8TC21;1.83E-18;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp29760_c2_seq1;GAXK01051936.1;Q8R1T4;1.20E-92;S35A3_MOUSE;UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3);"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]";"GO:0005794; GO:0008643; GO:0015165; GO:0030173; GO:1990569";"carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]";"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]";pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]
comp29761_c0_seq1;GAXK01052141.1;A6QQ14;1.32E-16;DPOE4_BOVIN;DNA polymerase epsilon subunit 4 (EC 2.7.7.7) (DNA polymerase II subunit 4);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; histone H3 acetylation [GO:0043966]";"GO:0003677; GO:0003887; GO:0005671; GO:0008622; GO:0043966; GO:0046982";histone H3 acetylation [GO:0043966];"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]"
comp297620_c0_seq1;GAXK01108733.1;F1RA39;2.98E-65;MCA2B_DANRE;Protein-methionine sulfoxide oxidase mical2b (EC 1.14.13.225) (Molecule interacting with CasL protein 2B) (MICAL-2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]";"GO:0001947; GO:0003779; GO:0004497; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016491; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]"
comp29763_c0_seq1;GAXK01051217.1;Q3MHJ5;1.32E-09;RM54_BOVIN;39S ribosomal protein L54, mitochondrial (L54mt) (MRP-L54);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005743; GO:0005762";;"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp297647_c0_seq1;GAXK01108820.1;P39806;2.09E-121;SALM_DROVI;Homeotic protein spalt-major;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2976529_c0_seq1;GAXK01039532.1;P48180;4.50E-08;ACH1_CAEEL;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp2976586_c0_seq1;GAXK01039538.1;Q9P2E2;1.02E-44;KIF17_HUMAN;Kinesin-like protein KIF17 (KIF3-related motor protein);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]";"GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030030; GO:0030992; GO:0032391; GO:0032839; GO:0035735; GO:0036064; GO:0043005; GO:0098971; GO:1990075";"anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp297681_c2_seq1;GAXK01108667.1;O45870;1.65E-38;NSMA_CAEEL;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp297715_c0_seq1;GAXK01108889.1;Q27607;0;DPOG1_DROME;DNA polymerase subunit gamma-1, mitochondrial (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (Protein tamas);"axon cytoplasm [GO:1904115]; gamma DNA polymerase complex [GO:0005760]; mitochondrion [GO:0005739]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; axonal transport of mitochondrion [GO:0019896]; determination of adult lifespan [GO:0008340]; DNA-dependent DNA replication [GO:0006261]; eclosion [GO:0007562]; mitochondrial DNA replication [GO:0006264]";"GO:0003677; GO:0003887; GO:0005739; GO:0005760; GO:0006261; GO:0006264; GO:0007562; GO:0008340; GO:0008408; GO:0019896; GO:1904115";"axonal transport of mitochondrion [GO:0019896]; determination of adult lifespan [GO:0008340]; DNA-dependent DNA replication [GO:0006261]; eclosion [GO:0007562]; mitochondrial DNA replication [GO:0006264]";"axon cytoplasm [GO:1904115]; gamma DNA polymerase complex [GO:0005760]; mitochondrion [GO:0005739]";"3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]"
comp2977217_c0_seq1;GAXK01039549.1;Q98989;4.66E-09;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp297723_c1_seq1;GAXK01108853.1;P51111;6.90E-167;HD_RAT;Huntingtin (Huntington disease protein homolog) (HD protein homolog) [Cleaved into: Huntingtin, myristoylated N-terminal fragment];"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; signaling receptor binding [GO:0005102]; central nervous system development [GO:0007417]; mRNA transport [GO:0051028]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; regulation of intracellular mRNA localization [GO:1904580]";"GO:0005102; GO:0005634; GO:0005776; GO:0005783; GO:0005829; GO:0007417; GO:0014069; GO:0030136; GO:0030424; GO:0030425; GO:0043025; GO:0048471; GO:0051028; GO:0071598; GO:0097060; GO:1904580; GO:2000117";"central nervous system development [GO:0007417]; mRNA transport [GO:0051028]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; regulation of intracellular mRNA localization [GO:1904580]";"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";signaling receptor binding [GO:0005102]
comp29775_c0_seq1;GAXK01052318.1;Q9BZI7;8.76E-38;REN3B_HUMAN;Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0006405; GO:0006406; GO:0017056; GO:0031124; GO:0035145; GO:0045727";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]"
comp2977622_c0_seq1;GAXK01039537.1;P83088;4.68E-28;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp2977699_c0_seq1;GAXK01039551.1;Q5VXM1;1.79E-57;CDCP2_HUMAN;CUB domain-containing protein 2;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp297777_c0_seq1;GAXK01108883.1;O02388;2.21E-15;CU22_BOMMO;Larval cuticle protein LCP-22;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp297809_c0_seq1;GAXK01108813.1;Q9W6Y1;2.03E-16;HSP7C_ORYLA;Heat shock cognate 71 kDa protein (Hsc70.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp2978523_c0_seq1;GAXK01200903.1;Q8TE60;3.25E-11;ATS18_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]";"GO:0001654; GO:0004222; GO:0005576; GO:0046872; GO:0090331";"eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp297918_c0_seq1;GAXK01108818.1;A2Q9L0;4.77E-23;CCR4_ASPNC;Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase);"CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]";"GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0030015; GO:0046872";nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289];"CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]";"metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]"
comp2979338_c0_seq1;GAXK01200899.1;O22608;8.99E-70;RL5_DUNSA;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp297938_c0_seq1;GAXK01108693.1;Q07553;1.02E-46;GCY3E_DROME;Guanylate cyclase 32E (EC 4.6.1.2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0019934; GO:0038023";"cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]"
comp2979387_c0_seq1;GAXK01200889.1;O57314;1.69E-07;DHB12_ANAPL;Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342";"estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]"
comp29794_c0_seq1;GAXK01052135.1;Q6PHY8;4.39E-18;SELTB_DANRE;Thioredoxin reductase-like selenoprotein T1b (EC 1.8.1.9);"endoplasmic reticulum membrane [GO:0005789]; thioredoxin-disulfide reductase activity [GO:0004791]";"GO:0004791; GO:0005789";;endoplasmic reticulum membrane [GO:0005789];thioredoxin-disulfide reductase activity [GO:0004791]
comp2979420_c0_seq1;GAXK01200916.1;Q14416;3.09E-20;GRM2_HUMAN;Metabotropic glutamate receptor 2 (mGluR2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0051966; GO:0090461; GO:0099055";"chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp297966_c0_seq1;GAXK01108819.1;Q9W719;1.35E-42;HPRT_CHICK;Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; guanine binding [GO:0002057]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine nucleobase binding [GO:0002060]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]";"GO:0000166; GO:0000287; GO:0002057; GO:0002060; GO:0004422; GO:0005694; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042803; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0051289; GO:0052657";"adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]";"guanine binding [GO:0002057]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine nucleobase binding [GO:0002060]"
comp297985_c1_seq1;GAXK01108887.1;O08699;2.06E-16;PGDH_RAT;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]"
comp297997_c0_seq1;GAXK01108756.1;Q8NB50;7.70E-19;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp2980_c0_seq1;GAXK01175284.1;P40689;5.32E-37;TSL_DROME;Torso-like protein;"extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; torso binding [GO:0005122]; embryonic pattern specification [GO:0009880]; germ cell development [GO:0007281]; maternal determination of anterior/posterior axis, embryo [GO:0008358]; pole cell fate determination [GO:0007278]; positive regulation of apical constriction involved in ventral furrow formation [GO:0110074]; positive regulation of multicellular organism growth [GO:0040018]; pupariation [GO:0035073]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]";"GO:0005122; GO:0005615; GO:0007278; GO:0007281; GO:0007362; GO:0008293; GO:0008358; GO:0009880; GO:0035073; GO:0040018; GO:0048018; GO:0110074";"embryonic pattern specification [GO:0009880]; germ cell development [GO:0007281]; maternal determination of anterior/posterior axis, embryo [GO:0008358]; pole cell fate determination [GO:0007278]; positive regulation of apical constriction involved in ventral furrow formation [GO:0110074]; positive regulation of multicellular organism growth [GO:0040018]; pupariation [GO:0035073]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]";extracellular space [GO:0005615];"receptor ligand activity [GO:0048018]; torso binding [GO:0005122]"
comp298006_c1_seq1;GAXK01042296.1;Q55CD9;9.85E-99;NDH_DICDI;Probable NADH dehydrogenase (EC 1.6.99.3);NADH dehydrogenase activity [GO:0003954];GO:0003954;;;NADH dehydrogenase activity [GO:0003954]
comp298014_c1_seq1;GAXK01042223.1;B5FYQ0;2.18E-93;ARL3_TAEGU;ADP-ribosylation factor-like protein 3;"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000139; GO:0000281; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0042461; GO:0060271";"cilium assembly [GO:0060271]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]";"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]"
comp298041_c0_seq1;GAXK01042260.1;Q5VUG0;1.45E-58;SMBT2_HUMAN;Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2);"aggresome [GO:0016235]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003714; GO:0005634; GO:0006355; GO:0010629; GO:0016235; GO:0016607; GO:0042393; GO:0043231";"negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]";"aggresome [GO:0016235]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]"
comp29811_c1_seq1;GAXK01051937.1;Q38813;3.26E-14;DNAJ1_ARATH;Chaperone protein dnaJ 1, mitochondrial (AtDjB1) (AtJ1);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0005739; GO:0009408; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051085";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp29815_c0_seq1;GAXK01052009.1;Q68FU5;2.42E-25;CI085_RAT;Uncharacterized protein C9orf85 homolog;;;;;
comp298230_c0_seq1;GAXK01042245.1;Q9FM14;1.28E-09;SIL11_ARATH;E3 ubiquitin-protein ligase SINA-like 11 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 11) (Seven in absentia-like protein 11);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp298269_c0_seq1;GAXK01042258.1;Q86W92;7.48E-95;LIPB1_HUMAN;Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2);"cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]";"GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0045296";cell adhesion [GO:0007155];"cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]";cadherin binding [GO:0045296]
comp2982692_c0_seq1;GAXK01069336.1;O08961;1.05E-07;ZN423_RAT;Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (rOAZ) (Smad- and Olf-interacting zinc finger protein);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0042803; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0046982; GO:0120163";"cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp2982783_c0_seq1;GAXK01069342.1;P84076;2.54E-24;HPCA_RAT;Neuron-specific calcium-binding protein hippocalcin (P23K);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; response to organic cyclic compound [GO:0014070]; retina development in camera-type eye [GO:0060041]";"GO:0003779; GO:0005509; GO:0005829; GO:0007420; GO:0010518; GO:0014070; GO:0019722; GO:0019898; GO:0019900; GO:0030424; GO:0031283; GO:0031584; GO:0032590; GO:0032809; GO:0032839; GO:0042802; GO:0043204; GO:0044327; GO:0045762; GO:0048839; GO:0060041; GO:0071257; GO:0071277; GO:0090314; GO:0098794; GO:0098978; GO:0099149; GO:1901385; GO:1901986; GO:1902065; GO:1904009; GO:1904010";"activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; response to organic cyclic compound [GO:0014070]; retina development in camera-type eye [GO:0060041]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; postsynapse [GO:0098794]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]"
comp298383_c0_seq1;GAXK01042221.1;Q9UHQ4;3.12E-13;BAP29_HUMAN;B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29);"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"GO:0001649; GO:0005789; GO:0005887; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0070973";"apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]";"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp2984449_c0_seq1;GAXK01159253.1;A0JNB1;1.70E-19;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2984531_c0_seq1;GAXK01159258.1;Q18297;5.05E-19;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp2984552_c0_seq1;GAXK01159269.1;Q96MU6;4.77E-10;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2984776_c0_seq1;GAXK01159256.1;Q4UMH6;4.64E-35;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp2984935_c0_seq1;GAXK01159267.1;Q9VZW5;8.27E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp298530_c0_seq1;GAXK01042263.1;Q54PN9;6.13E-16;ING1_DICDI;Inhibitor of growth protein 1 homolog;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; aggregation involved in sorocarp development [GO:0031152]; histone modification [GO:0016570]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0016570; GO:0031152; GO:0032991; GO:0035064; GO:0040008; GO:0046872";"aggregation involved in sorocarp development [GO:0031152]; histone modification [GO:0016570]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp298547_c0_seq1;GAXK01042275.1;Q8VD66;3.12E-79;ABHD4_MOUSE;(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4);"lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]";"GO:0004622; GO:0005811; GO:0016042; GO:0052689; GO:0055088; GO:0070291; GO:0070292";"lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]";lipid droplet [GO:0005811];"carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]"
comp298581_c1_seq1;GAXK01042239.1;Q8BQJ6;1.43E-63;TRM2_MOUSE;tRNA (uracil(54)-C(5))-methyltransferase homolog (EC 2.1.1.35) (TRM2 homolog);"mitochondrion [GO:0005739]; S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]";"GO:0005739; GO:0030697";;mitochondrion [GO:0005739];S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]
comp2986_c2_seq1;GAXK01176017.1;Q03168;2.08E-140;ASPP_AEDAE;Lysosomal aspartic protease (EC 3.4.23.-);"lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]";"GO:0004190; GO:0005764";;lysosome [GO:0005764];aspartic-type endopeptidase activity [GO:0004190]
comp2986177_c0_seq1;GAXK01090823.1;Q22165;1.91E-46;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp298627_c0_seq1;GAXK01042238.1;Q7KRI2;1.32E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp2987254_c0_seq1;GAXK01090828.1;Q8TCB0;2.12E-26;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp2987588_c0_seq1;GAXK01090821.1;Q9Y2P7;4.37E-16;ZN256_HUMAN;Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0045892; GO:0046872";"multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp298759_c0_seq1;GAXK01042378.1;Q8HXE3;8.96E-98;KMCP1_MACFA;Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial transport [GO:0006839]";"GO:0005743; GO:0006839; GO:0016021";mitochondrial transport [GO:0006839];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp298820_c0_seq1;GAXK01042307.1;P42690;1.10E-49;SRK4_SPOLA;Tyrosine-protein kinase isoform SRK4 (EC 2.7.10.2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524; GO:0005737";;cytoplasm [GO:0005737];"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp2988873_c0_seq1;GAXK01068838.1;A8MYZ0;4.61E-46;MIY4B_HUMAN;Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2);protein K48-linked deubiquitination [GO:0071108];GO:0071108;protein K48-linked deubiquitination [GO:0071108];;
comp29889_c0_seq1;GAXK01051883.1;Q32KN8;1.33E-67;TBA3_BOVIN;Tubulin alpha-3 chain (Alpha-tubulin 3) [Cleaved into: Detyrosinated tubulin alpha-3 chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp2989439_c0_seq1;GAXK01068828.1;Q95PM9;1.28E-142;KARG_PLOIN;Arginine kinase (AK) (EC 2.7.3.3) (allergen Plo i 1);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp298947_c1_seq1;GAXK01042298.1;Q96Q15;1.07E-11;SMG1_HUMAN;Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]";"GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0018105; GO:0032204; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020";"DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]"
comp298949_c0_seq1;GAXK01042281.1;Q9DBQ7;1.22E-35;PACE1_MOUSE;Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]";"GO:0004672; GO:0005524; GO:0005737; GO:0005794; GO:0030027";;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp298989_c0_seq1;GAXK01042257.1;P70414;4.48E-12;NAC1_MOUSE;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0008092; GO:0009791; GO:0010763; GO:0010881; GO:0014704; GO:0014829; GO:0016020; GO:0016021; GO:0016323; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0035994; GO:0036376; GO:0042383; GO:0042995; GO:0043197; GO:0043198; GO:0044325; GO:0044557; GO:0045211; GO:0048747; GO:0051481; GO:0051924; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0086036; GO:0086038; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]"
comp299_c0_seq1;GAXK01168570.1;Q6F444;4.35E-56;RL24_PLUXY;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp2990350_c0_seq1;GAXK01012858.1;Q4KTG9;1.59E-63;RL17_SUBDO;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp2990352_c0_seq1;GAXK01012879.1;Q9NBX4;2.89E-08;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp29907_c0_seq1;GAXK01051480.1;A8E4L1;1.50E-24;COX19_BOVIN;Cytochrome c oxidase assembly protein COX19;"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"GO:0005739; GO:0005758; GO:0005829; GO:0006878; GO:0033617";"cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]";"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";
comp2990811_c0_seq1;GAXK01012875.1;A0PJY2;1.51E-08;FEZF1_HUMAN;Fez family zinc finger protein 1 (Zinc finger protein 312B);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001227; GO:0001764; GO:0005634; GO:0005829; GO:0007411; GO:0008285; GO:0021772; GO:0021797; GO:0043697; GO:0045666; GO:0045893; GO:0046872";"axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp299112_c3_seq1;GAXK01042282.1;P32418;8.94E-27;NAC1_HUMAN;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular smooth muscle contraction [GO:0014829]";"GO:0002026; GO:0002027; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006883; GO:0006936; GO:0008092; GO:0009749; GO:0010649; GO:0010763; GO:0010881; GO:0010882; GO:0014704; GO:0014829; GO:0021537; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0033198; GO:0034614; GO:0035725; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042542; GO:0043197; GO:0043198; GO:0044325; GO:0044557; GO:0051481; GO:0055013; GO:0055074; GO:0055119; GO:0060048; GO:0060401; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071456; GO:0086012; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1903779; GO:1905060";"calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular smooth muscle contraction [GO:0014829]";"dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]"
comp2991793_c0_seq1;GAXK01012865.1;Q9JI93;1.85E-15;A4GAT_RAT;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp29918_c0_seq1;GAXK01051931.1;Q9VZH2;4.61E-07;MAS_DROME;Protein masquerade;"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007417; GO:0007422; GO:0010976; GO:0016203; GO:0030424; GO:0043025; GO:0061564; GO:0106030";"axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";
comp2991890_c0_seq1;GAXK01012864.1;E9QAG8;6.38E-08;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp2992043_c0_seq1;GAXK01057402.1;Q8NEV4;1.48E-20;MYO3A_HUMAN;Myosin-IIIa (EC 2.7.11.1);"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000146; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0030175; GO:0030898; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0050896; GO:0060002; GO:0090103";"cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp299227_c0_seq1;GAXK01042240.1;P59889;1.68E-20;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp29924_c0_seq1;GAXK01051948.1;Q9D4V0;3.25E-76;EKI1_MOUSE;Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646";phosphatidylethanolamine biosynthetic process [GO:0006646];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]"
comp299307_c0_seq1;GAXK01042241.1;P35500;0;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp2993078_c0_seq1;GAXK01057405.1;Q8NET6;9.10E-10;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp29931_c3_seq1;GAXK01052061.1;Q5XGI0;0;PRPS2_XENTR;Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp299325_c0_seq1;GAXK01042328.1;Q8N394;1.25E-88;TMTC2_HUMAN;Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269]";"GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0016021; GO:0035269; GO:0055074";"calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp2993548_c0_seq1;GAXK01057424.1;Q17328;3.31E-10;GLUCB_CAEEL;Glutamate-gated chloride channel subunit beta (Glu-Cl subunit beta) (Avermectin-sensitive glutamate-gated chloride channel subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp2993807_c0_seq1;GAXK01057408.1;Q8TF72;1.45E-10;SHRM3_HUMAN;Protein Shroom3 (Shroom-related protein) (hShrmL);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]";actin filament binding [GO:0051015]
comp2993933_c0_seq1;GAXK01057411.1;B4LPX5;6.41E-07;TRET1_DROVI;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp2994506_c0_seq1;GAXK01079489.1;Q8R0T2;5.57E-20;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp2995_c0_seq1;GAXK01176653.1;Q8K2K6;2.34E-42;AGFG1_MOUSE;Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP);"cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289]";"GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0007275; GO:0007289; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109; GO:0046872";"acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289]";"cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp299518_c0_seq1;GAXK01042225.1;Q9KBI9;1.41E-10;RRAAH_BACHD;Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase (HMG aldolase) (EC 4.1.3.17) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) (Regulator of ribonuclease activity homolog) (RraA-like protein);"4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0008948; GO:0046872; GO:0047443";;;"4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]"
comp2995215_c0_seq1;GAXK01079484.1;Q8T880;5.09E-26;AXP83_CIOIN;Axonemal 84 kDa protein (Ci-AXP83.9) (p83.9);;;;;
comp299556_c1_seq1;GAXK01042247.1;Q9EQW7;0;KI13A_MOUSE;Kinesin-like protein KIF13A;"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383";"cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp2995732_c0_seq1;GAXK01079493.1;Q9VZW5;2.69E-12;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp29964_c0_seq1;GAXK01051514.1;P48809;6.63E-87;RB27C_DROME;Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]";"GO:0003697; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0007411; GO:0008266; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904";"axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp2996595_c0_seq1;GAXK01153946.1;P36609;3.32E-22;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp2996681_c0_seq1;GAXK01153940.1;Q2KJG1;8.33E-14;SPAT6_BOVIN;Spermatogenesis-associated protein 6;"extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005576; GO:0007275; GO:0007283; GO:0030154; GO:0032027; GO:0044458; GO:0097224";"cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]";myosin light chain binding [GO:0032027]
comp299678_c0_seq1;GAXK01042255.1;P50429;6.07E-80;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp29972_c0_seq1;GAXK01052039.1;Q9Y3Z3;4.31E-108;SAMH1_HUMAN;Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337; GO:0060339; GO:0097197; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]";"dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]"
comp29974_c0_seq1;GAXK01051704.1;Q96H40;2.64E-19;ZN486_HUMAN;Zinc finger protein 486 (KRAB domain only protein 2);"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0070062";regulation of transcription, DNA-templated [GO:0006355];"extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp29976_c2_seq1;GAXK01051939.1;O46040;2.60E-29;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp299769_c2_seq1;GAXK01042226.1;F1NHE9;1.85E-94;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp2997744_c0_seq1;GAXK01153952.1;Q80WQ9;2.25E-21;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp299775_c0_seq1;GAXK01042279.1;Q28DB0;1.43E-135;TT39B_XENTR;Tetratricopeptide repeat protein 39B (TPR repeat protein 39B);lipid metabolic process [GO:0006629];GO:0006629;lipid metabolic process [GO:0006629];;
comp2997838_c0_seq1;GAXK01153950.1;Q05481;1.08E-14;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp2998_c0_seq1;GAXK01176019.1;B2KI79;1.08E-58;DOPP1_RHIFE;Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyldiphosphatase activity [GO:0047874]; protein glycosylation [GO:0006486]";"GO:0005789; GO:0006486; GO:0016021; GO:0047874";protein glycosylation [GO:0006486];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";dolichyldiphosphatase activity [GO:0047874]
comp29980_c0_seq1;GAXK01051995.1;Q62468;0;VILI_MOUSE;Villin-1;"actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]";"GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008360; GO:0009617; GO:0010634; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394";"actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]";"actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"
comp299806_c0_seq1;GAXK01042327.1;P40656;3.74E-20;SOX14_DROME;Putative transcription factor SOX-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0016322; GO:0030154; GO:0043565; GO:0044798; GO:0048813; GO:1904799; GO:1904801";"cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp29985_c3_seq1;GAXK01051857.1;P48758;1.31E-79;CBR1_MOUSE;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0016655; GO:0017144; GO:0042373; GO:0043231; GO:0047021; GO:0050221; GO:0055114";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"
comp299868_c0_seq1;GAXK01042269.1;Q9VEG6;1.83E-113;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp2998768_c0_seq1;GAXK01000115.1;Q8I6K0;4.89E-18;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp2998831_c0_seq1;GAXK01000124.1;Q9BY67;4.98E-07;CADM1_HUMAN;Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; viral process [GO:0016032]";"GO:0002376; GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007156; GO:0007157; GO:0007275; GO:0007283; GO:0008037; GO:0016021; GO:0016032; GO:0016323; GO:0030154; GO:0030165; GO:0034332; GO:0042271; GO:0042803; GO:0045202; GO:0045954; GO:0050715; GO:0051606";"adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; viral process [GO:0016032]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp2998933_c0_seq1;GAXK01000127.1;G3M4F8;2.95E-30;OCTB2_CHISP;Octopamine receptor beta-2R (CsOA2B2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]";"GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016021; GO:0071418; GO:0071927; GO:0071928";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]"
comp2998941_c0_seq1;GAXK01000116.1;Q9VCZ3;2.28E-20;OCTB1_DROME;Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]";"GO:0004935; GO:0004989; GO:0005887; GO:0007186; GO:0007188; GO:0007189; GO:0008227; GO:0016021; GO:0045886";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]"
comp29998_c0_seq1;GAXK01052042.1;P20241;0;NRG_DROME;Neuroglian;"bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]";"GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609";"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]";"bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]"
comp299992_c0_seq1;GAXK01042304.1;Q9BQA5;2.19E-66;HINFP_HUMAN;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000978; GO:0000981; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp2999957_c0_seq1;GAXK01000118.1;Q8N8E2;5.39E-08;ZN513_HUMAN;Zinc finger protein 513;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";"GO:0000979; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0044212; GO:0046872; GO:0050896; GO:0060041";"regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp3_c0_seq1;GAXK01165790.1;P23403;7.97E-67;RS20_XENLA;40S ribosomal protein S20 (S22);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp30_c2_seq1;GAXK01169285.1;Q6QAT0;1.25E-71;RL32_PIG;60S ribosomal protein L32;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0098556";translation [GO:0006412];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp3000128_c0_seq1;GAXK01094877.1;P16157;1.14E-27;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp300089_c0_seq1;GAXK01028027.1;O73874;5.05E-16;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp30015_c0_seq1;GAXK01049875.1;A2RRV3;1.70E-19;PATL1_DANRE;Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b);"nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]";"GO:0000290; GO:0000932; GO:0003723; GO:0016605; GO:0016607; GO:0033962";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]";"nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]";RNA binding [GO:0003723]
comp3001562_c0_seq1;GAXK01094892.1;Q07839;3.26E-25;EG13_ECHGR;Antigen EG13;;;;;
comp300222_c2_seq1;GAXK01027903.1;Q7SX99;0;FUMH_DANRE;Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2);"chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]";"GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]";"chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]";fumarate hydratase activity [GO:0004333]
comp3002796_c0_seq1;GAXK01107860.1;Q9SLG9;1.42E-24;PI5K5_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 5 (AtPIP5K5) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 5) (Diphosphoinositide kinase 5) (PtdIns(4)P-5-kinase 5);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol metabolic process [GO:0046488]; plant-type cell wall modification [GO:0009827]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]";"GO:0005524; GO:0005829; GO:0009827; GO:0009846; GO:0009860; GO:0016308; GO:0016324; GO:0046488; GO:0090406";"phosphatidylinositol metabolic process [GO:0046488]; plant-type cell wall modification [GO:0009827]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp30029_c1_seq1;GAXK01050124.1;Q6P963;1.46E-111;GLO2_DANRE;Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II);"mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]";"GO:0004416; GO:0005759; GO:0019243; GO:0046872";methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243];mitochondrial matrix [GO:0005759];"hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]"
comp300299_c0_seq1;GAXK01027925.1;P22814;5.64E-57;RUNT_DROME;Segmentation protein Runt;"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";"GO:0003700; GO:0005524; GO:0005634; GO:0007366; GO:0007367; GO:0007377; GO:0007400; GO:0007411; GO:0007419; GO:0007540; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048592";"axon guidance [GO:0007411]; eye morphogenesis [GO:0048592]; germ-band extension [GO:0007377]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; sex determination, establishment of X:A ratio [GO:0007540]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp3003258_c0_seq1;GAXK01107858.1;B1H1E4;5.27E-20;ARI1_XENTR;E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase arih1);"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0032436; GO:0061630; GO:0097413";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3004_c1_seq1;GAXK01176070.1;Q9N1Q0;6.22E-50;RSMB_MACEU;Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB');"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005683; GO:0005685; GO:0005687; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071005; GO:0071007";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U7 snRNP [GO:0005683]";RNA binding [GO:0003723]
comp30040_c0_seq1;GAXK01050139.1;Q9NFU0;4.17E-146;FMR1_DROME;Synaptic functional regulator FMR1 (Fragile X mental retardation syndrome-related protein 1) (dFMR1);"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendritic spine [GO:0043197]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; P granule [GO:0043186]; perikaryon [GO:0043204]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ribonucleoprotein granule [GO:0035770]; RISC complex [GO:0016442]; DEAD/H-box RNA helicase binding [GO:0017151]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; adult locomotory behavior [GO:0008344]; anterograde axonal transport [GO:0008089]; associative learning [GO:0008306]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellularization [GO:0007349]; central nervous system development [GO:0007417]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle, sleep [GO:0050802]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; grooming behavior [GO:0007625]; habituation [GO:0046959]; heterochromatin assembly [GO:0031507]; larval locomotory behavior [GO:0008345]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; mitotic cell cycle, embryonic [GO:0045448]; mRNA transport [GO:0051028]; mushroom body development [GO:0016319]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of synapse assembly [GO:0051964]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of translation [GO:0017148]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; neuron remodeling [GO:0016322]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte dorsal/ventral axis specification [GO:0007310]; pole cell formation [GO:0007279]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of programmed cell death [GO:0043068]; positive regulation of translation [GO:0045727]; regulation of cell population proliferation [GO:0042127]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine development [GO:0060998]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of modification of synaptic structure [GO:1905244]; regulation of mRNA stability [GO:0043488]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of olfactory learning [GO:0090328]; regulation of synapse organization [GO:0050807]; regulation of synapse structural plasticity [GO:0051823]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to odorant [GO:1990834]; short-term memory [GO:0007614]; social behavior [GO:0035176]; sperm axoneme assembly [GO:0007288]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synapse pruning [GO:0098883]; synaptic vesicle budding [GO:0070142]; synaptic vesicle clustering [GO:0097091]; terminal button organization [GO:0072553]; visual perception [GO:0007601]";"GO:0002052; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005844; GO:0006417; GO:0007279; GO:0007281; GO:0007288; GO:0007294; GO:0007310; GO:0007349; GO:0007409; GO:0007411; GO:0007413; GO:0007416; GO:0007417; GO:0007420; GO:0007528; GO:0007601; GO:0007614; GO:0007616; GO:0007623; GO:0007625; GO:0008049; GO:0008089; GO:0008306; GO:0008344; GO:0008345; GO:0008355; GO:0009794; GO:0010494; GO:0010629; GO:0014069; GO:0016319; GO:0016322; GO:0016442; GO:0017148; GO:0017151; GO:0030054; GO:0030424; GO:0031047; GO:0031507; GO:0032838; GO:0035176; GO:0035770; GO:0036464; GO:0040011; GO:0042048; GO:0042127; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043186; GO:0043197; GO:0043204; GO:0043488; GO:0043621; GO:0045182; GO:0045448; GO:0045475; GO:0045571; GO:0045727; GO:0045886; GO:0046627; GO:0046959; GO:0048134; GO:0048812; GO:0048813; GO:0048814; GO:0050774; GO:0050802; GO:0050807; GO:0050808; GO:0050976; GO:0051028; GO:0051823; GO:0051964; GO:0060998; GO:0070142; GO:0071598; GO:0072375; GO:0072553; GO:0090328; GO:0097091; GO:0098793; GO:0098883; GO:0099578; GO:1900073; GO:1900364; GO:1904115; GO:1905244; GO:1990124; GO:1990834";"adult locomotory behavior [GO:0008344]; anterograde axonal transport [GO:0008089]; associative learning [GO:0008306]; axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellularization [GO:0007349]; central nervous system development [GO:0007417]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle, sleep [GO:0050802]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; gene silencing by RNA [GO:0031047]; germarium-derived oocyte fate determination [GO:0007294]; germ cell development [GO:0007281]; germ-line cyst formation [GO:0048134]; grooming behavior [GO:0007625]; habituation [GO:0046959]; heterochromatin assembly [GO:0031507]; larval locomotory behavior [GO:0008345]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; mitotic cell cycle, embryonic [GO:0045448]; mRNA transport [GO:0051028]; mushroom body development [GO:0016319]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of synapse assembly [GO:0051964]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of translation [GO:0017148]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; neuron remodeling [GO:0016322]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte dorsal/ventral axis specification [GO:0007310]; pole cell formation [GO:0007279]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of programmed cell death [GO:0043068]; positive regulation of translation [GO:0045727]; regulation of cell population proliferation [GO:0042127]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine development [GO:0060998]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of modification of synaptic structure [GO:1905244]; regulation of mRNA stability [GO:0043488]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of olfactory learning [GO:0090328]; regulation of synapse organization [GO:0050807]; regulation of synapse structural plasticity [GO:0051823]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to odorant [GO:1990834]; short-term memory [GO:0007614]; social behavior [GO:0035176]; sperm axoneme assembly [GO:0007288]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synapse pruning [GO:0098883]; synaptic vesicle budding [GO:0070142]; synaptic vesicle clustering [GO:0097091]; terminal button organization [GO:0072553]; visual perception [GO:0007601]";"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendritic spine [GO:0043197]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; P granule [GO:0043186]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ribonucleoprotein granule [GO:0035770]; RISC complex [GO:0016442]";"DEAD/H-box RNA helicase binding [GO:0017151]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]"
comp3004926_c0_seq1;GAXK01181759.1;Q0VFN8;6.73E-32;CF157_XENTR;Cilia- and flagella-associated protein 157;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288]";"GO:0005737; GO:0007288; GO:0008017; GO:0036064";sperm axoneme assembly [GO:0007288];"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]";microtubule binding [GO:0008017]
comp3005028_c0_seq1;GAXK01181764.1;Q9TTJ7;8.68E-25;KCNQ1_PIG;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) (Fragment);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005769; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016021; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0071805; GO:0086009; GO:0086089; GO:0097623; GO:1902282";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp300516_c0_seq1;GAXK01027971.1;Q05319;3.59E-59;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3005200_c0_seq1;GAXK01181753.1;Q94900;1.29E-11;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3005290_c0_seq1;GAXK01181758.1;Q9VTG7;3.45E-28;B3G2P_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0005794; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695";"cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"
comp30054_c0_seq1;GAXK01050286.1;Q9CXE0;8.33E-26;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3005587_c0_seq1;GAXK01181765.1;Q96JL9;2.78E-08;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp300564_c1_seq1;GAXK01028040.1;Q61830;7.87E-11;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp300596_c0_seq1;GAXK01027924.1;Q6GMR7;4.36E-110;FAAH2_HUMAN;Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2);"integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]";"GO:0005811; GO:0016021; GO:0017064; GO:0019369; GO:0102077; GO:0103073";arachidonic acid metabolic process [GO:0019369];"integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]"
comp30061_c1_seq1;GAXK01049725.1;P14735;0;IDE_HUMAN;Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006625; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032461; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0045861; GO:0050435; GO:0051260; GO:0051289; GO:0051291; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"
comp3006211_c0_seq1;GAXK01120174.1;Q5XJQ7;8.59E-08;OSR1_DANRE;Protein odd-skipped-related 1 (zOsr1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; angioblast cell differentiation [GO:0035779]; glomerular visceral epithelial cell differentiation [GO:0072112]; intermediate mesoderm development [GO:0048389]; kidney development [GO:0001822]; mesendoderm development [GO:0048382]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pectoral fin development [GO:0033339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric distal tubule development [GO:0035777]; pronephric glomerulus morphogenesis [GO:0035775]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; pronephric proximal tubule development [GO:0035776]; pronephros development [GO:0048793]; regulation of endodermal cell differentiation [GO:1903224]; regulation of nodal signaling pathway [GO:1900107]; urogenital system development [GO:0001655]";"GO:0000122; GO:0000977; GO:0001655; GO:0001822; GO:0005634; GO:0033339; GO:0035775; GO:0035776; GO:0035777; GO:0035778; GO:0035779; GO:0045892; GO:0045944; GO:0046872; GO:0048382; GO:0048389; GO:0048793; GO:0072112; GO:1900107; GO:1903224";"angioblast cell differentiation [GO:0035779]; glomerular visceral epithelial cell differentiation [GO:0072112]; intermediate mesoderm development [GO:0048389]; kidney development [GO:0001822]; mesendoderm development [GO:0048382]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric distal tubule development [GO:0035777]; pronephric glomerulus morphogenesis [GO:0035775]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; pronephric proximal tubule development [GO:0035776]; pronephros development [GO:0048793]; regulation of endodermal cell differentiation [GO:1903224]; regulation of nodal signaling pathway [GO:1900107]; urogenital system development [GO:0001655]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3006294_c0_seq1;GAXK01120196.1;Q9DAJ5;1.07E-34;DLRB2_MOUSE;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505";microtubule-based movement [GO:0007018];"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp30064_c1_seq1;GAXK01049964.1;P06605;7.66E-111;TBA3_DROME;Tubulin alpha-3 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]";"GO:0000226; GO:0000278; GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0007283; GO:0007288; GO:0017022; GO:0048471";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; spermatogenesis [GO:0007283]; sperm axoneme assembly [GO:0007288]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]"
comp300663_c0_seq1;GAXK01027956.1;Q5XGI0;5.98E-156;PRPS2_XENTR;Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp3007498_c0_seq1;GAXK01120181.1;P0DH95;1.43E-08;CALM1_ARATH;Calmodulin-1 (CaM-1);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005886; GO:0019722";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp300758_c1_seq1;GAXK01028067.1;A9ZSY2;7.43E-48;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3007936_c0_seq1;GAXK01120171.1;P17972;1.29E-36;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp3007943_c0_seq1;GAXK01120191.1;A5HK05;1.62E-47;APBP2_RAT;Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2);"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]";"GO:0005634; GO:0005874; GO:0006886; GO:0030659";intracellular protein transport [GO:0006886];"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]";
comp3008199_c0_seq1;GAXK01189788.1;Q16YG0;3.43E-98;CDC42_AEDAE;Cdc42 homolog;"adherens junction [GO:0005912]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0007264; GO:0007275; GO:0045185; GO:0045860";"maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]";"adherens junction [GO:0005912]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3008752_c0_seq1;GAXK01189791.1;O93403;2.09E-16;CHST3_TETCF;Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Nervous system involved sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 6-sulfotransferase activity [GO:0008459]; carbohydrate metabolic process [GO:0005975]";"GO:0000139; GO:0005975; GO:0008459; GO:0016021";carbohydrate metabolic process [GO:0005975];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";chondroitin 6-sulfotransferase activity [GO:0008459]
comp3008988_c0_seq1;GAXK01189806.1;Q95VA8;1.80E-36;TPM_TRISP;Tropomyosin;;;;;
comp300937_c0_seq1;GAXK01028029.1;Q9ZQ47;2.75E-42;GRDP1_ARATH;Glycine-rich domain-containing protein 1 (AtGRDP1);"plasma membrane [GO:0005886]; abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]";"GO:0005886; GO:0009738; GO:0009787; GO:0071470";"abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]";plasma membrane [GO:0005886];
comp300959_c1_seq1;GAXK01027965.1;Q9V477;0;TOLL8_DROME;Toll-like receptor Tollo (Toll-like receptor 8);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]";"GO:0002227; GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0048935; GO:0060026; GO:0060049";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";
comp30098_c1_seq1;GAXK01049973.1;Q08CL3;2.15E-14;KBTB8_DANRE;Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP);"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"GO:0005794; GO:0005819; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463";"neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]";
comp3009904_c0_seq1;GAXK01189783.1;P31674;9.51E-60;RS15_ORYSJ;40S ribosomal protein S15;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp301_c0_seq1;GAXK01168204.1;Q9BKS0;4.25E-18;AT5G_CAEEL;ATP synthase lipid-binding protein, mitochondrial (ATP synthase c subunit) (ATPase protein 9) (ATPase subunit c);"integral component of membrane [GO:0016021]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000276; GO:0008289; GO:0015986; GO:0016021; GO:0045263; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";"lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp301014_c0_seq1;GAXK01027922.1;Q5R7K0;2.87E-54;HSDL1_PONAB;Inactive hydroxysteroid dehydrogenase-like protein 1;"mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0055114";oxidation-reduction process [GO:0055114];mitochondrion [GO:0005739];
comp301101_c0_seq1;GAXK01028044.1;P21896;2.66E-25;H2A_CHITH;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp3011105_c0_seq1;GAXK01136101.1;Q94HW2;2.14E-21;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3011118_c0_seq1;GAXK01136113.1;Q9VZW5;4.48E-19;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp301112_c0_seq1;GAXK01027921.1;Q9HCK4;4.53E-81;ROBO2_HUMAN;Roundabout homolog 2;"axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]";"GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021510; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062";"aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]";"axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]"
comp30112_c0_seq1;GAXK01049718.1;Q9BUQ8;3.90E-113;DDX23_HUMAN;Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000354; GO:0000375; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0070062; GO:0071013";"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp301131_c0_seq1;GAXK01028002.1;Q12797;8.44E-40;ASPH_HUMAN;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]"
comp301136_c1_seq1;GAXK01027964.1;Q8FZV1;1.02E-19;CRCB1_BRUSU;Putative fluoride ion transporter CrcB 1;"integral component of plasma membrane [GO:0005887]; inorganic anion transmembrane transporter activity [GO:0015103]";"GO:0005887; GO:0015103";;integral component of plasma membrane [GO:0005887];inorganic anion transmembrane transporter activity [GO:0015103]
comp3011481_c0_seq1;GAXK01136116.1;Q03720;6.82E-134;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp301176_c0_seq1;GAXK01027966.1;A9CEQ8;1.26E-49;GCI_AGRFC;D-galactarolactone cycloisomerase (EC 5.5.1.27);"isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; cellular amino acid catabolic process [GO:0009063]";"GO:0009063; GO:0016853; GO:0046872";cellular amino acid catabolic process [GO:0009063];;"isomerase activity [GO:0016853]; metal ion binding [GO:0046872]"
comp30118_c0_seq1;GAXK01049756.1;Q28895;2.87E-14;NPC2_CANLF;NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (cE1) (Niemann Pick type C2 protein homolog);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0030301; GO:0032367; GO:0032934; GO:0033344; GO:0120020";"cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]"
comp301205_c2_seq1;GAXK01027913.1;P24014;0;SLIT_DROME;"Protein slit (dSlit) [Cleaved into: Protein slit N-product; Protein slit C-product]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell migration [GO:0008078]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"GO:0001764; GO:0003151; GO:0005509; GO:0005576; GO:0005886; GO:0007411; GO:0007427; GO:0007432; GO:0007502; GO:0007509; GO:0008078; GO:0008201; GO:0008347; GO:0008406; GO:0010632; GO:0016199; GO:0016201; GO:0022409; GO:0030182; GO:0030335; GO:0035050; GO:0035385; GO:0048495; GO:0048813; GO:0050929; GO:0071666; GO:2000274";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesodermal cell migration [GO:0008078]; mesoderm migration involved in gastrulation [GO:0007509]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell migration [GO:0030335]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]"
comp3012109_c0_seq1;GAXK01080487.1;Q62651;6.75E-21;ECH1_RAT;Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]";"GO:0005739; GO:0005777; GO:0006635; GO:0051750";fatty acid beta-oxidation [GO:0006635];"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]
comp3012234_c0_seq1;GAXK01080496.1;Q9VA73;0;CMC_DROME;Calcium-binding mitochondrial carrier protein Aralar1;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490";"aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]"
comp3012475_c0_seq1;GAXK01080507.1;Q9GZV8;1.20E-07;PRD14_HUMAN;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp30129_c0_seq1;GAXK01049884.1;D3ZKV9;1.32E-28;MSS51_RAT;Putative protein MSS51 homolog, mitochondrial (Zinc finger MYND domain-containing protein 17);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp3013330_c0_seq1;GAXK01080512.1;Q91453;4.03E-18;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp30136_c0_seq1;GAXK01050272.1;Q8GWS0;1.00E-12;GRXC5_ARATH;Glutaredoxin-C5, chloroplastic (AtGrxC5);"chloroplast [GO:0009507]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; iron-sulfur cluster assembly [GO:0016226]";"GO:0004362; GO:0009055; GO:0009507; GO:0015035; GO:0016226; GO:0034599; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; iron-sulfur cluster assembly [GO:0016226]";chloroplast [GO:0009507];"electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]"
comp3013603_c0_seq1;GAXK01080505.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp301363_c0_seq1;GAXK01027962.1;P86854;4.17E-19;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp301364_c3_seq1;GAXK01028004.1;Q9V4U9;9.81E-69;C6A13_DROME;Probable cytochrome P450 6a13 (EC 1.14.-.-) (CYPVIA13);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; defense response to bacterium [GO:0042742]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037; GO:0042742";defense response to bacterium [GO:0042742];endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp301370_c0_seq1;GAXK01027907.1;Q17QS0;1.02E-78;SCRN3_BOVIN;Secernin-3;"dipeptidase activity [GO:0016805]; exocytosis [GO:0006887]";"GO:0006887; GO:0016805";exocytosis [GO:0006887];;dipeptidase activity [GO:0016805]
comp3013756_c0_seq1;GAXK01080514.1;P05084;6.84E-08;HUNB_DROME;Protein hunchback;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";"GO:0000122; GO:0000980; GO:0000981; GO:0003700; GO:0005634; GO:0007354; GO:0007400; GO:0007402; GO:0007419; GO:0007431; GO:0035289; GO:0035290; GO:0040034; GO:0043565; GO:0044324; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048699; GO:0050767; GO:2000177";"ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp3013843_c0_seq1;GAXK01080493.1;Q3UHD1;2.40E-08;AGRB1_MOUSE;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]"
comp3014_c0_seq2;GAXK01175815.1;Q1HR47;4.67E-115;EIF3F_AEDAE;Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Eukaryotic translation initiation factor 3 subunit 5);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";"translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp3014402_c0_seq1;GAXK01064461.1;O61492;4.68E-137;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp3014506_c0_seq1;GAXK01064452.1;P37236;2.18E-07;FREQ_DROME;Frequenin-1 (d-FRQ);"membrane [GO:0016020]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0007268; GO:0007269; GO:0007528; GO:0008048; GO:0016020; GO:0046928; GO:0098793";"chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"membrane [GO:0016020]; presynapse [GO:0098793]";"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp3014539_c0_seq1;GAXK01064455.1;Q18321;7.51E-08;DAF37_CAEEL;G-protein coupled receptor daf-37 (Abnormal dauer formation protein 37);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"GO:0005794; GO:0005886; GO:0008528; GO:0016021; GO:0042803; GO:0046982; GO:0097730; GO:1904066; GO:1904067; GO:1904068";"G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp3014697_c0_seq1;GAXK01064457.1;B7TB45;1.83E-17;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp301528_c1_seq1;GAXK01027961.1;Q5RE69;4.50E-32;NEP_PONAB;Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10);"axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cardiolipin binding [GO:1901612]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; learning or memory [GO:0007611]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]";"GO:0001786; GO:0001822; GO:0004222; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005903; GO:0006508; GO:0006518; GO:0007611; GO:0008021; GO:0008238; GO:0008270; GO:0016021; GO:0019233; GO:0030424; GO:0030425; GO:0042277; GO:0042803; GO:0043025; GO:0044306; GO:0045121; GO:0045202; GO:0046449; GO:0050435; GO:0050769; GO:0061837; GO:0071345; GO:0071492; GO:0071493; GO:0090399; GO:0150094; GO:1900273; GO:1901612";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; learning or memory [GO:0007611]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]";"axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]";"cardiolipin binding [GO:1901612]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp3015310_c0_seq1;GAXK01064444.1;Q9FS87;1.40E-54;IVD_SOLTU;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Isovaleryl-CoA dehydrogenase 2) (St-IVD2);"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; 3-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902198]; isovaleryl-CoA(4-) catabolic process [GO:1902196]; leucine catabolic process [GO:0006552]";"GO:0005739; GO:0006552; GO:0008470; GO:0050660; GO:1902196; GO:1902198";"3-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902198]; isovaleryl-CoA(4-) catabolic process [GO:1902196]; leucine catabolic process [GO:0006552]";mitochondrion [GO:0005739];"flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]"
comp301572_c0_seq1;GAXK01027878.1;Q9VIS1;5.33E-43;CDGAP_DROME;GTPase-activating protein CdGAPr (d-CdGAPr);"GTPase activator activity [GO:0005096]; retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0007264; GO:0031290";"retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";;GTPase activator activity [GO:0005096]
comp30159_c0_seq1;GAXK01050271.1;Q24143;3.76E-68;HR96_DROME;Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]";"GO:0000976; GO:0000977; GO:0000981; GO:0004879; GO:0005634; GO:0006357; GO:0007275; GO:0008134; GO:0008270; GO:0030154; GO:0030374; GO:0038023; GO:0042594; GO:0042632; GO:0045944; GO:0070328; GO:0070873; GO:0090575";"cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp3015967_c0_seq1;GAXK01064447.1;P42768;1.93E-22;WASP_HUMAN;Wiskott-Aldrich syndrome protein (WASp);"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"GO:0000147; GO:0002625; GO:0005634; GO:0005829; GO:0005884; GO:0005911; GO:0006897; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030479; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0038096; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0048365; GO:0050852; GO:0051015; GO:0051492; GO:0051497; GO:0051666; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146; GO:2000601";"actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament-based movement [GO:0030048]; actin filament polymerization [GO:0030041]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]";"actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]"
comp3015985_c0_seq1;GAXK01064454.1;P07949;1.13E-101;RET_HUMAN;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007399; GO:0007411; GO:0007497; GO:0010008; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp301609_c0_seq1;GAXK01028001.1;E9QAG8;9.67E-18;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3016092_c0_seq1;GAXK01146865.1;Q2KIL5;1.16E-10;PDIA5_BOVIN;Protein disulfide-isomerase A5 (EC 5.3.4.1);"endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005788; GO:0015037; GO:0045454";cell redox homeostasis [GO:0045454];endoplasmic reticulum lumen [GO:0005788];"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp3016341_c0_seq1;GAXK01146862.1;Q06985;2.45E-14;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp30169_c2_seq1;GAXK01049805.1;P0DPU3;1.67E-128;TX14A_SCOSD;"Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]";"extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729";"glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]"
comp3017_c0_seq1;GAXK01176501.1;Q9VZD5;1.26E-29;RT06_DROME;Probable 28S ribosomal protein S6, mitochondrial (MRP-S6) (S6mt);"mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005763; GO:0006412; GO:0032543; GO:0070181";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp3017671_c0_seq1;GAXK01146864.1;Q61847;4.44E-18;MEP1B_MOUSE;Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B);"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998]";"GO:0004222; GO:0005576; GO:0005887; GO:0006954; GO:0008270; GO:0016020; GO:0017090; GO:0042802; GO:1901998";"inflammatory response [GO:0006954]; toxin transport [GO:1901998]";"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; meprin A complex [GO:0017090]";"identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3017691_c0_seq1;GAXK01146863.1;P02993;1.22E-68;EF1A_ARTSA;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3017817_c0_seq1;GAXK01146847.1;G5ED00;3.42E-07;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp3017915_c0_seq1;GAXK01146856.1;Q2M3R5;3.33E-09;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3017986_c0_seq1;GAXK01146867.1;P81429;3.21E-19;EST1_SCHGA;Esterase SG1 (EC 3.1.1.1) (Carboxylic-ester hydrolase) (Fragment);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp30180_c0_seq1;GAXK01050268.1;A0JN27;4.26E-135;TF2H2_RAT;General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit);"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000438; GO:0003676; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006468; GO:0008270";"nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]";"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp3018009_c0_seq1;GAXK01095794.1;Q8TD17;1.26E-16;ZN398_HUMAN;Zinc finger protein 398 (Zinc finger DNA-binding protein p52/p71);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3018031_c0_seq1;GAXK01095799.1;Q9VCA2;8.22E-39;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp301813_c1_seq1;GAXK01027911.1;Q5U3C3;2.43E-58;TM164_HUMAN;Transmembrane protein 164;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp301870_c1_seq1;GAXK01028043.1;Q9VBW3;1.25E-35;CAD96_DROME;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0008284; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp301884_c0_seq1;GAXK01027926.1;Q7KRI2;3.09E-38;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp301915_c0_seq1;GAXK01027997.1;P08155;3.68E-35;KRH1_DROME;Krueppel homolog 1 (Krueppel homologous protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007552; GO:0010977; GO:0035075; GO:0045316; GO:0046872";"metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp301974_c0_seq1;GAXK01027923.1;Q5GH73;4.32E-21;XKR6_HUMAN;XK-related protein 6;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742";"apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp3019963_c0_seq1;GAXK01095791.1;Q99044;4.93E-26;LAC1_TRAVI;Laccase-1 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 1) (Diphenol oxidase 1) (Urishiol oxidase 1);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp3020898_c0_seq1;GAXK01063909.1;D3ZEN0;2.91E-23;MILK2_RAT;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp30209_c0_seq1;GAXK01050401.1;Q5BL73;1.38E-24;DDA1_XENTR;DET1- and DDB1-associated protein 1;"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]";"GO:0032436; GO:0080008";positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436];Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
comp3021269_c0_seq1;GAXK01063904.1;Q13105;2.75E-18;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp302172_c2_seq1;GAXK01117173.1;Q05319;1.82E-40;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3022210_c0_seq1;GAXK01045300.1;P40313;3.05E-24;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp302225_c1_seq1;GAXK01117362.1;Q6ZMG9;1.24E-62;CERS6_HUMAN;Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"GO:0000981; GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0050291";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]"
comp3022315_c0_seq1;GAXK01045286.1;Q02975;9.43E-11;Z354A_RAT;Zinc finger protein 354A (Kidney, ischemia, and developmentally-regulated protein 1) (Renal transcription factor Kid-1) (Transcription factor 17) (TCF-17);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleolar fragmentation [GO:0007576]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]";"GO:0000122; GO:0001666; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005730; GO:0007576; GO:0046872; GO:0051593";"kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleolar fragmentation [GO:0007576]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp30235_c1_seq1;GAXK01050336.1;P36609;1.37E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp302360_c1_seq1;GAXK01117160.1;Q95NQ0;2.49E-17;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp30239_c11_seq1;GAXK01050159.1;Q01820;1.19E-117;GCL_DROME;Protein germ cell-less;"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of transcription, DNA-templated [GO:0045892]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0005634; GO:0005635; GO:0005643; GO:0005938; GO:0007278; GO:0007279; GO:0007281; GO:0007315; GO:0016480; GO:0031234; GO:0031463; GO:0034399; GO:0043161; GO:0045892; GO:0120177; GO:1990756";"germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase III [GO:0016480]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]";"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]";protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]
comp3024064_c0_seq1;GAXK01119879.1;Q3UVD5;7.86E-13;LGR6_MOUSE;Leucine-rich repeat-containing G-protein coupled receptor 6;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"GO:0004930; GO:0005615; GO:0005886; GO:0016021; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523";"bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3024208_c0_seq1;GAXK01119875.1;P08159;9.82E-07;HDNO_PSEOX;6-hydroxy-D-nicotine oxidase (6-HDNO) (EC 1.5.3.6);"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]; nicotine catabolic process [GO:0019608]";"GO:0018530; GO:0019608; GO:0071949";nicotine catabolic process [GO:0019608];;"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]"
comp302444_c0_seq1;GAXK01117450.1;Q76MY7;3.94E-45;CYH2_CHLAE;Cytohesin-2 (PH, SEC7 and coiled-coil domain-containing protein 2);"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005737; GO:0005886; GO:0008289; GO:0030426; GO:0032012; GO:0070679";regulation of ARF protein signal transduction [GO:0032012];"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"
comp3024948_c0_seq1;GAXK01119873.1;Q09324;3.18E-10;GCNT1_MOUSE;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT);"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0006486; GO:0009101; GO:0016021; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993";"cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]";"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp3025017_c0_seq1;GAXK01119887.1;Q8TCX5;7.44E-38;RHPN1_HUMAN;Rhophilin-1 (GTP-Rho-binding protein 1);"cytosol [GO:0005829]; signal transduction [GO:0007165]";"GO:0005829; GO:0007165";signal transduction [GO:0007165];cytosol [GO:0005829];
comp3025285_c0_seq1;GAXK01119893.1;Q4ZJI4;1.55E-19;SL9B1_HUMAN;Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228";"flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]";solute:proton antiporter activity [GO:0015299]
comp302585_c1_seq1;GAXK01117325.1;Q4TZY1;1.94E-96;KCJ12_BOVIN;ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp3026038_c0_seq1;GAXK01063166.1;Q12719;4.87E-18;LAC4_TRAVE;Laccase-4 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 4) (Diphenol oxidase 4) (Urishiol oxidase 4);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp302622_c2_seq1;GAXK01117429.1;Q7ZVX5;1.17E-36;REEP3_DANRE;Receptor expression-enhancing protein 3;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"GO:0005789; GO:0005874; GO:0006998; GO:0007084; GO:0016021; GO:0051301";"cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]";
comp30263_c0_seq1;GAXK01049972.1;Q6GQE7;1.48E-133;ATG3_XENLA;Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like);"cytoplasm [GO:0005737]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031]";"GO:0000045; GO:0005737; GO:0015031; GO:0019776; GO:0019777; GO:0043653";"autophagosome assembly [GO:0000045]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031]";cytoplasm [GO:0005737];"Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]"
comp3026492_c0_seq1;GAXK01063158.1;Q7Z0G7;7.71E-34;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3026710_c0_seq1;GAXK01063163.1;Q22710;2.04E-15;NAS26_CAEEL;Zinc metalloproteinase nas-26 (EC 3.4.24.-) (Nematode astacin 26) (Tollish protein 1);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996";molting cycle, collagen and cuticulin-based cuticle [GO:0018996];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp302703_c1_seq1;GAXK01117339.1;Q27433;6.41E-58;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp3027089_c0_seq1;GAXK01063167.1;P02623;1.21E-07;PRVB_LATCH;Parvalbumin beta;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp30275_c0_seq1;GAXK01050200.1;Q5U4X5;4.65E-36;NDC80_XENTR;Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2);"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase plate congression [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]";"GO:0000776; GO:0000777; GO:0000778; GO:0007052; GO:0007059; GO:0031262; GO:0051301; GO:0051310; GO:0051315; GO:0090267";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase plate congression [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]";"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]";
comp302754_c0_seq1;GAXK01117399.1;Q27367;5.36E-78;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp302757_c0_seq1;GAXK01117408.1;O46107;1.88E-52;LIP1_DROME;Lipase 1 (DmLip1) (EC 3.1.1.-);"extracellular region [GO:0005576]; lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0007586; GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];lipase activity [GO:0016298]
comp302766_c6_seq1;GAXK01117442.1;Q7KRI2;3.23E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp30278_c0_seq1;GAXK01049722.1;Q86BE9;9.25E-34;PEN2_DROME;Gamma-secretase subunit pen-2 (Presenilin enhancer protein 2);"gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]";"GO:0005770; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0034205; GO:0035333; GO:0055037; GO:0070765";"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]";"gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]";
comp30281_c1_seq1;GAXK01049975.1;Q8VC57;6.35E-95;KCTD5_MOUSE;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp3028242_c0_seq1;GAXK01120256.1;O15438;2.20E-61;MRP3_HUMAN;Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0005886; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085";"bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp302861_c0_seq1;GAXK01117308.1;P57760;1.09E-74;STK16_RAT;Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2);"cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]";"GO:0001228; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005798; GO:0005829; GO:0016020; GO:0045944; GO:0046777; GO:0048471; GO:0071560";"cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]";"cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp3028717_c0_seq1;GAXK01120264.1;E9PV86;2.93E-14;MCTP1_MOUSE;Multiple C2 and transmembrane domain-containing protein 1;"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"GO:0005509; GO:0005789; GO:0016021; GO:0030054; GO:0030336; GO:0030672; GO:0045806; GO:0055037; GO:1902883";"negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp302898_c0_seq1;GAXK01117412.1;Q40593;1.16E-15;VDE_TOBAC;Violaxanthin de-epoxidase, chloroplastic (EC 1.23.5.1);"chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422]";"GO:0009535; GO:0046422";;chloroplast thylakoid membrane [GO:0009535];violaxanthin de-epoxidase activity [GO:0046422]
comp302910_c1_seq1;GAXK01117416.1;Q08180;4.96E-71;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp3029663_c0_seq1;GAXK01120263.1;Q5PQR3;7.36E-12;BTBD9_RAT;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";"GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050951; GO:0060586; GO:1900242";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";;
comp302974_c1_seq1;GAXK01117215.1;Q99MY8;5.51E-141;ASH1L_MOUSE;Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.43) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog);"bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; interleukin-6 production [GO:0032635]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]";"GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0007338; GO:0009791; GO:0010468; GO:0030317; GO:0032635; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0051568; GO:0061038; GO:0097676; GO:1903699; GO:1903709";"decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; interleukin-6 production [GO:0032635]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]";"bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]"
comp302986_c0_seq1;GAXK01117295.1;Q8K5B3;7.64E-12;MCFD2_RAT;Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0007420; GO:0015031; GO:0016192; GO:0019752; GO:0060548";"brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]";calcium ion binding [GO:0005509]
comp303_c0_seq1;GAXK01169317.1;Q6GQN4;3.20E-10;FA32A_DANRE;Protein FAM32A-like;"nucleolus [GO:0005730]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]";"GO:0005730; GO:0006915; GO:0007049";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]";nucleolus [GO:0005730];
comp303043_c0_seq1;GAXK01117316.1;P18746;3.22E-07;ZO26_XENLA;Oocyte zinc finger protein XlCOF26 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp30306_c1_seq1;GAXK01049927.1;Q9VCA2;1.31E-54;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp303106_c0_seq1;GAXK01117441.1;P83995;1.14E-07;CU18B_LOCMI;Cuticle protein 18.6, isoform B (LM-ACP 18.6B) (LM-18.6B);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp303116_c2_seq1;GAXK01117423.1;Q15750;3.36E-66;TAB1_HUMAN;TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1);"cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000185; GO:0000187; GO:0001701; GO:0002223; GO:0002755; GO:0003007; GO:0003279; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0007179; GO:0007249; GO:0007254; GO:0008047; GO:0010008; GO:0016579; GO:0016607; GO:0030295; GO:0030324; GO:0032991; GO:0035904; GO:0038095; GO:0044877; GO:0048273; GO:0051092; GO:0060976; GO:0070423; GO:0070498";"activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"enzyme activator activity [GO:0008047]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]"
comp3031806_c0_seq1;GAXK01061079.1;O61365;8.23E-13;NACH_DROME;Sodium channel protein Nach (Pickpocket protein 4);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0006814; GO:0016021; GO:0035002";"liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp303212_c3_seq1;GAXK01117353.1;Q6P3V2;3.32E-94;Z585A_HUMAN;Zinc finger protein 585A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3032329_c0_seq1;GAXK01015072.1;Q86LG1;9.43E-09;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp30331_c0_seq1;GAXK01050405.1;Q2TBG8;2.55E-78;UCHL3_BOVIN;Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3);"cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004843; GO:0005737; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytoplasm [GO:0005737];thiol-dependent ubiquitin-specific protease activity [GO:0004843]
comp303314_c0_seq1;GAXK01117284.1;P23677;8.57E-104;IP3KA_HUMAN;Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A);"cytosol [GO:0005829]; dendritic spine [GO:0043197]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]";"GO:0004683; GO:0005516; GO:0005524; GO:0005829; GO:0006020; GO:0007165; GO:0008440; GO:0030036; GO:0032958; GO:0043197; GO:0043647; GO:0048167; GO:0048365; GO:0061003; GO:0097062";"actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; dendritic spine [GO:0043197]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]"
comp303318_c2_seq1;GAXK01117312.1;O46040;5.90E-22;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp30332_c2_seq1;GAXK01050284.1;D3Z5L6;2.35E-40;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp303325_c0_seq1;GAXK01117400.1;Q5U236;5.20E-09;GGYF2_XENLA;GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2);;;;;
comp3033697_c0_seq1;GAXK01015073.1;Q92900;2.43E-61;RENT1_HUMAN;Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]";"GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0016032; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]"
comp303382_c6_seq1;GAXK01117371.1;Q8BJ56;5.06E-63;PLPL2_MOUSE;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Desnutrin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0019915; GO:0034389; GO:0044242; GO:0055088";"cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp3033877_c0_seq1;GAXK01015082.1;Q922B9;2.43E-07;ITPI2_MOUSE;Protein ITPRID2 (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2 homolog);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]";"GO:0005102; GO:0005634; GO:0005829; GO:0005886; GO:0051015";;"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]"
comp30343_c0_seq1;GAXK01049705.1;Q7KRI2;9.19E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp303442_c0_seq1;GAXK01117178.1;Q8UW76;3.88E-24;TBX20_CHICK;T-box transcription factor TBX20 (T-box protein 20) (cTbx20);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"GO:0000122; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010991; GO:0021524; GO:0030335; GO:0035922; GO:0036306; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0060973; GO:2000793";"aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]"
comp30348_c0_seq1;GAXK01050229.1;Q8C3I8;1.11E-84;HGH1_MOUSE;Protein HGH1 homolog;;;;;
comp303489_c0_seq1;GAXK01117411.1;Q95327;0;MANBA_CAPHI;Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase);"lysosome [GO:0005764]; beta-mannosidase activity [GO:0004567]; carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]";"GO:0004567; GO:0005764; GO:0005975; GO:0006516";"carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]";lysosome [GO:0005764];beta-mannosidase activity [GO:0004567]
comp3034948_c0_seq1;GAXK01173350.1;Q08046;5.17E-31;EF1A_GIAIN;Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein) (Fragment);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp303495_c0_seq1;GAXK01117179.1;Q9W3W5;2.69E-79;WIF1_DROME;Protein shifted (WIF-1-like protein);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to extracellular region [GO:0071692]; protein stabilization [GO:0050821]; smoothened signaling pathway [GO:0007224]; synaptic target recognition [GO:0008039]";"GO:0005576; GO:0007224; GO:0008039; GO:0031012; GO:0045880; GO:0050821; GO:0071692";"positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to extracellular region [GO:0071692]; protein stabilization [GO:0050821]; smoothened signaling pathway [GO:0007224]; synaptic target recognition [GO:0008039]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";
comp303527_c0_seq1;GAXK01117349.1;Q92536;2.70E-133;YLAT2_HUMAN;Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; leukocyte migration [GO:0050900]";"GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015179; GO:0015297; GO:0016323; GO:0043231; GO:0050900";"amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; leukocyte migration [GO:0050900]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]"
comp3035450_c0_seq1;GAXK01173357.1;P17789;3.15E-07;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3035738_c0_seq1;GAXK01204965.1;P20432;1.92E-75;GSTD1_DROME;Glutathione S-transferase D1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]";"GO:0004364; GO:0005737; GO:0006749; GO:0009636; GO:0018833";"glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]";cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp303581_c0_seq1;GAXK01117393.1;A7RJI7;6.04E-73;CCZ1_NEMVE;Vacuolar fusion protein CCZ1 homolog;"intracellular membrane-bounded organelle [GO:0043231]; Mon1-Ccz1 complex [GO:0035658]; vesicle-mediated transport [GO:0016192]";"GO:0016192; GO:0035658; GO:0043231";vesicle-mediated transport [GO:0016192];"intracellular membrane-bounded organelle [GO:0043231]; Mon1-Ccz1 complex [GO:0035658]";
comp303625_c0_seq1;GAXK01117315.1;Q3ZCX4;6.23E-17;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp303649_c0_seq1;GAXK01117176.1;Q28Z18;3.90E-137;SETB1_DROPS;Histone-lysine N-methyltransferase eggless (EC 2.1.1.43) (SETDB1 homolog);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038";"multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]"
comp303669_c0_seq1;GAXK01117406.1;O35547;1.80E-142;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp3036798_c0_seq1;GAXK01075297.1;Q12766;6.98E-09;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp3036848_c0_seq1;GAXK01075284.1;Q3SZE3;1.32E-20;PLPP3_BOVIN;Phospholipid phosphatase 3 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b);"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; gastrulation with mouth forming second [GO:0001702]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]";"GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0030111; GO:0042392; GO:0042577; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0060070; GO:0098609; GO:1902068";"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; gastrulation with mouth forming second [GO:0001702]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]";"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]";"integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]"
comp3037371_c0_seq1;GAXK01075290.1;P36609;2.04E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp303779_c0_seq1;GAXK01117336.1;Q9JHS1;2.20E-28;EPAS1_RAT;Endothelial PAS domain-containing protein 1 (EPAS-1) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of lung alveolus development [GO:1904655]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"GO:0000122; GO:0000981; GO:0001525; GO:0001666; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0016607; GO:0030154; GO:0042421; GO:0045944; GO:0046982; GO:0050897; GO:0071222; GO:0071347; GO:0071456; GO:0120162; GO:1903181; GO:1904655";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of lung alveolus development [GO:1904655]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]"
comp3037810_c0_seq1;GAXK01075301.1;Q86LG1;2.66E-14;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp3038271_c0_seq1;GAXK01119709.1;Q9VGY6;2.16E-08;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp303858_c0_seq1;GAXK01117405.1;Q26240;6.51E-72;NOS_RHOPR;Nitric oxide synthase, salivary gland (NOS) (EC 1.14.13.39);"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric oxide biosynthetic process [GO:0006809]";"GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0046872; GO:0050660; GO:0050661";nitric oxide biosynthetic process [GO:0006809];;"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]"
comp303878_c5_seq1;GAXK01117152.1;Q8C827;3.92E-15;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3039_c0_seq1;GAXK01176656.1;Q92005;1.59E-77;EF1A_DANRE;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414";"translation [GO:0006412]; translational elongation [GO:0006414]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp303915_c1_seq1;GAXK01117182.1;B0WC46;6.32E-59;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3039157_c0_seq1;GAXK01119703.1;P62302;1.07E-87;RS13_SOYBN;40S ribosomal protein S13;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp303918_c3_seq1;GAXK01117181.1;Q4AEG9;2.34E-43;GPX4_SAPAP;Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4);"mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"GO:0004602; GO:0005739; GO:0006979; GO:0007275; GO:0007283; GO:0047066; GO:0110076";"multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";mitochondrion [GO:0005739];"glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]"
comp30393_c0_seq1;GAXK01050197.1;B1A4F7;1.30E-163;VDDP4_VESVU;Venom dipeptidyl peptidase 4 (EC 3.4.14.5) (Venom dipeptidyl peptidase IV) (allergen Ves v 3);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp303931_c1_seq1;GAXK01117311.1;Q6NRT6;0;DJC10_XENLA;DnaJ homolog subfamily C member 10 (EC 1.8.4.-);"endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005788; GO:0015035; GO:0016671; GO:0030433; GO:0034975; GO:0045454";"cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433]";endoplasmic reticulum lumen [GO:0005788];"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]"
comp3039599_c0_seq1;GAXK01119716.1;Q6NZJ6;7.34E-16;IF4G1_MOUSE;Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0010942; GO:0016281; GO:0030307; GO:0031669; GO:0032270; GO:0033138; GO:0034645; GO:0042802; GO:0045666; GO:0097009; GO:0098794; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696";"behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]";"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp30396_c1_seq1;GAXK01049712.1;Q9Z0X1;0;AIFM1_MOUSE;Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to oxidative stress [GO:0006979]";"GO:0002931; GO:0003677; GO:0004174; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0006979; GO:0008637; GO:0010942; GO:0016174; GO:0016651; GO:0030182; GO:0032981; GO:0043065; GO:0043525; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding [GO:0003677]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]"
comp3039916_c0_seq1;GAXK01119717.1;Q6PC14;3.09E-60;RL23_DANRE;60S ribosomal protein L23;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0070180";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp3040441_c0_seq1;GAXK01135071.1;O82018;4.73E-09;CALM_MOUSC;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp304045_c0_seq1;GAXK01056568.1;Q01721;8.69E-12;GAS1_MOUSE;Growth arrest-specific protein 1 (GAS-1);"anchored component of plasma membrane [GO:0046658]; membrane [GO:0016020]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; camera-type eye development [GO:0043010]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cerebellum morphogenesis [GO:0021587]; developmental growth [GO:0048589]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic skeletal system development [GO:0048706]; eye morphogenesis [GO:0048592]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; negative regulation of smoothened signaling pathway [GO:0045879]; odontogenesis [GO:0042476]; outer ear morphogenesis [GO:0042473]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; programmed cell death [GO:0012501]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]";"GO:0002053; GO:0005886; GO:0007050; GO:0007411; GO:0008284; GO:0008589; GO:0009953; GO:0010955; GO:0012501; GO:0016020; GO:0021587; GO:0021904; GO:0030308; GO:0042473; GO:0042474; GO:0042476; GO:0042733; GO:0043010; GO:0043066; GO:0045165; GO:0045879; GO:0045880; GO:0045930; GO:0046658; GO:0048589; GO:0048592; GO:0048598; GO:0048701; GO:0048706; GO:0050679; GO:0050680; GO:0060021; GO:0060628; GO:1902807; GO:2001240";"axon guidance [GO:0007411]; camera-type eye development [GO:0043010]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cerebellum morphogenesis [GO:0021587]; developmental growth [GO:0048589]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic skeletal system development [GO:0048706]; eye morphogenesis [GO:0048592]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; negative regulation of smoothened signaling pathway [GO:0045879]; odontogenesis [GO:0042476]; outer ear morphogenesis [GO:0042473]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; programmed cell death [GO:0012501]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]";"anchored component of plasma membrane [GO:0046658]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp3040614_c0_seq1;GAXK01135054.1;P62755;1.34E-107;RS6_RAT;40S ribosomal protein S6;"cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0006412; GO:0022627; GO:0032868; GO:0042593; GO:0071361; GO:1903347";"cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp3040708_c0_seq1;GAXK01135059.1;Q9XYN1;1.23E-69;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp304103_c1_seq2;GAXK01056592.1;Q7KRI2;2.22E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3041467_c0_seq1;GAXK01135057.1;Q9QXZ9;2.02E-09;OPN4_MOUSE;Melanopsin (Opsin-4);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhodopsin mediated signaling pathway [GO:0016056]; rhythmic process [GO:0048511]; visual perception [GO:0007601]";"GO:0005502; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0016056; GO:0018298; GO:0042752; GO:0043153; GO:0045938; GO:0048511; GO:0071482";"cellular response to light stimulus [GO:0071482]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhodopsin mediated signaling pathway [GO:0016056]; rhythmic process [GO:0048511]; visual perception [GO:0007601]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]"
comp3042003_c0_seq1;GAXK01164772.1;E9Q3T6;5.66E-08;PRD14_MOUSE;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; stem cell population maintenance [GO:0019827]";"GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; stem cell population maintenance [GO:0019827]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp3042370_c0_seq1;GAXK01164783.1;P20662;3.90E-09;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3042699_c0_seq1;GAXK01164778.1;A1Z9L3;2.36E-40;DHX8_DROME;ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]";"GO:0000381; GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0030261; GO:0034458; GO:0048477; GO:0071011; GO:0071013";"chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp304289_c0_seq1;GAXK01056572.1;P29981;3.62E-147;CP4C1_BLADI;Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp3043757_c0_seq1;GAXK01164773.1;Q6NZJ6;3.94E-29;IF4G1_MOUSE;Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0010942; GO:0016281; GO:0030307; GO:0031669; GO:0032270; GO:0033138; GO:0034645; GO:0042802; GO:0045666; GO:0097009; GO:0098794; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696";"behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]";"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp304436_c1_seq1;GAXK01056558.1;Q9EQB9;1.16E-08;ZN287_MOUSE;Zinc finger protein 287 (Zfp-287) (Zinc finger protein SKAT-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";"GO:0003677; GO:0003700; GO:0005634; GO:0042035; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3044363_c0_seq1;GAXK01162643.1;Q9NUA8;6.66E-17;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp30444_c1_seq1;GAXK01050427.1;A2VEI2;1.57E-149;MICU1_DROME;Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1);"mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051561; GO:0072375; GO:1990246";"anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]";calcium ion binding [GO:0005509]
comp3044607_c0_seq1;GAXK01162654.1;A8MYZ0;4.54E-32;MIY4B_HUMAN;Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2);protein K48-linked deubiquitination [GO:0071108];GO:0071108;protein K48-linked deubiquitination [GO:0071108];;
comp3044672_c0_seq1;GAXK01162656.1;Q9Y7Z2;3.29E-15;ARF6_SCHPO;ADP-ribosylation factor 6;"cell cortex [GO:0005938]; cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; division septum [GO:0000935]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; activation of bipolar cell growth [GO:0051519]; cell growth mode switching, monopolar to bipolar [GO:0051523]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0000935; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005938; GO:0006886; GO:0006888; GO:0007264; GO:0016192; GO:0032153; GO:0051285; GO:0051519; GO:0051523";"activation of bipolar cell growth [GO:0051519]; cell growth mode switching, monopolar to bipolar [GO:0051523]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; division septum [GO:0000935]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3044704_c0_seq1;GAXK01162629.1;P08442;2.37E-07;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp3044768_c0_seq1;GAXK01162652.1;O95436;5.22E-63;NPT2B_HUMAN;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]";"GO:0001701; GO:0005436; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0015321; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031526; GO:0031982; GO:0042301; GO:0043627; GO:0044267; GO:0044341";"cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"phosphate ion binding [GO:0042301]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium ion binding [GO:0031402]"
comp3044828_c0_seq1;GAXK01162631.1;A8WQK3;4.94E-16;ACH1_CAEBR;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp3044912_c0_seq1;GAXK01162646.1;Q59H18;3.79E-17;TNI3K_HUMAN;Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779";"bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]"
comp304502_c0_seq1;GAXK01056495.1;Q6ING9;3.16E-92;PPM1K_XENLA;Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa);"mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]";"GO:0004722; GO:0005759; GO:0046872";;mitochondrial matrix [GO:0005759];"metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp30451_c0_seq1;GAXK01050425.1;P34275;8.27E-147;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp304557_c1_seq1;GAXK01056562.1;P52746;2.40E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3045958_c0_seq1;GAXK01162650.1;C3ZQF9;2.62E-12;QRFPR_BRAFL;QRFP-like peptide receptor;"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]";"GO:0004930; GO:0004983; GO:0005887; GO:1901653";cellular response to peptide [GO:1901653];integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]"
comp304599_c2_seq1;GAXK01056528.1;Q86WS5;4.77E-33;TMPSC_HUMAN;Transmembrane protease serine 12 (EC 3.4.21.-);"integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0016021";;integral component of membrane [GO:0016021];serine-type endopeptidase activity [GO:0004252]
comp3046_c1_seq1;GAXK01175291.1;Q9W436;6.21E-161;NEP_DROME;Neprilysin-1 (EC 3.4.24.11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp304602_c0_seq1;GAXK01056570.1;Q9VHH9;2.06E-09;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp3046164_c0_seq1;GAXK01108363.1;Q5W960;5.08E-07;VSP12_BOTJA;Snake venom serine protease HS112 (SVSP) (EC 3.4.21.-);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0090729";;extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp3046220_c0_seq1;GAXK01108361.1;Q5GF25;1.55E-48;MANEA_RAT;Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (rEndo) (EC 3.2.1.130) (Endo-alpha-D-mannosidase) (Enman);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]";"GO:0000139; GO:0004559; GO:0004569; GO:0005794; GO:0016021";;"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]"
comp3046528_c0_seq1;GAXK01108364.1;P02310;4.82E-47;H41_TETPY;Histone H4, major;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp3046628_c0_seq1;GAXK01108370.1;Q9NZ20;8.91E-29;PA2G3_HUMAN;Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3);"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"GO:0001675; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0007288; GO:0016042; GO:0019372; GO:0036148; GO:0036151; GO:0036152; GO:0042629; GO:0043303; GO:0046872; GO:0047498; GO:0050482; GO:0060271; GO:0102567; GO:0102568";"acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]";"calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp3046646_c0_seq1;GAXK01108360.1;P49858;2.29E-33;CNI_DROME;Protein cornichon;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005789; GO:0006888; GO:0007310; GO:0007350; GO:0009952; GO:0015031; GO:0016021; GO:0016192; GO:0046843";"anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp304671_c0_seq1;GAXK01056541.1;E7F1U2;9.81E-100;DNMBP_DANRE;Dynamin-binding protein (Scaffold protein Tuba);"cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035023; GO:0035556; GO:0045202; GO:0060271; GO:0098793";"cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; regulation of Rho protein signal transduction [GO:0035023]";"cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]";Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp3047422_c0_seq1;GAXK01108366.1;Q8BHI9;2.33E-117;NIM1_MOUSE;Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0031588; GO:0032007; GO:0035556; GO:0042149";"cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp30487_c1_seq1;GAXK01050207.1;Q9W6I0;1.89E-33;UQCC1_XENLA;Ubiquinol-cytochrome-c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein homolog) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog) (Zic3-binding protein);"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]";"GO:0005743; GO:0034551; GO:0070131";"mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]";mitochondrial inner membrane [GO:0005743];
comp3049014_c0_seq1;GAXK01000822.1;Q8NBI6;7.45E-10;XXLT1_HUMAN;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp3049166_c0_seq1;GAXK01000826.1;Q32KH7;1.13E-21;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp30492_c0_seq1;GAXK01050132.1;O96790;2.60E-18;DPGN_DIPMA;Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]";"GO:0004867; GO:0005576; GO:0050819";negative regulation of coagulation [GO:0050819];extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp3049244_c0_seq1;GAXK01000838.1;Q2LE78;7.91E-07;BTBD6_XENLA;BTB/POZ domain-containing protein 6;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp304934_c1_seq1;GAXK01056510.1;O75311;4.63E-31;GLRA3_HUMAN;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp30499_c0_seq1;GAXK01050137.1;P30173;9.79E-107;ACT13_SOLTU;Actin-101;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp3050_c0_seq1;GAXK01176073.1;Q1HPL8;1.20E-40;NDUBA_BOMMO;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10;"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; oxidation-reduction process [GO:0055114]";"GO:0005743; GO:0055114; GO:0070469";oxidation-reduction process [GO:0055114];"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";
comp30507_c1_seq1;GAXK01050262.1;Q32KT5;9.75E-19;CF136_BOVIN;Uncharacterized protein C6orf136 homolog;;;;;
comp305163_c0_seq1;GAXK01056454.1;Q552Z6;1.10E-07;GTPA_DICDI;GTP-binding protein A;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp30517_c2_seq1;GAXK01050331.1;Q2M3R5;7.93E-19;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp305210_c0_seq1;GAXK01056448.1;Q68F62;7.69E-21;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp3052582_c0_seq1;GAXK01059507.1;Q18163;5.33E-28;DDRA_CAEEL;Discoidin domain-containing receptor A;"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"GO:0004672; GO:0005524; GO:0005886; GO:0008045; GO:0016021; GO:0030424; GO:0043204; GO:0048680";"motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp305264_c0_seq1;GAXK01056549.1;A4FV54;5.48E-73;RAB8A_BOVIN;Ras-related protein Rab-8A;"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0006886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017137; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031489; GO:0032482; GO:0032869; GO:0036064; GO:0043197; GO:0045335; GO:0048210; GO:0055038; GO:0060271; GO:0072659; GO:0097546; GO:0097730; GO:0098969";"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]"
comp3053211_c0_seq1;GAXK01059505.1;P17972;9.26E-38;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp30534_c0_seq1;GAXK01049971.1;Q9CU62;0;SMC1A_MOUSE;Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8);"cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of mitotic spindle assembly [GO:1901673]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0009314; GO:0016363; GO:0019827; GO:0030893; GO:0032876; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0097431; GO:1901673";"cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of mitotic spindle assembly [GO:1901673]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]"
comp305340_c0_seq1;GAXK01056485.1;Q9NWM0;7.21E-35;SMOX_HUMAN;Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901";"polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp305371_c0_seq1;GAXK01056557.1;Q0JNL7;2.94E-50;CALM3_ORYSJ;Calmodulin-3 (CaM-3);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp30538_c0_seq1;GAXK01049719.1;P06605;1.16E-118;TBA3_DROME;Tubulin alpha-3 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]";"GO:0000226; GO:0000278; GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0007283; GO:0007288; GO:0017022; GO:0048471";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; spermatogenesis [GO:0007283]; sperm axoneme assembly [GO:0007288]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]"
comp30540_c0_seq1;GAXK01049723.1;Q99437;7.32E-81;VATO_HUMAN;V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit) (hATPL);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]";"GO:0005215; GO:0005774; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0030670; GO:0033179; GO:0033572; GO:0034220; GO:0046961; GO:0090383; GO:1902600";"insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]";"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";"proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"
comp3054201_c0_seq1;GAXK01079403.1;O80929;3.49E-30;RL361_ARATH;60S ribosomal protein L36-1;"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005783; GO:0022625";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]";structural constituent of ribosome [GO:0003735]
comp3054419_c0_seq1;GAXK01079424.1;P82151;9.34E-23;LEC6_TACTR;Lectin L6;"transport vesicle [GO:0030133]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]";"GO:0030133; GO:0030246; GO:0042742; GO:0046872";defense response to bacterium [GO:0042742];transport vesicle [GO:0030133];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp3054533_c0_seq1;GAXK01079425.1;Q8NB50;8.95E-08;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3054536_c0_seq1;GAXK01079408.1;Q6P280;2.94E-07;ZN529_HUMAN;Zinc finger protein 529;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp305487_c0_seq1;GAXK01056473.1;P28840;5.43E-168;NEC1_RAT;Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1);"axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]";"GO:0004175; GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0009749; GO:0010035; GO:0010157; GO:0014070; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030141; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042493; GO:0043005; GO:0043025; GO:0043204; GO:0043278; GO:0043434; GO:0043559; GO:0043679; GO:0044877; GO:0048471; GO:0048678; GO:0050714; GO:0051087; GO:0051384; GO:0051592; GO:0070542; GO:0070555";"neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]";"axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]";"chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]"
comp3055136_c0_seq1;GAXK01079407.1;Q6NW95;9.36E-14;FXL15_DANRE;F-box/LRR-repeat protein 15;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0005737; GO:0006511; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp30560_c0_seq1;GAXK01050196.1;Q9VHH9;1.32E-10;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp3056855_c0_seq1;GAXK01078081.1;O57415;1.15E-09;RREB1_CHICK;Ras-responsive element-binding protein 1 (RREB-1);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp305702_c0_seq1;GAXK01056545.1;P18749;8.26E-24;ZO6_XENLA;Oocyte zinc finger protein XlCOF6 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp305717_c0_seq1;GAXK01056449.1;Q6GNV7;6.09E-31;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp30578_c0_seq1;GAXK01050192.1;Q13901;5.25E-34;C1D_HUMAN;Nuclear nucleic acid-binding protein C1D (hC1D);"cytoplasm [GO:0005737]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of transcription, DNA-templated [GO:0045892]; rRNA processing [GO:0006364]";"GO:0000176; GO:0000460; GO:0003677; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006915; GO:0016922; GO:0017053; GO:0045892";"apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of transcription, DNA-templated [GO:0045892]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]"
comp3057821_c0_seq1;GAXK01078064.1;Q9VZW5;1.90E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp30579_c5_seq1;GAXK01050346.1;Q5BLE8;1.27E-110;RETST_DANRE;All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase A) (RetSat A) (All-trans-retinol 7,8-reductase);"endoplasmic reticulum membrane [GO:0005789]; all-trans-retinol 13,14-reductase activity [GO:0051786]";"GO:0005789; GO:0051786";;endoplasmic reticulum membrane [GO:0005789];all-trans-retinol 13,14-reductase activity [GO:0051786]
comp305831_c0_seq1;GAXK01056593.1;Q80U62;2.20E-68;RUBIC_MOUSE;Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon);"cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]";"GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:1901097";"autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]";"cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]";
comp30588_c0_seq1;GAXK01050006.1;Q24324;9.01E-152;DSOR1_DROME;Dual specificity mitogen-activated protein kinase kinase dSOR1 (Downstream of RAF) (MAPKK) (EC 2.7.12.2);"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000187; GO:0000793; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007095; GO:0007173; GO:0007298; GO:0007362; GO:0007430; GO:0007465; GO:0007623; GO:0008286; GO:0008293; GO:0008543; GO:0009953; GO:0023014; GO:0031098; GO:0032147; GO:0033314; GO:0042386; GO:0042461; GO:0045500; GO:0048010; GO:0051607; GO:0070371; GO:0071481";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp3058998_c0_seq1;GAXK01198166.1;O16374;3.61E-09;GALT1_CAEEL;Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]";"GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872";"N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]";"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]"
comp3059143_c0_seq1;GAXK01198155.1;P81018;3.34E-10;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp30592_c0_seq1;GAXK01050363.1;Q4U4S6;1.28E-13;XIRP2_MOUSE;Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Myogenic MEF2-activated Xin-related protein) (Myomaxin) (mXinbeta);"focal adhesion [GO:0005925]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281]";"GO:0001725; GO:0003281; GO:0005925; GO:0030018; GO:0030036; GO:0045216; GO:0046872; GO:0051015; GO:0051393; GO:0055008";"actin cytoskeleton organization [GO:0030036]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281]";"focal adhesion [GO:0005925]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]"
comp305953_c1_seq1;GAXK01056523.1;Q8I6K0;1.36E-45;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3059711_c0_seq1;GAXK01198160.1;Q6X6Z7;3.27E-73;TEKT3_MOUSE;Tektin-3;"acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005737; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp305975_c0_seq1;GAXK01056472.1;Q1L8F9;3.18E-74;CL066_DANRE;KICSTOR complex protein C12orf66 homolog;"KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"GO:0005765; GO:0034198; GO:0042149; GO:0061462; GO:0140007; GO:1904262";"cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]";
comp3060_c0_seq1;GAXK01175383.1;Q92193;3.33E-71;ACT_CRAVI;Actin (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp306017_c0_seq1;GAXK01200290.1;A6N6J5;0;WDR35_RAT;WD repeat-containing protein 35 (Naofen);"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]";"GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830";"cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]";"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]";
comp3060262_c0_seq1;GAXK01162314.1;Q7KRI2;1.01E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp306028_c0_seq1;GAXK01200216.1;Q5R2J2;1.28E-55;G3P_PELSI;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821]";"GO:0000226; GO:0004365; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006096; GO:0008017; GO:0015630; GO:0035605; GO:0035606; GO:0050661; GO:0050821; GO:0051287; GO:0051402";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]";"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]"
comp306069_c2_seq1;GAXK01200213.1;P15120;4.26E-33;UROK_CHICK;"Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator chain A; Urokinase-type plasminogen activator chain B]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0031639";"plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp30607_c1_seq1;GAXK01049785.1;Q28GG4;3.83E-11;CHCH7_XENTR;Coiled-coil-helix-coiled-coil-helix domain-containing protein 7;mitochondrial intermembrane space [GO:0005758];GO:0005758;;mitochondrial intermembrane space [GO:0005758];
comp306096_c0_seq1;GAXK01200168.1;Q27712;1.10E-66;CP2L1_PANAR;Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp3061349_c0_seq1;GAXK01162306.1;Q27433;7.76E-20;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp3061860_c0_seq1;GAXK01162315.1;Q8QMN3;1.76E-07;KBTB2_CWPXB;Kelch repeat and BTB domain-containing protein 2;"host cell cytoplasm [GO:0030430]; modulation by virus of host ubiquitin-protein ligase activity [GO:0039649]";"GO:0030430; GO:0039649";modulation by virus of host ubiquitin-protein ligase activity [GO:0039649];host cell cytoplasm [GO:0030430];
comp3062094_c0_seq1;GAXK01004488.1;Q6ZNA1;1.02E-12;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp306242_c7_seq1;GAXK01200327.1;Q5MCW4;1.11E-45;ZN569_HUMAN;Zinc finger protein 569;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp306261_c0_seq1;GAXK01200130.1;Q8BUH8;1.33E-54;SENP7_MOUSE;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp306279_c1_seq1;GAXK01200228.1;Q5UPG5;1.36E-10;YL093_MIMIV;Putative ankyrin repeat protein L93;;;;;
comp3062936_c0_seq1;GAXK01004487.1;Q9AP33;9.22E-34;ECTC_SPOPA;L-ectoine synthase (EC 4.2.1.108) (N-acetyldiaminobutyrate dehydratase);"ectoine synthase activity [GO:0033990]; ectoine biosynthetic process [GO:0019491]";"GO:0019491; GO:0033990";ectoine biosynthetic process [GO:0019491];;ectoine synthase activity [GO:0033990]
comp3063228_c0_seq1;GAXK01004489.1;Q3BAI2;4.58E-09;YCX91_PHAAO;Uncharacterized protein ORF91;chloroplast [GO:0009507];GO:0009507;;chloroplast [GO:0009507];
comp3063359_c0_seq1;GAXK01004482.1;W4VS53;1.24E-27;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp306344_c1_seq1;GAXK01200289.1;P35832;6.71E-99;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp30635_c0_seq1;GAXK01049717.1;Q9VL00;5.43E-89;OTUBL_DROME;Ubiquitin thioesterase otubain-like (EC 3.4.19.12) (Ubiquitin-specific-processing protease otubain-like) (Deubiquitinating enzyme otubain-like);"nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; protein K48-linked deubiquitination [GO:0071108]";"GO:0004843; GO:0005634; GO:0019784; GO:0043130; GO:0071108";protein K48-linked deubiquitination [GO:0071108];nucleus [GO:0005634];"NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]"
comp3063598_c0_seq1;GAXK01004480.1;X2JAU8;7.66E-09;NWK_DROME;Protein nervous wreck (Nwk);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030054; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601";"multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]";"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"
comp3064032_c0_seq1;GAXK01203087.1;P17537;1.36E-50;RBS_CHLMO;Ribulose bisphosphate carboxylase small chain, chloroplastic (RuBisCO small subunit) (EC 4.1.1.39);"chloroplast [GO:0009507]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]; photorespiration [GO:0009853]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0004497; GO:0009507; GO:0009853; GO:0016984; GO:0019253";"photorespiration [GO:0009853]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]"
comp306411_c0_seq1;GAXK01200159.1;Q5D014;2.13E-21;NATD1_DANRE;Protein NATD1 (N-acetyltransferase domain-containing protein 1);"N-acyltransferase activity [GO:0016410]; protein acetylation [GO:0006473]";"GO:0006473; GO:0016410";protein acetylation [GO:0006473];;N-acyltransferase activity [GO:0016410]
comp306414_c1_seq1;GAXK01200316.1;Q9I7U4;1.69E-11;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp30643_c0_seq1;GAXK01050292.1;P49802;1.25E-100;RGS7_HUMAN;Regulator of G-protein signaling 7 (RGS7);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]";"GO:0003924; GO:0005096; GO:0005829; GO:0005886; GO:0006457; GO:0007186; GO:0009968; GO:0031681; GO:0035556; GO:0043547";"G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]"
comp3064433_c0_seq1;GAXK01203088.1;Q504A5;4.61E-19;TPMT_DANRE;Probable thiopurine S-methyltransferase (Thiopurine methyltransferase) (EC 2.1.1.67);"cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]";"GO:0005737; GO:0008119";;cytoplasm [GO:0005737];thiopurine S-methyltransferase activity [GO:0008119]
comp3064483_c0_seq1;GAXK01203092.1;Q8N4W9;6.74E-07;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp30645_c1_seq1;GAXK01049776.1;Q8C2L6;5.64E-130;T161B_MOUSE;Transmembrane protein 161B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp306456_c0_seq1;GAXK01200299.1;Q9GRW0;4.00E-63;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3064676_c0_seq1;GAXK01203081.1;Q86V24;2.51E-26;PAQR2_HUMAN;Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II);"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; regulation of fatty acid biosynthetic process [GO:0042304]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]";"GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009755; GO:0016021; GO:0019395; GO:0030308; GO:0031226; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046326; GO:0046872; GO:0046982; GO:0055100; GO:0061042; GO:0097003; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; regulation of fatty acid biosynthetic process [GO:0042304]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]";"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]";"adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]"
comp3064854_c0_seq1;GAXK01203072.1;Q5EA06;1.06E-07;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp306517_c0_seq1;GAXK01200384.1;Q17ZY4;1.92E-81;PRAC_PEPD6;Proline racemase (EC 5.1.1.4);proline racemase activity [GO:0018112];GO:0018112;;;proline racemase activity [GO:0018112]
comp30652_c1_seq1;GAXK01049970.1;Q66HC5;0;NUP93_RAT;Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93);"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; renal system development [GO:0072001]; SMAD protein signal transduction [GO:0060395]";"GO:0005635; GO:0005643; GO:0006606; GO:0006998; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292; GO:0060391; GO:0060395; GO:0072001";"nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; renal system development [GO:0072001]; SMAD protein signal transduction [GO:0060395]";"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]";structural constituent of nuclear pore [GO:0017056]
comp3065216_c0_seq1;GAXK01203080.1;Q28HX4;8.87E-116;IFT57_XENTR;Intraflagellar transport protein 57 homolog;"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of apoptotic process [GO:0042981]; regulation of TOR signaling [GO:0032006]";"GO:0003351; GO:0005576; GO:0005794; GO:0005813; GO:0005929; GO:0006915; GO:0006919; GO:0007368; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0042462; GO:0042981; GO:0045494; GO:1905515";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of apoptotic process [GO:0042981]; regulation of TOR signaling [GO:0032006]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]";
comp3065246_c0_seq1;GAXK01203074.1;Q59DY6;6.76E-09;LEDL2_DROME;C-type lectin 37Da;"extracellular region [GO:0005576]; galactose binding [GO:0005534]; metal ion binding [GO:0046872]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]";"GO:0005534; GO:0005576; GO:0016339; GO:0046872";calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339];extracellular region [GO:0005576];"galactose binding [GO:0005534]; metal ion binding [GO:0046872]"
comp306592_c0_seq1;GAXK01200306.1;Q6TDP4;0;KLH17_HUMAN;Kelch-like protein 17 (Actinfilin);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"GO:0005615; GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0030054; GO:0031208; GO:0032839; GO:0043025; GO:0045211; GO:0051015; GO:0060090";"actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]"
comp3066485_c0_seq1;GAXK01149004.1;Q9V3X4;1.50E-16;BSCL2_DROME;Seipin;"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; diacylglycerol metabolic process [GO:0046339]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; fatty acid beta-oxidation [GO:0006635]; lipid biosynthetic process [GO:0008610]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of lipid storage [GO:0010884]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid storage [GO:0010883]; regulation of triglyceride metabolic process [GO:0090207]; response to starvation [GO:0042594]";"GO:0005783; GO:0006635; GO:0008610; GO:0010883; GO:0010884; GO:0019915; GO:0030176; GO:0032469; GO:0034389; GO:0042594; GO:0046339; GO:0046473; GO:0046890; GO:0048691; GO:0090207";"diacylglycerol metabolic process [GO:0046339]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; fatty acid beta-oxidation [GO:0006635]; lipid biosynthetic process [GO:0008610]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of lipid storage [GO:0010884]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid storage [GO:0010883]; regulation of triglyceride metabolic process [GO:0090207]; response to starvation [GO:0042594]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp30667_c1_seq1;GAXK01049787.1;D3YZP9;6.03E-102;CCDC6_MOUSE;Coiled-coil domain-containing protein 6;"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]";"GO:0005829; GO:0005856; GO:0017124";;"cytoskeleton [GO:0005856]; cytosol [GO:0005829]";SH3 domain binding [GO:0017124]
comp3067_c0_seq1;GAXK01175514.1;Q86T03;1.63E-51;PP4P1_HUMAN;Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]";"GO:0005654; GO:0005765; GO:0005886; GO:0006644; GO:0006991; GO:0008203; GO:0016021; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263";"cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]";"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]
comp3067038_c0_seq1;GAXK01148993.1;P17066;3.50E-163;HSP76_HUMAN;Heat shock 70 kDa protein 6 (Heat shock 70 kDa protein B');"blood microparticle [GO:0072562]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; neutrophil degranulation [GO:0043312]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0006986; GO:0016887; GO:0019899; GO:0031072; GO:0032991; GO:0034605; GO:0034620; GO:0034774; GO:0042026; GO:0042623; GO:0043312; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0072562; GO:1904813";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; neutrophil degranulation [GO:0043312]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"blood microparticle [GO:0072562]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp30681_c2_seq1;GAXK01049863.1;Q9BZH6;2.20E-175;WDR11_HUMAN;WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]";"GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041";"cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]";
comp3068369_c0_seq1;GAXK01112916.1;P42519;3.64E-08;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp3068666_c0_seq1;GAXK01112921.1;G5EDQ9;7.83E-13;ZIG2_CAEEL;Zwei Ig domain protein zig-2 (2 Ig domain protein zig-2);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0005576; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp3069497_c0_seq1;GAXK01112920.1;D3YXG0;1.90E-12;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp306997_c1_seq1;GAXK01200209.1;O00222;6.25E-24;GRM8_HUMAN;Metabotropic glutamate receptor 8 (mGluR8);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]";"GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0042734; GO:0051966";"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]"
comp3070016_c0_seq1;GAXK01042058.1;Q6VVW5;6.66E-58;ANPRB_MOUSE;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp30705_c0_seq1;GAXK01049755.1;P40265;1.07E-11;H13_GLYBA;Histone H1-III;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334";nucleosome assembly [GO:0006334];"nucleosome [GO:0000786]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp30710_c0_seq1;GAXK01050282.1;A4IG32;1.53E-44;MICU1_DANRE;Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog);"integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0051560; GO:0051561; GO:0070509; GO:1990246";"calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]";"integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]";calcium ion binding [GO:0005509]
comp3071199_c0_seq1;GAXK01042057.1;Q8IVF4;1.18E-33;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp30712_c0_seq1;GAXK01049779.1;P91622;4.55E-90;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp30719_c1_seq1;GAXK01050214.1;O60237;8.82E-112;MYPT2_HUMAN;Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2);"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]; enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]";"GO:0000086; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672";"G2/M transition of mitotic cell cycle [GO:0000086]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]";"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]";"enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]"
comp3072168_c0_seq1;GAXK01203513.1;Q9VQ56;3.14E-106;ERM_DROME;Fez family zinc finger protein erm (Earmuff);"axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; axon target recognition [GO:0007412]; axonogenesis involved in innervation [GO:0060385]; cell dedifferentiation [GO:0043697]; medulla oblongata morphogenesis [GO:0021579]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; stem cell population maintenance [GO:0019827]";"GO:0005634; GO:0007406; GO:0007412; GO:0010628; GO:0010629; GO:0019827; GO:0021579; GO:0043025; GO:0043565; GO:0043697; GO:0044212; GO:0044295; GO:0045666; GO:0045892; GO:0046872; GO:0050767; GO:0060385; GO:0072499; GO:1902692; GO:1902843";"axonogenesis involved in innervation [GO:0060385]; axon target recognition [GO:0007412]; cell dedifferentiation [GO:0043697]; medulla oblongata morphogenesis [GO:0021579]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; stem cell population maintenance [GO:0019827]";"axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp30731_c1_seq1;GAXK01049803.1;Q28DB5;0;ALAT2_XENTR;Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";"GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";;"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
comp307425_c0_seq1;GAXK01200291.1;Q10574;4.84E-18;LIN32_CAEEL;Protein lin-32 (Abnormal cell lineage protein 32);"nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";"GO:0005634; GO:0009792; GO:0042803; GO:0043565; GO:0045138; GO:0046982; GO:0048666; GO:0051179";"embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";nucleus [GO:0005634];"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp3074567_c0_seq1;GAXK01204972.1;P22813;8.35E-14;HSF_DROME;Heat shock factor protein (HSF) (Heat shock transcription factor) (HSTF);"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to heat [GO:0034605]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]";"GO:0000785; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0009408; GO:0034605; GO:0042742; GO:0042802; GO:0043388; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0050832; GO:0061408";"cellular response to heat [GO:0034605]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; response to heat [GO:0009408]";"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp3075_c0_seq1;GAXK01175257.1;Q07352;9.59E-25;TISB_HUMAN;mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; protein kinase B signaling [GO:0043491]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]";"GO:0000165; GO:0000288; GO:0000932; GO:0000981; GO:0001570; GO:0003342; GO:0003677; GO:0003700; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006915; GO:0007507; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0014065; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0046872; GO:0048382; GO:0051028; GO:0060710; GO:0060712; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904";"3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; protein kinase B signaling [GO:0043491]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]";"14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp3075334_c0_seq1;GAXK01001463.1;D3Z5L6;1.42E-27;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp307566_c1_seq1;GAXK01200212.1;P39087;0;GRIK2_MOUSE;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp3076243_c0_seq1;GAXK01046572.1;Q29RZ4;1.34E-13;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3076751_c0_seq1;GAXK01046569.1;Q96Q07;1.91E-09;BTBD9_HUMAN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";"GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050951; GO:0060586; GO:1900242";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";;
comp307679_c0_seq1;GAXK01200217.1;Q9UFB7;3.82E-11;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp307682_c0_seq1;GAXK01200308.1;Q9VIS1;1.50E-37;CDGAP_DROME;GTPase-activating protein CdGAPr (d-CdGAPr);"GTPase activator activity [GO:0005096]; retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0007264; GO:0031290";"retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";;GTPase activator activity [GO:0005096]
comp3076937_c0_seq1;GAXK01046584.1;P18715;9.71E-20;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp307826_c0_seq1;GAXK01200373.1;B3N8M1;2.89E-20;LPHN_DROER;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp30794_c0_seq1;GAXK01049792.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp307940_c0_seq1;GAXK01200292.1;Q95R48;7.74E-57;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp3079985_c0_seq1;GAXK01095192.1;Q86TJ5;7.61E-16;ZN554_HUMAN;Zinc finger protein 554;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp308_c0_seq1;GAXK01169224.1;Q94514;5.01E-45;COX5A_DROME;Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va);"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of cell cycle [GO:0045787]";"GO:0004129; GO:0005739; GO:0005751; GO:0006123; GO:0007406; GO:0045787; GO:0046872";"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of cell cycle [GO:0045787]";"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp3080117_c0_seq1;GAXK01021443.1;Q9V818;6.52E-20;MTH3_DROME;Probable G-protein coupled receptor Mth-like 3 (Protein methuselah-like 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp3080394_c0_seq1;GAXK01021439.1;P35033;4.63E-46;TRY3_SALSA;Trypsin-3 (EC 3.4.21.4) (Trypsin III) (Fragment);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3081_c0_seq1;GAXK01176002.1;Q9VGW6;0;MCM5_DROME;DNA replication licensing factor Mcm5 (EC 3.6.4.12) (Minichromosome maintenance 5 protein) (DmMCM5);"cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; chromosome condensation [GO:0030261]; DNA endoreduplication [GO:0042023]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005829; GO:0006267; GO:0006270; GO:0030261; GO:0042023; GO:0042555; GO:0051321";"chromosome condensation [GO:0030261]; DNA endoreduplication [GO:0042023]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; resolution of meiotic recombination intermediates [GO:0000712]";"cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp3081319_c0_seq1;GAXK01021438.1;P51532;5.91E-08;SMCA4_HUMAN;Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4);"extracellular space [GO:0005615]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; beta-catenin-TCF complex assembly [GO:1904837]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000790; GO:0001164; GO:0002039; GO:0003407; GO:0003677; GO:0003713; GO:0003714; GO:0003723; GO:0004386; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008134; GO:0016020; GO:0016514; GO:0030177; GO:0030308; GO:0030957; GO:0032991; GO:0038111; GO:0043044; GO:0043923; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050681; GO:0051091; GO:0060766; GO:0070182; GO:0070577; GO:0071564; GO:0071565; GO:1901838; GO:1902661; GO:1902895; GO:1904837";"ATP-dependent chromatin remodeling [GO:0043044]; beta-catenin-TCF complex assembly [GO:1904837]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]";"extracellular space [GO:0005615]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]";"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp308236_c1_seq1;GAXK01044733.1;Q9NRA2;1.71E-82;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp3082681_c0_seq1;GAXK01194305.1;Q9MYX8;1.03E-10;TAU_PAPHA;Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]";"GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425";;"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";microtubule binding [GO:0008017]
comp3083_c0_seq1;GAXK01205911.1;P25867;2.42E-94;UBCD1_DROME;Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061630; GO:0061631; GO:0097039";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]"
comp308314_c1_seq1;GAXK01044755.1;P55859;5.26E-72;PNPH_BOVIN;Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; purine-nucleoside phosphorylase activity [GO:0004731]; nucleoside metabolic process [GO:0009116]";"GO:0004731; GO:0005737; GO:0005856; GO:0009116";nucleoside metabolic process [GO:0009116];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";purine-nucleoside phosphorylase activity [GO:0004731]
comp308324_c0_seq1;GAXK01044873.1;Q9BRB3;1.60E-33;PIGQ_HUMAN;Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (EC 2.4.1.198) (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q);"endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; carbohydrate metabolic process [GO:0005975]; preassembly of GPI anchor in ER membrane [GO:0016254]";"GO:0000506; GO:0005789; GO:0005975; GO:0016021; GO:0016254; GO:0017176";"carbohydrate metabolic process [GO:0005975]; preassembly of GPI anchor in ER membrane [GO:0016254]";"endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]";phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]
comp308339_c0_seq2;GAXK01044851.1;P25342;5.64E-08;CDC10_YEAST;Cell division control protein 10;"ascospore-type prospore [GO:0042764]; cellular bud neck [GO:0005935]; cellular bud neck septin ring [GO:0000144]; mating projection base [GO:0001400]; mating projection tip [GO:0043332]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; prospore membrane [GO:0005628]; septin complex [GO:0031105]; septin filament array [GO:0032160]; septin ring [GO:0005940]; spindle microtubule [GO:0005876]; 1-phosphatidylinositol binding [GO:0005545]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; structural constituent of cytoskeleton [GO:0005200]; cytoskeleton-dependent cytokinesis [GO:0061640]; exit from mitosis [GO:0010458]; maintenance of cell polarity [GO:0030011]; mitotic cytokinesis [GO:0000281]; septin ring assembly [GO:0000921]; sporulation [GO:0043934]";"GO:0000144; GO:0000281; GO:0000921; GO:0001400; GO:0003924; GO:0005200; GO:0005525; GO:0005545; GO:0005628; GO:0005876; GO:0005935; GO:0005940; GO:0010314; GO:0010458; GO:0015630; GO:0030011; GO:0031105; GO:0032160; GO:0042764; GO:0043332; GO:0043934; GO:0060090; GO:0061640; GO:0070273; GO:0072687";"cytoskeleton-dependent cytokinesis [GO:0061640]; exit from mitosis [GO:0010458]; maintenance of cell polarity [GO:0030011]; mitotic cytokinesis [GO:0000281]; septin ring assembly [GO:0000921]; sporulation [GO:0043934]";"ascospore-type prospore [GO:0042764]; cellular bud neck [GO:0005935]; cellular bud neck septin ring [GO:0000144]; mating projection base [GO:0001400]; mating projection tip [GO:0043332]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; prospore membrane [GO:0005628]; septin complex [GO:0031105]; septin filament array [GO:0032160]; septin ring [GO:0005940]; spindle microtubule [GO:0005876]";"1-phosphatidylinositol binding [GO:0005545]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; structural constituent of cytoskeleton [GO:0005200]"
comp30835_c1_seq1;GAXK01050549.1;Q9V447;3.64E-63;KRH2_DROME;Krueppel homolog 2 (Protein Kr-h2);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"GO:0005783; GO:0012505; GO:0016021";;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";
comp3083529_c0_seq1;GAXK01194309.1;P34568;3.44E-08;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3083575_c0_seq1;GAXK01194308.1;Q9BUY5;5.77E-20;ZN426_HUMAN;Zinc finger protein 426;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp30837_c0_seq1;GAXK01049699.1;A6QQ71;6.08E-50;FKBP6_BOVIN;Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283]";"GO:0000413; GO:0000795; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]";"Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]"
comp3083761_c0_seq1;GAXK01194303.1;Q3U288;1.37E-15;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3084029_c0_seq1;GAXK01009680.1;Q8IN81;6.20E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp308430_c1_seq1;GAXK01044761.1;Q5EA59;1.70E-84;ABHD4_BOVIN;(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4) (Protein ABHD4) (EC 3.-.-.-);"lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]";"GO:0005811; GO:0016042; GO:0052689; GO:0055088; GO:0070292";"lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]";lipid droplet [GO:0005811];carboxylic ester hydrolase activity [GO:0052689]
comp308441_c2_seq1;GAXK01044771.1;O01735;2.32E-130;YC91_CAEEL;Uncharacterized MFS-type transporter C09D4.1;"integral component of plasma membrane [GO:0005887]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; heme export [GO:0097037]";"GO:0005887; GO:0015232; GO:0020037; GO:0097037";heme export [GO:0097037];integral component of plasma membrane [GO:0005887];"heme binding [GO:0020037]; heme transporter activity [GO:0015232]"
comp308449_c0_seq1;GAXK01044821.1;Q6DCX5;2.48E-18;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp30846_c3_seq1;GAXK01049724.1;P08928;4.86E-25;LAM0_DROME;Lamin Dm0;"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433";"adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp3085118_c0_seq1;GAXK01009683.1;E1C5V0;7.63E-07;SMYD2_CHICK;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp308525_c0_seq1;GAXK01044899.1;Q3SX23;0;LONP2_BOVIN;Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease);"nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]";"GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558; GO:0031998";"protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]";"nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]";"ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]"
comp3085423_c0_seq1;GAXK01009676.1;P77360;4.08E-18;YPHC_ECOLI;Uncharacterized zinc-type alcohol dehydrogenase-like protein YphC (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016491";;;"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]"
comp308571_c1_seq1;GAXK01044789.1;B3A0N5;7.28E-131;APY_TABYA;Apyrase (EC 3.6.1.5) (ATP-diphosphatase) (ADPase) (ATP-diphosphohydrolase) (Adenosine diphosphatase) (allergen Tab y 1);"extracellular region [GO:0005576]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; nucleotide catabolic process [GO:0009166]";"GO:0005524; GO:0005576; GO:0009166; GO:0016788; GO:0046872; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491";nucleotide catabolic process [GO:0009166];extracellular region [GO:0005576];"8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]"
comp3085755_c0_seq1;GAXK01009677.1;O01404;2.47E-21;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp3086371_c0_seq1;GAXK01041463.1;O60229;1.70E-17;KALRN_HUMAN;Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]";"GO:0004672; GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062";"adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp3086519_c0_seq1;GAXK01041470.1;Q8C8R3;7.58E-09;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp3086706_c0_seq1;GAXK01041469.1;Q9XYN1;7.41E-40;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp308685_c1_seq1;GAXK01044803.1;Q5R7B8;6.64E-31;KLH20_PONAB;Kelch-like protein 20;"axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390";"Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]";"actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]"
comp308702_c0_seq1;GAXK01044895.1;Q4R4T8;5.83E-113;LGMN_MACFA;Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1);"lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]";"GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185";"negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]";lysosome [GO:0005764];cysteine-type endopeptidase activity [GO:0004197]
comp30878_c0_seq1;GAXK01049783.1;A7SL20;1.59E-28;RRP36_NEMVE;Ribosomal RNA processing protein 36 homolog;"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0000469; GO:0005730; GO:0030686";"cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"90S preribosome [GO:0030686]; nucleolus [GO:0005730]";
comp3087951_c0_seq1;GAXK01041467.1;P49210;1.98E-27;RL9_ORYSJ;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp308816_c2_seq1;GAXK01044874.1;Q32LQ3;2.50E-113;OSGP2_DANRE;Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein osgepl1);"EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]";"GO:0000408; GO:0002949; GO:0004222; GO:0005739; GO:0046872; GO:0061711";tRNA threonylcarbamoyladenosine modification [GO:0002949];"EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]"
comp308862_c0_seq1;GAXK01044805.1;P34371;1.89E-14;BAT42_CAEEL;BTB and MATH domain-containing protein 42;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp30887_c0_seq1;GAXK01050426.1;Q6DE14;5.16E-94;E2F4_XENLA;Transcription factor E2F4 (E2F-4);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000278; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0044458; GO:0045944; GO:0046983; GO:0098534; GO:1903251";"centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]"
comp308896_c0_seq1;GAXK01044757.1;Q86MW9;3.19E-07;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp30893_c0_seq1;GAXK01049793.1;Q8IYR2;1.55E-07;SMYD4_HUMAN;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp309_c1_seq1;GAXK01169937.1;Q1HR79;3.11E-76;TCTP_AEDAE;Translationally-controlled tumor protein homolog (TCTP);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp309049_c1_seq1;GAXK01044751.1;Q32KI9;3.35E-112;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp3090574_c0_seq1;GAXK01079466.1;Q6H1V1;1.97E-96;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp30908_c0_seq1;GAXK01205213.1;P49071;2.05E-157;MAPK2_DROME;MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAPK-2) (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]";"GO:0004672; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0045793; GO:0046328; GO:0046777; GO:0051019";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]"
comp3091097_c0_seq1;GAXK01079468.1;P36609;6.52E-07;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp309117_c1_seq1;GAXK01044759.1;Q7T3I0;1.25E-27;ZC4H2_DANRE;Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127 homolog) (Hepatocellular carcinoma-associated antigen 127-like);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]";"GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0021522; GO:0030054; GO:0045211; GO:0045666; GO:0046872; GO:0048665; GO:0048666";"nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]";metal ion binding [GO:0046872]
comp30916_c0_seq1;GAXK01050467.1;Q9QZ67;1.59E-87;PPM1D_MOUSE;Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; response to bacterium [GO:0009617]";"GO:0000086; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006306; GO:0006342; GO:0009267; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019";"cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; response to bacterium [GO:0009617]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722]"
comp3091676_c0_seq1;GAXK01079465.1;Q5CC93;1.32E-65;UCRIA_CYAPA;Cytochrome b6-f complex iron-sulfur subunit 1, cyanelle (EC 7.1.1.6) (Plastohydroquinone:plastocyanin oxidoreductase iron-sulfur protein 1) (Rieske iron-sulfur protein 1) (ISP 1) (RISP 1);"cyanelle thylakoid membrane [GO:0033115]; integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transporter, transferring electrons within cytochrome b6/f complex of photosystem II activity [GO:0045158]; metal ion binding [GO:0046872]; plastoquinol--plastocyanin reductase activity [GO:0009496]; ubiquinol-cytochrome-c reductase activity [GO:0008121]";"GO:0008121; GO:0009496; GO:0016021; GO:0033115; GO:0045158; GO:0046872; GO:0051537";;"cyanelle thylakoid membrane [GO:0033115]; integral component of membrane [GO:0016021]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transporter, transferring electrons within cytochrome b6/f complex of photosystem II activity [GO:0045158]; metal ion binding [GO:0046872]; plastoquinol--plastocyanin reductase activity [GO:0009496]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp30926_c6_seq1;GAXK01050558.1;Q9Y5Z4;8.06E-15;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp30927_c0_seq1;GAXK01050548.1;Q6PFJ1;8.42E-39;NGDN_DANRE;Neuroguidin (EIF4E-binding protein);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]";"GO:0000462; GO:0005730; GO:0005737; GO:0006417; GO:0032040";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";
comp3092887_c0_seq1;GAXK01060328.1;P00771;2.33E-27;COGS_LEPPG;Brachyurin (EC 3.4.21.32) (Collagenolytic protease);"serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0030574";collagen catabolic process [GO:0030574];;serine-type endopeptidase activity [GO:0004252]
comp30934_c5_seq1;GAXK01049956.1;Q8R5H1;0;UBP15_MOUSE;Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0036459; GO:0042802; GO:0046332; GO:0060389; GO:0061649";"BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]"
comp3093567_c0_seq1;GAXK01060336.1;A6H730;1.23E-31;PPAP_BOVIN;Prostatic acid phosphatase (EC 3.1.3.2);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"GO:0003993; GO:0005615; GO:0005886; GO:0006772; GO:0008253; GO:0012506; GO:0016311; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168";"adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; thiamine phosphate phosphatase activity [GO:0042131]"
comp309377_c0_seq1;GAXK01044865.1;Q9VCX1;3.91E-07;RGS_DROME;Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco);"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0014045; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857";"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]"
comp3094065_c0_seq1;GAXK01083337.1;F4KD71;1.43E-20;DUR3_ARATH;Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]";"GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918";"cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]"
comp3094461_c0_seq1;GAXK01204847.1;P50878;1.98E-60;RL4_RAT;60S ribosomal protein L4 (60S ribosomal protein L1);"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; brainstem development [GO:0003360]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; translation [GO:0006412]";"GO:0003360; GO:0003735; GO:0006412; GO:0007420; GO:0008097; GO:0014069; GO:0015934; GO:0022625; GO:0030154; GO:0031672; GO:0045773; GO:0050772; GO:0071417";"brain development [GO:0007420]; brainstem development [GO:0003360]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; translation [GO:0006412]";"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp309453_c0_seq1;GAXK01044742.1;P55017;1.16E-167;S12A3_HUMAN;Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006814; GO:0006884; GO:0008511; GO:0015081; GO:0015378; GO:0015379; GO:0016020; GO:0016324; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573";"cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"potassium:chloride symporter activity [GO:0015379]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp30946_c3_seq1;GAXK01050418.1;O95861;1.62E-109;BPNT1_HUMAN;3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP);"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046872; GO:0050427";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]";cytosol [GO:0005829];"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"
comp309488_c0_seq1;GAXK01044902.1;Q7PEV7;6.91E-16;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp309493_c0_seq1;GAXK01044743.1;E9Q555;0;RN213_MOUSE;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp309526_c1_seq1;GAXK01044758.1;Q17QD9;4.05E-56;CSEN_BOVIN;Calsenilin (A-type potassium channel modulatory protein 3) (Kv channel-interacting protein 3) (KChIP3);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006915; GO:0008076; GO:0015459; GO:0072659; GO:1901379";"apoptotic process [GO:0006915]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp309557_c0_seq1;GAXK01044823.1;P35441;9.30E-07;TSP1_MOUSE;Thrombospondin-1 (Glycoprotein G);"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]";"GO:0000187; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002581; GO:0002605; GO:0003151; GO:0003197; GO:0003417; GO:0005178; GO:0005509; GO:0005577; GO:0005615; GO:0005737; GO:0005783; GO:0006954; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0010811; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0032026; GO:0032695; GO:0034976; GO:0040037; GO:0042327; GO:0042535; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048514; GO:0048661; GO:0050431; GO:0050840; GO:0050921; GO:0051592; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0071636; GO:0071732; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027";"activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]";"calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]"
comp3095692_c0_seq1;GAXK01083343.1;Q8BXX2;3.01E-16;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp309620_c0_seq1;GAXK01044875.1;Q7KRI2;6.42E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp309638_c1_seq1;GAXK01044871.1;Q96PH1;1.10E-129;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp309642_c0_seq1;GAXK01044893.1;Q9VMU8;2.30E-86;SENJU_DROME;UDP-galactose transporter senju;"Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]";"GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0008643; GO:0030173; GO:0045751; GO:0045824; GO:0060050; GO:0072334";"carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]";"Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]";UDP-galactose transmembrane transporter activity [GO:0005459]
comp309660_c1_seq1;GAXK01044768.1;Q7KRI2;1.12E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp309664_c0_seq1;GAXK01044708.1;O35119;1.40E-08;TRPC4_RAT;Short transient receptor potential channel 4 (Trp4) (TrpC4) (Capacitative calcium entry channel 1) (CCE1);"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005262; GO:0005737; GO:0005887; GO:0006816; GO:0006828; GO:0015279; GO:0034703; GO:0051480; GO:0051924; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480]";"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]";"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp3097155_c0_seq1;GAXK01015454.1;P35779;3.16E-39;VA3_SOLRI;Venom allergen 3 (Allergen Sol r III) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol r 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3097802_c0_seq1;GAXK01015452.1;Q502K3;4.83E-21;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp3098099_c0_seq1;GAXK01001505.1;Q9VLV7;2.11E-13;SPZ3_DROME;Protein spaetzle 3 (Protein spatzle 3);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp3098178_c0_seq1;GAXK01001492.1;P19211;3.72E-50;IF5A2_YEAST;Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (Anaerobically induced protein 1) (Hypusine-containing protein HP1) (eIF-4D);"cytosolic ribosome [GO:0022626]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003723; GO:0003746; GO:0006452; GO:0022626; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";cytosolic ribosome [GO:0022626];"ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]"
comp309818_c0_seq1;GAXK01044754.1;Q14192;3.71E-83;FHL2_HUMAN;Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3);"focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; androgen receptor signaling pathway [GO:0030521]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0009725; GO:0019216; GO:0030018; GO:0030521; GO:0042802; GO:0043066; GO:0045893; GO:0046872; GO:0050681; GO:0070885";"androgen receptor signaling pathway [GO:0030521]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]";"focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]";"androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp3099_c0_seq1;GAXK01175989.1;Q15907;1.02E-127;RB11B_HUMAN;Ras-related protein Rab-11B (GTP-binding protein YPT3);"anchored component of synaptic vesicle membrane [GO:0098993]; cell junction [GO:0030054]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]";"GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0005829; GO:0006886; GO:0006887; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0031489; GO:0032402; GO:0032482; GO:0033572; GO:0035773; GO:0043687; GO:0044070; GO:0045054; GO:0045055; GO:0045296; GO:0045335; GO:0055037; GO:0055038; GO:0070062; GO:0071468; GO:0090150; GO:0098993; GO:0150093; GO:1990126; GO:2000008; GO:2001135";"amyloid-beta clearance by transcytosis [GO:0150093]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]";"anchored component of synaptic vesicle membrane [GO:0098993]; cell junction [GO:0030054]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]";"cadherin binding [GO:0045296]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]"
comp3099198_c0_seq1;GAXK01001495.1;Q9U3F4;5.04E-13;ZYX_CAEEL;Zyxin;"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]; DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"GO:0000003; GO:0001725; GO:0005634; GO:0005925; GO:0007399; GO:0015629; GO:0017151; GO:0030424; GO:0031430; GO:0046872; GO:0055120; GO:0098609; GO:0099558";"cell-cell adhesion [GO:0098609]; maintenance of synapse structure [GO:0099558]; nervous system development [GO:0007399]; reproduction [GO:0000003]";"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleus [GO:0005634]; stress fiber [GO:0001725]; striated muscle dense body [GO:0055120]";"DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]"
comp309937_c0_seq1;GAXK01044739.1;Q94535;1.10E-123;U2AF1_DROME;Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit);"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701";"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]";"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]"
comp309946_c0_seq1;GAXK01044800.1;P0C6Y7;2.29E-16;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3099830_c0_seq1;GAXK01001493.1;E9NA96;5.39E-96;IR25A_DROME;Ionotropic receptor 25a;"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]; AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"GO:0004971; GO:0005886; GO:0005929; GO:0007610; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0032281; GO:0043204; GO:0048511; GO:0050907; GO:0050911; GO:0071683";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]";"AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]"
comp310_c1_seq2;GAXK01170213.1;Q95V31;1.17E-83;RS16_SPOFR;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3100133_c0_seq1;GAXK01117709.1;P86854;1.19E-12;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp310193_c2_seq1;GAXK01125700.1;Q99PW6;1.93E-81;MMP24_RAT;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008233; GO:0008270; GO:0010001; GO:0016021; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0050965; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp3102_c2_seq1;GAXK01175677.1;Q9VGY6;3.35E-21;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp31020_c1_seq1;GAXK01050193.1;Q8IU60;1.78E-90;DCP2_HUMAN;m7GpppN-mRNA hydrolase (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 20) (Nudix motif 20) (mRNA-decapping enzyme 2) (hDpc);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; 5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]";"GO:0000184; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0016896; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0043928; GO:0050072; GO:0070034; GO:0071044; GO:1904872";"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]";"5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]"
comp310244_c2_seq1;GAXK01125741.1;Q8BGM5;3.19E-74;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp310246_c2_seq1;GAXK01125759.1;Q5U3Q6;1.23E-23;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp3102619_c0_seq1;GAXK01080527.1;Q6NT16;4.07E-21;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp310270_c0_seq1;GAXK01125834.1;O95777;1.13E-08;LSM8_HUMAN;U6 snRNA-associated Sm-like protein LSm8;"Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0016070; GO:0017070; GO:0046540; GO:0071005; GO:0120115";"mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";"RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]"
comp3103348_c0_seq1;GAXK01080522.1;P34822;6.37E-12;DSL1_CHICK;Dorsalin-1 (DSL-1);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cell development [GO:0048468]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]; vasculogenesis [GO:0001570]";"GO:0001569; GO:0001570; GO:0001649; GO:0001937; GO:0001938; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0010596; GO:0010862; GO:0030308; GO:0030509; GO:0030513; GO:0032757; GO:0032924; GO:0042981; GO:0043408; GO:0045603; GO:0045766; GO:0045944; GO:0048468; GO:0060389; GO:0060395; GO:0061036; GO:2000279";"activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cell development [GO:0048468]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]; vasculogenesis [GO:0001570]";extracellular space [GO:0005615];"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]"
comp310386_c0_seq1;GAXK01125748.1;Q5UQ60;1.16E-10;YL662_MIMIV;Uncharacterized protein L662;;;;;
comp310392_c2_seq1;GAXK01125809.1;Q94900;1.02E-156;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3103966_c0_seq1;GAXK01080517.1;P30974;1.53E-42;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp3104579_c0_seq1;GAXK01063492.1;P83088;3.25E-48;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp310492_c1_seq1;GAXK01125749.1;P81601;6.37E-78;ADHL_GADMO;Alcohol dehydrogenase class-3 chain L (EC 1.1.1.1) (Alcohol dehydrogenase class-III chain L) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284);"cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]";"GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903";ethanol oxidation [GO:0006069];cytoplasm [GO:0005737];"alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"
comp31052_c0_seq1;GAXK01050138.1;P42693;1.91E-15;PPIA_ACIAD;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase);"periplasmic space [GO:0042597]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0006457; GO:0042597";protein folding [GO:0006457];periplasmic space [GO:0042597];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp3106330_c0_seq1;GAXK01200067.1;P0CG23;1.43E-10;ZN853_HUMAN;Zinc finger protein 853;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0046872";;;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp310651_c0_seq1;GAXK01125714.1;Q8BZ00;2.04E-131;SL9A9_MOUSE;Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0015385; GO:0015386; GO:0016021; GO:0031902; GO:0051453; GO:0055037; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp310665_c0_seq1;GAXK01125732.1;O35710;8.69E-57;NOCT_MOUSE;Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein);"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005737; GO:0005739; GO:0006397; GO:0006739; GO:0007623; GO:0009991; GO:0010629; GO:0019178; GO:0030014; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757";"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADPH phosphatase activity [GO:0102757]; NADP phosphatase activity [GO:0019178]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp310683_c0_seq1;GAXK01125753.1;A2ASS6;1.29E-09;TITIN_MOUSE;Titin (EC 2.7.11.1) (Connectin);"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897";"adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp310727_c0_seq1;GAXK01125771.1;A2BGU9;5.30E-36;SERHL_DANRE;Serine hydrolase-like protein (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]";"GO:0004377; GO:0005789; GO:0016787";;endoplasmic reticulum membrane [GO:0005789];"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]"
comp3107457_c0_seq1;GAXK01200063.1;P17538;1.72E-25;CTRB1_HUMAN;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp310748_c0_seq1;GAXK01125751.1;Q9VEG9;2.31E-37;NRM_DROME;Nurim homolog (Nuclear envelope membrane protein) (Nuclear rim protein);"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]";"GO:0005635; GO:0005637; GO:0016021; GO:0031965";;"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]";
comp310832_c2_seq1;GAXK01125719.1;A0JMG1;2.27E-07;SPOLB_DANRE;Speckle-type POZ protein-like B (HIB homolog 3);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp31085_c0_seq1;GAXK01050301.1;O09101;1.75E-19;PIGF_MOUSE;Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]";"GO:0005789; GO:0006506; GO:0016021; GO:0016780";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";phosphotransferase activity, for other substituted phosphate groups [GO:0016780]
comp3109137_c1_seq1;GAXK01195939.1;Q9UM19;4.33E-17;HPCL4_HUMAN;Hippocalcin-like protein 4 (HLP4);"intracellular [GO:0005622]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]";"GO:0005246; GO:0005509; GO:0005622; GO:0007165; GO:0007417; GO:0008022; GO:0019904";"central nervous system development [GO:0007417]; signal transduction [GO:0007165]";intracellular [GO:0005622];"calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]"
comp31094_c1_seq1;GAXK01049794.1;Q27567;1.06E-146;GPDA_DROEZ;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8);"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]";"GO:0004367; GO:0005975; GO:0006650; GO:0009331; GO:0042803; GO:0046168; GO:0051287";"carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]";glycerol-3-phosphate dehydrogenase complex [GO:0009331];"glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]"
comp310963_c0_seq1;GAXK01125802.1;Q0VDN7;4.49E-90;RUND1_MOUSE;RUN domain-containing protein 1;"cell [GO:0005623]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]";"GO:0001701; GO:0005096; GO:0005623; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; in utero embryonic development [GO:0001701]";cell [GO:0005623];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp310964_c1_seq1;GAXK01125735.1;Q01989;1.22E-19;MYS9_DROME;Myosin heavy chain 95F (95F MHC) (Protein jaguar);"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]; spindle organization [GO:0007051]";"GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005875; GO:0005938; GO:0006997; GO:0007015; GO:0007051; GO:0007283; GO:0007291; GO:0007297; GO:0007298; GO:0007391; GO:0007552; GO:0007560; GO:0008017; GO:0008104; GO:0008363; GO:0016333; GO:0016461; GO:0019749; GO:0030036; GO:0030048; GO:0030139; GO:0030317; GO:0030426; GO:0030589; GO:0031476; GO:0032027; GO:0032880; GO:0032956; GO:0032970; GO:0032991; GO:0040001; GO:0042623; GO:0045167; GO:0045172; GO:0045175; GO:0045178; GO:0045217; GO:0045921; GO:0047497; GO:0048477; GO:0051015; GO:0051647; GO:0055057; GO:0055059; GO:0061024; GO:0070856; GO:0070864; GO:0070865";"actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]"
comp311_c1_seq1;GAXK01169624.1;P00027;3.05E-44;CYC_SQUSU;Cytochrome c;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp311018_c0_seq1;GAXK01125957.1;Q03012;3.73E-08;SPP1_YEAST;COMPASS component SPP1 (Complex proteins associated with SET1 protein SPP1) (Set1C component SPP1) (Suppressor of PRP protein 1);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin silencing at telomere [GO:0006348]; histone H3-K4 methylation [GO:0051568]; regulation of meiotic DNA double-strand break formation [GO:1903341]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000781; GO:0003682; GO:0005634; GO:0005829; GO:0006348; GO:0006355; GO:0035064; GO:0046872; GO:0048188; GO:0051568; GO:1903341";"chromatin silencing at telomere [GO:0006348]; histone H3-K4 methylation [GO:0051568]; regulation of meiotic DNA double-strand break formation [GO:1903341]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp311020_c1_seq1;GAXK01125789.1;Q6GM78;3.41E-88;ASGL1_XENLA;"Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain]";"cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345]";"GO:0001917; GO:0004067; GO:0005737; GO:0008798; GO:0033345";asparagine catabolic process via L-aspartate [GO:0033345];"cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]";"asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]"
comp311039_c1_seq1;GAXK01125740.1;Q9R0Y5;3.96E-41;KAD1_MOUSE;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]";"GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006165; GO:0006172; GO:0007050; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0043005; GO:0046033; GO:0046034; GO:0046103; GO:0048471";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp31104_c3_seq1;GAXK01049922.1;P46436;3.28E-34;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp3112300_c0_seq1;GAXK01074725.1;Q9Y6N3;4.10E-25;CLCA3_HUMAN;Calcium-activated chloride channel regulator family member 3 (Calcium-activated chloride channel family member 3) (hCLCA3);"chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; transporter activity [GO:0005215]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005215; GO:0005244; GO:0005254; GO:0005262; GO:0005615; GO:0005886; GO:0034220; GO:0034707; GO:0034765";"ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765]";"chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; transporter activity [GO:0005215]; voltage-gated ion channel activity [GO:0005244]"
comp3112445_c0_seq1;GAXK01074739.1;O14792;1.15E-35;HS3S1_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0034483";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp31126_c2_seq1;GAXK01050274.1;Q8TEK3;1.51E-102;DOT1L_HUMAN;Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4);"chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription factor binding [GO:0008134]; chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]";"GO:0000077; GO:0000781; GO:0003677; GO:0005634; GO:0005654; GO:0006348; GO:0008134; GO:0008284; GO:0018024; GO:0031151; GO:0032200; GO:0032991; GO:0034729; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:2000677";"chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]";"chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; transcription factor binding [GO:0008134]"
comp3113_c0_seq1;GAXK01175485.1;O42587;0;PR6AA_XENLA;26S proteasome regulatory subunit 6A-A (26S proteasome AAA-ATPase subunit RPT5-A) (Proteasome 26S subunit ATPase 3-A) (Tat-binding protein 6) (TBP-6);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein catabolic process [GO:0030163]";"GO:0005524; GO:0005634; GO:0005737; GO:0016787; GO:0022624; GO:0030163";protein catabolic process [GO:0030163];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]";"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp3113268_c0_seq1;GAXK01074727.1;Q95RJ9;2.40E-08;EBI_DROME;F-box-like/WD repeat-containing protein ebi;"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cellular response to light stimulus [GO:0071482]; chaeta development [GO:0022416]; histone deacetylation [GO:0016575]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; photoreceptor cell development [GO:0042461]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of Notch signaling pathway [GO:0045747]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]; visual perception [GO:0007601]; wing disc development [GO:0035220]";"GO:0000118; GO:0003682; GO:0003714; GO:0005634; GO:0005700; GO:0006357; GO:0006979; GO:0007049; GO:0007601; GO:0008587; GO:0016575; GO:0017053; GO:0022416; GO:0031065; GO:0035220; GO:0042058; GO:0042461; GO:0043161; GO:0043524; GO:0045572; GO:0045747; GO:0045892; GO:0046329; GO:0070050; GO:0070491; GO:0071482";"cell cycle [GO:0007049]; cellular response to light stimulus [GO:0071482]; chaeta development [GO:0022416]; histone deacetylation [GO:0016575]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; photoreceptor cell development [GO:0042461]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of Notch signaling pathway [GO:0045747]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]; visual perception [GO:0007601]; wing disc development [GO:0035220]";"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]"
comp311376_c0_seq1;GAXK01125769.1;O61491;1.33E-29;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp3114593_c0_seq1;GAXK01108373.1;P12078;1.61E-27;HSP73_PLAFA;Heat shock 70 kDa protein PPF203 (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp31148_c0_seq1;GAXK01049980.1;Q5R839;1.22E-104;S41A1_PONAB;Solute carrier family 41 member 1;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]";"GO:0010961; GO:0015095; GO:0016021; GO:0016323; GO:0032991; GO:0061768; GO:0071286; GO:0072509";"cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";"divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium:sodium antiporter activity [GO:0061768]; magnesium ion transmembrane transporter activity [GO:0015095]"
comp31149_c0_seq1;GAXK01049709.1;P82923;5.40E-68;RT02_BOVIN;28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0061668";"mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]";"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";structural constituent of ribosome [GO:0003735]
comp3115261_c0_seq1;GAXK01108383.1;O14649;4.31E-32;KCNK3_HUMAN;Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0022841; GO:0030322; GO:0034220; GO:0042493; GO:0044548; GO:0051481; GO:0061337; GO:0071294; GO:0071456; GO:0071805; GO:0090102";"brain development [GO:0007420]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]"
comp3115279_c0_seq1;GAXK01108378.1;Q09575;4.72E-14;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp31158_c3_seq1;GAXK01050463.1;Q9W5U2;1.68E-95;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp311622_c0_seq1;GAXK01125803.1;Q9FWR4;7.82E-23;DHAR1_ARATH;Glutathione S-transferase DHAR1, mitochondrial (EC 2.5.1.18) (Chloride intracellular channel homolog 1) (CLIC homolog 1) (Glutathione-dependent dehydroascorbate reductase 1) (AtDHAR1) (GSH-dependent dehydroascorbate reductase 1) (mtDHAR) (EC 1.8.5.1);"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; copper ion binding [GO:0005507]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; voltage-gated ion channel activity [GO:0005244]; cellular response to hydrogen peroxide [GO:0070301]; defense response [GO:0006952]; positive regulation of salicylic acid mediated signaling pathway [GO:0080151]; protein glutathionylation [GO:0010731]; regulation of ion transmembrane transport [GO:0034765]; regulation of symbiosis, encompassing mutualism through parasitism [GO:0043903]; response to jasmonic acid [GO:0009753]; response to ozone [GO:0010193]; response to symbiotic fungus [GO:0009610]; response to zinc ion [GO:0010043]";"GO:0004364; GO:0005244; GO:0005507; GO:0005634; GO:0005739; GO:0005773; GO:0005777; GO:0005829; GO:0005886; GO:0006952; GO:0009507; GO:0009570; GO:0009610; GO:0009753; GO:0010043; GO:0010193; GO:0010731; GO:0034765; GO:0043903; GO:0045174; GO:0048046; GO:0070301; GO:0080151";"cellular response to hydrogen peroxide [GO:0070301]; defense response [GO:0006952]; positive regulation of salicylic acid mediated signaling pathway [GO:0080151]; protein glutathionylation [GO:0010731]; regulation of ion transmembrane transport [GO:0034765]; regulation of symbiosis, encompassing mutualism through parasitism [GO:0043903]; response to jasmonic acid [GO:0009753]; response to ozone [GO:0010193]; response to symbiotic fungus [GO:0009610]; response to zinc ion [GO:0010043]";"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";"copper ion binding [GO:0005507]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; voltage-gated ion channel activity [GO:0005244]"
comp31169_c3_seq1;GAXK01050067.1;Q6X0I2;4.55E-42;VGR_SOLIN;Vitellogenin receptor (SiVgR);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; receptor-mediated endocytosis [GO:0006898]";"GO:0005509; GO:0006898; GO:0016021; GO:0038024";receptor-mediated endocytosis [GO:0006898];integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]"
comp31174_c1_seq1;GAXK01049700.1;C3Y3G4;0;LIAS_BRAFL;Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]";"GO:0005737; GO:0005739; GO:0009107; GO:0009249; GO:0016992; GO:0046872; GO:0051539";"lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]"
comp311754_c1_seq1;GAXK01125843.1;A1YF16;5.16E-43;MSX2_GORGO;Homeobox protein MSX-2;"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]";"GO:0000122; GO:0000977; GO:0001649; GO:0005634; GO:0005829; GO:0016607; GO:0044212; GO:0045892; GO:0048598";"embryonic morphogenesis [GO:0048598]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp311766_c1_seq1;GAXK01125699.1;P77989;9.60E-23;BGAL_THEP3;Beta-galactosidase (Beta-gal) (EC 3.2.1.23) (Lactase);"beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]";"GO:0004565; GO:0005975";carbohydrate metabolic process [GO:0005975];;beta-galactosidase activity [GO:0004565]
comp31179_c2_seq1;GAXK01050016.1;Q80V42;9.06E-125;CBPM_MOUSE;Carboxypeptidase M (CPM) (EC 3.4.17.12);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]";"GO:0004181; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0031225";"peptide metabolic process [GO:0006518]; protein processing [GO:0016485]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp3118861_c0_seq1;GAXK01024535.1;Q94526;4.68E-12;ORK1_DROME;Open rectifier potassium channel protein 1 (Two pore domain potassium channel Ork1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; potassium ion leak channel activity [GO:0022841]; protein homodimerization activity [GO:0042803]; locomotor rhythm [GO:0045475]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate [GO:0002027]; stabilization of membrane potential [GO:0030322]";"GO:0002027; GO:0005886; GO:0005887; GO:0016021; GO:0022841; GO:0030322; GO:0034705; GO:0042803; GO:0045475; GO:0071805";"locomotor rhythm [GO:0045475]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate [GO:0002027]; stabilization of membrane potential [GO:0030322]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]";"potassium ion leak channel activity [GO:0022841]; protein homodimerization activity [GO:0042803]"
comp312_c2_seq1;GAXK01166054.1;Q9CQU3;5.18E-80;RER1_MOUSE;Protein RER1;"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; acetylcholine receptor binding [GO:0033130]; neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0007528; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078";"neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]";acetylcholine receptor binding [GO:0033130]
comp312036_c3_seq1;GAXK01069663.1;Q6MHJ5;6.39E-28;PIF1_BDEBA;ATP-dependent DNA helicase pif1 (EC 3.6.4.12);"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]";;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp31204_c0_seq1;GAXK01050409.1;Q4UMH6;1.84E-24;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp312096_c1_seq1;GAXK01069595.1;Q03936;1.03E-25;ZNF92_HUMAN;Zinc finger protein 92 (Zinc finger protein HTF12);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp31210_c0_seq1;GAXK01049802.1;P57790;4.91E-11;KEAP1_RAT;Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2);"cell-cell adherens junction [GO:0005913]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; transcription factor binding [GO:0008134]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of gene expression [GO:0010629]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein complex oligomerization [GO:0051259]; protein ubiquitination [GO:0016567]; response to immobilization stress [GO:0035902]; response to metal ion [GO:0010038]; response to thyroid hormone [GO:0097066]; selenium compound metabolic process [GO:0001887]";"GO:0001887; GO:0005634; GO:0005737; GO:0005913; GO:0005925; GO:0008134; GO:0010038; GO:0010499; GO:0010629; GO:0016567; GO:0031463; GO:0035902; GO:0042994; GO:0051259; GO:0071407; GO:0097066";"cellular response to organic cyclic compound [GO:0071407]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of gene expression [GO:0010629]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein complex oligomerization [GO:0051259]; protein ubiquitination [GO:0016567]; response to immobilization stress [GO:0035902]; response to metal ion [GO:0010038]; response to thyroid hormone [GO:0097066]; selenium compound metabolic process [GO:0001887]";"cell-cell adherens junction [GO:0005913]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]";transcription factor binding [GO:0008134]
comp312166_c2_seq1;GAXK01069540.1;Q1H9T6;9.51E-18;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp31217_c1_seq1;GAXK01050416.1;Q5RBL0;1.50E-65;YIPF1_PONAB;Protein YIPF1 (YIP1 family member 1);"Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; vesicle-mediated transport [GO:0016192]";"GO:0000138; GO:0005797; GO:0005802; GO:0016021; GO:0016192; GO:0031902";vesicle-mediated transport [GO:0016192];"Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]";
comp31222_c3_seq1;GAXK01049924.1;Q7M2W6;1.29E-11;CRYAB_PIG;Alpha-crystallin B chain (Alpha(B)-crystallin);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005212; GO:0005634; GO:0005737; GO:0032991; GO:0042803; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]"
comp3122400_c0_seq1;GAXK01004900.1;Q75WF2;4.88E-15;DNA2_ACAPL;"Plancitoxin-1 (EC 3.1.22.1) (Plancitoxin I) (Plan-I) [Cleaved into: Plancitoxin-1 subunit alpha; Plancitoxin-1 subunit beta]";"extracellular region [GO:0005576]; deoxyribonuclease II activity [GO:0004531]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]";"GO:0004531; GO:0005576; GO:0006915; GO:0090729";apoptotic process [GO:0006915];extracellular region [GO:0005576];"deoxyribonuclease II activity [GO:0004531]; toxin activity [GO:0090729]"
comp3122730_c0_seq1;GAXK01004870.1;O23755;1.69E-161;EF2_BETVU;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp31236_c0_seq1;GAXK01050264.1;Q61543;0;GSLG1_MOUSE;Golgi apparatus protein 1 (E-selectin ligand 1) (ESL-1) (Selel) (Golgi sialoglycoprotein MG-160);"extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330]";"GO:0000139; GO:0005794; GO:0005797; GO:0005886; GO:0010955; GO:0016021; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0043231; GO:0060349";"bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330]";"extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";fibroblast growth factor binding [GO:0017134]
comp3123747_c0_seq1;GAXK01004878.1;B7YZU2;1.41E-21;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp312389_c0_seq1;GAXK01069598.1;P54288;1.39E-147;CACB2_RABIT;Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2);"L-type voltage-gated calcium channel complex [GO:1990454]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0034765; GO:1990454";regulation of ion transmembrane transport [GO:0034765];L-type voltage-gated calcium channel complex [GO:1990454];voltage-gated calcium channel activity [GO:0005245]
comp3123907_c0_seq1;GAXK01004881.1;Q8BXX2;1.17E-13;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp3123908_c0_seq1;GAXK01004885.1;Q43291;3.13E-55;RL211_ARATH;60S ribosomal protein L21-1;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005576; GO:0005730; GO:0006412; GO:0022625; GO:0022626";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp3124294_c0_seq1;GAXK01062161.1;Q5YCC7;1.68E-73;TMC3_CHICK;Transmembrane channel-like protein 3;"integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]";"GO:0005216; GO:0005887; GO:0008381";;integral component of plasma membrane [GO:0005887];"ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]"
comp3124511_c0_seq1;GAXK01062164.1;Q9W3Y4;1.12E-22;GA2PE_DROME;GAS2-like protein pickled eggs;"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; microtubule binding [GO:0008017]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"GO:0005856; GO:0005938; GO:0008017; GO:0030707; GO:0030713";"ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]";microtubule binding [GO:0008017]
comp3124616_c0_seq1;GAXK01062176.1;Q03720;1.71E-07;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp3125469_c0_seq1;GAXK01062160.1;Q13398;8.63E-12;ZN211_HUMAN;Zinc finger protein 211 (Zinc finger protein C2H2-25);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp312548_c0_seq1;GAXK01069652.1;Q5ZKD9;1.09E-07;KLH20_CHICK;Kelch-like protein 20;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390";"Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]";"interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]"
comp312557_c4_seq1;GAXK01069580.1;Q8WYN3;1.54E-52;CSRN3_HUMAN;Cysteine/serine-rich nuclear protein 3 (CSRNP-3) (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2) (TAIP-2);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0043065; GO:0043565; GO:0045944";"apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp3125838_c0_seq1;GAXK01062167.1;A8J1V4;7.10E-10;CFA44_CHLRE;Cilia- and flagella-associated protein 44;"axoneme [GO:0005930]; motile cilium [GO:0031514]; nuclear speck [GO:0016607]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0016607; GO:0031514; GO:0060271; GO:0060285";"cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]";"axoneme [GO:0005930]; motile cilium [GO:0031514]; nuclear speck [GO:0016607]";
comp3126579_c0_seq1;GAXK01195612.1;P55215;2.73E-28;CASP2_RAT;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; neural retina development [GO:0003407]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"GO:0001554; GO:0003407; GO:0005634; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0012501; GO:0016020; GO:0016485; GO:0019904; GO:0035234; GO:0042802; GO:0043525; GO:0071260; GO:0097153; GO:0097192; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; neural retina development [GO:0003407]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp3126592_c0_seq1;GAXK01195616.1;Q98TR7;1.79E-59;RS16_HETFO;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp31267_c0_seq1;GAXK01205227.1;O88664;0;TAOK1_RAT;Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Thousand and one amino acid protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0008022; GO:0019901; GO:0023014; GO:0030295; GO:0031098; GO:0031489; GO:0032147; GO:0032874; GO:0032956; GO:0043539; GO:0046330; GO:0046777; GO:0051493; GO:0070507; GO:0097194";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]"
comp312702_c0_seq1;GAXK01069609.1;Q95221;1.30E-37;IP6K2_RABIT;Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (EC 2.7.4.-) (P(i)-uptake stimulator) (PiUS);"cell junction [GO:0030054]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]";"GO:0000832; GO:0001650; GO:0005524; GO:0030054; GO:0030308; GO:0032958; GO:0043065; GO:0043647; GO:0046854; GO:0097243; GO:1905396";"cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]";"cell junction [GO:0030054]; fibrillar center [GO:0001650]";"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]"
comp312721_c2_seq1;GAXK01069679.1;P35288;9.65E-74;RAB23_MOUSE;Ras-related protein Rab-23 (Protein open brain) (Rab-15);"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic digit morphogenesis [GO:0042733]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of proteolysis [GO:0045861]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; Rab protein signal transduction [GO:0032482]; regulation of smoothened signaling pathway [GO:0008589]; signal transduction [GO:0007165]; spinal cord dorsal/ventral patterning [GO:0021513]";"GO:0000045; GO:0001843; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0007165; GO:0007399; GO:0008589; GO:0010008; GO:0021513; GO:0021904; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0042733; GO:0045335; GO:0045861; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic digit morphogenesis [GO:0042733]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of proteolysis [GO:0045861]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; Rab protein signal transduction [GO:0032482]; regulation of smoothened signaling pathway [GO:0008589]; signal transduction [GO:0007165]; spinal cord dorsal/ventral patterning [GO:0021513]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3127436_c0_seq1;GAXK01195627.1;P51819;0;HSP83_IPONI;Heat shock protein 83;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp312758_c1_seq1;GAXK01069554.1;Q9VI93;4.77E-28;RN_DROME;Zinc finger protein rotund (Zinc finger protein roughened eye);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0007480; GO:0022416; GO:0045892; GO:0046872; GO:0048749";"cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3127745_c0_seq1;GAXK01195634.1;P82120;2.92E-24;CUO7_BLACR;Cuticle protein 7 (BcNCP15.0);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp31280_c0_seq1;GAXK01050420.1;P05661;1.68E-69;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp3128180_c0_seq1;GAXK01142849.1;Q9D7Z6;3.44E-17;CLCA1_MOUSE;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0006821; GO:0008237; GO:0016021; GO:0030141; GO:0042589; GO:0046872; GO:0071456";"calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3128244_c0_seq1;GAXK01142854.1;Q8RY89;2.57E-21;PI5K8_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 8 (AtPIP5K8) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 8) (Diphosphoinositide kinase 8) (PtdIns(4)P-5-kinase 8);"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]";"GO:0005524; GO:0016308";;;"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp31290_c2_seq1;GAXK01049857.1;Q07496;0;EPHA4_CHICK;Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8);"adherens junction [GO:0005912]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001756; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0005912; GO:0007155; GO:0007169; GO:0007411; GO:0007628; GO:0008045; GO:0018108; GO:0021957; GO:0030424; GO:0031901; GO:0035282; GO:0042731; GO:0042802; GO:0043005; GO:0043087; GO:0043197; GO:0043235; GO:0043507; GO:0046777; GO:0048681; GO:0048710; GO:0050770; GO:0050821; GO:0061001; GO:0061098; GO:0072178; GO:0090102; GO:0097155; GO:0097156; GO:0097161; GO:0098685; GO:0098883; GO:0098978; GO:0099055; GO:0099056; GO:1900272; GO:1902004; GO:1902961; GO:1903051; GO:1904646; GO:1905244; GO:1990782; GO:2001108";"adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"adherens junction [GO:0005912]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]";"ATP binding [GO:0005524]; DH domain binding [GO:0097161]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein tyrosine kinase binding [GO:1990782]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp3129661_c0_seq1;GAXK01142841.1;Q9D180;2.36E-30;CFA57_MOUSE;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp31297_c0_seq1;GAXK01050421.1;Q9N5Y2;1.63E-105;TECR_CAEEL;Probable very-long-chain enoyl-CoA reductase art-1 (EC 1.3.1.93);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005789; GO:0016021; GO:0016491; GO:0042761; GO:0102758";very long-chain fatty acid biosynthetic process [GO:0042761];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]"
comp3129901_c0_seq1;GAXK01142861.1;Q868Z9;3.24E-17;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp3130292_c0_seq1;GAXK01057622.1;Q07760;9.43E-77;RL23_TOBAC;60S ribosomal protein L23;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp313075_c0_seq1;GAXK01069551.1;P98196;0;AT11A_HUMAN;Probable phospholipid-transporting ATPase IH (EC 7.6.2.1) (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A);"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; in utero embryonic development [GO:0001701]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0001701; GO:0005524; GO:0005765; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0016020; GO:0016021; GO:0035579; GO:0043231; GO:0043312; GO:0045332; GO:0055037; GO:0070821; GO:0140326";"in utero embryonic development [GO:0001701]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp3130781_c0_seq1;GAXK01057617.1;Q9TSZ3;1.11E-08;KCNH2_CANLF;Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1);"integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005249; GO:0005887; GO:0034765; GO:0042391; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";integral component of plasma membrane [GO:0005887];voltage-gated potassium channel activity [GO:0005249]
comp313080_c1_seq1;GAXK01069613.1;Q52PJ5;1.47E-31;DPYL3_DANRE;Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4);"cytosol [GO:0005829]; growth cone [GO:0030426]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"GO:0005829; GO:0007409; GO:0007411; GO:0010975; GO:0016810; GO:0030334; GO:0030426; GO:0048678; GO:0048936; GO:0051017; GO:0051491; GO:0051764";"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"cytosol [GO:0005829]; growth cone [GO:0030426]";hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]
comp313139_c2_seq1;GAXK01069690.1;Q66S03;7.68E-12;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp3134_c0_seq1;GAXK01176630.1;Q6NU40;2.02E-171;CTF18_XENLA;Chromosome transmission fidelity protein 18 homolog;"DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; cell cycle [GO:0007049]; DNA replication [GO:0006260]";"GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0007049";"cell cycle [GO:0007049]; DNA replication [GO:0006260]";"DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]"
comp3134016_c0_seq1;GAXK01013176.1;Q9SMI2;9.64E-26;RS21_CYAPA;40S ribosomal protein S21;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3134616_c0_seq1;GAXK01013185.1;Q5RHR6;5.65E-29;BROMI_DANRE;Protein broad-minded (TBC1 domain family member 32);"cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; non-motile cilium assembly [GO:1905515]";"GO:0005737; GO:0005929; GO:0007275; GO:0035082; GO:0060271; GO:1905515";"axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; non-motile cilium assembly [GO:1905515]";"cilium [GO:0005929]; cytoplasm [GO:0005737]";
comp3134979_c0_seq1;GAXK01013167.1;Q75NA5;1.13E-38;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp31353_c1_seq1;GAXK01049874.1;O35218;0;CPSF2_MOUSE;Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]";"GO:0003723; GO:0005847; GO:0006378; GO:0006379; GO:0006398";"mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]";mRNA cleavage and polyadenylation specificity factor complex [GO:0005847];RNA binding [GO:0003723]
comp313538_c1_seq1;GAXK01069649.1;Q9V784;5.16E-08;SAM50_DROME;SAM50-like protein CG7639;"integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; cellular protein-containing complex assembly [GO:0034622]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]";"GO:0001401; GO:0016021; GO:0033108; GO:0034622; GO:0045040";"cellular protein-containing complex assembly [GO:0034622]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]";"integral component of membrane [GO:0016021]; SAM complex [GO:0001401]";
comp31356_c2_seq2;GAXK01050516.1;Q869Q0;5.00E-19;Y4527_DICDI;COBW domain-containing protein DDB_G0274527;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp3135753_c0_seq1;GAXK01013195.1;O94875;1.19E-13;SRBS2_HUMAN;Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]";"GO:0003723; GO:0005200; GO:0005634; GO:0005654; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0048471; GO:0061049";"actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";"cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]"
comp3135833_c0_seq1;GAXK01013200.1;Q0DYK7;7.29E-11;CDPK5_ORYSJ;Calcium-dependent protein kinase 5 (OsCDPK5) (OsCPK5) (EC 2.7.11.1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp313593_c1_seq1;GAXK01069673.1;A2ASS6;3.29E-07;TITIN_MOUSE;Titin (EC 2.7.11.1) (Connectin);"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897";"adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp3136131_c0_seq1;GAXK01078045.1;A6H7B8;9.47E-13;PGAP2_BOVIN;Post-GPI attachment to proteins factor 2;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000139; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp313634_c0_seq1;GAXK01069590.1;Q18932;2.55E-50;CAH2_CAEEL;Putative carbonic anhydrase-like protein 2;"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp3136550_c0_seq1;GAXK01078029.1;A9ZSY3;1.33E-79;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp31368_c0_seq1;GAXK01050553.1;Q8R3S2;9.65E-57;TSN33_MOUSE;Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]";"GO:0005886; GO:0005887; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197";"pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]";enzyme binding [GO:0019899]
comp313699_c0_seq1;GAXK01069616.1;Q7ZVG6;6.47E-15;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3137_c0_seq1;GAXK01175886.1;Q80W37;2.46E-79;SPN1_MOUSE;Snurportin-1 (RNA U transporter 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; RNA binding [GO:0003723]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]";"GO:0003723; GO:0005634; GO:0005737; GO:0006606; GO:0061015; GO:0061608";"protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"nuclear import signal receptor activity [GO:0061608]; RNA binding [GO:0003723]"
comp3137118_c0_seq1;GAXK01078030.1;P86854;2.79E-17;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp31372_c0_seq1;GAXK01049710.1;Q23983;2.72E-130;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp31374_c5_seq1;GAXK01050161.1;P54725;7.25E-09;RD23A_HUMAN;UV excision repair protein RAD23 homolog A (HR23A) (hHR23A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; viral process [GO:0016032]";"GO:0000502; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006289; GO:0016032; GO:0016579; GO:0019900; GO:0031593; GO:0031648; GO:0032434; GO:0032436; GO:0032991; GO:0043130; GO:0043161; GO:0043231; GO:0045070; GO:0045787; GO:0070628; GO:1990381";"nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]";"damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381]"
comp313743_c1_seq1;GAXK01069654.1;Q0IIH7;1.11E-25;ST14_BOVIN;Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Serine protease 14);"integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; keratinocyte differentiation [GO:0030216]";"GO:0004252; GO:0016021; GO:0030216";keratinocyte differentiation [GO:0030216];integral component of membrane [GO:0016021];serine-type endopeptidase activity [GO:0004252]
comp3137484_c0_seq1;GAXK01078033.1;Q08180;3.22E-78;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp31376_c3_seq1;GAXK01049929.1;Q7ZVS8;9.74E-84;CMTR2_DANRE;Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (MTr2) (FtsJ methyltransferase domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]";"GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310";"7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]
comp3137644_c0_seq1;GAXK01078036.1;Q9VY99;2.66E-80;NNAD_DROME;Cytosolic carboxypeptidase Nna1 (EC 3.4.17.-) (Nervous system nuclear protein induced by axotomy protein 1 homolog);"mitochondrion [GO:0005739]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";"GO:0002164; GO:0003407; GO:0004181; GO:0005739; GO:0007005; GO:0008270";"larval development [GO:0002164]; mitochondrion organization [GO:0007005]; neural retina development [GO:0003407]";mitochondrion [GO:0005739];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp3137909_c0_seq1;GAXK01078031.1;Q5G265;9.57E-15;NETR_SAGLB;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424";exocytosis [GO:0006887];"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp31380_c0_seq1;GAXK01050135.1;Q5R8W1;6.58E-102;KLDC4_PONAB;Kelch domain-containing protein 4;;;;;
comp3138189_c0_seq1;GAXK01180074.1;Q96JA1;1.13E-10;LRIG1_HUMAN;Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]";"GO:0005615; GO:0005886; GO:0007605; GO:0016021; GO:0022405; GO:0031012; GO:0032474; GO:0060384";"hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3138379_c0_seq1;GAXK01180064.1;Q9SIK2;4.45E-23;RS252_ARATH;40S ribosomal protein S25-2;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005773; GO:0005774; GO:0009506; GO:0022626; GO:0022627; GO:0042788";;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp3138597_c0_seq1;GAXK01180070.1;P16885;2.07E-25;PLCG2_HUMAN;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphotyrosine residue binding [GO:0001784]; activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"GO:0001784; GO:0002092; GO:0002223; GO:0002316; GO:0004435; GO:0004629; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010468; GO:0016055; GO:0019722; GO:0030168; GO:0030183; GO:0032237; GO:0032481; GO:0032496; GO:0032959; GO:0038095; GO:0038096; GO:0043069; GO:0043647; GO:0048015; GO:0050852; GO:0050853; GO:0051209; GO:0070062";"activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";"phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphotyrosine residue binding [GO:0001784]"
comp313902_c1_seq1;GAXK01069655.1;Q9H267;8.51E-115;VP33B_HUMAN;Vacuolar protein sorting-associated protein 33B (hVPS33B);"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; protein-containing complex binding [GO:0044877]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0006904; GO:0007032; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0044877; GO:0048471; GO:0055037; GO:0061025; GO:0070889";"collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]";protein-containing complex binding [GO:0044877]
comp3139021_c0_seq1;GAXK01180057.1;P08043;1.77E-08;ZFP2_MOUSE;Zinc finger protein 2 (Zfp-2) (Protein mKR2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3139157_c0_seq1;GAXK01180061.1;P17093;1.69E-62;RS11_SOYBN;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp314004_c0_seq1;GAXK01032745.1;Q60821;8.90E-34;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp314054_c0_seq1;GAXK01032744.1;Q9VD09;1.15E-34;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp3140580_c0_seq1;GAXK01139979.1;Q95XM2;1.44E-11;PHM_CAEEL;Probable peptidylglycine alpha-hydroxylating monooxygenase 1 (PHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide amidation [GO:0001519]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0016020";peptide amidation [GO:0001519];"extracellular region [GO:0005576]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp3140658_c0_seq1;GAXK01139994.1;Q94HW2;1.01E-20;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3141047_c0_seq1;GAXK01139976.1;Q28658;4.03E-19;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp314116_c1_seq1;GAXK01032993.1;Q7ZVR6;4.29E-07;MYNN_DANRE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3141578_c0_seq1;GAXK01139975.1;Q9W0P8;6.38E-07;MED14_DROME;Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14) (dRGR1);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003712; GO:0006357; GO:0006366; GO:0006367; GO:0016592; GO:0070847";"regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";transcription coregulator activity [GO:0003712]
comp314206_c1_seq1;GAXK01032837.1;B7ZTR0;4.76E-45;CPLN2_XENTR;Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle fusion [GO:0031338]";"GO:0003924; GO:0005525; GO:0005737; GO:0006887; GO:0015031; GO:0017157; GO:0031338; GO:0034613; GO:0036064; GO:0060271";"cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle fusion [GO:0031338]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3142325_c0_seq1;GAXK01162503.1;P17970;8.88E-25;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp314246_c0_seq1;GAXK01032772.1;Q67BJ4;5.47E-11;A4GAT_MOUSE;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp314282_c0_seq1;GAXK01032958.1;Q04652;4.55E-49;KELC_DROME;Ring canal kelch protein [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; germline ring canal [GO:0045172]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]";"GO:0003779; GO:0005737; GO:0005856; GO:0007297; GO:0007300; GO:0007301; GO:0007349; GO:0030036; GO:0030717; GO:0030723; GO:0035183; GO:0035324; GO:0045172; GO:0048477";"actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; germline ring canal [GO:0045172]";actin binding [GO:0003779]
comp3142845_c0_seq1;GAXK01162486.1;Q17005;2.98E-18;LYSC1_ANOGA;Lysozyme c-1 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase);"lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";"GO:0003796; GO:0008152; GO:0019835; GO:0042742";"cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";;lysozyme activity [GO:0003796]
comp31432_c0_seq1;GAXK01050232.1;Q94529;7.02E-62;GS1_DROME;Probable pseudouridine-5'-phosphatase (EC 3.1.3.96) (GS1-like protein) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase);"magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; wound healing [GO:0042060]";"GO:0000287; GO:0009117; GO:0042060; GO:1990738";"nucleotide metabolic process [GO:0009117]; wound healing [GO:0042060]";;"magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]"
comp314328_c0_seq1;GAXK01032774.1;Q8T674;2.89E-104;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp3143304_c0_seq1;GAXK01162485.1;Q9FNE2;2.83E-07;GRXC2_ARATH;Glutaredoxin-C2 (AtGrxC2);"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";"GO:0004362; GO:0005737; GO:0009055; GO:0015035; GO:0034599; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]"
comp3143435_c0_seq1;GAXK01162480.1;A9ZSY3;1.87E-55;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp314344_c0_seq1;GAXK01032944.1;Q8MKK4;2.10E-46;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp314354_c1_seq1;GAXK01032824.1;Q14588;1.21E-37;ZN234_HUMAN;Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp31436_c0_seq1;GAXK01049784.1;Q9DCM0;2.94E-97;ETHE1_MOUSE;Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]";"GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0050313; GO:0070813";"glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"hydrolase activity, acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"
comp31449_c0_seq1;GAXK01050408.1;P18262;1.59E-95;RAS_ARTSA;Ras-like protein (Fragment);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp314501_c0_seq1;GAXK01032769.1;Q9VCX1;1.55E-55;RGS_DROME;Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco);"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0014045; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857";"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]"
comp314505_c0_seq1;GAXK01032833.1;Q91WW7;1.16E-55;PLPL3_MOUSE;1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 (EC 2.3.1.51) (Acylglycerol transacylase) (Adiponutrin) (ADPN) (Calcium-independent phospholipase A2-epsilon) (iPLA2-epsilon) (Lysophosphatidic acid acyltransferase) (Patatin-like phospholipase domain-containing protein 3) (EC 3.1.1.3);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]; glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"GO:0001676; GO:0002021; GO:0003841; GO:0004623; GO:0004806; GO:0005737; GO:0005811; GO:0006650; GO:0006654; GO:0016020; GO:0016021; GO:0019432; GO:0019433; GO:0034389; GO:0035727; GO:0036042; GO:0036153; GO:0042171; GO:0051264; GO:0051265; GO:0055088";"glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]"
comp3145267_c0_seq1;GAXK01037044.1;Q24732;8.47E-74;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp31453_c1_seq1;GAXK01049801.1;Q9VND8;2.32E-75;RHEB_DROME;GTP-binding protein Rheb homolog;"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; apical protein localization [GO:0045176]; carbohydrate metabolic process [GO:0005975]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid metabolic process [GO:0006629]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]";"GO:0000082; GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007264; GO:0007430; GO:0008286; GO:0010506; GO:0010507; GO:0010942; GO:0019003; GO:0030307; GO:0035264; GO:0042594; GO:0042632; GO:0045176; GO:0045727; GO:0045793; GO:0045887; GO:0046872; GO:0090070; GO:1902669; GO:1903940; GO:1904263; GO:1904503; GO:2000377";"apical protein localization [GO:0045176]; carbohydrate metabolic process [GO:0005975]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid metabolic process [GO:0006629]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp3145738_c0_seq1;GAXK01037024.1;P18433;8.75E-22;PTPRA_HUMAN;Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]";"GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699";"axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp3145794_c0_seq1;GAXK01037041.1;Q8IVG5;8.29E-08;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp314626_c1_seq1;GAXK01032983.1;Q8IZD9;0;DOCK3_HUMAN;Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP);"cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997";"positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]";cytosol [GO:0005829];"Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]"
comp3146608_c0_seq1;GAXK01107945.1;Q9KJ22;9.84E-21;GSMT_HALHR;Glycine/sarcosine N-methyltransferase (EC 2.1.1.156);"glycine N-methyltransferase activity [GO:0017174]; sarcosine N-methyltransferase activity [GO:0052730]; glycine betaine biosynthetic process from glycine [GO:0019286]";"GO:0017174; GO:0019286; GO:0052730";glycine betaine biosynthetic process from glycine [GO:0019286];;"glycine N-methyltransferase activity [GO:0017174]; sarcosine N-methyltransferase activity [GO:0052730]"
comp3146645_c0_seq1;GAXK01107938.1;Q5VX52;6.32E-10;SPAT1_HUMAN;Spermatogenesis-associated protein 1 (Sperm-specific protein SP-2);;;;;
comp3146674_c0_seq1;GAXK01107955.1;Q7ZU45;3.72E-15;TTC25_DANRE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371";"cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp3146834_c0_seq1;GAXK01107939.1;P14329;4.18E-42;RL19_DICDI;60S ribosomal protein L19 (22 kDa calmodulin-binding protein) (Vegetative-specific protein V14);"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; lipid droplet [GO:0005811]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005516; GO:0005811; GO:0006412; GO:0015934; GO:0022625";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; lipid droplet [GO:0005811]";"calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp3146858_c0_seq1;GAXK01107957.1;G5EBR3;3.39E-14;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp3147124_c0_seq1;GAXK01107948.1;Q9Y530;8.68E-26;OARD1_HUMAN;ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]"
comp3147418_c0_seq1;GAXK01107932.1;Q9JJ57;1.25E-49;KCIP1_MOUSE;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]; positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0034705; GO:0043025; GO:0044325; GO:0045760; GO:0046982; GO:0047485; GO:1901379";"positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]"
comp314754_c2_seq1;GAXK01032806.1;W4VS53;1.40E-53;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3147764_c0_seq1;GAXK01107935.1;P04323;1.17E-11;POL3_DROME;"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3147859_c0_seq1;GAXK01107934.1;Q09587;3.11E-14;NHR22_CAEEL;Nuclear hormone receptor family member nhr-22;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0005829; GO:0008270; GO:0043565";;"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp314791_c0_seq1;GAXK01032831.1;Q5R6L1;5.76E-45;PKNX2_PONAB;Homeobox protein PKNOX2 (PBX/knotted homeobox 2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];DNA binding [GO:0003677]
comp314871_c1_seq1;GAXK01032991.1;Q99L20;1.20E-18;GSTT3_MOUSE;Glutathione S-transferase theta-3 (EC 2.5.1.18);"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];glutathione transferase activity [GO:0004364]
comp314906_c0_seq1;GAXK01032955.1;Q9CYL5;4.21E-27;GAPR1_MOUSE;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374";"positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";protein homodimerization activity [GO:0042803]
comp314920_c0_seq1;GAXK01032960.1;Q3MHW0;8.23E-37;SRGEF_BOVIN;Secretion-regulating guanine nucleotide exchange factor;"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of protein secretion [GO:0050709]";"GO:0005085; GO:0005654; GO:0005829; GO:0016235; GO:0050709";negative regulation of protein secretion [GO:0050709];"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp314999_c0_seq1;GAXK01032927.1;P05661;9.25E-11;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp3150_c0_seq1;GAXK01176645.1;Q9VMM6;5.41E-16;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp315002_c0_seq1;GAXK01032969.1;P26367;4.12E-125;PAX6_HUMAN;Paired box protein Pax-6 (Aniridia type II protein) (Oculorhombin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; blood vessel development [GO:0001568]; cell fate determination [GO:0001709]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; establishment of mitotic spindle orientation [GO:0000132]; eye development [GO:0001654]; eye photoreceptor cell development [GO:0042462]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; oligodendrocyte cell fate specification [GO:0021778]; pancreatic A cell development [GO:0003322]; pituitary gland development [GO:0021983]; positive regulation of core promoter binding [GO:1904798]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to organelle [GO:0033365]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [GO:0021918]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; salivary gland morphogenesis [GO:0007435]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; visual perception [GO:0007601]";"GO:0000132; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001568; GO:0001654; GO:0001709; GO:0001764; GO:0001933; GO:0002052; GO:0002088; GO:0003309; GO:0003322; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007224; GO:0007411; GO:0007417; GO:0007435; GO:0007601; GO:0008134; GO:0009611; GO:0009786; GO:0009887; GO:0009950; GO:0010628; GO:0019901; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021912; GO:0021913; GO:0021918; GO:0021983; GO:0021986; GO:0023019; GO:0030216; GO:0030334; GO:0030858; GO:0031625; GO:0032808; GO:0033365; GO:0035035; GO:0042462; GO:0042593; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048663; GO:0048708; GO:0050680; GO:0050768; GO:0060041; GO:0061072; GO:0061303; GO:0070410; GO:0070412; GO:0071837; GO:1904798; GO:1990830; GO:2000178";"animal organ morphogenesis [GO:0009887]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; blood vessel development [GO:0001568]; cell fate determination [GO:0001709]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; establishment of mitotic spindle orientation [GO:0000132]; eye development [GO:0001654]; eye photoreceptor cell development [GO:0042462]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; oligodendrocyte cell fate specification [GO:0021778]; pancreatic A cell development [GO:0003322]; pituitary gland development [GO:0021983]; positive regulation of core promoter binding [GO:1904798]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to organelle [GO:0033365]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [GO:0021918]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; salivary gland morphogenesis [GO:0007435]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; protein kinase binding [GO:0019901]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"
comp3150768_c0_seq1;GAXK01067316.1;P04052;2.14E-19;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp3151_c0_seq1;GAXK01175307.1;O16277;2.20E-08;H16_CAEEL;Putative histone H1.6 (Histone H1-like protein 6);"nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031492; GO:0031936; GO:0045910";"chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"nucleosome [GO:0000786]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]"
comp31519_c0_seq1;GAXK01050140.1;Q28FE2;8.93E-52;MED31_XENTR;Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003713; GO:0006357; GO:0016592; GO:0070847";regulation of transcription by RNA polymerase II [GO:0006357];"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";transcription coactivator activity [GO:0003713]
comp3152_c3_seq1;GAXK01175304.1;Q9BQI3;7.12E-53;E2AK1_HUMAN;Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; acute inflammatory response [GO:0002526]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]";"GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0055072; GO:1990641";"acute inflammatory response [GO:0002526]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]"
comp315212_c2_seq1;GAXK01032827.1;P54399;3.93E-104;PDI_DROME;Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1);"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0006457; GO:0012505; GO:0015037; GO:0034976; GO:0043025; GO:0045169; GO:0045454; GO:0048471; GO:0060187; GO:0070732";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp3152236_c0_seq1;GAXK01007501.1;Q5K2P9;4.79E-08;POLS2_RAT;Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]";"GO:0004252; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3152751_c0_seq1;GAXK01007506.1;P55738;3.51E-39;CCAC_AMPCA;Caroteno-chlorophyll a-c-binding protein (Fragment);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009522; GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp315290_c0_seq1;GAXK01032826.1;Q95NI4;1.36E-37;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp31531_c0_seq1;GAXK01050472.1;O15541;1.15E-83;R113A_HUMAN;E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]";"GO:0000398; GO:0004842; GO:0005634; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0070100; GO:0071005";"DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]";"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp3153278_c0_seq1;GAXK01007499.1;Q9NBX4;3.40E-09;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp3153324_c0_seq1;GAXK01007528.1;P24461;3.33E-20;CP2G1_RABIT;Cytochrome P450 2G1 (EC 1.14.14.1) (CYPIIG1) (Cytochrome P450 olfactive) (Cytochrome P450-NMB);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";"GO:0005506; GO:0005789; GO:0007608; GO:0020037; GO:0050896; GO:0070330";"response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp31535_c0_seq1;GAXK01050430.1;P23249;4.31E-156;MOV10_MOUSE;Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein);"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]";"GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011";"3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; P granule [GO:0043186]";"5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp3153516_c0_seq1;GAXK01007511.1;P61356;1.94E-41;RL27_BOVIN;60S ribosomal protein L27;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; rRNA processing [GO:0006364]; translation [GO:0006412]";"GO:0003735; GO:0006364; GO:0006412; GO:0015934; GO:0022625; GO:0098556";"rRNA processing [GO:0006364]; translation [GO:0006412]";"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp3153777_c0_seq1;GAXK01007529.1;Q0V9T6;1.93E-07;BICL1_XENTR;BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107";"Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]"
comp31538_c0_seq1;GAXK01050476.1;Q3UYG8;1.07E-65;MACD2_MOUSE;ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-);"centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617]";"GO:0005634; GO:0005730; GO:0005813; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293";"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617]";"centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]"
comp315387_c0_seq1;GAXK01032937.1;Q39208;4.05E-09;SC5D1_ARATH;Delta(7)-sterol-C5(6)-desaturase 1 (EC 1.14.19.20) (Delta(7)-sterol-C5-desaturase 1) (Delta-7-C-5 sterol desaturase 1) (Protein DWARF 7) (Protein STEROL 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000248; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]"
comp3153949_c0_seq1;GAXK01007516.1;Q8LC83;4.07E-19;RS242_ARATH;40S ribosomal protein S24-2;"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005618; GO:0006412; GO:0009536; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp315396_c1_seq1;GAXK01033000.1;O94673;5.57E-27;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp3154138_c0_seq1;GAXK01050632.1;P20693;5.65E-15;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp315416_c1_seq1;GAXK01032810.1;Q2KIW9;3.50E-74;KCY_BOVIN;UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]";"GO:0004127; GO:0004550; GO:0005524; GO:0005730; GO:0005737; GO:0006165; GO:0006207; GO:0006221; GO:0009041; GO:0009142";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]"
comp315420_c0_seq1;GAXK01032924.1;B3EWZ6;7.40E-134;MLRP2_ACRMI;MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp315429_c1_seq1;GAXK01032781.1;Q6V5K9;1.46E-19;ZN474_MOUSE;Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp3154552_c0_seq1;GAXK01050633.1;Q95RN0;9.14E-21;F172A_DROME;FAM172 family protein homolog CG10038;"nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]";"GO:0005634; GO:0031048";chromatin silencing by small RNA [GO:0031048];nucleus [GO:0005634];
comp315463_c0_seq1;GAXK01032750.1;Q6MGA9;6.08E-42;BRD2_RAT;Bromodomain-containing protein 2 (Protein RING3);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577";"nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";"chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]"
comp3154775_c0_seq1;GAXK01050631.1;Q9V5L3;3.26E-19;C49A1_DROME;Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016491; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp315510_c2_seq1;GAXK01032815.1;Q5RB07;9.11E-12;WDR6_PONAB;WD repeat-containing protein 6;"cytoplasm [GO:0005737]; cell cycle [GO:0007049]";"GO:0005737; GO:0007049";cell cycle [GO:0007049];cytoplasm [GO:0005737];
comp3155297_c0_seq1;GAXK01050613.1;P35187;1.41E-07;SGS1_YEAST;ATP-dependent helicase SGS1 (EC 3.6.4.12) (Helicase TPS1);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ helicase-Topo III complex [GO:0031422]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; nucleic acid binding [GO:0003676]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion at mating-type locus, DNA double-strand break processing [GO:0031292]; intra-S DNA damage checkpoint [GO:0031573]; meiotic chromosome segregation [GO:0045132]; meiotic DNA double-strand break processing [GO:0000706]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of meiotic joint molecule formation [GO:0010947]; regulation of reciprocal meiotic recombination [GO:0010520]; replicative cell aging [GO:0001302]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomeric 3' overhang formation [GO:0031860]";"GO:0000070; GO:0000706; GO:0000722; GO:0000723; GO:0000724; GO:0000729; GO:0001302; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0006265; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0009378; GO:0010520; GO:0010947; GO:0031292; GO:0031422; GO:0031573; GO:0031860; GO:0032508; GO:0043138; GO:0044818; GO:0045132; GO:0051276";"cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion at mating-type locus, DNA double-strand break processing [GO:0031292]; intra-S DNA damage checkpoint [GO:0031573]; meiotic chromosome segregation [GO:0045132]; meiotic DNA double-strand break processing [GO:0000706]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of meiotic joint molecule formation [GO:0010947]; regulation of reciprocal meiotic recombination [GO:0010520]; replicative cell aging [GO:0001302]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomeric 3' overhang formation [GO:0031860]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ helicase-Topo III complex [GO:0031422]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; nucleic acid binding [GO:0003676]"
comp31558_c5_seq1;GAXK01050395.1;Q7KNA0;1.86E-73;DYM_DROME;Dymeclin;"Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]";"GO:0005794; GO:0007030";Golgi organization [GO:0007030];Golgi apparatus [GO:0005794];
comp3156580_c0_seq1;GAXK01105909.1;P54254;9.59E-31;ATX1_MOUSE;Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]";"GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0032991; GO:0034046; GO:0035176; GO:0042326; GO:0042405; GO:0042802; GO:0043569; GO:0043621; GO:0045892; GO:0045944; GO:0048286; GO:0048856; GO:0051168; GO:0060079; GO:0060252; GO:0098794";"adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]"
comp315733_c2_seq1;GAXK01032933.1;Q3B7D3;2.19E-20;TECT2_RAT;Tectonic-2;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]";"GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0036038; GO:0060271; GO:1904491";"cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]";
comp3157766_c0_seq1;GAXK01105892.1;Q16706;7.37E-40;MA2A1_HUMAN;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp31579_c3_seq1;GAXK01205185.1;P82147;2.99E-18;L2EFL_DROME;Protein lethal(2)essential for life (Protein Efl21);"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";unfolded protein binding [GO:0051082]
comp3157926_c0_seq1;GAXK01105895.1;P39057;6.86E-45;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp315835_c1_seq1;GAXK01032917.1;Q6ZMW2;3.65E-18;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp315872_c3_seq1;GAXK01032866.1;Q24400;1.08E-72;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp3158848_c0_seq1;GAXK01160703.1;Q9V817;5.05E-14;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp31590_c0_seq1;GAXK01049878.1;Q0IHH9;2.99E-66;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp3159229_c0_seq1;GAXK01160707.1;Q8W257;1.07E-07;PFI_PTIFI;Polyenoic fatty acid isomerase (PFI) (EC 5.3.3.13);"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]";"GO:0016491; GO:0034016";;;"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]"
comp31593_c9_seq1;GAXK01050499.1;P35038;3.92E-51;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3159321_c0_seq1;GAXK01160717.1;Q8BXX2;5.58E-09;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp315943_c0_seq1;GAXK01032839.1;P10180;3.23E-69;CUT_DROME;Homeobox protein cut;"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0030713; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983";"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]";"Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp315950_c0_seq1;GAXK01032928.1;Q96PQ6;3.88E-13;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp315953_c0_seq1;GAXK01032926.1;Q6PHW0;2.43E-100;IYD1_HUMAN;Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; iodide peroxidase activity [GO:0004447]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]";"GO:0004447; GO:0005654; GO:0005886; GO:0005887; GO:0006570; GO:0006590; GO:0010181; GO:0016491; GO:0030659; GO:0042403; GO:0055114";"oxidation-reduction process [GO:0055114]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"FMN binding [GO:0010181]; iodide peroxidase activity [GO:0004447]; oxidoreductase activity [GO:0016491]"
comp3159546_c0_seq1;GAXK01160706.1;Q9JLV5;2.20E-08;CUL3_MOUSE;Cullin-3 (CUL-3);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; SCF ubiquitin ligase complex [GO:0019005]; sperm flagellum [GO:0036126]; cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000139; GO:0000209; GO:0000278; GO:0000902; GO:0001701; GO:0001831; GO:0004842; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005827; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0019005; GO:0030030; GO:0030332; GO:0031145; GO:0031146; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042803; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0046982; GO:0048208; GO:0071630; GO:0072576";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; SCF ubiquitin ligase complex [GO:0019005]; sperm flagellum [GO:0036126]";"cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp31597_c0_seq1;GAXK01050339.1;Q7SYR1;0;OSGEP_XENLA;Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep);"cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]";"GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711";tRNA threonylcarbamoyladenosine modification [GO:0002949];"cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]"
comp315990_c0_seq1;GAXK01032751.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp316_c0_seq1;GAXK01168185.1;P91891;6.60E-174;MO25_DROME;Protein Mo25 (dMo25);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014]";"GO:0005634; GO:0005737; GO:0023014";signal transduction by protein phosphorylation [GO:0023014];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp316003_c2_seq1;GAXK01089138.1;Q5RGT6;2.72E-60;ANGE2_DANRE;Protein angel homolog 2;"3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA stabilization [GO:0070935]";"GO:0000175; GO:0003730; GO:0070935";3'-UTR-mediated mRNA stabilization [GO:0070935];;"3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]"
comp3160218_c0_seq1;GAXK01084250.1;P36241;3.77E-53;RL19_DROME;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp316075_c1_seq1;GAXK01089077.1;Q99LX0;2.53E-43;PARK7_MOUSE;Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Parkinson disease protein 7 homolog) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1);"axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]; androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0000785; GO:0001933; GO:0001963; GO:0002866; GO:0003713; GO:0003723; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007338; GO:0008134; GO:0008233; GO:0008344; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0018323; GO:0019249; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031397; GO:0032091; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0034614; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036531; GO:0042177; GO:0042542; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043005; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061827; GO:0070301; GO:0070491; GO:0090073; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902958; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903204; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1904782; GO:1905259; GO:1905516; GO:1990381; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268";"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]";"axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]";"androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]"
comp3161187_c0_seq1;GAXK01084258.1;O42329;6.96E-30;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3161225_c0_seq1;GAXK01084252.1;Q6PGK7;1.03E-07;CHSTA_MOUSE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0007612; GO:0007616; GO:0008146; GO:0016021; GO:0016051; GO:0016232; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]"
comp3161731_c0_seq1;GAXK01084262.1;Q9CZ49;2.56E-07;KLH35_MOUSE;Kelch-like protein 35;;;;;
comp31618_c0_seq1;GAXK01049965.1;O00411;0;RPOM_HUMAN;DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6);"mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; transcription initiation from mitochondrial promoter [GO:0006391]";"GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0007005; GO:0032991; GO:0034245; GO:0042645; GO:0043565";"mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; transcription initiation from mitochondrial promoter [GO:0006391]";"mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]"
comp316204_c0_seq1;GAXK01088915.1;A7Y2X0;1.85E-108;SC6A5_XENLA;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp316213_c0_seq1;GAXK01088971.1;Q9Y4C0;0;NRX3A_HUMAN;Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]";"GO:0005886; GO:0005887; GO:0007158; GO:0007411; GO:0007612; GO:0030534; GO:0035176; GO:0038023; GO:0046872; GO:0050839; GO:0071625; GO:0097109";"adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]"
comp3162156_c0_seq1;GAXK01059790.1;B2D0J4;1.77E-16;VDPP4_APIME;Venom dipeptidyl peptidase 4 (Allergen C) (Venom dipeptidyl peptidase IV) (EC 3.4.14.5) (allergen Api m 5);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp3162281_c0_seq1;GAXK01059781.1;A1YF12;1.31E-26;ZNF16_GORGO;Zinc finger protein 16;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0005730; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0043565; GO:0045648; GO:0045654; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp31624_c4_seq1;GAXK01049982.1;P18715;9.17E-33;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3162701_c0_seq1;GAXK01059783.1;Q9JME5;1.39E-08;AP3B2_MOUSE;AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain);"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005802; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]";
comp316359_c0_seq1;GAXK01088941.1;P93748;8.30E-10;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp3164135_c0_seq1;GAXK01108217.1;Q28623;2.38E-11;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp3164186_c0_seq1;GAXK01108211.1;Q95ZJ1;1.41E-40;GALT5_CAEEL;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]";"GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872";protein O-linked glycosylation via threonine [GO:0018243];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp3164844_c0_seq1;GAXK01108225.1;O93931;4.10E-24;RS26_SCHCO;40S ribosomal protein S26;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp31654_c3_seq1;GAXK01050136.1;Q7ZUX1;2.39E-89;RPC3_DANRE;DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C);"RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase III [GO:0006383]";"GO:0003697; GO:0003899; GO:0005666; GO:0006383";transcription by RNA polymerase III [GO:0006383];RNA polymerase III complex [GO:0005666];"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]"
comp3165869_c0_seq1;GAXK01108228.1;P29563;1.34E-09;BACR2_HALS2;Archaerhodopsin-2 (AR 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005216; GO:0005886; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]"
comp316609_c1_seq1;GAXK01088981.1;G5EBQ8;1.06E-150;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp3166148_c0_seq1;GAXK01073636.1;P17141;5.44E-13;ZFP37_MOUSE;Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007281; GO:0007283; GO:0008270";"germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp316615_c1_seq1;GAXK01088959.1;P34568;2.79E-10;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp316640_c0_seq1;GAXK01088936.1;Q8N393;1.06E-39;ZN786_HUMAN;Zinc finger protein 786;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3166738_c0_seq1;GAXK01073651.1;Q9M7R0;6.64E-12;ALL8_OLEEU;Calcium-binding allergen Ole e 8 (PCA18/PCA23) (allergen Ole e 8);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp31669_c0_seq1;GAXK01050475.1;Q949P2;1.34E-73;COPDA_ARATH;Probable cytosolic oligopeptidase A (EC 3.4.24.70) (Thimet metalloendopeptidase 2) (Zincin-like metalloproteases family protein 2);"apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686]";"GO:0004222; GO:0005829; GO:0005886; GO:0006508; GO:0006518; GO:0009507; GO:0046686; GO:0046872; GO:0048046";"peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686]";"apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp3167543_c0_seq1;GAXK01073627.1;A1YG88;2.41E-23;ZNF16_PANPA;Zinc finger protein 16;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]";"GO:0003677; GO:0005634; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp316806_c0_seq1;GAXK01088933.1;Q8BIQ3;9.13E-21;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp316851_c0_seq1;GAXK01088956.1;P29294;7.13E-55;MYLK_RABIT;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp316893_c0_seq1;GAXK01088931.1;Q9CQ88;3.05E-11;TSN31_MOUSE;Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence homolog);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp3169073_c0_seq1;GAXK01143951.1;Q8BQ86;6.80E-08;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp316994_c5_seq1;GAXK01089076.1;Q0EEE2;2.09E-36;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp317_c0_seq1;GAXK01168750.1;Q96MC6;0;MF14A_HUMAN;Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein);"integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid nucleus differentiation [GO:0007289]";"GO:0001675; GO:0005887; GO:0007289; GO:0022857; GO:0030382";"acrosome assembly [GO:0001675]; spermatid nucleus differentiation [GO:0007289]; sperm mitochondrion organization [GO:0030382]";integral component of plasma membrane [GO:0005887];transmembrane transporter activity [GO:0022857]
comp317030_c0_seq1;GAXK01088986.1;P52746;9.30E-11;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3170389_c0_seq1;GAXK01117045.1;P35500;3.49E-45;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp3170762_c0_seq1;GAXK01117047.1;O88870;8.67E-07;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp3171343_c0_seq1;GAXK01117065.1;P0C227;3.47E-11;GLB_NERAL;Globin (Myoglobin);"extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005576; GO:0005833; GO:0019825; GO:0020037; GO:0046872";;"extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp3171940_c0_seq1;GAXK01117061.1;Q9UQ16;2.45E-13;DYN3_HUMAN;Dynamin-3 (EC 3.6.5.5) (Dynamin, testicular) (T-dynamin);"apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synapse assembly [GO:0007416]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]";"GO:0001917; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0016020; GO:0016185; GO:0030424; GO:0031410; GO:0031623; GO:0031798; GO:0031802; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046847; GO:0048471; GO:0050803; GO:0050998; GO:0051491; GO:0061002; GO:0061828; GO:0061829; GO:0070062; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099186; GO:1903423";"endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synapse assembly [GO:0007416]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]";"apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]"
comp3172077_c0_seq1;GAXK01116785.1;O95180;2.01E-88;CAC1H_HUMAN;Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005244; GO:0005886; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]"
comp317215_c0_seq1;GAXK01089143.1;Q641C9;3.27E-08;CD123_XENLA;Cell division cycle protein 123 homolog;"cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005737; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";cytoplasm [GO:0005737];
comp3172264_c0_seq1;GAXK01116789.1;P21251;1.30E-52;CALM_STIJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp317231_c0_seq1;GAXK01088995.1;P30679;8.09E-43;GNA15_HUMAN;Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16);"heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007202; GO:0007207; GO:0030168; GO:0031683; GO:0046872; GO:0051482; GO:0060158";"activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]";"heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]";"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp3172483_c0_seq1;GAXK01116778.1;Q9ULJ7;1.49E-25;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp3172827_c0_seq1;GAXK01116794.1;B3L3W7;8.28E-69;RS3A_PLAKH;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp317316_c0_seq1;GAXK01088964.1;P35038;1.57E-37;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3173162_c0_seq1;GAXK01116788.1;Q01528;8.23E-09;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3173937_c0_seq1;GAXK01116801.1;Q642B2;3.23E-08;ZN672_RAT;Zinc finger protein 672;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp317436_c0_seq1;GAXK01089139.1;P13796;3.37E-20;PLSL_HUMAN;Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1);"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]";"GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0035722; GO:0042802; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0070062; GO:0071803";"actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]";"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]"
comp3174429_c0_seq1;GAXK01159471.1;Q5RAQ1;1.85E-07;PTH1R_PONAB;Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor);"integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]";integral component of plasma membrane [GO:0005887];"parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]"
comp3174723_c0_seq1;GAXK01205866.1;Q119S1;0;CH601_TRIEI;60 kDa chaperonin 1 (GroEL protein 1) (Protein Cpn60 1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]";"GO:0005524; GO:0005737; GO:0042026; GO:0051082";protein refolding [GO:0042026];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp317474_c0_seq1;GAXK01088965.1;Q8R481;6.14E-88;PERL_MESAU;Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; thiocyanate peroxidase activity [GO:0036393]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979]";"GO:0001580; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872";"defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; thiocyanate peroxidase activity [GO:0036393]"
comp3174931_c0_seq1;GAXK01159494.1;O70244;1.53E-47;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp3175_c0_seq1;GAXK01176020.1;Q6EGX7;1.02E-42;UBL5_MESAU;Ubiquitin-like protein 5 (Beacon protein);"cytoplasm [GO:0005737]; cellular protein modification process [GO:0006464]";"GO:0005737; GO:0006464";cellular protein modification process [GO:0006464];cytoplasm [GO:0005737];
comp317520_c0_seq1;GAXK01088922.1;Q8R4S2;1.38E-96;AHR_MUSSP;Aryl hydrocarbon receptor (Ah receptor) (AhR);"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; toxic substance binding [GO:0015643]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to 3-methylcholanthrene [GO:1904682]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; gland development [GO:0048732]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of B cell proliferation [GO:0030888]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; reproductive structure development [GO:0048608]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]; xenobiotic metabolic process [GO:0006805]";"GO:0000122; GO:0000981; GO:0001094; GO:0001223; GO:0001541; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006805; GO:0007049; GO:0008134; GO:0009410; GO:0009636; GO:0010468; GO:0010693; GO:0014070; GO:0015643; GO:0017025; GO:0019933; GO:0030850; GO:0030888; GO:0032922; GO:0032991; GO:0033689; GO:0034751; GO:0035326; GO:0042803; GO:0043565; GO:0044212; GO:0045668; GO:0045892; GO:0045893; GO:0045899; GO:0045944; GO:0046982; GO:0048608; GO:0048732; GO:0051879; GO:0070888; GO:0071320; GO:1903170; GO:1904322; GO:1904613; GO:1904682; GO:1990837; GO:2000279";"cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to 3-methylcholanthrene [GO:1904682]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; gland development [GO:0048732]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle development [GO:0001541]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of B cell proliferation [GO:0030888]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]; xenobiotic metabolic process [GO:0006805]";"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; toxic substance binding [GO:0015643]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp317523_c0_seq1;GAXK01088963.1;P18613;2.12E-47;RAPA_DICDI;Ras-related protein rapA (Ras-related protein rap-1);"cell cortex [GO:0005938]; cell pole [GO:0060187]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activator activity [GO:0030250]; Ral GTPase binding [GO:0017160]; actin phosphorylation [GO:0031289]; activation of GTPase activity [GO:0090630]; actomyosin structure organization [GO:0031032]; chemotaxis [GO:0006935]; hyperosmotic response [GO:0006972]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic cytokinesis [GO:0000281]; negative regulation of pinocytosis [GO:0048550]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of phagocytosis [GO:0050766]; positive regulation of TORC2 signaling [GO:1904515]; Rap protein signal transduction [GO:0032486]; regulation of actin filament polymerization [GO:0030833]; regulation of cell-cell adhesion [GO:0022407]; regulation of myosin II filament assembly [GO:0043520]; regulation of Ras protein signal transduction [GO:0046578]; response to cold [GO:0009409]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]";"GO:0000281; GO:0003924; GO:0005525; GO:0005811; GO:0005886; GO:0005938; GO:0006935; GO:0006972; GO:0006997; GO:0007264; GO:0009409; GO:0017160; GO:0019003; GO:0022407; GO:0030250; GO:0030587; GO:0030833; GO:0030838; GO:0031012; GO:0031032; GO:0031289; GO:0031982; GO:0032486; GO:0043520; GO:0045335; GO:0046578; GO:0048550; GO:0050766; GO:0060187; GO:0090630; GO:1902850; GO:1904515";"actin phosphorylation [GO:0031289]; activation of GTPase activity [GO:0090630]; actomyosin structure organization [GO:0031032]; chemotaxis [GO:0006935]; hyperosmotic response [GO:0006972]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic cytokinesis [GO:0000281]; negative regulation of pinocytosis [GO:0048550]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of phagocytosis [GO:0050766]; positive regulation of TORC2 signaling [GO:1904515]; Rap protein signal transduction [GO:0032486]; regulation of actin filament polymerization [GO:0030833]; regulation of cell-cell adhesion [GO:0022407]; regulation of myosin II filament assembly [GO:0043520]; regulation of Ras protein signal transduction [GO:0046578]; response to cold [GO:0009409]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]";"cell cortex [GO:0005938]; cell pole [GO:0060187]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activator activity [GO:0030250]; Ral GTPase binding [GO:0017160]"
comp317547_c0_seq1;GAXK01089043.1;Q9HCN3;1.76E-48;TMM8A_HUMAN;Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]";"GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0070062; GO:0102567; GO:0102568";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp317562_c1_seq1;GAXK01089078.1;Q19958;8.81E-116;STO2_CAEEL;Stomatin-2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3175675_c0_seq1;GAXK01159477.1;P10074;4.70E-11;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3175707_c0_seq1;GAXK01159472.1;Q08DY9;4.85E-12;CASP3_BOVIN;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp3175777_c0_seq1;GAXK01159473.1;B7TB45;7.09E-20;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp3175883_c0_seq1;GAXK01159486.1;P41753;1.52E-155;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp3175985_c0_seq1;GAXK01159491.1;Q94HW2;6.75E-12;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp317612_c0_seq1;GAXK01088954.1;Q803E0;1.04E-20;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp3176470_c0_seq1;GAXK01059520.1;D3YXG0;1.03E-22;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp31773_c1_seq1;GAXK01050566.1;Q9CA28;1.02E-22;TKPR2_ARATH;Tetraketide alpha-pyrone reductase 2 (EC 1.1.1.-) (Protein CINNAMOYL-COA REDUCTASE-LIKE 6);"cytosol [GO:0005829]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; pollen exine formation [GO:0010584]; sporopollenin biosynthetic process [GO:0080110]";"GO:0005829; GO:0010584; GO:0016491; GO:0016616; GO:0050662; GO:0080110";"pollen exine formation [GO:0010584]; sporopollenin biosynthetic process [GO:0080110]";cytosol [GO:0005829];"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
comp317757_c3_seq1;GAXK01088987.1;Q6ZMW2;2.46E-46;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3177942_c0_seq1;GAXK01059532.1;P62762;1.72E-20;VISL1_RAT;Visinin-like protein 1 (VILIP) (21 kDa CABP) (Neural visinin-like protein 1) (NVL-1) (NVP-1);"cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; central nervous system development [GO:0007417]; negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]";"GO:0005509; GO:0005829; GO:0007417; GO:0016020; GO:0019722; GO:0035774; GO:0045921; GO:0046676";"calcium-mediated signaling [GO:0019722]; central nervous system development [GO:0007417]; negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]";"cytosol [GO:0005829]; membrane [GO:0016020]";calcium ion binding [GO:0005509]
comp3178010_c0_seq1;GAXK01152752.1;Q68Y21;1.02E-20;GRID2_DANRE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp31782_c0_seq1;GAXK01050460.1;P55066;1.33E-08;NCAN_MOUSE;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp317848_c1_seq1;GAXK01088928.1;Q13336;1.73E-18;UT1_HUMAN;Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; urea channel activity [GO:0015265]; water transmembrane transporter activity [GO:0005372]; transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"GO:0005372; GO:0005730; GO:0005886; GO:0005887; GO:0015265; GO:0015840; GO:0016323; GO:0043231; GO:0055085; GO:0071918";"transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]";"urea channel activity [GO:0015265]; water transmembrane transporter activity [GO:0005372]"
comp3178706_c0_seq1;GAXK01152737.1;Q6IQ16;2.14E-07;SPOPL_HUMAN;Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3178784_c0_seq1;GAXK01152746.1;Q9UFB7;8.94E-08;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp317930_c1_seq1;GAXK01088985.1;Q0VCR6;3.50E-65;TMM68_BOVIN;Transmembrane protein 68;"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]";"GO:0016021; GO:0016746";;integral component of membrane [GO:0016021];transferase activity, transferring acyl groups [GO:0016746]
comp3179516_c0_seq1;GAXK01152731.1;P46941;1.42E-30;TG325_CAEEL;WW domain-containing protein tag-325;"cytoplasm [GO:0005737]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0043087";"regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];
comp3179783_c0_seq1;GAXK01152740.1;Q9VZW5;1.09E-25;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp31798_c2_seq1;GAXK01049752.1;Q8WVM8;0;SCFD1_HUMAN;Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2);"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0015031; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0048208; GO:0051223; GO:0060628; GO:1901998; GO:1902902";"cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]";"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]";"protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]"
comp317989_c0_seq1;GAXK01088921.1;P29054;1.33E-115;TF2B_XENLA;Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB);"chromosome [GO:0005694]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; acetyltransferase activity [GO:0016407]; core promoter binding [GO:0001047]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]";"GO:0000979; GO:0000993; GO:0001047; GO:0001174; GO:0004402; GO:0005634; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0016407; GO:0017025; GO:0032993; GO:0043923; GO:0051123; GO:0060261; GO:1990114; GO:1990841";"positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"chromosome [GO:0005694]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]";"acetyltransferase activity [GO:0016407]; core promoter binding [GO:0001047]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]"
comp31799_c0_seq1;GAXK01050289.1;Q8XJR3;4.16E-07;DPO3_CLOPE;DNA polymerase III PolC-type (PolIII) (EC 2.7.7.7);"cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]";"GO:0003677; GO:0003887; GO:0005737; GO:0006261; GO:0008408";DNA-dependent DNA replication [GO:0006261];cytoplasm [GO:0005737];"3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]"
comp318143_c1_seq1;GAXK01010061.1;O75191;2.78E-146;XYLB_HUMAN;Xylulose kinase (Xylulokinase) (EC 2.7.1.17);"cytosol [GO:0005829]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]";"GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0016310; GO:0019640; GO:0042732";"carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]";cytosol [GO:0005829];"ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]"
comp318158_c0_seq1;GAXK01010102.1;Q16281;2.50E-134;CNGA3_HUMAN;Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3);"axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0008022; GO:0015276; GO:0030425; GO:0030553; GO:0031960; GO:0032026; GO:0043194; GO:0043204; GO:0051591; GO:0097386; GO:0098659; GO:1902495";"cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]";"cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]"
comp318188_c0_seq1;GAXK01010109.1;P21802;1.45E-144;FGFR2_HUMAN;Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332);"cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; MAPK cascade [GO:0000165]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]";"GO:0000122; GO:0000165; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007409; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0016020; GO:0016021; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032496; GO:0032808; GO:0033688; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042060; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043231; GO:0043235; GO:0043410; GO:0045165; GO:0045471; GO:0045667; GO:0045787; GO:0045944; GO:0046777; GO:0048286; GO:0048333; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048705; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0050680; GO:0051150; GO:0051781; GO:0051897; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0071300; GO:0071560; GO:0090263";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; mammary gland bud formation [GO:0060615]; MAPK cascade [GO:0000165]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smooth muscle cell differentiation [GO:0051150]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp31819_c4_seq1;GAXK01049767.1;P85007;1.83E-27;IR3IP_RAT;Immediate early response 3-interacting protein 1;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; regulation of fibroblast apoptotic process [GO:2000269]";"GO:0005789; GO:0016021; GO:2000269";regulation of fibroblast apoptotic process [GO:2000269];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp318214_c0_seq1;GAXK01010027.1;Q9H777;1.40E-81;RNZ1_HUMAN;Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005829; GO:0042781; GO:0046872";;"cytosol [GO:0005829]; nucleus [GO:0005634]";"3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]"
comp318284_c1_seq1;GAXK01010066.1;O46040;7.61E-34;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp3183_c0_seq1;GAXK01175691.1;O17953;4.77E-34;DLDH_CAEEL;Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase);"mitochondrial matrix [GO:0005759]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]";"GO:0004148; GO:0005759; GO:0006633; GO:0009055; GO:0045454; GO:0050660";"cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]";mitochondrial matrix [GO:0005759];"dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]"
comp3183010_c0_seq1;GAXK01184926.1;Q1RJR6;4.44E-09;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp3183280_c0_seq1;GAXK01184893.1;Q03938;8.57E-23;ZNF90_HUMAN;Zinc finger protein 90 (Zinc finger protein HTF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp3183460_c0_seq1;GAXK01184896.1;Q94900;1.45E-10;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp318350_c2_seq1;GAXK01010114.1;Q30PH2;1.28E-83;END4_SULDN;Probable endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV);"deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]";"GO:0003677; GO:0006281; GO:0008270; GO:0008833";DNA repair [GO:0006281];;"deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp318358_c2_seq1;GAXK01010012.1;Q5UQ60;3.91E-15;YL662_MIMIV;Uncharacterized protein L662;;;;;
comp3183775_c0_seq1;GAXK01184924.1;P05426;8.93E-82;RL7_RAT;60S ribosomal protein L7;"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0005840; GO:0008097; GO:0022625; GO:0031672; GO:0097421";"liver regeneration [GO:0097421]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp3185_c1_seq1;GAXK01175894.1;Q6P4Z2;2.17E-55;CO2A1_XENTR;Collagen alpha-1(II) chain (Alpha-1 type II collagen);"collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; notochord development [GO:0030903]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005201; GO:0005581; GO:0005615; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0046872";"collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; notochord development [GO:0030903]; skeletal system development [GO:0001501]";"collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]"
comp318504_c0_seq1;GAXK01010133.1;Q8IN81;9.67E-13;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp318529_c0_seq1;GAXK01010036.1;Q5ZJ69;4.01E-73;ARI5B_CHICK;AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B);"nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003713; GO:0005634; GO:0006357; GO:0044212; GO:0051091; GO:0060612";"adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp318550_c0_seq1;GAXK01010031.1;P18715;8.42E-17;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3185533_c0_seq1;GAXK01079570.1;O13769;2.41E-18;ULP2_SCHPO;Ubiquitin-like-specific protease 2 (EC 3.4.22.-);"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"GO:0005634; GO:0010494; GO:0016926; GO:0070140; GO:0070647; GO:2000765";"protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp3185571_c0_seq1;GAXK01079555.1;Q5SXJ3;2.33E-110;FANCJ_MOUSE;Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1);"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]; synapsis [GO:0007129]";"GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006289; GO:0006357; GO:0007129; GO:0007283; GO:0007284; GO:0007286; GO:0008285; GO:0008584; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918";"cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]; synapsis [GO:0007129]";"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"
comp3185608_c0_seq1;GAXK01079557.1;P39057;1.73E-120;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3185720_c0_seq1;GAXK01079572.1;P59509;1.01E-18;ATS19_MOUSE;A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp3185726_c0_seq1;GAXK01079558.1;P20385;5.14E-07;CF2_DROME;Chorion transcription factor Cf2;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872";"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp318619_c1_seq1;GAXK01010140.1;Q9Z2A7;1.47E-113;DGAT1_MOUSE;Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0005886; GO:0010867; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0043231; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491";"diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]"
comp3186367_c0_seq1;GAXK01009710.1;Q1LZI2;4.01E-35;S35F3_MOUSE;Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3);"integral component of membrane [GO:0016021]; thiamine transport [GO:0015888]";"GO:0015888; GO:0016021";thiamine transport [GO:0015888];integral component of membrane [GO:0016021];
comp3186424_c0_seq1;GAXK01009698.1;Q9M9W1;1.77E-30;RL222_ARATH;60S ribosomal protein L22-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp318700_c0_seq1;GAXK01010060.1;Q28658;5.97E-16;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp31872_c1_seq1;GAXK01049962.1;Q4KMI4;1.61E-44;REEP2_DANRE;Receptor expression-enhancing protein 2;"cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]";"GO:0005881; GO:0016021";;"cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]";
comp318777_c0_seq1;GAXK01010063.1;P36609;2.25E-43;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3187950_c0_seq1;GAXK01009692.1;Q5EA06;4.32E-37;GBRP_BOVIN;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp318831_c0_seq1;GAXK01010128.1;Q8BY02;5.87E-12;NKRF_MOUSE;NF-kappa-B-repressing factor (NFkB-repressing factor) (Transcription factor NRF);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp318837_c0_seq1;GAXK01010141.1;A2A935;1.04E-16;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp3189182_c0_seq1;GAXK01080429.1;P29763;2.40E-09;RLA1_CHLRE;60S acidic ribosomal protein P1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3189984_c0_seq1;GAXK01080447.1;P67883;5.71E-33;RL30_CHICK;60S ribosomal protein L30;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022625";;cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp31904_c0_seq1;GAXK01049786.1;Q9BZJ0;0;CRNL1_HUMAN;Crooked neck-like protein 1 (Crooked neck homolog) (hCrn);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]";RNA binding [GO:0003723]
comp3190519_c0_seq1;GAXK01155817.1;P30974;6.03E-33;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp3190713_c0_seq1;GAXK01155811.1;Q9VZW5;6.08E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3191_c1_seq1;GAXK01175295.1;Q568K5;4.47E-55;NAA40_DANRE;N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187]";"GO:0005634; GO:0005737; GO:0006474; GO:0010485; GO:0043967; GO:0043968; GO:0043998; GO:0061187; GO:1990189";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]"
comp319100_c1_seq1;GAXK01010112.1;Q9H8H3;1.81E-40;MET7A_HUMAN;Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0043312; GO:1904724";neutrophil degranulation [GO:0043312];"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]";methyltransferase activity [GO:0008168]
comp3191371_c0_seq1;GAXK01155807.1;O77821;4.46E-10;LYPA1_RABIT;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Calcium-independent phospholipase A2) (CaIPLA2) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]";"GO:0005737; GO:0006631; GO:0008474";fatty acid metabolic process [GO:0006631];cytoplasm [GO:0005737];palmitoyl-(protein) hydrolase activity [GO:0008474]
comp3192981_c0_seq1;GAXK01118776.1;B9EJV3;1.92E-11;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp31932_c0_seq1;GAXK01050195.1;Q8TBZ3;3.00E-134;WDR20_HUMAN;WD repeat-containing protein 20 (Protein DMR);"nucleoplasm [GO:0005654]; protein deubiquitination [GO:0016579]";"GO:0005654; GO:0016579";protein deubiquitination [GO:0016579];nucleoplasm [GO:0005654];
comp319321_c0_seq1;GAXK01010096.1;O46040;2.00E-20;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp3193917_c0_seq1;GAXK01118765.1;P00829;0;ATPB_BOVIN;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta);"cell surface [GO:0009986]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; regulation of intracellular pH [GO:0051453]";"GO:0001525; GO:0005524; GO:0005753; GO:0005886; GO:0006629; GO:0006933; GO:0009986; GO:0016887; GO:0042288; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0098761";"angiogenesis [GO:0001525]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; regulation of intracellular pH [GO:0051453]";"cell surface [GO:0009986]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"angiostatin binding [GO:0043532]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp3194_c0_seq1;GAXK01175480.1;Q6PS50;6.33E-23;RS28_BOMMO;40S ribosomal protein S28;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp31940_c1_seq1;GAXK01049899.1;Q6NRS1;9.48E-78;IBTK_XENLA;Inhibitor of Bruton tyrosine kinase (IBtk);"cytoplasm [GO:0005737]; membrane [GO:0016020]";"GO:0005737; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";
comp319430_c0_seq1;GAXK01010127.1;P86854;8.51E-11;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp3194361_c0_seq1;GAXK01099553.1;Q9HGN1;5.00E-25;GCN2_SCHPO;eIF-2-alpha kinase GCN2 (Serine/threonine-protein kinase gcn2) (EC 2.7.11.1) (Serine/threonine-protein kinase ppk28);"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]";"GO:0000049; GO:0004672; GO:0004694; GO:0005524; GO:0005829; GO:0022626; GO:0031571; GO:0034198; GO:0070301; GO:0071849; GO:0072431; GO:0072755; GO:1904803; GO:1990451; GO:1990625";"cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]";"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]";"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]"
comp3194394_c0_seq1;GAXK01099559.1;Q8BQ86;6.79E-07;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp31946_c0_seq1;GAXK01049877.1;Q3U2P1;0;SC24A_MOUSE;Protein transport protein Sec24A (SEC24-related protein A);"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]";"GO:0000139; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0030127; GO:0042632; GO:0045714; GO:0050714; GO:0090110";"cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]";"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";zinc ion binding [GO:0008270]
comp3194843_c0_seq1;GAXK01099558.1;P91119;3.19E-59;PDE5_CAEEL;Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17);"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";"GO:0004114; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";;"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"
comp3195348_c0_seq1;GAXK01099552.1;Q80TS5;7.16E-08;ZN423_MOUSE;Zinc finger protein 423 (Early B-cell factor-associated zinc finger protein) (Olf1/EBF-associated zinc finger protein) (Smad- and Olf-interacting zinc finger protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005654; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0042803; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0046982; GO:0120163";"cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp3197239_c0_seq1;GAXK01089675.1;Q5PQJ7;5.38E-66;TBCEL_RAT;Tubulin-specific chaperone cofactor E-like protein (Leucine-rich repeat-containing protein 35);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014";"microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";alpha-tubulin binding [GO:0043014]
comp319770_c0_seq1;GAXK01010099.1;Q6DGM8;6.23E-12;JDP2_DANRE;Jun dimerization protein 2;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0031063";"regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3197743_c0_seq1;GAXK01089690.1;Q8IN81;9.20E-26;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3197908_c0_seq1;GAXK01089672.1;Q9SMI2;8.03E-32;RS21_CYAPA;40S ribosomal protein S21;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp31982_c0_seq1;GAXK01049757.1;Q91717;1.57E-53;CO2A1_XENLA;Collagen alpha-1(II) chain (Alpha-1 type II collagen);"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]";"GO:0005201; GO:0005576; GO:0005581; GO:0046872";;"collagen trimer [GO:0005581]; extracellular region [GO:0005576]";"extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]"
comp319837_c0_seq1;GAXK01010089.1;O74467;5.70E-18;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3198524_c0_seq1;GAXK01041412.1;P52013;7.44E-60;CYP5_CAEEL;Peptidyl-prolyl cis-trans isomerase 5 (PPIase 5) (EC 5.2.1.8) (Cyclophilin-5) (Rotamase 5);"cytoplasm [GO:0005737]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"GO:0000413; GO:0003755; GO:0005737; GO:0016018; GO:0042026; GO:0051082";"protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";cytoplasm [GO:0005737];"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp319868_c0_seq1;GAXK01204992.1;P41827;0;HSP74_ANOAL;Heat shock protein 70 B2;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp319923_c0_seq1;GAXK01010038.1;Q8IN81;1.66E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp319963_c0_seq1;GAXK01010095.1;Q9VAC5;8.51E-77;ADA17_DROME;ADAM 17-like protease (EC 3.4.24.-);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";"GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp3199728_c0_seq1;GAXK01041410.1;Q80UG8;2.99E-38;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp3199786_c0_seq1;GAXK01041411.1;Q18297;7.24E-62;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp31999_c0_seq1;GAXK01050290.1;O70437;1.39E-38;SMAD4_RAT;Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; adrenal gland development [GO:0030325]; aging [GO:0007568]; cellular response to glucose stimulus [GO:0071333]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of protein catabolic process [GO:0042177]; osteoblast differentiation [GO:0001649]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]";"GO:0001541; GO:0001649; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0007568; GO:0010666; GO:0030325; GO:0031005; GO:0032991; GO:0042060; GO:0042177; GO:0046332; GO:0046872; GO:0070371; GO:0071333";"adrenal gland development [GO:0030325]; aging [GO:0007568]; cellular response to glucose stimulus [GO:0071333]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of protein catabolic process [GO:0042177]; osteoblast differentiation [GO:0001649]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]"
comp32_c7_seq1;GAXK01170069.1;Q6NT16;2.08E-30;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp320004_c1_seq1;GAXK01185452.1;Q0VCB0;3.27E-26;ZN350_BOVIN;Zinc finger protein 350;"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005634; GO:0005654; GO:0016363; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp320012_c0_seq1;GAXK01185341.1;Q5I0J5;6.14E-27;MITD1_RAT;MIT domain-containing protein 1;"extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; midbody abscission [GO:0061952]; negative regulation of protein binding [GO:0032091]";"GO:0019898; GO:0019904; GO:0030496; GO:0031902; GO:0032091; GO:0035091; GO:0042803; GO:0043231; GO:0061952";"midbody abscission [GO:0061952]; negative regulation of protein binding [GO:0032091]";"extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]";"phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]"
comp320030_c1_seq1;GAXK01185422.1;Q8JGM4;1.52E-76;QSOX1_CHICK;Sulfhydryl oxidase 1 (EC 1.8.3.2) (Quiescin Q6);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0000139; GO:0003756; GO:0005615; GO:0016971; GO:0030173; GO:0045454";cell redox homeostasis [GO:0045454];"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]";"flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]"
comp32011_c0_seq1;GAXK01018602.1;P54822;0;PUR8_MOUSE;Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; protein tetramerization [GO:0051262]; purine nucleotide metabolic process [GO:0006163]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0001666; GO:0004018; GO:0005739; GO:0005829; GO:0006163; GO:0006167; GO:0006189; GO:0007584; GO:0009060; GO:0009156; GO:0014850; GO:0042594; GO:0044208; GO:0051262; GO:0070626";"'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; protein tetramerization [GO:0051262]; purine nucleotide metabolic process [GO:0006163]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]"
comp3201853_c0_seq1;GAXK01146652.1;Q6P9J5;5.77E-08;KANK4_MOUSE;KN motif and ankyrin repeat domain-containing protein 4 (Ankyrin repeat domain-containing protein 38);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]";"GO:0005737; GO:0005829; GO:0015630; GO:0030837; GO:0051497";"negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]";
comp320199_c1_seq1;GAXK01185348.1;Q9QZR8;3.09E-20;PDZD2_RAT;PDZ domain-containing protein 2 (PDZ domain-containing protein 3) (Plakophilin-related armadillo repeat protein-interacting PDZ protein) [Cleaved into: Processed PDZ domain-containing protein 2];"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005911; GO:0007155; GO:0014069; GO:0035556; GO:0043005; GO:0045177";"cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";
comp32021_c2_seq1;GAXK01017799.1;Q9VK89;4.85E-173;TRM1_DROME;Probable tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase);"nucleus [GO:0005634]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA N2-guanine methylation [GO:0002940]";"GO:0000049; GO:0002940; GO:0004809; GO:0005634";tRNA N2-guanine methylation [GO:0002940];nucleus [GO:0005634];"tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]"
comp320227_c0_seq1;GAXK01205925.1;A9ULZ2;2.39E-44;BIR7B_XENLA;Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B);"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";"GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865";"multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";cytoplasm [GO:0005737];"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp32024_c0_seq1;GAXK01018183.1;P55112;2.06E-29;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3202663_c0_seq1;GAXK01162250.1;Q93008;9.87E-14;USP9X_HUMAN;Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0036459; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380";"axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]";"co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]"
comp3202721_c0_seq1;GAXK01162219.1;Q64455;1.43E-26;PTPRJ_MOUSE;Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (HPTP beta-like tyrosine phosphatase) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (Susceptibility to colon cancer 1) (CD antigen CD148);"cell surface [GO:0009986]; cell-cell junction [GO:0005911]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; B cell differentiation [GO:0030183]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; heart development [GO:0007507]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet activation [GO:0010572]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; vasculogenesis [GO:0001570]";"GO:0001570; GO:0001772; GO:0001954; GO:0004725; GO:0005161; GO:0005886; GO:0005911; GO:0006470; GO:0007507; GO:0007596; GO:0008013; GO:0008285; GO:0009986; GO:0010572; GO:0010642; GO:0010759; GO:0016021; GO:0016791; GO:0019901; GO:0030155; GO:0030183; GO:0030308; GO:0030336; GO:0032587; GO:0032760; GO:0035335; GO:0035584; GO:0042059; GO:0043116; GO:0043407; GO:0043410; GO:0045295; GO:0045296; GO:0045785; GO:0048008; GO:0048709; GO:0050731; GO:0050860; GO:0050918; GO:0051019; GO:0051894; GO:0051897; GO:0051898; GO:0070097; GO:1905451; GO:2000272";"B cell differentiation [GO:0030183]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; heart development [GO:0007507]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet activation [GO:0010572]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; vasculogenesis [GO:0001570]";"cell-cell junction [GO:0005911]; cell surface [GO:0009986]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]"
comp3202909_c0_seq1;GAXK01162218.1;Q94HW2;4.14E-28;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp320332_c0_seq1;GAXK01185354.1;Q6P6T4;0;EMAL2_RAT;Echinoderm microtubule-associated protein-like 2 (EMAP-2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; catalytic activity [GO:0003824]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]";"GO:0003824; GO:0005102; GO:0005737; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115; GO:0072686";"negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]";"catalytic activity [GO:0003824]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]"
comp3203555_c0_seq1;GAXK01162235.1;P35684;4.27E-138;RL3_ORYSJ;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3203830_c0_seq1;GAXK01162213.1;Q20585;8.46E-09;PSMD6_CAEEL;26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit rpn-7);"proteasome regulatory particle [GO:0005838]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0005838; GO:0030234; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];proteasome regulatory particle [GO:0005838];enzyme regulator activity [GO:0030234]
comp3204050_c0_seq1;GAXK01024552.1;Q32KI9;8.58E-11;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp3204369_c0_seq1;GAXK01024546.1;O14388;1.30E-43;RL27A_SCHPO;60S ribosomal protein L27-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp3204558_c0_seq1;GAXK01024548.1;P08953;8.81E-17;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp3205170_c0_seq1;GAXK01024561.1;P05426;5.81E-70;RL7_RAT;60S ribosomal protein L7;"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0005840; GO:0008097; GO:0022625; GO:0031672; GO:0097421";"liver regeneration [GO:0097421]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp32056_c0_seq1;GAXK01017849.1;Q2T9W1;1.21E-19;SNX20_BOVIN;Sorting nexin-20;"early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein transport [GO:0015031]";"GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp3206732_c0_seq1;GAXK01060695.1;Q5RFP4;8.38E-17;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3206845_c0_seq1;GAXK01060706.1;O15865;6.00E-23;CDPK2_PLAFK;Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2);"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005509; GO:0005524";;;"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]"
comp320696_c0_seq1;GAXK01185365.1;Q12178;3.77E-36;FCY1_YEAST;Cytosine deaminase (EC 3.5.4.1) (Cytosine aminohydrolase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5-fluorocytosine deaminase activity [GO:0102480]; cytosine deaminase activity [GO:0004131]; zinc ion binding [GO:0008270]; cytidine metabolic process [GO:0046087]; cytosine metabolic process [GO:0019858]; pyrimidine-containing compound salvage [GO:0008655]; UMP salvage [GO:0044206]";"GO:0004131; GO:0005634; GO:0005737; GO:0008270; GO:0008655; GO:0019858; GO:0044206; GO:0046087; GO:0102480";"cytidine metabolic process [GO:0046087]; cytosine metabolic process [GO:0019858]; pyrimidine-containing compound salvage [GO:0008655]; UMP salvage [GO:0044206]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"5-fluorocytosine deaminase activity [GO:0102480]; cytosine deaminase activity [GO:0004131]; zinc ion binding [GO:0008270]"
comp3207_c3_seq1;GAXK01175157.1;P09139;2.59E-144;SPYA_RAT;Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]";"GO:0004760; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0007219; GO:0008453; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042803; GO:0042853; GO:0042866; GO:0043621; GO:0046724; GO:0051384; GO:0051591";"glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]"
comp3207083_c0_seq1;GAXK01060688.1;Q8C827;1.04E-07;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp32072_c6_seq1;GAXK01017903.1;P54319;6.11E-108;PLAP_RAT;Phospholipase A-2-activating protein (PLA2P) (PLAP);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]; phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0005634; GO:0005737; GO:0006693; GO:0006954; GO:0010992; GO:0016005; GO:0016236; GO:0030054; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224";"cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin recycling [GO:0010992]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]";"phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]"
comp3207713_c0_seq1;GAXK01060683.1;Q4V8R6;2.60E-07;E4F1_DANRE;Transcription factor E4F1 (EC 2.3.2.27) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"GO:0003677; GO:0005654; GO:0005737; GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp3207970_c0_seq1;GAXK01060684.1;Q5R5U3;3.10E-28;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp320860_c0_seq1;GAXK01185471.1;Q4R4D7;1.02E-60;INP4B_MACFA;Type II inositol 3,4-bisphosphate 4-phosphatase (EC 3.1.3.66) (Inositol polyphosphate 4-phosphatase type II);"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]";"GO:0016316; GO:0034597";;;"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"
comp3209037_c0_seq1;GAXK01140167.1;P36181;2.45E-63;HSP80_SOLLC;Heat shock cognate protein 80;"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082";"cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp320910_c0_seq1;GAXK01185361.1;Q9NQZ8;4.80E-65;ZNF71_HUMAN;Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp320965_c1_seq1;GAXK01185367.1;Q7KRI2;2.49E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp32098_c0_seq1;GAXK01018380.1;Q6PHF0;1.32E-73;CHM1A_DANRE;Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a);"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0007076; GO:0015031; GO:0016363; GO:0021549; GO:0032509; GO:0045324";"cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]";
comp3210_c0_seq1;GAXK01175669.1;P62258;1.56E-150;1433E_HUMAN;14-3-3 protein epsilon (14-3-3E);"central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; neuron migration [GO:0001764]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; substantia nigra development [GO:0021762]; viral process [GO:0016032]";"GO:0000086; GO:0000165; GO:0001764; GO:0003064; GO:0003723; GO:0005246; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005871; GO:0005925; GO:0006605; GO:0010389; GO:0015459; GO:0016020; GO:0016032; GO:0019899; GO:0019904; GO:0021762; GO:0021766; GO:0021987; GO:0023026; GO:0031625; GO:0034504; GO:0034605; GO:0035329; GO:0035556; GO:0042470; GO:0042802; GO:0042826; GO:0043154; GO:0044325; GO:0045296; GO:0046827; GO:0046982; GO:0050815; GO:0051219; GO:0051480; GO:0060306; GO:0061024; GO:0070062; GO:0086013; GO:0086091; GO:0090724; GO:0097110; GO:0097711; GO:0098978; GO:0099072; GO:1900034; GO:1900740; GO:1901016; GO:1901020; GO:1902309; GO:1905913";"cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; hippocampus development [GO:0021766]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; neuron migration [GO:0001764]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; substantia nigra development [GO:0021762]; viral process [GO:0016032]";"central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cadherin binding [GO:0045296]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]"
comp3210176_c0_seq1;GAXK01089648.1;B5AJT4;3.73E-11;VMP03_EULPE;Venom metalloproteinase 3 (EpMP3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp321035_c0_seq1;GAXK01185538.1;Q9NTW7;1.09E-13;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp321096_c9_seq1;GAXK01185519.1;Q9W0S7;4.84E-10;SND1_DROME;Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (Tudor staphylococcal nuclease);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; RNA catabolic process [GO:0006401]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0004518; GO:0004519; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0007283; GO:0010529; GO:0016442; GO:0031047";"gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; RNA catabolic process [GO:0006401]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"endonuclease activity [GO:0004519]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]"
comp321131_c0_seq1;GAXK01185461.1;Q54HW1;8.65E-11;PSD10_DICDI;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28);"cytoplasm [GO:0005737]; proteasome regulatory particle assembly [GO:0070682]";"GO:0005737; GO:0070682";proteasome regulatory particle assembly [GO:0070682];cytoplasm [GO:0005737];
comp321180_c3_seq1;GAXK01185462.1;Q61554;3.03E-65;FBN1_MOUSE;Fibrillin-1 [Cleaved into: Asprosin];"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001527; GO:0001656; GO:0001822; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205";"activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]"
comp3212054_c0_seq2;GAXK01128179.1;Q7KVA1;7.55E-17;XYLT_DROME;Xylosyltransferase oxt (EC 2.4.2.26) (Imaginal disk type I) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030201; GO:0030204; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp32123_c0_seq1;GAXK01017755.1;P35738;0;ODBB_RAT;2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta);"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; protein-containing complex binding [GO:0044877]; branched-chain amino acid catabolic process [GO:0009083]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]";"GO:0003826; GO:0003863; GO:0005739; GO:0005947; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591";"branched-chain amino acid catabolic process [GO:0009083]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]";"mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]";"3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; protein-containing complex binding [GO:0044877]"
comp321280_c0_seq1;GAXK01185416.1;P17035;9.44E-79;ZNF28_HUMAN;Zinc finger protein 28 (Zinc finger protein KOX24);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp321306_c0_seq1;GAXK01185423.1;P21797;6.62E-27;TNNC1_BALNU;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3213092_c0_seq1;GAXK01128161.1;O54827;3.51E-34;AT10A_MOUSE;Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (P-locus fat-associated ATPase) (P4-ATPase flippase complex alpha subunit ATP10A);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp321341_c0_seq1;GAXK01185448.1;Q9GKT2;5.73E-32;FXDC2_MACFA;Fatty acid hydroxylase domain-containing protein 2;"integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]";"GO:0005506; GO:0008610; GO:0016021; GO:0016491";lipid biosynthetic process [GO:0008610];integral component of membrane [GO:0016021];"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"
comp321348_c1_seq1;GAXK01185352.1;P53589;7.10E-111;SUCB2_CAEEL;Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG);"mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0006099; GO:0006104; GO:0042709";"succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]"
comp321368_c0_seq1;GAXK01185380.1;Q24331;2.78E-38;TID_DROVI;Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID58);"mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005741; GO:0006457; GO:0007275; GO:0009408; GO:0031072; GO:0046872; GO:0051082";"multicellular organism development [GO:0007275]; protein folding [GO:0006457]; response to heat [GO:0009408]";mitochondrial outer membrane [GO:0005741];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp3215116_c0_seq1;GAXK01204885.1;Q9NQX1;4.24E-18;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp321533_c1_seq1;GAXK01185378.1;F6RIX4;3.16E-113;MCM9_XENTR;DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9);"MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006974; GO:0042555; GO:0097362";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]";"MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp321569_c1_seq1;GAXK01185376.1;Q9CWR2;8.61E-20;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp321627_c0_seq1;GAXK01185379.1;Q32L41;2.89E-27;GFRP_BOVIN;GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP cyclohydrolase binding [GO:0044549]; negative regulation of biosynthetic process [GO:0009890]; negative regulation of GTP cyclohydrolase I activity [GO:0043105]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0009890; GO:0030425; GO:0031965; GO:0042470; GO:0043105; GO:0044549";"negative regulation of biosynthetic process [GO:0009890]; negative regulation of GTP cyclohydrolase I activity [GO:0043105]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";GTP cyclohydrolase binding [GO:0044549]
comp321666_c1_seq1;GAXK01185439.1;P58545;6.87E-08;BTBD3_MOUSE;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp321674_c1_seq1;GAXK01185344.1;Q9VZS6;1.58E-09;NSMA_DROME;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp32169_c0_seq1;GAXK01018733.1;Q9Z2A5;4.55E-117;ATE1_MOUSE;Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]";"GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598";"proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";arginyltransferase activity [GO:0004057]
comp321731_c0_seq1;GAXK01185434.1;Q9R044;6.81E-17;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp321734_c0_seq1;GAXK01185443.1;O54904;6.07E-47;B3GT1_MOUSE;Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006682; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275";"galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp3217875_c0_seq1;GAXK01039518.1;P19174;2.72E-20;PLCG1_HUMAN;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1);"cell projection [GO:0042995]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; leukocyte migration [GO:0050900]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; release of sequestered calcium ion into cytosol [GO:0051209]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]";"GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007165; GO:0007173; GO:0007202; GO:0007411; GO:0008180; GO:0009395; GO:0010634; GO:0010863; GO:0016032; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030971; GO:0032959; GO:0035254; GO:0038095; GO:0038096; GO:0042995; GO:0043536; GO:0043647; GO:0045766; GO:0048015; GO:0050804; GO:0050852; GO:0050900; GO:0051209; GO:0051281; GO:0071364; GO:0098685; GO:0098978; GO:1905564; GO:2000353";"activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; release of sequestered calcium ion into cytosol [GO:0051209]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]";"cell-cell junction [GO:0005911]; cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]";"calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]"
comp321827_c3_seq1;GAXK01185385.1;Q0VCQ4;1.30E-30;RRFM_BOVIN;Ribosome-recycling factor, mitochondrial (RRF) (Ribosome-releasing factor, mitochondrial);"mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation [GO:0006412]";"GO:0005739; GO:0006412; GO:0043023";translation [GO:0006412];mitochondrion [GO:0005739];ribosomal large subunit binding [GO:0043023]
comp32186_c0_seq1;GAXK01018716.1;Q13148;1.54E-86;TADBP_HUMAN;TAR DNA-binding protein 43 (TDP-43);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"GO:0000980; GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003727; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0006366; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0070935; GO:0071765; GO:1990904";"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]";"DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; single-stranded RNA binding [GO:0003727]"
comp3219313_c0_seq1;GAXK01063185.1;P36609;1.48E-49;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3219461_c0_seq1;GAXK01063172.1;Q9NDM2;1.35E-23;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp321966_c0_seq1;GAXK01185419.1;Q09990;8.62E-23;LIN23_CAEEL;F-box/WD repeat-containing protein lin-23 (Abnormal cell lineage protein 23);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007049; GO:0008013; GO:0008285; GO:0010826; GO:0019902; GO:0031647; GO:0046983; GO:0048812; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]"
comp321969_c1_seq1;GAXK01185338.1;Q8SYD0;4.81E-36;TTC19_DROME;Tetratricopeptide repeat protein 19 homolog, mitochondrial;"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; jump response [GO:0007630]; mitochondrial respiratory chain complex III assembly [GO:0034551]; optomotor response [GO:0071632]";"GO:0005739; GO:0005743; GO:0007630; GO:0034551; GO:0071632";"jump response [GO:0007630]; mitochondrial respiratory chain complex III assembly [GO:0034551]; optomotor response [GO:0071632]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp321991_c1_seq1;GAXK01185469.1;O46040;6.49E-33;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp321995_c0_seq1;GAXK01185449.1;Q32PP9;2.86E-21;SOX14_DANRE;Transcription factor Sox-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation [GO:0030154]; hypothalamus development [GO:0021854]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0021854; GO:0030154; GO:0044798";"cell differentiation [GO:0030154]; hypothalamus development [GO:0021854]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp322015_c0_seq1;GAXK01081492.1;Q0EEE2;2.72E-45;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp3220184_c0_seq1;GAXK01099746.1;Q9HFY6;5.95E-08;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3220399_c0_seq1;GAXK01099735.1;P16709;6.49E-09;UBIL_NPVAC;viral Ubiquitin;"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; modulation by virus of host protein ubiquitination [GO:0039648]";"GO:0030430; GO:0039648; GO:0042025";modulation by virus of host protein ubiquitination [GO:0039648];"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]";
comp322116_c0_seq1;GAXK01081502.1;P24044;5.45E-29;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3221289_c0_seq1;GAXK01099745.1;Q94900;1.23E-27;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp322140_c0_seq1;GAXK01081643.1;Q24423;8.48E-09;NOC_DROME;Zinc finger protein Noc (Zinc finger protein NocA);"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]";"GO:0001752; GO:0003677; GO:0007219; GO:0007420; GO:0007424; GO:0007430; GO:0008056; GO:0008283; GO:0010629; GO:0035214; GO:0035218; GO:0035220; GO:0046872";"brain development [GO:0007420]; cell population proliferation [GO:0008283]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]";;"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3221494_c0_seq1;GAXK01099729.1;Q8VIG1;9.30E-10;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp32217_c0_seq1;GAXK01018744.1;Q8NBN7;1.97E-80;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp3221704_c0_seq1;GAXK01099751.1;Q1JRP2;3.50E-38;TM11C_MOUSE;"Transmembrane protease serine 11C (EC 3.4.21.-) (Neurobin) [Cleaved into: Transmembrane protease serine 11C non-catalytic chain; Transmembrane protease serine 11C catalytic chain]";"dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0030425; GO:0043204; GO:0097264";"proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]";serine-type endopeptidase activity [GO:0004252]
comp3221927_c0_seq1;GAXK01099747.1;Q0VGE8;1.75E-08;ZN816_HUMAN;Zinc finger protein 816;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp32224_c0_seq1;GAXK01017748.1;Q8BXX2;7.99E-08;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp3222402_c0_seq1;GAXK01098697.1;P90850;6.35E-30;YCF2E_CAEEL;Uncharacterized peptidase C1-like protein F26E4.3;"extracellular space [GO:0005615]; cysteine-type peptidase activity [GO:0008234]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; immune response [GO:0006955]";"GO:0005044; GO:0005615; GO:0006955; GO:0007155; GO:0008234; GO:0030247";"cell adhesion [GO:0007155]; immune response [GO:0006955]";extracellular space [GO:0005615];"cysteine-type peptidase activity [GO:0008234]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp3222639_c0_seq1;GAXK01098704.1;Q8WPA2;9.02E-12;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp322338_c1_seq1;GAXK01081673.1;Q68EA5;2.79E-16;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3223554_c0_seq1;GAXK01098695.1;Q14588;9.27E-09;ZN234_HUMAN;Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3223928_c0_seq1;GAXK01098708.1;Q10KY3;4.21E-08;CAMK1_ORYSJ;Calcium/calmodulin-dependent serine/threonine-protein kinase 1 (EC 2.7.11.17) (Calcium/calmodulin-binding serine/threonine-protein kinase) (CaM-binding protein kinase) (OsCBK);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp322428_c0_seq1;GAXK01081497.1;O34355;2.73E-19;YTCJ_BACSU;Putative amidohydrolase YtcJ (EC 3.5.-.-);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810];GO:0016810;;;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]
comp3224286_c0_seq1;GAXK01076173.1;P51575;3.64E-17;P2RX1_HUMAN;P2X purinoceptor 1 (P2X1) (ATP receptor) (Purinergic receptor);"external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cation channel activity [GO:0005261]; extracellularly ATP-gated cation channel activity [GO:0004931]; purinergic nucleotide receptor activity [GO:0001614]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cation transport [GO:0006812]; ceramide biosynthetic process [GO:0046513]; insemination [GO:0007320]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neuronal action potential [GO:0019228]; neutrophil degranulation [GO:0043312]; platelet activation [GO:0030168]; positive regulation of ion transport [GO:0043270]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vascular smooth muscle contraction [GO:0003056]; response to ATP [GO:0033198]; serotonin secretion by platelet [GO:0002554]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001614; GO:0002554; GO:0003056; GO:0004931; GO:0005261; GO:0005524; GO:0005639; GO:0005886; GO:0005887; GO:0006811; GO:0006812; GO:0006915; GO:0006919; GO:0007165; GO:0007320; GO:0007596; GO:0008217; GO:0008270; GO:0009897; GO:0016021; GO:0019228; GO:0030168; GO:0030667; GO:0032991; GO:0033198; GO:0034220; GO:0035249; GO:0035381; GO:0035579; GO:0043005; GO:0043270; GO:0043312; GO:0045121; GO:0046513; GO:0051260; GO:0051291; GO:0051924; GO:0098978; GO:0099055; GO:0099059; GO:0099509; GO:2000300";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cation transport [GO:0006812]; ceramide biosynthetic process [GO:0046513]; insemination [GO:0007320]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neuronal action potential [GO:0019228]; neutrophil degranulation [GO:0043312]; platelet activation [GO:0030168]; positive regulation of ion transport [GO:0043270]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vascular smooth muscle contraction [GO:0003056]; response to ATP [GO:0033198]; serotonin secretion by platelet [GO:0002554]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]";"external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cation channel activity [GO:0005261]; extracellularly ATP-gated cation channel activity [GO:0004931]; purinergic nucleotide receptor activity [GO:0001614]; zinc ion binding [GO:0008270]"
comp3224661_c0_seq1;GAXK01076158.1;Q8WN93;7.15E-28;CALRL_PIG;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell surface receptor signaling pathway [GO:0007166]";"GO:0001525; GO:0001605; GO:0001635; GO:0004948; GO:0005886; GO:0007166; GO:0007189; GO:0016021; GO:1990408; GO:1990410";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell surface receptor signaling pathway [GO:0007166]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]"
comp3224777_c0_seq1;GAXK01076159.1;P35464;2.31E-21;DIHR_MANSE;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp3224855_c1_seq1;GAXK01076164.1;Q9SS90;6.45E-34;RGLG1_ARATH;E3 ubiquitin-protein ligase RGLG1 (EC 2.3.2.27) (RING domain ligase 1);"nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534]";"GO:0004842; GO:0005634; GO:0005886; GO:0009738; GO:0009789; GO:0046872; GO:0061630; GO:0070534; GO:0080148";"abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534]";"nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp32254_c8_seq1;GAXK01018263.1;O35114;1.93E-12;SCRB2_MOUSE;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp3225519_c0_seq1;GAXK01076162.1;P77360;1.70E-58;YPHC_ECOLI;Uncharacterized zinc-type alcohol dehydrogenase-like protein YphC (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016491";;;"oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]"
comp3225736_c0_seq1;GAXK01076168.1;Q3T052;2.62E-18;ITIH4_BOVIN;Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";"GO:0004867; GO:0005576; GO:0006953; GO:0030212";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp3226854_c0_seq1;GAXK01000196.1;Q9Z0K8;4.43E-18;VNN1_MOUSE;Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1);"anchored component of membrane [GO:0031225]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; pantetheine hydrolase activity [GO:0017159]; acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]";"GO:0002526; GO:0002544; GO:0005886; GO:0006954; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0034235; GO:0045087; GO:0098609; GO:1902176";"acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]";"anchored component of membrane [GO:0031225]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GPI anchor binding [GO:0034235]; pantetheine hydrolase activity [GO:0017159]"
comp32272_c0_seq1;GAXK01018064.1;P04352;7.36E-49;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp322778_c1_seq1;GAXK01081513.1;Q9NB04;1.67E-64;PATJ_DROME;Patj homolog;"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; subapical complex [GO:0035003]; myosin II light chain binding [GO:0032033]; protein kinase C binding [GO:0005080]; adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; cell-cell junction assembly [GO:0007043]; establishment of planar polarity [GO:0001736]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; pupal development [GO:0035209]";"GO:0001736; GO:0002009; GO:0005080; GO:0005635; GO:0005737; GO:0005886; GO:0005912; GO:0005918; GO:0007043; GO:0007163; GO:0008594; GO:0016324; GO:0016327; GO:0016332; GO:0016333; GO:0016334; GO:0032033; GO:0034332; GO:0034334; GO:0035003; GO:0035088; GO:0035209; GO:0035509; GO:0045176; GO:0045179; GO:0045494";"adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; cell-cell junction assembly [GO:0007043]; establishment of planar polarity [GO:0001736]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; pupal development [GO:0035209]";"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; subapical complex [GO:0035003]";"myosin II light chain binding [GO:0032033]; protein kinase C binding [GO:0005080]"
comp3228215_c0_seq1;GAXK01025660.1;Q761X5;1.74E-08;UNC5C_RAT;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]";"GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0016021; GO:0030027; GO:0030054; GO:0030175; GO:0030424; GO:0030425; GO:0030426; GO:0043025; GO:0045202; GO:0061643; GO:1990791";"apoptotic process [GO:0006915]; axon guidance [GO:0007411]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]"
comp3229076_c0_seq1;GAXK01025637.1;Q91453;2.58E-15;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3229141_c0_seq1;GAXK01025658.1;P18741;1.08E-09;ZO15_XENLA;Oocyte zinc finger protein XlCOF15 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp322935_c3_seq1;GAXK01081494.1;F4I107;2.52E-17;PAE1_ARATH;Pectin acetylesterase 1 (EC 3.1.1.-);"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; pectin acetylesterase activity [GO:0052793]; cell wall organization [GO:0071555]";"GO:0005576; GO:0009505; GO:0052793; GO:0071555";cell wall organization [GO:0071555];"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]";pectin acetylesterase activity [GO:0052793]
comp3230648_c0_seq1;GAXK01101751.1;Q96PE6;1.09E-09;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3230745_c0_seq1;GAXK01101743.1;Q9NZJ4;1.49E-12;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp3230801_c0_seq1;GAXK01101752.1;Q9CWR2;1.92E-09;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3231_c0_seq1;GAXK01175892.1;Q9BX40;3.77E-44;LS14B_HUMAN;Protein LSM14 homolog B (Protein FAM61B) (RNA-associated protein 55B) (hRAP55B);"RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; regulation of translation [GO:0006417]";"GO:0003723; GO:0006417; GO:0007275";"multicellular organism development [GO:0007275]; regulation of translation [GO:0006417]";;RNA binding [GO:0003723]
comp323140_c0_seq1;GAXK01081505.1;Q9YGL3;3.25E-70;NR2E1_ORYLA;Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0007275; GO:0008270; GO:0030154; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp32316_c1_seq1;GAXK01018366.1;O01814;1.20E-13;FABP5_CAEEL;Fatty acid-binding protein homolog 5;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504]";"GO:0005504; GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";fatty acid binding [GO:0005504]
comp3231908_c0_seq1;GAXK01101761.1;Q557E0;3.06E-55;HS7C2_DICDI;Heat shock cognate 70 kDa protein 2 (HSC70-2);"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; microtubule organizing center [GO:0005815]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to bacterium [GO:0009617]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005811; GO:0005815; GO:0006986; GO:0009617; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0045335; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to bacterium [GO:0009617]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; microtubule organizing center [GO:0005815]; phagocytic vesicle [GO:0045335]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp3231976_c0_seq1;GAXK01101756.1;A0JMG1;2.00E-13;SPOLB_DANRE;Speckle-type POZ protein-like B (HIB homolog 3);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3232260_c0_seq1;GAXK01161005.1;Q866D6;3.61E-16;FUT1_LEOCY;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp3232451_c0_seq1;GAXK01161008.1;Q5B0W8;3.73E-09;LKHA4_EMENI;Leucine aminopeptidase 2 (EC 3.4.11.-) (Epoxide hydrolase) (EC 3.3.2.10) (Leukotriene A-4 hydrolase homolog) (LTA-4 hydrolase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004301; GO:0005634; GO:0005737; GO:0008237; GO:0008270; GO:0043171; GO:0044255";"cellular lipid metabolic process [GO:0044255]; peptide catabolic process [GO:0043171]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp323297_c1_seq1;GAXK01081696.1;Q96PQ6;1.82E-28;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3233104_c0_seq1;GAXK01161007.1;Q05481;5.45E-21;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp3233625_c0_seq1;GAXK01161010.1;Q8K389;9.14E-09;CK5P2_MOUSE;CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48);"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431";"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]";"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]";"calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]"
comp323392_c2_seq1;GAXK01081483.1;Q8BGM5;4.59E-79;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp3234378_c0_seq1;GAXK01052938.1;Q9NZJ4;2.33E-43;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp3235451_c0_seq1;GAXK01052928.1;Q539E5;1.08E-26;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp3235554_c0_seq1;GAXK01052935.1;Q86YE8;5.51E-10;ZN573_HUMAN;Zinc finger protein 573;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp323636_c3_seq1;GAXK01081651.1;P93400;1.82E-175;PLDA1_TOBAC;Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1);"membrane [GO:0016020]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004630; GO:0005509; GO:0016020; GO:0016042; GO:0046470; GO:0070290";"lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";membrane [GO:0016020];"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]"
comp3236404_c0_seq1;GAXK01056442.1;Q7ZVZ7;3.93E-122;AB17C_DANRE;Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]";"GO:0008474; GO:0014069; GO:0030054; GO:0043197; GO:0045211; GO:0055038";;"cell junction [GO:0030054]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]";palmitoyl-(protein) hydrolase activity [GO:0008474]
comp323707_c0_seq1;GAXK01081678.1;Q9D7X3;1.29E-40;DUS3_MOUSE;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001701; GO:0001772; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp3237083_c0_seq1;GAXK01056439.1;G2QDQ9;4.04E-23;VAO15_MYCTT;VAO-type flavoprotein oxidase VAO615;"extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0005576; GO:0016491; GO:0071949";;extracellular region [GO:0005576];"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp323710_c0_seq1;GAXK01081600.1;Q2TBI1;2.23E-25;NSE4A_BOVIN;Non-structural maintenance of chromosomes element 4 homolog A (Non-SMC element 4 homolog A);"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]";"GO:0000781; GO:0005634; GO:0006281; GO:0006310; GO:0016604; GO:0030915; GO:2001022";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]";"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]";
comp3237187_c0_seq1;GAXK01056447.1;Q86UC2;1.02E-16;RSPH3_HUMAN;Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp323725_c0_seq1;GAXK01081578.1;Q6H1V1;2.29E-13;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp3237279_c0_seq1;GAXK01056436.1;P61214;2.44E-25;ARL4A_RAT;ADP-ribosylation factor-like protein 4A;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873";"brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp32376_c1_seq1;GAXK01018146.1;P0CH36;2.98E-87;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp3238531_c0_seq1;GAXK01012193.1;Q2V2K5;5.87E-07;GNRHR_OCTVU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (oct-GnRHR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp323890_c0_seq1;GAXK01081632.1;Q7KRI2;4.21E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3238926_c0_seq1;GAXK01012183.1;Q9W0T5;3.30E-12;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp323912_c1_seq1;GAXK01081602.1;A5PJF6;6.82E-51;HSDL1_BOVIN;Inactive hydroxysteroid dehydrogenase-like protein 1;"mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0055114";oxidation-reduction process [GO:0055114];mitochondrion [GO:0005739];
comp323973_c0_seq1;GAXK01081697.1;Q5F2N4;6.59E-116;FUT10_CANLF;Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";alpha-(1->3)-fucosyltransferase activity [GO:0046920]
comp3239781_c0_seq1;GAXK01012187.1;A6H8H5;4.53E-15;KCNB2_MOUSE;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp3239826_c0_seq1;GAXK01012190.1;Q7TNC8;3.78E-11;GLRA2_MOUSE;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp323994_c0_seq1;GAXK01081499.1;P55053;9.28E-09;FABP5_RAT;Fatty acid-binding protein 5 (Cutaneous fatty acid-binding protein) (C-FABP) (DA11) (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein, epidermal);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; fatty acid binding [GO:0005504]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; response to wounding [GO:0009611]";"GO:0005504; GO:0005615; GO:0005634; GO:0005737; GO:0009611; GO:0014069; GO:0030054; GO:0045202; GO:0045211; GO:0099178; GO:0120162";"positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; response to wounding [GO:0009611]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";fatty acid binding [GO:0005504]
comp32404_c2_seq1;GAXK01017756.1;A0A0R4IES7;0;K1109_DANRE;Transmembrane protein KIAA1109 homolog;"integral component of membrane [GO:0016021]; presynapse [GO:0098793]; synaptic vesicle endocytosis [GO:0048488]";"GO:0016021; GO:0048488; GO:0098793";synaptic vesicle endocytosis [GO:0048488];"integral component of membrane [GO:0016021]; presynapse [GO:0098793]";
comp3240507_c0_seq1;GAXK01194399.1;O75122;3.25E-27;CLAP2_HUMAN;CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2);"axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]";"GO:0000226; GO:0000777; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:1903690; GO:1903754; GO:1904261; GO:1990782";"cell division [GO:0051301]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; vesicle targeting [GO:0006903]";"axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]"
comp324051_c0_seq1;GAXK01041500.1;P52168;1.44E-52;PNR_DROME;GATA-binding factor A (Protein pannier) (Transcription factor GATA-A) (dGATA-A);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000978; GO:0000981; GO:0001085; GO:0001103; GO:0005634; GO:0006351; GO:0006963; GO:0007350; GO:0007389; GO:0007391; GO:0007398; GO:0007507; GO:0007510; GO:0008270; GO:0008407; GO:0010002; GO:0022416; GO:0030154; GO:0035050; GO:0035051; GO:0042440; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048542; GO:0060047; GO:0061320";"blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]"
comp324066_c0_seq1;GAXK01041689.1;Q08C93;4.92E-37;ABD12_DANRE;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651";"acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp32408_c1_seq1;GAXK01017725.1;O75943;1.35E-84;RAD17_HUMAN;Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog);"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000076; GO:0000077; GO:0000790; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006974; GO:0007093; GO:0008156; GO:0031389; GO:0033314; GO:0042325; GO:1901796";"cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]";"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]"
comp3241_c13_seq2;GAXK01175181.1;Q5VYK3;0;ECM29_HUMAN;Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog);"centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000502; GO:0005634; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0030433; GO:0031410; GO:0043248; GO:0060090; GO:0070628";"proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433]";"centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";"molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]"
comp3241595_c0_seq1;GAXK01194395.1;Q9VZW5;9.99E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3241701_c0_seq1;GAXK01194393.1;P89116;7.94E-43;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp324193_c2_seq1;GAXK01041629.1;Q9UHH9;4.16E-34;IP6K2_HUMAN;Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (InsP6K2) (EC 2.7.4.-) (P(i)-uptake stimulator) (PiUS);"cell junction [GO:0030054]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]; type I interferon signaling pathway [GO:0060337]";"GO:0000828; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0006817; GO:0030054; GO:0030308; GO:0032958; GO:0043065; GO:0043647; GO:0046854; GO:0060337; GO:0097243; GO:1905396";"cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of apoptotic process [GO:0043065]; type I interferon signaling pathway [GO:0060337]";"cell junction [GO:0030054]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"
comp3242105_c0_seq1;GAXK01054258.1;Q0VAA5;8.87E-50;PLCX2_HUMAN;PI-PLC X domain-containing protein 2;"nucleus [GO:0005634]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"GO:0005634; GO:0007165; GO:0008081; GO:0016042";"lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";nucleus [GO:0005634];phosphoric diester hydrolase activity [GO:0008081]
comp324220_c0_seq1;GAXK01041684.1;Q9H1Q7;8.17E-31;PED1A_HUMAN;PC-esterase domain-containing protein 1A (Protein FAM113A) (Sarcoma antigen NY-SAR-23);;;;;
comp324263_c5_seq1;GAXK01041476.1;P16912;1.23E-112;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp3242918_c0_seq1;GAXK01054264.1;Q9Y2H8;3.06E-13;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3243389_c0_seq1;GAXK01054259.1;Q687X5;6.74E-42;STEA4_HUMAN;Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9);"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"GO:0000139; GO:0005768; GO:0005794; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706";"copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp324344_c0_seq1;GAXK01041622.1;O89016;8.44E-116;ABCD4_MOUSE;ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]";"GO:0005524; GO:0005789; GO:0009235; GO:0016021; GO:0016887; GO:0042626; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp324374_c0_seq1;GAXK01041562.1;A1A5X2;1.19E-102;FBXL7_DANRE;F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005737; GO:0005815; GO:0006511; GO:0016567; GO:0019005; GO:0031146";"protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; SCF ubiquitin ligase complex [GO:0019005]";
comp3243843_c0_seq1;GAXK01054267.1;Q7Z398;2.17E-13;ZN550_HUMAN;Zinc finger protein 550;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp324409_c0_seq1;GAXK01041572.1;Q8IUS5;1.07E-73;EPHX4_HUMAN;Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein);"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp32443_c0_seq1;GAXK01205085.1;Q5UEM7;1.89E-24;CR3L4_RAT;Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4];"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]";"GO:0001228; GO:0005654; GO:0005739; GO:0005789; GO:0005794; GO:0007283; GO:0016021; GO:0030968; GO:0031965; GO:0035497";"endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]"
comp324436_c0_seq1;GAXK01041517.1;Q8BZH4;4.31E-07;POGZ_MOUSE;Pogo transposable element with ZNF domain;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468]";"GO:0000790; GO:0000979; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0010468; GO:0046872; GO:0051301; GO:0051382";"cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp32444_c1_seq1;GAXK01018372.1;Q8BLV3;4.50E-142;SL9A7_MOUSE;Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005802; GO:0005886; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]";"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp324491_c0_seq1;GAXK01041626.1;Q9P0M2;2.03E-16;AKA7G_HUMAN;A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma);"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686";"modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]"
comp3245093_c0_seq1;GAXK01174424.1;Q9BY50;1.52E-55;SC11C_HUMAN;Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465]";"GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0008236; GO:0016021";signal peptide processing [GO:0006465];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";"peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]"
comp3245397_c0_seq1;GAXK01174412.1;P39057;8.13E-174;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3245598_c0_seq1;GAXK01174417.1;Q6NVF4;3.09E-66;HELB_MOUSE;DNA helicase B (EC 3.6.4.12);"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA-dependent DNA replication [GO:0006261]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005662; GO:0005737; GO:0006260; GO:0006261; GO:0006269; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp3245662_c0_seq1;GAXK01174406.1;Q8TCB0;2.25E-09;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp3245982_c0_seq1;GAXK01174416.1;Q18297;2.92E-11;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp3246682_c0_seq1;GAXK01038316.1;Q7XJS0;2.71E-08;ASHR1_ARATH;Histone-lysine N-methyltransferase ASHR1 (EC 2.1.1.43) (ASH1-related protein 1) (Protein SET DOMAIN GROUP 37);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005694; GO:0018024; GO:0046872";;"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]"
comp3247102_c0_seq1;GAXK01038314.1;Q8N2I2;1.94E-08;ZN619_HUMAN;Zinc finger protein 619;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3247507_c0_seq1;GAXK01038305.1;P13907;2.66E-39;PSBO_NOSS1;Photosystem II manganese-stabilizing polypeptide (MSP);"photosystem II oxygen evolving complex [GO:0009654]; oxygen evolving activity [GO:0010242]; photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";"GO:0009654; GO:0010207; GO:0010242; GO:0042549";"photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";photosystem II oxygen evolving complex [GO:0009654];oxygen evolving activity [GO:0010242]
comp3247526_c0_seq1;GAXK01038302.1;O01382;2.94E-38;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp3247612_c0_seq1;GAXK01038322.1;Q8BKK5;5.67E-17;ZN689_MOUSE;Zinc finger protein 689;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";"GO:0003677; GO:0005634; GO:0006355; GO:0035914; GO:0046872";"regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp324804_c1_seq1;GAXK01041662.1;Q09788;5.43E-12;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp32483_c2_seq1;GAXK01018508.1;D2TUZ4;3.15E-68;TATD_CITRI;3'-5' ssDNA/RNA exonuclease TatD (EC 3.1.11.-) (EC 3.1.13.-) (DNase TatD);"cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]";"GO:0000175; GO:0000287; GO:0005737; GO:0008310; GO:0016888";;cytoplasm [GO:0005737];"3'-5'-exoribonuclease activity [GO:0000175]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]"
comp32488_c0_seq1;GAXK01018719.1;A6H6W9;1.41E-45;SDS3_BOVIN;Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog);"nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]";"GO:0000122; GO:0005634; GO:0006915; GO:0016575; GO:0042826; GO:0043065; GO:0070822";"apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]";"nucleus [GO:0005634]; Sin3-type complex [GO:0070822]";histone deacetylase binding [GO:0042826]
comp325026_c0_seq1;GAXK01041485.1;Q09476;4.79E-24;PXL1_CAEEL;Paxillin homolog 1;"adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; M band [GO:0031430]; plasma membrane [GO:0005886]; podosome [GO:0002102]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]; muscle structure development [GO:0061061]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]";"GO:0002102; GO:0002119; GO:0003712; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0017166; GO:0031430; GO:0042995; GO:0043050; GO:0046872; GO:0055120; GO:0061061";"muscle structure development [GO:0061061]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]";"adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; M band [GO:0031430]; plasma membrane [GO:0005886]; podosome [GO:0002102]; striated muscle dense body [GO:0055120]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]"
comp325041_c0_seq1;GAXK01041539.1;Q5U3C3;5.97E-50;TM164_HUMAN;Transmembrane protein 164;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp325049_c1_seq1;GAXK01041566.1;Q8T3Y0;3.05E-07;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3250579_c0_seq1;GAXK01034578.1;Q9Z2I8;1.01E-09;SUCB2_MOUSE;Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG);"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004775; GO:0004776; GO:0004777; GO:0005524; GO:0005525; GO:0005739; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0019003; GO:0032991; GO:0042709; GO:0045244; GO:0046982";"succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]";"ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]"
comp3250807_c0_seq1;GAXK01034576.1;Q7PPU9;4.30E-08;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3251154_c0_seq1;GAXK01034575.1;Q6GQN5;8.70E-30;PPR42_DANRE;Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631]";"GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840";;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]";"actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631]"
comp3251650_c0_seq1;GAXK01034577.1;Q5RFU0;1.23E-75;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp3251725_c0_seq1;GAXK01034559.1;P82198;8.21E-10;BGH3_MOUSE;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp325274_c0_seq1;GAXK01041486.1;Q06831;1.13E-13;SOX4_MOUSE;Transcription factor SOX-4;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocrine pancreas development [GO:0031018]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin secretion [GO:0032024]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]";"GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001666; GO:0001841; GO:0002328; GO:0003183; GO:0003211; GO:0003215; GO:0003289; GO:0003357; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006355; GO:0006977; GO:0007507; GO:0008284; GO:0008285; GO:0014009; GO:0021510; GO:0021522; GO:0021782; GO:0030154; GO:0030217; GO:0031018; GO:0031397; GO:0031647; GO:0032024; GO:0035019; GO:0035910; GO:0042593; GO:0042769; GO:0043065; GO:0044798; GO:0045727; GO:0045893; GO:0045944; GO:0046982; GO:0048485; GO:0050821; GO:0060174; GO:0060412; GO:0060548; GO:0060563; GO:0060993; GO:0071333; GO:0090263; GO:2000761";"ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocrine pancreas development [GO:0031018]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin secretion [GO:0032024]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3253172_c0_seq1;GAXK01117975.1;Q6DHG0;6.10E-10;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3253568_c0_seq1;GAXK01117971.1;Q1RJR6;4.46E-12;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp3254242_c0_seq1;GAXK01141106.1;Q9VMA2;1.10E-18;GALT_DROME;Probable galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase);"cytoplasm [GO:0005737]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose homeostasis [GO:0033501]";"GO:0005737; GO:0008108; GO:0008270; GO:0008344; GO:0033499; GO:0033501";"adult locomotory behavior [GO:0008344]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose homeostasis [GO:0033501]";cytoplasm [GO:0005737];"UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]"
comp3254807_c0_seq1;GAXK01141103.1;Q19PY9;3.81E-08;GNRHR_BOSMU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp325501_c3_seq1;GAXK01041505.1;Q90YB1;4.38E-160;DNLI4_CHICK;DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4);"DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]";"GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006260; GO:0006297; GO:0006303; GO:0007049; GO:0032807; GO:0033152; GO:0046872; GO:0051103; GO:0051301; GO:0070419; GO:0071897";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]";"DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]"
comp32552_c3_seq1;GAXK01018547.1;O43463;2.25E-89;SUV91_HUMAN;Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1);"chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]; chromatin binding [GO:0003682]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]; viral process [GO:0016032]";"GO:0000122; GO:0000183; GO:0000775; GO:0000792; GO:0000794; GO:0000976; GO:0003682; GO:0005634; GO:0005652; GO:0005654; GO:0005677; GO:0006325; GO:0006364; GO:0006974; GO:0007049; GO:0008270; GO:0008757; GO:0016032; GO:0018024; GO:0030154; GO:0033553; GO:0034968; GO:0036123; GO:0036124; GO:0042054; GO:0042754; GO:0045892; GO:0046974; GO:0047485; GO:0048511; GO:0071456";"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]; viral process [GO:0016032]";"chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; protein N-terminus binding [GO:0047485]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp3255519_c0_seq1;GAXK01141102.1;Q2QI47;1.30E-07;USH2A_MOUSE;Usherin (Usher syndrome type IIa protein homolog) (Usher syndrome type-2A protein homolog);"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0017022; GO:0022008; GO:0032391; GO:0032420; GO:0032421; GO:0035315; GO:0036064; GO:0042803; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060041; GO:0060113; GO:0060171; GO:1990075; GO:1990696";"animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]";"collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]"
comp325553_c0_seq1;GAXK01041628.1;P10076;6.30E-08;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3255531_c0_seq1;GAXK01141104.1;A0JNT9;3.67E-20;BICL1_MOUSE;BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107";"Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]"
comp32560_c14_seq1;GAXK01018407.1;Q9WVK4;0;EHD1_MOUSE;EH domain-containing protein 1 (PAST homolog 1) (mPAST1);"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0010976; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043209; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]"
comp325627_c0_seq1;GAXK01041654.1;Q8IUS5;1.72E-59;EPHX4_HUMAN;Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein);"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp325642_c1_seq1;GAXK01041563.1;Q60ZN5;3.69E-07;SDK_CAEBR;Protein sidekick homolog (Neuronal IgCAM protein 4);"integral component of membrane [GO:0016021]; sarcomere [GO:0030017]; cell adhesion [GO:0007155]";"GO:0007155; GO:0016021; GO:0030017";cell adhesion [GO:0007155];"integral component of membrane [GO:0016021]; sarcomere [GO:0030017]";
comp3256546_c0_seq1;GAXK01040850.1;P53991;2.46E-55;FENR_CHLRE;Ferredoxin--NADP reductase, chloroplastic (FNR) (EC 1.18.1.2);"chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]; ferredoxin-NADP+ reductase activity [GO:0004324]; photosynthesis [GO:0015979]";"GO:0004324; GO:0009535; GO:0009570; GO:0015979";photosynthesis [GO:0015979];"chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]";ferredoxin-NADP+ reductase activity [GO:0004324]
comp3256797_c0_seq1;GAXK01040839.1;Q8C8R3;2.56E-17;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp325733_c4_seq1;GAXK01041579.1;O75373;4.07E-26;ZN737_HUMAN;Zinc finger protein 737 (Zinc finger protein 102);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp325736_c0_seq1;GAXK01041624.1;Q9CPW9;4.24E-99;MAP12_MOUSE;Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D);"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]";"GO:0005739; GO:0043231; GO:0046872; GO:0070006; GO:0070084";protein initiator methionine removal [GO:0070084];"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp3257837_c0_seq1;GAXK01040849.1;Q5SSM3;2.87E-26;RHG44_MOUSE;Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2);"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]; modification of dendritic spine [GO:0098886]; modification of postsynaptic structure [GO:0099010]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]";"GO:0005096; GO:0005543; GO:0007165; GO:0014069; GO:0030054; GO:0030425; GO:0031256; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048365; GO:0048786; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099010; GO:0099152";"modification of dendritic spine [GO:0098886]; modification of postsynaptic structure [GO:0099010]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]";"GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]"
comp325817_c0_seq1;GAXK01041504.1;Q8R0P8;1.23E-55;ABHD8_MOUSE;Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8);"carboxylic ester hydrolase activity [GO:0052689]; lipid homeostasis [GO:0055088]";"GO:0052689; GO:0055088";lipid homeostasis [GO:0055088];;carboxylic ester hydrolase activity [GO:0052689]
comp325865_c0_seq1;GAXK01041665.1;O75608;5.23E-12;LYPA1_HUMAN;Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]";"GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0006631; GO:0008474; GO:0016298; GO:0042997; GO:0050999; GO:0052689; GO:0070062";"fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp325900_c0_seq1;GAXK01041653.1;P24044;7.60E-13;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp325913_c4_seq1;GAXK01041667.1;Q9P0L1;6.77E-20;ZKSC7_HUMAN;Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3259241_c0_seq1;GAXK01119695.1;Q0VA42;5.80E-08;MINY4_XENTR;Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4);"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]";"GO:0016807; GO:0036459; GO:1990380";;;"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp325958_c1_seq1;GAXK01041515.1;Q8K342;2.22E-13;RASF9_MOUSE;Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1) (P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor);"cytosol [GO:0005829]; endosome [GO:0005768]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; signal transduction [GO:0007165]";"GO:0005768; GO:0005829; GO:0007165; GO:0012510; GO:0016197; GO:0019899; GO:0019904; GO:0046907; GO:0055037";"endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; endosome [GO:0005768]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]";"enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]"
comp325963_c0_seq1;GAXK01041621.1;Q27433;2.97E-57;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp32597_c1_seq1;GAXK01018361.1;Q6PCW6;1.49E-09;CNFN_MOUSE;Cornifelin;"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0001533; GO:0005737; GO:0031424";keratinization [GO:0031424];"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]";
comp326_c0_seq1;GAXK01169091.1;P10994;4.54E-15;ACTS_PLEWA;Actin, alpha skeletal muscle (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp326011_c1_seq1;GAXK01188791.1;A1ZBD6;1.72E-109;MCTP_DROME;Multiple C2 and transmembrane domain-containing protein;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0005789; GO:0016021; GO:0046928; GO:0048168";"regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";calcium ion binding [GO:0005509]
comp3261_c0_seq1;GAXK01175159.1;Q9VLP3;4.40E-25;MSS4_DROME;Guanine nucleotide exchange factor MSS4 homolog (Guanine nucleotide exchange factor stratum);"basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; zinc ion binding [GO:0008270]; polarized secretion of basement membrane proteins in epithelium [GO:0061865]; positive regulation of GTPase activity [GO:0043547]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0009925; GO:0015031; GO:0016020; GO:0017112; GO:0043547; GO:0045180; GO:0061865";"polarized secretion of basement membrane proteins in epithelium [GO:0061865]; positive regulation of GTPase activity [GO:0043547]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]";"basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; membrane [GO:0016020]";"guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; zinc ion binding [GO:0008270]"
comp326114_c0_seq1;GAXK01188680.1;P10925;5.82E-24;ZFY1_MOUSE;Zinc finger Y-chromosomal protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp326131_c0_seq1;GAXK01188779.1;Q99676;1.37E-35;ZN184_HUMAN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp3261526_c0_seq1;GAXK01028515.1;Q9Z1T1;7.99E-31;AP3B1_MOUSE;AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain);"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of NK T cell differentiation [GO:0051138]; protein targeting to lysosome [GO:0006622]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]; zinc ion transport [GO:0006829]";"GO:0005802; GO:0006622; GO:0006829; GO:0006886; GO:0007596; GO:0008089; GO:0016182; GO:0016192; GO:0019882; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0032438; GO:0045202; GO:0048007; GO:0048490; GO:0051138; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of NK T cell differentiation [GO:0051138]; protein targeting to lysosome [GO:0006622]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]; zinc ion transport [GO:0006829]";"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]";"GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]"
comp3261600_c0_seq1;GAXK01028522.1;Q9JJC8;3.52E-37;NIPA2_MOUSE;Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2 homolog);"early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]";"GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016021";magnesium ion transport [GO:0015693];"early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";magnesium ion transmembrane transporter activity [GO:0015095]
comp3261604_c0_seq1;GAXK01028529.1;O02151;3.43E-18;NHR14_CAEEL;Nuclear hormone receptor family member nhr-14;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp32617_c3_seq1;GAXK01017785.1;P90992;1.58E-138;M2OM_CAEEL;Mitochondrial 2-oxoglutarate/malate carrier protein (Mitochondrial solute carrier 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367]";"GO:0005739; GO:0005743; GO:0015367; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";oxoglutarate:malate antiporter activity [GO:0015367]
comp3262282_c0_seq1;GAXK01117837.1;Q9QZ85;2.43E-13;IIGP1_MOUSE;Interferon-inducible GTPase 1 (EC 3.6.5.-);"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829";"cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp326231_c0_seq1;GAXK01188642.1;P52746;1.31E-11;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3262372_c0_seq1;GAXK01117836.1;Q9HAZ2;3.84E-07;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp3262598_c0_seq1;GAXK01117833.1;O95180;1.65E-38;CAC1H_HUMAN;Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005244; GO:0005886; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]"
comp3262747_c0_seq1;GAXK01117818.1;P09643;2.21E-11;TBA4_CHICK;Tubulin alpha-4 chain (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp326285_c0_seq1;GAXK01188657.1;O42287;4.16E-113;ITSN1_XENLA;Intersectin-1;"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0030054; GO:0035023; GO:0035556; GO:0043005; GO:0045202; GO:0055037";"endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of Rho protein signal transduction [GO:0035023]";"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp3263625_c0_seq1;GAXK01117819.1;Q9VFP2;4.23E-11;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp3263695_c0_seq1;GAXK01117823.1;Q9U639;1.69E-81;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp326371_c0_seq1;GAXK01188789.1;Q7Z449;1.77E-58;CP2U1_HUMAN;Cytochrome P450 2U1 (EC 1.14.14.1);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267";"exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp32639_c0_seq1;GAXK01018242.1;P13602;1.32E-22;TBB2_XENLA;Tubulin beta-2 chain (Beta-2-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp326528_c2_seq1;GAXK01188770.1;Q0EEE2;6.46E-44;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp326543_c0_seq1;GAXK01188663.1;Q5G269;1.06E-07;NETR_PONPY;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424";exocytosis [GO:0006887];"axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp3266567_c0_seq1;GAXK01062346.1;P24045;3.42E-07;GBRB4_CHICK;Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp3266891_c0_seq1;GAXK01062331.1;P14381;1.11E-26;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp3267170_c0_seq1;GAXK01062343.1;O42329;8.27E-09;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3267309_c0_seq1;GAXK01062355.1;Q98943;1.79E-13;CASP2_CHICK;"Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200";"apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp326742_c1_seq1;GAXK01188697.1;Q58424;1.91E-26;SERA_METJA;D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95);"NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]";"GO:0004617; GO:0006520; GO:0006564; GO:0051287";"cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]";;"NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]"
comp3267911_c0_seq1;GAXK01062341.1;P41128;1.43E-34;RL131_BRANA;60S ribosomal protein L13-1 (Cold-induced protein C24A);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp326797_c0_seq1;GAXK01188794.1;P50607;2.85E-134;TUB_HUMAN;Tubby protein homolog;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]";"GO:0001664; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007605; GO:0008277; GO:0009725; GO:0042073; GO:0044877; GO:0045494; GO:0050766; GO:0060041; GO:0061512; GO:0097500; GO:0120160; GO:1903546";"intraciliary transport [GO:0042073]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; protein-containing complex binding [GO:0044877]"
comp32690_c1_seq1;GAXK01017751.1;P82119;8.57E-11;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp32692_c0_seq1;GAXK01018191.1;Q25158;3.81E-117;OPSC2_HEMSA;Compound eye opsin BCRH2;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp32693_c0_seq1;GAXK01018601.1;P55072;0;TERA_HUMAN;Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP);"ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-specific protease binding [GO:1990381]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; error-free translesion synthesis [GO:0070987]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; neutrophil degranulation [GO:0043312]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]";"GO:0000502; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006281; GO:0006302; GO:0006457; GO:0006734; GO:0006888; GO:0006914; GO:0006919; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0010918; GO:0016236; GO:0016567; GO:0016579; GO:0016887; GO:0018279; GO:0019079; GO:0019903; GO:0019904; GO:0019985; GO:0030433; GO:0030968; GO:0030970; GO:0031334; GO:0031593; GO:0031625; GO:0032436; GO:0032510; GO:0032991; GO:0034098; GO:0034214; GO:0034605; GO:0034774; GO:0035578; GO:0035617; GO:0035800; GO:0035861; GO:0036435; GO:0036503; GO:0036513; GO:0042288; GO:0042802; GO:0042981; GO:0043161; GO:0043231; GO:0043312; GO:0043531; GO:0044389; GO:0045184; GO:0045732; GO:0046034; GO:0048471; GO:0050807; GO:0051228; GO:0051260; GO:0055085; GO:0061857; GO:0070062; GO:0070842; GO:0070987; GO:0071712; GO:0072389; GO:0090263; GO:0097352; GO:0098978; GO:1903006; GO:1903007; GO:1903715; GO:1903843; GO:1903862; GO:1904288; GO:1904813; GO:1904949; GO:1990381; GO:1990730; GO:2001171";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; neutrophil degranulation [GO:0043312]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]";"ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]";"ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]"
comp326956_c8_seq1;GAXK01188639.1;Q60436;3.26E-37;SRRT_CRIGR;Serrate RNA effector molecule homolog (Arsenite-resistance protein 2) (Fragment);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0008283; GO:0031053; GO:0097150";"cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp327_c0_seq1;GAXK01168177.1;Q9IB83;1.86E-93;PSB1B_CARAU;Proteasome subunit beta type-1-B (EC 3.4.25.1) (20S proteasome beta-6 subunit B) (B6-B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";threonine-type endopeptidase activity [GO:0004298]
comp327028_c0_seq1;GAXK01188634.1;Q5ZJF4;7.20E-96;PRDX6_CHICK;Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Non-selenium glutathione peroxidase) (NSGPx);"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; lipid catabolic process [GO:0016042]";"GO:0004601; GO:0004623; GO:0005615; GO:0005764; GO:0005829; GO:0016042; GO:0034599; GO:0042744; GO:0045454; GO:0051920; GO:0102567; GO:0102568";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; lipid catabolic process [GO:0016042]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]";"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp3270406_c0_seq1;GAXK01073078.1;Q9UK10;9.01E-12;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3270603_c0_seq1;GAXK01073075.1;P36609;1.25E-15;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3270609_c0_seq1;GAXK01073080.1;Q92072;1.78E-11;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp3270658_c0_seq1;GAXK01073087.1;P0DKT4;5.04E-07;TU92_IOTCI;Turripeptide Ici9.2;"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]";"GO:0004867; GO:0005576; GO:0090729";;extracellular region [GO:0005576];"serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]"
comp327122_c0_seq1;GAXK01188778.1;Q96ND8;1.98E-40;ZN583_HUMAN;Zinc finger protein 583 (Zinc finger protein L3-5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3271882_c0_seq1;GAXK01073092.1;Q9V427;3.76E-47;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp327195_c0_seq1;GAXK01188645.1;Q9V7U0;3.72E-10;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp3272_c0_seq1;GAXK01175649.1;Q6DGL7;2.16E-61;TM147_DANRE;Transmembrane protein 147;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp32726_c0_seq1;GAXK01018221.1;Q9NZ63;2.77E-34;TLS1_HUMAN;Telomere length and silencing protein 1 homolog (Hepatocellular carcinoma-associated antigen 59);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0048024";regulation of mRNA splicing, via spliceosome [GO:0048024];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";
comp3272721_c0_seq1;GAXK01141184.1;B3DH20;1.20E-67;TILB_DANRE;Protein tilB homolog (Leucine-rich repeat-containing 6-like protein) (Leucine-rich repeat-containing protein 6) (Seahorse);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; convergent extension involved in gastrulation [GO:0060027]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]";"GO:0001947; GO:0003143; GO:0003146; GO:0003351; GO:0005576; GO:0005737; GO:0007368; GO:0009953; GO:0031514; GO:0035082; GO:0044458; GO:0048793; GO:0060027; GO:0060271; GO:0060285; GO:0060294";"axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; cilium movement involved in cell motility [GO:0060294]; convergent extension involved in gastrulation [GO:0060027]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]";
comp327376_c0_seq1;GAXK01188653.1;Q8T3Y0;1.61E-07;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp327419_c0_seq1;GAXK01188659.1;Q3ZU95;3.95E-21;PA1_VESGE;Phospholipase A1 (EC 3.1.1.32) (allergen Ves g 1);"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0008970; GO:0016042; GO:0052739; GO:0052740";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]"
comp3274336_c0_seq1;GAXK01068868.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3274861_c0_seq1;GAXK01068858.1;A8X679;4.40E-08;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp3274930_c0_seq1;GAXK01068869.1;P40809;3.03E-11;RG84C_DROME;GTPase-activating protein RacGAP84C (Protein rotund RacGAP);"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho GTPase binding [GO:0017048]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]";"GO:0001745; GO:0005085; GO:0005096; GO:0007266; GO:0007283; GO:0017048; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]";;"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho GTPase binding [GO:0017048]"
comp327525_c0_seq1;GAXK01188768.1;O96006;1.88E-26;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp327554_c0_seq1;GAXK01205966.1;P0C8G5;6.28E-25;UBC_ASFWA;Ubiquitin-conjugating enzyme E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) (pI215L);"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]";"GO:0005524; GO:0016567; GO:0016740; GO:0030430; GO:0042025";protein ubiquitination [GO:0016567];"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]";"ATP binding [GO:0005524]; transferase activity [GO:0016740]"
comp3276_c0_seq1;GAXK01176647.1;Q6NYS8;4.74E-177;OST48_DANRE;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0005783; GO:0008250; GO:0016021; GO:0018279";protein N-linked glycosylation via asparagine [GO:0018279];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]";
comp32763_c1_seq1;GAXK01017753.1;Q9JLH7;3.17E-67;CK5P3_RAT;CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]";"GO:0000079; GO:0001933; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0007346; GO:0007420; GO:0008283; GO:0010921; GO:0030262; GO:0030968; GO:0031398; GO:0032088; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045664; GO:0071901; GO:1900182; GO:1901798; GO:1903363";"apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]"
comp32769_c0_seq1;GAXK01017883.1;Q16981;1.75E-11;NCS1_APLCA;Neuronal calcium sensor 1 (NCS-1) (Aplycalcin);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp32771_c0_seq1;GAXK01017862.1;Q86TW2;9.79E-167;ADCK1_HUMAN;Uncharacterized aarF domain-containing protein kinase 1 (EC 2.7.11.-);"extracellular region [GO:0005576]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0005576";;extracellular region [GO:0005576];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp327724_c1_seq1;GAXK01188643.1;B4GVM9;1.17E-165;NAAT1_DROPE;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp3277286_c0_seq1;GAXK01180386.1;Q04634;6.66E-116;EF1A_TETPY;Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp32775_c0_seq1;GAXK01018734.1;Q32M08;1.30E-136;DUS4L_MOUSE;tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 4-like);"flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]";"GO:0017150; GO:0050660";;;"flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]"
comp327750_c1_seq1;GAXK01188781.1;Q789F3;1.70E-22;MAF_CHICK;Transcription factor Maf (V-maf musculoaponeurotic fibrosarcoma oncogene homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell development [GO:0048468]; cytokine production [GO:0001816]; inner ear development [GO:0048839]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]";"GO:0000122; GO:0000978; GO:0001228; GO:0001816; GO:0003700; GO:0005634; GO:0005737; GO:0032330; GO:0043565; GO:0048468; GO:0048839; GO:0070306";"cell development [GO:0048468]; cytokine production [GO:0001816]; inner ear development [GO:0048839]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp327781_c0_seq1;GAXK01188790.1;Q9CYF5;7.10E-62;RCC1L_MOUSE;RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein homolog);"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]";"GO:0005085; GO:0005087; GO:0005739; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613";"mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]";"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]"
comp3277858_c0_seq1;GAXK01180393.1;P12659;3.03E-24;HCYA_ENTDO;Hemocyanin A-type, units Ode to Odg (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp3278091_c0_seq1;GAXK01060536.1;P25162;6.93E-47;ACH4_DROME;Acetylcholine receptor subunit beta-like 2 (Nicotinic acetylcholine receptor beta 2);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp32787_c0_seq1;GAXK01017737.1;P34275;6.02E-57;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp327877_c0_seq1;GAXK01188681.1;Q922H2;4.28E-70;PDK3_MOUSE;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp32788_c0_seq1;GAXK01018017.1;Q5XI42;3.58E-153;AL3B1_RAT;Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7);"plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";"GO:0004028; GO:0004030; GO:0005886; GO:0006068; GO:0006081; GO:0018477; GO:0018479";"cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";plasma membrane [GO:0005886];"3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]"
comp3279003_c0_seq1;GAXK01060545.1;A0C767;5.69E-17;T4B_PARTE;"Trichocyst matrix protein T4-B (Secretory granule protein T4-B) (TMP 4-B) [Cleaved into: Trichocyst matrix protein T4-B 1; Trichocyst matrix protein T4-B 2]";trichocyst [GO:0055039];GO:0055039;;trichocyst [GO:0055039];
comp327972_c2_seq1;GAXK01188699.1;G5ECX0;3.67E-07;LPLT2_CAEEL;Latrophilin-like protein LAT-2;"integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";"GO:0004175; GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0030246; GO:0097264";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]";integral component of plasma membrane [GO:0005887];"carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]"
comp3280315_c0_seq1;GAXK01054875.1;Q68F64;4.98E-08;UN45B_XENLA;Protein unc-45 homolog B (Unc-45B);"cytosol [GO:0005829]; cell differentiation [GO:0030154]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]";"GO:0002088; GO:0005829; GO:0007517; GO:0030154";"cell differentiation [GO:0030154]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]";cytosol [GO:0005829];
comp328034_c0_seq1;GAXK01086867.1;B4F6U4;3.74E-32;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp328036_c0_seq1;GAXK01086949.1;Q839J4;2.65E-35;ADD_ENTFA;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0004000; GO:0008270; GO:0009117; GO:0009168";"nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";;"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp328196_c0_seq1;GAXK01086790.1;Q8MQW8;3.48E-57;SPRI_DROME;Protein sprint (SH2 poly-proline-containing Ras-interactor protein);"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688";"axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]"
comp3282_c0_seq1;GAXK01175706.1;Q61245;5.77E-58;COBA1_MOUSE;Collagen alpha-1(XI) chain;"collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]";"GO:0001502; GO:0001503; GO:0002063; GO:0003007; GO:0005201; GO:0005581; GO:0005592; GO:0005615; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0048705; GO:0050910; GO:0051216; GO:0055010; GO:0062023; GO:1904399";"cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]";"collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]"
comp3282211_c0_seq1;GAXK01034180.1;Q6AXZ5;4.54E-20;ZMY10_RAT;Zinc finger MYND domain-containing protein 10;"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"GO:0005737; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505";"inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]";metal ion binding [GO:0046872]
comp3282302_c0_seq1;GAXK01034174.1;P54779;3.27E-15;USP_MANSE;Protein ultraspiracle homolog (Nuclear receptor subfamily 2 group B member 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp32825_c0_seq1;GAXK01017740.1;Q9D415;2.58E-21;DLGP1_MOUSE;Disks large-associated protein 1 (DAP-1) (Guanylate kinase-associated protein) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1) (SAPAP1);"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of postsynaptic density [GO:0098919]; aggresome assembly [GO:0070842]; chemical synaptic transmission [GO:0007268]; protein localization to synapse [GO:0035418]; regulation of proteasomal protein catabolic process [GO:0061136]";"GO:0007268; GO:0014069; GO:0019904; GO:0030054; GO:0035418; GO:0044877; GO:0045202; GO:0045211; GO:0061136; GO:0070842; GO:0098919; GO:0098978; GO:0099092";"aggresome assembly [GO:0070842]; chemical synaptic transmission [GO:0007268]; protein localization to synapse [GO:0035418]; regulation of proteasomal protein catabolic process [GO:0061136]";"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; structural constituent of postsynaptic density [GO:0098919]"
comp328260_c0_seq1;GAXK01086788.1;Q92072;4.64E-15;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp3282981_c0_seq1;GAXK01034175.1;Q63170;2.85E-159;DYH7_RAT;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005509; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp32842_c1_seq1;GAXK01018378.1;A0NDG6;1.91E-143;RUMI_ANOGA;O-glucosyltransferase rumi homolog (EC 2.4.1.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]";"GO:0005576; GO:0005788; GO:0006493; GO:0018242; GO:0035251; GO:0035252; GO:0045747; GO:0046527";"positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]";"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]"
comp3285148_c0_seq1;GAXK01157026.1;Q69Z37;3.79E-23;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp3285248_c0_seq1;GAXK01157027.1;Q6PIL6;1.99E-39;KCIP4_HUMAN;Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; cardiac conduction [GO:0061337]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0061337; GO:0072659; GO:1901379";"cardiac conduction [GO:0061337]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp32854_c6_seq1;GAXK01018553.1;P49010;3.51E-136;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp3285520_c0_seq1;GAXK01157030.1;Q9JLF1;1.08E-11;GBRT_MOUSE;Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp3285870_c0_seq1;GAXK01157025.1;Q9VTG7;1.90E-34;B3G2P_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0005794; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695";"cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"
comp32862_c0_seq1;GAXK01018208.1;P40123;2.47E-55;CAP2_HUMAN;Adenylyl cyclase-associated protein 2 (CAP 2);"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0014069; GO:0030864; GO:0042802";"actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]"
comp3287009_c0_seq1;GAXK01203488.1;O01725;1.98E-16;RLA2_BRAFL;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp328721_c1_seq1;GAXK01205422.1;Q9VRM7;8.03E-93;CP307_DROME;Cytochrome P450 307a1 (EC 1.14.-.-) (CYPCCCVIIA1) (Protein spook);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; central nervous system development [GO:0007417]; cuticle development [GO:0042335]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic digestive tract development [GO:0048566]; head involution [GO:0008258]; midgut development [GO:0007494]; oogenesis [GO:0048477]";"GO:0001700; GO:0004497; GO:0005506; GO:0005783; GO:0005789; GO:0006697; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0016491; GO:0016705; GO:0020037; GO:0042335; GO:0048477; GO:0048566";"central nervous system development [GO:0007417]; cuticle development [GO:0042335]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic digestive tract development [GO:0048566]; head involution [GO:0008258]; midgut development [GO:0007494]; oogenesis [GO:0048477]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]";"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp32874_c0_seq1;GAXK01018743.1;Q15286;2.65E-104;RAB35_HUMAN;Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C);"anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482]";"GO:0000139; GO:0000281; GO:0003924; GO:0005525; GO:0005546; GO:0005829; GO:0005886; GO:0005905; GO:0006886; GO:0008104; GO:0010008; GO:0016197; GO:0019003; GO:0019882; GO:0030665; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0048227; GO:0055038; GO:0070062; GO:0098993; GO:1990090";"antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482]";"anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp3287890_c0_seq1;GAXK01203495.1;O24573;5.25E-70;RLA0_MAIZE;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0034059; GO:0044877; GO:0070180";"cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]"
comp3288370_c0_seq1;GAXK01016205.1;Q9LT77;2.70E-49;RDL2_ARATH;Probable cysteine protease RDL2 (EC 3.4.22.-) (Probable cysteine proteinase At3g19400) (RD21A-like protease 2);"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005829; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp32893_c0_seq1;GAXK01018122.1;Q3ZBT5;2.25E-37;STX7_BOVIN;Syntaxin-7;"azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005770; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0042582; GO:0048278; GO:0048471; GO:0055037; GO:0070820; GO:0070925; GO:1902685; GO:1903076";"intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]";"chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp328974_c0_seq1;GAXK01086965.1;Q08BT9;8.57E-120;P20D1_XENTR;N-fatty-acyl-amino acid synthase/hydrolase PM20D1 (EC 3.5.1.-) (EC 4.3.-.-) (Peptidase M20 domain-containing protein 1);"extracellular space [GO:0005615]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]";"GO:0005615; GO:0006520; GO:0006807; GO:0008233; GO:0016811; GO:0016829; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0097009; GO:1990845; GO:2000275";"adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]";extracellular space [GO:0005615];"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp3289754_c0_seq1;GAXK01016213.1;Q5RB30;3.54E-21;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp328989_c3_seq1;GAXK01086774.1;O00418;7.72E-105;EF2K_HUMAN;Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]";"GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637";"cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]"
comp3290040_c0_seq1;GAXK01145539.1;Q94900;6.17E-14;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3290376_c0_seq1;GAXK01145552.1;Q1H9T6;7.22E-15;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3291594_c0_seq1;GAXK01145544.1;Q9SIP7;1.47E-103;RS31_ARATH;40S ribosomal protein S3-1;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; structural constituent of ribosome [GO:0003735]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"GO:0003684; GO:0003729; GO:0003735; GO:0003906; GO:0005634; GO:0005773; GO:0005774; GO:0005777; GO:0005829; GO:0006281; GO:0006412; GO:0008534; GO:0009506; GO:0009507; GO:0022626; GO:0022627; GO:0032357; GO:0045739";"DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; structural constituent of ribosome [GO:0003735]"
comp329186_c0_seq1;GAXK01086787.1;P37236;3.37E-104;FREQ_DROME;Frequenin-1 (d-FRQ);"membrane [GO:0016020]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0007268; GO:0007269; GO:0007528; GO:0008048; GO:0016020; GO:0046928; GO:0098793";"chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"membrane [GO:0016020]; presynapse [GO:0098793]";"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp329217_c0_seq1;GAXK01086757.1;Q7KRI2;3.34E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp329246_c0_seq1;GAXK01086743.1;A0ZT93;5.55E-08;ISP2_BRASG;Type-2 ice-structuring protein (Type II antifreeze protein) (lpAFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp329296_c0_seq1;GAXK01086868.1;Q8R151;0;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp3293433_c0_seq1;GAXK01041017.1;Q9VZW5;1.30E-11;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3293589_c0_seq1;GAXK01041011.1;Q9C0F3;2.46E-14;ZN436_HUMAN;Zinc finger protein 436;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp329369_c0_seq1;GAXK01086846.1;Q7KRI2;1.94E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp329399_c0_seq1;GAXK01086798.1;P93748;1.18E-21;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp3294_c3_seq1;GAXK01176100.1;Q24407;1.62E-17;ATP5J_DROME;ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"GO:0000276; GO:0005739; GO:0005753; GO:0005756; GO:0015078; GO:0015986; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";proton transmembrane transporter activity [GO:0015078]
comp3294417_c0_seq1;GAXK01157589.1;Q9VZW5;7.92E-09;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3295_c0_seq1;GAXK01176631.1;P24156;1.94E-127;L2CC_DROME;Protein l(2)37Cc;"membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"GO:0005739; GO:0007275; GO:0016020; GO:0071456";"cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"membrane [GO:0016020]; mitochondrion [GO:0005739]";
comp3295217_c0_seq1;GAXK01157587.1;Q80T22;3.19E-10;MFS4B_RAT;Sodium-dependent glucose transporter 1 (rNaGLT1) (Major facilitator superfamily domain-containing protein 4B);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp329526_c0_seq1;GAXK01086866.1;Q9CQT7;4.42E-09;DESI1_MOUSE;Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]";"GO:0005634; GO:0005737; GO:0008233; GO:0042802";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
comp3295301_c0_seq1;GAXK01157590.1;O95863;3.05E-08;SNAI1_HUMAN;Zinc finger protein SNAI1 (Protein snail homolog 1) (Protein sna);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001649; GO:0001707; GO:0001837; GO:0003180; GO:0003198; GO:0005634; GO:0005654; GO:0005721; GO:0005737; GO:0005829; GO:0010718; GO:0010957; GO:0016477; GO:0019900; GO:0030335; GO:0031069; GO:0043518; GO:0045893; GO:0046872; GO:0060021; GO:0060536; GO:0060707; GO:0060806; GO:0060972; GO:0061314; GO:0070828; GO:0070888; GO:1902230; GO:2000810";"aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp329542_c2_seq1;GAXK01086825.1;Q3UV71;3.43E-58;TMTC1_MOUSE;Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]";"GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016021; GO:0035269";"protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp3295897_c0_seq1;GAXK01157598.1;A6QP84;4.50E-18;SOAT_BOVIN;Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]";"GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251";"bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]"
comp32962_c1_seq1;GAXK01017759.1;Q7KRI2;1.83E-32;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3296611_c0_seq1;GAXK01053595.1;Q8MRC9;2.52E-91;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp329666_c1_seq1;GAXK01086771.1;Q7ZXX2;7.72E-148;KIF19_XENLA;Kinesin-like protein KIF19;"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]";"GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0060404; GO:0070462";"axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]";"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]"
comp32968_c0_seq1;GAXK01017767.1;P98158;0;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp32969_c14_seq1;GAXK01205051.1;O96017;4.67E-104;CHK2_HUMAN;Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"GO:0000077; GO:0000086; GO:0001302; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:0090399; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210";"cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]"
comp3297471_c0_seq1;GAXK01053587.1;P37236;1.23E-15;FREQ_DROME;Frequenin-1 (d-FRQ);"membrane [GO:0016020]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0007268; GO:0007269; GO:0007528; GO:0008048; GO:0016020; GO:0046928; GO:0098793";"chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"membrane [GO:0016020]; presynapse [GO:0098793]";"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp329758_c1_seq1;GAXK01086759.1;O61064;3.17E-12;TCT2_PHYPO;Tectonin-2 (Tectonin II);"cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; carbohydrate binding [GO:0030246]";"GO:0009986; GO:0030246; GO:0030659";;"cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]";carbohydrate binding [GO:0030246]
comp329771_c1_seq1;GAXK01086741.1;P34275;3.80E-138;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp3297717_c0_seq1;GAXK01053600.1;P21328;4.66E-27;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp329793_c0_seq1;GAXK01086960.1;A6QR09;2.09E-53;SAMC_BOVIN;S-adenosylmethionine mitochondrial carrier protein (Mitochondrial S-adenosylmethionine transporter) (Solute carrier family 25 member 26);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; S-adenosyl-L-methionine transport [GO:0015805]";"GO:0000095; GO:0005743; GO:0015805; GO:0016021";S-adenosyl-L-methionine transport [GO:0015805];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]
comp329799_c2_seq1;GAXK01086947.1;P55939;1.00E-173;PLDA2_BRAOC;Phospholipase D alpha 2 (PLD 2) (EC 3.1.4.4) (Choline phosphatase 2) (Phosphatidylcholine-hydrolyzing phospholipase D 2);"cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004630; GO:0005509; GO:0005737; GO:0016020; GO:0016042; GO:0046470; GO:0070290";"lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]"
comp3298172_c0_seq1;GAXK01008924.1;P0CT83;2.59E-62;RL12A_SCHPO;60S ribosomal protein L12-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp32983_c0_seq1;GAXK01018220.1;Q6N069;0;NAA16_HUMAN;N-alpha-acetyltransferase 16, NatA auxiliary subunit (NMDA receptor-regulated 1-like protein) (NARG1-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";"GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0017196; GO:0031415; GO:0043022; GO:0043066; GO:0045893; GO:0050821; GO:0070062";"negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";ribosome binding [GO:0043022]
comp3298639_c0_seq1;GAXK01008922.1;Q80SU7;2.74E-10;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp3299157_c0_seq1;GAXK01008935.1;Q8SWR3;1.08E-32;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp32993_c0_seq1;GAXK01018121.1;Q4R347;2.57E-176;CNOT9_MACFA;CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1);"CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]";"GO:0000932; GO:0005634; GO:0006402; GO:0006417; GO:0030014; GO:0031047; GO:0033147; GO:2000327";"gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]";"CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]";
comp3299314_c0_seq1;GAXK01008926.1;P62755;7.59E-113;RS6_RAT;40S ribosomal protein S6;"cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0006412; GO:0022627; GO:0032868; GO:0042593; GO:0071361; GO:1903347";"cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp3299741_c0_seq1;GAXK01008925.1;Q6ZNG0;9.25E-07;ZN620_HUMAN;Zinc finger protein 620;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp329982_c0_seq1;GAXK01086944.1;A0A0G2K309;7.97E-78;ORNT1_RAT;Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; L-ornithine transmembrane transporter activity [GO:0000064]; mitochondrial L-ornithine transmembrane transport [GO:1990575]";"GO:0000064; GO:0005743; GO:0016021; GO:1990575";mitochondrial L-ornithine transmembrane transport [GO:1990575];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";L-ornithine transmembrane transporter activity [GO:0000064]
comp33_c0_seq1;GAXK01169085.1;P02350;5.26E-154;RS31_XENLA;40S ribosomal protein S3-A (EC 4.2.99.18) (S1A);"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp330002_c3_seq1;GAXK01110911.1;P52746;3.57E-15;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3300219_c0_seq1;GAXK01098361.1;Q75W84;1.91E-43;ANR_EISFE;Annetocin receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; oviposition [GO:0018991]";"GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0018991";"G protein-coupled receptor signaling pathway [GO:0007186]; oviposition [GO:0018991]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]"
comp33005_c5_seq1;GAXK01017851.1;Q66IV6;4.48E-22;CH2BB_XENLA;Charged multivesicular body protein 2b-B (Chromatin-modifying protein 2b-B) (CHMP2b-B);"cytosol [GO:0005829]; late endosome membrane [GO:0031902]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]";"GO:0005829; GO:0007034; GO:0015031; GO:0031902";"protein transport [GO:0015031]; vacuolar transport [GO:0007034]";"cytosol [GO:0005829]; late endosome membrane [GO:0031902]";
comp3300681_c0_seq1;GAXK01098369.1;P61129;2.19E-07;ZC3H6_HUMAN;Zinc finger CCCH domain-containing protein 6;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000790; GO:0000981; GO:0001162; GO:0003700; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"
comp3300959_c0_seq1;GAXK01098373.1;D0VWR2;1.36E-30;PSBO_THEVL;Photosystem II manganese-stabilizing polypeptide (MSP);"photosystem II oxygen evolving complex [GO:0009654]; oxygen evolving activity [GO:0010242]; photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";"GO:0009654; GO:0010207; GO:0010242; GO:0042549";"photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";photosystem II oxygen evolving complex [GO:0009654];oxygen evolving activity [GO:0010242]
comp3301795_c0_seq1;GAXK01098355.1;P13596;9.78E-07;NCAM1_RAT;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56);"glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]";"GO:0005104; GO:0005886; GO:0007155; GO:0007413; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0010035; GO:0010288; GO:0014012; GO:0014823; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030426; GO:0031100; GO:0033555; GO:0042220; GO:0042493; GO:0043025; GO:0048666; GO:0050804; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241; GO:0098685; GO:0098978; GO:0099055; GO:0099056";"aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]";"glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]"
comp3302156_c0_seq1;GAXK01197933.1;Q6ZSM3;7.63E-13;MOT12_HUMAN;Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp3302265_c0_seq1;GAXK01197923.1;Q93126;1.86E-11;GPR9_AMPAM;Probable G-protein coupled receptor No9;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]";"GO:0004935; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";adrenergic receptor activity [GO:0004935]
comp330250_c2_seq1;GAXK01205519.1;Q9PWL5;3.96E-27;HXA4A_DANRE;Homeobox protein Hox-A4a (Homeobox protein Zf-26) (Hoxx4);"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; skeletal system development [GO:0001501]";"GO:0000977; GO:0001228; GO:0001501; GO:0005634; GO:0009952; GO:0033613; GO:0048704";"anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; skeletal system development [GO:0001501]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3302696_c0_seq1;GAXK01197929.1;P35875;2.43E-12;PARP_DROME;Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase Parp) (EC 2.4.2.-);"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"GO:0003677; GO:0003950; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0005719; GO:0005730; GO:0006302; GO:0006325; GO:0006355; GO:0006471; GO:0006963; GO:0007000; GO:0007552; GO:0008069; GO:0008270; GO:0009303; GO:0015030; GO:0030576; GO:0035079; GO:0035080; GO:0035363; GO:0042393; GO:0043484; GO:0045087; GO:0051276; GO:0051287; GO:0051457; GO:0070212; GO:1900182; GO:1990404";"Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp3303589_c0_seq1;GAXK01197918.1;Q5R9A7;1.58E-08;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp330412_c0_seq1;GAXK01110835.1;Q93243;2.36E-07;NAS37_CAEEL;Zinc metalloproteinase nas-37 (EC 3.4.24.-) (Nematode astacin 37);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996; GO:0040002; GO:0042395";"collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3304353_c0_seq1;GAXK01080993.1;Q9NZJ4;9.60E-74;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp3304463_c0_seq1;GAXK01080998.1;O43934;3.52E-35;MFS11_HUMAN;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp330449_c0_seq1;GAXK01110836.1;O00391;1.39E-68;QSOX1_HUMAN;Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6);"endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; post-translational protein modification [GO:0043687]";"GO:0000139; GO:0002576; GO:0003756; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0016242; GO:0016971; GO:0030173; GO:0031093; GO:0035580; GO:0043231; GO:0043312; GO:0043687; GO:0044267; GO:0045171; GO:0045454; GO:0070062; GO:0071949; GO:0085029; GO:1904724";"cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; post-translational protein modification [GO:0043687]";"endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]";"FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]"
comp3305105_c0_seq1;GAXK01081017.1;P51030;6.81E-30;WNT8C_CHICK;Protein Wnt-8c (CWnt-8);"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0035116; GO:0045165; GO:0045743; GO:0060173; GO:0060828; GO:0090270";"cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp330526_c0_seq1;GAXK01110906.1;P41942;8.61E-32;YKB4_CAEEL;Uncharacterized protein B0272.4;"peroxisome [GO:0005777]; isomerase activity [GO:0016853]";"GO:0005777; GO:0016853";;peroxisome [GO:0005777];isomerase activity [GO:0016853]
comp3305694_c0_seq1;GAXK01080992.1;Q9VZW5;1.01E-25;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp330580_c0_seq1;GAXK01110847.1;C9D7R3;1.04E-16;VMPA3_LOXIN;Astacin-like metalloprotease toxin 3 (EC 3.4.24.-) (Loxosceles astacin-like protease 3) (LALP3);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270; GO:0090729";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]"
comp330603_c2_seq1;GAXK01110903.1;O02367;2.06E-42;CALM_CIOIN;Calmodulin (CaM) (Ci-CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3306290_c0_seq1;GAXK01023039.1;Q29H56;5.19E-09;MAB21_DROPS;Protein mab-21;;;;;
comp3306677_c0_seq1;GAXK01023054.1;Q9D074;2.35E-08;MGRN1_MOUSE;E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING-type E3 ubiquitin transferase MGRN1);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006513; GO:0008333; GO:0016567; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0061630";"endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp3306987_c0_seq1;GAXK01023042.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3307509_c0_seq1;GAXK01023043.1;P15043;4.09E-07;RECQ_ECOLI;ATP-dependent DNA helicase RecQ (EC 3.6.4.12);"bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"GO:0003677; GO:0003678; GO:0005524; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0043138; GO:0043590; GO:0046914";"cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]";"3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]"
comp3308_c0_seq1;GAXK01175665.1;Q6GL69;3.25E-33;MK67I_XENTR;MKI67 FHA domain-interacting nucleolar phosphoprotein-like;"nucleolus [GO:0005730]; RNA binding [GO:0003723]";"GO:0003723; GO:0005730";;nucleolus [GO:0005730];RNA binding [GO:0003723]
comp33084_c0_seq1;GAXK01018109.1;Q9VEN1;0;FLNA_DROME;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1);"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495";"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp3308706_c0_seq1;GAXK01044995.1;Q29J90;9.81E-11;MOODY_DROPS;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp3309000_c0_seq1;GAXK01044978.1;Q20065;3.41E-13;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp3309784_c0_seq1;GAXK01045009.1;P10751;3.69E-16;ZFP11_MOUSE;Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3310321_c0_seq1;GAXK01152618.1;O00748;6.10E-08;EST2_HUMAN;Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]";"GO:0005615; GO:0005783; GO:0005788; GO:0006693; GO:0006805; GO:0009056; GO:0047374; GO:0052689; GO:0080030";"catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]";"carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]"
comp3310335_c0_seq1;GAXK01152614.1;P34960;1.02E-23;MMP12_MOUSE;Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter binding [GO:0001047]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; wound healing, spreading of epidermal cells [GO:0035313]";"GO:0000122; GO:0001047; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0035313; GO:0043565; GO:0045944; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0098586; GO:1901163; GO:1902741; GO:1904905";"cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; wound healing, spreading of epidermal cells [GO:0035313]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter binding [GO:0001047]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp3310371_c0_seq1;GAXK01152623.1;Q9Y2H6;6.50E-30;FND3A_HUMAN;Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts);"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"GO:0000139; GO:0001669; GO:0003723; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0016021; GO:0060009; GO:0098609";"cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vesicle membrane [GO:0012506]";RNA binding [GO:0003723]
comp3310380_c0_seq1;GAXK01152631.1;Q504L7;7.83E-09;ZN574_RAT;Zinc finger protein 574;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3311048_c0_seq1;GAXK01152613.1;Q8N6F8;5.95E-12;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp331112_c1_seq1;GAXK01110895.1;Q1JPA0;1.11E-16;AL3B1_BOVIN;Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7);"plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";"GO:0004028; GO:0004030; GO:0005886; GO:0006068; GO:0006081; GO:0018477; GO:0018479";"cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]";plasma membrane [GO:0005886];"3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]"
comp33116_c0_seq1;GAXK01017786.1;Q9VFP2;0;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp33117_c4_seq1;GAXK01018134.1;A4VCL2;1.14E-167;FA20C_DROME;Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK);"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]";"GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872";protein phosphorylation [GO:0006468];"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp33123_c0_seq1;GAXK01018653.1;Q9CTY5;5.75E-103;MICU3_MOUSE;Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851]";"GO:0005509; GO:0005739; GO:0006851; GO:0016021";mitochondrial calcium ion transmembrane transport [GO:0006851];"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";calcium ion binding [GO:0005509]
comp33124_c0_seq1;GAXK01017726.1;Q8N448;3.35E-67;LNX2_HUMAN;Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1);"metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein homooligomerization [GO:0051260]";"GO:0030165; GO:0046872; GO:0051260";protein homooligomerization [GO:0051260];;"metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]"
comp331261_c1_seq1;GAXK01110942.1;P58215;1.46E-65;LOXL3_HUMAN;Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046";"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp331291_c1_seq1;GAXK01110909.1;P31319;1.41E-111;KAPR_APLCA;cAMP-dependent protein kinase regulatory subunit (N4 subunit of protein kinase A);"cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]";"GO:0005952; GO:0008603; GO:0030552";;cAMP-dependent protein kinase complex [GO:0005952];"cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp3312960_c0_seq1;GAXK01116351.1;Q9ULS6;1.62E-08;KCNS2_HUMAN;Potassium voltage-gated channel subfamily S member 2 (Delayed-rectifier K(+) channel alpha subunit 2) (Voltage-gated potassium channel subunit Kv9.2);"integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259]";"GO:0005249; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0048471; GO:0051260; GO:0071805; GO:1902259";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259]";"integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";voltage-gated potassium channel activity [GO:0005249]
comp3313112_c0_seq1;GAXK01116364.1;Q9VBW3;1.06E-10;CAD96_DROME;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0008284; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp3313194_c0_seq1;GAXK01116356.1;O57382;5.14E-19;TLL2_XENLA;Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3313256_c0_seq1;GAXK01116358.1;Q9XTY1;1.73E-08;GCY22_CAEEL;Receptor-type guanylate cyclase gcy-22 (EC 4.6.1.2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; associative learning [GO:0008306]; cGMP biosynthetic process [GO:0006182]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; positive regulation of calcium-mediated signaling [GO:0050850]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007635; GO:0008306; GO:0010035; GO:0010226; GO:0016021; GO:0032026; GO:0035556; GO:0050850; GO:1902074; GO:1904640";"associative learning [GO:0008306]; cGMP biosynthetic process [GO:0006182]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; positive regulation of calcium-mediated signaling [GO:0050850]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp33133_c1_seq1;GAXK01017739.1;Q91755;9.61E-32;GRIK2_XENLA;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]";"GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]"
comp3313569_c0_seq1;GAXK01116352.1;P23098;5.43E-99;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3313586_c0_seq1;GAXK01116359.1;Q9QYP1;1.23E-07;LRP4_RAT;Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp3313708_c0_seq1;GAXK01116376.1;Q8WTS6;4.18E-10;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp331396_c0_seq1;GAXK01110828.1;Q28FF3;9.18E-32;S49A3_XENTR;Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp3314007_c0_seq1;GAXK01098719.1;Q03685;2.41E-56;BIP5_TOBAC;Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp3314140_c0_seq1;GAXK01098728.1;Q12766;2.72E-07;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp3314216_c0_seq1;GAXK01098727.1;Q08277;1.11E-78;HSP82_MAIZE;Heat shock protein 82;"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082";"cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp331526_c0_seq1;GAXK01110893.1;Q9YHZ5;2.99E-59;PIM2_DANRE;Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Kinase pim-1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007346; GO:0030097; GO:0043066; GO:0046777";"apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp33153_c5_seq1;GAXK01018637.1;Q92793;0;CBP_HUMAN;CREB-binding protein (EC 2.3.1.48);"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"GO:0000122; GO:0000123; GO:0000790; GO:0000987; GO:0001085; GO:0001102; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0006473; GO:0007165; GO:0007219; GO:0007221; GO:0008134; GO:0008270; GO:0008589; GO:0016032; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0019216; GO:0030511; GO:0031648; GO:0032481; GO:0034644; GO:0042592; GO:0042733; GO:0042981; GO:0043426; GO:0045637; GO:0045747; GO:0045893; GO:0045944; GO:0048511; GO:0061418; GO:0065003; GO:1900034; GO:1904837";"beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; protein destabilization [GO:0031648]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp3315520_c0_seq1;GAXK01098712.1;Q9ULI1;3.17E-26;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp331654_c0_seq1;GAXK01110902.1;O22527;5.53E-10;CLH1_ARATH;Chlorophyllase-1 (AtCLH1) (EC 3.1.1.14) (Chlorophyll-chlorophyllido hydrolase 1) (Chlase 1) (Coronatine-induced protein 1) (CORI1);"nucleus [GO:0005634]; vacuole [GO:0005773]; chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]; chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"GO:0005634; GO:0005773; GO:0015996; GO:0042742; GO:0047746; GO:0050832; GO:0102293";"chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"nucleus [GO:0005634]; vacuole [GO:0005773]";"chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]"
comp33166_c2_seq1;GAXK01017856.1;Q4KML2;0;CRYD_DANRE;Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH);"damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]";"GO:0000719; GO:0003684; GO:0003904; GO:0018298; GO:0050660";"photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]";;"damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; flavin adenine dinucleotide binding [GO:0050660]"
comp3316786_c0_seq1;GAXK01164027.1;P08570;2.00E-15;RLA1_DROME;60S acidic ribosomal protein P1 (Acidic ribosomal protein RPA2) (RP21C);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0043021";"cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp3316791_c0_seq1;GAXK01164041.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp331698_c0_seq1;GAXK01110937.1;Q6PHS6;1.42E-86;SNX13_MOUSE;Sorting nexin-13;"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]";"GO:0005769; GO:0006886; GO:0009968; GO:0031901; GO:0032266; GO:0035091; GO:0043547";"intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]";"early endosome [GO:0005769]; early endosome membrane [GO:0031901]";"phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]"
comp3317113_c0_seq1;GAXK01164040.1;Q8IVG5;3.05E-22;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp331719_c0_seq1;GAXK01110926.1;Q6GNP2;2.47E-18;Z652A_XENLA;Zinc finger protein 652-A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3317533_c0_seq1;GAXK01164031.1;Q6DDL7;2.14E-36;UN93A_XENLA;Protein unc-93 homolog A (Unc-93A);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3317869_c0_seq1;GAXK01164033.1;P36415;8.37E-58;HS7C1_DICDI;Heat shock cognate 70 kDa protein 1 (HSC70-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006986; GO:0016887; GO:0031012; GO:0031072; GO:0031982; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0045335; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp3318054_c0_seq1;GAXK01060117.1;Q08875;5.14E-17;SUHW_DROAN;Protein suppressor of hairy wing;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp33182_c0_seq1;GAXK01017754.1;Q9CQR4;6.86E-36;ACO13_MOUSE;Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Thioesterase superfamily member 2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]";"GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0047617; GO:0051289; GO:0120163";"negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]";acyl-CoA hydrolase activity [GO:0047617]
comp331858_c0_seq1;GAXK01110930.1;Q09103;0;DGK2_DROME;Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein);"membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872";"deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";membrane [GO:0016020];"ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp3318680_c0_seq1;GAXK01060110.1;P91119;1.16E-34;PDE5_CAEEL;Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17);"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";"GO:0004114; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";;"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"
comp3318760_c0_seq1;GAXK01060105.1;Q9SWE7;4.69E-53;VATE_CITLI;V-type proton ATPase subunit E (V-ATPase subunit E) (ClVE-1) (Vacuolar proton pump subunit E);"proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0033178; GO:0046961";;proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178];proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp3319227_c0_seq1;GAXK01060113.1;Q8N9N7;1.98E-19;LRC57_HUMAN;Leucine-rich repeat-containing protein 57;"extracellular exosome [GO:0070062]; membrane [GO:0016020]";"GO:0016020; GO:0070062";;"extracellular exosome [GO:0070062]; membrane [GO:0016020]";
comp331949_c0_seq1;GAXK01110842.1;Q9DE14;0;ATR_XENLA;Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein);"PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]";"GO:0003677; GO:0004674; GO:0005524; GO:0006281; GO:0016605; GO:0018105; GO:0046982";"DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]";PML body [GO:0016605];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]"
comp3319612_c0_seq1;GAXK01060115.1;Q9URT8;2.12E-29;RL34B_SCHPO;60S ribosomal protein L34-B (60S ribosomal protein L34-2);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0022625; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp3319630_c0_seq1;GAXK01060114.1;P83373;1.31E-105;MDHM_FRAAN;Malate dehydrogenase, mitochondrial (EC 1.1.1.37);"mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0005759; GO:0005975; GO:0006099; GO:0006108; GO:0030060";"carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];L-malate dehydrogenase activity [GO:0030060]
comp332_c0_seq1;GAXK01168694.1;P00507;0;AATM_RAT;Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A);"cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]";"GO:0004069; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006520; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007565; GO:0007595; GO:0009986; GO:0014850; GO:0015908; GO:0016212; GO:0016597; GO:0019550; GO:0019551; GO:0019899; GO:0030170; GO:0030315; GO:0031406; GO:0032868; GO:0032991; GO:0042383; GO:0042803; GO:0043204; GO:0043278; GO:0043648; GO:0045471";"2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]";"cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]";"amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]"
comp3320349_c0_seq1;GAXK01123651.1;P93099;8.01E-79;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp332041_c0_seq1;GAXK01119611.1;Q0II73;3.07E-46;CBPO_BOVIN;Carboxypeptidase O (CPO) (EC 3.4.17.-);"anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016324; GO:0046658";proteolysis [GO:0006508];"anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp3320583_c0_seq1;GAXK01123646.1;P10993;1.24E-55;ACT2_TETPY;Actin, cytoplasmic (Actin, micronuclear);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp3321424_c0_seq1;GAXK01123647.1;B2FQP3;1.76E-19;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp33218_c0_seq1;GAXK01017857.1;O76767;1.25E-14;ERD2_DROME;ER lumen protein-retaining receptor;"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]";"GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0015031; GO:0016021";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";KDEL sequence binding [GO:0005046]
comp332184_c2_seq1;GAXK01119557.1;D4A2K4;4.87E-16;KLH21_RAT;Kelch-like protein 21;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; polar microtubule [GO:0005827]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]";"GO:0004842; GO:0005737; GO:0005827; GO:0007049; GO:0016567; GO:0031463; GO:0032465; GO:0035853; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; polar microtubule [GO:0005827]";ubiquitin-protein transferase activity [GO:0004842]
comp3321896_c0_seq1;GAXK01123639.1;Q60FS1;4.99E-59;TCTP_PLUXY;Translationally-controlled tumor protein homolog (TCTP);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp3321954_c0_seq1;GAXK01123657.1;P92133;5.26E-50;CATB3_GIAIN;Cathepsin B-like CP3 (EC 3.4.22.-) (Cathepsin B-like protease B3);"vacuole [GO:0005773]; cysteine-type peptidase activity [GO:0008234]";"GO:0005773; GO:0008234";;vacuole [GO:0005773];cysteine-type peptidase activity [GO:0008234]
comp332204_c0_seq1;GAXK01119658.1;Q7ZWG6;8.84E-20;PCFT_DANRE;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp3322444_c0_seq1;GAXK01143172.1;Q9P225;1.06E-58;DYH2_HUMAN;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp332278_c1_seq1;GAXK01119606.1;Q7PQ25;7.77E-48;CCDCX_ANOGA;Coiled-coil domain-containing protein AGAP005037;;;;;
comp3322897_c0_seq1;GAXK01143180.1;P30974;5.03E-92;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp3324_c1_seq1;GAXK01175775.1;Q803I8;6.55E-170;SYVN1_DANRE;E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1);"endomembrane system [GO:0012505]; Hrd1p ubiquitin ligase complex [GO:0000836]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ERAD pathway [GO:0036503]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000836; GO:0006511; GO:0012505; GO:0016021; GO:0018279; GO:0030433; GO:0036503; GO:0046872; GO:0061630";"ERAD pathway [GO:0036503]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"endomembrane system [GO:0012505]; Hrd1p ubiquitin ligase complex [GO:0000836]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp332429_c0_seq1;GAXK01119511.1;A1K471;4.31E-07;RLMM_AZOSB;Ribosomal RNA large subunit methyltransferase M (EC 2.1.1.186) (23S rRNA (cytidine2498-2'-O)-methyltransferase) (23S rRNA 2'-O-ribose methyltransferase RlmM);"cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; rRNA processing [GO:0006364]";"GO:0005737; GO:0006364; GO:0008757";rRNA processing [GO:0006364];cytoplasm [GO:0005737];S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]
comp332458_c2_seq1;GAXK01119572.1;P39769;8.92E-09;PHP_DROME;Polyhomeotic-proximal chromatin protein;"nucleolus [GO:0005730]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; central nervous system neuron development [GO:0021954]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell stalk formation [GO:0030713]; response to ecdysone [GO:0035075]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"GO:0000070; GO:0003677; GO:0003682; GO:0005634; GO:0005730; GO:0008270; GO:0016458; GO:0021954; GO:0030708; GO:0030713; GO:0035075; GO:0035102; GO:0035186; GO:0043565; GO:0044547; GO:0045892; GO:0051087";"central nervous system neuron development [GO:0021954]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell stalk formation [GO:0030713]; response to ecdysone [GO:0035075]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]";"chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp332474_c0_seq1;GAXK01119568.1;Q80WV7;5.05E-08;SRRM3_MOUSE;Serine/arginine repetitive matrix protein 3;mRNA binding [GO:0003729];GO:0003729;;;mRNA binding [GO:0003729]
comp332476_c0_seq1;GAXK01119473.1;Q0VD19;2.19E-130;ASM_BOVIN;Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase);"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]";"GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750";"ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]";"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp3324764_c0_seq1;GAXK01055784.1;P28724;2.27E-84;DHE4_GIAIN;NADP-specific glutamate dehydrogenase (NADP-GDH) (EC 1.4.1.4) (NADP-dependent glutamate dehydrogenase);"glutamate dehydrogenase (NADP+) activity [GO:0004354]; cellular amino acid metabolic process [GO:0006520]";"GO:0004354; GO:0006520";cellular amino acid metabolic process [GO:0006520];;glutamate dehydrogenase (NADP+) activity [GO:0004354]
comp3325898_c0_seq1;GAXK01055793.1;Q5K651;2.41E-17;SAMD9_HUMAN;Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005829; GO:0034058; GO:0043231";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]";
comp3326002_c0_seq1;GAXK01041758.1;Q9P6I5;6.04E-61;KGUA_SCHPO;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GMP metabolic process [GO:0046037]; GTP biosynthetic process [GO:0006183]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006163; GO:0006183; GO:0046037";"GMP metabolic process [GO:0046037]; GTP biosynthetic process [GO:0006183]; purine nucleotide metabolic process [GO:0006163]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp3326018_c0_seq1;GAXK01041755.1;Q802Y8;1.44E-07;ZB16A_DANRE;Zinc finger and BTB domain-containing protein 16-A (Promyelocytic leukemia zinc finger protein-A) (Zinc finger protein PLZF-A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"GO:0003677; GO:0005634; GO:0005737; GO:0016567; GO:0032481; GO:0046872; GO:0050767";"positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3326201_c0_seq1;GAXK01041747.1;P77968;1.41E-86;SODF_SYNY3;Superoxide dismutase [Fe] (EC 1.15.1.1);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005829; GO:0046872";;cytosol [GO:0005829];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp3326856_c0_seq1;GAXK01041762.1;Q9NU22;1.34E-16;MDN1_HUMAN;Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein);"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016020; GO:0016887; GO:0045111; GO:0051082; GO:0065003";"protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3326943_c0_seq1;GAXK01041749.1;P83088;1.17E-23;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp3326981_c0_seq1;GAXK01041764.1;Q3U4G3;1.00E-09;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp33275_c8_seq1;GAXK01018520.1;Q6A4L0;2.41E-50;S22AD_MOUSE;Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; nicotinate transmembrane transporter activity [GO:0090416]; nicotinate transport [GO:2001142]; urate transport [GO:0015747]";"GO:0015747; GO:0016021; GO:0016324; GO:0090416; GO:2001142";"nicotinate transport [GO:2001142]; urate transport [GO:0015747]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";nicotinate transmembrane transporter activity [GO:0090416]
comp3327843_c0_seq1;GAXK01041763.1;Q9W6X9;2.44E-64;RS24_ORYLA;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3327942_c0_seq1;GAXK01041751.1;O15228;2.13E-60;GNPAT_HUMAN;Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase);"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; protein targeting to peroxisome [GO:0006625]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]";"GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0006654; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0016020; GO:0016287; GO:0016290; GO:0021587; GO:0030913; GO:0031966; GO:0042493; GO:0042594; GO:0061024; GO:0070542";"cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; protein targeting to peroxisome [GO:0006625]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]";"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp3328088_c0_seq1;GAXK01198593.1;A5B4K1;4.62E-99;RS3A1_VITVI;40S ribosomal protein S3a-1;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp3328310_c0_seq1;GAXK01198591.1;F7J220;5.15E-12;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp3328427_c0_seq1;GAXK01198579.1;Q6GNV7;1.34E-21;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp3328559_c0_seq1;GAXK01198581.1;A4II46;3.03E-59;ABR_XENTR;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp3329_c0_seq1;GAXK01175876.1;P34454;2.33E-27;YMA9_CAEEL;Uncharacterized protein F54F2.9;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]";"GO:0003677; GO:0016021; GO:0031965";;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";DNA binding [GO:0003677]
comp3329552_c0_seq1;GAXK01198588.1;Q7TNC8;8.82E-21;GLRA2_MOUSE;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp3330_c0_seq1;GAXK01175800.1;P20478;0;GLNA2_DROME;Glutamine synthetase 2 cytoplasmic (EC 6.3.1.2) (Glutamate--ammonia ligase 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";"GO:0004356; GO:0005524; GO:0005737; GO:0006538; GO:0006542; GO:0007416; GO:0045213";"glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]"
comp33302_c2_seq1;GAXK01018579.1;Q8BTK5;1.12E-27;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp333025_c0_seq1;GAXK01119571.1;Q5TYP8;2.28E-08;STUM_DANRE;Protein stum homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3330296_c0_seq1;GAXK01120916.1;A8VU90;1.31E-42;ANKL1_MOUSE;Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of mitotic recombination [GO:0045950]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]";"GO:0004519; GO:0005634; GO:0005737; GO:0006611; GO:0006974; GO:0045950; GO:1905453; GO:1905456; GO:2001022";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of mitotic recombination [GO:0045950]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";endonuclease activity [GO:0004519]
comp3330520_c0_seq1;GAXK01120892.1;P41127;1.46E-51;RL131_ARATH;60S ribosomal protein L13-1 (Protein BBC1 homolog);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp3330535_c0_seq1;GAXK01120915.1;Q9SIP7;3.44E-92;RS31_ARATH;40S ribosomal protein S3-1;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; structural constituent of ribosome [GO:0003735]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"GO:0003684; GO:0003729; GO:0003735; GO:0003906; GO:0005634; GO:0005773; GO:0005774; GO:0005777; GO:0005829; GO:0006281; GO:0006412; GO:0008534; GO:0009506; GO:0009507; GO:0022626; GO:0022627; GO:0032357; GO:0045739";"DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; structural constituent of ribosome [GO:0003735]"
comp3330762_c0_seq1;GAXK01120909.1;Q95MH6;2.03E-09;GNRR2_CHLAE;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gonadotropin-releasing hormone receptor activity [GO:0004968]";"GO:0004968; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gonadotropin-releasing hormone receptor activity [GO:0004968]
comp333125_c2_seq1;GAXK01119657.1;Q20065;1.77E-43;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp333131_c0_seq1;GAXK01119616.1;P91622;5.92E-92;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp3331498_c0_seq1;GAXK01120910.1;P81429;2.80E-23;EST1_SCHGA;Esterase SG1 (EC 3.1.1.1) (Carboxylic-ester hydrolase) (Fragment);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp3331675_c0_seq1;GAXK01120898.1;P19476;9.06E-23;CR29_ENTHI;Putative peroxiredoxin (EC 1.11.1.15) (29 kDa cysteine-rich surface antigen) (Thioredoxin peroxidase);"plasma membrane [GO:0005886]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005886; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];plasma membrane [GO:0005886];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp3332045_c0_seq1;GAXK01054785.1;Q91740;6.29E-09;FINC_XENLA;Fibronectin (FN);"extracellular region [GO:0005576]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]";"GO:0005576; GO:0006953; GO:0007155; GO:0008201; GO:0008360";"acute-phase response [GO:0006953]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]";extracellular region [GO:0005576];heparin binding [GO:0008201]
comp3332390_c0_seq1;GAXK01054788.1;Q9NX52;8.21E-24;RHBL2_HUMAN;"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3332630_c0_seq1;GAXK01054806.1;Q8IXV7;7.81E-14;KLD8B_HUMAN;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp3333410_c0_seq1;GAXK01054803.1;P16157;1.59E-29;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp3333897_c0_seq1;GAXK01054792.1;P54281;1.67E-14;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3334_c1_seq1;GAXK01175880.1;Q9C551;4.89E-136;RH5_ARATH;DEAD-box ATP-dependent RNA helicase 5 (EC 3.6.4.13);"cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005829; GO:0006364";rRNA processing [GO:0006364];"cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp333414_c4_seq1;GAXK01119578.1;O44997;1.68E-42;DAPK_CAEEL;Death-associated protein kinase dapk-1 (EC 2.7.11.1);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005525; GO:0005634; GO:0005829; GO:0005856; GO:0007165; GO:0007275; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp33342_c0_seq1;GAXK01018108.1;A1Z9L3;0;DHX8_DROME;ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]";"GO:0000381; GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0030261; GO:0034458; GO:0048477; GO:0071011; GO:0071013";"chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp33344_c0_seq1;GAXK01018367.1;Q8TC21;1.21E-33;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp333468_c0_seq1;GAXK01119639.1;Q9UL36;8.17E-10;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3334977_c0_seq1;GAXK01150039.1;P34144;9.08E-68;RAC1A_DICDI;Rho-related protein rac1A;"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of actin filament polymerization [GO:0030838]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000281; GO:0001891; GO:0003924; GO:0005525; GO:0005737; GO:0005811; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016601; GO:0019901; GO:0030036; GO:0030838; GO:0032956; GO:0042995; GO:0045335; GO:0048471";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of actin filament polymerization [GO:0030838]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp3335074_c0_seq1;GAXK01150032.1;P14381;2.28E-13;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp33354_c2_seq1;GAXK01018129.1;P48612;6.37E-71;PELO_DROME;Protein pelota (EC 3.1.-.-);"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]";"GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0043022; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533";"compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]";"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]";"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]"
comp33355_c1_seq1;GAXK01018115.1;Q9XZT6;1.76E-58;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp3335694_c0_seq1;GAXK01150038.1;P33442;2.00E-57;RS3A1_YEAST;40S ribosomal protein S1-A (RP10A) (Small ribosomal subunit protein eS1-A);"90S preribosome [GO:0030686]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0002181; GO:0003735; GO:0005829; GO:0022627; GO:0030686";"cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"90S preribosome [GO:0030686]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp33359_c1_seq1;GAXK01017763.1;Q8VEH8;3.55E-108;ERLEC_MOUSE;Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin);"endoplasmic reticulum lumen [GO:0005788]; unfolded protein binding [GO:0051082]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005788; GO:0030433; GO:0030970; GO:0051082; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";endoplasmic reticulum lumen [GO:0005788];unfolded protein binding [GO:0051082]
comp33361_c0_seq1;GAXK01017741.1;Q12834;5.48E-147;CDC20_HUMAN;Cell division cycle protein 20 homolog (p55CDC);"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activator activity [GO:0097027]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000922; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007064; GO:0007094; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:0097027; GO:1901990; GO:1904668";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]";"anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activator activity [GO:0097027]"
comp333638_c0_seq1;GAXK01119494.1;Q9BWE0;8.84E-07;REPI1_HUMAN;Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464);"nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260]";"GO:0003677; GO:0003723; GO:0005634; GO:0005664; GO:0006260; GO:0046872";DNA replication [GO:0006260];"nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp3336389_c0_seq1;GAXK01133994.1;Q8VHE6;1.15E-22;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp33368_c0_seq1;GAXK01017848.1;Q8IGJ0;5.42E-173;EFR3_DROME;Protein EFR3 homolog cmp44E (Conserved membrane protein at 44E) (Protein stambha A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; bulk synaptic vesicle endocytosis [GO:0150008]; chemical synaptic transmission [GO:0007268]; mitotic cytokinesis [GO:0000281]; phototransduction [GO:0007602]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000281; GO:0005886; GO:0007268; GO:0007602; GO:0016021; GO:0016079; GO:0045202; GO:0048488; GO:0072659; GO:0098793; GO:0150008";"bulk synaptic vesicle endocytosis [GO:0150008]; chemical synaptic transmission [GO:0007268]; mitotic cytokinesis [GO:0000281]; phototransduction [GO:0007602]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]";
comp333680_c0_seq1;GAXK01119501.1;Q9WTN6;1.95E-56;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp333716_c0_seq1;GAXK01119466.1;Q0KIA2;8.69E-60;Y9801_DROME;PP2C-like domain-containing protein CG9801;catalytic activity [GO:0003824];GO:0003824;;;catalytic activity [GO:0003824]
comp3337725_c0_seq1;GAXK01133989.1;O75762;8.09E-07;TRPA1_HUMAN;Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"GO:0005886; GO:0005887; GO:0006811; GO:0007166; GO:0009409; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070588; GO:0097604";"calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]";"calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]"
comp3338086_c0_seq1;GAXK01136597.1;P11147;2.02E-66;HSP7D_DROME;Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"GO:0000398; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0016887; GO:0030707; GO:0031072; GO:0034605; GO:0034620; GO:0035967; GO:0042026; GO:0042623; GO:0044183; GO:0048471; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0097753; GO:0098793; GO:0106161";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp333814_c0_seq1;GAXK01119508.1;P91622;5.83E-100;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp3338314_c0_seq1;GAXK01136593.1;Q8TE73;9.24E-32;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp3338950_c0_seq1;GAXK01136594.1;Q9ZT94;1.30E-18;POLR2_ARATH;"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3339021_c0_seq1;GAXK01136586.1;Q9P2E3;1.22E-35;ZNFX1_HUMAN;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp333906_c2_seq1;GAXK01119660.1;Q5JJ64;9.23E-28;Y1782_THEKO;Uncharacterized serpin-like protein TK1782;"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp333922_c1_seq1;GAXK01119512.1;P98163;1.05E-07;YL_DROME;Putative vitellogenin receptor (Protein yolkless) (YL);"coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]";"GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477";oogenesis [GO:0048477];"coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]"
comp3339543_c0_seq1;GAXK01136603.1;Q8N5T2;5.11E-11;TBC19_HUMAN;TBC1 domain family member 19;GTPase activator activity [GO:0005096];GO:0005096;;;GTPase activator activity [GO:0005096]
comp333980_c1_seq1;GAXK01119652.1;P00768;2.10E-36;CTR2_VESOR;Chymotrypsin-2 (EC 3.4.21.1) (Chymotrypsin II);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp3340001_c0_seq1;GAXK01004628.1;Q6DCW1;1.15E-08;GFI1B_XENLA;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0006325; GO:0007275; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3340457_c0_seq1;GAXK01004634.1;Q9WVM6;1.59E-24;TLL2_MOUSE;Tolloid-like protein 2 (EC 3.4.24.-);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";"GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154; GO:0048632";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3340781_c0_seq1;GAXK01004633.1;Q90YQ4;1.14E-40;RS19_ICTPU;40S ribosomal protein S19;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; brain segmentation [GO:0035284]; chordate embryonic development [GO:0043009]; erythrocyte development [GO:0048821]; hemoglobin biosynthetic process [GO:0042541]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of erythrocyte differentiation [GO:0045646]; regulation of innate immune response [GO:0045088]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0035284; GO:0042541; GO:0043009; GO:0045088; GO:0045646; GO:0048821; GO:0072332";"brain segmentation [GO:0035284]; chordate embryonic development [GO:0043009]; erythrocyte development [GO:0048821]; hemoglobin biosynthetic process [GO:0042541]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of erythrocyte differentiation [GO:0045646]; regulation of innate immune response [GO:0045088]; translation [GO:0006412]";ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3341_c1_seq1;GAXK01175171.1;P47856;0;GFPT1_MOUSE;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1);"amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0016597; GO:0030246; GO:0032922; GO:0045719; GO:0051289; GO:0097367";"circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";;"amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]"
comp3341116_c0_seq1;GAXK01004627.1;Q02525;8.97E-11;ZFP39_MOUSE;Zinc finger protein 39 (Zfp-39) (CtFIN33);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp33414_c0_seq1;GAXK01018595.1;P11420;1.65E-32;DA_DROME;Protein daughterless;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0061101; GO:0061382";"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp334176_c0_seq1;GAXK01190903.1;Q8IRI6;0;GTR1_DROME;Glucose transporter type 1;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]";"GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277";"carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp33419_c1_seq1;GAXK01017750.1;Q9BQ70;5.59E-124;TCF25_HUMAN;Transcription factor 25 (TCF-25) (Nuclear localized protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507";"heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp3341902_c0_seq1;GAXK01004639.1;Q9JME2;2.46E-18;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp334191_c0_seq1;GAXK01190989.1;P17789;6.37E-19;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3341981_c0_seq1;GAXK01004618.1;Q9NY64;3.75E-19;GTR8_HUMAN;Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1);"clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; carbohydrate:proton symporter activity [GO:0005351]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005351; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659";"carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]";"clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"carbohydrate:proton symporter activity [GO:0005351]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]"
comp334229_c1_seq1;GAXK01190896.1;Q08180;1.00E-29;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp33423_c0_seq1;GAXK01018571.1;A2BIL8;2.68E-15;BC7BB_DANRE;B-cell CLL/lymphoma 7 protein family member B-B;;;;;
comp3342447_c0_seq1;GAXK01192976.1;Q95NI4;1.60E-48;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3342878_c0_seq1;GAXK01192970.1;Q93127;5.27E-11;GPR18_AMPAM;Probable G-protein coupled receptor No18;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp334298_c0_seq1;GAXK01190933.1;Q7K4B6;0;TMTC3_DROME;Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein CG4050);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]";"GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269";protein O-linked mannosylation [GO:0035269];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp334307_c1_seq1;GAXK01190919.1;Q05319;2.52E-58;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp334313_c1_seq1;GAXK01190927.1;O14594;3.79E-11;NCAN_HUMAN;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0043202";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp334367_c0_seq1;GAXK01190996.1;P28774;3.81E-54;AT1B_ARTSF;Sodium/potassium-transporting ATPase subunit alpha-B (Na(+)/K(+) ATPase alpha-B subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp3343689_c0_seq1;GAXK01192972.1;P23098;1.71E-79;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp334383_c0_seq1;GAXK01190960.1;Q8IN81;1.24E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3343922_c0_seq1;GAXK01192987.1;P41041;3.64E-14;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3344099_c0_seq1;GAXK01172618.1;Q7Z5L0;3.28E-25;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp3344100_c0_seq1;GAXK01172604.1;P51692;3.30E-31;STA5B_HUMAN;Signal transducer and activator of transcription 5B;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0019221; GO:0019530; GO:0032355; GO:0032870; GO:0035259; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0040014; GO:0042127; GO:0043434; GO:0045648; GO:0045944; GO:0046983; GO:0060397; GO:0071363; GO:0071364";"cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3344826_c0_seq1;GAXK01172620.1;Q19269;3.74E-19;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3345_c0_seq1;GAXK01176505.1;Q9V438;3.40E-110;PDIA6_DROME;Protein disulfide-isomerase A6 homolog (EC 5.3.4.1) (Calcium-binding protein 1) (DmCaBP1);"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]";"GO:0003756; GO:0005783; GO:0005788; GO:0006909; GO:0009986; GO:0012505; GO:0015037; GO:0045454; GO:2000427";"cell redox homeostasis [GO:0045454]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]";"cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp33455_c0_seq1;GAXK01017789.1;Q9V9W8;2.58E-38;PYGO_DROME;Protein pygopus (Protein gammy legs);"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription, DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472]";"GO:0003713; GO:0005634; GO:0005654; GO:0006351; GO:0007367; GO:0007472; GO:0009880; GO:0035064; GO:0035214; GO:0035293; GO:0045944; GO:0046872; GO:0048526; GO:0060070; GO:0060232; GO:1990907";"canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription, DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472]";"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]"
comp33459_c0_seq1;GAXK01017912.1;Q9NUQ3;1.62E-11;TXLNG_HUMAN;Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription) (FIAT) (Lipopolysaccharide-specific response protein 5);"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; protein heterodimerization activity [GO:0046982]; syntaxin binding [GO:0019905]; cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]";"GO:0005829; GO:0007049; GO:0010564; GO:0019905; GO:0030500; GO:0031965; GO:0046982; GO:0051726";"cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]";"protein heterodimerization activity [GO:0046982]; syntaxin binding [GO:0019905]"
comp33464_c2_seq1;GAXK01018548.1;O95900;5.62E-25;TRUB2_HUMAN;Mitochondrial mRNA pseudouridine synthase TRUB2 (EC 5.4.99.-);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]";"GO:0001522; GO:0003723; GO:0005759; GO:0005829; GO:0006397; GO:0009982; GO:0070131";"mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp334643_c1_seq1;GAXK01190898.1;Q8CBH5;5.61E-13;MFSD6_MOUSE;Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"GO:0002250; GO:0005886; GO:0016021; GO:0032393; GO:0042288; GO:0042590";"adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]"
comp3346545_c0_seq1;GAXK01000661.1;A1YF12;4.39E-34;ZNF16_GORGO;Zinc finger protein 16;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0005730; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0043565; GO:0045648; GO:0045654; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp334672_c0_seq1;GAXK01190911.1;B0JZG0;0;S23A2_XENTR;Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; transepithelial L-ascorbic acid transport [GO:0070904]";"GO:0005737; GO:0005886; GO:0005887; GO:0008520; GO:0009925; GO:0016324; GO:0019852; GO:0070890; GO:0070904";"L-ascorbic acid metabolic process [GO:0019852]; transepithelial L-ascorbic acid transport [GO:0070904]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]"
comp3346972_c0_seq1;GAXK01000664.1;P82119;4.71E-14;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp3347_c0_seq1;GAXK01176504.1;G4WAW9;3.19E-12;SELM_ERISI;Selenoprotein M;endoplasmic reticulum [GO:0005783];GO:0005783;;endoplasmic reticulum [GO:0005783];
comp334700_c2_seq1;GAXK01191004.1;Q99574;1.72E-52;NEUS_HUMAN;Neuroserpin (Peptidase inhibitor 12) (PI-12) (Serpin I1);"cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; serine-type endopeptidase inhibitor activity [GO:0004867]; central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155]";"GO:0004867; GO:0005615; GO:0007417; GO:0007422; GO:0010951; GO:0010976; GO:0030155; GO:0034774; GO:0043025; GO:0043204; GO:0060205; GO:0070062";"central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155]";"cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp334714_c0_seq1;GAXK01190915.1;B2D0J5;6.64E-70;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp3347159_c0_seq1;GAXK01000678.1;Q8IN81;5.90E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp334837_c0_seq1;GAXK01190901.1;Q24432;2.32E-102;OMB_DROME;Optomotor-blind protein (Lethal(1)optomotor-blind) (L(1)omb) (Protein bifid);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";"GO:0000122; GO:0000977; GO:0000978; GO:0001102; GO:0001228; GO:0001708; GO:0001745; GO:0003677; GO:0005634; GO:0007472; GO:0007476; GO:0035265; GO:0045944; GO:0048066; GO:0048100";"cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3348419_c0_seq1;GAXK01082849.1;Q95SX7;7.60E-08;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp334859_c0_seq1;GAXK01190952.1;Q7KRI2;3.74E-30;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp33487_c0_seq1;GAXK01018691.1;Q9V785;4.39E-54;3BP5H_DROME;SH3 domain-binding protein 5 homolog (Protein parcase);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]; anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]";"GO:0004860; GO:0005737; GO:0005886; GO:0007301; GO:0007498; GO:0007517; GO:0009952; GO:0017124; GO:0035556; GO:0042694; GO:0048644; GO:0061099";"anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]"
comp334885_c2_seq1;GAXK01190913.1;O72756;1.58E-08;KBTB2_CWPXG;Kelch repeat and BTB domain-containing protein 2;"host cell cytoplasm [GO:0030430]; modulation by virus of host ubiquitin-protein ligase activity [GO:0039649]";"GO:0030430; GO:0039649";modulation by virus of host ubiquitin-protein ligase activity [GO:0039649];host cell cytoplasm [GO:0030430];
comp3349150_c0_seq1;GAXK01082853.1;O54963;3.42E-11;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3349258_c0_seq1;GAXK01082842.1;Q94900;2.26E-56;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp334929_c0_seq1;GAXK01190956.1;P77735;4.16E-58;YAJO_ECOLI;1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-);"cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]";"GO:0005829; GO:0006772; GO:0016491";thiamine metabolic process [GO:0006772];cytosol [GO:0005829];oxidoreductase activity [GO:0016491]
comp3349845_c0_seq1;GAXK01082861.1;P02597;2.56E-13;CALMS_CHICK;Calmodulin, striated muscle;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3349955_c0_seq1;GAXK01082855.1;P83088;2.25E-27;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp335014_c0_seq1;GAXK01190866.1;Q8IY57;1.31E-14;YAF2_HUMAN;YY1-associated factor 2;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0045892; GO:0045893; GO:0046872; GO:0070317";"negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp335017_c1_seq1;GAXK01190917.1;O46043;4.24E-34;PARG_DROME;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; Cajal body organization [GO:0030576]; carbohydrate metabolic process [GO:0005975]; chromatin silencing [GO:0006342]; female germ-line stem cell population maintenance [GO:0036099]; maintenance of protein location in nucleus [GO:0051457]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone acetylation [GO:0035065]; regulation of RNA splicing [GO:0043484]; response to heat [GO:0009408]";"GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005975; GO:0006282; GO:0006342; GO:0009225; GO:0009408; GO:0030576; GO:0035065; GO:0036099; GO:0043484; GO:0051457; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; Cajal body organization [GO:0030576]; carbohydrate metabolic process [GO:0005975]; chromatin silencing [GO:0006342]; female germ-line stem cell population maintenance [GO:0036099]; maintenance of protein location in nucleus [GO:0051457]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone acetylation [GO:0035065]; regulation of RNA splicing [GO:0043484]; response to heat [GO:0009408]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";poly(ADP-ribose) glycohydrolase activity [GO:0004649]
comp3350364_c0_seq1;GAXK01198574.1;P0C6F1;7.42E-12;DYH2_MOUSE;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2);"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp33506_c0_seq1;GAXK01018745.1;A0A0B4K692;3.44E-52;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp335100_c0_seq1;GAXK01190993.1;Q8L840;1.03E-10;RQL4A_ARATH;ATP-dependent DNA helicase Q-like 4A (EC 3.6.4.12) (RecQ-like protein 4A) (AtRecQ4A) (AtRecQl4A) (SGS1-like protein) (AtSGS1);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to abscisic acid stimulus [GO:0071215]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0003676; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0009378; GO:0009506; GO:0032508; GO:0043138; GO:0046872; GO:0051276; GO:0070417; GO:0071215";"cellular response to abscisic acid stimulus [GO:0071215]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3351036_c0_seq1;GAXK01198564.1;Q90YP3;1.54E-20;RS28_ICTPU;40S ribosomal protein S28;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp335115_c1_seq1;GAXK01190951.1;Q96JB3;1.38E-12;HIC2_HUMAN;Hypermethylated in cancer 2 protein (Hic-2) (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0008022; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3351172_c0_seq1;GAXK01198566.1;P16870;9.11E-26;CBPE_HUMAN;Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]; carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; cellular protein modification process [GO:0006464]; insulin processing [GO:0030070]; neuropeptide signaling pathway [GO:0007218]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]";"GO:0003214; GO:0004180; GO:0004181; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006464; GO:0006518; GO:0007218; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030141; GO:0030658; GO:0030667; GO:0033366; GO:0042043; GO:0043025; GO:0050839; GO:0070062; GO:0072657; GO:0097060";"cardiac left ventricle morphogenesis [GO:0003214]; cellular protein modification process [GO:0006464]; insulin processing [GO:0030070]; neuropeptide signaling pathway [GO:0007218]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]";"carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]"
comp3351247_c0_seq1;GAXK01198570.1;Q90593;2.31E-87;BIP_CHICK;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein);"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090074; GO:1903895";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp335141_c0_seq1;GAXK01190949.1;P50429;2.49E-88;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp335144_c0_seq1;GAXK01190978.1;D4AK17;2.56E-15;PLCX1_ARTBC;PI-PLC X domain-containing protein 1;"extracellular region [GO:0005576]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";"GO:0005576; GO:0007165; GO:0008081; GO:0016042";"lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]";extracellular region [GO:0005576];phosphoric diester hydrolase activity [GO:0008081]
comp3351515_c0_seq1;GAXK01198563.1;Q28661;5.01E-10;PROC_RABIT;"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide] (Fragment)";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]";"GO:0004252; GO:0005509; GO:0005576; GO:0005783; GO:0005794; GO:0007596; GO:0043066; GO:0050728; GO:0050819; GO:1903142";"blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp335156_c1_seq1;GAXK01190976.1;Q9VD09;8.17E-22;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp33517_c0_seq1;GAXK01205014.1;Q8IN94;3.87E-123;OSA_DROME;Trithorax group protein osa (Protein eyelid);"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190";"chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";DNA binding [GO:0003677]
comp3351902_c0_seq1;GAXK01198572.1;P97295;1.35E-22;NPY2R_MOUSE;Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor);"cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cardiac left ventricle morphogenesis [GO:0003214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of feeding behavior [GO:2000252]; negative regulation of nervous system process [GO:0031645]; negative regulation of secretion [GO:0051048]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nitric oxide mediated signal transduction [GO:0007263]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of peptide secretion [GO:0002793]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of sensory perception of pain [GO:0051930]; secretion [GO:0046903]";"GO:0001601; GO:0001662; GO:0002793; GO:0003151; GO:0003214; GO:0004983; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007193; GO:0007204; GO:0007263; GO:0007568; GO:0010811; GO:0016020; GO:0031645; GO:0033603; GO:0043951; GO:0045987; GO:0046010; GO:0046903; GO:0050805; GO:0051048; GO:0051930; GO:0051967; GO:0090394; GO:0097730; GO:2000252";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cardiac left ventricle morphogenesis [GO:0003214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of feeding behavior [GO:2000252]; negative regulation of nervous system process [GO:0031645]; negative regulation of secretion [GO:0051048]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nitric oxide mediated signal transduction [GO:0007263]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of peptide secretion [GO:0002793]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of sensory perception of pain [GO:0051930]; secretion [GO:0046903]";"cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]"
comp3352_c1_seq1;GAXK01175326.1;P40423;1.14E-108;SQH_DROME;Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash);"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]";"GO:0000281; GO:0001736; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0030707; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144";"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]";"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]"
comp3352362_c1_seq1;GAXK01090368.1;Q9VZW5;5.53E-14;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3353282_c0_seq1;GAXK01090384.1;Q75V66;3.52E-12;ANO5_HUMAN;Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983";"chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]"
comp3353339_c0_seq1;GAXK01090379.1;O88427;2.15E-37;CAC1H_MOUSE;Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2);"caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]";"GO:0005244; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016021; GO:0019228; GO:0019233; GO:0030425; GO:0032342; GO:0034651; GO:0034765; GO:0042383; GO:0042391; GO:0043204; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0099055; GO:0099059; GO:0106134; GO:2000344";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]"
comp335355_c0_seq1;GAXK01190897.1;Q8N6T7;7.92E-13;SIR6_HUMAN;NAD-dependent protein deacetylase sirtuin-6 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6);"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; glucose homeostasis [GO:0042593]; histone H3 deacetylation [GO:0070932]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation blood vessel branching [GO:1905555]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of chromatin silencing at telomere [GO:0031940]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric heterochromatin assembly [GO:1905549]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; post-embryonic cardiac muscle cell growth involved in heart morphogenesis [GO:0003247]; protein ADP-ribosylation [GO:0006471]; protein destabilization [GO:0031648]; regulation of double-strand break repair via homologous recombination [GO:0010569]; response to nutrient levels [GO:0031667]";"GO:0000122; GO:0003247; GO:0003682; GO:0003714; GO:0003950; GO:0003956; GO:0004407; GO:0005634; GO:0005654; GO:0005724; GO:0005737; GO:0006284; GO:0006471; GO:0008270; GO:0008285; GO:0010569; GO:0017136; GO:0031648; GO:0031667; GO:0031940; GO:0032206; GO:0034979; GO:0042593; GO:0045820; GO:0046325; GO:0046969; GO:0048146; GO:0070403; GO:0070932; GO:0120162; GO:1902732; GO:1905549; GO:1905555; GO:1905564; GO:2000648";"base-excision repair [GO:0006284]; glucose homeostasis [GO:0042593]; histone H3 deacetylation [GO:0070932]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation blood vessel branching [GO:1905555]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of chromatin silencing at telomere [GO:0031940]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric heterochromatin assembly [GO:1905549]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; post-embryonic cardiac muscle cell growth involved in heart morphogenesis [GO:0003247]; protein ADP-ribosylation [GO:0006471]; protein destabilization [GO:0031648]; regulation of double-strand break repair via homologous recombination [GO:0010569]; response to nutrient levels [GO:0031667]";"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp33539_c2_seq1;GAXK01017876.1;Q5I0K5;9.10E-27;ABHDA_RAT;Mycophenolic acid acyl-glucuronide esterase, mitochondrial (EC 3.1.1.93) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10);"mitochondrion [GO:0005739]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]";"GO:0005739; GO:0102390";;mitochondrion [GO:0005739];mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]
comp335427_c1_seq1;GAXK01190931.1;Q8NEP9;5.52E-28;ZN555_HUMAN;Zinc finger protein 555;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3355_c0_seq1;GAXK01175527.1;Q9NG56;3.21E-40;TPM_BLAGE;Tropomyosin;;;;;
comp335542_c0_seq1;GAXK01190982.1;P24044;1.58E-41;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3355724_c0_seq1;GAXK01016503.1;Q9BDB7;2.26E-15;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp3355797_c0_seq1;GAXK01016517.1;Q5RJQ0;1.49E-09;CHST1_RAT;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0016021; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]"
comp3355831_c0_seq1;GAXK01016506.1;P40978;2.26E-51;RS19_ORYSJ;40S ribosomal protein S19;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp335590_c0_seq1;GAXK01190905.1;Q9VB68;4.38E-32;GRASS_DROME;Serine protease grass (EC 3.4.21.-) (Gram-positive specific serine protease);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]";"GO:0002804; GO:0004252; GO:0005509; GO:0005576; GO:0006508; GO:0006963; GO:0045087; GO:0045752; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp3355980_c0_seq1;GAXK01016512.1;Q9NQV8;1.53E-16;PRDM8_HUMAN;PR domain zinc finger protein 8 (EC 2.1.1.-) (PR domain-containing protein 8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; oligodendrocyte development [GO:0014003]";"GO:0003677; GO:0005634; GO:0008168; GO:0014003; GO:0046872";oligodendrocyte development [GO:0014003];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp335673_c0_seq1;GAXK01190946.1;Q9H165;1.76E-38;BC11A_HUMAN;B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173";"cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp3357361_c0_seq1;GAXK01039704.1;O35552;5.64E-105;F263_RAT;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; brain development [GO:0007420]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; regulation of glycolytic process [GO:0006110]";"GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0006110; GO:0007420";"brain development [GO:0007420]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; regulation of glycolytic process [GO:0006110]";cytosol [GO:0005829];"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp3357522_c0_seq1;GAXK01039711.1;Q8IS44;7.39E-65;DRD2L_DROME;Dopamine D2-like receptor (DD2R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001591; GO:0004930; GO:0004935; GO:0005887; GO:0007186; GO:0007188; GO:0007212; GO:0007615; GO:0008227; GO:0016021; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]"
comp3357815_c0_seq1;GAXK01039713.1;Q9HAZ2;1.36E-17;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp3358263_c0_seq1;GAXK01193014.1;P10675;3.70E-09;FAS1_SCHAM;Fasciclin-1 (Fasciclin I) (FAS I) (FCN);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp335828_c0_seq1;GAXK01190980.1;Q9VR07;0;INE_DROME;Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891";"glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]"
comp33589_c0_seq1;GAXK01017866.1;Q9QXP4;1.54E-52;DONS_MOUSE;Protein downstream neighbor of Son (Protein 3SG);"nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint [GO:0007095]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]";"GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0007275; GO:0030894; GO:0033260; GO:0048478";"DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint [GO:0007095]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]";"nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]";
comp3359058_c0_seq1;GAXK01193015.1;Q5FYB0;1.03E-41;ARSJ_HUMAN;Arylsulfatase J (ASJ) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp33593_c0_seq1;GAXK01018104.1;Q9NA75;3.65E-84;T38B1_CAEEL;Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";potassium channel activity [GO:0005267]
comp335957_c0_seq1;GAXK01190972.1;P51986;3.21E-18;CCNA_HYDVD;G2/mitotic-specific cyclin-A (Fragment);"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp3359664_c0_seq1;GAXK01193034.1;P29763;2.58E-10;RLA1_CHLRE;60S acidic ribosomal protein P1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp33597_c0_seq1;GAXK01017764.1;Q2KJ44;3.09E-97;PTPA_BOVIN;Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B');"calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]";"GO:0000159; GO:0003755; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0008160; GO:0016887; GO:0032515; GO:0032516; GO:0034704; GO:0042803; GO:0043065; GO:0051721";"mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]";"calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]"
comp336_c0_seq1;GAXK01170050.1;Q6PC91;3.84E-47;BT3L4_DANRE;Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4);;;;;
comp33603_c2_seq1;GAXK01018583.1;Q9BZF3;1.20E-128;OSBL6_HUMAN;Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]";"GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032934; GO:0043231; GO:0097038";bile acid biosynthetic process [GO:0006699];"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp336069_c1_seq1;GAXK01022017.1;Q91428;2.03E-64;GATA3_DANRE;Transcription factor GATA-3 (GATA-binding factor 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000978; GO:0000981; GO:0002520; GO:0005634; GO:0008270; GO:0008284; GO:0008543; GO:0021514; GO:0030856; GO:0031101; GO:0042246; GO:0043049; GO:0045582; GO:0048568; GO:0048702; GO:0050769; GO:0060788; GO:0061026; GO:0071696; GO:2001224";"cardiac muscle tissue regeneration [GO:0061026]; ectodermal placode development [GO:0071696]; ectodermal placode formation [GO:0060788]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; immune system development [GO:0002520]; otic placode formation [GO:0043049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron migration [GO:2001224]; positive regulation of T cell differentiation [GO:0045582]; regulation of epithelial cell differentiation [GO:0030856]; tissue regeneration [GO:0042246]; ventral spinal cord interneuron differentiation [GO:0021514]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp336070_c0_seq1;GAXK01021942.1;Q5BJ52;6.48E-20;TRBP2_XENTR;RISC-loading complex subunit tarbp2;"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"GO:0003725; GO:0005737; GO:0006417; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0035197; GO:0035198; GO:0035280; GO:0042803; GO:0046782; GO:0070578; GO:0070883; GO:0090065; GO:1903798";"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]"
comp33608_c6_seq1;GAXK01018489.1;P54281;1.71E-107;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3361233_c0_seq1;GAXK01000150.1;Q12884;9.95E-20;SEPR_HUMAN;Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)];"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917]";"GO:0001525; GO:0002020; GO:0004175; GO:0004222; GO:0004252; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030027; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0046983; GO:0051603; GO:0051917; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362; GO:1903054";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";"dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3361673_c0_seq1;GAXK01000132.1;Q9XSU4;7.41E-43;RS11_CANLF;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3361872_c0_seq1;GAXK01000146.1;O22286;1.17E-07;BPM3_ARATH;BTB/POZ and MATH domain-containing protein 3 (Protein BTB-POZ AND MATH DOMAIN 3) (AtBPM3);"cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to salt stress [GO:0071472]; protein ubiquitination [GO:0016567]; regulation of protein ubiquitination [GO:0031396]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0005829; GO:0006970; GO:0016567; GO:0031396; GO:0042802; GO:0071472";"cellular response to salt stress [GO:0071472]; protein ubiquitination [GO:0016567]; regulation of protein ubiquitination [GO:0031396]; response to osmotic stress [GO:0006970]";"cytosol [GO:0005829]; nucleus [GO:0005634]";identical protein binding [GO:0042802]
comp33621_c0_seq1;GAXK01018066.1;Q3ZCJ2;1.48E-84;AK1A1_BOVIN;Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0045202; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095";"aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]"
comp3362129_c0_seq1;GAXK01062893.1;Q7Z4T9;7.91E-32;CFA91_HUMAN;Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1);"axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341]";"GO:0003341; GO:0005739; GO:0005930; GO:0031514";cilium movement [GO:0003341];"axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]";
comp33622_c5_seq1;GAXK01018097.1;Q9H3H1;7.07E-38;MOD5_HUMAN;tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (hGRO1) (tRNA isopentenyltransferase 1) (IPTase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270]; mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400]";"GO:0003676; GO:0005524; GO:0005739; GO:0005759; GO:0006400; GO:0008270; GO:0052381; GO:0070900";"mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270]"
comp336220_c0_seq1;GAXK01021951.1;Q6A4J8;3.51E-25;UBP7_MOUSE;Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (mHAUSP) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001741; GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006283; GO:0006511; GO:0007275; GO:0008022; GO:0008134; GO:0010216; GO:0016579; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0036459; GO:0042752; GO:0042803; GO:0043065; GO:0048511; GO:0050821; GO:0051090; GO:0101005; GO:1901537; GO:1990380";"histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; XY body [GO:0001741]";"cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]"
comp3362586_c0_seq1;GAXK01062895.1;B2KFW1;3.56E-11;ZSC20_MOUSE;Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0003676; GO:0005634; GO:0006357; GO:0046872";regulation of transcription by RNA polymerase II [GO:0006357];nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3362672_c0_seq1;GAXK01062886.1;Q8STF0;1.44E-15;CALM_STRIE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3362964_c0_seq1;GAXK01062882.1;P05661;1.54E-82;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp33632_c1_seq1;GAXK01018123.1;Q96J01;9.75E-156;THOC3_HUMAN;THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]";"GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0046784";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]";RNA binding [GO:0003723]
comp3363263_c0_seq1;GAXK01062897.1;Q16983;2.44E-13;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp336356_c0_seq1;GAXK01021895.1;A9LMC0;4.20E-22;DPF3_DANRE;Zinc finger protein DPF3;"histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; cardiac muscle tissue morphogenesis [GO:0055008]; chromatin remodeling [GO:0006338]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0006338; GO:0006355; GO:0007399; GO:0008270; GO:0016514; GO:0042393; GO:0045892; GO:0045944; GO:0048644; GO:0055008; GO:0071565";"cardiac muscle tissue morphogenesis [GO:0055008]; chromatin remodeling [GO:0006338]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]"
comp33636_c1_seq1;GAXK01018210.1;Q4JIM4;3.85E-119;PSN1_CHICK;"Presenilin-1 (PS-1) (EC 3.4.23.-) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit]";"axon [GO:0030424]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; synapse [GO:0045202]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; endopeptidase activity [GO:0004175]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of phosphorylation [GO:0042325]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]";"GO:0000139; GO:0004175; GO:0005634; GO:0005739; GO:0005783; GO:0005789; GO:0005790; GO:0005794; GO:0005886; GO:0005887; GO:0006509; GO:0006915; GO:0007155; GO:0007219; GO:0008013; GO:0016021; GO:0016485; GO:0030054; GO:0030424; GO:0034205; GO:0035556; GO:0042325; GO:0042500; GO:0042982; GO:0043085; GO:0045202; GO:0045296; GO:0051563; GO:0060828; GO:0070765";"amyloid-beta formation [GO:0034205]; amyloid precursor protein metabolic process [GO:0042982]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of phosphorylation [GO:0042325]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]";"axon [GO:0030424]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; synapse [GO:0045202]";"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; endopeptidase activity [GO:0004175]"
comp3363927_c0_seq1;GAXK01062890.1;P36609;4.74E-41;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3364186_c0_seq1;GAXK01091545.1;Q9N0J3;3.47E-13;CEBPD_SHEEP;CCAAT/enhancer-binding protein delta (C/EBP delta);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp33642_c0_seq1;GAXK01018056.1;P0C0T0;1.26E-10;LITAF_RAT;Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Estrogen-enhanced transcript protein 1) (Eet-1);"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]";"GO:0000139; GO:0000978; GO:0001817; GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009898; GO:0043123; GO:0045944; GO:0050699; GO:0071222; GO:0098559; GO:0098560; GO:0098574; GO:1901223";"aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]";"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";"RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp3364985_c0_seq1;GAXK01091531.1;P50430;6.88E-20;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp3365_c2_seq1;GAXK01176545.1;P23438;1.27E-65;SSRB_CANLF;Translocon-associated protein subunit beta (TRAP-beta) (Glycoprotein 25H) (gp25H) (Signal sequence receptor subunit beta) (SSR-beta);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005783; GO:0005789; GO:0016021";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp336509_c2_seq1;GAXK01021909.1;Q9YIB9;3.94E-53;HIF1A_CHICK;Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein dimerization activity [GO:0046983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"GO:0000981; GO:0001666; GO:0003677; GO:0005634; GO:0005737; GO:0006357; GO:0016607; GO:0035035; GO:0045893; GO:0045944; GO:0046983";"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein dimerization activity [GO:0046983]"
comp3365121_c0_seq1;GAXK01091556.1;Q24352;1.16E-55;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp3365236_c0_seq1;GAXK01091549.1;O75362;5.17E-08;ZN217_HUMAN;Zinc finger protein 217;"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000118; GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016607; GO:0044212; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp33655_c9_seq1;GAXK01017914.1;Q9GM44;1.49E-16;HEAT1_MACFA;HEAT repeat-containing protein 1 (Protein BAP28) (Fragment);"nucleolus [GO:0005730]; rRNA processing [GO:0006364]";"GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];
comp3365877_c0_seq1;GAXK01091540.1;A2ASS6;1.70E-13;TITIN_MOUSE;Titin (EC 2.7.11.1) (Connectin);"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897";"adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp3366_c1_seq1;GAXK01176491.1;O44119;1.75E-75;TPM_HOMAM;Tropomyosin (allergen Hom a 1);;;;;
comp336647_c0_seq1;GAXK01022031.1;Q8VID5;5.29E-45;RECQ5_MOUSE;ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RECQL5beta) (RecQ protein-like 5);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0035690; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042";"cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]"
comp3366832_c0_seq1;GAXK01126056.1;Q18885;5.08E-17;BTF3_CAEEL;Transcription factor BTF3 homolog (Inhibitor of cell death 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]";"GO:0005634; GO:0005739; GO:0005829; GO:0005854; GO:0009792; GO:0042788; GO:0043066";"embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]";
comp336691_c0_seq1;GAXK01021891.1;P32030;2.89E-21;SLP1_DROME;Fork head domain transcription factor slp1 (Sloppy paired locus protein 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification, embryo [GO:0008595]; blastoderm segmentation [GO:0007350]; cell differentiation [GO:0030154]; heart development [GO:0007507]; heart formation [GO:0060914]; mesoderm formation [GO:0001707]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]";"GO:0000122; GO:0000977; GO:0000981; GO:0001707; GO:0005634; GO:0006357; GO:0007350; GO:0007366; GO:0007380; GO:0007507; GO:0008595; GO:0009653; GO:0010468; GO:0030154; GO:0060914";"anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification, embryo [GO:0008595]; blastoderm segmentation [GO:0007350]; cell differentiation [GO:0030154]; heart development [GO:0007507]; heart formation [GO:0060914]; mesoderm formation [GO:0001707]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3367_c0_seq1;GAXK01175511.1;P31402;8.07E-96;VATE_MANSE;V-type proton ATPase subunit E (V-ATPase subunit E) (V-ATPase 26 kDa subunit) (Vacuolar proton pump subunit E);"proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0033178; GO:0046961";;proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178];proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp33674_c1_seq1;GAXK01018379.1;Q9PU85;1.13E-112;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp336757_c0_seq1;GAXK01021887.1;P11584;5.40E-127;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp3367830_c0_seq1;GAXK01126058.1;Q99684;2.87E-07;GFI1_HUMAN;Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]";"GO:0000083; GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0010956; GO:0010957; GO:0010977; GO:0016032; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0044212; GO:0045892; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3367885_c0_seq1;GAXK01126069.1;P51901;1.53E-19;ANXA6_CHICK;Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (P68) (P70) (Protein III);"calcium channel complex [GO:0034704]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; ligand-gated ion channel activity [GO:0015276]; phosphatidylserine binding [GO:0001786]; apoptotic signaling pathway [GO:0097190]; calcium ion homeostasis [GO:0055074]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]";"GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005739; GO:0005925; GO:0006937; GO:0015276; GO:0015485; GO:0031982; GO:0034704; GO:0035374; GO:0042470; GO:0051015; GO:0051283; GO:0051560; GO:0055074; GO:0097190";"apoptotic signaling pathway [GO:0097190]; calcium ion homeostasis [GO:0055074]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]";"calcium channel complex [GO:0034704]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; vesicle [GO:0031982]";"actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; ligand-gated ion channel activity [GO:0015276]; phosphatidylserine binding [GO:0001786]"
comp3368018_c0_seq1;GAXK01069983.1;Q9Y2L8;2.28E-13;ZKSC5_HUMAN;Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp3368047_c0_seq1;GAXK01069974.1;Q8R516;5.00E-10;MIB2_MOUSE;E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Dystrophin-like protein) (Dyslike) (Mind bomb homolog 2) (Mind bomb-2) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0007219; GO:0008270; GO:0016567; GO:0061630";"Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]";"actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp33685_c0_seq1;GAXK01018381.1;Q05319;2.27E-40;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3368813_c0_seq1;GAXK01069975.1;Q9NE83;1.59E-42;RS6_LEIMA;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3368899_c0_seq1;GAXK01069966.1;Q99PW8;7.17E-54;KIF17_MOUSE;Kinesin-like protein KIF17 (MmKIF17);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]";"GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0008017; GO:0008574; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0030992; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098971; GO:1990075";"anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp336939_c0_seq1;GAXK01021949.1;Q9VTW2;1.67E-137;INP5E_DROME;Inositol polyphosphate 5-phosphatase E (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV);"ciliary base [GO:0097546]; cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol dephosphorylation [GO:0046856]; protein localization to cilium [GO:0061512]; sensory perception of sound [GO:0007605]";"GO:0004439; GO:0005737; GO:0007605; GO:0016020; GO:0046856; GO:0061512; GO:0097546";"phosphatidylinositol dephosphorylation [GO:0046856]; protein localization to cilium [GO:0061512]; sensory perception of sound [GO:0007605]";"ciliary base [GO:0097546]; cytoplasm [GO:0005737]; membrane [GO:0016020]";phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]
comp3369519_c0_seq1;GAXK01069987.1;Q93560;1.78E-08;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp3369736_c0_seq1;GAXK01069971.1;A2ANX9;1.43E-08;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp337000_c0_seq1;GAXK01022023.1;P36609;5.45E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3370215_c0_seq1;GAXK01182044.1;O54963;1.45E-12;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3370229_c0_seq1;GAXK01182032.1;O54963;6.40E-09;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp337024_c1_seq1;GAXK01021812.1;P15771;5.29E-09;NUCL_CHICK;Nucleolin (Protein C23);"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723]";"GO:0003677; GO:0003723; GO:0005730; GO:1990904";;"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp337051_c0_seq1;GAXK01021811.1;Q9QYP0;0;MEGF8_RAT;Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4);"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]";"GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0060971; GO:0060972; GO:0061371; GO:0071907; GO:0097155";"animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]";"integral component of membrane [GO:0016021]; nucleus [GO:0005634]";calcium ion binding [GO:0005509]
comp3370670_c0_seq1;GAXK01182036.1;P35449;7.65E-46;NHX9_CAEEL;Probable Na(+)/H(+) antiporter nhx-9 (Na(+)-H(+) exchanger protein 9);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp337073_c5_seq1;GAXK01021960.1;Q21701;1.05E-11;NHR12_CAEEL;Nuclear hormone receptor family member nhr-12;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp3370757_c0_seq1;GAXK01182046.1;Q9NU02;7.04E-08;ANKE1_HUMAN;Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp337112_c0_seq1;GAXK01022026.1;Q8TE56;5.44E-09;ATS17_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676]"
comp337226_c0_seq1;GAXK01021940.1;Q9D4V0;2.18E-78;EKI1_MOUSE;Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646";phosphatidylethanolamine biosynthetic process [GO:0006646];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]"
comp33728_c0_seq1;GAXK01017749.1;Q5R5X9;2.19E-39;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp33735_c0_seq1;GAXK01018487.1;P74615;2.03E-13;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp3373564_c0_seq1;GAXK01074819.1;Q98989;1.30E-14;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp33739_c2_seq1;GAXK01018117.1;Q7L1I2;2.56E-58;SV2B_HUMAN;Synaptic vesicle glycoprotein 2B;"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]";"GO:0001669; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030054; GO:0030672; GO:0043005";"chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]";"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";transmembrane transporter activity [GO:0022857]
comp337423_c1_seq1;GAXK01021839.1;Q5QQ53;1.78E-12;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp33744_c1_seq1;GAXK01017853.1;Q9CXW2;1.97E-59;RT22_MOUSE;28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt);"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005739; GO:0005763";;"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp3374427_c0_seq1;GAXK01107725.1;P51997;1.63E-29;RL25_PUCGR;60S ribosomal protein L25;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp337468_c0_seq1;GAXK01021904.1;Q7YU24;9.44E-105;MARF_DROME;Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin);"axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003924; GO:0005525; GO:0005740; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115";"adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]";"axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp33747_c1_seq1;GAXK01018154.1;Q5U458;1.03E-89;DJC11_MOUSE;DnaJ homolog subfamily C member 11;"MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cristae formation [GO:0042407]";"GO:0001401; GO:0005739; GO:0005741; GO:0005743; GO:0042407; GO:0061617";cristae formation [GO:0042407];"MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]";
comp3374955_c0_seq1;GAXK01107733.1;Q8WQI3;1.41E-13;RS29_SPOFR;40S ribosomal protein S29;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0008270; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";"structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]"
comp337506_c0_seq1;GAXK01021937.1;P0C5E4;1.22E-47;PTPRQ_MOUSE;Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);"integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; protein tyrosine phosphatase activity [GO:0004725]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]";"GO:0002244; GO:0004725; GO:0016021; GO:0032421; GO:0042472; GO:0045598; GO:0050885; GO:0050910; GO:0060116";"detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]";"integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]";protein tyrosine phosphatase activity [GO:0004725]
comp3375291_c0_seq1;GAXK01107714.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3375294_c0_seq1;GAXK01107717.1;P34788;5.23E-70;RS18_ARATH;40S ribosomal protein S18;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribosome [GO:0005840]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translational initiation [GO:0006413]";"GO:0003729; GO:0003735; GO:0005618; GO:0005634; GO:0005730; GO:0005773; GO:0005774; GO:0005829; GO:0005840; GO:0005886; GO:0006413; GO:0009506; GO:0019843; GO:0022626; GO:0022627";translational initiation [GO:0006413];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribosome [GO:0005840]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp33760_c4_seq1;GAXK01018654.1;P25071;1.48E-22;CML12_ARATH;Calmodulin-like protein 12 (Touch-induced calmodulin-related protein 3);"cytosol [GO:0005829]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; response to absence of light [GO:0009646]; response to mechanical stimulus [GO:0009612]; thigmotropism [GO:0009652]";"GO:0005509; GO:0005774; GO:0005829; GO:0009506; GO:0009612; GO:0009646; GO:0009652; GO:0019722";"calcium-mediated signaling [GO:0019722]; response to absence of light [GO:0009646]; response to mechanical stimulus [GO:0009612]; thigmotropism [GO:0009652]";"cytosol [GO:0005829]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]";calcium ion binding [GO:0005509]
comp3376309_c0_seq1;GAXK01080945.1;P25779;7.20E-37;CYSP_TRYCR;Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase);cysteine-type endopeptidase activity [GO:0004197];GO:0004197;;;cysteine-type endopeptidase activity [GO:0004197]
comp3376634_c0_seq1;GAXK01080943.1;O35643;2.32E-07;AP1B1_MOUSE;AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit);"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030131; GO:0030276; GO:0030665; GO:0043231; GO:0048268";"clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]";"clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]"
comp3376939_c0_seq1;GAXK01080942.1;Q8TE73;0;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp3377_c0_seq1;GAXK01175871.1;Q6NYE2;1.84E-114;RCC2_DANRE;Protein RCC2 homolog;"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]";"GO:0000775; GO:0001755; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0007049; GO:0030496; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]";"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]";
comp3377155_c0_seq1;GAXK01080951.1;Q86FP7;5.82E-51;RS23_DERVA;40S ribosomal protein S23;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";structural constituent of ribosome [GO:0003735]
comp3377529_c0_seq1;GAXK01080962.1;Q6Q629;2.14E-10;DPP10_RAT;Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase X) (DPP X) (Kv4 potassium channel auxiliary subunit);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008236; GO:0015459; GO:0016020; GO:0016021; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp337803_c0_seq1;GAXK01021855.1;P52741;1.61E-10;ZN134_HUMAN;Zinc finger protein 134;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3378362_c0_seq1;GAXK01157622.1;Q9UL36;4.23E-11;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3378447_c0_seq1;GAXK01157619.1;O43916;2.51E-10;CHST1_HUMAN;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp33785_c0_seq1;GAXK01018721.1;Q8IYJ1;2.14E-08;CPNE9_HUMAN;Copine-9 (Copine IX);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]";"GO:0005544; GO:0005615; GO:0005886; GO:0070062; GO:0071277; GO:1903861";"cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp3378768_c0_seq1;GAXK01157626.1;B5AJT4;3.83E-17;VMP03_EULPE;Venom metalloproteinase 3 (EpMP3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp33791_c0_seq1;GAXK01018542.1;Q9M571;3.23E-79;PEAMT_SPIOL;Phosphoethanolamine N-methyltransferase (EC 2.1.1.103);"cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000234; GO:0005737; GO:0006656";phosphatidylcholine biosynthetic process [GO:0006656];cytoplasm [GO:0005737];phosphoethanolamine N-methyltransferase activity [GO:0000234]
comp3379292_c0_seq1;GAXK01157624.1;Q9Y4F4;2.26E-21;TGRM1_HUMAN;TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B);"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515";"axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]";
comp337940_c0_seq1;GAXK01021948.1;Q9VUN0;3.18E-146;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp3379860_c0_seq1;GAXK01157617.1;P41753;9.32E-89;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp33799_c0_seq1;GAXK01017765.1;P0CP96;6.98E-43;FKBP2_CRYNJ;FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0005783; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp337991_c0_seq1;GAXK01021879.1;Q26609;1.17E-85;HXK_SCHMA;Hexokinase (EC 2.7.1.1);"cell [GO:0005623]; ATP binding [GO:0005524]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; cellular glucose homeostasis [GO:0001678]; glycolytic process [GO:0006096]";"GO:0001678; GO:0004396; GO:0005524; GO:0005536; GO:0005623; GO:0006096";"cellular glucose homeostasis [GO:0001678]; glycolytic process [GO:0006096]";cell [GO:0005623];"ATP binding [GO:0005524]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]"
comp338_c4_seq1;GAXK01166342.1;Q6NZQ2;5.10E-120;DDX31_MOUSE;Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0042254; GO:0043231";ribosome biogenesis [GO:0042254];"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp33800_c1_seq1;GAXK01017863.1;B4XSZ9;7.43E-08;SLA9_MACLB;Snaclec A9 (C-type lectin A9);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3380168_c0_seq1;GAXK01101487.1;Q9JLB4;2.08E-11;CUBN_MOUSE;Cubilin (Intrinsic factor-cobalamin receptor);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp338023_c0_seq1;GAXK01198206.1;Q7ZYC4;0;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp3380485_c0_seq1;GAXK01101481.1;Q9UNW1;7.11E-33;MINP1_HUMAN;Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]; bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]";"GO:0001503; GO:0003993; GO:0005783; GO:0005788; GO:0006797; GO:0030282; GO:0030351; GO:0034417; GO:0043647; GO:0051717; GO:0052745; GO:0052826; GO:0070062; GO:0101006";"bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]";"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; protein histidine phosphatase activity [GO:0101006]"
comp3380563_c0_seq1;GAXK01101491.1;Q9D180;5.87E-46;CFA57_MOUSE;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp338127_c1_seq1;GAXK01198181.1;Q99M85;2.90E-44;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp3381883_c0_seq1;GAXK01101486.1;P83040;1.06E-09;HCY2E_RAPVE;Hemocyanin type 2 unit e (RtH2-e);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005615; GO:0016491; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp338223_c1_seq1;GAXK01198190.1;Q6GNS1;4.24E-08;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp338236_c1_seq1;GAXK01198335.1;Q9Z2D6;3.70E-19;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp338387_c3_seq1;GAXK01198379.1;Q5R5X9;2.57E-22;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp3384149_c0_seq1;GAXK01131103.1;P13678;1.11E-104;KPC3_DROME;Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";"GO:0004674; GO:0004697; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872";"dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp3384206_c0_seq1;GAXK01131101.1;Q8CFE4;5.11E-40;SCYL2_MOUSE;SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa);"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370";"endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]";"clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]"
comp33844_c1_seq1;GAXK01018590.1;Q7KRI2;8.19E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3385072_c0_seq1;GAXK01131104.1;Q8SWR3;1.32E-08;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp338567_c0_seq1;GAXK01198193.1;Q8NCN2;2.78E-09;ZBT34_HUMAN;Zinc finger and BTB domain-containing protein 34;"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000790; GO:0000981; GO:0003677; GO:0005654; GO:0046872";;"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp338576_c0_seq1;GAXK01198262.1;A2T812;3.25E-67;ZN287_PONPY;Zinc finger protein 287;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp33861_c4_seq1;GAXK01018227.1;P40974;3.00E-12;PUO_KOCRO;Putrescine oxidase (EC 1.4.3.10);putrescine oxidase activity [GO:0050232];GO:0050232;;;putrescine oxidase activity [GO:0050232]
comp33865_c0_seq1;GAXK01017867.1;Q94B65;3.33E-44;UTR7_ARATH;UDP-galactose/UDP-glucose transporter 7 (AtUTr7);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]";"GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0008643; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0048527; GO:0072334; GO:0080147";"carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]"
comp338654_c0_seq1;GAXK01198260.1;Q9TTK0;6.17E-131;CDKL2_RABIT;Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Serine/threonine-protein kinase KKIAMRE);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]";"GO:0004693; GO:0005524; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp3386696_c0_seq1;GAXK01141761.1;A1X153;7.91E-56;WNT2_ECHTE;Protein Wnt-2;"extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]";"GO:0005102; GO:0005576; GO:0007275; GO:0016055";"multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];signaling receptor binding [GO:0005102]
comp3386912_c0_seq1;GAXK01141764.1;Q80SU7;3.22E-12;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp3388407_c0_seq1;GAXK01153752.1;Q9NL98;1.55E-39;PRDX_ASCSU;Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase);"cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005623; GO:0006979; GO:0008379; GO:0016209; GO:0045454";"cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";cell [GO:0005623];"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]"
comp3389733_c0_seq1;GAXK01153756.1;Q17778;3.18E-08;NUC1_CAEEL;Deoxyribonuclease-2 (EC 3.1.22.1) (Deoxyribonuclease II) (DNase II);"lysosome [GO:0005764]; nucleus [GO:0005634]; deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]";"GO:0000737; GO:0004520; GO:0004531; GO:0005634; GO:0005764; GO:0006309";"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]";"lysosome [GO:0005764]; nucleus [GO:0005634]";"deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]"
comp338980_c1_seq1;GAXK01198348.1;Q66IL0;2.43E-120;CHID1_XENTR;Chitinase domain-containing protein 1;"extracellular region [GO:0005576]; lysosome [GO:0005764]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]";"GO:0005576; GO:0005764; GO:0005975; GO:0008061; GO:0070492";carbohydrate metabolic process [GO:0005975];"extracellular region [GO:0005576]; lysosome [GO:0005764]";"chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]"
comp339071_c0_seq1;GAXK01198198.1;P91943;1.41E-48;PANG1_DROME;Protein pangolin, isoforms A/H/I/S (dTCF);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055]";"GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007367; GO:0007435; GO:0007476; GO:0007500; GO:0007507; GO:0008013; GO:0009880; GO:0010628; GO:0016055; GO:0019900; GO:0035277; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0060070; GO:0070491; GO:0072091";"canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp339116_c2_seq1;GAXK01198271.1;Q3U4G3;9.89E-26;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp3391387_c0_seq1;GAXK01090145.1;Q69Z23;6.91E-57;DYH17_MOUSE;Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Ciliary dynein heavy chain 17);"dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp3391864_c0_seq1;GAXK01090141.1;Q3U4G3;3.65E-14;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp339195_c0_seq1;GAXK01198182.1;P53405;5.17E-67;ISL1_DANRE;Insulin gene enhancer protein isl-1 (Islet-1);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial cardiac muscle cell differentiation [GO:0055011]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; endocrine pancreas development [GO:0031018]; exocrine pancreas development [GO:0031017]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; pancreatic A cell development [GO:0003322]; pancreatic D cell development [GO:0003324]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; type B pancreatic cell development [GO:0003323]";"GO:0000981; GO:0003322; GO:0003323; GO:0003324; GO:0005634; GO:0007409; GO:0007507; GO:0008016; GO:0021522; GO:0021527; GO:0031017; GO:0031018; GO:0043565; GO:0045944; GO:0046872; GO:0048665; GO:0048666; GO:0048675; GO:0048936; GO:0055011; GO:0097154";"atrial cardiac muscle cell differentiation [GO:0055011]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; endocrine pancreas development [GO:0031018]; exocrine pancreas development [GO:0031017]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; pancreatic A cell development [GO:0003322]; pancreatic D cell development [GO:0003324]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; type B pancreatic cell development [GO:0003323]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp339211_c0_seq1;GAXK01198194.1;Q7L099;9.72E-113;RUFY3_HUMAN;Protein RUFY3 (RUN and FYVE domain-containing protein 3) (Rap2-interacting protein x) (RIPx) (Single axon-regulated protein) (Singar);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; actin filament organization [GO:0007015]; negative regulation of axonogenesis [GO:0050771]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114]";"GO:0005737; GO:0005829; GO:0007015; GO:0012505; GO:0016020; GO:0030027; GO:0030054; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0043025; GO:0043204; GO:0045773; GO:0050770; GO:0050771; GO:0071437; GO:0090316; GO:2000114";"actin filament organization [GO:0007015]; negative regulation of axonogenesis [GO:0050771]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]";
comp3392153_c0_seq1;GAXK01119046.1;O75132;4.25E-11;ZBED4_HUMAN;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp339236_c2_seq1;GAXK01198263.1;Q9VEG6;3.82E-105;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp339294_c0_seq1;GAXK01198189.1;Q9GV41;1.63E-60;PGFS_TRYBB;9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase);"cytoplasm [GO:0005737]; aldo-keto reductase (NADP) activity [GO:0004033]; D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; nucleotide binding [GO:0000166]; D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]";"GO:0000166; GO:0001516; GO:0004033; GO:0005737; GO:0019571; GO:0045290";"D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]";cytoplasm [GO:0005737];"aldo-keto reductase (NADP) activity [GO:0004033]; D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; nucleotide binding [GO:0000166]"
comp3393176_c0_seq1;GAXK01119047.1;O43916;1.90E-11;CHST1_HUMAN;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp3393499_c0_seq1;GAXK01119024.1;P17970;5.52E-35;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp3393500_c0_seq1;GAXK01119033.1;O88427;2.08E-22;CAC1H_MOUSE;Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2);"caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]";"GO:0005244; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016021; GO:0019228; GO:0019233; GO:0030425; GO:0032342; GO:0034651; GO:0034765; GO:0042383; GO:0042391; GO:0043204; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0099055; GO:0099059; GO:0106134; GO:2000344";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]"
comp33937_c2_seq1;GAXK01018046.1;S4R2P9;9.17E-168;NAC3_MOUSE;Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3);"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]";"calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]"
comp339429_c0_seq1;GAXK01198269.1;Q9QYE6;1.94E-40;GOGA5_MOUSE;Golgin subfamily A member 5 (Golgin-84) (Protein Ret-II) (Protein Sumiko);"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna [GO:0031985]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]";"GO:0000137; GO:0000138; GO:0000139; GO:0000301; GO:0005794; GO:0005797; GO:0005801; GO:0007030; GO:0016021; GO:0017137; GO:0030663; GO:0030674; GO:0031985; GO:0042803; GO:0048193";"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]";"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna [GO:0031985]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]";"protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp33944_c0_seq1;GAXK01017803.1;Q16975;0;KPC2_APLCA;Calcium-independent protein kinase C (EC 2.7.11.13) (APL II);"membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556]";"GO:0004697; GO:0005524; GO:0016020; GO:0035556; GO:0046872";intracellular signal transduction [GO:0035556];membrane [GO:0016020];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp3395_c0_seq1;GAXK01175261.1;P05547;1.59E-58;TNNI_ASTLP;Troponin I (TnI);"troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]";"GO:0003779; GO:0005861; GO:0046872";;troponin complex [GO:0005861];"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp33950_c0_seq1;GAXK01017882.1;Q8MP06;2.78E-36;SNO1_TYRJA;Senecionine N-oxygenase (SNO) (EC 1.14.13.101);"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]";"GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114";"alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]"
comp3395215_c0_seq1;GAXK01110627.1;O61231;4.52E-55;RL10_DROME;60S ribosomal protein L10 (QM protein homolog) (dQM);"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]";structural constituent of ribosome [GO:0003735]
comp339596_c0_seq1;GAXK01198313.1;Q8HXD5;1.08E-07;RN220_MACFA;E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp3396_c0_seq1;GAXK01175643.1;Q02790;1.29E-144;FKBP4_HUMAN;Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed];"axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]";"GO:0000413; GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0061077; GO:0070062; GO:1900034";"androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein-containing complex localization [GO:0031503]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]";"axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]"
comp339604_c0_seq1;GAXK01198274.1;Q7KRI2;1.65E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3396144_c0_seq1;GAXK01165090.1;A2A935;3.90E-09;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp3396734_c0_seq1;GAXK01165081.1;P09478;1.49E-16;ACH1_DROME;Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp339697_c1_seq1;GAXK01198267.1;Q6UPE0;0;CHDH_RAT;Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1);"mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005743; GO:0008812; GO:0019285; GO:0050660";glycine betaine biosynthetic process from choline [GO:0019285];mitochondrial inner membrane [GO:0005743];"choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]"
comp339700_c0_seq1;GAXK01198283.1;Q03426;8.82E-74;KIME_HUMAN;Mevalonate kinase (MK) (EC 2.7.1.36);"cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; regulation of cholesterol biosynthetic process [GO:0045540]";"GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0019287; GO:0042802; GO:0045540; GO:0050728";"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; regulation of cholesterol biosynthetic process [GO:0045540]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]"
comp3397263_c0_seq1;GAXK01165102.1;Q8HY82;4.10E-07;CATS_SAIBB;Cathepsin S (EC 3.4.22.27);"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]";"GO:0005764; GO:0008234";;lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp339736_c1_seq1;GAXK01198213.1;Q9NHW7;3.26E-39;AQP_AEDAE;Aquaporin AQPAe.a;"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp339746_c0_seq1;GAXK01198345.1;P50257;6.47E-38;EF1AS_PORPU;Elongation factor 1-alpha S (EF-1-alpha S) (Sporophyte-specific EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp339816_c0_seq1;GAXK01198277.1;Q4PRC9;2.36E-09;SL4_DABSI;Snaclec 4 (C-type lectin-like 4);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3398429_c0_seq1;GAXK01086994.1;Q68Y21;1.38E-33;GRID2_DANRE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp3398514_c0_seq1;GAXK01086998.1;Q96JB1;0;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp339995_c0_seq1;GAXK01198286.1;Q9YGN6;1.15E-74;SMUG1_XENLA;Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-);"nucleus [GO:0005634]; DNA binding [GO:0003677]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; base-excision repair [GO:0006284]";"GO:0003677; GO:0005634; GO:0006284; GO:0017065";base-excision repair [GO:0006284];nucleus [GO:0005634];"DNA binding [GO:0003677]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]"
comp34_c0_seq1;GAXK01168701.1;Q24439;2.01E-61;ATPO_DROME;ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP);"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"GO:0005739; GO:0005756; GO:0042776; GO:0046933; GO:1902600";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]";proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]
comp3400_c0_seq1;GAXK01175666.1;Q9Y2X3;0;NOP58_HUMAN;Nucleolar protein 58 (Nucleolar protein 5);"box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]";"GO:0001094; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761";"rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]";"box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]";"ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]"
comp3400262_c0_seq1;GAXK01186740.1;P42577;2.95E-70;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp34003_c1_seq1;GAXK01161314.1;Q3ZBK1;4.09E-23;WDR89_BOVIN;WD repeat-containing protein 89;;;;;
comp3400372_c0_seq1;GAXK01186729.1;Q5RAX9;3.64E-13;PRD10_PONAB;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0003677; GO:0005634; GO:0008168; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp34005_c0_seq1;GAXK01161291.1;Q32PC3;1.68E-07;RM27_BOVIN;39S ribosomal protein L27, mitochondrial (L27mt) (MRP-L27);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005743; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp34010_c1_seq1;GAXK01161802.1;P55268;0;LAMB2_HUMAN;Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; post-translational protein modification [GO:0043687]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]";"GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0030198; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0043260; GO:0043687; GO:0044267; GO:0048677; GO:0060041; GO:0062023; GO:0070062; GO:0070831; GO:0072249; GO:0072274";"animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; post-translational protein modification [GO:0043687]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; laminin complex [GO:0043256]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083]";"extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]"
comp3401914_c0_seq1;GAXK01186743.1;Q61625;9.35E-14;GRID2_MOUSE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0007157; GO:0008066; GO:0008328; GO:0010975; GO:0014069; GO:0016020; GO:0021707; GO:0030054; GO:0030165; GO:0034613; GO:0035249; GO:0036477; GO:0042802; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0097110; GO:0098688; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861; GO:1905606";"cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]";"glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp3402335_c0_seq1;GAXK01185263.1;Q9DBI0;1.94E-10;TMPS6_MOUSE;Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016021; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264";"cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3402443_c0_seq1;GAXK01185248.1;Q63099;8.27E-29;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp3402830_c0_seq1;GAXK01185244.1;Q5XGG3;4.06E-11;PIHD2_XENTR;PIH1 domain-containing protein 2;"cytoplasm [GO:0005737]; R2TP complex [GO:0097255]; box C/D snoRNP assembly [GO:0000492]; rRNA processing [GO:0006364]";"GO:0000492; GO:0005737; GO:0006364; GO:0097255";"box C/D snoRNP assembly [GO:0000492]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; R2TP complex [GO:0097255]";
comp340319_c2_seq1;GAXK01027441.1;Q7Z5J4;1.60E-15;RAI1_HUMAN;Retinoic acid-induced protein 1;"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; enhancer binding [GO:0035326]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; skeletal system development [GO:0001501]";"GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0032922; GO:0035326; GO:0040015; GO:0044212; GO:0045893; GO:0045944; GO:0046872";"circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; enhancer binding [GO:0035326]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp340349_c0_seq1;GAXK01027421.1;P53356;1.93E-174;HTK16_HYDVU;Tyrosine-protein kinase HTK16 (EC 2.7.10.2);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524";;;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp34036_c0_seq1;GAXK01161408.1;Q8N1B3;4.15E-60;CCNQ_HUMAN;Cyclin-Q (CDK10-activating cyclin) (Cyclin-M) (Cyclin-related protein FAM58A);"nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016538";regulation of transcription by RNA polymerase II [GO:0006357];nucleus [GO:0005634];cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]
comp340397_c1_seq1;GAXK01027374.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp340398_c0_seq1;GAXK01027344.1;Q4V7Y4;1.27E-09;DAZLB_XENLA;Deleted in azoospermia-like-B (DAZ-like protein B) (xDazl-B);"cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003730; GO:0005737; GO:0007275; GO:0007281; GO:0007283; GO:0008354; GO:0008494; GO:0032019; GO:0045948; GO:0048477";"germ cell development [GO:0007281]; germ cell migration [GO:0008354]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]";"mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]"
comp340404_c0_seq1;GAXK01027447.1;O55226;6.90E-27;CHAD_MOUSE;Chondroadherin (Cartilage leucine-rich protein);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]";"GO:0005615; GO:0031012; GO:0060348; GO:1900155";"bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";
comp340426_c1_seq1;GAXK01027355.1;Q02388;6.13E-10;CO7A1_HUMAN;Collagen alpha-1(VII) chain (Long-chain collagen) (LC collagen);"basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; COPII vesicle coating [GO:0048208]; endodermal cell differentiation [GO:0035987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]";"GO:0000139; GO:0003429; GO:0004867; GO:0005576; GO:0005590; GO:0005604; GO:0005615; GO:0005788; GO:0006888; GO:0007155; GO:0008544; GO:0030020; GO:0030134; GO:0030198; GO:0031012; GO:0033116; GO:0035987; GO:0048208; GO:0062023";"cell adhesion [GO:0007155]; COPII vesicle coating [GO:0048208]; endodermal cell differentiation [GO:0035987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen type VII trimer [GO:0005590]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";"extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp3404303_c0_seq1;GAXK01059331.1;P97717;1.50E-07;ADA1B_MOUSE;Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor);"caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; glucose homeostasis [GO:0042593]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]; response to amphetamine [GO:0001975]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542]";"GO:0001974; GO:0001975; GO:0001987; GO:0001994; GO:0001996; GO:0001997; GO:0004935; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007188; GO:0007200; GO:0007204; GO:0007512; GO:0007626; GO:0008542; GO:0009725; GO:0014704; GO:0016020; GO:0016021; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0045818; GO:0045819; GO:0045907; GO:0045987; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; glucose homeostasis [GO:0042593]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]; response to amphetamine [GO:0001975]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]";"adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]"
comp340470_c0_seq1;GAXK01027347.1;Q9VW15;5.63E-68;ASH1_DROME;Histone-lysine N-methyltransferase ash1 (EC 2.1.1.43) (Absent small and homeotic disks protein 1) (Lysine N-methyltransferase 2H);"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000785; GO:0001700; GO:0003682; GO:0005634; GO:0005700; GO:0006355; GO:0010452; GO:0010628; GO:0016571; GO:0018991; GO:0032991; GO:0034770; GO:0035035; GO:0035097; GO:0042054; GO:0042800; GO:0042802; GO:0046872; GO:0046975; GO:0048096; GO:0048477; GO:0051567; GO:0051568; GO:0061086; GO:0097676";"chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp3404733_c0_seq1;GAXK01059329.1;Q92482;8.44E-39;AQP3_HUMAN;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"GO:0002684; GO:0003091; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323; GO:0032526; GO:0033280; GO:0042476; GO:0045616; GO:0051592; GO:0070295; GO:0071456; GO:0090650";"cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp3405672_c0_seq1;GAXK01059324.1;Q8CG14;2.77E-19;CS1A_MOUSE;"Complement C1s-A subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s-A) [Cleaved into: Complement C1s-A subcomponent heavy chain; Complement C1s-A subcomponent light chain]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";"GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006958; GO:0042802; GO:0045087";"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]"
comp34057_c3_seq1;GAXK01161180.1;Q62384;2.06E-162;ZPR1_MOUSE;Zinc finger protein ZPR1 (Zinc finger protein 259);"axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]";"GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672";"apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]";"axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]";"receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]"
comp3405722_c0_seq1;GAXK01059326.1;Q9VWH4;6.69E-89;IDH3A_DROME;Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp340588_c0_seq1;GAXK01027366.1;P24399;4.48E-40;ZN239_MOUSE;Zinc finger protein 239 (Zfp-239) (Zinc finger protein MOK-2);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp340614_c1_seq1;GAXK01027459.1;Q9R1S8;0;CAN7_MOUSE;Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH);"nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541]; positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";"GO:0004175; GO:0004198; GO:0005634; GO:0006508; GO:0010634; GO:0090541; GO:0097264";"positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]";nucleus [GO:0005634];"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541]"
comp3406563_c0_seq1;GAXK01152707.1;Q9N295;1.73E-27;B3GT5_PANTR;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp340675_c0_seq1;GAXK01027420.1;P52953;1.78E-30;MSX2_RAT;Homeobox protein MSX-2 (Homeobox protein Hox-8-1) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cartilage development [GO:0051216]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001649; GO:0002076; GO:0005634; GO:0006366; GO:0010942; GO:0043065; GO:0044212; GO:0045892; GO:0048598; GO:0051216";"cartilage development [GO:0051216]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp340739_c0_seq1;GAXK01027373.1;P45890;3.45E-09;ARP6_DROME;Actin-related protein 6 (dArp6) (Actin-like protein 13E);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; heterochromatin organization [GO:0070828]; histone exchange [GO:0043486]";"GO:0000785; GO:0000812; GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486; GO:0070828";"heterochromatin organization [GO:0070828]; histone exchange [GO:0043486]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]";"chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]"
comp34075_c0_seq1;GAXK01161755.1;P92204;6.18E-74;NELFE_DROME;Negative elongation factor E;"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000122; GO:0003723; GO:0003729; GO:0005634; GO:0005694; GO:0006368; GO:0008023; GO:0017053; GO:0032021; GO:0032785; GO:0034244; GO:0045944";"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription elongation factor complex [GO:0008023]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp3407859_c0_seq1;GAXK01152705.1;Q8T880;1.30E-07;AXP83_CIOIN;Axonemal 84 kDa protein (Ci-AXP83.9) (p83.9);;;;;
comp340786_c0_seq1;GAXK01027489.1;Q4R366;4.01E-24;MRPP3_MACFA;Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3);"mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]; mitochondrial tRNA 5'-end processing [GO:0097745]";"GO:0004526; GO:0030678; GO:0042645; GO:0046872; GO:0097745";mitochondrial tRNA 5'-end processing [GO:0097745];"mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]";"metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]"
comp340798_c2_seq1;GAXK01027488.1;Q8K248;6.54E-56;HPDL_MOUSE;4-hydroxyphenylpyruvate dioxygenase-like protein (EC 1.13.-.-) (Glyoxalase domain-containing protein 1);"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]";"GO:0003868; GO:0009072; GO:0046872";aromatic amino acid family metabolic process [GO:0009072];;"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]"
comp340863_c0_seq1;GAXK01027458.1;Q9UTA9;1.38E-11;YL89_SCHPO;Uncharacterized methyltransferase C25B8.09 (EC 2.1.1.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular carbohydrate metabolic process [GO:0044262]; cellular detoxification [GO:1990748]";"GO:0005634; GO:0005829; GO:0044262; GO:0046547; GO:1990748";"cellular carbohydrate metabolic process [GO:0044262]; cellular detoxification [GO:1990748]";"cytosol [GO:0005829]; nucleus [GO:0005634]";trans-aconitate 3-methyltransferase activity [GO:0046547]
comp34091_c2_seq1;GAXK01161727.1;Q9HAN9;3.04E-74;NMNA1_HUMAN;Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; nucleotide biosynthetic process [GO:0009165]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]";"GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0019674; GO:0042802; GO:0043410; GO:0043524; GO:1902511; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; nucleotide biosynthetic process [GO:0009165]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]"
comp34093_c0_seq1;GAXK01161701.1;Q6NZT6;3.51E-21;I2B2A_DANRE;Interferon regulatory factor 2-binding protein 2-A (IRF-2-binding protein 2-A) (IRF-2BP2-A);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]";"GO:0000977; GO:0001228; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp34094_c2_seq1;GAXK01161801.1;O00429;0;DNM1L_HUMAN;Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1);"brush border [GO:0005903]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein homotetramerization [GO:0051289]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of protein oligomerization [GO:0032459]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle recycling via endosome [GO:0036466]";"GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030054; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032459; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048312; GO:0048471; GO:0048488; GO:0048511; GO:0050714; GO:0051259; GO:0051289; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244";"apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein homotetramerization [GO:0051289]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of protein oligomerization [GO:0032459]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle recycling via endosome [GO:0036466]";"brush border [GO:0005903]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]";"BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]"
comp340956_c0_seq1;GAXK01027442.1;P59889;5.09E-15;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp34106_c1_seq1;GAXK01161807.1;Q9VWA8;9.21E-55;FRG1_DROME;Protein FRG1 homolog;"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; muscle organ development [GO:0007517]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of histone H4-K20 methylation [GO:0070511]; rRNA processing [GO:0006364]";"GO:0005730; GO:0005737; GO:0006364; GO:0007517; GO:0015030; GO:0030018; GO:0031936; GO:0051015; GO:0055120; GO:0070511; GO:0071013";"muscle organ development [GO:0007517]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of histone H4-K20 methylation [GO:0070511]; rRNA processing [GO:0006364]";"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]";actin filament binding [GO:0051015]
comp34107_c0_seq1;GAXK01161666.1;Q8STF0;7.77E-49;CALM_STRIE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3411033_c0_seq1;GAXK01162418.1;Q8TF32;1.10E-19;ZN431_HUMAN;Zinc finger protein 431;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0043433; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3411813_c0_seq1;GAXK01162414.1;Q10462;1.32E-17;CAH5_CAEEL;Putative carbonic anhydrase 5 (EC 4.2.1.1) (Carbonate dehydratase 5);"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp3412406_c0_seq1;GAXK01154246.1;O13046;6.31E-08;WDHD1_XENLA;WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]";"GO:0003677; GO:0005654; GO:0005737";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp3412813_c0_seq1;GAXK01154243.1;P61270;1.71E-67;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp34129_c2_seq1;GAXK01161946.1;Q9R0K7;0;AT2B2_MOUSE;Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; cerebellar granule cell differentiation [GO:0021707]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; cerebellum development [GO:0021549]; cGMP metabolic process [GO:0046068]; cochlea development [GO:0090102]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; lactation [GO:0007595]; locomotion [GO:0040011]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; organelle organization [GO:0006996]; otolith mineralization [GO:0045299]; positive regulation of calcium ion transport [GO:0051928]; regulation of cell size [GO:0008361]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; serotonin metabolic process [GO:0042428]; synapse organization [GO:0050808]";"GO:0000902; GO:0005388; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005783; GO:0005886; GO:0005929; GO:0006816; GO:0006874; GO:0006996; GO:0007595; GO:0007605; GO:0007626; GO:0008022; GO:0008361; GO:0016324; GO:0021549; GO:0021692; GO:0021702; GO:0021707; GO:0030054; GO:0030165; GO:0030182; GO:0030425; GO:0030899; GO:0032809; GO:0035254; GO:0040011; GO:0042428; GO:0042472; GO:0043025; GO:0045121; GO:0045299; GO:0046068; GO:0048167; GO:0048839; GO:0050808; GO:0050885; GO:0050910; GO:0051480; GO:0051928; GO:0060088; GO:0060113; GO:0090102; GO:0098688; GO:0098839; GO:0098978; GO:0098982; GO:0099055; GO:0099059; GO:0099061; GO:1905056; GO:1905059";"auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; cerebellar granule cell differentiation [GO:0021707]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; cerebellum development [GO:0021549]; cGMP metabolic process [GO:0046068]; cochlea development [GO:0090102]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; lactation [GO:0007595]; locomotion [GO:0040011]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; organelle organization [GO:0006996]; otolith mineralization [GO:0045299]; positive regulation of calcium ion transport [GO:0051928]; regulation of cell size [GO:0008361]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; serotonin metabolic process [GO:0042428]; synapse organization [GO:0050808]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]";"ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]"
comp3413_c2_seq1;GAXK01175974.1;Q24117;7.86E-60;DYL1_DROME;Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein);"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]";"GO:0000132; GO:0003774; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582";"actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; wing disc development [GO:0035220]";"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]";"disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]"
comp3413061_c0_seq1;GAXK01154240.1;P36609;1.12E-45;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp341314_c6_seq1;GAXK01027378.1;P52297;3.74E-11;IMB_XENLA;Importin subunit beta (Importin-90) (Karyopherin subunit beta) (p97);"cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]";"GO:0005635; GO:0005737; GO:0006606; GO:0008536";protein import into nucleus [GO:0006606];"cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]";Ran GTPase binding [GO:0008536]
comp3413258_c0_seq1;GAXK01154238.1;Q0WVE9;3.12E-12;PLST1_ARATH;Probable plastidic glucose transporter 1;"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]";"GO:0008643; GO:0016021; GO:0022857; GO:0031969";carbohydrate transport [GO:0008643];"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]";transmembrane transporter activity [GO:0022857]
comp34137_c0_seq1;GAXK01161111.1;Q32P85;2.33E-30;DLRB2_BOVIN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505";microtubule-based movement [GO:0007018];"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp341389_c0_seq1;GAXK01027370.1;Q9BQK8;7.04E-25;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp3414710_c0_seq1;GAXK01128222.1;Q8SWR3;1.09E-26;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp34149_c0_seq1;GAXK01161857.1;Q5T280;1.71E-106;CI114_HUMAN;Putative methyltransferase C9orf114 (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1);"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]; methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]";"GO:0000776; GO:0000777; GO:0003723; GO:0005737; GO:0007049; GO:0008168; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686";"cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]";"methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]"
comp3415_c0_seq1;GAXK01176471.1;O17287;6.15E-09;TOM22_CAEEL;Mitochondrial import receptor subunit TOM22 homolog;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; intracellular protein transport [GO:0006886]";"GO:0005741; GO:0006886; GO:0016021";intracellular protein transport [GO:0006886];"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";
comp341512_c2_seq1;GAXK01027333.1;Q28FE8;9.50E-20;ADAT1_XENTR;tRNA-specific adenosine deaminase 1 (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase);"metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA processing [GO:0008033]";"GO:0003723; GO:0008033; GO:0008251; GO:0046872";tRNA processing [GO:0008033];;"metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp34153_c1_seq1;GAXK01161748.1;Q9VI82;2.57E-108;NOC3L_DROME;Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein);"nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]";"GO:0003682; GO:0005634; GO:0005730";;"nucleolus [GO:0005730]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp34154_c0_seq1;GAXK01161639.1;Q502G5;3.85E-41;CA050_DANRE;Uncharacterized protein C1orf50 homolog;;;;;
comp3416_c0_seq1;GAXK01175653.1;Q1HPW4;3.90E-161;EIF3I_BOMMO;Eukaryotic translation initiation factor 3 subunit I (eIF3i);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp341637_c1_seq1;GAXK01027451.1;Q8IN81;2.17E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3416505_c0_seq1;GAXK01180851.1;P25773;5.07E-15;CATL1_FELCA;Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Progesterone-dependent protein) (PDP) (Fragment);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004175; GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";"cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]"
comp341706_c0_seq1;GAXK01027448.1;O13097;1.84E-16;EFNB1_XENLA;Ephrin-B1 (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) (XlERK);"integral component of membrane [GO:0016021]; ephrin receptor binding [GO:0046875]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0046875; GO:0048013";"cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];ephrin receptor binding [GO:0046875]
comp34177_c0_seq1;GAXK01161987.1;Q6PI48;2.30E-167;SYDM_HUMAN;Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000049; GO:0004815; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006418; GO:0042803; GO:0043039; GO:0050560; GO:0070145";"mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"aspartate-tRNA(Asn) ligase activity [GO:0050560]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]"
comp34178_c0_seq1;GAXK01161873.1;Q8RY89;7.23E-19;PI5K8_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 8 (AtPIP5K8) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 8) (Diphosphoinositide kinase 8) (PtdIns(4)P-5-kinase 8);"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]";"GO:0005524; GO:0016308";;;"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp3418229_c0_seq1;GAXK01203055.1;Q8VIG1;2.34E-14;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp341852_c1_seq1;GAXK01027331.1;Q8R0M8;2.56E-47;MOT5_MOUSE;Monocarboxylate transporter 5 (MCT 5);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp341888_c0_seq1;GAXK01027443.1;Q66KU1;1.32E-09;CLC3A_XENLA;C-type lectin domain family 3 member A homolog (C-type lectin superfamily member 1 homolog);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp3419560_c0_seq1;GAXK01203049.1;B3EWZ3;5.45E-28;CADN_ACRMI;Coadhesin (Fragment);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp342_c1_seq1;GAXK01170137.1;P26967;5.96E-07;CU20_TENMO;Adult-specific cuticular protein ACP-20;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp3420329_c0_seq1;GAXK01073764.1;A0A1I8M2I8;4.42E-19;CWC22_MUSDO;Pre-mRNA-splicing factor CWC22 homolog (Nucampholin);"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0006397; GO:0008380; GO:0016607";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];RNA binding [GO:0003723]
comp3421621_c0_seq1;GAXK01073753.1;P51410;6.07E-73;RL9_MOUSE;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003735; GO:0006412; GO:0019843; GO:0022625; GO:0045202";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3421755_c0_seq1;GAXK01073747.1;P39057;5.52E-60;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp34218_c0_seq1;GAXK01161238.1;Q92973;0;TNPO1_HUMAN;Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]";"GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0008536; GO:0016032; GO:0035735; GO:0043488; GO:0061608; GO:0070062";"intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]"
comp3421896_c0_seq1;GAXK01073748.1;Q5SPP5;1.13E-72;EFR3B_DANRE;Protein EFR3 homolog B;"plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";"GO:0005886; GO:0046854; GO:0072659";"phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";plasma membrane [GO:0005886];
comp34219_c1_seq1;GAXK01161107.1;Q3V1V3;3.91E-75;ESF1_MOUSE;ESF1 homolog (ABT1-associated protein);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005654; GO:0005730; GO:0006364";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";RNA binding [GO:0003723]
comp34222_c0_seq1;GAXK01162080.1;Q8K4G1;4.34E-55;LTBP4_MOUSE;Latent-transforming growth factor beta-binding protein 4 (LTBP-4);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; hormone secretion [GO:0046879]; regulation of proteolysis [GO:0030162]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005509; GO:0005615; GO:0007179; GO:0030162; GO:0031012; GO:0046879; GO:0050431; GO:0062023";"hormone secretion [GO:0046879]; regulation of proteolysis [GO:0030162]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]"
comp342227_c0_seq1;GAXK01203012.1;P23193;1.96E-21;TCEA1_HUMAN;Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006283; GO:0006366; GO:0006368; GO:0008270; GO:0045944; GO:1901919";"positive regulation of exoribonuclease activity [GO:1901919]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp3422389_c0_seq1;GAXK01193223.1;P34144;4.41E-46;RAC1A_DICDI;Rho-related protein rac1A;"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of actin filament polymerization [GO:0030838]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000281; GO:0001891; GO:0003924; GO:0005525; GO:0005737; GO:0005811; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016601; GO:0019901; GO:0030036; GO:0030838; GO:0032956; GO:0042995; GO:0045335; GO:0048471";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of actin filament polymerization [GO:0030838]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp342241_c3_seq1;GAXK01203007.1;O15226;1.52E-09;NKRF_HUMAN;NF-kappa-B-repressing factor (NFkB-repressing factor) (Protein ITBA4) (Transcription factor NRF);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3422447_c0_seq1;GAXK01193217.1;Q90YQ6;1.79E-55;RS17_ICTPU;40S ribosomal protein S17;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp342257_c0_seq1;GAXK01202968.1;Q17103;8.14E-09;MYC_ASTRU;Myc protein (c-myc) (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]";"GO:0000981; GO:0003677; GO:0005634; GO:0046983";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]"
comp342282_c0_seq1;GAXK01202771.1;P23607;1.15E-18;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp34231_c1_seq1;GAXK01162054.1;P74615;7.18E-23;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp34235_c0_seq1;GAXK01161816.1;Q803E0;4.11E-15;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp3424772_c0_seq1;GAXK01141093.1;Q9P109;1.61E-09;GCNT4_HUMAN;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993";"carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp342506_c0_seq1;GAXK01202852.1;Q6ZMW2;1.82E-14;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3425209_c1_seq1;GAXK01141083.1;Q13233;2.23E-24;M3K1_HUMAN;Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0002755; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0023014; GO:0031098; GO:0032147; GO:0038095; GO:0071260";"activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"
comp3425365_c0_seq1;GAXK01141091.1;P51414;4.92E-51;RL261_ARATH;60S ribosomal protein L26-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0009409; GO:0022625; GO:0022626; GO:0042273; GO:0042788";"cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp342641_c0_seq1;GAXK01202915.1;Q9I7U4;2.88E-19;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp3426631_c0_seq1;GAXK01114941.1;Q6P2X9;1.05E-09;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp342683_c1_seq1;GAXK01202787.1;Q7KRI2;3.23E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3427548_c0_seq1;GAXK01114942.1;P34371;5.60E-07;BAT42_CAEEL;BTB and MATH domain-containing protein 42;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3428_c0_seq1;GAXK01175532.1;Q4R6J2;3.80E-101;HSP7E_MACFA;Heat shock 70 kDa protein 14;"cytosol [GO:0005829]; ribosome [GO:0005840]; ATP binding [GO:0005524]";"GO:0005524; GO:0005829; GO:0005840";;"cytosol [GO:0005829]; ribosome [GO:0005840]";ATP binding [GO:0005524]
comp342802_c0_seq1;GAXK01202949.1;Q2KHS5;6.83E-99;MOG2A_XENLA;2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"GO:0003846; GO:0005789; GO:0006071; GO:0016021; GO:0019432; GO:1990578";"glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]";2-acylglycerol O-acyltransferase activity [GO:0003846]
comp34282_c0_seq1;GAXK01161398.1;Q9BW85;1.64E-67;YJU2_HUMAN;Splicing factor YJU2 (Coiled-coil domain-containing protein 94);"U2-type catalytic step 1 spliceosome [GO:0071006]; metal ion binding [GO:0046872]; mRNA processing [GO:0006397]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]";"GO:0006397; GO:0008380; GO:0043518; GO:0046872; GO:0071006";"mRNA processing [GO:0006397]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]";U2-type catalytic step 1 spliceosome [GO:0071006];metal ion binding [GO:0046872]
comp342821_c0_seq1;GAXK01202908.1;Q9D8U4;6.58E-10;C1QT2_MOUSE;Complement C1q tumor necrosis factor-related protein 2 (mCTRP2);"collagen trimer [GO:0005581]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; activation of MAPK activity [GO:0000187]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]";"GO:0000187; GO:0005102; GO:0005581; GO:0005615; GO:0032991; GO:0042802; GO:0045725; GO:0046321; GO:0046326; GO:0051260; GO:0070208";"activation of MAPK activity [GO:0000187]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]";"collagen trimer [GO:0005581]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]"
comp3428901_c0_seq1;GAXK01115785.1;Q24307;7.13E-12;DIAP2_DROME;Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001";"chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp34290_c0_seq1;GAXK01162000.1;Q7ZUH5;6.09E-31;RM14_DANRE;39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp342936_c4_seq1;GAXK01202962.1;Q7ZYC4;5.31E-161;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp3429807_c0_seq1;GAXK01115777.1;P34886;5.26E-24;MEC10_CAEEL;Degenerin mec-10 (Mechanosensory abnormality protein 10);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ligand-gated sodium channel activity [GO:0015280]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015280; GO:0016021; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ligand-gated sodium channel activity [GO:0015280]
comp34303_c0_seq1;GAXK01161823.1;Q9Y3C4;3.25E-19;TPRKB_HUMAN;EKC/KEOPS complex subunit TPRKB (PRPK-binding protein) (TP53RK-binding protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949]";"GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0005829; GO:0019901";tRNA threonylcarbamoyladenosine modification [GO:0002949];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp343039_c1_seq1;GAXK01202838.1;Q6ZSS7;9.55E-10;MFSD6_HUMAN;Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog);"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp34305_c2_seq1;GAXK01161999.1;Q502M5;3.75E-79;EDC3_DANRE;Enhancer of mRNA-decapping protein 3 (LSM16 protein homolog) (YjeF domain-containing protein 1);"P-body [GO:0000932]; mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]";"GO:0000932; GO:0003729; GO:0031087; GO:0033962; GO:1990174";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]";P-body [GO:0000932];"mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]"
comp343057_c0_seq1;GAXK01202848.1;Q6GNV7;2.28E-47;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp343090_c0_seq2;GAXK01202960.1;P13360;9.05E-10;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3431390_c0_seq1;GAXK01027628.1;P09478;2.08E-23;ACH1_DROME;Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp3431454_c0_seq1;GAXK01027633.1;Q90Z05;2.85E-11;VNG2B_XENLA;Vang-like protein 2-B (Protein strabismus-B) (Van Gogh-like protein 2-B) (Xstrabismus-B) (Xstbm-B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nervous system development [GO:0007399]; Wnt signaling pathway [GO:0016055]";"GO:0001736; GO:0005886; GO:0007399; GO:0016021; GO:0016055; GO:0060027; GO:0090090";"convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nervous system development [GO:0007399]; Wnt signaling pathway [GO:0016055]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp343174_c0_seq1;GAXK01203000.1;P15619;2.50E-10;SRYC_DROME;Serendipity locus protein H-1 (Protein pourquoi-pas) (Protein wings-down);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3432043_c0_seq1;GAXK01080014.1;Q8IVF4;3.58E-35;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp3432570_c0_seq1;GAXK01080013.1;Q9JHI5;2.29E-70;IVD_MOUSE;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]";"GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0031966; GO:0033539; GO:0050660";"fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]"
comp343267_c0_seq1;GAXK01202719.1;P10075;2.12E-15;GLI4_HUMAN;Zinc finger protein GLI4 (Krueppel-related zinc finger protein 4) (Protein HKR4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3432699_c0_seq1;GAXK01080019.1;P25600;1.44E-12;YCH4_YEAST;Putative transposon Ty5-1 protein YCL074W;"retrotransposon nucleocapsid [GO:0000943]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003723; GO:0003887; GO:0003964; GO:0004540; GO:0008233; GO:0032197";transposition, RNA-mediated [GO:0032197];retrotransposon nucleocapsid [GO:0000943];"DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3432850_c0_seq1;GAXK01080022.1;Q0V9S9;4.88E-12;DRC7_XENTR;Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]";"GO:0005737; GO:0005856; GO:0030317; GO:0031514; GO:0048870";"cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";
comp34334_c2_seq1;GAXK01161665.1;P87053;8.64E-13;POF1_SCHPO;F-box/WD repeat-containing protein pof1 (Skp1-binding protein 1);"COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein binding, bridging [GO:0030674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0005634; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0019005; GO:0030126; GO:0030674; GO:0031146";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";protein binding, bridging [GO:0030674]
comp343387_c1_seq1;GAXK01202905.1;Q499N5;1.49E-176;ACSF2_RAT;Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760";fatty acid metabolic process [GO:0006631];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]"
comp3434721_c0_seq1;GAXK01055773.1;Q95R48;1.28E-22;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp343510_c0_seq1;GAXK01202940.1;Q10715;0;ACE_HAEIX;Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II);"extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]";"GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872";;"extracellular space [GO:0005615]; membrane [GO:0016020]";"carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]"
comp343532_c0_seq1;GAXK01202910.1;Q8R550;2.87E-23;SH3K1_MOUSE;SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of cell shape [GO:0008360]";"GO:0005737; GO:0005856; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202";"actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of cell shape [GO:0008360]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]";"SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]"
comp3435612_c0_seq1;GAXK01055762.1;Q95L11;3.70E-32;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp343572_c0_seq1;GAXK01202809.1;Q96KG7;8.14E-37;MEG10_HUMAN;Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10);"cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]";"GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742";"apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]";"cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]";"complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]"
comp343620_c0_seq1;GAXK01202903.1;Q8NFZ3;4.41E-48;NLGNY_HUMAN;Neuroligin-4, Y-linked (Neuroligin Y);"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0014069; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054";"learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp343640_c2_seq1;GAXK01202961.1;P34559;3.02E-35;ECHM_CAEEL;Probable enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]";"GO:0004300; GO:0005739; GO:0005759; GO:0006635";fatty acid beta-oxidation [GO:0006635];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";enoyl-CoA hydratase activity [GO:0004300]
comp343728_c0_seq1;GAXK01202948.1;B0JYZ2;3.56E-56;PEX16_XENTR;Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16);"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome organization [GO:0007031]";"GO:0005778; GO:0007031; GO:0016021";peroxisome organization [GO:0007031];"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp343740_c0_seq1;GAXK01202967.1;P10076;1.15E-57;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp34375_c9_seq1;GAXK01161316.1;O95071;3.94E-63;UBR5_HUMAN;E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; viral process [GO:0016032]";"GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0016032; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000780";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; viral process [GO:0016032]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]"
comp343759_c0_seq1;GAXK01203010.1;Q8TF72;5.08E-15;SHRM3_HUMAN;Protein Shroom3 (Shroom-related protein) (hShrmL);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]";actin filament binding [GO:0051015]
comp3437732_c0_seq1;GAXK01058319.1;Q80SU7;2.14E-19;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp3437798_c0_seq1;GAXK01058312.1;O96860;3.66E-52;DYL2_DROME;Dynein light chain 2, cytoplasmic (8 kDa dynein light chain);"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp34380_c1_seq1;GAXK01161570.1;Q8BHN5;2.76E-42;RBM45_MOUSE;RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:1990904";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp343820_c0_seq1;GAXK01202942.1;Q9NY43;4.58E-42;BARH2_HUMAN;BarH-like 2 homeobox protein;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; cell fate determination [GO:0001709]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; positive regulation of translation [GO:0045727]; regulation of axon extension [GO:0030516]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001709; GO:0001764; GO:0005634; GO:0006357; GO:0007399; GO:0009888; GO:0030182; GO:0030516; GO:0045727; GO:0048513";"animal organ development [GO:0048513]; cell fate determination [GO:0001709]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; positive regulation of translation [GO:0045727]; regulation of axon extension [GO:0030516]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3438522_c0_seq1;GAXK01001139.1;P04352;4.31E-09;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp343878_c0_seq1;GAXK01202854.1;Q13637;1.16E-49;RAB32_HUMAN;Ras-related protein Rab-32;"cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032482; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232";"antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]";"AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]"
comp34388_c1_seq1;GAXK01161712.1;Q8BMJ7;2.00E-13;CGRF1_MOUSE;Cell growth regulator with RING finger domain protein 1 (Cell growth regulatory gene 19 protein);"endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; cell cycle arrest [GO:0007050]; negative regulation of cell growth [GO:0030308]";"GO:0005654; GO:0005783; GO:0007050; GO:0030308; GO:0043231; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell growth [GO:0030308]";"endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";metal ion binding [GO:0046872]
comp343912_c0_seq1;GAXK01203015.1;Q11177;6.02E-08;DHS27_CAEEL;Uncharacterized oxidoreductase dhs-27 (EC 1.-.-.-) (Short-chain dehydrogenase 27);"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491";;integral component of membrane [GO:0016021];oxidoreductase activity [GO:0016491]
comp343937_c0_seq1;GAXK01202721.1;O54963;1.63E-18;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3439663_c0_seq1;GAXK01001130.1;P48763;2.81E-17;SL9A2_RAT;Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0051453; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp343978_c0_seq1;GAXK01203009.1;Q05319;2.04E-120;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3440_c1_seq1;GAXK01175735.1;Q5MGH0;2.01E-34;SPI3_LONON;Serine protease inhibitor 3/4 (Serpin-3/4) (Fragment);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp344014_c0_seq1;GAXK01197402.1;Q8CG80;5.48E-22;SHF_MOUSE;SH2 domain-containing adapter protein F;"phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915]";"GO:0001784; GO:0006915";apoptotic process [GO:0006915];;phosphotyrosine residue binding [GO:0001784]
comp3440272_c0_seq1;GAXK01046446.1;Q0ITS8;1.43E-107;RL101_ORYSJ;60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3441_c0_seq1;GAXK01176061.1;Q8I1F4;6.57E-148;FBRL_DROER;rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase);"Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0001651; GO:0003723; GO:0006364; GO:0008168; GO:0015030";rRNA processing [GO:0006364];"Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]";"methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]"
comp34413_c0_seq1;GAXK01162149.1;Q7KRI2;8.86E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp344135_c1_seq1;GAXK01197292.1;Q5HFY5;5.90E-29;TDCB_STAAC;L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (Threonine deaminase);"L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689]";"GO:0000166; GO:0004794; GO:0030170; GO:0070689";L-threonine catabolic process to propionate [GO:0070689];;"L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]"
comp3441578_c0_seq1;GAXK01046450.1;Q91175;1.53E-07;ADA1A_ORYLA;Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);"integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vasoconstriction [GO:0045907]";"GO:0001994; GO:0004935; GO:0004937; GO:0005887; GO:0007188; GO:0007200; GO:0007204; GO:0045907; GO:0045987; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vasoconstriction [GO:0045907]";integral component of plasma membrane [GO:0005887];"adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]"
comp34419_c0_seq1;GAXK01161410.1;Q5XGU5;1.37E-20;DNJ6B_XENLA;DnaJ homolog subfamily B member 6-B;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp344224_c0_seq1;GAXK01197432.1;Q5M823;4.13E-35;NUDC2_RAT;NudC domain-containing protein 2;"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457]";"GO:0000777; GO:0000922; GO:0005737; GO:0005815; GO:0006457; GO:0032502; GO:0051082";"developmental process [GO:0032502]; protein folding [GO:0006457]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";unfolded protein binding [GO:0051082]
comp34431_c1_seq1;GAXK01161304.1;Q8N653;0;LZTR1_HUMAN;Leucine-zipper-like transcriptional regulator 1 (LZTR-1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; DNA-binding transcription factor activity [GO:0003700]; Ras GTPase binding [GO:0017016]; anatomical structure morphogenesis [GO:0009653]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]";"GO:0003700; GO:0005794; GO:0009653; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038";"anatomical structure morphogenesis [GO:0009653]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]";"DNA-binding transcription factor activity [GO:0003700]; Ras GTPase binding [GO:0017016]"
comp344325_c0_seq1;GAXK01197286.1;Q9UQC9;3.04E-52;CLCA2_HUMAN;"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872";"cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3443304_c0_seq1;GAXK01044651.1;Q07078;1.93E-33;HSP83_ORYSJ;Heat shock protein 81-3 (HSP81-3) (Gravity-specific protein GSC 381);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082";"cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3443347_c0_seq1;GAXK01044632.1;Q9P283;4.04E-15;SEM5B_HUMAN;Semaphorin-5B;"integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001755; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485";"axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";integral component of membrane [GO:0016021];"chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]"
comp344382_c0_seq1;GAXK01197391.1;Q9VIS1;3.10E-60;CDGAP_DROME;GTPase-activating protein CdGAPr (d-CdGAPr);"GTPase activator activity [GO:0005096]; retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0007264; GO:0031290";"retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";;GTPase activator activity [GO:0005096]
comp344394_c2_seq1;GAXK01197400.1;Q01295;7.75E-12;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3444118_c0_seq1;GAXK01165111.1;Q10984;1.95E-24;FUT2_RAT;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha 1,2-fucosyltransferase) (Alpha 1,2-fucosyltransferase B) (Alpha 1-2 fucosyltransferase) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (Secretor blood group alpha-2-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp34443_c1_seq1;GAXK01161853.1;Q66JJ4;6.89E-55;TM10A_XENTR;tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]";"GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0009019; GO:0052905; GO:0090646";mitochondrial tRNA processing [GO:0090646];"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]"
comp344443_c0_seq1;GAXK01197389.1;Q921Y4;1.32E-60;MFSD5_MOUSE;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp3445515_c0_seq1;GAXK01165104.1;O61231;8.15E-70;RL10_DROME;60S ribosomal protein L10 (QM protein homolog) (dQM);"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]";structural constituent of ribosome [GO:0003735]
comp3445529_c0_seq1;GAXK01165106.1;A0JNB1;1.25E-16;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp34456_c2_seq1;GAXK01161421.1;P0CH36;2.61E-93;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp3446_c0_seq1;GAXK01175290.1;Q9VXN2;1.71E-14;SUN_DROME;Protein stunted;"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"GO:0000275; GO:0001664; GO:0005615; GO:0005743; GO:0006979; GO:0008340; GO:0015986; GO:0045745; GO:0046933; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]";"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]";"G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp34468_c0_seq1;GAXK01161179.1;Q9Y232;2.53E-39;CDYL_HUMAN;Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-);"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0007283; GO:0007286; GO:0016607; GO:0030674; GO:0035064; GO:0060816; GO:0120092; GO:0120094";"negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]"
comp3446902_c0_seq1;GAXK01114201.1;P08106;4.74E-38;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp3446942_c0_seq1;GAXK01114199.1;Q8MQS8;5.86E-35;SP34_APIME;Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp3447440_c0_seq1;GAXK01114202.1;P41123;1.02E-32;RL13_RAT;60S ribosomal protein L13;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0097421";"liver regeneration [GO:0097421]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp34475_c3_seq1;GAXK01161194.1;O95235;2.47E-91;KI20A_HUMAN;Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6);"cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]";"GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952";"microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]";"cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]"
comp3447943_c0_seq1;GAXK01114196.1;Q3UF64;3.27E-19;RNFT2_MOUSE;RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]";"GO:0016021; GO:0046872";;integral component of membrane [GO:0016021];metal ion binding [GO:0046872]
comp34482_c1_seq1;GAXK01161904.1;P86854;5.36E-17;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp344825_c1_seq1;GAXK01197383.1;Q8K2J9;1.48E-08;BTBD6_MOUSE;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp344828_c0_seq1;GAXK01197285.1;Q9JJR7;1.85E-07;ASCL3_MOUSE;Achaete-scute homolog 3 (ASH-3) (mASH-3) (mASH3) (bHLH transcriptional regulator Sgn-1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0008134; GO:0046983; GO:0090575";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp344861_c0_seq1;GAXK01197287.1;Q3ZBV9;4.82E-37;DHR11_BOVIN;Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1);"extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]";"GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582";estrogen biosynthetic process [GO:0006703];extracellular region [GO:0005576];"17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]"
comp3448984_c0_seq1;GAXK01185280.1;P46286;1.15E-78;RL81_ARATH;60S ribosomal protein L8-1 (60S ribosomal protein L2) (Protein EMBRYO DEFECTIVE 2296);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003729; GO:0003735; GO:0005730; GO:0005739; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0022625; GO:0022626; GO:0042788";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp344934_c0_seq1;GAXK01197441.1;P93748;1.97E-08;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp3449724_c0_seq1;GAXK01185271.1;O15989;1.03E-47;KARG_TURCO;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp344987_c0_seq1;GAXK01197436.1;Q9CWP6;3.26E-41;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp3450_c0_seq1;GAXK01175638.1;Q9VMM6;2.49E-16;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp3450238_c0_seq1;GAXK01012886.1;Q9CHU6;3.20E-55;6PGD_LACLA;6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]";"GO:0004616; GO:0006098; GO:0019521; GO:0050661";"D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]";;"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]"
comp345070_c0_seq1;GAXK01197291.1;Q9UI36;5.01E-47;DACH1_HUMAN;Dachshund homolog 1 (Dach1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279";"cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp34509_c1_seq1;GAXK01161550.1;Q9H3F6;5.99E-116;BACD3_HUMAN;BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0043161; GO:0051260";"negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GTP-Rho binding [GO:0017049]; Notch binding [GO:0005112]"
comp3450965_c0_seq1;GAXK01012885.1;P15364;1.44E-09;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp3451_c1_seq1;GAXK01176644.1;P20397;7.30E-09;NUCL_XENLA;Nucleolin (Protein C23);"nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723]";"GO:0003677; GO:0003723; GO:0005730";;nucleolus [GO:0005730];"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp3451085_c0_seq1;GAXK01012883.1;Q6PGK7;2.48E-08;CHSTA_MOUSE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0007612; GO:0007616; GO:0008146; GO:0016021; GO:0016051; GO:0016232; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]"
comp3451099_c0_seq1;GAXK01012894.1;P91953;1.28E-35;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp345201_c0_seq1;GAXK01197339.1;P25152;7.49E-08;BSAP_BACSU;Aminopeptidase YwaD (Arginyl aminopeptidase) (EC 3.4.11.6) (BSAP) (Leucyl aminopeptidase) (EC 3.4.11.10);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004177; GO:0005576; GO:0006508; GO:0008237; GO:0046872";proteolysis [GO:0006508];extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp345259_c0_seq1;GAXK01197283.1;Q9CZL5;3.66E-27;PHS2_MOUSE;Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; phenylalanine 4-monooxygenase activity [GO:0004505]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"GO:0004505; GO:0005634; GO:0005739; GO:0006729; GO:0008124; GO:0045893; GO:0051289; GO:0051291";"positive regulation of transcription, DNA-templated [GO:0045893]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; phenylalanine 4-monooxygenase activity [GO:0004505]"
comp3453203_c0_seq1;GAXK01080396.1;Q8BTI7;6.41E-10;ANR52_MOUSE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp34534_c0_seq1;GAXK01161766.1;Q5BKW7;7.00E-34;ENPP6_DANRE;Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (E-NPP 6) (NPP-6) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Glycerophosphocholine cholinephosphodiesterase) (GPC-Cpde);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]";"GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0016042; GO:0019695; GO:0031225; GO:0047390";"choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]"
comp3453486_c0_seq1;GAXK01080394.1;P27401;9.89E-15;POL_SFV3L;"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]";"aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp34535_c0_seq1;GAXK01161675.1;P18562;1.03E-40;UPP_YEAST;Uracil phosphoribosyltransferase (UPRTase) (EC 2.4.2.9) (UMP pyrophosphorylase);"intracellular [GO:0005622]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; uracil phosphoribosyltransferase activity [GO:0004845]; nucleoside metabolic process [GO:0009116]; pyrimidine-containing compound salvage [GO:0008655]; UMP salvage [GO:0044206]";"GO:0004845; GO:0005525; GO:0005622; GO:0008655; GO:0009116; GO:0016301; GO:0044206";"nucleoside metabolic process [GO:0009116]; pyrimidine-containing compound salvage [GO:0008655]; UMP salvage [GO:0044206]";intracellular [GO:0005622];"GTP binding [GO:0005525]; kinase activity [GO:0016301]; uracil phosphoribosyltransferase activity [GO:0004845]"
comp345431_c3_seq1;GAXK01197422.1;Q95NQ0;1.46E-20;MTH2_DROSI;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp34544_c0_seq1;GAXK01161806.1;P42639;1.22E-20;TPM1_PIG;Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1);"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]";"GO:0005737; GO:0005884; GO:0007015; GO:0015629; GO:0042802; GO:0042803; GO:0046982; GO:0051015; GO:0060048";"actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]";"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp34549_c1_seq1;GAXK01161108.1;Q6DIR8;2.51E-28;PALD_XENTR;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp3454998_c0_seq1;GAXK01162365.1;Q3YK19;6.51E-166;FANCJ_CHICK;Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1);"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]";"GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006357; GO:0007284; GO:0007286; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0072520; GO:1990918";"chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]";"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"
comp3455324_c0_seq1;GAXK01162367.1;Q3UES3;6.83E-07;TNKS2_MOUSE;Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404";"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]";"enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]"
comp34555_c30_seq1;GAXK01161603.1;Q6NT99;4.55E-34;DUS23_MOUSE;Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]";"GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0016311; GO:0016791";dephosphorylation [GO:0016311];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp34561_c0_seq1;GAXK01161883.1;Q6INX3;3.03E-72;MLECA_XENLA;Malectin-A;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487]";"GO:0005783; GO:0005789; GO:0005975; GO:0006487; GO:0016020; GO:0016021; GO:0030246";"carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";carbohydrate binding [GO:0030246]
comp3456262_c0_seq1;GAXK01135447.1;Q6DRG7;2.55E-08;MYPT1_DANRE;Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit);"A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; signal transduction [GO:0007165]";"GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0046982; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357";"actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; signal transduction [GO:0007165]";"A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]";"14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]"
comp34563_c3_seq1;GAXK01161182.1;P17276;0;PH4H_DROME;Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase);"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";"GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427";"eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";;"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]"
comp345650_c1_seq1;GAXK01197351.1;Q9TZM3;0;LRK1_CAEEL;Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]";"GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215";"axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp345674_c0_seq1;GAXK01197348.1;P30432;3.84E-109;FUR2_DROME;Furin-like protease 2 (Furin-2) (EC 3.4.21.75);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048";"negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp34569_c0_seq1;GAXK01162057.1;Q05974;4.59E-46;RAB1A_LYMST;Ras-related protein Rab-1A;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0015031; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3457792_c0_seq1;GAXK01135444.1;P10925;6.42E-10;ZFY1_MOUSE;Zinc finger Y-chromosomal protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3457938_c0_seq1;GAXK01135449.1;Q9GZS9;1.17E-13;CHST5_HUMAN;Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha) (GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0008146; GO:0016021; GO:0018146; GO:0031228";"carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]";"N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp3458048_c0_seq1;GAXK01047219.1;A1XQS5;1.75E-11;AT5G1_PIG;ATP synthase F(0) complex subunit C1, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 1) (ATP synthase proteolipid P1) (ATPase protein 9) (ATPase subunit c);"integral component of membrane [GO:0016021]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000276; GO:0005753; GO:0008289; GO:0015986; GO:0016021; GO:0045263; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";"lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp3458052_c0_seq1;GAXK01047217.1;Q8VYS0;1.04E-19;RD19D_ARATH;Probable cysteine protease RD19D (EC 3.4.22.-);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp3458602_c0_seq1;GAXK01047223.1;P80010;5.41E-14;PLMN_HORSE;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Plasmin light chain B] (Fragment)";"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp3458781_c0_seq1;GAXK01047230.1;Q8VIG1;2.36E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp34588_c1_seq1;GAXK01161860.1;A7SWD3;2.49E-76;GID8_NEMVE;Glucose-induced degradation protein 8 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0005737; GO:0016055";Wnt signaling pathway [GO:0016055];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp345898_c0_seq1;GAXK01197303.1;Q9H0M4;2.63E-25;ZCPW1_HUMAN;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp3459060_c0_seq1;GAXK01047231.1;Q91X17;3.70E-08;UROM_MOUSE;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266";"chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";"calcium ion binding [GO:0005509]; IgG binding [GO:0019864]"
comp34591_c1_seq1;GAXK01161551.1;Q9ES56;3.80E-93;TPPC4_MOUSE;Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog);"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]";"GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0008021; GO:0016192; GO:0016358; GO:0017112; GO:0030008; GO:0030054; GO:0030425; GO:0045202; GO:0045211; GO:0045212";"dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]";Rab guanyl-nucleotide exchange factor activity [GO:0017112]
comp346_c0_seq1;GAXK01169100.1;P13184;1.57E-07;CX7A2_BOVIN;Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L);"mitochondrial respirasome [GO:0005746]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]";"GO:0002082; GO:0004129; GO:0005746; GO:0097250";"mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]";mitochondrial respirasome [GO:0005746];cytochrome-c oxidase activity [GO:0004129]
comp3460111_c0_seq1;GAXK01001152.1;Q9XTJ4;2.29E-14;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp3460591_c0_seq1;GAXK01001146.1;P23098;0;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3460651_c0_seq1;GAXK01001143.1;F1QEG2;9.46E-08;KL41B_DANRE;Kelch-like protein 41b (Kelch repeat and BTB domain-containing protein 10b);"cytoskeleton [GO:0005856]; sarcoplasmic reticulum membrane [GO:0033017]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"GO:0005856; GO:0033017; GO:0035914; GO:0045214; GO:0048741";"sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"cytoskeleton [GO:0005856]; sarcoplasmic reticulum membrane [GO:0033017]";
comp3461919_c0_seq1;GAXK01001149.1;P20147;1.12E-44;HSP90_PLAFP;Heat shock 90 kDa protein homolog (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3462485_c0_seq1;GAXK01095152.1;Q60417;1.31E-14;SCRB1_CRIGR;Scavenger receptor class B member 1 (SRB1) (HaSR-BI) (SR-BI);"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508";"adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]";"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]";"amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]"
comp3462809_c0_seq1;GAXK01095132.1;P17970;2.20E-69;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp346300_c0_seq1;GAXK01182560.1;Q80TI0;1.46E-07;ASTRB_MOUSE;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp34638_c0_seq1;GAXK01161241.1;Q9VJC7;1.36E-51;EFTS_DROME;Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414]";"GO:0003746; GO:0005739; GO:0005759; GO:0006414; GO:0070125";"mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";translation elongation factor activity [GO:0003746]
comp346419_c0_seq1;GAXK01182561.1;A5LGM7;1.11E-76;TRET1_POLVA;Facilitated trehalose transporter Tret1 (PvTret1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3464266_c0_seq1;GAXK01002995.1;Q8RZB5;1.87E-08;CML10_ORYSJ;Probable calcium-binding protein CML10 (Calmodulin-like protein 10);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp34645_c0_seq1;GAXK01161824.1;Q21502;1.76E-25;MEP1_CAEEL;MOG interacting and ectopic P-granules protein 1 (Nuclear zinc finger protein);"nucleus [GO:0005634]; DEAD/H-box RNA helicase binding [GO:0017151]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription factor binding [GO:0008134]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; hermaphrodite genitalia development [GO:0040035]; nematode larval development [GO:0002119]; oocyte development [GO:0048599]; regulation of gene expression [GO:0010468]; vulval development [GO:0040025]";"GO:0000979; GO:0002119; GO:0003723; GO:0005634; GO:0007506; GO:0008134; GO:0008406; GO:0010468; GO:0017151; GO:0040025; GO:0040035; GO:0042802; GO:0042826; GO:0046872; GO:0048599";"gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; hermaphrodite genitalia development [GO:0040035]; nematode larval development [GO:0002119]; oocyte development [GO:0048599]; regulation of gene expression [GO:0010468]; vulval development [GO:0040025]";nucleus [GO:0005634];"DEAD/H-box RNA helicase binding [GO:0017151]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription factor binding [GO:0008134]"
comp346497_c1_seq1;GAXK01182608.1;Q9TV69;3.16E-20;DHDH_PIG;Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Sus2DD);"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]";"GO:0042843; GO:0047115; GO:0047837";D-xylose catabolic process [GO:0042843];;"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
comp3465_c2_seq1;GAXK01175993.1;P0CB85;4.55E-16;NDUB8_PONAB;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005747; GO:0006120; GO:0008137; GO:0016021; GO:0032981";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp3465279_c0_seq1;GAXK01002998.1;Q0VCC5;5.85E-08;REPI1_BOVIN;Replication initiator 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]";"GO:0003677; GO:0005634; GO:0006260; GO:0046872";DNA replication [GO:0006260];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp346567_c0_seq1;GAXK01182447.1;Q9R044;3.94E-20;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp3465684_c0_seq1;GAXK01003011.1;O61492;6.61E-42;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp346593_c0_seq1;GAXK01182489.1;Q8R1P4;3.70E-17;ATG10_MOUSE;Ubiquitin-like-conjugating enzyme ATG10 (EC 2.3.2.-) (Autophagy-related protein 10) (APG10-like) (mAPG10);"cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]";"GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446";"autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]";cytosol [GO:0005829];Atg12 transferase activity [GO:0019777]
comp34660_c1_seq1;GAXK01161771.1;Q5ZLT0;0;XPO7_CHICK;Exportin-7;"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]";"GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0008536";protein export from nucleus [GO:0006611];"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]";"nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]"
comp346652_c0_seq1;GAXK01182466.1;Q9DCF9;3.41E-12;SSRG_MOUSE;Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005783; GO:0005789; GO:0006614; GO:0016021";SRP-dependent cotranslational protein targeting to membrane [GO:0006614];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp3466625_c0_seq1;GAXK01036643.1;P29240;3.72E-07;5NTD_DIPOM;5'-nucleotidase (EC 3.1.3.5) (Ecto-nucleotidase);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005886; GO:0008253; GO:0009166; GO:0031225; GO:0046872";nucleotide catabolic process [GO:0009166];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp3466667_c0_seq1;GAXK01036630.1;Q80ZF8;2.65E-11;AGRB3_MOUSE;Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0007520; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]";"G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]"
comp34668_c1_seq1;GAXK01161648.1;Q5ZKV4;1.70E-113;NUBP2_CHICK;Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2);"cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]";"GO:0005524; GO:0005634; GO:0005829; GO:0016226; GO:0031616; GO:0046872; GO:0051536; GO:0051539";iron-sulfur cluster assembly [GO:0016226];"cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]";"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"
comp346685_c0_seq1;GAXK01182596.1;Q6IR42;6.72E-27;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp3466976_c0_seq1;GAXK01036645.1;Q9ULJ7;1.64E-12;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp346711_c0_seq1;GAXK01182533.1;Q39799;3.88E-47;CHI1_GOSHI;Endochitinase 1 (EC 3.2.1.14);"chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";;"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp346816_c0_seq1;GAXK01182604.1;A6QPT6;6.84E-10;ZN274_BOVIN;Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of histone H3-K9 trimethylation [GO:1900112]";"GO:0003677; GO:0003682; GO:0003700; GO:0005730; GO:0005737; GO:0046872; GO:1900112";regulation of histone H3-K9 trimethylation [GO:1900112];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp346820_c0_seq1;GAXK01182607.1;A8WN62;1.04E-47;TUB1_CAEBR;Tubby protein homolog 1;"axon [GO:0030424]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; chemotaxis [GO:0006935]; lipid metabolic process [GO:0006629]; protein localization to cilium [GO:0061512]; receptor localization to non-motile cilium [GO:0097500]";"GO:0005737; GO:0005929; GO:0006629; GO:0006935; GO:0030424; GO:0030425; GO:0061512; GO:0097500";"chemotaxis [GO:0006935]; lipid metabolic process [GO:0006629]; protein localization to cilium [GO:0061512]; receptor localization to non-motile cilium [GO:0097500]";"axon [GO:0030424]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]";
comp3468219_c0_seq1;GAXK01075080.1;Q7Z6Z7;3.37E-17;HUWE1_HUMAN;E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043312; GO:0061630; GO:0070062; GO:1903955; GO:1904813";"base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp3468320_c0_seq1;GAXK01075078.1;Q9CXE0;1.42E-08;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3468614_c0_seq1;GAXK01075071.1;Q1LZI2;2.93E-07;S35F3_MOUSE;Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3);"integral component of membrane [GO:0016021]; thiamine transport [GO:0015888]";"GO:0015888; GO:0016021";thiamine transport [GO:0015888];integral component of membrane [GO:0016021];
comp34687_c0_seq1;GAXK01161156.1;P23978;1.76E-164;SC6A1_RAT;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp346914_c1_seq1;GAXK01182481.1;Q2V2M9;1.90E-66;FHOD3_HUMAN;FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2);"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003";"actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp34695_c0_seq1;GAXK01161653.1;P53624;0;MA1A1_DROME;Mannosyl-oligosaccharide alpha-1,2-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Mannosidase-1);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]";"GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0006486; GO:0006491; GO:0008340; GO:0012505; GO:0016021; GO:0035010; GO:0072347";"determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
comp347023_c2_seq1;GAXK01182521.1;Q5SW96;3.44E-38;ARH_HUMAN;Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein);"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030665; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0061024; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602";"amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]"
comp347049_c0_seq1;GAXK01182465.1;Q5F489;3.26E-08;TAF3_CHICK;Transcription initiation factor TFIID subunit 3 (TBP-associated factor 3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]";"GO:0005634; GO:0046872; GO:0046982";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]"
comp347088_c0_seq1;GAXK01182606.1;P42768;4.22E-27;WASP_HUMAN;Wiskott-Aldrich syndrome protein (WASp);"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"GO:0000147; GO:0002625; GO:0005634; GO:0005829; GO:0005884; GO:0005911; GO:0006897; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030479; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0038096; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0048365; GO:0050852; GO:0051015; GO:0051492; GO:0051497; GO:0051666; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146; GO:2000601";"actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament-based movement [GO:0030048]; actin filament polymerization [GO:0030041]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]";"actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]";"actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]"
comp3470884_c0_seq1;GAXK01152566.1;Q95KD7;1.32E-07;CC191_MACFA;Coiled-coil domain-containing protein 191;;;;;
comp34716_c0_seq1;GAXK01161878.1;P51615;2.05E-26;MAOX_VITVI;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40);"cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287";;cytoplasm [GO:0005737];"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp347184_c1_seq1;GAXK01182585.1;Q5MCW4;1.07E-29;ZN569_HUMAN;Zinc finger protein 569;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3472209_c0_seq1;GAXK01117743.1;Q6DHG0;1.25E-11;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3472251_c1_seq1;GAXK01117746.1;O96006;2.88E-24;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp3472850_c0_seq1;GAXK01117738.1;Q80V63;7.78E-07;PRDM4_MOUSE;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005123; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0035097; GO:0043565; GO:0045944; GO:0046872; GO:1990226; GO:2000177; GO:2000736";"negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp347335_c2_seq1;GAXK01182475.1;Q7K237;3.82E-122;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp34734_c0_seq1;GAXK01161199.1;E7E2N8;9.67E-22;GILT_CARAU;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]";"GO:0005576; GO:0005764; GO:0019882; GO:0047134";antigen processing and presentation [GO:0019882];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp347383_c2_seq1;GAXK01182609.1;O15254;0;ACOX3_HUMAN;Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase);"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625]";"GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949";"fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]"
comp34742_c2_seq1;GAXK01161836.1;Q6GM86;1.01E-21;H2AX_XENLA;Histone H2AX (H2a/x) (Histone H2A.X);"centrosome [GO:0005813]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]";"GO:0000786; GO:0003677; GO:0005634; GO:0005813; GO:0006281; GO:0006310; GO:0046982; GO:0051321";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]";"centrosome [GO:0005813]; nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp34745_c2_seq1;GAXK01161735.1;A5PK19;2.00E-119;EFNMT_BOVIN;"eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)]";"methyltransferase activity [GO:0008168]; protein methylation [GO:0006479]";"GO:0006479; GO:0008168";protein methylation [GO:0006479];;methyltransferase activity [GO:0008168]
comp347462_c3_seq1;GAXK01182495.1;Q9WV30;2.88E-67;NFAT5_MOUSE;Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0044798; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996";"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"
comp3474951_c0_seq1;GAXK01151263.1;Q13127;2.53E-19;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp3475128_c0_seq1;GAXK01151256.1;P23776;6.60E-12;EXG1_YEAST;Glucan 1,3-beta-glucosidase I/II (EC 3.2.1.58) (Exo-1,3-beta-glucanase I/II) (Soluble cell wall protein 6);"cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole [GO:0000324]; glucan exo-1,3-beta-glucosidase activity [GO:0004338]; cellular glucan metabolic process [GO:0006073]; fungal-type cell wall organization [GO:0031505]; glucan catabolic process [GO:0009251]";"GO:0000324; GO:0004338; GO:0005576; GO:0006073; GO:0009251; GO:0009277; GO:0009986; GO:0031505";"cellular glucan metabolic process [GO:0006073]; fungal-type cell wall organization [GO:0031505]; glucan catabolic process [GO:0009251]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole [GO:0000324]";glucan exo-1,3-beta-glucosidase activity [GO:0004338]
comp3476_c0_seq1;GAXK01175479.1;P19039;1.60E-67;EF1A_APIME;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3476530_c0_seq1;GAXK01072597.1;Q8BM89;3.42E-26;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp347659_c1_seq1;GAXK01182537.1;Q08890;1.20E-92;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp34771_c0_seq1;GAXK01161832.1;Q91VU7;1.55E-123;PUS7_MOUSE;Pseudouridylate synthase 7 homolog (EC 5.4.99.-);"nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]";"GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380";"mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]";nucleus [GO:0005634];"enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp34779_c0_seq1;GAXK01161192.1;Q4QQT0;5.37E-50;RUSD4_RAT;Mitochondrial RNA pseudouridine synthase Rpusd4 (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4);"mitochondrial matrix [GO:0005759]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]; tRNA processing [GO:0008033]";"GO:0001522; GO:0003723; GO:0005759; GO:0008033; GO:0009982; GO:0070131";"positive regulation of mitochondrial translation [GO:0070131]; pseudouridine synthesis [GO:0001522]; tRNA processing [GO:0008033]";mitochondrial matrix [GO:0005759];"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp347801_c0_seq1;GAXK01205922.1;P20852;1.69E-73;CP2A5_MOUSE;Cytochrome P450 2A5 (EC 1.14.14.1) (CYPIIA5) (Coumarin 7-hydroxylase) (Cytochrome P450-15-COH) (Cytochrome P450-IIA3.2);"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cellular response to cadmium ion [GO:0071276]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; heme metabolic process [GO:0042168]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to stilbenoid [GO:0035634]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0005881; GO:0006082; GO:0006805; GO:0008389; GO:0008392; GO:0008395; GO:0009804; GO:0016712; GO:0019373; GO:0019899; GO:0020037; GO:0035634; GO:0042168; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0071276";"cellular response to cadmium ion [GO:0071276]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; heme metabolic process [GO:0042168]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to stilbenoid [GO:0035634]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp347876_c0_seq1;GAXK01182542.1;Q9XT06;7.77E-19;TCPA_MONDO;T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha);"chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005815; GO:0005832; GO:0006457; GO:0051082";protein folding [GO:0006457];"chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3479597_c0_seq1;GAXK01136921.1;Q9VFP2;1.34E-12;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp347985_c2_seq1;GAXK01182564.1;Q9EQG6;2.29E-19;KDIS_RAT;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0005770; GO:0005829; GO:0010976; GO:0016021; GO:0019887; GO:0019901; GO:0030165; GO:0032991; GO:0038180; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]"
comp34802_c6_seq1;GAXK01161899.1;Q17FR9;3.88E-121;SRRT_AEDAE;Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog);"nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";"GO:0003676; GO:0005654; GO:0006397; GO:0031053";"mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";nucleoplasm [GO:0005654];nucleic acid binding [GO:0003676]
comp348035_c1_seq1;GAXK01005071.1;Q9BXB4;1.72E-35;OSB11_HUMAN;Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"GO:0005654; GO:0005794; GO:0005829; GO:0008289; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444";"fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp3481733_c0_seq1;GAXK01123796.1;Q9GKL8;4.05E-11;CATL1_CHLAE;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]";"lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; viral entry into host cell [GO:0046718]";"GO:0004197; GO:0005764; GO:0046718";viral entry into host cell [GO:0046718];lysosome [GO:0005764];cysteine-type endopeptidase activity [GO:0004197]
comp34822_c0_seq1;GAXK01161547.1;Q9VKX4;3.70E-39;RT07_DROME;28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt);"mitochondrial small ribosomal subunit [GO:0005763]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0005763; GO:0006412; GO:0019843; GO:0032543";"mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3482317_c0_seq1;GAXK01133635.1;Q05193;2.98E-29;DYN1_HUMAN;Dynamin-1 (EC 3.6.5.5);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"GO:0001917; GO:0002031; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0006898; GO:0007032; GO:0008017; GO:0008021; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0017124; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0031749; GO:0042802; GO:0043196; GO:0043197; GO:0044327; GO:0044877; GO:0045202; GO:0045211; GO:0048013; GO:0050803; GO:0050804; GO:0050998; GO:0070062; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1900244; GO:1901998; GO:1904645";"endocytosis [GO:0006897]; endosome organization [GO:0007032]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]";"D2 dopamine receptor binding [GO:0031749]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp34828_c0_seq1;GAXK01162076.1;Q8BH75;6.94E-143;RNF41_MOUSE;E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1);"endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010468; GO:0010498; GO:0016567; GO:0017160; GO:0019904; GO:0030336; GO:0030971; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051091; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000114; GO:2000377; GO:2000379";"autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]";"endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]";"erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp34833_c0_seq1;GAXK01161235.1;Q9V4W1;6.81E-64;GLE1_DROME;Nucleoporin GLE1;"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449]";"GO:0000822; GO:0005543; GO:0005643; GO:0005737; GO:0006406; GO:0006446; GO:0006449; GO:0016973; GO:0031369; GO:0044614";"mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449]";"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]";"inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]"
comp3483507_c0_seq1;GAXK01133653.1;Q9N290;9.41E-13;A4GAT_GORGO;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase) (Fragment);"Golgi membrane [GO:0000139]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; lipid metabolic process [GO:0006629]";"GO:0000139; GO:0006629; GO:0008378; GO:0050512";lipid metabolic process [GO:0006629];Golgi membrane [GO:0000139];"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]"
comp34838_c2_seq1;GAXK01161396.1;Q9WVC0;2.09E-176;SEPT7_RAT;Septin-7 (CDC10 protein homolog);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; postsynapse organization [GO:0099173]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0060271; GO:0061640; GO:0098978; GO:0099173";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; postsynapse organization [GO:0099173]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp34842_c3_seq1;GAXK01161753.1;Q86UP9;5.87E-54;LHPL3_HUMAN;LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp34846_c0_seq1;GAXK01162096.1;Q2M2I8;1.12E-135;AAK1_HUMAN;AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1);"cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]";"GO:0004674; GO:0005112; GO:0005524; GO:0005634; GO:0005829; GO:0005905; GO:0006468; GO:0006897; GO:0019897; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0046777; GO:0050821; GO:0061024; GO:2000369";"endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]";"cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]";"AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]"
comp3485_c0_seq1;GAXK01176582.1;Q54ZX8;8.83E-07;Y7331_DICDI;SET and MYND domain-containing protein DDB_G0277331 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp348550_c0_seq1;GAXK01004998.1;F1PT61;3.29E-12;MYH16_CANLF;Myosin-16 (Myosin heavy chain 16);"myofibril [GO:0030016]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]";"GO:0003774; GO:0005524; GO:0016459; GO:0030016; GO:0051015";;"myofibril [GO:0030016]; myosin complex [GO:0016459]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp348641_c0_seq1;GAXK01004942.1;P41996;3.25E-07;CPG2_CAEEL;Chondroitin proteoglycan-2 (Cytokinesis protein B0280.5);"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"GO:0000281; GO:0006030; GO:0008061; GO:0009792; GO:0030312; GO:0030703; GO:0032465; GO:0098595";"chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]";"external encapsulating structure [GO:0030312]; perivitelline space [GO:0098595]";chitin binding [GO:0008061]
comp348673_c0_seq1;GAXK01005070.1;Q4KLL9;1.75E-11;KI18B_RAT;Kinesin-like protein KIF18B;"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]";"GO:0000070; GO:0000278; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016887; GO:0051301; GO:0051302; GO:0061673; GO:1990023";"cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]";"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp3487755_c0_seq1;GAXK01162983.1;P17078;3.77E-24;RL35_RAT;60S ribosomal protein L35;"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625; GO:0043021; GO:0071493";"cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp348843_c0_seq1;GAXK01004943.1;Q10058;5.25E-38;YAM3_SCHPO;Putative oxidoreductase C1F5.03c (EC 1.-.-.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; oxidoreductase activity [GO:0016491]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005737; GO:0005770; GO:0005829; GO:0016021; GO:0016491; GO:0042147";retrograde transport, endosome to Golgi [GO:0042147];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]";oxidoreductase activity [GO:0016491]
comp3488809_c0_seq1;GAXK01165039.1;B2FQP3;8.26E-09;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp34894_c4_seq1;GAXK01161698.1;Q5R668;0;ACSL3_PONAB;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391";long-chain fatty acid metabolic process [GO:0001676];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp34896_c1_seq1;GAXK01161428.1;A2VDP4;1.53E-35;ZN567_BOVIN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp348997_c0_seq1;GAXK01004941.1;Q29611;1.24E-88;CLN3_CANLF;Battenin (Protein CLN3);"caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]; vesicle transport along microtubule [GO:0047496]";"GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0008021; GO:0015809; GO:0016021; GO:0030176; GO:0035752; GO:0042987; GO:0043005; GO:0043066; GO:0045121; GO:0047496; GO:0051453";"amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]; vesicle transport along microtubule [GO:0047496]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]";
comp3490_c0_seq1;GAXK01176469.1;P00765;4.12E-50;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp349003_c1_seq1;GAXK01004947.1;Q8K330;1.29E-09;SSH3_MOUSE;Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (mSSH-3L);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell morphogenesis [GO:0000902]";"GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0008138";cell morphogenesis [GO:0000902];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp3490477_c0_seq1;GAXK01062132.1;Q8CJ78;4.98E-08;ZN628_MOUSE;Zinc finger protein 628 (Zinc finger protein expressed in embryonal cells and certain adult organs);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp34906_c0_seq1;GAXK01161994.1;Q3SWZ4;3.98E-92;EXOS9_BOVIN;Exosome complex component RRP45 (Exosome component 9);"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; AU-rich element binding [GO:0017091]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0000467; GO:0005654; GO:0005730; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]";"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";AU-rich element binding [GO:0017091]
comp34911_c1_seq1;GAXK01162077.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp3491175_c0_seq1;GAXK01062125.1;Q9SB41;2.81E-40;GLPT2_ARATH;Putative glycerol-3-phosphate transporter 2 (G-3-P transporter 2) (Glycerol-3-phosphate permease 2) (AtG3Pp2) (G-3-P permease 2) (Protein ROOT HAIR SPECIFIC 15) (AtRHS15);"integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]";"GO:0005887; GO:0008643; GO:0022857; GO:0055062";"carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]";integral component of plasma membrane [GO:0005887];transmembrane transporter activity [GO:0022857]
comp349128_c1_seq1;GAXK01005090.1;Q8UWA5;1.19E-33;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp34916_c0_seq1;GAXK01161204.1;Q09527;2.85E-33;KAD6_CAEEL;Adenylate kinase isoenzyme 6 homolog (AK6) (EC 2.7.4.3) (Adrenal gland protein AD-004 like protein) (ADLP) (Dual activity adenylate kinase/ATPase) (AK/ATPase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0004017; GO:0005524; GO:0005634; GO:0005737; GO:0016887";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp34918_c0_seq1;GAXK01161236.1;P16568;4.49E-168;BICD_DROME;Protein bicaudal D;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; clathrin heavy chain binding [GO:0032050]; cytoskeletal adaptor activity [GO:0008093]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]; cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton organization [GO:0016325]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of endocytosis [GO:0030100]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007293; GO:0007294; GO:0007309; GO:0007312; GO:0008093; GO:0008103; GO:0008298; GO:0016325; GO:0017137; GO:0030100; GO:0032050; GO:0048477; GO:0048488; GO:0050658; GO:0051028; GO:0070727; GO:0070840; GO:0098793; GO:2000302; GO:2000370";"cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton organization [GO:0016325]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of endocytosis [GO:0030100]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]";"clathrin heavy chain binding [GO:0032050]; cytoskeletal adaptor activity [GO:0008093]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]"
comp34943_c5_seq1;GAXK01162003.1;P41731;1.01E-15;CD63_MOUSE;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0034613; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigmentation [GO:0043473]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";protein-containing complex binding [GO:0044877]
comp34948_c0_seq1;GAXK01161433.1;Q9DCD2;0;SYF1_MOUSE;Pre-mRNA-splicing factor SYF1 (XPA-binding protein 2);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0006283; GO:0006351; GO:0021987; GO:0071007; GO:0071013; GO:0071014";"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]";
comp349518_c0_seq1;GAXK01005068.1;Q01069;1.21E-25;ESMB_DROME;Enhancer of split mbeta protein (E(spl)mbeta) (HLH-mbeta) (Split locus enhancer protein mA);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0043565; GO:0046983; GO:0050767; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp3495267_c0_seq1;GAXK01090488.1;Q9DCM4;6.38E-10;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp3495307_c0_seq1;GAXK01090496.1;P20662;1.43E-12;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp34960_c0_seq1;GAXK01161734.1;Q76FK4;5.19E-16;NOL8_HUMAN;Nucleolar protein 8 (Nucleolar protein Nop132);"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005730; GO:0006364; GO:1902570; GO:1990904";"protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp349634_c1_seq1;GAXK01005019.1;Q9S725;1.93E-84;4CL2_ARATH;4-coumarate--CoA ligase 2 (4CL 2) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 2) (At4CL2) (4-coumaroyl-CoA synthase 2);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp3497303_c0_seq1;GAXK01199986.1;Q01728;9.23E-45;NAC1_RAT;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; calcium ion export [GO:1901660]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of sodium ion transport [GO:0002028]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0001666; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0007584; GO:0009749; GO:0010763; GO:0010881; GO:0014704; GO:0021537; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042493; GO:0042542; GO:0042995; GO:0043197; GO:0043198; GO:0045211; GO:0051924; GO:0060402; GO:0070509; GO:0070588; GO:0071320; GO:0071456; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of sodium ion transport [GO:0002028]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]"
comp349732_c0_seq2;GAXK01004929.1;A0ZSK4;1.79E-22;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp349735_c0_seq1;GAXK01005014.1;Q8I6K0;3.65E-21;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3497496_c0_seq1;GAXK01199978.1;Q03614;4.00E-28;NTDO_CAEEL;Sodium-dependent dopamine transporter (DA transporter) (DAT);"axolemma [GO:0030673]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; amine transmembrane transporter activity [GO:0005275]; chloride channel activity [GO:0005254]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; amine transport [GO:0015837]; chloride transport [GO:0006821]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; negative regulation of cellular response to manganese ion [GO:1905803]; negative regulation of cellular response to oxidopamine [GO:1905847]; norepinephrine transport [GO:0015874]; positive regulation of neuron death [GO:1901216]";"GO:0005254; GO:0005275; GO:0005328; GO:0005330; GO:0005886; GO:0006821; GO:0015837; GO:0015874; GO:0016021; GO:0030673; GO:0032590; GO:0032809; GO:0042734; GO:0043005; GO:0046872; GO:0051583; GO:0090494; GO:1901216; GO:1905803; GO:1905847";"amine transport [GO:0015837]; chloride transport [GO:0006821]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; negative regulation of cellular response to manganese ion [GO:1905803]; negative regulation of cellular response to oxidopamine [GO:1905847]; norepinephrine transport [GO:0015874]; positive regulation of neuron death [GO:1901216]";"axolemma [GO:0030673]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"amine transmembrane transporter activity [GO:0005275]; chloride channel activity [GO:0005254]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp349763_c0_seq1;GAXK01004931.1;Q9UI14;4.06E-11;PRAF1_HUMAN;Prenylated Rab acceptor protein 1 (PRA1 family protein 1);"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]";"GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016020; GO:0016021; GO:0030054; GO:0042802; GO:0070064";;"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]"
comp3497689_c0_seq1;GAXK01199966.1;Q5RE33;2.22E-27;REEP5_PONAB;Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp34977_c3_seq1;GAXK01161430.1;Q96DA2;1.22E-74;RB39B_HUMAN;Ras-related protein Rab-39B;"cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005622; GO:0005794; GO:0005886; GO:0006886; GO:0006914; GO:0010506; GO:0016192; GO:0030659; GO:0031489; GO:0031982; GO:0032482; GO:0043005; GO:0050808";"autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]";"cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]"
comp3497860_c0_seq1;GAXK01199982.1;O13418;8.38E-43;RL15_ASPNG;60S ribosomal protein L15;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3498081_c0_seq1;GAXK01008675.1;P39057;1.13E-78;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp34981_c2_seq1;GAXK01161732.1;Q28EE8;4.18E-11;SR1IP_XENTR;Protein SREK1IP1;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003676; GO:0006397; GO:0008270; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp34982_c1_seq1;GAXK01161668.1;P32019;0;I5P2_HUMAN;Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase);"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]";"GO:0001701; GO:0004439; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0016021; GO:0030317; GO:0030670; GO:0031901; GO:0043647; GO:0046855; GO:0046856; GO:0046872; GO:0051056; GO:0052658; GO:0070613";"flagellated sperm motility [GO:0030317]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"
comp3498277_c0_seq1;GAXK01008693.1;Q86WI1;3.37E-24;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp349844_c0_seq1;GAXK01004986.1;Q9UMX3;2.34E-21;BOK_HUMAN;Bcl-2-related ovarian killer protein (hBOK) (Bcl-2-like protein 9) (Bcl2-L-9);"cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836]";"GO:0001836; GO:0005102; GO:0005634; GO:0005640; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0006915; GO:0006919; GO:0006921; GO:0007420; GO:0008283; GO:0008584; GO:0008630; GO:0008635; GO:0010506; GO:0016020; GO:0016021; GO:0031625; GO:0031901; GO:0031966; GO:0032588; GO:0033106; GO:0042803; GO:0043065; GO:0043524; GO:0046982; GO:0048709; GO:0051259; GO:0051400; GO:0051402; GO:0051480; GO:0051902; GO:0055038; GO:0060546; GO:0072332; GO:0097192; GO:1900119; GO:1901029; GO:1901030; GO:1901382; GO:1902237; GO:1903899; GO:1904708; GO:2001244";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836]";"cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]";"BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]"
comp3498502_c0_seq1;GAXK01008670.1;Q7Z5L0;8.39E-18;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp3498856_c0_seq1;GAXK01008679.1;P18713;4.16E-13;ZG17_XENLA;Gastrula zinc finger protein XlCGF17.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3498895_c0_seq1;GAXK01008691.1;Q94984;2.93E-09;CU15_MANSE;Cuticle protein CP14.6 (MSCP14.6);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp3499136_c0_seq1;GAXK01008684.1;Q9D6P8;4.04E-35;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp349916_c0_seq1;GAXK01005013.1;Q01842;3.48E-09;POK_DROME;Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000980; GO:0000981; GO:0001012; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090175; GO:1903688; GO:2000051";"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp3499524_c0_seq1;GAXK01008689.1;P03010;3.66E-09;TRAC9_MAIZE;Putative AC9 transposase;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp349956_c4_seq1;GAXK01005020.1;Q9XFW4;4.15E-57;LPAT2_BRANA;1-acyl-sn-glycerol-3-phosphate acyltransferase 2 (EC 2.3.1.51) (Lysophosphatidyl acyltransferase 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0003841; GO:0005789; GO:0016021; GO:0016024";CDP-diacylglycerol biosynthetic process [GO:0016024];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp3500000_c0_seq1;GAXK01025956.1;A8Y9I2;6.32E-130;NINAB_GALME;Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B);"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]";"GO:0004497; GO:0016702; GO:0042572; GO:0046872";retinol metabolic process [GO:0042572];;"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp35004_c0_seq1;GAXK01161765.1;Q5XGE0;2.14E-74;OGFD3_XENTR;2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3;"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213";;integral component of membrane [GO:0016021];"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp3500456_c0_seq1;GAXK01025952.1;Q5U3H9;5.18E-13;SPIR2_DANRE;Protein spire homolog 2 (Spir-2);"cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0015031; GO:0016192; GO:0030659; GO:0045010; GO:0070649; GO:2000781";"actin nucleation [GO:0045010]; formin-nucleated actin cable assembly [GO:0070649]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp350081_c0_seq1;GAXK01082538.1;Q2KI95;3.82E-101;FHL2_BOVIN;Four and a half LIM domains protein 2 (FHL-2);"nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000122; GO:0001649; GO:0005634; GO:0008134; GO:0030018; GO:0043066; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885";"atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"nucleus [GO:0005634]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp3501313_c0_seq1;GAXK01025958.1;Q02280;3.37E-50;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp35017_c0_seq1;GAXK01161859.1;Q9VFC2;2.35E-82;SP88E_DROME;Serine protease inhibitor 88Ea (Serpin 88Ea);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]";"GO:0002376; GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0042438; GO:0045751; GO:0045824; GO:0045861; GO:0048526";"imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp3501877_c0_seq1;GAXK01025954.1;Q80UN1;1.24E-12;KCTD9_MOUSE;BTB/POZ domain-containing protein KCTD9;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602";"intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]"
comp350202_c1_seq1;GAXK01082579.1;P40757;1.70E-119;ALN_LITCT;Allantoinase, mitochondrial (EC 3.5.2.5);"mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256]";"GO:0000256; GO:0004038; GO:0005739; GO:0008270; GO:0050897";allantoin catabolic process [GO:0000256];mitochondrion [GO:0005739];"allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]"
comp3502485_c0_seq1;GAXK01044368.1;Q9M8J9;7.65E-10;BPM2_ARATH;BTB/POZ and MATH domain-containing protein 2 (Protein BTB-POZ AND MATH DOMAIN 2) (AtBPM2);"nucleus [GO:0005634]; cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0006970; GO:0016567; GO:0042631; GO:0071472";"cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];
comp35027_c1_seq1;GAXK01161834.1;P34519;1.97E-127;TXTP_CAEEL;Putative tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial citrate transmembrane transport [GO:0006843]";"GO:0005743; GO:0006843; GO:0016021";mitochondrial citrate transmembrane transport [GO:0006843];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp3502809_c0_seq1;GAXK01044360.1;P29766;1.88E-12;RL8_SOLLC;60S ribosomal protein L8 (L2) (Ribosomal protein TL2);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3503008_c0_seq1;GAXK01044373.1;Q8HXM1;5.02E-33;CSTF2_BOVIN;Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64);"cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"GO:0003723; GO:0003729; GO:0005847; GO:0006378; GO:0071920; GO:0098789";"mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]";"cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp3503425_c0_seq1;GAXK01044367.1;Q99MU5;1.47E-13;SPAT6_RAT;Spermatogenesis-associated protein 6 (Kinesin-related protein) (Spermatogenesis-related factor 1);"extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005576; GO:0007275; GO:0007283; GO:0030154; GO:0032027; GO:0044458; GO:0097224";"cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]";myosin light chain binding [GO:0032027]
comp350358_c0_seq1;GAXK01082568.1;Q17320;2.05E-105;WHITE_CERCA;Protein white;"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pigment binding [GO:0031409]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0055085";transmembrane transport [GO:0055085];integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; pigment binding [GO:0031409]"
comp350406_c1_seq1;GAXK01082631.1;P49291;2.72E-17;LAZA_SCHAM;Lazarillo protein;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; pigment binding [GO:0031409]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005886; GO:0007399; GO:0030154; GO:0031225; GO:0031409";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";pigment binding [GO:0031409]
comp3504397_c0_seq1;GAXK01127998.1;Q9UTG4;6.90E-23;RS26B_SCHPO;40S ribosomal protein S26-B;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003729; GO:0003735; GO:0005829; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp3504759_c0_seq1;GAXK01127987.1;Q86XW9;2.18E-23;TXND6_HUMAN;Thioredoxin domain-containing protein 6 (Thioredoxin-like protein 2) (Txl-2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoside diphosphate kinase activity [GO:0004550]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"GO:0004550; GO:0005737; GO:0005856; GO:0006183; GO:0006228; GO:0006241; GO:0045454";"cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";nucleoside diphosphate kinase activity [GO:0004550]
comp3504855_c0_seq1;GAXK01128003.1;Q16445;1.40E-66;GBRA6_HUMAN;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp3504989_c0_seq1;GAXK01128002.1;Q8JGR4;6.81E-27;RL24_DANRE;60S ribosomal protein L24;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; chordate embryonic development [GO:0043009]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; chordate embryonic development [GO:0043009]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp35053_c0_seq1;GAXK01161880.1;A4IGF3;9.37E-32;ATP23_DANRE;Mitochondrial inner membrane protease ATP23 homolog (EC 3.4.24.-);"extrinsic component of mitochondrial inner membrane [GO:0031314]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]";"GO:0004222; GO:0031314; GO:0033615; GO:0034982; GO:0046872";"mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]";extrinsic component of mitochondrial inner membrane [GO:0031314];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp3505367_c0_seq1;GAXK01127994.1;Q49A33;2.06E-09;Z876P_HUMAN;Putative zinc finger protein 876;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3505613_c0_seq1;GAXK01127997.1;A9YME1;9.55E-18;VA5_MICHY;Venom allergen 5 (Antigen 5) (Cysteine-rich venom protein) (CRVP) (Venom protein 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp350565_c1_seq1;GAXK01082611.1;Q0E671;3.89E-55;NEUAA_DANRE;N-acylneuraminate cytidylyltransferase A (EC 2.7.7.43) (CMP-sialic acid synthetase 1);"nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054]";"GO:0005634; GO:0006054; GO:0008781";N-acetylneuraminate metabolic process [GO:0006054];nucleus [GO:0005634];N-acylneuraminate cytidylyltransferase activity [GO:0008781]
comp3505695_c0_seq1;GAXK01127995.1;Q5CZA5;1.49E-20;ZN805_HUMAN;Zinc finger protein 805;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3506014_c0_seq1;GAXK01131062.1;P46222;2.51E-85;RL11_DROME;60S ribosomal protein L11;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3506407_c0_seq1;GAXK01131053.1;P36609;1.96E-50;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp350668_c0_seq1;GAXK01082600.1;P35035;5.01E-25;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3506834_c0_seq1;GAXK01131059.1;P06660;1.30E-38;HSP85_TRYCR;Heat shock-like 85 kDa protein;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3506882_c0_seq1;GAXK01131065.1;Q9SZR0;1.19E-12;CHMO_ARATH;Choline monooxygenase, chloroplastic (EC 1.14.15.7);"chloroplast stroma [GO:0009570]; 2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005506; GO:0009570; GO:0019133; GO:0019285; GO:0051537";glycine betaine biosynthetic process from choline [GO:0019285];chloroplast stroma [GO:0009570];"2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]"
comp35072_c0_seq1;GAXK01162083.1;Q6WV17;0;GALT5_DROME;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp350811_c0_seq1;GAXK01082582.1;Q76IQ7;1.43E-29;TOX2_RAT;TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698]";"GO:0001085; GO:0003677; GO:0005634; GO:0008585; GO:0034698; GO:0045944";"female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698]";nucleus [GO:0005634];"DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]"
comp3508309_c0_seq1;GAXK01084435.1;Q9V427;1.67E-09;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp3508797_c0_seq1;GAXK01084450.1;Q9Y664;6.13E-08;KPTN_HUMAN;KICSTOR complex protein kaptin (Actin-associated protein 2E4);"KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262";"actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]";"KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]";actin filament binding [GO:0051015]
comp3509013_c0_seq1;GAXK01084430.1;Q7Z407;1.80E-13;CSMD3_HUMAN;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3509322_c0_seq1;GAXK01084429.1;P06734;3.91E-08;FCER2_HUMAN;"Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0005178; GO:0005886; GO:0005887; GO:0007219; GO:0009897; GO:0019221; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062";"cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]"
comp350948_c0_seq1;GAXK01082629.1;Q6C8H7;1.13E-15;LPE10_YARLI;Mitochondrial inner membrane magnesium transporter LPE10;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";magnesium ion transmembrane transporter activity [GO:0015095]
comp350998_c0_seq1;GAXK01082536.1;P00765;5.75E-22;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp351009_c0_seq1;GAXK01082641.1;Q62219;1.17E-41;TGFI1_MOUSE;Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5) (TGF beta-stimulated clone 5) (TSC-5);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; androgen receptor binding [GO:0050681]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; Roundabout binding [GO:0048495]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to heat [GO:0009408]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway [GO:0016055]";"GO:0003712; GO:0003713; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0009408; GO:0010718; GO:0016055; GO:0016331; GO:0016363; GO:0030511; GO:0030512; GO:0030579; GO:0030855; GO:0045165; GO:0045599; GO:0045893; GO:0046872; GO:0048495; GO:0050681; GO:0070411";"cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to heat [GO:0009408]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway [GO:0016055]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]";"androgen receptor binding [GO:0050681]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; Roundabout binding [GO:0048495]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp3510423_c0_seq1;GAXK01148914.1;Q52KJ8;1.83E-31;MSRB1_RAT;Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X) (SelX);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]";"GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0030041; GO:0033743; GO:0033745; GO:0045087; GO:0046872";"actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]"
comp3510600_c0_seq1;GAXK01148904.1;P59328;5.69E-20;WDHD1_MOUSE;WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1);"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]";"GO:0000278; GO:0000775; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0006261; GO:0006281; GO:0006396; GO:0006974; GO:0031298; GO:0033044; GO:0043596; GO:0070063; GO:0070829";"cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]";"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]"
comp351116_c3_seq1;GAXK01082576.1;Q14527;1.39E-110;HLTF_HUMAN;Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0001228; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0006355; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0061630";"chromatin organization [GO:0006325]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp35112_c0_seq1;GAXK01161674.1;Q9NWQ9;2.12E-10;CN119_HUMAN;Uncharacterized protein C14orf119;"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005829";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]";
comp351175_c1_seq1;GAXK01082539.1;P10076;6.76E-46;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3511794_c0_seq1;GAXK01148905.1;Q5B995;4.16E-08;NHP6_EMENI;Non-histone chromosomal protein 6;"nuclear chromatin [GO:0000790]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0006281; GO:0006338; GO:0006357; GO:0008134; GO:0008301";"chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]";nuclear chromatin [GO:0000790];"DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]"
comp35118_c1_seq1;GAXK01161419.1;Q2LGB5;2.56E-49;TOLIP_BOVIN;Toll-interacting protein;"cytoplasm [GO:0005737]; kinase binding [GO:0019900]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005737; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0019900; GO:0030855; GO:0031624; GO:0035325; GO:0036010; GO:0043130; GO:0045087";"autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytoplasm [GO:0005737];"kinase binding [GO:0019900]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp3511931_c0_seq1;GAXK01148927.1;Q6DFV3;7.89E-13;RHG21_MOUSE;Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]";"GO:0000139; GO:0005096; GO:0005794; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030100; GO:0030659; GO:0051683; GO:0051684; GO:0072384";"establishment of Golgi localization [GO:0051683]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp3513275_c0_seq1;GAXK01047241.1;Q5AMH6;2.20E-07;CAS5_CANAL;Cell wall integrity transcriptional regulator CAS5 (Caspofungin sensitivity protein 5);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell adhesion [GO:0007155]; cellular response to cold [GO:0070417]; cellular response to drug [GO:0035690]; development of symbiont in host [GO:0044114]; filamentous growth [GO:0030447]; fungal-type cell wall organization [GO:0031505]; pathogenesis [GO:0009405]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";"GO:0003676; GO:0005634; GO:0006357; GO:0007155; GO:0009405; GO:0010811; GO:0030447; GO:0031505; GO:0035690; GO:0044011; GO:0044114; GO:0046872; GO:0070417; GO:1900189";"cell adhesion [GO:0007155]; cellular response to cold [GO:0070417]; cellular response to drug [GO:0035690]; development of symbiont in host [GO:0044114]; filamentous growth [GO:0030447]; fungal-type cell wall organization [GO:0031505]; pathogenesis [GO:0009405]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp351372_c1_seq1;GAXK01082555.1;Q32L53;8.36E-66;LFG1_BOVIN;Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3513803_c0_seq1;GAXK01047256.1;Q96RW7;1.20E-14;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp351383_c0_seq1;GAXK01082571.1;B7Z0W9;4.21E-43;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp351461_c0_seq1;GAXK01082632.1;P17710;3.07E-87;HXK1_MOUSE;Hexokinase-1 (EC 2.7.1.1) (Hexokinase type I) (HK I) (Hexokinase, tumor isozyme);"caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of interleukin-1 beta secretion [GO:0050718]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of anion channel activity [GO:0010359]; response to ischemia [GO:0002931]";"GO:0001678; GO:0002741; GO:0002931; GO:0004340; GO:0004396; GO:0004672; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0005901; GO:0005929; GO:0006002; GO:0006013; GO:0006096; GO:0006468; GO:0008865; GO:0010359; GO:0018105; GO:0018107; GO:0018108; GO:0019158; GO:0032991; GO:0042802; GO:0042803; GO:0042834; GO:0043066; GO:0044877; GO:0045121; GO:0046777; GO:0046835; GO:0050718; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:0097228";"canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of interleukin-1 beta secretion [GO:0050718]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of anion channel activity [GO:0010359]; response to ischemia [GO:0002931]";"caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228]";"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]"
comp3514933_c0_seq1;GAXK01139338.1;Q80V23;4.00E-11;ZNF32_MOUSE;Zinc finger protein 32 (Zinc finger protein 637);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp35150_c1_seq1;GAXK01161731.1;Q9Y105;0;SYQ_DROME;Probable glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; dendrite morphogenesis [GO:0048813]; glutaminyl-tRNA aminoacylation [GO:0006425]";"GO:0004819; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0017101; GO:0048813";"dendrite morphogenesis [GO:0048813]; glutaminyl-tRNA aminoacylation [GO:0006425]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]"
comp351507_c1_seq1;GAXK01082597.1;Q9VV43;1.85E-20;Y5057_DROME;TPPP family protein CG45057;"axon [GO:0030424]; neuronal cell body [GO:0043025]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"GO:0000226; GO:0001578; GO:0015631; GO:0030424; GO:0032273; GO:0043025; GO:0046785";"microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"axon [GO:0030424]; neuronal cell body [GO:0043025]";tubulin binding [GO:0015631]
comp351509_c0_seq1;GAXK01082557.1;Q15386;9.06E-08;UBE3C_HUMAN;Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2);"nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0000502; GO:0004842; GO:0005634; GO:0006511; GO:0061631";"protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"nucleus [GO:0005634]; proteasome complex [GO:0000502]";"ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp351518_c3_seq1;GAXK01082563.1;Q14500;8.50E-99;KCJ12_HUMAN;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; cardiac conduction [GO:0061337]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0006936; GO:0008016; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:0061337; GO:1990573";"cardiac conduction [GO:0061337]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp35155_c0_seq1;GAXK01161986.1;P83916;8.24E-07;CBX1_HUMAN;Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta);"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000775; GO:0000784; GO:0000785; GO:0001939; GO:0001940; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005819; GO:0006974; GO:0010369; GO:0019899; GO:0042803; GO:0045892; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]"
comp3515592_c0_seq1;GAXK01139334.1;P10074;3.27E-10;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3515909_c0_seq1;GAXK01139324.1;Q54Q80;3.31E-09;Y4059_DICDI;SET and MYND domain-containing protein DDB_G0284059 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp351652_c0_seq1;GAXK01082558.1;Q94420;1.04E-11;MEL26_CAEEL;Protein maternal effect lethal 26;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leucine [GO:0071233]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of mitotic spindle elongation [GO:0032888]; regulation of proteolysis [GO:0030162]; striated muscle myosin thick filament assembly [GO:0071688]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000132; GO:0000793; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006511; GO:0009792; GO:0010507; GO:0016020; GO:0016567; GO:0019901; GO:0030162; GO:0030163; GO:0030307; GO:0030674; GO:0031430; GO:0031625; GO:0031674; GO:0032154; GO:0032888; GO:0042802; GO:0043161; GO:0071233; GO:0071688; GO:1904263";"cellular response to leucine [GO:0071233]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of mitotic spindle elongation [GO:0032888]; regulation of proteolysis [GO:0030162]; striated muscle myosin thick filament assembly [GO:0071688]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]"
comp3516797_c0_seq1;GAXK01146712.1;Q7ZU45;3.35E-10;TTC25_DANRE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371";"cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp351688_c1_seq1;GAXK01082567.1;Q4R495;7.62E-16;MFS11_MACFA;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3517113_c0_seq1;GAXK01146717.1;Q8CDK2;4.80E-42;CBPC2_MOUSE;Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005814; GO:0005829; GO:0008270; GO:0035610; GO:0036064";protein side chain deglutamylation [GO:0035610];"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp3517141_c0_seq1;GAXK01146719.1;P50429;8.46E-15;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp35180_c1_seq1;GAXK01161849.1;Q58D31;4.74E-152;DHSO_BOVIN;Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9);"mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]";"GO:0003939; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526";flagellated sperm motility [GO:0030317];"mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]";"D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; zinc ion binding [GO:0008270]"
comp3518303_c0_seq1;GAXK01046485.1;Q9NL55;3.17E-11;CHHL_BOMMO;CHH-like protein (BmCHHL);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp35185_c0_seq1;GAXK01161659.1;Q6AZS2;3.10E-172;EEDB_XENLA;Polycomb protein eed-B (Xeed-B) (psXEED);"ESC/E(Z) complex [GO:0035098]; histone methylation [GO:0016571]";"GO:0016571; GO:0035098";histone methylation [GO:0016571];ESC/E(Z) complex [GO:0035098];
comp351863_c9_seq1;GAXK01082646.1;B3EWZ5;5.95E-74;MLRP1_ACRMI;MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp3518653_c0_seq1;GAXK01046503.1;P46313;3.47E-35;FAD6E_ARATH;Delta(12)-fatty-acid desaturase (EC 1.14.19.22) (EC 1.14.19.6) (Omega-6 fatty acid desaturase, endoplasmic reticulum);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Delta12-fatty-acid desaturase activity [GO:0102985]; omega-6 fatty acid desaturase activity [GO:0045485]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0005789; GO:0006636; GO:0016021; GO:0045485; GO:0102985";unsaturated fatty acid biosynthetic process [GO:0006636];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"Delta12-fatty-acid desaturase activity [GO:0102985]; omega-6 fatty acid desaturase activity [GO:0045485]"
comp35190_c0_seq1;GAXK01161711.1;Q9JHG6;1.84E-37;RCAN1_MOUSE;Calcipressin-1 (Down syndrome critical region protein 1 homolog) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; calcineurin-NFAT signaling cascade [GO:0033173]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; skeletal muscle fiber development [GO:0048741]";"GO:0002931; GO:0003676; GO:0005634; GO:0005737; GO:0006979; GO:0007614; GO:0008597; GO:0031987; GO:0033173; GO:0042802; GO:0043666; GO:0048741; GO:0070884; GO:0070885";"calcineurin-NFAT signaling cascade [GO:0033173]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; skeletal muscle fiber development [GO:0048741]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]"
comp3519071_c0_seq1;GAXK01046508.1;O65050;3.75E-70;RL15A_PICMA;60S ribosomal protein L15-1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3519296_c0_seq1;GAXK01046496.1;G5EE56;3.83E-34;SRC1_CAEEL;Tyrosine protein-kinase src-1 (EC 2.7.10.2) (SRC oncogene related protein 1);"cell projection [GO:0042995]; contractile fiber [GO:0043292]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; phagocytic cup [GO:0001891]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; netrin receptor binding [GO:1990890]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; anterior/posterior axis specification, embryo [GO:0008595]; cell differentiation [GO:0030154]; commissural neuron axon guidance [GO:0071679]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal cell fate specification [GO:0001714]; establishment of mitotic spindle orientation [GO:0000132]; gonad morphogenesis [GO:0035262]; left/right axis specification [GO:0070986]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of embryonic development [GO:0040019]; positive regulation of locomotion [GO:0040017]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000132; GO:0001714; GO:0001891; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0007169; GO:0008595; GO:0009792; GO:0030154; GO:0031234; GO:0035262; GO:0038083; GO:0040017; GO:0040019; GO:0042995; GO:0043292; GO:0046777; GO:0046872; GO:0048557; GO:0050731; GO:0070986; GO:0071679; GO:1990890";"anterior/posterior axis specification, embryo [GO:0008595]; cell differentiation [GO:0030154]; commissural neuron axon guidance [GO:0071679]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal cell fate specification [GO:0001714]; establishment of mitotic spindle orientation [GO:0000132]; gonad morphogenesis [GO:0035262]; left/right axis specification [GO:0070986]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of embryonic development [GO:0040019]; positive regulation of locomotion [GO:0040017]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cell projection [GO:0042995]; contractile fiber [GO:0043292]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; phagocytic cup [GO:0001891]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; netrin receptor binding [GO:1990890]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]"
comp3519369_c0_seq1;GAXK01046501.1;Q3V3N7;3.97E-95;BBS1_MOUSE;Bardet-Biedl syndrome 1 protein homolog;"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515";"adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]";"axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]";"patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]"
comp3519404_c0_seq1;GAXK01046489.1;Q6UY87;6.86E-23;BEST1_MACFA;Bestrophin-1 (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; response to stimulus [GO:0050896]";"GO:0005254; GO:0016323; GO:0034707; GO:0050896";response to stimulus [GO:0050896];"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";chloride channel activity [GO:0005254]
comp3519633_c0_seq1;GAXK01046510.1;Q9JHW1;2.24E-21;CBPD_RAT;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; cellular response to interleukin-2 [GO:0071352]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"GO:0004181; GO:0004185; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016021; GO:0016485; GO:0043231; GO:0044877; GO:0048471; GO:0051721; GO:0071352";"cellular response to interleukin-2 [GO:0071352]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"metallocarboxypeptidase activity [GO:0004181]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]"
comp3519763_c0_seq1;GAXK01046494.1;P34091;8.55E-50;RL6_MESCR;60S ribosomal protein L6 (YL16-like);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp35198_c2_seq1;GAXK01161660.1;Q5U508;1.15E-66;TBCE_XENLA;Tubulin-specific chaperone E (Tubulin-folding cofactor E);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023]";"GO:0005737; GO:0005856; GO:0007023";post-chaperonin tubulin folding pathway [GO:0007023];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp352010_c1_seq1;GAXK01120014.1;Q6ZMW2;6.76E-14;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp352036_c0_seq1;GAXK01120150.1;D4A1F2;7.11E-116;MICA2_RAT;[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";"GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp35205_c1_seq1;GAXK01161109.1;Q7ZUH1;1.01E-82;RTRAF_DANRE;RNA transcription, translation and transport factor protein;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"GO:0000993; GO:0003723; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0045944; GO:0048471; GO:0072669; GO:0072686";"negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]";"RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]"
comp35207_c0_seq1;GAXK01161879.1;P54961;0;HMCS1_BLAGE;Hydroxymethylglutaryl-CoA synthase 1 (HMG-CoA synthase 1) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase 1);"hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]";"GO:0004421; GO:0008299; GO:0016126";"isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]";;hydroxymethylglutaryl-CoA synthase activity [GO:0004421]
comp352098_c2_seq1;GAXK01120036.1;Q5UQ60;4.73E-07;YL662_MIMIV;Uncharacterized protein L662;;;;;
comp35212_c5_seq1;GAXK01204775.1;Q3BAI2;2.20E-16;YCX91_PHAAO;Uncharacterized protein ORF91;chloroplast [GO:0009507];GO:0009507;;chloroplast [GO:0009507];
comp3521237_c0_seq1;GAXK01055918.1;A2APF3;4.01E-09;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3521408_c0_seq1;GAXK01055916.1;Q8T5G8;1.35E-21;CHS_MELAT;Chitin synthase (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; embryo development ending in birth or egg hatching [GO:0009792]";"GO:0004100; GO:0005886; GO:0009792; GO:0016021";embryo development ending in birth or egg hatching [GO:0009792];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp3521902_c0_seq1;GAXK01055920.1;A8IB25;3.80E-79;RSSA_CHLRE;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp3521929_c0_seq1;GAXK01055909.1;Q07806;1.17E-28;PBPA_PSEAE;"Penicillin-binding protein 1A (PBP-1a) (PBP1a) [Includes: Penicillin-insensitive transglycosylase (EC 2.4.1.129) (Peptidoglycan TGase); Penicillin-sensitive transpeptidase (EC 3.4.16.4) (DD-transpeptidase)]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; drug binding [GO:0008144]; penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"GO:0005886; GO:0008144; GO:0008360; GO:0008658; GO:0008955; GO:0009002; GO:0009252; GO:0016021; GO:0046677; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"drug binding [GO:0008144]; penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]"
comp3522316_c0_seq1;GAXK01056798.1;Q9NAS9;1.24E-12;CLP15_ANOGA;CLIP domain-containing serine protease B15 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0042832; GO:0045087; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp352268_c0_seq1;GAXK01119946.1;A2ASS6;2.66E-07;TITIN_MOUSE;Titin (EC 2.7.11.1) (Connectin);"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897";"adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]";"A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp3522999_c0_seq1;GAXK01056781.1;P04052;6.53E-26;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp352307_c0_seq1;GAXK01119977.1;A0AAS4;3.41E-49;SMS1_PIG;Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Sphingomyelin synthase 1);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0005887; GO:0006686; GO:0006915; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493";"apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]"
comp3523266_c0_seq1;GAXK01056800.1;Q9FT72;7.20E-07;RQL3_ARATH;ATP-dependent DNA helicase Q-like 3 (EC 3.6.4.12) (RecQ-like protein 3) (AtRecQ3) (AtRecQl3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138; GO:0046872";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]"
comp3523532_c0_seq1;GAXK01056801.1;Q8NG08;2.68E-08;HELB_HUMAN;DNA helicase B (hDHB) (EC 3.6.4.12);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp3523896_c0_seq1;GAXK01056777.1;Q6ZEZ5;7.65E-16;NEK3_ORYSJ;Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (NimA-related protein kinase 3) (OsNek3);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp35239_c0_seq1;GAXK01161805.1;Q9Y697;0;NFS1_HUMAN;Cysteine desulfurase, mitochondrial (EC 2.8.1.7);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; protein-containing complex assembly [GO:0065003]; small molecule metabolic process [GO:0044281]; sulfur amino acid metabolic process [GO:0000096]";"GO:0000096; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0032324; GO:0042803; GO:0044281; GO:0044571; GO:0046872; GO:0051536; GO:0065003";"[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein-containing complex assembly [GO:0065003]; small molecule metabolic process [GO:0044281]; sulfur amino acid metabolic process [GO:0000096]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]"
comp352399_c0_seq1;GAXK01120004.1;Q8TAT5;7.19E-09;NEIL3_HUMAN;Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078";"base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"
comp35243_c2_seq1;GAXK01162117.1;Q9PTY5;0;RANB9_XENLA;Ran-binding protein 9 (RanBP9) (Ran-binding protein M) (RanBPM);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GO:0005634; GO:0005737; GO:0005886";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp3524311_c0_seq1;GAXK01069474.1;Q9M9W1;1.46E-28;RL222_ARATH;60S ribosomal protein L22-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp3524360_c0_seq1;GAXK01069484.1;P24044;1.27E-21;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3524670_c0_seq1;GAXK01069476.1;Q008X1;8.46E-08;DFP_BOMMO;Putative defense protein;"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp352493_c0_seq1;GAXK01119953.1;Q5RDR3;8.62E-09;AT1A1_PONAB;Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; regulation of sodium ion transport [GO:0002028]";"GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0042383; GO:0046872";regulation of sodium ion transport [GO:0002028];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp3525577_c0_seq1;GAXK01069495.1;Q14591;1.19E-18;ZN271_HUMAN;Deleted.;;;;;
comp3526854_c0_seq1;GAXK01062599.1;P21329;5.14E-20;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp3527103_c0_seq1;GAXK01062609.1;Q8X187;5.43E-10;CALM_PAXIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3527114_c0_seq1;GAXK01062604.1;O13672;1.48E-20;RL8_SCHPO;60S ribosomal protein L8 (L4) (L7A);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp3527141_c0_seq1;GAXK01062594.1;Q9W534;1.22E-14;MOODY_DROME;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp352732_c0_seq1;GAXK01120013.1;Q7ZYC4;1.52E-84;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp352748_c0_seq1;GAXK01120000.1;Q38PU3;2.27E-45;GRIK2_MACFA;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]";"GO:0004970; GO:0005234; GO:0016021; GO:0030054; GO:0030424; GO:0043197; GO:0045211";;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]"
comp3527562_c0_seq1;GAXK01062611.1;Q8VZB9;3.15E-67;R10A1_ARATH;60S ribosomal protein L10a-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0005576; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp35276_c1_seq1;GAXK01162099.1;Q8VI02;8.69E-102;PP4R1_RAT;Serine/threonine-protein phosphatase 4 regulatory subunit 1;"protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";"GO:0006470; GO:0007165; GO:0019888; GO:0030289";"protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";protein phosphatase 4 complex [GO:0030289];protein phosphatase regulator activity [GO:0019888]
comp3527655_c0_seq1;GAXK01062615.1;Q4PRC7;7.15E-09;SL6_DABSI;Snaclec 6 (C-type lectin-like 6);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3527711_c0_seq1;GAXK01062603.1;E1C8P7;1.05E-09;DSCL1_CHICK;Down syndrome cell adhesion molecule-like protein 1 homolog;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0007156; GO:0007416; GO:0007417; GO:0010842; GO:0016021; GO:0030017; GO:0030054; GO:0045202; GO:0060219";"camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]";
comp35280_c0_seq1;GAXK01161242.1;Q9Y3B2;6.09E-69;EXOS1_HUMAN;Exosome complex component CSL4 (Exosome component 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]";"GO:0000176; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0043488; GO:0043928; GO:0090503";"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";RNA binding [GO:0003723]
comp3528475_c0_seq1;GAXK01068669.1;P50429;5.81E-39;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp3529038_c0_seq1;GAXK01068679.1;P42674;1.04E-31;BP10_PARLI;Blastula protease 10 (EC 3.4.24.-);"cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471";;"cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp352934_c1_seq1;GAXK01119930.1;P58268;4.45E-55;REQU_CHICK;Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (Protein requiem);"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005737; GO:0006915; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071565";"apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp3529793_c0_seq1;GAXK01068665.1;P11121;4.10E-15;CALM_PYUSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3529976_c0_seq1;GAXK01068678.1;Q9CXE0;4.95E-21;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp35300_c0_seq1;GAXK01161106.1;Q5E9G6;2.33E-98;FBX8_BOVIN;F-box only protein 8;"ubiquitin ligase complex [GO:0000151]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; regulation of ARF protein signal transduction [GO:0032012]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0005086; GO:0006511; GO:0032012";"regulation of ARF protein signal transduction [GO:0032012]; ubiquitin-dependent protein catabolic process [GO:0006511]";ubiquitin ligase complex [GO:0000151];ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp3530000_c0_seq1;GAXK01165461.1;Q9N5X6;9.01E-08;ODD2_CAEEL;Protein odd-skipped-related 2;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0005634; GO:0007275; GO:0045944; GO:0046872";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp35302_c0_seq1;GAXK01161862.1;Q8NAB2;1.10E-16;KBTB3_HUMAN;Kelch repeat and BTB domain-containing protein 3 (BTB and kelch domain-containing protein 3);;;;;
comp3530482_c0_seq1;GAXK01165452.1;Q1RMB5;9.77E-07;SHSL1_DANRE;Protein shisa-like-1a;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3530566_c0_seq1;GAXK01165459.1;G5EBR3;4.65E-10;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp35307_c0_seq1;GAXK01161702.1;Q9JKC8;0;AP3M1_MOUSE;AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin);"axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Rab GTPase binding [GO:0017137]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0017137; GO:0030131; GO:0030659; GO:0048490; GO:1904115";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]";Rab GTPase binding [GO:0017137]
comp3530971_c0_seq1;GAXK01165453.1;Q0EEE2;1.10E-10;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp353100_c1_seq1;GAXK01119998.1;Q9HAZ2;3.34E-17;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp353133_c0_seq1;GAXK01120018.1;P26221;3.30E-105;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp3531454_c0_seq1;GAXK01165447.1;Q92766;2.98E-08;RREB1_HUMAN;Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006366; GO:0007265; GO:0007275; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:1900026; GO:1903691; GO:2000394";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3531608_c0_seq1;GAXK01165457.1;P0DPW4;1.52E-14;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp353165_c0_seq1;GAXK01120158.1;O46040;2.83E-15;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp353180_c0_seq1;GAXK01119951.1;Q9LXF8;1.94E-08;AVT1J_ARATH;Amino acid transporter AVT1J (AtAvt1J);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]";"GO:0003333; GO:0005886; GO:0015171; GO:0016021";amino acid transmembrane transport [GO:0003333];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";amino acid transmembrane transporter activity [GO:0015171]
comp35324_c0_seq1;GAXK01162018.1;Q66IS8;8.15E-24;TM177_XENLA;Transmembrane protein 177;integral component of mitochondrial inner membrane [GO:0031305];GO:0031305;;integral component of mitochondrial inner membrane [GO:0031305];
comp353247_c0_seq1;GAXK01120046.1;P90519;3.09E-34;EF1A_CRYPV;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3532719_c0_seq1;GAXK01001669.1;P56193;1.74E-08;LAC1_THACU;Laccase-1 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 1) (Diphenol oxidase 1) (Urishiol oxidase 1);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp35329_c6_seq1;GAXK01162022.1;Q28623;2.61E-106;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp3533884_c0_seq1;GAXK01001674.1;P17012;2.12E-08;ZFX_MOUSE;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; germ cell development [GO:0007281]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0007281; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746";"fertilization [GO:0009566]; germ cell development [GO:0007281]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp353391_c1_seq1;GAXK01120140.1;Q6GR09;5.49E-22;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp353442_c1_seq1;GAXK01120160.1;Q9VUL9;4.37E-85;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp353449_c0_seq1;GAXK01119967.1;Q8BI69;6.56E-07;ZN784_MOUSE;Zinc finger protein 784;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]";"GO:0002244; GO:0003677; GO:0005634; GO:0046872";hematopoietic progenitor cell differentiation [GO:0002244];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3534544_c0_seq1;GAXK01170835.1;O00534;1.98E-07;VMA5A_HUMAN;von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"GO:0005634; GO:0005654";;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp3534595_c0_seq1;GAXK01170839.1;Q9UTG4;2.43E-32;RS26B_SCHPO;40S ribosomal protein S26-B;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003729; GO:0003735; GO:0005829; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp353462_c0_seq1;GAXK01119947.1;O46040;1.02E-19;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp35348_c1_seq1;GAXK01161827.1;Q5R1S9;7.54E-101;CAF1B_CHICK;Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60);"CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; histone binding [GO:0042393]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]";"GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0007049; GO:0031497; GO:0033186; GO:0042393";"cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]";"CAF-1 complex [GO:0033186]; nucleus [GO:0005634]";histone binding [GO:0042393]
comp35350_c2_seq1;GAXK01161640.1;Q5R6Y0;0;HBS1L_PONAB;HBS1-like protein;"GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525";;;"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp35353_c0_seq1;GAXK01162072.1;A0A0G2JZ79;3.20E-98;SIR1_RAT;NAD-dependent protein deacetylase sirtuin-1 (EC 3.5.1.-);"axon [GO:0030424]; cytosol [GO:0005829]; growth cone [GO:0030426]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; p53 binding [GO:0002039]; protein kinase B binding [GO:0043422]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; cellular response to rotenone [GO:1904648]; cellular response to vitamin B3 [GO:0071303]; histone H3 deacetylation [GO:0070932]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; protein deacetylation [GO:0006476]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to kainic acid [GO:1904373]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to resveratrol [GO:1904638]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]";"GO:0002039; GO:0003714; GO:0005634; GO:0005637; GO:0005654; GO:0005719; GO:0005720; GO:0005829; GO:0006364; GO:0006476; GO:0006915; GO:0007517; GO:0007569; GO:0010046; GO:0010460; GO:0010667; GO:0010976; GO:0014858; GO:0016605; GO:0017136; GO:0019899; GO:0030424; GO:0030426; GO:0031667; GO:0032720; GO:0033553; GO:0035774; GO:0043392; GO:0043422; GO:0043524; GO:0045471; GO:0045722; GO:0045892; GO:0046872; GO:0048511; GO:0060125; GO:0060548; GO:0061051; GO:0070301; GO:0070403; GO:0070932; GO:0071236; GO:0071303; GO:0071407; GO:0090312; GO:0097755; GO:1900181; GO:1901984; GO:1902617; GO:1903427; GO:1904373; GO:1904638; GO:1904644; GO:1904646; GO:1904648; GO:2000270; GO:2000614";"apoptotic process [GO:0006915]; cell aging [GO:0007569]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; cellular response to rotenone [GO:1904648]; cellular response to vitamin B3 [GO:0071303]; histone H3 deacetylation [GO:0070932]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; protein deacetylation [GO:0006476]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to kainic acid [GO:1904373]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to resveratrol [GO:1904638]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]";"axon [GO:0030424]; cytosol [GO:0005829]; growth cone [GO:0030426]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]";"enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; p53 binding [GO:0002039]; protein kinase B binding [GO:0043422]; transcription corepressor activity [GO:0003714]"
comp353549_c0_seq1;GAXK01119955.1;Q6QR59;1.79E-21;TCAF3_MOUSE;TRPM8 channel-associated factor 3 (Experimental autoimmune prostatitis antigen 2);"plasma membrane [GO:0005886]; ion channel binding [GO:0044325]; negative regulation of anion channel activity [GO:0010360]; positive regulation of protein targeting to membrane [GO:0090314]";"GO:0005886; GO:0010360; GO:0044325; GO:0090314";"negative regulation of anion channel activity [GO:0010360]; positive regulation of protein targeting to membrane [GO:0090314]";plasma membrane [GO:0005886];ion channel binding [GO:0044325]
comp353583_c2_seq1;GAXK01119931.1;Q6XDT4;1.71E-08;IKZF_OIKDI;Ikaros family zinc finger protein (Ikaros-like transcription factor) (OIL);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3536712_c0_seq1;GAXK01146782.1;P0DN67;6.06E-14;ACTP1_TERSU;Tereporin-Ts1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp3536826_c0_seq1;GAXK01146781.1;B3NSE1;3.33E-18;TRET1_DROER;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3537_c0_seq1;GAXK01175478.1;P61291;1.70E-72;PSME3_PIG;Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]";"GO:0002039; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0042802; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]";"endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]"
comp3537133_c0_seq1;GAXK01146796.1;O75362;6.81E-08;ZN217_HUMAN;Zinc finger protein 217;"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000118; GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016607; GO:0044212; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp3537208_c0_seq1;GAXK01146799.1;Q9BS31;1.49E-07;ZN649_HUMAN;Zinc finger protein 649;"extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005615; GO:0005634; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp35375_c1_seq1;GAXK01161377.1;Q8T5C6;1.21E-146;RXR_BIOGL;Retinoic acid receptor RXR (RXR-like protein) (Retinoid X receptor) (BgRXR);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0016918; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp35376_c1_seq1;GAXK01161865.1;Q22505;1.10E-59;IMMT1_CAEEL;MICOS complex subunit MIC60-1 (Inner mitochondrial membrane protein 1) (Mitofilin homolog 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0005743; GO:0005753; GO:0016021; GO:0042407; GO:0070584";"cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; response to reactive oxygen species [GO:0000302]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]";
comp353788_c0_seq1;GAXK01119948.1;Q7ZYC4;1.22E-177;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp353799_c3_seq1;GAXK01120142.1;Q8NBN7;2.53E-53;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp353876_c0_seq1;;P07928;0;VGA_BPS13;A' protein (GPA);"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; viral DNA genome replication [GO:0039693]";"GO:0003677; GO:0004519; GO:0006260; GO:0039693; GO:0046872";"DNA replication [GO:0006260]; viral DNA genome replication [GO:0039693]";;"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp35388_c1_seq1;GAXK01161794.1;Q8WUA2;9.08E-140;PPIL4_HUMAN;Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]";"GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407";regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]"
comp35392_c2_seq1;GAXK01161721.1;Q8R2Y8;2.27E-36;PTH2_MOUSE;Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]";"GO:0004045; GO:0005739; GO:0005829; GO:0010629; GO:2000210; GO:2000811";"negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";aminoacyl-tRNA hydrolase activity [GO:0004045]
comp353920_c0_seq1;GAXK01119975.1;Q6P1S6;1.65E-07;MTPN_XENTR;Myotrophin;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp3539883_c0_seq1;GAXK01156483.1;Q7T070;8.80E-35;RHBG_DANRE;Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonia homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]";"GO:0005887; GO:0008519; GO:0015696; GO:0016323; GO:0030659; GO:0072488; GO:0097272";"ammonia homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]";ammonium transmembrane transporter activity [GO:0008519]
comp354_c1_seq1;GAXK01170099.1;Q7ZTZ2;3.58E-55;RLP24_DANRE;Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1);"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp3540108_c0_seq1;GAXK01189377.1;Q1DZK8;3.43E-11;DBP3_COCIM;ATP-dependent RNA helicase DBP3 (EC 3.6.4.13);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp3540113_c0_seq1;GAXK01189376.1;P48763;7.02E-26;SL9A2_RAT;Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0051453; GO:0071805; GO:0098719";"potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp354079_c1_seq1;GAXK01053327.1;P05164;1.25E-90;PERM_HUMAN;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141]; chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0003682; GO:0004601; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0006952; GO:0006979; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0035578; GO:0042582; GO:0042742; GO:0042744; GO:0043066; GO:0043231; GO:0043312; GO:0045454; GO:0046872; GO:0050832; GO:0055114; GO:0070062; GO:0097013; GO:1990268";"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141]";"chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp3541063_c0_seq1;GAXK01189392.1;Q8K1K9;8.02E-09;HINFP_MOUSE;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp35411_c0_seq1;GAXK01161884.1;Q01433;0;AMPD2_HUMAN;AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L);"cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]";"GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009";"AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]";cytosol [GO:0005829];"AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]"
comp354196_c1_seq1;GAXK01053070.1;Q922Q1;2.71E-48;MARC2_MOUSE;Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2);"mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0005741; GO:0005743; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0055114";"nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]";"mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]"
comp3542466_c0_seq1;GAXK01181094.1;Q99LI5;1.44E-10;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp35426_c0_seq1;GAXK01161409.1;Q32LL5;7.96E-17;INT12_BOVIN;Integrator complex subunit 12 (Int12) (PHD finger protein 22);"integrator complex [GO:0032039]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; snRNA 3'-end processing [GO:0034472]";"GO:0005634; GO:0032039; GO:0034472; GO:0046872";snRNA 3'-end processing [GO:0034472];"integrator complex [GO:0032039]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp354310_c0_seq1;GAXK01053110.1;G2XKQ0;3.88E-07;SUMO5_HUMAN;Small ubiquitin-related modifier 5 (SUMO-5) (SUMO1 pseudogene 1) (Ubiquitin-like 2) (Ubiquitin-like 6);"nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; PML body organization [GO:0030578]; protein sumoylation [GO:0016925]";"GO:0005634; GO:0008134; GO:0016925; GO:0030578; GO:0042802";"PML body organization [GO:0030578]; protein sumoylation [GO:0016925]";nucleus [GO:0005634];"identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]"
comp354312_c2_seq1;GAXK01053099.1;P15620;3.37E-37;ZN271_MOUSE;Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";"GO:0000976; GO:0002437; GO:0002829; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872";"cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp354353_c4_seq1;GAXK01053128.1;Q96RW7;2.03E-20;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp3543606_c0_seq1;GAXK01181074.1;Q9XYN1;8.03E-13;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp3543863_c0_seq1;GAXK01181088.1;Q9C0I9;2.97E-11;LRC27_HUMAN;Leucine-rich repeat-containing protein 27;;;;;
comp354390_c0_seq1;GAXK01053114.1;P49711;1.92E-08;CTCF_HUMAN;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]";"GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0007059; GO:0008270; GO:0008285; GO:0010216; GO:0010628; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0070602; GO:0071459";"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp3544026_c0_seq1;GAXK01093025.1;P42689;8.49E-28;SRK3_SPOLA;Tyrosine-protein kinase SRK3 (EC 2.7.10.2) (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524; GO:0005737";;cytoplasm [GO:0005737];"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp354431_c2_seq1;GAXK01053307.1;Q2HJ68;8.05E-14;RND1_BOVIN;Rho-related GTP-binding protein Rho6 (Rho family GTPase 1) (Rnd1);"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005102; GO:0005525; GO:0005737; GO:0005886; GO:0005912; GO:0005938; GO:0007015; GO:0007162; GO:0007266; GO:0008360; GO:0015629; GO:0016322; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]"
comp354433_c0_seq1;GAXK01053050.1;Q8VIG1;3.79E-08;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3544354_c0_seq1;GAXK01093023.1;P50428;4.09E-38;ARSA_MOUSE;Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597";"autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]"
comp35445_c0_seq1;GAXK01161646.1;Q1HRV8;2.53E-71;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp35447_c6_seq1;GAXK01161676.1;P56823;3.35E-51;HCYG_HELPO;Hemocyanin, beta-C chain unit G (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp354530_c0_seq1;GAXK01053094.1;P10076;1.37E-43;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp354575_c0_seq1;GAXK01053321.1;Q7KRI2;7.48E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3545841_c0_seq1;GAXK01093007.1;Q8K1K9;8.93E-07;HINFP_MOUSE;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp3546243_c0_seq1;GAXK01163928.1;Q9VNM1;6.60E-27;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp35472_c0_seq1;GAXK01162049.1;Q9WUQ2;1.73E-11;PREB_MOUSE;Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12);"endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000139; GO:0001228; GO:0003400; GO:0003677; GO:0003700; GO:0005090; GO:0005096; GO:0005634; GO:0006355; GO:0006888; GO:0009306; GO:0030176; GO:0032527; GO:0048208; GO:0051020; GO:0070971";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]; regulation of transcription, DNA-templated [GO:0006355]";"endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]"
comp3547608_c0_seq1;GAXK01163921.1;Q9C0Z7;2.11E-56;RS6B_SCHPO;40S ribosomal protein S6-B;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003735; GO:0005829; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp354763_c0_seq1;GAXK01053318.1;A6QNK1;5.60E-32;G3ST1_BOVIN;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021";"glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp35478_c1_seq1;GAXK01161552.1;P30352;2.27E-20;SRSF2_CHICK;Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0016607; GO:0036002; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";"pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]"
comp3548078_c0_seq1;GAXK01008775.1;Q9BY31;5.67E-10;ZN717_HUMAN;Zinc finger protein 717 (Krueppel-like factor X17);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp354821_c3_seq1;GAXK01053315.1;Q63515;1.47E-14;C4BPB_RAT;C4b-binding protein beta chain;"extracellular region [GO:0005576]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";"GO:0005576; GO:0006958; GO:0045087";"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp354834_c0_seq1;GAXK01053072.1;Q9DBB9;1.38E-23;CPN2_MOUSE;Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"GO:0005615; GO:0031012; GO:0062023";;"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";
comp354911_c1_seq1;GAXK01205365.1;Q09660;1.75E-115;CC44_CAEEL;Probable cytochrome P450 CYP44 (EC 1.14.-.-);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016705; GO:0020037";;;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp35493_c4_seq1;GAXK01161831.1;Q8BGA9;2.40E-68;OXA1L_MOUSE;Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein);"integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]";"GO:0005739; GO:0005743; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177";"aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]";"integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]"
comp3549442_c0_seq1;GAXK01008770.1;Q9P109;1.36E-08;GCNT4_HUMAN;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993";"carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp3549599_c0_seq1;GAXK01008783.1;Q62813;3.58E-11;LSAMP_RAT;Limbic system-associated membrane protein (LSAMP);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp3549707_c0_seq1;GAXK01008782.1;P42260;1.87E-112;GRIK2_RAT;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp355055_c1_seq1;GAXK01053068.1;Q9NFL4;2.11E-107;HCYG_APHSP;Hemocyanin G chain (HcG);"extracellular space [GO:0005615]; chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005507; GO:0005615; GO:0016491; GO:0031404";;extracellular space [GO:0005615];"chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp355101_c0_seq1;GAXK01053120.1;Q5ZIE8;1.48E-18;MCAF1_CHICK;Activating transcription factor 7-interacting protein 1 (MBD1-containing chromatin-associated factor 1);"nucleus [GO:0005634]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]";"GO:0005634; GO:0031647; GO:0050821; GO:0090309";"positive regulation of methylation-dependent chromatin silencing [GO:0090309]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]";nucleus [GO:0005634];
comp3551023_c0_seq1;GAXK01194450.1;Q2QI47;3.84E-10;USH2A_MOUSE;Usherin (Usher syndrome type IIa protein homolog) (Usher syndrome type-2A protein homolog);"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0017022; GO:0022008; GO:0032391; GO:0032420; GO:0032421; GO:0035315; GO:0036064; GO:0042803; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060041; GO:0060113; GO:0060171; GO:1990075; GO:1990696";"animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]";"collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]"
comp3551998_c0_seq1;GAXK01194449.1;Q9Y6Q3;5.59E-07;ZFP37_HUMAN;Zinc finger protein 37 homolog (Zfp-37);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp3552714_c0_seq1;GAXK01079180.1;Q8VIF2;4.99E-13;PRS42_MOUSE;Serine protease 42 (EC 3.4.21.-) (Testis serine protease 2);"anchored component of plasma membrane [GO:0046658]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]";"GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0007281; GO:0007283; GO:0046658";"germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]";"anchored component of plasma membrane [GO:0046658]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp355285_c0_seq1;GAXK01053320.1;Q96RY5;1.54E-56;CRML_HUMAN;Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]";"GO:0000981; GO:0003677; GO:0003682; GO:0005634";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp35530_c0_seq1;GAXK01161854.1;D7UQM5;1.65E-73;AURK_PATPE;Aurora kinase (EC 2.7.11.1) (ApAurora);"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]";"GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0007275; GO:0030496; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]";"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp355301_c1_seq1;GAXK01053064.1;Q4R646;0;SYIM_MACFA;Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS) (Fragment);"mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]";"GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005759; GO:0006428";isoleucyl-tRNA aminoacylation [GO:0006428];mitochondrial matrix [GO:0005759];"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]"
comp3553277_c0_seq1;GAXK01079179.1;O64425;3.52E-07;RMA1_ARATH;E3 ubiquitin-protein ligase RMA1 (EC 2.3.2.27) (Protein RING membrane-anchor 1) (RING-type E3 ubiquitin transferase RMA1);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0032527; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp3553461_c0_seq1;GAXK01079177.1;Q08DY9;2.17E-22;CASP3_BOVIN;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp3553736_c0_seq1;GAXK01079189.1;Q8MHY7;9.01E-09;UROK_RABIT;"Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B]";"cell surface [GO:0009986]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]";"GO:0001666; GO:0004252; GO:0005615; GO:0009986; GO:0010469; GO:0014909; GO:0014910; GO:0030335; GO:0031639; GO:0033628; GO:0042127; GO:0042730; GO:2000097";"fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; regulation of smooth muscle cell migration [GO:0014910]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]";"cell surface [GO:0009986]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp35538_c1_seq1;GAXK01161641.1;Q803E0;3.34E-18;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp355387_c0_seq1;GAXK01053126.1;Q98943;3.48E-42;CASP2_CHICK;"Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200";"apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp355430_c0_seq1;GAXK01053109.1;Q9NHD5;2.06E-13;SAN_DROME;Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0016573; GO:0031248; GO:0031415";"histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]";"N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]"
comp355436_c0_seq1;GAXK01053317.1;Q9N003;9.81E-10;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3555483_c0_seq1;GAXK01012708.1;Q6AXM1;3.11E-07;CHSTA_DANRE;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp35556_c2_seq1;GAXK01161114.1;P61406;3.95E-20;EST1A_MOUSE;Telomerase-binding protein EST1A (EC 3.1.-.-) (EST1-like protein A) (Ever shorter telomeres 1A) (Smg-6 homolog) (Telomerase subunit EST1A);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]";"GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0007004; GO:0032204; GO:0032210; GO:0035145; GO:0042162; GO:0043021; GO:0043487; GO:0046872; GO:0070034; GO:0070182; GO:1904354";"negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]";"DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]"
comp3555710_c0_seq1;GAXK01012713.1;P25975;4.32E-11;CATL1_BOVIN;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]; adaptive immune response [GO:0002250]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0001968; GO:0002250; GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005771; GO:0005886; GO:0030574; GO:0042393; GO:0043394; GO:0051603; GO:0097067; GO:0097655";"adaptive immune response [GO:0002250]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]"
comp3556063_c0_seq1;GAXK01139517.1;P60892;1.23E-94;PRPS1_RAT;Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I);"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0006167; GO:0009116; GO:0009165; GO:0016208; GO:0016301; GO:0019003; GO:0019693; GO:0030246; GO:0031100; GO:0032991; GO:0042803; GO:0043531";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693]";"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]";"ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp3556921_c0_seq1;GAXK01139510.1;Q54BA2;2.27E-10;Y3800_DICDI;Ankyrin repeat, bromo and BTB domain-containing protein DDB_G0293800;;;;;
comp35570_c1_seq1;GAXK01161557.1;Q8WWM7;1.73E-24;ATX2L_HUMAN;Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; stress granule assembly [GO:0034063]";"GO:0003723; GO:0005829; GO:0010494; GO:0010603; GO:0016020; GO:0016607; GO:0034063; GO:0045296";"regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; stress granule assembly [GO:0034063]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]";"cadherin binding [GO:0045296]; RNA binding [GO:0003723]"
comp3557169_c0_seq1;GAXK01139524.1;Q8WVV9;2.50E-07;HNRLL_HUMAN;Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor);"membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]";"GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0016020; GO:0033120";"mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]";"membrane [GO:0016020]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp3558567_c0_seq1;GAXK01162662.1;Q9NQX1;1.04E-07;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3559_c0_seq1;GAXK01176598.1;P05661;2.24E-41;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp355943_c0_seq1;GAXK01053049.1;Q17GZ9;6.51E-171;ARP5_AEDAE;Actin-related protein 5;"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0006355";"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];
comp3559470_c0_seq1;GAXK01162671.1;Q96TJ5;1.13E-28;RLA0_NEUCR;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp3559836_c0_seq1;GAXK01162664.1;Q16WU7;8.59E-12;WSCD_AEDAE;WSCD family member AAEL009094;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp35602_c2_seq1;GAXK01205867.1;P20228;0;DCE_DROME;Glutamate decarboxylase (GAD) (EC 4.1.1.15);"cytosol [GO:0005829]; glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]";"GO:0004351; GO:0005829; GO:0006538; GO:0007416; GO:0007528; GO:0008345; GO:0008355; GO:0009449; GO:0009612; GO:0030170; GO:0045213";"gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]";cytosol [GO:0005829];"glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]"
comp356053_c3_seq1;GAXK01084864.1;O18391;1.83E-47;KRAK_DROME;Probable serine hydrolase (EC 3.1.-.-) (Kraken protein);"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]; digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";"GO:0007275; GO:0007586; GO:0009636; GO:0017171; GO:0052689";"digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";;"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]"
comp3560567_c0_seq1;GAXK01112442.1;Q96PH1;2.15E-63;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp3560634_c0_seq1;GAXK01112458.1;Q9XHE4;6.55E-36;RL37A_GOSHI;60S ribosomal protein L37a;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp3560865_c0_seq1;GAXK01112463.1;P18740;5.26E-12;ZO14_XENLA;Oocyte zinc finger protein XlCOF14 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3560943_c0_seq1;GAXK01112455.1;Q8R5F3;4.61E-21;OARD1_MOUSE;ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]"
comp35620_c3_seq1;GAXK01162044.1;Q9VJQ5;9.73E-53;NC2B_DROME;Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (dNC2);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0001047; GO:0003714; GO:0005634; GO:0005671; GO:0006338; GO:0006366; GO:0008134; GO:0016573; GO:0017025; GO:0017054; GO:0042766; GO:0045892; GO:0045893; GO:0045898; GO:0045944; GO:0046982";"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]";"core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp356209_c0_seq1;GAXK01084758.1;P23286;1.70E-22;CALM_CANAX;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3562205_c0_seq1;GAXK01148110.1;P62277;4.03E-99;RS13_HUMAN;40S ribosomal protein S13 (Small ribosomal subunit protein uS15);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022627; GO:0033119; GO:0048027; GO:0070062; GO:0070181";"negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]";"mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp3562208_c0_seq1;GAXK01148096.1;Q94887;6.03E-43;NRX4_DROME;Neurexin-4 (Neurexin IV);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"GO:0003015; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0007163; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016080; GO:0016081; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105";"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]";
comp3562914_c0_seq1;GAXK01148116.1;Q96PY6;6.99E-120;NEK1_HUMAN;Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007049; GO:0016301; GO:0023014; GO:0031098; GO:0032147; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889";"activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]";"14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp3563_c1_seq1;GAXK01176579.1;Q5I0D7;0;PEPD_RAT;Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase);"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallopeptidase activity [GO:0008237]; proline dipeptidase activity [GO:0102009]; collagen catabolic process [GO:0030574]";"GO:0004177; GO:0008237; GO:0030145; GO:0030574; GO:0102009";collagen catabolic process [GO:0030574];;"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallopeptidase activity [GO:0008237]; proline dipeptidase activity [GO:0102009]"
comp3563269_c0_seq1;GAXK01148085.1;Q8NEP9;4.67E-16;ZN555_HUMAN;Zinc finger protein 555;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3563273_c0_seq1;GAXK01148111.1;Q7M4I3;2.62E-19;SP4_BOMPE;Venom protease (EC 3.4.21.-) (allergen Bom p 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp3563732_c0_seq1;GAXK01148089.1;Q7RZS0;8.36E-46;RL10A_NEUCR;60S ribosomal protein L10a (Cytoplasmic ribosomal protein 74);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp35643_c0_seq1;GAXK01161549.1;Q80U58;0;PUM2_MOUSE;Pumilio homolog 2;"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]";"GO:0003723; GO:0003730; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:1900246; GO:2000637";"positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]"
comp3564329_c0_seq1;GAXK01077294.1;P08548;4.62E-12;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3564411_c0_seq1;GAXK01077300.1;Q22038;9.56E-38;RHO1_CAEEL;Ras-like GTP-binding protein rhoA;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actomyosin contractile ring assembly [GO:0000915]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; multicellular organism development [GO:0007275]; myosin filament assembly [GO:0031034]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of locomotion [GO:0040017]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0000915; GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007266; GO:0007275; GO:0008360; GO:0014057; GO:0016477; GO:0019901; GO:0030241; GO:0030334; GO:0030950; GO:0031034; GO:0032153; GO:0032154; GO:0032794; GO:0032956; GO:0032970; GO:0040017; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actomyosin contractile ring assembly [GO:0000915]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; multicellular organism development [GO:0007275]; myosin filament assembly [GO:0031034]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of locomotion [GO:0040017]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; skeletal muscle myosin thick filament assembly [GO:0030241]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp3564611_c0_seq1;GAXK01077284.1;Q8IY82;3.54E-24;DRC7_HUMAN;Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]";"GO:0005737; GO:0005856; GO:0030317; GO:0031514; GO:0048870";"cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";
comp3565115_c0_seq1;GAXK01077296.1;Q9P2E3;6.15E-36;ZNFX1_HUMAN;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp356521_c0_seq1;GAXK01084870.1;P15370;1.18E-48;EGON_DROME;Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp35654_c0_seq1;GAXK01161992.1;Q8IWV8;0;UBR2_HUMAN;E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596";"cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp3565657_c0_seq1;GAXK01077297.1;Q60821;1.51E-19;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp35657_c1_seq1;GAXK01161391.1;Q3UHH1;7.92E-174;ZSWM8_MOUSE;Zinc finger SWIM domain-containing protein 8;"Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]";"GO:0005829; GO:0008270; GO:0031462; GO:1902667";regulation of axon guidance [GO:1902667];"Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]";zinc ion binding [GO:0008270]
comp356648_c0_seq1;GAXK01084786.1;P34519;9.48E-45;TXTP_CAEEL;Putative tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial citrate transmembrane transport [GO:0006843]";"GO:0005743; GO:0006843; GO:0016021";mitochondrial citrate transmembrane transport [GO:0006843];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp35665_c0_seq1;GAXK01161995.1;Q6P5M2;6.09E-122;WDR61_DANRE;WD repeat-containing protein 61;"Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]";"GO:0005634; GO:0005737; GO:0016593; GO:0032968; GO:0035327; GO:0045944; GO:0055087";"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]";"Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]";
comp3566511_c0_seq1;GAXK01129326.1;P0C6Y7;1.61E-15;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3566836_c0_seq1;GAXK01129333.1;Q18409;1.42E-17;RSP6_CAEEL;Probable splicing factor, arginine/serine-rich 6 (CeSRp20) (RNA-binding protein srp-1);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gonad development [GO:0008406]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of DNA-templated transcription, termination [GO:0031554]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007275; GO:0008380; GO:0008406; GO:0016607; GO:0030154; GO:0031554; GO:0045292";"cell differentiation [GO:0030154]; gonad development [GO:0008406]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of DNA-templated transcription, termination [GO:0031554]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp3567125_c0_seq1;GAXK01129335.1;Q9NQ03;9.37E-08;SCRT2_HUMAN;Transcriptional repressor scratch 2 (Scratch homolog 2 zinc finger protein);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000790; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0070888; GO:1902042; GO:2001222";"negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3567211_c0_seq1;GAXK01129331.1;Q9VMA2;8.24E-25;GALT_DROME;Probable galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase);"cytoplasm [GO:0005737]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose homeostasis [GO:0033501]";"GO:0005737; GO:0008108; GO:0008270; GO:0008344; GO:0033499; GO:0033501";"adult locomotory behavior [GO:0008344]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose homeostasis [GO:0033501]";cytoplasm [GO:0005737];"UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]"
comp35674_c7_seq1;GAXK01161638.1;A0JNB1;9.09E-31;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3567638_c0_seq1;GAXK01129321.1;P30974;4.75E-31;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp35684_c1_seq1;GAXK01161767.1;Q27594;3.36E-63;CP6A9_DROME;Cytochrome P450 6a9 (EC 1.14.-.-) (CYPVIA9);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp356851_c5_seq1;GAXK01084702.1;Q9VB11;0;UNC80_DROME;Protein unc-80 homolog;"axon [GO:0030424]; cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475]";"GO:0005261; GO:0030424; GO:0034703; GO:0045475; GO:0055080";"cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475]";"axon [GO:0030424]; cation channel complex [GO:0034703]";cation channel activity [GO:0005261]
comp3568619_c0_seq1;GAXK01029565.1;Q6X5S5;8.86E-09;SL27_ECHOC;Snaclec 27 (C-type lectin 27) (CTL-27) (Fragment);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3568688_c0_seq1;GAXK01029550.1;Q08180;8.29E-28;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp3569_c6_seq1;GAXK01175806.1;P40939;0;ECHA_HUMAN;"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]";"mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]";"GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287";"cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]";"mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]"
comp3569068_c0_seq1;GAXK01029545.1;Q9NRG4;1.28E-10;SMYD2_HUMAN;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975; GO:1901796";"heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp3569210_c0_seq1;GAXK01029560.1;B2FQP3;3.38E-11;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3569448_c0_seq1;GAXK01029554.1;P24524;1.91E-64;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp356969_c0_seq1;GAXK01084760.1;Q09788;5.61E-09;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp356974_c0_seq1;GAXK01084834.1;Q96QE2;2.27E-133;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp3569740_c0_seq1;GAXK01029549.1;Q9HCK0;1.44E-13;ZBT26_HUMAN;Zinc finger and BTB domain-containing protein 26 (Zinc finger protein 481) (Zinc finger protein Bioref);"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0042802; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp357048_c0_seq1;GAXK01084698.1;P34410;2.63E-25;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp357104_c0_seq1;GAXK01084764.1;Q9DG10;6.08E-15;STAR_DANRE;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005758; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020";"cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp357133_c0_seq1;GAXK01084865.1;Q84P21;1.05E-43;4CLL5_ARATH;4-coumarate--CoA ligase-like 5 (EC 6.2.1.-) (4-coumarate--CoA ligase isoform 9) (At4CL9) (Peroxisomal OPC-8:0-CoA ligase 1);"peroxisome [GO:0005777]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; jasmonic acid biosynthetic process [GO:0009695]; response to wounding [GO:0009611]";"GO:0005524; GO:0005777; GO:0009611; GO:0009695; GO:0016874";"jasmonic acid biosynthetic process [GO:0009695]; response to wounding [GO:0009611]";peroxisome [GO:0005777];"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp3571483_c0_seq1;GAXK01058289.1;Q3KQ77;6.94E-55;EFCB1_XENLA;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3571943_c0_seq1;GAXK01058295.1;P10394;9.84E-24;POL4_DROME;"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp357206_c1_seq1;GAXK01084841.1;Q10469;2.95E-92;MGAT2_HUMAN;Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0000139; GO:0005794; GO:0005795; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803";"oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"
comp3572334_c0_seq1;GAXK01057638.1;Q95LS7;7.54E-11;CCD96_MACFA;Coiled-coil domain-containing protein 96;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]";"GO:0005737; GO:0005815";;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]";
comp3572409_c0_seq1;GAXK01057657.1;Q9CPV7;4.67E-78;ZDHC6_MOUSE;Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 6) (DHHC-6);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp35727_c1_seq1;GAXK01162073.1;Q9VGH7;0;CLCN2_DROME;Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]";"GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]";"chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]"
comp3572756_c0_seq1;GAXK01057641.1;Q8L796;8.01E-17;PI5K2_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 2 (AtPIP5K2) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 2) (Diphosphoinositide kinase 2) (PtdIns(4)P-5-kinase 2);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";"GO:0003006; GO:0005524; GO:0005886; GO:0009958; GO:0010311; GO:0016308";"developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp35733_c3_seq1;GAXK01161188.1;P26016;0;FUR11_DROME;Furin-like protease 1, isoforms 1/1-X/2 (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688";"glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp357330_c0_seq1;GAXK01084826.1;Q9N003;1.60E-15;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3573379_c0_seq1;GAXK01057659.1;P42262;8.89E-12;GRIA2_HUMAN;Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2);"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0009897; GO:0014069; GO:0030054; GO:0030425; GO:0030666; GO:0032281; GO:0035235; GO:0035249; GO:0043197; GO:0045211; GO:0060076; GO:0098794; GO:0098843; GO:2000310";"chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]";"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]";"AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]"
comp3573857_c0_seq1;GAXK01057645.1;Q96JB1;0;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp357391_c0_seq1;GAXK01084816.1;Q9EQW7;0;KI13A_MOUSE;Kinesin-like protein KIF13A;"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383";"cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp3574487_c0_seq1;GAXK01140503.1;A6H782;4.70E-41;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp35751_c1_seq1;GAXK01161110.1;P70280;1.68E-72;VAMP7_MOUSE;Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1);"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008021; GO:0008333; GO:0009986; GO:0016020; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030054; GO:0030133; GO:0030141; GO:0030285; GO:0030667; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595";"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]";"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp3575267_c0_seq1;GAXK01140509.1;P20662;1.07E-09;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3575392_c0_seq1;GAXK01140506.1;P08519;2.00E-13;APOA_HUMAN;Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-);"extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358]; apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; low-density lipoprotein particle remodeling [GO:0034374]";"GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358; GO:0034374";"blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; low-density lipoprotein particle remodeling [GO:0034374]";"extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358]";"apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]"
comp3575659_c0_seq1;GAXK01140510.1;Q9Z2R9;8.80E-09;E2AK1_MOUSE;Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; acute inflammatory response [GO:0002526]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; response to iron ion starvation [GO:1990641]";"GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006417; GO:0006909; GO:0008285; GO:0010999; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0055072; GO:1990641";"acute inflammatory response [GO:0002526]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; response to iron ion starvation [GO:1990641]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]"
comp357597_c2_seq1;GAXK01084817.1;O54750;6.67E-67;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp3576_c1_seq1;GAXK01176031.1;P16100;0;IDH_AZOVI;Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (Oxalosuccinate decarboxylase);"cytoplasm [GO:0005737]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004450; GO:0005737; GO:0006097; GO:0006099; GO:0046872";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";cytoplasm [GO:0005737];"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]"
comp3576021_c0_seq1;GAXK01060278.1;P97353;6.19E-15;SEC1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp3576085_c0_seq1;GAXK01060291.1;B7TB45;6.52E-14;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp3576181_c0_seq1;GAXK01060284.1;O70237;7.65E-08;GFI1B_MOUSE;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"GO:0000122; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0007275; GO:0016363; GO:0030854; GO:0045646; GO:0046872; GO:0051572; GO:0051574";"multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp357635_c0_seq1;GAXK01084691.1;Q86AV4;8.33E-08;EXPL5_DICDI;Expansin-like protein 5 (Ddexpl5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3577_c0_seq1;GAXK01176556.1;Q5R7G6;0;PEPL1_PONAB;Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]";"GO:0004177; GO:0005737; GO:0008235; GO:0030145";;cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]"
comp3577510_c0_seq1;GAXK01060290.1;O09046;9.95E-23;OXLA_MOUSE;L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (Protein Fig-1) (mFIG1);"lysosome [GO:0005764]; L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; aromatic amino acid family metabolic process [GO:0009072]; cellular amino acid catabolic process [GO:0009063]";"GO:0001716; GO:0005764; GO:0009063; GO:0009072; GO:0016491";"aromatic amino acid family metabolic process [GO:0009072]; cellular amino acid catabolic process [GO:0009063]";lysosome [GO:0005764];"L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]"
comp35785_c0_seq1;GAXK01162106.1;Q9CY16;7.65E-28;RT28_MOUSE;28S ribosomal protein S28, mitochondrial (MRP-S28) (S28mt);"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005763";;"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";
comp3578630_c0_seq1;GAXK01193257.1;Q59SN6;1.14E-07;CRZ2_CANAL;Transcriptional regulator CRZ2 (Calcineurin-responsive zinc finger protein 2);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell adhesion [GO:0007155]; cellular response to acidic pH [GO:0071468]; cellular response to cold [GO:0070417]; cellular response to copper ion [GO:0071280]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of single-species biofilm formation on inanimate substrate [GO:1900231]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";"GO:0003676; GO:0005634; GO:0006357; GO:0007155; GO:0010811; GO:0044011; GO:0046872; GO:0070417; GO:0071280; GO:0071468; GO:1900189; GO:1900231";"cell adhesion [GO:0007155]; cellular response to acidic pH [GO:0071468]; cellular response to cold [GO:0070417]; cellular response to copper ion [GO:0071280]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of single-species biofilm formation on inanimate substrate [GO:1900231]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp357898_c1_seq1;GAXK01084766.1;Q6NTY6;1.25E-52;EGR1B_XENLA;Early growth response protein 1-B (EGR-1-B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841";"circadian regulation of gene expression [GO:0032922]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp3579638_c0_seq1;GAXK01193242.1;Q01800;8.95E-07;ESCA_TRICA;Escargot/snail protein homolog (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp35797_c1_seq1;GAXK01161411.1;Q55624;6.44E-23;Y755_SYNY3;Putative peroxiredoxin sll0755 (EC 1.11.1.15) (Thioredoxin reductase);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0005829; GO:0006979; GO:0008379; GO:0042744; GO:0045454";"cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp357986_c0_seq1;GAXK01084781.1;Q9WV74;6.85E-39;ASB1_MOUSE;Ankyrin repeat and SOCS box protein 1 (ASB-1);"ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; protein ubiquitination [GO:0016567]";"GO:0000151; GO:0016567; GO:0030539; GO:0035556; GO:0061630";"intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; protein ubiquitination [GO:0016567]";ubiquitin ligase complex [GO:0000151];ubiquitin protein ligase activity [GO:0061630]
comp358_c0_seq1;GAXK01168684.1;P21531;1.59E-53;RL3_RAT;60S ribosomal protein L3 (L4);"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005730; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0045202; GO:0071353";"cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; ribosome [GO:0005840]; synapse [GO:0045202]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp35810_c1_seq1;GAXK01161153.1;Q9W429;2.35E-121;S35B4_DROME;UDP-xylose and UDP-N-acetylglucosamine transporter (ER GDP-fucose transporter) (Solute carrier family 35 member B4 homolog);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]";"GO:0005457; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0008643; GO:0015012; GO:0015782; GO:0015783; GO:0015786; GO:0015787; GO:0015790; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0036066; GO:0036084; GO:1990569; GO:1990570";"carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]"
comp35812_c0_seq1;GAXK01161413.1;P27653;0;C1TC_RAT;"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]";"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0000105; GO:0004329; GO:0004477; GO:0004486; GO:0004488; GO:0005524; GO:0005737; GO:0006164; GO:0006730; GO:0009086; GO:0009113; GO:0009117; GO:0009257; GO:0035713; GO:0035999; GO:0046653";"10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]"
comp35813_c1_seq1;GAXK01161704.1;Q9HC07;1.33E-68;TM165_HUMAN;Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL);"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0016021; GO:0031901; GO:0031902; GO:0032472; GO:0032588; GO:0035751; GO:0043231";"cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]";
comp3581357_c0_seq1;GAXK01015848.1;Q9BLY8;1.29E-19;GBRB_DROSI;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor) (Protein cyclodiene resistance);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; ion transport [GO:0006811]";"GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0030054; GO:0030594; GO:0034707; GO:0045211";ion transport [GO:0006811];"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]"
comp3581510_c0_seq1;GAXK01015841.1;Q8WNQ5;1.64E-31;RHBG_PAPHA;Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; spectrin-associated cytoskeleton [GO:0014731]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transport [GO:0015696]";"GO:0008519; GO:0014731; GO:0015696; GO:0016021; GO:0016323; GO:0030659";ammonium transport [GO:0015696];"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; spectrin-associated cytoskeleton [GO:0014731]";ammonium transmembrane transporter activity [GO:0008519]
comp3581575_c0_seq1;GAXK01015851.1;P76071;3.89E-116;INSH5_ECOLI;Transposase InsH for insertion sequence element IS5Y;"cytosol [GO:0005829]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0005829; GO:0006313; GO:0045893";"positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";cytosol [GO:0005829];"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp3581728_c0_seq1;GAXK01015843.1;O61064;1.13E-18;TCT2_PHYPO;Tectonin-2 (Tectonin II);"cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; carbohydrate binding [GO:0030246]";"GO:0009986; GO:0030246; GO:0030659";;"cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]";carbohydrate binding [GO:0030246]
comp358176_c0_seq1;GAXK01034387.1;Q80V03;8.04E-92;ADCK5_MOUSE;Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005739; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";protein serine/threonine kinase activity [GO:0004674]
comp3582_c0_seq1;GAXK01175636.1;Q26636;2.66E-142;CATL_SARPE;"Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]";"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005764; GO:0007275; GO:0008234; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp3582239_c0_seq1;GAXK01077823.1;P14381;1.71E-14;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp3583000_c0_seq1;GAXK01077835.1;O54728;8.77E-18;PLB1_RAT;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp3583348_c0_seq1;GAXK01077821.1;A2AVJ0;3.87E-15;CF299_DANRE;Cilia- and flagella-associated protein 299;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp358338_c0_seq1;GAXK01034392.1;P54281;2.72E-21;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3583405_c0_seq1;GAXK01077836.1;Q9D180;2.32E-33;CFA57_MOUSE;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp3583510_c0_seq1;GAXK01077837.1;Q9H8M5;8.61E-90;CNNM2_HUMAN;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231";magnesium ion homeostasis [GO:0010960];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp3583957_c0_seq1;GAXK01077832.1;Q9NYC9;8.36E-27;DYH9_HUMAN;Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0097729; GO:0120135";"cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp358396_c0_seq1;GAXK01034531.1;Q9GZZ6;1.06E-23;ACH10_HUMAN;Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);"axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005102; GO:0005262; GO:0005887; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0016020; GO:0022848; GO:0030054; GO:0030424; GO:0034220; GO:0042127; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060";"chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]"
comp3584744_c0_seq1;GAXK01063784.1;Q86LG1;7.35E-10;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp3585087_c0_seq1;GAXK01063781.1;Q21005;1.82E-11;ACC1_CAEEL;Acetylcholine-gated chloride channel subunit acc-1;"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp3585180_c0_seq1;GAXK01063778.1;Q9WU81;9.11E-70;G6PT3_MOUSE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2) (cAMP-inducible protein 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0006072; GO:0006127; GO:0008643; GO:0015169; GO:0015760; GO:0015794; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";"glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]"
comp35855_c0_seq1;GAXK01161907.1;Q6P4Y0;0;CDKAL_XENTR;Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; tRNA methylthiolation [GO:0035600]";"GO:0005783; GO:0005789; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712";tRNA methylthiolation [GO:0035600];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"
comp358559_c0_seq1;GAXK01034468.1;Q06453;7.35E-39;AL_DROME;Homeobox protein aristaless;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; elongation of arista core [GO:0035015]; imaginal disc-derived leg morphogenesis [GO:0007480]; leg disc development [GO:0035218]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]";"GO:0000977; GO:0000981; GO:0005634; GO:0007480; GO:0022416; GO:0032991; GO:0035015; GO:0035218; GO:0045892; GO:0048666; GO:0048800";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; elongation of arista core [GO:0035015]; imaginal disc-derived leg morphogenesis [GO:0007480]; leg disc development [GO:0035218]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3586374_c0_seq1;GAXK01075064.1;Q4PM12;1.77E-45;RL36_IXOSC;60S ribosomal protein L36;"cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0005840; GO:0006412";translation [GO:0006412];"cytosol [GO:0005829]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp3587146_c0_seq1;GAXK01075039.1;P34024;2.26E-15;PLC_LISMO;1-phosphatidylinositol phosphodiesterase (EC 4.6.1.13) (Phosphatidylinositol diacylglycerol-lyase) (Phosphatidylinositol-specific phospholipase C) (PI-PLC);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"GO:0004436; GO:0005576; GO:0005737; GO:0008081; GO:0009405; GO:0016042";"lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]"
comp3587366_c0_seq1;GAXK01075052.1;Q9NSD4;6.01E-08;ZN275_HUMAN;Zinc finger protein 275;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3587819_c0_seq1;GAXK01075043.1;O14792;2.00E-19;HS3S1_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0034483";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp358798_c1_seq1;GAXK01034435.1;P17038;4.27E-09;ZNF43_HUMAN;Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3588_c1_seq1;GAXK01176648.1;Q9Y5Z4;2.74E-27;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp358800_c0_seq1;GAXK01034467.1;Q9VGY6;4.12E-36;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp35890_c0_seq1;GAXK01161869.1;Q9W2U4;8.45E-33;PP4R2_DROME;Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2-related protein);"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]";"GO:0000278; GO:0000775; GO:0005634; GO:0005737; GO:0006470; GO:0019888; GO:0030289; GO:0045879";"mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]";"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]";protein phosphatase regulator activity [GO:0019888]
comp358913_c0_seq1;GAXK01034442.1;O44252;3.76E-17;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp3589205_c0_seq1;GAXK01052771.1;Q27746;4.21E-13;DNMT1_PARLI;DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp358977_c1_seq1;GAXK01034403.1;Q9EQG6;0;KDIS_RAT;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0005770; GO:0005829; GO:0010976; GO:0016021; GO:0019887; GO:0019901; GO:0030165; GO:0032991; GO:0038180; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]"
comp358989_c2_seq1;GAXK01034536.1;Q27902;2.20E-21;CP6B4_PAPGL;Cytochrome P450 6B4 (EC 1.14.14.1) (CYP6B4v1/CYP6B4v2) (CYPVIB4);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp35903_c0_seq1;GAXK01161733.1;Q96PE6;3.94E-14;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp359034_c0_seq1;GAXK01034415.1;Q5EBL2;8.56E-14;ZN628_HUMAN;Zinc finger protein 628;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp359052_c0_seq1;GAXK01034416.1;Q8IN81;6.39E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp35913_c0_seq1;GAXK01162028.1;F6QEU4;1.86E-24;LIN41_XENTR;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);"P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";"GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177";"embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";P-body [GO:0000932];"miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3592279_c0_seq1;GAXK01049461.1;Q32KM6;1.15E-13;MORN3_BOVIN;MORN repeat-containing protein 3;;;;;
comp35923_c1_seq1;GAXK01161993.1;Q8BGI4;5.09E-10;FA13A_MOUSE;Protein FAM13A (Precm1 protein);;;;;
comp359258_c0_seq1;GAXK01034424.1;Q8STF0;6.60E-55;CALM_STRIE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3592580_c0_seq1;GAXK01049458.1;O35310;1.48E-42;HS3S1_MOUSE;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (Heparan sulfate 3-O-sulfotransferase 1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0008467; GO:0015012; GO:0034483";heparan sulfate proteoglycan biosynthetic process [GO:0015012];Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp3592612_c0_seq1;GAXK01049455.1;Q7ZVQ8;5.19E-08;NS1BB_DANRE;Influenza virus NS1A-binding protein homolog B (NS1-BP homolog B) (NS1-binding protein homolog B);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";
comp35928_c0_seq1;GAXK01161293.1;Q8BHN5;4.25E-89;RBM45_MOUSE;RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:1990904";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp35929_c5_seq1;GAXK01161852.1;B1AS29;0;GRIK3_MOUSE;Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315";"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp359299_c0_seq1;GAXK01034448.1;Q5R1W1;4.53E-102;SEPT7_PANTR;Septin-7 (CDC10 protein homolog) (Fragment);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0060271; GO:0061640";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3593555_c0_seq1;GAXK01049467.1;Q9XF97;1.36E-98;RL4_PRUAR;60S ribosomal protein L4 (L1);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3593572_c0_seq1;GAXK01049450.1;O62537;7.08E-07;HUNB_DROOR;Protein hunchback;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";"GO:0000981; GO:0003677; GO:0005634; GO:0035282; GO:0040034; GO:0046872";"regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp35936_c0_seq1;GAXK01162105.1;Q9CWU9;9.95E-70;NUP37_MOUSE;Nucleoporin Nup37 (Nup107-160 subcomplex subunit Nup37);"condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]";"GO:0000777; GO:0005654; GO:0007049; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]";"condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]";
comp3594078_c0_seq1;GAXK01007760.1;Q02527;6.23E-07;MGAT3_RAT;Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]; amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"GO:0000139; GO:0003830; GO:0006044; GO:0006487; GO:0008104; GO:0016021; GO:0016757; GO:0030334; GO:0034599; GO:0050435; GO:0050890; GO:1902966; GO:1905166";"amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp35952_c1_seq1;GAXK01162081.1;Q9VLQ1;8.00E-106;ALG5_DROME;Dolichyl-phosphate beta-glucosyltransferase (EC 2.4.1.117) (Wollknaeuel);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; Golgi organization [GO:0007030]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]";"GO:0004581; GO:0005783; GO:0005789; GO:0006487; GO:0006493; GO:0007009; GO:0007029; GO:0007030; GO:0007379; GO:0007509; GO:0009953; GO:0010004; GO:0016021; GO:0019991; GO:0040003";"chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; Golgi organization [GO:0007030]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]
comp359539_c6_seq1;GAXK01034495.1;Q9H251;1.09E-112;CAD23_HUMAN;Cadherin-23 (Otocadherin);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0005509; GO:0005886; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016021; GO:0016339; GO:0032420; GO:0045494; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060122";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transport [GO:0006816]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]";calcium ion binding [GO:0005509]
comp3595591_c0_seq1;GAXK01007764.1;Q9QZP2;1.41E-08;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp35960_c1_seq1;GAXK01161804.1;Q7ZXP0;4.41E-102;TWF2A_XENLA;Twinfilin-2-A;"cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; negative regulation of actin filament polymerization [GO:0030837]";"GO:0003779; GO:0005856; GO:0030837; GO:0048471";negative regulation of actin filament polymerization [GO:0030837];"cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]";actin binding [GO:0003779]
comp3596423_c0_seq1;GAXK01184054.1;Q8RX55;3.42E-14;B3GTI_ARATH;Hydroxyproline O-galactosyltransferase GALT5 (AtGALT5) (EC 2.4.1.-) (Beta-1,3-galactosyltransferase 18);"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; carbohydrate binding [GO:0030246]; hydroxyproline O-galactosyltransferase activity [GO:1990714]; arabinogalactan protein metabolic process [GO:0010405]; protein glycosylation [GO:0006486]; protein O-linked glycosylation via hydroxyproline [GO:0018258]; root hair cell development [GO:0080147]";"GO:0000139; GO:0005768; GO:0005783; GO:0005794; GO:0005802; GO:0006486; GO:0010405; GO:0016021; GO:0018258; GO:0030246; GO:0080147; GO:1990714";"arabinogalactan protein metabolic process [GO:0010405]; protein glycosylation [GO:0006486]; protein O-linked glycosylation via hydroxyproline [GO:0018258]; root hair cell development [GO:0080147]";"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"carbohydrate binding [GO:0030246]; hydroxyproline O-galactosyltransferase activity [GO:1990714]"
comp3597071_c0_seq1;GAXK01184056.1;P36609;2.81E-29;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp35971_c0_seq1;GAXK01161839.1;Q17015;2.50E-08;CU01_ANOGA;Cuticle protein;"extracellular matrix [GO:0031012]; structural constituent of cuticle [GO:0042302]";"GO:0031012; GO:0042302";;extracellular matrix [GO:0031012];structural constituent of cuticle [GO:0042302]
comp359733_c0_seq1;GAXK01034532.1;Q5M9B7;8.16E-25;OSTCB_XENLA;Oligosaccharyltransferase complex subunit ostc-B;"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008250; GO:0016021";protein glycosylation [GO:0006486];"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]";
comp359772_c0_seq1;GAXK01034485.1;G5ED00;5.37E-11;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp3597833_c0_seq1;GAXK01184072.1;P20482;1.77E-20;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp3597841_c0_seq1;GAXK01184073.1;A9YME1;2.13E-25;VA5_MICHY;Venom allergen 5 (Antigen 5) (Cysteine-rich venom protein) (CRVP) (Venom protein 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp359844_c1_seq1;GAXK01034489.1;Q687X5;1.93E-63;STEA4_HUMAN;Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9);"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"GO:0000139; GO:0005768; GO:0005794; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706";"copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp359859_c1_seq1;GAXK01034394.1;Q25390;1.88E-18;SCRA_LIMPO;Alpha-scruin;;;;;
comp3598591_c0_seq1;GAXK01016542.1;Q6NRH0;2.03E-07;KLH12_XENLA;Kelch-like protein 12;"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]";
comp3598692_c0_seq1;GAXK01016533.1;Q9LFR0;8.08E-34;GMAN2_ARATH;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (AtGMII) (Man II) (Protein hybrid glycosylation 1);"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; hyperosmotic salinity response [GO:0042538]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0004559; GO:0004572; GO:0005768; GO:0005794; GO:0005802; GO:0006013; GO:0006487; GO:0006491; GO:0006517; GO:0016021; GO:0030246; GO:0042538; GO:0046872";"hyperosmotic salinity response [GO:0042538]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein N-linked glycosylation [GO:0006487]";"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp359917_c1_seq1;GAXK01034412.1;P43144;8.33E-29;ACHA9_RAT;Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"GO:0004888; GO:0005262; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0007605; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060; GO:1904315";"chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp36_c1_seq1;GAXK01169643.1;P45842;5.83E-41;RL34_AEDAL;60S ribosomal protein L34 (L31);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp360030_c1_seq1;GAXK01188923.1;Q0P5W1;0;VPS8_MOUSE;Vacuolar protein sorting-associated protein 8 homolog;"CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]";"GO:0005769; GO:0033263; GO:0034058; GO:0046872";endosomal vesicle fusion [GO:0034058];"CORVET complex [GO:0033263]; early endosome [GO:0005769]";metal ion binding [GO:0046872]
comp360037_c1_seq1;GAXK01188890.1;Q56A10;7.57E-16;ZN608_MOUSE;Zinc finger protein 608;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003676; GO:0033085; GO:0046872";"negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3600489_c0_seq1;GAXK01057435.1;O42329;1.99E-08;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3600514_c0_seq1;GAXK01057439.1;P17970;2.85E-21;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp3600717_c0_seq1;GAXK01057438.1;Q8BJ56;2.81E-35;PLPL2_MOUSE;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Desnutrin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0019915; GO:0034389; GO:0044242; GO:0055088";"cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp36008_c0_seq1;GAXK01106837.1;P31597;7.67E-130;EAA3_RABIT;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476";"chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp3600951_c0_seq1;GAXK01057432.1;P41827;3.91E-37;HSP74_ANOAL;Heat shock protein 70 B2;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp3601_c1_seq1;GAXK01176591.1;Q28ZX3;3.02E-70;PABP2_DROPS;Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]";"GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143";mRNA polyadenylation [GO:0006378];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"poly(A) binding [GO:0008143]; RNA binding [GO:0003723]"
comp360142_c1_seq1;GAXK01188940.1;Q7TN73;0;CASD1_MOUSE;N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT);"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; acetyltransferase activity [GO:0016407]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]";"GO:0005794; GO:0005975; GO:0016407; GO:0030173; GO:0047186";carbohydrate metabolic process [GO:0005975];"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]";"acetyltransferase activity [GO:0016407]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]"
comp360215_c1_seq1;GAXK01188932.1;Q8I6K0;1.44E-51;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp360223_c1_seq1;GAXK01189073.1;P52746;2.58E-15;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp360397_c0_seq1;GAXK01189093.1;P86854;5.90E-08;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp3604439_c0_seq1;GAXK01115602.1;Q7Z2Y8;6.97E-12;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp36046_c0_seq1;GAXK01106824.1;Q6GNG8;1.96E-22;PKRI1_XENLA;PRKR-interacting protein 1 homolog;"nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; double-stranded RNA binding [GO:0003725]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003725; GO:0005681; GO:0005730; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]";double-stranded RNA binding [GO:0003725]
comp3604697_c0_seq1;GAXK01115600.1;Q6GQN7;7.21E-07;RABEK_DANRE;Rab9 effector protein with kelch motifs;;;;;
comp3604970_c0_seq1;GAXK01115597.1;Q08DF4;7.86E-90;DYN1_BOVIN;Dynamin-1 (EC 3.6.5.5);"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of exocytosis [GO:0045920]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"GO:0001917; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005874; GO:0005886; GO:0007032; GO:0008017; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0042584; GO:0042802; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0045920; GO:0050803; GO:0050804; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1901998";"endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of exocytosis [GO:0045920]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp3605_c0_seq1;GAXK01175361.1;Q61686;1.09E-30;CBX5_MOUSE;Chromobox protein homolog 5 (Heterochromatin protein 1 homolog alpha) (HP1 alpha);"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000118; GO:0000122; GO:0000776; GO:0000784; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005730; GO:0006974; GO:0010369; GO:0016605; GO:0017053; GO:0030674; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042803; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0070491; GO:0090734; GO:1990904";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]"
comp3605596_c0_seq1;GAXK01115603.1;A8MPY1;1.85E-16;GBRR3_HUMAN;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]"
comp36060_c0_seq1;GAXK01106873.1;Q4TVV3;0;DDX46_DANRE;Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46);"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621]";"GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007420; GO:0015030; GO:0016607; GO:0031017; GO:0045621; GO:0045648; GO:0048546; GO:0060216; GO:0072576; GO:1902038";"brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621]";"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp36062_c1_seq1;GAXK01107547.1;Q9U8W7;4.81E-31;TL5B_TACTR;Techylectin-5B;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp3606216_c0_seq1;GAXK01034068.1;P35789;1.33E-09;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp3606267_c0_seq1;GAXK01034073.1;P08770;3.35E-07;TRA1_MAIZE;Putative AC transposase (ORFA);"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp36067_c2_seq1;GAXK01107290.1;Q24547;2.54E-72;STX1A_DROME;Syntaxin-1A (dSynt1);"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030054; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787";"cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp360802_c0_seq1;GAXK01189085.1;Q90421;1.04E-95;LHX3_DANRE;LIM/homeobox protein Lhx3 (LIM homeobox protein 3) (Homeobox protein LIM-3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ventral spinal cord interneuron specification [GO:0021521]";"GO:0000977; GO:0000981; GO:0005634; GO:0021521; GO:0030182; GO:0045944; GO:0046872";"neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ventral spinal cord interneuron specification [GO:0021521]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp360821_c0_seq1;GAXK01189017.1;Q9BQR3;5.22E-17;PRS27_HUMAN;Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin);"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0019897; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]";serine-type endopeptidase activity [GO:0004252]
comp360877_c1_seq1;GAXK01189052.1;Q5T011;0;SZT2_HUMAN;KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog);"KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]";"GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262";"cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]";"KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]";
comp3608978_c0_seq1;GAXK01093521.1;Q1DQ20;3.65E-64;IF4A_COCIM;ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]";"GO:0003724; GO:0003743; GO:0005524; GO:0005737";;cytoplasm [GO:0005737];"ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp360932_c1_seq1;GAXK01189080.1;P10076;4.53E-38;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp360940_c0_seq1;GAXK01189027.1;O97341;8.18E-38;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3609529_c0_seq1;GAXK01093509.1;P0DJI8;6.77E-08;SAA1_HUMAN;"Serum amyloid A-1 protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)]";"cytoplasmic microtubule [GO:0005881]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; chemoattractant activity [GO:0042056]; G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]; activation of MAPK activity [GO:0000187]; acute-phase response [GO:0006953]; cell chemotaxis [GO:0060326]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of interleukin-1 secretion [GO:0050716]; receptor-mediated endocytosis [GO:0006898]; regulation of protein secretion [GO:0050708]";"GO:0000187; GO:0001664; GO:0005576; GO:0005615; GO:0005881; GO:0006898; GO:0006953; GO:0007186; GO:0007204; GO:0008201; GO:0019221; GO:0030168; GO:0030593; GO:0034364; GO:0042056; GO:0044267; GO:0045087; GO:0045785; GO:0048246; GO:0048247; GO:0050708; GO:0050715; GO:0050716; GO:0050728; GO:0060326; GO:0070062; GO:0071682";"activation of MAPK activity [GO:0000187]; acute-phase response [GO:0006953]; cell chemotaxis [GO:0060326]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of interleukin-1 secretion [GO:0050716]; receptor-mediated endocytosis [GO:0006898]; regulation of protein secretion [GO:0050708]";"cytoplasmic microtubule [GO:0005881]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]";"chemoattractant activity [GO:0042056]; G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]"
comp3609806_c0_seq1;GAXK01093505.1;P08575;2.54E-29;PTPRC_HUMAN;Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45);"bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016021; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0042110; GO:0042803; GO:0043312; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045085; GO:0045086; GO:0045121; GO:0045588; GO:0045860; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070062; GO:0070373; GO:0070374; GO:0098857; GO:1903615; GO:1903979; GO:1904155; GO:1905451; GO:2000473; GO:2000648; GO:2001238";"activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]";"ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp3609902_c0_seq1;GAXK01093519.1;P41044;8.88E-64;CAB32_DROME;Calbindin-32;"cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]";"GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043005; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271; GO:1903035";"negative regulation of response to wounding [GO:1903035]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]";"cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type III terminal bouton [GO:0097467]; type II terminal bouton [GO:0061175]";calcium ion binding [GO:0005509]
comp36116_c1_seq1;GAXK01106934.1;P50719;8.51E-29;TBA_HAECO;Tubulin alpha chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp3611715_c0_seq1;GAXK01063127.1;Q63099;3.12E-20;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp3612_c0_seq1;GAXK01176664.1;P46087;0;NOP2_HUMAN;Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475]";"GO:0000027; GO:0003723; GO:0005654; GO:0005730; GO:0006357; GO:0008284; GO:0009383; GO:0070475; GO:1901796";"positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]"
comp3612180_c0_seq1;GAXK01058009.1;Q9V3S9;1.02E-17;BGM_DROME;Very long-chain-fatty-acid--CoA ligase bubblegum (EC 6.2.1.3);"cell [GO:0005623]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005623; GO:0006631; GO:0006633; GO:0015645; GO:0034976; GO:0045938; GO:0070050; GO:0102391";"fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]";cell [GO:0005623];"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp3612491_c0_seq1;GAXK01058020.1;Q6NXH2;1.19E-52;MANEA_MOUSE;Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (mEndo) (EC 3.2.1.130);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]";"GO:0000139; GO:0004559; GO:0004569; GO:0005794; GO:0016021";;"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]"
comp361264_c0_seq1;GAXK01189068.1;Q99685;1.51E-48;MGLL_HUMAN;Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0019898; GO:0036155; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124";"acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]"
comp36128_c3_seq1;GAXK01106774.1;A2T737;2.41E-18;EHF_PANTR;ETS homologous factor (ETS domain-containing transcription factor);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000981; GO:0005634; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0043565; GO:0050673";"cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp361311_c0_seq1;GAXK01189014.1;P40313;1.80E-15;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3613888_c0_seq1;GAXK01058017.1;Q9VNM1;5.60E-14;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp3614074_c0_seq1;GAXK01123836.1;Q21974;2.14E-25;UNC8_CAEEL;Degenerin unc-8 (Uncoordinated protein 8);"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; cation transport [GO:0006812]; locomotion [GO:0040011]";"GO:0005261; GO:0005272; GO:0005886; GO:0006812; GO:0016021; GO:0040011; GO:0043025";"cation transport [GO:0006812]; locomotion [GO:0040011]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]"
comp3614100_c0_seq1;GAXK01123849.1;Q00433;9.44E-69;PHE3_RHDS2;Phycoerythrin alpha-3 chain, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]; oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"GO:0009535; GO:0015979; GO:0018298; GO:0030089; GO:0055114";"oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]";
comp3614112_c0_seq1;GAXK01123831.1;Q9BYN7;5.54E-07;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3615050_c0_seq1;GAXK01123846.1;O96081;3.92E-39;CALMB_HALRO;Calmodulin-B (CaM B);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp361506_c0_seq1;GAXK01188929.1;Q09506;2.53E-35;YQI7_CAEEL;Uncharacterized protein C45G9.7;;;;;
comp361594_c0_seq1;GAXK01188927.1;Q7KRI2;2.17E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3616188_c0_seq1;GAXK01063197.1;Q9EQJ9;4.81E-10;MAGI3_MOUSE;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3);"bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; frizzled binding [GO:0005109]; molecular adaptor activity [GO:0060090]; positive regulation of JUN kinase activity [GO:0043507]; signal transduction [GO:0007165]";"GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0030054; GO:0043507; GO:0060090";"positive regulation of JUN kinase activity [GO:0043507]; signal transduction [GO:0007165]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; frizzled binding [GO:0005109]; molecular adaptor activity [GO:0060090]"
comp36168_c1_seq1;GAXK01106947.1;Q7SY54;4.99E-129;AT2L1_DANRE;Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1);"mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]";"GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459";embryonic hemopoiesis [GO:0035162];mitochondrion [GO:0005739];"ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp3617160_c0_seq1;GAXK01063195.1;Q8MSF5;1.33E-30;RNK_DROME;Ribonuclease kappa (RNase K) (RNase kappa) (EC 3.1.-.-);"integral component of membrane [GO:0016021]; endoribonuclease activity [GO:0004521]; cellular response to virus [GO:0098586]";"GO:0004521; GO:0016021; GO:0098586";cellular response to virus [GO:0098586];integral component of membrane [GO:0016021];endoribonuclease activity [GO:0004521]
comp3617416_c0_seq1;GAXK01063206.1;P35500;5.87E-41;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp3617572_c0_seq1;GAXK01063190.1;Q5RG82;4.86E-07;NS1BA_DANRE;Influenza virus NS1A-binding protein homolog A (NS1-BP homolog A) (NS1-binding protein homolog A);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";
comp3618094_c0_seq1;GAXK01117601.1;O93430;2.75E-10;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp36181_c1_seq1;GAXK01106988.1;Q6P4Q7;1.65E-140;CNNM4_HUMAN;Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4);"basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0030425; GO:0032991; GO:0043025; GO:0050896; GO:0055065; GO:0070166";"enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]"
comp3618276_c1_seq1;GAXK01117618.1;Q8INF0;6.52E-15;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp361910_c1_seq1;GAXK01188888.1;Q93HT9;2.30E-10;IABN_GEOTD;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp361913_c0_seq1;GAXK01188936.1;Q9NA51;1.11E-09;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp36196_c1_seq1;GAXK01106879.1;P50533;0;SMC2_XENLA;Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]";"GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0007049; GO:0030261; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp3619795_c0_seq1;GAXK01117610.1;W8JMU7;1.05E-20;CYQ32_CATRO;Cytochrome P450 81Q32 (CrCYP81Q32) (EC 1.14.-.-);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037";;integral component of membrane [GO:0016021];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp362_c1_seq1;GAXK01170130.1;P42577;5.43E-69;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp3620_c0_seq1;GAXK01176065.1;Q6PBH5;8.10E-12;NDUA4_DANRE;Cytochrome c oxidase subunit NDUFA4;"mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";"GO:0005751; GO:0022900; GO:1902600";"electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";mitochondrial respiratory chain complex IV [GO:0005751];
comp36201_c0_seq1;GAXK01106777.1;O74503;9.32E-11;UAF30_SCHPO;Upstream activation factor subunit spp27 (Upstream activation factor 27 KDa subunit) (p27) (Upstream activation factor 30 KDa subunit) (p30) (Upstream activation factor subunit uaf30);"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0000500; GO:0001181; GO:0005634; GO:0005829; GO:0006361";transcription initiation from RNA polymerase I promoter [GO:0006361];"cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]";RNA polymerase I general transcription initiation factor activity [GO:0001181]
comp3620363_c0_seq1;GAXK01129231.1;Q64612;6.80E-14;PTPRV_RAT;Receptor-type tyrosine-protein phosphatase V (R-PTP-V) (EC 3.1.3.48) (Embryonic stem cell protein-tyrosine phosphatase) (ES cell phosphatase) (Osteotesticular protein-tyrosine phosphatase) (OST-PTP);"integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; bone remodeling [GO:0046849]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0006470; GO:0016021; GO:0046849";"bone remodeling [GO:0046849]; protein dephosphorylation [GO:0006470]";integral component of membrane [GO:0016021];protein tyrosine phosphatase activity [GO:0004725]
comp3620992_c0_seq1;GAXK01129229.1;P20662;3.44E-09;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3621201_c0_seq1;GAXK01129237.1;O93209;1.81E-10;POL_FFV;"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]";"aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp3621276_c0_seq1;GAXK01129228.1;Q08890;2.43E-96;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp362173_c0_seq1;GAXK01037655.1;P10123;4.33E-31;RLBP1_BOVIN;Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein);"cytoplasm [GO:0005737]; 11-cis retinal binding [GO:0005502]; retinol binding [GO:0019841]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005502; GO:0005737; GO:0007601; GO:0019841; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";cytoplasm [GO:0005737];"11-cis retinal binding [GO:0005502]; retinol binding [GO:0019841]"
comp3622038_c0_seq1;GAXK01163105.1;Q8IV35;1.76E-15;WDR49_HUMAN;WD repeat-containing protein 49;;;;;
comp36226_c17_seq1;GAXK01107433.1;G5E870;0;TRIPC_MOUSE;E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0045995; GO:0046966; GO:1901315; GO:2000780";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3622627_c0_seq1;GAXK01163106.1;P51554;1.70E-29;EF1A_HYDVU;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3622840_c0_seq1;GAXK01163111.1;P0C0L6;5.05E-18;NPSR1_RAT;Neuropeptide S receptor (G-protein coupled receptor 154);"integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]";"GO:0005000; GO:0005887; GO:0007218; GO:0008188; GO:0042755; GO:0051281; GO:0060013; GO:0070374; GO:1903999; GO:2000293";"eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]";integral component of plasma membrane [GO:0005887];"neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]"
comp3623156_c0_seq1;GAXK01163104.1;G3V9H8;6.62E-07;RET_RAT;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0010008; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797";"activation of MAPK activity [GO:0000187]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp3623186_c0_seq1;GAXK01163117.1;Q86WA9;4.41E-16;S2611_HUMAN;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062";"ion transport [GO:0006811]; sulfate transport [GO:0008272]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp36232_c0_seq1;GAXK01106660.1;P34697;2.32E-39;SODC_CAEEL;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; superoxide dismutase activity [GO:0004784]; age-dependent response to oxidative stress [GO:0001306]; oxidation-reduction process [GO:0055114]; regulation of brood size [GO:0060378]; regulation of vulval development [GO:0040028]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801]";"GO:0001306; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006801; GO:0019430; GO:0040028; GO:0042803; GO:0055114; GO:0060378";"age-dependent response to oxidative stress [GO:0001306]; oxidation-reduction process [GO:0055114]; regulation of brood size [GO:0060378]; regulation of vulval development [GO:0040028]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; superoxide dismutase activity [GO:0004784]"
comp36234_c2_seq1;GAXK01107055.1;Q91YE6;0;IPO9_MOUSE;Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]";"GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0042254; GO:0042393; GO:0050821; GO:0061608";"protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]";"histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]"
comp3623445_c0_seq1;GAXK01163112.1;Q682T9;2.77E-12;CALM5_ARATH;Calmodulin-5 (CaM-5);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp36236_c1_seq1;GAXK01204959.1;O18598;3.19E-25;GST1_BLAGE;Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma) (Major allergen Bla g 5) (allergen Bla g 5);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp3624_c2_seq1;GAXK01176138.1;Q21735;1.27E-31;NTF2_CAEEL;Probable nuclear transport factor 2 (NTF-2);"cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]";"GO:0005737; GO:0006606; GO:0006913; GO:0044613";"nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]";"cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]";
comp36247_c0_seq1;GAXK01106818.1;Q9VMM6;2.09E-18;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp3624753_c0_seq1;GAXK01122647.1;Q18253;1.21E-07;DPF2_CAEEL;Dipeptidyl peptidase family member 2 (EC 3.4.14.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005886; GO:0008236; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp3624817_c0_seq1;GAXK01122661.1;O59865;7.82E-22;RS24B_SCHPO;40S ribosomal protein S24-B;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; cytoplasmic translational elongation [GO:0002182]; rRNA processing [GO:0006364]";"GO:0002182; GO:0003735; GO:0005730; GO:0005829; GO:0006364; GO:0022627";"cytoplasmic translational elongation [GO:0002182]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp362495_c0_seq1;GAXK01037573.1;Q7PEV7;9.09E-42;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp362499_c0_seq1;GAXK01037548.1;B4MQJ1;3.86E-34;QVR_DROWI;Protein quiver (Protein sleepless);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"GO:0005886; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0048511; GO:1903818";"positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";GPI anchor binding [GO:0034235]
comp36252_c0_seq1;GAXK01106993.1;Q6PC19;2.37E-79;SSU72_DANRE;RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16);"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0005737; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940";"dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]";"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]";RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]
comp3625608_c0_seq1;GAXK01122639.1;Q9W747;3.02E-13;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp362583_c0_seq1;GAXK01037579.1;P07602;2.67E-07;SAP_HUMAN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-galactosidase activity [GO:0004565]; enzyme activator activity [GO:0008047]; G protein-coupled receptor binding [GO:0001664]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; corneocyte development [GO:0003335]; cornified envelope assembly [GO:1903575]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; G protein-coupled receptor signaling pathway [GO:0007186]; galactosylceramide catabolic process [GO:0006683]; ganglioside GM1 transport to membrane [GO:1905572]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; micturition [GO:0060073]; myelination [GO:0042552]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of MAPK cascade [GO:0043410]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sensory perception of sound [GO:0007605]; walking behavior [GO:0090659]";"GO:0001664; GO:0002020; GO:0002576; GO:0003335; GO:0004565; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006683; GO:0006687; GO:0006869; GO:0007041; GO:0007186; GO:0007193; GO:0007605; GO:0008047; GO:0008289; GO:0010506; GO:0019216; GO:0035577; GO:0042552; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0043410; GO:0050885; GO:0051345; GO:0060073; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0071310; GO:0090102; GO:0090659; GO:1903206; GO:1903575; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; corneocyte development [GO:0003335]; cornified envelope assembly [GO:1903575]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; galactosylceramide catabolic process [GO:0006683]; ganglioside GM1 transport to membrane [GO:1905572]; glycosphingolipid metabolic process [GO:0006687]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; micturition [GO:0060073]; myelination [GO:0042552]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of MAPK cascade [GO:0043410]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sensory perception of sound [GO:0007605]; walking behavior [GO:0090659]";"azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"beta-galactosidase activity [GO:0004565]; enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]"
comp3625978_c0_seq1;GAXK01122655.1;Q9JLB4;5.46E-53;CUBN_MOUSE;Cubilin (Intrinsic factor-cobalamin receptor);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp362769_c0_seq1;GAXK01037551.1;Q9NHV9;2.13E-09;VAV_DROME;Protein vav (DroVav) (dVAV);"cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035023; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; regulation of Rho protein signal transduction [GO:0035023]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";cytosol [GO:0005829];"metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]"
comp362803_c0_seq1;GAXK01037545.1;Q9VHH9;1.55E-07;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp36281_c7_seq1;GAXK01107087.1;Q9NFT7;1.35E-131;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp3628497_c0_seq1;GAXK01185042.1;G5EBQ8;5.68E-88;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp3628550_c0_seq1;GAXK01185037.1;Q7VJ74;1.22E-12;EFTU_HELHP;Elongation factor Tu (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3628705_c0_seq1;GAXK01185038.1;Q28113;1.38E-10;FUT2_BOVIN;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp3628706_c0_seq1;GAXK01185044.1;F7J220;5.92E-31;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp3629153_c0_seq1;GAXK01204916.1;P55083;4.40E-20;MFAP4_HUMAN;Microfibril-associated glycoprotein 4;"collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]";"GO:0001527; GO:0005576; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953; GO:0097435";"cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]";"collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; microfibril [GO:0001527]";
comp362958_c1_seq1;GAXK01037663.1;Q5ZIK0;3.01E-15;P4K2B_CHICK;Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta);"endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0007030; GO:0007032; GO:0046854";"endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]";"endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]"
comp363010_c0_seq1;GAXK01037658.1;A6H7A8;2.59E-56;TDIF1_BOVIN;Deoxynucleotidyltransferase terminal-interacting protein 1 (Terminal deoxynucleotidyltransferase-interacting factor 1) (TdIF1) (TdT-interacting factor 1);"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803]";"GO:0000118; GO:0003677; GO:0005634; GO:0005730; GO:0031491; GO:0042803";;"histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803]"
comp36308_c0_seq1;GAXK01106842.1;Q56K04;1.01E-07;CRIP1_BOVIN;Cysteine-rich protein 1 (CRP-1);"cytoplasm [GO:0005737]; AT DNA binding [GO:0003680]; DNA binding, bending [GO:0008301]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]";"GO:0003680; GO:0005737; GO:0008270; GO:0008301; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0071236; GO:0071493";"cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]";cytoplasm [GO:0005737];"AT DNA binding [GO:0003680]; DNA binding, bending [GO:0008301]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp3630956_c0_seq1;GAXK01103928.1;Q94900;1.34E-16;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3631_c1_seq1;GAXK01176053.1;Q3SYU1;3.49E-148;NOC2L_BOVIN;Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor);"cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243";"apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]"
comp3631475_c0_seq1;GAXK01103935.1;A8MQ14;6.25E-15;ZN850_HUMAN;Zinc finger protein 850;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp36317_c0_seq1;GAXK01107148.1;Q24K03;4.19E-61;THUM1_BOVIN;THUMP domain-containing protein 1;"RNA binding [GO:0003723]; tRNA modification [GO:0006400]";"GO:0003723; GO:0006400";tRNA modification [GO:0006400];;RNA binding [GO:0003723]
comp3632379_c0_seq1;GAXK01080419.1;Q3ULA2;4.04E-23;FBW1A_MOUSE;F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0071407";"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]"
comp363284_c0_seq1;GAXK01037649.1;O70624;3.38E-25;MYOC_MOUSE;"Myocilin (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)]";"cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mesaxon [GO:0097453]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]; Schmidt-Lanterman incisure [GO:0043220]; fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]; bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; skeletal muscle hypertrophy [GO:0014734]";"GO:0001649; GO:0001953; GO:0001968; GO:0005109; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005791; GO:0005794; GO:0005929; GO:0014068; GO:0014734; GO:0022011; GO:0030335; GO:0030971; GO:0031175; GO:0031410; GO:0032027; GO:0033268; GO:0035024; GO:0035748; GO:0038031; GO:0038133; GO:0043220; GO:0043408; GO:0045162; GO:0046872; GO:0051496; GO:0051497; GO:0051894; GO:0051897; GO:0051901; GO:0060348; GO:0062023; GO:0070062; GO:0097453; GO:1900026";"bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; skeletal muscle hypertrophy [GO:0014734]";"cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mesaxon [GO:0097453]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]; Schmidt-Lanterman incisure [GO:0043220]";"fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]"
comp36333_c0_seq1;GAXK01106721.1;Q9BLJ6;3.77E-18;BAGS_BOMMO;BAG domain-containing protein Samui;"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; multicellular organism development [GO:0007275]";"GO:0007275; GO:0030544; GO:0051087";multicellular organism development [GO:0007275];;"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]"
comp363331_c0_seq1;GAXK01037558.1;Q9HBW1;3.32E-32;LRRC4_HUMAN;Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]";"GO:0030054; GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861";"excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]";"cell junction [GO:0030054]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]";
comp363346_c1_seq1;GAXK01037570.1;Q6ZMG9;6.49E-88;CERS6_HUMAN;Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"GO:0000981; GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0050291";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]"
comp3633516_c0_seq1;GAXK01080414.1;Q6DJ83;4.49E-11;CADM2_XENTR;Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp363367_c0_seq1;GAXK01037577.1;O44252;5.05E-18;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp36342_c0_seq1;GAXK01106673.1;Q7KRI2;9.21E-31;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3636725_c0_seq1;GAXK01160694.1;P08953;8.51E-07;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp3637020_c0_seq1;GAXK01160696.1;Q91X17;4.56E-16;UROM_MOUSE;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266";"chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";"calcium ion binding [GO:0005509]; IgG binding [GO:0019864]"
comp36373_c1_seq1;GAXK01107519.1;Q8R235;3.35E-26;TM203_MOUSE;Transmembrane protein 203;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cellular calcium ion homeostasis [GO:0006874]; spermatogenesis [GO:0007283]";"GO:0005783; GO:0005789; GO:0006874; GO:0007283; GO:0016021";"cellular calcium ion homeostasis [GO:0006874]; spermatogenesis [GO:0007283]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp363747_c2_seq1;GAXK01037559.1;Q5PPV2;5.44E-79;TEKT4_XENLA;Tektin-4;"motile cilium [GO:0031514]; cell projection organization [GO:0030030]";"GO:0030030; GO:0031514";cell projection organization [GO:0030030];motile cilium [GO:0031514];
comp3637927_c0_seq1;GAXK01160689.1;P04464;1.82E-34;CALM_WHEAT;Calmodulin (CaM);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; protein domain specific binding [GO:0019904]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0019722; GO:0019904";calcium-mediated signaling [GO:0019722];cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; protein domain specific binding [GO:0019904]"
comp3638_c0_seq1;GAXK01176506.1;Q91Y44;7.19E-82;BRDT_MOUSE;Bromodomain testis-specific protein (Bromodomain-containing female sterile homeotic-like protein) (RING3-like protein);"nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]";"GO:0001207; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0007283; GO:0008380; GO:0030154; GO:0042393; GO:0043484; GO:0051039; GO:0070577";"cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]"
comp3638292_c0_seq1;GAXK01036322.1;P55042;7.06E-23;RAD_HUMAN;GTP-binding protein RAD (RAD1) (Ras associated with diabetes);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007264; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3638349_c0_seq1;GAXK01036313.1;Q03142;1.18E-12;FGFR4_MOUSE;Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334);"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640]";"GO:0001759; GO:0004714; GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010629; GO:0010715; GO:0010966; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0030324; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0051174; GO:0055062; GO:0061144; GO:0070374; GO:0070640; GO:0070857; GO:0090272; GO:2000573; GO:2000830";"alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640]";"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp363987_c0_seq1;GAXK01037569.1;Q9GV46;4.96E-10;LUCB_OPLGR;Oplophorus-luciferin 2-monooxygenase non-catalytic subunit;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3640040_c0_seq1;GAXK01059630.1;Q69QQ6;3.07E-46;HSP82_ORYSJ;Heat shock protein 81-2 (HSP81-2) (Heat shock protein 90);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082";"cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp364025_c0_seq1;GAXK01200475.1;P05661;5.93E-35;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp364054_c0_seq1;GAXK01200484.1;P54727;5.43E-07;RD23B_HUMAN;UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]";"GO:0000502; GO:0000715; GO:0000717; GO:0000978; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006289; GO:0006294; GO:0006457; GO:0007283; GO:0016579; GO:0031593; GO:0032434; GO:0043130; GO:0043161; GO:0048568; GO:0070628; GO:0070911; GO:0071942; GO:0098761";"cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]";"damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]"
comp3640821_c0_seq1;GAXK01059629.1;Q29449;6.83E-30;AT8A1_BOVIN;Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II);"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0042584; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp3640865_c0_seq1;GAXK01059635.1;Q9HFY6;4.84E-47;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp364098_c0_seq1;GAXK01200559.1;Q08180;2.75E-93;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp3641273_c0_seq1;GAXK01059637.1;Q9BRP0;2.53E-07;OVOL2_HUMAN;Transcription factor Ovo-like 2 (hOvo2) (Zinc finger protein 339);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]";"GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003682; GO:0005634; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0043565; GO:0044212; GO:0045617; GO:0045618; GO:0045746; GO:0045892; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:2000647";"angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3641531_c0_seq1;GAXK01059627.1;P20662;1.27E-12;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp364155_c2_seq1;GAXK01200496.1;O93309;0;SMC3_XENLA;Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3);"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321";"cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp3641626_c0_seq1;GAXK01059632.1;O74467;2.02E-15;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3641717_c0_seq1;GAXK01059639.1;Q8IT98;1.75E-62;RS18_ARGIR;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp364191_c0_seq1;GAXK01200650.1;Q9VD09;5.87E-34;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp3642_c0_seq1;GAXK01176029.1;Q9W3Y0;5.04E-34;ZN593_DROME;Zinc finger protein 593 homolog;"cell [GO:0005623]; preribosome, large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055]";"GO:0000055; GO:0003676; GO:0005623; GO:0008270; GO:0030687; GO:0043023";ribosomal large subunit export from nucleus [GO:0000055];"cell [GO:0005623]; preribosome, large subunit precursor [GO:0030687]";"nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]"
comp3642196_c0_seq1;GAXK01143725.1;P17970;3.98E-37;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp364251_c1_seq1;GAXK01200493.1;Q28BQ6;2.53E-22;TMED1_XENTR;Transmembrane emp24 domain-containing protein 1 (p24 family protein gamma-1) (p24gamma1);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3642542_c0_seq1;GAXK01143722.1;O77081;4.33E-19;TPSTA_CAEEL;Protein-tyrosine sulfotransferase A (EC 2.8.2.20) (Tyrosylprotein sulfotransferase A) (TPST-A);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; protein-tyrosine sulfotransferase activity [GO:0008476]; collagen metabolic process [GO:0032963]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; peptidyl-tyrosine sulfation [GO:0006478]; regulation of locomotion [GO:0040012]; regulation of nematode larval development [GO:0061062]";"GO:0000139; GO:0005794; GO:0005802; GO:0006478; GO:0008476; GO:0016021; GO:0032963; GO:0040012; GO:0042338; GO:0061062";"collagen metabolic process [GO:0032963]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; peptidyl-tyrosine sulfation [GO:0006478]; regulation of locomotion [GO:0040012]; regulation of nematode larval development [GO:0061062]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp364258_c0_seq1;GAXK01200575.1;P93748;3.15E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp3642965_c0_seq1;GAXK01143727.1;A6NDX5;3.68E-19;ZN840_HUMAN;Putative zinc finger protein 840 (Zinc finger protein 840 pseudogene);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp364367_c0_seq1;GAXK01200615.1;A0JMG1;2.69E-11;SPOLB_DANRE;Speckle-type POZ protein-like B (HIB homolog 3);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3644_c0_seq1;GAXK01176461.1;Q6PBH5;5.04E-08;NDUA4_DANRE;Cytochrome c oxidase subunit NDUFA4;"mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";"GO:0005751; GO:0022900; GO:1902600";"electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";mitochondrial respiratory chain complex IV [GO:0005751];
comp3644306_c0_seq1;GAXK01078427.1;Q2UH35;3.18E-11;DPP4_ASPOR;Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (DppIV);"extracellular region [GO:0005576]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0005576; GO:0006508; GO:0008236; GO:0008239; GO:0051603";"proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]";extracellular region [GO:0005576];"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]"
comp3644649_c0_seq1;GAXK01078409.1;Q66L42;1.02E-13;M3K10_MOUSE;Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor activity [GO:0003714]; activation of JUN kinase activity [GO:0007257]; cell death [GO:0008219]; MAPK cascade [GO:0000165]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; smoothened signaling pathway [GO:0007224]";"GO:0000165; GO:0003714; GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0007224; GO:0007257; GO:0008219; GO:0018105; GO:0018107; GO:0043065; GO:0043425; GO:0043433; GO:0043507; GO:0045892; GO:0046330";"activation of JUN kinase activity [GO:0007257]; cell death [GO:0008219]; MAPK cascade [GO:0000165]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; smoothened signaling pathway [GO:0007224]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor activity [GO:0003714]"
comp364601_c0_seq1;GAXK01200463.1;P53794;0;SC5A3_HUMAN;Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; regulation of respiratory gaseous exchange [GO:0043576]";"GO:0005367; GO:0005412; GO:0005886; GO:0005887; GO:0006020; GO:0007422; GO:0015798; GO:0016021; GO:0043576";"inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; regulation of respiratory gaseous exchange [GO:0043576]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]"
comp364614_c0_seq1;GAXK01200566.1;A7RX26;4.42E-174;HUTI_NEMVE;Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog);"cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";"GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480";"histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";cytoplasm [GO:0005737];"imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]"
comp36462_c2_seq1;GAXK01106755.1;Q9NVS2;5.26E-07;RT18A_HUMAN;39S ribosomal protein S18a, mitochondrial (MRP-S18-a) (Mrps18a) (S18mt-a) (39S ribosomal protein S18-3, mitochondrial) (MRP-S18-3) (Mitochondrial large ribosomal subunit protein bS18a) (Mitochondrial large ribosomal subunit protein mL66);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0006412; GO:0032543; GO:0070125; GO:0070126; GO:0070181";"mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp3646412_c0_seq1;GAXK01023789.1;Q6Q7X9;1.95E-07;KLH31_DANRE;Kelch-like protein 31 (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein Klhl);negative regulation of protein phosphorylation [GO:0001933];GO:0001933;negative regulation of protein phosphorylation [GO:0001933];;
comp364667_c0_seq1;GAXK01200556.1;Q9BSG1;5.98E-20;ZNF2_HUMAN;Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp3647060_c0_seq1;GAXK01023801.1;O15374;3.57E-11;MOT5_HUMAN;Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020";monocarboxylic acid transport [GO:0015718];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp36472_c1_seq1;GAXK01106876.1;A2XYY8;8.97E-60;ANM61_ORYSI;Probable protein arginine N-methyltransferase 6.1 (EC 2.1.1.-);"methyltransferase activity [GO:0008168]; protein methylation [GO:0006479]";"GO:0006479; GO:0008168";protein methylation [GO:0006479];;methyltransferase activity [GO:0008168]
comp3649287_c0_seq1;GAXK01180155.1;Q5ZI33;6.16E-11;KLHL7_CHICK;Kelch-like protein 7;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031463; GO:0042803; GO:0048471";protein ubiquitination [GO:0016567];"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";protein homodimerization activity [GO:0042803]
comp36495_c0_seq1;GAXK01106734.1;Q7ZUS1;8.42E-79;VRK1_DANRE;Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1);"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0007049; GO:0018105; GO:0018107; GO:0051301; GO:0090166";"cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp36497_c0_seq1;GAXK01107174.1;Q9Y3D9;4.38E-24;RT23_HUMAN;28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt) (Mitochondrial small ribosomal subunit protein mS23);"intermediate filament cytoskeleton [GO:0045111]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005840; GO:0031965; GO:0045111; GO:0070125; GO:0070126";"mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"intermediate filament cytoskeleton [GO:0045111]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; ribosome [GO:0005840]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp364988_c0_seq1;GAXK01200574.1;Q5UE96;5.88E-42;KCNK1_RABIT;Potassium channel subfamily K member 1;"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"GO:0005267; GO:0005272; GO:0005887; GO:0016021; GO:0016324; GO:0022841; GO:0030054; GO:0030425; GO:0034705; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0045202; GO:0055037; GO:0060075; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]";"identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]"
comp3649908_c0_seq1;GAXK01180163.1;Q95ZJ1;5.02E-35;GALT5_CAEEL;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]";"GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872";protein O-linked glycosylation via threonine [GO:0018243];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp364995_c0_seq1;GAXK01200477.1;Q9Y6N3;2.51E-07;CLCA3_HUMAN;Calcium-activated chloride channel regulator family member 3 (Calcium-activated chloride channel family member 3) (hCLCA3);"chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; transporter activity [GO:0005215]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005215; GO:0005244; GO:0005254; GO:0005262; GO:0005615; GO:0005886; GO:0034220; GO:0034707; GO:0034765";"ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765]";"chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; transporter activity [GO:0005215]; voltage-gated ion channel activity [GO:0005244]"
comp3650_c1_seq1;GAXK01176636.1;O73817;6.52E-104;PSB3_ONCMY;Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";threonine-type endopeptidase activity [GO:0004298]
comp36500_c0_seq1;GAXK01205502.1;E2QWQ2;0;NLK_CANLF;Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]";"GO:0000287; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0008134; GO:0010468; GO:0016055; GO:0018107; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0042501; GO:0046777; GO:0050821";"intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"
comp3650489_c0_seq1;GAXK01112957.1;Q92847;1.92E-19;GHSR_HUMAN;Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor);"cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]";"GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110";"actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; ghrelin secretion [GO:0036321]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]";"cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]";"G protein-coupled receptor activity [GO:0004930]; growth hormone-releasing hormone receptor activity [GO:0016520]; growth hormone secretagogue receptor activity [GO:0001616]; peptide hormone binding [GO:0017046]"
comp36507_c0_seq1;GAXK01106991.1;Q16HW7;1.06E-140;GNPI_AEDAE;Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase) (GNPDA) (GlcN6P deaminase);"cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]";"GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006044; GO:0006091";"carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]";cytoplasm [GO:0005737];glucosamine-6-phosphate deaminase activity [GO:0004342]
comp365096_c0_seq1;GAXK01200651.1;Q6GL72;3.49E-112;DPYL3_XENTR;Dihydropyrimidinase-related protein 3 (DRP-3) (Dihydropyrimidinase-like 3);"cytosol [GO:0005829]; growth cone [GO:0030426]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"GO:0005829; GO:0010975; GO:0016810; GO:0030334; GO:0030426; GO:0048678; GO:0051017; GO:0051491; GO:0051764";"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"cytosol [GO:0005829]; growth cone [GO:0030426]";hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]
comp3651096_c0_seq1;GAXK01112960.1;P24902;7.52E-50;ACT_PINCO;Actin (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp3651784_c1_seq1;GAXK01112963.1;Q75NA5;1.88E-44;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp3651802_c0_seq1;GAXK01112951.1;P10102;1.55E-26;KPCA_RABIT;Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of platelet aggregation [GO:0090330]";"GO:0001525; GO:0001938; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007155; GO:0008270; GO:0010595; GO:0010613; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035556; GO:0045651; GO:0045766; GO:0045785; GO:0045931; GO:0048471; GO:0070374; GO:0090330; GO:2000707";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of platelet aggregation [GO:0090330]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]"
comp3651900_c0_seq1;GAXK01112959.1;Q9BZG1;5.69E-56;RAB34_HUMAN;Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah);"cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; Ral GTPase binding [GO:0017160]; antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005525; GO:0005794; GO:0005795; GO:0005929; GO:0006886; GO:0006897; GO:0017160; GO:0019882; GO:0030030; GO:0030670; GO:0030742; GO:0031982; GO:0031985; GO:0032418; GO:0032482; GO:0043001; GO:0045335; GO:0045880; GO:0048471; GO:0070062; GO:0072659; GO:0090382; GO:0090385";"antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]";"cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; Ral GTPase binding [GO:0017160]"
comp365239_c2_seq1;GAXK01200669.1;Q7KVW5;0;KCNN_DROME;Small conductance calcium-activated potassium channel protein (Protein SK) (dSK);"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]";"GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043005; GO:0043025; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]"
comp365340_c0_seq1;GAXK01200476.1;A6MHQ4;2.84E-39;NKAIN_DROME;Sodium/potassium-transporting ATPase subunit beta-1-interacting protein (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein) (dNKAIN);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028]";"GO:0002028; GO:0005886; GO:0016021";regulation of sodium ion transport [GO:0002028];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp3653468_c1_seq1;GAXK01194335.1;P18714;8.41E-19;ZG20_XENLA;Gastrula zinc finger protein xFG20-1 (XlCGF20.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3653656_c0_seq1;GAXK01194324.1;Q91WW7;1.51E-34;PLPL3_MOUSE;1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 (EC 2.3.1.51) (Acylglycerol transacylase) (Adiponutrin) (ADPN) (Calcium-independent phospholipase A2-epsilon) (iPLA2-epsilon) (Lysophosphatidic acid acyltransferase) (Patatin-like phospholipase domain-containing protein 3) (EC 3.1.1.3);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]; glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"GO:0001676; GO:0002021; GO:0003841; GO:0004623; GO:0004806; GO:0005737; GO:0005811; GO:0006650; GO:0006654; GO:0016020; GO:0016021; GO:0019432; GO:0019433; GO:0034389; GO:0035727; GO:0036042; GO:0036153; GO:0042171; GO:0051264; GO:0051265; GO:0055088";"glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to dietary excess [GO:0002021]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; diolein transacylation activity [GO:0051265]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]"
comp3654_c0_seq1;GAXK01176066.1;P04069;5.23E-94;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp3654052_c0_seq1;GAXK01181935.1;Q98993;5.77E-33;VTXB_SYNVE;Verrucotoxin subunit beta (VTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp365456_c0_seq1;GAXK01200478.1;Q9D0Z3;1.16E-14;TMM53_MOUSE;Transmembrane protein 53;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp36547_c0_seq1;GAXK01204958.1;P20136;3.47E-53;GSTM2_CHICK;Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]";"GO:0004364; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042803; GO:0043295; GO:0045171";"glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]";"cytosol [GO:0005829]; intercellular bridge [GO:0045171]";"enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]"
comp3654940_c0_seq1;GAXK01181938.1;P24666;7.49E-09;PPAC_HUMAN;Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0003993; GO:0004725; GO:0004726; GO:0005737; GO:0009898; GO:0070062";;"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]";"acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]"
comp365527_c2_seq1;GAXK01200555.1;P94400;4.61E-27;YCIC_BACSU;Putative metal chaperone YciC;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp3655427_c0_seq1;GAXK01181942.1;Q9VUL9;2.44E-47;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp3655958_c0_seq1;GAXK01181939.1;Q96EG3;1.72E-09;ZN837_HUMAN;Zinc finger protein 837;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp365632_c0_seq1;GAXK01200483.1;Q3HNM7;8.40E-42;INSC_MOUSE;Protein inscuteable homolog (Minsc);"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp365664_c1_seq1;GAXK01200638.1;G5ED00;9.92E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp365683_c0_seq1;GAXK01200645.1;B7YZU2;4.29E-24;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp365690_c0_seq1;GAXK01200616.1;Q6DCZ7;6.39E-37;FBP1L_XENLA;Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1);"cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; autophagy [GO:0006914]; endocytosis [GO:0006897]";"GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006914; GO:0008289; GO:0031410";"autophagy [GO:0006914]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp3657145_c0_seq1;GAXK01127909.1;Q96D21;3.31E-25;RHES_HUMAN;GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2);"plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0051897";"locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";plasma membrane [GO:0005886];"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp365780_c1_seq1;GAXK01200546.1;Q99M85;2.92E-65;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp3658048_c0_seq1;GAXK01065291.1;P73728;2.72E-59;PRX5_SYNY3;Peroxiredoxin sll1621 (Prx) (EC 1.11.1.15) (Thioredoxin peroxidase);"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]";"GO:0005737; GO:0008379; GO:0034599; GO:0042744; GO:0042802; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]";cytoplasm [GO:0005737];"identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]"
comp365847_c2_seq1;GAXK01200551.1;Q9VZW5;1.72E-28;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3658560_c0_seq1;GAXK01065290.1;Q3SWX0;1.83E-31;NIPA2_BOVIN;Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2 homolog);"early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]";"GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016021";magnesium ion transport [GO:0015693];"early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";magnesium ion transmembrane transporter activity [GO:0015095]
comp36589_c0_seq1;GAXK01107013.1;Q6NZN0;7.03E-44;RBM26_MOUSE;RNA-binding protein 26 (Protein expressed in male leptotene and zygotene spermatocytes 393) (MLZ-393) (RNA-binding motif protein 26);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";"GO:0003729; GO:0005634; GO:0006397; GO:0010923; GO:0046833; GO:0046872";"mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of RNA export from nucleus [GO:0046833]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp365909_c0_seq1;GAXK01200563.1;Q05319;5.47E-40;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp36595_c3_seq1;GAXK01204960.1;Q9VSL3;2.86E-31;SEPIA_DROME;Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia);"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";"GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114";"eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";cytoplasm [GO:0005737];"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"
comp366_c0_seq1;GAXK01168231.1;P54985;1.20E-88;PPIA_BLAGE;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp36601_c0_seq1;GAXK01106822.1;P56270;7.99E-08;MAZ_HUMAN;Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor) (Serum amyloid A-activating factor-1) (SAF-1) (Transcription factor Zif87) (ZF87) (Zinc finger protein 801);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0006367; GO:0006369; GO:0008284; GO:0010628; GO:0014068; GO:0030335; GO:0045893; GO:0046872; GO:0051897; GO:2001234";"negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp366022_c0_seq1;GAXK01144448.1;A9CPT4;6.42E-09;TDRD1_ORYLA;Tudor domain-containing protein 1;"P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"P granule [GO:0043186]; pi-body [GO:0071546]";metal ion binding [GO:0046872]
comp366026_c0_seq1;GAXK01144524.1;P11929;1.88E-09;BSG2_DROME;Blastoderm-specific protein 25D;"centrosome [GO:0005813]; pericentriolar material [GO:0000242]; microtubule binding [GO:0008017]; microtubule organizing center attachment site organization [GO:0034994]; multicellular organism development [GO:0007275]";"GO:0000242; GO:0005813; GO:0007275; GO:0008017; GO:0034994";"microtubule organizing center attachment site organization [GO:0034994]; multicellular organism development [GO:0007275]";"centrosome [GO:0005813]; pericentriolar material [GO:0000242]";microtubule binding [GO:0008017]
comp3660874_c0_seq1;GAXK01067274.1;D2KBH9;3.24E-17;NAS8_STECR;Zinc metalloproteinase nas-8 (EC 3.4.24.21) (Nematode astacin 8) (Sc-AST);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3661119_c0_seq1;GAXK01067269.1;P04146;6.47E-08;COPIA_DROME;"Copia protein (Gag-int-pol protein) [Cleaved into: Copia VLP protein; Copia protease (EC 3.4.23.-)]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0004190; GO:0005524; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp366124_c0_seq1;GAXK01144439.1;Q96G04;8.49E-27;EF2KT_HUMAN;Protein-lysine N-methyltransferase EEF2KMT (EC 2.1.1.-) (eEF2-lysine methyltransferase) (eEF2-KMT);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";"GO:0005737; GO:0005829; GO:0006479; GO:0016279; GO:0018023; GO:0032991";"peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]";protein-lysine N-methyltransferase activity [GO:0016279]
comp3661758_c0_seq1;GAXK01067263.1;Q9VZW5;2.83E-14;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp366205_c1_seq1;GAXK01144508.1;O46040;2.15E-22;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp3662283_c0_seq1;GAXK01179822.1;Q9V427;8.77E-17;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp3662343_c0_seq1;GAXK01179811.1;Q14584;2.59E-08;ZN266_HUMAN;Zinc finger protein 266 (Zinc finger protein HZF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3662992_c0_seq1;GAXK01179827.1;Q1H9T6;2.38E-08;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp366327_c0_seq1;GAXK01144519.1;Q54HW1;3.17E-10;PSD10_DICDI;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28);"cytoplasm [GO:0005737]; proteasome regulatory particle assembly [GO:0070682]";"GO:0005737; GO:0070682";proteasome regulatory particle assembly [GO:0070682];cytoplasm [GO:0005737];
comp366388_c1_seq1;GAXK01144317.1;Q05481;3.90E-37;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp36642_c2_seq1;GAXK01106712.1;Q9TR36;1.11E-104;PIPNB_BOVIN;Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]";"GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091";;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";"phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]"
comp3664325_c0_seq1;GAXK01154812.1;P23607;2.69E-09;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp366465_c1_seq1;GAXK01144450.1;Q9WTN6;7.97E-21;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp366568_c1_seq1;GAXK01144395.1;Q7KRI2;9.09E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp36657_c1_seq1;GAXK01106718.1;B2D0J5;3.97E-67;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp366570_c0_seq1;GAXK01144393.1;Q7SZR5;4.98E-09;SUMO1_DANRE;Small ubiquitin-related modifier 1 (SUMO-1);"cytoplasm [GO:0005737]; nuclear stress granule [GO:0097165]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; chordate embryonic development [GO:0043009]; definitive hemopoiesis [GO:0060216]; protein sumoylation [GO:0016925]";"GO:0005634; GO:0005737; GO:0005886; GO:0016925; GO:0031386; GO:0034605; GO:0043009; GO:0044389; GO:0060216; GO:0071276; GO:0097165";"cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; chordate embryonic development [GO:0043009]; definitive hemopoiesis [GO:0060216]; protein sumoylation [GO:0016925]";"cytoplasm [GO:0005737]; nuclear stress granule [GO:0097165]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp366638_c0_seq1;GAXK01144562.1;Q566U4;6.95E-49;KFA_DANRE;Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354";"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";arylformamidase activity [GO:0004061]
comp366654_c2_seq1;GAXK01144330.1;Q568Y5;3.26E-46;TSN11_RAT;Tetraspanin-11 (Tspan-11);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp366657_c0_seq1;GAXK01144422.1;O73630;4.34E-15;NFKB2_XENLA;Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0048511";"rhythmic process [GO:0048511]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp366746_c0_seq1;GAXK01144339.1;Q9UJT9;4.03E-111;FBXL7_HUMAN;F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7);"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0004842; GO:0005813; GO:0005829; GO:0006511; GO:0008283; GO:0010265; GO:0010972; GO:0016567; GO:0019005; GO:0031146; GO:0043687; GO:0051301";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";ubiquitin-protein transferase activity [GO:0004842]
comp3667603_c0_seq1;GAXK01055884.1;P16157;3.70E-07;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp3667988_c0_seq1;GAXK01055899.1;Q69Z37;2.12E-10;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp3668395_c0_seq1;GAXK01057985.1;Q99MS4;5.99E-14;PRS29_MOUSE;Serine protease 29 (EC 3.4.21.-) (Implantation serine proteinase 2) (ISP-2) (Strypsin-2) (Strypsin-related protein) (Tryptase-like proteinase);"extracellular space [GO:0005615]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"GO:0001835; GO:0004252; GO:0005615; GO:0006508; GO:0007566; GO:0008236; GO:0046982";"blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3668661_c0_seq1;GAXK01057978.1;Q9XGL4;1.60E-47;RL31_CYAPA;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp366902_c0_seq1;GAXK01144341.1;Q1QBB9;1.72E-33;DHMA_PSYCK;Haloalkane dehalogenase (EC 3.8.1.5);haloalkane dehalogenase activity [GO:0018786];GO:0018786;;;haloalkane dehalogenase activity [GO:0018786]
comp3669239_c0_seq1;GAXK01057979.1;Q5M9H0;3.07E-14;ANKS3_RAT;Ankyrin repeat and SAM domain-containing protein 3;;;;;
comp366951_c0_seq1;GAXK01144515.1;Q18493;1.32E-28;UAP1_CAEEL;Probable UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23);"cytoplasm [GO:0005737]; uridylyltransferase activity [GO:0070569]";"GO:0005737; GO:0070569";;cytoplasm [GO:0005737];uridylyltransferase activity [GO:0070569]
comp3669662_c0_seq1;GAXK01057991.1;A4IF87;4.41E-35;GNPAT_BOVIN;Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase);"mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654]";"GO:0005778; GO:0006631; GO:0006650; GO:0008611; GO:0008654; GO:0016287; GO:0031966";"ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654]";"mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]";glycerone-phosphate O-acyltransferase activity [GO:0016287]
comp3669730_c0_seq1;GAXK01057992.1;Q24133;2.19E-22;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp366991_c0_seq1;GAXK01205813.1;Q16539;9.59E-177;MK14_HUMAN;Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to organic substance [GO:0071310]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 secretion [GO:2001184]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000077; GO:0000187; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001890; GO:0002062; GO:0002741; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006357; GO:0006915; GO:0006935; GO:0007165; GO:0007166; GO:0007178; GO:0007265; GO:0007519; GO:0010468; GO:0010628; GO:0010759; GO:0010831; GO:0016607; GO:0018105; GO:0019395; GO:0019899; GO:0019903; GO:0030278; GO:0030316; GO:0031281; GO:0031663; GO:0032495; GO:0034774; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0043312; GO:0045648; GO:0045663; GO:0045944; GO:0046326; GO:0048010; GO:0048273; GO:0051090; GO:0051146; GO:0051149; GO:0051525; GO:0060045; GO:0070935; GO:0071222; GO:0071223; GO:0071310; GO:0071356; GO:0071479; GO:0090090; GO:0090336; GO:0090400; GO:0098586; GO:0098978; GO:0099179; GO:1900015; GO:1901741; GO:1901796; GO:1904813; GO:1905050; GO:2000379; GO:2001184";"3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to organic substance [GO:0071310]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 secretion [GO:2001184]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]"
comp367059_c0_seq1;GAXK01144486.1;Q08180;6.11E-60;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp367110_c0_seq1;GAXK01144447.1;Q19958;1.79E-105;STO2_CAEEL;Stomatin-2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp36717_c6_seq1;GAXK01107255.1;Q99LM3;7.21E-30;SMTL1_MOUSE;Smoothelin-like protein 1 (Calponin homology-associated smooth muscle protein) (CHASM);"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to drug [GO:0042493]";"GO:0004864; GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0014823; GO:0017020; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042493; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718; GO:0097756";"actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to drug [GO:0042493]";"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]"
comp367236_c0_seq1;GAXK01144318.1;Q8I7Z8;1.94E-14;HAM_DROME;Transcription factor hamlet;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007219; GO:0008285; GO:0014017; GO:0046872; GO:0046974; GO:0048813; GO:0050773";"dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]"
comp3672515_c0_seq1;GAXK01171253.1;P36609;5.06E-14;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp36737_c0_seq1;GAXK01107324.1;Q96S44;3.38E-75;PRPK_HUMAN;EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]";"GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:1901796";"protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]"
comp36739_c0_seq1;GAXK01107052.1;Q8R3N6;1.69E-158;THOC1_MOUSE;THO complex subunit 1 (Tho1) (Nuclear matrix protein p84);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]";"GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0000784; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0045171; GO:0046784; GO:0048297; GO:2000002";"apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp3674030_c0_seq1;GAXK01193997.1;P62244;1.13E-73;RS15A_HUMAN;40S ribosomal protein S15a (Small ribosomal subunit protein uS8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0008284; GO:0009615; GO:0016020; GO:0019083; GO:0022627; GO:0045787; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp3674124_c0_seq1;GAXK01194007.1;P35441;3.19E-23;TSP1_MOUSE;Thrombospondin-1 (Glycoprotein G);"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]";"GO:0000187; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002581; GO:0002605; GO:0003151; GO:0003197; GO:0003417; GO:0005178; GO:0005509; GO:0005577; GO:0005615; GO:0005737; GO:0005783; GO:0006954; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0010811; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0032026; GO:0032695; GO:0034976; GO:0040037; GO:0042327; GO:0042535; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048514; GO:0048661; GO:0050431; GO:0050840; GO:0050921; GO:0051592; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0071636; GO:0071732; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027";"activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]";"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]";"calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]"
comp36745_c0_seq1;GAXK01107180.1;Q5XIT1;2.79E-62;MARE3_RAT;Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3);"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005815; GO:0005874; GO:0005881; GO:0008017; GO:0008022; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0045737; GO:0045893; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp367473_c0_seq1;GAXK01144490.1;P83088;4.96E-61;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp36758_c0_seq1;GAXK01106664.1;Q54ES6;4.02E-20;RPC19_DICDI;DNA-directed RNA polymerases I and III subunit rpc19;"RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005666; GO:0005736; GO:0006360; GO:0006383; GO:0046983";"transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]";"RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]"
comp367584_c0_seq1;GAXK01144390.1;P41182;3.33E-14;BCL6_HUMAN;B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51);"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; cytokine-mediated signaling pathway [GO:0019221]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0000981; GO:0001161; GO:0001227; GO:0001953; GO:0002467; GO:0002634; GO:0002903; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0019221; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0042802; GO:0042981; GO:0043065; GO:0043087; GO:0043380; GO:0043565; GO:0045591; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0050776; GO:0051272; GO:1903464; GO:2000773";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; cytokine-mediated signaling pathway [GO:0019221]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp3676075_c0_seq1;GAXK01189582.1;Q7Z269;1.29E-24;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp367638_c0_seq1;GAXK01144328.1;P48034;1.37E-25;AOXA_BOVIN;Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-);"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]";"GO:0004031; GO:0004854; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0017144; GO:0042803; GO:0043546; GO:0050250; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0071949; GO:0102797; GO:0102798";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]";cytosol [GO:0005829];"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]"
comp3676408_c0_seq1;GAXK01189571.1;P59510;4.35E-35;ATS20_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-);"extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]";"GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0043066; GO:0045636";"extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]";extracellular space [GO:0005615];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3677309_c0_seq1;GAXK01189569.1;P0AGF5;3.25E-19;XYLE_ECO57;D-xylose-proton symporter (D-xylose transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]";"GO:0005886; GO:0008643; GO:0015293; GO:0016021";carbohydrate transport [GO:0008643];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";symporter activity [GO:0015293]
comp367742_c1_seq1;GAXK01144513.1;Q05481;1.32E-23;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp367767_c0_seq1;GAXK01144561.1;Q921M4;8.86E-09;GOGA2_MOUSE;Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130);"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"GO:0000137; GO:0000139; GO:0000922; GO:0005737; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0032991; GO:0033116; GO:0042802; GO:0043025; GO:0044877; GO:0048471; GO:0050772; GO:0051225; GO:0051289; GO:0051645; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307";"asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]";"identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]"
comp3677779_c0_seq1;GAXK01189581.1;P35371;1.35E-07;BRS3_CAVPO;Bombesin receptor subtype-3 (BRS-3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]";"GO:0004946; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";bombesin receptor activity [GO:0004946]
comp367809_c0_seq1;GAXK01144442.1;G5ED00;8.32E-14;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp3678318_c0_seq1;GAXK01025022.1;Q6ZMW2;2.15E-09;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp367857_c0_seq1;GAXK01144516.1;Q502P7;7.19E-39;BANP_DANRE;Protein BANP;"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]";"GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177";"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp367922_c0_seq1;GAXK01144511.1;Q9VUN0;0;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp36793_c3_seq1;GAXK01106703.1;Q3T052;4.16E-57;ITIH4_BOVIN;Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";"GO:0004867; GO:0005576; GO:0006953; GO:0030212";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp3679886_c0_seq1;GAXK01025011.1;Q875B7;3.11E-43;H2B_PODAS;Histone H2B;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp368_c0_seq1;GAXK01169225.1;P05547;6.09E-32;TNNI_ASTLP;Troponin I (TnI);"troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]";"GO:0003779; GO:0005861; GO:0046872";;troponin complex [GO:0005861];"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp3680_c1_seq1;GAXK01175368.1;Q08473;1.58E-37;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp36810_c0_seq1;GAXK01107105.1;O35166;1.16E-54;GOSR2_MOUSE;Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0012507; GO:0016021; GO:0016192; GO:0031201; GO:0031902; GO:0042147; GO:0048280";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; SNARE complex [GO:0031201]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp368117_c1_seq1;GAXK01097282.1;P36609;3.01E-15;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3681581_c0_seq1;GAXK01136067.1;Q86YT5;2.12E-37;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp3682425_c0_seq1;GAXK01180686.1;P08311;7.82E-10;CATG_HUMAN;Cathepsin G (CG) (EC 3.4.21.20);"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; neutrophil mediated killing of gram-positive bacterium [GO:0070946]; positive regulation of immune response [GO:0050778]; protein phosphorylation [GO:0006468]; proteolysis [GO:0006508]";"GO:0002003; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006508; GO:0006955; GO:0008201; GO:0008233; GO:0008236; GO:0009986; GO:0010494; GO:0019730; GO:0019731; GO:0022617; GO:0030141; GO:0035578; GO:0043312; GO:0044267; GO:0050778; GO:0050829; GO:0050832; GO:0062023; GO:0070062; GO:0070946; GO:0071222";"angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; neutrophil mediated killing of gram-positive bacterium [GO:0070946]; positive regulation of immune response [GO:0050778]; protein phosphorylation [GO:0006468]; proteolysis [GO:0006508]";"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]";"heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp36836_c3_seq1;GAXK01106669.1;D4A734;7.86E-14;MOT12_RAT;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp368389_c0_seq1;GAXK01097189.1;Q8IWQ3;0;BRSK2_HUMAN;Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATPase activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]";"GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0150034; GO:1904152; GO:2000807";"actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATPase activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]"
comp3683991_c0_seq1;GAXK01180687.1;Q42262;6.12E-74;RS3A2_ARATH;40S ribosomal protein S3a-2;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp3684_c0_seq1;GAXK01175895.1;Q66JF3;8.24E-128;MKNK1_XENTR;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]"
comp368405_c0_seq1;GAXK01097231.1;A2T7F4;1.16E-20;ZSC12_PONPY;Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 96);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3684185_c0_seq1;GAXK01055710.1;O42329;2.35E-17;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3684558_c0_seq1;GAXK01055714.1;Q09575;2.13E-07;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp368485_c1_seq1;GAXK01097246.1;Q6DHC1;3.69E-58;RB18B_DANRE;Ras-related protein Rab-18-B;"Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";"GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007420; GO:0032482; GO:0034389; GO:0043009";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";Golgi apparatus [GO:0005794];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3685064_c0_seq1;GAXK01055713.1;Q7ZXX1;1.75E-15;CADM3_XENLA;Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0016021; GO:0030054";cell adhesion [GO:0007155];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp368507_c0_seq1;GAXK01097255.1;O88563;1.53E-83;MRP3_RAT;Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (MRP-like protein 2) (MLP-2) (Multidrug resistance-associated protein 3);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0006855; GO:0010033; GO:0010243; GO:0014070; GO:0015722; GO:0015893; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0032355; GO:0032496; GO:0042626; GO:0055085";"canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp368516_c0_seq1;GAXK01097308.1;P30682;7.19E-100;GNAI_LYMST;Guanine nucleotide-binding protein G(i) subunit alpha (Adenylate cyclase-inhibiting G alpha protein);"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]";"GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872";adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp36854_c0_seq1;GAXK01106881.1;Q5R9Z1;3.14E-109;VPS29_PONAB;Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29);"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005769; GO:0005770; GO:0005829; GO:0010008; GO:0015031; GO:0030904; GO:0032456; GO:0042147; GO:0046872; GO:1990126";"endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]";metal ion binding [GO:0046872]
comp368616_c1_seq1;GAXK01097314.1;Q0EEE2;3.83E-40;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp3686300_c0_seq1;GAXK01184833.1;Q3U0J8;6.49E-12;TBD2B_MOUSE;TBC1 domain family member 2B;"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp3686317_c0_seq1;GAXK01184817.1;Q8MKK4;2.70E-12;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp3686433_c0_seq1;GAXK01184827.1;Q9NPC7;6.22E-09;MYNN_HUMAN;Myoneurin (Zinc finger and BTB domain-containing protein 31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp36865_c7_seq1;GAXK01106731.1;P47245;0;NRDC_RAT;Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase);"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]";"GO:0004222; GO:0008233; GO:0046872; GO:0120163";negative regulation of cold-induced thermogenesis [GO:0120163];;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]"
comp368734_c0_seq1;GAXK01097202.1;A6NAF9;1.39E-31;TRD7A_DANRE;Tudor domain-containing protein 7A;"P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0007283; GO:0010608; GO:0030719; GO:0035770; GO:0043186; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]";mRNA binding [GO:0003729]
comp368777_c0_seq1;GAXK01097235.1;Q1H9T6;1.45E-17;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp368862_c0_seq1;GAXK01097310.1;Q9P278;2.30E-19;FNIP2_HUMAN;Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein);"cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]";"GO:0000122; GO:0001932; GO:0005737; GO:0006468; GO:0008630; GO:0010823; GO:0031334; GO:0033138; GO:0042030; GO:0051087; GO:1904262";"intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]";cytoplasm [GO:0005737];"ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]"
comp36892_c1_seq1;GAXK01107042.1;P17735;1.02E-169;ATTY_HUMAN;Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]";"GO:0004838; GO:0005739; GO:0005829; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0046689; GO:0051384";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]"
comp368942_c1_seq1;GAXK01097293.1;Q9VEG6;2.50E-50;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp36896_c2_seq1;GAXK01106989.1;Q5ZKM0;7.23E-20;DTBP1_CHICK;Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1);"axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; growth cone [GO:0030426]; melanosome membrane [GO:0033162]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]";"GO:0001956; GO:0005634; GO:0005789; GO:0008089; GO:0010008; GO:0014069; GO:0030054; GO:0030424; GO:0030426; GO:0030672; GO:0031083; GO:0031175; GO:0031532; GO:0033162; GO:0043005; GO:0043197; GO:0045211; GO:0048490; GO:0048812; GO:0060159; GO:1904115";"actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]";"axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; growth cone [GO:0030426]; melanosome membrane [GO:0033162]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]";
comp3690_c0_seq1;GAXK01175672.1;Q05024;1.22E-11;TRI1_YEAST;Protein TRI1;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"GO:0005634; GO:0005730; GO:0005737";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp36900_c0_seq1;GAXK01106691.1;Q552Z6;2.98E-09;GTPA_DICDI;GTP-binding protein A;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp369006_c1_seq1;GAXK01097173.1;Q501Q9;3.73E-166;MK15_XENLA;Mitogen-activated protein kinase 15 (EC 2.7.11.24);"cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; regulation of cilium assembly [GO:1902017]";"GO:0004707; GO:0005524; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0036064; GO:1902017";regulation of cilium assembly [GO:1902017];"cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]"
comp36902_c1_seq1;GAXK01106994.1;Q9N5Y2;3.58E-103;TECR_CAEEL;Probable very-long-chain enoyl-CoA reductase art-1 (EC 1.3.1.93);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005789; GO:0016021; GO:0016491; GO:0042761; GO:0102758";very long-chain fatty acid biosynthetic process [GO:0042761];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]"
comp3691_c1_seq1;GAXK01176013.1;P37193;1.13E-31;ADXH1_DROME;Adrenodoxin-like protein 1, mitochondrial (Ferredoxin-1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005759; GO:0006694; GO:0009055; GO:0045998; GO:0046872; GO:0051537";"positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"
comp369126_c0_seq1;GAXK01097204.1;Q29RM3;2.49E-17;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp3692203_c0_seq1;GAXK01108066.1;Q4UMH6;1.58E-13;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp369267_c1_seq1;GAXK01097218.1;P0C5E3;2.75E-12;PALLD_RAT;Palladin (Fragment);"axon [GO:0030424]; axonal growth cone [GO:0044295]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection development [GO:0031175]; positive regulation of podosome assembly [GO:0071803]; ruffle organization [GO:0031529]; trophoblast giant cell differentiation [GO:0060707]; wound healing [GO:0042060]";"GO:0001725; GO:0001726; GO:0002102; GO:0003779; GO:0005886; GO:0005925; GO:0007156; GO:0007411; GO:0008092; GO:0016477; GO:0030018; GO:0030027; GO:0030036; GO:0030175; GO:0030424; GO:0031175; GO:0031529; GO:0042060; GO:0043025; GO:0044295; GO:0060707; GO:0070593; GO:0071456; GO:0071803; GO:0098632";"actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection development [GO:0031175]; positive regulation of podosome assembly [GO:0071803]; ruffle organization [GO:0031529]; trophoblast giant cell differentiation [GO:0060707]; wound healing [GO:0042060]";"axon [GO:0030424]; axonal growth cone [GO:0044295]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]"
comp369324_c0_seq1;GAXK01097208.1;Q3UH06;6.74E-30;RREB1_MOUSE;Ras-responsive element-binding protein 1 (RREB-1) (RAS-responsive zinc finger transcription factor RREB);"fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]";"GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0010634; GO:0016607; GO:0033601; GO:0045892; GO:0045944; GO:0046872; GO:1900026; GO:1903691; GO:2000394";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]";"fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3693518_c0_seq1;GAXK01108075.1;P18061;9.70E-41;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp369352_c4_seq1;GAXK01097174.1;Q9JME2;1.01E-15;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp36937_c0_seq1;GAXK01106979.1;Q811Q9;1.62E-91;PCY1B_MOUSE;Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B);"endoplasmic reticulum [GO:0005783]; choline-phosphate cytidylyltransferase activity [GO:0004105]; phosphatidylcholine binding [GO:0031210]; ovarian follicle development [GO:0001541]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0004105; GO:0005783; GO:0007283; GO:0031210";"ovarian follicle development [GO:0001541]; spermatogenesis [GO:0007283]";endoplasmic reticulum [GO:0005783];"choline-phosphate cytidylyltransferase activity [GO:0004105]; phosphatidylcholine binding [GO:0031210]"
comp369384_c0_seq1;GAXK01097307.1;Q96H86;7.29E-14;ZN764_HUMAN;Zinc finger protein 764;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp369458_c0_seq1;GAXK01097197.1;Q9BUY5;5.28E-14;ZN426_HUMAN;Zinc finger protein 426;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3695_c1_seq1;GAXK01176010.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp3695187_c0_seq1;GAXK01095365.1;O43432;2.94E-43;IF4G3_HUMAN;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]";"GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016281";regulation of translational initiation [GO:0006446];"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp369532_c1_seq1;GAXK01097144.1;P16112;3.50E-15;PGCA_HUMAN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982";"cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]";"carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]"
comp36957_c1_seq1;GAXK01106680.1;Q7KNF2;1.32E-33;PABP2_DROME;Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (dPABP2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1) (Protein rox2);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of protein glycosylation [GO:0060050]";"GO:0000289; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0060050; GO:0071011; GO:0071013";"mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of protein glycosylation [GO:0060050]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";"mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]"
comp36969_c2_seq1;GAXK01106775.1;P82252;1.34E-158;BAT1_RAT;b(0,+)-type amino acid transporter 1 (b(0,+)AT) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]";"GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016021; GO:0016324; GO:0031526; GO:0042605";"amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]"
comp36973_c0_seq1;GAXK01106666.1;B1WAP7;0;DVL3_XENTR;Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3);"cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]";"GO:0005109; GO:0005829; GO:0008013; GO:0032053; GO:0035556; GO:0060070; GO:0060271; GO:0090179";"canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]";cytosol [GO:0005829];"beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]"
comp36977_c0_seq1;GAXK01106880.1;O13046;4.98E-124;WDHD1_XENLA;WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]";"GO:0003677; GO:0005654; GO:0005737";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp36982_c0_seq1;GAXK01107183.1;Q9H0H5;2.18E-99;RGAP1_HUMAN;Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4);"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019886; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0035556; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149";"actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]"
comp369822_c3_seq1;GAXK01097276.1;Q9JIL5;1.11E-63;TULP4_MOUSE;Tubby-related protein 4 (Tubby superfamily protein) (Tubby-like protein 4);"cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0016567";protein ubiquitination [GO:0016567];cytoplasm [GO:0005737];
comp369839_c0_seq1;GAXK01097180.1;P15336;1.56E-08;ATF2_HUMAN;Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (EC 2.3.1.48) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (Histone acetyltransferase ATF2) (cAMP response element-binding protein CRE-BP1);"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]";"GO:0000122; GO:0000790; GO:0000977; GO:0000980; GO:0000981; GO:0001102; GO:0001158; GO:0001228; GO:0003151; GO:0003682; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006970; GO:0006974; GO:0008140; GO:0009414; GO:0010628; GO:0016525; GO:0019901; GO:0031573; GO:0032915; GO:0035497; GO:0035861; GO:0043525; GO:0045444; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0051090; GO:0051091; GO:0060612; GO:0097186; GO:0110024; GO:1902110";"adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]";"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3698542_c0_seq1;GAXK01050885.1;Q75NA5;1.20E-34;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp369883_c0_seq1;GAXK01097317.1;P36975;1.14E-58;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp36989_c2_seq1;GAXK01107500.1;B4L184;0;WLS_DROMO;Protein wntless;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; intrinsic component of endosome membrane [GO:0031302]; intrinsic component of Golgi membrane [GO:0031228]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Wnt-protein binding [GO:0017147]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; positive regulation of protein secretion [GO:0050714]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of intracellular protein transport [GO:0033157]; segment polarity determination [GO:0007367]; Wnt signaling pathway [GO:0016055]";"GO:0005887; GO:0007367; GO:0008587; GO:0016055; GO:0017147; GO:0030054; GO:0030177; GO:0030285; GO:0031227; GO:0031228; GO:0031302; GO:0031594; GO:0033157; GO:0042734; GO:0045211; GO:0050714";"imaginal disc-derived wing margin morphogenesis [GO:0008587]; positive regulation of protein secretion [GO:0050714]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of intracellular protein transport [GO:0033157]; segment polarity determination [GO:0007367]; Wnt signaling pathway [GO:0016055]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; intrinsic component of endosome membrane [GO:0031302]; intrinsic component of Golgi membrane [GO:0031228]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";Wnt-protein binding [GO:0017147]
comp36994_c1_seq1;GAXK01107517.1;Q9V427;1.30E-65;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp3699982_c0_seq1;GAXK01050894.1;Q95167;1.40E-31;KCNB2_CANLF;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) (Fragment);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp370_c2_seq1;GAXK01170175.1;Q6PAX2;0;ATD3B_XENLA;ATPase family AAA domain-containing protein 3-B;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; ATP binding [GO:0005524]; mitochondrion organization [GO:0007005]";"GO:0005524; GO:0005743; GO:0007005; GO:0016021; GO:0042645";mitochondrion organization [GO:0007005];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]";ATP binding [GO:0005524]
comp370050_c1_seq1;GAXK01134930.1;Q9VEG6;1.80E-117;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp37016_c2_seq1;GAXK01107326.1;Q86U86;4.12E-170;PB1_HUMAN;Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D);"nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000228; GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0006368; GO:0008285; GO:0016586; GO:0043044";"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]"
comp370201_c0_seq1;GAXK01134907.1;P0DPU3;2.05E-135;TX14A_SCOSD;"Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]";"extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729";"glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]"
comp37022_c1_seq1;GAXK01106749.1;P53804;4.89E-22;TTC3_HUMAN;E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005730; GO:0005829; GO:0006511; GO:0046872; GO:0070936";"protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp370288_c0_seq1;GAXK01134974.1;Q52KB5;4.57E-07;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3703339_c0_seq1;GAXK01198714.1;Q9BMX5;7.28E-116;RS6_APLCA;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp3704620_c0_seq1;GAXK01121258.1;O75362;3.57E-07;ZN217_HUMAN;Zinc finger protein 217;"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000118; GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016607; GO:0044212; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp3704765_c0_seq1;GAXK01121266.1;Q8WPA2;4.92E-38;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp3705006_c0_seq1;GAXK01121251.1;Q9BYN7;5.73E-09;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp370546_c2_seq1;GAXK01134920.1;Q5SRX1;2.51E-31;TM1L2_MOUSE;TOM1-like protein 2 (Target of Myb-like protein 2);"cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]";"GO:0005623; GO:0006886; GO:0007165; GO:0019901; GO:0030276; GO:0045839";"intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]";cell [GO:0005623];"clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]"
comp3706208_c0_seq1;GAXK01162453.1;Q5T619;2.12E-11;ZN648_HUMAN;Zinc finger protein 648;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp37065_c1_seq1;GAXK01107136.1;A3KN83;0;SBNO1_HUMAN;Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3);"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];
comp370673_c0_seq1;GAXK01134918.1;Q15022;3.59E-08;SUZ12_HUMAN;Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog);"ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RSC-type complex [GO:0016586]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000122; GO:0000978; GO:0001739; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0008284; GO:0016574; GO:0016586; GO:0016604; GO:0031490; GO:0032993; GO:0035064; GO:0035098; GO:0042054; GO:0045596; GO:0045814; GO:0046872; GO:0070317; GO:0070734; GO:1990841";"histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]";"ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RSC-type complex [GO:0016586]; sex chromatin [GO:0001739]";"chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp37068_c0_seq1;GAXK01106878.1;Q8N6F8;9.52E-14;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp3706897_c0_seq1;GAXK01162450.1;Q93HT9;9.72E-13;IABN_GEOTD;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp37071_c0_seq1;GAXK01107033.1;O34499;4.06E-38;6PGL_BACSU;6-phosphogluconolactonase (EC 3.1.1.31);"cytosol [GO:0005829]; 6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0005829; GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";cytosol [GO:0005829];6-phosphogluconolactonase activity [GO:0017057]
comp37072_c1_seq1;GAXK01107062.1;P69735;7.82E-82;RB3GP_RAT;Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP) (Fragments);"cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; excitatory synapse [GO:0060076]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"GO:0005096; GO:0005737; GO:0017137; GO:0032483; GO:0032991; GO:0034389; GO:0043547; GO:0046982; GO:0048172; GO:0060076; GO:0060079; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786";"establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; excitatory synapse [GO:0060076]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]"
comp3707372_c0_seq1;GAXK01162456.1;Q6WNR0;2.09E-10;C81E7_MEDTR;Isoflavone 2'-hydroxylase (EC 1.14.14.89) (4'-methoxyisoflavone 2'-hydroxylase) (Cytochrome P450 81E7);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016021; GO:0016705; GO:0020037";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp370753_c0_seq1;GAXK01134969.1;Q9GZR2;8.29E-61;REXO4_HUMAN;RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2);"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]";"GO:0000726; GO:0000737; GO:0000738; GO:0003697; GO:0003713; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005730; GO:0006355; GO:0006364; GO:0008408; GO:0016607; GO:0045944";"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]";"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]"
comp3707703_c0_seq1;GAXK01162464.1;Q3U288;1.15E-08;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3707796_c0_seq1;GAXK01162458.1;Q9W0T5;3.19E-13;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp37080_c0_seq1;GAXK01106933.1;Q9VM95;4.71E-33;AATF_DROME;Protein Aatf (Apoptosis antagonizing transcription factor ortholog);"nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of programmed cell death [GO:0043069]; oogenesis [GO:0048477]";"GO:0005634; GO:0005730; GO:0043069; GO:0048477";"negative regulation of programmed cell death [GO:0043069]; oogenesis [GO:0048477]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp37086_c0_seq1;GAXK01106846.1;Q6UB98;3.01E-13;ANR12_HUMAN;Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp37087_c1_seq1;GAXK01107361.1;Q8BWM0;1.84E-77;PGES2_MOUSE;Prostaglandin E synthase 2 (EC 5.3.99.3) (GATE-binding factor 1) (GBF-1) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; positive regulation of transcription, DNA-templated [GO:0045893]; prostaglandin biosynthetic process [GO:0001516]; secretion [GO:0046903]";"GO:0000139; GO:0001516; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0020037; GO:0043295; GO:0045454; GO:0045893; GO:0046903; GO:0050220";"cell redox homeostasis [GO:0045454]; positive regulation of transcription, DNA-templated [GO:0045893]; prostaglandin biosynthetic process [GO:0001516]; secretion [GO:0046903]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]"
comp370949_c1_seq1;GAXK01134878.1;Q9UJU3;5.32E-24;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp370956_c0_seq1;GAXK01134906.1;P16375;1.67E-64;7UP1_DROME;Steroid receptor seven-up, isoforms B/C (Nuclear receptor subfamily 2 group F member 3, isoforms B/C);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0000977; GO:0001227; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0007270; GO:0007419; GO:0007462; GO:0007464; GO:0007503; GO:0007507; GO:0007510; GO:0007601; GO:0008270; GO:0014019; GO:0021782; GO:0030154; GO:0042331; GO:0042803; GO:0046530; GO:0046982; GO:0048856; GO:0061331";"anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp3709996_c0_seq1;GAXK01164012.1;Q7ZXC9;6.57E-14;PRPS2_XENLA;Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0004749; GO:0005524; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp3710480_c0_seq1;GAXK01089714.1;O60103;7.76E-11;DOA10_SCHPO;ERAD-associated E3 ubiquitin-protein ligase doa10 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase doa10);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein modification by small protein conjugation or removal [GO:0070647]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0008270; GO:0030176; GO:0030433; GO:0061630; GO:0070647";"protein modification by small protein conjugation or removal [GO:0070647]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp371067_c0_seq1;GAXK01134916.1;Q8IN81;1.23E-10;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3711255_c0_seq1;GAXK01089711.1;Q05516;6.35E-08;ZBT16_HUMAN;Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"GO:0000122; GO:0000980; GO:0001227; GO:0001823; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007417; GO:0008022; GO:0008285; GO:0009880; GO:0009952; GO:0016567; GO:0016604; GO:0016605; GO:0016607; GO:0017053; GO:0019904; GO:0030097; GO:0030099; GO:0032332; GO:0032991; GO:0034504; GO:0035116; GO:0035136; GO:0042733; GO:0042802; GO:0042803; GO:0043065; GO:0043565; GO:0043687; GO:0045600; GO:0045638; GO:0045778; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048133; GO:0051138; GO:0051216; GO:0061036";"anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp3711307_c0_seq1;GAXK01089719.1;Q6B9X6;6.90E-20;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp3712264_c0_seq1;GAXK01018808.1;P13395;7.33E-32;SPTCA_DROME;Spectrin alpha chain;"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693";"actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]"
comp37125_c0_seq1;GAXK01107046.1;P49756;3.48E-41;RBM25_HUMAN;RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]";"GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981";"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp37126_c1_seq1;GAXK01107287.1;Q9WYP5;2.37E-54;IOLG_THEMA;Myo-inositol 2-dehydrogenase (EC 1.1.1.18);"inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]";"GO:0006020; GO:0006740; GO:0016491; GO:0050112";"inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]";;"inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]"
comp37129_c0_seq1;GAXK01107008.1;Q8R059;1.14E-131;GALE_MOUSE;UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase);"cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]";"GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0019388; GO:0033499; GO:0042802; GO:0042803; GO:0061623";"galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]"
comp371416_c0_seq1;GAXK01134973.1;Q9QZR8;1.30E-18;PDZD2_RAT;PDZ domain-containing protein 2 (PDZ domain-containing protein 3) (Plakophilin-related armadillo repeat protein-interacting PDZ protein) [Cleaved into: Processed PDZ domain-containing protein 2];"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005911; GO:0007155; GO:0014069; GO:0035556; GO:0043005; GO:0045177";"cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";
comp371457_c1_seq1;GAXK01134951.1;Q9NUA8;5.59E-07;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp37149_c0_seq1;GAXK01107556.1;B4NE93;1.96E-61;NFU1_DROWI;NFU1 iron-sulfur cluster scaffold homolog, mitochondrial;"mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]";"GO:0005506; GO:0005739; GO:0016226; GO:0051536";iron-sulfur cluster assembly [GO:0016226];mitochondrion [GO:0005739];"iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]"
comp3715401_c0_seq1;GAXK01052865.1;A2A935;6.61E-11;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp3716457_c0_seq1;GAXK01034006.1;Q09363;3.80E-12;SQV8_CAEEL;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase sqv-8 (EC 2.4.1.135) (Glucuronyl transferase I) (GlcAT-I) (Squashed vulva protein 8) (Vulval invagination protein sqv-8);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryo development ending in birth or egg hatching [GO:0009792]; morphogenesis of an epithelium [GO:0002009]; oviposition [GO:0018991]; pharynx development [GO:0060465]; reproduction [GO:0000003]; spermatid development [GO:0007286]; vulval development [GO:0040025]";"GO:0000003; GO:0000139; GO:0002009; GO:0007286; GO:0009792; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0018991; GO:0030206; GO:0040025; GO:0046872; GO:0050650; GO:0060465";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryo development ending in birth or egg hatching [GO:0009792]; morphogenesis of an epithelium [GO:0002009]; oviposition [GO:0018991]; pharynx development [GO:0060465]; reproduction [GO:0000003]; spermatid development [GO:0007286]; vulval development [GO:0040025]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp3716589_c0_seq1;GAXK01033990.1;Q811F1;1.18E-13;ZBT41_MOUSE;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3716593_c0_seq1;GAXK01034002.1;Q08832;9.84E-08;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp3717038_c0_seq1;GAXK01033991.1;P28668;1.29E-14;SYEP_DROME;"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]; glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433]";"GO:0003723; GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0006424; GO:0006433; GO:0017101; GO:0046872";"glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]"
comp3717149_c0_seq1;GAXK01034007.1;Q9D099;4.64E-40;ACER3_MOUSE;Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512]";"GO:0005509; GO:0005783; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121";"ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]"
comp37173_c0_seq1;GAXK01107359.1;A0M8U1;0;ST7_CHICK;Suppressor of tumorigenicity 7 protein homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp37177_c0_seq1;GAXK01106875.1;O35790;3.37E-52;PIGL_RAT;N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000225; GO:0005783; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]
comp3718543_c0_seq1;GAXK01192953.1;Q8N8A2;1.41E-10;ANR44_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp37188_c1_seq1;GAXK01106823.1;Q9VWV8;5.24E-100;NOSIP_DROME;Nitric oxide synthase-interacting protein homolog;"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]";"GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0043086; GO:0051001; GO:0061630; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]"
comp37197_c0_seq1;GAXK01106748.1;Q5E9U6;2.43E-96;WNT16_BOVIN;Protein Wnt-16;"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0045165";"cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp37210_c2_seq1;GAXK01107035.1;Q2KJ84;1.46E-15;TMED5_BOVIN;Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma 2) (p24gamma2);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116; GO:0090161";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";
comp3721272_c0_seq1;GAXK01136207.1;Q8R151;1.07E-66;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp37223_c2_seq1;GAXK01106672.1;Q6PDM1;2.48E-11;MSL1_MOUSE;Male-specific lethal 1 homolog (MSL-1) (Hampin) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1);"MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone H4-K16 acetylation [GO:0043984]";"GO:0003682; GO:0005654; GO:0043984; GO:0072487";histone H4-K16 acetylation [GO:0043984];"MSL complex [GO:0072487]; nucleoplasm [GO:0005654]";chromatin binding [GO:0003682]
comp37227_c0_seq1;GAXK01106841.1;P36609;5.67E-56;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp372272_c1_seq1;GAXK01093608.1;P23773;1.63E-32;GATA3_XENLA;GATA-binding factor 3 (Transcription factor xGATA-3);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; positive regulation of T cell differentiation [GO:0045582]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045582";positive regulation of T cell differentiation [GO:0045582];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp3723056_c0_seq1;GAXK01177751.1;Q5DTV4;2.52E-12;ZC12C_MOUSE;Probable ribonuclease ZC3H12C (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12C);"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]";"GO:0004519; GO:0046872";;;"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp3723534_c0_seq1;GAXK01177757.1;P39057;4.05E-89;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3723843_c0_seq1;GAXK01177771.1;O94008;3.24E-38;RL32_CANAX;60S ribosomal protein L32;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp372447_c0_seq1;GAXK01093619.1;Q8NHY6;4.95E-07;ZFP28_HUMAN;Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp372470_c0_seq1;GAXK01093674.1;P16375;1.81E-39;7UP1_DROME;Steroid receptor seven-up, isoforms B/C (Nuclear receptor subfamily 2 group F member 3, isoforms B/C);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0000977; GO:0001227; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0007270; GO:0007419; GO:0007462; GO:0007464; GO:0007503; GO:0007507; GO:0007510; GO:0007601; GO:0008270; GO:0014019; GO:0021782; GO:0030154; GO:0042331; GO:0042803; GO:0046530; GO:0046982; GO:0048856; GO:0061331";"anatomical structure development [GO:0048856]; cardioblast cell fate determination [GO:0007510]; cell differentiation [GO:0030154]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; fat body development [GO:0007503]; glial cell development [GO:0021782]; heart development [GO:0007507]; neuroblast development [GO:0014019]; neuron-neuron synaptic transmission [GO:0007270]; photoreceptor cell differentiation [GO:0046530]; phototaxis [GO:0042331]; R1/R6 cell fate commitment [GO:0007462]; R3/R4 cell fate commitment [GO:0007464]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp3725133_c0_seq1;GAXK01123494.1;Q90805;4.73E-69;CNG1_CHICK;Cyclic nucleotide-gated channel cone photoreceptor subunit alpha (CNG channel 1) (CNG-1) (CNG1);"integral component of membrane [GO:0016021]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0007601; GO:0016021; GO:0030552; GO:0030553; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]"
comp3725244_c0_seq1;GAXK01123486.1;P21783;3.90E-45;NOTC1_XENLA;"Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]"
comp37254_c0_seq1;GAXK01107289.1;Q9GZR7;9.89E-17;DDX24_HUMAN;ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24);"membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0016020; GO:0016070";"RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]";"membrane [GO:0016020]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp3725876_c0_seq1;GAXK01123501.1;Q90YS0;9.41E-89;RS4_ICTPU;40S ribosomal protein S4;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp372602_c0_seq1;GAXK01093647.1;Q7Z2W4;8.10E-08;ZCCHV_HUMAN;Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein ADP-ribosylation [GO:0006471]; response to virus [GO:0009615]";"GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006471; GO:0009615; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein ADP-ribosylation [GO:0006471]; response to virus [GO:0009615]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp3726595_c0_seq1;GAXK01126121.1;Q811F1;2.46E-07;ZBT41_MOUSE;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3727000_c0_seq1;GAXK01126119.1;Q33E94;3.18E-76;RFX4_HUMAN;Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0021537; GO:0021914; GO:0045944; GO:0060271; GO:0070613";"cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp372789_c1_seq1;GAXK01093567.1;P49895;2.56E-35;IOD1_HUMAN;Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]";"GO:0004800; GO:0005789; GO:0005886; GO:0006590; GO:0008430; GO:0016021; GO:0042403; GO:0042446";"hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]"
comp37280_c0_seq1;GAXK01107362.1;Q9JLJ0;5.11E-10;LITAF_MOUSE;Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Estrogen-enhanced transcript protein) (mEET) (LITAF-like protein) (NEDD4 WW domain-binding protein 3);"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; response to lipopolysaccharide [GO:0032496]";"GO:0000139; GO:0000978; GO:0001817; GO:0005654; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007568; GO:0008270; GO:0009898; GO:0032496; GO:0043123; GO:0043231; GO:0045944; GO:0050699; GO:0071222; GO:0098559; GO:0098560; GO:0098574; GO:1901223";"aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; response to lipopolysaccharide [GO:0032496]";"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp372826_c0_seq1;GAXK01093569.1;Q5HFY5;1.15E-41;TDCB_STAAC;L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (Threonine deaminase);"L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689]";"GO:0000166; GO:0004794; GO:0030170; GO:0070689";L-threonine catabolic process to propionate [GO:0070689];;"L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]"
comp3728664_c0_seq1;GAXK01156649.1;P22105;7.66E-07;TENX_HUMAN;Tenascin-X (TN-X) (Hexabrachion-like protein);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]"
comp372870_c1_seq1;GAXK01093629.1;P14084;1.16E-08;SRC_AVISS;Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524";;;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp372911_c0_seq1;GAXK01093644.1;Q921M7;1.20E-30;FA49B_MOUSE;Protein FAM49B;"cilium [GO:0005929]; membrane [GO:0016020]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]";"GO:0001916; GO:0005929; GO:0016020; GO:0023030; GO:0032729; GO:0050870; GO:2000568";"positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]";"cilium [GO:0005929]; membrane [GO:0016020]";MHC class Ib protein binding, via antigen binding groove [GO:0023030]
comp3729114_c0_seq1;GAXK01156643.1;Q9AW48;3.94E-175;P2SAF_GUITH;Photosystem II stability/assembly factor HCF136, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; photosystem II [GO:0009523]; photosynthesis [GO:0015979]";"GO:0009523; GO:0009535; GO:0015979";photosynthesis [GO:0015979];"chloroplast thylakoid membrane [GO:0009535]; photosystem II [GO:0009523]";
comp3730441_c0_seq1;GAXK01198540.1;Q9H8M5;3.63E-81;CNNM2_HUMAN;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231";magnesium ion homeostasis [GO:0010960];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp373078_c1_seq1;GAXK01093570.1;P29523;2.24E-134;PPB_BOMMO;Membrane-bound alkaline phosphatase (M-ALP) (EC 3.1.3.1);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]";"GO:0004035; GO:0005886; GO:0031225; GO:0046872";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]"
comp3731_c0_seq1;GAXK01175294.1;Q6Z1J6;1.07E-111;OLA1_ORYSJ;Obg-like ATPase 1 (EC 3.6.5.-) (Ribosome-binding ATPase YchF) (OsYchF1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]";"GO:0003924; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0009506; GO:0009651; GO:0016887; GO:0043022; GO:0043023; GO:0046686; GO:0046872; GO:1900425; GO:1901001";"negative regulation of defense response to bacterium [GO:1900425]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]"
comp3731173_c0_seq1;GAXK01198557.1;Q9GLZ5;2.27E-30;STRP1_MACFA;Striatin-interacting protein 1 (Protein FAM40A);"cytoplasm [GO:0005737]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604]";"GO:0005737; GO:0022604; GO:0030866";"cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604]";cytoplasm [GO:0005737];
comp3731262_c0_seq1;GAXK01198541.1;Q6ZN19;7.96E-09;ZN841_HUMAN;Zinc finger protein 841;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp373140_c0_seq1;GAXK01093710.1;Q9R069;2.64E-07;BCAM_MOUSE;Basal cell adhesion molecule (B-CAM cell surface glycoprotein) (Lutheran antigen) (CD antigen CD239);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]";"GO:0005055; GO:0005886; GO:0005887; GO:0007155; GO:0007160; GO:0008022; GO:0009986; GO:0043236";"cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; protein C-terminus binding [GO:0008022]"
comp373155_c0_seq1;GAXK01093675.1;Q9N2M8;5.43E-10;HDC_DROME;Headcase protein [Cleaved into: Headcase short protein];"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"GO:0002165; GO:0005737; GO:0007430; GO:0016246; GO:0030424; GO:0030425; GO:0035071; GO:0048471; GO:0048675; GO:0050768; GO:1904799";"axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]";
comp373188_c0_seq1;GAXK01093628.1;Q0Q028;3.90E-19;DFP3_ANTMY;Putative defense protein 3 (DFP-3);"extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";"GO:0005576; GO:0042742; GO:0042832; GO:0045087";"defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]";extracellular region [GO:0005576];
comp3731946_c0_seq1;GAXK01198538.1;P0C6F1;7.52E-26;DYH2_MOUSE;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2);"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp37325_c1_seq1;GAXK01106655.1;Q99087;0;LDLR1_XENLA;Low-density lipoprotein receptor 1 (LDL receptor 1);"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]";"GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362";"cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]";"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp373252_c0_seq1;GAXK01205430.1;P07668;9.07E-152;CLAT_DROME;"Choline O-acetyltransferase (CHOACTase) (Choline acetylase) (EC 2.3.1.6) [Cleaved into: Choline O-acetyltransferase 67 kDa chain; Choline O-acetyltransferase 54 kDa chain; Choline O-acetyltransferase 13 kDa chain]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; choline O-acetyltransferase activity [GO:0004102]; acetylcholine biosynthetic process [GO:0008292]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]";"GO:0004102; GO:0005634; GO:0005737; GO:0005829; GO:0007268; GO:0007274; GO:0007399; GO:0008292; GO:0043005";"acetylcholine biosynthetic process [GO:0008292]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]";choline O-acetyltransferase activity [GO:0004102]
comp3733141_c0_seq1;GAXK01093118.1;Q9D6P8;3.98E-15;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp373408_c1_seq1;GAXK01093655.1;O54834;6.09E-55;RHG06_MOUSE;Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0007015; GO:0007165; GO:0007202; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0043087; GO:0043274; GO:0043547; GO:0048041; GO:0051497; GO:0051895";"actin filament organization [GO:0007015]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";"GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]"
comp37349_c0_seq1;GAXK01107016.1;Q9VVS4;6.69E-39;MED11_DROME;Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) (dMED21);"mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0006366; GO:0007406; GO:0016592";"negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"mediator complex [GO:0016592]; nucleus [GO:0005634]";"transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp373524_c0_seq1;GAXK01093672.1;Q9QXN0;4.73E-13;SHRM3_MOUSE;Protein Shroom3;"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; columnar/cuboidal epithelial cell development [GO:0002066]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"GO:0000902; GO:0001843; GO:0002066; GO:0003779; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0045177; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; columnar/cuboidal epithelial cell development [GO:0002066]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp3735408_c0_seq1;GAXK01157707.1;P48994;2.01E-11;TRPL_DROME;Transient-receptor-potential-like protein;"cation channel complex [GO:0034703]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]; body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]";"GO:0005261; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006812; GO:0006816; GO:0006828; GO:0007589; GO:0007603; GO:0007605; GO:0009416; GO:0010461; GO:0015075; GO:0015279; GO:0016021; GO:0016027; GO:0016028; GO:0019722; GO:0030425; GO:0034703; GO:0035997; GO:0042802; GO:0046982; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:0071454";"body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]";"cation channel complex [GO:0034703]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]"
comp373550_c0_seq1;GAXK01093592.1;Q9BN01;1.81E-139;AMYB_DROYA;Alpha-amylase B (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase);"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]";"GO:0004556; GO:0005975; GO:0046872; GO:0103025";carbohydrate metabolic process [GO:0005975];;"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]"
comp3735592_c0_seq1;GAXK01157702.1;Q1H9T6;2.46E-14;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp373606_c2_seq1;GAXK01093716.1;O08605;1.09E-113;MKNK1_MOUSE;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translational initiation [GO:0006446]; response to salt stress [GO:0009651]";"GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006446; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872; GO:0097192";"extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translational initiation [GO:0006446]; response to salt stress [GO:0009651]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp3736261_c0_seq1;GAXK01197876.1;F6Z5C0;6.05E-29;UBP15_XENTR;Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389";"BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp3736266_c0_seq1;GAXK01197874.1;Q96EX2;1.01E-09;RNFT2_HUMAN;RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]";"GO:0016021; GO:0046872";;integral component of membrane [GO:0016021];metal ion binding [GO:0046872]
comp3736327_c0_seq1;GAXK01197881.1;Q6AZB8;2.14E-13;HARB1_DANRE;Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]";"GO:0004518; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
comp3736431_c0_seq1;GAXK01197850.1;P02599;7.37E-22;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp37366_c4_seq1;GAXK01106765.1;Q6NU46;2.59E-127;THILA_XENLA;Acetyl-CoA acetyltransferase A, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase A);"mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]";"GO:0003985; GO:0005739; GO:0006635; GO:0046872";fatty acid beta-oxidation [GO:0006635];mitochondrion [GO:0005739];"acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872]"
comp3737_c1_seq1;GAXK01176547.1;Q9GRW0;1.03E-89;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3737165_c0_seq1;GAXK01197869.1;Q9V427;2.19E-48;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp3737379_c0_seq1;GAXK01197867.1;Q23716;9.68E-45;EF2_CRYPV;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp373750_c0_seq1;GAXK01093558.1;Q7KRI2;2.97E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3737755_c0_seq1;GAXK01197852.1;Q7KRI2;6.45E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp37378_c0_seq1;GAXK01107034.1;Q05086;0;UBE3A_HUMAN;Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54);"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0016032; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042220; GO:0042542; GO:0042752; GO:0043161; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0070936; GO:1990416; GO:2000058";"androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";"metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp373794_c0_seq1;GAXK01093607.1;Q5XGA9;5.00E-12;NAA50_XENTR;N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase NAT13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]";"GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0071962";"establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]";"H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]"
comp3738071_c0_seq1;GAXK01156942.1;Q90YR8;5.61E-89;RS6_ICTPU;40S ribosomal protein S6;"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; structural constituent of ribosome [GO:0003735]; glucose homeostasis [GO:0042593]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0006412; GO:0022627; GO:0042593; GO:0048471";"glucose homeostasis [GO:0042593]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";structural constituent of ribosome [GO:0003735]
comp3738193_c0_seq1;GAXK01156946.1;Q06827;6.21E-71;CATR_SCHDU;Caltractin (Centrin);"calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005509; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";;calcium ion binding [GO:0005509]
comp37382_c9_seq1;GAXK01106908.1;Q9YHD3;1.33E-23;BAG6A_XENLA;Large proline-rich protein bag6-A (BCL2-associated athanogene 6) (HLA-B-associated transcript 3-A) (Protein Scythe);"BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001822; GO:0005634; GO:0005829; GO:0006325; GO:0006511; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0018393; GO:0030324; GO:0030433; GO:0031593; GO:0032435; GO:0042771; GO:0043022; GO:0045861; GO:0045995; GO:0050821; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818";"brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]"
comp3739_c0_seq1;GAXK01175709.1;Q9I8F9;1.62E-66;HSP71_ORYLA;Heat shock 70 kDa protein 1 (HSP70-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005829; GO:0006986; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp3739217_c0_seq1;GAXK01156937.1;Q0UI93;8.91E-23;DCL1_PHANO;"Dicer-like protein 1 [Includes: Endoribonuclease DCL1 (EC 3.1.26.-); ATP-dependent helicase DCL1 (EC 3.6.4.-)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688]";"GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016442; GO:0030422; GO:0046872; GO:0050688; GO:0051607";"defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]"
comp3739230_c0_seq1;GAXK01156943.1;B4MYA4;3.79E-18;TRET1_DROWI;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3739251_c0_seq1;GAXK01156951.1;Q2TBP2;6.19E-10;HINFP_BOVIN;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3739261_c0_seq1;GAXK01156934.1;Q8VHE6;0;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp373977_c0_seq1;GAXK01093707.1;Q7KRI2;6.05E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3740229_c0_seq1;GAXK01061672.1;P0DKX0;1.14E-07;ZN728_HUMAN;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3740556_c0_seq1;GAXK01061666.1;P83088;2.13E-42;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp3740626_c0_seq1;GAXK01061650.1;O96006;1.56E-09;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp3740770_c0_seq1;GAXK01061651.1;O82574;1.45E-48;RL21_CYAPA;60S ribosomal protein L21;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp37411_c11_seq1;GAXK01107028.1;Q7SXP2;2.07E-179;ULA1_DANRE;NEDD8-activating enzyme E1 regulatory subunit (APP-BP1) (Amyloid protein-binding protein 1);"cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]";"GO:0005737; GO:0019781; GO:0032446; GO:0045116";"protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]";cytoplasm [GO:0005737];NEDD8 activating enzyme activity [GO:0019781]
comp374270_c0_seq1;GAXK01063582.1;P46575;1.95E-16;RL40_EIMBO;"Ubiquitin-60S ribosomal protein L40 (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52) (CEP53)]";"nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp37428_c0_seq1;GAXK01106838.1;Q0V8M0;7.84E-91;KRI1_BOVIN;Protein KRI1 homolog;"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]";"GO:0000447; GO:0005730; GO:0030686";endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447];"90S preribosome [GO:0030686]; nucleolus [GO:0005730]";
comp374286_c2_seq1;GAXK01063669.1;Q924N9;1.31E-25;PRS28_MOUSE;Serine protease 28 (EC 3.4.21.-) (Implantation serine proteinase 1) (ISP-1) (Strypsin) (Tryptase-like proteinase);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"GO:0001835; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007566; GO:0008236; GO:0046982";"blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp374316_c0_seq1;GAXK01063698.1;Q61830;1.13E-14;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp3743220_c0_seq1;GAXK01050598.1;Q6P5F6;2.09E-10;S39AA_MOUSE;Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]";"GO:0002903; GO:0005385; GO:0005886; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615";"cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp374436_c0_seq1;GAXK01063729.1;Q95ZS2;0;TDC1_CAEEL;Tyrosine decarboxylase (EC 4.1.1.25);"axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]; cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]";"GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0030170; GO:0030424; GO:0043025; GO:0043204";"cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]";"axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]";"pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]"
comp3744388_c0_seq1;GAXK01000365.1;Q80X44;2.70E-07;ZBT24_MOUSE;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Brain-specific protein 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3744557_c0_seq1;GAXK01000368.1;P23098;6.06E-73;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3745346_c0_seq1;GAXK01000353.1;P16157;2.25E-14;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp374542_c0_seq1;GAXK01063755.1;Q21882;2.18E-22;HIUH1_CAEEL;Probable 5-hydroxyisourate hydrolase R09H10.3 (HIU hydrolase) (HIUHase) (EC 3.5.2.17) (Transthyretin-like protein R09H10.3);"hydroxyisourate hydrolase activity [GO:0033971]; identical protein binding [GO:0042802]; purine nucleobase metabolic process [GO:0006144]";"GO:0006144; GO:0033971; GO:0042802";purine nucleobase metabolic process [GO:0006144];;"hydroxyisourate hydrolase activity [GO:0033971]; identical protein binding [GO:0042802]"
comp374560_c0_seq1;GAXK01063719.1;Q9D404;3.90E-121;OXSM_MOUSE;3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]";"GO:0004315; GO:0005739; GO:0005829; GO:0006633; GO:0006637; GO:0051790; GO:0051792";"acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]
comp3745601_c0_seq1;GAXK01000364.1;P97353;7.57E-10;SEC1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp3745833_c0_seq1;GAXK01000345.1;Q5D1D6;3.13E-08;GBP1_CHLAE;Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607";"defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp37459_c0_seq1;GAXK01107045.1;Q9NPI1;1.40E-31;BRD7_HUMAN;Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]";"GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007049; GO:0008134; GO:0008285; GO:0016055; GO:0035066; GO:0042393; GO:0044212; GO:0045892; GO:0045893; GO:0070577; GO:1901796; GO:2000134";"cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp3746422_c0_seq1;GAXK01024783.1;Q6ZN08;1.45E-07;ZNF66_HUMAN;Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3746438_c0_seq1;GAXK01024782.1;Q86GC8;1.11E-17;ACES_CULPI;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp3747089_c0_seq1;GAXK01024777.1;Q8N6D5;7.94E-12;ANR29_HUMAN;Ankyrin repeat domain-containing protein 29;;;;;
comp3747357_c0_seq1;GAXK01024768.1;Q86YD5;6.49E-07;LRAD3_HUMAN;Low-density lipoprotein receptor class A domain-containing protein 3 (LDLR class A domain-containing protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; receptor-mediated endocytosis [GO:0006898]; regulation of protein processing [GO:0070613]";"GO:0001540; GO:0005886; GO:0006898; GO:0016021; GO:0070613";"receptor-mediated endocytosis [GO:0006898]; regulation of protein processing [GO:0070613]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";amyloid-beta binding [GO:0001540]
comp3748_c0_seq1;GAXK01175338.1;Q08747;1.04E-14;UAF30_YEAST;Upstream activation factor subunit UAF30 (Upstream activation factor 30 KDa subunit) (p30);"nucleolus [GO:0005730]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]; chromatin organization [GO:0006325]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]";"GO:0000500; GO:0001165; GO:0001181; GO:0005730; GO:0006325; GO:0042790";"chromatin organization [GO:0006325]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]";"nucleolus [GO:0005730]; RNA polymerase I upstream activating factor complex [GO:0000500]";"RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]"
comp3748163_c0_seq1;GAXK01203418.1;O01382;4.87E-65;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp374846_c1_seq1;GAXK01063707.1;Q6ZMW2;2.32E-58;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3748568_c0_seq1;GAXK01203393.1;Q16960;2.25E-107;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp374894_c1_seq1;GAXK01063751.1;Q0VAW7;2.01E-25;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3749129_c0_seq1;GAXK01203420.1;O94875;2.63E-14;SRBS2_HUMAN;Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]";"GO:0003723; GO:0005200; GO:0005634; GO:0005654; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0048471; GO:0061049";"actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";"cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]"
comp3749349_c0_seq1;GAXK01203391.1;P31674;3.30E-59;RS15_ORYSJ;40S ribosomal protein S15;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp374935_c0_seq1;GAXK01063620.1;P51523;3.64E-21;ZNF84_HUMAN;Zinc finger protein 84 (Zinc finger protein HPF2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp3749475_c0_seq1;GAXK01203421.1;P13060;7.04E-54;EF2_DROME;Elongation factor 2 (EF-2);"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp37496_c1_seq1;GAXK01107509.1;P26632;2.25E-07;EGR1_DANRE;Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841";"camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp374987_c0_seq1;GAXK01063635.1;P25490;1.03E-36;TYY1_HUMAN;Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1);"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0000400; GO:0000724; GO:0000790; GO:0000978; GO:0000980; GO:0000981; GO:0000987; GO:0001158; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010629; GO:0016363; GO:0016579; GO:0030154; GO:0031011; GO:0031519; GO:0032688; GO:0034644; GO:0034696; GO:0043565; GO:0044212; GO:0045944; GO:0046332; GO:0048593; GO:0051276; GO:0061052; GO:0071347; GO:1902894";"anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp375117_c0_seq1;GAXK01063651.1;Q64018;4.05E-29;GLRA1_MOUSE;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0043576; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0050905; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp375123_c1_seq1;GAXK01063663.1;Q91677;1.16E-35;GATA4_XENLA;Transcription factor GATA-4 (GATA-binding factor 4) (xGATA-4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0048738";"cardiac muscle tissue development [GO:0048738]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp375130_c1_seq1;GAXK01063650.1;Q9BZ67;5.00E-66;FRMD8_HUMAN;FERM domain-containing protein 8 (Band4.1 inhibitor LRP interactor) (Bili) (iRhom tail-associated protein) (iTAP);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; positive regulation of tumor necrosis factor secretion [GO:1904469]";"GO:0005829; GO:0005856; GO:0005886; GO:1904469";positive regulation of tumor necrosis factor secretion [GO:1904469];"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp3751789_c0_seq1;GAXK01127411.1;Q7Z2Y8;2.40E-09;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp37518_c0_seq1;GAXK01107009.1;A0JN61;8.35E-13;RPC9_BOVIN;DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9);"DNA polymerase III complex [GO:0009360]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"GO:0000166; GO:0003899; GO:0005666; GO:0005886; GO:0006383; GO:0006384; GO:0009360; GO:0045087; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"DNA polymerase III complex [GO:0009360]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]"
comp3752595_c0_seq1;GAXK01079998.1;Q568Y5;2.59E-07;TSN11_RAT;Tetraspanin-11 (Tspan-11);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp37529_c0_seq1;GAXK01107499.1;Q9VMV6;2.65E-11;SELT_DROME;Thioredoxin reductase-like selenoprotein T homolog CG3887 (EC 1.8.1.9);"endomembrane system [GO:0012505]; thioredoxin-disulfide reductase activity [GO:0004791]";"GO:0004791; GO:0012505";;endomembrane system [GO:0012505];thioredoxin-disulfide reductase activity [GO:0004791]
comp3752913_c0_seq1;GAXK01079984.1;Q14DK5;7.32E-13;HIPL1_MOUSE;HHIP-like protein 1;"extracellular region [GO:0005576]; membrane [GO:0016020]; catalytic activity [GO:0003824]; scavenger receptor activity [GO:0005044]";"GO:0003824; GO:0005044; GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";"catalytic activity [GO:0003824]; scavenger receptor activity [GO:0005044]"
comp37533_c0_seq1;GAXK01106874.1;Q24562;4.34E-180;U2AF2_DROME;Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit);"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701";"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; U2-type prespliceosome [GO:0071004]";"mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]"
comp375361_c0_seq1;GAXK01063696.1;Q16TM5;1.61E-38;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3753791_c0_seq1;GAXK01080003.1;P21439;1.89E-101;MDR3_HUMAN;Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; ceramide translocation [GO:0099040]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; regulation of lipid metabolic process [GO:0019216]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0019216; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0099040; GO:1901557; GO:1903413; GO:2001140";"bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; ceramide translocation [GO:0099040]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; regulation of lipid metabolic process [GO:0019216]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid transporter activity [GO:0005548]"
comp37539_c0_seq1;GAXK01106716.1;O46040;1.45E-19;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp375449_c0_seq1;GAXK01063646.1;Q9CQR4;4.46E-28;ACO13_MOUSE;Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Thioesterase superfamily member 2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]";"GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0047617; GO:0051289; GO:0120163";"negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]";acyl-CoA hydrolase activity [GO:0047617]
comp37547_c0_seq1;GAXK01107525.1;Q148C8;7.52E-14;MIEN1_BOVIN;Migration and invasion enhancer 1;"cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491]; response to selenium ion [GO:0010269]";"GO:0005829; GO:0006915; GO:0010269; GO:0030335; GO:0031235; GO:0043066; GO:0051491";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491]; response to selenium ion [GO:0010269]";"cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]";
comp3754781_c0_seq1;GAXK01045049.1;P48166;1.25E-30;RL36A_CAEEL;Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3754832_c0_seq1;GAXK01045053.1;P61256;2.34E-39;RL26_MACFA;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0006977; GO:0015934; GO:0071479; GO:1902167";"cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; translation [GO:0006412]";large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp375567_c1_seq1;GAXK01063581.1;Q0P5H1;1.61E-07;PCYXL_BOVIN;Prenylcysteine oxidase-like (EC 1.8.3.-);"extracellular region [GO:0005576]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]";"GO:0001735; GO:0005576; GO:0030327; GO:0030328";"prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]";extracellular region [GO:0005576];prenylcysteine oxidase activity [GO:0001735]
comp375629_c0_seq1;GAXK01063697.1;Q60821;2.43E-13;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp3756530_c0_seq1;GAXK01052557.1;Q4WLV6;4.43E-24;FKB1A_ASPFU;FK506-binding protein 1A (FKBP) (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rapamycin-binding protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp3756676_c0_seq1;GAXK01052551.1;Q54RX6;1.78E-21;TCTP1_DICDI;Translationally-controlled tumor protein homolog 1 (TCTP 1);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005737";;cytoplasm [GO:0005737];calcium ion binding [GO:0005509]
comp3757_c0_seq1;GAXK01175252.1;Q9XZ71;9.46E-08;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp3757010_c0_seq1;GAXK01052549.1;P30974;1.64E-36;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp3757118_c0_seq1;GAXK01052572.1;P17078;1.78E-32;RL35_RAT;60S ribosomal protein L35;"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625; GO:0043021; GO:0071493";"cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp3757132_c0_seq1;GAXK01052547.1;P17970;1.72E-41;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp375719_c1_seq1;GAXK01063720.1;Q6ZUJ8;2.72E-21;BCAP_HUMAN;Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1);"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]";"GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727; GO:0051897";"positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]";"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]"
comp3758599_c0_seq1;GAXK01001853.1;Q8MKK4;9.17E-36;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp375929_c3_seq1;GAXK01063702.1;P31729;1.53E-17;OV16_ONCVO;OV-16 antigen;;;;;
comp3759527_c0_seq1;GAXK01001883.1;Q9NYC9;4.60E-41;DYH9_HUMAN;Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0097729; GO:0120135";"cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp376_c0_seq1;GAXK01168700.1;Q8ISP0;1.97E-52;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3760062_c0_seq1;GAXK01105837.1;A8CAG3;7.50E-97;RL17_PHLPP;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp3760098_c0_seq1;GAXK01105817.1;A0JND4;6.53E-12;SBNO2_BOVIN;Protein strawberry notch homolog 2;"nucleus [GO:0005634]; cellular response to interleukin-6 [GO:0071354]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]";"GO:0001503; GO:0002281; GO:0005634; GO:0030316; GO:0045892; GO:0045944; GO:0050727; GO:0071354";"cellular response to interleukin-6 [GO:0071354]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]";nucleus [GO:0005634];
comp3760855_c0_seq1;GAXK01105828.1;Q9P225;2.99E-17;DYH2_HUMAN;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp376094_c0_seq1;GAXK01062766.1;Q9VXN0;4.02E-122;GTDC1_DROME;Glycosyltransferase-like domain-containing protein 1-like;transferase activity, transferring glycosyl groups [GO:0016757];GO:0016757;;;transferase activity, transferring glycosyl groups [GO:0016757]
comp3761185_c0_seq1;GAXK01105846.1;Q08890;4.57E-32;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp3761395_c0_seq1;GAXK01105832.1;Q60519;5.91E-10;SEM5B_MOUSE;Semaphorin-5B (Semaphorin-G) (Sema G);"integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001755; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485; GO:1990138";"axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";integral component of membrane [GO:0016021];"chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]"
comp376162_c0_seq1;GAXK01062718.1;P52192;4.74E-70;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp3761847_c0_seq1;GAXK01105835.1;O55123;5.77E-18;MMP10_MOUSE;Stromelysin-2 (SL-2) (EC 3.4.24.22) (Matrix metalloproteinase-10) (MMP-10) (Transin-2);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; regulation of cell migration [GO:0030334]";"GO:0004222; GO:0005615; GO:0008270; GO:0030198; GO:0030334; GO:0030574; GO:0031012";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; regulation of cell migration [GO:0030334]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp376188_c0_seq1;GAXK01062668.1;O08701;2.61E-75;ARGI2_RAT;Arginase-2, mitochondrial (EC 3.5.3.1) (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; nitric-oxide synthase binding [GO:0050998]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; arginine catabolic process to ornithine [GO:0019547]; arginine metabolic process [GO:0006525]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; midgut development [GO:0007494]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of striated muscle contraction [GO:0045988]; regulation of L-arginine import [GO:0010963]; regulation of nitric oxide biosynthetic process [GO:0045428]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197]; urea cycle [GO:0000050]";"GO:0000050; GO:0001666; GO:0002250; GO:0004053; GO:0005737; GO:0005739; GO:0006525; GO:0006915; GO:0007494; GO:0007584; GO:0009635; GO:0009725; GO:0009749; GO:0010269; GO:0010963; GO:0014075; GO:0019547; GO:0030145; GO:0030324; GO:0033197; GO:0042493; GO:0043200; GO:0045428; GO:0045988; GO:0046686; GO:0046689; GO:0048678; GO:0050998; GO:0051001; GO:0060135; GO:0071222; GO:0071346; GO:0071353; GO:0071549";"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; arginine catabolic process to ornithine [GO:0019547]; arginine metabolic process [GO:0006525]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; midgut development [GO:0007494]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of striated muscle contraction [GO:0045988]; regulation of L-arginine import [GO:0010963]; regulation of nitric oxide biosynthetic process [GO:0045428]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197]; urea cycle [GO:0000050]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; nitric-oxide synthase binding [GO:0050998]"
comp376205_c1_seq1;GAXK01062764.1;P13903;8.21E-30;TWIST_XENLA;Twist-related protein (T18) (X-twist);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; neural crest formation [GO:0014029]";"GO:0003677; GO:0005634; GO:0014029; GO:0046983";neural crest formation [GO:0014029];nucleus [GO:0005634];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp3762383_c0_seq1;GAXK01086253.1;P82013;5.47E-131;VDAC2_MELGA;Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2);"mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]";"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930";;"mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]";"nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]"
comp376251_c1_seq1;GAXK01062646.1;P52556;1.28E-11;BLVRB_BOVIN;Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]";"GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602";heme catabolic process [GO:0042167];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]"
comp376253_c0_seq1;GAXK01062768.1;Q26492;2.07E-10;ITPL_SCHGR;Ion transport peptide-like;"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]";"GO:0005184; GO:0005576";;extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp3762841_c0_seq1;GAXK01086250.1;P17970;3.77E-37;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp376299_c0_seq1;GAXK01062749.1;Q7TSV3;2.18E-86;ZMY19_RAT;Zinc finger MYND domain-containing protein 19 (Melanin-concentrating hormone receptor 1-interacting zinc finger protein) (MCH-R1-interacting zinc finger protein);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]; metal ion binding [GO:0046872]";"GO:0005737; GO:0005886; GO:0045202; GO:0046872";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]";metal ion binding [GO:0046872]
comp3763304_c0_seq1;GAXK01086260.1;P02599;5.36E-32;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp376333_c1_seq1;GAXK01062670.1;P0CB49;1.31E-72;YLPM1_RAT;YLP motif-containing protein 1 (Nuclear protein ZAP3);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; regulation of telomere maintenance [GO:0032204]";"GO:0005634; GO:0016607; GO:0032204";regulation of telomere maintenance [GO:0032204];"nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp376360_c1_seq1;GAXK01062767.1;Q95V58;1.67E-154;KARG_ARTSF;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp376367_c0_seq1;GAXK01062746.1;P09645;8.86E-122;TBA8_CHICK;Tubulin alpha-8 chain (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp3763716_c0_seq1;GAXK01086261.1;Q96JB1;1.50E-54;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp3764039_c0_seq1;GAXK01159576.1;Q93127;6.43E-12;GPR18_AMPAM;Probable G-protein coupled receptor No18;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp3764115_c0_seq1;GAXK01159580.1;P23641;1.08E-76;MPCP_YEAST;Mitochondrial phosphate carrier protein (Mitochondrial import receptor) (Phosphate transport protein) (PTP) (mPic 1) (p32) [Cleaved into: Mitochondrial phosphate carrier protein, N-terminally processed];"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005739; GO:0005743; GO:0005758; GO:0031305; GO:0035435";phosphate ion transmembrane transport [GO:0035435];"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";inorganic phosphate transmembrane transporter activity [GO:0005315]
comp376418_c0_seq1;GAXK01062752.1;Q9Y0A7;2.34E-12;AMOS_DROME;Basic helix-loop-helix transcription factor amos (Absent MD neurons and olfactory sensilla protein) (Amos protein) (Reduced olfactory organs protein) (Rough eye protein);"nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; dendrite morphogenesis [GO:0048813]; sensory organ boundary specification [GO:0008052]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]";"GO:0005634; GO:0007423; GO:0008052; GO:0016360; GO:0046982; GO:0048813";"dendrite morphogenesis [GO:0048813]; sensory organ boundary specification [GO:0008052]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]";nucleus [GO:0005634];protein heterodimerization activity [GO:0046982]
comp37644_c2_seq1;GAXK01106684.1;Q969X6;1.33E-85;UTP4_HUMAN;U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component);"90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]";"GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0006364; GO:0030490; GO:0030686; GO:0032040; GO:0034455";"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]";RNA binding [GO:0003723]
comp3764766_c0_seq1;GAXK01159574.1;G5EBR3;7.92E-08;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp37655_c0_seq1;GAXK01107054.1;Q80TP3;1.34E-21;UBR5_MOUSE;E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647]";"GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:1905077; GO:2000780";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]"
comp37657_c1_seq1;GAXK01106902.1;Q9V427;1.74E-103;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp376616_c0_seq1;GAXK01062772.1;P91685;1.21E-07;GRM_DROME;Metabotropic glutamate receptor (DmGluRA);"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553";"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp376624_c1_seq1;GAXK01062643.1;Q94901;2.34E-07;LARK_DROME;RNA-binding protein lark;"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"GO:0000278; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0007303; GO:0007562; GO:0007623; GO:0008062; GO:0008104; GO:0008270; GO:0009792; GO:0016607; GO:0030036; GO:0042752; GO:0045292; GO:0045475; GO:0045804; GO:0045995; GO:0071011; GO:0071013; GO:2000767";"actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp376642_c0_seq1;GAXK01062765.1;Q9CXR1;2.27E-49;DHRS7_MOUSE;Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp376645_c0_seq1;GAXK01062640.1;Q2KI41;1.27E-07;CYH2_BOVIN;Cytohesin-2 (PH, SEC7 and coiled-coil domain-containing protein 2);"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005737; GO:0005886; GO:0008289; GO:0030426; GO:0032012; GO:0070679";regulation of ARF protein signal transduction [GO:0032012];"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"
comp3767560_c0_seq1;GAXK01110583.1;Q9JHE4;2.25E-18;G3ST1_MOUSE;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0001733; GO:0006682; GO:0007283; GO:0009247; GO:0016021; GO:0042552";"galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp3767741_c0_seq1;GAXK01110584.1;O61370;6.20E-10;NACH_DROAN;Sodium channel protein Nach;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp3768506_c0_seq1;GAXK01135488.1;G5EBR3;3.58E-10;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp3768882_c0_seq1;GAXK01135495.1;Q18297;8.60E-44;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp37689_c0_seq1;GAXK01106752.1;Q5R1W5;3.90E-29;SRSF2_PANTR;Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp376915_c0_seq1;GAXK01062685.1;P74615;6.27E-17;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp3769756_c0_seq1;GAXK01135494.1;Q8TE56;1.12E-08;ATS17_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676]"
comp376987_c1_seq1;GAXK01062742.1;Q9ERC5;6.47E-158;OTOF_RAT;Otoferlin (Fer-1-like protein 2);"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007605; GO:0016021; GO:0016079; GO:0016323; GO:0030054; GO:0030672; GO:0044877; GO:0045177; GO:0045178; GO:0090102";"cochlea development [GO:0090102]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]"
comp376990_c0_seq1;GAXK01062663.1;Q9PT61;2.37E-12;OTX5B_XENLA;Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0009952; GO:0042706; GO:0043565; GO:0045872; GO:0045893; GO:0045944";"anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp37700_c0_seq1;GAXK01107177.1;Q6ZZY0;2.61E-172;CRY1_SYLBO;Cryptochrome-1;"cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381";"circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]";"nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]"
comp3770098_c0_seq1;GAXK01158974.1;P0DJ14;4.55E-87;RL7A_TETTH;60S ribosomal protein L7a;"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp3770360_c0_seq1;GAXK01158965.1;P45481;2.33E-49;CBP_MOUSE;CREB-binding protein (EC 2.3.1.48);"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0000122; GO:0000123; GO:0000790; GO:0000940; GO:0000977; GO:0000987; GO:0001085; GO:0001093; GO:0002039; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0008134; GO:0008140; GO:0008270; GO:0008283; GO:0010628; GO:0016407; GO:0016573; GO:0016604; GO:0016605; GO:0018076; GO:0019904; GO:0030511; GO:0030718; GO:0031648; GO:0032793; GO:0032991; GO:0033613; GO:0034644; GO:0035729; GO:0042975; GO:0043426; GO:0045358; GO:0045893; GO:0045944; GO:0046332; GO:0046982; GO:0048511; GO:0048525; GO:0051091; GO:0060325; GO:0060355; GO:0061733; GO:0090575; GO:0097718; GO:0098586; GO:1900087; GO:1901224";"cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp377041_c0_seq1;GAXK01062648.1;Q53G59;2.22E-19;KLH12_HUMAN;Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR);"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0005815; GO:0005829; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0042802; GO:0043231; GO:0048208; GO:0090090";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]";identical protein binding [GO:0042802]
comp377049_c0_seq1;GAXK01062751.1;Q6P9I7;2.93E-37;SMC6_XENLA;Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398";"cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp3771591_c0_seq1;GAXK01158981.1;P10401;2.63E-13;POLY_DROME;"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3771988_c0_seq1;GAXK01158984.1;Q8N1W2;2.37E-11;ZN710_HUMAN;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3772_c3_seq1;GAXK01175869.1;P46507;0;PRS6B_MANSE;26S proteasome regulatory subunit 6B (ATPase MS73);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]";"GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402";protein catabolic process [GO:0030163];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";"ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]"
comp37721_c0_seq1;GAXK01106686.1;Q91YR7;0;PRP6_MOUSE;Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";"androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]"
comp3772260_c0_seq1;GAXK01075096.1;Q2NNR5;1.43E-08;CLTR1_CAVPO;Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor);"integral component of plasma membrane [GO:0005887]; leukotriene receptor activity [GO:0004974]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; inflammatory response to antigenic stimulus [GO:0002437]";"GO:0002437; GO:0004974; GO:0005887; GO:0006816; GO:0006935; GO:0007166";"calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; inflammatory response to antigenic stimulus [GO:0002437]";integral component of plasma membrane [GO:0005887];leukotriene receptor activity [GO:0004974]
comp37723_c2_seq1;GAXK01107358.1;Q99459;0;CDC5L_HUMAN;Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]";"GO:0000278; GO:0000398; GO:0000974; GO:0000977; GO:0000981; GO:0001222; GO:0001228; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008157; GO:0016020; GO:0016607; GO:0019901; GO:0032993; GO:0043522; GO:0044344; GO:0045944; GO:0048471; GO:0071007; GO:0071013; GO:0071352; GO:0071987; GO:0072422; GO:1904568; GO:1990090; GO:1990646";"cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]"
comp3772479_c0_seq1;GAXK01075103.1;Q8I1F6;9.28E-24;PPO3_DROER;Phenoloxidase 3 (EC 1.14.18.1) (Diphenoloxidase subunit A3) (Tyrosinase A3);"extracellular region [GO:0005576]; dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";"GO:0004503; GO:0005576; GO:0035011; GO:0036263; GO:0036264; GO:0042438; GO:0046872";"melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";extracellular region [GO:0005576];"dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]"
comp3772518_c0_seq1;GAXK01075102.1;P91730;2.00E-09;GLUCB_HAECO;Glutamate-gated chloride channel subunit beta (Glu-Cl subunit beta) (Avermectin-sensitive glutamate-gated chloride channel subunit) (HG4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp3772573_c0_seq1;GAXK01075105.1;P25169;6.21E-19;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp37728_c0_seq1;GAXK01107550.1;Q9CRA8;6.61E-56;EXOS5_MOUSE;Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46);"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0035327; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051";"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";RNA binding [GO:0003723]
comp3772936_c0_seq1;GAXK01075088.1;O23755;8.65E-10;EF2_BETVU;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3773409_c0_seq1;GAXK01075109.1;Q16983;3.50E-14;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp3773772_c0_seq1;GAXK01075106.1;E3LYX0;1.57E-10;EGG1_CAERE;LDL receptor repeat-containing protein egg-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"GO:0005886; GO:0007275; GO:0007338; GO:0016021";"multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp37741_c0_seq1;GAXK01106665.1;Q91ZV7;1.63E-30;PLDX1_MOUSE;Plexin domain-containing protein 1 (Tumor endothelial marker 7);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"GO:0001525; GO:0005737; GO:0005886; GO:0005923; GO:0016021; GO:0021510; GO:0030425; GO:0043025; GO:0043235";"angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";
comp3774833_c0_seq1;GAXK01123112.1;P98072;1.64E-24;ENTK_BOVIN;"Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; protein digestion [GO:0044256]; trypsinogen activation [GO:0032023]";"GO:0004252; GO:0005044; GO:0016020; GO:0016021; GO:0032023; GO:0044256";"protein digestion [GO:0044256]; trypsinogen activation [GO:0032023]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp3774919_c0_seq1;GAXK01123116.1;B8WI85;3.79E-09;USOM7_ACRMI;Uncharacterized skeletal organic matrix protein 7 (Uncharacterized SOMP-7);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3774931_c0_seq1;GAXK01123121.1;Q9JI67;1.49E-14;B3GT5_MOUSE;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (Stage-specific embryonic antigen 3 synthase) (SSEA-3 synthase) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to bacterium [GO:0009617]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0009617; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to bacterium [GO:0009617]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp3775281_c0_seq1;GAXK01123100.1;Q70JS2;4.60E-08;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp3775670_c0_seq1;GAXK01123123.1;P14381;8.05E-09;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp377588_c0_seq1;GAXK01062683.1;Q5U2Z0;9.97E-55;ZN367_RAT;Zinc finger protein 367;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872";regulation of transcription by RNA polymerase II [GO:0006357];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp377664_c0_seq1;GAXK01062679.1;R9UTQ8;3.31E-19;PROHY_STRGD;L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]";"GO:0005506; GO:0016706; GO:0016999; GO:0017000";"antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]";;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]"
comp3776687_c0_seq1;GAXK01011110.1;B7ZSK1;2.65E-07;NMDE1_XENLA;Glutamate receptor ionotropic, NMDA 2A (GluN2A) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic membrane [GO:0045211]; glutamate-gated calcium ion channel activity [GO:0022849]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; calcium ion transmembrane import into cytosol [GO:0097553]; protein heterotetramerization [GO:0051290]; response to zinc ion [GO:0010043]";"GO:0004972; GO:0005887; GO:0010043; GO:0017146; GO:0022849; GO:0030054; GO:0045211; GO:0046872; GO:0051290; GO:0097553";"calcium ion transmembrane import into cytosol [GO:0097553]; protein heterotetramerization [GO:0051290]; response to zinc ion [GO:0010043]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic membrane [GO:0045211]";"glutamate-gated calcium ion channel activity [GO:0022849]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]"
comp37768_c3_seq1;GAXK01106654.1;O08810;0;U5S1_MOUSE;116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa);"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016607; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:1990904";mRNA splicing, via spliceosome [GO:0000398];"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]"
comp3777595_c0_seq1;GAXK01011120.1;P34298;4.41E-15;DOXA1_CAEEL;Dual oxidase maturation factor 1;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0005789; GO:0015031; GO:0016021";protein transport [GO:0015031];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp377802_c1_seq1;GAXK01062678.1;Q9U8W7;1.88E-60;TL5B_TACTR;Techylectin-5B;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp3778070_c0_seq1;GAXK01108039.1;Q42395;1.84E-34;FCP_TRICV;Fucoxanthin-chlorophyll a-c binding protein, chloroplastic (FCP);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp37782_c0_seq1;GAXK01106682.1;Q8SX83;3.77E-59;SPEN_DROME;Protein split ends;"nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222]";"GO:0003723; GO:0005634; GO:0006351; GO:0006355; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263";"axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222]";nucleus [GO:0005634];RNA binding [GO:0003723]
comp3778834_c0_seq1;GAXK01108047.1;Q32KH7;2.27E-15;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp377892_c0_seq1;GAXK01062710.1;Q6PT52;1.85E-81;CLCA1_MACMU;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp377987_c0_seq1;GAXK01062756.1;P07463;3.98E-18;CALM_PARTE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp378_c1_seq1;GAXK01170218.1;Q9VWH4;0;IDH3A_DROME;Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp378005_c0_seq1;GAXK01065055.1;Q95XG9;2.36E-46;OXDA_CAEEL;D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3);"cytoplasm [GO:0005737]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]";"GO:0003884; GO:0005737; GO:0005777; GO:0007275; GO:0019478; GO:0055114; GO:0071949";"D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]";"cytoplasm [GO:0005737]; peroxisome [GO:0005777]";"D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]"
comp37803_c2_seq1;GAXK01107015.1;Q3MHR0;6.72E-54;LYPA1_BOVIN;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0006631; GO:0008474; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp3780739_c0_seq1;GAXK01179940.1;Q5R5U3;3.02E-17;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp37808_c0_seq1;GAXK01107501.1;Q8R4F0;2.26E-106;MCLN3_MOUSE;Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3);"autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]";"GO:0000421; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016021; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345";"inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]";"autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171]";"lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]"
comp37811_c0_seq1;GAXK01106745.1;Q91W90;1.34E-24;TXND5_MOUSE;Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46);"endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]";"GO:0005788; GO:0016853; GO:0043277; GO:0045454";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]";endoplasmic reticulum lumen [GO:0005788];isomerase activity [GO:0016853]
comp3781411_c0_seq1;GAXK01179933.1;Q9NBX4;9.64E-11;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp378172_c0_seq1;GAXK01065085.1;Q91994;5.60E-24;OTX1B_DANRE;Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]";"GO:0003406; GO:0003700; GO:0005634; GO:0042472; GO:0043565; GO:0060875";"inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp378186_c0_seq1;GAXK01065117.1;Q01069;1.50E-33;ESMB_DROME;Enhancer of split mbeta protein (E(spl)mbeta) (HLH-mbeta) (Split locus enhancer protein mA);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0043565; GO:0046983; GO:0050767; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp3781915_c0_seq1;GAXK01179953.1;Q86LG1;2.72E-12;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp3783_c2_seq1;GAXK01175374.1;Q7ZUW2;0;HYOU1_DANRE;Hypoxia up-regulated protein 1;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]";"GO:0005524; GO:0005783; GO:0005788; GO:0034663; GO:0071456; GO:1903298";"cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]";ATP binding [GO:0005524]
comp378305_c0_seq1;GAXK01065121.1;Q92820;9.17E-53;GGH_HUMAN;Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase);"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0005829; GO:0008238; GO:0008242; GO:0010043; GO:0032868; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0043312; GO:0045471; GO:0046900; GO:0070062; GO:1904724";"neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]";"exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]"
comp378312_c0_seq1;GAXK01065054.1;P0DSM7;2.20E-51;TPM02_PERAM;Tropomyosin Per a 7.0102 (Major allergen Per a 7) (allergen Per a 7.0102);"protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0042803";regulation of muscle contraction [GO:0006937];;protein homodimerization activity [GO:0042803]
comp378318_c4_seq1;GAXK01065059.1;P52746;5.80E-10;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp37836_c0_seq1;GAXK01107564.1;Q9Z2Z6;1.57E-79;MCAT_MOUSE;Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0015227; GO:0016021; GO:1902603";"carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp37839_c1_seq1;GAXK01107029.1;Q24168;1.16E-108;ORC2_DROME;Origin recognition complex subunit 2 (DmORC2);"alpha-heterochromatin [GO:0005723]; heterochromatin [GO:0000792]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; cell population proliferation [GO:0008283]; chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA-dependent DNA replication [GO:0006261]; eggshell chorion gene amplification [GO:0007307]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]";"GO:0000792; GO:0003682; GO:0003688; GO:0005634; GO:0005664; GO:0005723; GO:0006260; GO:0006261; GO:0006270; GO:0007052; GO:0007076; GO:0007307; GO:0008283; GO:0030261";"cell population proliferation [GO:0008283]; chromosome condensation [GO:0030261]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; eggshell chorion gene amplification [GO:0007307]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]";"alpha-heterochromatin [GO:0005723]; heterochromatin [GO:0000792]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]"
comp3784_c0_seq1;GAXK01175160.1;Q9W141;1.95E-44;ATPK_DROME;Putative ATP synthase subunit f, mitochondrial;"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]";"GO:0000276; GO:0005739; GO:0006754; GO:1902600";"ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";
comp378471_c0_seq1;GAXK01065122.1;P34410;4.18E-16;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp3784770_c0_seq1;GAXK01080971.1;Q02156;8.49E-26;KPCE_HUMAN;Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"GO:0002281; GO:0003785; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030168; GO:0030546; GO:0030838; GO:0031397; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043278; GO:0043410; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:1903078; GO:2000650; GO:2001031";"apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]"
comp3785120_c0_seq1;GAXK01080973.1;Q86WZ6;7.18E-10;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3785622_c0_seq1;GAXK01080970.1;O13755;1.21E-70;OSM1_SCHPO;Fumarate reductase (FRDS) (EC 1.3.1.6) (FAD-dependent oxidoreductase) (NADH-dependent fumarate reductase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fumarate reductase (NADH) activity [GO:0016156]; succinate dehydrogenase activity [GO:0000104]; fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005634; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0016156";"fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"fumarate reductase (NADH) activity [GO:0016156]; succinate dehydrogenase activity [GO:0000104]"
comp3785946_c0_seq1;GAXK01080972.1;Q5JVG2;1.15E-14;ZN484_HUMAN;Zinc finger protein 484;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp378611_c2_seq1;GAXK01065069.1;Q99LR1;5.30E-19;ABD12_MOUSE;Lysophosphatidylserine lipase ABHD12 (EC 3.1.1.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005739; GO:0005789; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651";"acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]"
comp3786113_c0_seq1;GAXK01002704.1;P49693;1.34E-50;RL193_ARATH;60S ribosomal protein L19-3;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp378638_c0_seq1;GAXK01065144.1;Q26636;3.54E-34;CATL_SARPE;"Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]";"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005764; GO:0007275; GO:0008234; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp3787077_c0_seq1;GAXK01002691.1;Q13127;9.38E-21;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp378771_c3_seq1;GAXK01065113.1;Q8RY16;8.64E-94;PEX6_ARATH;Peroxisome biogenesis protein 6 (Peroxin-6) (AtPEX6);"cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]";"GO:0005524; GO:0005778; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0016558; GO:0016887";"fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]";"cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp3788_c0_seq1;GAXK01176669.1;O14593;8.06E-34;RFXK_HUMAN;DNA-binding protein RFXANK (Ankyrin repeat family A protein 1) (Regulatory factor X subunit B) (RFX-B) (Regulatory factor X-associated ankyrin-containing protein);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005829; GO:0007265; GO:0042826; GO:0045171; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]";"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; transcription coregulator activity [GO:0003712]"
comp3788166_c0_seq1;GAXK01040791.1;O16797;3.49E-73;RL3_DROME;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3788823_c0_seq1;GAXK01040779.1;Q95RI5;2.30E-32;FAXC_DROME;Failed axon connections;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"GO:0005737; GO:0005886; GO:0007409; GO:0036099";"axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";
comp3789_c0_seq1;GAXK01175271.1;Q9VAL0;2.43E-26;SPCS1_DROME;Signal peptidase complex subunit 1 (EC 3.4.-.-) (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit);"integral component of endoplasmic reticulum membrane [GO:0030176]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"GO:0005787; GO:0006465; GO:0008233; GO:0019089; GO:0030176; GO:0045047";"protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"integral component of endoplasmic reticulum membrane [GO:0030176]; signal peptidase complex [GO:0005787]";peptidase activity [GO:0008233]
comp3789016_c0_seq1;GAXK01040778.1;Q1HPQ0;4.26E-14;TPM2_BOMMO;Tropomyosin-2;;;;;
comp3789239_c0_seq1;GAXK01040783.1;P18729;2.62E-12;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3789255_c0_seq1;GAXK01040802.1;Q6GP70;8.58E-43;ADA_XENLA;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0046103; GO:0060205";"adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp3789288_c0_seq1;GAXK01040798.1;P97864;4.15E-24;CASP7_MOUSE;"Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]";"GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200";"aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";"aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]"
comp37899_c0_seq1;GAXK01106845.1;Q96K80;3.50E-42;ZC3HA_HUMAN;Zinc finger CCCH domain-containing protein 10;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799";"negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]"
comp379026_c2_seq1;GAXK01065140.1;G5EBQ8;5.14E-10;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp37903_c1_seq1;GAXK01107325.1;Q761V0;4.08E-121;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp3790503_c0_seq1;GAXK01087021.1;Q9VUY0;5.31E-08;MOX11_DROME;MOXD1 homolog 1 (EC 1.14.17.-);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp379088_c0_seq1;GAXK01065057.1;Q99676;1.16E-15;ZN184_HUMAN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp3791153_c0_seq1;GAXK01087013.1;Q4R8N7;5.14E-11;STIP1_MACFA;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp37912_c2_seq1;GAXK01107169.1;O35405;5.56E-62;PLD3_MOUSE;Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Schwannoma-associated protein 9) (SAM-9);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]";"GO:0004630; GO:0005789; GO:0016021; GO:0016042; GO:0070290";lipid catabolic process [GO:0016042];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]"
comp379124_c0_seq1;GAXK01065045.1;Q9N003;2.07E-29;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp379143_c0_seq1;GAXK01065145.1;Q9VR35;9.35E-64;MXT_DROME;Eukaryotic translation initiation factor 4E-binding protein Mextli;"cytoplasm [GO:0005737]; RNA cap binding complex [GO:0034518]; eukaryotic initiation factor 4E binding [GO:0008190]; translation initiation factor activity [GO:0003743]; female germ-line stem cell population maintenance [GO:0036099]; positive regulation of translation [GO:0045727]; regulation of formation of translation initiation ternary complex [GO:1901190]";"GO:0003743; GO:0005737; GO:0008190; GO:0034518; GO:0036099; GO:0045727; GO:1901190";"female germ-line stem cell population maintenance [GO:0036099]; positive regulation of translation [GO:0045727]; regulation of formation of translation initiation ternary complex [GO:1901190]";"cytoplasm [GO:0005737]; RNA cap binding complex [GO:0034518]";"eukaryotic initiation factor 4E binding [GO:0008190]; translation initiation factor activity [GO:0003743]"
comp37915_c0_seq1;GAXK01107053.1;Q9CS74;3.29E-39;ECD_MOUSE;Protein ecdysoneless homolog;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008283; GO:0008380; GO:0035035; GO:0045944; GO:2000045";"cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";histone acetyltransferase binding [GO:0035035]
comp3791658_c0_seq1;GAXK01087022.1;Q6PF15;4.25E-09;KLH35_HUMAN;Kelch-like protein 35;;;;;
comp37918_c2_seq1;GAXK01107017.1;Q9ES00;0;UBE4B_MOUSE;Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0034976; GO:0043161; GO:0044257; GO:0051082; GO:0051117; GO:0051865; GO:0061630";"cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATPase binding [GO:0051117]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]"
comp3792179_c0_seq1;GAXK01195664.1;Q7RTY0;9.33E-12;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp379263_c0_seq1;GAXK01065042.1;Q9Y5Z4;1.05E-15;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp3793343_c0_seq1;GAXK01195660.1;Q9BDB7;1.37E-11;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp379352_c0_seq1;GAXK01065043.1;P00399;0;COX1_DROME;Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide I);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005751; GO:0006123; GO:0009060; GO:0015990; GO:0016021; GO:0020037; GO:0045277; GO:0046872";"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]";"cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp3793620_c0_seq1;GAXK01195657.1;Q62077;8.61E-25;PLCG1_MOUSE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1);"cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852]";"GO:0001701; GO:0001726; GO:0004435; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0009306; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030971; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0048015; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0098685; GO:0098978; GO:1901339; GO:1905564; GO:2000353";"calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852]";"cell-cell junction [GO:0005911]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]";"calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]"
comp379371_c5_seq1;GAXK01065044.1;Q5R7T9;3.15E-39;MTF2_PONAB;Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2);"cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]";"GO:0000122; GO:0000977; GO:0005737; GO:0005925; GO:0006325; GO:0007379; GO:0019827; GO:0035064; GO:0035098; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]";"cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3794020_c0_seq1;GAXK01139950.1;P09523;5.24E-08;POL_FMVD;"Enzymatic polyprotein [Includes: Aspartic protease (EC 3.4.23.-); Endonuclease; Reverse transcriptase (EC 2.7.7.49)]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0004190; GO:0004519";;;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3795_c1_seq1;GAXK01175875.1;P26270;1.81E-146;PSMD7_DROME;26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34);"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]";"GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030425; GO:0043161";"circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]";"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]";
comp3795323_c0_seq1;GAXK01139946.1;Q6GPQ3;4.39E-20;MFSD8_XENLA;Major facilitator superfamily domain-containing protein 8;"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp3795405_c0_seq1;GAXK01139947.1;Q9W0T5;3.82E-09;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp3796738_c0_seq1;GAXK01173846.1;P0CT66;7.41E-50;RS18A_SCHPO;40S ribosomal protein S18-A;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003735; GO:0005829; GO:0019843; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3797128_c0_seq1;GAXK01173857.1;P17032;1.76E-18;ZN37A_HUMAN;Zinc finger protein 37A (Zinc finger protein KOX21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp3797235_c0_seq1;GAXK01173848.1;Q9R1A9;2.29E-25;TREX2_MOUSE;Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2);"nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";"GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803";"DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";nucleus [GO:0005634];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp379807_c0_seq1;GAXK01065143.1;P19213;0;CREA_FLASU;Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase);creatinase activity [GO:0016980];GO:0016980;;;creatinase activity [GO:0016980]
comp3798148_c0_seq1;GAXK01199998.1;Q4LBB6;2.15E-36;OCTB3_DROME;Octopamine receptor beta-3R (DmOct-beta-3R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004989; GO:0005887; GO:0007186; GO:0007189; GO:0008227; GO:0016021";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]"
comp379821_c0_seq1;GAXK01065065.1;Q98862;1.74E-18;IHH_DANRE;"Indian hedgehog B protein (IHHB) (Echidna hedgehog protein) (EHH) [Cleaved into: Indian hedgehog B protein N-product; Indian hedgehog B protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016539; GO:0048709; GO:0055002; GO:0070445";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp3798757_c0_seq1;GAXK01200009.1;Q9SBN4;2.81E-29;PGKH_VOLCA;Phosphoglycerate kinase, chloroplastic (EC 2.7.2.3);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0004618; GO:0005524; GO:0006096; GO:0009507; GO:0019253";"glycolytic process [GO:0006096]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]"
comp379908_c0_seq1;GAXK01065147.1;O94889;2.47E-08;KLH18_HUMAN;Kelch-like protein 18;;;;;
comp3799470_c0_seq1;GAXK01200004.1;Q8SWR3;5.18E-25;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp3799533_c0_seq1;GAXK01200005.1;Q9D180;4.91E-78;CFA57_MOUSE;Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65);"axoneme [GO:0005930]; cilium-dependent cell motility [GO:0060285]";"GO:0005930; GO:0060285";cilium-dependent cell motility [GO:0060285];axoneme [GO:0005930];
comp3799731_c0_seq1;GAXK01199991.1;Q63ZM7;5.12E-18;STABP_XENLA;STAM-binding protein-like (EC 3.4.19.-);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp3799877_c0_seq1;GAXK01200003.1;Q9D4B2;2.72E-07;TTC25_MOUSE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp3799966_c0_seq1;GAXK01200000.1;Q7ZVX5;5.51E-15;REEP3_DANRE;Receptor expression-enhancing protein 3;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"GO:0005789; GO:0005874; GO:0006998; GO:0007084; GO:0016021; GO:0051301";"cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]";
comp3800608_c0_seq1;GAXK01159128.1;Q8C031;9.66E-09;LRC4C_MOUSE;Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1);"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560]";"GO:0016020; GO:0030054; GO:0050770; GO:0050804; GO:0050839; GO:0098632; GO:0098685; GO:0098978; GO:0099061; GO:0099560";"modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560]";"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]";"cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]"
comp380119_c2_seq1;GAXK01080616.1;C9D7C2;0;CAC1A_APIME;Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);"voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005509; GO:0005891; GO:0034765";regulation of ion transmembrane transport [GO:0034765];voltage-gated calcium channel complex [GO:0005891];"calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]"
comp380145_c2_seq1;GAXK01080674.1;P19848;3.98E-12;UBIQ_COPCO;Ubiquitin;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp3801584_c0_seq1;GAXK01159118.1;Q9ZT94;3.34E-21;POLR2_ARATH;"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp3802_c0_seq1;GAXK01176088.1;Q9CQR6;0;PPP6_MOUSE;Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]";"GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0007049; GO:0045087; GO:0046872";"cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp38021_c1_seq1;GAXK01098058.1;Q5R733;1.33E-122;CPEB1_PONAB;Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]";"GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0030054; GO:0030425; GO:0032869; GO:0035925; GO:0045211; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:2000766";"cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp380241_c0_seq1;GAXK01080632.1;A4IHB9;8.29E-94;SL9B2_XENTR;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]";"GO:0005886; GO:0010008; GO:0015385; GO:0016021; GO:0030054; GO:0030317; GO:0030672; GO:0031966";flagellated sperm motility [GO:0030317];"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";sodium:proton antiporter activity [GO:0015385]
comp3802529_c0_seq1;GAXK01022358.1;P28476;2.17E-08;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp3802712_c0_seq1;GAXK01022352.1;P16067;6.50E-08;ANPRB_RAT;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp380322_c0_seq1;GAXK01080684.1;Q9V427;9.23E-21;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp38035_c1_seq1;GAXK01097714.1;Q90629;2.22E-43;TRY3_CHICK;Trypsin II-P29 (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872";"digestion [GO:0007586]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp38043_c1_seq1;GAXK01097822.1;Q567C3;1.71E-12;CA074_DANRE;UPF0739 protein C1orf74 homolog;;;;;
comp3806_c0_seq1;GAXK01175641.1;Q9ERL7;4.31E-45;GMFG_MOUSE;Glia maturation factor gamma (GMF-gamma);"actin cortical patch [GO:0030479]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]";"GO:0003779; GO:0008083; GO:0030479; GO:0034316; GO:0071846; GO:0071933; GO:2000249";"actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]";actin cortical patch [GO:0030479];"actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]"
comp3807_c1_seq1;GAXK01175285.1;P62311;3.98E-53;LSM3_MOUSE;U6 snRNA-associated Sm-like protein LSm3;"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]";"GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005688; GO:0030629; GO:0033962; GO:0046540; GO:0071005; GO:0071013; GO:0120115; GO:1990726";"cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]";"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";"RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]"
comp3807188_c0_seq1;GAXK01087970.1;P50572;4.19E-11;GBRR1_RAT;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA receptor activity [GO:0016917]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0007601; GO:0016917; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0046982; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; GABA receptor activity [GO:0016917]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp3807272_c0_seq1;GAXK01087975.1;O74467;7.36E-17;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp38073_c0_seq1;GAXK01098056.1;Q2NL13;5.51E-85;TPPC5_BOVIN;Trafficking protein particle complex subunit 5;"endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]";"GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072";endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888];"endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; TRAPPII protein complex [GO:1990071]; TRAPPI protein complex [GO:1990070]";
comp3807562_c0_seq1;GAXK01087964.1;Q2RBK2;6.60E-14;LAC17_ORYSJ;Putative laccase-17 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 17) (Diphenol oxidase 17) (Urishiol oxidase 17);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp3807805_c0_seq1;GAXK01087967.1;Q8IVF4;6.56E-24;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp3807850_c0_seq1;GAXK01087979.1;Q5RJ54;1.39E-11;ZSC26_MOUSE;Zinc finger and SCAN domain-containing protein 26 (Zinc finger protein 187);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003676; GO:0003700; GO:0005654; GO:0005829; GO:0042552; GO:0045892; GO:0046872";"myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp3808332_c0_seq1;GAXK01121728.1;Q20191;2.46E-19;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp380839_c0_seq1;GAXK01080757.1;Q3HNM7;7.12E-22;INSC_MOUSE;Protein inscuteable homolog (Minsc);"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp3808648_c0_seq1;GAXK01121722.1;Q9JME2;6.22E-14;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp38087_c0_seq1;GAXK01097507.1;Q6P3Q6;2.71E-142;CERT_XENTR;Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]";"GO:0005783; GO:0005794; GO:0005829; GO:0008289; GO:0035621; GO:0035627; GO:0070273; GO:0120009; GO:1902387; GO:1902388";"ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]"
comp3808747_c0_seq1;GAXK01121719.1;Q9NZJ4;8.67E-57;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp3808910_c0_seq1;GAXK01121715.1;O23255;2.26E-61;SAHH1_ARATH;Adenosylhomocysteinase 1 (AdoHcyase 1) (EC 3.3.1.1) (Protein EMBRYO DEFECTIVE 1395) (Protein HOMOLOGY-DEPENDENT GENE SILENCING 1) (S-adenosyl-L-homocysteine hydrolase 1) (SAH hydrolase 1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; adenosylhomocysteinase activity [GO:0004013]; copper ion binding [GO:0005507]; embryo development ending in seed dormancy [GO:0009793]; methylation-dependent chromatin silencing [GO:0006346]; one-carbon metabolic process [GO:0006730]; posttranscriptional gene silencing [GO:0016441]; S-adenosylmethionine cycle [GO:0033353]";"GO:0004013; GO:0005507; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006346; GO:0006730; GO:0009506; GO:0009793; GO:0016441; GO:0033353";"embryo development ending in seed dormancy [GO:0009793]; methylation-dependent chromatin silencing [GO:0006346]; one-carbon metabolic process [GO:0006730]; posttranscriptional gene silencing [GO:0016441]; S-adenosylmethionine cycle [GO:0033353]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"adenosylhomocysteinase activity [GO:0004013]; copper ion binding [GO:0005507]"
comp38097_c0_seq1;GAXK01097337.1;Q28BQ6;1.99E-41;TMED1_XENTR;Transmembrane emp24 domain-containing protein 1 (p24 family protein gamma-1) (p24gamma1);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp381067_c0_seq1;GAXK01080646.1;Q7KRI2;1.37E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3810762_c0_seq1;GAXK01110679.1;P15086;4.90E-49;CBPB1_HUMAN;Carboxypeptidase B (EC 3.4.17.2) (Pancreas-specific protein) (PASP);"extracellular space [GO:0005615]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004180; GO:0004181; GO:0005615; GO:0006508; GO:0008270";proteolysis [GO:0006508];extracellular space [GO:0005615];"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp381080_c0_seq1;GAXK01080737.1;Q32PV5;1.93E-27;TCF21_DANRE;Transcription factor 21 (TCF-21) (Capsulin) (Epicardin) (MyoRa2);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; artery development [GO:0060840]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; skeletal muscle tissue development [GO:0007519]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]";"GO:0000122; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0007519; GO:0007530; GO:0014707; GO:0030855; GO:0032835; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0060840; GO:0070888; GO:0072162; GO:0072277";"artery development [GO:0060840]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; skeletal muscle tissue development [GO:0007519]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]"
comp3810942_c0_seq1;GAXK01110663.1;P91791;4.30E-84;PPIA_HEMPU;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp3811002_c0_seq1;GAXK01110677.1;P15387;1.22E-36;KCNB1_RAT;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp38111_c7_seq1;GAXK01097937.1;O14792;4.62E-73;HS3S1_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0034483";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; sulfotransferase activity [GO:0008146]"
comp3811119_c0_seq1;GAXK01110669.1;Q69ZU8;1.62E-09;ANKR6_MOUSE;Ankyrin repeat domain-containing protein 6 (Diversin);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";
comp38112_c0_seq1;GAXK01097409.1;Q40784;8.05E-41;AAPC_CENCI;Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C);"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]";"GO:0005975; GO:0030246; GO:0047938";carbohydrate metabolic process [GO:0005975];;"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]"
comp3811446_c0_seq1;GAXK01110686.1;Q9WV72;2.30E-09;ASB3_MOUSE;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp381166_c0_seq1;GAXK01080696.1;O17185;1.99E-14;SUP9_CAEEL;Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38);"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"GO:0005267; GO:0005887; GO:0006813; GO:0006937; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]";"potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]"
comp38117_c0_seq1;GAXK01097936.1;P11166;4.25E-114;GTR1_HUMAN;Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; lactose biosynthetic process [GO:0005989]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]";"GO:0000139; GO:0001666; GO:0001939; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005989; GO:0007565; GO:0010827; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0050796; GO:0055056; GO:0065003; GO:0070062; GO:0071260; GO:0071474; GO:0072562; GO:1904016; GO:1904659";"cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; lactose biosynthetic process [GO:0005989]; L-ascorbic acid metabolic process [GO:0019852]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]";"dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp381178_c1_seq1;GAXK01080694.1;Q9EQN5;1.51E-53;SMBP2_RAT;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Antifreeze enhancer-binding protein ortholog) (AEP);"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA-dependent ATPase activity [GO:0008186]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000049; GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0008094; GO:0008186; GO:0008270; GO:0030424; GO:0032574; GO:0043022; GO:0043139; GO:0043621";negative regulation of transcription by RNA polymerase II [GO:0000122];"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp381181_c2_seq1;GAXK01080733.1;Q8JIY1;1.83E-14;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp3812293_c0_seq1;GAXK01021796.1;Q97ET8;1.48E-18;RUBY2_CLOAB;Rubrerythrin-2 (Rr 2) (NADH peroxidase) (NPXase) (Npx) (EC 1.11.1.1);"iron ion binding [GO:0005506]; NADH peroxidase activity [GO:0016692]";"GO:0005506; GO:0016692";;;"iron ion binding [GO:0005506]; NADH peroxidase activity [GO:0016692]"
comp3812296_c0_seq1;GAXK01021800.1;A2AVA0;1.06E-17;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp381250_c0_seq1;GAXK01080636.1;Q9D3D0;1.24E-25;TTPAL_MOUSE;Alpha-tocopherol transfer protein-like;;;;;
comp38128_c0_seq1;GAXK01097515.1;Q9V3U2;8.89E-48;NHP2_DROME;H/ACA ribonucleoprotein complex subunit 2-like protein (H/ACA snoRNP protein NHP2) (Nucleolar protein family A member 2-like protein);"box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]";"GO:0000469; GO:0000470; GO:0003723; GO:0005732; GO:0031118; GO:0031120; GO:0031429; GO:0034513";"cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]";"box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]";"box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]"
comp381294_c1_seq1;GAXK01080714.1;Q68RJ7;2.40E-60;ACH92_ONCMY;Neuronal acetylcholine receptor subunit alpha-9-II (Nicotinic acetylcholine receptor subunit alpha-9-II) (NACHR alpha-9-II);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp381299_c1_seq1;GAXK01080614.1;P52186;1.13E-27;KCNJ2_CHICK;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]";inward rectifier potassium channel activity [GO:0005242]
comp3813026_c0_seq1;GAXK01021799.1;Q7T0Y4;6.50E-08;DRC1_XENLA;Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]";"GO:0005858; GO:0005930; GO:0031514; GO:0060285; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp3813232_c0_seq1;GAXK01021789.1;Q8VZT3;1.20E-08;EDL12_ARATH;Sugar transporter ERD6-like 12 (Sugar transporter-like protein 5);"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp3813674_c0_seq1;GAXK01021778.1;Q9ULL8;3.00E-07;SHRM4_HUMAN;Protein Shroom4 (Second homolog of apical protein);"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"GO:0001725; GO:0005737; GO:0005884; GO:0005912; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0045159; GO:0050890; GO:0051015";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]";"actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; myosin II binding [GO:0045159]"
comp38140_c0_seq1;GAXK01097731.1;O15405;7.82E-16;TOX3_HUMAN;TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]";"GO:0000981; GO:0003682; GO:0005634; GO:0006915; GO:0034056; GO:0042803; GO:0042981; GO:0043524; GO:0045893; GO:0051219";"apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]"
comp3814407_c0_seq1;GAXK01084652.1;Q9Z186;2.58E-21;G6PC2_MOUSE;Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]";"GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0016021; GO:0042593; GO:0050796; GO:0051156";"gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucose-6-phosphatase activity [GO:0004346]
comp3814427_c0_seq1;GAXK01084653.1;Q9M2P4;1.90E-09;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp38145_c4_seq1;GAXK01097999.1;Q7RTY5;2.86E-39;PRS48_HUMAN;Serine protease 48 (EC 3.4.21.-) (Epidermis-specific serine protease-like protein);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508";proteolysis [GO:0006508];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp3814948_c0_seq1;GAXK01084649.1;Q8I7P9;4.66E-11;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp38151_c0_seq1;GAXK01097520.1;P55112;1.16E-34;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp3815133_c0_seq1;GAXK01084648.1;A6QPM3;4.19E-11;PRDM6_BOVIN;Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.43) (PR domain zinc finger protein 6) (PR domain-containing protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"GO:0000977; GO:0003700; GO:0005634; GO:0018024; GO:0022008; GO:0031490; GO:0043565; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp381522_c0_seq1;GAXK01080701.1;P51905;1.52E-30;SC6A4_DROME;Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1);"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"GO:0005261; GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610";"monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; serotonin binding [GO:0051378]"
comp3815835_c0_seq1;GAXK01084637.1;P14533;1.31E-16;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp38159_c1_seq1;GAXK01097458.1;P14065;2.12E-53;GCY1_YEAST;Glycerol 2-dehydrogenase (NADP(+)) (EC 1.1.1.156) (Galactose-inducible crystallin-like protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; glycerol 2-dehydrogenase (NADP+) activity [GO:0047953]; glycerol dehydrogenase [NAD(P)+] activity [GO:1990042]; mRNA binding [GO:0003729]; oxidoreductase activity [GO:0016491]; arabinose catabolic process [GO:0019568]; cellular response to oxidative stress [GO:0034599]; D-xylose catabolic process [GO:0042843]; glycerol to glycerone phosphate metabolic process [GO:0061610]";"GO:0003729; GO:0004032; GO:0004033; GO:0005634; GO:0005737; GO:0005829; GO:0008106; GO:0016491; GO:0019568; GO:0034599; GO:0042843; GO:0047953; GO:0061610; GO:1990042";"arabinose catabolic process [GO:0019568]; cellular response to oxidative stress [GO:0034599]; D-xylose catabolic process [GO:0042843]; glycerol to glycerone phosphate metabolic process [GO:0061610]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; glycerol 2-dehydrogenase (NADP+) activity [GO:0047953]; glycerol dehydrogenase [NAD(P)+] activity [GO:1990042]; mRNA binding [GO:0003729]; oxidoreductase activity [GO:0016491]"
comp3816091_c0_seq1;GAXK01139474.1;B3EWZ6;7.33E-10;MLRP2_ACRMI;MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp38167_c0_seq1;GAXK01097529.1;Q9Y535;1.68E-85;RPC8_HUMAN;DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9);"centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0032481; GO:0043231; GO:0045087; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]";"centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp3816790_c0_seq1;GAXK01139476.1;Q08DF4;1.46E-62;DYN1_BOVIN;Dynamin-1 (EC 3.6.5.5);"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of exocytosis [GO:0045920]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"GO:0001917; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005874; GO:0005886; GO:0007032; GO:0008017; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0042584; GO:0042802; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0045920; GO:0050803; GO:0050804; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1901998";"endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of exocytosis [GO:0045920]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp3816803_c0_seq1;GAXK01139468.1;O94739;8.41E-11;CALM_PLEOS;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3817296_c0_seq1;GAXK01139477.1;Q3MHR0;1.25E-15;LYPA1_BOVIN;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0006631; GO:0008474; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp381742_c2_seq1;GAXK01080679.1;P35779;2.49E-42;VA3_SOLRI;Venom allergen 3 (Allergen Sol r III) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol r 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp3817470_c0_seq1;GAXK01139467.1;Q80SU7;3.55E-11;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp3817516_c0_seq1;GAXK01139482.1;Q7SXB3;7.00E-07;P3IP1_DANRE;Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]";"GO:0004252; GO:0005886; GO:0016021; GO:0043553";negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp3818475_c0_seq1;GAXK01159231.1;Q29RZ4;1.78E-16;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3818982_c0_seq1;GAXK01159212.1;Q6NZJ6;2.24E-15;IF4G1_MOUSE;Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0010942; GO:0016281; GO:0030307; GO:0031669; GO:0032270; GO:0033138; GO:0034645; GO:0042802; GO:0045666; GO:0097009; GO:0098794; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696";"behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]";"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp38199_c0_seq1;GAXK01097654.1;Q61496;1.48E-17;DDX4_MOUSE;ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Mvh) (Vasa homolog);"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007140; GO:0007141; GO:0007275; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0030317; GO:0031047; GO:0032880; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511; GO:1990904";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]; ribonucleoprotein complex [GO:1990904]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp3820387_c0_seq1;GAXK01133934.1;Q96MT7;5.84E-08;CFA44_HUMAN;Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52);"axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288]";"GO:0005930; GO:0007288; GO:0031514; GO:0060271; GO:0060285";"cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288]";"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp38209_c0_seq1;GAXK01097769.1;P48282;1.61E-34;CAH1_SHEEP;Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase I) (CA-I);"cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]";"GO:0004089; GO:0005737; GO:0006730; GO:0008270";one-carbon metabolic process [GO:0006730];cytoplasm [GO:0005737];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp382106_c1_seq1;GAXK01163897.1;O60494;2.90E-41;CUBN_HUMAN;Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062";"cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp3821193_c0_seq1;GAXK01133929.1;Q94900;1.26E-23;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3821486_c0_seq1;GAXK01133911.1;Q9ULI1;4.21E-36;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp38225_c0_seq1;GAXK01097642.1;Q96MH2;1.04E-13;HEXI2_HUMAN;Protein HEXIM2 (Hexamethylene bis-acetamide-inducible protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0017069; GO:0042802; GO:0045736; GO:0045892; GO:0097322";"negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]"
comp3823128_c0_seq1;GAXK01029966.1;Q9VSL7;4.57E-32;FOI_DROME;Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007280; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030154; GO:0035147; GO:0035262; GO:0071578";"branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp38236_c0_seq1;GAXK01097958.1;Q2KI04;4.49E-18;SZRD1_BOVIN;SUZ domain-containing protein 1;;;;;
comp3823937_c0_seq1;GAXK01029974.1;Q8CCE9;9.02E-16;E4F1_MOUSE;Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (Transcription factor phi AP3) (p120E4F);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0006355; GO:0007049; GO:0009794; GO:0010564; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]";"cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]"
comp3824145_c0_seq1;GAXK01171232.1;Q05B62;1.36E-08;SNX1_BOVIN;Sorting nexin-1;"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0030027; GO:0030904; GO:0031623; GO:0031901; GO:0034498; GO:0035091; GO:0042147; GO:0072673";"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]";phosphatidylinositol binding [GO:0035091]
comp3824358_c0_seq1;GAXK01171226.1;P05084;6.35E-09;HUNB_DROME;Protein hunchback;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";"GO:0000122; GO:0000980; GO:0000981; GO:0003700; GO:0005634; GO:0007354; GO:0007400; GO:0007402; GO:0007419; GO:0007431; GO:0035289; GO:0035290; GO:0040034; GO:0043565; GO:0044324; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048699; GO:0050767; GO:2000177";"ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp3824506_c0_seq1;GAXK01171245.1;P49165;4.67E-89;RL4_URECA;60S ribosomal protein L4 (L1);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp382465_c2_seq1;GAXK01163852.1;Q71SG7;5.90E-13;GCNT4_DANRE;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0003829; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp38247_c0_seq1;GAXK01097331.1;O42412;1.45E-38;IOD3_CHICK;Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]";"GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0042403; GO:0042446";"hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]";"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";thyroxine 5'-deiodinase activity [GO:0004800]
comp38253_c1_seq1;GAXK01097596.1;Q08DJ7;8.31E-85;AAR2_BOVIN;Protein AAR2 homolog (AAR2 splicing factor homolog);"spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0005681";spliceosomal tri-snRNP complex assembly [GO:0000244];spliceosomal complex [GO:0005681];
comp38254_c3_seq1;GAXK01097432.1;Q29RK4;1.32E-19;RD23B_BOVIN;UV excision repair protein RAD23 homolog B;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0003684; GO:0005654; GO:0005829; GO:0006289; GO:0031593; GO:0043130; GO:0043161; GO:0070628; GO:0071942";"nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]";"damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]"
comp38256_c2_seq1;GAXK01098011.1;P34595;3.85E-18;IGLR2_CAEEL;Immunoglobulin domain and leucine-rich repeat-containing protein 2;"integral component of membrane [GO:0016021]; mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005763; GO:0016021; GO:0070181";;"integral component of membrane [GO:0016021]; mitochondrial small ribosomal subunit [GO:0005763]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp38260_c0_seq1;GAXK01097851.1;O54749;3.39E-81;CP2J5_MOUSE;Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805]";"GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097254; GO:2000863";"angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp3826470_c0_seq1;GAXK01079726.1;Q96GW7;9.51E-09;PGCB_HUMAN;Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0098978";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp3826561_c0_seq1;GAXK01079737.1;O61703;1.10E-35;MPCP_CHOFU;Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp38274_c1_seq1;GAXK01098052.1;P46531;9.94E-28;NOTC1_HUMAN;"Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]";"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0046982; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027";"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]"
comp3828271_c0_seq1;GAXK01197231.1;P54281;1.23E-18;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp382831_c3_seq1;GAXK01163808.1;P13826;2.69E-08;CSP_PLAVS;Circumsporozoite protein (CS) (Fragment);cell surface [GO:0009986];GO:0009986;;cell surface [GO:0009986];
comp38289_c0_seq1;GAXK01097493.1;Q2HJF3;9.91E-12;ORC6_BOVIN;Origin recognition complex subunit 6;"fibrillar center [GO:0001650]; nuclear origin of replication recognition complex [GO:0005664]; DNA replication origin binding [GO:0003688]; DNA replication initiation [GO:0006270]; negative regulation of cell division [GO:0051782]";"GO:0001650; GO:0003688; GO:0005664; GO:0006270; GO:0051782";"DNA replication initiation [GO:0006270]; negative regulation of cell division [GO:0051782]";"fibrillar center [GO:0001650]; nuclear origin of replication recognition complex [GO:0005664]";DNA replication origin binding [GO:0003688]
comp382920_c0_seq1;GAXK01163795.1;E1C5V0;7.58E-08;SMYD2_CHICK;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp3829605_c0_seq1;GAXK01197243.1;Q9VZW5;3.98E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3830945_c0_seq1;GAXK01134809.1;P17038;4.95E-16;ZNF43_HUMAN;Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp383097_c1_seq1;GAXK01163904.1;P52034;0;PFKA_DROME;ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase);"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";"GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0007520; GO:0007525; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095";"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";6-phosphofructokinase complex [GO:0005945];"6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
comp3831060_c0_seq1;GAXK01134827.1;Q8IGJ0;1.49E-11;EFR3_DROME;Protein EFR3 homolog cmp44E (Conserved membrane protein at 44E) (Protein stambha A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; bulk synaptic vesicle endocytosis [GO:0150008]; chemical synaptic transmission [GO:0007268]; mitotic cytokinesis [GO:0000281]; phototransduction [GO:0007602]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000281; GO:0005886; GO:0007268; GO:0007602; GO:0016021; GO:0016079; GO:0045202; GO:0048488; GO:0072659; GO:0098793; GO:0150008";"bulk synaptic vesicle endocytosis [GO:0150008]; chemical synaptic transmission [GO:0007268]; mitotic cytokinesis [GO:0000281]; phototransduction [GO:0007602]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]";
comp3831140_c0_seq1;GAXK01134822.1;P39057;2.18E-99;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp3831916_c0_seq1;GAXK01134821.1;Q28615;1.04E-45;S13A2_RABIT;Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter);"integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];integral component of membrane [GO:0016021];symporter activity [GO:0015293]
comp3832_c0_seq1;GAXK01175205.1;Q6RY07;1.43E-56;CHIA_RAT;Acidic mammalian chitinase (AMCase) (EC 3.2.1.14);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197";"apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp3833317_c0_seq1;GAXK01072139.1;P11503;1.16E-75;HSP70_ONCVO;Heat shock 70 kDa protein (HSP70) (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp38352_c0_seq1;GAXK01097530.1;O08856;1.63E-33;ELL_MOUSE;RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein);"Cajal body [GO:0015030]; histone locus body [GO:0035363]; nuclear speck [GO:0016607]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; phosphatase binding [GO:0019902]; in utero embryonic development [GO:0001701]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0001701; GO:0006368; GO:0008023; GO:0010923; GO:0015030; GO:0016607; GO:0019902; GO:0032968; GO:0035327; GO:0035363; GO:0042795; GO:0042796; GO:0045945";"in utero embryonic development [GO:0001701]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"Cajal body [GO:0015030]; histone locus body [GO:0035363]; nuclear speck [GO:0016607]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]";phosphatase binding [GO:0019902]
comp383572_c4_seq1;GAXK01163885.1;P79098;3.56E-159;AMPN_BOVIN;Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"
comp3836019_c0_seq1;GAXK01068650.1;Q95L11;2.94E-36;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp38368_c5_seq1;GAXK01097455.1;F4HTM3;0;GCS1_ARATH;Mannosyl-oligosaccharide glucosidase GCS1 (EC 3.2.1.106) (Alpha-glucosidase 1) (Glucosidase 1) (Protein KNOPF) (Protein MUNCHKIN);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; alpha-1,4-glucosidase activity [GO:0004558]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; epidermal cell differentiation [GO:0009913]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]; root epidermal cell differentiation [GO:0010053]";"GO:0004558; GO:0004573; GO:0005739; GO:0005783; GO:0005789; GO:0006487; GO:0009311; GO:0009913; GO:0010053; GO:0016021";"epidermal cell differentiation [GO:0009913]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]; root epidermal cell differentiation [GO:0010053]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"alpha-1,4-glucosidase activity [GO:0004558]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]"
comp3836908_c0_seq1;GAXK01068661.1;Q5F364;5.27E-08;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp3837055_c0_seq1;GAXK01068657.1;P00079;5.23E-40;CYC_TETPY;Cytochrome c;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp3837298_c0_seq1;GAXK01068662.1;P36609;2.24E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp3837427_c0_seq1;GAXK01068649.1;A7MBH5;4.88E-11;CC151_BOVIN;Coiled-coil domain-containing protein 151;"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]";"GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0036064; GO:0036158; GO:1902017";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]";"axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]";
comp3837492_c0_seq1;GAXK01068648.1;P40694;9.71E-63;SMBP2_MOUSE;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Cardiac transcription factor 1) (CATF1) (Immunoglobulin mu-binding protein 2);"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; DNA-dependent ATPase activity [GO:0008094]; G-rich single-stranded DNA binding [GO:1990955]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process [GO:0050905]; protein homooligomerization [GO:0051260]; spinal cord motor neuron differentiation [GO:0021522]; translation [GO:0006412]";"GO:0000049; GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0021522; GO:0030424; GO:0030426; GO:0032574; GO:0043022; GO:0043025; GO:0043139; GO:0043621; GO:0048471; GO:0050905; GO:0051260; GO:1990904; GO:1990955";"negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process [GO:0050905]; protein homooligomerization [GO:0051260]; spinal cord motor neuron differentiation [GO:0021522]; translation [GO:0006412]";"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; DNA-dependent ATPase activity [GO:0008094]; G-rich single-stranded DNA binding [GO:1990955]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp3837532_c0_seq1;GAXK01068663.1;Q3T094;5.98E-35;ETHE1_BOVIN;Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Sulfur dioxygenase ETHE1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]";"GO:0005506; GO:0005654; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0050313; GO:0070813";"glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"hydrolase activity, acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"
comp383761_c1_seq1;GAXK01163910.1;Q9VSL3;7.76E-10;SEPIA_DROME;Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia);"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";"GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114";"eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";cytoplasm [GO:0005737];"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"
comp3837808_c0_seq1;GAXK01068641.1;Q94900;5.56E-11;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp3838_c0_seq1;GAXK01175156.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp38380_c0_seq1;GAXK01097511.1;Q99PP7;9.57E-40;TRI33_MOUSE;E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33);"nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]";"GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412";"negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]";nucleus [GO:0005634];"co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp383846_c5_seq1;GAXK01163901.1;Q7ZUV7;4.07E-32;EMSY_DANRE;BRCA2-interacting transcriptional repressor EMSY;"nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006281; GO:0006325; GO:0006355";"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];
comp3838533_c0_seq1;GAXK01030490.1;Q90YV5;1.31E-81;RL13_ICTPU;60S ribosomal protein L13;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp383868_c1_seq1;GAXK01163832.1;Q6DCX5;1.08E-17;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp383913_c0_seq1;GAXK01163831.1;P62144;7.94E-79;CALM_ANAPL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp38396_c1_seq1;GAXK01097956.1;Q803I2;6.79E-145;ERGI3_DANRE;Endoplasmic reticulum-Golgi intermediate compartment protein 3;"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]";
comp384_c1_seq1;GAXK01165896.1;P19804;2.47E-79;NDKB_RAT;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0008144; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051259; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
comp3840175_c0_seq1;GAXK01002895.1;P05934;9.77E-07;CALM_STRPU;Calmodulin (CaM) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp3840654_c1_seq1;GAXK01002889.1;Q9H4Z2;5.95E-09;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp3840950_c0_seq1;GAXK01002873.1;B2D0J5;1.98E-46;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp38411_c1_seq1;GAXK01097690.1;Q4V8C2;3.09E-101;ZW10_RAT;Centromere/kinetochore protein zw10 homolog;"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]";"GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005828; GO:0005829; GO:0006888; GO:0007030; GO:0007080; GO:0007093; GO:0007094; GO:0007096; GO:0015031; GO:0034501; GO:0051301; GO:0065003; GO:0070939; GO:1990423";"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein-containing complex assembly [GO:0065003]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; regulation of exit from mitosis [GO:0007096]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]";
comp384118_c0_seq1;GAXK01203856.1;Q5T619;4.00E-13;ZN648_HUMAN;Zinc finger protein 648;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp38412_c0_seq1;GAXK01097518.1;Q9VP22;4.10E-92;CDK12_DROME;Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) (dCdk12);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000228; GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0006368; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0019908; GO:0030332; GO:0032968; GO:0044212; GO:0045944; GO:0070816";"phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp3841217_c0_seq1;GAXK01002885.1;P70057;9.49E-64;KCNQ1_XENLA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha xKvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp3841439_c0_seq1;GAXK01002872.1;Q9CR58;1.11E-70;KMCP1_MOUSE;Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]";"GO:0005739; GO:0005743; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0071422; GO:0071423";"malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]"
comp38415_c0_seq1;GAXK01097759.1;Q8N6F8;1.30E-10;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp38418_c0_seq1;GAXK01098090.1;O16011;1.91E-51;MBL_DROME;Protein muscleblind (Protein mindmelt);"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"GO:0000381; GO:0001654; GO:0001751; GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007517; GO:0007601; GO:0010468; GO:0030018; GO:0031673; GO:0042052; GO:0045924; GO:0046716; GO:0046872; GO:0048471; GO:0050896";"apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]"
comp384210_c0_seq1;GAXK01203732.1;P34569;8.58E-12;KEL10_CAEEL;Kelch repeat-containing protein kel-10;;;;;
comp3842501_c0_seq1;GAXK01174119.1;Q08832;8.49E-16;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp384379_c0_seq1;GAXK01203796.1;Q6NYV8;8.37E-67;LCLT1_DANRE;Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid metabolic process [GO:0006644]";"GO:0001885; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0016021; GO:0016024; GO:0016746; GO:0035162; GO:0036149; GO:0060217";"CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid metabolic process [GO:0006644]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp384384_c0_seq1;GAXK01203922.1;Q29449;0;AT8A1_BOVIN;Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II);"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0042584; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp384397_c0_seq1;GAXK01203883.1;Q8IN81;2.48E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp3844_c0_seq1;GAXK01205912.1;P61081;8.04E-90;UBC12_HUMAN;NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.-) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; positive regulation of neuron apoptotic process [GO:0043525]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";"GO:0004842; GO:0005524; GO:0005654; GO:0005829; GO:0006464; GO:0019788; GO:0043525; GO:0043687; GO:0045116";"cellular protein modification process [GO:0006464]; positive regulation of neuron apoptotic process [GO:0043525]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]"
comp384484_c2_seq1;GAXK01203876.1;Q03717;6.55E-28;KCNB1_MOUSE;Potassium voltage-gated channel subfamily B member 1 (Voltage-gated potassium channel subunit Kv2.1) (mShab);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp3845_c1_seq1;GAXK01176557.1;Q02380;1.00E-18;NDUB5_BOVIN;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"GO:0005654; GO:0005747; GO:0016021; GO:0032981; GO:0055114";"mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]";
comp3845111_c0_seq1;GAXK01034701.1;Q96RW7;9.15E-10;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp38455_c0_seq1;GAXK01097460.1;Q9D273;6.21E-56;MMAB_MOUSE;Corrinoid adenosyltransferase (EC 2.5.1.17) (Cob(II)alamin adenosyltransferase) (Cob(II)yrinic acid a,c-diamide adenosyltransferase) (Cobinamide/cobalamin adenosyltransferase) (Methylmalonic aciduria type B homolog);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]";"GO:0005524; GO:0005739; GO:0008817; GO:0009235; GO:0009236; GO:0031419";"cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]"
comp3846_c0_seq1;GAXK01175637.1;P41042;1.10E-46;RS4_DROME;40S ribosomal protein S4;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003735; GO:0006412; GO:0019843; GO:0022626; GO:0022627";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp3846215_c0_seq1;GAXK01150097.1;O42984;1.27E-49;RS17A_SCHPO;40S ribosomal protein S17-A;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translational elongation [GO:0002182]; ribosome biogenesis [GO:0042254]";"GO:0002182; GO:0003735; GO:0005829; GO:0022627; GO:0042254";"cytoplasmic translational elongation [GO:0002182]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp384722_c0_seq1;GAXK01203887.1;Q9GRW0;1.51E-57;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3847898_c0_seq1;GAXK01150092.1;Q6NUB3;4.93E-15;S22AF_XENLA;Solute carrier family 22 member 15;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp3848297_c0_seq1;GAXK01015462.1;Q7Z0G7;4.36E-32;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp384849_c1_seq1;GAXK01203797.1;O74467;8.49E-08;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp3849_c0_seq1;GAXK01175161.1;P22695;1.03E-63;QCR2_HUMAN;Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2);"mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; response to drug [GO:0042493]";"GO:0004222; GO:0005654; GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006119; GO:0006122; GO:0006627; GO:0009060; GO:0017087; GO:0042493; GO:0044877; GO:0046872";"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; response to drug [GO:0042493]";"mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]"
comp3849648_c0_seq1;GAXK01015481.1;D3ZS74;9.50E-21;OMA1_RAT;Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0042407; GO:0046872; GO:0097009; GO:0120162";"cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp3850040_c0_seq1;GAXK01080370.1;Q9ULI1;6.98E-59;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp38502_c1_seq1;GAXK01097985.1;A1A4J6;0;ATP9B_BOVIN;Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B);"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326";"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp385028_c1_seq1;GAXK01203890.1;Q7M6U3;4.47E-30;TEX14_MOUSE;Inactive serine/threonine-protein kinase TEX14 (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein);"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]";"GO:0000776; GO:0000777; GO:0004672; GO:0005524; GO:0005623; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0019901; GO:0030496; GO:0032091; GO:0032466; GO:0043063; GO:0045171; GO:0051301; GO:0051306; GO:1990830";"attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]";"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp385039_c0_seq2;GAXK01203746.1;Q6R7M4;2.42E-69;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp3850546_c0_seq1;GAXK01080377.1;Q5D1D6;1.75E-85;GBP1_CHLAE;Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607";"defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp3851270_c0_seq1;GAXK01080378.1;Q6X5S0;3.84E-11;SL7_ECHPL;Snaclec 7 (C-type lectin 7) (CTL-7);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp3851495_c0_seq1;GAXK01080363.1;Q99571;9.02E-14;P2RX4_HUMAN;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0006812; GO:0007165; GO:0007596; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0016021; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035381; GO:0035590; GO:0042118; GO:0042803; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904124; GO:1904141; GO:2001028";"apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]";"cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]"
comp3851675_c0_seq1;GAXK01080379.1;A6H782;5.04E-08;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp385171_c1_seq1;GAXK01203966.1;Q5ZLC8;1.14E-09;ANR52_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp38518_c1_seq1;GAXK01097732.1;Q5I0I4;1.94E-20;DMAC2_RAT;Distal membrane-arm assembly complex protein 2 (ATP synthase subunit s-like protein);"mitochondrial respiratory chain complex I [GO:0005747]; SCF ubiquitin ligase complex [GO:0019005]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005747; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0032981";"mitochondrial respiratory chain complex I assembly [GO:0032981]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"mitochondrial respiratory chain complex I [GO:0005747]; SCF ubiquitin ligase complex [GO:0019005]";
comp38523_c0_seq1;GAXK01097665.1;Q02040;1.59E-101;AK17A_HUMAN;A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]";"GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018";"B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";"protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]"
comp38524_c0_seq1;GAXK01097618.1;D3ZF42;3.14E-43;SENP7_RAT;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp38525_c0_seq1;GAXK01097689.1;Q16836;8.12E-94;HCDH_HUMAN;Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]";"GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0014823; GO:0032868; GO:0042493; GO:0046676; GO:0070403; GO:0120162";"fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]"
comp38530_c0_seq1;GAXK01097411.1;Q8L850;2.07E-13;PI5K9_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 9 (AtPIP5K9) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 9) (Diphosphoinositide kinase 9) (PtdIns(4)P-5-kinase 9);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; carbohydrate metabolic process [GO:0005975]; cellular amino acid metabolic process [GO:0006520]";"GO:0005524; GO:0005634; GO:0005829; GO:0005975; GO:0006520; GO:0016020; GO:0016308";"carbohydrate metabolic process [GO:0005975]; cellular amino acid metabolic process [GO:0006520]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp385322_c1_seq1;GAXK01203977.1;A6NHJ4;7.77E-24;ZN860_HUMAN;Zinc finger protein 860;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp38534_c0_seq1;GAXK01097397.1;Q3T116;2.37E-12;ICT1_BOVIN;Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]";"GO:0004045; GO:0005739; GO:0005743; GO:0005762; GO:0016150; GO:0070126";mitochondrial translational termination [GO:0070126];"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"
comp3854021_c0_seq1;GAXK01029041.1;Q09884;8.61E-22;DCR1_SCHPO;"Protein Dicer (Cell cycle control protein dcr1) (RNA interference pathway protein dcr1) [Includes: Endoribonuclease dcr1 (EC 3.1.26.-); ATP-dependent helicase dcr1 (EC 3.6.4.-)]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nuclear pericentric heterochromatin [GO:0031618]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; euchromatin binding [GO:1990188]; helicase activity [GO:0004386]; ribonuclease activity [GO:0004540]; ribonuclease III activity [GO:0004525]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cellular protein localization [GO:0034613]; chromosome segregation [GO:0007059]; co-transcriptional gene silencing by RNA interference machinery [GO:0033562]; establishment of chromatin silencing at silent mating-type cassette [GO:0035389]; heterochromatin organization involved in chromatin silencing [GO:0070868]; negative regulation of gene expression [GO:0010629]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; production of siRNA involved in chromatin silencing by small RNA [GO:0070919]; production of siRNA involved in RNA interference [GO:0030422]; regulation of chromatin silencing at centromere [GO:0090052]; regulation of histone H3-K9 methylation [GO:0051570]; RNA processing [GO:0006396]";"GO:0000790; GO:0003690; GO:0003725; GO:0004386; GO:0004525; GO:0004540; GO:0005524; GO:0005634; GO:0005719; GO:0005737; GO:0005829; GO:0006396; GO:0007049; GO:0007059; GO:0008270; GO:0010629; GO:0016442; GO:0030422; GO:0031618; GO:0033562; GO:0034399; GO:0034613; GO:0035389; GO:0051570; GO:0070868; GO:0070919; GO:0090052; GO:1904595; GO:1990188";"cell cycle [GO:0007049]; cellular protein localization [GO:0034613]; chromosome segregation [GO:0007059]; co-transcriptional gene silencing by RNA interference machinery [GO:0033562]; establishment of chromatin silencing at silent mating-type cassette [GO:0035389]; heterochromatin organization involved in chromatin silencing [GO:0070868]; negative regulation of gene expression [GO:0010629]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; production of siRNA involved in chromatin silencing by small RNA [GO:0070919]; production of siRNA involved in RNA interference [GO:0030422]; regulation of chromatin silencing at centromere [GO:0090052]; regulation of histone H3-K9 methylation [GO:0051570]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nuclear pericentric heterochromatin [GO:0031618]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; euchromatin binding [GO:1990188]; helicase activity [GO:0004386]; ribonuclease activity [GO:0004540]; ribonuclease III activity [GO:0004525]; zinc ion binding [GO:0008270]"
comp385410_c0_seq1;GAXK01203872.1;P25823;6.01E-08;TUD_DROME;Maternal protein tudor;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"GO:0005634; GO:0005737; GO:0005739; GO:0007277; GO:0007281; GO:0007315; GO:0008298; GO:0030719; GO:0043186; GO:0045495";"germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]";
comp3854171_c0_seq1;GAXK01029033.1;Q5ZLD7;3.52E-11;VPS53_CHICK;Vacuolar protein sorting-associated protein 53 homolog;"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000938; GO:0005802; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0032456; GO:0042147; GO:0048471; GO:0055037; GO:1990745";"endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";
comp3854490_c0_seq1;GAXK01029034.1;Q8R151;5.61E-17;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp385454_c1_seq1;GAXK01203850.1;Q11073;5.62E-41;YT45_CAEEL;Uncharacterized protein B0416.5;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp385489_c0_seq1;GAXK01203794.1;B5DEL1;3.07E-12;KCTD5_RAT;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp38549_c0_seq1;GAXK01097521.1;Q8NHP1;8.40E-106;ARK74_HUMAN;Aflatoxin B1 aldehyde reductase member 4 (EC 1.-.-.-) (AFB1 aldehyde reductase 3) (AFB1-AR 3) (Aldoketoreductase 7-like);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; oxidoreductase activity [GO:0016491]; xenobiotic metabolic process [GO:0006805]";"GO:0005829; GO:0006805; GO:0016491; GO:0070062";xenobiotic metabolic process [GO:0006805];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";oxidoreductase activity [GO:0016491]
comp3855673_c0_seq1;GAXK01029043.1;O02443;4.65E-07;CULP1_HELAM;Larval cuticle protein 1;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp3855850_c0_seq1;GAXK01029035.1;Q6RFL5;6.78E-34;BSH_CHICK;Brain-specific homeobox protein homolog;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; eating behavior [GO:0042755]; locomotory behavior [GO:0007626]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0007626; GO:0042755; GO:0043565; GO:0045944";"brain development [GO:0007420]; eating behavior [GO:0042755]; locomotory behavior [GO:0007626]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp3856407_c0_seq1;GAXK01056666.1;O75800;1.15E-22;ZMY10_HUMAN;Zinc finger MYND domain-containing protein 10 (Protein BLu);"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"GO:0005737; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505";"inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]";metal ion binding [GO:0046872]
comp3856992_c0_seq1;GAXK01056652.1;P20892;2.15E-07;POL_HV1OY;"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]";"host cell nucleus [GO:0042025]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; viral nucleocapsid [GO:0019013]; virion membrane [GO:0055036]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exoribonuclease H activity [GO:0004533]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; induction by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039651]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0008289; GO:0015074; GO:0019013; GO:0020002; GO:0039651; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0055036; GO:0072494; GO:0075713; GO:0075732";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; induction by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039651]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"host cell nucleus [GO:0042025]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; viral nucleocapsid [GO:0019013]; virion membrane [GO:0055036]";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exoribonuclease H activity [GO:0004533]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]"
comp3857863_c0_seq1;GAXK01056658.1;Q80YX1;3.21E-13;TENA_MOUSE;Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; perisynaptic extracellular matrix [GO:0098966]; fibronectin binding [GO:0001968]; syndecan binding [GO:0045545]; bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]";"GO:0001968; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009612; GO:0010628; GO:0014012; GO:0031012; GO:0031175; GO:0042060; GO:0042475; GO:0045471; GO:0045545; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0098966";"bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; perisynaptic extracellular matrix [GO:0098966]";"fibronectin binding [GO:0001968]; syndecan binding [GO:0045545]"
comp3858343_c0_seq1;GAXK01148157.1;A8MYZ0;1.38E-25;MIY4B_HUMAN;Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2);protein K48-linked deubiquitination [GO:0071108];GO:0071108;protein K48-linked deubiquitination [GO:0071108];;
comp38587_c8_seq1;GAXK01097491.1;O45211;1.13E-124;TBP_BOMMO;TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit);"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0000995; GO:0003677; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006383";"DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]"
comp3858749_c0_seq1;GAXK01148158.1;P17786;5.96E-63;EF1A_SOLLC;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414";"translation [GO:0006412]; translational elongation [GO:0006414]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp38591_c0_seq1;GAXK01098038.1;O60841;0;IF2P_HUMAN;Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]";"GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872";regulation of translational initiation [GO:0006446];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
comp3859350_c0_seq1;GAXK01148161.1;Q9VW60;3.44E-41;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp385946_c1_seq1;GAXK01203744.1;A2A259;4.37E-157;PK2L1_MOUSE;Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog);"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]";"GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0015269; GO:0016020; GO:0031410; GO:0034703; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051262; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071467; GO:0071468; GO:0071805; GO:0097730; GO:0098662";"cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]";"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]"
comp3859675_c0_seq1;GAXK01148167.1;O46040;1.58E-11;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp3859826_c0_seq1;GAXK01148160.1;Q8VHE6;1.78E-37;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp386001_c0_seq1;GAXK01156286.1;Q9VLU0;1.30E-22;BAF_DROME;Barrier-to-autointegration factor;"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; oocyte karyosome formation [GO:0030717]";"GO:0003677; GO:0005635; GO:0005654; GO:0005694; GO:0005737; GO:0007059; GO:0030261; GO:0030717";"chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; oocyte karyosome formation [GO:0030717]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp386011_c8_seq1;GAXK01156267.1;Q5TYW1;4.70E-13;ZN658_HUMAN;Zinc finger protein 658;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";"GO:0000976; GO:0003677; GO:0005634; GO:0042254; GO:0045892; GO:0046872; GO:0071294";"cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp386084_c0_seq1;GAXK01156384.1;Q16832;3.19E-68;DDR2_HUMAN;Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001503; GO:0001952; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007160; GO:0007165; GO:0007169; GO:0008284; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030154; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091; GO:1903053";"biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp386107_c0_seq1;GAXK01156444.1;Q8NAT2;3.73E-13;TDRD5_HUMAN;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp3861348_c0_seq1;GAXK01107968.1;Q5FYB1;3.60E-15;ARSI_HUMAN;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp3862000_c0_seq1;GAXK01124031.1;A2A935;1.08E-09;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp386203_c1_seq1;GAXK01156332.1;P17970;8.61E-128;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp38631_c0_seq1;GAXK01097657.1;O08582;0;GTPB1_MOUSE;GTP-binding protein 1 (G-protein 1) (GP-1) (GP1);"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]";"GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014";"GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]";"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp386351_c0_seq1;GAXK01156259.1;P55113;1.15E-15;NAS7_CAEEL;Zinc metalloproteinase nas-7 (EC 3.4.24.-) (Nematode astacin 7);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp38637_c4_seq1;GAXK01097357.1;P05187;1.54E-55;PPB1_HUMAN;Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]";"GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0031225";;"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]"
comp38644_c2_seq1;GAXK01097626.1;Q7TNK0;5.81E-110;SERC1_RAT;Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein binding, bridging [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]";"GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222";"membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"enzyme binding [GO:0019899]; protein binding, bridging [GO:0030674]"
comp386453_c0_seq1;GAXK01156329.1;Q2UPB6;6.65E-10;ACLN_ASPOR;Aspirochlorine biosynthesis protein N;;;;;
comp38654_c0_seq1;GAXK01097641.1;P70261;2.06E-07;PALD_MOUSE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp3865429_c0_seq1;GAXK01174933.1;Q3U4G3;2.50E-22;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp386562_c1_seq1;GAXK01156245.1;Q09147;4.49E-25;FGFR2_DROME;Fibroblast growth factor receptor homolog 2 (EC 2.7.10.1) (Protein breathless) (Tyrosine kinase 2) (dTk2) (Tyrosine kinase receptor HD-311) (dFGF-R1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; border follicle cell migration [GO:0007298]; branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell type specification, open tracheal system [GO:0035153]; fibroblast growth factor receptor signaling pathway [GO:0008543]; filopodium assembly [GO:0046847]; genital disc development [GO:0035215]; glial cell migration [GO:0008347]; negative regulation of axon extension [GO:0030517]; open tracheal system development [GO:0007424]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; primary branching, open tracheal system [GO:0007428]; salivary gland morphogenesis [GO:0007435]; secondary branching, open tracheal system [GO:0007429]; terminal branching, open tracheal system [GO:0007430]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]";"GO:0001745; GO:0004714; GO:0005007; GO:0005524; GO:0005886; GO:0007298; GO:0007424; GO:0007426; GO:0007427; GO:0007428; GO:0007429; GO:0007430; GO:0007435; GO:0008347; GO:0008543; GO:0016021; GO:0030517; GO:0035153; GO:0035154; GO:0035202; GO:0035215; GO:0046847; GO:0060438; GO:0060446; GO:0070374";"border follicle cell migration [GO:0007298]; branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell type specification, open tracheal system [GO:0035153]; fibroblast growth factor receptor signaling pathway [GO:0008543]; filopodium assembly [GO:0046847]; genital disc development [GO:0035215]; glial cell migration [GO:0008347]; negative regulation of axon extension [GO:0030517]; open tracheal system development [GO:0007424]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; primary branching, open tracheal system [GO:0007428]; salivary gland morphogenesis [GO:0007435]; secondary branching, open tracheal system [GO:0007429]; terminal branching, open tracheal system [GO:0007430]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp3866559_c0_seq1;GAXK01173440.1;Q921X9;5.46E-100;PDIA5_MOUSE;Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein);"endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005788; GO:0015037; GO:0045454";cell redox homeostasis [GO:0045454];endoplasmic reticulum lumen [GO:0005788];"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp3866658_c0_seq1;GAXK01173451.1;Q86LG1;7.98E-13;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp38672_c0_seq1;GAXK01097957.1;Q9VZS6;5.09E-62;NSMA_DROME;Putative neutral sphingomyelinase (EC 3.1.4.12);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872";sphingomyelin metabolic process [GO:0006684];"caveola [GO:0005901]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp3867257_c0_seq1;GAXK01173434.1;Q8N823;1.00E-11;ZN611_HUMAN;Zinc finger protein 611;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp38676_c1_seq1;GAXK01097670.1;O55057;9.98E-86;PDE6D_MOUSE;Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta);"cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601]";"GO:0005095; GO:0005829; GO:0005856; GO:0007601; GO:0007602; GO:0017137; GO:0030659; GO:0031410; GO:0042995; GO:0047555";"phototransduction [GO:0007602]; visual perception [GO:0007601]";"cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]"
comp3868299_c0_seq1;GAXK01074746.1;Q9UL36;2.80E-10;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp386877_c0_seq1;GAXK01156281.1;Q9ULJ7;5.34E-43;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp386896_c1_seq1;GAXK01156414.1;Q62981;1.47E-44;ZN260_RAT;Zinc finger protein 260 (Zfp-260) (Pancreas-only zinc finger protein 1) (POZF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3869189_c0_seq1;GAXK01074749.1;P57721;9.50E-52;PCBP3_HUMAN;Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]";"GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829";mRNA metabolic process [GO:0016071];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp3869350_c0_seq1;GAXK01074747.1;P03010;7.01E-08;TRAC9_MAIZE;Putative AC9 transposase;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp3869410_c0_seq1;GAXK01074754.1;A5D7B7;5.95E-36;SEPR_BOVIN;Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) (Z-Pro-prolinal insensitive peptidase) (ZIP) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)];"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]";"GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0007155; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030054; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]";"apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]";"dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp38695_c0_seq1;GAXK01097470.1;P48506;0;GSH1_HUMAN;Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase);"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]";"GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237";"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]";"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]"
comp3869734_c0_seq1;GAXK01074764.1;O70244;1.05E-08;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp3869930_c0_seq1;GAXK01074761.1;Q9W141;5.25E-45;ATPK_DROME;Putative ATP synthase subunit f, mitochondrial;"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]";"GO:0000276; GO:0005739; GO:0006754; GO:1902600";"ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";
comp386997_c0_seq1;GAXK01156377.1;Q8UW76;3.49E-65;TBX20_CHICK;T-box transcription factor TBX20 (T-box protein 20) (cTbx20);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"GO:0000122; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010991; GO:0021524; GO:0030335; GO:0035922; GO:0036306; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0060973; GO:2000793";"aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]"
comp3870_c0_seq1;GAXK01176634.1;Q8IMA8;1.24E-42;PANG2_DROME;Protein pangolin, isoform J (dTCF);"beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; chitin-based larval cuticle pattern formation [GO:0035293]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0000980; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007367; GO:0007435; GO:0007476; GO:0007500; GO:0007507; GO:0008013; GO:0009880; GO:0010628; GO:0019900; GO:0035277; GO:0035293; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0060070; GO:0070491; GO:0072091; GO:0090254; GO:1990907";"canonical Wnt signaling pathway [GO:0060070]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; chitin-based larval cuticle pattern formation [GO:0035293]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]";"beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3870313_c0_seq1;GAXK01025696.1;Q27433;1.02E-09;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp38708_c1_seq1;GAXK01097862.1;G4SLH0;2.42E-25;TTN1_CAEEL;Titin homolog (EC 2.7.11.1);"A band [GO:0031672]; I band [GO:0031674]; M band [GO:0031430]; nuclear membrane [GO:0031965]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0017022; GO:0030017; GO:0031430; GO:0031672; GO:0031674; GO:0031965; GO:0046872; GO:0051015";;"A band [GO:0031672]; I band [GO:0031674]; M band [GO:0031430]; nuclear membrane [GO:0031965]; sarcomere [GO:0030017]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]"
comp3870865_c0_seq1;GAXK01025702.1;Q01528;6.61E-39;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp38711_c2_seq1;GAXK01097526.1;P86854;5.11E-13;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp3871420_c0_seq1;GAXK01025698.1;Q9VZW5;3.32E-12;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp387238_c3_seq1;GAXK01156383.1;A1A5Y0;2.14E-138;NELL2_DANRE;Protein kinase C-binding protein NELL2 (NEL-like protein 2);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]";"GO:0005080; GO:0005509; GO:0005576; GO:0005737; GO:0008201";;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]"
comp387285_c0_seq1;GAXK01156287.1;O54963;1.10E-08;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp3872986_c0_seq1;GAXK01061040.1;Q6JEL2;2.67E-07;KLH10_HUMAN;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp3872992_c0_seq1;GAXK01061055.1;Q96K83;3.80E-08;ZN521_HUMAN;Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; neuron fate commitment [GO:0048663]";"GO:0003677; GO:0005634; GO:0019904; GO:0046872; GO:0048663";neuron fate commitment [GO:0048663];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]"
comp3873_c0_seq1;GAXK01175508.1;P52009;1.11E-63;CYP1_CAEEL;Peptidyl-prolyl cis-trans isomerase 1 (PPIase 1) (EC 5.2.1.8) (Cyclophilin-1) (Rotamase 1);"mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]";"GO:0003755; GO:0005739; GO:0016018; GO:0042026; GO:0051082";protein refolding [GO:0042026];mitochondrion [GO:0005739];"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp387312_c0_seq1;GAXK01156255.1;Q8I6K1;1.10E-82;PPO1_HOLDI;Phenoloxidase 1 (EC 1.14.18.-) (Prophenoloxidase-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";"GO:0004497; GO:0005576; GO:0042438; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
comp387322_c4_seq1;GAXK01156363.1;P18172;4.56E-84;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp387326_c0_seq1;GAXK01156324.1;Q6DCX5;1.21E-22;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp387328_c0_seq1;GAXK01156365.1;Q5EAC5;1.91E-19;ZN410_BOVIN;Zinc finger protein 410;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp3873770_c0_seq1;GAXK01061039.1;Q8WPA2;2.82E-42;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp387388_c0_seq1;GAXK01156388.1;Q58E03;4.44E-75;DJC25_XENLA;DnaJ homolog subfamily C member 25;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp387392_c1_seq1;GAXK01156305.1;Q7KRI2;9.94E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp3873969_c0_seq1;GAXK01061037.1;Q54LV8;1.12E-34;RL34_DICDI;60S ribosomal protein L34;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0042254";"ribosome biogenesis [GO:0042254]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp3874207_c0_seq1;GAXK01155842.1;O93430;3.75E-27;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp38748_c1_seq2;GAXK01097473.1;Q2TBN3;5.79E-79;CETN2_BOVIN;Centrin-2;"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]";"GO:0000278; GO:0005509; GO:0005813; GO:0005814; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390; GO:0071942";"cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]";"calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]"
comp38758_c0_seq1;GAXK01097495.1;G5EFD9;6.70E-164;ADA10_CAEEL;Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]";"GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667";"cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp3876289_c0_seq1;GAXK01012289.1;Q8TDI7;8.79E-54;TMC2_HUMAN;Transmembrane channel-like protein 2 (Transmembrane cochlear-expressed protein 2);"integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005]";"GO:0005216; GO:0005245; GO:0005887; GO:0008381; GO:0032426; GO:0050910; GO:0060005; GO:1903169";"detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005]";"integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]";"ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]"
comp3876908_c0_seq1;GAXK01012288.1;Q02984;6.33E-49;RL27_PYRST;60S ribosomal protein L27;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp38780_c2_seq1;GAXK01097501.1;Q9XSR1;5.37E-30;ZN252_CANLF;Zinc finger protein 252;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp387809_c0_seq1;GAXK01156303.1;Q32KI9;6.27E-86;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp387881_c0_seq1;GAXK01156413.1;O43739;1.45E-58;CYH3_HUMAN;Cytohesin-3 (ARF nucleotide-binding site opener 3) (Protein ARNO3) (General receptor of phosphoinositides 1) (Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3);"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0000139; GO:0001726; GO:0005086; GO:0005547; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0031234; GO:0032012; GO:0045785; GO:0048193; GO:0090162";"establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012]";"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]"
comp3879_c1_seq1;GAXK01175673.1;Q9VCC3;4.01E-51;RT24_DROME;28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt);"mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005763; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];structural constituent of ribosome [GO:0003735]
comp387935_c1_seq1;GAXK01156333.1;Q96T23;2.13E-19;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp387946_c1_seq1;GAXK01156446.1;Q5EAA4;6.61E-82;MOB3C_BOVIN;MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp3879578_c0_seq1;GAXK01151371.1;A8HS48;1.47E-106;RS3A_CHLRE;40S ribosomal protein S3a;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp3879865_c0_seq1;GAXK01151365.1;P31403;1.46E-32;VATL_MANSE;V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit);"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]";"GO:0005774; GO:0015078; GO:0016021; GO:0033179";;"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";proton transmembrane transporter activity [GO:0015078]
comp388_c1_seq1;GAXK01168776.1;P29693;7.38E-53;EF1D_XENLA;Elongation factor 1-delta (EF-1-delta) (P36);"eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0005853";;eukaryotic translation elongation factor 1 complex [GO:0005853];translation elongation factor activity [GO:0003746]
comp388036_c0_seq1;GAXK01083103.1;Q811F1;3.32E-08;ZBT41_MOUSE;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp38805_c0_seq1;GAXK01097615.1;Q7YTY6;2.27E-55;SP42D_DROME;Serine protease inhibitor 42Dd (Serpin 42Dd);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; immune system process [GO:0002376]; multicellular organism reproduction [GO:0032504]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]";"GO:0002376; GO:0002785; GO:0004867; GO:0005615; GO:0010951; GO:0032504; GO:0045751; GO:0045861; GO:1905035";"immune system process [GO:0002376]; multicellular organism reproduction [GO:0032504]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]";extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp3880657_c0_seq1;GAXK01063789.1;Q05927;7.46E-19;5NTD_BOVIN;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; AMP catabolic process [GO:0006196]";"GO:0000166; GO:0005886; GO:0006196; GO:0008253; GO:0031225; GO:0046872";AMP catabolic process [GO:0006196];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp388106_c0_seq1;GAXK01083090.1;Q9ESG5;1.02E-70;HS3S1_RAT;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (Heparan sulfate 3-O-sulfotransferase 1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0008467; GO:0015012; GO:0034483";heparan sulfate proteoglycan biosynthetic process [GO:0015012];Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp38819_c0_seq1;GAXK01097508.1;P41041;1.42E-33;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp38821_c2_seq1;GAXK01097459.1;C1FXW9;0;THOC2_DASNO;THO complex subunit 2 (Tho2);"nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380]";"GO:0000347; GO:0003723; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0048666; GO:0048699";"generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; THO complex [GO:0000347]";RNA binding [GO:0003723]
comp388239_c0_seq1;GAXK01083110.1;Q8TB72;7.28E-135;PUM2_HUMAN;Pumilio homolog 2 (Pumilio-2);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]";"GO:0003723; GO:0003730; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637";"positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]"
comp38831_c0_seq1;GAXK01097772.1;Q6NYT3;1.58E-08;IER5L_DANRE;Immediate early response gene 5-like protein;;;;;
comp388316_c0_seq1;GAXK01083104.1;Q9P243;2.70E-10;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp388318_c1_seq1;GAXK01083234.1;Q1H9T6;1.55E-15;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp38837_c2_seq1;GAXK01097849.1;Q7KMJ6;1.52E-57;NITO_DROME;RNA-binding protein spenito;"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737";"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";RNA binding [GO:0003723]
comp388435_c1_seq1;GAXK01205418.1;Q26430;3.80E-38;ABDA_MANSE;Homeobox protein abdominal-A homolog (Fragment);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp388465_c2_seq1;GAXK01083218.1;Q8CHC4;6.69E-18;SYNJ1_MOUSE;Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1);"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]";"GO:0003723; GO:0004438; GO:0004439; GO:0005737; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030118; GO:0030132; GO:0032526; GO:0032991; GO:0034097; GO:0034595; GO:0043005; GO:0043195; GO:0043812; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048015; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052658; GO:0097060; GO:0098685; GO:0098688; GO:0098793; GO:0098794; GO:0098884; GO:0098978; GO:0099149; GO:1903423; GO:1904980; GO:1990175";"brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]";"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]";"EH domain binding [GO:1990175]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"
comp388476_c0_seq1;GAXK01083191.1;Q8TF45;1.23E-15;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3884831_c0_seq1;GAXK01194421.1;Q9H3Z4;2.09E-12;DNJC5_HUMAN;DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP);"anchored component of synaptic vesicle membrane [GO:0098993]; azurophil granule membrane [GO:0035577]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP-dependent protein binding [GO:0043008]; chaperone-mediated protein folding [GO:0061077]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; regulated exocytosis [GO:0045055]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005739; GO:0005765; GO:0005886; GO:0006887; GO:0007269; GO:0016020; GO:0016079; GO:0031594; GO:0035577; GO:0035579; GO:0042470; GO:0043008; GO:0043312; GO:0043524; GO:0045055; GO:0061077; GO:0061202; GO:0098693; GO:0098993";"chaperone-mediated protein folding [GO:0061077]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; regulated exocytosis [GO:0045055]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]";"anchored component of synaptic vesicle membrane [GO:0098993]; azurophil granule membrane [GO:0035577]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]";ATP-dependent protein binding [GO:0043008]
comp3884861_c0_seq1;GAXK01194411.1;Q16960;4.55E-17;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp3885592_c0_seq1;GAXK01194420.1;P31948;9.82E-11;STIP1_HUMAN;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521);"chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]";"GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0008022; GO:0030544; GO:0032991; GO:0051087; GO:0051879; GO:0098761; GO:0101031";cellular response to interleukin-7 [GO:0098761];"chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]"
comp3887085_c0_seq1;GAXK01119189.1;Q5JXX5;8.08E-14;GLRA4_HUMAN;Glycine receptor subunit alpha-4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0050877; GO:0060012; GO:0098690; GO:0099060; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]"
comp3888_c0_seq1;GAXK01175734.1;P47813;5.10E-69;IF1AX_HUMAN;Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C);"cytosol [GO:0005829]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]";"GO:0003723; GO:0003743; GO:0005829; GO:0006413; GO:0008135";translational initiation [GO:0006413];cytosol [GO:0005829];"RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp38890_c0_seq1;GAXK01097599.1;Q9I9A7;1.08E-63;CDT1_XENLA;DNA replication factor Cdt1 (XCDT1);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cell cycle [GO:0007049]; DNA replication [GO:0006260]";"GO:0005634; GO:0006260; GO:0007049; GO:0031490";"cell cycle [GO:0007049]; DNA replication [GO:0006260]";nucleus [GO:0005634];chromatin DNA binding [GO:0031490]
comp388904_c0_seq1;GAXK01083126.1;P14731;7.88E-10;LMNB1_CHICK;Lamin-B1;"intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]";"GO:0005637; GO:0005882";;"intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]";
comp388905_c0_seq1;GAXK01083215.1;Q9VUL9;1.91E-136;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp3889132_c0_seq1;GAXK01010913.1;Q26491;4.39E-15;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp3889148_c0_seq1;GAXK01010926.1;Q9BQ50;6.36E-24;TREX2_HUMAN;Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2);"nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";"GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803";"DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";nucleus [GO:0005634];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp3889353_c0_seq1;GAXK01010917.1;O01404;5.99E-23;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp388965_c0_seq1;GAXK01083102.1;Q03468;0;ERCC6_HUMAN;DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of gene expression, epigenetic [GO:0045815]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0030296; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0070063";"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of gene expression, epigenetic [GO:0045815]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]"
comp388976_c1_seq1;GAXK01083106.1;Q86T29;5.12E-32;ZN605_HUMAN;Zinc finger protein 605;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000976; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp388987_c1_seq1;GAXK01083170.1;Q9HAT2;2.99E-65;SIAE_HUMAN;Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062";"carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]";sialate O-acetylesterase activity [GO:0001681]
comp3890000_c0_seq1;GAXK01140214.1;A8MTY0;4.13E-36;ZN724_HUMAN;Zinc finger protein 724;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp38901_c0_seq1;GAXK01097516.1;P54278;6.90E-125;PMS2_HUMAN;Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2);"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0015630; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0042493";"mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]"
comp389057_c1_seq1;GAXK01083127.1;Q8NET6;1.25E-31;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp389079_c0_seq1;GAXK01083109.1;P33190;3.15E-28;RL40_TETPY;"Ubiquitin-60S ribosomal protein L40 [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52) (CEP53)]";"nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp3890956_c0_seq1;GAXK01140219.1;P30736;6.56E-95;RL15_CHITE;60S ribosomal protein L15 (YL10);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp38913_c0_seq1;GAXK01097426.1;Q9QZ08;3.29E-92;NAGK_MOUSE;N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase);"ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acylmannosamine kinase activity [GO:0009384]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]";"GO:0005524; GO:0006044; GO:0009384; GO:0019262; GO:0045127";"N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]";;"ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acylmannosamine kinase activity [GO:0009384]"
comp389137_c1_seq1;GAXK01083108.1;Q7SXV9;6.77E-29;CALUB_DANRE;Calumenin-B;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";calcium ion binding [GO:0005509]
comp3892130_c0_seq1;GAXK01075191.1;P50573;7.43E-19;GBRR3_RAT;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]"
comp38922_c1_seq1;GAXK01097954.1;P45973;1.43E-18;CBX5_HUMAN;Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha);"chromocenter [GO:0010369]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; blood coagulation [GO:0007596]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]";"GO:0000118; GO:0000122; GO:0000776; GO:0000784; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005720; GO:0005721; GO:0005730; GO:0006974; GO:0007596; GO:0010369; GO:0016032; GO:0017053; GO:0030674; GO:0031618; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042803; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0070317; GO:0070491; GO:0090734; GO:1990904";"blood coagulation [GO:0007596]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; viral process [GO:0016032]";"chromocenter [GO:0010369]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]"
comp389271_c3_seq1;GAXK01083222.1;P10090;0;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp3892799_c1_seq1;GAXK01075200.1;Q9CWR2;1.05E-08;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3893019_c0_seq1;GAXK01075196.1;Q00651;1.99E-15;ITA4_MOUSE;Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (Lymphocyte Peyer patch adhesion molecules subunit alpha) (LPAM subunit alpha) (VLA-4 subunit alpha) (CD antigen CD49d);"cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; cell adhesion molecule binding [GO:0050839]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; chorio-allantoic fusion [GO:0060710]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; face development [GO:0060324]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; mesenchyme development [GO:0060485]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678]; visceral serous pericardium development [GO:0061032]";"GO:0001968; GO:0001974; GO:0002687; GO:0003366; GO:0003823; GO:0005886; GO:0005911; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007507; GO:0009897; GO:0009986; GO:0016477; GO:0030426; GO:0033631; GO:0034113; GO:0034446; GO:0034669; GO:0043025; GO:0043113; GO:0046872; GO:0050839; GO:0050901; GO:0050904; GO:0060324; GO:0060385; GO:0060485; GO:0060710; GO:0061032; GO:0070062; GO:0072678; GO:0090074; GO:0098609; GO:0098657; GO:0140039; GO:1903039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406";"axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cell migration [GO:0016477]; cellular response to amyloid-beta [GO:1904646]; chorio-allantoic fusion [GO:0060710]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; face development [GO:0060324]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; mesenchyme development [GO:0060485]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678]; visceral serous pericardium development [GO:0061032]";"cell-cell junction [GO:0005911]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"antigen binding [GO:0003823]; cell adhesion molecule binding [GO:0050839]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]"
comp3893030_c0_seq1;GAXK01075197.1;Q8LBI9;5.09E-12;EDL16_ARATH;Sugar transporter ERD6-like 16;"integral component of plasma membrane [GO:0005887]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005887";;integral component of plasma membrane [GO:0005887];carbohydrate:proton symporter activity [GO:0005351]
comp3894577_c0_seq1;GAXK01025795.1;P70414;4.99E-09;NAC1_MOUSE;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0008092; GO:0009791; GO:0010763; GO:0010881; GO:0014704; GO:0014829; GO:0016020; GO:0016021; GO:0016323; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0035994; GO:0036376; GO:0042383; GO:0042995; GO:0043197; GO:0043198; GO:0044325; GO:0044557; GO:0045211; GO:0048747; GO:0051481; GO:0051924; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0086036; GO:0086038; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; muscle fiber development [GO:0048747]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; vascular smooth muscle contraction [GO:0014829]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; ion channel binding [GO:0044325]"
comp3895110_c0_seq1;GAXK01025801.1;Q64261;4.58E-21;CDK6_MOUSE;Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE);"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0007219; GO:0009615; GO:0010468; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000773";"cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]"
comp3895408_c0_seq1;GAXK01025794.1;Q90YI8;4.49E-14;TAL1_TAKRU;T-cell acute lymphocytic leukemia protein 1 (TAL-1) (FrSCL) (Stem cell protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; definitive hemopoiesis [GO:0060216]; endocardium formation [GO:0060214]; erythrocyte differentiation [GO:0030218]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; myeloid cell differentiation [GO:0030099]; primitive hemopoiesis [GO:0060215]; vasculogenesis [GO:0001570]";"GO:0001525; GO:0001570; GO:0003677; GO:0005634; GO:0030099; GO:0030218; GO:0046983; GO:0048844; GO:0060214; GO:0060215; GO:0060216; GO:0060217; GO:0060218";"angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; definitive hemopoiesis [GO:0060216]; endocardium formation [GO:0060214]; erythrocyte differentiation [GO:0030218]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; myeloid cell differentiation [GO:0030099]; primitive hemopoiesis [GO:0060215]; vasculogenesis [GO:0001570]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp3895697_c0_seq1;GAXK01025799.1;Q9BQ50;1.19E-19;TREX2_HUMAN;Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2);"nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";"GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803";"DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";nucleus [GO:0005634];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp389574_c0_seq1;GAXK01083220.1;Q91783;8.71E-22;KI11A_XENLA;Kinesin-like protein KIF11-A (Kinesin-5) (Kinesin-related motor protein Eg5-2) (XLEg5K2);"cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]";"GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp389578_c0_seq1;GAXK01083228.1;P49866;6.66E-137;HNF4_DROME;Transcription factor HNF-4 homolog (dHNF4) (Nuclear receptor subfamily 2 group A member 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; heterochromatin organization involved in chromatin silencing [GO:0070868]; lipid catabolic process [GO:0016042]; lipid oxidation [GO:0034440]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0016042; GO:0030154; GO:0032869; GO:0034440; GO:0042593; GO:0048856; GO:0070868";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; heterochromatin organization involved in chromatin silencing [GO:0070868]; lipid catabolic process [GO:0016042]; lipid oxidation [GO:0034440]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp38961_c1_seq1;GAXK01097457.1;P52034;0;PFKA_DROME;ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase);"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";"GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0007520; GO:0007525; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095";"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";6-phosphofructokinase complex [GO:0005945];"6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
comp38966_c0_seq1;GAXK01097471.1;Q5ZLY0;4.38E-18;PHAX_CHICK;Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"GO:0003723; GO:0005634; GO:0005737; GO:0006408; GO:0015031";"protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp389673_c0_seq1;GAXK01083114.1;P45481;3.97E-09;CBP_MOUSE;CREB-binding protein (EC 2.3.1.48);"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0000122; GO:0000123; GO:0000790; GO:0000940; GO:0000977; GO:0000987; GO:0001085; GO:0001093; GO:0002039; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0008134; GO:0008140; GO:0008270; GO:0008283; GO:0010628; GO:0016407; GO:0016573; GO:0016604; GO:0016605; GO:0018076; GO:0019904; GO:0030511; GO:0030718; GO:0031648; GO:0032793; GO:0032991; GO:0033613; GO:0034644; GO:0035729; GO:0042975; GO:0043426; GO:0045358; GO:0045893; GO:0045944; GO:0046332; GO:0046982; GO:0048511; GO:0048525; GO:0051091; GO:0060325; GO:0060355; GO:0061733; GO:0090575; GO:0097718; GO:0098586; GO:1900087; GO:1901224";"cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp389685_c1_seq1;GAXK01083112.1;Q9ULJ7;3.67E-14;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp3896926_c0_seq1;GAXK01160018.1;Q9YIB9;1.25E-12;HIF1A_CHICK;Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein dimerization activity [GO:0046983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"GO:0000981; GO:0001666; GO:0003677; GO:0005634; GO:0005737; GO:0006357; GO:0016607; GO:0035035; GO:0045893; GO:0045944; GO:0046983";"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein dimerization activity [GO:0046983]"
comp38973_c1_seq1;GAXK01097453.1;Q9BY12;1.50E-110;SCAPE_HUMAN;S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]";"GO:0003676; GO:0005634; GO:0005783; GO:0005829; GO:0008270";;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]";"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp3897410_c0_seq1;GAXK01160011.1;Q6NYW6;1.65E-29;CLAP2_DANRE;CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2);"cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; trans-Golgi network [GO:0005802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0000777; GO:0005794; GO:0005802; GO:0005815; GO:0005819; GO:0005874; GO:0005881; GO:0007020; GO:0007030; GO:0007052; GO:0008017; GO:0010458; GO:0031023; GO:0031110; GO:0031252; GO:0032587; GO:0032886; GO:0034453; GO:0051010; GO:0051301";"cell division [GO:0051301]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule polymerization or depolymerization [GO:0031110]";"cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; trans-Golgi network [GO:0005802]";"microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]"
comp389743_c1_seq1;GAXK01083190.1;Q27367;6.32E-46;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp389761_c1_seq1;GAXK01083116.1;Q5M7E1;1.16E-30;CLVS1_XENLA;Clavesin-1 (Retinaldehyde-binding protein 1-like 1);"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]";"GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0080025";lysosome organization [GO:0007040];"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]";phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]
comp389781_c1_seq1;GAXK01083121.1;D2GXS7;1.10E-180;TRIM2_AILME;Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);"cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]";"GO:0004842; GO:0005737; GO:0008270; GO:0043523";regulation of neuron apoptotic process [GO:0043523];cytoplasm [GO:0005737];"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp389798_c0_seq1;GAXK01083131.1;Q6NYJ3;5.63E-09;TE2IP_DANRE;Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog) (RAP1 homolog);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; DNA binding [GO:0003677]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000723; GO:0000781; GO:0003677; GO:0005634; GO:0005737; GO:0006355; GO:0010569; GO:0010833; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187";"negative regulation of DNA recombination at telomere [GO:0048239]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; shelterin complex [GO:0070187]";"DNA binding [GO:0003677]; telomeric DNA binding [GO:0042162]"
comp3898_c0_seq1;GAXK01175152.1;P55036;1.50E-107;PSMD4_HUMAN;26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006521; GO:0008540; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031593; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043248; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]";"identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]"
comp389802_c0_seq1;GAXK01083197.1;Q8C341;2.39E-29;SUCO_MOUSE;SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia) (SUN-like protein 1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of bone remodeling [GO:0046850]";"GO:0001503; GO:0005737; GO:0005791; GO:0007275; GO:0016020; GO:0016021; GO:0030867; GO:0032967; GO:0034975; GO:0045669; GO:0046850";"multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of bone remodeling [GO:0046850]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]";
comp389864_c0_seq1;GAXK01083200.1;Q2M2N2;8.63E-07;SPOPL_MOUSE;Speckle-type POZ protein-like (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp3898691_c0_seq1;GAXK01149012.1;Q9SFB8;6.62E-07;PI5K6_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 6 (AtPIP5K6) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 6) (Diphosphoinositide kinase 6) (PtdIns(4)P-5-kinase 6);"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005524; GO:0016308; GO:0016324; GO:0072583; GO:0090406";clathrin-dependent endocytosis [GO:0072583];"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp389888_c0_seq1;GAXK01083084.1;O93567;7.45E-07;ZBT7A_CHICK;Zinc finger and BTB domain-containing protein 7A (Leukemia/lymphoma-related factor) (cLRF);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription regulatory region DNA binding [GO:2000677]";"GO:0000978; GO:0001222; GO:0003700; GO:0003714; GO:0005634; GO:0006338; GO:0006974; GO:0045892; GO:0046872; GO:2000677";"cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription regulatory region DNA binding [GO:2000677]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]"
comp389941_c0_seq1;GAXK01083091.1;Q9CQ02;8.78E-27;COMD4_MOUSE;COMM domain-containing protein 4;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp3899589_c0_seq1;GAXK01149013.1;Q8L706;4.76E-16;SYT5_ARATH;Synaptotagmin-5 (NTMC2T2.1) (Synaptotagmin E);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; lipid transport [GO:0006869]";"GO:0005783; GO:0005886; GO:0006869; GO:0008289; GO:0009506; GO:0012505; GO:0016021; GO:0046872";lipid transport [GO:0006869];"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"lipid binding [GO:0008289]; metal ion binding [GO:0046872]"
comp3900020_c0_seq1;GAXK01112360.1;Q08069;2.72E-58;RS8_MAIZE;40S ribosomal protein S8;"chloroplast ribosome [GO:0043253]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosome assembly [GO:0042255]; translation [GO:0006412]";"GO:0000462; GO:0003735; GO:0006412; GO:0022627; GO:0042255; GO:0043253";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosome assembly [GO:0042255]; translation [GO:0006412]";"chloroplast ribosome [GO:0043253]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp390021_c1_seq1;GAXK01109277.1;Q8AVN9;1.02E-11;ZN346_XENLA;Zinc finger protein 346 (Double-stranded RNA-binding protein ZFa) (DsRBP-ZFa) (ZFa) (Just another zinc finger protein) (Protein jaz);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]";"GO:0003725; GO:0005634; GO:0005737; GO:0008270";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]"
comp390053_c0_seq1;GAXK01109282.1;Q0ZDF7;1.12E-38;URAD_AMICA;2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase);"peroxisome [GO:0005777]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";"GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628";"allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";peroxisome [GO:0005777];carboxy-lyase activity [GO:0016831]
comp3900672_c0_seq1;GAXK01112375.1;P24524;3.64E-31;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp39009_c0_seq1;GAXK01097813.1;Q8BQ89;1.14E-127;LIX1L_MOUSE;LIX1-like protein;"cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";"GO:0005737; GO:0006914; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";cytoplasm [GO:0005737];
comp3901233_c0_seq1;GAXK01112365.1;Q3U3I9;2.48E-08;ZN865_MOUSE;Zinc finger protein 865;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3901671_c0_seq1;GAXK01112361.1;Q8BXX2;2.75E-09;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp39023_c2_seq1;GAXK01097346.1;Q9W3J5;0;SYFA_DROME;Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]";"GO:0000049; GO:0002161; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328";phenylalanyl-tRNA aminoacylation [GO:0006432];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]";"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]"
comp3902640_c0_seq1;GAXK01150128.1;Q8CA95;5.56E-15;PDE10_MOUSE;cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35);"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]";"GO:0004112; GO:0004114; GO:0004118; GO:0005737; GO:0006198; GO:0007165; GO:0010738; GO:0010754; GO:0016020; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0043949; GO:0043951; GO:0046069; GO:0046872; GO:0047555";"cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"
comp390291_c2_seq1;GAXK01109274.1;Q9R1R4;4.17E-09;TDRD7_RAT;Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap);"mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0005759; GO:0007283; GO:0010608; GO:0035770; GO:0047485; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]";"mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]"
comp390295_c2_seq1;GAXK01109294.1;D0PRN3;5.56E-42;NRX3A_CHICK;Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]";"GO:0007155; GO:0016021; GO:0046872";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];metal ion binding [GO:0046872]
comp3903082_c0_seq1;GAXK01150138.1;Q9M8J5;3.34E-09;M2K8_ARATH;Mitogen-activated protein kinase kinase 8 (AtMKK8) (MAP kinase kinase 8) (EC 2.7.12.2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000187; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0023014; GO:0031098; GO:0032147";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]"
comp390366_c0_seq1;GAXK01109272.1;P23414;1.20E-89;ACH1_SCHGR;Acetylcholine receptor subunit alpha-L1;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp3903704_c0_seq1;GAXK01150130.1;Q9W1A4;2.45E-12;TAMO_DROME;Protein tamozhennic;"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005737; GO:0007275; GO:0008536; GO:0015031; GO:0046872";"multicellular organism development [GO:0007275]; protein transport [GO:0015031]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]"
comp3903936_c0_seq1;GAXK01150140.1;Q9VJ79;3.82E-26;PDE11_DROME;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp3903950_c0_seq1;GAXK01150139.1;Q32TF8;2.13E-14;EFHC2_DANRE;EF-hand domain-containing family member C2;regulation of neuron projection development [GO:0010975];GO:0010975;regulation of neuron projection development [GO:0010975];;
comp39043_c1_seq1;GAXK01098046.1;O02373;0;UGDH_DROME;UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper);"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]";"GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287";"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]"
comp390434_c0_seq1;GAXK01109273.1;Q03206;9.94E-56;RAC1_CAEEL;Ras-related protein ced-10 (CErac1) (Cell death protein 10) (Cell-corpse engulfment protein ced-10) (Ras-related protein rac-1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of cell migration [GO:0030334]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000132; GO:0001764; GO:0002119; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007264; GO:0007266; GO:0007369; GO:0008045; GO:0009898; GO:0010171; GO:0010172; GO:0016021; GO:0016477; GO:0019901; GO:0030036; GO:0030334; GO:0031103; GO:0031410; GO:0032228; GO:0033563; GO:0042995; GO:0043025; GO:0043652; GO:0045138; GO:0048598; GO:0048812; GO:0048846; GO:0050764; GO:0070986; GO:0097628; GO:1901076; GO:1903356";"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of cell migration [GO:0030334]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp3904457_c0_seq1;GAXK01192690.1;Q863A4;7.91E-20;DAAF4_PONPY;Dynein assembly factor 4, axonemal (Dyslexia susceptibility 1 candidate gene 1 protein homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136]";"GO:0001764; GO:0003341; GO:0005634; GO:0005737; GO:0007368; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0061136";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";estrogen receptor binding [GO:0030331]
comp390502_c1_seq1;GAXK01109191.1;Q66S03;8.30E-12;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp3905221_c0_seq1;GAXK01192706.1;Q5WA50;1.87E-12;CTR2_OCTVU;Cephalotocin receptor 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]";"GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0046887";"G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]"
comp390563_c0_seq1;GAXK01109280.1;P18756;2.17E-60;ETS1B_XENLA;Protein c-ets-1-B (C-ets-1B) (XE1-B) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";"GO:0003700; GO:0005634; GO:0010595; GO:0043565; GO:0045765";"positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp390570_c0_seq1;GAXK01109279.1;Q6UXN8;5.58E-10;CLC9A_HUMAN;C-type lectin domain family 9 member A (CD antigen CD370);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; positive regulation of cytokine secretion [GO:0050715]; receptor-mediated endocytosis [GO:0006898]";"GO:0006898; GO:0009986; GO:0016021; GO:0030246; GO:0050715";"positive regulation of cytokine secretion [GO:0050715]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";carbohydrate binding [GO:0030246]
comp3905742_c0_seq1;GAXK01192699.1;E9Q743;1.51E-16;CF251_MOUSE;Cilia- and flagella-associated protein 251 (CFAP251) (WD repeat-containing protein 66);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"GO:0003341; GO:0005737; GO:0005856; GO:0030317; GO:0031514; GO:0036126";"cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]";
comp390630_c1_seq1;GAXK01109433.1;P52485;2.69E-32;UBCD2_DROME;Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005524; GO:0019915; GO:0061631";"lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp3906465_c0_seq1;GAXK01003563.1;Q9F7P4;4.45E-08;PRRG_PRB01;Green-light absorbing proteorhodopsin (GPR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005886; GO:0007602; GO:0009881; GO:0010461; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]"
comp3907147_c0_seq1;GAXK01003572.1;Q9M7X7;1.31E-15;RL291_ARATH;60S ribosomal protein L29-1;"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005730; GO:0022625";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp3907339_c0_seq1;GAXK01003573.1;O42329;6.04E-18;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp3908205_c0_seq1;GAXK01163255.1;Q6ZNG9;1.17E-08;KRBA2_HUMAN;KRAB-A domain-containing protein 2;"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0015074";"DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";;nucleic acid binding [GO:0003676]
comp3908206_c1_seq1;GAXK01163262.1;P39057;2.40E-89;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp39083_c0_seq1;GAXK01097664.1;Q8L831;1.39E-71;NUDT3_ARATH;Nudix hydrolase 3 (AtNUDT3) (EC 3.6.1.-);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; vacuole [GO:0005773]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]";"GO:0005739; GO:0005773; GO:0005829; GO:0008239; GO:0046872";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; vacuole [GO:0005773]";"dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]"
comp3908585_c0_seq1;GAXK01163264.1;Q69D48;1.13E-50;RHBGA_XENLA;Ammonium transporter Rh type B-A (Rhesus blood group family type B glycoprotein A) (Rh family type B glycoprotein A) (Rh type B glycoprotein A);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]";"GO:0008519; GO:0016021; GO:0016323; GO:0030659";;"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";ammonium transmembrane transporter activity [GO:0008519]
comp390861_c0_seq1;GAXK01109244.1;Q8K3K9;1.95E-07;GIMA4_RAT;GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (Immunity-associated protein 4);"cytosol [GO:0005829]; GTP binding [GO:0005525]";"GO:0005525; GO:0005829";;cytosol [GO:0005829];GTP binding [GO:0005525]
comp390872_c0_seq1;GAXK01109241.1;Q0VDI3;2.41E-25;TM267_HUMAN;Transmembrane protein 267;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp3908830_c0_seq1;GAXK01163248.1;Q71S21;2.34E-37;INVSB_XENLA;Inversin-B;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]";"GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055";"multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";calmodulin binding [GO:0005516]
comp3909396_c0_seq1;GAXK01163270.1;Q93126;1.88E-41;GPR9_AMPAM;Probable G-protein coupled receptor No9;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]";"GO:0004935; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";adrenergic receptor activity [GO:0004935]
comp3909408_c0_seq1;GAXK01163266.1;P0DPA6;2.01E-09;PSID_PSICU;L-tryptophan decarboxylase (EC 4.1.1.105) (Psilocybin biosynthesis decarboxylase);"phosphatidylserine decarboxylase activity [GO:0004609]; phospholipid biosynthetic process [GO:0008654]";"GO:0004609; GO:0008654";phospholipid biosynthetic process [GO:0008654];;phosphatidylserine decarboxylase activity [GO:0004609]
comp391029_c0_seq1;GAXK01109287.1;O95279;6.78E-16;KCNK5_HUMAN;Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2);"integral component of plasma membrane [GO:0005887]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]; excretion [GO:0007588]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]";"GO:0005249; GO:0005267; GO:0005887; GO:0006813; GO:0007588; GO:0022841; GO:0030322; GO:0034765; GO:0071805; GO:1990573";"excretion [GO:0007588]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];"potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]"
comp3910423_c0_seq1;GAXK01060224.1;P34925;9.11E-23;RYK_HUMAN;Tyrosine-protein kinase RYK (EC 2.7.10.1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp3910518_c0_seq1;GAXK01060215.1;Q66S03;1.10E-20;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp3910730_c0_seq1;GAXK01060207.1;Q9GV46;1.78E-07;LUCB_OPLGR;Oplophorus-luciferin 2-monooxygenase non-catalytic subunit;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp391077_c0_seq1;GAXK01109435.1;P24524;3.53E-72;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp39111_c1_seq1;GAXK01097632.1;Q5R9Y1;1.60E-59;FSTL1_PONAB;Follistatin-related protein 1 (Follistatin-like protein 1);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]";"GO:0005509; GO:0005576; GO:0008201";;extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp3911442_c0_seq1;GAXK01060216.1;O15084;3.21E-39;ANR28_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]";"GO:0000139; GO:0005654; GO:0005829; GO:0048208";COPII vesicle coating [GO:0048208];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";
comp391165_c0_seq1;GAXK01109291.1;Q24372;3.43E-32;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp3912_c0_seq1;GAXK01175337.1;Q6DKC0;7.10E-147;ERL2B_XENLA;Erlin-2-B (Endoplasmic reticulum lipid raft-associated protein 2-B) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2-B) (SPFH domain-containing protein 2-B);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]";"GO:0005789; GO:0008203; GO:0016021; GO:0031625";cholesterol metabolic process [GO:0008203];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";ubiquitin protein ligase binding [GO:0031625]
comp39146_c1_seq1;GAXK01098054.1;Q95RX5;8.36E-80;KCMF1_DROME;E3 ubiquitin-protein ligase Kcmf1 (EC 2.3.2.27);"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0061630";;;"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp3914672_c0_seq1;GAXK01050857.1;P08775;4.19E-09;RPB1_MOUSE;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit);"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625]; cellular response to oxygen levels [GO:0071453]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]";"GO:0001047; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005719; GO:0005737; GO:0006353; GO:0006366; GO:0008022; GO:0014070; GO:0031625; GO:0033120; GO:0046872; GO:0071453; GO:1990841";"cellular response to oxygen levels [GO:0071453]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625]"
comp3914889_c0_seq1;GAXK01050849.1;Q6GL52;2.29E-08;ZN574_XENTR;Zinc finger protein 574;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp391582_c0_seq1;GAXK01109278.1;Q7JYV2;5.39E-45;SNG_DROME;Synaptogyrin;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]";"GO:0006897; GO:0016021; GO:0016079; GO:0030054; GO:0030672; GO:0031594; GO:0048489; GO:0098693";"endocytosis [GO:0006897]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]";
comp391600_c0_seq1;GAXK01109351.1;P17789;3.30E-23;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp3916171_c0_seq1;GAXK01027281.1;Q01528;8.63E-20;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp39169_c0_seq1;GAXK01098002.1;Q5R413;7.32E-41;DCP1B_PONAB;mRNA-decapping enzyme 1B (EC 3.-.-.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"GO:0000184; GO:0000290; GO:0005634; GO:0005737; GO:0008047; GO:0016787";"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]"
comp3916962_c0_seq1;GAXK01027282.1;Q9C091;9.55E-09;GRB1L_HUMAN;GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein);"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp3917035_c0_seq1;GAXK01027287.1;Q5R5U3;8.89E-17;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp39173_c0_seq1;GAXK01097454.1;Q91XE7;4.03E-15;VA0E2_MOUSE;V-type proton ATPase subunit e 2 (V-ATPase subunit e 2) (Vacuolar proton pump subunit e 2);"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; hydrolase activity [GO:0016787]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0016787; GO:0033179; GO:0046961; GO:0055085; GO:1902600";"proton transmembrane transport [GO:1902600]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]";"hydrolase activity [GO:0016787]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp3917555_c0_seq1;GAXK01027285.1;Q757G1;6.52E-16;RS29_ASHGO;40S ribosomal protein S29;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0008270; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]"
comp391826_c0_seq1;GAXK01109371.1;P51452;3.99E-30;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp39187_c4_seq1;GAXK01097799.1;Q9Y2Q0;0;AT8A1_HUMAN;Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1);"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0019829; GO:0030335; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0043312; GO:0045332; GO:0061092; GO:0070062; GO:0140326";"ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp39191_c4_seq1;GAXK01098016.1;P58058;3.22E-154;NADK_MOUSE;NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]";"GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872";"NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]";cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp391979_c0_seq1;GAXK01109439.1;P83501;1.14E-20;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp392_c1_seq1;GAXK01165872.1;P12261;2.71E-179;EF1G_ARTSA;Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma);translation elongation factor activity [GO:0003746];GO:0003746;;;translation elongation factor activity [GO:0003746]
comp392025_c1_seq1;GAXK01080207.1;Q96JL9;9.09E-30;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp392041_c0_seq1;GAXK01080224.1;Q9CXE0;1.38E-12;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp392043_c0_seq1;GAXK01080218.1;Q5F464;4.08E-87;LPP_CHICK;Lipoma-preferred partner homolog;"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]";metal ion binding [GO:0046872]
comp39208_c1_seq1;GAXK01097423.1;P35816;2.11E-103;PDP1_BOVIN;[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; protein serine/threonine phosphatase activity [GO:0004722]; dephosphorylation [GO:0016311]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]";"GO:0000287; GO:0004722; GO:0004724; GO:0004741; GO:0005509; GO:0005739; GO:0005759; GO:0016311; GO:1904184";"dephosphorylation [GO:0016311]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"[pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; calcium ion binding [GO:0005509]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]"
comp3920834_c0_seq1;GAXK01084369.1;Q6NP60;1.34E-07;MOX12_DROME;MOXD1 homolog 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005829; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp3921230_c0_seq1;GAXK01084382.1;Q08832;7.11E-13;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp392318_c0_seq1;GAXK01080244.1;P25155;4.50E-54;FA10_CHICK;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp3923206_c0_seq1;GAXK01185296.1;Q14679;1.17E-14;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp39235_c0_seq1;GAXK01097779.1;O55236;0;MCE1_MOUSE;"mRNA-capping enzyme (HCE) (MCE1) [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]";"nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396]";"GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0006370; GO:0006396; GO:0008138; GO:0008192; GO:0050355";"7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396]";nucleus [GO:0005634];"GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]"
comp39237_c0_seq1;GAXK01098042.1;P36609;6.24E-65;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp39244_c1_seq1;GAXK01097619.1;Q9V6Y3;4.09E-28;RT16_DROME;Probable 28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt);"mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005763; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];structural constituent of ribosome [GO:0003735]
comp392450_c0_seq1;GAXK01080198.1;Q5RFK6;6.59E-25;SUH_PONAB;Recombining binding protein suppressor of hairless (J kappa-recombination signal-binding protein) (RBP-J kappa);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]";"GO:0000978; GO:0001228; GO:0005634; GO:0005737; GO:0007221; GO:0008134; GO:0043565; GO:0061419";"positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp3925099_c0_seq1;GAXK01182684.1;O35310;2.47E-17;HS3S1_MOUSE;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (Heparan sulfate 3-O-sulfotransferase 1);"Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0005796; GO:0008467; GO:0015012; GO:0034483";heparan sulfate proteoglycan biosynthetic process [GO:0015012];Golgi lumen [GO:0005796];"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp392540_c0_seq1;GAXK01080351.1;P20693;1.99E-19;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp39255_c1_seq1;GAXK01097768.1;Q99PL6;1.89E-52;UBXN6_MOUSE;UBX domain-containing protein 6 (UBX domain-containing protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]";"GO:0005634; GO:0005737; GO:0005765; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503";"endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";
comp392552_c0_seq1;GAXK01080236.1;Q6ZN57;8.00E-39;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp39264_c2_seq1;GAXK01097825.1;Q9U1Q4;1.16E-92;SYV_CAEEL;Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS);"cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; determination of adult lifespan [GO:0008340]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006438; GO:0008340";"determination of adult lifespan [GO:0008340]; valyl-tRNA aminoacylation [GO:0006438]";cytosol [GO:0005829];"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]"
comp392694_c0_seq1;GAXK01080192.1;B5XBI1;3.02E-34;IF43A_SALSA;Intraflagellar transport protein 43 homolog A;"cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]";"GO:0005929; GO:0030991; GO:0035721; GO:0060271";"cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]";"cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]";
comp392697_c5_seq1;GAXK01080256.1;Q96PE2;3.26E-102;ARHGH_HUMAN;Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4);"cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0035023; GO:0043065; GO:0051056";"actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";cytosol [GO:0005829];"guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp392726_c1_seq1;GAXK01080243.1;P10090;2.40E-42;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp392731_c0_seq1;GAXK01080197.1;Q8T6L5;2.19E-15;TPM_PERFU;Tropomyosin;;;;;
comp392739_c0_seq1;GAXK01080177.1;Q9NYT6;6.07E-14;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp39276_c0_seq1;GAXK01097456.1;Q17IN5;8.38E-76;MED18_AEDAE;Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp3928_c0_seq1;GAXK01176497.1;Q9BY50;4.92E-91;SC11C_HUMAN;Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465]";"GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0008236; GO:0016021";signal peptide processing [GO:0006465];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";"peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]"
comp39282_c0_seq1;GAXK01098039.1;Q91WD1;3.31E-24;RPC4_MOUSE;DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"GO:0000790; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0016607; GO:0032728; GO:0045087; GO:0045089; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp3929817_c0_seq1;GAXK01121698.1;Q20930;8.90E-10;MIG17_CAEEL;Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]";"GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354";"gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp392998_c1_seq1;GAXK01080284.1;Q63488;1.63E-27;S20A2_RAT;Sodium-dependent phosphate transporter 2 (Phosphate transporter 2) (PiT-2) (Receptor for amphotropic viruses 1) (RAM-1) (Solute carrier family 20 member 2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]; viral process [GO:0016032]";"GO:0005315; GO:0005887; GO:0015319; GO:0016021; GO:0016032; GO:0035435";"phosphate ion transmembrane transport [GO:0035435]; viral process [GO:0016032]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp3930_c2_seq1;GAXK01176093.1;Q9AXQ5;4.50E-21;IF5A2_SOLLC;Eukaryotic translation initiation factor 5A-2 (eIF-5A-2);"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003743; GO:0003746; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";;"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp3930081_c0_seq1;GAXK01034212.1;Q9FLF0;4.08E-68;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp393017_c0_seq1;GAXK01080322.1;P20482;2.78E-13;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp393037_c0_seq1;GAXK01080176.1;P05661;2.65E-39;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp393039_c0_seq1;GAXK01080185.1;Q12749;6.07E-16;SMC6_YEAST;Structural maintenance of chromosomes protein 6 (DNA repair protein RHC18) (Rad18 homolog);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; chromosome separation [GO:0051304]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; resolution of recombination intermediates [GO:0071139]";"GO:0000724; GO:0003684; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0016925; GO:0030915; GO:0035861; GO:0051304; GO:0071139; GO:1990683";"chromosome separation [GO:0051304]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; resolution of recombination intermediates [GO:0071139]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]";"ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]"
comp3930865_c0_seq1;GAXK01034202.1;Q921V5;4.45E-73;MGAT2_MOUSE;Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803";"oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"
comp3931233_c0_seq1;GAXK01034205.1;P52292;1.76E-07;IMA1_HUMAN;Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"GO:0000018; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902";"DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]"
comp3931286_c0_seq1;GAXK01034214.1;O42820;9.86E-53;EF1A_SCHCO;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp39313_c1_seq1;GAXK01097348.1;B4GN43;8.02E-26;MAEL2_DROPE;Protein maelstrom 2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; transcription regulatory region DNA binding [GO:0044212]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]; piRNA metabolic process [GO:0034587]; regulation of gene silencing by miRNA [GO:0060964]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030718; GO:0031047; GO:0034587; GO:0043186; GO:0044212; GO:0045892; GO:0048471; GO:0048477; GO:0051321; GO:0060964";"gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]; piRNA metabolic process [GO:0034587]; regulation of gene silencing by miRNA [GO:0060964]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; P granule [GO:0043186]";transcription regulatory region DNA binding [GO:0044212]
comp3931513_c0_seq1;GAXK01034207.1;Q1H9T6;1.75E-07;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3931627_c0_seq1;GAXK01034209.1;Q5U263;3.48E-07;KDM2A_XENTR;Lysine-specific demethylase 2A (EC 1.14.11.27) (F-box and leucine-rich repeat protein 11) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A);"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; zinc ion binding [GO:0008270]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";"GO:0003677; GO:0005654; GO:0008270; GO:0042752; GO:0048511; GO:0051864";"regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]";nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; zinc ion binding [GO:0008270]"
comp393238_c0_seq1;GAXK01080223.1;Q80WC3;2.25E-25;TNC18_MOUSE;Trinucleotide repeat-containing gene 18 protein (Zinc finger protein 469);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]";"GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0031965";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp39324_c0_seq1;GAXK01097600.1;Q6P8G1;2.70E-152;ILF2_XENTR;Interleukin enhancer-binding factor 2 homolog;"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003725; GO:0005524; GO:0005634; GO:0005730; GO:0006351; GO:0006955; GO:0016740; GO:0045893";"immune response [GO:0006955]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]"
comp3933015_c0_seq1;GAXK01037320.1;O15084;4.37E-13;ANR28_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]";"GO:0000139; GO:0005654; GO:0005829; GO:0048208";COPII vesicle coating [GO:0048208];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";
comp393343_c0_seq1;GAXK01080219.1;Q92031;9.03E-07;VM1A_AGKCL;Snake venom metalloproteinase ACLF (SVMP) (EC 3.4.24.-) (ACLF-I) (Metalloproteinase VMP-I) (AclVMP-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp3933543_c0_seq1;GAXK01037321.1;Q9VZW5;1.46E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp3934142_c0_seq1;GAXK01129226.1;F7J220;1.27E-47;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp393442_c0_seq1;GAXK01080331.1;Q4LDE5;1.60E-12;SVEP1_HUMAN;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp39346_c0_seq1;GAXK01097602.1;P56399;6.00E-126;UBP5_MOUSE;Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5);"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0006511; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0071108";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp393489_c0_seq1;GAXK01080352.1;Q22707;1.93E-23;DUS11_CAEEL;RNA/RNP complex-1-interacting phosphatase homolog (EC 3.1.3.-) (Dual specificity protein phosphatase 11 homolog) (Phosphatase interacting with RNA/RNP complex-1);"nucleus [GO:0005634]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]";"GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0008138; GO:0031047";gene silencing by RNA [GO:0031047];nucleus [GO:0005634];"polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]"
comp39364_c0_seq1;GAXK01097635.1;B4JTT7;1.56E-128;HTRA2_DROGR;Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; Nebenkern [GO:0016006]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; spermatogenesis [GO:0007283]";"GO:0004252; GO:0005758; GO:0005829; GO:0006915; GO:0007005; GO:0007283; GO:0016006; GO:0016021; GO:0031966; GO:0035234; GO:0043065; GO:2001056";"apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; Nebenkern [GO:0016006]";serine-type endopeptidase activity [GO:0004252]
comp3937039_c0_seq1;GAXK01121042.1;P61270;2.65E-60;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp393817_c1_seq1;GAXK01080216.1;Q51330;2.22E-09;OXLT_OXAFO;Oxalate:formate antiporter (OFA) (Oxalate:formate antiport protein) (Oxalate:formate exchange protein);"integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]";"GO:0005887; GO:0015297; GO:0019531";;integral component of plasma membrane [GO:0005887];"antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]"
comp393853_c1_seq1;GAXK01080355.1;Q8R0T2;6.74E-16;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3938638_c0_seq1;GAXK01154519.1;P50430;2.64E-41;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp3939239_c0_seq1;GAXK01154527.1;Q54JE3;2.92E-28;RL221_DICDI;60S ribosomal protein L22 1;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp39399_c3_seq1;GAXK01097756.1;Q9Y115;7.30E-113;UN93L_DROME;UNC93-like protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120";"regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";potassium channel regulator activity [GO:0015459]
comp394065_c0_seq1;GAXK01095837.1;Q539E5;1.38E-27;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp39407_c0_seq1;GAXK01097871.1;Q29MA5;3.38E-74;RM24_DROPS;Probable 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412";translation [GO:0006412];mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp3941273_c0_seq1;GAXK01159692.1;P39057;5.14E-127;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp39413_c0_seq1;GAXK01097773.1;Q9NFZ2;3.18E-26;GBGE_CALVI;Guanine nucleotide-binding protein subunit gamma-e;"heterotrimeric G-protein complex [GO:0005834]; GTPase activity [GO:0003924]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"GO:0003924; GO:0005834; GO:0007200; GO:0007601; GO:0050909";"phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";heterotrimeric G-protein complex [GO:0005834];GTPase activity [GO:0003924]
comp3942177_c0_seq1;GAXK01185224.1;P0C2H6;1.93E-35;RL27A_YEAST;60S ribosomal protein L27-A (Large ribosomal subunit protein eL27-A);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp394259_c0_seq1;GAXK01095893.1;O45435;1.12E-23;BST13_CAEEL;Bestrophin homolog 13;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp3942734_c0_seq1;GAXK01185221.1;Q90YS3;8.59E-30;RS2_ICTPU;40S ribosomal protein S2;"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp39431_c5_seq1;GAXK01097374.1;Q9U3D4;2.32E-56;SMS1_CAEEL;Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Sphingomyelin synthase 1);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0005887; GO:0006686; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]"
comp394314_c0_seq1;GAXK01095919.1;Q9W6V2;5.54E-26;NEGR1_CHICK;Neuronal growth regulator 1 (Neurotractin);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp394358_c0_seq1;GAXK01095839.1;Q9WV06;8.72E-08;ANKR2_MOUSE;Ankyrin repeat domain-containing protein 2 (Skeletal muscle ankyrin repeat protein) (mArpp);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcomere [GO:0030017]; chromatin binding [GO:0003682]; protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to muscle stretch [GO:0035994]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]";"GO:0000122; GO:0000791; GO:0001817; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0007519; GO:0010832; GO:0016605; GO:0030016; GO:0030017; GO:0031432; GO:0031674; GO:0035914; GO:0035994; GO:0043231; GO:0043422; GO:0043619; GO:0045662; GO:0061629; GO:1902253; GO:2000291";"negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to muscle stretch [GO:0035994]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcomere [GO:0030017]";"chromatin binding [GO:0003682]; protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]"
comp3943614_c0_seq1;GAXK01185239.1;A2A761;2.32E-07;ZFP69_MOUSE;Zinc finger protein 69 (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3943765_c0_seq1;GAXK01185236.1;P36609;9.63E-16;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp394384_c0_seq1;GAXK01095922.1;A9ZSY3;1.12E-43;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp394434_c0_seq1;GAXK01095928.1;Q2HJF4;1.56E-85;PBLD_BOVIN;Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-);"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]";"GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394";"biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]";cytoplasm [GO:0005737];"identical protein binding [GO:0042802]; isomerase activity [GO:0016853]"
comp394447_c0_seq1;GAXK01095896.1;Q12SQ2;5.08E-32;SELU_SHEDO;tRNA 2-selenouridine synthase (EC 2.5.1.-);"transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; tRNA 2-selenouridine synthase activity [GO:0043828]; tRNA seleno-modification [GO:0070329]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0016765; GO:0043828; GO:0070329";"tRNA seleno-modification [GO:0070329]; tRNA wobble uridine modification [GO:0002098]";;"transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; tRNA 2-selenouridine synthase activity [GO:0043828]"
comp3944555_c0_seq1;GAXK01068901.1;P39101;8.43E-08;CAJ1_YEAST;Protein CAJ1;"cytosol [GO:0005829]; nucleus [GO:0005634]; protein folding [GO:0006457]; protein import into peroxisome matrix [GO:0016558]";"GO:0005634; GO:0005829; GO:0006457; GO:0016558";"protein folding [GO:0006457]; protein import into peroxisome matrix [GO:0016558]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp3944725_c0_seq1;GAXK01068914.1;Q9BY67;1.15E-16;CADM1_HUMAN;Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; viral process [GO:0016032]";"GO:0002376; GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007156; GO:0007157; GO:0007275; GO:0007283; GO:0008037; GO:0016021; GO:0016032; GO:0016323; GO:0030154; GO:0030165; GO:0034332; GO:0042271; GO:0042803; GO:0045202; GO:0045954; GO:0050715; GO:0051606";"adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; viral process [GO:0016032]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp3945096_c0_seq1;GAXK01068906.1;Q9V3Z2;1.10E-11;SER7_DROME;Serine protease 7 (EC 3.4.21.-) (Melanization protease 2);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0035006; GO:0035008; GO:0046872";"melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp3945794_c0_seq1;GAXK01068910.1;Q9VZW5;2.94E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp394585_c1_seq1;GAXK01095924.1;Q03720;9.74E-138;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp394627_c0_seq1;GAXK01095851.1;Q5VUJ5;1.78E-50;AGAP7_HUMAN;Putative Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7 (AGAP-7) (Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7 pseudogene) (Centaurin-gamma-like family member 4);"nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]";"GO:0005096; GO:0005634; GO:0046872";;nucleus [GO:0005634];"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp394774_c0_seq1;GAXK01095852.1;Q01295;3.85E-09;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp39479_c2_seq1;GAXK01098048.1;Q13615;1.07E-174;MTMR3_HUMAN;Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785";"cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp39482_c0_seq1;GAXK01097662.1;Q29C43;0;NCASE_DROPS;Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase);"extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]";"GO:0005576; GO:0017040; GO:0046514; GO:0102121";ceramide catabolic process [GO:0046514];extracellular region [GO:0005576];"ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]"
comp39486_c0_seq1;GAXK01097663.1;Q9NRH1;3.86E-09;YAE1_HUMAN;Protein YAE1 homolog (Yae1 domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]";"GO:0005634; GO:0005737; GO:0106035";protein maturation by [4Fe-4S] cluster transfer [GO:0106035];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp394979_c0_seq1;GAXK01095918.1;P68431;1.23E-08;H31_HUMAN;Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; DNA replication-dependent nucleosome assembly [GO:0006335]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; protein heterotetramerization [GO:0051290]; regulation of gene silencing [GO:0060968]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere organization [GO:0032200]";"GO:0000183; GO:0000228; GO:0000786; GO:0000788; GO:0005576; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006335; GO:0007596; GO:0016020; GO:0031492; GO:0032200; GO:0032991; GO:0038111; GO:0044267; GO:0045296; GO:0045652; GO:0045814; GO:0046982; GO:0051290; GO:0060964; GO:0060968; GO:0070062";"blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; DNA replication-dependent nucleosome assembly [GO:0006335]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; protein heterotetramerization [GO:0051290]; regulation of gene silencing [GO:0060968]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere organization [GO:0032200]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"cadherin binding [GO:0045296]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]"
comp39498_c1_seq1;GAXK01098034.1;P34454;4.36E-40;YMA9_CAEEL;Uncharacterized protein F54F2.9;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]";"GO:0003677; GO:0016021; GO:0031965";;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";DNA binding [GO:0003677]
comp3949836_c0_seq1;GAXK01010807.1;Q7XY82;2.50E-35;PSBU_GRIJA;Photosystem II 12 kDa extrinsic protein, chloroplastic (PS II complex 12 kDa extrinsic protein) (PSII-U);"chloroplast thylakoid membrane [GO:0009535]; extrinsic component of membrane [GO:0019898]; photosystem II oxygen evolving complex [GO:0009654]; oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; photosystem II stabilization [GO:0042549]";"GO:0009535; GO:0009654; GO:0015979; GO:0019898; GO:0042549; GO:0055114";"oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; photosystem II stabilization [GO:0042549]";"chloroplast thylakoid membrane [GO:0009535]; extrinsic component of membrane [GO:0019898]; photosystem II oxygen evolving complex [GO:0009654]";
comp395_c0_seq1;GAXK01168573.1;P25161;8.91E-167;PSMD3_DROME;Probable 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome subunit S3) (Diphenol oxidase A2 component) (DOX-A2) (Regulatory particle non-ATPase 3);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0006511; GO:0007623; GO:0008063; GO:0008270; GO:0008541; GO:0030234; GO:0042176; GO:0043161";"circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]";"enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]"
comp3950_c0_seq1;GAXK01175496.1;O43663;1.07E-76;PRC1_HUMAN;Protein regulator of cytokinesis 1;"contractile ring [GO:0070938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic spindle elongation [GO:0000022]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]";"GO:0000022; GO:0000922; GO:0001578; GO:0005634; GO:0005819; GO:0005829; GO:0005876; GO:0008017; GO:0008284; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0051301; GO:0070938";"cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic spindle elongation [GO:0000022]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]";"contractile ring [GO:0070938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]";"identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"
comp3950144_c0_seq1;GAXK01042197.1;P48613;4.61E-08;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp3950235_c0_seq1;GAXK01042194.1;P07898;2.31E-16;PGCA_CHICK;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp3950248_c0_seq1;GAXK01042196.1;Q9LUQ6;2.59E-54;RL192_ARATH;60S ribosomal protein L19-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp39507_c2_seq1;GAXK01098035.1;Q7QB13;3.36E-137;CCNC_ANOGA;Cyclin-C;"mediator complex [GO:0016592]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016538; GO:0016592; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"mediator complex [GO:0016592]; nucleus [GO:0005634]";cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]
comp395104_c1_seq1;GAXK01095841.1;Q6NXH8;1.78E-38;MET25_MOUSE;Methyltransferase-like protein 25 (EC 2.1.1.-);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp395127_c1_seq1;GAXK01095890.1;Q8N6F8;4.59E-12;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp39538_c2_seq1;GAXK01097707.1;Q9NP81;1.58E-82;SYSM_HUMAN;Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0003723; GO:0004828; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006434; GO:0097056";"selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]"
comp395547_c0_seq1;GAXK01095936.1;A4QP81;4.94E-09;FRRS1_DANRE;Putative ferric-chelate reductase 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491";;integral component of membrane [GO:0016021];oxidoreductase activity [GO:0016491]
comp39562_c0_seq1;GAXK01097345.1;P54653;9.89E-07;CBP2_DICDI;Calcium-binding protein 2;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp39575_c0_seq1;GAXK01097852.1;Q32LB0;0;WDR70_BOVIN;WD repeat-containing protein 70;"nucleus [GO:0005634]; site of double-strand break [GO:0035861]; regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173]";"GO:0005634; GO:0035861; GO:1903775; GO:2001173";"regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173]";"nucleus [GO:0005634]; site of double-strand break [GO:0035861]";
comp39576_c0_seq1;GAXK01097946.1;Q28FE0;2.76E-98;CPPED_XENTR;Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]";"GO:0004721; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]"
comp39579_c0_seq1;GAXK01098029.1;Q9NP59;1.73E-109;S40A1_HUMAN;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988";"cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]"
comp395866_c2_seq1;GAXK01095917.1;P12646;1.90E-44;G6PD_DROME;Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) (Zwischenferment);"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";"GO:0004345; GO:0006006; GO:0006098; GO:0006739; GO:0050661; GO:0051156";"glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";;"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]"
comp3959598_c0_seq1;GAXK01057720.1;P40123;2.74E-11;CAP2_HUMAN;Adenylyl cyclase-associated protein 2 (CAP 2);"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0014069; GO:0030864; GO:0042802";"actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; signal transduction [GO:0007165]";"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]"
comp39602_c0_seq1;GAXK01097933.1;Q96SZ5;6.01E-35;AEDO_HUMAN;2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase);"cytosol [GO:0005829]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]; sulfur amino acid catabolic process [GO:0000098]";"GO:0000098; GO:0005829; GO:0046872; GO:0047800";sulfur amino acid catabolic process [GO:0000098];cytosol [GO:0005829];"cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]"
comp3960794_c0_seq1;GAXK01177369.1;Q5X9L4;5.22E-20;CSPA_STRP6;Major cold shock protein;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]";"GO:0003677; GO:0005737";;cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp396084_c1_seq1;GAXK01037804.1;Q8BFZ9;2.35E-153;ERLN2_MOUSE;Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0008203; GO:0015485; GO:0016021; GO:0030433; GO:0031625; GO:0032933; GO:0032991; GO:0045121; GO:0045541; GO:0045717";"cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp396117_c0_seq1;GAXK01037877.1;P30975;2.81E-47;TLR2_DROME;Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058";"detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp3961559_c0_seq1;GAXK01177370.1;B4HNS0;1.75E-11;TRE11_DROSE;Facilitated trehalose transporter Tret1-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp396192_c1_seq1;GAXK01037768.1;B7Z6K7;1.98E-24;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp396254_c0_seq1;GAXK01037875.1;Q6ZPD9;2.23E-164;D19L3_HUMAN;Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3);"integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]";"GO:0000030; GO:0005637; GO:0016021; GO:0018406";protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406];"integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]";mannosyltransferase activity [GO:0000030]
comp396259_c0_seq1;GAXK01037783.1;Q9VCA2;1.86E-155;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp39628_c0_seq1;GAXK01097819.1;O43639;2.57E-102;NCK2_HUMAN;Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001771; GO:0001784; GO:0005070; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0007176; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0033137; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048010; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441";"actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]";"cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]"
comp396316_c0_seq1;GAXK01037926.1;O46040;4.04E-29;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp39633_c0_seq1;GAXK01098033.1;P05661;1.59E-168;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp3963532_c0_seq1;GAXK01155906.1;O18416;3.15E-27;TPM_DERPT;Tropomyosin (allergen Der p 10);;;;;
comp3964626_c0_seq1;GAXK01134059.1;O75132;2.14E-12;ZBED4_HUMAN;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp396468_c0_seq1;GAXK01037929.1;P22974;3.58E-07;H1L_MYTCA;Sperm-specific protein PHI-2B (PL-II*) (Sperm-specific linker histone H1-like protein);"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; multicellular organism development [GO:0007275]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0007275; GO:0007283; GO:0030154; GO:0030261";"cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; multicellular organism development [GO:0007275]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]";"nucleosome [GO:0000786]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp3965040_c0_seq1;GAXK01134057.1;Q9VZW5;4.41E-19;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp39663_c2_seq1;GAXK01097701.1;Q9NZN8;2.31E-09;CNOT2_HUMAN;CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036";"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]";"RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]"
comp396639_c1_seq1;GAXK01037810.1;Q17QR7;1.64E-12;ZN691_BOVIN;Zinc finger protein 691;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp396668_c4_seq1;GAXK01037842.1;P98066;1.94E-07;TSG6_HUMAN;Tumor necrosis factor-inducible gene 6 protein (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; neutrophil degranulation [GO:0043312]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]";"GO:0005540; GO:0005576; GO:0005615; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0030335; GO:0030728; GO:0043312; GO:0050728; GO:1904724; GO:1904813";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; neutrophil degranulation [GO:0043312]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]";hyaluronic acid binding [GO:0005540]
comp3967_c0_seq1;GAXK01176087.1;P45973;6.30E-41;CBX5_HUMAN;Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha);"chromocenter [GO:0010369]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; blood coagulation [GO:0007596]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]";"GO:0000118; GO:0000122; GO:0000776; GO:0000784; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005720; GO:0005721; GO:0005730; GO:0006974; GO:0007596; GO:0010369; GO:0016032; GO:0017053; GO:0030674; GO:0031618; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042803; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0070317; GO:0070491; GO:0090734; GO:1990904";"blood coagulation [GO:0007596]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; viral process [GO:0016032]";"chromocenter [GO:0010369]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]"
comp396705_c0_seq1;GAXK01037907.1;Q98892;1.39E-22;OBCAM_CHICK;Opioid-binding protein/cell adhesion molecule homolog (Neurite inhibitor GP55-A) (OBCAM protein gamma isoform);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp39678_c0_seq1;GAXK01097959.1;Q9D4H7;2.78E-134;LONF3_MOUSE;LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp3968918_c0_seq1;GAXK01135964.1;Q5F478;1.54E-21;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp3969_c0_seq1;GAXK01175737.1;Q9VMM6;7.30E-21;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp396928_c0_seq1;GAXK01037884.1;Q7KRI2;4.17E-11;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp396979_c0_seq1;GAXK01037918.1;Q8TD23;8.12E-16;ZN675_HUMAN;Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]";"GO:0000122; GO:0003677; GO:0005634; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678";"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp39699_c1_seq1;GAXK01097682.1;Q7KRY7;0;LAP4_DROME;Protein lap4 (Protein scribble) (Protein smell-impaired);"apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]";"GO:0000122; GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005913; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008283; GO:0008285; GO:0008593; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0035255; GO:0042048; GO:0042058; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0046425; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0051726; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794";"anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]";"apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]";ionotropic glutamate receptor binding [GO:0035255]
comp3969917_c0_seq1;GAXK01135957.1;Q09FC8;2.84E-22;ZN415_HUMAN;Zinc finger protein 415;"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0001650; GO:0003677; GO:0005634; GO:0005737; GO:0015630; GO:0046872";;"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3970_c1_seq1;GAXK01175327.1;Q9VMD0;9.99E-16;DAXX_DROME;Daxx-like protein (DLP);"cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; determination of adult lifespan [GO:0008340]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; response to oxidative stress [GO:0006979]";"GO:0003714; GO:0005634; GO:0005829; GO:0006334; GO:0006979; GO:0008134; GO:0008340; GO:0016605; GO:0042393; GO:0042981; GO:0045892; GO:0045893";"determination of adult lifespan [GO:0008340]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; response to oxidative stress [GO:0006979]";"cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]";"histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp397002_c0_seq1;GAXK01037925.1;Q9N1Q4;1.57E-127;LAT2_RABIT;Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; neutral amino acid transport [GO:0015804]";"GO:0005737; GO:0015101; GO:0015171; GO:0015179; GO:0015804; GO:0016021; GO:0016323; GO:0019534; GO:0042605";neutral amino acid transport [GO:0015804];"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]"
comp397006_c0_seq1;GAXK01037763.1;P46436;1.22E-33;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp39705_c0_seq1;GAXK01097528.1;Q94420;6.79E-16;MEL26_CAEEL;Protein maternal effect lethal 26;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leucine [GO:0071233]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of mitotic spindle elongation [GO:0032888]; regulation of proteolysis [GO:0030162]; striated muscle myosin thick filament assembly [GO:0071688]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000132; GO:0000793; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006511; GO:0009792; GO:0010507; GO:0016020; GO:0016567; GO:0019901; GO:0030162; GO:0030163; GO:0030307; GO:0030674; GO:0031430; GO:0031625; GO:0031674; GO:0032154; GO:0032888; GO:0042802; GO:0043161; GO:0071233; GO:0071688; GO:1904263";"cellular response to leucine [GO:0071233]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of mitotic spindle elongation [GO:0032888]; regulation of proteolysis [GO:0030162]; striated muscle myosin thick filament assembly [GO:0071688]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]"
comp39711_c0_seq1;GAXK01097735.1;Q7KRI2;4.99E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp397119_c1_seq1;GAXK01037796.1;Q5RFU0;2.89E-11;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp39714_c0_seq1;GAXK01097339.1;Q5U241;0;PD5BB_XENLA;Sister chromatid cohesion protein PDS5 homolog B-B (Androgen-induced proliferation inhibitor B);"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]";"GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301";"cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp3971452_c0_seq1;GAXK01028370.1;Q8BLB0;2.06E-27;ZFP3_MOUSE;Zinc finger protein 3 (Zfp-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3972816_c0_seq1;GAXK01012683.1;Q05A62;1.13E-51;DNAL1_MOUSE;Dynein light chain 1, axonemal;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]";"GO:0003774; GO:0005737; GO:0005874; GO:0036157; GO:0036158; GO:0043014; GO:0045504";outer dynein arm assembly [GO:0036158];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp397292_c0_seq1;GAXK01037879.1;Q26626;0;KIFA3_STRPU;Kinesin-associated protein 3 (SpKAP115);"kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017]";"GO:0007017; GO:0016939; GO:0019894";microtubule-based process [GO:0007017];kinesin II complex [GO:0016939];kinesin binding [GO:0019894]
comp397408_c0_seq1;GAXK01037792.1;Q3TTC2;2.67E-35;TYY2_MOUSE;Transcription factor YY2 (Yin and yang 2) (YY-2);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000978; GO:0000980; GO:0000987; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0031519; GO:0043565; GO:0045944; GO:0046872";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp397425_c0_seq1;GAXK01037901.1;Q94HW2;3.47E-22;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp39745_c0_seq1;GAXK01097872.1;Q62165;1.24E-24;DAG1_MOUSE;"Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]";"basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403]";"GO:0001954; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005913; GO:0005925; GO:0006509; GO:0007016; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014044; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016020; GO:0016021; GO:0016323; GO:0016340; GO:0017166; GO:0019048; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045121; GO:0045202; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261";"aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403]";"basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]";"actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]"
comp3974756_c0_seq1;GAXK01182412.1;P42280;8.81E-16;TRYZ_DROME;Trypsin zeta (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0008236";proteolysis [GO:0006508];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp3975_c3_seq1;GAXK01175750.1;Q802F3;9.94E-39;SEP15_DANRE;Selenoprotein F (15 kDa selenoprotein);"endoplasmic reticulum lumen [GO:0005788]; selenium binding [GO:0008430]";"GO:0005788; GO:0008430";;endoplasmic reticulum lumen [GO:0005788];selenium binding [GO:0008430]
comp39755_c1_seq1;GAXK01097543.1;Q9H490;3.98E-70;PIGU_HUMAN;Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U);"endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]";"GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0030176; GO:0034394; GO:0042765; GO:0046425";"attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]";"endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp39762_c0_seq1;GAXK01097597.1;P16905;0;KAPR1_DROME;cAMP-dependent protein kinase type I regulatory subunit (DRI class I to class IV);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"GO:0005737; GO:0005829; GO:0005952; GO:0007015; GO:0007274; GO:0007419; GO:0007591; GO:0008103; GO:0008355; GO:0008603; GO:0019933; GO:0019934; GO:0030552; GO:0045471; GO:0047555; GO:2000253";"actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp3976314_c0_seq1;GAXK01112839.1;Q9SIK2;1.95E-24;RS252_ARATH;40S ribosomal protein S25-2;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005773; GO:0005774; GO:0009506; GO:0022626; GO:0022627; GO:0042788";;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp3976716_c0_seq1;GAXK01112840.1;P36609;6.30E-09;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp397889_c0_seq1;GAXK01037923.1;Q27746;3.46E-07;DNMT1_PARLI;DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270";;nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp397899_c0_seq1;GAXK01037775.1;Q7T330;1.72E-21;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp397930_c1_seq1;GAXK01037807.1;Q8BXX2;2.17E-31;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp3979598_c0_seq1;GAXK01197780.1;Q6ZNH5;1.01E-13;ZN497_HUMAN;Zinc finger protein 497;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp3980117_c0_seq1;GAXK01170759.1;Q01799;1.90E-09;ESCA_BRACO;Escargot/snail protein homolog (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp39804_c3_seq1;GAXK01097645.1;F6WXT2;1.27E-86;NU188_XENTR;Nucleoporin NUP188 homolog;"nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]";"GO:0006606; GO:0017056; GO:0044611; GO:0051028";"mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]";nuclear pore inner ring [GO:0044611];structural constituent of nuclear pore [GO:0017056]
comp398147_c0_seq1;GAXK01146040.1;Q02934;1.29E-46;GUNI_CLOTH;Endoglucanase 1 (EC 3.2.1.4) (Cellulase I) (Endo-1,4-beta-glucanase) (Endoglucanase I) (EGI);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; identical protein binding [GO:0042802]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248; GO:0042802";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; identical protein binding [GO:0042802]"
comp398152_c0_seq1;GAXK01146219.1;P00772;2.24E-25;CELA1_PIG;Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0004252; GO:0005615; GO:0006508; GO:0006954; GO:0009791; GO:0016055; GO:0031017; GO:0035264; GO:0042127; GO:0045595; GO:0045766; GO:0045944; GO:0046872; GO:0048771; GO:0060309; GO:0061113";"elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp398201_c0_seq1;GAXK01146131.1;Q86T29;9.46E-28;ZN605_HUMAN;Zinc finger protein 605;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000976; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp398249_c0_seq1;GAXK01146147.1;Q96GN5;1.95E-31;CDA7L_HUMAN;Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001650; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0008284";"positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp398289_c0_seq1;GAXK01146204.1;Q90773;5.23E-26;CEPU1_CHICK;Protein CEPU-1;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp3983176_c0_seq1;GAXK01109159.1;P18460;1.02E-29;FGFR3_CHICK;Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005007; GO:0005524; GO:0005783; GO:0005794; GO:0005887; GO:0007169; GO:0008284; GO:0010518; GO:0017134; GO:0030133; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0070374; GO:1902178";"fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp3983560_c0_seq1;GAXK01109168.1;Q7Z0G7;1.77E-38;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp398362_c0_seq1;GAXK01146090.1;P81018;1.79E-14;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp398475_c0_seq1;GAXK01146129.1;H9IUR0;1.25E-23;EXD1_BOMMO;piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (BmExd1);"P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]";"GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:0090305; GO:1990923";"gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]";"PET complex [GO:1990923]; P granule [GO:0043186]";"protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp39854_c2_seq1;GAXK01097736.1;A1A5R7;9.72E-39;REXO5_RAT;RNA exonuclease 5 (EC 3.1.-.-) (Putative RNA exonuclease NEF-sp);"nucleus [GO:0005634]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]";"GO:0003723; GO:0004527; GO:0005634";;nucleus [GO:0005634];"exonuclease activity [GO:0004527]; RNA binding [GO:0003723]"
comp3985575_c0_seq1;GAXK01137965.1;P17017;3.64E-08;ZNF14_HUMAN;Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4) (GIOT-4) (Zinc finger protein KOX6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp39856_c0_seq1;GAXK01097955.1;B5XGE7;9.00E-58;TPC2L_SALSA;Trafficking protein particle complex subunit 2-like protein;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]";"GO:0005783; GO:0005794; GO:0006888; GO:0048471";endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";
comp398566_c0_seq1;GAXK01146202.1;P55859;1.85E-83;PNPH_BOVIN;Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; purine-nucleoside phosphorylase activity [GO:0004731]; nucleoside metabolic process [GO:0009116]";"GO:0004731; GO:0005737; GO:0005856; GO:0009116";nucleoside metabolic process [GO:0009116];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";purine-nucleoside phosphorylase activity [GO:0004731]
comp3985758_c0_seq1;GAXK01137964.1;Q09575;5.89E-12;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp398577_c0_seq1;GAXK01146257.1;P43025;3.67E-10;TETN_MOUSE;Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; granular component [GO:0001652]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]; kringle domain binding [GO:0036143]; bone mineralization [GO:0030282]; ossification [GO:0001503]; positive regulation of plasminogen activation [GO:0010756]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001503; GO:0001652; GO:0005509; GO:0005615; GO:0005737; GO:0008201; GO:0010756; GO:0030246; GO:0030282; GO:0031012; GO:0036143";"bone mineralization [GO:0030282]; ossification [GO:0001503]; positive regulation of plasminogen activation [GO:0010756]; skeletal system development [GO:0001501]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; granular component [GO:0001652]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]; kringle domain binding [GO:0036143]"
comp39859_c0_seq1;GAXK01097770.1;B0R1D5;4.35E-106;SZ12B_DANRE;Polycomb protein suz12-B (Suppressor of zeste 12 protein homolog B);"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; histone methylation [GO:0016571]";"GO:0005634; GO:0016571; GO:0016586; GO:0031490; GO:0035098; GO:0046872";histone methylation [GO:0016571];"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]";"chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]"
comp3985990_c0_seq1;GAXK01137971.1;P13608;2.50E-26;PGCA_BOVIN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp3986064_c0_seq1;GAXK01086191.1;Q6GN42;4.84E-14;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp3986147_c0_seq1;GAXK01086160.1;Q8VHZ8;8.00E-09;DSCAM_RAT;Down syndrome cell adhesion molecule homolog;"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0010842; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0038007; GO:0042327; GO:0043025; GO:0045202; GO:0048842; GO:0060219; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";cell-cell adhesion mediator activity [GO:0098632]
comp3986992_c0_seq1;GAXK01086163.1;Q23716;3.23E-34;EF2_CRYPV;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp3987_c0_seq1;GAXK01175865.1;O95336;6.65E-50;6PGL_HUMAN;6-phosphogluconolactonase (6PGL) (EC 3.1.1.31);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]";"GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062";"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";6-phosphogluconolactonase activity [GO:0017057]
comp398712_c0_seq1;GAXK01146056.1;P17023;4.24E-18;ZNF19_HUMAN;Zinc finger protein 19 (Zinc finger protein KOX12);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp398749_c4_seq1;GAXK01146057.1;O43345;6.69E-55;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp3987955_c0_seq1;GAXK01086182.1;P17507;6.87E-56;EF1A2_XENLA;Elongation factor 1-alpha, oocyte form (EF-1-alpha-O) (EF-1AO) (42S p48);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp398803_c0_seq1;GAXK01146074.1;Q07243;1.67E-49;MTF1_MOUSE;Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]";"GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006979; GO:0007417; GO:0035035; GO:0045893; GO:0045944; GO:0046686; GO:0046872";"central nervous system development [GO:0007417]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp39881_c2_seq1;GAXK01097950.1;B0WC46;4.13E-53;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp3988249_c0_seq1;GAXK01145574.1;Q6JEL3;1.53E-51;KLH10_RAT;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp3988609_c0_seq1;GAXK01145582.1;Q502K3;1.05E-14;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp3988730_c0_seq1;GAXK01145599.1;Q9SF53;2.73E-26;RL351_ARATH;60S ribosomal protein L35-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0009506; GO:0022625";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp39890_c0_seq1;GAXK01098087.1;P78317;8.79E-14;RNF4_HUMAN;E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0008134; GO:0008270; GO:0016605; GO:0030374; GO:0030521; GO:0031491; GO:0032184; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0070534; GO:0070936; GO:0070979; GO:0085020; GO:0090169; GO:0090234";"androgen receptor signaling pathway [GO:0030521]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp3989553_c0_seq1;GAXK01145575.1;Q1KKV8;4.39E-38;MFSD5_TAKRU;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp39896_c0_seq1;GAXK01097716.1;Q03755;1.06E-08;CUT1_CAEEL;Cuticlin-1;"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; structural constituent of cuticle [GO:0042302]";"GO:0042302; GO:0060102";;collagen and cuticulin-based cuticle extracellular matrix [GO:0060102];structural constituent of cuticle [GO:0042302]
comp398969_c0_seq1;GAXK01146223.1;O43829;1.50E-14;ZBT14_HUMAN;Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog) (ZF5) (Zfp-5) (hZF5);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016235; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0060976";"cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3989840_c0_seq1;GAXK01145600.1;O61379;9.43E-22;TPM_PANST;Tropomyosin (Allergen Pan s I) (allergen Pan s 1);;;;;
comp3989876_c0_seq1;GAXK01145588.1;Q0VA42;1.50E-19;MINY4_XENTR;Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4);"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]";"GO:0016807; GO:0036459; GO:1990380";;;"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp399_c1_seq1;GAXK01166409.1;O17449;0;TBB1_MANSE;Tubulin beta-1 chain (Beta-1-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp3990021_c0_seq1;GAXK01202619.1;P07814;3.20E-40;SYEP_HUMAN;"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0044539; GO:0051020; GO:0065003; GO:0071346; GO:0097452; GO:0140212; GO:1990904";"cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]"
comp3990087_c0_seq1;GAXK01202595.1;Q38997;1.27E-17;KIN10_ARATH;SNF1-related protein kinase catalytic subunit alpha KIN10 (AKIN10) (EC 2.7.11.1) (AKIN alpha-2) (AKINalpha2) (SNF1-related kinase 1.1) (SnRK1.1);"chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]";"GO:0001666; GO:0003006; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005982; GO:0006468; GO:0006633; GO:0006979; GO:0009507; GO:0009594; GO:0009635; GO:0009738; GO:0009749; GO:0009789; GO:0010050; GO:0010150; GO:0010182; GO:0010228; GO:0010508; GO:0016301; GO:0019900; GO:0019902; GO:0035556; GO:0042128; GO:0080022; GO:0099402; GO:1900055; GO:1902074";"abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]";"chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]"
comp3990423_c0_seq1;GAXK01202616.1;P14404;2.90E-09;MECOM_MOUSE;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein homolog);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"GO:0000977; GO:0001228; GO:0001701; GO:0001780; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0006954; GO:0009617; GO:0009791; GO:0016607; GO:0030154; GO:0030900; GO:0035115; GO:0035116; GO:0042127; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0060039; GO:0070828; GO:0071425; GO:0072197; GO:0090336; GO:0098727";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; inflammatory response [GO:0006954]; in utero embryonic development [GO:0001701]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp3990725_c0_seq1;GAXK01202615.1;P92519;5.11E-08;M810_ARATH;Uncharacterized mitochondrial protein AtMg00810 (ORF240b);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp3990837_c0_seq1;GAXK01202597.1;P63324;1.72E-26;RS12_RAT;40S ribosomal protein S12;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; response to organonitrogen compound [GO:0010243]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0010243; GO:0022625; GO:0022627";"response to organonitrogen compound [GO:0010243]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp3990936_c0_seq1;GAXK01202614.1;Q9SZJ5;1.65E-87;GLYM1_ARATH;Serine hydroxymethyltransferase 1, mitochondrial (AtSHMT1) (EC 2.1.2.1) (Glycine hydroxymethyltransferase 1) (Serine Transhydroxymethyltransferase) (STM) (Serine methylase 1);"apoplast [GO:0048046]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stromule [GO:0010319]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; poly(U) RNA binding [GO:0008266]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; plant-type hypersensitive response [GO:0009626]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to light stimulus [GO:0009416]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0004372; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0007623; GO:0008266; GO:0008270; GO:0009409; GO:0009416; GO:0009534; GO:0009570; GO:0009626; GO:0009853; GO:0010319; GO:0016597; GO:0019264; GO:0022626; GO:0030170; GO:0035999; GO:0046653; GO:0046655; GO:0046686; GO:0048046; GO:0050897; GO:0070905; GO:1904482";"cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; plant-type hypersensitive response [GO:0009626]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to light stimulus [GO:0009416]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"apoplast [GO:0048046]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stromule [GO:0010319]";"amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; poly(U) RNA binding [GO:0008266]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]"
comp3991288_c0_seq1;GAXK01202598.1;P47736;3.29E-21;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp3991329_c0_seq1;GAXK01202593.1;Q9C912;7.89E-41;R35A3_ARATH;60S ribosomal protein L35a-3;"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005739; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp399183_c0_seq1;GAXK01146089.1;Q3U288;9.95E-26;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3992223_c0_seq1;GAXK01107822.1;E2AX35;6.35E-19;PROH4_CAMFO;IDLSRF-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp399224_c1_seq1;GAXK01146046.1;Q5EBF1;6.46E-105;5NTC_XENTR;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";"GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp399227_c0_seq1;GAXK01146042.1;Q54RA4;2.26E-25;Y3291_DICDI;Probable iron/ascorbate oxidoreductase DDB_G0283291 (EC 1.14.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp3992303_c0_seq1;GAXK01107829.1;P35016;1.02E-55;ENPL_CATRO;Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005788; GO:0006457; GO:0051082";protein folding [GO:0006457];endoplasmic reticulum lumen [GO:0005788];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp3992595_c0_seq1;GAXK01107804.1;O48557;2.01E-68;RL17_MAIZE;60S ribosomal protein L17;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp399316_c0_seq1;GAXK01146184.1;Q99NF1;3.93E-41;BCDO2_MOUSE;Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2);"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";"GO:0003834; GO:0004744; GO:0005739; GO:0010436; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0055114; GO:0102076; GO:2000377";"carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]";mitochondrion [GO:0005739];"beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]"
comp399343_c0_seq1;GAXK01146054.1;P11121;1.72E-55;CALM_PYUSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp399350_c0_seq1;GAXK01146220.1;A0JN71;1.86E-27;SASH3_BOVIN;SAM and SH3 domain-containing protein 3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042102; GO:0043372; GO:0046622; GO:0048873";"homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp3993622_c0_seq1;GAXK01107826.1;Q8ITC7;9.35E-17;CAPAR_DROME;Neuropeptides capa receptor (Cap2b receptor) (Capability receptor);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465";"body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]"
comp399404_c0_seq1;GAXK01146093.1;Q0DZP5;1.41E-08;CML17_ORYSJ;Probable calcium-binding protein CML17 (Calmodulin-like protein 17);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp39942_c1_seq1;GAXK01097944.1;Q8R3V6;2.48E-35;CUED1_MOUSE;CUE domain-containing protein 1;;;;;
comp3994547_c0_seq1;GAXK01013210.1;E9RBR0;2.51E-21;ABR2_ASPFU;Laccase abr2 (EC 1.10.3.-) (Conidial pigment biosynthesis oxidase abr2);"cell surface [GO:0009986]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; melanin biosynthetic process [GO:0042438]; pigment biosynthetic process [GO:0046148]";"GO:0005507; GO:0009986; GO:0042438; GO:0046148; GO:0052716";"melanin biosynthetic process [GO:0042438]; pigment biosynthetic process [GO:0046148]";cell surface [GO:0009986];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp3994637_c0_seq1;GAXK01013205.1;Q5ZU30;4.17E-11;SETA_LEGPH;"Subversion of eukaryotic traffic protein A (Effector protein SetA) (Subversion of eukaryotic vesicle trafficking A) [Includes: Glucosyltransferase (EC 2.4.1.-); Phosphatidylinositol-3-phosphate-binding domain (PtdIns(3)P-binding domain)]";"extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]; pathogenesis [GO:0009405]";"GO:0005576; GO:0009405; GO:0016757";pathogenesis [GO:0009405];extracellular region [GO:0005576];transferase activity, transferring glycosyl groups [GO:0016757]
comp39947_c0_seq1;GAXK01097338.1;Q1JQE0;0;SNW1_BOVIN;SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein);"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]";"GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0016363; GO:0030511; GO:0035257; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0051571; GO:0070562; GO:0071007";"intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]";"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]";"nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]"
comp3995151_c0_seq1;GAXK01013202.1;Q9XU98;1.36E-08;EVA1_CAEEL;Protein eva-1 (Enhancer of ventral-axon guidance defects of unc-40 mutants);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; carbohydrate binding [GO:0030246]";"GO:0005886; GO:0016021; GO:0030054; GO:0030246; GO:0031430; GO:0055120";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";carbohydrate binding [GO:0030246]
comp399526_c9_seq1;GAXK01146228.1;Q04833;1.87E-18;LRP_CAEEL;Low-density lipoprotein receptor-related protein (LRP);"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]";"GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395";"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]";"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]"
comp399532_c0_seq1;GAXK01146130.1;Q95LI3;6.49E-21;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp399537_c0_seq1;GAXK01146045.1;A7MBP4;4.74E-96;IFT46_DANRE;Intraflagellar transport protein 46 homolog;"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041]";"GO:0005737; GO:0005813; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271";"cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]";
comp399546_c0_seq1;GAXK01146146.1;Q9U518;8.03E-145;ASPG_DIRIM;L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase);"asparaginase activity [GO:0004067]; asparagine metabolic process [GO:0006528]";"GO:0004067; GO:0006528";asparagine metabolic process [GO:0006528];;asparaginase activity [GO:0004067]
comp3995660_c0_seq1;GAXK01013226.1;P83916;8.25E-19;CBX1_HUMAN;Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta);"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000775; GO:0000784; GO:0000785; GO:0001939; GO:0001940; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005819; GO:0006974; GO:0010369; GO:0019899; GO:0042803; GO:0045892; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]"
comp3995718_c0_seq1;GAXK01013211.1;A1YG88;8.45E-21;ZNF16_PANPA;Zinc finger protein 16;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]";"GO:0003677; GO:0005634; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3996247_c0_seq1;GAXK01156698.1;Q9NQX1;1.65E-07;PRDM5_HUMAN;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp3996601_c0_seq1;GAXK01156723.1;Q9VAS7;2.97E-21;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp39967_c0_seq1;GAXK01097738.1;Q9W5N0;1.20E-55;COA7_DROME;Cytochrome c oxidase assembly factor 7 homolog (Beta-lactamase hcp-like protein CG13865) (Sel1 repeat-containing protein 1 homolog);;;;;
comp3996778_c0_seq1;GAXK01156730.1;O14027;5.45E-43;PDX1_SCHPO;Probable pyridoxal 5'-phosphate synthase subunit PDX1 (PLP synthase subunit PDX1) (EC 4.3.3.6);"cytosol [GO:0005829]; glutaminase complex [GO:1903600]; amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; cellular amino acid metabolic process [GO:0006520]; cysteine biosynthetic process from serine [GO:0006535]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";"GO:0005829; GO:0006520; GO:0006535; GO:0008615; GO:0016843; GO:0036381; GO:0042823; GO:1903600";"cellular amino acid metabolic process [GO:0006520]; cysteine biosynthetic process from serine [GO:0006535]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";"cytosol [GO:0005829]; glutaminase complex [GO:1903600]";"amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]"
comp399682_c0_seq1;GAXK01146086.1;Q58EB4;8.86E-93;HIBCH_DANRE;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp3997218_c0_seq1;GAXK01156727.1;O73763;1.24E-10;GCIP_LITPI;Guanylyl cyclase inhibitory protein;"calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005509; GO:0007601; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";;calcium ion binding [GO:0005509]
comp399724_c0_seq1;GAXK01146215.1;O55239;3.29E-09;NNMT_MOUSE;Nicotinamide N-methyltransferase (EC 2.1.1.1);"cytosol [GO:0005829]; nicotinamide N-methyltransferase activity [GO:0008112]; animal organ regeneration [GO:0031100]; methylation [GO:0032259]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]";"GO:0005829; GO:0008112; GO:0010243; GO:0031100; GO:0032259; GO:0042493";"animal organ regeneration [GO:0031100]; methylation [GO:0032259]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]";cytosol [GO:0005829];nicotinamide N-methyltransferase activity [GO:0008112]
comp399753_c4_seq1;GAXK01146135.1;Q8BIL5;5.39E-14;HOOK1_MOUSE;Protein Hook homolog 1 (mHK1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; HOPS complex [GO:0030897]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; spermatid development [GO:0007286]";"GO:0003779; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007030; GO:0007032; GO:0007040; GO:0007275; GO:0007286; GO:0008017; GO:0008333; GO:0015031; GO:0015630; GO:0030705; GO:0030897; GO:0031122; GO:0042802; GO:0045022; GO:0051959; GO:0070695; GO:1905198";"cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; spermatid development [GO:0007286]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; HOPS complex [GO:0030897]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]";"actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]"
comp3998_c2_seq1;GAXK01205913.1;O42227;0;HDA1B_XENLA;Probable histone deacetylase 1-B (HD1-B) (EC 3.5.1.98) (RPD3 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]";"GO:0005634; GO:0005737; GO:0032041";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]
comp39986_c0_seq1;GAXK01097688.1;P0DPW5;3.21E-10;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp3998625_c0_seq1;GAXK01138801.1;Q04634;1.36E-58;EF1A_TETPY;Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp399894_c2_seq1;GAXK01146088.1;Q8VDM6;3.05E-119;HNRL1_MOUSE;Heterogeneous nuclear ribonucleoprotein U-like protein 1;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]";"GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899";"response to virus [GO:0009615]; RNA processing [GO:0006396]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; RNA binding [GO:0003723]"
comp3999508_c0_seq1;GAXK01138778.1;O73925;6.03E-25;KCNQ1_SQUAC;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp399987_c2_seq1;GAXK01146052.1;P23607;3.64E-19;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp3999918_c0_seq1;GAXK01138800.1;P49690;1.98E-53;RL23_ARATH;60S ribosomal protein L23 (Protein EMBRYO DEFECTIVE 2171);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005576; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0070180";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]";"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp4_c0_seq1;GAXK01168823.1;P18077;9.73E-45;RL35A_HUMAN;60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000049; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0070062";"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp40_c0_seq1;GAXK01169223.1;Q9NB33;6.85E-49;RL44_OCHTR;60S ribosomal protein L44;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4000_c1_seq1;GAXK01065844.1;Q92932;7.35E-145;PTPR2_HUMAN;Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60];"cell junction [GO:0030054]; endoplasmic reticulum lumen [GO:0005788]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; negative regulation of GTPase activity [GO:0034260]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; protein dephosphorylation [GO:0006470]";"GO:0005001; GO:0005788; GO:0005886; GO:0005887; GO:0006470; GO:0006629; GO:0007269; GO:0030054; GO:0030285; GO:0030667; GO:0030672; GO:0034260; GO:0035773; GO:0043195; GO:0043235; GO:0043312; GO:0101003";"insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; negative regulation of GTPase activity [GO:0034260]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; protein dephosphorylation [GO:0006470]";"cell junction [GO:0030054]; endoplasmic reticulum lumen [GO:0005788]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]
comp400051_c0_seq1;GAXK01146449.1;Q9UK10;2.55E-07;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4000662_c0_seq1;GAXK01204912.1;P23098;1.02E-32;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp4000683_c0_seq1;GAXK01179692.1;Q9FMH8;3.77E-29;RD21B_ARATH;Probable cysteine protease RD21B (EC 3.4.22.-);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0051603; GO:0099503";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]";cysteine-type endopeptidase activity [GO:0004197]
comp4000785_c0_seq1;GAXK01179673.1;G5EFE7;2.24E-08;FUT8_CAEEL;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; fucosyltransferase activity [GO:0008417]; galactoside 6-L-fucosyltransferase activity [GO:0046702]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]";"GO:0006487; GO:0008417; GO:0008424; GO:0016021; GO:0032580; GO:0033578; GO:0036065; GO:0036071; GO:0046702; GO:0046872; GO:0046921";"fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; fucosyltransferase activity [GO:0008417]; galactoside 6-L-fucosyltransferase activity [GO:0046702]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]"
comp4001262_c0_seq1;GAXK01179679.1;Q9I8F9;6.58E-42;HSP71_ORYLA;Heat shock 70 kDa protein 1 (HSP70-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005829; GO:0006986; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp4001312_c0_seq1;GAXK01179654.1;A2ANX9;1.43E-07;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp4001370_c0_seq1;GAXK01179688.1;P18715;9.75E-21;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4001590_c0_seq1;GAXK01179672.1;O17214;1.36E-08;FUMH_CAEEL;Probable fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0004333; GO:0005739; GO:0005759; GO:0006099; GO:0006106; GO:0006108; GO:0045239";"fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]";fumarate hydratase activity [GO:0004333]
comp40016_c0_seq1;GAXK01191562.1;Q8N954;1.37E-24;GPT11_HUMAN;G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75);"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]";"GO:0000776; GO:0000777; GO:0003676";;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";nucleic acid binding [GO:0003676]
comp4001700_c0_seq1;GAXK01179677.1;P16374;2.03E-15;ZFP60_MOUSE;Zinc finger protein 60 (Zfp-60) (Zinc finger protein Mfg-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp400196_c0_seq1;GAXK01146337.1;Q9Y5R2;1.51E-73;MMP24_HUMAN;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4002001_c0_seq1;GAXK01061369.1;Q6B4Z5;4.20E-10;ZFY_PANTR;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4002107_c0_seq1;GAXK01061376.1;P98069;5.72E-07;BMPH_STRPU;Bone morphogenetic protein 1 homolog (EC 3.4.24.-) (SUBMP);"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0004222; GO:0005509; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];;"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4002334_c0_seq1;GAXK01061385.1;Q58CX9;3.79E-23;CBPC5_BOVIN;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp4002429_c0_seq1;GAXK01061379.1;P54145;5.01E-54;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp40027_c0_seq1;GAXK01192204.1;Q6P0C6;2.40E-21;LHPL2_DANRE;LHFPL tetraspan subfamily member 2a protein;"integral component of membrane [GO:0016021]; development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]";"GO:0007338; GO:0016021; GO:0046545; GO:0046546; GO:1905516";"development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]";integral component of membrane [GO:0016021];
comp4003535_c0_seq1;GAXK01061368.1;Q63170;1.40E-99;DYH7_RAT;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005509; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp400380_c0_seq1;GAXK01146464.1;Q3B7N9;2.17E-11;MYNN_BOVIN;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp400406_c0_seq1;GAXK01146398.1;P10754;3.95E-07;ZFP13_MOUSE;Zinc finger protein 13 (Zfp-13) (Zinc finger protein Krox-8);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005739; GO:0006357; GO:0010729; GO:0046872; GO:1901030";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp40042_c0_seq1;GAXK01191861.1;Q9JK30;6.23E-97;ORC3_MOUSE;Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo);"chromatin [GO:0000785]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]; DNA replication origin binding [GO:0003688]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; neural precursor cell proliferation [GO:0061351]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA replication [GO:0006275]";"GO:0000785; GO:0000808; GO:0003688; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006267; GO:0006270; GO:0006275; GO:0016604; GO:0031261; GO:0061351";"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; neural precursor cell proliferation [GO:0061351]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA replication [GO:0006275]";"chromatin [GO:0000785]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]";DNA replication origin binding [GO:0003688]
comp4004590_c0_seq1;GAXK01075223.1;P09648;1.52E-49;CATL1_CHICK;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain] (Fragments)";"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp40049_c0_seq1;GAXK01191692.1;Q5F4B8;2.20E-17;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp4005687_c0_seq1;GAXK01075228.1;P93664;1.45E-09;LHSR1_CHLRE;Light-harvesting complex stress-related protein 1, chloroplastic (Chlorophyll a-b binding protein LHCSR1);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0009416; GO:0009522; GO:0009523; GO:0009535; GO:0009768; GO:0016021; GO:0016168; GO:0018298";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp4005892_c0_seq1;GAXK01075211.1;Q90705;3.34E-44;EF2_CHICK;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp4006_c2_seq1;GAXK01066202.1;Q8JGT5;1.20E-96;SAE1_XENLA;SUMO-activating enzyme subunit 1 (SUMO-activating enzyme E1 N subunit) (Ubiquitin-like 1-activating enzyme E1A);"SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925]";"GO:0008641; GO:0016925; GO:0031510";protein sumoylation [GO:0016925];SUMO activating enzyme complex [GO:0031510];ubiquitin-like modifier activating enzyme activity [GO:0008641]
comp400651_c0_seq1;GAXK01146463.1;Q6GNS1;7.77E-12;CHSTA_XENLA;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051";carbohydrate biosynthetic process [GO:0016051];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp40068_c1_seq1;GAXK01191930.1;A6QPQ5;4.14E-17;RM01_BOVIN;39S ribosomal protein L1, mitochondrial (L1mt) (MRP-L1);"cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0005743; GO:0006412; GO:0022625";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp40069_c0_seq1;GAXK01191498.1;Q61824;7.96E-108;ADA12_MOUSE;Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]";"GO:0004222; GO:0005615; GO:0005654; GO:0005886; GO:0007155; GO:0016021; GO:0017124; GO:0045766; GO:0046872";"cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]"
comp4006938_c0_seq1;GAXK01113698.1;Q32KH7;1.60E-50;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp400712_c0_seq1;GAXK01146371.1;P89116;8.15E-71;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp40072_c0_seq1;GAXK01192197.1;Q9UQ90;0;SPG7_HUMAN;Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein);"axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]";"GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0006851; GO:0007005; GO:0007399; GO:0008089; GO:0008233; GO:0008270; GO:0046902; GO:0051082; GO:1902686; GO:1904115";"anterograde axonal transport [GO:0008089]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]";"axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp4007296_c0_seq1;GAXK01113710.1;C0IN03;6.62E-07;HENMT_XENTR;Small RNA 2'-O-methyltransferase (EC 2.1.1.n8) (HEN1 methyltransferase homolog 1) (piRNA methyltransferase 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]";"GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872";"piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]";"metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]"
comp4007709_c0_seq1;GAXK01113709.1;P36609;2.26E-41;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp400806_c2_seq1;GAXK01146430.1;Q60636;5.60E-07;PRDM1_MOUSE;PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841";"adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4008297_c0_seq1;GAXK01059163.1;Q8DJZ9;2.50E-105;CLPP2_THEEB;ATP-dependent Clp protease proteolytic subunit 2 (EC 3.4.21.92) (Endopeptidase Clp 2);"cytoplasm [GO:0005737]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005737";;cytoplasm [GO:0005737];serine-type endopeptidase activity [GO:0004252]
comp4008402_c0_seq1;GAXK01059186.1;E1C8P7;5.22E-10;DSCL1_CHICK;Down syndrome cell adhesion molecule-like protein 1 homolog;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0007156; GO:0007416; GO:0007417; GO:0010842; GO:0016021; GO:0030017; GO:0030054; GO:0045202; GO:0060219";"camera-type eye photoreceptor cell differentiation [GO:0060219]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; synapse [GO:0045202]";
comp4008471_c0_seq1;GAXK01059167.1;Q27367;1.03E-26;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp4008703_c0_seq1;GAXK01059188.1;Q9NPF2;1.41E-15;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp4008994_c0_seq1;GAXK01059178.1;Q32LG5;1.93E-23;REEP6_BOVIN;Receptor expression-enhancing protein 6;"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp4009136_c0_seq1;GAXK01059173.1;Q24278;4.48E-135;CNGA_DROME;Cyclic nucleotide-gated cation channel subunit A (Cyclic nucleotide-gated ion channel subunit A) (CNG channel);"intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005221; GO:0005222; GO:0005223; GO:0006812; GO:0017071; GO:0019934; GO:0030553";"cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]";intracellular cyclic nucleotide activated cation channel complex [GO:0017071];"cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]"
comp4009290_c0_seq1;GAXK01059162.1;Q95SX7;9.67E-08;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp40097_c0_seq1;GAXK01191626.1;Q9UBF6;4.70E-50;RBX2_HUMAN;RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein);"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; response to redox state [GO:0051775]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0019788; GO:0031146; GO:0031461; GO:0031462; GO:0031463; GO:0031466; GO:0031467; GO:0043224; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0080008; GO:0097602";"post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; response to redox state [GO:0051775]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp401_c1_seq1;GAXK01205902.1;P29844;0;BIP_DROME;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein homolog) (GRP-78 homolog) (Binding-immunoglobulin protein homolog) (BiP) (Heat shock 70 kDa protein cognate 3) (Heat shock protein cognate 72);"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006986; GO:0012505; GO:0016020; GO:0016246; GO:0016887; GO:0030431; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0034976; GO:0036335; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp40108_c0_seq1;GAXK01192018.1;Q9NQC7;7.18E-118;CYLD_HUMAN;Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD);"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0036459; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242";"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]";"Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]"
comp4011_c2_seq1;GAXK01065649.1;P07858;4.11E-123;CATB_HUMAN;"Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]";"collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]";"GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0008233; GO:0008234; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813";"cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]";"collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]"
comp401117_c0_seq1;GAXK01146358.1;Q8YRI1;6.37E-64;YY46_NOSS1;Uncharacterized WD repeat-containing protein alr3466;;;;;
comp4011380_c0_seq1;GAXK01133322.1;P09180;7.97E-58;RL4_DROME;60S ribosomal protein L4 (L1);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp4011452_c0_seq1;GAXK01133326.1;A0A126GUP6;2.97E-08;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp401263_c1_seq1;GAXK01146390.1;Q3SXZ3;5.93E-09;ZN718_HUMAN;Zinc finger protein 718;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp401270_c3_seq1;GAXK01146341.1;Q71RS6;2.21E-99;NCKX5_HUMAN;Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5);"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0032588; GO:0034220; GO:0042470; GO:0048022; GO:0050896; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp40128_c0_seq1;GAXK01191547.1;P02567;1.84E-70;MYO1_CAEEL;Myosin-1 (Myosin heavy chain D) (MHC D);"striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";"GO:0003774; GO:0005524; GO:0005863; GO:0006936; GO:0008307; GO:0043050; GO:0051015";"muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";striated muscle myosin thick filament [GO:0005863];"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]"
comp401299_c0_seq1;GAXK01146436.1;P36609;5.02E-27;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp401300_c1_seq1;GAXK01146465.1;Q9VR59;0;VIP1_DROME;Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase);"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]";"GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092";"inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]";cytosol [GO:0005829];"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"
comp401359_c1_seq1;GAXK01146550.1;Q1H9T6;1.76E-23;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp401364_c0_seq1;GAXK01146368.1;Q8MJY8;1.14E-41;PGDH_MACFA;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp40137_c2_seq1;GAXK01191448.1;O00767;1.81E-116;ACOD_HUMAN;Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty-acyl-CoA biosynthetic process [GO:0046949]; monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol biosynthetic process [GO:0045540]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0005506; GO:0005730; GO:0005783; GO:0005789; GO:0006636; GO:0016020; GO:0016021; GO:0016491; GO:0030176; GO:0032896; GO:0045540; GO:0046949; GO:0120162; GO:1903966";"fatty-acyl-CoA biosynthetic process [GO:0046949]; monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol biosynthetic process [GO:0045540]; unsaturated fatty acid biosynthetic process [GO:0006636]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]";"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]"
comp4014076_c0_seq1;GAXK01151166.1;P49641;7.31E-41;MA2A2_HUMAN;Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872";"mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp4014758_c0_seq1;GAXK01151178.1;P51905;9.80E-22;SC6A4_DROME;Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1);"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"GO:0005261; GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610";"monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; serotonin binding [GO:0051378]"
comp4014968_c0_seq1;GAXK01151170.1;P39872;1.34E-73;RL3_BOVIN;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005730; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp4015_c1_seq1;GAXK01065756.1;A7T0W1;1.44E-43;UXT_NEMVE;Protein UXT homolog;"chromatin [GO:0000785]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; beta-tubulin binding [GO:0048487]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein folding [GO:0006457]";"GO:0000122; GO:0000785; GO:0003712; GO:0003714; GO:0005634; GO:0006457; GO:0016272; GO:0048487; GO:0051082";"negative regulation of transcription by RNA polymerase II [GO:0000122]; protein folding [GO:0006457]";"chromatin [GO:0000785]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]";"beta-tubulin binding [GO:0048487]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]"
comp401587_c0_seq1;GAXK01146442.1;Q5R5X8;4.63E-24;CAP2_PONAB;Adenylyl cyclase-associated protein 2 (CAP 2);"plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]";"GO:0000902; GO:0003779; GO:0005886; GO:0007010";"cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]";plasma membrane [GO:0005886];actin binding [GO:0003779]
comp4015925_c0_seq1;GAXK01151161.1;P39057;1.22E-66;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp4016249_c0_seq1;GAXK01141249.1;Q02357;1.11E-10;ANK1_MOUSE;Ankyrin-1 (ANK-1) (Erythrocyte ankyrin);"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0043194; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]"
comp4017050_c0_seq1;GAXK01141253.1;P36609;1.20E-11;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4017576_c0_seq1;GAXK01141247.1;Q9R0N3;2.99E-29;SYT11_MOUSE;Synaptotagmin-11 (Synaptotagmin XI) (SytXI);"axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; beta-tubulin binding [GO:0048487]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of membrane invagination [GO:1905154]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; protein homotetramerization [GO:0051289]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; response to wounding [GO:0009611]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001778; GO:0001786; GO:0001891; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0008021; GO:0009611; GO:0014059; GO:0014069; GO:0016192; GO:0017156; GO:0017158; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0031369; GO:0031625; GO:0031982; GO:0032009; GO:0042803; GO:0043005; GO:0043195; GO:0043197; GO:0044297; GO:0045335; GO:0046872; GO:0048471; GO:0048487; GO:0048787; GO:0048791; GO:0050765; GO:0051289; GO:0055037; GO:0060076; GO:0060077; GO:0070382; GO:0071277; GO:0098685; GO:0098793; GO:0098794; GO:0099059; GO:1900165; GO:1900186; GO:1900243; GO:1900424; GO:1904468; GO:1905154; GO:1905162; GO:1905171; GO:1905469; GO:1990927";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of membrane invagination [GO:1905154]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; protein homotetramerization [GO:0051289]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; response to wounding [GO:0009611]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of synaptic vesicle membrane [GO:0030285]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; vesicle [GO:0031982]";"beta-tubulin binding [GO:0048487]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]"
comp4017926_c0_seq1;GAXK01141248.1;P70549;4.03E-43;NAC3_RAT;Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3);"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031594; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]"
comp4017956_c0_seq1;GAXK01141262.1;Q80SU7;7.94E-12;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp40182_c0_seq1;GAXK01191618.1;P52272;4.16E-19;HNRPM_HUMAN;Heterogeneous nuclear ribonucleoprotein M (hnRNP M);"catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; RNA metabolic process [GO:0016070]";"GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0008543; GO:0016020; GO:0016070; GO:0016363; GO:0019904; GO:0042382; GO:0062023; GO:0070062; GO:0071013; GO:0071014; GO:1990904; GO:2000815";"alternative mRNA splicing, via spliceosome [GO:0000380]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; RNA metabolic process [GO:0016070]";"catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]"
comp4018470_c0_seq1;GAXK01080457.1;O75096;1.12E-07;LRP4_HUMAN;Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp4018551_c0_seq1;GAXK01080456.1;P69744;5.65E-18;TRPV5_MOUSE;Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cellular calcium ion homeostasis [GO:0006874]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"GO:0005216; GO:0005262; GO:0005516; GO:0005887; GO:0006816; GO:0006874; GO:0016324; GO:0031226; GO:0035809; GO:0046872; GO:0051262; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cellular calcium ion homeostasis [GO:0006874]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of urine volume [GO:0035809]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp40186_c0_seq1;GAXK01191499.1;Q6PGG2;1.44E-109;GMIP_MOUSE;GEM-interacting protein (GMIP);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]";"GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872";"intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp4018931_c0_seq1;GAXK01080471.1;Q9CYT6;2.60E-16;CAP2_MOUSE;Adenylyl cyclase-associated protein 2 (CAP 2);"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]";"GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0014069; GO:0030864; GO:0042802";"actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]";"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]"
comp4019751_c0_seq1;GAXK01080479.1;P22105;3.33E-09;TENX_HUMAN;Tenascin-X (TN-X) (Hexabrachion-like protein);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]"
comp4020757_c0_seq1;GAXK01057516.1;P36609;2.61E-19;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4020938_c0_seq1;GAXK01057502.1;C9WMM5;1.65E-70;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp4021579_c0_seq1;GAXK01057520.1;P46252;1.47E-08;RLA2A_MAIZE;60S acidic ribosomal protein P2A (P2);"cytosolic large ribosomal subunit [GO:0022625]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0006414; GO:0022625; GO:0044877";translational elongation [GO:0006414];cytosolic large ribosomal subunit [GO:0022625];"protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]"
comp4021681_c0_seq1;GAXK01057504.1;Q05825;2.21E-46;ATPB_DROME;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"GO:0000275; GO:0005524; GO:0005739; GO:0005753; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:0046961; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp402171_c0_seq1;GAXK01152818.1;Q26474;6.62E-37;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp4021769_c0_seq1;GAXK01057512.1;Q94HW2;2.22E-16;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp40219_c1_seq1;GAXK01191535.1;P01040;4.05E-16;CYTA_HUMAN;Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed];"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149]";"GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0010466; GO:0018149; GO:0030216; GO:0045861; GO:0070268; GO:0098609";"cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149]";"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]"
comp4022778_c0_seq1;GAXK01074781.1;Q94900;5.36E-08;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp402343_c0_seq1;GAXK01152796.1;Q28623;2.31E-15;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp4023930_c0_seq1;GAXK01074773.1;Q805E5;6.65E-07;CHSTE_DANRE;Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0050655";"carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp402423_c0_seq1;GAXK01152794.1;Q9V3D6;3.47E-22;CPSF2_DROME;Probable cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]";"GO:0003723; GO:0005847; GO:0006378; GO:0006379; GO:0006398";"mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]";mRNA cleavage and polyadenylation specificity factor complex [GO:0005847];RNA binding [GO:0003723]
comp402435_c4_seq1;GAXK01152799.1;A5D6R3;3.05E-121;PLD3A_DANRE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3-A (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3-A) (Phospholipase C-delta-3-A) (PLC-delta-3-A);"cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]";"GO:0004435; GO:0005509; GO:0005737; GO:0016020; GO:0016042; GO:0032959; GO:0035556";"inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp402477_c0_seq1;GAXK01152935.1;O73872;7.72E-36;SODC_DANRE;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]";"GO:0004784; GO:0005507; GO:0005634; GO:0005739; GO:0005829; GO:0009410; GO:0010038; GO:0019430; GO:0051597; GO:0070050";"neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]"
comp40251_c0_seq1;GAXK01192095.1;Q14678;6.86E-68;KANK1_HUMAN;KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005634; GO:0005737; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393";"actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";beta-catenin binding [GO:0008013]
comp40256_c1_seq1;GAXK01191854.1;P57052;2.07E-16;RBM11_HUMAN;Splicing regulator RBM11 (RNA-binding motif protein 11);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0007275; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803";"cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]"
comp4025601_c0_seq1;GAXK01148688.1;Q9VZW5;2.28E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp4026091_c0_seq1;GAXK01044676.1;Q14624;3.97E-32;ITIH4_HUMAN;"Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]";"endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp4026340_c0_seq1;GAXK01044657.1;Q962U0;2.00E-69;RL13A_SPOFR;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp4026396_c0_seq1;GAXK01044673.1;Q9QY01;2.60E-19;ULK2_MOUSE;Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Serine/threonine-protein kinase Unc51.2) (Unc-51-like kinase 2);"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; negative regulation of collateral sprouting [GO:0048671]; positive regulation by symbiont of host autophagy [GO:0075044]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; signal transduction [GO:0007165]";"GO:0000045; GO:0000407; GO:0004674; GO:0005524; GO:0005829; GO:0006914; GO:0007165; GO:0010506; GO:0016020; GO:0030659; GO:0034045; GO:0042594; GO:0046777; GO:0048671; GO:0048675; GO:0075044";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; negative regulation of collateral sprouting [GO:0048671]; positive regulation by symbiont of host autophagy [GO:0075044]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; signal transduction [GO:0007165]";"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp40267_c0_seq1;GAXK01191513.1;Q8WR63;3.83E-39;TPM_TRIPS;Tropomyosin;;;;;
comp402700_c0_seq1;GAXK01152847.1;Q01989;3.24E-27;MYS9_DROME;Myosin heavy chain 95F (95F MHC) (Protein jaguar);"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]; spindle organization [GO:0007051]";"GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005875; GO:0005938; GO:0006997; GO:0007015; GO:0007051; GO:0007283; GO:0007291; GO:0007297; GO:0007298; GO:0007391; GO:0007552; GO:0007560; GO:0008017; GO:0008104; GO:0008363; GO:0016333; GO:0016461; GO:0019749; GO:0030036; GO:0030048; GO:0030139; GO:0030317; GO:0030426; GO:0030589; GO:0031476; GO:0032027; GO:0032880; GO:0032956; GO:0032970; GO:0032991; GO:0040001; GO:0042623; GO:0045167; GO:0045172; GO:0045175; GO:0045178; GO:0045217; GO:0045921; GO:0047497; GO:0048477; GO:0051015; GO:0051647; GO:0055057; GO:0055059; GO:0061024; GO:0070856; GO:0070864; GO:0070865";"actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]"
comp402715_c0_seq1;GAXK01152819.1;Q5GH73;5.96E-56;XKR6_HUMAN;XK-related protein 6;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742";"apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp4027385_c0_seq1;GAXK01044655.1;Q8VHE6;3.82E-36;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp4027396_c0_seq1;GAXK01044660.1;Q7ZU45;1.59E-16;TTC25_DANRE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371";"cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp402785_c0_seq1;GAXK01152897.1;Q09621;2.90E-32;LACT2_CAEEL;Beta-lactamase domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp40279_c0_seq1;GAXK01191931.1;B2D0J5;1.85E-93;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp4028102_c0_seq1;GAXK01104512.1;Q90352;8.76E-11;AVT_CATCO;[Arg8]-vasotocin receptor (AVT);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vasopressin receptor activity [GO:0005000]";"GO:0005000; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";vasopressin receptor activity [GO:0005000]
comp4028375_c0_seq1;GAXK01104500.1;P59671;1.28E-69;RL3_NEUCR;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp40289_c0_seq1;GAXK01191836.1;Q9BXB4;2.28E-29;OSB11_HUMAN;Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"GO:0005654; GO:0005794; GO:0005829; GO:0008289; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444";"fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"
comp4029_c0_seq1;GAXK01205375.1;P25867;9.80E-95;UBCD1_DROME;Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061630; GO:0061631; GO:0097039";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]"
comp402933_c0_seq1;GAXK01152876.1;Q64143;2.51E-98;P55G_MOUSE;Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK);"phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; cell migration involved in sprouting angiogenesis [GO:0002042]; insulin receptor signaling pathway [GO:0008286]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]";"GO:0001784; GO:0001934; GO:0002042; GO:0005942; GO:0008286; GO:0010628; GO:0043491; GO:0043551; GO:0046854; GO:0046935";"cell migration involved in sprouting angiogenesis [GO:0002042]; insulin receptor signaling pathway [GO:0008286]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]";phosphatidylinositol 3-kinase complex [GO:0005942];"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]"
comp40298_c0_seq1;GAXK01192003.1;Q12981;1.59E-27;SEC20_HUMAN;Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005484; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0006890; GO:0006915; GO:0007029; GO:0016320; GO:0030176; GO:0031201; GO:0031966; GO:0043066; GO:0043231; GO:0097194";"apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]";SNAP receptor activity [GO:0005484]
comp4029911_c0_seq1;GAXK01104499.1;Q5UPG5;4.73E-07;YL093_MIMIV;Putative ankyrin repeat protein L93;;;;;
comp40300_c1_seq1;GAXK01192145.1;P59110;9.46E-50;SENP1_MOUSE;Sentrin-specific protease 1 (EC 3.4.22.-) (SUMO-1 protease 2) (SuPr-2) (Sentrin/SUMO-specific protease SENP1);"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"GO:0005634; GO:0005737; GO:0005925; GO:0006919; GO:0007275; GO:0010724; GO:0016926; GO:0031965; GO:0032435; GO:0045944; GO:0070140; GO:0097190";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp403000_c0_seq1;GAXK01152917.1;Q96QG7;5.48E-149;MTMR9_HUMAN;Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"GO:0005737; GO:0005783; GO:0005829; GO:0006661; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0048471; GO:0050821; GO:0060304";"endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]";"enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]"
comp403041_c0_seq1;GAXK01152793.1;Q5F3N1;3.75E-92;PIMT_CHICK;Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase);"cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]";"GO:0004719; GO:0005737";;cytoplasm [GO:0005737];protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]
comp4030577_c0_seq1;GAXK01061423.1;Q9UJU3;1.64E-22;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp40306_c12_seq1;GAXK01191643.1;Q5E980;3.30E-37;CP20A_BOVIN;Cytochrome P450 20A1 (EC 1.14.-.-);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037";;integral component of membrane [GO:0016021];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp403087_c0_seq1;GAXK01152884.1;Q5VTD9;3.19E-21;GFI1B_HUMAN;Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000981; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872; GO:2000134";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp4031_c0_seq1;GAXK01066874.1;P05946;7.40E-73;SCP1_ASTLP;Sarcoplasmic calcium-binding protein 1 (Sarcoplasmic calcium-binding protein I) (SCP I);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp40323_c1_seq1;GAXK01191487.1;O42123;1.10E-31;FKB1A_XENLA;Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase);"cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"GO:0000413; GO:0001933; GO:0003007; GO:0003755; GO:0005528; GO:0005737; GO:0005829; GO:0006936; GO:0007183; GO:0008144; GO:0014802; GO:0016020; GO:0019221; GO:0019855; GO:0030018; GO:0031000; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0033017; GO:0042098; GO:0042803; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0051209; GO:0051280; GO:0055010; GO:0060314; GO:0060315; GO:0060347; GO:0070062; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425";"amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]";"activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]"
comp403302_c0_seq1;GAXK01152901.1;Q9NWM0;4.39E-59;SMOX_HUMAN;Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901";"polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp403358_c0_seq1;GAXK01152883.1;P54350;1.99E-19;WEE1_DROME;Wee1-like protein kinase (Dwee1) (EC 2.7.10.2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";"GO:0000287; GO:0001700; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0006468; GO:0007093; GO:0018108; GO:0045736; GO:0051225; GO:0051299; GO:0051301; GO:0051642";"cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp4033644_c0_seq1;GAXK01002850.1;P25600;1.73E-08;YCH4_YEAST;Putative transposon Ty5-1 protein YCL074W;"retrotransposon nucleocapsid [GO:0000943]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003723; GO:0003887; GO:0003964; GO:0004540; GO:0008233; GO:0032197";transposition, RNA-mediated [GO:0032197];retrotransposon nucleocapsid [GO:0000943];"DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4033653_c0_seq1;GAXK01002849.1;P02350;1.68E-87;RS31_XENLA;40S ribosomal protein S3-A (EC 4.2.99.18) (S1A);"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp40341_c0_seq1;GAXK01191455.1;Q32LJ2;3.47E-86;ARFRP_BOVIN;ADP-ribosylation factor-related protein 1 (ARF-related protein 1);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007369; GO:0016020; GO:0034067; GO:0042147; GO:0043001";"gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]";GTP binding [GO:0005525]
comp403418_c0_seq1;GAXK01152816.1;P38040;7.12E-10;GBG1_DROME;Guanine nucleotide-binding protein subunit gamma-1;"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343";"apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]"
comp4034377_c0_seq1;GAXK01085129.1;Q9U3P2;2.88E-15;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp403438_c2_seq1;GAXK01152823.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp4034430_c0_seq1;GAXK01085110.1;A4QNE6;4.90E-20;WDR92_XENTR;WD repeat-containing protein 92;"ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]";"GO:0006915; GO:0043130";apoptotic process [GO:0006915];;ubiquitin binding [GO:0043130]
comp403481_c0_seq1;GAXK01152809.1;Q9UHF3;2.59E-11;NAT8B_HUMAN;Putative N-acetyltransferase 8B (EC 2.3.1.-) (Acetyltransferase 1) (ATase1) (Camello-like protein 2);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]; amyloid-beta metabolic process [GO:0050435]; cellular protein metabolic process [GO:0044267]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]";"GO:0001702; GO:0004468; GO:0005789; GO:0005793; GO:0008080; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0043066; GO:0044267; GO:0050435";"amyloid-beta metabolic process [GO:0050435]; cellular protein metabolic process [GO:0044267]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]";"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]"
comp40349_c1_seq1;GAXK01192116.1;Q17Q97;2.58E-09;REX1B_BOVIN;Required for excision 1-B domain-containing protein;;;;;
comp4034939_c0_seq1;GAXK01085119.1;Q02753;2.88E-47;RL21A_YEAST;60S ribosomal protein L21-A (Large ribosomal subunit protein eL21-A);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp4035174_c0_seq2;GAXK01085132.1;P28799;2.25E-13;GRN_HUMAN;"Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)]";"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; signal transduction [GO:0007165]";"GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0043312; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050679; GO:0050821; GO:0051087; GO:0060266; GO:0070062; GO:0106016; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905247; GO:1905673";"astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; signal transduction [GO:0007165]";"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]"
comp403592_c0_seq1;GAXK01152790.1;Q05319;5.06E-31;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp40364_c0_seq1;GAXK01192139.1;Q5ZMP6;1.82E-43;AP2M1_CHICK;AP-2 complex subunit mu (AP-2 mu chain) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein);"AP-2 adaptor complex [GO:0030122]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]";"GO:0006886; GO:0008289; GO:0030122; GO:0072583; GO:0097718; GO:0098794; GO:0098884; GO:0098978";"clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]";"AP-2 adaptor complex [GO:0030122]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]";"disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]"
comp40368_c6_seq1;GAXK01192041.1;Q5RCU5;1.71E-26;CBR1_PONAB;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]";"GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047021; GO:0050221";"drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]"
comp4037144_c0_seq1;GAXK01084273.1;Q9C0G6;9.27E-15;DYH6_HUMAN;Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp403715_c0_seq1;GAXK01152835.1;Q64729;1.79E-130;TGFR1_MOUSE;TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I);"activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"GO:0000186; GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005623; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007389; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019838; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0035556; GO:0042118; GO:0043065; GO:0043066; GO:0043231; GO:0043235; GO:0043393; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046777; GO:0046872; GO:0046982; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070411; GO:0070723; GO:0071560; GO:1902894; GO:1902895; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237";"activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]";"activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]"
comp4037441_c0_seq1;GAXK01084286.1;Q4R353;3.97E-47;TEKT5_MACFA;Tektin-5;motile cilium [GO:0031514];GO:0031514;;motile cilium [GO:0031514];
comp40375_c0_seq1;GAXK01191494.1;Q6NRM1;7.00E-69;S399B_XENLA;Zinc transporter ZIP9-B (Solute carrier family 39 member 9-B) (Zrt- and Irt-like protein 9-B) (ZIP-9-B);"integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]";"GO:0006829; GO:0016021; GO:0046873";zinc ion transport [GO:0006829];integral component of membrane [GO:0016021];metal ion transmembrane transporter activity [GO:0046873]
comp403827_c0_seq1;GAXK01152854.1;P83501;1.27E-27;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp40383_c0_seq1;GAXK01192212.1;Q92546;6.05E-97;RGP1_HUMAN;RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000139; GO:0005829; GO:0005886; GO:0016020; GO:0017112; GO:0017137; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363";"negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]";"Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp403898_c0_seq1;GAXK01152874.1;Q0V8T0;2.12E-20;CNTP5_CANLF;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp4039_c0_seq1;GAXK01066760.1;Q14566;0;MCM6_HUMAN;DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM);"MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]";"GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:1902969";"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]";"MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]"
comp4039456_c0_seq1;GAXK01192319.1;Q54SJ5;1.00E-21;MYLKC_DICDI;Probable myosin light chain kinase DDB_G0282429 (EC 2.7.11.18);"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0004687; GO:0005524";;;"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]"
comp4039740_c0_seq1;GAXK01192321.1;Q8NA82;7.12E-10;MARHA_HUMAN;Probable E3 ubiquitin-protein ligase MARCH10 (EC 2.3.2.27) (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X) (MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCH10);"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]";"GO:0008270; GO:0016567; GO:0016740";protein ubiquitination [GO:0016567];;"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp404_c0_seq1;GAXK01169861.1;P55814;3.57E-17;OAZ1_XENLA;Ornithine decarboxylase antizyme 1 (ODC-Az);"cytosol [GO:0005829]; ornithine decarboxylase inhibitor activity [GO:0008073]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]";"GO:0005829; GO:0006596; GO:0008073; GO:0090316";"polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]";cytosol [GO:0005829];ornithine decarboxylase inhibitor activity [GO:0008073]
comp4040_c0_seq1;GAXK01066737.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp40403_c2_seq1;GAXK01192188.1;P26779;3.08E-07;SAP_BOVIN;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp4040546_c0_seq1;GAXK01119311.1;A6TR79;7.92E-07;MUTS_ALKMQ;DNA mismatch repair protein MutS;"ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]";"GO:0003684; GO:0005524; GO:0006298; GO:0030983";mismatch repair [GO:0006298];;"ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]"
comp40407_c0_seq1;GAXK01191684.1;Q5U3F2;5.20E-178;SLU7_DANRE;Pre-mRNA-splicing factor SLU7;"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000386; GO:0000398; GO:0005681; GO:0005737; GO:0016607; GO:0030628; GO:0046872";mRNA splicing, via spliceosome [GO:0000398];"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]";"metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]"
comp4040978_c0_seq1;GAXK01119301.1;F1MLB4;5.88E-36;DAAF3_BOVIN;Dynein assembly factor 3, axonemal;"cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; motile cilium assembly [GO:0044458]";"GO:0005737; GO:0007368; GO:0007507; GO:0044458; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; motile cilium assembly [GO:0044458]";cytoplasm [GO:0005737];
comp4040997_c0_seq1;GAXK01119316.1;F1PT61;2.39E-29;MYH16_CANLF;Myosin-16 (Myosin heavy chain 16);"myofibril [GO:0030016]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]";"GO:0003774; GO:0005524; GO:0016459; GO:0030016; GO:0051015";;"myofibril [GO:0030016]; myosin complex [GO:0016459]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp4041616_c0_seq1;GAXK01119305.1;Q8JGS9;4.03E-40;RS18_DANRE;40S ribosomal protein S18;"cytosol [GO:0005829]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; multicellular organism development [GO:0007275]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0005840; GO:0006412; GO:0007275; GO:0019843; GO:0051726";"multicellular organism development [GO:0007275]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"cytosol [GO:0005829]; ribosome [GO:0005840]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4041637_c0_seq1;GAXK01119302.1;P41596;4.98E-24;DOPR1_DROME;Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542]";"GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005887; GO:0007187; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016021; GO:0030425; GO:0030594; GO:0040040; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834";"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]";"dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]"
comp4041705_c0_seq1;GAXK01119309.1;Q5ZM39;4.07E-11;BCL6_CHICK;B-cell lymphoma 6 protein homolog;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001953; GO:0002467; GO:0002829; GO:0003677; GO:0003682; GO:0005634; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043087; GO:0043380; GO:0043565; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0051272";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4041862_c0_seq1;GAXK01119304.1;Q9DSN8;1.10E-11;POLS_ABPVR;"Structural polyprotein [Cleaved into: Protein VP1 (Virion protein 2); Protein VP4 (Virion protein 4); Protein VP2 (Virion protein 3); Protein VP3 (Virion protein 1)]";"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028; GO:0030430";;"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]";structural molecule activity [GO:0005198]
comp404225_c2_seq1;GAXK01128295.1;Q32KJ8;6.78E-34;ARSI_RAT;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp40429_c0_seq1;GAXK01192136.1;P28838;1.13E-121;AMPL_HUMAN;Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; proteolysis [GO:0006508]";"GO:0004177; GO:0005634; GO:0005654; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008235; GO:0030145; GO:0030496; GO:0070062";proteolysis [GO:0006508];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]";"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]"
comp404339_c0_seq1;GAXK01128455.1;Q86UP9;3.42E-57;LHPL3_HUMAN;LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp4043524_c0_seq1;GAXK01160870.1;P51281;3.98E-20;YCF45_PORPU;Uncharacterized protein ycf45 (ORF565);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005524; GO:0009507";;chloroplast [GO:0009507];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]"
comp4043853_c0_seq1;GAXK01160852.1;Q9DG39;7.47E-10;SLXA_GLOHA;Snaclec coagulation factor IX/factor X-binding protein subunit A (IX/X-bp subunit A) (Halyxin subunit A);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]";"GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp4044020_c0_seq1;GAXK01090213.1;Q2M3R5;1.13E-22;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4044234_c0_seq1;GAXK01090216.1;O70244;3.53E-07;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp4044431_c0_seq1;GAXK01090205.1;Q9NHW7;6.47E-14;AQP_AEDAE;Aquaporin AQPAe.a;"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp4044454_c0_seq1;GAXK01090200.1;P17970;7.16E-31;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4044556_c0_seq1;GAXK01090209.1;P11837;6.84E-09;NIMA_EMENI;G2-specific protein kinase nimA (EC 2.7.11.1) (Never in mitosis);"mitotic spindle pole body [GO:0044732]; new mitotic spindle pole body [GO:0071958]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation [GO:0043987]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of mitotic nuclear division [GO:0045840]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]";"GO:0000086; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007059; GO:0007088; GO:0043987; GO:0044732; GO:0045840; GO:0051301; GO:0071958; GO:0090307; GO:1903126";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation [GO:0043987]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of mitotic nuclear division [GO:0045840]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]";"mitotic spindle pole body [GO:0044732]; new mitotic spindle pole body [GO:0071958]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp404480_c0_seq1;GAXK01128283.1;P47238;8.75E-46;PAX6_COTJA;Paired box protein Pax-6 (Pax-QNR);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp4044813_c0_seq1;GAXK01090198.1;Q06572;0;AVP_HORVU;Pyrophosphate-energized vacuolar membrane proton pump (EC 7.1.3.1) (Pyrophosphate-energized inorganic pyrophosphatase) (H(+)-PPase);"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]";"GO:0004427; GO:0005774; GO:0009678; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";"inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp4045_c0_seq1;GAXK01066527.1;Q9U0S4;2.86E-103;VATD_MANSE;V-type proton ATPase subunit D (V-ATPase subunit D) (Vacuolar proton pump subunit D);"ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]";"GO:0006811; GO:0042626";ion transport [GO:0006811];;ATPase-coupled transmembrane transporter activity [GO:0042626]
comp404516_c1_seq1;GAXK01128291.1;P98165;9.56E-148;VLDLR_CHICK;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; ventral spinal cord development [GO:0021517]";"GO:0005509; GO:0005905; GO:0006869; GO:0008203; GO:0016021; GO:0021517; GO:0030228; GO:0030229; GO:0034185; GO:0034361";"cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; ventral spinal cord development [GO:0021517]";"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp4045471_c0_seq1;GAXK01090203.1;P36609;1.43E-35;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4045787_c0_seq1;GAXK01090208.1;P23286;1.01E-07;CALM_CANAX;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp404600_c0_seq1;GAXK01128544.1;Q5RFP4;1.91E-42;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp404601_c0_seq1;GAXK01128285.1;P11707;6.12E-54;CP3A6_RABIT;Cytochrome P450 3A6 (EC 1.14.14.1) (CYPIIIA6) (Cytochrome P450-3C);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]";"GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]"
comp40464_c0_seq1;GAXK01191444.1;Q9WVM3;3.52E-91;APC7_MOUSE;Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7) (Prediabetic NOD sera-reactive autoantigen);"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]";"GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0051301; GO:0070979";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]";"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]";protein phosphatase binding [GO:0019903]
comp404723_c0_seq1;GAXK01128452.1;P42125;1.37E-69;ECI1_MOUSE;Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]; fatty acid beta-oxidation [GO:0006635]";"GO:0004165; GO:0004300; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0042802";fatty acid beta-oxidation [GO:0006635];"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]"
comp4047345_c0_seq1;GAXK01082444.1;P05090;8.39E-15;APOD_HUMAN;Apolipoprotein D (Apo-D) (ApoD);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp4047401_c0_seq1;GAXK01082445.1;Q1ENI8;3.22E-25;PXDN_CAEEL;Peroxidasin homolog (EC 1.11.1.7);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679";"embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp404757_c2_seq1;GAXK01128277.1;D3ZWE7;7.49E-51;HORM1_RAT;HORMA domain-containing protein 1;"chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629";"blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]";
comp4047762_c0_seq1;GAXK01082448.1;Q9CZ49;2.31E-08;KLH35_MOUSE;Kelch-like protein 35;;;;;
comp4048476_c0_seq1;GAXK01069857.1;P48880;1.76E-23;ATP9_CHOCR;ATP synthase subunit 9, mitochondrial (Lipid-binding protein);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0008289; GO:0015078; GO:0015986; GO:0016021; GO:0031966; GO:0045263";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";"ATP binding [GO:0005524]; lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078]"
comp40487_c0_seq1;GAXK01191582.1;O08811;0;ERCC2_MOUSE;General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein);"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; aging [GO:0007568]; apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; cell population proliferation [GO:0008283]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair cycle process [GO:0022405]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of DNA binding [GO:0043388]; positive regulation of mitotic recombination [GO:0045951]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; skin development [GO:0043588]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]";"GO:0000019; GO:0000439; GO:0000717; GO:0001666; GO:0001701; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006915; GO:0006979; GO:0007059; GO:0007568; GO:0008022; GO:0008283; GO:0008353; GO:0009411; GO:0009650; GO:0009791; GO:0021510; GO:0022405; GO:0030198; GO:0030282; GO:0030674; GO:0032289; GO:0033683; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0043388; GO:0043588; GO:0045893; GO:0045944; GO:0045951; GO:0046872; GO:0047485; GO:0048568; GO:0048820; GO:0051539; GO:0060218; GO:0070516; GO:0071817; GO:1901990";"aging [GO:0007568]; apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; cell population proliferation [GO:0008283]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair cycle process [GO:0022405]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of DNA binding [GO:0043388]; positive regulation of mitotic recombination [GO:0045951]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; skin development [GO:0043588]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]";"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]";"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp40488_c0_seq1;GAXK01192181.1;Q28EX7;7.79E-50;MARH2_XENTR;E3 ubiquitin-protein ligase MARCH2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING-type E3 ubiquitin transferase MARCH2);"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; hemopoiesis [GO:0030097]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005765; GO:0005783; GO:0005789; GO:0006897; GO:0008270; GO:0010008; GO:0016021; GO:0016567; GO:0030097; GO:0031410";"endocytosis [GO:0006897]; hemopoiesis [GO:0030097]; protein ubiquitination [GO:0016567]";"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp404886_c0_seq1;GAXK01128478.1;Q16445;2.80E-63;GBRA6_HUMAN;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp4049208_c0_seq1;GAXK01069850.1;Q96C28;2.63E-09;ZN707_HUMAN;Zinc finger protein 707;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp40499_c2_seq1;GAXK01191957.1;Q8VDV3;7.49E-60;R3GEF_MOUSE;Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1) (Rab3A-interacting-like protein 1) (Rabin3-like 1);"kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; protein transport [GO:0015031]";"GO:0015031; GO:0017112; GO:0019900";protein transport [GO:0015031];;"kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp405210_c0_seq1;GAXK01128487.1;Q01693;2.55E-10;AMPX_VIBPR;Bacterial leucyl aminopeptidase (EC 3.4.11.10);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]";"GO:0004177; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]"
comp4052172_c0_seq1;GAXK01179482.1;Q9GZV8;2.51E-12;PRD14_HUMAN;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp405314_c0_seq1;GAXK01128532.1;Q68F62;1.41E-26;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp4053708_c0_seq1;GAXK01179468.1;Q80SU7;9.66E-50;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp40543_c0_seq1;GAXK01191516.1;Q5RJY2;3.79E-60;G2E3_MOUSE;G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0001824; GO:0005730; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243";"apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp405445_c0_seq1;GAXK01128557.1;Q9V576;3.57E-26;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp4054551_c0_seq1;GAXK01019095.1;Q9VV43;1.52E-14;Y5057_DROME;TPPP family protein CG45057;"axon [GO:0030424]; neuronal cell body [GO:0043025]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"GO:0000226; GO:0001578; GO:0015631; GO:0030424; GO:0032273; GO:0043025; GO:0046785";"microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"axon [GO:0030424]; neuronal cell body [GO:0043025]";tubulin binding [GO:0015631]
comp405458_c0_seq1;GAXK01128288.1;Q6DCM9;1.10E-10;HPCL1_XENLA;Hippocalcin-like protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp40546_c0_seq1;GAXK01192191.1;P60892;4.05E-68;PRPS1_RAT;Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I);"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0006167; GO:0009116; GO:0009165; GO:0016208; GO:0016301; GO:0019003; GO:0019693; GO:0030246; GO:0031100; GO:0032991; GO:0042803; GO:0043531";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693]";"cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]";"ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp4054791_c0_seq1;GAXK01019097.1;Q9XF97;8.11E-90;RL4_PRUAR;60S ribosomal protein L4 (L1);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp405500_c0_seq1;GAXK01128290.1;Q5T6C5;9.09E-10;AT7L2_HUMAN;Ataxin-7-like protein 2;;;;;
comp405517_c0_seq1;GAXK01128535.1;Q7KRI2;7.29E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4055716_c0_seq1;GAXK01019089.1;P23415;2.12E-24;GLRA1_HUMAN;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp4056_c0_seq1;GAXK01066633.1;Q1MTN8;2.52E-21;ACL4_SCHPO;Probable assembly chaperone of rpl4;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254]";"GO:0005634; GO:0005730; GO:0005737; GO:0042254";ribosome biogenesis [GO:0042254];"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";
comp4056205_c0_seq1;GAXK01140681.1;Q9VXX8;1.29E-39;RL371_DROME;Probable 60S ribosomal protein L37-A;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0046872";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4056548_c0_seq1;GAXK01140684.1;P71889;1.27E-33;DDAH_MYCTU;N(G),N(G)-dimethylarginine dimethylaminohydrolase (DDAH) (Dimethylarginine dimethylaminohydrolase) (EC 3.5.3.18) (Dimethylargininase);dimethylargininase activity [GO:0016403];GO:0016403;;;dimethylargininase activity [GO:0016403]
comp4056643_c0_seq1;GAXK01140689.1;Q94HW2;3.53E-23;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp40569_c0_seq1;GAXK01191575.1;P16905;4.14E-158;KAPR1_DROME;cAMP-dependent protein kinase type I regulatory subunit (DRI class I to class IV);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"GO:0005737; GO:0005829; GO:0005952; GO:0007015; GO:0007274; GO:0007419; GO:0007591; GO:0008103; GO:0008355; GO:0008603; GO:0019933; GO:0019934; GO:0030552; GO:0045471; GO:0047555; GO:2000253";"actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp4056953_c0_seq1;GAXK01140690.1;O54750;1.36E-40;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp405715_c0_seq1;GAXK01128490.1;Q19013;1.86E-119;GLS2_CAEEL;Putative glutaminase 2 (GLS) (EC 3.5.1.2) (L-glutamine amidohydrolase);"mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005739; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrion [GO:0005739];glutaminase activity [GO:0004359]
comp4057242_c0_seq1;GAXK01140676.1;Q7ZVR6;7.04E-12;MYNN_DANRE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4057376_c0_seq1;GAXK01140692.1;Q96JM2;5.64E-10;ZN462_HUMAN;Zinc finger protein 462 (Zinc finger PBX1-interacting protein) (ZFPIP);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872";"chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp4058155_c0_seq1;GAXK01181026.1;Q27403;8.24E-67;GCM_DROME;Transcription factor glial cells missing (Protein glide);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell population proliferation [GO:0008283]; dendrite morphogenesis [GO:0048813]; embryonic crystal cell differentiation [GO:0035165]; establishment of glial blood-brain barrier [GO:0060857]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; gliogenesis [GO:0042063]; hemocyte development [GO:0007516]; hemopoiesis [GO:0030097]; negative regulation of crystal cell differentiation [GO:0042690]; neuron differentiation [GO:0030182]; plasmatocyte differentiation [GO:0042387]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of hemocyte differentiation [GO:0045610]; regulation of phagocytosis [GO:0050764]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]";"GO:0000977; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007403; GO:0007516; GO:0008283; GO:0010001; GO:0010468; GO:0010628; GO:0021782; GO:0030097; GO:0030182; GO:0031290; GO:0035165; GO:0035289; GO:0042063; GO:0042387; GO:0042690; GO:0045610; GO:0045687; GO:0045893; GO:0045944; GO:0048813; GO:0050764; GO:0060252; GO:0060857";"cell population proliferation [GO:0008283]; dendrite morphogenesis [GO:0048813]; embryonic crystal cell differentiation [GO:0035165]; establishment of glial blood-brain barrier [GO:0060857]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; gliogenesis [GO:0042063]; hemocyte development [GO:0007516]; hemopoiesis [GO:0030097]; negative regulation of crystal cell differentiation [GO:0042690]; neuron differentiation [GO:0030182]; plasmatocyte differentiation [GO:0042387]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of hemocyte differentiation [GO:0045610]; regulation of phagocytosis [GO:0050764]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp405831_c0_seq1;GAXK01205649.1;Q00534;4.97E-113;CDK6_HUMAN;Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE);"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007050; GO:0007219; GO:0008285; GO:0009615; GO:0010468; GO:0010628; GO:0014002; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000134; GO:2000145; GO:2000773";"astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]"
comp405836_c0_seq1;GAXK01128292.1;Q0IES8;8.81E-103;MAB21_AEDAE;Protein mab-21;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp405854_c0_seq1;GAXK01128459.1;Q9ULE6;1.24E-29;PALD_HUMAN;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp4059077_c0_seq1;GAXK01181019.1;Q32TF8;2.88E-70;EFHC2_DANRE;EF-hand domain-containing family member C2;regulation of neuron projection development [GO:0010975];GO:0010975;regulation of neuron projection development [GO:0010975];;
comp4059632_c0_seq1;GAXK01181028.1;Q8IVG5;1.24E-07;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp4059844_c0_seq1;GAXK01181020.1;Q5R6T1;5.69E-51;PDIA6_PONAB;Protein disulfide-isomerase A6 (EC 5.3.4.1);"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]";"GO:0003756; GO:0005788; GO:0005886; GO:0030168; GO:0042470; GO:0045454; GO:0070527";"cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]";"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]";protein disulfide isomerase activity [GO:0003756]
comp4060346_c0_seq1;GAXK01072481.1;P35038;6.29E-32;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp4060352_c0_seq1;GAXK01072488.1;Q05516;7.97E-10;ZBT16_HUMAN;Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"GO:0000122; GO:0000980; GO:0001227; GO:0001823; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007417; GO:0008022; GO:0008285; GO:0009880; GO:0009952; GO:0016567; GO:0016604; GO:0016605; GO:0016607; GO:0017053; GO:0019904; GO:0030097; GO:0030099; GO:0032332; GO:0032991; GO:0034504; GO:0035116; GO:0035136; GO:0042733; GO:0042802; GO:0042803; GO:0043065; GO:0043565; GO:0043687; GO:0045600; GO:0045638; GO:0045778; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048133; GO:0051138; GO:0051216; GO:0061036";"anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp4060562_c0_seq1;GAXK01072472.1;P38754;5.77E-20;RL14B_YEAST;60S ribosomal protein L14-B (Large ribosomal subunit protein eL14-B);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp406092_c0_seq1;GAXK01036751.1;Q96MU6;2.78E-17;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4062_c0_seq1;GAXK01065911.1;Q6K953;8.27E-21;GRXC4_ORYSJ;Glutaredoxin-C4, chloroplastic (Glutaredoxin-C2 homolog 2);"chloroplast [GO:0009507]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";"GO:0004362; GO:0009055; GO:0009507; GO:0015035; GO:0034599; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";chloroplast [GO:0009507];"electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]"
comp4062061_c0_seq1;GAXK01114022.1;Q8WV37;9.86E-08;ZN480_HUMAN;Zinc finger protein 480;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp40622_c0_seq1;GAXK01192223.1;Q9VCI5;3.91E-16;DHSD_DROME;Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone reductase membrane anchor subunit);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; ubiquinone binding [GO:0048039]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0016021; GO:0020037; GO:0046872; GO:0048039";"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; ubiquinone binding [GO:0048039]"
comp4062329_c0_seq1;GAXK01114027.1;P04646;4.14E-40;RL35A_RAT;60S ribosomal protein L35a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";cytosolic large ribosomal subunit [GO:0022625];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp4062533_c0_seq1;GAXK01114019.1;P70057;2.51E-39;KCNQ1_XENLA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha xKvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp4062604_c0_seq1;GAXK01114023.1;P35500;1.92E-15;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp406268_c1_seq1;GAXK01036774.1;Q9VS29;1.98E-148;DSCL_DROME;Down syndrome cell adhesion molecule-like protein Dscam2;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]"
comp406312_c0_seq1;GAXK01036677.1;P57071;5.09E-17;PRD15_HUMAN;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4063759_c0_seq1;GAXK01114026.1;P04352;6.34E-09;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp4064264_c0_seq1;GAXK01091786.1;P79274;2.83E-112;ACADL_PIG;Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660";"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]"
comp40643_c2_seq1;GAXK01192219.1;Q96T88;0;UHRF1_HUMAN;E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Inverted CCAAT box-binding protein of 90 kDa) (Nuclear protein 95) (Nuclear zinc finger protein Np95) (HuNp95) (hNp95) (RING finger protein 106) (RING-type E3 ubiquitin transferase UHRF1) (Transcription factor ICBP90) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (hUHRF1) (Ubiquitin-like-containing PHD and RING finger domains protein 1);"euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; nucleosomal histone binding [GO:0031493]; proximal promoter sequence-specific DNA binding [GO:0000987]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0000987; GO:0004842; GO:0005634; GO:0005657; GO:0005720; GO:0006281; GO:0006511; GO:0007049; GO:0008270; GO:0008327; GO:0010216; GO:0010390; GO:0016363; GO:0016567; GO:0016574; GO:0031493; GO:0032270; GO:0035064; GO:0042393; GO:0042802; GO:0044729; GO:0045944; GO:0050678; GO:0051865; GO:0061630; GO:2000373";"cell cycle [GO:0007049]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511]";"euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; replication fork [GO:0005657]";"hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]; nucleosomal histone binding [GO:0031493]; proximal promoter sequence-specific DNA binding [GO:0000987]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp40644_c0_seq1;GAXK01191497.1;O08586;6.52E-94;PTEN_MOUSE;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog);"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]";"GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008284; GO:0008285; GO:0009749; GO:0009898; GO:0010043; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032869; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045475; GO:0045666; GO:0045736; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:1901017; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990090; GO:1990314; GO:1990381; GO:1990782; GO:2000060; GO:2000134; GO:2000272; GO:2000463; GO:2000808; GO:2001235";"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; neuron projection development [GO:0031175]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]";"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]";"anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]"
comp406450_c0_seq1;GAXK01036675.1;Q9C056;6.61E-47;NKX62_HUMAN;Homeobox protein Nkx-6.2 (Homeobox protein NK-6 homolog B);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; endocrine pancreas development [GO:0031018]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010454; GO:0010455; GO:0021912; GO:0021913; GO:0022010; GO:0030154; GO:0031018; GO:0031641; GO:0043565; GO:0045686; GO:0045687; GO:0045892; GO:0045944; GO:0050885";"cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; endocrine pancreas development [GO:0031018]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4065003_c0_seq1;GAXK01091785.1;P50346;1.90E-12;RLA0_SOYBN;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp40655_c0_seq1;GAXK01191489.1;Q99LM3;4.82E-32;SMTL1_MOUSE;Smoothelin-like protein 1 (Calponin homology-associated smooth muscle protein) (CHASM);"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to drug [GO:0042493]";"GO:0004864; GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0014823; GO:0017020; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042493; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718; GO:0097756";"actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to drug [GO:0042493]";"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]"
comp40661_c2_seq1;GAXK01191609.1;Q9VZQ1;8.67E-76;YTDC1_DROME;YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B);"nuclear body [GO:0016604]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; sex differentiation [GO:0007548]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0007530; GO:0007548; GO:0008380; GO:0016070; GO:0016604; GO:0030154; GO:0036002; GO:1990247";"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; sex differentiation [GO:0007548]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]"
comp4067_c0_seq1;GAXK01065417.1;Q8BVY0;3.96E-39;RL1D1_MOUSE;Ribosomal L1 domain-containing protein 1;"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]";"GO:0000470; GO:0003723; GO:0003730; GO:0005730; GO:0030686; GO:0032880; GO:0042981; GO:0048027; GO:2000772";"maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]";"90S preribosome [GO:0030686]; nucleolus [GO:0005730]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]"
comp4067491_c0_seq1;GAXK01009458.1;Q3U4G3;5.48E-14;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp4068_c0_seq1;GAXK01065375.1;Q8N6F8;3.92E-11;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp406818_c1_seq1;GAXK01036811.1;Q5U3Q6;8.66E-53;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp4068722_c0_seq1;GAXK01142967.1;Q9Y2H8;1.85E-19;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp40688_c3_seq1;GAXK01191649.1;Q92506;6.86E-72;DHB8_HUMAN;Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239);"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]";"GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0051290; GO:0055114; GO:0070404";"androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]";"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"
comp4068899_c0_seq1;GAXK01142958.1;Q08753;7.06E-25;TRHN1_CHLMO;Group 1 truncated hemoglobin LI637 (CtrHb) (Truncated Hb) (Globin LI637);"chloroplast [GO:0009507]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0009507; GO:0019825; GO:0020037; GO:0046872";;chloroplast [GO:0009507];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp4068954_c0_seq1;GAXK01142985.1;O70511;1.17E-07;ANK3_RAT;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0005764; GO:0005856; GO:0005886; GO:0007165; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016529; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]"
comp406907_c2_seq1;GAXK01036683.1;O16264;1.06E-07;PEBPH_CAEEL;Phosphatidylethanolamine-binding protein homolog F40A3.3;"mitochondrion [GO:0005739]; lipid binding [GO:0008289]";"GO:0005739; GO:0008289";;mitochondrion [GO:0005739];lipid binding [GO:0008289]
comp40693_c1_seq1;GAXK01192087.1;Q17449;1.33E-64;FAAH1_CAEEL;Fatty acid amide hydrolase 1 (EC 3.5.1.99);"amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; fatty acid catabolic process [GO:0009062]; positive regulation of axon regeneration [GO:0048680]";"GO:0004040; GO:0009062; GO:0017064; GO:0048680; GO:0102077; GO:0103073";"fatty acid catabolic process [GO:0009062]; positive regulation of axon regeneration [GO:0048680]";;"amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]"
comp40694_c0_seq1;GAXK01192137.1;Q92503;0;S14L1_HUMAN;SEC14-like protein 1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; molecular function regulator [GO:0098772]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]";"GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087; GO:0098772";"choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]";"molecular function regulator [GO:0098772]; RIG-I binding [GO:0039552]"
comp4069426_c0_seq1;GAXK01142972.1;Q7KRI2;1.33E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp406945_c0_seq1;GAXK01036746.1;P54281;1.10E-25;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp4069514_c0_seq1;GAXK01142980.1;P07584;1.97E-10;ASTA_ASTAS;Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase);"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360";"cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp4069535_c0_seq1;GAXK01142959.1;P08770;3.88E-07;TRA1_MAIZE;Putative AC transposase (ORFA);"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp406961_c0_seq1;GAXK01036681.1;Q2EI21;1.74E-09;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp406973_c0_seq1;GAXK01036667.1;Q9VCA2;2.98E-71;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp406994_c0_seq1;GAXK01036801.1;Q8IN81;2.45E-14;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp407_c0_seq1;GAXK01168764.1;P61958;8.92E-34;SUMO2_PIG;Small ubiquitin-related modifier 2 (SUMO-2) (MIF2 suppressor) (SMT3 homolog 2) (Sentrin-2) (Ubiquitin-like protein SMT3A) (Smt3A);"nucleus [GO:0005634]; PML body [GO:0016605]; protein tag [GO:0031386]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]";"GO:0005634; GO:0016605; GO:0016925; GO:0019789; GO:0031386; GO:0031625; GO:0044389; GO:0045944";"positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]";"nucleus [GO:0005634]; PML body [GO:0016605]";"protein tag [GO:0031386]; SUMO transferase activity [GO:0019789]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]"
comp40700_c1_seq1;GAXK01191512.1;P37235;6.49E-33;HPCL1_HUMAN;Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3);"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp407007_c0_seq1;GAXK01036747.1;P48742;7.02E-49;LHX1_HUMAN;LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (hLim-1);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; cervix development [GO:0060067]; comma-shaped body morphogenesis [GO:0072049]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; dorsal/ventral pattern formation [GO:0009953]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; horizontal cell localization [GO:0035852]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; mesendoderm development [GO:0048382]; mesonephric duct development [GO:0072177]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerulus development [GO:0072224]; metanephric part of ureteric bud development [GO:0035502]; metanephric renal vesicle morphogenesis [GO:0072283]; metanephric S-shaped body morphogenesis [GO:0072284]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct elongation [GO:0035849]; nephric duct morphogenesis [GO:0072178]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; oviduct development [GO:0060066]; oviduct epithelium development [GO:0035846]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; pronephros development [GO:0048793]; regulation of gene expression [GO:0010468]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; S-shaped body morphogenesis [GO:0072050]; somite rostral/caudal axis specification [GO:0032525]; spinal cord association neuron differentiation [GO:0021527]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; uterine epithelium development [GO:0035847]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventral spinal cord development [GO:0021517]";"GO:0000790; GO:0000977; GO:0000981; GO:0001158; GO:0001655; GO:0001657; GO:0001658; GO:0001702; GO:0001705; GO:0001706; GO:0001822; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006366; GO:0007267; GO:0007389; GO:0007399; GO:0008045; GO:0009653; GO:0009791; GO:0009880; GO:0009887; GO:0009948; GO:0009952; GO:0009953; GO:0010468; GO:0010842; GO:0021517; GO:0021527; GO:0021537; GO:0021549; GO:0021702; GO:0021871; GO:0021937; GO:0030182; GO:0032525; GO:0032991; GO:0035502; GO:0035846; GO:0035847; GO:0035849; GO:0035852; GO:0040019; GO:0044344; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048382; GO:0048646; GO:0048703; GO:0048793; GO:0060059; GO:0060065; GO:0060066; GO:0060067; GO:0060068; GO:0060322; GO:0060429; GO:0061205; GO:0072049; GO:0072050; GO:0072077; GO:0072177; GO:0072178; GO:0072197; GO:0072224; GO:0072278; GO:0072283; GO:0072284; GO:0090009; GO:0090190; GO:0097379; GO:0097477; GO:2000543; GO:2000744; GO:2000768";"anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; cervix development [GO:0060067]; comma-shaped body morphogenesis [GO:0072049]; dorsal/ventral pattern formation [GO:0009953]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; horizontal cell localization [GO:0035852]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; mesendoderm development [GO:0048382]; mesonephric duct development [GO:0072177]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerulus development [GO:0072224]; metanephric part of ureteric bud development [GO:0035502]; metanephric renal vesicle morphogenesis [GO:0072283]; metanephric S-shaped body morphogenesis [GO:0072284]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct elongation [GO:0035849]; nephric duct morphogenesis [GO:0072178]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; oviduct development [GO:0060066]; oviduct epithelium development [GO:0035846]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; pronephros development [GO:0048793]; regulation of gene expression [GO:0010468]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; somite rostral/caudal axis specification [GO:0032525]; spinal cord association neuron differentiation [GO:0021527]; S-shaped body morphogenesis [GO:0072050]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; ureteric bud development [GO:0001657]; ureter morphogenesis [GO:0072197]; urogenital system development [GO:0001655]; uterine epithelium development [GO:0035847]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventral spinal cord development [GO:0021517]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]"
comp4070138_c0_seq1;GAXK01113774.1;Q6XZB0;7.37E-08;LIPI_HUMAN;Lipase member I (LIPI) (EC 3.1.1.-) (Cancer/testis antigen 17) (CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta) (mPA-PLA1 beta);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"GO:0004620; GO:0005615; GO:0005886; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0052689";"lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]"
comp4070150_c0_seq1;GAXK01113767.1;Q5QQ53;5.99E-10;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp407037_c0_seq1;GAXK01204805.1;Q90632;1.28E-34;MOT3_CHICK;Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);"integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp4070478_c0_seq1;GAXK01113778.1;Q7Z2Y8;9.02E-17;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp407074_c1_seq1;GAXK01036682.1;O54904;5.61E-34;B3GT1_MOUSE;Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006682; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275";"galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp407208_c1_seq1;GAXK01036691.1;Q1LUA6;7.07E-15;TRIO_DANRE;Triple functional domain protein (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0035023";"axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp40726_c0_seq1;GAXK01191913.1;P56377;1.10E-59;AP1S2_HUMAN;AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin);"AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005765; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0016192; GO:0019886; GO:0030119; GO:0030659; GO:0032588; GO:0043231; GO:0050690";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]";"AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]";
comp4073464_c0_seq1;GAXK01182149.1;A1A5R8;4.91E-29;K1841_RAT;Uncharacterized protein KIAA1841 homolog;;;;;
comp4073534_c0_seq1;GAXK01182159.1;Q99N11;2.02E-31;DUS22_MOUSE;Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000122; GO:0002710; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0030336; GO:0031941; GO:0035335; GO:0042127; GO:0046330; GO:0050860; GO:0050868; GO:0051895; GO:0061851; GO:0071364; GO:1903996; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]"
comp40739_c0_seq1;GAXK01192019.1;Q9QZR0;6.49E-49;RNF25_MOUSE;E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) (RING-type E3 ubiquitin transferase RNF25);"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630";"positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp4074595_c0_seq1;GAXK01070051.1;P15043;7.53E-08;RECQ_ECOLI;ATP-dependent DNA helicase RecQ (EC 3.6.4.12);"bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"GO:0003677; GO:0003678; GO:0005524; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0043138; GO:0043590; GO:0046914";"cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]";"3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]"
comp407461_c1_seq1;GAXK01036739.1;Q91WL8;3.45E-125;WWOX_MOUSE;WW domain-containing oxidoreductase (EC 1.1.1.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor complex [GO:0090575]; enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]";"GO:0001649; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241";"cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor complex [GO:0090575]";"enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]"
comp4074887_c0_seq1;GAXK01070042.1;P13651;8.74E-45;IF5A_DICDI;Eukaryotic translation initiation factor 5A (eIF-5A) (eIF-4D);"phagocytic vesicle [GO:0045335]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003746; GO:0006452; GO:0043022; GO:0045335; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";phagocytic vesicle [GO:0045335];"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp4075154_c0_seq1;GAXK01070047.1;Q9UFB7;4.39E-15;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp407516_c0_seq1;GAXK01036680.1;O97341;1.30E-56;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp40762_c0_seq1;GAXK01205973.1;Q6PGN3;6.52E-156;DCLK2_MOUSE;Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860]";"GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0018105; GO:0021766; GO:0021860; GO:0035556; GO:1900181";"hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp407630_c0_seq1;GAXK01036748.1;Q9VFP2;3.31E-20;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp407642_c1_seq1;GAXK01036769.1;Q9CPW0;1.87E-07;CNTP2_MOUSE;Contactin-associated protein-like 2 (Cell recognition molecule Caspr2);"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]";"GO:0002020; GO:0005769; GO:0005794; GO:0005886; GO:0007155; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0021761; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0033270; GO:0035176; GO:0042297; GO:0043025; GO:0044224; GO:0044325; GO:0045163; GO:0048812; GO:0071205; GO:0071625; GO:0097060";"adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]";"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]";"enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]"
comp407670_c0_seq1;GAXK01036673.1;P61376;2.06E-83;LHX5_RAT;LIM/homeobox protein Lhx5 (LIM homeobox protein 5) (Homeobox protein LIM-2);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";"GO:0000977; GO:0000981; GO:0005634; GO:0021527; GO:0021702; GO:0021766; GO:0021846; GO:0021879; GO:0021937; GO:0030182; GO:0045944; GO:0046872";"cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spinal cord association neuron differentiation [GO:0021527]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4077007_c0_seq1;GAXK01205368.1;Q70PY2;1.12E-38;PGSB1_DROME;Peptidoglycan-recognition protein SB1 (EC 3.5.1.28);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]";"GO:0005576; GO:0005615; GO:0006955; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0019730; GO:0032827; GO:0042834; GO:0045087; GO:0050830";"antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]"
comp40771_c0_seq1;GAXK01192214.1;Q3Y8M6;4.97E-45;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp407761_c1_seq1;GAXK01036686.1;Q9VZW5;4.09E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp4077764_c0_seq1;GAXK01060467.1;M0R8U1;2.70E-64;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp407805_c0_seq1;GAXK01036760.1;P49119;1.48E-20;CDKA1_MESAU;Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor);cell cycle [GO:0007049];GO:0007049;cell cycle [GO:0007049];;
comp407812_c0_seq1;GAXK01036743.1;Q56K04;1.32E-09;CRIP1_BOVIN;Cysteine-rich protein 1 (CRP-1);"cytoplasm [GO:0005737]; AT DNA binding [GO:0003680]; DNA binding, bending [GO:0008301]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]";"GO:0003680; GO:0005737; GO:0008270; GO:0008301; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0071236; GO:0071493";"cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]";cytoplasm [GO:0005737];"AT DNA binding [GO:0003680]; DNA binding, bending [GO:0008301]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp407902_c0_seq1;GAXK01036773.1;Q0EEE2;4.56E-79;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp4079074_c0_seq1;GAXK01131422.1;P0C5E2;3.17E-12;LRL12_ARATH;LEAF RUST 10 DISEASE-RESISTANCE LOCUS RECEPTOR-LIKE PROTEIN KINASE-like 1.2 (EC 2.7.11.1) (Probable receptor-like serine/threonine-protein kinase LRK10L-1.2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]; cellular response to abscisic acid stimulus [GO:0071215]; cellular response to water deprivation [GO:0042631]; photoperiodism, flowering [GO:0048573]";"GO:0004674; GO:0005524; GO:0005886; GO:0016021; GO:0030247; GO:0042631; GO:0048573; GO:0071215";"cellular response to abscisic acid stimulus [GO:0071215]; cellular response to water deprivation [GO:0042631]; photoperiodism, flowering [GO:0048573]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]"
comp4079356_c0_seq1;GAXK01131424.1;Q63HN8;6.46E-63;RN213_HUMAN;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp4079497_c0_seq1;GAXK01131425.1;Q8IYB9;2.84E-19;ZN595_HUMAN;Zinc finger protein 595;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp407969_c0_seq1;GAXK01036759.1;O70273;1.65E-14;EHF_MOUSE;ETS homologous factor (ETS domain-containing transcription factor);"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0045893; GO:0045944; GO:0050673";"cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp407972_c0_seq1;GAXK01036799.1;Q761V0;4.25E-118;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp4079925_c0_seq1;GAXK01131445.1;P05661;3.85E-27;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp408_c0_seq1;GAXK01169692.1;P08570;1.73E-11;RLA1_DROME;60S acidic ribosomal protein P1 (Acidic ribosomal protein RPA2) (RP21C);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0043021";"cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp408045_c0_seq1;GAXK01009372.1;Q9TZL8;4.47E-70;PFKA1_CAEEL;ATP-dependent 6-phosphofructokinase 1 (ATP-PFK 1) (Phosphofructokinase 1) (EC 2.7.1.11) (Phosphohexokinase 1);"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]";"GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095";"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]";6-phosphofructokinase complex [GO:0005945];"6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
comp4080919_c0_seq1;GAXK01186679.1;Q94464;7.76E-26;DYNA_DICDI;Dynamin-A;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]";"GO:0000266; GO:0003374; GO:0003924; GO:0005522; GO:0005525; GO:0005543; GO:0005737; GO:0006907; GO:0006909; GO:0006997; GO:0007005; GO:0007015; GO:0007032; GO:0007163; GO:0008017; GO:0016020; GO:0031288; GO:0031966; GO:0032154; GO:0042802; GO:0044656; GO:0045335; GO:0048312; GO:0061025; GO:0061952; GO:0090383; GO:0097204; GO:1900756; GO:1905345";"actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]";"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]"
comp408148_c0_seq1;GAXK01009264.1;Q96EQ9;9.13E-19;PRDM9_MOUSE;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0007283; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0043565; GO:0044212; GO:0045944; GO:0046872; GO:0060903";"histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp408192_c0_seq1;GAXK01009203.1;Q9TUB5;1.11E-07;CLCA1_PIG;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (pCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp408210_c1_seq1;GAXK01009299.1;Q5R5X9;2.86E-23;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp40829_c1_seq1;GAXK01191555.1;O93309;0;SMC3_XENLA;Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3);"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321";"cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp4083562_c0_seq1;GAXK01035420.1;P47972;5.41E-09;NPTX2_HUMAN;Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005576; GO:0005886; GO:0007268; GO:0008306; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098962; GO:0098978";"associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp40838_c1_seq1;GAXK01191919.1;Q9QX47;1.78E-50;SON_MOUSE;Protein SON (Negative regulatory element-binding protein) (NRE-binding protein);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726";"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]"
comp4083849_c0_seq1;GAXK01035435.1;Q8SR34;1.73E-55;VATB_ENCCU;V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B);"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";"GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600";"ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";proton-transporting V-type ATPase, V1 domain [GO:0033180];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp40839_c3_seq1;GAXK01192097.1;Q05481;2.18E-54;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp408394_c0_seq1;GAXK01009266.1;Q9C907;5.92E-46;GDPD5_ARATH;Glycerophosphodiester phosphodiesterase GDPD5 (EC 3.1.4.46) (Glycerophosphodiester phosphodiesterase 5) (ATGDPD5);"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]";"GO:0005576; GO:0005618; GO:0005773; GO:0005829; GO:0006071; GO:0006629; GO:0008889";"glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]";"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]";glycerophosphodiester phosphodiesterase activity [GO:0008889]
comp4084_c0_seq1;GAXK01067179.1;P23588;1.52E-13;IF4B_HUMAN;Eukaryotic translation initiation factor 4B (eIF-4B);"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; polysome [GO:0005844]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"GO:0001731; GO:0002181; GO:0003723; GO:0003743; GO:0005829; GO:0005844; GO:0006413; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010";"cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; polysome [GO:0005844]";"ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]"
comp4084147_c0_seq1;GAXK01180470.1;Q62425;3.03E-17;NDUA4_MOUSE;Cytochrome c oxidase subunit NDUFA4;"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; protein-containing complex binding [GO:0044877]";"GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0044877";;"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";"cytochrome-c oxidase activity [GO:0004129]; protein-containing complex binding [GO:0044877]"
comp4084627_c0_seq1;GAXK01180454.1;P61865;1.15E-43;RL12_CAEBR;60S ribosomal protein L12;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0000381; GO:0003735; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4085129_c0_seq1;GAXK01180463.1;P09216;1.19E-37;KPCE_RAT;Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon);"cell periphery [GO:0071944]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; T-tubule [GO:0030315]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of wound healing [GO:0090303]; regulation of synaptic vesicle exocytosis [GO:2000300]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"GO:0000139; GO:0003785; GO:0004674; GO:0004697; GO:0004699; GO:0005102; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0007049; GO:0007155; GO:0010634; GO:0010763; GO:0010917; GO:0017124; GO:0018105; GO:0019901; GO:0030315; GO:0030838; GO:0031594; GO:0031663; GO:0032467; GO:0035556; GO:0035669; GO:0036120; GO:0043066; GO:0046872; GO:0048471; GO:0051280; GO:0051301; GO:0051562; GO:0071944; GO:0090303; GO:0098978; GO:0099523; GO:2000300";"cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of wound healing [GO:0090303]; regulation of synaptic vesicle exocytosis [GO:2000300]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"cell periphery [GO:0071944]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; T-tubule [GO:0030315]";"actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]"
comp408518_c1_seq1;GAXK01009355.1;P49283;1.01E-31;MVL_DROME;Protein Malvolio;"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838";"copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]"
comp408544_c0_seq1;GAXK01009321.1;Q2VPU4;3.65E-35;MLXIP_MOUSE;MLX-interacting protein (Transcriptional activator MondoA);"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter [GO:1900402]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006357; GO:0006913; GO:0045944; GO:0046983; GO:1900402";"nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter [GO:1900402]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4085471_c0_seq1;GAXK01180466.1;P41823;9.60E-09;SY65_APLCA;Synaptotagmin-1 (Synaptotagmin I) (p65);"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000149; GO:0005509; GO:0005544; GO:0016079; GO:0030054; GO:0030285; GO:0045955";"negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; SNARE binding [GO:0000149]"
comp408562_c1_seq1;GAXK01204990.1;O55071;1.39E-78;CP2BJ_MOUSE;Cytochrome P450 2B19 (EC 1.14.14.1) (CYPIIB19);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp4085747_c0_seq1;GAXK01180457.1;O61365;6.42E-12;NACH_DROME;Sodium channel protein Nach (Pickpocket protein 4);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0006814; GO:0016021; GO:0035002";"liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp40859_c0_seq1;GAXK01191835.1;A0QXD8;9.81E-136;ELTD_MYCS2;Erythritol/L-threitol dehydrogenase (EC 1.1.1.-);"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; carbohydrate catabolic process [GO:0016052]; carbohydrate utilization [GO:0009758]; cellular response to carbohydrate stimulus [GO:0071322]";"GO:0009758; GO:0016052; GO:0016616; GO:0030246; GO:0046872; GO:0071322";"carbohydrate catabolic process [GO:0016052]; carbohydrate utilization [GO:0009758]; cellular response to carbohydrate stimulus [GO:0071322]";;"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
comp4086101_c0_seq1;GAXK01172249.1;Q09582;3.02E-49;METH_CAEEL;Probable methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS);"cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0042558";pteridine-containing compound metabolic process [GO:0042558];cytosol [GO:0005829];"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp40863_c0_seq1;GAXK01192082.1;Q8BJS4;4.00E-54;SUN2_MOUSE;SUN domain-containing protein 2 (Protein unc-84 homolog B) (Sad1/unc-84 protein-like 2);"condensed nuclear chromosome [GO:0000794]; endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic cell cycle [GO:0051321]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]";"GO:0000784; GO:0000794; GO:0005521; GO:0005635; GO:0005637; GO:0005639; GO:0006998; GO:0010008; GO:0021817; GO:0030335; GO:0031022; GO:0031965; GO:0034993; GO:0042802; GO:0043495; GO:0051321; GO:0051642; GO:0090286; GO:0090292";"centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic cell cycle [GO:0051321]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]";"condensed nuclear chromosome [GO:0000794]; endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]";"identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]"
comp408658_c0_seq1;GAXK01009265.1;P20350;1.52E-25;RHOM_DROME;Protein rhomboid (EC 3.4.21.105) (Protein veinlet);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0006508; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0038005; GO:0042058; GO:0042327; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317; GO:0098609";"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]";serine-type endopeptidase activity [GO:0004252]
comp4086773_c0_seq1;GAXK01172251.1;Q02280;1.11E-80;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp4086978_c0_seq1;GAXK01172257.1;Q01528;2.51E-11;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp4086988_c0_seq1;GAXK01172266.1;P0CF65;5.73E-16;CRBN_CHICK;Protein cereblon;"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005737; GO:0016567; GO:0031464; GO:0043161; GO:0046872";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp408700_c1_seq1;GAXK01009243.1;P0DPW4;1.47E-10;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp4087018_c0_seq1;GAXK01172264.1;Q9SMI3;3.63E-46;RS12_CYAPA;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4087362_c0_seq1;GAXK01172256.1;P19515;1.22E-21;LIP_RHIMI;Lipase (EC 3.1.1.3) (Triacylglycerol lipase);"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];;"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp4087649_c0_seq1;GAXK01172253.1;Q9DAJ5;1.70E-23;DLRB2_MOUSE;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505";microtubule-based movement [GO:0007018];"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp408767_c0_seq1;GAXK01009241.1;Q9Y2C3;6.86E-40;B3GT5_HUMAN;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp4087861_c0_seq1;GAXK01172255.1;Q8MQS8;2.15E-24;SP34_APIME;Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp4089403_c0_seq1;GAXK01056399.1;P12261;1.33E-15;EF1G_ARTSA;Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma);translation elongation factor activity [GO:0003746];GO:0003746;;;translation elongation factor activity [GO:0003746]
comp40895_c0_seq1;GAXK01192140.1;Q3SZE9;2.62E-59;TBCC_BOVIN;Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"GO:0000902; GO:0003924; GO:0005737; GO:0005829; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391";"cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]";"GTPase activity [GO:0003924]; tubulin binding [GO:0015631]"
comp408960_c1_seq1;GAXK01009335.1;Q91Y77;1.32E-17;MOT10_RAT;Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]";"GO:0005887; GO:0015173; GO:0015349; GO:0016323";;"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]";"aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp4089711_c0_seq1;GAXK01056388.1;Q76LL6;6.38E-36;FHOD3_MOUSE;FH1/FH2 domain-containing protein 3 (Formin homolog overexpressed in spleen 2) (mFHOS2);"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030017; GO:0030018; GO:0030837; GO:0045214; GO:0051639; GO:0055003";"actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp40904_c0_seq1;GAXK01191492.1;P36609;1.42E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp409071_c0_seq1;GAXK01009294.1;Q9VVH9;3.25E-49;SO74D_DROME;Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D);"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702";"ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";"active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]"
comp4090814_c0_seq1;GAXK01000699.1;G3V8V5;1.97E-12;KCNK4_RAT;Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein) (TRAAK);"integral component of plasma membrane [GO:0005887]; potassium channel complex [GO:0034705]; mechanosensitived potassium channel activity [GO:0098782]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604]; cellular response to alkaline pH [GO:0071469]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]; stabilization of membrane potential [GO:0030322]";"GO:0005267; GO:0005887; GO:0007613; GO:0019233; GO:0022841; GO:0030322; GO:0034705; GO:0050951; GO:0050976; GO:0071260; GO:0071398; GO:0071469; GO:0071502; GO:0071805; GO:0097604; GO:0098782";"cellular response to alkaline pH [GO:0071469]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; potassium channel complex [GO:0034705]";"mechanosensitived potassium channel activity [GO:0098782]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604]"
comp409116_c0_seq1;GAXK01009259.1;B7Z0K8;4.47E-20;COLL1_DROME;Collagen alpha chain CG42342;"basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]";"GO:0005201; GO:0005594; GO:0005604; GO:0005615; GO:0005886; GO:0016021; GO:0030198; GO:0031012";extracellular matrix organization [GO:0030198];"basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";extracellular matrix structural constituent [GO:0005201]
comp4091220_c0_seq1;GAXK01000695.1;Q149M9;2.94E-37;NWD1_HUMAN;NACHT domain- and WD repeat-containing protein 1;"cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";"GO:0005524; GO:0005829; GO:0010628; GO:0032088";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";cytosol [GO:0005829];ATP binding [GO:0005524]
comp4091500_c0_seq1;GAXK01000689.1;Q5UQL7;7.27E-31;CAPS1_MIMIV;Capsid protein 1 (Capsid protein D13L);"viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028";;viral capsid [GO:0019028];structural molecule activity [GO:0005198]
comp4091650_c0_seq1;GAXK01000692.1;P19515;1.02E-07;LIP_RHIMI;Lipase (EC 3.1.1.3) (Triacylglycerol lipase);"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];;"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp4092142_c0_seq1;GAXK01153253.1;P39057;0;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp409269_c2_seq1;GAXK01009263.1;Q6GPK9;7.37E-23;TAOK2_XENLA;Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of stress-activated MAPK cascade [GO:0032874]; stress-activated MAPK cascade [GO:0051403]";"GO:0004674; GO:0005524; GO:0006974; GO:0007095; GO:0032874; GO:0051403";"cellular response to DNA damage stimulus [GO:0006974]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of stress-activated MAPK cascade [GO:0032874]; stress-activated MAPK cascade [GO:0051403]";;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp4092710_c0_seq1;GAXK01153268.1;Q9VUY0;2.71E-62;MOX11_DROME;MOXD1 homolog 1 (EC 1.14.17.-);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp4093080_c0_seq1;GAXK01153260.1;P41127;2.94E-42;RL131_ARATH;60S ribosomal protein L13-1 (Protein BBC1 homolog);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp4093174_c0_seq1;GAXK01153265.1;Q940B0;1.64E-36;RL183_ARATH;60S ribosomal protein L18-3;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005773; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0022625; GO:0022626";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp409323_c4_seq1;GAXK01009283.1;Q149N8;4.08E-61;SHPRH_HUMAN;E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase);"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp4093410_c0_seq1;GAXK01153254.1;P58171;9.65E-07;POLC3_SYRVU;Polcalcin Syr v 3 (Calcium-binding pollen allergen Syr v 3) (allergen Syr v 3);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp409357_c0_seq1;GAXK01009255.1;Q9YH37;9.14E-13;RAP1B_CYPCA;Ras-related protein Rap-1b;"cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486]";"GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0030054; GO:0032486";Rap protein signal transduction [GO:0032486];"cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp4093634_c0_seq1;GAXK01153255.1;P0C0L6;1.30E-19;NPSR1_RAT;Neuropeptide S receptor (G-protein coupled receptor 154);"integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]";"GO:0005000; GO:0005887; GO:0007218; GO:0008188; GO:0042755; GO:0051281; GO:0060013; GO:0070374; GO:1903999; GO:2000293";"eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]";integral component of plasma membrane [GO:0005887];"neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]"
comp4093894_c0_seq1;GAXK01153270.1;B0WC46;5.53E-09;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp4094352_c0_seq1;GAXK01155928.1;A0JNB1;1.56E-10;ZN227_BOVIN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp409481_c0_seq1;GAXK01009237.1;Q8R1T4;2.34E-77;S35A3_MOUSE;UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3);"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]";"GO:0005794; GO:0008643; GO:0015165; GO:0030173; GO:1990569";"carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]";"Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]";pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]
comp409498_c1_seq1;GAXK01009298.1;Q8CGF6;6.98E-117;WDR47_MOUSE;WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]";"GO:0005737; GO:0005874; GO:0007275";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";
comp40954_c6_seq1;GAXK01192028.1;Q95RA9;1.15E-28;GILT1_DROME;GILT-like protein 1;"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; disulfide oxidoreductase activity [GO:0015036]; immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"GO:0002376; GO:0005576; GO:0005886; GO:0015036; GO:0055114; GO:1900426";"immune system process [GO:0002376]; oxidation-reduction process [GO:0055114]; positive regulation of defense response to bacterium [GO:1900426]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]";disulfide oxidoreductase activity [GO:0015036]
comp40955_c2_seq1;GAXK01191689.1;Q9Y6X2;7.76E-89;PIAS3_HUMAN;E3 SUMO-protein ligase PIAS3 (EC 2.3.2.-) (E3 SUMO-protein transferase PIAS3) (Protein inhibitor of activated STAT protein 3);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"GO:0000122; GO:0001085; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008022; GO:0008270; GO:0009725; GO:0010628; GO:0015459; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0030425; GO:0033234; GO:0033235; GO:0045202; GO:0045671; GO:0045838; GO:0047485; GO:0061665; GO:0071847";"negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]";"enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]"
comp409558_c0_seq1;GAXK01009218.1;Q9Y6N9;5.32E-40;USH1C_HUMAN;Harmonin (Antigen NY-CO-38/NY-CO-37) (Autoimmune enteropathy-related antigen AIE-75) (Protein PDZ-73) (Renal carcinoma antigen NY-REN-3) (Usher syndrome type-1C protein);"apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"GO:0000086; GO:0001750; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0007605; GO:0030046; GO:0030507; GO:0032420; GO:0032426; GO:0032532; GO:0034622; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0046549; GO:0050953; GO:0050957; GO:0051015; GO:0051017; GO:0060122; GO:1904106; GO:1904970";"actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]";"apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]";"actin filament binding [GO:0051015]; spectrin binding [GO:0030507]"
comp40958_c4_seq1;GAXK01192200.1;O70244;4.29E-41;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp409659_c0_seq1;GAXK01009353.1;Q9UIJ5;9.59E-92;ZDHC2_HUMAN;Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; cellular protein metabolic process [GO:0044267]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0044267; GO:0055038";"cellular protein metabolic process [GO:0044267]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp4096634_c0_seq1;GAXK01118562.1;Q32KS2;7.66E-105;DNAI1_BOVIN;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005874; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp4096712_c0_seq1;GAXK01118557.1;Q98993;3.08E-10;VTXB_SYNVE;Verrucotoxin subunit beta (VTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp4096752_c0_seq1;GAXK01118563.1;O61365;1.17E-07;NACH_DROME;Sodium channel protein Nach (Pickpocket protein 4);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0006814; GO:0016021; GO:0035002";"liquid clearance, open tracheal system [GO:0035002]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp40968_c0_seq1;GAXK01191621.1;Q8NI77;1.12E-123;KI18A_HUMAN;Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]";"GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]";"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"
comp4097_c0_seq1;GAXK01065428.1;O08807;3.32E-116;PRDX4_MOUSE;Peroxiredoxin-4 (EC 1.11.1.15) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0019471; GO:0022417; GO:0030198; GO:0042744; GO:0042803; GO:0045454; GO:0055114; GO:0072593; GO:2000255";"4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]";"protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]"
comp4097958_c0_seq1;GAXK01118560.1;Q90W54;5.85E-12;OXLA_GLOBL;L-amino-acid oxidase (LAAO) (LAO) (M-LAO) (EC 1.4.3.2);"extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]";"GO:0001716; GO:0005576; GO:0006915; GO:0042742; GO:0044179; GO:0090729";"apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]"
comp4097960_c0_seq1;GAXK01118576.1;P10323;1.22E-08;ACRO_HUMAN;"Acrosin (EC 3.4.21.10) [Cleaved into: Acrosin light chain; Acrosin heavy chain]";"acrosomal matrix [GO:0043159]; extracellular region [GO:0005576]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; amidase activity [GO:0004040]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; drug binding [GO:0008144]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; acrosome matrix dispersal [GO:0002077]; acrosome reaction [GO:0007340]; activation of adenylate cyclase activity [GO:0007190]; binding of sperm to zona pellucida [GO:0007339]; penetration of zona pellucida [GO:0007341]; response to steroid hormone [GO:0048545]; single fertilization [GO:0007338]";"GO:0002020; GO:0002077; GO:0003677; GO:0004040; GO:0004252; GO:0005507; GO:0005537; GO:0005576; GO:0005634; GO:0005798; GO:0007190; GO:0007338; GO:0007339; GO:0007340; GO:0007341; GO:0008144; GO:0008270; GO:0032991; GO:0042806; GO:0043159; GO:0048545";"acrosome matrix dispersal [GO:0002077]; acrosome reaction [GO:0007340]; activation of adenylate cyclase activity [GO:0007190]; binding of sperm to zona pellucida [GO:0007339]; penetration of zona pellucida [GO:0007341]; response to steroid hormone [GO:0048545]; single fertilization [GO:0007338]";"acrosomal matrix [GO:0043159]; extracellular region [GO:0005576]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"amidase activity [GO:0004040]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; drug binding [GO:0008144]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp4098957_c0_seq1;GAXK01010771.1;Q3SZT9;3.54E-19;CYC2_BOVIN;Cytochrome c 2;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hydrogen peroxide metabolic process [GO:0042743]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]";"GO:0005758; GO:0006122; GO:0006123; GO:0006915; GO:0009055; GO:0020037; GO:0042743; GO:0046872; GO:0070469; GO:2001244";"apoptotic process [GO:0006915]; hydrogen peroxide metabolic process [GO:0042743]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]";"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp4099134_c0_seq1;GAXK01010775.1;Q80UG8;3.55E-10;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp4099297_c0_seq1;GAXK01010776.1;P08106;1.49E-36;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp4099305_c0_seq1;GAXK01010788.1;Q9CWR2;7.65E-07;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4099939_c0_seq1;GAXK01010790.1;P02402;3.46E-18;RLA1_ARTSA;60S acidic ribosomal protein P1 (eL12'/ eL12'-P);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp41_c2_seq1;GAXK01169388.1;P62972;1.11E-102;UBIQP_XENLA;Polyubiquitin [Cleaved into: Ubiquitin] (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp410028_c0_seq1;GAXK01204299.1;Q16825;1.38E-73;PTN21_HUMAN;Tyrosine-protein phosphatase non-receptor type 21 (EC 3.1.3.48) (Protein-tyrosine phosphatase D1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005737; GO:0005856; GO:0006470";protein dephosphorylation [GO:0006470];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";protein tyrosine phosphatase activity [GO:0004725]
comp4100833_c0_seq1;GAXK01000420.1;P22105;1.01E-13;TENX_HUMAN;Tenascin-X (TN-X) (Hexabrachion-like protein);"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]"
comp41009_c0_seq1;GAXK01191486.1;Q28H30;9.57E-75;CE022_XENTR;UPF0489 protein C5orf22 homolog;;;;;
comp4101146_c0_seq1;GAXK01000430.1;P28476;2.73E-16;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp41015_c4_seq1;GAXK01191998.1;Q6P6B7;1.21E-62;ANR16_HUMAN;Ankyrin repeat domain-containing protein 16;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA modification [GO:0006400]";"GO:0005634; GO:0005737; GO:0006400";tRNA modification [GO:0006400];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp4101765_c0_seq1;GAXK01000418.1;Q90YV7;1.53E-72;RL11_ICTPU;60S ribosomal protein L11;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0019843; GO:0034504";"protein localization to nucleus [GO:0034504]; translation [GO:0006412]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4101926_c0_seq1;GAXK01000429.1;Q61830;7.00E-24;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp4101957_c0_seq1;GAXK01000421.1;D7GXF9;6.17E-08;PORB_ZOBGA;Beta-porphyranase B (EC 3.2.1.178);"periplasmic space [GO:0042597]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005975; GO:0042597";carbohydrate metabolic process [GO:0005975];periplasmic space [GO:0042597];hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp410199_c0_seq1;GAXK01204115.1;Q8CHT6;5.30E-19;F169B_MOUSE;Protein FAM169B;;;;;
comp4102_c2_seq1;GAXK01065397.1;Q26454;0;MCM4_DROME;DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal);"MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]";"GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:1902975";"DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]";"MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp41025_c0_seq1;GAXK01191581.1;Q91YT2;6.53E-56;RN185_MOUSE;E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005741; GO:0005783; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0036513; GO:0043130; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0061630; GO:0071712; GO:1904294";"autophagy [GO:0006914]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]"
comp4102610_c0_seq1;GAXK01007567.1;Q9U3P2;1.86E-09;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp4102663_c0_seq1;GAXK01007570.1;O42387;1.04E-35;RS24_TAKRU;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp410272_c1_seq1;GAXK01204174.1;F7ASZ0;3.19E-08;BTBD3_CALJA;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]";"GO:0005634; GO:0005829; GO:0021987; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp410277_c0_seq1;GAXK01204273.1;Q5BL35;5.72E-07;SPOLA_DANRE;Speckle-type POZ protein-like A (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp41030_c3_seq1;GAXK01191917.1;Q8BRG8;2.61E-38;TM209_MOUSE;Transmembrane protein 209;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp410307_c0_seq1;GAXK01204286.1;Q18163;9.63E-26;DDRA_CAEEL;Discoidin domain-containing receptor A;"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"GO:0004672; GO:0005524; GO:0005886; GO:0008045; GO:0016021; GO:0030424; GO:0043204; GO:0048680";"motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp410332_c0_seq1;GAXK01204169.1;Q75NA5;2.42E-125;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp410333_c0_seq1;GAXK01204292.1;Q00534;2.99E-17;CDK6_HUMAN;Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE);"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007050; GO:0007219; GO:0008285; GO:0009615; GO:0010468; GO:0010628; GO:0014002; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000134; GO:2000145; GO:2000773";"astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]";"centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]"
comp410376_c0_seq1;GAXK01204109.1;Q9H2R5;7.82E-09;KLK15_HUMAN;Kallikrein-15 (EC 3.4.21.-) (ACO protease);"extracellular region [GO:0005576]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]";"GO:0004252; GO:0005576; GO:0008236; GO:0030141";;"extracellular region [GO:0005576]; secretory granule [GO:0030141]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp4104006_c0_seq1;GAXK01180731.1;Q4V348;8.91E-09;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4104069_c0_seq1;GAXK01180737.1;Q9VIK2;7.03E-15;CART_DROME;Carcinine transporter;"axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]; carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]";"GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0016021; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131";"carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]";"axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]"
comp41055_c6_seq1;GAXK01191705.1;Q96RL7;0;VP13A_HUMAN;Vacuolar protein sorting-associated protein 13A (Chorea-acanthocytosis protein) (Chorein);"cytosol [GO:0005829]; dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]";"GO:0005829; GO:0006623; GO:0006895; GO:0006914; GO:0007399; GO:0007626; GO:0008104; GO:0019898; GO:0031045; GO:0035176; GO:0045053";"autophagy [GO:0006914]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]";"cytosol [GO:0005829]; dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]";
comp4105943_c0_seq1;GAXK01180735.1;Q8STF0;3.78E-63;CALM_STRIE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4106392_c0_seq1;GAXK01181913.1;Q9BXS5;1.55E-11;AP1M1_HUMAN;AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin);"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690]";"GO:0000139; GO:0005765; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0019886; GO:0030131; GO:0030659; GO:0030665; GO:0032438; GO:0032588; GO:0035579; GO:0035646; GO:0043312; GO:0050690; GO:0070062";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690]";"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]";
comp4106541_c0_seq1;GAXK01181917.1;Q9JLF1;1.24E-13;GBRT_MOUSE;Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp410659_c1_seq1;GAXK01204280.1;Q7KRI2;1.49E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp410676_c1_seq1;GAXK01204138.1;Q60843;2.49E-39;KLF2_MOUSE;Krueppel-like factor 2 (Lung krueppel-like factor);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte homeostasis [GO:0034101]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]";"GO:0000122; GO:0000790; GO:0000902; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0032715; GO:0034101; GO:0035264; GO:0036003; GO:0040029; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0046872; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071409; GO:0071498; GO:0071499; GO:0097533; GO:1901653; GO:1903671";"cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte homeostasis [GO:0034101]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp410700_c1_seq1;GAXK01204172.1;Q9UA35;2.69E-110;S28A3_EPTST;Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT);"integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005887";;integral component of plasma membrane [GO:0005887];nucleoside transmembrane transporter activity [GO:0005337]
comp410779_c0_seq1;GAXK01204264.1;O08585;3.43E-29;CLCA_MOUSE;Clathrin light chain A (Lca);"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631";"cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]";"clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]"
comp410828_c0_seq1;GAXK01204161.1;Q619T5;2.14E-58;RASEF_CAEBR;Ras and EF-hand domain-containing protein homolog;"perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005509; GO:0005525; GO:0006886; GO:0032482; GO:0048471";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";perinuclear region of cytoplasm [GO:0048471];"calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp41084_c1_seq1;GAXK01191442.1;Q921M3;0;SF3B3_MOUSE;Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130);"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]";"GO:0000398; GO:0003676; GO:0005634; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]";"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]";"nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]"
comp4108532_c0_seq1;GAXK01050680.1;Q9VW60;6.61E-09;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp410895_c0_seq1;GAXK01204267.1;P16444;1.72E-97;DPEP1_HUMAN;Dipeptidase 1 (EC 3.4.13.19) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP);"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"GO:0005615; GO:0005634; GO:0005886; GO:0006691; GO:0006749; GO:0006805; GO:0008235; GO:0008239; GO:0008270; GO:0016324; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341";"antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]"
comp410924_c0_seq1;GAXK01204181.1;P52643;9.89E-59;LDHD_ECOLI;D-lactate dehydrogenase (D-LDH) (EC 1.1.1.28) (Fermentative lactate dehydrogenase);"cytosol [GO:0005829]; D-lactate dehydrogenase activity [GO:0008720]; NADH binding [GO:0070404]; mixed acid fermentation [GO:0019664]; response to heat [GO:0009408]";"GO:0005829; GO:0008720; GO:0009408; GO:0019664; GO:0070404";"mixed acid fermentation [GO:0019664]; response to heat [GO:0009408]";cytosol [GO:0005829];"D-lactate dehydrogenase activity [GO:0008720]; NADH binding [GO:0070404]"
comp4109346_c0_seq1;GAXK01050681.1;A2AVA0;5.88E-14;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp4109962_c0_seq1;GAXK01050686.1;Q9ER35;3.62E-30;FN3K_MOUSE;Fructosamine-3-kinase (EC 2.7.1.-);"cytosol [GO:0005829]; fructosamine-3-kinase activity [GO:0030387]; kinase activity [GO:0016301]; epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]";"GO:0005829; GO:0016301; GO:0030387; GO:0030389; GO:0030855";"epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]";cytosol [GO:0005829];"fructosamine-3-kinase activity [GO:0030387]; kinase activity [GO:0016301]"
comp4110020_c0_seq1;GAXK01029057.1;Q05556;2.11E-22;CP2AB_RABIT;Cytochrome P450 2A11 (EC 1.14.14.1) (CYPIIA11) (Cytochrome P450-IIA11);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp411003_c1_seq1;GAXK01204189.1;A6NHJ4;2.04E-09;ZN860_HUMAN;Zinc finger protein 860;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4110419_c0_seq1;GAXK01029059.1;O09053;1.20E-22;WRN_MOUSE;Werner syndrome ATP-dependent helicase homolog (EC 3.6.4.12) (Exonuclease WRN) (EC 3.1.-.-);"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; Y-form DNA binding [GO:0000403]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0070337; GO:0071480; GO:0098530; GO:1902570; GO:1905773";"base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]";"3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; telomeric D-loop binding [GO:0061821]; Y-form DNA binding [GO:0000403]"
comp4110530_c0_seq1;GAXK01029051.1;Q6GL04;7.78E-97;TERA_XENTR;Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0018279; GO:0019985; GO:0030433; GO:0030970; GO:0031593; GO:0032510; GO:0034098; GO:0034214; GO:0034605; GO:0035617; GO:0035861; GO:0036503; GO:0043161; GO:0044877; GO:0051228; GO:0061857; GO:0071712; GO:0097352; GO:1903843";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]"
comp411090_c0_seq1;GAXK01204302.1;Q9UBH6;1.03E-178;XPR1_HUMAN;Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]";"GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023";"cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]";"efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp4111004_c0_seq1;GAXK01029053.1;Q9VGI8;2.58E-09;BLM_DROME;Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]";"GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918";"cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]"
comp41111_c1_seq1;GAXK01191546.1;A6H7C9;2.87E-33;CEP19_BOVIN;Centrosomal protein of 19 kDa (Cep19);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]";"GO:0000922; GO:0005813; GO:0005814; GO:0034454; GO:0036064; GO:0060271; GO:0097712";"cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; spindle pole [GO:0000922]";
comp4111563_c0_seq1;GAXK01029060.1;G5EBR3;6.56E-16;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp4112012_c0_seq1;GAXK01001955.1;Q12901;8.72E-20;ZN155_HUMAN;Zinc finger protein 155;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp41123_c2_seq1;GAXK01192085.1;A1L1C7;0;PAN3_XENTR;PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3);"P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]";"GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0010606; GO:0031251; GO:0046872; GO:0090503";"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]";"PAN complex [GO:0031251]; P-body [GO:0000932]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]"
comp411271_c0_seq1;GAXK01204182.1;Q5RBY9;7.02E-16;ZNF2_PONAB;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp411277_c0_seq1;GAXK01204211.1;O15068;3.33E-83;MCF2L_HUMAN;Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0012505; GO:0031234; GO:0035023; GO:0035025; GO:0035091; GO:0035556; GO:0043065; GO:0051056";"G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]";"phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp41130_c2_seq1;GAXK01192225.1;Q9XZT6;2.16E-75;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp411315_c0_seq1;GAXK01204217.1;Q13569;5.20E-63;TDG_HUMAN;G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000122; GO:0000287; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0008134; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0045995; GO:0080111; GO:1902544";"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]";"ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]"
comp4113150_c0_seq1;GAXK01001962.1;P20385;3.49E-18;CF2_DROME;Chorion transcription factor Cf2;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872";"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp4113218_c0_seq1;GAXK01001966.1;P93664;7.40E-27;LHSR1_CHLRE;Light-harvesting complex stress-related protein 1, chloroplastic (Chlorophyll a-b binding protein LHCSR1);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0009416; GO:0009522; GO:0009523; GO:0009535; GO:0009768; GO:0016021; GO:0016168; GO:0018298";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp4113716_c0_seq1;GAXK01001968.1;P53440;3.28E-20;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp4114829_c0_seq1;GAXK01073055.1;O60041;8.32E-07;CALM_KLULA;Calmodulin (CaM);"actin fusion focus [GO:1990819]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; central plaque of spindle pole body [GO:0005823]; incipient cellular bud site [GO:0000131]; medial cortex [GO:0031097]; myosin I complex [GO:0045160]; prospore membrane [GO:0005628]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; mitogen-activated protein kinase binding [GO:0051019]; ascospore-type prospore membrane assembly [GO:0032120]; calcium-mediated signaling [GO:0019722]; cell budding [GO:0007114]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; lysosomal microautophagy [GO:0016237]; phosphatidylinositol biosynthetic process [GO:0006661]; protein import into nucleus [GO:0006606]; receptor-mediated endocytosis [GO:0006898]; regulation of membrane tubulation [GO:1903525]; spindle pole body organization [GO:0051300]; vacuole fusion, non-autophagic [GO:0042144]";"GO:0000131; GO:0000742; GO:0005509; GO:0005628; GO:0005823; GO:0005934; GO:0005935; GO:0006606; GO:0006661; GO:0006898; GO:0007114; GO:0016237; GO:0019722; GO:0031097; GO:0032120; GO:0042144; GO:0045160; GO:0048306; GO:0051019; GO:0051300; GO:1903525; GO:1990819";"ascospore-type prospore membrane assembly [GO:0032120]; calcium-mediated signaling [GO:0019722]; cell budding [GO:0007114]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; lysosomal microautophagy [GO:0016237]; phosphatidylinositol biosynthetic process [GO:0006661]; protein import into nucleus [GO:0006606]; receptor-mediated endocytosis [GO:0006898]; regulation of membrane tubulation [GO:1903525]; spindle pole body organization [GO:0051300]; vacuole fusion, non-autophagic [GO:0042144]";"actin fusion focus [GO:1990819]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; central plaque of spindle pole body [GO:0005823]; incipient cellular bud site [GO:0000131]; medial cortex [GO:0031097]; myosin I complex [GO:0045160]; prospore membrane [GO:0005628]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; mitogen-activated protein kinase binding [GO:0051019]"
comp4115305_c0_seq1;GAXK01073074.1;P55211;2.62E-25;CASP9_HUMAN;"Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10]";"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]";"GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0046677; GO:0071549; GO:0071887; GO:0097153; GO:0097192; GO:0097199; GO:2001020";"activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]";"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp4115871_c0_seq1;GAXK01073066.1;P26784;8.13E-72;RL16A_YEAST;60S ribosomal protein L16-A (L13a) (L21) (Large ribosomal subunit protein uL13-A) (RP22) (YL15);"cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; negative regulation of translation [GO:0017148]";"GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005840; GO:0017148; GO:0022625";"cytoplasmic translation [GO:0002181]; negative regulation of translation [GO:0017148]";"cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4116259_c0_seq1;GAXK01096027.1;Q8AVY1;1.51E-37;ODF3A_XENLA;Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp411660_c0_seq1;GAXK01204305.1;Q8TDM6;6.48E-97;DLG5_HUMAN;Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG);"cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]";"GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045211; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609";"apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]";"cell-cell adherens junction [GO:0005913]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]"
comp4116928_c0_seq1;GAXK01096038.1;Q95K49;2.26E-12;ZN614_MACFA;Zinc finger protein 614;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4117153_c0_seq1;GAXK01096031.1;P17970;1.08E-36;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4117393_c0_seq1;GAXK01096040.1;O00370;8.24E-07;LORF2_HUMAN;"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]";"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]";"GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305";"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]";;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]"
comp411754_c0_seq1;GAXK01204212.1;P54793;1.46E-107;ARSF_HUMAN;Arylsulfatase F (ASF) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005788; GO:0046872; GO:0070062";;"endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp4117802_c0_seq1;GAXK01096025.1;P02399;9.46E-16;RLA2_ARTSA;60S acidic ribosomal protein P2 (EL12);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp411838_c1_seq1;GAXK01204255.1;Q7KRI2;1.29E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp411851_c0_seq1;GAXK01204214.1;P36609;9.12E-41;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4119068_c0_seq1;GAXK01108601.1;Q9U8W8;4.63E-24;TL5A_TACTR;Techylectin-5A;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp411923_c2_seq1;GAXK01204233.1;G5ED00;5.52E-08;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp4119314_c0_seq1;GAXK01108606.1;Q9VZW5;1.22E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp411939_c0_seq1;GAXK01204201.1;Q24372;2.58E-19;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp411974_c0_seq1;GAXK01204284.1;O35569;5.58E-21;NRG2_RAT;Pro-neuregulin-2, membrane-bound isoform (Pro-NRG2) [Cleaved into: Neuregulin-2 (NRG-2) (Neural- and thymus-derived activator for ERBB kinases) (NTAK)];"extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; epidermal growth factor-activated receptor activity [GO:0005006]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; regulation of synapse maturation [GO:0090128]";"GO:0005006; GO:0005102; GO:0005154; GO:0005615; GO:0005886; GO:0007173; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0043125; GO:0051963; GO:0090128; GO:0098978; GO:0098982";"epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; regulation of synapse maturation [GO:0090128]";"extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]"
comp4120275_c0_seq1;GAXK01193428.1;Q9D3N2;1.39E-39;EFCB1_MOUSE;EF-hand calcium-binding domain-containing protein 1;"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent outer dynein arm binding [GO:0120152]; dynein heavy chain binding [GO:0045504]; cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity, minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317]";"GO:0005509; GO:0005930; GO:0045504; GO:0048487; GO:0060326; GO:0097729; GO:0120152; GO:1901317; GO:2000578";"cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity, minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]";"beta-tubulin binding [GO:0048487]; calcium-dependent outer dynein arm binding [GO:0120152]; calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]"
comp412052_c0_seq1;GAXK01190625.1;Q9N1U3;8.09E-13;GCR_PIG;Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor activity [GO:0004883]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003700; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0005819; GO:0006325; GO:0008270; GO:0016607; GO:0043565; GO:0045944; GO:0071383; GO:0071385; GO:1990239";"cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]";"DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor activity [GO:0004883]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]"
comp41215_c3_seq1;GAXK01191458.1;A8E7C5;0;SAC2_DANRE;Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2);"clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]";"GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135";"clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]";"clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]";"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]"
comp412222_c0_seq1;GAXK01190748.1;Q7KRI2;4.68E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp41229_c0_seq1;GAXK01191685.1;Q9NYG2;9.34E-46;ZDHC3_HUMAN;Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to photoreceptor outer segment [GO:1903546]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:1903546";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to photoreceptor outer segment [GO:1903546]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp4123_c0_seq1;GAXK01065847.1;Q17P98;2.95E-31;MED28_AEDAE;Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp4123551_c0_seq1;GAXK01115625.1;P17970;2.05E-55;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4124426_c0_seq1;GAXK01115474.1;P97443;7.47E-08;SMYD1_MOUSE;Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.43) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914]";"GO:0003677; GO:0003714; GO:0005634; GO:0005737; GO:0006338; GO:0007507; GO:0010831; GO:0018024; GO:0035914; GO:0045663; GO:0045892; GO:0046872";"chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp412462_c1_seq1;GAXK01190685.1;Q9V427;6.86E-64;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp4125229_c0_seq1;GAXK01115479.1;Q0P5F0;7.81E-42;PPAL_BOVIN;Lysosomal acid phosphatase (LAP) (EC 3.1.3.2);"integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501]";"GO:0001501; GO:0003993; GO:0005765; GO:0007040; GO:0016021; GO:0043202";"lysosome organization [GO:0007040]; skeletal system development [GO:0001501]";"integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]";acid phosphatase activity [GO:0003993]
comp412525_c0_seq1;GAXK01190632.1;Q86YT5;9.38E-97;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp412551_c1_seq1;GAXK01190640.1;B7Z0K8;1.75E-08;COLL1_DROME;Collagen alpha chain CG42342;"basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]";"GO:0005201; GO:0005594; GO:0005604; GO:0005615; GO:0005886; GO:0016021; GO:0030198; GO:0031012";extracellular matrix organization [GO:0030198];"basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";extracellular matrix structural constituent [GO:0005201]
comp412563_c0_seq1;GAXK01190735.1;P22757;1.21E-43;HE_PARLI;Hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: Hatching enzyme 18 kDa form];"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4126136_c0_seq1;GAXK01123767.1;P0C6B8;4.52E-18;SVEP1_RAT;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";calcium ion binding [GO:0005509]
comp412615_c1_seq1;GAXK01190711.1;A4IGL7;7.65E-120;PXDN_XENTR;Peroxidasin (EC 1.11.1.7);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp4126547_c0_seq1;GAXK01123765.1;Q6IVV8;1.23E-25;PKD2_DANRE;Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738";"atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp412663_c0_seq1;GAXK01190634.1;Q9N294;4.47E-13;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp41267_c0_seq1;GAXK01191443.1;Q5SUC9;5.69E-72;SCO1_MOUSE;Protein SCO1 homolog, mitochondrial;"host cell mitochondrial intermembrane space [GO:0072492]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; metal ion binding [GO:0046872]; cell redox homeostasis [GO:0045454]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]";"GO:0005739; GO:0005743; GO:0006878; GO:0030016; GO:0031305; GO:0033617; GO:0045454; GO:0046872; GO:0072492; GO:1901799";"cell redox homeostasis [GO:0045454]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]";"host cell mitochondrial intermembrane space [GO:0072492]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myofibril [GO:0030016]";metal ion binding [GO:0046872]
comp4126997_c0_seq1;GAXK01123781.1;Q6P5C7;7.90E-14;ZN728_MOUSE;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp41272_c0_seq1;GAXK01192126.1;Q2TBG7;7.15E-29;ISCA2_BOVIN;Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1);"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]";"GO:0005198; GO:0005506; GO:0005739; GO:0016226; GO:0051537; GO:0051539; GO:0051604; GO:0106035";"iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]";mitochondrion [GO:0005739];"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]"
comp41280_c0_seq1;GAXK01191955.1;Q5ZKT9;5.78E-65;MIER1_CHICK;Mesoderm induction early response protein 1 (Mi-er1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"GO:0000122; GO:0001103; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0016575; GO:0017053; GO:0031937; GO:0042826";"histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]"
comp4128398_c0_seq1;GAXK01200968.1;Q3LHL9;9.91E-23;WGE_DROME;Protein winged eye;"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"GO:0000785; GO:0003682; GO:0005634; GO:0007560; GO:0030154";"cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]";"chromatin [GO:0000785]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp412897_c0_seq1;GAXK01190642.1;Q9JHS6;6.23E-08;ASIC4_RAT;Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4) (Spinal chord ASIC);"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]";"GO:0005272; GO:0016021";;integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp412934_c0_seq1;GAXK01190631.1;Q6P9U1;2.73E-34;NUD22_RAT;Uridine diphosphate glucose pyrophosphatase NUDT22 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 22) (Nudix motif 22);"nucleoplasm [GO:0005654]; GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]";"GO:0005654; GO:0008768; GO:0046872; GO:0052751";;nucleoplasm [GO:0005654];"GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]"
comp41299_c0_seq1;GAXK01191781.1;Q8C6G8;0;WDR26_MOUSE;WD repeat-containing protein 26;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";
comp4130219_c0_seq1;GAXK01143713.1;P09480;3.78E-38;ACHA2_CHICK;Neuronal acetylcholine receptor subunit alpha-2;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp4130355_c0_seq1;GAXK01143703.1;C0HBT3;2.08E-25;RN146_SALSA;E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146);"cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp413078_c0_seq1;GAXK01190744.1;P63025;7.58E-17;VAMP3_RAT;Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to interferon-gamma [GO:0071346]; Golgi to plasma membrane protein transport [GO:0043001]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001921; GO:0005829; GO:0005886; GO:0009986; GO:0016192; GO:0016324; GO:0017075; GO:0017156; GO:0030054; GO:0030141; GO:0030285; GO:0030665; GO:0031201; GO:0034446; GO:0035493; GO:0042147; GO:0043001; GO:0043005; GO:0043229; GO:0043231; GO:0045335; GO:0048471; GO:0055037; GO:0065003; GO:0071346; GO:1903531";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to interferon-gamma [GO:0071346]; Golgi to plasma membrane protein transport [GO:0043001]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]";"SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]"
comp4130920_c0_seq1;GAXK01143714.1;A0ZSK3;1.03E-13;STXA_SYNVE;Neoverrucotoxin subunit alpha (NeoVTX subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp413156_c1_seq1;GAXK01190692.1;Q8CI15;1.75E-41;SPHK1_MOUSE;Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-);"axon [GO:0030424]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingolipid mediated signaling pathway [GO:0090520]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]";"GO:0000287; GO:0001568; GO:0001934; GO:0001956; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006670; GO:0006954; GO:0007420; GO:0008021; GO:0008284; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0010976; GO:0016310; GO:0016407; GO:0017050; GO:0019371; GO:0019722; GO:0030054; GO:0030100; GO:0030139; GO:0030307; GO:0030335; GO:0030424; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035924; GO:0038036; GO:0043005; GO:0043066; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071897; GO:0090520; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364";"blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingolipid mediated signaling pathway [GO:0090520]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]";"axon [GO:0030424]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]";"acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]"
comp413170_c0_seq1;GAXK01205970.1;Q804S5;0;MIB1_DANRE;E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Protein mind bomb) (RING-type E3 ubiquitin transferase mib1);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]";"GO:0000151; GO:0001568; GO:0001570; GO:0001756; GO:0001885; GO:0002040; GO:0002064; GO:0002090; GO:0002244; GO:0003407; GO:0003408; GO:0004842; GO:0005737; GO:0005815; GO:0005886; GO:0006897; GO:0007219; GO:0007368; GO:0007417; GO:0007420; GO:0007507; GO:0008270; GO:0008284; GO:0008593; GO:0009880; GO:0010001; GO:0016567; GO:0021508; GO:0021510; GO:0021514; GO:0021519; GO:0021520; GO:0021521; GO:0021536; GO:0021546; GO:0021654; GO:0021986; GO:0022008; GO:0030097; GO:0030139; GO:0030182; GO:0030318; GO:0030902; GO:0030903; GO:0031076; GO:0031398; GO:0031410; GO:0032991; GO:0035315; GO:0039022; GO:0042803; GO:0045664; GO:0045685; GO:0045747; GO:0048066; GO:0048259; GO:0048471; GO:0048514; GO:0048546; GO:0048663; GO:0048665; GO:0048666; GO:0048699; GO:0048793; GO:0048859; GO:0048892; GO:0048899; GO:0048916; GO:0048920; GO:0050931; GO:0051865; GO:0060035; GO:0060113; GO:0060216; GO:0060218; GO:0061195; GO:0061551; GO:0070086; GO:0071599";"anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]";"protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4132_c0_seq1;GAXK01065754.1;Q98SH3;1.65E-53;ADRM1_CHICK;Proteasomal ubiquitin receptor ADRM1 (Adhesion-regulating molecule 1) (ARM-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0005634; GO:0005737; GO:0006511; GO:0008541; GO:0043130; GO:0043248; GO:0061133; GO:0070628";"proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]";"endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]"
comp41322_c0_seq1;GAXK01192042.1;Q6RY07;3.59E-39;CHIA_RAT;Acidic mammalian chitinase (AMCase) (EC 3.2.1.14);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197";"apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp4132242_c0_seq1;GAXK01180662.1;Q3U2K5;6.60E-07;KDM4D_MOUSE;Lysine-specific demethylase 4D (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3D) (Jumonji domain-containing protein 2D);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932]";"GO:0000724; GO:0001932; GO:0003684; GO:0005634; GO:0005721; GO:0006338; GO:0006974; GO:0031490; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0035563; GO:0035861; GO:0046872; GO:0051213; GO:0071479; GO:1900113; GO:2001034";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]";"chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp41326_c1_seq1;GAXK01192015.1;P52758;1.56E-45;RIDA_HUMAN;2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]";"GO:0001822; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0030324; GO:0033993; GO:0036041; GO:0042803; GO:0046914; GO:0050680; GO:0061157; GO:0070062; GO:0070314; GO:1901565; GO:1902074";"brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]"
comp41333_c1_seq1;GAXK01192183.1;P30932;1.69E-33;CD9_BOVIN;CD9 antigen (CD antigen CD9);"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]";"GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007338; GO:0007342; GO:0008285; GO:0009897; GO:0014905; GO:0016020; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0051271; GO:0070062; GO:0071404; GO:0090331; GO:1905521";"cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]";"external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";integrin binding [GO:0005178]
comp413343_c0_seq1;GAXK01190694.1;Q9Z2D7;2.53E-58;MBD4_MOUSE;Methyl-CpG-binding domain protein 4 (EC 3.2.2.-) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; cellular response to DNA damage stimulus [GO:0006974]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint [GO:0007095]; response to radiation [GO:0009314]";"GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0006306; GO:0006974; GO:0007095; GO:0008263; GO:0008630; GO:0009314; GO:0016607";"cellular response to DNA damage stimulus [GO:0006974]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint [GO:0007095]; response to radiation [GO:0009314]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]"
comp4133954_c0_seq1;GAXK01180648.1;Q9VZW5;4.92E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp4134368_c0_seq1;GAXK01156028.1;P17012;8.62E-11;ZFX_MOUSE;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; germ cell development [GO:0007281]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0007281; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746";"fertilization [GO:0009566]; germ cell development [GO:0007281]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp41345_c1_seq1;GAXK01191657.1;Q15543;9.23E-50;TAF13_HUMAN;Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]; DNA-templated transcription, initiation [GO:0006352]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003677; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0008022; GO:0042795; GO:0046982; GO:1901796";"DNA-templated transcription, initiation [GO:0006352]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]"
comp413491_c0_seq1;GAXK01190707.1;Q9UDV7;1.98E-19;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp4135_c0_seq1;GAXK01066182.1;P42026;2.43E-98;NDUS7_BOVIN;NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit);"mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005747; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0046872; GO:0048038; GO:0051539";"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]";mitochondrial respiratory chain complex I [GO:0005747];"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"
comp413528_c0_seq1;GAXK01190641.1;P27701;1.20E-18;CD82_HUMAN;CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"GO:0005886; GO:0005887; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";
comp41357_c3_seq1;GAXK01191606.1;F1PRN2;0;MYO1D_CANLF;Unconventional myosin-Id (Unconventional myosin Myr 4);"axon [GO:0030424]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; perikaryon [GO:0043204]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein domain specific binding [GO:0019904]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923]; protein transport [GO:0015031]";"GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005829; GO:0005903; GO:0005938; GO:0006897; GO:0010923; GO:0015031; GO:0016459; GO:0019904; GO:0030424; GO:0030425; GO:0043204; GO:0043209; GO:0061502";"early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923]; protein transport [GO:0015031]";"axon [GO:0030424]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; perikaryon [GO:0043204]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein domain specific binding [GO:0019904]"
comp4136203_c0_seq1;GAXK01140769.1;Q4R723;2.17E-48;RL27A_MACFA;60S ribosomal protein L27a;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005783; GO:0005829; GO:0006412; GO:0015934";translation [GO:0006412];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp4136682_c0_seq1;GAXK01140762.1;P13674;3.48E-18;P4HA1_HUMAN;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp4136852_c0_seq1;GAXK01140776.1;Q9UTS5;1.41E-08;ZAS1_SCHPO;Zinc finger protein zas1;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000790; GO:0000981; GO:0005634; GO:0006351; GO:0008270; GO:0043565; GO:0045944; GO:0061586";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; transcription, DNA-templated [GO:0006351]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp41374_c0_seq1;GAXK01191517.1;Q9BQA5;4.52E-110;HINFP_HUMAN;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000978; GO:0000981; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp413745_c1_seq1;GAXK01190650.1;P36609;2.31E-69;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4137874_c0_seq1;GAXK01140774.1;A8WYE4;9.70E-23;PAR1_CAEBR;Serine/threonine-protein kinase par-1 (EC 2.7.11.1);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]";"GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005938; GO:0007275; GO:0035556; GO:0046872; GO:0050321";"intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp413823_c0_seq1;GAXK01190680.1;Q9WTN6;7.98E-18;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp4138702_c0_seq1;GAXK01090076.1;Q5RJI2;3.94E-10;CTL5_MOUSE;Choline transporter-like protein 5 (Solute carrier family 44 member 5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp41390_c1_seq1;GAXK01191915.1;P37276;0;DYHC_DROME;Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC);"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity, coupled [GO:0042623]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0042623; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045503; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904";"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]";"ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp413902_c0_seq1;GAXK01190633.1;P08962;2.74E-20;CD63_HUMAN;CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63);"azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0002576; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0015031; GO:0016477; GO:0031088; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0034613; GO:0035577; GO:0035646; GO:0042470; GO:0043312; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]";
comp413938_c0_seq1;GAXK01190649.1;G3X987;1.18E-08;GIMA9_MOUSE;GTPase IMAP family member 9 (Immune-associated nucleotide-binding protein 7) (IAN-7) (Immunity-associated nucleotide-binding protein 7);"cytosol [GO:0005829]; GTP binding [GO:0005525]";"GO:0005525; GO:0005829";;cytosol [GO:0005829];GTP binding [GO:0005525]
comp41403_c1_seq1;GAXK01192150.1;O70572;1.74E-16;NSMA_MOUSE;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase);"caveola [GO:0005901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005901; GO:0006684; GO:0006685; GO:0009612; GO:0016020; GO:0016021; GO:0035556; GO:0043065; GO:0046513; GO:0046872";"ceramide biosynthetic process [GO:0046513]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"caveola [GO:0005901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp41409_c0_seq1;GAXK01191624.1;Q28HM1;1.06E-94;TFB1M_XENTR;Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1);"mitochondrion [GO:0005739]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA methylation [GO:0031167]";"GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167";rRNA methylation [GO:0031167];mitochondrion [GO:0005739];"DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"
comp4141_c0_seq1;GAXK01066792.1;Q295V5;9.55E-56;ARMET_DROPS;Mesencephalic astrocyte-derived neurotrophic factor homolog (MANF/CDNF-like protein);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0005509; GO:0005576; GO:0005783; GO:0031175; GO:0042417; GO:0070050";"dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";calcium ion binding [GO:0005509]
comp4141077_c0_seq1;GAXK01084901.1;Q9VZW5;1.38E-14;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp4141531_c0_seq1;GAXK01084895.1;P55918;5.68E-18;MFAP4_BOVIN;Microfibril-associated glycoprotein 4 (36 kDa microfibril-associated glycoprotein) (36 kDa MAP);"collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; UV protection [GO:0009650]";"GO:0001527; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953";"cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; UV protection [GO:0009650]";"collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; microfibril [GO:0001527]";
comp4141700_c0_seq1;GAXK01084892.1;Q7KRI2;1.13E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp414192_c0_seq1;GAXK01101332.1;O43934;2.98E-56;MFS11_HUMAN;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp4141960_c0_seq1;GAXK01084905.1;Q9C0G6;1.44E-33;DYH6_HUMAN;Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp4142_c3_seq1;GAXK01066723.1;Q9Y5V0;1.32E-15;ZN706_HUMAN;Zinc finger protein 706;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455";"negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp41427_c0_seq1;GAXK01191653.1;Q9VQ30;1.89E-26;CHNMO_DROME;Zinc finger protein chinmo (Protein chronologically inappropriate morphogenesis);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]";"GO:0001933; GO:0003676; GO:0005634; GO:0006357; GO:0007548; GO:0016319; GO:0019102; GO:0030838; GO:0035214; GO:0046872; GO:0048666; GO:0051170; GO:2000035";"eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp41428_c7_seq1;GAXK01191551.1;Q4KLU2;2.40E-69;PRP39_XENLA;Pre-mRNA-processing factor 39 (PRP39 homolog);"nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0005634; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";nucleus [GO:0005634];
comp414310_c0_seq1;GAXK01101439.1;Q7Z7G8;1.05E-74;VP13B_HUMAN;Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1);protein transport [GO:0015031];GO:0015031;protein transport [GO:0015031];;
comp4143101_c0_seq1;GAXK01001167.1;Q96PZ7;1.16E-08;CSMD1_HUMAN;CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);"integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]";"GO:0001964; GO:0016021; GO:0042593";"glucose homeostasis [GO:0042593]; startle response [GO:0001964]";integral component of membrane [GO:0016021];
comp41432_c1_seq1;GAXK01191445.1;O89104;1.79E-40;SYPL2_MOUSE;Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29);"integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; syntaxin-1 binding [GO:0017075]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]";"GO:0006874; GO:0007507; GO:0016021; GO:0017075; GO:0030672; GO:0033292";"cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]";"integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]";syntaxin-1 binding [GO:0017075]
comp4143283_c0_seq1;GAXK01001158.1;Q9H2C0;7.04E-07;GAN_HUMAN;Gigaxonin (Kelch-like protein 16);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687";"cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";
comp4143388_c0_seq1;GAXK01001155.1;Q01758;8.00E-10;ISP2_OSMMO;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp4143870_c0_seq1;GAXK01001166.1;Q94900;4.79E-07;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp414480_c0_seq1;GAXK01101355.1;Q23045;3.29E-39;EGL13_CAEEL;Transcription factor egl-13 (Protein egg laying defective 13);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; anatomical structure morphogenesis [GO:0009653]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vulval development [GO:0040025]";"GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0009653; GO:0040025; GO:0045165; GO:0045892; GO:0045944; GO:0048664; GO:0055059";"anatomical structure morphogenesis [GO:0009653]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vulval development [GO:0040025]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp4145083_c0_seq1;GAXK01119408.1;F1NY98;1.31E-11;DSCAM_CHICK;Down syndrome cell adhesion molecule homolog;"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030017; GO:0030054; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]";"netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]"
comp414572_c0_seq1;GAXK01101441.1;Q9EPW2;2.14E-38;KLF15_MOUSE;Krueppel-like factor 15 (Cardiovascular Krueppel-like factor);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010001; GO:0010468; GO:0014898; GO:0032868; GO:0044212; GO:0045893; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:2000757";"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp41462_c1_seq1;GAXK01192081.1;Q5ZMS6;5.85E-56;TDRD3_CHICK;Tudor domain-containing protein 3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]";"GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005737; GO:0006325; GO:0006397; GO:0035064";"chromatin organization [GO:0006325]; mRNA processing [GO:0006397]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]"
comp4146574_c0_seq1;GAXK01142704.1;Q5VU57;1.04E-62;CBPC6_HUMAN;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp4147315_c0_seq1;GAXK01142705.1;Q5E9U1;1.12E-21;P2RX4_BOVIN;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; apoptotic signaling pathway [GO:0097190]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; relaxation of cardiac muscle [GO:0055119]; response to fluid shear stress [GO:0034405]";"GO:0001614; GO:0004931; GO:0005524; GO:0005639; GO:0005886; GO:0005887; GO:0006812; GO:0008217; GO:0010524; GO:0010614; GO:0016021; GO:0030054; GO:0034220; GO:0034405; GO:0035381; GO:0043536; GO:0045296; GO:0048471; GO:0050850; GO:0051899; GO:0055117; GO:0055119; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0098794; GO:0099604; GO:2001028";"apoptotic signaling pathway [GO:0097190]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; relaxation of cardiac muscle [GO:0055119]; response to fluid shear stress [GO:0034405]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]"
comp414740_c0_seq1;GAXK01101428.1;Q14584;5.89E-20;ZN266_HUMAN;Zinc finger protein 266 (Zinc finger protein HZF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4147428_c0_seq1;GAXK01142686.1;Q7Z5L0;5.36E-11;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp414801_c0_seq1;GAXK01101424.1;Q9C0G0;6.63E-18;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp414932_c0_seq1;GAXK01101471.1;Q642B2;9.99E-11;ZN672_RAT;Zinc finger protein 672;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4149359_c0_seq1;GAXK01129346.1;P16234;2.23E-30;PGFRA_HUMAN;Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a);"cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]; wound healing [GO:0042060]";"GO:0000165; GO:0001553; GO:0001701; GO:0001775; GO:0002244; GO:0004672; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0009897; GO:0010544; GO:0010863; GO:0014068; GO:0016020; GO:0016032; GO:0018108; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030539; GO:0031226; GO:0032991; GO:0033327; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043410; GO:0043552; GO:0044877; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048704; GO:0050920; GO:0051897; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0061298; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000249; GO:2000739";"adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]; wound healing [GO:0042060]";"cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]"
comp4149396_c0_seq1;GAXK01129348.1;Q10311;7.38E-08;YD58_SCHPO;Ankyrin repeat-containing protein C6C3.08;"cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; proteasome regulatory particle assembly [GO:0070682]";"GO:0005634; GO:0005829; GO:0032991; GO:0070682";proteasome regulatory particle assembly [GO:0070682];"cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";
comp41494_c0_seq1;GAXK01191852.1;Q9GPJ1;1.94E-22;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp4149535_c0_seq1;GAXK01129351.1;Q7KF90;1.73E-53;RL31_SPOFR;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp415040_c0_seq1;GAXK01101356.1;Q24432;5.67E-114;OMB_DROME;Optomotor-blind protein (Lethal(1)optomotor-blind) (L(1)omb) (Protein bifid);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";"GO:0000122; GO:0000977; GO:0000978; GO:0001102; GO:0001228; GO:0001708; GO:0001745; GO:0003677; GO:0005634; GO:0007472; GO:0007476; GO:0035265; GO:0045944; GO:0048066; GO:0048100";"cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp415127_c0_seq1;GAXK01101421.1;Q5RB30;2.90E-28;Z585B_PONAB;Zinc finger protein 585B;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp415156_c0_seq1;GAXK01101442.1;Q27874;9.30E-66;PAT3_CAEEL;Integrin beta pat-3 (Paralyzed arrest at two-fold protein 3);"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]";"GO:0005178; GO:0005604; GO:0005925; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009925; GO:0009986; GO:0016328; GO:0016477; GO:0030018; GO:0031430; GO:0032956; GO:0033627; GO:0040017; GO:0040028; GO:0042059; GO:0043005; GO:0043025; GO:0045987; GO:0046716; GO:0055001; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:0072327; GO:1903354; GO:1903356; GO:1904901";"cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]";"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]";integrin binding [GO:0005178]
comp4151619_c0_seq1;GAXK01083511.1;Q9VV43;3.29E-33;Y5057_DROME;TPPP family protein CG45057;"axon [GO:0030424]; neuronal cell body [GO:0043025]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"GO:0000226; GO:0001578; GO:0015631; GO:0030424; GO:0032273; GO:0043025; GO:0046785";"microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"axon [GO:0030424]; neuronal cell body [GO:0043025]";tubulin binding [GO:0015631]
comp415171_c0_seq1;GAXK01101363.1;P56407;1.03E-22;HM09_CAEEL;Homeobox protein ceh-9;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0003700; GO:0005634; GO:0007275; GO:0030154; GO:0043565; GO:0045944";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4151832_c0_seq1;GAXK01083505.1;P28724;1.67E-108;DHE4_GIAIN;NADP-specific glutamate dehydrogenase (NADP-GDH) (EC 1.4.1.4) (NADP-dependent glutamate dehydrogenase);"glutamate dehydrogenase (NADP+) activity [GO:0004354]; cellular amino acid metabolic process [GO:0006520]";"GO:0004354; GO:0006520";cellular amino acid metabolic process [GO:0006520];;glutamate dehydrogenase (NADP+) activity [GO:0004354]
comp4151848_c0_seq1;GAXK01083513.1;Q5RFP4;5.13E-34;OZF_PONAB;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp41520_c1_seq1;GAXK01191580.1;P35035;3.01E-44;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp4152422_c0_seq1;GAXK01081363.1;P55042;9.64E-21;RAD_HUMAN;GTP-binding protein RAD (RAD1) (Ras associated with diabetes);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007264; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp415311_c1_seq1;GAXK01101453.1;Q9GKT2;1.16E-93;FXDC2_MACFA;Fatty acid hydroxylase domain-containing protein 2;"integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]";"GO:0005506; GO:0008610; GO:0016021; GO:0016491";lipid biosynthetic process [GO:0008610];integral component of membrane [GO:0016021];"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"
comp41533_c0_seq1;GAXK01191845.1;O15213;1.48E-129;WDR46_HUMAN;WD repeat-containing protein 46 (WD repeat-containing protein BING4);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp415330_c0_seq1;GAXK01101357.1;P80387;2.45E-09;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp415361_c0_seq1;GAXK01101387.1;Q9VZW5;2.46E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp415376_c0_seq1;GAXK01101396.1;P06537;2.84E-13;GCR_MOUSE;Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromatin binding [GO:0003682]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor activity [GO:0004883]; heat shock protein binding [GO:0031072]; hormone binding [GO:0042562]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; adrenal gland development [GO:0030325]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; glucocorticoid metabolic process [GO:0008211]; glucocorticoid receptor signaling pathway [GO:0042921]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000978; GO:0001012; GO:0001047; GO:0001228; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005815; GO:0005819; GO:0005829; GO:0006111; GO:0006338; GO:0006351; GO:0006355; GO:0008134; GO:0008211; GO:0008270; GO:0010906; GO:0014049; GO:0014069; GO:0016020; GO:0016607; GO:0019901; GO:0030325; GO:0030544; GO:0030971; GO:0031072; GO:0031914; GO:0031946; GO:0032183; GO:0032991; GO:0042127; GO:0042562; GO:0042711; GO:0042803; GO:0042921; GO:0043005; GO:0043066; GO:0043116; GO:0043197; GO:0043525; GO:0043565; GO:0044877; GO:0045944; GO:0046685; GO:0046982; GO:0046983; GO:0048096; GO:0051879; GO:0060603; GO:0060999; GO:0061051; GO:0071383; GO:0071385; GO:0071549; GO:0071560; GO:0098978; GO:0099092; GO:1900170; GO:1902895; GO:1990239; GO:2000324";"adrenal gland development [GO:0030325]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin-mediated maintenance of transcription [GO:0048096]; chromatin remodeling [GO:0006338]; glucocorticoid metabolic process [GO:0008211]; glucocorticoid receptor signaling pathway [GO:0042921]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor activity [GO:0004883]; heat shock protein binding [GO:0031072]; hormone binding [GO:0042562]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp4154792_c0_seq1;GAXK01015546.1;Q9ZT94;7.91E-16;POLR2_ARATH;"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4155203_c0_seq1;GAXK01015552.1;Q8K4Q8;9.45E-09;COL12_MOUSE;Collectin-12 (Collectin placenta protein 1) (CL-P1) (Scavenger receptor with C-type lectin);"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]";"GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0062023";"immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]";"collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]"
comp4155219_c0_seq1;GAXK01015551.1;B1XXP1;1.87E-88;PYRF_LEPCP;Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMP decarboxylase) (OMPDCase) (OMPdecase);"orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]";"GO:0004590; GO:0006207; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]";;orotidine-5'-phosphate decarboxylase activity [GO:0004590]
comp415522_c0_seq1;GAXK01101470.1;P87064;3.22E-19;DODA_AMAMU;DOPA 4,5-dioxygenase (EC 1.14.99.-);"cytoplasm [GO:0005737]; dioxygenase activity [GO:0051213]";"GO:0005737; GO:0051213";;cytoplasm [GO:0005737];dioxygenase activity [GO:0051213]
comp4155717_c0_seq1;GAXK01015544.1;Q94900;2.74E-14;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp415594_c1_seq1;GAXK01101339.1;Q9V727;7.51E-44;ASX_DROME;Polycomb protein Asx (Additional sex combs);"chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"GO:0000785; GO:0001709; GO:0003677; GO:0003682; GO:0005634; GO:0007469; GO:0007475; GO:0009887; GO:0010468; GO:0035186; GO:0035517; GO:0035522; GO:0035800; GO:0045498; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:2000152";"animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]";"chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp415659_c3_seq1;GAXK01101369.1;Q94900;1.61E-28;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp415774_c0_seq1;GAXK01101335.1;O61307;0;TENM_DROME;Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0030054; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331";"cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp415779_c0_seq1;GAXK01101427.1;Q6IN84;5.59E-35;MRM1_HUMAN;rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]";"GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039";rRNA 2'-O-methylation [GO:0000451];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]"
comp4158394_c0_seq1;GAXK01122988.1;Q63099;7.02E-42;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp4158844_c0_seq1;GAXK01122980.1;Q05944;5.54E-16;HSP70_HYDVU;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp415917_c0_seq1;GAXK01101449.1;Q7KRI2;3.21E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp41600_c0_seq1;GAXK01192130.1;Q6TEK3;2.68E-27;VKORL_RAT;Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373]";"GO:0005789; GO:0016021; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038";"cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]"
comp4160048_c0_seq1;GAXK01195471.1;Q9XTR1;1.70E-13;CDK4_CAEEL;Cyclin-dependent kinase 4 homolog (CDK4/6) (EC 2.7.11.22) (Cell division protein kinase 4);"nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";"GO:0002119; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007530; GO:0008584; GO:0009791; GO:0018105; GO:0018107; GO:0032877; GO:0040035; GO:0044843; GO:0046872; GO:0051301; GO:0090727; GO:1900087";"cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";nucleus [GO:0005634];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp4160404_c0_seq1;GAXK01195474.1;P29409;1.34E-68;PGKH_SPIOL;Phosphoglycerate kinase, chloroplastic (EC 2.7.2.3) (Fragment);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0004618; GO:0005524; GO:0006096; GO:0009507; GO:0019253";"glycolytic process [GO:0006096]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]"
comp416080_c1_seq1;GAXK01045474.1;F1N2W9;4.34E-11;MCM9_BOVIN;DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9);"chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298]";"GO:0000724; GO:0003678; GO:0003682; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007276; GO:0007292; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0071168; GO:0097362";"cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298]";"chromosome [GO:0005694]; MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]"
comp41614_c5_seq1;GAXK01191870.1;Q8BTM8;1.11E-31;FLNA_MOUSE;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin);"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319]";"GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0008134; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043433; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048365; GO:0048471; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224";"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319]";"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]"
comp416153_c1_seq1;GAXK01045502.1;Q2VG86;3.99E-35;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4161590_c0_seq1;GAXK01195480.1;A2AVJ0;9.79E-16;CF299_DANRE;Cilia- and flagella-associated protein 299;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp4161635_c0_seq1;GAXK01195477.1;Q3UVU3;3.36E-07;ZNT10_MOUSE;Zinc transporter 10 (ZnT-10) (Solute carrier family 30 member 10);"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; cation transmembrane transporter activity [GO:0008324]; cellular response to angiotensin [GO:1904385]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transport [GO:0006829]";"GO:0005769; GO:0005794; GO:0005886; GO:0006828; GO:0006829; GO:0007173; GO:0008324; GO:0016021; GO:0043524; GO:0055037; GO:0070374; GO:0071421; GO:0071579; GO:1903427; GO:1904385; GO:1905802; GO:2000773";"cellular response to angiotensin [GO:1904385]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transport [GO:0006829]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";cation transmembrane transporter activity [GO:0008324]
comp416217_c0_seq1;GAXK01045491.1;Q9HA38;3.05E-15;ZMAT3_HUMAN;Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of apoptotic process [GO:0043065]; protein transport [GO:0015031]; regulation of growth [GO:0040008]";"GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0006915; GO:0006974; GO:0008270; GO:0015031; GO:0040008; GO:0043065";"apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of apoptotic process [GO:0043065]; protein transport [GO:0015031]; regulation of growth [GO:0040008]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp416237_c0_seq1;GAXK01045468.1;Q9UBL6;1.48E-08;CPNE7_HUMAN;Copine-7 (Copine VII);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]";"GO:0005215; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006629; GO:0046474; GO:0070062; GO:0071277";"cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; transporter activity [GO:0005215]"
comp4162502_c0_seq1;GAXK01201517.1;Q80SU7;9.21E-21;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp4165129_c0_seq1;GAXK01036549.1;Q8I6K0;5.20E-13;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4165197_c0_seq1;GAXK01036563.1;Q69Z37;1.28E-13;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp416525_c0_seq1;GAXK01045565.1;Q1RJR6;1.46E-08;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp41653_c0_seq1;GAXK01191918.1;Q8N567;4.10E-34;ZCHC9_HUMAN;Zinc finger CCHC domain-containing protein 9;"nucleolus [GO:0005730]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of phosphatase activity [GO:0010923]";"GO:0003723; GO:0005730; GO:0008270; GO:0010923";negative regulation of phosphatase activity [GO:0010923];nucleolus [GO:0005730];"RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp4165535_c0_seq1;GAXK01036553.1;Q71SG7;2.11E-12;GCNT4_DANRE;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0003829; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp416577_c1_seq1;GAXK01045568.1;Q9BQK8;4.97E-110;LPIN3_HUMAN;Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like);"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp416596_c1_seq1;GAXK01045414.1;P22792;2.44E-34;CPN2_HUMAN;Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit);"blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]";"GO:0005576; GO:0005615; GO:0030234; GO:0030449; GO:0031012; GO:0050821; GO:0070062; GO:0072562";"protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]";"blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";enzyme regulator activity [GO:0030234]
comp416607_c0_seq1;GAXK01045446.1;O93983;4.66E-12;EXG2_WICAO;Glucan 1,3-beta-glucosidase 2 (EC 3.2.1.58) (Exo-1,3-beta-glucanase 2);"extracellular region [GO:0005576]; glucan exo-1,3-beta-glucosidase activity [GO:0004338]; carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]";"GO:0004338; GO:0005576; GO:0005975; GO:0071555";"carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]";extracellular region [GO:0005576];glucan exo-1,3-beta-glucosidase activity [GO:0004338]
comp41664_c0_seq1;GAXK01192080.1;Q5F398;2.63E-153;MAEA_CHICK;E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Macrophage erythroblast attacher);"actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005826; GO:0005887; GO:0006511; GO:0007010; GO:0007049; GO:0007155; GO:0016363; GO:0016567; GO:0016740; GO:0033033; GO:0034657; GO:0043066; GO:0043161; GO:0043249; GO:0045721; GO:0046872; GO:0048822; GO:0051301";"cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]";"actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp4166846_c0_seq1;GAXK01123143.1;Q69Z37;2.04E-10;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp416754_c0_seq1;GAXK01045465.1;Q6P8Y1;8.63E-71;CAPSL_MOUSE;Calcyphosin-like protein;"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005737";;cytoplasm [GO:0005737];calcium ion binding [GO:0005509]
comp4167602_c0_seq1;GAXK01123138.1;Q10056;1.48E-15;SHK2_SCHPO;Serine/threonine-protein kinase shk2 (EC 2.7.11.1);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; MAPK cascade [GO:0000165]; plasma membrane fusion involved in cytogamy [GO:0032220]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000165; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0016477; GO:0023014; GO:0031098; GO:0032147; GO:0032220; GO:0043408; GO:0048365";"activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; MAPK cascade [GO:0000165]; plasma membrane fusion involved in cytogamy [GO:0032220]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]"
comp416761_c0_seq1;GAXK01205167.1;P83038;1.49E-154;HDAC4_CHICK;Histone deacetylase 4 (HD4) (EC 3.5.1.98);"actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]";"GO:0000118; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005829; GO:0006325; GO:0006338; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010832; GO:0010882; GO:0014894; GO:0017053; GO:0019901; GO:0030183; GO:0030955; GO:0031594; GO:0032041; GO:0033235; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045668; GO:0045820; GO:0045843; GO:0045892; GO:0045944; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070933; GO:1902894";"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]";"actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp416799_c0_seq1;GAXK01045495.1;Q39419;2.51E-10;POLC4_BETPN;Polcalcin Bet v 4 (Calcium-binding pollen allergen Bet v 4) (allergen Bet v 4);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4168_c0_seq1;GAXK01067188.1;Q24046;3.03E-44;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp416806_c0_seq1;GAXK01045470.1;B1A193;4.60E-09;RASFA_XENLA;Ras association domain-containing protein 10;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0050769; GO:2000179";"positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";
comp416876_c0_seq1;GAXK01045569.1;B4GVM9;4.71E-177;NAAT1_DROPE;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp416883_c0_seq1;GAXK01045557.1;Q8VHK2;1.17E-39;CSKI1_RAT;Caskin-1 (CASK-interacting protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0016020; GO:0019904";signal transduction [GO:0007165];"cytoplasm [GO:0005737]; membrane [GO:0016020]";protein domain specific binding [GO:0019904]
comp416885_c1_seq1;GAXK01045514.1;Q9VD09;1.44E-29;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp4168975_c0_seq1;GAXK01130460.1;P13612;1.86E-08;ITA4_HUMAN;Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; cellular response to cytokine stimulus [GO:0071345]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; regulation of immune response [GO:0050776]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0001968; GO:0003366; GO:0005886; GO:0005925; GO:0007159; GO:0007160; GO:0007229; GO:0009986; GO:0015026; GO:0016020; GO:0030183; GO:0030198; GO:0030426; GO:0032991; GO:0033631; GO:0034113; GO:0034446; GO:0034669; GO:0035987; GO:0043025; GO:0043113; GO:0046872; GO:0046982; GO:0050776; GO:0050839; GO:0050900; GO:0050901; GO:0050904; GO:0060385; GO:0070062; GO:0071345; GO:0090074; GO:0140039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406";"axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; cellular response to cytokine stimulus [GO:0071345]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; regulation of immune response [GO:0050776]; substrate adhesion-dependent cell spreading [GO:0034446]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]"
comp4169236_c0_seq1;GAXK01204877.1;P72065;1.55E-140;GYRA_MYCXE;DNA gyrase subunit A (EC 5.6.2.2) [Cleaved into: Mxe GyrA intein] (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; DNA topological change [GO:0006265]; intein-mediated protein splicing [GO:0016539]";"GO:0003677; GO:0003918; GO:0005524; GO:0005737; GO:0006265; GO:0016539";"DNA topological change [GO:0006265]; intein-mediated protein splicing [GO:0016539]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]"
comp4169351_c0_seq1;GAXK01130473.1;P73392;2.00E-14;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp41694_c0_seq1;GAXK01191542.1;Q9VED0;1.82E-165;TAPT1_DROME;Protein TAPT1 homolog;"ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; positive regulation of cilium assembly [GO:0045724]";"GO:0005783; GO:0030176; GO:0035437; GO:0036064; GO:0045724";"maintenance of protein localization in endoplasmic reticulum [GO:0035437]; positive regulation of cilium assembly [GO:0045724]";"ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp416944_c0_seq1;GAXK01045548.1;O05389;2.31E-58;YRBE_BACSU;Uncharacterized oxidoreductase YrbE (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]";"GO:0006740; GO:0016491";NADPH regeneration [GO:0006740];;oxidoreductase activity [GO:0016491]
comp4170450_c0_seq1;GAXK01137653.1;P23412;8.22E-28;PROF_TETPY;Profilin;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp4170687_c0_seq1;GAXK01137645.1;Q8R151;2.34E-17;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp417134_c1_seq1;GAXK01045479.1;Q7KRI2;3.90E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp41714_c1_seq1;GAXK01191844.1;Q9JMC3;1.82E-119;DNJA4_MOUSE;DnaJ homolog subfamily A member 4 (MmDjA4);"cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"GO:0005524; GO:0005829; GO:0009408; GO:0010596; GO:0010628; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0090084";"negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"cytosol [GO:0005829]; membrane [GO:0016020]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp41720_c1_seq1;GAXK01191672.1;Q0VC91;1.25E-67;SOCS4_BOVIN;Suppressor of cytokine signaling 4 (SOCS-4);"intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"GO:0007175; GO:0016567; GO:0032436; GO:0035556; GO:0040008";"intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";;
comp41721_c2_seq1;GAXK01192025.1;Q9ULZ9;1.95E-12;MMP17_HUMAN;Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]";"GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0042756; GO:0070006";"collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp417353_c2_seq1;GAXK01045434.1;Q08CL3;5.52E-07;KBTB8_DANRE;Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP);"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"GO:0005794; GO:0005819; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463";"neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]";
comp41740_c0_seq1;GAXK01191869.1;Q6P0D5;1.52E-34;WBP11_DANRE;WW domain-binding protein 11 (WBP-11);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA cis splicing, via spliceosome [GO:0045292]; rRNA processing [GO:0006364]";"GO:0005634; GO:0005737; GO:0006364; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp417405_c0_seq1;GAXK01045456.1;Q86UP9;1.52E-33;LHPL3_HUMAN;LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp41747_c0_seq1;GAXK01191953.1;O75689;1.98E-106;ADAP1_HUMAN;Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087]";"GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0043087; GO:0043533; GO:0046872; GO:1902936";"cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol bisphosphate binding [GO:1902936]"
comp417489_c0_seq1;GAXK01045449.1;O76360;1.02E-108;EGL4_CAEEL;cGMP-dependent protein kinase egl-4 (EC 2.7.11.12) (Egg-laying defective protein 4);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0004691; GO:0004692; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0006935; GO:0007165; GO:0007635; GO:0008286; GO:0008340; GO:0008355; GO:0010468; GO:0010753; GO:0010754; GO:0018105; GO:0030308; GO:0030431; GO:0030512; GO:0030536; GO:0030553; GO:0040014; GO:0040015; GO:0042542; GO:0043577; GO:0046621; GO:0046662; GO:0046872; GO:0050849; GO:0050913; GO:0050921; GO:0051343; GO:0061067; GO:0070482; GO:1901046; GO:1902160; GO:1903998; GO:1905959; GO:1990335; GO:1990834";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; chemotropism [GO:0043577]; determination of adult lifespan [GO:0008340]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of cell growth [GO:0030308]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cyclic nucleotide-gated ion channel activity [GO:1902160]; negative regulation of dauer larval development [GO:0061067]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular response to alcohol [GO:1905959]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of oviposition [GO:1901046]; process resulting in tolerance to alcohol [GO:1990335]; protein phosphorylation [GO:0006468]; regulation of eating behavior [GO:1903998]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of oviposition [GO:0046662]; response to hydrogen peroxide [GO:0042542]; response to odorant [GO:1990834]; response to oxygen levels [GO:0070482]; sensory perception of bitter taste [GO:0050913]; signal transduction [GO:0007165]; sleep [GO:0030431]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]"
comp4174925_c0_seq1;GAXK01139581.1;Q867Z4;3.49E-19;LOLA4_DROME;Longitudinals lacking protein, isoforms F/I/K/T;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0010468; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813; GO:1902667";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp41754_c0_seq1;GAXK01192124.1;P42284;4.14E-38;LOLA2_DROME;Longitudinals lacking protein, isoforms H/M/V;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";DNA-binding transcription factor activity [GO:0003700]
comp4176_c0_seq1;GAXK01066042.1;Q8L7K9;4.60E-162;MAO2_ARATH;NAD-dependent malic enzyme 2, mitochondrial (AtNAD-ME2) (NAD-malic enzyme 2) (EC 1.1.1.39);"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"GO:0004470; GO:0004471; GO:0005524; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008270; GO:0009507; GO:0042803; GO:0050897; GO:0051287";"malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp41763_c0_seq1;GAXK01192192.1;Q9BWQ8;5.21E-55;LFG2_HUMAN;Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35) (Transmembrane BAX inhibitor motif-containing protein 2);"cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]";"GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0030054; GO:0043066; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042";"apoptotic process [GO:0006915]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]";"cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]";
comp417683_c0_seq1;GAXK01045472.1;Q7KRI2;1.59E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp417795_c0_seq1;GAXK01045513.1;Q3U2J5;4.42E-43;CMKMT_MOUSE;Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]; mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]";"GO:0005634; GO:0005737; GO:0005794; GO:0007005; GO:0018022; GO:0018025; GO:0031072; GO:0032991";"mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]"
comp4178090_c0_seq1;GAXK01120870.1;Q20CR3;1.31E-19;RHCG_MACMU;Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]; ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]; cellular ion homeostasis [GO:0006873]; transepithelial ammonium transport [GO:0070634]";"GO:0005887; GO:0006873; GO:0008519; GO:0015696; GO:0016323; GO:0016324; GO:0030506; GO:0031410; GO:0070634; GO:0072488";"ammonium transmembrane transport [GO:0072488]; ammonium transport [GO:0015696]; cellular ion homeostasis [GO:0006873]; transepithelial ammonium transport [GO:0070634]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]";"ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]"
comp417826_c1_seq1;GAXK01045412.1;G5EBU4;3.42E-49;ZAG1_CAEEL;Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";"GO:0000122; GO:0005634; GO:0007411; GO:0043565; GO:0045773; GO:0046872";"axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp41788_c3_seq1;GAXK01191571.1;Q8VCC1;6.88E-38;PGDH_MOUSE;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]"
comp41789_c2_seq1;GAXK01192020.1;P21902;2.54E-54;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp41795_c0_seq1;GAXK01192141.1;P49010;2.10E-144;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp4179947_c0_seq1;GAXK01120865.1;Q95SX7;4.53E-07;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp418050_c0_seq1;GAXK01040609.1;B1LLJ9;5.26E-24;RHMA_ECOSM;2-keto-3-deoxy-L-rhamnonate aldolase (KDR aldolase) (EC 4.1.2.53) (2-dehydro-3-deoxyrhamnonate aldolase);"2-keto-3-deoxy-L-rhamnonate aldolase activity [GO:0106099]; magnesium ion binding [GO:0000287]";"GO:0000287; GO:0106099";;;"2-keto-3-deoxy-L-rhamnonate aldolase activity [GO:0106099]; magnesium ion binding [GO:0000287]"
comp418065_c0_seq1;GAXK01040556.1;O61491;9.31E-73;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp4180780_c0_seq1;GAXK01104276.1;P45443;3.59E-08;DYHC_NEUCR;Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC) (Ropy-1);"cell cortex [GO:0005938]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]";"GO:0000278; GO:0005524; GO:0005868; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008569; GO:0030286; GO:0031122; GO:0045503; GO:0045505; GO:0051293; GO:0051959; GO:0072382";"cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]";"cell cortex [GO:0005938]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp418177_c1_seq1;GAXK01040663.1;P35502;5.58E-45;ESTF_MYZPE;Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp4181937_c0_seq1;GAXK01104273.1;Q6SA95;9.33E-12;FA9_FELCA;"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638";"blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp4184538_c0_seq1;GAXK01194026.1;Q6BM25;2.02E-09;SSN3_DEBHA;Serine/threonine-protein kinase SSN3 (EC 2.7.11.22) (EC 2.7.11.23) (Cyclin-dependent kinase 8);"mediator complex [GO:0016592]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; negative regulation of filamentous growth [GO:0060258]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; protein destabilization [GO:0031648]";"GO:0000122; GO:0000435; GO:0004693; GO:0005524; GO:0008353; GO:0016592; GO:0031648; GO:0046872; GO:0060258; GO:0070481; GO:0070816";"negative regulation of filamentous growth [GO:0060258]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; protein destabilization [GO:0031648]";mediator complex [GO:0016592];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp418483_c1_seq1;GAXK01040590.1;O88879;3.55E-94;APAF_MOUSE;Apoptotic protease-activating factor 1 (APAF-1);"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; brain development [GO:0007420]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; multicellular organism development [GO:0007275]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein homooligomerization [GO:0051260]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]";"GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006919; GO:0007275; GO:0007420; GO:0007568; GO:0007584; GO:0008635; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0042802; GO:0043293; GO:0043531; GO:0051260; GO:0051402; GO:0070059; GO:0071560; GO:1902510; GO:2001235";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; brain development [GO:0007420]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; multicellular organism development [GO:0007275]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein homooligomerization [GO:0051260]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]";"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]"
comp418505_c1_seq1;GAXK01040547.1;P05661;2.42E-41;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp4185481_c0_seq1;GAXK01194033.1;Q9DE06;1.30E-19;STAR_SALFO;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0006694; GO:0008203; GO:0015485; GO:0120020";"cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694]";mitochondrion [GO:0005739];"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp41858_c12_seq1;GAXK01191807.1;Q9BWX1;5.19E-41;PHF7_HUMAN;PHD finger protein 7 (Testis development protein NYD-SP6);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872";;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp41875_c0_seq1;GAXK01192017.1;Q7PMT1;1.65E-130;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp4189261_c0_seq1;GAXK01059558.1;P22411;1.19E-31;DPP4_PIG;"Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]; T cell costimulation [GO:0031295]";"GO:0002020; GO:0004252; GO:0005102; GO:0005576; GO:0007155; GO:0008239; GO:0008284; GO:0009986; GO:0010716; GO:0016021; GO:0016324; GO:0030027; GO:0030054; GO:0030139; GO:0031258; GO:0031295; GO:0042803; GO:0043542; GO:0045121; GO:0071438";"cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]; T cell costimulation [GO:0031295]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]";"dipeptidyl-peptidase activity [GO:0008239]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]"
comp418939_c0_seq1;GAXK01040701.1;Q9NPF2;8.86E-07;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp418947_c0_seq1;GAXK01040674.1;P51522;5.09E-39;ZNF83_HUMAN;Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4189774_c0_seq1;GAXK01059556.1;Q5ZKQ3;2.04E-23;RPAP3_CHICK;RNA polymerase II-associated protein 3;;;;;
comp4189795_c0_seq1;GAXK01059564.1;P15619;1.22E-10;SRYC_DROME;Serendipity locus protein H-1 (Protein pourquoi-pas) (Protein wings-down);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp419010_c0_seq1;GAXK01040574.1;P31696;2.66E-45;AGRIN_CHICK;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"GO:0002162; GO:0004867; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007275; GO:0007399; GO:0007417; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030054; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978; GO:1902572";"actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]"
comp4190124_c0_seq1;GAXK01062439.1;A9WFT9;4.74E-102;PDXS_CHLAA;Pyridoxal 5'-phosphate synthase subunit PdxS (PLP synthase subunit PdxS) (EC 4.3.3.6) (Pdx1);"amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; cellular amino acid metabolic process [GO:0006520]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";"GO:0006520; GO:0008615; GO:0016843; GO:0036381; GO:0042823";"cellular amino acid metabolic process [GO:0006520]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]";;"amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]"
comp4190812_c0_seq1;GAXK01062427.1;Q96PH1;2.51E-10;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp4190850_c0_seq1;GAXK01062431.1;Q94HW2;1.84E-27;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp419109_c0_seq1;GAXK01040699.1;P70338;3.08E-08;GFI1_MOUSE;Zinc finger protein Gfi-1 (Growth factor independent protein 1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell fate specification [GO:0009996]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0007638; GO:0009996; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0042472; GO:0042491; GO:0042660; GO:0044212; GO:0045165; GO:0045892; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell fate specification [GO:0009996]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp4193074_c0_seq1;GAXK01118519.1;Q7JVE7;2.53E-27;SWET1_DROME;Sugar transporter SWEET1 (Protein saliva);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"GO:0000139; GO:0005886; GO:0007431; GO:0008643; GO:0016021; GO:0051119";"carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sugar transmembrane transporter activity [GO:0051119]
comp419332_c2_seq1;GAXK01040694.1;A1YG60;9.51E-16;ZKSC8_PANPA;Zinc finger protein with KRAB and SCAN domains 8 (Zinc finger protein 192);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4193534_c0_seq1;GAXK01118510.1;P36609;4.81E-27;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4193668_c0_seq1;GAXK01118534.1;P47840;8.90E-15;RS12_XENLA;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp41937_c0_seq1;GAXK01192004.1;Q8CFY5;9.58E-75;COX10_MOUSE;Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase);"cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme a biosynthetic process [GO:0006784]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]";"GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069";"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme a biosynthetic process [GO:0006784]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]";"cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]"
comp419393_c0_seq1;GAXK01040570.1;O54963;2.29E-15;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4194961_c0_seq1;GAXK01172420.1;Q9SJM7;2.41E-12;URH1_ARATH;Uridine nucleosidase 1 (EC 3.2.2.3) (Uridine ribohydrolase 1);"cytosol [GO:0005829]; adenosine nucleosidase activity [GO:0047622]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585]; purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218]";"GO:0005829; GO:0006152; GO:0006218; GO:0008477; GO:0045437; GO:0047622; GO:0047724; GO:0072585";"purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218]";cytosol [GO:0005829];"adenosine nucleosidase activity [GO:0047622]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585]"
comp419525_c0_seq1;GAXK01040680.1;P52746;1.63E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4195700_c0_seq1;GAXK01172413.1;Q5R5U3;5.38E-11;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4196339_c0_seq1;GAXK01181954.1;P10394;1.92E-14;POL4_DROME;"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4196516_c0_seq1;GAXK01181966.1;E9NA96;1.01E-14;IR25A_DROME;Ionotropic receptor 25a;"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]; AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"GO:0004971; GO:0005886; GO:0005929; GO:0007610; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0032281; GO:0043204; GO:0048511; GO:0050907; GO:0050911; GO:0071683";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]";"AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]"
comp4196990_c0_seq1;GAXK01181970.1;P35381;1.95E-52;ATPA_DROME;ATP synthase subunit alpha, mitochondrial (Protein bellwether);"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0000275; GO:0005524; GO:0005739; GO:0015986; GO:0019915; GO:0022900; GO:0043531; GO:0046933; GO:1902769";"ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp41974_c0_seq1;GAXK01192128.1;O70237;2.93E-15;GFI1B_MOUSE;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"GO:0000122; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0007275; GO:0016363; GO:0030854; GO:0045646; GO:0046872; GO:0051572; GO:0051574";"multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp4197537_c0_seq1;GAXK01181962.1;P83774;3.18E-69;GBLP_CANAL;Guanine nucleotide-binding protein subunit beta-like protein (Cytoplasmic antigenic protein 1);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; GDP-dissociation inhibitor activity [GO:0005092]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; cell adhesion [GO:0007155]; cellular response to neutral pH [GO:0036244]; cellular response to starvation [GO:0009267]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; G protein-coupled receptor signaling pathway [GO:0007186]; invasive growth in response to glucose limitation [GO:0001403]; pathogenesis [GO:0009405]; positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]";"GO:0001403; GO:0001934; GO:0005080; GO:0005092; GO:0005634; GO:0005829; GO:0007155; GO:0007186; GO:0009267; GO:0009405; GO:0019899; GO:0022627; GO:0030447; GO:0036170; GO:0036178; GO:0036180; GO:0036244; GO:0043022; GO:0072344";"cell adhesion [GO:0007155]; cellular response to neutral pH [GO:0036244]; cellular response to starvation [GO:0009267]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; G protein-coupled receptor signaling pathway [GO:0007186]; invasive growth in response to glucose limitation [GO:0001403]; pathogenesis [GO:0009405]; positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; GDP-dissociation inhibitor activity [GO:0005092]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp419788_c3_seq1;GAXK01040548.1;Q80W31;2.58E-14;ZN569_MOUSE;Zinc finger protein 569 (Mszf21) (Zinc finger protein 74) (Zfp-74);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4198172_c0_seq1;GAXK01057685.1;Q8VIG1;5.93E-12;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4199181_c0_seq1;GAXK01057687.1;Q8R1B0;6.23E-07;STAC2_MOUSE;SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005829; GO:0031234; GO:0035556; GO:0042383; GO:0046872; GO:1901387; GO:1903078";"intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]";metal ion binding [GO:0046872]
comp41994_c2_seq1;GAXK01191496.1;P51610;0;HCFC1_HUMAN;"Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]";"GO:0000122; GO:0000123; GO:0000980; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0048188; GO:0050821; GO:0071339; GO:0071407";"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]";"activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]"
comp419953_c0_seq1;GAXK01040687.1;O43345;2.06E-20;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp4199967_c0_seq1;GAXK01057681.1;P89116;2.16E-41;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp42_c1_seq1;GAXK01169202.1;Q2YGT9;8.56E-69;RL6_PIG;60S ribosomal protein L6;"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0014069; GO:0015934; GO:0022625; GO:0036464; GO:0042788; GO:0098556";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp420_c0_seq1;GAXK01166348.1;Q9D0F3;1.16E-120;LMAN1_MOUSE;Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1) (p58);"collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; sarcomere [GO:0030017]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of organelle organization [GO:0010638]; protein transport [GO:0015031]";"GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0010638; GO:0015031; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0042802; GO:0043231; GO:0044220; GO:0046872; GO:0062023";"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of organelle organization [GO:0010638]; protein transport [GO:0015031]";"collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; sarcomere [GO:0030017]";"identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp420004_c0_seq1;GAXK01089559.1;Q94900;1.65E-23;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp420024_c0_seq1;GAXK01089618.1;Q925T0;9.41E-32;DJC12_RAT;DnaJ homolog subfamily C member 12 (J domain-containing protein 1);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp4200443_c0_seq1;GAXK01008723.1;Q9VFP2;6.99E-10;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp420118_c1_seq1;GAXK01089643.1;Q5R5B6;3.53E-131;PDIA1_PONAB;Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0005886; GO:0042470; GO:0045454; GO:0046982";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]";"protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]"
comp4201216_c0_seq1;GAXK01008716.1;Q9Y257;6.69E-07;KCNK6_HUMAN;Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion leak channel activity [GO:0022841]; cardiac conduction [GO:0061337]; negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322]";"GO:0003085; GO:0005242; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0022841; GO:0030322; GO:0034765; GO:0060075; GO:0061337; GO:0071805";"cardiac conduction [GO:0061337]; negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"inward rectifier potassium channel activity [GO:0005242]; potassium ion leak channel activity [GO:0022841]"
comp4201427_c0_seq1;GAXK01008719.1;P48157;2.05E-57;RL11_LEIMA;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4201940_c0_seq1;GAXK01008730.1;O35626;7.63E-09;RASD1_MOUSE;Dexamethasone-induced Ras-related protein 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007263; GO:0016529; GO:0045892; GO:0048471";"negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp42023_c0_seq1;GAXK01147221.1;P57722;2.33E-94;PCBP3_MOUSE;Poly(rC)-binding protein 3 (Alpha-CP3);"cytoplasm [GO:0005737]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001227; GO:0003690; GO:0003723; GO:0005737; GO:1990829";negative regulation of transcription by RNA polymerase II [GO:0000122];cytoplasm [GO:0005737];"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp4202389_c0_seq1;GAXK01009802.1;Q9LHA8;4.26E-42;MD37C_ARATH;Probable mediator of RNA polymerase II transcription subunit 37c (Heat shock 70 kDa protein 4) (Heat shock cognate 70 kDa protein 4) (Heat shock cognate protein 70-4) (AtHsc70-4) (Heat shock protein 70-4) (AtHsp70-4);"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]";"GO:0005524; GO:0005618; GO:0005634; GO:0005737; GO:0005739; GO:0005774; GO:0005794; GO:0005829; GO:0005886; GO:0006986; GO:0009266; GO:0009408; GO:0009615; GO:0009617; GO:0016567; GO:0016887; GO:0031072; GO:0031625; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0046686; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]";"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp4202817_c0_seq1;GAXK01009807.1;Q14526;8.84E-16;HIC1_HUMAN;Hypermethylated in cancer 1 protein (Hic-1) (Zinc finger and BTB domain-containing protein 29);"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000785; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006974; GO:0007275; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp42036_c1_seq1;GAXK01147523.1;Q969G6;3.88E-50;RIFK_HUMAN;Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771]";"GO:0005524; GO:0005737; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072593";"apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]"
comp420426_c0_seq1;GAXK01089571.1;Q5GIT4;1.66E-39;VGFR2_DANRE;Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B);"cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0001525; GO:0001568; GO:0002040; GO:0004714; GO:0005021; GO:0005524; GO:0005634; GO:0005769; GO:0005783; GO:0005887; GO:0007169; GO:0008284; GO:0014068; GO:0016477; GO:0030054; GO:0035924; GO:0038085; GO:0043235; GO:0043410; GO:0045446; GO:0045766; GO:0048010; GO:0070374";"angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]"
comp4204410_c0_seq1;GAXK01056415.1;O57592;1.62E-26;RL7A_TAKRU;60S ribosomal protein L7a (Surfeit locus protein 3);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp4204413_c0_seq1;GAXK01056428.1;Q5T7P8;1.32E-08;SYT6_HUMAN;Synaptotagmin-6 (Synaptotagmin VI) (SytVI);"cell junction [GO:0030054]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic membrane [GO:0099699]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030054; GO:0030276; GO:0030672; GO:0042803; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0098978; GO:0099525; GO:0099699";"acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic membrane [GO:0099699]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp42046_c0_seq1;GAXK01147522.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp42050_c1_seq1;GAXK01147562.1;A8E657;0;AASS_BOVIN;"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]";"GO:0004753; GO:0005737; GO:0005739; GO:0033512; GO:0047130; GO:0047131";L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512];"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]"
comp4205048_c0_seq1;GAXK01056412.1;P54116;3.08E-43;STOM_MOUSE;Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005737; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0034765; GO:0042470; GO:0042802; GO:0042803; GO:0044829; GO:0045121; GO:0048471; GO:0048524; GO:0051260; GO:0070063; GO:0090314; GO:1901585";"positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of ion transmembrane transport [GO:0034765]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]"
comp420594_c1_seq1;GAXK01089640.1;A0A286LEZ8;2.63E-32;PSID_PSICY;L-tryptophan decarboxylase (EC 4.1.1.105) (Psilocybin biosynthesis decarboxylase);"phosphatidylserine decarboxylase activity [GO:0004609]; phospholipid biosynthetic process [GO:0008654]";"GO:0004609; GO:0008654";phospholipid biosynthetic process [GO:0008654];;phosphatidylserine decarboxylase activity [GO:0004609]
comp42061_c0_seq1;GAXK01147375.1;P00528;0;SRC64_DROME;Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000185; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0018108; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0031234; GO:0034332; GO:0036058; GO:0038083; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176";"actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]"
comp420648_c0_seq1;GAXK01089622.1;P55200;7.35E-07;KMT2A_MOUSE;"Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]";"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; cognition [GO:0050890]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA methylation [GO:1905642]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; visual learning [GO:0008542]";"GO:0000980; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0008270; GO:0008285; GO:0008542; GO:0009416; GO:0009791; GO:0009952; GO:0010468; GO:0018026; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044212; GO:0044648; GO:0045322; GO:0045893; GO:0045944; GO:0048172; GO:0048536; GO:0048873; GO:0050890; GO:0051568; GO:0051569; GO:0051571; GO:0051899; GO:0060216; GO:0065003; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:1901674; GO:1905642; GO:2000615; GO:2001040";"anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; cognition [GO:0050890]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA methylation [GO:1905642]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; visual learning [GO:0008542]";"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]"
comp42065_c1_seq1;GAXK01147096.1;Q9V427;3.39E-89;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp42066_c0_seq1;GAXK01147711.1;Q7T0X5;3.75E-33;CHMP7_XENLA;Charged multivesicular body protein 7 (Chromatin-modifying protein 7);"ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]";"GO:0000815; GO:0005635; GO:0010458; GO:0015031; GO:0031468; GO:0045324";"exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]";"ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]";
comp42069_c3_seq1;GAXK01147371.1;O70239;7.68E-28;AXIN1_RAT;Axin-1 (Axis inhibition protein 1) (rAxin);"beta-catenin destruction complex [GO:0030877]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein homooligomerization [GO:0051260]; Wnt signaling pathway [GO:0016055]";"GO:0005102; GO:0005634; GO:0005886; GO:0006915; GO:0007275; GO:0008013; GO:0014069; GO:0016055; GO:0019901; GO:0019904; GO:0030178; GO:0030877; GO:0031410; GO:0042802; GO:0042803; GO:0045860; GO:0046330; GO:0051260; GO:0070016; GO:0090090; GO:2000060";"apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein homooligomerization [GO:0051260]; Wnt signaling pathway [GO:0016055]";"beta-catenin destruction complex [GO:0030877]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]"
comp42073_c0_seq1;GAXK01147205.1;Q5BL35;2.10E-08;SPOLA_DANRE;Speckle-type POZ protein-like A (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp420749_c2_seq1;GAXK01089542.1;Q6EEF3;5.81E-174;TTLL5_CHLAE;Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (SRC1 and TIF2-associated modulatory protein) (Tubulin--tyrosine ligase-like protein 5);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; cellular protein modification process [GO:0006464]";"GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0006464; GO:0016874";cellular protein modification process [GO:0006464];"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp42076_c0_seq1;GAXK01147586.1;Q66S03;3.06E-23;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp420800_c2_seq1;GAXK01089625.1;A8Y1P7;8.36E-71;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp420875_c0_seq1;GAXK01089583.1;P42282;6.21E-12;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp42088_c0_seq1;GAXK01147118.1;Q8KU07;5.88E-17;AZOB_XENAZ;NAD(P)H azoreductase (EC 1.7.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp420919_c0_seq1;GAXK01089548.1;W4VSJ0;4.83E-49;ACES_TRILK;Acetylcholinesterase-1 (AChE) (EC 3.1.1.7);"extracellular region [GO:0005576]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0042135";neurotransmitter catabolic process [GO:0042135];extracellular region [GO:0005576];acetylcholinesterase activity [GO:0003990]
comp42093_c1_seq1;GAXK01147597.1;Q5T4T1;1.10E-14;T170B_HUMAN;Transmembrane protein 170B;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]";"GO:0005886; GO:0016021; GO:0016055; GO:0090090";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4209357_c0_seq1;GAXK01115758.1;Q5R5Q6;1.87E-07;ZN571_PONAB;Zinc finger protein 571;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp421015_c0_seq1;GAXK01089558.1;P21589;2.39E-120;5NTD_HUMAN;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; AMP catabolic process [GO:0006196]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; NAD metabolic process [GO:0019674]; negative regulation of inflammatory response [GO:0050728]; purine nucleotide catabolic process [GO:0006195]; pyrimidine nucleoside catabolic process [GO:0046135]";"GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006195; GO:0006196; GO:0006259; GO:0007159; GO:0008253; GO:0009986; GO:0016020; GO:0019674; GO:0031225; GO:0046086; GO:0046135; GO:0046872; GO:0050728; GO:0070062";"adenosine biosynthetic process [GO:0046086]; AMP catabolic process [GO:0006196]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; NAD metabolic process [GO:0019674]; negative regulation of inflammatory response [GO:0050728]; purine nucleotide catabolic process [GO:0006195]; pyrimidine nucleoside catabolic process [GO:0046135]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp421018_c0_seq1;GAXK01089606.1;Q9R044;1.19E-22;NPHN_RAT;Nephrin (Renal glomerulus-specific cell adhesion receptor);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"GO:0003094; GO:0005886; GO:0007155; GO:0007517; GO:0016020; GO:0016021; GO:0019904; GO:0030507; GO:0032991; GO:0036057; GO:0045121; GO:0051393";"cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; muscle organ development [GO:0007517]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]";"alpha-actinin binding [GO:0051393]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]"
comp4211228_c0_seq1;GAXK01136024.1;Q9HFY6;4.11E-36;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4212664_c0_seq1;GAXK01001912.1;P24288;1.77E-106;BCAT1_MOUSE;Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid catabolic process [GO:0009083]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"GO:0004084; GO:0005737; GO:0005739; GO:0005829; GO:0009083; GO:0009098; GO:0009099; GO:0042802; GO:0052654; GO:0052655; GO:0052656";"branched-chain amino acid catabolic process [GO:0009083]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]"
comp42138_c1_seq1;GAXK01147706.1;Q3SYU3;9.56E-48;S39A1_BOVIN;Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]";"GO:0001701; GO:0005385; GO:0005886; GO:0016021; GO:0048701; GO:0060173; GO:0071577";"embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp42144_c0_seq1;GAXK01147475.1;Q9UJA5;1.58E-40;TRM6_HUMAN;tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]";"GO:0003723; GO:0005634; GO:0005654; GO:0006400; GO:0030488; GO:0031515; GO:0080009";"mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]";RNA binding [GO:0003723]
comp4214467_c0_seq1;GAXK01082529.1;Q6INU2;2.64E-12;BSC1A_XENLA;BSD domain-containing protein 1-A;;;;;
comp4215_c0_seq1;GAXK01065675.1;P13607;2.44E-154;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp4215033_c0_seq1;GAXK01082512.1;Q14593;1.42E-09;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp42154_c1_seq1;GAXK01147157.1;Q8C3S2;8.84E-79;TNG6_MOUSE;Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7);"integral component of membrane [GO:0016021]; protein secretion [GO:0009306]";"GO:0009306; GO:0016021";protein secretion [GO:0009306];integral component of membrane [GO:0016021];
comp421541_c2_seq1;GAXK01089528.1;Q9NVV4;1.09E-26;PAPD1_HUMAN;Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP);"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]";"GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005739; GO:0006378; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044";"histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]";"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]"
comp421570_c1_seq1;GAXK01089624.1;B7Z6K7;2.41E-16;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4215974_c0_seq1;GAXK01082519.1;Q96MT7;2.31E-29;CFA44_HUMAN;Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52);"axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288]";"GO:0005930; GO:0007288; GO:0031514; GO:0060271; GO:0060285";"cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288]";"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp421607_c0_seq1;GAXK01089620.1;Q9UPZ6;1.13E-177;THS7A_HUMAN;Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form];"cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]";"GO:0001525; GO:0005576; GO:0005886; GO:0016021; GO:0030154; GO:0031532; GO:0042995";"actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]";"cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp42162_c1_seq1;GAXK01147965.1;A4QN59;8.31E-112;DPH2_DANRE;2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (EC 2.5.1.108) (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2);"transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]";"GO:0016740; GO:0017183";peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183];;transferase activity [GO:0016740]
comp421701_c0_seq1;GAXK01089595.1;P22770;5.85E-63;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp421704_c0_seq1;GAXK01089644.1;Q9CWP6;1.38E-53;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp4217269_c0_seq1;GAXK01001897.1;Q05319;1.62E-15;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp4217274_c0_seq1;GAXK01001902.1;Q9CXE0;4.78E-12;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp42173_c0_seq1;GAXK01147739.1;Q8BNI4;3.01E-114;DERL2_MOUSE;Derlin-2 (Degradation in endoplasmic reticulum protein 2) (Der1-like protein 2) (F-LANa);"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; signal recognition particle [GO:0048500]; signal recognition particle receptor complex [GO:0005785]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005785; GO:0008284; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0048500; GO:0051787; GO:1904153; GO:1990381";"endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; signal recognition particle [GO:0048500]; signal recognition particle receptor complex [GO:0005785]";"misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]"
comp421754_c0_seq1;GAXK01089611.1;Q93HT9;8.63E-13;IABN_GEOTD;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp421843_c0_seq1;GAXK01089610.1;Q9VD09;5.95E-39;PINTA_DROME;Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent);"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";"GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841";"phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]";;"retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]"
comp4218692_c0_seq1;GAXK01088673.1;Q8NBH2;1.36E-22;KY_HUMAN;Kyphoscoliosis peptidase (EC 3.4.-.-);"cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]";"GO:0005856; GO:0008233; GO:0030018";;"cytoskeleton [GO:0005856]; Z disc [GO:0030018]";peptidase activity [GO:0008233]
comp4219046_c0_seq1;GAXK01088683.1;Q9D4B2;3.98E-18;TTC25_MOUSE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp421964_c0_seq1;GAXK01089588.1;Q8H5F8;1.12E-19;ADPRM_ORYSJ;Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase);"ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; metal ion binding [GO:0046872]";"GO:0046872; GO:0047631; GO:0047734";;;"ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; metal ion binding [GO:0046872]"
comp4219906_c0_seq1;GAXK01088680.1;Q16696;7.61E-17;CP2AD_HUMAN;Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0009804; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp422_c0_seq1;GAXK01168988.1;Q9XZ71;7.83E-67;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp42200_c0_seq1;GAXK01147194.1;Q0VA36;1.82E-21;ODR4_XENTR;Protein odr-4 homolog;"integral component of membrane [GO:0016021]; protein localization [GO:0008104]";"GO:0008104; GO:0016021";protein localization [GO:0008104];integral component of membrane [GO:0016021];
comp4220381_c0_seq1;GAXK01133559.1;Q8NDA2;5.00E-10;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp4221_c0_seq1;GAXK01065820.1;Q8BK35;3.74E-27;NOP53_MOUSE;Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0014067; GO:0031333; GO:0032435; GO:0032436; GO:0033553; GO:0039535; GO:0042802; GO:0042981; GO:0043231; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]";"5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]"
comp42215_c0_seq1;GAXK01147312.1;Q8WR63;5.67E-47;TPM_TRIPS;Tropomyosin;;;;;
comp422167_c4_seq1;GAXK01016954.1;Q9V3Z2;1.46E-36;SER7_DROME;Serine protease 7 (EC 3.4.21.-) (Melanization protease 2);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0035006; GO:0035008; GO:0046872";"melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp422186_c0_seq1;GAXK01016979.1;Q9Y303;2.13E-155;NAGA_HUMAN;N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25) (Amidohydrolase domain-containing protein 2);"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0005634; GO:0005829; GO:0005975; GO:0006046; GO:0006048; GO:0008448; GO:0019262; GO:0046872; GO:0047419";"carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]"
comp4222110_c0_seq1;GAXK01090164.1;Q803E0;7.09E-08;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp42239_c0_seq1;GAXK01147688.1;Q6NYW6;0;CLAP2_DANRE;CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2);"cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; trans-Golgi network [GO:0005802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0000777; GO:0005794; GO:0005802; GO:0005815; GO:0005819; GO:0005874; GO:0005881; GO:0007020; GO:0007030; GO:0007052; GO:0008017; GO:0010458; GO:0031023; GO:0031110; GO:0031252; GO:0032587; GO:0032886; GO:0034453; GO:0051010; GO:0051301";"cell division [GO:0051301]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule polymerization or depolymerization [GO:0031110]";"cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; trans-Golgi network [GO:0005802]";"microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]"
comp422419_c1_seq1;GAXK01016921.1;O75467;3.56E-18;Z324A_HUMAN;Zinc finger protein 324A (Zinc finger protein ZF5128);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp422513_c0_seq1;GAXK01016903.1;P85831;2.46E-87;PROH4_APIME;"Prohormone-4 [Cleaved into: Brain peptide IDLSRFYGHFNT; Brain peptide IDLSRFYGHFN; Brain peptide IDLSRFYGHF; Brain peptide DLSRFYGHFNT; Brain peptide DLSRFYGHFN; Brain peptide DLSRFYGHF]";extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp422592_c0_seq1;GAXK01016902.1;P06601;3.55E-111;PRD_DROME;Segmentation protein paired;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0006366; GO:0007366; GO:0045944";"periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4226469_c0_seq1;GAXK01110162.1;Q6AYT7;4.59E-20;ABD12_RAT;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0047372; GO:0050727; GO:0052651";"acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]"
comp4226836_c0_seq1;GAXK01110155.1;C7J0A2;3.02E-11;TOP3A_ORYSJ;DNA topoisomerase 3-alpha (EC 5.6.2.1);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; DNA topological change [GO:0006265]";"GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0006265; GO:0008270";DNA topological change [GO:0006265];"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]"
comp422719_c3_seq1;GAXK01016940.1;Q9W747;1.36E-13;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4227818_c0_seq1;GAXK01110156.1;Q66K89;8.16E-09;E4F1_HUMAN;Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transferase activity [GO:0016740]; cell division [GO:0051301]; DNA replication [GO:0006260]; mitotic cell cycle arrest [GO:0071850]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; viral process [GO:0016032]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0009794; GO:0010564; GO:0016032; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0046872; GO:0051301; GO:0071850";"cell division [GO:0051301]; DNA replication [GO:0006260]; mitotic cell cycle arrest [GO:0071850]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]";"cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transferase activity [GO:0016740]"
comp422799_c0_seq1;GAXK01016963.1;P21461;7.56E-13;SINA_DROME;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007465; GO:0007601; GO:0008270; GO:0010498; GO:0031624; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676; GO:0061630";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; R7 cell fate commitment [GO:0007465]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp42280_c2_seq1;GAXK01147747.1;O75355;1.92E-49;ENTP3_HUMAN;Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143]";"GO:0005524; GO:0005886; GO:0009134; GO:0009143; GO:0016021; GO:0017110; GO:0017111; GO:0034656; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491";"nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]"
comp422838_c0_seq1;GAXK01016847.1;Q9W0Y2;6.11E-34;YS11_DROME;Putative gamma-glutamylcyclotransferase CG2811 (EC 2.3.2.-);"gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity, transferring acyl groups [GO:0016746]; cellular modified amino acid catabolic process [GO:0042219]";"GO:0016746; GO:0042219; GO:0061929";cellular modified amino acid catabolic process [GO:0042219];;"gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity, transferring acyl groups [GO:0016746]"
comp422855_c1_seq1;GAXK01016938.1;Q9CZR2;1.06E-156;NALD2_MOUSE;N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]";"GO:0004180; GO:0005886; GO:0006508; GO:0008233; GO:0008237; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129";"neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]"
comp4228713_c0_seq1;GAXK01069051.1;Q7ZY60;6.49E-20;SAE2B_XENLA;SUMO-activating enzyme subunit 2-B (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B-B) (Ubiquitin-like modifier-activating enzyme 2-B);"SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein sumoylation [GO:0016925]";"GO:0005524; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0046872";protein sumoylation [GO:0016925];SUMO activating enzyme complex [GO:0031510];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]"
comp42290_c0_seq1;GAXK01147199.1;Q9NU19;1.27E-135;TB22B_HUMAN;TBC1 domain family member 22B;"cell [GO:0005623]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005623; GO:0006886; GO:0017137; GO:0071889; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cell [GO:0005623];"14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp422903_c0_seq1;GAXK01016961.1;A8X679;1.75E-15;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp42292_c0_seq1;GAXK01147274.1;Q6P1B1;0;XPP1_MOUSE;Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]";"GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006";"bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]"
comp422954_c0_seq1;GAXK01016964.1;Q3MHH5;1.09E-34;CCND3_BOVIN;G1/S-specific cyclin-D3;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0016020; GO:0016538; GO:0019901; GO:0044772; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp42296_c0_seq1;GAXK01147519.1;Q9VCY8;3.49E-106;ADRL_DROME;Adiponectin receptor protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]"
comp4229727_c0_seq1;GAXK01069045.1;P86854;7.08E-09;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp42301_c0_seq1;GAXK01147204.1;Q8T3X9;2.71E-48;ISCA1_DROME;Iron-sulfur cluster assembly 1 homolog, mitochondrial (Lethal (1) G0136) (Putative magnetoreceptor subunit MagR);"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]";"GO:0005198; GO:0005739; GO:0016226; GO:0046872; GO:0051537; GO:0071000; GO:0097428";"iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]";mitochondrion [GO:0005739];"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"
comp4230287_c0_seq1;GAXK01143348.1;Q9GRW0;4.18E-55;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp42306_c0_seq1;GAXK01147217.1;Q9H6F5;2.29E-12;CCD86_HUMAN;Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; viral process [GO:0016032]";"GO:0003723; GO:0005634; GO:0005730; GO:0016032";viral process [GO:0016032];"nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp4230913_c0_seq1;GAXK01143341.1;Q9W534;4.29E-15;MOODY_DROME;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp423162_c0_seq1;GAXK01016892.1;Q9NA75;3.30E-28;T38B1_CAEEL;Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";potassium channel activity [GO:0005267]
comp423167_c3_seq1;GAXK01016900.1;Q8BVR6;8.82E-78;RSPRY_MOUSE;RING finger and SPRY domain-containing protein 1;"extracellular region [GO:0005576]; metal ion binding [GO:0046872]";"GO:0005576; GO:0046872";;extracellular region [GO:0005576];metal ion binding [GO:0046872]
comp4232_c0_seq1;GAXK01066882.1;Q26065;1.45E-47;ACT_PLAMG;Actin, adductor muscle;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp4232166_c0_seq1;GAXK01091748.1;B3RPX6;2.79E-91;RSSA_TRIAD;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp4232499_c0_seq1;GAXK01091761.1;O60128;2.74E-50;RS3_SCHPO;40S ribosomal protein S3;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]";"GO:0002181; GO:0003684; GO:0003723; GO:0003735; GO:0003906; GO:0005634; GO:0005829; GO:0006281; GO:0008534; GO:0022627; GO:0032357; GO:0045739";"cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4232934_c0_seq1;GAXK01091752.1;Q96H40;2.46E-11;ZN486_HUMAN;Zinc finger protein 486 (KRAB domain only protein 2);"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0070062";regulation of transcription, DNA-templated [GO:0006355];"extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp423320_c1_seq1;GAXK01016973.1;P51452;4.78E-32;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp42340_c0_seq1;GAXK01147507.1;Q6PHF0;1.87E-43;CHM1A_DANRE;Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a);"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0007076; GO:0015031; GO:0016363; GO:0021549; GO:0032509; GO:0045324";"cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]";"ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]";
comp423413_c0_seq1;GAXK01016934.1;Q8BZ20;2.03E-09;PAR12_MOUSE;Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]";"GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404";"protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]"
comp423435_c0_seq1;GAXK01016844.1;O18767;1.72E-50;MMP20_BOVIN;Matrix metalloproteinase-20 (MMP-20) (EC 3.4.24.-) (Enamel metalloproteinase) (Enamelysin);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]";"GO:0004222; GO:0005615; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0097186";"amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp423464_c2_seq1;GAXK01016976.1;Q9RKB5;1.00E-97;BVMO2_STRCO;Baeyer-Villiger monooxygenase (BVMO) (EC 1.14.13.-);"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidation-reduction process [GO:0055114]";"GO:0004499; GO:0016709; GO:0050660; GO:0050661; GO:0055114";oxidation-reduction process [GO:0055114];;"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp423486_c0_seq1;GAXK01016865.1;A4IGL7;2.24E-108;PXDN_XENTR;Peroxidasin (EC 1.11.1.7);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005615; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp4235048_c0_seq1;GAXK01123205.1;P25804;2.32E-34;CYSP_PEA;Cysteine proteinase 15A (EC 3.4.22.-) (Turgor-responsive protein 15A);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp42352_c0_seq1;GAXK01147405.1;O55035;3.36E-70;PPIG_RAT;Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (Cyclophilin G) (Matrin cyclophilin) (Matrin-cyp) (Rotamase G);"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]";"GO:0003755; GO:0016018; GO:0016363; GO:0016607; GO:0042026; GO:0051082";protein refolding [GO:0042026];"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp423583_c0_seq1;GAXK01016982.1;P48148;4.09E-32;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp423634_c0_seq1;GAXK01016846.1;Q91ZW7;8.97E-09;C209E_MOUSE;CD209 antigen-like protein E (DC-SIGN-related protein 4) (DC-SIGNR4) (CD antigen CD209);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"GO:0005537; GO:0005886; GO:0006897; GO:0009897; GO:0016021; GO:0042102; GO:0097323";"B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";mannose binding [GO:0005537]
comp4237425_c0_seq1;GAXK01062443.1;Q71SG7;3.37E-20;GCNT4_DANRE;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0003829; GO:0006486; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp42376_c0_seq1;GAXK01147518.1;Q6GM06;4.04E-74;OTU6B_XENLA;Deubiquitinase OTUD6B (EC 3.4.19.12);"thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]";"GO:0016579; GO:0036459";protein deubiquitination [GO:0016579];;thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
comp423773_c0_seq1;GAXK01016874.1;P40656;3.98E-34;SOX14_DROME;Putative transcription factor SOX-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0016322; GO:0030154; GO:0043565; GO:0044798; GO:0048813; GO:1904799; GO:1904801";"cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp42383_c0_seq1;GAXK01147336.1;Q03017;1.98E-42;CACT_DROME;NF-kappa-B inhibitor cactus;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059";"antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]";NF-kappaB binding [GO:0051059]
comp423854_c0_seq1;GAXK01016850.1;P51523;1.83E-08;ZNF84_HUMAN;Zinc finger protein 84 (Zinc finger protein HPF2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp4239561_c0_seq1;GAXK01123803.1;A5PKG7;6.43E-22;KCTD5_BOVIN;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0043161; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";cullin family protein binding [GO:0097602]
comp42400_c1_seq1;GAXK01147266.1;Q8UVC1;8.64E-22;INVS_DANRE;Inversin;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; body morphogenesis [GO:0010171]; cloaca development [GO:0035844]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; kidney development [GO:0001822]; opsin transport [GO:0036372]; pronephros formation [GO:0072116]; pronephros morphogenesis [GO:0072114]; Wnt signaling pathway [GO:0016055]";"GO:0001736; GO:0001822; GO:0001947; GO:0005516; GO:0005737; GO:0005856; GO:0005929; GO:0010171; GO:0016055; GO:0035844; GO:0036372; GO:0060027; GO:0072114; GO:0072116";"body morphogenesis [GO:0010171]; cloaca development [GO:0035844]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; kidney development [GO:0001822]; opsin transport [GO:0036372]; pronephros formation [GO:0072116]; pronephros morphogenesis [GO:0072114]; Wnt signaling pathway [GO:0016055]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";calmodulin binding [GO:0005516]
comp424073_c0_seq1;GAXK01137658.1;Q99P84;1.10E-75;PLCE1_RAT;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; release of sequestered calcium ion into cytosol [GO:0051209]";"GO:0000139; GO:0000187; GO:0004435; GO:0004629; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007200; GO:0007265; GO:0008277; GO:0016042; GO:0017016; GO:0019899; GO:0032959; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0051209";"activation of MAPK activity [GO:0000187]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; release of sequestered calcium ion into cytosol [GO:0051209]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]"
comp42409_c4_seq1;GAXK01147294.1;Q6ZQL4;3.07E-60;WDR43_MOUSE;WD repeat-containing protein 43;"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"GO:0001650; GO:0005730; GO:0006364; GO:0045943; GO:2000234";"positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]";"fibrillar center [GO:0001650]; nucleolus [GO:0005730]";
comp424099_c1_seq1;GAXK01137739.1;Q3ZCX4;6.06E-82;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp42410_c1_seq1;GAXK01147681.1;Q5F410;5.22E-23;TMM18_CHICK;Transmembrane protein 18;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]";"GO:0003677; GO:0016021; GO:0031965";;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";DNA binding [GO:0003677]
comp42411_c2_seq1;GAXK01147971.1;P48053;3.83E-153;YPD1_CAEEL;Uncharacterized protein C05D11.1;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0046872";;;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp424156_c0_seq1;GAXK01137749.1;P10076;2.51E-36;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4241576_c0_seq1;GAXK01159070.1;Q06396;2.80E-64;ARF1_ORYSJ;ADP-ribosylation factor 1 (13 kDa cold-induced protein);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005737; GO:0005794; GO:0006886; GO:0016192";"intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";GTP binding [GO:0005525]
comp4241634_c0_seq1;GAXK01159067.1;Q9VMM6;2.51E-10;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp424288_c0_seq1;GAXK01137720.1;Q9VEX0;3.19E-07;SULF1_DROME;Extracellular sulfatase SULF-1 homolog (DmSulf-1) (EC 3.1.6.-);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0008045; GO:0008449; GO:0009986; GO:0016201; GO:0030202; GO:0042059; GO:0045879; GO:0045880; GO:0046872; GO:0048100; GO:0048190; GO:0090090";"heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]";"glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]"
comp424443_c0_seq1;GAXK01137700.1;Q00939;4.52E-23;FOXG1_RAT;Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (Forkhead-related protein FKHL1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0007346; GO:0007420; GO:0007568; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0043565; GO:0045665; GO:0045666; GO:0045787; GO:0048664";"aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp4244923_c0_seq1;GAXK01140240.1;Q86WZ6;8.34E-13;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4245060_c0_seq1;GAXK01140241.1;Q02280;2.18E-30;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp4245311_c0_seq1;GAXK01140237.1;P49641;4.43E-49;MA2A2_HUMAN;Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872";"mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp424617_c1_seq1;GAXK01137743.1;Q9GLD9;1.85E-52;UDB33_MACMU;UDP-glucuronosyltransferase 2B33 (UDPGT 2B33) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]";"GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0043231";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]"
comp42463_c0_seq1;GAXK01147203.1;Q9WVA4;2.10E-09;TAGL2_MOUSE;Transgelin-2 (SM22-beta);epithelial cell differentiation [GO:0030855];GO:0030855;epithelial cell differentiation [GO:0030855];;
comp424682_c0_seq1;GAXK01137661.1;Q03042;0;KGP1_DROME;cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; larval somatic muscle development [GO:0007526]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007526; GO:0018105; GO:0030553";"larval somatic muscle development [GO:0007526]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp4248669_c0_seq1;GAXK01025754.1;P83088;4.71E-08;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp42496_c0_seq1;GAXK01147529.1;Q6P6X9;9.11E-36;NUP35_DANRE;Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53);"nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]";"GO:0003697; GO:0005543; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028";"mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]";"nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]";"phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]"
comp424968_c0_seq1;GAXK01137770.1;Q86YT5;1.41E-97;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp424980_c0_seq1;GAXK01137698.1;Q8NEV4;1.11E-21;MYO3A_HUMAN;Myosin-IIIa (EC 2.7.11.1);"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000146; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0030175; GO:0030898; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0050896; GO:0060002; GO:0090103";"cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp4249817_c0_seq1;GAXK01025758.1;Q24352;7.92E-45;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp424996_c0_seq1;GAXK01137745.1;Q9W747;5.55E-09;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp42504_c2_seq1;GAXK01147160.1;Q9VU84;3.20E-53;DBNL_DROME;Drebrin-like protein (Actin binding protein 1);"axon [GO:0030424]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; terminal button organization [GO:0072553]";"GO:0001786; GO:0003779; GO:0005546; GO:0005547; GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0022416; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030864; GO:0031594; GO:0045211; GO:0045773; GO:0045887; GO:0048812; GO:0051015; GO:0061003; GO:0061176; GO:0061177; GO:0072553; GO:0098974";"chaeta development [GO:0022416]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; terminal button organization [GO:0072553]";"axon [GO:0030424]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]"
comp425040_c0_seq1;GAXK01137752.1;O46040;3.53E-24;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp4250400_c0_seq1;GAXK01145616.1;Q24174;8.88E-13;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp425046_c6_seq1;GAXK01137762.1;Q08879;7.76E-62;FBLN1_MOUSE;Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]";"GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647; GO:2001202";"blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]"
comp425105_c0_seq1;GAXK01137693.1;P17026;1.32E-32;ZNF22_HUMAN;Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; odontogenesis [GO:0042476]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0008270; GO:0042476";"odontogenesis [GO:0042476]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp42513_c0_seq1;GAXK01147599.1;P0C606;1.40E-79;SGF29_RAT;SAGA-associated factor 29 (rSGF29) (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29);"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription regulator recruiting activity [GO:0001135]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]";"GO:0000124; GO:0001135; GO:0005634; GO:0005671; GO:0016573; GO:0019899; GO:0035064; GO:0043966; GO:0047485; GO:0070461";"histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]";"enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription regulator recruiting activity [GO:0001135]"
comp4251630_c0_seq1;GAXK01145607.1;Q9UT98;4.26E-23;POS5_SCHPO;NADH kinase pos5, mitochondrial (EC 2.7.1.86);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; NADH kinase activity [GO:0042736]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]";"GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042736";"NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; NADH kinase activity [GO:0042736]"
comp425253_c0_seq1;GAXK01137735.1;Q95KV0;1.18E-99;IKKB_BOVIN;Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB);"IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0008384; GO:0008385; GO:0018105; GO:0033209; GO:0042803; GO:0045121; GO:0045944; GO:0046982; GO:0051092; GO:0071356";"cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp4252756_c0_seq1;GAXK01192298.1;P36609;1.05E-08;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp425377_c0_seq1;GAXK01137692.1;P28159;0;SUH_DROME;Suppressor of hairless protein (J kappa-recombination signal-binding protein) (RBP-J kappa);"CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; asymmetric cell division [GO:0008356]; cell fate determination [GO:0001709]; crystal cell differentiation [GO:0042688]; hemopoiesis [GO:0030097]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; long-term memory [GO:0007616]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ precursor cell fate determination [GO:0016360]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000122; GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001228; GO:0001709; GO:0003677; GO:0005634; GO:0005667; GO:0005700; GO:0005737; GO:0007219; GO:0007616; GO:0008356; GO:0008586; GO:0016360; GO:0017053; GO:0030097; GO:0032991; GO:0042683; GO:0042688; GO:0043565; GO:0045746; GO:0045892; GO:0045893; GO:0045944; GO:0048190; GO:0061629; GO:0090571; GO:1900087; GO:1990433";"asymmetric cell division [GO:0008356]; cell fate determination [GO:0001709]; crystal cell differentiation [GO:0042688]; hemopoiesis [GO:0030097]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; long-term memory [GO:0007616]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ precursor cell fate determination [GO:0016360]; wing disc dorsal/ventral pattern formation [GO:0048190]";"CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]"
comp42538_c2_seq1;GAXK01147288.1;Q9QZK8;5.38E-64;DNS2A_RAT;Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (DNase II alpha) (Lysosomal DNase II);"lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]; apoptotic DNA fragmentation [GO:0006309]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776]";"GO:0004520; GO:0004531; GO:0005764; GO:0006309; GO:0030218; GO:0050776";"apoptotic DNA fragmentation [GO:0006309]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776]";lysosome [GO:0005764];"deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]"
comp42541_c0_seq1;GAXK01147269.1;Q2HJ89;9.08E-25;FKB10_BOVIN;Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (FK506-binding protein 10) (FKBP-10) (Rotamase);"endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005509; GO:0005528; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];"calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp4254430_c0_seq1;GAXK01159663.1;Q9YHB5;1.68E-07;CND3_XENLA;Condensin complex subunit 3 (Chromosome assembly protein xCAP-G) (Chromosome-associated protein G) (Condensin subunit CAP-G) (Non-SMC condensin I complex subunit G);"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0000796; GO:0005634; GO:0005829; GO:0007076; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]";
comp425517_c0_seq1;GAXK01137778.1;Q4H3N8;6.26E-23;ENY2_CIOIN;Transcription and mRNA export factor ENY2 (Enhancer of yellow 2 transcription factor homolog);"DUBm complex [GO:0071819]; nuclear pore [GO:0005643]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000124; GO:0003682; GO:0003713; GO:0005643; GO:0006357; GO:0006368; GO:0016578; GO:0016973; GO:0045893; GO:0070390; GO:0071819";"histone deubiquitination [GO:0016578]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"DUBm complex [GO:0071819]; nuclear pore [GO:0005643]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]";"chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]"
comp4256374_c0_seq1;GAXK01131185.1;Q80RC7;1.62E-26;GCNT3_BHV4;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M);"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; protein glycosylation [GO:0006486]";"GO:0003829; GO:0006486; GO:0008109; GO:0016021; GO:0044178; GO:0047225";protein glycosylation [GO:0006486];"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]";"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp425726_c0_seq1;GAXK01137711.1;P52746;2.39E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp42573_c1_seq2;GAXK01147770.1;P93748;2.32E-09;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp425762_c7_seq1;GAXK01137679.1;Q2TU62;6.49E-15;CLCA1_HORSE;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp4257860_c0_seq1;GAXK01131182.1;Q3BXC6;2.78E-99;SAHH_XANC5;Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase);"cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0005737; GO:0006730";one-carbon metabolic process [GO:0006730];cytoplasm [GO:0005737];adenosylhomocysteinase activity [GO:0004013]
comp425792_c1_seq1;GAXK01137751.1;Q6P0D7;2.95E-139;MPP7_DANRE;MAGUK p55 subfamily member 7 (Protein humpback);"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; membrane [GO:0016020]";"GO:0005912; GO:0005923; GO:0016020";;"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; membrane [GO:0016020]";
comp425800_c0_seq1;GAXK01137703.1;Q7KRI2;6.43E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp42582_c0_seq1;GAXK01147259.1;Q9QXN5;9.36E-115;MIOX_MOUSE;Inositol oxygenase (EC 1.13.99.1) (Aldehyde reductase-like 6) (Myo-inositol oxygenase) (MI oxygenase) (Renal-specific oxidoreductase);"cytoplasm [GO:0005737]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310]";"GO:0004033; GO:0005737; GO:0008199; GO:0016234; GO:0016491; GO:0016651; GO:0016701; GO:0019310; GO:0050113; GO:0050661";inositol catabolic process [GO:0019310];"cytoplasm [GO:0005737]; inclusion body [GO:0016234]";"aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]"
comp425860_c1_seq1;GAXK01137742.1;Q9H1D0;2.77E-52;TRPV6_HUMAN;Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592]";"GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0017158; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp42592_c5_seq1;GAXK01147764.1;Q86VR2;3.66E-11;RETR3_HUMAN;Reticulophagy regulator 3;"integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; positive regulation of neuron projection development [GO:0010976]";"GO:0010976; GO:0016021; GO:0032991";positive regulation of neuron projection development [GO:0010976];"integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";
comp425921_c0_seq1;GAXK01137803.1;O46040;4.27E-28;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp42594_c0_seq1;GAXK01147587.1;Q9VFP2;1.37E-40;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp425940_c0_seq1;GAXK01137699.1;Q68F62;4.03E-27;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp4259504_c0_seq1;GAXK01065167.1;Q1ENI8;7.96E-16;PXDN_CAEEL;Peroxidasin homolog (EC 1.11.1.7);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679";"embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp4260_c0_seq1;GAXK01065990.1;P29117;1.58E-93;PPIF_RAT;Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptide binding [GO:0042277]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein refolding [GO:0042026]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]";"GO:0002931; GO:0003755; GO:0005739; GO:0005743; GO:0005757; GO:0005759; GO:0008637; GO:0010849; GO:0010939; GO:0016018; GO:0032780; GO:0042026; GO:0042277; GO:0042981; GO:0043066; GO:0046902; GO:0051082; GO:0070266; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243";"apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein refolding [GO:0042026]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]";"cyclosporin A binding [GO:0016018]; peptide binding [GO:0042277]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp42600_c0_seq1;GAXK01147299.1;P21902;3.76E-48;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4260058_c0_seq1;GAXK01159139.1;P33727;4.70E-24;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp4260260_c0_seq1;GAXK01159135.1;Q9JM59;1.01E-18;KCIP2_RAT;Kv channel-interacting protein 2 (KChIP2) (A-type potassium channel modulatory protein 2) (Potassium channel-interacting protein 2);"dendrite [GO:0030425]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; clustering of voltage-gated potassium channels [GO:0045163]; protein heterooligomerization [GO:0051291]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0045163; GO:0051291; GO:1901379";"clustering of voltage-gated potassium channels [GO:0045163]; protein heterooligomerization [GO:0051291]; regulation of potassium ion transmembrane transport [GO:1901379]";"dendrite [GO:0030425]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp426049_c1_seq1;GAXK01077416.1;Q9ULE6;1.84E-23;PALD_HUMAN;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp426063_c0_seq1;GAXK01077503.1;Q13972;1.28E-36;RGRF1_HUMAN;Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25);"cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000165; GO:0005085; GO:0005088; GO:0005089; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0007616; GO:0008283; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310";"activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]";"cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp426136_c2_seq1;GAXK01077428.1;Q28Z18;2.18E-99;SETB1_DROPS;Histone-lysine N-methyltransferase eggless (EC 2.1.1.43) (SETDB1 homolog);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038";"multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]"
comp42614_c0_seq1;GAXK01147119.1;Q14692;0;BMS1_HUMAN;Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog);"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"GO:0000462; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0030686; GO:0034511";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]"
comp4261812_c0_seq1;GAXK01159146.1;Q03601;3.70E-14;NHL1_CAEEL;RING finger protein nhl-1;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0004842; GO:0016567; GO:0043161; GO:0046872; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp4262_c8_seq1;GAXK01065918.1;P36204;1.14E-117;PGKT_THEMA;"Bifunctional PGK/TIM [Includes: Phosphoglycerate kinase (EC 2.7.2.3); Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)]";"cytosol [GO:0005829]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; triose-phosphate isomerase activity [GO:0004807]; fatty acid biosynthetic process [GO:0006633]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of oxidative phosphorylation [GO:1903862]";"GO:0004618; GO:0004807; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0006633; GO:0043531; GO:1903862";"fatty acid biosynthetic process [GO:0006633]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of oxidative phosphorylation [GO:1903862]";cytosol [GO:0005829];"ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; triose-phosphate isomerase activity [GO:0004807]"
comp426203_c0_seq1;GAXK01077425.1;Q95036;1.44E-14;CP6B5_PAPGL;Cytochrome P450 6B5 (EC 1.14.14.1) (CYP6B5v1) (CYPVIB5) (Fragment);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp426239_c1_seq1;GAXK01077522.1;Q8BQZ4;1.90E-87;RLGPB_MOUSE;Ral GTPase-activating protein subunit beta (p170);"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; Ral protein signal transduction [GO:0032484]; regulation of exocyst localization [GO:0060178]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005829; GO:0032484; GO:0032880; GO:0046982; GO:0051056; GO:0060178; GO:0090630";"activation of GTPase activity [GO:0090630]; Ral protein signal transduction [GO:0032484]; regulation of exocyst localization [GO:0060178]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]"
comp426307_c0_seq1;GAXK01077541.1;Q9UDX3;1.71E-61;S14L4_HUMAN;SEC14-like protein 4 (Tocopherol-associated protein 3);lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp42639_c3_seq1;GAXK01147527.1;P82295;4.80E-45;PROML_DROME;Prominin-like protein;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp426399_c3_seq1;GAXK01077423.1;Q12912;2.74E-10;LRMP_HUMAN;Lymphoid-restricted membrane protein (Protein Jaw1) [Cleaved into: Processed lymphoid-restricted membrane protein];"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"GO:0000922; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0007338; GO:0016020; GO:0016021; GO:0035577; GO:0043312";"neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]";
comp4264221_c0_seq1;GAXK01142609.1;Q1HPK6;1.67E-93;EF2_BOMMO;Translation elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp426443_c0_seq1;GAXK01077500.1;Q6UB98;7.17E-13;ANR12_HUMAN;Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp426450_c0_seq1;GAXK01077536.1;Q965M2;3.85E-25;SMA10_CAEEL;Leucine-rich repeats and immunoglobulin-like domains protein sma-10;"anchored component of membrane [GO:0031225]; cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mesodermal cell fate specification [GO:0042661]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005114; GO:0005615; GO:0005887; GO:0007179; GO:0030511; GO:0030659; GO:0031012; GO:0031225; GO:0034713; GO:0040018; GO:0042661";"positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mesodermal cell fate specification [GO:0042661]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"anchored component of membrane [GO:0031225]; cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]"
comp4265_c1_seq1;GAXK01065638.1;Q7KLV9;1.92E-137;PSD11_DROME;26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory complex subunit p42B) (26S proteasome regulatory subunit Rpn6);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; circadian rhythm [GO:0007623]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0005198; GO:0005654; GO:0005829; GO:0005838; GO:0006511; GO:0007623; GO:0008063; GO:0008541; GO:0043161; GO:0043248";"circadian rhythm [GO:0007623]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]";structural molecule activity [GO:0005198]
comp42656_c2_seq1;GAXK01147716.1;P36776;0;LONM_HUMAN;Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15);"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]";"GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0032042; GO:0034599; GO:0042645; GO:0043531; GO:0043565; GO:0051131; GO:0051260; GO:0051603; GO:0051880; GO:0070182; GO:0070407";"aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]";"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]"
comp42658_c0_seq1;GAXK01147145.1;Q9VB74;3.89E-47;NKAP_DROME;NKAP family protein CG6066;"catalytic step 2 spliceosome [GO:0071013]; chromatin binding [GO:0003682]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]";"GO:0000398; GO:0003682; GO:0007219; GO:0045892; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]";catalytic step 2 spliceosome [GO:0071013];chromatin binding [GO:0003682]
comp4266147_c0_seq1;GAXK01019673.1;O57592;1.03E-72;RL7A_TAKRU;60S ribosomal protein L7a (Surfeit locus protein 3);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp426656_c0_seq1;GAXK01077415.1;O74467;3.50E-14;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp426697_c0_seq1;GAXK01077478.1;P35875;8.83E-10;PARP_DROME;Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase Parp) (EC 2.4.2.-);"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"GO:0003677; GO:0003950; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0005719; GO:0005730; GO:0006302; GO:0006325; GO:0006355; GO:0006471; GO:0006963; GO:0007000; GO:0007552; GO:0008069; GO:0008270; GO:0009303; GO:0015030; GO:0030576; GO:0035079; GO:0035080; GO:0035363; GO:0042393; GO:0043484; GO:0045087; GO:0051276; GO:0051287; GO:0051457; GO:0070212; GO:1900182; GO:1990404";"Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp42685_c0_seq1;GAXK01147271.1;Q5W5U4;2.82E-140;DDX4_BOVIN;Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4);"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp42687_c1_seq1;GAXK01147268.1;Q6CAW6;7.31E-50;GWT1_YARLI;GPI-anchored wall transfer protein 1 (EC 2.3.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; GPI anchor biosynthetic process [GO:0006506]; protein localization to plasma membrane [GO:0072659]";"GO:0005789; GO:0006506; GO:0016021; GO:0032216; GO:0072659";"GPI anchor biosynthetic process [GO:0006506]; protein localization to plasma membrane [GO:0072659]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]
comp42693_c0_seq1;GAXK01147270.1;Q8VBV3;7.01E-90;EXOS2_MOUSE;Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4);"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0030307; GO:0034427; GO:0034475; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051";"CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp426958_c0_seq1;GAXK01077530.1;O32449;1.54E-32;PIP_SERMA;Proline iminopeptidase (PIP) (EC 3.4.11.5) (Prolyl aminopeptidase) (PAP);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]";"GO:0004177; GO:0005737";;cytoplasm [GO:0005737];aminopeptidase activity [GO:0004177]
comp4269612_c0_seq1;GAXK01092768.1;Q75NA5;1.61E-07;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp426985_c0_seq1;GAXK01077534.1;Q6IR42;1.87E-26;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp4270733_c0_seq1;GAXK01196931.1;A6YB01;0;TKT_PHYPO;Transketolase (TK) (EC 2.2.1.1);"metal ion binding [GO:0046872]; transketolase activity [GO:0004802]";"GO:0004802; GO:0046872";;;"metal ion binding [GO:0046872]; transketolase activity [GO:0004802]"
comp4270843_c0_seq1;GAXK01196927.1;Q86UE3;3.47E-09;ZN546_HUMAN;Zinc finger protein 546 (Zinc finger protein 49);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp42710_c1_seq1;GAXK01147278.1;O95777;3.79E-47;LSM8_HUMAN;U6 snRNA-associated Sm-like protein LSm8;"Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0016070; GO:0017070; GO:0046540; GO:0071005; GO:0120115";"mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]";"RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]"
comp427153_c0_seq1;GAXK01077477.1;P98165;3.21E-137;VLDLR_CHICK;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; ventral spinal cord development [GO:0021517]";"GO:0005509; GO:0005905; GO:0006869; GO:0008203; GO:0016021; GO:0021517; GO:0030228; GO:0030229; GO:0034185; GO:0034361";"cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; ventral spinal cord development [GO:0021517]";"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp4271608_c0_seq1;GAXK01196928.1;Q6ZNH5;1.05E-09;ZN497_HUMAN;Zinc finger protein 497;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp427226_c2_seq1;GAXK01077492.1;Q7F1X5;1.04E-21;4CLL5_ORYSJ;4-coumarate--CoA ligase-like 5 (EC 6.2.1.-);"ATP binding [GO:0005524]; ligase activity [GO:0016874]";"GO:0005524; GO:0016874";;;"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp4273_c0_seq1;GAXK01066883.1;P33215;5.58E-38;NEDD1_MOUSE;Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1);"apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex, centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201]";"GO:0000242; GO:0000922; GO:0000924; GO:0005737; GO:0005813; GO:0005814; GO:0007019; GO:0007049; GO:0031109; GO:0036064; GO:0045177; GO:0051301; GO:0070201; GO:0071539";"cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201]";"apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex, centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]";
comp42731_c0_seq1;GAXK01147306.1;P05661;2.04E-14;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp4273460_c0_seq1;GAXK01176742.1;Q08180;9.06E-19;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp427354_c2_seq1;GAXK01077455.1;P34057;5.03E-17;RECO_MOUSE;Recoverin (23 kDa photoreceptor cell-specific protein) (Cancer-associated retinopathy protein) (Protein CAR);"dendrite [GO:0030425]; calcium ion binding [GO:0005509]; phototransduction [GO:0007602]; regulation of calcium ion transport [GO:0051924]; visual perception [GO:0007601]";"GO:0005509; GO:0007601; GO:0007602; GO:0030425; GO:0051924";"phototransduction [GO:0007602]; regulation of calcium ion transport [GO:0051924]; visual perception [GO:0007601]";dendrite [GO:0030425];calcium ion binding [GO:0005509]
comp427373_c0_seq1;GAXK01077456.1;Q9VI10;2.09E-08;SMD2_DROME;Probable small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2);"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000278; GO:0000387; GO:0000398; GO:0003723; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0030532; GO:0046540; GO:0071011; GO:0071013";"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";RNA binding [GO:0003723]
comp4274039_c0_seq1;GAXK01149700.1;Q90YR8;5.67E-62;RS6_ICTPU;40S ribosomal protein S6;"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; structural constituent of ribosome [GO:0003735]; glucose homeostasis [GO:0042593]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0006412; GO:0022627; GO:0042593; GO:0048471";"glucose homeostasis [GO:0042593]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";structural constituent of ribosome [GO:0003735]
comp4274251_c0_seq1;GAXK01149703.1;A2ANX9;3.89E-07;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp42744_c1_seq1;GAXK01147363.1;Q09137;0;AAPK2_RAT;5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0014823; GO:0016055; GO:0016241; GO:0016324; GO:0019216; GO:0030424; GO:0030425; GO:0030674; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0032991; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0051291; GO:0055089; GO:0071277; GO:0071333; GO:0071417; GO:0097009";"autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp427645_c0_seq1;GAXK01077442.1;Q6ETN3;2.83E-98;4CL3_ORYSJ;Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp42765_c1_seq1;GAXK01147741.1;P54356;4.39E-49;TSG_DROME;Protein twisted gastrulation;"extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; heparin binding [GO:0008201]; amnioserosa formation [GO:0007378]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of metalloendopeptidase activity [GO:1904685]";"GO:0005576; GO:0005615; GO:0007378; GO:0008201; GO:0030514; GO:0036122; GO:1904685";"amnioserosa formation [GO:0007378]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of metalloendopeptidase activity [GO:1904685]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"BMP binding [GO:0036122]; heparin binding [GO:0008201]"
comp427722_c0_seq1;GAXK01077427.1;Q95LI3;9.14E-13;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4278_c0_seq1;GAXK01066263.1;Q8T8R1;1.01E-24;Y3800_DROME;CCHC-type zinc finger protein CG3800;"cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]";"GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767";positive regulation of cytoplasmic translation [GO:2000767];cytoplasm [GO:0005737];"mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]"
comp42783_c1_seq1;GAXK01147330.1;Q4R828;1.69E-40;RCCD1_MACFA;RCC1 domain-containing protein 1;"chromosome [GO:0005694]; chromatin organization [GO:0006325]";"GO:0005694; GO:0006325";chromatin organization [GO:0006325];chromosome [GO:0005694];
comp4278347_c0_seq1;GAXK01085082.1;Q8I1F6;2.26E-18;PPO3_DROER;Phenoloxidase 3 (EC 1.14.18.1) (Diphenoloxidase subunit A3) (Tyrosinase A3);"extracellular region [GO:0005576]; dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";"GO:0004503; GO:0005576; GO:0035011; GO:0036263; GO:0036264; GO:0042438; GO:0046872";"melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]";extracellular region [GO:0005576];"dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]"
comp42784_c1_seq1;GAXK01147103.1;Q68CP9;2.08E-96;ARID2_HUMAN;AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200);"nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cardiac muscle cell proliferation [GO:0060038]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0003677; GO:0005654; GO:0005886; GO:0006337; GO:0006355; GO:0008285; GO:0030336; GO:0042592; GO:0046872; GO:0048568; GO:0060038; GO:0060982";"cardiac muscle cell proliferation [GO:0060038]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp427961_c1_seq1;GAXK01077521.1;Q14593;5.68E-26;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp4279868_c0_seq1;GAXK01085075.1;Q8IYI8;4.92E-08;ZN440_HUMAN;Zinc finger protein 440;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4279988_c0_seq1;GAXK01085073.1;P51512;1.61E-13;MMP16_HUMAN;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0019538; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094";"chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp428005_c0_seq1;GAXK01056300.1;Q24432;2.93E-117;OMB_DROME;Optomotor-blind protein (Lethal(1)optomotor-blind) (L(1)omb) (Protein bifid);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";"GO:0000122; GO:0000977; GO:0000978; GO:0001102; GO:0001228; GO:0001708; GO:0001745; GO:0003677; GO:0005634; GO:0007472; GO:0007476; GO:0035265; GO:0045944; GO:0048066; GO:0048100";"cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4281123_c0_seq1;GAXK01108053.1;Q94HW2;1.68E-11;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4281712_c0_seq1;GAXK01108055.1;P0C5E2;4.72E-16;LRL12_ARATH;LEAF RUST 10 DISEASE-RESISTANCE LOCUS RECEPTOR-LIKE PROTEIN KINASE-like 1.2 (EC 2.7.11.1) (Probable receptor-like serine/threonine-protein kinase LRK10L-1.2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]; cellular response to abscisic acid stimulus [GO:0071215]; cellular response to water deprivation [GO:0042631]; photoperiodism, flowering [GO:0048573]";"GO:0004674; GO:0005524; GO:0005886; GO:0016021; GO:0030247; GO:0042631; GO:0048573; GO:0071215";"cellular response to abscisic acid stimulus [GO:0071215]; cellular response to water deprivation [GO:0042631]; photoperiodism, flowering [GO:0048573]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]"
comp42820_c0_seq1;GAXK01147282.1;Q2TLZ5;3.00E-94;MACOI_PANTR;Macoilin (Transmembrane protein 57);"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]";"GO:0006935; GO:0008017; GO:0016021; GO:0023041; GO:0030867; GO:0031965; GO:0051015";"chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]";"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]";"actin filament binding [GO:0051015]; microtubule binding [GO:0008017]"
comp428211_c0_seq1;GAXK01056270.1;Q9W0Y8;0;SCN60_DROME;Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2);"plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010";"membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]";"voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]"
comp4282142_c0_seq1;GAXK01004455.1;Q4WJ81;1.63E-08;CRZA_ASPFU;C2H2 finger domain transcription factor crzA;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277]; conidium formation [GO:0048315]; pathogenesis [GO:0009405]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spore germination [GO:0009847]; unidimensional cell growth [GO:0009826]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0009405; GO:0009826; GO:0009847; GO:0045944; GO:0046872; GO:0048315; GO:0071277";"cellular response to calcium ion [GO:0071277]; conidium formation [GO:0048315]; pathogenesis [GO:0009405]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spore germination [GO:0009847]; unidimensional cell growth [GO:0009826]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp428275_c0_seq1;GAXK01056370.1;Q99LB7;0;SARDH_MOUSE;Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]";"GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053";"sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]"
comp428276_c0_seq1;GAXK01056376.1;A8X679;7.16E-10;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp42840_c0_seq1;GAXK01147341.1;P25304;5.05E-22;AGRIN_RAT;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030054; GO:0031012; GO:0033691; GO:0035374; GO:0036122; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0045202; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0070507; GO:0071340; GO:0098978; GO:1902667";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp4284241_c0_seq1;GAXK01109592.1;P51779;8.41E-07;CFAD_PIG;Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; complement activation, alternative pathway [GO:0006957]; Notch signaling pathway [GO:0007219]; response to bacterium [GO:0009617]";"GO:0004252; GO:0005615; GO:0006957; GO:0007219; GO:0009617";"complement activation, alternative pathway [GO:0006957]; Notch signaling pathway [GO:0007219]; response to bacterium [GO:0009617]";extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp42845_c2_seq1;GAXK01147210.1;P29375;0;KDM5A_HUMAN;Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2);"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0033169; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0044212; GO:0045893; GO:0051090; GO:0051213; GO:1901726";"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]";"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]";"chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp4284882_c0_seq1;GAXK01109579.1;Q9Y2Q0;1.25E-11;AT8A1_HUMAN;Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1);"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0019829; GO:0030335; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0043312; GO:0045332; GO:0061092; GO:0070062; GO:0140326";"ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp428575_c0_seq1;GAXK01056261.1;O46640;7.54E-31;ST3A1_RABIT;Amine sulfotransferase (EC 2.8.2.3) (AST-RB1) (Sulfotransferase 3A1) (ST3A1);"cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685]";"GO:0005737; GO:0047685";;cytoplasm [GO:0005737];amine sulfotransferase activity [GO:0047685]
comp4285774_c0_seq1;GAXK01109581.1;Q9VNM1;1.71E-25;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp428621_c0_seq1;GAXK01056338.1;Q8N8Z8;2.46E-21;ZN441_HUMAN;Zinc finger protein 441;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp428636_c0_seq1;GAXK01056332.1;Q4V8R6;3.34E-17;E4F1_DANRE;Transcription factor E4F1 (EC 2.3.2.27) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"GO:0003677; GO:0005654; GO:0005737; GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp428642_c0_seq1;GAXK01056251.1;O14709;7.66E-13;ZN197_HUMAN;Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp42866_c0_seq1;GAXK01147123.1;Q8C854;4.94E-24;MYEF2_MOUSE;Myelin expression factor 2 (MEF-2) (MyEF-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]";"GO:0000122; GO:0000978; GO:0001227; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0071014; GO:1990904; GO:2000815";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"
comp42871_c0_seq1;GAXK01147261.1;P54399;1.82E-147;PDI_DROME;Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1);"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0006457; GO:0012505; GO:0015037; GO:0034976; GO:0043025; GO:0045169; GO:0045454; GO:0048471; GO:0060187; GO:0070732";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp42874_c0_seq1;GAXK01147124.1;Q08180;4.39E-22;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp42875_c0_seq1;GAXK01147510.1;Q9Z1W9;0;STK39_MOUSE;STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (Serine/threonine-protein kinase 39);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000187; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0008217; GO:0010820; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019898; GO:0019901; GO:0023014; GO:0023016; GO:0031098; GO:0032147; GO:0032414; GO:0035556; GO:0036438; GO:0038146; GO:0043231; GO:0043268; GO:0046777; GO:0050727; GO:0050801; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:1905408; GO:1990869; GO:2000650";"activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]"
comp42876_c4_seq1;GAXK01147627.1;Q24498;0;RYR_DROME;Ryanodine receptor (Ryanodine receptor 44F);"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"GO:0005219; GO:0005509; GO:0005790; GO:0005886; GO:0006816; GO:0006936; GO:0007275; GO:0016021; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0035206; GO:0042383; GO:0048763; GO:0051209; GO:0060047; GO:0072347";"calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]";"calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]"
comp428777_c0_seq1;GAXK01056326.1;Q53G44;4.83E-34;IF44L_HUMAN;Interferon-induced protein 44-like;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005525; GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp42880_c0_seq1;GAXK01147156.1;P86854;1.02E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp42884_c0_seq1;GAXK01147195.1;Q91ZV7;1.16E-74;PLDX1_MOUSE;Plexin domain-containing protein 1 (Tumor endothelial marker 7);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"GO:0001525; GO:0005737; GO:0005886; GO:0005923; GO:0016021; GO:0021510; GO:0030425; GO:0043025; GO:0043235";"angiogenesis [GO:0001525]; spinal cord development [GO:0021510]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";
comp428849_c1_seq1;GAXK01056382.1;Q9CW42;2.76E-24;MARC1_MOUSE;Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]";"GO:0005739; GO:0005741; GO:0005743; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0055114";"nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]"
comp42887_c0_seq1;GAXK01147140.1;Q7KRI2;1.36E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp428940_c0_seq1;GAXK01056318.1;Q9H2C0;1.19E-08;GAN_HUMAN;Gigaxonin (Kelch-like protein 16);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687";"cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";
comp428994_c1_seq1;GAXK01056249.1;Q7ZVG6;1.67E-08;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp429_c1_seq1;GAXK01168825.1;Q1RJR6;2.96E-08;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp42900_c1_seq1;GAXK01147718.1;P29147;6.46E-105;BDH_RAT;D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH);"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]";"GO:0001889; GO:0003858; GO:0005543; GO:0005743; GO:0005759; GO:0007420; GO:0007584; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042493; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617";"adipose tissue development [GO:0060612]; brain development [GO:0007420]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]";"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]";"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]"
comp42903_c0_seq1;GAXK01147292.1;Q4KLV6;3.52E-99;AGO4_XENLA;Protein argonaute-4 (Argonaute4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4);"P-body [GO:0000932]; RISC complex [GO:0016442]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"GO:0000932; GO:0006402; GO:0016442; GO:0035198; GO:0035278";"miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"P-body [GO:0000932]; RISC complex [GO:0016442]";miRNA binding [GO:0035198]
comp42904_c7_seq1;GAXK01147799.1;Q8NF91;6.89E-20;SYNE1_HUMAN;Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292";"cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]"
comp4291204_c0_seq1;GAXK01084456.1;P83501;1.90E-15;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp42915_c2_seq1;GAXK01147339.1;Q9JMH9;1.68E-61;MY18A_MOUSE;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]"
comp42918_c2_seq1;GAXK01147564.1;Q3ZC33;1.49E-14;GGLO_BOVIN;L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; L-gulonolactone oxidase activity [GO:0050105]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0003885; GO:0005789; GO:0016021; GO:0019853; GO:0050105; GO:0050660; GO:0071949";L-ascorbic acid biosynthetic process [GO:0019853];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; L-gulonolactone oxidase activity [GO:0050105]"
comp429220_c0_seq1;GAXK01056339.1;Q9NW07;1.29E-15;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp429227_c1_seq1;GAXK01056256.1;Q6PFH3;1.81E-39;DCA15_MOUSE;DDB1- and CUL4-associated factor 15;"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; protein-containing complex [GO:0032991]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0032991; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; protein-containing complex [GO:0032991]";
comp4292486_c0_seq1;GAXK01090124.1;P52746;3.58E-07;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp429340_c1_seq1;GAXK01056262.1;Q9UJW7;1.97E-28;ZN229_HUMAN;Zinc finger protein 229;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp429352_c0_seq1;GAXK01056250.1;P18715;2.62E-27;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4293657_c0_seq1;GAXK01090118.1;Q96GW7;1.11E-11;PGCB_HUMAN;Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0098978";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]";"carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp42942_c3_seq1;GAXK01147163.1;Q9VY86;2.35E-48;TM2D2_DROME;TM2 domain-containing protein CG11103;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp429433_c0_seq1;GAXK01056381.1;Q5BJ29;8.26E-84;FBXL7_MOUSE;F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000278; GO:0005737; GO:0005813; GO:0006511; GO:0008283; GO:0016567; GO:0019005; GO:0031146; GO:0051301";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp429456_c0_seq1;GAXK01056276.1;P58872;1.66E-73;RHBL3_HUMAN;Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005509; GO:0016021";;integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp429468_c1_seq1;GAXK01056363.1;Q80X44;2.08E-18;ZBT24_MOUSE;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Brain-specific protein 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4295604_c0_seq1;GAXK01087587.1;Q3UHD1;2.54E-08;AGRB1_MOUSE;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]";"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]"
comp429562_c0_seq1;GAXK01056377.1;Q80YE7;9.35E-13;DAPK1_MOUSE;Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]";"GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:1902042; GO:2000310";"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]"
comp42958_c0_seq1;GAXK01147373.1;Q2TBI1;2.91E-31;NSE4A_BOVIN;Non-structural maintenance of chromosomes element 4 homolog A (Non-SMC element 4 homolog A);"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]";"GO:0000781; GO:0005634; GO:0006281; GO:0006310; GO:0016604; GO:0030915; GO:2001022";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]";"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]";
comp42965_c0_seq1;GAXK01147560.1;Q6P6J9;2.17E-25;TXD15_MOUSE;Thioredoxin domain-containing protein 15;"cell [GO:0005623]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0016021; GO:0045454";cell redox homeostasis [GO:0045454];"cell [GO:0005623]; integral component of membrane [GO:0016021]";
comp4296933_c0_seq1;GAXK01115850.1;Q29HY3;3.79E-38;CDC42_DROPS;Cdc42 homolog (EC 3.6.5.2);"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0005912; GO:0005938; GO:0006909; GO:0007266; GO:0007274; GO:0007286; GO:0007391; GO:0008045; GO:0008360; GO:0008582; GO:0010592; GO:0016028; GO:0016318; GO:0019901; GO:0030011; GO:0030027; GO:0030031; GO:0030041; GO:0030426; GO:0030833; GO:0030866; GO:0031532; GO:0032794; GO:0035011; GO:0035099; GO:0035318; GO:0042060; GO:0045177; GO:0045185; GO:0045200; GO:0045860; GO:0046330; GO:0046843; GO:0048010; GO:0048675; GO:0048813; GO:0050770; GO:0050975; GO:0051491; GO:0051601; GO:0060446; GO:0072659; GO:0090303; GO:0097206";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp4296969_c0_seq1;GAXK01115840.1;Q32KS2;2.09E-54;DNAI1_BOVIN;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005874; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp4297636_c0_seq1;GAXK01115844.1;P91119;1.13E-37;PDE5_CAEEL;Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17);"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";"GO:0004114; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";;"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"
comp42992_c0_seq1;GAXK01205819.1;O94806;0;KPCD3_HUMAN;Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700";"protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp43_c0_seq1;GAXK01166214.1;P60842;0;IF4A1_HUMAN;Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]; viral process [GO:0016032]";"GO:0000339; GO:0002183; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0003743; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016020; GO:0016032; GO:0016281; GO:0070062";"cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]";"ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp4300256_c0_seq1;GAXK01087727.1;Q9JME2;9.41E-11;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp4300404_c0_seq1;GAXK01087726.1;Q9U3U0;5.65E-56;RLA0_CERCA;60S acidic ribosomal protein P0 (CcP0);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp4300410_c0_seq1;GAXK01087723.1;Q76CA2;1.47E-27;ACTP2_MONPT;Echotoxin-2 (Echt 2);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp4300994_c0_seq1;GAXK01087732.1;Q95V31;5.34E-89;RS16_SPOFR;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp43016_c0_seq1;GAXK01147685.1;Q9UQB3;5.27E-159;CTND2_HUMAN;Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin);"cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0007043; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609";"cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055]";"cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]"
comp4301955_c0_seq1;GAXK01087731.1;P00791;2.47E-18;PEPA_PIG;Pepsin A (EC 3.4.23.1);"extracellular region [GO:0005576]; aspartic-type endopeptidase activity [GO:0004190]; digestion [GO:0007586]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"GO:0004190; GO:0005576; GO:0006508; GO:0007586; GO:0030163";"digestion [GO:0007586]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";extracellular region [GO:0005576];aspartic-type endopeptidase activity [GO:0004190]
comp430197_c0_seq1;GAXK01072731.1;A8Y1P7;1.74E-100;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp4302062_c0_seq1;GAXK01102487.1;Q9URZ5;6.25E-22;VPS1_SCHPO;Vacuolar protein sorting-associated protein 1;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisome [GO:0005777]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; membrane scission GTPase motor activity [GO:1990606]; microtubule binding [GO:0008017]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; vesicle scission [GO:0099050]";"GO:0000266; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005777; GO:0005794; GO:0006897; GO:0007031; GO:0008017; GO:0016020; GO:0016559; GO:0031966; GO:0061025; GO:0099050; GO:1990606";"dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; vesicle scission [GO:0099050]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisome [GO:0005777]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; membrane scission GTPase motor activity [GO:1990606]; microtubule binding [GO:0008017]"
comp430228_c0_seq1;GAXK01072756.1;A8K855;1.57E-46;EFCB7_HUMAN;EF-hand calcium-binding domain-containing protein 7;"ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0005509; GO:0005929; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569";"positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]";calcium ion binding [GO:0005509]
comp4302303_c0_seq1;GAXK01205492.1;P89116;6.77E-37;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp4302743_c0_seq1;GAXK01102484.1;P16168;2.87E-37;RL11_DICDI;60S ribosomal protein L11 (Vegetative-specific protein V18);"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625; GO:0031012; GO:0045335";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp430289_c0_seq1;GAXK01072834.1;O44252;5.87E-09;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp4303234_c0_seq1;GAXK01102477.1;A7S8T5;4.38E-20;CCD42_NEMVE;Coiled-coil domain-containing protein 42 homolog;;;;;
comp4303690_c0_seq1;GAXK01102496.1;Q16706;2.84E-25;MA2A1_HUMAN;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp4303727_c0_seq1;GAXK01102481.1;Q64481;2.90E-42;CP3AG_MOUSE;Cytochrome P450 3A16 (EC 1.14.14.1) (CYPIIIA16);"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH or CH2 groups [GO:0016725]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]";"GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0016491; GO:0016725; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020";"oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]";"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH or CH2 groups [GO:0016725]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]"
comp4304296_c0_seq1;GAXK01170989.1;Q5RC67;5.80E-27;DDX23_PONAB;Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (DEAD box protein 23);"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003676; GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0008380";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";spliceosomal complex [GO:0005681];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp4304713_c0_seq1;GAXK01170996.1;E9PTT0;3.54E-08;ZDH17_RAT;Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 17);"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953";"lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]";"identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp4304821_c0_seq1;GAXK01170974.1;Q6BEA2;1.12E-29;PRS27_RAT;Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin);"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0019897; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]";serine-type endopeptidase activity [GO:0004252]
comp430506_c0_seq1;GAXK01072829.1;O95475;3.50E-104;SIX6_HUMAN;Homeobox protein SIX6 (Homeodomain protein OPTX2) (Optic homeobox 2) (Sine oculis homeobox homolog 6);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; eye development [GO:0001654]; negative regulation of transcription, DNA-templated [GO:0045892]; visual perception [GO:0007601]";"GO:0000790; GO:0000976; GO:0000980; GO:0000981; GO:0001654; GO:0005634; GO:0005667; GO:0007601; GO:0009887; GO:0045892; GO:0048856";"anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; eye development [GO:0001654]; negative regulation of transcription, DNA-templated [GO:0045892]; visual perception [GO:0007601]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4305139_c0_seq1;GAXK01170999.1;Q9AT34;3.95E-63;RS15A_DAUCA;40S ribosomal protein S15a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp430519_c3_seq1;GAXK01072766.1;E9QAG8;1.27E-56;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp43053_c2_seq1;GAXK01147134.1;Q9VGY6;1.75E-64;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp4306_c0_seq1;GAXK01066747.1;Q95VA8;6.46E-77;TPM_TRISP;Tropomyosin;;;;;
comp430604_c0_seq1;GAXK01072738.1;P0C6Y7;8.29E-18;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp430629_c0_seq1;GAXK01205397.1;Q04859;2.28E-166;MAK_MOUSE;Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK);"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]";"GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0010468; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0097542; GO:1902856";"cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]";"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
comp430675_c2_seq1;GAXK01072801.1;Q8N895;4.80E-14;ZN366_HUMAN;Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT);"nucleus [GO:0005634]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to estrogen [GO:0043627]";"GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0030331; GO:0033147; GO:0043627; GO:0046872";"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to estrogen [GO:0043627]";nucleus [GO:0005634];"DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp4307086_c0_seq1;GAXK01025576.1;O02002;7.16E-28;CASP1_DROME;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p22; Caspase-1 subunit p13]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"GO:0004197; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007275; GO:0007300; GO:0007303; GO:0009267; GO:0010508; GO:0010623; GO:0012501; GO:0016239; GO:0016322; GO:0043025; GO:0045476; GO:0048477; GO:0071598; GO:0097153; GO:0097194; GO:0097200; GO:1900074; GO:1990124; GO:1990525";"apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]";"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp4307306_c0_seq1;GAXK01025600.1;Q9KQ30;1.04E-12;5NTD_VIBCH;5'-nucleotidase (EC 3.1.3.5);"cell outer membrane [GO:0009279]; outer membrane-bounded periplasmic space [GO:0030288]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]; nucleotide catabolic process [GO:0009166]; nucleotide-sugar metabolic process [GO:0009225]";"GO:0000166; GO:0008253; GO:0008768; GO:0009166; GO:0009225; GO:0009279; GO:0030288; GO:0046872";"nucleotide catabolic process [GO:0009166]; nucleotide-sugar metabolic process [GO:0009225]";"cell outer membrane [GO:0009279]; outer membrane-bounded periplasmic space [GO:0030288]";"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; UDP-sugar diphosphatase activity [GO:0008768]"
comp4307312_c0_seq1;GAXK01025581.1;P36609;1.97E-37;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp43074_c1_seq1;GAXK01147584.1;A6QLT2;0;MTMR2_BOVIN;Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64);"axon [GO:0030424]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"GO:0004438; GO:0004725; GO:0005634; GO:0005774; GO:0005829; GO:0030424; GO:0031642; GO:0031901; GO:0032288; GO:0042803; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304";"inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]";"axon [GO:0030424]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]";"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]"
comp430750_c1_seq1;GAXK01072840.1;Q9BUY5;1.05E-22;ZN426_HUMAN;Zinc finger protein 426;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp43076_c2_seq1;GAXK01147517.1;Q9VPY8;1.18E-174;TGT_DROME;Queuine tRNA-ribosyltransferase catalytic subunit (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]";"GO:0005737; GO:0008479; GO:0046872; GO:0101030";tRNA-guanine transglycosylation [GO:0101030];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]"
comp43078_c0_seq1;GAXK01147241.1;O35547;0;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp4308936_c0_seq1;GAXK01005380.1;P13360;2.65E-15;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp4309001_c0_seq1;GAXK01005399.1;Q963B7;1.34E-89;RL9_SPOFR;60S ribosomal protein L9;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4309485_c0_seq1;GAXK01005384.1;Q9GZU5;1.03E-18;NYX_HUMAN;Nyctalopin;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005615; GO:0007601; GO:0031012; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";
comp4309841_c0_seq1;GAXK01005383.1;Q7Z407;4.73E-23;CSMD3_HUMAN;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4310_c0_seq1;GAXK01066050.1;P91929;3.16E-67;NDUAA_DROME;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0003954; GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0008137";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]"
comp4310028_c0_seq1;GAXK01129002.1;Q90YV0;9.99E-42;RL18_ICTPU;60S ribosomal protein L18;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";structural constituent of ribosome [GO:0003735]
comp431063_c2_seq1;GAXK01072741.1;P98160;5.61E-09;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp43108_c0_seq1;GAXK01147515.1;Q2KIL7;1.59E-16;R3HD4_BOVIN;R3H domain-containing protein 4;"nucleus [GO:0005634]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634";;nucleus [GO:0005634];nucleic acid binding [GO:0003676]
comp4311447_c0_seq1;GAXK01129017.1;P10978;2.30E-12;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp431163_c0_seq1;GAXK01072848.1;P41894;3.43E-11;DEI_DROME;Helix-loop-helix protein delilah (Protein taxi);"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0033627; GO:0043425; GO:0046982";"cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]";nucleus [GO:0005634];"bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]"
comp431167_c0_seq1;GAXK01072742.1;Q5TFG8;1.60E-11;ZC21B_HUMAN;Zinc finger C2HC domain-containing protein 1B;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp4312251_c0_seq1;GAXK01197972.1;P16905;3.38E-32;KAPR1_DROME;cAMP-dependent protein kinase type I regulatory subunit (DRI class I to class IV);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"GO:0005737; GO:0005829; GO:0005952; GO:0007015; GO:0007274; GO:0007419; GO:0007591; GO:0008103; GO:0008355; GO:0008603; GO:0019933; GO:0019934; GO:0030552; GO:0045471; GO:0047555; GO:2000253";"actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp4312280_c0_seq1;GAXK01197952.1;P14381;6.91E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp431238_c0_seq1;GAXK01072791.1;Q9CR23;3.23E-19;TMEM9_MOUSE;Transmembrane protein 9;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";"GO:0005764; GO:0005765; GO:0005770; GO:0016021; GO:0031902";;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";
comp4313274_c0_seq1;GAXK01197965.1;Q9DCM4;7.63E-14;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp4313358_c0_seq1;GAXK01197950.1;Q8WXX0;1.19E-24;DYH7_HUMAN;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2);"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp4313388_c0_seq1;GAXK01197946.1;P10394;1.95E-13;POL4_DROME;"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4313943_c0_seq1;GAXK01197957.1;Q8HYB7;1.44E-08;PERT_CANLF;Thyroid peroxidase (TPO) (EC 1.11.1.8);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0006590; GO:0006979; GO:0016021; GO:0020037; GO:0035162; GO:0042446; GO:0042744";"embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]"
comp4314328_c0_seq1;GAXK01084342.1;Q0V9W6;7.02E-12;BTBD6_XENTR;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp4314353_c0_seq1;GAXK01084323.1;O61463;1.12E-16;RLA2_CRYST;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp431532_c1_seq1;GAXK01072853.1;Q5FYB0;6.33E-66;ARSJ_HUMAN;Arylsulfatase J (ASJ) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp4316501_c0_seq1;GAXK01038596.1;Q09575;4.46E-13;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp431651_c0_seq1;GAXK01072729.1;P52746;2.07E-18;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp431688_c0_seq1;GAXK01072825.1;Q6P8U6;1.18E-79;LIPP_MOUSE;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3);"extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791]";"GO:0004806; GO:0005615; GO:0006629; GO:0009791; GO:0016042; GO:0016298; GO:0030299; GO:0046872; GO:0061365";"intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791]";extracellular space [GO:0005615];"lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp4316887_c0_seq1;GAXK01038583.1;Q9VMM6;3.23E-14;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp4317021_c0_seq1;GAXK01038574.1;Q7KRI2;9.16E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp43172_c0_seq1;GAXK01147107.1;Q9NYV6;1.09E-58;RRN3_HUMAN;RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0010976; GO:0042254; GO:0045893; GO:0048872; GO:1902254; GO:2000142";"cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"RNA polymerase I core binding [GO:0001042]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]"
comp431753_c0_seq1;GAXK01072762.1;Q7TS63;6.41E-09;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4317931_c0_seq1;GAXK01038575.1;P0C6F1;7.32E-31;DYH2_MOUSE;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2);"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp431837_c1_seq1;GAXK01072784.1;Q8BM89;9.73E-82;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp4318389_c0_seq1;GAXK01057383.1;P54131;6.60E-58;ACHA7_BOVIN;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp4318449_c0_seq1;GAXK01057394.1;Q8N0V5;1.20E-10;GNT2A_HUMAN;N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000139; GO:0005794; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0016021; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374";"glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]
comp431879_c0_seq1;GAXK01205399.1;O54750;1.45E-72;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp4318894_c0_seq1;GAXK01057387.1;O15084;2.90E-12;ANR28_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]";"GO:0000139; GO:0005654; GO:0005829; GO:0048208";COPII vesicle coating [GO:0048208];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";
comp43191_c0_seq1;GAXK01147298.1;M9PBE2;7.64E-69;HAKAI_DROME;E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27);"cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282]";"GO:0004842; GO:0005634; GO:0005886; GO:0007015; GO:0007391; GO:0007427; GO:0007494; GO:0008258; GO:0008270; GO:0016567; GO:0031410; GO:0035282; GO:0036396; GO:0040003; GO:0045296; GO:0048471; GO:0060429; GO:0061630";"actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282]";"cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";"cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4319498_c0_seq1;GAXK01057367.1;P29453;1.20E-33;RL8B_YEAST;60S ribosomal protein L8-B (L4) (L4-1) (Large ribosomal subunit protein eL8-B) (RP6) (YL5);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp431980_c0_seq1;GAXK01072750.1;Q5BL56;1.41E-35;HMGX4_XENTR;HMG box-containing protein 4 (High mobility group protein 2-like 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; multicellular organism development [GO:0007275]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0005634; GO:0007275; GO:0016055; GO:0019901; GO:0030178";"multicellular organism development [GO:0007275]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein kinase binding [GO:0019901]"
comp4319876_c0_seq1;GAXK01057379.1;O23507;3.29E-09;1MMP_ARATH;Metalloendoproteinase 1-MMP (At1-MMP) (EC 3.4.24.-);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]";"GO:0004222; GO:0005886; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0031225";"collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp432_c0_seq1;GAXK01169441.1;Q08473;1.63E-42;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp4320001_c0_seq1;GAXK01087646.1;P41148;2.53E-48;ENPL_CANLF;Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1);"endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005783; GO:0006457; GO:0030433; GO:0033018; GO:0042470; GO:0048471; GO:0051082";"protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp43211_c0_seq1;GAXK01147293.1;P04352;6.48E-45;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp4321508_c0_seq1;GAXK01087659.1;B3NLX1;5.94E-18;DAAF1_DROER;Dynein assembly factor 1, axonemal homolog (Defective transmitter-recycling protein) (Leucine-rich repeat-containing protein 50 homolog);"axoneme [GO:0005930]; dynein complex binding [GO:0070840]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]";"GO:0005930; GO:0007268; GO:0044458; GO:0060271; GO:0070840";"chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]";axoneme [GO:0005930];dynein complex binding [GO:0070840]
comp4322016_c0_seq1;GAXK01115052.1;P0A134;7.86E-14;TRA6_PSEAI;Transposase for insertion sequences IS1326/IS1353;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp4322670_c0_seq1;GAXK01115024.1;B4KMZ1;1.66E-12;LPHN_DROMO;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp4323629_c0_seq1;GAXK01115050.1;Q09575;4.47E-23;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp4324_c3_seq1;GAXK01066698.1;Q1LX51;8.63E-72;WEE2_DANRE;Wee1-like protein kinase 2 (EC 2.7.10.2) (Wee1-like protein kinase 1B) (Wee1B kinase);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; regulation of meiosis I [GO:0060631]";"GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0007093; GO:0051321; GO:0060631";"meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; regulation of meiosis I [GO:0060631]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp432401_c0_seq1;GAXK01019740.1;P52730;2.71E-41;HME2B_XENLA;Homeobox protein engrailed-2-B (En-2B) (Homeobox protein en-2-B) (En2 MABEN);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp43242_c0_seq1;GAXK01147327.1;P13496;0;DCTN1_DROME;Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (Dynactin 1 subunit p150) (Protein glued);"aster [GO:0005818]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; midbody [GO:0030496]; spindle microtubule [GO:0005876]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; axon extension [GO:0048675]; axonal transport of mitochondrion [GO:0019896]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; establishment of epithelial cell apical/basal polarity [GO:0045198]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]";"GO:0000278; GO:0000776; GO:0001709; GO:0001751; GO:0001754; GO:0003774; GO:0005737; GO:0005813; GO:0005818; GO:0005828; GO:0005876; GO:0006886; GO:0007349; GO:0008017; GO:0008090; GO:0016330; GO:0019896; GO:0030286; GO:0030496; GO:0031616; GO:0034501; GO:0035011; GO:0035149; GO:0042051; GO:0042052; GO:0045198; GO:0045505; GO:0048489; GO:0048491; GO:0048675; GO:0050772; GO:0051028; GO:0051225; GO:0051256; GO:0051299; GO:0051383; GO:0051642; GO:0061176; GO:0061670; GO:0070840; GO:1904115; GO:1990049";"axonal transport of mitochondrion [GO:0019896]; axon extension [GO:0048675]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; establishment of epithelial cell apical/basal polarity [GO:0045198]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]";"aster [GO:0005818]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; midbody [GO:0030496]; spindle microtubule [GO:0005876]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]";"dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; motor activity [GO:0003774]"
comp4324716_c0_seq1;GAXK01149861.1;Q96JB1;2.24E-98;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp432493_c0_seq1;GAXK01019766.1;Q8K2C8;1.88E-39;GPAT4_MOUSE;Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420";"acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";"glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]"
comp432589_c0_seq1;GAXK01019707.1;Q147U1;4.42E-22;ZN846_HUMAN;Zinc finger protein 846;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4325959_c0_seq1;GAXK01149849.1;Q09575;8.54E-09;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp432599_c0_seq1;GAXK01019694.1;P45947;1.10E-15;ARSC_BACSU;Arsenate reductase (EC 1.20.4.4) (Arsenical pump modifier) (Protein ArsC);"cytoplasm [GO:0005737]; arsenate reductase (thioredoxin) activity [GO:0030612]; protein tyrosine phosphatase activity [GO:0004725]; response to arsenic-containing substance [GO:0046685]";"GO:0004725; GO:0005737; GO:0030612; GO:0046685";response to arsenic-containing substance [GO:0046685];cytoplasm [GO:0005737];"arsenate reductase (thioredoxin) activity [GO:0030612]; protein tyrosine phosphatase activity [GO:0004725]"
comp4326112_c0_seq1;GAXK01022548.1;P39057;3.19E-13;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp4326253_c0_seq1;GAXK01022560.1;P45842;2.80E-38;RL34_AEDAL;60S ribosomal protein L34 (L31);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp432627_c0_seq1;GAXK01019729.1;Q9Y6N7;2.48E-75;ROBO1_HUMAN;Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1);"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]"
comp43263_c0_seq1;GAXK01147559.1;P51859;5.37E-19;HDGF_MOUSE;Hepatoma-derived growth factor (HDGF);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]; cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"GO:0000122; GO:0000166; GO:0000978; GO:0001222; GO:0001227; GO:0003714; GO:0003779; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0008083; GO:0008201; GO:0009987; GO:0015631; GO:0017053; GO:0034504; GO:0045944; GO:0051781; GO:0098761";"cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]"
comp432638_c2_seq1;GAXK01019723.1;P80646;1.07E-56;CTRB_GADMO;"Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586";digestion [GO:0007586];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp432659_c0_seq1;GAXK01019790.1;Q1RMH4;2.05E-10;PRAF1_BOVIN;Prenylated Rab acceptor protein 1 (PRA1 family protein 1);"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"GO:0005794; GO:0005886; GO:0008021; GO:0016021; GO:0030054";;"cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";
comp43270_c0_seq1;GAXK01147234.1;Q9HB90;7.47E-172;RRAGC_HUMAN;Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]";"GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007050; GO:0007264; GO:0008380; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131";"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]"
comp43271_c1_seq1;GAXK01147197.1;Q5EA79;1.39E-109;GALM_BOVIN;Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase);"cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";"GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499";"galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";cytoplasm [GO:0005737];"aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]"
comp432777_c0_seq1;GAXK01019764.1;Q7KRI2;2.15E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4327860_c0_seq1;GAXK01022541.1;Q39779;4.34E-20;ACBP_GOSHI;Acyl-CoA-binding protein (ACBP);"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0008289";;;"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp43280_c0_seq1;GAXK01147307.1;P31396;2.01E-49;HR3_DROME;Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]";"GO:0000122; GO:0000977; GO:0003707; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944";"metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp4328159_c0_seq1;GAXK01000441.1;O54898;9.22E-31;CAC1G_RAT;Voltage-dependent T-type calcium channel subunit alpha-1G (Voltage-gated calcium channel subunit alpha Cav3.1);"cell body [GO:0044297]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; artery smooth muscle contraction [GO:0014824]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to dexamethasone stimulus [GO:0071549]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"GO:0005886; GO:0005891; GO:0007204; GO:0008332; GO:0014824; GO:0016020; GO:0019228; GO:0030425; GO:0034765; GO:0043025; GO:0044297; GO:0045956; GO:0048471; GO:0051924; GO:0060402; GO:0070509; GO:0071549; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091";"artery smooth muscle contraction [GO:0014824]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to dexamethasone stimulus [GO:0071549]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"cell body [GO:0044297]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]"
comp432836_c0_seq1;GAXK01019780.1;Q5F477;1.48E-39;LDAH_CHICK;Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase);"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipase activity [GO:0016298]";"GO:0005783; GO:0005811; GO:0016298";;"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]";lipase activity [GO:0016298]
comp43284_c0_seq1;GAXK01147513.1;Q7KN62;1.06E-116;TERA_DROME;Transitional endoplasmic reticulum ATPase TER94 (EC 3.6.4.6) (Valosin-containing protein homolog);"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fusome [GO:0045169]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; ER-associated misfolded protein catabolic process [GO:0071712]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000226; GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006511; GO:0007029; GO:0007030; GO:0007040; GO:0007279; GO:0007317; GO:0016236; GO:0016320; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0031965; GO:0032436; GO:0034098; GO:0035096; GO:0043186; GO:0043523; GO:0043525; GO:0044754; GO:0045169; GO:0046598; GO:0046716; GO:0048477; GO:0048813; GO:0051228; GO:0071712; GO:0090090; GO:0097352; GO:0098586";"autophagosome maturation [GO:0097352]; cellular response to virus [GO:0098586]; dendrite morphogenesis [GO:0048813]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; ER-associated misfolded protein catabolic process [GO:0071712]; Golgi organization [GO:0007030]; larval midgut cell programmed cell death [GO:0035096]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle disassembly [GO:0051228]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral entry into host cell [GO:0046598]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; regulation of pole plasm oskar mRNA localization [GO:0007317]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fusome [GO:0045169]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]"
comp4328865_c0_seq1;GAXK01000452.1;P0C6B8;6.45E-10;SVEP1_RAT;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]";"GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]";calcium ion binding [GO:0005509]
comp4328869_c0_seq1;GAXK01000457.1;Q0IUU4;2.65E-08;CML2_ORYSJ;Putative calmodulin-like protein 2;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp4329_c1_seq1;GAXK01066262.1;P36975;5.67E-61;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp432937_c0_seq1;GAXK01019763.1;A3A9H6;1.29E-19;ACET1_ORYSJ;Probable ascorbate-specific transmembrane electron transporter 1 (EC 1.-.-.-) (Cytochrome b561-1);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491; GO:0046872";;integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp4329551_c0_seq1;GAXK01000437.1;O76090;2.21E-07;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp432963_c3_seq1;GAXK01019733.1;Q9ULC3;1.77E-78;RAB23_HUMAN;Ras-related protein Rab-23;"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp4329926_c0_seq1;GAXK01000459.1;P0DJ54;5.46E-26;RL24_TETTS;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp4330297_c0_seq1;GAXK01073838.1;Q16960;2.59E-25;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp4330767_c0_seq1;GAXK01073833.1;Q2TA17;2.76E-08;ZN668_BOVIN;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]";"GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4330991_c0_seq1;GAXK01073840.1;Q9D6N1;7.89E-10;CAH13_MOUSE;Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005829; GO:0008270; GO:0043209; GO:0043231";;"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp4331042_c0_seq1;GAXK01073837.1;P42260;3.44E-89;GRIK2_RAT;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp433131_c1_seq1;GAXK01019745.1;Q96BH3;4.41E-08;ESPB1_HUMAN;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12);"cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";heparin binding [GO:0008201]
comp4331816_c0_seq1;GAXK01073839.1;Q07113;2.71E-07;MPRI_MOUSE;Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222);"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0042981; GO:0043065; GO:0044794; GO:0048471; GO:0051219";"animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]";"enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]"
comp43319_c1_seq1;GAXK01205823.1;Q92630;0;DYRK2_HUMAN;Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224]";"GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006974; GO:0007224; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:1901796; GO:1990904";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp433201_c0_seq1;GAXK01019700.1;Q0DJV6;2.31E-14;CML18_ORYSJ;Probable calcium-binding protein CML18 (Calmodulin-like protein 18);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4332111_c0_seq1;GAXK01068794.1;Q941X2;5.50E-09;LAC3_ORYSJ;Laccase-3 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 3) (Diphenol oxidase 3) (Urishiol oxidase 3);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp4332285_c0_seq1;GAXK01068784.1;P55828;1.22E-30;RS20_DROME;40S ribosomal protein S20;"cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp43323_c1_seq1;GAXK01147486.1;P00766;6.50E-33;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp4332315_c0_seq1;GAXK01068776.1;Q9JLC8;4.87E-11;SACS_MOUSE;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]";"GO:0005737; GO:0050750";;cytoplasm [GO:0005737];low-density lipoprotein particle receptor binding [GO:0050750]
comp4332600_c0_seq1;GAXK01068775.1;P23576;1.47E-17;GBRA2_RAT;Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0030659; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315; GO:1904862";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp4332795_c0_seq1;GAXK01068789.1;Q8ISQ3;4.72E-29;RL24_BRABE;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp4332879_c0_seq1;GAXK01068795.1;P05130;2.35E-53;KPC1_DROME;Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR));"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]";"GO:0004674; GO:0004697; GO:0004712; GO:0005524; GO:0005886; GO:0006468; GO:0008270; GO:0018105; GO:0035206; GO:0035556; GO:2000370";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"
comp4333167_c0_seq1;GAXK01068786.1;Q06827;2.59E-85;CATR_SCHDU;Caltractin (Centrin);"calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005509; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";;calcium ion binding [GO:0005509]
comp4333440_c0_seq1;GAXK01068801.1;Q9UI46;2.84E-69;DNAI1_HUMAN;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003774; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp433359_c9_seq1;GAXK01019727.1;B0WSX1;0;MOCO2_CULQU;Molybdenum cofactor sulfurase 2 (MCS 2) (MOS 2) (MoCo sulfurase 2) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase 2) (Protein maroon-like 2) (Ma-l 2);"lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]";"GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0043545; GO:0102867";"molybdopterin cofactor metabolic process [GO:0043545]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]";;"lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; pyridoxal phosphate binding [GO:0030170]"
comp433368_c0_seq1;GAXK01019779.1;O08747;1.69E-73;UNC5C_MOUSE;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C) (Rostral cerebellar malformation protein);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030054; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0033564; GO:0038007; GO:0043025; GO:0043065; GO:0045202; GO:0061643; GO:1990791";"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"
comp4333756_c0_seq1;GAXK01068803.1;D2EAC2;2.27E-15;ZBED6_MOUSE;Zinc finger BED domain-containing protein 6 (Muscle growth regulator) (MGR);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0001835; GO:0003677; GO:0005634; GO:0005730; GO:0045892; GO:0046872; GO:0046983";"blastocyst hatching [GO:0001835]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp4334_c0_seq1;GAXK01067187.1;Q9GPJ1;1.15E-08;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp43345_c1_seq1;GAXK01147589.1;O89033;8.17E-102;CDC6_MOUSE;Cell division control protein 6 homolog (CDC6-related protein) (p62(cdc6));"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";"GO:0000278; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0006270; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984";"cell division [GO:0051301]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of mitotic metaphase/anaphase transition [GO:0030071]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]"
comp4334697_c0_seq1;GAXK01059833.1;Q94HW2;1.32E-13;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4334773_c0_seq1;GAXK01059825.1;Q6UWB4;3.15E-19;PRS55_HUMAN;Serine protease 55 (EC 3.4.21.-) (Testis serine protease 1) (T-SP1);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005829; GO:0016021";;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]";serine-type endopeptidase activity [GO:0004252]
comp433607_c0_seq1;GAXK01019718.1;Q5T2R2;8.90E-49;DPS1_HUMAN;Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1);"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234";"isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]";"metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]"
comp433609_c2_seq1;GAXK01019751.1;Q5VTB9;4.18E-18;RN220_HUMAN;E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0061630; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp4336606_c0_seq1;GAXK01064799.1;O35764;5.25E-08;NPTXR_RAT;Neuronal pentraxin receptor;"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; pentraxin receptor activity [GO:0008029]; protein-containing complex binding [GO:0044877]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to hydrogen peroxide [GO:0042542]";"GO:0005615; GO:0005886; GO:0008029; GO:0009898; GO:0016021; GO:0030175; GO:0030425; GO:0030426; GO:0031175; GO:0042542; GO:0043025; GO:0044877; GO:0046872; GO:0099645";"neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to hydrogen peroxide [GO:0042542]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; pentraxin receptor activity [GO:0008029]; protein-containing complex binding [GO:0044877]"
comp4336725_c0_seq1;GAXK01064815.1;Q86LG1;2.14E-14;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp4336900_c0_seq1;GAXK01064818.1;P23098;8.50E-94;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp4337_c2_seq1;GAXK01065363.1;Q58EA2;7.02E-39;THO4A_XENLA;THO complex subunit 4-A (Tho4-A) (Aly/REF export factor-A);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0051028";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";RNA binding [GO:0003723]
comp433730_c1_seq1;GAXK01019776.1;Q20065;3.00E-49;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp433756_c0_seq1;GAXK01019794.1;B7Z0W9;7.89E-41;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp43379_c0_seq1;GAXK01147743.1;P35381;3.65E-74;ATPA_DROME;ATP synthase subunit alpha, mitochondrial (Protein bellwether);"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0000275; GO:0005524; GO:0005739; GO:0015986; GO:0019915; GO:0022900; GO:0043531; GO:0046933; GO:1902769";"ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp4337910_c0_seq1;GAXK01064812.1;Q95276;3.16E-40;RL5_PIG;60S ribosomal protein L5 (Fragment);"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0008097; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp433801_c0_seq1;GAXK01019761.1;D3ZDK7;6.52E-62;PGP_RAT;Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]";"GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0005829; GO:0006114; GO:0006650; GO:0008967; GO:0016311; GO:0016791; GO:0043136; GO:0045721; GO:0098519";"dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]"
comp43381_c0_seq1;GAXK01147746.1;Q5R4Q3;6.09E-23;SEC62_PONAB;Translocation protein SEC62 (Translocation protein 1) (TP-1);"integral component of endoplasmic reticulum membrane [GO:0030176]; rough endoplasmic reticulum [GO:0005791]; posttranslational protein targeting to membrane, translocation [GO:0031204]";"GO:0005791; GO:0030176; GO:0031204";posttranslational protein targeting to membrane, translocation [GO:0031204];"integral component of endoplasmic reticulum membrane [GO:0030176]; rough endoplasmic reticulum [GO:0005791]";
comp43384_c1_seq1;GAXK01147216.1;G3H0N9;1.05E-31;DNJB9_CRIGR;DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0002377; GO:0005783; GO:0005788; GO:0006986; GO:0030183; GO:0030433; GO:0030544; GO:0034976; GO:0051087; GO:0051787; GO:1903895";"B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]"
comp4338778_c0_seq1;GAXK01000512.1;P22607;3.70E-16;FGFR3_HUMAN;Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0018108; GO:0030133; GO:0030282; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048640; GO:0051897; GO:0060349; GO:0070374; GO:0070977; GO:1902178";"bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]";"ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp4339_c0_seq1;GAXK01066051.1;Q00577;5.12E-68;PURA_HUMAN;Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha);"dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; postsynapse [GO:0098794]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000784; GO:0000900; GO:0000977; GO:0000981; GO:0001227; GO:0003690; GO:0003691; GO:0003697; GO:0003723; GO:0005634; GO:0005662; GO:0006268; GO:0006270; GO:0007399; GO:0008134; GO:0008284; GO:0030154; GO:0032422; GO:0032839; GO:0043025; GO:0043565; GO:0046332; GO:0046651; GO:0050673; GO:0098794; GO:0098963; GO:0098978";"cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; postsynapse [GO:0098794]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp4340098_c0_seq1;GAXK01067261.1;Q9FJX2;7.31E-50;RL262_ARATH;60S ribosomal protein L26-2;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003735; GO:0009536; GO:0022625; GO:0022626; GO:0042273; GO:0042788";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4340139_c0_seq1;GAXK01067241.1;O60909;2.85E-21;B4GT2_HUMAN;Beta-1,4-galactosyltransferase 2 (Beta-1,4-GalTase 2) (Beta4Gal-T2) (b4Gal-T2) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2);"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; keratan sulfate biosynthetic process [GO:0018146]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542]";"GO:0000139; GO:0003831; GO:0003945; GO:0004461; GO:0005654; GO:0005794; GO:0005975; GO:0006486; GO:0007613; GO:0007626; GO:0008378; GO:0008542; GO:0016021; GO:0018146; GO:0021680; GO:0032580; GO:0043231; GO:0046872";"carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; keratan sulfate biosynthetic process [GO:0018146]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542]";"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]"
comp4340636_c0_seq1;GAXK01067238.1;D0E0C2;3.37E-08;SCNA1_PERAM;Sodium channel protein PaFPC1 (PaFPC1) (NavPaS);"voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; regulation of ion transmembrane transport [GO:0034765]";"GO:0001518; GO:0005244; GO:0005248; GO:0034765";regulation of ion transmembrane transport [GO:0034765];voltage-gated sodium channel complex [GO:0001518];"voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp4340950_c0_seq1;GAXK01067257.1;P15918;1.91E-10;RAG1_HUMAN;"V(D)J recombination-activating protein 1 (RAG-1) (RING finger protein 74) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)]";"DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542]";"GO:0002250; GO:0002331; GO:0003677; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006955; GO:0008270; GO:0008542; GO:0010390; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042803; GO:0043029; GO:0043154; GO:0043565; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070244; GO:0097519; GO:1905347; GO:2000822";"adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542]";"DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4341363_c0_seq1;GAXK01067250.1;Q6CX73;1.57E-13;FAL1_KLULA;ATP-dependent RNA helicase FAL1 (EC 3.6.4.13);"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030688; GO:0097078";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp43414_c0_seq1;GAXK01147687.1;Q99KL7;1.21E-74;RAB28_MOUSE;Ras-related protein Rab-28;"ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; toxin transport [GO:1901998]";"GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0019003; GO:0032482; GO:0035253; GO:0036064; GO:1901998";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; toxin transport [GO:1901998]";"ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp4341698_c0_seq1;GAXK01067239.1;P29562;3.63E-26;IF4A1_RABIT;Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1) (Fragment);"ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]";"GO:0003724; GO:0003743; GO:0005524";;;"ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp4342311_c0_seq1;GAXK01000528.1;Q8ITC9;1.80E-16;PK1R_DROME;Pyrokinin-1 receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]"
comp43434_c4_seq1;GAXK01147152.1;Q658Y4;0;F91A1_HUMAN;Protein FAM91A1;"cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]";"GO:0005802; GO:0006886; GO:0031410; GO:0099041";"intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]";"cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]";
comp4344096_c0_seq1;GAXK01089767.1;Q5K651;4.66E-11;SAMD9_HUMAN;Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005829; GO:0034058; GO:0043231";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]";
comp434469_c0_seq1;GAXK01021498.1;Q8AY47;4.06E-07;PA2B2_BUNCA;Basic phospholipase A2 beta-bungarotoxin A2 chain (Beta-BuTX A2 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Fragment);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; toxin activity [GO:0090729]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0050482; GO:0090729; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; toxin activity [GO:0090729]"
comp4344871_c0_seq1;GAXK01089781.1;P46222;2.80E-103;RL11_DROME;60S ribosomal protein L11;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4345_c2_seq1;GAXK01065401.1;P81139;1.06E-23;LIPR2_CAVPO;Pancreatic lipase-related protein 2 (PL-RP2) (EC 3.1.1.26) (EC 3.1.1.3) (GPL) (Galactolipase);"extracellular space [GO:0005615]; 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0009395; GO:0019376; GO:0047372; GO:0047714; GO:0102549";"galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]";extracellular space [GO:0005615];"1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]"
comp434500_c0_seq1;GAXK01021486.1;Q9VIP7;1.32E-71;ACASE_DROME;Alkaline ceramidase (AlkCDase) (EC 3.5.1.23) (Alkaline N-acylsphingosine amidohydrolase) (Alkaline acylsphingosine deacylase) (Protein brainwashing);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]; brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005783; GO:0006665; GO:0007420; GO:0016021; GO:0017040; GO:0019216; GO:0046514; GO:0046872; GO:0102121";"brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]"
comp4345933_c0_seq1;GAXK01089766.1;O42820;1.21E-65;EF1A_SCHCO;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp4346245_c0_seq1;GAXK01163658.1;Q02975;2.81E-08;Z354A_RAT;Zinc finger protein 354A (Kidney, ischemia, and developmentally-regulated protein 1) (Renal transcription factor Kid-1) (Transcription factor 17) (TCF-17);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleolar fragmentation [GO:0007576]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]";"GO:0000122; GO:0001666; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005730; GO:0007576; GO:0046872; GO:0051593";"kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleolar fragmentation [GO:0007576]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4346422_c0_seq1;GAXK01163639.1;Q9Y6V7;1.18E-13;DDX49_HUMAN;Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364";rRNA processing [GO:0006364];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp43468_c4_seq1;GAXK01147345.1;P33527;0;MRP1_HUMAN;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005524; GO:0005774; GO:0005886; GO:0005887; GO:0006691; GO:0006855; GO:0008559; GO:0009235; GO:0015420; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0071716; GO:0099039; GO:0140359";"cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp4347762_c0_seq1;GAXK01163641.1;O61598;3.10E-39;RL37A_OSTOS;60S ribosomal protein L37a;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp43478_c4_seq1;GAXK01205818.1;Q6R7M4;1.03E-102;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp4348_c0_seq1;GAXK01204949.1;P46436;2.34E-38;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp4348188_c0_seq1;GAXK01126169.1;Q4XFJ8;9.69E-26;TCTP_PLACH;Translationally-controlled tumor protein homolog (TCTP);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp4348382_c0_seq1;GAXK01126146.1;Q9JME2;2.79E-15;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp434873_c0_seq1;GAXK01021485.1;Q58087;6.84E-34;Y674_METJA;Uncharacterized protein MJ0674;"4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]";"GO:0003824; GO:0046872; GO:0051539";;;"4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]"
comp4349106_c0_seq1;GAXK01126164.1;Q9P283;1.93E-09;SEM5B_HUMAN;Semaphorin-5B;"integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001755; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485";"axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";integral component of membrane [GO:0016021];"chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]"
comp4349367_c0_seq1;GAXK01126141.1;Q6ZR08;2.87E-12;DYH12_HUMAN;Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0030286";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp434952_c0_seq1;GAXK01021564.1;Q8S3N1;5.67E-07;SINA5_ARATH;E3 ubiquitin-protein ligase SINAT5 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT5) (Seven in absentia homolog 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp435079_c1_seq1;GAXK01021489.1;Q8UWA5;1.06E-37;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp43514_c1_seq1;GAXK01147201.1;Q7PMT1;8.66E-100;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp4351477_c0_seq1;GAXK01115408.1;Q7KRI2;3.13E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4352278_c0_seq1;GAXK01060306.1;Q10982;8.79E-08;FUT2_PIG;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp43525_c6_seq1;GAXK01147650.1;Q02290;1.35E-42;XYNB_NEOPA;Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B);"extracellular region [GO:0005576]; cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0005576; GO:0030248; GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];extracellular region [GO:0005576];"cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]"
comp4353355_c0_seq1;GAXK01060321.1;Q9H3D4;2.75E-34;P63_HUMAN;Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"GO:0000122; GO:0000790; GO:0000981; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0005794; GO:0005829; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0042981; GO:0043281; GO:0043565; GO:0043589; GO:0044212; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051289; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1900740; GO:1901796; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773";"apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]";"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]"
comp43536_c3_seq1;GAXK01147202.1;Q9VH20;6.09E-08;TAF1B_DROME;TATA box-binding protein-associated factor RNA polymerase I subunit B (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B);"nucleolus [GO:0005730]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; RNA polymerase I preinitiation complex assembly [GO:0001188]";"GO:0001164; GO:0001188; GO:0005668; GO:0005730; GO:0042790; GO:0046872; GO:0070860; GO:1901838";"nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; RNA polymerase I preinitiation complex assembly [GO:0001188]";"nucleolus [GO:0005730]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]";"metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]"
comp4354059_c0_seq1;GAXK01041032.1;Q98943;2.75E-26;CASP2_CHICK;"Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200";"apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp435427_c0_seq1;GAXK01021552.1;Q4V7T8;7.25E-52;ROP1L_XENLA;Ropporin-1-like protein;motile cilium [GO:0031514];GO:0031514;;motile cilium [GO:0031514];
comp435448_c1_seq1;GAXK01021515.1;Q9PW72;1.83E-09;PDLI4_CHICK;PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein);"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; limb development [GO:0060173]; muscle structure development [GO:0061061]";"GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005913; GO:0007507; GO:0019903; GO:0030018; GO:0030027; GO:0030036; GO:0031532; GO:0031901; GO:0031905; GO:0031941; GO:0034777; GO:0042803; GO:0043197; GO:0045211; GO:0046872; GO:0048471; GO:0051015; GO:0051371; GO:0055038; GO:0060173; GO:0061061; GO:0098976";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; limb development [GO:0060173]; muscle structure development [GO:0061061]";"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]"
comp435506_c0_seq1;GAXK01021500.1;Q59E36;9.72E-40;RCOR_DROME;REST corepressor (CoREST);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"GO:0000122; GO:0003682; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006325; GO:0008134; GO:0017053; GO:0044212; GO:0045892; GO:0061086; GO:0090309; GO:2000619";"chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp4355253_c0_seq1;GAXK01041026.1;O61366;1.45E-36;GPRS_DROME;Serine-enriched protein;;;;;
comp4355285_c0_seq1;GAXK01041030.1;P62083;3.40E-38;RS7_RAT;40S ribosomal protein S7 (S8);"centrosome [GO:0005813]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(U) RNA binding [GO:0008266]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]";"GO:0001843; GO:0003730; GO:0003735; GO:0005730; GO:0005813; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0019901; GO:0022627; GO:0030154; GO:0032040; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1990948; GO:2000059";"cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]";"centrosome [GO:0005813]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; synapse [GO:0045202]";"mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(U) RNA binding [GO:0008266]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]"
comp435568_c0_seq1;GAXK01021496.1;Q9Y462;1.19E-15;ZN711_HUMAN;Zinc finger protein 711 (Zinc finger protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0031490; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp435574_c0_seq1;GAXK01021535.1;Q9V477;9.54E-142;TOLL8_DROME;Toll-like receptor Tollo (Toll-like receptor 8);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]";"GO:0002227; GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0048935; GO:0060026; GO:0060049";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";
comp4355855_c0_seq1;GAXK01041034.1;Q56K03;1.32E-73;RL27A_BOVIN;60S ribosomal protein L27a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp435604_c0_seq1;GAXK01021530.1;Q9I7U4;1.30E-64;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp435661_c0_seq1;GAXK01021549.1;O27188;4.43E-16;MFNA_METTH;Probable L-tyrosine/L-aspartate decarboxylase (TDC/ADC) (EC 4.1.1.11) (EC 4.1.1.25);"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]; carboxylic acid metabolic process [GO:0019752]; coenzyme A biosynthetic process [GO:0015937]; methanofuran biosynthetic process [GO:2001120]";"GO:0004068; GO:0004837; GO:0015937; GO:0019752; GO:0030170; GO:2001120";"carboxylic acid metabolic process [GO:0019752]; coenzyme A biosynthetic process [GO:0015937]; methanofuran biosynthetic process [GO:2001120]";;"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]"
comp4356812_c0_seq1;GAXK01170940.1;Q86Y01;2.43E-26;DTX1_HUMAN;E3 ubiquitin-protein ligase DTX1 (EC 2.3.2.27) (Protein deltex-1) (Deltex1) (hDTX1) (RING-type E3 ubiquitin transferase DTX1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cellular response to leukemia inhibitory factor [GO:1990830]; glial cell differentiation [GO:0010001]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of T cell differentiation [GO:0045581]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]";"GO:0003713; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0007166; GO:0007219; GO:0008270; GO:0008593; GO:0010001; GO:0016567; GO:0016604; GO:0016740; GO:0017124; GO:0031625; GO:0045581; GO:0045665; GO:1990830";"cell surface receptor signaling pathway [GO:0007166]; cellular response to leukemia inhibitory factor [GO:1990830]; glial cell differentiation [GO:0010001]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of T cell differentiation [GO:0045581]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]";"Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp43571_c0_seq1;GAXK01147193.1;P42282;5.55E-12;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4357217_c0_seq1;GAXK01170939.1;Q7RZS0;2.56E-52;RL10A_NEUCR;60S ribosomal protein L10a (Cytoplasmic ribosomal protein 74);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4358261_c0_seq1;GAXK01112390.1;Q8G9F9;7.08E-23;INHA_PSEPU;Isonitrile hydratase (EC 4.2.1.103) (Cyclohexyl-isocyanide hydratase);cyclohexyl-isocyanide hydratase activity [GO:0050549];GO:0050549;;;cyclohexyl-isocyanide hydratase activity [GO:0050549]
comp435828_c0_seq1;GAXK01021557.1;Q7ZVG6;8.03E-08;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp43584_c1_seq1;GAXK01147296.1;Q61165;7.24E-93;SL9A1_MOUSE;Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"GO:0002026; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014070; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051930; GO:0055007; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1903281";"cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]";"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]"
comp43596_c3_seq1;GAXK01147406.1;P07207;0;NOTCH_DROME;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];"adherens junction [GO:0005912]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]";"GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048";"actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]";"adherens junction [GO:0005912]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]"
comp436034_c0_seq1;GAXK01174667.1;Q9VCA2;1.20E-110;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp436125_c0_seq1;GAXK01174504.1;Q8C261;6.15E-13;NCKX5_MOUSE;Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5);"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"GO:0005262; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0034220; GO:0042470; GO:0048022; GO:0050896; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]";"integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp4361734_c0_seq1;GAXK01181736.1;B7Z031;1.32E-25;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp43622_c0_seq2;GAXK01147149.1;A1ZA47;1.29E-07;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp436229_c0_seq1;GAXK01174675.1;Q05192;1.23E-13;FTF1B_DROME;Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"GO:0000976; GO:0000978; GO:0003682; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0009755; GO:0009888; GO:0035211; GO:0045944; GO:0060968; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp43623_c0_seq1;GAXK01147708.1;Q9VUJ0;2.97E-98;RM39_DROME;39S ribosomal protein L39, mitochondrial (MRP-L39) (MRP-L5);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0000166; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006417; GO:0031047; GO:0032543";"gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412]";"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";"nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]"
comp4363928_c0_seq1;GAXK01068928.1;Q63406;5.27E-12;MCF2L_RAT;Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene);"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"GO:0005089; GO:0005737; GO:0005886; GO:0008289; GO:0019898; GO:0035025; GO:0035556";"intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]";"lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp4364223_c0_seq1;GAXK01081873.1;Q8N184;1.03E-07;ZN567_HUMAN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4364263_c0_seq1;GAXK01081892.1;Q9R0Y1;1.05E-07;ASIC5_MOUSE;Acid-sensing ion channel 5 (ASIC5) (Amiloride-sensitive cation channel 5) (Brain-liver-intestine amiloride-sensitive Na(+) channel) (BLINaC);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; sodium ion transmembrane transport [GO:0035725]";"GO:0005272; GO:0005886; GO:0015252; GO:0015280; GO:0016020; GO:0016021; GO:0035725";sodium ion transmembrane transport [GO:0035725];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]"
comp43650_c0_seq1;GAXK01147329.1;Q9GRW0;1.34E-86;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp43652_c0_seq1;GAXK01147295.1;P36958;4.75E-71;RPB9_DROME;DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II 15.1 kDa polypeptide);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mitotic cell cycle [GO:0000278]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000278; GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0006379; GO:0008270";"maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mitotic cell cycle [GO:0000278]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]";"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp4365242_c0_seq1;GAXK01081878.1;Q9LHP1;1.34E-49;RL74_ARATH;60S ribosomal protein L7-4;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003729; GO:0003735; GO:0005829; GO:0022625; GO:0022626; GO:0042788";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp4365500_c0_seq1;GAXK01081872.1;P40656;1.10E-36;SOX14_DROME;Putative transcription factor SOX-14;"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0016322; GO:0030154; GO:0043565; GO:0044798; GO:0048813; GO:1904799; GO:1904801";"cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp4365794_c0_seq1;GAXK01081876.1;P00051;2.47E-45;CYC_CUCMA;Cytochrome c;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp436602_c0_seq1;GAXK01174671.1;Q6IVV8;1.48E-119;PKD2_DANRE;Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738";"atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp43661_c0_seq1;GAXK01147311.1;P06803;4.52E-85;PIM1_MOUSE;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0008283; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hyaluronan metabolic process [GO:0030212]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp4366131_c0_seq1;GAXK01003587.1;P08548;3.35E-07;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp436631_c1_seq1;GAXK01174710.1;P28750;4.63E-09;EXU_DROME;Maternal protein exuperantia;"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]; anterior/posterior axis specification, embryo [GO:0008595]; bicoid mRNA localization [GO:0045450]; embryonic development via the syncytial blastoderm [GO:0001700]; mRNA splicing, via spliceosome [GO:0000398]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]";"GO:0000398; GO:0000932; GO:0001700; GO:0003727; GO:0005737; GO:0007283; GO:0007300; GO:0007317; GO:0008595; GO:0036464; GO:0042803; GO:0045450; GO:0045451; GO:0071011; GO:0090305";"anterior/posterior axis specification, embryo [GO:0008595]; bicoid mRNA localization [GO:0045450]; embryonic development via the syncytial blastoderm [GO:0001700]; mRNA splicing, via spliceosome [GO:0000398]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]";"protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]"
comp4366341_c0_seq1;GAXK01003594.1;Q9BQS2;2.35E-11;SYT15_HUMAN;Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV);"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]"
comp4366849_c0_seq1;GAXK01003588.1;P17538;3.06E-25;CTRB1_HUMAN;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp43669_c3_seq1;GAXK01147543.1;Q8C156;2.95E-33;CND2_MOUSE;Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (mCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog);"chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]";"GO:0000796; GO:0000799; GO:0003682; GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0007143; GO:0010032; GO:0044547; GO:0045132; GO:0051301; GO:0051309; GO:0072587";"cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]";"chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]"
comp4366945_c0_seq1;GAXK01003593.1;P27075;7.31E-47;RL44_CANTR;60S ribosomal protein L44 (60S ribosomal protein L41);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to cycloheximide [GO:0046898]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046898";"response to cycloheximide [GO:0046898]; translation [GO:0006412]";ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp43673_c0_seq1;GAXK01147281.1;Q8BH16;1.84E-11;FBXL2_MOUSE;F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2);"membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005516; GO:0006511; GO:0006513; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830";"modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]";"calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]"
comp4367316_c0_seq1;GAXK01003590.1;Q9CX98;2.09E-30;CP2U1_MOUSE;Cytochrome P450 2U1 (EC 1.14.14.1);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp436742_c1_seq1;GAXK01174531.1;Q69L99;3.45E-35;LAC14_ORYSJ;Laccase-14 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 14) (Diphenol oxidase 14) (Urishiol oxidase 14);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp4367855_c0_seq1;GAXK01003583.1;Q24756;4.29E-39;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp43680_c2_seq1;GAXK01147740.1;O54924;3.64E-113;EXOC8_RAT;Exocyst complex component 8 (Exocyst complex 84 kDa subunit);"cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; Ral GTPase binding [GO:0017160]; cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; protein localization [GO:0008104]; protein transport [GO:0015031]";"GO:0000145; GO:0005770; GO:0005829; GO:0006887; GO:0006893; GO:0007032; GO:0008104; GO:0015031; GO:0017160; GO:0022617; GO:0030426; GO:0031252; GO:0034613; GO:0048471";"cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; protein localization [GO:0008104]; protein transport [GO:0015031]";"cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]";Ral GTPase binding [GO:0017160]
comp436856_c0_seq1;GAXK01174688.1;Q5R5X9;8.73E-32;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp4369118_c0_seq1;GAXK01203440.1;Q5F3X8;6.21E-50;SC31A_CHICK;Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A);"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"GO:0000139; GO:0005198; GO:0005789; GO:0006886; GO:0006888; GO:0007029; GO:0030127; GO:0030134; GO:0070971; GO:0090110; GO:0090114";"COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";structural molecule activity [GO:0005198]
comp43693_c5_seq1;GAXK01147722.1;P52432;3.33E-106;RPAC1_MOUSE;DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPC40);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383; GO:0046983";"transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]"
comp4370788_c0_seq1;GAXK01179786.1;F1QQA8;6.39E-08;ZN219_DANRE;Zinc finger protein 219 (Zinc finger protein 219-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; notochord development [GO:0030903]";"GO:0001228; GO:0003677; GO:0005634; GO:0030903; GO:0046872";notochord development [GO:0030903];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]"
comp4371328_c0_seq1;GAXK01179784.1;A8Q2D1;4.04E-13;NAS35_BRUMA;Zinc metalloproteinase dpy-31 (EC 3.4.24.-) (Nematode astacin 35) (Procollagen C-proteinase);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]";"GO:0004222; GO:0005576; GO:0008270; GO:0042338";cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp437139_c0_seq1;GAXK01174597.1;O43435;3.10E-114;TBX1_HUMAN;T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001102; GO:0001228; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0001947; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:2000027; GO:2001037; GO:2001054";"angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4371579_c0_seq1;GAXK01179804.1;Q10574;1.53E-11;LIN32_CAEEL;Protein lin-32 (Abnormal cell lineage protein 32);"nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";"GO:0005634; GO:0009792; GO:0042803; GO:0043565; GO:0045138; GO:0046982; GO:0048666; GO:0051179";"embryo development ending in birth or egg hatching [GO:0009792]; localization [GO:0051179]; nematode male tail tip morphogenesis [GO:0045138]; neuron development [GO:0048666]";nucleus [GO:0005634];"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp43721_c0_seq1;GAXK01147591.1;Q96GC5;3.69E-19;RM48_HUMAN;39S ribosomal protein L48, mitochondrial (L48mt) (MRP-L48) (Mitochondrial large ribosomal subunit protein mL48);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0070125; GO:0070126";"mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";
comp4372456_c0_seq1;GAXK01067310.1;Q99315;2.69E-14;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp437255_c2_seq1;GAXK01174591.1;Q6AYY8;1.83E-130;ACATN_RAT;Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; central nervous system development [GO:0007417]";"GO:0005789; GO:0007417; GO:0008521; GO:0015295; GO:0016021";central nervous system development [GO:0007417];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]"
comp437311_c0_seq1;GAXK01174590.1;Q6DCH7;2.25E-35;SBP1B_XENLA;Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1-B);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]";"GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549";protein transport [GO:0015031];"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]"
comp4373326_c0_seq1;GAXK01067303.1;Q9U6Z1;2.62E-55;KM11_TRYCR;Kinetoplastid membrane protein 11 (KMP-11);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cilium-dependent cell motility [GO:0060285]; cytoskeleton organization [GO:0007010]; defense response [GO:0006952]; entry into host cell [GO:0030260]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005737; GO:0005874; GO:0006952; GO:0007010; GO:0008284; GO:0015630; GO:0030260; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cytoskeleton organization [GO:0007010]; defense response [GO:0006952]; entry into host cell [GO:0030260]; positive regulation of cell population proliferation [GO:0008284]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]";
comp4373626_c0_seq1;GAXK01067307.1;D4AK47;4.34E-13;EASE_ARTBC;FAD-linked oxidoreductase easE (EC 1.-.-.-) (Chanoclavine I synthase) (Ergot alkaloid synthesis protein E);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; indole alkaloid biosynthetic process [GO:0035835]";"GO:0016491; GO:0035835; GO:0071949";indole alkaloid biosynthetic process [GO:0035835];;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp437375_c0_seq1;GAXK01174522.1;Q5DX34;3.23E-32;RPGRH_CAEEL;X-linked retinitis pigmentosa GTPase regulator homolog (Gut granule loss protein 4);"axon [GO:0030424]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of axon extension [GO:0030517]";"GO:0005085; GO:0030424; GO:0030517; GO:0045202";negative regulation of axon extension [GO:0030517];"axon [GO:0030424]; synapse [GO:0045202]";guanyl-nucleotide exchange factor activity [GO:0005085]
comp43741_c0_seq1;GAXK01147230.1;Q6DI37;3.36E-130;UBCP1_DANRE;Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1);"nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]";"GO:0004722; GO:0005634; GO:0006470";protein dephosphorylation [GO:0006470];nucleus [GO:0005634];protein serine/threonine phosphatase activity [GO:0004722]
comp4374124_c0_seq1;GAXK01047272.1;A0JMP0;4.70E-13;PGGHG_DANRE;Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1);"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005829; GO:0005975; GO:0047402";carbohydrate metabolic process [GO:0005975];cytosol [GO:0005829];"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]"
comp43742_c0_seq1;GAXK01147228.1;Q6P2B1;0;TNPO3_MOUSE;Transportin-3;"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein import into nucleus [GO:0006606]";"GO:0005634; GO:0005737; GO:0006606; GO:0042802; GO:0043231";protein import into nucleus [GO:0006606];"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";identical protein binding [GO:0042802]
comp43743_c1_seq1;GAXK01147133.1;Q7ZVJ8;2.17E-56;MTL26_DANRE;Methyltransferase-like 26;;;;;
comp43745_c4_seq1;GAXK01147158.1;Q5BKN5;3.25E-83;CD123_XENTR;Cell division cycle protein 123 homolog;"cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005737; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";cytoplasm [GO:0005737];
comp4374691_c0_seq1;GAXK01047281.1;P97353;2.19E-08;SEC1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp4374714_c0_seq1;GAXK01047266.1;P05661;5.64E-08;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp4374795_c0_seq1;GAXK01047269.1;Q9ZT56;7.11E-34;RS8_GRIJA;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4375_c1_seq1;GAXK01066672.1;Q9V3P0;2.58E-100;PRDX1_DROME;Peroxiredoxin 1 (EC 1.11.1.15) (Cytosolic thioredoxin peroxidase) (DPx-4783) (DmTPx-1) (Thioredoxin peroxidase);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]";"GO:0005829; GO:0006979; GO:0007155; GO:0007281; GO:0008340; GO:0008354; GO:0008379; GO:0019430; GO:0042594; GO:0042744; GO:0045321; GO:0045454";"cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp437521_c0_seq1;GAXK01174685.1;P43304;2.22E-34;GPDM_HUMAN;Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mtGPD);"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264]";"GO:0004367; GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006127; GO:0009331; GO:0019563; GO:0035264; GO:0043010; GO:0046168; GO:0052591";"camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol catabolic process [GO:0019563]; glycerophosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264]";"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]"
comp43759_c2_seq1;GAXK01147184.1;P51521;8.33E-78;OVO_DROME;Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)];"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896";"adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp4376167_c0_seq1;GAXK01115261.1;Q13790;1.29E-08;APOF_HUMAN;Apolipoprotein F (Apo-F) (Lipid transfer inhibitor protein) (LTIP);"extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]";"GO:0005102; GO:0005319; GO:0005615; GO:0006629; GO:0006869; GO:0008203; GO:0015485; GO:0034362; GO:0034364";"cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]";"extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]"
comp4376675_c0_seq1;GAXK01115272.1;Q8TD84;2.84E-10;DSCL1_HUMAN;Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030054; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]"
comp437684_c0_seq1;GAXK01174599.1;Q9Y2P7;4.76E-32;ZN256_HUMAN;Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0045892; GO:0046872";"multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp43775_c2_seq1;GAXK01147512.1;Q4QR29;0;CTR9_XENLA;RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1);"Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]";"GO:0000122; GO:0016593; GO:0032968; GO:0035327; GO:0045944; GO:0051571; GO:0080182";"histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]";"Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]";
comp4377613_c0_seq1;GAXK01115273.1;P0DO19;3.32E-36;LHR31_CHLRE;Light-harvesting complex stress-related protein 3.1, chloroplastic (Chlorophyll a-b binding protein LHCSR3.1);;;;;
comp437871_c0_seq1;GAXK01174510.1;F1NHE9;1.02E-53;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp43789_c1_seq1;GAXK01147686.1;P63208;1.48E-39;SKP1_HUMAN;S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1);"centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; protein domain specific binding [GO:0019904]; ubiquitin-protein transferase activity [GO:0004842]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H2A monoubiquitination [GO:0035518]; interleukin-1-mediated signaling pathway [GO:0070498]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0008013; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0035518; GO:0038061; GO:0038095; GO:0043687; GO:0050852; GO:0051403; GO:0051457; GO:0070498; GO:0097602; GO:1901990";"cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H2A monoubiquitination [GO:0035518]; interleukin-1-mediated signaling pathway [GO:0070498]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; protein domain specific binding [GO:0019904]; ubiquitin-protein transferase activity [GO:0004842]"
comp4379083_c0_seq1;GAXK01079459.1;Q8N0N3;1.73E-27;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp4379140_c0_seq1;GAXK01079462.1;Q9V817;1.41E-13;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp4379144_c0_seq1;GAXK01079461.1;P60868;8.64E-43;RS20_RAT;40S ribosomal protein S20;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4379398_c0_seq1;GAXK01079458.1;Q13127;7.79E-10;REST_HUMAN;RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043922; GO:0044212; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp437968_c0_seq1;GAXK01174683.1;Q9D7X3;6.55E-21;DUS3_MOUSE;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001701; GO:0001772; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp4379884_c0_seq1;GAXK01079434.1;Q29486;2.15E-61;PPBT_FELCA;Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme);"anchored component of plasma membrane [GO:0046658]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]";"GO:0004035; GO:0016311; GO:0046658; GO:0046872";dephosphorylation [GO:0016311];anchored component of plasma membrane [GO:0046658];"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]"
comp438044_c0_seq1;GAXK01186912.1;P16066;5.28E-53;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp43805_c1_seq1;GAXK01147516.1;Q92620;0;PRP16_HUMAN;Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38);"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]";"GO:0000398; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0006405; GO:0006406; GO:0016020; GO:0031124; GO:0034458; GO:0071013";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp4380515_c0_seq1;GAXK01069719.1;Q14204;6.40E-43;DYHC1_HUMAN;Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic);"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]";"GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045503; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]";"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"
comp438098_c0_seq1;GAXK01186975.1;P0DN13;1.25E-14;VKT9_ANEVI;U-actitoxin-Avd3l (U-AITX-Avd3l) (AsKC9);"extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]";"GO:0004867; GO:0005576; GO:0042151; GO:0090729";;"extracellular region [GO:0005576]; nematocyst [GO:0042151]";"serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]"
comp4381192_c0_seq1;GAXK01069723.1;P21328;7.86E-10;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp43812_c3_seq1;GAXK01147719.1;Q62901;1.15E-125;RERE_RAT;Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein);"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000118; GO:0001085; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0016605; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813";"branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]";"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp4381223_c0_seq1;GAXK01069709.1;O77683;3.54E-09;RND3_PIG;Rho-related GTP-binding protein RhoE (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp4381230_c0_seq1;GAXK01069707.1;Q7LHG5;8.31E-08;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp4381741_c0_seq1;GAXK01069715.1;Q86LG1;4.09E-16;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp438229_c0_seq1;GAXK01186988.1;P0CF52;1.31E-60;KDM7B_DANRE;Lysine-specific demethylase 7B (DrKDM7b) (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D-B);"nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]";"GO:0005634; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035574; GO:0035575; GO:0046872; GO:0051864; GO:0070544; GO:0071557; GO:0071558";"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]";nucleus [GO:0005634];"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]"
comp438282_c2_seq1;GAXK01186941.1;Q9TXD8;2.17E-42;ISOHC_AGEAP;Venom peptide isomerase heavy chain (EC 5.-.-.-);"extracellular region [GO:0005576]; isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0016853";;extracellular region [GO:0005576];"isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]"
comp438291_c0_seq1;GAXK01186905.1;O35678;1.02E-65;MGLL_MOUSE;Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL);"axon [GO:0030424]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0005654; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0097756; GO:2000124";"acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"axon [GO:0030424]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; varicosity [GO:0043196]";"acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]"
comp4383117_c0_seq1;GAXK01080883.1;P13277;1.46E-26;CYSP1_HOMAM;Digestive cysteine proteinase 1 (EC 3.4.22.-);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp438320_c0_seq1;GAXK01186917.1;Q196Z3;7.15E-07;VF197_IIV3;Putative tyrosine phosphatase 067L (EC 3.1.3.-);"protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]";"GO:0004725; GO:0008138";;;"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp43833_c1_seq1;GAXK01147524.1;Q7KRI2;1.17E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4383983_c0_seq1;GAXK01080880.1;Q09499;1.07E-25;IRE1_CAEEL;"Serine/threonine-protein kinase/endoribonuclease ire-1 (Inositol-requiring protein 2) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]";"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; nematode larval development [GO:0002119]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein phosphorylation [GO:0006468]; response to hypoxia [GO:0001666]; response to topologically incorrect protein [GO:0035966]; response to tunicamycin [GO:1904576]";"GO:0001666; GO:0002119; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0006990; GO:0030176; GO:0030968; GO:0035966; GO:0036498; GO:0051082; GO:0070059; GO:0090305; GO:1902255; GO:1904576; GO:1990440; GO:1990604";"endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; nematode larval development [GO:0002119]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein phosphorylation [GO:0006468]; response to hypoxia [GO:0001666]; response to topologically incorrect protein [GO:0035966]; response to tunicamycin [GO:1904576]";"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-TRAF2-ASK1 complex [GO:1990604]";"ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]"
comp4383994_c0_seq1;GAXK01080876.1;Q9FLF0;6.68E-40;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp438421_c0_seq1;GAXK01186936.1;Q0P5B3;8.21E-64;RBTN1_BOVIN;Rhombotin-1 (LIM domain only protein 1) (LMO-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]";"GO:0005634; GO:0046872";;nucleus [GO:0005634];metal ion binding [GO:0046872]
comp438459_c0_seq1;GAXK01186918.1;Q91924;1.41E-63;SNAI2_XENLA;Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]";"GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872";"neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4385151_c0_seq1;GAXK01054898.1;P24862;3.38E-09;CCNB_PATVU;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp4386148_c0_seq1;GAXK01180601.1;P24045;2.09E-07;GBRB4_CHICK;Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp4386211_c0_seq1;GAXK01180597.1;Q9CXE0;1.07E-08;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp438634_c5_seq1;GAXK01186887.1;Q8TC12;7.68E-51;RDH11_HUMAN;Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";"GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"
comp438674_c0_seq1;GAXK01186885.1;Q8IRC7;1.31E-80;AWH_DROME;LIM/homeobox protein Awh (Protein arrowhead);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007444; GO:0010468; GO:0030182; GO:0045944; GO:0046872; GO:0048749";"compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp43868_c0_seq1;GAXK01147120.1;Q9H8M7;8.30E-100;MINY3_HUMAN;Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP);"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; apoptotic process [GO:0006915]";"GO:0005654; GO:0006915; GO:0016807; GO:0031965; GO:0036459; GO:1990380";apoptotic process [GO:0006915];"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp4387227_c0_seq1;GAXK01180605.1;O44001;3.94E-74;HSP90_EIMTE;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp4387313_c0_seq1;GAXK01180608.1;E9NA96;3.73E-17;IR25A_DROME;Ionotropic receptor 25a;"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]; AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"GO:0004971; GO:0005886; GO:0005929; GO:0007610; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0032281; GO:0043204; GO:0048511; GO:0050907; GO:0050911; GO:0071683";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]";"AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]"
comp438846_c3_seq1;GAXK01186970.1;Q9U943;7.30E-85;APLP_LOCMI;"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]";"extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]";"GO:0005319; GO:0005576; GO:0008289; GO:0016055";Wnt signaling pathway [GO:0016055];extracellular region [GO:0005576];"lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]"
comp438947_c0_seq1;GAXK01186880.1;Q9Y5W3;2.14E-44;KLF2_HUMAN;Krueppel-like factor 2 (Lung krueppel-like factor);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]";"GO:0000122; GO:0000790; GO:0000902; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0032715; GO:0035264; GO:0036003; GO:0040029; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0046872; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071409; GO:0071498; GO:0071499; GO:0097533; GO:1901653; GO:1903671";"cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp43901_c3_seq1;GAXK01147583.1;Q5RFT1;5.71E-47;S35F6_PONAB;Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005739; GO:0005765; GO:0008284; GO:0016021; GO:0022857; GO:1901029";"negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]";transmembrane transporter activity [GO:0022857]
comp4391_c0_seq1;GAXK01065604.1;P15206;3.67E-91;CCNB_MARGL;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp4391036_c0_seq1;GAXK01158932.1;Q54YJ6;1.36E-36;IF1A_DICDI;Eukaryotic translation initiation factor 1A (eIF-1A) (Eukaryotic translation initiation factor 4C) (eIF-4C);translation initiation factor activity [GO:0003743];GO:0003743;;;translation initiation factor activity [GO:0003743]
comp43912_c2_seq1;GAXK01147975.1;P50532;0;SMC4_XENLA;Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome assembly protein XCAP-C) (Chromosome-associated protein C);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0046982; GO:0051301";"cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]"
comp439139_c1_seq1;GAXK01186903.1;Q3TN34;5.26E-38;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp4391445_c0_seq1;GAXK01158949.1;Q8CFS6;2.55E-16;KCNV2_MOUSE;Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2);"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]";voltage-gated potassium channel activity [GO:0005249]
comp4393287_c0_seq1;GAXK01019657.1;Q14191;9.45E-07;WRN_HUMAN;Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2);"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090656; GO:0098530; GO:1901796; GO:1902570; GO:1905773";"aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]";"3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]"
comp43944_c0_seq1;GAXK01147365.1;Q9C0D3;1.27E-161;ZY11B_HUMAN;Protein zyg-11 homolog B;Cul2-RING ubiquitin ligase complex [GO:0031462];GO:0031462;;Cul2-RING ubiquitin ligase complex [GO:0031462];
comp4394417_c0_seq1;GAXK01170708.1;Q9UEG4;2.00E-11;ZN629_HUMAN;Zinc finger protein 629 (Zinc finger protein 65);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4394460_c0_seq1;GAXK01170717.1;P42791;2.48E-80;RL182_ARATH;60S ribosomal protein L18-2;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0015934; GO:0022625";translation [GO:0006412];"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp43948_c0_seq1;GAXK01147262.1;Q69ZF8;2.34E-29;MSL2_MOUSE;E3 ubiquitin-protein ligase MSL2 (EC 2.3.2.-) (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184);"MSL complex [GO:0072487]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0043984; GO:0046872; GO:0061630; GO:0072487";"histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]";MSL complex [GO:0072487];"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp43949_c1_seq1;GAXK01147155.1;Q6P5L7;6.91E-20;ARGLA_DANRE;Arginine and glutamate-rich protein 1-A;"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005739";;"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";
comp4395287_c0_seq1;GAXK01170715.1;Q9P0X4;2.91E-15;CAC1I_HUMAN;Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3);"plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]";"GO:0005245; GO:0005886; GO:0005891; GO:0007165; GO:0008332; GO:0019228; GO:0030317; GO:0030431; GO:0034765; GO:0045956; GO:0070509; GO:0086010";"calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]";"plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]"
comp4395782_c0_seq1;GAXK01170705.1;Q54KA7;1.60E-10;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp4396174_c0_seq1;GAXK01119103.1;Q16960;2.46E-12;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp439630_c0_seq1;GAXK01186890.1;P35038;4.36E-23;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp439657_c0_seq1;GAXK01186990.1;P41696;6.87E-08;AZF1_YEAST;Asparagine-rich zinc finger protein AZF1;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0001228; GO:0005634; GO:0005829; GO:0006357; GO:0043565; GO:0046872; GO:0060237; GO:0071322";"cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4396780_c0_seq1;GAXK01119104.1;Q54KA7;4.31E-35;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp4397034_c0_seq1;GAXK01119095.1;P46023;2.19E-07;GR101_LYMST;G-protein coupled receptor GRL101;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp439725_c1_seq1;GAXK01186893.1;O46040;1.75E-13;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp439736_c0_seq1;GAXK01186960.1;Q64105;9.54E-09;SPRE_MOUSE;Sepiapterin reductase (SPR) (EC 1.1.1.153);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein homodimerization activity [GO:0042803]; sepiapterin reductase activity [GO:0004757]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dopamine metabolic process [GO:0042417]; L-phenylalanine metabolic process [GO:0006558]; nitric oxide biosynthetic process [GO:0006809]; norepinephrine metabolic process [GO:0042415]; pteridine metabolic process [GO:0019889]; regulation of multicellular organism growth [GO:0040014]; response to organic substance [GO:0010033]; serotonin metabolic process [GO:0042428]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrobiopterin metabolic process [GO:0046146]; voluntary musculoskeletal movement [GO:0050882]";"GO:0004757; GO:0005654; GO:0005739; GO:0005829; GO:0006558; GO:0006729; GO:0006809; GO:0010033; GO:0019889; GO:0040014; GO:0042415; GO:0042417; GO:0042428; GO:0042803; GO:0046146; GO:0048667; GO:0050882";"cell morphogenesis involved in neuron differentiation [GO:0048667]; dopamine metabolic process [GO:0042417]; L-phenylalanine metabolic process [GO:0006558]; nitric oxide biosynthetic process [GO:0006809]; norepinephrine metabolic process [GO:0042415]; pteridine metabolic process [GO:0019889]; regulation of multicellular organism growth [GO:0040014]; response to organic substance [GO:0010033]; serotonin metabolic process [GO:0042428]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrobiopterin metabolic process [GO:0046146]; voluntary musculoskeletal movement [GO:0050882]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"protein homodimerization activity [GO:0042803]; sepiapterin reductase activity [GO:0004757]"
comp439875_c0_seq1;GAXK01186877.1;A6NMX2;5.77E-31;I4E1B_HUMAN;Eukaryotic translation initiation factor 4E type 1B;"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]";"GO:0000340; GO:0003743; GO:0005845; GO:0016281";;"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]";"RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]"
comp4399_c0_seq1;GAXK01065596.1;Q91309;3.14E-163;F26_LITCT;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";"GO:0003873; GO:0004331; GO:0005524; GO:0006000; GO:0006003";"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]";;"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp439946_c0_seq1;GAXK01186939.1;P54269;2.43E-48;CAUP_DROME;Homeobox protein caupolican;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000981; GO:0001745; GO:0003700; GO:0005634; GO:0007346; GO:0007474; GO:0042693; GO:0043565; GO:0045317; GO:0045926; GO:0045944";"compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp43997_c0_seq1;GAXK01147592.1;Q15831;2.54E-129;STK11_HUMAN;Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944]";"GO:0000287; GO:0001558; GO:0001894; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006914; GO:0006974; GO:0007050; GO:0007283; GO:0007409; GO:0008285; GO:0010212; GO:0010508; GO:0016020; GO:0030010; GO:0030275; GO:0030295; GO:0030308; GO:0030511; GO:0032147; GO:0042593; GO:0043276; GO:0045059; GO:0046777; GO:0048814; GO:0050772; GO:0050852; GO:0051645; GO:0051896; GO:0060070; GO:0060770; GO:0070062; GO:0071493; GO:0072332; GO:0090090; GO:0097484; GO:0120163; GO:1900182; GO:1901796; GO:1904262";"activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]"
comp44_c0_seq1;GAXK01169457.1;P32429;8.26E-102;RL7A_CHICK;60S ribosomal protein L7a;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp4400256_c0_seq1;GAXK01115236.1;Q5ENN5;0;RBL2_HETTR;Ribulose bisphosphate carboxylase, chloroplastic (RuBisCO) (EC 4.1.1.39);"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0000287; GO:0004497; GO:0016021; GO:0016984; GO:0019253; GO:0031969";reductive pentose-phosphate cycle [GO:0019253];"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]";"magnesium ion binding [GO:0000287]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]"
comp4400641_c0_seq1;GAXK01115228.1;P17970;1.48E-16;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4402_c1_seq1;GAXK01065674.1;Q66KC4;5.24E-21;HSDL2_XENTR;Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-);"peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]";"GO:0005777; GO:0016491";;peroxisome [GO:0005777];oxidoreductase activity [GO:0016491]
comp44031_c0_seq1;GAXK01186231.1;A1Z7K9;3.25E-113;PAN2_DROME;PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2);"nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]";"GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872";"mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]";"nucleus [GO:0005634]; PAN complex [GO:0031251]; P-body [GO:0000932]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp4403194_c0_seq1;GAXK01077305.1;Q9UDY8;1.32E-07;MALT1_HUMAN;Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase);"CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"GO:0001650; GO:0001923; GO:0002020; GO:0002223; GO:0002726; GO:0004197; GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0038095; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051259; GO:2000321";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; B-1 B cell differentiation [GO:0001923]; B cell activation [GO:0042113]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]"
comp440352_c0_seq1;GAXK01012723.1;Q15652;2.63E-27;JHD2C_HUMAN;Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8);"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blood coagulation [GO:0007596]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006355; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213";"blood coagulation [GO:0007596]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4404_c1_seq1;GAXK01065765.1;Q6TYB5;3.36E-42;FEZ2_MOUSE;Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2);"axon [GO:0030424]; cytoplasm [GO:0005737]; negative regulation of autophagosome assembly [GO:1902902]";"GO:0005737; GO:0030424; GO:1902902";negative regulation of autophagosome assembly [GO:1902902];"axon [GO:0030424]; cytoplasm [GO:0005737]";
comp44041_c4_seq1;GAXK01186171.1;Q9BWT3;0;PAPOG_HUMAN;Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme);"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]";"GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872";"mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]";"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]"
comp4404412_c0_seq1;GAXK01115647.1;P15454;8.00E-15;KGUA_YEAST;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006163; GO:0046711";"GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp44048_c0_seq1;GAXK01185932.1;Q6ZN54;1.01E-84;DEFI8_HUMAN;Differentially expressed in FDCP 8 homolog (DEF-8);"metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]";"GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029";"intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]";;metal ion binding [GO:0046872]
comp4404824_c0_seq1;GAXK01115639.1;O14134;1.17E-32;ELF1_SCHPO;mRNA export factor elf1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; poly(A)+ mRNA export from nucleus [GO:0016973]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0016887; GO:0016973; GO:0032991";poly(A)+ mRNA export from nucleus [GO:0016973];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp4404971_c0_seq1;GAXK01115637.1;Q16960;7.88E-98;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp440546_c0_seq1;GAXK01012750.1;P81018;1.08E-12;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp44060_c3_seq1;GAXK01186589.1;P35500;0;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp4406772_c0_seq1;GAXK01086535.1;Q6ZMT1;4.36E-11;STAC2_HUMAN;SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2);"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"GO:0003009; GO:0005829; GO:0031234; GO:0035556; GO:0042383; GO:0046872; GO:1901387; GO:1903078";"intracellular signal transduction [GO:0035556]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]";metal ion binding [GO:0046872]
comp4406925_c0_seq1;GAXK01086528.1;Q9L4P4;1.44E-73;CLPR_SYNE7;Putative ATP-dependent Clp protease proteolytic subunit-like (Endopeptidase Clp-like);"cytoplasm [GO:0005737]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005737";;cytoplasm [GO:0005737];serine-type endopeptidase activity [GO:0004252]
comp440709_c0_seq1;GAXK01012825.1;Q1RDC8;5.31E-34;GHRA_ECOUT;Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]";"GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]"
comp4407288_c0_seq1;GAXK01086523.1;Q9XSK2;9.58E-12;CD63_BOVIN;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005765; GO:0005887; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]";
comp44075_c0_seq1;GAXK01186083.1;Q8K301;2.54E-165;DDX52_MOUSE;Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030490";maturation of SSU-rRNA [GO:0030490];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp440751_c0_seq1;GAXK01204939.1;P20432;2.97E-28;GSTD1_DROME;Glutathione S-transferase D1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]";"GO:0004364; GO:0005737; GO:0006749; GO:0009636; GO:0018833";"glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]";cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp4408382_c0_seq1;GAXK01087541.1;D3Z813;8.23E-62;S38AB_RAT;Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp440839_c0_seq1;GAXK01012774.1;Q7KRI2;9.98E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4408452_c0_seq1;GAXK01087540.1;P82198;1.97E-24;BGH3_MOUSE;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp4408537_c0_seq1;GAXK01087527.1;O42249;4.81E-106;GBLP_ORENI;Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK);"ribosome [GO:0005840]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]";"GO:0005840; GO:0030178; GO:0032880; GO:0051302; GO:2000114; GO:2000543";"negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]";ribosome [GO:0005840];
comp4408607_c0_seq1;GAXK01087530.1;P42325;3.81E-13;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp4408722_c0_seq1;GAXK01087546.1;Q962T1;3.17E-75;RL32_SPOFR;60S ribosomal protein L32;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4408728_c0_seq1;GAXK01087514.1;Q14679;4.77E-13;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp440873_c0_seq1;GAXK01012793.1;Q9XZP2;1.93E-32;CALM2_BRAFL;Calmodulin-2 (CaM 2);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4409141_c0_seq1;GAXK01087518.1;P41752;2.12E-30;EF1A_ASHGO;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414";"translation [GO:0006412]; translational elongation [GO:0006414]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp4409373_c0_seq1;GAXK01087536.1;P87365;6.83E-11;OPSB_ORYLA;Blue-sensitive opsin (Blue cone photoreceptor pigment) (KFH-B);"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0001750; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]";G protein-coupled photoreceptor activity [GO:0008020]
comp4409697_c0_seq1;GAXK01087520.1;Q19269;2.01E-21;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4409747_c0_seq1;GAXK01087526.1;Q5G271;2.15E-25;NETR_PANTR;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp4409899_c0_seq1;GAXK01087525.1;B5U2W0;9.40E-07;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp441_c8_seq1;GAXK01169431.1;P02567;5.35E-63;MYO1_CAEEL;Myosin-1 (Myosin heavy chain D) (MHC D);"striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";"GO:0003774; GO:0005524; GO:0005863; GO:0006936; GO:0008307; GO:0043050; GO:0051015";"muscle contraction [GO:0006936]; pharyngeal pumping [GO:0043050]";striated muscle myosin thick filament [GO:0005863];"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]"
comp4410242_c0_seq1;GAXK01058749.1;Q7RTX9;5.41E-10;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp4410388_c0_seq1;GAXK01058742.1;Q8UUZ1;6.34E-08;MB212_DANRE;Protein mab-21-like 2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic eye morphogenesis [GO:0048048]; eye development [GO:0001654]; lens development in camera-type eye [GO:0002088]; retina development in camera-type eye [GO:0060041]";"GO:0001654; GO:0002088; GO:0005634; GO:0005737; GO:0043010; GO:0048048; GO:0048701; GO:0060041";"camera-type eye development [GO:0043010]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic eye morphogenesis [GO:0048048]; eye development [GO:0001654]; lens development in camera-type eye [GO:0002088]; retina development in camera-type eye [GO:0060041]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp441074_c0_seq1;GAXK01012737.1;Q3UVD5;3.25E-33;LGR6_MOUSE;Leucine-rich repeat-containing G-protein coupled receptor 6;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"GO:0004930; GO:0005615; GO:0005886; GO:0016021; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523";"bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp4411067_c0_seq1;GAXK01058738.1;Q8TD17;1.05E-09;ZN398_HUMAN;Zinc finger protein 398 (Zinc finger DNA-binding protein p52/p71);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp44112_c0_seq1;GAXK01186158.1;Q9BRP4;1.82E-66;PAAF1_HUMAN;Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71);"proteasome complex [GO:0000502]; viral process [GO:0016032]";"GO:0000502; GO:0016032";viral process [GO:0016032];proteasome complex [GO:0000502];
comp44113_c0_seq1;GAXK01186214.1;Q8T6B9;5.91E-100;PUF68_DROME;Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog);"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]";"GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003729; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008266; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013";"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]";"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]";"mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]"
comp44120_c1_seq1;GAXK01186300.1;Q3MHR0;5.62E-57;LYPA1_BOVIN;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0006631; GO:0008474; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp4412515_c0_seq1;GAXK01134848.1;Q1L8W0;7.51E-11;ZBT18_DANRE;Zinc finger and BTB domain-containing protein 18 (Zinc finger protein 238);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp44127_c0_seq1;GAXK01185716.1;B0BNA9;1.41E-168;CNO11_RAT;CCR4-NOT transcription complex subunit 11;"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]";"GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047";"gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp441287_c0_seq1;GAXK01012763.1;Q9SFB8;1.49E-19;PI5K6_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 6 (AtPIP5K6) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 6) (Diphosphoinositide kinase 6) (PtdIns(4)P-5-kinase 6);"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005524; GO:0016308; GO:0016324; GO:0072583; GO:0090406";clathrin-dependent endocytosis [GO:0072583];"apical plasma membrane [GO:0016324]; pollen tube [GO:0090406]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp441289_c0_seq1;GAXK01012795.1;P47193;6.31E-15;VAMP2_XENLA;Vesicle-associated membrane protein 2 (VAMP-2) (SYBII) (Synaptobrevin-2);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192]";"GO:0005886; GO:0016021; GO:0016192; GO:0030054; GO:0030672; GO:0043005";vesicle-mediated transport [GO:0016192];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";
comp441424_c0_seq1;GAXK01012731.1;P77989;2.88E-22;BGAL_THEP3;Beta-galactosidase (Beta-gal) (EC 3.2.1.23) (Lactase);"beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]";"GO:0004565; GO:0005975";carbohydrate metabolic process [GO:0005975];;beta-galactosidase activity [GO:0004565]
comp44149_c1_seq1;GAXK01186663.1;P0DPW4;9.16E-09;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp44153_c0_seq1;GAXK01185930.1;P50540;1.57E-23;MXI1_MOUSE;Max-interacting protein 1 (Max interactor 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; blastocyst formation [GO:0001825]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0001825; GO:0003677; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0046983; GO:0090575";"blastocyst formation [GO:0001825]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp44159_c0_seq1;GAXK01185922.1;Q8K3X3;0;GMDS_CRIGR;GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD);"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]";"GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401";"'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]";;"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"
comp441595_c0_seq1;GAXK01012776.1;Q8K4K7;5.22E-12;ABRA_RAT;Actin-binding Rho-activating protein (MS1) (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp4416223_c0_seq1;GAXK01129290.1;Q9NA51;2.85E-12;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp44169_c1_seq1;GAXK01186019.1;P08985;1.26E-64;H2AV_DROME;Histone H2A.v (H2A.F/Z) (H2A.Z);"chromosome [GO:0005694]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; male germ-line stem cell population maintenance [GO:0036098]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; somatic stem cell population maintenance [GO:0035019]";"GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0005694; GO:0005700; GO:0005701; GO:0006281; GO:0006325; GO:0007275; GO:0035019; GO:0035861; GO:0036098; GO:0044877; GO:0046982; GO:0071168";"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; male germ-line stem cell population maintenance [GO:0036098]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; somatic stem cell population maintenance [GO:0035019]";"chromosome [GO:0005694]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; site of double-strand break [GO:0035861]";"DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]"
comp4417323_c0_seq1;GAXK01129285.1;P10074;1.94E-15;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp441733_c0_seq1;GAXK01012718.1;P70080;2.61E-159;TPH1_CHICK;Tryptophan 5-hydroxylase 1 (EC 1.14.16.4) (Tryptophan 5-monooxygenase 1);"neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; serotonin biosynthetic process [GO:0042427]";"GO:0004510; GO:0005506; GO:0009072; GO:0042427; GO:0043005";"aromatic amino acid family metabolic process [GO:0009072]; serotonin biosynthetic process [GO:0042427]";neuron projection [GO:0043005];"iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]"
comp4417445_c0_seq1;GAXK01129283.1;Q8N0N3;7.80E-13;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp441788_c0_seq1;GAXK01012778.1;Q6YCH2;4.58E-12;TDPZ4_MOUSE;TD and POZ domain-containing protein 4;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp44192_c0_seq1;GAXK01186664.1;Q5E9X1;1.11E-60;NFYC_BOVIN;Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC);"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]";"GO:0000978; GO:0000980; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0016602; GO:0032993; GO:0046982";;"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4419609_c0_seq1;GAXK01093091.1;Q94900;1.56E-31;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp4419734_c0_seq1;GAXK01093097.1;O76090;6.01E-13;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp442004_c1_seq1;GAXK01157192.1;P00920;2.14E-46;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp4420647_c0_seq1;GAXK01193967.1;P05934;2.78E-25;CALM_STRPU;Calmodulin (CaM) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp44208_c0_seq1;GAXK01185987.1;Q9W5D4;2.37E-131;POMT2_DROME;Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (DmPOMT2) (dPOMT2) (Protein twisted);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]";"GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]
comp4421131_c0_seq1;GAXK01193965.1;O76856;4.68E-64;CATD_DICDI;Cathepsin D (EC 3.4.23.5) (Ddp44);"early endosome [GO:0005769]; early phagosome [GO:0032009]; extracellular region [GO:0005576]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; aspartic-type endopeptidase activity [GO:0004190]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"GO:0004190; GO:0005576; GO:0005764; GO:0005769; GO:0006508; GO:0012501; GO:0030163; GO:0032009; GO:0045335";"programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"early endosome [GO:0005769]; early phagosome [GO:0032009]; extracellular region [GO:0005576]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]";aspartic-type endopeptidase activity [GO:0004190]
comp4421183_c0_seq1;GAXK01193971.1;Q9VNM1;7.06E-15;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp4421322_c0_seq1;GAXK01193975.1;P07742;4.21E-10;RIR1_MOUSE;Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]";"GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0017076; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051259; GO:0051290; GO:0060041; GO:0097718";"cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]";"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"
comp44223_c0_seq1;GAXK01186284.1;Q7ZYC4;5.07E-172;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp4422509_c0_seq1;GAXK01014929.1;Q8R1L4;2.42E-30;ERD23_MOUSE;ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3) (KDEL receptor 3);"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";KDEL sequence binding [GO:0005046]
comp44227_c1_seq1;GAXK01185927.1;P29304;4.62E-07;SINA_DROVI;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of R7 cell differentiation [GO:0045676]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0005634; GO:0005737; GO:0006511; GO:0007423; GO:0007601; GO:0008270; GO:0016567; GO:0016740; GO:0045676; GO:0050896";"protein ubiquitination [GO:0016567]; regulation of R7 cell differentiation [GO:0045676]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp44229_c0_seq1;GAXK01186114.1;Q25452;1.85E-164;CAC1M_MUSDO;Muscle calcium channel subunit alpha-1 (MDL-alpha-1);"voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005245; GO:0005891; GO:0034765; GO:0046872";regulation of ion transmembrane transport [GO:0034765];voltage-gated calcium channel complex [GO:0005891];"metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]"
comp44230_c1_seq1;GAXK01185880.1;Q3SZY9;6.89E-80;MED6_BOVIN;Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]";"GO:0003712; GO:0006357; GO:0016592; GO:0051123; GO:0070847";"regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";transcription coregulator activity [GO:0003712]
comp442419_c2_seq1;GAXK01157157.1;P91766;0;ACH1_MANSE;Acetylcholine receptor subunit alpha-like (MARA1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp4424828_c0_seq1;GAXK01144255.1;Q91453;4.88E-18;STXB_SYNHO;Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp4424834_c0_seq1;GAXK01144247.1;G5EBR3;5.14E-08;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp44250_c0_seq1;GAXK01186298.1;Q9HH99;4.50E-55;P5CR_METAC;Pyrroline-5-carboxylate reductase (P5C reductase) (P5CR) (EC 1.5.1.2) (PCA reductase);"cytoplasm [GO:0005737]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]";"GO:0004735; GO:0005737; GO:0055129";L-proline biosynthetic process [GO:0055129];cytoplasm [GO:0005737];pyrroline-5-carboxylate reductase activity [GO:0004735]
comp442570_c0_seq1;GAXK01157105.1;Q7KRI2;5.97E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp44258_c0_seq1;GAXK01185721.1;P22059;0;OSBP1_HUMAN;Oxysterol-binding protein 1;"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"GO:0000139; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006699; GO:0008142; GO:0008289; GO:0015248; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015";"bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]"
comp44260_c0_seq1;GAXK01186445.1;O17449;9.55E-149;TBB1_MANSE;Tubulin beta-1 chain (Beta-1-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp442604_c0_seq1;GAXK01157137.1;B2RUR8;7.37E-117;OTU7B_MOUSE;OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]";"GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0036459; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380";"adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]"
comp442634_c1_seq1;GAXK01205831.1;Q24418;0;NMDA1_DROME;Glutamate [NMDA] receptor subunit 1 (DNMDAR-I) (dNR1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; ionotropic glutamate receptor complex [GO:0008328]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; NMDA glutamate receptor activity [GO:0004972]; associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]";"GO:0004972; GO:0005886; GO:0007268; GO:0007616; GO:0008306; GO:0008328; GO:0008355; GO:0014069; GO:0016021; GO:0017146; GO:0030054; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375";"associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; ionotropic glutamate receptor complex [GO:0008328]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";NMDA glutamate receptor activity [GO:0004972]
comp44269_c0_seq1;GAXK01185552.1;P17141;9.69E-21;ZFP37_MOUSE;Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007281; GO:0007283; GO:0008270";"germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp44270_c2_seq1;GAXK01186278.1;P05661;3.81E-33;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp442707_c0_seq1;GAXK01157194.1;Q04896;3.15E-39;HME1A_DANRE;Homeobox protein engrailed-1a (Homeobox protein en-1a);"nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016586; GO:0030182; GO:0043565; GO:0060385";"axonogenesis involved in innervation [GO:0060385]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RSC-type complex [GO:0016586]";sequence-specific DNA binding [GO:0043565]
comp4427320_c0_seq1;GAXK01172837.1;O74391;8.48E-33;RL25B_SCHPO;60S ribosomal protein L25-B;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0019843; GO:0022625";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp442826_c0_seq1;GAXK01157155.1;Q01295;7.23E-07;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp44298_c7_seq1;GAXK01186227.1;Q9BZE2;4.20E-105;PUS3_HUMAN;tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119]";"GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0009982; GO:0031119; GO:0106029; GO:1990481";"mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]"
comp443_c0_seq1;GAXK01169778.1;O75964;8.91E-22;ATP5L_HUMAN;ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g);"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]";"GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0015078; GO:0015986; GO:0022857; GO:0042407; GO:0042776";"ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]";"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";"proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]"
comp4430328_c0_seq1;GAXK01071732.1;P34042;8.28E-22;GPA4_DICDI;Guanine nucleotide-binding protein alpha-4 subunit (G alpha-4);"heterotrimeric G-protein complex [GO:0005834]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of MAPK activity [GO:0000187]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aggregation involved in sorocarp development [GO:0031152]; chemotaxis [GO:0006935]; chemotaxis to folate [GO:0043326]; positive regulation of MAP kinase activity [GO:0043406]; regulation of macropinocytosis [GO:1905301]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0000187; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0006935; GO:0007188; GO:0030435; GO:0031152; GO:0031683; GO:0043326; GO:0043406; GO:0045335; GO:0046872; GO:1905301";"activation of MAPK activity [GO:0000187]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aggregation involved in sorocarp development [GO:0031152]; chemotaxis [GO:0006935]; chemotaxis to folate [GO:0043326]; positive regulation of MAP kinase activity [GO:0043406]; regulation of macropinocytosis [GO:1905301]; sporulation resulting in formation of a cellular spore [GO:0030435]";"heterotrimeric G-protein complex [GO:0005834]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp4430344_c0_seq1;GAXK01071727.1;P05140;6.84E-10;ISP2_HEMAM;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp4430789_c0_seq1;GAXK01071729.1;Q6INV3;3.02E-07;LRC57_XENLA;Leucine-rich repeat-containing protein 57;;;;;
comp44309_c1_seq1;GAXK01186448.1;Q5ZJU4;1.82E-34;URM1_CHICK;Ubiquitin-related modifier 1;"cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0005829; GO:0032447; GO:0034227; GO:0097163";"protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]";cytosol [GO:0005829];sulfur carrier activity [GO:0097163]
comp443125_c2_seq1;GAXK01157148.1;O46108;1.34E-67;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp4431682_c0_seq1;GAXK01071745.1;Q4WJ81;1.01E-10;CRZA_ASPFU;C2H2 finger domain transcription factor crzA;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277]; conidium formation [GO:0048315]; pathogenesis [GO:0009405]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spore germination [GO:0009847]; unidimensional cell growth [GO:0009826]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0009405; GO:0009826; GO:0009847; GO:0045944; GO:0046872; GO:0048315; GO:0071277";"cellular response to calcium ion [GO:0071277]; conidium formation [GO:0048315]; pathogenesis [GO:0009405]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spore germination [GO:0009847]; unidimensional cell growth [GO:0009826]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp443182_c0_seq1;GAXK01157176.1;Q95V34;1.90E-07;RS4_SPOFR;40S ribosomal protein S4;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4431925_c0_seq1;GAXK01071739.1;Q5R5H7;1.15E-16;S22A2_PONAB;Solute carrier family 22 member 2 (Organic cation transporter 2);"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp4432223_c0_seq1;GAXK01079692.1;Q6BXH8;1.97E-58;RS6_DEBHA;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp443246_c1_seq1;GAXK01157113.1;Q6YHK3;1.51E-51;CD109_HUMAN;CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675";"hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]";"serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]"
comp44326_c2_seq1;GAXK01185961.1;A2ACG1;2.74E-42;TLDC2_MOUSE;TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2);negative regulation of oxidative stress-induced neuron death [GO:1903204];GO:1903204;negative regulation of oxidative stress-induced neuron death [GO:1903204];;
comp44327_c0_seq1;GAXK01185767.1;Q9NBK5;0;TRC_DROME;Serine/threonine-protein kinase tricorner (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like);"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0007476; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0070451; GO:0070593; GO:0071944";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp4433076_c0_seq1;GAXK01079703.1;Q9N2V2;1.84E-15;NAS30_CAEEL;Zinc metalloproteinase nas-30 (EC 3.4.24.-) (Nematode astacin 30);"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270";;;"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4433318_c0_seq1;GAXK01079717.1;Q8K988;4.83E-07;LON_BUCAP;Lon protease (EC 3.4.21.53) (ATP-dependent protease La);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565";"cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]"
comp4433547_c0_seq1;GAXK01079718.1;Q9NWF9;2.89E-07;RN216_HUMAN;E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (Ubiquitin-conjugating enzyme 7-interacting protein 1) (Zinc finger protein inhibiting NF-kappa-B);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]; viral process [GO:0016032]";"GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0016032; GO:0032480; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546";"apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]; viral process [GO:0016032]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp4433757_c0_seq1;GAXK01079707.1;P10076;1.04E-19;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp44338_c2_seq1;GAXK01186059.1;Q9UNH5;5.72E-161;CC14A_HUMAN;Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]";"GO:0000226; GO:0000278; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0071850; GO:0072686; GO:1902636";"cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp443392_c0_seq1;GAXK01157102.1;P35779;6.25E-41;VA3_SOLRI;Venom allergen 3 (Allergen Sol r III) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol r 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp443409_c0_seq1;GAXK01157103.1;P52746;2.08E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp443454_c1_seq1;GAXK01157166.1;Q29451;0;MA2B1_BOVIN;"Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]";"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"GO:0004559; GO:0005764; GO:0005774; GO:0006013; GO:0006517; GO:0030246; GO:0046872";"mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]";"lysosome [GO:0005764]; vacuolar membrane [GO:0005774]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp44346_c0_seq1;GAXK01185547.1;Q866A2;4.06E-39;ACHA7_MACMU;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045766; GO:0050877; GO:0050890; GO:0098978; GO:0098981; GO:0099056; GO:0099061";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp4434680_c0_seq1;GAXK01037272.1;P42773;8.48E-10;CDN2C_HUMAN;Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphorylation [GO:0042326]; oligodendrocyte differentiation [GO:0048709]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000082; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007050; GO:0008285; GO:0019901; GO:0030308; GO:0042326; GO:0048709; GO:2000134";"cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphorylation [GO:0042326]; oligodendrocyte differentiation [GO:0048709]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]"
comp44347_c0_seq1;GAXK01185733.1;Q96Q07;0;BTBD9_HUMAN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";"GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050951; GO:0060586; GO:1900242";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]";;
comp443508_c0_seq1;GAXK01157188.1;P83501;3.41E-29;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp4435170_c0_seq1;GAXK01037286.1;Q5XJN2;1.70E-08;GILT_DANRE;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376]";"GO:0002376; GO:0005576; GO:0005764; GO:0047134";immune system process [GO:0002376];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp4435230_c0_seq1;GAXK01037267.1;Q02742;2.54E-24;GCNT1_HUMAN;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT);"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]";"GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0009101; GO:0016021; GO:0016266; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993";"cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]";"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]
comp4435485_c0_seq1;GAXK01037283.1;Q80XI3;4.28E-25;IF4G3_MOUSE;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";"GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903";"positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";eukaryotic translation initiation factor 4F complex [GO:0016281];"mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]"
comp4435580_c0_seq1;GAXK01037285.1;Q7T2N4;3.79E-41;RL15_SILME;60S ribosomal protein L15;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp443581_c3_seq1;GAXK01157132.1;Q98UF7;1.12E-87;PCX1_TAKRU;Pecanex-like protein 1 (Pecanex homolog protein 1);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp4436103_c0_seq1;GAXK01035663.1;Q96IR2;1.72E-11;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp44362_c3_seq1;GAXK01185933.1;P42658;1.99E-43;DPP6_HUMAN;Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016021; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp4436233_c0_seq1;GAXK01035654.1;Q7ZXX1;1.13E-07;CADM3_XENLA;Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0016021; GO:0030054";cell adhesion [GO:0007155];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp443664_c0_seq1;GAXK01157178.1;P00417;5.86E-91;COX3_DROME;Cytochrome c oxidase subunit 3 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide III);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; oxidoreduction-driven active transmembrane transporter activity [GO:0015453]; aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0009055; GO:0009060; GO:0015453; GO:0016021";"aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; oxidoreduction-driven active transmembrane transporter activity [GO:0015453]"
comp4436728_c0_seq1;GAXK01035662.1;P18730;1.29E-07;ZG58_XENLA;Gastrula zinc finger protein XlCGF58.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp443693_c0_seq1;GAXK01157179.1;P17863;6.10E-70;SKI_AVIES;Transforming protein Ski;"SMAD binding [GO:0046332]; transcription, DNA-templated [GO:0006351]";"GO:0006351; GO:0046332";transcription, DNA-templated [GO:0006351];;SMAD binding [GO:0046332]
comp4437020_c0_seq1;GAXK01035669.1;P50757;1.09E-07;MMP2_RABIT;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) [Cleaved into: PEX];"extracellular matrix [GO:0031012]; membrane [GO:0016020]; nucleus [GO:0005634]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]";"GO:0001525; GO:0004222; GO:0005634; GO:0008270; GO:0016020; GO:0030574; GO:0031012";"angiogenesis [GO:0001525]; collagen catabolic process [GO:0030574]";"extracellular matrix [GO:0031012]; membrane [GO:0016020]; nucleus [GO:0005634]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4437553_c0_seq1;GAXK01035660.1;P98155;1.95E-10;VLDLR_HUMAN;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; axon guidance [GO:0007411]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"GO:0005041; GO:0005509; GO:0005765; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007165; GO:0007399; GO:0007411; GO:0007613; GO:0008203; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0032802; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006";"axon guidance [GO:0007411]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp443758_c0_seq1;GAXK01157186.1;Q9V9A8;5.67E-65;PHTF_DROME;Putative homeodomain transcription factor;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0046983";regulation of transcription by RNA polymerase II [GO:0006357];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]"
comp4437707_c0_seq1;GAXK01035665.1;Q95SX7;4.98E-09;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp443788_c0_seq1;GAXK01157165.1;P05140;6.06E-14;ISP2_HEMAM;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp443794_c0_seq1;GAXK01157187.1;Q4R628;0;KIF3A_MACFA;Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A);"centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005814; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0010457; GO:0034454; GO:0060271";"centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]";"centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp4438007_c0_seq1;GAXK01110643.1;Q5ZL98;3.92E-17;RPC1_CHICK;DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A);"RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872";transcription by RNA polymerase III [GO:0006383];RNA polymerase III complex [GO:0005666];"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp443859_c0_seq1;GAXK01157177.1;Q8C827;3.60E-17;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp4438907_c0_seq1;GAXK01110638.1;E9AGH7;2.39E-45;NTR2_LEIIN;Probable flavin mononucleotide-dependent alkene reductase (EC 1.3.1.-) (Flavin mononucleotide-dependent nitroreductase) (EC 1.7.1.-) (NTR2);"cytosol [GO:0005829]; FMN binding [GO:0010181]; oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO:0016657]";"GO:0005829; GO:0010181; GO:0016657";;cytosol [GO:0005829];"FMN binding [GO:0010181]; oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO:0016657]"
comp443925_c0_seq1;GAXK01157101.1;Q9NFZ3;5.98E-25;GBGE_DROME;Guanine nucleotide-binding protein subunit gamma-e (Ggamma(e));"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]; GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]; cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"GO:0003924; GO:0005737; GO:0005834; GO:0007186; GO:0007200; GO:0007601; GO:0007602; GO:0016028; GO:0046982; GO:0050909; GO:0071244";"cellular response to carbon dioxide [GO:0071244]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phototransduction [GO:0007602]; sensory perception of taste [GO:0050909]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; rhabdomere [GO:0016028]";"GTPase activity [GO:0003924]; protein heterodimerization activity [GO:0046982]"
comp44398_c1_seq1;GAXK01186464.1;O70571;3.75E-86;PDK4_MOUSE;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 4);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of bone resorption [GO:0045124]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]; response to starvation [GO:0042594]";"GO:0004672; GO:0004712; GO:0004740; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006006; GO:0006468; GO:0006885; GO:0008286; GO:0009267; GO:0010510; GO:0010565; GO:0010906; GO:0042304; GO:0042593; GO:0042594; GO:0045124; GO:0046320; GO:0071398; GO:0072593; GO:2000811";"cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of bone resorption [GO:0045124]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]; response to starvation [GO:0042594]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp4439946_c1_seq1;GAXK01110647.1;P34917;1.86E-45;G3P2_ANAVT;Glyceraldehyde-3-phosphate dehydrogenase 2 (GAPDH 2) (EC 1.2.1.59) (NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0004365; GO:0005737; GO:0006006; GO:0019253; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp4440189_c0_seq1;GAXK01174027.1;Q7T163;1.98E-07;KDISB_DANRE;Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B);"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]";"GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902";nervous system development [GO:0007399];"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]";"PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]"
comp4441081_c0_seq1;GAXK01174018.1;P14381;6.04E-28;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp44413_c0_seq1;GAXK01185918.1;Q0IIV2;1.76E-121;RHBG_XENTR;Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0016323; GO:0030659; GO:0072488";ammonium transmembrane transport [GO:0072488];"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]";ammonium transmembrane transporter activity [GO:0008519]
comp4443287_c0_seq1;GAXK01195771.1;Q24046;6.87E-09;ATPB1_DROME;Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1);"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573";"cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]";"plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";ATPase activator activity [GO:0001671]
comp4443325_c0_seq1;GAXK01195783.1;Q9U539;1.80E-14;OCT1_CAEEL;Organic cation transporter 1 (CeOCT1);"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";"GO:0008340; GO:0015101; GO:0015695; GO:0016021";"determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp444341_c0_seq1;GAXK01140298.1;P18756;7.52E-74;ETS1B_XENLA;Protein c-ets-1-B (C-ets-1B) (XE1-B) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";"GO:0003700; GO:0005634; GO:0010595; GO:0043565; GO:0045765";"positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp44436_c0_seq1;GAXK01185966.1;P42700;5.65E-37;RO60_XENLA;60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (TROVE domain family member 2);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; cell projection organization [GO:0030030]";"GO:0005737; GO:0030030; GO:0034336; GO:0046872";cell projection organization [GO:0030030];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]"
comp4443827_c0_seq1;GAXK01195797.1;Q41011;1.05E-80;EF1A_PEA;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp44442_c0_seq1;GAXK01186161.1;P05661;2.27E-14;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp44443_c0_seq1;GAXK01185923.1;Q9UBR1;0;BUP1_HUMAN;Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]";"GO:0003837; GO:0005829; GO:0019482; GO:0033396; GO:0042803; GO:0046135; GO:0051260; GO:0051289; GO:0070062";"beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803]"
comp444453_c0_seq1;GAXK01140285.1;Q7KRI2;1.40E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp444458_c0_seq1;GAXK01140345.1;Q13227;3.87E-10;GPS2_HUMAN;G protein pathway suppressor 2 (GPS-2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; response to mitochondrial depolarisation [GO:0098780]; viral process [GO:0016032]";"GO:0000122; GO:0000188; GO:0003713; GO:0003714; GO:0005095; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0007254; GO:0010804; GO:0010875; GO:0016032; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045";"B cell differentiation [GO:0030183]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; response to mitochondrial depolarisation [GO:0098780]; viral process [GO:0016032]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp4446842_c0_seq1;GAXK01102525.1;Q28113;1.96E-27;FUT2_BOVIN;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp4448193_c0_seq1;GAXK01094938.1;O94762;6.29E-07;RECQ5_HUMAN;ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042";"cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]"
comp44491_c0_seq1;GAXK01185734.1;P23654;7.96E-66;NRT_DROME;Neurotactin;"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]";"GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0016021; GO:0016323; GO:0052689";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";carboxylic ester hydrolase activity [GO:0052689]
comp444911_c0_seq1;GAXK01140290.1;O65493;2.32E-41;XCP1_ARATH;Cysteine protease XCP1 (EC 3.4.22.-) (Xylem cysteine peptidase 1) (AtXCP1);"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0000325; GO:0004197; GO:0005615; GO:0005634; GO:0005764; GO:0005886; GO:0010623; GO:0051603";"programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]";cysteine-type endopeptidase activity [GO:0004197]
comp4449444_c0_seq1;GAXK01094940.1;P39413;8.84E-08;AEF1_DROME;Adult enhancer factor 1 (AEF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4450084_c0_seq1;GAXK01111000.1;O16087;1.68E-52;HSP83_DROMI;Heat shock protein 83 (HSP 82) (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp4450306_c0_seq1;GAXK01111006.1;P12309;2.60E-17;GLRX1_PIG;Glutaredoxin-1 (Thioltransferase-1) (TTase-1);"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp44505_c10_seq1;GAXK01186180.1;Q8MQW8;2.23E-28;SPRI_DROME;Protein sprint (SH2 poly-proline-containing Ras-interactor protein);"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688";"axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]"
comp44511_c0_seq1;GAXK01186063.1;O05389;2.27E-42;YRBE_BACSU;Uncharacterized oxidoreductase YrbE (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]";"GO:0006740; GO:0016491";NADPH regeneration [GO:0006740];;oxidoreductase activity [GO:0016491]
comp44516_c0_seq1;GAXK01185604.1;Q9USH8;3.05E-20;GLU2B_SCHPO;Glucosidase 2 subunit beta (Alpha-glucosidase 2 subunit beta);"endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]";"GO:0005783; GO:0006487; GO:0006491; GO:0017177";"N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]";
comp4451938_c0_seq1;GAXK01111001.1;Q90705;0;EF2_CHICK;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp44521_c1_seq1;GAXK01186282.1;P27615;1.57E-71;SCRB2_RAT;Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36);"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"GO:0001786; GO:0005044; GO:0005548; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123";"aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]";"endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]"
comp445219_c2_seq1;GAXK01140301.1;Q8VIG1;7.18E-14;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4452213_c0_seq1;GAXK01090227.1;Q6PH52;5.83E-38;PCH2_DANRE;Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13 homolog) (Thyroid receptor-interacting protein 13 homolog) (TR-interacting protein 13 homolog) (TRIP-13 homolog);"chromosome [GO:0005694]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0005524; GO:0005694; GO:0006302; GO:0007130; GO:0007131; GO:0007283; GO:0048477; GO:0051598";"double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";chromosome [GO:0005694];ATP binding [GO:0005524]
comp44524_c0_seq1;GAXK01185956.1;Q6ZS10;1.52E-12;CL17A_HUMAN;C-type lectin domain family 17, member A (Prolectin);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]";"GO:0005537; GO:0009986; GO:0016021; GO:0042806; GO:0046872";;"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";"fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp44536_c1_seq1;GAXK01186023.1;Q8IZ69;1.54E-113;TRM2A_HUMAN;tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein);"RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]";"GO:0003723; GO:0006396; GO:0008173";RNA processing [GO:0006396];;"RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]"
comp44539_c0_seq1;GAXK01185638.1;P18754;4.36E-38;RCC1_HUMAN;Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1);"chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]";"GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0016032; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051290; GO:0051301";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]";"chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]"
comp44549_c3_seq1;GAXK01186162.1;Q9GPJ1;1.36E-19;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp4454956_c0_seq1;GAXK01004641.1;Q8TCB0;3.27E-08;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp445565_c1_seq1;GAXK01140304.1;Q9PT84;0;KCNH6_CHICK;Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel) (ERG) (Eag-related protein) (Ether-a-go-go-related protein) (Voltage-gated potassium channel subunit Kv11.2);"integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005249; GO:0005887; GO:0034765; GO:0042391; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";integral component of plasma membrane [GO:0005887];voltage-gated potassium channel activity [GO:0005249]
comp44559_c3_seq1;GAXK01185907.1;Q2HJ23;1.75E-55;MLP3A_BOVIN;Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0097352";"autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]";"microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]"
comp4456030_c0_seq1;GAXK01027272.1;Q9ULJ7;9.92E-19;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp4456559_c0_seq1;GAXK01027261.1;Q21565;3.81E-26;AMT3_CAEEL;Putative ammonium transporter 3;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp445697_c0_seq1;GAXK01140276.1;B4HNS0;3.11E-07;TRE11_DROSE;Facilitated trehalose transporter Tret1-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp4457_c1_seq1;GAXK01066821.1;Q9GQN5;0;ATRX_DROME;Transcriptional regulator ATRX homolog (EC 3.6.4.12) (ATP-dependent helicase XNP) (X-linked nuclear protein) (d-xnp) (dXNP);"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]";"GO:0000775; GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0005722; GO:0006281; GO:0006336; GO:0007399; GO:0007411; GO:0008347; GO:0016887; GO:0042585; GO:0046328; GO:0051276; GO:0070868; GO:0097193";"axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]";"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp445808_c2_seq1;GAXK01140245.1;Q90W04;1.97E-07;NGB_TETNG;Neuroglobin;"cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005344; GO:0005737; GO:0019825; GO:0020037; GO:0043204; GO:0046872; GO:0098809";response to hypoxia [GO:0001666];"cytoplasm [GO:0005737]; perikaryon [GO:0043204]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp445847_c0_seq1;GAXK01140263.1;Q969R8;3.15E-89;ITFG2_HUMAN;KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2);"cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]";"GO:0002314; GO:0005654; GO:0005765; GO:0005829; GO:0034198; GO:0042149; GO:0140007; GO:1904262";"cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]";"cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]";
comp4459156_c0_seq1;GAXK01010385.1;P04069;1.84E-23;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp445925_c0_seq1;GAXK01140300.1;Q5M868;0;GBA2_RAT;Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.104) (Glucosylceramidase 2);"cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]";"GO:0004348; GO:0005829; GO:0006680; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035";"bile acid metabolic process [GO:0008206]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]";"cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]";"beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]"
comp4459259_c0_seq1;GAXK01010375.1;Q5K651;2.89E-10;SAMD9_HUMAN;Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005829; GO:0034058; GO:0043231";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]";
comp445953_c0_seq1;GAXK01140253.1;P49010;9.28E-48;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp4459534_c0_seq1;GAXK01010391.1;F1NY98;4.08E-08;DSCAM_CHICK;Down syndrome cell adhesion molecule homolog;"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030017; GO:0030054; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]";"netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]"
comp445974_c3_seq1;GAXK01140339.1;P98156;5.47E-136;VLDLR_MOUSE;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R);"apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"GO:0005509; GO:0005615; GO:0005634; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0009986; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045177; GO:0045860; GO:0048306; GO:0048471; GO:0048813; GO:0071456; GO:1900006";"cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]";"apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]";"apolipoprotein binding [GO:0034185]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp446_c0_seq1;GAXK01168688.1;Q5R1W5;1.93E-26;SRSF2_PANTR;Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp4460097_c0_seq1;GAXK01160889.1;Q05746;8.89E-44;HSP70_PLACB;Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp44607_c0_seq1;GAXK01185551.1;Q01780;6.87E-152;EXOSX_HUMAN;Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]";"GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0032211; GO:0035327; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872";"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]"
comp4461_c1_seq1;GAXK01065356.1;Q7Z0G7;7.99E-47;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp446141_c2_seq1;GAXK01099484.1;Q8K3Z0;7.86E-13;NOD2_MOUSE;Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; cytokine production involved in immune response [GO:0002367]; cytokine secretion involved in immune response [GO:0002374]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; macrophage inflammatory protein-1 alpha production [GO:0071608]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]";"GO:0002227; GO:0002253; GO:0002367; GO:0002374; GO:0002381; GO:0002606; GO:0002710; GO:0002732; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006952; GO:0006954; GO:0006963; GO:0006965; GO:0007165; GO:0008284; GO:0009595; GO:0009986; GO:0016045; GO:0016323; GO:0016888; GO:0019899; GO:0019901; GO:0030277; GO:0030544; GO:0031398; GO:0031982; GO:0032088; GO:0032494; GO:0032495; GO:0032496; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034136; GO:0035556; GO:0042742; GO:0042834; GO:0043123; GO:0043330; GO:0043406; GO:0043410; GO:0043552; GO:0044877; GO:0045087; GO:0045089; GO:0045747; GO:0045944; GO:0046330; GO:0050679; GO:0050700; GO:0050718; GO:0050727; GO:0050731; GO:0050766; GO:0050830; GO:0050871; GO:0051092; GO:0051259; GO:0051353; GO:0051770; GO:0051879; GO:0060585; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071608; GO:0071639; GO:0090022; GO:1900017; GO:1901224; GO:1902523; GO:1904417; GO:2000110; GO:2000363";"activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; cytokine production involved in immune response [GO:0002367]; cytokine secretion involved in immune response [GO:0002374]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; macrophage inflammatory protein-1 alpha production [GO:0071608]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; peptidoglycan binding [GO:0042834]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]"
comp44617_c0_seq1;GAXK01186160.1;P80387;1.50E-09;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp4462009_c0_seq1;GAXK01128269.1;Q09GJ8;8.80E-12;SLA_PHIOL;Snaclec subunit A (C-type lectin subunit A);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp44622_c2_seq1;GAXK01185553.1;Q80XC2;9.96E-102;TRM61_MOUSE;tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A);"nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]";"GO:0005634; GO:0016429; GO:0030488; GO:0031515; GO:0061953; GO:0080009";"mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]";"nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]";"mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]"
comp4462234_c0_seq1;GAXK01128272.1;P48995;4.13E-18;TRPC1_HUMAN;Short transient receptor potential channel 1 (TrpC1) (Transient receptor protein 1) (TRP-1);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion channel binding [GO:0044325]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; melanin biosynthetic process [GO:0042438]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to calcium ion [GO:0051592]";"GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0015279; GO:0034703; GO:0042438; GO:0043235; GO:0044325; GO:0051281; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903779";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; melanin biosynthetic process [GO:0042438]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to calcium ion [GO:0051592]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion channel binding [GO:0044325]; store-operated calcium channel activity [GO:0015279]"
comp446277_c0_seq1;GAXK01099475.1;Q7Z5L0;1.07E-22;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp44629_c1_seq1;GAXK01186225.1;Q6P1M0;0;S27A4_HUMAN;Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4);"brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]";"GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005789; GO:0005886; GO:0005902; GO:0007584; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043588; GO:0044539";"long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]";"brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]";"long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp446310_c0_seq1;GAXK01099535.1;Q1RJR6;1.30E-08;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp4463908_c0_seq1;GAXK01128243.1;Q6PBC4;5.83E-125;RS4_XENTR;40S ribosomal protein S4;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0007420; GO:0019843; GO:0022627; GO:0043009";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp446419_c0_seq1;GAXK01099515.1;Q7KRI2;6.57E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp446457_c1_seq1;GAXK01099480.1;P29993;2.70E-95;ITPR_DROME;Inositol 1,4,5-trisphosphate receptor (InsP3 receptor) (IP3R) (InsP3R);"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]";"GO:0000280; GO:0005220; GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0006979; GO:0007591; GO:0007601; GO:0007608; GO:0007629; GO:0009267; GO:0010888; GO:0016021; GO:0016319; GO:0016529; GO:0030322; GO:0030536; GO:0030659; GO:0030667; GO:0035071; GO:0035091; GO:0042594; GO:0044295; GO:0046000; GO:0050909; GO:0051209; GO:0051482; GO:0055088; GO:0055089; GO:0060259; GO:0070588; GO:0070679; GO:0071361";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]";"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]";"calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"
comp4464753_c0_seq1;GAXK01000582.1;P42577;6.35E-56;FRIS_LYMST;Soma ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp4465_c2_seq1;GAXK01065597.1;Q17G75;0;PURA_AEDAE;Adenylosuccinate synthetase (AMPSase) (AdSS) (EC 6.3.4.4) (IMP--aspartate ligase);"cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]";"GO:0000287; GO:0004019; GO:0005525; GO:0005737; GO:0044208";'de novo' AMP biosynthetic process [GO:0044208];cytoplasm [GO:0005737];"adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp44653_c0_seq1;GAXK01185965.1;Q9W062;1.92E-70;MFAP1_DROME;Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1);"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000398; GO:0010389; GO:0032991; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]";
comp446593_c0_seq1;GAXK01099526.1;P10076;2.53E-15;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp446626_c0_seq1;GAXK01099525.1;P05661;1.00E-55;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp44663_c0_seq1;GAXK01185881.1;Q5SRY7;6.21E-15;FBW1B_MOUSE;F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";"GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007049; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031648; GO:0042752; GO:0042753; GO:0043161; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:1901223";"cell cycle [GO:0007049]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]"
comp446687_c1_seq1;GAXK01099511.1;Q9BJK5;4.78E-12;NHR97_CAEEL;Nuclear hormone receptor family member nhr-97;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp4466883_c0_seq1;GAXK01129204.1;Q09575;2.37E-10;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp4467490_c0_seq1;GAXK01129199.1;Q94HW2;1.29E-07;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp446761_c0_seq1;GAXK01099514.1;Q7KRI2;5.53E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4467860_c0_seq1;GAXK01129210.1;F1NZI4;1.25E-28;PGGHG_CHICK;Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1);"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005829; GO:0005975; GO:0047402";carbohydrate metabolic process [GO:0005975];cytosol [GO:0005829];"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]"
comp4468067_c0_seq1;GAXK01181068.1;Q9VNM1;2.38E-22;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp4468806_c0_seq1;GAXK01181070.1;Q9V427;2.50E-38;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp44690_c3_seq1;GAXK01186072.1;Q9U8W7;1.66E-27;TL5B_TACTR;Techylectin-5B;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]";"GO:0005576; GO:0030246; GO:0046872; GO:0098609";cell-cell adhesion [GO:0098609];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp44697_c0_seq1;GAXK01186222.1;P0DMR5;3.09E-13;TDPZ1_MOUSE;TD and POZ domain-containing protein 1 (MAPP family protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp446983_c0_seq1;GAXK01099481.1;Q9JK45;5.47E-143;KCNQ5_MOUSE;Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5);"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005516; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4470_c1_seq1;GAXK01065982.1;Q8K2A1;1.43E-54;GULP1_MOUSE;PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP);"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";"GO:0005737; GO:0006869; GO:0006911; GO:0006915";"apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]";cytoplasm [GO:0005737];
comp4470039_c0_seq1;GAXK01064424.1;Q94HW2;2.06E-13;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4470102_c0_seq1;GAXK01064436.1;Q9VLV7;2.01E-20;SPZ3_DROME;Protein spaetzle 3 (Protein spatzle 3);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp4470305_c0_seq1;GAXK01064434.1;Q9VZU2;9.64E-19;HHAT_DROME;Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0046843; GO:0048100";"dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp44705_c1_seq1;GAXK01185694.1;Q9CWP6;7.13E-66;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp447138_c0_seq1;GAXK01099518.1;P48987;6.84E-10;ATO_DROME;Protein atonal;"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; optic lobe placode development [GO:0001748]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate commitment [GO:0007460]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]";"GO:0001746; GO:0001748; GO:0003677; GO:0005634; GO:0007399; GO:0007420; GO:0007423; GO:0007438; GO:0007455; GO:0007460; GO:0007605; GO:0008038; GO:0016360; GO:0045165; GO:0045433; GO:0045944; GO:0046982; GO:0048800; GO:0048801";"antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; optic lobe placode development [GO:0001748]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate commitment [GO:0007460]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp44716_c0_seq1;GAXK01185917.1;Q3UFB2;3.12E-32;BCD1_MOUSE;Box C/D snoRNA protein 1 (Zinc finger HIT domain-containing protein 6);"nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]";"GO:0000463; GO:0000492; GO:0001094; GO:0005634; GO:0019899; GO:0042802; GO:0046872; GO:0048254; GO:0051117; GO:0051259; GO:0070761";"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]";"nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]";"ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094]"
comp4471926_c0_seq1;GAXK01064429.1;P98160;4.64E-07;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp4471949_c0_seq2;GAXK01064439.1;Q24732;2.27E-11;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4472_c0_seq1;GAXK01066266.1;Q4U3L0;0;G3P_GLOMM;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12);"cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0015630; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]";"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp447206_c0_seq1;GAXK01099485.1;Q9XTJ4;6.42E-11;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp4472286_c0_seq1;GAXK01140732.1;Q8N5T2;8.83E-98;TBC19_HUMAN;TBC1 domain family member 19;GTPase activator activity [GO:0005096];GO:0005096;;;GTPase activator activity [GO:0005096]
comp4473042_c0_seq1;GAXK01140720.1;O97341;1.79E-37;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp44732_c1_seq1;GAXK01185544.1;Q5SPL2;2.46E-52;PHF12_MOUSE;PHD finger protein 12 (PHD factor 1) (Pf1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0016580; GO:0017053; GO:0035091; GO:0045892; GO:0046872; GO:0070822";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]"
comp447337_c0_seq1;GAXK01099473.1;Q9C3Y4;1.24E-65;RHOA_EMENI;GTP-binding protein rhoA (Rho1 protein homolog);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fungal-type cell wall organization [GO:0031505]; hyphal growth [GO:0030448]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030448; GO:0030950; GO:0031505; GO:0032153; GO:0032956; GO:0043231; GO:0051017";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fungal-type cell wall organization [GO:0031505]; hyphal growth [GO:0030448]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp4473534_c0_seq1;GAXK01140733.1;O57683;6.11E-08;SF3B1_XENLA;Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155);"spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0003729; GO:0005681";spliceosomal complex assembly [GO:0000245];spliceosomal complex [GO:0005681];mRNA binding [GO:0003729]
comp447358_c0_seq1;GAXK01099498.1;O94673;5.22E-23;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp4473632_c0_seq1;GAXK01140726.1;P25932;9.86E-10;ESCA_DROME;Protein escargot (Protein fleabag);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; asymmetric neuroblast division [GO:0055059]; branch fusion, open tracheal system [GO:0035147]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc development [GO:0035215]; germ-line stem cell population maintenance [GO:0030718]; gravitaxis [GO:0042332]; intestinal stem cell homeostasis [GO:0036335]; maintenance of imaginal histoblast diploidy [GO:0007489]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of compound eye pigmentation [GO:0048076]; regulation of neural precursor cell proliferation [GO:2000177]; response to nicotine [GO:0035094]; somatic stem cell population maintenance [GO:0035019]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0001227; GO:0001708; GO:0001709; GO:0003677; GO:0005634; GO:0007417; GO:0007424; GO:0007427; GO:0007489; GO:0030718; GO:0032876; GO:0035019; GO:0035094; GO:0035147; GO:0035215; GO:0035220; GO:0036335; GO:0042332; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048076; GO:0055059; GO:2000177";"asymmetric neuroblast division [GO:0055059]; branch fusion, open tracheal system [GO:0035147]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc development [GO:0035215]; germ-line stem cell population maintenance [GO:0030718]; gravitaxis [GO:0042332]; intestinal stem cell homeostasis [GO:0036335]; maintenance of imaginal histoblast diploidy [GO:0007489]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of compound eye pigmentation [GO:0048076]; regulation of neural precursor cell proliferation [GO:2000177]; response to nicotine [GO:0035094]; somatic stem cell population maintenance [GO:0035019]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4473844_c0_seq1;GAXK01140715.1;A0ZT93;9.09E-07;ISP2_BRASG;Type-2 ice-structuring protein (Type II antifreeze protein) (lpAFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp447387_c0_seq1;GAXK01099478.1;Q8BGK6;2.12E-148;YLAT2_MOUSE;Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]";"GO:0005886; GO:0015179; GO:0015297; GO:0016021; GO:0016323; GO:0043231";;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]"
comp4474120_c0_seq1;GAXK01110032.1;Q24732;1.04E-07;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4474853_c0_seq1;GAXK01110037.1;Q10082;8.41E-56;YAO3_SCHPO;Uncharacterized protein C11D3.03c;catalytic activity [GO:0003824];GO:0003824;;;catalytic activity [GO:0003824]
comp447507_c1_seq1;GAXK01099519.1;Q9NFT7;5.19E-150;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp4475376_c0_seq1;GAXK01110029.1;P11118;8.13E-23;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp44755_c0_seq1;GAXK01185639.1;Q03460;2.89E-81;GLSN_MEDSA;Glutamate synthase [NADH], amyloplastic (EC 1.4.1.14) (NADH-GOGAT);"amyloplast [GO:0009501]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]";"GO:0005506; GO:0006541; GO:0009501; GO:0010181; GO:0016040; GO:0050660; GO:0051538; GO:0097054";"glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]";amyloplast [GO:0009501];"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]"
comp4475909_c0_seq1;GAXK01110041.1;Q9SZ67;2.36E-07;WRK19_ARATH;Probable WRKY transcription factor 19 (WRKY DNA-binding protein 19);"chloroplast envelope [GO:0009941]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; defense response [GO:0006952]";"GO:0003700; GO:0004674; GO:0005524; GO:0005634; GO:0006952; GO:0009941; GO:0043531; GO:0043565; GO:0044212";defense response [GO:0006952];"chloroplast envelope [GO:0009941]; nucleus [GO:0005634]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp4476282_c0_seq1;GAXK01114224.1;P50567;4.73E-09;H2A_CHLRE;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp447654_c0_seq1;GAXK01099507.1;P74615;2.93E-09;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp4476604_c0_seq1;GAXK01114217.1;O13262;1.21E-07;SCNNC_XENLA;Amiloride-sensitive sodium channel subunit beta-2 (Beta-2-NaCH) (Epithelial Na(+) channel subunit beta-2) (Beta-2-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta-2) (SCNEB2);"apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transport [GO:0035725]";"GO:0015280; GO:0016021; GO:0016324; GO:0030659; GO:0035725";sodium ion transmembrane transport [GO:0035725];"apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";ligand-gated sodium channel activity [GO:0015280]
comp4477_c1_seq1;GAXK01065678.1;Q8K0V4;7.27E-89;CNOT3_MOUSE;CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829]";"GO:0000932; GO:0001829; GO:0005634; GO:0006355; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036";"gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]";
comp44773_c0_seq1;GAXK01185869.1;P10960;1.05E-09;SAP_RAT;"Prosaposin (Sulfated glycoprotein 1) (SGP-1) [Cleaved into: Saposin-A; Saposin-B-Val; Saposin-B; Saposin-C; Saposin-D]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; glycolipid transport [GO:0046836]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0046836; GO:0060736; GO:0060742";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; glycolipid transport [GO:0046836]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]";
comp4477726_c0_seq1;GAXK01114215.1;P21369;5.85E-23;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp4478219_c0_seq1;GAXK01029926.1;P36609;9.16E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4478953_c0_seq1;GAXK01029931.1;Q9BYN7;3.13E-08;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp44790_c1_seq1;GAXK01186172.1;Q02427;6.21E-12;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp448038_c0_seq1;GAXK01083286.1;P42787;3.96E-91;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp4480750_c0_seq1;GAXK01162575.1;P39057;4.84E-88;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp44825_c0_seq1;GAXK01185727.1;P08159;3.92E-14;HDNO_PSEOX;6-hydroxy-D-nicotine oxidase (6-HDNO) (EC 1.5.3.6);"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]; nicotine catabolic process [GO:0019608]";"GO:0018530; GO:0019608; GO:0071949";nicotine catabolic process [GO:0019608];;"(R)-6-hydroxynicotine oxidase activity [GO:0018530]; FAD binding [GO:0071949]"
comp448267_c0_seq1;GAXK01083247.1;O75325;2.83E-11;LRRN2_HUMAN;Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023";"cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp448268_c0_seq1;GAXK01083242.1;A7Y2W8;3.33E-100;SC6A9_XENLA;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005283; GO:0005328; GO:0005887";;integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp4482951_c0_seq1;GAXK01161030.1;D0EYG3;1.06E-08;SELW_CHICK;Selenoprotein W (SelW);"cytosol [GO:0005829]; antioxidant activity [GO:0016209]; response to selenium ion [GO:0010269]";"GO:0005829; GO:0010269; GO:0016209";response to selenium ion [GO:0010269];cytosol [GO:0005829];antioxidant activity [GO:0016209]
comp4483247_c0_seq1;GAXK01161028.1;Q9JLF1;3.34E-10;GBRT_MOUSE;Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp448343_c1_seq1;GAXK01083287.1;Q9P121;4.86E-35;NTRI_HUMAN;Neurotrimin (hNT) (IgLON family member 2);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp4483513_c0_seq1;GAXK01161033.1;O02151;3.35E-13;NHR14_CAEEL;Nuclear hormone receptor family member nhr-14;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp448390_c0_seq1;GAXK01083313.1;P14083;9.14E-16;LOV_DROME;Protein jim lovell (Protein TKR) (Tyrosine kinase-related) (dTKR);"nucleus [GO:0005634]; DNA binding [GO:0003677]; gravitaxis [GO:0042332]; larval feeding behavior [GO:0030536]; larval walking behavior [GO:0008346]; male courtship behavior [GO:0008049]; negative gravitaxis [GO:0048060]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";"GO:0003677; GO:0005634; GO:0006357; GO:0007418; GO:0008049; GO:0008346; GO:0030536; GO:0042332; GO:0048060; GO:0048477";"gravitaxis [GO:0042332]; larval feeding behavior [GO:0030536]; larval walking behavior [GO:0008346]; male courtship behavior [GO:0008049]; negative gravitaxis [GO:0048060]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp44842_c0_seq1;GAXK01186666.1;Q5ZLN1;4.68E-123;PGAM1_CHICK;Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1);"cell [GO:0005623]; cytosol [GO:0005829]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004082; GO:0004619; GO:0005623; GO:0005829; GO:0006094; GO:0006096; GO:0016787";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cell [GO:0005623]; cytosol [GO:0005829]";"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]"
comp4484563_c0_seq1;GAXK01200453.1;Q00874;1.57E-16;DR100_ARATH;DNA damage-repair/toleration protein DRT100;"chloroplast [GO:0009507]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]";"GO:0000166; GO:0006281; GO:0009507";DNA repair [GO:0006281];chloroplast [GO:0009507];nucleotide binding [GO:0000166]
comp4484693_c0_seq1;GAXK01200440.1;E9PW05;4.88E-07;ZFP54_MOUSE;Zinc finger protein 54 (Krueppel-associated box protein 10) (KRAB10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4484940_c0_seq1;GAXK01200456.1;P10074;1.76E-08;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp44850_c3_seq1;GAXK01186271.1;Q3UUQ7;6.37E-116;PGAP1_MOUSE;GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]; anterior/posterior axis specification [GO:0009948]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; head development [GO:0060322]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]";"GO:0004518; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0015798; GO:0016021; GO:0021871; GO:0042578; GO:0050185; GO:0060322";"anterior/posterior axis specification [GO:0009948]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; head development [GO:0060322]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]"
comp448513_c0_seq1;GAXK01083317.1;Q2EI20;9.12E-13;REST_DANRE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"GO:0000381; GO:0001666; GO:0001764; GO:0003676; GO:0005634; GO:0005737; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475";"branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp448524_c0_seq1;GAXK01083246.1;Q99PD4;6.96E-95;ARC1A_RAT;Actin-related protein 2/3 complex subunit 1A;"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0051015";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin filament binding [GO:0051015]
comp44853_c0_seq1;GAXK01185588.1;Q2YDR3;5.68E-59;IMPA3_DANRE;Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3);"integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0006021; GO:0008254; GO:0008934; GO:0016021; GO:0046854; GO:0046872; GO:0052832; GO:0052833";"inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854]";integral component of membrane [GO:0016021];"3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]"
comp44854_c2_seq1;GAXK01186272.1;Q14746;4.97E-113;COG2_HUMAN;Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"GO:0000139; GO:0005795; GO:0005829; GO:0006888; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]";protein-containing complex binding [GO:0044877]
comp448627_c0_seq2;GAXK01083259.1;Q8JJC0;1.00E-60;ZIC1_CHICK;Zinc finger protein ZIC 1 (Zinc finger protein of the cerebellum 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]";"GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0007389; GO:0007417; GO:0008589; GO:0021510; GO:0030154; GO:0042472; GO:0046872";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp44866_c0_seq1;GAXK01186452.1;Q1HPQ0;1.43E-51;TPM2_BOMMO;Tropomyosin-2;;;;;
comp448662_c1_seq1;GAXK01083278.1;Q8TBH0;2.22E-09;ARRD2_HUMAN;Arrestin domain-containing protein 2;"cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031410";;"cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]";
comp448802_c1_seq1;GAXK01083315.1;P18729;5.92E-19;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp44881_c1_seq1;GAXK01185726.1;Q8BIY1;3.83E-82;GPTC3_MOUSE;G patch domain-containing protein 3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003676; GO:0005634; GO:0005737; GO:0032480; GO:0039536; GO:0045893";"negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";nucleic acid binding [GO:0003676]
comp448816_c0_seq1;GAXK01083306.1;Q9XYN1;3.27E-84;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp4488165_c0_seq1;GAXK01112432.1;Q8BGM5;1.42E-20;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp4488250_c0_seq1;GAXK01112437.1;Q3T052;8.35E-15;ITIH4_BOVIN;Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";"GO:0004867; GO:0005576; GO:0006953; GO:0030212";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]";extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp4488441_c0_seq1;GAXK01112417.1;Q13796;1.08E-07;SHRM2_HUMAN;Protein Shroom2 (Apical-like protein) (Protein APXL);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"GO:0002089; GO:0003779; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005913; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0030036; GO:0030864; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]"
comp4488708_c0_seq1;GAXK01112420.1;Q9HAE3;1.88E-35;EFCB1_HUMAN;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp448875_c0_seq1;GAXK01083257.1;Q6ZVD7;2.68E-24;STOX1_HUMAN;Storkhead-box protein 1 (Winged-helix domain-containing protein);"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]";"GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007049; GO:0008284; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0050679; GO:0051301; GO:0051881; GO:0051897; GO:0061418; GO:0071500; GO:1901858; GO:1902882; GO:1904031; GO:1904120";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]";"cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]
comp4489768_c0_seq1;GAXK01112423.1;Q9WVJ4;6.35E-07;SYJ2B_RAT;Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25) (NPW16);"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of mitochondrial outer membrane [GO:0031307]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; Rho protein signal transduction [GO:0007266]";"GO:0001937; GO:0006605; GO:0007266; GO:0007268; GO:0008022; GO:0008593; GO:0010596; GO:0016323; GO:0016525; GO:0030054; GO:0030100; GO:0031307; GO:0031594; GO:0035255; GO:0043005; GO:0043113; GO:0045197; GO:0048312; GO:0070373; GO:0097120; GO:0098609; GO:0098839; GO:1903671";"cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; Rho protein signal transduction [GO:0007266]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of mitochondrial outer membrane [GO:0031307]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]";"ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]"
comp44900_c0_seq1;GAXK01186017.1;Q3KQ23;4.18E-167;UBA5_XENLA;Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]";"GO:0005524; GO:0005634; GO:0005737; GO:0046872; GO:0071566; GO:0071569; GO:1990592";"protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]"
comp449007_c0_seq1;GAXK01083274.1;P11480;8.39E-69;TBAE_PHYPO;Tubulin alpha-2B chain (Tubulin alpha-E chain);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp4490268_c0_seq1;GAXK01127386.1;P50573;4.39E-09;GBRR3_RAT;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]"
comp44904_c1_seq1;GAXK01186463.1;P0DPW5;1.75E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp4490817_c0_seq1;GAXK01127391.1;P0DF72;3.13E-46;SODM_STRP3;Superoxide dismutase [Mn] (EC 1.15.1.1);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp4491_c0_seq1;GAXK01066861.1;P0C6Y7;1.43E-10;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp44913_c1_seq1;GAXK01185749.1;P20009;1.65E-26;DLL_DROME;Homeotic protein distal-less (Protein brista);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; analia development [GO:0007487]; antennal development [GO:0007469]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; olfactory behavior [GO:0042048]; olfactory nerve development [GO:0021553]; positive regulation of transcription, DNA-templated [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]";"GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0021553; GO:0035114; GO:0035215; GO:0042048; GO:0043565; GO:0045893; GO:0048264; GO:0048728";"analia development [GO:0007487]; antennal development [GO:0007469]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; olfactory behavior [GO:0042048]; olfactory nerve development [GO:0021553]; positive regulation of transcription, DNA-templated [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4491479_c0_seq1;GAXK01127389.1;Q5F478;4.84E-29;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp44917_c0_seq1;GAXK01186357.1;Q94535;4.45E-121;U2AF1_DROME;Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit);"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701";"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]";"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]"
comp44921_c2_seq1;GAXK01186009.1;Q0AXT9;8.77E-24;DDL_SYNWW;D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]"
comp4492343_c0_seq1;GAXK01046461.1;Q9QZU4;5.06E-14;PLAT1_MOUSE;Phospholipase A and acyltransferase 1 (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (HRAS-like suppressor 1) (HRSL1) (Phospholipid-metabolizing enzyme A-C1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; O-acyltransferase activity [GO:0008374]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipase activity [GO:0004620]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; peroxisome organization [GO:0007031]; phosphatidylcholine metabolic process [GO:0046470]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]";"GO:0001558; GO:0004620; GO:0004623; GO:0005634; GO:0005641; GO:0005737; GO:0005777; GO:0007031; GO:0007265; GO:0008374; GO:0008970; GO:0016021; GO:0016042; GO:0016410; GO:0046470; GO:0046485; GO:0052739; GO:0052740; GO:0070292; GO:0102567; GO:0102568";"ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; peroxisome organization [GO:0007031]; phosphatidylcholine metabolic process [GO:0046470]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; O-acyltransferase activity [GO:0008374]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipase activity [GO:0004620]"
comp4493427_c0_seq1;GAXK01046477.1;Q8C8R3;7.42E-17;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp44940_c0_seq1;GAXK01186324.1;Q5JRX3;0;PREP_HUMAN;Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]";"GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485";"protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp44941_c1_seq1;GAXK01186060.1;Q9Z160;1.60E-44;COG1_MOUSE;Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"GO:0000139; GO:0005794; GO:0006891; GO:0015031; GO:0017119";"intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]";
comp4494363_c0_seq1;GAXK01101936.1;P08712;1.08E-48;ENPL_MESAU;Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Fragment);"melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0006457; GO:0030433; GO:0033018; GO:0042470; GO:0051082";"protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp4494678_c0_seq1;GAXK01101937.1;Q7TNC8;1.74E-13;GLRA2_MOUSE;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp4494941_c0_seq1;GAXK01101941.1;P15880;1.60E-62;RS2_HUMAN;40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0017134; GO:0019083; GO:0019899; GO:0022627; GO:0045296; GO:0051443; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4495_c0_seq1;GAXK01066693.1;Q54LX0;8.85E-15;CBPM_DICDI;Calcium-binding protein M;"phagocytic vesicle [GO:0045335]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0045335";;phagocytic vesicle [GO:0045335];calcium ion binding [GO:0005509]
comp4495392_c0_seq1;GAXK01101931.1;P36609;1.08E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp449578_c0_seq1;GAXK01083319.1;O17214;1.38E-13;FUMH_CAEEL;Probable fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0004333; GO:0005739; GO:0005759; GO:0006099; GO:0006106; GO:0006108; GO:0045239";"fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]";fumarate hydratase activity [GO:0004333]
comp449616_c1_seq1;GAXK01083255.1;Q9P0M2;3.54E-14;AKA7G_HUMAN;A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma);"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686";"modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]"
comp44963_c1_seq1;GAXK01186065.1;Q8INK9;2.79E-54;MSRB_DROME;Methionine-R-sulfoxide reductase B1 (EC 1.8.4.12) (Selenoprotein R);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; cellular response to oxidative stress [GO:0034599]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; skeletal muscle thin filament assembly [GO:0030240]";"GO:0005654; GO:0005829; GO:0005856; GO:0007015; GO:0007411; GO:0008270; GO:0008407; GO:0030041; GO:0030091; GO:0030240; GO:0033743; GO:0034599";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; cellular response to oxidative stress [GO:0034599]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; skeletal muscle thin filament assembly [GO:0030240]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]"
comp449690_c0_seq1;GAXK01083253.1;O74467;3.92E-15;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp4497002_c0_seq1;GAXK01052691.1;P08736;1.58E-41;EF1A1_DROME;Elongation factor 1-alpha 1 (EF-1-alpha-1) (50 kDa female-specific protein);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp449703_c0_seq1;GAXK01083282.1;Q961J5;9.49E-61;BALAT_DROME;Beta-alanine transporter (BalaT);"integral component of plasma membrane [GO:0005887]; beta-alanine transmembrane transporter activity [GO:0001761]; beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]";"GO:0001694; GO:0001761; GO:0001762; GO:0005887";"beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]";integral component of plasma membrane [GO:0005887];beta-alanine transmembrane transporter activity [GO:0001761]
comp4497346_c0_seq1;GAXK01052690.1;Q6Q420;1.85E-44;RS15A_DANRE;40S ribosomal protein S15a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0007420; GO:0022627; GO:0030218; GO:0043009; GO:0051726";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp449736_c1_seq1;GAXK01083299.1;Q9W2S3;2.91E-34;BTBD9_DROME;BTB/POZ domain-containing protein 9;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; protein binding, bridging [GO:0030674]; adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of synaptic transmission, dopaminergic [GO:0032225]";"GO:0005737; GO:0008344; GO:0030674; GO:0031463; GO:0032225; GO:0045938; GO:0048512";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of synaptic transmission, dopaminergic [GO:0032225]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]";protein binding, bridging [GO:0030674]
comp4497404_c0_seq1;GAXK01052679.1;A2A935;9.65E-07;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp449743_c0_seq1;GAXK01083314.1;Q17R06;1.39E-87;RAB21_BOVIN;Ras-related protein Rab-21;"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005789; GO:0006886; GO:0019003; GO:0030659; GO:0031901; GO:0032154; GO:0032482";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp449865_c0_seq1;GAXK01083277.1;P49902;3.94E-18;5NTC_HUMAN;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II);"cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]";"GO:0000166; GO:0005829; GO:0006195; GO:0008253; GO:0017144; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]";cytosol [GO:0005829];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp45_c1_seq1;GAXK01170182.1;P05389;1.01E-13;RLA2_DROME;60S acidic ribosomal protein P2 (Acidic ribosomal protein RPA1);"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp4500359_c0_seq1;GAXK01175121.1;P41234;1.53E-18;ABCA2_MOUSE;ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2);"cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; central nervous system myelin formation [GO:0032289]; cholesterol homeostasis [GO:0042632]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to steroid hormone [GO:0048545]";"GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0006357; GO:0006869; GO:0007626; GO:0010008; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0042626; GO:0042632; GO:0043231; GO:0048545; GO:0060049; GO:1904375; GO:2000008";"central nervous system myelin formation [GO:0032289]; cholesterol homeostasis [GO:0042632]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to steroid hormone [GO:0048545]";"cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp45007_c0_seq1;GAXK01185696.1;P05661;2.54E-27;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp45021_c2_seq1;GAXK01186269.1;P70297;1.37E-115;STAM1_MOUSE;Signal transducing adapter molecule 1 (STAM-1);"early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; ubiquitin-like protein ligase binding [GO:0044389]; intracellular protein transport [GO:0006886]; positive regulation of exosomal secretion [GO:1903543]; regulation of extracellular exosome assembly [GO:1903551]";"GO:0006886; GO:0031901; GO:0033565; GO:0044389; GO:1903543; GO:1903551";"intracellular protein transport [GO:0006886]; positive regulation of exosomal secretion [GO:1903543]; regulation of extracellular exosome assembly [GO:1903551]";"early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]";ubiquitin-like protein ligase binding [GO:0044389]
comp450280_c1_seq1;GAXK01016368.1;Q96RW7;9.95E-32;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp4502884_c0_seq1;GAXK01072530.1;Q3TYG6;2.40E-16;TGRM2_MOUSE;TOG array regulator of axonemal microtubules protein 2 (Crescerin-2) (Protein FAM179A);;;;;
comp4502924_c0_seq1;GAXK01072529.1;Q62293;9.24E-07;TGTP1_MOUSE;T-cell-specific guanine nucleotide triphosphate-binding protein 1 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb5);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to interferon-alpha [GO:0035455]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]";"GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0006955; GO:0009615; GO:0009617; GO:0034341; GO:0035455; GO:0035458";"cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to interferon-alpha [GO:0035455]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp45035_c0_seq1;GAXK01185589.1;P18395;0;CSDE1_RAT;Cold shock domain-containing protein E1 (Protein UNR);"CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]";"GO:0003723; GO:0005794; GO:0005829; GO:0005886; GO:0070937; GO:0070966";nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966];"CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";RNA binding [GO:0003723]
comp4503651_c0_seq1;GAXK01072532.1;P49210;7.36E-56;RL9_ORYSJ;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4503922_c0_seq1;GAXK01072525.1;Q9HAZ2;3.56E-08;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp45040_c0_seq1;GAXK01186170.1;Q9UH92;9.93E-66;MLX_HUMAN;Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp4504498_c0_seq1;GAXK01201533.1;Q962R9;1.57E-39;RS10_SPOFR;40S ribosomal protein S10;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp4505367_c0_seq1;GAXK01201539.1;O96006;4.43E-10;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp4505556_c0_seq1;GAXK01201544.1;Q20657;1.04E-58;STO3_CAEEL;Stomatin-3;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4505947_c0_seq1;GAXK01201527.1;Q9UFH2;3.40E-64;DYH17_HUMAN;Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein light chain 2, axonemal);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp450635_c1_seq1;GAXK01016325.1;Q9VSL3;1.21E-40;SEPIA_DROME;Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia);"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";"GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114";"eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]";cytoplasm [GO:0005737];"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"
comp450644_c0_seq1;GAXK01016385.1;Q9NYT6;6.20E-14;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4506639_c0_seq1;GAXK01180194.1;Q8R151;9.88E-16;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp45069_c1_seq1;GAXK01185715.1;Q8N3G9;1.41E-07;TM130_HUMAN;Transmembrane protein 130;"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"GO:0000139; GO:0005794; GO:0005887";;"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";
comp4507315_c0_seq1;GAXK01180197.1;O42329;1.58E-21;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp4507402_c0_seq1;GAXK01180190.1;P36537;2.16E-26;UDB10_HUMAN;UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]";"GO:0005789; GO:0006629; GO:0008194; GO:0016021; GO:0016758; GO:0043231";lipid metabolic process [GO:0006629];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]"
comp450753_c0_seq1;GAXK01016321.1;Q7KRI2;1.21E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4507755_c0_seq1;GAXK01180200.1;P13608;6.70E-13;PGCA_BOVIN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp450841_c1_seq1;GAXK01016418.1;P34846;4.92E-93;NU1M_ANOGA;NADH-ubiquinone oxidoreductase chain 1 (EC 7.1.1.2) (NADH dehydrogenase subunit 1);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]";"GO:0005747; GO:0008137; GO:0009060; GO:0016021";aerobic respiration [GO:0009060];"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp45086_c7_seq1;GAXK01185548.1;P28227;0;MAOX_ANAPL;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40);"cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287";;cytoplasm [GO:0005737];"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp450904_c2_seq1;GAXK01016357.1;Q6DCX5;2.98E-21;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp450927_c1_seq1;GAXK01016302.1;Q8JIY1;5.43E-10;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp451023_c0_seq1;GAXK01016323.1;Q5PPS7;3.71E-11;TM53A_XENLA;Transmembrane protein 53-A;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp451216_c0_seq1;GAXK01016414.1;Q9H2A9;9.75E-08;CHST8_HUMAN;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp451239_c0_seq1;GAXK01016327.1;Q49LX5;4.53E-32;SSR1_CANLF;Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R);"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; glutamate receptor signaling pathway [GO:0007215]; neuropeptide signaling pathway [GO:0007218]";"GO:0004930; GO:0004994; GO:0005887; GO:0007215; GO:0007218; GO:0042277; GO:0071392; GO:1990830";"cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; glutamate receptor signaling pathway [GO:0007215]; neuropeptide signaling pathway [GO:0007218]";integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]"
comp4512749_c0_seq1;GAXK01136463.1;B0JZD0;5.58E-25;CTL5_XENTR;Choline transporter-like protein 5 (Solute carrier family 44 member 5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp451291_c0_seq1;GAXK01016329.1;Q9NA51;7.74E-11;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp4513152_c0_seq1;GAXK01136458.1;Q9NPF2;4.36E-07;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp45133_c2_seq1;GAXK01186212.1;O77821;3.72E-80;LYPA1_RABIT;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Calcium-independent phospholipase A2) (CaIPLA2) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]";"GO:0005737; GO:0006631; GO:0008474";fatty acid metabolic process [GO:0006631];cytoplasm [GO:0005737];palmitoyl-(protein) hydrolase activity [GO:0008474]
comp451436_c0_seq1;GAXK01016423.1;F1NY98;1.35E-10;DSCAM_CHICK;Down syndrome cell adhesion molecule homolog;"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005887; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030017; GO:0030054; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890";"axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; synapse [GO:0045202]";"netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]"
comp4514758_c0_seq1;GAXK01197017.1;Q08180;1.16E-22;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp451486_c0_seq1;GAXK01016343.1;Q9Y2H8;6.33E-14;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp451514_c1_seq1;GAXK01016410.1;Q9XWZ2;1.03E-174;ACD11_CAEEL;Acyl-CoA dehydrogenase family member 11 (EC 1.3.99.-);"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; fatty acid metabolic process [GO:0006631]";"GO:0000166; GO:0006631; GO:0016627";fatty acid metabolic process [GO:0006631];;"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp4515537_c0_seq1;GAXK01197008.1;O01382;1.13E-38;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp4516_c0_seq1;GAXK01065917.1;Q24297;1.80E-39;RUXF_DROME;Small nuclear ribonucleoprotein F (snRNP-F) (Membrane-associated protein Deb-B) (Sm protein F) (Sm-F) (SmF);"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005681; GO:0005685; GO:0005732; GO:0030532; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]";RNA binding [GO:0003723]
comp451641_c0_seq1;GAXK01016351.1;B0VXE8;4.81E-144;CDK14_CALJA;Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14);"cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005886; GO:0016055; GO:0051301; GO:0060828";"cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]";"cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp4516487_c0_seq1;GAXK01038709.1;Q8IVG5;2.18E-15;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp451655_c0_seq1;GAXK01016339.1;P19967;9.80E-85;CYB5R_DROME;Cytochrome b5-related protein (Protein TU-36B);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; lipid metabolic process [GO:0006629]";"GO:0005739; GO:0006629; GO:0016021; GO:0016491; GO:0020037; GO:0046872";lipid metabolic process [GO:0006629];"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp4516770_c0_seq1;GAXK01038701.1;Q8N2I2;2.71E-07;ZN619_HUMAN;Zinc finger protein 619;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp451710_c0_seq1;GAXK01016299.1;Q24372;3.07E-31;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp45172_c0_seq1;GAXK01185545.1;Q01611;3.25E-11;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp45173_c4_seq1;GAXK01186194.1;P34897;0;GLYM_HUMAN;Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase);"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0046655; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482";"cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]"
comp451753_c0_seq1;GAXK01016426.1;B5U2W0;4.39E-56;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp451754_c1_seq1;GAXK01016452.1;Q9Z2D6;4.69E-14;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp451795_c0_seq1;GAXK01016308.1;P03952;4.22E-48;KLKB1_HUMAN;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007597; GO:0022617; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062";"blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp4518674_c0_seq1;GAXK01001178.1;P50886;5.60E-31;RL22_XENLA;60S ribosomal protein L22;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4519_c2_seq1;GAXK01065658.1;Q868N5;1.76E-32;VIT_APIME;Vitellogenin;"extracellular region [GO:0005576]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]";"GO:0005319; GO:0005576; GO:0045735";;extracellular region [GO:0005576];"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp451932_c0_seq1;GAXK01016399.1;Q8N0W3;8.98E-124;FCSK_HUMAN;L-fucose kinase (Fucokinase) (EC 2.7.1.52);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]";"GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350";"carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fucokinase activity [GO:0050201]"
comp4519519_c0_seq1;GAXK01001171.1;P54685;1.94E-14;CDK7_DICDI;Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (CDK-activating kinase) (CAK) (Cell division protein kinase 7) (MO15 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]";"GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008353; GO:0045944; GO:0051301; GO:0051321; GO:0070985";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor TFIIK complex [GO:0070985]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp452009_c0_seq1;GAXK01195341.1;Q6DIP9;0;WASC5_XENTR;WASH complex subunit 5 (WASH complex subunit strumpellin);"early endosome [GO:0005769]; WASH complex [GO:0071203]; protein transport [GO:0015031]";"GO:0005769; GO:0015031; GO:0071203";protein transport [GO:0015031];"early endosome [GO:0005769]; WASH complex [GO:0071203]";
comp452227_c2_seq1;GAXK01195349.1;Q7KRI2;9.07E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp452406_c1_seq1;GAXK01195401.1;Q24478;2.07E-31;CP190_DROME;Centrosome-associated zinc finger protein CP190 (Protein enhancer of mod(mdg4)4-1) (dMAP190);"centrosome [GO:0005813]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; spindle microtubule [GO:0005876]; chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; gene looping [GO:0090202]; nuclear axial expansion [GO:0035191]; positive regulation of chromatin silencing [GO:0031937]; regulation of cytoskeleton organization [GO:0051493]; regulation of gene expression [GO:0010468]";"GO:0000242; GO:0000793; GO:0003677; GO:0003682; GO:0005634; GO:0005700; GO:0005704; GO:0005813; GO:0005876; GO:0008017; GO:0010468; GO:0031208; GO:0031937; GO:0035191; GO:0042803; GO:0043035; GO:0046872; GO:0051493; GO:0090202";"gene looping [GO:0090202]; nuclear axial expansion [GO:0035191]; positive regulation of chromatin silencing [GO:0031937]; regulation of cytoskeleton organization [GO:0051493]; regulation of gene expression [GO:0010468]";"centrosome [GO:0005813]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; spindle microtubule [GO:0005876]";"chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp452419_c1_seq1;GAXK01195402.1;Q99MD8;3.24E-14;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp45242_c0_seq1;GAXK01186303.1;Q9V9J3;0;SRC42_DROME;Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41);"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136";"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]"
comp452427_c0_seq1;GAXK01195345.1;Q61382;2.80E-58;TRAF4_MOUSE;TNF receptor-associated factor 4 (Cysteine-rich motif associated to RING and Traf domains protein 1);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]";"GO:0005164; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0032991; GO:0042802; GO:0042981; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0090073";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp452439_c0_seq1;GAXK01195459.1;Q7KRI2;7.36E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4525_c1_seq1;GAXK01065648.1;Q0VC92;5.20E-96;MGN2_BOVIN;Protein mago nashi homolog 2;"catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]";"GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0008380; GO:0035145; GO:0051028; GO:0071005; GO:0071006; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]";RNA binding [GO:0003723]
comp452519_c0_seq1;GAXK01195351.1;Q90632;2.69E-30;MOT3_CHICK;Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);"integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp45255_c0_seq1;GAXK01185717.1;Q17QH8;1.64E-76;D39U1_BOVIN;Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1);"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0050662";;;"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]"
comp452615_c0_seq1;GAXK01195352.1;Q8N9F8;9.52E-26;ZN454_HUMAN;Zinc finger protein 454;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp452635_c1_seq1;GAXK01195425.1;Q08180;1.94E-30;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp4527464_c0_seq1;GAXK01181778.1;Q5R8I8;2.20E-35;PISD_PONAB;"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]";"integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305";"phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]";phosphatidylserine decarboxylase activity [GO:0004609]
comp4527645_c0_seq1;GAXK01181770.1;P14659;6.22E-19;HSP72_RAT;Heat shock-related 70 kDa protein 2 (Heat shock protein 70.2) (Testis-specific heat shock protein-related) (HST);"CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; multicellular organism development [GO:0007275]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192]";"GO:0000795; GO:0001673; GO:0001934; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0007141; GO:0007275; GO:0007283; GO:0007286; GO:0009408; GO:0009409; GO:0009986; GO:0010971; GO:0016192; GO:0016887; GO:0019899; GO:0031072; GO:0032781; GO:0034605; GO:0034620; GO:0036128; GO:0042026; GO:0042623; GO:0044183; GO:0048156; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0051861; GO:0070194; GO:0072687; GO:0090084; GO:0097718; GO:1901896";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; multicellular organism development [GO:0007275]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192]";"CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082]"
comp4527985_c0_seq1;GAXK01181777.1;P05661;8.42E-24;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp4528373_c0_seq1;GAXK01025992.1;A0A286LEZ8;1.34E-07;PSID_PSICY;L-tryptophan decarboxylase (EC 4.1.1.105) (Psilocybin biosynthesis decarboxylase);"phosphatidylserine decarboxylase activity [GO:0004609]; phospholipid biosynthetic process [GO:0008654]";"GO:0004609; GO:0008654";phospholipid biosynthetic process [GO:0008654];;phosphatidylserine decarboxylase activity [GO:0004609]
comp4529_c1_seq1;GAXK01065991.1;Q9VHS7;2.24E-103;COQ2_DROME;4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (Coenzyme Q biosynthesis protein 2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; 4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; isoprenoid biosynthetic process [GO:0008299]; transcription by RNA polymerase I [GO:0006360]; ubiquinone biosynthetic process [GO:0006744]";"GO:0002083; GO:0005666; GO:0005736; GO:0005739; GO:0005743; GO:0006360; GO:0006744; GO:0008299; GO:0008340; GO:0008412; GO:0016765; GO:0031305; GO:0047293; GO:0050829; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; isoprenoid biosynthetic process [GO:0008299]; transcription by RNA polymerase I [GO:0006360]; ubiquinone biosynthetic process [GO:0006744]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]";"4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]"
comp452919_c0_seq1;GAXK01195456.1;P17644;0;ACH2_DROME;Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp4529849_c0_seq1;GAXK01025982.1;P62718;5.54E-07;RL18A_RAT;60S ribosomal protein L18a;"cytosolic large ribosomal subunit [GO:0022625]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; synapse [GO:0045202]; structural constituent of ribosome [GO:0003735]; response to antineoplastic agent [GO:0097327]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0014069; GO:0022625; GO:0045202; GO:0097327";"response to antineoplastic agent [GO:0097327]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; synapse [GO:0045202]";structural constituent of ribosome [GO:0003735]
comp45301_c0_seq1;GAXK01186326.1;Q80Z30;5.66E-64;PPM1E_RAT;Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]";"GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006469; GO:0032991; GO:0035690; GO:0035970; GO:0046872; GO:0051496";"cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp453054_c0_seq1;GAXK01195455.1;Q4UMH6;1.21E-27;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp45306_c1_seq1;GAXK01205931.1;Q2V2M9;5.68E-121;FHOD3_HUMAN;FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2);"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003";"actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp453066_c1_seq1;GAXK01195353.1;Q09225;6.21E-58;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp4530678_c0_seq1;GAXK01055651.1;Q58L94;2.78E-09;FAXD2_NOTSC;"Venom prothrombin activator notecarin-D2 (vPA) (EC 3.4.21.6) (Venom coagulation factor Xa-like protease) [Cleaved into: Notecarin-D2 light chain; Notecarin-D2 heavy chain]";"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]; blood coagulation [GO:0007596]; envenomation resulting in positive regulation of blood coagulation in other organism [GO:0044469]; positive regulation of blood coagulation in other organism [GO:0035807]";"GO:0004252; GO:0005509; GO:0005576; GO:0007596; GO:0016504; GO:0035807; GO:0044469; GO:0090729";"blood coagulation [GO:0007596]; envenomation resulting in positive regulation of blood coagulation in other organism [GO:0044469]; positive regulation of blood coagulation in other organism [GO:0035807]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp4530738_c0_seq1;GAXK01055638.1;Q0EEE2;4.28E-18;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp453080_c1_seq1;GAXK01195451.1;P06601;9.34E-67;PRD_DROME;Segmentation protein paired;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0006366; GO:0007366; GO:0045944";"periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp4532153_c0_seq1;GAXK01141866.1;Q9VCH5;1.31E-08;NUP98_DROME;"Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (Nucleoporin Nup96) (Nup96)]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]; chromatin DNA binding [GO:0031490]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; transcriptional activation by promoter-enhancer looping [GO:0071733]";"GO:0000785; GO:0000973; GO:0002230; GO:0003723; GO:0005634; GO:0005643; GO:0005654; GO:0005700; GO:0005703; GO:0005704; GO:0005737; GO:0006405; GO:0006606; GO:0008139; GO:0008236; GO:0010628; GO:0017056; GO:0030718; GO:0030838; GO:0031490; GO:0031965; GO:0034398; GO:0034605; GO:0035075; GO:0035080; GO:0035167; GO:0036098; GO:0043922; GO:0044613; GO:0044614; GO:0045944; GO:0046822; GO:0051028; GO:0060261; GO:0071390; GO:0071733; GO:1990841";"cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; transcriptional activation by promoter-enhancer looping [GO:0071733]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]";"chromatin DNA binding [GO:0031490]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]"
comp45327_c0_seq1;GAXK01185725.1;Q24093;7.54E-60;ABHD2_DROME;Abhydrolase domain-containing protein 2 (EC 3.1.1.-);"integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]";"GO:0006629; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524";"acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]";"integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]";"acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]"
comp4532794_c0_seq1;GAXK01141873.1;Q60716;9.93E-38;P4HA2_MOUSE;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; procollagen-proline 4-dioxygenase complex [GO:0016222]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0016222; GO:0016702; GO:0018401; GO:0031418; GO:0043231";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp453299_c0_seq1;GAXK01195343.1;Q9ZP54;7.83E-09;PARP1_ARATH;Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase 1) (ADPRT-1) (Poly[ADP-ribose] synthase 1) (Protein ADP-ribosyltransferase PARP1) (EC 2.4.2.-);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; response to abscisic acid [GO:0009737]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003950; GO:0005634; GO:0005730; GO:0006281; GO:0006302; GO:0006471; GO:0006979; GO:0008270; GO:0009737; GO:0051287; GO:0070212; GO:1990404";"DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; response to abscisic acid [GO:0009737]; response to oxidative stress [GO:0006979]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp453306_c0_seq1;GAXK01195347.1;Q52M93;9.41E-21;Z585B_HUMAN;Zinc finger protein 585B (zinc finger protein 41-like protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4533354_c0_seq1;GAXK01141878.1;Q9VYB7;3.18E-31;TPST_DROME;Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase) (TPST);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0009306; GO:0016021";"peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp453345_c1_seq1;GAXK01205976.1;P42232;0;STA5B_MOUSE;Signal transducer and activator of transcription 5B;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0032355; GO:0032496; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0043029; GO:0043066; GO:0043434; GO:0043565; GO:0045086; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0048661; GO:0050729; GO:0051272; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531";"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4534_c0_seq1;GAXK01066622.1;Q9P0U1;2.26E-09;TOM7_HUMAN;Mitochondrial import receptor subunit TOM7 homolog (Translocase of outer membrane 7 kDa subunit homolog);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; macroautophagy [GO:0016236]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of protein stability [GO:0031647]";"GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016021; GO:0016236; GO:0030150; GO:0031647; GO:0098779; GO:1903955";"macroautophagy [GO:0016236]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of protein stability [GO:0031647]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]";protein transmembrane transporter activity [GO:0008320]
comp45340_c0_seq1;GAXK01186085.1;Q9DC37;1.47E-163;MFSD1_MOUSE;Major facilitator superfamily domain-containing protein 1;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp45344_c0_seq1;GAXK01186584.1;Q2ABP2;5.30E-33;PGAP2_CRIGR;Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000139; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp4534661_c0_seq1;GAXK01128084.1;P40614;2.73E-94;MPCP_CAEEL;Phosphate carrier protein, mitochondrial (PTP);"integral component of mitochondrial inner membrane [GO:0031305]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0031305; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of mitochondrial inner membrane [GO:0031305];inorganic phosphate transmembrane transporter activity [GO:0005315]
comp453475_c2_seq1;GAXK01195433.1;Q7KRI2;4.56E-09;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp453541_c0_seq1;GAXK01195342.1;Q969G2;5.12E-20;LHX4_HUMAN;LIM/homeobox protein Lhx4 (LIM homeobox protein 4);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0030182; GO:0043066; GO:0043565; GO:0045944; GO:0046872";"animal organ morphogenesis [GO:0009887]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp453573_c0_seq1;GAXK01195360.1;Q62839;9.84E-09;GOGA2_RAT;Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130);"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"GO:0000137; GO:0000139; GO:0000922; GO:0005737; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0015031; GO:0019901; GO:0032580; GO:0032991; GO:0033116; GO:0043025; GO:0044877; GO:0051225; GO:0051289; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307";"asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]";"importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]"
comp4536261_c0_seq1;GAXK01147039.1;Q16670;1.40E-09;ZSC26_HUMAN;Zinc finger and SCAN domain-containing protein 26 (Protein SRE-ZBP) (Zinc finger protein 187);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0042552; GO:0045892; GO:0046872";"myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp45373_c1_seq1;GAXK01186040.1;Q5B5X8;1.72E-61;EXGA_EMENI;Probable glucan 1,3-beta-glucosidase A (EC 3.2.1.58) (Exo-1,3-beta-glucanase 1) (Exo-1,3-beta-glucanase A);"cell surface [GO:0009986]; extracellular region [GO:0005576]; glucan exo-1,3-beta-glucosidase activity [GO:0004338]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; cellular glucan metabolic process [GO:0006073]; glucan catabolic process [GO:0009251]";"GO:0004338; GO:0005576; GO:0006073; GO:0009251; GO:0009986; GO:0046872; GO:0071555";"cellular glucan metabolic process [GO:0006073]; cell wall organization [GO:0071555]; glucan catabolic process [GO:0009251]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";"glucan exo-1,3-beta-glucosidase activity [GO:0004338]; metal ion binding [GO:0046872]"
comp453746_c0_seq1;GAXK01195346.1;Q68FK8;0;DHX9_XENLA;ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II);"actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005815; GO:0005844; GO:0006260; GO:0006353; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035613; GO:0036464; GO:0042788; GO:0043138; GO:0044806; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071356; GO:0097165; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767";"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]"
comp45380_c0_seq1;GAXK01186174.1;P05946;1.05E-68;SCP1_ASTLP;Sarcoplasmic calcium-binding protein 1 (Sarcoplasmic calcium-binding protein I) (SCP I);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4539_c0_seq1;GAXK01065627.1;Q90679;3.96E-82;THYN1_CHICK;Thymocyte nuclear protein 1 (Thymocyte protein Thy28) (cThy28);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp453905_c0_seq1;GAXK01205991.1;Q59H18;0;TNI3K_HUMAN;Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779";"bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]"
comp45394_c4_seq1;GAXK01186165.1;P17019;1.49E-40;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp453982_c0_seq1;GAXK01195363.1;Q16720;0;AT2B3_HUMAN;Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3);"extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005388; GO:0005516; GO:0005524; GO:0005794; GO:0005886; GO:0006874; GO:0015085; GO:0016021; GO:0030165; GO:0034220; GO:0046872; GO:0051480; GO:0098793; GO:0098978; GO:0098982; GO:1903561; GO:1903779; GO:1905056; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]";"extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]"
comp45399_c1_seq1;GAXK01185842.1;Q00174;0;LAMA_DROME;Laminin subunit alpha (Laminin A chain);"axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005102; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030054; GO:0030155; GO:0030334; GO:0030424; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0062023; GO:0071711";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]";signaling receptor binding [GO:0005102]
comp454_c0_seq1;GAXK01165543.1;P07705;5.80E-26;NU3M_DROYA;NADH-ubiquinone oxidoreductase chain 3 (EC 7.1.1.2) (NADH dehydrogenase subunit 3);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]";"GO:0008137; GO:0016021; GO:0031966; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp45413_c3_seq1;GAXK01186091.1;Q802R8;5.27E-29;SMC6_TAKRU;Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398";"cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp4541369_c0_seq1;GAXK01157638.1;Q4GXH5;2.10E-32;RL17_CARGR;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp454154_c1_seq1;GAXK01003652.1;A0A0B4K692;0;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp454182_c1_seq1;GAXK01003676.1;P11118;1.29E-54;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4542044_c0_seq1;GAXK01143526.1;Q6VV64;1.47E-24;KCNKI_MOUSE;Potassium channel subfamily K member 18 (Two-pore-domain potassium channel TRESK);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623";"cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp45425_c0_seq1;GAXK01186323.1;A2AM29;3.49E-18;AF9_MOUSE;Protein AF-9 (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein homolog);"chromosome [GO:0005694]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; segment specification [GO:0007379]";"GO:0003682; GO:0005694; GO:0007379; GO:0008023; GO:0009952; GO:0042393; GO:0045893; GO:0070577; GO:0090090; GO:0140030; GO:2000096";"anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; segment specification [GO:0007379]";"chromosome [GO:0005694]; transcription elongation factor complex [GO:0008023]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]"
comp4542538_c0_seq1;GAXK01143530.1;P00571;1.57E-45;KAD1_PIG;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase);"cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0006165; GO:0006172; GO:0009142; GO:0046033; GO:0046034";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";cytoplasm [GO:0005737];"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp454321_c0_seq1;GAXK01003731.1;Q6ZMW2;7.42E-18;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4543947_c0_seq1;GAXK01143533.1;Q96PE6;3.49E-12;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4544255_c0_seq1;GAXK01131010.1;D2H0Y8;5.73E-11;RN146_AILME;E3 ubiquitin-protein ligase RNF146 (EC 2.3.2.27) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146);"cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4545_c0_seq1;GAXK01065444.1;P52033;1.52E-37;GPXC_DIRIM;Glutathione peroxidase (EC 1.11.1.9) (Di29);"extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0005615; GO:0006979";response to oxidative stress [GO:0006979];extracellular space [GO:0005615];glutathione peroxidase activity [GO:0004602]
comp454577_c1_seq1;GAXK01003738.1;F1NHE9;9.35E-64;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp4545971_c0_seq1;GAXK01131004.1;B8HSK8;6.87E-11;SYR_CYAP4;Arginine--tRNA ligase (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS);"cytoplasm [GO:0005737]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]";"GO:0004814; GO:0005524; GO:0005737; GO:0006420";arginyl-tRNA aminoacylation [GO:0006420];cytoplasm [GO:0005737];"arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]"
comp4546276_c0_seq1;GAXK01193900.1;A5LGM7;4.12E-14;TRET1_POLVA;Facilitated trehalose transporter Tret1 (PvTret1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp45470_c1_seq1;GAXK01185596.1;Q80UX8;3.74E-63;ABHDD_MOUSE;Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13);"cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0005737; GO:0008474; GO:0016021; GO:0032839";protein depalmitoylation [GO:0002084];"cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]";palmitoyl-(protein) hydrolase activity [GO:0008474]
comp45476_c9_seq1;GAXK01185739.1;Q8C341;2.28E-35;SUCO_MOUSE;SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia) (SUN-like protein 1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of bone remodeling [GO:0046850]";"GO:0001503; GO:0005737; GO:0005791; GO:0007275; GO:0016020; GO:0016021; GO:0030867; GO:0032967; GO:0034975; GO:0045669; GO:0046850";"multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of bone remodeling [GO:0046850]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]";
comp4547813_c0_seq1;GAXK01193892.1;P23653;9.83E-33;PRTR_PARAQ;Proteinase R (EC 3.4.21.-);"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0046872";;;"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp45484_c0_seq1;GAXK01185841.1;Q5E9C0;8.89E-111;RSU1_BOVIN;Ras suppressor protein 1 (Rsu-1);;;;;
comp45488_c12_seq1;GAXK01186405.1;P56079;0;CDSA_DROME;Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016021; GO:0016024; GO:0016056; GO:0043052";"CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";phosphatidate cytidylyltransferase activity [GO:0004605]
comp4549157_c0_seq1;GAXK01090620.1;Q8Q0U0;1.75E-08;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp45492_c0_seq1;GAXK01185605.1;Q13233;2.87E-105;M3K1_HUMAN;Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0002755; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0023014; GO:0031098; GO:0032147; GO:0038095; GO:0071260";"activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"
comp454937_c0_seq1;GAXK01003728.1;P24387;3.61E-23;CRHBP_HUMAN;Corticotropin-releasing factor-binding protein (CRF-BP) (CRF-binding protein) (Corticotropin-releasing hormone-binding protein) (CRH-BP);"axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]; corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]; behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; female pregnancy [GO:0007565]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; maternal aggressive behavior [GO:0002125]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0002125; GO:0005576; GO:0005615; GO:0005634; GO:0005767; GO:0005771; GO:0005874; GO:0006954; GO:0007165; GO:0007565; GO:0007611; GO:0009755; GO:0030141; GO:0030425; GO:0031045; GO:0035690; GO:0035865; GO:0042277; GO:0042445; GO:0043196; GO:0043204; GO:0043679; GO:0045055; GO:0048149; GO:0051424; GO:0051459; GO:0051460; GO:0071277; GO:0071314; GO:0071320; GO:0071356; GO:0071391; GO:0071392; GO:0080135; GO:0097211; GO:1900011; GO:2000310";"behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; maternal aggressive behavior [GO:0002125]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; negative regulation of corticotropin secretion [GO:0051460]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]";"corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]"
comp454941_c0_seq1;GAXK01003778.1;Q9CWR2;3.85E-24;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp454956_c0_seq1;GAXK01003658.1;A4QN56;1.95E-18;MFS4B_DANRE;Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp454960_c0_seq1;GAXK01003777.1;Q8MRC9;0;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp454967_c0_seq1;GAXK01003680.1;Q5XIT1;6.39E-86;MARE3_RAT;Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3);"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005815; GO:0005874; GO:0005881; GO:0008017; GO:0008022; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0045737; GO:0045893; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]"
comp4549683_c0_seq1;GAXK01090615.1;Q7YQD7;1.24E-10;FBLN3_MACFA;EGF-containing fibulin-like extracellular matrix protein 1 (Fibulin-3) (FIBL-3);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; epidermal growth factor-activated receptor activity [GO:0005006]; growth factor activity [GO:0008083]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005006; GO:0005154; GO:0005509; GO:0005615; GO:0006355; GO:0007173; GO:0008083; GO:0018108; GO:0032331; GO:0062023";"epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of transcription, DNA-templated [GO:0006355]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]"
comp4550_c1_seq1;GAXK01065393.1;Q8VHE0;1.21E-137;SEC63_MOUSE;Translocation protein SEC63 homolog;"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0001889; GO:0005783; GO:0006614; GO:0006620; GO:0006807; GO:0010259; GO:0016020; GO:0016021; GO:0031204; GO:0031207";"liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]";
comp455015_c1_seq1;GAXK01204975.1;P05179;1.07E-65;CP2C7_RAT;Cytochrome P450 2C7 (EC 1.14.14.1) (CYPIIC7) (Cytochrome P450F) (PTF1);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to retinoic acid [GO:0032526]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0007584; GO:0008392; GO:0008395; GO:0010243; GO:0014070; GO:0016712; GO:0019373; GO:0020037; GO:0032496; GO:0032526; GO:0042493; GO:0042738; GO:0043231; GO:0043434; GO:0045471; GO:0055114; GO:0070330";"epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to retinoic acid [GO:0032526]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp45503_c0_seq1;GAXK01186207.1;P79942;1.84E-79;NOCT_XENLA;Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) (Rhythmic message 1) (RM1);"mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397]; NADP metabolic process [GO:0006739]";"GO:0004535; GO:0005739; GO:0006397; GO:0006739; GO:0019178; GO:0032922; GO:0046872; GO:0102757";"circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397]; NADP metabolic process [GO:0006739]";mitochondrion [GO:0005739];"metal ion binding [GO:0046872]; NADPH phosphatase activity [GO:0102757]; NADP phosphatase activity [GO:0019178]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp455036_c3_seq1;GAXK01003765.1;B0WC46;3.46E-102;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp45505_c0_seq1;GAXK01186426.1;Q7ZVB2;0;A9A1A_DANRE;4-trimethylaminobutyraldehyde dehydrogenase A (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1-A) (EC 1.2.1.3);"cytosol [GO:0005829]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]";"GO:0004029; GO:0005829; GO:0006081; GO:0019145; GO:0043878; GO:0045329; GO:0047105; GO:0051289";"carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]";cytosol [GO:0005829];"4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]"
comp4550650_c0_seq1;GAXK01159385.1;Q96NH3;1.42E-15;BROMI_HUMAN;Protein broad-minded (TBC1 domain family member 32);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042733; GO:0060271; GO:0060831; GO:0061512; GO:1905515";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]";"cilium [GO:0005929]; cytoplasm [GO:0005737]";
comp45508_c1_seq1;GAXK01185870.1;O57429;8.03E-120;UBP2_CHICK;Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004843; GO:0005737; GO:0006511; GO:0016579; GO:0046872; GO:0048471; GO:0048511";"protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp45512_c1_seq1;GAXK01185979.1;Q3MHZ2;1.08E-22;SPSB3_BOVIN;SPRY domain-containing SOCS box protein 3 (SSB-3);"SCF ubiquitin ligase complex [GO:0019005]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0006511; GO:0016567; GO:0019005; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";SCF ubiquitin ligase complex [GO:0019005];
comp45516_c0_seq1;GAXK01185766.1;Q4R3J0;3.56E-122;RTCA_MACFA;RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1);"nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963]; RNA processing [GO:0006396]";"GO:0003963; GO:0005524; GO:0005654; GO:0006396";RNA processing [GO:0006396];nucleoplasm [GO:0005654];"ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963]"
comp4552494_c0_seq1;GAXK01042663.1;P08964;1.83E-29;MYO1_YEAST;Myosin-1 (Type II myosin);"cellular bud neck [GO:0005935]; cellular bud neck contractile ring [GO:0000142]; incipient cellular bud site [GO:0000131]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actomyosin contractile ring assembly [GO:0000915]; actomyosin contractile ring contraction [GO:0000916]; septum digestion after cytokinesis [GO:0000920]";"GO:0000131; GO:0000142; GO:0000146; GO:0000915; GO:0000916; GO:0000920; GO:0005524; GO:0005935; GO:0016460; GO:0051015";"actomyosin contractile ring assembly [GO:0000915]; actomyosin contractile ring contraction [GO:0000916]; septum digestion after cytokinesis [GO:0000920]";"cellular bud neck [GO:0005935]; cellular bud neck contractile ring [GO:0000142]; incipient cellular bud site [GO:0000131]; myosin II complex [GO:0016460]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]"
comp455286_c0_seq1;GAXK01003727.1;P52899;2.69E-40;ODPA_CAEEL;Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096";"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]
comp455337_c0_seq1;GAXK01003659.1;A2VDP4;1.31E-19;ZN567_BOVIN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp45537_c2_seq1;GAXK01185718.1;Q6ZNB7;3.78E-108;ALKMO_HUMAN;Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432]";"GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0016021; GO:0019432; GO:0046485; GO:0050479";"ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]"
comp4554104_c0_seq1;GAXK01148946.1;P97738;1.33E-10;NPTX2_RAT;Neuronal pentraxin-2 (NP2) (Neuronal activity-regulated pentraxin) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"GO:0005576; GO:0005886; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098892; GO:0098978; GO:0099645";"neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp45543_c2_seq1;GAXK01185920.1;Q7Z9I4;1.80E-21;YCP6_SCHPO;Uncharacterized oxidoreductase C663.06c (EC 1.-.-.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]";"GO:0005634; GO:0005829; GO:0016491; GO:0110095";cellular detoxification of aldehyde [GO:0110095];"cytosol [GO:0005829]; nucleus [GO:0005634]";oxidoreductase activity [GO:0016491]
comp4554344_c0_seq1;GAXK01148942.1;Q8H166;2.04E-19;ALEU_ARATH;Thiol protease aleurain (AtALEU) (EC 3.4.22.16) (Senescence-associated gene product 2);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp455520_c1_seq1;GAXK01003747.1;A8XJD0;2.91E-27;HM30_CAEBR;Homeobox protein ceh-30;"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; tissue development [GO:0009888]";"GO:0000977; GO:0001228; GO:0005634; GO:0006357; GO:0007399; GO:0007548; GO:0009888; GO:0030154; GO:0043066; GO:0048513";"animal organ development [GO:0048513]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; tissue development [GO:0009888]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp455528_c0_seq1;GAXK01003737.1;Q9MFN9;7.27E-168;CYB_COLHO;Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex III [GO:0045275]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"GO:0005743; GO:0006122; GO:0008121; GO:0016021; GO:0045275; GO:0046872";mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex III [GO:0045275]";"metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp455564_c0_seq1;GAXK01003749.1;Q21276;1.63E-39;NOP56_CAEEL;Nucleolar protein 56;"box C/D snoRNP complex [GO:0031428]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; ribosome biogenesis [GO:0042254]";"GO:0030515; GO:0031428; GO:0032040; GO:0042254";ribosome biogenesis [GO:0042254];"box C/D snoRNP complex [GO:0031428]; small-subunit processome [GO:0032040]";snoRNA binding [GO:0030515]
comp4555706_c0_seq1;GAXK01148940.1;Q28596;1.41E-26;TRFR_SHEEP;Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]";"GO:0004997; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";thyrotropin-releasing hormone receptor activity [GO:0004997]
comp45559_c0_seq1;GAXK01186086.1;Q08BB5;2.82E-112;CTL2A_DANRE;CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-);phosphoprotein phosphatase activity [GO:0004721];GO:0004721;;;phosphoprotein phosphatase activity [GO:0004721]
comp455611_c0_seq1;GAXK01003672.1;Q91206;7.73E-18;MYOD2_ONCMY;Myoblast determination protein 1 homolog 2 (Myogenic factor 1-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]";"GO:0003677; GO:0005634; GO:0007517; GO:0030154; GO:0046983; GO:1905382; GO:1990841";"cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]";nucleus [GO:0005634];"DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]"
comp455633_c0_seq1;GAXK01003775.1;Q05481;1.70E-50;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp45570_c1_seq1;GAXK01186462.1;Q6P2L6;1.47E-10;NSD3_MOUSE;Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.43) (Nuclear SET domain-containing protein 3) (Wolf-Hirschhorn syndrome candidate 1-like protein 1 homolog) (WHSC1-like protein 1);"chromatin [GO:0000785]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000785; GO:0003713; GO:0005634; GO:0006355; GO:0016571; GO:0018024; GO:0042800; GO:0045892; GO:0045893; GO:0046872; GO:0046975; GO:0046976; GO:2001255";"histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]"
comp455703_c0_seq1;GAXK01003725.1;Q9NYT6;2.29E-27;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp45572_c0_seq1;GAXK01185695.1;Q7PMT1;3.38E-30;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp4558_c0_seq1;GAXK01066774.1;P62138;0;PP1A_RAT;Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16);"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288]";"GO:0000164; GO:0000784; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005913; GO:0005977; GO:0005979; GO:0005981; GO:0006470; GO:0007049; GO:0008157; GO:0010288; GO:0016791; GO:0030324; GO:0032922; GO:0042587; GO:0042752; GO:0043005; GO:0043021; GO:0043025; GO:0043153; GO:0043197; GO:0043204; GO:0044877; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:0098793; GO:0098794; GO:0098978; GO:2001241";"branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288]";"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]";"cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021]"
comp4558587_c0_seq1;GAXK01145933.1;P55212;1.52E-09;CASP6_HUMAN;"Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]";"GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0030855; GO:0042802; GO:0042981; GO:0072734; GO:0097153; GO:0097194; GO:0097200";"apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]"
comp455916_c1_seq1;GAXK01003648.1;P23975;0;SC6A2_HUMAN;Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; norepinephrine transport [GO:0015874]; response to pain [GO:0048265]";"GO:0003779; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0007268; GO:0008504; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0032809; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0070050";"chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; norepinephrine transport [GO:0015874]; response to pain [GO:0048265]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]"
comp4560180_c0_seq1;GAXK01060533.1;Q9GLP1;4.74E-11;FA5_PIG;"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]";"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; blood coagulation [GO:0007596]";"GO:0005507; GO:0005576; GO:0007596";blood coagulation [GO:0007596];extracellular region [GO:0005576];copper ion binding [GO:0005507]
comp4561_c0_seq1;GAXK01065659.1;P04764;1.45E-53;ENOA_RAT;Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 1) (Non-neural enolase) (NNE);"cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; ERK1 and ERK2 cascade [GO:0070371]; glycolytic process [GO:0006096]; protein heterotetramerization [GO:0051290]";"GO:0000015; GO:0000287; GO:0004634; GO:0005737; GO:0005829; GO:0005886; GO:0006096; GO:0009986; GO:0019899; GO:0030426; GO:0031072; GO:0042803; GO:0043005; GO:0045121; GO:0046982; GO:0051290; GO:0061621; GO:0070371; GO:0071456; GO:0097060; GO:0099738";"canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; ERK1 and ERK2 cascade [GO:0070371]; glycolytic process [GO:0006096]; protein heterotetramerization [GO:0051290]";"cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]";"enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp4561242_c0_seq1;GAXK01060521.1;Q9XT55;1.32E-35;UDB19_MACFA;UDP-glucuronosyltransferase 2B19 (UDPGT 2B19) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp45620_c1_seq1;GAXK01185981.1;P08106;1.37E-63;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp456334_c2_seq1;GAXK01091001.1;Q38UX8;3.26E-07;MNTH_LACSS;Divalent metal cation transporter MntH;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]";"GO:0005886; GO:0015293; GO:0016021; GO:0046872; GO:0046873";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]"
comp4563423_c0_seq1;GAXK01059545.1;P05661;7.89E-35;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp45636_c13_seq1;GAXK01186203.1;Q70JS2;0;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp456397_c0_seq1;GAXK01090926.1;A4QUF0;6.56E-41;PABP_MAGO7;Polyadenylate-binding protein, cytoplasmic and nuclear (PABP) (Poly(A)-binding protein) (Polyadenylate tail-binding protein);"cytoplasmic stress granule [GO:0010494]; post-mRNA release spliceosomal complex [GO:0071014]; poly(A) binding [GO:0008143]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of exoribonuclease activity [GO:1901918]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of translation [GO:0006417]";"GO:0006397; GO:0006417; GO:0008143; GO:0010494; GO:0051028; GO:0060212; GO:0071014; GO:1901918; GO:1901919";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of exoribonuclease activity [GO:1901918]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of translation [GO:0006417]";"cytoplasmic stress granule [GO:0010494]; post-mRNA release spliceosomal complex [GO:0071014]";poly(A) binding [GO:0008143]
comp4564203_c0_seq1;GAXK01082799.1;Q96RW7;1.24E-11;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp45645_c1_seq1;GAXK01186039.1;Q6DG22;4.70E-98;ADA_DANRE;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase);"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0043103; GO:0046103; GO:0060205";"adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]";"cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]"
comp45650_c0_seq1;GAXK01186301.1;O95359;7.53E-39;TACC2_HUMAN;Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear hormone receptor binding [GO:0035257]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]";"GO:0000226; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007052; GO:0008283; GO:0021987; GO:0035257";"cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";nuclear hormone receptor binding [GO:0035257]
comp456516_c0_seq1;GAXK01090971.1;Q28955;2.66E-13;NTAN1_PIG;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0008418";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp456565_c0_seq1;GAXK01090965.1;P28344;3.63E-103;MASY_EMENI;Malate synthase, glyoxysomal (EC 2.3.3.9);"cytoplasm [GO:0005737]; glyoxysome [GO:0009514]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; malate synthase activity [GO:0004474]; acetate catabolic process [GO:0045733]; carbon utilization [GO:0015976]; fatty acid catabolic process [GO:0009062]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004474; GO:0005737; GO:0005777; GO:0005782; GO:0006097; GO:0006099; GO:0009062; GO:0009514; GO:0015976; GO:0045733";"acetate catabolic process [GO:0045733]; carbon utilization [GO:0015976]; fatty acid catabolic process [GO:0009062]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"cytoplasm [GO:0005737]; glyoxysome [GO:0009514]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";malate synthase activity [GO:0004474]
comp456577_c0_seq1;GAXK01091005.1;Q1H9T6;2.65E-20;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp456632_c0_seq1;GAXK01090953.1;O14494;5.02E-13;PLPP1_HUMAN;Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; androgen receptor signaling pathway [GO:0030521]; germ cell migration [GO:0008354]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein dephosphorylation [GO:0006470]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]";"GO:0005886; GO:0005887; GO:0006470; GO:0006629; GO:0006644; GO:0007205; GO:0008195; GO:0008285; GO:0008354; GO:0016020; GO:0016791; GO:0019216; GO:0030148; GO:0030518; GO:0030521; GO:0042392; GO:0042577; GO:0046839; GO:0070062";"androgen receptor signaling pathway [GO:0030521]; germ cell migration [GO:0008354]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein dephosphorylation [GO:0006470]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]"
comp456696_c0_seq1;GAXK01090952.1;Q8NB42;4.29E-07;ZN527_HUMAN;Zinc finger protein 527;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4567_c0_seq1;GAXK01066746.1;Q6NYD4;4.12E-83;MAK16_DANRE;Protein MAK16 homolog (MAK16-like protein) (Protein RBM13);"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; multicellular organism development [GO:0007275]";"GO:0005730; GO:0007275; GO:0030687";multicellular organism development [GO:0007275];"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";
comp4567160_c0_seq1;GAXK01009929.1;P29522;4.70E-14;EF1B2_BOMMO;Elongation factor 1-beta';"eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0005853";;eukaryotic translation elongation factor 1 complex [GO:0005853];translation elongation factor activity [GO:0003746]
comp456726_c0_seq1;GAXK01090954.1;Q5E9I8;1.13E-49;DCA11_BOVIN;DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0043161; GO:0080008";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
comp4567444_c0_seq1;GAXK01009934.1;P52292;2.13E-13;IMA1_HUMAN;Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"GO:0000018; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902";"DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]"
comp456770_c0_seq1;GAXK01090940.1;Q76LL6;3.82E-24;FHOD3_MOUSE;FH1/FH2 domain-containing protein 3 (Formin homolog overexpressed in spleen 2) (mFHOS2);"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030017; GO:0030018; GO:0030837; GO:0045214; GO:0051639; GO:0055003";"actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp4567969_c0_seq1;GAXK01009941.1;Q5VU57;7.08E-41;CBPC6_HUMAN;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp4568169_c0_seq1;GAXK01151198.1;P28492;6.23E-16;GLSL_RAT;Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase);"mitochondrial matrix [GO:0005759]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005759; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrial matrix [GO:0005759];glutaminase activity [GO:0004359]
comp456827_c0_seq2;GAXK01091053.1;O60235;4.15E-17;TM11D_HUMAN;"Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007585; GO:0008233; GO:0070062";"proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";"peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp456834_c0_seq1;GAXK01090980.1;P98160;1.18E-26;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp45697_c0_seq1;GAXK01185556.1;Q9CZT4;7.93E-49;RPC5_MOUSE;DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit 5) (RNA polymerase III subunit C5) (Sex-lethal interactor homolog) (Sxl interactor);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]";"GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0006383; GO:0045087; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]";DNA-directed 5'-3' RNA polymerase activity [GO:0003899]
comp457_c2_seq1;GAXK01169094.1;P84169;1.67E-114;PSD13_CHICK;26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5);"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0007127; GO:0008541; GO:0022624; GO:0043248";"meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]";structural molecule activity [GO:0005198]
comp457024_c1_seq1;GAXK01090963.1;P54185;1.18E-12;OBA5_DROME;Putative odorant-binding protein A5 (Antennal protein 5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp4571171_c0_seq1;GAXK01193150.1;B2GUZ1;5.95E-26;UBP4_RAT;Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872";"negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp457127_c0_seq1;GAXK01090932.1;Q7TSL3;2.08E-07;FBX11_RAT;F-box only protein 11;"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0004842; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981";"protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ubiquitin ligase complex [GO:0000151]";"protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4571456_c0_seq1;GAXK01193152.1;Q10981;7.31E-10;FUT2_HUMAN;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (SE2) (Secretor blood group alpha-2-fucosyltransferase) (Secretor factor) (Se);"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"GO:0005794; GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0042355; GO:0070062";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]";"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp457171_c0_seq1;GAXK01090958.1;P23607;1.11E-20;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4572_c0_seq1;GAXK01066872.1;P83916;4.80E-40;CBX1_HUMAN;Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta);"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000775; GO:0000784; GO:0000785; GO:0001939; GO:0001940; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005819; GO:0006974; GO:0010369; GO:0019899; GO:0042803; GO:0045892; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]";"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; protein homodimerization activity [GO:0042803]"
comp4572425_c0_seq1;GAXK01112786.1;Q6DHG0;5.50E-17;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp457250_c0_seq1;GAXK01091011.1;Q84MB6;8.98E-34;DIOX2_ARATH;Probable 2-oxoglutarate-dependent dioxygenase At3g50210 (EC 1.14.11.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp4572804_c0_seq1;GAXK01112775.1;Q8I6K0;1.85E-18;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4573_c0_seq1;GAXK01066219.1;Q18786;1.30E-50;SMD2_CAEEL;Probable small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2);"catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0005682; GO:0005685; GO:0005686; GO:0046540; GO:0071013";spliceosomal snRNP assembly [GO:0000387];"catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";
comp4573021_c0_seq1;GAXK01112788.1;A8X679;4.78E-08;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp457358_c0_seq1;GAXK01090944.1;Q556Y8;6.12E-13;DUSPR_DICDI;Probable rhodanese domain-containing dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; response to cisplatin [GO:0072718]; sorocarp development [GO:0030587]";"GO:0004721; GO:0004725; GO:0005737; GO:0008138; GO:0030587; GO:0072718";"response to cisplatin [GO:0072718]; sorocarp development [GO:0030587]";cytoplasm [GO:0005737];"phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp4574238_c0_seq1;GAXK01033052.1;Q7PWV1;2.65E-27;AQP_ANOGA;Aquaporin AQPAn.G;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]";"GO:0005886; GO:0015250; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";water channel activity [GO:0015250]
comp457473_c0_seq1;GAXK01090947.1;Q7M4F4;1.42E-22;CUD1_SCHGR;Endocuticle structural glycoprotein SgAbd-1;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp4575788_c0_seq1;GAXK01033042.1;P14381;5.47E-18;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp45759_c3_seq1;GAXK01185982.1;Q9BW91;7.26E-92;NUDT9_HUMAN;ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9);"extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]";"GO:0005759; GO:0019144; GO:0034656; GO:0043262; GO:0046032; GO:0046709; GO:0047631; GO:0070062";"ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]";"extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]";"adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]"
comp4575905_c0_seq1;GAXK01033038.1;Q9JHI0;6.75E-24;MMP19_MOUSE;Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0005886; GO:0008270; GO:0009725; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0051591";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4576108_c0_seq1;GAXK01039572.1;O43497;5.71E-45;CAC1G_HUMAN;Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"GO:0005737; GO:0005886; GO:0005891; GO:0007268; GO:0008332; GO:0010045; GO:0019228; GO:0034765; GO:0042391; GO:0045956; GO:0060371; GO:0070509; GO:0070588; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110";"AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]"
comp4576666_c0_seq1;GAXK01039573.1;Q9HAZ2;3.18E-14;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp4576919_c0_seq1;GAXK01039580.1;A4II46;6.73E-20;ABR_XENTR;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp45770_c0_seq1;GAXK01185697.1;Q6PFK1;4.64E-16;ZN598_DANRE;E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598);"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]";"GO:0003676; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344";"protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]";;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]"
comp4577735_c0_seq1;GAXK01039574.1;Q28FY0;5.12E-19;TILB_XENTR;Protein tilB homolog (Leucine-rich repeat-containing protein 6);"cytoplasm [GO:0005737]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium-dependent cell motility [GO:0060285]; motile cilium assembly [GO:0044458]";"GO:0005737; GO:0031514; GO:0035082; GO:0044458; GO:0060285";"axoneme assembly [GO:0035082]; cilium-dependent cell motility [GO:0060285]; motile cilium assembly [GO:0044458]";"cytoplasm [GO:0005737]; motile cilium [GO:0031514]";
comp4578120_c0_seq1;GAXK01153964.1;Q00725;1.49E-08;SGS4_DROME;Salivary glue protein Sgs-4;"adhesive extracellular matrix [GO:0062130]; puparial adhesion [GO:0007594]";"GO:0007594; GO:0062130";puparial adhesion [GO:0007594];adhesive extracellular matrix [GO:0062130];
comp45793_c1_seq1;GAXK01185699.1;Q9CPY4;1.69E-21;CDKA2_MOUSE;Cyclin-dependent kinase 2-associated protein 2 (CDK2-associated protein 2) (DOC-1-related protein) (DOC-1R);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stem cell division [GO:2000035]";"GO:0005634; GO:0005737; GO:0005874; GO:0070507; GO:2000035; GO:2000134";"negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stem cell division [GO:2000035]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]";
comp45800_c5_seq1;GAXK01185720.1;F6ZDS4;1.02E-81;TPR_MOUSE;Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein);"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]";"GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673";"cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]";"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]"
comp458042_c0_seq1;GAXK01071505.1;P00765;6.27E-24;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4581429_c0_seq1;GAXK01116636.1;P11118;8.21E-35;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4582004_c0_seq1;GAXK01001373.1;Q9VTP4;1.96E-62;R10AB_DROME;60S ribosomal protein L10a-2;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4582544_c0_seq1;GAXK01001381.1;P36609;1.67E-12;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp458304_c0_seq1;GAXK01071577.1;Q8R000;8.43E-07;OSTA_MOUSE;Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha);"basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702]";"GO:0005789; GO:0005886; GO:0015125; GO:0015721; GO:0016021; GO:0016323; GO:0022857; GO:0032782; GO:0032991; GO:0042803; GO:0046982; GO:0071702";"bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702]";"basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]"
comp458333_c0_seq1;GAXK01071609.1;Q1H9T6;3.74E-08;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp4583947_c0_seq1;GAXK01001374.1;P14650;3.54E-20;PERT_RAT;Thyroid peroxidase (TPO) (EC 1.11.1.8);"cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; cellular response to nitric oxide [GO:0071732]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid [GO:0033993]; thyroid hormone generation [GO:0006590]";"GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0006590; GO:0009986; GO:0016021; GO:0020037; GO:0033993; GO:0042446; GO:0042744; GO:0071732";"cellular response to nitric oxide [GO:0071732]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid [GO:0033993]; thyroid hormone generation [GO:0006590]";"cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]"
comp458599_c0_seq1;GAXK01071450.1;Q8AYA4;2.84E-09;SLB1_DEIAC;Snaclec agglucetin subunit beta-1;"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp45863_c0_seq1;GAXK01186287.1;O88307;4.71E-148;SORL_MOUSE;Sortilin-related receptor (Gp250) (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (mSorLA);"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910]";"GO:0001540; GO:0002024; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006605; GO:0006622; GO:0006869; GO:0006892; GO:0006897; GO:0008203; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030306; GO:0030514; GO:0031985; GO:0032091; GO:0032460; GO:0034067; GO:0034362; GO:0038020; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0048471; GO:0050768; GO:0051604; GO:0055037; GO:0070863; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137";"adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";"ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]"
comp45867_c2_seq1;GAXK01185572.1;A0JM51;4.03E-69;CELF5_XENTR;CUGBP Elav-like family member 5 (CELF-5) (Bruno-like protein 5) (CUG-BP- and ETR-3-like factor 5) (RNA-binding protein BRUNOL-5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904";"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp4587393_c0_seq1;GAXK01025008.1;Q8VIG1;2.64E-14;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp458754_c1_seq1;GAXK01071542.1;O75325;5.94E-34;LRRN2_HUMAN;Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023";"cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp45876_c4_seq1;GAXK01185710.1;Q687X5;7.58E-89;STEA4_HUMAN;Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9);"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"GO:0000139; GO:0005768; GO:0005794; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706";"copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp458767_c2_seq1;GAXK01071540.1;Q5E9M8;4.74E-117;SFXN1_BOVIN;Sideroflexin-1;"integral component of mitochondrial inner membrane [GO:0031305]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; D-serine transport [GO:0042942]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";"GO:0006730; GO:0015194; GO:0015825; GO:0031305; GO:0042942; GO:0042945; GO:0140300";"D-serine transport [GO:0042942]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]";integral component of mitochondrial inner membrane [GO:0031305];"D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]"
comp45880_c0_seq1;GAXK01185546.1;Q7TQK4;9.36E-79;EXOS3_MOUSE;Exosome complex component RRP40 (EC 3.1.13.-) (Exosome component 3) (Ribosomal RNA-processing protein 40);"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051";"CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"exonuclease activity [GO:0004527]; RNA binding [GO:0003723]"
comp458819_c0_seq1;GAXK01071465.1;Q7KRI2;6.29E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp458903_c0_seq1;GAXK01071462.1;P64918;6.68E-91;Y2023_MYCBO;Uncharacterized protein Mb2023;;;;;
comp458953_c0_seq1;GAXK01071515.1;Q90935;2.20E-12;NEUS_CHICK;Neuroserpin (Axonin-2) (Peptidase inhibitor 12) (PI-12) (Serpin I1);"cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0010951; GO:0034774; GO:0043025; GO:0043204; GO:0060205";negative regulation of endopeptidase activity [GO:0010951];"cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp458982_c2_seq1;GAXK01071556.1;O80596;5.08E-41;XYN2_ARATH;Endo-1,4-beta-xylanase 2 (AtXyn2) (Xylan endohydrolase 2) (Xylanase 2) (EC 3.2.1.8);"endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];;endo-1,4-beta-xylanase activity [GO:0031176]
comp459044_c1_seq1;GAXK01071508.1;P54802;0;ANAG_HUMAN;"Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]";"GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062";"cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]";"extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";alpha-N-acetylglucosaminidase activity [GO:0004561]
comp4590463_c0_seq1;GAXK01017611.1;P10737;4.25E-22;VA53_DOLMA;Venom allergen 5.02 (Allergen Dol m V-B) (Antigen 5 form 3) (Ag5-3) (Cysteine-rich venom protein) (CRVP) (allergen Dol m 5.02) (Fragment);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp4590874_c0_seq1;GAXK01017608.1;P83088;3.78E-45;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp459124_c1_seq1;GAXK01071510.1;Q96PH1;1.11E-49;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp4591452_c0_seq1;GAXK01017612.1;A5PK30;6.74E-07;ZN639_BOVIN;Zinc finger protein 639;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; viral entry into host cell [GO:0046718]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0030307; GO:0043621; GO:0043922; GO:0043923; GO:0044212; GO:0045892; GO:0045944; GO:0046718; GO:0046872";"negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; viral entry into host cell [GO:0046718]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp45922_c5_seq1;GAXK01185691.1;A1E952;1.80E-44;MSRB1_PIG;Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X) (SelX);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; methionine-R-sulfoxide reductase activity [GO:0070191]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]";"GO:0003779; GO:0005634; GO:0005737; GO:0008270; GO:0015629; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0070191";"actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; methionine-R-sulfoxide reductase activity [GO:0070191]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]"
comp45924_c1_seq1;GAXK01186210.1;Q9JK41;6.67E-23;COPT1_RAT;High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; drug transmembrane transport [GO:0006855]";"GO:0005375; GO:0005737; GO:0005770; GO:0005886; GO:0006855; GO:0006878; GO:0015677; GO:0016021; GO:0042802; GO:0043025; GO:0055037; GO:0072719; GO:0098705";"cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; drug transmembrane transport [GO:0006855]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]"
comp45927_c2_seq1;GAXK01185755.1;Q86VS8;4.77E-112;HOOK3_HUMAN;Protein Hook homolog 3 (h-hook3) (hHK3);"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031]";"GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150";"cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031]";"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]";"dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]"
comp45928_c1_seq1;GAXK01186087.1;P49010;5.38E-146;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp4592813_c0_seq1;GAXK01069506.1;O96015;2.96E-17;DNAL4_HUMAN;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp4594312_c0_seq1;GAXK01087956.1;Q94900;3.71E-12;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp45949_c0_seq1;GAXK01185978.1;Q9SJD4;5.86E-37;LACS8_ARATH;Long chain acyl-CoA synthetase 8 (EC 6.2.1.3);"chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]";"GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005783; GO:0005794; GO:0006631; GO:0009941; GO:0102391";fatty acid metabolic process [GO:0006631];"chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]";"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp459500_c0_seq1;GAXK01071517.1;Q8BGS1;6.41E-134;E41L5_MOUSE;Band 4.1-like protein 5;"cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]";"GO:0000904; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001954; GO:0003382; GO:0003383; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032091; GO:0032092; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560";"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]";"cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";"cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]"
comp459516_c0_seq1;GAXK01071605.1;Q3MHH5;2.54E-31;CCND3_BOVIN;G1/S-specific cyclin-D3;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0016020; GO:0016538; GO:0019901; GO:0044772; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp4595711_c0_seq1;GAXK01087957.1;P48866;0;COX1_CHOCR;Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide I);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; oxidative phosphorylation [GO:0006119]";"GO:0004129; GO:0005743; GO:0006119; GO:0009060; GO:0015990; GO:0016021; GO:0020037; GO:0045277; GO:0046872";"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; oxidative phosphorylation [GO:0006119]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]";"cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp45959_c1_seq1;GAXK01185558.1;Q99816;8.93E-51;TS101_HUMAN;Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]";"GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0045892; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397";"autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]";"calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]"
comp45960_c1_seq1;GAXK01185606.1;Q1JQ92;3.79E-18;POP5_BOVIN;Ribonuclease P/MRP protein subunit POP5 (EC 3.1.26.5);"multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]";"GO:0000172; GO:0001682; GO:0004526; GO:0005655; GO:0005730; GO:0006364; GO:0008033; GO:0030681; GO:0033204";"rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]";"multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; ribonuclease MRP complex [GO:0000172]";"ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]"
comp459608_c1_seq1;GAXK01071539.1;Q9I7U4;1.51E-68;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp459692_c0_seq1;GAXK01071470.1;Q9UKG4;1.21E-80;S13A4_HUMAN;Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; sodium:sulfate symporter activity [GO:0015382]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]; sulfate transport [GO:0008272]";"GO:0005886; GO:0005887; GO:0008272; GO:0015137; GO:0015141; GO:0015382; GO:0015746; GO:0016021; GO:0017153";"citrate transport [GO:0015746]; sulfate transport [GO:0008272]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; sodium:sulfate symporter activity [GO:0015382]; succinate transmembrane transporter activity [GO:0015141]"
comp459729_c0_seq1;GAXK01071464.1;Q7KRI2;1.64E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4597860_c0_seq1;GAXK01016461.1;Q9FNX5;3.44E-17;DRP1E_ARATH;Dynamin-related protein 1E (Dynamin-like protein 4) (Dynamin-like protein DLP2) (Dynamin-like protein E);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; defense response to fungus [GO:0050832]; mitochondrial fission [GO:0000266]; response to cadmium ion [GO:0046686]; vesicle-mediated transport [GO:0016192]";"GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005773; GO:0005774; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0008017; GO:0009506; GO:0009524; GO:0016020; GO:0016192; GO:0046686; GO:0050832; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; defense response to fungus [GO:0050832]; mitochondrial fission [GO:0000266]; response to cadmium ion [GO:0046686]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]"
comp4598_c0_seq1;GAXK01066892.1;Q95VA8;5.41E-39;TPM_TRISP;Tropomyosin;;;;;
comp460_c1_seq1;GAXK01169997.1;Q6PD24;7.11E-163;AN13D_MOUSE;Ankyrin repeat domain-containing protein 13D;"cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]";"GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036";negative regulation of receptor internalization [GO:0002091];"cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";ubiquitin-dependent protein binding [GO:0140036]
comp4600038_c0_seq1;GAXK01134982.1;Q92618;7.88E-12;ZN516_HUMAN;Zinc finger protein 516;"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cold [GO:0009409]";"GO:0000987; GO:0005634; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162";"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cold [GO:0009409]";nucleus [GO:0005634];"activating transcription factor binding [GO:0033613]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]"
comp46003_c0_seq1;GAXK01126307.1;P46150;1.74E-164;MOEH_DROME;Moesin/ezrin/radixin homolog 1 (Ezrin-moesin-radixin 1) (Moesin) (dMoesin) (Protein D17);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]";"GO:0002009; GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005938; GO:0006405; GO:0007010; GO:0007314; GO:0007315; GO:0007318; GO:0007368; GO:0008017; GO:0008104; GO:0008284; GO:0008360; GO:0009952; GO:0016057; GO:0016324; GO:0016336; GO:0030029; GO:0030036; GO:0030866; GO:0032154; GO:0032956; GO:0034453; GO:0035003; GO:0035088; GO:0035149; GO:0035327; GO:0042052; GO:0042462; GO:0043622; GO:0045197; GO:0045313; GO:0045807; GO:0060446; GO:0072499; GO:1902846; GO:1990023";"actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp46004_c0_seq1;GAXK01126761.1;O61491;5.13E-150;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp46005_c3_seq1;GAXK01126789.1;P47823;4.62E-91;EI2BE_RABIT;Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0034976; GO:0042552; GO:0043434; GO:0045948; GO:0048708; GO:0050852";"astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]";"guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]"
comp4601252_c0_seq1;GAXK01134986.1;P78958;5.43E-29;G3P1_SCHPO;Glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH 1) (EC 1.2.1.12);"cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; Mcs4 RR-MAPKKK complex [GO:1990315]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; small molecule sensor activity [GO:0140299]; canonical glycolysis [GO:0061621]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; glycolytic process [GO:0006096]; positive regulation of stress-activated MAPK cascade [GO:0032874]";"GO:0004365; GO:0005829; GO:0006096; GO:0009277; GO:0032874; GO:0034599; GO:0050661; GO:0051287; GO:0061621; GO:0070994; GO:0140299; GO:1990315";"canonical glycolysis [GO:0061621]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; glycolytic process [GO:0006096]; positive regulation of stress-activated MAPK cascade [GO:0032874]";"cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; Mcs4 RR-MAPKKK complex [GO:1990315]";"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; small molecule sensor activity [GO:0140299]"
comp46020_c0_seq1;GAXK01126785.1;O43747;0;AP1G1_HUMAN;AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1);"AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of defense response to virus by virus [GO:0050690]";"GO:0000139; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0006886; GO:0016020; GO:0017137; GO:0019886; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0032438; GO:0032588; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0050690; GO:0055037; GO:0090160";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of defense response to virus by virus [GO:0050690]";"AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]";"GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]"
comp4602003_c0_seq1;GAXK01057745.1;Q9SS90;2.03E-16;RGLG1_ARATH;E3 ubiquitin-protein ligase RGLG1 (EC 2.3.2.27) (RING domain ligase 1);"nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534]";"GO:0004842; GO:0005634; GO:0005886; GO:0009738; GO:0009789; GO:0046872; GO:0061630; GO:0070534; GO:0080148";"abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534]";"nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp4602291_c0_seq1;GAXK01057739.1;Q24789;1.86E-20;HSP70_ECHGR;Heat shock cognate 70 kDa protein (HSP70);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp460306_c0_seq1;GAXK01177388.1;Q7KRI2;1.16E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4603478_c0_seq1;GAXK01057732.1;P92133;4.72E-53;CATB3_GIAIN;Cathepsin B-like CP3 (EC 3.4.22.-) (Cathepsin B-like protease B3);"vacuole [GO:0005773]; cysteine-type peptidase activity [GO:0008234]";"GO:0005773; GO:0008234";;vacuole [GO:0005773];cysteine-type peptidase activity [GO:0008234]
comp460375_c2_seq1;GAXK01177377.1;Q16983;2.94E-70;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp460395_c1_seq1;GAXK01177452.1;Q7RTX9;1.11E-33;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp46042_c0_seq1;GAXK01127071.1;Q9VYA0;0;NADE_DROME;Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]";"GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435";NAD biosynthetic process [GO:0009435];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]"
comp46043_c1_seq1;GAXK01126404.1;Q93034;0;CUL5_HUMAN;Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1);"Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0006511; GO:0016032; GO:0019005; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0043161; GO:0043687; GO:0097193";"ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]";"calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp4604380_c0_seq1;GAXK01015262.1;Q9H611;9.70E-10;PIF1_HUMAN;ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein);"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]";"GO:0000002; GO:0000287; GO:0000723; GO:0000784; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0010521; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]";"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]";"5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]"
comp46047_c0_seq1;GAXK01126600.1;O75828;1.60E-35;CBR3_HUMAN;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Short chain dehydrogenase/reductase family 21C member 2);"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"GO:0000253; GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0042376; GO:0050890; GO:0070402";"cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]"
comp460550_c0_seq1;GAXK01177491.1;E9Q8T2;2.97E-12;PRD15_MOUSE;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000977; GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0031490; GO:0043409; GO:0043565; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp46058_c0_seq1;GAXK01126758.1;O57460;2.52E-09;TLL1_DANRE;Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";"GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264";"blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp46060_c0_seq1;GAXK01127091.1;Q9CY94;4.55E-48;PSF3_MOUSE;DNA replication complex GINS protein PSF3 (GINS complex subunit 3);"nucleoplasm [GO:0005654]; DNA replication [GO:0006260]";"GO:0005654; GO:0006260";DNA replication [GO:0006260];nucleoplasm [GO:0005654];
comp460606_c0_seq1;GAXK01177419.1;W4VS53;2.69E-42;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp460629_c0_seq1;GAXK01177492.1;P70623;2.78E-11;FABP4_RAT;Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4);"cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of inflammatory response [GO:0050727]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]";"GO:0005324; GO:0005504; GO:0005634; GO:0005811; GO:0005829; GO:0006631; GO:0008284; GO:0015909; GO:0036041; GO:0042493; GO:0050727; GO:0051384; GO:0120162";"fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of inflammatory response [GO:0050727]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]";"cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";"fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]"
comp460697_c0_seq1;GAXK01177433.1;Q2V2M9;9.18E-59;FHOD3_HUMAN;FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2);"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003";"actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp4606975_c0_seq1;GAXK01025933.1;P39057;1.33E-118;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp460728_c0_seq1;GAXK01177430.1;Q06466;5.12E-17;TDA6_YEAST;Putative vacuolar protein sorting-associated protein TDA6 (Topoisomerase I damage affected protein 6);"cell periphery [GO:0071944]; fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0000324; GO:0015031; GO:0016021; GO:0071944";protein transport [GO:0015031];"cell periphery [GO:0071944]; fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]";
comp460903_c1_seq1;GAXK01177421.1;Q9W436;0;NEP_DROME;Neprilysin-1 (EC 3.4.24.11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp4609144_c0_seq1;GAXK01159461.1;P24524;1.40E-41;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp460918_c0_seq1;GAXK01177457.1;P14533;7.29E-07;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp460941_c0_seq1;GAXK01177428.1;P33527;8.90E-60;MRP1_HUMAN;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005524; GO:0005774; GO:0005886; GO:0005887; GO:0006691; GO:0006855; GO:0008559; GO:0009235; GO:0015420; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0071716; GO:0099039; GO:0140359";"cell chemotaxis [GO:0060326]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp4609437_c0_seq1;GAXK01159460.1;P31692;8.29E-15;ADT_PARKE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp4609542_c0_seq1;GAXK01159467.1;Q96IR2;3.68E-16;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp46098_c0_seq1;GAXK01126478.1;Q7KRI2;9.62E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp461_c0_seq1;GAXK01168704.1;P86854;3.44E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp461011_c1_seq1;GAXK01177484.1;Q9BUD6;8.27E-52;SPON2_HUMAN;Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin);"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222";"cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]";"antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]"
comp461041_c1_seq1;GAXK01177376.1;P0DPW5;1.57E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp46110_c0_seq1;GAXK01127041.1;Q6B860;3.04E-17;RT14_BOVIN;28S ribosomal protein S14, mitochondrial (MRP-S14) (S14mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005743; GO:0005763; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";structural constituent of ribosome [GO:0003735]
comp4612008_c0_seq1;GAXK01082819.1;Q9FLF0;9.71E-53;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4613014_c0_seq1;GAXK01082829.1;Q99829;6.63E-50;CPNE1_HUMAN;Copine-1 (Chromobindin 17) (Copine I);"azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192]";"GO:0001786; GO:0004175; GO:0005215; GO:0005509; GO:0005544; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006629; GO:0010629; GO:0016020; GO:0016192; GO:0031965; GO:0035577; GO:0042803; GO:0043122; GO:0043312; GO:0043392; GO:0045666; GO:0046474; GO:0051059; GO:0051897; GO:0070062; GO:0071277; GO:1901223; GO:1903265; GO:1990138";"cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192]";"azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]"
comp46131_c0_seq1;GAXK01126371.1;P63074;2.28E-07;IF4E_RAT;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);"chromatoid body [GO:0033391]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; RISC complex [GO:0016442]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; stem cell population maintenance [GO:0019827]";"GO:0000082; GO:0000340; GO:0000932; GO:0001662; GO:0003743; GO:0005829; GO:0005845; GO:0006417; GO:0010494; GO:0016281; GO:0016442; GO:0017148; GO:0019827; GO:0019899; GO:0030324; GO:0031370; GO:0032991; GO:0033391; GO:0045665; GO:0045931; GO:0048471; GO:0070491; GO:0071549; GO:0098794; GO:0098978; GO:0099524; GO:0099578";"behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; stem cell population maintenance [GO:0019827]";"chromatoid body [GO:0033391]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; RISC complex [GO:0016442]";"enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]"
comp461359_c0_seq1;GAXK01177425.1;Q9Y2F9;7.20E-08;BTBD3_HUMAN;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp46137_c2_seq1;GAXK01127070.1;Q5ZKF4;4.82E-66;HM20A_CHICK;High mobility group protein 20A (HMG box-containing protein 20A);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp461399_c1_seq1;GAXK01177438.1;Q969K4;5.19E-116;ABTB1_HUMAN;Ankyrin repeat and BTB/POZ domain-containing protein 1 (Elongation factor 1A-binding protein);"cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; translation elongation factor activity [GO:0003746]";"GO:0000151; GO:0003746; GO:0005730; GO:0005829; GO:0005886";;"cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]";translation elongation factor activity [GO:0003746]
comp4614337_c0_seq1;GAXK01038612.1;Q02221;5.12E-18;CX6A2_HUMAN;Cytochrome c oxidase subunit 6A2, mitochondrial (Cytochrome c oxidase polypeptide VIa-heart) (COXVIAH) (Cytochrome c oxidase subunit VIA-muscle) (COX VIa-M);"mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; aerobic respiration [GO:0009060]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005751; GO:0006091; GO:0006123; GO:0009060; GO:0030234";"aerobic respiration [GO:0009060]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";mitochondrial respiratory chain complex IV [GO:0005751];"cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]"
comp46145_c0_seq1;GAXK01127068.1;Q6ZN04;5.31E-75;MEX3B_HUMAN;RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3) (RING finger protein 195);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0000932; GO:0003723; GO:0005509; GO:0005654; GO:0005829; GO:0006468; GO:0046777";"protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]";"calcium ion binding [GO:0005509]; RNA binding [GO:0003723]"
comp461590_c1_seq1;GAXK01177489.1;Q91V87;1.75E-54;FGRL1_MOUSE;Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (Fibroblast growth factor receptor 5) (FGFR-5);"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; non-tyrosine kinase fibroblast growth factor receptor activity [GO:0001571]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0001501; GO:0001571; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0005887; GO:0007166; GO:0008201; GO:0008285; GO:0017134; GO:0030133; GO:0040037; GO:0044291; GO:0051260; GO:0060412; GO:0060539; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; non-tyrosine kinase fibroblast growth factor receptor activity [GO:0001571]"
comp4616145_c0_seq1;GAXK01059808.1;Q80SU7;1.98E-74;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp46168_c0_seq1;GAXK01126277.1;Q8R821;1.10E-09;PPAX_CALS4;Putative pyrophosphatase PpaX (EC 3.6.1.1);"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]";"GO:0000287; GO:0004427";;;"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp46174_c0_seq1;GAXK01127034.1;Q2YDU3;2.39E-92;OTUD5_RAT;OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA);"Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]";"GO:0004843; GO:0016579; GO:0032496; GO:0061578; GO:0070536; GO:0071108";"protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]";;"Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp461776_c4_seq1;GAXK01177461.1;Q569T7;1.26E-07;MFS4B_XENLA;Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0008643; GO:0015293; GO:0016324";"carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";symporter activity [GO:0015293]
comp4618020_c0_seq1;GAXK01197475.1;D7GXG0;6.18E-08;PORA_ZOBGA;Beta-porphyranase A (EC 3.2.1.178);"periplasmic space [GO:0042597]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005975; GO:0042597";carbohydrate metabolic process [GO:0005975];periplasmic space [GO:0042597];hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp46182_c0_seq1;GAXK01126567.1;Q7TMF2;1.80E-80;ERI1_MOUSE;3'-5' exoribonuclease 1 (EC 3.1.-.-) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-exonuclease 1);"cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]";"GO:0000175; GO:0000467; GO:0000738; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207";"DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]";"cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]"
comp4618225_c0_seq1;GAXK01197476.1;Q9QZP2;4.84E-18;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4618636_c0_seq1;GAXK01197487.1;Q18321;2.33E-09;DAF37_CAEEL;G-protein coupled receptor daf-37 (Abnormal dauer formation protein 37);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"GO:0005794; GO:0005886; GO:0008528; GO:0016021; GO:0042803; GO:0046982; GO:0097730; GO:1904066; GO:1904067; GO:1904068";"G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp46193_c0_seq1;GAXK01126266.1;Q5ZKH0;8.06E-26;TF2H5_CHICK;General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; rDNA binding [GO:0000182]; cellular response to gamma radiation [GO:0071480]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]";"GO:0000182; GO:0000439; GO:0005654; GO:0005669; GO:0005675; GO:0005730; GO:0006281; GO:0006289; GO:0006294; GO:0006362; GO:0006364; GO:0006366; GO:0070816; GO:0071480";"cellular response to gamma radiation [GO:0071480]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]";rDNA binding [GO:0000182]
comp461968_c1_seq1;GAXK01177390.1;Q2KI95;1.91E-38;FHL2_BOVIN;Four and a half LIM domains protein 2 (FHL-2);"nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000122; GO:0001649; GO:0005634; GO:0008134; GO:0030018; GO:0043066; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885";"atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; ventricular cardiac muscle cell development [GO:0055015]";"nucleus [GO:0005634]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp46206_c2_seq1;GAXK01126432.1;Q2L6K8;1.77E-46;CNPY4_DANRE;Protein canopy 4;"extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]";"GO:0005102; GO:0005576";;extracellular region [GO:0005576];signaling receptor binding [GO:0005102]
comp462074_c0_seq1;GAXK01134120.1;Q96NR8;2.86E-43;RDH12_HUMAN;Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2);"endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]";"NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]"
comp4620868_c0_seq1;GAXK01059483.1;Q555L8;4.14E-08;Y4695_DICDI;SH3 and F-BAR domain-containing protein DDB_G0274695;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; actin filament polymerization [GO:0030041]; chemotaxis to cAMP [GO:0043327]; clathrin-dependent endocytosis [GO:0072583]; vesicle organization [GO:0016050]";"GO:0005737; GO:0005856; GO:0005886; GO:0008017; GO:0008092; GO:0016050; GO:0030041; GO:0031982; GO:0035091; GO:0043327; GO:0048471; GO:0072583";"actin filament polymerization [GO:0030041]; chemotaxis to cAMP [GO:0043327]; clathrin-dependent endocytosis [GO:0072583]; vesicle organization [GO:0016050]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]"
comp4620976_c0_seq1;GAXK01059485.1;P39086;5.37E-24;GRIK1_HUMAN;Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007399; GO:0007417; GO:0008066; GO:0015277; GO:0030054; GO:0032983; GO:0035249; GO:0042734; GO:0045211; GO:0050804; GO:0051966; GO:1904315";"central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp4621041_c0_seq1;GAXK01059493.1;Q9V3Z2;8.20E-25;SER7_DROME;Serine protease 7 (EC 3.4.21.-) (Melanization protease 2);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0035006; GO:0035008; GO:0046872";"melanization defense response [GO:0035006]; positive regulation of melanization defense response [GO:0035008]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp462128_c0_seq1;GAXK01134153.1;Q08875;1.80E-13;SUHW_DROAN;Protein suppressor of hairy wing;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4621712_c0_seq1;GAXK01059486.1;P20662;2.34E-07;ZFY2_MOUSE;Zinc finger Y-chromosomal protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598";"dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint [GO:0051598]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4621942_c0_seq1;GAXK01059497.1;P46941;8.47E-15;TG325_CAEEL;WW domain-containing protein tag-325;"cytoplasm [GO:0005737]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0043087";"regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];
comp46228_c4_seq1;GAXK01126426.1;Q6ZQ89;0;MARH6_MOUSE;E3 ubiquitin-protein ligase MARCH6 (EC 2.3.2.27) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (RING-type E3 ubiquitin transferase MARCH6);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0004842; GO:0005783; GO:0008270; GO:0010498; GO:0016021; GO:0016567; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0043161; GO:0061630; GO:0070936; GO:1990381";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]";"enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]"
comp46237_c3_seq1;GAXK01126855.1;Q5ZKD5;0;RRP12_CHICK;RRP12-like protein;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]";"GO:0005730; GO:0016021; GO:0031965";;"integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]";
comp4625161_c0_seq1;GAXK01193206.1;Q5R7Y8;4.56E-62;RL8_PONAB;60S ribosomal protein L8;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp462617_c3_seq1;GAXK01134164.1;Q6P1L6;1.78E-17;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp462632_c0_seq1;GAXK01134145.1;O54698;1.52E-68;S29A1_RAT;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0007595; GO:0015858; GO:0015862; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794";"cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp4626567_c0_seq1;GAXK01081028.1;O46411;2.14E-11;5NTC_BOVIN;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II) (Cytosolic IMP/GMP-specific 5'-nucleotidase);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";"GO:0000166; GO:0005737; GO:0008253; GO:0042802; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]";cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp462776_c1_seq1;GAXK01134087.1;Q7Z269;7.30E-25;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp462880_c0_seq1;GAXK01134102.1;P15370;7.61E-49;EGON_DROME;Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491";"cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp4629029_c0_seq1;GAXK01024657.1;Q05192;1.38E-10;FTF1B_DROME;Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"GO:0000976; GO:0000978; GO:0003682; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0009755; GO:0009888; GO:0035211; GO:0045944; GO:0060968; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp4629090_c0_seq1;GAXK01024654.1;Q86LG1;1.63E-18;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp46292_c0_seq1;GAXK01205644.1;Q6R7M4;2.61E-93;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp4629325_c0_seq1;GAXK01024651.1;P08106;1.70E-51;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp462970_c1_seq1;GAXK01134189.1;P00765;4.04E-61;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4630223_c0_seq1;GAXK01102542.1;P82596;1.23E-07;PLC_HALLA;Perlucin;carbohydrate binding [GO:0030246];GO:0030246;;;carbohydrate binding [GO:0030246]
comp46306_c1_seq1;GAXK01126230.1;Q9NQ29;4.47E-111;LUC7L_HUMAN;Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89);"U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]";"GO:0003729; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004";"mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]";"U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";"identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]"
comp4631_c0_seq1;GAXK01066530.1;P19109;5.43E-129;DDX17_DROME;ATP-dependent RNA helicase p62 (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005700; GO:0005703; GO:0005730; GO:0005737; GO:0005829; GO:0006417; GO:0016246; GO:0019730; GO:0050688; GO:0051607; GO:0071011; GO:0071013; GO:1990904";"antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp46311_c11_seq1;GAXK01126583.1;Q12788;5.48E-146;TBL3_HUMAN;Transducin beta-like protein 3 (WD repeat-containing protein SAZD);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"GO:0000462; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0032040; GO:0034388";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp463116_c0_seq1;GAXK01134192.1;P0C1J6;1.47E-08;FKBP4_RHIO9;FK506-binding protein 4 (EC 5.2.1.8) (Histone proline isomerase) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005634";;nucleus [GO:0005634];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp4631361_c0_seq1;GAXK01102546.1;P36609;1.07E-24;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp46314_c2_seq1;GAXK01126508.1;P55155;2.08E-11;VIT1_CAEEL;Vitellogenin-1;"extracellular region [GO:0005576]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]";"GO:0005319; GO:0005576; GO:0045735";;extracellular region [GO:0005576];"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp46316_c0_seq1;GAXK01126625.1;Q1LZ96;1.70E-73;ATPF2_BOVIN;ATP synthase mitochondrial F1 complex assembly factor 2;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461]";"GO:0005739; GO:0005829; GO:0016607; GO:0043461";proton-transporting ATP synthase complex assembly [GO:0043461];"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]";
comp463165_c1_seq1;GAXK01134186.1;Q8K430;9.61E-13;KLH17_RAT;Kelch-like protein 17 (Actinfilin);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0030054; GO:0031208; GO:0032839; GO:0043025; GO:0045211; GO:0051015; GO:0060090";"actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]"
comp463188_c0_seq1;GAXK01134144.1;Q9YGI5;1.62E-60;DNAS1_CHICK;Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I);"extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; actin binding [GO:0003779]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]";"GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0004536; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0070948";"apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]";"extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]";"actin binding [GO:0003779]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]"
comp463390_c2_seq1;GAXK01134136.1;A5DQN2;2.57E-07;SET5_PICGU;Potential protein lysine methyltransferase SET5 (EC 2.1.1.-) (SET domain-containing protein 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]";"GO:0005634; GO:0005737; GO:0008168";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";methyltransferase activity [GO:0008168]
comp46343_c0_seq1;GAXK01126497.1;Q6NYE7;3.07E-15;TM192_DANRE;Transmembrane protein 192;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]";"GO:0005765; GO:0005770; GO:0016021";;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]";
comp46349_c0_seq1;GAXK01126770.1;P42731;2.22E-14;PABP2_ARATH;Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral process [GO:0016032]";"GO:0000184; GO:0003723; GO:0003729; GO:0003730; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006413; GO:0006446; GO:0008143; GO:0008266; GO:0016032; GO:0060211; GO:1900151; GO:1990904";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
comp4637_c1_seq1;GAXK01066711.1;Q58EA2;1.17E-37;THO4A_XENLA;THO complex subunit 4-A (Tho4-A) (Aly/REF export factor-A);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0051028";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";RNA binding [GO:0003723]
comp463744_c0_seq1;GAXK01134154.1;A6NFQ2;3.78E-20;TCAF2_HUMAN;TRPM8 channel-associated factor 2 (TRP channel-associated factor 2);"cell junction [GO:0030054]; plasma membrane [GO:0005886]; ion channel binding [GO:0044325]; negative regulation of anion channel activity [GO:0010360]; positive regulation of cell migration [GO:0030335]; positive regulation of protein targeting to membrane [GO:0090314]";"GO:0005886; GO:0010360; GO:0030054; GO:0030335; GO:0044325; GO:0090314";"negative regulation of anion channel activity [GO:0010360]; positive regulation of cell migration [GO:0030335]; positive regulation of protein targeting to membrane [GO:0090314]";"cell junction [GO:0030054]; plasma membrane [GO:0005886]";ion channel binding [GO:0044325]
comp4638071_c0_seq1;GAXK01155898.1;Q9VZW5;6.08E-22;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp4639_c1_seq1;GAXK01066759.1;Q9VHI4;8.55E-41;SF3B5_DROME;Splicing factor 3B subunit 5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit);"precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]";"GO:0000124; GO:0000398; GO:0005686; GO:0007283; GO:0010468; GO:0071011";"mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]";"precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]";
comp4639202_c0_seq1;GAXK01155893.1;Q6GM59;2.43E-13;MOT12_XENLA;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]";"GO:0005308; GO:0005887; GO:0015293; GO:0015881";creatine transmembrane transport [GO:0015881];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]"
comp4641371_c0_seq1;GAXK01092977.1;A7Y7X5;4.51E-09;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp46418_c1_seq1;GAXK01127040.1;O09130;2.56E-07;NF2IP_MOUSE;NFATC2-interacting protein (45 kDa NF-AT-interacting protein) (45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytokine production [GO:0001816]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001816; GO:0005634; GO:0005737; GO:0045944";"cytokine production [GO:0001816]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp4641867_c0_seq1;GAXK01092974.1;Q6GR09;9.83E-12;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp46421_c0_seq1;GAXK01127037.1;Q16RL8;0;KLHDB_AEDAE;Kelch-like protein diablo;"actin binding [GO:0003779]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]";"GO:0003779; GO:0016567; GO:0045886";"negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]";;actin binding [GO:0003779]
comp464218_c0_seq1;GAXK01054504.1;Q86YT5;1.87E-44;S13A5_HUMAN;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]";"GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153";citrate transport [GO:0015746];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]"
comp46425_c2_seq1;GAXK01126623.1;O45947;0;GLT10_CAEEL;Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872";protein glycosylation [GO:0006486];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp46430_c0_seq1;GAXK01126479.1;A2VDB3;4.35E-56;RBM42_XENLA;RNA-binding protein 42 (RNA-binding motif protein 42);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp4643636_c0_seq1;GAXK01071267.1;Q12955;2.77E-15;ANK3_HUMAN;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp4643841_c0_seq1;GAXK01071268.1;P41115;6.94E-34;RS11_XENLA;40S ribosomal protein S11;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4644_c1_seq1;GAXK01066201.1;O43143;0;DHX15_HUMAN;Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15);"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]";"GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0034458; GO:0043279";"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp464446_c0_seq1;GAXK01054501.1;O46040;1.21E-21;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp464464_c2_seq1;GAXK01054575.1;Q7Z0G7;2.18E-57;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp46452_c1_seq1;GAXK01127092.1;Q6DHR8;5.05E-38;NGBR_DANRE;Dehydrodolichyl diphosphate synthase complex subunit nus1 (EC 2.5.1.87) (Di-trans,poly-cis-decaprenylcistransferase) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog);"dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; dolichol biosynthetic process [GO:0019408]; protein glycosylation [GO:0006486]; sprouting angiogenesis [GO:0002040]";"GO:0002040; GO:0005789; GO:0006486; GO:0016021; GO:0016765; GO:0019408; GO:1904423";"dolichol biosynthetic process [GO:0019408]; protein glycosylation [GO:0006486]; sprouting angiogenesis [GO:0002040]";"dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]
comp4645287_c0_seq1;GAXK01148901.1;Q08AN1;1.12E-14;ZN616_HUMAN;Zinc finger protein 616;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp46453_c0_seq1;GAXK01126271.1;Q7TPM9;1.10E-58;MTMRA_MOUSE;Myotubularin-related protein 10 (Inactive phosphatidylinositol 3-phosphatase 10);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp46465_c0_seq1;GAXK01126384.1;Q9D2D9;1.36E-07;KLD8B_MOUSE;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp4647524_c0_seq1;GAXK01126209.1;Q6IP09;5.78E-11;PABPB_XENLA;Polyadenylate-binding protein 1-B (PABP-1-B) (Poly(A)-binding protein 1-B) (xPABP1-B) (Cytoplasmic poly(A)-binding protein 1-B);"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153";"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]";"cytoplasm [GO:0005737]; polysome [GO:0005844]";"eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]"
comp46476_c0_seq1;GAXK01126498.1;Q95KD9;1.36E-92;DIRA2_MACFA;GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp46478_c0_seq1;GAXK01126782.1;O01346;1.35E-164;EGH_DROME;Beta-1,4-mannosyltransferase egh (EC 2.4.1.-) (Protein egghead) (Protein zeste-white 4);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; beta-1,4-mannosyltransferase activity [GO:0019187]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]";"GO:0001744; GO:0005737; GO:0006688; GO:0007281; GO:0007293; GO:0007298; GO:0007299; GO:0007411; GO:0008049; GO:0016021; GO:0016325; GO:0016333; GO:0019187; GO:0030707; GO:0030720; GO:0033227; GO:0042248; GO:0045165; GO:0045434; GO:0046662; GO:0048935";"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germarium-derived egg chamber formation [GO:0007293]; germ cell development [GO:0007281]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell-cell adhesion [GO:0007299]; ovarian follicle cell development [GO:0030707]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";beta-1,4-mannosyltransferase activity [GO:0019187]
comp4648232_c0_seq1;GAXK01062405.1;Q9UR07;5.09E-09;TF211_SCHPO;Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4648608_c0_seq1;GAXK01062407.1;Q8AXU4;6.79E-15;CALRL_ONCGO;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004948; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcitonin receptor activity [GO:0004948]
comp4648916_c0_seq1;GAXK01062412.1;Q9UBR2;1.81E-61;CATZ_HUMAN;Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X);"cell cortex region [GO:0099738]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; angiotensin maturation [GO:0002003]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of neuron projection development [GO:0010977]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; neutrophil degranulation [GO:0043312]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0006508; GO:0006888; GO:0008234; GO:0009986; GO:0010757; GO:0010977; GO:0030134; GO:0030426; GO:0031410; GO:0032091; GO:0033116; GO:0035580; GO:0043231; GO:0043312; GO:0043525; GO:0048208; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:0099738; GO:1901214; GO:1904813; GO:2000179";"angiotensin maturation [GO:0002003]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of neuron projection development [GO:0010977]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; neutrophil degranulation [GO:0043312]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214]";"cell cortex region [GO:0099738]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]";"carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]"
comp4649_c0_seq1;GAXK01065392.1;Q16VD3;8.74E-08;LIG_AEDAE;Protein lingerer;"cytoplasm [GO:0005737]; behavior [GO:0007610]; copulation [GO:0007620]";"GO:0005737; GO:0007610; GO:0007620";"behavior [GO:0007610]; copulation [GO:0007620]";cytoplasm [GO:0005737];
comp46493_c0_seq1;GAXK01126792.1;Q6UIM1;3.47E-19;ZNHI3_MACMU;Zinc finger HIT domain-containing protein 3 (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3) (TR-interacting protein 3) (TRIP-3) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; metal ion binding [GO:0046872]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; snoRNA localization [GO:0048254]";"GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0046872; GO:0048254; GO:0070761";"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; snoRNA localization [GO:0048254]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]";metal ion binding [GO:0046872]
comp464973_c0_seq1;GAXK01054513.1;O08550;2.83E-10;KMT2B_MOUSE;Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0001541; GO:0003677; GO:0005634; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0030728; GO:0034968; GO:0035097; GO:0042800; GO:0045893; GO:0051568; GO:0051569; GO:0080182";"gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]"
comp465_c0_seq1;GAXK01165886.1;P35979;1.90E-91;RL12_MOUSE;60S ribosomal protein L12;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4650_c0_seq1;GAXK01066715.1;O62829;8.97E-141;PPM1A_BOVIN;Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; N-terminal protein myristoylation [GO:0006499]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]";"GO:0000287; GO:0004721; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0043123; GO:0043124; GO:0070412; GO:0090263; GO:1901223";"negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]"
comp465156_c2_seq1;GAXK01054639.1;Q96NG8;1.01E-38;ZN582_HUMAN;Zinc finger protein 582;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp46520_c0_seq1;GAXK01126306.1;P05661;2.53E-147;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp465226_c1_seq1;GAXK01054497.1;P79881;4.34E-22;GUC1B_CHICK;Guanylyl cyclase-activating protein 2 (GCAP 2) (Guanylate cyclase activator 1B);"calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005509; GO:0007601; GO:0050896";"response to stimulus [GO:0050896]; visual perception [GO:0007601]";;calcium ion binding [GO:0005509]
comp46529_c0_seq1;GAXK01127039.1;Q8R0X2;2.75E-66;CACL1_MOUSE;CDK2-associated and cullin domain-containing protein 1;"protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000082; GO:0006511; GO:0008284; GO:0019901; GO:0031625; GO:0045860";"G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]"
comp46530_c7_seq1;GAXK01126798.1;O46108;2.30E-85;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp4653700_c0_seq1;GAXK01056604.1;Q05546;2.58E-36;TENR_RAT;Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin);"extracellular matrix [GO:0031012]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perisynaptic extracellular matrix [GO:0098966]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]";"GO:0005178; GO:0007155; GO:0007162; GO:0007399; GO:0031012; GO:0050767; GO:0098686; GO:0098966";"cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]";"extracellular matrix [GO:0031012]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perisynaptic extracellular matrix [GO:0098966]";integrin binding [GO:0005178]
comp46553_c2_seq1;GAXK01126357.1;Q8BZI6;6.53E-24;GUCD1_MOUSE;Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4);;;;;
comp465541_c1_seq1;GAXK01054486.1;Q26474;7.11E-11;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp46563_c7_seq1;GAXK01126310.1;Q91ZJ5;4.51E-104;UGPA_MOUSE;UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase);"cytoplasm [GO:0005737]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]";"GO:0003983; GO:0005536; GO:0005737; GO:0005977; GO:0006011; GO:0019255; GO:0032557; GO:0042802; GO:0046872";"glucose 1-phosphate metabolic process [GO:0019255]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]";cytoplasm [GO:0005737];"glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]"
comp46564_c4_seq1;GAXK01126788.1;Q9Z254;1.85E-106;GIPC1_RAT;PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin);"brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]";"GO:0003779; GO:0005102; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031647; GO:0032435; GO:0032467; GO:0042803; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098978; GO:2000300";"cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]";"brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp4656425_c0_seq1;GAXK01005435.1;Q2QUN2;1.18E-26;LAC24_ORYSJ;Laccase-24 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 24) (Diphenol oxidase 24) (Urishiol oxidase 24);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp465767_c0_seq1;GAXK01054652.1;A7Y2X0;1.18E-71;SC6A5_XENLA;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp465863_c0_seq1;GAXK01054606.1;F1MDL2;1.20E-103;INTU_BOVIN;Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6);"cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord dorsal/ventral patterning [GO:0021513]";"GO:0001736; GO:0005737; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0036064; GO:0042733; GO:0044458; GO:0045880; GO:0051782; GO:0060173; GO:0060271; GO:1905515";"cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord dorsal/ventral patterning [GO:0021513]";"cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]";
comp4659006_c0_seq1;GAXK01024717.1;Q8WPA2;9.01E-20;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp466_c0_seq1;GAXK01168567.1;Q08747;1.66E-11;UAF30_YEAST;Upstream activation factor subunit UAF30 (Upstream activation factor 30 KDa subunit) (p30);"nucleolus [GO:0005730]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]; chromatin organization [GO:0006325]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]";"GO:0000500; GO:0001165; GO:0001181; GO:0005730; GO:0006325; GO:0042790";"chromatin organization [GO:0006325]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]";"nucleolus [GO:0005730]; RNA polymerase I upstream activating factor complex [GO:0000500]";"RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase I upstream control element sequence-specific DNA binding [GO:0001165]"
comp4660969_c0_seq1;GAXK01131408.1;P18445;5.52E-58;RL27A_RAT;60S ribosomal protein L27a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp46616_c2_seq1;GAXK01126611.1;O60765;2.43E-08;Z354A_HUMAN;Zinc finger protein 354A (Transcription factor 17) (TCF-17) (Zinc finger protein eZNF);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]";"GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0007605; GO:0046872";"regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp466176_c1_seq1;GAXK01113679.1;Q8N3Y7;8.98E-57;RDHE2_HUMAN;Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0008134; GO:0016021; GO:0017053; GO:0031065; GO:0033613; GO:0035067; GO:0042572; GO:0042574; GO:0043616";"keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp466212_c0_seq1;GAXK01113639.1;Q14586;4.43E-20;ZN267_HUMAN;Zinc finger protein 267 (Zinc finger protein HZF2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp46626_c2_seq1;GAXK01126247.1;Q28709;2.08E-13;CD63_RABIT;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005765; GO:0007160; GO:0009986; GO:0015031; GO:0016021; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]";
comp4663_c0_seq1;GAXK01065994.1;Q99595;5.65E-47;TI17A_HUMAN;Mitochondrial import inner membrane translocase subunit Tim17-A (Inner membrane preprotein translocase Tim17a);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]";"GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0010954; GO:0015450; GO:0030150; GO:0031305";"positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]";P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]
comp4663783_c0_seq1;GAXK01048249.1;F1RWC3;1.13E-09;CUBN_PIG;Cubilin (Intrinsic factor-cobalamin receptor);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006898; GO:0009617; GO:0016324; GO:0030139; GO:0042803; GO:0042953; GO:0070062";"lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]"
comp4663824_c0_seq1;GAXK01048263.1;Q95R48;3.58E-10;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp4664028_c0_seq1;GAXK01025566.1;Q80VN0;8.86E-07;CP100_MOUSE;Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37);"axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574]";"GO:0003341; GO:0031514; GO:0036159; GO:0070840; GO:0097545; GO:2000574";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574]";"axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]";dynein complex binding [GO:0070840]
comp4664554_c0_seq1;GAXK01025562.1;P72991;1.73E-64;FTSH3_SYNY3;ATP-dependent zinc metalloprotease FtsH 3 (EC 3.4.24.-);"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"GO:0004176; GO:0004222; GO:0005524; GO:0006508; GO:0008270; GO:0009535; GO:0009941; GO:0010027; GO:0010205; GO:0010206; GO:0010304; GO:0016021";"photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4665159_c0_seq1;GAXK01205114.1;P89116;7.21E-45;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp4665399_c0_seq1;GAXK01025548.1;Q9GPJ1;8.51E-08;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp4665567_c0_seq1;GAXK01025571.1;Q63507;7.86E-36;RL14_RAT;60S ribosomal protein L14;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0042273";"ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp46656_c1_seq1;GAXK01126482.1;P59235;4.66E-54;NUP43_MOUSE;Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43);"condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]";"GO:0000777; GO:0007049; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]";"condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]";
comp4665728_c0_seq1;GAXK01025553.1;Q7U3V0;2.78E-49;PGK_SYNPX;Phosphoglycerate kinase (EC 2.7.2.3);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]";"GO:0004618; GO:0005524; GO:0005737; GO:0006096";glycolytic process [GO:0006096];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]"
comp466609_c0_seq1;GAXK01113684.1;Q28DB5;0;ALAT2_XENTR;Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";"GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";;"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
comp4667090_c0_seq1;GAXK01122786.1;Q19PY9;2.77E-13;GNRHR_BOSMU;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp4667437_c0_seq1;GAXK01122780.1;P00130;3.78E-16;QCR9_BOVIN;Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein);"mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005750; GO:0006122; GO:0009060; GO:0034551";"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";mitochondrial respiratory chain complex III [GO:0005750];
comp4668_c0_seq1;GAXK01066648.1;Q28EB4;2.41E-67;NP1L1_XENTR;Nucleosome assembly protein 1-like 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030154; GO:0030332; GO:0042393; GO:0045944; GO:0051260; GO:0060215";"cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; histone binding [GO:0042393]"
comp46686_c0_seq1;GAXK01126541.1;O35929;5.56E-23;REM1_MOUSE;GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp4668934_c0_seq1;GAXK01156242.1;P0C6F1;8.00E-22;DYH2_MOUSE;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2);"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp4669437_c0_seq1;GAXK01156233.1;P14780;2.18E-07;MMP9_HUMAN;"Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007566; GO:0008237; GO:0008270; GO:0019221; GO:0022617; GO:0030198; GO:0030225; GO:0030335; GO:0030574; GO:0034614; GO:0035987; GO:0042802; GO:0043066; GO:0043312; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071276; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]";"collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp4670286_c0_seq1;GAXK01139445.1;O96006;3.01E-12;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp467033_c0_seq1;GAXK01113621.1;Q13105;8.60E-07;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp46705_c4_seq1;GAXK01126496.1;P0DPU3;5.82E-113;TX14A_SCOSD;"Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]";"extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729";"glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]"
comp467153_c1_seq1;GAXK01113685.1;O75897;1.03E-59;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp46716_c0_seq1;GAXK01126476.1;A1ZA47;1.51E-19;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp4671815_c0_seq1;GAXK01139448.1;Q42395;1.45E-44;FCP_TRICV;Fucoxanthin-chlorophyll a-c binding protein, chloroplastic (FCP);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp467256_c0_seq1;GAXK01113697.1;Q7ZYC4;2.80E-125;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp4673_c1_seq1;GAXK01066627.1;Q5ZJX5;3.05E-26;MEAK7_CHICK;MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1);"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]";"GO:0005737; GO:0005765; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032";"positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]";
comp4673134_c0_seq1;GAXK01128904.1;Q16959;7.27E-56;DYI2_HELCR;Dynein intermediate chain 2, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp4673798_c0_seq1;GAXK01128884.1;Q90YS0;4.58E-61;RS4_ICTPU;40S ribosomal protein S4;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4674176_c0_seq1;GAXK01152647.1;Q96PQ6;1.49E-08;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4674903_c0_seq1;GAXK01152641.1;Q9NYC9;1.60E-100;DYH9_HUMAN;Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0097729; GO:0120135";"cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp467501_c0_seq1;GAXK01113625.1;A4IFG2;1.78E-10;BTBD9_BOVIN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";"GO:0008344; GO:0048512";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";;
comp467568_c0_seq1;GAXK01113646.1;Q29RU9;7.43E-93;SOX_BOVIN;Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase);"peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031";"L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; tetrahydrofolate metabolic process [GO:0046653]";peroxisome [GO:0005777];"L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]"
comp4675956_c0_seq1;GAXK01152652.1;Q8IU80;8.96E-12;TMPS6_HUMAN;Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]";"GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006879; GO:0016021; GO:0022617; GO:0030514; GO:0030574; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264";"cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp467596_c0_seq1;GAXK01113686.1;P10076;2.89E-14;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp467597_c0_seq1;GAXK01113663.1;Q9VCU9;1.55E-66;DCR1_DROME;Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883";"apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]"
comp46767_c0_seq1;GAXK01126246.1;Q9V3C0;0;DDX41_DROME;ATP-dependent RNA helicase abstrakt (DEAD box protein abstrakt) (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005681; GO:0008270; GO:0071011; GO:0071013";mRNA splicing, via spliceosome [GO:0000398];"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]";"ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]"
comp4677093_c0_seq1;GAXK01152173.1;Q54YW4;9.84E-08;Y8045_DICDI;Probable poly [ADP-ribose] polymerase DDB_G0278045 (EC 2.4.2.30);NAD+ ADP-ribosyltransferase activity [GO:0003950];GO:0003950;;;NAD+ ADP-ribosyltransferase activity [GO:0003950]
comp46771_c3_seq1;GAXK01127054.1;Q9H8T0;3.15E-73;AKTIP_HUMAN;AKT-interacting protein (Ft1) (Fused toes protein homolog);"cytosol [GO:0005829]; FHF complex [GO:0070695]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein transport [GO:0015031]";"GO:0001934; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0032092; GO:0045022; GO:0070695";"apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein transport [GO:0015031]";"cytosol [GO:0005829]; FHF complex [GO:0070695]; plasma membrane [GO:0005886]";
comp46772_c0_seq1;GAXK01127045.1;Q05895;0;TSP3_MOUSE;Thrombospondin-3;"collagen-containing extracellular matrix [GO:0062023]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell adhesion [GO:0007155]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]";"GO:0003417; GO:0005509; GO:0007155; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; cell adhesion [GO:0007155]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]";"collagen-containing extracellular matrix [GO:0062023]; perinuclear region of cytoplasm [GO:0048471]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp4677482_c0_seq1;GAXK01152179.1;P86854;1.33E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp4677936_c0_seq1;GAXK01152174.1;Q5Z627;2.48E-29;EF1G3_ORYSJ;Elongation factor 1-gamma 3 (EF-1-gamma 3) (eEF-1B gamma 3);translation elongation factor activity [GO:0003746];GO:0003746;;;translation elongation factor activity [GO:0003746]
comp46780_c0_seq1;GAXK01126441.1;Q9VVN2;2.38E-21;RT26_DROME;Probable 28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt);"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";"mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp4678928_c0_seq1;GAXK01057299.1;Q6PH52;1.36E-11;PCH2_DANRE;Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13 homolog) (Thyroid receptor-interacting protein 13 homolog) (TR-interacting protein 13 homolog) (TRIP-13 homolog);"chromosome [GO:0005694]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0005524; GO:0005694; GO:0006302; GO:0007130; GO:0007131; GO:0007283; GO:0048477; GO:0051598";"double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";chromosome [GO:0005694];ATP binding [GO:0005524]
comp4679691_c0_seq1;GAXK01057306.1;Q29RM3;7.59E-20;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp468_c2_seq1;GAXK01166143.1;P86704;2.80E-49;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp4680033_c0_seq1;GAXK01050655.1;O14802;6.60E-11;RPC1_HUMAN;DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0006383; GO:0016020; GO:0032481; GO:0032728; GO:0045087; GO:0046872; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase III [GO:0006383]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp468067_c0_seq1;GAXK01028629.1;Q6IQ97;1.43E-19;RBM41_DANRE;RNA-binding protein 4.1 (RNA-binding motif protein 4.1);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0008270; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp4681218_c0_seq1;GAXK01050661.1;Q8NE62;5.61E-17;CHDH_HUMAN;Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1);"mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005743; GO:0008812; GO:0019285; GO:0042426; GO:0050660";"choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]";mitochondrial inner membrane [GO:0005743];"choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]"
comp468155_c0_seq1;GAXK01028566.1;Q569T7;1.37E-21;MFS4B_XENLA;Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]";"GO:0005887; GO:0006814; GO:0008643; GO:0015293; GO:0016324";"carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";symporter activity [GO:0015293]
comp4682299_c0_seq1;GAXK01014991.1;P10978;5.34E-12;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp4683521_c0_seq1;GAXK01014984.1;P47736;3.15E-08;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp468361_c0_seq1;GAXK01028587.1;Q8BGC3;9.42E-40;MOT12_MOUSE;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp468388_c1_seq1;GAXK01028650.1;P30432;0;FUR2_DROME;Furin-like protease 2 (Furin-2) (EC 3.4.21.75);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048";"negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp4684010_c0_seq1;GAXK01085061.1;Q7RYV5;1.54E-08;TCTP_NEUCR;Translationally-controlled tumor protein homolog (TCTP);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; translation [GO:0006412]";"GO:0005509; GO:0005737; GO:0005874; GO:0006412";translation [GO:0006412];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";calcium ion binding [GO:0005509]
comp468446_c1_seq1;GAXK01028610.1;Q5RC79;2.82E-17;ZFP1_PONAB;Zinc finger protein 1 homolog (Zfp-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4685_c4_seq1;GAXK01065979.1;Q9UKX7;2.77E-39;NUP50_HUMAN;Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50);"cytoplasm [GO:0005737]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0008536; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043231; GO:0043547; GO:0043657; GO:0060964; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";Ran GTPase binding [GO:0008536]
comp468510_c0_seq1;GAXK01028605.1;P41156;1.13E-14;ETS1_RAT;Protein C-ets-1 (p54);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune system process [GO:0002376]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of angiogenesis [GO:0045765]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]";"GO:0000978; GO:0000981; GO:0001666; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007565; GO:0008284; GO:0009611; GO:0009612; GO:0010595; GO:0010715; GO:0021854; GO:0021983; GO:0030154; GO:0030335; GO:0030578; GO:0032355; GO:0034616; GO:0035035; GO:0042802; GO:0043536; GO:0043565; GO:0044849; GO:0045648; GO:0045765; GO:0045766; GO:0045893; GO:0045944; GO:0048870; GO:0050728; GO:0050729; GO:0060055; GO:0061614; GO:0070301; GO:0070555; GO:1904996";"angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune system process [GO:0002376]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of angiogenesis [GO:0045765]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp4685193_c0_seq1;GAXK01085042.1;Q9DG68;9.01E-27;RLA0_RANSY;60S acidic ribosomal protein P0 (60S ribosomal protein L10E);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp4685429_c0_seq1;GAXK01085065.1;Q8VIG1;1.13E-13;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4685439_c0_seq1;GAXK01085060.1;P31674;8.63E-55;RS15_ORYSJ;40S ribosomal protein S15;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4686078_c0_seq1;GAXK01009827.1;P23751;2.88E-31;H42_EMENI;Histone H4.2;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982";nucleosome assembly [GO:0006334];"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp4686754_c0_seq1;GAXK01009826.1;Q8R426;2.44E-32;KCIP1_RAT;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]; positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0034705; GO:0043025; GO:0044325; GO:0045760; GO:0046982; GO:0047485; GO:1901379";"positive regulation of action potential [GO:0045760]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; voltage-gated ion channel activity [GO:0005244]"
comp4687154_c0_seq1;GAXK01009831.1;Q9SZR0;1.22E-42;CHMO_ARATH;Choline monooxygenase, chloroplastic (EC 1.14.15.7);"chloroplast stroma [GO:0009570]; 2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005506; GO:0009570; GO:0019133; GO:0019285; GO:0051537";glycine betaine biosynthetic process from choline [GO:0019285];chloroplast stroma [GO:0009570];"2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]"
comp468723_c0_seq1;GAXK01028649.1;P51859;3.83E-18;HDGF_MOUSE;Hepatoma-derived growth factor (HDGF);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]; cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"GO:0000122; GO:0000166; GO:0000978; GO:0001222; GO:0001227; GO:0003714; GO:0003779; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0008083; GO:0008201; GO:0009987; GO:0015631; GO:0017053; GO:0034504; GO:0045944; GO:0051781; GO:0098761";"cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]"
comp46873_c0_seq1;GAXK01126374.1;Q9ESJ0;0;XPO4_MOUSE;Exportin-4 (Exp4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]";"GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827";"positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";nuclear export signal receptor activity [GO:0005049]
comp4687859_c0_seq1;GAXK01009841.1;Q7M6U3;3.04E-17;TEX14_MOUSE;Inactive serine/threonine-protein kinase TEX14 (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein);"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]";"GO:0000776; GO:0000777; GO:0004672; GO:0005524; GO:0005623; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0019901; GO:0030496; GO:0032091; GO:0032466; GO:0043063; GO:0045171; GO:0051301; GO:0051306; GO:1990830";"attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]";"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp4687944_c0_seq1;GAXK01009820.1;P13418;2.19E-13;POLS_CRPVC;"Structural polyprotein [Cleaved into: Capsid protein 1 (CP1); Capsid protein 4 (CP4); Capsid protein 2 (CP2); Capsid protein 3 (CP3)]";"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028; GO:0030430";;"host cell cytoplasm [GO:0030430]; viral capsid [GO:0019028]";structural molecule activity [GO:0005198]
comp4688_c0_seq1;GAXK01065590.1;Q3BCR3;2.34E-40;TPMT_GORGO;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase);"cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144]";"GO:0005737; GO:0008119; GO:0017144; GO:1904047";drug metabolic process [GO:0017144];cytoplasm [GO:0005737];"S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]"
comp4688036_c0_seq1;GAXK01190289.1;Q9XZH6;3.90E-20;VATG_DROME;V-type proton ATPase subunit G (V-ATPase subunit G) (V-ATPase 13 kDa subunit) (Vacuolar proton pump subunit G);"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]";"GO:0007430; GO:0008553; GO:0016471; GO:0033181; GO:0035002; GO:1902600";"liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]";"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]
comp468871_c0_seq1;GAXK01028583.1;Q7KRI2;2.46E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp46891_c3_seq1;GAXK01126608.1;Q8VDU0;0;GPSM2_MOUSE;G-protein-signaling modulator 2 (Pins homolog);"cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]";"GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832";"cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]";"cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]";"dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]"
comp468914_c0_seq1;GAXK01028598.1;A8DYE2;0;TRPCG_DROME;Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog);"cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]";"GO:0005385; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655";"cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]";cation channel complex [GO:0034703];"divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"
comp4689180_c0_seq1;GAXK01190306.1;Q41803;3.51E-91;EF1A_MAIZE;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414";"translation [GO:0006412]; translational elongation [GO:0006414]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp4689263_c0_seq1;GAXK01190287.1;Q9M0E2;7.05E-17;RL282_ARATH;60S ribosomal protein L28-2;"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005886; GO:0006412; GO:0009506; GO:0022625";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";structural constituent of ribosome [GO:0003735]
comp4689307_c0_seq1;GAXK01190292.1;P41436;9.10E-10;IAP_GVCPM;Apoptosis inhibitor IAP;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp46894_c1_seq1;GAXK01126437.1;O23320;1.03E-11;CML8_ARATH;Calmodulin-like protein 8 (AtCaM-8);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]";"GO:0005509; GO:0005513; GO:0019722";"calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]";;calcium ion binding [GO:0005509]
comp469_c0_seq1;GAXK01170052.1;Q5RBB3;1.33E-61;NOB1_PONAB;RNA-binding protein NOB1;"nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; ribosomal small subunit biogenesis [GO:0042274]; visual perception [GO:0007601]";"GO:0000469; GO:0004521; GO:0005634; GO:0007601; GO:0042274; GO:0046872";"cleavage involved in rRNA processing [GO:0000469]; ribosomal small subunit biogenesis [GO:0042274]; visual perception [GO:0007601]";nucleus [GO:0005634];"endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]"
comp4690711_c0_seq1;GAXK01117871.1;Q6IQ21;7.52E-09;ZN770_HUMAN;Zinc finger protein 770;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4690995_c0_seq1;GAXK01117864.1;P39057;3.84E-60;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp469168_c1_seq1;GAXK01028562.1;Q9VEG6;1.35E-56;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp469193_c0_seq1;GAXK01028584.1;Q7ZYC4;4.89E-90;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp469241_c1_seq1;GAXK01028647.1;Q66JG1;6.31E-107;DDB2_XENTR;DNA damage-binding protein 2 (Damage-specific DNA-binding protein 2);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]";"GO:0003684; GO:0005634; GO:0006281; GO:0009411; GO:0016567; GO:0080008";"DNA repair [GO:0006281]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]";damaged DNA binding [GO:0003684]
comp4692587_c0_seq1;GAXK01160740.1;P51029;1.59E-41;WNT8B_DANRE;Protein Wnt-8b;"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]";"GO:0001654; GO:0005109; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679";"canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp469265_c0_seq1;GAXK01028560.1;G5ED00;1.97E-11;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp4692750_c0_seq1;GAXK01160721.1;Q28G94;2.78E-68;DNAL1_XENTR;Dynein light chain 1, axonemal;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]";"GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504";outer dynein arm assembly [GO:0036158];"cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp4692934_c0_seq1;GAXK01160743.1;Q99707;0;METH_HUMAN;Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS);"cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]";"GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732";"axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]";cytosol [GO:0005829];"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp469295_c0_seq1;GAXK01028563.1;Q8I6K0;1.64E-47;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4692954_c0_seq1;GAXK01160722.1;Q9CXE0;9.90E-07;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp4693_c0_seq1;GAXK01065594.1;A1ZA47;9.72E-07;ZASP_DROME;PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein);"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]";"actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]"
comp469340_c0_seq1;GAXK01028627.1;O46606;3.77E-127;DDHD1_BOVIN;Phospholipase DDHD1 (EC 3.1.1.-) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1) (PA-PLA1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]";"GO:0004620; GO:0005737; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]"
comp4693672_c0_seq1;GAXK01160747.1;A6QAM9;2.30E-40;DAPD_SULNB;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (EC 2.3.1.117) (Tetrahydrodipicolinate N-succinyltransferase) (THDP succinyltransferase) (THP succinyltransferase) (Tetrahydropicolinate succinylase);"cytoplasm [GO:0005737]; 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity [GO:0008666]; diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089]";"GO:0005737; GO:0008666; GO:0009089; GO:0019877";"diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089]";cytoplasm [GO:0005737];2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity [GO:0008666]
comp4693683_c0_seq1;GAXK01160726.1;P54933;3.01E-53;SMOK_RHOSH;ATP-binding transport protein SmoK (Protein PolK);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; transmembrane transporter activity [GO:0022857]";"GO:0005524; GO:0016887; GO:0022857; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]"
comp4693710_c0_seq1;GAXK01160738.1;Q7RZS0;6.13E-29;RL10A_NEUCR;60S ribosomal protein L10a (Cytoplasmic ribosomal protein 74);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4693730_c0_seq1;GAXK01160736.1;D3ZZ80;8.43E-07;OBSL1_RAT;Obscurin-like protein 1;"3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0000226; GO:0005737; GO:0005794; GO:0005813; GO:0005865; GO:0006936; GO:0007030; GO:0007088; GO:0008307; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0034067; GO:0045214; GO:0048471; GO:0048739; GO:0050775; GO:0051015; GO:0051371; GO:0055003; GO:0055008; GO:0071688; GO:1990393";"cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]"
comp46943_c0_seq1;GAXK01127116.1;O54956;0;DPOE2_MOUSE;DNA polymerase epsilon subunit 2 (EC 2.7.7.7) (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B);"epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]";"GO:0003677; GO:0003887; GO:0005654; GO:0006261; GO:0008622; GO:0016604; GO:0042276; GO:0043231";"DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]";"epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]"
comp46945_c2_seq1;GAXK01126766.1;Q2VG86;6.61E-23;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4694734_c0_seq1;GAXK01003459.1;Q9HBE1;5.17E-07;PATZ1_HUMAN;POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872";"male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4694825_c0_seq1;GAXK01003461.1;P62302;5.37E-87;RS13_SOYBN;40S ribosomal protein S13;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp4695102_c0_seq1;GAXK01003458.1;Q8L7K0;5.84E-22;R18A1_ARATH;60S ribosomal protein L18a-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0009506; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; plasmodesma [GO:0009506]";structural constituent of ribosome [GO:0003735]
comp4695884_c0_seq1;GAXK01003464.1;P62244;4.74E-76;RS15A_HUMAN;40S ribosomal protein S15a (Small ribosomal subunit protein uS8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0008284; GO:0009615; GO:0016020; GO:0019083; GO:0022627; GO:0045787; GO:0070062";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4696150_c0_seq1;GAXK01179916.1;P55865;1.27E-14;CAS1A_XENLA;Caspase-1-A (CASP-1-A) (EC 3.4.22.36) (Interleukin-1 beta convertase homolog A) (xICE-A);"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; regulation of apoptotic process [GO:0042981]";"GO:0004197; GO:0005737; GO:0042981";regulation of apoptotic process [GO:0042981];cytoplasm [GO:0005737];cysteine-type endopeptidase activity [GO:0004197]
comp46975_c1_seq1;GAXK01126781.1;Q68F45;4.76E-162;WIPI3_XENLA;WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B);"lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]";"GO:0000045; GO:0000407; GO:0005764; GO:0009267; GO:0032266; GO:0080025";"autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]";"lysosome [GO:0005764]; phagophore assembly site [GO:0000407]";"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp46977_c2_seq1;GAXK01126599.1;O54967;9.78E-170;ACK1_MOUSE;Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2);"adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286]";"GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007165; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369";"cell differentiation [GO:0030154]; endocytosis [GO:0006897]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286]";"adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]"
comp46978_c1_seq1;GAXK01127118.1;Q8NF37;2.54E-77;PCAT1_HUMAN;Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3);"azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; calcium ion binding [GO:0005509]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; neutrophil degranulation [GO:0043312]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]";"GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0006656; GO:0008654; GO:0016020; GO:0016021; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0043312; GO:0045732; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0060041; GO:2001246";"negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; neutrophil degranulation [GO:0043312]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]";"azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; calcium ion binding [GO:0005509]"
comp4697987_c0_seq1;GAXK01179915.1;Q8VHE6;1.13E-32;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp469836_c0_seq1;GAXK01028641.1;Q7KRI2;1.01E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp469849_c1_seq1;GAXK01028606.1;Q8BM89;2.20E-71;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp46985_c0_seq1;GAXK01126267.1;P48778;1.27E-55;GOR_PANTR;Exonuclease GOR (EC 3.1.-.-) (Antigen GOR) (RNA exonuclease 1 homolog-like);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0004527; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]"
comp4698810_c0_seq1;GAXK01000155.1;Q94HW2;2.05E-16;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4699337_c0_seq1;GAXK01000172.1;P56475;3.72E-09;GBRR1_MOUSE;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA receptor activity [GO:0016917]; GABA-A receptor activity [GO:0004890]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0016917; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0046982; GO:0050877; GO:0098978; GO:0098982; GO:0099507; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA receptor activity [GO:0016917]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp469957_c1_seq1;GAXK01028636.1;Q9BRP7;3.75E-28;FDXA1_HUMAN;Ferredoxin-fold anticodon-binding domain-containing protein 1 (FDX-ACDB domain-containing protein 1);"cytoplasm [GO:0005737]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; rRNA base methylation [GO:0070475]";"GO:0005737; GO:0070042; GO:0070475";rRNA base methylation [GO:0070475];cytoplasm [GO:0005737];rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]
comp46998_c2_seq1;GAXK01126597.1;P35778;2.93E-38;VA3_SOLIN;Venom allergen 3 (Allergen Sol i III) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (Venom allergen III) (allergen Sol i 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp47_c0_seq1;GAXK01170071.1;Q6X9Z5;2.02E-10;RLA2_HORSE;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp47001_c0_seq1;GAXK01126411.1;Q01069;1.97E-44;ESMB_DROME;Enhancer of split mbeta protein (E(spl)mbeta) (HLH-mbeta) (Split locus enhancer protein mA);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0043565; GO:0046983; GO:0050767; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp470163_c0_seq1;GAXK01036870.1;P25169;3.74E-81;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp4701832_c0_seq1;GAXK01193164.1;Q9NYC9;9.52E-62;DYH9_HUMAN;Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0097729; GO:0120135";"cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp4701859_c0_seq1;GAXK01193168.1;P14869;4.07E-46;RLA0_MOUSE;60S acidic ribosomal protein P0 (60S ribosomal protein L10E);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0014069; GO:0016020; GO:0022625; GO:0030425; GO:0036464; GO:0042277; GO:0045202; GO:0070180; GO:0071353; GO:0098794; GO:1990904";"cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]";"large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; structural constituent of ribosome [GO:0003735]"
comp470238_c0_seq1;GAXK01036848.1;Q7Z7L9;1.74E-34;ZSCA2_HUMAN;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp4702609_c0_seq1;GAXK01044606.1;Q8X187;2.03E-09;CALM_PAXIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp47027_c0_seq1;GAXK01126415.1;Q99K30;1.89E-31;ES8L2_MOUSE;Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]";"GO:0001726; GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0007605; GO:0016601; GO:0030676; GO:0032421; GO:0032426; GO:0032587; GO:0032991; GO:0035023; GO:0051015; GO:1900029";"positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]"
comp47040_c2_seq1;GAXK01126376.1;Q2KID9;5.41E-63;RT05_BOVIN;28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4704102_c0_seq1;GAXK01147996.1;A7S3J7;1.26E-30;RS3A_NEMVE;40S ribosomal protein S3a;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp4704172_c0_seq1;GAXK01147997.1;P54145;1.63E-22;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp470447_c0_seq1;GAXK01036865.1;P21902;4.21E-76;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4705444_c0_seq1;GAXK01147990.1;Q8BIY3;1.71E-38;ZC12D_MOUSE;Probable ribonuclease ZC3H12D (EC 3.1.-.-) (MCP-induced protein 4) (Transformed follicular lymphoma homolog) (Zinc finger CCCH domain-containing protein 12D);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of T cell proliferation [GO:0042130]";"GO:0000932; GO:0004519; GO:0005634; GO:0005654; GO:0005737; GO:0006402; GO:0030308; GO:0036464; GO:0042130; GO:0046872; GO:0061158; GO:2000134";"3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of T cell proliferation [GO:0042130]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]";"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp4705811_c0_seq1;GAXK01147992.1;Q9XTR1;3.66E-18;CDK4_CAEEL;Cyclin-dependent kinase 4 homolog (CDK4/6) (EC 2.7.11.22) (Cell division protein kinase 4);"nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";"GO:0002119; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007530; GO:0008584; GO:0009791; GO:0018105; GO:0018107; GO:0032877; GO:0040035; GO:0044843; GO:0046872; GO:0051301; GO:0090727; GO:1900087";"cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";nucleus [GO:0005634];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp47059_c0_seq1;GAXK01127093.1;P58004;5.32E-55;SESN2_HUMAN;Sestrin-2 (EC 1.11.1.15) (Hypoxia-induced gene);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; sulfiredoxin activity [GO:0032542]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]";"GO:0001932; GO:0005092; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006635; GO:0009749; GO:0016239; GO:0016684; GO:0030308; GO:0030330; GO:0031588; GO:0031932; GO:0032042; GO:0032542; GO:0032868; GO:0034198; GO:0034599; GO:0036091; GO:0042149; GO:0042593; GO:0043491; GO:0046323; GO:0070328; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:1900182; GO:1901031; GO:1902010; GO:1904262; GO:1904504; GO:1990253; GO:2000479";"cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]";"GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; sulfiredoxin activity [GO:0032542]"
comp4705943_c0_seq1;GAXK01148005.1;Q9Z218;3.08E-18;DPP6_MOUSE;Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0008076; GO:0008236; GO:0009986; GO:0015459; GO:0016020; GO:0016021; GO:0019228; GO:0042391; GO:0043025; GO:0043266; GO:0043268; GO:0072659; GO:1901379; GO:1901381; GO:1903078";"neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp470867_c0_seq1;GAXK01036881.1;Q6AXL5;2.55E-25;HBAP1_DANRE;HSPB1-associated protein 1 homolog;"cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]";"GO:0005737; GO:0016706";;cytoplasm [GO:0005737];2-oxoglutarate-dependent dioxygenase activity [GO:0016706]
comp4709968_c0_seq1;GAXK01101914.1;Q24352;3.16E-15;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp471_c2_seq1;GAXK01168180.1;P48608;3.50E-139;DIA_DROME;Protein diaphanous;"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005912; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"
comp4710_c0_seq1;GAXK01066012.1;Q9XZ71;1.04E-62;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp4710259_c0_seq1;GAXK01058515.1;Q505D1;3.33E-16;ANR28_MOUSE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp4710911_c0_seq1;GAXK01058513.1;O57422;3.26E-16;OPN4B_XENLA;Melanopsin-B (Opsin-4B) (xMOP);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp4710981_c0_seq1;GAXK01058531.1;P26797;6.57E-29;HM19_CAEEL;Homeobox protein ceh-19;"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp4711_c2_seq1;GAXK01065661.1;P0DPD7;1.82E-39;EFMT4_HUMAN;EEF1A lysine methyltransferase 4 (EC 2.1.1.-);"methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]";"GO:0008168; GO:0016279";;;"methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp4711198_c0_seq1;GAXK01058503.1;Q9V3G1;2.62E-40;RL8_DROME;60S ribosomal protein L8;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp4711209_c0_seq1;GAXK01058504.1;P0CT83;4.06E-81;RL12A_SCHPO;60S ribosomal protein L12-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp47114_c1_seq1;GAXK01126225.1;Q5XQC7;9.17E-09;BON3_ARATH;Protein BONZAI 3;"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332]";"GO:0005544; GO:0005886; GO:0006952; GO:0060548; GO:0071277; GO:0090332";"cellular response to calcium ion [GO:0071277]; defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332]";plasma membrane [GO:0005886];calcium-dependent phospholipid binding [GO:0005544]
comp47118_c0_seq1;GAXK01126754.1;P22682;0;CBL_MOUSE;E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL);"axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; mast cell granule [GO:0042629]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001784; GO:0005154; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006468; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0007175; GO:0008584; GO:0010332; GO:0014068; GO:0014823; GO:0017124; GO:0019901; GO:0030424; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0042629; GO:0043066; GO:0043303; GO:0045121; GO:0045453; GO:0045471; GO:0046677; GO:0046875; GO:0048260; GO:0048471; GO:0061630; GO:0070997; GO:0071364; GO:0090650; GO:1901215; GO:1990090; GO:1990782; GO:2000583";"bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; mast cell granule [GO:0042629]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]"
comp4712164_c0_seq1;GAXK01144061.1;A0ZSK4;1.92E-15;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp4712186_c0_seq1;GAXK01144087.1;P18910;7.04E-40;ANPRA_RAT;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662";"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp47124_c3_seq1;GAXK01126845.1;Q8N5J2;6.44E-108;MINY1_HUMAN;Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type carboxypeptidase activity [GO:0016807]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]";"GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0016807; GO:0036435; GO:0071108; GO:1990380";protein K48-linked deubiquitination [GO:0071108];"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cysteine-type carboxypeptidase activity [GO:0016807]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp4712617_c0_seq1;GAXK01144073.1;Q5FYB1;8.48E-23;ARSI_HUMAN;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp47127_c0_seq1;GAXK01126545.1;Q3MHE4;7.58E-106;MSH2_BOVIN;DNA mismatch repair protein Msh2 (MutS protein homolog 2);"chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; single-stranded DNA binding [GO:0003697]; B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]";"GO:0000287; GO:0000400; GO:0000406; GO:0001701; GO:0002204; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006119; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016446; GO:0019237; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032300; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168";"B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]";"chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single-stranded DNA binding [GO:0003697]; single thymine insertion binding [GO:0032143]"
comp4712919_c0_seq1;GAXK01144067.1;P50580;2.62E-43;PA2G4_MOUSE;Proliferation-associated protein 2G4 (IRES-specific cellular trans-acting factor 45 kDa) (ITAF45) (Mpp1) (Proliferation-associated protein 1) (Protein p38-2G4);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"GO:0003676; GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904";"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]"
comp471326_c0_seq1;GAXK01036867.1;Q9V0D5;1.48E-37;MDH_PYRAB;Malate dehydrogenase (EC 1.1.1.37);"cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]";"GO:0005737; GO:0006099; GO:0030060";tricarboxylic acid cycle [GO:0006099];cytoplasm [GO:0005737];L-malate dehydrogenase activity [GO:0030060]
comp47134_c1_seq1;GAXK01126474.1;Q3KQW7;4.69E-20;LIMC1_XENLA;LIM and calponin homology domains-containing protein 1;"cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]";"GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0046872; GO:0051496; GO:0051893";"actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]";"cytoplasm [GO:0005737]; stress fiber [GO:0001725]";"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp47140_c0_seq1;GAXK01126756.1;P36975;1.89E-54;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp471445_c1_seq1;GAXK01036861.1;A2A761;6.12E-24;ZFP69_MOUSE;Zinc finger protein 69 (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4714812_c0_seq1;GAXK01149749.1;Q91XB0;1.22E-23;TREX1_MOUSE;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; activation of immune response [GO:0002253]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to type I interferon [GO:0071357]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response [GO:0006955]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organ or tissue specific immune response [GO:0002251]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular metabolic process [GO:0031323]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; response to UV [GO:0009411]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"GO:0000287; GO:0001568; GO:0001822; GO:0002250; GO:0002251; GO:0002253; GO:0002281; GO:0002320; GO:0002379; GO:0002383; GO:0002437; GO:0002457; GO:0002637; GO:0003007; GO:0003015; GO:0003228; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006091; GO:0006110; GO:0006259; GO:0006260; GO:0006304; GO:0006308; GO:0006954; GO:0006955; GO:0006974; GO:0008250; GO:0008296; GO:0008301; GO:0008340; GO:0008408; GO:0008853; GO:0009411; GO:0010468; GO:0019217; GO:0031323; GO:0032197; GO:0032405; GO:0032407; GO:0032479; GO:0032508; GO:0032558; GO:0032607; GO:0032680; GO:0032993; GO:0034599; GO:0034614; GO:0034644; GO:0035458; GO:0035781; GO:0042803; GO:0043277; GO:0043457; GO:0043596; GO:0045087; GO:0045088; GO:0045184; GO:0046890; GO:0050699; GO:0050727; GO:0050790; GO:0050821; GO:0050863; GO:0051607; GO:0060337; GO:0060339; GO:0061635; GO:0071310; GO:0071357; GO:0071480; GO:0072394; GO:0072421; GO:0072422; GO:0072711; GO:0097281; GO:1904161; GO:1905671";"activation of immune response [GO:0002253]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to type I interferon [GO:0071357]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response [GO:0006955]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organ or tissue specific immune response [GO:0002251]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular metabolic process [GO:0031323]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; response to UV [GO:0009411]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]"
comp4715243_c0_seq1;GAXK01149743.1;O80929;5.83E-18;RL361_ARATH;60S ribosomal protein L36-1;"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005783; GO:0022625";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]";structural constituent of ribosome [GO:0003735]
comp471543_c1_seq1;GAXK01036843.1;Q6ZSM3;3.47E-28;MOT12_HUMAN;Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp4715480_c0_seq1;GAXK01149752.1;Q5F3N5;6.57E-07;KLH14_CHICK;Kelch-like protein 14;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]";"GO:0005783; GO:0005789; GO:0005829; GO:0043005; GO:0043025";;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";
comp471553_c1_seq1;GAXK01036874.1;P04352;1.13E-30;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp471628_c0_seq1;GAXK01036856.1;P16143;8.61E-69;PO2F1_XENLA;POU domain, class 2, transcription factor 1 (Octamer-binding protein 1) (Oct-1) (XOct1) (Octamer-binding transcription factor 1) (OTF-1) (Xloct1-32);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007219; GO:0042981; GO:0043565; GO:0045893; GO:0045944; GO:0060019";"Notch signaling pathway [GO:0007219]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp4717327_c0_seq1;GAXK01140803.1;O62836;6.17E-10;ZFX_BOVIN;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746";"fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp471771_c1_seq1;GAXK01036871.1;Q9VLA1;6.15E-64;B3G2S_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase S (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase S) (Glucuronosyltransferase S) (GlcAT-S) (UDP-glucuronosyltransferase S) (DmGlcAT-BSI);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0006486; GO:0006688; GO:0009101; GO:0015018; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650";"chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"
comp47184_c0_seq1;GAXK01126429.1;Q9D9G3;2.21E-54;CHIC2_MOUSE;Cysteine-rich hydrophobic domain-containing protein 2;"Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Golgi to plasma membrane transport [GO:0006893]";"GO:0005794; GO:0005798; GO:0005886; GO:0006893; GO:0043231";Golgi to plasma membrane transport [GO:0006893];"Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";
comp4718792_c1_seq1;GAXK01063864.1;P89116;1.96E-21;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp47188_c0_seq1;GAXK01126841.1;Q5R8W6;4.45E-65;LC7L3_PONAB;Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]";"GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607";"mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]";"DNA binding [GO:0003677]; mRNA binding [GO:0003729]"
comp4719044_c0_seq1;GAXK01063858.1;O06179;7.33E-21;Y1533_MYCTU;Putative monooxygenase Rv1533 (EC 1.13.12.-);"cytosol [GO:0005829]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; nitronate monooxygenase activity [GO:0018580]; fatty acid biosynthetic process [GO:0006633]";"GO:0004314; GO:0005829; GO:0006633; GO:0018580";fatty acid biosynthetic process [GO:0006633];cytosol [GO:0005829];"[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; nitronate monooxygenase activity [GO:0018580]"
comp4719056_c0_seq1;GAXK01063865.1;Q5R558;5.01E-36;STALP_PONAB;AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp4719084_c0_seq1;GAXK01063851.1;Q9I9B9;8.70E-41;CTL1_TORMA;Choline transporter-like protein 1 (Solute carrier family 44 member 1);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp471981_c0_seq1;GAXK01036869.1;Q5M7N9;7.06E-36;ESYT3_XENTR;Extended synaptotagmin-3 (E-Syt3);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0006869; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0061817; GO:0140268";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp47201_c0_seq1;GAXK01205645.1;P52632;9.85E-171;STA5B_RAT;Signal transducer and activator of transcription 5B;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0001228; GO:0001553; GO:0001666; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0019221; GO:0032496; GO:0042127; GO:0043434; GO:0043565; GO:0045471; GO:0045648; GO:0045944; GO:0046983; GO:0048661; GO:0051272; GO:0060397; GO:0071363; GO:0071364";"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp47205_c1_seq1;GAXK01127042.1;Q9NXE8;1.08E-08;CWC25_HUMAN;Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0005654; GO:0016607; GO:0071006";mRNA splicing, via spliceosome [GO:0000398];"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]";
comp47211_c0_seq1;GAXK01126485.1;P31483;9.59E-26;TIA1_HUMAN;Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0008543; GO:0010494; GO:0017148; GO:0035925; GO:0042036; GO:0048024; GO:0097165; GO:1903608; GO:1904037";"apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]";"mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]"
comp4721170_c0_seq1;GAXK01173895.1;P19536;8.57E-26;COX5B_MOUSE;Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0042776; GO:0043209; GO:0046872";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp47215_c0_seq1;GAXK01126728.1;B6ZLK2;0;CHD1_CHICK;Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1);"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]";"GO:0000775; GO:0003677; GO:0003678; GO:0005524; GO:0005634";;"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp4721940_c0_seq1;GAXK01173901.1;Q95L11;2.94E-20;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp47221_c0_seq1;GAXK01126359.1;P05205;2.19E-07;HP1_DROME;Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen);"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]; polytene chromosome, telomeric region [GO:0035012]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; chromatin silencing [GO:0006342]; chromatin silencing at centromere [GO:0030702]; chromosome organization [GO:0051276]; establishment of chromatin silencing [GO:0006343]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]";"GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000780; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005704; GO:0005720; GO:0005721; GO:0006342; GO:0006343; GO:0006355; GO:0010629; GO:0016458; GO:0030544; GO:0030674; GO:0030702; GO:0031060; GO:0031507; GO:0033697; GO:0034773; GO:0035012; GO:0035064; GO:0042393; GO:0042981; GO:0044877; GO:0045892; GO:0045893; GO:0051276; GO:0061408; GO:0070063; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646";"chromatin silencing [GO:0006342]; chromatin silencing at centromere [GO:0030702]; chromosome organization [GO:0051276]; establishment of chromatin silencing [GO:0006343]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]";"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome, telomeric region [GO:0035012]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]"
comp47226_c0_seq1;GAXK01127023.1;O75330;1.52E-17;HMMR_HUMAN;Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168);"cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; hyaluronic acid binding [GO:0005540]; hyaluronan catabolic process [GO:0030214]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0005540; GO:0005813; GO:0005829; GO:0005886; GO:0009986; GO:0010389; GO:0015630; GO:0016020; GO:0030214";"hyaluronan catabolic process [GO:0030214]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]";hyaluronic acid binding [GO:0005540]
comp4723_c0_seq1;GAXK01066268.1;P48729;0;KC1A_HUMAN;Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1);"beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"GO:0000777; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0016020; GO:0016055; GO:0016301; GO:0016607; GO:0018105; GO:0018107; GO:0030877; GO:0032436; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:1904424; GO:1904885; GO:1904886; GO:1990904";"beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]";"beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp4723220_c0_seq1;GAXK01068703.1;P41753;3.62E-07;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp47237_c0_seq1;GAXK01126373.1;Q5FWR0;0;SMRCD_XENTR;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12);"nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]";"GO:0000729; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0008094; GO:0035861; GO:0043044";"ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]";"nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]"
comp4723897_c0_seq1;GAXK01068711.1;P47736;2.66E-36;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp4724_c1_seq1;GAXK01065415.1;Q9VNE2;3.31E-143;PKRA_DROME;Protein krasavietz (Eukaryotic translation initiation factor 5C domain-containing protein) (Decp) (eIF5C domain-containing protein) (Protein extra bases);"axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuronal cell body [GO:0043025]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]; axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of filopodium assembly [GO:0051491]";"GO:0005737; GO:0007616; GO:0016199; GO:0017148; GO:0030175; GO:0030424; GO:0030707; GO:0031369; GO:0043022; GO:0043024; GO:0043025; GO:0044295; GO:0048149; GO:0048477; GO:0051491";"axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of filopodium assembly [GO:0051491]";"axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuronal cell body [GO:0043025]";"ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]"
comp4724021_c0_seq1;GAXK01181122.1;Q6ZJ05;7.25E-17;URH1_ORYSJ;Probable uridine nucleosidase 1 (EC 3.2.2.3) (Uridine ribohydrolase 1);"cytosol [GO:0005829]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; purine nucleoside catabolic process [GO:0006152]";"GO:0005829; GO:0006152; GO:0008477; GO:0045437";purine nucleoside catabolic process [GO:0006152];cytosol [GO:0005829];"purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]"
comp472405_c0_seq1;GAXK01192621.1;Q6P1D7;1.97E-17;SLX4_MOUSE;Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12);"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 3'-flap endonuclease activity [GO:0048257]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]";"GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0000784; GO:0000790; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0008821; GO:0010792; GO:0017108; GO:0030054; GO:0033557; GO:0036297; GO:0048257; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431";"DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]";"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]";"3'-flap endonuclease activity [GO:0048257]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; enzyme activator activity [GO:0008047]"
comp47245_c0_seq1;GAXK01126610.1;Q08738;6.13E-09;CU30_BOMMO;Larval cuticle protein LCP-30;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp472533_c1_seq1;GAXK01192620.1;A2BGU9;1.81E-34;SERHL_DANRE;Serine hydrolase-like protein (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]";"GO:0004377; GO:0005789; GO:0016787";;endoplasmic reticulum membrane [GO:0005789];"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]"
comp472547_c0_seq1;GAXK01192616.1;Q9FR44;2.14E-10;PEAM1_ARATH;Phosphoethanolamine N-methyltransferase 1 (AtNMT1) (PEAMT 1) (EC 2.1.1.103) (Protein XIPOTL 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; choline biosynthetic process [GO:0042425]; phosphatidylcholine biosynthetic process [GO:0006656]; pollen development [GO:0009555]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; post-embryonic root development [GO:0048528]; unidimensional cell growth [GO:0009826]";"GO:0000234; GO:0005737; GO:0005829; GO:0006656; GO:0008168; GO:0009555; GO:0009826; GO:0009860; GO:0010183; GO:0042425; GO:0048528";"choline biosynthetic process [GO:0042425]; phosphatidylcholine biosynthetic process [GO:0006656]; pollen development [GO:0009555]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; post-embryonic root development [GO:0048528]; unidimensional cell growth [GO:0009826]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"methyltransferase activity [GO:0008168]; phosphoethanolamine N-methyltransferase activity [GO:0000234]"
comp472597_c0_seq1;GAXK01192614.1;Q9UJZ1;8.75E-129;STML2_HUMAN;Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7);"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]";"GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046";"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]";"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]";"cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]"
comp4726_c0_seq1;GAXK01066871.1;P05661;2.23E-44;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp472607_c0_seq1;GAXK01192624.1;O95847;4.39E-112;UCP4_HUMAN;Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27);"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]";"GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600";"cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]";"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]";
comp4726087_c0_seq1;GAXK01141047.1;Q86LG1;8.33E-13;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp4727437_c0_seq1;GAXK01141045.1;P78363;1.65E-51;ABCA4_HUMAN;Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein);"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]";"GO:0001523; GO:0005215; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0140326; GO:0140327; GO:0140347";"lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]";"ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]"
comp472784_c0_seq1;GAXK01192655.1;Q66S03;1.22E-13;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp47279_c0_seq1;GAXK01126562.1;Q63ZM9;6.82E-10;ZN830_XENLA;Zinc finger protein 830 (Coiled-coil domain-containing protein 16);"chromosome [GO:0005694]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; multicellular organism development [GO:0007275]";"GO:0003676; GO:0005681; GO:0005694; GO:0007049; GO:0007275; GO:0008270; GO:0016607; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; multicellular organism development [GO:0007275]";"chromosome [GO:0005694]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]";"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp4728174_c0_seq1;GAXK01028379.1;P30796;1.74E-18;GASR_MASNA;Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gastrin receptor activity [GO:0015054]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0005886; GO:0007204; GO:0008284; GO:0015054; GO:0016021";"positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gastrin receptor activity [GO:0015054]
comp4728745_c0_seq1;GAXK01028382.1;Q8R151;1.77E-09;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp472899_c0_seq1;GAXK01192586.1;Q6AYY8;2.53E-125;ACATN_RAT;Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; central nervous system development [GO:0007417]";"GO:0005789; GO:0007417; GO:0008521; GO:0015295; GO:0016021";central nervous system development [GO:0007417];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]"
comp4729_c1_seq1;GAXK01066528.1;Q9Z2I9;5.64E-168;SUCB1_MOUSE;Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA);"mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004774; GO:0004775; GO:0005524; GO:0005739; GO:0006099; GO:0006104; GO:0006105; GO:0042709; GO:0043209";"succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]"
comp4729075_c0_seq1;GAXK01028393.1;P40814;1.36E-12;T3MO_SALTY;Type III restriction-modification system StyLTI enzyme mod (M.StyLTI) (EC 2.1.1.72) (StyLTI methyltransferase);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; methyltransferase activity [GO:0008168]; N-methyltransferase activity [GO:0008170]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; DNA restriction-modification system [GO:0009307]";"GO:0003677; GO:0005737; GO:0008168; GO:0008170; GO:0009007; GO:0009307";DNA restriction-modification system [GO:0009307];cytoplasm [GO:0005737];"DNA binding [GO:0003677]; methyltransferase activity [GO:0008168]; N-methyltransferase activity [GO:0008170]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]"
comp472909_c0_seq1;GAXK01192582.1;Q967D7;7.52E-17;TUTL_DROME;Protein turtle;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632";"adult locomotory behavior [GO:0008344]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp473167_c0_seq1;GAXK01192615.1;Q7TNE1;3.66E-163;SUCHY_MOUSE;Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (SuccinylCoA:glutarate-CoA transferase);"mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]";"GO:0005739; GO:0047369";;mitochondrion [GO:0005739];succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]
comp4731978_c0_seq1;GAXK01163053.1;P36609;2.18E-17;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp473225_c1_seq1;GAXK01192656.1;Q3URR7;9.16E-09;ZSC10_MOUSE;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863";"negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp473273_c8_seq1;GAXK01192630.1;O61307;5.06E-40;TENM_DROME;Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0030054; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331";"cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp47328_c1_seq1;GAXK01126305.1;P40821;1.00E-31;CRJ1C_TRICY;Crystallin J1C;structural constituent of eye lens [GO:0005212];GO:0005212;;;structural constituent of eye lens [GO:0005212]
comp4732813_c0_seq1;GAXK01154510.1;P58307;6.07E-15;OX1R_MOUSE;Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1);"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0051480; GO:0070374";"feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]";integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]"
comp47329_c0_seq1;GAXK01126753.1;B9E6X0;1.31E-09;DNAJ_MACCJ;Chaperone protein DnaJ;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082";"DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp4733_c4_seq1;GAXK01066195.1;K8FE10;8.43E-07;SYT2_CAEEL;Synaptotagmin 2;"axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0048488; GO:0048791; GO:0070382; GO:0071277";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp4733125_c0_seq1;GAXK01154506.1;A8QZJ5;9.17E-07;MCTX1_MILDI;Millepora cytotoxin-1 (MCTx-1);"extracellular region [GO:0005576]; nematocyst [GO:0042151]";"GO:0005576; GO:0042151";;"extracellular region [GO:0005576]; nematocyst [GO:0042151]";
comp4733232_c0_seq1;GAXK01154493.1;A1WSA8;4.96E-10;IF1_VEREI;Translation initiation factor IF-1;"cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0005737; GO:0019843; GO:0043022";;cytoplasm [GO:0005737];"ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; translation initiation factor activity [GO:0003743]"
comp4733262_c0_seq1;GAXK01154508.1;Q5ISE2;1.60E-13;Z36L3_MOUSE;mRNA decay activator protein ZFP36L3 (Zinc finger protein 36, C3H1 type-like 3) (zinc finger protein 36-like 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]";"GO:0000288; GO:0000289; GO:0003677; GO:0003723; GO:0003730; GO:0005737; GO:0005829; GO:0016021; GO:0035925; GO:0046872; GO:0061158";"3'-UTR-mediated mRNA destabilization [GO:0061158]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]"
comp47333_c1_seq1;GAXK01127162.1;Q86UD4;4.50E-07;ZN329_HUMAN;Zinc finger protein 329;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4734624_c0_seq1;GAXK01204758.1;P0AG25;5.76E-40;SPOT_ECO57;Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase (EC 3.1.7.2) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase);"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; guanosine tetraphosphate biosynthetic process [GO:0015970]";"GO:0008893; GO:0015970";guanosine tetraphosphate biosynthetic process [GO:0015970];;guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]
comp473499_c1_seq1;GAXK01192611.1;Q5RCU4;7.85E-50;SOX6_PONAB;Transcription factor SOX-6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp4735055_c0_seq1;GAXK01204733.1;Q9H7R5;8.25E-20;ZN665_HUMAN;Zinc finger protein 665 (Zinc finger protein 160-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp47354_c0_seq1;GAXK01127044.1;Q8BGA9;2.01E-58;OXA1L_MOUSE;Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein);"integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]";"GO:0005739; GO:0005743; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177";"aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]";"integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]"
comp473585_c0_seq1;GAXK01192647.1;Q6DHG0;1.06E-65;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp4736356_c0_seq1;GAXK01041064.1;Q0PXY6;4.59E-90;RL18_DIACI;60S ribosomal protein L18;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4737532_c0_seq1;GAXK01041061.1;P48044;8.88E-07;V2R_BOVIN;Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor);"integral component of plasma membrane [GO:0005887]; vasopressin receptor activity [GO:0005000]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interferon-gamma production [GO:0032609]; positive regulation of gene expression [GO:0010628]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to cytokine [GO:0034097]";"GO:0001992; GO:0005000; GO:0005887; GO:0007186; GO:0007249; GO:0010628; GO:0032609; GO:0032870; GO:0034097; GO:0045907";"cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interferon-gamma production [GO:0032609]; positive regulation of gene expression [GO:0010628]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to cytokine [GO:0034097]";integral component of plasma membrane [GO:0005887];vasopressin receptor activity [GO:0005000]
comp4737944_c0_seq1;GAXK01041046.1;Q9UDV7;2.52E-22;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp473823_c2_seq1;GAXK01192593.1;Q63054;8.67E-115;ICA69_RAT;Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69);"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]";"GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030425; GO:0030667; GO:0030672; GO:0043496; GO:0048471; GO:0050796";"neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]";"cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]";protein domain specific binding [GO:0019904]
comp4738264_c0_seq1;GAXK01116769.1;Q5N725;5.29E-33;ALFC3_ORYSJ;Fructose-bisphosphate aldolase 3, cytoplasmic (EC 4.1.2.13) (Aldolase C-1) (AldC-1);"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";cytosol [GO:0005829];fructose-bisphosphate aldolase activity [GO:0004332]
comp47383_c1_seq1;GAXK01126281.1;Q63186;8.85E-110;EI2BD_RAT;Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta);"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"GO:0001541; GO:0003743; GO:0005085; GO:0005737; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0021766; GO:0031369; GO:0042552; GO:0043434; GO:0050852; GO:1905098";"hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]";"guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp4739218_c0_seq1;GAXK01116776.1;Q4N3P0;2.68E-50;RS8_THEPA;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp47393_c1_seq1;GAXK01126827.1;Q5SPB6;3.01E-54;CHAC1_DANRE;Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Cation transport regulator-like protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]; apoptotic process [GO:0006915]; glutathione catabolic process [GO:0006751]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]";"GO:0003839; GO:0005112; GO:0005737; GO:0005802; GO:0005829; GO:0006751; GO:0006915; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061928";"apoptotic process [GO:0006915]; glutathione catabolic process [GO:0006751]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802]";"gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]"
comp474_c0_seq1;GAXK01169177.1;P36609;2.97E-71;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4740175_c0_seq1;GAXK01102438.1;Q8HYJ7;4.73E-10;FUT5_GORGO;Alpha-(1,3)-fucosyltransferase 5 (EC 2.4.1.65) (Fucosyltransferase 5) (Fucosyltransferase V) (Fuc-TV) (FucT-V) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]"
comp47404_c0_seq1;GAXK01126360.1;P25843;1.59E-11;PROF_DROME;Profilin (Protein chickadee);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007411; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]";actin monomer binding [GO:0003785]
comp474078_c0_seq1;GAXK01205993.1;Q9NGX9;4.60E-119;CP302_DROME;Cytochrome P450 302a1, mitochondrial (EC 1.14.99.-) (Protein disembodied);"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ecdysteroid 22-hydroxylase activity [GO:0042767]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; central nervous system development [GO:0007417]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]";"GO:0005506; GO:0005739; GO:0006697; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0008362; GO:0016491; GO:0016705; GO:0020037; GO:0031966; GO:0042767";"central nervous system development [GO:0007417]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]";"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"ecdysteroid 22-hydroxylase activity [GO:0042767]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp4741171_c0_seq1;GAXK01102446.1;P25932;9.87E-09;ESCA_DROME;Protein escargot (Protein fleabag);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; asymmetric neuroblast division [GO:0055059]; branch fusion, open tracheal system [GO:0035147]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc development [GO:0035215]; germ-line stem cell population maintenance [GO:0030718]; gravitaxis [GO:0042332]; intestinal stem cell homeostasis [GO:0036335]; maintenance of imaginal histoblast diploidy [GO:0007489]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of compound eye pigmentation [GO:0048076]; regulation of neural precursor cell proliferation [GO:2000177]; response to nicotine [GO:0035094]; somatic stem cell population maintenance [GO:0035019]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0001227; GO:0001708; GO:0001709; GO:0003677; GO:0005634; GO:0007417; GO:0007424; GO:0007427; GO:0007489; GO:0030718; GO:0032876; GO:0035019; GO:0035094; GO:0035147; GO:0035215; GO:0035220; GO:0036335; GO:0042332; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048076; GO:0055059; GO:2000177";"asymmetric neuroblast division [GO:0055059]; branch fusion, open tracheal system [GO:0035147]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc development [GO:0035215]; germ-line stem cell population maintenance [GO:0030718]; gravitaxis [GO:0042332]; intestinal stem cell homeostasis [GO:0036335]; maintenance of imaginal histoblast diploidy [GO:0007489]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of compound eye pigmentation [GO:0048076]; regulation of neural precursor cell proliferation [GO:2000177]; response to nicotine [GO:0035094]; somatic stem cell population maintenance [GO:0035019]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp474172_c0_seq1;GAXK01196029.1;Q8IN81;6.06E-22;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4741965_c0_seq1;GAXK01102456.1;Q9FZ76;2.68E-38;RL61_ARATH;60S ribosomal protein L6-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0009506; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4742050_c0_seq1;GAXK01072693.1;Q90YR7;2.63E-109;RS7_ICTPU;40S ribosomal protein S7;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726";"chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4742100_c0_seq1;GAXK01072696.1;Q8VHL1;5.78E-24;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp4744_c1_seq1;GAXK01065849.1;Q9VIH7;6.70E-99;SKY_DROME;GTPase-activating protein skywalker;"cell junction [GO:0030054]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]";"GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030054; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422";"chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]"
comp47440_c0_seq1;GAXK01126475.1;O43251;4.09E-40;RFOX2_HUMAN;RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell population proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]";"GO:0000381; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007399; GO:0008134; GO:0008380; GO:0008543; GO:0010724; GO:0016070; GO:0021942; GO:0030520; GO:0042127; GO:0045892; GO:0048813; GO:0050885";"dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell population proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp4744291_c0_seq1;GAXK01203132.1;Q5D1D6;3.61E-12;GBP1_CHLAE;Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607";"defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp47444_c0_seq1;GAXK01126239.1;Q4KMC4;0;GFPT2_RAT;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2);"carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"GO:0004360; GO:0006002; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0097367; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";;"carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]"
comp474449_c0_seq1;GAXK01196088.1;Q10096;5.02E-07;YAOH_SCHPO;Zinc finger protein C11D3.17;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0000981; GO:0005634; GO:0006351; GO:0006357; GO:0008270";"regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp47460_c1_seq1;GAXK01126452.1;Q9NZM3;1.29E-47;ITSN2_HUMAN;Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3/SH2 adaptor activity [GO:0005070]; endocytosis [GO:0006897]; positive regulation of dendrite extension [GO:1903861]; regulation of Rho protein signal transduction [GO:0035023]; viral process [GO:0016032]";"GO:0005070; GO:0005089; GO:0005509; GO:0005737; GO:0005813; GO:0006897; GO:0016032; GO:0035023; GO:0070062; GO:1903861";"endocytosis [GO:0006897]; positive regulation of dendrite extension [GO:1903861]; regulation of Rho protein signal transduction [GO:0035023]; viral process [GO:0016032]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3/SH2 adaptor activity [GO:0005070]"
comp4746027_c0_seq1;GAXK01157364.1;Q8TED4;5.97E-34;G6PT3_HUMAN;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005789; GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513; GO:0070062";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp474675_c0_seq1;GAXK01196089.1;Q6XP49;1.72E-45;GLIS3_MOUSE;Zinc finger protein GLIS3 (GLI-similar 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp47481_c0_seq1;GAXK01126481.1;Q9BG99;2.69E-15;TREX1_BOVIN;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"GO:0003676; GO:0005634; GO:0005789; GO:0005829; GO:0006259; GO:0007049; GO:0008296; GO:0008408; GO:0008853; GO:0046872";"cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp47482_c0_seq1;GAXK01126592.1;O81884;9.45E-57;GALDH_ARATH;L-galactose dehydrogenase (At-GalDH) (L-GalDH) (EC 1.1.1.316);"cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0005829; GO:0006012; GO:0010349; GO:0016491; GO:0019853";"galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853]";cytosol [GO:0005829];"L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]"
comp4748762_c0_seq1;GAXK01060045.1;Q91VY5;9.61E-09;KDM4B_MOUSE;Lysine-specific demethylase 4B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B);"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]";"GO:0005634; GO:0005829; GO:0006338; GO:0031618; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0046872; GO:0051864; GO:0070544; GO:1900113";"chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]";"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp4749676_c0_seq1;GAXK01060044.1;Q54MK8;1.90E-66;RL18A_DICDI;60S ribosomal protein L18a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp4749793_c0_seq1;GAXK01060026.1;P08770;1.07E-08;TRA1_MAIZE;Putative AC transposase (ORFA);"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp4749808_c0_seq1;GAXK01060039.1;P51030;3.16E-16;WNT8C_CHICK;Protein Wnt-8c (CWnt-8);"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0035116; GO:0045165; GO:0045743; GO:0060173; GO:0060828; GO:0090270";"cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp4749820_c0_seq1;GAXK01060038.1;Q8WQI5;6.92E-88;RS8_SPOFR;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4750709_c0_seq1;GAXK01172530.1;Q64617;2.51E-33;KPCL_RAT;Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta);"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Ral GTPase binding [GO:0017160]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]";"GO:0004674; GO:0004699; GO:0005524; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0010744; GO:0016020; GO:0017160; GO:0018105; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070528; GO:2000810";"intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]";"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Ral GTPase binding [GO:0017160]"
comp475126_c0_seq1;GAXK01196083.1;Q6PBT5;1.17E-155;PYRD1_DANRE;Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-);"nucleus [GO:0005634]; sarcomere [GO:0030017]; oxidoreductase activity [GO:0016491]";"GO:0005634; GO:0016491; GO:0030017";;"nucleus [GO:0005634]; sarcomere [GO:0030017]";oxidoreductase activity [GO:0016491]
comp47513_c1_seq1;GAXK01126565.1;Q28GL6;3.74E-19;S7A6O_XENTR;Probable RNA polymerase II nuclear localization protein SLC7A6OS (Solute carrier family 7 member 6 opposite strand transcript homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; developmental process [GO:0032502]; protein transport [GO:0015031]";"GO:0005634; GO:0005737; GO:0015031; GO:0032502";"developmental process [GO:0032502]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp4751566_c0_seq1;GAXK01172542.1;P55500;1.18E-20;Y4IQ_SINFN;Putative insertion sequence ATP-binding protein y4iQ/y4nD/y4sD;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp4751592_c0_seq1;GAXK01172540.1;P21369;8.49E-26;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp47518_c0_seq1;GAXK01126242.1;Q96KB5;4.10E-94;TOPK_HUMAN;Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase);"nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]";"GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0032435; GO:0032873; GO:0034644; GO:0050728";"cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]";nucleus [GO:0005634];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp4751946_c0_seq1;GAXK01172545.1;Q18120;2.66E-11;TWK18_CAEEL;TWiK family of potassium channels protein 18;"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0030322; GO:0040011; GO:0071805";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp4752098_c0_seq1;GAXK01049603.1;Q7M761;1.47E-21;OVCH2_MOUSE;Ovochymase-2 (EC 3.4.21.-) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp4752107_c0_seq1;GAXK01049614.1;Q9Z2D5;1.19E-07;NPY2R_CAVPO;Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]";"GO:0004983; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";neuropeptide Y receptor activity [GO:0004983]
comp475306_c0_seq1;GAXK01196020.1;Q7RTP6;2.30E-96;MICA3_HUMAN;[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0017137; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0051301; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]";"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]"
comp4753478_c0_seq1;GAXK01049597.1;P48613;3.30E-19;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp4753494_c0_seq1;GAXK01049611.1;Q86YV6;3.17E-27;MYLK4_HUMAN;Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085);"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]";"GO:0004687; GO:0005524";;;"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]"
comp4754_c0_seq1;GAXK01066748.1;P24861;5.54E-103;CCNA_PATVU;G2/mitotic-specific cyclin-A;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp47541_c1_seq1;GAXK01126390.1;Q6NT16;9.97E-52;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp4754172_c0_seq1;GAXK01062476.1;P13709;2.65E-10;FSH_DROME;Homeotic protein female sterile (Fragile-chorion membrane protein);"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]";"GO:0005634; GO:0007362; GO:0016021; GO:0032968; GO:0045892; GO:0048813";"dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]";"integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp47553_c0_seq1;GAXK01126385.1;Q8TEL6;5.21E-124;TP4AP_HUMAN;Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS);"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]";phosphatase binding [GO:0019902]
comp47558_c0_seq1;GAXK01126793.1;Q9NRM2;3.46E-92;ZN277_HUMAN;Zinc finger protein 277 (Nuclear receptor-interacting factor 4);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]";"GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772";"cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp4756898_c0_seq1;GAXK01195575.1;F1NZI4;7.97E-39;PGGHG_CHICK;Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1);"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005829; GO:0005975; GO:0047402";carbohydrate metabolic process [GO:0005975];cytosol [GO:0005829];"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]"
comp4757164_c0_seq1;GAXK01195595.1;Q94HW2;5.24E-18;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp4757251_c0_seq1;GAXK01195574.1;P17326;1.30E-12;AT1A_ARTSF;Sodium/potassium-transporting ATPase subunit alpha-A (Na(+)/K(+) ATPase alpha-A subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp4758140_c0_seq1;GAXK01080578.1;Q95218;3.07E-16;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp4758626_c0_seq1;GAXK01080594.1;Q9LYQ2;6.36E-16;LAC13_ARATH;Laccase-13 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 13) (Diphenol oxidase 13) (Urishiol oxidase 13);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp47589_c0_seq1;GAXK01126433.1;Q6PCF9;1.66E-76;S38AA_XENLA;Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10);"integral component of membrane [GO:0016021]; amino acid transport [GO:0006865]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0006865; GO:0016021";"amino acid transport [GO:0006865]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];
comp47593_c0_seq1;GAXK01126238.1;Q7Q6A7;6.64E-172;KMO_ANOGA;Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]";"GO:0004502; GO:0005739; GO:0005741; GO:0006569; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071949";"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]"
comp475936_c0_seq1;GAXK01196042.1;Q5U4Q9;4.03E-106;SCLY_XENTR;Selenocysteine lyase (EC 4.4.1.16);"cytosol [GO:0005829]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]; selenocysteine catabolic process [GO:0016261]";"GO:0005829; GO:0009000; GO:0016261; GO:0016740";selenocysteine catabolic process [GO:0016261];cytosol [GO:0005829];"selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]"
comp475965_c1_seq1;GAXK01196059.1;Q41745;1.88E-38;LPAT_MAIZE;1-acyl-sn-glycerol-3-phosphate acyltransferase PLS1 (EC 2.3.1.51) (Phospholipid synthesis protein 1);"integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phospholipid metabolic process [GO:0006644]";"GO:0003841; GO:0006644; GO:0016021; GO:0016024; GO:0016746";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phospholipid metabolic process [GO:0006644]";integral component of membrane [GO:0016021];"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp4759760_c0_seq1;GAXK01080598.1;Q32KH7;2.52E-25;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp4760035_c0_seq1;GAXK01024582.1;Q17895;9.24E-07;MNM2_CAEEL;Zinc finger protein mnm-2;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; positive regulation of axon guidance [GO:1902669]";"GO:0003676; GO:0005634; GO:0046872; GO:1902669";positive regulation of axon guidance [GO:1902669];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp47601_c0_seq1;GAXK01126752.1;Q5ZJ75;7.83E-159;SL9A8_CHICK;Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]";"GO:0000139; GO:0005794; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp4760525_c0_seq1;GAXK01024590.1;Q8BMF5;1.93E-12;GRIK4_MOUSE;Glutamate receptor ionotropic, kainate 4 (GluK4);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005634; GO:0005886; GO:0008066; GO:0015277; GO:0016020; GO:0030054; GO:0030424; GO:0030425; GO:0032983; GO:0035249; GO:0042734; GO:0043195; GO:0043204; GO:0045202; GO:0045211; GO:0050804; GO:0098686; GO:0098978; GO:0099055; GO:0099056; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp476057_c0_seq1;GAXK01140561.1;Q8BTK5;4.94E-34;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp4760801_c0_seq1;GAXK01024571.1;Q86LG1;9.76E-13;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp4761007_c0_seq1;GAXK01024573.1;Q924N9;6.21E-19;PRS28_MOUSE;Serine protease 28 (EC 3.4.21.-) (Implantation serine proteinase 1) (ISP-1) (Strypsin) (Tryptase-like proteinase);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"GO:0001835; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007566; GO:0008236; GO:0046982";"blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp476126_c1_seq1;GAXK01140552.1;Q80T22;2.05E-13;MFS4B_RAT;Sodium-dependent glucose transporter 1 (rNaGLT1) (Major facilitator superfamily domain-containing protein 4B);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp476169_c1_seq1;GAXK01140531.1;A5A3E0;2.93E-07;POTEF_HUMAN;POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein);"blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895]";"GO:0001895; GO:0005615; GO:0005938; GO:0070062; GO:0072562";retina homeostasis [GO:0001895];"blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]";
comp476221_c0_seq1;GAXK01140580.1;Q09803;6.75E-38;VPS4_SCHPO;Suppressor protein of bem1/bed5 double mutants (EC 3.6.4.6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006998; GO:0007033; GO:0010008; GO:0016887; GO:0043328; GO:0045324";"late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp4762301_c0_seq1;GAXK01001038.1;Q8N6D5;3.23E-10;ANR29_HUMAN;Ankyrin repeat domain-containing protein 29;;;;;
comp476270_c1_seq1;GAXK01140556.1;Q8IZU9;3.72E-20;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp476273_c0_seq1;GAXK01140587.1;Q7RTU5;9.80E-13;ASCL5_HUMAN;Achaete-scute homolog 5 (ASH-5) (hASH5) (Class A basic helix-loop-helix protein 47) (bHLHa47);"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0008134; GO:0045944; GO:0046983; GO:0090575";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp4762810_c0_seq1;GAXK01001031.1;P52746;1.37E-07;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4763004_c0_seq1;GAXK01001045.1;P22685;2.80E-58;RLA0_DICDI;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0005811; GO:0022625; GO:0031012; GO:0045335; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]";"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp476341_c1_seq1;GAXK01140528.1;Q8I6K0;1.32E-34;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp47639_c0_seq1;GAXK01126730.1;P36975;1.62E-53;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp476396_c0_seq1;GAXK01140607.1;Q7Z0G7;6.34E-44;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp4764414_c0_seq1;GAXK01068814.1;Q21355;1.54E-10;GST4_CAEEL;Glutathione S-transferase 4 (EC 2.5.1.18) (CeGST1) (GST class-sigma);"contractile fiber [GO:0043292]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749; GO:0043292";glutathione metabolic process [GO:0006749];contractile fiber [GO:0043292];glutathione transferase activity [GO:0004364]
comp4765134_c0_seq1;GAXK01068805.1;Q9NBX4;1.01E-25;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp4765428_c0_seq1;GAXK01068820.1;P89116;3.42E-38;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp476557_c2_seq1;GAXK01140592.1;Q96IR2;4.18E-40;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp476590_c0_seq1;GAXK01140568.1;Q3URR7;5.63E-15;ZSC10_MOUSE;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863";"negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp47663_c0_seq1;GAXK01126604.1;Q9XYM0;3.76E-125;CRK_DROME;Adapter molecule Crk;"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013";"border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";;receptor tyrosine kinase binding [GO:0030971]
comp4766823_c0_seq1;GAXK01077712.1;P97414;2.49E-13;KCNQ1_MOUSE;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; zymogen granule membrane [GO:0042589]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; scaffold protein binding [GO:0097110]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; cardiovascular system development [GO:0072358]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; gene silencing [GO:0016458]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of gastric acid secretion [GO:0060453]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; renal absorption [GO:0070293]; response to anesthetic [GO:0072347]; ventricular cardiac muscle cell action potential [GO:0086005]";"GO:0005249; GO:0005251; GO:0005267; GO:0005516; GO:0005546; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005886; GO:0005887; GO:0006349; GO:0006813; GO:0008076; GO:0008157; GO:0010460; GO:0015271; GO:0016021; GO:0016323; GO:0016458; GO:0030659; GO:0034236; GO:0034237; GO:0034702; GO:0035690; GO:0042383; GO:0042391; GO:0042589; GO:0042803; GO:0044325; GO:0045121; GO:0046676; GO:0048839; GO:0050892; GO:0060048; GO:0060306; GO:0060307; GO:0060372; GO:0060452; GO:0060453; GO:0060454; GO:0070293; GO:0071320; GO:0071805; GO:0072347; GO:0072358; GO:0086005; GO:0086008; GO:0086009; GO:0086011; GO:0086013; GO:0086014; GO:0086089; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:0098915; GO:1901381; GO:1902260; GO:1902282; GO:1903817";"atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; cardiovascular system development [GO:0072358]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; gene silencing [GO:0016458]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of gastric acid secretion [GO:0060453]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; renal absorption [GO:0070293]; response to anesthetic [GO:0072347]; ventricular cardiac muscle cell action potential [GO:0086005]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; zymogen granule membrane [GO:0042589]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; scaffold protein binding [GO:0097110]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp4767_c0_seq1;GAXK01066113.1;Q9IA79;1.74E-41;BI1_PAROL;Probable Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein homolog) (Transmembrane BAX inhibitor motif-containing protein 6);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]";"GO:0005789; GO:0006915; GO:0006986; GO:0016021; GO:0043066";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp47675_c6_seq1;GAXK01126298.1;P19476;1.27E-07;CR29_ENTHI;Putative peroxiredoxin (EC 1.11.1.15) (29 kDa cysteine-rich surface antigen) (Thioredoxin peroxidase);"plasma membrane [GO:0005886]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005886; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];plasma membrane [GO:0005886];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp4767534_c0_seq1;GAXK01077725.1;P52186;7.64E-28;KCNJ2_CHICK;Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]";inward rectifier potassium channel activity [GO:0005242]
comp476790_c0_seq1;GAXK01140606.1;E7E2N8;1.29E-21;GILT_CARAU;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]";"GO:0005576; GO:0005764; GO:0019882; GO:0047134";antigen processing and presentation [GO:0019882];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp4767962_c0_seq1;GAXK01204841.1;Q8PYZ8;6.77E-60;HPPA1_METMA;K(+)-stimulated pyrophosphate-energized sodium pump (EC 7.2.3.-) (Membrane-bound sodium-translocating pyrophosphatase) (Mm-PPase) (Pyrophosphate-energized inorganic pyrophosphatase) (Na(+)-PPase);"integral component of plasma membrane [GO:0005887]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]; sodium ion transport [GO:0006814]";"GO:0000287; GO:0004427; GO:0005887; GO:0006814; GO:0009678; GO:0030955";sodium ion transport [GO:0006814];integral component of plasma membrane [GO:0005887];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp47685_c0_seq1;GAXK01126803.1;Q8MKK4;8.77E-61;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp47686_c2_seq1;GAXK01126402.1;P13676;1.59E-89;ACPH_RAT;Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase);"cytoplasm [GO:0005737]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005737";;cytoplasm [GO:0005737];serine-type endopeptidase activity [GO:0004252]
comp476906_c0_seq1;GAXK01140520.1;Q9U518;1.37E-172;ASPG_DIRIM;L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase);"asparaginase activity [GO:0004067]; asparagine metabolic process [GO:0006528]";"GO:0004067; GO:0006528";asparagine metabolic process [GO:0006528];;asparaginase activity [GO:0004067]
comp476965_c1_seq1;GAXK01140530.1;P54001;1.40E-47;P4HA1_RAT;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp47698_c0_seq1;GAXK01126507.1;Q99J83;2.05E-84;ATG5_MOUSE;Autophagy protein 5 (APG5-like);"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular homeostasis [GO:0019725]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000045; GO:0000422; GO:0001974; GO:0002739; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009267; GO:0009620; GO:0016020; GO:0016236; GO:0019725; GO:0019883; GO:0031397; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0042493; GO:0043066; GO:0043687; GO:0044233; GO:0045060; GO:0048840; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061739; GO:0070257; GO:0071500; GO:0075044; GO:1902017; GO:2000377; GO:2000378; GO:2000619";"aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; cellular homeostasis [GO:0019725]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]";"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]";
comp4770582_c0_seq1;GAXK01185133.1;O34313;5.53E-11;NTPES_BACSU;"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]";"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005576; GO:0005618; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872";nucleotide catabolic process [GO:0009166];"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]";"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp4770736_c0_seq1;GAXK01185127.1;P51508;4.19E-10;ZNF81_HUMAN;Zinc finger protein 81 (HFZ20);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp47713_c0_seq1;GAXK01126480.1;Q8TB61;1.11E-112;S35B2_HUMAN;Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"GO:0000139; GO:0005794; GO:0016020; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0043123; GO:0046963; GO:0046964; GO:0050428";"3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]"
comp477169_c0_seq1;GAXK01140619.1;F1LQX4;1.84E-34;RHG44_RAT;Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2);"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005096; GO:0006887; GO:0007165; GO:0014069; GO:0030054; GO:0030425; GO:0031256; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048365; GO:0048786; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978";"exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]";"GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]"
comp477173_c0_seq1;GAXK01140581.1;P32456;4.18E-56;GBP2_HUMAN;Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; protein localization to nucleus [GO:0034504]; type I interferon signaling pathway [GO:0060337]";"GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0015629; GO:0020005; GO:0031410; GO:0034504; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0060333; GO:0060337; GO:0071346; GO:0071347; GO:0071356";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; protein localization to nucleus [GO:0034504]; type I interferon signaling pathway [GO:0060337]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803]"
comp4771733_c0_seq1;GAXK01185125.1;Q54P92;1.65E-89;METH_DICDI;Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS);"cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0042558";"methionine biosynthetic process [GO:0009086]; pteridine-containing compound metabolic process [GO:0042558]";cytosol [GO:0005829];"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp47723_c2_seq1;GAXK01126853.1;Q7KRI2;4.25E-39;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4772549_c0_seq1;GAXK01182018.1;P69478;4.54E-15;CHSTB_RAT;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp4772651_c0_seq1;GAXK01182022.1;Q38PU2;4.02E-37;GRIK3_MACFA;Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; ionotropic glutamate receptor activity [GO:0004970]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]";"GO:0001640; GO:0004970; GO:0007216; GO:0016021; GO:0030054; GO:0043197; GO:0045211";G protein-coupled glutamate receptor signaling pathway [GO:0007216];"cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; ionotropic glutamate receptor activity [GO:0004970]"
comp477306_c0_seq1;GAXK01140588.1;A2VDP4;7.60E-11;ZN567_BOVIN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp47735_c0_seq1;GAXK01127088.1;O00468;2.87E-23;AGRIN_HUMAN;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]";"GO:0001523; GO:0002162; GO:0005200; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005829; GO:0005886; GO:0006024; GO:0006027; GO:0007165; GO:0007213; GO:0007411; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030054; GO:0030198; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]"
comp477382_c0_seq1;GAXK01140615.1;A8WGS4;4.27E-20;TLCD2_DANRE;TLC domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4773966_c0_seq1;GAXK01182027.1;P23098;3.39E-125;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp4774916_c0_seq1;GAXK01075434.1;P0A134;8.09E-42;TRA6_PSEAI;Transposase for insertion sequences IS1326/IS1353;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp4774994_c0_seq1;GAXK01075446.1;A8HS48;1.99E-28;RS3A_CHLRE;40S ribosomal protein S3a;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp4775159_c0_seq1;GAXK01075455.1;P84199;2.44E-24;NEKL4_CAEEL;Serine/threonine-protein kinase D1044.8 (EC 2.7.11.1) (Never in mitosis kinase like 4);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of MAP kinase activity [GO:0043406]; regulation of cell cycle G2/M phase transition [GO:1902749]";"GO:0004674; GO:0005524; GO:0043406; GO:0046872; GO:1902749";"positive regulation of MAP kinase activity [GO:0043406]; regulation of cell cycle G2/M phase transition [GO:1902749]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp477635_c0_seq1;GAXK01140621.1;Q5RJH2;1.64E-46;MCTP2_MOUSE;Multiple C2 and transmembrane domain-containing protein 2;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; multicellular organism development [GO:0007275]";"GO:0005509; GO:0005654; GO:0005829; GO:0007275; GO:0016021; GO:0030672";multicellular organism development [GO:0007275];"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp4776443_c0_seq1;GAXK01034294.1;O48649;7.79E-81;ARF1_SALBA;ADP-ribosylation factor 1;"Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005794; GO:0015031; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";Golgi apparatus [GO:0005794];GTP binding [GO:0005525]
comp477679_c2_seq1;GAXK01140623.1;Q09225;2.62E-30;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp47768_c0_seq1;GAXK01126590.1;Q568R1;1.56E-41;NSRP1_DANRE;Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55);;;;;
comp4777000_c0_seq1;GAXK01034289.1;B2RXF5;3.52E-10;ZBT42_HUMAN;Zinc finger and BTB domain-containing protein 42;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006974; GO:0007517; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp477743_c0_seq1;GAXK01140609.1;Q95ZV7;3.85E-43;DDRB_CAEEL;Discoidin domain-containing receptor tyrosine kinase B (EC 2.7.10.1) (Discoidin domain-containing receptor B);"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; interneuron axon guidance [GO:0097376]; motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix organization [GO:1903053]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001952; GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0007160; GO:0007169; GO:0008045; GO:0008284; GO:0030154; GO:0030424; GO:0038062; GO:0043204; GO:0043235; GO:0048680; GO:0097376; GO:1903053";"cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; interneuron axon guidance [GO:0097376]; motor neuron axon guidance [GO:0008045]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix organization [GO:1903053]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp477744_c0_seq1;GAXK01140579.1;P00720;1.10E-12;ENLYS_BPT4;Endolysin (EC 3.2.1.17) (Lysis protein) (Lysozyme) (Muramidase);"host cell cytoplasm [GO:0030430]; lysozyme activity [GO:0003796]; cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; cytolysis by virus of host cell [GO:0044659]; defense response to bacterium [GO:0042742]; peptidoglycan catabolic process [GO:0009253]";"GO:0003796; GO:0009253; GO:0016998; GO:0019835; GO:0030430; GO:0042742; GO:0044659";"cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; cytolysis by virus of host cell [GO:0044659]; defense response to bacterium [GO:0042742]; peptidoglycan catabolic process [GO:0009253]";host cell cytoplasm [GO:0030430];lysozyme activity [GO:0003796]
comp47778_c1_seq1;GAXK01126775.1;P49247;4.88E-85;RPIA_HUMAN;Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]";"GO:0004751; GO:0005829; GO:0006014; GO:0006098; GO:0009052; GO:0019693; GO:0042802; GO:0043231; GO:0048029";"D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]";"identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751]"
comp477857_c0_seq1;GAXK01140560.1;Q2KHS5;1.69E-77;MOG2A_XENLA;2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"GO:0003846; GO:0005789; GO:0006071; GO:0016021; GO:0019432; GO:1990578";"glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]";2-acylglycerol O-acyltransferase activity [GO:0003846]
comp477928_c1_seq1;GAXK01140525.1;P81382;8.02E-47;OXLA_CALRH;L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2);"extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]";"GO:0001716; GO:0005576; GO:0006915; GO:0019835; GO:0042742; GO:0090729";"apoptotic process [GO:0006915]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]";extracellular region [GO:0005576];"L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]"
comp4779397_c0_seq1;GAXK01022120.1;Q54E20;2.25E-28;RL13_DICDI;60S ribosomal protein L13;"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0031012";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]";structural constituent of ribosome [GO:0003735]
comp4779689_c0_seq1;GAXK01022103.1;P22217;5.31E-12;TRX1_YEAST;Thioredoxin-1 (Thioredoxin I) (TR-I) (Thioredoxin-2);"cytosol [GO:0005829]; fungal-type vacuole [GO:0000324]; Golgi membrane [GO:0000139]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; disulfide oxidoreductase activity [GO:0015036]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; deoxyribonucleotide biosynthetic process [GO:0009263]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycerol ether metabolic process [GO:0006662]; protein deglutathionylation [GO:0080058]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vacuole fusion, non-autophagic [GO:0042144]; vacuole inheritance [GO:0000011]";"GO:0000011; GO:0000139; GO:0000324; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0006662; GO:0006888; GO:0006890; GO:0009263; GO:0015031; GO:0015035; GO:0015036; GO:0042144; GO:0045454; GO:0080058";"cell redox homeostasis [GO:0045454]; deoxyribonucleotide biosynthetic process [GO:0009263]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycerol ether metabolic process [GO:0006662]; protein deglutathionylation [GO:0080058]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vacuole fusion, non-autophagic [GO:0042144]; vacuole inheritance [GO:0000011]";"cytosol [GO:0005829]; fungal-type vacuole [GO:0000324]; Golgi membrane [GO:0000139]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"disulfide oxidoreductase activity [GO:0015036]; protein disulfide oxidoreductase activity [GO:0015035]"
comp478_c1_seq1;GAXK01169372.1;Q8WMY2;1.13E-33;FPPS_BOVIN;Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase);"cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; viral process [GO:0016032]";"GO:0004161; GO:0004337; GO:0005737; GO:0006695; GO:0016032; GO:0033384; GO:0045337; GO:0046872";"cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; viral process [GO:0016032]";cytoplasm [GO:0005737];"dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]"
comp478009_c0_seq1;GAXK01086497.1;O46040;3.54E-24;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp47803_c3_seq1;GAXK01127119.1;Q9UM54;0;MYO6_HUMAN;Unconventional myosin-VI (Unconventional myosin-6);"actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605]";"GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007605; GO:0016020; GO:0016461; GO:0016591; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0042493; GO:0042802; GO:0043531; GO:0045177; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060001; GO:0070062";"actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605]";"actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]"
comp478131_c1_seq1;GAXK01086485.1;Q4R599;6.31E-16;TSNAX_MACFA;Translin-associated protein X (Translin-associated factor X);"Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005794; GO:0007275; GO:0007283; GO:0030154; GO:0043565; GO:0046872; GO:0048471";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp478153_c0_seq1;GAXK01086426.1;O44857;1.30E-45;NEPL2_CAEEL;Neprilysin-2 (EC 3.4.24.-);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; olfactory learning [GO:0008355]; regulation of chemotaxis [GO:0050920]";"GO:0004222; GO:0008237; GO:0008270; GO:0008355; GO:0009986; GO:0016021; GO:0050920";"olfactory learning [GO:0008355]; regulation of chemotaxis [GO:0050920]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp4781895_c0_seq1;GAXK01156899.1;Q1ZXG4;3.96E-35;PRLA_DICDI;Proliferation-associated protein A;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005730; GO:0005737; GO:0045335";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]";nucleic acid binding [GO:0003676]
comp4782157_c0_seq1;GAXK01064778.1;Q64337;1.18E-07;SQSTM_MOUSE;Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62);"aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]";"GO:0000122; GO:0000407; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007005; GO:0007032; GO:0008270; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0031625; GO:0035255; GO:0035973; GO:0042169; GO:0042802; GO:0042803; GO:0043122; GO:0043130; GO:0043231; GO:0044753; GO:0044754; GO:0051291; GO:0061635; GO:0061912; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]";"aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]";"enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp4782164_c0_seq1;GAXK01064772.1;Q8K078;1.56E-25;SO4A1_MOUSE;Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12);"integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";"GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252";"organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";integral component of plasma membrane [GO:0005887];"organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp478229_c3_seq1;GAXK01086339.1;Q03717;3.60E-44;KCNB1_MOUSE;Potassium voltage-gated channel subfamily B member 1 (Voltage-gated potassium channel subunit Kv2.1) (mShab);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp4782642_c0_seq1;GAXK01064788.1;O44001;6.65E-31;HSP90_EIMTE;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp478280_c0_seq1;GAXK01086435.1;Q99K82;3.51E-38;SMOX_MOUSE;Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"GO:0005634; GO:0005654; GO:0005737; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901";"polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp478295_c0_seq1;GAXK01086323.1;Q9V427;1.34E-40;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp47835_c1_seq1;GAXK01126240.1;P48375;1.20E-15;FKB12_DROME;12 kDa FK506-binding protein (FKBP) (EC 5.2.1.8) (Macrolide-binding protein) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0005886; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp4784011_c0_seq1;GAXK01115428.1;P35684;8.56E-43;RL3_ORYSJ;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp4784170_c0_seq1;GAXK01115436.1;P05661;2.28E-52;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp478420_c0_seq1;GAXK01086367.1;A9ZSY2;9.42E-52;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp4785018_c0_seq1;GAXK01115432.1;Q9N2V2;3.55E-11;NAS30_CAEEL;Zinc metalloproteinase nas-30 (EC 3.4.24.-) (Nematode astacin 30);"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270";;;"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp47852_c1_seq1;GAXK01126622.1;O93257;3.21E-104;XRCC6_CHICK;X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70);"Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription, DNA-templated [GO:0045892]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0000784; GO:0003678; GO:0003684; GO:0003723; GO:0005524; GO:0005654; GO:0006303; GO:0006310; GO:0042162; GO:0043564; GO:0045892; GO:0051575; GO:0070419; GO:0071480; GO:0071481; GO:1990904";"cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription, DNA-templated [GO:0045892]; telomere maintenance [GO:0000723]";"Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]"
comp4785310_c0_seq1;GAXK01115423.1;P18172;6.40E-45;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp47856_c1_seq1;GAXK01127069.1;Q5HZE0;9.88E-60;MCATL_RAT;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015822; GO:0016021; GO:0089709; GO:1903400; GO:1903401; GO:1990575";"acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903400]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]"
comp478651_c1_seq1;GAXK01086327.1;A9ZSY2;7.75E-28;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp478671_c0_seq1;GAXK01086364.1;Q68DX3;9.09E-23;FRPD2_HUMAN;FERM and PDZ domain-containing protein 2 (PDZ domain-containing protein 4) (PDZ domain-containing protein 5C);"basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830]";"GO:0005545; GO:0005737; GO:0005856; GO:0005923; GO:0016323; GO:0070830";bicellular tight junction assembly [GO:0070830];"basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";1-phosphatidylinositol binding [GO:0005545]
comp47873_c0_seq1;GAXK01126369.1;P11584;0;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp478782_c0_seq1;GAXK01086357.1;O08992;8.88E-46;SDCB1_MOUSE;Syntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 1);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0042803; GO:0043231; GO:0045121; GO:0045545; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0099054; GO:1903543; GO:1903553";"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"
comp4788388_c0_seq1;GAXK01151081.1;P46195;2.21E-59;KGUA_BOVIN;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163";purine nucleotide metabolic process [GO:0006163];cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp4788461_c0_seq1;GAXK01151082.1;Q02427;1.29E-26;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp4788540_c0_seq1;GAXK01151100.1;Q9R1Y5;1.65E-10;HIC1_MOUSE;Hypermethylated in cancer 1 protein (Hic-1);"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000785; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007275; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; Wnt signaling pathway [GO:0016055]";"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp478860_c0_seq1;GAXK01086454.1;P41180;1.87E-08;CASR_HUMAN;Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1);"apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; phosphatidylinositol phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATPase activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311]";"GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0038023; GO:0042311; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATPase activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311]";"apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; phosphatidylinositol phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]"
comp478863_c1_seq1;GAXK01086492.1;P27361;7.76E-07;MK03_HUMAN;Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]";"GO:0000165; GO:0000186; GO:0000187; GO:0001784; GO:0001934; GO:0002741; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006361; GO:0006468; GO:0006915; GO:0006975; GO:0007049; GO:0007411; GO:0007568; GO:0008543; GO:0009636; GO:0010468; GO:0010628; GO:0010759; GO:0014066; GO:0016032; GO:0016310; GO:0018105; GO:0019233; GO:0019369; GO:0019902; GO:0030168; GO:0030278; GO:0030509; GO:0030641; GO:0030878; GO:0031143; GO:0031281; GO:0031663; GO:0032212; GO:0032872; GO:0032991; GO:0033129; GO:0034198; GO:0034614; GO:0035066; GO:0035556; GO:0038083; GO:0038095; GO:0038096; GO:0042473; GO:0042802; GO:0043330; GO:0045727; GO:0045944; GO:0046697; GO:0048538; GO:0051090; GO:0051216; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060324; GO:0060425; GO:0060440; GO:0061308; GO:0065003; GO:0070371; GO:0070374; GO:0070498; GO:0070849; GO:0071260; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0090170; GO:0097110; GO:1900034; GO:1903351; GO:1904355; GO:1904417; GO:1905050; GO:2000641; GO:2000657";"activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein-containing complex assembly [GO:0065003]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; scaffold protein binding [GO:0097110]"
comp4789043_c0_seq1;GAXK01151087.1;P21328;9.35E-09;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp479_c3_seq1;GAXK01168975.1;Q8JH71;1.32E-119;ALDOB_DANRE;Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005815; GO:0005829; GO:0006096; GO:0030388; GO:0061609";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]";"fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]"
comp47902_c0_seq1;GAXK01127033.1;Q5R8H5;1.08E-81;T2EA_PONAB;General transcription factor IIE subunit 1 (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha);"cytosol [GO:0005829]; transcription factor TFIID complex [GO:0005669]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0005669; GO:0005829; GO:0006367; GO:0016251; GO:0046872; GO:0097550";transcription initiation from RNA polymerase II promoter [GO:0006367];"cytosol [GO:0005829]; transcriptional preinitiation complex [GO:0097550]; transcription factor TFIID complex [GO:0005669]";"metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]"
comp4790208_c0_seq1;GAXK01045081.1;O42329;5.26E-11;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp47903_c0_seq1;GAXK01126835.1;P0DPW5;8.68E-07;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp4790396_c0_seq1;GAXK01045078.1;P09450;6.84E-08;JUNB_MOUSE;Transcription factor jun-B (MyD21);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]";"GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001701; GO:0001829; GO:0003677; GO:0003690; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006366; GO:0008134; GO:0009314; GO:0009612; GO:0009987; GO:0010033; GO:0030316; GO:0032496; GO:0032870; GO:0033687; GO:0034097; GO:0035976; GO:0042493; GO:0043565; GO:0045597; GO:0045944; GO:0046697; GO:0051591; GO:0051726; GO:0060136; GO:0060716; GO:0071277";"cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; cellular response to hormone stimulus [GO:0032870]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]; response to radiation [GO:0009314]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp479045_c0_seq1;GAXK01086448.1;P36609;3.09E-20;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp479095_c0_seq1;GAXK01086449.1;Q0V8T0;2.14E-17;CNTP5_CANLF;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp479109_c0_seq1;GAXK01086442.1;Q95R48;1.63E-27;OCTL_DROME;Organic cation transporter-like protein;"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";"GO:0007390; GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018";"germ-band shortening [GO:0007390]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp479132_c1_seq2;GAXK01086499.1;P41696;2.03E-11;AZF1_YEAST;Asparagine-rich zinc finger protein AZF1;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0001228; GO:0005634; GO:0005829; GO:0006357; GO:0043565; GO:0046872; GO:0060237; GO:0071322";"cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp479138_c0_seq1;GAXK01086441.1;Q6UXN8;1.09E-09;CLC9A_HUMAN;C-type lectin domain family 9 member A (CD antigen CD370);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; positive regulation of cytokine secretion [GO:0050715]; receptor-mediated endocytosis [GO:0006898]";"GO:0006898; GO:0009986; GO:0016021; GO:0030246; GO:0050715";"positive regulation of cytokine secretion [GO:0050715]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";carbohydrate binding [GO:0030246]
comp479210_c0_seq1;GAXK01086358.1;P36975;7.79E-32;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp479221_c1_seq1;GAXK01086344.1;Q5SVQ8;1.67E-11;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp479240_c0_seq1;GAXK01086375.1;Q7SYC9;3.08E-51;CTL2_DANRE;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp47927_c2_seq1;GAXK01126624.1;Q5I597;2.16E-128;BHMT1_BOVIN;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]";"GO:0005829; GO:0006579; GO:0008270; GO:0047150; GO:0070062; GO:0071267";"amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp479329_c0_seq1;GAXK01086360.1;P18172;6.10E-116;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp4794186_c0_seq1;GAXK01073851.1;Q6PHZ8;6.92E-38;KCIP4_MOUSE;Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0030425; GO:0043025; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp4794406_c0_seq1;GAXK01073844.1;O14317;7.01E-20;RLA6_SCHPO;60S acidic ribosomal protein P2-C;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translational elongation [GO:0002182]";"GO:0002182; GO:0003735; GO:0005829; GO:0022625";cytoplasmic translational elongation [GO:0002182];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp4794581_c0_seq1;GAXK01073845.1;Q46927;7.27E-15;TCDA_ECOLI;tRNA threonylcarbamoyladenosine dehydratase (EC 6.1.-.-) (t(6)A37 dehydratase);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; potassium ion binding [GO:0030955]; sodium ion binding [GO:0031402]; tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504]";"GO:0005524; GO:0008641; GO:0016021; GO:0030955; GO:0031402; GO:0061503; GO:0061504";cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; potassium ion binding [GO:0030955]; sodium ion binding [GO:0031402]; tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641]"
comp4794587_c0_seq1;GAXK01073848.1;P63245;6.11E-10;RACK1_RAT;Receptor of activated protein C kinase 1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0007205; GO:0007369; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:0072344; GO:1903076; GO:2000114; GO:2000543";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]"
comp4794841_c0_seq1;GAXK01073850.1;P36604;1.90E-51;BIP_SCHPO;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (Immunoglobulin heavy chain-binding protein homolog) (BiP);"cortical endoplasmic reticulum lumen [GO:0099021]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0031965; GO:0034605; GO:0034620; GO:0034663; GO:0036498; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0099020; GO:0099021";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cortical endoplasmic reticulum lumen [GO:0099021]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp47952_c0_seq1;GAXK01127163.1;Q4VBI7;2.96E-40;STX18_DANRE;Syntaxin-18;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0016021; GO:0031201";"intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]";SNAP receptor activity [GO:0005484]
comp479558_c0_seq1;GAXK01086473.1;Q6TEN1;3.00E-86;RAP1B_DANRE;Ras-related protein Rap-1b;"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; MAP kinase kinase activity [GO:0004708]; cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; small GTPase mediated signal transduction [GO:0007264]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";"GO:0001756; GO:0003428; GO:0003924; GO:0004708; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0007264; GO:0007507; GO:0019003; GO:0032486; GO:0032525; GO:0060026; GO:0060536; GO:0071320; GO:2000301";"cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; small GTPase mediated signal transduction [GO:0007264]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]";"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; MAP kinase kinase activity [GO:0004708]"
comp4796077_c0_seq1;GAXK01031075.1;Q91291;2.71E-42;HSP70_PLEWA;Heat shock 70 kDa protein (HSP70);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp4796240_c0_seq1;GAXK01031062.1;Q9VWE0;4.36E-07;DOME_DROME;Cytokine receptor (Protein domeless);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"GO:0001745; GO:0004896; GO:0005886; GO:0006955; GO:0007259; GO:0007298; GO:0007350; GO:0007424; GO:0007442; GO:0007472; GO:0007616; GO:0008284; GO:0016021; GO:0016324; GO:0016327; GO:0019221; GO:0045475; GO:0046982; GO:0050829; GO:0097677; GO:0097678; GO:1990782";"blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]"
comp4796460_c0_seq1;GAXK01031058.1;Q8LC83;4.85E-47;RS242_ARATH;40S ribosomal protein S24-2;"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005618; GO:0006412; GO:0009536; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp47965_c3_seq1;GAXK01205646.1;P38532;1.26E-67;HSF1_MOUSE;Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1);"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]; cellular protein-containing complex assembly [GO:0034622]; cellular response to amino acid stimulus [GO:0071230]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to organic cyclic compound [GO:0071407]; cellular response to potassium ion [GO:0035865]; cellular response to radiation [GO:0071478]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of gene expression [GO:0010629]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of protein heterodimerization activity [GO:0043497]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0000165; GO:0000776; GO:0000777; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006468; GO:0006952; GO:0007143; GO:0007283; GO:0008284; GO:0008285; GO:0009299; GO:0009408; GO:0010628; GO:0010629; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031490; GO:0032355; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0034622; GO:0035865; GO:0040018; GO:0042531; GO:0042802; GO:0043280; GO:0043497; GO:0043565; GO:0043621; GO:0045120; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0051028; GO:0051260; GO:0051879; GO:0060136; GO:0061408; GO:0061770; GO:0070207; GO:0070301; GO:0071222; GO:0071230; GO:0071276; GO:0071280; GO:0071392; GO:0071407; GO:0071478; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0120162; GO:1900034; GO:1900365; GO:1901215; GO:1902512; GO:1903936; GO:1904385; GO:1904528; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033";"cellular protein-containing complex assembly [GO:0034622]; cellular response to amino acid stimulus [GO:0071230]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to organic cyclic compound [GO:0071407]; cellular response to potassium ion [GO:0035865]; cellular response to radiation [GO:0071478]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of gene expression [GO:0010629]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of protein heterodimerization activity [GO:0043497]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]"
comp4797133_c0_seq1;GAXK01031056.1;D3YXG0;8.16E-14;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp479726_c0_seq1;GAXK01086489.1;P18956;1.81E-28;GGT_ECOLI;"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]";"outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597]; gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264]";"GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0102953; GO:0103068";"amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264]";"outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597]";"gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]"
comp4797917_c0_seq1;GAXK01031057.1;Q9DGI3;3.58E-30;THIO_ICTPU;Thioredoxin (Trx);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; protein disulfide oxidoreductase activity [GO:0015035]; B cell proliferation [GO:0042100]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]";"GO:0005576; GO:0005634; GO:0005737; GO:0006662; GO:0009314; GO:0015035; GO:0042100; GO:0043388; GO:0045454; GO:0055114";"B cell proliferation [GO:0042100]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]";protein disulfide oxidoreductase activity [GO:0015035]
comp4798029_c0_seq1;GAXK01155055.1;P11678;4.71E-11;PERE_HUMAN;"Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]";"GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0043312; GO:0046872; GO:0070062; GO:0072677";"defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp479839_c0_seq1;GAXK01086453.1;Q09990;4.16E-27;LIN23_CAEEL;F-box/WD repeat-containing protein lin-23 (Abnormal cell lineage protein 23);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007049; GO:0008013; GO:0008285; GO:0010826; GO:0019902; GO:0031647; GO:0046983; GO:0048812; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]"
comp4798832_c0_seq1;GAXK01155061.1;Q97Z97;4.54E-10;Y1033_SACS2;Kelch domain-containing protein SSO1033;;;;;
comp4799807_c0_seq1;GAXK01155059.1;Q9UFH2;6.75E-59;DYH17_HUMAN;Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein light chain 2, axonemal);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp479982_c2_seq1;GAXK01086437.1;A0JPE9;3.42E-137;GLPK5_DANRE;Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]";"GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0019563; GO:0046167";"glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]"
comp48_c2_seq1;GAXK01169642.1;Q4V7W2;2.48E-11;FBX5B_XENLA;F-box only protein 5-B (Early mitotic inhibitor 1-B);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; ubiquitin ligase inhibitor activity [GO:1990948]; cell division [GO:0051301]; mitotic cell cycle arrest [GO:0071850]; negative regulation of exit from meiosis [GO:0106061]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0016567; GO:0045841; GO:0046872; GO:0051301; GO:0071850; GO:0106061; GO:1904667; GO:1990948";"cell division [GO:0051301]; mitotic cell cycle arrest [GO:0071850]; negative regulation of exit from meiosis [GO:0106061]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"metal ion binding [GO:0046872]; ubiquitin ligase inhibitor activity [GO:1990948]"
comp480093_c0_seq1;GAXK01143902.1;O02388;1.78E-07;CU22_BOMMO;Larval cuticle protein LCP-22;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp480170_c0_seq2;GAXK01143907.1;Q8CGZ2;1.74E-17;ADIP_RAT;Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein);"cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020]";"GO:0005634; GO:0005913; GO:0007098; GO:0007155; GO:0019904; GO:0030036; GO:0030674; GO:0031252; GO:0032991; GO:0034451; GO:0035020; GO:0035735; GO:0036064; GO:0060271; GO:2000145";"actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020]";"cell-cell adherens junction [GO:0005913]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp48018_c2_seq1;GAXK01094482.1;Q9Z2Y1;0;TIM_RAT;Protein timeless homolog (rTIM) (Timeless-like protein) (rTLP);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]";"GO:0000076; GO:0000790; GO:0001658; GO:0001822; GO:0002009; GO:0003677; GO:0005634; GO:0006281; GO:0006974; GO:0007049; GO:0007623; GO:0031298; GO:0035861; GO:0042752; GO:0042753; GO:0043111; GO:0045892; GO:0048478; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781";"branching involved in ureteric bud morphogenesis [GO:0001658]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]";DNA binding [GO:0003677]
comp4801895_c0_seq1;GAXK01143312.1;Q5F3G7;3.12E-18;C1GLT_CHICK;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]";"GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872";"angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]";integral component of membrane [GO:0016021];"glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp4802132_c0_seq1;GAXK01202701.1;Q6PFM1;8.76E-32;S20AB_DANRE;Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp480269_c1_seq1;GAXK01143928.1;Q3SYV7;7.35E-32;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp48029_c0_seq1;GAXK01094275.1;Q6DC39;7.50E-83;DESI2_DANRE;Deubiquitinase DESI2 (EC 3.4.19.12) (Desumoylating isopeptidase 2) (DeSI-2) (PPPDE peptidase domain-containing protein 1) (Protein FAM152A);"cytoplasm [GO:0005737]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; convergent extension involved in gastrulation [GO:0060027]";"GO:0005737; GO:0036459; GO:0060027";convergent extension involved in gastrulation [GO:0060027];cytoplasm [GO:0005737];thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
comp4803610_c0_seq1;GAXK01202692.1;Q8VIG1;1.09E-08;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp4803761_c0_seq1;GAXK01202700.1;Q93560;2.42E-07;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp480433_c0_seq1;GAXK01143923.1;Q7ZVG6;5.58E-08;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp4804831_c0_seq1;GAXK01115452.1;P62866;5.76E-11;RS30_BOVIN;40S ribosomal protein S30;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp4804979_c0_seq1;GAXK01115465.1;Q99542;4.55E-12;MMP19_HUMAN;Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp480569_c1_seq1;GAXK01143876.1;Q90694;4.03E-91;CDC42_CHICK;Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein);"adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; maintenance of protein location [GO:0045185]; modification of synaptic structure [GO:0099563]; negative regulation of protein complex assembly [GO:0031333]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0019901; GO:0030031; GO:0030036; GO:0030175; GO:0030496; GO:0031274; GO:0031333; GO:0032467; GO:0032488; GO:0032956; GO:0034329; GO:0042995; GO:0043005; GO:0043197; GO:0043552; GO:0045185; GO:0045198; GO:0045860; GO:0046847; GO:0051233; GO:0051489; GO:0051988; GO:0060997; GO:0072686; GO:0099563";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; maintenance of protein location [GO:0045185]; modification of synaptic structure [GO:0099563]; negative regulation of protein complex assembly [GO:0031333]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; Rho protein signal transduction [GO:0007266]";"adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp4806289_c0_seq1;GAXK01038168.1;A6R3K5;2.50E-10;YTM1_AJECN;Ribosome biogenesis protein YTM1;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0043021";"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]";ribonucleoprotein complex binding [GO:0043021]
comp480644_c0_seq1;GAXK01143922.1;Q5RC79;1.50E-11;ZFP1_PONAB;Zinc finger protein 1 homolog (Zfp-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp480649_c0_seq1;GAXK01143896.1;Q96S53;3.81E-103;TESK2_HUMAN;Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]";"GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041";"actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp480664_c3_seq1;GAXK01143845.1;Q8MQW8;7.94E-37;SPRI_DROME;Protein sprint (SH2 poly-proline-containing Ras-interactor protein);"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688";"axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]";"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]"
comp48068_c2_seq1;GAXK01094735.1;Q6ICB0;1.41E-54;DESI1_HUMAN;Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Polyubiquitinated substrate transporter) (POST);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]";"GO:0005634; GO:0005737; GO:0008233; GO:0042802";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
comp4806855_c0_seq1;GAXK01038180.1;P43219;8.73E-13;GIPR_RAT;Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; peptide hormone binding [GO:0017046]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]";"GO:0002029; GO:0005886; GO:0007166; GO:0007204; GO:0008528; GO:0009749; GO:0016021; GO:0016519; GO:0017046; GO:0031018; GO:0032024; GO:0043950; GO:0048678; GO:0051592; GO:0070542";"cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gastric inhibitory peptide receptor activity [GO:0016519]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]"
comp48071_c8_seq1;GAXK01094499.1;Q8BWF0;5.71E-155;SSDH_MOUSE;Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase);"mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105]";"GO:0004777; GO:0005739; GO:0006006; GO:0006083; GO:0006105; GO:0006536; GO:0006541; GO:0006650; GO:0006678; GO:0006681; GO:0006749; GO:0007417; GO:0009013; GO:0009448; GO:0009450; GO:0009791; GO:0022904; GO:0031406; GO:0042135; GO:0046459; GO:0051287; GO:0051289; GO:0055114";"acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105]";mitochondrion [GO:0005739];"carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]"
comp4807107_c0_seq1;GAXK01038183.1;P83118;1.28E-08;MTH11_DROME;Probable G-protein coupled receptor Mth-like 11 (Protein methuselah-like 11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp4807169_c0_seq1;GAXK01038178.1;P09238;5.42E-10;MMP10_HUMAN;Stromelysin-2 (SL-2) (EC 3.4.24.22) (Matrix metalloproteinase-10) (MMP-10) (Transin-2);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012";"collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp48073_c0_seq1;GAXK01093977.1;Q7QH62;8.01E-53;MED4_ANOGA;Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592; GO:0070847";regulation of transcription by RNA polymerase II [GO:0006357];"core mediator complex [GO:0070847]; mediator complex [GO:0016592]";transcription coregulator activity [GO:0003712]
comp4807388_c0_seq1;GAXK01038179.1;P09531;1.87E-08;TGFB1_CHICK;"Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; microvillus [GO:0005902]; nucleus [GO:0005634]; antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein serine/threonine kinase activator activity [GO:0043539]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains [GO:0002460]; aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; cell cycle arrest [GO:0007050]; cell development [GO:0048468]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic liver development [GO:1990402]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; evasion or tolerance of host defenses by virus [GO:0019049]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; face morphogenesis [GO:0060325]; germ cell migration [GO:0008354]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lens fiber cell differentiation [GO:0070306]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic cell cycle checkpoint [GO:0007093]; mononuclear cell proliferation [GO:0032943]; muscle cell cellular homeostasis [GO:0046716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; ossification involved in bone remodeling [GO:0043932]; osteoclast differentiation [GO:0030316]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell division [GO:0051781]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein secretion [GO:0050714]; positive regulation of receptor clustering [GO:1903911]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of vascular permeability [GO:0043117]; progesterone secretion [GO:0042701]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; receptor catabolic process [GO:0032801]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cartilage development [GO:0061035]; regulation of cell population proliferation [GO:0042127]; regulation of interleukin-23 production [GO:0032667]; regulation of MAPK cascade [GO:0043408]; regulation of protein secretion [GO:0050708]; regulation of sodium ion transport [GO:0002028]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulatory T cell differentiation [GO:0045066]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; T cell homeostasis [GO:0043029]; tolerance induction to self antigen [GO:0002513]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"GO:0000122; GO:0000165; GO:0001570; GO:0001657; GO:0001837; GO:0001843; GO:0001933; GO:0002028; GO:0002062; GO:0002244; GO:0002460; GO:0002513; GO:0003180; GO:0003823; GO:0005114; GO:0005125; GO:0005160; GO:0005615; GO:0005634; GO:0005737; GO:0005902; GO:0006611; GO:0006754; GO:0006874; GO:0006954; GO:0007050; GO:0007093; GO:0007173; GO:0007179; GO:0007182; GO:0007183; GO:0007219; GO:0007435; GO:0007492; GO:0008083; GO:0008354; GO:0009611; GO:0009986; GO:0010718; GO:0010763; GO:0010800; GO:0010862; GO:0010936; GO:0014003; GO:0014008; GO:0017015; GO:0019049; GO:0019899; GO:0030214; GO:0030279; GO:0030308; GO:0030316; GO:0030501; GO:0031012; GO:0031065; GO:0031293; GO:0031334; GO:0031663; GO:0032355; GO:0032570; GO:0032667; GO:0032700; GO:0032740; GO:0032801; GO:0032930; GO:0032943; GO:0032967; GO:0033138; GO:0033686; GO:0034713; GO:0034714; GO:0035066; GO:0035307; GO:0042127; GO:0042130; GO:0042307; GO:0042327; GO:0042482; GO:0042701; GO:0042802; GO:0042981; GO:0043011; GO:0043029; GO:0043117; GO:0043406; GO:0043408; GO:0043491; GO:0043536; GO:0043537; GO:0043539; GO:0043552; GO:0043932; GO:0045066; GO:0045216; GO:0045591; GO:0045599; GO:0045662; GO:0045918; GO:0046716; GO:0046881; GO:0048146; GO:0048298; GO:0048468; GO:0048535; GO:0048642; GO:0050680; GO:0050708; GO:0050714; GO:0050731; GO:0050921; GO:0051781; GO:0051897; GO:0055010; GO:0060325; GO:0060389; GO:0060391; GO:0060395; GO:0060762; GO:0061035; GO:0070168; GO:0070306; GO:0070374; GO:0070723; GO:0071158; GO:0071407; GO:0085029; GO:0097191; GO:1900126; GO:1901666; GO:1902895; GO:1903077; GO:1903799; GO:1903800; GO:1903911; GO:1905313; GO:1990402; GO:2000249; GO:2000679; GO:2000727";"adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains [GO:0002460]; aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell development [GO:0048468]; cellular calcium ion homeostasis [GO:0006874]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic liver development [GO:1990402]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; evasion or tolerance of host defenses by virus [GO:0019049]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; face morphogenesis [GO:0060325]; germ cell migration [GO:0008354]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lens fiber cell differentiation [GO:0070306]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic cell cycle checkpoint [GO:0007093]; mononuclear cell proliferation [GO:0032943]; muscle cell cellular homeostasis [GO:0046716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; ossification involved in bone remodeling [GO:0043932]; osteoclast differentiation [GO:0030316]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell division [GO:0051781]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein secretion [GO:0050714]; positive regulation of receptor clustering [GO:1903911]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of vascular permeability [GO:0043117]; progesterone secretion [GO:0042701]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; receptor catabolic process [GO:0032801]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cartilage development [GO:0061035]; regulation of cell population proliferation [GO:0042127]; regulation of interleukin-23 production [GO:0032667]; regulation of MAPK cascade [GO:0043408]; regulation of protein secretion [GO:0050708]; regulation of sodium ion transport [GO:0002028]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulatory T cell differentiation [GO:0045066]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; T cell homeostasis [GO:0043029]; tolerance induction to self antigen [GO:0002513]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; microvillus [GO:0005902]; nucleus [GO:0005634]";"antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein serine/threonine kinase activator activity [GO:0043539]; transforming growth factor beta receptor binding [GO:0005160]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]"
comp480782_c0_seq1;GAXK01143903.1;Q9EQG6;4.10E-159;KDIS_RAT;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0005770; GO:0005829; GO:0010976; GO:0016021; GO:0019887; GO:0019901; GO:0030165; GO:0032991; GO:0038180; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]"
comp480788_c0_seq1;GAXK01143890.1;Q7KRI2;2.62E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4807893_c0_seq1;GAXK01038175.1;Q5IS50;2.36E-13;DPP6_PANTR;Dipeptidyl aminopeptidase-like protein 6 (Dipeptidyl peptidase 6) (Dipeptidyl peptidase VI) (DPP VI);"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp480803_c0_seq1;GAXK01143799.1;A0A0R4IBK5;0;R213A_DANRE;E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872";"blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp480929_c1_seq1;GAXK01143820.1;O77245;2.11E-47;E75_METEN;Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp480975_c0_seq1;GAXK01143822.1;Q14591;1.14E-28;ZN271_HUMAN;Deleted.;;;;;
comp48099_c0_seq1;GAXK01094278.1;Q8VE42;2.50E-20;ANR49_MOUSE;Ankyrin repeat domain-containing protein 49 (Fetal globin-increasing factor) (Fetal globin-inducing factor);"nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0007283; GO:0030154; GO:0045893";"cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];
comp48101_c1_seq1;GAXK01094768.1;Q6DFV3;3.92E-82;RHG21_MOUSE;Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]";"GO:0000139; GO:0005096; GO:0005794; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030100; GO:0030659; GO:0051683; GO:0051684; GO:0072384";"establishment of Golgi localization [GO:0051683]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp4810118_c0_seq1;GAXK01181038.1;O01498;1.15E-07;STAM1_CAEEL;Signal transducing adapter molecule 1 (STAM-1) (Prion-like-(Q/N-rich) domain-bearing protein 19);"cilium [GO:0005929]; early endosome [GO:0005769]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; protein C-terminus binding [GO:0008022]; ubiquitin binding [GO:0043130]; endosome to lysosome transport [GO:0008333]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; protein localization to non-motile cilium [GO:0097499]; response to hermaphrodite contact [GO:0034606]";"GO:0005768; GO:0005769; GO:0005929; GO:0006886; GO:0007275; GO:0008022; GO:0008333; GO:0033565; GO:0034606; GO:0043130; GO:0043409; GO:0048013; GO:0097499";"endosome to lysosome transport [GO:0008333]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; protein localization to non-motile cilium [GO:0097499]; response to hermaphrodite contact [GO:0034606]";"cilium [GO:0005929]; early endosome [GO:0005769]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]";"protein C-terminus binding [GO:0008022]; ubiquitin binding [GO:0043130]"
comp4810464_c0_seq1;GAXK01181052.1;P47835;3.51E-101;RS32_XENLA;40S ribosomal protein S3-B (EC 4.2.99.18) (S1B);"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp4810834_c0_seq1;GAXK01181051.1;Q9UFB7;2.08E-16;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4810938_c0_seq1;GAXK01181054.1;Q86YR7;2.73E-10;MF2L2_HUMAN;Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2);"Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0035023";regulation of Rho protein signal transduction [GO:0035023];;Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp48110_c0_seq1;GAXK01094315.1;P05619;7.43E-68;ILEU_HORSE;Leukocyte elastase inhibitor (LEI) (Serpin B1);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0005737; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp48124_c0_seq1;GAXK01094513.1;Q17QM8;1.41E-11;DUS14_BOVIN;Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48);"MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004725; GO:0017017";;;"MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]"
comp4812847_c0_seq1;GAXK01073607.1;Q03253;9.95E-55;RS12_TRYBB;40S ribosomal protein S12;"cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; posttranscriptional regulation of gene expression [GO:0010608]; translation [GO:0006412]";"GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0010608";"posttranscriptional regulation of gene expression [GO:0010608]; translation [GO:0006412]";"cytoplasm [GO:0005737]; ribosome [GO:0005840]";structural constituent of ribosome [GO:0003735]
comp4813887_c0_seq1;GAXK01073606.1;P36609;1.77E-10;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4814718_c0_seq1;GAXK01040954.1;A1A5Q4;1.77E-24;CF206_RAT;Cilia- and flagella-associated protein 206;"motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"GO:0001534; GO:0003341; GO:0031514; GO:0035082";"axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"motile cilium [GO:0031514]; radial spoke [GO:0001534]";
comp4815_c2_seq1;GAXK01066186.1;P61244;1.31E-35;MAX_HUMAN;Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; transcription by RNA polymerase II [GO:0006366]";"GO:0000082; GO:0000122; GO:0000790; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0009267; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042803; GO:0044877; GO:0045944; GO:0046982; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070317; GO:0070888; GO:0071339; GO:0071375; GO:0090575";"cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp4815118_c0_seq1;GAXK01040952.1;P15848;1.45E-30;ARSB_HUMAN;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp4815280_c0_seq1;GAXK01040957.1;Q24789;2.86E-29;HSP70_ECHGR;Heat shock cognate 70 kDa protein (HSP70);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp481556_c0_seq1;GAXK01143843.1;Q7RTY7;1.10E-42;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp48156_c0_seq1;GAXK01093786.1;Q502M5;1.17E-14;EDC3_DANRE;Enhancer of mRNA-decapping protein 3 (LSM16 protein homolog) (YjeF domain-containing protein 1);"P-body [GO:0000932]; mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]";"GO:0000932; GO:0003729; GO:0031087; GO:0033962; GO:1990174";"cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]";P-body [GO:0000932];"mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]"
comp481579_c0_seq1;GAXK01143814.1;Q4V8E5;3.81E-22;MFSD3_RAT;Major facilitator superfamily domain-containing protein 3;"integral component of plasma membrane [GO:0005887]; solute:proton symporter activity [GO:0015295]";"GO:0005887; GO:0015295";;integral component of plasma membrane [GO:0005887];solute:proton symporter activity [GO:0015295]
comp481586_c0_seq1;GAXK01143898.1;P23286;2.88E-23;CALM_CANAX;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp48161_c1_seq1;GAXK01094209.1;O01761;3.71E-41;UNC89_CAEEL;Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89);"A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0035023; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905";"cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]";"ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp481645_c0_seq1;GAXK01143879.1;P10073;1.18E-28;ZSC22_HUMAN;Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp48170_c0_seq1;GAXK01094014.1;Q8AVI4;0;SHOC2_XENLA;Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase binding [GO:0019903]; positive regulation of Ras protein signal transduction [GO:0046579]";"GO:0000164; GO:0005634; GO:0005737; GO:0019903; GO:0046579";positive regulation of Ras protein signal transduction [GO:0046579];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]";protein phosphatase binding [GO:0019903]
comp481722_c1_seq1;GAXK01143925.1;Q01611;1.85E-18;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4817277_c0_seq1;GAXK01140200.1;Q91924;3.36E-07;SNAI2_XENLA;Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]";"GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872";"neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp48175_c1_seq1;GAXK01094203.1;Q7T0P4;7.13E-132;POC1A_XENLA;POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp48180_c1_seq1;GAXK01094213.1;Q9JI44;1.15E-130;DMAP1_MOUSE;DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1) (MAT1-mediated transcriptional repressor);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]";"GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892";"DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]";"RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]"
comp48181_c12_seq1;GAXK01094858.1;P15364;9.06E-33;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp4818114_c0_seq1;GAXK01038772.1;Q6PHZ8;1.84E-30;KCIP4_MOUSE;Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0030425; GO:0043025; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp4818162_c0_seq1;GAXK01038756.1;O96006;2.30E-11;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp4818303_c0_seq1;GAXK01038760.1;Q8CDK2;1.29E-58;CBPC2_MOUSE;Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005814; GO:0005829; GO:0008270; GO:0035610; GO:0036064";protein side chain deglutamylation [GO:0035610];"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp48189_c4_seq1;GAXK01094397.1;Q9Y210;1.64E-16;TRPC6_HUMAN;Short transient receptor potential channel 6 (TrpC6) (Transient receptor protein 6) (TRP-6);"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; cation channel activity [GO:0005261]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; aging [GO:0007568]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; platelet activation [GO:0030168]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0003779; GO:0005261; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006828; GO:0007204; GO:0007338; GO:0007568; GO:0010800; GO:0015279; GO:0016020; GO:0030168; GO:0030182; GO:0030276; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0042805; GO:0045666; GO:0050774; GO:0051117; GO:0051480; GO:0051928; GO:0070301; GO:0070588; GO:0070679; GO:0071456";"aging [GO:0007568]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron differentiation [GO:0030182]; platelet activation [GO:0030168]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; cation channel activity [GO:0005261]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]"
comp481914_c0_seq1;GAXK01143920.1;P53753;2.37E-09;ENG1_YEAST;Endo-1,3(4)-beta-glucanase 1 (Endo-1,3-beta-glucanase 1) (Endo-1,4-beta-glucanase 1) (EC 3.2.1.6) (Daughter specific expression protein 4) (Laminarinase-1);"cell septum [GO:0030428]; cell surface [GO:0009986]; cellular bud neck [GO:0005935]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; glucan endo-1,3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920]";"GO:0000920; GO:0005576; GO:0005935; GO:0008152; GO:0009277; GO:0009986; GO:0030428; GO:0042973; GO:0052861; GO:0052862";"metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920]";"cell septum [GO:0030428]; cell surface [GO:0009986]; cellular bud neck [GO:0005935]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]";"glucan endo-1,3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]"
comp481956_c0_seq1;GAXK01143889.1;Q24491;2.64E-10;RX21_DROME;RNA-binding protein Rsf1 (RNA-binding protein Rox21);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0010468; GO:0016607; GO:0031440; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp4819707_c0_seq1;GAXK01038768.1;Q0IHH9;4.29E-11;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp4821125_c0_seq1;GAXK01075387.1;Q8CTX6;8.54E-68;PFLB_STAES;Formate acetyltransferase (EC 2.3.1.54) (Pyruvate formate-lyase);"cytoplasm [GO:0005737]; formate C-acetyltransferase activity [GO:0008861]; glucose metabolic process [GO:0006006]";"GO:0005737; GO:0006006; GO:0008861";glucose metabolic process [GO:0006006];cytoplasm [GO:0005737];formate C-acetyltransferase activity [GO:0008861]
comp48213_c0_seq1;GAXK01094636.1;P86854;1.47E-15;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp482259_c0_seq1;GAXK01154184.1;O36966;5.86E-25;POLN_DCVEB;"Replicase polyprotein [Cleaved into: Protein 1A; Protein 2A; Protein 2B; Protein 2C; Protein 3A; Protein 3B; 3C-like protease (EC 3.4.22.-); RNA-directed RNA polymerase 3D-POL (EC 2.7.7.48)]";"ATP binding [GO:0005524]; cysteine-type peptidase activity [GO:0008234]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; transcription, DNA-templated [GO:0006351]; viral RNA genome replication [GO:0039694]";"GO:0003723; GO:0003724; GO:0003968; GO:0005524; GO:0006351; GO:0008234; GO:0039694";"transcription, DNA-templated [GO:0006351]; viral RNA genome replication [GO:0039694]";;"ATP binding [GO:0005524]; cysteine-type peptidase activity [GO:0008234]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; RNA helicase activity [GO:0003724]"
comp4823654_c0_seq1;GAXK01185178.1;P13360;2.33E-18;GLAS_DROME;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";"GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086";"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp48238_c1_seq1;GAXK01093895.1;Q9W5U2;1.10E-36;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp482424_c0_seq1;GAXK01154156.1;P21213;1.03E-10;HUTH_RAT;Histidine ammonia-lyase (Histidase) (EC 4.3.1.3);"cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547]";"GO:0004397; GO:0005829; GO:0006547; GO:0006548; GO:0019556; GO:0019557";"histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547]";cytosol [GO:0005829];histidine ammonia-lyase activity [GO:0004397]
comp4824272_c0_seq1;GAXK01000720.1;A7MBJ2;2.67E-09;SENP7_BOVIN;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp48244_c0_seq1;GAXK01093796.1;B3NGA1;3.49E-76;SHEP_DROER;Protein alan shepard;"ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; response to gravity [GO:0009629]";"GO:0003723; GO:0009629; GO:1990904";response to gravity [GO:0009629];ribonucleoprotein complex [GO:1990904];RNA binding [GO:0003723]
comp48248_c0_seq1;GAXK01093879.1;P0DQC6;9.40E-07;TXG3A_ETHRU;U-scoloptoxin(16)-Er3a (U-SLPTX(16)-Er3a);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp482489_c0_seq1;GAXK01154194.1;P36178;3.47E-46;CTRB2_PENVA;Chymotrypsin BII (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp48251_c0_seq1;GAXK01094185.1;Q9V3X4;7.21E-20;BSCL2_DROME;Seipin;"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; diacylglycerol metabolic process [GO:0046339]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; fatty acid beta-oxidation [GO:0006635]; lipid biosynthetic process [GO:0008610]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of lipid storage [GO:0010884]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid storage [GO:0010883]; regulation of triglyceride metabolic process [GO:0090207]; response to starvation [GO:0042594]";"GO:0005783; GO:0006635; GO:0008610; GO:0010883; GO:0010884; GO:0019915; GO:0030176; GO:0032469; GO:0034389; GO:0042594; GO:0046339; GO:0046473; GO:0046890; GO:0048691; GO:0090207";"diacylglycerol metabolic process [GO:0046339]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; fatty acid beta-oxidation [GO:0006635]; lipid biosynthetic process [GO:0008610]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of lipid storage [GO:0010884]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid storage [GO:0010883]; regulation of triglyceride metabolic process [GO:0090207]; response to starvation [GO:0042594]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp48261_c0_seq1;GAXK01094622.1;Q9BUQ8;0;DDX23_HUMAN;Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000354; GO:0000375; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0070062; GO:0071013";"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp4827517_c0_seq1;GAXK01159403.1;Q6NLQ8;1.96E-07;XB32_ARATH;E3 ubiquitin-protein ligase XBAT32 (EC 2.3.2.27) (Ankyrin repeat domain and RING finger-containing protein XBAT32) (Protein XB3 homolog 2) (RING-type E3 ubiquitin transferase XBAT32);"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to auxin [GO:0009733]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0006511; GO:0009733; GO:0010311; GO:0010366; GO:0016567; GO:0046872; GO:0051865";"lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to auxin [GO:0009733]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp48278_c0_seq1;GAXK01094677.1;Q8NEG7;7.06E-158;DEN6B_HUMAN;Protein DENND6B (DENN domain-containing protein 6B);"cytosol [GO:0005829]; recycling endosome [GO:0055037]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]";"GO:0005829; GO:0017112; GO:0055037";;"cytosol [GO:0005829]; recycling endosome [GO:0055037]";Rab guanyl-nucleotide exchange factor activity [GO:0017112]
comp482789_c1_seq1;GAXK01154166.1;Q865C5;3.73E-16;UBIQ_CAMDR;Ubiquitin;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp48282_c2_seq1;GAXK01093888.1;Q3UJK4;0;GTPB2_MOUSE;GTP-binding protein 2 (GTP-binding-like protein 2);"intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0043231";translational elongation [GO:0006414];intracellular membrane-bounded organelle [GO:0043231];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp482822_c0_seq1;GAXK01154136.1;Q6P3S6;1.04E-86;FBX42_HUMAN;F-box only protein 42 (Just one F-box and Kelch domain-containing protein);;;;;
comp48284_c0_seq1;GAXK01093885.1;Q92614;4.71E-55;MY18A_HUMAN;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp4828823_c0_seq1;GAXK01069834.1;Q93560;2.02E-07;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp48289_c2_seq1;GAXK01093917.1;Q7KRI2;7.19E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp482938_c0_seq1;GAXK01154191.1;P69525;5.24E-44;TMPS9_MOUSE;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";"GO:0004252; GO:0005887; GO:0006508; GO:0008236; GO:0031639";"plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";integral component of plasma membrane [GO:0005887];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp482995_c1_seq1;GAXK01154200.1;Q9VDT6;9.44E-51;MRM2_DROME;rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (rRNA (uridine-2'-O)-methyltransferase);"mitochondrion [GO:0005739]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]";"GO:0005739; GO:0008650";;mitochondrion [GO:0005739];rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]
comp483_c0_seq1;GAXK01169419.1;Q5BJ68;3.39E-128;NB5R2_XENTR;NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2);"integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126]";"GO:0001878; GO:0004128; GO:0016021; GO:0016126; GO:0071949";"response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126]";integral component of membrane [GO:0016021];"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"
comp4830394_c0_seq1;GAXK01019067.1;Q80X44;6.65E-08;ZBT24_MOUSE;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Brain-specific protein 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4830555_c0_seq1;GAXK01019070.1;Q9P7V8;2.17E-66;MPCP_SCHPO;Probable mitochondrial phosphate carrier protein;"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005739; GO:0005743; GO:0031305; GO:0035435; GO:1990547";"mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";inorganic phosphate transmembrane transporter activity [GO:0005315]
comp483062_c0_seq1;GAXK01154180.1;P0C599;5.33E-34;DUPD1_TAKRU;Dual specificity phosphatase DUPD1 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp48310_c1_seq1;GAXK01094199.1;Q562A2;7.06E-62;ZFR_RAT;Zinc finger RNA-binding protein;"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]"
comp4831834_c0_seq1;GAXK01019075.1;P36889;1.53E-97;SAHH_LEIDO;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0005737; GO:0006730";one-carbon metabolic process [GO:0006730];cytoplasm [GO:0005737];adenosylhomocysteinase activity [GO:0004013]
comp4831852_c0_seq1;GAXK01019079.1;P92519;1.69E-07;M810_ARATH;Uncharacterized mitochondrial protein AtMg00810 (ORF240b);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp4832_c0_seq1;GAXK01067186.1;P52162;1.99E-28;MAX_CHICK;Protein max (Myc-associated factor X);"MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0001227; GO:0003700; GO:0005634; GO:0032993; GO:0042803; GO:0045944; GO:0070888; GO:0071339; GO:0090575";positive regulation of transcription by RNA polymerase II [GO:0045944];"MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]"
comp483202_c0_seq1;GAXK01154137.1;P34334;4.51E-53;RL21_CAEEL;60S ribosomal protein L21;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp4832181_c0_seq1;GAXK01056999.1;Q93560;1.06E-09;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp483243_c0_seq1;GAXK01154179.1;Q7KRI2;1.68E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp48329_c0_seq1;GAXK01094548.1;Q28J24;3.84E-64;TAF8_XENTR;Transcription initiation factor TFIID subunit 8 (TBP-associated factor 8);"cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005669; GO:0005737; GO:0007275; GO:0030154; GO:0046982";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]";protein heterodimerization activity [GO:0046982]
comp4833_c2_seq1;GAXK01066664.1;Q6DIQ3;6.44E-88;PP1R7_XENTR;Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp4833264_c0_seq1;GAXK01057003.1;A9NUH8;2.10E-40;METK1_PICSI;S-adenosylmethionine synthase 1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp4833307_c0_seq1;GAXK01057005.1;P50430;2.43E-22;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp4833540_c0_seq1;GAXK01057001.1;Q80SU7;8.28E-36;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp4834278_c0_seq1;GAXK01180581.1;Q9ERK0;3.34E-08;RIPK4_MOUSE;Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase);"cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]";"GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092";"morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp4835494_c0_seq1;GAXK01180584.1;Q96SQ5;3.13E-11;ZN587_HUMAN;Zinc finger protein 587;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4836900_c0_seq1;GAXK01104534.1;Q9XGL4;2.71E-54;RL31_CYAPA;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4837403_c0_seq1;GAXK01104536.1;Q22DH9;2.13E-15;RL31_TETTS;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4837475_c0_seq1;GAXK01104520.1;P34092;8.53E-17;MYOB_DICDI;Myosin IB heavy chain;"actin-based cell projection [GO:0098858]; actomyosin [GO:0042641]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; leading edge of lamellipodium [GO:0061851]; phagocytic cup lip [GO:0097203]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin I head/neck binding [GO:0032031]; actin cytoskeleton organization [GO:0030036]; actin-myosin filament sliding [GO:0033275]; cell motility [GO:0048870]; chemotaxis to cAMP [GO:0043327]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; filopodium assembly [GO:0046847]; negative regulation of lateral pseudopodium assembly [GO:0031276]; phagocytosis [GO:0006909]; phagosome reneutralization [GO:0044655]; pinocytosis [GO:0006907]; regulation of post-lysosomal vacuole size [GO:0044656]; response to differentiation-inducing factor 1 [GO:1903013]; response to other organism [GO:0051707]";"GO:0000146; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0006907; GO:0006909; GO:0016197; GO:0016461; GO:0030036; GO:0030175; GO:0030670; GO:0030898; GO:0031143; GO:0031252; GO:0031276; GO:0032031; GO:0033275; GO:0042641; GO:0043327; GO:0044291; GO:0044655; GO:0044656; GO:0045335; GO:0046847; GO:0048870; GO:0051015; GO:0051707; GO:0061851; GO:0097203; GO:0098858; GO:1903013";"actin cytoskeleton organization [GO:0030036]; actin-myosin filament sliding [GO:0033275]; cell motility [GO:0048870]; chemotaxis to cAMP [GO:0043327]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; filopodium assembly [GO:0046847]; negative regulation of lateral pseudopodium assembly [GO:0031276]; phagocytosis [GO:0006909]; phagosome reneutralization [GO:0044655]; pinocytosis [GO:0006907]; regulation of post-lysosomal vacuole size [GO:0044656]; response to differentiation-inducing factor 1 [GO:1903013]; response to other organism [GO:0051707]";"actin-based cell projection [GO:0098858]; actomyosin [GO:0042641]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; leading edge of lamellipodium [GO:0061851]; phagocytic cup lip [GO:0097203]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; unconventional myosin complex [GO:0016461]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin I head/neck binding [GO:0032031]"
comp48375_c1_seq1;GAXK01094619.1;Q8N7Z5;8.70E-12;ANR31_HUMAN;Ankyrin repeat domain-containing protein 31;"chromatin [GO:0000785]; nucleus [GO:0005634]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]; synapsis [GO:0007129]";"GO:0000785; GO:0005634; GO:0007129; GO:0010780; GO:1903343";"meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]; synapsis [GO:0007129]";"chromatin [GO:0000785]; nucleus [GO:0005634]";
comp483766_c2_seq1;GAXK01154134.1;Q8L765;2.12E-10;BPM1_ARATH;BTB/POZ and MATH domain-containing protein 1 (Protein BTB-POZ AND MATH DOMAIN 1) (AtBPM1);"nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0006970; GO:0016567; GO:0042631; GO:0042802; GO:0071472";"cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];identical protein binding [GO:0042802]
comp48382_c0_seq1;GAXK01094181.1;Q07139;4.05E-129;ECT2_MOUSE;Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0015031; GO:0017048; GO:0030496; GO:0032147; GO:0032154; GO:0032467; GO:0035023; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043547; GO:0045666; GO:0045859; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431";"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp483874_c0_seq1;GAXK01154148.1;P23901;4.91E-46;ALDR_HORVU;Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase);alditol:NADP+ 1-oxidoreductase activity [GO:0004032];GO:0004032;;;alditol:NADP+ 1-oxidoreductase activity [GO:0004032]
comp48388_c2_seq1;GAXK01094184.1;Q9TTV2;5.07E-29;ROA2_SAGOE;Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1) (Vitamin D response element-binding protein 2) (VDRE-BP 2);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006406; GO:0031053; GO:0035198; GO:0043047; GO:0070062; GO:1990247; GO:1990428; GO:1990904";"miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]"
comp4838983_c0_seq1;GAXK01105935.1;Q24732;2.41E-11;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4839373_c0_seq1;GAXK01105945.1;Q9VL18;8.38E-10;EF1D_DROME;Probable elongation factor 1-delta (EF-1-delta);"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414";translational elongation [GO:0006414];"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]";"guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]"
comp483953_c0_seq1;GAXK01204895.1;Q9NP58;1.64E-171;ABCB6_HUMAN;ATP-binding cassette sub-family B member 6, mitochondrial (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]; brain development [GO:0007420]; cellular iron ion homeostasis [GO:0006879]; heme transport [GO:0015886]; porphyrin-containing compound biosynthetic process [GO:0006779]; skin development [GO:0043588]; transmembrane transport [GO:0055085]";"GO:0000139; GO:0005524; GO:0005654; GO:0005739; GO:0005740; GO:0005741; GO:0005768; GO:0005774; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006779; GO:0006879; GO:0007420; GO:0010008; GO:0015439; GO:0015562; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0031307; GO:0042626; GO:0043190; GO:0043588; GO:0055085; GO:0070062";"brain development [GO:0007420]; cellular iron ion homeostasis [GO:0006879]; heme transport [GO:0015886]; porphyrin-containing compound biosynthetic process [GO:0006779]; skin development [GO:0043588]; transmembrane transport [GO:0055085]";"ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]"
comp484_c0_seq1;GAXK01169783.1;P62145;2.27E-98;CALM_APLCA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp48412_c4_seq1;GAXK01093999.1;Q15120;3.75E-69;PDK3_HUMAN;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp4842069_c0_seq1;GAXK01114039.1;P52208;2.40E-53;6PGD_SYNY3;6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);"cytosol [GO:0005829]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate catabolic process [GO:0046177]; pentose-phosphate shunt, oxidative branch [GO:0009051]";"GO:0004616; GO:0005829; GO:0009051; GO:0046177; GO:0050661";"D-gluconate catabolic process [GO:0046177]; pentose-phosphate shunt, oxidative branch [GO:0009051]";cytosol [GO:0005829];"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]"
comp4842847_c0_seq1;GAXK01114047.1;Q93560;1.89E-13;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp48434_c0_seq1;GAXK01094659.1;Q7QCJ9;2.55E-73;MED27_ANOGA;Mediator of RNA polymerase II transcription subunit 27 (Mediator complex subunit 27);mediator complex [GO:0016592];GO:0016592;;mediator complex [GO:0016592];
comp48438_c0_seq1;GAXK01094607.1;Q5EA11;1.10E-76;TTC4_BOVIN;Tetratricopeptide repeat protein 4 (TPR repeat protein 4);;;;;
comp48439_c0_seq1;GAXK01094751.1;Q52KD8;2.50E-43;EAF6_XENLA;Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog);"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"GO:0000776; GO:0000777; GO:0005730; GO:0035267; GO:0043968; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776";"histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]";
comp4843982_c0_seq1;GAXK01114042.1;Q7Z2Y8;1.89E-11;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp4844251_c0_seq1;GAXK01000852.1;O93233;6.98E-10;PLIB_GLOBS;Phospholipase A2 inhibitor (beta-PLI);phospholipase A2 inhibitor activity [GO:0019834];GO:0019834;;;phospholipase A2 inhibitor activity [GO:0019834]
comp4844363_c0_seq1;GAXK01000856.1;Q7PEV7;2.58E-21;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp484499_c0_seq1;GAXK01024396.1;P82120;1.19E-09;CUO7_BLACR;Cuticle protein 7 (BcNCP15.0);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp484512_c0_seq1;GAXK01024403.1;Q539E5;3.33E-23;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp484524_c0_seq1;GAXK01024325.1;Q9D110;1.77E-50;MTHFS_MOUSE;5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009396; GO:0030272; GO:0035999; GO:0046653; GO:0046872";"folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]"
comp4845327_c0_seq1;GAXK01000857.1;A8HYU5;1.72E-90;METK_CHLRE;S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp484638_c0_seq1;GAXK01024399.1;Q7Z269;9.00E-25;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp484648_c0_seq1;GAXK01024397.1;O61394;6.20E-164;GALT6_CAEEL;Probable N-acetylgalactosaminyltransferase 6 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005794; GO:0006486; GO:0016021; GO:0016757; GO:0030246; GO:0046872";protein glycosylation [GO:0006486];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp4847298_c0_seq1;GAXK01078016.1;P07898;5.23E-08;PGCA_CHICK;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp4847679_c0_seq1;GAXK01078022.1;P28494;6.50E-93;MA2A1_RAT;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp4848408_c0_seq1;GAXK01058426.1;Q7XJS0;8.65E-08;ASHR1_ARATH;Histone-lysine N-methyltransferase ASHR1 (EC 2.1.1.43) (ASH1-related protein 1) (Protein SET DOMAIN GROUP 37);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005694; GO:0018024; GO:0046872";;"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]"
comp4849_c1_seq1;GAXK01065414.1;Q5R440;9.18E-167;CALX_PONAB;Calnexin;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005509; GO:0005783; GO:0005789; GO:0006457; GO:0016021; GO:0030246; GO:0042470; GO:0048488; GO:0051082; GO:0072583; GO:0098793";"clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp48493_c3_seq1;GAXK01094130.1;Q8MRC9;1.63E-132;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp4849496_c0_seq1;GAXK01058424.1;P56826;4.82E-14;HCYG_SEPOF;Hemocyanin, units G and H (Fragments);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp4849875_c0_seq1;GAXK01058429.1;P69525;8.58E-09;TMPS9_MOUSE;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";"GO:0004252; GO:0005887; GO:0006508; GO:0008236; GO:0031639";"plasminogen activation [GO:0031639]; proteolysis [GO:0006508]";integral component of plasma membrane [GO:0005887];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp4850477_c0_seq1;GAXK01052374.1;P17970;4.26E-32;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4850534_c0_seq1;GAXK01052376.1;P42659;1.26E-07;DPP6_BOVIN;Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI);"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp48514_c0_seq1;GAXK01094657.1;P51545;1.45E-101;KARG_PENJP;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp4852_c0_seq1;GAXK01066898.1;P24367;1.96E-73;PPIB_CHICK;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"GO:0000413; GO:0003755; GO:0005788; GO:0016018; GO:0032991; GO:0042026; GO:0042470; GO:0051082; GO:0061077; GO:1904027";"chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp485231_c0_seq1;GAXK01024302.1;Q6VVW5;4.79E-48;ANPRB_MOUSE;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp4852451_c0_seq1;GAXK01163693.1;Q9ULJ7;2.91E-47;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp485293_c0_seq1;GAXK01024348.1;Q91V26;1.98E-56;SPHK1_RAT;Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-);"axon [GO:0030424]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to starvation [GO:0009267]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of cell migration [GO:0030335]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to amine [GO:0014075]; response to ATP [GO:0033198]; response to interleukin-1 [GO:0070555]; response to magnesium ion [GO:0032026]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; response to tumor necrosis factor [GO:0034612]; sphingosine metabolic process [GO:0006670]";"GO:0000287; GO:0001934; GO:0001956; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006670; GO:0007565; GO:0008021; GO:0008289; GO:0008481; GO:0009267; GO:0010803; GO:0010976; GO:0014070; GO:0014075; GO:0016407; GO:0017050; GO:0019371; GO:0030054; GO:0030100; GO:0030139; GO:0030335; GO:0030424; GO:0031398; GO:0031901; GO:0032026; GO:0032570; GO:0032740; GO:0033198; GO:0034612; GO:0035924; GO:0043005; GO:0043066; GO:0050764; GO:0051092; GO:0070301; GO:0070555; GO:0071363; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364";"cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to starvation [GO:0009267]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of cell migration [GO:0030335]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to amine [GO:0014075]; response to ATP [GO:0033198]; response to interleukin-1 [GO:0070555]; response to magnesium ion [GO:0032026]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; response to tumor necrosis factor [GO:0034612]; sphingosine metabolic process [GO:0006670]";"axon [GO:0030424]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]"
comp485331_c0_seq1;GAXK01024379.1;P86854;1.10E-21;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp485338_c0_seq1;GAXK01024326.1;Q5RA75;1.77E-108;F135A_PONAB;Protein FAM135A;;;;;
comp485360_c0_seq1;GAXK01024350.1;Q8IN81;1.39E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp4853682_c0_seq1;GAXK01163694.1;A5PKJ4;5.03E-18;MK07_BOVIN;Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of angiogenesis [GO:0045765]; regulation of gene expression [GO:0010468]";"GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0010468; GO:0016605; GO:0018105; GO:0030154; GO:0034115; GO:0035556; GO:0036003; GO:0045765; GO:0051019; GO:0051247; GO:0060761; GO:0070301; GO:0070885; GO:0071310; GO:0071499; GO:0071560; GO:1902176; GO:2000352; GO:2001240";"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of angiogenesis [GO:0045765]; regulation of gene expression [GO:0010468]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]";"ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]"
comp4854038_c0_seq1;GAXK01060666.1;Q92260;3.33E-44;HSP70_PENCI;Heat shock 70 kDa protein (allergen Pen c 19) (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp4854542_c0_seq1;GAXK01060664.1;O70405;2.04E-13;ULK1_MOUSE;Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Serine/threonine-protein kinase Unc51.1) (Unc-51-like kinase 1);"Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; cerebellar granule cell differentiation [GO:0021707]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; radial glia guided migration of cerebellar granule cell [GO:0021933]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of autophagy [GO:0010506]; regulation of cell death [GO:0010941]; regulation of gene expression [GO:0010468]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; response to mitochondrial depolarisation [GO:0098780]; response to starvation [GO:0042594]";"GO:0000045; GO:0000407; GO:0000423; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007265; GO:0007409; GO:0008104; GO:0010468; GO:0010506; GO:0010508; GO:0010941; GO:0016020; GO:0016236; GO:0017137; GO:0018105; GO:0018107; GO:0019901; GO:0021707; GO:0021933; GO:0030424; GO:0030659; GO:0031102; GO:0031175; GO:0031333; GO:0031623; GO:0031669; GO:0034045; GO:0034198; GO:0042594; GO:0042802; GO:0043005; GO:0043025; GO:0044877; GO:0046777; GO:0048671; GO:0048675; GO:0051020; GO:0051386; GO:0051879; GO:0075044; GO:0097629; GO:0097632; GO:0097635; GO:0098780; GO:1990316; GO:2000786";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; cerebellar granule cell differentiation [GO:0021707]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; radial glia guided migration of cerebellar granule cell [GO:0021933]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of autophagy [GO:0010506]; regulation of cell death [GO:0010941]; regulation of gene expression [GO:0010468]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; response to mitochondrial depolarisation [GO:0098780]; response to starvation [GO:0042594]";"Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]";"ATP binding [GO:0005524]; GTPase binding [GO:0051020]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; Rab GTPase binding [GO:0017137]"
comp48553_c0_seq1;GAXK01094212.1;Q5F3Z1;0;PYRG2_CHICK;CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2);"cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]";"GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0042802; GO:0044210; GO:0097268";"'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]";"cytoophidium [GO:0097268]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]"
comp48554_c0_seq1;GAXK01094344.1;G4RK44;1.76E-121;TPSP_THETK;"Bifunctional trehalose-6-phosphate synthase/phosphatase [Includes: Alpha,alpha-trehalose-phosphate synthase [UDP-forming] (EC 2.4.1.15) (Trehalose-6-phosphate synthase); Trehalose-6-phosphate phosphatase (EC 3.1.3.12)]";"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]; trehalose biosynthetic process [GO:0005992]";"GO:0003825; GO:0004805; GO:0005992; GO:0046872";trehalose biosynthetic process [GO:0005992];;"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]"
comp4855427_c0_seq1;GAXK01060676.1;Q885Q4;3.30E-21;TPMT_PSESM;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase);"cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; response to metal ion [GO:0010038]; response to tellurium ion [GO:0046690]";"GO:0005737; GO:0008119; GO:0010038; GO:0046690";"response to metal ion [GO:0010038]; response to tellurium ion [GO:0046690]";cytoplasm [GO:0005737];thiopurine S-methyltransferase activity [GO:0008119]
comp48559_c0_seq1;GAXK01094160.1;Q7Q6R1;2.43E-45;SNMP2_ANOGA;Sensory neuron membrane protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";"GO:0005886; GO:0007608; GO:0016021; GO:0050896";"response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4855983_c0_seq1;GAXK01060675.1;P10978;8.78E-12;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp48565_c0_seq1;GAXK01094462.1;Q8VDS4;1.34E-56;RPR1A_MOUSE;Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein);"RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]";"GO:0000993; GO:0016591; GO:0031124; GO:0042802; GO:0070940";"dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]";RNA polymerase II, holoenzyme [GO:0016591];"identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]"
comp48574_c2_seq1;GAXK01094176.1;Q5FVM7;9.73E-110;DJC16_RAT;DnaJ homolog subfamily C member 16;"cell [GO:0005623]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0016021; GO:0045454";cell redox homeostasis [GO:0045454];"cell [GO:0005623]; integral component of membrane [GO:0016021]";
comp4858113_c0_seq1;GAXK01034310.1;Q96QI5;3.98E-23;HS3S6_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) (h3-OST-6);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0001835; GO:0006024; GO:0008467; GO:0015012; GO:0016021; GO:0034483";"blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp48588_c0_seq1;GAXK01094207.1;Q5NVI3;1.98E-29;RED_PONAB;Protein Red (Cytokine IK) (IK factor);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]";"GO:0000278; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0034501; GO:0071005";"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]";
comp485912_c0_seq1;GAXK01024392.1;Q96FM1;3.61E-75;PGAP3_HUMAN;Post-GPI attachment to proteins factor 3 (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]";"GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227";"GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";hydrolase activity, acting on ester bonds [GO:0016788]
comp48593_c2_seq1;GAXK01094188.1;Q96IR2;1.64E-10;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4859500_c0_seq1;GAXK01034317.1;Q7T2X7;6.83E-11;BMP3_XENLA;Bone morphogenetic protein 3 (BMP-3) (xBMP-3);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0005125; GO:0005615; GO:0007275; GO:0008083; GO:0009653; GO:0016015";"anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]";extracellular space [GO:0005615];"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]"
comp485982_c2_seq1;GAXK01024314.1;Q94900;1.18E-92;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp4860150_c0_seq1;GAXK01090765.1;P26591;3.64E-14;GLRK_LYMST;Glutamate receptor;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]";"GO:0004970; GO:0016021; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";ionotropic glutamate receptor activity [GO:0004970]
comp4860153_c0_seq1;GAXK01090767.1;Q9N2R3;3.35E-24;TPM_CHAFE;Tropomyosin (Allergen Cha f I) (allergen Cha f 1) (Fragment);;;;;
comp4860468_c0_seq1;GAXK01090760.1;Q9UDX3;8.46E-08;S14L4_HUMAN;SEC14-like protein 4 (Tocopherol-associated protein 3);lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp4861955_c0_seq1;GAXK01090762.1;B2FQP3;6.20E-07;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp4862_c1_seq1;GAXK01067174.1;Q2L969;1.15E-95;MTX2_PIG;Metaxin-2 (Mitochondrial outer membrane import complex protein 2);"nucleolus [GO:0005730]; SAM complex [GO:0001401]; protein transport [GO:0015031]";"GO:0001401; GO:0005730; GO:0015031";protein transport [GO:0015031];"nucleolus [GO:0005730]; SAM complex [GO:0001401]";
comp486376_c1_seq1;GAXK01077237.1;Q7KRI2;2.65E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4864251_c0_seq1;GAXK01004445.1;A4IIF2;1.01E-21;S26A9_XENTR;Solute carrier family 26 member 9 (Anion transporter/exchanger protein 9);"integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]";"GO:0005254; GO:0005887; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531";;integral component of plasma membrane [GO:0005887];"anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp4864302_c0_seq1;GAXK01004429.1;Q08519;5.32E-12;SPI1_SWPVK;Probable serine proteinase inhibitor 1 (Serp-1) (Serpin-1);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp4865458_c0_seq1;GAXK01004444.1;Q9VAC5;4.10E-15;ADA17_DROME;ADAM 17-like protease (EC 3.4.24.-);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";"GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp4865484_c0_seq1;GAXK01004428.1;Q9CR40;1.45E-07;KLH28_MOUSE;Kelch-like protein 28 (BTB/POZ domain-containing protein 5);;;;;
comp486564_c4_seq1;GAXK01077146.1;P50429;6.18E-104;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp4866_c0_seq1;GAXK01066896.1;Q23551;9.94E-145;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp4866991_c0_seq1;GAXK01184079.1;Q13596;1.50E-10;SNX1_HUMAN;Sorting nexin-1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031623; GO:0031901; GO:0031982; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0043231; GO:0045296; GO:0045732; GO:0046982; GO:0072673; GO:1990459; GO:1990460";"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; vesicle [GO:0031982]";"cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]"
comp4867010_c0_seq1;GAXK01184092.1;P17970;3.15E-32;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp4867394_c0_seq1;GAXK01184078.1;P46023;1.31E-07;GR101_LYMST;G-protein coupled receptor GRL101;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp486777_c0_seq1;GAXK01077151.1;Q640U7;5.09E-120;CCD93_XENTR;Coiled-coil domain-containing protein 93;"early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]";"GO:0005769; GO:0006893; GO:0015031";"Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]";early endosome [GO:0005769];
comp48678_c1_seq1;GAXK01094662.1;O08746;9.63E-07;MATN2_MOUSE;Matrilin-2;"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678]";"GO:0001764; GO:0003429; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0062023";"axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp486782_c0_seq1;GAXK01077180.1;O46040;6.11E-39;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp48683_c1_seq1;GAXK01094171.1;P37759;3.34E-44;RMLB1_ECOLI;dTDP-glucose 4,6-dehydratase 1 (EC 4.2.1.46);"cytosol [GO:0005829]; coenzyme binding [GO:0050662]; dTDP-glucose 4,6-dehydratase activity [GO:0008460]; identical protein binding [GO:0042802]; dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; lipopolysaccharide biosynthetic process [GO:0009103]; nucleotide-sugar biosynthetic process [GO:0009226]; O antigen biosynthetic process [GO:0009243]";"GO:0005829; GO:0008460; GO:0009103; GO:0009226; GO:0009243; GO:0019305; GO:0042802; GO:0045226; GO:0050662";"dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; lipopolysaccharide biosynthetic process [GO:0009103]; nucleotide-sugar biosynthetic process [GO:0009226]; O antigen biosynthetic process [GO:0009243]";cytosol [GO:0005829];"coenzyme binding [GO:0050662]; dTDP-glucose 4,6-dehydratase activity [GO:0008460]; identical protein binding [GO:0042802]"
comp4868421_c0_seq1;GAXK01197808.1;Q700K0;1.46E-08;SSPO_RAT;SCO-spondin;"extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005615; GO:0007155; GO:0007399; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";extracellular space [GO:0005615];
comp4868722_c0_seq1;GAXK01197802.1;P30943;1.72E-40;PHE2_RHDS2;Phycoerythrin alpha-2 chain, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]; oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"GO:0009535; GO:0015979; GO:0018298; GO:0030089; GO:0055114";"oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]";
comp48690_c0_seq1;GAXK01094330.1;Q06985;6.65E-30;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp486904_c0_seq1;GAXK01077245.1;Q9BZE3;2.34E-19;BARH1_HUMAN;BarH-like 1 homeobox protein;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001764; GO:0005634; GO:0006357; GO:0007399; GO:0007605; GO:0009888; GO:0030901; GO:0043524; GO:0048513";"animal organ development [GO:0048513]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp48692_c0_seq1;GAXK01093775.1;Q6B9X6;8.94E-16;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp486954_c1_seq1;GAXK01077147.1;Q28658;1.19E-08;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp48697_c2_seq1;GAXK01094660.1;O43791;2.19E-45;SPOP_HUMAN;Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp487039_c0_seq1;GAXK01077243.1;Q86UP3;9.71E-70;ZFHX4_HUMAN;Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0008270; GO:0044212; GO:0045893";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp4870499_c0_seq1;GAXK01059425.1;Q49A33;2.84E-18;Z876P_HUMAN;Putative zinc finger protein 876;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4870929_c0_seq1;GAXK01059424.1;P05772;1.78E-32;KPCB_RABIT;Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of glucose transmembrane transport [GO:0010827]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0002250; GO:0003682; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0008270; GO:0010827; GO:0010829; GO:0016020; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092";"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of glucose transmembrane transport [GO:0010827]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]"
comp4871127_c0_seq1;GAXK01059432.1;P28996;4.17E-41;EF2_PARKE;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp487168_c0_seq1;GAXK01077177.1;P36609;7.34E-55;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4871842_c0_seq1;GAXK01059437.1;Q7PPU9;1.01E-34;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp487258_c0_seq1;GAXK01077223.1;Q866C5;1.90E-19;FUT1_PLEBR;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp4873178_c0_seq1;GAXK01098129.1;Q9SKT0;6.49E-14;THF1_ARATH;Protein THYLAKOID FORMATION 1, chloroplastic;"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast outer membrane [GO:0009707]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plastid inner membrane [GO:0009528]; plastid outer membrane [GO:0009527]; plastid stroma [GO:0009532]; stromule [GO:0010319]; chlorophyll catabolic process [GO:0015996]; photosystem II assembly [GO:0010207]; positive regulation of stomatal opening [GO:1902458]; protein import into chloroplast stroma [GO:0045037]; protein import into chloroplast thylakoid membrane [GO:0045038]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of response to water deprivation [GO:2000070]; sugar mediated signaling pathway [GO:0010182]; thylakoid membrane organization [GO:0010027]";"GO:0005739; GO:0009507; GO:0009527; GO:0009528; GO:0009532; GO:0009534; GO:0009535; GO:0009570; GO:0009707; GO:0009941; GO:0010027; GO:0010182; GO:0010207; GO:0010319; GO:0015996; GO:0016021; GO:0045037; GO:0045038; GO:1902458; GO:1903426; GO:2000070";"chlorophyll catabolic process [GO:0015996]; photosystem II assembly [GO:0010207]; positive regulation of stomatal opening [GO:1902458]; protein import into chloroplast stroma [GO:0045037]; protein import into chloroplast thylakoid membrane [GO:0045038]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of response to water deprivation [GO:2000070]; sugar mediated signaling pathway [GO:0010182]; thylakoid membrane organization [GO:0010027]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast outer membrane [GO:0009707]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plastid inner membrane [GO:0009528]; plastid outer membrane [GO:0009527]; plastid stroma [GO:0009532]; stromule [GO:0010319]";
comp4874893_c0_seq1;GAXK01008971.1;Q25479;1.81E-08;NKCL_MANSE;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter);"integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0006813; GO:0006814; GO:0015377; GO:0016021";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];cation:chloride symporter activity [GO:0015377]
comp48753_c0_seq1;GAXK01093909.1;Q6GVH4;1.29E-47;GGNB2_CHICK;Gametogenetin-binding protein 2 (Protein ZNF403);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp487642_c0_seq1;GAXK01077133.1;Q7KRI2;7.67E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp48772_c0_seq1;GAXK01094224.1;Q28XY0;1.71E-65;FL2D_DROPS;Pre-mRNA-splicing regulator female-lethal(2)D;"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]";"GO:0000375; GO:0000381; GO:0005634; GO:0006397; GO:0007530; GO:0007548; GO:0030154; GO:0036396; GO:0048749; GO:0070868; GO:0080009";"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]";"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";
comp48777_c0_seq1;GAXK01094664.1;Q16K67;4.52E-87;MED16_AEDAE;Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16);mediator complex [GO:0016592];GO:0016592;;mediator complex [GO:0016592];
comp487797_c1_seq1;GAXK01077170.1;Q8TC21;1.27E-09;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4878052_c0_seq1;GAXK01025893.1;P38935;7.86E-26;SMBP2_HUMAN;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2);"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homooligomerization [GO:0051260]; translation [GO:0006412]";"GO:0000049; GO:0000122; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0016020; GO:0030424; GO:0030426; GO:0032574; GO:0043022; GO:0043139; GO:0051260; GO:1990904";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homooligomerization [GO:0051260]; translation [GO:0006412]";"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp487820_c0_seq1;GAXK01077220.1;Q9NAS5;5.65E-39;TPM_ANISI;Tropomyosin (allergen Ani s 3);;;;;
comp487834_c1_seq1;GAXK01077152.1;P52746;6.10E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4881_c0_seq1;GAXK01065846.1;Q60648;4.07E-07;SAP3_MOUSE;Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]";"GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345";"ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]";"beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]"
comp4881272_c0_seq1;GAXK01004476.1;Q6ZR08;1.13E-87;DYH12_HUMAN;Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0030286";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp48814_c1_seq1;GAXK01093795.1;Q7TPD2;4.16E-25;F185A_MOUSE;Protein FAM185A;cytosol [GO:0005829];GO:0005829;;cytosol [GO:0005829];
comp488148_c1_seq1;GAXK01078903.1;Q6DHN0;7.74E-11;TMM53_DANRE;Transmembrane protein 53;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp488165_c0_seq1;GAXK01078919.1;P18117;2.41E-30;THBA_XENLA;Thyroid hormone receptor beta-A (TRbetaA) (xTR) (Nuclear receptor subfamily 1 group A member 2-A);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0070324";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp4881765_c0_seq1;GAXK01004468.1;P27046;5.69E-16;MA2A1_MOUSE;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005794; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0015923; GO:0016021; GO:0016787; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp488220_c0_seq1;GAXK01078787.1;Q96IR2;2.35E-51;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp488239_c0_seq1;GAXK01078797.1;P18489;8.04E-13;SYB_DROME;Synaptobrevin;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNAP receptor activity [GO:0005484]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081]; vesicle-mediated transport [GO:0016192]";"GO:0005484; GO:0005886; GO:0007269; GO:0008021; GO:0016021; GO:0016081; GO:0016192; GO:0030054; GO:0030672; GO:0043005";"neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";SNAP receptor activity [GO:0005484]
comp48825_c0_seq1;GAXK01094665.1;Q0P5A1;8.28E-14;DCTN3_BOVIN;Dynactin subunit 3;"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017]";"GO:0000777; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0032154; GO:0048471; GO:0061640";"cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]";
comp48833_c4_seq1;GAXK01094523.1;Q9UQQ1;1.37E-131;NALDL_HUMAN;Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004180; GO:0005509; GO:0008233; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171";peptide catabolic process [GO:0043171];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
comp4883489_c0_seq1;GAXK01156006.1;P21671;1.03E-17;PLCD4_BOVIN;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (PLC-85) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-2) (PLC-delta-2) (Phospholipase C-delta-4) (PLC-delta-4);"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0007340; GO:0016020; GO:0016042; GO:0032959; GO:0035556; GO:0046488";"acrosome reaction [GO:0007340]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp4884_c1_seq1;GAXK01065848.1;P25782;1.38E-44;CYSP2_HOMAM;Digestive cysteine proteinase 2 (EC 3.4.22.-);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp4884471_c0_seq1;GAXK01062024.1;P30974;4.05E-42;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp48845_c0_seq1;GAXK01094202.1;Q9PTJ6;1.67E-101;CTDSL_CHICK;CTD small phosphatase-like protein (CTDSP-like) (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 1) (NLI-interacting factor 1) (Small C-terminal domain phosphatase 3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001933; GO:0004721; GO:0005634; GO:0006357; GO:0008420; GO:0046872; GO:2000134";"negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]"
comp488462_c0_seq1;GAXK01078922.1;Q9D6K9;1.00E-81;CERS5_MOUSE;Ceramide synthase 5 (CerS5) (EC 2.3.1.-) (LAG1 longevity assurance homolog 5) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 4) (TRAM homolog 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0050291";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]"
comp48854_c0_seq1;GAXK01094239.1;Q9H1I8;3.47E-37;ASCC2_HUMAN;Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100);"activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005654; GO:0006307; GO:0006355; GO:0016607; GO:0043130; GO:0099053";"DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription, DNA-templated [GO:0006355]";"activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";ubiquitin binding [GO:0043130]
comp48858_c0_seq1;GAXK01094678.1;Q3KRE6;3.05E-62;KLDC2_RAT;Kelch domain-containing protein 2;"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"GO:0005634; GO:0016604; GO:0031965";;"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";
comp488614_c1_seq1;GAXK01078810.1;Q0IHH9;7.32E-20;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp4886715_c0_seq1;GAXK01090890.1;A2A935;1.63E-08;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp4886720_c0_seq1;GAXK01090901.1;P90519;6.79E-27;EF1A_CRYPV;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp48872_c4_seq1;GAXK01094626.1;Q9XW13;3.16E-07;MXT_CAEEL;Eukaryotic translation initiation factor 4E-binding protein Mextli homolog;"cytoplasm [GO:0005737]; RNA cap binding complex [GO:0034518]; eukaryotic initiation factor 4E binding [GO:0008190]; translation initiation factor activity [GO:0003743]; positive regulation of translation [GO:0045727]; regulation of formation of translation initiation ternary complex [GO:1901190]";"GO:0003743; GO:0005737; GO:0008190; GO:0034518; GO:0045727; GO:1901190";"positive regulation of translation [GO:0045727]; regulation of formation of translation initiation ternary complex [GO:1901190]";"cytoplasm [GO:0005737]; RNA cap binding complex [GO:0034518]";"eukaryotic initiation factor 4E binding [GO:0008190]; translation initiation factor activity [GO:0003743]"
comp4887592_c0_seq1;GAXK01090877.1;Q8T880;4.04E-14;AXP83_CIOIN;Axonemal 84 kDa protein (Ci-AXP83.9) (p83.9);;;;;
comp4887972_c0_seq1;GAXK01090898.1;Q7PPU9;1.49E-20;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp4888253_c0_seq1;GAXK01137924.1;Q09575;5.27E-09;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp488843_c0_seq1;GAXK01078921.1;Q8TF32;6.17E-32;ZN431_HUMAN;Zinc finger protein 431;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0043433; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp488895_c1_seq1;GAXK01078929.1;P43693;2.95E-43;GATA6_CHICK;Transcription factor GATA-6 (GATA-binding factor 6);"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]; animal organ formation [GO:0048645]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; Clara cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; transcription by RNA polymerase II [GO:0006366]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]";"GO:0000122; GO:0000978; GO:0000981; GO:0001103; GO:0001889; GO:0003148; GO:0003309; GO:0003310; GO:0003682; GO:0005634; GO:0005667; GO:0006366; GO:0006644; GO:0007493; GO:0008270; GO:0008584; GO:0014898; GO:0019901; GO:0030855; GO:0031965; GO:0032911; GO:0032912; GO:0035239; GO:0042493; GO:0043066; GO:0043627; GO:0045766; GO:0045893; GO:0045944; GO:0048645; GO:0051891; GO:0055007; GO:0060045; GO:0060430; GO:0060486; GO:0060510; GO:0060575; GO:0060947; GO:0071158; GO:0071371; GO:0071456; GO:0071773; GO:0110024";"animal organ formation [GO:0048645]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; Clara cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; transcription by RNA polymerase II [GO:0006366]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]";"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]"
comp48890_c0_seq1;GAXK01094681.1;P52899;4.11E-45;ODPA_CAEEL;Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096";"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]
comp4889501_c0_seq1;GAXK01137935.1;Q9ULJ7;7.45E-08;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp489_c2_seq1;GAXK01168564.1;A3KMV2;1.58E-79;RD23A_BOVIN;UV excision repair protein RAD23 homolog A;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]";"GO:0000502; GO:0003684; GO:0005654; GO:0005815; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043130; GO:0043161; GO:0045070; GO:0045787; GO:0070628; GO:1990381";"nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]";"damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381]"
comp489014_c0_seq1;GAXK01078890.1;P62749;1.14E-20;HPCL1_RAT;Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3);"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp4891078_c0_seq1;GAXK01069743.1;Q6DDT1;2.00E-24;INO1B_XENLA;Inositol-3-phosphate synthase 1-B (IPS 1-B) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase B) (MI-1-P synthase B) (MIP synthase B);"cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654]";"GO:0004512; GO:0005737; GO:0006021; GO:0008654";"inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654]";cytoplasm [GO:0005737];inositol-3-phosphate synthase activity [GO:0004512]
comp48914_c0_seq1;GAXK01094655.1;E9PVA8;0;GCN1_MOUSE;eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1);"cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]";"GO:0005829; GO:0005844; GO:0006417; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:1990253";"cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]";"cytosol [GO:0005829]; polysome [GO:0005844]";"protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]"
comp489152_c0_seq1;GAXK01078798.1;Q8BLK3;7.56E-08;LSAMP_MOUSE;Limbic system-associated membrane protein (LSAMP);"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]";"GO:0005829; GO:0005886; GO:0007155; GO:0031225; GO:0035641";"cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]";"anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp489158_c1_seq1;GAXK01078804.1;P98160;6.19E-09;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp4892061_c0_seq1;GAXK01153870.1;G5EDN0;3.27E-11;ACC3_CAEEL;Acetylcholine-gated chloride channel subunit acc-3;"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp48921_c1_seq1;GAXK01093887.1;O43929;3.20E-109;ORC4_HUMAN;Origin recognition complex subunit 4;"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]";"GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006260; GO:0006270";"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]";"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]";"ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]"
comp48930_c1_seq1;GAXK01094109.1;P49760;4.54E-137;CLK2_HUMAN;Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2);"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]";"GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777";"negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]";"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp489375_c0_seq1;GAXK01078836.1;Q8WV28;4.80E-12;BLNK_HUMAN;B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa) (SLP-65);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0005068; GO:0005070; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006959; GO:0007169; GO:0030183; GO:0035556; GO:0036464";"B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]"
comp4893878_c0_seq1;GAXK01153856.1;P23098;1.95E-23;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp48943_c0_seq1;GAXK01094675.1;Q8WVL7;5.75E-07;ANR49_HUMAN;Ankyrin repeat domain-containing protein 49 (Fetal globin-inducing factor);"nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0007283; GO:0030154; GO:0045893";"cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];
comp4894366_c0_seq1;GAXK01056766.1;Q18297;5.51E-13;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp48944_c4_seq1;GAXK01093794.1;Q1LU93;9.85E-24;ABITM_DANRE;Protein Abitram (Actin-binding transcription modulator) (Protein Simiate);"dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489]";"GO:0016607; GO:0030027; GO:0030425; GO:0030426; GO:0030833; GO:0032433; GO:0048813; GO:0051489";"dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489]";"dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]";
comp4894458_c0_seq1;GAXK01056757.1;Q9W6Y0;1.56E-07;RS30_ORYLA;40S ribosomal protein S30;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp4894560_c0_seq1;GAXK01056762.1;Q9LXG1;3.58E-84;RS91_ARATH;40S ribosomal protein S9-1;"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0006412; GO:0009506; GO:0009507; GO:0009536; GO:0019843; GO:0022626; GO:0022627; GO:0042788; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp489481_c0_seq1;GAXK01078894.1;Q6FW67;3.55E-14;PEX6_CANGA;Peroxisomal biogenesis factor 6 (Peroxin-6);"cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein heterodimerization activity [GO:0046982]; fatty acid metabolic process [GO:0006631]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein targeting to peroxisome [GO:0006625]; protein unfolding [GO:0043335]; replicative cell aging [GO:0001302]";"GO:0001302; GO:0005524; GO:0005777; GO:0005829; GO:0006625; GO:0006631; GO:0016562; GO:0016887; GO:0043335; GO:0046982";"fatty acid metabolic process [GO:0006631]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein targeting to peroxisome [GO:0006625]; protein unfolding [GO:0043335]; replicative cell aging [GO:0001302]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]"
comp4894814_c0_seq1;GAXK01056758.1;Q2V419;2.00E-10;CKB12_ARATH;"Cyclin-dependent kinase B1-2 (CDKB1;2) (EC 2.7.11.22) (EC 2.7.11.23)";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; guard mother cell differentiation [GO:0010444]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA endoreduplication [GO:0032875]; regulation of stomatal complex patterning [GO:2000037]";"GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0008353; GO:0010444; GO:0032875; GO:0051726; GO:1902806; GO:2000037";"guard mother cell differentiation [GO:0010444]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA endoreduplication [GO:0032875]; regulation of stomatal complex patterning [GO:2000037]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp48954_c1_seq1;GAXK01094122.1;B0XN12;2.05E-62;EXGA_ASPFC;Probable glucan 1,3-beta-glucosidase A (EC 3.2.1.58) (Exo-1,3-beta-glucanase 1) (Exo-1,3-beta-glucanase A);"extracellular region [GO:0005576]; glucan exo-1,3-beta-glucosidase activity [GO:0004338]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004338; GO:0005576; GO:0046872; GO:0071555";"cell wall organization [GO:0071555]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"glucan exo-1,3-beta-glucosidase activity [GO:0004338]; metal ion binding [GO:0046872]"
comp4895607_c0_seq1;GAXK01056768.1;Q9WTW5;1.03E-33;S22A3_MOUSE;Solute carrier family 22 member 3 (Organic cation transporter 3);"integral component of plasma membrane [GO:0005887]; dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; dopamine transport [GO:0015872]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";"GO:0005330; GO:0005887; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0019534; GO:0032098; GO:0051608; GO:0051615";"dopamine transport [GO:0015872]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";integral component of plasma membrane [GO:0005887];"dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]"
comp48964_c0_seq1;GAXK01093894.1;P0DPW4;2.60E-08;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp489683_c0_seq1;GAXK01078927.1;O74467;1.08E-17;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp489693_c0_seq1;GAXK01078893.1;P08537;1.46E-74;TBA_XENLA;Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp48971_c0_seq1;GAXK01093797.1;Q02224;6.64E-98;CENPE_HUMAN;Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE);"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007275; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019886; GO:0030071; GO:0030496; GO:0043515; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0099606; GO:0099607; GO:1990023";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp48975_c6_seq1;GAXK01094458.1;A2BD66;1.45E-26;BRK1B_XENLA;Probable protein BRICK1-B;"cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]";"GO:0005856; GO:0007015; GO:0031209; GO:0044877";actin filament organization [GO:0007015];"cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]";protein-containing complex binding [GO:0044877]
comp4897707_c0_seq1;GAXK01141073.1;P21328;8.37E-07;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp4897720_c0_seq1;GAXK01141065.1;B2RRL2;1.01E-14;JERKL_MOUSE;Jerky protein homolog-like;"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp48978_c0_seq1;GAXK01094663.1;P52654;1.12E-10;TF2AA_DROME;"Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (dTFIIA-L) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p30 subunit); Transcription initiation factor IIA beta chain (TFIIA p20 subunit)]";"nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001094; GO:0005634; GO:0005672; GO:0006366; GO:0006367; GO:0017025";"transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]";"TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]"
comp48980_c0_seq1;GAXK01094329.1;Q8SPI0;3.32E-09;APOD_MACFA;Apolipoprotein D (Apo-D) (ApoD);"cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";cholesterol binding [GO:0015485]
comp48985_c6_seq1;GAXK01094244.1;Q5SWK7;1.40E-65;RN145_MOUSE;RING finger protein 145 (EC 2.3.2.27);"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]";"GO:0005783; GO:0005789; GO:0008270; GO:0012505; GO:0016021; GO:0061630";;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp4898587_c0_seq1;GAXK01193990.1;P23677;1.02E-28;IP3KA_HUMAN;Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A);"cytosol [GO:0005829]; dendritic spine [GO:0043197]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]";"GO:0004683; GO:0005516; GO:0005524; GO:0005829; GO:0006020; GO:0007165; GO:0008440; GO:0030036; GO:0032958; GO:0043197; GO:0043647; GO:0048167; GO:0048365; GO:0061003; GO:0097062";"actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; dendritic spine [GO:0043197]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; Rac GTPase binding [GO:0048365]"
comp4898676_c0_seq1;GAXK01193986.1;P11118;1.23E-45;CALM_EUGGR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp48987_c10_seq1;GAXK01094712.1;Q86T82;6.39E-12;UBP37_HUMAN;Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0036459; GO:0051301; GO:0071108";"cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp4899968_c0_seq1;GAXK01193984.1;Q641F3;6.53E-07;COLA1_XENLA;Collagen alpha-1(XXI) chain;"collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"GO:0005576; GO:0005581; GO:0005737";;"collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]";
comp49_c0_seq1;GAXK01166606.1;P29877;1.53E-90;COX2_PERAM;Cytochrome c oxidase subunit 2 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide II);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005507; GO:0005743; GO:0016021; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";"copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]"
comp4900_c0_seq1;GAXK01065995.1;A2V735;1.18E-15;TPM_CHIOP;Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic);protein homodimerization activity [GO:0042803];GO:0042803;;;protein homodimerization activity [GO:0042803]
comp49004_c0_seq1;GAXK01094477.1;Q02988;3.35E-09;LECA_PLEWA;Lectin;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp49005_c0_seq1;GAXK01094127.1;Q9P0S9;1.39E-11;TM14C_HUMAN;Transmembrane protein 14C;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]";"GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0070453";"erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp490088_c0_seq1;GAXK01116943.1;Q5VXM1;2.17E-18;CDCP2_HUMAN;CUB domain-containing protein 2;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp490178_c0_seq1;GAXK01116884.1;P15206;7.78E-67;CCNB_MARGL;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp49020_c0_seq1;GAXK01094279.1;Q71KT5;1.46E-49;ERG24_MOUSE;Delta(14)-sterol reductase TM7SF2 (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; organelle membrane [GO:0031090]; receptor complex [GO:0043235]; delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"GO:0005637; GO:0005783; GO:0005789; GO:0006695; GO:0016126; GO:0030176; GO:0031090; GO:0043231; GO:0043235; GO:0050613; GO:0050661";"cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; organelle membrane [GO:0031090]; receptor complex [GO:0043235]";"delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]"
comp490203_c0_seq1;GAXK01116902.1;Q01484;6.54E-20;ANK2_HUMAN;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp4905_c0_seq1;GAXK01066115.1;Q3SLM6;7.16E-07;RS11_THIDA;30S ribosomal protein S11;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp490620_c0_seq1;GAXK01116867.1;Q54Y32;9.05E-08;MPL3_DICDI;MAP kinase phosphatase with leucine-rich repeats protein 3 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]";"GO:0004725; GO:0005737; GO:0008138";;cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp4906383_c0_seq1;GAXK01117590.1;P70057;2.98E-53;KCNQ1_XENLA;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha xKvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009";"inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]"
comp4906978_c0_seq1;GAXK01117578.1;P16912;9.03E-33;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp490724_c0_seq1;GAXK01116890.1;Q7KRI2;5.76E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp490743_c1_seq1;GAXK01116951.1;B7Z6K7;1.80E-12;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4907791_c0_seq1;GAXK01117581.1;Q8BW94;1.55E-18;DYH3_MOUSE;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp490812_c0_seq1;GAXK01116995.1;Q8TD23;9.83E-36;ZN675_HUMAN;Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]";"GO:0000122; GO:0003677; GO:0005634; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678";"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp49086_c0_seq1;GAXK01094609.1;O46037;0;VINC_DROME;Vinculin;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"GO:0005198; GO:0005737; GO:0005925; GO:0007016; GO:0007155; GO:0015629; GO:0051015; GO:0098592";"cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]";"actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]"
comp490949_c0_seq1;GAXK01116886.1;P36609;4.63E-31;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4910108_c0_seq1;GAXK01185025.1;P23358;1.06E-70;RL12_RAT;60S ribosomal protein L12;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational elongation [GO:0045901]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0045901; GO:0070180";"positive regulation of translational elongation [GO:0045901]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp49105_c0_seq1;GAXK01094687.1;Q7ZWE3;1.04E-21;LARP7_DANRE;La-related protein 7 (La ribonucleoprotein domain family member 7);"nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396]";"GO:0003723; GO:0005654; GO:0006396; GO:0060043; GO:0061026; GO:1990904";"cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396]";"nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp491080_c2_seq1;GAXK01116904.1;Q08180;6.99E-96;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp4911372_c0_seq1;GAXK01185034.1;B3RPX6;1.73E-58;RSSA_TRIAD;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp4911547_c0_seq1;GAXK01185030.1;Q95V35;4.58E-46;RS3A_SPOFR;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp491210_c1_seq1;GAXK01117021.1;P35789;5.72E-28;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp491257_c0_seq1;GAXK01117012.1;Q5TZE1;2.84E-08;BTB6B_DANRE;BTB/POZ domain-containing protein 6-B;"cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp49126_c0_seq1;GAXK01094133.1;P12080;4.58E-175;ITA2_DROME;"Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]";"GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609";"apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]"
comp491289_c1_seq1;GAXK01117020.1;Q9BX70;1.81E-25;BTBD2_HUMAN;BTB/POZ domain-containing protein 2;"cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]";"GO:0000932; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; P-body [GO:0000932]";
comp4912958_c0_seq1;GAXK01145795.1;O95935;1.11E-28;TBX18_HUMAN;T-box transcription factor TBX18 (T-box protein 18);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell fate specification [GO:0001708]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; somitogenesis [GO:0001756]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001102; GO:0001227; GO:0001228; GO:0001708; GO:0001756; GO:0005634; GO:0016331; GO:0042803; GO:0045944; GO:0046982; GO:0060829; GO:0072001";"cell fate specification [GO:0001708]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; somitogenesis [GO:0001756]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp49145_c0_seq1;GAXK01094158.1;P36609;2.08E-30;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp4915150_c0_seq1;GAXK01189820.1;Q08890;1.14E-45;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp491520_c2_seq1;GAXK01116891.1;A0JPQ8;6.04E-88;ALKMO_RAT;Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]";"GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479";"ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]"
comp4915880_c0_seq1;GAXK01189826.1;F1QN74;7.41E-17;ZMY10_DANRE;Zinc finger MYND domain-containing protein 10;"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"GO:0005737; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505";"inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]";"apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]";metal ion binding [GO:0046872]
comp4916673_c0_seq1;GAXK01109036.1;Q80XI3;2.18E-13;IF4G3_MOUSE;Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";"GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903";"positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]";eukaryotic translation initiation factor 4F complex [GO:0016281];"mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]"
comp4917188_c0_seq1;GAXK01109034.1;Q9P2N4;1.93E-18;ATS9_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]";"GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671";"aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp491733_c0_seq1;GAXK01116896.1;O14672;1.23E-59;ADA10_HUMAN;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cell-cell signaling [GO:0007267]; cellular protein metabolic process [GO:0044267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; neutrophil degranulation [GO:0043312]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; post-translational protein modification [GO:0043687]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]";"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030307; GO:0030335; GO:0034205; GO:0034612; GO:0035333; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0043312; GO:0043687; GO:0044267; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0061001; GO:0070062; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945";"amyloid-beta formation [GO:0034205]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cellular protein metabolic process [GO:0044267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; neutrophil degranulation [GO:0043312]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]";"endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]"
comp4917370_c0_seq1;GAXK01109037.1;Q40832;3.16E-48;TBA2_PELFA;Tubulin alpha-2 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp4917461_c0_seq1;GAXK01109046.1;Q9BYN7;3.99E-09;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp49176_c0_seq1;GAXK01094549.1;P70470;3.44E-79;LYPA1_RAT;Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";"GO:0002084; GO:0004622; GO:0005737; GO:0006631; GO:0008474; GO:0052689";"fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]";cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp491771_c0_seq1;GAXK01116933.1;O88177;1.64E-46;PEX12_RAT;Peroxisome assembly protein 12 (Peroxin-12) (Peroxisome assembly factor 3) (PAF-3);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]";"GO:0004842; GO:0005777; GO:0005778; GO:0005779; GO:0006513; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:1990429";"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp491796_c0_seq1;GAXK01116944.1;Q8BG39;8.17E-24;SV2B_MOUSE;Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B);"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]";"GO:0001669; GO:0005887; GO:0006836; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030054; GO:0030285; GO:0030672; GO:0043005";"chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]";"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";transmembrane transporter activity [GO:0022857]
comp49190_c0_seq1;GAXK01094134.1;P51452;4.15E-42;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp4919066_c0_seq1;GAXK01117640.1;Q7Z5L0;5.22E-12;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp49192_c0_seq1;GAXK01094123.1;Q6DIR8;1.07E-17;PALD_XENTR;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp4919531_c0_seq1;GAXK01117641.1;Q94900;7.90E-41;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp49196_c1_seq1;GAXK01094334.1;Q9W032;2.97E-09;ECD_DROME;Protein ecdysoneless;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; snRNP binding [GO:0070990]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysone biosynthetic process [GO:0006697]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; Golgi organization [GO:0007030]; head involution [GO:0008258]; instar larval development [GO:0002168]; instar larval or pupal development [GO:0002165]; lymph gland development [GO:0048542]; Malpighian tubule morphogenesis [GO:0007443]; molting cycle, chitin-based cuticle [GO:0007591]; mRNA splicing, via spliceosome [GO:0000398]; mushroom body development [GO:0016319]; oogenesis [GO:0048477]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to symbiont [GO:0009608]";"GO:0000398; GO:0002165; GO:0002168; GO:0005634; GO:0005737; GO:0006697; GO:0007030; GO:0007281; GO:0007390; GO:0007443; GO:0007458; GO:0007591; GO:0008258; GO:0008362; GO:0009608; GO:0016319; GO:0048477; GO:0048542; GO:0070990; GO:1903220";"chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysone biosynthetic process [GO:0006697]; germ-band shortening [GO:0007390]; germ cell development [GO:0007281]; Golgi organization [GO:0007030]; head involution [GO:0008258]; instar larval development [GO:0002168]; instar larval or pupal development [GO:0002165]; lymph gland development [GO:0048542]; Malpighian tubule morphogenesis [GO:0007443]; molting cycle, chitin-based cuticle [GO:0007591]; mRNA splicing, via spliceosome [GO:0000398]; mushroom body development [GO:0016319]; oogenesis [GO:0048477]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to symbiont [GO:0009608]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";snRNP binding [GO:0070990]
comp491965_c0_seq1;GAXK01117003.1;Q6AYR9;1.39E-10;TSN1_RAT;Tetraspanin-1 (Tspan-1);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]";"GO:0005654; GO:0005765; GO:0005887; GO:0008283; GO:0016477; GO:0030054; GO:0031982; GO:0045807; GO:0048471; GO:0050821";"cell migration [GO:0016477]; cell population proliferation [GO:0008283]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]";
comp492069_c5_seq1;GAXK01007615.1;Q9ULH7;3.65E-27;MRTFB_HUMAN;Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2);"nucleus [GO:0005634]; cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]; muscle organ development [GO:0007517]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]";"GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145";"muscle organ development [GO:0007517]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]";nucleus [GO:0005634];"cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]"
comp4921254_c0_seq1;GAXK01057961.1;Q4WTN5;3.93E-17;BUR1_ASPFU;Serine/threonine-protein kinase bur1 (EC 2.7.11.22) (EC 2.7.11.23);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0006368; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0030332; GO:0032968; GO:0044212; GO:0045944; GO:0070816";"phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp4921710_c0_seq1;GAXK01057969.1;Q9NAS5;2.72E-26;TPM_ANISI;Tropomyosin (allergen Ani s 3);;;;;
comp4922378_c0_seq1;GAXK01088716.1;P60040;5.49E-10;RL72_ARATH;60S ribosomal protein L7-2;"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003729; GO:0003735; GO:0005618; GO:0005739; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0009507; GO:0022625; GO:0022626; GO:0042788";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp4922381_c0_seq1;GAXK01088706.1;Q9UFH2;1.37E-49;DYH17_HUMAN;Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein light chain 2, axonemal);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp49227_c0_seq1;GAXK01094273.1;Q8K3A0;4.94E-36;HSC20_MOUSE;"Iron-sulfur cluster co-chaperone protein HscB [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, mitochondrial (C-HSC20); Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"GO:0001671; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0097428";"[2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp492288_c0_seq1;GAXK01007707.1;P00765;8.45E-24;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp49229_c0_seq1;GAXK01093774.1;P0DPW5;3.72E-11;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp4924108_c0_seq1;GAXK01057580.1;Q9CZK6;3.41E-16;ANKS3_MOUSE;Ankyrin repeat and SAM domain-containing protein 3;;;;;
comp492468_c0_seq1;GAXK01007737.1;P16373;6.96E-15;ZFP59_MOUSE;Zinc finger protein 59 (Zfp-59) (Zinc finger protein Mfg-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp49249_c11_seq1;GAXK01094019.1;P30531;2.93E-148;SC6A1_HUMAN;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp492502_c0_seq1;GAXK01007604.1;P16233;8.46E-47;LIPP_HUMAN;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid digestion [GO:0044241]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; retinoid metabolic process [GO:0001523]";"GO:0001523; GO:0004806; GO:0005576; GO:0005615; GO:0006629; GO:0016042; GO:0016298; GO:0030299; GO:0044241; GO:0046872; GO:0061365";"intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid digestion [GO:0044241]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; retinoid metabolic process [GO:0001523]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp492604_c0_seq1;GAXK01007710.1;P05661;1.22E-19;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp492668_c0_seq1;GAXK01007735.1;Q9UQC9;1.14E-31;CLCA2_HUMAN;"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872";"cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp4927205_c0_seq1;GAXK01037249.1;Q9VZX1;7.47E-08;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp492863_c1_seq1;GAXK01007647.1;Q9UJU3;7.40E-26;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp492900_c1_seq1;GAXK01007649.1;Q9UL51;3.62E-138;HCN2_HUMAN;Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2);"HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]";"GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0007267; GO:0008076; GO:0030552; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0098719; GO:0098855; GO:1990573";"cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]";"HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]"
comp4929136_c0_seq1;GAXK01154700.1;P34501;3.26E-07;YMS5_CAEEL;Uncharacterized protein K03H1.5;cell-matrix adhesion [GO:0007160];GO:0007160;cell-matrix adhesion [GO:0007160];;
comp4929499_c0_seq1;GAXK01154699.1;P31319;9.25E-115;KAPR_APLCA;cAMP-dependent protein kinase regulatory subunit (N4 subunit of protein kinase A);"cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]";"GO:0005952; GO:0008603; GO:0030552";;cAMP-dependent protein kinase complex [GO:0005952];"cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp4930095_c0_seq1;GAXK01201546.1;Q9VMM6;5.83E-14;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp4930135_c0_seq1;GAXK01201557.1;Q684P5;3.24E-39;RPGP2_HUMAN;Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4);"centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0010977; GO:0031965; GO:0043005; GO:0048471; GO:0051056";"negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]";"centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp49309_c0_seq1;GAXK01094466.1;Q8IMP6;6.02E-16;SPT2_DROME;Protein SPT2 homolog;"nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0042393; GO:0043486";"histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]";nucleolus [GO:0005730];"DNA binding [GO:0003677]; histone binding [GO:0042393]"
comp4931810_c0_seq1;GAXK01201548.1;P48149;3.77E-80;RS15A_DROME;40S ribosomal protein S15Aa;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp4932193_c0_seq1;GAXK01012164.1;Q47944;3.39E-12;SDH_GLUOY;L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32);"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0016614; GO:0050660";;;"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp4933387_c0_seq1;GAXK01012167.1;Q6B9X6;2.38E-22;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp493347_c3_seq1;GAXK01007691.1;Q8UWA5;1.03E-56;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp4933531_c0_seq1;GAXK01012174.1;P18172;1.73E-25;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp4933924_c0_seq1;GAXK01012175.1;Q9GZV8;5.26E-08;PRD14_HUMAN;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4934444_c0_seq1;GAXK01174736.1;Q9NZR2;1.72E-23;LRP1B_HUMAN;Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT);"integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235";"protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]";"integral component of membrane [GO:0016021]; receptor complex [GO:0043235]";calcium ion binding [GO:0005509]
comp493456_c0_seq1;GAXK01007603.1;Q969F9;8.39E-19;HPS3_HUMAN;Hermansky-Pudlak syndrome 3 protein;"BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; organelle organization [GO:0006996]; pigmentation [GO:0043473]";"GO:0005737; GO:0006996; GO:0031084; GO:0043473";"organelle organization [GO:0006996]; pigmentation [GO:0043473]";"BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]";
comp49350_c2_seq1;GAXK01094168.1;P32865;0;GPRK1_DROME;G protein-coupled receptor kinase 1 (EC 2.7.11.16);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]";"GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007603; GO:0016060; GO:0035091; GO:0045880; GO:0050254";"metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]"
comp49358_c2_seq1;GAXK01094616.1;Q9VXK0;2.68E-67;NIPSN_DROME;Protein NipSnap;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp4936_c1_seq1;GAXK01065760.1;A8DYP0;0;OBSCN_DROME;Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89);"M band [GO:0031430]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]";"GO:0005089; GO:0005523; GO:0005524; GO:0006468; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0035023; GO:0036309; GO:0045214; GO:0046872";"adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]";"M band [GO:0031430]; sarcomere [GO:0030017]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; tropomyosin binding [GO:0005523]"
comp49361_c0_seq1;GAXK01094505.1;P42519;9.78E-17;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp4936261_c0_seq1;GAXK01192533.1;Q94504;1.39E-14;CYSP7_DICDI;Cysteine proteinase 7 (EC 3.4.22.-) (Proteinase 1);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]"
comp4936451_c0_seq1;GAXK01192535.1;Q99JT1;1.42E-16;GATB_MOUSE;Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp4936464_c0_seq1;GAXK01192525.1;Q9QZP2;1.07E-07;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp4936856_c0_seq1;GAXK01192545.1;Q5NKN4;1.23E-07;KRBBB_RAT;Killer cell lectin-like receptor subfamily B member 1B allele B (CD161 antigen-like family member B) (Immunoreceptor NKR-P1C) (Natural killer cell surface protein NKR-P1B allele WAG/PVG/BS) (Natural killer lymphocyte receptor P1B) (CD antigen CD161b);"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]";"GO:0016021; GO:0030246";;integral component of membrane [GO:0016021];carbohydrate binding [GO:0030246]
comp49372_c13_seq1;GAXK01094580.1;Q9C0D6;5.02E-70;FHDC1_HUMAN;FH2 domain-containing protein 1 (Inverted formin-1);"cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]";"GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005929; GO:0008017; GO:0043149; GO:0060271; GO:0090161";"cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]";"cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]"
comp49373_c0_seq1;GAXK01205431.1;O01382;2.43E-65;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp4938118_c0_seq1;GAXK01189212.1;P05932;9.46E-33;CALMB_ARBPU;Calmodulin-beta (Cam B) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4938314_c0_seq1;GAXK01189223.1;Q7KRI2;3.10E-12;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp49386_c1_seq1;GAXK01093878.1;Q8TB96;9.20E-85;TIP_HUMAN;T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";
comp493861_c0_seq1;GAXK01007689.1;Q5EA40;1.83E-121;BCAT2_BOVIN;Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42);"mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656";"leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";mitochondrion [GO:0005739];"branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]"
comp493936_c4_seq1;GAXK01007693.1;Q3TN34;1.32E-14;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp4939366_c0_seq1;GAXK01189220.1;P10401;6.56E-08;POLY_DROME;"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp49396_c0_seq1;GAXK01094204.1;Q9VHR6;2.55E-45;ATG13_DROME;Autophagy-related protein 13 homolog;"Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]";"GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0045850; GO:0060729; GO:1990316";"activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]";"Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]";"protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]"
comp49405_c0_seq1;GAXK01094438.1;Q0VDQ9;1.99E-13;FEZF1_MOUSE;Fez family zinc finger protein 1;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; telencephalon development [GO:0021537]";"GO:0000122; GO:0000978; GO:0001227; GO:0001764; GO:0005634; GO:0005829; GO:0007411; GO:0008285; GO:0021537; GO:0021772; GO:0021797; GO:0030900; GO:0043565; GO:0043697; GO:0044212; GO:0045666; GO:0045893; GO:0046872; GO:0050767";"axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; telencephalon development [GO:0021537]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp49407_c1_seq1;GAXK01094205.1;P34082;4.31E-158;FAS2_DROME;Fasciclin-2 (Fasciclin II) (FAS II);"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning [GO:0007612]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]";"GO:0001746; GO:0005737; GO:0005829; GO:0005886; GO:0007156; GO:0007411; GO:0007413; GO:0007528; GO:0007611; GO:0007612; GO:0007614; GO:0008038; GO:0008045; GO:0008355; GO:0008582; GO:0016021; GO:0016319; GO:0030424; GO:0031225; GO:0031594; GO:0035158; GO:0035159; GO:0036062; GO:0042059; GO:0042734; GO:0042995; GO:0043005; GO:0045211; GO:0048149; GO:0048167; GO:0048667; GO:0048786; GO:0048803; GO:0050803; GO:0050808; GO:0061174; GO:0070593; GO:0072499; GO:0072553; GO:0097482; GO:0098632; GO:1904800";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning [GO:0007612]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]";cell-cell adhesion mediator activity [GO:0098632]
comp4940908_c0_seq1;GAXK01193319.1;Q9XYN1;1.03E-18;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp4941765_c0_seq1;GAXK01193325.1;P62184;8.34E-22;CALM_RENRE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp494196_c1_seq1;GAXK01039356.1;Q91757;1.84E-62;GSK3B_XENLA;Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Xgsk-3 protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007399; GO:0016055; GO:0030154; GO:0045892; GO:0048511; GO:0050321; GO:0090090";"cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp4942663_c0_seq1;GAXK01052473.1;Q5R5M1;8.38E-14;PRDM4_PONAB;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005634; GO:0006366; GO:0008168; GO:0046872; GO:1990226";transcription by RNA polymerase II [GO:0006366];nucleus [GO:0005634];"DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp4942834_c0_seq1;GAXK01052476.1;Q6IVV8;1.27E-07;PKD2_DANRE;Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738";"atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp494298_c1_seq1;GAXK01039354.1;Q9VH19;1.37E-50;LMLN_DROME;Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin);"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0004222; GO:0005737; GO:0006338; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0031252; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:1902769";"brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]"
comp4943153_c0_seq1;GAXK01052471.1;Q7KRI2;2.13E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp494334_c0_seq1;GAXK01039248.1;Q5RFT1;2.14E-74;S35F6_PONAB;Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog);"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"GO:0005739; GO:0005765; GO:0008284; GO:0016021; GO:0022857; GO:1901029";"negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]";transmembrane transporter activity [GO:0022857]
comp4943823_c0_seq1;GAXK01052474.1;Q3U0J8;1.65E-34;TBD2B_MOUSE;TBC1 domain family member 2B;"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp4944_c0_seq1;GAXK01066731.1;Q66I79;4.28E-07;SELK_DANRE;Selenoprotein K (SelK);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein palmitoylation [GO:0018345]";"GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006816; GO:0016021; GO:0018345; GO:0032469";"calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein palmitoylation [GO:0018345]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp49449_c0_seq1;GAXK01094750.1;Q4R713;1.89E-100;CWC27_MACFA;Spliceosome-associated protein CWC27 homolog (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog) (PPIase CWC27);"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; U2-type precatalytic spliceosome [GO:0071005]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005654; GO:0006457; GO:0071005; GO:0071013";protein folding [GO:0006457];"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; U2-type precatalytic spliceosome [GO:0071005]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp49450_c0_seq1;GAXK01094350.1;O77503;0;AGO2_RABIT;Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer) (Fragment);"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000340; GO:0000932; GO:0005634; GO:0005844; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153; GO:1990904";"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"
comp49456_c0_seq1;GAXK01094348.1;Q7KRI2;3.53E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp4945882_c0_seq1;GAXK01197839.1;B7TB45;4.46E-21;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp4946_c1_seq1;GAXK01066216.1;Q9Y6V7;1.45E-123;DDX49_HUMAN;Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364";rRNA processing [GO:0006364];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp49467_c0_seq1;GAXK01094242.1;O44783;2.36E-15;SPY_DROME;Protein sprouty (Spry);"apical part of cell [GO:0045177]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; glial cell development [GO:0021782]; lamellocyte differentiation [GO:0035171]; muscle fiber development [GO:0048747]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of imaginal disc-derived wing vein specification [GO:0110109]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of torso signaling pathway [GO:0120177]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; regulation of compound eye photoreceptor development [GO:0045314]";"GO:0001745; GO:0005829; GO:0005886; GO:0007424; GO:0008069; GO:0009898; GO:0016318; GO:0021782; GO:0035171; GO:0040037; GO:0042059; GO:0043407; GO:0045177; GO:0045314; GO:0046580; GO:0048747; GO:0060446; GO:0070373; GO:0110109; GO:0120177";"branching involved in open tracheal system development [GO:0060446]; compound eye morphogenesis [GO:0001745]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; glial cell development [GO:0021782]; lamellocyte differentiation [GO:0035171]; muscle fiber development [GO:0048747]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of imaginal disc-derived wing vein specification [GO:0110109]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of torso signaling pathway [GO:0120177]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; regulation of compound eye photoreceptor development [GO:0045314]";"apical part of cell [GO:0045177]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp49470_c2_seq1;GAXK01094485.1;Q6P7W0;4.23E-28;SENP6_MOUSE;Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234";"protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp4947031_c0_seq1;GAXK01081917.1;Q68EK2;4.28E-28;CALRL_DANRE;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064";"angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcitonin receptor activity [GO:0004948]
comp494772_c0_seq1;GAXK01039265.1;Q5RC43;8.95E-15;RFA2_PONAB;Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2);"DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0010569; GO:0016605; GO:0034502; GO:2000001";"base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]";"DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]";"damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]"
comp4947884_c0_seq1;GAXK01081921.1;P86854;7.01E-10;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp4947989_c0_seq1;GAXK01081923.1;P41753;2.88E-49;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp4948942_c0_seq1;GAXK01016244.1;Q9BG99;1.32E-11;TREX1_BOVIN;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"GO:0003676; GO:0005634; GO:0005789; GO:0005829; GO:0006259; GO:0007049; GO:0008296; GO:0008408; GO:0008853; GO:0046872";"cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp4948996_c0_seq1;GAXK01016243.1;C0HKA4;1.37E-31;Y0031_DROME;Trypsin delta/gamma-like protein CG30031 (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0008236";proteolysis [GO:0006508];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp494916_c1_seq1;GAXK01039332.1;O43295;0;SRGP3_HUMAN;SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056";"negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]"
comp4949262_c0_seq1;GAXK01016251.1;P05084;2.05E-07;HUNB_DROME;Protein hunchback;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";"GO:0000122; GO:0000980; GO:0000981; GO:0003700; GO:0005634; GO:0007354; GO:0007400; GO:0007402; GO:0007419; GO:0007431; GO:0035289; GO:0035290; GO:0040034; GO:0043565; GO:0044324; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048699; GO:0050767; GO:2000177";"ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription involved in anterior/posterior axis specification [GO:0044324]; salivary gland development [GO:0007431]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp494972_c0_seq1;GAXK01039347.1;Q9HAZ2;9.43E-15;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp49500_c3_seq1;GAXK01094335.1;Q8L796;1.83E-20;PI5K2_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 2 (AtPIP5K2) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 2) (Diphosphoinositide kinase 2) (PtdIns(4)P-5-kinase 2);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";"GO:0003006; GO:0005524; GO:0005886; GO:0009958; GO:0010311; GO:0016308";"developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp4951022_c0_seq1;GAXK01115731.1;Q9UII5;4.28E-08;ZN107_HUMAN;Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4951310_c0_seq1;GAXK01115725.1;O74884;6.65E-13;RL24B_SCHPO;60S ribosomal protein L24-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0022625; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp495186_c0_seq1;GAXK01039342.1;Q54ZX8;3.34E-08;Y7331_DICDI;SET and MYND domain-containing protein DDB_G0277331 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp4952_c2_seq1;GAXK01066013.1;Q9VFS5;0;PP4R3_DROME;Serine/threonine-protein phosphatase 4 regulatory subunit 3 (PP4R3) (Protein falafel);"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]";"GO:0000775; GO:0005634; GO:0005737; GO:0006281; GO:0016020; GO:0030289; GO:0045175; GO:0055059";"asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]";"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]";
comp49520_c2_seq1;GAXK01094316.1;A3KP37;2.00E-102;NDUF5_DANRE;Arginine-hydroxylase NDUFAF5, mitochondrial (EC 1.-.-.-) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5) (EC 2.1.1.-);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961]";"GO:0005739; GO:0005743; GO:0008168; GO:0016491; GO:0030961; GO:0032981";"mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]"
comp49522_c2_seq1;GAXK01094653.1;Q80W14;6.44E-103;PR40B_MOUSE;Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C);"nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005685; GO:0016607; GO:0045292; GO:0071004";"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";RNA binding [GO:0003723]
comp4952551_c0_seq1;GAXK01023011.1;Q90473;4.97E-33;HSP7C_DANRE;Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; fin regeneration [GO:0031101]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to early endosome [GO:1902946]; protein refolding [GO:0042026]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0031101; GO:0034605; GO:0034620; GO:0040036; GO:0042026; GO:0042623; GO:0044183; GO:0048260; GO:0051082; GO:0051085; GO:0051787; GO:1902946";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; fin regeneration [GO:0031101]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to early endosome [GO:1902946]; protein refolding [GO:0042026]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp4952791_c0_seq1;GAXK01023022.1;Q27081;9.35E-07;CFB_TACTR;"Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]";"GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381";"hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp495316_c4_seq1;GAXK01039310.1;P34400;1.77E-54;MIG10_CAEEL;Abnormal cell migration protein 10;"filamentous actin [GO:0031941]; growth cone membrane [GO:0032584]; lamellipodium [GO:0030027]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; presynaptic cytosol [GO:0099523]; SH3 domain binding [GO:0017124]; axon regeneration [GO:0031103]; cell projection morphogenesis [GO:0048858]; lamellipodium assembly [GO:0030032]; locomotion [GO:0040011]; mesodermal cell migration [GO:0008078]; neuron migration [GO:0001764]; oviposition [GO:0018991]; presynapse assembly [GO:0099054]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vulval development [GO:0040025]";"GO:0001764; GO:0007165; GO:0008078; GO:0017124; GO:0018991; GO:0030027; GO:0030032; GO:0030334; GO:0031103; GO:0031941; GO:0032584; GO:0032809; GO:0040011; GO:0040025; GO:0043204; GO:0048858; GO:0099054; GO:0099523";"axon regeneration [GO:0031103]; cell projection morphogenesis [GO:0048858]; lamellipodium assembly [GO:0030032]; locomotion [GO:0040011]; mesodermal cell migration [GO:0008078]; neuron migration [GO:0001764]; oviposition [GO:0018991]; presynapse assembly [GO:0099054]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vulval development [GO:0040025]";"filamentous actin [GO:0031941]; growth cone membrane [GO:0032584]; lamellipodium [GO:0030027]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; presynaptic cytosol [GO:0099523]";SH3 domain binding [GO:0017124]
comp49537_c0_seq1;GAXK01094446.1;Q9CXF4;1.40E-117;TBC15_MOUSE;TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]";"GO:0005096; GO:0005576; GO:0005737; GO:0005739; GO:0006886; GO:0017137; GO:0043087; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp4953930_c0_seq1;GAXK01023006.1;Q86LG1;7.04E-09;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp4953944_c0_seq1;GAXK01023015.1;Q7TPB1;1.51E-57;TCPD_RAT;T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta);"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]";"GO:0002199; GO:0005524; GO:0005654; GO:0005813; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874";"binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]";"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp4954_c0_seq1;GAXK01065976.1;Q9VU02;2.93E-49;SMD1_DROME;Probable small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1);"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0030532; GO:0034715; GO:0034719; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]";RNA binding [GO:0003723]
comp495457_c0_seq1;GAXK01039316.1;P42282;2.90E-09;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp495492_c2_seq1;GAXK01039266.1;Q9Y2C2;1.25E-20;UST_HUMAN;Uronyl 2-sulfotransferase (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770";"dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp495654_c1_seq1;GAXK01039267.1;Q32KV0;3.09E-80;PGAM2_BOVIN;Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2);"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]";"GO:0004082; GO:0004619; GO:0006096; GO:0016787";glycolytic process [GO:0006096];;"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]"
comp4956724_c0_seq1;GAXK01187000.1;Q8K4G1;6.80E-16;LTBP4_MOUSE;Latent-transforming growth factor beta-binding protein 4 (LTBP-4);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; hormone secretion [GO:0046879]; regulation of proteolysis [GO:0030162]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0005509; GO:0005615; GO:0007179; GO:0030162; GO:0031012; GO:0046879; GO:0050431; GO:0062023";"hormone secretion [GO:0046879]; regulation of proteolysis [GO:0030162]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]"
comp49580_c2_seq1;GAXK01094520.1;Q5R733;6.03E-37;CPEB1_PONAB;Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]";"GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0030054; GO:0030425; GO:0032869; GO:0035925; GO:0045211; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:2000766";"cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp4959_c0_seq1;GAXK01065591.1;P0DKM0;5.98E-10;COA3_DROME;Cytochrome c oxidase assembly factor 3, mitochondrial (Coiled-coil domain-containing protein 56 homolog);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV assembly [GO:0008535]";"GO:0005739; GO:0005751; GO:0008535; GO:0016021";respiratory chain complex IV assembly [GO:0008535];"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";
comp4959708_c0_seq1;GAXK01021327.1;Q02427;1.44E-16;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp4959960_c0_seq1;GAXK01021323.1;A0JN92;1.62E-18;URGCP_BOVIN;Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein homolog) (HBxAg up-regulated gene 4 protein homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049]";"GO:0005525; GO:0005634; GO:0005737; GO:0007049";cell cycle [GO:0007049];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp496046_c0_seq1;GAXK01193687.1;Q90703;7.74E-42;NOS2_CHICK;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (Macrophage NOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0031284; GO:0032310; GO:0032496; GO:0042742; GO:0045776; GO:0046872; GO:0050660; GO:0050661; GO:0072604; GO:0072606; GO:1900015";"arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp496153_c0_seq1;GAXK01193655.1;Q01083;4.53E-11;SPITZ_DROME;Protein spitz;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; receptor ligand activity [GO:0048018]; behavioral response to ethanol [GO:0048149]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; ectodermal cell fate determination [GO:0001713]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; heart process [GO:0003015]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; oenocyte development [GO:0007438]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]";"GO:0000139; GO:0001713; GO:0003015; GO:0005154; GO:0005615; GO:0005783; GO:0005789; GO:0005886; GO:0007173; GO:0007391; GO:0007421; GO:0007422; GO:0007438; GO:0007476; GO:0008284; GO:0008355; GO:0010629; GO:0016021; GO:0016318; GO:0035225; GO:0035277; GO:0043066; GO:0043703; GO:0046530; GO:0048018; GO:0048149; GO:0048865; GO:0050769; GO:0061331; GO:0070374; GO:1903688";"behavioral response to ethanol [GO:0048149]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; ectodermal cell fate determination [GO:0001713]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; heart process [GO:0003015]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; oenocyte development [GO:0007438]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"epidermal growth factor receptor binding [GO:0005154]; receptor ligand activity [GO:0048018]"
comp49632_c0_seq1;GAXK01094439.1;Q9VCX3;4.24E-93;RM45_DROME;Probable 39S ribosomal protein L45, mitochondrial (L45mt) (MRP-L45);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005739; GO:0005762; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp49640_c1_seq1;GAXK01094515.1;Q8IN81;1.01E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp49662_c0_seq1;GAXK01204952.1;Q03013;8.53E-79;GSTM4_HUMAN;Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]";"GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171; GO:1901687";"glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]";"enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]"
comp496680_c0_seq1;GAXK01193603.1;P62749;5.30E-19;HPCL1_RAT;Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3);"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp49675_c9_seq1;GAXK01094145.1;P35440;1.21E-15;TSP2_CHICK;Thrombospondin-2;"collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]";"GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023";"cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]";collagen-containing extracellular matrix [GO:0062023];"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp4968129_c0_seq1;GAXK01112269.1;Q8BIQ3;1.24E-10;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4968154_c0_seq1;GAXK01112275.1;Q8Q0U0;1.66E-11;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp496821_c0_seq1;GAXK01193656.1;P50719;7.36E-13;TBA_HAECO;Tubulin alpha chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp49684_c0_seq1;GAXK01094269.1;O70437;1.31E-72;SMAD4_RAT;Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; adrenal gland development [GO:0030325]; aging [GO:0007568]; cellular response to glucose stimulus [GO:0071333]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of protein catabolic process [GO:0042177]; osteoblast differentiation [GO:0001649]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]";"GO:0001541; GO:0001649; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0007568; GO:0010666; GO:0030325; GO:0031005; GO:0032991; GO:0042060; GO:0042177; GO:0046332; GO:0046872; GO:0070371; GO:0071333";"adrenal gland development [GO:0030325]; aging [GO:0007568]; cellular response to glucose stimulus [GO:0071333]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of protein catabolic process [GO:0042177]; osteoblast differentiation [GO:0001649]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]"
comp49686_c0_seq1;GAXK01093772.1;Q5RGU1;2.07E-155;COQ8A_DANRE;Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3);"extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005524; GO:0005739; GO:0006468; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531";"phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]";"extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]"
comp4968910_c0_seq1;GAXK01112283.1;A8HYU5;2.89E-49;METK_CHLRE;S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp4969_c2_seq1;GAXK01065350.1;Q9D1M0;4.30E-159;SEC13_MOUSE;Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein);"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]";"GO:0000139; GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263";"COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]";"COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp4969002_c0_seq1;GAXK01112267.1;P62909;2.62E-31;RS3_RAT;40S ribosomal protein S3 (EC 4.2.99.18);"cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]";"GO:0000977; GO:0003684; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005730; GO:0005743; GO:0005759; GO:0005783; GO:0005844; GO:0006281; GO:0006412; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0008134; GO:0008534; GO:0010628; GO:0012505; GO:0014069; GO:0017148; GO:0019900; GO:0019901; GO:0022627; GO:0030425; GO:0030544; GO:0031116; GO:0031397; GO:0032079; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0042104; GO:0042769; GO:0042981; GO:0043507; GO:0044390; GO:0044877; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051092; GO:0051225; GO:0051301; GO:0051879; GO:0061481; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:1901224; GO:1902231; GO:1902546; GO:1905053; GO:1990090; GO:1990904; GO:2001235; GO:2001272";"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine DNA binding [GO:0032358]; protein-containing complex binding [GO:0044877]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]"
comp49697_c1_seq1;GAXK01094686.1;Q08C92;0;TYW1_DANRE;S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein);"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; oxidation-reduction process [GO:0055114]; tRNA processing [GO:0008033]";"GO:0008033; GO:0010181; GO:0046872; GO:0051539; GO:0055114; GO:0102521";"oxidation-reduction process [GO:0055114]; tRNA processing [GO:0008033]";;"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]"
comp49701_c1_seq1;GAXK01094314.1;F1M625;0;UBP46_RAT;Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46);"glutamatergic synapse [GO:0098978]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001662; GO:0004197; GO:0004843; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0045202; GO:0046872; GO:0048149; GO:0060013; GO:0098978; GO:0099149";"adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]";"glutamatergic synapse [GO:0098978]; synapse [GO:0045202]";"cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp4970156_c0_seq1;GAXK01009166.1;Q93YP9;3.42E-11;ERDL4_ARATH;Sugar transporter ERD6-like 4;"integral component of plasma membrane [GO:0005887]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; carbohydrate:proton symporter activity [GO:0005351]";"GO:0005351; GO:0005773; GO:0005774; GO:0005887";;"integral component of plasma membrane [GO:0005887]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";carbohydrate:proton symporter activity [GO:0005351]
comp497035_c0_seq1;GAXK01193649.1;Q9VGJ5;4.32E-23;FER3_DROME;Protein Fer3 (Basic helix-loop-helix protein N-twist) (Nephew of atonal 3) (Neuronal twist);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0045892; GO:0046983";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]"
comp4970469_c0_seq1;GAXK01009175.1;P61256;1.30E-73;RL26_MACFA;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0006977; GO:0015934; GO:0071479; GO:1902167";"cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; translation [GO:0006412]";large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp4970830_c0_seq1;GAXK01009163.1;P08052;6.61E-08;MLR_TODPA;Myosin regulatory light chain LC-2, mantle muscle (RLC);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp49714_c3_seq1;GAXK01094770.1;P98999;1.59E-71;ADCY9_XENLA;Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]";"GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp4971722_c0_seq1;GAXK01009162.1;Q2QY53;6.56E-28;CIPKW_ORYSJ;CBL-interacting protein kinase 32 (EC 2.7.11.1) (OsCIPK32);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556";"intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp4972_c0_seq1;GAXK01065763.1;Q6NVP6;0;PRP31_XENTR;U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31);"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071339";"mRNA splicing, via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]";U4atac snRNA binding [GO:0030622]
comp4973089_c0_seq1;GAXK01162438.1;Q3U3I9;2.54E-10;ZN865_MOUSE;Zinc finger protein 865;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4973256_c0_seq1;GAXK01162429.1;P17970;1.10E-19;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp497462_c0_seq1;GAXK01193698.1;P82251;2.63E-114;BAT1_HUMAN;b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]";"GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003";"amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]"
comp4974722_c0_seq1;GAXK01152124.1;Q40302;2.35E-68;CALM_MACPY;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp4974817_c0_seq1;GAXK01152120.1;Q6ZUK4;1.14E-12;TMM26_HUMAN;Transmembrane protein 26;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp4975_c0_seq1;GAXK01066717.1;Q5S1U6;5.77E-78;IFRD1_PIG;Interferon-related developmental regulator 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"GO:0005634; GO:0005737; GO:0014706; GO:0030517; GO:0042692; GO:0043403; GO:0048671";"muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp497528_c1_seq1;GAXK01193646.1;Q6P720;2.70E-33;ARHGP_RAT;Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT);"myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005886; GO:0030016; GO:0030017; GO:0035023";regulation of Rho protein signal transduction [GO:0035023];"myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";Rho guanyl-nucleotide exchange factor activity [GO:0005089]
comp497587_c1_seq1;GAXK01193686.1;P52746;1.46E-12;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4975912_c0_seq1;GAXK01152111.1;P17970;1.35E-21;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp497609_c2_seq1;GAXK01193668.1;P12804;8.54E-34;FGL2_MOUSE;Fibroleukin (Cytotoxic T-lymphocyte-specific protein) (Fibrinogen-like protein 2) (Prothrombinase);"extracellular region [GO:0005576]; peptidase activity [GO:0008233]; cytolysis [GO:0019835]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]";"GO:0002291; GO:0002381; GO:0002605; GO:0002617; GO:0005576; GO:0008233; GO:0019835; GO:0043381; GO:0050687";"cytolysis [GO:0019835]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]";extracellular region [GO:0005576];peptidase activity [GO:0008233]
comp4976131_c0_seq1;GAXK01136902.1;O96006;3.61E-17;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp497638_c1_seq1;GAXK01193636.1;Q05481;3.39E-12;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp4976595_c0_seq1;GAXK01136910.1;P20693;3.24E-13;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp4977033_c0_seq1;GAXK01136912.1;Q6DCX5;2.65E-07;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp497767_c1_seq1;GAXK01193538.1;Q3UHB8;2.87E-09;CC177_MOUSE;Coiled-coil domain-containing protein 177;;;;;
comp4978_c0_seq1;GAXK01066637.1;Q9EQJ9;4.94E-09;MAGI3_MOUSE;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3);"bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; frizzled binding [GO:0005109]; molecular adaptor activity [GO:0060090]; positive regulation of JUN kinase activity [GO:0043507]; signal transduction [GO:0007165]";"GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0030054; GO:0043507; GO:0060090";"positive regulation of JUN kinase activity [GO:0043507]; signal transduction [GO:0007165]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; frizzled binding [GO:0005109]; molecular adaptor activity [GO:0060090]"
comp49783_c0_seq1;GAXK01094277.1;P97875;3.10E-10;JDP2_MOUSE;Jun dimerization protein 2;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003714; GO:0005634; GO:0031065; GO:0045599; GO:0046982";"negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]"
comp4978724_c1_seq1;GAXK01044695.1;Q9UPG8;2.11E-14;PLAL2_HUMAN;Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; transcription, DNA-templated [GO:0006351]";"GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006351; GO:0006629; GO:0009791; GO:0034378; GO:0043565; GO:0046872; GO:2001244";"chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp49793_c3_seq1;GAXK01093949.1;B3DJT0;3.73E-99;SART3_DANRE;Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3);"ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]";"GO:0000245; GO:0000381; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586";"exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]";"ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]"
comp4979797_c0_seq1;GAXK01044705.1;Q28181;3.36E-16;CNGB1_BOVIN;Cyclic nucleotide-gated cation channel beta-1 (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0005222; GO:0005223; GO:0005737; GO:0007601; GO:0007608; GO:0010628; GO:0016021; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0050896; GO:0051289";"positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; photoreceptor outer segment membrane [GO:0042622]; protein-containing complex [GO:0032991]";"cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein homodimerization activity [GO:0042803]"
comp4979985_c0_seq1;GAXK01044701.1;Q39752;2.16E-25;CALM_FAGSY;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp498_c0_seq1;GAXK01165988.1;Q3T108;1.36E-78;PSB4_BOVIN;Proteasome subunit beta type-4 (EC 3.4.25.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0001530; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]"
comp498040_c0_seq1;GAXK01036409.1;Q96IR2;6.47E-39;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4981250_c0_seq1;GAXK01101626.1;P41203;5.92E-25;EF1A_DESMO;Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp498139_c1_seq1;GAXK01036341.1;O17185;1.92E-99;SUP9_CAEEL;Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38);"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"GO:0005267; GO:0005887; GO:0006813; GO:0006937; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]";"potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]"
comp498275_c0_seq1;GAXK01036355.1;Q8VHK1;1.02E-28;CSKI2_MOUSE;Caskin-2;"cytoplasm [GO:0005737]; membrane [GO:0016020]";"GO:0005737; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";
comp4982860_c0_seq1;GAXK01056827.1;P55112;3.24E-42;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp4983896_c0_seq1;GAXK01056830.1;Q96D21;2.89E-25;RHES_HUMAN;GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2);"plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0051897";"locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";plasma membrane [GO:0005886];"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp498474_c0_seq1;GAXK01036340.1;Q9HCG1;8.63E-33;ZN160_HUMAN;Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; hemopoiesis [GO:0030097]";"GO:0000981; GO:0003677; GO:0005634; GO:0030097; GO:0046872";hemopoiesis [GO:0030097];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp498523_c1_seq1;GAXK01036387.1;Q9D119;6.05E-24;PPR27_MOUSE;Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1);"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]";"GO:0004864; GO:0010923; GO:0019902";negative regulation of phosphatase activity [GO:0010923];;"phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]"
comp498578_c0_seq1;GAXK01036376.1;G5ECS8;5.62E-79;ADT1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp49866_c3_seq1;GAXK01094623.1;Q96N95;5.27E-16;ZN396_HUMAN;Zinc finger protein 396 (Zinc finger and SCAN domain-containing protein 14);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0042803; GO:0045892; GO:0046872; GO:0046982";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp4987_c1_seq1;GAXK01065602.1;Q9UBQ5;1.19E-80;EIF3K_HUMAN;Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28);"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022";"formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]";"ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]"
comp498736_c2_seq1;GAXK01036362.1;Q7TPQ9;7.98E-46;ARRD3_MOUSE;Arrestin domain-containing protein 3;"early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"GO:0001659; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163";"fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]";"early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";beta-3 adrenergic receptor binding [GO:0031699]
comp498743_c0_seq1;GAXK01036344.1;Q9GRW0;1.58E-29;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp49884_c0_seq1;GAXK01094683.1;O14744;0;ANM5_HUMAN;Protein arginine N-methyltransferase 5 (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992";"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]"
comp4988461_c0_seq1;GAXK01035704.1;Q9PVG3;3.20E-07;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp4989494_c0_seq1;GAXK01035709.1;P37236;8.23E-17;FREQ_DROME;Frequenin-1 (d-FRQ);"membrane [GO:0016020]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0007268; GO:0007269; GO:0007528; GO:0008048; GO:0016020; GO:0046928; GO:0098793";"chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]";"membrane [GO:0016020]; presynapse [GO:0098793]";"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp49896_c0_seq1;GAXK01094682.1;Q8WV93;5.11E-127;AFG1L_HUMAN;AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog);"cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]";"GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694";"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]";"cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp4989948_c0_seq1;GAXK01035703.1;Q8UVC1;7.71E-55;INVS_DANRE;Inversin;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; body morphogenesis [GO:0010171]; cloaca development [GO:0035844]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; kidney development [GO:0001822]; opsin transport [GO:0036372]; pronephros formation [GO:0072116]; pronephros morphogenesis [GO:0072114]; Wnt signaling pathway [GO:0016055]";"GO:0001736; GO:0001822; GO:0001947; GO:0005516; GO:0005737; GO:0005856; GO:0005929; GO:0010171; GO:0016055; GO:0035844; GO:0036372; GO:0060027; GO:0072114; GO:0072116";"body morphogenesis [GO:0010171]; cloaca development [GO:0035844]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; kidney development [GO:0001822]; opsin transport [GO:0036372]; pronephros formation [GO:0072116]; pronephros morphogenesis [GO:0072114]; Wnt signaling pathway [GO:0016055]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";calmodulin binding [GO:0005516]
comp4990212_c0_seq1;GAXK01087845.1;P08879;9.59E-73;NDKA_DROME;Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) (Abnormal wing disks protein) (Killer of prune protein);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear microtubule [GO:0005880]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; nucleoside diphosphate kinase activity [GO:0004550]; adherens junction organization [GO:0034332]; CTP biosynthetic process [GO:0006241]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; GTP biosynthetic process [GO:0006183]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide metabolic process [GO:0009117]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of tube architecture, open tracheal system [GO:0035152]; UTP biosynthetic process [GO:0006228]";"GO:0000278; GO:0000287; GO:0004550; GO:0005524; GO:0005525; GO:0005737; GO:0005874; GO:0005880; GO:0005886; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006468; GO:0007017; GO:0007424; GO:0007427; GO:0008017; GO:0009117; GO:0016301; GO:0016334; GO:0018105; GO:0034332; GO:0035152; GO:0046777";"adherens junction organization [GO:0034332]; CTP biosynthetic process [GO:0006241]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; GTP biosynthetic process [GO:0006183]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide metabolic process [GO:0009117]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of tube architecture, open tracheal system [GO:0035152]; UTP biosynthetic process [GO:0006228]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear microtubule [GO:0005880]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; nucleoside diphosphate kinase activity [GO:0004550]"
comp4990794_c0_seq1;GAXK01087846.1;P41849;4.14E-07;LGC50_CAEEL;Ligand-gated ion channel 50;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp49909_c0_seq1;GAXK01093890.1;Q24546;1.79E-103;SYN_DROME;"Synapsin [Cleaved into: Synapsin-1 (Syn1) (Syn1-S); Synapsin-2 (Syn2)]";"cell junction [GO:0030054]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; male courtship behavior [GO:0008049]; memory [GO:0007613]; neurotransmitter secretion [GO:0007269]; olfactory learning [GO:0008355]; optomotor response [GO:0071632]; response to heat [GO:0009408]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle exocytosis [GO:0016079]; terminal button organization [GO:0072553]";"GO:0005524; GO:0007269; GO:0007613; GO:0008049; GO:0008306; GO:0008355; GO:0009408; GO:0016079; GO:0030054; GO:0030672; GO:0043195; GO:0048149; GO:0051124; GO:0071632; GO:0072553";"associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; male courtship behavior [GO:0008049]; memory [GO:0007613]; neurotransmitter secretion [GO:0007269]; olfactory learning [GO:0008355]; optomotor response [GO:0071632]; response to heat [GO:0009408]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle exocytosis [GO:0016079]; terminal button organization [GO:0072553]";"cell junction [GO:0030054]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";ATP binding [GO:0005524]
comp49911_c0_seq1;GAXK01094656.1;Q8R2H1;7.17E-13;IKBL1_RAT;NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]";"GO:0005634; GO:0005829; GO:0007249; GO:0031665; GO:0032088; GO:0032720; GO:0034122; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp49918_c0_seq1;GAXK01094270.1;Q3UFM5;5.46E-147;NOM1_MOUSE;Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003723; GO:0005634; GO:0005730; GO:0042274; GO:0048820";"hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp4991996_c0_seq1;GAXK01087843.1;Q9C912;6.23E-36;R35A3_ARATH;60S ribosomal protein L35a-3;"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005739; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp4991997_c0_seq1;GAXK01087837.1;Q8IWG1;8.51E-09;WDR63_HUMAN;WD repeat-containing protein 63 (Testis development protein NYD-SP29);"inner dynein arm [GO:0036156]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0007018; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0060294";"cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";inner dynein arm [GO:0036156];"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]"
comp4992_c0_seq1;GAXK01065373.1;Q02366;5.29E-25;NDUA6_BOVIN;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"GO:0005747; GO:0006979; GO:0032981; GO:0055114";"mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";mitochondrial respiratory chain complex I [GO:0005747];
comp499240_c0_seq1;GAXK01036360.1;Q5XM24;2.33E-62;APRA_DICDI;Autocrine proliferation repressor protein A (PhoPQ-activated pathogenicity-related protein);"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005096; GO:0005102; GO:0005576; GO:0007049; GO:0008233; GO:0030435; GO:0031157; GO:0032991; GO:0045499; GO:0050919; GO:0072659; GO:0090630; GO:1903665";"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]";"chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp499274_c1_seq1;GAXK01036363.1;Q5LT18;2.38E-09;DDDQ_RUEPO;Dimethlysulfonioproprionate lyase DddQ (DMSP lyase) (EC 4.4.1.3);"dimethylpropiothetin dethiomethylase activity [GO:0047869]; metal ion binding [GO:0046872]";"GO:0046872; GO:0047869";;;"dimethylpropiothetin dethiomethylase activity [GO:0047869]; metal ion binding [GO:0046872]"
comp4993321_c0_seq1;GAXK01150286.1;Q09711;1.91E-32;NCS1_SCHPO;Calcium-binding protein NCS-1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activator activity [GO:0098744]; calcium ion binding [GO:0005509]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030435; GO:0035584; GO:0098744; GO:1905949";"calcium-mediated signaling using intracellular calcium source [GO:0035584]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; sporulation resulting in formation of a cellular spore [GO:0030435]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"1-phosphatidylinositol 4-kinase activator activity [GO:0098744]; calcium ion binding [GO:0005509]"
comp49937_c2_seq1;GAXK01094668.1;Q9NYB9;2.34E-29;ABI2_HUMAN;Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1);"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209]; cytoskeletal adaptor activity [GO:0008093]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; viral process [GO:0016032]; zonula adherens assembly [GO:0045186]";"GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005912; GO:0007010; GO:0008093; GO:0008154; GO:0016032; GO:0016477; GO:0016601; GO:0017124; GO:0018108; GO:0019900; GO:0030027; GO:0031209; GO:0031625; GO:0032433; GO:0043197; GO:0045186; GO:0061001; GO:0070064; GO:0070309; GO:2000601";"actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; viral process [GO:0016032]; zonula adherens assembly [GO:0045186]";"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209]";"cytoskeletal adaptor activity [GO:0008093]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]"
comp49938_c0_seq1;GAXK01094276.1;Q27421;7.74E-73;OSP_DROME;Protein outspread;;;;;
comp4994416_c0_seq1;GAXK01060234.1;Q9QUJ7;9.51E-19;ACSL4_MOUSE;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) (mACS4);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005789; GO:0005811; GO:0006629; GO:0006631; GO:0007584; GO:0008610; GO:0015908; GO:0016021; GO:0019217; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp4995023_c0_seq1;GAXK01060237.1;Q7L2R6;3.32E-08;ZN765_HUMAN;Zinc finger protein 765;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp4996049_c0_seq1;GAXK01172467.1;A8XY95;5.32E-41;METH_CAEBR;Probable methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS);"cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0042558";pteridine-containing compound metabolic process [GO:0042558];cytosol [GO:0005829];"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp499634_c2_seq1;GAXK01036345.1;P13674;8.67E-20;P4HA1_HUMAN;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp49973_c1_seq1;GAXK01094186.1;Q9JJ66;5.22E-167;CDC20_MOUSE;Cell division cycle protein 20 homolog (mmCdc20) (p55CDC);"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activator activity [GO:0097027]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]";"GO:0000922; GO:0005634; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:0097027; GO:1904668";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]";"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]";"anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activator activity [GO:0097027]"
comp49980_c1_seq1;GAXK01093948.1;A1ZAI5;5.72E-141;FACR1_DROME;Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965";"ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]"
comp4998204_c0_seq1;GAXK01067357.1;P29763;8.69E-11;RLA1_CHLRE;60S acidic ribosomal protein P1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp4998576_c0_seq1;GAXK01067358.1;O73885;1.07E-25;HSP7C_CHICK;Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8);"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; phosphoprotein binding [GO:0051219]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; late endosomal microautophagy [GO:0061738]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006986; GO:0007369; GO:0008088; GO:0009792; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043195; GO:0044183; GO:0048568; GO:0051082; GO:0051085; GO:0051219; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904";"axo-dendritic transport [GO:0008088]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; late endosomal microautophagy [GO:0061738]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]";"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; terminal bouton [GO:0043195]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; phosphoprotein binding [GO:0051219]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp4999031_c0_seq1;GAXK01067356.1;O13614;5.51E-25;RS10B_SCHPO;40S ribosomal protein S10-B;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]";"GO:0000028; GO:0002181; GO:0003735; GO:0005829; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp499941_c0_seq1;GAXK01036377.1;Q9VCX1;1.05E-31;RGS_DROME;Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco);"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0014045; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857";"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]"
comp49996_c0_seq1;GAXK01093964.1;Q24400;5.47E-77;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp5000148_c0_seq1;GAXK01091804.1;B3A0Q8;9.77E-29;PLSP3_LOTGI;Peroxidase-like protein 3 (Fragment);"extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0020037";response to oxidative stress [GO:0006979];extracellular region [GO:0005576];"heme binding [GO:0020037]; peroxidase activity [GO:0004601]"
comp500054_c1_seq1;GAXK01074525.1;Q68EA5;1.41E-19;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5002249_c0_seq1;GAXK01081909.1;P51522;4.94E-15;ZNF83_HUMAN;Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5002335_c0_seq1;GAXK01081914.1;Q26473;2.85E-31;SEM1A_SCHAM;Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I);"integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];semaphorin receptor binding [GO:0030215]
comp5002393_c0_seq1;GAXK01081916.1;Q24F59;2.55E-18;RL36_TETTS;60S ribosomal protein L36;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp500247_c0_seq1;GAXK01074414.1;O54963;1.17E-16;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp500284_c0_seq1;GAXK01074498.1;Q8R4H4;6.50E-29;CBPA5_MOUSE;Carboxypeptidase A5 (EC 3.4.17.-);"extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0005615; GO:0006508; GO:0008233; GO:0008270";proteolysis [GO:0006508];extracellular space [GO:0005615];"metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp500290_c0_seq1;GAXK01074405.1;F7D3V9;6.20E-31;LGR5_XENTR;Leucine-rich repeat-containing G-protein coupled receptor 5;"integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]";"GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0008528; GO:0009755; GO:0016500; GO:0032588; GO:0090263";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]";"integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]"
comp500292_c1_seq1;GAXK01074503.1;Q1EHB4;2.17E-100;SC5AC_HUMAN;Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; ion transport [GO:0006811]";"GO:0005343; GO:0005886; GO:0006811; GO:0015129; GO:0016021; GO:0016324; GO:0070062";ion transport [GO:0006811];"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]"
comp5003028_c0_seq1;GAXK01081904.1;C0HL13;6.37E-28;LRP2_PIG;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167";"coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]"
comp500475_c0_seq1;GAXK01074411.1;Q9N2R3;3.29E-62;TPM_CHAFE;Tropomyosin (Allergen Cha f I) (allergen Cha f 1) (Fragment);;;;;
comp500479_c0_seq1;GAXK01074502.1;A5E8F3;1.02E-10;Y150_BRASB;UPF0314 protein BBta_0150;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp50050_c0_seq1;GAXK01043640.1;O60488;0;ACSL4_HUMAN;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp5005078_c0_seq1;GAXK01131255.1;Q64487;6.19E-09;PTPRD_MOUSE;Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);"glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]";"GO:0004725; GO:0005102; GO:0006470; GO:0007157; GO:0030182; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0099151; GO:0099560";"heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]";"glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; Schaffer collateral - CA1 synapse [GO:0098685]";"cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]"
comp50059_c0_seq1;GAXK01043769.1;Q7RTY7;3.91E-43;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp500605_c2_seq1;GAXK01074462.1;Q9BSK1;1.23E-16;ZN577_HUMAN;Zinc finger protein 577;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp50062_c2_seq1;GAXK01043390.1;Q3SZA5;4.07E-57;SPSY_BOVIN;Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase);"spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]";"GO:0006597; GO:0016768";spermine biosynthetic process [GO:0006597];;spermine synthase activity [GO:0016768]
comp500815_c0_seq1;GAXK01074570.1;Q9NPC7;1.21E-09;MYNN_HUMAN;Myoneurin (Zinc finger and BTB domain-containing protein 31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp50086_c1_seq1;GAXK01043864.1;Q9W0S9;0;DIP2_DROME;Disco-interacting protein 2;"nucleus [GO:0005634]; catalytic activity [GO:0003824]; multicellular organism development [GO:0007275]";"GO:0003824; GO:0005634; GO:0007275";multicellular organism development [GO:0007275];nucleus [GO:0005634];catalytic activity [GO:0003824]
comp501019_c0_seq1;GAXK01074413.1;P82343;1.34E-134;RENBP_MOUSE;N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP);"ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; protein homodimerization activity [GO:0042803]; purine nucleotide binding [GO:0017076]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004857; GO:0005524; GO:0006044; GO:0006051; GO:0010951; GO:0017076; GO:0019262; GO:0030414; GO:0042803; GO:0043086; GO:0050121";"N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]";;"ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; protein homodimerization activity [GO:0042803]; purine nucleotide binding [GO:0017076]"
comp5010286_c0_seq1;GAXK01149922.1;Q7Z020;2.45E-13;TRPA1_DROME;Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1);"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016021; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]"
comp50106_c3_seq1;GAXK01043904.1;B7Q5K1;7.20E-79;QTRT2_IXOSC;Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]";"GO:0005737; GO:0008479; GO:0046872; GO:0101030";tRNA-guanine transglycosylation [GO:0101030];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]"
comp501099_c0_seq1;GAXK01074568.1;Q9VUX3;3.84E-110;NOTUM_DROME;Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM);"cell surface [GO:0009986]; extracellular space [GO:0005615]; palmitoleyl hydrolase activity [GO:1990699]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055]";"GO:0005615; GO:0006507; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0090090; GO:1990697; GO:1990699";"GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; extracellular space [GO:0005615]";palmitoleyl hydrolase activity [GO:1990699]
comp501100_c1_seq1;GAXK01074518.1;Q52V16;1.19E-15;ZFY_GORGO;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp50122_c0_seq1;GAXK01043029.1;Q8VIG6;1.52E-17;TRAIP_MOUSE;E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAIP) (TRAF-interacting protein);"nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]";"GO:0004842; GO:0005730; GO:0007165; GO:0010804; GO:0016567; GO:0032088; GO:0032688; GO:0046872; GO:0048471; GO:0061630";"negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]";"nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp5012568_c0_seq1;GAXK01179923.1;P55956;2.35E-36;ASP3_CAEEL;Aspartic protease 3 (EC 3.4.23.-);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]; cell death [GO:0008219]; necrotic cell death [GO:0070265]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"GO:0004190; GO:0005576; GO:0005737; GO:0005764; GO:0006508; GO:0008219; GO:0012501; GO:0030163; GO:0070265";"cell death [GO:0008219]; necrotic cell death [GO:0070265]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosome [GO:0005764]";aspartic-type endopeptidase activity [GO:0004190]
comp501263_c0_seq1;GAXK01074464.1;Q8IV36;0;HID1_HUMAN;Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog);"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]";"GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0006886; GO:0016020; GO:0070062; GO:0090498";intracellular protein transport [GO:0006886];"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]";
comp501299_c3_seq1;GAXK01074585.1;Q1RJR6;5.58E-11;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp50130_c2_seq1;GAXK01043717.1;P47825;4.57E-66;TAF4_DROME;Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110);"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001092; GO:0003677; GO:0003700; GO:0005634; GO:0005669; GO:0006355; GO:0006366; GO:0006367; GO:0008134; GO:0045944; GO:0046982";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]"
comp5013403_c0_seq1;GAXK01179926.1;P98070;6.95E-12;BMP1_XENLA;Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.-);"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]";"GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0008083; GO:0008270; GO:0030154; GO:0051216";"cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]";"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp501380_c0_seq1;GAXK01074436.1;C4NYZ3;3.02E-78;AOXB_MACFA;Aldehyde oxidase 2 (EC 1.2.3.1) (Aldehyde oxidase homolog 3) (Azaheterocycle hydroxylase 2) (EC 1.17.3.-);"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]";"GO:0004031; GO:0005506; GO:0005829; GO:0009055; GO:0017144; GO:0042803; GO:0043546; GO:0050250; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0071949; GO:0102797; GO:0102798";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]";cytosol [GO:0005829];"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]"
comp50141_c0_seq1;GAXK01043472.1;Q0IJ01;7.76E-22;ZWILC_XENTR;Protein zwilch homolog;"condensed chromosome kinetochore [GO:0000777]; RZZ complex [GO:1990423]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]";"GO:0000777; GO:0007093; GO:0051301; GO:1990423";"cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]";"condensed chromosome kinetochore [GO:0000777]; RZZ complex [GO:1990423]";
comp5014160_c0_seq1;GAXK01165356.1;Q7KRI2;5.07E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp501525_c2_seq1;GAXK01074521.1;P58317;1.03E-09;ZN121_HUMAN;Zinc finger protein 121 (Zinc finger protein 20);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp501533_c0_seq1;GAXK01074450.1;P36513;3.23E-55;UDB14_RABIT;UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp501559_c1_seq1;GAXK01074397.1;P0AF49;8.30E-14;YJBQ_ECO57;UPF0047 protein YjbQ;;;;;
comp501596_c0_seq1;GAXK01074457.1;O60500;1.22E-24;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp5016121_c0_seq1;GAXK01180859.1;Q9VY77;4.82E-24;AJUBA_DROME;LIM domain-containing protein jub;"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0007010; GO:0030707; GO:0035331; GO:0045177; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:2000637";"cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]";"metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp501680_c0_seq1;GAXK01074454.1;Q965X6;3.21E-11;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp5016815_c0_seq1;GAXK01180853.1;P62885;6.52E-35;RL37_LEIDO;60S ribosomal protein L37;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp50178_c2_seq1;GAXK01043155.1;P50461;1.50E-09;CSRP3_HUMAN;Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; actin cytoskeleton organization [GO:0030036]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac myofibril assembly [GO:0055003]; cellular calcium ion homeostasis [GO:0006874]; detection of muscle stretch [GO:0035995]; glucose homeostasis [GO:0042593]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; muscle tissue development [GO:0060537]; negative regulation of actin filament severing [GO:1903919]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of actin filament severing [GO:1903920]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase C signaling [GO:0070528]; protein localization to organelle [GO:0033365]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; T-tubule organization [GO:0033292]";"GO:0002026; GO:0003300; GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0006874; GO:0006954; GO:0007519; GO:0008286; GO:0008307; GO:0030018; GO:0030036; GO:0031433; GO:0033292; GO:0033365; GO:0035995; GO:0042593; GO:0042802; GO:0042805; GO:0045214; GO:0045662; GO:0045663; GO:0045944; GO:0046872; GO:0048738; GO:0055003; GO:0060048; GO:0060537; GO:0070528; GO:1903076; GO:1903919; GO:1903920";"actin cytoskeleton organization [GO:0030036]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac myofibril assembly [GO:0055003]; cellular calcium ion homeostasis [GO:0006874]; detection of muscle stretch [GO:0035995]; glucose homeostasis [GO:0042593]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; muscle tissue development [GO:0060537]; negative regulation of actin filament severing [GO:1903919]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of actin filament severing [GO:1903920]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase C signaling [GO:0070528]; protein localization to organelle [GO:0033365]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; T-tubule organization [GO:0033292]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actin binding [GO:0003779]; actinin binding [GO:0042805]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]"
comp501811_c2_seq1;GAXK01074438.1;Q15776;5.80E-24;ZKSC8_HUMAN;Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5018611_c0_seq1;GAXK01203708.1;P35036;5.73E-10;TRY2_ANOGA;Trypsin-2 (EC 3.4.21.4) (Antryp2);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp501894_c0_seq1;GAXK01074428.1;Q8K0T2;1.30E-77;DC2L1_MOUSE;Cytoplasmic dynein 2 light intermediate chain 1 (mD2LIC);"apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017]";"GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005930; GO:0007368; GO:0008569; GO:0031514; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045177; GO:0045504; GO:0060271; GO:1902017";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017]";"apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]"
comp501943_c0_seq1;GAXK01074442.1;Q5M7Q1;9.28E-37;FLCN_XENTR;Folliculin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]";"GO:0000122; GO:0001932; GO:0001934; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007043; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032465; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044877; GO:0045785; GO:0045944; GO:0051898; GO:0070373; GO:0097009; GO:1900181; GO:1901723; GO:1904263; GO:2000973; GO:2001170";"cell-cell junction assembly [GO:0007043]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]"
comp50195_c0_seq1;GAXK01043350.1;Q9XZC8;0;SEM2A_SCHGR;Semaphorin-2A (Sema-2A) (Sema II);"extracellular region [GO:0005576]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005576; GO:0007399; GO:0030154; GO:0030215";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";extracellular region [GO:0005576];semaphorin receptor binding [GO:0030215]
comp501956_c0_seq1;GAXK01074504.1;O88846;1.53E-14;RNF4_RAT;E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of cell death [GO:0060548]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008134; GO:0008270; GO:0008584; GO:0016567; GO:0016605; GO:0017025; GO:0030331; GO:0031491; GO:0031624; GO:0032184; GO:0032355; GO:0033142; GO:0042802; GO:0042803; GO:0043161; GO:0044752; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0060548; GO:0061630; GO:0070534; GO:0070936; GO:0070979; GO:0071243; GO:0071345; GO:0071394; GO:0071480; GO:0072711; GO:0085020; GO:0090169; GO:0090234";"cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of cell death [GO:0060548]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp501960_c0_seq1;GAXK01074453.1;P08941;3.94E-179;ROS1_CHICK;Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase);"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0008283; GO:0030154; GO:0032006; GO:0043235; GO:0070372";"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp5019975_c0_seq1;GAXK01203710.1;Q9CXE0;2.78E-08;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp502_c1_seq1;GAXK01169226.1;Q98SP8;0;EPABA_XENLA;Embryonic polyadenylate-binding protein A (Embryonic poly(A)-binding protein A) (ePAB-A) (ePABP-A) (XePABP-A);"cytoplasm [GO:0005737]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; chordate embryonic development [GO:0043009]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; translation [GO:0006412]";"GO:0005737; GO:0006397; GO:0006412; GO:0008143; GO:0031370; GO:0043009; GO:0043621; GO:0048255; GO:0060212";"chordate embryonic development [GO:0043009]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; translation [GO:0006412]";cytoplasm [GO:0005737];"eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]"
comp5020012_c0_seq1;GAXK01064869.1;Q96PH1;9.65E-31;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp502013_c1_seq1;GAXK01160965.1;Q8SQG9;8.21E-14;NHRF2_RABIT;Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (PDZ domain-containing protein NHERF-2) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2);"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]";"GO:0005634; GO:0008022; GO:0012505; GO:0016324; GO:0060090";;"apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]";"molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]"
comp5020256_c0_seq1;GAXK01064866.1;Q9FLF0;4.45E-69;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp502067_c2_seq1;GAXK01160943.1;P50430;2.39E-84;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp50216_c2_seq1;GAXK01043856.1;B0BM28;3.06E-26;SKA1_XENTR;Spindle and kinetochore-associated protein 1;"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]";"GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0008017; GO:0031110; GO:0051301; GO:0072686";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]";"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]";microtubule binding [GO:0008017]
comp502165_c0_seq1;GAXK01160931.1;Q99MD8;1.52E-20;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5022273_c0_seq1;GAXK01113722.1;P36609;1.48E-15;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp5022475_c0_seq1;GAXK01113733.1;P0CH36;4.65E-30;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp502259_c1_seq1;GAXK01160950.1;Q2EI21;3.46E-15;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5024460_c0_seq1;GAXK01022223.1;Q7RTX9;9.48E-24;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp5024798_c0_seq1;GAXK01022221.1;A0ZSK3;1.38E-13;STXA_SYNVE;Neoverrucotoxin subunit alpha (NeoVTX subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp5025_c0_seq1;GAXK01065361.1;Q6P026;3.61E-46;BAF_DANRE;Barrier-to-autointegration factor;"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]";"GO:0003677; GO:0005654; GO:0005694; GO:0007059; GO:0030261";"chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp5025102_c0_seq1;GAXK01022218.1;Q95V25;2.56E-16;SLO1_CAEEL;Calcium-activated potassium channel slo-1 (BK channel) (Maxi K channel) (MaxiK) (Slo homolog) (Slowpoke protein 1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"GO:0005249; GO:0005886; GO:0006813; GO:0015269; GO:0015271; GO:0016021; GO:0030054; GO:0031430; GO:0034765; GO:0040011; GO:0042391; GO:0042493; GO:0043050; GO:0045202; GO:0045211; GO:0045214; GO:0046928; GO:0048149; GO:0050804; GO:0055120; GO:0060072";"behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]"
comp50253_c1_seq1;GAXK01043632.1;Q9VEN1;0;FLNA_DROME;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1);"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495";"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp502531_c0_seq1;GAXK01160989.1;Q2VG86;2.09E-40;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp50259_c0_seq1;GAXK01042985.1;Q3MHG0;0;COG4_BOVIN;Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0048213";"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]";
comp5026108_c0_seq1;GAXK01085007.1;Q811B3;1.98E-11;ATS12_MOUSE;A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]";"GO:0004222; GO:0005576; GO:0007160; GO:0016477; GO:0030167; GO:0032331; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp502696_c1_seq1;GAXK01160987.1;Q9ESJ4;4.40E-73;SPN90_MOUSE;NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (VIP54) (90 kDa N-WASP-interacting protein) (90 kDa SH3 protein interacting with Nck) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-binding protein) (N-WASP-binding protein);"COP9 signalosome [GO:0008180]; SH3 domain binding [GO:0017124]; positive regulation of neuron projection development [GO:0010976]";"GO:0008180; GO:0010976; GO:0017124";positive regulation of neuron projection development [GO:0010976];COP9 signalosome [GO:0008180];SH3 domain binding [GO:0017124]
comp5027526_c0_seq1;GAXK01085009.1;Q10232;1.11E-44;RL9A_SCHPO;60S ribosomal protein L9-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0019843; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5027632_c0_seq1;GAXK01085004.1;P41243;2.88E-30;MATK_RAT;Megakaryocyte-associated tyrosine-protein kinase (EC 2.7.10.2) (Protein kinase BATK) (Tyrosine-protein kinase CTK);"cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; regulation of cell population proliferation [GO:0042127]";"GO:0004715; GO:0005524; GO:0005737; GO:0031234; GO:0042127";regulation of cell population proliferation [GO:0042127];"cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]";"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp502774_c0_seq1;GAXK01160951.1;Q63285;4.12E-21;UHMK1_RAT;Serine/threonine-protein kinase Kist (EC 2.7.11.1) (Kinase interacting with stathmin) (PAM COOH-terminal interactor protein 2) (P-CIP2) (U2AF homology motif kinase 1);"cytoplasm [GO:0005737]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; regulation of protein export from nucleus [GO:0046825]";"GO:0003723; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007050; GO:0018105; GO:0019899; GO:0043021; GO:0045948; GO:0046825; GO:0071598";"cell cycle arrest [GO:0007050]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; regulation of protein export from nucleus [GO:0046825]";"cytoplasm [GO:0005737]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]"
comp5028254_c0_seq1;GAXK01140703.1;Q60870;8.05E-12;REEP5_MOUSE;Receptor expression-enhancing protein 5 (GP106) (Polyposis locus protein 1 homolog) (Protein TB2 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp50283_c0_seq1;GAXK01043023.1;P23708;1.42E-32;NFYA_MOUSE;Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA);"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"GO:0000978; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008134; GO:0016602; GO:0032993; GO:0043565; GO:0045893; GO:0045944; GO:0048511; GO:0090575; GO:2000036; GO:2000648";"positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]";"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]"
comp50289_c0_seq1;GAXK01043691.1;Q5U593;2.80E-65;STYXB_XENLA;Serine/threonine/tyrosine-interacting protein B;protein tyrosine/serine/threonine phosphatase activity [GO:0008138];GO:0008138;;;protein tyrosine/serine/threonine phosphatase activity [GO:0008138]
comp5030442_c0_seq1;GAXK01021173.1;Q24352;1.10E-30;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp503071_c0_seq1;GAXK01161002.1;Q9NGC3;2.70E-59;CEG1A_DROME;Centaurin-gamma-1A;"membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375";"medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp5030730_c0_seq1;GAXK01021182.1;Q9UDV7;9.20E-17;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp5031110_c0_seq1;GAXK01021171.1;P93664;1.52E-16;LHSR1_CHLRE;Light-harvesting complex stress-related protein 1, chloroplastic (Chlorophyll a-b binding protein LHCSR1);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0009416; GO:0009522; GO:0009523; GO:0009535; GO:0009768; GO:0016021; GO:0016168; GO:0018298";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp5031155_c0_seq1;GAXK01021181.1;Q8BJA2;1.55E-64;S41A1_MOUSE;Solute carrier family 41 member 1;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; divalent metal ion transport [GO:0070838]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]";"GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0032991; GO:0061768; GO:0070838; GO:0071286; GO:0072509; GO:1903830";"cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; divalent metal ion transport [GO:0070838]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium:sodium antiporter activity [GO:0061768]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp503130_c0_seq1;GAXK01160940.1;Q9DAT2;6.00E-16;MRGBP_MOUSE;MRG/MORF4L-binding protein (MRG-binding protein);"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0005634; GO:0006357; GO:0016573; GO:0035267; GO:0040008";"histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]";
comp50319_c1_seq1;GAXK01043355.1;Q9VUY9;0;PGM_DROME;Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase);"cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]";"GO:0000287; GO:0004614; GO:0005829; GO:0005978; GO:0006006; GO:0019388";"galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]";cytosol [GO:0005829];"magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]"
comp50323_c0_seq1;GAXK01043546.1;Q800L1;1.04E-61;SURF1_CHICK;Surfeit locus protein 1;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; oxidative phosphorylation [GO:0006119]";"GO:0004129; GO:0005743; GO:0006119; GO:0016021; GO:0033617";"mitochondrial respiratory chain complex IV assembly [GO:0033617]; oxidative phosphorylation [GO:0006119]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp503251_c0_seq1;GAXK01160974.1;P16066;0;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp503358_c1_seq1;GAXK01160946.1;Q8BY79;1.30E-10;S35G1_MOUSE;Solute carrier family 35 member G1 (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5033746_c0_seq1;GAXK01070006.1;P39675;1.69E-14;DERP3_DERPT;Mite allergen Der p 3 (EC 3.4.21.-) (Allergen Der p III) (allergen Der p 3);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp5034009_c0_seq1;GAXK01078116.1;P26591;5.48E-09;GLRK_LYMST;Glutamate receptor;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]";"GO:0004970; GO:0016021; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";ionotropic glutamate receptor activity [GO:0004970]
comp503435_c0_seq1;GAXK01160988.1;P17678;1.41E-18;GATA1_CHICK;Erythroid transcription factor (Eryf1) (GATA-binding factor 1) (GATA-1) (NF-E1 DNA-binding protein) (NF-E1a);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of definitive erythrocyte differentiation [GO:0010724]";"GO:0000978; GO:0000981; GO:0005634; GO:0008270; GO:0010724";regulation of definitive erythrocyte differentiation [GO:0010724];nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp5034460_c0_seq1;GAXK01078122.1;Q9FRL3;9.03E-11;ERDL6_ARATH;Sugar transporter ERD6-like 6;"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; carbohydrate:proton symporter activity [GO:0005351]; glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"GO:0005351; GO:0005739; GO:0005774; GO:0005794; GO:0005887; GO:0009705; GO:0010030; GO:0042593";"glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]";carbohydrate:proton symporter activity [GO:0005351]
comp50353_c0_seq1;GAXK01043076.1;Q9R0P9;6.76E-27;UCHL1_MOUSE;Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1);"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cell population proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002931; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0007409; GO:0007412; GO:0007628; GO:0008242; GO:0008283; GO:0016579; GO:0016874; GO:0019233; GO:0019896; GO:0030424; GO:0031625; GO:0031694; GO:0042755; GO:0043025; GO:0043130; GO:0043209; GO:0043407; GO:0044306; GO:0048747; GO:0050905; GO:1904115";"adult walking behavior [GO:0007628]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; axon target recognition [GO:0007412]; cell population proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; ubiquitin-dependent protein catabolic process [GO:0006511]";"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
comp5036_c0_seq1;GAXK01066650.1;Q9GKQ9;2.60E-73;SMAD4_PIG;Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4);"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; SMAD protein complex [GO:0071141]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; molecular function regulator [GO:0098772]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription coregulator activity [GO:0003712]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]";"GO:0000122; GO:0000790; GO:0000978; GO:0001085; GO:0001228; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003712; GO:0005518; GO:0005654; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042803; GO:0043199; GO:0046872; GO:0046881; GO:0046982; GO:0048382; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0072133; GO:0072134; GO:0072520; GO:0098772; GO:1905305; GO:2000617";"atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]";"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; SMAD protein complex [GO:0071141]";"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; molecular function regulator [GO:0098772]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; R-SMAD binding [GO:0070412]; sulfate binding [GO:0043199]; transcription coregulator activity [GO:0003712]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]"
comp5036071_c0_seq1;GAXK01041294.1;Q6B9X6;9.42E-17;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp5038_c0_seq1;GAXK01066738.1;Q9XZ71;7.26E-62;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp503883_c2_seq1;GAXK01160977.1;Q8BM89;1.62E-62;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp503899_c0_seq1;GAXK01160961.1;Q5XI52;2.78E-11;VEZA_RAT;Vezatin;"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]";"GO:0001669; GO:0002142; GO:0005654; GO:0005829; GO:0005912; GO:0016021; GO:0017022; GO:0060171; GO:0098609";cell-cell adhesion [GO:0098609];"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]";myosin binding [GO:0017022]
comp504035_c0_seq1;GAXK01015698.1;P0C599;5.76E-29;DUPD1_TAKRU;Dual specificity phosphatase DUPD1 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp504101_c1_seq1;GAXK01015687.1;Q9VZU2;1.57E-54;HHAT_DROME;Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0046843; GO:0048100";"dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp504106_c0_seq1;GAXK01015837.1;Q01484;9.65E-35;ANK2_HUMAN;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp504152_c2_seq1;GAXK01015771.1;P75063;7.81E-11;Y051_MYCPN;Uncharacterized protein MG039 homolog;oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp5042114_c0_seq1;GAXK01071075.1;P10056;3.51E-18;PAPA3_CARPA;Caricain (EC 3.4.22.30) (Papaya peptidase A) (Papaya proteinase III) (PPIII) (Papaya proteinase omega);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp50427_c0_seq1;GAXK01043226.1;D8Q9M3;5.69E-45;AMYG_SCHCM;Glucoamylase ARB_02327-1 (EC 3.2.1.3) (1,4-alpha-D-glucan glucohydrolase) (Glucan 1,4-alpha-glucosidase) (allergen Sch c 1);"extracellular region [GO:0005576]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004339; GO:0005576; GO:2001070";polysaccharide catabolic process [GO:0000272];extracellular region [GO:0005576];"glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]"
comp50437_c0_seq1;GAXK01043352.1;Q8BHL8;1.47E-18;PSMF1_MOUSE;Proteasome inhibitor PI31 subunit;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0005783; GO:0005829; GO:0006511; GO:0042803; GO:0046982; GO:0048471; GO:0070628; GO:1901799";"negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]";"proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp5044_c3_seq1;GAXK01067219.1;Q9U1G2;1.28E-08;ALL7_LEPDS;Mite allergen Lep d 7 (allergen Lep d 7);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp504531_c0_seq1;GAXK01015775.1;Q96IR2;1.55E-16;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp504608_c2_seq1;GAXK01015816.1;Q9DCD5;1.76E-07;TJAP1_MOUSE;Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030]";"GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0007030";Golgi organization [GO:0007030];"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";
comp5046968_c0_seq1;GAXK01197894.1;O54963;1.64E-15;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp5047073_c0_seq1;GAXK01197888.1;Q99KE8;7.40E-08;ZFP64_MOUSE;Zinc finger protein 64 (Zfp-64);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0007275; GO:0010468; GO:0032728; GO:0032755; GO:0032760; GO:0046872; GO:0048026";"multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp50471_c0_seq1;GAXK01043277.1;P49906;3.79E-40;TAF11_DROME;Transcription initiation factor TFIID subunit 11 (TAFII30 beta) (Transcription initiation factor TFIID 28 kDa subunit beta) (p28-beta);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003713; GO:0005634; GO:0005669; GO:0005737; GO:0006367; GO:0008134; GO:0046982; GO:0051123; GO:0070578; GO:1900370";"positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]";"protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp50477_c0_seq1;GAXK01043770.1;Q922E4;9.13E-167;PCY2_MOUSE;Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase);"ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004306; GO:0006646";phosphatidylethanolamine biosynthetic process [GO:0006646];;ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]
comp5047974_c0_seq1;GAXK01197902.1;Q9SS17;4.16E-27;RS241_ARATH;40S ribosomal protein S24-1;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp504837_c0_seq1;GAXK01015650.1;Q6DCX5;3.63E-13;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp5050_c0_seq1;GAXK01065669.1;P21894;0;SYAC_BOMMO;Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS);"cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]";"GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270";alanyl-tRNA aminoacylation [GO:0006419];cytoplasm [GO:0005737];"alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp505109_c0_seq1;GAXK01015824.1;Q4AC99;7.09E-61;1A1L2_HUMAN;Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2 (ACC synthase-like protein 2);"catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]";"GO:0003824; GO:0009058; GO:0030170";biosynthetic process [GO:0009058];;"catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]"
comp5051583_c0_seq1;GAXK01137012.1;O17795;4.74E-10;STDH2_CAEEL;Putative steroid dehydrogenase 2 (EC 1.1.1.-);"endoplasmic reticulum [GO:0005783]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"GO:0005783; GO:0006694; GO:0016491; GO:0030497";"fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";endoplasmic reticulum [GO:0005783];oxidoreductase activity [GO:0016491]
comp50519_c7_seq1;GAXK01043485.1;Q14624;3.28E-91;ITIH4_HUMAN;"Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]";"endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp5051916_c0_seq1;GAXK01137018.1;P51405;2.91E-93;RS4_DICDI;40S ribosomal protein S4;"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]; inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"GO:0000822; GO:0003735; GO:0005856; GO:0006412; GO:0019843; GO:0022627; GO:0030036; GO:0031012; GO:0032991";"actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]";"inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5051952_c0_seq1;GAXK01137019.1;Q9M2F1;1.74E-29;RS272_ARATH;40S ribosomal protein S27-2;"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005618; GO:0005840; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788; GO:0046872";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]";"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp505210_c1_seq1;GAXK01015701.1;P10076;9.99E-88;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp50522_c2_seq1;GAXK01043511.1;Q5NC05;1.68E-158;TTF2_MOUSE;Transcription termination factor 2 (EC 3.6.4.-) (RNA polymerase II termination factor) (Transcription release factor 2);"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003677; GO:0004386; GO:0005524; GO:0005681; GO:0005829; GO:0006353; GO:0006397; GO:0008270; GO:0008380";"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]"
comp50534_c0_seq1;GAXK01043652.1;P41386;3.29E-102;TBB_HALDI;Tubulin beta chain (Beta-tubulin) (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp505580_c0_seq1;GAXK01015647.1;Q4TZY1;1.10E-67;KCJ12_BOVIN;ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp5056052_c0_seq1;GAXK01057199.1;P19515;4.35E-25;LIP_RHIMI;Lipase (EC 3.1.1.3) (Triacylglycerol lipase);"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];;"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp50563_c9_seq1;GAXK01043132.1;O75165;0;DJC13_HUMAN;DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8);"azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]";"GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641";"endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]";"azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]";
comp505654_c1_seq1;GAXK01015817.1;A0A0D3QS97;2.69E-19;NOTU2_XENLA;Palmitoleoyl-protein carboxylesterase notum2 (EC 3.1.1.98);"extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0016055; GO:0052689";Wnt signaling pathway [GO:0016055];extracellular region [GO:0005576];carboxylic ester hydrolase activity [GO:0052689]
comp50579_c1_seq1;GAXK01043875.1;P43006;1.14E-93;EAA2_MOUSE;Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);"axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0007399; GO:0007632; GO:0008509; GO:0009416; GO:0009611; GO:0009986; GO:0010259; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0042734; GO:0043005; GO:0043197; GO:0043198; GO:0043200; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098656; GO:0098712; GO:0098810; GO:0098978; GO:0099056";"adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]";"axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp505800_c2_seq1;GAXK01015703.1;P09478;3.93E-28;ACH1_DROME;Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp50584_c0_seq1;GAXK01043227.1;Q6DGV1;3.09E-98;CELF4_DANRE;CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904";"mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp5058486_c0_seq1;GAXK01089723.1;P51554;4.38E-20;EF1A_HYDVU;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp505949_c0_seq1;GAXK01015699.1;G3V9R3;1.41E-45;ST1D1_RAT;Sulfotransferase 1 family member D1 (ST1D1) (EC 2.8.2.-) (Dopamine sulfotransferase Sult1d1) (Tyrosine-ester sulfotransferase);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; lipid metabolic process [GO:0006629]";"GO:0005737; GO:0006584; GO:0006629; GO:0008146";"catecholamine metabolic process [GO:0006584]; lipid metabolic process [GO:0006629]";cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp50595_c0_seq1;GAXK01043071.1;Q8R3N1;2.06E-57;NOP14_MOUSE;Nucleolar protein 14 (Nucleolar complex protein 14);"Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; snoRNA binding [GO:0030515]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]";"GO:0005634; GO:0005730; GO:0006364; GO:0019899; GO:0030515; GO:0030692; GO:0032040; GO:0042274";"ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]";"Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]";"enzyme binding [GO:0019899]; snoRNA binding [GO:0030515]"
comp5059560_c0_seq1;GAXK01089736.1;O76190;5.08E-49;RL5_BOMMO;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp50596_c1_seq1;GAXK01042973.1;Q01989;0;MYS9_DROME;Myosin heavy chain 95F (95F MHC) (Protein jaguar);"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]; spindle organization [GO:0007051]";"GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005875; GO:0005938; GO:0006997; GO:0007015; GO:0007051; GO:0007283; GO:0007291; GO:0007297; GO:0007298; GO:0007391; GO:0007552; GO:0007560; GO:0008017; GO:0008104; GO:0008363; GO:0016333; GO:0016461; GO:0019749; GO:0030036; GO:0030048; GO:0030139; GO:0030317; GO:0030426; GO:0030589; GO:0031476; GO:0032027; GO:0032880; GO:0032956; GO:0032970; GO:0032991; GO:0040001; GO:0042623; GO:0045167; GO:0045172; GO:0045175; GO:0045178; GO:0045217; GO:0045921; GO:0047497; GO:0048477; GO:0051015; GO:0051647; GO:0055057; GO:0055059; GO:0061024; GO:0070856; GO:0070864; GO:0070865";"actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; border follicle cell migration [GO:0007298]; cell-cell junction maintenance [GO:0045217]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; dorsal closure [GO:0007391]; establishment of mitotic spindle localization [GO:0040001]; flagellated sperm motility [GO:0030317]; imaginal disc morphogenesis [GO:0007560]; larval chitin-based cuticle development [GO:0008363]; membrane organization [GO:0061024]; metamorphosis [GO:0007552]; mitochondrion transport along microtubule [GO:0047497]; morphogenesis of follicular epithelium [GO:0016333]; neuroblast division [GO:0055057]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; positive regulation of exocytosis [GO:0045921]; protein localization [GO:0008104]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; germline ring canal [GO:0045172]; growth cone [GO:0030426]; investment cone [GO:0070865]; microtubule associated complex [GO:0005875]; myosin VI complex [GO:0031476]; protein-containing complex [GO:0032991]; sperm individualization complex [GO:0070864]; unconventional myosin complex [GO:0016461]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; myosin VI light chain binding [GO:0070856]"
comp5059683_c0_seq1;GAXK01089734.1;Q80SU7;5.28E-38;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp5060448_c0_seq1;GAXK01137173.1;Q98993;3.17E-32;VTXB_SYNVE;Verrucotoxin subunit beta (VTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp5060449_c0_seq1;GAXK01137178.1;Q8ISQ3;5.97E-07;RL24_BRABE;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp50610_c1_seq1;GAXK01043859.1;Q86TM3;2.22E-42;DDX53_HUMAN;Probable ATP-dependent RNA helicase DDX53 (EC 3.6.4.13) (Cancer-associated gene protein) (Cancer/testis antigen 26) (CT26) (DEAD box protein 53) (DEAD box protein CAGE);"nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634";;nucleus [GO:0005634];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp506302_c2_seq1;GAXK01198459.1;P49640;5.33E-29;EVX1_HUMAN;Homeobox even-skipped homolog protein 1 (EVX-1);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]";"GO:0000790; GO:0000981; GO:0003700; GO:0005654; GO:0009792; GO:0021913; GO:0043565; GO:0045944";"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp5063267_c0_seq1;GAXK01137912.1;P52292;4.26E-12;IMA1_HUMAN;Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"GO:0000018; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902";"DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]"
comp5063887_c0_seq1;GAXK01137909.1;Q5TYW1;2.74E-08;ZN658_HUMAN;Zinc finger protein 658;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";"GO:0000976; GO:0003677; GO:0005634; GO:0042254; GO:0045892; GO:0046872; GO:0071294";"cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp5064505_c0_seq1;GAXK01146324.1;P58374;6.41E-59;RL30_BRABE;60S ribosomal protein L30;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022625";;cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp506572_c1_seq1;GAXK01198499.1;Q9NVR0;4.08E-13;KLH11_HUMAN;Kelch-like protein 11;"cytosol [GO:0005829]; post-translational protein modification [GO:0043687]";"GO:0005829; GO:0043687";post-translational protein modification [GO:0043687];cytosol [GO:0005829];
comp50666_c2_seq1;GAXK01043871.1;P35038;1.19E-47;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp50667_c0_seq1;GAXK01042978.1;Q9DC37;2.63E-135;MFSD1_MOUSE;Major facilitator superfamily domain-containing protein 1;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp5066750_c0_seq1;GAXK01122863.1;Q9NYC9;4.57E-42;DYH9_HUMAN;Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0097729; GO:0120135";"cell projection organization [GO:0030030]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp506694_c0_seq1;GAXK01198476.1;Q28F51;1.88E-28;TADBP_XENTR;TAR DNA-binding protein 43 (TDP-43);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]";"GO:0003690; GO:0003723; GO:0003727; GO:0003730; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0031647; GO:0042752; GO:0048511; GO:0070935; GO:1990904";"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp506716_c0_seq1;GAXK01198486.1;Q61493;3.05E-65;REV3L_MOUSE;DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4);"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305";"DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]";"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp50676_c2_seq1;GAXK01043758.1;P19213;1.68E-163;CREA_FLASU;Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase);creatinase activity [GO:0016980];GO:0016980;;;creatinase activity [GO:0016980]
comp50678_c1_seq1;GAXK01043371.1;Q3UQA7;5.54E-08;SELH_MOUSE;Selenoprotein H (SelH);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";"GO:0005737; GO:0005794";;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";
comp506795_c1_seq1;GAXK01198450.1;Q9NYT6;1.73E-12;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp50681_c1_seq2;GAXK01043067.1;A6QLU1;0;GPDM_BOVIN;Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3);"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]";"GO:0004367; GO:0004368; GO:0005509; GO:0005739; GO:0009331; GO:0019563; GO:0046168; GO:0052591";"glycerol-3-phosphate catabolic process [GO:0046168]; glycerol catabolic process [GO:0019563]";"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]";"calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]"
comp506819_c0_seq1;GAXK01198473.1;Q6ZMB0;2.81E-31;B3GN6_HUMAN;Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0008376; GO:0008378; GO:0008532; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016269; GO:0030311; GO:0047223; GO:0047224";"glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]"
comp506841_c3_seq1;GAXK01198461.1;Q9VZX1;2.44E-10;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp506844_c0_seq1;GAXK01198454.1;Q14591;6.66E-21;ZN271_HUMAN;Deleted.;;;;;
comp5069_c0_seq1;GAXK01066862.1;Q32L92;3.31E-44;CNN3_BOVIN;Calponin-3 (Calponin, acidic isoform);"actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actomyosin structure organization [GO:0031032]";"GO:0003779; GO:0005516; GO:0008017; GO:0031032";actomyosin structure organization [GO:0031032];;"actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]"
comp506913_c0_seq1;GAXK01198515.1;Q9UHJ6;3.38E-143;SHPK_HUMAN;Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353";"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277]"
comp5069176_c0_seq1;GAXK01118787.1;P41203;3.24E-15;EF1A_DESMO;Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp5069548_c0_seq1;GAXK01118794.1;P08922;2.50E-18;ROS1_HUMAN;Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0007283; GO:0008283; GO:0009986; GO:0010629; GO:0010966; GO:0016020; GO:0019903; GO:0023014; GO:0030154; GO:0032006; GO:0038083; GO:0043235; GO:0048471; GO:0070372";"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp506962_c0_seq1;GAXK01198458.1;P35875;1.14E-13;PARP_DROME;Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase Parp) (EC 2.4.2.-);"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"GO:0003677; GO:0003950; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0005719; GO:0005730; GO:0006302; GO:0006325; GO:0006355; GO:0006471; GO:0006963; GO:0007000; GO:0007552; GO:0008069; GO:0008270; GO:0009303; GO:0015030; GO:0030576; GO:0035079; GO:0035080; GO:0035363; GO:0042393; GO:0043484; GO:0045087; GO:0051276; GO:0051287; GO:0051457; GO:0070212; GO:1900182; GO:1990404";"Cajal body organization [GO:0030576]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; double-strand break repair [GO:0006302]; heat shock-mediated polytene chromosome puffing [GO:0035080]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; metamorphosis [GO:0007552]; nucleolus organization [GO:0007000]; polytene chromosome puffing [GO:0035079]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein localization to nucleus [GO:1900182]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]";"Cajal body [GO:0015030]; chromosome [GO:0005694]; histone locus body [GO:0035363]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp507_c0_seq1;GAXK01168743.1;Q7ZY35;7.65E-08;LLPH_XENLA;Protein LLP homolog (Protein LAPS18-like);"chromosome [GO:0005694]; nucleolus [GO:0005730]; basal RNA polymerase II transcription machinery binding [GO:0001099]; dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999]";"GO:0001099; GO:0005694; GO:0005730; GO:0060999; GO:0097484";"dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999]";"chromosome [GO:0005694]; nucleolus [GO:0005730]";basal RNA polymerase II transcription machinery binding [GO:0001099]
comp5070218_c0_seq1;GAXK01131284.1;Q23F79;7.31E-41;RL26_TETTS;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp5070739_c0_seq1;GAXK01131273.1;Q8K2R5;1.29E-07;ZN668_MOUSE;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp507110_c1_seq1;GAXK01198472.1;Q8N7K0;5.44E-09;ZN433_HUMAN;Zinc finger protein 433;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp507146_c2_seq1;GAXK01198508.1;Q6NY73;1.39E-08;L3BPB_DANRE;Galectin-3-binding protein B (Lectin galactoside-binding soluble 3-binding protein B);"extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]";"GO:0005044; GO:0005576; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"extracellular region [GO:0005576]; membrane [GO:0016020]";scavenger receptor activity [GO:0005044]
comp5071571_c0_seq1;GAXK01131276.1;Q8VEH8;4.45E-18;ERLEC_MOUSE;Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin);"endoplasmic reticulum lumen [GO:0005788]; unfolded protein binding [GO:0051082]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005788; GO:0030433; GO:0030970; GO:0051082; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";endoplasmic reticulum lumen [GO:0005788];unfolded protein binding [GO:0051082]
comp507163_c1_seq1;GAXK01198455.1;Q1A3B0;3.48E-51;CERS3_MOUSE;Ceramide synthase 3 (CerS3) (mCerS3) (EC 2.3.1.-) (Dihydroceramide synthase 3) (LAG1 longevity assurance homolog 3) (Sphingosine N-acyltransferase CERS3) (EC 2.3.1.24);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; sphingolipid biosynthetic process [GO:0030148]";"GO:0003677; GO:0005783; GO:0008544; GO:0016021; GO:0030148; GO:0030216; GO:0031965; GO:0046513; GO:0050291; GO:0070268";"ceramide biosynthetic process [GO:0046513]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]"
comp507180_c0_seq1;GAXK01198483.1;Q66S03;5.78E-10;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp5072031_c0_seq1;GAXK01110948.1;O76756;1.14E-118;RS8_APIME;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp507525_c2_seq1;GAXK01198501.1;P18117;1.62E-16;THBA_XENLA;Thyroid hormone receptor beta-A (TRbetaA) (xTR) (Nuclear receptor subfamily 1 group A member 2-A);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0070324";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp5075688_c0_seq1;GAXK01112408.1;P35034;6.84E-11;TRYP_PLEPL;Trypsin (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp507588_c0_seq1;GAXK01198531.1;O65621;8.68E-44;CADH6_ARATH;Probable cinnamyl alcohol dehydrogenase 6 (AtCAD6) (EC 1.1.1.195) (Cinnamyl alcohol dehydrogenase-like protein A);"cinnamyl-alcohol dehydrogenase activity [GO:0045551]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sinapyl alcohol dehydrogenase activity [GO:0052747]; zinc ion binding [GO:0008270]; lignin biosynthetic process [GO:0009809]";"GO:0008270; GO:0009809; GO:0016616; GO:0045551; GO:0052747";lignin biosynthetic process [GO:0009809];;"cinnamyl-alcohol dehydrogenase activity [GO:0045551]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sinapyl alcohol dehydrogenase activity [GO:0052747]; zinc ion binding [GO:0008270]"
comp5076_c1_seq1;GAXK01066223.1;P62305;1.06E-42;RUXE_MOUSE;Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE);"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0042633; GO:0046540; GO:0071005; GO:0071007; GO:1990446";"hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]";"RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]"
comp507633_c0_seq1;GAXK01198440.1;Q8IN81;1.89E-18;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5077_c1_seq1;GAXK01066011.1;Q9XYN1;2.42E-116;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp5077180_c0_seq1;GAXK01095993.1;Q26491;6.69E-17;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp50772_c0_seq1;GAXK01043826.1;P24014;0;SLIT_DROME;"Protein slit (dSlit) [Cleaved into: Protein slit N-product; Protein slit C-product]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell migration [GO:0008078]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"GO:0001764; GO:0003151; GO:0005509; GO:0005576; GO:0005886; GO:0007411; GO:0007427; GO:0007432; GO:0007502; GO:0007509; GO:0008078; GO:0008201; GO:0008347; GO:0008406; GO:0010632; GO:0016199; GO:0016201; GO:0022409; GO:0030182; GO:0030335; GO:0035050; GO:0035385; GO:0048495; GO:0048813; GO:0050929; GO:0071666; GO:2000274";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesodermal cell migration [GO:0008078]; mesoderm migration involved in gastrulation [GO:0007509]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell migration [GO:0030335]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]"
comp5077364_c0_seq1;GAXK01095992.1;Q8YSQ6;3.92E-41;TMBP_NOSS1;Monocarboxylate 2-oxoacid-binding periplasmic protein all3028 (Extracellular solute-binding protein) (Extracytoplasmic solute receptor protein all3028) (TRAP transporter monocarboxylate 2-oxoacid-binding subunit P);"periplasmic space [GO:0042597]; tripartite ATP-independent periplasmic transporter complex [GO:0031317]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; organic acid transmembrane transporter activity [GO:0005342]; protein homodimerization activity [GO:0042803]; organic acid transport [GO:0015849]";"GO:0005342; GO:0015849; GO:0031317; GO:0042597; GO:0042803; GO:0043177; GO:0046872";organic acid transport [GO:0015849];"periplasmic space [GO:0042597]; tripartite ATP-independent periplasmic transporter complex [GO:0031317]";"metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; organic acid transmembrane transporter activity [GO:0005342]; protein homodimerization activity [GO:0042803]"
comp507874_c0_seq1;GAXK01198530.1;P93748;4.60E-10;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp5078993_c0_seq1;GAXK01182178.1;O35604;5.66E-12;NPC1_MOUSE;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp507962_c1_seq1;GAXK01198497.1;Q7T005;2.06E-17;RFIP3_DANRE;Rab11 family-interacting protein 3 (FIP3-Rab11) (Rab11-FIP3);"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465]";"GO:0005509; GO:0005768; GO:0005813; GO:0007049; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0051301; GO:0055037; GO:0055038";"cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]";"ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp50800_c1_seq1;GAXK01043163.1;Q6PGW3;0;ARMD3_DANRE;Armadillo-like helical domain-containing protein 3;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5080387_c0_seq1;GAXK01136622.1;P55390;4.49E-12;Y4CH_SINFN;Probable cold shock protein y4cH;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]";"GO:0003677; GO:0005737";;cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp508065_c0_seq1;GAXK01122607.1;Q8AYA4;8.44E-14;SLB1_DEIAC;Snaclec agglucetin subunit beta-1;"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp508102_c0_seq1;GAXK01122579.1;Q17BA4;2.11E-08;MED15_AEDAE;Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp508186_c0_seq1;GAXK01122567.1;P20482;3.38E-10;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp50820_c0_seq1;GAXK01204814.1;Q04073;3.19E-106;P3A2_STRPU;DNA-binding protein P3A2;"nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0001046; GO:0003700; GO:0005634; GO:0006357";regulation of transcription by RNA polymerase II [GO:0006357];nucleus [GO:0005634];"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5082095_c0_seq1;GAXK01123573.1;Q8SWR3;2.13E-33;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp508219_c0_seq1;GAXK01122575.1;P05661;1.99E-07;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp5082285_c0_seq1;GAXK01123577.1;P07949;3.00E-25;RET_HUMAN;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007399; GO:0007411; GO:0007497; GO:0010008; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp508398_c0_seq1;GAXK01122617.1;Q6P1Q0;1.24E-18;LTMD1_HUMAN;LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]";"GO:0005654; GO:0005739; GO:0005741; GO:0005743; GO:0016021; GO:0043022";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";ribosome binding [GO:0043022]
comp50843_c2_seq1;GAXK01043299.1;Q3UCQ1;2.98E-73;FOXK2_MOUSE;Forkhead box protein K2 (Cellular transcription factor ILF-1) (Interleukin enhancer-binding factor 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]";"GO:0000287; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001678; GO:0003700; GO:0005634; GO:0005737; GO:0010507; GO:0010906; GO:0035947; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0061621";"canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp5084492_c0_seq1;GAXK01098173.1;P55112;4.98E-22;NAS4_CAEEL;Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp508465_c0_seq1;GAXK01122593.1;Q96RW7;3.74E-40;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp50850_c0_seq1;GAXK01043823.1;Q5XM24;1.64E-70;APRA_DICDI;Autocrine proliferation repressor protein A (PhoPQ-activated pathogenicity-related protein);"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005096; GO:0005102; GO:0005576; GO:0007049; GO:0008233; GO:0030435; GO:0031157; GO:0032991; GO:0045499; GO:0050919; GO:0072659; GO:0090630; GO:1903665";"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435]";"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]";"chemorepellent activity [GO:0045499]; GTPase activator activity [GO:0005096]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]"
comp5085286_c0_seq1;GAXK01098168.1;Q6IQX8;1.95E-08;ZN219_MOUSE;Zinc finger protein 219;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0030154; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174";"cell differentiation [GO:0030154]; limb bud formation [GO:0060174]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5085565_c0_seq1;GAXK01098171.1;O91250;2.12E-17;REP7_FBNY2;Para-Rep C7 (Rep7) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3) (ATP-dependent helicase C7) (Replication-associated protein of non-essential DNA C7);"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";"GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872";"DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]";host cell nucleus [GO:0042025];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5086252_c0_seq1;GAXK01087106.1;P98150;5.51E-12;NFKB2_CHICK;Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (Lyt-10) (Nuclear factor NF-kappa-B p97 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit (Nuclear factor NF-kappa-B p50B subunit)];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0048511";"rhythmic process [GO:0048511]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp5086683_c0_seq1;GAXK01087115.1;Q6NRF4;1.13E-09;CCY1B_XENLA;Cyclin-Y-like protein 1-B;"protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0019901";regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079];;protein kinase binding [GO:0019901]
comp50874_c0_seq1;GAXK01043363.1;Q6PJP8;1.23E-76;DCR1A_HUMAN;DNA cross-link repair 1A protein (SNM1 homolog A) (hSNM1) (hSNM1A);"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"GO:0000784; GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0031848; GO:0035312; GO:0036297; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]";"5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]"
comp50878_c1_seq1;GAXK01043438.1;O54862;4.84E-14;MBTP2_CRIGR;Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0004222; GO:0005737; GO:0008203; GO:0016021; GO:0031293; GO:0034976; GO:0046872; GO:0051091; GO:0070977; GO:1990440";"bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; response to endoplasmic reticulum stress [GO:0034976]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp508810_c0_seq1;GAXK01122595.1;Q96LZ3;3.65E-25;CANB2_HUMAN;Calcineurin subunit B type 2 (Calcineurin B-like protein) (CBLP) (Calcineurin BII) (CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp50882_c16_seq1;GAXK01043015.1;P24350;4.03E-99;IPOU_DROME;Inhibitory POU protein (I-POU) (Abnormal chemosensory jump 6 protein);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; axon guidance [GO:0007411]; chemosensory jump behavior [GO:0007636]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; synaptic target recognition [GO:0008039]";"GO:0003700; GO:0003714; GO:0005634; GO:0007411; GO:0007636; GO:0008039; GO:0043565; GO:0045944; GO:0048813; GO:0050911; GO:0070983";"axon guidance [GO:0007411]; chemosensory jump behavior [GO:0007636]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]"
comp5088583_c0_seq1;GAXK01010252.1;Q8BW94;1.16E-17;DYH3_MOUSE;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp509081_c1_seq1;GAXK01122572.1;Q8N2M4;1.79E-19;TM86A_HUMAN;Lysoplasmalogenase-like protein TMEM86A (Transmembrane protein 86A);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409]; ether lipid metabolic process [GO:0046485]";"GO:0016020; GO:0016021; GO:0046485; GO:0047408; GO:0047409";ether lipid metabolic process [GO:0046485];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409]"
comp509226_c0_seq1;GAXK01122553.1;Q6P2X9;4.49E-18;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp5092384_c0_seq1;GAXK01001923.1;P54774;9.40E-130;CDC48_SOYBN;Cell division cycle protein 48 homolog (Valosin-containing protein homolog) (VCP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0071712; GO:0097352";"autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]"
comp5092429_c0_seq1;GAXK01001922.1;Q9XU98;7.56E-07;EVA1_CAEEL;Protein eva-1 (Enhancer of ventral-axon guidance defects of unc-40 mutants);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; carbohydrate binding [GO:0030246]";"GO:0005886; GO:0016021; GO:0030054; GO:0030246; GO:0031430; GO:0055120";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]";carbohydrate binding [GO:0030246]
comp509274_c1_seq1;GAXK01122529.1;Q91ZH7;3.83E-17;ABHD3_MOUSE;Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3);"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";"GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568";"cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]";integral component of membrane [GO:0016021];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"
comp509298_c0_seq1;GAXK01122526.1;A8E0R9;6.47E-56;GRIP2_XENLA;Glutamate receptor-interacting protein 2 (xGRIP2) (xGRIP2.1);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; pole plasm [GO:0045495]; receptor signaling complex adaptor activity [GO:0030159]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; multicellular organism development [GO:0007275]";"GO:0005737; GO:0005938; GO:0007275; GO:0007281; GO:0008354; GO:0030159; GO:0032019; GO:0045495";"germ cell development [GO:0007281]; germ cell migration [GO:0008354]; multicellular organism development [GO:0007275]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; pole plasm [GO:0045495]";receptor signaling complex adaptor activity [GO:0030159]
comp5093_c0_seq1;GAXK01065984.1;O01814;1.17E-16;FABP5_CAEEL;Fatty acid-binding protein homolog 5;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504]";"GO:0005504; GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";fatty acid binding [GO:0005504]
comp5093300_c0_seq1;GAXK01001930.1;P35464;3.16E-08;DIHR_MANSE;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp509352_c0_seq1;GAXK01122532.1;O42115;5.12E-22;ARX_DANRE;Aristaless-related homeobox protein (ARX);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]";"GO:0000977; GO:0000981; GO:0003322; GO:0005634; GO:0021537; GO:0021539; GO:0021794; GO:0048666";"neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp50936_c0_seq1;GAXK01043898.1;O88447;6.02E-19;KLC1_MOUSE;Kinesin light chain 1 (KLC 1);"axon [GO:0030424]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]; microtubule motor activity [GO:0003777]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; intracellular protein transport [GO:0006886]; microtubule-based movement [GO:0007018]; protein localization to synapse [GO:0035418]; stress granule disassembly [GO:0035617]";"GO:0003777; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008088; GO:0015631; GO:0016020; GO:0030424; GO:0030426; GO:0031410; GO:0031982; GO:0035253; GO:0035418; GO:0035617; GO:0043005; GO:0043025; GO:0043227";"axo-dendritic transport [GO:0008088]; intracellular protein transport [GO:0006886]; microtubule-based movement [GO:0007018]; protein localization to synapse [GO:0035418]; stress granule disassembly [GO:0035617]";"axon [GO:0030424]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; vesicle [GO:0031982]";"microtubule motor activity [GO:0003777]; tubulin binding [GO:0015631]"
comp509421_c1_seq1;GAXK01122578.1;Q8K4R9;6.62E-28;DLGP5_MOUSE;Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; phosphoprotein phosphatase activity [GO:0004721]; cell cycle [GO:0007049]; signaling [GO:0023052]";"GO:0004721; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0007049; GO:0023052; GO:0031616";"cell cycle [GO:0007049]; signaling [GO:0023052]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]";phosphoprotein phosphatase activity [GO:0004721]
comp50951_c0_seq1;GAXK01043753.1;Q24174;4.96E-18;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp509632_c2_seq1;GAXK01122611.1;Q8BX70;3.82E-57;VP13C_MOUSE;Vacuolar protein sorting-associated protein 13C;"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]";"GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:1905090";"mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]";"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]";
comp5096349_c0_seq1;GAXK01024413.1;Q15937;4.00E-08;ZNF79_HUMAN;Zinc finger protein 79 (ZNFpT7);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5096472_c0_seq1;GAXK01024412.1;P36182;3.30E-38;HSP82_TOBAC;Heat shock protein 82 (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp509677_c0_seq1;GAXK01122591.1;Q80UG8;6.78E-87;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp5097154_c0_seq1;GAXK01024420.1;A2RRD8;1.94E-07;ZN320_HUMAN;Zinc finger protein 320;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5098094_c0_seq1;GAXK01198804.1;Q5M7N9;4.26E-14;ESYT3_XENTR;Extended synaptotagmin-3 (E-Syt3);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0006869; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0061817; GO:0140268";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp50989_c5_seq1;GAXK01043862.1;Q5R5U3;6.13E-08;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp50993_c0_seq2;GAXK01043670.1;Q17QJ5;2.13E-83;TSN5_BOVIN;Tetraspanin-5 (Tspan-5);"integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]";"GO:0005887; GO:0019899; GO:0045747; GO:0051604; GO:0072659";"positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]";integral component of plasma membrane [GO:0005887];enzyme binding [GO:0019899]
comp51_c1_seq1;GAXK01169486.1;P62924;1.15E-73;IF5A_SPOEX;Eukaryotic translation initiation factor 5A (eIF-5A);"cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003746; GO:0005737; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";cytoplasm [GO:0005737];"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp51003_c0_seq1;GAXK01043164.1;P31729;1.81E-10;OV16_ONCVO;OV-16 antigen;;;;;
comp510065_c0_seq1;GAXK01138671.1;B7IA66;2.45E-73;RIBA_ACIB5;GTP cyclohydrolase-2 (EC 3.5.4.25) (GTP cyclohydrolase II);"GTP binding [GO:0005525]; GTP cyclohydrolase II activity [GO:0003935]; zinc ion binding [GO:0008270]; riboflavin biosynthetic process [GO:0009231]";"GO:0003935; GO:0005525; GO:0008270; GO:0009231";riboflavin biosynthetic process [GO:0009231];;"GTP binding [GO:0005525]; GTP cyclohydrolase II activity [GO:0003935]; zinc ion binding [GO:0008270]"
comp510175_c0_seq1;GAXK01138730.1;P50430;6.77E-64;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp51029_c0_seq1;GAXK01043426.1;Q8BSK8;1.20E-123;KS6B1_MOUSE;Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA);"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]";"GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006468; GO:0006915; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009611; GO:0009612; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030054; GO:0030165; GO:0031667; GO:0031929; GO:0032496; GO:0032868; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0035556; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0071346; GO:0071363; GO:0071407; GO:0071549; GO:2001237";"aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]";"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]"
comp51037_c0_seq1;GAXK01043824.1;Q16527;1.22E-43;CSRP2_HUMAN;Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2) (LIM domain only protein 5) (LMO-5) (Smooth muscle cell LIM protein) (SmLIM);"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0005925; GO:0007275; GO:0008307; GO:0030018; GO:0030036; GO:0030154; GO:0042805; GO:0045214; GO:0046872; GO:0060537";"actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp51039_c0_seq1;GAXK01043648.1;Q9VB74;2.23E-13;NKAP_DROME;NKAP family protein CG6066;"catalytic step 2 spliceosome [GO:0071013]; chromatin binding [GO:0003682]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]";"GO:0000398; GO:0003682; GO:0007219; GO:0045892; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]";catalytic step 2 spliceosome [GO:0071013];chromatin binding [GO:0003682]
comp510396_c0_seq1;GAXK01138695.1;Q8AV58;4.30E-10;SDK1_CHICK;Protein sidekick-1;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0030054; GO:0042802; GO:0045202";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";identical protein binding [GO:0042802]
comp51056_c1_seq1;GAXK01205165.1;P52485;6.33E-106;UBCD2_DROME;Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0004842; GO:0005524; GO:0019915; GO:0061631";"lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp5106353_c0_seq1;GAXK01005804.1;P57929;1.28E-30;Y1258_PASMU;UPF0114 protein PM1258;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5106452_c0_seq1;GAXK01005798.1;Q8K2R5;3.45E-11;ZN668_MOUSE;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5107_c1_seq1;GAXK01065907.1;Q8R3R5;4.02E-82;T185B_MOUSE;Transmembrane protein 185B (Erythropoietin-induced EST 3-2) (Protein FAM11B);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5107068_c0_seq1;GAXK01005787.1;P21902;5.10E-57;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp510707_c0_seq1;GAXK01138690.1;Q7M4F0;3.57E-07;CUD9_SCHGR;Endocuticle structural glycoprotein SgAbd-9;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp5107543_c0_seq1;GAXK01005789.1;P41127;7.32E-38;RL131_ARATH;60S ribosomal protein L13-1 (Protein BBC1 homolog);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp5107652_c0_seq1;GAXK01005802.1;Q24732;3.39E-07;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp510825_c5_seq1;GAXK01138733.1;Q5RG49;1.21E-35;ACSF4_DANRE;Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4);"acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0006631; GO:0016878";fatty acid metabolic process [GO:0006631];;"acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]"
comp5108471_c0_seq1;GAXK01192927.1;Q8BIQ3;2.25E-19;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5109462_c0_seq1;GAXK01192911.1;P59230;2.72E-77;R10A2_ARATH;60S ribosomal protein L10a-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; peroxisome [GO:0005777]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; adaxial/abaxial pattern specification [GO:0009955]; maturation of LSU-rRNA [GO:0000470]; post-embryonic plant organ development [GO:0090696]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0005777; GO:0005829; GO:0006412; GO:0009955; GO:0022625; GO:0022626; GO:0042788; GO:0090696";"adaxial/abaxial pattern specification [GO:0009955]; maturation of LSU-rRNA [GO:0000470]; post-embryonic plant organ development [GO:0090696]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; peroxisome [GO:0005777]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp510999_c0_seq1;GAXK01138687.1;Q8K370;3.65E-36;ACD10_MOUSE;Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-);"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]";"GO:0005739; GO:0016627; GO:0016787; GO:0050660";;mitochondrion [GO:0005739];"flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp5110026_c0_seq1;GAXK01117937.1;Q6C2P2;3.24E-11;MRS2_YARLI;Mitochondrial inner membrane magnesium transporter MRS2 (RNA-splicing protein MRS2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";magnesium ion transmembrane transporter activity [GO:0015095]
comp511066_c0_seq1;GAXK01138689.1;Q5RDQ2;2.21E-136;MPP5_PONAB;MAGUK p55 subfamily member 5;"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]";"GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0030424; GO:0043204; GO:0070830; GO:0090162";"bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]";ATP binding [GO:0005524]
comp5111026_c0_seq1;GAXK01117962.1;Q66K89;2.92E-07;E4F1_HUMAN;Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transferase activity [GO:0016740]; cell division [GO:0051301]; DNA replication [GO:0006260]; mitotic cell cycle arrest [GO:0071850]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; viral process [GO:0016032]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0009794; GO:0010564; GO:0016032; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0046872; GO:0051301; GO:0071850";"cell division [GO:0051301]; DNA replication [GO:0006260]; mitotic cell cycle arrest [GO:0071850]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]";"cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transferase activity [GO:0016740]"
comp511104_c0_seq1;GAXK01138694.1;Q28C22;9.26E-60;OGFD2_XENTR;2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-);"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0005506; GO:0016705; GO:0031418; GO:0051213";;;"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp5111043_c0_seq1;GAXK01117930.1;O29853;1.03E-09;DLD_ARCFU;D-lactate dehydrogenase (acceptor) (EC 1.1.99.6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; D-2-hydroxy-acid dehydrogenase activity [GO:0047809]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]";"GO:0005886; GO:0016021; GO:0047809; GO:0050660; GO:0071949";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"D-2-hydroxy-acid dehydrogenase activity [GO:0047809]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]"
comp5111369_c0_seq1;GAXK01117933.1;A2SKA3;8.50E-12;Y3039_METPP;UPF0234 protein Mpe_A3039;;;;;
comp5112017_c0_seq1;GAXK01078743.1;P61270;2.82E-69;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5112173_c0_seq1;GAXK01078751.1;Q9LHP1;3.33E-29;RL74_ARATH;60S ribosomal protein L7-4;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003729; GO:0003735; GO:0005829; GO:0022625; GO:0022626; GO:0042788";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp5112451_c0_seq1;GAXK01078753.1;P41127;1.69E-38;RL131_ARATH;60S ribosomal protein L13-1 (Protein BBC1 homolog);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp511264_c1_seq1;GAXK01138685.1;A2A935;8.01E-11;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp511300_c6_seq1;GAXK01138714.1;Q6UXH8;7.68E-25;CCBE1_HUMAN;Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog);"collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845]";"GO:0001946; GO:0002020; GO:0002040; GO:0003016; GO:0005509; GO:0005518; GO:0005581; GO:0005615; GO:0010575; GO:0010595; GO:0010954; GO:0030324; GO:0031012; GO:0045766; GO:0048845; GO:1900748; GO:1901492";"lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845]";"collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]"
comp5113336_c0_seq1;GAXK01078762.1;B2RX14;1.95E-53;TUT4_MOUSE;Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]";"GO:0001556; GO:0001816; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032088; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:1990074";"cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]"
comp5113441_c0_seq1;GAXK01078766.1;P50408;4.20E-37;VATF_RAT;V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F);"membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0016020; GO:0033180; GO:0042625; GO:0046961";;"membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]";"ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp511366_c0_seq1;GAXK01138744.1;P41041;1.21E-31;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp5113682_c0_seq1;GAXK01078767.1;P43024;3.58E-33;CX6A1_MOUSE;Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver);"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"GO:0004129; GO:0005739; GO:0005751; GO:0006123; GO:0009060; GO:0030234; GO:0043209";"aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]";"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]"
comp5113697_c0_seq1;GAXK01078773.1;O75074;6.17E-07;LRP3_HUMAN;Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105);"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor-mediated endocytosis [GO:0006898]";"GO:0005905; GO:0006898; GO:0016021";receptor-mediated endocytosis [GO:0006898];"clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]";
comp5113805_c0_seq1;GAXK01078755.1;Q61792;3.39E-19;LASP1_MOUSE;LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50);"cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; ion transmembrane transporter activity [GO:0015075]; metal ion binding [GO:0046872]; ion transport [GO:0006811]";"GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015";ion transport [GO:0006811];"cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]";"actin filament binding [GO:0051015]; ion transmembrane transporter activity [GO:0015075]; metal ion binding [GO:0046872]"
comp5114153_c0_seq1;GAXK01182417.1;Q99315;2.19E-08;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp5114361_c0_seq1;GAXK01182433.1;Q3U5Q7;1.48E-11;CMPK2_MOUSE;UMP-CMP kinase 2, mitochondrial (EC 2.7.4.14) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Thymidylate kinase LPS-inducible member) (TYKi);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";"GO:0004127; GO:0004550; GO:0004798; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0009142; GO:0033862; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]"
comp5115028_c0_seq1;GAXK01182439.1;O57460;2.69E-09;TLL1_DANRE;Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";"GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264";"blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp511517_c0_seq1;GAXK01138722.1;Q6ZMW2;2.08E-23;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5115358_c0_seq1;GAXK01182438.1;C3ZQF9;9.62E-18;QRFPR_BRAFL;QRFP-like peptide receptor;"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]";"GO:0004930; GO:0004983; GO:0005887; GO:1901653";cellular response to peptide [GO:1901653];integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]"
comp5115548_c0_seq1;GAXK01182416.1;O76756;1.56E-64;RS8_APIME;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp511560_c0_seq1;GAXK01138641.1;Q9D2Z8;1.25E-86;KIF12_MOUSE;Kinesin-like protein KIF12;"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp511590_c0_seq1;GAXK01138686.1;O55230;2.64E-08;RA51D_MOUSE;DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3);"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]";"GO:0000400; GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0003697; GO:0005524; GO:0005634; GO:0005657; GO:0005737; GO:0005813; GO:0006289; GO:0006974; GO:0008094; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051276; GO:0051726";"cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]";"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]";"ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]"
comp5116340_c0_seq1;GAXK01128194.1;Q69Z37;2.14E-26;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp511691_c0_seq1;GAXK01138696.1;O94673;1.24E-29;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp5117_c1_seq1;GAXK01065928.1;Q5RFB6;2.34E-156;RPN1_PONAB;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; protein glycosylation [GO:0006486]";"GO:0004579; GO:0005789; GO:0006486; GO:0016021; GO:0042470";protein glycosylation [GO:0006486];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]";dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]
comp5117493_c0_seq1;GAXK01128189.1;P03554;5.52E-08;POL_CAMVS;"Enzymatic polyprotein [Includes: Aspartic protease (EC 3.4.23.-); Endonuclease; Reverse transcriptase (EC 2.7.7.49)]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0004190; GO:0004519";;;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]"
comp511753_c1_seq1;GAXK01138711.1;P18729;2.89E-17;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5117621_c0_seq1;GAXK01128204.1;Q93560;1.68E-24;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp511778_c0_seq1;GAXK01138717.1;Q5R5X9;1.05E-12;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp51178_c0_seq1;GAXK01043471.1;Q6DFN1;3.92E-33;NDUF3_XENTR;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3;"mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005634; GO:0005743; GO:0032981";mitochondrial respiratory chain complex I assembly [GO:0032981];"mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";
comp5117830_c0_seq1;GAXK01128199.1;Q569L8;9.71E-22;CENPJ_MOUSE;Centromere protein J (CENP-J);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]";"GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005886; GO:0007099; GO:0007224; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046785; GO:0051298; GO:0051301; GO:0061511; GO:0098534; GO:1902857; GO:1903087; GO:1903724; GO:1904951; GO:1905515";"astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]"
comp5118326_c0_seq1;GAXK01115054.1;P07237;5.77E-28;PDIA1_HUMAN;Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0003723; GO:0003756; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0015037; GO:0016222; GO:0018401; GO:0019899; GO:0034378; GO:0034379; GO:0034663; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0043687; GO:0044267; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1902175";"cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]"
comp5118408_c0_seq1;GAXK01115061.1;Q9H7R5;1.38E-07;ZN665_HUMAN;Zinc finger protein 665 (Zinc finger protein 160-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5118905_c0_seq1;GAXK01115068.1;Q92766;3.52E-07;RREB1_HUMAN;Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006366; GO:0007265; GO:0007275; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:1900026; GO:1903691; GO:2000394";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp51195_c2_seq1;GAXK01043764.1;Q5DTN8;7.89E-08;JKIP3_MOUSE;Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2);"Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]";"GO:0005794; GO:0008017; GO:0019900";;Golgi apparatus [GO:0005794];"kinase binding [GO:0019900]; microtubule binding [GO:0008017]"
comp5119975_c0_seq1;GAXK01115080.1;Q7TN88;7.12E-09;PK1L2_MOUSE;Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]";"GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982";detection of mechanical stimulus [GO:0050982];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]"
comp512009_c0_seq1;GAXK01153086.1;Q9V6L0;2.62E-109;KDM4B_DROME;Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp512053_c1_seq1;GAXK01153066.1;Q4KMC9;2.54E-11;CA198_DANRE;Uncharacterized protein C1orf198 homolog;;;;;
comp512090_c4_seq1;GAXK01153119.1;P0C7T5;8.72E-34;ATX1L_HUMAN;Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1);"dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]";"GO:0000122; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0035176; GO:0048286; GO:0048856; GO:1902035";"anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]";"dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp51210_c1_seq1;GAXK01043890.1;Q9NTN3;1.86E-71;S35D1_HUMAN;UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter (UDP-GlcA/UDP-GalNAc transporter) (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7) (UGTrel7);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; transmembrane transporter activity [GO:0022857]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; chondroitin sulfate biosynthetic process [GO:0030206]; embryonic skeletal system development [GO:0048706]; UDP-glucuronate biosynthetic process [GO:0006065]";"GO:0005461; GO:0005462; GO:0005463; GO:0005789; GO:0005794; GO:0006065; GO:0008643; GO:0015165; GO:0015297; GO:0016021; GO:0022857; GO:0030206; GO:0048706";"carbohydrate transport [GO:0008643]; chondroitin sulfate biosynthetic process [GO:0030206]; embryonic skeletal system development [GO:0048706]; UDP-glucuronate biosynthetic process [GO:0006065]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"antiporter activity [GO:0015297]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; transmembrane transporter activity [GO:0022857]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]"
comp5121650_c0_seq1;GAXK01069964.1;Q4UMH6;1.11E-07;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp512183_c0_seq1;GAXK01153105.1;Q22328;3.47E-99;LEV9_CAEEL;Protein lev-9;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase inhibitor activity [GO:0030414]";"GO:0005615; GO:0030054; GO:0030414; GO:0045202";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";peptidase inhibitor activity [GO:0030414]
comp512188_c0_seq1;GAXK01153065.1;Q90837;4.12E-45;ERG_CHICK;Transcriptional regulator Erg;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565";"cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp5122262_c0_seq1;GAXK01137093.1;Q94HW2;1.60E-07;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5122282_c0_seq1;GAXK01137106.1;P54145;4.12E-19;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp512253_c0_seq1;GAXK01153097.1;P36609;7.30E-33;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp51226_c3_seq1;GAXK01043374.1;Q6DRI7;6.84E-121;DDX51_DANRE;ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51);"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5122727_c0_seq1;GAXK01137117.1;B9FFD2;9.03E-12;OPR12_ORYSJ;Putative 12-oxophytodienoate reductase 12 (EC 1.3.1.-) (OPDA-reductase 12) (OsOPR12);"FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]; oxylipin biosynthetic process [GO:0031408]";"GO:0010181; GO:0016491; GO:0031408";oxylipin biosynthetic process [GO:0031408];;"FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]"
comp5122859_c0_seq1;GAXK01137087.1;O23755;1.87E-100;EF2_BETVU;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp512298_c0_seq1;GAXK01153186.1;P72991;3.46E-19;FTSH3_SYNY3;ATP-dependent zinc metalloprotease FtsH 3 (EC 3.4.24.-);"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"GO:0004176; GO:0004222; GO:0005524; GO:0006508; GO:0008270; GO:0009535; GO:0009941; GO:0010027; GO:0010205; GO:0010206; GO:0010304; GO:0016021";"photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp5123245_c0_seq1;GAXK01137094.1;P49196;6.44E-29;RS12_CAEEL;40S ribosomal protein S12;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp5123358_c0_seq1;GAXK01137092.1;P20825;5.24E-07;POL2_DROME;"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5123847_c0_seq1;GAXK01137085.1;Q55909;4.70E-37;Y305_SYNY3;TVP38/TMEM64 family membrane protein slr0305;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5123857_c0_seq1;GAXK01137105.1;A2A259;8.69E-24;PK2L1_MOUSE;Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog);"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]";"GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0015269; GO:0016020; GO:0031410; GO:0034703; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051262; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071467; GO:0071468; GO:0071805; GO:0097730; GO:0098662";"cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]";"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]"
comp5124511_c0_seq1;GAXK01181973.1;Q56JY1;3.34E-19;RL35A_BOVIN;60S ribosomal protein L35a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";cytosolic large ribosomal subunit [GO:0022625];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp512454_c0_seq1;GAXK01153064.1;P35220;0;CTNA_DROME;Catenin alpha;"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323";"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp51246_c7_seq1;GAXK01043568.1;P48608;2.70E-32;DIA_DROME;Protein diaphanous;"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005912; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"
comp512535_c0_seq1;GAXK01153188.1;P86854;7.91E-16;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp51258_c0_seq1;GAXK01043768.1;Q6DN90;2.80E-144;IQEC1_HUMAN;IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005730; GO:0005737; GO:0008289; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0043547; GO:0051549; GO:1903393";"actin cytoskeleton organization [GO:0030036]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]"
comp5125827_c0_seq1;GAXK01181996.1;Q9VWG3;1.58E-20;RS10B_DROME;40S ribosomal protein S10b;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005634; GO:0022626; GO:0022627";cytoplasmic translation [GO:0002181];"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp51262_c0_seq1;GAXK01205166.1;O61443;0;MK38B_DROME;Mitogen-activated protein kinase p38b (MAP kinase p38b) (MAPK p38b) (EC 2.7.11.24);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; SAP kinase activity [GO:0016909]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; heart morphogenesis [GO:0003007]; imaginal disc-derived wing morphogenesis [GO:0007476]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; paracrine signaling [GO:0038001]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of BMP signaling pathway [GO:0030510]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of innate immune response [GO:0045088]; regulation of terminal button organization [GO:2000331]; response to bacterium [GO:0009617]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to salt stress [GO:0009651]; response to starvation [GO:0042594]";"GO:0000165; GO:0001934; GO:0003007; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006955; GO:0007476; GO:0007623; GO:0008340; GO:0009408; GO:0009617; GO:0009651; GO:0010468; GO:0016909; GO:0030510; GO:0034614; GO:0035556; GO:0038001; GO:0040018; GO:0042542; GO:0042594; GO:0042742; GO:0045088; GO:0045793; GO:0048082; GO:0050832; GO:0071243; GO:0071276; GO:0071310; GO:1900407; GO:2000331";"cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; heart morphogenesis [GO:0003007]; imaginal disc-derived wing morphogenesis [GO:0007476]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; paracrine signaling [GO:0038001]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of BMP signaling pathway [GO:0030510]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of innate immune response [GO:0045088]; regulation of terminal button organization [GO:2000331]; response to bacterium [GO:0009617]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to salt stress [GO:0009651]; response to starvation [GO:0042594]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; SAP kinase activity [GO:0016909]"
comp51263_c0_seq1;GAXK01043673.1;Q9Y388;1.14E-61;RBMX2_HUMAN;RNA-binding motif protein, X-linked 2;"nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634; GO:0005686; GO:0071005";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]";RNA binding [GO:0003723]
comp512711_c0_seq1;GAXK01153190.1;P24785;1.69E-169;MLE_DROME;Dosage compensation regulator (EC 3.6.4.13) (ATP-dependent RNA helicase mle) (Protein male-less) (Protein maleless) (Protein no action potential);"chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]";"GO:0000228; GO:0000785; GO:0000805; GO:0001069; GO:0003678; GO:0003682; GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005730; GO:0005829; GO:0007549; GO:0008340; GO:0009047; GO:0016456; GO:0016457; GO:0031453; GO:0032508; GO:0034458; GO:0043138; GO:0045433; GO:0045944; GO:0048675; GO:0050684; GO:0072487; GO:1990904; GO:2000373; GO:2000765";"axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]";"chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]";"3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5127273_c0_seq1;GAXK01041201.1;D5WQ56;1.05E-22;LIPM_KYRT2;Octanoyltransferase LipM (EC 2.3.1.181) (Octanoyl-[acyl-carrier-protein]:[GcvH] N-octanoyltransferase);"lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]";"GO:0009107; GO:0009249; GO:0033819; GO:0102555";"lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]";;"lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]"
comp5127395_c0_seq1;GAXK01041215.1;P54652;9.41E-40;HSP72_HUMAN;Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2);"blood microparticle [GO:0072562]; CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192]";"GO:0000795; GO:0001673; GO:0001934; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0007140; GO:0007141; GO:0007283; GO:0007286; GO:0009408; GO:0009409; GO:0009986; GO:0010971; GO:0016020; GO:0016192; GO:0016887; GO:0019899; GO:0031072; GO:0032781; GO:0034605; GO:0034620; GO:0036128; GO:0042026; GO:0042623; GO:0044183; GO:0048156; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0051861; GO:0070062; GO:0070194; GO:0072562; GO:0072687; GO:0090084; GO:0097718; GO:1901896";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192]";"blood microparticle [GO:0072562]; CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082]"
comp5127605_c0_seq1;GAXK01041216.1;Q96SB3;1.96E-28;NEB2_HUMAN;Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin);"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]";"GO:0000164; GO:0001560; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007050; GO:0007096; GO:0008157; GO:0008380; GO:0014069; GO:0015629; GO:0016477; GO:0019722; GO:0030027; GO:0030175; GO:0030308; GO:0030425; GO:0031175; GO:0032587; GO:0042127; GO:0043197; GO:0046847; GO:0050804; GO:0051015; GO:0071315; GO:2000474";"actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]";"actin filament binding [GO:0051015]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]"
comp5127843_c0_seq1;GAXK01041184.1;Q54GN8;3.24E-53;NSA2_DICDI;Ribosome biogenesis protein NSA2 homolog;"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; rRNA processing [GO:0006364]";"GO:0005730; GO:0006364; GO:0030687";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";
comp51283_c0_seq1;GAXK01043647.1;Q9H237;6.44E-63;PORCN_HUMAN;Protein-serine O-palmitoleoyltransferase porcupine (EC 2.3.1.250) (Protein MG61);"AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055]";"GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016055; GO:0017147; GO:0030176; GO:0032281; GO:0045234; GO:0060070; GO:0098978; GO:0099072; GO:1990698";"canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055]";"AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]";"palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]"
comp5128332_c0_seq1;GAXK01033902.1;O61370;5.29E-07;NACH_DROAN;Sodium channel protein Nach;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp512883_c0_seq1;GAXK01153137.1;Q27433;7.55E-09;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp5128871_c0_seq1;GAXK01033905.1;O09452;5.15E-35;G3PA_GUITH;Glyceraldehyde-3-phosphate dehydrogenase, chloroplastic (EC 1.2.1.59) (NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase);"chloroplast [GO:0009507]; glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0006006; GO:0009507; GO:0019253; GO:0043891; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp512888_c0_seq1;GAXK01153087.1;Q11002;7.06E-111;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp51289_c1_seq1;GAXK01043171.1;Q28J34;1.17E-42;ERLN2_XENTR;Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0031625; GO:0032933";"cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp51292_c0_seq1;GAXK01043225.1;Q9KBI9;4.78E-08;RRAAH_BACHD;Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase (HMG aldolase) (EC 4.1.3.17) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) (Regulator of ribonuclease activity homolog) (RraA-like protein);"4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0008948; GO:0046872; GO:0047443";;;"4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]"
comp5129413_c0_seq1;GAXK01033910.1;Q63481;1.17E-31;RAB7L_RAT;Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29);"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0032482; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0048471; GO:0050862; GO:0055037; GO:0070840; GO:0072657; GO:0090316; GO:1901214; GO:1905279; GO:1990967";"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]";"dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]"
comp512958_c0_seq1;GAXK01153111.1;Q9VS29;0;DSCL_DROME;Down syndrome cell adhesion molecule-like protein Dscam2;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]"
comp5130170_c0_seq1;GAXK01101731.1;O75445;4.79E-09;USH2A_HUMAN;Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein);"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0017022; GO:0022008; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042803; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060041; GO:0060113; GO:0060171; GO:1990075; GO:1990696";"animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]";"collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]"
comp513071_c0_seq1;GAXK01153185.1;Q9H0M4;8.39E-26;ZCPW1_HUMAN;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp5130779_c0_seq1;GAXK01101729.1;Q4IAA0;3.60E-32;FAL1_GIBZE;ATP-dependent RNA helicase FAL1 (EC 3.6.4.13);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5131459_c0_seq1;GAXK01101718.1;B7ZRM8;1.74E-07;EVI1B_XENLA;MDS1 and EVI1 complex locus protein EVI1-B (Ecotropic virus integration site 1 protein homolog-B);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";"GO:0003677; GO:0016607; GO:0039013; GO:0039022; GO:0046872; GO:0072196";"pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5132266_c0_seq1;GAXK01052586.1;O97341;6.00E-21;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp513266_c0_seq1;GAXK01153041.1;P0C6Y7;1.30E-20;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp5132782_c0_seq1;GAXK01052576.1;Q684P5;4.23E-39;RPGP2_HUMAN;Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4);"centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0010977; GO:0031965; GO:0043005; GO:0048471; GO:0051056";"negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]";"centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp513298_c0_seq1;GAXK01153084.1;A0A126GUP6;6.50E-28;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp5134086_c0_seq1;GAXK01089921.1;P70059;2.87E-45;TRY2_XENLA;Trypsin (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp5134353_c0_seq1;GAXK01089906.1;P22462;3.79E-09;KCNC2_RAT;Potassium voltage-gated channel subfamily C member 2 (Potassium channel voltage-gated Shaw-related subfamily C member 2) (Shaw-like potassium channel) (Voltage-gated potassium channel subunit Kv3.2);"apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; ion transmembrane transport [GO:0034220]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]";"GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009636; GO:0009642; GO:0014070; GO:0014075; GO:0016021; GO:0016323; GO:0016324; GO:0021759; GO:0030054; GO:0030424; GO:0030425; GO:0030673; GO:0031982; GO:0032026; GO:0032590; GO:0032809; GO:0034220; GO:0038060; GO:0042734; GO:0043025; GO:0043195; GO:0043204; GO:0044325; GO:0045202; GO:0045211; GO:0045471; GO:0051260; GO:0051291; GO:0071242; GO:0071732; GO:0071805; GO:0097237; GO:0099508; GO:1901381; GO:1903818; GO:1990089";"cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; ion transmembrane transport [GO:0034220]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]";"apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]"
comp513495_c0_seq1;GAXK01153089.1;P00172;3.04E-25;CYB5_PIG;Cytochrome b5;"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005789; GO:0005829; GO:0016021; GO:0019899; GO:0020037; GO:0046872; GO:0055114";oxidation-reduction process [GO:0055114];"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp513548_c1_seq1;GAXK01153108.1;Q9N4V4;7.38E-46;SCPL3_CAEEL;CTD small phosphatase-like protein 3 (CTDSP-like 3) (EC 3.1.3.-);phosphoprotein phosphatase activity [GO:0004721];GO:0004721;;;phosphoprotein phosphatase activity [GO:0004721]
comp5135638_c0_seq1;GAXK01089895.1;Q91XQ0;1.15E-94;DYH8_MOUSE;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097228";"microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp513599_c0_seq1;GAXK01153033.1;P85118;3.15E-13;NT8F2_RAT;N-acetyltransferase family 8 member 2 (EC 2.3.1.-) (Camello-like protein 2) (N-acetyltransferase-like protein CML2);"integral component of membrane [GO:0016021]; N-acetyltransferase activity [GO:0008080]; gastrulation [GO:0007369]";"GO:0007369; GO:0008080; GO:0016021";gastrulation [GO:0007369];integral component of membrane [GO:0016021];N-acetyltransferase activity [GO:0008080]
comp51361_c1_seq1;GAXK01043432.1;O15945;0;ARNT_DROME;Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0060173; GO:0071456; GO:0090575";"brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"
comp513631_c0_seq1;GAXK01153136.1;Q9Y305;2.61E-12;ACOT9_HUMAN;Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]";"GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689";acyl-CoA metabolic process [GO:0006637];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]"
comp51365_c0_seq1;GAXK01043549.1;Q3YEC7;8.26E-74;RABL6_HUMAN;Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829";;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp5137183_c0_seq1;GAXK01021005.1;Q6B9X6;1.32E-17;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp51372_c0_seq1;GAXK01043285.1;A0A0B4K692;0;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp51374_c2_seq1;GAXK01043627.1;Q9H1Q7;3.97E-42;PED1A_HUMAN;PC-esterase domain-containing protein 1A (Protein FAM113A) (Sarcoma antigen NY-SAR-23);;;;;
comp513801_c0_seq1;GAXK01153189.1;Q9V3S9;1.41E-18;BGM_DROME;Very long-chain-fatty-acid--CoA ligase bubblegum (EC 6.2.1.3);"cell [GO:0005623]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005623; GO:0006631; GO:0006633; GO:0015645; GO:0034976; GO:0045938; GO:0070050; GO:0102391";"fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]";cell [GO:0005623];"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp5138014_c0_seq1;GAXK01052843.1;P57424;8.45E-45;FLGG_BUCAI;Flagellar basal-body rod protein FlgG (Distal rod protein);"bacterial-type flagellum basal body, distal rod [GO:0009426]; bacterial-type flagellum-dependent cell motility [GO:0071973]";"GO:0009426; GO:0071973";bacterial-type flagellum-dependent cell motility [GO:0071973];bacterial-type flagellum basal body, distal rod [GO:0009426];
comp513803_c1_seq1;GAXK01153195.1;Q80UG8;2.29E-65;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp5138040_c0_seq1;GAXK01052854.1;P28476;3.54E-15;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp5138071_c0_seq1;GAXK01052841.1;P93748;2.71E-07;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp513839_c0_seq1;GAXK01153082.1;Q8BRU6;8.19E-86;VMAT2_MOUSE;Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2);"axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; dopaminergic synapse [GO:0098691]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; amine transmembrane transporter activity [GO:0005275]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]; aging [GO:0007568]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular response to drug [GO:0035690]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of neurotransmitter transport [GO:0051589]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]";"GO:0001975; GO:0005275; GO:0005335; GO:0005737; GO:0005887; GO:0006836; GO:0007568; GO:0007626; GO:0008021; GO:0008144; GO:0008504; GO:0009636; GO:0009791; GO:0015842; GO:0015844; GO:0019899; GO:0030073; GO:0030285; GO:0030672; GO:0031045; GO:0031072; GO:0035690; GO:0042593; GO:0042910; GO:0042995; GO:0043005; GO:0043025; GO:0043195; GO:0043679; GO:0044297; GO:0051589; GO:0098691; GO:0098700; GO:0098794; GO:0098992; GO:0099066";"aging [GO:0007568]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular response to drug [GO:0035690]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of neurotransmitter transport [GO:0051589]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]";"axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; dopaminergic synapse [GO:0098691]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"amine transmembrane transporter activity [GO:0005275]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp5138581_c0_seq1;GAXK01052847.1;P23301;1.12E-32;IF5A1_YEAST;Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (Hypusine-containing protein HP2) (eIF-4D);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of cytoplasmic translational elongation through polyproline stretches [GO:1903272]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational initiation [GO:0045948]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003723; GO:0003743; GO:0003746; GO:0005737; GO:0005739; GO:0006452; GO:0043022; GO:0045901; GO:0045905; GO:0045948; GO:0048471; GO:1903272";"positive regulation of cytoplasmic translational elongation through polyproline stretches [GO:1903272]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational initiation [GO:0045948]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]";"ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp51393_c0_seq1;GAXK01043070.1;O43290;2.96E-40;SNUT1_HUMAN;U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1);"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013";"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]";"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";RNA binding [GO:0003723]
comp514_c2_seq1;GAXK01168593.1;P86704;2.67E-104;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp5140109_c0_seq1;GAXK01034237.1;P92177;2.13E-39;1433E_DROME;14-3-3 protein epsilon (Suppressor of Ras1 3-9);"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007093; GO:0007280; GO:0007294; GO:0007411; GO:0007444; GO:0007623; GO:0008103; GO:0008134; GO:0008340; GO:0009314; GO:0009411; GO:0019904; GO:0035332; GO:0040008; GO:0042994; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815";"axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]";"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp5140185_c0_seq1;GAXK01034243.1;Q2TBA3;4.83E-08;MALT1_MOUSE;Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase);"CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; response to molecule of bacterial origin [GO:0002237]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"GO:0001650; GO:0001923; GO:0002020; GO:0002237; GO:0002726; GO:0004197; GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006508; GO:0007250; GO:0008233; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051092; GO:0051168; GO:0051259; GO:2000321";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; B-1 B cell differentiation [GO:0001923]; B cell activation [GO:0042113]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; response to molecule of bacterial origin [GO:0002237]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]";"CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]"
comp5140258_c0_seq1;GAXK01034251.1;Q6NLQ8;2.19E-08;XB32_ARATH;E3 ubiquitin-protein ligase XBAT32 (EC 2.3.2.27) (Ankyrin repeat domain and RING finger-containing protein XBAT32) (Protein XB3 homolog 2) (RING-type E3 ubiquitin transferase XBAT32);"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to auxin [GO:0009733]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0006511; GO:0009733; GO:0010311; GO:0010366; GO:0016567; GO:0046872; GO:0051865";"lateral root formation [GO:0010311]; negative regulation of ethylene biosynthetic process [GO:0010366]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to auxin [GO:0009733]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp5140335_c0_seq1;GAXK01034244.1;P10074;1.16E-09;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp5141252_c0_seq1;GAXK01034246.1;P08879;1.45E-70;NDKA_DROME;Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) (Abnormal wing disks protein) (Killer of prune protein);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear microtubule [GO:0005880]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; nucleoside diphosphate kinase activity [GO:0004550]; adherens junction organization [GO:0034332]; CTP biosynthetic process [GO:0006241]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; GTP biosynthetic process [GO:0006183]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide metabolic process [GO:0009117]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of tube architecture, open tracheal system [GO:0035152]; UTP biosynthetic process [GO:0006228]";"GO:0000278; GO:0000287; GO:0004550; GO:0005524; GO:0005525; GO:0005737; GO:0005874; GO:0005880; GO:0005886; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006468; GO:0007017; GO:0007424; GO:0007427; GO:0008017; GO:0009117; GO:0016301; GO:0016334; GO:0018105; GO:0034332; GO:0035152; GO:0046777";"adherens junction organization [GO:0034332]; CTP biosynthetic process [GO:0006241]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; GTP biosynthetic process [GO:0006183]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide metabolic process [GO:0009117]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of tube architecture, open tracheal system [GO:0035152]; UTP biosynthetic process [GO:0006228]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear microtubule [GO:0005880]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; nucleoside diphosphate kinase activity [GO:0004550]"
comp5141333_c0_seq1;GAXK01034245.1;P41413;1.25E-11;PCSK5_RAT;Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin/kexin-like protease PC5) (rPC5);"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; response to gonadotropin [GO:0034698]; response to luteinizing hormone [GO:0034699]; vascular smooth muscle cell proliferation [GO:1990874]";"GO:0004252; GO:0005576; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0007565; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0033625; GO:0034698; GO:0034699; GO:0036120; GO:0043204; GO:1904754; GO:1905609; GO:1990635; GO:1990874; GO:2001046";"cellular response to platelet-derived growth factor stimulus [GO:0036120]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; response to gonadotropin [GO:0034698]; response to luteinizing hormone [GO:0034699]; vascular smooth muscle cell proliferation [GO:1990874]";"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp5141971_c0_seq1;GAXK01034248.1;Q9VZW5;4.48E-10;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp5142_c1_seq1;GAXK01065340.1;Q8CDN6;3.45E-44;TXNL1_MOUSE;Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]";"GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036; GO:0045454";cell redox homeostasis [GO:0045454];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";disulfide oxidoreductase activity [GO:0015036]
comp5142002_c0_seq1;GAXK01052748.1;P54654;3.17E-09;CAP_DICDI;Adenylyl cyclase-associated protein (CAP);"cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; macropinosome [GO:0044354]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; pseudopodium [GO:0031143]; vacuolar membrane [GO:0005774]; vesicle [GO:0031982]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; aggregation involved in sorocarp development [GO:0031152]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; contractile vacuole organization [GO:0033298]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; pinocytosis [GO:0006907]; regulation of gene expression [GO:0010468]; response to osmotic stress [GO:0006970]";"GO:0000281; GO:0000902; GO:0001891; GO:0003779; GO:0005737; GO:0005774; GO:0005938; GO:0006907; GO:0006970; GO:0007163; GO:0008154; GO:0008179; GO:0010468; GO:0030670; GO:0030864; GO:0031012; GO:0031143; GO:0031152; GO:0031982; GO:0033298; GO:0044354; GO:0098609";"actin polymerization or depolymerization [GO:0008154]; aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; contractile vacuole organization [GO:0033298]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; pinocytosis [GO:0006907]; regulation of gene expression [GO:0010468]; response to osmotic stress [GO:0006970]";"cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; macropinosome [GO:0044354]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; pseudopodium [GO:0031143]; vacuolar membrane [GO:0005774]; vesicle [GO:0031982]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]"
comp514220_c0_seq1;GAXK01048343.1;Q86YS3;2.16E-11;RFIP4_HUMAN;Rab11 family-interacting protein 4 (FIP4-Rab11) (Rab11-FIP4) (Arfophilin-2);"cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032]";"GO:0003407; GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0016032; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048471; GO:0055038; GO:1903452";"endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032]";"cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]";"ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp514223_c0_seq1;GAXK01048325.1;Q2KJ93;3.55E-81;CDC42_BOVIN;Cell division control protein 42 homolog (EC 3.6.5.2);"apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; modification of synaptic structure [GO:0099563]; neuron fate determination [GO:0048664]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein heterodimerization activity [GO:0043497]; Rho protein signal transduction [GO:0007266]";"GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007163; GO:0007266; GO:0008360; GO:0016020; GO:0019901; GO:0030031; GO:0030036; GO:0030496; GO:0030742; GO:0031258; GO:0032467; GO:0032488; GO:0032956; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0042995; GO:0043005; GO:0043197; GO:0043410; GO:0043497; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0071346; GO:0072686; GO:0099563; GO:1900026";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; modification of synaptic structure [GO:0099563]; neuron fate determination [GO:0048664]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein heterodimerization activity [GO:0043497]; Rho protein signal transduction [GO:0007266]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; protein kinase binding [GO:0019901]"
comp51425_c0_seq1;GAXK01043790.1;Q80LP4;9.20E-11;CATV_NPVAH;Viral cathepsin (V-cath) (EC 3.4.22.50) (Cysteine proteinase) (CP);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp51428_c0_seq1;GAXK01043646.1;Q5R4R9;5.42E-19;NDUF4_PONAB;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa homolog) (Protein HRPAP20);"membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005516; GO:0005739; GO:0016020; GO:0032981";mitochondrial respiratory chain complex I assembly [GO:0032981];"membrane [GO:0016020]; mitochondrion [GO:0005739]";calmodulin binding [GO:0005516]
comp51429_c2_seq1;GAXK01043854.1;Q7Z3V4;0;UBE3B_HUMAN;Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B);"ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0006511; GO:0061631";"protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";;ubiquitin conjugating enzyme activity [GO:0061631]
comp51431_c0_seq1;GAXK01043068.1;Q9VXA0;7.87E-97;NPRL2_DROME;GATOR complex protein NPRL2 (Nitrogen permease regulator 2-like protein);"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; germarium-derived egg chamber formation [GO:0007293]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]";"GO:0005634; GO:0005737; GO:0006995; GO:0007293; GO:0010508; GO:0010898; GO:0032007; GO:0034198; GO:0035859; GO:0038202; GO:0044754; GO:0045792; GO:0048477; GO:0051301; GO:0051321; GO:0051729; GO:1904262; GO:1904766; GO:1990130; GO:2000785";"cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; germarium-derived egg chamber formation [GO:0007293]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; oogenesis [GO:0048477]; positive regulation of autophagy [GO:0010508]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]";"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]";
comp514324_c0_seq1;GAXK01048316.1;Q8VIG1;7.23E-08;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp51437_c0_seq1;GAXK01043793.1;Q9V6L0;6.43E-110;KDM4B_DROME;Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp5144131_c0_seq1;GAXK01057316.1;Q95UJ0;3.57E-62;RAB7A_PAROT;Ras-related protein Rab-7a;"autophagosome membrane [GO:0000421]; extrinsic component of lysosome membrane [GO:0032419]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]";"GO:0000421; GO:0003924; GO:0005525; GO:0005811; GO:0016042; GO:0030670; GO:0031902; GO:0032419; GO:0045335; GO:0061724; GO:0090382; GO:0090383";"lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]";"autophagosome membrane [GO:0000421]; extrinsic component of lysosome membrane [GO:0032419]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp514435_c0_seq1;GAXK01048289.1;O95847;6.66E-120;UCP4_HUMAN;Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27);"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]";"GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600";"cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]";"apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]";
comp5144712_c0_seq1;GAXK01057326.1;O42329;2.29E-26;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp51452_c1_seq1;GAXK01043671.1;Q6GPW4;2.46E-07;TM205_XENLA;Transmembrane protein 205;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp514550_c0_seq1;GAXK01048306.1;Q95NT6;3.51E-19;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp5145528_c0_seq1;GAXK01057321.1;Q9ER30;2.24E-07;KLH41_RAT;Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"GO:0001726; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014";"myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]";
comp514580_c0_seq1;GAXK01048317.1;Q07075;0;AMPE_HUMAN;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"GO:0001525; GO:0002003; GO:0003081; GO:0004177; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0005903; GO:0006508; GO:0007267; GO:0008270; GO:0008283; GO:0009897; GO:0016324; GO:0016477; GO:0031410; GO:0032835; GO:0042277; GO:0043171; GO:0045177; GO:0070006; GO:0070062";"angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp514594_c0_seq1;GAXK01048312.1;Q8BIQ3;1.81E-15;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp51471_c1_seq1;GAXK01043364.1;Q9NZ43;2.61E-30;USE1_HUMAN;Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]";"GO:0005783; GO:0005789; GO:0006890; GO:0007041; GO:0015031; GO:0016021; GO:0030163; GO:0032940";"lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp5147302_c0_seq1;GAXK01194535.1;P14780;4.23E-10;MMP9_HUMAN;"Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007566; GO:0008237; GO:0008270; GO:0019221; GO:0022617; GO:0030198; GO:0030225; GO:0030335; GO:0030574; GO:0034614; GO:0035987; GO:0042802; GO:0043066; GO:0043312; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071276; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]";"collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp5147365_c0_seq1;GAXK01194542.1;P08770;2.87E-12;TRA1_MAIZE;Putative AC transposase (ORFA);"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0032196; GO:0046983";"DNA recombination [GO:0006310]; transposition [GO:0032196]";;"DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]"
comp5148180_c0_seq1;GAXK01141010.1;P10074;3.47E-08;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp51484_c0_seq1;GAXK01043170.1;Q2KJI7;0;AFG32_BOVIN;AFG3-like protein 2 (EC 3.4.24.-);"m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]";"GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013";"axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]";"m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]";"ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp5149004_c0_seq1;GAXK01141022.1;P93253;1.46E-53;SAHH_MESCR;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp5149624_c0_seq1;GAXK01141007.1;Q99LI5;1.84E-09;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp5149864_c0_seq1;GAXK01140998.1;Q9VNM1;5.76E-10;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp5150089_c0_seq1;GAXK01192859.1;P00766;8.04E-14;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp51513_c0_seq1;GAXK01043388.1;Q91348;2.98E-61;F26L_CHICK;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]";"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0006094; GO:0006096; GO:0043540";"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]";"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp5151583_c0_seq1;GAXK01192850.1;Q9ULI1;1.16E-26;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp5152332_c0_seq1;GAXK01111311.1;O16259;5.66E-10;STIP1_CAEEL;Stress-induced-phosphoprotein 1 (CeSTI1) (STI1) (Hsc70/Hsp90-organizing protein) (CeHop) (Hop);"cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";"GO:0000003; GO:0005737; GO:0008340; GO:0009408; GO:0030544; GO:0032780; GO:0042030; GO:0051879";"determination of adult lifespan [GO:0008340]; negative regulation of ATPase activity [GO:0032780]; reproduction [GO:0000003]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]"
comp515251_c0_seq1;GAXK01048353.1;Q9R226;8.39E-58;KHDR3_MOUSE;KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein Etoile) (Sam68-like mammalian protein 2) (SLM-2);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0033120; GO:0042802; GO:0048024; GO:0051259";"mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; protein complex oligomerization [GO:0051259]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; single-stranded RNA binding [GO:0003727]"
comp5153202_c0_seq1;GAXK01111313.1;Q4GXU6;2.53E-168;RS4_CARGR;40S ribosomal protein S4;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5153596_c0_seq1;GAXK01111309.1;O16116;1.08E-12;GST3_CAEEL;Glutathione S-transferase 3 (EC 2.5.1.18) (CeGST3) (GST class-sigma);"glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749";glutathione metabolic process [GO:0006749];;glutathione transferase activity [GO:0004364]
comp51538_c0_seq1;GAXK01043870.1;O43683;2.64E-56;BUB1_HUMAN;Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A);"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]; viral process [GO:0016032]";"GO:0000776; GO:0000777; GO:0000778; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007093; GO:0007094; GO:0008283; GO:0016020; GO:0016032; GO:0051301; GO:0051754; GO:0051983";"apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]; viral process [GO:0016032]";"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp5154418_c0_seq1;GAXK01049416.1;Q95L11;7.39E-37;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp51552_c1_seq1;GAXK01043372.1;Q298L5;0;MIRO_DROPS;Mitochondrial Rho GTPase (Miro) (EC 3.6.5.-);"integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]";"GO:0003924; GO:0005509; GO:0005525; GO:0019725; GO:0031307; GO:0047497; GO:0097345";"cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]";integral component of mitochondrial outer membrane [GO:0031307];"calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5155277_c0_seq1;GAXK01049411.1;Q91WP6;8.08E-16;SPA3N_MOUSE;Serine protease inhibitor A3N (Serpin A3N);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; negative regulation of endopeptidase activity [GO:0010951]; response to bacterium [GO:0009617]; response to cytokine [GO:0034097]; response to peptide hormone [GO:0043434]";"GO:0004867; GO:0005576; GO:0005615; GO:0006953; GO:0009617; GO:0010951; GO:0034097; GO:0043434";"acute-phase response [GO:0006953]; negative regulation of endopeptidase activity [GO:0010951]; response to bacterium [GO:0009617]; response to cytokine [GO:0034097]; response to peptide hormone [GO:0043434]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp5155348_c0_seq1;GAXK01049406.1;Q03017;6.65E-09;CACT_DROME;NF-kappa-B inhibitor cactus;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059";"antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]";NF-kappaB binding [GO:0051059]
comp51557_c0_seq1;GAXK01042967.1;Q07598;7.26E-40;NLTP_CHICK;Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X) (Fragment);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]";"GO:0005739; GO:0005777; GO:0006869; GO:0008289; GO:0032385; GO:0033814";"lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]"
comp515604_c0_seq1;GAXK01048295.1;Q80WQ9;1.78E-08;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp515781_c0_seq1;GAXK01048335.1;Q8C8M1;3.27E-27;SHCAF_MOUSE;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp5158091_c0_seq1;GAXK01063997.1;P16372;5.43E-08;ZFP58_MOUSE;Zinc finger protein 58 (Zfp-58) (Regulator of sex-limitation candidate 5) (Zinc finger protein Mfg-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5158340_c0_seq1;GAXK01064000.1;Q9UNX3;1.63E-27;RL26L_HUMAN;60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1);"cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5158537_c0_seq1;GAXK01063996.1;P29183;1.59E-42;LIPP_HORSE;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment);"extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005615; GO:0016042; GO:0016298; GO:0046872";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];"lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp5158589_c0_seq1;GAXK01063985.1;Q9W1A4;9.31E-08;TAMO_DROME;Protein tamozhennic;"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005737; GO:0007275; GO:0008536; GO:0015031; GO:0046872";"multicellular organism development [GO:0007275]; protein transport [GO:0015031]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]"
comp51588_c0_seq1;GAXK01043631.1;Q99447;1.39E-92;PCY2_HUMAN;Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase);"endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]";"GO:0004306; GO:0005789; GO:0006646; GO:0008654";"phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]";endoplasmic reticulum membrane [GO:0005789];ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]
comp51595_c0_seq1;GAXK01043692.1;P17789;6.87E-32;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5159526_c0_seq1;GAXK01063992.1;Q86LG1;1.42E-13;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp515975_c1_seq1;GAXK01048309.1;A1ZBD6;1.16E-100;MCTP_DROME;Multiple C2 and transmembrane domain-containing protein;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0005789; GO:0016021; GO:0046928; GO:0048168";"regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";calcium ion binding [GO:0005509]
comp516021_c0_seq1;GAXK01057803.1;Q6AXL4;6.00E-11;NCLDB_DANRE;Neurocalcin-delta B;"calcium ion binding [GO:0005509]; regulation of axon extension involved in axon guidance [GO:0048841]";"GO:0005509; GO:0048841";regulation of axon extension involved in axon guidance [GO:0048841];;calcium ion binding [GO:0005509]
comp5160870_c0_seq1;GAXK01088365.1;A2AC93;7.76E-07;DNAI2_MOUSE;Dynein intermediate chain 2, axonemal (Axonemal dynein intermediate chain 2);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]"
comp5160871_c0_seq1;GAXK01088375.1;Q2KTS6;6.29E-07;TATB_BORA1;Sec-independent protein translocase protein TatB;"integral component of plasma membrane [GO:0005887]; TAT protein transport complex [GO:0033281]; protein transmembrane transporter activity [GO:0008320]; protein transport by the Tat complex [GO:0043953]";"GO:0005887; GO:0008320; GO:0033281; GO:0043953";protein transport by the Tat complex [GO:0043953];"integral component of plasma membrane [GO:0005887]; TAT protein transport complex [GO:0033281]";protein transmembrane transporter activity [GO:0008320]
comp51609_c13_seq1;GAXK01043195.1;Q9HCD6;0;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp5160929_c0_seq1;GAXK01088361.1;P41920;5.73E-33;YRB1_YEAST;Ran-specific GTPase-activating protein 1 (Chromosome stability protein 20) (Perinuclear array-localized protein) (Ran-binding protein 1) (RANBP1);"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; G1/S transition of mitotic cell cycle [GO:0000082]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000082; GO:0005096; GO:0005634; GO:0005643; GO:0005737; GO:0006405; GO:0006511; GO:0006606; GO:0006607; GO:0008536";"G1/S transition of mitotic cell cycle [GO:0000082]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]"
comp5161285_c0_seq1;GAXK01088379.1;Q12AE5;6.32E-14;SELO_POLSJ;Protein adenylyltransferase SelO (EC 2.7.7.-) (EC 2.7.7.n1);"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]";"GO:0000287; GO:0005524; GO:0016779";;;"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]"
comp516160_c0_seq1;GAXK01057892.1;Q2Y0W8;0;S4A8_HUMAN;Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3);"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]";"GO:0005452; GO:0005886; GO:0005887; GO:0008510; GO:0015301; GO:0015701; GO:0032809; GO:0043005; GO:0051453";"bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]";"integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]"
comp516164_c0_seq1;GAXK01057837.1;Q9GV16;1.56E-52;EGCSE_CYANO;Endoglycoceramidase (EGCase) (EC 3.2.1.123) (Glycosphingolipid-specific enzyme) (GSL-specific enzyme);"extracellular region [GO:0005576]; nematocyst [GO:0042151]; endoglycosylceramidase activity [GO:0047876]; cellulose catabolic process [GO:0030245]";"GO:0005576; GO:0030245; GO:0042151; GO:0047876";cellulose catabolic process [GO:0030245];"extracellular region [GO:0005576]; nematocyst [GO:0042151]";endoglycosylceramidase activity [GO:0047876]
comp516169_c0_seq1;GAXK01057861.1;Q9V576;2.99E-44;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp516170_c0_seq1;GAXK01057827.1;Q7ZWF4;1.08E-09;RN145_DANRE;RING finger protein 145;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; hemopoiesis [GO:0030097]; myeloid cell development [GO:0061515]";"GO:0005783; GO:0008270; GO:0012505; GO:0016021; GO:0030097; GO:0061515; GO:0061630";"hemopoiesis [GO:0030097]; myeloid cell development [GO:0061515]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp5162426_c0_seq1;GAXK01077682.1;Q91590;6.20E-08;TEFF1_XENLA;Tomoregulin-1 (TR-1) (Transmembrane protein with EGF-like and one follistatin-like domain) (X7365);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]";"GO:0005886; GO:0007275; GO:0016021";multicellular organism development [GO:0007275];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp516265_c0_seq1;GAXK01057804.1;Q27249;4.17E-27;TPM3_CAEEL;Tropomyosin isoforms c/e (Levamisole resistant protein 11);"actin filament [GO:0005884]; cytoplasm [GO:0005737]; striated muscle thin filament [GO:0005865]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; negative regulation of actin filament depolymerization [GO:0030835]; regulation of actin filament polymerization [GO:0030833]; regulation of protein binding [GO:0043393]; spicule insertion [GO:0034609]";"GO:0005737; GO:0005865; GO:0005884; GO:0007015; GO:0009792; GO:0030833; GO:0030835; GO:0034609; GO:0040011; GO:0043393; GO:0051015";"actin filament organization [GO:0007015]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; negative regulation of actin filament depolymerization [GO:0030835]; regulation of actin filament polymerization [GO:0030833]; regulation of protein binding [GO:0043393]; spicule insertion [GO:0034609]";"actin filament [GO:0005884]; cytoplasm [GO:0005737]; striated muscle thin filament [GO:0005865]";actin filament binding [GO:0051015]
comp516285_c1_seq1;GAXK01057839.1;B1A193;1.74E-09;RASFA_XENLA;Ras association domain-containing protein 10;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0050769; GO:2000179";"positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";
comp5163324_c0_seq1;GAXK01077688.1;Q94900;6.98E-13;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp5163377_c0_seq1;GAXK01077680.1;P42800;3.52E-75;INO1_CANAL;Inositol-3-phosphate synthase (MIP synthase) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (IPS) (MI-1-P synthase);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; hyphal cell wall [GO:0030446]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654]";"GO:0004512; GO:0005737; GO:0006021; GO:0008654; GO:0009986; GO:0030446";"inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; hyphal cell wall [GO:0030446]";inositol-3-phosphate synthase activity [GO:0004512]
comp5163470_c0_seq1;GAXK01077711.1;P87262;5.87E-42;RL34A_YEAST;60S ribosomal protein L34-A (Large ribosomal subunit protein eL34-A);"cytosolic large ribosomal subunit [GO:0022625]; preribosome, large subunit precursor [GO:0030687]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"GO:0002181; GO:0003735; GO:0022625; GO:0030687; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]";"cytosolic large ribosomal subunit [GO:0022625]; preribosome, large subunit precursor [GO:0030687]";structural constituent of ribosome [GO:0003735]
comp516455_c0_seq1;GAXK01057849.1;Q5AG40;1.23E-38;VPS4_CANAL;Vacuolar protein sorting-associated protein 4;"endosome membrane [GO:0010008]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to lithium ion [GO:0071285]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; hyphal growth [GO:0030448]; late endosome to vacuole transport [GO:0045324]; pathogenesis [GO:0009405]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vacuole organization [GO:0007033]";"GO:0005524; GO:0005634; GO:0006623; GO:0007033; GO:0009306; GO:0009405; GO:0010008; GO:0016887; GO:0030447; GO:0030448; GO:0044182; GO:0045324; GO:0071285";"cellular response to lithium ion [GO:0071285]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; hyphal growth [GO:0030448]; late endosome to vacuole transport [GO:0045324]; pathogenesis [GO:0009405]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vacuole organization [GO:0007033]";"endosome membrane [GO:0010008]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp51646_c2_seq1;GAXK01042980.1;Q8MV48;0;GALT7_DROME;N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp516528_c0_seq1;GAXK01057879.1;Q7KRI2;8.85E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp51654_c1_seq1;GAXK01043476.1;Q9HAB8;9.65E-66;PPCS_HUMAN;Phosphopantothenate--cysteine ligase (EC 6.3.2.51) (Phosphopantothenoylcysteine synthetase) (PPC synthetase);"cytosol [GO:0005829]; phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803]; acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]; heart process [GO:0003015]";"GO:0003015; GO:0004632; GO:0005829; GO:0006085; GO:0009108; GO:0015937; GO:0042803";"acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]; heart process [GO:0003015]";cytosol [GO:0005829];"phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803]"
comp5165873_c0_seq1;GAXK01007139.1;Q8VHE6;9.77E-43;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp516682_c0_seq1;GAXK01057863.1;P34371;4.00E-12;BAT42_CAEEL;BTB and MATH domain-containing protein 42;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp516796_c0_seq1;GAXK01057893.1;A2A761;1.64E-20;ZFP69_MOUSE;Zinc finger protein 69 (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5168321_c0_seq1;GAXK01172164.1;Q60636;2.27E-09;PRDM1_MOUSE;PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841";"adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp51688_c4_seq1;GAXK01043263.1;Q09920;4.64E-28;FIO1_SCHPO;Iron transport multicopper oxidase fio1 (EC 1.-.-.-);"endoplasmic reticulum [GO:0005783]; high-affinity iron permease complex [GO:0033573]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; cellular response to iron ion starvation [GO:0010106]; iron ion transmembrane transport [GO:0034755]; reductive iron assimilation [GO:0033215]";"GO:0004322; GO:0005507; GO:0005783; GO:0005886; GO:0010106; GO:0033215; GO:0033573; GO:0034755";"cellular response to iron ion starvation [GO:0010106]; iron ion transmembrane transport [GO:0034755]; reductive iron assimilation [GO:0033215]";"endoplasmic reticulum [GO:0005783]; high-affinity iron permease complex [GO:0033573]; plasma membrane [GO:0005886]";"copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]"
comp5168881_c0_seq1;GAXK01172155.1;Q19200;4.31E-36;STO1_CAEEL;Stomatin-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp51694_c1_seq1;GAXK01043159.1;P47791;3.45E-177;GSHR_MOUSE;Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7);"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"GO:0004362; GO:0005739; GO:0005829; GO:0006749; GO:0007283; GO:0009055; GO:0009897; GO:0034599; GO:0042803; GO:0043295; GO:0045454; GO:0050660; GO:0050661";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]"
comp5169640_c0_seq1;GAXK01172152.1;P47736;1.20E-11;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp5170178_c0_seq1;GAXK01136884.1;P08428;7.38E-84;ATPA_XENLA;ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha);"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp5170226_c0_seq1;GAXK01136895.1;Q54BM2;4.28E-20;PAP1A_DICDI;Polyadenylate-binding protein 1-A (PABP-1-A) (Poly(A)-binding protein, cytoplasmic 1-A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]";"GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008143; GO:0008266; GO:0045335; GO:1990904";mRNA processing [GO:0006397];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]"
comp5170607_c0_seq1;GAXK01136892.1;Q9BDB7;7.03E-20;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp5171616_c0_seq1;GAXK01136875.1;Q6XI08;1.51E-49;RS14A_DROYA;40S ribosomal protein S14a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp51725_c0_seq1;GAXK01043858.1;Q8R149;4.06E-43;BUD13_MOUSE;BUD13 homolog;"nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0005684; GO:0070274; GO:0071005";mRNA splicing, via spliceosome [GO:0000398];"nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]";
comp51728_c0_seq1;GAXK01043398.1;P42003;4.02E-88;MAD_DROME;Protein mothers against dpp;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0000122; GO:0000977; GO:0000980; GO:0000981; GO:0001012; GO:0001102; GO:0001227; GO:0001228; GO:0001745; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0007391; GO:0007419; GO:0007476; GO:0007480; GO:0007488; GO:0007507; GO:0007560; GO:0008586; GO:0030509; GO:0030707; GO:0030718; GO:0032924; GO:0035019; GO:0035290; GO:0042078; GO:0043565; GO:0045464; GO:0045595; GO:0045705; GO:0045887; GO:0045944; GO:0046872; GO:0048100; GO:0060395; GO:0060799; GO:0071144; GO:0090571; GO:1904398; GO:2000134";"activin receptor signaling pathway [GO:0032924]; BMP signaling pathway [GO:0030509]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc morphogenesis [GO:0007560]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]"
comp51737_c0_seq1;GAXK01043629.1;Q58DQ5;7.78E-76;RT09_BOVIN;28S ribosomal protein S9, mitochondrial (MRP-S9) (S9mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"GO:0000462; GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp517382_c2_seq1;GAXK01057844.1;A2VDP4;8.25E-20;ZN567_BOVIN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp51739_c1_seq1;GAXK01043430.1;Q9BRS2;1.42E-138;RIOK1_HUMAN;Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1);"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:2000234";"maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]";"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp51745_c0_seq1;GAXK01043116.1;Q9W1X9;8.68E-17;OCAD1_DROME;OCIA domain-containing protein 1 (OCAD1);"cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; recycling endosome [GO:0055037]; embryonic hemopoiesis [GO:0035162]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland development [GO:0048542]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736]";"GO:0005764; GO:0005768; GO:0005769; GO:0005794; GO:0016021; GO:0031410; GO:0035162; GO:0035167; GO:0046427; GO:0048542; GO:0055037; GO:2000736";"embryonic hemopoiesis [GO:0035162]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland development [GO:0048542]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736]";"cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; recycling endosome [GO:0055037]";
comp517472_c0_seq1;GAXK01057864.1;P49888;1.51E-29;ST1E1_HUMAN;Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring);"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]";"GO:0004304; GO:0005496; GO:0005829; GO:0006068; GO:0006711; GO:0008146; GO:0008202; GO:0008210; GO:0031965; GO:0045600; GO:0047894; GO:0050294; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]";"cytosol [GO:0005829]; nuclear membrane [GO:0031965]";"estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]"
comp51748_c0_seq1;GAXK01043354.1;O61492;2.16E-130;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp517502_c0_seq1;GAXK01057807.1;Q502K3;6.59E-21;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp51751_c1_seq1;GAXK01043820.1;Q9CWV0;5.80E-22;MASU1_MOUSE;Mitochondrial assembly of ribosomal large subunit protein 1;"cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0005739; GO:0005762; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071";"negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";ribosomal large subunit binding [GO:0043023]
comp5175394_c0_seq1;GAXK01154335.1;Q7SIC1;1.37E-09;FUCL_ANGAN;Fucolectin;"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";"GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088";"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
comp5175442_c0_seq1;GAXK01154333.1;Q6C0Y0;4.67E-49;COFI_YARLI;Cofilin (Actin-depolymerizing factor 1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0003779; GO:0005737; GO:0007049; GO:0015629; GO:0016363; GO:0030042; GO:0051301";"actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]";actin binding [GO:0003779]
comp51757_c0_seq1;GAXK01043905.1;P64918;4.94E-81;Y2023_MYCBO;Uncharacterized protein Mb2023;;;;;
comp5176571_c0_seq1;GAXK01038202.1;P61129;1.81E-08;ZC3H6_HUMAN;Zinc finger CCCH domain-containing protein 6;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000790; GO:0000981; GO:0001162; GO:0003700; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"
comp5177108_c0_seq1;GAXK01038189.1;P0C6Y7;2.46E-14;PRDM9_RAT;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp51772_c1_seq1;GAXK01043693.1;Q3URK3;2.36E-80;TET1_MOUSE;Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Ten-eleven translocation 1 gene protein homolog);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of methylation-dependent chromatin silencing [GO:0090310]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; regulation of DNA methylation [GO:0044030]; regulation of genetic imprinting [GO:2000653]; stem cell population maintenance [GO:0019827]";"GO:0001826; GO:0003677; GO:0005506; GO:0005634; GO:0005654; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008284; GO:0019827; GO:0031062; GO:0035511; GO:0044030; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0090310; GO:2000653";"5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of methylation-dependent chromatin silencing [GO:0090310]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; regulation of DNA methylation [GO:0044030]; regulation of genetic imprinting [GO:2000653]; stem cell population maintenance [GO:0019827]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]"
comp51780_c0_seq1;GAXK01043158.1;Q8R4N0;8.60E-98;CLYBL_MOUSE;Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein, mitochondrial) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9);"mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]";"GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064";"protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]";mitochondrion [GO:0005739];"(3S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]"
comp5178766_c0_seq1;GAXK01010175.1;O54963;8.93E-10;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp517886_c0_seq1;GAXK01057805.1;Q03112;4.56E-08;MECOM_HUMAN;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0016607; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0070828; GO:0071425";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
comp51789_c0_seq1;GAXK01043072.1;O00716;1.10E-48;E2F3_HUMAN;Transcription factor E2F3 (E2F-3);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000122; GO:0000790; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006367; GO:0007049; GO:0008134; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0070345; GO:0090575; GO:1905461";"cell cycle [GO:0007049]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp517891_c1_seq1;GAXK01057817.1;Q8IZU9;1.04E-18;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5179135_c0_seq1;GAXK01010188.1;Q80WQ9;4.87E-15;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp517960_c2_seq1;GAXK01057865.1;Q26474;2.86E-33;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp51802_c0_seq1;GAXK01043436.1;Q8L831;4.53E-102;NUDT3_ARATH;Nudix hydrolase 3 (AtNUDT3) (EC 3.6.1.-);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; vacuole [GO:0005773]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]";"GO:0005739; GO:0005773; GO:0005829; GO:0008239; GO:0046872";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; vacuole [GO:0005773]";"dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]"
comp5180382_c0_seq1;GAXK01203141.1;Q8I7Z8;1.25E-09;HAM_DROME;Transcription factor hamlet;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007219; GO:0008285; GO:0014017; GO:0046872; GO:0046974; GO:0048813; GO:0050773";"dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]"
comp5180444_c0_seq1;GAXK01203151.1;Q95LI3;9.82E-07;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp518046_c0_seq1;GAXK01079929.1;Q86V71;1.01E-22;ZN429_HUMAN;Zinc finger protein 429;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp51813_c4_seq1;GAXK01043162.1;Q6P9N1;8.47E-34;HYCCI_MOUSE;Hyccin (Down-regulated by CTNNB1 protein A) (Protein FAM126A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";"GO:0005737; GO:0005829; GO:0005886; GO:0042552; GO:0043005; GO:0046854; GO:0072659";"myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";
comp518362_c0_seq1;GAXK01079889.1;Q95NI4;3.02E-44;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp5184022_c0_seq1;GAXK01153615.1;Q7Z3F1;2.04E-10;GP155_HUMAN;Integral membrane protein GPR155 (G-protein coupled receptor PGR22);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062";"cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";
comp5184204_c0_seq1;GAXK01153598.1;Q9UKB1;1.73E-20;FBW1B_HUMAN;F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS);"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000151; GO:0000209; GO:0002223; GO:0004842; GO:0005634; GO:0005813; GO:0005829; GO:0006470; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031648; GO:0038061; GO:0038095; GO:0042753; GO:0043161; GO:0043687; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0051403; GO:0061630; GO:0070498; GO:1901223";"Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";"protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp5184623_c0_seq1;GAXK01153595.1;Q09LZ8;2.66E-40;CBPC6_MOUSE;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp51853_c0_seq1;GAXK01042976.1;Q96JL9;7.04E-29;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp518537_c0_seq1;GAXK01079928.1;O97162;9.80E-33;TPM_RHIMP;Tropomyosin;;;;;
comp51859_c2_seq1;GAXK01043278.1;P00765;1.38E-47;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp5186032_c0_seq1;GAXK01078133.1;P0CT41;2.62E-11;TF212_SCHPO;Transposon Tf2-12 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp518622_c1_seq1;GAXK01079941.1;Q9HAT2;4.42E-89;SIAE_HUMAN;Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062";"carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]";"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]";sialate O-acetylesterase activity [GO:0001681]
comp5186366_c0_seq1;GAXK01078137.1;A2T7F4;4.75E-14;ZSC12_PONPY;Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 96);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5187094_c0_seq1;GAXK01078142.1;P11718;3.92E-08;ATXA_LEIDO;Probable proton ATPase 1A (EC 7.1.2.1) (LdH1A);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]";"GO:0005524; GO:0008553; GO:0016021; GO:0046872; GO:0120029";proton export across plasma membrane [GO:0120029];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp518711_c0_seq1;GAXK01079905.1;Q8TEB1;1.66E-47;DCA11_HUMAN;DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005654; GO:0016567; GO:0043161; GO:0043687; GO:0080008";"post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]";
comp5187194_c0_seq1;GAXK01078126.1;O04834;6.09E-20;SAR1A_ARATH;GTP-binding protein SAR1A;"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0061024; GO:0070863; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp51880_c1_seq1;GAXK01042975.1;P04055;4.12E-17;PA21B_RAT;Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B);"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; arachidonic acid secretion [GO:0050482]; cellular response to insulin stimulus [GO:0032869]; defense response to Gram-positive bacterium [GO:0050830]; fatty acid biosynthetic process [GO:0006633]; innate immune response in mucosa [GO:0002227]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of glucose import [GO:0046324]";"GO:0002227; GO:0004623; GO:0005102; GO:0005509; GO:0005543; GO:0005615; GO:0005829; GO:0006633; GO:0006644; GO:0008284; GO:0009986; GO:0016042; GO:0019731; GO:0030141; GO:0032869; GO:0046324; GO:0046470; GO:0047498; GO:0048146; GO:0050482; GO:0050830; GO:0061844; GO:0102567; GO:0102568";"antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; arachidonic acid secretion [GO:0050482]; cellular response to insulin stimulus [GO:0032869]; defense response to Gram-positive bacterium [GO:0050830]; fatty acid biosynthetic process [GO:0006633]; innate immune response in mucosa [GO:0002227]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of glucose import [GO:0046324]";"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; secretory granule [GO:0030141]";"calcium-dependent phospholipase A2 activity [GO:0047498]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]"
comp518805_c0_seq1;GAXK01079946.1;Q29RZ4;2.21E-07;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp518899_c0_seq1;GAXK01079945.1;Q66S03;5.51E-10;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp5189010_c0_seq1;GAXK01101685.1;Q9Y2W7;5.22E-11;CSEN_HUMAN;Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator) (DREAM) (Kv channel-interacting protein 3) (KChIP3);"axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]";"GO:0000978; GO:0001227; GO:0003677; GO:0003714; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006357; GO:0006886; GO:0006915; GO:0007165; GO:0008076; GO:0015459; GO:0030425; GO:0032993; GO:0043679; GO:0044325; GO:0061337; GO:0072659; GO:1901379";"apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]";"axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; voltage-gated ion channel activity [GO:0005244]"
comp5189866_c0_seq1;GAXK01101679.1;A2I3Z2;1.05E-36;RSSA_MACHI;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp519017_c0_seq1;GAXK01079962.1;Q99676;1.35E-81;ZN184_HUMAN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp519027_c0_seq1;GAXK01079930.1;P13670;2.72E-07;CHB_VIBHA;N,N'-diacetylchitobiase (Chitobiase) (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase);"cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0009279; GO:0030247; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";cell outer membrane [GO:0009279];"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]"
comp51907_c1_seq1;GAXK01043704.1;P70340;3.25E-10;SMAD1_MOUSE;Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (Dwarfin-A) (Dwf-A) (Mothers-against-DPP-related 1) (Mad-related protein 1) (mMad1) (SMAD family member 1) (SMAD 1) (Smad1);"cytoplasm [GO:0005737]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]";"GO:0000165; GO:0000978; GO:0001228; GO:0001657; GO:0001710; GO:0002051; GO:0003700; GO:0005634; GO:0005637; GO:0005667; GO:0005737; GO:0006357; GO:0006468; GO:0006954; GO:0007179; GO:0007183; GO:0007276; GO:0008285; GO:0009880; GO:0010628; GO:0017151; GO:0019901; GO:0030509; GO:0030901; GO:0030902; GO:0032991; GO:0042493; GO:0042592; GO:0042802; GO:0042803; GO:0043565; GO:0045597; GO:0045669; GO:0045944; GO:0046872; GO:0046982; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071407; GO:0071773; GO:1901522; GO:1902895; GO:1903672";"BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]";"cytoplasm [GO:0005737]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp5190861_c0_seq1;GAXK01064888.1;P0DJ19;2.13E-33;RL27_TETTH;60S ribosomal protein L27;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5192054_c0_seq1;GAXK01141193.1;P34644;2.98E-41;EAT4_CAEEL;Probable vesicular glutamate transporter eat-4 (Abnormal pharyngeal pumping eat-4);"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; synaptic vesicle membrane [GO:0030672]; glutamate:sodium symporter activity [GO:0015501]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; adult locomotory behavior [GO:0008344]; hyperosmotic response [GO:0006972]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of turning behavior involved in mating [GO:0061096]; neurotransmitter loading into synaptic vesicle [GO:0098700]; positive regulation of backward locomotion [GO:1905852]; regulation of pharyngeal pumping [GO:0043051]; regulation of synapse structure or activity [GO:0050803]; response to inorganic substance [GO:0010035]; response to mechanical stimulus [GO:0009612]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005313; GO:0005326; GO:0005887; GO:0006972; GO:0008344; GO:0009612; GO:0010035; GO:0015501; GO:0015813; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043051; GO:0050803; GO:0060076; GO:0061096; GO:0098700; GO:1905852";"adult locomotory behavior [GO:0008344]; hyperosmotic response [GO:0006972]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of turning behavior involved in mating [GO:0061096]; neurotransmitter loading into synaptic vesicle [GO:0098700]; positive regulation of backward locomotion [GO:1905852]; regulation of pharyngeal pumping [GO:0043051]; regulation of synapse structure or activity [GO:0050803]; response to inorganic substance [GO:0010035]; response to mechanical stimulus [GO:0009612]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; synaptic vesicle membrane [GO:0030672]";"glutamate:sodium symporter activity [GO:0015501]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]"
comp5192113_c0_seq1;GAXK01141199.1;B9EJV3;5.38E-08;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp51931_c0_seq2;GAXK01043359.1;P45517;1.36E-08;YDHY_CITFR;Uncharacterized 15.0 kDa protein in dhaT-dhaS intergenic region (ORFY);;;;;
comp5193348_c0_seq1;GAXK01141198.1;O61462;1.86E-39;RL37A_CRYST;60S ribosomal protein L37a;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp5193687_c0_seq1;GAXK01141211.1;P08548;2.45E-11;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp519393_c0_seq1;GAXK01079942.1;Q01295;5.86E-20;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp5194036_c0_seq1;GAXK01000217.1;Q9I3A4;1.27E-11;Y1618_PSEAE;Putative esterase PA1618 (EC 3.1.2.-);"cytosol [GO:0005829]; 1,4-dihydroxy-2-naphthoyl-CoA thioesterase activity [GO:0061522]; CoA hydrolase activity [GO:0016289]";"GO:0005829; GO:0016289; GO:0061522";;cytosol [GO:0005829];"1,4-dihydroxy-2-naphthoyl-CoA thioesterase activity [GO:0061522]; CoA hydrolase activity [GO:0016289]"
comp51942_c1_seq1;GAXK01043431.1;A7M7B9;4.88E-89;NTH_CHICK;Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]";"GO:0000703; GO:0003690; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006296; GO:0046872; GO:0051539; GO:0140078";"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]"
comp5194220_c0_seq1;GAXK01000208.1;Q86LG1;7.44E-09;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp5194509_c0_seq1;GAXK01000231.1;Q76EC5;2.46E-10;CHST9_MOUSE;Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp5194884_c0_seq1;GAXK01000227.1;Q1LZE1;4.92E-11;KCMF1_BOVIN;E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCMF1);"nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]";"GO:0003676; GO:0008270; GO:0061630";;;"nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp5195_c0_seq1;GAXK01205379.1;P25867;9.15E-93;UBCD1_DROME;Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase);"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061630; GO:0061631; GO:0097039";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]"
comp51950_c0_seq1;GAXK01043888.1;Q80XP8;4.33E-66;FA76B_MOUSE;Protein FAM76B;nuclear speck [GO:0016607];GO:0016607;;nuclear speck [GO:0016607];
comp5195233_c0_seq1;GAXK01000220.1;O42706;1.61E-54;RL21B_SCHPO;60S ribosomal protein L21-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp519590_c0_seq1;GAXK01079927.1;Q96RW7;1.86E-16;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp5196481_c0_seq1;GAXK01077641.1;Q29RL1;4.37E-26;CF206_BOVIN;Cilia- and flagella-associated protein 206;"motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"GO:0001534; GO:0003341; GO:0031514; GO:0035082";"axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"motile cilium [GO:0031514]; radial spoke [GO:0001534]";
comp5196765_c0_seq1;GAXK01204840.1;O07329;6.91E-12;CCPA_STRMU;Catabolite control protein A;"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];;DNA binding [GO:0003677]
comp5196852_c0_seq1;GAXK01077653.1;P15387;4.59E-31;KCNB1_RAT;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp5197924_c0_seq1;GAXK01077642.1;Q39444;3.37E-123;FTSH_CAPAN;ATP-dependent zinc metalloprotease FTSH, chloroplastic (EC 3.4.24.-) (Fragment);"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004222; GO:0005524; GO:0007049; GO:0016021; GO:0031969; GO:0046872; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp5198045_c0_seq1;GAXK01040821.1;Q99542;1.02E-20;MMP19_HUMAN;Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18);"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]";"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp519836_c0_seq1;GAXK01079953.1;Q568A0;5.35E-09;PKRI1_DANRE;PRKR-interacting protein 1 homolog;"nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity [GO:0006469]; RNA splicing [GO:0008380]";"GO:0003725; GO:0004860; GO:0005681; GO:0005730; GO:0006397; GO:0006469; GO:0008380; GO:0019901";"mRNA processing [GO:0006397]; negative regulation of protein kinase activity [GO:0006469]; RNA splicing [GO:0008380]";"nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]";"double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]"
comp51985_c0_seq1;GAXK01043855.1;Q52KD8;3.76E-21;EAF6_XENLA;Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog);"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"GO:0000776; GO:0000777; GO:0005730; GO:0035267; GO:0043968; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776";"histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]";
comp5198562_c0_seq1;GAXK01040822.1;P17970;9.22E-12;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp5198725_c0_seq1;GAXK01040837.1;Q552Z6;6.88E-08;GTPA_DICDI;GTP-binding protein A;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp5199_c0_seq1;GAXK01065585.1;Q6DH66;9.13E-40;TM20B_DANRE;Mitochondrial import receptor subunit TOM20 homolog B (Mitochondrial 20 kDa outer membrane protein B) (Outer mitochondrial membrane receptor Tom20-B);"integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031]";"GO:0005742; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0031307; GO:0070096";"mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031]";"integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]";"mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]"
comp51990_c0_seq1;GAXK01043351.1;Q8WYH8;1.86E-72;ING5_HUMAN;Inhibitor of growth protein 5 (p28ING5);"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006473; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0045893; GO:0045926; GO:0046872; GO:0070776; GO:1901796; GO:2001235";"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]";"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp519901_c0_seq1;GAXK01079887.1;G5ED00;3.44E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp5199268_c0_seq1;GAXK01040814.1;P0C227;3.35E-16;GLB_NERAL;Globin (Myoglobin);"extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005576; GO:0005833; GO:0019825; GO:0020037; GO:0046872";;"extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp5199875_c0_seq1;GAXK01040832.1;Q95ZJ1;3.21E-19;GALT5_CAEEL;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]";"GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872";protein O-linked glycosylation via threonine [GO:0018243];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp52_c0_seq1;GAXK01168772.1;Q09JW2;6.25E-92;RL17_ARGMO;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp520_c0_seq1;GAXK01205876.1;O02649;0;CH60A_DROME;Heat shock protein 60A;"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]";"GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006458; GO:0006626; GO:0007005; GO:0008637; GO:0034605; GO:0042026; GO:0045041; GO:0051082";"'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp520014_c0_seq1;GAXK01206006.1;P15848;5.63E-109;ARSB_HUMAN;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp520195_c0_seq1;GAXK01204937.1;Q924Y4;4.46E-20;GATA2_RAT;Endothelial transcription factor GATA-2 (GATA-binding protein 2);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell differentiation in hindbrain [GO:0021533]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventral spinal cord interneuron differentiation [GO:0021514]";"GO:0000122; GO:0000978; GO:0000980; GO:0000981; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006909; GO:0007204; GO:0008134; GO:0008270; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0021983; GO:0032991; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0043565; GO:0045599; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048469; GO:0048873; GO:0050766; GO:0060100; GO:0060216; GO:0060872; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1902895; GO:1903589; GO:2000178; GO:2000352; GO:2000977";"cell differentiation in hindbrain [GO:0021533]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventral spinal cord interneuron differentiation [GO:0021514]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp5202146_c0_seq1;GAXK01045591.1;Q9VS77;2.14E-08;MTH6_DROME;Probable G-protein coupled receptor Mth-like 6 (Protein methuselah-like 6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp5202394_c0_seq1;GAXK01045580.1;P19913;2.50E-75;DCML_HYDPS;Carbon monoxide dehydrogenase large chain (CO dehydrogenase subunit L) (CO-DH L) (EC 1.2.5.3);"carbon-monoxide dehydrogenase (acceptor) activity [GO:0018492]; copper ion binding [GO:0005507]; molybdenum ion binding [GO:0030151]";"GO:0005507; GO:0018492; GO:0030151";;;"carbon-monoxide dehydrogenase (acceptor) activity [GO:0018492]; copper ion binding [GO:0005507]; molybdenum ion binding [GO:0030151]"
comp5202556_c0_seq1;GAXK01045589.1;E2AX35;1.64E-50;PROH4_CAMFO;IDLSRF-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp5202706_c0_seq1;GAXK01045584.1;P18737;3.94E-08;ZG8_XENLA;Gastrula zinc finger protein XlCGF8.2DB (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp520281_c0_seq1;GAXK01203298.1;Q2TAP8;1.12E-08;CHCH7_XENLA;Coiled-coil-helix-coiled-coil-helix domain-containing protein 7;mitochondrial intermembrane space [GO:0005758];GO:0005758;;mitochondrial intermembrane space [GO:0005758];
comp52030_c5_seq1;GAXK01111473.1;O00534;4.83E-69;VMA5A_HUMAN;von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"GO:0005634; GO:0005654";;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp5203204_c0_seq1;GAXK01045590.1;Q8WQI7;5.40E-28;RL18A_SPOFR;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5203536_c0_seq1;GAXK01045588.1;Q5ZHN3;1.58E-13;WIPI2_CHICK;WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2);"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0061739; GO:0080025; GO:0098792";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]";"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp520367_c0_seq1;GAXK01203249.1;P28159;5.40E-22;SUH_DROME;Suppressor of hairless protein (J kappa-recombination signal-binding protein) (RBP-J kappa);"CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; asymmetric cell division [GO:0008356]; cell fate determination [GO:0001709]; crystal cell differentiation [GO:0042688]; hemopoiesis [GO:0030097]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; long-term memory [GO:0007616]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ precursor cell fate determination [GO:0016360]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000122; GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001228; GO:0001709; GO:0003677; GO:0005634; GO:0005667; GO:0005700; GO:0005737; GO:0007219; GO:0007616; GO:0008356; GO:0008586; GO:0016360; GO:0017053; GO:0030097; GO:0032991; GO:0042683; GO:0042688; GO:0043565; GO:0045746; GO:0045892; GO:0045893; GO:0045944; GO:0048190; GO:0061629; GO:0090571; GO:1900087; GO:1990433";"asymmetric cell division [GO:0008356]; cell fate determination [GO:0001709]; crystal cell differentiation [GO:0042688]; hemopoiesis [GO:0030097]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; long-term memory [GO:0007616]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ precursor cell fate determination [GO:0016360]; wing disc dorsal/ventral pattern formation [GO:0048190]";"CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]"
comp52038_c1_seq1;GAXK01112024.1;Q96KR1;0;ZFR_HUMAN;Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]"
comp5204703_c0_seq1;GAXK01009865.1;A0A0R4IBK5;3.35E-17;R213A_DANRE;E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872";"blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp5205231_c0_seq1;GAXK01009844.1;O74864;1.33E-37;RLA0_SCHPO;60S acidic ribosomal protein P0;"90S preribosome [GO:0030686]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; cytoplasmic translational elongation [GO:0002182]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0002182; GO:0003735; GO:0005829; GO:0022625; GO:0030686; GO:0070180";"cytoplasmic translation [GO:0002181]; cytoplasmic translational elongation [GO:0002182]; ribosomal large subunit assembly [GO:0000027]";"90S preribosome [GO:0030686]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";"large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp52056_c0_seq1;GAXK01111966.1;Q9DF50;3.06E-16;CLSPN_XENLA;Claspin (xClaspin);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]";"GO:0003677; GO:0005634; GO:0006281; GO:0007095";"DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp52058_c1_seq1;GAXK01112168.1;Q8WV41;2.20E-109;SNX33_HUMAN;Sorting nexin-33 (SH3 and PX domain-containing protein 3);"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]";"GO:0000281; GO:0005829; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0019898; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010";"cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]";"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]";"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]"
comp5205902_c0_seq1;GAXK01009868.1;Q6NQE2;2.20E-47;FQRL1_ARATH;Probable NAD(P)H dehydrogenase (quinone) FQR1-like 1 (EC 1.6.5.2);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; FMN binding [GO:0010181]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; oxidation-reduction process [GO:0055114]";"GO:0003955; GO:0005829; GO:0005886; GO:0009506; GO:0010181; GO:0055114";oxidation-reduction process [GO:0055114];"cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"FMN binding [GO:0010181]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]"
comp5206072_c0_seq1;GAXK01172736.1;Q28709;1.82E-11;CD63_RABIT;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005765; GO:0007160; GO:0009986; GO:0015031; GO:0016021; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]";
comp52066_c0_seq1;GAXK01111805.1;P32866;0;GPRK2_DROME;G protein-coupled receptor kinase 2 (EC 2.7.11.16);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0003384; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0043950; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273";"apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]"
comp5206646_c0_seq1;GAXK01172743.1;P33749;9.07E-08;MSN4_YEAST;Zinc finger protein MSN4 (Multicopy suppressor of SNF1 protein 4);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; cellular response to acidic pH [GO:0071468]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to a hypotonic environment [GO:0061401]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; positive regulation of transcription from RNA polymerase II promoter in response to alkaline pH [GO:0061422]; positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation [GO:0061412]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to cold [GO:0061411]; positive regulation of transcription from RNA polymerase II promoter in response to ethanol [GO:0061410]; positive regulation of transcription from RNA polymerase II promoter in response to freezing [GO:0061409]; positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation [GO:0061406]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide [GO:0061407]; positive regulation of transcription from RNA polymerase II promoter in response to hydrostatic pressure [GO:0061405]; positive regulation of transcription from RNA polymerase II promoter in response to increased salt [GO:0061404]; positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation [GO:0036278]; positive regulation of transcription from RNA polymerase II promoter in response to nitrosative stress [GO:0061403]; positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation [GO:0097236]; regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction [GO:0061434]; replicative cell aging [GO:0001302]";"GO:0000981; GO:0000987; GO:0001302; GO:0001324; GO:0005634; GO:0005829; GO:0006338; GO:0036278; GO:0045944; GO:0046872; GO:0061395; GO:0061401; GO:0061402; GO:0061403; GO:0061404; GO:0061405; GO:0061406; GO:0061407; GO:0061408; GO:0061409; GO:0061410; GO:0061411; GO:0061412; GO:0061422; GO:0061434; GO:0071468; GO:0097236";"age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; cellular response to acidic pH [GO:0071468]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; positive regulation of transcription from RNA polymerase II promoter in response to a hypotonic environment [GO:0061401]; positive regulation of transcription from RNA polymerase II promoter in response to alkaline pH [GO:0061422]; positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation [GO:0061412]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to cold [GO:0061411]; positive regulation of transcription from RNA polymerase II promoter in response to ethanol [GO:0061410]; positive regulation of transcription from RNA polymerase II promoter in response to freezing [GO:0061409]; positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation [GO:0061406]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide [GO:0061407]; positive regulation of transcription from RNA polymerase II promoter in response to hydrostatic pressure [GO:0061405]; positive regulation of transcription from RNA polymerase II promoter in response to increased salt [GO:0061404]; positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation [GO:0036278]; positive regulation of transcription from RNA polymerase II promoter in response to nitrosative stress [GO:0061403]; positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation [GO:0097236]; regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction [GO:0061434]; replicative cell aging [GO:0001302]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]"
comp520712_c2_seq1;GAXK01203282.1;Q9JJQ0;1.93E-88;PIGB_MOUSE;GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]";"GO:0000030; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0016021; GO:0097502";"GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";mannosyltransferase activity [GO:0000030]
comp5207323_c0_seq1;GAXK01172735.1;Q962T1;9.87E-34;RL32_SPOFR;60S ribosomal protein L32;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp52074_c1_seq1;GAXK01111936.1;Q8K4Y7;3.50E-118;CANT1_RAT;Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog);"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; proteoglycan biosynthetic process [GO:0030166]";"GO:0004382; GO:0005509; GO:0005789; GO:0016021; GO:0030166; GO:0032580; GO:0042803; GO:0043262; GO:0045134";proteoglycan biosynthetic process [GO:0030166];"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]"
comp520813_c0_seq1;GAXK01203250.1;P17970;6.17E-174;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp5208592_c0_seq1;GAXK01102411.1;Q8I7P9;4.17E-13;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5208702_c0_seq1;GAXK01102400.1;P05659;1.01E-07;MYSN_ACACA;Myosin-2 heavy chain, non muscle (Myosin II heavy chain, non muscle);"myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0051015";;myosin complex [GO:0016459];"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp5208855_c0_seq1;GAXK01102394.1;Q9UJW2;1.89E-09;TINAG_HUMAN;Tubulointerstitial nephritis antigen (TIN-Ag);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; immune response [GO:0006955]";"GO:0000166; GO:0004197; GO:0005044; GO:0005604; GO:0005615; GO:0006955; GO:0007155; GO:0030247";"cell adhesion [GO:0007155]; immune response [GO:0006955]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp5209152_c0_seq1;GAXK01102392.1;P73392;9.48E-07;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp520928_c0_seq1;GAXK01203230.1;P31228;1.08E-75;OXDD_BOVIN;D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1);"cytoplasm [GO:0005737]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]";"GO:0003884; GO:0005737; GO:0005777; GO:0006531; GO:0006533; GO:0008445; GO:0019478; GO:0071949";"aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]";"cytoplasm [GO:0005737]; peroxisome [GO:0005777]";"D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]"
comp5209642_c0_seq1;GAXK01102397.1;Q90YW2;1.12E-87;RL7A_ICTPU;60S ribosomal protein L7a;"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp52101_c0_seq1;GAXK01111976.1;A2VDY4;1.03E-76;HPF1_BOVIN;Histone PARylation factor 1;"nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]";"GO:0005634; GO:0006974; GO:0008270; GO:0010835; GO:0018312; GO:0042393; GO:0072572";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]";nucleus [GO:0005634];"histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]"
comp521026_c0_seq1;GAXK01203259.1;P18751;1.93E-44;ZO71_XENLA;Oocyte zinc finger protein XlCOF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp521057_c0_seq1;GAXK01203304.1;P24524;6.68E-16;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp5210612_c0_seq1;GAXK01203353.1;P15112;5.92E-70;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp5210690_c0_seq1;GAXK01203355.1;P44334;2.00E-40;IMDH_HAEIN;Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205);"IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]";"GO:0000166; GO:0003938; GO:0006177; GO:0006183; GO:0046872";"GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]";;"IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp521099_c0_seq1;GAXK01203294.1;Q8MUJ1;6.09E-11;EIGER_DROME;"Protein eiger [Cleaved into: Protein eiger, membrane form; Protein eiger, soluble form]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006955; GO:0007254; GO:0014009; GO:0032813; GO:0035006; GO:0043652; GO:0044214; GO:0045087; GO:0045167; GO:0045176; GO:0050829; GO:0070050; GO:0097191; GO:1900074; GO:1904058";"apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell proliferation [GO:0014009]; immune response [GO:0006955]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; melanization defense response [GO:0035006]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron cellular homeostasis [GO:0070050]; positive regulation of sensory perception of pain [GO:1904058]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]";"cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]"
comp52112_c0_seq1;GAXK01111405.1;Q9V9W8;2.42E-37;PYGO_DROME;Protein pygopus (Protein gammy legs);"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription, DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472]";"GO:0003713; GO:0005634; GO:0005654; GO:0006351; GO:0007367; GO:0007472; GO:0009880; GO:0035064; GO:0035214; GO:0035293; GO:0045944; GO:0046872; GO:0048526; GO:0060070; GO:0060232; GO:1990907";"canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription, DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472]";"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]"
comp5213_c3_seq1;GAXK01065839.1;P56571;5.51E-68;ES1_RAT;ES1 protein homolog, mitochondrial;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp5213080_c0_seq1;GAXK01093422.1;Q8IS64;4.65E-12;ECE_LOCMI;Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp52132_c0_seq1;GAXK01111946.1;Q08CG8;6.46E-43;RNF44_DANRE;RING finger protein 44;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp52144_c6_seq1;GAXK01111911.1;Q8BGK6;7.96E-134;YLAT2_MOUSE;Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]";"GO:0005886; GO:0015179; GO:0015297; GO:0016021; GO:0016323; GO:0043231";;"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]"
comp521496_c3_seq1;GAXK01203292.1;Q5F364;0;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp5215721_c0_seq1;GAXK01057126.1;B1Y0V7;8.59E-32;RLMH_LEPCP;Ribosomal RNA large subunit methyltransferase H (EC 2.1.1.177) (23S rRNA (pseudouridine1915-N3)-methyltransferase) (23S rRNA m3Psi1915 methyltransferase) (rRNA (pseudouridine-N3-)-methyltransferase RlmH);"cytoplasm [GO:0005737]; rRNA (pseudouridine-N3-)-methyltransferase activity [GO:0070038]";"GO:0005737; GO:0070038";;cytoplasm [GO:0005737];rRNA (pseudouridine-N3-)-methyltransferase activity [GO:0070038]
comp52163_c0_seq1;GAXK01205526.1;P97477;1.90E-141;AURKA_MOUSE;Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A);"axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; liver regeneration [GO:0097421]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]";"GO:0000212; GO:0000226; GO:0000278; GO:0000780; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005815; GO:0005819; GO:0005829; GO:0005876; GO:0005929; GO:0006468; GO:0007051; GO:0007052; GO:0007057; GO:0007098; GO:0007100; GO:0009611; GO:0009948; GO:0015630; GO:0019901; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0042585; GO:0043066; GO:0043203; GO:0045120; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051321; GO:0051642; GO:0071539; GO:0072686; GO:0072687; GO:0097421; GO:0097431; GO:1900195; GO:1990138";"anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; liver regeneration [GO:0097421]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]";"axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]";"ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]"
comp52166_c0_seq1;GAXK01111838.1;P41073;3.43E-13;PEP_DROME;Zinc finger protein on ecdysone puffs;"catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; precatalytic spliceosome [GO:0071011]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0000398; GO:0003677; GO:0003697; GO:0003727; GO:0005694; GO:0046872; GO:0048024; GO:0071011; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; precatalytic spliceosome [GO:0071011]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]"
comp521723_c3_seq1;GAXK01203217.1;Q71N41;9.34E-96;GAMT_DANRE;Guanidinoacetate N-methyltransferase (EC 2.1.1.2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanidinoacetate N-methyltransferase activity [GO:0030731]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; creatine biosynthetic process [GO:0006601]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]";"GO:0005634; GO:0005737; GO:0006601; GO:0008757; GO:0030731; GO:0046498; GO:0046500";"creatine biosynthetic process [GO:0006601]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"guanidinoacetate N-methyltransferase activity [GO:0030731]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp521855_c3_seq1;GAXK01203203.1;Q3TZZ7;2.72E-85;ESYT2_MOUSE;Extended synaptotagmin-2 (E-Syt2);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268";"endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp521866_c1_seq1;GAXK01203207.1;P49746;1.24E-84;TSP3_HUMAN;Thrombospondin-3;"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]";"GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]";"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp5219307_c0_seq1;GAXK01086292.1;Q94HW2;4.17E-07;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp521943_c1_seq1;GAXK01203279.1;Q7TSI0;4.98E-07;ZNF12_MOUSE;Zinc finger protein 12;"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003676; GO:0005634; GO:0005654; GO:0005813; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5219621_c0_seq1;GAXK01086305.1;Q6PAJ1;9.71E-08;BCR_MOUSE;Breakpoint cluster region protein (EC 2.7.11.1);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase mediated signal transduction [GO:0007264]";"GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005089; GO:0005096; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0014069; GO:0019899; GO:0030036; GO:0030054; GO:0030216; GO:0030336; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0045211; GO:0046777; GO:0048008; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:2000378";"actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase mediated signal transduction [GO:0007264]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp5220_c0_seq1;GAXK01065407.1;P48591;0;RIR1_DROME;Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit);"ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; tissue regeneration [GO:0042246]";"GO:0004748; GO:0005524; GO:0005971; GO:0006260; GO:0006919; GO:0009263; GO:0042246";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; tissue regeneration [GO:0042246]";ribonucleoside-diphosphate reductase complex [GO:0005971];"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"
comp5220277_c0_seq1;GAXK01036975.1;Q01292;1.50E-14;ILV5_SPIOL;Ketol-acid reductoisomerase, chloroplastic (EC 1.1.1.86) (Acetohydroxy-acid reductoisomerase) (Alpha-keto-beta-hydroxylacyl reductoisomerase);"chloroplast [GO:0009507]; ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";"GO:0000287; GO:0004455; GO:0009097; GO:0009099; GO:0009507; GO:0042803; GO:0070402";"isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";chloroplast [GO:0009507];"ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]"
comp5220462_c0_seq1;GAXK01036993.1;Q9HBA0;1.02E-08;TRPV4_HUMAN;Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Transient receptor potential protein 12) (TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2) (VRL-2) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of vascular permeability [GO:0043117]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; signal transduction involved in regulation of aerobic respiration [GO:1903759]; vasopressin secretion [GO:0030103]";"GO:0000122; GO:0002024; GO:0003779; GO:0005034; GO:0005080; GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005783; GO:0005881; GO:0005886; GO:0005887; GO:0005912; GO:0005925; GO:0005929; GO:0006816; GO:0006874; GO:0006884; GO:0007015; GO:0007043; GO:0007204; GO:0007231; GO:0008017; GO:0008289; GO:0009612; GO:0009986; GO:0010628; GO:0010759; GO:0010977; GO:0015275; GO:0016021; GO:0016324; GO:0019901; GO:0030027; GO:0030103; GO:0030175; GO:0030426; GO:0030864; GO:0031117; GO:0031410; GO:0031532; GO:0032587; GO:0032868; GO:0034605; GO:0042169; GO:0042538; GO:0042593; GO:0042802; GO:0043014; GO:0043117; GO:0043622; GO:0046330; GO:0046785; GO:0046872; GO:0047484; GO:0048487; GO:0050729; GO:0050891; GO:0051015; GO:0060351; GO:0070374; GO:0070509; GO:0070588; GO:0071470; GO:0071476; GO:0071477; GO:0071639; GO:0071642; GO:0071651; GO:0097009; GO:0097497; GO:1903444; GO:1903759; GO:2000340; GO:2000778";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cell volume homeostasis [GO:0006884]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of vascular permeability [GO:0043117]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; signal transduction involved in regulation of aerobic respiration [GO:1903759]; vasopressin secretion [GO:0030103]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]"
comp522049_c0_seq1;GAXK01192435.1;Q05941;9.31E-65;ACHA7_RAT;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0007165; GO:0007268; GO:0007271; GO:0007613; GO:0008144; GO:0008179; GO:0014069; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032279; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042416; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0050877; GO:0050893; GO:0051117; GO:0070373; GO:0070374; GO:0095500; GO:0097110; GO:0098690; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:1904315; GO:1905144; GO:2000300";"acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp5221_c0_seq1;GAXK01065628.1;P21868;0;CSK21_CHICK;Casein kinase II subunit alpha (CK II) (EC 2.7.11.1);"cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell cycle [GO:0051726]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0016055; GO:0018105; GO:0018107; GO:0048511; GO:0051726";"peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell cycle [GO:0051726]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp522176_c0_seq1;GAXK01192390.1;Q9PTN2;1.77E-14;VDRA_DANRE;Vitamin D3 receptor A (VDR-A) (1,25-dihydroxyvitamin D3 receptor A) (Nuclear receptor subfamily 1 group I member 1-A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000976; GO:0000977; GO:0000981; GO:0001503; GO:0001947; GO:0003146; GO:0003707; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0007275; GO:0008134; GO:0008270; GO:0030154; GO:0030374; GO:0038023; GO:0045944; GO:0055074; GO:0071425; GO:0090575; GO:1902098; GO:1902121";"calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"calcitriol binding [GO:1902098]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]"
comp5221796_c0_seq1;GAXK01036988.1;Q9MZ19;4.58E-21;KCNB1_RABIT;Potassium voltage-gated channel subfamily B member 1 (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005251; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp5221807_c0_seq1;GAXK01036980.1;Q15818;1.28E-10;NPTX1_HUMAN;Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I);"glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005886; GO:0007268; GO:0007417; GO:0030133; GO:0043005; GO:0046872; GO:0060385; GO:0098962; GO:0098978";"axonogenesis involved in innervation [GO:0060385]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";metal ion binding [GO:0046872]
comp522186_c0_seq1;GAXK01192431.1;Q9UFB7;7.34E-08;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5222269_c0_seq1;GAXK01078211.1;Q96UQ7;6.07E-16;RLA2_RHOGU;60S acidic ribosomal protein P2 (Acyl carrier protein);"ribosome [GO:0005840]; acyl carrier activity [GO:0000036]; structural constituent of ribosome [GO:0003735]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; translational elongation [GO:0006414]";"GO:0000036; GO:0003735; GO:0005840; GO:0006414; GO:0006633; GO:0008610";"fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; translational elongation [GO:0006414]";ribosome [GO:0005840];"acyl carrier activity [GO:0000036]; structural constituent of ribosome [GO:0003735]"
comp5222387_c0_seq1;GAXK01078220.1;P53879;7.58E-12;RHO5_YEAST;GTP-binding protein RHO5;"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell death in response to hydrogen peroxide [GO:0036474]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"GO:0000329; GO:0000902; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007015; GO:0007266; GO:0012505; GO:0016477; GO:0019901; GO:0030036; GO:0030838; GO:0036474; GO:0043652";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell death in response to hydrogen peroxide [GO:0036474]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; engulfment of apoptotic cell [GO:0043652]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp5222580_c0_seq1;GAXK01078224.1;Q0VCR6;3.65E-15;TMM68_BOVIN;Transmembrane protein 68;"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]";"GO:0016021; GO:0016746";;integral component of membrane [GO:0016021];transferase activity, transferring acyl groups [GO:0016746]
comp5222964_c0_seq1;GAXK01078229.1;P34737;2.08E-42;RS15_PODAS;40S ribosomal protein S15 (S12);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5222999_c0_seq1;GAXK01078215.1;Q9ES14;1.59E-08;GBRE_RAT;Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0042493; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099055; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp522316_c0_seq1;GAXK01192410.1;P16257;4.98E-24;TSPO_RAT;Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; ion channel binding [GO:0044325]; adrenal gland development [GO:0030325]; aging [GO:0007568]; behavioral response to pain [GO:0048266]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; contact inhibition [GO:0060242]; establishment of protein localization to mitochondrion [GO:0072655]; glial cell migration [GO:0008347]; ion transport [GO:0006811]; lipid transport [GO:0006869]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of steroid biosynthetic process [GO:0050810]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to manganese ion [GO:0010042]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; steroid biosynthetic process [GO:0006694]";"GO:0005497; GO:0005739; GO:0005741; GO:0005783; GO:0006694; GO:0006811; GO:0006821; GO:0006869; GO:0007568; GO:0008347; GO:0008503; GO:0010042; GO:0010266; GO:0010940; GO:0014012; GO:0015485; GO:0016021; GO:0030325; GO:0031397; GO:0032570; GO:0032720; GO:0033574; GO:0042493; GO:0043065; GO:0044325; GO:0045019; GO:0048265; GO:0048266; GO:0048678; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0071222; GO:0071294; GO:0071476; GO:0072655; GO:0072656; GO:1903147; GO:1903579; GO:2000379";"adrenal gland development [GO:0030325]; aging [GO:0007568]; behavioral response to pain [GO:0048266]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; contact inhibition [GO:0060242]; establishment of protein localization to mitochondrion [GO:0072655]; glial cell migration [GO:0008347]; ion transport [GO:0006811]; lipid transport [GO:0006869]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of steroid biosynthetic process [GO:0050810]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to manganese ion [GO:0010042]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; steroid biosynthetic process [GO:0006694]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; ion channel binding [GO:0044325]"
comp5223380_c0_seq1;GAXK01078219.1;Q87AD4;6.55E-07;Y1892_XYLFT;UPF0394 membrane protein PD_1892;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp522377_c1_seq1;GAXK01192440.1;Q4TZY1;5.43E-87;KCJ12_BOVIN;ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp5224361_c0_seq1;GAXK01077578.1;E9Q555;1.36E-29;RN213_MOUSE;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp5224450_c0_seq1;GAXK01077577.1;Q7SYD5;2.77E-30;SC31A_DANRE;Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A);"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]";"GO:0000139; GO:0001889; GO:0005198; GO:0005789; GO:0006886; GO:0006888; GO:0007029; GO:0030127; GO:0030134; GO:0055123; GO:0070971; GO:0090110; GO:0090114";"COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";structural molecule activity [GO:0005198]
comp5224979_c0_seq1;GAXK01077569.1;Q9NZJ4;1.96E-24;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp52261_c0_seq1;GAXK01111657.1;Q8IRI6;8.93E-118;GTR1_DROME;Glucose transporter type 1;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]";"GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277";"carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp522682_c0_seq1;GAXK01192412.1;Q5M9G8;6.00E-34;DCA11_RAT;DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0043161; GO:0080008";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
comp522704_c0_seq1;GAXK01192382.1;Q18786;2.94E-26;SMD2_CAEEL;Probable small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2);"catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0005682; GO:0005685; GO:0005686; GO:0046540; GO:0071013";spliceosomal snRNP assembly [GO:0000387];"catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";
comp5227835_c0_seq1;GAXK01057531.1;P32251;7.35E-10;ADRA2_CARAU;Alpha-2 adrenergic receptor (Alpha-2 adrenoreceptor) (Alpha-2 adrenoceptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]";"GO:0004935; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";adrenergic receptor activity [GO:0004935]
comp52279_c1_seq1;GAXK01111933.1;O14657;5.46E-102;TOR1B_HUMAN;Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum organization [GO:0007029]; nuclear membrane organization [GO:0071763]; protein homooligomerization [GO:0051260]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0006986; GO:0007029; GO:0016887; GO:0031965; GO:0051085; GO:0051260; GO:0070062; GO:0071763";"chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum organization [GO:0007029]; nuclear membrane organization [GO:0071763]; protein homooligomerization [GO:0051260]; response to unfolded protein [GO:0006986]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp522865_c0_seq1;GAXK01192437.1;A0A0B4K692;7.55E-152;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp522903_c0_seq1;GAXK01192429.1;Q68EA5;5.65E-25;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp522946_c1_seq1;GAXK01192379.1;P16444;2.13E-101;DPEP1_HUMAN;Dipeptidase 1 (EC 3.4.13.19) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP);"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"GO:0005615; GO:0005634; GO:0005886; GO:0006691; GO:0006749; GO:0006805; GO:0008235; GO:0008239; GO:0008270; GO:0016324; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341";"antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]"
comp5229544_c0_seq1;GAXK01161057.1;Q93560;2.89E-09;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5229802_c0_seq1;GAXK01161047.1;Q50KB1;1.78E-21;SEP2_EMIHU;Protein disulfide-isomerase-like protein EhSep2;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein disulfide isomerase activity [GO:0003756]
comp52302_c0_seq1;GAXK01111967.1;Q803U7;5.97E-118;EXO1_DANRE;Exonuclease 1 (EC 3.1.-.-) (Exonuclease I);"nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; mismatch repair [GO:0006298]";"GO:0003677; GO:0005634; GO:0006298; GO:0006310; GO:0017108; GO:0035312; GO:0045145; GO:0046872; GO:0048256";"DNA recombination [GO:0006310]; mismatch repair [GO:0006298]";nucleus [GO:0005634];"5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]"
comp523036_c0_seq1;GAXK01192421.1;Q17005;6.28E-36;LYSC1_ANOGA;Lysozyme c-1 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase);"lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";"GO:0003796; GO:0008152; GO:0019835; GO:0042742";"cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";;lysozyme activity [GO:0003796]
comp5230815_c0_seq1;GAXK01163086.1;P21328;1.56E-08;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp523098_c1_seq1;GAXK01192370.1;Q5R8T6;4.37E-70;IPYR_PONAB;Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase);"cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796]";"GO:0000287; GO:0004427; GO:0005737; GO:0006796";phosphate-containing compound metabolic process [GO:0006796];cytoplasm [GO:0005737];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp5231224_c0_seq1;GAXK01163080.1;Q94738;1.85E-07;HSP97_MESFR;97 kDa heat shock protein (Heat shock protein 110);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737";;cytoplasm [GO:0005737];ATP binding [GO:0005524]
comp5231280_c0_seq1;GAXK01163078.1;Q08180;7.13E-09;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp523136_c0_seq1;GAXK01192387.1;P50750;8.66E-134;CDK9_HUMAN;Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000307; GO:0000790; GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006282; GO:0006366; GO:0006367; GO:0006368; GO:0006468; GO:0008023; GO:0008024; GO:0008134; GO:0008283; GO:0008353; GO:0010613; GO:0016020; GO:0016301; GO:0016605; GO:0019901; GO:0030332; GO:0031056; GO:0031297; GO:0032968; GO:0033129; GO:0036464; GO:0042493; GO:0042795; GO:0044212; GO:0045944; GO:0050434; GO:0051147; GO:0070816; GO:0071157; GO:0071345; GO:0097322; GO:1900364; GO:1903839; GO:2001168";"cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]";"7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp52319_c0_seq1;GAXK01111939.1;Q5E9X1;6.99E-54;NFYC_BOVIN;Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC);"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]";"GO:0000978; GO:0000980; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0016602; GO:0032993; GO:0046982";;"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp523288_c1_seq1;GAXK01192413.1;A0A1L8EXB5;1.68E-34;AR1AB_XENLA;Actin-related protein 2/3 complex subunit 1A-B;"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp5233074_c0_seq1;GAXK01084184.1;Q0GBZ5;1.47E-15;OX1R_BOVIN;Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1);"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0051480";"feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of cytosolic calcium ion concentration [GO:0051480]";integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]"
comp523312_c2_seq1;GAXK01192393.1;A4IIY1;7.77E-69;R144A_XENTR;Probable E3 ubiquitin-protein ligase RNF144A (EC 2.3.2.31) (RING finger protein 144A);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp5233470_c0_seq1;GAXK01084194.1;P07237;5.70E-32;PDIA1_HUMAN;Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0003723; GO:0003756; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005925; GO:0006457; GO:0009897; GO:0015037; GO:0016222; GO:0018401; GO:0019899; GO:0034378; GO:0034379; GO:0034663; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0043687; GO:0044267; GO:0045454; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1902175";"cell redox homeostasis [GO:0045454]; cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]"
comp523365_c0_seq1;GAXK01192439.1;Q58D55;3.36E-179;BGAL_BOVIN;Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase);"lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]";"GO:0004565; GO:0005764; GO:0005773; GO:0005975";carbohydrate metabolic process [GO:0005975];"lysosome [GO:0005764]; vacuole [GO:0005773]";beta-galactosidase activity [GO:0004565]
comp5233833_c0_seq1;GAXK01084177.1;O42766;1.85E-19;1433_CANAL;14-3-3 protein homolog;"cell surface [GO:0009986]; plasma membrane [GO:0005886]; yeast-form cell wall [GO:0030445]; protein domain specific binding [GO:0019904]; cellular response to heat [GO:0034605]; cellular response to neutral pH [GO:0036244]; chlamydospore formation [GO:0001410]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to heat [GO:0036168]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; pathogenesis [GO:0009405]; positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:1900445]; positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH [GO:1900442]; regulation of carbohydrate metabolic process [GO:0006109]";"GO:0001410; GO:0005886; GO:0006109; GO:0009405; GO:0009986; GO:0019904; GO:0030445; GO:0030447; GO:0034605; GO:0036168; GO:0036178; GO:0036180; GO:0036244; GO:0044182; GO:1900442; GO:1900445";"cellular response to heat [GO:0034605]; cellular response to neutral pH [GO:0036244]; chlamydospore formation [GO:0001410]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to heat [GO:0036168]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; pathogenesis [GO:0009405]; positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:1900445]; positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH [GO:1900442]; regulation of carbohydrate metabolic process [GO:0006109]";"cell surface [GO:0009986]; plasma membrane [GO:0005886]; yeast-form cell wall [GO:0030445]";protein domain specific binding [GO:0019904]
comp523399_c0_seq1;GAXK01192451.1;Q08BA6;5.16E-91;ALKB5_DANRE;RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; RNA N6-methyladenosine dioxygenase activity [GO:1990931]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]";"GO:0001666; GO:0005634; GO:0006397; GO:0006406; GO:0007283; GO:0016607; GO:0016706; GO:0035515; GO:0035553; GO:0046872; GO:1990931";"mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; RNA N6-methyladenosine dioxygenase activity [GO:1990931]"
comp523409_c1_seq1;GAXK01192386.1;P49596;3.34E-63;PP2C2_CAEEL;Probable protein phosphatase 2C T23F11.1 (PP2C) (EC 3.1.3.16);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0004722; GO:0004724; GO:0005634; GO:0005737; GO:0030517; GO:0031625; GO:0032873; GO:0046872; GO:0048786; GO:0051965; GO:0071470; GO:1990439";"cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]";"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]"
comp52345_c0_seq1;GAXK01111592.1;Q9UGM6;3.61E-99;SYWM_HUMAN;Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570]";"GO:0001570; GO:0004830; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006418; GO:0006436; GO:0070183";"mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]"
comp5235459_c0_seq1;GAXK01028972.1;P97570;1.86E-08;PLPL9_RAT;85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9);"cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]";"GO:0001934; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005743; GO:0005815; GO:0005829; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016042; GO:0017171; GO:0019731; GO:0019901; GO:0032049; GO:0034976; GO:0035774; GO:0043008; GO:0045921; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102567; GO:0102568; GO:1901339; GO:2000304";"antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"
comp523558_c0_seq1;GAXK01205974.1;Q9VA27;1.50E-158;CP4C3_DROME;Cytochrome P450 4c3 (EC 1.14.-.-) (CYPIVC3);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp523593_c0_seq1;GAXK01192385.1;Q17529;4.49E-07;BEST2_CAEEL;Bestrophin homolog 2;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp5235962_c0_seq1;GAXK01028966.1;P14381;4.74E-10;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp52360_c1_seq1;GAXK01111731.1;Q5ZKH3;6.55E-164;EED_CHICK;Polycomb protein EED;"cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]";"GO:0000122; GO:0000978; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0061087; GO:1990830; GO:2000011";"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]";"cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]";"chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp52362_c0_seq1;GAXK01111539.1;O75925;5.18E-110;PIAS1_HUMAN;E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]";"GO:0000082; GO:0000122; GO:0001085; GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0007259; GO:0007283; GO:0008022; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0019904; GO:0030521; GO:0031625; GO:0032436; GO:0033235; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0050681; GO:0051152; GO:0060334; GO:0061665; GO:0065004";"androgen receptor signaling pathway [GO:0030521]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex assembly [GO:0065004]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp5236245_c0_seq1;GAXK01084400.1;A8CAG3;6.74E-40;RL17_PHLPP;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp5237129_c0_seq1;GAXK01084389.1;P53173;1.11E-13;ERV14_YEAST;ER-derived vesicles protein ERV14;"cell periphery [GO:0071944]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cargo receptor activity [GO:0038024]; ascospore formation [GO:0030437]; axial cellular bud site selection [GO:0007120]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of receptor localization to synapse [GO:1902684]; regulation of AMPA receptor activity [GO:2000311]";"GO:0000139; GO:0005783; GO:0005789; GO:0006888; GO:0007120; GO:0016021; GO:0030134; GO:0030437; GO:0038024; GO:0071944; GO:1902684; GO:2000311";"ascospore formation [GO:0030437]; axial cellular bud site selection [GO:0007120]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of receptor localization to synapse [GO:1902684]; regulation of AMPA receptor activity [GO:2000311]";"cell periphery [GO:0071944]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";cargo receptor activity [GO:0038024]
comp52374_c0_seq1;GAXK01111824.1;P9WK86;3.52E-12;NLHH_MYCTO;Carboxylesterase NlhH (EC 3.1.1.1);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp523752_c0_seq1;GAXK01192455.1;Q9QZE7;3.24E-20;TSNAX_MOUSE;Translin-associated protein X (Translin-associated factor X);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003697; GO:0004521; GO:0005634; GO:0005737; GO:0005794; GO:0007275; GO:0007283; GO:0030154; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]"
comp52386_c0_seq1;GAXK01111808.1;Q9UJY5;1.99E-95;GGA1_HUMAN;ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1);"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ADP-ribosylation factor binding [GO:0030306]; protein heterodimerization activity [GO:0046982]; cellular protein metabolic process [GO:0044267]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]";"GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0008104; GO:0010008; GO:0016020; GO:0030306; GO:0031901; GO:0032991; GO:0034394; GO:0042147; GO:0043001; GO:0043231; GO:0044267; GO:0045732; GO:0046982; GO:1901998; GO:1903441";"cellular protein metabolic process [GO:0044267]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]";"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"ADP-ribosylation factor binding [GO:0030306]; protein heterodimerization activity [GO:0046982]"
comp5239_c0_seq1;GAXK01066251.1;Q9R062;3.98E-117;GLYG_MOUSE;Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186);"glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]";"GO:0005536; GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751";glycogen biosynthetic process [GO:0005978];;"glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]"
comp52390_c3_seq1;GAXK01111806.1;Q6N075;1.89E-107;MFSD5_HUMAN;Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp523913_c0_seq1;GAXK01192446.1;P30974;7.76E-32;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp5239223_c0_seq1;GAXK01182310.1;Q3T0B7;1.84E-23;RS27L_BOVIN;40S ribosomal protein S27-like;"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005634; GO:0006412; GO:0006978; GO:0008494; GO:0008656; GO:0022627; GO:0031571; GO:0042771; GO:0046872";"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]"
comp523954_c0_seq1;GAXK01192388.1;P18288;1.14E-84;TBAT_ONCMY;Tubulin alpha chain, testis-specific [Cleaved into: Detyrosinated tubulin alpha chain, testis-specific];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp5239923_c0_seq1;GAXK01182300.1;P83852;1.17E-32;CBPD_LOPSP;Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D) (Fragment);"integral component of membrane [GO:0016021]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0004185; GO:0006508; GO:0008270; GO:0016021";proteolysis [GO:0006508];integral component of membrane [GO:0016021];"metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]"
comp5240179_c0_seq1;GAXK01197168.1;Q9UUY8;6.08E-76;NDK_NEUCR;Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"GO:0004550; GO:0005524; GO:0006183; GO:0006228; GO:0006241; GO:0046872";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]"
comp5240515_c0_seq1;GAXK01197167.1;Q9DCM4;7.60E-23;DNAL4_MOUSE;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]"
comp5240551_c0_seq1;GAXK01197154.1;Q43291;6.11E-64;RL211_ARATH;60S ribosomal protein L21-1;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005576; GO:0005730; GO:0006412; GO:0022625; GO:0022626";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp5240820_c0_seq1;GAXK01197171.1;P23098;1.85E-108;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp524092_c0_seq1;GAXK01143559.1;P10090;0;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp5241258_c0_seq1;GAXK01197161.1;Q63HN8;1.43E-12;RN213_HUMAN;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp5241550_c0_seq1;GAXK01197152.1;O49886;4.70E-34;CYPH_LUPLU;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp52416_c0_seq1;GAXK01111538.1;O43719;9.26E-72;HTSF1_HUMAN;HIV Tat-specific factor 1 (Tat-SF1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784";"mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]";RNA binding [GO:0003723]
comp5241930_c0_seq1;GAXK01197155.1;Q8N2S1;4.69E-19;LTBP4_HUMAN;Latent-transforming growth factor beta-binding protein 4 (LTBP-4);"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001558; GO:0005024; GO:0005178; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0006457; GO:0007179; GO:0007275; GO:0017015; GO:0030162; GO:0030252; GO:0031012; GO:0045595; GO:0050431; GO:0062023";"growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]"
comp52425_c2_seq1;GAXK01112263.1;Q7RTX9;1.35E-40;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp524327_c0_seq1;GAXK01143590.1;Q9JHE4;4.84E-33;G3ST1_MOUSE;Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"GO:0000139; GO:0001733; GO:0006682; GO:0007283; GO:0009247; GO:0016021; GO:0042552";"galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosylceramide sulfotransferase activity [GO:0001733]
comp5243578_c0_seq1;GAXK01027588.1;Q9QZP2;6.78E-08;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5244002_c0_seq1;GAXK01079669.1;G5EBQ8;7.29E-21;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp5245133_c0_seq1;GAXK01079672.1;Q93356;9.86E-09;HM37_CAEEL;Homeobox protein ceh-37;"chromosome, telomeric region [GO:0000781]; nuclear chromosome, telomeric region [GO:0000784]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; telomeric DNA binding [GO:0042162]; mRNA transcription [GO:0009299]; neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]";"GO:0000723; GO:0000781; GO:0000784; GO:0003691; GO:0006355; GO:0006357; GO:0008301; GO:0009299; GO:0016233; GO:0032200; GO:0042048; GO:0042162; GO:0048665";"mRNA transcription [GO:0009299]; neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]";"chromosome, telomeric region [GO:0000781]; nuclear chromosome, telomeric region [GO:0000784]";"DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; telomeric DNA binding [GO:0042162]"
comp524529_c1_seq1;GAXK01143580.1;B2D0J5;2.99E-66;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp52454_c2_seq1;GAXK01205520.1;P32023;8.16E-107;KGP25_DROME;cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0018105; GO:0030536; GO:0030553; GO:0032095; GO:0046959";"feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp5245460_c0_seq1;GAXK01079673.1;Q99758;4.47E-33;ABCA3_HUMAN;ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3);"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233";"cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp5245482_c0_seq1;GAXK01079688.1;Q8WQI7;3.85E-38;RL18A_SPOFR;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5246457_c0_seq1;GAXK01090606.1;O77404;3.29E-35;TYPX_TRYBB;Tryparedoxin (TryX);"cell [GO:0005623]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]";"GO:0005623; GO:0045454; GO:0055114";"cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]";cell [GO:0005623];
comp524663_c0_seq1;GAXK01143584.1;Q2M3R5;4.55E-09;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5247283_c0_seq1;GAXK01090605.1;P90850;6.79E-07;YCF2E_CAEEL;Uncharacterized peptidase C1-like protein F26E4.3;"extracellular space [GO:0005615]; cysteine-type peptidase activity [GO:0008234]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; immune response [GO:0006955]";"GO:0005044; GO:0005615; GO:0006955; GO:0007155; GO:0008234; GO:0030247";"cell adhesion [GO:0007155]; immune response [GO:0006955]";extracellular space [GO:0005615];"cysteine-type peptidase activity [GO:0008234]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp52475_c3_seq1;GAXK01111781.1;Q9VMA7;2.34E-13;TGO1_DROME;Transport and Golgi organization protein 1;"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"GO:0000137; GO:0000139; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0007030; GO:0009306; GO:0012505; GO:0016021; GO:0033363; GO:0035459; GO:0051047; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp5247781_c0_seq1;GAXK01090598.1;Q9P0M2;2.54E-09;AKA7G_HUMAN;A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma);"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686";"modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]";"cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]"
comp52484_c0_seq1;GAXK01111656.1;G4V4G1;8.50E-48;IGFBP_CUPSA;Insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1);"extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of cell growth [GO:0001558]";"GO:0001558; GO:0004867; GO:0005520; GO:0005576";regulation of cell growth [GO:0001558];extracellular region [GO:0005576];"insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp5249_c4_seq1;GAXK01066772.1;Q08473;4.52E-47;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp5249396_c0_seq1;GAXK01109000.1;Q8BGM5;7.19E-21;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp52498_c4_seq1;GAXK01111513.1;Q9Z0W3;3.75E-177;NU160_MOUSE;Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Gene trap locus 1-13 protein) (GTL-13) (Nucleoporin Nup160);"kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]";"GO:0000776; GO:0005643; GO:0006406; GO:0017056; GO:0031080; GO:0072006";"mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]";"kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]";structural constituent of nuclear pore [GO:0017056]
comp5249946_c0_seq1;GAXK01109012.1;Q962R1;6.40E-40;RS18_SPOFR;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp525_c0_seq1;GAXK01168778.1;P48159;2.25E-80;RL23_DROME;60S ribosomal protein L23 (L17A);"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]"
comp5250334_c0_seq1;GAXK01075958.1;P29476;2.19E-16;NOS1_RAT;Nitric oxide synthase, brain (EC 1.14.13.39) (BNOS) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1);"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; zinc ion binding [GO:0008270]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; brain development [GO:0007420]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hepatic stellate cell contraction [GO:0061875]; negative regulation of insulin secretion [GO:0046676]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; regulation of heart contraction [GO:0008016]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nitric oxide [GO:0071731]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to vitamin E [GO:0033197]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]";"GO:0001666; GO:0001917; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0007420; GO:0007565; GO:0007568; GO:0008016; GO:0008270; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010243; GO:0010288; GO:0012506; GO:0014069; GO:0014070; GO:0014823; GO:0016020; GO:0016491; GO:0017080; GO:0018119; GO:0019899; GO:0020037; GO:0030141; GO:0030425; GO:0031284; GO:0031667; GO:0031965; GO:0032496; GO:0032991; GO:0033137; GO:0033197; GO:0034760; GO:0035094; GO:0042383; GO:0042582; GO:0042803; GO:0043066; GO:0043197; GO:0043434; GO:0043524; GO:0043627; GO:0044325; GO:0045184; GO:0045202; GO:0045471; GO:0045776; GO:0045822; GO:0045906; GO:0046676; GO:0046870; GO:0048148; GO:0048471; GO:0050660; GO:0050661; GO:0051117; GO:0051219; GO:0051481; GO:0051930; GO:0061875; GO:0070402; GO:0071260; GO:0071731; GO:0071872; GO:0097110; GO:0097755; GO:0098924; GO:0098978; GO:0099091; GO:0099092; GO:1900273; GO:1901216; GO:1902307";"aging [GO:0007568]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; brain development [GO:0007420]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hepatic stellate cell contraction [GO:0061875]; negative regulation of insulin secretion [GO:0046676]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; regulation of heart contraction [GO:0008016]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nitric oxide [GO:0071731]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to vitamin E [GO:0033197]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; synapse [GO:0045202]; vesicle membrane [GO:0012506]";"ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; zinc ion binding [GO:0008270]"
comp5251_c2_seq1;GAXK01066900.1;Q9VCA9;2.89E-80;SPCS3_DROME;Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit);"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0019089; GO:0045047";"protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]";"integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]";peptidase activity [GO:0008233]
comp5251415_c0_seq1;GAXK01075959.1;Q96WM9;6.79E-13;LAC2_BOTFU;Laccase-2 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 2) (Diphenol oxidase 2) (Urishiol oxidase 2);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp52518_c0_seq1;GAXK01112142.1;Q8WXD5;4.55E-11;GEMI6_HUMAN;Gem-associated protein 6 (Gemin-6) (SIP2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000245; GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0051170; GO:0097504";"import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]";
comp525180_c0_seq1;GAXK01143629.1;Q9W747;1.71E-07;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp525185_c0_seq1;GAXK01143555.1;A5DQN2;2.56E-11;SET5_PICGU;Potential protein lysine methyltransferase SET5 (EC 2.1.1.-) (SET domain-containing protein 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]";"GO:0005634; GO:0005737; GO:0008168";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";methyltransferase activity [GO:0008168]
comp52522_c0_seq1;GAXK01111744.1;Q9NYB9;1.50E-69;ABI2_HUMAN;Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1);"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209]; cytoskeletal adaptor activity [GO:0008093]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; viral process [GO:0016032]; zonula adherens assembly [GO:0045186]";"GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005912; GO:0007010; GO:0008093; GO:0008154; GO:0016032; GO:0016477; GO:0016601; GO:0017124; GO:0018108; GO:0019900; GO:0030027; GO:0031209; GO:0031625; GO:0032433; GO:0043197; GO:0045186; GO:0061001; GO:0070064; GO:0070309; GO:2000601";"actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; viral process [GO:0016032]; zonula adherens assembly [GO:0045186]";"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209]";"cytoskeletal adaptor activity [GO:0008093]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]"
comp5253505_c0_seq1;GAXK01150120.1;Q5R5M1;6.28E-11;PRDM4_PONAB;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005634; GO:0006366; GO:0008168; GO:0046872; GO:1990226";transcription by RNA polymerase II [GO:0006366];nucleus [GO:0005634];"DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp525357_c1_seq1;GAXK01143696.1;Q9Z7M4;4.95E-36;Y680_CHLPN;Putative phosphate permease CPn_0680/CP_0067/CPj0680/CpB0707;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transport [GO:0006817]";"GO:0005315; GO:0005886; GO:0006817; GO:0016021";phosphate ion transport [GO:0006817];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";inorganic phosphate transmembrane transporter activity [GO:0005315]
comp5253645_c0_seq1;GAXK01150108.1;Q29458;1.60E-34;LIPG_BOVIN;Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Pregastric esterase) (PGE);"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0016298; GO:0043231; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]";"lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]"
comp52538_c2_seq1;GAXK01111372.1;Q3U288;4.21E-10;ZN710_MOUSE;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp525390_c1_seq1;GAXK01143616.1;B2D0J5;9.91E-82;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp525394_c1_seq1;GAXK01143628.1;Q505I4;2.86E-21;CO040_RAT;UPF0235 protein C15orf40 homolog;;;;;
comp5254005_c0_seq1;GAXK01059594.1;P12659;1.54E-09;HCYA_ENTDO;Hemocyanin A-type, units Ode to Odg (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp525418_c0_seq1;GAXK01143562.1;A8X679;3.77E-09;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp52542_c1_seq1;GAXK01111968.1;B4GDM7;9.18E-131;CIAO1_DROPE;Probable cytosolic iron-sulfur protein assembly protein Ciao1;"CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226]";"GO:0016226; GO:0097361";iron-sulfur cluster assembly [GO:0016226];CIA complex [GO:0097361];
comp525428_c0_seq1;GAXK01143563.1;Q8JH92;3.43E-36;PPD1A_XENLA;Blood vessel epicardial substance-A (Xbves-A) (Popeye domain-containing protein 1-A) (Popeye protein 1-A) (Xpop-1-A);"bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; epithelial cell-cell adhesion [GO:0090136]; multicellular organism development [GO:0007275]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of cell-cell adhesion involved in gastrulation [GO:0070587]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]";"GO:0001921; GO:0005198; GO:0005886; GO:0005923; GO:0007275; GO:0008360; GO:0016021; GO:0016192; GO:0016328; GO:0034446; GO:0040017; GO:0043087; GO:0070587; GO:0090136";"epithelial cell-cell adhesion [GO:0090136]; multicellular organism development [GO:0007275]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell-cell adhesion involved in gastrulation [GO:0070587]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]";"bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp5254385_c0_seq1;GAXK01059572.1;Q9Z218;7.98E-32;DPP6_MOUSE;Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]";"GO:0005886; GO:0008076; GO:0008236; GO:0009986; GO:0015459; GO:0016020; GO:0016021; GO:0019228; GO:0042391; GO:0043025; GO:0043266; GO:0043268; GO:0072659; GO:1901379; GO:1901381; GO:1903078";"neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp525472_c1_seq1;GAXK01143631.1;A2SWM2;4.58E-09;SPNS2_DANRE;Protein spinster homolog 2 (Protein two of hearts);"integral component of plasma membrane [GO:0005887]; branching involved in blood vessel morphogenesis [GO:0001569]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; lipid transport [GO:0006869]; regulation of cartilage development [GO:0061035]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane transport [GO:0055085]; vasculature development [GO:0001944]";"GO:0001569; GO:0001944; GO:0003143; GO:0003319; GO:0003376; GO:0005887; GO:0006869; GO:0048703; GO:0055085; GO:0061035";"branching involved in blood vessel morphogenesis [GO:0001569]; cardioblast migration to the midline involved in heart rudiment formation [GO:0003319]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; lipid transport [GO:0006869]; regulation of cartilage development [GO:0061035]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane transport [GO:0055085]; vasculature development [GO:0001944]";integral component of plasma membrane [GO:0005887];
comp525515_c1_seq1;GAXK01143637.1;P16912;2.10E-110;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp5255411_c0_seq1;GAXK01059575.1;Q03427;3.42E-07;LAMC_DROME;Lamin-C (pG-IF);"lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]; structural constituent of cytoskeleton [GO:0005200]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear pore distribution [GO:0031081]; regulation of actin filament polymerization [GO:0030833]; tendon development [GO:0035989]";"GO:0005200; GO:0005638; GO:0005652; GO:0006325; GO:0006342; GO:0007112; GO:0016020; GO:0030833; GO:0031081; GO:0034399; GO:0035989; GO:0060415; GO:0070732";"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear pore distribution [GO:0031081]; regulation of actin filament polymerization [GO:0030833]; tendon development [GO:0035989]";"lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]";structural constituent of cytoskeleton [GO:0005200]
comp5255812_c0_seq1;GAXK01059586.1;P0A4X1;1.17E-41;ADHC_MYCBO;NADP-dependent alcohol dehydrogenase C (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp5256065_c0_seq1;GAXK01009189.1;Q9VW60;4.19E-33;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp52561_c6_seq1;GAXK01111462.1;Q9HBD1;2.25E-174;RC3H2_HUMAN;Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2);"cell surface [GO:0009986]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]";"GO:0000209; GO:0000932; GO:0000981; GO:0001782; GO:0003677; GO:0003723; GO:0003725; GO:0003729; GO:0004842; GO:0009791; GO:0009986; GO:0010608; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0043231; GO:0046872; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:1901224; GO:2000320; GO:2000628";"B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]";"cell surface [GO:0009986]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]"
comp5256705_c0_seq1;GAXK01009201.1;Q8VBX4;7.38E-07;CLC4K_MOUSE;C-type lectin domain family 4 member K (Langerin) (CD antigen CD207);"integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; defense response to virus [GO:0051607]";"GO:0005887; GO:0030246; GO:0051607";defense response to virus [GO:0051607];integral component of plasma membrane [GO:0005887];carbohydrate binding [GO:0030246]
comp5256975_c0_seq1;GAXK01009181.1;Q9SIK2;3.93E-24;RS252_ARATH;40S ribosomal protein S25-2;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]";"GO:0003735; GO:0005773; GO:0005774; GO:0009506; GO:0022626; GO:0022627; GO:0042788";;"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp525777_c0_seq1;GAXK01143591.1;Q09453;1.42E-31;GLRB4_CAEEL;Glycine receptor subunit beta-type 4;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp52579_c0_seq1;GAXK01111937.1;Q99KU1;3.95E-92;DHDDS_MOUSE;Dehydrodolichyl diphosphate synthase complex subunit Dhdds (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase);"dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; polyprenyltransferase activity [GO:0002094]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]";"GO:0002094; GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:1904423";"dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]";"dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]";"dehydrodolichyl diphosphate synthase activity [GO:0045547]; polyprenyltransferase activity [GO:0002094]"
comp525847_c1_seq1;GAXK01143670.1;P17970;2.02E-138;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp52585_c3_seq1;GAXK01205542.1;P15330;1.93E-99;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5258589_c0_seq1;GAXK01072640.1;Q18297;5.28E-09;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp525863_c1_seq1;GAXK01143619.1;O15118;9.84E-89;NPC1_HUMAN;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp5258787_c0_seq1;GAXK01072650.1;E9Q3T6;1.90E-09;PRD14_MOUSE;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; stem cell population maintenance [GO:0019827]";"GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; stem cell population maintenance [GO:0019827]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp52591_c3_seq1;GAXK01111721.1;Q8UWA5;3.94E-29;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp525926_c1_seq1;GAXK01143576.1;Q9ULC3;2.35E-10;RAB23_HUMAN;Ras-related protein Rab-23;"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5259526_c0_seq1;GAXK01072649.1;Q0P585;2.56E-13;SMYD2_BOVIN;N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (SET and MYND domain-containing protein 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp5259553_c0_seq1;GAXK01072630.1;Q8PSR0;2.03E-11;Y3016_METMA;Putative ABC transporter ATP-binding protein MM_3016 (EC 3.6.3.-);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0005886; GO:0016887";;plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp5259602_c0_seq1;GAXK01072639.1;Q6UVY6;6.77E-24;MOXD1_HUMAN;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp5259745_c0_seq1;GAXK01072651.1;Q7ZV96;1.89E-62;RL10_DANRE;60S ribosomal protein L10 (Protein QM) (Ribosomal protein L10);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; brain development [GO:0007420]; embryonic brain development [GO:1990403]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0006417; GO:0007420; GO:0022625; GO:0045182; GO:1990403";"brain development [GO:0007420]; embryonic brain development [GO:1990403]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]"
comp5260033_c0_seq1;GAXK01070218.1;P20350;7.90E-21;RHOM_DROME;Protein rhomboid (EC 3.4.21.105) (Protein veinlet);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0006508; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0038005; GO:0042058; GO:0042327; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317; GO:0098609";"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]";serine-type endopeptidase activity [GO:0004252]
comp5260311_c0_seq1;GAXK01070208.1;Q642H9;1.33E-37;RS4X_DANRE;40S ribosomal protein S4, X isoform;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0007420; GO:0019843; GO:0022627; GO:0043009";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp526068_c0_seq1;GAXK01098235.1;Q9W391;0;KPBA_DROME;Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha);"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"GO:0003824; GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468";"glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]"
comp5260906_c0_seq1;GAXK01070205.1;P55097;6.88E-21;CATK_MOUSE;Cathepsin K (EC 3.4.22.38);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0001957; GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0008234; GO:0030574; GO:0043231; GO:0043394; GO:0045453; GO:0051603; GO:0061037";"bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]"
comp5261121_c0_seq1;GAXK01070217.1;Q5ZMV8;1.21E-55;RPGP2_CHICK;Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4);"cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0005737; GO:0051056";regulation of small GTPase mediated signal transduction [GO:0051056];cytoplasm [GO:0005737];GTPase activator activity [GO:0005096]
comp526250_c0_seq1;GAXK01098178.1;P32031;2.11E-36;SLP2_DROME;Fork head domain transcription factor slp2 (Sloppy paired locus protein 2);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; segment polarity determination [GO:0007367]";"GO:0003700; GO:0005634; GO:0007367; GO:0043565";segment polarity determination [GO:0007367];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp5262908_c0_seq1;GAXK01059755.1;Q6DCW1;4.09E-07;GFI1B_XENLA;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0005634; GO:0006325; GO:0007275; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5263_c10_seq1;GAXK01066286.1;Q6P3N5;2.22E-27;CNIH4_XENTR;Protein cornichon homolog 4 (CNIH-4) (Cornichon family AMPA receptor auxiliary protein 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]";"GO:0005783; GO:0005793; GO:0006888; GO:0015031; GO:0016021";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]";
comp52632_c0_seq1;GAXK01111469.1;Q6PBK1;1.95E-21;CCD58_DANRE;Coiled-coil domain-containing protein 58;;;;;
comp526398_c1_seq1;GAXK01098218.1;O15442;3.37E-83;MPPD1_HUMAN;Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp526515_c0_seq1;GAXK01098224.1;Q8N988;9.56E-09;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp52653_c2_seq1;GAXK01111844.1;Q9UBC2;3.27E-112;EP15R_HUMAN;Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R);"clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";"GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0030132; GO:0042059; GO:0045296; GO:0061024";"endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";"clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
comp526543_c1_seq1;GAXK01098210.1;Q4UMH6;2.81E-17;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp5265602_c0_seq1;GAXK01164975.1;Q54Y73;7.38E-08;BZPD_DICDI;Probable basic-leucine zipper transcription factor D;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp5265952_c0_seq1;GAXK01164973.1;P04352;2.89E-18;CALM_CHLRE;Calmodulin (CaM);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calcium ion binding [GO:0005509]
comp526713_c1_seq1;GAXK01098223.1;Q90744;3.13E-28;NAGAB_CHICK;Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B);"cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477";"glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"cytoplasm [GO:0005737]; lysosome [GO:0005764]";"alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]"
comp526723_c0_seq1;GAXK01098204.1;P40657;7.93E-24;SOX15_DROME;Putative transcription factor SOX-15 (Sox50E);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; wing disc development [GO:0035220]";"GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008285; GO:0022416; GO:0030154; GO:0035220; GO:0043066; GO:0044798; GO:0045892";"cell differentiation [GO:0030154]; chaeta development [GO:0022416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; wing disc development [GO:0035220]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp526827_c0_seq1;GAXK01098229.1;P48544;1.63E-50;KCNJ5_HUMAN;G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5);"external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625]";"GO:0005242; GO:0005886; GO:0006813; GO:0008076; GO:0009897; GO:0015467; GO:0030315; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:0099625; GO:1902282; GO:1990573";"membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625]";"external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]";"G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp5268382_c0_seq1;GAXK01008372.1;Q7Q297;1.82E-13;WSCD_ANOGA;WSCD family member AGAP003962;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp526864_c0_seq1;GAXK01098302.1;Q3T0I2;8.36E-27;CATH_BOVIN;"Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]";"alveolar lamellar body [GO:0097208]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]; bradykinin catabolic process [GO:0010815]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]";"GO:0001656; GO:0001913; GO:0002764; GO:0004175; GO:0004177; GO:0004197; GO:0004252; GO:0005615; GO:0005764; GO:0005829; GO:0006508; GO:0008234; GO:0008284; GO:0008656; GO:0010628; GO:0010634; GO:0010813; GO:0010815; GO:0010952; GO:0030108; GO:0030335; GO:0031638; GO:0031648; GO:0032526; GO:0033619; GO:0036464; GO:0043066; GO:0043129; GO:0045766; GO:0051603; GO:0060448; GO:0070324; GO:0070371; GO:0097067; GO:0097208; GO:2001235";"bradykinin catabolic process [GO:0010815]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]";"alveolar lamellar body [GO:0097208]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]";"aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]"
comp52689_c0_seq1;GAXK01111934.1;B5DE93;8.87E-53;CDK12_XENTR;Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12);"chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; mRNA processing [GO:0006397]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0008380; GO:0016607; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0044212; GO:0045944; GO:0070816";"mRNA processing [GO:0006397]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp52691_c1_seq1;GAXK01111831.1;Q68CZ6;4.30E-07;HAUS3_HUMAN;HAUS augmin-like complex subunit 3;"centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]";"GO:0000086; GO:0005654; GO:0005739; GO:0005813; GO:0005829; GO:0005874; GO:0007098; GO:0010389; GO:0015630; GO:0045171; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:0097711";"cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]";
comp52699_c0_seq1;GAXK01111836.1;P29052;8.77E-33;TF2B_DROME;Transcription initiation factor IIB (General transcription factor TFIIB);"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]";"GO:0000979; GO:0001139; GO:0001174; GO:0005634; GO:0006352; GO:0006357; GO:0006367; GO:0008134; GO:0017025; GO:0046872; GO:0051101; GO:0051123; GO:0097550";"DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]";"metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp5270174_c0_seq1;GAXK01140743.1;P17970;1.43E-22;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp527106_c0_seq1;GAXK01098185.1;P17970;2.72E-82;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp52719_c1_seq1;GAXK01112255.1;Q8IU60;1.13E-87;DCP2_HUMAN;m7GpppN-mRNA hydrolase (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 20) (Nudix motif 20) (mRNA-decapping enzyme 2) (hDpc);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; 5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]";"GO:0000184; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0016896; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0043928; GO:0050072; GO:0070034; GO:0071044; GO:1904872";"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]";"5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]"
comp5272_c0_seq1;GAXK01066641.1;P82979;1.01E-13;SARNP_HUMAN;SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29);"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; RNA export from nucleus [GO:0006405]";"GO:0000346; GO:0000978; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0006405; GO:0006406; GO:0006417; GO:0008022; GO:0016607; GO:0031124; GO:0036464; GO:0050733";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; RNA export from nucleus [GO:0006405]";"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]"
comp5272351_c0_seq1;GAXK01163148.1;Q26630;3.26E-66;IDLC_STRPU;33 kDa inner dynein arm light chain, axonemal (p33);"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504";inner dynein arm assembly [GO:0036159];"axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp5272495_c0_seq1;GAXK01163139.1;Q920E3;6.41E-22;KCNH5_MOUSE;Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2) (Eag2) (Voltage-gated potassium channel subunit Kv10.2);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005249; GO:0005516; GO:0005887; GO:0009986; GO:0010389; GO:0034765; GO:0042391; GO:0044325; GO:0046982; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]";"calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp5273699_c0_seq1;GAXK01163127.1;Q23808;4.39E-08;AQP_CICVR;Aquaporin AQPcic;"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp5274_c1_seq1;GAXK01065992.1;Q9VLN1;2.87E-146;WDR82_DROME;WD repeat-containing protein 82;"histone methyltransferase complex [GO:0035097]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"GO:0003682; GO:0035097; GO:0048188; GO:0051568; GO:0080182";"histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"histone methyltransferase complex [GO:0035097]; Set1C/COMPASS complex [GO:0048188]";chromatin binding [GO:0003682]
comp5274722_c0_seq1;GAXK01102571.1;P58372;2.13E-44;RL30_ICTPU;60S ribosomal protein L30;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022625";;cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5275343_c0_seq1;GAXK01102575.1;Q17528;2.11E-12;BEST1_CAEEL;Bestrophin homolog 1;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp5275426_c0_seq1;GAXK01102564.1;M0R8U1;1.09E-52;DYH5_RAT;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment);"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0007368; GO:0008569; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0097729";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp527631_c1_seq1;GAXK01098174.1;G5E8K5;3.80E-65;ANK3_MOUSE;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp52768_c0_seq1;GAXK01111396.1;O61492;8.99E-43;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp5277_c0_seq1;GAXK01065420.1;P45878;1.43E-59;FKBP2_MOUSE;Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase);"endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005789";;endoplasmic reticulum membrane [GO:0005789];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp5277296_c0_seq1;GAXK01204350.1;P93099;1.44E-82;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp5277363_c0_seq1;GAXK01204361.1;P50947;3.99E-19;PHO23_YEAST;Transcriptional regulatory protein PHO23;"histone deacetylase complex [GO:0000118]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Rpd3L complex [GO:0033698]; Rpd3L-Expanded complex [GO:0070210]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; negative regulation of autophagy [GO:0010507]; negative regulation of chromatin silencing at rDNA [GO:0061188]; negative regulation of chromatin silencing at silent mating-type cassette [GO:0061186]; negative regulation of chromatin silencing at telomere [GO:0031939]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of invasive growth in response to glucose limitation [GO:2000219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of protein localization by the Cvt pathway [GO:2001159]";"GO:0000118; GO:0000122; GO:0005634; GO:0006325; GO:0010507; GO:0016479; GO:0016573; GO:0031939; GO:0033698; GO:0035064; GO:0035267; GO:0045944; GO:0046872; GO:0061186; GO:0061188; GO:0061408; GO:0070210; GO:2000219; GO:2001159";"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; negative regulation of autophagy [GO:0010507]; negative regulation of chromatin silencing at rDNA [GO:0061188]; negative regulation of chromatin silencing at silent mating-type cassette [GO:0061186]; negative regulation of chromatin silencing at telomere [GO:0031939]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of invasive growth in response to glucose limitation [GO:2000219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of protein localization by the Cvt pathway [GO:2001159]";"histone deacetylase complex [GO:0000118]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Rpd3L complex [GO:0033698]; Rpd3L-Expanded complex [GO:0070210]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp527746_c1_seq1;GAXK01098207.1;Q9VJN5;5.14E-22;WEK_DROME;Zinc finger protein weckle;"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270]; dorsal/ventral axis specification [GO:0009950]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; Toll signaling pathway [GO:0008063]";"GO:0003676; GO:0005634; GO:0005829; GO:0007311; GO:0008063; GO:0008270; GO:0009898; GO:0009950; GO:0035591; GO:0042803";"dorsal/ventral axis specification [GO:0009950]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; Toll signaling pathway [GO:0008063]";"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]";"nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270]"
comp527772_c0_seq1;GAXK01205466.1;Q9Y2G4;6.70E-54;ANKR6_HUMAN;Ankyrin repeat domain-containing protein 6 (Diversin);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";
comp52790_c0_seq1;GAXK01111487.1;P62025;2.79E-56;PHAR2_RAT;Phosphatase and actin regulator 2;"actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]";"GO:0003779; GO:0004864";;;"actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]"
comp5279993_c0_seq1;GAXK01028981.1;P02362;2.21E-65;RS7_XENLA;40S ribosomal protein S7 (40S ribosomal protein S8);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5280308_c0_seq1;GAXK01005107.1;Q940B0;5.48E-76;RL183_ARATH;60S ribosomal protein L18-3;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005773; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0022625; GO:0022626";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp5280341_c0_seq1;GAXK01005115.1;P26591;1.04E-10;GLRK_LYMST;Glutamate receptor;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]";"GO:0004970; GO:0016021; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";ionotropic glutamate receptor activity [GO:0004970]
comp5281_c3_seq1;GAXK01067195.1;Q2KJE4;1.46E-135;ETFA_BOVIN;Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]";"GO:0005739; GO:0005759; GO:0009055; GO:0016491; GO:0033539; GO:0050660";fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]"
comp528122_c1_seq1;GAXK01139725.1;Q86B87;3.48E-09;MMD4_DROME;Modifier of mdg4;"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; germ cell migration [GO:0008354]; male meiosis chromosome segregation [GO:0007060]; male meiosis I [GO:0007141]; meiotic chromosome condensation [GO:0010032]; oogenesis [GO:0048477]; regulation of chromatin assembly or disassembly [GO:0001672]";"GO:0000785; GO:0001672; GO:0003677; GO:0003682; GO:0005634; GO:0005700; GO:0005704; GO:0006325; GO:0006915; GO:0007060; GO:0007141; GO:0008354; GO:0010032; GO:0031208; GO:0042803; GO:0046872; GO:0048477";"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; germ cell migration [GO:0008354]; male meiosis chromosome segregation [GO:0007060]; male meiosis I [GO:0007141]; meiotic chromosome condensation [GO:0010032]; oogenesis [GO:0048477]; regulation of chromatin assembly or disassembly [GO:0001672]";"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5281463_c0_seq1;GAXK01005098.1;P18173;3.51E-37;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp528160_c0_seq1;GAXK01139625.1;Q27638;1.56E-19;G6PD_DROYA;Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) (Fragment);"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";"GO:0004345; GO:0006006; GO:0006098; GO:0006739; GO:0050661; GO:0051156";"glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]";;"glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]"
comp5282_c0_seq1;GAXK01066899.1;Q6DED0;3.00E-113;TR1L1_XENLA;Translocating chain-associated membrane protein 1-like 1;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]";"GO:0005789; GO:0006616; GO:0016021";SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp52821_c0_seq1;GAXK01112180.1;Q6NT16;8.58E-35;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp5282442_c0_seq1;GAXK01156734.1;P51824;4.36E-89;ARF1_SOLTU;ADP-ribosylation factor 1;"Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005794; GO:0015031; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";Golgi apparatus [GO:0005794];GTP binding [GO:0005525]
comp5282575_c0_seq1;GAXK01156749.1;Q8NDX2;7.51E-43;VGLU3_HUMAN;Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8);"apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0003407; GO:0005313; GO:0005326; GO:0005771; GO:0005887; GO:0006811; GO:0006814; GO:0007420; GO:0007605; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043204; GO:0043679; GO:0050803; GO:0060076; GO:0090102; GO:0097440; GO:0097441; GO:0097451; GO:0098700; GO:1990030";"brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp528260_c0_seq1;GAXK01139752.1;Q52KZ7;2.36E-23;SBP1A_XENLA;Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1-A);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]";"GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549";protein transport [GO:0015031];"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]"
comp528265_c0_seq1;GAXK01139767.1;P05932;1.07E-23;CALMB_ARBPU;Calmodulin-beta (Cam B) (Fragment);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp528407_c0_seq1;GAXK01139688.1;O54963;5.62E-13;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp528410_c0_seq1;GAXK01139742.1;Q7KRI2;3.04E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5284279_c0_seq1;GAXK01029206.1;O01382;2.00E-27;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp528454_c0_seq1;GAXK01139614.1;Q8TGM6;2.06E-09;TAR1_YEAST;Protein TAR1 (Transcript antisense to ribosomal RNA protein 1);"mitochondrion [GO:0005739]; regulation of cellular respiration [GO:0043457]";"GO:0005739; GO:0043457";regulation of cellular respiration [GO:0043457];mitochondrion [GO:0005739];
comp5285113_c0_seq1;GAXK01029213.1;Q03498;2.03E-23;VATA_PLAFA;V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha);"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]";"GO:0005524; GO:0033180; GO:0046034; GO:0046961";ATP metabolic process [GO:0046034];proton-transporting V-type ATPase, V1 domain [GO:0033180];"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp52854_c0_seq1;GAXK01111534.1;Q9QZR8;2.33E-16;PDZD2_RAT;PDZ domain-containing protein 2 (PDZ domain-containing protein 3) (Plakophilin-related armadillo repeat protein-interacting PDZ protein) [Cleaved into: Processed PDZ domain-containing protein 2];"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005911; GO:0007155; GO:0014069; GO:0035556; GO:0043005; GO:0045177";"cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";
comp5285695_c0_seq1;GAXK01029210.1;Q9HBE1;1.98E-07;PATZ1_HUMAN;POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872";"male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5285780_c0_seq1;GAXK01029222.1;P02269;1.24E-16;H2A_ASTRU;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp528599_c0_seq1;GAXK01139582.1;P17948;1.30E-50;VGFR1_HUMAN;Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor);"actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]";"GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0030949; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036332; GO:0038085; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:0070374; GO:1905563";"blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]"
comp528681_c0_seq1;GAXK01139720.1;Q8MRC9;0;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp5287_c0_seq1;GAXK01066749.1;Q5ZMW3;8.46E-114;API5_CHICK;Apoptosis inhibitor 5 (API-5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]";"GO:0005634; GO:0005737; GO:0006915; GO:0017134; GO:0043066";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";fibroblast growth factor binding [GO:0017134]
comp528717_c0_seq1;GAXK01139595.1;Q9V427;8.04E-64;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp52874_c0_seq1;GAXK01111795.1;Q8HXQ5;0;MRP1_BOVIN;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005524; GO:0005774; GO:0005887; GO:0006855; GO:0008559; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0071716; GO:0099039; GO:0140359";"drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp528776_c0_seq1;GAXK01139592.1;Q6XPS3;1.30E-87;TPTE2_HUMAN;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314";phosphatidylinositol biosynthetic process [GO:0006661];"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp5288271_c0_seq1;GAXK01108136.1;B8JKP6;3.60E-09;GRB1L_DANRE;GREB1-like protein;"integral component of membrane [GO:0016021]; kidney development [GO:0001822]; pronephros development [GO:0048793]";"GO:0001822; GO:0016021; GO:0048793";"kidney development [GO:0001822]; pronephros development [GO:0048793]";integral component of membrane [GO:0016021];
comp5288280_c0_seq1;GAXK01108150.1;Q2M3R5;3.16E-07;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp52885_c0_seq1;GAXK01112037.1;A2VDL9;4.95E-151;T184B_BOVIN;Transmembrane protein 184B;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5288572_c0_seq1;GAXK01108149.1;O00341;8.91E-40;EAA5_HUMAN;Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]; dicarboxylic acid transport [GO:0006835]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]";"GO:0001504; GO:0005313; GO:0005886; GO:0006811; GO:0006835; GO:0014047; GO:0015293; GO:0016021; GO:0098793; GO:0098810";"dicarboxylic acid transport [GO:0006835]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]"
comp52887_c0_seq1;GAXK01111901.1;Q9VWE0;1.96E-10;DOME_DROME;Cytokine receptor (Protein domeless);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"GO:0001745; GO:0004896; GO:0005886; GO:0006955; GO:0007259; GO:0007298; GO:0007350; GO:0007424; GO:0007442; GO:0007472; GO:0007616; GO:0008284; GO:0016021; GO:0016324; GO:0016327; GO:0019221; GO:0045475; GO:0046982; GO:0050829; GO:0097677; GO:0097678; GO:1990782";"blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye morphogenesis [GO:0001745]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; hindgut morphogenesis [GO:0007442]; immune response [GO:0006955]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; open tracheal system development [GO:0007424]; positive regulation of cell population proliferation [GO:0008284]; receptor signaling pathway via JAK-STAT [GO:0007259]; wing disc morphogenesis [GO:0007472]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cytokine receptor activity [GO:0004896]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; SOCS family protein binding [GO:0097678]; STAT family protein binding [GO:0097677]"
comp5289267_c0_seq1;GAXK01108137.1;Q503L9;2.97E-57;NXN_DANRE;Nucleoredoxin (EC 1.8.1.8);"cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";"GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358";"cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleus [GO:0005634]";protein-disulfide reductase activity [GO:0047134]
comp52899_c1_seq1;GAXK01112208.1;Q757M3;1.84E-08;NUF2_ASHGO;Probable kinetochore protein NUF2;"condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; spindle microtubule [GO:0005876]; spindle pole body [GO:0005816]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle organization [GO:0007052]";"GO:0000778; GO:0005816; GO:0005876; GO:0007052; GO:0008017; GO:0031262; GO:0044877; GO:0045132; GO:0051301; GO:0051315; GO:0051383";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle organization [GO:0007052]";"condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; spindle microtubule [GO:0005876]; spindle pole body [GO:0005816]";"microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]"
comp5290347_c0_seq1;GAXK01176723.1;Q96IR2;1.55E-11;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5291_c1_seq1;GAXK01066696.1;Q6ZQ11;3.50E-120;CHSS1_MOUSE;Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1);"extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]";"GO:0002063; GO:0005576; GO:0009954; GO:0016021; GO:0016757; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051216; GO:0051923; GO:0060349";"bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]";"extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp529102_c1_seq1;GAXK01139749.1;Q8VIG1;6.71E-15;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp529138_c0_seq1;GAXK01139626.1;Q8WPJ2;2.01E-79;MANA_MYTED;Mannan endo-1,4-beta-mannosidase (EC 3.2.1.78) (Beta-mannanase) (Endo-beta-1,4-mannanase) (Man5A) (ManA);"mannan endo-1,4-beta-mannosidase activity [GO:0016985]; mannan catabolic process [GO:0046355]";"GO:0016985; GO:0046355";mannan catabolic process [GO:0046355];;mannan endo-1,4-beta-mannosidase activity [GO:0016985]
comp5291611_c0_seq1;GAXK01176732.1;Q8N823;4.11E-11;ZN611_HUMAN;Zinc finger protein 611;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5291943_c0_seq1;GAXK01176720.1;Q9NUA8;5.19E-16;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5292_c0_seq1;GAXK01065996.1;P25843;8.63E-51;PROF_DROME;Profilin (Protein chickadee);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007411; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]";actin monomer binding [GO:0003785]
comp5292052_c0_seq1;GAXK01063214.1;Q86AD7;1.21E-07;MYLKB_DICDI;Probable myosin light chain kinase DDB_G0271550 (EC 2.7.11.18);"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0004687; GO:0005524";;;"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine/threonine kinase activity [GO:0004674]"
comp5292148_c0_seq1;GAXK01063208.1;Q6ZUK4;8.13E-26;TMM26_HUMAN;Transmembrane protein 26;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5292438_c0_seq1;GAXK01063225.1;Q55BJ9;1.00E-38;SODM_DICDI;Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; superoxide metabolic process [GO:0006801]";"GO:0004784; GO:0005739; GO:0005759; GO:0006801; GO:0030145; GO:0046872";superoxide metabolic process [GO:0006801];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp52930_c0_seq1;GAXK01112230.1;Q6AYI2;9.07E-121;KLDC3_RAT;Kelch domain-containing protein 3;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; meiotic cell cycle [GO:0051321]";"GO:0000790; GO:0003682; GO:0005654; GO:0005737; GO:0051321";meiotic cell cycle [GO:0051321];"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";chromatin binding [GO:0003682]
comp52931_c7_seq1;GAXK01111659.1;P05130;0;KPC1_DROME;Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR));"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]";"GO:0004674; GO:0004697; GO:0004712; GO:0005524; GO:0005886; GO:0006468; GO:0008270; GO:0018105; GO:0035206; GO:0035556; GO:2000370";"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"
comp52937_c1_seq1;GAXK01111867.1;Q07327;4.72E-171;ROP_DROME;Protein ROP;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005737; GO:0005829; GO:0006887; GO:0006904; GO:0007268; GO:0007269; GO:0007317; GO:0009416; GO:0015031; GO:0016020; GO:0016082; GO:0016192; GO:0019898; GO:0030707; GO:0032940; GO:0043195; GO:0048489; GO:1900006";"chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]";SNARE binding [GO:0000149]
comp5294132_c0_seq1;GAXK01198647.1;O01382;3.12E-07;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp529430_c0_seq1;GAXK01139757.1;Q7KRI2;1.40E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5294529_c0_seq1;GAXK01198661.1;P04323;1.19E-11;POL3_DROME;"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp529464_c0_seq1;GAXK01139606.1;Q5R816;2.98E-32;ABHEB_PONAB;Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]";"GO:0005634; GO:0005737; GO:0016787";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";hydrolase activity [GO:0016787]
comp5295_c2_seq1;GAXK01067182.1;P02482;3.08E-11;CRYAA_ARTJA;Alpha-crystallin A chain;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]";"GO:0005212; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]"
comp529589_c0_seq1;GAXK01139624.1;Q5RGE5;1.27E-38;DCR1C_DANRE;Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein);"nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"GO:0000784; GO:0003684; GO:0004519; GO:0006303; GO:0006310; GO:0031848; GO:0035312; GO:0036297; GO:0070419";"DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]";"nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]";"5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]"
comp529593_c0_seq1;GAXK01139766.1;Q60HC5;1.61E-106;DHC24_MACFA;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]; cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"GO:0000139; GO:0005634; GO:0005783; GO:0005789; GO:0006695; GO:0006979; GO:0009888; GO:0016021; GO:0019899; GO:0042605; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0071949";"cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]"
comp52960_c1_seq1;GAXK01111908.1;O01761;1.07E-43;UNC89_CAEEL;Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89);"A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0035023; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905";"cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]";"ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp529606_c1_seq1;GAXK01139604.1;P18744;1.40E-16;ZO20_XENLA;Oocyte zinc finger protein XlCOF20 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5296068_c0_seq1;GAXK01045199.1;A6ZXP4;7.54E-41;SUB2_YEAS7;ATP-dependent RNA helicase SUB2 (EC 3.6.4.13) (Suppressor of BRR1 protein 2);"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";"GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0051028";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]";spliceosomal complex [GO:0005681];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp52961_c0_seq1;GAXK01111593.1;Q9VEG6;5.68E-113;PERC_DROME;Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt);"extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";"GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872";"chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]"
comp5296160_c0_seq1;GAXK01045189.1;Q6PAY8;6.72E-11;HSDL2_XENLA;Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-);"peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]";"GO:0005777; GO:0016491";;peroxisome [GO:0005777];oxidoreductase activity [GO:0016491]
comp5296578_c0_seq1;GAXK01045197.1;Q16587;4.45E-08;ZNF74_HUMAN;Zinc finger protein 74 (Zinc finger protein 520) (hZNF7);"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003723; GO:0005654; GO:0006355; GO:0007275; GO:0015629; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp52971_c1_seq1;GAXK01111797.1;Q5ZLY5;4.52E-114;PKHF2_CHICK;Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872";protein transport [GO:0015031];"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]";"metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]"
comp52972_c2_seq1;GAXK01111730.1;Q8SS56;1.93E-134;SYKC_ENCCU;Probable lysine--tRNA ligase, cytoplasmic (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]";"GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430";lysyl-tRNA aminoacylation [GO:0006430];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]"
comp529724_c0_seq1;GAXK01139690.1;Q80T41;5.06E-166;GABR2_MOUSE;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]";"GO:0004965; GO:0005737; GO:0005887; GO:0007214; GO:0030054; GO:0038039; GO:0043005; GO:0046982; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1902710";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; GABA receptor complex [GO:1902710]; glutamatergic synapse [GO:0098978]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]";"G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]"
comp5297556_c0_seq1;GAXK01045186.1;Q8BP56;4.44E-10;PGGHG_MOUSE;Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1);"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005829; GO:0005975; GO:0047402";carbohydrate metabolic process [GO:0005975];cytosol [GO:0005829];"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]"
comp52979_c2_seq1;GAXK01111533.1;Q8BH74;3.73E-151;NU107_MOUSE;Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107);"condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]";"GO:0000777; GO:0000973; GO:0005643; GO:0006406; GO:0006606; GO:0008585; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006";"female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]";"condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]";structural constituent of nuclear pore [GO:0017056]
comp5298001_c0_seq1;GAXK01061252.1;Q9VNM1;7.26E-11;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp529839_c0_seq1;GAXK01139603.1;Q96AB3;1.44E-69;ISOC2_HUMAN;Isochorismatase domain-containing protein 2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; protein destabilization [GO:0031648]";"GO:0003824; GO:0005634; GO:0005737; GO:0031648";protein destabilization [GO:0031648];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";catalytic activity [GO:0003824]
comp529878_c0_seq1;GAXK01139612.1;Q9CYK2;5.51E-64;QPCT_MOUSE;Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);"extracellular region [GO:0005576]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]";"GO:0005576; GO:0008270; GO:0016603; GO:0017186";peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186];extracellular region [GO:0005576];"glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]"
comp5299144_c0_seq1;GAXK01061256.1;Q75K27;8.51E-26;RS24_DICDI;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp53_c2_seq1;GAXK01166116.1;P14569;4.48E-41;ATP6_LOCMI;ATP synthase subunit a (F-ATPase protein 6);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005743; GO:0015078; GO:0015986; GO:0016021; GO:0045263";ATP synthesis coupled proton transport [GO:0015986];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";proton transmembrane transporter activity [GO:0015078]
comp530024_c0_seq1;GAXK01136557.1;Q4KLV6;1.08E-07;AGO4_XENLA;Protein argonaute-4 (Argonaute4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4);"P-body [GO:0000932]; RISC complex [GO:0016442]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"GO:0000932; GO:0006402; GO:0016442; GO:0035198; GO:0035278";"miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]";"P-body [GO:0000932]; RISC complex [GO:0016442]";miRNA binding [GO:0035198]
comp53005_c0_seq1;GAXK01111551.1;Q7KRI2;1.36E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp53006_c6_seq1;GAXK01111517.1;O14578;1.61E-66;CTRO_HUMAN;Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21);"actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]";"GO:0000086; GO:0000278; GO:0000281; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0015629; GO:0016020; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110";"actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]";"actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]"
comp5301055_c0_seq1;GAXK01054823.1;Q12729;2.13E-25;LAC1_PLEOS;Laccase-1 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 1) (Diphenol oxidase 1) (Urishiol oxidase 1);"extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0005576; GO:0046274; GO:0052716";lignin catabolic process [GO:0046274];extracellular region [GO:0005576];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp530108_c1_seq1;GAXK01136532.1;Q8IYA7;6.74E-38;MKX_HUMAN;Homeobox protein Mohawk;"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; muscle organ development [GO:0007517]";"GO:0000790; GO:0000981; GO:0007517; GO:0043565";muscle organ development [GO:0007517];nuclear chromatin [GO:0000790];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp5301662_c0_seq1;GAXK01054837.1;Q494W8;2.59E-27;CRFM7_HUMAN;CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10);"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005230; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp530211_c0_seq1;GAXK01136513.1;P52746;2.85E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp53027_c2_seq1;GAXK01111940.1;Q6KC79;0;NIPBL_HUMAN;Nipped-B-like protein (Delangin) (SCC2 homolog);"chromatin [GO:0000785]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]";"GO:0000122; GO:0000228; GO:0000785; GO:0000790; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0006302; GO:0006974; GO:0007064; GO:0007076; GO:0007420; GO:0007507; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045892; GO:0045995; GO:0047485; GO:0048557; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0070062; GO:0070087; GO:0070550; GO:0071169; GO:0071481; GO:0071733; GO:0071921; GO:0090694; GO:1905406; GO:1990414; GO:2001224";"brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]";"chromatin [GO:0000785]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]";"chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]"
comp5303360_c0_seq1;GAXK01035717.1;Q61041;1.96E-19;NPY4R_MOUSE;Neuropeptide Y receptor type 4 (NPY4-R) (NPYR-D) (Pancreatic polypeptide receptor 1) (PP1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601]";"GO:0001601; GO:0001602; GO:0005886; GO:0016021; GO:0042277";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601]"
comp5304_c0_seq1;GAXK01067217.1;Q9W2D6;4.17E-37;TIM10_DROME;Mitochondrial import inner membrane translocase subunit Tim10;"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; metal ion binding [GO:0046872]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; protein insertion into mitochondrial inner membrane [GO:0045039]";"GO:0005743; GO:0042719; GO:0045039; GO:0045824; GO:0046872; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; protein insertion into mitochondrial inner membrane [GO:0045039]";"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space protein transporter complex [GO:0042719]";metal ion binding [GO:0046872]
comp53041_c2_seq1;GAXK01111898.1;Q9H074;5.07E-34;PAIP1_HUMAN;Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; mRNA stabilization [GO:0048255]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255";"mRNA stabilization [GO:0048255]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"RNA binding [GO:0003723]; translation activator activity [GO:0008494]"
comp5304449_c0_seq1;GAXK01111045.1;Q966L8;1.81E-08;CHE1_CAEEL;Transcription factor che-1 (Abnormal chemotaxis protein 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of chemotaxis [GO:0050921]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of chemotaxis [GO:0050920]; response to alkaline pH [GO:0010446]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]";"GO:0000977; GO:0003700; GO:0005634; GO:0006935; GO:0007635; GO:0010035; GO:0010226; GO:0010446; GO:0030182; GO:0032026; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050920; GO:0050921; GO:1902074; GO:1904640";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of chemotaxis [GO:0050921]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of chemotaxis [GO:0050920]; response to alkaline pH [GO:0010446]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5304862_c0_seq1;GAXK01111055.1;A8MYZ0;4.01E-25;MIY4B_HUMAN;Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2);protein K48-linked deubiquitination [GO:0071108];GO:0071108;protein K48-linked deubiquitination [GO:0071108];;
comp530501_c1_seq1;GAXK01136525.1;O02776;3.36E-55;PARG_BOVIN;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"GO:0004649; GO:0005634; GO:0005737; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";poly(ADP-ribose) glycohydrolase activity [GO:0004649]
comp530506_c0_seq1;GAXK01136559.1;P94400;5.92E-19;YCIC_BACSU;Putative metal chaperone YciC;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp530639_c0_seq1;GAXK01136562.1;P81429;5.34E-22;EST1_SCHGA;Esterase SG1 (EC 3.1.1.1) (Carboxylic-ester hydrolase) (Fragment);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp5306559_c0_seq1;GAXK01089275.1;O94489;4.32E-52;EF3_SCHPO;Elongation factor 3 (EF-3);"cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]";"GO:0002182; GO:0003746; GO:0005524; GO:0005829; GO:0016887";cytoplasmic translational elongation [GO:0002182];cytosol [GO:0005829];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; translation elongation factor activity [GO:0003746]"
comp5307380_c0_seq1;GAXK01089279.1;Q557E0;1.16E-22;HS7C2_DICDI;Heat shock cognate 70 kDa protein 2 (HSC70-2);"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; microtubule organizing center [GO:0005815]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to bacterium [GO:0009617]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005811; GO:0005815; GO:0006986; GO:0009617; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0045335; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to bacterium [GO:0009617]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; microtubule organizing center [GO:0005815]; phagocytic vesicle [GO:0045335]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp5308541_c0_seq1;GAXK01196845.1;Q8IN35;5.14E-10;SIFAR_DROME;Neuropeptide SIFamide receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]";"GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047";"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]"
comp53089_c1_seq1;GAXK01112035.1;Q0KHY3;0;MESH_DROME;Protein mesh;"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]; cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]";"GO:0005920; GO:0007160; GO:0007275; GO:0016021; GO:0016327; GO:0090528";"cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]";"apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]";
comp5309221_c0_seq1;GAXK01196849.1;Q8C8R3;1.05E-14;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp5309327_c0_seq1;GAXK01196822.1;Q9DG68;2.63E-28;RLA0_RANSY;60S acidic ribosomal protein P0 (60S ribosomal protein L10E);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp530941_c0_seq1;GAXK01136575.1;Q6X6Z7;1.22E-48;TEKT3_MOUSE;Tektin-3;"acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005737; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp5309604_c0_seq1;GAXK01196839.1;Q8K274;2.99E-13;KT3K_MOUSE;Ketosamine-3-kinase (EC 2.7.1.-) (Fructosamine-3-kinase-related protein);kinase activity [GO:0016301];GO:0016301;;;kinase activity [GO:0016301]
comp5309723_c0_seq1;GAXK01196851.1;Q4KTG9;6.89E-62;RL17_SUBDO;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp531_c0_seq1;GAXK01204963.1;Q9CPU4;5.08E-42;MGST3_MOUSE;Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0043231";"leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]"
comp53103_c0_seq1;GAXK01111512.1;P13002;5.21E-78;ELF1_DROME;Protein grainyhead (DNA-binding protein ELF-1) (Element I-binding activity) (Protein grainy-head) (Transcription factor NTF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";"GO:0003382; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007402; GO:0007419; GO:0007424; GO:0007426; GO:0007464; GO:0008362; GO:0008543; GO:0035159; GO:0040003; GO:0042052; GO:0042127; GO:0042803; GO:0043565; GO:0045944; GO:0050767; GO:0061024; GO:0061041";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp53106_c0_seq1;GAXK01111859.1;P25843;7.24E-47;PROF_DROME;Profilin (Protein chickadee);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007411; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]";actin monomer binding [GO:0003785]
comp53115_c0_seq1;GAXK01111377.1;Q964R1;2.44E-27;CP6J1_BLAGE;Cytochrome P450 6j1 (EC 1.14.-.-) (CYPVIJ1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp531169_c2_seq1;GAXK01136521.1;Q01721;2.12E-10;GAS1_MOUSE;Growth arrest-specific protein 1 (GAS-1);"anchored component of plasma membrane [GO:0046658]; membrane [GO:0016020]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; camera-type eye development [GO:0043010]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cerebellum morphogenesis [GO:0021587]; developmental growth [GO:0048589]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic skeletal system development [GO:0048706]; eye morphogenesis [GO:0048592]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; negative regulation of smoothened signaling pathway [GO:0045879]; odontogenesis [GO:0042476]; outer ear morphogenesis [GO:0042473]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; programmed cell death [GO:0012501]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]";"GO:0002053; GO:0005886; GO:0007050; GO:0007411; GO:0008284; GO:0008589; GO:0009953; GO:0010955; GO:0012501; GO:0016020; GO:0021587; GO:0021904; GO:0030308; GO:0042473; GO:0042474; GO:0042476; GO:0042733; GO:0043010; GO:0043066; GO:0045165; GO:0045879; GO:0045880; GO:0045930; GO:0046658; GO:0048589; GO:0048592; GO:0048598; GO:0048701; GO:0048706; GO:0050679; GO:0050680; GO:0060021; GO:0060628; GO:1902807; GO:2001240";"axon guidance [GO:0007411]; camera-type eye development [GO:0043010]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cerebellum morphogenesis [GO:0021587]; developmental growth [GO:0048589]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic skeletal system development [GO:0048706]; eye morphogenesis [GO:0048592]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; negative regulation of smoothened signaling pathway [GO:0045879]; odontogenesis [GO:0042476]; outer ear morphogenesis [GO:0042473]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; programmed cell death [GO:0012501]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]";"anchored component of plasma membrane [GO:0046658]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp53118_c1_seq1;GAXK01111818.1;Q80U87;3.88E-92;UBP8_MOUSE;Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp5312009_c0_seq1;GAXK01030400.1;Q7LHG5;8.48E-10;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp5312521_c0_seq1;GAXK01030399.1;P79781;1.28E-19;RS27A_CHICK;"Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a]";"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006412; GO:0016567; GO:0019941; GO:0022627; GO:0031386; GO:0031625; GO:0046872";"DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]"
comp531310_c1_seq1;GAXK01136572.1;P48613;6.84E-13;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp53136_c0_seq1;GAXK01111378.1;A7YWD2;1.88E-172;IPO13_BOVIN;Importin-13 (Imp13);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]";"GO:0005634; GO:0005737; GO:0006606; GO:0008536";protein import into nucleus [GO:0006606];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";Ran GTPase binding [GO:0008536]
comp5313812_c0_seq1;GAXK01030403.1;Q24352;1.91E-20;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp531497_c0_seq1;GAXK01136508.1;P56270;1.12E-14;MAZ_HUMAN;Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor) (Serum amyloid A-activating factor-1) (SAF-1) (Transcription factor Zif87) (ZF87) (Zinc finger protein 801);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0006367; GO:0006369; GO:0008284; GO:0010628; GO:0014068; GO:0030335; GO:0045893; GO:0046872; GO:0051897; GO:2001234";"negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5315060_c0_seq1;GAXK01118752.1;Q3SFZ6;4.82E-42;MSBA_THIDA;Lipid A export ATP-binding/permease protein MsbA (EC 7.5.2.6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]"
comp5315516_c0_seq1;GAXK01118758.1;Q54MK8;7.09E-56;RL18A_DICDI;60S ribosomal protein L18a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp531564_c0_seq1;GAXK01136576.1;Q18297;7.91E-68;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp531609_c0_seq1;GAXK01136574.1;Q761V0;1.56E-89;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp53166_c1_seq1;GAXK01111326.1;Q7SY29;1.67E-159;G6PT3_DANRE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]
comp5317013_c0_seq1;GAXK01035339.1;P16373;1.08E-07;ZFP59_MOUSE;Zinc finger protein 59 (Zfp-59) (Zinc finger protein Mfg-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp531735_c1_seq1;GAXK01136578.1;Q3KR37;6.38E-19;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp531748_c0_seq1;GAXK01136512.1;Q96PH1;5.53E-57;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp5318327_c0_seq1;GAXK01163624.1;P08220;1.75E-22;GBRB1_BOVIN;Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0015276; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0071420; GO:1902711";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]"
comp5318504_c0_seq1;GAXK01163625.1;Q28658;1.16E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp5318736_c0_seq1;GAXK01163629.1;Q8TE73;3.01E-71;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp532_c0_seq1;GAXK01168587.1;B7PY76;1.77E-132;WDR12_IXOSC;Ribosome biogenesis protein WDR12 homolog;"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545";"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]";ribonucleoprotein complex binding [GO:0043021]
comp5320120_c0_seq1;GAXK01129184.1;Q9D733;1.07E-08;GP2_MOUSE;Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2);"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]";"GO:0002412; GO:0003823; GO:0005576; GO:0016324; GO:0031225";antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412];"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]";antigen binding [GO:0003823]
comp5320526_c0_seq1;GAXK01129185.1;O15403;2.94E-24;MOT7_HUMAN;Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020";monocarboxylic acid transport [GO:0015718];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp532054_c0_seq1;GAXK01195968.1;P02595;4.54E-13;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp532079_c1_seq1;GAXK01196008.1;A8X679;1.40E-09;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp53211_c8_seq1;GAXK01111490.1;Q91WQ9;8.57E-35;CALL4_MOUSE;Calmodulin-like protein 4 (Calmodulin-related) (CALM-Rel);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp5321154_c0_seq1;GAXK01129178.1;Q37620;1.16E-63;COX3_PROWI;Cytochrome c oxidase subunit 3 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide III);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; aerobic electron transport chain [GO:0019646]";"GO:0004129; GO:0005743; GO:0016021; GO:0019646";aerobic electron transport chain [GO:0019646];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp532167_c0_seq1;GAXK01196012.1;Q7ZYC4;8.93E-175;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp53218_c1_seq1;GAXK01111392.1;O95497;6.36E-84;VNN1_HUMAN;Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1);"anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neutrophil degranulation [GO:0043312]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979]";"GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0035577; GO:0043312; GO:0045087; GO:0098609; GO:1902176";"acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neutrophil degranulation [GO:0043312]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979]";"anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";pantetheine hydrolase activity [GO:0017159]
comp5322203_c0_seq1;GAXK01173978.1;Q6UXH9;3.80E-13;PAMR1_HUMAN;Inactive serine protease PAMR1 (Peptidase domain-containing protein associated with muscle regeneration 1) (Regeneration-associated muscle protease homolog);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576";;extracellular region [GO:0005576];calcium ion binding [GO:0005509]
comp532293_c0_seq1;GAXK01196017.1;E9PW05;1.82E-10;ZFP54_MOUSE;Zinc finger protein 54 (Krueppel-associated box protein 10) (KRAB10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5323785_c0_seq1;GAXK01173989.1;P81286;1.14E-16;PLMN_SHEEP;Plasminogen (EC 3.4.21.7) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp5323941_c0_seq1;GAXK01173986.1;Q0IP28;9.04E-07;LAC25_ORYSJ;Laccase-25 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 25) (Diphenol oxidase 25) (Urishiol oxidase 25);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp5324460_c0_seq1;GAXK01073804.1;A8JAM0;1.10E-18;DRC7_CHLRE;Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein lobo homolog) (Flagellar-associated protein 50) (Fragment);"axoneme [GO:0005930]; motile cilium [GO:0031514]";"GO:0005930; GO:0031514";;"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp53253_c2_seq1;GAXK01111464.1;Q26474;2.35E-13;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp532540_c0_seq1;GAXK01195993.1;Q96KE9;6.76E-07;BTBD6_HUMAN;BTB/POZ domain-containing protein 6 (Lens BTB domain protein);"cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";"GO:0005829; GO:0022008; GO:0043687";"neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";cytosol [GO:0005829];
comp5325700_c0_seq1;GAXK01073809.1;Q8IVF4;1.56E-18;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp5325789_c0_seq1;GAXK01073803.1;Q0IUU4;1.76E-09;CML2_ORYSJ;Putative calmodulin-like protein 2;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp5326342_c0_seq1;GAXK01163708.1;P02566;1.80E-18;MYO4_CAEEL;Myosin-4 (Myosin heavy chain B) (MHC B) (Uncoordinated protein 54);"A band [GO:0031672]; muscle myosin complex [GO:0005859]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; structural constituent of muscle [GO:0008307]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; oviposition [GO:0018991]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0000146; GO:0005524; GO:0005859; GO:0005863; GO:0006936; GO:0008307; GO:0018991; GO:0030241; GO:0031672; GO:0040011; GO:0051015";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; oviposition [GO:0018991]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; muscle myosin complex [GO:0005859]; striated muscle myosin thick filament [GO:0005863]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; structural constituent of muscle [GO:0008307]"
comp5327884_c0_seq1;GAXK01163721.1;P32176;1.35E-53;FDOG_ECOLI;Formate dehydrogenase-O major subunit (EC 1.17.1.9) (Aerobic formate dehydrogenase major subunit) (FDH-Z subunit alpha) (Formate dehydrogenase-O subunit alpha);"cytosol [GO:0005829]; formate dehydrogenase complex [GO:0009326]; membrane [GO:0016020]; periplasmic space [GO:0042597]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; formate dehydrogenase (cytochrome-c-553) activity [GO:0047111]; formate dehydrogenase (NAD+) activity [GO:0008863]; formate dehydrogenase (quinone) activity [GO:0036397]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; cellular respiration [GO:0045333]; cellular response to DNA damage stimulus [GO:0006974]; formate oxidation [GO:0015944]";"GO:0005829; GO:0006974; GO:0008863; GO:0009055; GO:0009326; GO:0015944; GO:0016020; GO:0036397; GO:0042597; GO:0043546; GO:0045333; GO:0046872; GO:0047111; GO:0051539";"cellular respiration [GO:0045333]; cellular response to DNA damage stimulus [GO:0006974]; formate oxidation [GO:0015944]";"cytosol [GO:0005829]; formate dehydrogenase complex [GO:0009326]; membrane [GO:0016020]; periplasmic space [GO:0042597]";"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; formate dehydrogenase (cytochrome-c-553) activity [GO:0047111]; formate dehydrogenase (NAD+) activity [GO:0008863]; formate dehydrogenase (quinone) activity [GO:0036397]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]"
comp5328401_c0_seq1;GAXK01131224.1;P03360;9.00E-08;POL_AVIRE;"Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";;"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp5328638_c0_seq1;GAXK01131220.1;Q7Z2Y8;1.11E-16;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp53289_c2_seq1;GAXK01111877.1;Q8C0D5;1.78E-58;EFL1_MOUSE;Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A);"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]";"GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904";"GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]";"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp53290_c1_seq1;GAXK01112178.1;P21251;1.22E-52;CALM_STIJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp532932_c0_seq1;GAXK01195989.1;Q6ZMW2;5.74E-21;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5330337_c0_seq1;GAXK01068963.1;O94762;2.25E-100;RECQ5_HUMAN;ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042";"cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]"
comp53304_c0_seq1;GAXK01111354.1;Q2T9W2;8.07E-74;THUM3_BOVIN;THUMP domain-containing protein 3;"RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488]";"GO:0003723; GO:0016423; GO:0030488";tRNA methylation [GO:0030488];;"RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]"
comp533125_c0_seq1;GAXK01195953.1;Q9VUN0;0;TOLL6_DROME;Toll-like receptor 6;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983";"axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"
comp533153_c0_seq1;GAXK01195990.1;A8WHP3;5.68E-173;SC5A9_DANRE;Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]";"GO:0005412; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";glucose:sodium symporter activity [GO:0005412]
comp53316_c0_seq1;GAXK01111956.1;P24156;2.37E-59;L2CC_DROME;Protein l(2)37Cc;"membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"GO:0005739; GO:0007275; GO:0016020; GO:0071456";"cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"membrane [GO:0016020]; mitochondrion [GO:0005739]";
comp5331842_c0_seq1;GAXK01068957.1;P10076;5.45E-07;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp533301_c0_seq1;GAXK01195952.1;P05661;8.29E-18;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp5333396_c0_seq1;GAXK01077815.1;Q9NKX1;7.53E-23;ENPL_DICDI;Endoplasmin homolog (92 kDa phosphoprotein) (Glucose-regulated protein 94 homolog) (GRP-94 homolog);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005783; GO:0005794; GO:0005798; GO:0006457; GO:0030433; GO:0048471; GO:0051082";"protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp533408_c0_seq1;GAXK01195982.1;Q68FA2;1.18E-11;CT027_XENTR;UPF0687 protein C20orf27 homolog;;;;;
comp5334527_c0_seq1;GAXK01059662.1;A8ESU6;6.06E-75;RL2_ARCB4;50S ribosomal protein L2;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; transferase activity [GO:0016740]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0016740; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; transferase activity [GO:0016740]"
comp533464_c0_seq1;GAXK01195977.1;Q86SX6;6.89E-15;GLRX5_HUMAN;Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5);"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]";"GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0015038; GO:0030097; GO:0030425; GO:0043025; GO:0044281; GO:0045454; GO:0046872; GO:0051537";"cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]";"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"
comp5335104_c0_seq1;GAXK01059677.1;Q6XIM7;2.37E-24;RL38_DROYA;60S ribosomal protein L38;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5335414_c0_seq1;GAXK01059682.1;B4F6U4;7.95E-09;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp5335612_c0_seq1;GAXK01059679.1;P76594;3.71E-15;LYSAC_ECOLI;Peptidyl-lysine N-acetyltransferase PatZ (EC 2.3.1.-) (Protein lysine acetyltransferase);"ATP binding [GO:0005524]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peptidyl-lysine acetyltransferase activity [GO:0052858]; internal peptidyl-lysine acetylation [GO:0018393]; protein homotetramerization [GO:0051289]; regulation of protein homooligomerization [GO:0032462]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]";"GO:0005524; GO:0006979; GO:0009408; GO:0018393; GO:0032462; GO:0046872; GO:0048037; GO:0051289; GO:0052858; GO:0061733";"internal peptidyl-lysine acetylation [GO:0018393]; protein homotetramerization [GO:0051289]; regulation of protein homooligomerization [GO:0032462]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]";;"ATP binding [GO:0005524]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peptidyl-lysine acetyltransferase activity [GO:0052858]"
comp5335721_c0_seq1;GAXK01059664.1;A4IF62;2.56E-07;RPC1_BOVIN;DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A);"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0046872; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp5335784_c0_seq1;GAXK01059681.1;P53444;1.11E-92;ALF_NEUCR;Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase);"cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; plasma membrane [GO:0005886]; fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0008270; GO:0009277";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; plasma membrane [GO:0005886]";"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]"
comp533580_c0_seq1;GAXK01195954.1;Q7ZVG6;1.37E-14;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp5336380_c0_seq1;GAXK01153455.1;Q6UWB4;9.18E-23;PRS55_HUMAN;Serine protease 55 (EC 3.4.21.-) (Testis serine protease 1) (T-SP1);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005829; GO:0016021";;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]";serine-type endopeptidase activity [GO:0004252]
comp53369_c1_seq1;GAXK01111355.1;Q80TR8;6.07E-127;DCAF1_MOUSE;DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1);"COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]";"GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005737; GO:0008180; GO:0016032; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0080008; GO:1990244; GO:1990245";"B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]";"COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]"
comp53370_c0_seq1;GAXK01112081.1;Q9NXV2;2.74E-20;KCTD5_HUMAN;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; viral process [GO:0016032]";"GO:0005634; GO:0005737; GO:0005829; GO:0016032; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; viral process [GO:0016032]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]"
comp533763_c0_seq1;GAXK01195964.1;P28362;7.14E-42;MSX2_CHICK;Homeobox protein MSX-2 (Homeobox protein Hox-8) (CHOX-8) (GHox-8);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway involved in heart development [GO:0061312]; bone trabecula formation [GO:0060346]; cellular response to estradiol stimulus [GO:0071392]; chondrocyte development [GO:0002063]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic morphogenesis [GO:0048598]; embryonic nail plate morphogenesis [GO:0035880]; endochondral bone growth [GO:0003416]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; frontal suture morphogenesis [GO:0060364]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of timing of catagen [GO:0051795]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; wound healing, spreading of epidermal cells [GO:0035313]";"GO:0000977; GO:0001227; GO:0002063; GO:0002076; GO:0003148; GO:0003198; GO:0003416; GO:0003712; GO:0005634; GO:0005829; GO:0008134; GO:0008285; GO:0009952; GO:0016607; GO:0023019; GO:0030513; GO:0032792; GO:0035115; GO:0035116; GO:0035313; GO:0035880; GO:0043066; GO:0045599; GO:0045617; GO:0045669; GO:0048598; GO:0048863; GO:0051795; GO:0060346; GO:0060364; GO:0061312; GO:0071392; GO:0090427; GO:2000678; GO:2001055";"activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway involved in heart development [GO:0061312]; bone trabecula formation [GO:0060346]; cellular response to estradiol stimulus [GO:0071392]; chondrocyte development [GO:0002063]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic morphogenesis [GO:0048598]; embryonic nail plate morphogenesis [GO:0035880]; endochondral bone growth [GO:0003416]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; frontal suture morphogenesis [GO:0060364]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of timing of catagen [GO:0051795]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; wound healing, spreading of epidermal cells [GO:0035313]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]"
comp5338272_c0_seq1;GAXK01109908.1;Q84M24;9.30E-59;AB1A_ARATH;ABC transporter A family member 1 (ABC transporter ABCA.1) (AtABCA1) (ABC one homolog protein 1) (AtAOH1);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]";"GO:0005319; GO:0005524; GO:0005774; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231";lipid transport [GO:0006869];"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp5338672_c0_seq1;GAXK01109906.1;Q96K62;2.52E-10;ZBT45_HUMAN;Zinc finger and BTB domain-containing protein 45 (Zinc finger protein 499);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]";"GO:0003677; GO:0005634; GO:0007399; GO:0046872";nervous system development [GO:0007399];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5339307_c0_seq1;GAXK01109913.1;Q14982;4.42E-19;OPCM_HUMAN;Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp53394_c2_seq1;GAXK01112034.1;Q9DBU3;3.12E-152;RIOK3_MOUSE;Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3);"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]";"GO:0004674; GO:0005524; GO:0005829; GO:0030490; GO:0030688; GO:0032463; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786";"cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]";"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp534_c0_seq1;GAXK01168201.1;Q3MHL4;0;SAHH_BOVIN;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"cytosol [GO:0005829]; melanosome [GO:0042470]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";"GO:0004013; GO:0005829; GO:0006730; GO:0033353; GO:0042470";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";"cytosol [GO:0005829]; melanosome [GO:0042470]";adenosylhomocysteinase activity [GO:0004013]
comp5341084_c0_seq1;GAXK01032631.1;Q96X45;7.87E-68;EF2_NEUCR;Elongation factor 2 (EF-2) (Colonial temperature-sensitive 3);"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp5342305_c0_seq1;GAXK01055740.1;A0ZSK4;7.83E-16;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp534283_c0_seq1;GAXK01159824.1;Q96PE6;5.46E-15;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp53437_c0_seq1;GAXK01111515.1;Q6GMK8;0;GMPAA_DANRE;Mannose-1-phosphate guanyltransferase alpha-A (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-A) (GTP-mannose-1-phosphate guanylyltransferase subunit alpha-A);"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]";"GO:0004475; GO:0005525; GO:0009298";GDP-mannose biosynthetic process [GO:0009298];;"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]"
comp5344755_c0_seq1;GAXK01198422.1;P0DJE3;1.04E-09;LATA_LATHE;Alpha-latrotoxin-Lhe1a (Alpha-LTX-Lhe1a) (Alpha-latrotoxin);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; exocytosis [GO:0006887]";"GO:0005576; GO:0006887; GO:0016021; GO:0044218; GO:0090729";exocytosis [GO:0006887];"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp53450_c0_seq1;GAXK01111977.1;Q9D4H2;3.18E-18;GCC1_MOUSE;GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GO:0000139; GO:0005794; GO:0005829; GO:0005886";;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";
comp5345238_c0_seq1;GAXK01198414.1;P30974;9.38E-26;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp534582_c0_seq1;GAXK01159814.1;Q9V3T9;1.05E-18;ADRO_DROME;NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol catabolic process [GO:0006707]; metamorphosis [GO:0007552]; molting cycle, chitin-based cuticle [GO:0007591]; olfactory behavior [GO:0042048]; pupariation [GO:0035073]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005739; GO:0005743; GO:0005759; GO:0006694; GO:0006707; GO:0006744; GO:0007552; GO:0007591; GO:0009055; GO:0015039; GO:0035073; GO:0042048";"cholesterol catabolic process [GO:0006707]; metamorphosis [GO:0007552]; molting cycle, chitin-based cuticle [GO:0007591]; olfactory behavior [GO:0042048]; pupariation [GO:0035073]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; NADPH-adrenodoxin reductase activity [GO:0015039]"
comp5346227_c0_seq1;GAXK01073720.1;Q8IN81;3.72E-11;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp53465_c1_seq1;GAXK01111555.1;P62289;0;ASPM_GORGO;Abnormal spindle-like microcephaly-associated protein homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; cell division [GO:0051301]; spindle organization [GO:0007051]";"GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0051301";"cell division [GO:0051301]; spindle organization [GO:0007051]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";calmodulin binding [GO:0005516]
comp5347152_c0_seq1;GAXK01073731.1;Q8K203;5.76E-08;NEIL3_MOUSE;Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078";"base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"
comp5347417_c0_seq1;GAXK01073725.1;P51776;7.21E-55;PPDK_GIAIN;Pyruvate, phosphate dikinase (EC 2.7.9.1) (Pyruvate, orthophosphate dikinase);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]; pyruvate metabolic process [GO:0006090]";"GO:0005524; GO:0006090; GO:0016301; GO:0046872; GO:0050242";pyruvate metabolic process [GO:0006090];;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]"
comp5347449_c0_seq1;GAXK01073721.1;P10076;4.88E-14;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5347832_c0_seq1;GAXK01073719.1;Q29J90;4.32E-18;MOODY_DROPS;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp53491_c2_seq1;GAXK01112256.1;O75356;1.93E-84;ENTP5_HUMAN;Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0008283; GO:0014066; GO:0034656; GO:0045134; GO:0045821; GO:0046034; GO:0051084";"'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]"
comp534923_c0_seq1;GAXK01159829.1;Q3UDF0;3.60E-08;GTR6_MOUSE;Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; carbohydrate:proton symporter activity [GO:0005351]; glucose transmembrane transport [GO:1904659]; regulation of glycolytic process [GO:0006110]";"GO:0005351; GO:0005765; GO:0005887; GO:0006110; GO:1904659";"glucose transmembrane transport [GO:1904659]; regulation of glycolytic process [GO:0006110]";"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";carbohydrate:proton symporter activity [GO:0005351]
comp5349777_c0_seq1;GAXK01196575.1;Q9JJS8;1.03E-19;MASP2_RAT;"Mannan-binding lectin serine protease 2 (EC 3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]";"GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0006956; GO:0006958; GO:0008233";"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp5350172_c0_seq1;GAXK01193777.1;Q84UI5;1.97E-14;MPK1_ORYSJ;Mitogen-activated protein kinase 1 (MAP kinase 1) (EC 2.7.11.24) (MAP kinase 6) (OsMAPK6) (OsSIPK);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; preprophase band [GO:0009574]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; abscisic acid-activated signaling pathway [GO:0009738]; camalexin biosynthetic process [GO:0010120]; cell division [GO:0051301]; induced systemic resistance, jasmonic acid mediated signaling pathway [GO:0009864]; inflorescence development [GO:0010229]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; pollen tube guidance [GO:0010183]; priming of cellular response to stress [GO:0080136]; regulation of gene expression [GO:0010468]; response to ethylene [GO:0009723]; response to freezing [GO:0050826]; response to fungus [GO:0009620]; response to hydrogen peroxide [GO:0042542]; response to L-glutamate [GO:1902065]; response to salt stress [GO:0009651]; response to UV-B [GO:0010224]; root development [GO:0048364]";"GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005802; GO:0005938; GO:0009524; GO:0009555; GO:0009574; GO:0009620; GO:0009651; GO:0009723; GO:0009738; GO:0009864; GO:0010120; GO:0010150; GO:0010183; GO:0010224; GO:0010229; GO:0010468; GO:0019902; GO:0035556; GO:0042542; GO:0048364; GO:0048481; GO:0050826; GO:0051301; GO:0080136; GO:1902065";"abscisic acid-activated signaling pathway [GO:0009738]; camalexin biosynthetic process [GO:0010120]; cell division [GO:0051301]; induced systemic resistance, jasmonic acid mediated signaling pathway [GO:0009864]; inflorescence development [GO:0010229]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; pollen tube guidance [GO:0010183]; priming of cellular response to stress [GO:0080136]; regulation of gene expression [GO:0010468]; response to ethylene [GO:0009723]; response to freezing [GO:0050826]; response to fungus [GO:0009620]; response to hydrogen peroxide [GO:0042542]; response to L-glutamate [GO:1902065]; response to salt stress [GO:0009651]; response to UV-B [GO:0010224]; root development [GO:0048364]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; preprophase band [GO:0009574]; trans-Golgi network [GO:0005802]";"ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]"
comp53502_c0_seq1;GAXK01111802.1;Q8BGZ3;3.14E-109;DCA12_MOUSE;DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A);"centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0005813; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]";
comp535067_c1_seq1;GAXK01159810.1;Q8WW35;2.77E-37;TC1D2_HUMAN;Tctex1 domain-containing protein 2;"cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]";"GO:0005868; GO:0045505; GO:0060271; GO:1902017; GO:1905799";"cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]";cytoplasmic dynein complex [GO:0005868];dynein intermediate chain binding [GO:0045505]
comp5350871_c0_seq1;GAXK01193771.1;P0C6F1;4.72E-19;DYH2_MOUSE;Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2);"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp5351_c0_seq1;GAXK01066897.1;Q60LV4;1.49E-20;MYO3_CAEBR;Myosin-3 (Myosin heavy chain A) (MHC A);"A band [GO:0031672]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; locomotory behavior [GO:0007626]";"GO:0003774; GO:0005524; GO:0007626; GO:0031672; GO:0032982; GO:0051015";locomotory behavior [GO:0007626];"A band [GO:0031672]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp5351197_c0_seq1;GAXK01193762.1;Q4DZ41;2.94E-74;RS3A2_TRYCC;40S ribosomal protein S3a-2;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp535135_c3_seq1;GAXK01159707.1;Q86MW9;6.61E-09;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp53514_c6_seq1;GAXK01111961.1;Q7Z2H8;4.75E-51;S36A1_HUMAN;Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"GO:0003333; GO:0005280; GO:0005765; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015078; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015808; GO:0015816; GO:0016021; GO:0035524; GO:1902600";"amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"amino acid:proton symporter activity [GO:0005280]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]"
comp5351731_c0_seq1;GAXK01193767.1;Q9TTC1;2.24E-09;POL_KORV;"Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]";"host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]";"host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]"
comp5352096_c0_seq1;GAXK01170849.1;Q6V5K9;6.31E-11;ZN474_MOUSE;Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp5352125_c0_seq1;GAXK01170851.1;P52115;1.47E-07;RENI_SHEEP;Renin (EC 3.4.23.15) (Angiotensinogenase);"extracellular region [GO:0005576]; membrane [GO:0016020]; aspartic-type endopeptidase activity [GO:0004190]";"GO:0004190; GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";aspartic-type endopeptidase activity [GO:0004190]
comp5352550_c0_seq1;GAXK01170855.1;Q38PU2;9.47E-10;GRIK3_MACFA;Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; ionotropic glutamate receptor activity [GO:0004970]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]";"GO:0001640; GO:0004970; GO:0007216; GO:0016021; GO:0030054; GO:0043197; GO:0045211";G protein-coupled glutamate receptor signaling pathway [GO:0007216];"cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; ionotropic glutamate receptor activity [GO:0004970]"
comp5352711_c0_seq1;GAXK01170848.1;P18445;3.64E-46;RL27A_RAT;60S ribosomal protein L27a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp5352713_c0_seq1;GAXK01170863.1;Q9Y272;2.28E-18;RASD1_HUMAN;Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1);"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0045892; GO:0048471";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]";"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5353154_c0_seq1;GAXK01170859.1;B3WFY8;4.03E-12;DYF5_CAEEL;Serine/threonine-protein kinase dyf-5 (EC 2.7.11.1);"axon [GO:0030424]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]";"GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0008104; GO:0010468; GO:0030424; GO:0030425; GO:0035556; GO:0035720; GO:0042073; GO:0043025; GO:0043204; GO:0046872; GO:0060271; GO:0097730; GO:1902856; GO:1902857; GO:1905515";"cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]";"axon [GO:0030424]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp53540_c1_seq1;GAXK01111888.1;Q86KD0;7.34E-36;Y7416_DICDI;BolA-like protein DDB_G0274169;"mitochondrion [GO:0005739]; transcription, DNA-templated [GO:0006351]";"GO:0005739; GO:0006351";transcription, DNA-templated [GO:0006351];mitochondrion [GO:0005739];
comp5354133_c0_seq1;GAXK01084227.1;P91730;8.73E-08;GLUCB_HAECO;Glutamate-gated chloride channel subunit beta (Glu-Cl subunit beta) (Avermectin-sensitive glutamate-gated chloride channel subunit) (HG4);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211";;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp535418_c2_seq1;GAXK01159716.1;Q9PVG3;6.44E-12;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp53542_c0_seq1;GAXK01111734.1;Q5RF08;1.13E-16;CA043_PONAB;Uncharacterized protein C1orf43 homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp535453_c1_seq1;GAXK01159780.1;Q20765;2.28E-13;NHR7_CAEEL;Nuclear hormone receptor family member nhr-7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp5354847_c0_seq1;GAXK01084221.1;P63245;6.50E-60;RACK1_RAT;Receptor of activated protein C kinase 1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0007205; GO:0007369; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:0072344; GO:1903076; GO:2000114; GO:2000543";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]"
comp5355075_c0_seq1;GAXK01084232.1;P01131;8.91E-07;LDLR_BOVIN;Low-density lipoprotein receptor (LDL receptor);"apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; PCSK9-LDLR complex [GO:1990666]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771]";"GO:0001540; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005771; GO:0005794; GO:0005901; GO:0005905; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016021; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0034362; GO:0034383; GO:0034384; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771]";"apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; PCSK9-LDLR complex [GO:1990666]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp535515_c1_seq1;GAXK01159713.1;O96790;9.32E-14;DPGN_DIPMA;Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment);"extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]";"GO:0004867; GO:0005576; GO:0050819";negative regulation of coagulation [GO:0050819];extracellular region [GO:0005576];serine-type endopeptidase inhibitor activity [GO:0004867]
comp5355533_c0_seq1;GAXK01084225.1;P00920;2.90E-22;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp53556_c1_seq1;GAXK01111401.1;Q9ULD0;7.78E-84;OGDHL_HUMAN;2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.-) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";"GO:0004591; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0030976; GO:0045252; GO:0046872";"glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]";"metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]"
comp535600_c0_seq1;GAXK01159698.1;P23416;3.10E-80;GLRA2_HUMAN;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp535629_c0_seq1;GAXK01159779.1;B4K5R2;1.94E-07;SPNE_DROMO;Probable ATP-dependent RNA helicase spindle-E (EC 3.6.4.13) (Homeless);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]";"GO:0003676; GO:0003724; GO:0005524; GO:0005737; GO:0007275; GO:0007283; GO:0031047; GO:0048477; GO:0051321";"gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp53564_c0_seq1;GAXK01111315.1;Q9V7U0;3.74E-08;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp535662_c0_seq1;GAXK01159839.1;Q8Q0U0;2.61E-08;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp5356660_c0_seq1;GAXK01131897.1;Q5XHA0;2.82E-23;SCMC1_XENTR;Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]";"GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015867; GO:0016021; GO:0034599; GO:0071277";"ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]"
comp53573_c1_seq1;GAXK01111890.1;Q8SX37;1.32E-76;CDIPT_DROME;CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase);"apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872]; basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]";"GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016021; GO:0016324; GO:0016328; GO:0046872; GO:0071711";"basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]";"apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";"CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872]"
comp5357712_c0_seq1;GAXK01131906.1;P41129;6.70E-15;RL132_BRANA;60S ribosomal protein L13-2 (Cold-induced protein C24B);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5358_c1_seq1;GAXK01065448.1;Q95VA8;1.92E-49;TPM_TRISP;Tropomyosin;;;;;
comp5358002_c0_seq1;GAXK01079531.1;F7J220;1.35E-07;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp53581_c0_seq1;GAXK01111833.1;O88900;2.88E-28;GRB14_RAT;Growth factor receptor-bound protein 14 (GRB14 adapter protein);"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; SH3/SH2 adaptor activity [GO:0005070]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]";"GO:0005070; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0008286; GO:0010008; GO:0032869; GO:0035556; GO:0046627; GO:0051219; GO:1904145";"cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904145]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";"phosphoprotein binding [GO:0051219]; SH3/SH2 adaptor activity [GO:0005070]"
comp5358341_c0_seq1;GAXK01079532.1;Q9LF30;8.82E-21;RS192_ARATH;40S ribosomal protein S19-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0009506; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp535896_c0_seq1;GAXK01159777.1;O70157;1.48E-14;TOP3A_MOUSE;DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha);"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; mitochondrial DNA metabolic process [GO:0032042]";"GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304";"chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; mitochondrial DNA metabolic process [GO:0032042]";"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"
comp5359073_c0_seq1;GAXK01079554.1;P40792;5.13E-59;RAC1_DROME;Ras-related protein Rac1;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; adherens junction maintenance [GO:0034334]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]";"GO:0000902; GO:0001726; GO:0001954; GO:0002433; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007254; GO:0007266; GO:0007298; GO:0007390; GO:0007391; GO:0007394; GO:0007395; GO:0007411; GO:0007413; GO:0007419; GO:0007422; GO:0007424; GO:0007426; GO:0007435; GO:0007516; GO:0007520; GO:0007613; GO:0008045; GO:0008078; GO:0008258; GO:0008283; GO:0008347; GO:0009611; GO:0010593; GO:0016028; GO:0016199; GO:0016203; GO:0016358; GO:0016477; GO:0019897; GO:0019901; GO:0030032; GO:0030036; GO:0030707; GO:0030866; GO:0031175; GO:0031410; GO:0031532; GO:0032147; GO:0032794; GO:0034334; GO:0035010; GO:0035011; GO:0035099; GO:0035212; GO:0035320; GO:0042052; GO:0042995; GO:0045773; GO:0046330; GO:0046664; GO:0046843; GO:0048010; GO:0048615; GO:0048675; GO:0048747; GO:0048812; GO:0048813; GO:0048814; GO:0050770; GO:0050807; GO:0050975; GO:0051017; GO:0051450; GO:0051491; GO:0051963; GO:0071902; GO:0071907; GO:0090303; GO:0097206; GO:1902669; GO:1903688; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; adherens junction maintenance [GO:0034334]; axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp5359346_c0_seq1;GAXK01079537.1;Q96HM7;1.55E-15;PED1B_HUMAN;PC-esterase domain-containing protein 1B (Protein FAM113B);;;;;
comp53603_c0_seq1;GAXK01111722.1;Q9I8B3;9.97E-47;RB24B_XENLA;RNA-binding protein 24-B (MTR-1a) (RNA-binding motif protein 24-B);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; sequence-specific mRNA binding [GO:1990825]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; RNA splicing [GO:0008380]";"GO:0000381; GO:0003730; GO:0005634; GO:0005737; GO:0006397; GO:0006974; GO:0008380; GO:0010830; GO:0010831; GO:0030154; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0061157; GO:0061158; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766";"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; sequence-specific mRNA binding [GO:1990825]"
comp5361777_c0_seq1;GAXK01105242.1;P16912;1.06E-45;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp536200_c0_seq1;GAXK01037193.1;P22770;2.54E-155;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp5363_c0_seq1;GAXK01066642.1;Q4R6I6;1.09E-25;SRP09_MACFA;Signal recognition particle 9 kDa protein (SRP9);"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";"GO:0005786; GO:0006614; GO:0008312; GO:0045900";"negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]";signal recognition particle, endoplasmic reticulum targeting [GO:0005786];7S RNA binding [GO:0008312]
comp5364_c96_seq1;GAXK01067039.1;Q8MQJ9;0;BRAT_DROME;Brain tumor protein;"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007411; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0043161; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061630; GO:0099738; GO:1900242; GO:1902692";"asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]";"mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp5364249_c0_seq1;GAXK01204042.1;P10076;1.69E-16;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp536546_c2_seq1;GAXK01037168.1;O45405;5.10E-42;EXL1_CAEEL;Chloride intracellular channel exl-1 (Exc-4-like protein);"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]";"GO:0000139; GO:0005244; GO:0005254; GO:0005634; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0016324; GO:0034707; GO:0034765; GO:0036195; GO:0055120";regulation of ion transmembrane transport [GO:0034765];"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]";"chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]"
comp5366190_c0_seq1;GAXK01145638.1;Q08972;8.99E-46;NEW1_YEAST;[NU+] prion formation protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0016887; GO:0016973; GO:0042274";"poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]"
comp5367108_c0_seq1;GAXK01145623.1;A8ET67;1.33E-49;YBEY_ARCB4;Endoribonuclease YbeY (EC 3.1.-.-);"cytoplasm [GO:0005737]; endoribonuclease activity [GO:0004521]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; rRNA processing [GO:0006364]";"GO:0004222; GO:0004521; GO:0005737; GO:0006364; GO:0008270";rRNA processing [GO:0006364];cytoplasm [GO:0005737];"endoribonuclease activity [GO:0004521]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp5367473_c0_seq1;GAXK01145634.1;Q07113;2.97E-07;MPRI_MOUSE;Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222);"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0042981; GO:0043065; GO:0044794; GO:0048471; GO:0051219";"animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; response to retinoic acid [GO:0032526]; spermatogenesis [GO:0007283]";"cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]";"enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]"
comp5368386_c0_seq1;GAXK01025900.1;Q9BYN7;4.76E-07;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5368735_c0_seq1;GAXK01025907.1;P11503;2.01E-32;HSP70_ONCVO;Heat shock 70 kDa protein (HSP70) (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp537052_c0_seq1;GAXK01037206.1;Q0EEE2;1.99E-14;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp53712_c0_seq1;GAXK01111863.1;P46735;0;MYO1B_MOUSE;Unconventional myosin-Ib (MIH-L) (Myosin I alpha) (MMI-alpha) (MMIa);"actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572]";"GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005903; GO:0006892; GO:0007015; GO:0010008; GO:0016459; GO:0030048; GO:0030175; GO:0030898; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944";"actin filament-based movement [GO:0030048]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572]";"actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp5371575_c0_seq1;GAXK01021136.1;A6NJL1;2.07E-14;ZSA5B_HUMAN;Zinc finger and SCAN domain-containing protein 5B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5374019_c0_seq1;GAXK01041785.1;Q16774;1.65E-76;KGUA_HUMAN;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0015949; GO:0019673; GO:0034436; GO:0046034; GO:0046054; GO:0046060; GO:0046711; GO:0046939";"ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp53742_c0_seq1;GAXK01111472.1;P06295;1.10E-07;MYC_AVIMD;Viral myc transforming protein (v-Myc);"host cell nucleus [GO:0042025]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0003700; GO:0042025; GO:0046983";;host cell nucleus [GO:0042025];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]"
comp537438_c0_seq1;GAXK01037153.1;O75995;3.41E-14;SASH3_HUMAN;SAM and SH3 domain-containing protein 3 (SH3 protein expressed in lymphocytes homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042102; GO:0043372; GO:0046622; GO:0048873";"homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp5374513_c0_seq1;GAXK01041768.1;A0A0H2ZDG9;4.15E-23;LYSRL_PSEAB;HTH-type transcriptional repressor PA14_22550;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700";;;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp537659_c0_seq1;GAXK01037236.1;Q6NXR0;1.87E-55;IIGP5_HUMAN;Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1);"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525; GO:0016020";;membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5377_c0_seq1;GAXK01065835.1;Q9VGY6;8.54E-12;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp537762_c0_seq1;GAXK01037209.1;P35832;0;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp5378764_c0_seq1;GAXK01136374.1;A4HQ28;4.99E-96;RSSA_LEIBR;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp53794_c0_seq1;GAXK01111963.1;Q6NS57;0;MABP1_MOUSE;Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1) (JNKBP-1);"cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; activation of JNKK activity [GO:0007256]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 secretion [GO:2000483]";"GO:0005634; GO:0005737; GO:0007256; GO:0043124; GO:0097431; GO:1900425; GO:2000483";"activation of JNKK activity [GO:0007256]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 secretion [GO:2000483]";"cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]";
comp537952_c2_seq1;GAXK01037150.1;Q9Y2H8;6.41E-19;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp537992_c2_seq1;GAXK01037154.1;Q61164;1.11E-26;CTCF_MOUSE;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006355; GO:0007059; GO:0008285; GO:0009048; GO:0010216; GO:0010628; GO:0010629; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0046872; GO:0071459; GO:1902895";"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp538_c0_seq1;GAXK01169213.1;O15992;5.17E-93;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp53800_c0_seq1;GAXK01112036.1;Q569B7;5.24E-37;RWDD4_RAT;RWD domain-containing protein 4;;;;;
comp5380751_c0_seq1;GAXK01014962.1;P23403;6.83E-49;RS20_XENLA;40S ribosomal protein S20 (S22);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp538136_c0_seq1;GAXK01205389.1;P09087;1.38E-30;ABDB_DROME;Homeobox protein abdominal-B (Infraabdominal 7) (IAB-7) (P3) (PH189);"nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; determination of genital disc primordium [GO:0035225]; developmental pigmentation [GO:0048066]; external genitalia morphogenesis [GO:0035261]; female genitalia development [GO:0030540]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; genital disc sexually dimorphic development [GO:0035263]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; imaginal disc-derived female genitalia development [GO:0007486]; imaginal disc-derived genitalia development [GO:0007484]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male pigmentation [GO:0048094]; midgut development [GO:0007494]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of female receptivity [GO:0007621]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of striated muscle tissue development [GO:0045843]; neuroendocrine cell differentiation [GO:0061101]; open tracheal system development [GO:0007424]; pole cell migration [GO:0007280]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland development [GO:0007431]; segment specification [GO:0007379]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; specification of segmental identity, abdomen [GO:0007385]; sperm storage [GO:0046693]; spiracle morphogenesis, open tracheal system [GO:0035277]";"GO:0000976; GO:0000980; GO:0003700; GO:0005634; GO:0005704; GO:0007280; GO:0007379; GO:0007385; GO:0007424; GO:0007431; GO:0007484; GO:0007486; GO:0007494; GO:0007506; GO:0007507; GO:0007548; GO:0007621; GO:0008354; GO:0008584; GO:0009997; GO:0030539; GO:0030540; GO:0035215; GO:0035224; GO:0035225; GO:0035261; GO:0035263; GO:0035277; GO:0045705; GO:0045843; GO:0045944; GO:0046693; GO:0048066; GO:0048071; GO:0048087; GO:0048094; GO:0061101; GO:1902339";"determination of genital disc primordium [GO:0035225]; developmental pigmentation [GO:0048066]; external genitalia morphogenesis [GO:0035261]; female genitalia development [GO:0030540]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; genital disc sexually dimorphic development [GO:0035263]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; imaginal disc-derived female genitalia development [GO:0007486]; imaginal disc-derived genitalia development [GO:0007484]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male pigmentation [GO:0048094]; midgut development [GO:0007494]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of female receptivity [GO:0007621]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of striated muscle tissue development [GO:0045843]; neuroendocrine cell differentiation [GO:0061101]; open tracheal system development [GO:0007424]; pole cell migration [GO:0007280]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland development [GO:0007431]; segment specification [GO:0007379]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; specification of segmental identity, abdomen [GO:0007385]; sperm storage [GO:0046693]; spiracle morphogenesis, open tracheal system [GO:0035277]";"nucleus [GO:0005634]; polytene chromosome band [GO:0005704]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp538178_c1_seq1;GAXK01070992.1;P33085;1.19E-126;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp5381897_c0_seq1;GAXK01014979.1;P48608;9.63E-30;DIA_DROME;Protein diaphanous;"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005912; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"
comp538239_c0_seq1;GAXK01070893.1;Q4V832;3.18E-18;AP4AT_XENLA;AP-4 complex accessory subunit tepsin (Tetra-epsin);"coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"GO:0005794; GO:0005829; GO:0030662";;"coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";
comp53828_c0_seq1;GAXK01111864.1;Q5BKM3;1.64E-72;CHMP3_XENTR;Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein-sorting-associated protein 24);"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324";"endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]";
comp53833_c0_seq1;GAXK01111865.1;Q9UL12;0;SARDH_HUMAN;Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]";"GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053";"choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]"
comp538409_c0_seq1;GAXK01071013.1;P39900;4.57E-41;MMP12_HUMAN;Macrophage metalloelastase (MME) (EC 3.4.24.65) (Macrophage elastase) (ME) (hME) (Matrix metalloproteinase-12) (MMP-12);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter binding [GO:0001047]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]";"GO:0000122; GO:0001047; GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035313; GO:0043565; GO:0045944; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0098586; GO:1902741; GO:1904645; GO:1904905";"cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter binding [GO:0001047]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp5384784_c0_seq1;GAXK01079576.1;P27080;3.36E-69;ADT_CHLRE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp538563_c2_seq1;GAXK01070968.1;Q9NRA2;4.63E-91;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp53858_c0_seq1;GAXK01111382.1;Q9VUR7;1.28E-53;PHLP_DROME;Phosducin-like protein (PHLP);;;;;
comp5386939_c0_seq1;GAXK01039068.1;P18173;3.56E-25;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp5387142_c0_seq1;GAXK01039062.1;G5ECJ0;1.37E-08;GBR1_CAEEL;Gamma-aminobutyric acid receptor exp-1 (Expulsion defective protein 3) (GABA(A) receptor);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor activity [GO:0016917]; chemical synaptic transmission [GO:0007268]; defecation [GO:0030421]; ion transmembrane transport [GO:0034220]; lipid transport involved in lipid storage [GO:0010877]; nervous system process [GO:0050877]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of muscle contraction [GO:0045933]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]";"GO:0005231; GO:0005887; GO:0006813; GO:0006814; GO:0007165; GO:0007268; GO:0010877; GO:0016917; GO:0030054; GO:0030421; GO:0031594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045933; GO:0050877; GO:0098794; GO:1904731";"chemical synaptic transmission [GO:0007268]; defecation [GO:0030421]; ion transmembrane transport [GO:0034220]; lipid transport involved in lipid storage [GO:0010877]; nervous system process [GO:0050877]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of muscle contraction [GO:0045933]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; synapse [GO:0045202]";"excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor activity [GO:0016917]"
comp5387424_c0_seq1;GAXK01039064.1;Q9VZW5;3.78E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp5387714_c0_seq1;GAXK01039072.1;Q8BJ64;9.24E-51;CHDH_MOUSE;Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005739; GO:0005743; GO:0008812; GO:0019285; GO:0050660";glycine betaine biosynthetic process from choline [GO:0019285];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]"
comp538787_c1_seq1;GAXK01070967.1;Q8INB9;0;AKT1_DROME;RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB);"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006629; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007520; GO:0007525; GO:0007623; GO:0008284; GO:0008286; GO:0008362; GO:0010884; GO:0010897; GO:0018105; GO:0030307; GO:0031104; GO:0032869; GO:0035091; GO:0035206; GO:0035264; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0060292; GO:0090278; GO:1901215; GO:1904262; GO:1904263";"apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp5388571_c0_seq1;GAXK01134197.1;Q580X6;3.00E-07;PIF5_TRYB2;ATP-dependent DNA helicase PIF5 (EC 3.6.4.12) (DNA repair and recombination helicase PIF5);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005730; GO:0005737; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0032508; GO:0033567; GO:0043137; GO:0043139";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; telomere maintenance [GO:0000723]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]"
comp538921_c0_seq1;GAXK01070987.1;Q967D7;6.83E-60;TUTL_DROME;Protein turtle;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632";"adult locomotory behavior [GO:0008344]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp53898_c1_seq1;GAXK01111357.1;Q80U95;0;UBE3C_MOUSE;Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C);"nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005634; GO:0006511; GO:0061631";"protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp53902_c1_seq1;GAXK01111904.1;Q8I190;1.05E-87;SH3G3_DROVI;Endophilin-A (SH3 domain-containing GRB2-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; type I terminal bouton [GO:0061174]; lysophosphatidic acid acyltransferase activity [GO:0042171]; phospholipid binding [GO:0005543]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; membrane bending [GO:0097753]; membrane tubulation [GO:0097749]; plasma membrane tubulation [GO:0097320]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle endocytosis [GO:0048488]";"GO:0000045; GO:0005543; GO:0005737; GO:0005829; GO:0009267; GO:0016020; GO:0042171; GO:0048488; GO:0050803; GO:0061174; GO:0097320; GO:0097749; GO:0097753; GO:0150007";"autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; membrane bending [GO:0097753]; membrane tubulation [GO:0097749]; plasma membrane tubulation [GO:0097320]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle endocytosis [GO:0048488]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; type I terminal bouton [GO:0061174]";"lysophosphatidic acid acyltransferase activity [GO:0042171]; phospholipid binding [GO:0005543]"
comp5391_c3_seq1;GAXK01066047.1;Q9V3H2;0;PSDE_DROME;26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory complex subunit p37B) (26S proteasome regulatory subunit rpn11) (Yippee-interacting protein 5);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; Toll signaling pathway [GO:0008063]";"GO:0000502; GO:0004843; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008237; GO:0008541; GO:0016579; GO:0043161; GO:0046872; GO:0061578; GO:0070628";"circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; Toll signaling pathway [GO:0008063]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]";"Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp5391159_c0_seq1;GAXK01075458.1;Q9BG99;8.45E-16;TREX1_BOVIN;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"GO:0003676; GO:0005634; GO:0005789; GO:0005829; GO:0006259; GO:0007049; GO:0008296; GO:0008408; GO:0008853; GO:0046872";"cell cycle [GO:0007049]; DNA metabolic process [GO:0006259]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp53913_c3_seq1;GAXK01111379.1;A2VDC2;1.11E-113;HIBCH_XENLA;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574";valine catabolic process [GO:0006574];mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp539198_c4_seq1;GAXK01070927.1;Q06518;3.27E-157;NOS2_RAT;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; glycoside metabolic process [GO:0016137]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"GO:0001935; GO:0001974; GO:0003779; GO:0003958; GO:0004517; GO:0005516; GO:0005615; GO:0005634; GO:0005737; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0007165; GO:0007199; GO:0007263; GO:0007568; GO:0008013; GO:0008016; GO:0008217; GO:0008603; GO:0009612; GO:0009725; GO:0010181; GO:0012506; GO:0014823; GO:0016137; GO:0016491; GO:0018119; GO:0019901; GO:0019934; GO:0020037; GO:0031284; GO:0032310; GO:0032355; GO:0032496; GO:0034612; GO:0035556; GO:0035902; GO:0042060; GO:0042742; GO:0042803; GO:0043065; GO:0045296; GO:0045776; GO:0046872; GO:0048384; GO:0048471; GO:0050660; GO:0050661; GO:0050829; GO:0050998; GO:0051879; GO:0071222; GO:0071285; GO:0071305; GO:0071345; GO:0071347; GO:0071356; GO:0071407; GO:0071461; GO:0071548; GO:0072604; GO:0072606; GO:1900015";"aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; glycoside metabolic process [GO:0016137]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"
comp53925_c3_seq1;GAXK01111403.1;P54358;0;DPOD1_DROME;DNA polymerase delta catalytic subunit (EC 2.7.7.7);"delta DNA polymerase complex [GO:0043625]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]";"GO:0000166; GO:0003677; GO:0003887; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539";"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]";delta DNA polymerase complex [GO:0043625];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp539252_c2_seq1;GAXK01070899.1;C9WMM5;4.61E-60;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp5392618_c0_seq1;GAXK01060504.1;F1N152;2.83E-07;HTRA1_BOVIN;Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (Serine protease 11);"cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase activity [GO:0004252]; chorionic trophoblast cell differentiation [GO:0060718]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]";"GO:0001890; GO:0004252; GO:0005520; GO:0005576; GO:0005829; GO:0005886; GO:0030512; GO:0030514; GO:0042802; GO:0060718";"chorionic trophoblast cell differentiation [GO:0060718]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]";"cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase activity [GO:0004252]"
comp5392751_c0_seq1;GAXK01060512.1;P23098;2.12E-18;DYHC_TRIGR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp5392980_c0_seq1;GAXK01060500.1;Q7PEV7;3.74E-15;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp5393_c0_seq1;GAXK01065418.1;Q6NYU7;1.44E-99;UPP_DANRE;Uracil phosphoribosyltransferase homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; nucleoside metabolic process [GO:0009116]";"GO:0005525; GO:0005634; GO:0005737; GO:0009116; GO:0016301";nucleoside metabolic process [GO:0009116];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GTP binding [GO:0005525]; kinase activity [GO:0016301]"
comp53930_c1_seq1;GAXK01111724.1;Q6ZUT9;0;DEN5B_HUMAN;DENN domain-containing protein 5B (Rab6IP1-like protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]";"GO:0005829; GO:0016021; GO:0017112";;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]";Rab guanyl-nucleotide exchange factor activity [GO:0017112]
comp53931_c1_seq1;GAXK01111327.1;Q6ZN16;0;M3K15_HUMAN;Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15);"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]";"GO:0000186; GO:0004672; GO:0004709; GO:0005524; GO:0046872";activation of MAPKK activity [GO:0000186];;"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]"
comp53932_c1_seq1;GAXK01111471.1;Q3UF64;2.12E-61;RNFT2_MOUSE;RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]";"GO:0016021; GO:0046872";;integral component of membrane [GO:0016021];metal ion binding [GO:0046872]
comp5393742_c0_seq1;GAXK01060503.1;Q6JAN1;2.86E-21;INVS_CANLF;Inversin (Inversion of embryo turning protein) (Nephrocystin-2);"cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]";"GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007275; GO:0016020; GO:0016055; GO:0090090";"multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]";calmodulin binding [GO:0005516]
comp5394308_c0_seq1;GAXK01113955.1;O96015;5.64E-12;DNAL4_HUMAN;Dynein light chain 4, axonemal;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0045505; GO:0051959; GO:2000582";"microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp539441_c1_seq1;GAXK01070971.1;Q6X0I2;1.07E-08;VGR_SOLIN;Vitellogenin receptor (SiVgR);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; receptor-mediated endocytosis [GO:0006898]";"GO:0005509; GO:0006898; GO:0016021; GO:0038024";receptor-mediated endocytosis [GO:0006898];integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]"
comp539519_c0_seq1;GAXK01070898.1;Q9CWP6;4.10E-39;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp539565_c0_seq1;GAXK01070880.1;P46197;3.02E-66;ANPRB_BOVIN;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0016941; GO:0017046; GO:0022414; GO:0035556; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp5396026_c0_seq1;GAXK01108420.1;P60039;2.50E-47;RL73_ARATH;60S ribosomal protein L7-3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp539619_c1_seq1;GAXK01071005.1;Q8C8R3;1.38E-23;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp539638_c0_seq1;GAXK01071056.1;Q9Z1D8;2.44E-16;ZKSC5_MOUSE;Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95) (Zfp-95);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp53969_c0_seq1;GAXK01112233.1;Q28EH9;3.04E-42;NEMP1_XENTR;Nuclear envelope integral membrane protein 1;"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; eye development [GO:0001654]";"GO:0001654; GO:0005635; GO:0005637; GO:0016021";eye development [GO:0001654];"integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]";
comp5397_c2_seq1;GAXK01065382.1;Q9V3P6;0;PSMD1_DROME;26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory complex subunit p110) (26S proteasome regulatory subunit RPN2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]";"GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008270; GO:0008540; GO:0030234; GO:0034515; GO:0042176; GO:0043161";"circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]";"enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]"
comp539754_c0_seq1;GAXK01071010.1;Q9VIS1;3.03E-78;CDGAP_DROME;GTPase-activating protein CdGAPr (d-CdGAPr);"GTPase activator activity [GO:0005096]; retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0007264; GO:0031290";"retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";;GTPase activator activity [GO:0005096]
comp539755_c0_seq1;GAXK01071044.1;Q9R0P9;3.14E-11;UCHL1_MOUSE;Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1);"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cell population proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002931; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0007409; GO:0007412; GO:0007628; GO:0008242; GO:0008283; GO:0016579; GO:0016874; GO:0019233; GO:0019896; GO:0030424; GO:0031625; GO:0031694; GO:0042755; GO:0043025; GO:0043130; GO:0043209; GO:0043407; GO:0044306; GO:0048747; GO:0050905; GO:1904115";"adult walking behavior [GO:0007628]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; axon target recognition [GO:0007412]; cell population proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; protein deubiquitination [GO:0016579]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; ubiquitin-dependent protein catabolic process [GO:0006511]";"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
comp5398096_c0_seq1;GAXK01189778.1;P48148;5.85E-78;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp5399_c0_seq1;GAXK01205383.1;O62619;0;KPYK_DROME;Pyruvate kinase (PK) (EC 2.7.1.40);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";"GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006090; GO:0006096; GO:0007520; GO:0007525; GO:0009744; GO:0016301; GO:0030955; GO:0032869; GO:0042593; GO:0043186";"cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]"
comp5399140_c0_seq1;GAXK01189775.1;Q3KR37;9.68E-10;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp54_c0_seq1;GAXK01166113.1;P36241;1.10E-93;RL19_DROME;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5400_c0_seq1;GAXK01065592.1;Q7Z6E9;2.64E-29;RBBP6_HUMAN;E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis);"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001701; GO:0003723; GO:0004842; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]";"protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp540019_c0_seq1;GAXK01204792.1;Q9JIS1;7.04E-65;RIMS2_RAT;Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2);"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]";"GO:0006886; GO:0006887; GO:0010628; GO:0017137; GO:0017156; GO:0017157; GO:0019904; GO:0019933; GO:0030054; GO:0030073; GO:0030154; GO:0032991; GO:0042391; GO:0042734; GO:0044325; GO:0045202; GO:0046872; GO:0046982; GO:0048167; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:2000300; GO:2000463";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]";"cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]";"ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]"
comp54003_c2_seq1;GAXK01096209.1;Q5RH01;2.24E-46;CNDH2_DANRE;Condensin-2 complex subunit H2 (Non-SMC condensin II complex subunit H2);"condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromosome organization [GO:0051276]; meiotic chromosome condensation [GO:0010032]; mitotic sister chromatid separation [GO:0051306]";"GO:0000793; GO:0000796; GO:0003682; GO:0005634; GO:0010032; GO:0051276; GO:0051306";"chromosome organization [GO:0051276]; meiotic chromosome condensation [GO:0010032]; mitotic sister chromatid separation [GO:0051306]";"condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp5400417_c0_seq1;GAXK01203026.1;P53421;1.49E-27;HSP71_PICAN;Heat shock protein 70 1 (HSP72);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737";;cytoplasm [GO:0005737];ATP binding [GO:0005524]
comp5400938_c0_seq1;GAXK01203022.1;Q5NCI0;5.04E-11;URGCP_MOUSE;Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein homolog) (HBxAg up-regulated gene 4 protein homolog);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049]";"GO:0005525; GO:0005634; GO:0005829; GO:0007049";cell cycle [GO:0007049];"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp540097_c0_seq1;GAXK01007855.1;P80109;2.19E-128;PHLD_BOVIN;Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]";"GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0005615; GO:0005737; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0034364; GO:0035690; GO:0035774; GO:0043065; GO:0043231; GO:0045919; GO:0046470; GO:0051044; GO:0051047; GO:0070633; GO:0071277; GO:0071397; GO:0071401; GO:0071467; GO:1900076";"cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]";"glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]"
comp5400971_c0_seq1;GAXK01203034.1;P04323;4.36E-10;POL3_DROME;"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5401026_c0_seq1;GAXK01203029.1;Q7Z2Y8;2.33E-20;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp5401468_c0_seq1;GAXK01203027.1;Q9ASR1;1.05E-88;EF2_ARATH;Elongation factor 2 (EF-2) (Protein LOW EXPRESSION OF OSMOTICALLY RESPONSIVE GENES 1);"chloroplast [GO:0009507]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribonucleoprotein complex [GO:1990904]; vacuolar membrane [GO:0005774]; copper ion binding [GO:0005507]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; cold acclimation [GO:0009631]; response to cold [GO:0009409]; translational elongation [GO:0006414]";"GO:0003729; GO:0003746; GO:0003924; GO:0005507; GO:0005525; GO:0005634; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006414; GO:0009409; GO:0009506; GO:0009507; GO:0009631; GO:0043022; GO:1990904";"cold acclimation [GO:0009631]; response to cold [GO:0009409]; translational elongation [GO:0006414]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribonucleoprotein complex [GO:1990904]; vacuolar membrane [GO:0005774]";"copper ion binding [GO:0005507]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp5401861_c0_seq1;GAXK01203030.1;Q9XTR1;1.84E-14;CDK4_CAEEL;Cyclin-dependent kinase 4 homolog (CDK4/6) (EC 2.7.11.22) (Cell division protein kinase 4);"nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";"GO:0002119; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007530; GO:0008584; GO:0009791; GO:0018105; GO:0018107; GO:0032877; GO:0040035; GO:0044843; GO:0046872; GO:0051301; GO:0090727; GO:1900087";"cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; hermaphrodite genitalia development [GO:0040035]; male gonad development [GO:0008584]; nematode larval development [GO:0002119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of brood size [GO:0090727]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; sex determination [GO:0007530]";nucleus [GO:0005634];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp5402675_c0_seq1;GAXK01077009.1;A5ULM5;1.12E-18;EF1A_METS3;Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp5403266_c0_seq1;GAXK01077000.1;Q0VGE8;7.91E-10;ZN816_HUMAN;Zinc finger protein 816;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5403364_c0_seq1;GAXK01077012.1;P25600;2.25E-10;YCH4_YEAST;Putative transposon Ty5-1 protein YCL074W;"retrotransposon nucleocapsid [GO:0000943]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003723; GO:0003887; GO:0003964; GO:0004540; GO:0008233; GO:0032197";transposition, RNA-mediated [GO:0032197];retrotransposon nucleocapsid [GO:0000943];"DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5405523_c0_seq1;GAXK01059965.1;Q6QAT0;1.98E-53;RL32_PIG;60S ribosomal protein L32;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0098556";translation [GO:0006412];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp540682_c0_seq1;GAXK01007842.1;P49660;7.03E-18;SSR4_MOUSE;Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R);"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0004930; GO:0004994; GO:0005737; GO:0005886; GO:0005887; GO:0007218; GO:0016477; GO:0042277; GO:0070374; GO:0071385; GO:0090238; GO:0106072";"cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]"
comp5407005_c0_seq1;GAXK01155983.1;P51413;2.05E-49;RL172_ARATH;60S ribosomal protein L17-2;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005730; GO:0005739; GO:0005773; GO:0009506; GO:0022625; GO:0022626; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp540702_c0_seq1;GAXK01007832.1;Q16181;5.34E-120;SEPT7_HUMAN;Septin-7 (CDC10 protein homolog);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]";"cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp540780_c0_seq1;GAXK01007864.1;A6NN14;1.54E-20;ZN729_HUMAN;Zinc finger protein 729;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5407867_c0_seq1;GAXK01155986.1;Q95L11;4.12E-09;KCNB2_RABIT;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]"
comp540850_c0_seq1;GAXK01007827.1;Q24174;7.75E-07;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp54088_c0_seq1;GAXK01096146.1;Q9VJE5;7.01E-28;CL190_DROME;Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190);"axon [GO:0030424]; axonal growth cone [GO:0044295]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]";"GO:0000776; GO:0003779; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854";cellularization [GO:0007349];"axon [GO:0030424]; axonal growth cone [GO:0044295]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]";"actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]"
comp540898_c1_seq1;GAXK01007825.1;Q6YAT4;9.86E-18;SGCE_RAT;Epsilon-sarcoglycan (Epsilon-SG);"cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; brain development [GO:0007420]; kidney development [GO:0001822]; skeletal muscle tissue development [GO:0007519]";"GO:0001822; GO:0005794; GO:0005856; GO:0005886; GO:0007420; GO:0007519; GO:0016012; GO:0016021; GO:0032590; GO:0042383";"brain development [GO:0007420]; kidney development [GO:0001822]; skeletal muscle tissue development [GO:0007519]";"cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]";
comp5409_c0_seq1;GAXK01065834.1;Q9D7P6;1.73E-75;ISCU_MOUSE;Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]";"GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0051537; GO:0051539; GO:0060090; GO:1902958; GO:1904234; GO:1904439";"cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; molecular adaptor activity [GO:0060090]"
comp54093_c0_seq1;GAXK01096993.1;Q13625;1.73E-63;ASPP2_HUMAN;Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"GO:0002039; GO:0005070; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007165; GO:0017124; GO:0030054; GO:0042802; GO:0042981; GO:0045786; GO:0048471; GO:0051059; GO:0072332; GO:1900119; GO:1900740; GO:1901216; GO:1901796";"cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3/SH2 adaptor activity [GO:0005070]; SH3 domain binding [GO:0017124]"
comp54094_c0_seq1;GAXK01096219.1;P61922;3.67E-168;GABT_MOUSE;4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT);"4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]";"GO:0001666; GO:0003867; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042493; GO:0042803; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450";"aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]";"4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]";"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; 4-aminobutyrate transaminase activity [GO:0003867]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]"
comp54100_c3_seq1;GAXK01096223.1;Q6P0Q8;0;MAST2_HUMAN;Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1);"cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 biosynthetic process [GO:0045075]; spermatid differentiation [GO:0048515]";"GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0035556; GO:0045075; GO:0048515";"cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 biosynthetic process [GO:0045075]; spermatid differentiation [GO:0048515]";"cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]"
comp5410204_c0_seq1;GAXK01186752.1;P59271;4.91E-31;R27AA_ARATH;"Ubiquitin-40S ribosomal protein S27a-1 [Cleaved into: Ubiquitin; 40S ribosomal protein S27a-1]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0016567; GO:0019941; GO:0022627; GO:0031386; GO:0031625; GO:0046872";"modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]"
comp5410254_c0_seq1;GAXK01186763.1;Q5AR49;1.23E-10;ASQF_EMENI;FAD-linked oxidoreductase asqF (EC 1.-.-.-) (4'-methoxyviridicatin/aspoquinolone biosynthesis cluster protein asqF) (Aspoquinolone biosynthesis protein F);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0071949";;;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp54104_c1_seq1;GAXK01096133.1;Q29449;0;AT8A1_BOVIN;Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II);"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0042584; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp5410446_c0_seq1;GAXK01186751.1;Q8NFD2;3.39E-13;ANKK1_HUMAN;Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995";regulation of cell cycle process [GO:0010564];"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp5410486_c0_seq1;GAXK01186746.1;P61314;1.35E-48;RL15_RAT;60S ribosomal protein L15;"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]";"GO:0002181; GO:0003723; GO:0003735; GO:0016020; GO:0022625; GO:0031672; GO:0045471";"cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]";"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5410545_c0_seq1;GAXK01186745.1;O61370;2.47E-07;NACH_DROAN;Sodium channel protein Nach;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp5410722_c0_seq1;GAXK01186755.1;P97353;3.06E-14;SEC1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp541077_c0_seq1;GAXK01007845.1;Q67W82;1.03E-95;4CL4_ORYSJ;Probable 4-coumarate--CoA ligase 4 (4CL 4) (Os4CL4) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 4);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp54108_c0_seq1;GAXK01096926.1;B2GV06;0;SCOT1_RAT;Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]";"GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042803; GO:0045471; GO:0046950; GO:0046952; GO:0060612";"adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]"
comp541083_c3_seq1;GAXK01007822.1;P18459;2.80E-149;TY3H_DROME;Tyrosine 3-monooxygenase (EC 1.14.16.2) (Protein Pale) (Tyrosine 3-hydroxylase) (TH);"axon [GO:0030424]; cytoplasm [GO:0005737]; perikaryon [GO:0043204]; iron ion binding [GO:0005506]; tyrosine 3-monooxygenase activity [GO:0004511]; adult chitin-containing cuticle pigmentation [GO:0048085]; adult locomotory behavior [GO:0008344]; catecholamine metabolic process [GO:0006584]; courtship behavior [GO:0007619]; cuticle pigmentation [GO:0048067]; developmental pigmentation [GO:0048066]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; dopamine metabolic process [GO:0042417]; male courtship behavior [GO:0008049]; neurotransmitter biosynthetic process [GO:0042136]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; wing disc development [GO:0035220]";"GO:0004511; GO:0005506; GO:0005737; GO:0006584; GO:0006585; GO:0007619; GO:0008049; GO:0008344; GO:0009611; GO:0030424; GO:0035220; GO:0040040; GO:0042136; GO:0042416; GO:0042417; GO:0042542; GO:0043052; GO:0043204; GO:0048066; GO:0048067; GO:0048082; GO:0048085; GO:2000274";"adult chitin-containing cuticle pigmentation [GO:0048085]; adult locomotory behavior [GO:0008344]; catecholamine metabolic process [GO:0006584]; courtship behavior [GO:0007619]; cuticle pigmentation [GO:0048067]; developmental pigmentation [GO:0048066]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; dopamine metabolic process [GO:0042417]; male courtship behavior [GO:0008049]; neurotransmitter biosynthetic process [GO:0042136]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; wing disc development [GO:0035220]";"axon [GO:0030424]; cytoplasm [GO:0005737]; perikaryon [GO:0043204]";"iron ion binding [GO:0005506]; tyrosine 3-monooxygenase activity [GO:0004511]"
comp541104_c0_seq1;GAXK01007824.1;O76082;4.50E-43;S22A5_HUMAN;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0005886; GO:0006814; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0015893; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0052106; GO:0060731; GO:0070062; GO:0070715; GO:1902603";"carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp541187_c0_seq1;GAXK01007898.1;Q13905;6.84E-123;RPGF1_HUMAN;Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0000186; GO:0001568; GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0007169; GO:0010976; GO:0017034; GO:0017124; GO:0019221; GO:0030670; GO:0032486; GO:0032991; GO:0038180; GO:0043547; GO:0046328; GO:0046579; GO:0046580; GO:0048008; GO:0048471; GO:0051898; GO:0061028; GO:0070373; GO:0070374; GO:0071320; GO:0090090; GO:0090630; GO:0098609; GO:1901888; GO:1905451; GO:1990090; GO:2000178";"activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]";"guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]"
comp541220_c1_seq1;GAXK01007916.1;Q00771;3.04E-18;KCC1A_EMENI;Calcium/calmodulin-dependent protein kinase cmkA (CMPK) (EC 2.7.11.17) (Multifunctional calcium/calmodulin-dependent protein kinase) (ACMPK) (CaMK);"cytosol [GO:0005829]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; cell division [GO:0051301]; cellular response to oxidative stress [GO:0034599]; G2/M transition of mitotic cell cycle [GO:0000086]; protein phosphorylation [GO:0006468]";"GO:0000086; GO:0004683; GO:0005516; GO:0005524; GO:0005829; GO:0006468; GO:0034599; GO:0051301";"cell division [GO:0051301]; cellular response to oxidative stress [GO:0034599]; G2/M transition of mitotic cell cycle [GO:0000086]; protein phosphorylation [GO:0006468]";cytosol [GO:0005829];"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp541275_c1_seq1;GAXK01007886.1;P52746;1.96E-11;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp541291_c0_seq1;GAXK01007903.1;P11584;1.16E-09;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp54139_c0_seq1;GAXK01096643.1;Q90YY5;1.15E-15;MED26_XENLA;Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp541454_c0_seq1;GAXK01007830.1;A6NHC0;6.82E-73;CAN8_HUMAN;Calpain-8 (EC 3.4.22.53) (New calpain 2) (nCL-2) (Stomach-specific M-type calpain);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0005794; GO:0006508; GO:0007586";"digestion [GO:0007586]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp54146_c2_seq1;GAXK01096916.1;Q7SXV9;1.26E-86;CALUB_DANRE;Calumenin-B;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";calcium ion binding [GO:0005509]
comp541507_c0_seq1;GAXK01007913.1;Q9VAC5;7.09E-144;ADA17_DROME;ADAM 17-like protease (EC 3.4.24.-);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";"GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp541519_c0_seq1;GAXK01007858.1;P17789;6.24E-30;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp541535_c1_seq1;GAXK01007897.1;Q9H9D4;1.11E-11;ZN408_HUMAN;Zinc finger protein 408 (PR domain zinc finger protein 17);"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0042802; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp54155_c0_seq1;GAXK01096231.1;P11420;5.71E-34;DA_DROME;Protein daughterless;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0061101; GO:0061382";"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp541565_c0_seq1;GAXK01007810.1;Q7A742;1.95E-11;ADH_STAAN;Alcohol dehydrogenase (ADH) (EC 1.1.1.1);"alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270]";"GO:0004022; GO:0008270";;;"alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270]"
comp5416137_c0_seq1;GAXK01045279.1;Q9PYY5;3.47E-19;CATV_GVXN;Viral cathepsin (V-cath) (EC 3.4.22.50) (Cysteine proteinase) (CP);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp541615_c1_seq1;GAXK01007871.1;Q6VVW5;4.12E-55;ANPRB_MOUSE;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp5417054_c0_seq1;GAXK01045276.1;Q86WZ6;3.73E-12;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp541742_c0_seq1;GAXK01007862.1;A1L0Y2;0;NEUL4_XENTR;Neuralized-like protein 4;"centriole [GO:0005814]; ubiquitin protein ligase activity [GO:0061630]";"GO:0005814; GO:0061630";;centriole [GO:0005814];ubiquitin protein ligase activity [GO:0061630]
comp5418060_c0_seq1;GAXK01042872.1;Q7T3Q7;2.75E-16;OPSO_RUTRU;Opsin-VA (Vertebrate ancient opsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0004930; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp5418314_c0_seq1;GAXK01042871.1;Q9M2A0;7.00E-58;PMA8_ARATH;ATPase 8, plasma membrane-type (EC 7.1.2.1) (Proton pump 8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"GO:0005524; GO:0005886; GO:0008553; GO:0016021; GO:0046872; GO:0051453; GO:0120029; GO:1902600";"proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp54192_c3_seq1;GAXK01096372.1;P16671;2.54E-35;CD36_HUMAN;Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; amyloid-beta binding [GO:0001540]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid receptor activity [GO:0070892]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431]; amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipoprotein transport [GO:0042953]; long-chain fatty acid import into cell [GO:0044539]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neutrophil degranulation [GO:0043312]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; platelet degranulation [GO:0002576]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; production of molecular mediator involved in inflammatory response [GO:0002532]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of lipid metabolic process [GO:0019216]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein heterodimerization activity [GO:0043497]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; triglyceride transport [GO:0034197]";"GO:0000122; GO:0001540; GO:0001954; GO:0002224; GO:0002479; GO:0002532; GO:0002576; GO:0002755; GO:0005041; GO:0005044; GO:0005615; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006629; GO:0006631; GO:0006898; GO:0006910; GO:0006911; GO:0007155; GO:0007204; GO:0007263; GO:0007596; GO:0008035; GO:0008289; GO:0009897; GO:0009986; GO:0010628; GO:0010744; GO:0010886; GO:0010942; GO:0016020; GO:0016324; GO:0019216; GO:0019221; GO:0019915; GO:0019934; GO:0030169; GO:0030194; GO:0030299; GO:0030301; GO:0030666; GO:0031092; GO:0031526; GO:0031623; GO:0031664; GO:0032735; GO:0032755; GO:0032760; GO:0033993; GO:0034121; GO:0034197; GO:0034381; GO:0034383; GO:0035325; GO:0035579; GO:0035634; GO:0038124; GO:0042308; GO:0042953; GO:0043123; GO:0043235; GO:0043277; GO:0043312; GO:0043497; GO:0044539; GO:0044877; GO:0045121; GO:0045335; GO:0045429; GO:0050431; GO:0050702; GO:0050731; GO:0050830; GO:0050892; GO:0050909; GO:0051092; GO:0055096; GO:0060100; GO:0060907; GO:0070053; GO:0070374; GO:0070508; GO:0070542; GO:0070543; GO:0070892; GO:0071222; GO:0071223; GO:0071404; GO:0071447; GO:0071726; GO:0071813; GO:0097009; GO:0098900; GO:0120162; GO:0140052; GO:0150024; GO:0150025; GO:0150094; GO:1900227; GO:1903428; GO:1904646; GO:1990000; GO:2000121; GO:2000334";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid fibril formation [GO:1990000]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipoprotein transport [GO:0042953]; long-chain fatty acid import into cell [GO:0044539]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neutrophil degranulation [GO:0043312]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; platelet degranulation [GO:0002576]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; production of molecular mediator involved in inflammatory response [GO:0002532]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of lipid metabolic process [GO:0019216]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein heterodimerization activity [GO:0043497]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; triglyceride transport [GO:0034197]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]";"amyloid-beta binding [GO:0001540]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid receptor activity [GO:0070892]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431]"
comp5419337_c0_seq1;GAXK01042878.1;P35064;1.24E-38;H2AX_TETTS;Histone H2AX (Histone H2A.1) (H2A1) (Histone H2A.X);"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp54199_c0_seq1;GAXK01096341.1;Q8K354;5.46E-43;CBR3_MOUSE;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]";"GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0042376; GO:0050890; GO:0070402";"cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]"
comp5420057_c0_seq1;GAXK01077749.1;Q502K3;2.63E-15;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp542074_c0_seq1;GAXK01062997.1;Q54F46;7.77E-14;WARA_DICDI;Homeobox protein Wariai (Homeobox protein 1) (DdHbx-1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; negative regulation of sorocarp stalk cell differentiation [GO:0031286]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0009653; GO:0031286; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; negative regulation of sorocarp stalk cell differentiation [GO:0031286]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp5421496_c0_seq1;GAXK01077755.1;A2RRD8;1.03E-12;ZN320_HUMAN;Zinc finger protein 320;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5421675_c0_seq1;GAXK01077756.1;Q3KQ77;2.14E-27;EFCB1_XENLA;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp5422113_c0_seq1;GAXK01162932.1;P15387;2.06E-21;KCNB1_RAT;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp54227_c1_seq1;GAXK01096301.1;Q8IX12;3.79E-24;CCAR1_HUMAN;Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000398; GO:0000980; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0048471";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp542281_c4_seq1;GAXK01063006.1;E6ZHJ8;4.35E-26;FXL15_DICLA;F-box/LRR-repeat protein 15;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0000086; GO:0005737; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp5423224_c0_seq1;GAXK01162922.1;Q9MBF8;2.44E-31;DYH1B_CHLRE;Dynein-1-beta heavy chain, flagellar inner arm I1 complex (1-beta DHC) (Dynein-1, subspecies f);"axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008017; GO:0031514; GO:0036156; GO:0036159; GO:0060294";"cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp54235_c6_seq1;GAXK01096624.1;P17032;2.25E-07;ZN37A_HUMAN;Zinc finger protein 37A (Zinc finger protein KOX21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp5423780_c0_seq1;GAXK01162924.1;Q69L99;2.34E-10;LAC14_ORYSJ;Laccase-14 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 14) (Diphenol oxidase 14) (Urishiol oxidase 14);"apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]";"GO:0005507; GO:0046274; GO:0048046; GO:0052716";lignin catabolic process [GO:0046274];apoplast [GO:0048046];"copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]"
comp5425145_c0_seq1;GAXK01159300.1;Q86XW9;1.38E-15;TXND6_HUMAN;Thioredoxin domain-containing protein 6 (Thioredoxin-like protein 2) (Txl-2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoside diphosphate kinase activity [GO:0004550]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"GO:0004550; GO:0005737; GO:0005856; GO:0006183; GO:0006228; GO:0006241; GO:0045454";"cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";nucleoside diphosphate kinase activity [GO:0004550]
comp542595_c1_seq1;GAXK01062977.1;P10733;8.02E-57;SEVE_DICDI;Severin;"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"GO:0015629; GO:0030043; GO:0045335; GO:0048306; GO:0051014; GO:0051015; GO:0051693";"actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]";"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]"
comp54267_c0_seq1;GAXK01096220.1;Q9CPY6;1.35E-117;GID4_MOUSE;Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog);"ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000151; GO:0043161; GO:0061630";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];ubiquitin ligase complex [GO:0000151];ubiquitin protein ligase activity [GO:0061630]
comp542719_c0_seq1;GAXK01063011.1;Q96IV6;1.91E-35;FXDC2_HUMAN;Fatty acid hydroxylase domain-containing protein 2;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; sterol biosynthetic process [GO:0016126]";"GO:0000254; GO:0005506; GO:0005789; GO:0016021; GO:0016126";sterol biosynthetic process [GO:0016126];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]"
comp54272_c11_seq1;GAXK01096901.1;P46060;8.49E-102;RAGP1_HUMAN;Ran GTPase-activating protein 1 (RanGAP1);"aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"GO:0000777; GO:0003723; GO:0005096; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008536; GO:0016235; GO:0016925; GO:0030425; GO:0031625; GO:0031965; GO:0043231; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0072686; GO:0090630; GO:1904115; GO:1904117; GO:1990723";"activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]";"cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]"
comp542744_c0_seq1;GAXK01062985.1;Q80W31;1.24E-19;ZN569_MOUSE;Zinc finger protein 569 (Mszf21) (Zinc finger protein 74) (Zfp-74);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5427781_c0_seq1;GAXK01052887.1;Q9VW60;5.34E-07;ADCY2_DROME;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E);"integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";"GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0040015; GO:0042594; GO:0046872";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]";integral component of plasma membrane [GO:0005887];"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp5428039_c0_seq1;GAXK01088873.1;P25204;1.13E-80;RS8_LEIMA;40S ribosomal protein S8;"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"GO:0000462; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0022627";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp5428219_c0_seq1;GAXK01088880.1;A7S3J7;3.35E-28;RS3A_NEMVE;40S ribosomal protein S3a;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp5428959_c0_seq1;GAXK01088877.1;Q95V58;5.26E-36;KARG_ARTSF;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp54299_c0_seq1;GAXK01096985.1;Q16RX1;8.40E-38;MED21_AEDAE;Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21);mediator complex [GO:0016592];GO:0016592;;mediator complex [GO:0016592];
comp5430200_c0_seq1;GAXK01177309.1;Q8I6K0;5.50E-14;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp543036_c1_seq1;GAXK01062955.1;B7Z0W9;8.76E-21;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp5430673_c0_seq1;GAXK01177310.1;Q0KHU5;1.86E-33;PCAT_DROME;Lysophosphatidylcholine acyltransferase (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (Acyltransferase-like 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0008654; GO:0016021; GO:0030258; GO:0047184; GO:0071617";"lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]"
comp543075_c0_seq1;GAXK01063007.1;Q5RFU0;1.00E-79;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp543121_c1_seq1;GAXK01062978.1;Q2M3R5;2.76E-44;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp543205_c0_seq1;GAXK01062960.1;P21521;4.33E-128;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp543214_c0_seq1;GAXK01063031.1;Q9V410;2.58E-18;LZTR1_DROME;Leucine-zipper-like transcriptional regulator 1 homolog;"Golgi apparatus [GO:0005794]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]";"GO:0005794; GO:0016567; GO:0046580";"negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]";Golgi apparatus [GO:0005794];
comp543229_c0_seq1;GAXK01063014.1;Q66HG4;3.33E-78;GALM_RAT;Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase);"cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";"GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499";"galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";cytoplasm [GO:0005737];"aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]"
comp543251_c2_seq1;GAXK01062966.1;Q9GRW0;2.05E-66;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp5432532_c0_seq1;GAXK01185113.1;Q9SZR0;2.16E-27;CHMO_ARATH;Choline monooxygenase, chloroplastic (EC 1.14.15.7);"chloroplast stroma [GO:0009570]; 2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]; glycine betaine biosynthetic process from choline [GO:0019285]";"GO:0005506; GO:0009570; GO:0019133; GO:0019285; GO:0051537";glycine betaine biosynthetic process from choline [GO:0019285];chloroplast stroma [GO:0009570];"2 iron, 2 sulfur cluster binding [GO:0051537]; choline monooxygenase activity [GO:0019133]; iron ion binding [GO:0005506]"
comp543271_c0_seq1;GAXK01063019.1;Q7RTX9;3.96E-38;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp54333_c6_seq1;GAXK01096929.1;Q14008;0;CKAP5_HUMAN;Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG);"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]";"GO:0000086; GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007098; GO:0010389; GO:0016020; GO:0030951; GO:0032991; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0097711";"cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]";"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]";"cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]"
comp54351_c1_seq1;GAXK01096616.1;Q5WA76;1.02E-07;PUB70_ORYSJ;"U-box domain-containing protein 70 (OsPUB70) (Plant U-box protein 70) (Receptor-like cytoplasmic kinase 197) (OsRLCK197) [Includes: E3 ubiquitin ligase (EC 2.3.2.27) (RING-type E3 ubiquitin transferase); Serine/threonine-protein kinase (EC 2.7.11.-)]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin-protein transferase activity [GO:0004842]";"GO:0004674; GO:0004842; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin-protein transferase activity [GO:0004842]"
comp5435220_c0_seq1;GAXK01175023.1;P69104;4.46E-50;GBLP_TRYBR;Guanine nucleotide-binding protein subunit beta-like protein (Activated protein kinase C receptor homolog) (Track);ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp54367_c0_seq1;GAXK01096207.1;D3ZSI8;9.68E-115;PI51A_RAT;Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha);"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"GO:0005524; GO:0005829; GO:0005847; GO:0006661; GO:0010761; GO:0016308; GO:0016607; GO:0019900; GO:0030027; GO:0031532; GO:0032587; GO:0048041; GO:0060326; GO:0072659; GO:0090630; GO:0097178";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]"
comp5437167_c0_seq1;GAXK01148130.1;Q9N289;4.25E-10;A4GAT_PONPY;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase) (Fragment);"Golgi membrane [GO:0000139]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; lipid metabolic process [GO:0006629]";"GO:0000139; GO:0006629; GO:0050512";lipid metabolic process [GO:0006629];Golgi membrane [GO:0000139];lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]
comp5437242_c0_seq1;GAXK01148126.1;Q6PHZ8;4.86E-13;KCIP4_MOUSE;Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0030425; GO:0043025; GO:0072659; GO:1901379";"protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp543747_c0_seq1;GAXK01063005.1;P55115;4.30E-69;NAS15_CAEEL;Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp5437724_c0_seq1;GAXK01148121.1;Q99MD8;2.04E-07;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5440498_c0_seq1;GAXK01174467.1;Q2HFP1;5.01E-47;IF4A_CHAGB;ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]";"GO:0003724; GO:0003743; GO:0005524; GO:0005737";;cytoplasm [GO:0005737];"ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp5440641_c0_seq1;GAXK01174469.1;Q3URR7;1.23E-11;ZSC10_MOUSE;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863";"negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp5440889_c0_seq1;GAXK01174459.1;Q80TT8;1.89E-11;CUL9_MOUSE;Cullin-9 (CUL-9) (p53-associated parkin-like cytoplasmic protein);"cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000226; GO:0005524; GO:0005829; GO:0006511; GO:0007088; GO:0016567; GO:0016740; GO:0031461; GO:0031625; GO:0046872";"microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]"
comp544150_c0_seq1;GAXK01153355.1;P12955;6.59E-165;PEPD_HUMAN;Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase);"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]";"GO:0004177; GO:0004181; GO:0005634; GO:0005654; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009";"cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]"
comp5442128_c0_seq1;GAXK01063240.1;P58308;1.03E-09;OX2R_MOUSE;Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2);"integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0051480";"circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";integral component of plasma membrane [GO:0005887];"G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]"
comp544252_c0_seq1;GAXK01153373.1;Q51330;7.22E-11;OXLT_OXAFO;Oxalate:formate antiporter (OFA) (Oxalate:formate antiport protein) (Oxalate:formate exchange protein);"integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]";"GO:0005887; GO:0015297; GO:0019531";;integral component of plasma membrane [GO:0005887];"antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]"
comp5442867_c0_seq1;GAXK01063234.1;Q2EI21;1.66E-10;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp544308_c0_seq1;GAXK01153303.1;O70596;1.76E-12;KCJ14_RAT;ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4) (IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0016021; GO:0030425; GO:0034765; GO:0043025; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";inward rectifier potassium channel activity [GO:0005242]
comp544315_c0_seq1;GAXK01153432.1;Q6DHC1;7.11E-53;RB18B_DANRE;Ras-related protein Rab-18-B;"Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";"GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007420; GO:0032482; GO:0034389; GO:0043009";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; Rab protein signal transduction [GO:0032482]";Golgi apparatus [GO:0005794];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5443219_c0_seq1;GAXK01063232.1;Q9VZW5;5.69E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp544556_c0_seq1;GAXK01153383.1;A9ZSY2;1.78E-49;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp544614_c0_seq1;GAXK01153442.1;D3YXG0;5.24E-20;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp544708_c0_seq1;GAXK01153311.1;Q9D1G1;1.93E-47;RAB1B_MOUSE;Ras-related protein Rab-1B;"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site membrane [GO:0034045]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; Rab protein signal transduction [GO:0032482]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068]";"GO:0000139; GO:0003924; GO:0005525; GO:0005739; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006914; GO:0019068; GO:0032482; GO:0034045; GO:0045202; GO:0048471; GO:1903020; GO:2000785";"autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; Rab protein signal transduction [GO:0032482]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068]";"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site membrane [GO:0034045]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp54474_c0_seq1;GAXK01096878.1;Q9ER00;6.49E-54;STX12_MOUSE;Syntaxin-12;"BLOC-1 complex [GO:0031083]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0016189; GO:0030285; GO:0031083; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038; GO:0098837";"autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"BLOC-1 complex [GO:0031083]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp54480_c0_seq1;GAXK01096433.1;P32138;5.55E-172;SQASE_ECOLI;Sulfoquinovosidase (SQase) (EC 3.2.1.199);"carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929]; 6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929";"6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]";;"carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929]"
comp544807_c0_seq1;GAXK01153364.1;O97341;1.70E-50;CALM_SUBDO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp5448126_c0_seq1;GAXK01046591.1;A2VDP4;2.33E-43;ZN567_BOVIN;Zinc finger protein 567;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5448304_c0_seq1;GAXK01046600.1;Q54KA7;5.59E-08;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp54489_c0_seq1;GAXK01096979.1;Q5PQ71;3.82E-64;ISOC2_XENLA;Isochorismatase domain-containing protein 2;catalytic activity [GO:0003824];GO:0003824;;;catalytic activity [GO:0003824]
comp545_c1_seq1;GAXK01166607.1;Q9Z2E1;1.10E-32;MBD2_MOUSE;Methyl-CpG-binding domain protein 2 (Methyl-CpG-binding protein MBD2);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; siRNA binding [GO:0035197]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"GO:0000118; GO:0000122; GO:0000785; GO:0000790; GO:0000792; GO:0003677; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0034622; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0044030; GO:0048568; GO:0070742; GO:0071407";"aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; siRNA binding [GO:0035197]"
comp5450996_c0_seq1;GAXK01070192.1;P27482;2.53E-08;CALL3_HUMAN;Calmodulin-like protein 3 (CaM-like protein) (CLP) (Calmodulin-related protein NB-1);"extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0070062";calcium-mediated signaling [GO:0019722];extracellular exosome [GO:0070062];calcium ion binding [GO:0005509]
comp5451316_c0_seq1;GAXK01070199.1;Q56FH2;4.24E-71;RS4_LYSTE;40S ribosomal protein S4;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp545187_c0_seq1;GAXK01153347.1;P10925;3.72E-12;ZFY1_MOUSE;Zinc finger Y-chromosomal protein 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5452_c3_seq1;GAXK01065387.1;Q9EPF3;2.02E-15;CRYAB_SPAJD;Alpha-crystallin B chain (Alpha(B)-crystallin);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005212; GO:0005634; GO:0005737; GO:0032991; GO:0042803; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]"
comp5452106_c0_seq1;GAXK01204719.1;A2A935;7.49E-11;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp54525_c1_seq1;GAXK01096720.1;P91953;3.41E-41;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp54527_c0_seq1;GAXK01096082.1;Q64512;1.35E-14;PTN13_MOUSE;Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP);"cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0001933; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0030496; GO:0035335; GO:0036312; GO:0043005; GO:0044297";"negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]"
comp545310_c0_seq1;GAXK01153316.1;P91645;0;CAC1A_DROME;Voltage-dependent calcium channel type A subunit alpha-1 (Protein cacophony) (Protein nightblind A) (Protein no-on-transient B) (Dmca1A);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; adult locomotory behavior [GO:0008344]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; detection of light stimulus involved in visual perception [GO:0050908]; epithelial fluid transport [GO:0042045]; exocytosis [GO:0006887]; male courtship behavior, veined wing generated song production [GO:0045433]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neurotransmitter secretion [GO:0007269]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of neurotransmitter secretion [GO:0046928]; visual behavior [GO:0007632]";"GO:0002027; GO:0005245; GO:0005509; GO:0005891; GO:0006816; GO:0006887; GO:0006914; GO:0007268; GO:0007269; GO:0007602; GO:0007619; GO:0007632; GO:0008331; GO:0008332; GO:0008344; GO:0010524; GO:0016057; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0031594; GO:0034765; GO:0042045; GO:0045433; GO:0045887; GO:0046928; GO:0048786; GO:0050908; GO:0070050; GO:0070509; GO:0070588; GO:0097352";"adult locomotory behavior [GO:0008344]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; detection of light stimulus involved in visual perception [GO:0050908]; epithelial fluid transport [GO:0042045]; exocytosis [GO:0006887]; male courtship behavior, veined wing generated song production [GO:0045433]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neurotransmitter secretion [GO:0007269]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of neurotransmitter secretion [GO:0046928]; visual behavior [GO:0007632]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; voltage-gated calcium channel complex [GO:0005891]";"calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]"
comp54535_c3_seq1;GAXK01096081.1;P91875;0;RPA1_DROME;DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A);"RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]";"GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0008270";transcription by RNA polymerase I [GO:0006360];RNA polymerase I complex [GO:0005736];"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]"
comp545353_c0_seq1;GAXK01153312.1;O83142;2.29E-10;5NTD_TREPA;Probable 5'-nucleotidase (EC 3.1.3.5);"plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005886; GO:0008253; GO:0009166; GO:0046872";nucleotide catabolic process [GO:0009166];plasma membrane [GO:0005886];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp545408_c1_seq1;GAXK01153380.1;Q94IR2;1.55E-48;CCD1_PHAVU;Carotenoid 9,10(9',10')-cleavage dioxygenase 1 (EC 1.14.99.n4) (Neoxanthin cleavage enzyme NC2) (PvCCD1) (PvNCED2);"Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; 9-cis-epoxycarotenoid dioxygenase activity [GO:0045549]; metal ion binding [GO:0046872]; carotene catabolic process [GO:0016121]; xanthophyll catabolic process [GO:0016124]";"GO:0005774; GO:0005794; GO:0005886; GO:0009506; GO:0016121; GO:0016124; GO:0045549; GO:0046872";"carotene catabolic process [GO:0016121]; xanthophyll catabolic process [GO:0016124]";"Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]";"9-cis-epoxycarotenoid dioxygenase activity [GO:0045549]; metal ion binding [GO:0046872]"
comp545445_c0_seq1;GAXK01153404.1;Q63406;2.36E-44;MCF2L_RAT;Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene);"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"GO:0005089; GO:0005737; GO:0005886; GO:0008289; GO:0019898; GO:0035025; GO:0035556";"intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]";"lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp545588_c0_seq1;GAXK01153301.1;Q6AXN3;3.49E-12;TMED5_RAT;Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2);"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005801; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116; GO:0070971; GO:0090161";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]";"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";
comp5456_c0_seq1;GAXK01066619.1;Q2KI24;3.62E-28;MTHSD_BOVIN;Methenyltetrahydrofolate synthase domain-containing protein;"cytoplasm [GO:0005737]; RNA binding [GO:0003723]";"GO:0003723; GO:0005737";;cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp54560_c0_seq1;GAXK01096937.1;A0JJX5;5.55E-14;SYT4_ARATH;Synaptotagmin-4 (NTMC2T2.2) (Synaptotagmin D);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; lipid transport [GO:0006869]";"GO:0005783; GO:0006869; GO:0008289; GO:0016021; GO:0046872";lipid transport [GO:0006869];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"lipid binding [GO:0008289]; metal ion binding [GO:0046872]"
comp5456368_c0_seq1;GAXK01034384.1;O24573;2.88E-21;RLA0_MAIZE;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0034059; GO:0044877; GO:0070180";"cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]"
comp54567_c0_seq1;GAXK01096711.1;P13255;3.05E-118;GNMT_RAT;Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein);"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]; folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]";"GO:0005542; GO:0005634; GO:0005829; GO:0006111; GO:0006544; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0046655; GO:0051262; GO:0051289; GO:1901052; GO:1904047";"folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]";"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]";"folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp545690_c0_seq1;GAXK01153352.1;P19223;1.48E-33;CBPB1_RAT;Carboxypeptidase B (EC 3.4.17.2);"extracellular space [GO:0005615]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004180; GO:0004181; GO:0005615; GO:0006508; GO:0008270";proteolysis [GO:0006508];extracellular space [GO:0005615];"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp5456945_c0_seq1;GAXK01034378.1;Q69TH4;9.53E-64;OPR2_ORYSJ;Putative 12-oxophytodienoate reductase 2 (EC 1.3.1.-) (OPDA-reductase 2) (OsOPR2);"12-oxophytodienoate reductase activity [GO:0016629]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]; jasmonic acid biosynthetic process [GO:0009695]; oxylipin biosynthetic process [GO:0031408]";"GO:0009695; GO:0010181; GO:0016491; GO:0016629; GO:0031408";"jasmonic acid biosynthetic process [GO:0009695]; oxylipin biosynthetic process [GO:0031408]";;"12-oxophytodienoate reductase activity [GO:0016629]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]"
comp54574_c4_seq1;GAXK01096751.1;P77736;2.70E-07;YAHD_ECOLI;Putative ankyrin repeat protein YahD;response to radiation [GO:0009314];GO:0009314;response to radiation [GO:0009314];;
comp5457657_c0_seq1;GAXK01034383.1;P62302;3.71E-62;RS13_SOYBN;40S ribosomal protein S13;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp545789_c1_seq1;GAXK01153356.1;Q9NFT7;6.03E-120;HXK2_DROME;Hexokinase type 2 (EC 2.7.1.1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";"GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158";"cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]";cytosol [GO:0005829];"ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]"
comp54583_c0_seq1;GAXK01096641.1;P06352;2.07E-14;H3_STRPU;Histone H3, embryonic;"nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0005634; GO:0031492; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]"
comp54586_c0_seq1;GAXK01096849.1;Q6P1M0;2.79E-178;S27A4_HUMAN;Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4);"brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]";"GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005789; GO:0005886; GO:0005902; GO:0007584; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043588; GO:0044539";"long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]";"brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]";"long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp546_c1_seq1;GAXK01166089.1;Q05825;0;ATPB_DROME;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"GO:0000275; GO:0005524; GO:0005739; GO:0005753; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:0046961; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp5460312_c0_seq1;GAXK01144058.1;P50573;9.88E-08;GBRR3_RAT;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; protein domain specific binding [GO:0019904]; transmembrane signaling receptor activity [GO:0004888]"
comp54612_c0_seq1;GAXK01096199.1;Q58DK5;8.89E-143;HEM2_BOVIN;Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase);"cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270; GO:0042802; GO:0051260; GO:0071353; GO:1901799";"cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]"
comp5461674_c0_seq1;GAXK01144049.1;Q8SWR3;2.19E-09;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp54618_c0_seq1;GAXK01096710.1;O15992;1.42E-39;KARG_ANTJA;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp546275_c0_seq1;GAXK01056183.1;A0PJ29;1.85E-73;D4FAD_REBSA;Acyl-lipid (7-3)-desaturase (EC 1.14.19.31) (Acyl-lipid 4-desaturase) (Delta-4 desaturase) (PsD4Des);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0006636; GO:0016021; GO:0016717; GO:0042759; GO:0046872";"long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]"
comp54652_c0_seq1;GAXK01096881.1;Q99LI5;1.95E-10;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp5465349_c0_seq1;GAXK01151119.1;Q27571;2.41E-41;NOS_DROME;Nitric oxide synthase (EC 1.14.13.39) (dNOS);"cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]";"GO:0002027; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0007399; GO:0007416; GO:0007444; GO:0008156; GO:0008285; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0020037; GO:0031284; GO:0032496; GO:0046620; GO:0046872; GO:0050660; GO:0050661";"arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]";"cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp546750_c0_seq1;GAXK01056201.1;A2RRT3;7.97E-17;FB31A_XENLA;F-box only protein 31-A;"SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";SCF ubiquitin ligase complex [GO:0019005];cyclin binding [GO:0030332]
comp546806_c0_seq1;GAXK01056187.1;Q1L981;4.90E-17;TDRD5_DANRE;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp5468901_c0_seq1;GAXK01007584.1;P36609;3.50E-18;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp546994_c0_seq1;GAXK01056205.1;P17970;1.45E-50;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp54702_c1_seq1;GAXK01096982.1;Q7T293;6.32E-10;SDE2_DANRE;Replication stress response regulator SDE2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]";"GO:0003677; GO:0005634; GO:0006260; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp5470496_c0_seq1;GAXK01092748.1;Q9GS23;6.19E-75;ATPA_TRYBB;ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha);"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp547084_c0_seq1;GAXK01056166.1;P15690;1.67E-21;NDUS1_BOVIN;NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-75kD) (CI-75kD);"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]";"GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045272; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593";"apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]";"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane respiratory chain complex I [GO:0045272]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp54712_c0_seq1;GAXK01096680.1;Q969T9;5.87E-33;WBP2_HUMAN;WW domain-binding protein 2 (WBP-2);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]";"GO:0000790; GO:0000978; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045944; GO:0050847; GO:0071391; GO:0071442";"cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]"
comp547161_c0_seq1;GAXK01056162.1;Q9VTI8;8.03E-10;CHRB_DROME;Protein charybde (Protein charybdis) (Protein regulated in development and DNA damage response 1) (REDD-1);"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]";"GO:0005737; GO:0006915; GO:0006979; GO:0008219; GO:0008258; GO:0009968; GO:0032006; GO:0045926";"apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]";cytoplasm [GO:0005737];
comp5471927_c0_seq1;GAXK01092755.1;P42820;2.06E-07;CHIP_BETVU;Acidic endochitinase SP2 (EC 3.2.1.14);"extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005615; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";extracellular space [GO:0005615];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp5472106_c0_seq1;GAXK01170662.1;Q962Q5;4.28E-20;RS25_SPOFR;40S ribosomal protein S25;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp547278_c0_seq1;GAXK01056203.1;B7Z6K7;1.05E-19;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5472834_c0_seq1;GAXK01170655.1;Q9NBX4;2.64E-10;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp5473_c0_seq1;GAXK01065645.1;Q9CQT9;1.13E-27;RAB5I_MOUSE;Uncharacterized protein RAB5IF homolog (Rab5-interacting protein) (RIP5);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp54741_c0_seq1;GAXK01096229.1;Q9VSR3;2.87E-168;ORB2_DROME;Translational regulator orb2;"axon [GO:0030424]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; asymmetric cell division [GO:0008356]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; male meiosis I [GO:0007141]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]";"GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007141; GO:0007283; GO:0007288; GO:0007291; GO:0007616; GO:0008049; GO:0008135; GO:0008356; GO:0008494; GO:0017148; GO:0030054; GO:0030424; GO:0042802; GO:0043005; GO:0043022; GO:0043204; GO:0043679; GO:0044292; GO:0044297; GO:0045202; GO:0045727; GO:0048471; GO:0097060; GO:0098793; GO:0098794; GO:1990124; GO:2000766";"asymmetric cell division [GO:0008356]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; male meiosis I [GO:0007141]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291]";"axon [GO:0030424]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic membrane [GO:0097060]";"identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp547504_c1_seq1;GAXK01056148.1;P11247;2.11E-80;PERM_MOUSE;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268";"aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]";"heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp5475077_c0_seq1;GAXK01163675.1;Q54DF2;1.95E-12;MRKA_DICDI;Probable serine/threonine-protein kinase MARK-A (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]";"GO:0004674; GO:0005524; GO:0005737; GO:0035556";intracellular signal transduction [GO:0035556];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp547511_c2_seq1;GAXK01056170.1;Q67BJ4;1.04E-18;A4GAT_MOUSE;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp547516_c1_seq1;GAXK01056182.1;Q5I598;0;MTHR_BOVIN;Methylenetetrahydrofolate reductase (EC 1.5.1.20);"cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";"GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949";"methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";cytosol [GO:0005829];"FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]"
comp5475514_c0_seq1;GAXK01163671.1;Q9WTW5;6.23E-07;S22A3_MOUSE;Solute carrier family 22 member 3 (Organic cation transporter 3);"integral component of plasma membrane [GO:0005887]; dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; dopamine transport [GO:0015872]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";"GO:0005330; GO:0005887; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0019534; GO:0032098; GO:0051608; GO:0051615";"dopamine transport [GO:0015872]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]";integral component of plasma membrane [GO:0005887];"dopamine:sodium symporter activity [GO:0005330]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]"
comp5476295_c0_seq1;GAXK01198777.1;Q09864;1.17E-46;HSP60_SCHPO;Heat shock protein 60, mitochondrial (HSP60);"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; post-mRNA release spliceosomal complex [GO:0071014]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; chaperone-mediated protein folding [GO:0061077]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein import into mitochondrial matrix [GO:0030150]; protein refolding [GO:0042026]";"GO:0005524; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006458; GO:0007005; GO:0008637; GO:0030150; GO:0031966; GO:0042026; GO:0042645; GO:0045041; GO:0051082; GO:0061077; GO:0071014";"'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; chaperone-mediated protein folding [GO:0061077]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein import into mitochondrial matrix [GO:0030150]; protein refolding [GO:0042026]";"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; post-mRNA release spliceosomal complex [GO:0071014]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp547740_c0_seq1;GAXK01056202.1;P36609;1.25E-14;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp54779_c0_seq1;GAXK01096191.1;Q0V9L3;2.49E-10;CELF4_XENTR;CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904";"mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp547986_c3_seq1;GAXK01056140.1;P27473;8.51E-20;IFI44_PANTR;Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp548019_c1_seq1;GAXK01115383.1;O14972;2.87E-57;VP26C_HUMAN;Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A);"endosome [GO:0005768]; nucleus [GO:0005634]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005634; GO:0005768; GO:0006886; GO:0032456; GO:1990126";"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]";"endosome [GO:0005768]; nucleus [GO:0005634]";
comp548154_c1_seq1;GAXK01115380.1;Q86L54;2.07E-09;Y2829_DICDI;TNF receptor-associated factor family protein DDB_G0272829;"cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]";"GO:0005737; GO:0008270";;cytoplasm [GO:0005737];zinc ion binding [GO:0008270]
comp548429_c0_seq1;GAXK01115387.1;Q90W04;4.21E-11;NGB_TETNG;Neuroglobin;"cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005344; GO:0005737; GO:0019825; GO:0020037; GO:0043204; GO:0046872; GO:0098809";response to hypoxia [GO:0001666];"cytoplasm [GO:0005737]; perikaryon [GO:0043204]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp548553_c0_seq1;GAXK01115382.1;A0PJX2;2.34E-37;TLDC2_HUMAN;TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2);;;;;
comp548584_c1_seq1;GAXK01115367.1;O61363;2.74E-33;HCYG_ENTDO;Hemocyanin G-type, units Oda to Odg;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp5486008_c0_seq1;GAXK01193855.1;Q5T4S7;1.30E-11;UBR4_HUMAN;E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1);"centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0070821; GO:0101003";"neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";"calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp54865_c0_seq1;GAXK01096044.1;Q05048;7.27E-174;CSTF1_HUMAN;Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit) (CSTF 50 kDa subunit) (CstF-50);"mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000398; GO:0003723; GO:0005654; GO:0005848; GO:0006369; GO:0031124";"mRNA 3'-end processing [GO:0031124]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]";"mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]";RNA binding [GO:0003723]
comp54866_c1_seq1;GAXK01096674.1;P42765;1.54E-156;THIM_HUMAN;3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109";"cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]"
comp54874_c0_seq1;GAXK01096295.1;Q99L20;1.58E-49;GSTT3_MOUSE;Glutathione S-transferase theta-3 (EC 2.5.1.18);"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];glutathione transferase activity [GO:0004364]
comp54878_c0_seq1;GAXK01204859.1;Q9Y345;7.58E-168;SC6A5_HUMAN;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804";"chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]"
comp54888_c2_seq1;GAXK01096609.1;P42695;1.18E-159;CNDD3_HUMAN;Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3);"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]";"GO:0000779; GO:0000799; GO:0003682; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0031618; GO:0035064; GO:0042393; GO:0051301; GO:0051304";"cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]";"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]"
comp5489147_c0_seq1;GAXK01177740.1;O42248;1.16E-54;GBLP_DANRE;Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543";"angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp548924_c0_seq1;GAXK01115375.1;P10775;2.55E-07;RINI_PIG;Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1);"angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; regulation of angiogenesis [GO:0045765]";"GO:0005654; GO:0005829; GO:0008428; GO:0032311; GO:0045765";regulation of angiogenesis [GO:0045765];"angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";ribonuclease inhibitor activity [GO:0008428]
comp549035_c0_seq1;GAXK01115390.1;Q94521;2.50E-10;DNAT_DROME;Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase);"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";"GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066";"catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]";cytoplasm [GO:0005737];"aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]"
comp5491_c2_seq1;GAXK01065660.1;P31401;0;VATB_MANSE;V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B);"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";"GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600";"ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";proton-transporting V-type ATPase, V1 domain [GO:0033180];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp5492078_c0_seq1;GAXK01101877.1;P08042;1.82E-23;ZFP1_MOUSE;Zinc finger protein 1 (Zfp-1) (Protein mKR1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp54921_c1_seq1;GAXK01096719.1;Q24247;2.54E-160;ITA1_DROME;"Integrin alpha-PS1 (Position-specific antigen subunit alpha-1) (Protein multiple edematous wings) [Cleaved into: Integrin alpha-PS1 heavy chain; Integrin alpha-PS1 light chain]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; cell adhesion molecule binding [GO:0050839]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; ectodermal digestive tract morphogenesis [GO:0048567]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; salivary gland boundary specification [GO:0007432]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005887; GO:0005925; GO:0007015; GO:0007155; GO:0007157; GO:0007229; GO:0007411; GO:0007414; GO:0007431; GO:0007432; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0030154; GO:0033627; GO:0034446; GO:0035160; GO:0046982; GO:0048567; GO:0050839; GO:0050840; GO:0098609";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; ectodermal digestive tract morphogenesis [GO:0048567]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; salivary gland boundary specification [GO:0007432]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]";"cell adhesion molecule binding [GO:0050839]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]"
comp549221_c1_seq1;GAXK01115368.1;Q8IYP9;2.47E-11;ZDH23_HUMAN;Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp549253_c0_seq1;GAXK01115394.1;O35453;5.20E-10;HEPS_MOUSE;"Serine protease hepsin (EC 3.4.21.106) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; basement membrane disassembly [GO:0034769]; cholesterol homeostasis [GO:0042632]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; epithelium development [GO:0060429]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]";"GO:0004252; GO:0005576; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0006508; GO:0007605; GO:0008233; GO:0008236; GO:0008360; GO:0009986; GO:0010628; GO:0010693; GO:0010719; GO:0010756; GO:0015269; GO:0016021; GO:0016324; GO:0030307; GO:0034769; GO:0042632; GO:0043025; GO:0043066; GO:0043923; GO:0050680; GO:0050910; GO:0060429; GO:0070008; GO:0071805; GO:0090103; GO:0097066; GO:0097195; GO:2000347; GO:2000611";"basement membrane disassembly [GO:0034769]; cholesterol homeostasis [GO:0042632]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; epithelium development [GO:0060429]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]";"apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"calcium-activated potassium channel activity [GO:0015269]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]"
comp5493_c0_seq1;GAXK01066638.1;Q2TBR6;1.81E-18;PFD4_BOVIN;Prefoldin subunit 4;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082";protein folding [GO:0006457];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]";unfolded protein binding [GO:0051082]
comp54930_c2_seq1;GAXK01096384.1;P49902;0;5NTC_HUMAN;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II);"cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]";"GO:0000166; GO:0005829; GO:0006195; GO:0008253; GO:0017144; GO:0046040; GO:0046085; GO:0046872";"adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]";cytosol [GO:0005829];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp5493928_c0_seq1;GAXK01101866.1;Q7Z2Y8;5.32E-12;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp5494_c0_seq1;GAXK01065860.1;Q6IQ16;3.89E-08;SPOPL_HUMAN;Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp5494131_c0_seq1;GAXK01069463.1;Q16KN5;9.40E-24;RETM_AEDAE;Protein real-time;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp54947_c2_seq1;GAXK01096859.1;P49762;1.74E-165;DOA_DROME;Serine/threonine-protein kinase Doa (EC 2.7.12.1) (Protein darkener of apricot);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]";"GO:0000381; GO:0002225; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006468; GO:0007350; GO:0007399; GO:0007548; GO:0007601; GO:0009306; GO:0010508; GO:0016301; GO:0018993; GO:0042051; GO:0045752; GO:0046777; GO:0048749; GO:0050896; GO:2000255";"blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp5495_c2_seq1;GAXK01067160.1;Q9VI75;3.02E-165;PICAL_DROME;Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180);"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]";"GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370";"chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]";"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]";"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"
comp549531_c0_seq1;GAXK01115377.1;P20693;3.32E-16;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp54957_c4_seq1;GAXK01096649.1;Q9YGY3;1.03E-158;BUB3_XENLA;Mitotic checkpoint protein BUB3 (xbub3) (WD repeat protein Bub3);"condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]";"GO:0000777; GO:0005634; GO:0007059; GO:0051301; GO:0051321";"cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]";"condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]";
comp549596_c0_seq1;GAXK01115376.1;P15531;1.16E-70;NDKA_HUMAN;Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]";"GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0008285; GO:0010629; GO:0010976; GO:0014075; GO:0015949; GO:0016020; GO:0019215; GO:0019899; GO:0021766; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0042981; GO:0043015; GO:0043024; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0070062; GO:0071333; GO:0071398";"cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]";"ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]"
comp5497106_c0_seq1;GAXK01118635.1;Q6P1L6;6.29E-09;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5497875_c0_seq1;GAXK01118638.1;Q10134;1.97E-09;FEP1_SCHPO;Iron-sensing transcription factor 1 (Transcription factor gaf2) (Gaf-2);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cellular iron ion homeostasis [GO:0006879]; negative regulation of ferrichrome biosynthetic process [GO:1905569]; negative regulation of ferrichrome biosynthetic process in response to iron [GO:0097739]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034396]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003690; GO:0005506; GO:0005634; GO:0006879; GO:0008270; GO:0034396; GO:0051536; GO:0097739; GO:1905569";"cellular iron ion homeostasis [GO:0006879]; negative regulation of ferrichrome biosynthetic process [GO:1905569]; negative regulation of ferrichrome biosynthetic process in response to iron [GO:0097739]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034396]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"
comp54982_c2_seq1;GAXK01096107.1;Q2PFU6;4.34E-26;RN146_MACFA;E3 ubiquitin-protein ligase RNF146 (EC 2.3.2.27) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp549840_c0_seq1;GAXK01115371.1;Q8N7K0;1.79E-07;ZN433_HUMAN;Zinc finger protein 433;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp54988_c1_seq1;GAXK01096766.1;Q9CR23;1.04E-16;TMEM9_MOUSE;Transmembrane protein 9;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";"GO:0005764; GO:0005765; GO:0005770; GO:0016021; GO:0031902";;"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]";
comp55004_c0_seq1;GAXK01096261.1;O97162;9.09E-29;TPM_RHIMP;Tropomyosin;;;;;
comp550044_c0_seq1;GAXK01071889.1;Q10L91;1.33E-09;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp5500496_c0_seq1;GAXK01164394.1;Q26422;1.59E-23;LFC_CARRO;"Limulus clotting factor C (FC) (EC 3.4.21.84) [Cleaved into: Limulus clotting factor C heavy chain; Limulus clotting factor C light chain; Limulus clotting factor C chain A; Limulus clotting factor C chain B]";"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]; cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0007155; GO:0030246; GO:0042381";"cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]";extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]"
comp550078_c0_seq1;GAXK01071968.1;Q9Y5R2;2.23E-50;MMP24_HUMAN;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp5501673_c0_seq1;GAXK01164404.1;P18445;2.01E-42;RL27A_RAT;60S ribosomal protein L27a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp5501711_c0_seq1;GAXK01164403.1;Q9W5R8;1.52E-45;RL5_DROME;60S ribosomal protein L5;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0008097; GO:0022625; GO:0022626";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp550282_c3_seq1;GAXK01071913.1;Q18932;4.10E-42;CAH2_CAEEL;Putative carbonic anhydrase-like protein 2;"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp550287_c0_seq1;GAXK01071991.1;Q5T0B9;8.76E-37;ZN362_HUMAN;Zinc finger protein 362;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp550305_c0_seq1;GAXK01071938.1;Q95NT6;9.37E-18;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp55031_c5_seq1;GAXK01096042.1;Q9VKJ0;0;HGD_DROME;Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase);"homogentisate 1,2-dioxygenase activity [GO:0004411]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0004411; GO:0006520; GO:0006559; GO:0006572; GO:0046872";"cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";;"homogentisate 1,2-dioxygenase activity [GO:0004411]; metal ion binding [GO:0046872]"
comp5503762_c0_seq1;GAXK01078697.1;Q2UBZ9;3.72E-64;RSSA_ASPOR;40S ribosomal protein S0;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp550416_c0_seq1;GAXK01071997.1;Q3TCN2;3.78E-88;PLBL2_MOUSE;"Putative phospholipase B-like 2 (EC 3.1.1.-) (66.3 kDa protein) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 28 kDa form; Putative phospholipase B-like 2 40 kDa form; Putative phospholipase B-like 2 15 kDa form]";"lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]";"GO:0004620; GO:0005764; GO:0016042; GO:0043202";lipid catabolic process [GO:0016042];"lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";phospholipase activity [GO:0004620]
comp5504567_c0_seq1;GAXK01162377.1;A1A5R8;5.81E-15;K1841_RAT;Uncharacterized protein KIAA1841 homolog;;;;;
comp55047_c2_seq1;GAXK01096204.1;Q761V0;1.02E-138;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp550510_c0_seq1;GAXK01071893.1;Q5RFU0;1.50E-82;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp550669_c0_seq1;GAXK01072021.1;Q556Z9;8.24E-12;Y3361_DICDI;Transmembrane protein DDB_G0273707/DDB_G0273361;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp55071_c0_seq1;GAXK01096911.1;O57579;1.83E-94;AMPN_CHICK;Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N);"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0042277; GO:0043171; GO:0070006; GO:0070062";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp550745_c3_seq1;GAXK01072002.1;Q7Z0G7;3.72E-39;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp55077_c7_seq1;GAXK01096956.1;Q9BXM7;1.24E-67;PINK1_HUMAN;Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1);"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein complex assembly [GO:0043254]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000287; GO:0000422; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0016020; GO:0016236; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:1900407; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903147; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243";"activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein complex assembly [GO:0043254]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]";"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine/threonine kinase activity [GO:0004674]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]"
comp5508091_c0_seq1;GAXK01108201.1;Q8ITC9;1.68E-15;PK1R_DROME;Pyrokinin-1 receptor;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]"
comp550820_c0_seq1;GAXK01071931.1;Q91W53;6.52E-50;GOGA7_MOUSE;Golgin subfamily A member 7;"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]";"GO:0000139; GO:0002178; GO:0005795; GO:0006612; GO:0006893; GO:0018230; GO:0031228; GO:0043001; GO:0050821";"Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]";"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]";
comp550826_c0_seq1;GAXK01072007.1;Q5NUA6;7.12E-18;NF2L2_BOVIN;Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0045454; GO:0045893; GO:0045944; GO:0071498";"cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp5509078_c0_seq1;GAXK01108197.1;A1TVS9;3.16E-26;RPOC_ACIAC;DNA-directed RNA polymerase subunit beta' (RNAP subunit beta') (EC 2.7.7.6) (RNA polymerase subunit beta') (Transcriptase subunit beta');"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]";"GO:0000287; GO:0003677; GO:0003899; GO:0006351; GO:0008270";transcription, DNA-templated [GO:0006351];;"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]"
comp5509692_c0_seq1;GAXK01108202.1;Q68EA5;4.05E-10;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp551_c0_seq1;GAXK01169728.1;Q32NS4;0;ARI1_XENLA;E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase arih1);"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0016604; GO:0097413";protein ubiquitination [GO:0016567];"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp55105_c4_seq1;GAXK01096505.1;Q92539;1.49E-97;LPIN2_HUMAN;Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp55108_c0_seq1;GAXK01096375.1;Q6NRP2;0;PSME4_XENLA;Proteasome activator complex subunit 4 (Proteasome activator PA200);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]";"GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]";"lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]"
comp5510819_c0_seq1;GAXK01139931.1;O75899;1.34E-08;GABR2_HUMAN;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]";"GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007214; GO:0007268; GO:0030054; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0150099; GO:1902710";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; GABA receptor complex [GO:1902710]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]"
comp551125_c0_seq1;GAXK01072019.1;O77633;1.76E-11;ADA10_PIG;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005798; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030307; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945";"cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp551218_c0_seq1;GAXK01071926.1;Q9FKD5;2.39E-10;SINL9_ARATH;Putative E3 ubiquitin-protein ligase SINA-like 9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 9) (Seven in absentia-like protein 9);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp5512457_c0_seq1;GAXK01007118.1;Q16602;1.06E-13;CALRL_HUMAN;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein transport [GO:0015031]; receptor internalization [GO:0031623]";"GO:0001525; GO:0001605; GO:0001635; GO:0004930; GO:0004948; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0006816; GO:0007166; GO:0007186; GO:0007187; GO:0007189; GO:0007507; GO:0015031; GO:0031623; GO:0045986; GO:0048661; GO:0050728; GO:0071329; GO:1903143; GO:1990406; GO:1990408; GO:1990409; GO:1990410";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein transport [GO:0015031]; receptor internalization [GO:0031623]";"adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled receptor activity [GO:0004930]"
comp551326_c0_seq1;GAXK01071884.1;O43014;5.89E-68;MPI_SCHPO;Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI);"cytosol [GO:0005829]; nucleus [GO:0005634]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; fungal-type cell wall organization [GO:0031505]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486]";"GO:0000032; GO:0004476; GO:0005634; GO:0005829; GO:0005975; GO:0006486; GO:0008270; GO:0009298; GO:0031505";"carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; fungal-type cell wall organization [GO:0031505]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]"
comp55137_c0_seq1;GAXK01096119.1;P16444;1.02E-103;DPEP1_HUMAN;Dipeptidase 1 (EC 3.4.13.19) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP);"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"GO:0005615; GO:0005634; GO:0005886; GO:0006691; GO:0006749; GO:0006805; GO:0008235; GO:0008239; GO:0008270; GO:0016324; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341";"antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]"
comp551399_c0_seq1;GAXK01071947.1;Q2UPB1;9.05E-28;ACLC_ASPOR;Cytochrome P450 monooxygenase aclC (EC 1.-.-.-) (Aspirochlorine biosynthesis protein C);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016705; GO:0020037";;;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp55140_c2_seq1;GAXK01096696.1;Q9QZQ1;8.09E-40;AFAD_MOUSE;Afadin (Afadin adherens junction formation factor) (Protein Af-6);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]";"GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0007165; GO:0010628; GO:0016607; GO:0017016; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0043547; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0140059; GO:1902414; GO:1903861; GO:2000049";"adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]";"actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]"
comp551451_c1_seq1;GAXK01072000.1;Q8NCC3;2.06E-97;PAG15_HUMAN;Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006672; GO:0008374; GO:0009062; GO:0016020; GO:0034638; GO:0043231; GO:0046338; GO:0047499; GO:0070062";"ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]"
comp55147_c2_seq1;GAXK01096174.1;Q4V9P0;1.03E-94;SAMC_DANRE;S-adenosylmethionine mitochondrial carrier protein (Mitochondrial S-adenosylmethionine transporter) (Solute carrier family 25 member 26);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; S-adenosyl-L-methionine transport [GO:0015805]";"GO:0000095; GO:0005743; GO:0015805; GO:0016021";S-adenosyl-L-methionine transport [GO:0015805];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]
comp5515_c0_seq1;GAXK01065455.1;O75937;2.79E-53;DNJC8_HUMAN;DnaJ homolog subfamily C member 8 (Splicing protein spf31);"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0005654; GO:0005829; GO:0030544; GO:0045171";mRNA splicing, via spliceosome [GO:0000398];"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";Hsp70 protein binding [GO:0030544]
comp5515103_c0_seq1;GAXK01001479.1;Q9QUM9;3.56E-29;PSA6_MOUSE;Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]";"GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0007519; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603";"positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]";"endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]"
comp55152_c4_seq1;GAXK01205450.1;P27361;0;MK03_HUMAN;Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]";"GO:0000165; GO:0000186; GO:0000187; GO:0001784; GO:0001934; GO:0002741; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006361; GO:0006468; GO:0006915; GO:0006975; GO:0007049; GO:0007411; GO:0007568; GO:0008543; GO:0009636; GO:0010468; GO:0010628; GO:0010759; GO:0014066; GO:0016032; GO:0016310; GO:0018105; GO:0019233; GO:0019369; GO:0019902; GO:0030168; GO:0030278; GO:0030509; GO:0030641; GO:0030878; GO:0031143; GO:0031281; GO:0031663; GO:0032212; GO:0032872; GO:0032991; GO:0033129; GO:0034198; GO:0034614; GO:0035066; GO:0035556; GO:0038083; GO:0038095; GO:0038096; GO:0042473; GO:0042802; GO:0043330; GO:0045727; GO:0045944; GO:0046697; GO:0048538; GO:0051090; GO:0051216; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060324; GO:0060425; GO:0060440; GO:0061308; GO:0065003; GO:0070371; GO:0070374; GO:0070498; GO:0070849; GO:0071260; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0090170; GO:0097110; GO:1900034; GO:1903351; GO:1904355; GO:1904417; GO:1905050; GO:2000641; GO:2000657";"activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein-containing complex assembly [GO:0065003]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; scaffold protein binding [GO:0097110]"
comp551547_c0_seq1;GAXK01071999.1;Q8BX57;2.90E-112;PXK_MOUSE;PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]";"GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0035091; GO:0042391; GO:0043271; GO:0050804";"inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]"
comp5515691_c0_seq1;GAXK01001482.1;Q93560;1.08E-08;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp55165_c0_seq1;GAXK01096297.1;Q5ZHN3;6.18E-136;WIPI2_CHICK;WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2);"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0061739; GO:0080025; GO:0098792";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]";"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp5516526_c0_seq1;GAXK01052925.1;Q91X17;1.84E-07;UROM_MOUSE;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266";"chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]";"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";"calcium ion binding [GO:0005509]; IgG binding [GO:0019864]"
comp55184_c7_seq1;GAXK01096434.1;P25823;5.97E-10;TUD_DROME;Maternal protein tudor;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"GO:0005634; GO:0005737; GO:0005739; GO:0007277; GO:0007281; GO:0007315; GO:0008298; GO:0030719; GO:0043186; GO:0045495";"germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]";
comp552114_c0_seq1;GAXK01181285.1;P70704;0;AT8A1_MOUSE;Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1);"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0030285; GO:0030335; GO:0042584; GO:0043231; GO:0045332; GO:0061092; GO:0140326";"learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp552204_c0_seq1;GAXK01181272.1;Q60821;1.78E-12;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp552234_c2_seq1;GAXK01181248.1;P83501;2.00E-27;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp552281_c0_seq1;GAXK01181198.1;P12031;6.36E-24;HCYB_HELPO;Hemocyanin, beta-C chain unit D (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp5523836_c0_seq1;GAXK01027522.1;P17970;5.93E-45;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp552440_c1_seq1;GAXK01181185.1;P02707;6.10E-07;LECH_CHICK;Hepatic lectin;"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]";"GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];integral component of membrane [GO:0016021];carbohydrate binding [GO:0030246]
comp5524565_c0_seq1;GAXK01141770.1;P34885;2.82E-32;KPC1B_CAEEL;Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005623; GO:0005737; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008306; GO:0016020; GO:0016079; GO:0018105; GO:0035556; GO:0040012; GO:0040024; GO:0046872; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:1902074; GO:1990504; GO:2001024";"associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp5524577_c0_seq1;GAXK01141766.1;Q61990;5.16E-08;PCBP2_MOUSE;Poly(rC)-binding protein 2 (Alpha-CP2) (CTBP) (CBP) (Putative heterogeneous nuclear ribonucleoprotein X) (hnRNP X);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; C-rich single-stranded DNA binding [GO:1990829]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of defense response to virus [GO:0050687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; viral RNA genome replication [GO:0039694]";"GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0014069; GO:0019899; GO:0031625; GO:0039694; GO:0043161; GO:0045087; GO:0050687; GO:0051607; GO:0075522; GO:1990829";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of defense response to virus [GO:0050687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; viral RNA genome replication [GO:0039694]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"C-rich single-stranded DNA binding [GO:1990829]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]"
comp5524627_c0_seq1;GAXK01141771.1;Q3KQ77;1.17E-37;EFCB1_XENLA;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp552469_c0_seq1;GAXK01181281.1;Q920M9;4.14E-08;SIAH1_RAT;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244";"cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]";"disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp5525706_c0_seq1;GAXK01141768.1;Q8W453;1.06E-14;DIRL1_ARATH;Putative lipid-transfer protein DIR1 (Protein DEFECTIVE IN INDUCED RESISTANCE 1);"apoplast [GO:0048046]; endoplasmic reticulum [GO:0005783]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; fatty acid binding [GO:0005504]; protein self-association [GO:0043621]; zinc ion binding [GO:0008270]; lipid transport [GO:0006869]; systemic acquired resistance [GO:0009627]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]";"GO:0005504; GO:0005783; GO:0006869; GO:0008270; GO:0009506; GO:0009627; GO:0009862; GO:0043621; GO:0048046; GO:0099503";"lipid transport [GO:0006869]; systemic acquired resistance [GO:0009627]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]";"apoplast [GO:0048046]; endoplasmic reticulum [GO:0005783]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]";"fatty acid binding [GO:0005504]; protein self-association [GO:0043621]; zinc ion binding [GO:0008270]"
comp55266_c1_seq1;GAXK01096260.1;Q4R4R4;1.41E-41;PRAF3_MACFA;PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5);"cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]";"GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0016021";negative regulation of L-glutamate import across plasma membrane [GO:0002037];"cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp55282_c0_seq1;GAXK01096976.1;P05661;3.26E-99;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp552874_c1_seq1;GAXK01181205.1;Q9BTX7;9.11E-11;TTPAL_HUMAN;Alpha-tocopherol transfer protein-like;membrane [GO:0016020];GO:0016020;;membrane [GO:0016020];
comp55295_c0_seq1;GAXK01096383.1;Q8SXD4;3.06E-34;MIDN_DROME;Midnolin homolog (Protein stuxnet);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]";"GO:0005634; GO:0005654; GO:0010499";proteasomal ubiquitin-independent protein catabolic process [GO:0010499];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp55298_c1_seq1;GAXK01096728.1;Q9VCU9;1.14E-56;DCR1_DROME;Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883";"apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]"
comp553000_c2_seq1;GAXK01181293.1;Q86BJ3;8.57E-45;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp553034_c0_seq1;GAXK01181263.1;P82968;1.63E-13;MCPI_MELCP;Four-domain proteases inhibitor (McaPI);serine-type endopeptidase inhibitor activity [GO:0004867];GO:0004867;;;serine-type endopeptidase inhibitor activity [GO:0004867]
comp5530526_c0_seq1;GAXK01048269.1;Q7ZYC4;1.55E-26;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp55312_c0_seq2;GAXK01096206.1;P0C1J5;1.47E-39;FKB2B_RHIO9;FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0016021";;integral component of membrane [GO:0016021];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp55314_c0_seq1;GAXK01096757.1;P26675;0;SOS_DROME;Protein son of sevenless;"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleosome [GO:0000786]; rhabdomere microvillus membrane [GO:0035997]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon midline choice point recognition [GO:0016199]; defense response to virus [GO:0051607]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; photoreceptor cell fate determination [GO:0043703]; positive regulation of cell size [GO:0045793]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; R7 cell fate commitment [GO:0007465]; regulation of Rho protein signal transduction [GO:0035023]; sevenless signaling pathway [GO:0045500]; small GTPase mediated signal transduction [GO:0007264]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000786; GO:0003677; GO:0005088; GO:0005829; GO:0007173; GO:0007264; GO:0007426; GO:0007427; GO:0007465; GO:0007480; GO:0008293; GO:0008543; GO:0016199; GO:0030676; GO:0031234; GO:0035022; GO:0035023; GO:0035997; GO:0043703; GO:0045500; GO:0045793; GO:0046579; GO:0046982; GO:0048010; GO:0051607; GO:2000134";"axon midline choice point recognition [GO:0016199]; defense response to virus [GO:0051607]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; photoreceptor cell fate determination [GO:0043703]; positive regulation of cell size [GO:0045793]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; R7 cell fate commitment [GO:0007465]; regulation of Rho protein signal transduction [GO:0035023]; sevenless signaling pathway [GO:0045500]; small GTPase mediated signal transduction [GO:0007264]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleosome [GO:0000786]; rhabdomere microvillus membrane [GO:0035997]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]"
comp5531589_c0_seq1;GAXK01048264.1;Q7Z269;9.34E-14;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp553273_c1_seq1;GAXK01181262.1;Q7SIG2;1.36E-08;CTR1_SOLIN;Chymotrypsin-1 (EC 3.4.21.1) (Chymotrypsin I) (Soli C1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp55339_c0_seq1;GAXK01096508.1;Q9UHR5;5.48E-25;S30BP_HUMAN;SAP30-binding protein (Transcriptional regulator protein HCNGP);"intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005654; GO:0006355; GO:0006915; GO:0010942; GO:0045111";"apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]";"intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp553450_c1_seq1;GAXK01181253.1;Q20065;2.43E-61;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp5535664_c0_seq1;GAXK01119905.1;P17970;2.58E-31;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp55365_c0_seq1;GAXK01096973.1;Q96D71;3.48E-28;REPS1_HUMAN;RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1);"clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]";"GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0017124; GO:0061024";"membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]";"clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]"
comp553672_c0_seq1;GAXK01181251.1;Q9CL21;4.87E-16;RECQ_PASMU;ATP-dependent DNA helicase RecQ (EC 3.6.4.12);"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0006260; GO:0006281; GO:0006310; GO:0009432; GO:0043138";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";;"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]"
comp55373_c2_seq1;GAXK01096380.1;Q6L6S1;1.62E-106;EGCSE_HYDVU;Endoglycoceramidase (EGCase) (EC 3.2.1.123) (Glycosphingolipid-specific enzyme) (GSL-specific enzyme);"extracellular region [GO:0005576]; endoglycosylceramidase activity [GO:0047876]; cellulose catabolic process [GO:0030245]; glycosphingolipid catabolic process [GO:0046479]";"GO:0005576; GO:0030245; GO:0046479; GO:0047876";"cellulose catabolic process [GO:0030245]; glycosphingolipid catabolic process [GO:0046479]";extracellular region [GO:0005576];endoglycosylceramidase activity [GO:0047876]
comp55381_c2_seq1;GAXK01096364.1;P54397;1.34E-32;FKB39_DROME;39 kDa FK506-binding nuclear protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"heterochromatin [GO:0000792]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; juvenile hormone response element binding [GO:0070594]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; juvenile hormone mediated signaling pathway [GO:0035626]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]";"GO:0000792; GO:0003755; GO:0005528; GO:0005634; GO:0010507; GO:0016242; GO:0035626; GO:0070594";"juvenile hormone mediated signaling pathway [GO:0035626]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]";"heterochromatin [GO:0000792]; nucleus [GO:0005634]";"FK506 binding [GO:0005528]; juvenile hormone response element binding [GO:0070594]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp5538952_c0_seq1;GAXK01062418.1;O44012;3.74E-38;RS6_LEIIN;40S ribosomal protein S6;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp55394_c1_seq1;GAXK01097004.1;O01382;6.20E-39;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp553970_c1_seq1;GAXK01181270.1;P0C1J5;2.01E-13;FKB2B_RHIO9;FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0016021";;integral component of membrane [GO:0016021];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp55405_c0_seq1;GAXK01096935.1;Q7ZX20;3.55E-12;RNF8A_XENLA;E3 ubiquitin-protein ligase rnf8-A (EC 2.3.2.27) (RING finger protein 8-A) (RING-type E3 ubiquitin transferase rnf8-A);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007286; GO:0008270; GO:0010212; GO:0033522; GO:0033523; GO:0034244; GO:0035861; GO:0042393; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0070534; GO:0070535; GO:0070936";"cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp554068_c0_seq1;GAXK01189662.1;Q9UH92;2.09E-67;MLX_HUMAN;Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp5541688_c0_seq1;GAXK01023779.1;P49691;7.59E-78;RL4B_ARATH;60S ribosomal protein L4-2 (L1);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005730; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp55417_c0_seq1;GAXK01096198.1;P13497;1.99E-12;BMP1_HUMAN;Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; high-density lipoprotein particle assembly [GO:0034380]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0007275; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030154; GO:0031982; GO:0034380; GO:0042802; GO:0061036";"cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; high-density lipoprotein particle assembly [GO:0034380]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]";"calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp554265_c0_seq1;GAXK01189630.1;P12764;4.34E-11;ALLS_DIPPU;"Allatostatins [Cleaved into: Allatostatin-1 (AST1); Allatostatin-2 (AST2) (ASA5) (ASB2); Allatostatin-3 (AST3); Allatostatin-4 (AST4) (ASA7); Allatostatin-5 (AST5) (ASA4); Allatostatin-6 (AST6); Allatostatin-7 (AST7) (ASA1); Allatostatin-8 (AST8) (ASA3); Allatostatin-9 (AST9) (ASA2); Allatostatin-10 (AST10); Allatostatin-11 (AST11) (ASA6); Allatostatin-12 (AST12); Allatostatin-13 (AST13)]";"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp554402_c0_seq1;GAXK01189625.1;Q95NI4;1.88E-29;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp5544782_c0_seq1;GAXK01193706.1;B8B9K6;1.22E-31;R10A_ORYSI;60S ribosomal protein L10a;"large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5544850_c0_seq1;GAXK01193712.1;P14381;3.22E-11;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp55450_c0_seq1;GAXK01097015.1;Q64267;2.82E-50;XPA_MOUSE;DNA repair protein complementing XP-A cells homolog (Xeroderma pigmentosum group A-complementing protein homolog);"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; intercellular bridge [GO:0045171]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; regulation of autophagy [GO:0010506]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]";"GO:0000110; GO:0000715; GO:0003684; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0006284; GO:0006289; GO:0006979; GO:0008630; GO:0009411; GO:0009636; GO:0009650; GO:0010506; GO:0019904; GO:0033683; GO:0034504; GO:0035264; GO:0042803; GO:0045171; GO:0046872; GO:0070914; GO:1901255";"base-excision repair [GO:0006284]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; protein localization to nucleus [GO:0034504]; regulation of autophagy [GO:0010506]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]";"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; intercellular bridge [GO:0045171]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]";"damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]"
comp5545544_c0_seq1;GAXK01193707.1;Q4N655;5.84E-64;RL5_THEPA;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp5545546_c0_seq1;GAXK01193709.1;Q2VYT1;2.33E-101;DNAK_MAGSA;Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70);"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0006457; GO:0051082";protein folding [GO:0006457];;"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp5546089_c0_seq1;GAXK01141886.1;P08048;2.31E-07;ZFY_HUMAN;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005654; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp55461_c2_seq1;GAXK01096296.1;O17473;4.17E-32;CATL_BRUPA;Cathepsin L-like (EC 3.4.22.15);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp5546718_c0_seq1;GAXK01141892.1;Q95NT6;4.47E-10;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp554723_c1_seq1;GAXK01189650.1;Q7KRI2;6.49E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5547405_c0_seq1;GAXK01141884.1;A8X765;9.81E-09;EGG1_CAEBR;LDL receptor repeat-containing protein egg-1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"GO:0005886; GO:0007275; GO:0007338; GO:0016021";"multicellular organism development [GO:0007275]; single fertilization [GO:0007338]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5548536_c0_seq1;GAXK01061181.1;Q9NDM2;2.08E-09;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp554924_c1_seq1;GAXK01189647.1;Q0EEE2;2.44E-18;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp554927_c1_seq1;GAXK01189638.1;Q9VXD9;8.01E-26;MTH1_DROME;Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252";"actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp5549644_c0_seq1;GAXK01061180.1;Q8A0U2;2.22E-10;TPIS_BACTN;Triosephosphate isomerase (TIM) (TPI) (EC 5.3.1.1) (Triose-phosphate isomerase);"cytosol [GO:0005829]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]";"GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0019563; GO:0046166";"gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]";cytosol [GO:0005829];triose-phosphate isomerase activity [GO:0004807]
comp5549733_c0_seq1;GAXK01061174.1;Q94900;7.38E-08;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp5549954_c0_seq1;GAXK01061178.1;Q8R0F9;3.91E-14;S14L4_MOUSE;SEC14-like protein 4;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp5551353_c0_seq1;GAXK01176781.1;P62628;9.37E-30;DLRB1_RAT;Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (robl/LC7-like protein) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23);"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]; response to light stimulus [GO:0009416]; retrograde axonal transport [GO:0008090]; visual behavior [GO:0007632]";"GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0007632; GO:0008090; GO:0009416; GO:0045505; GO:1904115";"microtubule-based movement [GO:0007018]; response to light stimulus [GO:0009416]; retrograde axonal transport [GO:0008090]; visual behavior [GO:0007632]";"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]"
comp555149_c1_seq1;GAXK01189659.1;Q8UWA5;1.08E-65;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp55534_c0_seq1;GAXK01096915.1;Q9JKK1;1.69E-67;STX6_MOUSE;Syntaxin-6;"cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0008021; GO:0012505; GO:0016020; GO:0016021; GO:0016189; GO:0016192; GO:0019905; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0055037; GO:0090161; GO:1903827";"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp555373_c0_seq1;GAXK01189648.1;A9ZSY3;2.66E-29;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp5554095_c0_seq1;GAXK01203563.1;P05661;1.79E-38;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp55543_c4_seq1;GAXK01096244.1;Q8CG65;1.56E-07;SSPO_MOUSE;SCO-spondin;"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154; GO:0062023";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]";
comp555477_c0_seq1;GAXK01189635.1;A0A0M3KKW3;3.94E-20;PA1_VESBA;Phospholipase A1 (vPLA2) (EC 3.1.1.32);"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; hemolysis in other organism [GO:0044179]; lipid metabolic process [GO:0006629]";"GO:0005576; GO:0006629; GO:0008970; GO:0044179; GO:0052739; GO:0052740";"hemolysis in other organism [GO:0044179]; lipid metabolic process [GO:0006629]";extracellular region [GO:0005576];"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]"
comp55559_c4_seq1;GAXK01096611.1;Q99P72;1.60E-26;RTN4_MOUSE;Reticulon-4 (Neurite outgrowth inhibitor) (Nogo protein);"axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of postsynaptic density membrane [GO:0099061]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of dendrite extension [GO:1903860]; negative regulation of formation of growth cone in injured axon [GO:1905943]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of vasculogenesis [GO:2001213]; nervous system development [GO:0007399]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of nervous system development [GO:0051960]; regulation of sensory perception of pain [GO:0051930]";"GO:0001825; GO:0002523; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007029; GO:0007399; GO:0007413; GO:0010634; GO:0010977; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030308; GO:0030334; GO:0030424; GO:0030517; GO:0031625; GO:0032991; GO:0033601; GO:0033603; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043209; GO:0044294; GO:0044877; GO:0045296; GO:0045665; GO:0045687; GO:0045766; GO:0048694; GO:0050771; GO:0050821; GO:0051292; GO:0051897; GO:0051930; GO:0051960; GO:0060317; GO:0060907; GO:0061462; GO:0070571; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0099061; GO:0120078; GO:1902624; GO:1903860; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1905943; GO:1990809; GO:2000172; GO:2000347; GO:2001213";"axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of dendrite extension [GO:1903860]; negative regulation of formation of growth cone in injured axon [GO:1905943]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of vasculogenesis [GO:2001213]; nervous system development [GO:0007399]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of nervous system development [GO:0051960]; regulation of sensory perception of pain [GO:0051930]";"axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of postsynaptic density membrane [GO:0099061]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]";"cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp55560_c1_seq1;GAXK01096675.1;Q0P5A2;3.40E-112;COQ5_BOVIN;2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5);"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005739; GO:0005759; GO:0006744; GO:0031314; GO:0032991; GO:0043333";ubiquinone biosynthetic process [GO:0006744];"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]
comp555734_c0_seq1;GAXK01189618.1;Q9U3D4;4.74E-34;SMS1_CAEEL;Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Sphingomyelin synthase 1);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0005887; GO:0006686; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188]"
comp55579_c1_seq1;GAXK01096941.1;Q7KRI2;1.27E-09;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp55581_c0_seq1;GAXK01096196.1;Q6ZMW2;3.36E-23;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp55585_c2_seq1;GAXK01096513.1;B2RX14;1.22E-44;TUT4_MOUSE;Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]";"GO:0001556; GO:0001816; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032088; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:1990074";"cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]"
comp55590_c1_seq1;GAXK01205433.1;Q5E9J6;1.24E-34;RNF34_BOVIN;E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (RING finger protein 34) (RING-type E3 ubiquitin transferase RNF34);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0012505; GO:0016567; GO:0016607; GO:0031625; GO:0035872; GO:0043161; GO:0046872; GO:0061630; GO:0070417; GO:0070936; GO:1901797; GO:1901981; GO:1902042; GO:2000374; GO:2001271";"apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]"
comp555915_c0_seq1;GAXK01189634.1;Q99N28;1.25E-07;CADM3_MOUSE;Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (TSLC1-like protein 1);"cell-cell junction [GO:0005911]; integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]; protein homodimerization activity [GO:0042803]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein localization [GO:0008104]";"GO:0005911; GO:0007156; GO:0007157; GO:0008104; GO:0042803; GO:0098688; GO:0099056";"heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein localization [GO:0008104]";"cell-cell junction [GO:0005911]; integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]";protein homodimerization activity [GO:0042803]
comp5559436_c0_seq1;GAXK01001984.1;Q94900;5.96E-07;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp556001_c0_seq1;GAXK01148056.1;O75897;7.37E-26;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp55601_c3_seq1;GAXK01096723.1;P17789;9.19E-46;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp556132_c0_seq1;GAXK01148059.1;Q5UQ60;2.32E-10;YL662_MIMIV;Uncharacterized protein L662;;;;;
comp5561786_c0_seq1;GAXK01142886.1;P39057;1.68E-47;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp556184_c0_seq1;GAXK01148066.1;P17010;9.52E-14;ZFX_HUMAN;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]";"GO:0000981; GO:0003677; GO:0003713; GO:0005654; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]"
comp5562_c1_seq1;GAXK01066742.1;A5PKG7;9.94E-12;KCTD5_BOVIN;BTB/POZ domain-containing protein KCTD5;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0043161; GO:0051260; GO:0097602";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";cullin family protein binding [GO:0097602]
comp556274_c0_seq1;GAXK01148020.1;Q6ZV73;6.62E-14;FGD6_HUMAN;FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0035023; GO:0043087; GO:0046847; GO:0046872";"actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]";"guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]"
comp556315_c0_seq1;GAXK01148068.1;A1UTM4;2.80E-11;GPMA_BARBK;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11);"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0006094; GO:0006096; GO:0046538";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]
comp55633_c0_seq1;GAXK01096218.1;P18700;1.42E-99;TBB_STRPU;Tubulin beta chain (Beta-tubulin) (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp5563891_c0_seq1;GAXK01118744.1;Q54UG4;1.34E-43;RL37A_DICDI;60S ribosomal protein L37a;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp556452_c0_seq1;GAXK01148044.1;Q5BKW7;5.48E-59;ENPP6_DANRE;Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (E-NPP 6) (NPP-6) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Glycerophosphocholine cholinephosphodiesterase) (GPC-Cpde);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]";"GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0016042; GO:0019695; GO:0031225; GO:0047390";"choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]"
comp556554_c0_seq1;GAXK01148071.1;Q8MRC9;1.46E-146;GALT9_DROME;Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872";"multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp55661_c0_seq1;GAXK01096046.1;Q9Z1X1;2.15E-11;ESYT1_RAT;Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein) (vp115);"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0006869; GO:0008429; GO:0030176; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0061817";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp556677_c0_seq1;GAXK01148081.1;P23640;5.13E-87;RB27A_RAT;Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram) (Ram p25);"apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; Weibel-Palade body [GO:0033093]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; Rab protein signal transduction [GO:0032482]";"GO:0001750; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006605; GO:0006886; GO:0006887; GO:0007596; GO:0010628; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0030667; GO:0031489; GO:0032402; GO:0032482; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0045921; GO:0050766; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182";"antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; Rab protein signal transduction [GO:0032482]";"apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; Weibel-Palade body [GO:0033093]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]"
comp556748_c0_seq1;GAXK01148024.1;Q52RG8;9.91E-28;FRS3_RAT;Fibroblast growth factor receptor substrate 3 (FGFR substrate 3) (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2) (SNT-2);plasma membrane [GO:0005886];GO:0005886;;plasma membrane [GO:0005886];
comp556816_c0_seq1;GAXK01148072.1;P84076;3.26E-13;HPCA_RAT;Neuron-specific calcium-binding protein hippocalcin (P23K);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; response to organic cyclic compound [GO:0014070]; retina development in camera-type eye [GO:0060041]";"GO:0003779; GO:0005509; GO:0005829; GO:0007420; GO:0010518; GO:0014070; GO:0019722; GO:0019898; GO:0019900; GO:0030424; GO:0031283; GO:0031584; GO:0032590; GO:0032809; GO:0032839; GO:0042802; GO:0043204; GO:0044327; GO:0045762; GO:0048839; GO:0060041; GO:0071257; GO:0071277; GO:0090314; GO:0098794; GO:0098978; GO:0099149; GO:1901385; GO:1901986; GO:1902065; GO:1904009; GO:1904010";"activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; response to organic cyclic compound [GO:0014070]; retina development in camera-type eye [GO:0060041]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; postsynapse [GO:0098794]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]"
comp55682_c0_seq1;GAXK01096580.1;Q9VRP9;0;BRE1_DROME;E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1);"nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]";"GO:0004842; GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574";"histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]";nucleus [GO:0005634];"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp55690_c0_seq1;GAXK01096673.1;Q640W6;4.47E-63;UBTD1_XENLA;Ubiquitin domain-containing protein 1;;;;;
comp5569624_c0_seq1;GAXK01035443.1;O42329;4.39E-16;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp5569866_c0_seq1;GAXK01035439.1;Q94900;1.16E-13;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp557_c1_seq1;GAXK01170100.1;Q03114;1.16E-172;CDK5_RAT;Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]";"GO:0001764; GO:0001934; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006886; GO:0006887; GO:0006913; GO:0007005; GO:0007049; GO:0007160; GO:0007409; GO:0007416; GO:0007417; GO:0007519; GO:0008045; GO:0008092; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0016572; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035249; GO:0035418; GO:0042501; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045055; GO:0045211; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048812; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098794; GO:0098883; GO:0098978; GO:0099635; GO:1901215; GO:1901216; GO:1903076; GO:1904646";"axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]";"acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]"
comp5570_c1_seq1;GAXK01066639.1;Q6GQG3;1.61E-09;AR19B_XENLA;cAMP-regulated phosphoprotein 19-B (ARPP-19-B);"cytoplasm [GO:0005737]; phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]";"GO:0000086; GO:0000278; GO:0004864; GO:0005737; GO:0019212; GO:0019888; GO:0051301; GO:0051721";"cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]";cytoplasm [GO:0005737];"phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]"
comp5570448_c0_seq1;GAXK01021024.1;Q0DK10;2.39E-61;RL11_ORYSJ;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp55712_c7_seq1;GAXK01096105.1;Q9H211;6.07E-56;CDT1_HUMAN;DNA replication factor Cdt1 (Double parked homolog) (DUP);"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to sorbitol [GO:0072708]";"GO:0000076; GO:0000082; GO:0000083; GO:0000278; GO:0000281; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to sorbitol [GO:0072708]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]"
comp55724_c0_seq1;GAXK01096426.1;Q6ZQ82;0;RHG26_MOUSE;Rho GTPase-activating protein 26 (Rho-type GTPase-activating protein 26);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005543; GO:0005737; GO:0005856; GO:0005925; GO:0007165; GO:0030036; GO:0051056";"actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]";"GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]"
comp5572512_c0_seq1;GAXK01089748.1;P49922;1.20E-23;GNRHR_PIG;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (Luteinizing hormone-releasing hormone receptor) (LHRH);"integral component of plasma membrane [GO:0005887]; gonadotropin-releasing hormone receptor activity [GO:0004968]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004968; GO:0005887; GO:0007186; GO:0032870";"cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]";integral component of plasma membrane [GO:0005887];gonadotropin-releasing hormone receptor activity [GO:0004968]
comp55727_c0_seq1;GAXK01096331.1;Q58DD9;1.37E-115;GPN2_PIG;GPN-loop GTPase 2 (ATP-binding domain 1 family member B);"GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525";;;"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5572992_c0_seq1;GAXK01089738.1;P92519;8.12E-10;M810_ARATH;Uncharacterized mitochondrial protein AtMg00810 (ORF240b);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp55730_c3_seq1;GAXK01096343.1;Q9NV58;4.81E-132;RN19A_HUMAN;E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008134; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576";"microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp5573009_c0_seq1;;P0A3G2;5.05E-69;DHAA_RHORH;Haloalkane dehalogenase (EC 3.8.1.5);"haloalkane dehalogenase activity [GO:0018786]; response to toxic substance [GO:0009636]";"GO:0009636; GO:0018786";response to toxic substance [GO:0009636];;haloalkane dehalogenase activity [GO:0018786]
comp557308_c0_seq1;GAXK01148033.1;Q24432;2.08E-111;OMB_DROME;Optomotor-blind protein (Lethal(1)optomotor-blind) (L(1)omb) (Protein bifid);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";"GO:0000122; GO:0000977; GO:0000978; GO:0001102; GO:0001228; GO:0001708; GO:0001745; GO:0003677; GO:0005634; GO:0007472; GO:0007476; GO:0035265; GO:0045944; GO:0048066; GO:0048100";"cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of transcription by RNA polymerase II [GO:0045944]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp5573951_c0_seq1;GAXK01089743.1;P10401;1.64E-11;POLY_DROME;"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5574852_c0_seq1;GAXK01140186.1;P36241;4.28E-53;RL19_DROME;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp55761_c0_seq1;GAXK01096144.1;Q9VFJ2;3.85E-67;RM11_DROME;39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11);"large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005762; GO:0006412; GO:0006417; GO:0015934; GO:0019843; GO:0031047; GO:0032543; GO:0070180";"gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5576546_c0_seq1;GAXK01082807.1;O59953;1.27E-38;RL5_NEUCR;60S ribosomal protein L5 (CPR4);"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0008097; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp5576886_c0_seq1;GAXK01082811.1;Q18321;4.31E-14;DAF37_CAEEL;G-protein coupled receptor daf-37 (Abnormal dauer formation protein 37);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"GO:0005794; GO:0005886; GO:0008528; GO:0016021; GO:0042803; GO:0046982; GO:0097730; GO:1904066; GO:1904067; GO:1904068";"G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]";"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";"ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp55776_c0_seq1;GAXK01096141.1;Q11076;2.71E-52;UBC17_CAEEL;Probable ubiquitin-conjugating enzyme protein 17;"nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004869; GO:0005634; GO:0006511; GO:0016874; GO:0043066; GO:0061631";"negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"cysteine-type endopeptidase inhibitor activity [GO:0004869]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]"
comp557803_c0_seq1;GAXK01148069.1;P51905;2.76E-29;SC6A4_DROME;Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1);"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"GO:0005261; GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610";"monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]";"axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; serotonin binding [GO:0051378]"
comp557932_c1_seq1;GAXK01148031.1;Q5U206;3.50E-13;CALL3_RAT;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp557982_c0_seq1;GAXK01148041.1;P02627;2.13E-08;PRVA_PELES;Parvalbumin alpha (Parvalbumin pI 4.88);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp5580372_c0_seq1;GAXK01081751.1;O76554;1.88E-07;ACH4_CAEEL;Acetylcholine receptor subunit alpha-type des-2;"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp558131_c0_seq1;GAXK01031162.1;Q55EH8;7.60E-95;ABCGN_DICDI;ABC transporter G family member 23 (ABC transporter ABCG.23);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016021; GO:0016887";;integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp558157_c0_seq1;GAXK01031121.1;A8DZE6;1.23E-16;WTIP_DANRE;Wilms tumor protein 1-interacting protein homolog (WT1-interacting protein homolog);"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; cytoskeleton organization [GO:0007010]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; establishment of mitotic spindle orientation [GO:0000132]; heart looping [GO:0001947]; negative regulation of hippo signaling [GO:0035331]; neural crest cell development [GO:0014032]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of cell morphogenesis [GO:0022604]; response to hypoxia [GO:0001666]; visceral serous pericardium development [GO:0061032]";"GO:0000132; GO:0000932; GO:0001666; GO:0001947; GO:0003140; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0007010; GO:0014032; GO:0022604; GO:0035331; GO:0035844; GO:0036064; GO:0046872; GO:0060271; GO:0061032; GO:0061371; GO:2000637";"cilium assembly [GO:0060271]; cloaca development [GO:0035844]; cytoskeleton organization [GO:0007010]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; establishment of mitotic spindle orientation [GO:0000132]; heart looping [GO:0001947]; negative regulation of hippo signaling [GO:0035331]; neural crest cell development [GO:0014032]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of cell morphogenesis [GO:0022604]; response to hypoxia [GO:0001666]; visceral serous pericardium development [GO:0061032]";"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]";"metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp558200_c0_seq1;GAXK01031102.1;P49010;1.08E-15;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp55823_c5_seq1;GAXK01096182.1;A2AH22;1.45E-26;AMRA1_MOUSE;Activating molecule in BECN1-regulated autophagy protein 1;"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; GTPase binding [GO:0051020]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to mitochondrial depolarisation [GO:0098780]";"GO:0000045; GO:0000422; GO:0000423; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0005930; GO:0006914; GO:0008285; GO:0009267; GO:0010508; GO:0010667; GO:0021915; GO:0030154; GO:0031625; GO:0043524; GO:0043552; GO:0045335; GO:0051020; GO:0098780";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to mitochondrial depolarisation [GO:0098780]";"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]";"GTPase binding [GO:0051020]; ubiquitin protein ligase binding [GO:0031625]"
comp55829_c0_seq1;GAXK01096942.1;A8D8P8;1.16E-118;SIWI_BOMMO;Piwi-like protein Siwi (EC 3.1.26.-);"cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; PET complex [GO:1990923]";"endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]"
comp5582927_c0_seq1;GAXK01105214.1;Q9VZW5;5.74E-17;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp5582931_c0_seq1;GAXK01105227.1;Q235M8;8.09E-59;RL10_TETTS;60S ribosomal protein L10;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp558301_c0_seq1;GAXK01031116.1;O93366;4.17E-40;TLX1_CHICK;T-cell leukemia homeobox protein 1 (Homeobox TLX-1) (Homeobox protein Hox-11);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]";"GO:0000978; GO:0001228; GO:0005634; GO:0007275";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp5583116_c0_seq1;GAXK01105222.1;P18173;1.20E-11;DHGL_DROME;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";"GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660";"glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]";extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp55839_c1_seq1;GAXK01096193.1;Q5XGY9;1.68E-60;MND1_XENLA;Meiotic nuclear division protein 1 homolog;"nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; reciprocal meiotic recombination [GO:0007131]";"GO:0003690; GO:0005634; GO:0007131";reciprocal meiotic recombination [GO:0007131];nucleus [GO:0005634];double-stranded DNA binding [GO:0003690]
comp558482_c0_seq1;GAXK01031104.1;Q66JZ4;6.41E-24;TCAIM_MOUSE;T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein) (TOAG-1);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp558519_c1_seq1;GAXK01031090.1;Q00566;3.10E-15;MECP2_RAT;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"chromatin [GO:0000785]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; unmethylated CpG binding [GO:0045322]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; heart development [GO:0007507]; hippocampus development [GO:0021766]; lung alveolus development [GO:0048286]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of gene expression [GO:0010628]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; regulation of DNA methylation [GO:0044030]; regulation of synapse organization [GO:0050807]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; striatum development [GO:0021756]; thalamus development [GO:0021794]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0007507; GO:0008327; GO:0009314; GO:0010212; GO:0010288; GO:0010385; GO:0010628; GO:0010629; GO:0014003; GO:0014070; GO:0019899; GO:0019904; GO:0021510; GO:0021549; GO:0021740; GO:0021756; GO:0021766; GO:0021772; GO:0021794; GO:0021987; GO:0030182; GO:0031490; GO:0031915; GO:0032091; GO:0032355; GO:0032991; GO:0035176; GO:0035865; GO:0042220; GO:0042826; GO:0044030; GO:0045322; GO:0045892; GO:0048286; GO:0048709; GO:0048712; GO:0050807; GO:0060999; GO:0061000; GO:0071317; GO:0098978; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1990841; GO:2000635";"cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; heart development [GO:0007507]; hippocampus development [GO:0021766]; lung alveolus development [GO:0048286]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of gene expression [GO:0010628]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; regulation of DNA methylation [GO:0044030]; regulation of synapse organization [GO:0050807]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; striatum development [GO:0021756]; thalamus development [GO:0021794]";"chromatin [GO:0000785]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; unmethylated CpG binding [GO:0045322]"
comp5585944_c0_seq1;GAXK01139348.1;Q91755;5.76E-36;GRIK2_XENLA;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]";"GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]"
comp5586_c2_seq1;GAXK01065912.1;Q6NWX7;1.19E-71;NTM1A_DANRE;N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051]";"GO:0005634; GO:0005737; GO:0007051; GO:0007059; GO:0008276; GO:0016571; GO:0018013; GO:0018016; GO:0035572; GO:0035573; GO:0042054; GO:0071885";"chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]"
comp55871_c3_seq1;GAXK01096117.1;Q5QJ74;6.16E-68;TBCEL_HUMAN;Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014";"microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";alpha-tubulin binding [GO:0043014]
comp5588_c0_seq1;GAXK01065357.1;Q9W770;3.39E-62;SPON1_CHICK;Spondin-1 (F-spondin);"extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]";"GO:0007155; GO:0031012; GO:0046872";cell adhesion [GO:0007155];extracellular matrix [GO:0031012];metal ion binding [GO:0046872]
comp55888_c0_seq1;GAXK01096263.1;A5D9H7;6.90E-22;UBP12_BOVIN;Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-specific-processing protease 12);"cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0006511; GO:0016579; GO:0036459; GO:0046872";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp55892_c0_seq1;GAXK01096424.1;Q28BQ6;1.23E-22;TMED1_XENTR;Transmembrane emp24 domain-containing protein 1 (p24 family protein gamma-1) (p24gamma1);"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp55902_c1_seq1;GAXK01096200.1;Q6QI44;1.86E-140;NAA25_RAT;N-alpha-acetyltransferase 25, NatB auxiliary subunit (Liver regeneration-related protein LRRGT00164) (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25);"cytoplasm [GO:0005737]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]";"GO:0005737; GO:0017196; GO:0031416";N-terminal peptidyl-methionine acetylation [GO:0017196];"cytoplasm [GO:0005737]; NatB complex [GO:0031416]";
comp5590462_c0_seq1;GAXK01148198.1;P36975;1.73E-25;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp559102_c0_seq1;GAXK01031091.1;Q25479;3.85E-18;NKCL_MANSE;Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter);"integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0006813; GO:0006814; GO:0015377; GO:0016021";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];cation:chloride symporter activity [GO:0015377]
comp559214_c0_seq1;GAXK01031088.1;F1RD85;1.18E-20;LOX3A_DANRE;Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046";"collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp55932_c2_seq1;GAXK01096138.1;Q9W0T5;3.89E-15;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp5593744_c0_seq1;GAXK01041353.1;Q6CT46;2.12E-46;DBP3_KLULA;ATP-dependent RNA helicase DBP3 (EC 3.6.4.13);"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464]";"GO:0000464; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0008186; GO:0030687";endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464];"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]"
comp55945_c0_seq1;GAXK01096978.1;Q6P3X3;1.20E-126;TTC27_HUMAN;Tetratricopeptide repeat protein 27 (TPR repeat protein 27);;;;;
comp559604_c0_seq1;GAXK01031086.1;O75311;4.02E-37;GLRA3_HUMAN;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp559669_c0_seq1;GAXK01031078.1;Q7JVE7;5.95E-34;SWET1_DROME;Sugar transporter SWEET1 (Protein saliva);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"GO:0000139; GO:0005886; GO:0007431; GO:0008643; GO:0016021; GO:0051119";"carbohydrate transport [GO:0008643]; salivary gland development [GO:0007431]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sugar transmembrane transporter activity [GO:0051119]
comp5597_c0_seq1;GAXK01066626.1;Q9VLM5;2.13E-59;DAD1_DROME;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD-1) (Oligosaccharyl transferase subunit DAD1) (Defender against apoptotic cell death 1) (Defender against cell death 1);"endomembrane system [GO:0012505]; integral component of endoplasmic reticulum membrane [GO:0030176]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; apoptotic process [GO:0006915]; protein N-linked glycosylation [GO:0006487]";"GO:0004579; GO:0006487; GO:0006915; GO:0008250; GO:0012505; GO:0030176";"apoptotic process [GO:0006915]; protein N-linked glycosylation [GO:0006487]";"endomembrane system [GO:0012505]; integral component of endoplasmic reticulum membrane [GO:0030176]; oligosaccharyltransferase complex [GO:0008250]";dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]
comp55978_c0_seq1;GAXK01096938.1;Q5FVR2;7.44E-105;TYPH_RAT;Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase);"cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]";"GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154; GO:0031641; GO:0042803; GO:0051969; GO:1905333";"mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]";cytosol [GO:0005829];"phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]"
comp55982_c0_seq1;GAXK01096656.1;Q6DIH5;1.70E-33;I2BP2_XENTR;Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]";"GO:0000977; GO:0001228; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp559857_c0_seq1;GAXK01031077.1;Q8IWZ3;6.07E-13;ANKH1_HUMAN;Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK);"cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]";"GO:0003723; GO:0005737; GO:0045087";innate immune response [GO:0045087];cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp5599_c3_seq1;GAXK01065780.1;Q6INP8;2.97E-07;MED1_XENLA;Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp55997_c5_seq1;GAXK01096385.1;Q8IN81;5.43E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp56_c0_seq1;GAXK01170217.1;Q9MGM4;3.63E-153;CYB_DROMA;Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex III [GO:0045275]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"GO:0005743; GO:0006122; GO:0008121; GO:0016021; GO:0045275; GO:0046872";mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex III [GO:0045275]";"metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp5600893_c0_seq1;GAXK01057038.1;P41753;2.24E-38;HSP70_ACHKL;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp56021_c3_seq1;GAXK01183894.1;Q6GLQ4;8.57E-11;PP1RA_XENLA;Serine/threonine-protein phosphatase 1 regulatory subunit 10;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]";"GO:0004864; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]"
comp5603282_c0_seq1;GAXK01201503.1;O31398;2.16E-10;YKWD_BACSU;Uncharacterized protein YkwD;;;;;
comp56034_c2_seq1;GAXK01183711.1;B3W6P3;3.39E-08;MNTH_LACCB;Divalent metal cation transporter MntH;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]";"GO:0005886; GO:0015293; GO:0016021; GO:0046872; GO:0046873";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]"
comp5603455_c0_seq1;GAXK01201495.1;Q8NFU0;2.41E-09;BEST4_HUMAN;Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp56042_c2_seq1;GAXK01183305.1;Q96PH1;1.86E-73;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp56045_c0_seq1;GAXK01183333.1;P00687;1.03E-141;AMY1_MOUSE;Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase);"extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617]";"GO:0004556; GO:0005509; GO:0005615; GO:0009617; GO:0016052; GO:0016160; GO:0031404; GO:0103025";"carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617]";extracellular space [GO:0005615];"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]"
comp5606_c1_seq1;GAXK01066253.1;Q92038;1.18E-113;ACOD_CYPCA;Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491";unsaturated fatty acid biosynthetic process [GO:0006636];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]"
comp56068_c1_seq1;GAXK01183318.1;Q966L5;1.43E-84;SRRT_CAEEL;Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog);"nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";"GO:0005654; GO:0006397; GO:0031053";"mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";nucleoplasm [GO:0005654];
comp560751_c0_seq1;GAXK01197513.1;Q8CI04;7.12E-08;COG3_MOUSE;Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3);"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0033365; GO:0050821";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]";
comp5607596_c0_seq1;GAXK01057182.1;Q63HN8;4.43E-08;RN213_HUMAN;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp560781_c0_seq1;GAXK01197518.1;Q66S03;2.05E-15;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp5608265_c0_seq1;GAXK01131265.1;Q5AMH6;3.42E-08;CAS5_CANAL;Cell wall integrity transcriptional regulator CAS5 (Caspofungin sensitivity protein 5);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell adhesion [GO:0007155]; cellular response to cold [GO:0070417]; cellular response to drug [GO:0035690]; development of symbiont in host [GO:0044114]; filamentous growth [GO:0030447]; fungal-type cell wall organization [GO:0031505]; pathogenesis [GO:0009405]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";"GO:0003676; GO:0005634; GO:0006357; GO:0007155; GO:0009405; GO:0010811; GO:0030447; GO:0031505; GO:0035690; GO:0044011; GO:0044114; GO:0046872; GO:0070417; GO:1900189";"cell adhesion [GO:0007155]; cellular response to cold [GO:0070417]; cellular response to drug [GO:0035690]; development of symbiont in host [GO:0044114]; filamentous growth [GO:0030447]; fungal-type cell wall organization [GO:0031505]; pathogenesis [GO:0009405]; positive regulation of cell adhesion involved in single-species biofilm formation [GO:1900189]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of transcription by RNA polymerase II [GO:0006357]; single-species biofilm formation on inanimate substrate [GO:0044011]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp560883_c1_seq1;GAXK01197539.1;Q7Z0G7;1.38E-33;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp56090_c0_seq1;GAXK01183334.1;Q8R3J4;4.06E-62;MTEF3_MOUSE;Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTERF3) (mTERF domain-containing protein 1, mitochondrial);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; double-stranded DNA binding [GO:0003690]; transcription regulatory region DNA binding [GO:0044212]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003690; GO:0005654; GO:0005739; GO:0006390; GO:0032543; GO:0044212; GO:0045892; GO:0061668";"mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; negative regulation of transcription, DNA-templated [GO:0045892]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"double-stranded DNA binding [GO:0003690]; transcription regulatory region DNA binding [GO:0044212]"
comp560962_c1_seq1;GAXK01197559.1;Q796P5;1.83E-38;YITY_BACSU;Uncharacterized FAD-linked oxidoreductase YitY (EC 1.-.-.-);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0071949";;;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp561047_c0_seq1;GAXK01197522.1;Q86YQ8;8.87E-95;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp561052_c0_seq1;GAXK01197512.1;A0JC51;5.90E-108;ZIC4_XENLA;Zinc finger protein ZIC 4 (XlZic4) (Zinc finger protein of the cerebellum 4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neural crest formation [GO:0014029]";"GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872";"nervous system development [GO:0007399]; neural crest formation [GO:0014029]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5610885_c0_seq1;GAXK01030554.1;P35443;5.87E-17;TSP4_HUMAN;Thrombospondin-4;"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]";"GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023";"behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]";"calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]"
comp56119_c0_seq1;GAXK01183900.1;Q9C8U0;4.97E-74;GSXL5_ARATH;Flavin-containing monooxygenase FMO GS-OX-like 5 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 5);"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]";"GO:0004497; GO:0004499; GO:0050660; GO:0050661";;;"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp56121_c0_seq1;GAXK01183467.1;Q8N3U4;1.89E-151;STAG2_HUMAN;Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2);"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]";"GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0032876; GO:0051301; GO:0051321; GO:0097431; GO:1901673";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]";"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp5612318_c0_seq1;GAXK01063917.1;Q96PH1;2.76E-22;NOX5_HUMAN;NADPH oxidase 5 (EC 1.6.3.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp56125_c1_seq1;GAXK01183757.1;P05661;2.91E-110;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp5612654_c0_seq1;GAXK01063915.1;Q94900;7.36E-13;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp561290_c0_seq2;GAXK01197556.1;O02151;6.12E-09;NHR14_CAEEL;Nuclear hormone receptor family member nhr-14;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856; GO:1990239";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone binding [GO:1990239]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp5613116_c0_seq1;GAXK01063914.1;Q57YG0;2.99E-10;PIF7_TRYB2;ATP-dependent DNA helicase PIF7 (EC 3.6.4.12) (DNA repair and recombination helicase PIF7);"kinetoplast [GO:0020023]; mitochondrion [GO:0005739]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; telomere maintenance [GO:0000723]";"GO:0000287; GO:0000723; GO:0003677; GO:0004386; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0020023; GO:0032508; GO:0043139; GO:0051276";"chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; telomere maintenance [GO:0000723]";"kinetoplast [GO:0020023]; mitochondrion [GO:0005739]; replication fork [GO:0005657]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]"
comp561345_c0_seq1;GAXK01197553.1;Q6P9I7;1.36E-84;SMC6_XENLA;Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6);"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398";"cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp56145_c1_seq1;GAXK01183319.1;Q6P698;1.29E-161;PLSL_DANRE;Plastin-2 (L-plastin) (Lymphocyte cytosolic plastin 1);"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]";"GO:0005509; GO:0005737; GO:0005884; GO:0030054; GO:0032432; GO:0032587; GO:0051015; GO:0051017; GO:0051639";"actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]";"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ruffle membrane [GO:0032587]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp56160_c0_seq1;GAXK01183680.1;P16157;4.17E-10;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp561656_c2_seq1;GAXK01197571.1;P15364;7.08E-24;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp5617807_c0_seq1;GAXK01000785.1;Q80SU7;2.42E-20;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp561863_c2_seq1;GAXK01197578.1;P56649;3.42E-60;G3P_PANVR;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp561885_c0_seq1;GAXK01197508.1;Q96JM7;1.02E-107;LMBL3_HUMAN;Lethal(3)malignant brain tumor-like protein 3 (H-l(3)mbt-like protein 3) (L(3)mbt-like protein 3) (MBT-1);"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]";"GO:0003700; GO:0005634; GO:0005730; GO:0006325; GO:0008270; GO:0030225; GO:0030851; GO:0043249";"chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp561891_c0_seq1;GAXK01197537.1;P63324;3.97E-15;RS12_RAT;40S ribosomal protein S12;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; response to organonitrogen compound [GO:0010243]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0010243; GO:0022625; GO:0022627";"response to organonitrogen compound [GO:0010243]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]";structural constituent of ribosome [GO:0003735]
comp5619_c2_seq1;GAXK01066710.1;Q00871;5.59E-74;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp5620_c0_seq1;GAXK01065454.1;Q9CX48;8.30E-11;ZCH10_MOUSE;Zinc finger CCHC domain-containing protein 10;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]";"GO:0003676; GO:0008270";;;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp562080_c0_seq1;GAXK01110082.1;Q9BUD6;1.10E-53;SPON2_HUMAN;Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin);"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222";"cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]";"antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]"
comp5621_c0_seq1;GAXK01205380.1;Q7M767;1.35E-64;UB2V2_RAT;Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2);"nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]";"GO:0005634; GO:0006301; GO:0010976; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0061631; GO:0070534";"error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]";nucleus [GO:0005634];ubiquitin conjugating enzyme activity [GO:0061631]
comp5621127_c0_seq1;GAXK01015234.1;Q40832;1.76E-57;TBA2_PELFA;Tubulin alpha-2 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp562184_c0_seq1;GAXK01110081.1;P02599;8.62E-13;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp562219_c0_seq1;GAXK01110069.1;Q3U0J8;2.11E-113;TBD2B_MOUSE;TBC1 domain family member 2B;"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";"GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]";cytosol [GO:0005829];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp562291_c1_seq1;GAXK01110072.1;Q8L9C4;1.28E-09;KCR1_ARATH;Very-long-chain 3-oxoacyl-CoA reductase 1 (EC 1.1.1.330) (Beta-ketoacyl reductase 1) (AtKCR1) (Protein GLOSSY 8) (gl8At);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; acetoacetyl-CoA reductase activity [GO:0018454]; ketoreductase activity [GO:0045703]; embryo development ending in seed dormancy [GO:0009793]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005739; GO:0005783; GO:0005789; GO:0009793; GO:0016021; GO:0018454; GO:0042761; GO:0045703; GO:0102339; GO:0102340; GO:0102341; GO:0102342";"embryo development ending in seed dormancy [GO:0009793]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; acetoacetyl-CoA reductase activity [GO:0018454]; ketoreductase activity [GO:0045703]"
comp56236_c0_seq1;GAXK01183772.1;Q9H1U9;1.09E-79;S2551_HUMAN;Solute carrier family 25 member 51 (Mitochondrial carrier triple repeat protein 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp5623637_c0_seq1;GAXK01089958.1;P26988;1.46E-64;G3P_PHYIN;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp562483_c0_seq1;GAXK01110083.1;Q9NUJ1;9.52E-36;ABHDA_HUMAN;Mycophenolic acid acyl-glucuronide esterase, mitochondrial (EC 3.1.1.93) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]";"GO:0004553; GO:0005739; GO:0005759; GO:0005829; GO:0019391; GO:0052695; GO:0102390";"cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"
comp5625_c1_seq1;GAXK01065840.1;P0C953;2.68E-18;H2A_ASPNC;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA repair [GO:0006281]";"GO:0000786; GO:0003677; GO:0005634; GO:0006281; GO:0046982";DNA repair [GO:0006281];"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp56255_c0_seq1;GAXK01184024.1;O94818;2.38E-40;NOL4_HUMAN;Nucleolar protein 4 (Nucleolar-localized protein);"nucleolus [GO:0005730]; RNA binding [GO:0003723]";"GO:0003723; GO:0005730";;nucleolus [GO:0005730];RNA binding [GO:0003723]
comp56276_c2_seq1;GAXK01183751.1;O42122;2.30E-133;WNT5B_ORYLA;Protein Wnt-5b;"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0045165";"cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp562841_c0_seq1;GAXK01110090.1;P82968;1.22E-09;MCPI_MELCP;Four-domain proteases inhibitor (McaPI);serine-type endopeptidase inhibitor activity [GO:0004867];GO:0004867;;;serine-type endopeptidase inhibitor activity [GO:0004867]
comp562962_c0_seq1;GAXK01110096.1;Q54P79;3.67E-35;4CL3_DICDI;Probable 4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp563049_c0_seq1;GAXK01110127.1;Q9Y3Z3;5.22E-71;SAMH1_HUMAN;Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337; GO:0060339; GO:0097197; GO:0110025";"cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]";"dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]"
comp56306_c1_seq1;GAXK01183430.1;Q5U2Q4;5.24E-59;PAR16_RAT;Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]";"GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0006471; GO:0016021; GO:0019900; GO:0030968; GO:0043539; GO:0070213; GO:0071782; GO:0140289; GO:1990404";"endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]";"kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539]"
comp563093_c0_seq1;GAXK01110132.1;P0DPW5;3.34E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp563112_c0_seq1;GAXK01110121.1;Q6ZQ12;8.75E-09;NINL_MOUSE;Ninein-like protein;"centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454]";"GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454; GO:0045171";microtubule anchoring at centrosome [GO:0034454];"centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]";calcium ion binding [GO:0005509]
comp563173_c1_seq1;GAXK01110137.1;Q6PCR6;1.27E-66;ZFR_DANRE;Zinc finger RNA-binding protein;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007275; GO:0008270";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]"
comp563345_c1_seq1;GAXK01110089.1;P81926;4.29E-40;SODC_HALRO;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp563514_c0_seq1;GAXK01110085.1;Q568Y5;2.50E-12;TSN11_RAT;Tetraspanin-11 (Tspan-11);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp56363_c0_seq1;GAXK01183756.1;Q8VIJ5;9.21E-131;OGA_RAT;Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]";"GO:0004402; GO:0005634; GO:0005739; GO:0006044; GO:0006612; GO:0007568; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0048545; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571";"aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]"
comp56364_c1_seq1;GAXK01183531.1;Q9W4E2;0;NBEA_DROME;Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614]";"GO:0005737; GO:0007528; GO:0007614; GO:0008355; GO:0016021; GO:0016319; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018";"compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]";protein kinase A binding [GO:0051018]
comp56373_c0_seq1;GAXK01183929.1;A1Z9A8;2.93E-91;PTCD3_DROME;Protein PTCD3 homolog, mitochondrial;"mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]";"GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024";"mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]";"mitochondrion [GO:0005739]; ribosome [GO:0005840]";"ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]"
comp563834_c1_seq1;GAXK01110088.1;Q9EQW7;0;KI13A_MOUSE;Kinesin-like protein KIF13A;"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383";"cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]";"centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp56386_c0_seq1;GAXK01183572.1;Q27958;1.16E-132;DPOLB_BOVIN;DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]";"GO:0003677; GO:0003887; GO:0005634; GO:0005737; GO:0006261; GO:0006284; GO:0006303; GO:0006974; GO:0016829; GO:0046872";"base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]"
comp5638750_c0_seq1;GAXK01142987.1;Q63HN8;3.48E-59;RN213_HUMAN;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp56406_c0_seq1;GAXK01184020.1;Q9VUC6;1.67E-128;FRL_DROME;Formin-like protein (Formin related in leukocytes);"actin binding [GO:0003779]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]";"GO:0003779; GO:0016318; GO:0016319; GO:0017048; GO:0030036; GO:0048675; GO:0051020";"actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]";;"actin binding [GO:0003779]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]"
comp564188_c0_seq1;GAXK01080103.1;Q9NXL6;2.53E-98;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp5641977_c0_seq1;GAXK01007328.1;P36609;5.85E-26;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp564223_c0_seq1;GAXK01080133.1;Q02357;8.87E-09;ANK1_MOUSE;Ankyrin-1 (ANK-1) (Erythrocyte ankyrin);"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0043194; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"A band [GO:0031672]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]"
comp56434_c0_seq1;GAXK01183226.1;Q9V7U0;3.91E-10;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp56438_c1_seq1;GAXK01204968.1;P28338;6.20E-40;GSTT1_MUSDO;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp5644_c1_seq1;GAXK01065668.1;Q13423;0;NNTM_HUMAN;NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]";"GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285";"cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]";"NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp564429_c0_seq1;GAXK01080113.1;Q23983;2.13E-63;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp564626_c0_seq1;GAXK01080112.1;Q7KRI2;7.38E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp564628_c1_seq1;GAXK01080117.1;Q7KRI2;4.62E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5646372_c0_seq1;GAXK01197795.1;A0A0R4IBK5;8.46E-15;R213A_DANRE;E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha);"cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872";"blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytosol [GO:0005829];"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp564812_c0_seq1;GAXK01080101.1;P41366;3.57E-07;VMO1_CHICK;Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI);"cell [GO:0005623]; extracellular space [GO:0005615]";"GO:0005615; GO:0005623";;"cell [GO:0005623]; extracellular space [GO:0005615]";
comp5648461_c0_seq1;GAXK01057455.1;Q8L4L4;1.16E-65;RL52_ORYSJ;60S ribosomal protein L5-2;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0008097; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp56490_c5_seq1;GAXK01183774.1;Q8N695;4.75E-68;SC5A8_HUMAN;Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161";"apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]"
comp565031_c0_seq1;GAXK01080084.1;B4DU55;3.07E-40;ZN879_HUMAN;Zinc finger protein 879;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp56506_c1_seq1;GAXK01183227.1;Q8NI36;0;WDR36_HUMAN;WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601]";"GO:0001895; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007601; GO:0030516; GO:0032040; GO:0034388; GO:0050896";"regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp5651873_c0_seq1;GAXK01076119.1;P18281;3.62E-22;ACTO_ACACA;Actobindin;actin binding [GO:0003779];GO:0003779;;;actin binding [GO:0003779]
comp56531_c0_seq1;GAXK01183595.1;P97584;1.79E-86;PTGR1_RAT;Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74);"cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]; response to antineoplastic agent [GO:0097327]";"GO:0005737; GO:0032440; GO:0036132; GO:0047522; GO:0097327";response to antineoplastic agent [GO:0097327];cytoplasm [GO:0005737];"13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440]"
comp5653368_c0_seq1;GAXK01131248.1;P84335;2.03E-08;TPM1_CHEAU;Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]";"GO:0005737; GO:0015629; GO:0042802; GO:0042803; GO:0046982; GO:0051015";;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp565376_c0_seq1;GAXK01080108.1;P19334;0;TRP_DROME;Transient receptor potential protein;"cation channel complex [GO:0034703]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in sensory perception [GO:0050962]; detection of light stimulus involved in visual perception [GO:0050908]; inorganic cation transmembrane transport [GO:0098662]; light-induced release of internally sequestered calcium ion [GO:0008377]; manganese ion transport [GO:0006828]; mitochondrion organization [GO:0007005]; olfactory learning [GO:0008355]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; protein localization [GO:0008104]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]";"GO:0001895; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007005; GO:0007602; GO:0007603; GO:0007605; GO:0007608; GO:0008104; GO:0008355; GO:0008377; GO:0009416; GO:0010461; GO:0015279; GO:0016021; GO:0016027; GO:0016028; GO:0034703; GO:0035997; GO:0042802; GO:0042803; GO:0046982; GO:0050908; GO:0050962; GO:0051480; GO:0070588; GO:0070679; GO:0071454; GO:0098662";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in sensory perception [GO:0050962]; detection of light stimulus involved in visual perception [GO:0050908]; inorganic cation transmembrane transport [GO:0098662]; light-induced release of internally sequestered calcium ion [GO:0008377]; manganese ion transport [GO:0006828]; mitochondrion organization [GO:0007005]; olfactory learning [GO:0008355]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; protein localization [GO:0008104]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]";"cation channel complex [GO:0034703]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]"
comp565406_c0_seq1;GAXK01080102.1;P16905;7.30E-106;KAPR1_DROME;cAMP-dependent protein kinase type I regulatory subunit (DRI class I to class IV);"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"GO:0005737; GO:0005829; GO:0005952; GO:0007015; GO:0007274; GO:0007419; GO:0007591; GO:0008103; GO:0008355; GO:0008603; GO:0019933; GO:0019934; GO:0030552; GO:0045471; GO:0047555; GO:2000253";"actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; response to ethanol [GO:0045471]; ventral cord development [GO:0007419]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp565469_c1_seq1;GAXK01080139.1;O43345;1.20E-47;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp5654972_c0_seq1;GAXK01024597.1;Q19626;6.53E-68;VATB_CAEEL;Probable V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B);"cell [GO:0005623]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; cell death [GO:0008219]; cell-cell adhesion [GO:0098609]; energy coupled proton transmembrane transport, against electrochemical gradient [GO:0015988]; positive regulation of programmed cell death [GO:0043068]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005524; GO:0005623; GO:0008219; GO:0015988; GO:0016787; GO:0033180; GO:0043068; GO:0046034; GO:0046961; GO:0051453; GO:0060142; GO:0098609; GO:1902600";"ATP metabolic process [GO:0046034]; cell-cell adhesion [GO:0098609]; cell death [GO:0008219]; energy coupled proton transmembrane transport, against electrochemical gradient [GO:0015988]; positive regulation of programmed cell death [GO:0043068]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]; response to hypoxia [GO:0001666]";"cell [GO:0005623]; proton-transporting V-type ATPase, V1 domain [GO:0033180]";"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp565504_c0_seq2;GAXK01080122.1;Q9VWB0;1.67E-12;TECPR_DROME;Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein);"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]";"GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266";peroxisome organization [GO:0007031];"autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp5655468_c0_seq1;GAXK01024592.1;P90519;5.87E-23;EF1A_CRYPV;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp56557_c5_seq1;GAXK01183086.1;Q9XYN1;6.36E-62;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp5655800_c0_seq1;GAXK01024596.1;P53623;2.47E-59;HSP72_PICAN;Heat shock protein 70 2;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737";;cytoplasm [GO:0005737];ATP binding [GO:0005524]
comp565730_c0_seq1;GAXK01080106.1;Q6DKP5;1.30E-95;WDR13_PANTR;WD repeat-containing protein 13;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp565764_c0_seq1;GAXK01080094.1;P83088;2.81E-19;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp565844_c0_seq1;GAXK01080097.1;Q9CXE0;2.72E-24;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp565847_c0_seq1;GAXK01080107.1;Q5UQ13;1.28E-12;COLL2_MIMIV;Collagen-like protein 2;virion [GO:0019012];GO:0019012;;virion [GO:0019012];
comp5658899_c0_seq1;GAXK01008876.1;Q8HY82;1.95E-21;CATS_SAIBB;Cathepsin S (EC 3.4.22.27);"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]";"GO:0005764; GO:0008234";;lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp565903_c0_seq1;GAXK01080088.1;Q8IN81;1.34E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp565924_c0_seq1;GAXK01080086.1;B0WC46;9.90E-28;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp5659669_c0_seq1;GAXK01008879.1;Q9BYN7;9.85E-12;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp56597_c2_seq1;GAXK01183520.1;P15206;7.91E-26;CCNB_MARGL;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp5659788_c0_seq1;GAXK01008880.1;Q91610;2.58E-12;DHHA_XENLA;"Desert hedgehog protein A (Cephalic hedgehog protein) (Desert hedgehog protein 1) (DHH-1) (X-CHH) [Cleaved into: Desert hedgehog protein A N-product; Desert hedgehog protein A C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0016539; GO:0046872";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp566119_c0_seq1;GAXK01057230.1;Q9VZW5;8.82E-25;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp56614_c1_seq1;GAXK01183218.1;Q86TI4;2.32E-88;WDR86_HUMAN;WD repeat-containing protein 86;;;;;
comp5662542_c0_seq1;GAXK01194206.1;P98064;4.67E-10;MASP1_MOUSE;"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; complement activation, lectin pathway [GO:0001867]";"GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0042803; GO:0048306";complement activation, lectin pathway [GO:0001867];"cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp5662938_c0_seq1;GAXK01194202.1;P34722;2.04E-20;KPC1_CAEEL;Protein kinase C-like 1 (PKC) (EC 2.7.11.13) (Tetradecanoyl phorbol acetate-resistant protein 1);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of axon regeneration [GO:0048680]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus [GO:1901244]; regulation of defense response to fungus [GO:1900150]; response to wounding [GO:0009611]";"GO:0002225; GO:0004674; GO:0004697; GO:0005524; GO:0009611; GO:0018105; GO:0031435; GO:0035556; GO:0043410; GO:0046872; GO:0048680; GO:0050832; GO:1900150; GO:1901244";"defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of axon regeneration [GO:0048680]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus [GO:1901244]; regulation of defense response to fungus [GO:1900150]; response to wounding [GO:0009611]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp56634_c1_seq1;GAXK01183761.1;Q9NYT6;1.49E-24;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp56639_c0_seq1;GAXK01184017.1;Q86BN8;7.55E-73;PTPM1_DROME;Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16) (EC 3.1.3.48);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]";"GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008138; GO:0008962; GO:0016311";"dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp56644_c1_seq1;GAXK01183848.1;Q9UKT8;3.33E-40;FBXW2_HUMAN;F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6);"cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004842; GO:0005829; GO:0006464; GO:0006508; GO:0043687";"cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";cytosol [GO:0005829];ubiquitin-protein transferase activity [GO:0004842]
comp56654_c0_seq1;GAXK01183853.1;Q10430;7.90E-13;SPC25_SCHPO;Kinetochore protein spc25;"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]";"GO:0000070; GO:0000777; GO:0000778; GO:0007059; GO:0031262; GO:0031617; GO:0051301; GO:0051455";"attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation [GO:0051455]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]";"condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]";
comp566542_c0_seq1;GAXK01057280.1;P05661;4.30E-64;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp566546_c0_seq1;GAXK01057232.1;Q6GL52;8.69E-14;ZN574_XENTR;Zinc finger protein 574;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp566559_c0_seq1;GAXK01057285.1;Q86UD5;1.77E-74;SL9B2_HUMAN;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206";"clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]";"identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]"
comp5665647_c0_seq1;GAXK01059761.1;P80977;9.63E-22;CX6C1_THUOB;Cytochrome c oxidase subunit 6C-1 (Cytochrome c oxidase polypeptide VIc-1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp5666035_c0_seq1;GAXK01196995.1;Q9L9C1;2.37E-17;PAAK_AZOEV;Phenylacetate-coenzyme A ligase (EC 6.2.1.30) (Phenylacetyl-CoA ligase) (PA-CoA ligase);"ATP binding [GO:0005524]; phenylacetate-CoA ligase activity [GO:0047475]; phenylacetate catabolic process [GO:0010124]";"GO:0005524; GO:0010124; GO:0047475";phenylacetate catabolic process [GO:0010124];;"ATP binding [GO:0005524]; phenylacetate-CoA ligase activity [GO:0047475]"
comp566673_c0_seq1;GAXK01057206.1;A6H8I2;0;SGSM3_XENLA;Small G protein signaling modulator 3 homolog (RUN and TBC1 domain-containing protein 3);;;;;
comp5667593_c0_seq1;GAXK01196999.1;P00079;6.60E-25;CYC_TETPY;Cytochrome c;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp5667645_c0_seq1;GAXK01197001.1;P34121;1.52E-24;COAA_DICDI;Coactosin (Cyclic AMP-regulated protein p16) (Cytoskeletal protein p17);"actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]";"GO:0005886; GO:0009617; GO:0015629; GO:0030833; GO:0030864; GO:0045335; GO:0051015";"regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]";"actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";actin filament binding [GO:0051015]
comp5667700_c0_seq1;GAXK01196989.1;Q6P878;1.90E-12;EIF3L_XENTR;Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp566781_c0_seq1;GAXK01057200.1;B0BMX9;3.11E-64;MEIOB_RAT;Meiosis-specific with OB domain-containing protein (EC 3.1.-.-);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712]; synapsis [GO:0007129]";"GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007141; GO:0007144; GO:0008310; GO:0009566";"double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712]; synapsis [GO:0007129]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697]"
comp5668_c48_seq1;GAXK01065544.1;Q8NB50;4.24E-23;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5668975_c0_seq1;GAXK01082402.1;Q9XYN0;2.86E-12;INX1_SCHAM;Innexin inx1 (Innexin-1) (G-Inx1);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp56696_c0_seq1;GAXK01183681.1;Q1H9T6;1.08E-09;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp5670303_c0_seq1;GAXK01004238.1;P52301;1.96E-43;RAN_XENLA;GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein);"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; eye development [GO:0001654]; GTP metabolic process [GO:0046039]; mitotic sister chromatid segregation [GO:0000070]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; snRNA import into nucleus [GO:0061015]";"GO:0000055; GO:0000056; GO:0000070; GO:0000287; GO:0001654; GO:0003924; GO:0005525; GO:0005634; GO:0005635; GO:0005829; GO:0006606; GO:0046039; GO:0061015";"eye development [GO:0001654]; GTP metabolic process [GO:0046039]; mitotic sister chromatid segregation [GO:0000070]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; snRNA import into nucleus [GO:0061015]";"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp567154_c0_seq1;GAXK01057236.1;Q28623;3.88E-16;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp56719_c0_seq1;GAXK01183306.1;P0CP96;1.19E-37;FKBP2_CRYNJ;FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0005783; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp567261_c2_seq1;GAXK01057216.1;O94256;2.88E-16;SET6_SCHPO;SET domain and MYND-type zinc finger protein 6 (EC 2.1.1.-);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; histone modification [GO:0016570]";"GO:0000790; GO:0005634; GO:0005829; GO:0016570; GO:0018024; GO:0046872";histone modification [GO:0016570];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]"
comp567448_c0_seq1;GAXK01057275.1;Q9CR24;8.25E-30;NUDT8_MOUSE;Nucleoside diphosphate-linked moiety X motif 8 (Nudix motif 8) (EC 3.6.1.-);"mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0005739; GO:0016787; GO:0046872";;mitochondrion [GO:0005739];"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp567454_c0_seq1;GAXK01057272.1;Q7Z3F1;2.28E-68;GP155_HUMAN;Integral membrane protein GPR155 (G-protein coupled receptor PGR22);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062";"cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";
comp56751_c0_seq1;GAXK01183886.1;Q9LDN2;5.41E-113;UMPS1_ORYSJ;"Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]";"orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]";"GO:0004588; GO:0004590; GO:0006207; GO:0006222; GO:0009116; GO:0019856; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]";;"orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]"
comp5675289_c0_seq1;GAXK01007309.1;P07764;3.13E-57;ALF_DROME;Fructose-bisphosphate aldolase (EC 4.1.2.13);"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]";"GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]";"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]";fructose-bisphosphate aldolase activity [GO:0004332]
comp5675464_c0_seq1;GAXK01007313.1;Q23858;1.71E-36;CALR_DICDI;Calreticulin;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006911; GO:0030246; GO:0030968; GO:0045335; GO:0051082; GO:0051707";"endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp5675804_c0_seq1;GAXK01007306.1;P31944;1.01E-09;CASPE_HUMAN;"Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008544; GO:0008630; GO:0031424; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]"
comp5676047_c0_seq1;GAXK01154839.1;P0CT83;4.02E-62;RL12A_SCHPO;60S ribosomal protein L12-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5676596_c0_seq1;GAXK01154849.1;Q9FNP8;2.81E-49;RS193_ARATH;40S ribosomal protein S19-3;"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005773; GO:0005829; GO:0006412; GO:0009536; GO:0022626; GO:0022627; GO:0042788";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp5676696_c0_seq1;GAXK01154847.1;Q9XYN1;1.63E-12;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp5677_c3_seq1;GAXK01066784.1;O54781;4.51E-104;SRPK2_MOUSE;"SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000287; GO:0001525; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045787; GO:0050684; GO:0071889";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp567715_c0_seq1;GAXK01057286.1;Q9VCA2;1.57E-70;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp5677298_c0_seq1;GAXK01154848.1;Q5XEP2;1.58E-15;HSOP2_ARATH;Hsp70-Hsp90 organizing protein 2 (AtHop2);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]; chaperone-mediated protein complex assembly [GO:0051131]; response to cadmium ion [GO:0046686]";"GO:0005634; GO:0005829; GO:0005886; GO:0046686; GO:0051131; GO:0051879; GO:0070678";"chaperone-mediated protein complex assembly [GO:0051131]; response to cadmium ion [GO:0046686]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]"
comp5677375_c0_seq1;GAXK01154859.1;Q9H7X3;1.30E-07;ZN696_HUMAN;Zinc finger protein 696;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5677837_c0_seq1;GAXK01154845.1;P36609;1.40E-28;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp5678253_c0_seq1;GAXK01182366.1;B2UCA2;1.04E-23;DAPB_RALPJ;4-hydroxy-tetrahydrodipicolinate reductase (HTPA reductase) (EC 1.17.1.8);"cytoplasm [GO:0005737]; 4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor [GO:0016726]; diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089]";"GO:0005737; GO:0008839; GO:0009089; GO:0016726; GO:0019877; GO:0050661; GO:0051287";"diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089]";cytoplasm [GO:0005737];"4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor [GO:0016726]"
comp5678508_c0_seq1;GAXK01182340.1;B1WC58;2.76E-07;CTIP_RAT;DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2);"nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; transcriptional repressor complex [GO:0017053]; damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II repressing transcription factor binding [GO:0001103]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]; blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; response to estradiol [GO:0032355]";"GO:0000014; GO:0000082; GO:0000403; GO:0000406; GO:0000724; GO:0001103; GO:0001835; GO:0003684; GO:0003690; GO:0003697; GO:0003714; GO:0005654; GO:0006289; GO:0010792; GO:0017053; GO:0032355; GO:0035861; GO:0042802; GO:0051301; GO:0051321; GO:0070336";"blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; response to estradiol [GO:0032355]";"nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; transcriptional repressor complex [GO:0017053]";"damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II repressing transcription factor binding [GO:0001103]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]"
comp567863_c0_seq1;GAXK01057228.1;Q96J84;2.61E-20;KIRR1_HUMAN;Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1);"cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"GO:0001933; GO:0005886; GO:0005911; GO:0007588; GO:0016021; GO:0017022; GO:0030838; GO:0031253; GO:0043198; GO:0045121; GO:0048471; GO:0098609";"cell-cell adhesion [GO:0098609]; excretion [GO:0007588]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]";"cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";myosin binding [GO:0017022]
comp5678875_c0_seq1;GAXK01182364.1;P06710;1.09E-63;DPO3X_ECOLI;DNA polymerase III subunit tau (EC 2.7.7.7) (DNA polymerase III subunit gamma);"DNA polymerase III, clamp loader complex [GO:0043846]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; nucleoside-triphosphatase activity [GO:0017111]; DNA replication [GO:0006260]";"GO:0003677; GO:0003887; GO:0005524; GO:0006260; GO:0016887; GO:0017111; GO:0030337; GO:0042802; GO:0043846";DNA replication [GO:0006260];DNA polymerase III, clamp loader complex [GO:0043846];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA polymerase processivity factor activity [GO:0030337]; identical protein binding [GO:0042802]; nucleoside-triphosphatase activity [GO:0017111]"
comp567906_c1_seq1;GAXK01057214.1;Q8BGM5;1.05E-68;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp5679085_c0_seq1;GAXK01182345.1;O93430;1.34E-15;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp5679284_c0_seq1;GAXK01182369.1;P40429;3.03E-31;RL13A_HUMAN;60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0015934; GO:0016020; GO:0017148; GO:0019083; GO:0022625; GO:0071346; GO:0097452; GO:1901194; GO:1990904";"cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp56796_c7_seq1;GAXK01183308.1;Q93008;0;USP9X_HUMAN;Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0036459; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380";"axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]";"co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]"
comp56801_c0_seq1;GAXK01183336.1;Q9V498;5.47E-26;CSTN1_DROME;Calsyntenin-1 (Cadherin-102F);"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]";"GO:0005509; GO:0005576; GO:0005887; GO:0007156; GO:0009986; GO:0016339; GO:0044331; GO:0045211; GO:0050806; GO:0051965";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]";calcium ion binding [GO:0005509]
comp5680397_c0_seq1;GAXK01091080.1;Q99PJ0;5.19E-08;NTRI_MOUSE;Neurotrimin;"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"GO:0005615; GO:0005886; GO:0007155; GO:0009986; GO:0010977; GO:0030424; GO:0031225; GO:0048471; GO:0060076";"cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";
comp5681680_c0_seq1;GAXK01091089.1;P08155;2.65E-07;KRH1_DROME;Krueppel homolog 1 (Krueppel homologous protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007552; GO:0010977; GO:0035075; GO:0045316; GO:0046872";"metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5682465_c0_seq1;GAXK01087886.1;Q9M5K2;8.04E-24;DLDH2_ARATH;Dihydrolipoyl dehydrogenase 2, mitochondrial (AtmLPD2) (mtLPD2) (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase 2) (Glycine cleavage system L protein 2) (Pyruvate dehydrogenase complex E3 subunit 2) (E3-2) (PDC-E3 2);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; copper ion binding [GO:0005507]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; zinc ion binding [GO:0008270]; cell redox homeostasis [GO:0045454]; response to cadmium ion [GO:0046686]";"GO:0004148; GO:0005507; GO:0005524; GO:0005739; GO:0005747; GO:0005759; GO:0005829; GO:0008270; GO:0009055; GO:0045454; GO:0046686; GO:0050660; GO:0050897";"cell redox homeostasis [GO:0045454]; response to cadmium ion [GO:0046686]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; copper ion binding [GO:0005507]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; zinc ion binding [GO:0008270]"
comp56825_c4_seq1;GAXK01183106.1;Q07929;1.73E-07;SP63_STRPU;63 kDa sperm flagellar membrane protein;"anchored component of membrane [GO:0031225]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005886; GO:0031225; GO:0031514";;"anchored component of membrane [GO:0031225]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp568276_c1_seq1;GAXK01112313.1;Q28620;1.87E-101;NPT2A_RABIT;Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-6) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; symporter activity [GO:0015293]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; response to mercury ion [GO:0046689]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006814; GO:0006817; GO:0010288; GO:0015293; GO:0015321; GO:0016021; GO:0016324; GO:0016607; GO:0046686; GO:0046689; GO:0055062; GO:0072686";"phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; response to mercury ion [GO:0046689]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]";"sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; symporter activity [GO:0015293]"
comp5682817_c0_seq1;GAXK01087892.1;Q5R895;2.98E-80;DPYD_PONAB;Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; uracil catabolic process [GO:0006212]";"GO:0000166; GO:0005737; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0046872; GO:0051539";"beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; uracil catabolic process [GO:0006212]";cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp5683965_c0_seq1;GAXK01087871.1;Q92000;5.70E-14;SHH_XENLA;Sonic hedgehog protein (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) (VHH-1) (X-SHH) [Cleaved into: Sonic hedgehog protein N-product (ShhN) (Shh N-terminal processed signaling domains) (ShhNp)];"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]; positive regulation of smoothened signaling pathway [GO:0045880]";"GO:0005509; GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0008270; GO:0016539; GO:0045880";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]; positive regulation of smoothened signaling pathway [GO:0045880]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp5684064_c0_seq1;GAXK01128141.1;Q6PE87;3.12E-21;CF206_MOUSE;Cilia- and flagella-associated protein 206;"motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"GO:0001534; GO:0003341; GO:0031514; GO:0035082";"axoneme assembly [GO:0035082]; cilium movement [GO:0003341]";"motile cilium [GO:0031514]; radial spoke [GO:0001534]";
comp5684332_c0_seq1;GAXK01128130.1;P08106;3.13E-35;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp5684839_c0_seq1;GAXK01128152.1;O42602;6.79E-08;CRFR1_XENLA;Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1);"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]";"GO:0007166; GO:0007189; GO:0015056; GO:0016021; GO:0031226; GO:0051458; GO:0071376; GO:2000852";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]";"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]";corticotrophin-releasing factor receptor activity [GO:0015056]
comp568533_c0_seq1;GAXK01112304.1;Q8T674;4.88E-17;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp568543_c0_seq1;GAXK01112358.1;Q06453;1.27E-33;AL_DROME;Homeobox protein aristaless;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; elongation of arista core [GO:0035015]; imaginal disc-derived leg morphogenesis [GO:0007480]; leg disc development [GO:0035218]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]";"GO:0000977; GO:0000981; GO:0005634; GO:0007480; GO:0022416; GO:0032991; GO:0035015; GO:0035218; GO:0045892; GO:0048666; GO:0048800";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; elongation of arista core [GO:0035015]; imaginal disc-derived leg morphogenesis [GO:0007480]; leg disc development [GO:0035218]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp5685519_c0_seq1;GAXK01128153.1;P16394;5.16E-15;HSP70_BRELC;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp56857_c0_seq1;GAXK01183946.1;Q9BQF6;1.18E-33;SENP7_HUMAN;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005622; GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp5685985_c0_seq1;GAXK01128144.1;Q09575;2.66E-11;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp5686273_c0_seq1;GAXK01104492.1;Q8CCG1;3.32E-29;ZC21C_MOUSE;Zinc finger C2HC domain-containing protein 1C;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp568709_c0_seq1;GAXK01112342.1;Q7KRI2;1.10E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp568810_c2_seq1;GAXK01112359.1;Q7KML2;0;ACOX1_DROME;Probable peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6);"peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]";"GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006635; GO:0006693; GO:0019395; GO:0033540; GO:0050660; GO:0055088; GO:0071949";"fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]";peroxisome [GO:0005777];"acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]"
comp5689012_c0_seq1;GAXK01088656.1;Q06238;8.99E-22;TNP6_ENTFC;Transposase for transposon Tn1546;"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0006313";transposition, DNA-mediated [GO:0006313];;"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp56891_c0_seq1;GAXK01183721.1;P47809;4.38E-168;MP2K4_MOUSE;Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (C-JUN N-terminal kinase kinase 1) (JNK kinase 1) (JNKK 1) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000165; GO:0000187; GO:0001934; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0023014; GO:0030424; GO:0031098; GO:0031435; GO:0032147; GO:0032839; GO:0034393; GO:0043065; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672";"activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]";"ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp5689485_c0_seq1;GAXK01088647.1;Q9M0Z3;2.38E-16;KEA3_ARATH;K(+) efflux antiporter 3, chloroplastic (AtKEA3);"chloroplast [GO:0009507]; chloroplast membrane [GO:0031969]; chloroplast thylakoid membrane [GO:0009535]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; thylakoid membrane [GO:0042651]; solute:proton antiporter activity [GO:0015299]; chloroplast organization [GO:0009658]; photosynthetic acclimation [GO:0009643]; positive regulation of photosynthesis [GO:1905157]; potassium ion transport [GO:0006813]; regulation of photosynthesis [GO:0010109]";"GO:0000139; GO:0006813; GO:0009507; GO:0009535; GO:0009643; GO:0009658; GO:0010109; GO:0015299; GO:0016020; GO:0016021; GO:0031969; GO:0042651; GO:1905157";"chloroplast organization [GO:0009658]; photosynthetic acclimation [GO:0009643]; positive regulation of photosynthesis [GO:1905157]; potassium ion transport [GO:0006813]; regulation of photosynthesis [GO:0010109]";"chloroplast [GO:0009507]; chloroplast membrane [GO:0031969]; chloroplast thylakoid membrane [GO:0009535]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; thylakoid membrane [GO:0042651]";solute:proton antiporter activity [GO:0015299]
comp569_c0_seq1;GAXK01168523.1;P48148;6.79E-131;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp5690563_c0_seq1;GAXK01081067.1;Q1ZXG4;2.04E-18;PRLA_DICDI;Proliferation-associated protein A;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005730; GO:0005737; GO:0045335";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]";nucleic acid binding [GO:0003676]
comp5690641_c0_seq1;GAXK01081063.1;P08548;2.55E-14;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp569093_c0_seq1;GAXK01112335.1;C0HL12;1.38E-10;AGRB1_RAT;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendritic spine [GO:0043197]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; phagocytic cup [GO:0001891]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]";"GO:0001891; GO:0004930; GO:0005576; GO:0005925; GO:0006909; GO:0007166; GO:0007399; GO:0007517; GO:0014069; GO:0016525; GO:0043197; GO:0045087; GO:0051963; GO:0098974; GO:0098978; GO:0099055";"cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]";"dendritic spine [GO:0043197]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; phagocytic cup [GO:0001891]; postsynaptic density [GO:0014069]";G protein-coupled receptor activity [GO:0004930]
comp5691555_c0_seq1;GAXK01081071.1;Q4R7G8;5.79E-09;MUL1_MACFA;Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase MUL1) (RING-type E3 ubiquitin transferase NFKB 1);"integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]";"GO:0000266; GO:0004842; GO:0005777; GO:0006919; GO:0007257; GO:0016567; GO:0016925; GO:0030308; GO:0031307; GO:0042802; GO:0043123; GO:0045824; GO:0046872; GO:0050689; GO:0051646; GO:0051898; GO:0060339; GO:0071360; GO:0071650; GO:1901028";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]";"integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp5691738_c0_seq1;GAXK01081064.1;Q9BRP0;7.39E-08;OVOL2_HUMAN;Transcription factor Ovo-like 2 (hOvo2) (Zinc finger protein 339);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]";"GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003682; GO:0005634; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0043565; GO:0044212; GO:0045617; GO:0045618; GO:0045746; GO:0045892; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:2000647";"angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp5691794_c0_seq1;GAXK01081085.1;P08594;1.04E-24;AQL1_THEAQ;Aqualysin-1 (EC 3.4.21.111) (Aqualysin-I);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp569264_c3_seq1;GAXK01112301.1;P9WLL8;2.76E-16;Y2067_MYCTO;Uncharacterized protein MT2127;;;;;
comp5692713_c0_seq1;GAXK01180509.1;Q9Y2W6;3.31E-16;TDRKH_HUMAN;Tudor and KH domain-containing protein (Tudor domain-containing protein 2);"mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546; GO:0071547";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547]";RNA binding [GO:0003723]
comp5692727_c0_seq1;GAXK01180514.1;Q7RXY1;1.28E-42;RL32_NEUCR;60S ribosomal protein L32 (Cytoplasmic ribosomal protein-63);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp56928_c0_seq1;GAXK01183845.1;A9CJC9;8.36E-80;PHRA_AGRFC;Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (Cyclobutane pyrimidine dimer photolyase) (CPD photolyase) (DNA photolyase PhrA) (Photoreactivating enzyme PhrA);"deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]";"GO:0000719; GO:0003677; GO:0003904; GO:0018298; GO:0071949";"photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]";;"deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]"
comp5692807_c0_seq1;GAXK01180515.1;O64425;2.58E-13;RMA1_ARATH;E3 ubiquitin-protein ligase RMA1 (EC 2.3.2.27) (Protein RING membrane-anchor 1) (RING-type E3 ubiquitin transferase RMA1);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0032527; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp5692868_c0_seq1;GAXK01180518.1;Q8IVF4;9.31E-24;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp56930_c0_seq1;GAXK01183519.1;Q6AXX4;7.75E-21;SAS10_RAT;Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog);"nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040";"brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]";
comp5693406_c0_seq1;GAXK01180508.1;C5BCK8;5.29E-43;GLK_EDWI9;Glucokinase (EC 2.7.1.2) (Glucose kinase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; glycolytic process [GO:0006096]";"GO:0004340; GO:0005524; GO:0005536; GO:0005737; GO:0006096";glycolytic process [GO:0006096];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]"
comp56937_c0_seq1;GAXK01183526.1;B1LIP1;2.45E-90;FRMA_ECOSM;S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Alcohol dehydrogenase class-3) (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-);"cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]";"GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903";ethanol oxidation [GO:0006069];cytoplasm [GO:0005737];"alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"
comp5693909_c0_seq1;GAXK01180503.1;P38412;1.09E-34;GNAQ_LOLFO;Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q);"G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp56941_c0_seq1;GAXK01183598.1;Q7KRI2;2.15E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5694115_c0_seq1;GAXK01109975.1;Q01410;8.72E-17;MANC_SALMO;Mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) (GDP-mannose pyrophosphorylase) (GMP) (GMPP);"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; lipopolysaccharide biosynthetic process [GO:0009103]";"GO:0004475; GO:0005525; GO:0009103; GO:0009298";"GDP-mannose biosynthetic process [GO:0009298]; lipopolysaccharide biosynthetic process [GO:0009103]";;"GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]"
comp569446_c0_seq1;GAXK01112344.1;Q14590;1.43E-18;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5695038_c0_seq1;GAXK01109983.1;Q9ZT94;1.65E-12;POLR2_ARATH;"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5695925_c0_seq1;GAXK01109985.1;P21328;1.49E-09;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp5696618_c0_seq1;GAXK01058411.1;Q96X45;1.57E-51;EF2_NEUCR;Elongation factor 2 (EF-2) (Colonial temperature-sensitive 3);"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp5696789_c0_seq1;GAXK01058399.1;P21328;8.12E-10;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp5696790_c0_seq1;GAXK01058394.1;Q09LZ8;1.96E-08;CBPC6_MOUSE;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp569682_c0_seq1;GAXK01112325.1;Q923W1;1.43E-28;TGS1_MOUSE;Trimethylguanosine synthase (EC 2.1.1.-) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT);"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]";"GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0009452; GO:0015030; GO:0036261; GO:0071164";"7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA trimethylguanosine synthase activity [GO:0071164]
comp5697009_c0_seq1;GAXK01058393.1;Q5WA50;1.24E-17;CTR2_OCTVU;Cephalotocin receptor 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]";"GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0046887";"G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]"
comp569708_c0_seq1;GAXK01112348.1;Q8BM89;5.62E-76;ARSJ_MOUSE;Arylsulfatase J (ASJ) (EC 3.1.6.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0008484; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp5698145_c0_seq1;GAXK01149710.1;P33727;9.31E-30;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp5698486_c0_seq1;GAXK01149714.1;Q1H9T6;9.34E-11;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp5699281_c0_seq1;GAXK01149704.1;Q9NZJ4;1.68E-58;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp5699318_c0_seq1;GAXK01149722.1;Q01292;2.15E-12;ILV5_SPIOL;Ketol-acid reductoisomerase, chloroplastic (EC 1.1.1.86) (Acetohydroxy-acid reductoisomerase) (Alpha-keto-beta-hydroxylacyl reductoisomerase);"chloroplast [GO:0009507]; ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";"GO:0000287; GO:0004455; GO:0009097; GO:0009099; GO:0009507; GO:0042803; GO:0070402";"isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";chloroplast [GO:0009507];"ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]"
comp56996_c0_seq1;GAXK01183460.1;P46461;0;NSF1_DROME;Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1);"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0005524; GO:0005737; GO:0005795; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031594; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:0099523; GO:1900073";"autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp56999_c0_seq1;GAXK01183592.1;Q7T330;1.34E-53;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp570_c0_seq1;GAXK01170000.1;C9WMM5;2.48E-159;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp5700281_c0_seq1;GAXK01012473.1;Q9ZT94;1.82E-17;POLR2_ARATH;"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5700312_c0_seq1;GAXK01012467.1;Q3KR37;5.38E-12;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp570061_c0_seq1;GAXK01145790.1;P54904;8.51E-57;P5CR1_ARATH;Pyrroline-5-carboxylate reductase (P5C reductase) (P5CR) (EC 1.5.1.2) (Protein EMBRYO DEFECTIVE 2772);"cell wall [GO:0005618]; cytosol [GO:0005829]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]; response to heat [GO:0009408]; response to salt stress [GO:0009651]";"GO:0004735; GO:0005618; GO:0005829; GO:0009408; GO:0009651; GO:0055129";"L-proline biosynthetic process [GO:0055129]; response to heat [GO:0009408]; response to salt stress [GO:0009651]";"cell wall [GO:0005618]; cytosol [GO:0005829]";pyrroline-5-carboxylate reductase activity [GO:0004735]
comp5701262_c0_seq1;GAXK01012458.1;A4KDP1;1.32E-19;D8FAD_REBSA;Acyl-lipid 8-desaturase (EC 1.14.19.-) (Delta-8 desaturase);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0006636; GO:0016021; GO:0016717; GO:0042759; GO:0046872";"long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]"
comp5701762_c0_seq1;GAXK01012476.1;Q9VZU2;6.37E-29;HHAT_DROME;Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0046843; GO:0048100";"dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp57019_c1_seq1;GAXK01183420.1;A1A619;6.06E-12;OCAD1_XENLA;OCIA domain-containing protein 1;endosome [GO:0005768];GO:0005768;;endosome [GO:0005768];
comp570218_c0_seq1;GAXK01145771.1;P18714;1.22E-11;ZG20_XENLA;Gastrula zinc finger protein xFG20-1 (XlCGF20.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5702272_c0_seq1;GAXK01009892.1;Q96SZ4;7.11E-09;ZSC10_HUMAN;Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; somatic stem cell population maintenance [GO:0035019]";"GO:0003700; GO:0005634; GO:0005654; GO:0035019; GO:0043565; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp5703505_c0_seq1;GAXK01009886.1;P12261;0;EF1G_ARTSA;Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma);translation elongation factor activity [GO:0003746];GO:0003746;;;translation elongation factor activity [GO:0003746]
comp5704330_c0_seq1;GAXK01076023.1;Q55BZ5;3.17E-21;DCD1A_DICDI;Protein dcd1A (Acid ceramidase-like protein A);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp570474_c0_seq1;GAXK01145779.1;Q60560;2.27E-09;SMBP2_MESAU;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Immunoglobulin mu-binding protein 2) (Insulin II gene enhancer-binding protein) (RIPE3B-binding complex 3B2 p110 subunit) (RIP-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; protein homooligomerization [GO:0051260]";"GO:0000049; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0030424; GO:0032574; GO:0043022; GO:0043139; GO:0043621; GO:0051260";protein homooligomerization [GO:0051260];"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp570483_c0_seq1;GAXK01145738.1;Q8BG22;1.29E-38;CLCA2_MOUSE;Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 5) (mCLCA5);"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006821; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0046872";"cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp57055_c0_seq1;GAXK01183219.1;Q15542;0;TAF5_HUMAN;Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100);"actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"GO:0000790; GO:0005634; GO:0005654; GO:0005669; GO:0006325; GO:0006352; GO:0006355; GO:0006366; GO:0006367; GO:0015629; GO:0016032; GO:0016251; GO:0016573; GO:0033276; GO:0042795; GO:0042802; GO:0044212; GO:0046983; GO:1901796";"chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]";"identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region DNA binding [GO:0044212]"
comp570567_c1_seq1;GAXK01145734.1;Q7KVA1;7.31E-14;XYLT_DROME;Xylosyltransferase oxt (EC 2.4.2.26) (Imaginal disk type I) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030201; GO:0030204; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp5705715_c0_seq1;GAXK01076027.1;Q46087;2.95E-24;TRAT_AMIAI;Transposase;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp570660_c0_seq1;GAXK01145776.1;Q7KRI2;2.94E-10;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5707004_c0_seq1;GAXK01034027.1;Q70JS2;2.33E-07;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp57083_c1_seq1;GAXK01183924.1;Q8WWW0;5.44E-38;RASF5_HUMAN;Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]";"GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0008285; GO:0017016; GO:0031398; GO:0035556; GO:0042802; GO:0042981; GO:0046872; GO:1900180";"apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; Ras GTPase binding [GO:0017016]"
comp57085_c1_seq1;GAXK01183594.1;D4A1J4;2.98E-93;BDH2_RAT;3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (R-beta-hydroxybutyrate dehydrogenase);"cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]";"GO:0003858; GO:0005737; GO:0016628; GO:0019290; GO:0042168; GO:0055072";"heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]";cytoplasm [GO:0005737];"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"
comp5708936_c0_seq1;GAXK01075427.1;Q55CT0;5.07E-13;TPP1_DICDI;Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I);"extracellular region [GO:0005576]; lysosome [GO:0005764]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; asexual reproduction [GO:0019954]; macropinocytosis [GO:0044351]; phagocytosis [GO:0006909]; proteolysis [GO:0006508]; response to chloroquine [GO:1902349]; sorocarp development [GO:0030587]";"GO:0004175; GO:0004252; GO:0005576; GO:0005764; GO:0006508; GO:0006909; GO:0008240; GO:0019954; GO:0030587; GO:0044351; GO:0046872; GO:1902349";"asexual reproduction [GO:0019954]; macropinocytosis [GO:0044351]; phagocytosis [GO:0006909]; proteolysis [GO:0006508]; response to chloroquine [GO:1902349]; sorocarp development [GO:0030587]";"extracellular region [GO:0005576]; lysosome [GO:0005764]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]"
comp5709150_c0_seq1;GAXK01075430.1;Q9HBH5;4.74E-11;RDH14_HUMAN;Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650";osteoblast differentiation [GO:0001649];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]";NADP-retinol dehydrogenase activity [GO:0052650]
comp5709770_c0_seq1;GAXK01075414.1;Q7LHG5;4.78E-14;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp5709929_c0_seq1;GAXK01075408.1;F7J220;1.73E-08;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp57102_c1_seq1;GAXK01183901.1;Q8TF09;3.42E-17;DLRB2_HUMAN;Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2);"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0035735; GO:0045505; GO:0097542";"intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]";"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]";"dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]"
comp57103_c3_seq1;GAXK01183770.1;O75691;0;UTP20_HUMAN;Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6);"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]";"GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040";"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp57104_c3_seq1;GAXK01183702.1;Q8NBZ7;0;UXS1_HUMAN;UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]; protein tetramerization [GO:0051262]; UDP-D-xylose biosynthetic process [GO:0033320]";"GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042803; GO:0048040; GO:0051262; GO:0070062; GO:0070403";"protein tetramerization [GO:0051262]; UDP-D-xylose biosynthetic process [GO:0033320]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]"
comp57105_c1_seq1;GAXK01183022.1;Q01793;9.54E-07;KRUP_TRICA;Protein krueppel (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; segmentation [GO:0035282]";"GO:0003677; GO:0005634; GO:0035282; GO:0046872";segmentation [GO:0035282];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp571095_c1_seq1;GAXK01145726.1;P58242;1.46E-88;ASM3B_MOUSE;Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0045824; GO:0046466; GO:0050728";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp5711724_c0_seq1;GAXK01148259.1;P0C0T2;1.13E-20;ANKS6_RAT;Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6);"cilium [GO:0005929]; cytoplasm [GO:0005737]; protein homodimerization activity [GO:0042803]";"GO:0005737; GO:0005929; GO:0042803";;"cilium [GO:0005929]; cytoplasm [GO:0005737]";protein homodimerization activity [GO:0042803]
comp5713010_c0_seq1;GAXK01078111.1;P83118;6.98E-07;MTH11_DROME;Probable G-protein coupled receptor Mth-like 11 (Protein methuselah-like 11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp57131_c2_seq1;GAXK01205923.1;Q969S8;2.90E-108;HDA10_HUMAN;Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10);"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]";"GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0014003; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048";"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte development [GO:0014003]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]";"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]"
comp5713319_c0_seq1;GAXK01078101.1;Q962R9;3.67E-35;RS10_SPOFR;40S ribosomal protein S10;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp5713323_c0_seq1;GAXK01078108.1;O04066;2.01E-12;ACBP_RICCO;Acyl-CoA-binding protein (ACBP);"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0008289";;;"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp5713741_c0_seq1;GAXK01078094.1;Q7SY24;4.69E-20;KPCB_DANRE;Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; embryonic hemopoiesis [GO:0035162]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0007596; GO:0008270; GO:0016020; GO:0018105; GO:0030374; GO:0035162; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0050681; GO:0050853";"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; embryonic hemopoiesis [GO:0035162]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"
comp5713752_c0_seq1;GAXK01078093.1;P35685;3.03E-41;RL7A1_ORYSJ;60S ribosomal protein L7a-1;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp5713885_c0_seq1;GAXK01078112.1;Q8BYK8;1.73E-07;ZC3H6_MOUSE;Zinc finger CCCH domain-containing protein 6;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0001162; GO:0003700; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"
comp5714669_c0_seq1;GAXK01179447.1;P17093;3.70E-66;RS11_SOYBN;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5714763_c0_seq1;GAXK01179450.1;P49087;2.38E-59;VATA_MAIZE;V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) (Fragment);"plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]";"GO:0000325; GO:0005524; GO:0005774; GO:0005886; GO:0033180; GO:0046034; GO:0046961";ATP metabolic process [GO:0046034];"plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]";"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp5715012_c0_seq1;GAXK01179456.1;Q54JE3;1.89E-08;RL221_DICDI;60S ribosomal protein L22 1;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp57158_c0_seq1;GAXK01183104.1;Q94545;1.45E-134;ASH2_DROME;Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2);"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; transcription, DNA-templated [GO:0006351]";"GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006351; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044212; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571";"brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; transcription, DNA-templated [GO:0006351]";"MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]";"DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp5715830_c0_seq1;GAXK01179459.1;P98158;1.70E-07;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp571599_c2_seq1;GAXK01145729.1;Q8VHL1;1.16E-35;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp571659_c0_seq1;GAXK01145781.1;Q5REH1;3.14E-173;PICK1_PONAB;PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein);"cell junction [GO:0030054]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]";"GO:0002092; GO:0005856; GO:0014069; GO:0019904; GO:0021782; GO:0030054; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0045211; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062";"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]";"cell junction [GO:0030054]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]"
comp5717386_c0_seq1;GAXK01123222.1;P78825;1.12E-11;ADK_SCHPO;Adenosine kinase (EC 2.7.1.20);"cytosol [GO:0005829]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; purine nucleobase metabolic process [GO:0006144]";"GO:0004001; GO:0005524; GO:0005634; GO:0005829; GO:0006144; GO:0006169; GO:0044209";"adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; purine nucleobase metabolic process [GO:0006144]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]"
comp571741_c3_seq1;GAXK01145736.1;P83111;9.05E-26;LACTB_HUMAN;Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]";"GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802";"lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
comp5717640_c0_seq1;GAXK01123216.1;P27323;6.03E-134;HS901_ARATH;Heat shock protein 90-1 (AtHSP90.1) (AtHsp90-1) (Heat shock protein 81-1) (Hsp81-1) (Heat shock protein 83);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";"GO:0005524; GO:0005737; GO:0009816; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp571770_c0_seq1;GAXK01145777.1;Q3B725;6.75E-08;ZBT24_RAT;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp571820_c0_seq1;GAXK01145744.1;Q8W468;6.50E-13;ARI8_ARATH;Probable E3 ubiquitin-protein ligase ARI8 (EC 2.3.2.31) (ARIADNE-like protein ARI8) (Protein ariadne homolog 8) (RING-type E3 ubiquitin transferase ARI8);"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp5718920_c0_seq1;GAXK01173785.1;P05661;3.61E-98;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp5719031_c0_seq1;GAXK01173783.1;Q5ZLR5;4.95E-75;UCRI_CHICK;Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (Complex III subunit IX)];"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"GO:0005739; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0016021; GO:0046872; GO:0051537";mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122];"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp571906_c0_seq1;GAXK01145780.1;Q06HQ7;7.01E-21;PLB1_MONDO;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0050253; GO:0102567; GO:0102568";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp571960_c1_seq1;GAXK01145737.1;Q99MD8;8.60E-16;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5719929_c0_seq1;GAXK01173781.1;Q9QZP2;5.91E-08;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5720574_c0_seq1;GAXK01049127.1;Q9UF47;7.96E-21;DNJ5B_HUMAN;DnaJ homolog subfamily C member 5B (Cysteine string protein beta) (CSP-beta);membrane [GO:0016020];GO:0016020;;membrane [GO:0016020];
comp5720618_c0_seq1;GAXK01049130.1;Q9N003;4.31E-12;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5720644_c0_seq1;GAXK01049131.1;P42656;7.44E-47;RAD24_SCHPO;DNA damage checkpoint protein rad24;"actomyosin contractile ring, distal actin filament layer [GO:0120106]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; meiotic cell cycle [GO:0051321]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of septation initiation signaling [GO:0031031]";"GO:0000122; GO:0004864; GO:0005634; GO:0005737; GO:0005829; GO:0007095; GO:0010515; GO:0019904; GO:0031031; GO:0032153; GO:0033314; GO:0034613; GO:0044732; GO:0044878; GO:0046826; GO:0051220; GO:0051321; GO:0120106; GO:0140311; GO:1990023";"cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; meiotic cell cycle [GO:0051321]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of septation initiation signaling [GO:0031031]";"actomyosin contractile ring, distal actin filament layer [GO:0120106]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]";"protein domain specific binding [GO:0019904]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]"
comp572091_c0_seq1;GAXK01150991.1;Q9QXW9;1.08E-116;LAT2_MOUSE;Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]";"GO:0005275; GO:0005737; GO:0005886; GO:0006865; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0015807; GO:0016021; GO:0016323; GO:0019534";"amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]"
comp5721270_c0_seq1;GAXK01049116.1;Q09099;2.00E-30;CYC6_CHLBR;Cytochrome c6 (Cytochrome c-552) (Cytochrome c-553) (Cytochrome c553) (Soluble cytochrome f);"chloroplast thylakoid lumen [GO:0009543]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; photosynthesis [GO:0015979]";"GO:0005506; GO:0009055; GO:0009543; GO:0015979; GO:0020037";photosynthesis [GO:0015979];chloroplast thylakoid lumen [GO:0009543];"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp57221_c1_seq1;GAXK01183904.1;Q8N1B4;0;VPS52_HUMAN;Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein);"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0017137; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745";"ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]";"Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]"
comp572229_c0_seq1;GAXK01151007.1;Q9PVG3;2.02E-14;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp57229_c0_seq1;GAXK01183923.1;Q6TEL1;6.74E-83;RA21A_DANRE;Double-strand-break repair protein rad21 homolog A (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)];"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; meiotic cohesin complex [GO:0030893]; nuclear matrix [GO:0016363]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood circulation [GO:0008015]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; embryonic viscerocranium morphogenesis [GO:0048703]; enteric nervous system development [GO:0048484]; heart development [GO:0007507]; heart looping [GO:0001947]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; pharyngeal system development [GO:0060037]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA transcription [GO:0009303]; sister chromatid cohesion [GO:0007062]; translation [GO:0006412]; ventriculo bulbo valve morphogenesis [GO:0003187]";"GO:0000775; GO:0000922; GO:0001947; GO:0003181; GO:0003187; GO:0003682; GO:0005829; GO:0006302; GO:0006357; GO:0006412; GO:0006915; GO:0007062; GO:0007064; GO:0007507; GO:0008015; GO:0009303; GO:0016363; GO:0030893; GO:0043280; GO:0043565; GO:0048484; GO:0048703; GO:0051301; GO:0051321; GO:0060037";"apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood circulation [GO:0008015]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; embryonic viscerocranium morphogenesis [GO:0048703]; enteric nervous system development [GO:0048484]; heart development [GO:0007507]; heart looping [GO:0001947]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; pharyngeal system development [GO:0060037]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA transcription [GO:0009303]; sister chromatid cohesion [GO:0007062]; translation [GO:0006412]; ventriculo bulbo valve morphogenesis [GO:0003187]";"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; meiotic cohesin complex [GO:0030893]; nuclear matrix [GO:0016363]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]"
comp5723_c0_seq1;GAXK01065376.1;Q6P073;1.71E-89;UB2J2_MOUSE;Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000151; GO:0000209; GO:0005524; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625; GO:0061631";"protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]"
comp5723177_c0_seq1;GAXK01154689.1;Q18812;7.56E-07;ACC2_CAEEL;Acetylcholine-gated chloride channel subunit acc-2;"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp572372_c1_seq1;GAXK01151014.1;Q7KRI2;4.59E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp572384_c0_seq1;GAXK01151018.1;Q1RJR6;5.50E-08;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp5723948_c0_seq1;GAXK01154684.1;P30277;4.88E-09;CCNB1_RAT;G2/mitotic-specific cyclin-B1;"centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; response to toxic substance [GO:0009636]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000079; GO:0000278; GO:0000307; GO:0000922; GO:0000942; GO:0001556; GO:0001701; GO:0001933; GO:0005113; GO:0005634; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0007052; GO:0007080; GO:0007283; GO:0009612; GO:0009636; GO:0010629; GO:0010971; GO:0016020; GO:0016301; GO:0016538; GO:0019901; GO:0031442; GO:0033129; GO:0042246; GO:0042493; GO:0044389; GO:0044772; GO:0046680; GO:0048146; GO:0048565; GO:0051301; GO:0051726; GO:0051987; GO:0055015; GO:0060045; GO:0060623; GO:0061575; GO:0065003; GO:0071283; GO:0071398; GO:0071407; GO:0071456; GO:0090266; GO:0097125; GO:1905448; GO:2000775";"cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; response to toxic substance [GO:0009636]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; ventricular cardiac muscle cell development [GO:0055015]";"centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]"
comp57242_c1_seq1;GAXK01183518.1;B2D0J4;6.36E-149;VDPP4_APIME;Venom dipeptidyl peptidase 4 (Allergen C) (Venom dipeptidyl peptidase IV) (EC 3.4.14.5) (allergen Api m 5);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp5724434_c0_seq1;GAXK01091812.1;Q9A943;1.18E-20;LLDD_CAUVC;L-lactate dehydrogenase (EC 1.1.-.-);"plasma membrane [GO:0005886]; FMN binding [GO:0010181]; lactate dehydrogenase activity [GO:0004457]; lactate oxidation [GO:0019516]";"GO:0004457; GO:0005886; GO:0010181; GO:0019516";lactate oxidation [GO:0019516];plasma membrane [GO:0005886];"FMN binding [GO:0010181]; lactate dehydrogenase activity [GO:0004457]"
comp572478_c0_seq1;GAXK01151047.1;Q9VCJ8;5.42E-38;SPE_DROME;"Spaetzle-processing enzyme (EC 3.4.21.-) (Spatzle-processing enzyme) [Cleaved into: Spaetzle-processing enzyme light chain; Spaetzle-processing enzyme heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; regulation of Toll signaling pathway [GO:0008592]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0004252; GO:0005576; GO:0006508; GO:0006965; GO:0008063; GO:0008592; GO:0009620; GO:0045087; GO:0045752; GO:0046872; GO:0050829; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; regulation of Toll signaling pathway [GO:0008592]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp572524_c0_seq1;GAXK01151044.1;Q63016;1.41E-15;LAT1_RAT;Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (Integral membrane protein E16) (Protein TA1) (L-type amino acid transporter 1) (LAT-1) (Solute carrier family 7 member 5);"amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; peptide antigen binding [GO:0042605]; L-tryptophan transmembrane transport [GO:1904556]; neutral amino acid transport [GO:0015804]";"GO:0005765; GO:0005829; GO:0005886; GO:0015171; GO:0015179; GO:0015190; GO:0015196; GO:0015804; GO:0016021; GO:0016324; GO:0042605; GO:1904556; GO:1990184";"L-tryptophan transmembrane transport [GO:1904556]; neutral amino acid transport [GO:0015804]";"amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; peptide antigen binding [GO:0042605]"
comp5725508_c0_seq1;GAXK01091816.1;O08648;1.40E-15;M3K4_MOUSE;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp5725511_c0_seq1;GAXK01091836.1;A1WLP8;6.41E-67;PNP_VEREI;Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]";"GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402";"mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]";cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]"
comp572594_c2_seq1;GAXK01151053.1;Q16983;2.52E-53;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp5726507_c0_seq1;GAXK01010956.1;Q3SZQ6;9.55E-36;RL32_BOVIN;60S ribosomal protein L32;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp57270_c2_seq1;GAXK01183428.1;P52655;1.80E-27;TF2AA_HUMAN;"Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001103; GO:0003677; GO:0003713; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0008134; GO:0016251; GO:0017025; GO:0042795; GO:0046982";"snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp572814_c0_seq1;GAXK01151015.1;Q6DEL1;1.32E-35;S38A7_DANRE;Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp5728380_c0_seq1;GAXK01085098.1;A2SIR1;8.08E-88;HEMH_METPP;Ferrochelatase (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase);"cytoplasm [GO:0005737]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783]";"GO:0004325; GO:0005737; GO:0006783; GO:0046872";heme biosynthetic process [GO:0006783];cytoplasm [GO:0005737];"ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]"
comp5728638_c0_seq1;GAXK01085103.1;A7Y2X0;3.82E-48;SC6A5_XENLA;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp5728798_c0_seq1;GAXK01085086.1;P57727;1.85E-09;TMPS3_HUMAN;Transmembrane protease serine 3 (EC 3.4.21.-) (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"GO:0004252; GO:0005044; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0016021; GO:0017080; GO:0043025";"cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]"
comp572929_c0_seq1;GAXK01151035.1;P18729;1.18E-48;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5729932_c0_seq1;GAXK01085105.1;Q8K596;1.75E-07;NAC2_MOUSE;Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0016323; GO:0032592; GO:0035725; GO:0042995; GO:0043025; GO:0043197; GO:0046872; GO:0048172; GO:0060291; GO:0060402; GO:0070588; GO:0098703; GO:0098794; GO:0099055; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp572999_c0_seq1;GAXK01151041.1;Q17529;2.67E-08;BEST2_CAEEL;Bestrophin homolog 2;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0005886; GO:0034707";;"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp573_c0_seq1;GAXK01166334.1;P43295;8.47E-53;RD19B_ARATH;Probable cysteine protease RD19B (EC 3.4.22.-) (RD19-like protein 1) (Thiol protease A1494);"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0000323; GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]";cysteine-type endopeptidase activity [GO:0004197]
comp5730376_c0_seq1;GAXK01088780.1;Q05746;2.53E-45;HSP70_PLACB;Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp5730445_c0_seq1;GAXK01088761.1;Q7TNB8;1.71E-25;SBNO2_MOUSE;Protein strawberry notch homolog 2;"nucleus [GO:0005634]; bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; multinuclear osteoclast differentiation [GO:0072674]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]";"GO:0002281; GO:0005634; GO:0030282; GO:0030316; GO:0045892; GO:0045944; GO:0050727; GO:0061430; GO:0071222; GO:0071348; GO:0071354; GO:0072674; GO:0072675; GO:1990830";"bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; multinuclear osteoclast differentiation [GO:0072674]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]";nucleus [GO:0005634];
comp57310_c6_seq1;GAXK01183065.1;Q6NWH0;1.47E-35;CK068_DANRE;UPF0696 protein C11orf68 homolog;;;;;
comp5731136_c0_seq1;GAXK01088772.1;P17094;8.87E-67;RL31_ARATH;60S ribosomal protein L3-1 (Protein EMBRYO DEFECTIVE 2207);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003729; GO:0003735; GO:0005618; GO:0005634; GO:0005730; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp57314_c1_seq1;GAXK01183031.1;O46072;0;KZ_DROME;Probable ATP-dependent RNA helicase kurz (EC 3.6.4.13);"nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0034458";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]"
comp5731555_c0_seq1;GAXK01088771.1;Q9VZX1;2.02E-08;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp5732539_c0_seq1;GAXK01101705.1;A0MS83;3.12E-08;ZN148_DANRE;Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89);"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; hemopoiesis [GO:0030097]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003700; GO:0005654; GO:0030097; GO:0044212; GO:0045944; GO:0046872";"hemopoiesis [GO:0030097]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp573260_c1_seq1;GAXK01150997.1;Q91994;6.94E-15;OTX1B_DANRE;Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]";"GO:0003406; GO:0003700; GO:0005634; GO:0042472; GO:0043565; GO:0060875";"inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp573261_c0_seq1;GAXK01150984.1;Q8Q0U0;7.77E-16;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp57328_c0_seq1;GAXK01183525.1;Q86YH6;5.32E-75;DLP1_HUMAN;Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]";"GO:0000010; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:0051290; GO:1990234";"isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]";"protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]"
comp5733943_c0_seq1;GAXK01101700.1;P36418;8.10E-19;VILB_DICDI;Protovillin (100 kDa actin-binding protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; barbed-end actin filament capping [GO:0051016]; cytoskeleton organization [GO:0007010]";"GO:0003785; GO:0005737; GO:0005856; GO:0007010; GO:0051015; GO:0051016";"barbed-end actin filament capping [GO:0051016]; cytoskeleton organization [GO:0007010]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]"
comp573431_c1_seq1;GAXK01151029.1;P17035;6.78E-35;ZNF28_HUMAN;Zinc finger protein 28 (Zinc finger protein KOX24);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp5734712_c0_seq1;GAXK01111022.1;O61363;1.21E-14;HCYG_ENTDO;Hemocyanin G-type, units Oda to Odg;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp5735627_c0_seq1;GAXK01111033.1;Q69Z37;4.13E-15;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp5736259_c0_seq1;GAXK01185081.1;Q54J69;2.77E-92;RL10_DICDI;60S ribosomal protein L10;"cytosolic large ribosomal subunit [GO:0022625]; lipid droplet [GO:0005811]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005811; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; lipid droplet [GO:0005811]";structural constituent of ribosome [GO:0003735]
comp5736565_c0_seq1;GAXK01185089.1;P10978;1.08E-08;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp573746_c2_seq1;GAXK01151046.1;Q52KB5;1.66E-11;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5737518_c0_seq1;GAXK01185088.1;Q5RFH0;1.46E-30;ATP5L_PONAB;ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000276; GO:0005753; GO:0015078; GO:0015986";ATP synthesis coupled proton transport [GO:0015986];"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]";proton transmembrane transporter activity [GO:0015078]
comp5738269_c0_seq1;GAXK01118677.1;Q95SX7;1.06E-17;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp5738330_c0_seq1;GAXK01118674.1;A5HK05;3.43E-19;APBP2_RAT;Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2);"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]";"GO:0005634; GO:0005874; GO:0006886; GO:0030659";intracellular protein transport [GO:0006886];"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]";
comp5738747_c0_seq1;GAXK01118678.1;P08369;2.18E-14;CRED_ECOLI;Inner membrane protein CreD;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp57403_c2_seq1;GAXK01183314.1;Q4V8A2;2.22E-177;CDC27_RAT;Cell division cycle protein 27 homolog;"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]; protein phosphatase binding [GO:0019903]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]";"GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005876; GO:0007091; GO:0019903; GO:0070979";"metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]";"anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]";protein phosphatase binding [GO:0019903]
comp5743220_c0_seq1;GAXK01202626.1;Q9C8C1;5.65E-09;LCV2_ARATH;Protein LIKE COV 2;"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; stem vascular tissue pattern formation [GO:0010222]";"GO:0005768; GO:0005794; GO:0005802; GO:0010222; GO:0016021";stem vascular tissue pattern formation [GO:0010222];"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";
comp5743821_c0_seq1;GAXK01202639.1;P75452;3.43E-14;Y110_MYCPN;Uncharacterized protein MPN_110;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787]";"GO:0003677; GO:0005524; GO:0016787";;;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787]"
comp57441_c0_seq1;GAXK01183105.1;Q7KRI2;1.30E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp574531_c0_seq1;GAXK01164302.1;Q8N608;4.80E-128;DPP10_HUMAN;Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2);"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078";"positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp5745579_c0_seq1;GAXK01177779.1;Q12MB6;1.75E-11;Y2128_SHEDO;UPF0312 protein Sden_2128;periplasmic space [GO:0042597];GO:0042597;;periplasmic space [GO:0042597];
comp57457_c2_seq1;GAXK01183210.1;Q0P5A4;3.33E-21;UCK1_BOVIN;Uridine-cytidine kinase 1 (UCK 1) (EC 2.7.1.48) (Cytidine monophosphokinase 1) (Uridine monophosphokinase 1);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp5746169_c0_seq1;GAXK01077864.1;Q58A42;1.36E-14;DD3_DICDI;Protein DD3-3;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5746252_c0_seq1;GAXK01077857.1;O15460;2.24E-19;P4HA2_HUMAN;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0016702; GO:0018401; GO:0031418; GO:0043231";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp574635_c0_seq1;GAXK01164297.1;A9YME1;4.18E-40;VA5_MICHY;Venom allergen 5 (Antigen 5) (Cysteine-rich venom protein) (CRVP) (Venom protein 3);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp5747499_c0_seq1;GAXK01077858.1;Q5F478;9.49E-10;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp5747603_c0_seq1;GAXK01077869.1;Q09103;2.16E-20;DGK2_DROME;Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein);"membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872";"deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";membrane [GO:0016020];"ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp5748_c1_seq1;GAXK01065821.1;A1Z6E0;6.39E-80;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp574972_c0_seq1;GAXK01164305.1;Q5U206;1.65E-15;CALL3_RAT;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp57501_c1_seq1;GAXK01183337.1;Q5XJS5;4.98E-55;THOC6_DANRE;THO complex subunit 6 homolog (WD repeat-containing protein 58);"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";"GO:0003723; GO:0006397; GO:0006915; GO:0007275; GO:0008380; GO:0016607; GO:0051028";"apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";nuclear speck [GO:0016607];RNA binding [GO:0003723]
comp575019_c1_seq1;GAXK01164279.1;Q7KRI2;4.95E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp575043_c0_seq1;GAXK01164256.1;Q24799;3.48E-08;MYPH_ECHGR;Myophilin;;;;;
comp575058_c1_seq1;GAXK01164299.1;Q98862;1.40E-18;IHH_DANRE;"Indian hedgehog B protein (IHHB) (Echidna hedgehog protein) (EHH) [Cleaved into: Indian hedgehog B protein N-product; Indian hedgehog B protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016539; GO:0048709; GO:0055002; GO:0070445";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp5750894_c0_seq1;GAXK01122880.1;A1L1R6;3.64E-10;ZN423_DANRE;Zinc finger protein 423;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp575133_c0_seq1;GAXK01164204.1;Q9NRP7;7.36E-108;STK36_HUMAN;Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]";"GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007228; GO:0007420; GO:0008134; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271";"brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]"
comp5751825_c0_seq1;GAXK01122883.1;P10978;4.31E-09;POLX_TOBAC;"Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp575300_c0_seq1;GAXK01164309.1;Q7KRI2;4.79E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp575334_c1_seq1;GAXK01164239.1;P17405;6.66E-87;ASM_HUMAN;Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase);"endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]";"GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006684; GO:0006685; GO:0006687; GO:0007165; GO:0007399; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043407; GO:0046513; GO:0061750; GO:0070062";"ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]";"endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp5754315_c0_seq1;GAXK01197141.1;P49211;5.15E-28;RL321_ARATH;60S ribosomal protein L32-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp5754520_c0_seq1;GAXK01197124.1;Q9UHC6;6.68E-12;CNTP2_HUMAN;Contactin-associated protein-like 2 (Cell recognition molecule Caspr2);"axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]";"GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625";"adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]";"axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]";enzyme binding [GO:0019899]
comp57546_c0_seq1;GAXK01183312.1;Q5TZ07;1.73E-24;PLPP6_DANRE;Phospholipid phosphatase 6 (EC 3.1.3.-) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Presqualene diphosphate phosphatase);"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp575481_c0_seq1;GAXK01164298.1;Q2KJ93;2.08E-71;CDC42_BOVIN;Cell division control protein 42 homolog (EC 3.6.5.2);"apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; modification of synaptic structure [GO:0099563]; neuron fate determination [GO:0048664]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein heterodimerization activity [GO:0043497]; Rho protein signal transduction [GO:0007266]";"GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007163; GO:0007266; GO:0008360; GO:0016020; GO:0019901; GO:0030031; GO:0030036; GO:0030496; GO:0030742; GO:0031258; GO:0032467; GO:0032488; GO:0032956; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0042995; GO:0043005; GO:0043197; GO:0043410; GO:0043497; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0071346; GO:0072686; GO:0099563; GO:1900026";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; modification of synaptic structure [GO:0099563]; neuron fate determination [GO:0048664]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein heterodimerization activity [GO:0043497]; Rho protein signal transduction [GO:0007266]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; protein kinase binding [GO:0019901]"
comp57552_c2_seq1;GAXK01183795.1;O18016;1.11E-16;IGDB1_CAEEL;Ig-like and fibronectin type-III domain-containing protein 1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"GO:0005886; GO:0016021; GO:0030017";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";
comp575524_c2_seq1;GAXK01164258.1;Q9CXE0;3.64E-22;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp5755447_c0_seq1;GAXK01197127.1;Q96FJ0;5.41E-13;STALP_HUMAN;AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1);"cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"GO:0004843; GO:0005768; GO:0005829; GO:0008237; GO:0016020; GO:0016579; GO:0046872; GO:0061578; GO:0070536";"protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]";"Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp5756374_c0_seq1;GAXK01131329.1;Q59H18;3.19E-17;TNI3K_HUMAN;Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779";"bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]"
comp575685_c0_seq1;GAXK01164237.1;Q50LG9;6.39E-31;LRC24_HUMAN;Leucine-rich repeat-containing protein 24;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp5757093_c0_seq1;GAXK01131322.1;Q7M3E1;1.90E-15;CTRC_BOVIN;Chymotrypsin-C (EC 3.4.21.2) (bPTLP);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp575820_c0_seq1;GAXK01164205.1;Q9TU53;3.74E-08;CUBN_CANLF;Cubilin;"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"GO:0005509; GO:0005765; GO:0008144; GO:0008203; GO:0010008; GO:0015031; GO:0016324; GO:0031419; GO:0031526";"cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]";"calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]"
comp5758456_c0_seq1;GAXK01140445.1;Q4N938;2.93E-10;TCTP_THEPA;Translationally-controlled tumor protein homolog (TCTP);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp5759219_c0_seq1;GAXK01140451.1;Q4ZG55;1.20E-08;GREB1_HUMAN;Protein GREB1 (Gene regulated in breast cancer 1 protein);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0016021; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";
comp5759461_c0_seq1;GAXK01140439.1;Q8FK36;9.82E-47;CUSA_ECOL6;Cation efflux system protein CusA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; copper ion transport [GO:0006825]";"GO:0005886; GO:0006825; GO:0008324; GO:0016021";copper ion transport [GO:0006825];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp575947_c0_seq1;GAXK01164301.1;Q7Z407;8.71E-25;CSMD3_HUMAN;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5759762_c0_seq1;GAXK01140444.1;Q9WV72;1.55E-15;ASB3_MOUSE;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp5761_c2_seq1;GAXK01066624.1;Q0P4L9;2.01E-81;TMM19_XENTR;Transmembrane protein 19;"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp5761233_c0_seq1;GAXK01010274.1;P21328;3.66E-16;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp5762161_c0_seq1;GAXK01011072.1;P34750;3.27E-31;PILQ_PSEAE;Fimbrial assembly protein PilQ;"cell outer membrane [GO:0009279]; protein secretion [GO:0009306]; type IV pilus biogenesis [GO:0043683]";"GO:0009279; GO:0009306; GO:0043683";"protein secretion [GO:0009306]; type IV pilus biogenesis [GO:0043683]";cell outer membrane [GO:0009279];
comp57623_c1_seq1;GAXK01183522.1;Q9BWU0;7.90E-91;NADAP_HUMAN;Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]";"GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231";;"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";mRNA binding [GO:0003729]
comp576248_c0_seq1;GAXK01196465.1;Q9N003;5.22E-20;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp57626_c0_seq1;GAXK01183915.1;Q9CWT6;1.74E-63;DDX28_MOUSE;Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28);"cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; mitochondrial large ribosomal subunit assembly [GO:1902775]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005739; GO:0005829; GO:0019843; GO:0035770; GO:0042645; GO:1902775; GO:1990400";mitochondrial large ribosomal subunit assembly [GO:1902775];"cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]";"ATP binding [GO:0005524]; mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]"
comp576449_c0_seq1;GAXK01196434.1;Q6ZV73;1.04E-110;FGD6_HUMAN;FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0035023; GO:0043087; GO:0046847; GO:0046872";"actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]";"guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]"
comp576503_c1_seq1;GAXK01196471.1;P17026;6.14E-09;ZNF22_HUMAN;Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; odontogenesis [GO:0042476]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0008270; GO:0042476";"odontogenesis [GO:0042476]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp57654_c0_seq1;GAXK01183335.1;B7P877;2.35E-75;NCBP2_IXOSC;Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20);"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000339; GO:0000398; GO:0005634; GO:0005846; GO:0031047; GO:0045292";"gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]";"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]";RNA cap binding [GO:0000339]
comp576604_c0_seq1;GAXK01196448.1;Q16TM5;1.83E-113;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5766424_c0_seq1;GAXK01052615.1;Q52KB5;2.01E-10;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp576725_c0_seq1;GAXK01196451.1;Q96NR8;1.01E-46;RDH12_HUMAN;Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2);"endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0110095";"cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]";"NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]"
comp576740_c0_seq1;GAXK01196478.1;P37610;4.63E-14;TAUD_ECOLI;Alpha-ketoglutarate-dependent taurine dioxygenase (EC 1.14.11.17) (2-aminoethanesulfonate dioxygenase) (Sulfate starvation-induced protein 3) (SSI3);"cytoplasm [GO:0005737]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; taurine dioxygenase activity [GO:0000908]; sulfur compound metabolic process [GO:0006790]";"GO:0000908; GO:0005737; GO:0006790; GO:0031418; GO:0046872";sulfur compound metabolic process [GO:0006790];cytoplasm [GO:0005737];"L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; taurine dioxygenase activity [GO:0000908]"
comp5767611_c0_seq1;GAXK01052614.1;P00919;8.66E-30;CAH2_RABIT;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; positive regulation of dipeptide transmembrane transport [GO:2001150]; regulation of anion transport [GO:0044070]; regulation of intracellular pH [GO:0051453]";"GO:0004064; GO:0004089; GO:0005737; GO:0005886; GO:0008270; GO:0038166; GO:0044070; GO:0045177; GO:0051453; GO:2001150";"angiotensin-activated signaling pathway [GO:0038166]; positive regulation of dipeptide transmembrane transport [GO:2001150]; regulation of anion transport [GO:0044070]; regulation of intracellular pH [GO:0051453]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp57677_c1_seq1;GAXK01183465.1;Q9VQI9;4.85E-28;AFF4_DROME;AF4/FMR2 family member 4 (Protein lilliputian) (Suppressor of Raf at 2A) (Suppressor of sina 2-1);"ELL-EAF complex [GO:0032783]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; compound eye photoreceptor development [GO:0042051]; learning or memory [GO:0007611]; neuronal stem cell population maintenance [GO:0097150]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell size [GO:0008361]; regulation of cytoskeleton organization [GO:0051493]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0006355; GO:0007366; GO:0007379; GO:0007611; GO:0008023; GO:0008361; GO:0032368; GO:0032783; GO:0035327; GO:0042051; GO:0045944; GO:0048190; GO:0051493; GO:0061629; GO:0097150";"compound eye photoreceptor development [GO:0042051]; learning or memory [GO:0007611]; neuronal stem cell population maintenance [GO:0097150]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell size [GO:0008361]; regulation of cytoskeleton organization [GO:0051493]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]";"ELL-EAF complex [GO:0032783]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"
comp576820_c0_seq1;GAXK01196477.1;P10073;1.60E-42;ZSC22_HUMAN;Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp57683_c1_seq1;GAXK01183024.1;Q92614;4.80E-61;MY18A_HUMAN;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp5768701_c0_seq1;GAXK01189205.1;I7HJS4;3.69E-10;ZN683_MOUSE;Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]";"GO:0001779; GO:0002250; GO:0003677; GO:0005634; GO:0010468; GO:0032823; GO:0032826; GO:0033082; GO:0045087; GO:0046872; GO:0051136; GO:1990841";"adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]"
comp5769887_c0_seq1;GAXK01189196.1;Q2PC93;2.73E-07;SSPO_CHICK;SCO-spondin;"extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005615; GO:0007155; GO:0007399; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";extracellular space [GO:0005615];
comp5770225_c0_seq1;GAXK01004915.1;P15387;2.24E-32;KCNB1_RAT;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp5770672_c0_seq1;GAXK01004903.1;A3LQW7;1.49E-33;DBP2_PICST;ATP-dependent RNA helicase DBP2 (EC 3.6.4.13);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]";"GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:0008186; GO:0071042; GO:1990120";"messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]"
comp5770777_c0_seq1;GAXK01004909.1;Q8TFH1;2.62E-39;RL18B_SCHPO;60S ribosomal protein L18-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp57717_c0_seq1;GAXK01183215.1;Q5TJG6;4.34E-13;BRD2_CANLF;Bromodomain-containing protein 2;"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577";"nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";"chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]"
comp5773012_c0_seq1;GAXK01030508.1;Q8VHE6;6.61E-120;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp57731_c1_seq1;GAXK01183307.1;Q3V6T2;1.19E-138;GRDN_HUMAN;Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; G-protein gamma-subunit binding [GO:0031682]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";"GO:0001932; GO:0003779; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006260; GO:0006275; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030142; GO:0030705; GO:0031122; GO:0031410; GO:0031682; GO:0031929; GO:0032148; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042803; GO:0043422; GO:0045724; GO:0051959; GO:0061024; GO:1903566";"activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; G-protein gamma-subunit binding [GO:0031682]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]"
comp5774403_c0_seq1;GAXK01120414.1;O43614;7.06E-09;OX2R_HUMAN;Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0051480";"chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]"
comp5774969_c0_seq1;GAXK01120425.1;Q9Z0E8;3.00E-14;S22A5_MOUSE;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0048608; GO:0052106; GO:0060731; GO:0070715";"adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]"
comp5775074_c0_seq1;GAXK01120416.1;Q6NSZ9;2.11E-10;ZSC25_HUMAN;Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp577517_c0_seq1;GAXK01196444.1;P31319;9.76E-43;KAPR_APLCA;cAMP-dependent protein kinase regulatory subunit (N4 subunit of protein kinase A);"cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]";"GO:0005952; GO:0008603; GO:0030552";;cAMP-dependent protein kinase complex [GO:0005952];"cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp5775327_c0_seq1;GAXK01120436.1;O94489;8.22E-22;EF3_SCHPO;Elongation factor 3 (EF-3);"cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]";"GO:0002182; GO:0003746; GO:0005524; GO:0005829; GO:0016887";cytoplasmic translational elongation [GO:0002182];cytosol [GO:0005829];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; translation elongation factor activity [GO:0003746]"
comp5776839_c0_seq1;GAXK01039156.1;O65731;2.87E-57;RS5_CICAR;40S ribosomal protein S5 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5777301_c0_seq1;GAXK01039148.1;P16157;2.80E-26;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp577755_c0_seq1;GAXK01196485.1;O08717;3.06E-07;INHBE_MOUSE;Inhibin beta E chain (Activin beta-E chain);"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160]; cell development [GO:0048468]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]";"GO:0005125; GO:0005160; GO:0005179; GO:0005615; GO:0008083; GO:0010862; GO:0042981; GO:0043408; GO:0048468; GO:0060395";"cell development [GO:0048468]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]";extracellular space [GO:0005615];"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160]"
comp577778_c0_seq1;GAXK01196496.1;Q9R112;1.03E-141;SQOR_MOUSE;Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-) (Sulfide quinone oxidoreductase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";"GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949";"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]"
comp577806_c2_seq1;GAXK01196453.1;P35789;6.19E-19;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp57781_c0_seq1;GAXK01183427.1;Q94901;5.19E-35;LARK_DROME;RNA-binding protein lark;"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"GO:0000278; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0007303; GO:0007562; GO:0007623; GO:0008062; GO:0008104; GO:0008270; GO:0009792; GO:0016607; GO:0030036; GO:0042752; GO:0045292; GO:0045475; GO:0045804; GO:0045995; GO:0071011; GO:0071013; GO:2000767";"actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp57790_c1_seq1;GAXK01183945.1;Q5F3G0;1.61E-51;RHG19_CHICK;Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19);"cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005737; GO:0007165; GO:0051056";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];GTPase activator activity [GO:0005096]
comp57792_c4_seq1;GAXK01183221.1;Q06180;1.18E-66;PTN2_MOUSE;Tyrosine-protein phosphatase non-receptor type 2 (Protein-tyrosine phosphatase PTP-2) (EC 3.1.3.48) (MPTP);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein dephosphorylation [GO:0006470]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; T cell differentiation [GO:0030217]";"GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0006470; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587";"B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein dephosphorylation [GO:0006470]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; T cell differentiation [GO:0030217]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]"
comp577923_c0_seq1;GAXK01196497.1;Q9NR61;1.61E-23;DLL4_HUMAN;Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601]";"GO:0000122; GO:0001525; GO:0001569; GO:0001974; GO:0003180; GO:0003208; GO:0003209; GO:0003222; GO:0003344; GO:0005112; GO:0005509; GO:0005886; GO:0007165; GO:0007219; GO:0007601; GO:0008015; GO:0008285; GO:0010596; GO:0010628; GO:0010629; GO:0016021; GO:0030217; GO:0035912; GO:0035924; GO:0044344; GO:0045746; GO:0045747; GO:0050767; GO:0060579; GO:0061074; GO:0061314; GO:0072554; GO:0090051; GO:1903588; GO:2000179";"angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]"
comp5779277_c0_seq1;GAXK01141221.1;Q9P243;1.93E-09;ZFAT_HUMAN;Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5780816_c0_seq1;GAXK01152268.1;Q9WV06;1.84E-10;ANKR2_MOUSE;Ankyrin repeat domain-containing protein 2 (Skeletal muscle ankyrin repeat protein) (mArpp);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcomere [GO:0030017]; chromatin binding [GO:0003682]; protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to muscle stretch [GO:0035994]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]";"GO:0000122; GO:0000791; GO:0001817; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0007519; GO:0010832; GO:0016605; GO:0030016; GO:0030017; GO:0031432; GO:0031674; GO:0035914; GO:0035994; GO:0043231; GO:0043422; GO:0043619; GO:0045662; GO:0061629; GO:1902253; GO:2000291";"negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to muscle stretch [GO:0035994]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcomere [GO:0030017]";"chromatin binding [GO:0003682]; protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]"
comp578114_c0_seq1;GAXK01024873.1;Q7T3C7;1.79E-41;RT4I1_DANRE;Reticulon-4-interacting protein 1 homolog, mitochondrial;"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"GO:0005739; GO:0005741; GO:0010842; GO:0016491; GO:0042462; GO:0050773";"eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp57812_c0_seq1;GAXK01183204.1;Q5ZJP5;1.20E-106;FND3A_CHICK;Fibronectin type-III domain-containing protein 3a;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017]";"GO:0000139; GO:0016021; GO:0030017";;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017]";
comp578203_c2_seq1;GAXK01024914.1;Q8VIG1;2.57E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp57829_c1_seq1;GAXK01183338.1;Q62077;0;PLCG1_MOUSE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1);"cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852]";"GO:0001701; GO:0001726; GO:0004435; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0009306; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030971; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0048015; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0098685; GO:0098978; GO:1901339; GO:1905564; GO:2000353";"calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852]";"cell-cell junction [GO:0005911]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]";"calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]"
comp5783771_c0_seq1;GAXK01143009.1;Q7L1S5;6.40E-07;CHST9_HUMAN;Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp57841_c0_seq1;GAXK01183317.1;Q9W3N6;0;USO1_DROME;General vesicular transport factor p115;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; Golgi stack [GO:0005795]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of imaginal disc-derived wing size [GO:0044719]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]";"GO:0005783; GO:0005789; GO:0005795; GO:0006886; GO:0006888; GO:0007030; GO:0010389; GO:0012507; GO:0032580; GO:0044719; GO:0045056; GO:0048211; GO:0048280; GO:0061025";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of imaginal disc-derived wing size [GO:0044719]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; Golgi stack [GO:0005795]";
comp57845_c0_seq1;GAXK01183898.1;Q3T197;3.75E-58;CX056_BOVIN;UPF0428 protein CXorf56 homolog;"cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0044297";;"cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp578497_c0_seq1;GAXK01024879.1;Q9P255;6.89E-28;ZN492_HUMAN;Zinc finger protein 492 (Zinc finger protein 115);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5785485_c0_seq1;GAXK01059364.1;Q21565;8.99E-38;AMT3_CAEEL;Putative ammonium transporter 3;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp5788_c3_seq1;GAXK01065339.1;Q8VEL0;5.28E-43;MSPD1_MOUSE;Motile sperm domain-containing protein 1;"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0016021; GO:0030154; GO:0045944; GO:0048471";"cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp578862_c0_seq1;GAXK01024872.1;Q8R420;2.90E-95;ABCA3_MOUSE;ATP-binding cassette sub-family A member 3;"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]";"GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233";"lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]";"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp5789023_c0_seq1;GAXK01137999.1;Q95VA8;1.91E-32;TPM_TRISP;Tropomyosin;;;;;
comp5789098_c0_seq1;GAXK01138002.1;P0C0T2;8.02E-42;ANKS6_RAT;Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6);"cilium [GO:0005929]; cytoplasm [GO:0005737]; protein homodimerization activity [GO:0042803]";"GO:0005737; GO:0005929; GO:0042803";;"cilium [GO:0005929]; cytoplasm [GO:0005737]";protein homodimerization activity [GO:0042803]
comp5789283_c0_seq1;GAXK01138011.1;Q64520;2.33E-38;KGUA_MOUSE;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939";"ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp5789629_c0_seq1;GAXK01137996.1;O75385;1.25E-15;ULK1_HUMAN;Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1);"Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; macroautophagy [GO:0016236]; negative regulation of protein complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; response to starvation [GO:0042594]; signal transduction [GO:0007165]";"GO:0000045; GO:0000407; GO:0004674; GO:0005524; GO:0005737; GO:0005741; GO:0005776; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007165; GO:0008104; GO:0010506; GO:0010508; GO:0016020; GO:0016236; GO:0016241; GO:0016301; GO:0017137; GO:0018105; GO:0018107; GO:0030424; GO:0031102; GO:0031175; GO:0031333; GO:0031669; GO:0034045; GO:0042594; GO:0042802; GO:0044877; GO:0046777; GO:0048675; GO:0051020; GO:0055037; GO:0075044; GO:0097629; GO:0097632; GO:0097635; GO:1990316; GO:2000786";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; macroautophagy [GO:0016236]; negative regulation of protein complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; response to starvation [GO:0042594]; signal transduction [GO:0007165]";"Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]";"ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein-containing complex binding [GO:0044877]; protein serine/threonine kinase activity [GO:0004674]; Rab GTPase binding [GO:0017137]"
comp57897_c2_seq1;GAXK01183922.1;O35920;1.56E-56;CAN9_RAT;Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; sarcomere organization [GO:0045214]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0045214";"proteolysis [GO:0006508]; sarcomere organization [GO:0045214]";cytoplasm [GO:0005737];"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp57899_c7_seq1;GAXK01183937.1;Q6J201;9.50E-21;SPI_CYACP;Serine protease inhibitor (Jellypin) (JP);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]";"GO:0004867; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp57903_c0_seq1;GAXK01183707.1;Q6GNR9;8.49E-167;OST48_XENLA;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit);"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006486; GO:0008250; GO:0016021; GO:0018279";"protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]";"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]";
comp57907_c0_seq1;GAXK01183330.1;Q2HJ10;3.11E-82;ZNT2_MOUSE;Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005737; GO:0005770; GO:0005774; GO:0005886; GO:0006829; GO:0010043; GO:0016021; GO:0031410; GO:0043231; GO:0061088; GO:0061090; GO:0071577";"positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";zinc ion transmembrane transporter activity [GO:0005385]
comp579081_c0_seq1;GAXK01024890.1;Q93353;2.90E-123;IDH3B_CAEEL;Probable isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp579117_c0_seq1;GAXK01024931.1;Q9HCX4;7.96E-20;TRPC7_HUMAN;Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (hTRP7);"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0030168; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp5791931_c0_seq1;GAXK01028318.1;Q01791;1.37E-07;HUNB_TRICA;Protein hunchback;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";"GO:0000981; GO:0003677; GO:0005634; GO:0035282; GO:0040034; GO:0046872";"regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp579239_c0_seq1;GAXK01024958.1;Q20657;4.02E-55;STO3_CAEEL;Stomatin-3;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp57924_c2_seq1;GAXK01183217.1;P35600;0;RFC1_DROME;Replication factor C subunit 1 (Activator 1 140 kDa subunit) (Activator 1 subunit 1) (Germline transcription factor 1) (Replication factor C large subunit);"DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; dendrite morphogenesis [GO:0048813]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0003677; GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006281; GO:0048813";"dendrite morphogenesis [GO:0048813]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]"
comp5792438_c0_seq1;GAXK01076140.1;Q5ZKY4;1.25E-20;ING4_CHICK;Inhibitor of growth protein 4 (p29ING4);"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]";"GO:0000123; GO:0003713; GO:0005634; GO:0005829; GO:0006260; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872";"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]";"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]"
comp5792480_c0_seq1;GAXK01076126.1;O77649;5.57E-34;UDB20_MACFA;UDP-glucuronosyltransferase 2B20 (UDPGT 2B20) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp5792888_c0_seq1;GAXK01076128.1;Q9BQS2;1.28E-11;SYT15_HUMAN;Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV);"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]";"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]"
comp5793_c2_seq1;GAXK01066691.1;Q15050;2.93E-62;RRS1_HUMAN;Ribosome biogenesis regulatory protein homolog;"condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]";"GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0001650; GO:0002244; GO:0003723; GO:0005634; GO:0005730; GO:0005783; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570";"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]";"condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]";"5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]"
comp579333_c2_seq1;GAXK01024907.1;P02751;7.97E-07;FINC_HUMAN;"Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-substrate junction assembly [GO:0007044]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; integrin activation [GO:0033622]; interaction with symbiont [GO:0051702]; leukocyte migration [GO:0050900]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; post-translational protein modification [GO:0043687]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiotic process mediated by secreted substance [GO:0052047]; wound healing [GO:0042060]";"GO:0001525; GO:0001932; GO:0002020; GO:0002576; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0006953; GO:0007044; GO:0007155; GO:0007161; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0016324; GO:0016504; GO:0018149; GO:0019221; GO:0019899; GO:0030198; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042060; GO:0042802; GO:0043394; GO:0043687; GO:0044267; GO:0045773; GO:0048146; GO:0050900; GO:0051087; GO:0051702; GO:0052047; GO:0062023; GO:0070062; GO:0070372; GO:0072562; GO:0097718; GO:1901166; GO:1904237; GO:2001202";"acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-substrate junction assembly [GO:0007044]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; integrin activation [GO:0033622]; interaction with symbiont [GO:0051702]; leukocyte migration [GO:0050900]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; post-translational protein modification [GO:0043687]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiotic process mediated by secreted substance [GO:0052047]; wound healing [GO:0042060]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]";"chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]"
comp5793341_c0_seq1;GAXK01076148.1;Q8MUF6;4.18E-27;MYSP_BLOTA;Paramyosin (allergen Blo t 11);"myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]";"GO:0003774; GO:0030016; GO:0032982";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";motor activity [GO:0003774]
comp57936_c0_seq1;GAXK01183203.1;O70444;4.81E-75;PIM3_RAT;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0016572; GO:0043066; GO:0046777; GO:0061179";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp5793808_c0_seq1;GAXK01076144.1;Q6UWB4;9.75E-11;PRS55_HUMAN;Serine protease 55 (EC 3.4.21.-) (Testis serine protease 1) (T-SP1);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005829; GO:0016021";;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]";serine-type endopeptidase activity [GO:0004252]
comp5794143_c0_seq1;GAXK01005372.1;Q7M4I3;3.35E-18;SP4_BOMPE;Venom protease (EC 3.4.21.-) (allergen Bom p 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp57946_c0_seq1;GAXK01183914.1;Q5XXA7;6.47E-13;HDGR2_DANRE;Hepatoma-derived growth factor-related protein 2 (HRP-2);;;;;
comp57949_c3_seq1;GAXK01183593.1;Q95209;7.18E-43;SORL_RABIT;Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA);"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; adaptive thermogenesis [GO:1990845]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]";"GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005794; GO:0005886; GO:0006605; GO:0006869; GO:0006897; GO:0008203; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0030514; GO:0034362; GO:0038020; GO:0046628; GO:1904179; GO:1990845";"adaptive thermogenesis [GO:1990845]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]";
comp579536_c1_seq1;GAXK01024876.1;Q9VTY4;1.33E-36;KXDL1_DROME;KxDL motif-containing protein CG10681;"BORC complex [GO:0099078]; lysosome localization [GO:0032418]";"GO:0032418; GO:0099078";lysosome localization [GO:0032418];BORC complex [GO:0099078];
comp57955_c0_seq1;GAXK01183928.1;Q7RTY0;1.80E-42;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp5795563_c0_seq1;GAXK01005374.1;B5DF27;1.22E-17;LOXL2_RAT;Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2);"basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]";"GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0006464; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0046688; GO:0070492; GO:0070828; GO:1902455";"cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]";"basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]"
comp5796400_c0_seq1;GAXK01041371.1;Q9XW78;5.10E-08;F172A_CAEEL;FAM172 family protein homolog Y75B8A.31;"nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]";"GO:0005634; GO:0031048";chromatin silencing by small RNA [GO:0031048];nucleus [GO:0005634];
comp579711_c0_seq1;GAXK01024871.1;Q5SW96;1.47E-31;ARH_HUMAN;Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein);"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030665; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0061024; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602";"amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]"
comp57978_c1_seq1;GAXK01183600.1;Q05941;1.81E-16;ACHA7_RAT;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005216; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0007165; GO:0007268; GO:0007271; GO:0007613; GO:0008144; GO:0008179; GO:0014069; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032279; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042416; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0050877; GO:0050893; GO:0051117; GO:0070373; GO:0070374; GO:0095500; GO:0097110; GO:0098690; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:1904315; GO:1905144; GO:2000300";"acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; ATPase binding [GO:0051117]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp5797836_c0_seq1;GAXK01041369.1;Q6F6A2;1.16E-61;PHR_ORYSJ;Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (DNA photolyase) (OsCPDII) (Photoreactivating enzyme);"nucleus [GO:0005634]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; DNA repair [GO:0006281]; photoreactive repair [GO:0000719]; UV protection [GO:0009650]";"GO:0000719; GO:0003677; GO:0003904; GO:0005634; GO:0006281; GO:0009650; GO:0071949";"DNA repair [GO:0006281]; photoreactive repair [GO:0000719]; UV protection [GO:0009650]";nucleus [GO:0005634];"deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]"
comp579841_c0_seq1;GAXK01024951.1;G5ED00;3.17E-11;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp5798916_c0_seq1;GAXK01009601.1;P21329;2.41E-07;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp5799044_c0_seq1;GAXK01009600.1;Q9M3D2;9.45E-35;RL353_ARATH;60S ribosomal protein L35-3;"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp57991_c0_seq1;GAXK01183722.1;P79098;0;AMPN_BOVIN;Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"
comp57995_c0_seq1;GAXK01183710.1;Q9LQN4;4.16E-13;CML17_ARATH;Probable calcium-binding protein CML17 (Calmodulin-like protein 17);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp57999_c4_seq1;GAXK01183870.1;Q80VJ3;3.94E-45;DNPH1_MOUSE;2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein Rcl);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307]";"GO:0005634; GO:0005737; GO:0009116; GO:0009117; GO:0009159; GO:0030307; GO:0030855; GO:0042802; GO:0042803; GO:0070694";"deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp5800523_c0_seq1;GAXK01089932.1;Q2F637;6.13E-40;1433Z_BOMMO;14-3-3 protein zeta;"cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]";"GO:0005737; GO:0019904";;cytoplasm [GO:0005737];protein domain specific binding [GO:0019904]
comp58009_c1_seq1;GAXK01144713.1;Q2KIS2;3.33E-51;RM44_BOVIN;39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; mitochondrial translational elongation [GO:0070125]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396]";"GO:0003725; GO:0004525; GO:0005634; GO:0005743; GO:0005762; GO:0005886; GO:0006396; GO:0030422; GO:0031053; GO:0031054; GO:0070125";"mitochondrial translational elongation [GO:0070125]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]"
comp5801061_c0_seq1;GAXK01089942.1;Q11126;7.08E-11;FUT3_BOVIN;Galactoside 3(4)-L-fucosyltransferase (EC 2.4.1.65) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (FUTB) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]"
comp5801233_c0_seq1;GAXK01089936.1;Q24439;4.62E-34;ATPO_DROME;ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP);"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"GO:0005739; GO:0005756; GO:0042776; GO:0046933; GO:1902600";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]";proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]
comp5801913_c0_seq1;GAXK01089947.1;Q96JP5;9.28E-07;ZFP91_HUMAN;E3 ubiquitin-protein ligase ZFP91 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog) (Zfp-91);"nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]";"GO:0003676; GO:0004842; GO:0005634; GO:0005730; GO:0007250; GO:0046872; GO:0070534";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ubiquitin-protein transferase activity [GO:0004842]"
comp5801974_c0_seq1;GAXK01089930.1;Q6UB98;1.05E-08;ANR12_HUMAN;Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp58021_c0_seq1;GAXK01145195.1;Q69D48;6.57E-136;RHBGA_XENLA;Ammonium transporter Rh type B-A (Rhesus blood group family type B glycoprotein A) (Rh family type B glycoprotein A) (Rh type B glycoprotein A);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]";"GO:0008519; GO:0016021; GO:0016323; GO:0030659";;"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";ammonium transmembrane transporter activity [GO:0008519]
comp58028_c0_seq1;GAXK01145331.1;Q9VJ34;2.57E-102;GSTCD_DROME;Glutathione S-transferase C-terminal domain-containing protein homolog;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp58031_c0_seq1;GAXK01144593.1;Q6T3U3;0;NPCL1_RAT;NPC1-like intracellular cholesterol transporter 1 (Niemann-Pick C1-like protein 1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; spanning component of plasma membrane [GO:0044214]; drug binding [GO:0008144]; lipid transporter activity [GO:0005319]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; response to drug [GO:0042493]";"GO:0005319; GO:0006695; GO:0008144; GO:0016324; GO:0017137; GO:0030299; GO:0031489; GO:0031526; GO:0042157; GO:0042493; GO:0044214; GO:0071501";"cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; response to drug [GO:0042493]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; spanning component of plasma membrane [GO:0044214]";"drug binding [GO:0008144]; lipid transporter activity [GO:0005319]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]"
comp580340_c0_seq1;GAXK01046295.1;Q687X5;5.37E-34;STEA4_HUMAN;Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9);"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"GO:0000139; GO:0005768; GO:0005794; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706";"copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]";"early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp5803492_c0_seq1;GAXK01194113.1;Q13733;2.31E-31;AT1A4_HUMAN;Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cardiac conduction [GO:1903779]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]";"GO:0005391; GO:0005524; GO:0005886; GO:0005887; GO:0005890; GO:0006813; GO:0006814; GO:0006883; GO:0007283; GO:0009566; GO:0030007; GO:0030317; GO:0030641; GO:0034220; GO:0036376; GO:0042391; GO:0046872; GO:1902600; GO:1903779; GO:1990573";"cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cardiac conduction [GO:1903779]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp5804_c0_seq1;GAXK01065342.1;Q22460;6.72E-63;BCA1_CAEEL;Beta carbonic anhydrase 1 (EC 4.2.1.1);"cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0008270";;cytoplasm [GO:0005737];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp5804506_c0_seq1;GAXK01158906.1;P0CT83;1.46E-51;RL12A_SCHPO;60S ribosomal protein L12-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]";"large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp580475_c2_seq1;GAXK01046303.1;Q8CJ78;7.19E-16;ZN628_MOUSE;Zinc finger protein 628 (Zinc finger protein expressed in embryonal cells and certain adult organs);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp58048_c0_seq1;GAXK01145183.1;Q5T2D3;2.10E-64;OTUD3_HUMAN;OTU domain-containing protein 3 (EC 3.4.19.12);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; negative regulation of protein kinase B signaling [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]";"GO:0004843; GO:0005737; GO:0005829; GO:0016579; GO:0035871; GO:0036459; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167";"negative regulation of protein kinase B signaling [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp580484_c0_seq1;GAXK01046349.1;P51987;7.00E-49;CCNB_HYDVD;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp5805109_c0_seq1;GAXK01158920.1;A1CX29;3.13E-09;DPP4_NEOFI;Probable dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (DppIV);"extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005576; GO:0008236";;extracellular region [GO:0005576];"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp580599_c0_seq1;GAXK01046347.1;A2RSX7;8.72E-87;TYW5_MOUSE;tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]";"GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524";wybutosine biosynthetic process [GO:0031591];;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]"
comp5806772_c0_seq1;GAXK01101504.1;P93748;3.04E-10;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp580712_c0_seq1;GAXK01046409.1;Q4R2Z0;2.49E-28;RBM46_MACFA;Probable RNA-binding protein 46 (RNA-binding motif protein 46);RNA binding [GO:0003723];GO:0003723;;;RNA binding [GO:0003723]
comp5807137_c0_seq1;GAXK01101498.1;P27590;5.32E-12;UROM_RAT;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; response to organic substance [GO:0010033]";"GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0010033; GO:0016323; GO:0016324; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0060170";response to organic substance [GO:0010033];"anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]";calcium ion binding [GO:0005509]
comp580792_c0_seq1;GAXK01046350.1;Q9VJJ7;0;TRPG_DROME;Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635";"adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"
comp58081_c0_seq1;GAXK01144607.1;Q6PAV2;0;HERC4_MOUSE;Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0016567; GO:0030154; GO:0061630";"cell differentiation [GO:0030154]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]";"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp5808758_c0_seq1;GAXK01056953.1;Q7M761;2.36E-08;OVCH2_MOUSE;Ovochymase-2 (EC 3.4.21.-) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp580924_c0_seq1;GAXK01046311.1;P21575;6.13E-69;DYN1_RAT;Dynamin-1 (EC 3.6.5.5) (B-dynamin) (D100) (Dynamin, brain);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"GO:0001917; GO:0002031; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006898; GO:0007032; GO:0008017; GO:0008021; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0017124; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0031749; GO:0032991; GO:0042802; GO:0043196; GO:0043197; GO:0044327; GO:0044877; GO:0045202; GO:0045211; GO:0050803; GO:0050804; GO:0050998; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1900242; GO:1900244; GO:1901998; GO:1903423; GO:1904645";"endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]";"D2 dopamine receptor binding [GO:0031749]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp58103_c0_seq1;GAXK01145348.1;O70496;0;CLCN7_MOUSE;H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7);"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]";"GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0031410; GO:0043231";response to pH [GO:0009268];"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]";"antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]"
comp58106_c0_seq1;GAXK01145218.1;Q09325;4.84E-154;MGAT1_RAT;Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]";"GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016021; GO:0018279; GO:0030145";"in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"
comp581088_c0_seq1;GAXK01046305.1;Q28039;3.89E-49;SC6A9_BOVIN;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; regulation of synaptic transmission, glycinergic [GO:0060092]";"GO:0005283; GO:0005328; GO:0005886; GO:0005887; GO:0015187; GO:0060092; GO:0061537; GO:0098793";"glycine secretion, neurotransmission [GO:0061537]; regulation of synaptic transmission, glycinergic [GO:0060092]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]"
comp58110_c5_seq1;GAXK01144575.1;Q9VCG3;1.86E-24;OPA32_DROME;Putative OPA3-like protein CG13603;"mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]";"GO:0005739; GO:0019216";regulation of lipid metabolic process [GO:0019216];mitochondrion [GO:0005739];
comp581162_c0_seq1;GAXK01046338.1;Q26474;1.58E-35;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp5811719_c0_seq1;GAXK01020967.1;O01358;2.09E-36;RL27A_OSCTI;60S ribosomal protein L27a (Ribosomal protein RPL-27);"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0015934; GO:0098556";translation [GO:0006412];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp5812031_c0_seq1;GAXK01190604.1;P34114;2.68E-24;PHS2_DICDI;Glycogen phosphorylase 2 (GP2) (EC 2.4.1.1);"cytoplasm [GO:0005737]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; response to ammonia [GO:1903717]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]";"GO:0005737; GO:0005980; GO:0008184; GO:0030170; GO:0042803; GO:0051591; GO:0102250; GO:0102499; GO:1903013; GO:1903717";"glycogen catabolic process [GO:0005980]; response to ammonia [GO:1903717]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]";cytoplasm [GO:0005737];"glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]"
comp5812143_c0_seq1;GAXK01190603.1;P42766;6.06E-46;RL35_HUMAN;60S ribosomal protein L35 (Large ribosomal subunit protein uL29);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"GO:0000184; GO:0000463; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5812692_c0_seq1;GAXK01190619.1;Q0PB48;4.06E-12;TRHBP_CAMJE;Group 3 truncated hemoglobin ctb (Cj-trHbP) (Truncated Hb);"cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]";"GO:0005737; GO:0019825; GO:0020037; GO:0046872";;cytoplasm [GO:0005737];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]"
comp581305_c0_seq1;GAXK01046306.1;Q98989;1.39E-26;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp581385_c0_seq1;GAXK01046300.1;O46040;4.59E-07;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp5814275_c0_seq1;GAXK01048221.1;O42248;4.24E-42;GBLP_DANRE;Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543";"angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp58146_c0_seq1;GAXK01144591.1;Q3UTJ2;4.00E-56;SRBS2_MOUSE;Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2);"apical plasma membrane [GO:0016324]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; Z disc [GO:0030018]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]";"GO:0003676; GO:0005654; GO:0005856; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030018; GO:0030027; GO:0030425; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393";"acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]";"apical plasma membrane [GO:0016324]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; Z disc [GO:0030018]";"nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]"
comp581472_c0_seq1;GAXK01046307.1;G5ED00;1.65E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp5814817_c0_seq1;GAXK01048225.1;P13674;5.25E-17;P4HA1_HUMAN;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231";"collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]";"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp58153_c1_seq1;GAXK01145181.1;P31942;1.56E-18;HNRH3_HUMAN;Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0030855";"epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp581581_c0_seq1;GAXK01205169.1;P16157;1.77E-36;ANK1_HUMAN;Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659";"cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]";"axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
comp5816_c2_seq1;GAXK01066793.1;Q9WVK4;0;EHD1_MOUSE;EH domain-containing protein 1 (PAST homolog 1) (mPAST1);"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0010976; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043209; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]"
comp5816371_c0_seq1;GAXK01088476.1;O95477;4.63E-15;ABCA1_HUMAN;Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein);"endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]";"GO:0005102; GO:0005319; GO:0005524; GO:0005543; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008509; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016887; GO:0019216; GO:0019905; GO:0030139; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071397; GO:0071404; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140328";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]";"endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]";"anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]"
comp5817152_c0_seq1;GAXK01088471.1;P42674;3.69E-20;BP10_PARLI;Blastula protease 10 (EC 3.4.24.-);"cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471";;"cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp58176_c0_seq1;GAXK01144632.1;Q803R5;0;CMTR1_DANRE;Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (FtsJ methyltransferase domain-containing protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009]";"GO:0003676; GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0080009; GO:0097309";"7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]"
comp5817770_c0_seq1;GAXK01088477.1;P34092;2.18E-07;MYOB_DICDI;Myosin IB heavy chain;"actin-based cell projection [GO:0098858]; actomyosin [GO:0042641]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; leading edge of lamellipodium [GO:0061851]; phagocytic cup lip [GO:0097203]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin I head/neck binding [GO:0032031]; actin cytoskeleton organization [GO:0030036]; actin-myosin filament sliding [GO:0033275]; cell motility [GO:0048870]; chemotaxis to cAMP [GO:0043327]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; filopodium assembly [GO:0046847]; negative regulation of lateral pseudopodium assembly [GO:0031276]; phagocytosis [GO:0006909]; phagosome reneutralization [GO:0044655]; pinocytosis [GO:0006907]; regulation of post-lysosomal vacuole size [GO:0044656]; response to differentiation-inducing factor 1 [GO:1903013]; response to other organism [GO:0051707]";"GO:0000146; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0006907; GO:0006909; GO:0016197; GO:0016461; GO:0030036; GO:0030175; GO:0030670; GO:0030898; GO:0031143; GO:0031252; GO:0031276; GO:0032031; GO:0033275; GO:0042641; GO:0043327; GO:0044291; GO:0044655; GO:0044656; GO:0045335; GO:0046847; GO:0048870; GO:0051015; GO:0051707; GO:0061851; GO:0097203; GO:0098858; GO:1903013";"actin cytoskeleton organization [GO:0030036]; actin-myosin filament sliding [GO:0033275]; cell motility [GO:0048870]; chemotaxis to cAMP [GO:0043327]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; filopodium assembly [GO:0046847]; negative regulation of lateral pseudopodium assembly [GO:0031276]; phagocytosis [GO:0006909]; phagosome reneutralization [GO:0044655]; pinocytosis [GO:0006907]; regulation of post-lysosomal vacuole size [GO:0044656]; response to differentiation-inducing factor 1 [GO:1903013]; response to other organism [GO:0051707]";"actin-based cell projection [GO:0098858]; actomyosin [GO:0042641]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; leading edge of lamellipodium [GO:0061851]; phagocytic cup lip [GO:0097203]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; unconventional myosin complex [GO:0016461]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin I head/neck binding [GO:0032031]"
comp581934_c0_seq1;GAXK01046404.1;Q9UKB1;6.97E-55;FBW1B_HUMAN;F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS);"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"GO:0000086; GO:0000151; GO:0000209; GO:0002223; GO:0004842; GO:0005634; GO:0005813; GO:0005829; GO:0006470; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031648; GO:0038061; GO:0038095; GO:0042753; GO:0043161; GO:0043687; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0051403; GO:0061630; GO:0070498; GO:1901223";"Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";"protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp58197_c0_seq1;GAXK01144589.1;Q9D0A0;0;DET1_MOUSE;DET1 homolog (De-etiolated-1 homolog);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nucleus [GO:0005634]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]";"GO:0005634; GO:0016567; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]";"protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]"
comp582226_c0_seq1;GAXK01146037.1;A2ALS5;8.63E-31;RPGP1_MOUSE;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792";"cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp5822312_c0_seq1;GAXK01089793.1;Q945U1;6.54E-39;RS15_ELAOL;40S ribosomal protein S15;"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5822376_c0_seq1;GAXK01089799.1;Q8H715;4.75E-64;ATG8_PHYIN;Autophagy-related protein 8 (Autophagy-related ubiquitin-like modifier ATG8);"autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; autophagy [GO:0006914]; protein transport [GO:0015031]";"GO:0000421; GO:0006914; GO:0015031; GO:0031410";"autophagy [GO:0006914]; protein transport [GO:0015031]";"autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]";
comp5822410_c0_seq1;GAXK01089790.1;P51508;9.90E-12;ZNF81_HUMAN;Zinc finger protein 81 (HFZ20);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp58228_c5_seq1;GAXK01145276.1;P49762;1.21E-88;DOA_DROME;Serine/threonine-protein kinase Doa (EC 2.7.12.1) (Protein darkener of apricot);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]";"GO:0000381; GO:0002225; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006468; GO:0007350; GO:0007399; GO:0007548; GO:0007601; GO:0009306; GO:0010508; GO:0016301; GO:0018993; GO:0042051; GO:0045752; GO:0046777; GO:0048749; GO:0050896; GO:2000255";"blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp582303_c0_seq1;GAXK01146002.1;Q8NCK3;8.74E-30;ZN485_HUMAN;Zinc finger protein 485;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp582324_c0_seq1;GAXK01145993.1;Q29449;2.70E-58;AT8A1_BOVIN;Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II);"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0042584; GO:0045332; GO:0140326";phospholipid translocation [GO:0045332];"chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp582360_c0_seq1;GAXK01145957.1;P0A2L1;8.76E-23;YJBQ_SALTY;UPF0047 protein YjbQ;;;;;
comp58241_c2_seq1;GAXK01144613.1;Q8MSU3;4.75E-69;FRRS1_DROME;Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-);"integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]";"GO:0000293; GO:0016021; GO:0055114";oxidation-reduction process [GO:0055114];integral component of membrane [GO:0016021];ferric-chelate reductase activity [GO:0000293]
comp5824878_c0_seq1;GAXK01113887.1;P41827;2.10E-36;HSP74_ANOAL;Heat shock protein 70 B2;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp58259_c0_seq1;GAXK01144628.1;P42669;5.77E-46;PURA_MOUSE;Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000900; GO:0000977; GO:0001227; GO:0003677; GO:0003690; GO:0003691; GO:0003697; GO:0003700; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006268; GO:0006915; GO:0007093; GO:0007399; GO:0008134; GO:0008283; GO:0008284; GO:0014069; GO:0030154; GO:0030425; GO:0032422; GO:0032839; GO:0043025; GO:0043565; GO:0045892; GO:0046332; GO:0046651; GO:0050673; GO:0098794; GO:0098963; GO:0098978";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp582603_c0_seq1;GAXK01146008.1;Q15942;3.41E-10;ZYX_HUMAN;Zyxin (Zyxin-2);"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]";"GO:0001725; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005913; GO:0005925; GO:0007160; GO:0007165; GO:0007179; GO:0007229; GO:0007267; GO:0016032; GO:0043149; GO:0045335; GO:0046872; GO:0050727; GO:0071346";"cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]";"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]";"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp5826593_c0_seq1;GAXK01007275.1;P40313;2.28E-40;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp5826842_c0_seq1;GAXK01007294.1;Q9VNM1;1.39E-23;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp5826994_c0_seq1;GAXK01007295.1;P25387;4.83E-35;GBLP_CHLRE;Guanine nucleotide-binding protein subunit beta-like protein;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp5827590_c0_seq1;GAXK01007274.1;P30974;9.07E-20;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp5827676_c0_seq1;GAXK01007284.1;Q66S03;8.72E-14;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp5828_c1_seq1;GAXK01065682.1;Q6P616;2.31E-101;RBM22_XENTR;Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; chordate embryonic development [GO:0043009]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]";"GO:0000974; GO:0005634; GO:0005737; GO:0017070; GO:0033120; GO:0036002; GO:0043009; GO:0045292; GO:0046872; GO:0071006; GO:0071007";"chordate embryonic development [GO:0043009]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]";"metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]"
comp582826_c2_seq1;GAXK01146000.1;Q9VY77;1.48E-22;AJUBA_DROME;LIM domain-containing protein jub;"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0007010; GO:0030707; GO:0035331; GO:0045177; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:2000637";"cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]";"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]";"metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp5828382_c0_seq1;GAXK01090743.1;O04397;5.25E-55;FENR2_TOBAC;Ferredoxin--NADP reductase, root-type isozyme, chloroplastic (FNR) (EC 1.18.1.2);"chloroplast [GO:0009507]; ferredoxin-NADP+ reductase activity [GO:0004324]; photosynthesis [GO:0015979]";"GO:0004324; GO:0009507; GO:0015979";photosynthesis [GO:0015979];chloroplast [GO:0009507];ferredoxin-NADP+ reductase activity [GO:0004324]
comp5828596_c0_seq1;GAXK01090750.1;P23403;4.84E-48;RS20_XENLA;40S ribosomal protein S20 (S22);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5828756_c0_seq1;GAXK01090741.1;Q2HJ46;1.28E-15;RNF8_BOVIN;E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0042393; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070535; GO:0070936";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]";"chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp5828785_c0_seq1;GAXK01090745.1;Q95ND5;8.54E-11;CASP3_PIG;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032]";"GO:0005634; GO:0005737; GO:0006508; GO:0006915; GO:0016032; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp5829178_c0_seq1;GAXK01090742.1;Q91W43;2.11E-69;GCSP_MOUSE;Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring));"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]";"GO:0004375; GO:0005634; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0046983; GO:0070280; GO:1903442; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]";"glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]"
comp58296_c1_seq1;GAXK01145353.1;Q8IN81;3.22E-24;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp582973_c2_seq1;GAXK01145943.1;Q18823;4.58E-07;LAM2_CAEEL;Laminin-like protein lam-2;"basement membrane [GO:0005604]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; positive regulation of locomotion [GO:0040017]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005604; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0040017";"animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; positive regulation of locomotion [GO:0040017]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";basement membrane [GO:0005604];
comp5829757_c0_seq1;GAXK01090727.1;Q8BJ51;4.33E-10;MFS11_MOUSE;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5829777_c0_seq1;GAXK01090726.1;Q9VXX8;1.50E-34;RL371_DROME;Probable 60S ribosomal protein L37-A;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0046872";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp5829869_c0_seq1;GAXK01090739.1;Q700K0;6.27E-08;SSPO_RAT;SCO-spondin;"extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0005615; GO:0007155; GO:0007399; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";extracellular space [GO:0005615];
comp583011_c1_seq1;GAXK01145975.1;P35501;8.11E-37;ESTE_MYZPE;Esterase E4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp5830771_c0_seq1;GAXK01194280.1;P22953;1.32E-65;MD37E_ARATH;Probable mediator of RNA polymerase II transcription subunit 37e (Heat shock 70 kDa protein 1) (Heat shock cognate 70 kDa protein 1) (Heat shock cognate protein 70-1) (AtHsc70-1) (Heat shock protein 70-1) (AtHsp70-1) (Protein EARLY-RESPONSIVE TO DEHYDRATION 2);"apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]";"GO:0002020; GO:0005524; GO:0005618; GO:0005634; GO:0005730; GO:0005737; GO:0005774; GO:0005794; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0009506; GO:0009507; GO:0009615; GO:0010187; GO:0016887; GO:0022626; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0042742; GO:0044183; GO:0046686; GO:0048046; GO:0050832; GO:0051082; GO:0051085; GO:0051787; GO:0090332; GO:0098542";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]";"apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp5831134_c0_seq1;GAXK01194290.1;P08548;1.42E-08;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp5831718_c0_seq1;GAXK01194282.1;Q9NBX4;1.10E-08;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp5831798_c0_seq1;GAXK01194286.1;Q8LCQ4;9.04E-10;LHCA6_ARATH;Photosystem I chlorophyll a/b-binding protein 6, chloroplastic (LHCI type III LHCA6);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; plastoglobule [GO:0010287]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to blue light [GO:0009637]; response to far red light [GO:0010218]; response to light stimulus [GO:0009416]; response to red light [GO:0010114]";"GO:0009416; GO:0009507; GO:0009522; GO:0009535; GO:0009637; GO:0009768; GO:0009941; GO:0010114; GO:0010218; GO:0010287; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to blue light [GO:0009637]; response to far red light [GO:0010218]; response to light stimulus [GO:0009416]; response to red light [GO:0010114]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; plastoglobule [GO:0010287]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp5832276_c0_seq1;GAXK01091618.1;Q6ZNA1;2.40E-08;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5832411_c0_seq1;GAXK01091600.1;P98158;5.78E-08;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp583267_c2_seq1;GAXK01146026.1;Q96MC6;4.80E-129;MF14A_HUMAN;Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein);"integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid nucleus differentiation [GO:0007289]";"GO:0001675; GO:0005887; GO:0007289; GO:0022857; GO:0030382";"acrosome assembly [GO:0001675]; spermatid nucleus differentiation [GO:0007289]; sperm mitochondrion organization [GO:0030382]";integral component of plasma membrane [GO:0005887];transmembrane transporter activity [GO:0022857]
comp58329_c1_seq1;GAXK01144597.1;P35381;3.53E-92;ATPA_DROME;ATP synthase subunit alpha, mitochondrial (Protein bellwether);"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0000275; GO:0005524; GO:0005739; GO:0015986; GO:0019915; GO:0022900; GO:0043531; GO:0046933; GO:1902769";"ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp5833362_c0_seq1;GAXK01091619.1;Q9GZS0;7.41E-36;DNAI2_HUMAN;Dynein intermediate chain 2, axonemal (Axonemal dynein intermediate chain 2);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]"
comp5834951_c0_seq1;GAXK01042390.1;Q04799;1.61E-18;FMO5_RABIT;Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (FMO 1C1) (FMO form 3) (Hepatic flavin-containing monooxygenase 5) (FMO 5);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]";"GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp5834993_c0_seq1;GAXK01042394.1;Q9H0L4;2.52E-32;CSTFT_HUMAN;Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant) (CSTF 64 kDa subunit tau variant) (TauCstF-64);"intracellular [GO:0005622]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000398; GO:0003723; GO:0003729; GO:0005622; GO:0005654; GO:0005847; GO:0006369; GO:0031124; GO:0098789";"mRNA 3'-end processing [GO:0031124]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]";"intracellular [GO:0005622]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp5835291_c0_seq1;GAXK01042397.1;Q14591;5.09E-11;ZN271_HUMAN;Deleted.;;;;;
comp5836_c2_seq1;GAXK01066261.1;Q17FR9;1.67E-40;SRRT_AEDAE;Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog);"nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";"GO:0003676; GO:0005654; GO:0006397; GO:0031053";"mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]";nucleoplasm [GO:0005654];nucleic acid binding [GO:0003676]
comp5836212_c0_seq1;GAXK01155833.1;Q05017;1.21E-12;PLB1_RABIT;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase AdRab-B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; lipid catabolic process [GO:0016042]";"GO:0004622; GO:0004623; GO:0016021; GO:0016042; GO:0016324; GO:0102567; GO:0102568";lipid catabolic process [GO:0016042];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp5836896_c0_seq1;GAXK01155834.1;Q24278;4.87E-28;CNGA_DROME;Cyclic nucleotide-gated cation channel subunit A (Cyclic nucleotide-gated ion channel subunit A) (CNG channel);"intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005221; GO:0005222; GO:0005223; GO:0006812; GO:0017071; GO:0019934; GO:0030553";"cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]";intracellular cyclic nucleotide activated cation channel complex [GO:0017071];"cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]"
comp5837471_c0_seq1;GAXK01155820.1;Q9D6M3;4.79E-16;GHC1_MOUSE;Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]";"GO:0005313; GO:0005739; GO:0005743; GO:0015183; GO:0015293; GO:0015810; GO:0015813; GO:0016021; GO:0043490";"aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]"
comp583770_c0_seq1;GAXK01145973.1;Q6P1J9;6.59E-15;CDC73_HUMAN;Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein);"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000784; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:1904837; GO:2000134";"beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";RNA polymerase II complex binding [GO:0000993]
comp58384_c0_seq1;GAXK01144629.1;Q5HB45;6.39E-11;OBG_EHRRW;GTPase Obg (EC 3.6.5.-) (GTP-binding protein Obg);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; ribosome biogenesis [GO:0042254]";"GO:0000287; GO:0003924; GO:0005525; GO:0005737; GO:0042254";ribosome biogenesis [GO:0042254];cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp583884_c0_seq1;GAXK01145954.1;P46218;1.40E-16;Y1674_SULAC;Uncharacterized protein Saci_1674;;;;;
comp583946_c0_seq1;GAXK01145959.1;Q6ZP65;2.63E-21;BICL1_HUMAN;BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) (CCDC64A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107";"Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]"
comp583982_c0_seq1;GAXK01145949.1;Q8K1K9;3.62E-08;HINFP_MOUSE;Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein);"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872";"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]";"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]"
comp58406_c0_seq1;GAXK01145347.1;Q6AXT0;5.56E-12;RM37_RAT;39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp5840849_c0_seq1;GAXK01062090.1;Q8AYG3;5.05E-09;TTK_DANRE;Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap);"kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246]";"GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005819; GO:0007059; GO:0007060; GO:0007093; GO:0007094; GO:0016321; GO:0018105; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0051304; GO:0060249";"anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246]";"kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp58424_c0_seq1;GAXK01144848.1;Q8BP74;4.33E-31;PSTK_MOUSE;L-seryl-tRNA(Sec) kinase (EC 2.7.1.164) (O-phosphoseryl-tRNA(Sec) kinase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]";"GO:0000049; GO:0001514; GO:0005524; GO:0005739; GO:0005829; GO:0016301; GO:0097056";"selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; tRNA binding [GO:0000049]"
comp584314_c0_seq1;GAXK01064592.1;Q5YLM1;9.71E-08;DGLA_RAT;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp5843165_c0_seq1;GAXK01015533.1;Q940B0;7.25E-83;RL183_ARATH;60S ribosomal protein L18-3;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005773; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0022625; GO:0022626";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plasmodesma [GO:0009506]; plastid [GO:0009536]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp5843246_c0_seq1;GAXK01015523.1;Q8ZBY6;2.02E-29;FADE_YERPE;Acyl-coenzyme A dehydrogenase (ACDH) (Acyl-CoA dehydrogenase) (EC 1.3.8.7) (EC 1.3.8.8);"plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]";"GO:0003995; GO:0005886; GO:0033539; GO:0050660; GO:0052890";fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539];plasma membrane [GO:0005886];"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]"
comp5843284_c0_seq1;GAXK01015520.1;Q9NPF2;6.08E-11;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp5843357_c0_seq1;GAXK01015527.1;P07154;2.71E-14;CATL1_RAT;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Cyclic protein 2) (CP-2) (Major excreted protein) (MEP) [Cleaved into: Procathepsin L; Cathepsin L1 heavy chain; Cathepsin L1 light chain]";"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"GO:0004177; GO:0004197; GO:0005615; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0014070; GO:0021675; GO:0030984; GO:0034698; GO:0042277; GO:0043005; GO:0043204; GO:0044877; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:1990834";"autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; vacuole [GO:0005773]";"aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]"
comp5843763_c0_seq1;GAXK01015535.1;A1L1R6;6.53E-07;ZN423_DANRE;Zinc finger protein 423;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp584401_c1_seq1;GAXK01064510.1;Q94900;7.14E-137;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp584411_c0_seq1;GAXK01064508.1;Q6CGG3;4.47E-11;FKBP2_YARLI;FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"endoplasmic reticulum [GO:0005783]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005783";;endoplasmic reticulum [GO:0005783];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp5844290_c0_seq1;GAXK01137974.1;Q90YS2;2.29E-56;RS3_ICTPU;40S ribosomal protein S3 (EC 4.2.99.18);"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp58443_c0_seq1;GAXK01145340.1;Q9CYI4;1.17E-80;LUC7L_MOUSE;Putative RNA-binding protein Luc7-like 1;"nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]";"GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004";"mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]";"nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";"identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]"
comp5844387_c0_seq1;GAXK01137981.1;Q8WPA2;2.97E-11;AR_BOMMO;Allatostatin-A receptor (BAR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]";"GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]"
comp584462_c0_seq1;GAXK01064584.1;Q6R7D0;9.13E-12;IAP3_OSHVF;Putative apoptosis inhibitor ORF99;;;;;
comp5845_c3_seq1;GAXK01067189.1;D3ZWZ9;2.50E-133;GP107_RAT;Protein GPR107;"clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]";"GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016021; GO:0030136; GO:0032050; GO:0072583";clathrin-dependent endocytosis [GO:0072583];"clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";clathrin heavy chain binding [GO:0032050]
comp584512_c0_seq1;GAXK01064519.1;O46040;4.61E-31;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp58454_c1_seq1;GAXK01145302.1;Q297K8;1.03E-23;JAGN_DROPS;Protein jagunal;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]";"GO:0001555; GO:0005789; GO:0006887; GO:0007029; GO:0007296; GO:0008407; GO:0016021; GO:0022416; GO:0051686";"chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp58461_c1_seq1;GAXK01145328.1;Q8IUQ4;2.03E-166;SIAH1_HUMAN;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell cycle [GO:0007049]; cellular protein metabolic process [GO:0044267]; negative regulation of netrin-activated signaling pathway [GO:1902842]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0007049; GO:0007283; GO:0007399; GO:0007411; GO:0008022; GO:0008270; GO:0009653; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0042802; GO:0043065; GO:0043161; GO:0044267; GO:0051402; GO:0061630; GO:1902842; GO:2001244";"anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell cycle [GO:0007049]; cellular protein metabolic process [GO:0044267]; negative regulation of netrin-activated signaling pathway [GO:1902842]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp584618_c0_seq1;GAXK01064463.1;P16260;1.69E-97;GDC_HUMAN;Graves disease carrier protein (GDC) (Graves disease autoantigen) (GDA) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; secondary active transmembrane transporter activity [GO:0015291]; coenzyme biosynthetic process [GO:0009108]; mitochondrial transport [GO:0006839]";"GO:0005739; GO:0005743; GO:0006839; GO:0009108; GO:0015291; GO:0015297; GO:0016021";"coenzyme biosynthetic process [GO:0009108]; mitochondrial transport [GO:0006839]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"antiporter activity [GO:0015297]; secondary active transmembrane transporter activity [GO:0015291]"
comp58466_c2_seq1;GAXK01144756.1;P26221;9.42E-66;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp5847134_c0_seq1;GAXK01095768.1;Q24352;2.13E-26;GBRAL_DROME;Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1904456";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]"
comp58474_c1_seq1;GAXK01145006.1;Q803C9;2.96E-142;PTSS1_DANRE;Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]";"GO:0005789; GO:0006659; GO:0016021; GO:0016740";phosphatidylserine biosynthetic process [GO:0006659];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";transferase activity [GO:0016740]
comp584751_c1_seq1;GAXK01064577.1;P29503;4.47E-21;NEUR_DROME;Protein neuralized;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007398; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030707; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981";"asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp584811_c0_seq1;GAXK01064586.1;P53368;1.34E-35;8ODP_MOUSE;7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1);"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]";"GO:0001669; GO:0003924; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0035539; GO:0036219; GO:0042262; GO:0046061; GO:0046686; GO:0046872; GO:0047693";"aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]";"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTPase activity [GO:0003924]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]"
comp584873_c0_seq1;GAXK01064591.1;O96081;3.26E-73;CALMB_HALRO;Calmodulin-B (CaM B);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp584881_c0_seq1;GAXK01064464.1;P17644;8.39E-29;ACH2_DROME;Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655";"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp5849_c0_seq1;GAXK01065755.1;Q5ZK63;3.60E-15;TCP4_CHICK;Activated RNA polymerase II transcriptional coactivator p15 (SUB1 homolog);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]";"GO:0003677; GO:0003713; GO:0005634; GO:0005667; GO:0060261";positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261];"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp58491_c1_seq1;GAXK01144577.1;P23978;0;SC6A1_RAT;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp58494_c0_seq1;GAXK01145202.1;Q8IX12;3.00E-16;CCAR1_HUMAN;Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000398; GO:0000980; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0048471";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp5849565_c0_seq1;GAXK01153902.1;Q9BWQ8;4.09E-21;LFG2_HUMAN;Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35) (Transmembrane BAX inhibitor motif-containing protein 2);"cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]";"GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0030054; GO:0043066; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042";"apoptotic process [GO:0006915]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]";"cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]";
comp584979_c2_seq1;GAXK01064488.1;C9D7R2;1.22E-16;VMPA2_LOXIN;Astacin-like metalloprotease toxin 2 (EC 3.4.24.-) (Loxosceles astacin-like protease 2) (LALP2);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270; GO:0090729";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]"
comp584980_c0_seq1;GAXK01064521.1;Q3URE9;4.40E-32;LIGO2_MOUSE;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp585_c1_seq1;GAXK01166595.1;Q05974;1.33E-125;RAB1A_LYMST;Ras-related protein Rab-1A;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0015031; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp5850320_c0_seq1;GAXK01061208.1;Q8NF86;8.58E-08;PRS33_HUMAN;Serine protease 33 (EC 3.4.21.-) (Serine protease EOS);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528";"protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp5850397_c0_seq1;GAXK01061193.1;Q3SGL1;8.99E-74;METE_THIDA;5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14) (Cobalamin-independent methionine synthase) (Methionine synthase, vitamin-B12 independent isozyme);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp585141_c0_seq1;GAXK01064590.1;Q80U87;3.49E-21;UBP8_MOUSE;Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp58515_c1_seq1;GAXK01145249.1;Q8CH18;2.47E-109;CCAR1_MOUSE;Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1);"nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000980; GO:0003713; GO:0003714; GO:0005634; GO:0005641; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0043065; GO:0048471";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp58519_c0_seq1;GAXK01144968.1;Q2LZ59;2.36E-81;MOB2_DROPS;MOB kinase activator-like 2 (Mob as tumor suppressor protein 2) (Mps one binder kinase activator-like 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell morphogenesis [GO:0000902]";"GO:0000902; GO:0005634; GO:0005737; GO:0046872";cell morphogenesis [GO:0000902];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp5851999_c0_seq1;GAXK01061194.1;G5EBQ8;4.01E-13;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp5852_c0_seq1;GAXK01065453.1;Q7YQM4;2.12E-22;ATRX_PANTR;Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP);"condensed nuclear chromosome, centromeric region [GO:0000780]; nuclear chromosome, telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]";"GO:0000212; GO:0000780; GO:0000784; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006281; GO:0006334; GO:0006336; GO:0006338; GO:0007283; GO:0010571; GO:0015616; GO:0016605; GO:0030330; GO:0030900; GO:0031297; GO:0031618; GO:0031933; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:1900112; GO:1901581; GO:1901582; GO:1904908; GO:1990707";"cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]";"condensed nuclear chromosome, centromeric region [GO:0000780]; nuclear chromosome, telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]";"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp585273_c0_seq1;GAXK01064487.1;Q9EQC0;4.86E-27;CHST1_MOUSE;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp585284_c0_seq1;GAXK01064520.1;Q8BI99;1.91E-09;ZN879_MOUSE;Zinc finger protein 879;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5853675_c0_seq1;GAXK01015178.1;O61267;5.45E-21;LOK_DROME;Ovarian-specific serine/threonine-protein kinase Lok (EC 2.7.11.1) (Protein loki) (dMNK);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic DNA damage checkpoint [GO:0044773]; oocyte karyosome formation [GO:0030717]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; signal transduction in response to DNA damage [GO:0042770]";"GO:0000077; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006282; GO:0006468; GO:0006915; GO:0006919; GO:0006974; GO:0007281; GO:0008630; GO:0016607; GO:0030717; GO:0035234; GO:0042770; GO:0044773; GO:0045944; GO:0050321; GO:0051091; GO:0071480; GO:0071481; GO:0072332";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic DNA damage checkpoint [GO:0044773]; oocyte karyosome formation [GO:0030717]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; signal transduction in response to DNA damage [GO:0042770]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp5854_c0_seq1;GAXK01065379.1;P50395;0;GDIB_HUMAN;Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0045202; GO:0051056; GO:0070062";"neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]";"GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]"
comp5854234_c0_seq1;GAXK01195566.1;O05118;1.40E-31;KPYK_METEA;Pyruvate kinase (PK) (EC 2.7.1.40);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]";"GO:0000287; GO:0004743; GO:0005524; GO:0016301; GO:0030955";;;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]"
comp585523_c1_seq1;GAXK01064545.1;Q80UG8;2.38E-92;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp5855248_c0_seq1;GAXK01195568.1;Q46087;8.93E-65;TRAT_AMIAI;Transposase;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp5855638_c0_seq1;GAXK01195549.1;P23653;7.22E-14;PRTR_PARAQ;Proteinase R (EC 3.4.21.-);"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0046872";;;"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp5856_c0_seq1;GAXK01066264.1;Q6P9U4;1.01E-50;PLD3B_RAT;PRELI domain containing protein 3B (Protein slowmo homolog 2);"mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914]";"GO:0005758; GO:0015914; GO:1990050";phospholipid transport [GO:0015914];mitochondrial intermembrane space [GO:0005758];phosphatidic acid transfer activity [GO:1990050]
comp585618_c0_seq1;GAXK01064532.1;Q11002;0;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp5856672_c0_seq1;GAXK01061354.1;Q7Z442;4.18E-07;PK1L2_HUMAN;Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]";"GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982";detection of mechanical stimulus [GO:0050982];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]"
comp5857691_c0_seq1;GAXK01061358.1;Q63099;2.37E-24;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp5858_c0_seq1;GAXK01065586.1;Q02427;2.75E-28;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp58584_c0_seq1;GAXK01145366.1;Q68FI3;2.84E-15;DOPDA_XENLA;D-dopachrome decarboxylase-A (EC 4.1.1.84) (D-dopachrome tautomerase-A);"cytoplasm [GO:0005737]; D-dopachrome decarboxylase activity [GO:0033981]; melanin biosynthetic process [GO:0042438]";"GO:0005737; GO:0033981; GO:0042438";melanin biosynthetic process [GO:0042438];cytoplasm [GO:0005737];D-dopachrome decarboxylase activity [GO:0033981]
comp585901_c0_seq1;GAXK01064572.1;Q92051;1.73E-44;CAHZ_DANRE;Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";"GO:0004089; GO:0008270; GO:0015670; GO:0042539";"carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]";;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp5859830_c0_seq1;GAXK01089191.1;Q9NQV7;9.77E-12;PRDM9_HUMAN;Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9);"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872";"meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp586_c0_seq1;GAXK01169313.1;P35381;0;ATPA_DROME;ATP synthase subunit alpha, mitochondrial (Protein bellwether);"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0000275; GO:0005524; GO:0005739; GO:0015986; GO:0019915; GO:0022900; GO:0043531; GO:0046933; GO:1902769";"ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]";"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp5860088_c0_seq1;GAXK01105191.1;Q5R536;2.53E-09;AACT_PONAB;Alpha-1-antichymotrypsin (ACT) (Serpin A3);"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]";"GO:0004867; GO:0005615; GO:0006953";acute-phase response [GO:0006953];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp5860557_c0_seq1;GAXK01105203.1;B0FHH8;1.40E-07;ML1P_MANSE;MD-2-related lipid-recognition protein (MsML-1);"extracellular region [GO:0005576]; lipid binding [GO:0008289]";"GO:0005576; GO:0008289";;extracellular region [GO:0005576];lipid binding [GO:0008289]
comp586075_c2_seq1;GAXK01029193.1;O15393;3.19E-25;TMPS2_HUMAN;"Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004252; GO:0005044; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016540; GO:0046598; GO:0070062";"positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp58611_c0_seq1;GAXK01145342.1;Q01528;8.70E-41;HAAF_LIMPO;Hemagglutinin/amebocyte aggregation factor (18K-LAF);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp5861387_c0_seq1;GAXK01105198.1;P29356;6.08E-90;ALF_SPIOL;Fructose-bisphosphate aldolase, cytoplasmic isozyme (EC 4.1.2.13);"cytosol [GO:0005829]; protein-containing complex [GO:0032991]; fructose-bisphosphate aldolase activity [GO:0004332]; protein self-association [GO:0043621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005829; GO:0006096; GO:0030388; GO:0032991; GO:0043621";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]";"cytosol [GO:0005829]; protein-containing complex [GO:0032991]";"fructose-bisphosphate aldolase activity [GO:0004332]; protein self-association [GO:0043621]"
comp58626_c0_seq1;GAXK01145282.1;Q60LV4;1.31E-37;MYO3_CAEBR;Myosin-3 (Myosin heavy chain A) (MHC A);"A band [GO:0031672]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; locomotory behavior [GO:0007626]";"GO:0003774; GO:0005524; GO:0007626; GO:0031672; GO:0032982; GO:0051015";locomotory behavior [GO:0007626];"A band [GO:0031672]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp5862689_c0_seq1;GAXK01194218.1;O70566;2.12E-33;DIAP2_MOUSE;Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2) (mDia3);"actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";"GO:0003779; GO:0007275; GO:0017048; GO:0030041; GO:0048477";"actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";;"actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]"
comp58632_c0_seq1;GAXK01144865.1;Q8NFA0;0;UBP32_HUMAN;Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp58635_c0_seq1;GAXK01145260.1;Q9VKV5;1.31E-62;CD2B2_DROME;CD2 antigen cytoplasmic tail-binding protein 2 homolog (Protein hole-in-one);"nucleus [GO:0005634]; U5 snRNP [GO:0005682]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; positive regulation of wound healing [GO:0090303]; wing disc development [GO:0035220]; wound healing [GO:0042060]";"GO:0005634; GO:0005682; GO:0022416; GO:0035220; GO:0042060; GO:0048749; GO:0090303";"chaeta development [GO:0022416]; compound eye development [GO:0048749]; positive regulation of wound healing [GO:0090303]; wing disc development [GO:0035220]; wound healing [GO:0042060]";"nucleus [GO:0005634]; U5 snRNP [GO:0005682]";
comp586357_c0_seq1;GAXK01029125.1;P48052;3.60E-31;CBPA2_HUMAN;Carboxypeptidase A2 (EC 3.4.17.15);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]";"GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270";"protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp58637_c0_seq1;GAXK01145341.1;Q3U410;6.47E-16;KLH21_MOUSE;Kelch-like protein 21;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; polar microtubule [GO:0005827]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]";"GO:0004842; GO:0005737; GO:0005827; GO:0007049; GO:0016567; GO:0031463; GO:0032465; GO:0035853; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; polar microtubule [GO:0005827]";ubiquitin-protein transferase activity [GO:0004842]
comp58644_c1_seq1;GAXK01145333.1;Q9XZC0;3.99E-11;LCTA_LATTR;Alpha-latrocrustotoxin-Lt1a (Alpha-LCT-Lt1a) (Alpha-latrocrustotoxin) (Alpha-LCT) (Crusta1) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; exocytosis [GO:0006887]";"GO:0005576; GO:0006887; GO:0016021; GO:0044218; GO:0090729";exocytosis [GO:0006887];"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp5864741_c0_seq1;GAXK01120198.1;P14381;6.71E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp5866487_c0_seq1;GAXK01021158.1;Q2YDD9;8.67E-28;ADT4_BOVIN;ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4) (ANT 4) (Solute carrier family 25 member 31);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; motile cilium [GO:0031514]; ATP:ADP antiporter activity [GO:0005471]";"GO:0005471; GO:0005743; GO:0016021; GO:0031514";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; motile cilium [GO:0031514]";ATP:ADP antiporter activity [GO:0005471]
comp586705_c0_seq1;GAXK01029131.1;Q7K4B3;4.72E-07;ELP2_DROME;Probable elongator complex protein 2 (ELP2) (Stat3-interacting protein homolog);"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"GO:0000502; GO:0002098; GO:0005737; GO:0006368; GO:0008023; GO:0033588; GO:0043248; GO:0061133";"proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]";endopeptidase activator activity [GO:0061133]
comp586822_c1_seq1;GAXK01029096.1;P0DKX0;1.76E-25;ZN728_HUMAN;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5868250_c0_seq1;GAXK01049570.1;Q3SZQ6;5.13E-37;RL32_BOVIN;60S ribosomal protein L32;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp5868783_c0_seq1;GAXK01049577.1;Q91291;2.88E-44;HSP70_PLEWA;Heat shock 70 kDa protein (HSP70);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp5869_c0_seq1;GAXK01066773.1;Q02427;5.88E-35;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp58691_c0_seq1;GAXK01145200.1;Q9VHJ6;2.91E-24;ICH_DROME;Ichor;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";"GO:0000122; GO:0003677; GO:0005634; GO:0010628; GO:0035149; GO:0045944; GO:0046872; GO:0060439; GO:1901148";"gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp586936_c0_seq1;GAXK01029156.1;Q13002;0;GRIK2_HUMAN;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6);"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp58706_c0_seq1;GAXK01144711.1;Q5R6K7;4.92E-21;WRB_PONAB;Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]";"GO:0005789; GO:0016021; GO:0071816";tail-anchored membrane protein insertion into ER membrane [GO:0071816];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp5871450_c0_seq1;GAXK01141301.1;B8WI85;1.21E-09;USOM7_ACRMI;Uncharacterized skeletal organic matrix protein 7 (Uncharacterized SOMP-7);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp5871910_c0_seq1;GAXK01141294.1;P30974;6.86E-07;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp5872195_c0_seq1;GAXK01087572.1;Q16P20;1.75E-37;CISY2_AEDAE;Probable citrate synthase 2, mitochondrial (EC 2.3.3.16);"mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";"GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101";"carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];citrate (Si)-synthase activity [GO:0004108]
comp58724_c2_seq1;GAXK01144580.1;Q2TAW0;9.30E-106;CNDG2_XENLA;Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (Non-SMC condensin II complex subunit G2) (XCAP-G2);"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]";"GO:0005634; GO:0007049; GO:0030261; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]";nucleus [GO:0005634];
comp58731_c0_seq1;GAXK01145297.1;Q9H6R0;0;DHX33_HUMAN;ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33);"cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]";"GO:0000182; GO:0003723; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0034458; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227";"positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5' RNA helicase activity [GO:0034458]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]"
comp587399_c0_seq1;GAXK01029088.1;Q502K3;5.08E-24;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp587563_c0_seq1;GAXK01029198.1;Q8IZU9;1.11E-33;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp58762_c1_seq1;GAXK01205814.1;A9ULZ2;6.34E-42;BIR7B_XENLA;Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B);"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";"GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865";"multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]";cytoplasm [GO:0005737];"cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]"
comp58769_c0_seq1;GAXK01144590.1;Q6DIR8;6.39E-12;PALD_XENTR;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp5877055_c0_seq1;GAXK01049551.1;Q2F637;2.17E-88;1433Z_BOMMO;14-3-3 protein zeta;"cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]";"GO:0005737; GO:0019904";;cytoplasm [GO:0005737];protein domain specific binding [GO:0019904]
comp5877151_c0_seq1;GAXK01049555.1;P48768;7.83E-38;NAC2_RAT;Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2);"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to vitamin D [GO:0033280]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0007154; GO:0007612; GO:0007613; GO:0016323; GO:0021537; GO:0032592; GO:0033280; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048172; GO:0060291; GO:0060402; GO:0098703; GO:0098794; GO:0099055; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to vitamin D [GO:0033280]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp5877278_c0_seq1;GAXK01049557.1;Q3T0P6;7.30E-47;PGK1_BOVIN;Phosphoglycerate kinase 1 (EC 2.7.2.3);"cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]";"GO:0004618; GO:0005524; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0045121; GO:0047134; GO:0071456; GO:1903862";"cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]"
comp5877338_c0_seq1;GAXK01049553.1;A0ZSK3;3.07E-09;STXA_SYNVE;Neoverrucotoxin subunit alpha (NeoVTX subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp58775_c0_seq1;GAXK01145351.1;Q18192;2.36E-15;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp58781_c5_seq1;GAXK01144780.1;Q24174;1.20E-08;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5878801_c0_seq1;GAXK01184726.1;P0CQ73;2.21E-73;FAL1_CRYNB;ATP-dependent RNA helicase FAL1 (EC 3.6.4.13);"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030688; GO:0097078";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp587904_c0_seq1;GAXK01029163.1;Q9H4Z2;4.58E-13;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp587924_c0_seq1;GAXK01029158.1;Q16534;1.64E-14;HLF_HUMAN;Hepatic leukemia factor;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5879307_c0_seq1;GAXK01184715.1;O15891;2.96E-86;TCPA_TETPY;T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp58803_c5_seq1;GAXK01145231.1;Q539E5;3.59E-38;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp5880391_c0_seq1;GAXK01164449.1;P52035;3.66E-14;BSAA_BACSU;Glutathione peroxidase homolog BsaA (EC 1.-.-.-);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599]";"GO:0004601; GO:0004602; GO:0005739; GO:0005829; GO:0034599";cellular response to oxidative stress [GO:0034599];"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]"
comp58807_c4_seq1;GAXK01145130.1;P14381;4.16E-21;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp5881184_c0_seq1;GAXK01164458.1;P00125;4.44E-53;CY1_BOVIN;Cytochrome c1, heme protein, mitochondrial (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0016021; GO:0020037; GO:0042776; GO:0045153; GO:0046872";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]";"electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp5881220_c0_seq1;GAXK01164448.1;P43395;2.87E-59;ATPBM_ACTDE;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (Fragment);"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; ATP biosynthetic process [GO:0006754]; ion transport [GO:0006811]";"GO:0005524; GO:0005743; GO:0006754; GO:0006811; GO:0045261";"ATP biosynthetic process [GO:0006754]; ion transport [GO:0006811]";"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";ATP binding [GO:0005524]
comp5881552_c0_seq1;GAXK01164447.1;P22909;3.47E-35;ADA2A_RAT;Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; DNA replication [GO:0006260]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of uterine smooth muscle contraction [GO:0070473]; platelet activation [GO:0030168]; positive regulation of blood vessel diameter [GO:0097755]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; thermoception [GO:0050955]";"GO:0002526; GO:0004935; GO:0004938; GO:0005737; GO:0005886; GO:0005887; GO:0006260; GO:0007165; GO:0007186; GO:0007188; GO:0007565; GO:0019229; GO:0030168; GO:0042593; GO:0043025; GO:0043679; GO:0045202; GO:0045955; GO:0050955; GO:0061179; GO:0070473; GO:0071880; GO:0097755; GO:0098978; GO:0098982; GO:0099055; GO:0099059; GO:0099061";"acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; DNA replication [GO:0006260]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of uterine smooth muscle contraction [GO:0070473]; platelet activation [GO:0030168]; positive regulation of blood vessel diameter [GO:0097755]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; thermoception [GO:0050955]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]"
comp5882045_c0_seq1;GAXK01146737.1;P10076;3.11E-08;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5882165_c0_seq1;GAXK01146725.1;O24111;6.31E-65;RS5_NICPL;40S ribosomal protein S5 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5882546_c0_seq1;GAXK01146738.1;Q6ZUK4;1.21E-23;TMM26_HUMAN;Transmembrane protein 26;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5882570_c0_seq1;GAXK01146734.1;P25197;3.88E-11;NOLG_RHIME;Nodulation protein NolG;"membrane [GO:0016020]; transmembrane transporter activity [GO:0022857]; nodulation [GO:0009877]";"GO:0009877; GO:0016020; GO:0022857";nodulation [GO:0009877];membrane [GO:0016020];transmembrane transporter activity [GO:0022857]
comp588319_c0_seq1;GAXK01058621.1;Q8JIY1;1.05E-27;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp58832_c0_seq1;GAXK01144795.1;Q5E9T8;5.92E-50;KIME_BOVIN;Mevalonate kinase (MK) (EC 2.7.1.36);"cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; negative regulation of inflammatory response [GO:0050728]";"GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0019287; GO:0042802; GO:0050728";"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; negative regulation of inflammatory response [GO:0050728]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]"
comp588346_c0_seq1;GAXK01058586.1;Q55EX9;8.77E-23;Y8948_DICDI;Putative methyltransferase DDB_G0268948 (EC 2.1.1.-);"phagocytic vesicle [GO:0045335]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]";"GO:0008757; GO:0045335";;phagocytic vesicle [GO:0045335];S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]
comp5884155_c0_seq1;GAXK01026014.1;Q08832;2.03E-08;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp588492_c0_seq1;GAXK01058618.1;P08045;3.22E-14;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp588503_c0_seq1;GAXK01058627.1;P10076;1.41E-28;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5885183_c0_seq1;GAXK01026015.1;P85084;8.09E-34;CHIT_CARPA;Endochitinase (EC 3.2.1.14);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp588545_c0_seq1;GAXK01058578.1;Q9JME2;3.25E-14;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp5885704_c0_seq1;GAXK01026011.1;Q3B725;1.77E-08;ZBT24_RAT;Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5886404_c0_seq1;GAXK01136940.1;Q24238;1.11E-32;APH4_DROME;Alkaline phosphatase 4 (EC 3.1.3.1);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]; epithelial fluid transport [GO:0042045]; multicellular organism reproduction [GO:0032504]; nervous system development [GO:0007399]";"GO:0004035; GO:0005576; GO:0005615; GO:0005886; GO:0007399; GO:0009986; GO:0016021; GO:0016311; GO:0031225; GO:0032504; GO:0042045; GO:0046872";"dephosphorylation [GO:0016311]; epithelial fluid transport [GO:0042045]; multicellular organism reproduction [GO:0032504]; nervous system development [GO:0007399]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]"
comp588702_c0_seq1;GAXK01058567.1;Q27433;2.29E-104;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp5887206_c0_seq1;GAXK01136946.1;P58234;3.37E-42;RS19A_SCHPO;40S ribosomal protein S19-A (S16-A);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; ribosome biogenesis [GO:0042254]";"GO:0000028; GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005829; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp5887584_c0_seq1;GAXK01136956.1;P18729;2.18E-12;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5887637_c0_seq1;GAXK01136954.1;P48148;1.60E-24;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp5887836_c0_seq1;GAXK01136953.1;Q9SGA6;5.13E-37;RS191_ARATH;40S ribosomal protein S19-1;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005618; GO:0005829; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp5888_c0_seq1;GAXK01065390.1;Q8CG46;2.91E-100;SMC5_MOUSE;Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453);"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000724; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0030054; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0051301; GO:0051984; GO:0090398";"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp588813_c0_seq1;GAXK01058605.1;Q8BQ86;3.92E-18;CHST8_MOUSE;Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446";"carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp5888159_c0_seq1;GAXK01104433.1;Q9VD44;1.12E-18;GLD2A_DROME;Poly(A) RNA polymerase gld-2 homolog A (DmGLD2) (EC 2.7.7.19);"cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; long-term memory [GO:0007616]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]";"GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005737; GO:0006397; GO:0007616; GO:0043005; GO:0043631; GO:0046872";"long-term memory [GO:0007616]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]";"cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]"
comp5888610_c0_seq1;GAXK01104437.1;P29419;1.43E-08;ATP5I_RAT;ATP synthase subunit e, mitochondrial (ATPase subunit e) (ATP synthase membrane subunit e);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATPase activity [GO:0016887]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000276; GO:0005739; GO:0005753; GO:0015078; GO:0015986; GO:0016887; GO:0044877; GO:0046034";"ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]";"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]"
comp588914_c0_seq1;GAXK01058557.1;Q5R7I8;2.52E-20;ZNF19_PONAB;Zinc finger protein 19;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5889379_c0_seq1;GAXK01104423.1;P86810;1.49E-16;OXLA_SIGCA;L-amino-acid oxidase (EC 1.4.3.2) (Antiparasitic protein) (APP) (Serum L-amino-acid oxidase) (SR-LAAO);"extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";"GO:0001716; GO:0005576; GO:0042742; GO:0045087";"defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]";extracellular region [GO:0005576];L-amino-acid oxidase activity [GO:0001716]
comp58897_c1_seq1;GAXK01145373.1;B0WC46;9.85E-79;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp5889780_c0_seq1;GAXK01104428.1;Q2KJ63;7.13E-07;KLKB1_BOVIN;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]";"extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";"GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]";extracellular space [GO:0005615];"protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
comp589_c0_seq1;GAXK01170210.1;P45594;3.78E-71;CADF_DROME;Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar);"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0050714; GO:0051299";"actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]";"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]";actin binding [GO:0003779]
comp589024_c0_seq1;GAXK01058654.1;Q8IN81;3.79E-16;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp5891106_c0_seq1;GAXK01003823.1;Q9W0T5;2.38E-12;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp5891285_c0_seq1;GAXK01003817.1;O60074;1.18E-08;DID2_SCHPO;Vacuolar protein-sorting-associated protein 46 (Charged multivesicular body protein 1) (Doa4-independent degradation protein 2);"ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000815; GO:0005770; GO:0005771; GO:0006623; GO:0015031; GO:0032509; GO:0032511; GO:0043162; GO:0045324";"endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; multivesicular body [GO:0005771]";
comp5891916_c0_seq1;GAXK01003809.1;P10074;1.76E-12;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp589244_c0_seq1;GAXK01058588.1;Q7ZX06;5.82E-16;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp5893646_c0_seq1;GAXK01139500.1;Q6IFY7;1.20E-12;RTN1A_XENLA;Reticulon-1-A (RTN1.1) (xRTN1) (XRTN1-C.1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"GO:0005634; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp58937_c3_seq1;GAXK01144828.1;Q86YS3;6.37E-19;RFIP4_HUMAN;Rab11 family-interacting protein 4 (FIP4-Rab11) (Rab11-FIP4) (Arfophilin-2);"cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032]";"GO:0003407; GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0016032; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048471; GO:0055038; GO:1903452";"endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032]";"cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]";"ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]"
comp58940_c1_seq1;GAXK01144612.1;Q28CH8;1.03E-75;YIPF6_XENTR;Protein YIPF6 (YIP1 family member 6);"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"GO:0000138; GO:0000139; GO:0005797; GO:0005802; GO:0016021";;"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";
comp5894970_c0_seq1;GAXK01011130.1;Q54MC6;7.25E-18;LRLA_DICDI;Latrophilin receptor-like protein A;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];integral component of membrane [GO:0016021];G protein-coupled receptor activity [GO:0004930]
comp58950_c1_seq1;GAXK01144812.1;Q80UG2;0;PLXA4_MOUSE;Plexin-A4;"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]";"GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007399; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048812; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287";"anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]";semaphorin receptor activity [GO:0017154]
comp5895163_c0_seq1;GAXK01011131.1;Q44879;1.23E-22;CTPA_BARBK;Carboxy-terminal-processing protease (C-terminal-processing protease) (EC 3.4.21.102);"extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236]";"GO:0005576; GO:0008236";;extracellular region [GO:0005576];serine-type peptidase activity [GO:0008236]
comp5895788_c0_seq1;GAXK01011125.1;Q9U6A0;2.30E-07;NCKX_DROME;Sodium/potassium/calcium exchanger Nckx30C (Na(+)/K(+)/Ca(2+)-exchange protein Nckx30C);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]";"GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0048749; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp5896061_c0_seq1;GAXK01064408.1;Q9ER30;6.22E-07;KLH41_RAT;Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"GO:0001726; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014";"myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]";
comp5898166_c0_seq1;GAXK01119150.1;O65272;1.85E-09;KEA2_ARATH;K(+) efflux antiporter 2, chloroplastic (AtKEA2);"chloroplast [GO:0009507]; chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; potassium:proton antiporter activity [GO:0015386]";"GO:0009507; GO:0009706; GO:0015386; GO:0016020; GO:0016021";;"chloroplast [GO:0009507]; chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";potassium:proton antiporter activity [GO:0015386]
comp589863_c0_seq1;GAXK01058620.1;F1RWC3;5.03E-12;CUBN_PIG;Cubilin (Intrinsic factor-cobalamin receptor);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006898; GO:0009617; GO:0016324; GO:0030139; GO:0042803; GO:0042953; GO:0070062";"lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]";"calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]"
comp589864_c5_seq1;GAXK01058645.1;P12024;2.59E-119;CHAO_DROME;Chaoptin (Photoreceptor cell-specific membrane protein);"anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus [GO:0035996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microvillus organization [GO:0032528]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"GO:0005886; GO:0007156; GO:0007601; GO:0016028; GO:0032528; GO:0035996; GO:0042052; GO:0046658; GO:0050896";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microvillus organization [GO:0032528]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus [GO:0035996]";
comp589902_c0_seq1;GAXK01058594.1;Q8I4E2;2.62E-64;LST4_CAEEL;Sorting nexin lst-4 (Lateral signaling target protein 4);"cytoplasm [GO:0005737]; early phagosome [GO:0032009]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTPase binding [GO:0051020]; phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein self-association [GO:0043621]; execution phase of apoptosis [GO:0097194]; mitotic cell cycle [GO:0000278]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome maturation involved in apoptotic cell clearance [GO:0090386]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein transport [GO:0015031]";"GO:0000278; GO:0005546; GO:0005547; GO:0005737; GO:0015031; GO:0019902; GO:0030670; GO:0032009; GO:0035091; GO:0043621; GO:0045335; GO:0051020; GO:0090386; GO:0090387; GO:0090389; GO:0097194";"execution phase of apoptosis [GO:0097194]; mitotic cell cycle [GO:0000278]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; phagosome maturation involved in apoptotic cell clearance [GO:0090386]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; early phagosome [GO:0032009]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]";"GTPase binding [GO:0051020]; phosphatase binding [GO:0019902]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol binding [GO:0035091]; protein self-association [GO:0043621]"
comp589937_c2_seq1;GAXK01058558.1;Q9BX70;8.68E-15;BTBD2_HUMAN;BTB/POZ domain-containing protein 2;"cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]";"GO:0000932; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; P-body [GO:0000932]";
comp58994_c2_seq1;GAXK01145306.1;Q9Y2L1;7.69E-163;RRP44_HUMAN;Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44);"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]";"GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0016020; GO:0016075; GO:0043488; GO:0043928; GO:0071034";"CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]";"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]"
comp59_c1_seq1;GAXK01169995.1;Q1HR24;5.62E-90;RS14_AEDAE;40S ribosomal protein S14;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp590067_c0_seq1;GAXK01036511.1;Q95LI3;2.26E-09;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp590075_c1_seq1;GAXK01036476.1;G5ED00;5.20E-07;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp59008_c2_seq1;GAXK01144851.1;Q9V576;7.47E-44;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp5900905_c0_seq1;GAXK01150862.1;Q8HXB8;3.30E-13;RL29_MACFA;60S ribosomal protein L29;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp5901809_c0_seq1;GAXK01150853.1;Q9UJQ4;2.17E-09;SALL4_HUMAN;Sal-like protein 4 (Zinc finger protein 797) (Zinc finger protein SALL4);"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; embryonic limb morphogenesis [GO:0030326]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000792; GO:0001833; GO:0001843; GO:0003281; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008134; GO:0030326; GO:0032991; GO:0035019; GO:0043231; GO:0045944; GO:0046872";"embryonic limb morphogenesis [GO:0030326]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]"
comp5903128_c0_seq1;GAXK01042032.1;G5EBR3;6.84E-09;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp5903343_c0_seq1;GAXK01042038.1;E9Q5M6;3.10E-10;CFA44_MOUSE;Cilia- and flagella-associated protein 44;"axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]";"GO:0005930; GO:0007288; GO:0030317; GO:0031514; GO:0060271; GO:0060285";"cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]";"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp590356_c1_seq1;GAXK01036500.1;Q8NB50;2.87E-16;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5903576_c0_seq1;GAXK01042027.1;P08548;3.65E-11;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp590391_c1_seq1;GAXK01036541.1;A2A870;3.55E-09;FBF1_MOUSE;Fas-binding factor 1 (FBF-1);"apical junction complex [GO:0043296]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; keratin filament [GO:0045095]; spindle pole [GO:0000922]; apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162]";"GO:0000922; GO:0005813; GO:0005814; GO:0036064; GO:0043296; GO:0043297; GO:0045095; GO:0060271; GO:0090162; GO:0097539";"apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162]";"apical junction complex [GO:0043296]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; keratin filament [GO:0045095]; spindle pole [GO:0000922]";
comp5904_c1_seq1;GAXK01065430.1;Q5ZMS3;0;IF2G_CHICK;Eukaryotic translation initiation factor 2 subunit 3 (Eukaryotic translation initiation factor 2 subunit gamma) (eIF-2-gamma);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]";"GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0045903";"formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]"
comp590406_c0_seq1;GAXK01036483.1;P52746;6.97E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp590409_c1_seq1;GAXK01036497.1;B2FQP3;4.25E-23;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp59041_c1_seq1;GAXK01145252.1;P17719;1.31E-57;DYR_DROME;Dihydrofolate reductase (EC 1.5.1.3);"mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; DNA replication [GO:0006260]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]";"GO:0004146; GO:0005739; GO:0006260; GO:0006545; GO:0006730; GO:0046452; GO:0046654; GO:0046655; GO:0050661";"dihydrofolate metabolic process [GO:0046452]; DNA replication [GO:0006260]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]";mitochondrion [GO:0005739];"dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]"
comp5904842_c0_seq1;GAXK01143509.1;Q07051;9.77E-65;EF1A_EIMBO;Elongation factor 1-alpha (EF-1-alpha) (Fragment);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp59054_c1_seq1;GAXK01144712.1;Q9D9N8;5.79E-43;PADC1_MOUSE;Protease-associated domain-containing protein 1 (Protease-associated domain-containing protein of 21 kDa);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp590560_c0_seq1;GAXK01036448.1;Q9PVG3;6.54E-19;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp59063_c2_seq1;GAXK01144716.1;Q9V427;1.68E-16;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp5906443_c0_seq1;GAXK01027241.1;Q9FRL3;4.03E-12;ERDL6_ARATH;Sugar transporter ERD6-like 6;"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; carbohydrate:proton symporter activity [GO:0005351]; glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"GO:0005351; GO:0005739; GO:0005774; GO:0005794; GO:0005887; GO:0009705; GO:0010030; GO:0042593";"glucose homeostasis [GO:0042593]; positive regulation of seed germination [GO:0010030]";"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]";carbohydrate:proton symporter activity [GO:0005351]
comp59074_c0_seq1;GAXK01144794.1;A8WGS4;2.54E-58;TLCD2_DANRE;TLC domain-containing protein 2;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5907426_c0_seq1;GAXK01027240.1;Q63447;9.23E-07;NPY4R_RAT;Neuropeptide Y receptor type 4 (NPY4-R) (Pancreatic polypeptide receptor 1) (PP1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601]";"GO:0001601; GO:0001602; GO:0005886; GO:0016021; GO:0042277";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"pancreatic polypeptide receptor activity [GO:0001602]; peptide binding [GO:0042277]; peptide YY receptor activity [GO:0001601]"
comp5907456_c0_seq1;GAXK01027249.1;P49211;6.87E-58;RL321_ARATH;60S ribosomal protein L32-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp59079_c1_seq1;GAXK01145300.1;Q13356;0;PPIL2_HUMAN;RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2);"cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0050900; GO:0061630; GO:0072659";"leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]";"cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]"
comp5908332_c0_seq1;GAXK01174064.1;Q9V7U0;2.85E-15;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp59090_c0_seq1;GAXK01145182.1;Q32L63;7.11E-61;VTA1_BOVIN;Vacuolar protein sorting-associated protein VTA1 homolog;"endosome membrane [GO:0010008]; protein transport [GO:0015031]";"GO:0010008; GO:0015031";protein transport [GO:0015031];endosome membrane [GO:0010008];
comp5909935_c0_seq1;GAXK01174076.1;Q87L85;4.47E-10;DUSA_VIBPA;tRNA-dihydrouridine(20/20a) synthase (EC 1.3.1.-) (EC 1.3.1.91) (U20-specific dihydrouridine synthase) (U20-specific Dus) (tRNA-dihydrouridine synthase A);"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; tRNA binding [GO:0000049]; tRNA-dihydrouridine20 synthase activity [GO:0102264]";"GO:0000049; GO:0010181; GO:0050660; GO:0102264";;;"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; tRNA binding [GO:0000049]; tRNA-dihydrouridine20 synthase activity [GO:0102264]"
comp5910_c0_seq1;GAXK01065753.1;P25169;1.27E-66;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp5910392_c0_seq1;GAXK01098130.1;Q08972;6.66E-35;NEW1_YEAST;[NU+] prion formation protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0016887; GO:0016973; GO:0042274";"poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]"
comp5910574_c0_seq1;GAXK01098145.1;Q8DNS0;5.57E-09;STKP_STRR6;Serine/threonine-protein kinase StkP (Ser/Thr-protein kinase StkP) (EC 2.7.11.1) (Eukaryotic-type Ser/Thr protein kinase) (ESTPK);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; division septum assembly [GO:0000917]; regulation of cell shape [GO:0008360]";"GO:0000917; GO:0004674; GO:0005524; GO:0005886; GO:0008360; GO:0016021";"division septum assembly [GO:0000917]; regulation of cell shape [GO:0008360]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp59106_c0_seq1;GAXK01145233.1;Q5RAT4;9.81E-172;ENOF1_PONAB;Mitochondrial enolase superfamily member 1 (EC 4.2.1.68) (L-fuconate dehydratase);"mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]";"GO:0000287; GO:0005739; GO:0009063; GO:0016853; GO:0044275; GO:0050023";"cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]";mitochondrion [GO:0005739];"isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]"
comp5910762_c0_seq1;GAXK01098139.1;Q9SUD3;3.69E-16;CX6B3_ARATH;Cytochrome c oxidase subunit 6b-3 (AtCOX6b-3);"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"GO:0005739; GO:0005886";;"mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";
comp5911_c0_seq1;GAXK01065986.1;Q9D0I8;7.05E-81;MRT4_MOUSE;mRNA turnover protein 4 homolog (Ribosome assembly factor Mrto4);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]";"GO:0000027; GO:0000956; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273";"nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";
comp591113_c0_seq1;GAXK01036495.1;Q9GRW0;1.99E-13;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp59116_c1_seq1;GAXK01145261.1;O08585;3.12E-15;CLCA_MOUSE;Clathrin light chain A (Lca);"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631";"cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]";"clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]"
comp5912203_c0_seq1;GAXK01009713.1;P15330;6.94E-21;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp5912394_c0_seq1;GAXK01009718.1;Q9F234;5.48E-09;AGL2_BACTQ;Alpha-glucosidase 2 (EC 3.2.1.20) (Alpha-glucosidase II);"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]";"GO:0004558; GO:0030246; GO:0032450";;;"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"
comp591255_c0_seq1;GAXK01036447.1;Q9WTN6;2.99E-63;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp5912840_c0_seq1;GAXK01009712.1;Q9VKY2;5.54E-11;CAND1_DROME;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1);"nucleus [GO:0005634]; negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";"GO:0005634; GO:0010265; GO:0016567; GO:0031647; GO:2000435";"negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";nucleus [GO:0005634];
comp591320_c0_seq2;GAXK01036513.1;Q7K237;1.61E-93;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp59145_c1_seq1;GAXK01145253.1;P52555;2.93E-32;ERP29_RAT;Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 31) (ERp31);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0000187; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0030133; GO:0034976; GO:0042470; GO:0042803; GO:0050709; GO:0051087; GO:1902235";"activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]";"chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]"
comp59166_c0_seq1;GAXK01144610.1;Q8ETH0;2.54E-30;HMP_OCEIH;Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17);"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";"GO:0005344; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046872; GO:0051409; GO:0071949";"response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";;"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp5917069_c0_seq1;GAXK01204829.1;Q3STC2;2.31E-46;GLGB_NITWN;1,4-alpha-glucan branching enzyme GlgB (EC 2.4.1.18) (1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-glucosyl-transferase) (Alpha-(1->4)-glucan branching enzyme) (Glycogen branching enzyme) (BE);"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; glycogen biosynthetic process [GO:0005978]";"GO:0003844; GO:0004553; GO:0005978; GO:0043169; GO:0102752";glycogen biosynthetic process [GO:0005978];;"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp591721_c0_seq1;GAXK01036509.1;O34313;1.82E-30;NTPES_BACSU;"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]";"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005576; GO:0005618; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872";nucleotide catabolic process [GO:0009166];"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]";"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp5917384_c0_seq1;GAXK01064725.1;P42765;8.63E-117;THIM_HUMAN;3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109";"cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]"
comp591743_c0_seq1;GAXK01036493.1;Q8BLA8;8.31E-09;TRPA1_MOUSE;Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; stereocilium bundle [GO:0032421]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; osmolarity-sensing cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]";"GO:0005216; GO:0005245; GO:0005262; GO:0005887; GO:0006816; GO:0007166; GO:0009409; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016021; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042493; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070417; GO:0070588; GO:0071244; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760";"calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; stereocilium bundle [GO:0032421]";"calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; osmolarity-sensing cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245]"
comp5917975_c0_seq1;GAXK01064740.1;Q9VG58;3.84E-59;HSP74_DROME;Major heat shock 70 kDa protein Bbb (Heat shock protein 70Bbb) (HSP70-87C1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; heat shock-mediated polytene chromosome puffing [GO:0035080]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to unfolded protein [GO:0006986]";"GO:0001666; GO:0005524; GO:0005737; GO:0005829; GO:0006986; GO:0009408; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0035080; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; heat shock-mediated polytene chromosome puffing [GO:0035080]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp5919_c3_seq1;GAXK01066712.1;Q5ZIA5;0;COPB_CHICK;Coatomer subunit beta (Beta-coat protein) (Beta-COP);"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]";"GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]";"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]";structural molecule activity [GO:0005198]
comp59198_c1_seq1;GAXK01145188.1;Q8JZX4;1.42E-23;SPF45_MOUSE;Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000375; GO:0000380; GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006281; GO:0032991";"alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp5920058_c0_seq1;GAXK01155863.1;Q9FLF0;1.19E-61;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp59208_c0_seq1;GAXK01145002.1;Q8CIB9;1.30E-54;ESCO2_MOUSE;N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2);"cell junction [GO:0030054]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; acetyltransferase activity [GO:0016407]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; double-strand break repair [GO:0006302]; hematopoietic progenitor cell differentiation [GO:0002244]; post-translational protein acetylation [GO:0034421]; protein localization to chromatin [GO:0071168]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]";"GO:0000785; GO:0001741; GO:0002244; GO:0004468; GO:0005634; GO:0005694; GO:0005794; GO:0006275; GO:0006302; GO:0007059; GO:0007062; GO:0010369; GO:0016407; GO:0030054; GO:0031618; GO:0034421; GO:0035861; GO:0046872; GO:0071168";"chromosome segregation [GO:0007059]; double-strand break repair [GO:0006302]; hematopoietic progenitor cell differentiation [GO:0002244]; post-translational protein acetylation [GO:0034421]; protein localization to chromatin [GO:0071168]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]";"cell junction [GO:0030054]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; XY body [GO:0001741]";"acetyltransferase activity [GO:0016407]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; metal ion binding [GO:0046872]"
comp592082_c0_seq1;GAXK01188579.1;O88327;1.43E-53;CTNL1_MOUSE;Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]";"GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015";"cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]"
comp592115_c0_seq1;GAXK01188558.1;Q9W6V2;6.42E-08;NEGR1_CHICK;Neuronal growth regulator 1 (Neurotractin);"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp5921229_c0_seq1;GAXK01155874.1;Q9SKZ1;8.46E-12;PUR_ARATH;Transcription factor Pur-alpha 1 (Purine-rich single-stranded DNA-binding protein alpha 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; response to cadmium ion [GO:0046686]";"GO:0000977; GO:0001227; GO:0003690; GO:0003729; GO:0005634; GO:0005737; GO:0005777; GO:0032422; GO:0043565; GO:0046686";response to cadmium ion [GO:0046686];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp59213_c1_seq1;GAXK01144810.1;Q7KRI2;9.57E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp5922_c1_seq1;GAXK01066259.1;Q9VCI5;9.59E-20;DHSD_DROME;Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone reductase membrane anchor subunit);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; ubiquinone binding [GO:0048039]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0016021; GO:0020037; GO:0046872; GO:0048039";"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; ubiquinone binding [GO:0048039]"
comp5922132_c0_seq1;GAXK01069010.1;Q12766;5.39E-09;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp592236_c0_seq1;GAXK01188615.1;Q9M815;6.29E-08;PCR8_ARATH;Protein PLANT CADMIUM RESISTANCE 8 (AtPCR8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to oxidative stress [GO:0006979]";"GO:0005886; GO:0006979; GO:0016021";response to oxidative stress [GO:0006979];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp5923_c0_seq1;GAXK01065577.1;Q2KHT8;7.15E-152;DIM1_BOVIN;Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]";"GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234";"positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"
comp59233_c2_seq1;GAXK01145288.1;Q5EAU9;4.21E-48;RMD3_XENLA;Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"GO:0000922; GO:0005634; GO:0005741; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]";
comp592381_c0_seq1;GAXK01188571.1;Q7Z269;3.69E-47;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp5926114_c0_seq1;GAXK01140992.1;Q9C3Z5;1.72E-16;RLA2_PODAS;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp592664_c0_seq1;GAXK01188611.1;O97366;3.44E-33;PPAF1_HOLDI;"Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp5927027_c0_seq1;GAXK01140990.1;Q9SMI3;8.16E-48;RS12_CYAPA;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp59276_c1_seq1;GAXK01144608.1;Q9R1D7;0;GBF1_CRIGR;Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1);"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005793; GO:0005794; GO:0005811; GO:0008289; GO:0015031; GO:0016020; GO:0032012";"protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]";"endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]"
comp59284_c0_seq1;GAXK01145008.1;Q6P6S9;2.20E-10;ENTP5_RAT;Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0008283; GO:0014066; GO:0045134; GO:0045821; GO:0046034; GO:0051084";"'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; cell population proliferation [GO:0008283]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]"
comp5928480_c0_seq1;GAXK01082779.1;Q9GUM2;2.39E-30;BRE4_CAEEL;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";"GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872";"carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";integral component of membrane [GO:0016021];"acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"
comp5930681_c0_seq1;GAXK01109867.1;Q502K3;1.04E-11;ANR52_DANRE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C);;;;;
comp5930771_c0_seq1;GAXK01109862.1;Q6VTH5;2.70E-21;RSPH1_CYPCA;Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0005856; GO:0007275; GO:0007283; GO:0030154; GO:0031514; GO:0051321";"cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";
comp593078_c1_seq1;GAXK01188616.1;Q9W4S1;4.42E-55;GRCR2_DROME;Glutaredoxin domain-containing cysteine-rich protein CG12206;"cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005623; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cell [GO:0005623];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp5931_c40_seq1;GAXK01066598.1;P08928;7.33E-61;LAM0_DROME;Lamin Dm0;"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433";"adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]";"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp5931143_c0_seq1;;P38975;1.89E-33;ETFB_PARDE;Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS);electron transfer activity [GO:0009055];GO:0009055;;;electron transfer activity [GO:0009055]
comp5932_c1_seq1;GAXK01066732.1;P78344;2.63E-82;IF4G2_HUMAN;Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97);"cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of translational initiation [GO:0006446]";"GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0005913; GO:0006446; GO:0007050; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0034645; GO:0045296";"cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of translational initiation [GO:0006446]";"cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]";"cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp5932263_c0_seq1;GAXK01156774.1;Q88H32;6.14E-47;OCD_PSEPK;Ornithine cyclodeaminase (OCD) (EC 4.3.1.12);"nucleotide binding [GO:0000166]; ornithine cyclodeaminase activity [GO:0008473]; L-proline biosynthetic process [GO:0055129]";"GO:0000166; GO:0008473; GO:0055129";L-proline biosynthetic process [GO:0055129];;"nucleotide binding [GO:0000166]; ornithine cyclodeaminase activity [GO:0008473]"
comp5932277_c0_seq1;GAXK01156759.1;P21328;4.10E-11;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp593248_c1_seq1;GAXK01188610.1;Q5RGL7;1.04E-16;SMY2B_DANRE;N-lysine methyltransferase SMYD2-B (EC 2.1.1.-) (Histone methyltransferase SMYD2-B) (EC 2.1.1.43) (SET and MYND domain-containing protein 2B);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart contraction [GO:0060047]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975; GO:0060047";"heart contraction [GO:0060047]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp5932910_c0_seq1;GAXK01156763.1;Q12EI9;3.12E-27;PRMA_POLSJ;Ribosomal protein L11 methyltransferase (L11 Mtase) (EC 2.1.1.-);"cytoplasm [GO:0005737]; protein methyltransferase activity [GO:0008276]";"GO:0005737; GO:0008276";;cytoplasm [GO:0005737];protein methyltransferase activity [GO:0008276]
comp593344_c0_seq1;GAXK01188557.1;Q9VCA2;3.12E-64;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp59337_c0_seq1;GAXK01144710.1;E7E2N8;1.27E-20;GILT_CARAU;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]";"GO:0005576; GO:0005764; GO:0019882; GO:0047134";antigen processing and presentation [GO:0019882];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp5934256_c0_seq1;GAXK01176750.1;Q9ULK0;2.46E-11;GRID1_HUMAN;Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit);"cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0030054; GO:0035176; GO:0035249; GO:0045211; GO:0050804; GO:0070062; GO:0098978; GO:0099061; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp593432_c0_seq1;GAXK01188618.1;Q06985;8.48E-08;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp5935559_c0_seq1;GAXK01176761.1;P98160;8.12E-13;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp593565_c0_seq1;GAXK01188599.1;G5EBQ8;7.17E-69;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp5936062_c0_seq1;GAXK01015861.1;P09933;8.82E-17;PERT_PIG;Thyroid peroxidase (TPO) (EC 1.11.1.8);"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0006590; GO:0006979; GO:0016021; GO:0020037; GO:0042446; GO:0042744";"hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]"
comp5939_c1_seq1;GAXK01065398.1;P32234;0;128UP_DROME;GTP-binding protein 128up;"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0005525; GO:0005737";cytoplasmic translation [GO:0002181];cytoplasm [GO:0005737];GTP binding [GO:0005525]
comp594012_c2_seq1;GAXK01079101.1;Q9UBN4;1.52E-13;TRPC4_HUMAN;Short transient receptor potential channel 4 (TrpC4) (Trp-related protein 4) (hTrp-4) (hTrp4);"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005886; GO:0005887; GO:0005901; GO:0006816; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034703; GO:0034704; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070588; GO:0070679";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]";"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp59419_c0_seq1;GAXK01145247.1;P35290;1.85E-65;RAB24_MOUSE;Ras-related protein Rab-24 (Rab-16);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0016020; GO:0030139; GO:0032482";"autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020]; mitochondrion [GO:0005739]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp594313_c0_seq1;GAXK01079163.1;Q8K2R5;4.41E-32;ZN668_MOUSE;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp594359_c0_seq1;GAXK01079094.1;Q63664;3.26E-79;KCNJ8_RAT;ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1);"intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; defense response to virus [GO:0051607]; heart development [GO:0007507]; kidney development [GO:0001822]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]";"GO:0001822; GO:0005242; GO:0005524; GO:0005739; GO:0006813; GO:0007507; GO:0008282; GO:0015272; GO:0016020; GO:0017098; GO:0030016; GO:0032496; GO:0034765; GO:0042383; GO:0043231; GO:0043330; GO:0051607; GO:1990573";"defense response to virus [GO:0051607]; heart development [GO:0007507]; kidney development [GO:0001822]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]";"intracellular membrane-bounded organelle [GO:0043231]; inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; sarcolemma [GO:0042383]";"ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATP binding [GO:0005524]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]"
comp5944122_c0_seq1;GAXK01075177.1;P46384;4.62E-08;PILG_PSEAE;Protein PilG;phosphorelay signal transduction system [GO:0000160];GO:0000160;phosphorelay signal transduction system [GO:0000160];;
comp59442_c0_seq1;GAXK01145369.1;Q1JPD2;5.62E-131;ABHGA_BOVIN;Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23);"integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]";"GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651";"monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]";integral component of membrane [GO:0016021];"acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]"
comp5944279_c0_seq1;GAXK01075174.1;Q6AYD3;2.85E-70;PA2G4_RAT;Proliferation-associated protein 2G4;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"GO:0003676; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0043066; GO:0045597";"negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]"
comp594476_c0_seq1;GAXK01079116.1;Q24342;1.39E-67;FNG_DROME;Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0001745; GO:0005737; GO:0005783; GO:0005794; GO:0005795; GO:0005797; GO:0006493; GO:0007293; GO:0007450; GO:0007476; GO:0008375; GO:0008587; GO:0008593; GO:0030173; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]"
comp5945151_c0_seq1;GAXK01075175.1;Q32L26;4.45E-47;EFCB1_BOVIN;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp5945333_c0_seq1;GAXK01075179.1;Q99PV8;7.67E-07;BC11B_MOUSE;B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (mRit1);"neuron projection [GO:0043005]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006355; GO:0007409; GO:0008285; GO:0009791; GO:0010468; GO:0010837; GO:0019216; GO:0021773; GO:0021902; GO:0021953; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043066; GO:0043368; GO:0043565; GO:0043588; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0071678; GO:0097535";"alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"neuron projection [GO:0043005]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp5945458_c0_seq1;GAXK01075171.1;O09452;4.61E-51;G3PA_GUITH;Glyceraldehyde-3-phosphate dehydrogenase, chloroplastic (EC 1.2.1.59) (NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase);"chloroplast [GO:0009507]; glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0006006; GO:0009507; GO:0019253; GO:0043891; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast [GO:0009507];"glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO:0043891]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp5946027_c0_seq1;GAXK01038366.1;Q5RH95;1.92E-61;RSAD2_DANRE;Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible);"endoplasmic reticulum membrane [GO:0005789]; 4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; response to virus [GO:0009615]";"GO:0003824; GO:0005789; GO:0009615; GO:0045087; GO:0046872; GO:0051539; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; response to virus [GO:0009615]";endoplasmic reticulum membrane [GO:0005789];"4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]"
comp59462_c0_seq1;GAXK01145349.1;Q7ZVG6;1.08E-16;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp59463_c1_seq1;GAXK01145017.1;P55094;6.50E-18;NR2C2_RAT;Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TR4) (Testicular receptor 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";"GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0030154; GO:0040019; GO:0045944; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp59471_c1_seq1;GAXK01144873.1;Q5U3Q6;6.90E-112;CIP4_DANRE;Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog);"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036";"actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp594759_c0_seq1;GAXK01079161.1;Q7TPM1;7.00E-13;PRC2B_MOUSE;Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B);in utero embryonic development [GO:0001701];GO:0001701;in utero embryonic development [GO:0001701];;
comp5947624_c0_seq1;GAXK01038373.1;Q8BGF3;7.47E-47;WDR92_MOUSE;WD repeat-containing protein 92 (WD repeat-containing protein Monad);"ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]";"GO:0006915; GO:0043130";apoptotic process [GO:0006915];;ubiquitin binding [GO:0043130]
comp594814_c0_seq1;GAXK01079027.1;Q8NB50;1.44E-12;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp5948417_c0_seq1;GAXK01009978.1;Q9M0Z3;1.10E-31;KEA3_ARATH;K(+) efflux antiporter 3, chloroplastic (AtKEA3);"chloroplast [GO:0009507]; chloroplast membrane [GO:0031969]; chloroplast thylakoid membrane [GO:0009535]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; thylakoid membrane [GO:0042651]; solute:proton antiporter activity [GO:0015299]; chloroplast organization [GO:0009658]; photosynthetic acclimation [GO:0009643]; positive regulation of photosynthesis [GO:1905157]; potassium ion transport [GO:0006813]; regulation of photosynthesis [GO:0010109]";"GO:0000139; GO:0006813; GO:0009507; GO:0009535; GO:0009643; GO:0009658; GO:0010109; GO:0015299; GO:0016020; GO:0016021; GO:0031969; GO:0042651; GO:1905157";"chloroplast organization [GO:0009658]; photosynthetic acclimation [GO:0009643]; positive regulation of photosynthesis [GO:1905157]; potassium ion transport [GO:0006813]; regulation of photosynthesis [GO:0010109]";"chloroplast [GO:0009507]; chloroplast membrane [GO:0031969]; chloroplast thylakoid membrane [GO:0009535]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; thylakoid membrane [GO:0042651]";solute:proton antiporter activity [GO:0015299]
comp5948967_c0_seq1;GAXK01009968.1;P04052;1.20E-17;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp59490_c0_seq1;GAXK01144793.1;P09848;1.00E-153;LPH_HUMAN;"Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]";"GO:0000016; GO:0005886; GO:0005887; GO:0005975; GO:0008422; GO:0016020; GO:0016324; GO:0017042; GO:0044245";"carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]"
comp595_c0_seq1;GAXK01170053.1;P82921;4.58E-22;RT21_HUMAN;28S ribosomal protein S21, mitochondrial (MRP-S21) (S21mt) (Mitochondrial small ribosomal subunit protein bS21m);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543; GO:0070125; GO:0070126";"mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]";"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp5951048_c0_seq1;GAXK01022607.1;Q4GXH5;2.19E-45;RL17_CARGR;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp5951081_c0_seq1;GAXK01022612.1;Q557E4;7.89E-50;SKP1B_DICDI;"SCF ubiquitin ligase complex protein SKP1b (Glycoprotein FP21 isoform B) [Cleaved into: SCF ubiquitin ligase complex protein SKP1b(4-162); SCF ubiquitin ligase complex protein SKP1b(6-162)]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sorocarp development [GO:0030587]";"GO:0005634; GO:0005737; GO:0005938; GO:0016567; GO:0030587; GO:0031146; GO:0097602";"protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sorocarp development [GO:0030587]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";cullin family protein binding [GO:0097602]
comp5951316_c0_seq1;GAXK01022624.1;Q8VZB9;1.74E-26;R10A1_ARATH;60S ribosomal protein L10a-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0005576; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp59516_c0_seq1;GAXK01145189.1;P49858;5.26E-59;CNI_DROME;Protein cornichon;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005789; GO:0006888; GO:0007310; GO:0007350; GO:0009952; GO:0015031; GO:0016021; GO:0016192; GO:0046843";"anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp595164_c0_seq1;GAXK01079038.1;Q24133;1.96E-17;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp5951895_c0_seq1;GAXK01022619.1;O01382;8.89E-38;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp595193_c0_seq1;GAXK01079109.1;Q8VEG4;4.46E-29;EXD2_MOUSE;Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0006302; GO:0008310; GO:0008408; GO:0008852; GO:0090305";"DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]"
comp595261_c0_seq1;GAXK01079095.1;P11247;3.26E-60;PERM_MOUSE;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268";"aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]";"azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]";"heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp595380_c0_seq1;GAXK01079107.1;Q6B8I0;1.29E-32;DS13A_MOUSE;Dual specificity protein phosphatase 13 isoform A (DUSP13A) (EC 3.1.3.16) (EC 3.1.3.48) (Muscle-restricted DSP);"cytoplasm [GO:0005737]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]";"GO:0004725; GO:0005737; GO:0008138; GO:0016311; GO:0016791";dephosphorylation [GO:0016311];cytoplasm [GO:0005737];"phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp59545_c0_seq1;GAXK01145184.1;Q6P2X9;1.04E-53;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp595470_c0_seq1;GAXK01079030.1;A4IF63;1.30E-48;TRIM2_BOVIN;Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";"GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp5956561_c0_seq1;GAXK01203377.1;P37167;2.26E-42;ACTP_ACACA;Actophorin;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]";"GO:0003779; GO:0005737; GO:0015629; GO:0030042";actin filament depolymerization [GO:0030042];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";actin binding [GO:0003779]
comp59568_c0_seq1;GAXK01145007.1;Q92556;2.07E-124;ELMO1_HUMAN;Engulfment and cell motility protein 1 (Protein ced-12 homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048870; GO:0050690";"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]";SH3 domain binding [GO:0017124]
comp5956811_c0_seq1;GAXK01203371.1;Q8AVG0;1.15E-30;ABR_XENLA;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp595696_c0_seq1;GAXK01079112.1;Q8T674;1.19E-30;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp59570_c2_seq1;GAXK01145372.1;P86704;5.58E-46;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp5957370_c0_seq1;GAXK01203372.1;Q90YT3;1.48E-39;RL35A_ICTPU;60S ribosomal protein L35a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]";"GO:0000049; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp59574_c0_seq1;GAXK01145000.1;Q9H6K1;3.12E-64;ILRUN_HUMAN;Protein ILRUN (Inflammation and lipid regulator with UBA-like and NBR1-like domains protein);"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480]";"GO:0000407; GO:0005634; GO:0005737; GO:0005776; GO:0016236; GO:0032480; GO:0032720; GO:0043130; GO:0043392; GO:0045087; GO:0050687; GO:1900181";"innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480]";"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]";ubiquitin binding [GO:0043130]
comp5959135_c0_seq1;GAXK01137159.1;Q39057;2.79E-09;CONS_ARATH;Zinc finger protein CONSTANS;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; far-red light signaling pathway [GO:0010018]; flower development [GO:0009908]; regulation of flower development [GO:0009909]; response to far red light [GO:0010218]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0009908; GO:0009909; GO:0010018; GO:0010218; GO:0030154";"cell differentiation [GO:0030154]; far-red light signaling pathway [GO:0010018]; flower development [GO:0009908]; regulation of flower development [GO:0009909]; response to far red light [GO:0010218]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp59594_c2_seq1;GAXK01145374.1;Q90YA8;6.04E-89;QPCT_GLOBL;Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);"extracellular region [GO:0005576]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]";"GO:0005576; GO:0008270; GO:0016603; GO:0017186";peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186];extracellular region [GO:0005576];"glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]"
comp596_c1_seq1;GAXK01168379.1;P38062;0;MAP2_RAT;Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]";"GO:0004177; GO:0005737; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084";"N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]";cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]"
comp5960_c0_seq1;GAXK01065671.1;Q9JK83;1.06E-90;PAR6B_MOUSE;Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]";"GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0016324; GO:0017048; GO:0032991; GO:0045177; GO:0051301; GO:0060341; GO:0065003";"cell-cell junction assembly [GO:0007043]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]"
comp596030_c0_seq1;GAXK01196312.1;Q96IR2;1.74E-11;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5960689_c0_seq1;GAXK01079649.1;P79251;2.89E-11;VATG1_BOVIN;V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16);"cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]";"GO:0005765; GO:0005829; GO:0005886; GO:0006879; GO:0008553; GO:0016471; GO:0016887; GO:0036295; GO:0051117";"cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]";"cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";"ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp5961500_c0_seq1;GAXK01079646.1;Q8R151;2.17E-08;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp596152_c0_seq1;GAXK01196360.1;Q8N0W4;1.15E-90;NLGNX_HUMAN;Neuroligin-4, X-linked (Neuroligin X) (HNLX);"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0014069; GO:0016021; GO:0021549; GO:0030054; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045211; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054";"adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp5961590_c0_seq1;GAXK01079654.1;Q23858;3.95E-37;CALR_DICDI;Calreticulin;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006911; GO:0030246; GO:0030968; GO:0045335; GO:0051082; GO:0051707";"endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp596174_c0_seq1;GAXK01196351.1;Q6AXL4;1.33E-13;NCLDB_DANRE;Neurocalcin-delta B;"calcium ion binding [GO:0005509]; regulation of axon extension involved in axon guidance [GO:0048841]";"GO:0005509; GO:0048841";regulation of axon extension involved in axon guidance [GO:0048841];;calcium ion binding [GO:0005509]
comp5962697_c0_seq1;GAXK01148716.1;Q7KF90;1.75E-26;RL31_SPOFR;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp596341_c0_seq1;GAXK01196339.1;Q9VCA2;5.86E-20;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp596508_c1_seq1;GAXK01196337.1;P83088;4.43E-61;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp59651_c0_seq1;GAXK01145337.1;O54698;6.96E-42;S29A1_RAT;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0007595; GO:0015858; GO:0015862; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794";"cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp5965621_c0_seq1;GAXK01150319.1;Q8I7P9;2.35E-09;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp596574_c0_seq1;GAXK01196308.1;P32028;6.35E-70;FD4_DROME;Fork head domain-containing protein FD4;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0009653; GO:0030154; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp5966275_c0_seq1;GAXK01061991.1;Q8W490;5.81E-20;PEPK2_ARATH;Serine/threonine-protein kinase PEPKR2 (EC 2.7.11.-) (Protein PHOSPHOENOLPYRUVATE CARBOXYLASE-RELATED KINASE 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp596709_c0_seq1;GAXK01196362.1;Q27128;1.91E-17;PAPSS_URECA;"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]";"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103]";"GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779";sulfate assimilation [GO:0000103];;"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]"
comp596782_c1_seq1;GAXK01196311.1;Q88PP0;3.38E-30;HMP_PSEPK;Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17);"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";"GO:0005344; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046872; GO:0051409; GO:0071949";"response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";;"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp597009_c0_seq1;GAXK01196288.1;P09456;3.59E-129;KAP0_RAT;cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed];"axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; cardiac muscle cell proliferation [GO:0060038]; cGMP-mediated signaling [GO:0019934]; female meiotic nuclear division [GO:0007143]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of meiotic nuclear division [GO:0045835]; regulation of protein kinase activity [GO:0045859]; sarcomere organization [GO:0045214]";"GO:0001707; GO:0001772; GO:0004862; GO:0005737; GO:0005829; GO:0005930; GO:0005952; GO:0007143; GO:0008603; GO:0019904; GO:0019934; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0034236; GO:0044853; GO:0045214; GO:0045835; GO:0045859; GO:0046007; GO:0047555; GO:0060038; GO:0098978; GO:2000480";"cardiac muscle cell proliferation [GO:0060038]; cGMP-mediated signaling [GO:0019934]; female meiotic nuclear division [GO:0007143]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of meiotic nuclear division [GO:0045835]; regulation of protein kinase activity [GO:0045859]; sarcomere organization [GO:0045214]";"axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]"
comp597020_c0_seq1;GAXK01196292.1;Q13472;7.89E-07;TOP3A_HUMAN;DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha);"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796";"chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]";"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"
comp59703_c1_seq1;GAXK01144739.1;O30825;3.77E-15;Y322_HAEDU;RutC family protein HD_0322;;;;;
comp5970500_c0_seq1;GAXK01118542.1;O96006;1.88E-10;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp59718_c0_seq1;GAXK01145301.1;Q58CU2;6.98E-145;E41L5_BOVIN;Band 4.1-like protein 5;"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]";"GO:0005737; GO:0005856; GO:0005912; GO:0008092; GO:0031032";actomyosin structure organization [GO:0031032];"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";cytoskeletal protein binding [GO:0008092]
comp59720_c0_seq1;GAXK01145248.1;P27779;8.10E-15;CUP7_DROME;Pupal cuticle protein Edg-78E;"extracellular matrix [GO:0031012]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin-based cuticle development [GO:0040003]";"GO:0008010; GO:0008011; GO:0031012; GO:0040003";chitin-based cuticle development [GO:0040003];extracellular matrix [GO:0031012];"structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp597339_c0_seq1;GAXK01196310.1;Q16983;3.34E-39;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp597442_c0_seq1;GAXK01196294.1;Q6DJ83;9.56E-07;CADM2_XENTR;Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp5975172_c0_seq1;GAXK01170913.1;Q4R6T7;7.18E-39;IQUB_MACFA;IQ and ubiquitin-like domain-containing protein;cell projection organization [GO:0030030];GO:0030030;cell projection organization [GO:0030030];;
comp5975755_c0_seq1;GAXK01170922.1;O15084;5.39E-09;ANR28_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]";"GO:0000139; GO:0005654; GO:0005829; GO:0048208";COPII vesicle coating [GO:0048208];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";
comp5975772_c0_seq1;GAXK01170906.1;Q9VV43;2.97E-14;Y5057_DROME;TPPP family protein CG45057;"axon [GO:0030424]; neuronal cell body [GO:0043025]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"GO:0000226; GO:0001578; GO:0015631; GO:0030424; GO:0032273; GO:0043025; GO:0046785";"microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"axon [GO:0030424]; neuronal cell body [GO:0043025]";tubulin binding [GO:0015631]
comp5976_c1_seq1;GAXK01065636.1;Q12904;2.06E-63;AIMP1_HUMAN;Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)];"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006418; GO:0006915; GO:0006935; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0009611; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tRNA aminoacylation for protein translation [GO:0006418]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]";"cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]"
comp5976040_c0_seq1;GAXK01155313.1;Q9PVG3;1.68E-13;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp59764_c1_seq1;GAXK01144594.1;Q9H4B6;1.69E-56;SAV1_HUMAN;Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412]";"GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007165; GO:0030216; GO:0035329; GO:0042802; GO:0043065; GO:0045600; GO:0050680; GO:0050821; GO:0051091; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:2000036";"apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]"
comp5976553_c0_seq1;GAXK01155321.1;Q6P9A1;1.30E-22;ZN530_HUMAN;Zinc finger protein 530;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5976633_c0_seq1;GAXK01155311.1;Q4DZP2;5.60E-72;RL18_TRYCC;60S ribosomal protein L18;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp59770_c0_seq1;GAXK01145380.1;P16912;3.01E-174;KAPC3_DROME;cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2);"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105";"imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]"
comp5977385_c0_seq1;GAXK01155306.1;Q46635;3.24E-13;AMSE_ERWAM;Amylovoran biosynthesis glycosyltransferase AmsE (EC 2.4.-.-);"transferase activity, transferring glycosyl groups [GO:0016757]; pathogenesis [GO:0009405]; polysaccharide biosynthetic process [GO:0000271]";"GO:0000271; GO:0009405; GO:0016757";"pathogenesis [GO:0009405]; polysaccharide biosynthetic process [GO:0000271]";;transferase activity, transferring glycosyl groups [GO:0016757]
comp59776_c2_seq1;GAXK01145304.1;Q9W3E1;2.54E-149;INT4_DROME;Integrator complex subunit 4;"integrator complex [GO:0032039]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"GO:0005634; GO:0016180; GO:0032039; GO:0034472";"snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]";"integrator complex [GO:0032039]; nucleus [GO:0005634]";
comp597805_c0_seq1;GAXK01205994.1;Q9V5L3;9.47E-74;C49A1_DROME;Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016491; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp59782_c0_seq1;GAXK01145005.1;Q92541;2.22E-91;RTF1_HUMAN;RNA polymerase-associated protein RTF1 homolog;"Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0006368; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0032968; GO:0045944; GO:0051571; GO:0080182; GO:1990269";"blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]";"Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]"
comp597828_c0_seq1;GAXK01196298.1;Q8BV42;2.75E-08;ZN786_MOUSE;Zinc finger protein 786;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp59793_c0_seq1;GAXK01145264.1;O60306;0;AQR_HUMAN;RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160);"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006283; GO:0016020; GO:0071007; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]";"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5979342_c0_seq1;GAXK01004261.1;Q5ZKR7;2.10E-25;ACBG2_CHICK;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp5979559_c0_seq1;GAXK01004269.1;Q06033;6.47E-22;ITIH3_HUMAN;Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]";"GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0030212; GO:0031089; GO:0070062";"hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]";"endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp5979705_c0_seq1;GAXK01004267.1;Q29J90;1.31E-07;MOODY_DROPS;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp598_c0_seq1;GAXK01168695.1;P62255;6.93E-93;UB2G1_RAT;Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0043161; GO:0061631; GO:0070534; GO:0070936";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp59803_c0_seq1;GAXK01144966.1;O16129;6.68E-169;SYFM_DROME;Probable phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]";"GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033";"phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]";"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]"
comp598042_c0_seq1;GAXK01164711.1;Q32L50;1.71E-08;SBSPO_BOVIN;Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin);"extracellular region [GO:0005576]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]";"GO:0005044; GO:0005576; GO:0006955; GO:0030247";immune response [GO:0006955];extracellular region [GO:0005576];"polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp5980669_c0_seq1;GAXK01173999.1;Q9AFF7;7.48E-21;PRRB_PRB02;Blue-light absorbing proteorhodopsin (BPR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005886; GO:0007602; GO:0009881; GO:0010461; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]"
comp598190_c0_seq1;GAXK01164643.1;P38571;2.44E-13;LICH_HUMAN;Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase);"fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]";"GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0044255; GO:0048771; GO:0048873";"cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]";"fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]";"lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]"
comp59822_c0_seq1;GAXK01145014.1;O16852;2.15E-138;PCNA_SARCR;Proliferating cell nuclear antigen (PCNA) (Cyclin);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]";"GO:0003677; GO:0005634; GO:0006260; GO:0006275; GO:0030337";"DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]"
comp59823_c0_seq1;GAXK01144813.1;Q5SRY7;2.10E-08;FBW1B_MOUSE;F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";"GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007049; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031648; GO:0042752; GO:0042753; GO:0043161; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:1901223";"cell cycle [GO:0007049]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]"
comp598359_c0_seq1;GAXK01164618.1;B8M9K5;2.85E-13;TROPC_TALSN;2-oxoglutarate-dependent dioxygenase tropC (EC 1.14.-.-) (Tropolone synthesis protein C);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp598361_c0_seq1;GAXK01164645.1;K4BW79;1.22E-16;ENOX_SOLLC;2-methylene-furan-3-one reductase (EC 1.3.1.105) (Enone oxidoreductase) (SlEO);"chloroplast [GO:0009507]; furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0009507; GO:0102978";;chloroplast [GO:0009507];"furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]"
comp5984_c0_seq1;GAXK01066224.1;Q9VMM6;6.18E-15;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp598450_c1_seq1;GAXK01164760.1;P41245;5.28E-12;MMP9_MOUSE;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"GO:0001501; GO:0001934; GO:0001968; GO:0002687; GO:0004175; GO:0004222; GO:0004252; GO:0005615; GO:0006508; GO:0006979; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0019087; GO:0030198; GO:0030335; GO:0030574; GO:0031915; GO:0032991; GO:0034614; GO:0035987; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0044877; GO:0045742; GO:0045766; GO:0048147; GO:0048771; GO:0051259; GO:0051549; GO:0062023; GO:0071276; GO:0071460; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp598488_c0_seq1;GAXK01164613.1;Q8WZ42;1.72E-16;TITIN_HUMAN;Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14);"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493";"cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]";"condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]"
comp5986182_c0_seq1;GAXK01164101.1;Q9UK10;2.91E-11;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp5986533_c0_seq1;GAXK01164087.1;Q9F7P4;4.91E-08;PRRG_PRB01;Green-light absorbing proteorhodopsin (GPR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005886; GO:0007602; GO:0009881; GO:0010461; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]"
comp5987136_c0_seq1;GAXK01164100.1;Q9JHF7;1.18E-16;HPGDS_MOUSE;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp5987483_c0_seq1;GAXK01164089.1;P58659;2.04E-13;EVA1C_MOUSE;Protein eva-1 homolog C (Protein FAM176C);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]";"GO:0005576; GO:0005886; GO:0008201; GO:0016021; GO:0030246";;"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]"
comp5987978_c0_seq1;GAXK01164103.1;Q28113;7.51E-16;FUT2_BOVIN;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp598866_c1_seq1;GAXK01164644.1;P35789;1.57E-15;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp59891_c0_seq1;GAXK01144796.1;Q9DFZ4;8.30E-24;CHUR_XENLA;Protein Churchill;"zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0007275; GO:0008270; GO:0045893";"multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]";;zinc ion binding [GO:0008270]
comp599057_c0_seq1;GAXK01164621.1;Q5XIC0;8.49E-33;ECI2_RAT;Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]";"GO:0000062; GO:0004165; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0016863";fatty acid beta-oxidation [GO:0006635];"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]"
comp599066_c0_seq1;GAXK01164649.1;Q7QH73;4.25E-34;PERC_ANOGA;Chorion peroxidase (EC 1.11.1.7);"extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477";"hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";extracellular region [GO:0005576];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp599067_c1_seq1;GAXK01164604.1;P48554;1.41E-60;RAC2_DROME;Ras-related protein Rac2;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; adherens junction maintenance [GO:0034334]; aggressive behavior [GO:0002118]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; defense response to bacterium [GO:0042742]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, elongation of leading edge cells [GO:0007394]; encapsulation of foreign target [GO:0035010]; feeding behavior [GO:0007631]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; hemocyte migration [GO:0035099]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; mating behavior [GO:0007617]; melanotic encapsulation of foreign target [GO:0035011]; mesodermal cell migration [GO:0008078]; morphogenesis of an epithelium [GO:0002009]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; open tracheal system development [GO:0007424]; phagocytosis [GO:0006909]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of lipid storage [GO:0010883]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000902; GO:0002009; GO:0002118; GO:0002433; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0006909; GO:0007254; GO:0007266; GO:0007390; GO:0007391; GO:0007394; GO:0007424; GO:0007426; GO:0007435; GO:0007520; GO:0007617; GO:0007631; GO:0008045; GO:0008078; GO:0008258; GO:0010883; GO:0016203; GO:0016477; GO:0019901; GO:0030032; GO:0030036; GO:0031410; GO:0031532; GO:0034334; GO:0035010; GO:0035011; GO:0035099; GO:0042742; GO:0042995; GO:0046843; GO:0050770; GO:0051017; GO:0090303";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; adherens junction maintenance [GO:0034334]; aggressive behavior [GO:0002118]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; defense response to bacterium [GO:0042742]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, elongation of leading edge cells [GO:0007394]; encapsulation of foreign target [GO:0035010]; feeding behavior [GO:0007631]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; hemocyte migration [GO:0035099]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; mating behavior [GO:0007617]; melanotic encapsulation of foreign target [GO:0035011]; mesodermal cell migration [GO:0008078]; morphogenesis of an epithelium [GO:0002009]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; open tracheal system development [GO:0007424]; phagocytosis [GO:0006909]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of lipid storage [GO:0010883]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp5990716_c0_seq1;GAXK01109176.1;P23128;7.29E-08;DDX6_DROME;ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]";"GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0030707; GO:0033962; GO:0034063; GO:0035195; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:1905618; GO:1990120; GO:1990124; GO:2000766";"cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P-body [GO:0000932]; P granule [GO:0043186]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp5992419_c0_seq1;GAXK01086208.1;Q13418;1.54E-15;ILK_HUMAN;Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK);"cell junction [GO:0030054]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterooligomerization [GO:0051291]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0000165; GO:0001658; GO:0001725; GO:0001934; GO:0001954; GO:0003151; GO:0004674; GO:0005178; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006469; GO:0007050; GO:0007160; GO:0007229; GO:0007569; GO:0008283; GO:0008284; GO:0009967; GO:0010667; GO:0010761; GO:0014912; GO:0016020; GO:0017124; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030054; GO:0030335; GO:0030513; GO:0032288; GO:0032956; GO:0032991; GO:0033209; GO:0034329; GO:0034446; GO:0042327; GO:0043025; GO:0043034; GO:0043195; GO:0043198; GO:0043406; GO:0043491; GO:0043524; GO:0045197; GO:0045663; GO:0045669; GO:0045773; GO:0045893; GO:0048662; GO:0048812; GO:0050775; GO:0051291; GO:0051897; GO:0070527; GO:0090263; GO:0097435; GO:1901224; GO:2000178";"branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; cell population proliferation [GO:0008283]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterooligomerization [GO:0051291]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"cell-cell junction [GO:0005911]; cell junction [GO:0030054]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]"
comp5993_c0_seq1;GAXK01065588.1;O18405;2.08E-138;SURF4_DROME;Surfeit locus protein 4 homolog;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0012505; GO:0016021; GO:0045169";;"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fusome [GO:0045169]; integral component of membrane [GO:0016021]";
comp599313_c0_seq1;GAXK01164708.1;P36609;1.78E-22;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp599346_c0_seq1;GAXK01164617.1;O60315;2.39E-13;ZEB2_HUMAN;Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (SMADIP1) (Zinc finger homeobox protein 1b);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; cell proliferation in forebrain [GO:0021846]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of melanosome organization [GO:1903056]; somitogenesis [GO:0001756]";"GO:0000122; GO:0000790; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0005634; GO:0005730; GO:0005829; GO:0007399; GO:0019208; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0043507; GO:0043565; GO:0045636; GO:0045944; GO:0046872; GO:0048023; GO:0048066; GO:0048668; GO:0050772; GO:0061373; GO:0070412; GO:0097324; GO:1902748; GO:1903056";"cell proliferation in forebrain [GO:0021846]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of melanosome organization [GO:1903056]; somitogenesis [GO:0001756]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]"
comp5995649_c0_seq1;GAXK01155027.1;Q898Q9;7.57E-45;HPPA_CLOTE;Putative K(+)-stimulated pyrophosphate-energized sodium pump (EC 7.2.3.-) (Membrane-bound sodium-translocating pyrophosphatase) (Pyrophosphate-energized inorganic pyrophosphatase) (Na(+)-PPase);"integral component of plasma membrane [GO:0005887]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]; sodium ion transport [GO:0006814]";"GO:0000287; GO:0004427; GO:0005887; GO:0006814; GO:0009678; GO:0030955";sodium ion transport [GO:0006814];integral component of plasma membrane [GO:0005887];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp599684_c0_seq1;GAXK01164606.1;P80003;2.15E-20;PA2A2_HELSU;Acidic phospholipase A2 PA4 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) [Cleaved into: Acidic phospholipase A2 PA2];"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp5997269_c0_seq1;GAXK01193137.1;Q8MZS4;8.31E-47;PHYSA_PHYPO;"Physarolisin (EC 3.4.21.103) (Physaropepsin) [Cleaved into: Physarolisin heavy chain; Physarolisin light chain]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0046872";;;"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp599734_c0_seq1;GAXK01164716.1;A6NDV4;2.04E-33;TMM8B_HUMAN;Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]";"GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007160; GO:0007346; GO:0009986; GO:0016021; GO:0040008";"cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp599774_c0_seq1;GAXK01164610.1;Q4FZ58;5.98E-10;RTN2_XENTR;Reticulon-2;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp6_c1_seq1;GAXK01165996.1;P19889;6.27E-138;RLA0_DROME;60S acidic ribosomal protein P0 (Apurinic-apyrimidinic endonuclease) (DNA-(apurinic or apyrimidinic site) lyase) (EC 4.2.99.18);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; calcium ion binding [GO:0005509]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]; base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0000287; GO:0002181; GO:0003735; GO:0003906; GO:0004519; GO:0005509; GO:0005654; GO:0005829; GO:0005840; GO:0006284; GO:0016363; GO:0022625; GO:0022626; GO:0052720; GO:0070180; GO:0090305; GO:0140078";"base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]";"calcium ion binding [GO:0005509]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]"
comp60_c1_seq1;GAXK01165525.1;Q1HPS0;7.25E-23;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp6000914_c0_seq1;GAXK01102432.1;Q8LC83;4.06E-48;RS242_ARATH;40S ribosomal protein S24-2;"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005618; GO:0006412; GO:0009536; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp60015_c1_seq1;GAXK01103180.1;Q9WVQ1;9.26E-103;MAGI2_MOUSE;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Activin receptor-interacting protein 1) (Acvrip1) (Atrophin-1-interacting protein 1) (AIP-1) (Membrane-associated guanylate kinase inverted 2) (MAGI-2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; activin receptor binding [GO:0070697]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]";"GO:0002092; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0008285; GO:0010976; GO:0014069; GO:0019894; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0044877; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070697; GO:0070699; GO:0071850; GO:0072015; GO:0097118; GO:0098696; GO:0098879; GO:0098890; GO:0098919; GO:0098978; GO:0098982; GO:0099179; GO:1990090; GO:2000809";"cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]";"activin receptor binding [GO:0070697]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]"
comp600151_c0_seq1;GAXK01029716.1;Q4TU93;5.65E-08;MRC2_RAT;C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; endocytosis [GO:0006897]";"GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0016021; GO:0030246";endocytosis [GO:0006897];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp600349_c0_seq1;GAXK01029704.1;F1NHE9;4.40E-34;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp60037_c0_seq1;GAXK01103015.1;P28740;1.32E-65;KIF2A_MOUSE;Kinesin-like protein KIF2A (Kinesin-2);"centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]";"GO:0000226; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005813; GO:0005814; GO:0005871; GO:0005874; GO:0005876; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016604; GO:0016887; GO:0019901; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0097228; GO:0120103";"cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]";"centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]"
comp60038_c0_seq1;GAXK01103154.1;Q98989;1.30E-37;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp6004032_c0_seq1;GAXK01109029.1;P73530;4.01E-08;RS1A_SYNY3;30S ribosomal protein S1 homolog A;"ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp600406_c0_seq1;GAXK01029695.1;A9ZSY3;1.14E-15;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp600500_c0_seq1;GAXK01029738.1;Q8BJ56;1.07E-56;PLPL2_MOUSE;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Desnutrin);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0019915; GO:0034389; GO:0044242; GO:0055088";"cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp600613_c1_seq1;GAXK01029748.1;P51512;8.40E-32;MMP16_HUMAN;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0019538; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094";"chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein metabolic process [GO:0019538]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6007076_c0_seq1;GAXK01123852.1;P0CT34;2.09E-07;TF21_SCHPO;Transposon Tf2-1 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp600833_c0_seq1;GAXK01029743.1;O43315;3.38E-14;AQP9_HUMAN;Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; carboxylic acid transmembrane transporter activity [GO:0046943]; glycerol channel activity [GO:0015254]; polyol transmembrane transporter activity [GO:0015166]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]; amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; carboxylic acid transport [GO:0046942]; cellular response to cAMP [GO:0071320]; excretion [GO:0007588]; glycerol transport [GO:0015793]; polyol transport [GO:0015791]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; response to mercury ion [GO:0046689]; response to organic substance [GO:0010033]; response to osmotic stress [GO:0006970]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]; water transport [GO:0006833]";"GO:0005275; GO:0005345; GO:0005350; GO:0005372; GO:0005886; GO:0005887; GO:0006833; GO:0006863; GO:0006970; GO:0007588; GO:0010033; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015722; GO:0015791; GO:0015793; GO:0015837; GO:0015855; GO:0016021; GO:0016323; GO:0030104; GO:0043231; GO:0046689; GO:0046942; GO:0046943; GO:0071320; GO:0071918";"amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; carboxylic acid transport [GO:0046942]; cellular response to cAMP [GO:0071320]; excretion [GO:0007588]; glycerol transport [GO:0015793]; polyol transport [GO:0015791]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; response to mercury ion [GO:0046689]; response to organic substance [GO:0010033]; response to osmotic stress [GO:0006970]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"amine transmembrane transporter activity [GO:0005275]; carboxylic acid transmembrane transporter activity [GO:0046943]; glycerol channel activity [GO:0015254]; polyol transmembrane transporter activity [GO:0015166]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]"
comp6008457_c0_seq1;GAXK01076248.1;Q86KC1;2.02E-22;LYSG2_DICDI;Probable GH family 25 lysozyme 2 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 2);"extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; peptidoglycan catabolic process [GO:0009253]; signal transduction [GO:0007165]";"GO:0003796; GO:0005576; GO:0007165; GO:0009253; GO:0016998; GO:0019835; GO:0042742";"cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; peptidoglycan catabolic process [GO:0009253]; signal transduction [GO:0007165]";extracellular region [GO:0005576];lysozyme activity [GO:0003796]
comp6009592_c0_seq1;GAXK01076235.1;P50429;2.75E-15;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp60125_c3_seq1;GAXK01102618.1;Q8VHI6;1.58E-58;WASF3_MOUSE;Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]";"GO:0003779; GO:0005737; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031643; GO:0098794; GO:0098885; GO:0098978";"actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]";actin binding [GO:0003779]
comp60146_c0_seq1;GAXK01103002.1;Q08DA3;1.64E-64;UBP16_BOVIN;Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16);"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000278; GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006357; GO:0006511; GO:0006974; GO:0008270; GO:0016578; GO:0035522; GO:0036459; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537; GO:0140014";"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp60159_c1_seq1;GAXK01103470.1;P35396;9.02E-10;PPARD_MOUSE;Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; drug binding [GO:0008144]; enzyme activator activity [GO:0008047]; fatty acid binding [GO:0005504]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; prostacyclin receptor activity [GO:0016501]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; cellular process [GO:0009987]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; epidermis development [GO:0008544]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; fatty acid oxidation [GO:0019395]; fatty acid transport [GO:0015908]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; mRNA transcription [GO:0009299]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid biosynthetic process [GO:0008654]; placenta development [GO:0001890]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermis development [GO:0045684]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of cell population proliferation [GO:0042127]; regulation of fat cell differentiation [GO:0045598]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001103; GO:0001227; GO:0001890; GO:0003677; GO:0003700; GO:0003707; GO:0003713; GO:0004879; GO:0005504; GO:0005634; GO:0006029; GO:0006629; GO:0006631; GO:0006635; GO:0006776; GO:0006915; GO:0007275; GO:0007507; GO:0007566; GO:0008047; GO:0008134; GO:0008144; GO:0008270; GO:0008284; GO:0008289; GO:0008366; GO:0008544; GO:0008654; GO:0009299; GO:0009749; GO:0009755; GO:0009987; GO:0010628; GO:0010887; GO:0014068; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0016501; GO:0019216; GO:0019395; GO:0030154; GO:0030308; GO:0030374; GO:0031589; GO:0032024; GO:0032966; GO:0033189; GO:0033993; GO:0038023; GO:0042060; GO:0042127; GO:0043066; GO:0043415; GO:0043616; GO:0045598; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045944; GO:0046697; GO:0046965; GO:0046982; GO:0048662; GO:0050680; GO:0050728; GO:0050796; GO:0051059; GO:0051546; GO:0060612; GO:0070539; GO:0071222; GO:0071456; GO:0090575; GO:0097190; GO:0097755; GO:1902894; GO:2000288";"adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; cellular process [GO:0009987]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; epidermis development [GO:0008544]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; fatty acid oxidation [GO:0019395]; fatty acid transport [GO:0015908]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; mRNA transcription [GO:0009299]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phospholipid biosynthetic process [GO:0008654]; placenta development [GO:0001890]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermis development [GO:0045684]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan metabolic process [GO:0006029]; regulation of cell population proliferation [GO:0042127]; regulation of fat cell differentiation [GO:0045598]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; drug binding [GO:0008144]; enzyme activator activity [GO:0008047]; fatty acid binding [GO:0005504]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; prostacyclin receptor activity [GO:0016501]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp6016455_c0_seq1;GAXK01137629.1;Q6SYB9;3.40E-34;METK2_TOBAC;S-adenosylmethionine synthase 2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp60181_c2_seq1;GAXK01102945.1;Q8K4R9;1.19E-32;DLGP5_MOUSE;Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; phosphoprotein phosphatase activity [GO:0004721]; cell cycle [GO:0007049]; signaling [GO:0023052]";"GO:0004721; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0007049; GO:0023052; GO:0031616";"cell cycle [GO:0007049]; signaling [GO:0023052]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]";phosphoprotein phosphatase activity [GO:0004721]
comp60183_c0_seq1;GAXK01102949.1;P55567;9.09E-25;Y4MH_SINFN;Uncharacterized protein y4mH;hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp6018630_c0_seq1;GAXK01175098.1;Q54J97;1.63E-44;CH60_DICDI;60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; asexual reproduction [GO:0019954]; mitochondrion organization [GO:0007005]; positive phototaxis [GO:0046956]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; sorocarp morphogenesis [GO:0031288]";"GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006458; GO:0007005; GO:0019954; GO:0031288; GO:0042026; GO:0045041; GO:0046956; GO:0051082";"'de novo' protein folding [GO:0006458]; asexual reproduction [GO:0019954]; mitochondrion organization [GO:0007005]; positive phototaxis [GO:0046956]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; sorocarp morphogenesis [GO:0031288]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp601904_c0_seq1;GAXK01029732.1;Q9UBQ7;6.24E-35;GRHPR_HUMAN;Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]";"GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402";"cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]";"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"
comp60200_c3_seq1;GAXK01102882.1;Q29RZ4;1.97E-15;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6020611_c0_seq1;GAXK01110607.1;P28492;3.55E-16;GLSL_RAT;Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase);"mitochondrial matrix [GO:0005759]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005759; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrial matrix [GO:0005759];glutaminase activity [GO:0004359]
comp602071_c0_seq1;GAXK01097114.1;B0JZV4;3.88E-10;CBPC5_XENTR;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp602080_c0_seq1;GAXK01097100.1;Q8IN81;4.51E-17;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6021263_c0_seq1;GAXK01110596.1;P60868;1.23E-47;RS20_RAT;40S ribosomal protein S20;"cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp6022781_c0_seq1;GAXK01087506.1;O93530;4.68E-34;WRN_XENLA;Werner syndrome ATP-dependent helicase homolog (EC 3.6.4.12) (Exonuclease WRN) (EC 3.1.-.-) (Focus-forming activity 1) (FFA-1);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000287; GO:0003677; GO:0005524; GO:0005654; GO:0005730; GO:0006259; GO:0006260; GO:0006281; GO:0006310; GO:0008408; GO:0030145; GO:0043138";"DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]"
comp6023_c0_seq1;GAXK01100799.1;P80387;1.97E-12;AAKB1_PIG;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit) (Fragment);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0019901; GO:0031588; GO:0050790";"fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";protein kinase binding [GO:0019901]
comp6023790_c0_seq1;GAXK01087500.1;P15330;7.94E-08;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp602465_c0_seq1;GAXK01097091.1;Q9P2E2;3.89E-33;KIF17_HUMAN;Kinesin-like protein KIF17 (KIF3-related motor protein);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]";"GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030030; GO:0030992; GO:0032391; GO:0032839; GO:0035735; GO:0036064; GO:0043005; GO:0098971; GO:1990075";"anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp60247_c0_seq1;GAXK01103000.1;Q9Y345;1.27E-154;SC6A5_HUMAN;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804";"chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]"
comp6025103_c0_seq1;GAXK01117877.1;Q9CWP6;1.66E-08;MSPD2_MOUSE;Motile sperm domain-containing protein 2;"integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";"GO:0005887; GO:0006935; GO:0090023; GO:0090026";"chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]";integral component of plasma membrane [GO:0005887];
comp6025391_c0_seq1;GAXK01117876.1;Q9JL27;2.42E-07;FUT2_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (Secretory blood group protein 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp60254_c1_seq1;GAXK01103177.1;O76090;2.38E-81;BEST1_HUMAN;Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp6026_c0_seq1;GAXK01100815.1;P15870;2.82E-08;H1D_STRPU;Histone H1-delta;"nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031492; GO:0031936; GO:0045910";"chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]";"nucleosome [GO:0000786]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]"
comp602666_c0_seq1;GAXK01097108.1;Q5ZLK5;7.20E-47;P4HA2_CHICK;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp60268_c1_seq1;GAXK01103316.1;Q66HG8;1.85E-18;RED_RAT;Protein Red (Cytokine IK) (IK factor);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]";"GO:0000278; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0034501; GO:0071005";"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]";
comp60277_c0_seq1;GAXK01103152.1;Q6RWA9;2.38E-107;AT1A_TAESO;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha) (TNaK1-alpha);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp6029018_c0_seq1;GAXK01140830.1;P0ACD6;1.68E-52;ISCU_ECO57;Iron-sulfur cluster assembly scaffold protein IscU (Sulfur acceptor protein IscU);"iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]";"GO:0005506; GO:0016226; GO:0051536";iron-sulfur cluster assembly [GO:0016226];;"iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]"
comp60291_c1_seq1;GAXK01103318.1;Q9VLT1;2.06E-131;MON2_DROME;Protein MON2 homolog;"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]";"GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0031532";"actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]";"endosome [GO:0005768]; Golgi apparatus [GO:0005794]";cytoskeletal regulatory protein binding [GO:0005519]
comp60300_c0_seq1;GAXK01103387.1;Q9W596;1.42E-168;FUTSC_DROME;"Microtubule-associated protein futsch (MAP1B homolog) [Cleaved into: Futsch heavy chain; Futsch light chain LC(f)]";"axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0000226; GO:0003779; GO:0005829; GO:0005874; GO:0005875; GO:0007399; GO:0007409; GO:0007528; GO:0008017; GO:0008088; GO:0008355; GO:0008582; GO:0015630; GO:0015631; GO:0016358; GO:0019900; GO:0030424; GO:0030425; GO:0031114; GO:0042995; GO:0043025; GO:0043524; GO:0045202; GO:0048749; GO:0048813; GO:0060052; GO:1901215";"axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]";"actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]"
comp6030403_c0_seq1;GAXK01070266.1;Q5R5Y7;1.24E-09;ZN436_PONAB;Zinc finger protein 436;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp603077_c0_seq1;GAXK01097128.1;Q7Z5P4;3.37E-40;DHB13_HUMAN;17-beta-hydroxysteroid dehydrogenase 13 (17-beta-HSD 13) (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 16C member 3) (Short-chain dehydrogenase/reductase 9);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; steroid dehydrogenase activity [GO:0016229]; lipid droplet organization [GO:0034389]; positive regulation of lipid biosynthetic process [GO:0046889]";"GO:0005783; GO:0005811; GO:0005829; GO:0016229; GO:0034389; GO:0046889";"lipid droplet organization [GO:0034389]; positive regulation of lipid biosynthetic process [GO:0046889]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]";steroid dehydrogenase activity [GO:0016229]
comp60314_c2_seq1;GAXK01103499.1;B4KXJ5;1.59E-114;UBP36_DROMO;Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Protein scrawny) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36);"nucleolus [GO:0005730]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005730; GO:0006511; GO:0016242; GO:0016579; GO:0030718; GO:0035019; GO:0036459";"germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleolus [GO:0005730];thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
comp6031409_c0_seq1;GAXK01070261.1;P98158;2.89E-07;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp6031528_c0_seq1;GAXK01070268.1;Q86V71;5.91E-09;ZN429_HUMAN;Zinc finger protein 429;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6031770_c0_seq1;GAXK01070269.1;Q9PG89;3.12E-13;RMUC_XYLFA;DNA recombination protein RmuC homolog;DNA recombination [GO:0006310];GO:0006310;DNA recombination [GO:0006310];;
comp603271_c0_seq1;GAXK01097119.1;P08045;2.93E-19;XFIN_XENLA;Zinc finger protein Xfin (Xenopus fingers protein) (Xfin);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005737; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp603273_c1_seq1;GAXK01097092.1;Q05319;3.61E-20;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp6032766_c0_seq1;GAXK01163096.1;Q6S4P4;2.50E-07;RF2B_ORYSJ;Transcription factor RF2b;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp6034_c1_seq1;GAXK01100303.1;Q02332;1.64E-94;PDHK2_CAEEL;Probable [pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]";"GO:0004740; GO:0005524; GO:0005737; GO:0005759; GO:0006006; GO:0048471";glucose metabolic process [GO:0006006];"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp60341_c0_seq1;GAXK01103317.1;Q9STL5;2.00E-33;CEP3_ARATH;KDEL-tailed cysteine endopeptidase CEP3 (EC 3.4.22.-);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to nutrient levels [GO:0031667]";"GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0031667; GO:0051603";"proteolysis involved in cellular protein catabolic process [GO:0051603]; response to nutrient levels [GO:0031667]";"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp6035182_c0_seq1;GAXK01024807.1;A0BQL0;5.50E-55;PP2C3_PARTE;Probable protein phosphatase 2C 3 (PP2C 3) (EC 3.1.3.16);"membrane [GO:0016020]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]";"GO:0004722; GO:0004724; GO:0016020; GO:0046872";;membrane [GO:0016020];"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp6035204_c0_seq1;GAXK01024800.1;Q6NYL3;1.94E-33;ECHP_DANRE;"Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]";"peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]";"GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635";fatty acid beta-oxidation [GO:0006635];peroxisome [GO:0005777];"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]"
comp60355_c0_seq1;GAXK01102977.1;Q9L9D7;4.23E-18;COCE_RHOSM;Cocaine esterase (EC 3.1.1.84);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; dipeptidyl-peptidase activity [GO:0008239]; cocaine catabolic process [GO:0050784]";"GO:0005737; GO:0008239; GO:0050784; GO:0052689";cocaine catabolic process [GO:0050784];cytoplasm [GO:0005737];"carboxylic ester hydrolase activity [GO:0052689]; dipeptidyl-peptidase activity [GO:0008239]"
comp603640_c0_seq1;GAXK01097109.1;Q9UT27;1.76E-10;PVG1_SCHPO;Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]";"GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555";"4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]";pyruvyltransferase activity [GO:0046919]
comp603675_c0_seq1;GAXK01097078.1;P49024;3.95E-22;PAXI_CHICK;Paxillin;"cell [GO:0005623]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]; endothelial cell migration [GO:0043542]; response to muscle stretch [GO:0035994]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001725; GO:0003712; GO:0005623; GO:0005829; GO:0005886; GO:0005925; GO:0007179; GO:0017166; GO:0034446; GO:0035994; GO:0043542; GO:0046872";"endothelial cell migration [GO:0043542]; response to muscle stretch [GO:0035994]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cell [GO:0005623]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]"
comp603676_c0_seq1;GAXK01097127.1;Q11073;4.71E-36;YT45_CAEEL;Uncharacterized protein B0416.5;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp603738_c1_seq1;GAXK01097082.1;Q8TF68;4.37E-08;ZN384_HUMAN;Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp60375_c1_seq1;GAXK01103255.1;Q9VGU5;1.53E-58;TTC14_DROME;Tetratricopeptide repeat protein 14 homolog (TPR repeat protein 14 homolog);;;;;
comp6037759_c0_seq1;GAXK01202651.1;Q13002;5.28E-12;GRIK2_HUMAN;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6);"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp603787_c0_seq1;GAXK01097143.1;Q24174;7.45E-07;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6038213_c0_seq1;GAXK01075901.1;P22465;9.11E-19;ANX10_DROME;Annexin B10 (Annexin X) (Annexin-10);"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]";"GO:0005509; GO:0005544; GO:0016020";;membrane [GO:0016020];"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]"
comp603915_c0_seq1;GAXK01097129.1;Q03938;2.03E-26;ZNF90_HUMAN;Zinc finger protein 90 (Zinc finger protein HTF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0003700; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp603929_c1_seq1;GAXK01097115.1;Q9WU81;1.83E-44;G6PT3_MOUSE;Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2) (cAMP-inducible protein 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005887; GO:0006072; GO:0006127; GO:0008643; GO:0015169; GO:0015760; GO:0015794; GO:0030176; GO:0035435; GO:0061513";"carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]";"glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]"
comp603943_c0_seq1;GAXK01097075.1;P25155;7.20E-17;FA10_CHICK;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]";"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]";"GO:0004252; GO:0005509; GO:0005615; GO:0007596";blood coagulation [GO:0007596];extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp603957_c0_seq1;GAXK01097136.1;B7TB45;5.60E-14;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp6040_c0_seq1;GAXK01100090.1;Q03601;7.30E-83;NHL1_CAEEL;RING finger protein nhl-1;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";"GO:0000209; GO:0004842; GO:0016567; GO:0043161; GO:0046872; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]";;"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp60407_c0_seq1;GAXK01103351.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp604092_c0_seq1;GAXK01125999.1;P10083;4.54E-08;AST5_DROME;Achaete-scute complex protein T5 (Protein achaete);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; Malpighian tubule tip cell differentiation [GO:0061382]; nervous system development [GO:0007399]; neuroblast fate determination [GO:0007400]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419]";"GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0006963; GO:0007346; GO:0007399; GO:0007400; GO:0007417; GO:0007419; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030182; GO:0043565; GO:0045944; GO:0046982; GO:0050767; GO:0061331; GO:0061382; GO:0090575";"central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; Malpighian tubule tip cell differentiation [GO:0061382]; nervous system development [GO:0007399]; neuroblast fate determination [GO:0007400]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp6041_c0_seq1;GAXK01101229.1;Q5XGM3;0;BHMT1_XENLA;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";"GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0047150";"amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]";cytoplasm [GO:0005737];"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp60414_c1_seq1;GAXK01103311.1;O14681;2.04E-68;EI24_HUMAN;Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]";"GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965";"apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";
comp6042375_c0_seq1;GAXK01024256.1;Q48815;1.33E-09;HELA_LEGPN;Protein HelA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]";"GO:0005886; GO:0008324; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp60424_c1_seq1;GAXK01103151.1;Q9Y385;1.49E-86;UB2J1_HUMAN;Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0042534; GO:0061631; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]"
comp604256_c1_seq1;GAXK01125991.1;Q9UL36;1.07E-89;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp604404_c0_seq1;GAXK01126041.1;Q68ED2;0;GRM7_MOUSE;Metabotropic glutamate receptor 7 (mGluR7);"asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of neuron death [GO:1901214]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]";"GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005791; GO:0005794; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016021; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042803; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045202; GO:0045211; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0070905; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:1901214; GO:2000300";"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of neuron death [GO:1901214]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]";"asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245]"
comp6044273_c0_seq1;GAXK01153841.1;O54702;1.13E-10;CHSTA_RAT;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST) (RaHNK-1ST) (Sul-T);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0016232; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]"
comp6044914_c0_seq1;GAXK01153849.1;Q8H859;1.92E-29;CADH1_ORYSJ;Probable cinnamyl alcohol dehydrogenase 1 (OsCAD1) (EC 1.1.1.195);"cinnamyl-alcohol dehydrogenase activity [GO:0045551]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sinapyl alcohol dehydrogenase activity [GO:0052747]; zinc ion binding [GO:0008270]; lignin biosynthetic process [GO:0009809]";"GO:0008270; GO:0009809; GO:0016616; GO:0045551; GO:0052747";lignin biosynthetic process [GO:0009809];;"cinnamyl-alcohol dehydrogenase activity [GO:0045551]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sinapyl alcohol dehydrogenase activity [GO:0052747]; zinc ion binding [GO:0008270]"
comp604554_c0_seq1;GAXK01126012.1;Q5R5U3;2.48E-14;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp604581_c0_seq1;GAXK01126043.1;Q9W0T5;2.55E-90;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp60459_c1_seq1;GAXK01102963.1;Q14186;4.74E-114;TFDP1_HUMAN;Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]";"GO:0000083; GO:0000790; GO:0000981; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0006977; GO:0008134; GO:0008544; GO:0019904; GO:0043276; GO:0045944; GO:0070317; GO:0070345; GO:0090575; GO:1900740; GO:2000278";"anoikis [GO:0043276]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp60460_c0_seq1;GAXK01102591.1;Q9Y5Q8;2.09E-86;TF3C5_HUMAN;General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon);"nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; RNA polymerase III preinitiation complex assembly [GO:0070898]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0035914; GO:0042791; GO:0042797; GO:0070898";"5S class rRNA transcription by RNA polymerase III [GO:0042791]; RNA polymerase III preinitiation complex assembly [GO:0070898]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]";DNA binding [GO:0003677]
comp6046969_c0_seq1;GAXK01187020.1;P40261;1.08E-12;NNMT_HUMAN;Nicotinamide N-methyltransferase (EC 2.1.1.1);"cytosol [GO:0005829]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]; animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]";"GO:0005829; GO:0008112; GO:0010243; GO:0030760; GO:0031100; GO:0032259; GO:0034356; GO:0042493";"animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; response to drug [GO:0042493]; response to organonitrogen compound [GO:0010243]";cytosol [GO:0005829];"nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]"
comp6047413_c0_seq1;GAXK01187017.1;Q4WQU0;5.00E-09;SED4_ASPFU;Tripeptidyl-peptidase sed4 (EC 3.4.14.10) (Sedolisin-D);"extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; pathogenesis [GO:0009405]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005615; GO:0006508; GO:0008240; GO:0009405; GO:0046872";"pathogenesis [GO:0009405]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]"
comp6049011_c0_seq1;GAXK01029230.1;Q3ZBG9;5.04E-58;PLS2_BOVIN;Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]";"GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872";plasma membrane phospholipid scrambling [GO:0017121];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]"
comp60491_c0_seq1;GAXK01102784.1;Q6R5J2;9.88E-122;DISP1_DANRE;Protein dispatched homolog 1 (Protein chameleon);"integral component of membrane [GO:0016021]; adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]";"GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016021; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839";"adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]";integral component of membrane [GO:0016021];
comp60510_c4_seq1;GAXK01103022.1;Q5RJY2;3.59E-67;G2E3_MOUSE;G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0001824; GO:0005730; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243";"apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp6051761_c0_seq1;GAXK01057565.1;Q05319;2.62E-10;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp6053_c1_seq1;GAXK01100437.1;P48738;1.88E-113;PIPNA_RABIT;Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha);"cytoplasm [GO:0005737]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]";"GO:0005548; GO:0005737; GO:0008289";;cytoplasm [GO:0005737];"lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]"
comp605343_c0_seq1;GAXK01126046.1;P29993;4.32E-59;ITPR_DROME;Inositol 1,4,5-trisphosphate receptor (InsP3 receptor) (IP3R) (InsP3R);"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]";"GO:0000280; GO:0005220; GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0006979; GO:0007591; GO:0007601; GO:0007608; GO:0007629; GO:0009267; GO:0010888; GO:0016021; GO:0016319; GO:0016529; GO:0030322; GO:0030536; GO:0030659; GO:0030667; GO:0035071; GO:0035091; GO:0042594; GO:0044295; GO:0046000; GO:0050909; GO:0051209; GO:0051482; GO:0055088; GO:0055089; GO:0060259; GO:0070588; GO:0070679; GO:0071361";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]";"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]";"calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"
comp605349_c0_seq1;GAXK01126011.1;P42280;7.03E-17;TRYZ_DROME;Trypsin zeta (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0008236";proteolysis [GO:0006508];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp6053992_c0_seq1;GAXK01081896.1;A6QPM3;4.26E-12;PRDM6_BOVIN;Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.43) (PR domain zinc finger protein 6) (PR domain-containing protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"GO:0000977; GO:0003700; GO:0005634; GO:0018024; GO:0022008; GO:0031490; GO:0043565; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp6054_c1_seq1;GAXK01100254.1;P34933;7.28E-55;HSP72_BOVIN;Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 3) (HSP70.3);"CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0007283; GO:0009408; GO:0009409; GO:0016192; GO:0016887; GO:0030154; GO:0031072; GO:0034605; GO:0034620; GO:0036128; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0072687";"cell differentiation [GO:0030154]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]";"CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp605440_c0_seq1;GAXK01126032.1;Q2M3R5;4.05E-07;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6054457_c0_seq1;GAXK01023030.1;Q9VNM1;6.44E-15;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp6054852_c0_seq1;GAXK01023031.1;Q99315;5.80E-12;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp605511_c0_seq1;GAXK01125974.1;Q61554;7.77E-48;FBN1_MOUSE;Fibrillin-1 [Cleaved into: Asprosin];"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001527; GO:0001656; GO:0001822; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205";"activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]"
comp605571_c0_seq1;GAXK01125984.1;Q28IZ3;2.34E-42;RAB19_XENTR;Ras-related protein Rab-19;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005886; GO:0006886; GO:0006888; GO:0032482";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp60578_c1_seq1;GAXK01205493.1;P35129;4.62E-85;UBC2_CAEEL;Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2);"chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0004842; GO:0005524; GO:0005634; GO:0005694; GO:0006511; GO:0016567; GO:0031625; GO:0061631";"protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp605816_c0_seq1;GAXK01125973.1;Q24799;4.10E-50;MYPH_ECHGR;Myophilin;;;;;
comp605905_c0_seq1;GAXK01125994.1;Q9WVM1;8.63E-30;RGAP1_MOUSE;Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP);"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0035556; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051233; GO:0051256; GO:0051988; GO:0072686; GO:0090543; GO:0097149";"actomyosin contractile ring assembly [GO:0000915]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]"
comp606_c0_seq1;GAXK01165930.1;P28021;5.23E-136;CSK2B_XENLA;Casein kinase II subunit beta (CK II beta) (Phosvitin);"protein kinase CK2 complex [GO:0005956]; metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]; Wnt signaling pathway [GO:0016055]";"GO:0005956; GO:0016055; GO:0019887; GO:0046872";Wnt signaling pathway [GO:0016055];protein kinase CK2 complex [GO:0005956];"metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]"
comp6061815_c0_seq1;GAXK01190839.1;Q8N1W2;7.02E-09;ZN710_HUMAN;Zinc finger protein 710;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp60621_c1_seq1;GAXK01103018.1;B3EWY9;2.64E-15;MLP_ACRMI;Mucin-like protein (Fragment);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]";"GO:0005509; GO:0007160; GO:0016021";cell-matrix adhesion [GO:0007160];integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp60629_c2_seq1;GAXK01103388.1;Q7SYC9;1.20E-49;CTL2_DANRE;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp6063_c6_seq1;GAXK01100358.1;Q9UBC9;1.62E-08;SPRR3_HUMAN;Small proline-rich protein 3 (22 kDa pancornulin) (Cornifin beta) (Esophagin);"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; structural molecule activity [GO:0005198]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060]";"GO:0001533; GO:0005198; GO:0005737; GO:0005794; GO:0005829; GO:0008544; GO:0018149; GO:0030216; GO:0042060; GO:0048471; GO:0070062; GO:0070268";"cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060]";"cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]";structural molecule activity [GO:0005198]
comp6063186_c0_seq1;GAXK01080154.1;Q9PVG3;2.09E-07;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp6063690_c0_seq1;GAXK01080165.1;P00861;2.14E-91;DCDA_ECOLI;Diaminopimelate decarboxylase (DAP decarboxylase) (DAPDC) (EC 4.1.1.20);"diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170]; lysine biosynthetic process via diaminopimelate [GO:0009089]";"GO:0008836; GO:0009089; GO:0030170";lysine biosynthetic process via diaminopimelate [GO:0009089];;"diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170]"
comp6064_c7_seq1;GAXK01100116.1;Q7ZYJ3;1.61E-45;AGK_XENLA;Acylglycerol kinase, mitochondrial (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (MuLK) (Multi-substrate lipid kinase);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; NAD+ kinase activity [GO:0003951]; glycerolipid metabolic process [GO:0046486]; protein insertion into mitochondrial inner membrane [GO:0045039]";"GO:0001729; GO:0003951; GO:0004143; GO:0005524; GO:0005743; GO:0005758; GO:0031305; GO:0031966; GO:0042721; GO:0045039; GO:0046486; GO:0047620; GO:0102773";"glycerolipid metabolic process [GO:0046486]; protein insertion into mitochondrial inner membrane [GO:0045039]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]";"acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; NAD+ kinase activity [GO:0003951]"
comp60641_c0_seq1;GAXK01103095.1;Q9NAS5;1.30E-20;TPM_ANISI;Tropomyosin (allergen Ani s 3);;;;;
comp60649_c0_seq1;GAXK01103005.1;Q14155;3.36E-102;ARHG7_HUMAN;Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85);"cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; ephrin receptor signaling pathway [GO:0048013]; focal adhesion assembly [GO:0048041]; G protein-coupled receptor signaling pathway [GO:0007186]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of GTPase activity [GO:0043547]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of GTP binding [GO:1904424]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0001726; GO:0005085; GO:0005089; GO:0005829; GO:0005925; GO:0005938; GO:0007030; GO:0007165; GO:0007186; GO:0007399; GO:0010763; GO:0019901; GO:0030027; GO:0030032; GO:0032991; GO:0035023; GO:0035556; GO:0042059; GO:0043005; GO:0043025; GO:0043065; GO:0043547; GO:0048013; GO:0048041; GO:0051056; GO:1900026; GO:1904424; GO:2000394";"ephrin receptor signaling pathway [GO:0048013]; focal adhesion assembly [GO:0048041]; Golgi organization [GO:0007030]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of GTPase activity [GO:0043547]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of GTP binding [GO:1904424]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]";"guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp60652_c1_seq1;GAXK01102629.1;P04745;1.87E-138;AMY1_HUMAN;Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase);"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]";"GO:0004556; GO:0005615; GO:0005975; GO:0046872; GO:0070062; GO:0103025";carbohydrate metabolic process [GO:0005975];"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]";"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]"
comp606527_c0_seq1;GAXK01117457.1;Q96IR2;1.80E-16;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6065766_c0_seq1;GAXK01189860.1;Q17QL1;1.41E-41;GNPI2_BOVIN;Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2);"cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0019262; GO:0042802";"carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";cytoplasm [GO:0005737];"glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]"
comp6066621_c0_seq1;GAXK01065308.1;Q9SMI3;6.36E-40;RS12_CYAPA;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp6066764_c0_seq1;GAXK01065306.1;Q9VNM1;5.96E-11;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp606763_c0_seq1;GAXK01117552.1;P51510;1.61E-28;RELB_XENLA;Transcription factor RelB homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0048511";"regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp606780_c0_seq1;GAXK01117504.1;Q90WJ3;4.90E-46;PAXI1_XENLA;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) (SMAD wing for transcriptional activation) (Protein Swift);"nucleus [GO:0005634]; DNA repair [GO:0006281]";"GO:0005634; GO:0006281";DNA repair [GO:0006281];nucleus [GO:0005634];
comp606943_c0_seq1;GAXK01117511.1;Q6BER5;6.58E-07;NU301_CAEEL;Nucleosome-remodeling factor subunit NURF301-like;"NURF complex [GO:0016589]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0006325; GO:0007275; GO:0016589; GO:0045944; GO:0046872";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]";NURF complex [GO:0016589];metal ion binding [GO:0046872]
comp607_c0_seq1;GAXK01165947.1;Q24733;1.43E-08;ACT_DICVI;Actin (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp60700_c1_seq1;GAXK01103286.1;F1QMV3;4.63E-55;TPC6B_DANRE;Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B);"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]";"GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0043087";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]";"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]";
comp607042_c1_seq1;GAXK01117514.1;Q6ZNA1;2.64E-51;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6070454_c0_seq1;GAXK01080032.1;Q98N59;1.30E-64;EFG_RHILO;Elongation factor G (EF-G);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp6070868_c0_seq1;GAXK01080025.1;Q42479;7.13E-09;CDPK3_ARATH;Calcium-dependent protein kinase 3 (EC 2.7.11.1) (Calcium-dependent protein kinase isoform CDPK6) (AtCDPK6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of anion channel activity [GO:0010359]; regulation of stomatal movement [GO:0010119]; response to salt stress [GO:0009651]";"GO:0004672; GO:0004674; GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005773; GO:0005829; GO:0005886; GO:0009651; GO:0009738; GO:0009931; GO:0010119; GO:0010359; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of anion channel activity [GO:0010359]; regulation of stomatal movement [GO:0010119]; response to salt stress [GO:0009651]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp6071_c0_seq1;GAXK01101302.1;B7TB45;1.95E-13;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp60716_c1_seq1;GAXK01102588.1;Q61207;4.16E-07;SAP_MOUSE;"Prosaposin (Sulfated glycoprotein 1) (SGP-1) [Cleaved into: Saposin-A; Saposin-B-Val; Saposin-B; Saposin-C; Saposin-D]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-galactosidase activity [GO:0004565]; G protein-coupled receptor binding [GO:0001664]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; corneocyte development [GO:0003335]; cornified envelope assembly [GO:1903575]; developmental growth [GO:0048589]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; galactosylceramide catabolic process [GO:0006683]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; micturition [GO:0060073]; myelination [GO:0042552]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuromuscular process controlling balance [GO:0050885]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of MAPK cascade [GO:0043410]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; sphingolipid metabolic process [GO:0006665]; walking behavior [GO:0090659]";"GO:0001664; GO:0002020; GO:0003335; GO:0004565; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005739; GO:0005764; GO:0005770; GO:0006665; GO:0006683; GO:0007041; GO:0007193; GO:0007605; GO:0019216; GO:0042552; GO:0042802; GO:0042803; GO:0043231; GO:0043408; GO:0043410; GO:0048589; GO:0050885; GO:0051345; GO:0060073; GO:0060736; GO:0060742; GO:0071310; GO:0090102; GO:0090659; GO:1903206; GO:1903575; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; corneocyte development [GO:0003335]; cornified envelope assembly [GO:1903575]; developmental growth [GO:0048589]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; galactosylceramide catabolic process [GO:0006683]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; micturition [GO:0060073]; myelination [GO:0042552]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuromuscular process controlling balance [GO:0050885]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of MAPK cascade [GO:0043410]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; sphingolipid metabolic process [GO:0006665]; walking behavior [GO:0090659]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]";"beta-galactosidase activity [GO:0004565]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]"
comp6071924_c0_seq1;GAXK01080028.1;Q9L523;1.42E-12;SRRB_STAAU;Sensor protein SrrB (EC 2.7.13.3) (Staphylococcal respiratory response protein B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]";"GO:0000155; GO:0005524; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp6072335_c0_seq1;GAXK01065023.1;P51030;8.62E-18;WNT8C_CHICK;Protein Wnt-8c (CWnt-8);"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";"GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0035116; GO:0045165; GO:0045743; GO:0060173; GO:0060828; GO:0090270";"cell fate commitment [GO:0045165]; embryonic hindlimb morphogenesis [GO:0035116]; limb development [GO:0060173]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; Wnt signaling pathway [GO:0016055]";extracellular space [GO:0005615];frizzled binding [GO:0005109]
comp607243_c0_seq1;GAXK01117454.1;A1ZBD6;4.19E-161;MCTP_DROME;Multiple C2 and transmembrane domain-containing protein;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0005789; GO:0016021; GO:0046928; GO:0048168";"regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";calcium ion binding [GO:0005509]
comp6072567_c0_seq1;GAXK01065012.1;Q5PQ44;8.62E-08;CF299_XENLA;Cilia- and flagella-associated protein 299;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp6072734_c0_seq1;GAXK01065024.1;Q9VZU2;5.65E-09;HHAT_DROME;Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0046843; GO:0048100";"dorsal appendage formation [GO:0046843]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp6074093_c0_seq1;GAXK01058767.1;Q987N5;1.44E-25;PANE_RHILO;Putative 2-dehydropantoate 2-reductase (EC 1.1.1.169) (Ketopantoate reductase) (KPA reductase) (KPR);"cytoplasm [GO:0005737]; 2-dehydropantoate 2-reductase activity [GO:0008677]; pantothenate biosynthetic process [GO:0015940]";"GO:0005737; GO:0008677; GO:0015940";pantothenate biosynthetic process [GO:0015940];cytoplasm [GO:0005737];2-dehydropantoate 2-reductase activity [GO:0008677]
comp607424_c0_seq1;GAXK01117568.1;Q5F4B8;1.50E-14;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp6075212_c0_seq1;GAXK01058773.1;P50305;2.14E-60;METK3_CAEEL;Probable S-adenosylmethionine synthase 3 (AdoMet synthase 3) (EC 2.5.1.6) (Methionine adenosyltransferase 3) (MAT 3);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp607528_c0_seq1;GAXK01117567.1;C4N147;3.78E-11;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp60755_c4_seq1;GAXK01102789.1;Q9VZ08;2.22E-30;RME6_DROME;Receptor-mediated endocytosis protein 6 homolog;"cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0017112; GO:0032483; GO:0032794; GO:0051223";"endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; membrane [GO:0016020]";"GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp6075647_c0_seq1;GAXK01058761.1;G3V893;2.29E-07;ZN335_RAT;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000979; GO:0002052; GO:0005634; GO:0007420; GO:0010468; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0050671; GO:0050769; GO:0080182; GO:2000327";"brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp6075839_c0_seq1;GAXK01058760.1;A6QLJ0;6.95E-07;ERCC2_BOVIN;General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein);"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]";"GO:0000019; GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005819; GO:0006366; GO:0006468; GO:0006979; GO:0007059; GO:0008022; GO:0009411; GO:0033683; GO:0035315; GO:0043139; GO:0045893; GO:0045944; GO:0045951; GO:0046872; GO:0051539; GO:0070516; GO:0071817; GO:1901990";"chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]";"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]";"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]"
comp607589_c0_seq1;GAXK01117556.1;P31729;5.76E-18;OV16_ONCVO;OV-16 antigen;;;;;
comp607671_c1_seq1;GAXK01117512.1;Q4UMH6;1.59E-54;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp607727_c3_seq1;GAXK01117547.1;P52746;6.64E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp607771_c0_seq1;GAXK01117489.1;Q8CBX0;9.03E-11;CSC1_MOUSE;Calcium permeable stress-gated cation channel 1 (Transmembrane protein 63C);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; cation transport [GO:0006812]";"GO:0005227; GO:0005886; GO:0006812; GO:0016021";cation transport [GO:0006812];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium activated cation channel activity [GO:0005227]
comp607816_c1_seq1;GAXK01117549.1;Q9JME2;1.41E-17;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp6079142_c0_seq1;GAXK01143773.1;F4JNU8;8.13E-09;P4H8_ARATH;Probable prolyl 4-hydroxylase 8 (AtP4H8) (EC 1.14.11.2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005789; GO:0016021; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp607947_c0_seq1;GAXK01117495.1;Q9CWR2;7.77E-10;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp60797_c0_seq1;GAXK01103237.1;K4BW79;4.85E-14;ENOX_SOLLC;2-methylene-furan-3-one reductase (EC 1.3.1.105) (Enone oxidoreductase) (SlEO);"chloroplast [GO:0009507]; furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0009507; GO:0102978";;chloroplast [GO:0009507];"furaneol oxidoreductase activity [GO:0102978]; zinc ion binding [GO:0008270]"
comp607993_c0_seq1;GAXK01117546.1;Q8C436;3.44E-13;MT21D_MOUSE;Protein-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]";"GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023; GO:0032780; GO:0032991; GO:0051117";"negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]";"ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp608_c0_seq1;GAXK01168398.1;P82013;1.98E-122;VDAC2_MELGA;Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2);"mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]";"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930";;"mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]";"nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]"
comp6080037_c0_seq1;GAXK01126100.1;A5IBW4;2.49E-08;BIOH_LEGPC;Pimeloyl-[acyl-carrier protein] methyl ester esterase (EC 3.1.1.85) (Biotin synthesis protein BioH) (Carboxylesterase BioH);"cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; biotin biosynthetic process [GO:0009102]";"GO:0005737; GO:0009102; GO:0052689";biotin biosynthetic process [GO:0009102];cytoplasm [GO:0005737];carboxylic ester hydrolase activity [GO:0052689]
comp6080165_c0_seq1;GAXK01126101.1;Q86WZ6;3.13E-22;ZN227_HUMAN;Zinc finger protein 227;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp608033_c1_seq1;GAXK01165309.1;Q0VAW7;2.93E-24;ZN112_MOUSE;Zinc finger protein 112 (Zfp-112);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp60817_c0_seq1;GAXK01102978.1;Q7T0V2;3.58E-22;LTR3A_XENLA;Ragulator complex protein LAMTOR3-A (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3-A) (Mitogen-activated protein kinase scaffold protein 1);"Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]";"GO:0032008; GO:0034613; GO:0071230; GO:0071986";"cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]";Ragulator complex [GO:0071986];
comp608174_c0_seq1;GAXK01165198.1;Q9VVY3;1.84E-38;GBS76_DROME;Glycogen-binding subunit 76A (CBM21 domain-containing protein CG9619);protein phosphatase 1 binding [GO:0008157];GO:0008157;;;protein phosphatase 1 binding [GO:0008157]
comp60819_c0_seq1;GAXK01103353.1;P34275;4.06E-78;IVD_CAEEL;Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4);"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552]";"GO:0003995; GO:0006552; GO:0050660";leucine catabolic process [GO:0006552];;"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp60820_c0_seq1;GAXK01103013.1;Q8IYB7;0;DI3L2_HUMAN;DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-);"cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844]; 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]";"GO:0000175; GO:0000178; GO:0000278; GO:0000287; GO:0000291; GO:0000932; GO:0004540; GO:0005737; GO:0005844; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0034427; GO:0051301; GO:0051306; GO:1990074";"cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]";"cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844]";"3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540]"
comp6082026_c0_seq1;GAXK01070252.1;P31693;1.17E-09;SRC_RSVPA;Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524";;;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp608254_c0_seq1;GAXK01165315.1;P42282;1.02E-14;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp60828_c1_seq1;GAXK01102702.1;P98159;6.66E-16;NUDEL_DROME;Serine protease nudel (EC 3.4.21.-);"extracellular region [GO:0005576]; perivitelline space [GO:0098595]; serine-type endopeptidase activity [GO:0004252]; dorsal/ventral axis specification [GO:0009950]; egg activation [GO:0007343]; eggshell chorion assembly [GO:0007306]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of Toll signaling pathway [GO:0045752]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005576; GO:0006508; GO:0007306; GO:0007313; GO:0007343; GO:0009950; GO:0016485; GO:0016540; GO:0031638; GO:0045752; GO:0098595";"dorsal/ventral axis specification [GO:0009950]; egg activation [GO:0007343]; eggshell chorion assembly [GO:0007306]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of Toll signaling pathway [GO:0045752]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"extracellular region [GO:0005576]; perivitelline space [GO:0098595]";serine-type endopeptidase activity [GO:0004252]
comp60836_c5_seq1;GAXK01102928.1;Q800K6;2.00E-29;TOB1A_XENLA;DNA topoisomerase 2-binding protein 1-A (Cut5 protein) (DNA topoisomerase II-binding protein 1-A) (TopBP1-A) (XtopBP);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"GO:0000076; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0005815; GO:0006270; GO:0006281; GO:0006974; GO:0019900; GO:0030174; GO:0033138; GO:0035563; GO:0045860; GO:0071163; GO:0071165; GO:0071168";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]"
comp6083952_c0_seq1;GAXK01070244.1;P25600;8.62E-07;YCH4_YEAST;Putative transposon Ty5-1 protein YCL074W;"retrotransposon nucleocapsid [GO:0000943]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003723; GO:0003887; GO:0003964; GO:0004540; GO:0008233; GO:0032197";transposition, RNA-mediated [GO:0032197];retrotransposon nucleocapsid [GO:0000943];"DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp6084762_c0_seq1;GAXK01203308.1;Q9UL36;3.78E-09;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp6084881_c0_seq1;GAXK01203305.1;P48608;3.43E-49;DIA_DROME;Protein diaphanous;"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005912; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"
comp60853_c0_seq1;GAXK01103036.1;P36609;1.16E-44;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp6086_c2_seq1;GAXK01100721.1;Q176V0;1.12E-51;UFM1_AEDAE;Ubiquitin-fold modifier 1;protein ufmylation [GO:0071569];GO:0071569;protein ufmylation [GO:0071569];;
comp608604_c0_seq1;GAXK01165274.1;Q6IR42;6.72E-20;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp608728_c2_seq1;GAXK01165298.1;Q9TU34;0;ITPR1_BOVIN;Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor);"axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209]";"GO:0005220; GO:0005509; GO:0005789; GO:0005791; GO:0005886; GO:0015278; GO:0016529; GO:0030141; GO:0030176; GO:0030424; GO:0030658; GO:0030659; GO:0030667; GO:0035091; GO:0048471; GO:0051209; GO:0070059; GO:0070679; GO:0098793";"intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209]";"axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]";"calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"
comp6087686_c0_seq1;GAXK01146937.1;P91883;1.16E-22;TDX_FASHE;Thioredoxin peroxidase (EC 1.11.1.15) (Peroxiredoxin) (Thiol-specific antioxidant protein) (Thioredoxin-dependent peroxide reductase);"cell [GO:0005623]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005623; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];cell [GO:0005623];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp608870_c0_seq1;GAXK01165271.1;O18868;6.49E-152;KCNB1_PIG;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp608894_c0_seq1;GAXK01165253.1;G5CTG4;1.23E-65;AQP7_MILTA;Aquaporin-7 (AQP-7);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]";"GO:0005886; GO:0015267; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";channel activity [GO:0015267]
comp6089376_c0_seq1;GAXK01005780.1;A4XZ62;8.47E-51;KATG_PSEMY;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp60895_c0_seq1;GAXK01103251.1;Q9JI12;0;VGLU2_RAT;Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6);"cell junction [GO:0030054]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; pericellular basket [GO:1990030]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; brain development [GO:0007420]; hippocampus development [GO:0021766]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001504; GO:0003407; GO:0005313; GO:0005326; GO:0005769; GO:0005887; GO:0006814; GO:0007420; GO:0008021; GO:0015293; GO:0016021; GO:0021766; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0050803; GO:0060076; GO:0098700; GO:1990030";"brain development [GO:0007420]; hippocampus development [GO:0021766]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; pericellular basket [GO:1990030]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";"L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]"
comp609_c0_seq1;GAXK01169450.1;Q95WA0;2.32E-73;RL26_LITLI;60S ribosomal protein L26;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp60903_c1_seq1;GAXK01102864.1;Q4KKX4;1.79E-72;NCOR1_XENTR;Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (xN-CoR);"histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"GO:0000118; GO:0000122; GO:0000790; GO:0001012; GO:0003682; GO:0003714; GO:0005634; GO:0006325; GO:0017053; GO:0035257; GO:0042826; GO:0043565; GO:0045892; GO:0046966; GO:0048511";"chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rhythmic process [GO:0048511]";"histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]"
comp6090925_c0_seq1;GAXK01021033.1;Q10133;1.22E-24;RHO2_SCHPO;GTP-binding protein rho2;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process [GO:0070610]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007015; GO:0007264; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0035840; GO:0035841; GO:0043231; GO:0051017; GO:0070610";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process [GO:0070610]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp6091004_c0_seq1;GAXK01021035.1;P58545;5.58E-08;BTBD3_MOUSE;BTB/POZ domain-containing protein 3;"cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813";"cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp609189_c0_seq1;GAXK01165272.1;O60242;3.60E-13;AGRB3_HUMAN;Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]";"G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]"
comp6092712_c0_seq1;GAXK01075474.1;Q09624;3.99E-15;PKD1_CAEEL;Location of vulva defective 1 (Polycystic kidney disease 1 protein homolog) (Polycystin-1);"cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; protein domain specific binding [GO:0019904]; detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608]";"GO:0005262; GO:0005929; GO:0007617; GO:0016020; GO:0016021; GO:0019904; GO:0034606; GO:0034608; GO:0043025; GO:0050982; GO:0060179; GO:0097730";"detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608]";"cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]";"calcium channel activity [GO:0005262]; protein domain specific binding [GO:0019904]"
comp60928_c1_seq1;GAXK01102950.1;Q6YHK3;2.98E-155;CD109_HUMAN;CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109);"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675";"hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]";"anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]";"serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]"
comp60931_c1_seq1;GAXK01103272.1;Q9Y2J2;4.84E-138;E41L3_HUMAN;Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed];"axolemma [GO:0030673]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]";"GO:0001558; GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0007016; GO:0008360; GO:0014069; GO:0030673; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659";"actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]";"axolemma [GO:0030673]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]"
comp609429_c0_seq1;GAXK01165313.1;Q28036;6.44E-29;SL9A1_BOVIN;Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; cellular response to acidic pH [GO:0071468]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to acidic pH [GO:0010447]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005516; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006885; GO:0010447; GO:0015385; GO:0015386; GO:0016021; GO:0036376; GO:0048306; GO:0051259; GO:0051453; GO:0071468; GO:0071805; GO:0098719";"cellular response to acidic pH [GO:0071468]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to acidic pH [GO:0010447]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp6095_c0_seq1;GAXK01100109.1;Q07021;2.78E-28;C1QBP_HUMAN;Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; blood coagulation, intrinsic pathway [GO:0007597]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]; viral process [GO:0016032]";"GO:0000122; GO:0001849; GO:0003714; GO:0003729; GO:0005080; GO:0005540; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0006955; GO:0006958; GO:0007597; GO:0008134; GO:0008380; GO:0008494; GO:0009986; GO:0014065; GO:0016020; GO:0016032; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0045087; GO:0045785; GO:0048025; GO:0048786; GO:0050687; GO:0051897; GO:0070131; GO:0090023; GO:0097177; GO:0098978; GO:0098982; GO:1900026; GO:1901165; GO:2000510";"apoptotic process [GO:0006915]; blood coagulation, intrinsic pathway [GO:0007597]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]; viral process [GO:0016032]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]";"adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]"
comp6096097_c0_seq1;GAXK01039558.1;Q4GZT3;2.00E-16;PKD2_BOVIN;Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2);"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738";"calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]";"basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; polycystin complex [GO:0002133]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
comp6096603_c0_seq1;GAXK01039561.1;P24603;2.99E-24;OPSD_LOLFO;Rhodopsin;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; retinal binding [GO:0016918]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0016918; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; retinal binding [GO:0016918]"
comp609680_c0_seq1;GAXK01165251.1;Q9NYT6;4.85E-19;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp609741_c0_seq1;GAXK01165269.1;Q27367;1.63E-07;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp60980_c6_seq1;GAXK01103428.1;Q5U3S1;0;KATL1_DANRE;Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031122";"cytoplasmic microtubule organization [GO:0031122]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]"
comp609832_c0_seq1;GAXK01165236.1;P23415;1.36E-48;GLRA1_HUMAN;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp60986_c1_seq1;GAXK01103121.1;O35491;2.22E-150;CLK2_MOUSE;Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2);"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]";"GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010033; GO:0010212; GO:0016604; GO:0016607; GO:0018108; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777";"negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]";"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp6099_c4_seq1;GAXK01101306.1;P91682;2.41E-131;SMO_DROME;Protein smoothened (SMOH) (Smooth) (dSMO);"cilium [GO:0005929]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; patched binding [GO:0005113]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; blastoderm segmentation [GO:0007350]; Bolwig's organ morphogenesis [GO:0001746]; central nervous system development [GO:0007417]; commissural neuron axon guidance [GO:0071679]; eye morphogenesis [GO:0048592]; eye-antennal disc morphogenesis [GO:0007455]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; ovarian follicle cell development [GO:0030707]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of TORC1 signaling [GO:1904263]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; wing disc anterior/posterior pattern formation [GO:0048100]";"GO:0001746; GO:0002385; GO:0004930; GO:0005113; GO:0005886; GO:0005887; GO:0005929; GO:0007193; GO:0007224; GO:0007346; GO:0007350; GO:0007367; GO:0007417; GO:0007455; GO:0007476; GO:0030425; GO:0030707; GO:0035019; GO:0042802; GO:0042803; GO:0042981; GO:0043025; GO:0045880; GO:0048099; GO:0048100; GO:0048592; GO:0070273; GO:0071679; GO:1903078; GO:1904263; GO:2000134";"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; blastoderm segmentation [GO:0007350]; Bolwig's organ morphogenesis [GO:0001746]; central nervous system development [GO:0007417]; commissural neuron axon guidance [GO:0071679]; eye-antennal disc morphogenesis [GO:0007455]; eye morphogenesis [GO:0048592]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; ovarian follicle cell development [GO:0030707]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of TORC1 signaling [GO:1904263]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; wing disc anterior/posterior pattern formation [GO:0048100]";"cilium [GO:0005929]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; patched binding [GO:0005113]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]"
comp60990_c0_seq1;GAXK01103176.1;Q8WXE0;6.91E-34;CSKI2_HUMAN;Caskin-2 (CASK-interacting protein 2);"cytoplasm [GO:0005737]; membrane [GO:0016020]";"GO:0005737; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";
comp61_c0_seq1;GAXK01169103.1;P11501;0;HS90A_CHICK;Heat shock protein HSP 90-alpha;"axon [GO:0030424]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0008022; GO:0008284; GO:0009408; GO:0009409; GO:0009986; GO:0010243; GO:0014070; GO:0016887; GO:0030235; GO:0030331; GO:0030424; GO:0030911; GO:0031072; GO:0032570; GO:0032991; GO:0033142; GO:0034605; GO:0042470; GO:0042803; GO:0043025; GO:0043204; GO:0043209; GO:0043235; GO:0045429; GO:0046677; GO:0046790; GO:0048471; GO:0050821; GO:0051082; GO:0051087; GO:0051219; GO:0051879; GO:0097718; GO:1902751";"cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]";"axon [GO:0030424]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]"
comp6100_c0_seq1;GAXK01101177.1;Q5ZLN1;3.30E-127;PGAM1_CHICK;Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1);"cell [GO:0005623]; cytosol [GO:0005829]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004082; GO:0004619; GO:0005623; GO:0005829; GO:0006094; GO:0006096; GO:0016787";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cell [GO:0005623]; cytosol [GO:0005829]";"bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]"
comp610008_c0_seq1;GAXK01001843.1;P34568;2.74E-19;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp61011_c2_seq1;GAXK01102997.1;Q03442;3.90E-40;CRJ1A_TRICY;Crystallin J1A;structural constituent of eye lens [GO:0005212];GO:0005212;;;structural constituent of eye lens [GO:0005212]
comp6101826_c0_seq1;GAXK01163063.1;Q8T6B7;1.23E-34;ABCF2_DICDI;ABC transporter F family member 2;"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]";"GO:0005524; GO:0016887; GO:0031152; GO:0031288";"aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]";;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp61024_c0_seq1;GAXK01102885.1;Q94HW2;8.97E-21;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp610248_c0_seq1;GAXK01001842.1;P55864;9.19E-43;PAX6_XENLA;Paired box protein Pax-6;"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp6102697_c0_seq1;GAXK01128983.1;Q8NG08;6.99E-15;HELB_HUMAN;DNA helicase B (hDHB) (EC 3.6.4.12);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp6103_c6_seq1;GAXK01100629.1;Q03168;1.01E-166;ASPP_AEDAE;Lysosomal aspartic protease (EC 3.4.23.-);"lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]";"GO:0004190; GO:0005764";;lysosome [GO:0005764];aspartic-type endopeptidase activity [GO:0004190]
comp610329_c0_seq1;GAXK01001774.1;Q05652;8.67E-27;KPEL_DROME;Serine/threonine-protein kinase pelle (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antifungal innate immune response [GO:0061760]; apoptotic process [GO:0006915]; determination of dorsal/ventral asymmetry [GO:0048262]; dorsal/ventral pattern formation [GO:0009953]; hemocyte proliferation [GO:0035172]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; positive regulation of antifungal peptide production [GO:0002804]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]";"GO:0002804; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007352; GO:0007526; GO:0008063; GO:0009953; GO:0019904; GO:0035172; GO:0035556; GO:0045087; GO:0046777; GO:0048262; GO:0061760";"antifungal innate immune response [GO:0061760]; apoptotic process [GO:0006915]; determination of dorsal/ventral asymmetry [GO:0048262]; dorsal/ventral pattern formation [GO:0009953]; hemocyte proliferation [GO:0035172]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; positive regulation of antifungal peptide production [GO:0002804]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp6103331_c0_seq1;GAXK01128982.1;Q91ZX7;1.88E-14;LRP1_MOUSE;"Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]";"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]";"GO:0002020; GO:0002265; GO:0003279; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005887; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048471; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060548; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:1900149; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905167; GO:2000587";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]";"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]";"alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]"
comp610453_c0_seq1;GAXK01001790.1;Q9VCY8;3.18E-84;ADRL_DROME;Adiponectin receptor protein;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]"
comp610540_c0_seq1;GAXK01001745.1;Q9XSR1;2.37E-41;ZN252_CANLF;Zinc finger protein 252;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp61059_c0_seq1;GAXK01102652.1;Q93112;2.75E-22;GST1C_ANOGA;Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749; GO:0018833";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp61070_c0_seq1;GAXK01103017.1;Q86KC7;6.92E-14;Y4171_DICDI;Uncharacterized protein DDB_G0274171;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp610705_c0_seq1;GAXK01001817.1;Q6GPQ3;2.73E-10;MFSD8_XENLA;Major facilitator superfamily domain-containing protein 8;"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp61072_c0_seq1;GAXK01103268.1;O75486;2.13E-45;SUPT3_HUMAN;Transcription initiation protein SPT3 homolog (SPT3-like protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982";"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"
comp6107583_c0_seq1;GAXK01194344.1;P39057;5.32E-35;DYHC_HELCR;Dynein beta chain, ciliary;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp6107902_c0_seq1;GAXK01194358.1;Q7Z3F1;7.86E-11;GP155_HUMAN;Integral membrane protein GPR155 (G-protein coupled receptor PGR22);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062";"cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]";
comp6109137_c0_seq1;GAXK01121596.1;Q8UUG8;3.59E-21;5HT2B_TETFL;5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; Gq/11-coupled serotonin receptor activity [GO:0001587]; neurotransmitter receptor activity [GO:0030594]; behavior [GO:0007610]; embryonic morphogenesis [GO:0048598]; heart development [GO:0007507]; regulation of behavior [GO:0050795]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]";"GO:0001587; GO:0005887; GO:0006939; GO:0007507; GO:0007610; GO:0030054; GO:0030594; GO:0042310; GO:0043005; GO:0045202; GO:0048598; GO:0050795";"behavior [GO:0007610]; embryonic morphogenesis [GO:0048598]; heart development [GO:0007507]; regulation of behavior [GO:0050795]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"Gq/11-coupled serotonin receptor activity [GO:0001587]; neurotransmitter receptor activity [GO:0030594]"
comp610969_c0_seq1;GAXK01001744.1;Q08473;1.78E-17;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp6110_c0_seq1;GAXK01101046.1;G5ECN9;0;NEC2_CAEEL;Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Egg-laying defective protein 3) (Kex2-like prohormone convertase 2) (CELPC2) (Prohormone convertase 2) (PC2) (Proprotein convertase 2);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]; arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]";"GO:0004252; GO:0005615; GO:0006937; GO:0007274; GO:0008340; GO:0008582; GO:0009612; GO:0014057; GO:0016020; GO:0016485; GO:0016486; GO:0030070; GO:0030424; GO:0030536; GO:0031410; GO:0043005; GO:0043058; GO:0045887; GO:0060456; GO:0061096; GO:0061837; GO:0090325; GO:0090326; GO:0090472; GO:0090474; GO:0098770; GO:1900073; GO:1901046; GO:1903998; GO:1904014; GO:1904810; GO:1905850; GO:1905852; GO:1905910; GO:1905954";"arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]";"FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]"
comp611027_c1_seq1;GAXK01001800.1;P12659;8.14E-27;HCYA_ENTDO;Hemocyanin A-type, units Ode to Odg (Fragment);"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0016491; GO:0046872";;;"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp6111759_c0_seq1;GAXK01099326.1;O43424;9.45E-10;GRID2_HUMAN;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; glutamate receptor signaling pathway [GO:0007215]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0005887; GO:0007157; GO:0007215; GO:0008066; GO:0008328; GO:0010975; GO:0021707; GO:0030054; GO:0030165; GO:0034613; GO:0035249; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0097110; GO:0098688; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861";"cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; glutamate receptor signaling pathway [GO:0007215]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp611219_c0_seq1;GAXK01001810.1;Q9VN12;9.97E-64;NCKXH_DROME;Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp611290_c2_seq1;GAXK01001722.1;O02467;9.01E-120;ASPG_SPOFR;"N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] (Fragment)";"lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]";"GO:0003948; GO:0005764; GO:0008233";;lysosome [GO:0005764];"N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]"
comp61135_c0_seq1;GAXK01103441.1;Q9NXW9;1.45E-60;ALKB4_HUMAN;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-);"contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; actomyosin structure organization [GO:0031032]; cleavage furrow ingression [GO:0036090]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]";"GO:0003779; GO:0005634; GO:0005737; GO:0006482; GO:0016491; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0036090; GO:0046872; GO:0070938; GO:0070989";"actomyosin structure organization [GO:0031032]; cleavage furrow ingression [GO:0036090]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]";"contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp61140_c0_seq1;GAXK01103407.1;Q96L94;1.32E-13;SNX22_HUMAN;Sorting nexin-22;"cytoplasmic vesicle membrane [GO:0030659]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]";"GO:0015031; GO:0030659; GO:0035091";protein transport [GO:0015031];cytoplasmic vesicle membrane [GO:0030659];phosphatidylinositol binding [GO:0035091]
comp61154_c0_seq1;GAXK01102979.1;Q9DDT5;1.77E-51;SPT5H_DANRE;Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Protein foggy);"DSIF complex [GO:0032044]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; central nervous system neuron development [GO:0021954]; hemopoiesis [GO:0030097]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; neuron migration [GO:0001764]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0001764; GO:0003677; GO:0003729; GO:0005634; GO:0006357; GO:0006368; GO:0021954; GO:0030097; GO:0032044; GO:0032968; GO:0034244; GO:0040037; GO:0046427; GO:0060335; GO:1901534; GO:1902038";"central nervous system neuron development [GO:0021954]; hemopoiesis [GO:0030097]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; neuron migration [GO:0001764]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"DSIF complex [GO:0032044]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; mRNA binding [GO:0003729]"
comp6115464_c0_seq1;GAXK01064717.1;Q57749;2.68E-08;DHPSL_METJA;7,8-dihydropterin-6-methyl-4-(beta-D-ribofuranosyl)-aminobenzene-5'-phosphate synthase (EC 2.5.1.105);"7,8-dihydropterin-6-yl-methyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase [GO:0102041]; [1-(2-amino-7-methyl-4-oxo-7,8-dihydro-3H-pteridin-6-yl)]ethyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase activity [GO:0102638]; metal ion binding [GO:0046872]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; coenzyme biosynthetic process [GO:0009108]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0009108; GO:0016765; GO:0042558; GO:0046872; GO:0102041; GO:0102638";"coenzyme biosynthetic process [GO:0009108]; pteridine-containing compound metabolic process [GO:0042558]";;"[1-(2-amino-7-methyl-4-oxo-7,8-dihydro-3H-pteridin-6-yl)]ethyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase activity [GO:0102638]; 7,8-dihydropterin-6-yl-methyl-4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase [GO:0102041]; metal ion binding [GO:0046872]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]"
comp611567_c0_seq1;GAXK01001821.1;Q2HJ23;4.84E-18;MLP3A_BOVIN;Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0097352";"autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]";"microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]"
comp611689_c0_seq1;GAXK01001748.1;O93430;4.01E-28;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp6117056_c0_seq1;GAXK01201054.1;Q5EA68;3.22E-37;S61A1_BOVIN;Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; calcium channel activity [GO:0005262]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; endoplasmic reticulum organization [GO:0007029]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]";"GO:0005048; GO:0005262; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0006620; GO:0007029; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047";"endoplasmic reticulum organization [GO:0007029]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]";"calcium channel activity [GO:0005262]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]"
comp6117194_c0_seq1;GAXK01201045.1;A9LNK9;5.59E-07;CPSF_ARATH;30-kDa cleavage and polyadenylation specificity factor 30 (EC 3.1.21.-) (Protein OXIDATIVE STRESS TOLERANT 6) (Zinc finger CCCH domain-containing protein 11) (AtC3H11);"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; plant-type hypersensitive response [GO:0009626]; positive regulation of plant-type hypersensitive response [GO:0034052]; positive regulation of programmed cell death [GO:0043068]; regulation of mRNA polyadenylation [GO:1900363]; regulation of salicylic acid mediated signaling pathway [GO:2000031]; response to oxidative stress [GO:0006979]; RNA processing [GO:0006396]";"GO:0003677; GO:0003723; GO:0003729; GO:0004519; GO:0004521; GO:0005516; GO:0005634; GO:0005737; GO:0005847; GO:0006378; GO:0006396; GO:0006979; GO:0009626; GO:0031124; GO:0034052; GO:0043068; GO:0046872; GO:1900363; GO:2000031";"mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; plant-type hypersensitive response [GO:0009626]; positive regulation of plant-type hypersensitive response [GO:0034052]; positive regulation of programmed cell death [GO:0043068]; regulation of mRNA polyadenylation [GO:1900363]; regulation of salicylic acid mediated signaling pathway [GO:2000031]; response to oxidative stress [GO:0006979]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp6117671_c0_seq1;GAXK01201061.1;Q32KY1;7.77E-07;DRC1_BOVIN;Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of cilium movement [GO:0003352]";"GO:0003352; GO:0005858; GO:0005930; GO:0007368; GO:0007507; GO:0031514; GO:0060285; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of cilium movement [GO:0003352]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp6117930_c0_seq1;GAXK01201043.1;Q54D63;1.66E-26;RL6_DICDI;60S ribosomal protein L6;"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0031012";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"cytosolic large ribosomal subunit [GO:0022625]; extracellular matrix [GO:0031012]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp611796_c0_seq1;GAXK01001811.1;P17972;1.19E-91;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp6118_c3_seq1;GAXK01100341.1;A3KMV5;0;UBA1_BOVIN;Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]";"GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006974; GO:0016567; GO:0032446";"cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]"
comp611843_c0_seq1;GAXK01204973.1;P02833;3.57E-41;ANTP_DROME;Homeotic protein antennapedia;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]";"GO:0000122; GO:0000980; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0007383; GO:0007384; GO:0007419; GO:0007494; GO:0007507; GO:0009948; GO:0009952; GO:0014019; GO:0042694; GO:0043565; GO:0045944; GO:0048542; GO:0050767";"anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp611851_c1_seq1;GAXK01001795.1;Q5RFR0;4.42E-26;TTPAL_PONAB;Alpha-tocopherol transfer protein-like;;;;;
comp611870_c1_seq1;GAXK01001741.1;P28851;2.33E-16;KITH_MYXVU;Thymidine kinase (EC 2.7.1.21);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]";"GO:0004797; GO:0005524; GO:0046872; GO:0071897";DNA biosynthetic process [GO:0071897];;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; thymidine kinase activity [GO:0004797]"
comp6119262_c0_seq1;GAXK01098540.1;Q8NCK7;4.47E-07;MOT11_HUMAN;Monocarboxylate transporter 11 (MCT 11) (Solute carrier family 16 member 11);"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lipid metabolic process [GO:0006629]; monocarboxylic acid transport [GO:0015718]";"GO:0005789; GO:0005886; GO:0005887; GO:0006629; GO:0008028; GO:0015293; GO:0015718; GO:0050833";"lipid metabolic process [GO:0006629]; monocarboxylic acid transport [GO:0015718]";"endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]"
comp61199_c0_seq1;GAXK01102782.1;Q9BRT2;4.59E-12;UQCC2_HUMAN;Ubiquinol-cytochrome-c reductase complex assembly factor 2 (Breast cancer-associated protein SGA-81M) (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19);"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014]";"GO:0002082; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0016604; GO:0034551; GO:0042645; GO:0050796; GO:0070131; GO:1903364; GO:2001014";"mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014]";"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]";
comp612_c2_seq1;GAXK01169364.1;O16852;6.01E-152;PCNA_SARCR;Proliferating cell nuclear antigen (PCNA) (Cyclin);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]";"GO:0003677; GO:0005634; GO:0006260; GO:0006275; GO:0030337";"DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]"
comp61201_c1_seq1;GAXK01103240.1;Q29EP6;0;JIP3_DROPS;JNK-interacting protein 3 (Protein sunday driver);"Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005078; GO:0008088; GO:0016192; GO:0019894; GO:0030140; GO:0043005; GO:0046328";"axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]";"Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]";"kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]"
comp612178_c0_seq1;GAXK01004305.1;O46040;2.34E-18;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp6122166_c0_seq1;GAXK01069525.1;P37167;2.63E-14;ACTP_ACACA;Actophorin;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]";"GO:0003779; GO:0005737; GO:0015629; GO:0030042";actin filament depolymerization [GO:0030042];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";actin binding [GO:0003779]
comp612285_c2_seq1;GAXK01004328.1;A1L1W9;4.48E-20;MOT10_DANRE;Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10);"integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]";"GO:0005887; GO:0015173; GO:0015349";;integral component of plasma membrane [GO:0005887];"aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp6123_c0_seq1;GAXK01100763.1;Q9V3U2;3.97E-56;NHP2_DROME;H/ACA ribonucleoprotein complex subunit 2-like protein (H/ACA snoRNP protein NHP2) (Nucleolar protein family A member 2-like protein);"box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]";"GO:0000469; GO:0000470; GO:0003723; GO:0005732; GO:0031118; GO:0031120; GO:0031429; GO:0034513";"cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]";"box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]";"box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]"
comp6124005_c0_seq1;GAXK01195522.1;P35556;6.37E-07;FBN2_HUMAN;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030023; GO:0030198; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]"
comp612403_c2_seq1;GAXK01004359.1;Q9VEU1;0;CAD89_DROME;Cadherin-89D;"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0005509; GO:0005887; GO:0007156; GO:0016339; GO:0044331";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";integral component of plasma membrane [GO:0005887];calcium ion binding [GO:0005509]
comp6124302_c0_seq1;GAXK01195520.1;P27795;2.44E-32;H2B_TRYCR;Histone H2B;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp6124973_c0_seq1;GAXK01195517.1;O14460;5.52E-59;EF2_SCHPO;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translational elongation [GO:0006414]";"GO:0002182; GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0043022; GO:1990904";"cytoplasmic translational elongation [GO:0002182]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp61254_c1_seq1;GAXK01103408.1;Q7M3M8;9.85E-82;CAS_DROME;Transcription factor castor (Protein ming);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; glial cell development [GO:0021782]; mushroom body development [GO:0016319]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; post-embryonic development [GO:0009791]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription, DNA-templated [GO:0006355]; ventral cord development [GO:0007419]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007402; GO:0007417; GO:0007419; GO:0009791; GO:0014019; GO:0016319; GO:0021782; GO:0040034; GO:0045892; GO:0046872; GO:0048699; GO:2000177";"central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; generation of neurons [GO:0048699]; glial cell development [GO:0021782]; mushroom body development [GO:0016319]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; post-embryonic development [GO:0009791]; regulation of development, heterochronic [GO:0040034]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription, DNA-templated [GO:0006355]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp61258_c0_seq1;GAXK01102899.1;Q32LP4;0;S4A10_BOVIN;Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10);"apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]";"GO:0005452; GO:0005887; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016323; GO:0016324; GO:0021860; GO:0030054; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0051453; GO:0097440; GO:0097441; GO:0097442; GO:1902600";"bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]";"apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]";"anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]"
comp612607_c0_seq1;GAXK01004293.1;O74467;2.77E-19;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp6126131_c0_seq1;GAXK01170877.1;O74892;1.50E-21;RS2_SCHPO;40S ribosomal protein S2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0022627; GO:0032040";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small-subunit processome [GO:0032040]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp612918_c1_seq1;GAXK01004373.1;Q08832;4.81E-10;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp61298_c0_seq1;GAXK01102589.1;Q9XZ08;0;EXT3_DROME;Exostosin-3 (EC 2.4.1.223) (Protein brother of tout-velu);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin biosynthetic process [GO:0030210]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0001888; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007275; GO:0008375; GO:0015012; GO:0015014; GO:0016021; GO:0016055; GO:0016757; GO:0030201; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0090263";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparan sulfate proteoglycan metabolic process [GO:0030201]; heparin biosynthetic process [GO:0030210]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp613_c0_seq1;GAXK01168673.1;P11147;9.03E-49;HSP7D_DROME;Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"GO:0000398; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0016887; GO:0030707; GO:0031072; GO:0034605; GO:0034620; GO:0035967; GO:0042026; GO:0042623; GO:0044183; GO:0048471; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0097753; GO:0098793; GO:0106161";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp61307_c0_seq1;GAXK01102964.1;P80964;6.55E-07;PB1_PIG;Seminal plasma protein pB1 (Protein DQH) (pAIF-1);"cell surface [GO:0009986]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005615; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular space [GO:0005615]";heparin binding [GO:0008201]
comp6132_c0_seq1;GAXK01100767.1;Q8SPH5;2.27E-15;QCR6_MACFA;Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein);"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]";"GO:0005743; GO:0006122; GO:0008121; GO:0070469";mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122];"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";ubiquinol-cytochrome-c reductase activity [GO:0008121]
comp613205_c0_seq1;GAXK01004290.1;Q0IIF6;1.66E-66;FAIM1_BOVIN;Fas apoptotic inhibitory molecule 1;"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769]";"GO:0005737; GO:0006915; GO:0007249; GO:0050769; GO:1902042";"apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769]";cytoplasm [GO:0005737];
comp61341_c0_seq1;GAXK01103153.1;A0PJE2;1.51E-124;DHR12_HUMAN;Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp613459_c0_seq1;GAXK01004362.1;P18910;3.60E-56;ANPRA_RAT;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662";"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp613497_c2_seq1;GAXK01004282.1;Q96ER9;3.07E-21;CCD51_HUMAN;Coiled-coil domain-containing protein 51;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp6135015_c0_seq1;GAXK01201488.1;P01131;6.40E-07;LDLR_BOVIN;Low-density lipoprotein receptor (LDL receptor);"apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; PCSK9-LDLR complex [GO:1990666]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771]";"GO:0001540; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005771; GO:0005794; GO:0005901; GO:0005905; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016021; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0034362; GO:0034383; GO:0034384; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771]";"apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; PCSK9-LDLR complex [GO:1990666]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
comp61363_c1_seq1;GAXK01102590.1;Q9D8T4;3.22E-25;TV23B_MOUSE;Golgi apparatus membrane protein TVP23 homolog B;"integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]";"GO:0009306; GO:0016192; GO:0030173";"protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]";integral component of Golgi membrane [GO:0030173];
comp613770_c0_seq1;GAXK01004284.1;Q9V427;5.27E-53;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp6138739_c0_seq1;GAXK01084663.1;Q45GW3;7.21E-12;IQUB_RAT;IQ and ubiquitin-like domain-containing protein (Protein TRS4);"acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224]";"GO:0001669; GO:0007224; GO:0031514; GO:0060271";"cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224]";"acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]";
comp613900_c0_seq1;GAXK01004304.1;Q9HCX4;7.14E-19;TRPC7_HUMAN;Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (hTRP7);"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0030168; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; platelet activation [GO:0030168]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp61393_c1_seq1;GAXK01102863.1;Q99JF5;6.33E-119;MVD1_MOUSE;Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase);"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]";"GO:0004163; GO:0005524; GO:0005777; GO:0005782; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803";"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]";"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]"
comp6140_c1_seq1;GAXK01100537.1;Q6PCX9;0;TRI37_MOUSE;E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37);"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]";"GO:0000122; GO:0003682; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035098; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842";"aggresome assembly [GO:0070842]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]";"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]";"chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp6140304_c0_seq1;GAXK01053029.1;A7ZWF6;1.24E-09;RNH_ECOHS;Ribonuclease H (RNase H) (EC 3.1.26.4);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; RNA catabolic process [GO:0006401]";"GO:0000287; GO:0003676; GO:0004523; GO:0005737; GO:0006401";RNA catabolic process [GO:0006401];cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp61406_c1_seq1;GAXK01102872.1;P35220;0;CTNA_DROME;Catenin alpha;"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323";"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp61411_c0_seq1;GAXK01103236.1;O94889;0;KLH18_HUMAN;Kelch-like protein 18;;;;;
comp614127_c0_seq1;GAXK01092831.1;O09160;4.52E-18;FUT1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp61417_c0_seq1;GAXK01102944.1;Q9CWQ0;2.18E-122;DPH5_MOUSE;Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase);"diphthine synthase activity [GO:0004164]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]";"GO:0004164; GO:0017183";peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183];;diphthine synthase activity [GO:0004164]
comp61419_c1_seq1;GAXK01103291.1;Q8WXA3;3.76E-124;RUFY2_HUMAN;RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related);"cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]";"GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872";regulation of endocytosis [GO:0030100];"cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]"
comp61427_c0_seq1;GAXK01102973.1;Q9H6X4;1.75E-12;TM134_HUMAN;Transmembrane protein 134;"integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"GO:0016021; GO:0048471";;"integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";
comp6144471_c0_seq1;GAXK01064603.1;Q8BZM0;1.30E-07;KLH12_MOUSE;Kelch-like protein 12 (CUL3-interacting protein 1);"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0005815; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0042802; GO:0043231; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]";identical protein binding [GO:0042802]
comp614589_c0_seq1;GAXK01092809.1;Q9W436;1.35E-72;NEP_DROME;Neprilysin-1 (EC 3.4.24.11);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp614629_c0_seq1;GAXK01092861.1;Q5FWI3;1.33E-88;CEIP2_MOUSE;Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2);"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";"GO:0001525; GO:0004415; GO:0005509; GO:0005887; GO:0030214; GO:1903670";"angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]";integral component of plasma membrane [GO:0005887];"calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]"
comp614647_c0_seq1;GAXK01092794.1;Q8IN81;7.87E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6147026_c0_seq1;GAXK01072889.1;Q6RYS3;1.21E-70;RL8_MAMBR;60S ribosomal protein L8;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp61471_c1_seq1;GAXK01102653.1;Q8I7Z8;4.29E-13;HAM_DROME;Transcription factor hamlet;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007219; GO:0008285; GO:0014017; GO:0046872; GO:0046974; GO:0048813; GO:0050773";"dendrite morphogenesis [GO:0048813]; negative regulation of cell population proliferation [GO:0008285]; neuroblast fate commitment [GO:0014017]; Notch signaling pathway [GO:0007219]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]"
comp61473_c1_seq1;GAXK01102633.1;Q9U539;1.01E-54;OCT1_CAEEL;Organic cation transporter 1 (CeOCT1);"integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";"GO:0008340; GO:0015101; GO:0015695; GO:0016021";"determination of adult lifespan [GO:0008340]; organic cation transport [GO:0015695]";integral component of membrane [GO:0016021];organic cation transmembrane transporter activity [GO:0015101]
comp61475_c1_seq1;GAXK01103440.1;Q5R615;1.95E-76;RB33B_PONAB;Ras-related protein Rab-33B;"Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]";"GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005796; GO:0006891; GO:0015031; GO:0032482; GO:0034067; GO:0048705; GO:1903358; GO:1903434; GO:2000156";"autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]";"Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp614764_c0_seq1;GAXK01092843.1;Q29P71;0;MYO7A_DROPS;Myosin-VIIa (Protein crinkled);"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0005524; GO:0005737; GO:0005902; GO:0007015; GO:0007605; GO:0008407; GO:0008586; GO:0030048; GO:0030898; GO:0031477; GO:0032027; GO:0032529; GO:0035182; GO:0035293; GO:0035317; GO:0045179; GO:0045180; GO:0045296; GO:0048800; GO:0051015; GO:0070825";"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp614770_c0_seq1;GAXK01092773.1;P58006;2.00E-11;SESN1_MOUSE;Sestrin-1 (EC 1.11.1.15);"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxiredoxin activity [GO:0051920]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]";"GO:0001650; GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0030308; GO:0034198; GO:0042149; GO:0051896; GO:0051920; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253";"cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]";"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]";"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxiredoxin activity [GO:0051920]"
comp6148_c2_seq1;GAXK01100286.1;Q498E6;3.20E-55;KT5AB_XENLA;N-lysine methyltransferase KMT5A-B (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-B) (EC 2.1.1.43) (Lysine-specific methylase 5A-B) (Mitotic phosphoprotein 36) (SET domain-containing protein 8-B);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0005694; GO:0007049; GO:0018024; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"chromosome [GO:0005694]; nucleus [GO:0005634]";histone-lysine N-methyltransferase activity [GO:0018024]
comp614904_c0_seq1;GAXK01092832.1;Q32NH8;2.36E-114;PLCD4_XENLA;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4);"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0007340; GO:0016020; GO:0016042; GO:0035556; GO:0046488";"acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp614976_c0_seq1;GAXK01092826.1;P04755;1.05E-33;ACH3_DROME;Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1);"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp615_c0_seq1;GAXK01169022.1;P62870;8.55E-38;ELOB_RAT;Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2);"elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0044877; GO:0045944; GO:0070449";"positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]";"protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]"
comp615092_c0_seq1;GAXK01092833.1;Q8BG22;6.59E-08;CLCA2_MOUSE;Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 5) (mCLCA5);"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006821; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0046872";"cell adhesion [GO:0007155]; chloride transport [GO:0006821]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp6151242_c0_seq1;GAXK01029910.1;P14381;1.45E-07;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp6151316_c0_seq1;GAXK01029917.1;Q8SWR3;4.69E-20;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp615174_c2_seq1;GAXK01092828.1;P52736;2.22E-24;ZN133_HUMAN;Zinc finger protein 133 (Zinc finger protein 150);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp61520_c1_seq1;GAXK01102968.1;P37747;5.56E-70;GLF_ECOLI;UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) (UDP-GALP mutase) (Uridine 5-diphosphate galactopyranose mutase);"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]; lipopolysaccharide biosynthetic process [GO:0009103]";"GO:0005829; GO:0008767; GO:0009103; GO:0050660";lipopolysaccharide biosynthetic process [GO:0009103];cytosol [GO:0005829];"flavin adenine dinucleotide binding [GO:0050660]; UDP-galactopyranose mutase activity [GO:0008767]"
comp61541_c0_seq1;GAXK01103248.1;P25822;6.01E-26;PUM_DROME;Maternal protein pumilio;"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0000278; GO:0000288; GO:0000900; GO:0003723; GO:0003730; GO:0005635; GO:0005737; GO:0007268; GO:0007280; GO:0007281; GO:0007616; GO:0008258; GO:0008582; GO:0008595; GO:0016441; GO:0016477; GO:0017148; GO:0031594; GO:0042059; GO:0042078; GO:0045727; GO:0045786; GO:0045892; GO:0048149; GO:0048477; GO:0048813; GO:0050804; GO:0060213; GO:0061176; GO:0061177; GO:0071598; GO:0097482; GO:1990124";"anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]";"mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp61551_c0_seq1;GAXK01102952.1;Q8VCY6;1.30E-63;UTP6_MOUSE;U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein);"nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0005730; GO:0030515; GO:0032040; GO:0034388";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]";snoRNA binding [GO:0030515]
comp61559_c0_seq1;GAXK01102593.1;Q803E0;9.37E-11;PALD_DANRE;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]";"GO:0001525; GO:0004722; GO:0004725; GO:0005737; GO:0005829";angiogenesis [GO:0001525];"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp615612_c1_seq1;GAXK01092839.1;P17863;1.18E-43;SKI_AVIES;Transforming protein Ski;"SMAD binding [GO:0046332]; transcription, DNA-templated [GO:0006351]";"GO:0006351; GO:0046332";transcription, DNA-templated [GO:0006351];;SMAD binding [GO:0046332]
comp6156631_c0_seq1;GAXK01149947.1;Q9VV43;7.25E-14;Y5057_DROME;TPPP family protein CG45057;"axon [GO:0030424]; neuronal cell body [GO:0043025]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"GO:0000226; GO:0001578; GO:0015631; GO:0030424; GO:0032273; GO:0043025; GO:0046785";"microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]";"axon [GO:0030424]; neuronal cell body [GO:0043025]";tubulin binding [GO:0015631]
comp6156852_c0_seq1;GAXK01149956.1;Q97GC0;3.43E-18;FPRA2_CLOAB;Flavo-diiron protein FprA2 (FDP 2) (Flavoprotein A2) (H(2)O-forming NADH oxidase) (EC 1.6.3.4) (NADH oxidase) (NADH:O(2) oxidoreductase);"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; iron ion binding [GO:0005506]; nitric oxide reductase activity [GO:0016966]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]; reactive oxygen species metabolic process [GO:0072593]; response to toxic substance [GO:0009636]";"GO:0005506; GO:0009055; GO:0009636; GO:0010181; GO:0016966; GO:0050664; GO:0072593";"reactive oxygen species metabolic process [GO:0072593]; response to toxic substance [GO:0009636]";;"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; iron ion binding [GO:0005506]; nitric oxide reductase activity [GO:0016966]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]"
comp6156857_c0_seq1;GAXK01149943.1;Q8CGK7;1.20E-12;GNAL_MOUSE;Guanine nucleotide-binding protein G(olf) subunit alpha (Adenylate cyclase-stimulating G alpha protein, olfactory type);"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; sensory perception of smell [GO:0007608]";"GO:0001664; GO:0001975; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0007188; GO:0007189; GO:0007190; GO:0007191; GO:0007608; GO:0031000; GO:0031683; GO:0046872";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; sensory perception of smell [GO:0007608]";heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp61573_c1_seq1;GAXK01103106.1;Q7Z3C6;0;ATG9A_HUMAN;Autophagy-related protein 9A (APG9-like 1) (mATG9);"autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; response to nutrient levels [GO:0031667]";"GO:0000045; GO:0000407; GO:0000422; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005802; GO:0008021; GO:0015031; GO:0016020; GO:0016021; GO:0031667; GO:0031902; GO:0034497; GO:0043231; GO:0044805; GO:0055037";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; response to nutrient levels [GO:0031667]";"autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]";
comp615730_c0_seq1;GAXK01092808.1;O08901;5.11E-31;BUB1_MOUSE;Mitotic checkpoint serine/threonine-protein kinase BUB1 (mBUB1) (EC 2.7.11.1) (BUB1A);"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000780; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0051301; GO:0051754; GO:0051983; GO:2001244";"apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]";"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp615760_c0_seq1;GAXK01092867.1;P52746;2.50E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp615781_c0_seq1;GAXK01092817.1;Q86W11;2.23E-19;ZSC30_HUMAN;Zinc finger and SCAN domain-containing protein 30 (ZNF-WYM) (Zinc finger protein 397 opposite strand) (Zinc finger protein 397OS);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6159813_c0_seq1;GAXK01142937.1;P31696;1.27E-11;AGRIN_CHICK;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"GO:0002162; GO:0004867; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007275; GO:0007399; GO:0007417; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030054; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978; GO:1902572";"actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]";"axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]"
comp6160480_c0_seq1;GAXK01012490.1;P02595;2.62E-10;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6160599_c0_seq1;GAXK01012488.1;O75445;1.89E-09;USH2A_HUMAN;Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein);"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0017022; GO:0022008; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042803; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060041; GO:0060113; GO:0060171; GO:1990075; GO:1990696";"animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; neurogenesis [GO:0022008]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]";"collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]"
comp616076_c0_seq1;GAXK01035459.1;Q18120;1.84E-14;TWK18_CAEEL;TWiK family of potassium channels protein 18;"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0030322; GO:0040011; GO:0071805";"locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp61608_c1_seq1;GAXK01103467.1;Q9YGP6;2.07E-12;SLBP2_XENLA;Oocyte-specific histone RNA stem-loop-binding protein 2;"cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; regulation of translation [GO:0006417]";"GO:0003729; GO:0005737; GO:0006417";regulation of translation [GO:0006417];cytoplasm [GO:0005737];mRNA binding [GO:0003729]
comp61615_c1_seq1;GAXK01102606.1;O45244;0;DHX16_CAEEL;Probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-4 (EC 3.6.4.13) (Masculinization of germline protein 4) (Sex determination protein mog-4);"spliceosomal complex [GO:0005681]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005524; GO:0005681; GO:0006397; GO:0007281; GO:0008380; GO:0010172; GO:0034458; GO:0040022; GO:0048589";"developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";spliceosomal complex [GO:0005681];"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp6161881_c0_seq1;GAXK01012481.1;Q8ISP0;2.62E-46;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp616351_c1_seq1;GAXK01035524.1;P14533;1.55E-09;CABO_DORPE;Squidulin (Optic lobe calcium-binding protein) (SCABP);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp61637_c0_seq2;GAXK01102927.1;Q01295;2.33E-20;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp616375_c2_seq1;GAXK01035571.1;Q9Z173;3.06E-79;AGRL3_RAT;Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0098742";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp616488_c0_seq1;GAXK01035465.1;O88576;3.09E-126;S6A18_MOUSE;Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]";"GO:0003333; GO:0005328; GO:0005886; GO:0005887; GO:0015175; GO:0016324; GO:0031526";amino acid transmembrane transport [GO:0003333];"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp616500_c1_seq1;GAXK01035474.1;Q63099;3.26E-55;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp6165326_c0_seq1;GAXK01140228.1;Q93560;5.34E-11;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp616566_c0_seq1;GAXK01035460.1;Q8K1S6;3.49E-60;SPIR2_MOUSE;Protein spire homolog 2 (Spir-2);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0051295; GO:0070649; GO:2000781";"actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp616580_c1_seq1;GAXK01035562.1;P18172;8.50E-122;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp61668_c0_seq1;GAXK01103465.1;Q803S3;5.63E-121;MEMO1_DANRE;Protein MEMO1 (Mediator of ErbB2-driven cell motility 1) (Memo-1);;;;;
comp6167163_c0_seq1;GAXK01025030.1;P25387;1.34E-30;GBLP_CHLRE;Guanine nucleotide-binding protein subunit beta-like protein;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp61688_c0_seq1;GAXK01103309.1;Q94901;5.24E-56;LARK_DROME;RNA-binding protein lark;"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"GO:0000278; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0007303; GO:0007562; GO:0007623; GO:0008062; GO:0008104; GO:0008270; GO:0009792; GO:0016607; GO:0030036; GO:0042752; GO:0045292; GO:0045475; GO:0045804; GO:0045995; GO:0071011; GO:0071013; GO:2000767";"actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp6169085_c0_seq1;GAXK01136163.1;P31579;5.41E-16;LCE_ORYLA;Low choriolytic enzyme (EC 3.4.24.66) (Choriolysin L) (Hatching enzyme zinc-protease subunit LCE);"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005886; GO:0008270; GO:0030133; GO:0060468; GO:0060473; GO:2000360";"negative regulation of binding of sperm to zona pellucida [GO:2000360]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp616916_c1_seq1;GAXK01035540.1;P83088;6.32E-62;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp6169823_c0_seq1;GAXK01136162.1;Q06518;2.47E-40;NOS2_RAT;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; glycoside metabolic process [GO:0016137]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"GO:0001935; GO:0001974; GO:0003779; GO:0003958; GO:0004517; GO:0005516; GO:0005615; GO:0005634; GO:0005737; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0007165; GO:0007199; GO:0007263; GO:0007568; GO:0008013; GO:0008016; GO:0008217; GO:0008603; GO:0009612; GO:0009725; GO:0010181; GO:0012506; GO:0014823; GO:0016137; GO:0016491; GO:0018119; GO:0019901; GO:0019934; GO:0020037; GO:0031284; GO:0032310; GO:0032355; GO:0032496; GO:0034612; GO:0035556; GO:0035902; GO:0042060; GO:0042742; GO:0042803; GO:0043065; GO:0045296; GO:0045776; GO:0046872; GO:0048384; GO:0048471; GO:0050660; GO:0050661; GO:0050829; GO:0050998; GO:0051879; GO:0071222; GO:0071285; GO:0071305; GO:0071345; GO:0071347; GO:0071356; GO:0071407; GO:0071461; GO:0071548; GO:0072604; GO:0072606; GO:1900015";"aging [GO:0007568]; arginine catabolic process [GO:0006527]; blood vessel remodeling [GO:0001974]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cGMP-mediated signaling [GO:0019934]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; endothelial cell proliferation [GO:0001935]; glycoside metabolic process [GO:0016137]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; intracellular signal transduction [GO:0035556]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of apoptotic process [GO:0043065]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; superoxide metabolic process [GO:0006801]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"
comp617_c0_seq1;GAXK01169056.1;P84245;2.00E-89;H33_RAT;Histone H3.3;"Barr body [GO:0001740]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; DNA replication-independent nucleosome assembly [GO:0006336]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; response to hormone [GO:0009725]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; telomeric heterochromatin assembly [GO:0031509]";"GO:0000784; GO:0000786; GO:0000788; GO:0000979; GO:0000980; GO:0001649; GO:0001740; GO:0005634; GO:0006336; GO:0006997; GO:0007286; GO:0007338; GO:0007420; GO:0007566; GO:0008283; GO:0008584; GO:0009725; GO:0030307; GO:0031492; GO:0031508; GO:0031509; GO:0035264; GO:0042692; GO:0046982; GO:0048477; GO:0090230; GO:1902340";"brain development [GO:0007420]; cell population proliferation [GO:0008283]; DNA replication-independent nucleosome assembly [GO:0006336]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; response to hormone [GO:0009725]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; telomeric heterochromatin assembly [GO:0031509]";"Barr body [GO:0001740]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleosome [GO:0000786]; nucleus [GO:0005634]";"nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]"
comp61721_c1_seq1;GAXK01102607.1;Q92614;0;MY18A_HUMAN;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp617213_c0_seq1;GAXK01035538.1;Q9PVG3;3.65E-15;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp61722_c1_seq1;GAXK01103290.1;Q8IZN3;1.19E-67;ZDH14_HUMAN;Probable palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14) (DHHC-14);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp617244_c0_seq1;GAXK01035600.1;O77487;7.26E-26;FUT2_PONPY;Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp61730_c2_seq1;GAXK01102649.1;Q9TZC4;0;ILKH_CAEEL;Integrin-linked protein kinase homolog pat-4 (ILK homolog) (Paralyzed and arrested elongation at two-fold protein 4);"adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein binding, bridging [GO:0030674]; protein serine/threonine kinase activity [GO:0004674]; cell-matrix adhesion [GO:0007160]; embryo development ending in birth or egg hatching [GO:0009792]; hermaphrodite genitalia morphogenesis [GO:0048815]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; myofibril assembly [GO:0030239]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; striated muscle cell development [GO:0055002]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000165; GO:0004674; GO:0005178; GO:0005524; GO:0005912; GO:0005925; GO:0006468; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009792; GO:0009925; GO:0030239; GO:0030674; GO:0031430; GO:0032956; GO:0034446; GO:0040017; GO:0045987; GO:0046716; GO:0048815; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:1903356; GO:1903829; GO:1904901; GO:1904951";"cell-matrix adhesion [GO:0007160]; embryo development ending in birth or egg hatching [GO:0009792]; hermaphrodite genitalia morphogenesis [GO:0048815]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; myofibril assembly [GO:0030239]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; striated muscle cell development [GO:0055002]; substrate adhesion-dependent cell spreading [GO:0034446]";"adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]";"ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein binding, bridging [GO:0030674]; protein serine/threonine kinase activity [GO:0004674]"
comp61732_c0_seq1;GAXK01102883.1;Q4UKI1;3.84E-07;Y1099_RICFE;Putative ankyrin repeat protein RF_1099;;;;;
comp617343_c2_seq1;GAXK01035515.1;Q05481;2.55E-15;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp617391_c0_seq1;GAXK01035575.1;O93430;1.42E-35;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp6174884_c0_seq1;GAXK01000080.1;O59948;3.35E-136;ERF1_PODAS;Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1);"cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]";"GO:0003747; GO:0005737";;cytoplasm [GO:0005737];translation release factor activity [GO:0003747]
comp617532_c0_seq1;GAXK01035499.1;Q5U206;3.27E-13;CALL3_RAT;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6175556_c0_seq1;GAXK01000074.1;P35007;1.92E-40;SAHH_CATRO;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp61756_c1_seq1;GAXK01102620.1;P08510;0;KCNAS_DROME;Potassium voltage-gated channel protein Shaker (Protein minisleep);"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; axon extension [GO:0048675]; behavioral response to ether [GO:0048150]; cellular response to dopamine [GO:1903351]; courtship behavior [GO:0007619]; detection of visible light [GO:0009584]; larval locomotory behavior [GO:0008345]; learning or memory [GO:0007611]; mating behavior, sex discrimination [GO:0048047]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of membrane potential [GO:0045838]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proboscis extension reflex [GO:0007637]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]; sensory perception of taste [GO:0050909]; sleep [GO:0030431]";"GO:0001508; GO:0005249; GO:0005251; GO:0006813; GO:0007611; GO:0007619; GO:0007637; GO:0008076; GO:0008345; GO:0009584; GO:0016021; GO:0022843; GO:0030431; GO:0034765; GO:0045187; GO:0045838; GO:0045938; GO:0048047; GO:0048150; GO:0048675; GO:0050909; GO:0051260; GO:0060025; GO:0071805; GO:1903351";"action potential [GO:0001508]; axon extension [GO:0048675]; behavioral response to ether [GO:0048150]; cellular response to dopamine [GO:1903351]; courtship behavior [GO:0007619]; detection of visible light [GO:0009584]; larval locomotory behavior [GO:0008345]; learning or memory [GO:0007611]; mating behavior, sex discrimination [GO:0048047]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of membrane potential [GO:0045838]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proboscis extension reflex [GO:0007637]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]; sensory perception of taste [GO:0050909]; sleep [GO:0030431]";"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp6175838_c0_seq1;GAXK01000078.1;Q09JW2;9.56E-49;RL17_ARGMO;60S ribosomal protein L17;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp6176070_c0_seq1;GAXK01008528.1;Q8A407;2.04E-56;SAHH_BACTN;Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase);"cytosol [GO:0005829]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";"GO:0004013; GO:0005829; GO:0006730; GO:0033353";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";cytosol [GO:0005829];adenosylhomocysteinase activity [GO:0004013]
comp6176099_c0_seq1;GAXK01008529.1;P0A9Q8;2.60E-58;ADHE_ECO57;"Aldehyde-alcohol dehydrogenase [Includes: Alcohol dehydrogenase (ADH) (EC 1.1.1.1); Acetaldehyde dehydrogenase [acetylating] (ACDH) (EC 1.2.1.10); Pyruvate-formate-lyase deactivase (PFL deactivase)]";"acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; alcohol dehydrogenase (NAD) activity [GO:0004022]; metal ion binding [GO:0046872]; alcohol metabolic process [GO:0006066]; carbon utilization [GO:0015976]";"GO:0004022; GO:0006066; GO:0008774; GO:0015976; GO:0046872";"alcohol metabolic process [GO:0006066]; carbon utilization [GO:0015976]";;"acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; alcohol dehydrogenase (NAD) activity [GO:0004022]; metal ion binding [GO:0046872]"
comp6176409_c0_seq1;GAXK01008530.1;Q69RJ0;1.40E-34;GLTB_ORYSJ;Ferredoxin-dependent glutamate synthase, chloroplastic (EC 1.4.7.1) (Fd-GOGAT);"chloroplast [GO:0009507]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; metal ion binding [GO:0046872]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";"GO:0006537; GO:0009507; GO:0016041; GO:0019676; GO:0046872; GO:0051538; GO:0097054";"ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";chloroplast [GO:0009507];"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; metal ion binding [GO:0046872]"
comp617825_c0_seq1;GAXK01035521.1;Q93112;1.48E-14;GST1C_ANOGA;Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749; GO:0018833";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp6180_c0_seq1;GAXK01100343.1;Q8SX83;3.54E-51;SPEN_DROME;Protein split ends;"nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222]";"GO:0003723; GO:0005634; GO:0006351; GO:0006355; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263";"axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription, DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222]";nucleus [GO:0005634];RNA binding [GO:0003723]
comp618135_c1_seq1;GAXK01136259.1;Q8NDL9;4.89E-80;CBPC5_HUMAN;Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0045171; GO:0051607; GO:0072686";"defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp61821_c1_seq1;GAXK01103264.1;Q9VH90;0;TRBID_DROME;Ubiquitin thioesterase trabid (dTrbd) (EC 3.4.19.12);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]";"GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0016055; GO:0016477; GO:0016579; GO:0030177; GO:0035523; GO:0036459; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:0090263; GO:1990168";"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp61825_c0_seq1;GAXK01103247.1;P13002;3.16E-119;ELF1_DROME;Protein grainyhead (DNA-binding protein ELF-1) (Element I-binding activity) (Protein grainy-head) (Transcription factor NTF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";"GO:0003382; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007402; GO:0007419; GO:0007424; GO:0007426; GO:0007464; GO:0008362; GO:0008543; GO:0035159; GO:0040003; GO:0042052; GO:0042127; GO:0042803; GO:0043565; GO:0045944; GO:0050767; GO:0061024; GO:0061041";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; epithelial cell morphogenesis [GO:0003382]; fibroblast growth factor receptor signaling pathway [GO:0008543]; ganglion mother cell fate determination [GO:0007402]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R3/R4 cell fate commitment [GO:0007464]; regulation of cell population proliferation [GO:0042127]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube length, open tracheal system [GO:0035159]; regulation of wound healing [GO:0061041]; rhabdomere development [GO:0042052]; tracheal outgrowth, open tracheal system [GO:0007426]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp61829_c1_seq1;GAXK01103168.1;Q68F62;9.04E-34;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp61842_c2_seq1;GAXK01103436.1;P0C8L7;6.18E-27;ACBP_HYPDU;Putative acyl-CoA-binding protein (ACBP);"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0008289";;;"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp618508_c1_seq1;GAXK01136307.1;Q0V8T9;9.10E-08;CTP5A_MOUSE;Contactin-associated protein like 5-1 (Cell recognition molecule Caspr5-1) (Cell recognition molecule Caspr5a) (Contactin-associated protein-like 5a);"integral component of membrane [GO:0016021]; aspartic-type endopeptidase activity [GO:0004190]; cell adhesion [GO:0007155]";"GO:0004190; GO:0007155; GO:0016021";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];aspartic-type endopeptidase activity [GO:0004190]
comp6186_c0_seq1;GAXK01100333.1;P82198;3.18E-33;BGH3_MOUSE;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp618660_c2_seq1;GAXK01136276.1;Q5M7N9;9.95E-36;ESYT3_XENTR;Extended synaptotagmin-3 (E-Syt3);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0006869; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0061817; GO:0140268";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp618667_c0_seq1;GAXK01136253.1;P62749;1.45E-24;HPCL1_RAT;Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3);"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp61869_c0_seq1;GAXK01102628.1;Q8N5L8;3.80E-10;RP25L_HUMAN;Ribonuclease P protein subunit p25-like protein (RNase P protein subunit-like p25) (Rpp25-like protein);"nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634";;nucleus [GO:0005634];RNA binding [GO:0003723]
comp61881_c1_seq1;GAXK01103122.1;Q297K8;2.39E-15;JAGN_DROPS;Protein jagunal;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]";"GO:0001555; GO:0005789; GO:0006887; GO:0007029; GO:0007296; GO:0008407; GO:0016021; GO:0022416; GO:0051686";"chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp618877_c0_seq1;GAXK01136250.1;Q0VGE8;1.88E-22;ZN816_HUMAN;Zinc finger protein 816;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6189_c0_seq1;GAXK01101228.1;O01814;1.87E-22;FABP5_CAEEL;Fatty acid-binding protein homolog 5;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504]";"GO:0005504; GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";fatty acid binding [GO:0005504]
comp6190346_c0_seq1;GAXK01007920.1;Q9ET66;1.97E-07;PI16_MOUSE;Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364);"extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]";"GO:0005615; GO:0030414; GO:0061052";negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052];extracellular space [GO:0005615];peptidase inhibitor activity [GO:0030414]
comp6190390_c0_seq1;GAXK01007924.1;Q9VD28;3.98E-10;JMJD6_DROME;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0035212; GO:0043066; GO:0046329; GO:0046872; GO:0070815";"cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp619228_c1_seq1;GAXK01136251.1;P86854;5.50E-19;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp61923_c0_seq1;GAXK01103261.1;Q9NW08;0;RPC2_HUMAN;DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]"
comp619315_c0_seq1;GAXK01136302.1;P0DPW4;7.83E-13;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp6193341_c0_seq1;GAXK01087615.1;P21932;4.84E-14;ADCY3_RAT;Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3);"cilium [GO:0005929]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; single fertilization [GO:0007338]";"GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008294; GO:0008355; GO:0016020; GO:0016021; GO:0030317; GO:0045121; GO:0046872; GO:1904322";"acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; single fertilization [GO:0007338]";"cilium [GO:0005929]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp619350_c1_seq1;GAXK01136279.1;Q95218;7.43E-11;DMBT1_RABIT;Deleted in malignant brain tumors 1 protein (Hensin);"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp6193599_c0_seq1;GAXK01087619.1;Q60519;1.82E-10;SEM5B_MOUSE;Semaphorin-5B (Semaphorin-G) (Sema G);"integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001755; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485; GO:1990138";"axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";integral component of membrane [GO:0016021];"chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]"
comp619369_c0_seq1;GAXK01136294.1;O60237;3.51E-09;MYPT2_HUMAN;Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2);"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]; enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]";"GO:0000086; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672";"G2/M transition of mitotic cell cycle [GO:0000086]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]";"A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]";"enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]"
comp6194_c2_seq1;GAXK01100811.1;A9LMC0;3.25E-55;DPF3_DANRE;Zinc finger protein DPF3;"histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; cardiac muscle tissue morphogenesis [GO:0055008]; chromatin remodeling [GO:0006338]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0006338; GO:0006355; GO:0007399; GO:0008270; GO:0016514; GO:0042393; GO:0045892; GO:0045944; GO:0048644; GO:0055008; GO:0071565";"cardiac muscle tissue morphogenesis [GO:0055008]; chromatin remodeling [GO:0006338]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]"
comp6194249_c0_seq1;GAXK01172196.1;P43140;2.59E-07;ADA1A_RAT;Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);"caveola [GO:0005901]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to drug [GO:0042493]; response to hormone [GO:0009725]";"GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004935; GO:0004937; GO:0005634; GO:0005886; GO:0005887; GO:0005901; GO:0007188; GO:0007200; GO:0007202; GO:0007204; GO:0007512; GO:0007568; GO:0009725; GO:0010460; GO:0010507; GO:0010613; GO:0016020; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0042493; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300";"activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to drug [GO:0042493]; response to hormone [GO:0009725]";"caveola [GO:0005901]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]"
comp61944_c0_seq1;GAXK01103433.1;Q96JL9;2.25E-09;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp619492_c0_seq1;GAXK01136255.1;Q7PEV7;5.46E-18;CL14D_ANOGA;CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-);serine-type endopeptidase activity [GO:0004252];GO:0004252;;;serine-type endopeptidase activity [GO:0004252]
comp6195644_c0_seq1;GAXK01172186.1;Q10462;1.42E-09;CAH5_CAEEL;Putative carbonic anhydrase 5 (EC 4.2.1.1) (Carbonate dehydratase 5);"extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp61958_c1_seq1;GAXK01103245.1;Q9W440;7.71E-33;THEM6_DROME;Protein THEM6;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp61960_c0_seq1;GAXK01102745.1;Q9ULI0;0;ATD2B_HUMAN;ATPase family AAA domain-containing protein 2B;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0031936; GO:0042393; GO:0045944; GO:0070577";"negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]"
comp619666_c0_seq1;GAXK01136290.1;P18745;8.76E-09;ZO22_XENLA;Oocyte zinc finger protein XlCOF22;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp619723_c1_seq1;GAXK01136262.1;Q6DCX5;6.67E-15;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp6198206_c0_seq1;GAXK01085155.1;Q95SX7;4.32E-10;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp6198333_c0_seq1;GAXK01085151.1;P40903;2.78E-12;ISP6_SCHPO;Sexual differentiation process putative subtilase-type proteinase isp6 (EC 3.4.21.-);"extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; Golgi apparatus [GO:0005794]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; autophagy [GO:0006914]; conjugation with cellular fusion [GO:0000747]; vacuole organization [GO:0007033]";"GO:0000324; GO:0000747; GO:0004175; GO:0004252; GO:0005615; GO:0005794; GO:0006914; GO:0007033; GO:0008233";"autophagy [GO:0006914]; conjugation with cellular fusion [GO:0000747]; vacuole organization [GO:0007033]";"extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; Golgi apparatus [GO:0005794]";"endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp61988_c0_seq1;GAXK01103289.1;P59331;3.28E-69;HCHA_ECOL6;Protein/nucleic acid deglycase HchA (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase);"cytoplasm [GO:0005737]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; protein deglycase activity [GO:0036524]; thiolester hydrolase activity [GO:0016790]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]";"GO:0005737; GO:0006281; GO:0008270; GO:0016790; GO:0016811; GO:0036524";DNA repair [GO:0006281];cytoplasm [GO:0005737];"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; protein deglycase activity [GO:0036524]; thiolester hydrolase activity [GO:0016790]; zinc ion binding [GO:0008270]"
comp619954_c0_seq1;GAXK01136311.1;Q26622;8.37E-13;SHR2_STRPU;Orphan steroid hormone receptor 2 (SpSHR2);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp620_c19_seq1;GAXK01168462.1;Q6DIR8;8.22E-17;PALD_XENTR;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp6200_c0_seq1;GAXK01100468.1;P80728;1.43E-10;MAVI_CUCPE;Mavicyanin;"electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]";"GO:0009055; GO:0046872";;;"electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"
comp6200060_c0_seq1;GAXK01197459.1;Q0DK10;1.06E-51;RL11_ORYSJ;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp620018_c0_seq1;GAXK01189451.1;Q08874;1.51E-15;MITF_MOUSE;Microphthalmia-associated transcription factor;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141";"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp62008_c0_seq1;GAXK01171302.1;O95631;0;NET1_HUMAN;Netrin-1 (Epididymis tissue protein Li 131P);"basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of netrin-activated signaling pathway [GO:1902842]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]";"GO:0001764; GO:0005576; GO:0005604; GO:0005737; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0008045; GO:0008284; GO:0009887; GO:0009888; GO:0016358; GO:0030334; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060603; GO:0061643; GO:0098609; GO:1902842; GO:2000147";"animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of netrin-activated signaling pathway [GO:1902842]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]";
comp62010_c0_seq1;GAXK01171522.1;P42282;1.91E-44;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp62026_c2_seq1;GAXK01171989.1;Q76LW2;5.58E-85;H6ST2_CHICK;Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (cHS6ST-2) (EC 2.8.2.-);"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]";"GO:0005654; GO:0015015; GO:0016021; GO:0017095; GO:0060173";"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";heparan sulfate 6-O-sulfotransferase activity [GO:0017095]
comp620296_c1_seq1;GAXK01204921.1;Q7KRI2;7.13E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp620364_c3_seq1;GAXK01189457.1;O35604;0;NPC1_MOUSE;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp6204114_c0_seq1;GAXK01190852.1;P13115;2.38E-10;SRC1_XENLA;Tyrosine-protein kinase Src-1 (EC 2.7.10.2) (p60-Src-1);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524; GO:0005886";;plasma membrane [GO:0005886];"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp62044_c0_seq1;GAXK01171456.1;Q0P5H8;1.28E-10;HERP2_BOVIN;Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein;"integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]";"GO:0007283; GO:0016021; GO:0030968";"endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]";integral component of membrane [GO:0016021];
comp6205381_c0_seq1;GAXK01190847.1;Q4VBJ9;4.09E-07;MORN5_DANRE;MORN repeat-containing protein 5;;;;;
comp620545_c0_seq1;GAXK01189521.1;Q49AA0;8.64E-08;ZFP69_HUMAN;Zinc finger protein 69 homolog (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp62056_c1_seq1;GAXK01171716.1;P55201;3.09E-157;BRPF1_HUMAN;Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0043966; GO:0043972; GO:0045893; GO:0046872; GO:0070776; GO:1901796";"histone H3 acetylation [GO:0043966]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp620641_c0_seq1;GAXK01189476.1;P9WK86;4.27E-25;NLHH_MYCTO;Carboxylesterase NlhH (EC 3.1.1.1);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp62068_c0_seq1;GAXK01171718.1;Q9VFC8;0;GYS_DROME;Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase);"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]";"GO:0004373; GO:0005737; GO:0005776; GO:0005977; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0045819; GO:0061723; GO:0071329";"cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]";"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]";glycogen (starch) synthase activity [GO:0004373]
comp6206857_c0_seq1;GAXK01149105.1;Q3J827;5.37E-61;TPIS_NITOC;Triosephosphate isomerase (TIM) (TPI) (EC 5.3.1.1) (Triose-phosphate isomerase);"cytoplasm [GO:0005737]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004807; GO:0005737; GO:0006094; GO:0006096";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];triose-phosphate isomerase activity [GO:0004807]
comp62075_c1_seq1;GAXK01171480.1;Q9P2K3;1.28E-114;RCOR3_HUMAN;REST corepressor 3;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]";"GO:0000981; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0008134; GO:0017053; GO:0044212";;"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp620757_c0_seq1;GAXK01189501.1;Q8CIF6;2.86E-84;SIDT2_MOUSE;SID1 transmembrane family member 2;"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033]; cell morphogenesis [GO:0000902]; dsRNA transport [GO:0033227]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342]";"GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0016021; GO:0033227; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178";"cell morphogenesis [GO:0000902]; dsRNA transport [GO:0033227]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033]"
comp620829_c0_seq1;GAXK01189522.1;Q94981;1.41E-32;ARI1_DROME;Potential E3 ubiquitin-protein ligase ariadne-1 (EC 2.3.2.31) (Protein ariadne-1) (Ari-1) (RING-type E3 ubiquitin transferase ariadne-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endoplasmic reticulum organization [GO:0007029]; oogenesis [GO:0048477]; positive regulation of neurogenesis [GO:0050769]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0006513; GO:0007029; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0042803; GO:0046983; GO:0048477; GO:0050769; GO:0061630; GO:1901800";"endoplasmic reticulum organization [GO:0007029]; oogenesis [GO:0048477]; positive regulation of neurogenesis [GO:0050769]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp6208447_c0_seq1;GAXK01098316.1;Q5R9A7;9.62E-18;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp6208744_c0_seq1;GAXK01098313.1;Q5FYB0;7.76E-15;ARSJ_HUMAN;Arylsulfatase J (ASJ) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp6208747_c0_seq1;GAXK01098315.1;Q96N20;1.02E-10;ZN75A_HUMAN;Zinc finger protein 75A;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp62089_c0_seq1;GAXK01171454.1;Q0R4F1;0;PIF1_XENLA;ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]";"GO:0000002; GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp62094_c1_seq1;GAXK01171514.1;Q497B0;4.34E-140;NIT2_RAT;Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2);"centrosome [GO:0005813]; cytosol [GO:0005829]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]";"GO:0005813; GO:0005829; GO:0006107; GO:0006528; GO:0006541; GO:0050152";"asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]";"centrosome [GO:0005813]; cytosol [GO:0005829]";omega-amidase activity [GO:0050152]
comp620943_c0_seq1;GAXK01189513.1;Q14BI2;1.19E-50;GRM2_MOUSE;Metabotropic glutamate receptor 2 (mGluR2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0051966; GO:0090461; GO:0099055";"chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]";"calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp62095_c1_seq1;GAXK01171501.1;P34568;1.03E-15;BAT43_CAEEL;BTB and MATH domain-containing protein 43 (HIB homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp62096_c0_seq1;GAXK01171918.1;P31483;7.30E-78;TIA1_HUMAN;Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0008543; GO:0010494; GO:0017148; GO:0035925; GO:0042036; GO:0048024; GO:0097165; GO:1903608; GO:1904037";"apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]";"mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]"
comp62098_c0_seq1;GAXK01172118.1;O22527;2.74E-15;CLH1_ARATH;Chlorophyllase-1 (AtCLH1) (EC 3.1.1.14) (Chlorophyll-chlorophyllido hydrolase 1) (Chlase 1) (Coronatine-induced protein 1) (CORI1);"nucleus [GO:0005634]; vacuole [GO:0005773]; chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]; chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"GO:0005634; GO:0005773; GO:0015996; GO:0042742; GO:0047746; GO:0050832; GO:0102293";"chlorophyll catabolic process [GO:0015996]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]";"nucleus [GO:0005634]; vacuole [GO:0005773]";"chlorophyllase activity [GO:0047746]; pheophytinase b activity [GO:0102293]"
comp6210_c2_seq1;GAXK01100175.1;Q9H3K2;5.44E-103;GHITM_HUMAN;Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]";"GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062";apoptotic process [GO:0006915];"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp6210713_c0_seq1;GAXK01190360.1;Q29043;5.37E-07;FUT1_PIG;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp6211824_c0_seq1;GAXK01190355.1;Q05481;4.38E-07;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp62124_c1_seq1;GAXK01171617.1;Q6DJ55;6.00E-47;FAKD4_XENTR;FAST kinase domain-containing protein 4 (Protein TBRG4) (Transforming growth factor beta regulator 4);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528]";"GO:0004672; GO:0005739; GO:0005759; GO:0016071; GO:0044528; GO:0090615";"mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";protein kinase activity [GO:0004672]
comp62127_c2_seq1;GAXK01171932.1;Q9GRW0;2.08E-30;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp62129_c0_seq1;GAXK01171638.1;Q7LBC6;3.21E-65;KDM3B_HUMAN;Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA);"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718";"histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]";"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp621329_c1_seq1;GAXK01189489.1;Q6ZNA1;1.11E-57;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6214108_c0_seq1;GAXK01060424.1;Q01369;4.18E-52;GBLP_NEUCR;Guanine nucleotide-binding protein subunit beta-like protein (Cross-pathway control WD-repeat protein cpc-2);"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]";"GO:0001934; GO:0005080; GO:0005634; GO:0005829; GO:0019899; GO:0022627; GO:0043022; GO:0072344";"positive regulation of protein phosphorylation [GO:0001934]; rescue of stalled ribosome [GO:0072344]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]"
comp62148_c1_seq1;GAXK01172092.1;A2ALS5;8.64E-123;RPGP1_MOUSE;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792";"cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]";"GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp621498_c0_seq1;GAXK01189477.1;P24044;9.01E-35;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp621520_c0_seq1;GAXK01189516.1;Q7KRI2;4.75E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp62154_c20_seq1;GAXK01171681.1;Q52PJ5;4.84E-159;DPYL3_DANRE;Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4);"cytosol [GO:0005829]; growth cone [GO:0030426]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"GO:0005829; GO:0007409; GO:0007411; GO:0010975; GO:0016810; GO:0030334; GO:0030426; GO:0048678; GO:0048936; GO:0051017; GO:0051491; GO:0051764";"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell migration [GO:0030334]; regulation of neuron projection development [GO:0010975]; response to axon injury [GO:0048678]";"cytosol [GO:0005829]; growth cone [GO:0030426]";hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]
comp621556_c0_seq1;GAXK01189464.1;Q7PWV1;3.90E-18;AQP_ANOGA;Aquaporin AQPAn.G;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]";"GO:0005886; GO:0015250; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";water channel activity [GO:0015250]
comp62157_c0_seq1;GAXK01172019.1;Q148G4;8.51E-110;TATD1_BOVIN;Putative deoxyribonuclease TATDN1 (EC 3.1.21.-);"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]";"GO:0005654; GO:0008296; GO:0016888; GO:0046872";;nucleoplasm [GO:0005654];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
comp62163_c1_seq1;GAXK01171990.1;Q9EPU7;1.92E-21;Z354C_RAT;Zinc finger protein 354C (Protein AJ18);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp6216649_c0_seq1;GAXK01049216.1;A2SL50;5.01E-37;Y3336_METPP;Nucleotide-binding protein Mpe_A3336;"ATP binding [GO:0005524]; GTP binding [GO:0005525]";"GO:0005524; GO:0005525";;;"ATP binding [GO:0005524]; GTP binding [GO:0005525]"
comp6216984_c0_seq1;GAXK01049218.1;P17970;2.85E-61;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp6217728_c0_seq1;GAXK01049214.1;P10056;3.45E-11;PAPA3_CARPA;Caricain (EC 3.4.22.30) (Papaya peptidase A) (Papaya proteinase III) (PPIII) (Papaya proteinase omega);cysteine-type peptidase activity [GO:0008234];GO:0008234;;;cysteine-type peptidase activity [GO:0008234]
comp62181_c1_seq1;GAXK01171745.1;Q5RJY2;5.26E-19;G2E3_MOUSE;G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0001824; GO:0005730; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243";"apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp621825_c1_seq1;GAXK01189510.1;A2AVA0;0;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp621892_c0_seq1;GAXK01189555.1;Q86MW9;1.36E-15;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp6219380_c0_seq1;GAXK01046518.1;Q9JME2;9.28E-10;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp6219469_c0_seq1;GAXK01046515.1;P10401;2.17E-12;POLY_DROME;"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp622011_c1_seq1;GAXK01171138.1;Q05481;2.33E-38;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp622026_c1_seq1;GAXK01171045.1;A7Y7X5;4.90E-15;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp62211_c1_seq1;GAXK01205904.1;Q91727;3.74E-114;CDK4_XENLA;Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4);"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";;"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp62220_c0_seq1;GAXK01171340.1;P62070;3.02E-85;RRAS2_HUMAN;Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]";"GO:0001649; GO:0003924; GO:0005525; GO:0005783; GO:0005886; GO:0005925; GO:0007265; GO:0016020; GO:0019003; GO:0030335; GO:0070062; GO:1901214";"osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp62223_c0_seq1;GAXK01171739.1;Q24248;5.40E-45;ARA_DROME;Homeobox protein araucan;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; dendrite morphogenesis [GO:0048813]; equator specification [GO:0045317]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; notum cell fate specification [GO:0035310]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000981; GO:0001745; GO:0005634; GO:0005737; GO:0007474; GO:0007476; GO:0035310; GO:0042693; GO:0043565; GO:0045317; GO:0045893; GO:0045926; GO:0045944; GO:0048813";"compound eye morphogenesis [GO:0001745]; dendrite morphogenesis [GO:0048813]; equator specification [GO:0045317]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; notum cell fate specification [GO:0035310]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp6222328_c0_seq1;GAXK01028538.1;Q8IVG5;5.33E-07;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp62226_c0_seq1;GAXK01171303.1;Q6GNL7;0;AL1L1_XENLA;Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1);"cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]";"GO:0005737; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016620; GO:0016742";"10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]";cytoplasm [GO:0005737];"formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"
comp6222963_c0_seq1;GAXK01028535.1;P94325;1.50E-66;CISY_BRADU;Citrate synthase (EC 2.3.3.16);"cytoplasm [GO:0005737]; citrate (Si)-synthase activity [GO:0004108]; tricarboxylic acid cycle [GO:0006099]";"GO:0004108; GO:0005737; GO:0006099";tricarboxylic acid cycle [GO:0006099];cytoplasm [GO:0005737];citrate (Si)-synthase activity [GO:0004108]
comp6223_c2_seq1;GAXK01101248.1;P37141;7.54E-44;GPX3_BOVIN;Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P);"extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; hydrogen peroxide catabolic process [GO:0042744]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0004602; GO:0005615; GO:0006979; GO:0008430; GO:0042744; GO:0051289";"hydrogen peroxide catabolic process [GO:0042744]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]"
comp6223261_c0_seq1;GAXK01028541.1;Q60755;1.84E-16;CALCR_MOUSE;Calcitonin receptor (CT-R);"acrosomal vesicle [GO:0001669]; amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; cilium [GO:0005929]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; amylin receptor activity [GO:0097643]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; negative regulation of ossification [GO:0030279]; osteoclast differentiation [GO:0030316]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of mRNA stability [GO:0043488]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384]";"GO:0001635; GO:0001669; GO:0004948; GO:0005929; GO:0007166; GO:0007188; GO:0007189; GO:0007204; GO:0010628; GO:0010739; GO:0010942; GO:0030279; GO:0030316; GO:0030424; GO:0032841; GO:0033138; GO:0038041; GO:0043005; GO:0043025; GO:0043488; GO:0045762; GO:0051384; GO:0051897; GO:0070374; GO:0097643; GO:0097647; GO:0150056; GO:0150057; GO:0150058; GO:1904645; GO:1905665";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; negative regulation of ossification [GO:0030279]; osteoclast differentiation [GO:0030316]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of mRNA stability [GO:0043488]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384]";"acrosomal vesicle [GO:0001669]; amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; cilium [GO:0005929]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";"amylin receptor activity [GO:0097643]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]"
comp622332_c0_seq1;GAXK01171144.1;P52192;6.74E-89;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp622631_c0_seq1;GAXK01171137.1;P52746;4.06E-19;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6226687_c0_seq1;GAXK01179609.1;Q9QZ85;2.83E-12;IIGP1_MOUSE;Interferon-inducible GTPase 1 (EC 3.6.5.-);"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829";"cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]";"endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp6227657_c0_seq1;GAXK01179614.1;P03360;2.61E-07;POL_AVIRE;"Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";;"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp622836_c0_seq1;GAXK01171083.1;A7MBI1;1.83E-19;ZFP69_BOVIN;Zinc finger protein 69 homolog (Zinc finger protein 642);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]";"GO:0003677; GO:0003700; GO:0005634; GO:0006629; GO:0019216; GO:0046872";"lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp622907_c1_seq1;GAXK01171142.1;O94806;9.58E-85;KPCD3_HUMAN;Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700";"protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp62291_c0_seq1;GAXK01171477.1;P52948;2.44E-18;NUP98_HUMAN;"Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]";"cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016032; GO:0016604; GO:0016925; GO:0017056; GO:0019083; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0043231; GO:0043657; GO:0044614; GO:0044615; GO:0048026; GO:0051292; GO:0060964; GO:0075733; GO:1900034; GO:1990841; GO:1990904";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]"
comp6229503_c0_seq1;GAXK01105255.1;Q86BJ3;3.60E-15;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp622960_c0_seq1;GAXK01171042.1;Q19978;5.52E-20;BST14_CAEEL;Bestrophin homolog 14;"chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]";"GO:0005254; GO:0034707";;chloride channel complex [GO:0034707];chloride channel activity [GO:0005254]
comp6230169_c0_seq1;GAXK01001384.1;O15084;4.54E-08;ANR28_HUMAN;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]";"GO:0000139; GO:0005654; GO:0005829; GO:0048208";COPII vesicle coating [GO:0048208];"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]";
comp6230601_c0_seq1;GAXK01001387.1;P98158;1.43E-07;LRP2_RAT;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007568; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0038023; GO:0042493; GO:0042562; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0060068; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447";"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]"
comp6232_c0_seq1;GAXK01100470.1;O17389;4.43E-15;TYB_CAEEL;Thymosin beta (Tetrathymosin beta);"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]";"GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054";actin filament organization [GO:0007015];"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";actin monomer binding [GO:0003785]
comp62323_c0_seq1;GAXK01171741.1;P35063;2.77E-14;H2AX_PICAB;Histone H2AX;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp6233_c0_seq1;GAXK01100443.1;Q9Y2P8;8.57E-153;RCL1_HUMAN;RNA 3'-terminal phosphate cyclase-like protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]";"GO:0000447; GO:0000480; GO:0004521; GO:0005654; GO:0005730; GO:0006364";"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";endoribonuclease activity [GO:0004521]
comp623406_c0_seq1;GAXK01171136.1;Q1LX51;5.70E-29;WEE2_DANRE;Wee1-like protein kinase 2 (EC 2.7.10.2) (Wee1-like protein kinase 1B) (Wee1B kinase);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; regulation of meiosis I [GO:0060631]";"GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0007093; GO:0051321; GO:0060631";"meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; regulation of meiosis I [GO:0060631]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp62344_c0_seq1;GAXK01172150.1;Q682U6;3.05E-10;DPD1_ARATH;Exonuclease DPD1, chloroplastic/mitochondrial (EC 3.1.11.-) (Mg2+-dependent DNA exonuclease) (Protein DEFECTIVE IN POLLEN DNA DEGRADATION 1);"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; plastid [GO:0009536]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]";"GO:0000738; GO:0003676; GO:0004527; GO:0005739; GO:0009507; GO:0009536; GO:0046872";DNA catabolic process, exonucleolytic [GO:0000738];"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; plastid [GO:0009536]";"exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp62350_c0_seq1;GAXK01171339.1;B3MF31;1.73E-169;ANM7_DROAN;Protein arginine N-methyltransferase 7 (EC 2.1.1.-);"protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; peptidyl-arginine methylation [GO:0018216]";"GO:0018216; GO:0035243";peptidyl-arginine methylation [GO:0018216];;protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]
comp623548_c0_seq1;GAXK01171121.1;Q8JFZ2;4.17E-12;GSTP1_XENLA;Glutathione S-transferase P 1 (EC 2.5.1.18) (GST class-pi) (GST-Pi) (XlGSTP1-1);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005634; GO:0005739; GO:0006749";glutathione metabolic process [GO:0006749];"mitochondrion [GO:0005739]; nucleus [GO:0005634]";glutathione transferase activity [GO:0004364]
comp623667_c0_seq1;GAXK01171050.1;Q0VGW6;0;S12A9_XENLA;Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0005886; GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp6237348_c0_seq1;GAXK01030333.1;P32176;1.78E-55;FDOG_ECOLI;Formate dehydrogenase-O major subunit (EC 1.17.1.9) (Aerobic formate dehydrogenase major subunit) (FDH-Z subunit alpha) (Formate dehydrogenase-O subunit alpha);"cytosol [GO:0005829]; formate dehydrogenase complex [GO:0009326]; membrane [GO:0016020]; periplasmic space [GO:0042597]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; formate dehydrogenase (cytochrome-c-553) activity [GO:0047111]; formate dehydrogenase (NAD+) activity [GO:0008863]; formate dehydrogenase (quinone) activity [GO:0036397]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; cellular respiration [GO:0045333]; cellular response to DNA damage stimulus [GO:0006974]; formate oxidation [GO:0015944]";"GO:0005829; GO:0006974; GO:0008863; GO:0009055; GO:0009326; GO:0015944; GO:0016020; GO:0036397; GO:0042597; GO:0043546; GO:0045333; GO:0046872; GO:0047111; GO:0051539";"cellular respiration [GO:0045333]; cellular response to DNA damage stimulus [GO:0006974]; formate oxidation [GO:0015944]";"cytosol [GO:0005829]; formate dehydrogenase complex [GO:0009326]; membrane [GO:0016020]; periplasmic space [GO:0042597]";"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; formate dehydrogenase (cytochrome-c-553) activity [GO:0047111]; formate dehydrogenase (NAD+) activity [GO:0008863]; formate dehydrogenase (quinone) activity [GO:0036397]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]"
comp6237524_c0_seq1;GAXK01030336.1;P42787;1.94E-21;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp62402_c2_seq1;GAXK01171279.1;Q5SQH8;1.46E-13;CF136_HUMAN;Uncharacterized protein C6orf136;;;;;
comp62427_c1_seq1;GAXK01171890.1;Q5TYV4;6.39E-37;SPE39_DANRE;Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008";"cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]";
comp6243970_c0_seq1;GAXK01051083.1;Q9JJ00;2.40E-16;PLS1_MOUSE;Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Transplantability-associated protein 1) (NOR1) (TRA1);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]";"GO:0001228; GO:0003677; GO:0005154; GO:0005509; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0010628; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032091; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045944; GO:0048471; GO:0051607; GO:0060368; GO:0062023; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:2000373";"acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]"
comp6244_c1_seq1;GAXK01100804.1;Q99323;0;MYSN_DROME;Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein);"actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]";"GO:0000281; GO:0001736; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005856; GO:0005929; GO:0005938; GO:0006936; GO:0007297; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016318; GO:0016460; GO:0016461; GO:0030018; GO:0030239; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045179; GO:0045200; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0106037; GO:1901739; GO:1903688";"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]";"actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp6244946_c0_seq1;GAXK01138055.1;Q6P2D0;2.83E-09;ZFP1_HUMAN;Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6245428_c0_seq1;GAXK01138053.1;P92939;5.32E-106;ECA1_ARATH;Calcium-transporting ATPase 1, endoplasmic reticulum-type (EC 7.2.2.10);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transport [GO:0006816]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]";"GO:0005388; GO:0005524; GO:0005576; GO:0005774; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0008553; GO:0010042; GO:0030176; GO:0046686; GO:0046872";"calcium ion transport [GO:0006816]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp62458_c0_seq1;GAXK01171933.1;Q9M2P4;1.71E-28;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp62467_c4_seq1;GAXK01171894.1;F7J220;1.44E-12;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp624752_c0_seq1;GAXK01076341.1;P10074;3.07E-19;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp62476_c0_seq1;GAXK01171403.1;Q03173;2.43E-51;ENAH_MOUSE;Protein enabled homolog (NPC-derived proline-rich protein 1) (NDPP-1);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; neural tube closure [GO:0001843]";"GO:0001725; GO:0001843; GO:0003779; GO:0005522; GO:0005829; GO:0005886; GO:0005925; GO:0007015; GO:0007411; GO:0008154; GO:0015629; GO:0017124; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358; GO:1990830";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization-dependent cell motility [GO:0070358]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; neural tube closure [GO:0001843]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]";"actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]"
comp6248_c1_seq1;GAXK01100049.1;Q5R7Z5;1.61E-92;MARE1_PONAB;Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1);"cortical microtubule cytoskeleton [GO:0030981]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of microtubule polymerization [GO:0031115]; protein localization to microtubule [GO:0035372]";"GO:0005815; GO:0005874; GO:0007049; GO:0030981; GO:0031115; GO:0035372; GO:0051010; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of microtubule polymerization [GO:0031115]; protein localization to microtubule [GO:0035372]";"cortical microtubule cytoskeleton [GO:0030981]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]";microtubule plus-end binding [GO:0051010]
comp6248192_c0_seq1;GAXK01009525.1;P51427;1.27E-60;RS52_ARATH;40S ribosomal protein S5-2 (AtRPS5A) (Protein ARABIDOPSIS MINUTE-LIKE 1);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0005618; GO:0005773; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0019843; GO:0022626; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp6248357_c0_seq1;GAXK01009522.1;P06206;2.53E-12;CRP4_LIMPO;C-reactive protein 1.4;"extracellular region [GO:0005576]; metal ion binding [GO:0046872]";"GO:0005576; GO:0046872";;extracellular region [GO:0005576];metal ion binding [GO:0046872]
comp62487_c0_seq1;GAXK01171482.1;O95573;0;ACSL3_HUMAN;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp62495_c1_seq1;GAXK01171423.1;P30279;2.40E-40;CCND2_HUMAN;G1/S-specific cyclin-D2;"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp62497_c0_seq1;GAXK01171923.1;Q90669;1.74E-156;AVR2A_CHICK;Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA);"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type II [GO:0005026]; transforming growth factor beta-activated receptor activity [GO:0005024]; type I transforming growth factor beta receptor binding [GO:0034713]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesodermal cell differentiation [GO:0048333]; pattern specification process [GO:0007389]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001702; GO:0005024; GO:0005026; GO:0005524; GO:0005737; GO:0005887; GO:0007179; GO:0007283; GO:0007368; GO:0007389; GO:0008283; GO:0009798; GO:0009952; GO:0009986; GO:0010862; GO:0015026; GO:0016020; GO:0017002; GO:0019838; GO:0030165; GO:0030501; GO:0032924; GO:0032927; GO:0034673; GO:0034711; GO:0034713; GO:0042713; GO:0043084; GO:0043235; GO:0043621; GO:0045648; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048333; GO:0048706; GO:0050999; GO:0060011; GO:0098821";"activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesodermal cell differentiation [GO:0048333]; pattern specification process [GO:0007389]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; sperm ejaculation [GO:0042713]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235]";"activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; type I transforming growth factor beta receptor binding [GO:0034713]"
comp62501_c0_seq1;GAXK01171337.1;Q8C3P7;4.22E-170;MTA70_MOUSE;N6-adenosine-methyltransferase subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]";"GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006382; GO:0006397; GO:0006402; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016422; GO:0016556; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0051445; GO:0060339; GO:0061157; GO:0080009; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990744";"adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";"mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]"
comp625010_c0_seq1;GAXK01076283.1;Q6P9Q4;1.50E-15;FHOD1_MOUSE;FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1);"bleb [GO:0032059]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; nucleus [GO:0005634]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001725; GO:0003779; GO:0005634; GO:0005829; GO:0007097; GO:0014704; GO:0019904; GO:0032059; GO:0042802; GO:0043621; GO:0045944; GO:0051496; GO:0051660";"establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"bleb [GO:0032059]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; nucleus [GO:0005634]; stress fiber [GO:0001725]";"actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]"
comp6251054_c0_seq1;GAXK01042671.1;P16939;1.24E-07;YIS1_SHISO;Insertion element IS600 uncharacterized 11 kDa protein (ISO-S3 11 kDa protein);"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0006313";transposition, DNA-mediated [GO:0006313];;"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp625188_c1_seq1;GAXK01076313.1;Q9LW44;1.08E-15;MANP_ARATH;Putative mannan endo-1,4-beta-mannosidase P (EC 3.2.1.78) (Beta-mannanase P) (Endo-beta-1,4-mannanase P) (AtMANP);"extracellular region [GO:0005576]; mannan endo-1,4-beta-mannosidase activity [GO:0016985]; carbohydrate metabolic process [GO:0005975]";"GO:0005576; GO:0005975; GO:0016985";carbohydrate metabolic process [GO:0005975];extracellular region [GO:0005576];mannan endo-1,4-beta-mannosidase activity [GO:0016985]
comp625245_c1_seq1;GAXK01076312.1;O15213;6.87E-21;WDR46_HUMAN;WD repeat-containing protein 46 (WD repeat-containing protein BING4);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp625325_c2_seq1;GAXK01076360.1;Q28262;1.22E-44;PAFA_CANLF;Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase);"extracellular space [GO:0005615]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]";"GO:0003847; GO:0005615; GO:0016042";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]
comp625345_c0_seq1;GAXK01076337.1;Q11002;4.91E-115;CANA_DROME;Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832";"cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp625361_c0_seq1;GAXK01076253.1;Q28BL7;2.02E-59;PO2F1_XENTR;POU domain, class 2, transcription factor 1 (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007219; GO:0042981; GO:0043565; GO:0045893; GO:0045944; GO:0060019";"Notch signaling pathway [GO:0007219]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp625395_c0_seq1;GAXK01076355.1;A6QLU5;1.62E-19;ZN184_BOVIN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6255404_c0_seq1;GAXK01159055.1;P14381;4.22E-09;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp62559_c0_seq1;GAXK01172151.1;Q9VBV3;6.88E-16;TAKT_DROME;Protein takeout;"extracellular region [GO:0005576]; extracellular space [GO:0005615]; adult feeding behavior [GO:0008343]; behavioral response to starvation [GO:0042595]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; response to starvation [GO:0042594]; rhythmic behavior [GO:0007622]";"GO:0005576; GO:0005615; GO:0007617; GO:0007622; GO:0007623; GO:0007631; GO:0008049; GO:0008343; GO:0042594; GO:0042595";"adult feeding behavior [GO:0008343]; behavioral response to starvation [GO:0042595]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; response to starvation [GO:0042594]; rhythmic behavior [GO:0007622]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";
comp625707_c0_seq1;GAXK01076350.1;C1C4M8;6.25E-60;MTNB_LITCT;Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog);"cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";"GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570";"apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]";cytoplasm [GO:0005737];"methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]"
comp62585_c0_seq1;GAXK01171352.1;Q8CHS8;1.34E-08;VP37A_MOUSE;Vacuolar protein sorting-associated protein 37A (Vps37A) (ESCRT-I complex subunit VPS37A);"centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0031902; GO:0032509; GO:0043162; GO:0043231";"endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]";
comp6258904_c0_seq1;GAXK01163605.1;P14381;4.46E-13;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp62594_c0_seq1;GAXK01171595.1;Q9VR99;0;CATIN_DROME;Cactin (Cactus-interacting protein);"catalytic step 2 spliceosome [GO:0071013]; RNA binding [GO:0003723]; dorsal/ventral axis specification [GO:0009950]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of Toll signaling pathway [GO:0045752]";"GO:0000398; GO:0003723; GO:0009950; GO:0045752; GO:0071013";"dorsal/ventral axis specification [GO:0009950]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of Toll signaling pathway [GO:0045752]";catalytic step 2 spliceosome [GO:0071013];RNA binding [GO:0003723]
comp62598_c0_seq1;GAXK01172077.1;P97931;8.82E-100;UNG_MOUSE;Uracil-DNA glycosylase (UDG) (EC 3.2.2.27);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]";"GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016446; GO:0016447; GO:0043024; GO:0043066; GO:0045190; GO:0097510";"base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]"
comp625984_c2_seq1;GAXK01076362.1;Q39493;1.79E-10;DSK1_CYLFU;Diatom spindle kinesin-1;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp625999_c0_seq1;GAXK01076343.1;P36609;2.57E-09;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp626_c0_seq1;GAXK01169232.1;X1WGX5;1.45E-117;PUM3_DANRE;Pumilio homolog 3;"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; germ cell migration [GO:0008354]";"GO:0003677; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008354";germ cell migration [GO:0008354];"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp626014_c0_seq1;GAXK01028941.1;Q7KRI2;1.40E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp62602_c3_seq1;GAXK01171528.1;Q7KRI2;1.34E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp626038_c0_seq1;GAXK01028863.1;Q28Z18;3.47E-75;SETB1_DROPS;Histone-lysine N-methyltransferase eggless (EC 2.1.1.43) (SETDB1 homolog);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038";"multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]"
comp6261867_c0_seq1;GAXK01079860.1;Q3MJ62;1.29E-10;ZSC23_HUMAN;Zinc finger and SCAN domain-containing protein 23 (Zinc finger protein 390) (Zinc finger protein 453);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6262_c1_seq1;GAXK01100520.1;Q8BFR5;9.48E-97;EFTU_MOUSE;Elongation factor Tu, mitochondrial;"mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0006414; GO:0042645; GO:0043209; GO:0045202; GO:0045471; GO:0070125";"mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]";"mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp626274_c0_seq1;GAXK01028915.1;Q8R0T2;2.04E-11;ZN768_MOUSE;Zinc finger protein 768;"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0005665; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];RNA polymerase II, core complex [GO:0005665];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp626304_c0_seq1;GAXK01028936.1;P52746;1.59E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp62632_c2_seq1;GAXK01171667.1;W4VS53;2.84E-37;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp626324_c0_seq1;GAXK01028872.1;Q5RFR0;1.83E-42;TTPAL_PONAB;Alpha-tocopherol transfer protein-like;;;;;
comp626341_c2_seq1;GAXK01028876.1;Q08890;4.70E-102;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp6263508_c0_seq1;GAXK01086737.1;P23818;5.22E-10;GRIA1_MOUSE;Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1);"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; myosin V binding [GO:0031489]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to toxic substance [GO:0009636]";"GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007616; GO:0008021; GO:0008022; GO:0008179; GO:0008328; GO:0009636; GO:0009986; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0030165; GO:0030425; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032590; GO:0032591; GO:0032991; GO:0036477; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045838; GO:0048167; GO:0050804; GO:0050806; GO:0051018; GO:0055037; GO:0055038; GO:0060076; GO:0060078; GO:0060292; GO:0097060; GO:0097110; GO:0098794; GO:0098839; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:0099583; GO:1904315";"chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to toxic substance [GO:0009636]";"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]";"adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; myosin V binding [GO:0031489]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp62637_c0_seq1;GAXK01172082.1;Q8R3C6;1.44E-152;RBM19_MOUSE;Probable RNA-binding protein 19 (RNA-binding motif protein 19);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016607; GO:0040019; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp62641_c1_seq1;GAXK01172016.1;P84770;3.77E-36;IRS1B_XENLA;Insulin receptor substrate 1-B (IRS1-B) (xIRS-1-B) (XIRS-L');"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]";"GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0008286; GO:0042169; GO:0043231; GO:0043548; GO:0048009";"insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";"insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]"
comp626438_c0_seq1;GAXK01028885.1;P06027;2.19E-10;LECE_HELCR;Echinoidin;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp6265_c0_seq1;GAXK01100070.1;P42765;1.64E-165;THIM_HUMAN;3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109";"cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]"
comp626527_c1_seq1;GAXK01028864.1;P35789;3.07E-26;ZNF93_HUMAN;Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp6266_c0_seq1;GAXK01100625.1;Q8WYQ3;1.74E-10;CHC10_HUMAN;Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (Protein N27C7-4);"MICOS complex [GO:0061617]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; maintenance of synapse structure [GO:0099558]; mitochondrial nucleoid organization [GO:0090144]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; positive regulation of cristae formation [GO:1903852]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to nucleus [GO:0034504]; protein-containing complex disassembly [GO:0032984]; stabilization of membrane potential [GO:0030322]";"GO:0005634; GO:0005739; GO:0005758; GO:0006119; GO:0007005; GO:0030322; GO:0032984; GO:0034504; GO:0061617; GO:0090144; GO:0090200; GO:0099558; GO:1901030; GO:1903109; GO:1903852; GO:1904960";"maintenance of synapse structure [GO:0099558]; mitochondrial nucleoid organization [GO:0090144]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; positive regulation of cristae formation [GO:1903852]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein-containing complex disassembly [GO:0032984]; protein localization to nucleus [GO:0034504]; stabilization of membrane potential [GO:0030322]";"MICOS complex [GO:0061617]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";
comp626703_c1_seq1;GAXK01028890.1;P50429;5.65E-97;ARSB_MOUSE;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065";"anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp62682_c1_seq1;GAXK01171882.1;Q99633;2.30E-92;PRP18_HUMAN;Pre-mRNA-splicing factor 18 (PRP18 homolog) (hPRP18);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA processing [GO:0006397]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; RNA splicing [GO:0008380]";"GO:0000350; GO:0005634; GO:0005681; GO:0005682; GO:0006397; GO:0008380; GO:0016607; GO:0046540; GO:0071021; GO:0071048";"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA processing [GO:0006397]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";
comp626884_c0_seq1;GAXK01028900.1;P10076;1.10E-08;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6269110_c0_seq1;GAXK01158852.1;Q9VZW5;8.56E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp6269382_c0_seq1;GAXK01158854.1;Q7M761;8.86E-13;OVCH2_MOUSE;Ovochymase-2 (EC 3.4.21.-) (Oviductin);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp6269862_c0_seq1;GAXK01158853.1;P08548;1.53E-09;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp627_c0_seq1;GAXK01169513.1;Q13501;1.39E-17;SQSTM_HUMAN;Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62);"aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; immune system process [GO:0002376]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000122; GO:0000407; GO:0000422; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0004674; GO:0005080; GO:0005654; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006511; GO:0006914; GO:0006915; GO:0007005; GO:0007032; GO:0008104; GO:0008270; GO:0010821; GO:0016197; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030971; GO:0031625; GO:0035255; GO:0035556; GO:0035973; GO:0042169; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043122; GO:0043130; GO:0043231; GO:0044753; GO:0044754; GO:0045944; GO:0046578; GO:0051291; GO:0061635; GO:0061912; GO:0070062; GO:0070498; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; immune system process [GO:0002376]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511]";"aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]";"enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp627026_c0_seq1;GAXK01028883.1;Q09711;2.45E-20;NCS1_SCHPO;Calcium-binding protein NCS-1;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activator activity [GO:0098744]; calcium ion binding [GO:0005509]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030435; GO:0035584; GO:0098744; GO:1905949";"calcium-mediated signaling using intracellular calcium source [GO:0035584]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; sporulation resulting in formation of a cellular spore [GO:0030435]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"1-phosphatidylinositol 4-kinase activator activity [GO:0098744]; calcium ion binding [GO:0005509]"
comp62711_c0_seq1;GAXK01171743.1;Q16U49;0;MED14_AEDAE;Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp627130_c1_seq1;GAXK01028918.1;Q18192;1.65E-10;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp62722_c0_seq1;GAXK01171783.1;Q92733;2.08E-15;PRCC_HUMAN;Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0005634; GO:0005654; GO:0007093; GO:0016607";"mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp62726_c0_seq1;GAXK01171984.1;P08761;4.87E-51;MSRA_DROME;Peptide methionine sulfoxide reductase (EC 1.8.4.11) (Ecdysone-induced protein 28/29 kDa) (Methionine-S-sulfoxide reductase) (Peptide-methionine (S)-S-oxide reductase);"cytoplasm [GO:0005737]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]";"GO:0000096; GO:0005737; GO:0006979; GO:0008113; GO:0008340; GO:0034599; GO:0036456";"cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]";cytoplasm [GO:0005737];"L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]"
comp62728_c0_seq1;GAXK01171449.1;P0DPW5;8.65E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp6273350_c0_seq1;GAXK01062625.1;Q20191;1.65E-07;NAS13_CAEEL;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp62738_c1_seq1;GAXK01171995.1;B7Z031;6.35E-83;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6275942_c0_seq1;GAXK01057627.1;P27085;2.42E-17;RS26_OCTVU;40S ribosomal protein S26;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp627604_c0_seq1;GAXK01028899.1;Q27433;8.80E-56;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp62768_c0_seq1;GAXK01172018.1;Q9JII6;1.76E-127;AK1A1_MOUSE;Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0045202; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095";"aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]"
comp62776_c0_seq1;GAXK01171974.1;Q20765;1.24E-16;NHR7_CAEEL;Nuclear hormone receptor family member nhr-7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp6278_c0_seq1;GAXK01100432.1;Q9QZS2;5.69E-15;RNF4_MOUSE;E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; negative regulation of cell death [GO:0060548]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008134; GO:0008270; GO:0016567; GO:0016605; GO:0017025; GO:0030331; GO:0031491; GO:0031624; GO:0032184; GO:0033142; GO:0042802; GO:0042803; GO:0043161; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0060548; GO:0061630; GO:0070534; GO:0070936; GO:0070979; GO:0071394; GO:0071480; GO:0072711; GO:0085020; GO:0090169; GO:0090234";"cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; negative regulation of cell death [GO:0060548]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp62821_c0_seq1;GAXK01171915.1;Q9UKX7;1.69E-28;NUP50_HUMAN;Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50);"cytoplasm [GO:0005737]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0008536; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043231; GO:0043547; GO:0043657; GO:0060964; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"cytoplasm [GO:0005737]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";Ran GTPase binding [GO:0008536]
comp628245_c0_seq1;GAXK01159927.1;P23978;3.21E-38;SC6A1_RAT;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp628274_c0_seq1;GAXK01159912.1;Q7TS63;2.83E-18;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp628302_c0_seq1;GAXK01159940.1;Q9HFY6;3.32E-45;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6283054_c0_seq1;GAXK01019671.1;Q6FYA7;9.81E-44;EF2_CANGA;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp628369_c0_seq1;GAXK01159919.1;W4VS53;1.37E-33;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp6284370_c0_seq1;GAXK01029071.1;A2ALK8;1.85E-23;PTN3_MOUSE;Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48);"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080]; liver regeneration [GO:0097421]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649]";"GO:0001784; GO:0004725; GO:0005737; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0017080; GO:0045930; GO:0051045; GO:0051117; GO:0097421; GO:0098902; GO:2000649";"liver regeneration [GO:0097421]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649]";"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]";"ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080]"
comp628499_c0_seq1;GAXK01159943.1;Q68EA5;1.79E-16;ZNF57_HUMAN;Zinc finger protein 57 (Zinc finger protein 424);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6287315_c0_seq1;GAXK01110963.1;P42196;2.65E-10;BACS2_NATPH;Sensory rhodopsin-2 (Sensory rhodopsin II) (SR-II);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005216; GO:0005886; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]"
comp628748_c0_seq1;GAXK01159939.1;Q8AVT9;3.02E-124;AR1AA_XENLA;Actin-related protein 2/3 complex subunit 1A-A;"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]";"GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861";Arp2/3 complex-mediated actin nucleation [GO:0034314];"Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";actin binding [GO:0003779]
comp6288001_c0_seq1;GAXK01105926.1;Q9HQD7;5.19E-09;HUTG_HALSA;Formimidoylglutamase (EC 3.5.3.8) (Formiminoglutamase) (Formiminoglutamate hydrolase);"agmatinase activity [GO:0008783]; formimidoylglutamase activity [GO:0050415]; manganese ion binding [GO:0030145]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]";"GO:0008783; GO:0019556; GO:0019557; GO:0030145; GO:0033389; GO:0050415";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]";;"agmatinase activity [GO:0008783]; formimidoylglutamase activity [GO:0050415]; manganese ion binding [GO:0030145]"
comp6288118_c0_seq1;GAXK01105927.1;Q9SGA6;6.19E-17;RS191_ARATH;40S ribosomal protein S19-1;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005618; GO:0005829; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp628940_c0_seq1;GAXK01159916.1;Q9UFB7;3.72E-08;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp628989_c1_seq1;GAXK01159953.1;P56695;3.21E-08;WFS1_MOUSE;Wolframin;"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of synaptic vesicle membrane [GO:0030285]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601]";"GO:0000122; GO:0001822; GO:0003091; GO:0005516; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030285; GO:0030425; GO:0030433; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0033613; GO:0034976; GO:0042048; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045927; GO:0048306; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:0070628; GO:1902236; GO:1903892; GO:2000675";"calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601]";"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of synaptic vesicle membrane [GO:0030285]";"activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625]"
comp6290641_c0_seq1;GAXK01196499.1;Q01239;1.86E-13;HCC1_CRYCO;Major basic nuclear protein 1 (Protein p14 alpha/beta chain);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp629095_c0_seq1;GAXK01159946.1;Q8I6K0;9.03E-30;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp629105_c0_seq1;GAXK01159933.1;P98092;3.24E-43;HMCT_BOMMO;Hemocytin (Humoral lectin);"carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]";"GO:0007155; GO:0030246";cell adhesion [GO:0007155];;carbohydrate binding [GO:0030246]
comp62914_c1_seq1;GAXK01171347.1;Q8VC12;0;HUTU_MOUSE;Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase);"cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";"GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557";"histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";cytosol [GO:0005829];urocanate hydratase activity [GO:0016153]
comp6293171_c0_seq1;GAXK01123365.1;Q9UJL9;2.24E-12;ZF69B_HUMAN;Zinc finger protein 69 homolog B (Zinc finger protein 643);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp629338_c0_seq1;GAXK01159963.1;O00305;4.39E-126;CACB4_HUMAN;Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4);"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; cardiac conduction [GO:0061337]; chemical synaptic transmission [GO:0007268]; membrane depolarization [GO:0051899]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385]";"GO:0005829; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0008331; GO:0009898; GO:0045202; GO:0051899; GO:0061337; GO:1901385";"cardiac conduction [GO:0061337]; chemical synaptic transmission [GO:0007268]; membrane depolarization [GO:0051899]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385]";"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]";high voltage-gated calcium channel activity [GO:0008331]
comp62961_c2_seq1;GAXK01171916.1;P0C599;1.57E-31;DUPD1_TAKRU;Dual specificity phosphatase DUPD1 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];cytoplasm [GO:0005737];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp62965_c0_seq1;GAXK01171781.1;Q99P72;4.31E-18;RTN4_MOUSE;Reticulon-4 (Neurite outgrowth inhibitor) (Nogo protein);"axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of postsynaptic density membrane [GO:0099061]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of dendrite extension [GO:1903860]; negative regulation of formation of growth cone in injured axon [GO:1905943]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of vasculogenesis [GO:2001213]; nervous system development [GO:0007399]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of nervous system development [GO:0051960]; regulation of sensory perception of pain [GO:0051930]";"GO:0001825; GO:0002523; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007029; GO:0007399; GO:0007413; GO:0010634; GO:0010977; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030308; GO:0030334; GO:0030424; GO:0030517; GO:0031625; GO:0032991; GO:0033601; GO:0033603; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043209; GO:0044294; GO:0044877; GO:0045296; GO:0045665; GO:0045687; GO:0045766; GO:0048694; GO:0050771; GO:0050821; GO:0051292; GO:0051897; GO:0051930; GO:0051960; GO:0060317; GO:0060907; GO:0061462; GO:0070571; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0099061; GO:0120078; GO:1902624; GO:1903860; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1905943; GO:1990809; GO:2000172; GO:2000347; GO:2001213";"axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of dendrite extension [GO:1903860]; negative regulation of formation of growth cone in injured axon [GO:1905943]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of vasculogenesis [GO:2001213]; nervous system development [GO:0007399]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of nervous system development [GO:0051960]; regulation of sensory perception of pain [GO:0051930]";"axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of postsynaptic density membrane [GO:0099061]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]";"cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp6296800_c0_seq1;GAXK01108551.1;P17970;1.20E-31;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp6296895_c0_seq1;GAXK01108550.1;P93748;1.79E-09;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp6297629_c0_seq1;GAXK01108546.1;B5AJT4;2.13E-09;VMP03_EULPE;Venom metalloproteinase 3 (EpMP3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp62977_c0_seq1;GAXK01171357.1;P51950;2.59E-76;MAT1_MARGL;CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Menage a trois) (RING finger protein MAT1);"transcription factor TFIIH holo complex [GO:0005675]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; nucleotide-excision repair [GO:0006289]";"GO:0005675; GO:0006289; GO:0007049; GO:0046872; GO:0051301; GO:0061575";"cell cycle [GO:0007049]; cell division [GO:0051301]; nucleotide-excision repair [GO:0006289]";transcription factor TFIIH holo complex [GO:0005675];"cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; metal ion binding [GO:0046872]"
comp629854_c0_seq1;GAXK01159923.1;Q92793;1.32E-17;CBP_HUMAN;CREB-binding protein (EC 2.3.1.48);"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"GO:0000122; GO:0000123; GO:0000790; GO:0000987; GO:0001085; GO:0001102; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0006473; GO:0007165; GO:0007219; GO:0007221; GO:0008134; GO:0008270; GO:0008589; GO:0016032; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0019216; GO:0030511; GO:0031648; GO:0032481; GO:0034644; GO:0042592; GO:0042733; GO:0042981; GO:0043426; GO:0045637; GO:0045747; GO:0045893; GO:0045944; GO:0048511; GO:0061418; GO:0065003; GO:1900034; GO:1904837";"beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; protein destabilization [GO:0031648]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp6298671_c0_seq1;GAXK01077910.1;Q9CXE0;2.14E-07;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp629883_c0_seq1;GAXK01159965.1;P52746;3.51E-25;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp62989_c0_seq1;GAXK01171457.1;P46461;0;NSF1_DROME;Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1);"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0005524; GO:0005737; GO:0005795; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031594; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:0099523; GO:1900073";"autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp63_c0_seq1;GAXK01166114.1;P67985;3.42E-32;RL22_PIG;60S ribosomal protein L22 (Heparin-binding protein HBp15);"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; presynapse [GO:0098793]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0008201; GO:0015934; GO:0022625; GO:0045182; GO:0046632; GO:0098556; GO:0098793; GO:0098978; GO:0099577";"alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; translation [GO:0006412]";"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; presynapse [GO:0098793]";"heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]"
comp6300057_c0_seq1;GAXK01190183.1;P00768;1.93E-23;CTR2_VESOR;Chymotrypsin-2 (EC 3.4.21.1) (Chymotrypsin II);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp630007_c0_seq1;GAXK01015278.1;Q7RTY0;9.34E-32;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp630043_c1_seq1;GAXK01015333.1;P47825;1.72E-20;TAF4_DROME;Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110);"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0001092; GO:0003677; GO:0003700; GO:0005634; GO:0005669; GO:0006355; GO:0006366; GO:0006367; GO:0008134; GO:0045944; GO:0046982";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]"
comp630154_c0_seq1;GAXK01015281.1;Q08D64;5.42E-41;ABCB6_XENTR;ATP-binding cassette sub-family B member 6, mitochondrial;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0016887; GO:0042626";;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp630172_c0_seq1;GAXK01015357.1;A7Z063;1.55E-40;WASH1_BOVIN;WASH complex subunit 1 (WAS protein family homolog 1);"autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0015031; GO:0016197; GO:0031901; GO:0034314; GO:0042147; GO:0043014; GO:0055037; GO:0055038; GO:0071203";"Arp2/3 complex-mediated actin nucleation [GO:0034314]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]"
comp6302250_c0_seq1;GAXK01063873.1;Q54TR1;8.88E-11;CFAD_DICDI;Counting factor associated protein D;"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0030435; GO:0031288; GO:0031410; GO:0051603; GO:0072659; GO:1903665; GO:1903669";"negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp63024_c1_seq1;GAXK01171408.1;Q8I7C3;1.58E-57;LASP1_DROME;LIM and SH3 domain protein Lasp;"A band [GO:0031672]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; sperm individualization complex [GO:0070864]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]";"GO:0003779; GO:0005829; GO:0005925; GO:0007279; GO:0007283; GO:0007291; GO:0014881; GO:0030018; GO:0031672; GO:0045214; GO:0045856; GO:0046872; GO:0051015; GO:0070864; GO:0071689";"muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]";"A band [GO:0031672]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; sperm individualization complex [GO:0070864]; Z disc [GO:0030018]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp630277_c0_seq1;GAXK01015312.1;A2AGA4;4.50E-31;RHBL2_MOUSE;"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp630313_c0_seq1;GAXK01015345.1;Q9JMH9;9.77E-25;MY18A_MOUSE;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]"
comp630317_c0_seq1;GAXK01015336.1;P17027;9.60E-17;ZNF23_HUMAN;Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp6303302_c0_seq1;GAXK01063871.1;Q05423;4.45E-15;FABP7_CHICK;Fatty acid-binding protein, brain (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7) (Fatty acid-binding protein, retina) (R-FABP);"cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134]";"GO:0003407; GO:0005737; GO:0005911; GO:0007420; GO:0008134; GO:0008289; GO:0021846; GO:0022008; GO:0042995; GO:0043025; GO:0060134; GO:0071944";"brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134]";"cell-cell junction [GO:0005911]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]";"lipid binding [GO:0008289]; transcription factor binding [GO:0008134]"
comp630350_c0_seq1;GAXK01015339.1;Q9Y6Y0;8.76E-17;NS1BP_HUMAN;Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription factor complex [GO:0005667]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]";"GO:0005654; GO:0005667; GO:0005681; GO:0005829; GO:0005856; GO:0006383; GO:0008380; GO:0009615; GO:0016032; GO:0031397; GO:2001243";"negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription factor complex [GO:0005667]";
comp6303547_c0_seq1;GAXK01063874.1;Q99814;4.59E-08;EPAS1_HUMAN;Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601]";"GO:0000790; GO:0000981; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0007005; GO:0007165; GO:0007601; GO:0008134; GO:0016567; GO:0016607; GO:0030218; GO:0030324; GO:0035035; GO:0042415; GO:0043129; GO:0043565; GO:0043619; GO:0043687; GO:0045944; GO:0046982; GO:0048469; GO:0048625; GO:0055072; GO:0061418; GO:0071456; GO:0120162";"angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp6303741_c0_seq1;GAXK01063870.1;Q9XGL4;1.14E-38;RL31_CYAPA;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp630389_c1_seq1;GAXK01015299.1;Q7MBZ9;1.72E-40;UXUA_VIBVY;Mannonate dehydratase (EC 4.2.1.8) (D-mannonate hydro-lyase);"mannonate dehydratase activity [GO:0008927]; glucuronate catabolic process [GO:0006064]";"GO:0006064; GO:0008927";glucuronate catabolic process [GO:0006064];;mannonate dehydratase activity [GO:0008927]
comp630454_c0_seq1;GAXK01015331.1;B5BLW5;1.47E-16;ARE_SACSO;Arylesterase (A-esterase) (EC 3.1.1.2) (Paraoxonase) (EC 3.1.8.1);"aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; aromatic compound catabolic process [GO:0019439]";"GO:0004063; GO:0004064; GO:0019439";aromatic compound catabolic process [GO:0019439];;"aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]"
comp6305_c0_seq1;GAXK01100422.1;A8Y9I2;8.49E-27;NINAB_GALME;Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B);"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]";"GO:0004497; GO:0016702; GO:0042572; GO:0046872";retinol metabolic process [GO:0042572];;"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp6306_c0_seq1;GAXK01100559.1;Q9ULE6;1.97E-26;PALD_HUMAN;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp630600_c0_seq1;GAXK01015300.1;Q96QE2;4.11E-141;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp630791_c1_seq1;GAXK01015297.1;Q6XZB0;2.54E-25;LIPI_HUMAN;Lipase member I (LIPI) (EC 3.1.1.-) (Cancer/testis antigen 17) (CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta) (mPA-PLA1 beta);"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"GO:0004620; GO:0005615; GO:0005886; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0052689";"lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carboxylic ester hydrolase activity [GO:0052689]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]"
comp630890_c0_seq1;GAXK01015301.1;Q9NXS3;3.46E-10;KLH28_HUMAN;Kelch-like protein 28 (BTB/POZ domain-containing protein 5);;;;;
comp630977_c0_seq1;GAXK01015304.1;E2JA28;1.80E-28;DDAC_ENTAG;Dapdiamide synthesis protein DdaC (EC 1.-.-.-);"oxidoreductase activity [GO:0016491]; antibiotic biosynthetic process [GO:0017000]";"GO:0016491; GO:0017000";antibiotic biosynthetic process [GO:0017000];;oxidoreductase activity [GO:0016491]
comp631113_c0_seq1;GAXK01015306.1;Q9Y490;2.31E-139;TLN1_HUMAN;Talin-1;"cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]";"GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005925; GO:0006936; GO:0007016; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527";"cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]";"cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]"
comp6311192_c0_seq1;GAXK01095198.1;Q9BXS9;2.08E-33;S26A6_HUMAN;Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]";"GO:0005254; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0008271; GO:0008272; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015499; GO:0015562; GO:0015660; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:2001150";"angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]";"anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp63117_c0_seq1;GAXK01172112.1;Q6PBY7;1.25E-106;TPC13_DANRE;Trafficking protein particle complex subunit 13;;;;;
comp631182_c0_seq1;GAXK01015335.1;Q66S03;1.07E-17;LECG_THANI;Galactose-specific lectin nattectin (CTL);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]";"GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729";inflammatory response [GO:0006954];extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]"
comp631204_c0_seq1;GAXK01015359.1;P20385;5.80E-09;CF2_DROME;Chorion transcription factor Cf2;"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872";"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp631221_c0_seq1;GAXK01015382.1;P41216;0;ACSL1_MOUSE;Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0014070; GO:0015908; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0042493; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]"
comp63130_c0_seq1;GAXK01171453.1;Q9GUM2;3.77E-102;BRE4_CAEEL;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";"GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872";"carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";integral component of membrane [GO:0016021];"acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"
comp63132_c1_seq1;GAXK01172105.1;P70032;1.82E-152;PLK1_XENLA;Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte maturation [GO:0001556]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"GO:0000086; GO:0000122; GO:0000278; GO:0000281; GO:0000776; GO:0001556; GO:0001578; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007098; GO:0008017; GO:0019901; GO:0030496; GO:0043066; GO:0051233; GO:0071168; GO:0072425; GO:1904668";"centrosome cycle [GO:0007098]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte maturation [GO:0001556]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]"
comp6313712_c0_seq1;GAXK01191278.1;Q3ZCX4;5.04E-09;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6313750_c0_seq1;GAXK01191279.1;Q96JB1;1.47E-69;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp631444_c0_seq1;GAXK01015334.1;Q6TGZ5;4.29E-46;HPPD_DANRE;4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0000139; GO:0003868; GO:0004462; GO:0005789; GO:0006559; GO:0006572; GO:0046872";"L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]"
comp631523_c0_seq1;GAXK01015326.1;Q8BHK3;4.08E-51;S36A2_MOUSE;Proton-coupled amino acid transporter 2 (Proton/amino acid transporter 2) (Solute carrier family 36 member 2) (Tramdorin-1);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]; amino acid export across plasma membrane [GO:0032973]; amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; positive regulation of glycine import across plasma membrane [GO:1900925]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; regulation of proline transport [GO:0070881]; regulation of proton transport [GO:0010155]; tyrosine transport [GO:0015828]";"GO:0003333; GO:0005280; GO:0005737; GO:0005886; GO:0010155; GO:0015078; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015808; GO:0015816; GO:0015824; GO:0015828; GO:0016021; GO:0032973; GO:0035524; GO:0070881; GO:1900925; GO:1902600";"amino acid export across plasma membrane [GO:0032973]; amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; positive regulation of glycine import across plasma membrane [GO:1900925]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; regulation of proline transport [GO:0070881]; regulation of proton transport [GO:0010155]; tyrosine transport [GO:0015828]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"amino acid:proton symporter activity [GO:0005280]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proton transmembrane transporter activity [GO:0015078]"
comp6316_c0_seq1;GAXK01100281.1;Q9Y266;2.84E-74;NUDC_HUMAN;Nuclear migration protein nudC (Nuclear distribution protein C homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457]";"GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0007049; GO:0032502; GO:0045296; GO:0051082; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]";"cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]"
comp63173_c0_seq1;GAXK01171341.1;Q5I0I5;2.92E-51;USB1_RAT;U6 snRNA phosphodiesterase (EC 3.1.4.-);"intercellular bridge [GO:0045171]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]";"GO:0000175; GO:0005634; GO:0008380; GO:0034477; GO:0045171; GO:1990838";"RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]";"intercellular bridge [GO:0045171]; nucleus [GO:0005634]";"3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]"
comp631813_c2_seq1;GAXK01015279.1;O74467;4.06E-23;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp6318976_c0_seq1;GAXK01072716.1;O01404;1.57E-08;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp6319784_c0_seq1;GAXK01072711.1;P24918;6.16E-11;NDUS1_NEUCR;NADH-ubiquinone oxidoreductase 78 kDa subunit, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-78kD) (CI-78kD);"mitochondrial respiratory chain complex I [GO:0005747]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]";"GO:0005747; GO:0008137; GO:0009055; GO:0042773; GO:0045272; GO:0045333; GO:0046872; GO:0051537; GO:0051539";"ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]";"mitochondrial respiratory chain complex I [GO:0005747]; plasma membrane respiratory chain complex I [GO:0045272]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp632066_c0_seq1;GAXK01162538.1;Q9Y5X9;3.85E-13;LIPE_HUMAN;Endothelial lipase (EC 3.1.1.3) (Endothelial cell-derived lipase) (EDL) (EL);"cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; cell population proliferation [GO:0008283]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; regulation of lipoprotein metabolic process [GO:0050746]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]";"GO:0004465; GO:0004620; GO:0005576; GO:0005615; GO:0005769; GO:0005794; GO:0006629; GO:0006633; GO:0007584; GO:0008201; GO:0008283; GO:0008970; GO:0009395; GO:0009986; GO:0010983; GO:0016042; GO:0016298; GO:0019433; GO:0032376; GO:0034372; GO:0034375; GO:0042632; GO:0043691; GO:0050746; GO:0055091; GO:0070328";"cell population proliferation [GO:0008283]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; regulation of lipoprotein metabolic process [GO:0050746]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]";"cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]";"heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]"
comp6320947_c0_seq1;GAXK01204653.1;Q8K0L9;1.94E-07;ZBT20_MOUSE;Zinc finger and BTB domain-containing protein 20 (BTB/POZ domain zinc finger factor HOF) (Zinc finger protein 288);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0000122; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0010629; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0044212; GO:0045821; GO:0045892; GO:0046872; GO:0046889; GO:0055088; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp6321_c0_seq1;GAXK01101270.1;Q63ZL2;7.31E-44;HOP2_XENLA;Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein);"nucleus [GO:0005634]; reciprocal meiotic recombination [GO:0007131]";"GO:0005634; GO:0007131";reciprocal meiotic recombination [GO:0007131];nucleus [GO:0005634];
comp632193_c3_seq1;GAXK01162537.1;P97353;1.74E-24;SEC1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]"
comp63237_c0_seq1;GAXK01171353.1;Q3SWT4;1.73E-51;IWS1_RAT;Protein IWS1 homolog (IWS1-like protein);"nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]";"GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]";nucleus [GO:0005634];
comp63242_c0_seq1;GAXK01171887.1;Q9VBW3;6.08E-102;CAD96_DROME;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0008284; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp63254_c1_seq1;GAXK01172116.1;Q07327;0;ROP_DROME;Protein ROP;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000281; GO:0005737; GO:0005829; GO:0006887; GO:0006904; GO:0007268; GO:0007269; GO:0007317; GO:0009416; GO:0015031; GO:0016020; GO:0016082; GO:0016192; GO:0019898; GO:0030707; GO:0032940; GO:0043195; GO:0048489; GO:1900006";"chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of dendrite development [GO:1900006]; protein transport [GO:0015031]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to light stimulus [GO:0009416]; secretion by cell [GO:0032940]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; terminal bouton [GO:0043195]";SNARE binding [GO:0000149]
comp632583_c0_seq1;GAXK01162566.1;Q03347;7.28E-54;RUNX1_MOUSE;Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit);"basement membrane [GO:0005604]; core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; behavioral response to pain [GO:0048266]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; hair follicle morphogenesis [GO:0031069]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; myeloid cell differentiation [GO:0030099]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell maturation [GO:1903431]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hair follicle cell proliferation [GO:0071336]; regulation of signal transduction [GO:0009966]; regulation of T cell anergy [GO:0002667]; regulation of transcription, DNA-templated [GO:0006355]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001701; GO:0001889; GO:0002318; GO:0002667; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005604; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007417; GO:0008134; GO:0008285; GO:0009966; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0031069; GO:0032526; GO:0032729; GO:0032743; GO:0032991; GO:0035162; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0044212; GO:0045766; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048266; GO:0048663; GO:0048666; GO:0060216; GO:0070491; GO:0071336; GO:0071560; GO:1903431; GO:1990837; GO:1990841; GO:2000872";"behavioral response to pain [GO:0048266]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; hair follicle morphogenesis [GO:0031069]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; myeloid cell differentiation [GO:0030099]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell maturation [GO:1903431]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hair follicle cell proliferation [GO:0071336]; regulation of signal transduction [GO:0009966]; regulation of T cell anergy [GO:0002667]; regulation of transcription, DNA-templated [GO:0006355]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp632757_c0_seq1;GAXK01162534.1;Q9VGY6;5.79E-11;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp63277_c1_seq1;GAXK01171775.1;Q868N5;3.07E-09;VIT_APIME;Vitellogenin;"extracellular region [GO:0005576]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]";"GO:0005319; GO:0005576; GO:0045735";;extracellular region [GO:0005576];"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp632874_c0_seq1;GAXK01162558.1;P93748;5.69E-19;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp63290_c3_seq1;GAXK01171618.1;Q8N988;1.93E-14;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp63299_c1_seq1;GAXK01171993.1;Q8NCJ5;2.07E-134;SPRY3_HUMAN;SPRY domain-containing protein 3;;;;;
comp633057_c0_seq1;GAXK01162556.1;Q8INF0;2.19E-128;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp6330705_c0_seq1;GAXK01192941.1;P57078;1.95E-08;RIPK4_HUMAN;Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-delta-interacting protein kinase);"cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]";"GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092";"morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp6331333_c0_seq1;GAXK01192944.1;Q99758;1.52E-42;ABCA3_HUMAN;ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3);"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233";"cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]";"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp633254_c0_seq1;GAXK01162565.1;P46941;1.21E-30;TG325_CAEEL;WW domain-containing protein tag-325;"cytoplasm [GO:0005737]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0043087";"regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];
comp63331_c1_seq1;GAXK01171947.1;O55013;7.97E-81;TPPC3_MOUSE;Trafficking protein particle complex subunit 3 (BET3 homolog);"cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]";"GO:0000139; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]";"cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]";
comp633449_c0_seq1;GAXK01162531.1;Q8K1T0;1.01E-22;TMPS3_MOUSE;Transmembrane protease serine 3 (EC 3.4.21.-);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; cellular sodium ion homeostasis [GO:0006883]; sensory perception of sound [GO:0007605]";"GO:0004252; GO:0005044; GO:0005783; GO:0005789; GO:0006883; GO:0007605; GO:0016021; GO:0017080; GO:0043025";"cellular sodium ion homeostasis [GO:0006883]; sensory perception of sound [GO:0007605]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]"
comp6334886_c0_seq1;GAXK01153204.1;Q7K237;7.90E-09;C1GLT_DROME;Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1);"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";"GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037";"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]";integral component of membrane [GO:0016021];"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"
comp6335910_c0_seq1;GAXK01204894.1;P33744;4.64E-16;ADHE_CLOAB;"Aldehyde-alcohol dehydrogenase (AAD) [Includes: Alcohol dehydrogenase (ADH) (EC 1.1.1.1); Aldehyde dehydrogenase (ALDH) (EC 1.2.1.3)]";"acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; alcohol dehydrogenase (NAD) activity [GO:0004022]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; metal ion binding [GO:0046872]; alcohol metabolic process [GO:0006066]; carbon utilization [GO:0015976]";"GO:0004022; GO:0004029; GO:0006066; GO:0008774; GO:0015976; GO:0043878; GO:0046872";"alcohol metabolic process [GO:0006066]; carbon utilization [GO:0015976]";;"acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; alcohol dehydrogenase (NAD) activity [GO:0004022]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; metal ion binding [GO:0046872]"
comp6336_c0_seq1;GAXK01100294.1;Q9V9Z9;6.56E-52;EBP2_DROME;Probable rRNA-processing protein EBP2 homolog;"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273";"ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]";"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";RNA binding [GO:0003723]
comp63363_c0_seq1;GAXK01171679.1;Q7PMT1;1.68E-106;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp6338706_c0_seq1;GAXK01025870.1;B4LPX5;6.87E-07;TRET1_DROVI;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp6338975_c0_seq1;GAXK01025873.1;O57535;3.63E-88;NDK_CHICK;Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6);"extracellular space [GO:0005615]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; transcription coactivator activity [GO:0003713]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermis development [GO:0045682]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0003713; GO:0004550; GO:0005524; GO:0005615; GO:0005739; GO:0005886; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0019003; GO:0030027; GO:0043066; GO:0045618; GO:0045682; GO:0045944; GO:0046872; GO:0050679; GO:0051880";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermis development [GO:0045682]; UTP biosynthetic process [GO:0006228]";"extracellular space [GO:0005615]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; transcription coactivator activity [GO:0003713]"
comp63394_c1_seq1;GAXK01172083.1;Q499R4;1.08E-52;YRDC_RAT;YrdC domain-containing protein, mitochondrial (Ischemia/reperfusion-inducible protein homolog);"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; double-stranded RNA binding [GO:0003725]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]";"GO:0000049; GO:0003725; GO:0005737; GO:0005739; GO:0006450; GO:0016020; GO:0016779; GO:0051051";"negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]";"double-stranded RNA binding [GO:0003725]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]"
comp634_c1_seq1;GAXK01205886.1;P26584;4.92E-27;HMGB2_CHICK;High mobility group protein B2 (High mobility group protein 2) (HMG-2);"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding, bending [GO:0008301]; drug binding [GO:0008144]; four-way junction DNA binding [GO:0000400]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]";"GO:0000400; GO:0000790; GO:0000793; GO:0002437; GO:0005615; GO:0005634; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008144; GO:0008301; GO:0032392; GO:0032496; GO:0042493; GO:0045087; GO:0045089; GO:0045944; GO:0048471; GO:0050829; GO:0050830";"chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]";"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"DNA binding, bending [GO:0008301]; drug binding [GO:0008144]; four-way junction DNA binding [GO:0000400]; transcription factor binding [GO:0008134]"
comp6340156_c0_seq1;GAXK01039490.1;Q86UE3;8.47E-07;ZN546_HUMAN;Zinc finger protein 546 (Zinc finger protein 49);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp63402_c1_seq1;GAXK01171612.1;Q5TJG6;4.65E-100;BRD2_CANLF;Bromodomain-containing protein 2;"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577";"nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]";"chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]"
comp6340310_c0_seq1;GAXK01039492.1;P45482;3.31E-15;FTSZ_NOSS1;Cell division protein FtsZ;"cell division site [GO:0032153]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; division septum assembly [GO:0000917]; FtsZ-dependent cytokinesis [GO:0043093]; protein polymerization [GO:0051258]";"GO:0000917; GO:0003924; GO:0005525; GO:0005737; GO:0032153; GO:0043093; GO:0051258";"division septum assembly [GO:0000917]; FtsZ-dependent cytokinesis [GO:0043093]; protein polymerization [GO:0051258]";"cell division site [GO:0032153]; cytoplasm [GO:0005737]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp634051_c0_seq1;GAXK01010988.1;B5U2W0;2.83E-29;VSP_BOMIG;Venom serine protease Bi-VSP (EC 3.4.21.-) (Thrombin-like enzyme);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]";"GO:0004252; GO:0005576; GO:0016504; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; toxin activity [GO:0090729]"
comp63406_c0_seq1;GAXK01171496.1;B0TMW0;2.57E-22;SELU_SHEHH;tRNA 2-selenouridine synthase (EC 2.5.1.-);"transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; tRNA 2-selenouridine synthase activity [GO:0043828]; tRNA seleno-modification [GO:0070329]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0016765; GO:0043828; GO:0070329";"tRNA seleno-modification [GO:0070329]; tRNA wobble uridine modification [GO:0002098]";;"transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; tRNA 2-selenouridine synthase activity [GO:0043828]"
comp634091_c1_seq1;GAXK01011002.1;Q8N988;2.53E-15;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6341404_c0_seq1;GAXK01039489.1;Q9MBB3;7.66E-92;RS3A_DAUCA;40S ribosomal protein S3a (Protein cyc07);"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp6344_c0_seq1;GAXK01101267.1;P61292;0;PP1B_PIG;Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]";"GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357";"cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]";"metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]"
comp6345453_c0_seq1;GAXK01035192.1;Q60870;4.24E-36;REEP5_MOUSE;Receptor expression-enhancing protein 5 (GP106) (Polyposis locus protein 1 homolog) (Protein TB2 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp63458_c6_seq1;GAXK01172066.1;Q6P4F7;1.32E-18;RHGBA_HUMAN;Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A);"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005829; GO:0007165; GO:0051056";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";cytosol [GO:0005829];GTPase activator activity [GO:0005096]
comp63461_c0_seq1;GAXK01171354.1;Q6P3B9;1.53E-08;RBFA_MOUSE;Putative ribosome-binding factor A, mitochondrial;"mitochondrion [GO:0005739]; rRNA processing [GO:0006364]";"GO:0005739; GO:0006364";rRNA processing [GO:0006364];mitochondrion [GO:0005739];
comp6346301_c0_seq1;GAXK01009897.1;A6VVN4;5.70E-38;KATG_MARMS;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp63465_c1_seq1;GAXK01171358.1;Q1LV46;6.03E-33;ABHEA_DANRE;Protein ABHD14A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14A) (Abhydrolase domain-containing protein 14A);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0005737; GO:0016021; GO:0016787";;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]";hydrolase activity [GO:0016787]
comp6347_c0_seq1;GAXK01100463.1;P21158;2.90E-32;CSGA_MYXXA;C-factor (C signal);"extracellular region [GO:0005576]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005576; GO:0030435";sporulation resulting in formation of a cellular spore [GO:0030435];extracellular region [GO:0005576];
comp634749_c0_seq1;GAXK01011019.1;P19397;6.11E-14;CD53_HUMAN;Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25) (Tspan-25) (CD antigen CD53);"cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; neutrophil degranulation [GO:0043312]; positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165]";"GO:0001772; GO:0005886; GO:0005887; GO:0005911; GO:0007165; GO:0009986; GO:0035579; GO:0043312; GO:0070062; GO:0070821; GO:1901741";"neutrophil degranulation [GO:0043312]; positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165]";"cell-cell junction [GO:0005911]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]";
comp6347721_c0_seq1;GAXK01009899.1;P0C862;3.80E-12;C1T9A_HUMAN;Complement C1q and tumor necrosis factor-related protein 9A (Complement C1q and tumor necrosis factor-related protein 9);"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]";"GO:0005179; GO:0005576; GO:0005581; GO:0042802";;"collagen trimer [GO:0005581]; extracellular region [GO:0005576]";"hormone activity [GO:0005179]; identical protein binding [GO:0042802]"
comp634856_c3_seq1;GAXK01010980.1;Q7ZYC4;2.30E-142;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp6348727_c0_seq1;GAXK01075500.1;O01812;5.08E-25;FABP6_CAEEL;Fatty acid-binding protein homolog 6;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp63489_c2_seq1;GAXK01171283.1;Q13630;1.60E-140;FCL_HUMAN;GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; coenzyme binding [GO:0050662]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; T cell mediated cytotoxicity [GO:0001913]";"GO:0001913; GO:0005829; GO:0007159; GO:0009055; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0050662; GO:0070062";"'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; T cell mediated cytotoxicity [GO:0001913]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"coenzyme binding [GO:0050662]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"
comp634935_c0_seq1;GAXK01010982.1;Q61371;0;IFT88_MOUSE;Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw);"acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]";"GO:0001654; GO:0001822; GO:0001886; GO:0001889; GO:0002080; GO:0002081; GO:0005737; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031514; GO:0032391; GO:0034405; GO:0036064; GO:0036126; GO:0036334; GO:0042073; GO:0042487; GO:0042733; GO:0043568; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1903929; GO:1905515; GO:2000785";"animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]";"acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]";kinesin binding [GO:0019894]
comp635_c0_seq1;GAXK01204907.1;Q2HJ97;2.74E-136;PHB2_BOVIN;Prohibitin-2;"mitochondrial inner membrane [GO:0005743]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sphingolipid binding [GO:0046625]; regulation of cytochrome-c oxidase activity [GO:1904959]";"GO:0005634; GO:0005743; GO:0016363; GO:0032991; GO:0046625; GO:1904959";regulation of cytochrome-c oxidase activity [GO:1904959];"mitochondrial inner membrane [GO:0005743]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";sphingolipid binding [GO:0046625]
comp635142_c0_seq1;GAXK01010984.1;O01803;2.78E-62;RB11A_CAEEL;Ras-related protein rab-11.1 (Rab GTPase rab-11.1);"apical plasma membrane [GO:0016324]; cortical granule [GO:0060473]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; positive regulation of cytokinesis [GO:0032467]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]";"GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0006887; GO:0006898; GO:0009792; GO:0016324; GO:0030133; GO:0030703; GO:0032467; GO:0032482; GO:0055037; GO:0055038; GO:0060471; GO:0060473";"cortical granule exocytosis [GO:0060471]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; positive regulation of cytokinesis [GO:0032467]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]";"apical plasma membrane [GO:0016324]; cortical granule [GO:0060473]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; transport vesicle [GO:0030133]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp6352_c0_seq1;GAXK01100525.1;P47758;2.49E-50;SRPRB_MOUSE;Signal recognition particle receptor subunit beta (SR-beta);"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]";"GO:0005525; GO:0005737; GO:0005789; GO:0005881; GO:0016020; GO:0016021; GO:0031625";;"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]"
comp6352638_c0_seq1;GAXK01120985.1;H3ZPL1;3.73E-17;ARAT1_THELN;Aromatic-amino-acid aminotransferase 1 (ARAT-I) (AROAT) (EC 2.6.1.57);"L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]";"GO:0009058; GO:0030170; GO:0080130";biosynthetic process [GO:0009058];;"L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]"
comp63532_c5_seq1;GAXK01171937.1;Q27319;0;GELS_HOMAM;Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]";"GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693";actin filament capping [GO:0051693];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp63540_c0_seq1;GAXK01171925.1;Q7KRI2;2.06E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6355_c0_seq1;GAXK01100817.1;Q9VTP4;2.98E-56;R10AB_DROME;60S ribosomal protein L10a-2;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp635561_c0_seq1;GAXK01010994.1;Q9Y2H8;1.21E-13;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6356634_c0_seq1;GAXK01176827.1;A4II46;3.04E-22;ABR_XENTR;Active breakpoint cluster region-related protein;"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005096; GO:0030054; GO:0030424; GO:0035023; GO:0035556; GO:0043197";"intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]";"axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]";"GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp6356834_c0_seq1;GAXK01176824.1;Q80V63;6.87E-09;PRDM4_MOUSE;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005123; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0035097; GO:0043565; GO:0045944; GO:0046872; GO:1990226; GO:2000177; GO:2000736";"negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp6357_c0_seq1;GAXK01100436.1;Q14318;1.04E-42;FKBP8_HUMAN;Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]";"GO:0001708; GO:0001933; GO:0003755; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0097718";"apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]";"disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp6357085_c0_seq1;GAXK01176829.1;Q14624;6.15E-12;ITIH4_HUMAN;"Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562";"acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]";"endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp635746_c0_seq1;GAXK01011015.1;Q8IN81;2.27E-12;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6358216_c0_seq1;GAXK01138065.1;Q8T6B7;1.78E-50;ABCF2_DICDI;ABC transporter F family member 2;"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]";"GO:0005524; GO:0016887; GO:0031152; GO:0031288";"aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]";;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp635835_c0_seq1;GAXK01010997.1;Q0V8S9;2.64E-16;CNTP5_CHICK;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]";"GO:0007155; GO:0016021";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];
comp636_c0_seq1;GAXK01169734.1;Q06943;2.62E-07;HMGZ_DROME;High mobility group protein Z (HMG-Z);"nuclear chromatin [GO:0000790]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0006338; GO:0006357; GO:0008134; GO:0008301";"chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]";nuclear chromatin [GO:0000790];"DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]"
comp636264_c0_seq1;GAXK01153484.1;Q8NDA2;2.64E-09;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp6363417_c0_seq1;GAXK01142947.1;Q14721;1.71E-15;KCNB1_HUMAN;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0050796; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp636357_c0_seq1;GAXK01153479.1;G5ED00;1.21E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp636365_c0_seq1;GAXK01153472.1;O64411;1.44E-09;PAO1_MAIZE;Polyamine oxidase 1 (EC 1.5.3.14) (EC 1.5.3.15);"apoplast [GO:0048046]; plant-type cell wall [GO:0009505]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052898]; N1-acetylspermine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052893]; N8-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052897]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine oxidase (propane-1,3-diamine-forming) activity [GO:0052896]; spermine oxidase (propane-1,3-diamine-forming) activity [GO:0052900]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"GO:0006598; GO:0009505; GO:0016491; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052893; GO:0052896; GO:0052897; GO:0052898; GO:0052900";"polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]";"apoplast [GO:0048046]; plant-type cell wall [GO:0009505]";"flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052898]; N1-acetylspermine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052893]; N8-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052897]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine oxidase (propane-1,3-diamine-forming) activity [GO:0052896]; spermine oxidase (propane-1,3-diamine-forming) activity [GO:0052900]"
comp63638_c2_seq1;GAXK01171729.1;P62700;3.31E-71;YPEL5_MOUSE;Protein yippee-like 5;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283]";"GO:0000151; GO:0005634; GO:0005737; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431";cell population proliferation [GO:0008283];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";metal ion binding [GO:0046872]
comp63644_c1_seq1;GAXK01171678.1;P11029;0;ACAC_CHICK;Acetyl-CoA carboxylase (ACC) (EC 6.4.1.2) [Includes: Biotin carboxylase (EC 6.3.4.14)];"cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression, epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]";"GO:0003989; GO:0004075; GO:0005102; GO:0005524; GO:0005623; GO:0005737; GO:0006633; GO:0006810; GO:0009374; GO:0009743; GO:0010628; GO:0032810; GO:0040029; GO:0045893; GO:0046872; GO:0046966; GO:0050692; GO:0065008; GO:0070542; GO:0097066; GO:2001295";"fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression, epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]";"cell [GO:0005623]; cytoplasm [GO:0005737]";"acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]"
comp636618_c0_seq1;GAXK01153539.1;R9UTQ8;1.30E-19;PROHY_STRGD;L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]";"GO:0005506; GO:0016706; GO:0016999; GO:0017000";"antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]";;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]"
comp63684_c3_seq1;GAXK01172020.1;P62036;2.11E-29;Y1074_GEOSL;Probable transcriptional regulatory protein GSU1074;"cytosol [GO:0005829]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005829; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];cytosol [GO:0005829];DNA binding [GO:0003677]
comp636897_c0_seq1;GAXK01153488.1;P49010;2.39E-41;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp63695_c0_seq1;GAXK01171483.1;Q9UHW9;0;S12A6_HUMAN;Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]";"GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:1902476; GO:1990573";"angiogenesis [GO:0001525]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]"
comp636994_c1_seq1;GAXK01153548.1;Q90419;2.26E-18;TWHH_DANRE;"Tiggy-winkle hedgehog protein (TWHH) (Sonic hedgehog protein B) (SHHB) [Cleaved into: Tiggy-winkle hedgehog protein N-product; Tiggy-winkle hedgehog protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0030182; GO:0030900; GO:0042063; GO:0048663; GO:0048702; GO:0048703; GO:0048709; GO:0055002; GO:0060956";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp637098_c0_seq1;GAXK01153541.1;Q8VDM6;1.05E-35;HNRL1_MOUSE;Heterogeneous nuclear ribonucleoprotein U-like protein 1;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]";"GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899";"response to virus [GO:0009615]; RNA processing [GO:0006396]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; RNA binding [GO:0003723]"
comp6371_c3_seq1;GAXK01100238.1;P52209;0;6PGD_HUMAN;6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate catabolic process [GO:0046177]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]";"GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0055114; GO:0070062";"D-gluconate catabolic process [GO:0046177]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]"
comp63729_c0_seq1;GAXK01171930.1;Q8TB22;0;SPT20_HUMAN;Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411);"extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003824; GO:0005576; GO:0007275; GO:0007283; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";extracellular region [GO:0005576];catalytic activity [GO:0003824]
comp637305_c0_seq1;GAXK01153538.1;Q7KRI2;1.89E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp637344_c1_seq1;GAXK01153489.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp63735_c0_seq1;GAXK01172024.1;Q9X248;1.23E-34;FABG_THEMA;3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase);"3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]";"GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132";fatty acid elongation [GO:0030497];;"3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp6373775_c0_seq1;GAXK01084585.1;P56008;1.27E-39;RS1_HELPY;30S ribosomal protein S1;"cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp6374213_c0_seq1;GAXK01038011.1;Q9GPS3;2.06E-07;RACF2_DICDI;Rho-related protein racF2;"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; sexual reproduction [GO:0019953]";"GO:0000281; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0019901; GO:0019953; GO:0030036; GO:0031152; GO:0032956; GO:0042995; GO:0098609";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; sexual reproduction [GO:0019953]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp6374569_c0_seq1;GAXK01038006.1;P17970;5.10E-38;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp637746_c3_seq1;GAXK01153542.1;Q8G9F9;1.22E-29;INHA_PSEPU;Isonitrile hydratase (EC 4.2.1.103) (Cyclohexyl-isocyanide hydratase);cyclohexyl-isocyanide hydratase activity [GO:0050549];GO:0050549;;;cyclohexyl-isocyanide hydratase activity [GO:0050549]
comp63781_c0_seq1;GAXK01171478.1;Q7ZVE3;1.46E-26;TIGRB_DANRE;Fructose-2,6-bisphosphatase TIGAR B (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator B);"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; bisphosphoglycerate 2-phosphatase activity [GO:0004083]; catalytic activity [GO:0003824]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]";"GO:0003824; GO:0004083; GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006003; GO:0006914; GO:0006915; GO:0030388";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]";"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"bisphosphoglycerate 2-phosphatase activity [GO:0004083]; catalytic activity [GO:0003824]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"
comp637921_c0_seq1;GAXK01153476.1;Q8N0N3;3.36E-76;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp638000_c5_seq1;GAXK01001005.1;Q7RTS1;2.70E-13;BHA15_HUMAN;Class A basic helix-loop-helix protein 15 (bHLHa15) (Class B basic helix-loop-helix protein 8) (bHLHb8) (Muscle, intestine and stomach expression 1) (MIST-1);"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0006851; GO:0007030; GO:0007186; GO:0007267; GO:0010832; GO:0019722; GO:0030968; GO:0042149; GO:0042593; GO:0042803; GO:0048312; GO:0048469";"calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cell maturation [GO:0048469]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]";nuclear chromatin [GO:0000790];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp638085_c2_seq1;GAXK01000960.1;P61871;3.16E-07;LIP_RHINI;Lipase (EC 3.1.1.3) (Lipase II) (RNL) (Triacylglycerol lipase);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005615; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp6381119_c0_seq1;GAXK01150277.1;P02269;1.98E-39;H2A_ASTRU;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp63812_c1_seq1;GAXK01172027.1;Q16X15;2.38E-66;MED24_AEDAE;Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24);mediator complex [GO:0016592];GO:0016592;;mediator complex [GO:0016592];
comp63830_c0_seq1;GAXK01172025.1;Q66H20;1.11E-18;PTBP2_RAT;Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (PTB-like protein);"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"GO:0003729; GO:0005634; GO:0005681; GO:0006376; GO:0021510; GO:0021549; GO:0030426; GO:0033119; GO:0043025; GO:2000177";"cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; spinal cord development [GO:0021510]";"growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";mRNA binding [GO:0003729]
comp63833_c1_seq1;GAXK01171994.1;Q86NP2;1.22E-90;NELFA_DROME;Negative elongation factor A;"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]";"GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0007275; GO:0017053; GO:0032021; GO:0034244";"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]";"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";RNA binding [GO:0003723]
comp6383676_c0_seq1;GAXK01107833.1;Q9VZW5;3.59E-13;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp63837_c1_seq1;GAXK01171517.1;Q1QSX1;4.80E-21;DNAJ_CHRSD;Chaperone protein DnaJ;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082";"DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp63839_c0_seq1;GAXK01171596.1;Q6PDL0;5.07E-104;DC1L2_MOUSE;Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic);"centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260]";"GO:0000226; GO:0000776; GO:0003777; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504; GO:0051260; GO:0051642; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein homooligomerization [GO:0051260]";"centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]"
comp638465_c0_seq1;GAXK01000938.1;Q8TCB0;7.31E-34;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp6385_c0_seq1;GAXK01100195.1;P86221;1.06E-67;TBB4B_MESAU;Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp63861_c0_seq1;GAXK01171715.1;Q6AY04;2.01E-12;MAIP1_RAT;m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ribosome binding [GO:0043022]; calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]";"GO:0005743; GO:0005759; GO:0007007; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560";"calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]";"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]";ribosome binding [GO:0043022]
comp63865_c0_seq1;GAXK01171425.1;Q5RFQ3;0;PWP2_PONAB;Periodic tryptophan protein 2 homolog;nucleolus [GO:0005730];GO:0005730;;nucleolus [GO:0005730];
comp638679_c0_seq1;GAXK01000949.1;Q91611;3.87E-15;DHHB_XENLA;"Desert hedgehog protein B (Desert hedgehog protein 2) (DHH-2) (Hedgehog protein 4) (X-HH4) [Cleaved into: Desert hedgehog protein B N-product; Desert hedgehog protein B C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0046872";"cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp6388150_c0_seq1;GAXK01029239.1;Q9ZLZ3;1.62E-09;TYPA_HELPJ;GTP-binding protein TypA/BipA homolog;"GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525";;;"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp6388631_c0_seq1;GAXK01029247.1;P0C6P6;7.87E-14;TYY2_RAT;Transcription factor YY2 (Yin and yang 2) (YY-2);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]";"GO:0000790; GO:0000978; GO:0000980; GO:0003677; GO:0005634; GO:0005667; GO:0031519; GO:0043565; GO:0046872";;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp638907_c0_seq1;GAXK01000982.1;Q9R0Y5;2.50E-41;KAD1_MOUSE;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]";"GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006165; GO:0006172; GO:0007050; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0043005; GO:0046033; GO:0046034; GO:0046103; GO:0048471";"ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]";"adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]"
comp638998_c0_seq1;GAXK01000981.1;P45961;2.76E-09;CEX2_CAEEL;Calexcitin-2;"endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; calcium-ion regulated exocytosis [GO:0017156]";"GO:0005509; GO:0005783; GO:0017156";calcium-ion regulated exocytosis [GO:0017156];endoplasmic reticulum [GO:0005783];calcium ion binding [GO:0005509]
comp639_c0_seq1;GAXK01166406.1;Q1HPS0;6.00E-26;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp6390037_c0_seq1;GAXK01155335.1;O95180;5.12E-47;CAC1H_HUMAN;Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005244; GO:0005886; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344";"aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]";"low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]"
comp63901_c4_seq1;GAXK01171983.1;Q9V8K2;0;EXOC3_DROME;Exocyst complex component 3 (Exocyst complex component Sec6);"cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; SNARE binding [GO:0000149]; border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793";"border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]";SNARE binding [GO:0000149]
comp639013_c0_seq1;GAXK01000879.1;P35858;3.97E-13;ALS_HUMAN;Insulin-like growth factor-binding protein complex acid labile subunit (ALS);"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]; nucleoplasm [GO:0005654]; insulin-like growth factor binding [GO:0005520]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; signal transduction [GO:0007165]";"GO:0005520; GO:0005576; GO:0005615; GO:0005654; GO:0007155; GO:0007165; GO:0031012; GO:0042567; GO:0044267; GO:0070062";"cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; signal transduction [GO:0007165]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]; nucleoplasm [GO:0005654]";insulin-like growth factor binding [GO:0005520]
comp6390295_c0_seq1;GAXK01155347.1;Q9I154;2.73E-73;PK21B_PSEAE;Polyphosphate:ADP phosphotransferase (EC 2.7.4.1) (Polyphosphate kinase PPK2 2);"polyphosphate kinase activity [GO:0008976]; ATP biosynthetic process [GO:0006754]";"GO:0006754; GO:0008976";ATP biosynthetic process [GO:0006754];;polyphosphate kinase activity [GO:0008976]
comp6390636_c0_seq1;GAXK01155348.1;P63245;5.25E-56;RACK1_RAT;Receptor of activated protein C kinase 1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0007205; GO:0007369; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:0072344; GO:1903076; GO:2000114; GO:2000543";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]";"enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]"
comp639080_c0_seq1;GAXK01001027.1;Q90632;6.55E-29;MOT3_CHICK;Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);"integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp639099_c0_seq1;GAXK01000951.1;Q01070;6.18E-30;ESMC_DROME;Enhancer of split mgamma protein (E(spl)mgamma) (Split locus enhancer protein mB);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003700; GO:0005634; GO:0007219; GO:0008134; GO:0009952; GO:0030154; GO:0035326; GO:0043565; GO:0046983; GO:0048190; GO:0050767; GO:0097150; GO:1902692; GO:1990837";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; wing disc dorsal/ventral pattern formation [GO:0048190]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"
comp6391159_c0_seq1;GAXK01155334.1;Q9VHH9;9.48E-09;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp6392496_c0_seq1;GAXK01137864.1;O86564;7.53E-12;SDHL_STRCO;L-serine dehydratase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-SD);"4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]; gluconeogenesis [GO:0006094]";"GO:0003941; GO:0006094; GO:0046872; GO:0051539";gluconeogenesis [GO:0006094];;"4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]"
comp63927_c5_seq1;GAXK01171382.1;G3X9K3;0;BIG1_MOUSE;Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005085; GO:0005086; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0010256; GO:0015031; GO:0016192; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090284; GO:0090303; GO:2000114";"endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]";"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]"
comp6392853_c0_seq1;GAXK01137858.1;Q54BU4;1.02E-21;ABCB1_DICDI;ABC transporter B family member 1 (ABC transporter ABCB.1);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]";"GO:0005524; GO:0006935; GO:0006972; GO:0016021; GO:0016887; GO:0031154; GO:0042626";"chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]";integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp639345_c1_seq1;GAXK01000974.1;O46108;2.24E-89;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp639360_c1_seq1;GAXK01000958.1;Q2TDY4;6.77E-19;ECTD_VIRSA;Ectoine dioxygenase (EC 1.14.11.55) (Ectoine hydroxylase);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; ectoine catabolic process [GO:0042400]";"GO:0005506; GO:0016706; GO:0042400";ectoine catabolic process [GO:0042400];;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]"
comp6393639_c0_seq1;GAXK01137860.1;Q91WD2;4.27E-07;TRPV6_MOUSE;Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016021; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp6394_c0_seq1;GAXK01100241.1;Q8BP78;4.96E-63;F10C1_MOUSE;Protein FRA10AC1 homolog;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp6394014_c0_seq1;GAXK01123861.1;Q9UI46;6.21E-07;DNAI1_HUMAN;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003774; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"cilium [GO:0005929]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp639412_c0_seq1;GAXK01000966.1;P08716;4.31E-15;HLYBP_ECOLX;Alpha-hemolysin translocation ATP-binding protein HlyB;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; type I protein secretion system complex [GO:0030256]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; peptidase activity [GO:0008233]; toxin transmembrane transporter activity [GO:0019534]; protein secretion by the type I secretion system [GO:0030253]; secretion by cell [GO:0032940]; toxin transport [GO:1901998]";"GO:0005524; GO:0005886; GO:0008233; GO:0016021; GO:0016887; GO:0019534; GO:0030253; GO:0030256; GO:0032940; GO:0042626; GO:1901998";"protein secretion by the type I secretion system [GO:0030253]; secretion by cell [GO:0032940]; toxin transport [GO:1901998]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; type I protein secretion system complex [GO:0030256]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; peptidase activity [GO:0008233]; toxin transmembrane transporter activity [GO:0019534]"
comp6394296_c0_seq1;GAXK01123864.1;Q27433;8.48E-31;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp6394846_c0_seq1;GAXK01123875.1;B0RLE7;3.52E-12;EXBD1_XANCB;Biopolymer transport protein exbD1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; protein transport [GO:0015031]";"GO:0005886; GO:0015031; GO:0016021; GO:0022857";protein transport [GO:0015031];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp639518_c0_seq1;GAXK01000957.1;P58872;3.63E-30;RHBL3_HUMAN;Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005509; GO:0016021";;integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp6395304_c0_seq1;GAXK01123880.1;Q08E00;9.80E-12;RASLC_BOVIN;Ras-like protein family member 12;"plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003";signal transduction [GO:0007165];plasma membrane [GO:0005886];"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp63954_c1_seq1;GAXK01171268.1;Q4KLQ5;8.25E-71;WDR76_XENLA;WD repeat-containing protein 76;cellular response to DNA damage stimulus [GO:0006974];GO:0006974;cellular response to DNA damage stimulus [GO:0006974];;
comp639563_c0_seq1;GAXK01001026.1;P23607;1.42E-26;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6396_c0_seq1;GAXK01101318.1;P04069;2.49E-95;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp639670_c0_seq1;GAXK01000971.1;Q5R668;2.49E-24;ACSL3_PONAB;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391";long-chain fatty acid metabolic process [GO:0001676];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp6396830_c0_seq1;GAXK01022917.1;Q86GF7;1.15E-29;CRUST_PANBO;Crustapain (EC 3.4.22.-) (NsCys);"extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";"GO:0005576; GO:0007586; GO:0008234; GO:0030163; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";extracellular region [GO:0005576];cysteine-type peptidase activity [GO:0008234]
comp6397560_c0_seq1;GAXK01022916.1;Q9NDM2;3.12E-13;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp639765_c0_seq1;GAXK01000937.1;E2AX35;4.97E-73;PROH4_CAMFO;IDLSRF-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp63977_c0_seq1;GAXK01171356.1;O42936;4.45E-13;LAS1_SCHPO;Pre-rRNA-processing protein las1;"chromosome, centromeric region [GO:0000775]; Las1 complex [GO:0090730]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; spindle pole [GO:0000922]; endonuclease activity [GO:0004519]; chromatin silencing at centromere [GO:0030702]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]";"GO:0000448; GO:0000460; GO:0000470; GO:0000775; GO:0000922; GO:0004519; GO:0005634; GO:0005635; GO:0005720; GO:0006364; GO:0030687; GO:0030702; GO:0090730";"chromatin silencing at centromere [GO:0030702]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]";"chromosome, centromeric region [GO:0000775]; Las1 complex [GO:0090730]; nuclear envelope [GO:0005635]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; spindle pole [GO:0000922]";endonuclease activity [GO:0004519]
comp639842_c1_seq1;GAXK01000923.1;O43345;2.85E-11;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp6398441_c0_seq1;GAXK01145889.1;P44121;6.24E-23;DNLI_HAEIN;DNA ligase (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP]);"ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";"GO:0003910; GO:0005524; GO:0006260; GO:0006310; GO:0046872; GO:0051103";"DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";;"ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]"
comp6398549_c0_seq1;GAXK01145896.1;Q9CAT7;9.52E-29;BTF3L_ARATH;Nascent polypeptide-associated complex subunit beta;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";"GO:0005739; GO:0005829; GO:0005854; GO:0042788";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";
comp6398759_c0_seq1;GAXK01145903.1;O96006;9.51E-10;ZBED1_HUMAN;Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0019789; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]"
comp6398848_c0_seq1;GAXK01145913.1;P15387;3.23E-24;KCNB1_RAT;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016020; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043025; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051259; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; voltage-gated potassium channel activity [GO:0005249]"
comp6399205_c0_seq1;GAXK01145914.1;P04323;3.54E-14;POL3_DROME;"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp6399525_c0_seq1;GAXK01145915.1;Q8JHJ1;8.29E-23;RL35_DANRE;60S ribosomal protein L35;"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625; GO:0030218; GO:0043009; GO:0051726";"chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp6399833_c0_seq1;GAXK01145899.1;P92519;1.42E-11;M810_ARATH;Uncharacterized mitochondrial protein AtMg00810 (ORF240b);mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp640_c0_seq1;GAXK01169832.1;Q00168;0;KCC2A_DROME;Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443";"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]"
comp64001_c0_seq1;GAXK01048542.1;P63100;8.23E-66;CANB1_RAT;Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1);"cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470]";"GO:0004721; GO:0005509; GO:0005829; GO:0006470; GO:0042383";protein dephosphorylation [GO:0006470];"cytosol [GO:0005829]; sarcolemma [GO:0042383]";"calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]"
comp6400577_c0_seq1;GAXK01019799.1;P48282;2.90E-07;CAH1_SHEEP;Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase I) (CA-I);"cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]";"GO:0004089; GO:0005737; GO:0006730; GO:0008270";one-carbon metabolic process [GO:0006730];cytoplasm [GO:0005737];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp6400580_c0_seq1;GAXK01019826.1;Q83JZ0;7.66E-42;PNCC_SHIFL;Nicotinamide-nucleotide amidohydrolase PncC (NMN amidohydrolase PncC) (EC 3.5.1.42) (NMN deamidase) (Nicotinamide-nucleotide amidase);"nicotinamide-nucleotide amidase activity [GO:0019159]; pyridine nucleotide biosynthetic process [GO:0019363]";"GO:0019159; GO:0019363";pyridine nucleotide biosynthetic process [GO:0019363];;nicotinamide-nucleotide amidase activity [GO:0019159]
comp6400828_c0_seq1;GAXK01019813.1;P16423;1.25E-13;POLR_DROME;"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0046872";;;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp640091_c0_seq1;GAXK01098399.1;O17754;2.83E-10;CBPE_CAEEL;Carboxypeptidase E (CPE) (EC 3.4.17.10) (Egg-laying defective protein 21);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; presynapse [GO:0098793]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; acetylcholine secretion, neurotransmission [GO:0014055]; cellular response to carbon dioxide [GO:0071244]; larval feeding behavior [GO:0030536]; negative regulation of pharyngeal pumping [GO:1903745]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of defecation [GO:2000294]; positive regulation of digestive system process [GO:0060456]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of eating behavior [GO:1903998]; regulation of muscle contraction [GO:0006937]";"GO:0004180; GO:0004181; GO:0005615; GO:0006518; GO:0006937; GO:0008270; GO:0014055; GO:0014057; GO:0016485; GO:0030424; GO:0030536; GO:0031410; GO:0043025; GO:0043204; GO:0045887; GO:0060456; GO:0061837; GO:0071244; GO:0090326; GO:0098793; GO:1903745; GO:1903998; GO:2000294";"acetylcholine secretion, neurotransmission [GO:0014055]; cellular response to carbon dioxide [GO:0071244]; larval feeding behavior [GO:0030536]; negative regulation of pharyngeal pumping [GO:1903745]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of defecation [GO:2000294]; positive regulation of digestive system process [GO:0060456]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of eating behavior [GO:1903998]; regulation of muscle contraction [GO:0006937]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; presynapse [GO:0098793]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp6401_c0_seq1;GAXK01101271.1;Q9Y5B9;0;SP16H_HUMAN;FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16);"chromosome [GO:0005694]; FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:0042393; GO:1901796";"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"chromosome [GO:0005694]; FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]"
comp640148_c0_seq1;GAXK01098476.1;Q9Z2D6;2.11E-08;MECP2_MOUSE;Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2);"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820";"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]";"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"
comp6402281_c0_seq1;GAXK01102216.1;Q8INF0;2.22E-47;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp64027_c2_seq1;GAXK01048573.1;Q9W0K4;2.64E-31;BAB2_DROME;Protein bric-a-brac 2;"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736";"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp6402742_c0_seq1;GAXK01102240.1;B8IN03;4.29E-72;ATPA_METNO;ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha);"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005886; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp64030_c0_seq1;GAXK01048416.1;Q91437;0;PYR1_SQUAC;"CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]";"GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]"
comp64032_c0_seq1;GAXK01049043.1;Q9VQ37;7.65E-90;RIM2_DROME;Mitochondrial carrier protein Rim2;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]";"GO:0005739; GO:0005743; GO:0006390; GO:0007005; GO:0015218; GO:0016021; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519";"cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";pyrimidine nucleotide transmembrane transporter activity [GO:0015218]
comp6403465_c0_seq1;GAXK01102225.1;Q94HW2;2.32E-23;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp6403612_c0_seq1;GAXK01102228.1;Q9VNM1;1.87E-13;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp6404206_c0_seq1;GAXK01200927.1;Q63HN8;1.79E-16;RN213_HUMAN;E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051";"angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]";"ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp640470_c0_seq1;GAXK01098478.1;A9ULY7;8.06E-127;IFT57_XENLA;Intraflagellar transport protein 57 homolog;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"GO:0005737; GO:0006915; GO:0006919; GO:0030992; GO:0036064; GO:0042981";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]";
comp6404738_c0_seq1;GAXK01200936.1;P35479;3.74E-23;CPI1_PIG;Leukocyte cysteine proteinase inhibitor 1 (PLCPI) (Stefin-D1);"cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]";"GO:0004869; GO:0005829";;cytosol [GO:0005829];cysteine-type endopeptidase inhibitor activity [GO:0004869]
comp640515_c0_seq1;GAXK01098465.1;Q3SXZ3;5.61E-20;ZN718_HUMAN;Zinc finger protein 718;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp64060_c1_seq1;GAXK01048485.1;Q08180;1.31E-61;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp640607_c0_seq1;GAXK01098444.1;E9PTT0;3.18E-116;ZDH17_RAT;Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 17);"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953";"lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]";"identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp640633_c1_seq1;GAXK01098384.1;Q8R420;1.54E-108;ABCA3_MOUSE;ATP-binding cassette sub-family A member 3;"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]";"GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233";"lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]";"alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp640670_c0_seq1;GAXK01098441.1;Q8K4K7;1.66E-21;ABRA_RAT;Actin-binding Rho-activating protein (MS1) (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp6408_c1_seq1;GAXK01100622.1;Q9Y3C1;3.57E-19;NOP16_HUMAN;Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3);"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0003723; GO:0005634; GO:0005730; GO:0042273; GO:0043231";ribosomal large subunit biogenesis [GO:0042273];"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp6408524_c0_seq1;GAXK01172553.1;Q9CL21;5.92E-09;RECQ_PASMU;ATP-dependent DNA helicase RecQ (EC 3.6.4.12);"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0006260; GO:0006281; GO:0006310; GO:0009432; GO:0043138";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";;"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]"
comp6408666_c0_seq1;GAXK01172568.1;A2SCX6;1.52E-18;MRAZ_METPP;Transcriptional regulator MraZ;"cytoplasm [GO:0005737]; nucleoid [GO:0009295]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005737; GO:0009295";;"cytoplasm [GO:0005737]; nucleoid [GO:0009295]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp6409_c3_seq1;GAXK01101094.1;Q17N71;0;CLU_AEDAE;Clustered mitochondria protein homolog;"cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312]";"GO:0005737; GO:0048312";intracellular distribution of mitochondria [GO:0048312];cytoplasm [GO:0005737];
comp6409944_c0_seq1;GAXK01172565.1;Q7KQZ4;9.98E-07;LOLA3_DROME;Longitudinals lacking protein, isoforms A/B/D/L;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6410_c0_seq1;GAXK01100099.1;Q01295;1.97E-34;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp6410035_c0_seq1;GAXK01049286.1;P0ACY5;5.41E-63;YEAG_ECO57;Uncharacterized protein YeaG;protein kinase activity [GO:0004672];GO:0004672;;;protein kinase activity [GO:0004672]
comp6410532_c0_seq1;GAXK01049290.1;Q9VNM1;8.92E-24;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp641129_c0_seq1;GAXK01098411.1;Q9VGW1;1.20E-118;CAD86_DROME;Cadherin-86C;"cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell shape [GO:0008360]";"GO:0005509; GO:0005887; GO:0005913; GO:0007156; GO:0008360; GO:0016339; GO:0035003; GO:0044331";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell shape [GO:0008360]";"cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; subapical complex [GO:0035003]";calcium ion binding [GO:0005509]
comp6411516_c0_seq1;GAXK01049283.1;P94408;1.51E-14;YCLF_BACSU;Uncharacterized transporter YclF;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937]";"GO:0005886; GO:0005887; GO:0015333; GO:0016021; GO:0035673; GO:0042937; GO:0071916; GO:1904680";;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide:proton symporter activity [GO:0015333]; peptide transmembrane transporter activity [GO:1904680]; tripeptide transmembrane transporter activity [GO:0042937]"
comp6411935_c0_seq1;GAXK01049281.1;Q19269;9.98E-25;NAS14_CAEEL;Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6412173_c0_seq1;GAXK01022589.1;Q09624;4.79E-12;PKD1_CAEEL;Location of vulva defective 1 (Polycystic kidney disease 1 protein homolog) (Polycystin-1);"cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; protein domain specific binding [GO:0019904]; detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608]";"GO:0005262; GO:0005929; GO:0007617; GO:0016020; GO:0016021; GO:0019904; GO:0034606; GO:0034608; GO:0043025; GO:0050982; GO:0060179; GO:0097730";"detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608]";"cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]";"calcium channel activity [GO:0005262]; protein domain specific binding [GO:0019904]"
comp6413004_c0_seq1;GAXK01022596.1;P14567;9.46E-17;DPO3A_SALTY;DNA polymerase III subunit alpha (EC 2.7.7.7);"cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; nucleic acid binding [GO:0003676]; DNA replication [GO:0006260]";"GO:0003676; GO:0003887; GO:0005737; GO:0006260; GO:0008408";DNA replication [GO:0006260];cytoplasm [GO:0005737];"3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; nucleic acid binding [GO:0003676]"
comp6413981_c0_seq1;GAXK01022600.1;H8EXN1;1.53E-08;SIGL_MYCTE;ECF RNA polymerase sigma factor SigL (ECF sigma factor SigL) (Alternative RNA polymerase sigma factor SigL) (RNA polymerase sigma-L factor) (Sigma-L factor);"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]; DNA-templated transcription, initiation [GO:0006352]";"GO:0003677; GO:0003700; GO:0006352; GO:0016987";DNA-templated transcription, initiation [GO:0006352];;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]"
comp6414782_c0_seq1;GAXK01027190.1;Q9V3G1;4.99E-88;RL8_DROME;60S ribosomal protein L8;"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp6415092_c0_seq1;GAXK01027184.1;P77495;5.21E-38;PRPE_ECOLI;Propionate--CoA ligase (EC 6.2.1.17) (Propionyl-CoA synthetase);"ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; propionate catabolic process, 2-methylcitrate cycle [GO:0019629]";"GO:0005524; GO:0019629; GO:0050218";propionate catabolic process, 2-methylcitrate cycle [GO:0019629];;"ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]"
comp6415603_c0_seq1;GAXK01027204.1;B7YZU2;3.58E-11;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp6415686_c0_seq1;GAXK01027194.1;Q3V0Q1;6.63E-10;DYH12_MOUSE;Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; protein ubiquitination [GO:0016567]";"GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0016567; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959";"microtubule-based movement [GO:0007018]; protein ubiquitination [GO:0016567]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp64159_c2_seq1;GAXK01048815.1;Q96RT1;2.82E-12;ERBIN_HUMAN;Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2);"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]";"GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0038128; GO:0045104; GO:0045175; GO:0045197; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072";"basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]";"basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]";"ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]"
comp6416_c0_seq1;GAXK01100297.1;Q4H2R2;1.74E-09;SSRP1_CIOIN;FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Structure-specific recognition protein 1);"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";"FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]"
comp6416457_c0_seq1;GAXK01154627.1;A3F5L3;7.46E-34;DES2_SORBI;Fatty acid desaturase DES2 (SbDES2) (EC 1.14.19.-);"integral component of membrane [GO:0016021]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0006636; GO:0016021; GO:0016717";unsaturated fatty acid biosynthetic process [GO:0006636];integral component of membrane [GO:0016021];oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]
comp6416563_c0_seq1;GAXK01154615.1;O97594;5.14E-16;SMC3_BOVIN;Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chondroitin sulfate proteoglycan 6);"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; dynein complex binding [GO:0070840]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"GO:0000775; GO:0000785; GO:0005524; GO:0006275; GO:0006281; GO:0016363; GO:0030893; GO:0051276; GO:0051301; GO:0051321; GO:0070840; GO:0097431";"cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]";"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]";"ATP binding [GO:0005524]; dynein complex binding [GO:0070840]"
comp6416776_c0_seq1;GAXK01154621.1;Q9NZJ4;5.05E-30;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp64173_c2_seq1;GAXK01048544.1;P25823;5.07E-18;TUD_DROME;Maternal protein tudor;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"GO:0005634; GO:0005737; GO:0005739; GO:0007277; GO:0007281; GO:0007315; GO:0008298; GO:0030719; GO:0043186; GO:0045495";"germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; P granule organization [GO:0030719]; pole cell development [GO:0007277]; pole plasm assembly [GO:0007315]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; pole plasm [GO:0045495]";
comp641789_c0_seq1;GAXK01098380.1;P07146;6.84E-35;TRY2_MOUSE;Anionic trypsin-2 (EC 3.4.21.4) (Anionic trypsin II) (Pretrypsinogen II) (Serine protease 2);"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]; response to caffeine [GO:0031000]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]";"GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007584; GO:0007586; GO:0030574; GO:0031000; GO:0035094; GO:0062023";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]; response to caffeine [GO:0031000]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]";"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]"
comp641791_c0_seq1;GAXK01098383.1;O02485;8.81E-49;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp6418_c1_seq1;GAXK01100052.1;P00766;2.71E-44;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp6418897_c0_seq1;GAXK01077588.1;Q96252;8.96E-24;ATP4_ARATH;ATP synthase subunit delta', mitochondrial (F-ATPase delta' subunit);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; plastid [GO:0009536]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; zinc ion binding [GO:0008270]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0000275; GO:0005739; GO:0005753; GO:0008270; GO:0009536; GO:0015986; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; plastid [GO:0009536]";"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; zinc ion binding [GO:0008270]"
comp642_c0_seq1;GAXK01166398.1;Q90YT6;1.47E-40;RL32_ICTPU;60S ribosomal protein L32;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp6420773_c0_seq1;GAXK01080781.1;Q5XIL8;1.08E-20;DNAI1_RAT;Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1);"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005874; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0036157; GO:0036158; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]"
comp642127_c0_seq1;GAXK01128704.1;Q04841;6.61E-61;3MG_MOUSE;DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase);"mitochondrial nucleoid [GO:0042645]; nucleus [GO:0005634]; alkylbase DNA N-glycosylase activity [GO:0003905]; DNA binding [GO:0003677]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]";"GO:0003677; GO:0003905; GO:0005634; GO:0006284; GO:0008725; GO:0042645; GO:0043916; GO:0052821; GO:0052822";base-excision repair [GO:0006284];"mitochondrial nucleoid [GO:0042645]; nucleus [GO:0005634]";"alkylbase DNA N-glycosylase activity [GO:0003905]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA binding [GO:0003677]"
comp642244_c0_seq1;GAXK01128821.1;P26323;1.33E-45;FLI1_MOUSE;Friend leukemia integration 1 transcription factor (Retroviral integration site protein Fli-1);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000978; GO:0000980; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005829; GO:0006355; GO:0006357; GO:0008015; GO:0009887; GO:0009987; GO:0016604; GO:0030154; GO:0035855; GO:0043565; GO:0045893; GO:0045944";"animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp6423150_c0_seq1;GAXK01110796.1;P05332;6.71E-17;YP20_BACLI;Uncharacterized N-acetyltransferase p20 (EC 2.3.1.-);N-acetyltransferase activity [GO:0008080];GO:0008080;;;N-acetyltransferase activity [GO:0008080]
comp6423310_c0_seq1;GAXK01110805.1;Q9LT78;2.59E-31;RD21C_ARATH;Probable cysteine protease RD21C (EC 3.4.22.-);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp6423385_c0_seq1;GAXK01110807.1;P11718;7.29E-24;ATXA_LEIDO;Probable proton ATPase 1A (EC 7.1.2.1) (LdH1A);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]";"GO:0005524; GO:0008553; GO:0016021; GO:0046872; GO:0120029";proton export across plasma membrane [GO:0120029];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp642380_c0_seq1;GAXK01128716.1;P08562;8.75E-58;TBB_TRYCR;Tubulin beta chain (Beta-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp6424015_c0_seq1;GAXK01057062.1;Q8BTK5;3.61E-11;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp642462_c0_seq1;GAXK01128707.1;Q0EEE2;1.41E-27;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp64249_c2_seq1;GAXK01048984.1;Q6DBN1;3.96E-19;Y4845_ARATH;BTB/POZ domain-containing protein At4g08455;"cytoplasm [GO:0005737]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";cytoplasm [GO:0005737];ubiquitin protein ligase binding [GO:0031625]
comp642525_c0_seq1;GAXK01128738.1;P34358;1.12E-09;CED7_CAEEL;ABC transporter ced-7 (Cell death protein 7);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; transmembrane transporter activity [GO:0022857]; aminophospholipid transport [GO:0015917]; apoptotic process involved in development [GO:1902742]; establishment of mitotic spindle orientation [GO:0000132]; left/right axis specification [GO:0070986]; lipid transport [GO:0006869]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; programmed cell death [GO:0012501]";"GO:0000132; GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0012501; GO:0015917; GO:0016021; GO:0016887; GO:0022857; GO:0042626; GO:0043231; GO:0070986; GO:1901076; GO:1902742; GO:1903356; GO:1904747";"aminophospholipid transport [GO:0015917]; apoptotic process involved in development [GO:1902742]; establishment of mitotic spindle orientation [GO:0000132]; left/right axis specification [GO:0070986]; lipid transport [GO:0006869]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; programmed cell death [GO:0012501]";"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]; transmembrane transporter activity [GO:0022857]"
comp642572_c0_seq1;GAXK01128815.1;Q8BXJ9;1.33E-112;TMM62_MOUSE;Transmembrane protein 62;"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp6426080_c0_seq1;GAXK01027619.1;Q09575;2.72E-20;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp642611_c2_seq1;GAXK01128796.1;O77721;4.51E-29;ADA2B_HORSE;Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) (Fragment);"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]";"GO:0004935; GO:0004938; GO:0005887; GO:0006940; GO:0007188; GO:0009986; GO:0019229; GO:0030168; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]";"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]";"adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]"
comp6426477_c0_seq1;GAXK01027625.1;O76080;3.77E-10;ZFAN5_HUMAN;AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0005737; GO:0008270";;cytoplasm [GO:0005737];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp6426857_c0_seq1;GAXK01027627.1;Q4W946;1.26E-20;ENCD_ASPFU;2-oxoglutarate-Fe(II) type oxidoreductase (EC 1.14.11.-) (Endocrocin synthesis protein D);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; endocrocin biosynthetic process [GO:1900602]";"GO:0046872; GO:0051213; GO:1900602";endocrocin biosynthetic process [GO:1900602];;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp64273_c2_seq1;GAXK01048404.1;O17468;2.33E-151;HIRA_DROME;Protein HIRA homolog (Protein sesame) (dHIRA);"chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; HIR complex [GO:0000417]; male germ cell nucleus [GO:0001673]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; chromatin silencing at centromere [GO:0030702]; DNA replication-independent nucleosome assembly [GO:0006336]; fertilization, exchange of chromosomal proteins [GO:0035042]; mitotic sister chromatid segregation [GO:0000070]; regulation of chromatin silencing [GO:0031935]; sperm chromatin decondensation [GO:0035041]; transcription, DNA-templated [GO:0006351]";"GO:0000070; GO:0000417; GO:0000775; GO:0000790; GO:0001673; GO:0003682; GO:0003714; GO:0005634; GO:0006336; GO:0006338; GO:0006351; GO:0030702; GO:0031935; GO:0035041; GO:0035042; GO:0042585";"chromatin remodeling [GO:0006338]; chromatin silencing at centromere [GO:0030702]; DNA replication-independent nucleosome assembly [GO:0006336]; fertilization, exchange of chromosomal proteins [GO:0035042]; mitotic sister chromatid segregation [GO:0000070]; regulation of chromatin silencing [GO:0031935]; sperm chromatin decondensation [GO:0035041]; transcription, DNA-templated [GO:0006351]";"chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; HIR complex [GO:0000417]; male germ cell nucleus [GO:0001673]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]"
comp64288_c1_seq1;GAXK01048735.1;B7PDC5;2.77E-37;GATA_IXOSC;Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7);"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"GO:0004040; GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681";"glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]";"glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]";"amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp6429_c0_seq1;GAXK01100722.1;O18334;4.17E-132;RAB6_DROME;Ras-related protein Rab6 (Protein warthog);"cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0016192; GO:0030054; GO:0031410; GO:0031982; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0050832; GO:0060078";"axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp643_c0_seq1;GAXK01168178.1;Q07832;0;PLK1_MOUSE;Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13);"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to organelle [GO:0033365]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; synaptonemal complex disassembly [GO:0070194]";"GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000780; GO:0000785; GO:0000795; GO:0000922; GO:0000942; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005876; GO:0006468; GO:0007094; GO:0007098; GO:0007346; GO:0008017; GO:0010800; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0033365; GO:0034451; GO:0040038; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0070194; GO:0071168; GO:0072425; GO:0090435; GO:1901673; GO:1904668; GO:1904776";"centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to organelle [GO:0033365]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; synaptonemal complex disassembly [GO:0070194]";"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]";"anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]"
comp64303_c0_seq1;GAXK01048674.1;O97018;1.64E-60;SXL_CHRRU;Sex-lethal homolog;"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]";"GO:0000380; GO:0003723; GO:0005634; GO:0007530; GO:1990904";"alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]";"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp64304_c1_seq1;GAXK01048698.1;Q3TN34;1.03E-20;MILK2_MOUSE;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp6430420_c0_seq1;GAXK01034641.1;Q80V63;3.34E-07;PRDM4_MOUSE;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005123; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0035097; GO:0043565; GO:0045944; GO:0046872; GO:1990226; GO:2000177; GO:2000736";"negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp64307_c0_seq1;GAXK01048415.1;Q8T3B9;2.73E-27;SEM2_CAEEL;Transcription factor sem-2 (Sex muscle abnormal protein 2);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; myoblast fate specification [GO:0048626]; positive regulation of embryonic development [GO:0040019]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of oviposition [GO:1901046]; positive regulation of post-embryonic development [GO:0048582]; positive regulation of vulval development [GO:0040026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007501; GO:0030154; GO:0040019; GO:0040026; GO:0044798; GO:0048337; GO:0048582; GO:0048626; GO:1901046";"cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; myoblast fate specification [GO:0048626]; positive regulation of embryonic development [GO:0040019]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of oviposition [GO:1901046]; positive regulation of post-embryonic development [GO:0048582]; positive regulation of vulval development [GO:0040026]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp6431531_c0_seq1;GAXK01034640.1;P00760;4.38E-18;TRY1_BOVIN;"Cationic trypsin (EC 3.4.21.4) (Beta-trypsin) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872; GO:0046982; GO:0097180; GO:0097655";"digestion [GO:0007586]; proteolysis [GO:0006508]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp643175_c0_seq1;GAXK01128719.1;Q29458;2.16E-15;LIPG_BOVIN;Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Pregastric esterase) (PGE);"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0016298; GO:0043231; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]";"lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]"
comp6432_c0_seq1;GAXK01100564.1;P62330;7.74E-48;ARF6_HUMAN;ADP-ribosylation factor 6;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006886; GO:0007049; GO:0007155; GO:0016020; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0048261; GO:0048488; GO:0050714; GO:0051301; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0070062; GO:0090073; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098978; GO:0099562; GO:1903078; GO:1903393; GO:1905606; GO:1990090; GO:2000009; GO:2000171";"cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]"
comp64329_c2_seq1;GAXK01048805.1;Q5R4J5;4.38E-40;SYT1_PONAB;Synaptotagmin-1 (Synaptotagmin I) (SytI);"cell junction [GO:0030054]; chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]";"GO:0005544; GO:0007269; GO:0016021; GO:0030054; GO:0030154; GO:0030672; GO:0042584; GO:0046872; GO:1903235";"cell differentiation [GO:0030154]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]";"cell junction [GO:0030054]; chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]";"calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]"
comp643313_c0_seq1;GAXK01128740.1;P42282;1.35E-26;TTKA_DROME;Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp6433488_c0_seq1;GAXK01188805.1;Q73U14;3.92E-32;MSRA_MYCPA;Peptide methionine sulfoxide reductase MsrA (Protein-methionine-S-oxide reductase) (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase);"peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]";"GO:0006464; GO:0008113";cellular protein modification process [GO:0006464];;peptide-methionine (S)-S-oxide reductase activity [GO:0008113]
comp6434329_c0_seq1;GAXK01184953.1;Q5M8X6;7.28E-09;COL10_XENTR;Collectin-10;"collagen trimer [GO:0005581]; extracellular space [GO:0005615]; mannose binding [GO:0005537]; monosaccharide binding [GO:0048029]; developmental process [GO:0032502]";"GO:0005537; GO:0005581; GO:0005615; GO:0032502; GO:0048029";developmental process [GO:0032502];"collagen trimer [GO:0005581]; extracellular space [GO:0005615]";"mannose binding [GO:0005537]; monosaccharide binding [GO:0048029]"
comp6434714_c0_seq1;GAXK01184948.1;Q03413;4.59E-11;MEF2D_XENLA;Myocyte-specific enhancer factor 2D homolog (Serum response factor-like protein 1) (SL-1);"nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000977; GO:0005634; GO:0045944; GO:0046983";positive regulation of transcription by RNA polymerase II [GO:0045944];nucleus [GO:0005634];"protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp64351_c0_seq1;GAXK01048612.1;Q95M18;6.52E-21;ENPL_BOVIN;Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0001666; GO:0003723; GO:0005524; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006457; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0033018; GO:0034663; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0071318";"actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]";"ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]"
comp6435843_c0_seq1;GAXK01184935.1;D4A612;3.96E-15;ELOV2_RAT;Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp6436132_c0_seq1;GAXK01022337.1;Q9RA11;7.88E-73;SELO_MORMI;Protein adenylyltransferase SelO (EC 2.7.7.-) (EC 2.7.7.n1);"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]";"GO:0000287; GO:0005524; GO:0016779";;;"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]"
comp643680_c0_seq1;GAXK01128709.1;P74615;3.57E-12;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp643683_c1_seq1;GAXK01128758.1;P22770;1.78E-54;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp643694_c0_seq1;GAXK01128817.1;Q9PVG3;1.69E-18;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp6436969_c0_seq1;GAXK01022319.1;Q9DAK2;3.76E-28;PACRG_MOUSE;Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein);"cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]";"GO:0001664; GO:0003779; GO:0005739; GO:0005829; GO:0005929; GO:0007286; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225";"cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]";"cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]";"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]"
comp6436990_c0_seq1;GAXK01022314.1;P10733;3.25E-74;SEVE_DICDI;Severin;"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"GO:0015629; GO:0030043; GO:0045335; GO:0048306; GO:0051014; GO:0051015; GO:0051693";"actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]";"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]"
comp6437_c3_seq1;GAXK01101169.1;Q28DB5;0;ALAT2_XENTR;Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2);"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";"GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853";"2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]";;"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
comp643731_c0_seq1;GAXK01128710.1;A8Y1P7;3.16E-77;BRE4_CAEBR;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";integral component of membrane [GO:0016021];"metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp643765_c2_seq1;GAXK01128777.1;Q3EBC8;8.27E-37;DCL2_ARATH;Endoribonuclease Dicer homolog 2 (EC 3.1.26.-) (Dicer-like protein 2) (AtDCL2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; maintenance of DNA methylation [GO:0010216]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; RNA virus induced gene silencing [GO:0051214]";"GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0010216; GO:0010267; GO:0016442; GO:0030422; GO:0046872; GO:0051214";"maintenance of DNA methylation [GO:0010216]; production of siRNA involved in RNA interference [GO:0030422]; production of ta-siRNAs involved in RNA interference [GO:0010267]; RNA virus induced gene silencing [GO:0051214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]"
comp6438161_c0_seq1;GAXK01129127.1;Q3KQ77;1.02E-22;EFCB1_XENLA;EF-hand calcium-binding domain-containing protein 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp64383_c0_seq1;GAXK01049088.1;Q9GKX2;2.21E-98;DHRS4_RABIT;Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (rabNRDR) (Fragment);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]";"GO:0004090; GO:0005739; GO:0005777";;"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";carbonyl reductase (NADPH) activity [GO:0004090]
comp6438805_c0_seq1;GAXK01129124.1;P98081;3.28E-10;DAB_DROME;Protein disabled;"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005118; GO:0005737; GO:0005829; GO:0007349; GO:0007391; GO:0008045; GO:0017124; GO:0030424; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793";"cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; presynapse [GO:0098793]";"sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]"
comp643903_c0_seq1;GAXK01128734.1;Q9P121;1.60E-23;NTRI_HUMAN;Neurotrimin (hNT) (IgLON family member 2);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp643961_c0_seq1;GAXK01128717.1;Q61116;1.00E-34;ZN235_MOUSE;Zinc finger protein 235 (Zinc finger protein 93) (Zfp-93);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6439786_c0_seq1;GAXK01129128.1;Q80YP6;2.34E-09;ZIK1_MOUSE;Zinc finger protein interacting with ribonucleoprotein K;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp64401_c0_seq1;GAXK01048423.1;Q9HBH1;2.26E-35;DEFM_HUMAN;Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase);"mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]";"GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872";"co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]";mitochondrion [GO:0005739];"metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]"
comp6440286_c0_seq1;GAXK01172514.1;Q00519;9.22E-44;XDH_MOUSE;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]";"GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006150; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010044; GO:0010629; GO:0016491; GO:0016529; GO:0030151; GO:0030856; GO:0042803; GO:0043546; GO:0045602; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0055114; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp6440487_c0_seq1;GAXK01172526.1;P21783;1.43E-08;NOTC1_XENLA;"Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314";"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]";"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]"
comp644092_c0_seq1;GAXK01061564.1;P05090;6.28E-08;APOD_HUMAN;Apolipoprotein D (Apo-D) (ApoD);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp6440973_c0_seq1;GAXK01172497.1;P05661;4.68E-26;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp6441_c0_seq1;GAXK01100578.1;Q18359;3.05E-35;NDUA5_CAEEL;Probable NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5;"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0005747; GO:0006120";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];mitochondrial respiratory chain complex I [GO:0005747];
comp6441394_c0_seq1;GAXK01172513.1;Q86MW9;1.60E-12;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp6441639_c0_seq1;GAXK01172512.1;P17970;2.21E-15;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp6441830_c0_seq1;GAXK01172515.1;Q94HW2;3.17E-17;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp644303_c0_seq1;GAXK01061553.1;O42449;2.27E-16;IOD1_ORENI;Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]";"GO:0004800; GO:0005789; GO:0016021; GO:0042446";hormone biosynthetic process [GO:0042446];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";thyroxine 5'-deiodinase activity [GO:0004800]
comp6443771_c0_seq1;GAXK01037056.1;Q86YE8;3.17E-16;ZN573_HUMAN;Zinc finger protein 573;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp644448_c0_seq1;GAXK01061600.1;O54749;2.32E-69;CP2J5_MOUSE;Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805]";"GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097254; GO:2000863";"angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp6444624_c0_seq1;GAXK01117660.1;Q5VTY9;8.14E-08;HHAT_HUMAN;Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2) (MART-2) (Skinny hedgehog protein 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; multicellular organism development [GO:0007275]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]";"GO:0005525; GO:0005783; GO:0005789; GO:0007224; GO:0007275; GO:0008374; GO:0016021; GO:0016409; GO:0016746; GO:0018345";"multicellular organism development [GO:0007275]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"
comp644492_c0_seq1;GAXK01061535.1;Q9VVE5;1.18E-48;MSIR6_DROME;RNA-binding protein Musashi homolog Rbp6;"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]";"GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904";stem cell development [GO:0048864];"cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp6445_c1_seq1;GAXK01100311.1;Q8QG64;6.32E-64;RBX1_SALSA;RING-box protein 1 (Rbx1) (Hyperosmotic protein 21) (sHOP21);"Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; NEDD8 transferase activity [GO:0019788]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0019005; GO:0019788; GO:0031146; GO:0031463; GO:0031464; GO:0031465; GO:0031467; GO:0043161; GO:0045116";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]";"NEDD8 transferase activity [GO:0019788]; zinc ion binding [GO:0008270]"
comp644568_c0_seq1;GAXK01061583.1;Q13360;5.34E-22;ZN177_HUMAN;Zinc finger protein 177;"blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0005634; GO:0046872; GO:0072562";negative regulation of transcription by RNA polymerase II [GO:0000122];"blood microparticle [GO:0072562]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6446_c1_seq1;GAXK01100565.1;Q9UBV7;3.47E-88;B4GT7_HUMAN;Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase);"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0097435";"carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]";"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"
comp6446201_c0_seq1;GAXK01157009.1;O61998;4.67E-45;HSP90_BRUPA;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp6446294_c0_seq1;GAXK01156992.1;Q21355;9.07E-10;GST4_CAEEL;Glutathione S-transferase 4 (EC 2.5.1.18) (CeGST1) (GST class-sigma);"contractile fiber [GO:0043292]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749; GO:0043292";glutathione metabolic process [GO:0006749];contractile fiber [GO:0043292];glutathione transferase activity [GO:0004364]
comp644691_c0_seq1;GAXK01061586.1;Q0IHH9;5.66E-15;SPOPB_XENLA;Speckle-type POZ protein B;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp644729_c0_seq1;GAXK01061623.1;Q1H9T6;2.03E-23;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp6448212_c0_seq1;GAXK01046531.1;D9IA43;1.64E-83;CCON1_PSEST;Cbb3-type cytochrome c oxidase subunit CcoN1 (EC 1.9.3.1) (Cytochrome CBB3 subunit CcoN1);"cytochrome complex [GO:0070069]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane respirasome [GO:0070470]; plasma membrane respiratory chain complex IV [GO:0045278]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]; electron transporter, transferring electrons within cytochrome c oxidase complex activity [GO:0045154]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; oxygen binding [GO:0019825]; aerobic electron transport chain [GO:0019646]; aerobic respiration, using ferrous ions as electron donor [GO:0019411]; electron transport coupled proton transport [GO:0015990]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; proton transmembrane transport [GO:1902600]";"GO:0004129; GO:0005506; GO:0005507; GO:0005886; GO:0005887; GO:0006119; GO:0015990; GO:0016705; GO:0019411; GO:0019646; GO:0019825; GO:0020037; GO:0045154; GO:0045278; GO:0055114; GO:0070069; GO:0070470; GO:1902600";"aerobic electron transport chain [GO:0019646]; aerobic respiration, using ferrous ions as electron donor [GO:0019411]; electron transport coupled proton transport [GO:0015990]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; proton transmembrane transport [GO:1902600]";"cytochrome complex [GO:0070069]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane respirasome [GO:0070470]; plasma membrane respiratory chain complex IV [GO:0045278]";"copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]; electron transporter, transferring electrons within cytochrome c oxidase complex activity [GO:0045154]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; oxygen binding [GO:0019825]"
comp6448219_c0_seq1;GAXK01046537.1;Q9EQG6;3.49E-17;KDIS_RAT;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0005770; GO:0005829; GO:0010976; GO:0016021; GO:0019887; GO:0019901; GO:0030165; GO:0032991; GO:0038180; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]"
comp64484_c3_seq1;GAXK01048721.1;Q9Y606;6.78E-88;TRUA_HUMAN;tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]";"GO:0000049; GO:0002153; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0009982; GO:0031119; GO:0070902; GO:0106029; GO:1990481";"mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]"
comp644841_c0_seq1;GAXK01061594.1;Q9HB97;6.71E-67;PARVA_RAT;Alpha-parvin (Actopaxin);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; actin binding [GO:0003779]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein heterooligomerization [GO:0051291]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0002040; GO:0003148; GO:0003779; GO:0005737; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0019904; GO:0030018; GO:0030031; GO:0030036; GO:0031532; GO:0032991; GO:0034113; GO:0034446; GO:0051291; GO:0060271; GO:0070252; GO:0071670";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein heterooligomerization [GO:0051291]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]";"actin binding [GO:0003779]; protein domain specific binding [GO:0019904]"
comp64487_c0_seq1;GAXK01049044.1;Q27HK4;4.32E-65;MTX1_PIG;Metaxin-1 (Mitochondrial outer membrane import complex protein 1);"integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; protein transport [GO:0015031]";"GO:0001401; GO:0015031; GO:0016021";protein transport [GO:0015031];"integral component of membrane [GO:0016021]; SAM complex [GO:0001401]";
comp6448879_c0_seq1;GAXK01046536.1;Q5AF03;2.09E-15;HSP31_CANAL;Glyoxalase 3 (EC 4.2.1.130) (Glutathione-independent glyoxalase);"fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]";"GO:0019172; GO:0019243; GO:0030445; GO:0030446; GO:0062040";methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243];"fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]";glyoxalase III activity [GO:0019172]
comp6449069_c0_seq1;GAXK01046522.1;P13110;8.80E-07;TYTR_TRYCO;Trypanothione reductase (TR) (EC 1.8.1.12) (N(1),N(8)-bis(glutathionyl)spermidine reductase);"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; trypanothione-disulfide reductase activity [GO:0015042]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015042; GO:0045454; GO:0050660";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; trypanothione-disulfide reductase activity [GO:0015042]"
comp6449222_c0_seq1;GAXK01046527.1;Q17152;4.07E-45;EF2_BLAHO;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp64495_c2_seq1;GAXK01048905.1;Q641Y5;1.04E-41;ATG7_RAT;Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like);"axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; aging [GO:0007568]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to morphine [GO:0071315]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; regulation of neuron death [GO:1901214]; response to fluoride [GO:1902617]; response to glucose [GO:0009749]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]";"GO:0000045; GO:0000407; GO:0000422; GO:0005737; GO:0005930; GO:0006501; GO:0006914; GO:0006995; GO:0007568; GO:0008134; GO:0009267; GO:0009749; GO:0010508; GO:0015031; GO:0019778; GO:0019779; GO:0030424; GO:0031401; GO:0031667; GO:0032446; GO:0034727; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0060548; GO:0061684; GO:0071315; GO:0071455; GO:0075044; GO:0090298; GO:1901214; GO:1902617; GO:1903204";"aging [GO:0007568]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to hyperoxia [GO:0071455]; cellular response to morphine [GO:0071315]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; regulation of neuron death [GO:1901214]; response to fluoride [GO:1902617]; response to glucose [GO:0009749]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]";"axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]";"Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]"
comp6449712_c0_seq1;GAXK01046535.1;P18714;2.65E-14;ZG20_XENLA;Gastrula zinc finger protein xFG20-1 (XlCGF20.1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6450_c0_seq1;GAXK01100453.1;P51644;1.75E-64;ARF4_XENLA;ADP-ribosylation factor 4;"Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005794; GO:0015031; GO:0016192";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";Golgi apparatus [GO:0005794];GTP binding [GO:0005525]
comp64508_c1_seq1;GAXK01048838.1;Q8BFX3;0;KCTD3_MOUSE;BTB/POZ domain-containing protein KCTD3;"plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]";"GO:0005886; GO:0051260";protein homooligomerization [GO:0051260];plasma membrane [GO:0005886];
comp645098_c0_seq1;GAXK01061597.1;Q875S9;3.32E-08;AKR1_LACK1;Palmitoyltransferase AKR1 (EC 2.3.1.225) (Ankyrin repeat-containing protein AKR1);"early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]";"GO:0000139; GO:0016021; GO:0019706; GO:0031901";;"early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-cysteine S-palmitoyltransferase activity [GO:0019706]
comp6451524_c0_seq1;GAXK01189703.1;Q25691;2.29E-65;VATB_PLAFA;V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B);"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";"GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600";"ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]";proton-transporting V-type ATPase, V1 domain [GO:0033180];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
comp6451878_c0_seq1;GAXK01189721.1;P21599;4.46E-40;KPYK2_ECOLI;Pyruvate kinase II (EC 2.7.1.40) (PK-2);"cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; protein homotetramerization [GO:0051289]";"GO:0000287; GO:0004743; GO:0005524; GO:0005829; GO:0016301; GO:0030955; GO:0042802; GO:0051289";protein homotetramerization [GO:0051289];cytosol [GO:0005829];"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]"
comp6451993_c0_seq1;GAXK01189709.1;P12078;8.10E-29;HSP73_PLAFA;Heat shock 70 kDa protein PPF203 (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp6452400_c0_seq1;GAXK01073876.1;O46040;1.02E-11;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp6453_c0_seq1;GAXK01100260.1;A8WMM4;6.29E-68;ZC3HF_CAEBR;Zinc finger CCCH domain-containing protein 15 homolog;"cytosol [GO:0005829]; metal ion binding [GO:0046872]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0005829; GO:0046872";cytoplasmic translation [GO:0002181];cytosol [GO:0005829];metal ion binding [GO:0046872]
comp645304_c0_seq1;GAXK01061549.1;Q91YL3;8.52E-118;UCKL1_MOUSE;Uridine-cytidine kinase-like 1 (EC 2.7.1.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206";"nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp645339_c0_seq1;GAXK01061569.1;P02833;1.09E-11;ANTP_DROME;Homeotic protein antennapedia;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]";"GO:0000122; GO:0000980; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0007383; GO:0007384; GO:0007419; GO:0007494; GO:0007507; GO:0009948; GO:0009952; GO:0014019; GO:0042694; GO:0043565; GO:0045944; GO:0048542; GO:0050767";"anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]"
comp645401_c0_seq1;GAXK01061520.1;Q8VHE6;0;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp645408_c0_seq1;GAXK01061589.1;Q5R9S5;7.05E-21;ZN182_PONAB;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6454467_c0_seq1;GAXK01156676.1;Q9LV21;8.78E-34;TCPD_ARATH;T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Chaperonin CCT4);"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]";"GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082";"protein folding [GO:0006457]; response to cadmium ion [GO:0046686]";"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp645496_c0_seq1;GAXK01061550.1;Q8IS64;3.66E-145;ECE_LOCMI;Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp645520_c2_seq1;GAXK01061514.1;Q9UDX3;8.77E-46;S14L4_HUMAN;SEC14-like protein 4 (Tocopherol-associated protein 3);lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp6455287_c0_seq1;GAXK01156673.1;Q8NBS9;1.25E-27;TXND5_HUMAN;Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46);"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005783; GO:0005788; GO:0016853; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0045454; GO:0070062";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]";isomerase activity [GO:0016853]
comp645559_c0_seq1;GAXK01061554.1;D4AZ24;2.43E-12;ENG1_ARTBC;Probable endo-1,3(4)-beta-glucanase ARB_01444 (Endo-1,3-beta-glucanase) (Endo-1,4-beta-glucanase) (EC 3.2.1.6) (Laminarinase);"cell wall [GO:0005618]; extracellular region [GO:0005576]; glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]";"GO:0005576; GO:0005618; GO:0008152; GO:0052861; GO:0052862";metabolic process [GO:0008152];"cell wall [GO:0005618]; extracellular region [GO:0005576]";"glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]"
comp6456015_c0_seq1;GAXK01072124.1;Q9VMU4;2.48E-46;RL37A_DROME;60S ribosomal protein L37a;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0046872";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp645655_c0_seq1;GAXK01061560.1;Q2LE78;4.22E-11;BTBD6_XENLA;BTB/POZ domain-containing protein 6;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp64573_c1_seq1;GAXK01049024.1;Q571H0;3.95E-15;NPA1P_MOUSE;Nucleolar pre-ribosomal-associated protein 1 (URB1 ribosome biogenesis 1 homolog);"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0000466; GO:0001650; GO:0005730";"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"fibrillar center [GO:0001650]; nucleolus [GO:0005730]";
comp6457302_c0_seq1;GAXK01072106.1;Q9N1U2;4.01E-11;HSP76_SAGOE;Heat shock 70 kDa protein 6 (Hsp-70-related intracellular vitamin D-binding protein);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp64577_c3_seq1;GAXK01048679.1;Q8BXQ2;1.84E-130;PIGT_MOUSE;GPI transamidase component PIG-T (Neuronal development-associated protein 7) (Phosphatidylinositol-glycan biosynthesis class T protein);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]";"GO:0005737; GO:0016255; GO:0030182; GO:0031410; GO:0042765; GO:0051402";"attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765]";
comp64579_c3_seq1;GAXK01048585.1;Q90593;1.56E-176;BIP_CHICK;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein);"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090074; GO:1903895";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp6458_c0_seq1;GAXK01100140.1;A7SE05;5.85E-82;UBE2S_NEMVE;Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S);"anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005524; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";anaphase-promoting complex [GO:0005680];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]"
comp645804_c0_seq1;GAXK01061518.1;P21902;1.47E-34;PCE_TACTR;"Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]";"extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0030133; GO:0042381; GO:0046872";hemolymph coagulation [GO:0042381];"extracellular region [GO:0005576]; transport vesicle [GO:0030133]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp645839_c0_seq1;GAXK01061539.1;Q6DN12;6.68E-38;MCTP2_HUMAN;Multiple C2 and transmembrane domain-containing protein 2;"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; multicellular organism development [GO:0007275]";"GO:0005509; GO:0005654; GO:0005829; GO:0007275; GO:0016020; GO:0016021; GO:0019722; GO:0030672";"calcium-mediated signaling [GO:0019722]; multicellular organism development [GO:0007275]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp64585_c4_seq1;GAXK01048525.1;Q9W1A4;3.60E-37;TAMO_DROME;Protein tamozhennic;"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005737; GO:0007275; GO:0008536; GO:0015031; GO:0046872";"multicellular organism development [GO:0007275]; protein transport [GO:0015031]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]"
comp6458809_c0_seq1;GAXK01045212.1;Q8BFQ9;2.15E-08;KLH42_MOUSE;Kelch-like protein 42 (Cullin-3-binding protein 9) (Ctb9) (Kelch domain-containing protein 5);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; spindle [GO:0005819]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of microtubule-based process [GO:0032886]";"GO:0000209; GO:0004842; GO:0005737; GO:0005819; GO:0007049; GO:0031463; GO:0032886; GO:0043161; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of microtubule-based process [GO:0032886]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; spindle [GO:0005819]";ubiquitin-protein transferase activity [GO:0004842]
comp6458924_c0_seq1;GAXK01045217.1;O13672;2.33E-20;RL8_SCHPO;60S ribosomal protein L8 (L4) (L7A);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp64591_c4_seq1;GAXK01048467.1;O14976;3.31E-154;GAK_HUMAN;Cyclin-G-associated kinase (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]";"GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0061024; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:1905224";"cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]"
comp6459244_c0_seq1;GAXK01045216.1;Q30QN8;1.36E-22;RL21_SULDN;50S ribosomal protein L21;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp645982_c0_seq1;GAXK01061519.1;P46472;3.05E-23;PRS7_XENLA;26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1) (xMSS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0016887; GO:0022624; GO:0036402";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]"
comp646082_c1_seq1;GAXK01008423.1;P29981;3.59E-75;CP4C1_BLADI;Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp6461_c4_seq1;GAXK01100454.1;Q9VC57;0;ATLAS_DROME;Atlastin (EC 3.6.5.-);"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl ribonucleotide binding [GO:0032561]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; microtubule depolymerization [GO:0007019]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein homooligomerization [GO:0051260]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]";"GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005794; GO:0007019; GO:0007029; GO:0007030; GO:0007517; GO:0007528; GO:0008582; GO:0012505; GO:0016020; GO:0016021; GO:0016320; GO:0031114; GO:0031227; GO:0032561; GO:0042802; GO:0042803; GO:0048691; GO:0051124; GO:0051260; GO:0061025";"endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; microtubule depolymerization [GO:0007019]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein homooligomerization [GO:0051260]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]";"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanyl ribonucleotide binding [GO:0032561]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp64610_c0_seq1;GAXK01048692.1;Q8BH24;4.07E-40;TM9S4_MOUSE;Transmembrane 9 superfamily member 4;"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010";"cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp646109_c2_seq1;GAXK01008458.1;Q7KRI2;5.10E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp646139_c2_seq1;GAXK01008447.1;Q24400;6.59E-47;MLP2_DROME;Muscle LIM protein Mlp84B;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537; GO:0090175";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp64614_c0_seq1;GAXK01049085.1;Q9ESV0;8.80E-117;DDX24_MOUSE;ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp6461528_c0_seq1;GAXK01137878.1;P10074;5.92E-07;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp6461546_c0_seq1;GAXK01137900.1;Q2Q426;2.71E-08;AGRE2_MACMU;Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312);"integral component of plasma membrane [GO:0005887]; leading edge membrane [GO:0031256]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]";"GO:0004930; GO:0005509; GO:0005887; GO:0006954; GO:0007155; GO:0007166; GO:0007189; GO:0016477; GO:0031256; GO:0032587; GO:0035374; GO:0071621";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]";"integral component of plasma membrane [GO:0005887]; leading edge membrane [GO:0031256]; ruffle membrane [GO:0032587]";"calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; G protein-coupled receptor activity [GO:0004930]"
comp646197_c1_seq1;GAXK01008429.1;Q5R4G5;6.07E-62;ARL6_PONAB;ADP-ribosylation factor-like protein 6;"axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; membrane coat [GO:0030117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cell projection organization [GO:0030030]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]";"GO:0003924; GO:0005525; GO:0005543; GO:0005879; GO:0005930; GO:0006612; GO:0030030; GO:0030117; GO:0046872; GO:0051258; GO:0060170";"cell projection organization [GO:0030030]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]";"axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; membrane coat [GO:0030117]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]"
comp646207_c0_seq1;GAXK01008435.1;Q6IWH7;0;ANO7_HUMAN;Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);"cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0030054; GO:0034220; GO:0046983; GO:0061589; GO:0061590; GO:0061591";"calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]";"cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]"
comp64622_c0_seq1;GAXK01048609.1;Q6NUW5;3.62E-28;AN32E_DANRE;Acidic leucine-rich nuclear phosphoprotein 32 family member E;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone binding [GO:0042393]; histone exchange [GO:0043486]";"GO:0000812; GO:0005634; GO:0005737; GO:0042393; GO:0043486";histone exchange [GO:0043486];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]";histone binding [GO:0042393]
comp646252_c0_seq1;GAXK01008421.1;Q9VKY1;8.25E-58;LIX1_DROME;Protein limb expression 1 homolog (lowfat);"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; subapical complex [GO:0035003]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; imaginal disc-derived wing morphogenesis [GO:0007476]";"GO:0005737; GO:0005829; GO:0006914; GO:0007476; GO:0016324; GO:0035003; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; imaginal disc-derived wing morphogenesis [GO:0007476]";"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; subapical complex [GO:0035003]";
comp6462931_c0_seq1;GAXK01056008.1;Q9WV27;4.48E-33;AT1A4_MOUSE;Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]";"GO:0005391; GO:0005524; GO:0005886; GO:0006814; GO:0006883; GO:0007283; GO:0009566; GO:0016021; GO:0030007; GO:0030317; GO:0030641; GO:0036376; GO:0042391; GO:0046872; GO:1902600; GO:1990573";"cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp646295_c0_seq1;GAXK01008471.1;Q92008;6.08E-121;SHH_DANRE;Sonic hedgehog protein A (SHHA) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) (VHH-1) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)];"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardioblast differentiation [GO:0010002]; caudal fin morphogenesis [GO:0035143]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; determination of left/right symmetry [GO:0007368]; diencephalon development [GO:0021536]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; endocrine pancreas development [GO:0031018]; eye photoreceptor cell development [GO:0042462]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; gliogenesis [GO:0042063]; glomerulus development [GO:0032835]; habenula development [GO:0021986]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; midbrain-hindbrain boundary development [GO:0030917]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural plate morphogenesis [GO:0001839]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; oligodendrocyte differentiation [GO:0048709]; oligodendrocyte progenitor proliferation [GO:0070444]; pancreas development [GO:0031016]; pectoral fin development [GO:0033339]; photoreceptor cell maintenance [GO:0045494]; post-embryonic foregut morphogenesis [GO:0048618]; pronephros development [GO:0048793]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; regulation of cardiac muscle tissue regeneration [GO:1905178]; regulation of cartilage development [GO:0061035]; regulation of gene expression [GO:0010468]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; spinal cord motor neuron cell fate specification [GO:0021520]; striated muscle cell development [GO:0055002]; swim bladder morphogenesis [GO:0048795]";"GO:0001708; GO:0001756; GO:0001839; GO:0001947; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007368; GO:0007399; GO:0007411; GO:0007417; GO:0007420; GO:0007507; GO:0007517; GO:0008015; GO:0008233; GO:0008285; GO:0009952; GO:0009953; GO:0010001; GO:0010002; GO:0010468; GO:0016539; GO:0021508; GO:0021520; GO:0021536; GO:0021984; GO:0021986; GO:0030182; GO:0030900; GO:0030902; GO:0030917; GO:0030947; GO:0031016; GO:0031018; GO:0031076; GO:0032835; GO:0033339; GO:0033504; GO:0035143; GO:0042063; GO:0042462; GO:0042476; GO:0042694; GO:0043010; GO:0045494; GO:0048557; GO:0048618; GO:0048663; GO:0048702; GO:0048703; GO:0048709; GO:0048741; GO:0048793; GO:0048795; GO:0048839; GO:0055002; GO:0060956; GO:0061035; GO:0070444; GO:1905178; GO:2000223";"adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardioblast differentiation [GO:0010002]; caudal fin morphogenesis [GO:0035143]; cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; determination of left/right symmetry [GO:0007368]; diencephalon development [GO:0021536]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; endocrine pancreas development [GO:0031018]; eye photoreceptor cell development [GO:0042462]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; gliogenesis [GO:0042063]; glomerulus development [GO:0032835]; habenula development [GO:0021986]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; midbrain-hindbrain boundary development [GO:0030917]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural plate morphogenesis [GO:0001839]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; oligodendrocyte differentiation [GO:0048709]; oligodendrocyte progenitor proliferation [GO:0070444]; pancreas development [GO:0031016]; pectoral fin development [GO:0033339]; photoreceptor cell maintenance [GO:0045494]; post-embryonic foregut morphogenesis [GO:0048618]; pronephros development [GO:0048793]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; regulation of cardiac muscle tissue regeneration [GO:1905178]; regulation of cartilage development [GO:0061035]; regulation of gene expression [GO:0010468]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; spinal cord motor neuron cell fate specification [GO:0021520]; striated muscle cell development [GO:0055002]; swim bladder morphogenesis [GO:0048795]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp6463852_c0_seq1;GAXK01056009.1;P15112;1.18E-42;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp64640_c2_seq1;GAXK01048933.1;Q9DG10;2.07E-21;STAR_DANRE;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005758; GO:0006694; GO:0008203; GO:0015485; GO:0032367; GO:0050810; GO:0120020";"cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp6464918_c0_seq1;GAXK01084912.1;B1Y2Y7;8.29E-39;G6PI_LEPCP;Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI);"cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004347; GO:0005737; GO:0006094; GO:0006096";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];glucose-6-phosphate isomerase activity [GO:0004347]
comp6465_c1_seq1;GAXK01101210.1;Q9W6S8;1.25E-08;SMN1_DANRE;Survival motor neuron protein 1;"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; SMN complex [GO:0032797]; spliceosomal complex [GO:0005681]; Z disc [GO:0030018]; RNA binding [GO:0003723]; axon development [GO:0061564]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; mRNA splicing, via spliceosome [GO:0000398]; neuromuscular junction development [GO:0007528]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of oxidative phosphorylation [GO:1903862]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of neuromuscular junction development [GO:1904396]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0007409; GO:0007528; GO:0008045; GO:0015030; GO:0016358; GO:0030018; GO:0032797; GO:0032991; GO:0036464; GO:0043005; GO:0043204; GO:0048675; GO:0048841; GO:0048936; GO:0061564; GO:0097504; GO:1903862; GO:1904396";"axon development [GO:0061564]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; mRNA splicing, via spliceosome [GO:0000398]; neuromuscular junction development [GO:0007528]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of oxidative phosphorylation [GO:1903862]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of neuromuscular junction development [GO:1904396]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; SMN complex [GO:0032797]; spliceosomal complex [GO:0005681]; Z disc [GO:0030018]";RNA binding [GO:0003723]
comp64656_c2_seq1;GAXK01048787.1;P60321;1.00E-18;NANO2_HUMAN;Nanos homolog 2 (NOS-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007275; GO:0007283; GO:0008270; GO:0017148; GO:0030154; GO:0030718; GO:0045835; GO:0048471; GO:1900153";"cell differentiation [GO:0030154]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; multicellular organism development [GO:0007275]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]"
comp6466105_c0_seq1;GAXK01160839.1;P24046;2.31E-14;GBRR1_HUMAN;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098978; GO:0098982; GO:0099507; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp64672_c1_seq1;GAXK01048739.1;Q60636;1.10E-64;PRDM1_MOUSE;PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841";"adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp646782_c0_seq1;GAXK01008445.1;Q9LVW9;1.11E-09;ARI4_ARATH;Putative E3 ubiquitin-protein ligase ARI4 (EC 2.3.2.31) (ARIADNE-like protein ARI4) (Protein ariadne homolog 4) (RING-type E3 ubiquitin transferase ARI4);"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]";"GO:0004842; GO:0046872";;;"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp646786_c0_seq1;GAXK01008433.1;Q502M6;8.59E-18;ANR29_DANRE;Ankyrin repeat domain-containing protein 29;;;;;
comp64679_c0_seq1;GAXK01048779.1;D4AZ24;9.45E-64;ENG1_ARTBC;Probable endo-1,3(4)-beta-glucanase ARB_01444 (Endo-1,3-beta-glucanase) (Endo-1,4-beta-glucanase) (EC 3.2.1.6) (Laminarinase);"cell wall [GO:0005618]; extracellular region [GO:0005576]; glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]";"GO:0005576; GO:0005618; GO:0008152; GO:0052861; GO:0052862";metabolic process [GO:0008152];"cell wall [GO:0005618]; extracellular region [GO:0005576]";"glucan endo-1,3-beta-glucanase activity, C-3 substituted reducing group [GO:0052861]; glucan endo-1,4-beta-glucanase activity, C-3 substituted reducing group [GO:0052862]"
comp646795_c0_seq1;GAXK01008472.1;Q6ZR52;1.04E-13;ZN493_HUMAN;Zinc finger protein 493;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6468025_c0_seq1;GAXK01122440.1;Q149M9;2.71E-14;NWD1_HUMAN;NACHT domain- and WD repeat-containing protein 1;"cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";"GO:0005524; GO:0005829; GO:0010628; GO:0032088";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";cytosol [GO:0005829];ATP binding [GO:0005524]
comp646864_c0_seq1;GAXK01008436.1;Q805E5;3.35E-19;CHSTE_DANRE;Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0050655";"carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp646929_c0_seq1;GAXK01008412.1;A1L1W9;9.83E-101;MOT10_DANRE;Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10);"integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]";"GO:0005887; GO:0015173; GO:0015349";;integral component of plasma membrane [GO:0005887];"aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp6470177_c0_seq1;GAXK01122927.1;Q9QYI5;5.10E-32;DNJB2_MOUSE;DnaJ homolog subfamily B member 2 (DnaJ homolog subfamily B member 10) (mDj8);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0043130; GO:0043161; GO:0051082; GO:0051087; GO:0061077; GO:0070628; GO:0090084; GO:0090086; GO:0140036; GO:1903644";"chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp647024_c0_seq1;GAXK01008396.1;Q8NB42;3.83E-26;ZN527_HUMAN;Zinc finger protein 527;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6470298_c0_seq1;GAXK01122930.1;P24136;6.32E-32;OPPD_BACSU;Oligopeptide transport ATP-binding protein OppD (Stage 0 sporulation protein KD);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; transmembrane transporter activity [GO:0022857]; establishment of competence for transformation [GO:0030420]; protein transport [GO:0015031]; sporulation resulting in formation of a cellular spore [GO:0030435]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0015031; GO:0016887; GO:0022857; GO:0030420; GO:0030435; GO:0055085";"establishment of competence for transformation [GO:0030420]; protein transport [GO:0015031]; sporulation resulting in formation of a cellular spore [GO:0030435]; transmembrane transport [GO:0055085]";plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]"
comp647035_c1_seq1;GAXK01008419.1;Q9W0K7;1.08E-13;BAB1_DROME;Protein bric-a-brac 1;"nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092";"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp6470564_c0_seq1;GAXK01122943.1;P11442;1.60E-24;CLH1_RAT;Clathrin heavy chain 1;"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; extrinsic component of synaptic vesicle membrane [GO:0098850]; melanosome [GO:0042470]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]; terminal bouton [GO:0043195]; ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; heat shock protein binding [GO:0031072]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; clathrin coat assembly [GO:0048268]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]";"GO:0000278; GO:0005198; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0008022; GO:0030118; GO:0030130; GO:0030132; GO:0030315; GO:0030506; GO:0030669; GO:0031072; GO:0032051; GO:0042277; GO:0042383; GO:0042470; GO:0043195; GO:0045334; GO:0048268; GO:0048488; GO:0071439; GO:0098850; GO:1900126";"autophagy [GO:0006914]; clathrin coat assembly [GO:0048268]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]";"clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; extrinsic component of synaptic vesicle membrane [GO:0098850]; melanosome [GO:0042470]; sarcolemma [GO:0042383]; spindle [GO:0005819]; terminal bouton [GO:0043195]; T-tubule [GO:0030315]";"ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; heat shock protein binding [GO:0031072]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]"
comp6471029_c0_seq1;GAXK01122937.1;B7ZRU9;1.70E-08;EVI1A_XENLA;MDS1 and EVI1 complex locus protein EVI1-A (Ecotropic virus integration site 1 protein homolog-A) (Evi-1) (xEvi-1);"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";"GO:0000122; GO:0003677; GO:0016607; GO:0039013; GO:0039022; GO:0045892; GO:0046872; GO:0048793; GO:0072196";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pronephric distal tubule morphogenesis [GO:0039013]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; proximal/distal pattern formation involved in pronephric nephron development [GO:0072196]";nuclear speck [GO:0016607];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6471186_c0_seq1;GAXK01122929.1;Q28008;1.69E-07;CLC3A_BOVIN;C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin);"extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; ossification [GO:0001503]";"GO:0001503; GO:0005615; GO:0030246";ossification [GO:0001503];extracellular space [GO:0005615];carbohydrate binding [GO:0030246]
comp6472069_c0_seq1;GAXK01110569.1;A6QNM3;1.00E-14;ORC2_BOVIN;Origin recognition complex subunit 2;"nuclear origin of replication recognition complex [GO:0005664]; DNA replication origin binding [GO:0003688]; DNA replication [GO:0006260]";"GO:0003688; GO:0005664; GO:0006260";DNA replication [GO:0006260];nuclear origin of replication recognition complex [GO:0005664];DNA replication origin binding [GO:0003688]
comp64725_c0_seq1;GAXK01048482.1;Q0VEE6;7.11E-11;ZN800_MOUSE;Zinc finger protein 800;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp64729_c0_seq1;GAXK01048413.1;Q9NRZ5;3.84E-69;PLCD_HUMAN;1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0016746";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp6474432_c0_seq1;GAXK01071093.1;P50430;2.95E-20;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp647446_c0_seq1;GAXK01008415.1;P39413;2.73E-10;AEF1_DROME;Adult enhancer factor 1 (AEF-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp64749_c0_seq1;GAXK01048836.1;A4IHD2;0;ARIP4_XENTR;Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]";"GO:0003677; GO:0003678; GO:0005524; GO:0005634";;nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp647523_c1_seq1;GAXK01008444.1;Q9CXE0;2.07E-30;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp64754_c0_seq1;GAXK01049047.1;Q7ZX06;2.98E-13;SPOPA_XENLA;Speckle-type POZ protein A;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";
comp6476101_c0_seq1;GAXK01008884.1;Q80W47;3.56E-14;WIPI2_MOUSE;WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2);"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0061739; GO:0080025; GO:0098792";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]";"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]"
comp64765_c0_seq1;GAXK01049042.1;F1QRX7;1.58E-54;TBCD7_DANRE;TBC1 domain family member 7;"cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; negative regulation of TOR signaling [GO:0032007]; response to growth factor [GO:0070848]";"GO:0005096; GO:0017137; GO:0031410; GO:0032007; GO:0070848; GO:0090630";"activation of GTPase activity [GO:0090630]; negative regulation of TOR signaling [GO:0032007]; response to growth factor [GO:0070848]";cytoplasmic vesicle [GO:0031410];"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp647655_c0_seq1;GAXK01008406.1;Q7KRI2;2.96E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp64766_c0_seq1;GAXK01048763.1;Q8CCP0;0;NEMF_MOUSE;Nuclear export mediator factor Nemf (Serologically defined colon cancer antigen 1 homolog);"nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]";"GO:0000049; GO:0005634; GO:0043023; GO:0051168; GO:0072344; GO:1990112; GO:1990116";"nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]";"nucleus [GO:0005634]; RQC complex [GO:1990112]";"ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]"
comp647930_c0_seq1;GAXK01008470.1;Q5ZJ81;2.76E-26;SHLB2_CHICK;Endophilin-B2 (SH3 domain-containing GRB2-like protein B2);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp6480332_c0_seq1;GAXK01120926.1;Q9SZY7;6.25E-13;VATO1_ARATH;V-type proton ATPase subunit c''1 (V-ATPase subunit c''1) (Vacuolar H(+)-ATPase subunit c'' isoform 1) (Vacuolar proton pump subunit c''1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0000139; GO:0005789; GO:0016021; GO:0033179; GO:0046961";;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp6481_c0_seq1;GAXK01100262.1;Q32PE0;4.52E-46;RPAB2_BOVIN;DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog);"nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383";"transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp6481083_c0_seq1;GAXK01120920.1;P45447;1.66E-14;E78C_DROME;Ecdysone-induced protein 78C (DR-78) (Nuclear receptor subfamily 1 group E member 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565; GO:0045892";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp648125_c0_seq1;GAXK01173741.1;O94892;1.20E-51;ZN432_HUMAN;Zinc finger protein 432;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005654; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6482473_c0_seq1;GAXK01077892.1;A0A086F3E3;3.05E-39;TM175_CHRP1;Potassium channel HX13_20290;"integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]";"GO:0016021; GO:0022841; GO:0042802; GO:0051289; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]";integral component of membrane [GO:0016021];"identical protein binding [GO:0042802]; potassium ion leak channel activity [GO:0022841]"
comp6482598_c0_seq1;GAXK01077882.1;Q8BXX2;2.27E-08;ZBT49_MOUSE;Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872";"cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp64827_c0_seq1;GAXK01048387.1;P04253;1.34E-75;HCY2_LIMPO;Hemocyanin II;"extracellular space [GO:0005615]; chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]; oxygen transport [GO:0015671]; protein complex oligomerization [GO:0051259]";"GO:0005344; GO:0005507; GO:0005615; GO:0015671; GO:0016491; GO:0031404; GO:0051259";"oxygen transport [GO:0015671]; protein complex oligomerization [GO:0051259]";extracellular space [GO:0005615];"chloride ion binding [GO:0031404]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp648283_c0_seq1;GAXK01173729.1;P17970;0;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp6483069_c0_seq1;GAXK01077900.1;Q9P7I2;7.66E-08;KCC1_SCHPO;Calcium/calmodulin-dependent protein kinase type I (CaMK-I) (EC 2.7.11.17);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; negative regulation of calcineurin-mediated signaling [GO:0106057]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]";"GO:0000122; GO:0004672; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005829; GO:0010621; GO:0010972; GO:0034599; GO:0071277; GO:0106057";"cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; negative regulation of calcineurin-mediated signaling [GO:0106057]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]"
comp648319_c0_seq1;GAXK01173735.1;Q9Z2Z6;2.19E-39;MCAT_MOUSE;Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0015227; GO:0016021; GO:1902603";"carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";acyl carnitine transmembrane transporter activity [GO:0015227]
comp6483249_c0_seq1;GAXK01077897.1;Q7Z5M8;7.95E-07;AB12B_HUMAN;Protein ABHD12B (EC 3.-.-.-) (Abhydrolase domain-containing protein 12B) (Alpha/beta hydrolase domain-containing protein 12B);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp6483519_c0_seq1;GAXK01077905.1;O65581;3.40E-25;ALFC5_ARATH;Fructose-bisphosphate aldolase 5, cytosolic (AtFBA5) (EC 4.1.2.13);"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";cytosol [GO:0005829];fructose-bisphosphate aldolase activity [GO:0004332]
comp648369_c0_seq1;GAXK01173721.1;Q9U7D1;2.88E-12;H3_MASBA;Histone H3;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp6484016_c0_seq1;GAXK01090914.1;Q09575;5.87E-07;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp6484035_c0_seq1;GAXK01090916.1;Q55595;1.47E-26;LGUL_SYNY3;Probable lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase);"lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]";"GO:0004462; GO:0046872";;;"lactoylglutathione lyase activity [GO:0004462]; metal ion binding [GO:0046872]"
comp648438_c0_seq1;GAXK01173669.1;Q86IC9;1.01E-35;CAMT1_DICDI;Probable caffeoyl-CoA O-methyltransferase 1 (EC 2.1.1.104) (O-methyltransferase 5);"caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]";"GO:0042409; GO:0046872";;;"caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]"
comp648527_c0_seq1;GAXK01173738.1;P02981;1.23E-09;TCR3_ECOLX;Tetracycline resistance protein, class C (TetA(C));"integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; ion transport [GO:0006811]; response to antibiotic [GO:0046677]";"GO:0005887; GO:0006811; GO:0015297; GO:0046677";"ion transport [GO:0006811]; response to antibiotic [GO:0046677]";integral component of plasma membrane [GO:0005887];antiporter activity [GO:0015297]
comp6485618_c0_seq1;GAXK01090910.1;Q99MD8;1.63E-14;MYNN_MOUSE;Myoneurin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to leukemia inhibitory factor [GO:1990830]";"GO:0003677; GO:0005634; GO:0046872; GO:1990830";cellular response to leukemia inhibitory factor [GO:1990830];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6485732_c0_seq1;GAXK01090908.1;Q1WNP0;4.99E-16;DHB1_PANTR;Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1);"cytoplasm [GO:0005737]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]";"GO:0004303; GO:0005737; GO:0006703";estrogen biosynthetic process [GO:0006703];cytoplasm [GO:0005737];estradiol 17-beta-dehydrogenase activity [GO:0004303]
comp648775_c0_seq1;GAXK01173719.1;Q6GR09;1.33E-20;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp6488_c1_seq1;GAXK01101233.1;P21914;1.49E-146;SDHB_DROME;Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip);"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]";"GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539";"aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]"
comp648928_c1_seq1;GAXK01205910.1;Q6R7M4;4.52E-80;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp6490_c0_seq1;GAXK01100503.1;Q92797;0;SYMPK_HUMAN;Symplekin;"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006369; GO:0006378; GO:0006406; GO:0007155; GO:0031124; GO:0032091; GO:0035307; GO:0097165";"cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";
comp6490612_c0_seq1;GAXK01203549.1;Q5DW34;4.98E-12;EHMT1_MOUSE;Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Lysine N-methyltransferase 1D);"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0060992; GO:0070742; GO:0120162";"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]"
comp64913_c2_seq1;GAXK01048445.1;P97876;1.46E-07;BATF3_RAT;Basic leucine zipper transcriptional factor ATF-like 3 (B-ATF-3) (Jun dimerization protein 1) (JDP-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; dendritic cell differentiation [GO:0097028]; myeloid dendritic cell differentiation [GO:0043011]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]";"GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0009615; GO:0043011; GO:0046982; GO:0097028";"dendritic cell differentiation [GO:0097028]; myeloid dendritic cell differentiation [GO:0043011]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp6491376_c0_seq1;GAXK01203534.1;P72991;1.12E-26;FTSH3_SYNY3;ATP-dependent zinc metalloprotease FtsH 3 (EC 3.4.24.-);"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"GO:0004176; GO:0004222; GO:0005524; GO:0006508; GO:0008270; GO:0009535; GO:0009941; GO:0010027; GO:0010205; GO:0010206; GO:0010304; GO:0016021";"photoinhibition [GO:0010205]; photosystem II repair [GO:0010206]; proteolysis [GO:0006508]; PSII associated light-harvesting complex II catabolic process [GO:0010304]; thylakoid membrane organization [GO:0010027]";"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6492591_c0_seq1;GAXK01030534.1;Q5ZM39;4.20E-09;BCL6_CHICK;B-cell lymphoma 6 protein homolog;"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";"GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001953; GO:0002467; GO:0002829; GO:0003677; GO:0003682; GO:0005634; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043087; GO:0043380; GO:0043565; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0051272";"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell population proliferation [GO:0042127]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp6493198_c0_seq1;GAXK01030525.1;P21329;2.83E-13;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp64938_c0_seq1;GAXK01048611.1;A6KXU3;2.00E-29;DDL_BACV8;D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]"
comp6494080_c0_seq1;GAXK01144016.1;P40114;5.58E-09;TOP1_BACAN;DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I) (Omega-protein) (Relaxing enzyme) (Swivelase) (Untwisting enzyme);"DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]; pathogenesis [GO:0009405]";"GO:0003677; GO:0003917; GO:0006265; GO:0009405; GO:0046872";"DNA topological change [GO:0006265]; pathogenesis [GO:0009405]";;"DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; metal ion binding [GO:0046872]"
comp6494174_c0_seq1;GAXK01144031.1;Q88PP0;1.10E-30;HMP_PSEPK;Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17);"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";"GO:0005344; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046872; GO:0051409; GO:0071949";"response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";;"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp64945_c0_seq1;GAXK01048965.1;Q5ZIL9;1.92E-85;KBP_CHICK;KIF1-binding protein homolog;"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; kinesin binding [GO:0019894]; cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]";"GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0019894; GO:0030154";"cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]";"cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]";kinesin binding [GO:0019894]
comp6494520_c0_seq1;GAXK01144026.1;P46293;7.23E-82;RS16_GOSHI;40S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp649666_c2_seq1;GAXK01173743.1;Q3ZBH3;2.81E-19;CD151_BOVIN;CD151 antigen (CD antigen CD151);"integral component of plasma membrane [GO:0005887]; integrin binding [GO:0005178]; cell migration [GO:0016477]";"GO:0005178; GO:0005887; GO:0016477";cell migration [GO:0016477];integral component of plasma membrane [GO:0005887];integrin binding [GO:0005178]
comp6497302_c0_seq1;GAXK01072444.1;Q6ZR08;9.56E-30;DYH12_HUMAN;Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0030286";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp6497462_c0_seq1;GAXK01072434.1;Q9Y5X1;3.40E-11;SNX9_HUMAN;Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A);"clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032437; GO:0032461; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045296; GO:0045860; GO:0051044; GO:0060988; GO:0061024; GO:0070062; GO:0071933; GO:0097320";"cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898]";"clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]";"1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp64976_c1_seq1;GAXK01048412.1;Q5ZJ85;2.05E-153;PRPF3_CHICK;U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540";"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]";
comp6498457_c0_seq1;GAXK01021727.1;Q9CAT7;8.22E-32;BTF3L_ARATH;Nascent polypeptide-associated complex subunit beta;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";"GO:0005739; GO:0005829; GO:0005854; GO:0042788";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";
comp649862_c0_seq1;GAXK01173740.1;Q9D6P8;4.41E-27;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6498949_c0_seq1;GAXK01021704.1;O96952;2.19E-40;THIO_GEOCY;Thioredoxin (Trx);"cytoplasm [GO:0005737]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"GO:0005737; GO:0006662; GO:0015035; GO:0045454";"cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";cytoplasm [GO:0005737];protein disulfide oxidoreductase activity [GO:0015035]
comp6499295_c0_seq1;GAXK01021708.1;Q3J4D7;1.44E-54;MCM_RHOS4;Methylmalonyl-CoA mutase (MCM) (EC 5.4.99.2);"cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]";"GO:0004494; GO:0031419; GO:0046872";;;"cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]"
comp649933_c0_seq1;GAXK01173737.1;O54963;1.80E-11;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6499505_c0_seq1;GAXK01021728.1;Q95209;4.16E-15;SORL_RABIT;Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA);"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; adaptive thermogenesis [GO:1990845]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]";"GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005794; GO:0005886; GO:0006605; GO:0006869; GO:0006897; GO:0008203; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0030514; GO:0034362; GO:0038020; GO:0046628; GO:1904179; GO:1990845";"adaptive thermogenesis [GO:1990845]; cholesterol metabolic process [GO:0008203]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; lipid transport [GO:0006869]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]";"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]";
comp6499551_c0_seq1;GAXK01021703.1;P05661;3.20E-33;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp6499594_c0_seq1;GAXK01021722.1;P14381;7.02E-07;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp649963_c0_seq1;GAXK01173715.1;Q91Y77;3.46E-83;MOT10_RAT;Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]";"GO:0005887; GO:0015173; GO:0015349; GO:0016323";;"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]";"aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp649989_c0_seq1;GAXK01173730.1;P93748;3.65E-14;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp65001_c0_seq1;GAXK01048483.1;Q86GF7;2.57E-42;CRUST_PANBO;Crustapain (EC 3.4.22.-) (NsCys);"extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";"GO:0005576; GO:0007586; GO:0008234; GO:0030163; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";extracellular region [GO:0005576];cysteine-type peptidase activity [GO:0008234]
comp6500536_c0_seq1;GAXK01021424.1;P49311;9.10E-17;GRP2_SINAL;Glycine-rich RNA-binding protein GRP2A;"nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634";;nucleus [GO:0005634];RNA binding [GO:0003723]
comp650170_c0_seq1;GAXK01099226.1;Q6GM59;8.33E-32;MOT12_XENLA;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]";"GO:0005308; GO:0005887; GO:0015293; GO:0015881";creatine transmembrane transport [GO:0015881];integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]"
comp650257_c0_seq1;GAXK01099261.1;Q7KRI2;3.34E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp650301_c0_seq1;GAXK01099216.1;Q61102;2.20E-151;ABCB7_MOUSE;ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular iron ion homeostasis [GO:0006879]";"GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0016021; GO:0016887; GO:0042626";cellular iron ion homeostasis [GO:0006879];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp6503703_c0_seq1;GAXK01196396.1;P54408;7.03E-74;TCPG_TETPY;T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp650395_c0_seq1;GAXK01099227.1;Q9R1D1;3.25E-19;CTCF_RAT;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"GO:0000775; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0008285; GO:0044212; GO:0045944; GO:0046872; GO:0071459; GO:1902895";"chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp650487_c0_seq1;GAXK01099267.1;Q8VIG1;6.94E-12;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp650497_c0_seq1;GAXK01099275.1;Q8BQ89;1.93E-29;LIX1L_MOUSE;LIX1-like protein;"cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";"GO:0005737; GO:0006914; GO:0097352";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]";cytoplasm [GO:0005737];
comp650500_c0_seq1;GAXK01099259.1;Q9N2R3;2.24E-23;TPM_CHAFE;Tropomyosin (Allergen Cha f I) (allergen Cha f 1) (Fragment);;;;;
comp6505589_c0_seq1;GAXK01014941.1;Q95SX7;4.33E-08;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp6506407_c0_seq1;GAXK01087672.1;Q09575;3.08E-11;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp650724_c0_seq1;GAXK01099238.1;P33511;1.38E-51;NU4M_ANOQU;NADH-ubiquinone oxidoreductase chain 4 (EC 7.1.1.2) (NADH dehydrogenase subunit 4);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0006120; GO:0008137; GO:0016021; GO:0031966; GO:0070469";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp65079_c0_seq1;GAXK01048743.1;Q9VKG9;1.08E-47;SPZ4_DROME;Protein spaetzle 4 (Protein spatzle 4);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0008083; GO:0008592; GO:0021556; GO:0045087";"central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp6507921_c0_seq1;GAXK01087664.1;Q3SI46;1.55E-91;SYE_THIDA;Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]";"GO:0000049; GO:0004818; GO:0005524; GO:0005737; GO:0006424; GO:0008270";glutamyl-tRNA aminoacylation [GO:0006424];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp65081_c0_seq1;GAXK01048741.1;Q9VL13;3.06E-98;MOB3_DROME;MOB kinase activator-like 3 (Mob as tumor suppressor protein 3) (Dmob3) (Mps one binder kinase activator-like 3);"metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]";"GO:0019901; GO:0046872";;;"metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]"
comp6508354_c0_seq1;GAXK01198081.1;Q12618;9.04E-25;ACO1_AJECA;Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0006636; GO:0016021; GO:0020037; GO:0046872";unsaturated fatty acid biosynthetic process [GO:0006636];integral component of membrane [GO:0016021];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]"
comp650866_c0_seq1;GAXK01099219.1;P06537;4.05E-16;GCR_MOUSE;Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromatin binding [GO:0003682]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor activity [GO:0004883]; heat shock protein binding [GO:0031072]; hormone binding [GO:0042562]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; adrenal gland development [GO:0030325]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; glucocorticoid metabolic process [GO:0008211]; glucocorticoid receptor signaling pathway [GO:0042921]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000978; GO:0001012; GO:0001047; GO:0001228; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005815; GO:0005819; GO:0005829; GO:0006111; GO:0006338; GO:0006351; GO:0006355; GO:0008134; GO:0008211; GO:0008270; GO:0010906; GO:0014049; GO:0014069; GO:0016020; GO:0016607; GO:0019901; GO:0030325; GO:0030544; GO:0030971; GO:0031072; GO:0031914; GO:0031946; GO:0032183; GO:0032991; GO:0042127; GO:0042562; GO:0042711; GO:0042803; GO:0042921; GO:0043005; GO:0043066; GO:0043116; GO:0043197; GO:0043525; GO:0043565; GO:0044877; GO:0045944; GO:0046685; GO:0046982; GO:0046983; GO:0048096; GO:0051879; GO:0060603; GO:0060999; GO:0061051; GO:0071383; GO:0071385; GO:0071549; GO:0071560; GO:0098978; GO:0099092; GO:1900170; GO:1902895; GO:1990239; GO:2000324";"adrenal gland development [GO:0030325]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin-mediated maintenance of transcription [GO:0048096]; chromatin remodeling [GO:0006338]; glucocorticoid metabolic process [GO:0008211]; glucocorticoid receptor signaling pathway [GO:0042921]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; spindle [GO:0005819]";"chromatin binding [GO:0003682]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor activity [GO:0004883]; heat shock protein binding [GO:0031072]; hormone binding [GO:0042562]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp6508698_c0_seq1;GAXK01198087.1;P54811;1.38E-138;TERA1_CAEEL;Transitional endoplasmic reticulum ATPase homolog 1 (EC 3.6.4.6) (Cell division cycle-related protein 48.1) (p97/CDC48 homolog 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of protein localization to chromatin [GO:1905634]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008340; GO:0009792; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0032436; GO:0034098; GO:0042802; GO:0044877; GO:0045977; GO:0048471; GO:0051228; GO:0071712; GO:0097352; GO:1905634";"autophagosome maturation [GO:0097352]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of protein localization to chromatin [GO:1905634]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]"
comp650923_c0_seq1;GAXK01099303.1;Q6NSZ9;7.14E-26;ZSC25_HUMAN;Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp650982_c1_seq1;GAXK01099262.1;Q8JIY1;1.20E-27;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp651_c0_seq1;GAXK01168223.1;P40320;0;METK_DROME;S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT);"cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0008340; GO:0046872";"determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytosol [GO:0005829];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp6510045_c0_seq1;GAXK01089809.1;P0AC86;2.55E-46;PHSG_ECOLI;Glycogen phosphorylase (EC 2.4.1.1);"glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; carbohydrate catabolic process [GO:0016052]; glycogen catabolic process [GO:0005980]";"GO:0005980; GO:0008184; GO:0016052; GO:0030170; GO:0102250; GO:0102499";"carbohydrate catabolic process [GO:0016052]; glycogen catabolic process [GO:0005980]";;"glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]"
comp6511282_c0_seq1;GAXK01089807.1;P62820;1.65E-36;RAB1A_HUMAN;Ras-related protein Rab-1A (YPT1-related protein);"cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; transport vesicle membrane [GO:0030658]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 secretion [GO:0072606]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]; virion assembly [GO:0019068]";"GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006897; GO:0006914; GO:0007030; GO:0016192; GO:0016477; GO:0019068; GO:0030252; GO:0030658; GO:0032402; GO:0032482; GO:0034446; GO:0042470; GO:0042742; GO:0043687; GO:0045296; GO:0047496; GO:0048208; GO:0070062; GO:0072606; GO:0090110; GO:1903020; GO:1904668";"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 secretion [GO:0072606]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; transport vesicle membrane [GO:0030658]";"cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp651143_c0_seq1;GAXK01099231.1;A1Z7G7;1.35E-30;LPHN_DROME;Latrophilin Cirl;"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurotransmitter secretion [GO:0007269]; vesicle-mediated transport [GO:0016192]";"GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007269; GO:0008021; GO:0008344; GO:0016021; GO:0016192; GO:0016524; GO:0030246";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurotransmitter secretion [GO:0007269]; vesicle-mediated transport [GO:0016192]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]"
comp65120_c0_seq1;GAXK01049046.1;Q80ZJ7;1.30E-140;SNX32_MOUSE;Sorting nexin-32 (Sorting nexin-6B);"cytosol [GO:0005829]; endosome [GO:0005768]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005768; GO:0005829; GO:0015031; GO:0035091; GO:0042147";"protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; endosome [GO:0005768]";phosphatidylinositol binding [GO:0035091]
comp65121_c0_seq1;GAXK01048738.1;Q27081;6.84E-43;CFB_TACTR;"Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]";"GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381";"hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]";extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
comp651295_c0_seq1;GAXK01099246.1;P32028;2.72E-69;FD4_DROME;Fork head domain-containing protein FD4;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0009653; GO:0030154; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp6513416_c0_seq1;GAXK01184747.1;Q87AD3;4.38E-17;Y1893_XYLFT;UPF0394 membrane protein PD_1893;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6515011_c0_seq1;GAXK01004501.1;P07271;2.89E-07;PIF1_YEAST;ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (Petite integration frequency protein 1) (Telomere stability protein 1);"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; single-stranded DNA binding [GO:0003697]; telomerase inhibitor activity [GO:0010521]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via break-induced replication [GO:0000727]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; replication fork reversal [GO:0071932]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]";"GO:0000002; GO:0000722; GO:0000723; GO:0000727; GO:0000733; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005657; GO:0005730; GO:0005739; GO:0005743; GO:0006260; GO:0006310; GO:0010521; GO:0031966; GO:0032211; GO:0032508; GO:0043139; GO:0043596; GO:0044806; GO:0051276; GO:0051880; GO:0071932";"chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via break-induced replication [GO:0000727]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; replication fork reversal [GO:0071932]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]";"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; replication fork [GO:0005657]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; single-stranded DNA binding [GO:0003697]; telomerase inhibitor activity [GO:0010521]"
comp651512_c0_seq1;GAXK01099264.1;A0JPE9;6.75E-146;GLPK5_DANRE;Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]";"GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0019563; GO:0046167";"glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]"
comp6515318_c0_seq1;GAXK01004514.1;Q41773;3.10E-20;VATL_MAIZE;V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit) (Fragment);"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0005774; GO:0016021; GO:0033179; GO:0046961";;"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp651563_c2_seq1;GAXK01099269.1;Q92859;7.62E-07;NEO1_HUMAN;Neogenin (Immunoglobulin superfamily DCC subclass member 2);"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; positive regulation of BMP signaling pathway [GO:0030513]";"GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0030513; GO:0038023; GO:0039706; GO:0055072; GO:0098797";"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; positive regulation of BMP signaling pathway [GO:0030513]";"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]"
comp6516864_c0_seq1;GAXK01072498.1;Q7SIC1;7.55E-07;FUCL_ANGAN;Fucolectin;"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";"GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088";"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
comp6518519_c0_seq1;GAXK01042738.1;G5EBR3;6.25E-12;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp6519066_c0_seq1;GAXK01042740.1;O31214;2.79E-43;UCRI_ALLVD;Ubiquinol-cytochrome c reductase iron-sulfur subunit (EC 7.1.1.8) (Rieske iron-sulfur protein) (RISP);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]";"GO:0005886; GO:0008121; GO:0016021; GO:0046872; GO:0051537";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp65191_c0_seq1;GAXK01048463.1;O77676;3.04E-75;KGP1_RABIT;cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; negative regulation of platelet aggregation [GO:0090331]; regulation of GTPase activity [GO:0043087]";"GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0030553; GO:0043087; GO:0090331";"negative regulation of platelet aggregation [GO:0090331]; regulation of GTPase activity [GO:0043087]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]"
comp6519192_c0_seq1;GAXK01042756.1;P10074;9.54E-07;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp6519627_c0_seq1;GAXK01042758.1;Q3SZ10;4.77E-40;RL3L_BOVIN;60S ribosomal protein L3-like;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp6519806_c0_seq1;GAXK01042749.1;Q9Y6R4;2.08E-15;M3K4_HUMAN;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp6519868_c0_seq1;GAXK01042743.1;O18750;2.39E-24;ENPL_RABIT;Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Fragment);"melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0006457; GO:0030433; GO:0033018; GO:0042470; GO:0051082";"protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]";"melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp652_c1_seq1;GAXK01165895.1;P42025;0;ACTY_HUMAN;Beta-centractin (Actin-related protein 1B) (ARP1B);"cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; establishment of mitotic spindle orientation [GO:0000132]; neutrophil degranulation [GO:0043312]; nuclear migration along microtubule [GO:0030473]";"GO:0000132; GO:0005524; GO:0005576; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0015630; GO:0016020; GO:0019886; GO:0030473; GO:0034774; GO:0043312; GO:0070062; GO:0099738; GO:1904813";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; establishment of mitotic spindle orientation [GO:0000132]; neutrophil degranulation [GO:0043312]; nuclear migration along microtubule [GO:0030473]";"cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]";ATP binding [GO:0005524]
comp6520567_c0_seq1;GAXK01077760.1;P36241;3.25E-68;RL19_DROME;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp6520630_c0_seq1;GAXK01077767.1;Q8IVG5;2.94E-07;SAM9L_HUMAN;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosomal vesicle fusion [GO:0034058]";"GO:0005737; GO:0005769; GO:0034058";endosomal vesicle fusion [GO:0034058];"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp65207_c5_seq1;GAXK01049016.1;Q7TNL4;4.28E-128;STK40_RAT;Serine/threonine-protein kinase 40 (EC 2.7.11.1) (Serine/threonine-protein kinase lyk4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp65215_c0_seq1;GAXK01048777.1;C4N147;1.65E-23;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp6521762_c0_seq1;GAXK01077778.1;P22458;1.56E-26;VTNC_RABIT;Vitronectin (VN) (Glycoprotein 66) (S-protein) (Serum-spreading factor);"extracellular space [GO:0005615]; heparin binding [GO:0008201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; immune response [GO:0006955]";"GO:0005044; GO:0005615; GO:0006955; GO:0007155; GO:0008201; GO:0030247";"cell adhesion [GO:0007155]; immune response [GO:0006955]";extracellular space [GO:0005615];"heparin binding [GO:0008201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp652218_c0_seq1;GAXK01119838.1;Q9NWZ3;1.41E-60;IRAK4_HUMAN;Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]";"GO:0000287; GO:0001816; GO:0002224; GO:0002446; GO:0002755; GO:0004672; GO:0004674; GO:0005149; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007254; GO:0010008; GO:0019221; GO:0034162; GO:0035556; GO:0043123; GO:0045087; GO:0048661; GO:0051092; GO:0070498; GO:1990266";"cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp6522222_c0_seq1;GAXK01073668.1;Q9LVI8;1.34E-112;GLN13_ARATH;"Glutamine synthetase cytosolic isozyme 1-3 (GS1) (EC 6.3.1.2) (Glutamate--ammonia ligase GLN1;3) (GLN1;3)";"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; glutamate-ammonia ligase activity [GO:0004356]; structural constituent of ribosome [GO:0003735]; glutamine biosynthetic process [GO:0006542]; nitrate assimilation [GO:0042128]; response to cadmium ion [GO:0046686]";"GO:0003735; GO:0004356; GO:0005507; GO:0005524; GO:0005829; GO:0005886; GO:0006542; GO:0009507; GO:0022626; GO:0042128; GO:0042788; GO:0046686";"glutamine biosynthetic process [GO:0006542]; nitrate assimilation [GO:0042128]; response to cadmium ion [GO:0046686]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]";"ATP binding [GO:0005524]; copper ion binding [GO:0005507]; glutamate-ammonia ligase activity [GO:0004356]; structural constituent of ribosome [GO:0003735]"
comp65226_c0_seq1;GAXK01048678.1;Q9VKJ9;2.58E-151;C2D1_DROME;Coiled-coil and C2 domain-containing protein 1-like (Lethal giant disks protein);"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]";"GO:0000122; GO:0000281; GO:0001227; GO:0005543; GO:0005634; GO:0005737; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0016197; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592";"compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]";"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phospholipid binding [GO:0005543]"
comp652353_c0_seq1;GAXK01119782.1;Q7TS63;6.78E-20;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6523725_c0_seq1;GAXK01073667.1;P08548;2.59E-10;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp6524_c0_seq1;GAXK01101300.1;O45040;0;GBB1_HOMAM;Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1);signal transduction [GO:0007165];GO:0007165;signal transduction [GO:0007165];;
comp6524292_c0_seq1;GAXK01082875.1;P0DPA6;1.59E-20;PSID_PSICU;L-tryptophan decarboxylase (EC 4.1.1.105) (Psilocybin biosynthesis decarboxylase);"phosphatidylserine decarboxylase activity [GO:0004609]; phospholipid biosynthetic process [GO:0008654]";"GO:0004609; GO:0008654";phospholipid biosynthetic process [GO:0008654];;phosphatidylserine decarboxylase activity [GO:0004609]
comp6525_c0_seq1;GAXK01205490.1;P82147;5.53E-17;L2EFL_DROME;Protein lethal(2)essential for life (Protein Efl21);"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]";"perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";unfolded protein binding [GO:0051082]
comp6525115_c0_seq1;GAXK01082872.1;Q55DA0;8.03E-30;ABCGM_DICDI;ABC transporter G family member 22 (ABC transporter ABCG.22);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085";"aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp6525253_c0_seq1;GAXK01082881.1;Q54BT3;6.51E-16;ABCB2_DICDI;ABC transporter B family member 2 (ABC transporter ABCB.2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp6525832_c0_seq1;GAXK01082878.1;P09435;1.14E-18;HSP73_YEAST;Heat shock protein SSA3;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0006515; GO:0006616; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp6526568_c0_seq1;GAXK01056836.1;Q08972;2.52E-30;NEW1_YEAST;[NU+] prion formation protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0016887; GO:0016973; GO:0042274";"poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]"
comp652662_c0_seq1;GAXK01119780.1;Q63421;4.07E-40;PDE1C_RAT;Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (3',5'-cyclic-AMP phosphodiesterase) (EC 3.1.4.-) (3',5'-cyclic-GMP phosphodiesterase) (EC 3.1.4.35);"neuronal cell body [GO:0043025]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]";"GO:0004117; GO:0005516; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0048101; GO:0051592; GO:0061179";"negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]";neuronal cell body [GO:0043025];"calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]"
comp6526832_c0_seq1;GAXK01056835.1;Q8TE73;4.50E-38;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp6527300_c0_seq1;GAXK01056842.1;A2SE09;1.52E-73;HIS6_METPP;Imidazole glycerol phosphate synthase subunit HisF (EC 4.3.2.10) (IGP synthase cyclase subunit) (IGP synthase subunit HisF) (ImGP synthase subunit HisF) (IGPS subunit HisF);"cytoplasm [GO:0005737]; imidazoleglycerol-phosphate synthase activity [GO:0000107]; lyase activity [GO:0016829]; histidine biosynthetic process [GO:0000105]";"GO:0000105; GO:0000107; GO:0005737; GO:0016829";histidine biosynthetic process [GO:0000105];cytoplasm [GO:0005737];"imidazoleglycerol-phosphate synthase activity [GO:0000107]; lyase activity [GO:0016829]"
comp6527488_c0_seq1;GAXK01056837.1;P45215;4.22E-14;Y1459_HAEIN;Probable RNA polymerase sigma factor HI_1459;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]; DNA-templated transcription, initiation [GO:0006352]";"GO:0003677; GO:0003700; GO:0006352; GO:0016987";DNA-templated transcription, initiation [GO:0006352];;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]"
comp65276_c0_seq1;GAXK01049090.1;Q8MSU3;1.17E-81;FRRS1_DROME;Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-);"integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]";"GO:0000293; GO:0016021; GO:0055114";oxidation-reduction process [GO:0055114];integral component of membrane [GO:0016021];ferric-chelate reductase activity [GO:0000293]
comp6528273_c0_seq1;GAXK01133540.1;P35556;1.43E-17;FBN2_HUMAN;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030023; GO:0030198; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]"
comp652836_c0_seq1;GAXK01119841.1;Q9U4G1;1.87E-08;BDL_DROME;Protein borderless;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; glial cell growth [GO:0042065]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron cell-cell adhesion [GO:0007158]; R7 cell development [GO:0045467]";"GO:0005886; GO:0005887; GO:0007156; GO:0007158; GO:0007411; GO:0008366; GO:0030424; GO:0042065; GO:0045467; GO:0070593; GO:0098632";"axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; glial cell growth [GO:0042065]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron cell-cell adhesion [GO:0007158]; R7 cell development [GO:0045467]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp652853_c0_seq1;GAXK01119847.1;Q52KR2;2.15E-21;LRIG2_MOUSE;Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]";"GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0010977; GO:0016020; GO:0016021; GO:0030426; GO:0031012; GO:0043005; GO:0043025; GO:0048679; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222";"innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";signaling receptor binding [GO:0005102]
comp6529229_c0_seq1;GAXK01133537.1;P86854;5.53E-17;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp65297_c1_seq1;GAXK01048802.1;E7E2N8;1.29E-23;GILT_CARAU;Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-);"extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]";"GO:0005576; GO:0005764; GO:0019882; GO:0047134";antigen processing and presentation [GO:0019882];"extracellular region [GO:0005576]; lysosome [GO:0005764]";protein-disulfide reductase activity [GO:0047134]
comp65298_c1_seq1;GAXK01048817.1;P43378;1.74E-82;PTN9_HUMAN;Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2);"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:0071345; GO:1903078";"cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]";"non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]"
comp6530075_c0_seq1;GAXK01036434.1;P41127;8.59E-26;RL131_ARATH;60S ribosomal protein L13-1 (Protein BBC1 homolog);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp653046_c0_seq1;GAXK01119862.1;Q9W0T5;6.52E-65;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp6532169_c0_seq1;GAXK01042105.1;Q5UQL7;2.72E-17;CAPS1_MIMIV;Capsid protein 1 (Capsid protein D13L);"viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028";;viral capsid [GO:0019028];structural molecule activity [GO:0005198]
comp653278_c0_seq1;GAXK01119773.1;O60906;7.85E-59;NSMA_HUMAN;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase);"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005886; GO:0005887; GO:0005901; GO:0006684; GO:0006685; GO:0006687; GO:0009612; GO:0035556; GO:0046513; GO:0046872; GO:2000304";"ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp6533367_c0_seq1;GAXK01042093.1;P10776;4.73E-07;NPAB_LOCMI;Neuroparsin-A (NPA) [Cleaved into: Neuroparsin-B (NPB)];"hormone activity [GO:0005179]; neuropeptide signaling pathway [GO:0007218]";"GO:0005179; GO:0007218";neuropeptide signaling pathway [GO:0007218];;hormone activity [GO:0005179]
comp6533726_c0_seq1;GAXK01042099.1;B1Y8E7;1.01E-68;PYRB_LEPCP;Aspartate carbamoyltransferase (EC 2.1.3.2) (Aspartate transcarbamylase) (ATCase);"amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]";"GO:0004070; GO:0006207; GO:0006520; GO:0016597; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]";;"amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]"
comp653375_c0_seq1;GAXK01119775.1;A0A0B4K692;1.29E-64;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp65342_c2_seq1;GAXK01048690.1;Q8T6J1;1.47E-102;ABCA6_DICDI;ABC transporter A family member 6 (ABC transporter ABCA.6);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; sorocarp morphogenesis [GO:0031288]";"GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0031288; GO:0042626; GO:0043231";"lipid transport [GO:0006869]; sorocarp morphogenesis [GO:0031288]";"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp65349_c0_seq1;GAXK01048434.1;Q21743;2.51E-34;GST9_CAEEL;Probable glutathione S-transferase 9 (EC 2.5.1.18) (GST class-sigma);"glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0006749";glutathione metabolic process [GO:0006749];;glutathione transferase activity [GO:0004364]
comp653496_c0_seq1;GAXK01119840.1;Q7KRI2;1.57E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6535608_c0_seq1;GAXK01090696.1;G5EBQ8;4.50E-19;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp653566_c0_seq1;GAXK01119777.1;B0WC46;2.95E-59;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp653613_c0_seq1;GAXK01119774.1;Q6IV72;2.55E-15;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp65364_c0_seq1;GAXK01048541.1;O75167;4.93E-43;PHAR2_HUMAN;Phosphatase and actin regulator 2;"plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]; platelet degranulation [GO:0002576]";"GO:0002576; GO:0003779; GO:0004864; GO:0005886; GO:0031092";platelet degranulation [GO:0002576];"plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]";"actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]"
comp6536460_c0_seq1;GAXK01202562.1;Q949Q5;4.41E-14;PSAO_ARATH;Photosystem I subunit O (PSI-O);"chloroplast [GO:0009507]; chloroplast thylakoid membrane [GO:0009535]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; thylakoid [GO:0009579]; photosynthesis, light harvesting in photosystem I [GO:0009768]; photosynthetic electron transport chain [GO:0009767]";"GO:0005576; GO:0009507; GO:0009522; GO:0009535; GO:0009579; GO:0009767; GO:0009768; GO:0016021";"photosynthesis, light harvesting in photosystem I [GO:0009768]; photosynthetic electron transport chain [GO:0009767]";"chloroplast [GO:0009507]; chloroplast thylakoid membrane [GO:0009535]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; thylakoid [GO:0009579]";
comp6537364_c0_seq1;GAXK01202559.1;P47727;3.74E-21;CBR1_RAT;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]";"GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0017144; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0043231; GO:0047021; GO:0050221; GO:1905344";"drug metabolic process [GO:0017144]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]"
comp653743_c0_seq1;GAXK01119866.1;Q8BIK6;3.10E-07;TMPS7_MOUSE;Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0016021";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp6538689_c0_seq1;GAXK01024640.1;Q9SMH3;3.61E-09;DYH1A_CHLRE;Dynein-1-alpha heavy chain, flagellar inner arm I1 complex (1-alpha DHC) (Dynein-1, subspecies f);"inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"GO:0003777; GO:0005524; GO:0005874; GO:0008017; GO:0031514; GO:0036156; GO:0036159; GO:0060294";"cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp654_c0_seq1;GAXK01169440.1;Q9I7I0;2.56E-98;CCNB3_DROME;G2/mitotic-specific cyclin-B3;"centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic cytokinesis [GO:0000281]; protein phosphorylation [GO:0006468]; regulation of chromatin binding [GO:0035561]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"GO:0000079; GO:0000278; GO:0000281; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0010389; GO:0016538; GO:0019901; GO:0035186; GO:0035561; GO:0044772";"mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic cytokinesis [GO:0000281]; protein phosphorylation [GO:0006468]; regulation of chromatin binding [GO:0035561]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp65400_c4_seq1;GAXK01048914.1;A6QR44;4.43E-63;DGCR8_BOVIN;Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog);"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";"GO:0003725; GO:0005730; GO:0020037; GO:0031053; GO:0042802; GO:0046872; GO:0070877; GO:0070878; GO:0090502";"primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]";"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]";"double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]"
comp6540343_c0_seq1;GAXK01152251.1;P18715;8.08E-09;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6540506_c0_seq1;GAXK01152258.1;P62907;3.89E-18;RL10A_RAT;60S ribosomal protein L10a;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412]";"GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0006412; GO:0014069; GO:0022625; GO:0042788; GO:0045471";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp65407_c0_seq1;GAXK01048436.1;Q08CW1;0;TLK2_XENTR;Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (Tousled-like kinase 2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]";"GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0007059; GO:0018105; GO:0035556";"chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]";nucleus [GO:0005634];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp6541_c0_seq1;GAXK01100106.1;Q96DI7;9.62E-152;SNR40_HUMAN;U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57);"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000375; GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0071007; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]";RNA binding [GO:0003723]
comp65410_c2_seq1;GAXK01048484.1;P56079;9.61E-61;CDSA_DROME;Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016021; GO:0016024; GO:0016056; GO:0043052";"CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";phosphatidate cytidylyltransferase activity [GO:0004605]
comp6541551_c0_seq1;GAXK01152248.1;P35685;3.54E-69;RL7A1_ORYSJ;60S ribosomal protein L7a-1;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp654165_c0_seq1;GAXK01162264.1;Q9V576;4.87E-43;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp65418_c8_seq1;GAXK01048994.1;Q8BJY1;2.45E-80;PSMD5_MOUSE;26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B);"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome regulatory particle assembly [GO:0070682]";"GO:0008540; GO:0022624; GO:0070682";proteasome regulatory particle assembly [GO:0070682];"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]";
comp6542113_c0_seq1;GAXK01056026.1;Q90YR7;3.78E-48;RS7_ICTPU;40S ribosomal protein S7;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726";"chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp654260_c0_seq1;GAXK01162260.1;Q12901;8.89E-26;ZN155_HUMAN;Zinc finger protein 155;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6542719_c0_seq1;GAXK01056027.1;P54253;2.41E-08;ATX1_HUMAN;Ataxin-1 (Spinocerebellar ataxia type 1 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]";"GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006396; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0016363; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043621; GO:0045892; GO:0048856; GO:0051168";"anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]"
comp6544588_c0_seq1;GAXK01152160.1;P48375;5.42E-60;FKB12_DROME;12 kDa FK506-binding protein (FKBP) (EC 5.2.1.8) (Macrolide-binding protein) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0005886; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp6544954_c0_seq1;GAXK01152158.1;P40614;1.27E-59;MPCP_CAEEL;Phosphate carrier protein, mitochondrial (PTP);"integral component of mitochondrial inner membrane [GO:0031305]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0031305; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of mitochondrial inner membrane [GO:0031305];inorganic phosphate transmembrane transporter activity [GO:0005315]
comp6545_c1_seq1;GAXK01100105.1;Q5RBS5;2.12E-17;BOREA_PONAB;Borealin (Cell division cycle-associated protein 8);"chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0000775; GO:0005730; GO:0005737; GO:0005819; GO:0007049; GO:0032133; GO:0032991; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; spindle [GO:0005819]";
comp654529_c0_seq1;GAXK01162255.1;P49675;1.17E-26;STAR_HUMAN;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"cytosol [GO:0005829]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; bile acid biosynthetic process [GO:0006699]; biphenyl metabolic process [GO:0018879]; brain development [GO:0007420]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol metabolic process [GO:0008203]; circadian sleep/wake cycle, REM sleep [GO:0042747]; dibenzo-p-dioxin metabolic process [GO:0018894]; diterpenoid metabolic process [GO:0016101]; estrogen biosynthetic process [GO:0006703]; glucocorticoid metabolic process [GO:0008211]; insecticide metabolic process [GO:0017143]; intracellular cholesterol transport [GO:0032367]; male gonad development [GO:0008584]; negative regulation of neuron apoptotic process [GO:0043524]; phenol-containing compound metabolic process [GO:0018958]; phthalate metabolic process [GO:0018963]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of gene expression [GO:0010628]; positive regulation of neurogenesis [GO:0050769]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to corticosterone [GO:0051412]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to herbicide [GO:0009635]; response to hydrogen peroxide [GO:0042542]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to leptin [GO:0044321]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]";"GO:0005739; GO:0005758; GO:0005829; GO:0006694; GO:0006699; GO:0006700; GO:0006703; GO:0007420; GO:0007584; GO:0008203; GO:0008211; GO:0008584; GO:0009635; GO:0010212; GO:0010288; GO:0010628; GO:0014823; GO:0015485; GO:0016101; GO:0017143; GO:0018879; GO:0018894; GO:0018958; GO:0018963; GO:0030061; GO:0032367; GO:0032869; GO:0035094; GO:0035457; GO:0042542; GO:0042747; GO:0043005; GO:0043025; GO:0043524; GO:0043627; GO:0044321; GO:0044344; GO:0045471; GO:0048168; GO:0050769; GO:0050810; GO:0051412; GO:0060992; GO:0061370; GO:0070859; GO:0071222; GO:0071236; GO:0071276; GO:0071312; GO:0071320; GO:0071333; GO:0071346; GO:0071372; GO:0071373; GO:0071378; GO:0071549; GO:0071560; GO:0071872; GO:0120020";"bile acid biosynthetic process [GO:0006699]; biphenyl metabolic process [GO:0018879]; brain development [GO:0007420]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol metabolic process [GO:0008203]; circadian sleep/wake cycle, REM sleep [GO:0042747]; dibenzo-p-dioxin metabolic process [GO:0018894]; diterpenoid metabolic process [GO:0016101]; estrogen biosynthetic process [GO:0006703]; glucocorticoid metabolic process [GO:0008211]; insecticide metabolic process [GO:0017143]; intracellular cholesterol transport [GO:0032367]; male gonad development [GO:0008584]; negative regulation of neuron apoptotic process [GO:0043524]; phenol-containing compound metabolic process [GO:0018958]; phthalate metabolic process [GO:0018963]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of gene expression [GO:0010628]; positive regulation of neurogenesis [GO:0050769]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to corticosterone [GO:0051412]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to herbicide [GO:0009635]; response to hydrogen peroxide [GO:0042542]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to leptin [GO:0044321]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]";"cytosol [GO:0005829]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp6545309_c0_seq1;GAXK01152156.1;Q51697;3.89E-29;IORA_BREDI;Isoquinoline 1-oxidoreductase subunit alpha (EC 1.3.99.16);"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; isoquinoline 1-oxidoreductase activity [GO:0047121]; metal ion binding [GO:0046872]";"GO:0009055; GO:0046872; GO:0047121; GO:0051537";;;"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; isoquinoline 1-oxidoreductase activity [GO:0047121]; metal ion binding [GO:0046872]"
comp654589_c0_seq1;GAXK01162268.1;Q6UWL6;4.99E-24;KIRR2_HUMAN;Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3);"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"GO:0001933; GO:0005886; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0098609";"cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";identical protein binding [GO:0042802]
comp65460_c1_seq1;GAXK01048762.1;Q9NX07;2.09E-49;TSAP1_HUMAN;tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; selenocysteine incorporation [GO:0001514]";"GO:0001514; GO:0003723; GO:0005634; GO:0005737";selenocysteine incorporation [GO:0001514];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp65463_c1_seq1;GAXK01048464.1;O96005;0;CLPT1_HUMAN;Cleft lip and palate transmembrane protein 1;"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp6547431_c0_seq1;GAXK01173324.1;Q796Y8;3.32E-28;BCP_BACSU;Peroxiredoxin Bcp (EC 1.11.1.15) (Bacterioferritin comigratory protein) (Thioredoxin peroxidase);"cytoplasm [GO:0005737]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";"GO:0005737; GO:0008379; GO:0034599; GO:0045454";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]";cytoplasm [GO:0005737];thioredoxin peroxidase activity [GO:0008379]
comp6547771_c0_seq1;GAXK01173333.1;P93099;2.55E-48;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp6548881_c0_seq1;GAXK01085028.1;Q9LXM8;1.77E-11;RLA24_ARATH;60S acidic ribosomal protein P2-4;"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; secretory vesicle [GO:0099503]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005634; GO:0005829; GO:0006414; GO:0022626; GO:0099503";translational elongation [GO:0006414];"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; secretory vesicle [GO:0099503]";structural constituent of ribosome [GO:0003735]
comp65493_c1_seq1;GAXK01048822.1;P54399;5.16E-113;PDI_DROME;Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1);"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0006457; GO:0012505; GO:0015037; GO:0034976; GO:0043025; GO:0045169; GO:0045454; GO:0048471; GO:0060187; GO:0070732";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp6550375_c0_seq1;GAXK01155951.1;Q91611;6.68E-08;DHHB_XENLA;"Desert hedgehog protein B (Desert hedgehog protein 2) (DHH-2) (Hedgehog protein 4) (X-HH4) [Cleaved into: Desert hedgehog protein B N-product; Desert hedgehog protein B C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0046872";"cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp655057_c0_seq1;GAXK01162274.1;Q8N4S7;2.09E-49;PAQR4_HUMAN;Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV);"integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]";"GO:0016021; GO:0038023";;integral component of membrane [GO:0016021];signaling receptor activity [GO:0038023]
comp65510_c0_seq1;GAXK01048682.1;Q96ER9;8.62E-24;CCD51_HUMAN;Coiled-coil domain-containing protein 51;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp6551195_c0_seq1;GAXK01155947.1;Q9BQR3;3.99E-11;PRS27_HUMAN;Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin);"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0019897; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]";serine-type endopeptidase activity [GO:0004252]
comp655173_c3_seq1;GAXK01162278.1;A1DA64;5.13E-08;FTMF_NEOFI;Verruculogen synthase (EC 1.14.11.38) (Fumitremorgin biosynthesis protein F);"dioxygenase activity [GO:0051213]; alkaloid metabolic process [GO:0009820]";"GO:0009820; GO:0051213";alkaloid metabolic process [GO:0009820];;dioxygenase activity [GO:0051213]
comp6552846_c0_seq1;GAXK01092935.1;Q9SZX9;2.27E-32;RL92_ARATH;60S ribosomal protein L9-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005829; GO:0019843; GO:0022625; GO:0022626; GO:0042788";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp65533_c3_seq1;GAXK01049065.1;Q8C0L8;4.45E-158;COG5_MOUSE;Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleoplasm [GO:0005654]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0015031; GO:0017119; GO:0048219";"inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleoplasm [GO:0005654]";
comp6553777_c0_seq1;GAXK01092937.1;P59223;2.09E-58;RS131_ARATH;40S ribosomal protein S13-1;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005618; GO:0005730; GO:0005829; GO:0006412; GO:0022626; GO:0022627; GO:0070181";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp65539_c1_seq1;GAXK01048736.1;Q9H871;6.18E-130;RMD5A_HUMAN;E3 ubiquitin-protein transferase RMND5A (EC 2.3.2.27) (P44CTLH) (Protein RMD5 homolog A);"cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0034657; GO:0043161; GO:0046872";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp6553986_c0_seq1;GAXK01092945.1;O88870;2.34E-21;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp6554021_c0_seq1;GAXK01101974.1;Q6DEL1;9.51E-33;S38A7_DANRE;Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp65555_c1_seq1;GAXK01204820.1;A6QQM4;3.80E-20;ZN474_BOVIN;Zinc finger protein 474;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp6556560_c0_seq1;GAXK01185215.1;P48727;1.77E-20;GLC7B_CAEEL;Serine/threonine-protein phosphatase PP1-beta (EC 3.1.3.16) (CeGLC-7-beta) (Glc seven-like phosphatase 2);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell division [GO:0051301]; chromatin organization [GO:0006325]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; peptidyl-serine dephosphorylation [GO:0070262]";"GO:0004722; GO:0005634; GO:0005694; GO:0005737; GO:0006325; GO:0007275; GO:0031965; GO:0046872; GO:0051301; GO:0051321; GO:0070262";"cell division [GO:0051301]; chromatin organization [GO:0006325]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; peptidyl-serine dephosphorylation [GO:0070262]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp6556928_c0_seq1;GAXK01185210.1;Q9BUZ4;4.42E-25;TRAF4_HUMAN;TNF receptor-associated factor 4 (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83);"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165]";"GO:0003677; GO:0005164; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007250; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0032991; GO:0042802; GO:0042981; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0090073";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165]";"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp6557133_c0_seq1;GAXK01185212.1;Q99KE8;8.91E-14;ZFP64_MOUSE;Zinc finger protein 64 (Zfp-64);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0007275; GO:0010468; GO:0032728; GO:0032755; GO:0032760; GO:0046872; GO:0048026";"multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp655737_c0_seq1;GAXK01162289.1;Q25158;1.92E-101;OPSC2_HEMSA;Compound eye opsin BCRH2;"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp6557844_c0_seq1;GAXK01185217.1;A2SLD0;2.41E-55;RL17_METPP;50S ribosomal protein L17;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp6557935_c0_seq1;GAXK01185206.1;Q9L8J5;2.39E-54;BCHL_RHORU;Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (DPOR subunit L) (LI-POR subunit L) (EC 1.3.7.7);"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on iron-sulfur proteins as donors [GO:0016730]; oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor [GO:0016636]; light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis, dark reaction [GO:0019685]";"GO:0005524; GO:0016636; GO:0016730; GO:0019685; GO:0036070; GO:0046872; GO:0051539";"light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis, dark reaction [GO:0019685]";;"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on iron-sulfur proteins as donors [GO:0016730]; oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor [GO:0016636]"
comp6558_c0_seq1;GAXK01100125.1;P35604;3.69E-81;COPZ1_BOVIN;Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"GO:0000139; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:1901998";"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]";
comp6558119_c0_seq1;GAXK01009906.1;Q99315;3.03E-10;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp6560240_c0_seq1;GAXK01080545.1;P30975;3.21E-39;TLR2_DROME;Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058";"detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp656151_c0_seq1;GAXK01082977.1;Q7Z0G7;5.72E-45;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp656156_c0_seq1;GAXK01083064.1;Q95NI4;5.27E-37;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6561752_c0_seq1;GAXK01080548.1;P44804;3.03E-27;REP_HAEIN;ATP-dependent DNA helicase Rep (EC 3.6.4.12);"cytosol [GO:0005829]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; recombinational repair [GO:0000725]";"GO:0000725; GO:0003697; GO:0005524; GO:0005829; GO:0006268; GO:0006281; GO:0008408; GO:0043138";"DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; recombinational repair [GO:0000725]";cytosol [GO:0005829];"3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; single-stranded DNA binding [GO:0003697]"
comp6562_c0_seq1;GAXK01101259.1;P61221;0;ABCE1_HUMAN;ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]";"GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702";"defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]"
comp6562015_c0_seq1;GAXK01123353.1;Q5CP76;2.49E-47;RS3A_CRYHO;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp656231_c0_seq1;GAXK01083017.1;Q9XYN1;2.07E-61;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp6563483_c0_seq1;GAXK01123346.1;Q9LZ57;4.78E-22;RL363_ARATH;60S ribosomal protein L36-3;"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005774; GO:0005886; GO:0009506; GO:0022625";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]";structural constituent of ribosome [GO:0003735]
comp6563707_c0_seq1;GAXK01123351.1;Q90611;1.43E-07;MMP2_CHICK;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2);"basement membrane [GO:0005604]; cell [GO:0005623]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"GO:0001666; GO:0001933; GO:0001955; GO:0001957; GO:0004222; GO:0005604; GO:0005615; GO:0005623; GO:0005886; GO:0008270; GO:0030017; GO:0030198; GO:0030574; GO:0034614; GO:0035987; GO:0043408; GO:0048771; GO:0051895; GO:0060325; GO:0060346; GO:0061037; GO:0062023; GO:0071230; GO:1904645; GO:1904707; GO:1904932; GO:1990314";"blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"basement membrane [GO:0005604]; cell [GO:0005623]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6563865_c0_seq1;GAXK01123355.1;Q9VNM1;2.90E-17;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp6564486_c0_seq1;GAXK01180624.1;Q6GCQ0;6.36E-143;PFLB_STAAS;Formate acetyltransferase (EC 2.3.1.54) (Pyruvate formate-lyase);"cytoplasm [GO:0005737]; formate C-acetyltransferase activity [GO:0008861]; glucose metabolic process [GO:0006006]";"GO:0005737; GO:0006006; GO:0008861";glucose metabolic process [GO:0006006];cytoplasm [GO:0005737];formate C-acetyltransferase activity [GO:0008861]
comp65651_c0_seq1;GAXK01205183.1;Q62829;5.57E-172;PAK3_RAT;Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (p21-activated kinase 3) (PAK-3) (p65-PAK);"cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0004672; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0006468; GO:0007409; GO:0010763; GO:0010975; GO:0014069; GO:0016358; GO:0016477; GO:0017124; GO:0023014; GO:0030833; GO:0031098; GO:0032147; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0048365; GO:0050770; GO:0051020; GO:0060997; GO:0061003; GO:0071407; GO:0098978; GO:2000573";"activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]"
comp6565136_c0_seq1;GAXK01180639.1;P07018;1.73E-22;MCP4_ECOLI;Methyl-accepting chemotaxis protein IV (MCP-IV) (Dipeptide chemoreceptor protein);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"GO:0004888; GO:0005886; GO:0006935; GO:0007165; GO:0016021";"chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane signaling receptor activity [GO:0004888]
comp6565764_c0_seq1;GAXK01180623.1;Q2YDJ8;1.19E-15;KMT5A_BOVIN;N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.43) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0002039; GO:0003714; GO:0005634; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]"
comp656617_c0_seq1;GAXK01083067.1;Q9W740;3.61E-21;NOGG2_DANRE;Noggin-2;"extracellular space [GO:0005615]; cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]";"GO:0001649; GO:0005615; GO:0009953; GO:0030514; GO:0045596; GO:0051216";"cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]";extracellular space [GO:0005615];
comp656645_c0_seq1;GAXK01082999.1;Q6ZQ38;3.04E-09;CAND1_MOUSE;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1);"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0043086; GO:0045893; GO:0045899";"cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]";"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";TBP-class protein binding [GO:0017025]
comp656744_c1_seq1;GAXK01083006.1;Q9UQ05;6.86E-36;KCNH4_HUMAN;Potassium voltage-gated channel subfamily H member 4 (Brain-specific eag-like channel 2) (BEC2) (Ether-a-go-go-like potassium channel 1) (ELK channel 1) (ELK1) (Voltage-gated potassium channel subunit Kv12.3);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0034765; GO:0042391; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";voltage-gated potassium channel activity [GO:0005249]
comp6567578_c0_seq1;GAXK01060130.1;Q9H469;2.58E-07;FXL15_HUMAN;F-box/LRR-repeat protein 15 (F-box only protein 37);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000209; GO:0005737; GO:0005829; GO:0006511; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146; GO:0043687";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]";
comp65680_c1_seq1;GAXK01048431.1;P51452;3.96E-25;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp6568132_c0_seq1;GAXK01008388.1;P30974;4.31E-30;TLR1_DROME;Tachykinin-like peptides receptor 86C (NKD);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021";"G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp65694_c0_seq1;GAXK01049084.1;Q8BG30;2.73E-39;NELFA_MOUSE;Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 homolog) (mWHSC2);"cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571";"negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp6570_c0_seq1;GAXK01101039.1;Q6AYQ6;8.27E-50;MMAD_RAT;Methylmalonic aciduria and homocystinuria type D homolog, mitochondrial (CblD);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cobalamin metabolic process [GO:0009235]; coenzyme biosynthetic process [GO:0009108]";"GO:0005737; GO:0005739; GO:0009108; GO:0009235";"cobalamin metabolic process [GO:0009235]; coenzyme biosynthetic process [GO:0009108]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";
comp657000_c0_seq1;GAXK01083020.1;O75325;1.36E-15;LRRN2_HUMAN;Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023";"cell adhesion [GO:0007155]; signal transduction [GO:0007165]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp6570314_c0_seq1;GAXK01087913.1;Q69BJ8;7.72E-19;UCRI_LAGLA;Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (Ubiquinol-cytochrome c reductase 8 kDa protein)];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]";"GO:0005743; GO:0008121; GO:0016021; GO:0046872; GO:0051537; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"
comp657066_c0_seq1;GAXK01082970.1;O01382;1.47E-46;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp65708_c0_seq1;GAXK01048539.1;Q64458;3.36E-17;CP2CT_MOUSE;Cytochrome P450 2C29 (EC 1.14.14.1) (Aldehyde oxygenase) (CYPIIC29) (Cytochrome P-450 MUT-2);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0019373; GO:0020037; GO:0034875; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0101020";"epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]"
comp657102_c0_seq1;GAXK01082961.1;D4A6L0;6.38E-65;GP158_RAT;Probable G-protein coupled receptor 158;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp6571778_c0_seq1;GAXK01087914.1;Q8WQI7;3.29E-49;RL18A_SPOFR;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp6572180_c0_seq1;GAXK01136441.1;Q8IWG1;8.28E-07;WDR63_HUMAN;WD repeat-containing protein 63 (Testis development protein NYD-SP29);"inner dynein arm [GO:0036156]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0007018; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0060294";"cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";inner dynein arm [GO:0036156];"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]"
comp65724_c0_seq1;GAXK01048938.1;P31597;1.33E-92;EAA3_RABIT;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476";"chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp6572526_c0_seq1;GAXK01136451.1;P08106;1.47E-38;HSP70_CHICK;Heat shock 70 kDa protein (HSP70);"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0010243; GO:0014070; GO:0016192; GO:0016887; GO:0031072; GO:0032570; GO:0033142; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043204; GO:0043235; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; progesterone receptor binding [GO:0033142]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp6572965_c0_seq1;GAXK01136437.1;Q9GZV8;2.42E-10;PRD14_HUMAN;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp657310_c0_seq1;GAXK01083050.1;Q3SYV7;3.40E-17;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6573194_c0_seq1;GAXK01136447.1;Q09575;5.52E-07;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp6573598_c0_seq1;GAXK01136439.1;P48613;5.30E-07;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp6573912_c0_seq1;GAXK01136438.1;Q962R9;6.37E-35;RS10_SPOFR;40S ribosomal protein S10;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp6574042_c0_seq1;GAXK01042772.1;P41245;1.13E-08;MMP9_MOUSE;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"GO:0001501; GO:0001934; GO:0001968; GO:0002687; GO:0004175; GO:0004222; GO:0004252; GO:0005615; GO:0006508; GO:0006979; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0019087; GO:0030198; GO:0030335; GO:0030574; GO:0031915; GO:0032991; GO:0034614; GO:0035987; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0044877; GO:0045742; GO:0045766; GO:0048147; GO:0048771; GO:0051259; GO:0051549; GO:0062023; GO:0071276; GO:0071460; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; transformation of host cell by virus [GO:0019087]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp6574047_c0_seq1;GAXK01042791.1;Q54MK8;7.63E-25;RL18A_DICDI;60S ribosomal protein L18a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp657448_c0_seq1;GAXK01082972.1;P98106;1.19E-09;LYAM3_RAT;P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P);"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of cell adhesion [GO:0045785]; regulation of cellular extravasation [GO:0002691]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]";"GO:0002691; GO:0005509; GO:0005615; GO:0005887; GO:0009897; GO:0014070; GO:0016339; GO:0032496; GO:0045785; GO:0050900; GO:0050901; GO:0070492; GO:0098609";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of cell adhesion [GO:0045785]; regulation of cellular extravasation [GO:0002691]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]";"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]"
comp657471_c0_seq1;GAXK01083063.1;P52729;7.24E-51;HME2A_XENLA;Homeobox protein engrailed-2-A (En-2A) (Homeobox protein en-2-A) (En2 1.4);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp657552_c1_seq1;GAXK01083048.1;Q9Y462;9.07E-15;ZN711_HUMAN;Zinc finger protein 711 (Zinc finger protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0031490; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp657571_c1_seq1;GAXK01082994.1;P08953;1.34E-86;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp6575785_c0_seq1;GAXK01042788.1;O44001;6.75E-07;HSP90_EIMTE;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp6576_c2_seq1;GAXK01101027.1;Q9CQS4;5.01E-83;S2546_MOUSE;Solute carrier family 25 member 46;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrial membrane fission [GO:0090149]";"GO:0005739; GO:0005741; GO:0016021; GO:0090149";mitochondrial membrane fission [GO:0090149];"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";
comp6576484_c0_seq1;GAXK01052407.1;Q16960;1.31E-25;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp6576775_c0_seq1;GAXK01052403.1;Q9CAT7;9.32E-57;BTF3L_ARATH;Nascent polypeptide-associated complex subunit beta;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";"GO:0005739; GO:0005829; GO:0005854; GO:0042788";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; polysomal ribosome [GO:0042788]";
comp6577396_c0_seq1;GAXK01052394.1;Q9VAQ1;2.45E-07;SIR7_DROME;NAD-dependent protein deacetylase Sirt7 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7);"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0004407; GO:0005634; GO:0005724; GO:0046872; GO:0070403; GO:0070932; GO:0097372";"histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear telomeric heterochromatin [GO:0005724]; nucleus [GO:0005634]";"histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]"
comp6578014_c0_seq1;GAXK01164144.1;A8MT65;6.06E-14;ZN891_HUMAN;Zinc finger protein 891;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6579456_c0_seq1;GAXK01164143.1;Q5JJ64;8.12E-24;Y1782_THEKO;Uncharacterized serpin-like protein TK1782;"extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];extracellular space [GO:0005615];serine-type endopeptidase inhibitor activity [GO:0004867]
comp6579545_c0_seq1;GAXK01164129.1;P65808;1.00E-14;YGEY_ECOL6;Uncharacterized protein YgeY;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp65804_c2_seq1;GAXK01049107.1;Q9VC61;9.50E-56;CRERF_DROME;Protein CREBRF homolog (Protein Repressed by Tor);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; positive regulation of transcription, DNA-templated [GO:0045893]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; TORC1 signaling [GO:0038202]";"GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006986; GO:0038202; GO:0042594; GO:0045893; GO:0046982";"positive regulation of transcription, DNA-templated [GO:0045893]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; TORC1 signaling [GO:0038202]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp6580636_c0_seq1;GAXK01078146.1;Q09575;4.07E-10;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp6580740_c0_seq1;GAXK01078148.1;Q54BU4;2.78E-19;ABCB1_DICDI;ABC transporter B family member 1 (ABC transporter ABCB.1);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]";"GO:0005524; GO:0006935; GO:0006972; GO:0016021; GO:0016887; GO:0031154; GO:0042626";"chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]";integral component of membrane [GO:0016021];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp658085_c0_seq1;GAXK01007471.1;A6H7B8;6.26E-45;PGAP2_BOVIN;Post-GPI attachment to proteins factor 2;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000139; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp65809_c0_seq1;GAXK01048931.1;Q17QH7;8.43E-10;TFPT_BOVIN;TCF3 fusion partner homolog;"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of apoptotic process [GO:0043065]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006310; GO:0006915; GO:0019901; GO:0031011; GO:0031965; GO:0043065; GO:0097190";"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of apoptotic process [GO:0043065]";"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein kinase binding [GO:0019901]"
comp6581997_c0_seq1;GAXK01078152.1;B0BN95;9.92E-08;HARB1_RAT;Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]";"GO:0004518; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
comp658274_c0_seq1;GAXK01007467.1;Q9IB89;1.29E-30;ZIC5_XENLA;Zinc finger protein ZIC 5 (XZic5) (XlZic5) (Zinc finger protein of the cerebellum 5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neural crest formation [GO:0014029]";"GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872";"nervous system development [GO:0007399]; neural crest formation [GO:0014029]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6583181_c0_seq1;GAXK01058545.1;Q5U315;9.75E-09;GLD2_RAT;Poly(A) RNA polymerase GLD2 (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2);"cytosol [GO:0005829]; nucleus [GO:0005634]; 5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]";"GO:0002244; GO:0004652; GO:0005524; GO:0005634; GO:0005829; GO:0006397; GO:0021766; GO:0030182; GO:0034062; GO:0043489; GO:0043631; GO:0046872; GO:0060041; GO:0070566; GO:0071044; GO:1990603; GO:2000626";"dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]"
comp65833_c0_seq1;GAXK01048823.1;Q5RHQ8;1.14E-79;LIN9_DANRE;Protein lin-9 homolog;"nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]";"GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0017053; GO:0051726";"regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]";"nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]";DNA binding [GO:0003677]
comp65834_c1_seq1;GAXK01048833.1;Q8N0N3;4.08E-107;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp6583840_c0_seq1;GAXK01058550.1;Q556J0;3.65E-53;TKT_DICDI;Transketolase (TK) (EC 2.2.1.1);"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; pentose-phosphate shunt [GO:0006098]";"GO:0004802; GO:0005829; GO:0006098; GO:0045335; GO:0046872";pentose-phosphate shunt [GO:0006098];"cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]";"metal ion binding [GO:0046872]; transketolase activity [GO:0004802]"
comp6583881_c0_seq1;GAXK01058556.1;Q9P792;1.20E-10;YN8B_SCHPO;ZZ-type zinc finger-containing protein P35G2.11c;"fungal-type vacuole lumen [GO:0000328]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; NVT complex [GO:0061957]; zinc ion binding [GO:0008270]; macroautophagy [GO:0016236]; protein localization by the NVT pathway [GO:0120113]";"GO:0000328; GO:0005771; GO:0005794; GO:0008270; GO:0016236; GO:0061957; GO:0120113";"macroautophagy [GO:0016236]; protein localization by the NVT pathway [GO:0120113]";"fungal-type vacuole lumen [GO:0000328]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; NVT complex [GO:0061957]";zinc ion binding [GO:0008270]
comp6584199_c0_seq1;GAXK01098546.1;Q1XDF9;1.36E-48;FTSH_PYRYE;ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]";"GO:0004222; GO:0005524; GO:0008270; GO:0009535; GO:0016021; GO:0016887; GO:0030163";protein catabolic process [GO:0030163];"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6584310_c0_seq1;GAXK01098556.1;Q9STR1;5.52E-18;RL312_ARATH;60S ribosomal protein L31-2;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp658522_c0_seq1;GAXK01007450.1;Q3Y8M6;1.09E-10;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp6585844_c0_seq1;GAXK01098551.1;Q5UQL7;5.62E-40;CAPS1_MIMIV;Capsid protein 1 (Capsid protein D13L);"viral capsid [GO:0019028]; structural molecule activity [GO:0005198]";"GO:0005198; GO:0019028";;viral capsid [GO:0019028];structural molecule activity [GO:0005198]
comp658599_c0_seq1;GAXK01007460.1;Q8L493;8.17E-48;DAAA_ARATH;D-amino-acid transaminase, chloroplastic (EC 2.6.1.21) (EC 4.1.3.38) (Aminodeoxychorismate lyase) (AtADCL) (Branched-chain-amino-acid aminotransferase-like protein 3);"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; 4-amino-4-deoxychorismate lyase activity [GO:0008696]; branched-chain-amino-acid transaminase activity [GO:0004084]; D-alanine:2-oxoglutarate aminotransferase activity [GO:0047810]; para-aminobenzoic acid biosynthetic process [GO:0008153]; tetrahydrofolate biosynthetic process [GO:0046654]";"GO:0004084; GO:0005829; GO:0008153; GO:0008696; GO:0009507; GO:0009570; GO:0046654; GO:0047810";"para-aminobenzoic acid biosynthetic process [GO:0008153]; tetrahydrofolate biosynthetic process [GO:0046654]";"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]";"4-amino-4-deoxychorismate lyase activity [GO:0008696]; branched-chain-amino-acid transaminase activity [GO:0004084]; D-alanine:2-oxoglutarate aminotransferase activity [GO:0047810]"
comp6586405_c0_seq1;GAXK01154792.1;P49643;5.66E-18;PRI2_HUMAN;DNA primase large subunit (EC 2.7.7.-) (DNA primase 58 kDa subunit) (p58);"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539";"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]";"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"
comp65874_c0_seq1;GAXK01048693.1;P48984;2.97E-178;TEAD4_CHICK;Transcriptional enhancer factor TEF-3 (M-CAT-binding factor) (RTEF-1) (TEA domain family member 4) (TEAD-4) (TEF-1);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"GO:0001085; GO:0003700; GO:0005634; GO:0005667; GO:0006351; GO:0035329; GO:0043565; GO:0044212; GO:0045944";"hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp6587814_c0_seq1;GAXK01154809.1;Q3SYV4;3.90E-07;CAP1_BOVIN;Adenylyl cyclase-associated protein 1 (CAP 1);"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]";"GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0030864";"actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]";"cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]"
comp6587898_c0_seq1;GAXK01154798.1;Q7PPU9;1.04E-09;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6587932_c0_seq1;GAXK01154800.1;P44545;1.30E-35;HFLC_HAEIN;Protein HflC;"integral component of membrane [GO:0016021]; regulation of peptidase activity [GO:0052547]";"GO:0016021; GO:0052547";regulation of peptidase activity [GO:0052547];integral component of membrane [GO:0016021];
comp65883_c0_seq1;GAXK01048543.1;Q9NVF7;8.66E-72;FBX28_HUMAN;F-box only protein 28;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";"GO:0000776; GO:0000777";;"condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]";
comp6588328_c0_seq1;GAXK01078160.1;Q9UJU3;3.07E-10;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6588601_c0_seq1;GAXK01078181.1;O70244;6.85E-12;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp65887_c4_seq1;GAXK01049079.1;Q6Y685;7.64E-38;TACC1_MOUSE;Transforming acidic coiled-coil-containing protein 1;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0007052; GO:0008283; GO:0016922; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301; GO:2000327";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]";"estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]"
comp6590_c2_seq1;GAXK01100471.1;Q9W4P5;0;VA0D1_DROME;V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (V-ATPase 39 kDa subunit) (Vacuolar H+ ATPase subunit AC39-1) (Vacuolar proton pump subunit d 1);"plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035]";"GO:0000220; GO:0005886; GO:0006879; GO:0007035; GO:0007430; GO:0033181; GO:0036295; GO:0046961; GO:1902600";"cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035]";"plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp6591397_c0_seq1;GAXK01077095.1;P96694;3.64E-14;MHQP_BACSU;Putative oxidoreductase MhqP (EC 1.-.-.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; aromatic compound catabolic process [GO:0019439]; response to toxic substance [GO:0009636]";"GO:0005886; GO:0009636; GO:0016021; GO:0016491; GO:0019439";"aromatic compound catabolic process [GO:0019439]; response to toxic substance [GO:0009636]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";oxidoreductase activity [GO:0016491]
comp6591958_c0_seq1;GAXK01077103.1;Q9FLF0;1.33E-26;RS92_ARATH;40S ribosomal protein S9-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003735; GO:0005829; GO:0006412; GO:0009506; GO:0009536; GO:0019843; GO:0022627; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp6592052_c0_seq1;GAXK01089512.1;P27420;9.64E-53;HSP7C_CAEEL;Heat shock 70 kDa protein C;"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp659217_c1_seq1;GAXK01007495.1;Q9UNY5;5.11E-14;ZN232_HUMAN;Zinc finger protein 232 (Zinc finger and SCAN domain-containing protein 11);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0043231; GO:0046872";;"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp65922_c0_seq1;GAXK01048411.1;Q7KRI2;2.49E-29;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp65923_c1_seq1;GAXK01048554.1;Q8R205;1.88E-08;ZC3HA_MOUSE;Zinc finger CCCH domain-containing protein 10;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799";"negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]"
comp65929_c0_seq1;GAXK01048452.1;Q7KRI2;1.14E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp65938_c1_seq1;GAXK01048465.1;Q3KNW5;1.36E-25;SOAT_HUMAN;Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085]";"GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251; GO:0055085";"bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]"
comp6593856_c0_seq1;GAXK01089506.1;A8ER63;5.70E-36;RL31_ARCB4;50S ribosomal protein L31;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp6594_c0_seq1;GAXK01101220.1;Q9VE46;1.44E-137;SC5A7_DROME;High-affinity choline transporter 1;"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";"GO:0003333; GO:0005307; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021; GO:0033265";"acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";integral component of membrane [GO:0016021];"amino acid transmembrane transporter activity [GO:0015171]; choline:sodium symporter activity [GO:0005307]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]"
comp6594235_c0_seq1;GAXK01101881.1;Q9SVM8;6.35E-25;RBG2_ARATH;Glycine-rich RNA-binding protein 2, mitochondrial (AtGR-RBP2) (AtRBG2) (Glycine-rich protein 2) (AtGRP2) (Mitochondrial RNA-binding protein 1a) (At-mRBP1a);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; double-stranded DNA binding [GO:0003690]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cold acclimation [GO:0009631]; mitochondrial mRNA modification [GO:0080156]; negative regulation of DNA-templated transcription, termination [GO:0060567]; response to cold [GO:0009409]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]; seed germination [GO:0009845]";"GO:0003690; GO:0003697; GO:0003723; GO:0005507; GO:0005524; GO:0005739; GO:0005829; GO:0006970; GO:0009409; GO:0009414; GO:0009631; GO:0009651; GO:0009845; GO:0034336; GO:0060567; GO:0080156; GO:1990904";"cold acclimation [GO:0009631]; mitochondrial mRNA modification [GO:0080156]; negative regulation of DNA-templated transcription, termination [GO:0060567]; response to cold [GO:0009409]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]; seed germination [GO:0009845]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; copper ion binding [GO:0005507]; double-stranded DNA binding [GO:0003690]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]"
comp65944_c0_seq1;GAXK01048545.1;Q8CJD3;7.86E-08;ZG16_RAT;Zymogen granule membrane protein 16 (Zymogen granule protein 16) (Secretory lectin ZG16);"collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; zymogen granule membrane [GO:0042589]; carbohydrate binding [GO:0030246]; protein transport [GO:0015031]";"GO:0005615; GO:0005796; GO:0015031; GO:0030246; GO:0042589; GO:0060205; GO:0062023";protein transport [GO:0015031];"collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle lumen [GO:0060205]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; zymogen granule membrane [GO:0042589]";carbohydrate binding [GO:0030246]
comp6594906_c0_seq1;GAXK01101883.1;Q27324;6.90E-10;RYK1_DROME;Tyrosine-protein kinase Drl (EC 2.7.10.1) (Protein derailed);"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; dendrite guidance [GO:0070983]; determination of muscle attachment site [GO:0016204]; haltere development [GO:0007482]; learning or memory [GO:0007611]; memory [GO:0007613]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; nervous system development [GO:0007399]; olfactory learning [GO:0008355]; peptidyl-tyrosine phosphorylation [GO:0018108]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]";"GO:0004672; GO:0005524; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0007435; GO:0007482; GO:0007611; GO:0007613; GO:0008355; GO:0016055; GO:0016199; GO:0016203; GO:0016204; GO:0016319; GO:0017147; GO:0018108; GO:0019901; GO:0030424; GO:0030425; GO:0042803; GO:0042813; GO:0043235; GO:0046982; GO:0061643; GO:0070983";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; dendrite guidance [GO:0070983]; determination of muscle attachment site [GO:0016204]; haltere development [GO:0007482]; learning or memory [GO:0007611]; memory [GO:0007613]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; nervous system development [GO:0007399]; olfactory learning [GO:0008355]; peptidyl-tyrosine phosphorylation [GO:0018108]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]";"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
comp6595095_c0_seq1;GAXK01101889.1;E1WA34;1.41E-09;TCTD_SALTS;Transcriptional regulatory protein tctD;"DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";;DNA binding [GO:0003677]
comp6595260_c0_seq1;GAXK01101887.1;B7EA73;2.62E-19;PSA_ORYSJ;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"chloroplast [GO:0009507]; cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005737; GO:0006508; GO:0008237; GO:0008270; GO:0009507; GO:0043171";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"chloroplast [GO:0009507]; cytoplasm [GO:0005737]";"aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp659628_c0_seq1;GAXK01007465.1;P05661;7.28E-33;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp659741_c1_seq1;GAXK01007466.1;Q8CBH5;1.04E-15;MFSD6_MOUSE;Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"GO:0002250; GO:0005886; GO:0016021; GO:0032393; GO:0042288; GO:0042590";"adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]"
comp65980_c0_seq1;GAXK01048913.1;Q96HR9;1.51E-42;REEP6_HUMAN;Receptor expression-enhancing protein 6 (Polyposis locus protein 1-like 1);"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"GO:0001917; GO:0005634; GO:0005783; GO:0005789; GO:0016021; GO:0030665; GO:0032386; GO:0044317; GO:0045177; GO:0050908";"detection of light stimulus involved in visual perception [GO:0050908]; regulation of intracellular transport [GO:0032386]";"apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; rod spherule [GO:0044317]";
comp6598330_c0_seq1;GAXK01123752.1;P15112;5.42E-56;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp659835_c0_seq1;GAXK01007486.1;Q9NZF1;1.39E-09;PLAC8_HUMAN;Placenta-specific gene 8 protein (Protein C15);"azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; chromatin binding [GO:0003682]; brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]";"GO:0003682; GO:0005576; GO:0008284; GO:0009409; GO:0035578; GO:0040015; GO:0042742; GO:0043066; GO:0043312; GO:0045944; GO:0050873; GO:0120162";"brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]";"azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]";chromatin binding [GO:0003682]
comp6598994_c0_seq1;GAXK01123735.1;Q5E968;2.64E-13;CATK_BOVIN;Cathepsin K (EC 3.4.22.38);"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037";"bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]"
comp66001_c3_seq1;GAXK01158084.1;O75882;6.71E-39;ATRN_HUMAN;Attractin (DPPT-L) (Mahogany homolog);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; tissue development [GO:0009888]";"GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006979; GO:0009887; GO:0009888; GO:0021549; GO:0030246; GO:0038023; GO:0040014; GO:0042552; GO:0043473; GO:0070062";"animal organ morphogenesis [GO:0009887]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]"
comp6600994_c0_seq1;GAXK01067284.1;Q9RFD5;3.24E-34;BCHH_RHOS4;Magnesium-chelatase subunit H (EC 6.6.1.1) (Mg-protoporphyrin IX chelatase subunit H);"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]; light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";"GO:0005524; GO:0015979; GO:0016851; GO:0036070";"light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";;"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]"
comp660129_c0_seq1;GAXK01001274.1;Q8C8R3;6.61E-78;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp660172_c0_seq1;GAXK01001348.1;Q9P0K7;2.47E-07;RAI14_HUMAN;Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14);"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";"GO:0001650; GO:0003779; GO:0005634; GO:0005829; GO:0005856; GO:0005938; GO:0007283; GO:0030054; GO:0030154";"cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]";"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]";actin binding [GO:0003779]
comp6602866_c0_seq1;GAXK01090053.1;Q09575;3.98E-31;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp6602906_c0_seq1;GAXK01090054.1;Q9I452;2.24E-17;THTM_PSEAE;Probable 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) (Rhodanese-like protein);"cytoplasm [GO:0005737]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; thiosulfate sulfurtransferase activity [GO:0004792]; transsulfuration [GO:0019346]";"GO:0004792; GO:0005737; GO:0016784; GO:0019346";transsulfuration [GO:0019346];cytoplasm [GO:0005737];"3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; thiosulfate sulfurtransferase activity [GO:0004792]"
comp6603323_c0_seq1;GAXK01090065.1;Q94HW2;3.77E-16;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp660351_c0_seq1;GAXK01001312.1;Q94900;8.62E-32;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp660363_c0_seq1;GAXK01001281.1;Q27433;1.04E-94;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp66037_c0_seq1;GAXK01158275.1;Q5ZHY5;3.01E-94;CHIP_CHICK;STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP);"chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]";"GO:0000151; GO:0000209; GO:0001664; GO:0004842; GO:0005654; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030911; GO:0030968; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0042405; GO:0042803; GO:0043161; GO:0046332; GO:0051087; GO:0051443; GO:0051787; GO:0051865; GO:0051879; GO:0070534; GO:0071218; GO:0090035; GO:0101031";"cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]";"chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]";"chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]"
comp6603922_c0_seq1;GAXK01090064.1;Q2S6X1;7.41E-40;EFG2_HAHCH;Elongation factor G 2 (EF-G 2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp6604878_c0_seq1;GAXK01037956.1;Q9NSU2;2.40E-15;TREX1_HUMAN;Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1) (Deoxyribonuclease III) (DNase III);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response to antigenic stimulus [GO:0002437]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"GO:0000287; GO:0001568; GO:0001822; GO:0002253; GO:0002281; GO:0002320; GO:0002379; GO:0002383; GO:0002437; GO:0002457; GO:0002637; GO:0003007; GO:0003015; GO:0003228; GO:0003690; GO:0003697; GO:0005635; GO:0005789; GO:0005829; GO:0006091; GO:0006110; GO:0006259; GO:0006260; GO:0006281; GO:0006298; GO:0006304; GO:0006308; GO:0006310; GO:0008250; GO:0008296; GO:0008301; GO:0008340; GO:0008408; GO:0008853; GO:0010468; GO:0019217; GO:0032197; GO:0032405; GO:0032407; GO:0032479; GO:0032508; GO:0032558; GO:0032607; GO:0032680; GO:0032993; GO:0034614; GO:0035458; GO:0035781; GO:0042803; GO:0043277; GO:0043457; GO:0043596; GO:0045184; GO:0046872; GO:0046890; GO:0050699; GO:0050727; GO:0050790; GO:0050821; GO:0050863; GO:0051607; GO:0060337; GO:0060339; GO:0061635; GO:0071480; GO:0072394; GO:0072421; GO:0072422; GO:0072711; GO:0097281; GO:1904161; GO:1905671";"activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; detection of DNA damage stimulus involved in DNA damage checkpoint [GO:0072421]; detection of stimulus involved in cell cycle checkpoint [GO:0072394]; determination of adult lifespan [GO:0008340]; DNA catabolic process [GO:0006308]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; immunoglobulin biosynthetic process involved in immune response [GO:0002379]; inflammatory response to antigenic stimulus [GO:0002437]; interferon-alpha production [GO:0032607]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; signal transduction involved in DNA damage checkpoint [GO:0072422]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]";"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]"
comp6605455_c0_seq1;GAXK01037945.1;P51776;8.21E-64;PPDK_GIAIN;Pyruvate, phosphate dikinase (EC 2.7.9.1) (Pyruvate, orthophosphate dikinase);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]; pyruvate metabolic process [GO:0006090]";"GO:0005524; GO:0006090; GO:0016301; GO:0046872; GO:0050242";pyruvate metabolic process [GO:0006090];;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]"
comp66058_c0_seq1;GAXK01158331.1;P31597;1.61E-115;EAA3_RABIT;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476";"chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]";"apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]";"chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
comp660615_c0_seq1;GAXK01001346.1;P14318;1.57E-34;MP20_DROME;Muscle-specific protein 20;"cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]";"GO:0005737; GO:0007520; GO:1901739";"myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]";cytoplasm [GO:0005737];
comp660618_c0_seq1;GAXK01001356.1;Q7KRI2;7.61E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp66065_c1_seq1;GAXK01158484.1;P21521;1.99E-123;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp6606738_c0_seq1;GAXK01003951.1;P0CT77;4.07E-48;RL11A_SCHPO;60S ribosomal protein L11-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0019843; GO:0022625; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp660687_c1_seq1;GAXK01001358.1;P27473;9.83E-36;IFI44_PANTR;Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp66076_c3_seq1;GAXK01205861.1;Q23023;3.09E-38;UNC51_CAEEL;Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51);"axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]";"GO:0000045; GO:0000407; GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0010506; GO:0012501; GO:0016020; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0040014; GO:0040024; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046777; GO:0046872";"apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]";"axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; phagophore assembly site [GO:0000407]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp66085_c0_seq1;GAXK01158624.1;O95619;1.72E-90;YETS4_HUMAN;YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1);"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; structural constituent of cytoskeleton [GO:0005200]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]";"GO:0000278; GO:0003677; GO:0003700; GO:0005200; GO:0005654; GO:0008022; GO:0016363; GO:0031965; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045893; GO:0045944";"histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]";"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; structural constituent of cytoskeleton [GO:0005200]"
comp6609026_c0_seq1;GAXK01098747.1;P10074;6.37E-11;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp6609126_c0_seq1;GAXK01098748.1;Q00433;1.58E-13;PHE3_RHDS2;Phycoerythrin alpha-3 chain, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]; oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"GO:0009535; GO:0015979; GO:0018298; GO:0030089; GO:0055114";"oxidation-reduction process [GO:0055114]; photosynthesis [GO:0015979]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; phycobilisome [GO:0030089]";
comp6609247_c0_seq1;GAXK01098739.1;Q22398;1.71E-07;NAS22_CAEEL;Zinc metalloproteinase nas-22 (EC 3.4.24.-) (Nematode astacin 22);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996";molting cycle, collagen and cuticulin-based cuticle [GO:0018996];extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6610619_c0_seq1;GAXK01075670.1;Q9VNM1;4.35E-08;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp6611199_c0_seq1;GAXK01075680.1;Q9URX7;7.08E-37;ANM1_SCHPO;Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Type I protein arginine N-methyltransferase) (Type I PRMT);"cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005829; GO:0006355; GO:0008469; GO:0016274; GO:0019919; GO:0034969; GO:0035242";"histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]"
comp661228_c0_seq1;GAXK01001340.1;Q6AZW2;6.30E-48;A1A1A_DANRE;Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]";"GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0110095";cellular detoxification of aldehyde [GO:0110095];"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"
comp661245_c0_seq1;GAXK01001285.1;P19484;1.10E-15;TFEB_HUMAN;Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000790; GO:0000981; GO:0001892; GO:0002250; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006914; GO:0006959; GO:0007040; GO:0010508; GO:0032418; GO:0044212; GO:0045893; GO:0045944; GO:0046983";"adaptive immune response [GO:0002250]; autophagy [GO:0006914]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]"
comp6612769_c0_seq1;GAXK01044945.1;Q5ZIE4;4.67E-17;CHSTA_CHICK;Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166";"carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";sulfotransferase activity [GO:0008146]
comp6612836_c0_seq1;GAXK01044935.1;Q9CW03;1.85E-13;SMC3_MOUSE;Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome segregation protein SmcD) (Mad member-interacting protein 1);"basement membrane [GO:0005604]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; interaction with symbiont [GO:0051702]; meiotic cell cycle [GO:0051321]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of DNA replication [GO:0006275]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"GO:0000775; GO:0000785; GO:0000800; GO:0003682; GO:0005524; GO:0005604; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0007062; GO:0008278; GO:0016363; GO:0019827; GO:0030893; GO:0032876; GO:0034991; GO:0036033; GO:0044791; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0051702; GO:0070840; GO:0097431; GO:1901673";"cell division [GO:0051301]; DNA repair [GO:0006281]; interaction with symbiont [GO:0051702]; meiotic cell cycle [GO:0051321]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of DNA replication [GO:0006275]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"basement membrane [GO:0005604]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]"
comp6613427_c0_seq1;GAXK01044943.1;Q9Y2Q0;2.56E-07;AT8A1_HUMAN;Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1);"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0019829; GO:0030335; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0043312; GO:0045332; GO:0061092; GO:0070062; GO:0140326";"ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]";"azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp661355_c2_seq1;GAXK01001290.1;Q3UVD5;7.06E-24;LGR6_MOUSE;Leucine-rich repeat-containing G-protein coupled receptor 6;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"GO:0004930; GO:0005615; GO:0005886; GO:0016021; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523";"bone regeneration [GO:1990523]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp66142_c1_seq1;GAXK01158507.1;P04069;3.97E-96;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp66148_c0_seq1;GAXK01158509.1;Q60414;3.21E-27;NTCP2_CRIGR;Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]";"GO:0008508; GO:0016021; GO:0016324";;"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";bile acid:sodium symporter activity [GO:0008508]
comp661500_c0_seq1;GAXK01001350.1;Q5E9V5;4.43E-10;KLD8B_BOVIN;Kelch domain-containing protein 8B;"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"GO:0005737; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410";"mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]";"cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; midbody [GO:0030496]";
comp6616221_c0_seq1;GAXK01136074.1;Q9NZJ4;9.43E-14;SACS_HUMAN;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084";"negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]";"axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]"
comp661643_c0_seq1;GAXK01001332.1;Q17QK6;1.59E-25;FBX2_BOVIN;F-box only protein 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; SCF ubiquitin ligase complex [GO:0019005]; amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0001540; GO:0005737; GO:0005783; GO:0005829; GO:0006516; GO:0016567; GO:0019005; GO:0030246; GO:0030433; GO:0031090; GO:0031146; GO:0031396; GO:0043197";"glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; SCF ubiquitin ligase complex [GO:0019005]";"amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]"
comp661667_c0_seq1;GAXK01001309.1;Q9Y226;9.95E-60;S22AD_HUMAN;Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; organic cation transmembrane transporter activity [GO:0015101]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinate transport [GO:2001142]; organic cation transport [GO:0015695]; urate transport [GO:0015747]";"GO:0005886; GO:0005887; GO:0015101; GO:0015695; GO:0015747; GO:0016324; GO:0034356; GO:0070062; GO:0090416; GO:2001142";"NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinate transport [GO:2001142]; organic cation transport [GO:0015695]; urate transport [GO:0015747]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"nicotinate transmembrane transporter activity [GO:0090416]; organic cation transmembrane transporter activity [GO:0015101]"
comp661770_c0_seq1;GAXK01204970.1;Q9Y4A8;1.82E-14;NF2L3_HUMAN;Nuclear factor erythroid 2-related factor 3 (NF-E2-related factor 3) (NFE2-related factor 3) (Nuclear factor, erythroid derived 2, like 3);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0003713; GO:0005634; GO:0005737; GO:0006366; GO:0045893";"positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6618444_c0_seq1;GAXK01039052.1;C7RSI4;1.72E-20;BAMC_ACCPU;Outer membrane protein assembly factor BamC;"cell outer membrane [GO:0009279]; Gram-negative-bacterium-type cell outer membrane assembly [GO:0043165]; protein insertion into membrane [GO:0051205]";"GO:0009279; GO:0043165; GO:0051205";"Gram-negative-bacterium-type cell outer membrane assembly [GO:0043165]; protein insertion into membrane [GO:0051205]";cell outer membrane [GO:0009279];
comp6618588_c0_seq1;GAXK01039057.1;O42784;2.37E-14;GPA1_COLTR;Guanine nucleotide-binding protein subunit alpha;"heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0031683; GO:0046872";G protein-coupled receptor signaling pathway [GO:0007186];heterotrimeric G-protein complex [GO:0005834];"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp661874_c0_seq1;GAXK01001288.1;Q5ZKD9;2.19E-13;KLH20_CHICK;Kelch-like protein 20;"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390";"Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]";"interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]"
comp6619745_c0_seq1;GAXK01039056.1;P46044;6.10E-46;NIFB_FRAAL;FeMo cofactor biosynthesis protein NifB (EC 4.-.-.-) (Nitrogenase cofactor maturase NifB) (Radical SAM assemblase NifB);"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; coenzyme biosynthetic process [GO:0009108]; nitrogen fixation [GO:0009399]";"GO:0009108; GO:0009399; GO:0016829; GO:0046872; GO:0051539";"coenzyme biosynthetic process [GO:0009108]; nitrogen fixation [GO:0009399]";;"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]"
comp662073_c0_seq1;GAXK01164379.1;A3KMR8;1.64E-14;MAFA_DANRE;Transcription factor MafAa (Somite Maf1) (SMaf1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]";"GO:0000978; GO:0003700; GO:0005634; GO:0007275; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp6621406_c0_seq1;GAXK01081381.1;P84029;6.91E-25;CYC2_DROME;Cytochrome c-2 (Cytochrome c-proximal);"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0055114; GO:0070469";oxidation-reduction process [GO:0055114];"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp66221_c2_seq1;GAXK01158147.1;Q8VC42;4.54E-57;RMC1_MOUSE;Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1);"late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]";"GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658";"autophagy [GO:0006914]; regulation of autophagy [GO:0010506]";"late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]";
comp6622271_c0_seq1;GAXK01086273.1;P98163;4.19E-07;YL_DROME;Putative vitellogenin receptor (Protein yolkless) (YL);"coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]";"GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477";oogenesis [GO:0048477];"coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]"
comp6622705_c0_seq1;GAXK01086280.1;Q146L7;1.22E-59;ICMF_PARXL;"Fused isobutyryl-CoA mutase [Includes: Isobutyryl-CoA mutase (ICM) (EC 5.4.99.13); P-loop GTPase (EC 3.6.5.-) (G-protein chaperone)]";"cobalamin binding [GO:0031419]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; isobutyryl-CoA mutase activity [GO:0047727]; magnesium ion binding [GO:0000287]; methylmalonyl-CoA mutase activity [GO:0004494]; pivalyl-CoA mutase activity [GO:0034784]; acyl-CoA metabolic process [GO:0006637]";"GO:0000287; GO:0003924; GO:0004494; GO:0005525; GO:0006637; GO:0031419; GO:0034784; GO:0047727";acyl-CoA metabolic process [GO:0006637];;"cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; isobutyryl-CoA mutase activity [GO:0047727]; magnesium ion binding [GO:0000287]; methylmalonyl-CoA mutase activity [GO:0004494]; pivalyl-CoA mutase activity [GO:0034784]"
comp66229_c1_seq1;GAXK01158632.1;Q6DGM3;1.74E-72;RM15_DANRE;39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15);"mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412";translation [GO:0006412];mitochondrial large ribosomal subunit [GO:0005762];structural constituent of ribosome [GO:0003735]
comp6624028_c0_seq1;GAXK01045320.1;P42791;4.79E-54;RL182_ARATH;60S ribosomal protein L18-2;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0015934; GO:0022625";translation [GO:0006412];"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp6624490_c0_seq1;GAXK01045314.1;Q6PC69;2.05E-43;RL10A_DANRE;60S ribosomal protein L10a;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";"GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp6624857_c0_seq1;GAXK01045325.1;Q6Q4H1;8.53E-13;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp6625544_c0_seq1;GAXK01045322.1;P77526;2.39E-34;YFCG_ECOLI;Disulfide-bond oxidoreductase YfcG (EC 1.8.4.-) (GSH-dependent disulfide-bond oxidoreductase YfcG) (GST N1-1) (GST-like protein YfcG) (Organic hydroperoxidase) (EC 1.11.1.-);"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0006979; GO:0015036";response to oxidative stress [GO:0006979];;"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]"
comp662565_c0_seq1;GAXK01164352.1;Q9C0F3;9.14E-15;ZN436_HUMAN;Zinc finger protein 436;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp662647_c0_seq1;GAXK01164328.1;A1B3B4;1.80E-14;Y1914_PARDP;UPF0314 protein Pden_1914;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6627_c0_seq1;GAXK01100560.1;Q9HAV7;2.55E-59;GRPE1_HUMAN;GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PAM complex, Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]";"GO:0000774; GO:0001405; GO:0005634; GO:0005739; GO:0005759; GO:0006457; GO:0030150; GO:0042803; GO:0051082; GO:0051087";"protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PAM complex, Tim23 associated import motor [GO:0001405]";"adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]"
comp662735_c2_seq1;GAXK01164333.1;Q38882;3.15E-178;PLDA1_ARATH;Phospholipase D alpha 1 (AtPLDalpha1) (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (PLDalpha) (Phosphatidylcholine-hydrolyzing phospholipase D 1);"chloroplast [GO:0009507]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase activity [GO:0004620]; phospholipase D activity [GO:0004630]; abscisic acid-activated signaling pathway [GO:0009738]; ethylene-activated signaling pathway [GO:0009873]; fatty acid metabolic process [GO:0006631]; leaf shaping [GO:0010358]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cadmium ion [GO:0046686]; seed germination [GO:0009845]";"GO:0004620; GO:0004630; GO:0005096; GO:0005509; GO:0005546; GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0009506; GO:0009507; GO:0009737; GO:0009738; GO:0009789; GO:0009845; GO:0009873; GO:0010119; GO:0010358; GO:0016020; GO:0016042; GO:0030136; GO:0031966; GO:0046470; GO:0046686; GO:0070290";"abscisic acid-activated signaling pathway [GO:0009738]; ethylene-activated signaling pathway [GO:0009873]; fatty acid metabolic process [GO:0006631]; leaf shaping [GO:0010358]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cadmium ion [GO:0046686]; seed germination [GO:0009845]";"chloroplast [GO:0009507]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]";"calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase activity [GO:0004620]; phospholipase D activity [GO:0004630]"
comp662745_c0_seq1;GAXK01164348.1;B8A4F4;1.83E-26;TDRD9_DANRE;ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9);"nucleus [GO:0005634]; piP-body [GO:0071547]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003723; GO:0005524; GO:0005634; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034458; GO:0034587; GO:0043046; GO:0071547";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"nucleus [GO:0005634]; piP-body [GO:0071547]";"3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]"
comp66277_c0_seq1;GAXK01158125.1;Q2KHR2;1.52E-36;RFX7_HUMAN;DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357";regulation of transcription by RNA polymerase II [GO:0006357];"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp6629191_c0_seq1;GAXK01003610.1;O23016;1.12E-11;KCAB_ARATH;Probable voltage-gated potassium channel subunit beta (K(+) channel subunit beta) (Potassium voltage beta 1) (KV-beta1);"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; voltage-gated ion channel activity [GO:0005244]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005244; GO:0005576; GO:0005886; GO:0006813; GO:0009506; GO:0034765";"potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";voltage-gated ion channel activity [GO:0005244]
comp6629215_c0_seq1;GAXK01003603.1;Q82T49;1.10E-13;FLIE_NITEU;Flagellar hook-basal body complex protein FliE;"bacterial-type flagellum basal body [GO:0009425]; motor activity [GO:0003774]; structural molecule activity [GO:0005198]; bacterial-type flagellum-dependent cell motility [GO:0071973]";"GO:0003774; GO:0005198; GO:0009425; GO:0071973";bacterial-type flagellum-dependent cell motility [GO:0071973];bacterial-type flagellum basal body [GO:0009425];"motor activity [GO:0003774]; structural molecule activity [GO:0005198]"
comp663_c0_seq1;GAXK01169106.1;P06144;5.19E-13;H1_LYTPI;Late histone H1;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334";nucleosome assembly [GO:0006334];"nucleosome [GO:0000786]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp6630091_c0_seq1;GAXK01165425.1;Q94HW2;8.59E-12;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp66305_c0_seq1;GAXK01158781.1;Q99LZ3;2.80E-57;SLD5_MOUSE;DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed];"cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]";"GO:0000727; GO:0000811; GO:0001833; GO:0005634; GO:0005737; GO:0006261; GO:0031298; GO:0032508";"DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]";"cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]";
comp6630537_c0_seq1;GAXK01165420.1;P07898;7.40E-18;PGCA_CHICK;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp663093_c0_seq1;GAXK01164350.1;B2GUN4;1.51E-27;MARF1_XENTR;Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog);"peroxisome [GO:0005777]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";"GO:0003723; GO:0005777; GO:0010468; GO:0048477; GO:0051321";"meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]";peroxisome [GO:0005777];RNA binding [GO:0003723]
comp6631287_c0_seq1;GAXK01165418.1;P18491;4.52E-17;EMC_DROME;Protein extra-macrochaetae;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cell cycle [GO:0051726]; sex determination [GO:0007530]; sex determination, primary response to X:A ratio [GO:0007541]";"GO:0000122; GO:0001085; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007391; GO:0007458; GO:0007476; GO:0007494; GO:0007530; GO:0007541; GO:0007623; GO:0008134; GO:0008258; GO:0008407; GO:0008586; GO:0030182; GO:0030381; GO:0042675; GO:0043392; GO:0045466; GO:0045665; GO:0045892; GO:0046552; GO:0046843; GO:0046982; GO:0048056; GO:0051726";"chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cell cycle [GO:0051726]; sex determination [GO:0007530]; sex determination, primary response to X:A ratio [GO:0007541]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp663129_c0_seq1;GAXK01164378.1;Q16445;7.21E-68;GBRA6_HUMAN;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6);"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0099192; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp66316_c3_seq1;GAXK01158535.1;O35083;3.17E-42;PLCA_MOUSE;1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of cytokine production [GO:0001819]";"GO:0001819; GO:0003841; GO:0005783; GO:0005789; GO:0006654; GO:0016021; GO:0016024";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of cytokine production [GO:0001819]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp663253_c1_seq1;GAXK01164371.1;B7YZV4;4.69E-63;PDE1_DROME;Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1) (EC 3.1.4.17);"extracellular space [GO:0005615]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]";"GO:0004115; GO:0005516; GO:0005615; GO:0007165; GO:0032504; GO:0046058; GO:0046068; GO:0046872; GO:0047555; GO:0048101; GO:0060179";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]";extracellular space [GO:0005615];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp66329_c0_seq1;GAXK01158511.1;Q28DE7;1.45E-73;KLD10_XENTR;Kelch domain-containing protein 10;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of stress-activated MAPK cascade [GO:0032874]";"GO:0005634; GO:0005737; GO:0032874";positive regulation of stress-activated MAPK cascade [GO:0032874];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp6633_c0_seq1;GAXK01101232.1;Q7ZT46;1.12E-58;PSF2_XENLA;DNA replication complex GINS protein PSF2 (GINS complex subunit 2);"GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; regulation of DNA-templated transcription, elongation [GO:0032784]";"GO:0000811; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006271; GO:0032784";"DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; regulation of DNA-templated transcription, elongation [GO:0032784]";"GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";chromatin binding [GO:0003682]
comp6633300_c0_seq1;GAXK01173528.1;P83373;2.77E-54;MDHM_FRAAN;Malate dehydrogenase, mitochondrial (EC 1.1.1.37);"mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0005759; GO:0005975; GO:0006099; GO:0006108; GO:0030060";"carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];L-malate dehydrogenase activity [GO:0030060]
comp663334_c2_seq1;GAXK01164380.1;O01404;3.93E-93;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp66334_c2_seq1;GAXK01158747.1;G5EBQ8;0;CHS2_CAEEL;Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063";"chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";chitin synthase activity [GO:0004100]
comp66335_c1_seq1;GAXK01158499.1;Q24206;9.18E-32;BRC4_DROME;Broad-complex core protein isoform 6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp663456_c0_seq1;GAXK01164316.1;B3MRS1;2.82E-61;NAAT1_DROAN;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp6634832_c0_seq1;GAXK01152239.1;Q9W747;2.52E-10;DRL_DANRE;Zinc finger protein draculin;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gastrulation with mouth forming second [GO:0001702]";"GO:0001702; GO:0003677; GO:0005634; GO:0046872";gastrulation with mouth forming second [GO:0001702];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6635_c0_seq1;GAXK01100304.1;Q90512;1.21E-126;ODO2_TAKRU;Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006103; GO:0006104; GO:0033512; GO:0045252; GO:0106077";"2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]";dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]
comp663615_c0_seq1;GAXK01164342.1;P48035;1.75E-19;FABP4_BOVIN;Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cholesterol homeostasis [GO:0042632]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; white fat cell differentiation [GO:0050872]";"GO:0001816; GO:0005324; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006631; GO:0008284; GO:0010628; GO:0010629; GO:0015909; GO:0036041; GO:0042632; GO:0045892; GO:0050729; GO:0050872; GO:0050873; GO:0071285";"brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cholesterol homeostasis [GO:0042632]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; white fat cell differentiation [GO:0050872]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]"
comp6637039_c0_seq1;GAXK01033948.1;Q65XK0;1.70E-65;ILV5_ORYSJ;Ketol-acid reductoisomerase, chloroplastic (EC 1.1.1.86) (Acetohydroxy-acid reductoisomerase) (Alpha-keto-beta-hydroxylacyl reductoisomerase) (Protein KARI);"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; branched-chain amino acid biosynthetic process [GO:0009082]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";"GO:0000287; GO:0004455; GO:0005739; GO:0009082; GO:0009097; GO:0009099; GO:0009507; GO:0042803; GO:0070402";"branched-chain amino acid biosynthetic process [GO:0009082]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]";"chloroplast [GO:0009507]; mitochondrion [GO:0005739]";"ketol-acid reductoisomerase activity [GO:0004455]; magnesium ion binding [GO:0000287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]"
comp663764_c0_seq1;GAXK01164343.1;Q9H4Z2;7.84E-09;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp663781_c1_seq1;GAXK01164370.1;W4VS53;5.87E-57;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp6638619_c0_seq1;GAXK01192836.1;P36609;2.73E-50;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp663886_c0_seq1;GAXK01164337.1;B0W2W6;5.17E-16;MAEL_CULQU;Protein maelstrom homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"GO:0003677; GO:0005634; GO:0005737; GO:0007275; GO:0030154; GO:0031047; GO:0051321; GO:0060964";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; regulation of gene silencing by miRNA [GO:0060964]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp66393_c1_seq1;GAXK01158066.1;Q8K4P0;0;WDR33_MOUSE;pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa);"collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA polyadenylation [GO:0006378]";"GO:0001650; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006378";mRNA polyadenylation [GO:0006378];"collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp66396_c0_seq1;GAXK01158276.1;Q9IBD1;1.15E-25;CELF3_DANRE;CUGBP Elav-like family member 3 (CELF-3) (Bruno-like protein 1) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1) (ETR-1) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904";"mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp664079_c0_seq1;GAXK01038459.1;O46040;1.57E-20;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp6641_c0_seq1;GAXK01100574.1;Q90629;1.68E-34;TRY3_CHICK;Trypsin II-P29 (EC 3.4.21.4);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872";"digestion [GO:0007586]; proteolysis [GO:0006508]";extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp66414_c0_seq1;GAXK01158593.1;A6QLZ5;1.04E-10;F177A_BOVIN;Protein FAM177A1;;;;;
comp6641481_c0_seq1;GAXK01110222.1;P61270;2.66E-43;RS11_MACFA;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp66424_c0_seq1;GAXK01158481.1;Q9NQX5;1.67E-18;NPDC1_HUMAN;Neural proliferation differentiation and control protein 1 (NPDC-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of immune response [GO:0050776]";"GO:0005886; GO:0016021; GO:0050776";regulation of immune response [GO:0050776];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6642822_c0_seq1;GAXK01144299.1;P21328;1.86E-11;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp6643064_c0_seq1;GAXK01144300.1;P42878;8.42E-19;Y2474_RHIME;Uncharacterized protein R02474;;;;;
comp6643192_c0_seq1;GAXK01144305.1;O44001;1.97E-51;HSP90_EIMTE;Heat shock protein 90;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp66435_c0_seq1;GAXK01158243.1;Q6AY09;8.23E-45;HNRH2_RAT;Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]";"GO:0003723; GO:0005654; GO:0005829; GO:0014069; GO:1990904";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp6643736_c0_seq1;GAXK01144295.1;G5EG11;1.14E-10;FAT4_CAEEL;Delta(5) fatty acid desaturase fat-4 (EC 1.14.19.-) (Fatty acid desaturase 4);"integral component of membrane [GO:0016021]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0006636; GO:0016021";unsaturated fatty acid biosynthetic process [GO:0006636];integral component of membrane [GO:0016021];stearoyl-CoA 9-desaturase activity [GO:0004768]
comp664494_c0_seq1;GAXK01038468.1;P34465;8.43E-18;CY561_CAEEL;Putative cytochrome b561 (Cytochrome b-561);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0005765; GO:0016021; GO:0016491; GO:0031902; GO:0046872";;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp6645092_c0_seq1;GAXK01003478.1;Q6BJ25;5.08E-35;EF2_DEBHA;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp6646458_c0_seq1;GAXK01188887.1;P49922;1.14E-17;GNRHR_PIG;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (Luteinizing hormone-releasing hormone receptor) (LHRH);"integral component of plasma membrane [GO:0005887]; gonadotropin-releasing hormone receptor activity [GO:0004968]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004968; GO:0005887; GO:0007186; GO:0032870";"cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]";integral component of plasma membrane [GO:0005887];gonadotropin-releasing hormone receptor activity [GO:0004968]
comp664815_c0_seq1;GAXK01038458.1;Q8R550;2.41E-17;SH3K1_MOUSE;SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes);"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of cell shape [GO:0008360]";"GO:0005737; GO:0005856; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202";"actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of cell shape [GO:0008360]";"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]";"SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]"
comp6648304_c0_seq1;GAXK01150294.1;P35615;1.77E-58;ERF1_XENLA;Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog);"cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]; translation termination factor activity [GO:0008079]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational termination [GO:0006449]";"GO:0000184; GO:0003747; GO:0005737; GO:0006449; GO:0008079";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational termination [GO:0006449]";cytoplasm [GO:0005737];"translation release factor activity [GO:0003747]; translation termination factor activity [GO:0008079]"
comp66487_c1_seq1;GAXK01158209.1;Q56YP2;1.75E-13;PI5K1_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 1 (AtPIP5K1) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 1) (Diphosphoinositide kinase 1) (PtdIns(4)P-5-kinase 1);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]";"GO:0003785; GO:0005524; GO:0005886; GO:0016307; GO:0016308; GO:0051015";;plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]"
comp664877_c0_seq1;GAXK01038465.1;Q9GRW0;3.95E-15;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp66488_c2_seq1;GAXK01158604.1;Q96H78;6.41E-81;S2544_HUMAN;Solute carrier family 25 member 44;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp6649_c0_seq1;GAXK01100474.1;Q9P0U1;2.87E-07;TOM7_HUMAN;Mitochondrial import receptor subunit TOM7 homolog (Translocase of outer membrane 7 kDa subunit homolog);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; macroautophagy [GO:0016236]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of protein stability [GO:0031647]";"GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016021; GO:0016236; GO:0030150; GO:0031647; GO:0098779; GO:1903955";"macroautophagy [GO:0016236]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of protein stability [GO:0031647]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]";protein transmembrane transporter activity [GO:0008320]
comp66492_c0_seq1;GAXK01158130.1;Q5HZT9;1.11E-78;DJC25_XENTR;DnaJ homolog subfamily C member 25;"integral component of membrane [GO:0016021]; protein folding [GO:0006457]";"GO:0006457; GO:0016021";protein folding [GO:0006457];integral component of membrane [GO:0016021];
comp6649799_c0_seq1;GAXK01150299.1;Q1LZG6;1.99E-10;CCNB1_BOVIN;G2/mitotic-specific cyclin-B1;"centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0007080; GO:0016538; GO:0019901; GO:0044772; GO:0051301; GO:0097125";"cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp66503_c0_seq1;GAXK01158471.1;Q96DP5;3.06E-49;FMT_HUMAN;Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9);"mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]";"GO:0004479; GO:0005739; GO:0071951";conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951];mitochondrion [GO:0005739];methionyl-tRNA formyltransferase activity [GO:0004479]
comp6650424_c0_seq1;GAXK01198094.1;P41116;8.05E-92;RL8_XENLA;60S ribosomal protein L8;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp66507_c1_seq1;GAXK01158202.1;Q9V853;0;SMUF1_DROME;E3 ubiquitin-protein ligase Smurf1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Smurf1) (Lethal with a checkpoint kinase protein) (SMAD ubiquitination regulatory factor 1 homolog) (DSmurf);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic hindgut morphogenesis [GO:0048619]; germarium-derived egg chamber formation [GO:0007293]; male gamete generation [GO:0048232]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]";"GO:0000151; GO:0000209; GO:0001700; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007293; GO:0016567; GO:0030509; GO:0030514; GO:0030579; GO:0035331; GO:0040008; GO:0043161; GO:0045732; GO:0045879; GO:0045880; GO:0048232; GO:0048260; GO:0048619; GO:0061630";"BMP signaling pathway [GO:0030509]; embryonic development via the syncytial blastoderm [GO:0001700]; embryonic hindgut morphogenesis [GO:0048619]; germarium-derived egg chamber formation [GO:0007293]; male gamete generation [GO:0048232]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]";"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp665124_c0_seq1;GAXK01038450.1;A1CRI1;2.81E-86;XYL1_ASPCL;Probable NAD(P)H-dependent D-xylose reductase xyl1 (XR) (EC 1.1.1.307);"oxidoreductase activity [GO:0016491]; D-xylose catabolic process [GO:0042843]";"GO:0016491; GO:0042843";D-xylose catabolic process [GO:0042843];;oxidoreductase activity [GO:0016491]
comp6651373_c0_seq1;GAXK01198109.1;P50430;1.10E-24;ARSB_RAT;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580";"autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]";"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]"
comp66514_c2_seq1;GAXK01158409.1;Q6NY74;1.02E-33;RFA1_DANRE;Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1);"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0007507; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321";"DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]";"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]";"damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]"
comp6651436_c0_seq1;GAXK01198104.1;P23314;3.21E-12;EXPR_XANCP;Extracellular protease (EC 3.4.21.-);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp6651559_c0_seq1;GAXK01198108.1;P14381;6.76E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp6651696_c0_seq1;GAXK01198106.1;Q56YP2;1.24E-18;PI5K1_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 1 (AtPIP5K1) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 1) (Diphosphoinositide kinase 1) (PtdIns(4)P-5-kinase 1);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]";"GO:0003785; GO:0005524; GO:0005886; GO:0016307; GO:0016308; GO:0051015";;plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol phosphate kinase activity [GO:0016307]"
comp66531_c0_seq1;GAXK01158201.1;E7FDW8;6.43E-55;TRD7B_DANRE;Tudor domain-containing protein 7B;"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0005737; GO:0007283; GO:0010608; GO:0035770; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]";mRNA binding [GO:0003729]
comp6653655_c0_seq1;GAXK01114053.1;Q8BIQ3;4.91E-18;ZNF2_MOUSE;Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp665394_c0_seq1;GAXK01038410.1;Q7KRI2;2.70E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp66544_c0_seq1;GAXK01158269.1;O45782;3.38E-30;ARD17_CAEEL;Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1);"protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]";"GO:0007610; GO:0030346";behavior [GO:0007610];;protein phosphatase 2B binding [GO:0030346]
comp665467_c0_seq1;GAXK01038412.1;O77695;3.77E-109;BGLR_CHLAE;Beta-glucuronidase (EC 3.2.1.31) (Fragment);"lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate metabolic process [GO:0005975]";"GO:0004566; GO:0005764; GO:0005975";carbohydrate metabolic process [GO:0005975];lysosome [GO:0005764];beta-glucuronidase activity [GO:0004566]
comp6654849_c0_seq1;GAXK01116649.1;Q9LXG1;1.53E-65;RS91_ARATH;40S ribosomal protein S9-1;"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0006412; GO:0009506; GO:0009507; GO:0009536; GO:0019843; GO:0022626; GO:0022627; GO:0042788; GO:0045903";"positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]";"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp66553_c0_seq1;GAXK01158387.1;Q9NGC3;6.41E-139;CEG1A_DROME;Centaurin-gamma-1A;"membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375";"medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]";"membrane [GO:0016020]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp6655438_c0_seq1;GAXK01116652.1;B0VYY3;9.17E-42;COX5A_OTOCR;Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va);"mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]";"GO:0004129; GO:0005743; GO:0046872";;mitochondrial inner membrane [GO:0005743];"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp665572_c0_seq1;GAXK01038477.1;Q9W679;5.24E-37;P53_TETMU;Cellular tumor antigen p53 (Tumor suppressor p53);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; transcription regulatory region DNA binding [GO:0044212]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]";"GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0006974; GO:0007049; GO:0044212; GO:0045944; GO:0046872; GO:0051262; GO:1990841";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; transcription regulatory region DNA binding [GO:0044212]"
comp6656_c0_seq1;GAXK01101247.1;Q9WVK7;3.92E-119;HCDH_RAT;Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase);"mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]";"GO:0003857; GO:0005654; GO:0005759; GO:0006635; GO:0009725; GO:0014823; GO:0032868; GO:0042493; GO:0046676; GO:0070403; GO:0120162";"fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]";"mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]"
comp665651_c0_seq1;GAXK01038425.1;Q6PT52;2.48E-12;CLCA1_MACMU;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp6656982_c0_seq1;GAXK01015200.1;Q02UU0;2.56E-50;AHPC_PSEAB;Alkyl hydroperoxide reductase C (EC 1.11.1.15) (Peroxiredoxin) (Thioredoxin peroxidase);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0005737; GO:0006979; GO:0045454; GO:0051920";"cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp665808_c0_seq1;GAXK01038406.1;Q80SU7;4.64E-45;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp66582_c4_seq1;GAXK01158241.1;P58355;1.50E-56;S45A2_MOUSE;Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2);"integral component of membrane [GO:0016021]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; developmental pigmentation [GO:0048066]; melanin biosynthetic process [GO:0042438]; response to stimulus [GO:0050896]; sucrose transport [GO:0015770]; visual perception [GO:0007601]";"GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0016021; GO:0033162; GO:0042438; GO:0048066; GO:0050896";"developmental pigmentation [GO:0048066]; melanin biosynthetic process [GO:0042438]; response to stimulus [GO:0050896]; sucrose transport [GO:0015770]; visual perception [GO:0007601]";"integral component of membrane [GO:0016021]; melanosome membrane [GO:0033162]; membrane [GO:0016020]";sucrose:proton symporter activity [GO:0008506]
comp665834_c0_seq1;GAXK01038409.1;Q9NAS5;2.69E-28;TPM_ANISI;Tropomyosin (allergen Ani s 3);;;;;
comp665835_c0_seq1;GAXK01038479.1;P10076;2.71E-28;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp665897_c0_seq1;GAXK01038473.1;Q8IRC7;1.24E-69;AWH_DROME;LIM/homeobox protein Awh (Protein arrowhead);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007444; GO:0010468; GO:0030182; GO:0045944; GO:0046872; GO:0048749";"compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp665931_c0_seq1;GAXK01038428.1;Q7TSH9;9.87E-09;ZN184_MOUSE;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp666016_c0_seq1;GAXK01123953.1;P84023;4.99E-12;SMAD3_CHICK;Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]";"GO:0000122; GO:0000790; GO:0000978; GO:0000987; GO:0001102; GO:0001228; GO:0001657; GO:0001666; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0003712; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008270; GO:0009880; GO:0010718; GO:0016202; GO:0017015; GO:0017151; GO:0019049; GO:0019901; GO:0019902; GO:0030308; GO:0030618; GO:0030878; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032909; GO:0033689; GO:0035259; GO:0038092; GO:0042110; GO:0042803; GO:0043130; GO:0043235; GO:0043425; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045930; GO:0046982; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0051098; GO:0051481; GO:0060039; GO:0060395; GO:0061045; GO:0070306; GO:0070410; GO:0070412; GO:0070878; GO:0071141; GO:0071144; GO:0097191; GO:1901203; GO:1902895";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription coregulator activity [GO:0003712]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp666068_c2_seq1;GAXK01123916.1;O43345;1.91E-19;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp6660787_c0_seq1;GAXK01093526.1;Q8F641;3.06E-43;HPPA_LEPIN;Putative K(+)-stimulated pyrophosphate-energized sodium pump (EC 7.2.3.-) (Membrane-bound sodium-translocating pyrophosphatase) (Pyrophosphate-energized inorganic pyrophosphatase) (Na(+)-PPase);"integral component of plasma membrane [GO:0005887]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]; sodium ion transport [GO:0006814]";"GO:0000287; GO:0004427; GO:0005887; GO:0006814; GO:0009678; GO:0030955";sodium ion transport [GO:0006814];integral component of plasma membrane [GO:0005887];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp6661256_c0_seq1;GAXK01093529.1;Q05187;2.89E-22;TGMH_TACTR;Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase);"membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]";"GO:0003810; GO:0016020; GO:0018149; GO:0046872";peptide cross-linking [GO:0018149];membrane [GO:0016020];"metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
comp66615_c3_seq1;GAXK01158769.1;Q8R332;7.33E-38;NUP58_MOUSE;Nucleoporin p58/p45 (58 kDa nucleoporin) (Nucleoporin-like protein 1);"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306]";"GO:0005635; GO:0005643; GO:0006913; GO:0008139; GO:0015031; GO:0017056; GO:0031965; GO:0032991; GO:0042306; GO:0051028; GO:0051260; GO:0051290; GO:0051291; GO:0070208";"mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306]";"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]";"nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]"
comp66634_c0_seq1;GAXK01158502.1;P45244;1.38E-07;Y1542_HAEIN;Putative NAD(P)H nitroreductase HI_1542 (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp666434_c0_seq1;GAXK01123945.1;Q05062;3.56E-66;CDC42_CAEEL;Cell division control protein 42 homolog (CDC42Ce);"cell cortex [GO:0005938]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell division [GO:0051301]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; epithelial tube morphogenesis [GO:0060562]; establishment of mitotic spindle localization [GO:0040001]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell shape [GO:0008360]; regulation of Golgi organization [GO:1903358]; Rho protein signal transduction [GO:0007266]";"GO:0000132; GO:0003924; GO:0005525; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016021; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0032970; GO:0040001; GO:0042995; GO:0048471; GO:0051301; GO:0055037; GO:0060562; GO:1903358; GO:2000370";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell division [GO:0051301]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; epithelial tube morphogenesis [GO:0060562]; establishment of mitotic spindle localization [GO:0040001]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell shape [GO:0008360]; regulation of Golgi organization [GO:1903358]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp6664468_c0_seq1;GAXK01193347.1;B1XXK8;5.89E-48;HFQ_LEPCP;RNA-binding protein Hfq;"RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0006355";regulation of transcription, DNA-templated [GO:0006355];;RNA binding [GO:0003723]
comp6664555_c0_seq1;GAXK01193339.1;Q9NBX4;5.19E-18;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp66647_c0_seq1;GAXK01158522.1;P20936;0;RASA1_HUMAN;Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]";"GO:0000165; GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252";"blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]"
comp6665149_c0_seq1;GAXK01193342.1;P00129;1.30E-34;QCR7_BOVIN;Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein);"mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005750; GO:0006122; GO:0009060; GO:0034551";"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]";mitochondrial respiratory chain complex III [GO:0005750];
comp66659_c1_seq1;GAXK01158214.1;Q15650;3.01E-122;TRIP4_HUMAN;Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4);"activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]";"GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0019901; GO:0030331; GO:0030520; GO:0031594; GO:0032991; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0099053; GO:1901998";"intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]";"activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]"
comp666638_c0_seq1;GAXK01123895.1;Q5RHH4;0;IF172_DANRE;Intraflagellar transport protein 172 homolog;"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]";"GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271";"cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]";
comp666680_c0_seq1;GAXK01123915.1;Q25414;3.56E-89;5HTR_LYMST;5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp6667286_c0_seq1;GAXK01064347.1;Q8CFS6;1.21E-18;KCNV2_MOUSE;Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2);"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]";voltage-gated potassium channel activity [GO:0005249]
comp6667918_c0_seq1;GAXK01064352.1;P55561;3.43E-09;Y4MB_SINFN;Uncharacterized outer-membrane protein y4mB;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";"GO:0009279; GO:0016021";;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";
comp6668913_c0_seq1;GAXK01120368.1;P86854;3.43E-14;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp6669232_c0_seq1;GAXK01120361.1;Q9C551;1.85E-22;RH5_ARATH;DEAD-box ATP-dependent RNA helicase 5 (EC 3.6.4.13);"cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005829; GO:0006364";rRNA processing [GO:0006364];"cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp6669413_c0_seq1;GAXK01120365.1;Q9FZH0;1.14E-23;R35A2_ARATH;60S ribosomal protein L35a-2;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp6669545_c0_seq1;GAXK01120353.1;P54989;2.09E-36;NTAA_AMIAI;Nitrilotriacetate monooxygenase component A (NTA monooxygenase component A) (NTA-MO A) (EC 1.14.14.10);"nitrilotriacetate monooxygenase activity [GO:0018529]; nitrilotriacetate monooxygenase activity (FMN-dependent) [GO:0102977]";"GO:0018529; GO:0102977";;;"nitrilotriacetate monooxygenase activity [GO:0018529]; nitrilotriacetate monooxygenase activity (FMN-dependent) [GO:0102977]"
comp6670425_c0_seq1;GAXK01123596.1;Q96D21;3.03E-15;RHES_HUMAN;GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2);"plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";"GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0051897";"locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]";plasma membrane [GO:0005886];"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp667067_c1_seq1;GAXK01123885.1;Q8BUJ9;3.33E-07;LRP12_MOUSE;Low-density lipoprotein receptor-related protein 12 (LRP-12);"clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]";"GO:0001764; GO:0005887; GO:0005905; GO:0006897; GO:0031175";"endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]";"clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]";
comp6670691_c0_seq1;GAXK01123594.1;O07834;8.97E-40;DAPB1_PSEMX;Dipeptidyl aminopeptidase BI (DAP BI) (EC 3.4.14.-);"dipeptidyl-peptidase activity [GO:0008239]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004252; GO:0008239; GO:0051603; GO:0070008";proteolysis involved in cellular protein catabolic process [GO:0051603];;"dipeptidyl-peptidase activity [GO:0008239]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]"
comp667355_c2_seq1;GAXK01123884.1;P52746;1.96E-14;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6673735_c0_seq1;GAXK01093157.1;Q32KH7;7.30E-20;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp66746_c0_seq1;GAXK01158623.1;A2V735;1.00E-12;TPM_CHIOP;Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic);protein homodimerization activity [GO:0042803];GO:0042803;;;protein homodimerization activity [GO:0042803]
comp66755_c8_seq1;GAXK01158296.1;O15085;1.49E-68;ARHGB_HUMAN;Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]";"GO:0001558; GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0006941; GO:0007186; GO:0007266; GO:0016020; GO:0030010; GO:0030036; GO:0035023; GO:0043065; GO:0045893; GO:0051056";"actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]";"G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp6676532_c0_seq1;GAXK01098151.1;Q20605;5.27E-22;AMT2_CAEEL;Putative ammonium transporter 2;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0007568; GO:0008519; GO:0072488";"aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]";integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp66766_c0_seq1;GAXK01158277.1;Q7ZWD4;1.45E-153;UAP1L_DANRE;UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-);"UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0003977; GO:0006048";UDP-N-acetylglucosamine biosynthetic process [GO:0006048];;UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]
comp667716_c0_seq1;GAXK01123883.1;Q2TL60;3.64E-17;ZN667_MOUSE;Zinc finger protein 667 (Myocardial ischemic preconditioning up-regulated protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp667774_c1_seq1;GAXK01123947.1;Q02386;1.20E-36;ZNF45_HUMAN;Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006367; GO:0007275; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp6678010_c0_seq1;GAXK01120214.1;Q41094;3.54E-54;FCPF_PHATR;Fucoxanthin-chlorophyll a-c binding protein F, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp6678045_c0_seq1;GAXK01204874.1;P00082;4.09E-22;CYC2_RHOVT;Cytochrome c2;"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; photosynthesis [GO:0015979]";"GO:0009055; GO:0015979; GO:0020037; GO:0046872";photosynthesis [GO:0015979];;"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp6678701_c0_seq1;GAXK01120217.1;Q9UG63;7.36E-19;ABCF2_HUMAN;ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2);"membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0016020; GO:0016887";;membrane [GO:0016020];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp668_c0_seq1;GAXK01169201.1;P49642;1.93E-150;PRI1_HUMAN;DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49);"alpha DNA polymerase:primase complex [GO:0005658]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003697; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0016020; GO:0032201; GO:0046872";"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"alpha DNA polymerase:primase complex [GO:0005658]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]"
comp6680_c0_seq1;GAXK01101273.1;Q9CR98;4.35E-24;F136A_MOUSE;Protein FAM136A;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"GO:0005737; GO:0005739";;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";
comp668148_c0_seq1;GAXK01010721.1;Q8L796;9.79E-26;PI5K2_ARATH;Phosphatidylinositol 4-phosphate 5-kinase 2 (AtPIP5K2) (EC 2.7.1.68) (1-phosphatidylinositol 4-phosphate kinase 2) (Diphosphoinositide kinase 2) (PtdIns(4)P-5-kinase 2);"plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";"GO:0003006; GO:0005524; GO:0005886; GO:0009958; GO:0010311; GO:0016308";"developmental process involved in reproduction [GO:0003006]; lateral root formation [GO:0010311]; positive gravitropism [GO:0009958]";plasma membrane [GO:0005886];"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]"
comp6683415_c0_seq1;GAXK01065180.1;Q8IZT8;2.09E-12;HS3S5_HUMAN;Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (3-OST-5) (Heparan sulfate 3-O-sulfotransferase 5) (h3-OST-5);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate sulfotransferase activity [GO:0034483]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]";"GO:0000139; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0016021; GO:0034483; GO:0046596; GO:0050656; GO:0050819";"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; heparan sulfate sulfotransferase activity [GO:0034483]"
comp668425_c1_seq1;GAXK01010712.1;P91622;4.63E-18;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp66852_c2_seq1;GAXK01158782.1;P34371;1.11E-07;BAT42_CAEEL;BTB and MATH domain-containing protein 42;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp66874_c1_seq1;GAXK01158524.1;P59108;3.28E-15;CPNE2_MOUSE;Copine-2 (Copine II);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0071277";cellular response to calcium ion [GO:0071277];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp668742_c1_seq1;GAXK01010759.1;Q96AB6;9.46E-25;NTAN1_HUMAN;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418";"adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp66876_c1_seq1;GAXK01158760.1;Q641F8;6.40E-57;TYW3_XENLA;tRNA wybutosine-synthesizing protein 3 homolog (tRNA-yW-synthesizing protein 3) (EC 2.1.1.282) (tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase);"methyltransferase activity [GO:0008168]; tRNA processing [GO:0008033]";"GO:0008033; GO:0008168";tRNA processing [GO:0008033];;methyltransferase activity [GO:0008168]
comp6687936_c0_seq1;GAXK01024686.1;Q46087;2.00E-30;TRAT_AMIAI;Transposase;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp6688950_c0_seq1;GAXK01163238.1;Q5RHP9;4.88E-18;ERIC3_HUMAN;Glutamate-rich protein 3;;;;;
comp6689_c0_seq1;GAXK01100316.1;P46436;8.94E-17;GST1_ASCSU;Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma);"brush border [GO:0005903]; cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0055114; GO:0098869";"cellular oxidant detoxification [GO:0098869]; oxidation-reduction process [GO:0055114]";"brush border [GO:0005903]; cytoplasm [GO:0005737]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]"
comp6689154_c0_seq1;GAXK01163235.1;Q8I7P9;2.38E-17;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp669_c0_seq1;GAXK01169350.1;Q9VFR0;2.29E-43;BCCIP_DROME;Protein BCCIP homolog;"centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]";"GO:0000079; GO:0000132; GO:0005813; GO:0006974; GO:0007052; GO:0015631; GO:0019207; GO:0019887; GO:0034453; GO:0045859; GO:0090307; GO:0097431";"cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]";"centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]";"kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]"
comp669060_c0_seq1;GAXK01010754.1;Q06985;4.66E-08;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp66915_c0_seq1;GAXK01158390.1;P24156;3.52E-22;L2CC_DROME;Protein l(2)37Cc;"membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"GO:0005739; GO:0007275; GO:0016020; GO:0071456";"cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]";"membrane [GO:0016020]; mitochondrion [GO:0005739]";
comp669179_c0_seq1;GAXK01010762.1;Q9W092;3.19E-23;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp669214_c0_seq1;GAXK01010716.1;Q28623;7.80E-21;SLMAP_RABIT;Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; muscle contraction [GO:0006936]";"GO:0005615; GO:0005737; GO:0005815; GO:0006936; GO:0016021; GO:0042383";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]";
comp669274_c0_seq1;GAXK01010739.1;P62289;6.95E-13;ASPM_GORGO;Abnormal spindle-like microcephaly-associated protein homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; cell division [GO:0051301]; spindle organization [GO:0007051]";"GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0051301";"cell division [GO:0051301]; spindle organization [GO:0007051]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";calmodulin binding [GO:0005516]
comp6692891_c0_seq1;GAXK01081472.1;P55892;3.96E-43;MOTB_SALTY;Motility protein B (Chemotaxis protein MotB);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; archaeal or bacterial-type flagellum-dependent cell motility [GO:0097588]; chemotaxis [GO:0006935]";"GO:0005886; GO:0006935; GO:0016021; GO:0097588";"archaeal or bacterial-type flagellum-dependent cell motility [GO:0097588]; chemotaxis [GO:0006935]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp669328_c1_seq1;GAXK01010702.1;Q6GR09;5.67E-15;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp66935_c1_seq1;GAXK01158250.1;O94913;5.63E-27;PCF11_HUMAN;Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0000398; GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379; GO:0031124";"mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]";"mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]"
comp669379_c0_seq1;GAXK01204994.1;P20482;2.06E-14;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp669404_c0_seq1;GAXK01010741.1;B3EYM8;8.87E-16;IABN_GEOSE;Intracellular endo-alpha-(1->5)-L-arabinanase (ABN) (EC 3.2.1.99) (Endo-1,5-alpha-L-arabinanase);"cytoplasm [GO:0005737]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005737; GO:0031222; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];cytoplasm [GO:0005737];"arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp66942_c0_seq1;GAXK01158240.1;Q40784;1.35E-41;AAPC_CENCI;Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C);"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]";"GO:0005975; GO:0030246; GO:0047938";carbohydrate metabolic process [GO:0005975];;"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]"
comp669441_c0_seq1;GAXK01010752.1;Q6GNV5;1.50E-18;FNBP1_XENLA;Formin-binding protein 1 homolog;"cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]";"GO:0005764; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0008289; GO:0031410";endocytosis [GO:0006897];"cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";lipid binding [GO:0008289]
comp6694490_c0_seq1;GAXK01174952.1;Q9ULI1;1.99E-15;NWD2_HUMAN;NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239);"unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0042273; GO:0051082";ribosomal large subunit biogenesis [GO:0042273];;unfolded protein binding [GO:0051082]
comp669502_c0_seq1;GAXK01010704.1;Q9BZE3;6.53E-38;BARH1_HUMAN;BarH-like 1 homeobox protein;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]";"GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001764; GO:0005634; GO:0006357; GO:0007399; GO:0007605; GO:0009888; GO:0030901; GO:0043524; GO:0048513";"animal organ development [GO:0048513]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp66951_c0_seq1;GAXK01158044.1;Q66IZ5;2.51E-60;TAD3B_XENLA;Transcriptional adapter 3-B (ADA3 homolog B) (Transcriptional adapter 3-like B) (ADA3-like protein B);nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp669544_c1_seq1;GAXK01010747.1;Q6NSJ0;1.61E-123;MYORG_HUMAN;Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]";"GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897";"carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp6695465_c0_seq1;GAXK01174960.1;P10733;3.75E-15;SEVE_DICDI;Severin;"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"GO:0015629; GO:0030043; GO:0045335; GO:0048306; GO:0051014; GO:0051015; GO:0051693";"actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]";"actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]";"actin filament binding [GO:0051015]; calcium-dependent protein binding [GO:0048306]"
comp669699_c1_seq1;GAXK01010744.1;P39060;5.46E-31;COIA1_HUMAN;"Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1 (NC1)]";"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; response to drug [GO:0042493]; response to hydrostatic pressure [GO:0051599]; visual perception [GO:0007601]";"GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008284; GO:0008285; GO:0009887; GO:0030198; GO:0030335; GO:0031012; GO:0042493; GO:0042802; GO:0046872; GO:0051599; GO:0062023; GO:0070062; GO:2000353";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; response to drug [GO:0042493]; response to hydrostatic pressure [GO:0051599]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp6697920_c0_seq1;GAXK01180887.1;B1Q236;7.23E-09;SYG1_CAEEL;Synaptogenesis protein syg-1 (Synaptogenesis abnormal protein 1);"axon [GO:0030424]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; actin filament bundle assembly [GO:0051017]; branching morphogenesis of a nerve [GO:0048755]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005886; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0016021; GO:0030054; GO:0030424; GO:0044877; GO:0045202; GO:0048668; GO:0048755; GO:0050808; GO:0050839; GO:0051017";"actin filament bundle assembly [GO:0051017]; branching morphogenesis of a nerve [GO:0048755]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"axon [GO:0030424]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]"
comp669812_c0_seq1;GAXK01010742.1;Q866F1;3.30E-15;FUT1_SAISC;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580";"carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp66996_c1_seq1;GAXK01158631.1;P22897;8.64E-85;MRC1_HUMAN;Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp670_c1_seq1;GAXK01169629.1;Q9HD45;0;TM9S3_HUMAN;Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]";"GO:0016020; GO:0016021; GO:0072657";protein localization to membrane [GO:0072657];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp670039_c2_seq1;GAXK01084051.1;Q9NP80;2.35E-16;PLPL8_HUMAN;Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]";"GO:0000139; GO:0001516; GO:0004622; GO:0005524; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008219; GO:0016020; GO:0016021; GO:0019369; GO:0034638; GO:0036151; GO:0036152; GO:0043651; GO:0046338; GO:0047499; GO:0048471; GO:0050482";"arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]"
comp6700543_c0_seq1;GAXK01077544.1;Q9LN49;4.85E-42;KCS4_ARATH;3-ketoacyl-CoA synthase 4 (KCS-4) (EC 2.3.1.199) (Very long-chain fatty acid condensing enzyme 4) (VLCFA condensing enzyme 4);"integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0016021; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of membrane [GO:0016021];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp670115_c1_seq1;GAXK01084092.1;A2APF3;8.45E-13;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp6701209_c0_seq1;GAXK01077552.1;Q9H211;2.50E-11;CDT1_HUMAN;DNA replication factor Cdt1 (Double parked homolog) (DUP);"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to sorbitol [GO:0072708]";"GO:0000076; GO:0000082; GO:0000083; GO:0000278; GO:0000281; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to sorbitol [GO:0072708]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]"
comp670172_c0_seq1;GAXK01084046.1;Q9Y2G4;1.41E-64;ANKR6_HUMAN;Ankyrin repeat domain-containing protein 6 (Diversin);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096";"negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]";
comp670176_c0_seq1;GAXK01084013.1;Q7PPU9;2.63E-69;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6702320_c0_seq1;GAXK01114158.1;Q94HW2;7.52E-07;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp670254_c0_seq1;GAXK01084089.1;Q8BZW4;3.88E-16;ZN120_MOUSE;Zinc finger protein 120 (Zinc finger protein 31) (mZF31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp67031_c4_seq1;GAXK01158591.1;Q9H8Y5;3.43E-75;ANKZ1_HUMAN;Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744);"Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0003676; GO:0005737; GO:0016020; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671";"cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]";"Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp6703161_c0_seq1;GAXK01114153.1;A5BUU4;4.50E-67;RSSA_VITVI;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp67036_c0_seq1;GAXK01158588.1;Q9VJS7;1.03E-31;PBURS_DROME;Partner of bursicon (Bursicon subunit beta);"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; protein heterodimerization activity [GO:0046982]; chitin-based cuticle sclerotization [GO:0007593]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of establishment of planar polarity [GO:0090175]";"GO:0001664; GO:0005184; GO:0005576; GO:0007186; GO:0007593; GO:0018990; GO:0031395; GO:0046982; GO:0071855; GO:0090175";"chitin-based cuticle sclerotization [GO:0007593]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of establishment of planar polarity [GO:0090175]";"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]";"G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; protein heterodimerization activity [GO:0046982]"
comp6704_c0_seq1;GAXK01100335.1;Q9UQ80;1.16E-133;PA2G4_HUMAN;Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"GO:0003676; GO:0003677; GO:0003700; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062";"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]"
comp6704010_c0_seq1;GAXK01040813.1;O65050;6.06E-47;RL15A_PICMA;60S ribosomal protein L15-1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp6706407_c0_seq1;GAXK01158040.1;Q63734;1.57E-08;KCNC4_RAT;Potassium voltage-gated channel subfamily C member 4 (Raw3) (Voltage-gated potassium channel subunit Kv3.4);"axon [GO:0030424]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; forebrain development [GO:0030900]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of sensory perception of pain [GO:1904057]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005783; GO:0005794; GO:0005886; GO:0008076; GO:0009986; GO:0016021; GO:0030424; GO:0030425; GO:0030900; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0044305; GO:0051260; GO:0071805; GO:0098690; GO:0098794; GO:0098978; GO:0099055; GO:0099056; GO:0099508; GO:1904057; GO:1904456; GO:1905030";"forebrain development [GO:0030900]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of sensory perception of pain [GO:1904057]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]";"axon [GO:0030424]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]"
comp6706451_c0_seq1;GAXK01158037.1;Q55DV9;3.15E-33;CGL_DICDI;Cystathionine gamma-lyase (EC 4.4.1.1) (Gamma-cystathionase);"cytoplasm [GO:0005737]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; transsulfuration [GO:0019346]";"GO:0004123; GO:0005737; GO:0006534; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146";"cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; transsulfuration [GO:0019346]";cytoplasm [GO:0005737];"carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]"
comp67067_c0_seq1;GAXK01158123.1;Q9JJ00;2.76E-75;PLS1_MOUSE;Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Transplantability-associated protein 1) (NOR1) (TRA1);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]";"GO:0001228; GO:0003677; GO:0005154; GO:0005509; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0010628; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032091; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045944; GO:0048471; GO:0051607; GO:0060368; GO:0062023; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:2000373";"acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]"
comp67077_c0_seq1;GAXK01158510.1;Q32LQ0;0;AMPE_BOVIN;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006";"cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp670811_c0_seq1;GAXK01084028.1;Q9W349;2.89E-58;LOZEN_DROME;Protein lozenge;"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; antennal development [GO:0007469]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; crystal cell differentiation [GO:0042688]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemocyte differentiation [GO:0035163]; embryonic hemopoiesis [GO:0035162]; eye morphogenesis [GO:0048592]; imaginal disc-derived female genitalia development [GO:0007486]; larval lymph gland hemocyte differentiation [GO:0035168]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R7 cell development [GO:0045467]; scab formation [GO:0035314]; sensory organ precursor cell fate determination [GO:0016360]; spermathecum morphogenesis [GO:0035211]; wound healing [GO:0042060]";"GO:0000122; GO:0003677; GO:0003700; GO:0005524; GO:0005634; GO:0007469; GO:0007486; GO:0016360; GO:0035162; GO:0035163; GO:0035165; GO:0035168; GO:0035211; GO:0035314; GO:0042060; GO:0042675; GO:0042688; GO:0042691; GO:0043565; GO:0044212; GO:0045467; GO:0045944; GO:0046672; GO:0048592; GO:0048749";"antennal development [GO:0007469]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; crystal cell differentiation [GO:0042688]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemocyte differentiation [GO:0035163]; embryonic hemopoiesis [GO:0035162]; eye morphogenesis [GO:0048592]; imaginal disc-derived female genitalia development [GO:0007486]; larval lymph gland hemocyte differentiation [GO:0035168]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R7 cell development [GO:0045467]; scab formation [GO:0035314]; sensory organ precursor cell fate determination [GO:0016360]; spermathecum morphogenesis [GO:0035211]; wound healing [GO:0042060]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp67089_c8_seq1;GAXK01158360.1;Q9VT28;0;FRY_DROME;Protein furry;"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]";"GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0070593";"antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]";"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]";
comp6710_c0_seq1;GAXK01101231.1;P31836;2.18E-08;NCAM1_BOVIN;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030424; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp6711563_c0_seq1;GAXK01051044.1;A0A126GUP6;9.16E-09;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp671322_c0_seq1;GAXK01084086.1;P23607;6.75E-09;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6715_c0_seq1;GAXK01101009.1;A4IFG2;6.89E-10;BTBD9_BOVIN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";"GO:0008344; GO:0048512";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";;
comp67150_c0_seq1;GAXK01158630.1;P09242;4.00E-110;PPBT_MOUSE;Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme);"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]";"GO:0001958; GO:0003006; GO:0004035; GO:0005615; GO:0005886; GO:0016311; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0071407; GO:0071529";"cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]";"anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]"
comp671528_c0_seq1;GAXK01084022.1;P0C2S3;6.96E-07;GUNC_CLOTM;Endoglucanase C (EC 3.2.1.4) (Cellulase C) (Endo-1,4-beta-glucanase C) (EgC);"cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245";cellulose catabolic process [GO:0030245];;cellulase activity [GO:0008810]
comp67157_c0_seq1;GAXK01158761.1;Q292G3;7.60E-96;KTU_DROPS;Protein kintoun (Dynein assembly factor 2, axonemal homolog) (PP1-interacting protein 20);"cytoplasm [GO:0005737]; protein phosphatase 1 binding [GO:0008157]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]";"GO:0005737; GO:0008157; GO:0060285; GO:0070286";"axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]";cytoplasm [GO:0005737];protein phosphatase 1 binding [GO:0008157]
comp6715785_c0_seq1;GAXK01091645.1;Q12955;2.24E-13;ANK3_HUMAN;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp67162_c0_seq1;GAXK01158616.1;P46873;0;OSM3_CAEEL;Osmotic avoidance abnormal protein 3 (Kinesin-like protein osm-3);"ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]";"GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030030; GO:0032839; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0043025; GO:0043053; GO:0046626; GO:0048471; GO:0060271; GO:0061066; GO:0097730; GO:0098971; GO:1902856; GO:1902857; GO:1905515";"anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]";"ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp671798_c0_seq1;GAXK01084077.1;Q9VYV5;2.18E-71;FUT8_DROME;Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921";"GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]"
comp671814_c0_seq1;GAXK01084084.1;E9PV86;2.01E-75;MCTP1_MOUSE;Multiple C2 and transmembrane domain-containing protein 1;"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"GO:0005509; GO:0005789; GO:0016021; GO:0030054; GO:0030336; GO:0030672; GO:0045806; GO:0055037; GO:1902883";"negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]";"cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]";calcium ion binding [GO:0005509]
comp67186_c0_seq1;GAXK01158248.1;Q9NA75;7.01E-50;T38B1_CAEEL;Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]";"GO:0005267; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";potassium channel activity [GO:0005267]
comp67188_c4_seq1;GAXK01158396.1;Q9I4V0;2.21E-98;NQRED_PSEAE;NADH:quinone reductase (EC 1.6.5.11);"nitronate monooxygenase activity [GO:0018580]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]";"GO:0000166; GO:0016491; GO:0018580; GO:0055114";oxidation-reduction process [GO:0055114];;"nitronate monooxygenase activity [GO:0018580]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]"
comp671920_c0_seq1;GAXK01084075.1;Q9C6H2;1.29E-09;SINL3_ARATH;E3 ubiquitin-protein ligase SINA-like 3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 3) (Seven in absentia-like protein 3);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp6719215_c0_seq1;GAXK01126088.1;Q9S745;1.05E-08;PAD4_ARATH;Lipase-like PAD4 (EC 2.3.1.-) (Protein ENHANCED DISEASE SUSCEPTIBILITY 9) (Protein PHYTOALEXIN DEFICIENT 4) (AtPAD4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; lipase activity [GO:0016298]; transferase activity [GO:0016740]; aerenchyma formation [GO:0010618]; cellular response to trehalose stimulus [GO:0071327]; defense response to bacterium, incompatible interaction [GO:0009816]; defense response to Gram-negative bacterium [GO:0050829]; defense response to insect [GO:0002213]; ethylene-activated signaling pathway [GO:0009873]; leaf abscission [GO:0060866]; leaf senescence [GO:0010150]; lipid catabolic process [GO:0016042]; negative regulation of defense response [GO:0031348]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; plant-type hypersensitive response [GO:0009626]; positive regulation of camalexin biosynthetic process [GO:1901183]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of defense response to insect [GO:1900367]; positive regulation of salicylic acid mediated signaling pathway [GO:0080151]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of jasmonic acid mediated signaling pathway [GO:2000022]; regulation of salicylic acid biosynthetic process [GO:0080142]; regulation of salicylic acid mediated signaling pathway [GO:2000031]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; response to insect [GO:0009625]; response to other organism [GO:0051707]; response to salicylic acid [GO:0009751]; response to UV-C [GO:0010225]; systemic acquired resistance [GO:0009627]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]";"GO:0001666; GO:0002213; GO:0005634; GO:0005737; GO:0009617; GO:0009625; GO:0009626; GO:0009627; GO:0009751; GO:0009816; GO:0009862; GO:0009873; GO:0010105; GO:0010150; GO:0010225; GO:0010310; GO:0010618; GO:0010942; GO:0016042; GO:0016298; GO:0016740; GO:0031348; GO:0050829; GO:0051707; GO:0060866; GO:0071327; GO:0080142; GO:0080151; GO:1900367; GO:1900426; GO:1901183; GO:2000022; GO:2000031";"aerenchyma formation [GO:0010618]; cellular response to trehalose stimulus [GO:0071327]; defense response to bacterium, incompatible interaction [GO:0009816]; defense response to Gram-negative bacterium [GO:0050829]; defense response to insect [GO:0002213]; ethylene-activated signaling pathway [GO:0009873]; leaf abscission [GO:0060866]; leaf senescence [GO:0010150]; lipid catabolic process [GO:0016042]; negative regulation of defense response [GO:0031348]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; plant-type hypersensitive response [GO:0009626]; positive regulation of camalexin biosynthetic process [GO:1901183]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of defense response to insect [GO:1900367]; positive regulation of salicylic acid mediated signaling pathway [GO:0080151]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of jasmonic acid mediated signaling pathway [GO:2000022]; regulation of salicylic acid biosynthetic process [GO:0080142]; regulation of salicylic acid mediated signaling pathway [GO:2000031]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; response to insect [GO:0009625]; response to other organism [GO:0051707]; response to salicylic acid [GO:0009751]; response to UV-C [GO:0010225]; systemic acquired resistance [GO:0009627]; systemic acquired resistance, salicylic acid mediated signaling pathway [GO:0009862]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"lipase activity [GO:0016298]; transferase activity [GO:0016740]"
comp67206_c0_seq1;GAXK01158414.1;O14562;1.42E-49;UBFD1_HUMAN;Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog);"cadherin binding [GO:0045296]; RNA binding [GO:0003723]";"GO:0003723; GO:0045296";;;"cadherin binding [GO:0045296]; RNA binding [GO:0003723]"
comp67216_c1_seq1;GAXK01205834.1;O60285;3.08E-95;NUAK1_HUMAN;NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1);"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0046872; GO:1901796; GO:2000772";"cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]";"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]"
comp67227_c1_seq1;GAXK01158415.1;P23286;6.75E-23;CALM_CANAX;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp672353_c0_seq1;GAXK01038803.1;P70610;5.06E-57;DOC2B_RAT;Double C2-like domain-containing protein beta (Doc2-beta);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]";"GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0031340; GO:0032024; GO:0045956; GO:0048791; GO:0098793";"calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]"
comp6724188_c0_seq1;GAXK01024690.1;P47943;1.16E-47;IF4A_SCHPO;ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]";"GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005829; GO:0010494; GO:0016281";cytoplasmic translational initiation [GO:0002183];"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp6725177_c0_seq1;GAXK01024699.1;Q21565;1.17E-30;AMT3_CAEEL;Putative ammonium transporter 3;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp6725608_c0_seq1;GAXK01024697.1;Q0E908;9.34E-09;HIL_DROME;Hillarin (D-Hillarin) (D-hil);"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]";"GO:0005938; GO:0032154; GO:0046872";;"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]";metal ion binding [GO:0046872]
comp67258_c0_seq1;GAXK01158442.1;Q86UW9;3.90E-44;DTX2_HUMAN;Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2);"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0016740; GO:0031965";"Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp6726288_c0_seq1;GAXK01108615.1;Q9BLY8;2.38E-46;GBRB_DROSI;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor) (Protein cyclodiene resistance);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; ion transport [GO:0006811]";"GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0030054; GO:0030594; GO:0034707; GO:0045211";ion transport [GO:0006811];"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]"
comp67263_c0_seq1;GAXK01158472.1;Q8R5K4;9.62E-38;NOL6_MOUSE;Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap);"condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]";"GO:0000794; GO:0003723; GO:0005634; GO:0005730; GO:0005739; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456";"rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]";"condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]";RNA binding [GO:0003723]
comp67265_c0_seq1;GAXK01158077.1;Q0V8T0;6.54E-17;CNTP5_CANLF;Contactin-associated protein-like 5 (Cell recognition molecule Caspr5);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp67266_c0_seq1;GAXK01158213.1;P18887;3.89E-10;XRCC1_HUMAN;DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1);"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]";"GO:0000012; GO:0000724; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006283; GO:0006284; GO:0006288; GO:0006297; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599";"base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]";"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]"
comp672710_c0_seq1;GAXK01038773.1;Q9GRW0;2.17E-38;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp6727610_c0_seq1;GAXK01108617.1;P30975;7.62E-21;TLR2_DROME;Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058";"detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
comp672806_c0_seq1;GAXK01038779.1;O46040;3.41E-28;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp67282_c0_seq1;GAXK01158468.1;P10040;0;CRB_DROME;Protein crumbs (95F);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]";"GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007163; GO:0007219; GO:0007391; GO:0007399; GO:0007424; GO:0007435; GO:0007443; GO:0008284; GO:0016021; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032435; GO:0032880; GO:0033157; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036";"adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]"
comp672851_c0_seq1;GAXK01038826.1;Q9W0T5;1.36E-22;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp67287_c1_seq1;GAXK01158608.1;Q642A2;6.85E-08;ATRAP_RAT;Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]";"GO:0000139; GO:0001666; GO:0004945; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005938; GO:0008217; GO:0016021; GO:0030659";"regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";angiotensin type II receptor activity [GO:0004945]
comp672878_c0_seq1;GAXK01038817.1;P49858;1.67E-64;CNI_DROME;Protein cornichon;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005789; GO:0006888; GO:0007310; GO:0007350; GO:0009952; GO:0015031; GO:0016021; GO:0016192; GO:0046843";"anterior/posterior pattern specification [GO:0009952]; blastoderm segmentation [GO:0007350]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; oocyte dorsal/ventral axis specification [GO:0007310]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp672920_c0_seq1;GAXK01038805.1;P36609;2.48E-10;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp672968_c0_seq1;GAXK01038793.1;P59889;9.68E-18;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp67297_c1_seq1;GAXK01158391.1;Q2PFD7;1.64E-102;PSD3_MOUSE;PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3);"cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0014069; GO:0016020; GO:0030054; GO:0032011; GO:0032012; GO:0032587; GO:0045211";"ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012]";"cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp6730666_c0_seq1;GAXK01103529.1;B4N0L0;3.33E-71;EIF3I_DROWI;Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (TRIP-1 homolog);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp67313_c2_seq1;GAXK01158429.1;Q9VMA7;3.46E-12;TGO1_DROME;Transport and Golgi organization protein 1;"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"GO:0000137; GO:0000139; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0007030; GO:0009306; GO:0012505; GO:0016021; GO:0033363; GO:0035459; GO:0051047; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]; vesicle cargo loading [GO:0035459]";"endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp67314_c0_seq1;GAXK01158410.1;Q84M94;2.32E-09;FBK15_ARATH;F-box/kelch-repeat protein At1g26930;"nucleus [GO:0005634]; peroxisome [GO:0005777]";"GO:0005634; GO:0005777";;"nucleus [GO:0005634]; peroxisome [GO:0005777]";
comp67318_c1_seq1;GAXK01158500.1;A0A0R4IXF6;0;KAT2A_DANRE;Histone acetyltransferase KAT2A (EC 2.3.1.48) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A);"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; bone morphogenesis [GO:0060349]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]";"GO:0001816; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0007507; GO:0007616; GO:0018393; GO:0043966; GO:0045589; GO:0045944; GO:0048167; GO:0050863; GO:0060173; GO:0060349; GO:0061733; GO:0106077; GO:0106078";"bone morphogenesis [GO:0060349]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]";"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]"
comp6732362_c0_seq1;GAXK01163617.1;Q9VZW5;2.01E-12;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp6732608_c0_seq1;GAXK01163614.1;Q1XA76;8.43E-07;ASIC1_CHICK;Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal);"integral component of plasma membrane [GO:0005887]; acid-sensing ion channel activity [GO:0044736]; identical protein binding [GO:0042802]; cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]";"GO:0005887; GO:0035725; GO:0042802; GO:0044736; GO:0070207; GO:0071467";"cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]";integral component of plasma membrane [GO:0005887];"acid-sensing ion channel activity [GO:0044736]; identical protein binding [GO:0042802]"
comp6733_c1_seq1;GAXK01100072.1;Q7L523;0;RRAGA_HUMAN;Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]";"GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0007050; GO:0008219; GO:0009267; GO:0010506; GO:0010507; GO:0016241; GO:0016567; GO:0019048; GO:0031625; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0042803; GO:0045919; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131";"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp673405_c0_seq1;GAXK01038868.1;Q9UFB7;6.11E-11;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp67347_c2_seq1;GAXK01158137.1;Q8NBS3;0;S4A11_HUMAN;Sodium bicarbonate transporter-like protein 11 (Bicarbonate transporter-related protein 1) (Sodium borate cotransporter 1) (NaBC1) (Solute carrier family 4 member 11);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; fluid transport [GO:0042044]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005452; GO:0005887; GO:0006814; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016323; GO:0030003; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0051453; GO:1902600";"bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; fluid transport [GO:0042044]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]";"active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]"
comp6735724_c0_seq1;GAXK01143361.1;P62184;3.44E-12;CALM_RENRE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp67360_c3_seq1;GAXK01158488.1;Q59E36;1.47E-57;RCOR_DROME;REST corepressor (CoREST);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"GO:0000122; GO:0003682; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006325; GO:0008134; GO:0017053; GO:0044212; GO:0045892; GO:0061086; GO:0090309; GO:2000619";"chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp673647_c0_seq1;GAXK01038821.1;Q7KRI2;8.14E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6737027_c0_seq1;GAXK01170646.1;O61463;1.87E-08;RLA2_CRYST;60S acidic ribosomal protein P2;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]";"GO:0003735; GO:0005840; GO:0006414";translational elongation [GO:0006414];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp673808_c0_seq1;GAXK01038849.1;Q9Z254;1.40E-22;GIPC1_RAT;PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin);"brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]";"GO:0003779; GO:0005102; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031647; GO:0032435; GO:0032467; GO:0042803; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098978; GO:2000300";"cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]";"brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp673893_c0_seq1;GAXK01038871.1;Q8C5P5;2.49E-31;NT5D1_MOUSE;5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-) (Cytosolic 5'-nucleotidase II-like protein 1);"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]";"GO:0008253; GO:0046872";;;"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]"
comp6739665_c0_seq1;GAXK01078956.1;Q9N2V2;2.36E-11;NAS30_CAEEL;Zinc metalloproteinase nas-30 (EC 3.4.24.-) (Nematode astacin 30);"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270";;;"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp6739720_c0_seq1;GAXK01078951.1;Q8X5V3;6.41E-08;DNAB_ECO57;Replicative DNA helicase (EC 3.6.4.12);"primosome complex [GO:1990077]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication, synthesis of RNA primer [GO:0006269]";"GO:0003677; GO:0003678; GO:0005524; GO:0006269; GO:1990077";DNA replication, synthesis of RNA primer [GO:0006269];primosome complex [GO:1990077];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp673984_c0_seq1;GAXK01038780.1;P11632;1.66E-07;NHP6A_YEAST;Non-histone chromosomal protein 6A;"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA binding, bending [GO:0008301]; MutSalpha complex binding [GO:0032407]; nucleosome binding [GO:0031491]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA replication-independent nucleosome organization [GO:0034724]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase III promoter [GO:0001195]; mismatch repair [GO:0006298]; negative regulation of DNA binding [GO:0043392]; protein-DNA complex assembly [GO:0065004]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"GO:0000790; GO:0001195; GO:0005634; GO:0006298; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0031491; GO:0032407; GO:0032993; GO:0034724; GO:0043392; GO:0051123; GO:0065004; GO:0070898";"chromatin remodeling [GO:0006338]; DNA replication-independent nucleosome organization [GO:0034724]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase III promoter [GO:0001195]; mismatch repair [GO:0006298]; negative regulation of DNA binding [GO:0043392]; protein-DNA complex assembly [GO:0065004]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase III preinitiation complex assembly [GO:0070898]; RNA polymerase II preinitiation complex assembly [GO:0051123]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]";"DNA binding, bending [GO:0008301]; MutSalpha complex binding [GO:0032407]; nucleosome binding [GO:0031491]; transcription factor binding [GO:0008134]"
comp6740087_c0_seq1;GAXK01008943.1;O77408;4.31E-12;OAR1_LYMST;Octopamine receptor 1 (OA1);"integral component of plasma membrane [GO:0005887]; G protein-coupled acetylcholine receptor activity [GO:0016907]";"GO:0005887; GO:0016907";;integral component of plasma membrane [GO:0005887];G protein-coupled acetylcholine receptor activity [GO:0016907]
comp6740214_c0_seq1;GAXK01008953.1;P62302;5.07E-57;RS13_SOYBN;40S ribosomal protein S13;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp674025_c0_seq1;GAXK01164905.1;Q8NEP9;1.69E-18;ZN555_HUMAN;Zinc finger protein 555;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6741045_c0_seq1;GAXK01008952.1;Q91756;3.12E-07;GLRK_XENLA;Glutamate receptor U1 (Kainate-binding protein) (Unitary non-NMDA glutamate receptor subunit 1) (XENU1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]";"GO:0004970; GO:0016021; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";ionotropic glutamate receptor activity [GO:0004970]
comp6741320_c0_seq1;GAXK01008948.1;Q25188;3.32E-19;OAR_HELVI;Octopamine receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp67416_c2_seq1;GAXK01158200.1;P21158;1.46E-31;CSGA_MYXXA;C-factor (C signal);"extracellular region [GO:0005576]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005576; GO:0030435";sporulation resulting in formation of a cellular spore [GO:0030435];extracellular region [GO:0005576];
comp67417_c0_seq1;GAXK01158164.1;O94889;5.58E-09;KLH18_HUMAN;Kelch-like protein 18;;;;;
comp6742523_c0_seq1;GAXK01176679.1;P14381;8.98E-15;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp674373_c0_seq1;GAXK01164884.1;C7G046;4.02E-26;Y6969_DICDI;von Willebrand factor A domain-containing protein DDB_G0286969;RNA binding [GO:0003723];GO:0003723;;;RNA binding [GO:0003723]
comp67444_c1_seq1;GAXK01158830.1;Q8K339;7.04E-59;KIN17_MOUSE;DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]";"GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0016363; GO:0032991; GO:0043231; GO:0046872";"cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp674466_c0_seq1;GAXK01164913.1;B4MEG2;1.04E-107;NAAT1_DROVI;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp67447_c0_seq1;GAXK01158797.1;Q9VZJ9;5.85E-54;MUL1_DROME;Mitochondrial E3 ubiquitin protein ligase 1 (EC 2.3.2.27) (Mitochondrial E3 ubiquitin protein transferase 1);"integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; organelle organization [GO:0006996]; positive regulation of mitochondrial fission [GO:0090141]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005777; GO:0006996; GO:0008270; GO:0016567; GO:0031307; GO:0090141";"organelle organization [GO:0006996]; positive regulation of mitochondrial fission [GO:0090141]; protein ubiquitination [GO:0016567]";"integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp6745350_c0_seq1;GAXK01174435.1;Q8C3F7;3.18E-09;KLH30_MOUSE;Kelch-like protein 30;;;;;
comp674616_c0_seq1;GAXK01164927.1;Q96Q04;1.79E-36;LMTK3_HUMAN;Serine/threonine-protein kinase LMTK3 (EC 2.7.11.1) (Lemur tyrosine kinase 3);"axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of phosphatase activity [GO:0010923]";"GO:0000139; GO:0004674; GO:0005524; GO:0010923; GO:0016021; GO:0030424; GO:0030425; GO:0046872";negative regulation of phosphatase activity [GO:0010923];"axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp674658_c0_seq1;GAXK01164867.1;Q8K5B2;3.63E-14;MCFD2_MOUSE;Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192; GO:0019752; GO:0060548";"carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]";calcium ion binding [GO:0005509]
comp6746799_c0_seq1;GAXK01059318.1;P24629;9.72E-29;HSP71_SOLLC;Heat shock cognate 70 kDa protein 1;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0006986; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp6746979_c0_seq1;GAXK01059310.1;P23685;3.02E-08;NAC1_CANLF;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]";"GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070509; GO:0070588; GO:0098719; GO:0098735; GO:0098794; GO:1905060";"calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]"
comp67470_c3_seq1;GAXK01158439.1;Q92820;6.48E-76;GGH_HUMAN;Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase);"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0005829; GO:0008238; GO:0008242; GO:0010043; GO:0032868; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0043312; GO:0045471; GO:0046900; GO:0070062; GO:1904724";"neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]";"exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]"
comp67471_c1_seq1;GAXK01158466.1;D3ZEN0;4.81E-31;MILK2_RAT;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"actin filament binding [GO:0051015]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp674789_c0_seq1;GAXK01164858.1;P18061;2.38E-47;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6748297_c0_seq1;GAXK01047327.1;Q8TE73;1.97E-15;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp6748709_c0_seq1;GAXK01047318.1;P28996;5.77E-43;EF2_PARKE;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp674877_c0_seq1;GAXK01164866.1;Q86VZ5;2.24E-30;SMS1_HUMAN;Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Medulla oblongata-derived protein) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23);"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; positive regulation of gene expression [GO:0010628]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0000138; GO:0000139; GO:0002950; GO:0005634; GO:0005783; GO:0005886; GO:0005887; GO:0006686; GO:0006915; GO:0006954; GO:0010628; GO:0016020; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:0071222; GO:0071356; GO:2001242";"apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; positive regulation of gene expression [GO:0010628]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]"
comp674926_c0_seq1;GAXK01164875.1;Q7KRI2;5.53E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp67493_c2_seq1;GAXK01158634.1;A2AIV2;1.07E-51;VIR_MOUSE;Protein virilizer homolog;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007275; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104";"mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";
comp67494_c0_seq1;GAXK01158160.1;Q02752;1.11E-13;PHPA_PLACH;Acidic phosphoprotein (50 kDa antigen);plasma membrane [GO:0005886];GO:0005886;;plasma membrane [GO:0005886];
comp674980_c0_seq1;GAXK01164915.1;Q5RGJ8;3.05E-39;GNPTA_DANRE;"N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]";"GO:0000139; GO:0002063; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348";"bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"
comp67505_c0_seq1;GAXK01158052.1;Q5R6X7;9.03E-08;CBX3_PONAB;Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma);"chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"GO:0000779; GO:0000785; GO:0005635; GO:0005719; GO:0005720; GO:0005819; GO:0006325; GO:0006974; GO:0019904; GO:0031618; GO:0042802; GO:0045892; GO:0048511; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp67515_c1_seq1;GAXK01158165.1;Q6AYB8;5.03E-19;GO45_RAT;Golgin-45 (Basic leucine zipper nuclear factor 1);"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]";"GO:0000139; GO:0005634; GO:0007030; GO:0031625; GO:0043001";"Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]";"Golgi membrane [GO:0000139]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp6751779_c0_seq1;GAXK01002614.1;P60039;4.31E-33;RL73_ARATH;60S ribosomal protein L7-3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp675236_c0_seq1;GAXK01164856.1;Q6UWL6;1.31E-11;KIRR2_HUMAN;Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3);"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"GO:0001933; GO:0005886; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0098609";"cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";identical protein binding [GO:0042802]
comp6754_c2_seq1;GAXK01100132.1;Q8K1S6;8.20E-43;SPIR2_MOUSE;Protein spire homolog 2 (Spir-2);"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0051295; GO:0070649; GO:2000781";"actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp6756710_c0_seq1;GAXK01113970.1;Q42688;5.20E-32;GLNA1_CHLRE;Glutamine synthetase cytosolic isozyme (EC 6.3.1.2) (GS1) (Glutamate--ammonia ligase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamine biosynthetic process [GO:0006542]";"GO:0004356; GO:0005524; GO:0005737; GO:0006542";glutamine biosynthetic process [GO:0006542];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]"
comp6757_c0_seq1;GAXK01100136.1;Q8BUI3;4.08E-53;LRWD1_MOUSE;Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein);"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; telomeric heterochromatin [GO:0031933]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]";"GO:0000776; GO:0000777; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0008327; GO:0031933; GO:0035064; GO:0043231; GO:0071169";"chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]";"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; telomeric heterochromatin [GO:0031933]";"chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]"
comp67573_c0_seq1;GAXK01158597.1;P05625;3.24E-174;RAF1_CHICK;RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (C-MIL) (C-RAF) (MIL proto-oncogene serine/threonine-protein kinase) (RAF-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; activation of adenylate cyclase activity [GO:0007190]; activation of MAPKK activity [GO:0000186]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]";"GO:0000165; GO:0000186; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0007190; GO:0008285; GO:0016607; GO:0017016; GO:0030154; GO:0030878; GO:0031143; GO:0031333; GO:0033138; GO:0035019; GO:0035773; GO:0035994; GO:0042802; GO:0045104; GO:0045944; GO:0046872; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:1902042";"activation of adenylate cyclase activity [GO:0007190]; activation of MAPKK activity [GO:0000186]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]"
comp6757940_c0_seq1;GAXK01113971.1;Q6B9X6;4.83E-09;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp675854_c0_seq1;GAXK01164869.1;P00636;3.48E-133;F16P1_PIG;Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]";"GO:0000122; GO:0001085; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0051289; GO:0071286";"cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]"
comp675862_c0_seq1;GAXK01164868.1;Q8N0N3;2.21E-58;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp675935_c1_seq1;GAXK01164883.1;Q7KRI2;2.27E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp67599_c0_seq1;GAXK01158244.1;Q32PF0;2.01E-23;TM201_BOVIN;Transmembrane protein 201;"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]; actin filament binding [GO:0051015]; lamin binding [GO:0005521]; nuclear migration along microtubule [GO:0030473]";"GO:0000922; GO:0005521; GO:0005639; GO:0005737; GO:0030473; GO:0031965; GO:0051015";nuclear migration along microtubule [GO:0030473];"cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]";"actin filament binding [GO:0051015]; lamin binding [GO:0005521]"
comp676100_c0_seq1;GAXK01048126.1;Q9UQC9;1.38E-40;CLCA2_HUMAN;"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0008237; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872";"cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]";"basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp676108_c0_seq1;GAXK01048091.1;P22122;1.59E-23;RHO_DIPOM;Ras-like GTP-binding protein O-RHO;"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005525; GO:0005886; GO:0007264";small GTPase mediated signal transduction [GO:0007264];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp6761572_c0_seq1;GAXK01186688.1;Q29KL8;4.36E-13;DAAF1_DROPS;Dynein assembly factor 1, axonemal homolog (Defective transmitter-recycling protein) (Leucine-rich repeat-containing protein 50 homolog);"axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]";"GO:0005930; GO:0044458; GO:0060271; GO:0070840";"cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]";axoneme [GO:0005930];dynein complex binding [GO:0070840]
comp676182_c0_seq1;GAXK01048105.1;P73392;2.10E-11;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp67619_c0_seq1;GAXK01158156.1;Q5BK09;3.07E-31;DRAM2_RAT;DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]";"GO:0001917; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0045494";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]";
comp6762012_c0_seq1;GAXK01109497.1;P40401;7.25E-16;SSUC_BACSU;Putative aliphatic sulfonates transport permease protein SsuC;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkanesulfonate transmembrane transporter activity [GO:0042959]; alkanesulfonate transport [GO:0042918]";"GO:0005886; GO:0016021; GO:0042918; GO:0042959";alkanesulfonate transport [GO:0042918];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";alkanesulfonate transmembrane transporter activity [GO:0042959]
comp67624_c0_seq1;GAXK01158798.1;Q6GQB9;0;EDEM3_XENLA;ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3);"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]";"GO:0004571; GO:0005509; GO:0005788; GO:0006486; GO:0006986; GO:0016020; GO:1904382";"mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]";"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
comp6762547_c0_seq1;GAXK01109490.1;Q51761;3.32E-49;TRA2_PSEFL;Putative transposase for insertion sequence IS1162;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp6762617_c0_seq1;GAXK01109493.1;O25748;2.47E-23;SLYD_HELPY;FKBP-type peptidyl-prolyl cis-trans isomerase SlyD (PPIase) (EC 5.2.1.8) (Metallochaperone SlyD);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp6762712_c0_seq1;GAXK01109495.1;Q7UXK9;5.86E-53;DNAE2_RHOBA;Error-prone DNA polymerase (EC 2.7.7.7);"cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0003887; GO:0005737; GO:0006260; GO:0006281; GO:0008408";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";cytoplasm [GO:0005737];"3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]"
comp67633_c4_seq1;GAXK01158259.1;Q7TT18;6.60E-25;MCAF1_MOUSE;Activating transcription factor 7-interacting protein 1 (ATFa-associated modulator) (mAM) (MBD1-containing chromatin-associated factor 1);"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]";"GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309";"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]";"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]"
comp6763733_c0_seq1;GAXK01109502.1;Q8VYF1;8.39E-45;RL152_ARATH;60S ribosomal protein L15-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp676376_c0_seq1;GAXK01048142.1;Q7KRI2;1.16E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp67641_c0_seq1;GAXK01158625.1;Q2YDC9;1.16E-49;PDCD2_BOVIN;Programmed cell death protein 2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]";"GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0006919; GO:0019899; GO:0046872; GO:1901532; GO:1902035";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]"
comp6764224_c0_seq1;GAXK01151061.1;Q9XGU0;2.42E-16;RAC9_ARATH;Rac-like GTP-binding protein ARAC9 (GTPase protein ROP8);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"GO:0000902; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007015; GO:0007266; GO:0016477; GO:0019901; GO:0030036; GO:0030838";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; positive regulation of actin filament polymerization [GO:0030838]; Rho protein signal transduction [GO:0007266]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp6764630_c0_seq1;GAXK01151078.1;P55748;5.10E-16;CBP22_HORVU;"Serine carboxypeptidase II-2 (EC 3.4.16.6) (CP-MII.2) [Cleaved into: Serine carboxypeptidase II-2 chain A; Serine carboxypeptidase II-2 chain B] (Fragment)";"vacuole [GO:0005773]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005773";;vacuole [GO:0005773];serine-type carboxypeptidase activity [GO:0004185]
comp676464_c0_seq1;GAXK01048172.1;Q2M3R5;5.80E-19;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp67647_c1_seq1;GAXK01158198.1;Q39493;4.54E-50;DSK1_CYLFU;Diatom spindle kinesin-1;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017";microtubule-based movement [GO:0007018];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp676499_c2_seq1;GAXK01048085.1;Q9W0Y6;1.68E-14;PAIN_DROME;Transient receptor potential cation channel protein painless;"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"GO:0005216; GO:0005227; GO:0005262; GO:0005886; GO:0006816; GO:0007620; GO:0007631; GO:0007638; GO:0008016; GO:0008049; GO:0009408; GO:0009612; GO:0016021; GO:0019233; GO:0034704; GO:0035179; GO:0042048; GO:0045924; GO:0048060; GO:0048266; GO:0050960; GO:0050965; GO:0050966; GO:0050974; GO:0070588";"behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; copulation [GO:0007620]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; feeding behavior [GO:0007631]; larval turning behavior [GO:0035179]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; negative gravitaxis [GO:0048060]; olfactory behavior [GO:0042048]; regulation of female receptivity [GO:0045924]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]";"calcium channel complex [GO:0034704]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; ion channel activity [GO:0005216]"
comp67653_c1_seq1;GAXK01158440.1;Q8BJ05;4.79E-24;ZC3HE_MOUSE;Zinc finger CCCH domain-containing protein 14;"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]";"GO:0005634; GO:0005730; GO:0005737; GO:0008143; GO:0016607; GO:0032839; GO:0043488; GO:0046872; GO:1900364; GO:1904115; GO:1990904";"negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]";"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]"
comp6765466_c0_seq1;GAXK01151070.1;P59671;3.41E-45;RL3_NEUCR;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp67658_c0_seq1;GAXK01158262.1;Q9VE46;2.44E-144;SC5A7_DROME;High-affinity choline transporter 1;"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";"GO:0003333; GO:0005307; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021; GO:0033265";"acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]";integral component of membrane [GO:0016021];"amino acid transmembrane transporter activity [GO:0015171]; choline:sodium symporter activity [GO:0005307]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]"
comp6767167_c0_seq1;GAXK01159165.1;P42094;1.24E-17;PHYT_BACSU;3-phytase (EC 3.1.3.8) (Myo-inositol-hexaphosphate 3-phosphohydrolase) (Phytate 3-phosphatase);"extracellular region [GO:0005576]; 3-phytase activity [GO:0016158]";"GO:0005576; GO:0016158";;extracellular region [GO:0005576];3-phytase activity [GO:0016158]
comp6767721_c0_seq1;GAXK01159167.1;P14834;4.19E-34;HSP70_LEIMA;Heat shock 70 kDa protein (Fragment);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp6768217_c0_seq1;GAXK01078778.1;Q9QW30;6.76E-11;NOTC2_RAT;"Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]";"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; marginal zone B cell differentiation [GO:0002315]; negative regulation of growth rate [GO:0045967]; Notch signaling pathway [GO:0007219]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]";"GO:0001709; GO:0002315; GO:0005509; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0007050; GO:0007219; GO:0009887; GO:0009986; GO:0010838; GO:0038023; GO:0042060; GO:0042246; GO:0045967; GO:0046579; GO:2000249; GO:2001204";"animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; marginal zone B cell differentiation [GO:0002315]; negative regulation of growth rate [GO:0045967]; Notch signaling pathway [GO:0007219]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]";"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]"
comp676998_c0_seq1;GAXK01048132.1;Q6DHG0;4.99E-40;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp677_c0_seq1;GAXK01170003.1;P55853;3.32E-42;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp6770190_c0_seq1;GAXK01089834.1;P24733;1.92E-07;MYS_ARGIR;Myosin heavy chain, striated muscle;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp677099_c0_seq1;GAXK01048144.1;P48758;2.47E-73;CBR1_MOUSE;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0016655; GO:0017144; GO:0042373; GO:0043231; GO:0047021; GO:0050221; GO:0055114";"drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"
comp677100_c0_seq1;GAXK01048138.1;Q9UJT9;2.53E-21;FBXL7_HUMAN;F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7);"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0004842; GO:0005813; GO:0005829; GO:0006511; GO:0008283; GO:0010265; GO:0010972; GO:0016567; GO:0019005; GO:0031146; GO:0043687; GO:0051301";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]";ubiquitin-protein transferase activity [GO:0004842]
comp6771030_c0_seq1;GAXK01089835.1;O61491;1.73E-91;FLOT1_DROME;Flotillin-1;"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]";"GO:0005198; GO:0005737; GO:0007275; GO:0016600";multicellular organism development [GO:0007275];"cytoplasm [GO:0005737]; flotillin complex [GO:0016600]";structural molecule activity [GO:0005198]
comp6771178_c0_seq1;GAXK01089842.1;E2RKN7;4.36E-16;FXL15_CANLF;F-box/LRR-repeat protein 15;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000086; GO:0005737; GO:0006511; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp67718_c0_seq1;GAXK01158487.1;Q9LZX1;6.18E-08;LOR15_ARATH;Protein LURP-one-related 15;"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein domain specific binding [GO:0019904]";"GO:0005829; GO:0005886; GO:0019904";;"cytosol [GO:0005829]; plasma membrane [GO:0005886]";protein domain specific binding [GO:0019904]
comp67726_c2_seq1;GAXK01158445.1;Q64701;2.23E-149;RBL1_MOUSE;Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1);"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000122; GO:0000785; GO:0001012; GO:0001102; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0007346; GO:0008134; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:1990841; GO:2000134; GO:2000773";"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]";"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]"
comp6773318_c0_seq1;GAXK01165395.1;P08548;3.92E-07;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp677338_c0_seq1;GAXK01048156.1;P20693;4.32E-12;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp677383_c0_seq1;GAXK01048088.1;Q7KRI2;4.29E-23;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6773974_c0_seq1;GAXK01165383.1;P83120;1.57E-09;MTH_DROSI;G-protein coupled receptor Mth (Protein methuselah);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp6774008_c0_seq1;GAXK01055723.1;Q84K47;6.17E-25;AB2A_ARATH;ABC transporter A family member 2 (ABC transporter ABCA.2) (AtABCA2) (ABC2 homolog 1);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]";"GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231";lipid transport [GO:0006869];"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp677424_c0_seq1;GAXK01048162.1;P10751;1.08E-08;ZFP11_MOUSE;Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6775116_c0_seq1;GAXK01055715.1;Q9GSU4;2.29E-41;HSP72_DROSI;Major heat shock 70 kDa protein Ba (Heat shock protein 70Ba) (HSP70-87C1);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp677515_c1_seq1;GAXK01048119.1;Q10836;4.00E-90;TRHDE_RAT;Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006";"peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp6775837_c0_seq1;GAXK01055731.1;Q26365;2.59E-34;ADT_DROME;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]";"GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0015866; GO:0015867; GO:0016021; GO:0034599; GO:0040011; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:2001171";"action potential [GO:0001508]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";ATP:ADP antiporter activity [GO:0005471]
comp6776264_c0_seq1;GAXK01050867.1;P54690;2.11E-28;BCAT1_RAT;Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"GO:0004084; GO:0005737; GO:0005739; GO:0009098; GO:0009099; GO:0042802; GO:0052654; GO:0052655; GO:0052656";"leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]"
comp677645_c0_seq1;GAXK01048158.1;Q9VKA4;1.34E-114;Y1760_DROME;Probable G-protein coupled receptor CG31760;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp677677_c1_seq1;GAXK01048176.1;P24524;9.22E-89;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp67772_c0_seq1;GAXK01158212.1;Q7KRI2;1.85E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp677726_c0_seq1;GAXK01048170.1;P36975;4.79E-19;SNP25_DROME;Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp67774_c0_seq1;GAXK01158512.1;Q8VHR5;1.15E-34;P66B_MOUSE;Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0005654; GO:0008270; GO:0016581; GO:0016607; GO:0043565";negative regulation of transcription by RNA polymerase II [GO:0000122];"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]";"sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp677786_c0_seq1;GAXK01048137.1;Q5BIM8;3.53E-67;ERCC8_BOVIN;DNA excision repair protein ERCC-8;"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000109; GO:0000209; GO:0004842; GO:0006283; GO:0006289; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0044877; GO:0045739; GO:0051865";"cellular response to DNA damage stimulus [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; transcription-coupled nucleotide-excision repair [GO:0006283]";"Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; protein-containing complex [GO:0032991]";"protein-containing complex binding [GO:0044877]; ubiquitin-protein transferase activity [GO:0004842]"
comp677839_c0_seq1;GAXK01048104.1;Q8WPW2;6.12E-143;PDX1_SUBDO;Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1);"pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823]";"GO:0036381; GO:0042823";pyridoxal phosphate biosynthetic process [GO:0042823];;pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]
comp67787_c0_seq1;GAXK01158438.1;Q9LFU1;0;ASNS3_ARATH;Asparagine synthetase [glutamine-hydrolyzing] 3 (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase 3);"cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]";"GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0070981";"asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]";cytosol [GO:0005829];"asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]"
comp67790_c2_seq1;GAXK01158045.1;Q5RDY3;6.32E-16;KBTB2_PONAB;Kelch repeat and BTB domain-containing protein 2;;;;;
comp67791_c2_seq1;GAXK01158610.1;P10754;9.63E-07;ZFP13_MOUSE;Zinc finger protein 13 (Zfp-13) (Zinc finger protein Krox-8);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005739; GO:0006357; GO:0010729; GO:0046872; GO:1901030";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp6780_c0_seq1;GAXK01100683.1;Q02645;0;HTS_DROME;Protein hu-li tai shao (Adducin-like protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]";"GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793; GO:0098794";"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]";"actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]"
comp6780200_c0_seq1;GAXK01069033.1;P93748;2.81E-09;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp678034_c0_seq1;GAXK01012521.1;Q28151;2.22E-19;OZF_BOVIN;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp678053_c0_seq1;GAXK01012515.1;P80944;8.07E-18;ZFX_PIG;Zinc finger X-chromosomal protein (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp67809_c0_seq1;GAXK01158824.1;Q8K4Q6;1.00E-58;NEIL1_MOUSE;Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; lyase activity [GO:0016829]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]";"GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006281; GO:0006284; GO:0006289; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0016829; GO:0019104; GO:0032074; GO:0140078";"base-excision repair [GO:0006284]; DNA repair [GO:0006281]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; lyase activity [GO:0016829]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]"
comp678199_c0_seq1;GAXK01012562.1;Q5SVQ8;2.29E-10;ZBT41_HUMAN;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6782_c1_seq1;GAXK01101217.1;P14540;1.31E-153;ALF_YEAST;Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0008270; GO:0009277";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]"
comp6782060_c0_seq1;GAXK01181898.1;Q61846;1.13E-16;MELK_MOUSE;Maternal embryonic leucine zipper kinase (EC 2.7.11.1) (Protein kinase PK38) (mPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0004672; GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0008631; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp6782905_c0_seq1;GAXK01181899.1;P51786;2.79E-16;ZN157_HUMAN;Zinc finger protein 157 (Zinc finger protein HZF22);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp67845_c1_seq1;GAXK01158157.1;Q96L50;2.63E-52;LLR1_HUMAN;Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1) (LRR-1) (Peptidylprolyl isomerase-like 5);"cytosol [GO:0005829]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005829; GO:0016567; GO:0043687";"post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";cytosol [GO:0005829];
comp67848_c0_seq1;GAXK01158603.1;Q9VSJ8;7.29E-152;EXOC7_DROME;Exocyst complex component 7 (Exocyst complex component Exo70);"exocyst [GO:0000145]; presynapse [GO:0098793]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"GO:0000145; GO:0005546; GO:0007269; GO:0008013; GO:0015031; GO:0016080; GO:0016081; GO:0016192; GO:0098793";"neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]";"exocyst [GO:0000145]; presynapse [GO:0098793]";"beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp6786161_c0_seq1;GAXK01181796.1;Q9I676;2.63E-49;HYDA_PSEAE;D-hydantoinase/dihydropyrimidinase (DHPase) (EC 3.5.2.2);"cytosol [GO:0005829]; dihydropyrimidinase activity [GO:0004157]; metal ion binding [GO:0046872]";"GO:0004157; GO:0005829; GO:0046872";;cytosol [GO:0005829];"dihydropyrimidinase activity [GO:0004157]; metal ion binding [GO:0046872]"
comp678621_c0_seq1;GAXK01012511.1;Q9GTD4;2.37E-14;NHR71_CAEEL;Nuclear hormone receptor family member nhr-71;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp678623_c0_seq1;GAXK01012536.1;O44252;1.83E-07;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp678667_c0_seq1;GAXK01012497.1;O35547;7.66E-177;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp678766_c0_seq1;GAXK01012567.1;Q24372;1.56E-34;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp678843_c0_seq1;GAXK01012509.1;P17276;7.66E-75;PH4H_DROME;Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase);"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";"GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427";"eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]";;"iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]"
comp6788534_c0_seq1;GAXK01070275.1;Q9GQQ0;7.58E-16;SPIN_DROME;Protein spinster (Protein benchwarmer) (Protein diphthong);"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0055085; GO:0098793";"cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]";"integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]";
comp678863_c0_seq1;GAXK01012514.1;A9ZSY3;1.93E-70;TRET1_BOMMO;Facilitated trehalose transporter Tret1 (BmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp678971_c0_seq1;GAXK01012520.1;Q7Z407;1.86E-22;CSMD3_HUMAN;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6793048_c0_seq1;GAXK01042629.1;O34817;4.32E-19;NAGR_BACSU;HTH-type transcriptional repressor NagR (N-acetylglucosamine utilization regulator);"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0045892";negative regulation of transcription, DNA-templated [GO:0045892];;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp6793479_c0_seq1;GAXK01042631.1;P32899;4.85E-30;IMP3_YEAST;U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (Interacting with MPP10 protein 3);"90S preribosome [GO:0030686]; Mpp10 complex [GO:0034457]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]";"GO:0005654; GO:0006364; GO:0019843; GO:0030515; GO:0030686; GO:0031167; GO:0032040; GO:0034457; GO:0042274";"ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; Mpp10 complex [GO:0034457]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";"rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]"
comp679411_c0_seq1;GAXK01012535.1;Q8BKE6;2.08E-30;CP20A_MOUSE;Cytochrome P450 20A1 (EC 1.14.-.-);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037";;integral component of membrane [GO:0016021];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp67948_c0_seq1;GAXK01158465.1;Q91ZW7;1.78E-11;C209E_MOUSE;CD209 antigen-like protein E (DC-SIGN-related protein 4) (DC-SIGNR4) (CD antigen CD209);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"GO:0005537; GO:0005886; GO:0006897; GO:0009897; GO:0016021; GO:0042102; GO:0097323";"B cell adhesion [GO:0097323]; endocytosis [GO:0006897]; positive regulation of T cell proliferation [GO:0042102]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";mannose binding [GO:0005537]
comp679512_c0_seq1;GAXK01012569.1;Q8WXB4;1.61E-21;ZN606_HUMAN;Zinc finger protein 606 (Zinc finger protein 328);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp679570_c0_seq1;GAXK01012510.1;Q8BLY1;2.69E-34;SMOC1_MOUSE;SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1);"basement membrane [GO:0005604]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667]";"GO:0001654; GO:0005509; GO:0005604; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173";"cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667]";basement membrane [GO:0005604];"calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]"
comp6796263_c0_seq1;GAXK01064825.1;P12374;5.88E-26;COPA_PSEUB;Copper resistance protein A;"periplasmic space [GO:0042597]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]";"GO:0005507; GO:0016491; GO:0042597";;periplasmic space [GO:0042597];"copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]"
comp6797386_c0_seq1;GAXK01064833.1;Q3U3I9;3.20E-08;ZN865_MOUSE;Zinc finger protein 865;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp679770_c2_seq1;GAXK01012543.1;Q3HNM7;1.16E-22;INSC_MOUSE;Protein inscuteable homolog (Minsc);"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991";"asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]";"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]"
comp67978_c0_seq1;GAXK01158411.1;Q6DBY9;1.46E-28;CHST1_DANRE;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0042339; GO:0045130";"carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]"
comp6798_c0_seq1;GAXK01101277.1;Q6GL77;9.52E-20;UBXN1_XENTR;UBX domain-containing protein 1 (SAPK substrate protein 1);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp67986_c2_seq1;GAXK01158336.1;Q9VW15;3.58E-67;ASH1_DROME;Histone-lysine N-methyltransferase ash1 (EC 2.1.1.43) (Absent small and homeotic disks protein 1) (Lysine N-methyltransferase 2H);"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000785; GO:0001700; GO:0003682; GO:0005634; GO:0005700; GO:0006355; GO:0010452; GO:0010628; GO:0016571; GO:0018991; GO:0032991; GO:0034770; GO:0035035; GO:0035097; GO:0042054; GO:0042800; GO:0042802; GO:0046872; GO:0046975; GO:0048096; GO:0048477; GO:0051567; GO:0051568; GO:0061086; GO:0097676";"chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp6798854_c0_seq1;GAXK01075246.1;P21823;3.54E-16;MCPD_KLEAK;Methyl-accepting chemotaxis aspartate transducer;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"GO:0004888; GO:0005886; GO:0006935; GO:0007165; GO:0016021";"chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane signaling receptor activity [GO:0004888]
comp6799_c1_seq1;GAXK01100995.1;P54399;4.32E-176;PDI_DROME;Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1);"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0006457; GO:0012505; GO:0015037; GO:0034976; GO:0043025; GO:0045169; GO:0045454; GO:0048471; GO:0060187; GO:0070732";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]";"peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]"
comp6799020_c0_seq1;GAXK01075242.1;Q64018;6.37E-11;GLRA1_MOUSE;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0043576; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0050905; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344";"acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; anion transport [GO:0006820]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]";"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]"
comp67996_c0_seq1;GAXK01158385.1;Q8HYW0;2.55E-26;FA13A_BOVIN;Protein FAM13A (Protein Precm1);;;;;
comp680000_c0_seq1;GAXK01012999.1;P48822;2.94E-18;TDX1_BRUMA;Peroxiredoxin 1 (EC 1.11.1.15) (Thiol-specific antioxidant protein 1) (Thioredoxin peroxidase 1) (Bm-TPx-1) (Thioredoxin-dependent peroxide reductase 1);"cell [GO:0005623]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005623; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];cell [GO:0005623];"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp6800491_c0_seq1;GAXK01107787.1;A5PL98;2.18E-71;SDHB_DANRE;Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip);"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]";"GO:0005743; GO:0005749; GO:0006099; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539";"aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]";"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]"
comp68023_c2_seq1;GAXK01006159.1;P83103;1.56E-74;HASP_DROME;Putative serine/threonine-protein kinase haspin homolog (EC 2.7.11.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]";"GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556; GO:0072354";"intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein serine/threonine kinase activity [GO:0004674]"
comp680249_c0_seq1;GAXK01012971.1;Q2EI21;2.42E-08;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp6804_c1_seq1;GAXK01100577.1;Q568W0;1.60E-31;SELW_DANRE;Selenoprotein W (SelW);"cytosol [GO:0005829]; antioxidant activity [GO:0016209]; response to selenium ion [GO:0010269]";"GO:0005829; GO:0010269; GO:0016209";response to selenium ion [GO:0010269];cytosol [GO:0005829];antioxidant activity [GO:0016209]
comp680432_c0_seq1;GAXK01013027.1;Q86XU0;7.48E-28;ZN677_HUMAN;Zinc finger protein 677;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp680468_c0_seq1;GAXK01013020.1;Q60HC5;3.29E-68;DHC24_MACFA;Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]; cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"GO:0000139; GO:0005634; GO:0005783; GO:0005789; GO:0006695; GO:0006979; GO:0009888; GO:0016021; GO:0019899; GO:0042605; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0071949";"cholesterol biosynthetic process [GO:0006695]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; peptide antigen binding [GO:0042605]"
comp6805224_c0_seq1;GAXK01072874.1;Q8L7K0;5.57E-21;R18A1_ARATH;60S ribosomal protein L18a-1;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0009506; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; plasmodesma [GO:0009506]";structural constituent of ribosome [GO:0003735]
comp6805614_c0_seq1;GAXK01072880.1;Q9CXE0;1.25E-09;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp680600_c0_seq1;GAXK01012997.1;Q8R5M8;1.16E-07;CADM1_MOUSE;Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1);"axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell body fiber [GO:0070852]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; bone development [GO:0060348]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; liver development [GO:0001889]; maintenance of postsynaptic specialization structure [GO:0098880]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; presynapse assembly [GO:0099054]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; unidimensional cell growth [GO:0009826]";"GO:0001889; GO:0002376; GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007155; GO:0007156; GO:0007157; GO:0007283; GO:0007416; GO:0008021; GO:0008037; GO:0009826; GO:0014069; GO:0016323; GO:0016338; GO:0030154; GO:0030165; GO:0030424; GO:0030425; GO:0042271; GO:0042803; GO:0043005; GO:0043196; GO:0045202; GO:0045954; GO:0050715; GO:0050839; GO:0051606; GO:0060348; GO:0070852; GO:0098685; GO:0098880; GO:0098942; GO:0098978; GO:0099054; GO:0099055; GO:0099056; GO:0099560";"apoptotic process [GO:0006915]; bone development [GO:0060348]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; liver development [GO:0001889]; maintenance of postsynaptic specialization structure [GO:0098880]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; presynapse assembly [GO:0099054]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; unidimensional cell growth [GO:0009826]";"axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell body fiber [GO:0070852]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]";"cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]"
comp6806029_c0_seq1;GAXK01003936.1;Q8T5Z4;5.51E-24;RS19_BRABE;40S ribosomal protein S19;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp680603_c0_seq1;GAXK01012966.1;Q24498;1.72E-159;RYR_DROME;Ryanodine receptor (Ryanodine receptor 44F);"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"GO:0005219; GO:0005509; GO:0005790; GO:0005886; GO:0006816; GO:0006936; GO:0007275; GO:0016021; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0035206; GO:0042383; GO:0048763; GO:0051209; GO:0060047; GO:0072347";"calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]";"calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]"
comp68062_c0_seq1;GAXK01006162.1;Q5R4C9;1.89E-15;NRBF2_PONAB;Nuclear receptor-binding factor 2 (NRBF-2);"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; autophagy [GO:0006914]; regulation of lipid kinase activity [GO:0043550]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0005634; GO:0005776; GO:0006914; GO:0031410; GO:0034976; GO:0035032; GO:0043550";"autophagy [GO:0006914]; regulation of lipid kinase activity [GO:0043550]; response to endoplasmic reticulum stress [GO:0034976]";"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]";
comp680684_c0_seq1;GAXK01012978.1;P56260;3.35E-49;QIN_AVIS3;Transforming protein Qin (Oncogene Qin);"host cell nucleus [GO:0042025]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0042025; GO:0043565";;host cell nucleus [GO:0042025];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp68085_c1_seq1;GAXK01006063.1;P42787;0;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp680890_c1_seq1;GAXK01013032.1;Q7RTY7;2.06E-48;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp6808912_c0_seq1;GAXK01049591.1;Q0ADD1;1.52E-70;RF3_NITEC;Peptide chain release factor 3 (RF-3);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity, codon specific [GO:0016149]; regulation of translational termination [GO:0006449]";"GO:0003924; GO:0005525; GO:0005737; GO:0006449; GO:0016149";regulation of translational termination [GO:0006449];cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation release factor activity, codon specific [GO:0016149]"
comp6809499_c0_seq1;GAXK01049589.1;Q7KRI2;2.92E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6810_c0_seq1;GAXK01101192.1;Q5ZIK6;1.13E-22;BSDC1_CHICK;BSD domain-containing protein 1;;;;;
comp681005_c0_seq1;GAXK01012975.1;Q8TCT0;4.00E-93;CERK1_HUMAN;Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]";"GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006687; GO:0016021; GO:0102773";"ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]"
comp681018_c0_seq1;GAXK01012959.1;Q9NYT6;4.96E-63;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6810628_c0_seq1;GAXK01101646.1;P50729;2.17E-09;RECS_BACSU;Probable ATP-dependent DNA helicase RecS (EC 3.6.4.12) (Recombination protein S);"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006281; GO:0006310; GO:0009378; GO:0030894; GO:0032508; GO:0043138; GO:0043590";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp6811_c1_seq1;GAXK01100031.1;O14530;3.82E-81;TXND9_HUMAN;Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4);"centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; cell redox homeostasis [GO:0045454]";"GO:0005634; GO:0005813; GO:0005829; GO:0030496; GO:0045296; GO:0045454";cell redox homeostasis [GO:0045454];"centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]";cadherin binding [GO:0045296]
comp681210_c0_seq1;GAXK01012958.1;P42787;2.21E-28;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp6812239_c0_seq1;GAXK01029951.1;P41366;1.06E-08;VMO1_CHICK;Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI);"cell [GO:0005623]; extracellular space [GO:0005615]";"GO:0005615; GO:0005623";;"cell [GO:0005623]; extracellular space [GO:0005615]";
comp681244_c0_seq1;GAXK01012979.1;Q9H4Z2;9.17E-14;ZN335_HUMAN;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0000979; GO:0000981; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182";"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]";"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp6813031_c0_seq1;GAXK01029956.1;A4VPB6;1.01E-22;MURI_PSEU5;Glutamate racemase (EC 5.1.1.3);"glutamate racemase activity [GO:0008881]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0008360; GO:0008881; GO:0009252; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";;glutamate racemase activity [GO:0008881]
comp68133_c22_seq1;GAXK01006693.1;Q9Y620;6.66E-163;RA54B_HUMAN;DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B);"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; DNA-dependent ATPase activity [GO:0008094]; RNA helicase activity [GO:0003724]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]";"GO:0000724; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0006312; GO:0007131; GO:0008094; GO:0015616";"double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; RNA helicase activity [GO:0003724]"
comp68135_c0_seq1;GAXK01006825.1;O46040;2.37E-21;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp681362_c2_seq1;GAXK01012983.1;Q8BZ25;2.24E-11;ANKK1_MOUSE;Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995";regulation of cell cycle process [GO:0010564];"cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp681367_c0_seq1;GAXK01012956.1;Q9W0T5;1.13E-07;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp681515_c0_seq1;GAXK01013028.1;Q9U3P2;8.11E-08;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp68153_c2_seq1;GAXK01006877.1;Q5R9B3;1.54E-73;CC186_PONAB;Coiled-coil domain-containing protein 186 (Fragment);;;;;
comp68170_c16_seq1;GAXK01006633.1;Q9PU85;1.73E-99;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp6817624_c0_seq1;GAXK01068591.1;B9EJV3;3.54E-10;GRB1L_MOUSE;GREB1-like protein;"integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";"GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0060562; GO:0061205; GO:0072177";"branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]";integral component of membrane [GO:0016021];
comp681790_c0_seq1;GAXK01013004.1;Q68US5;3.62E-09;EVA1C_PANTR;Protein eva-1 homolog C (Protein FAM176C);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]";"GO:0005886; GO:0008201; GO:0016021; GO:0030246";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]"
comp6818353_c0_seq1;GAXK01185052.1;O70320;4.81E-11;PLB1_CAVPO;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; lipid catabolic process [GO:0016042]";"GO:0004622; GO:0004623; GO:0016021; GO:0016042; GO:0016324; GO:0102567; GO:0102568";lipid catabolic process [GO:0016042];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp6818547_c0_seq1;GAXK01185053.1;Q5R9A7;3.93E-14;GP155_PONAB;Integral membrane protein GPR155;"integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";"GO:0016021; GO:0035556; GO:0055085";"intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]";integral component of membrane [GO:0016021];
comp681919_c0_seq1;GAXK01013024.1;A0A0B4K692;0;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp68195_c0_seq1;GAXK01006513.1;P78383;8.40E-34;S35B1_HUMAN;Solute carrier family 35 member B1 (UDP-galactose transporter-related protein 1) (UGTrel1) (hUGTrel1);"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; UDP-galactose transmembrane transport [GO:0072334]";"GO:0005459; GO:0005460; GO:0008643; GO:0022857; GO:0030173; GO:0030176; GO:0043231; GO:0072334";"carbohydrate transport [GO:0008643]; UDP-galactose transmembrane transport [GO:0072334]";"integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]";"transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]"
comp682009_c2_seq1;GAXK01037414.1;Q2EI21;3.15E-12;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp682041_c0_seq1;GAXK01037439.1;P02597;3.11E-25;CALMS_CHICK;Calmodulin, striated muscle;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6820600_c0_seq1;GAXK01023724.1;A2AJ76;3.23E-11;HMCN2_MOUSE;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp682081_c1_seq1;GAXK01037486.1;Q2YDF6;8.76E-18;RT35_BOVIN;28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt);"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]";"GO:0003735; GO:0005743; GO:0005763; GO:0032543";mitochondrial translation [GO:0032543];"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]";structural constituent of ribosome [GO:0003735]
comp6821_c0_seq1;GAXK01100425.1;Q7T2A5;0;EIF3L_DANRE;Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp6821064_c0_seq1;GAXK01023722.1;Q94900;5.23E-40;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp682157_c0_seq1;GAXK01037419.1;P17970;4.38E-152;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp682184_c0_seq1;GAXK01037471.1;Q7KRI2;4.89E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6822_c0_seq1;GAXK01101272.1;Q4AEI0;6.61E-71;GPX2_PONPY;Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI);"cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0005737; GO:0006979";response to oxidative stress [GO:0006979];cytoplasm [GO:0005737];glutathione peroxidase activity [GO:0004602]
comp682204_c0_seq1;GAXK01037470.1;A6QP05;8.74E-28;DHR12_BOVIN;Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp68221_c0_seq1;GAXK01006130.1;P12845;2.99E-59;MYO2_CAEEL;Myosin-2 (Myosin heavy chain C) (MHC C);"muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; muscle contraction [GO:0006936]";"GO:0000146; GO:0005524; GO:0005859; GO:0006936; GO:0030016; GO:0032982; GO:0051015";muscle contraction [GO:0006936];"muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]"
comp68232_c0_seq1;GAXK01005928.1;Q9KLY7;4.63E-103;PHNW_VIBCH;2-aminoethylphosphonate--pyruvate transaminase (EC 2.6.1.37) (2-aminoethylphosphonate aminotransferase) (AEP transaminase) (AEPT);"2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; catalytic activity [GO:0003824]; organic phosphonate catabolic process [GO:0019700]";"GO:0003824; GO:0019700; GO:0047304";organic phosphonate catabolic process [GO:0019700];;"2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; catalytic activity [GO:0003824]"
comp682362_c0_seq1;GAXK01037417.1;P54131;1.26E-95;ACHA7_BOVIN;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp68237_c1_seq1;GAXK01007011.1;P82094;2.54E-63;TMF1_HUMAN;TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription, DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]";"GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003712; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0006366; GO:0007289; GO:0010629; GO:0030317; GO:0032275; GO:0033327; GO:0042742; GO:0043066; GO:0061136; GO:0071407; GO:2000845";"acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription, DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]"
comp682396_c0_seq1;GAXK01037407.1;A7RNG8;3.26E-54;CCD22_NEMVE;Coiled-coil domain-containing protein 22 homolog;"cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]";"GO:0097602; GO:2000060";positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060];;cullin family protein binding [GO:0097602]
comp682410_c0_seq1;GAXK01037487.1;Q14588;1.66E-08;ZN234_HUMAN;Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp68245_c0_seq1;GAXK01005926.1;A4K526;1.59E-15;TM256_BUFGR;Transmembrane protein 256 homolog;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp6824927_c0_seq1;GAXK01204668.1;Q88RC0;2.75E-41;DAVD_PSEPK;Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-);"glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]";"GO:0009013; GO:0009450; GO:0019477; GO:0047949";"gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]";;"glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]"
comp682603_c0_seq1;GAXK01037390.1;Q1LZB4;1.48E-90;IFT46_BOVIN;Intraflagellar transport protein 46 homolog;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; smoothened signaling pathway [GO:0007224]";"GO:0005737; GO:0005813; GO:0007224; GO:0030992; GO:0031514; GO:0042073; GO:0060271";"cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; smoothened signaling pathway [GO:0007224]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]";
comp68264_c0_seq1;GAXK01006118.1;Q96P11;6.34E-61;NSUN5_HUMAN;Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein);"nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475]";"GO:0003723; GO:0005634; GO:0005730; GO:0008168; GO:0070475";rRNA base methylation [GO:0070475];"nucleolus [GO:0005730]; nucleus [GO:0005634]";"methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]"
comp682748_c0_seq1;GAXK01037434.1;Q8I6K0;6.94E-38;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp682757_c0_seq1;GAXK01037506.1;Q9JJS0;1.74E-37;SCUB2_MOUSE;Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);"cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; hedgehog family protein binding [GO:0097108]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880]";"GO:0003413; GO:0005509; GO:0005615; GO:0008289; GO:0009986; GO:0019897; GO:0042802; GO:0045669; GO:0045778; GO:0045880; GO:0097108; GO:1902732";"chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880]";"cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]";"calcium ion binding [GO:0005509]; hedgehog family protein binding [GO:0097108]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]"
comp682803_c1_seq1;GAXK01037395.1;P35500;0;SCNA_DROME;Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1);"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0034765; GO:0035725; GO:0045433; GO:0060078";"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]";"integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]";"calcium ion binding [GO:0005509]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]"
comp6828343_c0_seq1;GAXK01082463.1;Q54N49;6.03E-61;INO1_DICDI;Inositol-3-phosphate synthase (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (IPS) (MI-1-P synthase) (MIP synthase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; autophagy [GO:0006914]; cell-substrate adhesion [GO:0031589]; inositol biosynthetic process [GO:0006021]; mitotic cytokinesis [GO:0000281]; phospholipid biosynthetic process [GO:0008654]; regulation of phospholipid metabolic process [GO:1903725]";"GO:0000281; GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0006914; GO:0008654; GO:0031589; GO:1903725";"autophagy [GO:0006914]; cell-substrate adhesion [GO:0031589]; inositol biosynthetic process [GO:0006021]; mitotic cytokinesis [GO:0000281]; phospholipid biosynthetic process [GO:0008654]; regulation of phospholipid metabolic process [GO:1903725]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";inositol-3-phosphate synthase activity [GO:0004512]
comp682839_c0_seq1;GAXK01037391.1;F7J220;7.08E-36;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp682844_c0_seq1;GAXK01037392.1;Q9HAZ2;8.59E-07;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp6828793_c0_seq1;GAXK01082465.1;P25773;8.79E-09;CATL1_FELCA;Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Progesterone-dependent protein) (PDP) (Fragment);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004175; GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";"cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]"
comp6829012_c0_seq1;GAXK01082453.1;P40392;2.56E-54;RIC1_ORYSJ;Ras-related protein RIC1;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005886; GO:0006886; GO:0006888; GO:0032482";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp682905_c1_seq1;GAXK01037415.1;Q9CYL5;3.85E-14;GAPR1_MOUSE;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374";"positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";protein homodimerization activity [GO:0042803]
comp6829654_c0_seq1;GAXK01082462.1;Q5R7B7;4.16E-10;VA0D2_PONAB;V-type proton ATPase subunit d 2 (V-ATPase subunit d 2) (Vacuolar proton pump subunit d 2);"apical plasma membrane [GO:0016324]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; proton transmembrane transporter activity [GO:0015078]";"GO:0015078; GO:0016324; GO:0033179";;"apical plasma membrane [GO:0016324]; proton-transporting V-type ATPase, V0 domain [GO:0033179]";proton transmembrane transporter activity [GO:0015078]
comp682975_c0_seq1;GAXK01037476.1;P39087;0;GRIK2_MOUSE;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp683_c0_seq1;GAXK01169647.1;P70195;8.22E-107;PSB7_MOUSE;Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp68301_c13_seq1;GAXK01007090.1;Q9NXL6;9.92E-72;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp683043_c0_seq1;GAXK01037440.1;P35832;2.28E-34;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp68315_c0_seq1;GAXK01006076.1;E7F0Z8;9.70E-17;NOTU2_DANRE;Carboxylesterase notum2 (EC 3.1.1.-);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]";"GO:0005576; GO:0008045; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp68316_c0_seq1;GAXK01007017.1;F1M3L7;7.10E-70;EPS8_RAT;Epidermal growth factor receptor kinase substrate 8;"brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]";"GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030054; GO:0030426; GO:0030832; GO:0031532; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0035591; GO:0036336; GO:0048149; GO:0048365; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830";"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]";"brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]";"actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]"
comp6832_c0_seq1;GAXK01100030.1;Q9VMM6;7.03E-12;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp6832444_c0_seq1;;P55586;1.83E-07;Y4OA_SINFN;Uncharacterized protein y4oA;ubiquitin-like modifier activating enzyme activity [GO:0008641];GO:0008641;;;ubiquitin-like modifier activating enzyme activity [GO:0008641]
comp683258_c0_seq1;GAXK01037503.1;Q6P7K0;2.56E-11;CMBL_XENTR;Carboxymethylenebutenolidase homolog (EC 3.1.-.-);"cytosol [GO:0005829]; hydrolase activity [GO:0016787]";"GO:0005829; GO:0016787";;cytosol [GO:0005829];hydrolase activity [GO:0016787]
comp6832957_c0_seq1;GAXK01073895.1;P31692;2.42E-37;ADT_PARKE;ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp68330_c0_seq1;GAXK01006914.1;P62283;3.67E-09;ASPM_AOTVO;Abnormal spindle-like microcephaly-associated protein homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cell division [GO:0051301]; spindle organization [GO:0007051]";"GO:0005516; GO:0005634; GO:0005737; GO:0007051; GO:0051301";"cell division [GO:0051301]; spindle organization [GO:0007051]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";calmodulin binding [GO:0005516]
comp6833478_c0_seq1;GAXK01073904.1;P47813;7.80E-35;IF1AX_HUMAN;Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C);"cytosol [GO:0005829]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]";"GO:0003723; GO:0003743; GO:0005829; GO:0006413; GO:0008135";translational initiation [GO:0006413];cytosol [GO:0005829];"RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"
comp68338_c0_seq1;GAXK01006052.1;Q9D061;4.51E-39;ACBD6_MOUSE;Acyl-CoA-binding domain-containing protein 6;"cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0005737; GO:0008289";;cytoplasm [GO:0005737];"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp68346_c0_seq1;GAXK01006561.1;C4N147;2.73E-24;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp6835198_c0_seq1;GAXK01108190.1;Q8WXX0;1.69E-33;DYH7_HUMAN;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2);"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp68354_c0_seq1;GAXK01006952.1;O88846;7.15E-14;RNF4_RAT;E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of cell death [GO:0060548]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008134; GO:0008270; GO:0008584; GO:0016567; GO:0016605; GO:0017025; GO:0030331; GO:0031491; GO:0031624; GO:0032184; GO:0032355; GO:0033142; GO:0042802; GO:0042803; GO:0043161; GO:0044752; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0060548; GO:0061630; GO:0070534; GO:0070936; GO:0070979; GO:0071243; GO:0071345; GO:0071394; GO:0071480; GO:0072711; GO:0085020; GO:0090169; GO:0090234";"cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to testosterone stimulus [GO:0071394]; male gonad development [GO:0008584]; negative regulation of cell death [GO:0060548]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; nucleosome binding [GO:0031491]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; SUMO polymer binding [GO:0032184]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp68355_c0_seq1;GAXK01006089.1;Q5IS41;4.63E-16;NCAN_PANTR;Neurocan core protein (Chondroitin sulfate proteoglycan 3);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp683608_c1_seq1;GAXK01037492.1;Q9HCG1;1.80E-53;ZN160_HUMAN;Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; hemopoiesis [GO:0030097]";"GO:0000981; GO:0003677; GO:0005634; GO:0030097; GO:0046872";hemopoiesis [GO:0030097];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp6837871_c0_seq1;GAXK01179501.1;O01382;2.22E-23;DRICE_DROME;"Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]";"cytoplasm [GO:0005737]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";"GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0045476; GO:0046668; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269";"apoptotic process [GO:0006915]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; regulation of retinal cell programmed cell death [GO:0046668]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]";cytoplasm [GO:0005737];"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp68382_c1_seq1;GAXK01006054.1;Q8L7W2;4.26E-47;NUDT8_ARATH;Nudix hydrolase 8 (AtNUDT8) (EC 3.6.1.-);"cytosol [GO:0005829]; ADP-ribose diphosphatase activity [GO:0047631]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; response to wounding [GO:0009611]";"GO:0005829; GO:0009611; GO:0035529; GO:0046872; GO:0047631; GO:0051287";response to wounding [GO:0009611];cytosol [GO:0005829];"ADP-ribose diphosphatase activity [GO:0047631]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]"
comp683875_c0_seq1;GAXK01037438.1;Q61474;3.46E-21;MSI1H_MOUSE;RNA-binding protein Musashi homolog 1 (Musashi-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; response to hormone [GO:0009725]";"GO:0003723; GO:0003727; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0008266; GO:0009725; GO:0042802; GO:1990904";response to hormone [GO:0009725];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"
comp683895_c1_seq1;GAXK01205155.1;G5E8K5;5.88E-84;ANK3_MOUSE;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp683988_c0_seq1;GAXK01037389.1;Q96BH3;1.38E-08;ESPB1_HUMAN;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12);"cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240";"single fertilization [GO:0007338]; sperm capacitation [GO:0048240]";"cell surface [GO:0009986]; extracellular region [GO:0005576]";heparin binding [GO:0008201]
comp684_c0_seq1;GAXK01169046.1;B3M1G0;2.69E-79;WDR55_DROAN;WD repeat-containing protein 55 homolog;defense response to Gram-negative bacterium [GO:0050829];GO:0050829;defense response to Gram-negative bacterium [GO:0050829];;
comp68401_c0_seq1;GAXK01006909.1;Q9BV38;4.28E-68;WDR18_HUMAN;WD repeat-containing protein 18;"cytoplasm [GO:0005737]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rix1 complex [GO:0097344]; multicellular organism development [GO:0007275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; rRNA processing [GO:0006364]";"GO:0005654; GO:0005656; GO:0005730; GO:0005737; GO:0006364; GO:0007275; GO:0030174; GO:0097344";"multicellular organism development [GO:0007275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rix1 complex [GO:0097344]";
comp6841123_c0_seq1;GAXK01127836.1;Q8XAX1;1.96E-23;YDEP_ECO57;Protein YdeP;"4 iron, 4 sulfur cluster binding [GO:0051539]; formate dehydrogenase (NAD+) activity [GO:0008863]; molybdenum ion binding [GO:0030151]";"GO:0008863; GO:0030151; GO:0051539";;;"4 iron, 4 sulfur cluster binding [GO:0051539]; formate dehydrogenase (NAD+) activity [GO:0008863]; molybdenum ion binding [GO:0030151]"
comp684131_c0_seq1;GAXK01024507.1;Q8IUM7;1.96E-49;NPAS4_HUMAN;Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (Class E basic helix-loop-helix protein 79) (bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862";"cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp684184_c0_seq1;GAXK01024517.1;Q96PQ6;2.05E-11;ZN317_HUMAN;Zinc finger protein 317;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp684224_c0_seq1;GAXK01024491.1;Q6P0F9;3.28E-28;INS1A_DANRE;Insulinoma-associated protein 1a (Insulinoma-associated 1-like protein a) (Zinc finger protein IA-1a);"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell dedifferentiation [GO:0043697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]";"GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0010564; GO:0017053; GO:0021522; GO:0030182; GO:0031490; GO:0035677; GO:0042670; GO:0043565; GO:0043697; GO:0045892; GO:0046872; GO:0048920; GO:0060221; GO:0060290; GO:0070654";"cell dedifferentiation [GO:0043697]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]";"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp6843354_c0_seq1;GAXK01069755.1;P35685;1.03E-47;RL7A1_ORYSJ;60S ribosomal protein L7a-1;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0022625";maturation of LSU-rRNA [GO:0000470];cytosolic large ribosomal subunit [GO:0022625];RNA binding [GO:0003723]
comp68443_c0_seq1;GAXK01006913.1;P81282;2.70E-17;CSPG2_BOVIN;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M);"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";"GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012";"cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]";extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
comp684460_c0_seq1;GAXK01024459.1;Q95NT6;9.71E-17;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp684473_c0_seq1;GAXK01024521.1;P04052;1.97E-13;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp6845193_c0_seq1;GAXK01172205.1;Q94523;3.72E-43;SDHA_DROME;Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (FP) (Succinyl coenzyme A synthetase flavoprotein subunit);"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; plasma membrane succinate dehydrogenase complex [GO:0045282]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]; electron transport chain [GO:0022900]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"GO:0000104; GO:0005739; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0022900; GO:0045282; GO:0050660";"electron transport chain [GO:0022900]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; plasma membrane succinate dehydrogenase complex [GO:0045282]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; succinate dehydrogenase activity [GO:0000104]"
comp6845388_c0_seq1;GAXK01172201.1;Q6NYZ4;5.37E-11;PLA1A_DANRE;Phospholipase A1 member A (EC 3.1.1.-);"extracellular space [GO:0005615]; lipase activity [GO:0016298]; phospholipase A1 activity [GO:0008970]; lipid catabolic process [GO:0016042]";"GO:0005615; GO:0008970; GO:0016042; GO:0016298";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];"lipase activity [GO:0016298]; phospholipase A1 activity [GO:0008970]"
comp6845667_c0_seq1;GAXK01172203.1;Q9CAP8;6.17E-23;LACS9_ARATH;Long chain acyl-CoA synthetase 9, chloroplastic (EC 6.2.1.3);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; mitochondrion [GO:0005739]; plastid [GO:0009536]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]";"GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0006631; GO:0009507; GO:0009536; GO:0009941; GO:0102391";fatty acid metabolic process [GO:0006631];"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; mitochondrion [GO:0005739]; plastid [GO:0009536]";"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp684593_c0_seq1;GAXK01024482.1;O18048;6.47E-13;NH213_CAEEL;Nuclear hormone receptor family member nhr-213;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp68460_c0_seq1;GAXK01006060.1;A3KMZ6;3.06E-86;COX11_BOVIN;Cytochrome c oxidase assembly protein COX11, mitochondrial;"integral component of mitochondrial inner membrane [GO:0031305]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132]";"GO:0005507; GO:0031305; GO:0032991; GO:0033132; GO:0055065";"metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132]";"integral component of mitochondrial inner membrane [GO:0031305]; protein-containing complex [GO:0032991]";copper ion binding [GO:0005507]
comp684605_c0_seq1;GAXK01024514.1;Q9Y619;5.73E-91;ORNT1_HUMAN;Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; L-ornithine transmembrane transporter activity [GO:0000064]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050]";"GO:0000050; GO:0000064; GO:0005743; GO:0016021; GO:1990575";"mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";L-ornithine transmembrane transporter activity [GO:0000064]
comp6846175_c0_seq1;GAXK01038882.1;Q63170;1.50E-13;DYH7_RAT;Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005509; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp684689_c0_seq1;GAXK01024522.1;Q02361;2.50E-59;FD3_DROME;Fork head domain-containing protein FD3;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0009653; GO:0030154; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp68472_c0_seq1;GAXK01006041.1;Q8BTS4;5.10E-91;NUP54_MOUSE;Nuclear pore complex protein Nup54 (54 kDa nucleoporin) (Nucleoporin Nup54);"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306]";"GO:0005635; GO:0005643; GO:0006605; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0032991; GO:0036228; GO:0042306; GO:0044613; GO:0051028; GO:0051260; GO:0051290; GO:0051291; GO:0070208";"mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306]";"nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]";structural constituent of nuclear pore [GO:0017056]
comp68473_c0_seq1;GAXK01006566.1;P46953;7.40E-94;3HAO_RAT;3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; 3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; tryptophan catabolic process [GO:0006569]";"GO:0000334; GO:0005506; GO:0005737; GO:0005829; GO:0006569; GO:0008198; GO:0019805; GO:0019825; GO:0031966; GO:0034354; GO:0043420; GO:0046874";"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; tryptophan catabolic process [GO:0006569]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]";"3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]"
comp6847763_c0_seq1;GAXK01038884.1;P61485;1.23E-25;RL36A_DANRE;60S ribosomal protein L36a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726";"chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp68479_c5_seq1;GAXK01007012.1;Q9NUQ7;1.69E-112;UFSP2_HUMAN;Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]";"GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0016790; GO:0033146; GO:0071567";"proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]";"thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]"
comp684844_c1_seq1;GAXK01024506.1;P0DPU3;5.14E-125;TX14A_SCOSD;"Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]";"extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729";"glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]";extracellular region [GO:0005576];"glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]"
comp68486_c2_seq1;GAXK01006893.1;Q0JRZ9;3.30E-89;FCHO2_HUMAN;F-BAR domain only protein 2;"AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]";"GO:0001786; GO:0005543; GO:0005546; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0008017; GO:0008092; GO:0010324; GO:0015631; GO:0030122; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0061024; GO:0072583; GO:0072659; GO:0097320; GO:0098835";"clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]";"AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]";"cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]"
comp6849_c0_seq1;GAXK01101268.1;Q8BMB3;1.46E-96;IF4E2_MOUSE;Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (eIF4E-2) (mRNA cap-binding protein type 2) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP);"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]";"GO:0000340; GO:0001701; GO:0003743; GO:0005845; GO:0016281; GO:0017148; GO:0031625";"in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]";"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]";"RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]"
comp684953_c0_seq1;GAXK01024463.1;P27042;1.34E-28;LYG_CHICK;Lysozyme g (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase) (Goose-type lysozyme);"extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253]";"GO:0003796; GO:0005576; GO:0009253; GO:0016998; GO:0019835; GO:0050830";"cell wall macromolecule catabolic process [GO:0016998]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253]";extracellular region [GO:0005576];lysozyme activity [GO:0003796]
comp68503_c0_seq1;GAXK01006880.1;P41731;1.22E-40;CD63_MOUSE;CD63 antigen (CD antigen CD63);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"GO:0002092; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0034613; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046";"cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigmentation [GO:0043473]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body, internal vesicle [GO:0097487]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";protein-containing complex binding [GO:0044877]
comp68507_c0_seq1;GAXK01006810.1;Q9Y5P8;4.16E-157;P2R3B_HUMAN;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle arrest [GO:0007050]; protein dephosphorylation [GO:0006470]";"GO:0000159; GO:0004722; GO:0005509; GO:0005634; GO:0005654; GO:0006470; GO:0007050; GO:0019888";"cell cycle arrest [GO:0007050]; protein dephosphorylation [GO:0006470]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]";"calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]"
comp6851649_c0_seq1;GAXK01061220.1;Q6ZNG9;1.10E-07;KRBA2_HUMAN;KRAB-A domain-containing protein 2;"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0015074";"DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";;nucleic acid binding [GO:0003676]
comp68521_c1_seq1;GAXK01007014.1;O77237;0;PELI_DROME;Protein pellino;"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; kinase regulator activity [GO:0019207]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; innate immune response [GO:0045087]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063]";"GO:0000209; GO:0002225; GO:0004842; GO:0005829; GO:0008063; GO:0009898; GO:0019207; GO:0045087; GO:0045751; GO:0045752; GO:0061630; GO:0070936; GO:1900425; GO:1905035";"innate immune response [GO:0045087]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063]";"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]";"kinase regulator activity [GO:0019207]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp685306_c0_seq1;GAXK01024479.1;O77215;5.77E-44;UNC4_DROME;Homeobox protein unc-4 (Paired-like homeodomain protein unc-4) (DPHD-1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0043565";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp68536_c1_seq1;GAXK01006955.1;Q9W5U2;2.21E-161;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp68543_c0_seq1;GAXK01005858.1;Q9PVG3;2.22E-14;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp68549_c0_seq1;GAXK01006055.1;Q5RJY2;1.37E-55;G2E3_MOUSE;G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0001824; GO:0005730; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243";"apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp685507_c1_seq1;GAXK01024480.1;Q66KI8;2.06E-70;APCD1_XENLA;Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo);"integral component of plasma membrane [GO:0005887]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";"GO:0005887; GO:0016055; GO:0017147; GO:0030178";"negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]";integral component of plasma membrane [GO:0005887];Wnt-protein binding [GO:0017147]
comp685578_c0_seq1;GAXK01024473.1;Q29IL2;0;POMT2_DROPS;Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (Protein twisted);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]";"GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0045214";"lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]
comp685620_c0_seq1;GAXK01024513.1;Q5JVG2;5.23E-19;ZN484_HUMAN;Zinc finger protein 484;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp68565_c1_seq1;GAXK01005852.1;Q0VCC5;6.56E-14;REPI1_BOVIN;Replication initiator 1;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]";"GO:0003677; GO:0005634; GO:0006260; GO:0046872";DNA replication [GO:0006260];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6856807_c0_seq1;GAXK01045266.1;Q0P9V4;1.93E-12;PIF1_CAMJE;ATP-dependent DNA helicase pif1 (EC 3.6.4.12);"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]";;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp685696_c0_seq1;GAXK01024490.1;Q05319;1.31E-39;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp6857048_c0_seq1;GAXK01045271.1;P29357;3.91E-31;HSP7E_SPIOL;Chloroplast envelope membrane 70 kDa heat shock-related protein;"chloroplast membrane [GO:0031969]; ATP binding [GO:0005524]";"GO:0005524; GO:0031969";;chloroplast membrane [GO:0031969];ATP binding [GO:0005524]
comp68578_c0_seq1;GAXK01006741.1;Q86V86;2.21E-114;PIM3_HUMAN;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp68582_c0_seq1;GAXK01006049.1;P63045;5.95E-21;VAMP2_RAT;Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2);"cell junction [GO:0030054]; clathrin-coated vesicle [GO:0030136]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; myosin binding [GO:0017022]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle recycling [GO:1903421]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0000322; GO:0005516; GO:0005543; GO:0005802; GO:0005886; GO:0008021; GO:0008022; GO:0009749; GO:0015031; GO:0016020; GO:0016079; GO:0016081; GO:0016192; GO:0017022; GO:0017075; GO:0017156; GO:0017157; GO:0030054; GO:0030136; GO:0030141; GO:0030285; GO:0030672; GO:0031201; GO:0032869; GO:0035493; GO:0042589; GO:0042802; GO:0043001; GO:0043005; GO:0043195; GO:0043229; GO:0043231; GO:0044306; GO:0044325; GO:0044877; GO:0046879; GO:0048306; GO:0048471; GO:0060291; GO:0065003; GO:0070032; GO:0070033; GO:0070044; GO:0090316; GO:0098967; GO:1902259; GO:1903421";"calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; positive regulation of intracellular protein transport [GO:0090316]; protein-containing complex assembly [GO:0065003]; protein transport [GO:0015031]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle recycling [GO:1903421]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"cell junction [GO:0030054]; clathrin-coated vesicle [GO:0030136]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; zymogen granule membrane [GO:0042589]";"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; myosin binding [GO:0017022]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]"
comp6860032_c0_seq1;GAXK01095353.1;Q9SIM4;4.39E-34;RL141_ARATH;60S ribosomal protein L14-1;"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0005739; GO:0005773; GO:0005783; GO:0006412; GO:0009506; GO:0022625; GO:0042273";"ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasmodesma [GO:0009506]; vacuole [GO:0005773]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp686013_c0_seq1;GAXK01140096.1;Q5T6J7;2.03E-42;GNTK_HUMAN;Probable gluconokinase (EC 2.7.1.12) (Gluconate kinase);"ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]; D-gluconate catabolic process [GO:0046177]";"GO:0005524; GO:0046177; GO:0046316";D-gluconate catabolic process [GO:0046177];;"ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]"
comp6860278_c0_seq1;GAXK01095360.1;P81018;1.26E-11;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp686033_c0_seq1;GAXK01140062.1;B0WC46;1.07E-64;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp686091_c0_seq1;GAXK01140045.1;Q61321;3.88E-73;SIX4_MOUSE;Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]";"GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007519; GO:0008582; GO:0008584; GO:0010468; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043565; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0045944; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048704; GO:0048856; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725";"anatomical structure development [GO:0048856]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6861601_c0_seq1;GAXK01095356.1;Q8N4W9;1.61E-13;ZN808_HUMAN;Zinc finger protein 808;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6861696_c0_seq1;GAXK01095358.1;Q8K2J0;5.75E-18;PLCD3_MOUSE;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3);"cleavage furrow [GO:0032154]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; angiogenesis [GO:0001525]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127]";"GO:0001525; GO:0004435; GO:0005829; GO:0016020; GO:0016042; GO:0032154; GO:0032959; GO:0035556; GO:0042127; GO:0046872; GO:0060716";"angiogenesis [GO:0001525]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127]";"cleavage furrow [GO:0032154]; cytosol [GO:0005829]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp6862134_c0_seq1;GAXK01163936.1;Q9LF30;1.01E-47;RS192_ARATH;40S ribosomal protein S19-2;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0009506; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp686235_c0_seq1;GAXK01140051.1;Q7KRI2;1.41E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp6862560_c0_seq1;GAXK01163935.1;O95573;6.12E-16;ACSL3_HUMAN;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp6862701_c0_seq1;GAXK01163931.1;P17970;6.00E-21;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp6863164_c0_seq1;GAXK01163941.1;P57747;5.53E-25;VATD_SUBDO;V-type proton ATPase subunit D (V-ATPase subunit D) (Vacuolar proton pump subunit D);"ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]";"GO:0006811; GO:0042626";ion transport [GO:0006811];;ATPase-coupled transmembrane transporter activity [GO:0042626]
comp68633_c0_seq1;GAXK01006058.1;O61661;1.10E-97;CHK1_DROME;Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]";"GO:0000077; GO:0001700; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007050; GO:0007093; GO:0007348; GO:0007349; GO:0007444; GO:0009314; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299";"cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp6863315_c0_seq1;GAXK01163939.1;P18761;5.20E-11;CAH6_MOUSE;Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730]";"GO:0001580; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0006730; GO:0008270";"detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp686412_c0_seq1;GAXK01140078.1;Q9UJU3;7.18E-30;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp68647_c4_seq1;GAXK01006050.1;Q6GLK6;2.06E-98;ACSF3_XENLA;Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0005739; GO:0006631; GO:0016874";fatty acid metabolic process [GO:0006631];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; ligase activity [GO:0016874]"
comp6865_c0_seq1;GAXK01100027.1;Q14677;5.11E-69;EPN4_HUMAN;Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR);"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]";"GO:0005654; GO:0005794; GO:0005829; GO:0006897; GO:0008289; GO:0016020; GO:0030136; GO:0030276; GO:0043231; GO:0045296; GO:0048268; GO:0048471";"clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]";"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]";"cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]"
comp6865003_c0_seq1;GAXK01155180.1;A2CI56;3.29E-37;EFTU_CHLAT;Elongation factor Tu, chloroplastic (EF-Tu);"chloroplast [GO:0009507]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0009507";;chloroplast [GO:0009507];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp686524_c0_seq1;GAXK01140087.1;P54281;1.48E-30;CLCA1_BOVIN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005887; GO:0006816; GO:0008237; GO:0016324; GO:0046872";calcium ion transport [GO:0006816];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp68653_c0_seq1;GAXK01006707.1;Q9H9Y6;4.19E-168;RPA2_HUMAN;DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0003677; GO:0003899; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0006361; GO:0006362; GO:0006363; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0045815; GO:0046872";"embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]"
comp68656_c0_seq1;GAXK01006572.1;A4IF63;2.28E-56;TRIM2_BOVIN;Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2);"cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";"GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]";cytoplasm [GO:0005737];"ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp686563_c1_seq1;GAXK01140079.1;P15428;9.35E-07;PGDH_HUMAN;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001822; GO:0003824; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0019372; GO:0030728; GO:0032355; GO:0032496; GO:0042759; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070062; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:2001301";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]"
comp6865921_c0_seq1;GAXK01155183.1;Q8UAA8;1.19E-17;BIGR_AGRFC;Biofilm growth-associated repressor;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700";;;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp6868047_c0_seq1;GAXK01102301.1;Q43291;7.84E-38;RL211_ARATH;60S ribosomal protein L21-1;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005576; GO:0005730; GO:0006412; GO:0022625; GO:0022626";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]";structural constituent of ribosome [GO:0003735]
comp6868353_c0_seq1;GAXK01102307.1;A8MYZ0;8.87E-09;MIY4B_HUMAN;Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2);protein K48-linked deubiquitination [GO:0071108];GO:0071108;protein K48-linked deubiquitination [GO:0071108];;
comp68684_c0_seq1;GAXK01006127.1;O95551;2.06E-80;TYDP2_HUMAN;Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase);"aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]; cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666]";"GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260";"cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666]";"aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]"
comp68688_c2_seq1;GAXK01005924.1;Q3UHD2;9.18E-91;GFOD1_MOUSE;Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-);"extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]";"GO:0005576; GO:0016491";;extracellular region [GO:0005576];oxidoreductase activity [GO:0016491]
comp6868888_c0_seq1;GAXK01102303.1;A1K9L8;3.34E-15;SYV_AZOSB;Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS);"cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438";valyl-tRNA aminoacylation [GO:0006438];cytoplasm [GO:0005737];"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]"
comp6871462_c0_seq1;GAXK01188872.1;O13769;1.36E-07;ULP2_SCHPO;Ubiquitin-like-specific protease 2 (EC 3.4.22.-);"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"GO:0005634; GO:0010494; GO:0016926; GO:0070140; GO:0070647; GO:2000765";"protein desumoylation [GO:0016926]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of cytoplasmic translation [GO:2000765]";"cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp687157_c0_seq1;GAXK01140090.1;P09102;5.27E-37;PDIA1_CHICK;Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (Retina cognin) (R-cognin);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0009897; GO:0034976; GO:0045454";"cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]";protein disulfide isomerase activity [GO:0003756]
comp6871655_c0_seq1;GAXK01188865.1;P04052;8.05E-21;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp68726_c0_seq1;GAXK01006573.1;P69097;2.55E-49;CALM_TRYBB;Calmodulin (CaM);"axoneme [GO:0005930]; cilium [GO:0005929]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0005929; GO:0005930; GO:0019722";calcium-mediated signaling [GO:0019722];"axoneme [GO:0005930]; cilium [GO:0005929]";calcium ion binding [GO:0005509]
comp687272_c1_seq1;GAXK01140066.1;Q9VZX1;9.19E-28;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp68737_c0_seq1;GAXK01006550.1;P79293;7.36E-57;MYH7_PIG;Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta);"myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0030017; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp687402_c0_seq1;GAXK01140050.1;Q84MN0;3.52E-15;CML4_ORYSJ;Calmodulin-like protein 4;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp6875_c0_seq1;GAXK01100994.1;P14315;1.54E-170;CAPZB_CHICK;F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2);"brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]";"GO:0000902; GO:0005829; GO:0005903; GO:0007010; GO:0008290; GO:0010591; GO:0014069; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030032; GO:0030036; GO:0030863; GO:0051015; GO:0051016; GO:0051490; GO:0098685; GO:0098686";"actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]";"brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018]";actin filament binding [GO:0051015]
comp68752_c1_seq1;GAXK01006704.1;Q5R533;1.11E-132;SERC3_PONAB;Serine incorporator 3;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016021; GO:0045087; GO:0051607; GO:1902237";"defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp687537_c0_seq1;GAXK01140105.1;Q7Z0G7;6.01E-64;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp68757_c0_seq1;GAXK01006903.1;Q5RCE0;7.53E-57;GPDA_PONAB;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8);"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophosphate shuttle [GO:0006127]; positive regulation of glycolytic process [GO:0045821]";"GO:0004367; GO:0006094; GO:0006127; GO:0009331; GO:0042803; GO:0045821; GO:0046168; GO:0051287; GO:0071320; GO:0071356";"cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophosphate shuttle [GO:0006127]; positive regulation of glycolytic process [GO:0045821]";glycerol-3-phosphate dehydrogenase complex [GO:0009331];"glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]"
comp687648_c0_seq1;GAXK01140097.1;Q01603;9.27E-103;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp687697_c2_seq1;GAXK01140040.1;Q717B4;2.09E-07;TDPZ3_MOUSE;TD and POZ domain-containing protein 3;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp687815_c1_seq1;GAXK01140046.1;Q3TTY0;6.55E-67;PLB1_MOUSE;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp687928_c0_seq1;GAXK01140060.1;O88898;6.04E-32;P63_MOUSE;Tumor protein 63 (p63) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; multicellular organism aging [GO:0010259]; multicellular organism development [GO:0007275]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"GO:0000122; GO:0000790; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0001738; GO:0001942; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007275; GO:0007283; GO:0007389; GO:0007499; GO:0007569; GO:0008283; GO:0008544; GO:0009887; GO:0009913; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0019904; GO:0030154; GO:0030216; GO:0030326; GO:0030425; GO:0030850; GO:0030855; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043005; GO:0043281; GO:0043565; GO:0043589; GO:0043616; GO:0044212; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048646; GO:0048807; GO:0050699; GO:0051289; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:0098773; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773; GO:2001235";"anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermal cell differentiation [GO:0009913]; epidermal cell division [GO:0010481]; epidermis development [GO:0008544]; epithelial cell development [GO:0002064]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; morphogenesis of a polarized epithelium [GO:0001738]; multicellular organism aging [GO:0010259]; multicellular organism development [GO:0007275]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostate gland development [GO:0030850]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin epidermis development [GO:0098773]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]";"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]"
comp687956_c1_seq1;GAXK01140104.1;P42787;6.45E-87;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp6879597_c0_seq1;GAXK01095046.1;O44105;1.63E-78;G3P2_DROSU;Glyceraldehyde-3-phosphate dehydrogenase 2 (EC 1.2.1.12) (Glyceraldehyde-3-phosphate dehydrogenase II) (GAPDH II) (Fragment);"cytoplasm [GO:0005737]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";"GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]";cytoplasm [GO:0005737];"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp6880160_c0_seq1;GAXK01154825.1;F7J220;2.07E-14;SRCR1_PATPE;Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087";"innate immune response [GO:0045087]; phagocytosis [GO:0006909]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]";scavenger receptor activity [GO:0005044]
comp68819_c0_seq1;GAXK01006153.1;Q53FA7;2.61E-102;QORX_HUMAN;Quinone oxidoreductase PIG3 (EC 1.-.-.-) (Tumor protein p53-inducible protein 3) (p53-induced gene 3 protein);"cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]";"GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0042981; GO:0048038; GO:0070402";"NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]";cytosol [GO:0005829];"NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]"
comp688229_c0_seq1;GAXK01061338.1;Q6GN68;2.35E-17;SMY2B_XENLA;N-lysine methyltransferase SMYD2-B (EC 2.1.1.-) (Histone methyltransferase SMYD2-B) (EC 2.1.1.43) (SET and MYND domain-containing protein 2B);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0043516; GO:0046872; GO:0046975";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp68825_c3_seq1;GAXK01006574.1;Q8IWZ3;1.12E-28;ANKH1_HUMAN;Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK);"cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]";"GO:0003723; GO:0005737; GO:0045087";innate immune response [GO:0045087];cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp6882826_c0_seq1;GAXK01078319.1;Q9VC99;1.50E-08;UCK_DROME;Uridine-cytidine kinase (UCK) (EC 2.7.1.48) (Cytidine monophosphokinase) (Uridine monophosphokinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp6883286_c0_seq1;GAXK01078327.1;Q9VZS5;2.74E-24;RL28_DROME;60S ribosomal protein L28;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp688393_c0_seq1;GAXK01061321.1;O60494;9.94E-08;CUBN_HUMAN;Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062";"cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp688548_c0_seq1;GAXK01061337.1;B3EWZ5;3.35E-53;MLRP1_ACRMI;MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp688572_c0_seq1;GAXK01061342.1;P16112;1.87E-17;PGCA_HUMAN;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982";"cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]";"carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]"
comp6886360_c0_seq1;GAXK01039373.1;Q9P7I2;4.78E-08;KCC1_SCHPO;Calcium/calmodulin-dependent protein kinase type I (CaMK-I) (EC 2.7.11.17);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; negative regulation of calcineurin-mediated signaling [GO:0106057]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]";"GO:0000122; GO:0004672; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005829; GO:0010621; GO:0010972; GO:0034599; GO:0071277; GO:0106057";"cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; negative regulation of calcineurin-mediated signaling [GO:0106057]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein kinase activity [GO:0004672]"
comp68864_c0_seq1;GAXK01006100.1;Q9VBW3;4.02E-157;CAD96_DROME;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0008284; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp6887079_c0_seq1;GAXK01039381.1;Q24537;4.62E-07;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp68892_c0_seq1;GAXK01006813.1;A5D7E2;3.46E-31;TM9S4_BOVIN;Transmembrane 9 superfamily member 4;"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010";"cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp689072_c0_seq1;GAXK01061332.1;Q922B1;9.41E-58;MACD1_MOUSE;ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.5.1.-) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"GO:0005634; GO:0005654; GO:0005739; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]"
comp6890987_c0_seq1;GAXK01081703.1;A1WJU9;3.56E-48;LNT_VEREI;Apolipoprotein N-acyltransferase (ALP N-acyltransferase) (EC 2.3.1.269);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; N-acyltransferase activity [GO:0016410]; lipoprotein biosynthetic process [GO:0042158]";"GO:0005886; GO:0016021; GO:0016410; GO:0042158";lipoprotein biosynthetic process [GO:0042158];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";N-acyltransferase activity [GO:0016410]
comp68931_c0_seq1;GAXK01006511.1;Q9GZS1;8.53E-12;RPA49_HUMAN;DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53);"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA polymerase I preinitiation complex assembly [GO:0001188]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006362; GO:0006363; GO:0042790; GO:0045815";"nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA polymerase I preinitiation complex assembly [GO:0001188]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]"
comp689497_c0_seq1;GAXK01061325.1;Q90WR8;4.32E-56;SP3_CHICK;Transcription factor Sp3;"nucleus [GO:0005634]; PML body [GO:0016605]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]";"GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0003682; GO:0005634; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060216";"B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]";"nucleus [GO:0005634]; PML body [GO:0016605]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp6895028_c0_seq1;GAXK01012160.1;Q59RR3;9.39E-12;MNL1_CANAL;Transcriptional regulator MNL1 (MSN2- and MSN4-like protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to acetate [GO:0071311]; cellular response to drug [GO:0035690]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]";"GO:0003677; GO:0005634; GO:0035690; GO:0043618; GO:0046872; GO:0071311";"cellular response to acetate [GO:0071311]; cellular response to drug [GO:0035690]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp68961_c1_seq1;GAXK01006096.1;P21927;2.99E-76;CHLE_RABIT;Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase);"extracellular region [GO:0005576]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]";"GO:0003990; GO:0004104; GO:0005576";;extracellular region [GO:0005576];"acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]"
comp689619_c0_seq1;GAXK01061331.1;Q9CPW0;2.39E-12;CNTP2_MOUSE;Contactin-associated protein-like 2 (Cell recognition molecule Caspr2);"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]";"GO:0002020; GO:0005769; GO:0005794; GO:0005886; GO:0007155; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0021761; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0033270; GO:0035176; GO:0042297; GO:0043025; GO:0044224; GO:0044325; GO:0045163; GO:0048812; GO:0071205; GO:0071625; GO:0097060";"adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]";"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]";"enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]"
comp689868_c0_seq1;GAXK01061293.1;Q5QQ53;2.32E-21;XYLT_DROPS;Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]"
comp68991_c1_seq1;GAXK01006894.1;D2H3M0;1.92E-17;TDRD5_AILME;Tudor domain-containing protein 5;"chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546";"DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]";"chromatoid body [GO:0033391]; pi-body [GO:0071546]";
comp69_c1_seq1;GAXK01169411.1;Q24756;3.20E-32;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp690_c6_seq1;GAXK01166093.1;P55861;0;MCM2_XENLA;DNA replication licensing factor mcm2 (EC 3.6.4.12) (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112);"chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872; GO:1905775";"cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]";"chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"
comp6902079_c0_seq1;GAXK01172357.1;Q9LHQ6;5.59E-10;OCT4_ARATH;Organic cation/carnitine transporter 4 (AtOCT4);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]; cellular response to water deprivation [GO:0042631]; ion transport [GO:0006811]";"GO:0005524; GO:0006811; GO:0009535; GO:0009705; GO:0016021; GO:0022857; GO:0042631";"cellular response to water deprivation [GO:0042631]; ion transport [GO:0006811]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]";"ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]"
comp6903_c10_seq1;GAXK01100780.1;Q05319;1.79E-78;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp690437_c0_seq1;GAXK01191241.1;Q8NE22;1.68E-66;SETD9_HUMAN;SET domain-containing protein 9 (EC 2.1.1.-);"nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0005654; GO:0016278; GO:1901796";regulation of signal transduction by p53 class mediator [GO:1901796];nucleoplasm [GO:0005654];lysine N-methyltransferase activity [GO:0016278]
comp690450_c1_seq1;GAXK01191182.1;Q5DTI8;6.96E-34;ESYT3_MOUSE;Extended synaptotagmin-3 (E-Syt3);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268";"endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp690458_c0_seq1;GAXK01191198.1;Q6IQP3;4.55E-40;CALUA_DANRE;Calumenin-A;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";calcium ion binding [GO:0005509]
comp6905160_c0_seq1;GAXK01196962.1;Q9LR33;2.48E-45;R27A2_ARATH;60S ribosomal protein L27a-2;"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; structural constituent of ribosome [GO:0003735]; flower development [GO:0009908]; inflorescence development [GO:0010229]; post-embryonic development [GO:0009791]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005730; GO:0006412; GO:0009506; GO:0009791; GO:0009908; GO:0010229; GO:0022625; GO:0022626";"flower development [GO:0009908]; inflorescence development [GO:0010229]; post-embryonic development [GO:0009791]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]";structural constituent of ribosome [GO:0003735]
comp6905562_c0_seq1;GAXK01196967.1;O43613;1.12E-07;OX1R_HUMAN;Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0007268; GO:0007631; GO:0016499; GO:0017046; GO:0051480; GO:0070374";"chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]"
comp69057_c0_seq1;GAXK01006551.1;Q3T0Q4;6.90E-60;NDKB_BOVIN;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; transcription coactivator activity [GO:0003713]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0009142; GO:0019003; GO:0030027; GO:0043066; GO:0045618; GO:0045893; GO:0045944; GO:0046872; GO:0050679; GO:0051880; GO:0071944";"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; transcription coactivator activity [GO:0003713]"
comp69058_c0_seq1;GAXK01006059.1;Q5RFR0;1.22E-58;TTPAL_PONAB;Alpha-tocopherol transfer protein-like;;;;;
comp69060_c4_seq1;GAXK01204987.1;Q28BP9;4.37E-85;FAF2_XENTR;FAS-associated factor 2 (UBX domain-containing protein 8);"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]";"GO:0005783; GO:0005811";;"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]";
comp69074_c0_seq1;GAXK01006553.1;P48611;7.19E-42;PTPS_DROME;6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12) (Protein purple) (Sepiapterin synthase A);"mitochondrion [GO:0005739]; 6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; metal ion binding [GO:0046872]; pteridine biosynthetic process [GO:0006728]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"GO:0003874; GO:0005739; GO:0006728; GO:0006729; GO:0046872";"pteridine biosynthetic process [GO:0006728]; tetrahydrobiopterin biosynthetic process [GO:0006729]";mitochondrion [GO:0005739];"6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; metal ion binding [GO:0046872]"
comp690748_c1_seq1;GAXK01191180.1;O54963;8.80E-16;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp6908001_c0_seq1;GAXK01037708.1;Q9C505;1.09E-24;IF5A3_ARATH;Eukaryotic translation initiation factor 5A-3 (AtELF5A-3) (eIF-5A-3);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003743; GO:0003746; GO:0005739; GO:0005829; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp69087_c0_seq1;GAXK01006080.1;Q9UI26;0;IPO11_HUMAN;Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]";"GO:0001650; GO:0005634; GO:0005635; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608";"protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]";"nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]"
comp6909_c0_seq1;GAXK01100176.1;Q8MJV1;6.56E-49;MYH2_HORSE;Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain, skeletal muscle, adult 2);"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp69098_c1_seq1;GAXK01006087.1;Q99766;6.34E-37;ATP5S_HUMAN;ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B);"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"GO:0005743; GO:0006754; GO:0015078; GO:0042407; GO:0042776; GO:0045263; GO:0046872; GO:1902600";"ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]";"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]";"metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078]"
comp691_c0_seq1;GAXK01170208.1;P60510;0;PP4C_HUMAN;Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X);"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569]";"GO:0004704; GO:0004722; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0010569; GO:0030289; GO:0046872";regulation of double-strand break repair via homologous recombination [GO:0010569];"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]";"metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]"
comp6910093_c0_seq1;GAXK01069837.1;P52715;5.97E-24;CTS12_CAEEL;Serine carboxypeptidase ctsa-1.2 (EC 3.4.16.-);"serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004185; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];;serine-type carboxypeptidase activity [GO:0004185]
comp6911_c0_seq1;GAXK01101283.1;Q3TZI6;3.56E-28;CCNJ_MOUSE;Cyclin-J;"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0016538; GO:0019901; GO:0044772";"mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]"
comp69110_c1_seq1;GAXK01006811.1;Q9H6R6;3.68E-88;ZDHC6_HUMAN;Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp691140_c0_seq1;GAXK01191195.1;Q14CB8;1.04E-26;RHG19_HUMAN;Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0043231; GO:0051056";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTPase activator activity [GO:0005096]
comp6911451_c0_seq1;GAXK01069843.1;Q95SX7;4.26E-09;RTBS_DROME;Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp691290_c0_seq1;GAXK01191214.1;Q8SWR3;8.69E-09;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp6913004_c0_seq1;GAXK01123054.1;P09446;1.22E-34;HSP7A_CAEEL;Heat shock 70 kDa protein A;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0008340; GO:0009408; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042147; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp69132_c0_seq1;GAXK01006116.1;Q8N4B1;4.04E-30;SESQ1_HUMAN;Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1);"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037";"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]";"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";protein homodimerization activity [GO:0042803]
comp69142_c0_seq1;GAXK01204981.1;Q94527;3.02E-59;NFKB1_DROME;"Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]";"GO:0000981; GO:0001228; GO:0002230; GO:0003677; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0043565; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:0061059; GO:1901224; GO:2000647";"cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]"
comp6914506_c0_seq1;GAXK01136013.1;Q9SAL0;8.39E-12;RGLG4_ARATH;E3 ubiquitin-protein ligase RGLG4 (EC 2.3.2.27) (RING domain ligase 4);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; response to wounding [GO:0009611]";"GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0009611; GO:0009867; GO:0042742; GO:0046872";"defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; response to wounding [GO:0009611]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp6915063_c0_seq1;GAXK01136018.1;Q9R0Y1;5.27E-09;ASIC5_MOUSE;Acid-sensing ion channel 5 (ASIC5) (Amiloride-sensitive cation channel 5) (Brain-liver-intestine amiloride-sensitive Na(+) channel) (BLINaC);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; sodium ion transmembrane transport [GO:0035725]";"GO:0005272; GO:0005886; GO:0015252; GO:0015280; GO:0016020; GO:0016021; GO:0035725";sodium ion transmembrane transport [GO:0035725];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]"
comp691531_c0_seq1;GAXK01191210.1;Q6NLL1;5.59E-46;Y1411_DROME;WD repeat-containing protein CG11141;;;;;
comp69159_c0_seq1;GAXK01006157.1;Q5VV67;3.46E-20;PPRC1_HUMAN;Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0007005; GO:0008134; GO:0030374; GO:0045944; GO:0051091";"mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]"
comp6916208_c0_seq1;GAXK01124306.1;Q2N8Z2;3.62E-33;ATPB_ERYLH;ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta);"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005886; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp69168_c1_seq1;GAXK01006552.1;Q13884;5.38E-73;SNTB1_HUMAN;Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936]";"GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202";muscle contraction [GO:0006936];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]";"actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]"
comp691718_c0_seq1;GAXK01191200.1;Q9H0J4;1.27E-09;QRIC2_HUMAN;Glutamine-rich protein 2;"sperm flagellum [GO:0036126]; cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]";"GO:0030031; GO:0030317; GO:0036126; GO:2000059";"cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]";sperm flagellum [GO:0036126];
comp6917242_c0_seq1;GAXK01124303.1;Q9HAR2;5.01E-09;AGRL3_HUMAN;Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp691873_c0_seq1;GAXK01191220.1;O88870;1.12E-52;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp69212_c0_seq1;GAXK01007107.1;O60688;2.87E-68;YPEL1_HUMAN;Protein yippee-like 1;"nucleus [GO:0005634]; metal ion binding [GO:0046872]";"GO:0005634; GO:0046872";;nucleus [GO:0005634];metal ion binding [GO:0046872]
comp69213_c22_seq1;GAXK01006962.1;Q9VVY3;4.69E-12;GBS76_DROME;Glycogen-binding subunit 76A (CBM21 domain-containing protein CG9619);protein phosphatase 1 binding [GO:0008157];GO:0008157;;;protein phosphatase 1 binding [GO:0008157]
comp692153_c0_seq1;GAXK01133491.1;Q10904;6.75E-13;YWO1_CAEEL;Probable G-protein coupled receptor AH9.1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]";"GO:0004930; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp692162_c3_seq1;GAXK01133515.1;Q80UG8;5.06E-32;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp692288_c0_seq1;GAXK01133496.1;Q8T3Y0;5.82E-08;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp692333_c1_seq1;GAXK01133469.1;G5EGL9;7.22E-07;AFF1_CAEEL;Cell fusion protein aff-1 (Anchor cell fusion failure protein 1);"apical plasma membrane [GO:0016324]; cell-cell contact zone [GO:0044291]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]; regulation of oviposition [GO:0046662]; syncytium formation by plasma membrane fusion [GO:0000768]";"GO:0000768; GO:0005576; GO:0005886; GO:0007275; GO:0016021; GO:0016324; GO:0043229; GO:0044291; GO:0046662";"multicellular organism development [GO:0007275]; regulation of oviposition [GO:0046662]; syncytium formation by plasma membrane fusion [GO:0000768]";"apical plasma membrane [GO:0016324]; cell-cell contact zone [GO:0044291]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";
comp69236_c0_seq1;GAXK01007015.1;Q9D0B5;2.98E-24;TSTD3_MOUSE;Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3);thiosulfate sulfurtransferase activity [GO:0004792];GO:0004792;;;thiosulfate sulfurtransferase activity [GO:0004792]
comp692469_c0_seq1;GAXK01133424.1;Q8IN81;1.79E-12;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp692476_c0_seq1;GAXK01133488.1;Q9W0T5;0;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp69252_c2_seq1;GAXK01006874.1;Q96LT4;3.00E-130;SAMD8_HUMAN;Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303";"ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]"
comp692573_c1_seq1;GAXK01133403.1;Q96PQ7;1.44E-49;KLHL5_HUMAN;Kelch-like protein 5;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]";"GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687";post-translational protein modification [GO:0043687];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";actin binding [GO:0003779]
comp692586_c1_seq1;GAXK01133504.1;A2T7F3;7.09E-23;HXA7_PANTR;Homeobox protein Hox-A7;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; anterior/posterior pattern specification [GO:0009952]";"GO:0000980; GO:0003700; GO:0005634; GO:0009952";anterior/posterior pattern specification [GO:0009952];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]"
comp692772_c0_seq1;GAXK01133508.1;Q01714;1.55E-25;SP1_RAT;Transcription factor Sp1;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]";"GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0017053; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0042803; GO:0042826; GO:0043536; GO:0043565; GO:0043923; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0070491; GO:0071837; GO:1904828; GO:1905564";"cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp692857_c0_seq1;GAXK01133527.1;Q539E5;4.80E-38;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp692858_c0_seq1;GAXK01133507.1;Q01758;4.24E-15;ISP2_OSMMO;Type-2 ice-structuring protein (Type II antifreeze protein) (AFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp692887_c0_seq1;GAXK01133420.1;O46040;8.98E-27;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp692905_c1_seq1;GAXK01133521.1;O16011;1.44E-13;MBL_DROME;Protein muscleblind (Protein mindmelt);"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"GO:0000381; GO:0001654; GO:0001751; GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007517; GO:0007601; GO:0010468; GO:0030018; GO:0031673; GO:0042052; GO:0045924; GO:0046716; GO:0046872; GO:0048471; GO:0050896";"apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]"
comp6929827_c0_seq1;GAXK01081735.1;P21158;6.27E-21;CSGA_MYXXA;C-factor (C signal);"extracellular region [GO:0005576]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005576; GO:0030435";sporulation resulting in formation of a cellular spore [GO:0030435];extracellular region [GO:0005576];
comp6930242_c0_seq1;GAXK01068729.1;Q24180;3.02E-17;DEAF1_DROME;Deformed epidermal autoregulatory factor 1 (Protein DEAF-1);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776";"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp69303_c2_seq1;GAXK01006544.1;Q8CGC6;1.61E-56;RBM28_MOUSE;RNA-binding protein 28 (RNA-binding motif protein 28);"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380; GO:1990904";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";RNA binding [GO:0003723]
comp6931754_c0_seq1;GAXK01068724.1;Q5JWF2;7.57E-31;GNAS1_HUMAN;Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas);"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]";"GO:0001664; GO:0001894; GO:0001958; GO:0003924; GO:0005159; GO:0005525; GO:0005829; GO:0005834; GO:0006112; GO:0006306; GO:0007188; GO:0007189; GO:0007191; GO:0010856; GO:0016020; GO:0016324; GO:0030425; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035116; GO:0035255; GO:0035264; GO:0040032; GO:0043588; GO:0045669; GO:0045672; GO:0046872; GO:0048589; GO:0048701; GO:0051216; GO:0051430; GO:0060348; GO:0070062; GO:0070527; GO:0071514; GO:0120162; GO:2000828";"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]";"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]";"adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]"
comp6932214_c0_seq1;GAXK01078050.1;Q7TN88;7.73E-10;PK1L2_MOUSE;Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]";"GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982";detection of mechanical stimulus [GO:0050982];"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]"
comp693280_c1_seq1;GAXK01133524.1;P10076;2.49E-44;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp693285_c1_seq1;GAXK01133455.1;Q6DCX2;1.53E-12;AGO2_XENLA;Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer);"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000340; GO:0000932; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153";"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]";"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"
comp69330_c4_seq1;GAXK01006150.1;Q07864;0;DPOE1_HUMAN;DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A);"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539";"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]";"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"
comp693464_c0_seq1;GAXK01133489.1;Q95L87;8.78E-08;STF1_MACEU;Steroidogenic factor 1 (SF-1) (STF-1) (Nuclear receptor subfamily 5 group A member 1);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; lipid binding [GO:0008289]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]";"GO:0003700; GO:0003707; GO:0005634; GO:0007530; GO:0008270; GO:0008289; GO:0008584; GO:0008585; GO:0010628; GO:0043565";"female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; lipid binding [GO:0008289]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp693499_c0_seq1;GAXK01133493.1;P10447;1.51E-19;ABL_FSVHY;Tyrosine-protein kinase transforming protein Abl (EC 2.7.10.2) (V-abl);"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]";"GO:0004715; GO:0005524";;;"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]"
comp693514_c1_seq1;GAXK01133401.1;Q6NXH8;7.12E-37;MET25_MOUSE;Methyltransferase-like protein 25 (EC 2.1.1.-);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp69354_c0_seq1;GAXK01006602.1;P91928;5.85E-45;MIC60_DROME;MICOS complex subunit Mic60;"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]";"GO:0005737; GO:0005739; GO:0005743; GO:0007005; GO:0016021; GO:0019901; GO:0043008; GO:0070584";"mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]"
comp6936740_c0_seq1;GAXK01117075.1;Q1LRB3;3.29E-41;PUR9_CUPMC;"Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]";"IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]";"GO:0003937; GO:0004643; GO:0006189";'de novo' IMP biosynthetic process [GO:0006189];;"IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]"
comp6937_c1_seq1;GAXK01100177.1;Q68EW0;0;OGDHL_XENLA;2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.-) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like);"mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";"GO:0004591; GO:0005759; GO:0006096; GO:0006099; GO:0030976; GO:0046872";"glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];"metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]"
comp69387_c1_seq1;GAXK01006953.1;O97422;3.99E-85;B3GI_DROME;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase I) (Glucuronosyltransferase I) (DmGlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0030206; GO:0046872; GO:0050650";"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]"
comp694025_c1_seq1;GAXK01164499.1;P37288;7.89E-15;V1AR_HUMAN;Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor);"endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]; activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]";"GO:0001992; GO:0002125; GO:0003084; GO:0005000; GO:0005080; GO:0005768; GO:0005886; GO:0005887; GO:0006091; GO:0007186; GO:0007202; GO:0007204; GO:0007621; GO:0007625; GO:0008015; GO:0008284; GO:0010460; GO:0014049; GO:0014902; GO:0017046; GO:0019722; GO:0021537; GO:0030307; GO:0031394; GO:0031894; GO:0032849; GO:0032870; GO:0035176; GO:0035815; GO:0042631; GO:0042711; GO:0042713; GO:0043084; GO:0045907; GO:0051412; GO:0051970";"activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; generation of precursor metabolites and energy [GO:0006091]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]";"endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]"
comp6940952_c0_seq1;GAXK01034622.1;Q9P7W3;1.29E-51;ACL1_SCHPO;Probable ATP-citrate synthase subunit 1 (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase 1) (Citrate cleavage enzyme subunit 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]";"GO:0003878; GO:0005524; GO:0005634; GO:0005829; GO:0006085; GO:0006091; GO:0006101; GO:0006629; GO:0046872; GO:0048037";"acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]"
comp694106_c0_seq1;GAXK01164532.1;P43295;5.51E-39;RD19B_ARATH;Probable cysteine protease RD19B (EC 3.4.22.-) (RD19-like protein 1) (Thiol protease A1494);"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0000323; GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]";cysteine-type endopeptidase activity [GO:0004197]
comp694137_c0_seq1;GAXK01164526.1;Q5SRE7;4.01E-12;PHYD1_HUMAN;Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-);"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]";"GO:0046872; GO:0051213";;;"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp6941660_c0_seq1;GAXK01034621.1;Q5XIS9;6.05E-12;KPCD2_RAT;Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; T cell receptor signaling pathway [GO:0050852]";"GO:0001525; GO:0001938; GO:0002250; GO:0004697; GO:0005080; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0070374; GO:0089700; GO:1901727; GO:2000573";"adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; T cell receptor signaling pathway [GO:0050852]";"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]"
comp6943005_c0_seq1;GAXK01069000.1;O34748;6.86E-09;RECQ_BACSU;Probable ATP-dependent DNA helicase RecQ (EC 3.6.4.12);"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0030894; GO:0032508; GO:0043138; GO:0043590";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]";"bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]";"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp6943621_c0_seq1;GAXK01068997.1;Q99315;4.33E-09;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp694400_c0_seq1;GAXK01164514.1;P08048;1.04E-17;ZFY_HUMAN;Zinc finger Y-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005654; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp694583_c0_seq1;GAXK01164513.1;Q91610;4.08E-19;DHHA_XENLA;"Desert hedgehog protein A (Cephalic hedgehog protein) (Desert hedgehog protein 1) (DHH-1) (X-CHH) [Cleaved into: Desert hedgehog protein A N-product; Desert hedgehog protein A C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0016539; GO:0046872";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp69467_c1_seq1;GAXK01006603.1;Q8IUQ4;1.83E-20;SIAH1_HUMAN;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell cycle [GO:0007049]; cellular protein metabolic process [GO:0044267]; negative regulation of netrin-activated signaling pathway [GO:1902842]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0007049; GO:0007283; GO:0007399; GO:0007411; GO:0008022; GO:0008270; GO:0009653; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0042802; GO:0043065; GO:0043161; GO:0044267; GO:0051402; GO:0061630; GO:1902842; GO:2001244";"anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell cycle [GO:0007049]; cellular protein metabolic process [GO:0044267]; negative regulation of netrin-activated signaling pathway [GO:1902842]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp69475_c4_seq1;GAXK01006520.1;Q10715;1.42E-138;ACE_HAEIX;Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II);"extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]";"GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872";;"extracellular space [GO:0005615]; membrane [GO:0016020]";"carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]"
comp6951558_c0_seq1;GAXK01062070.1;Q142P6;1.97E-14;MSBA_PARXL;Lipid A export ATP-binding/permease protein MsbA (EC 7.5.2.6);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]"
comp695177_c0_seq1;GAXK01164501.1;Q9N1F5;3.89E-26;GSTO1_PIG;Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; L-ascorbic acid metabolic process [GO:0019852]; oxidation-reduction process [GO:0055114]; xenobiotic catabolic process [GO:0042178]";"GO:0004364; GO:0005737; GO:0005829; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0071243";"cellular response to arsenic-containing substance [GO:0071243]; L-ascorbic acid metabolic process [GO:0019852]; oxidation-reduction process [GO:0055114]; xenobiotic catabolic process [GO:0042178]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]"
comp69527_c1_seq1;GAXK01005839.1;Q96KE9;9.46E-07;BTBD6_HUMAN;BTB/POZ domain-containing protein 6 (Lens BTB domain protein);"cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";"GO:0005829; GO:0022008; GO:0043687";"neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]";cytosol [GO:0005829];
comp695483_c0_seq1;GAXK01164516.1;Q14586;3.05E-14;ZN267_HUMAN;Zinc finger protein 267 (Zinc finger protein HZF2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]";"GO:0000981; GO:0003677; GO:0005634; GO:0007275; GO:0046872";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp69549_c2_seq1;GAXK01006787.1;Q9D4H9;1.49E-112;PHF14_MOUSE;PHD finger protein 14;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0005634; GO:0008285; GO:0046872; GO:0048286; GO:0072201; GO:2000584; GO:2000791";"lung alveolus development [GO:0048286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];metal ion binding [GO:0046872]
comp6954914_c0_seq1;GAXK01123357.1;G3V801;7.04E-09;NETR_RAT;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195";"exocytosis [GO:0006887]; zymogen activation [GO:0031638]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp69556_c1_seq1;GAXK01006097.1;Q5ZKV8;2.58E-146;KIF2A_CHICK;Kinesin-like protein KIF2A;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301";"cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp6956079_c0_seq1;GAXK01075997.1;Q9ZS34;3.35E-55;CHLP_TOBAC;Geranylgeranyl diphosphate reductase, chloroplastic (EC 1.3.1.83) (Geranylgeranyl reductase);"chloroplast [GO:0009507]; FAD binding [GO:0071949]; geranylgeranyl diphosphate reductase activity [GO:0102067]; geranylgeranyl reductase activity [GO:0045550]; chlorophyll biosynthetic process [GO:0015995]; geranylgeranyl diphosphate metabolic process [GO:0033385]; photosynthesis [GO:0015979]; phytyl diphosphate biosynthetic process [GO:0033521]; vitamin E biosynthetic process [GO:0010189]";"GO:0009507; GO:0010189; GO:0015979; GO:0015995; GO:0033385; GO:0033521; GO:0045550; GO:0071949; GO:0102067";"chlorophyll biosynthetic process [GO:0015995]; geranylgeranyl diphosphate metabolic process [GO:0033385]; photosynthesis [GO:0015979]; phytyl diphosphate biosynthetic process [GO:0033521]; vitamin E biosynthetic process [GO:0010189]";chloroplast [GO:0009507];"FAD binding [GO:0071949]; geranylgeranyl diphosphate reductase activity [GO:0102067]; geranylgeranyl reductase activity [GO:0045550]"
comp6957523_c0_seq1;GAXK01076001.1;P15112;5.25E-71;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp6957668_c0_seq1;GAXK01076000.1;P14381;3.29E-16;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp695889_c0_seq1;GAXK01164511.1;Q6Y685;9.78E-23;TACC1_MOUSE;Transforming acidic coiled-coil-containing protein 1;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0007052; GO:0008283; GO:0016922; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301; GO:2000327";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]";"estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]"
comp695949_c0_seq1;GAXK01164492.1;Q2M389;0;WASC4_HUMAN;WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP);"early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]";"GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203";"endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]";"early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]";
comp6959548_c0_seq1;GAXK01142865.1;Q9XU75;1.32E-23;SURO1_CAEEL;Putative carboxypeptidase suro-1 (EC 3.4.17.-) (Suppressor of roller 1);"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0005615; GO:0005737; GO:0006508; GO:0008270; GO:0031410; GO:0060102";proteolysis [GO:0006508];"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]";"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp696_c0_seq1;GAXK01168574.1;Q170J7;0;MOEH_AEDAE;Moesin/ezrin/radixin homolog 1;"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]";"GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0045197";establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197];"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp696025_c0_seq1;GAXK01111117.1;Q25188;1.39E-47;OAR_HELVI;Octopamine receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]";"GO:0004989; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";octopamine receptor activity [GO:0004989]
comp696118_c0_seq1;GAXK01111126.1;Q96IR2;1.37E-23;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp6962_c0_seq1;GAXK01101103.1;Q5R1W5;3.31E-44;SRSF2_PANTR;Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp69620_c2_seq1;GAXK01006814.1;Q69ZL1;2.79E-41;FGD6_MOUSE;FYVE, RhoGEF and PH domain-containing protein 6;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005737; GO:0005856; GO:0035023; GO:0043087; GO:0046872";"regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp6962207_c0_seq1;GAXK01069768.1;Q6DHG0;8.78E-08;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp696307_c0_seq1;GAXK01111134.1;P36609;3.98E-11;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp696376_c0_seq1;GAXK01111128.1;P17019;1.46E-52;ZN708_HUMAN;Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp696429_c0_seq1;GAXK01111138.1;Q9IAL1;1.48E-70;VSX2_CHICK;Visual system homeobox 2 (Ceh-10 homeodomain-containing homolog) (Homeobox protein CHX10);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005634; GO:0006355; GO:0007275; GO:0007601; GO:0043565; GO:0050896";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp696588_c0_seq1;GAXK01111136.1;Q27319;6.58E-137;GELS_HOMAM;Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]";"GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693";actin filament capping [GO:0051693];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp696676_c1_seq1;GAXK01111149.1;Q90773;8.54E-27;CEPU1_CHICK;Protein CEPU-1;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp696727_c0_seq1;GAXK01111121.1;Q02527;1.56E-82;MGAT3_RAT;Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]; amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"GO:0000139; GO:0003830; GO:0006044; GO:0006487; GO:0008104; GO:0016021; GO:0016757; GO:0030334; GO:0034599; GO:0050435; GO:0050890; GO:1902966; GO:1905166";"amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp696917_c0_seq1;GAXK01111133.1;Q86MW9;1.99E-08;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp696998_c0_seq1;GAXK01111113.1;Q6P2X9;5.09E-22;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp697123_c1_seq1;GAXK01111130.1;Q3U4G3;4.39E-25;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp69718_c0_seq1;GAXK01006881.1;Q6TNS7;1.64E-60;RABL3_DANRE;Rab-like protein 3;"cell [GO:0005623]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";"GO:0003924; GO:0005525; GO:0005623; GO:0006886; GO:0032482";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]";cell [GO:0005623];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp69722_c0_seq1;GAXK01006546.1;O94887;0;FARP2_HUMAN;FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain-including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2) (Pleckstrin homology domain-containing family C member 3) (PH domain-containing family C member 3);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0005089; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0008092; GO:0016322; GO:0016601; GO:0022405; GO:0030316; GO:0030676; GO:0031532; GO:0033623; GO:0035023; GO:0071526; GO:0071800";"actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";"cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp69723_c3_seq1;GAXK01007018.1;B7Z031;1.34E-45;PESTE_DROME;Protein peste;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp697269_c2_seq1;GAXK01111152.1;O75962;1.37E-13;TRIO_HUMAN;Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein);"cell projection [GO:0042995]; cytosol [GO:0005829]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]";"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005829; GO:0007185; GO:0007186; GO:0007411; GO:0007417; GO:0035023; GO:0042995; GO:0043065; GO:0045599; GO:0051056";"axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]";"cell projection [GO:0042995]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp697326_c2_seq1;GAXK01111090.1;Q96IR2;2.24E-40;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp697489_c0_seq1;GAXK01111142.1;E1BBG2;7.01E-31;MILK1_BOVIN;MICAL-like protein 1;"extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; slow endocytic recycling [GO:0032458]";"GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0017137; GO:0019898; GO:0031175; GO:0031902; GO:0032458; GO:0036010; GO:0042802; GO:0046872; GO:0055038; GO:0070300; GO:0097320; GO:1990126";"endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; slow endocytic recycling [GO:0032458]";"extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; Rab GTPase binding [GO:0017137]"
comp697511_c1_seq1;GAXK01111127.1;Q9BXJ4;2.21E-07;C1QT3_HUMAN;Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26);"cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]";"GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223";"cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]";"cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]";
comp69754_c0_seq1;GAXK01005854.1;Q9GR88;5.17E-122;ERF1_POLMI;Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1);"cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]";"GO:0003747; GO:0005737";;cytoplasm [GO:0005737];translation release factor activity [GO:0003747]
comp69760_c0_seq1;GAXK01005921.1;P53440;2.61E-10;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp69767_c0_seq1;GAXK01006149.1;Q9W2H1;1.80E-49;TM2D1_DROME;TM2 domain-containing protein CG10795;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp69775_c0_seq1;GAXK01006102.1;Q28658;3.30E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp69778_c3_seq1;GAXK01007075.1;Q6P0N0;4.44E-07;M18BP_HUMAN;Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243);"condensed nuclear chromosome kinetochore [GO:0000778]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]";"GO:0000778; GO:0000981; GO:0003677; GO:0005654; GO:0007049; GO:0034080; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]";"condensed nuclear chromosome kinetochore [GO:0000778]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp69785_c1_seq1;GAXK01005840.1;Q5ZHS1;0;ELP3_CHICK;Elongator complex protein 3 (tRNA uridine(34) acetyltransferase) (EC 2.3.1.-);"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; RNA polymerase II complex binding [GO:0000993]; central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]";"GO:0000993; GO:0001764; GO:0002926; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0007417; GO:0008607; GO:0030335; GO:0033588; GO:0046872; GO:0051536";"central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]";"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"histone acetyltransferase activity [GO:0004402]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; RNA polymerase II complex binding [GO:0000993]"
comp697856_c0_seq1;GAXK01111188.1;Q6R7M4;1.96E-78;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp6982_c1_seq1;GAXK01101223.1;P19804;3.59E-37;NDKB_RAT;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0008144; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051259; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
comp6983894_c0_seq1;GAXK01159115.1;C0SPA5;2.31E-15;ADHA_BACSU;Probable formaldehyde dehydrogenase AdhA (EC 1.1.1.-);"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016616";;;"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; zinc ion binding [GO:0008270]"
comp698405_c0_seq1;GAXK01084587.1;Q4FZV3;7.48E-19;IDLC_RAT;Axonemal dynein light intermediate polypeptide 1 (Inner dynein arm light chain, axonemal);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159]";"GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0036159; GO:0045504; GO:0097729";inner dynein arm assembly [GO:0036159];"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]";"dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]"
comp698426_c0_seq1;GAXK01084618.1;Q14982;2.35E-28;OPCM_HUMAN;Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp6985163_c0_seq1;GAXK01093728.1;Q03683;1.59E-29;BIP3_TOBAC;Luminal-binding protein 3 (BiP 3) (78 kDa glucose-regulated protein homolog 3) (GRP-78-3) (Fragment);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp6986898_c0_seq1;GAXK01153875.1;Q9ER04;4.60E-10;TMPS5_MOUSE;Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin);"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]";"GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0008233; GO:0016021; GO:0043025";proteolysis [GO:0006508];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp6988756_c0_seq1;GAXK01001197.1;P51405;2.34E-41;RS4_DICDI;40S ribosomal protein S4;"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]; inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"GO:0000822; GO:0003735; GO:0005856; GO:0006412; GO:0019843; GO:0022627; GO:0030036; GO:0031012; GO:0032991";"actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]";"inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp698964_c1_seq1;GAXK01084596.1;Q9WVK4;2.32E-162;EHD1_MOUSE;EH domain-containing protein 1 (PAST homolog 1) (mPAST1);"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0010976; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043209; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]"
comp6990197_c0_seq1;GAXK01172208.1;P16885;2.23E-14;PLCG2_HUMAN;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphotyrosine residue binding [GO:0001784]; activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"GO:0001784; GO:0002092; GO:0002223; GO:0002316; GO:0004435; GO:0004629; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010468; GO:0016055; GO:0019722; GO:0030168; GO:0030183; GO:0032237; GO:0032481; GO:0032496; GO:0032959; GO:0038095; GO:0038096; GO:0043069; GO:0043647; GO:0048015; GO:0050852; GO:0050853; GO:0051209; GO:0070062";"activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";"phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphotyrosine residue binding [GO:0001784]"
comp69908_c0_seq1;GAXK01006163.1;Q4R4S5;1.17E-91;LICH_MACFA;Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase);"lysosome [GO:0005764]; sterol esterase activity [GO:0004771]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0005764; GO:0016042";lipid catabolic process [GO:0016042];lysosome [GO:0005764];sterol esterase activity [GO:0004771]
comp69920_c0_seq1;GAXK01006554.1;Q5I598;0;MTHR_BOVIN;Methylenetetrahydrofolate reductase (EC 1.5.1.20);"cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";"GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949";"methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";cytosol [GO:0005829];"FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]"
comp6993022_c0_seq1;GAXK01080791.1;Q09575;1.50E-12;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp6993284_c0_seq1;GAXK01080796.1;P80865;8.81E-71;SUCD_BACSU;Succinate--CoA ligase [ADP-forming] subunit alpha (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha);"cytosol [GO:0005829]; cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000166; GO:0004550; GO:0004775; GO:0005829; GO:0006099; GO:0006104; GO:0006105; GO:0009142; GO:0048037";"nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";cytosol [GO:0005829];"cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]"
comp6995098_c0_seq1;GAXK01034296.1;Q09221;3.74E-43;CPNA2_CAEEL;Copine family protein 2;;;;;
comp699565_c0_seq1;GAXK01084606.1;O43791;5.19E-13;SPOP_HUMAN;Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp699823_c0_seq1;GAXK01084611.1;Q9UJU3;2.79E-16;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp69994_c0_seq1;GAXK01006078.1;P05661;4.54E-42;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp6999414_c0_seq1;GAXK01112768.1;O97370;4.35E-11;EURM3_EURMA;Mite allergen Eur m 3 (EC 3.4.21.-) (allergen Eur m 3);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp69999_c0_seq1;GAXK01006882.1;Q9NZ56;1.05E-67;FMN2_HUMAN;Formin-2;"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of actin nucleation [GO:0051127]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0007275; GO:0015031; GO:0016192; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051127; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of actin nucleation [GO:0051127]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]";actin binding [GO:0003779]
comp7_c1_seq1;GAXK01169281.1;Q6RYS3;9.67E-149;RL8_MAMBR;60S ribosomal protein L8;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp70_c0_seq1;GAXK01169351.1;P02268;2.77E-64;H2A_SEPOF;Histone H2A;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp700033_c0_seq1;GAXK01196117.1;O82018;2.99E-20;CALM_MOUSC;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7001691_c0_seq1;GAXK01062147.1;Q0IIY2;3.71E-13;WSCD1_XENTR;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp7002069_c0_seq1;GAXK01056630.1;Q9NXS3;1.85E-09;KLH28_HUMAN;Kelch-like protein 28 (BTB/POZ domain-containing protein 5);;;;;
comp70031_c1_seq1;GAXK01130315.1;Q6DIY4;2.81E-65;TBPL1_XENTR;TATA box-binding protein-like protein 1 (TBP-like protein 1) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase III regulatory region DNA binding [GO:0001016]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]";"GO:0000126; GO:0000978; GO:0000979; GO:0001016; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0005737; GO:0006366; GO:0008134; GO:0009792; GO:0070898";"embryo development ending in birth or egg hatching [GO:0009792]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase III regulatory region DNA binding [GO:0001016]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"
comp7003736_c0_seq1;GAXK01056613.1;P21328;4.13E-09;RTJK_DROME;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp7003903_c0_seq1;GAXK01056629.1;P43837;2.32E-62;MAO2_HAEIN;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40);"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; transferase activity, transferring acyl groups [GO:0016746]; malate metabolic process [GO:0006108]";"GO:0004471; GO:0004473; GO:0006108; GO:0008948; GO:0016746; GO:0046872; GO:0051287";malate metabolic process [GO:0006108];;"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; transferase activity, transferring acyl groups [GO:0016746]"
comp700423_c0_seq1;GAXK01196113.1;P08043;1.04E-09;ZFP2_MOUSE;Zinc finger protein 2 (Zfp-2) (Protein mKR2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp700512_c0_seq1;GAXK01196128.1;O46040;4.43E-20;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp70056_c4_seq1;GAXK01130390.1;Q99574;5.71E-36;NEUS_HUMAN;Neuroserpin (Peptidase inhibitor 12) (PI-12) (Serpin I1);"cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; serine-type endopeptidase inhibitor activity [GO:0004867]; central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155]";"GO:0004867; GO:0005615; GO:0007417; GO:0007422; GO:0010951; GO:0010976; GO:0030155; GO:0034774; GO:0043025; GO:0043204; GO:0060205; GO:0070062";"central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155]";"cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp70058_c2_seq1;GAXK01130001.1;Q9QYI3;4.45E-51;DNJC7_MOUSE;DnaJ homolog subfamily C member 7 (Cytoplasmic CAR retention protein) (CCRP) (MDj11) (Tetratricopeptide repeat protein 2) (TPR repeat protein 2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]";"GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0031072; GO:0051085";chaperone cofactor-dependent protein refolding [GO:0051085];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";heat shock protein binding [GO:0031072]
comp700588_c0_seq1;GAXK01196138.1;Q9XYN1;1.52E-47;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp70064_c2_seq1;GAXK01130066.1;Q8K4Q0;0;RPTOR_MOUSE;Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]";"GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087";"cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]";"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]";"14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]"
comp70065_c1_seq1;GAXK01130324.1;Q3SZH7;5.22E-71;LKHA4_BOVIN;Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0019370; GO:0043171; GO:0044255; GO:0044267; GO:0070006";"cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]"
comp700813_c0_seq1;GAXK01196146.1;Q17BA4;3.65E-08;MED15_AEDAE;Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15);"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003712; GO:0006357; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];mediator complex [GO:0016592];transcription coregulator activity [GO:0003712]
comp700835_c1_seq1;GAXK01196143.1;Q6PFJ9;9.44E-45;ARI1_DANRE;E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase arih1);"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0032436; GO:0061630; GO:0097413";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7008583_c0_seq1;GAXK01186869.1;P28629;1.51E-26;ADIA_ECOLI;Biodegradative arginine decarboxylase (ADC) (EC 4.1.1.19);"cytosol [GO:0005829]; arginine decarboxylase activity [GO:0008792]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process [GO:0006527]; intracellular pH elevation [GO:0051454]";"GO:0005829; GO:0006527; GO:0008792; GO:0030170; GO:0051454";"arginine catabolic process [GO:0006527]; intracellular pH elevation [GO:0051454]";cytosol [GO:0005829];"arginine decarboxylase activity [GO:0008792]; pyridoxal phosphate binding [GO:0030170]"
comp700871_c0_seq1;GAXK01196135.1;P41041;2.52E-56;CALM_PNECA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp701035_c1_seq1;GAXK01196125.1;Q7ZVG6;3.23E-08;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7010884_c0_seq1;GAXK01056214.1;P0DJ14;1.10E-82;RL7A_TETTH;60S ribosomal protein L7a;"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp701168_c0_seq1;GAXK01196137.1;P42573;4.18E-32;CED3_CAEEL;"Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"GO:0004175; GO:0004197; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006919; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0012501; GO:0016020; GO:0016540; GO:0030042; GO:0030054; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043025; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050807; GO:0050829; GO:0097153; GO:0097194; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845";"actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]";"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]"
comp70126_c0_seq1;GAXK01129869.1;Q9CQ40;5.56E-10;RM49_MOUSE;39S ribosomal protein L49, mitochondrial (L49mt) (MRP-L49);"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005739; GO:0005761; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp7015_c0_seq1;GAXK01100705.1;Q863B3;0;SND1_BOVIN;Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]";"GO:0003723; GO:0004518; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172";"gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]"
comp701542_c0_seq1;GAXK01196104.1;P04569;2.36E-10;SCP1_BRALA;Sarcoplasmic calcium-binding proteins I, III, and IV (SCP I, III, IV);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7015871_c0_seq1;GAXK01195533.1;P52232;1.54E-12;THIO1_SYNY3;Thioredoxin-like protein slr0233;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"GO:0005737; GO:0005829; GO:0006662; GO:0015035; GO:0016671; GO:0045454; GO:0047134";"cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]"
comp701676_c0_seq1;GAXK01196130.1;Q6F6B3;1.39E-07;TANC1_RAT;Protein TANC1 (TPR domain, ankyrin-repeat and coiled-coil domain-containing protein 1);"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; regulation of postsynapse organization [GO:0099175]";"GO:0030054; GO:0045211; GO:0098978; GO:0099092; GO:0099175";regulation of postsynapse organization [GO:0099175];"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]";
comp7017100_c0_seq1;GAXK01075388.1;P32598;1.29E-62;PP12_YEAST;Serine/threonine-protein phosphatase PP1-2 (EC 3.1.3.16);"cell division site [GO:0032153]; cellular bud neck [GO:0005935]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; mating projection base [GO:0001400]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; spindle pole body [GO:0005816]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ascospore formation [GO:0030437]; cellular ion homeostasis [GO:0006873]; chromosome segregation [GO:0007059]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; DNA damage checkpoint [GO:0000077]; DNA replication checkpoint [GO:0000076]; glycogen metabolic process [GO:0005977]; histone dephosphorylation [GO:0016576]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA processing [GO:0006397]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of mitotic actomyosin contractile ring assembly [GO:1903501]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; protein localization to kinetochore [GO:0034501]; regulation of cell budding [GO:0007116]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of glycogen metabolic process [GO:0070873]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell division site involved in cytokinesis [GO:1901901]; replication fork processing [GO:0031297]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; transfer RNA gene-mediated silencing [GO:0061587]";"GO:0000076; GO:0000077; GO:0000164; GO:0000723; GO:0000778; GO:0001400; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0005816; GO:0005847; GO:0005935; GO:0005977; GO:0006397; GO:0006470; GO:0006873; GO:0006986; GO:0007059; GO:0007094; GO:0007116; GO:0007346; GO:0008360; GO:0009408; GO:0016576; GO:0030437; GO:0031297; GO:0032153; GO:0034501; GO:0035307; GO:0046872; GO:0051321; GO:0051726; GO:0061587; GO:0070873; GO:0070940; GO:1901901; GO:1903501; GO:2000370";"ascospore formation [GO:0030437]; cellular ion homeostasis [GO:0006873]; chromosome segregation [GO:0007059]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; DNA damage checkpoint [GO:0000077]; DNA replication checkpoint [GO:0000076]; glycogen metabolic process [GO:0005977]; histone dephosphorylation [GO:0016576]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA processing [GO:0006397]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of mitotic actomyosin contractile ring assembly [GO:1903501]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; protein localization to kinetochore [GO:0034501]; regulation of cell budding [GO:0007116]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of glycogen metabolic process [GO:0070873]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell division site involved in cytokinesis [GO:1901901]; replication fork processing [GO:0031297]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; transfer RNA gene-mediated silencing [GO:0061587]";"cell division site [GO:0032153]; cellular bud neck [GO:0005935]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; mating projection base [GO:0001400]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; spindle pole body [GO:0005816]";"metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp7017340_c0_seq1;GAXK01075396.1;P93099;1.25E-67;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp7018696_c0_seq1;GAXK01077849.1;Q9D4B2;1.55E-07;TTC25_MOUSE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp70189_c0_seq1;GAXK01129936.1;P42787;8.44E-94;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp701917_c0_seq1;GAXK01196154.1;Q62009;2.53E-14;POSTN_MOUSE;Periostin (PN) (Osteoblast-specific factor 2) (OSF-2);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]";"GO:0001666; GO:0001953; GO:0003073; GO:0005615; GO:0005737; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0050839; GO:0062023; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523";"bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]"
comp702096_c0_seq1;GAXK01154916.1;Q0VCN3;1.03E-38;IFT27_BOVIN;Intraflagellar transport protein 27 homolog (IFT27) (Putative GTP-binding protein RAY-like) (Rab-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]";"GO:0001822; GO:0003924; GO:0005525; GO:0005737; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016020; GO:0030154; GO:0030992; GO:0032482; GO:0036126; GO:0042073";"cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; membrane [GO:0016020]; sperm flagellum [GO:0036126]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp70213_c0_seq1;GAXK01129860.1;Q61102;0;ABCB7_MOUSE;ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular iron ion homeostasis [GO:0006879]";"GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0016021; GO:0016887; GO:0042626";cellular iron ion homeostasis [GO:0006879];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp7021437_c0_seq1;GAXK01009526.1;P37739;1.25E-07;DCTS_RHOCA;C4-dicarboxylate transport sensor protein DctS (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000155; GO:0005524; GO:0005886; GO:0006355; GO:0016021";regulation of transcription, DNA-templated [GO:0006355];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp7021757_c0_seq1;GAXK01009528.1;Q66J52;9.47E-16;S226B_XENLA;Solute carrier family 22 member 6-B (Organic cation transporter 1-B) (Renal organic anion transporter 1-B) (ROAT1-B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]";"GO:0005886; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp70231_c2_seq1;GAXK01130302.1;Q08705;2.17E-111;CTCF_CHICK;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp702498_c0_seq1;GAXK01155024.1;Q8S919;3.13E-22;UBC5B_ORYSJ;Ubiquitin-conjugating enzyme E2 5B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 5B) (Ubiquitin carrier protein 5b) (OsUBC5b) (Ubiquitin-protein ligase 5B);"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005524; GO:0016567; GO:0061631";protein ubiquitination [GO:0016567];;"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
comp702509_c1_seq1;GAXK01154929.1;Q5BL07;2.89E-110;PEX1_MOUSE;Peroxisome biogenesis factor 1 (Peroxin-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]";"GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0008289; GO:0016558; GO:0016887; GO:0042623; GO:0044877; GO:0060152";"microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]"
comp7025798_c0_seq1;GAXK01195714.1;P42791;6.37E-35;RL182_ARATH;60S ribosomal protein L18-2;"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0015934; GO:0022625";translation [GO:0006412];"chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";structural constituent of ribosome [GO:0003735]
comp702621_c0_seq1;GAXK01154933.1;P56561;3.25E-14;CUD5_LOCMI;Endocuticle structural glycoprotein ABD-5;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp7026476_c0_seq1;GAXK01068736.1;O15439;1.06E-22;MRP4_HUMAN;Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0048661; GO:0055085; GO:0060271";"cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]";"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]"
comp7026811_c0_seq1;GAXK01068731.1;Q16651;3.04E-07;PRSS8_HUMAN;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]; cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0008236; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0046658; GO:0070062; GO:0070268";"cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]"
comp70270_c8_seq1;GAXK01130425.1;Q9D7X3;4.76E-38;DUS3_MOUSE;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001701; GO:0001772; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp703_c0_seq1;GAXK01168691.1;P58374;2.16E-40;RL30_BRABE;60S ribosomal protein L30;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]";"GO:0003723; GO:0003735; GO:0022625";;cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7030_c0_seq1;GAXK01100478.1;Q9GLW7;8.68E-64;PRDX5_CHLAE;Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Peroxiredoxin V) (Prx-V) (Thioredoxin peroxidase);"mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]";"GO:0004601; GO:0005739; GO:0005782; GO:0045454; GO:0051920";cell redox homeostasis [GO:0045454];"mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]";"peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]"
comp703011_c0_seq1;GAXK01155014.1;Q9Y6N7;1.18E-07;ROBO1_HUMAN;Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1);"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]";"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]"
comp70303_c1_seq1;GAXK01130054.1;Q6ZPL9;3.10E-166;DDX55_MOUSE;ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005829";;"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp703123_c0_seq1;GAXK01154900.1;Q95V25;0;SLO1_CAEEL;Calcium-activated potassium channel slo-1 (BK channel) (Maxi K channel) (MaxiK) (Slo homolog) (Slowpoke protein 1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"GO:0005249; GO:0005886; GO:0006813; GO:0015269; GO:0015271; GO:0016021; GO:0030054; GO:0031430; GO:0034765; GO:0040011; GO:0042391; GO:0042493; GO:0043050; GO:0045202; GO:0045211; GO:0045214; GO:0046928; GO:0048149; GO:0050804; GO:0055120; GO:0060072";"behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]"
comp703199_c0_seq1;GAXK01154914.1;Q9HCG1;1.07E-20;ZN160_HUMAN;Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; hemopoiesis [GO:0030097]";"GO:0000981; GO:0003677; GO:0005634; GO:0030097; GO:0046872";hemopoiesis [GO:0030097];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp703280_c0_seq1;GAXK01154919.1;Q80WQ9;1.19E-31;ZBED4_MOUSE;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp7033_c0_seq1;GAXK01101281.1;Q16222;5.20E-137;UAP1_HUMAN;"UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]";"GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802";UDP-N-acetylglucosamine biosynthetic process [GO:0006048];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]"
comp7033293_c0_seq1;GAXK01128967.1;Q6K9C1;1.12E-09;ATAB2_ORYSJ;Protein TAB2 homolog, chloroplastic;"chloroplast [GO:0009507]; RNA binding [GO:0003723]";"GO:0003723; GO:0009507";;chloroplast [GO:0009507];RNA binding [GO:0003723]
comp703464_c0_seq1;GAXK01154936.1;A0JMF8;5.71E-160;RFX3_DANRE;Transcription factor RFX3 (Regulatory factor X 3);"extracellular region [GO:0005576]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000978; GO:0003700; GO:0005576; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0030154; GO:0031018; GO:0044212; GO:0050796; GO:0060285; GO:0060287";"cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"extracellular region [GO:0005576]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp70355_c0_seq1;GAXK01130049.1;Q9D4B1;8.64E-64;SMS2_MOUSE;Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2);"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"GO:0002950; GO:0005794; GO:0005887; GO:0006686; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373";"ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]";"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]";"ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]"
comp703609_c0_seq1;GAXK01154915.1;Q96JL9;6.95E-15;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp703685_c0_seq1;GAXK01154918.1;Q3SYV7;1.59E-19;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp703862_c0_seq1;GAXK01155017.1;Q8NB50;5.80E-23;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp704030_c0_seq1;GAXK01134748.1;Q9FNU2;6.68E-85;AB25B_ORYSJ;ABC transporter B family member 25 (ABC transporter ABCB.25) (OsABCB25) (Protein ALS1 homolog) (Protein ALUMINUM SENSITIVE 1) (OsALS1);"integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; aluminum ion transmembrane transporter activity [GO:0015083]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; aluminum ion transmembrane transport [GO:1902602]; cellular aluminum ion homeostasis [GO:0010217]; response to aluminum ion [GO:0010044]";"GO:0005524; GO:0009705; GO:0010044; GO:0010217; GO:0015083; GO:0016021; GO:0016887; GO:0042626; GO:1902602";"aluminum ion transmembrane transport [GO:1902602]; cellular aluminum ion homeostasis [GO:0010217]; response to aluminum ion [GO:0010044]";"integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]";"aluminum ion transmembrane transporter activity [GO:0015083]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp704063_c0_seq1;GAXK01134777.1;Q8NET6;5.21E-28;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp70414_c0_seq1;GAXK01129817.1;Q3ZBG9;4.17E-92;PLS2_BOVIN;Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]";"GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872";plasma membrane phospholipid scrambling [GO:0017121];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]"
comp704177_c0_seq1;GAXK01134758.1;Q08DV5;9.32E-09;RN220_BOVIN;E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";"GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]";cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
comp70420_c3_seq1;GAXK01129969.1;Q0KHU5;2.96E-61;PCAT_DROME;Lysophosphatidylcholine acyltransferase (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (Acyltransferase-like 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0008654; GO:0016021; GO:0030258; GO:0047184; GO:0071617";"lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; calcium ion binding [GO:0005509]; lysophospholipid acyltransferase activity [GO:0071617]"
comp704276_c0_seq1;GAXK01134787.1;Q9NDM2;4.06E-14;GUTR1_DROME;Protein trapped in endoderm-1;"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]";"GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234";"ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]";"cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp70428_c0_seq1;GAXK01130108.1;P70541;4.80E-78;EI2BG_RAT;Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma);"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]";"GO:0003743; GO:0005085; GO:0005737; GO:0005851; GO:0006412; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0016779; GO:0021766; GO:0043434; GO:0050852";"hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]";"cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]";"guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]"
comp704301_c1_seq1;GAXK01134716.1;P82596;1.73E-15;PLC_HALLA;Perlucin;carbohydrate binding [GO:0030246];GO:0030246;;;carbohydrate binding [GO:0030246]
comp704460_c0_seq1;GAXK01134788.1;G5ECS8;6.30E-53;ADT1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp70448_c0_seq1;GAXK01130457.1;O62666;2.37E-40;IL16_PANTR;Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]";"GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0030595; GO:0042609; GO:0050930";"induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]"
comp70453_c0_seq1;GAXK01130358.1;Q9JJS6;3.01E-31;BCDO1_MOUSE;Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1);"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";"GO:0001523; GO:0003834; GO:0004744; GO:0010436; GO:0016121; GO:0042572; GO:0042574; GO:0046872; GO:1901810";"beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]";;"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]"
comp70458_c2_seq1;GAXK01130157.1;Q7KRI2;2.11E-18;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp70464_c0_seq1;GAXK01130368.1;P70684;1.73E-36;PGDH_CAVPO;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1);"cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070";"ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]";cytoplasm [GO:0005737];"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]"
comp70478_c15_seq1;GAXK01129764.1;Q80ZA4;2.72E-46;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp70486_c0_seq1;GAXK01130359.1;Q8WYA6;0;CTBL1_HUMAN;Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]";"GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065";"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]";enzyme binding [GO:0019899]
comp7049_c0_seq1;GAXK01101199.1;P05661;1.14E-58;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp704906_c0_seq1;GAXK01134802.1;Q14679;3.96E-09;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp704933_c0_seq1;GAXK01134743.1;P03362;2.22E-11;POL_HTL1A;"Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol) [Cleaved into: Matrix protein p19 (MA); Capsid protein p24 (CA); Nucleocapsid protein p15-pro (NC') (NC-pro); Protease (PR) (EC 3.4.23.-); p1; Reverse transcriptase/ribonuclease H, p49 subunit (p49 RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Reverse transcriptase/ribonuclease H, p62 subunit (p62 RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]";"viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005198; GO:0006310; GO:0008270; GO:0015074; GO:0019013; GO:0039657; GO:0044826; GO:0046718; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";viral nucleocapsid [GO:0019013];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]"
comp7050753_c0_seq1;GAXK01184116.1;Q1RJR6;2.00E-13;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp705108_c1_seq1;GAXK01134767.1;Q8VHL1;1.96E-35;SETD7_MOUSE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005634; GO:0005694; GO:0005730; GO:0006974; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp7051082_c0_seq1;GAXK01184110.1;P76071;4.54E-36;INSH5_ECOLI;Transposase InsH for insertion sequence element IS5Y;"cytosol [GO:0005829]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0005829; GO:0006313; GO:0045893";"positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";cytosol [GO:0005829];"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp70516_c1_seq1;GAXK01130454.1;Q8BMP6;3.23E-43;GCP60_MOUSE;Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694]";"GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0034237";steroid biosynthetic process [GO:0006694];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]";"fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]"
comp70519_c0_seq1;GAXK01129718.1;O02443;4.15E-15;CULP1_HELAM;Larval cuticle protein 1;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp705204_c3_seq1;GAXK01134709.1;O55131;3.24E-115;SEPT7_MOUSE;Septin-7 (CDC10 protein homolog);"axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000281; GO:0000777; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030336; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043065; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046982; GO:0048668; GO:0051291; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0097730; GO:0098978; GO:0099173; GO:1902857; GO:2000134";"cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; protein heterooligomerization [GO:0051291]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]"
comp70521_c0_seq1;GAXK01130300.1;Q3MIT2;5.68E-81;PUS10_HUMAN;Putative tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase);"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine synthesis [GO:0031119]";"GO:0003723; GO:0009982; GO:0031119; GO:0106029";tRNA pseudouridine synthesis [GO:0031119];;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]"
comp705223_c0_seq1;GAXK01134757.1;Q14591;2.35E-18;ZN271_HUMAN;Deleted.;;;;;
comp705228_c0_seq1;GAXK01134752.1;P56941;1.05E-15;NPC1_PIG;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103";"bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]"
comp70526_c1_seq1;GAXK01130320.1;Q3KR37;2.07E-36;ASTRB_HUMAN;Protein Aster-B (GRAM domain-containing protein 1B);"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268";"cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]";"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]"
comp705265_c0_seq1;GAXK01134745.1;P42787;1.22E-49;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp7052884_c0_seq1;GAXK01175082.1;P19109;3.29E-68;DDX17_DROME;ATP-dependent RNA helicase p62 (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005700; GO:0005703; GO:0005730; GO:0005737; GO:0005829; GO:0006417; GO:0016246; GO:0019730; GO:0050688; GO:0051607; GO:0071011; GO:0071013; GO:1990904";"antimicrobial humoral response [GO:0019730]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of defense response to virus [GO:0050688]; regulation of translation [GO:0006417]; RNA interference [GO:0016246]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp7053926_c0_seq1;GAXK01175078.1;O35595;3.28E-15;PTC2_MOUSE;Protein patched homolog 2 (PTC2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0008544; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0097108";"cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp7054_c0_seq1;GAXK01100444.1;Q6DRH5;2.22E-27;NOP10_DANRE;H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10);"box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]; primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]";"GO:0005697; GO:0006364; GO:0007004; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0060215; GO:0070034; GO:0090661";"primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]";"box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]";"box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]"
comp70548_c0_seq1;GAXK01129640.1;P11103;0;PARP1_MOUSE;Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 secretion [GO:1905077]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]";"GO:0000723; GO:0000977; GO:0001228; GO:0003682; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0006259; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010613; GO:0010990; GO:0016540; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0040009; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0046332; GO:0047485; GO:0048148; GO:0050790; GO:0050882; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0071451; GO:0071560; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903516; GO:1903518; GO:1903827; GO:1904357; GO:1904646; GO:1904762; GO:1905077; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170";"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 secretion [GO:1905077]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp705659_c0_seq1;GAXK01134768.1;Q98862;9.91E-20;IHH_DANRE;"Indian hedgehog B protein (IHHB) (Echidna hedgehog protein) (EHH) [Cleaved into: Indian hedgehog B protein N-product; Indian hedgehog B protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016539; GO:0048709; GO:0055002; GO:0070445";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; intein-mediated protein splicing [GO:0016539]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp705694_c0_seq1;GAXK01134778.1;Q90ZC7;0;KCMA1_XENLA;Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo);"integral component of membrane [GO:0016021]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005244; GO:0016021; GO:0034765; GO:0046872; GO:0060072";regulation of ion transmembrane transport [GO:0034765];integral component of membrane [GO:0016021];"large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated ion channel activity [GO:0005244]"
comp7057251_c0_seq1;GAXK01000088.1;Q7Z269;1.84E-11;SP4_POLDO;Venom serine protease (EC 3.4.21.-) (allergen Pol d 4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576";;extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp705746_c2_seq1;GAXK01134740.1;Q2VG86;2.99E-26;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp705760_c1_seq1;GAXK01134769.1;Q54HH2;4.85E-38;SRR_DICDI;Probable serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]";"GO:0000287; GO:0003941; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0018114; GO:0018249; GO:0030170; GO:0030378; GO:0042866; GO:0070179";"D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]"
comp70586_c0_seq1;GAXK01129939.1;Q9C0D7;7.94E-37;ZC12C_HUMAN;Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C);"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]";"GO:0004519; GO:0046872";;;"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp705889_c0_seq1;GAXK01134764.1;Q5TH69;4.30E-134;BIG3_HUMAN;Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3);"integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0010923; GO:0016021; GO:0030658; GO:0032012";"negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012]";"integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp7061993_c0_seq1;GAXK01143102.1;Q6ZUK4;2.07E-07;TMM26_HUMAN;Transmembrane protein 26;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp7063_c2_seq1;GAXK01101051.1;Q1LZB6;1.99E-25;CAPR1_BOVIN;Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (RNA granule protein 105);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; P-body [GO:0000932]; synapse [GO:0045202]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]";"GO:0000932; GO:0003723; GO:0005829; GO:0010494; GO:0017148; GO:0030425; GO:0045202; GO:0050775; GO:0061003";"negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; P-body [GO:0000932]; synapse [GO:0045202]";RNA binding [GO:0003723]
comp706359_c0_seq1;GAXK01041835.1;Q9GRW0;4.78E-35;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp7064423_c0_seq1;GAXK01084873.1;O54804;4.46E-08;CHKA_MOUSE;Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]";"GO:0004103; GO:0004104; GO:0004305; GO:0005524; GO:0005737; GO:0006580; GO:0006646; GO:0006656; GO:0008144; GO:0009636; GO:0019695; GO:0033265; GO:0042803; GO:1904681";"choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]"
comp70646_c1_seq1;GAXK01129858.1;Q8N6M3;2.46E-36;FITM2_HUMAN;Fat storage-inducing transmembrane protein 2 (Fat-inducing protein 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]";"GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0019915; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356";"cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]";"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]";
comp7064743_c0_seq1;GAXK01084871.1;Q9WVL0;3.47E-31;MAAI_MOUSE;Maleylacetoacetate isomerase (MAAI) (EC 5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (EC 2.5.1.18);"mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0004364; GO:0005739; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803";"glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";mitochondrion [GO:0005739];"glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]"
comp70649_c0_seq1;GAXK01130046.1;Q5ZLT5;7.97E-16;PKHJ1_CHICK;Pleckstrin homology domain-containing family J member 1 (PH domain-containing family J member 1);"cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0042147; GO:0055037";"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]";
comp706516_c2_seq1;GAXK01041879.1;Q3URE9;9.83E-19;LIGO2_MOUSE;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp70669_c1_seq1;GAXK01130038.1;Q9GRW0;5.16E-37;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp706800_c1_seq1;GAXK01041828.1;Q9Y2U9;7.27E-35;KLDC2_HUMAN;Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1) (HCLP-1);"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"GO:0005634; GO:0016604; GO:0031965";;"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";
comp706856_c0_seq1;GAXK01041867.1;Q7KRI2;5.31E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp70687_c1_seq1;GAXK01130214.1;Q8BTK5;6.24E-41;SMYD4_MOUSE;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp70706_c0_seq1;GAXK01129870.1;P45479;3.25E-105;PPT1_RAT;Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1);"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synaptic plasticity [GO:0048167]; visual perception [GO:0007601]";"GO:0002084; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016042; GO:0016290; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0043005; GO:0043025; GO:0043066; GO:0043524; GO:0044257; GO:0045121; GO:0045202; GO:0048167; GO:0048260; GO:0048549; GO:0051181; GO:0051186";"adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synaptic plasticity [GO:0048167]; visual perception [GO:0007601]";"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]";"palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp7070649_c0_seq1;GAXK01114069.1;Q63099;3.24E-15;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp70717_c0_seq1;GAXK01129931.1;B1H349;5.52E-44;SOX6_XENTR;Transcription factor Sox-6 (SRY (sex determining region Y)-box 6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell fate commitment [GO:0045165]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003677; GO:0005634; GO:0007275; GO:0032332; GO:0045165; GO:0045892; GO:0045944";"cell fate commitment [GO:0045165]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp707430_c0_seq1;GAXK01041888.1;Q8VIG1;9.21E-14;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp70745_c2_seq1;GAXK01130036.1;Q8CFK2;3.78E-127;TF3B_MOUSE;Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1);"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898";"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]";"metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp70769_c2_seq1;GAXK01129893.1;Q01295;7.40E-20;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp70778_c0_seq1;GAXK01129916.1;Q02427;7.01E-21;RBP1_DROME;RNA-binding protein 1;"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"GO:0000381; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp7078_c0_seq1;GAXK01101275.1;P34528;1.12E-89;YM67_CAEEL;Putative serine protease K12H4.7 (EC 3.4.-.-);"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]";"GO:0006508; GO:0008236; GO:0008239; GO:0045087";"innate immune response [GO:0045087]; proteolysis [GO:0006508]";;"dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]"
comp707807_c0_seq1;GAXK01041901.1;Q3J6K9;1.61E-83;ACUI_RHOS4;Acrylyl-CoA reductase AcuI (EC 1.3.1.84) (Acryloyl-coenzyme A reductase);"cytoplasm [GO:0005737]; acryloyl-CoA reductase (NADP+) activity [GO:0043957]";"GO:0005737; GO:0043957";;cytoplasm [GO:0005737];acryloyl-CoA reductase (NADP+) activity [GO:0043957]
comp70788_c0_seq1;GAXK01130037.1;Q7RTY7;1.21E-53;OVCH1_HUMAN;Ovochymase-1 (EC 3.4.21.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp708079_c0_seq1;GAXK01065212.1;Q9V5M6;5.53E-12;LOLA5_DROME;Longitudinals lacking protein, isoforms J/P/Q/S/Z;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp70829_c0_seq1;GAXK01129937.1;P55155;7.98E-14;VIT1_CAEEL;Vitellogenin-1;"extracellular region [GO:0005576]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]";"GO:0005319; GO:0005576; GO:0045735";;extracellular region [GO:0005576];"lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
comp7083_c0_seq1;GAXK01101207.1;Q7JXF7;6.90E-34;SEELE_DROME;Protein seele;"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; chaperone-mediated protein folding [GO:0061077]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of protein processing [GO:0070613]; regulation of protein secretion [GO:0050708]";"GO:0005783; GO:0007311; GO:0009951; GO:0012505; GO:0050708; GO:0051087; GO:0061077; GO:0070613";"chaperone-mediated protein folding [GO:0061077]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; polarity specification of dorsal/ventral axis [GO:0009951]; regulation of protein processing [GO:0070613]; regulation of protein secretion [GO:0050708]";"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]";chaperone binding [GO:0051087]
comp70831_c0_seq1;GAXK01129821.1;Q8GZ43;1.02E-07;YZR3_ARATH;RanBP2-type zinc finger protein At1g67325;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]";"GO:0003729; GO:0046872";;;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp7083180_c0_seq1;GAXK01022584.1;Q0MQE9;1.18E-29;NDUB9_GORGO;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005747; GO:0006120; GO:0032981";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]";mitochondrial respiratory chain complex I [GO:0005747];
comp708319_c1_seq1;GAXK01065261.1;Q90718;9.77E-61;SRF_CHICK;Serum response factor (SRF) (Fragment);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; serum response element binding [GO:0010736]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; positive regulation of transcription via serum response element binding [GO:0010735]";"GO:0000981; GO:0003700; GO:0005634; GO:0007275; GO:0008134; GO:0010735; GO:0010736; GO:0030036; GO:0043565; GO:0044212; GO:0046983";"actin cytoskeleton organization [GO:0030036]; multicellular organism development [GO:0007275]; positive regulation of transcription via serum response element binding [GO:0010735]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; serum response element binding [GO:0010736]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp7084_c0_seq1;GAXK01100192.1;Q9R0Q9;1.67E-61;MPU1_MOUSE;Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15);"integral component of membrane [GO:0016021]; oligosaccharide biosynthetic process [GO:0009312]";"GO:0009312; GO:0016021";oligosaccharide biosynthetic process [GO:0009312];integral component of membrane [GO:0016021];
comp70852_c0_seq1;GAXK01130186.1;Q76FS2;3.90E-07;TBB8_ORYSJ;Tubulin beta-8 chain (Beta-8-tubulin);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp7085221_c0_seq1;GAXK01186848.1;V5YMB3;2.69E-13;DAPB3_PSEMX;Dipeptidyl aminopeptidase BIII (DAP BIII) (EC 3.4.14.-);"dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004175; GO:0008236; GO:0008239; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];;"dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]"
comp708622_c1_seq1;GAXK01065249.1;P52176;3.02E-09;MMP9_BOVIN;Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB);"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001934; GO:0004222; GO:0005615; GO:0006508; GO:0007566; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0034614; GO:0035987; GO:0042802; GO:0043388; GO:0045742; GO:0051549; GO:0071276; GO:0090200; GO:1900122; GO:1904645; GO:1904707; GO:2000697; GO:2001243; GO:2001258; GO:2001268";"cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501]";"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";"identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp708649_c0_seq1;GAXK01065270.1;Q60636;3.99E-10;PRDM1_MOUSE;PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841";"adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp70866_c0_seq1;GAXK01130410.1;Q299F9;2.52E-98;FAM50_DROPS;Protein FAM50 homolog;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp7087394_c0_seq1;GAXK01057442.1;Q9SZJ5;3.51E-53;GLYM1_ARATH;Serine hydroxymethyltransferase 1, mitochondrial (AtSHMT1) (EC 2.1.2.1) (Glycine hydroxymethyltransferase 1) (Serine Transhydroxymethyltransferase) (STM) (Serine methylase 1);"apoplast [GO:0048046]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stromule [GO:0010319]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; poly(U) RNA binding [GO:0008266]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; plant-type hypersensitive response [GO:0009626]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to light stimulus [GO:0009416]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0004372; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0007623; GO:0008266; GO:0008270; GO:0009409; GO:0009416; GO:0009534; GO:0009570; GO:0009626; GO:0009853; GO:0010319; GO:0016597; GO:0019264; GO:0022626; GO:0030170; GO:0035999; GO:0046653; GO:0046655; GO:0046686; GO:0048046; GO:0050897; GO:0070905; GO:1904482";"cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; plant-type hypersensitive response [GO:0009626]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to light stimulus [GO:0009416]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]";"apoplast [GO:0048046]; chloroplast stroma [GO:0009570]; chloroplast thylakoid [GO:0009534]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stromule [GO:0010319]";"amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; poly(U) RNA binding [GO:0008266]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]"
comp708822_c0_seq1;GAXK01065263.1;Q2KI24;1.32E-84;MTHSD_BOVIN;Methenyltetrahydrofolate synthase domain-containing protein;"cytoplasm [GO:0005737]; RNA binding [GO:0003723]";"GO:0003723; GO:0005737";;cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp70888_c2_seq1;GAXK01130311.1;Q9W0T1;4.45E-84;NU301_DROME;Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215);"nucleus [GO:0005634]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0005634; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0035064; GO:0035073; GO:0035076; GO:0042766; GO:0045824; GO:0046426; GO:0046872; GO:0048515; GO:0070577";"chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; NURF complex [GO:0016589]";"DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]"
comp7089_c0_seq1;GAXK01100798.1;P67999;0;KS6B1_RAT;Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA);"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]";"GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009611; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0010033; GO:0010243; GO:0014070; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030054; GO:0030165; GO:0031929; GO:0032496; GO:0032868; GO:0032869; GO:0032870; GO:0033574; GO:0033762; GO:0034612; GO:0035556; GO:0042277; GO:0042493; GO:0042802; GO:0043005; GO:0043200; GO:0043201; GO:0043434; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045948; GO:0046324; GO:0046627; GO:0048471; GO:0048633; GO:0048661; GO:0051384; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:2001237";"aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]";"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]"
comp7089592_c0_seq1;GAXK01038380.1;P96086;3.96E-18;TRI_THEAC;Tricorn protease (EC 3.4.21.-);"cytoplasm [GO:0005737]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]";"GO:0005737; GO:0006508; GO:0008236";proteolysis [GO:0006508];cytoplasm [GO:0005737];serine-type peptidase activity [GO:0008236]
comp70912_c2_seq1;GAXK01129863.1;O00291;1.21E-113;HIP1_HUMAN;Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I);"actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]";"GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030479; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0061024; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588";"actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]";"actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]";"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]"
comp7091496_c0_seq1;GAXK01154581.1;P47972;1.14E-09;NPTX2_HUMAN;Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005576; GO:0005886; GO:0007268; GO:0008306; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098962; GO:0098978";"associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; neuron projection development [GO:0031175]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp7092_c0_seq1;GAXK01100449.1;P17790;5.09E-07;BASI_CHICK;Basigin (5A11 antigen) (Blood-brain barrier HT7 antigen) (Neurothelin);"acrosomal membrane [GO:0002080]; axon [GO:0030424]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0002080; GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030424; GO:0042470; GO:0043231; GO:0070593; GO:0098632";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"acrosomal membrane [GO:0002080]; axon [GO:0030424]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp70938_c1_seq1;GAXK01129642.1;Q9BS26;3.24E-91;ERP44_HUMAN;Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4);"cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062";"cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]";"cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]";protein disulfide isomerase activity [GO:0003756]
comp70951_c3_seq1;GAXK01130059.1;Q96RG2;1.99E-82;PASK_HUMAN;PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0045727; GO:0046777; GO:0070092; GO:0097009";"energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp7095721_c0_seq1;GAXK01163021.1;Q46EH7;1.28E-18;HDG_METBF;Hypoxanthine DNA glycosylase (HDG) (EC 3.2.2.-);"hypoxanthine DNA N-glycosylase activity [GO:0097507]; DNA repair [GO:0006281]";"GO:0006281; GO:0097507";DNA repair [GO:0006281];;hypoxanthine DNA N-glycosylase activity [GO:0097507]
comp7096483_c0_seq1;GAXK01105210.1;A9BZW2;2.26E-33;SMC_DELAS;Chromosome partition protein Smc;"chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; sister chromatid cohesion [GO:0007062]";"GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0007062; GO:0030261";"chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; sister chromatid cohesion [GO:0007062]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]"
comp70968_c0_seq1;GAXK01129853.1;Q6GQ67;1.12E-22;LMD1A_XENLA;N-alpha-acetyltransferase 38-A, NatC auxiliary subunit (LSM domain-containing protein 1-A);"cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]";"GO:0005634; GO:0005737; GO:0031417; GO:0043066";negative regulation of apoptotic process [GO:0043066];"cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]";
comp70973_c3_seq1;GAXK01129846.1;Q9VVG4;0;EXOC1_DROME;Exocyst complex component 1 (Exocyst complex component Sec3);"exocyst [GO:0000145]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]";"GO:0000145; GO:0005546; GO:0005886; GO:0006887; GO:0006893; GO:0015031; GO:0017049; GO:0051601";"exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]";"exocyst [GO:0000145]; plasma membrane [GO:0005886]";"GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp709760_c2_seq1;GAXK01065227.1;Q9WV75;2.97E-56;SPON2_RAT;Spondin-2 (Mindin);"extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]";"GO:0005102; GO:0007155; GO:0031012; GO:0045087; GO:0046872";"cell adhesion [GO:0007155]; innate immune response [GO:0045087]";extracellular matrix [GO:0031012];"metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]"
comp7098630_c0_seq1;GAXK01083079.1;A2A935;3.80E-09;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp70998_c1_seq1;GAXK01130342.1;Q05AQ3;8.93E-78;S2542_XENTR;Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]";"GO:0005347; GO:0005739; GO:0005743; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122";"ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]"
comp71010_c0_seq1;GAXK01130134.1;Q9VMM6;2.83E-22;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp710100_c0_seq1;GAXK01028141.1;P10090;0;WHITE_DROME;Protein white;"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]";"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"
comp7102186_c0_seq1;GAXK01128238.1;P36609;1.86E-23;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7103220_c0_seq1;GAXK01128233.1;Q9Y462;1.75E-10;ZN711_HUMAN;Zinc finger protein 711 (Zinc finger protein 6);"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0031490; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp7103483_c0_seq1;GAXK01128240.1;A8ESU2;3.74E-53;RS10_ARCB4;30S ribosomal protein S10;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]";"GO:0000049; GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp710374_c0_seq1;GAXK01028088.1;P13497;4.03E-08;BMP1_HUMAN;Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; high-density lipoprotein particle assembly [GO:0034380]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0007275; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030154; GO:0031982; GO:0034380; GO:0042802; GO:0061036";"cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; high-density lipoprotein particle assembly [GO:0034380]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]";"calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp71046_c0_seq1;GAXK01130353.1;B2D0J5;1.65E-94;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp7105_c0_seq1;GAXK01101189.1;Q8N6F8;6.37E-11;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp710590_c0_seq1;GAXK01028085.1;Q91YL3;8.65E-76;UCKL1_MOUSE;Uridine-cytidine kinase-like 1 (EC 2.7.1.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206";"nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp7107485_c0_seq1;GAXK01146927.1;P55626;7.43E-31;Y4QE_SINFN;Putative transposase y4qE;"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0006313";transposition, DNA-mediated [GO:0006313];;"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp71087_c0_seq1;GAXK01130341.1;Q6P0I8;8.53E-20;EXOS6_DANRE;Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog);"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0071028; GO:0071051";"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]";"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]";RNA binding [GO:0003723]
comp7109546_c0_seq1;GAXK01140924.1;A1WHC3;7.35E-37;EFTU_VEREI;Elongation factor Tu (EF-Tu);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp71104_c0_seq1;GAXK01129815.1;Q7TSC3;8.24E-71;NEK5_MOUSE;Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5);"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]";"GO:0004672; GO:0004674; GO:0005524; GO:0046872; GO:0051155; GO:2001056";"positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]";;"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp711058_c0_seq1;GAXK01028129.1;Q9VPF0;1.47E-147;ATK_DROME;Protein artichoke;"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271";"cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]";
comp7112570_c0_seq1;GAXK01197941.1;Q0DK10;2.84E-68;RL11_ORYSJ;60S ribosomal protein L11;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp711298_c1_seq1;GAXK01028092.1;P11121;3.49E-53;CALM_PYUSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7115776_c0_seq1;GAXK01172428.1;Q9FJA6;2.12E-64;RS33_ARATH;40S ribosomal protein S3-3;"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; plastid [GO:0009536]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"GO:0003684; GO:0003723; GO:0003735; GO:0003906; GO:0005634; GO:0005730; GO:0005829; GO:0006281; GO:0006412; GO:0008534; GO:0009506; GO:0009536; GO:0022626; GO:0022627; GO:0032357; GO:0045739";"DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; plastid [GO:0009536]";"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7118415_c0_seq1;GAXK01038392.1;Q7LHG5;3.26E-12;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp711973_c1_seq1;GAXK01028133.1;A7Y7X5;2.90E-12;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp71214_c0_seq1;GAXK01130170.1;Q8NDN9;0;RCBT1_HUMAN;RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]";"GO:0005634; GO:0005737; GO:0006325; GO:0007049";"cell cycle [GO:0007049]; chromatin organization [GO:0006325]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp712169_c0_seq1;GAXK01191427.1;P17972;0;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp712190_c0_seq1;GAXK01191405.1;O75164;2.55E-25;KDM4A_HUMAN;Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]";"GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0008270; GO:0010507; GO:0010629; GO:0016032; GO:0016577; GO:0031625; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035097; GO:0045892; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
comp712226_c0_seq1;GAXK01191391.1;Q08C93;8.36E-31;ABD12_DANRE;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651";"acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp7123_c2_seq1;GAXK01100060.1;P14083;1.38E-41;LOV_DROME;Protein jim lovell (Protein TKR) (Tyrosine kinase-related) (dTKR);"nucleus [GO:0005634]; DNA binding [GO:0003677]; gravitaxis [GO:0042332]; larval feeding behavior [GO:0030536]; larval walking behavior [GO:0008346]; male courtship behavior [GO:0008049]; negative gravitaxis [GO:0048060]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";"GO:0003677; GO:0005634; GO:0006357; GO:0007418; GO:0008049; GO:0008346; GO:0030536; GO:0042332; GO:0048060; GO:0048477";"gravitaxis [GO:0042332]; larval feeding behavior [GO:0030536]; larval walking behavior [GO:0008346]; male courtship behavior [GO:0008049]; negative gravitaxis [GO:0048060]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral midline development [GO:0007418]";nucleus [GO:0005634];DNA binding [GO:0003677]
comp71231_c3_seq1;GAXK01129812.1;Q1HRV8;9.33E-79;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp71235_c0_seq1;GAXK01130112.1;A7S1L6;5.30E-131;FUCT1_NEMVE;GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; protein O-linked fucosylation [GO:0036066]";"GO:0000139; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0022857; GO:0036066; GO:0036085";"carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; protein O-linked fucosylation [GO:0036066]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]"
comp712560_c0_seq1;GAXK01191371.1;Q761V0;1.36E-16;SC6A5_MOUSE;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5);"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804";"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]";"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]";"glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]; metal ion binding [GO:0046872]"
comp7125929_c0_seq1;GAXK01127399.1;O02654;1.29E-66;ENO_DORPE;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase);"phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0006096";glycolytic process [GO:0006096];phosphopyruvate hydratase complex [GO:0000015];"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp71266_c0_seq1;GAXK01129859.1;Q8MKK4;1.47E-68;TRE12_DROME;Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; trehalose transport [GO:0015771]";"GO:0005351; GO:0005886; GO:0005887; GO:0015771; GO:0016020";trehalose transport [GO:0015771];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";carbohydrate:proton symporter activity [GO:0005351]
comp71269_c0_seq1;GAXK01130058.1;Q99NH2;1.68E-84;PARD3_MOUSE;Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Ephrin-interacting protein) (PHIP);"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-cell adhesion [GO:0098609]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]";"GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005913; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0098609";"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell cycle [GO:0007049]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]";"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol binding [GO:0035091]; protein phosphatase binding [GO:0019903]"
comp712755_c0_seq1;GAXK01191433.1;O75608;3.85E-18;LYPA1_HUMAN;Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]";"GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0006631; GO:0008474; GO:0016298; GO:0042997; GO:0050999; GO:0052689; GO:0070062";"fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]"
comp71279_c0_seq1;GAXK01130173.1;O46037;1.26E-90;VINC_DROME;Vinculin;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"GO:0005198; GO:0005737; GO:0005925; GO:0007016; GO:0007155; GO:0015629; GO:0051015; GO:0098592";"cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]";"actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]"
comp71283_c1_seq1;GAXK01129713.1;Q26491;1.96E-14;ITP_SCHGR;Ion transport peptide (ITP);"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp713_c0_seq1;GAXK01205884.1;P48643;0;TCPE_HUMAN;T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon);"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]";"GO:0003730; GO:0005524; GO:0005730; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874";"binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]";"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]"
comp713060_c0_seq1;GAXK01191361.1;Q12912;3.60E-17;LRMP_HUMAN;Lymphoid-restricted membrane protein (Protein Jaw1) [Cleaved into: Processed lymphoid-restricted membrane protein];"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"GO:0000922; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0007338; GO:0016020; GO:0016021; GO:0035577; GO:0043312";"neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]";"azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]";
comp71317_c0_seq1;GAXK01129872.1;A1L1P7;2.62E-31;DNLZ_DANRE;DNL-type zinc finger protein (mtHsp70-escort protein);"mitochondrion [GO:0005739]; chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]";"GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087";"protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]";mitochondrion [GO:0005739];"chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]"
comp713229_c0_seq1;GAXK01191412.1;Q3UVC0;1.98E-37;KSR2_MOUSE;Kinase suppressor of Ras 2 (EC 2.7.11.1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]";"GO:0004674; GO:0005078; GO:0005524; GO:0005829; GO:0005886; GO:0007265; GO:0019722; GO:0031434; GO:0043410; GO:0046872; GO:0120162";"calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]"
comp713262_c0_seq1;GAXK01191347.1;Q7TNG8;2.43E-177;LDHD_MOUSE;Probable D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.2.4);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; ATP biosynthetic process [GO:0006754]; lactate catabolic process [GO:1903457]";"GO:0004458; GO:0005739; GO:0005743; GO:0006754; GO:0008720; GO:0050660; GO:0071949; GO:1903457";"ATP biosynthetic process [GO:0006754]; lactate catabolic process [GO:1903457]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]"
comp7132791_c0_seq1;GAXK01065151.1;Q8CVJ0;1.98E-11;BTUB_ECOL6;Vitamin B12 transporter BtuB (Cobalamin receptor) (Outer membrane cobalamin translocator);"cell outer membrane [GO:0009279]; pore complex [GO:0046930]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; ion transport [GO:0006811]";"GO:0006811; GO:0009279; GO:0015288; GO:0015420; GO:0046872; GO:0046930";ion transport [GO:0006811];"cell outer membrane [GO:0009279]; pore complex [GO:0046930]";"ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; metal ion binding [GO:0046872]; porin activity [GO:0015288]"
comp713351_c0_seq1;GAXK01191409.1;Q9GRW0;2.36E-13;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp7133736_c0_seq1;GAXK01065152.1;Q3EDL4;6.71E-07;Y1154_ARATH;Probable serine/threonine-protein kinase At1g01540 (EC 2.7.11.1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0004674; GO:0004675; GO:0005524; GO:0005886; GO:0006468; GO:0016021; GO:0046777";"protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"
comp7134_c2_seq1;GAXK01101264.1;Q99L13;1.60E-116;3HIDH_MOUSE;3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31);"mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; valine catabolic process [GO:0006574]";"GO:0005739; GO:0006574; GO:0008442; GO:0050661; GO:0051287";valine catabolic process [GO:0006574];mitochondrion [GO:0005739];"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp71340_c2_seq1;GAXK01130057.1;Q3T0X7;1.28E-14;NSE1_BOVIN;Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]";"GO:0000724; GO:0000781; GO:0004842; GO:0005634; GO:0006301; GO:0030915; GO:0035556; GO:0046872; GO:0046983; GO:2001022";"double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]";"metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]"
comp71342_c0_seq1;GAXK01129929.1;E1BYJ2;0;MSH6_CHICK;DNA mismatch repair protein Msh6;"mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]";"GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910";"interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]";"mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]";"ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]"
comp71345_c1_seq1;GAXK01130124.1;Q64419;2.17E-15;EST1_MESAU;Liver carboxylesterase (EC 3.1.1.1);"endoplasmic reticulum lumen [GO:0005788]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005788; GO:0080030";;endoplasmic reticulum lumen [GO:0005788];methyl indole-3-acetate esterase activity [GO:0080030]
comp713500_c0_seq1;GAXK01191362.1;Q9NTW7;4.48E-20;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp71354_c5_seq1;GAXK01129650.1;O15374;2.55E-46;MOT5_HUMAN;Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020";monocarboxylic acid transport [GO:0015718];"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp7136261_c0_seq1;GAXK01058356.1;Q5IFJ7;1.17E-31;RL9_MACFA;60S ribosomal protein L9;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp713784_c0_seq1;GAXK01191403.1;Q9XVI9;1.12E-15;MLC5_CAEEL;Myosin-2 essential light chain;"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; mitotic cytokinesis [GO:0000281]";"GO:0000281; GO:0005509; GO:0005737; GO:0015629; GO:0016459";mitotic cytokinesis [GO:0000281];"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]";calcium ion binding [GO:0005509]
comp7138_c2_seq1;GAXK01100067.1;P41822;4.13E-29;FRI_AEDAE;Ferritin subunit (EC 1.16.3.1) (AeFer(H)) (Ferritin heavy chain-like protein);"cell [GO:0005623]; extracellular region [GO:0005576]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005576; GO:0005623; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"cell [GO:0005623]; extracellular region [GO:0005576]";"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp713983_c0_seq1;GAXK01191435.1;O94806;3.08E-26;KPCD3_HUMAN;Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700";"protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp71400_c0_seq1;GAXK01129820.1;E1C231;6.46E-95;LTN1_CHICK;E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (Zfp-294) (RING-type E3 ubiquitin transferase listerin);"cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]";"GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0061630; GO:0072344; GO:1990112; GO:1990116";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]";"cytosol [GO:0005829]; RQC complex [GO:1990112]";"ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp71411_c2_seq1;GAXK01130155.1;P57709;0;AT2C1_BOVIN;Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (Secretory pathway Ca(2+)-transporting ATPase);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005794; GO:0005802; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016021; GO:0016339; GO:0030026; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0043123; GO:0070588";"actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp7142_c0_seq1;GAXK01100237.1;P42325;5.79E-11;NCAH_DROME;Neurocalcin homolog (DrosNCa);"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";"GO:0005509; GO:0045938; GO:1902848";"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]";;calcium ion binding [GO:0005509]
comp714220_c0_seq1;GAXK01181873.1;P49632;8.58E-12;RL40_CAEEL;"Ubiquitin-60S ribosomal protein L40 (CEP52) [Cleaved into: Ubiquitin; 60S ribosomal protein L40]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; polarity specification of anterior/posterior axis [GO:0009949]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0009949; GO:0016567; GO:0019941; GO:0031386; GO:0031625";"modification-dependent protein catabolic process [GO:0019941]; polarity specification of anterior/posterior axis [GO:0009949]; protein ubiquitination [GO:0016567]; translation [GO:0006412]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]";"protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]"
comp7142694_c0_seq1;GAXK01198180.1;Q9DE27;4.41E-69;RUVB2_XENLA;RuvB-like 2 (EC 3.6.4.12) (Reptin);"Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]"
comp7143474_c0_seq1;GAXK01198177.1;Q5ENN5;1.91E-118;RBL2_HETTR;Ribulose bisphosphate carboxylase, chloroplastic (RuBisCO) (EC 4.1.1.39);"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0000287; GO:0004497; GO:0016021; GO:0016984; GO:0019253; GO:0031969";reductive pentose-phosphate cycle [GO:0019253];"chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]";"magnesium ion binding [GO:0000287]; monooxygenase activity [GO:0004497]; ribulose-bisphosphate carboxylase activity [GO:0016984]"
comp7145_c0_seq1;GAXK01101198.1;Q91WD5;0;NDUS2_MOUSE;NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979]";"GO:0005654; GO:0005739; GO:0005747; GO:0006979; GO:0008137; GO:0031625; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539";"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]"
comp714671_c0_seq1;GAXK01181808.1;O88780;2.62E-24;KLK8_RAT;Kallikrein-8 (EC 3.4.21.118) (Brain serine protease 1) (Neuropsin) (NP) (Serine protease 19);"extracellular space [GO:0005615]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]";"GO:0004252; GO:0005615; GO:0007613; GO:0008219; GO:0009611; GO:0030141; GO:0031642; GO:0043616; GO:0048681; GO:0048812; GO:0050807";"cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]";"extracellular space [GO:0005615]; secretory granule [GO:0030141]";serine-type endopeptidase activity [GO:0004252]
comp71471_c1_seq1;GAXK01130323.1;Q7KRI2;1.48E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp71474_c3_seq1;GAXK01129946.1;Q9HFV1;1.81E-17;CYB5_RHIST;Cytochrome b5;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005789; GO:0016021; GO:0020037; GO:0046872; GO:0055114";oxidation-reduction process [GO:0055114];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp71483_c0_seq1;GAXK01129930.1;O61492;0;FLOT2_DROME;Flotillin-2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0061357";"cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]";structural molecule activity [GO:0005198]
comp7148360_c0_seq1;GAXK01003560.1;Q46087;5.29E-20;TRAT_AMIAI;Transposase;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";"GO:0003677; GO:0006310; GO:0015074; GO:0032196";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196]";;DNA binding [GO:0003677]
comp714847_c0_seq1;GAXK01181885.1;P20482;1.88E-32;CNC_DROME;Segmentation protein cap'n'collar;"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"GO:0003677; GO:0003700; GO:0005634; GO:0005703; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465";"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]";"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]"
comp714849_c0_seq1;GAXK01181877.1;Q10L91;1.39E-09;DIS1_ORYSJ;E3 ubiquitin-protein ligase DIS1 (EC 2.3.2.27) (Drought-induced SINA protein 1) (OsDIS1) (RING-type E3 ubiquitin transferase DIS1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0061630; GO:0080148";"multicellular organism development [GO:0007275]; negative regulation of response to water deprivation [GO:0080148]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp714959_c0_seq1;GAXK01181864.1;Q27433;1.95E-63;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp7151027_c0_seq1;GAXK01197937.1;O08893;4.74E-14;CALCR_CAVPO;Calcitonin receptor (CT-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004948; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcitonin receptor activity [GO:0004948]
comp71514_c1_seq1;GAXK01129720.1;Q9W092;7.47E-131;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp715232_c0_seq1;GAXK01181825.1;Q8W257;2.27E-13;PFI_PTIFI;Polyenoic fatty acid isomerase (PFI) (EC 5.3.3.13);"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]";"GO:0016491; GO:0034016";;;"oxidoreductase activity [GO:0016491]; polyenoic fatty acid isomerase activity [GO:0034016]"
comp71524_c1_seq1;GAXK01130411.1;Q92072;2.38E-07;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp71535_c9_seq1;GAXK01130020.1;Q3ZBI6;4.22E-36;FHL3_BOVIN;Four and a half LIM domains protein 3 (FHL-3);"nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]";"GO:0001725; GO:0003779; GO:0005634; GO:0030018; GO:0030036; GO:0046872";actin cytoskeleton organization [GO:0030036];"nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; metal ion binding [GO:0046872]"
comp7153971_c0_seq1;GAXK01089854.1;Q21SF4;5.98E-50;RL1_RHOFT;50S ribosomal protein L1;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; translation [GO:0006412]";"GO:0000049; GO:0003735; GO:0006412; GO:0006417; GO:0015934; GO:0019843";"regulation of translation [GO:0006417]; translation [GO:0006412]";large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp7154123_c0_seq1;GAXK01090524.1;Q9ZF60;8.49E-21;GLTI_SALTY;Glutamate/aspartate import solute-binding protein;"outer membrane-bounded periplasmic space [GO:0030288]; amino acid transport [GO:0006865]";"GO:0006865; GO:0030288";amino acid transport [GO:0006865];outer membrane-bounded periplasmic space [GO:0030288];
comp7154367_c0_seq1;GAXK01090523.1;Q874B9;4.91E-47;EF2_PICPA;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp715450_c0_seq1;GAXK01181824.1;Q96GR2;5.39E-33;ACBG1_HUMAN;Long-chain-fatty-acid--CoA ligase ACSBG1 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 1) (hBG1) (hsBG) (hsBGM) (Lipidosin);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038]";"GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0031957; GO:0035338; GO:0042552; GO:0051384; GO:0102391";"long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp715457_c0_seq1;GAXK01181853.1;O09174;2.73E-133;AMACR_MOUSE;Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase);"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]";"GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008300; GO:0008410; GO:0043231";"bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]";"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]";"alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]"
comp71562_c0_seq1;GAXK01130313.1;P0DPW5;1.46E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp715683_c0_seq1;GAXK01181841.1;Q6DHG0;1.75E-34;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp71574_c0_seq1;GAXK01130031.1;Q63150;0;DPYS_RAT;Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase);"cytosol [GO:0005829]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]";"GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0051219; GO:0051260; GO:0051289";"beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]";cytosol [GO:0005829];"amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]"
comp715841_c0_seq1;GAXK01181847.1;Q5E9Y5;6.36E-56;DXO_BOVIN;Decapping and exoribonuclease protein (DXO) (EC 3.1.13.-) (EC 3.6.1.-) (Dom-3 homolog Z);"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]";"GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305";"mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]";nucleus [GO:0005634];"5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA pyrophosphohydrolase activity [GO:0034353]"
comp715887_c0_seq1;GAXK01181816.1;P48607;2.64E-07;SPZ_DROME;Protein spaetzle [Cleaved into: Protein spaetzle C-106];"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0002804; GO:0002807; GO:0005121; GO:0005125; GO:0005576; GO:0005615; GO:0006965; GO:0006967; GO:0007310; GO:0007399; GO:0007526; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0009611; GO:0009950; GO:0009953; GO:0021556; GO:0031334; GO:0031640; GO:0032991; GO:0042542; GO:0042803; GO:0045087; GO:0045752; GO:0048018; GO:0050829; GO:0050830; GO:0050832; GO:0061760";"antifungal innate immune response [GO:0061760]; central nervous system formation [GO:0021556]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; oocyte dorsal/ventral axis specification [GO:0007310]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of Toll signaling pathway [GO:0008592]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; Toll signaling pathway [GO:0008063]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]";"cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp715963_c1_seq1;GAXK01181826.1;Q9VXD1;1.98E-20;SINGL_DROME;Protein singles bar;"integral component of membrane [GO:0016021]; adult somatic muscle development [GO:0007527]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]";"GO:0007517; GO:0007520; GO:0007527; GO:0016021";"adult somatic muscle development [GO:0007527]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]";integral component of membrane [GO:0016021];
comp715996_c2_seq1;GAXK01181861.1;O09160;5.11E-13;FUT1_MOUSE;Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065";"carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]
comp71602_c6_seq1;GAXK01130269.1;Q27128;1.48E-133;PAPSS_URECA;"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]";"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103]";"GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779";sulfate assimilation [GO:0000103];;"adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]"
comp716137_c0_seq1;GAXK01136682.1;Q69Z37;6.89E-52;SAM9L_MOUSE;Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536";"common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]";"cytoplasm [GO:0005737]; early endosome [GO:0005769]";
comp716248_c0_seq1;GAXK01136714.1;Q5BJJ5;6.45E-57;HDHD2_DANRE;Haloacid dehalogenase-like hydrolase domain-containing protein 2;"metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]";"GO:0016311; GO:0016791; GO:0046872";dephosphorylation [GO:0016311];;"metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]"
comp716368_c0_seq1;GAXK01136806.1;P00765;5.97E-45;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp7164699_c0_seq1;GAXK01131016.1;O70244;1.17E-09;CUBN_RAT;Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"GO:0001701; GO:0005509; GO:0005765; GO:0005798; GO:0005886; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0043202; GO:0070207";"cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]"
comp7166225_c0_seq1;GAXK01054335.1;Q09575;8.21E-14;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp71669_c0_seq1;GAXK01129648.1;Q6DJR2;9.56E-51;WWC2_XENTR;Protein WWC2 (WW domain-containing protein 2);;;;;
comp71673_c0_seq1;GAXK01130317.1;A7MD70;7.11E-15;SPDLY_DANRE;Protein Spindly (Coiled-coil domain-containing protein 99) (Spindle apparatus coiled-coil domain-containing protein 1);"condensed chromosome outer kinetochore [GO:0000940]; nucleus [GO:0005634]; spindle pole [GO:0000922]; kinetochore binding [GO:0043515]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]";"GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0007080; GO:0007094; GO:0034501; GO:0043515; GO:0051301";"cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]";"condensed chromosome outer kinetochore [GO:0000940]; nucleus [GO:0005634]; spindle pole [GO:0000922]";kinetochore binding [GO:0043515]
comp716757_c0_seq1;GAXK01136688.1;Q8VCV9;4.11E-27;MF4B1_MOUSE;Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp71687_c3_seq1;GAXK01129876.1;Q9BJZ5;0;FUSIL_DROME;RNA-binding protein fusilli;"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";"GO:0003729; GO:0005634; GO:0006397; GO:0008380; GO:0043484";"mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]";nucleus [GO:0005634];mRNA binding [GO:0003729]
comp7169_c7_seq1;GAXK01100426.1;E2RG47;0;STT3B_CANLF;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18);"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0004579; GO:0006516; GO:0006986; GO:0008250; GO:0016021; GO:0018279; GO:0030433; GO:0034998; GO:0034999; GO:0043686; GO:0043687; GO:0046872";"co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]";"dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]"
comp716906_c0_seq1;GAXK01136771.1;P0C8G5;7.91E-20;UBC_ASFWA;Ubiquitin-conjugating enzyme E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) (pI215L);"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]";"GO:0005524; GO:0016567; GO:0016740; GO:0030430; GO:0042025";protein ubiquitination [GO:0016567];"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]";"ATP binding [GO:0005524]; transferase activity [GO:0016740]"
comp716955_c0_seq1;GAXK01136753.1;P94681;1.41E-35;TSAC_COMTE;4-formylbenzenesulfonate dehydrogenase TsaC1/TsaC2 (EC 1.2.1.62) (Toluenesulfonate zinc-independent alcohol dehydrogenase TsaC);"4-formylbenzenesulfonate dehydrogenase activity [GO:0018482]; aromatic compound catabolic process [GO:0019439]";"GO:0018482; GO:0019439";aromatic compound catabolic process [GO:0019439];;4-formylbenzenesulfonate dehydrogenase activity [GO:0018482]
comp716966_c0_seq1;GAXK01136813.1;Q9H165;1.33E-18;BC11A_HUMAN;B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173";"cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp717189_c1_seq1;GAXK01136735.1;P52759;1.27E-44;RIDA_RAT;2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (Liver perchloric acid-soluble protein) (L-PSP) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog) (rp14.5);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; ion binding [GO:0043167]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]";"GO:0001822; GO:0003729; GO:0005634; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0030324; GO:0033993; GO:0036041; GO:0042803; GO:0043167; GO:0046914; GO:0050680; GO:0061157; GO:0070314; GO:1901565; GO:1902074";"brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]";"deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; ion binding [GO:0043167]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; transition metal ion binding [GO:0046914]"
comp717205_c0_seq1;GAXK01136710.1;Q9NRA2;4.46E-75;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp7172303_c0_seq1;GAXK01034090.1;P46348;8.90E-23;MNES_BACSU;Manganese efflux system protein MneS;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; cation transmembrane transporter activity [GO:0008324]; ferrous iron transmembrane transporter activity [GO:0015093]; zinc efflux active transmembrane transporter activity [GO:0015341]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; cellular zinc ion homeostasis [GO:0006882]";"GO:0005886; GO:0006876; GO:0006879; GO:0006882; GO:0008324; GO:0015086; GO:0015093; GO:0015341; GO:0016020; GO:0016021";"cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; cellular zinc ion homeostasis [GO:0006882]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cadmium ion transmembrane transporter activity [GO:0015086]; cation transmembrane transporter activity [GO:0008324]; ferrous iron transmembrane transporter activity [GO:0015093]; zinc efflux active transmembrane transporter activity [GO:0015341]"
comp7172792_c0_seq1;GAXK01034089.1;Q9C1C2;9.67E-26;KAPR_COLOR;cAMP-dependent protein kinase regulatory subunit (PKA regulatory subunit);"cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]";"GO:0005952; GO:0008603; GO:0030552";;cAMP-dependent protein kinase complex [GO:0005952];"cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp717318_c1_seq1;GAXK01136686.1;Q9UII5;7.08E-26;ZN107_HUMAN;Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7173273_c0_seq1;GAXK01034084.1;Q9GZV8;1.64E-14;PRD14_HUMAN;PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459";"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp7173336_c0_seq1;GAXK01034083.1;Q24732;1.72E-08;GLAS_DROVI;Protein glass;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0046872; GO:0050896";"regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp717357_c0_seq1;GAXK01136703.1;Q9WTN6;3.11E-33;S22AL_MOUSE;Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9);"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]";"GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231";carnitine transport [GO:0015879];"integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]"
comp71737_c0_seq1;GAXK01130135.1;Q9N2M8;3.80E-69;HDC_DROME;Headcase protein [Cleaved into: Headcase short protein];"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"GO:0002165; GO:0005737; GO:0007430; GO:0016246; GO:0030424; GO:0030425; GO:0035071; GO:0048471; GO:0048675; GO:0050768; GO:1904799";"axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]";
comp7175959_c0_seq1;GAXK01099762.1;P69051;6.37E-13;BACR1_HALC1;Archaerhodopsin-1 (AR 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005216; GO:0005886; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]"
comp717604_c0_seq1;GAXK01136796.1;A6QLU5;4.53E-22;ZN184_BOVIN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp71761_c1_seq1;GAXK01130405.1;Q9V579;4.16E-28;PREL_DROME;Protein preli-like;"mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]";"GO:0005739; GO:0005758; GO:0015914; GO:0030061; GO:0048813; GO:0070584; GO:1990050";"dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]";"mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";phosphatidic acid transfer activity [GO:1990050]
comp717625_c0_seq1;GAXK01136734.1;Q9VCA2;6.54E-72;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp717651_c0_seq1;GAXK01136754.1;O13124;3.33E-07;VDR_XENLA;Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0008270; GO:0043565; GO:0070561";vitamin D receptor signaling pathway [GO:0070561];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp7177173_c0_seq1;GAXK01071193.1;A3KN36;1.39E-14;ZNF19_BOVIN;Zinc finger protein 19;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7178840_c0_seq1;GAXK01198756.1;Q96JB1;1.81E-48;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp717914_c0_seq1;GAXK01136746.1;Q9NZ20;3.72E-21;PA2G3_HUMAN;Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3);"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"GO:0001675; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0007288; GO:0016042; GO:0019372; GO:0036148; GO:0036151; GO:0036152; GO:0042629; GO:0043303; GO:0046872; GO:0047498; GO:0050482; GO:0060271; GO:0102567; GO:0102568";"acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]";"calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp717974_c0_seq1;GAXK01136773.1;O35923;6.32E-51;BRCA2_RAT;Breast cancer type 2 susceptibility protein homolog (Fanconi anemia group D1 protein homolog);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome orientation involved in meiotic metaphase I plate congression [GO:0031619]; mammary gland development [GO:0030879]; multicellular organism growth [GO:0035264]; response to estradiol [GO:0032355]; response to nutrient [GO:0007584]; spermatogenesis [GO:0007283]";"GO:0000724; GO:0003697; GO:0005634; GO:0005737; GO:0005813; GO:0006310; GO:0007283; GO:0007584; GO:0030879; GO:0031619; GO:0032355; GO:0035264";"DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome orientation involved in meiotic metaphase I plate congression [GO:0031619]; mammary gland development [GO:0030879]; multicellular organism growth [GO:0035264]; response to estradiol [GO:0032355]; response to nutrient [GO:0007584]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";single-stranded DNA binding [GO:0003697]
comp718004_c0_seq1;GAXK01039465.1;Q5RBF2;0;NED4L_PONAB;E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L);"Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005771; GO:0005794; GO:0006511; GO:0030154; GO:0061630";"cell differentiation [GO:0030154]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]";ubiquitin protein ligase activity [GO:0061630]
comp71808_c2_seq1;GAXK01130360.1;Q8NAB2;1.53E-21;KBTB3_HUMAN;Kelch repeat and BTB domain-containing protein 3 (BTB and kelch domain-containing protein 3);;;;;
comp71817_c0_seq1;GAXK01129719.1;Q9PU85;1.70E-106;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp718219_c2_seq1;GAXK01039450.1;Q8K4K7;1.55E-24;ABRA_RAT;Actin-binding Rho-activating protein (MS1) (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp718262_c0_seq1;GAXK01039428.1;Q8WTS6;7.36E-27;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp71827_c0_seq1;GAXK01130276.1;Q6WV17;1.30E-176;GALT5_DROME;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp718337_c1_seq1;GAXK01039433.1;P40792;1.36E-44;RAC1_DROME;Ras-related protein Rac1;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; adherens junction maintenance [GO:0034334]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]";"GO:0000902; GO:0001726; GO:0001954; GO:0002433; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0007015; GO:0007254; GO:0007266; GO:0007298; GO:0007390; GO:0007391; GO:0007394; GO:0007395; GO:0007411; GO:0007413; GO:0007419; GO:0007422; GO:0007424; GO:0007426; GO:0007435; GO:0007516; GO:0007520; GO:0007613; GO:0008045; GO:0008078; GO:0008258; GO:0008283; GO:0008347; GO:0009611; GO:0010593; GO:0016028; GO:0016199; GO:0016203; GO:0016358; GO:0016477; GO:0019897; GO:0019901; GO:0030032; GO:0030036; GO:0030707; GO:0030866; GO:0031175; GO:0031410; GO:0031532; GO:0032147; GO:0032794; GO:0034334; GO:0035010; GO:0035011; GO:0035099; GO:0035212; GO:0035320; GO:0042052; GO:0042995; GO:0045773; GO:0046330; GO:0046664; GO:0046843; GO:0048010; GO:0048615; GO:0048675; GO:0048747; GO:0048812; GO:0048813; GO:0048814; GO:0050770; GO:0050807; GO:0050975; GO:0051017; GO:0051450; GO:0051491; GO:0051963; GO:0071902; GO:0071907; GO:0090303; GO:0097206; GO:1902669; GO:1903688; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; adherens junction maintenance [GO:0034334]; axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]";"GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp71844_c0_seq1;GAXK01130166.1;Q6IMZ0;3.53E-18;NFIL3_RAT;Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";"GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893; GO:0071353";"cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp7184977_c0_seq1;GAXK01109563.1;Q1H9T6;6.48E-09;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp7185226_c0_seq1;GAXK01109564.1;Q3SZQ6;2.26E-41;RL32_BOVIN;60S ribosomal protein L32;"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp7185275_c0_seq1;GAXK01109560.1;Q92193;7.11E-60;ACT_CRAVI;Actin (Fragment);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]";"GO:0005524; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";ATP binding [GO:0005524]
comp718650_c0_seq1;GAXK01039434.1;Q9ULC3;3.82E-52;RAB23_HUMAN;Ras-related protein Rab-23;"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0030054; GO:0030670; GO:0032482; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094";"autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; Rab protein signal transduction [GO:0032482]";"autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp7186520_c0_seq1;GAXK01119459.1;O54904;3.29E-10;B3GT1_MOUSE;Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006682; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275";"galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp718660_c0_seq1;GAXK01039481.1;A2APF3;2.42E-24;CTCFL_MOUSE;Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0006349; GO:0010628; GO:0016571; GO:0042393; GO:0043046; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051569";"DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp718765_c0_seq1;GAXK01039487.1;P52746;5.95E-10;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp71877_c1_seq1;GAXK01130263.1;Q27367;1.17E-30;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp7188_c0_seq1;GAXK01100324.1;Q4R562;2.88E-163;ARRB1_MACFA;Beta-arrestin-1 (Arrestin beta-1);"clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001934; GO:0002092; GO:0005634; GO:0005886; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746";"negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]";
comp718898_c0_seq1;GAXK01039429.1;O62849;4.77E-90;ACOD_SHEEP;Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491";unsaturated fatty acid biosynthetic process [GO:0006636];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]"
comp71901_c0_seq1;GAXK01129932.1;B4LMQ3;1.63E-145;FBSP1_DROVI;F-box/SPRY domain-containing protein 1;"cell cortex [GO:0005938]; cell junction [GO:0030054]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005938; GO:0007274; GO:0007399; GO:0010629; GO:0016567; GO:0019005; GO:0030054; GO:0031594; GO:0045495; GO:0045732; GO:0045886";"negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]";"cell cortex [GO:0005938]; cell junction [GO:0030054]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp7190266_c0_seq1;GAXK01195544.1;Q9DC53;1.32E-36;CPNE8_MOUSE;Copine-8 (Copine VIII);"plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0071277";cellular response to calcium ion [GO:0071277];plasma membrane [GO:0005886];calcium-dependent phospholipid binding [GO:0005544]
comp7190271_c0_seq1;GAXK01195541.1;P50886;2.08E-30;RL22_XENLA;60S ribosomal protein L22;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp719181_c0_seq1;GAXK01039388.1;Q20065;5.42E-40;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp7192824_c0_seq1;GAXK01069469.1;P51405;5.07E-54;RS4_DICDI;40S ribosomal protein S4;"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]; inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"GO:0000822; GO:0003735; GO:0005856; GO:0006412; GO:0019843; GO:0022627; GO:0030036; GO:0031012; GO:0032991";"actin cytoskeleton organization [GO:0030036]; translation [GO:0006412]";"cytoskeleton [GO:0005856]; cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; protein-containing complex [GO:0032991]";"inositol hexakisphosphate binding [GO:0000822]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp7196085_c0_seq1;GAXK01034361.1;P04323;2.67E-07;POL3_DROME;"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp71972_c0_seq1;GAXK01130369.1;Q8IN81;2.80E-20;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7197412_c0_seq1;GAXK01034363.1;P63326;5.36E-22;RS10_RAT;40S ribosomal protein S10;"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; ribosomal small subunit assembly [GO:0000028]";"GO:0000028; GO:0000049; GO:0003735; GO:0005730; GO:0022627";ribosomal small subunit assembly [GO:0000028];"cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp7197447_c0_seq1;GAXK01034362.1;Q27238;1.69E-29;ADT1_ANOGA;ADP,ATP carrier protein 1 (ADP/ATP translocase 1) (Adenine nucleotide translocator 1) (ANT 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]";"GO:0005471; GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP:ADP antiporter activity [GO:0005471]
comp719781_c0_seq1;GAXK01039435.1;Q75NA5;1.81E-145;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp719785_c0_seq1;GAXK01039452.1;P42788;1.61E-27;CBPZ_SIMVI;Zinc carboxypeptidase (EC 3.4.17.-) (Fragment);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp7197980_c0_seq1;GAXK01034356.1;O02002;2.10E-46;CASP1_DROME;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p22; Caspase-1 subunit p13]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"GO:0004197; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007275; GO:0007300; GO:0007303; GO:0009267; GO:0010508; GO:0010623; GO:0012501; GO:0016239; GO:0016322; GO:0043025; GO:0045476; GO:0048477; GO:0071598; GO:0097153; GO:0097194; GO:0097200; GO:1900074; GO:1990124; GO:1990525";"apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; execution phase of apoptosis [GO:0097194]; multicellular organism development [GO:0007275]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]";"BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]"
comp719801_c1_seq1;GAXK01039447.1;Q9NUA8;6.48E-19;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7198119_c0_seq1;GAXK01049445.1;P0DM39;1.14E-10;SLDB_TRIAB;Snaclec alboaggregin-D subunit beta;"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp7199254_c0_seq1;GAXK01049441.1;P15112;2.69E-47;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp71993_c1_seq1;GAXK01129924.1;Q16JS8;0;SPNE_AEDAE;Probable ATP-dependent RNA helicase spindle-E (EC 3.6.4.13);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003676; GO:0003724; GO:0005524; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0051321";"cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp719940_c1_seq1;GAXK01039387.1;B2RU80;3.19E-45;PTPRB_MOUSE;Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP);"integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]";"GO:0001525; GO:0004725; GO:0016021; GO:0016311; GO:0043235; GO:0045296";"angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]";"integral component of membrane [GO:0016021]; receptor complex [GO:0043235]";"cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]"
comp719942_c0_seq1;GAXK01039419.1;Q8C3J5;3.63E-28;DOCK2_MOUSE;Dedicator of cytokinesis protein 2 (Protein Hch);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell activation [GO:0046631]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive regulation of Rac protein signal transduction [GO:0035022]; positive thymic T cell selection [GO:0045059]; small GTPase mediated signal transduction [GO:0007264]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]";"GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005096; GO:0005737; GO:0005856; GO:0006935; GO:0007010; GO:0007264; GO:0012505; GO:0016020; GO:0030036; GO:0030676; GO:0035022; GO:0042098; GO:0042110; GO:0042608; GO:0044351; GO:0045059; GO:0045060; GO:0046631; GO:0046633; GO:0050766";"actin cytoskeleton organization [GO:0030036]; alpha-beta T cell activation [GO:0046631]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive regulation of Rac protein signal transduction [GO:0035022]; positive thymic T cell selection [GO:0045059]; small GTPase mediated signal transduction [GO:0007264]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]"
comp719956_c1_seq1;GAXK01039445.1;P49010;6.65E-21;HEXC_BOMMO;Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase);"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004563; GO:0006032; GO:0102148";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";;"beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp7199565_c0_seq1;GAXK01049442.1;P42972;9.64E-11;YCSN_BACSU;Uncharacterized oxidoreductase YcsN (EC 1.-.-.-);"cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]";"GO:0005829; GO:0016491";;cytosol [GO:0005829];oxidoreductase activity [GO:0016491]
comp720282_c1_seq1;GAXK01093185.1;Q75N90;9.29E-44;FBN3_HUMAN;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];"extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]";"GO:0005201; GO:0005509; GO:0031012";;extracellular matrix [GO:0031012];"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
comp72030_c3_seq1;GAXK01017193.1;Q8WVV9;5.62E-26;HNRLL_HUMAN;Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor);"membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]";"GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0016020; GO:0033120";"mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]";"membrane [GO:0016020]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp72031_c0_seq1;GAXK01017304.1;Q9VR50;6.21E-99;S35E1_DROME;Solute carrier family 35 member E1 homolog;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]";"GO:0005794; GO:0015297; GO:0016021; GO:0022857";;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]"
comp7203698_c0_seq1;GAXK01022645.1;Q9P4W9;1.20E-56;RS4C_SCHPO;40S ribosomal protein S4-C;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003735; GO:0005829; GO:0006412; GO:0019843; GO:0022627";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp720371_c1_seq1;GAXK01093243.1;E9PW05;1.83E-12;ZFP54_MOUSE;Zinc finger protein 54 (Krueppel-associated box protein 10) (KRAB10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp720434_c0_seq1;GAXK01093184.1;Q6YCH1;1.46E-15;TDPZ5_MOUSE;TD and POZ domain-containing protein 5;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp720439_c0_seq1;GAXK01093210.1;X2JAU8;2.02E-93;NWK_DROME;Protein nervous wreck (Nwk);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030054; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601";"multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]";"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"
comp7204413_c0_seq1;GAXK01081400.1;Q8WTS6;8.50E-13;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp7205533_c0_seq1;GAXK01081399.1;Q8TE73;1.28E-41;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7206_c1_seq1;GAXK01100255.1;Q9NZN8;1.73E-98;CNOT2_HUMAN;CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2);"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036";"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]";"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]";"RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]"
comp720644_c0_seq1;GAXK01093282.1;Q90271;1.01E-15;RARAA_DANRE;Retinoic acid receptor alpha-A (RAR-alpha-A) (Nuclear receptor subfamily 1 group B member 1-A) (Retinoic acid receptor alpha) (zRAR alpha) (Retinoic acid receptor alpha-2.A) (RAR-alpha-2.A);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; epithelium development [GO:0060429]; gland development [GO:0048732]; hindbrain morphogenesis [GO:0021575]; hormone-mediated signaling pathway [GO:0009755]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001889; GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0021575; GO:0030154; GO:0030374; GO:0032526; GO:0033993; GO:0038023; GO:0045944; GO:0048384; GO:0048732; GO:0060349; GO:0060429; GO:0071300; GO:0090575";"bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; epithelium development [GO:0060429]; gland development [GO:0048732]; hindbrain morphogenesis [GO:0021575]; hormone-mediated signaling pathway [GO:0009755]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp720645_c1_seq1;GAXK01093234.1;Q7KRI2;1.05E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp72072_c8_seq1;GAXK01017333.1;B0W429;9.05E-126;FICD_CULQU;Protein adenylyltransferase Fic (EC 2.7.7.n1) (De-AMPylase Fic) (EC 3.1.4.-);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117]";"GO:0005524; GO:0016021; GO:0016787; GO:0018117; GO:0070733";protein adenylylation [GO:0018117];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]"
comp7207501_c0_seq1;GAXK01087627.1;P75853;1.33E-57;SSUA_ECOLI;Putative aliphatic sulfonates-binding protein;"membrane [GO:0016020]; periplasmic space [GO:0042597]; ATPase-coupled transmembrane transporter activity [GO:0042626]; sulfur compound metabolic process [GO:0006790]";"GO:0006790; GO:0016020; GO:0042597; GO:0042626";sulfur compound metabolic process [GO:0006790];"membrane [GO:0016020]; periplasmic space [GO:0042597]";ATPase-coupled transmembrane transporter activity [GO:0042626]
comp720753_c0_seq1;GAXK01093208.1;Q7TSH9;2.79E-22;ZN184_MOUSE;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp720775_c0_seq1;GAXK01093171.1;P13590;7.23E-10;NCAM1_CHICK;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]";"GO:0005886; GO:0007156; GO:0016021; GO:0099560";"homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp72078_c2_seq1;GAXK01017069.1;Q24206;1.04E-31;BRC4_DROME;Broad-complex core protein isoform 6;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp72094_c0_seq1;GAXK01017221.1;Q2VG86;1.27E-60;BAEE_BOMMO;"CLIP domain-containing serine protease 2 (EC 3.4.21.-) (BzArgOEtase) (BAEEase) [Cleaved into: CLIP domain-containing serine protease 2 light chain; CLIP domain-containing serine protease 2 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004175; GO:0004252; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp721003_c0_seq1;GAXK01093258.1;P11734;1.59E-07;CU08_LOCMI;Cuticle protein 8 (LM-ACP 8) (LM-8);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp72109_c0_seq1;GAXK01017406.1;Q9NW07;1.74E-21;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp721119_c0_seq1;GAXK01093176.1;D3YXG0;1.76E-22;HMCN1_MOUSE;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp7212674_c0_seq1;GAXK01148010.1;Q42684;3.88E-54;SODM_CHLRE;Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1);"mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005759; GO:0046872";;mitochondrial matrix [GO:0005759];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp721368_c0_seq1;GAXK01093244.1;Q8VCV9;1.33E-17;MF4B1_MOUSE;Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005355; GO:0005887; GO:0006814; GO:0015293; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]";"glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]"
comp72140_c0_seq1;GAXK01017281.1;Q8BLB0;1.53E-20;ZFP3_MOUSE;Zinc finger protein 3 (Zfp-3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp72142_c0_seq1;GAXK01017134.1;Q9VUB4;1.64E-35;NPRL3_DROME;GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein);"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]";"GO:0005634; GO:0005737; GO:0005764; GO:0007293; GO:0010898; GO:0016239; GO:0032007; GO:0034198; GO:0035859; GO:0038202; GO:0044754; GO:0045792; GO:0048477; GO:0051301; GO:0051321; GO:0061700; GO:1904262; GO:1904766; GO:1990130; GO:2000785";"cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; oogenesis [GO:0048477]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]";"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]";
comp721432_c0_seq1;GAXK01093265.1;Q14588;7.82E-09;ZN234_HUMAN;Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp721485_c0_seq1;GAXK01093237.1;P17789;4.34E-23;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp7215_c0_seq1;GAXK01205491.1;Q9Z255;1.09E-96;UBE2A_MOUSE;Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A);"chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]";"GO:0000209; GO:0000785; GO:0000790; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0006281; GO:0008284; GO:0009411; GO:0016567; GO:0031625; GO:0033503; GO:0033522; GO:0043161; GO:0051865; GO:0060135; GO:0061631; GO:0070936; GO:0070979";"blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]";"chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp721532_c0_seq1;GAXK01093187.1;O54963;2.40E-17;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp72160_c0_seq1;GAXK01017473.1;Q9VMM6;1.45E-10;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp72161_c0_seq1;GAXK01017283.1;Q6PFX9;0;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp721675_c1_seq1;GAXK01093222.1;Q9JI74;3.24E-15;KLHL1_MOUSE;Kelch-like protein 1;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]";"GO:0003779; GO:0005737; GO:0005856; GO:0007626; GO:0007628; GO:0016358; GO:0021680; GO:0030425; GO:0043025";"adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]";actin binding [GO:0003779]
comp72208_c1_seq1;GAXK01016997.1;Q9Z2Z3;2.71E-20;PEX14_CRILO;Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14);"peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]";"GO:0003714; GO:0005777; GO:0005778; GO:0016558; GO:0016560; GO:0043433; GO:0045892; GO:0047485; GO:0051260";"negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]";"peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]"
comp72215_c5_seq1;GAXK01017243.1;Q9NZ20;4.65E-22;PA2G3_HUMAN;Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3);"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"GO:0001675; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0007288; GO:0016042; GO:0019372; GO:0036148; GO:0036151; GO:0036152; GO:0042629; GO:0043303; GO:0046872; GO:0047498; GO:0050482; GO:0060271; GO:0102567; GO:0102568";"acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]";"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]";"calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
comp7221515_c0_seq1;GAXK01072252.1;Q8W4N3;5.95E-07;UBP2_ARATH;Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (Deubiquitinating enzyme 2) (AtUBP2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2);"proteasome complex [GO:0000502]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0004197; GO:0004843; GO:0006511; GO:0008270; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";proteasome complex [GO:0000502];"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]"
comp72222_c0_seq1;GAXK01017323.1;F4ILY9;3.04E-10;AVT3B_ARATH;Amino acid transporter AVT3B (AtAvt3B) (Aromatic and neutral amino acid transporter-like protein 1);"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]";"GO:0003333; GO:0005774; GO:0015171; GO:0015175; GO:0015804; GO:0016021";"amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]";"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";"amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp7222386_c0_seq1;GAXK01185143.1;Q8NBI6;5.68E-16;XXLT1_HUMAN;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp72229_c0_seq1;GAXK01017036.1;Q9VMM6;9.39E-15;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp7223392_c0_seq1;GAXK01185147.1;P21865;3.92E-42;KDPD_ECOLI;Sensor protein KdpD (EC 2.7.13.3);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155]; transcription factor binding [GO:0008134]; cellular response to extracellular stimulus [GO:0031668]; cellular response to salt stress [GO:0071472]; detection of chemical stimulus [GO:0009593]; protein autophosphorylation [GO:0046777]; signal transduction by protein phosphorylation [GO:0023014]";"GO:0000155; GO:0005524; GO:0005886; GO:0005887; GO:0008134; GO:0009593; GO:0016791; GO:0023014; GO:0031668; GO:0046777; GO:0071472";"cellular response to extracellular stimulus [GO:0031668]; cellular response to salt stress [GO:0071472]; detection of chemical stimulus [GO:0009593]; protein autophosphorylation [GO:0046777]; signal transduction by protein phosphorylation [GO:0023014]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155]; transcription factor binding [GO:0008134]"
comp72240_c1_seq1;GAXK01017486.1;Q80X41;3.41E-73;VRK1_MOUSE;Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0007049; GO:0018105; GO:0018107; GO:0019901; GO:0031493; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166";"cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]";"ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]"
comp72247_c2_seq1;GAXK01017376.1;Q6P286;0;DHTK1_XENLA;Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1);"mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";"GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976";"glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]"
comp7225_c2_seq1;GAXK01100999.1;Q5BK63;4.35E-76;NDUA9_RAT;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit) (Sperm flagella protein 3);"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]";"GO:0003954; GO:0005654; GO:0005739; GO:0005747; GO:0005759; GO:0007623; GO:0009749; GO:0032981; GO:0044877; GO:1901006";"circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]";"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]"
comp722664_c1_seq1;GAXK01174823.1;Q08705;1.25E-14;CTCF_CHICK;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp72270_c1_seq1;GAXK01017382.1;O94826;8.43E-114;TOM70_HUMAN;Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70);"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; macroautophagy [GO:0016236]; protein targeting to mitochondrion [GO:0006626]";"GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016020; GO:0016021; GO:0016236; GO:0070062";"macroautophagy [GO:0016236]; protein targeting to mitochondrion [GO:0006626]";"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]";protein transmembrane transporter activity [GO:0008320]
comp72278_c0_seq1;GAXK01017220.1;Q17335;4.52E-64;ADHX_CAEEL;Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; alcohol metabolic process [GO:0006066]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]";"GO:0004024; GO:0005737; GO:0005829; GO:0006066; GO:0006069; GO:0008270; GO:0046294; GO:0051903";"alcohol metabolic process [GO:0006066]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"
comp72280_c2_seq1;GAXK01017372.1;Q9W429;1.46E-11;S35B4_DROME;UDP-xylose and UDP-N-acetylglucosamine transporter (ER GDP-fucose transporter) (Solute carrier family 35 member B4 homolog);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]";"GO:0005457; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0008643; GO:0015012; GO:0015782; GO:0015783; GO:0015786; GO:0015787; GO:0015790; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0036066; GO:0036084; GO:1990569; GO:1990570";"carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]";"GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]"
comp722877_c0_seq1;GAXK01174818.1;P18729;1.79E-20;ZG57_XENLA;Gastrula zinc finger protein XlCGF57.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7230_c0_seq1;GAXK01100332.1;Q5ZL33;1.21E-126;STRAP_CHICK;Serine-threonine kinase receptor-associated protein;"cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0030512; GO:0032797; GO:0034719";"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]";signaling receptor binding [GO:0005102]
comp723024_c1_seq1;GAXK01174847.1;Q8BYF6;4.23E-135;SC5A8_MOUSE;Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"GO:0005343; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161";"apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]"
comp72305_c0_seq1;GAXK01017511.1;Q5RBG4;0;KAT5_PONAB;Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5);"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]";"GO:0000812; GO:0003713; GO:0004402; GO:0005730; GO:0006978; GO:0010508; GO:0018394; GO:0032777; GO:0035267; GO:0040008; GO:0045893; GO:0046872; GO:0048471; GO:0061733";"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]";"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]";"histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]"
comp723106_c0_seq1;GAXK01174831.1;Q6DBP4;1.46E-13;PAE8_ARATH;Pectin acetylesterase 8 (EC 3.1.1.-);"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; pectin acetylesterase activity [GO:0052793]; cell wall organization [GO:0071555]";"GO:0005576; GO:0009505; GO:0052793; GO:0071555";cell wall organization [GO:0071555];"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]";pectin acetylesterase activity [GO:0052793]
comp723195_c0_seq1;GAXK01174849.1;Q9UJU3;1.65E-12;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp72331_c0_seq1;GAXK01017006.1;Q52KB5;5.40E-18;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp72340_c3_seq1;GAXK01017258.1;Q28J44;1.06E-80;S39AB_XENTR;Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11);"cytoplasm [GO:0005737]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]";"GO:0000329; GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016021; GO:0071577";zinc ion transmembrane transport [GO:0071577];"cytoplasm [GO:0005737]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";zinc ion transmembrane transporter activity [GO:0005385]
comp723400_c1_seq1;GAXK01174832.1;O89114;3.96E-25;DNJB5_MOUSE;DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40);"cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"GO:0000122; GO:0005634; GO:0005829; GO:0006986; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp7234008_c0_seq1;GAXK01099212.1;P45322;5.69E-19;MODB_HAEIN;Molybdenum transport system permease protein ModB;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]";"GO:0005886; GO:0015098; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";molybdate ion transmembrane transporter activity [GO:0015098]
comp72343_c3_seq1;GAXK01017300.1;Q5R5J6;1.06E-146;GCP2_PONAB;Gamma-tubulin complex component 2 (GCP-2);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule nucleation [GO:0007020]";"GO:0000922; GO:0005737; GO:0005815; GO:0005874; GO:0007020; GO:0043015";microtubule nucleation [GO:0007020];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";gamma-tubulin binding [GO:0043015]
comp723470_c0_seq1;GAXK01174863.1;Q12458;3.38E-51;YPR1_YEAST;Putative reductase 1 (EC 1.1.1.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity [GO:0016491]; arabinose catabolic process [GO:0019568]; cellular response to oxidative stress [GO:0034599]; D-xylose catabolic process [GO:0042843]";"GO:0004032; GO:0004090; GO:0005634; GO:0005737; GO:0005829; GO:0008106; GO:0016491; GO:0019568; GO:0034599; GO:0042843";"arabinose catabolic process [GO:0019568]; cellular response to oxidative stress [GO:0034599]; D-xylose catabolic process [GO:0042843]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity [GO:0016491]"
comp7235_c2_seq1;GAXK01100477.1;Q8CFK2;1.90E-149;TF3B_MOUSE;Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1);"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898";"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]";"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]";"metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp723564_c0_seq1;GAXK01174858.1;P59722;7.73E-72;EGLN1_RAT;Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (Fragment);"cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline dioxygenase activity [GO:0031543]; negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron death [GO:1901216]; regulation of angiogenesis [GO:0045765]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]";"GO:0001666; GO:0005634; GO:0005829; GO:0008198; GO:0019899; GO:0031418; GO:0031543; GO:0043065; GO:0043433; GO:0045765; GO:0051344; GO:0071731; GO:1901216; GO:1905290";"negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron death [GO:1901216]; regulation of angiogenesis [GO:0045765]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline dioxygenase activity [GO:0031543]"
comp7235817_c0_seq1;GAXK01099211.1;Q09LZ8;3.34E-20;CBPC6_MOUSE;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp7236_c2_seq1;GAXK01100527.1;P97629;4.62E-83;LCAP_RAT;Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (GP160) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) (Vesicle protein of 165 kDa) (Vp165);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; insulin-responsive compartment [GO:0032593]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuropeptide catabolic process [GO:0010813]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; proteolysis [GO:0006508]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to hormone [GO:0009725]";"GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0009725; GO:0009986; GO:0010813; GO:0016021; GO:0031982; GO:0032593; GO:0042277; GO:0043025; GO:0043171; GO:0043229; GO:0043231; GO:0045777; GO:0048169; GO:0048471; GO:0070006; GO:0120163";"negative regulation of cold-induced thermogenesis [GO:0120163]; neuropeptide catabolic process [GO:0010813]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; proteolysis [GO:0006508]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to hormone [GO:0009725]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; insulin-responsive compartment [GO:0032593]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp7236559_c0_seq1;GAXK01150978.1;Q9FEF8;7.75E-13;MD36B_ARATH;Probable mediator of RNA polymerase II transcription subunit 36b (Histone-glutamine methyltransferase) (SKP1-interacting partner 7) (rRNA 2'-O-methyltransferase fibrillarin 1) (EC 2.1.1.-);"box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; nucleolus [GO:0005730]; plastid [GO:0009536]; small-subunit processome [GO:0032040]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; snoRNA binding [GO:0030515]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]";"GO:0000494; GO:0003723; GO:0005730; GO:0008649; GO:0009536; GO:0015030; GO:0030515; GO:0031167; GO:0031428; GO:0032040; GO:1990258; GO:1990259";"box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]";"box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; nucleolus [GO:0005730]; plastid [GO:0009536]; small-subunit processome [GO:0032040]";"histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; snoRNA binding [GO:0030515]"
comp72374_c1_seq1;GAXK01017211.1;A4IH88;7.63E-71;K2013_XENTR;Uncharacterized protein KIAA2013 homolog;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp723838_c0_seq1;GAXK01174816.1;B7ZR65;9.05E-38;SOX9A_XENLA;Transcription factor Sox-9-A;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ubiquitin-like protein ligase binding [GO:0044389]; cartilage development [GO:0051216]; gonadal mesoderm development [GO:0007506]; neural crest formation [GO:0014029]; otic placode formation [GO:0043049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0007506; GO:0014029; GO:0043049; GO:0044389; GO:0045893; GO:0045944; GO:0051216";"cartilage development [GO:0051216]; gonadal mesoderm development [GO:0007506]; neural crest formation [GO:0014029]; otic placode formation [GO:0043049]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ubiquitin-like protein ligase binding [GO:0044389]"
comp72386_c1_seq1;GAXK01017239.1;Q27963;1.72E-122;VMAT2_BOVIN;Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2);"chromaffin granule [GO:0042583]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; monoamine transmembrane transporter activity [GO:0008504]; organic cyclic compound binding [GO:0097159]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; neurotransmitter transport [GO:0006836]; response to potassium ion [GO:0035864]";"GO:0005335; GO:0005887; GO:0006836; GO:0008504; GO:0015842; GO:0030672; GO:0035864; GO:0042583; GO:0042910; GO:0043195; GO:0097159";"aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; neurotransmitter transport [GO:0006836]; response to potassium ion [GO:0035864]";"chromaffin granule [GO:0042583]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"monoamine transmembrane transporter activity [GO:0008504]; organic cyclic compound binding [GO:0097159]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp723901_c0_seq1;GAXK01174828.1;Q9CQV6;4.79E-28;MLP3B_MOUSE;Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta);"autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]";"GO:0000045; GO:0000421; GO:0000422; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0005930; GO:0006914; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0015631; GO:0016020; GO:0016236; GO:0019904; GO:0030424; GO:0030425; GO:0031410; GO:0031625; GO:0032092; GO:0043025; GO:0044754; GO:0070257; GO:0097352";"autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]";"autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]";"microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]"
comp7239422_c0_seq1;GAXK01061639.1;P55211;1.82E-17;CASP9_HUMAN;"Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10]";"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]";"GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0046677; GO:0071549; GO:0071887; GO:0097153; GO:0097192; GO:0097199; GO:2001020";"activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]";"apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp7239558_c0_seq1;GAXK01061640.1;Q03279;2.17E-09;PO21_BRACO;"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)";"endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0004519";;;"endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]"
comp7240427_c0_seq1;GAXK01164544.1;Q9S7W1;2.89E-39;CB4C_ARATH;Chlorophyll a-b binding protein CP29.3, chloroplastic (LHCB4.3) (LHCII protein 4.3);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; plastoglobule [GO:0010287]; thylakoid [GO:0009579]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to blue light [GO:0009637]; response to far red light [GO:0010218]; response to light stimulus [GO:0009416]; response to red light [GO:0010114]";"GO:0005794; GO:0009416; GO:0009507; GO:0009522; GO:0009523; GO:0009534; GO:0009535; GO:0009579; GO:0009637; GO:0009768; GO:0009941; GO:0010114; GO:0010218; GO:0010287; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to blue light [GO:0009637]; response to far red light [GO:0010218]; response to light stimulus [GO:0009416]; response to red light [GO:0010114]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; plastoglobule [GO:0010287]; thylakoid [GO:0009579]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp7240937_c0_seq1;GAXK01164546.1;P62865;1.24E-07;UBIM_BOVIN;Ubiquitin-like protein FUBI;;;;;
comp724119_c0_seq1;GAXK01197666.1;P11584;3.16E-55;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp72414_c0_seq1;GAXK01017008.1;Q83P19;4.32E-29;HPCH_SHIFL;4-hydroxy-2-oxo-heptane-1,7-dioate aldolase (EC 4.1.2.52) (2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase) (HHED aldolase) (4-hydroxy-2-ketoheptane-1,7-dioate aldolase) (HKHD aldolase);"2,4-dihydroxyhept-2-ene-1,7-dioate aldolase activity [GO:0018802]; aldehyde-lyase activity [GO:0016832]; metal ion binding [GO:0046872]; phenylacetate catabolic process [GO:0010124]";"GO:0010124; GO:0016832; GO:0018802; GO:0046872";phenylacetate catabolic process [GO:0010124];;"2,4-dihydroxyhept-2-ene-1,7-dioate aldolase activity [GO:0018802]; aldehyde-lyase activity [GO:0016832]; metal ion binding [GO:0046872]"
comp7244035_c0_seq1;GAXK01192960.1;O14388;2.34E-44;RL27A_SCHPO;60S ribosomal protein L27-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";structural constituent of ribosome [GO:0003735]
comp72442_c7_seq1;GAXK01017536.1;A2VDQ7;2.75E-23;ZN420_BOVIN;Zinc finger protein 420;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp72444_c0_seq1;GAXK01017169.1;P36609;2.78E-25;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7245_c0_seq1;GAXK01101250.1;Q6NYE2;7.86E-52;RCC2_DANRE;Protein RCC2 homolog;"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]";"GO:0000775; GO:0001755; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0007049; GO:0030496; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]";"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]";
comp724527_c0_seq1;GAXK01197662.1;Q14982;9.19E-28;OPCM_HUMAN;Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp724533_c0_seq1;GAXK01197603.1;Q9VZX1;5.00E-10;SPZ5_DROME;Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";"GO:0002225; GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]"
comp724551_c0_seq1;GAXK01197651.1;Q8BH70;8.68E-88;FBXL4_MOUSE;F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4);"mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005758; GO:0006511; GO:0016567; GO:0016607; GO:0019005; GO:0031146";"protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]";"mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; SCF ubiquitin ligase complex [GO:0019005]";
comp72457_c0_seq1;GAXK01017039.1;Q8BVI5;3.86E-60;STX16_MOUSE;Syntaxin-16;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161";"Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp7246947_c0_seq1;GAXK01194568.1;Q42883;1.05E-26;ECAP_SOLLC;Calcium-transporting ATPase, endoplasmic reticulum-type (EC 7.2.2.10);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transport [GO:0006816]";"GO:0005388; GO:0005524; GO:0005783; GO:0006816; GO:0008553; GO:0030176; GO:0046872";calcium ion transport [GO:0006816];"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp7250142_c0_seq1;GAXK01099756.1;P77526;1.54E-31;YFCG_ECOLI;Disulfide-bond oxidoreductase YfcG (EC 1.8.4.-) (GSH-dependent disulfide-bond oxidoreductase YfcG) (GST N1-1) (GST-like protein YfcG) (Organic hydroperoxidase) (EC 1.11.1.-);"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0006979; GO:0015036";response to oxidative stress [GO:0006979];;"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]"
comp7251612_c0_seq1;GAXK01099758.1;P93099;7.05E-96;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp7252_c9_seq1;GAXK01100664.1;P13395;0;SPTCA_DROME;Spectrin alpha chain;"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693";"actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]";"actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]"
comp725296_c1_seq1;GAXK01197677.1;Q9PT61;6.92E-36;OTX5B_XENLA;Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0009952; GO:0042706; GO:0043565; GO:0045872; GO:0045893; GO:0045944";"anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp725367_c0_seq1;GAXK01197650.1;P51814;1.63E-25;ZNF41_HUMAN;Zinc finger protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp725457_c0_seq2;GAXK01197674.1;Q5M8H5;1.15E-96;MOGT2_XENTR;2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Monoacylglycerol O-acyltransferase 2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"GO:0003846; GO:0005789; GO:0006071; GO:0016021; GO:0019432; GO:1990578";"glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]";2-acylglycerol O-acyltransferase activity [GO:0003846]
comp7255_c0_seq1;GAXK01100307.1;B2RZ37;7.98E-53;REEP5_RAT;Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog);"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp7255156_c0_seq1;GAXK01058261.1;A2SD37;1.56E-50;PROB_METPP;Glutamate 5-kinase (EC 2.7.2.11) (Gamma-glutamyl kinase) (GK);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; RNA binding [GO:0003723]; L-proline biosynthetic process [GO:0055129]";"GO:0003723; GO:0004349; GO:0005524; GO:0005737; GO:0055129";L-proline biosynthetic process [GO:0055129];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; RNA binding [GO:0003723]"
comp725662_c0_seq1;GAXK01197628.1;Q6GMR7;8.21E-117;FAAH2_HUMAN;Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2);"integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]";"GO:0005811; GO:0016021; GO:0017064; GO:0019369; GO:0102077; GO:0103073";arachidonic acid metabolic process [GO:0019369];"integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]";"anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]"
comp72574_c0_seq1;GAXK01017185.1;Q9NBK5;0;TRC_DROME;Serine/threonine-protein kinase tricorner (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like);"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0007476; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0070451; GO:0070593; GO:0071944";"antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]";"axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp7257687_c0_seq1;GAXK01176793.1;P36609;6.24E-26;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7260_c0_seq1;GAXK01100130.1;Q9XSJ0;1.37E-135;UCHL5_BOVIN;Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000502; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0036459; GO:0048853; GO:0070628";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";"proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp7260518_c0_seq1;GAXK01101516.1;P28011;3.12E-46;AAT1_MEDSA;Aspartate aminotransferase 1 (EC 2.6.1.1) (Transaminase A);"cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]";"GO:0004069; GO:0005737; GO:0006520; GO:0009058; GO:0030170";"biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]";cytoplasm [GO:0005737];"L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]"
comp72606_c4_seq1;GAXK01017328.1;Q3SZH7;0;LKHA4_BOVIN;Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0019370; GO:0043171; GO:0044255; GO:0044267; GO:0070006";"cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]"
comp72607_c2_seq1;GAXK01017250.1;Q96C24;1.27E-70;SYTL4_HUMAN;Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin);"cytosol [GO:0005829]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; platelet degranulation [GO:0002576]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684]";"GO:0001778; GO:0002576; GO:0005543; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0017137; GO:0019898; GO:0030658; GO:0031092; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0046872; GO:0050714; GO:0070382; GO:0071985; GO:1905684";"intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; platelet degranulation [GO:0002576]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684]";"cytosol [GO:0005829]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; transport vesicle membrane [GO:0030658]";"metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]"
comp72612_c1_seq1;GAXK01017384.1;Q05B17;9.34E-160;WDR48_XENTR;WD repeat-containing protein 48 (USP1-associated factor 1);"late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]";"GO:0005634; GO:0005764; GO:0005770; GO:0016579; GO:0043130; GO:1903003";"positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]";"late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]";ubiquitin binding [GO:0043130]
comp726150_c0_seq1;GAXK01074652.1;A1L272;7.78E-32;S29A4_DANRE;Equilibrative nucleoside transporter 4 (Solute carrier family 29 member 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monoamine transmembrane transporter activity [GO:0008504]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005886; GO:0008504; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"monoamine transmembrane transporter activity [GO:0008504]; nucleoside transmembrane transporter activity [GO:0005337]"
comp726198_c0_seq1;GAXK01074686.1;Q14973;2.90E-19;NTCP_HUMAN;Sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618]; bile acid and bile salt transport [GO:0015721]";"GO:0001618; GO:0005886; GO:0005887; GO:0008508; GO:0015721; GO:0016323";bile acid and bile salt transport [GO:0015721];"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618]"
comp72620_c0_seq1;GAXK01017322.1;Q09103;7.99E-82;DGK2_DROME;Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein);"membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872";"deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";membrane [GO:0016020];"ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]"
comp726207_c1_seq1;GAXK01074659.1;Q10572;5.37E-23;FOX1_CAEEL;Sex determination protein fox-1 (Feminizing locus on X protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; dosage compensation by hypoactivation of X chromosome [GO:0042464]; mating behavior [GO:0007617]; mRNA metabolic process [GO:0016071]; nervous system development [GO:0007399]; primary sex determination [GO:0007538]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0007538; GO:0007617; GO:0008143; GO:0008266; GO:0016071; GO:0034046; GO:0042464";"dosage compensation by hypoactivation of X chromosome [GO:0042464]; mating behavior [GO:0007617]; mRNA metabolic process [GO:0016071]; nervous system development [GO:0007399]; primary sex determination [GO:0007538]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]"
comp726232_c0_seq1;GAXK01074709.1;Q9NXL6;1.37E-68;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp7262492_c0_seq1;GAXK01069319.1;Q7T2B9;2.88E-08;MTPN_DANRE;Myotrophin;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp7263_c0_seq1;GAXK01101326.1;Q13895;3.80E-159;BYST_HUMAN;Bystin;"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; cell population proliferation [GO:0008283]; female pregnancy [GO:0007565]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]";"GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007565; GO:0008283; GO:0016020; GO:0030515; GO:0030688; GO:0042254; GO:0043231; GO:0045177; GO:1904749";"cell population proliferation [GO:0008283]; female pregnancy [GO:0007565]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]";"RNA binding [GO:0003723]; snoRNA binding [GO:0030515]"
comp72648_c2_seq1;GAXK01017597.1;P42124;9.16E-139;EZ_DROME;Histone-lysine N-methyltransferase E(z) (EC 2.1.1.43) (Lysine N-methyltransferase 6) (Protein enhancer of zeste);"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692";"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]";"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]"
comp7265982_c0_seq1;GAXK01022228.1;Q8R508;9.50E-11;FAT3_RAT;Protocadherin Fat 3 (FAT tumor suppressor homolog 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]";"GO:0005509; GO:0005886; GO:0007156; GO:0007275; GO:0016021; GO:0098609";"cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcium ion binding [GO:0005509]
comp7266297_c0_seq1;GAXK01105271.1;A4JS72;6.43E-16;BV3F_BURVG;DNA-binding protein Bv3F;"cytoplasm [GO:0005737]; nucleoid [GO:0009295]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005737; GO:0006355; GO:0009295";regulation of transcription, DNA-templated [GO:0006355];"cytoplasm [GO:0005737]; nucleoid [GO:0009295]";DNA binding [GO:0003677]
comp72670_c0_seq1;GAXK01017477.1;P58249;2.58E-44;PHS_DROVI;Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Pterin carbinolamine dehydratase) (PCD);"4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"GO:0006729; GO:0008124";tetrahydrobiopterin biosynthetic process [GO:0006729];;4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]
comp72673_c2_seq1;GAXK01017067.1;Q9D1E5;5.71E-76;LMBRL_MOUSE;Protein LMBR1L (Uteroglobin receptor);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]";"GO:0004888; GO:0005886; GO:0005887; GO:0006898; GO:0007165";"receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";transmembrane signaling receptor activity [GO:0004888]
comp726772_c1_seq1;GAXK01074654.1;Q91WD2;3.45E-38;TRPV6_MOUSE;Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016021; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703";"calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]"
comp7268_c5_seq1;GAXK01100085.1;Q9V427;4.98E-120;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp7268002_c0_seq1;GAXK01075971.1;Q07120;1.67E-10;GFI1_RAT;Zinc finger protein Gfi-1 (Growth factor independent protein 1);"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"GO:0000122; GO:0001227; GO:0003700; GO:0005654; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0044212; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222";"cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]";"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp726884_c1_seq1;GAXK01074695.1;O15460;3.97E-33;P4HA2_HUMAN;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0016702; GO:0018401; GO:0031418; GO:0043231";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp72695_c0_seq1;GAXK01017252.1;H9D1R1;3.62E-44;TXD12_EPICO;Thioredoxin domain-containing protein 12 (EC 1.8.4.2);"endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032]";"GO:0005788; GO:0009055; GO:0016032; GO:0019153; GO:0045454; GO:0051607; GO:0055114";"cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032]";endoplasmic reticulum lumen [GO:0005788];"electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]"
comp7270_c1_seq1;GAXK01100462.1;P0DOV5;4.23E-16;SQD_PSEPU;Sulfoquinovose 1-dehydrogenase (SQ dehydrogenase) (EC 1.1.1.390);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp727040_c0_seq1;GAXK01074714.1;Q8IN81;4.68E-18;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp727071_c0_seq1;GAXK01074713.1;P34024;3.31E-31;PLC_LISMO;1-phosphatidylinositol phosphodiesterase (EC 4.6.1.13) (Phosphatidylinositol diacylglycerol-lyase) (Phosphatidylinositol-specific phospholipase C) (PI-PLC);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"GO:0004436; GO:0005576; GO:0005737; GO:0008081; GO:0009405; GO:0016042";"lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]";"phosphatidylinositol diacylglycerol-lyase activity [GO:0004436]; phosphoric diester hydrolase activity [GO:0008081]"
comp72708_c0_seq1;GAXK01017310.1;Q9CXI3;1.33E-121;MOXD1_MOUSE;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016020; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp7271200_c0_seq1;GAXK01078377.1;P08418;1.58E-29;HSP70_SCHMA;Heat shock 70 kDa protein homolog (HSP70) (Major surface antigen);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp727190_c0_seq1;GAXK01074697.1;Q8N608;3.31E-89;DPP10_HUMAN;Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2);"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078";"positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp72729_c0_seq1;GAXK01017065.1;Q9WVK4;1.79E-67;EHD1_MOUSE;EH domain-containing protein 1 (PAST homolog 1) (mPAST1);"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"GO:0005509; GO:0005524; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0010976; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043209; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137";"cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]";"ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]"
comp7273463_c0_seq1;GAXK01045595.1;P04052;4.59E-40;RPB1_DROME;DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp727384_c0_seq1;GAXK01074651.1;C1DJZ7;1.82E-25;DADA_AZOVD;D-amino acid dehydrogenase (EC 1.4.99.-);"D-amino-acid dehydrogenase activity [GO:0008718]; D-alanine catabolic process [GO:0055130]";"GO:0008718; GO:0055130";D-alanine catabolic process [GO:0055130];;D-amino-acid dehydrogenase activity [GO:0008718]
comp727411_c0_seq1;GAXK01205401.1;P29294;8.16E-97;MYLK_RABIT;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp7277664_c0_seq1;GAXK01057067.1;Q8SWR3;7.92E-08;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp72781_c1_seq1;GAXK01017044.1;P02552;3.39E-71;TBA1_CHICK;Tubulin alpha-1 chain [Cleaved into: Detyrosinated tubulin alpha-1 chain] (Fragment);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp727979_c0_seq1;GAXK01074689.1;F1NHE9;4.04E-104;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp72799_c0_seq1;GAXK01017271.1;Q8HXG8;1.10E-25;BCDO2_MACFA;Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2);"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; carotene metabolic process [GO:0016119]";"GO:0005739; GO:0016119; GO:0016702; GO:0046872; GO:0102076";carotene metabolic process [GO:0016119];mitochondrion [GO:0005739];"beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp728_c1_seq1;GAXK01165540.1;Q3MHN0;2.02E-86;PSB6_BOVIN;Proteasome subunit beta type-6 (EC 3.4.25.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp7280_c0_seq1;GAXK01100334.1;Q8TCA0;2.11E-22;LRC20_HUMAN;Leucine-rich repeat-containing protein 20;;;;;
comp72801_c0_seq1;GAXK01017266.1;Q01295;1.48E-18;BRC1_DROME;Broad-complex core protein isoforms 1/2/3/4/5;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";"GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007552; GO:0007562; GO:0008219; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035072; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390";"autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; metamorphosis [GO:0007552]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp728036_c0_seq1;GAXK01193080.1;Q575T0;5.54E-10;CYGB1_ORYLA;Cytoglobin-1;"cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037";;cytoplasm [GO:0005737];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp7280580_c0_seq1;GAXK01004736.1;P91953;2.70E-32;HE_HEMPU;"50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide]";"extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0008270; GO:0031012";;extracellular matrix [GO:0031012];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp728227_c0_seq1;GAXK01193040.1;P58467;3.09E-47;SETD4_MOUSE;SET domain-containing protein 4 (EC 2.1.1.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]";"GO:0005634; GO:0005829; GO:0016279; GO:0018023; GO:0018026";"peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]";"cytosol [GO:0005829]; nucleus [GO:0005634]";protein-lysine N-methyltransferase activity [GO:0016279]
comp72843_c1_seq1;GAXK01017423.1;P48818;0;ACADV_BOVIN;Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9);"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]";"GO:0000062; GO:0001659; GO:0005730; GO:0005739; GO:0005743; GO:0005829; GO:0009409; GO:0017099; GO:0030855; GO:0033539; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181";"epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]"
comp728625_c1_seq1;GAXK01193123.1;Q9ULJ7;8.33E-15;ANR50_HUMAN;Ankyrin repeat domain-containing protein 50;"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005768; GO:0015031; GO:1990126";"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]";endosome [GO:0005768];
comp72865_c0_seq1;GAXK01017535.1;Q9UJX0;1.42E-60;OSGI1_HUMAN;Oxidative stress-induced growth inhibitor 1 (Bone marrow stromal cell-derived growth inhibitor) (BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38) (huOKL38) (Pregnancy-induced growth inhibitor OKL38);"growth factor activity [GO:0008083]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]";"GO:0007275; GO:0008083; GO:0030154; GO:0030308; GO:0030334; GO:0042127; GO:0042981; GO:0043065";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]";;growth factor activity [GO:0008083]
comp72867_c1_seq1;GAXK01017034.1;Q91XD8;4.31E-74;S2538_MOUSE;Mitochondrial glycine transporter (Solute carrier family 25 member 38);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; glycine transmembrane transporter activity [GO:0015187]; erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]";"GO:0005739; GO:0005743; GO:0015187; GO:0016021; GO:0030218; GO:1904983";"erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";glycine transmembrane transporter activity [GO:0015187]
comp728724_c0_seq1;GAXK01193106.1;P42283;1.37E-11;LOLA1_DROME;Longitudinals lacking protein, isoform G;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp728767_c0_seq1;GAXK01193057.1;Q27433;2.36E-91;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp72877_c0_seq1;GAXK01017306.1;P24733;5.97E-35;MYS_ARGIR;Myosin heavy chain, striated muscle;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp728854_c1_seq1;GAXK01193132.1;Q8I147;4.79E-07;SINA_DROWI;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia protein);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"GO:0000151; GO:0005634; GO:0005829; GO:0006511; GO:0007423; GO:0007601; GO:0008270; GO:0016567; GO:0016740; GO:0032436; GO:0035883; GO:0042802; GO:0043161; GO:0045500; GO:0045676";"enteroendocrine cell differentiation [GO:0035883]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; sevenless signaling pathway [GO:0045500]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601]";"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp72887_c1_seq1;GAXK01016998.1;P36609;3.14E-29;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7289379_c0_seq1;GAXK01087854.1;P43672;6.49E-24;UUP_ECOLI;ABC transporter ATP-binding protein uup;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]; regulation of transposon integration [GO:0070894]; response to radiation [GO:0009314]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0003677; GO:0004832; GO:0005524; GO:0005737; GO:0005886; GO:0006438; GO:0009314; GO:0016887; GO:0070894";"regulation of transposon integration [GO:0070894]; response to radiation [GO:0009314]; valyl-tRNA aminoacylation [GO:0006438]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]"
comp7289708_c0_seq1;GAXK01087862.1;Q99J85;9.29E-12;NPTXR_MOUSE;Neuronal pentraxin receptor;"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; pentraxin receptor activity [GO:0008029]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of postsynaptic specialization assembly [GO:0099150]";"GO:0005615; GO:0005886; GO:0008029; GO:0009898; GO:0016021; GO:0019903; GO:0030175; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0044877; GO:0046872; GO:0098962; GO:0098978; GO:0099150; GO:0099645";"neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of postsynaptic specialization assembly [GO:0099150]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; pentraxin receptor activity [GO:0008029]; protein-containing complex binding [GO:0044877]; protein phosphatase binding [GO:0019903]"
comp7292122_c0_seq1;GAXK01000739.1;Q5VU57;4.86E-18;CBPC6_HUMAN;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp72933_c1_seq1;GAXK01017377.1;Q6DFQ7;9.82E-46;TM198_XENTR;Transmembrane protein 198;"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; multicellular organism development [GO:0007275]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]";"GO:0005886; GO:0007275; GO:0012506; GO:0016021; GO:0016055; GO:0031410; GO:0090263";"multicellular organism development [GO:0007275]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]";"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";
comp7293340_c0_seq1;GAXK01000742.1;Q9H2K2;1.62E-08;TNKS2_HUMAN;Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2) (Tankyrase-like protein) (Tankyrase-related protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000242; GO:0000784; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404";"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]";"enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]"
comp729467_c0_seq1;GAXK01193100.1;Q6Q1P3;8.23E-27;KCNKI_RAT;Potassium channel subfamily K member 18 (Tresk-2) (Two-pore-domain potassium channel TRESK);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623";"cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
comp729528_c0_seq1;GAXK01193075.1;O46040;1.51E-13;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp729532_c0_seq1;GAXK01193102.1;Q8T3Y0;8.53E-07;SINAL_DROME;Probable E3 ubiquitin-protein ligase sinah (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sinah) (Sina homolog);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0006511; GO:0007423; GO:0008270; GO:0010498; GO:0031624; GO:0043161; GO:0045676; GO:0061630";"proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of R7 cell differentiation [GO:0045676]; sensory organ development [GO:0007423]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp729767_c0_seq1;GAXK01193107.1;Q5VVW2;3.31E-176;GARL3_HUMAN;GTPase-activating Rap/Ran-GAP domain-like protein 3;"intracellular membrane-bounded organelle [GO:0043231]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005096; GO:0043231; GO:0051056";regulation of small GTPase mediated signal transduction [GO:0051056];intracellular membrane-bounded organelle [GO:0043231];GTPase activator activity [GO:0005096]
comp729789_c0_seq1;GAXK01193045.1;O69060;1.17E-10;HTXA_PSEST;Probable alpha-ketoglutarate-dependent hypophosphite dioxygenase (EC 1.-.-.-);dioxygenase activity [GO:0051213];GO:0051213;;;dioxygenase activity [GO:0051213]
comp72984_c1_seq1;GAXK01017324.1;Q62356;9.78E-42;FSTL1_MOUSE;Follistatin-related protein 1 (Follistatin-like protein 1) (TGF-beta-inducible protein TSC-36);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of BMP signaling pathway [GO:0030510]; response to starvation [GO:0042594]";"GO:0005509; GO:0005615; GO:0007275; GO:0008201; GO:0030154; GO:0030510; GO:0042594";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of BMP signaling pathway [GO:0030510]; response to starvation [GO:0042594]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp72986_c0_seq1;GAXK01017287.1;Q3T106;2.43E-18;SRSF7_BOVIN;Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp729906_c0_seq1;GAXK01193088.1;B0WC46;1.38E-79;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp729929_c0_seq1;GAXK01193074.1;P11799;2.29E-76;MYLK_CHICK;Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin light chain kinase activity [GO:0004687]; structural constituent of muscle [GO:0008307]; cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004687; GO:0005516; GO:0005524; GO:0005829; GO:0005865; GO:0006936; GO:0008307; GO:0016020; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0045214; GO:0046872; GO:0048739; GO:0051015; GO:0051371; GO:0055003; GO:0055008; GO:0071688";"cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin light chain kinase activity [GO:0004687]; structural constituent of muscle [GO:0008307]"
comp730001_c1_seq1;GAXK01070873.1;Q8C0J6;4.14E-21;SWAHC_MOUSE;Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C);;;;;
comp730058_c0_seq1;GAXK01070815.1;P48445;1.27E-34;BPL1_YEAST;"Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-[pyruvate-carboxylase] ligase activity [GO:0071734]; protein biotinylation [GO:0009305]";"GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005634; GO:0005737; GO:0009305; GO:0071734";protein biotinylation [GO:0009305];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-[pyruvate-carboxylase] ligase activity [GO:0071734]"
comp73007_c0_seq1;GAXK01017365.1;Q9XSC1;1.28E-66;SFRP5_BOVIN;Secreted frizzled-related protein 5 (sFRP-5);"extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510]";"GO:0005615; GO:0007275; GO:0008285; GO:0017147; GO:0030154; GO:0030178; GO:0030510; GO:0035567; GO:0043433; GO:0051898; GO:0060070; GO:0090090; GO:2000057";"canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510]";extracellular space [GO:0005615];Wnt-protein binding [GO:0017147]
comp730136_c0_seq1;GAXK01070786.1;Q7PPU9;1.66E-24;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp73035_c0_seq1;GAXK01017381.1;Q17QF0;0;AGT2_BOVIN;Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT);"mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]";"GO:0005739; GO:0008453; GO:0009436; GO:0019481; GO:0030170; GO:0045429; GO:0047305";"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]";mitochondrion [GO:0005739];"(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]"
comp730393_c0_seq1;GAXK01070809.1;O76082;3.26E-57;S22A5_HUMAN;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0005886; GO:0006814; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0015893; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0052106; GO:0060731; GO:0070062; GO:0070715; GO:1902603";"carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp730788_c0_seq1;GAXK01070875.1;A3DH97;8.89E-51;RSGI6_CLOTH;Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]";"GO:0005886; GO:0016021; GO:0031176; GO:0045493";xylan catabolic process [GO:0045493];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";endo-1,4-beta-xylanase activity [GO:0031176]
comp7308_c0_seq1;GAXK01100032.1;Q9XZ71;1.28E-18;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp730800_c0_seq1;GAXK01070869.1;Q91447;5.04E-11;MP2K1_SERCA;Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK1) (Fragment);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]";"GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005815";;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
comp73087_c0_seq1;GAXK01017288.1;Q921X6;5.50E-104;RPC6_MOUSE;DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F);"RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"GO:0003690; GO:0003899; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";RNA polymerase III complex [GO:0005666];"DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]"
comp73096_c2_seq1;GAXK01017291.1;Q3LSS0;1.02E-103;C19L2_DANRE;CWF19-like protein 2;"post-mRNA release spliceosomal complex [GO:0071014]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0071014";mRNA splicing, via spliceosome [GO:0000398];post-mRNA release spliceosomal complex [GO:0071014];
comp73099_c3_seq1;GAXK01017525.1;A0A096ZEC9;3.00E-10;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp731013_c0_seq1;GAXK01070842.1;P22770;2.13E-28;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp731033_c0_seq1;GAXK01070844.1;Q96WZ1;1.62E-25;EF1A_COCIM;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp731111_c0_seq1;GAXK01070847.1;P43693;1.31E-24;GATA6_CHICK;Transcription factor GATA-6 (GATA-binding factor 6);"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]; animal organ formation [GO:0048645]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; Clara cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; transcription by RNA polymerase II [GO:0006366]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]";"GO:0000122; GO:0000978; GO:0000981; GO:0001103; GO:0001889; GO:0003148; GO:0003309; GO:0003310; GO:0003682; GO:0005634; GO:0005667; GO:0006366; GO:0006644; GO:0007493; GO:0008270; GO:0008584; GO:0014898; GO:0019901; GO:0030855; GO:0031965; GO:0032911; GO:0032912; GO:0035239; GO:0042493; GO:0043066; GO:0043627; GO:0045766; GO:0045893; GO:0045944; GO:0048645; GO:0051891; GO:0055007; GO:0060045; GO:0060430; GO:0060486; GO:0060510; GO:0060575; GO:0060947; GO:0071158; GO:0071371; GO:0071456; GO:0071773; GO:0110024";"animal organ formation [GO:0048645]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; Clara cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; transcription by RNA polymerase II [GO:0006366]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]";"nuclear membrane [GO:0031965]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]"
comp731134_c0_seq1;GAXK01070839.1;Q6KZM5;1.15E-24;GLFT_PICTO;Glutamate formimidoyltransferase (EC 2.1.2.5) (5-formyltetrahydrofolate cyclo-ligase) (EC 6.3.3.2) (Glutamate formiminotransferase) (Glutamate formyltransferase);"cytoplasm [GO:0005737]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; folic acid binding [GO:0005542]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]";"GO:0005542; GO:0005737; GO:0019556; GO:0019557; GO:0030272; GO:0030409; GO:0035999";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]";cytoplasm [GO:0005737];"5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; folic acid binding [GO:0005542]; glutamate formimidoyltransferase activity [GO:0030409]"
comp7311398_c0_seq1;GAXK01113614.1;Q8N823;1.42E-12;ZN611_HUMAN;Zinc finger protein 611;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7311477_c0_seq1;GAXK01113616.1;P20273;2.43E-07;CD22_HUMAN;B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776]";"GO:0001791; GO:0005102; GO:0005737; GO:0005769; GO:0005886; GO:0007155; GO:0009986; GO:0016021; GO:0019903; GO:0030100; GO:0030246; GO:0030888; GO:0032809; GO:0033691; GO:0042113; GO:0042609; GO:0050776; GO:0050849; GO:0050859; GO:0051025; GO:0055037; GO:0070062";"B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]"
comp731189_c0_seq1;GAXK01070777.1;P16273;1.55E-25;PRPX_HORVU;Pathogen-related protein;"defense response [GO:0006952]; response to biotic stimulus [GO:0009607]";"GO:0006952; GO:0009607";"defense response [GO:0006952]; response to biotic stimulus [GO:0009607]";;
comp73120_c0_seq1;GAXK01017308.1;P57071;2.04E-12;PRD15_HUMAN;PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0016604; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035";"multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp73128_c0_seq1;GAXK01017072.1;A0A0E0RTV6;3.68E-21;ZEB1_GIBZE;FAD-linked oxidoreductase ZEB1 (EC 1.-.-.-) (Zearalenone biosynthesis protein 1);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0071949";;;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp731438_c0_seq1;GAXK01070874.1;P05661;6.60E-40;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp73158_c0_seq1;GAXK01017362.1;P20456;2.69E-81;IMPA1_BOVIN;Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1);"cytoplasm [GO:0005737]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";"GO:0000287; GO:0005737; GO:0006021; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834";"inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]";cytoplasm [GO:0005737];"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]"
comp731601_c0_seq1;GAXK01070846.1;P62747;1.84E-59;RHOB_RAT;Rho-related GTP-binding protein RhoB;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"GO:0000281; GO:0001525; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0006915; GO:0007015; GO:0007155; GO:0007266; GO:0008333; GO:0008360; GO:0010008; GO:0010595; GO:0016020; GO:0016477; GO:0019003; GO:0019901; GO:0030154; GO:0030334; GO:0030336; GO:0030950; GO:0031902; GO:0032153; GO:0032154; GO:0032956; GO:0043065; GO:0043231; GO:0045766; GO:0045786; GO:0051017; GO:0061154; GO:0070301; GO:0071479";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp731676_c0_seq1;GAXK01070870.1;Q5YLM1;4.98E-10;DGLA_RAT;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp731782_c0_seq1;GAXK01070868.1;P28167;6.51E-44;ZFH2_DROME;Zinc finger protein 2 (Zinc finger homeodomain protein 2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0000978; GO:0003677; GO:0005634; GO:0007399; GO:0007476; GO:0035220; GO:0044212; GO:0045893; GO:0046872";"imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]"
comp7319426_c0_seq1;GAXK01119917.1;Q90Z10;3.41E-34;RL13_DANRE;60S ribosomal protein L13;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0051726";"regulation of cell cycle [GO:0051726]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp731972_c0_seq1;GAXK01070872.1;A0A096ZEC9;6.21E-10;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp7320_c1_seq1;GAXK01100278.1;Q28EB4;7.95E-61;NP1L1_XENTR;Nucleosome assembly protein 1-like 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030154; GO:0030332; GO:0042393; GO:0045944; GO:0051260; GO:0060215";"cell differentiation [GO:0030154]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; protein homooligomerization [GO:0051260]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"cyclin binding [GO:0030332]; histone binding [GO:0042393]"
comp732083_c0_seq1;GAXK01071714.1;P52192;2.84E-11;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp73214_c3_seq1;GAXK01017512.1;Q9W4M9;0;NSUN2_DROME;tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (NOP2/Sun domain family member 2 ortholog);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]";"GO:0000049; GO:0001510; GO:0005634; GO:0005730; GO:0005737; GO:0007614; GO:0008168; GO:0016428; GO:0030488";"RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]"
comp732248_c1_seq1;GAXK01071657.1;Q9JME2;1.03E-11;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp73229_c1_seq1;GAXK01017476.1;Q6Y685;1.40E-32;TACC1_MOUSE;Transforming acidic coiled-coil-containing protein 1;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0007052; GO:0008283; GO:0016922; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301; GO:2000327";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of microtubule-based process [GO:0032886]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]";"estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]"
comp732290_c0_seq1;GAXK01071676.1;P43699;1.15E-43;NKX21_HUMAN;Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region DNA binding [GO:0044213]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; Clara cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510]";"GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001012; GO:0001161; GO:0001764; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006644; GO:0007411; GO:0007420; GO:0007492; GO:0007626; GO:0009725; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0021766; GO:0021795; GO:0021798; GO:0021877; GO:0021892; GO:0021983; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0031128; GO:0033327; GO:0042753; GO:0043565; GO:0044212; GO:0044213; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048646; GO:0048709; GO:0060430; GO:0060441; GO:0060486; GO:0060510";"anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; Clara cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region DNA binding [GO:0044213]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp732365_c0_seq1;GAXK01071646.1;A0A096ZEC9;4.82E-11;DNHA_NOCS1;2,4-dinitroanisole O-demethylase subunit alpha (DNAN hydrolase subunit alpha) (DNHA) (EC 3.3.2.14);"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016803";;;"ether hydrolase activity [GO:0016803]; zinc ion binding [GO:0008270]"
comp732492_c0_seq1;GAXK01071642.1;Q9P2F9;1.96E-11;ZN319_HUMAN;Zinc finger protein 319;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp732680_c0_seq1;GAXK01071695.1;Q58DA5;7.70E-10;NTRI_BOVIN;Neurotrimin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp73275_c3_seq1;GAXK01017049.1;Q6PD29;4.05E-16;ZN513_MOUSE;Zinc finger protein 513;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0044212; GO:0046872; GO:0060041";"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp732754_c1_seq1;GAXK01071668.1;A5PJT0;2.71E-60;MBLC2_BOVIN;Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp732996_c0_seq1;GAXK01071694.1;Q8BQN6;1.17E-20;OZF_MOUSE;Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146);"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp733010_c0_seq1;GAXK01071720.1;Q498E6;4.79E-43;KT5AB_XENLA;N-lysine methyltransferase KMT5A-B (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-B) (EC 2.1.1.43) (Lysine-specific methylase 5A-B) (Mitotic phosphoprotein 36) (SET domain-containing protein 8-B);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0005694; GO:0007049; GO:0018024; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"chromosome [GO:0005694]; nucleus [GO:0005634]";histone-lysine N-methyltransferase activity [GO:0018024]
comp73303_c10_seq1;GAXK01017502.1;Q4R4A2;2.71E-69;ZUP1_MACFA;Zinc finger-containing ubiquitin peptidase 1 (EC 3.4.19.12) (Lys-63-specific deubiquitinase ZUFSP) (DUB) (Ubiquitin carboxyl-terminal hydrolase ZUFSP) (EC 3.4.19.12) (Zinc finger with UFM1-specific peptidase domain protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]";"GO:0003676; GO:0005634; GO:0005737; GO:0036459; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp733235_c0_seq1;GAXK01071702.1;Q92820;2.80E-42;GGH_HUMAN;Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase);"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0005829; GO:0008238; GO:0008242; GO:0010043; GO:0032868; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0043312; GO:0045471; GO:0046900; GO:0070062; GO:1904724";"neutrophil degranulation [GO:0043312]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]";"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]";"exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]"
comp733300_c2_seq1;GAXK01071688.1;Q5ZJV7;9.91E-29;SHCAF_CHICK;SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog);"Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";"GO:0008284; GO:0016580; GO:0030336; GO:0045596";"negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]";Sin3 complex [GO:0016580];
comp733495_c0_seq1;GAXK01071648.1;P34586;2.79E-21;TRPL_CAEEL;Transient-receptor-potential-like protein (TRP homologous cation channel protein 1);"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679";"calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]";"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]";"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
comp7335_c0_seq1;GAXK01101303.1;P34743;1.65E-37;BTG1_CHICK;Protein BTG1 (B-cell translocation gene 1 protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]";"GO:0005634; GO:0005737; GO:0008285; GO:0019899; GO:0045603; GO:0045766; GO:0045930; GO:2000271";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";enzyme binding [GO:0019899]
comp733679_c0_seq1;GAXK01071660.1;Q9VCA2;4.30E-70;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp733686_c0_seq1;GAXK01071701.1;P56180;4.32E-20;TPTE_HUMAN;Putative tyrosine-protein phosphatase TPTE (EC 3.1.3.48) (Cancer/testis antigen 44) (CT44) (Transmembrane phosphatase with tensin homology) (Tumor antigen BJ-HCC-5);"integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";"GO:0004725; GO:0006470; GO:0007165; GO:0008138; GO:0016021";"protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";integral component of membrane [GO:0016021];"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp733778_c0_seq1;GAXK01071713.1;P80299;9.82E-11;HYES_RAT;"Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)]";"cytosol [GO:0005829]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; toxic substance binding [GO:0015643]; aromatic compound catabolic process [GO:0019439]; cholesterol homeostasis [GO:0042632]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; phospholipid dephosphorylation [GO:0046839]; positive regulation of blood pressure [GO:0045777]; prostaglandin production involved in inflammatory response [GO:0002539]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]";"GO:0000287; GO:0002539; GO:0004301; GO:0005777; GO:0005829; GO:0006954; GO:0009636; GO:0015643; GO:0016791; GO:0019233; GO:0019439; GO:0033885; GO:0042577; GO:0042632; GO:0043651; GO:0045777; GO:0046839";"aromatic compound catabolic process [GO:0019439]; cholesterol homeostasis [GO:0042632]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; phospholipid dephosphorylation [GO:0046839]; positive regulation of blood pressure [GO:0045777]; prostaglandin production involved in inflammatory response [GO:0002539]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; toxic substance binding [GO:0015643]"
comp73389_c0_seq1;GAXK01017380.1;B4F6J6;1.09E-77;ATAD1_XENTR;ATPase family AAA domain-containing protein 1 (EC 3.6.1.3);"cell junction [GO:0030054]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0005777; GO:0016887; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp733912_c0_seq1;GAXK01071683.1;O43345;1.98E-17;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp733937_c2_seq1;GAXK01071650.1;Q8Q0U0;4.16E-30;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp7339657_c0_seq1;GAXK01071379.1;O48557;4.38E-37;RL17_MAIZE;60S ribosomal protein L17;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp734_c0_seq1;GAXK01169030.1;Q9BZE4;0;NOG1_HUMAN;Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]"
comp73402_c0_seq1;GAXK01017041.1;Q53S33;1.95E-20;BOLA3_HUMAN;BolA-like protein 3;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp7340398_c0_seq1;GAXK01131467.1;B4NDL8;1.60E-21;NAAT1_DROWI;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp73414_c0_seq1;GAXK01017203.1;Q9NDJ2;7.63E-164;DOM_DROME;Helicase domino (EC 3.6.4.-);"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]";"GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983; GO:2000637";"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]";"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]"
comp73415_c2_seq1;GAXK01017027.1;Q9UKN7;0;MYO15_HUMAN;Unconventional myosin-XV (Unconventional myosin-15);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0007605; GO:0007626; GO:0016459; GO:0032420; GO:0042472; GO:0070062";"inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp734191_c0_seq1;GAXK01045608.1;O54705;3.74E-129;NOS2_CAVPO;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytosol [GO:0005829]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; nitric oxide biosynthetic process [GO:0006809]; peptidyl-cysteine S-nitrosylation [GO:0018119]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; superoxide metabolic process [GO:0006801]";"GO:0004517; GO:0005516; GO:0005829; GO:0006801; GO:0006809; GO:0010181; GO:0018119; GO:0020037; GO:0032310; GO:0042742; GO:0046872; GO:0050660; GO:0050661; GO:0072604; GO:0072606; GO:1900015";"defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; nitric oxide biosynthetic process [GO:0006809]; peptidyl-cysteine S-nitrosylation [GO:0018119]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; superoxide metabolic process [GO:0006801]";cytosol [GO:0005829];"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]"
comp734232_c0_seq1;GAXK01045625.1;Q5RD64;9.82E-21;CNTP2_PONAB;Contactin-associated protein-like 2;"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]; cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"GO:0007155; GO:0016021; GO:0033010; GO:0044224; GO:0048812; GO:0071205";"cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]";
comp7342371_c0_seq1;GAXK01175015.1;B3N8M1;2.11E-23;LPHN_DROER;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp734268_c0_seq1;GAXK01045648.1;Q96N22;2.19E-20;ZN681_HUMAN;Zinc finger protein 681;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp734381_c0_seq1;GAXK01045610.1;Q8BSY0;2.57E-41;ASPH_MOUSE;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]"
comp73451_c0_seq1;GAXK01017465.1;Q17QH8;2.60E-22;D39U1_BOVIN;Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1);"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0050662";;;"coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]"
comp73452_c0_seq1;GAXK01016999.1;Q99LJ6;3.58E-46;GPX7_MOUSE;Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0006979";response to oxidative stress [GO:0006979];"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]"
comp734594_c0_seq1;GAXK01045601.1;Q5CZA5;5.15E-26;ZN805_HUMAN;Zinc finger protein 805;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp73460_c0_seq1;GAXK01017000.1;Q9EQB9;6.77E-39;ZN287_MOUSE;Zinc finger protein 287 (Zfp-287) (Zinc finger protein SKAT-2);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";"GO:0003677; GO:0003700; GO:0005634; GO:0042035; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7346030_c0_seq1;GAXK01048360.1;Q9SV68;1.94E-08;QORH_ARATH;Chloroplast envelope quinone oxidoreductase homolog (ceQORH) (EC 1.3.1.-);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; oxidoreductase activity [GO:0016491]";"GO:0005773; GO:0005829; GO:0005886; GO:0009507; GO:0009535; GO:0009706; GO:0009941; GO:0016491";;"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";oxidoreductase activity [GO:0016491]
comp7346189_c0_seq1;GAXK01048354.1;Q60431;2.95E-16;CASP3_MESAU;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0031647; GO:0097199; GO:1902004";"positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]
comp7348046_c0_seq1;GAXK01186793.1;A4IHT0;3.78E-32;FIGL1_XENTR;Fidgetin-like protein 1 (EC 3.6.4.-);"nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cytoplasmic microtubule organization [GO:0031122]; regulation of double-strand break repair via homologous recombination [GO:0010569]";"GO:0000228; GO:0000287; GO:0005524; GO:0005634; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0031122; GO:0046034; GO:0048471";"ATP metabolic process [GO:0046034]; cytoplasmic microtubule organization [GO:0031122]; regulation of double-strand break repair via homologous recombination [GO:0010569]";"nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]"
comp734950_c1_seq1;GAXK01045637.1;P08970;1.82E-08;SUHW_DROME;Protein suppressor of hairy wing;"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization to euchromatin [GO:1905632]; response to ecdysone [GO:0035075]; transcription, DNA-templated [GO:0006351]";"GO:0000785; GO:0003677; GO:0005634; GO:0005700; GO:0006325; GO:0006351; GO:0031936; GO:0035075; GO:0043035; GO:0043565; GO:0045892; GO:0046872; GO:1905632; GO:1990188";"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization to euchromatin [GO:1905632]; response to ecdysone [GO:0035075]; transcription, DNA-templated [GO:0006351]";"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp7351_c2_seq1;GAXK01100760.1;Q9D024;5.16E-109;CCD47_MOUSE;Coiled-coil domain-containing protein 47 (Adipocyte-specific protein 4) (Calumin);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005509; GO:0005783; GO:0005791; GO:0006983; GO:0007029; GO:0009791; GO:0016021; GO:0030433; GO:0032469; GO:0055074";"calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]";calcium ion binding [GO:0005509]
comp735118_c1_seq1;GAXK01045670.1;Q9V576;3.10E-07;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp73518_c0_seq1;GAXK01205013.1;P92208;0;JNK_DROME;Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]";"GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0009408; GO:0010468; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0035556; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071310; GO:0071907; GO:1903688; GO:1904801";"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp735260_c0_seq1;GAXK01045615.1;Q9VMM6;1.26E-22;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp735361_c0_seq1;GAXK01045672.1;P20693;6.80E-13;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp7354439_c0_seq1;GAXK01012684.1;Q9SD61;7.60E-10;C3H42_ARATH;Zinc finger CCCH domain-containing protein 42 (AtC3H42);"nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003677; GO:0003723; GO:0005686; GO:0016607; GO:0046872";mRNA splicing, via spliceosome [GO:0000398];"nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp73555_c0_seq1;GAXK01017064.1;Q14B46;5.91E-46;RTKN2_MOUSE;Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243";"hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";
comp735558_c0_seq1;GAXK01045619.1;Q6H1V1;1.98E-73;BEST3_MOUSE;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271";"inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]";"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp735574_c0_seq1;GAXK01045620.1;P29176;7.04E-11;FOSX_MSVFR;Transforming protein v-Fos/v-Fox;"host cell nucleus [GO:0042025]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0003700; GO:0006357; GO:0042025";regulation of transcription by RNA polymerase II [GO:0006357];host cell nucleus [GO:0042025];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp735648_c0_seq1;GAXK01045644.1;P28606;5.57E-70;Y1628_SYNP2;Uncharacterized protein SYNPCC7002_A1628;hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp73571_c1_seq1;GAXK01017383.1;P04836;1.01E-131;CBPE_BOVIN;Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase);"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]";"GO:0003214; GO:0004181; GO:0005615; GO:0005794; GO:0006518; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030141; GO:0030658; GO:0030667; GO:0033366; GO:0042043; GO:0043025; GO:0050839; GO:0072657; GO:0097060";"cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]";"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]";"cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]"
comp73572_c1_seq1;GAXK01017319.1;P83632;5.78E-26;P27K_GALME;27 kDa hemolymph protein (P27K) (27k);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp73580_c2_seq1;GAXK01017070.1;P42696;3.08E-43;RBM34_HUMAN;RNA-binding protein 34 (RNA-binding motif protein 34);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634; GO:0005730";;"nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp73585_c0_seq1;GAXK01017485.1;Q5F4A9;6.04E-21;AR6P4_CHICK;ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4);"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"GO:0005730; GO:0006397; GO:0008380; GO:0016607";"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleolus [GO:0005730]";
comp7359_c1_seq1;GAXK01100325.1;Q22460;4.12E-37;BCA1_CAEEL;Beta carbonic anhydrase 1 (EC 4.2.1.1);"cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0008270";;cytoplasm [GO:0005737];"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp73593_c0_seq1;GAXK01017208.1;Q76IC5;6.69E-52;PGPI_RAT;Pyroglutamyl-peptidase 1 (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl aminopeptidase I) (PAP-I) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrrolidone-carboxylate peptidase);"cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508]";"GO:0005829; GO:0006508; GO:0008234; GO:0016920";proteolysis [GO:0006508];cytosol [GO:0005829];"cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]"
comp735976_c1_seq1;GAXK01045671.1;P35220;0;CTNA_DROME;Catenin alpha;"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323";"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of cell polarity [GO:0007163]; head morphogenesis [GO:0060323]";"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp7360074_c0_seq1;GAXK01075257.1;C5D3T6;5.71E-09;RL15_GEOSW;50S ribosomal protein L15;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp736016_c0_seq1;GAXK01115163.1;Q05187;0;TGMH_TACTR;Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase);"membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]";"GO:0003810; GO:0016020; GO:0018149; GO:0046872";peptide cross-linking [GO:0018149];membrane [GO:0016020];"metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
comp7360366_c0_seq1;GAXK01075268.1;P35442;1.12E-10;TSP2_HUMAN;Thrombospondin-2;"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]";"GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023";"cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]";"calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
comp7360437_c0_seq1;GAXK01075270.1;O70247;6.75E-13;SC5A6_RAT;Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6);"brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; vesicle membrane [GO:0012506]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]";"GO:0008523; GO:0012506; GO:0015878; GO:0015887; GO:0016021; GO:0031526";"biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]";"brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; vesicle membrane [GO:0012506]";sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]
comp7360527_c0_seq1;GAXK01075261.1;Q05036;4.78E-09;HS110_CAEEL;Heat shock protein 110;"cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; determination of adult lifespan [GO:0008340]; response to topologically incorrect protein [GO:0035966]";"GO:0005524; GO:0005634; GO:0005829; GO:0008340; GO:0035966";"determination of adult lifespan [GO:0008340]; response to topologically incorrect protein [GO:0035966]";"cytosol [GO:0005829]; nucleus [GO:0005634]";ATP binding [GO:0005524]
comp7360795_c0_seq1;GAXK01075259.1;Q12BB2;1.05E-58;PSTB_POLSJ;Phosphate import ATP-binding protein PstB (EC 7.3.2.1) (ABC phosphate transporter) (Phosphate-transporting ATPase);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; inorganic phosphate transmembrane transporter activity [GO:0005315]";"GO:0005315; GO:0005524; GO:0005886; GO:0015415; GO:0016887";;plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; ATP binding [GO:0005524]; inorganic phosphate transmembrane transporter activity [GO:0005315]"
comp7360981_c0_seq1;GAXK01075254.1;Q99MN1;5.67E-23;SYK_MOUSE;Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0000049; GO:0000187; GO:0002276; GO:0002741; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050";"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]"
comp7361_c0_seq1;GAXK01100473.1;Q502G5;2.22E-45;CA050_DANRE;Uncharacterized protein C1orf50 homolog;;;;;
comp7361392_c0_seq1;GAXK01075275.1;A2SMA4;2.28E-77;KATG_METPP;Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase);"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp7361724_c0_seq1;GAXK01075252.1;Q7Z0G7;5.35E-07;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp7362420_c0_seq1;GAXK01128584.1;Q01781;1.12E-48;SAHH_PETCR;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp73629_c0_seq1;GAXK01017405.1;Q9BSK1;1.34E-31;ZN577_HUMAN;Zinc finger protein 577;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7363113_c0_seq1;GAXK01128577.1;Q8PYZ8;1.72E-47;HPPA1_METMA;K(+)-stimulated pyrophosphate-energized sodium pump (EC 7.2.3.-) (Membrane-bound sodium-translocating pyrophosphatase) (Mm-PPase) (Pyrophosphate-energized inorganic pyrophosphatase) (Na(+)-PPase);"integral component of plasma membrane [GO:0005887]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]; sodium ion transport [GO:0006814]";"GO:0000287; GO:0004427; GO:0005887; GO:0006814; GO:0009678; GO:0030955";sodium ion transport [GO:0006814];integral component of plasma membrane [GO:0005887];"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp7363711_c0_seq1;GAXK01128585.1;B1XY48;2.65E-69;TRPB_LEPCP;Tryptophan synthase beta chain (EC 4.2.1.20);tryptophan synthase activity [GO:0004834];GO:0004834;;;tryptophan synthase activity [GO:0004834]
comp7363895_c0_seq1;GAXK01128580.1;Q9HU78;2.83E-32;HUTC_PSEAE;Histidine utilization repressor;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0019556; GO:0019557; GO:0045892";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; negative regulation of transcription, DNA-templated [GO:0045892]";;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp736400_c0_seq1;GAXK01115174.1;Q7RTX9;1.18E-17;MOT14_HUMAN;Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp73641_c0_seq1;GAXK01017479.1;P05661;2.11E-56;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp7364433_c0_seq1;GAXK01034692.1;P31911;1.15E-43;HOXQ_CUPNH;Hydrogenase expression/formation protein HoxQ;;;;;
comp7364746_c0_seq1;GAXK01034687.1;P08134;2.89E-13;RHOC_HUMAN;Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9);"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]";"GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007015; GO:0007186; GO:0007266; GO:0008360; GO:0016477; GO:0019901; GO:0030334; GO:0030335; GO:0030950; GO:0032153; GO:0032154; GO:0032420; GO:0032464; GO:0032956; GO:0043123; GO:0043231; GO:0043297; GO:0044319; GO:0051017; GO:0051056; GO:0051496; GO:0060193; GO:0070062; GO:1902766";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp7364964_c0_seq1;GAXK01034684.1;P07202;4.27E-07;PERT_HUMAN;Thyroid peroxidase (TPO) (EC 1.11.1.8);"cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0005887; GO:0006590; GO:0006979; GO:0009986; GO:0020037; GO:0035162; GO:0042446; GO:0042744";"embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]";"cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]"
comp736533_c1_seq1;GAXK01115159.1;G5CTG7;5.93E-25;AQP10_MILTA;Aquaporin-10 (AQP-10);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]";"GO:0005886; GO:0015267; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";channel activity [GO:0015267]
comp7365476_c0_seq1;GAXK01034690.1;Q96321;3.60E-31;IMPA1_ARATH;Importin subunit alpha-1 (IMPa-1) (Karyopherin subunit alpha-1) (KAP-alpha-1);"cell wall [GO:0005618]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]";"GO:0005618; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0061608";"NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]";"cell wall [GO:0005618]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]"
comp73656_c0_seq1;GAXK01017290.1;Q20065;5.01E-165;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp736561_c0_seq1;GAXK01115133.1;Q8UWA5;1.05E-27;CAH2_TRIHK;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005737; GO:0005886; GO:0008270";;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp736564_c3_seq1;GAXK01115199.1;Q94900;2.36E-10;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp7365869_c0_seq1;GAXK01034679.1;Q8R151;4.90E-07;ZNFX1_MOUSE;NFX1-type zinc finger-containing protein 1;"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380";"chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]";"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp73659_c3_seq1;GAXK01017601.1;Q9CR50;1.49E-82;ZN363_MOUSE;RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0002039; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7366154_c0_seq1;GAXK01059400.1;Q04831;6.53E-61;GLNA_PANAR;Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]";"GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872";glutamine biosynthetic process [GO:0006542];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]"
comp7366895_c0_seq1;GAXK01059407.1;Q9I2W4;2.82E-26;SUMT_PSEAE;Uroporphyrinogen-III C-methyltransferase (Urogen III methylase) (EC 2.1.1.107) (SUMT) (Uroporphyrinogen III methylase) (UROM);"uroporphyrin-III C-methyltransferase activity [GO:0004851]; cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114]; siroheme biosynthetic process [GO:0019354]";"GO:0004851; GO:0009236; GO:0019354; GO:0055114";"cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114]; siroheme biosynthetic process [GO:0019354]";;uroporphyrin-III C-methyltransferase activity [GO:0004851]
comp7367561_c0_seq1;GAXK01059410.1;O34421;2.58E-13;ACDC_BACSU;Probable acyl-CoA dehydrogenase YngJ (EC 1.3.99.-);"plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]";"GO:0003995; GO:0005886; GO:0050660; GO:0052890";;plasma membrane [GO:0005886];"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]"
comp7368099_c0_seq1;GAXK01013132.1;P10686;9.36E-13;PLCG1_RAT;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1);"clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; insulin receptor binding [GO:0005158]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; calcium ion transport [GO:0006816]; cellular response to epidermal growth factor stimulus [GO:0071364]; inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to morphine [GO:0043278]; response to organonitrogen compound [GO:0010243]; signal transduction [GO:0007165]";"GO:0001726; GO:0004435; GO:0005158; GO:0005509; GO:0005737; GO:0005886; GO:0006816; GO:0007165; GO:0008180; GO:0009306; GO:0009395; GO:0009629; GO:0010243; GO:0010634; GO:0030027; GO:0030136; GO:0032959; GO:0042542; GO:0043278; GO:0048015; GO:0051209; GO:0051219; GO:0071364; GO:1901339";"calcium ion transport [GO:0006816]; cellular response to epidermal growth factor stimulus [GO:0071364]; inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to morphine [GO:0043278]; response to organonitrogen compound [GO:0010243]; signal transduction [GO:0007165]";"clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]";"calcium ion binding [GO:0005509]; insulin receptor binding [GO:0005158]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]"
comp73681_c2_seq1;GAXK01017350.1;B4JJQ3;5.01E-94;NNRE_DROGR;NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase);"metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166]";"GO:0000166; GO:0046872; GO:0052856";;;"metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166]"
comp7368226_c0_seq1;GAXK01013140.1;Q9XSU4;1.05E-51;RS11_CANLF;40S ribosomal protein S11;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp736826_c0_seq1;GAXK01115193.1;Q9NXL6;6.97E-36;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp7368678_c0_seq1;GAXK01013143.1;Q9JXP4;4.57E-51;UBIX_NEIMB;Flavin prenyltransferase UbiX (EC 2.5.1.129);"carboxy-lyase activity [GO:0016831]; flavin prenyltransferase activity [GO:0106141]; coenzyme biosynthetic process [GO:0009108]";"GO:0009108; GO:0016831; GO:0106141";coenzyme biosynthetic process [GO:0009108];;"carboxy-lyase activity [GO:0016831]; flavin prenyltransferase activity [GO:0106141]"
comp7368915_c0_seq1;GAXK01013146.1;Q6FYA7;6.89E-44;EF2_CANGA;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp736966_c0_seq1;GAXK01115148.1;P46267;9.02E-38;F16P2_BRANA;Fructose-1,6-bisphosphatase, cytosolic (FBPase) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase);"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]";"GO:0005737; GO:0005975; GO:0042132; GO:0046872";carbohydrate metabolic process [GO:0005975];cytoplasm [GO:0005737];"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]"
comp737_c0_seq1;GAXK01168774.1;O14737;5.30E-12;PDCD5_HUMAN;Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]";"GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0070062; GO:0071560; GO:0090200; GO:1903638; GO:1903645";"apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]"
comp7370036_c0_seq1;GAXK01120995.1;P21369;1.47E-14;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp7370477_c0_seq1;GAXK01120992.1;Q11DD7;5.65E-51;ATPA_CHESB;ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha);"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005886; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp73706_c1_seq1;GAXK01017045.1;O75600;2.91E-176;KBL_HUMAN;2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; L-threonine catabolic process to glycine [GO:0019518]";"GO:0005654; GO:0005739; GO:0005743; GO:0006520; GO:0008890; GO:0009058; GO:0016607; GO:0019518; GO:0030170";"biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; L-threonine catabolic process to glycine [GO:0019518]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]";"glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]"
comp7370619_c0_seq1;GAXK01120999.1;Q12C28;8.53E-44;TOLB_POLSJ;Tol-Pal system protein TolB;"periplasmic space [GO:0042597]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein import [GO:0017038]";"GO:0007049; GO:0017038; GO:0042597; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein import [GO:0017038]";periplasmic space [GO:0042597];
comp73708_c0_seq1;GAXK01017210.1;Q5FWT1;6.29E-55;FA98A_RAT;Protein FAM98A;"tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]";"GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029";"lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]";tRNA-splicing ligase complex [GO:0072669];protein methyltransferase activity [GO:0008276]
comp737105_c1_seq1;GAXK01115139.1;O54963;2.31E-17;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp7371279_c0_seq1;GAXK01120987.1;Q6F3I7;6.76E-10;DAP4_PSEMX;Dipeptidyl aminopeptidase 4 (EC 3.4.14.5) (Dipeptidyl aminopeptidase IV) (DAP IV);"cytoplasm [GO:0005737]; periplasmic space [GO:0042597]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0005737; GO:0008236; GO:0008239; GO:0042597; GO:0042802; GO:0042803; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytoplasm [GO:0005737]; periplasmic space [GO:0042597]";"dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; serine-type peptidase activity [GO:0008236]"
comp7371452_c0_seq1;GAXK01121002.1;Q8TE73;1.95E-45;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp737203_c0_seq1;GAXK01115184.1;Q93560;2.15E-13;BLMP1_CAEEL;B lymphocyte-induced maturation protein 1 homolog;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0001158; GO:0003700; GO:0005634; GO:0005737; GO:0008340; GO:0031490; GO:0040035; GO:0042826; GO:0043053; GO:0043565; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:1903355";"cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp7372557_c0_seq1;GAXK01033963.1;Q4A3R3;2.19E-11;DMBT1_PIG;Deleted in malignant brain tumors 1 protein (Hensin);"external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"GO:0005044; GO:0007275; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830";"cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]";"external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]";"scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
comp737278_c0_seq1;GAXK01115214.1;P0C1B4;1.79E-85;AMYA3_ASPOR;Alpha-amylase A type-3 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase) (Taka-amylase A) (TAA);"extracellular region [GO:0005576]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; calcium ion binding [GO:0005509]; carbohydrate catabolic process [GO:0016052]";"GO:0004556; GO:0005509; GO:0005576; GO:0016052; GO:0103025";carbohydrate catabolic process [GO:0016052];extracellular region [GO:0005576];"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; calcium ion binding [GO:0005509]"
comp73730_c2_seq1;GAXK01017303.1;Q80TS3;8.17E-31;AGRL3_MOUSE;Adhesion G protein-coupled receptor L3 (Latrophilin-3) (Lectomedin-3);"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]";"GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0050808; GO:0051965; GO:0098742; GO:0098978";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp73735_c1_seq1;GAXK01016996.1;Q96IR2;9.12E-33;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7373669_c0_seq1;GAXK01033976.1;Q92793;2.41E-14;CBP_HUMAN;CREB-binding protein (EC 2.3.1.48);"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"GO:0000122; GO:0000123; GO:0000790; GO:0000987; GO:0001085; GO:0001102; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0006473; GO:0007165; GO:0007219; GO:0007221; GO:0008134; GO:0008270; GO:0008589; GO:0016032; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0019216; GO:0030511; GO:0031648; GO:0032481; GO:0034644; GO:0042592; GO:0042733; GO:0042981; GO:0043426; GO:0045637; GO:0045747; GO:0045893; GO:0045944; GO:0048511; GO:0061418; GO:0065003; GO:1900034; GO:1904837";"beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; protein destabilization [GO:0031648]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"
comp7374_c0_seq1;GAXK01100448.1;P29338;7.72E-71;IF4E_RABIT;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein);"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417]";"GO:0000340; GO:0000932; GO:0003743; GO:0005737; GO:0005829; GO:0005845; GO:0006417; GO:0010494; GO:0016281; GO:0019899; GO:0031370; GO:0048471; GO:0070491";regulation of translation [GO:0006417];"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]";"enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]"
comp737411_c0_seq1;GAXK01115188.1;Q96JL9;7.42E-44;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7374201_c0_seq1;GAXK01078401.1;P32959;5.58E-08;PBPE_BACSU;Penicillin-binding protein 4* (PBP 4*) (PBP 4A) (Penicillin-binding protein E);"plasma membrane [GO:0005886]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0005886; GO:0008360; GO:0009252; GO:0030435; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; sporulation resulting in formation of a cellular spore [GO:0030435]";plasma membrane [GO:0005886];
comp73743_c0_seq1;GAXK01017004.1;Q5BK68;2.15E-37;SNPC3_RAT;snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Small nuclear RNA-activating complex polypeptide 3);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; DNA binding [GO:0003677]";"GO:0003677; GO:0005730; GO:0016604";;"nuclear body [GO:0016604]; nucleolus [GO:0005730]";DNA binding [GO:0003677]
comp7375080_c0_seq1;GAXK01078393.1;P14381;1.60E-10;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp7375390_c0_seq1;GAXK01078386.1;O96647;1.68E-63;RL10_BOMMA;60S ribosomal protein L10 (QM protein homolog);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7375480_c0_seq1;GAXK01078390.1;P30336;7.14E-34;CADA_BACPE;Probable cadmium-transporting ATPase (EC 3.6.3.3) (Cadmium-efflux ATPase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadmium transmembrane transporter activity, phosphorylative mechanism [GO:0008551]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; response to cadmium ion [GO:0046686]";"GO:0005524; GO:0005886; GO:0008551; GO:0016021; GO:0016787; GO:0046686; GO:0046872";response to cadmium ion [GO:0046686];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cadmium transmembrane transporter activity, phosphorylative mechanism [GO:0008551]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp737591_c0_seq1;GAXK01115191.1;Q8IN81;8.88E-19;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7376332_c0_seq1;GAXK01113874.1;Q39AN3;1.00E-60;METE_BURL3;5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14) (Cobalamin-independent methionine synthase) (Methionine synthase, vitamin-B12 independent isozyme);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp7376720_c0_seq1;GAXK01113871.1;P46863;3.29E-12;KL61_DROME;Kinesin-like protein Klp61F (Bipolar kinesin KRP-130);"aster [GO:0005818]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; cell division [GO:0051301]; centrosome separation [GO:0051299]; fusome organization [GO:0045478]; Golgi organization [GO:0007030]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end directed microtubule sliding [GO:0031535]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; protein secretion [GO:0009306]";"GO:0000278; GO:0001578; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005818; GO:0005819; GO:0005871; GO:0005874; GO:0005875; GO:0005876; GO:0007018; GO:0007030; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0009306; GO:0016887; GO:0031535; GO:0042998; GO:0045169; GO:0045478; GO:0051299; GO:0051301; GO:0072686; GO:0090307; GO:0097431; GO:1990498";"cell division [GO:0051301]; centrosome separation [GO:0051299]; fusome organization [GO:0045478]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end directed microtubule sliding [GO:0031535]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; protein secretion [GO:0009306]";"aster [GO:0005818]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]"
comp737722_c0_seq1;GAXK01115167.1;O34678;5.09E-23;YTBE_BACSU;Uncharacterized oxidoreductase YtbE (EC 1.-.-.-);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp7378084_c0_seq1;GAXK01083486.1;P10401;6.03E-07;POLY_DROME;"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp7378163_c0_seq1;GAXK01083483.1;Q9FGC7;1.66E-19;ZEP_ARATH;Zeaxanthin epoxidase, chloroplastic (AtZEP) (EC 1.14.15.21) (Protein ABA DEFICIENT 1) (AtABA1) (Protein IMPAIRED IN BABA-INDUCED STERILITY 3) (Protein LOW EXPRESSION OF OSMOTIC STRESS-RESPONSIVE GENES 6) (Protein NON-PHOTOCHEMICAL QUENCHING 2);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; membrane [GO:0016020]; plastid [GO:0009536]; FAD binding [GO:0071949]; zeaxanthin epoxidase [overall] activity [GO:0009540]; abscisic acid biosynthetic process [GO:0009688]; response to heat [GO:0009408]; response to red light [GO:0010114]; response to water deprivation [GO:0009414]; sugar mediated signaling pathway [GO:0010182]; xanthophyll biosynthetic process [GO:0016123]";"GO:0009408; GO:0009414; GO:0009507; GO:0009536; GO:0009540; GO:0009688; GO:0009941; GO:0010114; GO:0010182; GO:0016020; GO:0016123; GO:0071949";"abscisic acid biosynthetic process [GO:0009688]; response to heat [GO:0009408]; response to red light [GO:0010114]; response to water deprivation [GO:0009414]; sugar mediated signaling pathway [GO:0010182]; xanthophyll biosynthetic process [GO:0016123]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; membrane [GO:0016020]; plastid [GO:0009536]";"FAD binding [GO:0071949]; zeaxanthin epoxidase [overall] activity [GO:0009540]"
comp73782_c1_seq1;GAXK01017240.1;Q61880;0;DMC1_MOUSE;Meiotic recombination protein DMC1/LIM15 homolog;"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; DNA recombinase assembly [GO:0000730]; gamete generation [GO:0007276]; male meiosis I [GO:0007141]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]; synapsis [GO:0007129]";"GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0001541; GO:0001556; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0008094; GO:0016887; GO:0042148";"DNA recombinase assembly [GO:0000730]; gamete generation [GO:0007276]; male meiosis I [GO:0007141]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]; synapsis [GO:0007129]";"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]"
comp7378208_c0_seq1;GAXK01083478.1;Q56242;6.99E-43;UVRA_THET8;UvrABC system protein A (UvrA protein) (Excinuclease ABC subunit A);"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0005737; GO:0006289; GO:0008270; GO:0009380; GO:0009381; GO:0009432; GO:0016887";"nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]"
comp73784_c0_seq1;GAXK01017326.1;Q99MY2;3.62E-30;NUDT4_RAT;Diphosphoinositol polyphosphate phosphohydrolase 2 (DIPP-2) (rDIPP2) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 4) (Nudix motif 4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; phosphatidylinositol metabolic process [GO:0046488]";"GO:0000298; GO:0005634; GO:0005737; GO:0008486; GO:0030515; GO:0034431; GO:0034432; GO:0046488; GO:0046872; GO:0050072; GO:0052840; GO:0052842; GO:0071543; GO:1901907; GO:1901909; GO:1901911";"adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; phosphatidylinositol metabolic process [GO:0046488]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]"
comp7378752_c0_seq1;GAXK01083481.1;Q5SV42;3.64E-14;ILEUC_MOUSE;Leukocyte elastase inhibitor C (Serine protease inhibitor EIC) (Serpin B1c);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta secretion [GO:0050713]";"GO:0004867; GO:0005615; GO:0005737; GO:0010951; GO:0050713";"negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta secretion [GO:0050713]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp737897_c0_seq1;GAXK01115153.1;Q8IN81;6.62E-22;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7379577_c0_seq1;GAXK01083487.1;Q94128;3.75E-07;WRT1_CAEEL;"Warthog protein 1 [Cleaved into: Warthog protein 1 N-product; Warthog protein 1 C-product]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"GO:0005576; GO:0005615; GO:0005886; GO:0007267; GO:0007367; GO:0008233; GO:0009986; GO:0016539; GO:0016540";"cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; segment polarity determination [GO:0007367]";"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";peptidase activity [GO:0008233]
comp73797_c1_seq1;GAXK01017379.1;Q567J8;5.18E-09;OSR2_DANRE;Protein odd-skipped-related 2 (zOsr2);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pectoral fin development [GO:0033339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; urogenital system development [GO:0001655]";"GO:0000122; GO:0000977; GO:0001655; GO:0001822; GO:0005634; GO:0033339; GO:0045892; GO:0045944; GO:0046872; GO:0048793";"kidney development [GO:0001822]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; urogenital system development [GO:0001655]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp7380_c1_seq1;GAXK01100725.1;P97826;7.45E-26;STAR_RAT;Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1);"cytosol [GO:0005829]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; bile acid biosynthetic process [GO:0006699]; biphenyl metabolic process [GO:0018879]; brain development [GO:0007420]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to metal ion [GO:0071248]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle, REM sleep [GO:0042747]; dibenzo-p-dioxin metabolic process [GO:0018894]; diterpenoid metabolic process [GO:0016101]; estrogen biosynthetic process [GO:0006703]; glucocorticoid metabolic process [GO:0008211]; insecticide metabolic process [GO:0017143]; intracellular cholesterol transport [GO:0032367]; male gonad development [GO:0008584]; negative regulation of neuron apoptotic process [GO:0043524]; organic acid metabolic process [GO:0006082]; phenol-containing compound metabolic process [GO:0018958]; phthalate metabolic process [GO:0018963]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of gene expression [GO:0010628]; positive regulation of neurogenesis [GO:0050769]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hydrogen peroxide [GO:0042542]; response to insecticide [GO:0017085]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to leptin [GO:0044321]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]";"GO:0005739; GO:0005758; GO:0005829; GO:0006082; GO:0006694; GO:0006699; GO:0006703; GO:0007420; GO:0007584; GO:0007623; GO:0008203; GO:0008211; GO:0008584; GO:0009635; GO:0009636; GO:0010033; GO:0010212; GO:0010288; GO:0010628; GO:0014070; GO:0014823; GO:0015485; GO:0016101; GO:0017085; GO:0017143; GO:0018879; GO:0018894; GO:0018958; GO:0018963; GO:0030061; GO:0031667; GO:0032367; GO:0032869; GO:0034698; GO:0035094; GO:0035457; GO:0042493; GO:0042542; GO:0042747; GO:0043005; GO:0043025; GO:0043434; GO:0043524; GO:0043627; GO:0044321; GO:0044344; GO:0045471; GO:0046677; GO:0048168; GO:0048545; GO:0050769; GO:0050810; GO:0051412; GO:0060992; GO:0061370; GO:0070859; GO:0071222; GO:0071236; GO:0071248; GO:0071276; GO:0071312; GO:0071320; GO:0071333; GO:0071346; GO:0071371; GO:0071372; GO:0071373; GO:0071378; GO:0071407; GO:0071549; GO:0071560; GO:0071872; GO:0120020";"bile acid biosynthetic process [GO:0006699]; biphenyl metabolic process [GO:0018879]; brain development [GO:0007420]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to metal ion [GO:0071248]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle, REM sleep [GO:0042747]; dibenzo-p-dioxin metabolic process [GO:0018894]; diterpenoid metabolic process [GO:0016101]; estrogen biosynthetic process [GO:0006703]; glucocorticoid metabolic process [GO:0008211]; insecticide metabolic process [GO:0017143]; intracellular cholesterol transport [GO:0032367]; male gonad development [GO:0008584]; negative regulation of neuron apoptotic process [GO:0043524]; organic acid metabolic process [GO:0006082]; phenol-containing compound metabolic process [GO:0018958]; phthalate metabolic process [GO:0018963]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of gene expression [GO:0010628]; positive regulation of neurogenesis [GO:0050769]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hydrogen peroxide [GO:0042542]; response to insecticide [GO:0017085]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to leptin [GO:0044321]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]";"cytosol [GO:0005829]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]"
comp7380025_c0_seq1;GAXK01133834.1;Q9JUS4;5.72E-39;UVRA_NEIMA;UvrABC system protein A (UvrA protein) (Excinuclease ABC subunit A);"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0005737; GO:0006289; GO:0008270; GO:0009380; GO:0009381; GO:0009432; GO:0016887";"nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]"
comp738016_c0_seq1;GAXK01133681.1;P05661;9.48E-82;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp738039_c0_seq1;GAXK01133728.1;C3YWU0;2.33E-170;FUCO_BRAFL;Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase);"extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139";"fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]";"extracellular region [GO:0005576]; lysosome [GO:0005764]";alpha-L-fucosidase activity [GO:0004560]
comp7380555_c0_seq1;GAXK01133829.1;B1Y0I9;8.76E-12;Y695_LEPCP;UPF0758 protein Lcho_0695;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp738112_c0_seq1;GAXK01133724.1;A2BGU9;1.57E-55;SERHL_DANRE;Serine hydrolase-like protein (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]";"GO:0004377; GO:0005789; GO:0016787";;endoplasmic reticulum membrane [GO:0005789];"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; hydrolase activity [GO:0016787]"
comp7381291_c0_seq1;GAXK01133824.1;Q8RWW1;2.95E-24;TMN10_ARATH;Transmembrane 9 superfamily member 10 (Endomembrane protein 3) (Transmembrane nine protein 10) (AtTMN10);"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; protein localization to membrane [GO:0072657]";"GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0010008; GO:0016020; GO:0016021; GO:0072657";protein localization to membrane [GO:0072657];"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]";
comp7381556_c0_seq1;GAXK01133810.1;Q8XYN6;5.92E-48;PUR4_RALSO;Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]";"GO:0004642; GO:0005524; GO:0005737; GO:0006189; GO:0006541; GO:0046872";"'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]"
comp73816_c1_seq1;GAXK01017168.1;Q8VE95;2.61E-45;CH082_MOUSE;UPF0598 protein C8orf82 homolog;mitochondrion [GO:0005739];GO:0005739;;mitochondrion [GO:0005739];
comp738171_c0_seq1;GAXK01133713.1;Q8R821;4.65E-12;PPAX_CALS4;Putative pyrophosphatase PpaX (EC 3.6.1.1);"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]";"GO:0000287; GO:0004427";;;"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp73822_c6_seq1;GAXK01017073.1;Q9NU22;0;MDN1_HUMAN;Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein);"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016020; GO:0016887; GO:0045111; GO:0051082; GO:0065003";"protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp738256_c0_seq1;GAXK01133679.1;Q6GNV7;4.05E-36;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp7382949_c0_seq1;;P55614;1.86E-10;Y4PE_SINFN;Uncharacterized protein y4pE/y4sA;;;;;
comp7383701_c0_seq1;GAXK01189690.1;P24733;7.61E-13;MYS_ARGIR;Myosin heavy chain, striated muscle;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp73841_c1_seq1;GAXK01017275.1;Q6NUA7;2.74E-63;SIL1_XENLA;Nucleotide exchange factor SIL1;"endoplasmic reticulum lumen [GO:0005788]; protein transport [GO:0015031]";"GO:0005788; GO:0015031";protein transport [GO:0015031];endoplasmic reticulum lumen [GO:0005788];
comp738415_c0_seq1;GAXK01133678.1;Q80ZA4;1.76E-07;PKHL1_MOUSE;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);"cilium [GO:0005929]; integral component of membrane [GO:0016021]";"GO:0005929; GO:0016021";;"cilium [GO:0005929]; integral component of membrane [GO:0016021]";
comp73846_c2_seq1;GAXK01017277.1;D2HWM5;1.45E-52;RFWD3_AILME;E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]";"GO:0000724; GO:0002039; GO:0004842; GO:0005634; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0090734; GO:0097371";"cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]";"MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin-protein transferase activity [GO:0004842]"
comp7385852_c0_seq1;GAXK01197174.1;Q9SMH3;1.55E-09;DYH1A_CHLRE;Dynein-1-alpha heavy chain, flagellar inner arm I1 complex (1-alpha DHC) (Dynein-1, subspecies f);"inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"GO:0003777; GO:0005524; GO:0005874; GO:0008017; GO:0031514; GO:0036156; GO:0036159; GO:0060294";"cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]";"inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp73859_c0_seq1;GAXK01017375.1;Q8K2C8;1.34E-147;GPAT4_MOUSE;Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420";"acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";"glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]"
comp738596_c0_seq1;GAXK01133688.1;Q9X248;1.48E-27;FABG_THEMA;3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase);"3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]";"GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132";fatty acid elongation [GO:0030497];;"3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp7387077_c0_seq1;GAXK01010157.1;P9WN18;1.88E-39;GLTD_MYCTO;Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain);"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; L-glutamate biosynthetic process [GO:0097054]";"GO:0004355; GO:0046872; GO:0051539; GO:0097054";L-glutamate biosynthetic process [GO:0097054];;"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"
comp738729_c0_seq1;GAXK01133693.1;Q9N294;4.50E-15;B3GT5_PANPA;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0006486; GO:0008378; GO:0016021";protein glycosylation [GO:0006486];"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";galactosyltransferase activity [GO:0008378]
comp7387935_c0_seq1;GAXK01010167.1;P44466;1.97E-20;DACA_HAEIN;D-alanyl-D-alanine carboxypeptidase DacA (DD-carboxypeptidase) (DD-peptidase) (EC 3.4.16.4) (Penicillin-binding protein 5) (PBP-5);"plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0004175; GO:0005886; GO:0008360; GO:0009002; GO:0009252; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";plasma membrane [GO:0005886];"endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]"
comp7387986_c0_seq1;GAXK01010142.1;A2SFL2;3.54E-24;LGT_METPP;Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase (EC 2.5.1.145);"integral component of plasma membrane [GO:0005887]; phosphatidylglycerol-prolipoprotein diacylglyceryl transferase activity [GO:0008961]; lipoprotein biosynthetic process [GO:0042158]";"GO:0005887; GO:0008961; GO:0042158";lipoprotein biosynthetic process [GO:0042158];integral component of plasma membrane [GO:0005887];phosphatidylglycerol-prolipoprotein diacylglyceryl transferase activity [GO:0008961]
comp73887_c2_seq1;GAXK01205012.1;Q24537;2.69E-20;HMG2_DROME;High mobility group protein DSP1 (Protein dorsal switch 1);"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944";"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp7389_c0_seq1;GAXK01204955.1;Q9CPU4;4.01E-17;MGST3_MOUSE;Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0043231";"leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]";"glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]"
comp738902_c3_seq1;GAXK01133672.1;Q8N608;8.97E-128;DPP10_HUMAN;Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2);"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078";"positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]";"membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]"
comp73891_c1_seq1;GAXK01017035.1;P13217;0;PIPA_DROME;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase (EC 3.1.4.11) (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta) (No receptor potential A protein) (Phosphoinositide phospholipase C) (Phosphoinositide phospholipase C-beta);"inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; inositol trisphosphate biosynthetic process [GO:0032959]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"GO:0001580; GO:0002385; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0006644; GO:0006651; GO:0007601; GO:0007602; GO:0008344; GO:0008377; GO:0008654; GO:0009649; GO:0016027; GO:0016028; GO:0016042; GO:0016056; GO:0016059; GO:0019722; GO:0032959; GO:0043052; GO:0043153; GO:0045494; GO:0046488; GO:0046673; GO:0051482; GO:0071482; GO:2000370";"adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; inositol trisphosphate biosynthetic process [GO:0032959]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]";"inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]";"calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]"
comp73903_c2_seq1;GAXK01017531.1;Q6AZD4;2.24E-32;IMP2L_DANRE;Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein);"integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; serine-type peptidase activity [GO:0008236]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465]";"GO:0006465; GO:0006627; GO:0008236; GO:0016021; GO:0033108; GO:0042720";"mitochondrial respiratory chain complex assembly [GO:0033108]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]";serine-type peptidase activity [GO:0008236]
comp739183_c0_seq1;GAXK01133733.1;Q6GNV7;2.26E-31;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp7392710_c0_seq1;GAXK01052903.1;A2A935;9.41E-08;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp739359_c0_seq1;GAXK01133716.1;Q14591;4.24E-22;ZN271_HUMAN;Deleted.;;;;;
comp73937_c0_seq1;GAXK01017466.1;P59889;1.27E-36;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp73948_c0_seq1;GAXK01017132.1;Q5R5X8;8.14E-57;CAP2_PONAB;Adenylyl cyclase-associated protein 2 (CAP 2);"plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]";"GO:0000902; GO:0003779; GO:0005886; GO:0007010";"cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]";plasma membrane [GO:0005886];actin binding [GO:0003779]
comp7394805_c0_seq1;GAXK01135022.1;P51776;2.41E-100;PPDK_GIAIN;Pyruvate, phosphate dikinase (EC 2.7.9.1) (Pyruvate, orthophosphate dikinase);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]; pyruvate metabolic process [GO:0006090]";"GO:0005524; GO:0006090; GO:0016301; GO:0046872; GO:0050242";pyruvate metabolic process [GO:0006090];;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]"
comp7394998_c0_seq1;GAXK01135040.1;Q5NVM7;3.38E-72;S61A2_PONAB;Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0005789; GO:0015031; GO:0016021";protein transport [GO:0015031];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp7395060_c0_seq1;GAXK01135028.1;Q02370;3.70E-13;NDUA2_BOVIN;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit);"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"GO:0005747; GO:0031966; GO:0032981; GO:0055114";"mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]";"mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]";
comp73951_c0_seq1;GAXK01017253.1;Q8IN94;1.01E-11;OSA_DROME;Trithorax group protein osa (Protein eyelid);"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190";"chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055]";"brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]";DNA binding [GO:0003677]
comp7395333_c0_seq1;GAXK01135029.1;Q9C996;2.93E-09;GLIP6_ARATH;GDSL esterase/lipase 6 (EC 3.1.1.-) (Extracellular lipase 6);"extracellular region [GO:0005576]; lipase activity [GO:0016298]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0016042; GO:0016298";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];lipase activity [GO:0016298]
comp7395719_c0_seq1;GAXK01204879.1;P24203;2.93E-09;YJIA_ECOLI;P-loop guanosine triphosphatase YjiA (EC 3.6.-.-) (GTP-binding protein YjiA);"cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003924; GO:0005525; GO:0005829; GO:0006974; GO:0042802; GO:0046914";cellular response to DNA damage stimulus [GO:0006974];cytosol [GO:0005829];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]"
comp739604_c2_seq1;GAXK01133707.1;Q7KRI2;1.48E-14;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp73966_c0_seq1;GAXK01017209.1;Q6NVN0;2.96E-54;SOX2_XENTR;Transcription factor Sox-2 (SRY (sex determining region Y)-box 2);"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; inner ear receptor cell development [GO:0060119]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0007399; GO:0007417; GO:0008283; GO:0021538; GO:0021982; GO:0030154; GO:0030182; GO:0030900; GO:0031101; GO:0043565; GO:0044798; GO:0045165; GO:0045893; GO:0045944; GO:0048592; GO:0048839; GO:0051091; GO:0060119; GO:0071599; GO:1905040";"cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; inner ear receptor cell development [GO:0060119]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp7396608_c0_seq1;GAXK01003878.1;Q43298;3.98E-46;CH62_MAIZE;Chaperonin CPN60-2, mitochondrial (HSP60-2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]";"GO:0005524; GO:0005739; GO:0005829; GO:0006458; GO:0007005; GO:0042026; GO:0045041; GO:0051082";"'de novo' protein folding [GO:0006458]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp7396928_c0_seq1;GAXK01003890.1;Q9C0G6;9.12E-12;DYH6_HUMAN;Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7397632_c0_seq1;GAXK01003876.1;Q9PVG3;2.19E-09;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp7397759_c0_seq1;GAXK01003877.1;P41436;2.24E-15;IAP_GVCPM;Apoptosis inhibitor IAP;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp73978_c0_seq1;GAXK01017204.1;Q9Y4C8;1.35E-08;RBM19_HUMAN;Probable RNA-binding protein 19 (RNA-binding motif protein 19);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016020; GO:0016607; GO:0040019; GO:0045292";"mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp739960_c0_seq1;GAXK01133659.1;Q68J42;3.81E-57;LIPS_PIG;Hormone-sensitive lipase (HSL) (EC 3.1.1.79);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone-sensitive lipase activity [GO:0033878]; lipase activity [GO:0016298]; rRNA primary transcript binding [GO:0042134]; cholesterol metabolic process [GO:0008203]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]";"GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016042; GO:0016298; GO:0019433; GO:0033878; GO:0042134";"cholesterol metabolic process [GO:0008203]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"hormone-sensitive lipase activity [GO:0033878]; lipase activity [GO:0016298]; rRNA primary transcript binding [GO:0042134]"
comp7399716_c0_seq1;GAXK01010525.1;P00766;1.27E-16;CTRA_BOVIN;"Chymotrypsinogen A (EC 3.4.21.1) [Cleaved into: Chymotrypsin A chain A; Chymotrypsin A chain B; Chymotrypsin A chain C]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0097180; GO:0097655";digestion [GO:0007586];"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp73999_c0_seq1;GAXK01017594.1;E9Q6P5;1.13E-126;TTC7B_MOUSE;Tetratricopeptide repeat protein 7B (TPR repeat protein 7B);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";"GO:0005829; GO:0005886; GO:0046854; GO:0072659";"phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp740_c1_seq1;GAXK01169366.1;Q9VZ23;3.12E-142;RAN_DROME;GTP-binding nuclear protein Ran (Ras-related nuclear protein);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; meiotic spindle organization [GO:0000212]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]";"GO:0000132; GO:0000212; GO:0003924; GO:0005525; GO:0005634; GO:0005635; GO:0005737; GO:0005938; GO:0006606; GO:0006611; GO:0006886; GO:0007346; GO:0032880; GO:0046872; GO:0051301; GO:1990498";"cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; meiotic spindle organization [GO:0000212]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp7401134_c0_seq1;GAXK01150060.1;P0DOV9;6.69E-12;SLAD_PSEPU;3-sulfolactaldehyde dehydrogenase (SLA dehydrogenase) (EC 1.2.1.97);"succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]";"GO:0009013; GO:0009450";gamma-aminobutyric acid catabolic process [GO:0009450];;succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]
comp7401816_c0_seq1;GAXK01150057.1;O02228;5.06E-09;SC5A7_CAEEL;High-affinity choline transporter 1;"axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]";"GO:0005307; GO:0008021; GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0030424; GO:0033265; GO:0043005; GO:0043025; GO:0045202";"acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]";"choline:sodium symporter activity [GO:0005307]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]"
comp7402610_c0_seq1;GAXK01017649.1;A3B529;2.20E-13;CIPKS_ORYSJ;CBL-interacting protein kinase 28 (EC 2.7.11.1) (OsCIPK28);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]";"GO:0004674; GO:0005524; GO:0007165";signal transduction [GO:0007165];;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp740283_c0_seq1;GAXK01041122.1;P35502;5.97E-80;ESTF_MYZPE;Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp7403927_c0_seq1;GAXK01017669.1;P44797;1.19E-10;PUR8_HAEIN;Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase);"cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]";"GO:0004018; GO:0005829; GO:0006189; GO:0044208; GO:0070626";"'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]";cytosol [GO:0005829];"(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]"
comp74041_c0_seq1;GAXK01047507.1;Q6WV19;0;GALT2_DROME;Polypeptide N-acetylgalactosaminyltransferase 2 (pp-GaNTase 2) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp740473_c0_seq1;GAXK01041094.1;Q9VCA2;2.34E-94;ORCT_DROME;Organic cation transporter protein;"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]";"GO:0006811; GO:0006915; GO:0016021; GO:0022857";"apoptotic process [GO:0006915]; ion transport [GO:0006811]";integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp740509_c0_seq1;GAXK01041143.1;Q22165;1.72E-33;STO4_CAEEL;Stomatin-4;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp7405308_c0_seq1;GAXK01038901.1;P14381;1.56E-07;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp7405441_c0_seq1;GAXK01038895.1;P43329;1.12E-21;HRPA_ECOLI;ATP-dependent RNA helicase HrpA (EC 3.6.4.13);"ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA modification [GO:0009451]";"GO:0003676; GO:0003724; GO:0004386; GO:0005524; GO:0006397; GO:0009451";"mRNA processing [GO:0006397]; RNA modification [GO:0009451]";;"ATP binding [GO:0005524]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp7406132_c0_seq1;GAXK01131020.1;Q7Z2Y8;2.42E-35;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp7406349_c0_seq1;GAXK01131026.1;Q9U8U5;2.52E-10;ERF1_TETTH;Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1);"cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]";"GO:0003747; GO:0005737";;cytoplasm [GO:0005737];translation release factor activity [GO:0003747]
comp7406400_c0_seq1;GAXK01131019.1;Q8RWV0;1.04E-43;TKTC1_ARATH;Transketolase-1, chloroplastic (TK) (EC 2.2.1.1);"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; plastid [GO:0009536]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]; response to cadmium ion [GO:0046686]";"GO:0004802; GO:0005829; GO:0006098; GO:0009507; GO:0009536; GO:0009570; GO:0009941; GO:0019253; GO:0046686; GO:0046872";"pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]; response to cadmium ion [GO:0046686]";"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; plastid [GO:0009536]";"metal ion binding [GO:0046872]; transketolase activity [GO:0004802]"
comp740701_c1_seq1;GAXK01041155.1;Q9VCR7;6.95E-75;CTNS_DROME;Cystinosin homolog;"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]; amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]";"GO:0003333; GO:0005765; GO:0005774; GO:0015171; GO:0015184; GO:0015811; GO:0016021";"amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]";"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]";"amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]"
comp7407489_c0_seq1;GAXK01131024.1;Q6ZDJ7;3.94E-11;UGE2_ORYSJ;UDP-glucose 4-epimerase 2 (OsUGE-2) (EC 5.1.3.2) (UDP-galactose 4-epimerase 2);"cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]";"GO:0003978; GO:0005829; GO:0019388; GO:0033499";"galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]";cytosol [GO:0005829];UDP-glucose 4-epimerase activity [GO:0003978]
comp74077_c0_seq1;GAXK01047422.1;O70237;4.98E-18;GFI1B_MOUSE;Zinc finger protein Gfi-1b (Growth factor independent protein 1B);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"GO:0000122; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0007275; GO:0016363; GO:0030854; GO:0045646; GO:0046872; GO:0051572; GO:0051574";"multicellular organism development [GO:0007275]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of erythrocyte differentiation [GO:0045646]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp7408440_c0_seq1;GAXK01041070.1;O76082;2.06E-19;S22A5_HUMAN;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0005886; GO:0006814; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0015893; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0052106; GO:0060731; GO:0070062; GO:0070715; GO:1902603";"carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp740959_c0_seq1;GAXK01041088.1;Q9ULH0;3.69E-24;KDIS_HUMAN;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090";"activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]"
comp7409655_c0_seq1;GAXK01041076.1;Q5U206;1.14E-09;CALL3_RAT;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7409661_c0_seq1;GAXK01041075.1;P09648;6.81E-39;CATL1_CHICK;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain] (Fragments)";"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp7410069_c0_seq1;GAXK01146888.1;P46284;3.83E-24;S17P_CHLRE;Sedoheptulose-1,7-bisphosphatase, chloroplastic (EC 3.1.3.37) (SED(1,7)P2ase) (Sedoheptulose bisphosphatase) (SBPase);"apoplast [GO:0048046]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; thylakoid [GO:0009579]; metal ion binding [GO:0046872]; sedoheptulose-bisphosphatase activity [GO:0050278]; defense response to bacterium [GO:0042742]; reductive pentose-phosphate cycle [GO:0019253]; starch biosynthetic process [GO:0019252]; sucrose biosynthetic process [GO:0005986]";"GO:0005986; GO:0009570; GO:0009579; GO:0009941; GO:0019252; GO:0019253; GO:0042742; GO:0046872; GO:0048046; GO:0050278";"defense response to bacterium [GO:0042742]; reductive pentose-phosphate cycle [GO:0019253]; starch biosynthetic process [GO:0019252]; sucrose biosynthetic process [GO:0005986]";"apoplast [GO:0048046]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; thylakoid [GO:0009579]";"metal ion binding [GO:0046872]; sedoheptulose-bisphosphatase activity [GO:0050278]"
comp741026_c2_seq1;GAXK01041109.1;P08442;3.79E-19;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp7410368_c0_seq1;GAXK01146881.1;P0CT41;3.13E-11;TF212_SCHPO;Transposon Tf2-12 polyprotein (Retrotransposable element Tf2 155 kDa protein);"nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";nucleus [GO:0005634];"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
comp74105_c1_seq1;GAXK01047856.1;Q9ZCN5;2.60E-15;Y688_RICPR;Uncharacterized protein RP688;"integral component of membrane [GO:0016021]; transferase activity [GO:0016740]";"GO:0016021; GO:0016740";;integral component of membrane [GO:0016021];transferase activity [GO:0016740]
comp741089_c0_seq1;GAXK01041138.1;O75123;9.04E-66;ZN623_HUMAN;Zinc finger protein 623;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7410900_c0_seq1;GAXK01146890.1;B1XYL1;2.20E-49;MNMG_LEPCP;tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A);"cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0005737; GO:0050660";tRNA wobble uridine modification [GO:0002098];cytoplasm [GO:0005737];flavin adenine dinucleotide binding [GO:0050660]
comp7411042_c0_seq1;GAXK01146872.1;P25387;1.00E-50;GBLP_CHLRE;Guanine nucleotide-binding protein subunit beta-like protein;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp7411314_c0_seq1;GAXK01146880.1;Q8VYK9;7.52E-18;CKL12_ARATH;Casein kinase 1-like protein 12 (EC 2.7.11.1) (Protein CASEIN KINASE I-LIKE 12);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006897; GO:0018105; GO:0018107";"endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp7411416_c0_seq1;GAXK01146885.1;Q27589;6.70E-20;CP4D2_DROME;Cytochrome P450 4d2 (EC 1.14.-.-) (CYPIVD2);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp741180_c0_seq1;GAXK01041107.1;Q8QZV1;2.78E-18;PDE9A_RAT;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471";"cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp7412201_c0_seq1;GAXK01024832.1;P45455;2.38E-31;RPE_SERMA;Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Pentose-5-phosphate 3-epimerase) (PPE) (R5P3E);"metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]";"GO:0004750; GO:0005975; GO:0006098; GO:0046872";"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]";;"metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]"
comp7412780_c0_seq1;GAXK01024841.1;P83654;2.00E-14;ERVC_TABDI;Ervatamin-C (ERV-C) (EC 3.4.22.-);"extracellular region [GO:0005576]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis [GO:0006508]";"GO:0004197; GO:0005576; GO:0006508";proteolysis [GO:0006508];extracellular region [GO:0005576];cysteine-type endopeptidase activity [GO:0004197]
comp7413103_c0_seq1;GAXK01024828.1;P12235;1.76E-51;ADT1_HUMAN;ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4);"integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]";"GO:0000002; GO:0005471; GO:0005739; GO:0005743; GO:0005887; GO:0006091; GO:0008637; GO:0015207; GO:0015866; GO:0016032; GO:0032592; GO:0050796; GO:0060546";"ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]";"integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]"
comp7413166_c0_seq1;GAXK01024824.1;Q12955;9.36E-09;ANK3_HUMAN;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp7413454_c0_seq1;GAXK01024821.1;P62924;1.51E-33;IF5A_SPOEX;Eukaryotic translation initiation factor 5A (eIF-5A);"cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003746; GO:0005737; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";cytoplasm [GO:0005737];"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp7413482_c0_seq1;GAXK01024818.1;P0ABI1;2.53E-07;CLPA_ECO57;ATP-dependent Clp protease ATP-binding subunit ClpA;"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein metabolic process [GO:0019538]; protein unfolding [GO:0043335]";"GO:0005524; GO:0016887; GO:0019538; GO:0043335";"protein metabolic process [GO:0019538]; protein unfolding [GO:0043335]";;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp7413867_c0_seq1;GAXK01024819.1;Q2RSB4;5.64E-45;PNTB_RHORT;NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]";"GO:0005886; GO:0008750; GO:0016021; GO:0050661";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]"
comp74146_c7_seq1;GAXK01047991.1;Q4ZIN3;1.21E-133;MBRL_HUMAN;Membralin (Transmembrane protein 259);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294";"negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp741597_c0_seq1;GAXK01041134.1;Q5R5X9;1.70E-24;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp7416318_c0_seq1;GAXK01109883.1;P29843;1.04E-34;HSP7A_DROME;Heat shock 70 kDa protein cognate 1 (Heat shock 70 kDa protein 70C);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp7417369_c0_seq1;GAXK01109881.1;Q05187;5.38E-13;TGMH_TACTR;Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase);"membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]";"GO:0003810; GO:0016020; GO:0018149; GO:0046872";peptide cross-linking [GO:0018149];membrane [GO:0016020];"metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
comp741806_c0_seq1;GAXK01041092.1;Q9VQU9;1.61E-76;BOWEL_DROME;Protein bowel (Brother of odd with entrails limited);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";"GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619";"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp7418398_c0_seq1;GAXK01044972.1;Q887P8;2.69E-38;ALGD_PSESM;GDP-mannose 6-dehydrogenase (GMD) (EC 1.1.1.132);"GDP-mannose 6-dehydrogenase activity [GO:0047919]; NAD binding [GO:0051287]; alginic acid biosynthetic process [GO:0042121]";"GO:0042121; GO:0047919; GO:0051287";alginic acid biosynthetic process [GO:0042121];;"GDP-mannose 6-dehydrogenase activity [GO:0047919]; NAD binding [GO:0051287]"
comp74184_c1_seq1;GAXK01047857.1;Q6AY75;7.21E-16;PHF23_RAT;PHD finger protein 23 (PDH-containing protein JUNE-1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; mitotic chromosome condensation [GO:0007076]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of protein ubiquitination [GO:0031398]";"GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006914; GO:0007076; GO:0031398; GO:0046872; GO:1901097; GO:1902902";"autophagy [GO:0006914]; mitotic chromosome condensation [GO:0007076]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of protein ubiquitination [GO:0031398]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]"
comp7419497_c0_seq1;GAXK01044960.1;Q42093;1.38E-27;AB2C_ARATH;ABC transporter C family member 2 (ABC transporter ABCC.2) (AtABCC2) (EC 7.6.2.2) (ATP-energized glutathione S-conjugate pump 2) (Glutathione S-conjugate-transporting ATPase 2) (Multidrug resistance-associated protein 2);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; (+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity [GO:1902417]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; calmodulin binding [GO:0005516]; (+)-abscisic acid D-glucopyranosyl ester transmembrane transport [GO:1902418]; transmembrane transport [GO:0055085]";"GO:0000325; GO:0005516; GO:0005524; GO:0005773; GO:0005774; GO:0005783; GO:0008559; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085; GO:1902417; GO:1902418";"(+)-abscisic acid D-glucopyranosyl ester transmembrane transport [GO:1902418]; transmembrane transport [GO:0055085]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]";"(+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity [GO:1902417]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]"
comp7420727_c0_seq1;GAXK01089218.1;Q42670;9.00E-08;PLSC_COCNU;1-acyl-sn-glycerol-3-phosphate acyltransferase (1-AGP acyltransferase) (1-AGPAT) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase) (LPAAT);"integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; phospholipid biosynthetic process [GO:0008654]";"GO:0003841; GO:0008654; GO:0016021";phospholipid biosynthetic process [GO:0008654];integral component of membrane [GO:0016021];1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp7422856_c0_seq1;GAXK01099366.1;Q5NVR2;7.22E-49;MDHM_PONAB;Malate dehydrogenase, mitochondrial (EC 1.1.1.37);"mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";"GO:0005759; GO:0005975; GO:0006099; GO:0006108; GO:0006475; GO:0009060; GO:0030060; GO:0042803";"aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];"L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]"
comp7422985_c0_seq1;GAXK01099365.1;P0DJ60;8.11E-32;RL19_TETTS;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7423911_c0_seq1;GAXK01099360.1;P85194;1.51E-29;PSBO_HELAN;Oxygen-evolving enhancer protein 1, chloroplastic (OEE1) (33 kDa subunit of oxygen evolving system of photosystem II) (33 kDa thylakoid membrane protein) (OEC 33 kDa subunit);"chloroplast thylakoid membrane [GO:0009535]; photosystem II oxygen evolving complex [GO:0009654]; oxygen evolving activity [GO:0010242]; photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";"GO:0009535; GO:0009654; GO:0010207; GO:0010242; GO:0042549";"photosystem II assembly [GO:0010207]; photosystem II stabilization [GO:0042549]";"chloroplast thylakoid membrane [GO:0009535]; photosystem II oxygen evolving complex [GO:0009654]";oxygen evolving activity [GO:0010242]
comp742429_c0_seq1;GAXK01148730.1;Q3SX26;9.61E-23;TRIP6_BOVIN;Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"GO:0001725; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0019900; GO:0030335; GO:0046872; GO:1901224";"cell adhesion [GO:0007155]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]"
comp742440_c0_seq1;GAXK01148772.1;Q9R0D8;4.25E-42;WDR54_MOUSE;WD repeat-containing protein 54;microtubule binding [GO:0008017];GO:0008017;;;microtubule binding [GO:0008017]
comp7424904_c0_seq1;GAXK01086618.1;P31683;1.74E-49;ENO_CHLRE;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase) (Fragment);"nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0005634; GO:0006096";glycolytic process [GO:0006096];"nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]";"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp7425_c1_seq1;GAXK01100493.1;P45883;3.31E-27;ACBP_PELRI;Acyl-CoA-binding protein homolog (ACBP) (Diazepam-binding inhibitor homolog) (DBI);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]";"GO:0000062; GO:0005783; GO:0005794; GO:0008289";;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]";"fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]"
comp7425040_c0_seq1;GAXK01086616.1;Q4UFS9;3.92E-42;RS8_THEAN;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7425045_c0_seq1;GAXK01086625.1;P31937;8.34E-51;3HIDH_HUMAN;3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]";"GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0009083; GO:0050661; GO:0051287";"branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
comp742508_c1_seq1;GAXK01148804.1;Q505D1;5.52E-09;ANR28_MOUSE;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK);nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp7426_c1_seq1;GAXK01100299.1;P18824;0;ARM_DROME;Armadillo segment polarity protein;"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; beta-catenin-TCF complex [GO:1990907]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]";"GO:0000122; GO:0000902; GO:0001709; GO:0001745; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005913; GO:0005915; GO:0007155; GO:0007367; GO:0007370; GO:0007391; GO:0007399; GO:0007472; GO:0007507; GO:0007616; GO:0008134; GO:0008587; GO:0014017; GO:0014019; GO:0016324; GO:0016342; GO:0019900; GO:0019903; GO:0030139; GO:0030424; GO:0035017; GO:0035019; GO:0035147; GO:0035153; GO:0035257; GO:0035293; GO:0045186; GO:0045294; GO:0045296; GO:0045893; GO:0045944; GO:0046530; GO:0046667; GO:0048477; GO:0048526; GO:0048754; GO:0060070; GO:0060232; GO:0060914; GO:0071896; GO:0072659; GO:0090254; GO:0098609; GO:1990907";"branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; beta-catenin-TCF complex [GO:1990907]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]";"alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp7426079_c0_seq1;GAXK01090867.1;P05661;4.07E-59;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp7426253_c0_seq1;GAXK01090853.1;Q25074;6.70E-20;AQP_HAEIX;Aquaporin (BfWC1) (Water channel 1);"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp7426345_c0_seq1;GAXK01090848.1;A0A126GUP6;8.52E-07;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp7426542_c0_seq1;GAXK01090864.1;Q9BYN7;5.18E-08;ZN341_HUMAN;Zinc finger protein 341;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7426897_c0_seq1;GAXK01090865.1;P37419;2.59E-36;KBL_SALTY;2-amino-3-ketobutyrate coenzyme A ligase (AKB ligase) (KBL) (EC 2.3.1.29) (Glycine acetyltransferase);"glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]";"GO:0008890; GO:0009058; GO:0019518; GO:0030170";"biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]";;"glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]"
comp742750_c0_seq1;GAXK01148746.1;Q24372;1.10E-32;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp742756_c3_seq1;GAXK01148836.1;Q8WTS6;1.12E-18;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp742778_c2_seq1;GAXK01148820.1;A4VCH4;2.16E-51;VP35L_DANRE;VPS35 endosomal protein sorting factor-like;"cell [GO:0005623]; cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]";"GO:0005623; GO:0005768; GO:0005829; GO:0015031; GO:0030906; GO:0032456; GO:0042147; GO:1990126";"endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]";"cell [GO:0005623]; cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]";
comp7428591_c0_seq1;GAXK01001069.1;P19672;1.99E-08;YQXC_BACSU;Putative rRNA methyltransferase YqxC (EC 2.1.1.-);"methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0003723; GO:0006364; GO:0008168";rRNA processing [GO:0006364];;"methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]"
comp7429_c0_seq1;GAXK01100482.1;Q9W5U2;1.24E-163;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp7429181_c0_seq1;GAXK01001067.1;C5CM20;8.83E-31;ANMK_VARPS;Anhydro-N-acetylmuramic acid kinase (EC 2.7.1.170) (AnhMurNAc kinase);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; 1,6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254]";"GO:0005524; GO:0005975; GO:0006040; GO:0009254; GO:0016301; GO:0016773; GO:0097175";"1,6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254]";;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"
comp7429185_c0_seq1;GAXK01001057.1;P22003;1.74E-07;BMP5_HUMAN;Bone morphogenetic protein 5 (BMP-5);"extracellular space [GO:0005615]; vesicle [GO:0031982]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]";"GO:0001501; GO:0001503; GO:0003272; GO:0003323; GO:0003344; GO:0005125; GO:0005160; GO:0005615; GO:0007389; GO:0008083; GO:0008284; GO:0008285; GO:0010719; GO:0010862; GO:0010894; GO:0021502; GO:0030509; GO:0030539; GO:0030902; GO:0031982; GO:0032348; GO:0042981; GO:0043408; GO:0043569; GO:0043583; GO:0045944; GO:0048468; GO:0048738; GO:0050679; GO:0051216; GO:0060037; GO:0060395; GO:0060411; GO:0060710; GO:0061384; GO:0070700; GO:0071676; GO:0097065; GO:1900006; GO:1902042; GO:1905069; GO:2000065";"allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]";"extracellular space [GO:0005615]; vesicle [GO:0031982]";"BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]"
comp7429278_c0_seq1;GAXK01001059.1;Q86LG1;1.70E-14;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp7429622_c0_seq1;GAXK01001055.1;P37740;2.04E-22;DCTR_RHOCA;C4-dicarboxylate transport transcriptional regulatory protein DctR;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0005737; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp742971_c2_seq1;GAXK01148832.1;Q14585;2.87E-69;ZN345_HUMAN;Zinc finger protein 345 (Zinc finger protein HZF10);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0000122; GO:0003700; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp743_c0_seq1;GAXK01169694.1;P41824;6.88E-33;YBOXH_APLCA;Y-box factor homolog (APY1);"nucleus [GO:0005634]; RNA binding [GO:0003723]";"GO:0003723; GO:0005634";;nucleus [GO:0005634];RNA binding [GO:0003723]
comp74301_c0_seq1;GAXK01047785.1;Q9Z0F6;1.21E-60;RAD9A_MOUSE;Cell cycle checkpoint control protein RAD9A (mRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A) (Rad9-like protein);"checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; enzyme binding [GO:0019899]; exodeoxyribonuclease III activity [GO:0008853]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]";"GO:0000077; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0017124; GO:0019899; GO:0019901; GO:0030896; GO:0031573; GO:0042826; GO:0071479; GO:1902231";"cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]";"checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; enzyme binding [GO:0019899]; exodeoxyribonuclease III activity [GO:0008853]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp7430369_c0_seq1;GAXK01110050.1;P45112;6.44E-38;RECJ_HAEIN;Single-stranded-DNA-specific exonuclease RecJ (EC 3.1.-.-);"5'-3' exonuclease activity [GO:0008409]; nucleic acid binding [GO:0003676]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0003676; GO:0006281; GO:0006310; GO:0008409";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]";;"5'-3' exonuclease activity [GO:0008409]; nucleic acid binding [GO:0003676]"
comp7430454_c0_seq1;GAXK01110065.1;A1WHB4;7.16E-42;KUP_VEREI;Probable potassium transport system protein kup;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium ion transmembrane transporter activity [GO:0015079]";"GO:0005886; GO:0015079; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";potassium ion transmembrane transporter activity [GO:0015079]
comp7430804_c0_seq1;GAXK01110046.1;Q9GSU7;2.01E-33;HSP71_DROSI;Major heat shock 70 kDa protein Ab (Heat shock protein 70Ab) (HSP70-87C1);"ATP binding [GO:0005524]; response to heat [GO:0009408]";"GO:0005524; GO:0009408";response to heat [GO:0009408];;ATP binding [GO:0005524]
comp74310_c1_seq1;GAXK01047444.1;Q01842;7.16E-54;POK_DROME;Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000980; GO:0000981; GO:0001012; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090175; GO:1903688; GO:2000051";"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp7431495_c0_seq1;GAXK01110064.1;P40639;4.96E-07;AES4_ALLMI;SRY-related protein AES4 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp7431606_c0_seq1;GAXK01110051.1;P39595;3.96E-07;EFEU_BACSU;Ferrous iron permease EfeU (Fe(2+) ion permease EfeU) (Ferrous iron uptake protein);"high-affinity iron permease complex [GO:0033573]; plasma membrane [GO:0005886]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]";"GO:0005886; GO:0015093; GO:0033573; GO:0034755; GO:0055072";"iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]";"high-affinity iron permease complex [GO:0033573]; plasma membrane [GO:0005886]";ferrous iron transmembrane transporter activity [GO:0015093]
comp743207_c0_seq1;GAXK01148808.1;Q23983;8.67E-08;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp743234_c1_seq1;GAXK01148827.1;P42573;1.62E-33;CED3_CAEEL;"Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"GO:0004175; GO:0004197; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006919; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0012501; GO:0016020; GO:0016540; GO:0030042; GO:0030054; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043025; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050807; GO:0050829; GO:0097153; GO:0097194; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845";"actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]";"caspase complex [GO:0008303]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]";"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]"
comp7433368_c0_seq1;GAXK01153661.1;Q0P4S0;4.29E-16;LST2_XENTR;Lateral signaling target protein 2 homolog (Zinc finger FYVE domain-containing protein 28);"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]";"GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872";"negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]";"metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp7433372_c0_seq1;GAXK01153666.1;Q9FMH8;1.26E-35;RD21B_ARATH;Probable cysteine protease RD21B (EC 3.4.22.-);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0051603; GO:0099503";proteolysis involved in cellular protein catabolic process [GO:0051603];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]";cysteine-type endopeptidase activity [GO:0004197]
comp743351_c0_seq1;GAXK01148791.1;Q5FYB0;1.18E-91;ARSJ_HUMAN;Arylsulfatase J (ASJ) (EC 3.1.6.-);"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]";"GO:0004065; GO:0005576; GO:0005788; GO:0046872";;"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";"arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]"
comp743407_c0_seq1;GAXK01148792.1;A6H7B8;3.88E-41;PGAP2_BOVIN;Post-GPI attachment to proteins factor 2;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]";"GO:0000139; GO:0005789; GO:0006506; GO:0016021";GPI anchor biosynthetic process [GO:0006506];"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp7434308_c0_seq1;GAXK01172489.1;P39909;6.64E-07;BLTD_BACSU;Spermine/spermidine acetyltransferase (EC 2.3.1.57);"diamine N-acetyltransferase activity [GO:0004145]; putrescine catabolic process [GO:0009447]";"GO:0004145; GO:0009447";putrescine catabolic process [GO:0009447];;diamine N-acetyltransferase activity [GO:0004145]
comp74346_c0_seq1;GAXK01047883.1;Q9UBY0;2.47E-143;SL9A2_HUMAN;Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"GO:0005886; GO:0006811; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719";"ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp74348_c1_seq1;GAXK01047463.1;Q5F364;6.26E-122;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp74350_c1_seq1;GAXK01047895.1;O43805;8.18E-24;SSNA1_HUMAN;Sjoegren syndrome nuclear autoantigen 1 (Nuclear autoantigen of 14 kDa);"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"GO:0000086; GO:0005634; GO:0005813; GO:0005829; GO:0010389; GO:0036064; GO:0042073; GO:0042802; GO:0060830; GO:0097711";"ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]";identical protein binding [GO:0042802]
comp743611_c0_seq1;GAXK01148843.1;P38806;1.89E-15;YNG2_YEAST;Chromatin modification-related protein YNG2 (ESA1-associated factor 4) (ING1 homolog 2);"cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; covalent chromatin modification [GO:0016569]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; meiotic cell cycle [GO:0051321]";"GO:0005634; GO:0005829; GO:0006281; GO:0016569; GO:0016573; GO:0032777; GO:0035064; GO:0035267; GO:0046872; GO:0051321";"covalent chromatin modification [GO:0016569]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; meiotic cell cycle [GO:0051321]";"cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]";"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp7436180_c0_seq1;GAXK01191065.1;Q8I7P9;9.68E-10;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp7436775_c0_seq1;GAXK01191067.1;Q9J5A7;1.17E-15;V155_FOWPN;Putative ankyrin repeat protein FPV115;;;;;
comp7437101_c0_seq1;GAXK01191073.1;P75451;3.34E-20;Y111_MYCPN;Uncharacterized adenine-specific methylase MPN_111 (EC 2.1.1.72);"DNA binding [GO:0003677]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]";"GO:0003677; GO:0009007";;;"DNA binding [GO:0003677]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]"
comp743715_c1_seq1;GAXK01204888.1;Q0KK59;4.54E-166;UNC79_MOUSE;Protein unc-79 homolog;"integral component of membrane [GO:0016021]; adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]";"GO:0016021; GO:0030534; GO:0035264; GO:0048149";"adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]";integral component of membrane [GO:0016021];
comp74374_c1_seq1;GAXK01048004.1;Q9Y6D9;2.60E-25;MD1L1_HUMAN;Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181);"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]";"GO:0000776; GO:0000777; GO:0000922; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]";"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]";"identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]"
comp7437607_c0_seq1;GAXK01191061.1;Q8T6Z1;2.71E-19;TRXB_SPIBA;Thioredoxin reductase (EC 1.8.1.9) (L-TrxR) (Fragment);"cytoplasm [GO:0005737]; thioredoxin-disulfide reductase activity [GO:0004791]; removal of superoxide radicals [GO:0019430]";"GO:0004791; GO:0005737; GO:0019430";removal of superoxide radicals [GO:0019430];cytoplasm [GO:0005737];thioredoxin-disulfide reductase activity [GO:0004791]
comp74379_c1_seq1;GAXK01047481.1;P34329;7.06E-07;PDIA4_CAEEL;Probable protein disulfide-isomerase A4 (EC 5.3.4.1) (ERp-72 homolog);"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0030968; GO:0034976; GO:0045454";"cell redox homeostasis [GO:0045454]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]";"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein disulfide isomerase activity [GO:0003756]
comp743793_c1_seq1;GAXK01148822.1;P83006;1.04E-37;PAFA2_RAT;Platelet-activating factor acetylhydrolase 2, cytoplasmic (EC 3.1.1.47) (Serine-dependent phospholipase A2) (SD-PLA2);"endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]; negative regulation of apoptotic process [GO:0043066]";"GO:0003847; GO:0005789; GO:0016042; GO:0031966; GO:0043066";"lipid catabolic process [GO:0016042]; negative regulation of apoptotic process [GO:0043066]";"endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]";1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]
comp74388_c1_seq1;GAXK01047810.1;O95425;8.45E-180;SVIL_HUMAN;Supervillin (Archvillin) (p205/p250);"actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]";"GO:0002102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007010; GO:0007519; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0043034; GO:0051015; GO:0071437";"cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]";"actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]";actin filament binding [GO:0051015]
comp7439744_c0_seq1;GAXK01135501.1;Q9ZNS1;1.31E-25;RS7_AVIMR;40S ribosomal protein S7;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7439963_c0_seq1;GAXK01135500.1;Q51463;7.96E-11;FLIF_PSEAE;Flagellar M-ring protein;"bacterial-type flagellum basal body, MS ring [GO:0009431]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; motor activity [GO:0003774]; bacterial-type flagellum-dependent cell motility [GO:0071973]";"GO:0003774; GO:0005886; GO:0009431; GO:0016021; GO:0071973";bacterial-type flagellum-dependent cell motility [GO:0071973];"bacterial-type flagellum basal body, MS ring [GO:0009431]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";motor activity [GO:0003774]
comp743998_c0_seq1;GAXK01148773.1;O15525;2.37E-13;MAFG_HUMAN;Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult behavior [GO:0030534]; blood coagulation [GO:0007596]; in utero embryonic development [GO:0001701]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]";"GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0007596; GO:0030534; GO:0030641; GO:0042127; GO:0043565; GO:0045604; GO:0046982";"adult behavior [GO:0030534]; blood coagulation [GO:0007596]; in utero embryonic development [GO:0001701]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp74400_c0_seq1;GAXK01047880.1;Q5ZK63;7.55E-11;TCP4_CHICK;Activated RNA polymerase II transcriptional coactivator p15 (SUB1 homolog);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]";"GO:0003677; GO:0003713; GO:0005634; GO:0005667; GO:0060261";positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261];"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp7440128_c0_seq1;GAXK01053428.1;P28269;3.68E-14;OAPT_PSEPU;Omega-amino acid--pyruvate aminotransferase (Omega-APT) (EC 2.6.1.18) (Beta-alanine--pyruvate aminotransferase);"beta-alanine-pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170]";"GO:0016223; GO:0030170";;;"beta-alanine-pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170]"
comp7440133_c0_seq1;GAXK01053432.1;O50172;4.15E-18;BFR2_MAGMG;Putative bacterioferritin subunit 2 (BFR 2);"cell [GO:0005623]; ferric iron binding [GO:0008199]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0005623; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cell [GO:0005623];ferric iron binding [GO:0008199]
comp7440866_c0_seq1;GAXK01053435.1;Q9PDX7;5.86E-27;A2MG_XYLFA;Alpha-2-macroglobulin;"plasma membrane [GO:0005886]; endopeptidase inhibitor activity [GO:0004866]";"GO:0004866; GO:0005886";;plasma membrane [GO:0005886];endopeptidase inhibitor activity [GO:0004866]
comp7440964_c0_seq1;GAXK01053425.1;A2BDX4;3.48E-14;KCNG1_MOUSE;Potassium voltage-gated channel subfamily G member 1 (Voltage-gated potassium channel subunit Kv6.1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0051260; GO:0071805; GO:1902259";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp7441030_c0_seq1;GAXK01053438.1;Q24F59;1.28E-18;RL36_TETTS;60S ribosomal protein L36;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp74412_c2_seq1;GAXK01047401.1;Q3T0Z7;1.27E-72;DHPR_BOVIN;Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase);"cytoplasm [GO:0005737]; 6,7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]";"GO:0004155; GO:0005737; GO:0006559; GO:0006729; GO:0070402; GO:0070404";"L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]";cytoplasm [GO:0005737];"6,7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]"
comp74420_c0_seq1;GAXK01047962.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp744228_c0_seq1;GAXK01121170.1;O35594;0;IFT81_MOUSE;Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1);"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]";"GO:0005813; GO:0005929; GO:0007275; GO:0007283; GO:0008589; GO:0015631; GO:0030154; GO:0030992; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]";tubulin binding [GO:0015631]
comp7442745_c0_seq1;GAXK01046557.1;P92177;1.53E-68;1433E_DROME;14-3-3 protein epsilon (Suppressor of Ras1 3-9);"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007093; GO:0007280; GO:0007294; GO:0007411; GO:0007444; GO:0007623; GO:0008103; GO:0008134; GO:0008340; GO:0009314; GO:0009411; GO:0019904; GO:0035332; GO:0040008; GO:0042994; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815";"axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]";"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp7443264_c0_seq1;GAXK01046552.1;Q7NXN3;5.31E-10;NORM_CHRVO;Probable multidrug resistance protein NorM (Multidrug-efflux transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; xenobiotic transmembrane transporter activity [GO:0042910]; ion transport [GO:0006811]";"GO:0005886; GO:0006811; GO:0015297; GO:0016021; GO:0042910";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp744359_c0_seq1;GAXK01121228.1;A9ZSY2;3.58E-27;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp74439_c1_seq1;GAXK01047788.1;Q9VJ62;8.82E-42;NAF1_DROME;H/ACA ribonucleoprotein complex non-core subunit NAF1;"nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"GO:0000493; GO:0001522; GO:0003723; GO:0005634; GO:0005732; GO:0006364; GO:0042254";"box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]";RNA binding [GO:0003723]
comp7444391_c0_seq1;GAXK01185074.1;Q40784;4.27E-24;AAPC_CENCI;Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C);"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]";"GO:0005975; GO:0030246; GO:0047938";carbohydrate metabolic process [GO:0005975];;"carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]"
comp7444850_c0_seq1;GAXK01185075.1;Q9BDB7;7.31E-14;IF44L_MOUSE;Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)];"cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]";"GO:0005737; GO:0006955; GO:0051607";"defense response to virus [GO:0051607]; immune response [GO:0006955]";cytoplasm [GO:0005737];
comp744580_c0_seq1;GAXK01121243.1;P74615;4.49E-16;Y1483_SYNY3;Uncharacterized protein sll1483;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";"GO:0005615; GO:0030288";;"extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]";
comp7446262_c0_seq1;GAXK01050974.1;P0AEK5;1.05E-55;FABI_ECO57;Enoyl-[acyl-carrier-protein] reductase [NADH] FabI (ENR) (EC 1.3.1.9) (NADH-dependent enoyl-ACP reductase);"enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; enoyl-[acyl-carrier-protein] reductase activity [GO:0016631]; biotin biosynthetic process [GO:0009102]; fatty acid elongation [GO:0030497]; protein homotetramerization [GO:0051289]; response to antibiotic [GO:0046677]";"GO:0004318; GO:0009102; GO:0016631; GO:0030497; GO:0046677; GO:0051289";"biotin biosynthetic process [GO:0009102]; fatty acid elongation [GO:0030497]; protein homotetramerization [GO:0051289]; response to antibiotic [GO:0046677]";;"enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; enoyl-[acyl-carrier-protein] reductase activity [GO:0016631]"
comp7446961_c0_seq1;GAXK01050967.1;O88902;5.13E-07;PTN23_RAT;Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) (Fragment);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0004725; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0015031; GO:0036064; GO:0043162; GO:0060271";"cilium assembly [GO:0060271]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; nucleus [GO:0005634]";protein tyrosine phosphatase activity [GO:0004725]
comp7447_c0_seq1;GAXK01100141.1;Q9VYG2;0;BAP60_DROME;Brahma-associated protein of 60 kDa (BRM-associated protein 60);"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001085; GO:0003677; GO:0005634; GO:0005719; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0016586; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0045944; GO:0071564; GO:0071565";"negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]";"DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]"
comp7448368_c0_seq1;GAXK01118661.1;Q96BV0;6.59E-08;ZN775_HUMAN;Zinc finger protein 775;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7448690_c0_seq1;GAXK01118660.1;Q9NPF2;2.02E-11;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp7449_c0_seq1;GAXK01100267.1;Q58DS9;1.73E-108;RAB5C_BOVIN;Ras-related protein Rab-5C;"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0032482; GO:0042470";"intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]";"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; melanosome [GO:0042470]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp7449218_c0_seq1;GAXK01118657.1;Q16960;7.75E-28;DYI3_HELCR;Dynein intermediate chain 3, ciliary;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]";"GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";motor activity [GO:0003774]
comp7450875_c0_seq1;GAXK01182194.1;P60593;2.33E-13;SPEE_NEIMA;Polyamine aminopropyltransferase (Putrescine aminopropyltransferase) (PAPT) (Spermidine synthase) (SPDS) (SPDSY) (EC 2.5.1.16);"cytoplasm [GO:0005737]; spermidine synthase activity [GO:0004766]; spermidine biosynthetic process [GO:0008295]";"GO:0004766; GO:0005737; GO:0008295";spermidine biosynthetic process [GO:0008295];cytoplasm [GO:0005737];spermidine synthase activity [GO:0004766]
comp745151_c0_seq1;GAXK01121238.1;P10077;9.92E-43;ZFP27_MOUSE;Zinc finger protein 27 (Zfp-27) (Protein mKR4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7451632_c0_seq1;GAXK01182199.1;Q9NW07;4.62E-07;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7451782_c0_seq1;GAXK01182193.1;P84100;3.31E-34;RL19_RAT;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; 5.8S rRNA binding [GO:1990932]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022625; GO:0070180; GO:0097421; GO:1990932";"liver regeneration [GO:0097421]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"5.8S rRNA binding [GO:1990932]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]"
comp7451940_c0_seq1;GAXK01182202.1;Q2NS30;6.51E-39;ISCR_SODGM;HTH-type transcriptional regulator IscR;"2 iron, 2 sulfur cluster binding [GO:0051537]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; iron ion binding [GO:0005506]";"GO:0003690; GO:0003700; GO:0005506; GO:0051537";;;"2 iron, 2 sulfur cluster binding [GO:0051537]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; iron ion binding [GO:0005506]"
comp7452270_c0_seq1;GAXK01139919.1;Q09785;3.39E-15;GCSP_SCHPO;Putative glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring));"glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; pyridoxal phosphate binding [GO:0030170]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"GO:0004375; GO:0005739; GO:0005759; GO:0005960; GO:0016594; GO:0019464; GO:0030170";glycine decarboxylation via glycine cleavage system [GO:0019464];"glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; pyridoxal phosphate binding [GO:0030170]"
comp745244_c0_seq1;GAXK01205607.1;Q6R7M4;1.01E-96;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp745276_c0_seq1;GAXK01121155.1;O15072;0;ATS3_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme);"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]";"GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748";"collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp7453_c0_seq1;GAXK01101221.1;P05661;1.81E-58;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp745335_c0_seq1;GAXK01121150.1;A0AVF1;0;IFT56_HUMAN;Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26);"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]";"GO:0005813; GO:0005929; GO:0007224; GO:0030992; GO:0031514; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198";"axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]";"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]";intraciliary transport particle B binding [GO:0120170]
comp7454342_c0_seq1;GAXK01004740.1;P37276;5.72E-07;DYHC_DROME;Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC);"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity, coupled [GO:0042623]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0042623; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045503; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904";"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]";"ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp745435_c0_seq1;GAXK01121218.1;P17141;1.78E-29;ZFP37_MOUSE;Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007281; GO:0007283; GO:0008270";"germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp7455278_c0_seq1;GAXK01004749.1;Q44006;5.48E-42;CZCR_CUPMC;Transcriptional activator protein CzcR;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0005737; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp7457414_c0_seq1;GAXK01185161.1;B1Y3R5;2.03E-38;GPMA_LEPCP;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11);"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0006094; GO:0006096; GO:0046538";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]
comp7457748_c0_seq1;GAXK01185165.1;Q00174;1.80E-15;LAMA_DROME;Laminin subunit alpha (Laminin A chain);"axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0005102; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030054; GO:0030155; GO:0030334; GO:0030424; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0062023; GO:0071711";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]";signaling receptor binding [GO:0005102]
comp745779_c1_seq1;GAXK01121244.1;P20825;8.28E-60;POL2_DROME;"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp7457810_c0_seq1;GAXK01185160.1;Q96JM3;6.33E-07;CHAP1_HUMAN;Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828);"condensed chromosome [GO:0000793]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134]";"GO:0000777; GO:0000793; GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0031134; GO:0034501; GO:0035372; GO:0046872; GO:0051315; GO:0090543";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134]";"condensed chromosome [GO:0000793]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp74586_c0_seq1;GAXK01047878.1;Q8TB40;2.22E-76;ABHD4_HUMAN;(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4);"endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]";"GO:0005789; GO:0005811; GO:0016042; GO:0016787; GO:0036152; GO:0052689; GO:0055088; GO:0070292";"lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]";"endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]";"carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]"
comp745972_c0_seq1;GAXK01121165.1;Q9VN91;4.64E-45;MORN4_DROME;MORN repeat-containing protein 4 homolog (Retinophilin) (undertaker);"rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; phototransduction [GO:0007602]; response to axon injury [GO:0048678]; response to paclitaxel [GO:1901555]; visual perception [GO:0007601]";"GO:0007601; GO:0007602; GO:0016028; GO:0033583; GO:0048678; GO:1901555";"phototransduction [GO:0007602]; response to axon injury [GO:0048678]; response to paclitaxel [GO:1901555]; visual perception [GO:0007601]";"rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]";
comp745976_c0_seq1;GAXK01121178.1;Q8NDA2;5.17E-17;HMCN2_HUMAN;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp74600_c2_seq1;GAXK01047527.1;Q2KI83;7.03E-54;DJC17_BOVIN;DnaJ homolog subfamily C member 17;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]";"GO:0000122; GO:0003723; GO:0005634; GO:0005737; GO:1901998";"negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp74612_c6_seq1;GAXK01047778.1;Q6DD45;1.43E-29;ZCHC8_XENLA;Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8);"nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]";"GO:0003676; GO:0005654; GO:0008270";;nucleoplasm [GO:0005654];"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp7461305_c0_seq1;GAXK01059649.1;Q9QZP2;9.45E-12;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp7462_c0_seq1;GAXK01100475.1;A7MB28;3.16E-62;NDRG3_BOVIN;Protein NDRG3 (N-myc downstream-regulated gene 3 protein);"cytoplasm [GO:0005737]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165";signal transduction [GO:0007165];cytoplasm [GO:0005737];
comp7462114_c0_seq1;GAXK01090324.1;Q63099;7.42E-13;KCNB2_RAT;Potassium voltage-gated channel subfamily B member 2 (CDRK) (Voltage-gated potassium channel subunit Kv2.2);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0044325; GO:0046982; GO:0051260; GO:0071805; GO:0072659";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp74624_c1_seq1;GAXK01047500.1;Q6NY88;1.90E-63;CHMP3_DANRE;Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein-sorting-associated protein 24);"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324";"endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]";"cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]";
comp7462907_c0_seq1;GAXK01090327.1;Q8X613;1.82E-25;ZRAR_ECO57;Transcriptional regulatory protein ZraR;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0005524; GO:0005737; GO:0006355; GO:0008134; GO:0043565";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp746376_c0_seq1;GAXK01010572.1;O43791;8.14E-19;SPOP_HUMAN;Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp7464212_c0_seq1;GAXK01051087.1;Q9XSU7;1.65E-36;RL27_CANLF;60S ribosomal protein L27;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; rRNA processing [GO:0006364]; translation [GO:0006412]";"GO:0003735; GO:0006364; GO:0006412; GO:0015934; GO:0022625; GO:0098556";"rRNA processing [GO:0006364]; translation [GO:0006412]";"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]";structural constituent of ribosome [GO:0003735]
comp7464346_c0_seq1;GAXK01051099.1;Q6ZR08;3.50E-09;DYH12_HUMAN;Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0030286";microtubule-based movement [GO:0007018];"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp7464411_c0_seq1;GAXK01051101.1;P08645;7.66E-53;RAP1_DROME;Ras-related protein Rap1 (Rap1 GTPase) (Ras-like protein 3);"cell leading edge [GO:0031252]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adherens junction assembly [GO:0034333]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ovarian follicle cell stalk formation [GO:0030713]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; small GTPase mediated signal transduction [GO:0007264]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]";"GO:0003924; GO:0005525; GO:0005886; GO:0006930; GO:0007264; GO:0007391; GO:0007465; GO:0007601; GO:0008293; GO:0016476; GO:0019003; GO:0022409; GO:0030713; GO:0030718; GO:0031252; GO:0032486; GO:0034333; GO:0035099; GO:0045874; GO:0070374; GO:0071320; GO:2000301";"adherens junction assembly [GO:0034333]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ovarian follicle cell stalk formation [GO:0030713]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; small GTPase mediated signal transduction [GO:0007264]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]";"cell leading edge [GO:0031252]; plasma membrane [GO:0005886]";"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp746525_c1_seq1;GAXK01010577.1;Q18297;1.99E-48;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp7465590_c0_seq1;GAXK01051091.1;Q9HI37;1.55E-24;TPF20_PSEAE;Probable family 20 transposase;"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0006313";transposition, DNA-mediated [GO:0006313];;"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp746614_c0_seq1;GAXK01010584.1;P35033;3.25E-46;TRY3_SALSA;Trypsin-3 (EC 3.4.21.4) (Trypsin III) (Fragment);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp746628_c0_seq1;GAXK01010604.1;Q64425;5.12E-24;LIPP_MYOCO;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp746642_c1_seq1;GAXK01010617.1;P13264;6.81E-175;GLSK_RAT;"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]";"GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0051289";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";glutaminase activity [GO:0004359]
comp7467046_c0_seq1;GAXK01196408.1;P13713;1.00E-18;FLIC_SERMA;Flagellin;"bacterial-type flagellum filament [GO:0009420]; extracellular region [GO:0005576]; structural molecule activity [GO:0005198]; bacterial-type flagellum-dependent cell motility [GO:0071973]";"GO:0005198; GO:0005576; GO:0009420; GO:0071973";bacterial-type flagellum-dependent cell motility [GO:0071973];"bacterial-type flagellum filament [GO:0009420]; extracellular region [GO:0005576]";structural molecule activity [GO:0005198]
comp7467978_c0_seq1;GAXK01196402.1;P13060;7.05E-56;EF2_DROME;Elongation factor 2 (EF-2);"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904";translational elongation [GO:0006414];"cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp7468_c2_seq1;GAXK01100506.1;Q6AZ28;9.41E-109;PIAS2_RAT;E3 SUMO-protein ligase PIAS2 (EC 2.3.2.-) (Androgen receptor-interacting protein 3) (ARIP3) (DAB2-interacting protein) (DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting-zinc finger protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"GO:0001085; GO:0003677; GO:0003712; GO:0005634; GO:0006355; GO:0006357; GO:0007283; GO:0008270; GO:0010033; GO:0016605; GO:0016607; GO:0016925; GO:0019904; GO:0030331; GO:0030521; GO:0033574; GO:0035259; GO:0045893; GO:0050681; GO:0050775; GO:0060765; GO:0061665";"androgen receptor signaling pathway [GO:0030521]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]"
comp7468366_c0_seq1;GAXK01075855.1;A1TU04;4.12E-53;COXX_ACIAC;Protoheme IX farnesyltransferase (EC 2.5.1.141) (Heme B farnesyltransferase) (Heme O synthase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protoheme IX farnesyltransferase activity [GO:0008495]; heme O biosynthetic process [GO:0048034]";"GO:0005886; GO:0008495; GO:0016021; GO:0048034";heme O biosynthetic process [GO:0048034];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";protoheme IX farnesyltransferase activity [GO:0008495]
comp74690_c1_seq1;GAXK01047380.1;Q9VQH2;0;DUOX_DROME;Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1);"endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]";"GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593";"adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]";"endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]"
comp746915_c0_seq1;GAXK01010579.1;O43345;3.33E-29;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp746918_c1_seq1;GAXK01010546.1;Q9JMH9;5.97E-36;MY18A_MOUSE;Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210);"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028";"actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]";"actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]";"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]"
comp747_c0_seq1;GAXK01169724.1;Q5DC69;4.61E-27;CH10_SCHJA;10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein folding [GO:0006457]";"GO:0005524; GO:0005759; GO:0006457";protein folding [GO:0006457];mitochondrial matrix [GO:0005759];ATP binding [GO:0005524]
comp7470756_c0_seq1;GAXK01195507.1;P25017;8.13E-09;TR2M2_AGRVI;Tryptophan 2-monooxygenase (EC 1.13.12.3);"tryptophan 2-monooxygenase activity [GO:0050361]; auxin biosynthetic process [GO:0009851]";"GO:0009851; GO:0050361";auxin biosynthetic process [GO:0009851];;tryptophan 2-monooxygenase activity [GO:0050361]
comp747161_c0_seq1;GAXK01010633.1;P31533;2.03E-53;HME2B_DANRE;Homeobox protein engrailed-2b (Homeobox protein en-2b) (Zf-En-1);"nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; cell fate specification [GO:0001708]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001708; GO:0005634; GO:0006357; GO:0009952; GO:0016586; GO:0030182; GO:0030901; GO:0030917; GO:0043565";"anterior/posterior pattern specification [GO:0009952]; cell fate specification [GO:0001708]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; RSC-type complex [GO:0016586]";sequence-specific DNA binding [GO:0043565]
comp747168_c0_seq1;GAXK01010614.1;P81021;1.44E-25;VIGLN_CHICK;Vigilin;"cytoplasm [GO:0005737]; RNA binding [GO:0003723]";"GO:0003723; GO:0005737";;cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp747197_c0_seq1;GAXK01010564.1;P18061;3.93E-46;CALM_TRYCR;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7472898_c0_seq1;GAXK01105287.1;B9MH48;2.76E-21;RL7_ACIET;50S ribosomal protein L7/L12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7472906_c0_seq1;GAXK01105276.1;Q61753;2.37E-28;SERA_MOUSE;D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10);"myelin sheath [GO:0043209]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]";"GO:0004617; GO:0006520; GO:0006541; GO:0006544; GO:0006563; GO:0006564; GO:0006566; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0022008; GO:0031175; GO:0043209; GO:0051287; GO:0070314";"cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]";myelin sheath [GO:0043209];"NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]"
comp74739_c0_seq1;GAXK01047897.1;Q5VIY5;1.25E-22;ZN468_HUMAN;Zinc finger protein 468;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp74741_c1_seq1;GAXK01047705.1;Q7K4B6;0;TMTC3_DROME;Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein CG4050);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]";"GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269";protein O-linked mannosylation [GO:0035269];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp747445_c0_seq1;GAXK01010602.1;Q14585;3.61E-74;ZN345_HUMAN;Zinc finger protein 345 (Zinc finger protein HZF10);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";"GO:0000122; GO:0003700; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp7477_c0_seq1;GAXK01100727.1;Q8R3G1;1.12E-100;PP1R8_MOUSE;Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8);"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380]";"GO:0003677; GO:0003729; GO:0004865; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007275; GO:0008283; GO:0008380; GO:0016607; GO:0019888; GO:0035196; GO:0035308";"cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";"DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]"
comp74774_c0_seq1;GAXK01047501.1;Q9NVH0;1.10E-137;EXD2_HUMAN;Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0006302; GO:0008310; GO:0008408; GO:0008852; GO:0090305";"DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]"
comp7477859_c0_seq1;GAXK01021305.1;Q9LZF6;1.63E-61;CD48E_ARATH;Cell division control protein 48 homolog E (AtCDC48e) (Transitional endoplasmic reticulum ATPase E);"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005618; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0009524; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0051301; GO:0071712; GO:0097352";"autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]"
comp747819_c0_seq1;GAXK01010612.1;Q52KR2;1.38E-07;LRIG2_MOUSE;Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2);"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]";"GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0010977; GO:0016020; GO:0016021; GO:0030426; GO:0031012; GO:0043005; GO:0043025; GO:0048679; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222";"innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";signaling receptor binding [GO:0005102]
comp74783_c1_seq1;GAXK01047483.1;Q5ZMD2;2.87E-96;ANKY2_CHICK;Ankyrin repeat and MYND domain-containing protein 2;"cilium [GO:0005929]; metal ion binding [GO:0046872]";"GO:0005929; GO:0046872";;cilium [GO:0005929];metal ion binding [GO:0046872]
comp74786_c0_seq1;GAXK01047846.1;Q869C3;0;ACES_ANOGA;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp7479574_c0_seq1;GAXK01065330.1;Q8XDR6;4.46E-32;LCFA_ECO57;Long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) (Long-chain acyl-CoA synthetase) (Acyl-CoA synthetase);"membrane [GO:0016020]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0016020; GO:0102391";;membrane [GO:0016020];"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp74803_c4_seq1;GAXK01047439.1;Q9ESM0;1.50E-62;IP6K1_RAT;Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1);"cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0000832; GO:0001650; GO:0005524; GO:0005829; GO:0032958; GO:0046854; GO:0052723; GO:0052724; GO:0120163";"inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854]";"cytosol [GO:0005829]; fibrillar center [GO:0001650]";"ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]"
comp748078_c0_seq1;GAXK01114816.1;Q17RM4;1.28E-09;CC142_HUMAN;Coiled-coil domain-containing protein 142;;;;;
comp74815_c0_seq1;GAXK01047345.1;P15159;1.46E-16;TNNC_TACTR;Troponin C;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp748197_c0_seq1;GAXK01204871.1;Q108T9;2.98E-12;CTTB2_LOXAF;Cortactin-binding protein 2 (CortBP2);"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";"GO:0005938; GO:0043197";;"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";
comp748232_c0_seq1;GAXK01114824.1;Q05481;2.42E-12;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp748272_c0_seq1;GAXK01114795.1;O42230;7.09E-38;GBX2_CHICK;Homeobox protein GBX-2 (Gastrulation and brain-specific homeobox protein 2);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cerebellum development [GO:0021549]; hindbrain development [GO:0030902]; regulation of nervous system development [GO:0051960]";"GO:0000977; GO:0001228; GO:0005634; GO:0021549; GO:0030902; GO:0051960";"cerebellum development [GO:0021549]; hindbrain development [GO:0030902]; regulation of nervous system development [GO:0051960]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp74844_c1_seq1;GAXK01047556.1;Q13569;5.57E-58;TDG_HUMAN;G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000122; GO:0000287; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0008134; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0045995; GO:0080111; GO:1902544";"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]";"ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]"
comp7484561_c0_seq1;GAXK01139855.1;P11003;4.99E-25;METF_SALTY;5,10-methylenetetrahydrofolate reductase (EC 1.5.1.20);"cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";"GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949";"methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";cytosol [GO:0005829];"FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]"
comp74847_c0_seq1;GAXK01047382.1;P02599;1.51E-50;CALM_DICDI;Calmodulin (CaM);"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665";"calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]";"contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]"
comp74849_c1_seq1;GAXK01047445.1;Q1LZ79;1.82E-08;GEMI8_BOVIN;Gem-associated protein 8 (Gemin-8);"cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0005829; GO:0032797; GO:0034719; GO:0097504";spliceosomal snRNP assembly [GO:0000387];"cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]";
comp7485008_c0_seq1;GAXK01139869.1;P0AE07;1.47E-19;ACRA_ECO57;Multidrug efflux pump subunit AcrA (AcrAB-TolC multidrug efflux pump subunit AcrA) (Acriflavine resistance protein A);"plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; response to antibiotic [GO:0046677]";"GO:0005886; GO:0022857; GO:0046677";response to antibiotic [GO:0046677];plasma membrane [GO:0005886];transmembrane transporter activity [GO:0022857]
comp748533_c0_seq1;GAXK01114821.1;P48180;5.78E-13;ACH1_CAEEL;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp748625_c0_seq1;GAXK01114857.1;Q8NBS3;0;S4A11_HUMAN;Sodium bicarbonate transporter-like protein 11 (Bicarbonate transporter-related protein 1) (Sodium borate cotransporter 1) (NaBC1) (Solute carrier family 4 member 11);"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; fluid transport [GO:0042044]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005452; GO:0005887; GO:0006814; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016323; GO:0030003; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0051453; GO:1902600";"bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; fluid transport [GO:0042044]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]";"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]";"active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]"
comp748660_c0_seq1;GAXK01114811.1;P14404;1.26E-88;MECOM_MOUSE;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein homolog);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"GO:0000977; GO:0001228; GO:0001701; GO:0001780; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0006954; GO:0009617; GO:0009791; GO:0016607; GO:0030154; GO:0030900; GO:0035115; GO:0035116; GO:0042127; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0060039; GO:0070828; GO:0071425; GO:0072197; GO:0090336; GO:0098727";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; inflammatory response [GO:0006954]; in utero embryonic development [GO:0001701]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp7486813_c0_seq1;GAXK01113745.1;Q06572;1.54E-42;AVP_HORVU;Pyrophosphate-energized vacuolar membrane proton pump (EC 7.1.3.1) (Pyrophosphate-energized inorganic pyrophosphatase) (H(+)-PPase);"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]";"GO:0004427; GO:0005774; GO:0009678; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";"inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp748703_c0_seq1;GAXK01114842.1;Q9CYK2;1.23E-77;QPCT_MOUSE;Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);"extracellular region [GO:0005576]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]";"GO:0005576; GO:0008270; GO:0016603; GO:0017186";peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186];extracellular region [GO:0005576];"glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]"
comp7487051_c0_seq1;GAXK01113749.1;Q5ZJH9;1.61E-76;DKC1_CHICK;H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin);"box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; box H/ACA snoRNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]";"GO:0000455; GO:0000495; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:1990481";"box H/ACA snoRNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]";"box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp7487148_c0_seq1;GAXK01113751.1;P10127;7.79E-12;ADH4_YEAST;Alcohol dehydrogenase 4 (EC 1.1.1.1) (Alcohol dehydrogenase IV) (ADHIV);"mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; metal ion binding [GO:0046872]; amino acid catabolic process to alcohol via Ehrlich pathway [GO:0000947]; fermentation [GO:0006113]";"GO:0000947; GO:0004022; GO:0005739; GO:0006113; GO:0046872";"amino acid catabolic process to alcohol via Ehrlich pathway [GO:0000947]; fermentation [GO:0006113]";mitochondrion [GO:0005739];"alcohol dehydrogenase (NAD) activity [GO:0004022]; metal ion binding [GO:0046872]"
comp748719_c0_seq1;GAXK01114859.1;Q5F478;1.77E-07;ANR44_CHICK;Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44);;;;;
comp7488_c0_seq1;GAXK01100421.1;Q99MN1;0;SYK_MOUSE;Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"GO:0000049; GO:0000187; GO:0002276; GO:0002741; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050";"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]"
comp74880_c3_seq1;GAXK01047999.1;Q8N9M1;1.79E-12;CS047_HUMAN;Uncharacterized protein C19orf47;nucleoplasm [GO:0005654];GO:0005654;;nucleoplasm [GO:0005654];
comp7488299_c0_seq1;GAXK01143984.1;P40313;1.20E-16;CTRL_HUMAN;Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]";"GO:0004252; GO:0005615; GO:0008236; GO:0030163";protein catabolic process [GO:0030163];extracellular space [GO:0005615];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp748830_c0_seq1;GAXK01114800.1;Q6AZW8;1.22E-18;ZN660_HUMAN;Zinc finger protein 660;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp748859_c0_seq1;GAXK01114836.1;P18740;5.01E-11;ZO14_XENLA;Oocyte zinc finger protein XlCOF14 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp74888_c2_seq1;GAXK01047872.1;P26967;3.06E-10;CU20_TENMO;Adult-specific cuticular protein ACP-20;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp74891_c0_seq1;GAXK01047900.1;Q24133;3.72E-28;DNAJ1_DROME;DnaJ protein homolog 1 (DROJ1);"cytosol [GO:0005829]; chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";"GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]";cytosol [GO:0005829];"chaperone binding [GO:0051087]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp748931_c2_seq1;GAXK01114867.1;O60522;9.87E-12;TDRD6_HUMAN;Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2) (CT41.2);"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0033391";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]";
comp748948_c1_seq1;GAXK01114920.1;Q8IWX5;1.73E-35;SGPP2_HUMAN;Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]";"GO:0005783; GO:0005789; GO:0006670; GO:0016021; GO:0030148; GO:0042392; GO:0061469";"regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";sphingosine-1-phosphate phosphatase activity [GO:0042392]
comp7490073_c0_seq1;GAXK01081865.1;Q6T1W6;2.53E-42;FDTB_ANETH;dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase (EC 2.6.1.90) (dTDP-6-deoxy-D-xylo-hex-3-ulose aminase);transferase activity [GO:0016740];GO:0016740;;;transferase activity [GO:0016740]
comp749009_c0_seq1;GAXK01114815.1;Q9Y2H8;2.40E-21;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7490386_c0_seq1;GAXK01081854.1;Q05146;8.72E-26;OMPA_BORAV;Outer membrane protein A;"cell outer membrane [GO:0009279]; pore complex [GO:0046930]; porin activity [GO:0015288]; ion transport [GO:0006811]";"GO:0006811; GO:0009279; GO:0015288; GO:0046930";ion transport [GO:0006811];"cell outer membrane [GO:0009279]; pore complex [GO:0046930]";porin activity [GO:0015288]
comp749049_c0_seq1;GAXK01114856.1;Q9VAS7;4.60E-35;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp7490751_c0_seq1;GAXK01081859.1;P54641;2.83E-07;VA0D_DICDI;V-type proton ATPase subunit d (V-ATPase subunit d) (DVA41) (V-ATPase 41 kDa accessory protein) (Vacuolar proton pump subunit d);"contractile vacuolar membrane [GO:0031164]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; lysosomal membrane [GO:0005765]; phagocytic vesicle [GO:0045335]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]";"GO:0005765; GO:0007034; GO:0007035; GO:0008553; GO:0016471; GO:0030139; GO:0031164; GO:0032009; GO:0033179; GO:0045335; GO:0046961";"vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]";"contractile vacuolar membrane [GO:0031164]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; lysosomal membrane [GO:0005765]; phagocytic vesicle [GO:0045335]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp749225_c0_seq1;GAXK01114916.1;Q9ASR1;4.20E-39;EF2_ARATH;Elongation factor 2 (EF-2) (Protein LOW EXPRESSION OF OSMOTICALLY RESPONSIVE GENES 1);"chloroplast [GO:0009507]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribonucleoprotein complex [GO:1990904]; vacuolar membrane [GO:0005774]; copper ion binding [GO:0005507]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; cold acclimation [GO:0009631]; response to cold [GO:0009409]; translational elongation [GO:0006414]";"GO:0003729; GO:0003746; GO:0003924; GO:0005507; GO:0005525; GO:0005634; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006414; GO:0009409; GO:0009506; GO:0009507; GO:0009631; GO:0043022; GO:1990904";"cold acclimation [GO:0009631]; response to cold [GO:0009409]; translational elongation [GO:0006414]";"chloroplast [GO:0009507]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribonucleoprotein complex [GO:1990904]; vacuolar membrane [GO:0005774]";"copper ion binding [GO:0005507]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp7492652_c0_seq1;GAXK01096004.1;Q4LB22;3.90E-39;METK3_HORVU;S-adenosylmethionine synthase 3 (AdoMet synthase 3) (EC 2.5.1.6) (Methionine adenosyltransferase 3) (MAT 3);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]"
comp749343_c0_seq1;GAXK01114814.1;Q9NXL6;2.42E-32;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp749426_c0_seq1;GAXK01114862.1;Q8TF45;1.56E-38;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7494560_c0_seq1;GAXK01062305.1;Q08638;3.00E-30;BGLA_THEMA;Beta-glucosidase A (EC 3.2.1.21) (Beta-D-glucoside glucohydrolase) (Cellobiase) (Gentiobiase);"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]; cellulose catabolic process [GO:0030245]";"GO:0008422; GO:0030245; GO:0102483";cellulose catabolic process [GO:0030245];;"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]"
comp74949_c0_seq1;GAXK01047848.1;Q7KRI2;2.03E-42;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7495_c0_seq1;GAXK01101211.1;Q00963;0;SPTCB_DROME;Spectrin beta chain;"apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807]";"GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007009; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016327; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499";"actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807]";"apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]";"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]"
comp749584_c0_seq1;GAXK01114812.1;Q99808;6.30E-38;S29A1_HUMAN;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0006139; GO:0015858; GO:0015862; GO:0016020; GO:0016323; GO:0016324; GO:0098793; GO:0098810";"neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp7495865_c0_seq1;GAXK01062307.1;Q86GF7;2.53E-26;CRUST_PANBO;Crustapain (EC 3.4.22.-) (NsCys);"extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";"GO:0005576; GO:0007586; GO:0008234; GO:0030163; GO:0030574";"collagen catabolic process [GO:0030574]; digestion [GO:0007586]; protein catabolic process [GO:0030163]";extracellular region [GO:0005576];cysteine-type peptidase activity [GO:0008234]
comp74981_c17_seq1;GAXK01047672.1;Q9VDW6;1.15E-117;DMDA_DROME;Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699";"establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]"
comp7498770_c0_seq1;GAXK01098574.1;P17970;1.40E-27;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp7499417_c0_seq1;GAXK01098565.1;Q8TE73;1.90E-46;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7499525_c0_seq1;GAXK01098581.1;Q9CQ69;5.84E-22;QCR8_MOUSE;Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C);"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]";"GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901";"cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]";"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]";ubiquinol-cytochrome-c reductase activity [GO:0008121]
comp7499564_c0_seq1;GAXK01098577.1;P52192;5.29E-11;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp74997_c0_seq1;GAXK01047982.1;Q5EAQ1;7.72E-13;M4GDB_DANRE;MIF4G domain-containing protein B;"cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; regulation of translational initiation [GO:0006446]";"GO:0003723; GO:0005634; GO:0005829; GO:0006446; GO:0008494; GO:0042802";regulation of translational initiation [GO:0006446];"cytosol [GO:0005829]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]"
comp7499930_c0_seq1;GAXK01098566.1;P48613;6.03E-12;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp7500_c0_seq1;GAXK01205489.1;P56616;1.35E-76;UBE2C_XENLA;Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UBC-X) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C);"anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005524; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0016740; GO:0031145; GO:0051301; GO:0070979";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";anaphase-promoting complex [GO:0005680];"ATP binding [GO:0005524]; transferase activity [GO:0016740]"
comp750006_c4_seq1;GAXK01122821.1;P35502;1.90E-08;ESTF_MYZPE;Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp7500062_c0_seq1;GAXK01001403.1;Q9UFH2;7.15E-32;DYH17_HUMAN;Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein light chain 2, axonemal);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp7501206_c0_seq1;GAXK01001397.1;Q9NBX4;1.38E-09;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp7501632_c0_seq1;GAXK01001406.1;P37145;6.27E-57;THRC_METGL;Threonine synthase (TS) (EC 4.2.3.1);"pyridoxal phosphate binding [GO:0030170]; threonine synthase activity [GO:0004795]; threonine biosynthetic process [GO:0009088]";"GO:0004795; GO:0009088; GO:0030170";threonine biosynthetic process [GO:0009088];;"pyridoxal phosphate binding [GO:0030170]; threonine synthase activity [GO:0004795]"
comp75017_c1_seq1;GAXK01047961.1;Q9DB85;7.05E-65;RRP8_MOUSE;Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1 homolog);"chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]; cellular response to glucose starvation [GO:0042149]; chromatin silencing at rDNA [GO:0000183]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of cell cycle arrest [GO:0071158]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]";"GO:0000183; GO:0005634; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008168; GO:0033553; GO:0035064; GO:0042149; GO:0046015; GO:0071158; GO:0072332";"cellular response to glucose starvation [GO:0042149]; chromatin silencing at rDNA [GO:0000183]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of cell cycle arrest [GO:0071158]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]";"chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]";"methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]"
comp7502062_c0_seq1;GAXK01133633.1;Q8HY03;1.30E-08;CD209_HYLLA;CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209);"integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]";"GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872";"adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]";integral component of membrane [GO:0016021];"mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp750210_c0_seq1;GAXK01122789.1;Q7PPU9;7.58E-27;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp75025_c2_seq1;GAXK01047881.1;Q7T3C7;2.11E-51;RT4I1_DANRE;Reticulon-4-interacting protein 1 homolog, mitochondrial;"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"GO:0005739; GO:0005741; GO:0010842; GO:0016491; GO:0042462; GO:0050773";"eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp75029_c0_seq1;GAXK01047951.1;P93258;3.40E-40;SODC1_MESCR;Superoxide dismutase [Cu-Zn] 1 (EC 1.15.1.1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp750293_c0_seq1;GAXK01122832.1;Q6SZ65;6.22E-27;OTP_LYTVA;Homeobox protein orthopedia;"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0043565";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp7503116_c0_seq1;GAXK01133618.1;A2ARV4;4.75E-07;LRP2_MOUSE;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]";"GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0140058; GO:0140077; GO:1904447";"aorta development [GO:0035904]; cell population proliferation [GO:0008283]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]";"calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]"
comp75039_c0_seq1;GAXK01047522.1;Q9BTT6;6.04E-71;LRRC1_HUMAN;Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein);"cytosol [GO:0005829]; membrane [GO:0016020]";"GO:0005829; GO:0016020";;"cytosol [GO:0005829]; membrane [GO:0016020]";
comp7505648_c0_seq1;GAXK01130485.1;A5JUY8;2.43E-08;PERL_BUBBU;Lactoperoxidase (LPO) (WBLP) (EC 1.11.1.7);"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; thiocyanate peroxidase activity [GO:0036393]; antibacterial humoral response [GO:0019731]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0005509; GO:0005615; GO:0006979; GO:0019731; GO:0020037; GO:0036393; GO:0042744";"antibacterial humoral response [GO:0019731]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";extracellular space [GO:0005615];"calcium ion binding [GO:0005509]; heme binding [GO:0020037]; thiocyanate peroxidase activity [GO:0036393]"
comp7506603_c0_seq1;GAXK01060451.1;Q90YP3;1.13E-30;RS28_ICTPU;40S ribosomal protein S28;"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556";cytoplasmic translation [GO:0002181];"cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp7507315_c0_seq1;GAXK01060443.1;Q6ZNA1;6.59E-10;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7507490_c0_seq1;GAXK01060448.1;Q9VXX8;7.56E-34;RL371_DROME;Probable 60S ribosomal protein L37-A;"cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0046872";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp750791_c0_seq1;GAXK01122858.1;Q8I6K0;2.66E-08;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp7508_c1_seq1;GAXK01100514.1;A6QQ21;6.08E-130;CSN6_BOVIN;COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6);"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338]";"GO:0000338; GO:0005737; GO:0008180";protein deneddylation [GO:0000338];"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]";
comp750819_c0_seq1;GAXK01122792.1;Q0DJV6;9.34E-14;CML18_ORYSJ;Probable calcium-binding protein CML18 (Calmodulin-like protein 18);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp75082_c0_seq1;GAXK01047506.1;Q9WVF8;2.92E-19;TUSC2_MOUSE;Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2);"mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";"GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0032618; GO:0032700; GO:0032733; GO:0048469; GO:0050829; GO:0051881; GO:0052567; GO:0070945; GO:0071609; GO:2000377";"cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567]";mitochondrion [GO:0005739];
comp7509433_c0_seq1;GAXK01039585.1;P48643;4.05E-54;TCPE_HUMAN;T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon);"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]";"GO:0003730; GO:0005524; GO:0005730; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874";"binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]";"cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]"
comp750967_c0_seq1;GAXK01122840.1;Q86YV6;9.92E-77;MYLK4_HUMAN;Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085);"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]";"GO:0004687; GO:0005524";;;"ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]"
comp7510682_c0_seq1;GAXK01084462.1;Q8IVF4;1.12E-13;DYH10_HUMAN;Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10);"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]";"GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959";microtubule-based movement [GO:0007018];"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7511558_c0_seq1;GAXK01084464.1;O70511;1.02E-19;ANK3_RAT;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"GO:0005764; GO:0005856; GO:0005886; GO:0007165; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016529; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]";"axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]"
comp7513_c2_seq1;GAXK01100196.1;Q9UV33;1.68E-08;H1_ASCIM;Histone H1;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0003677; GO:0005634; GO:0006334";nucleosome assembly [GO:0006334];"nucleosome [GO:0000786]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp751328_c0_seq1;GAXK01122827.1;P52187;7.92E-64;KCJ12_MOUSE;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Potassium channel, inwardly rectifying subfamily J member 12);"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; T-tubule [GO:0030315]; inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0006813; GO:0016021; GO:0030165; GO:0030315; GO:0030425; GO:0031224; GO:0034765; GO:0043025; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; T-tubule [GO:0030315]";"inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165]"
comp7515103_c0_seq1;GAXK01160758.1;P9WKB6;1.97E-08;Y221_MYCTO;Putative diacyglycerol O-acyltransferase MT0231 (EC 2.3.1.20) (Putative triacylglycerol synthase MT0231);"diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";"GO:0004144; GO:0006071; GO:0019432";"glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]";;diacylglycerol O-acyltransferase activity [GO:0004144]
comp7516048_c0_seq1;GAXK01099632.1;P26208;1.23E-30;BGLA_CLOTH;Beta-glucosidase A (EC 3.2.1.21) (Beta-D-glucoside glucohydrolase) (Cellobiase) (Gentiobiase);"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]; cellulose catabolic process [GO:0030245]";"GO:0008422; GO:0030245; GO:0102483";cellulose catabolic process [GO:0030245];;"beta-glucosidase activity [GO:0008422]; scopolin beta-glucosidase activity [GO:0102483]"
comp75161_c0_seq1;GAXK01047519.1;W4VS53;4.46E-50;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp7516486_c0_seq1;GAXK01099624.1;P70549;6.41E-33;NAC3_RAT;Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3);"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031594; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]"
comp7517367_c0_seq1;GAXK01099615.1;Q8K078;1.71E-15;SO4A1_MOUSE;Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12);"integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";"GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252";"organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]";integral component of plasma membrane [GO:0005887];"organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]"
comp751743_c1_seq1;GAXK01122835.1;P52746;4.33E-26;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp751745_c1_seq1;GAXK01122810.1;Q8C0L6;1.41E-37;PAOX_MOUSE;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase);"peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";"GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307";"polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]";peroxisomal matrix [GO:0005782];"N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"
comp7517688_c0_seq1;GAXK01099617.1;Q61171;4.57E-34;PRDX2_MOUSE;Peroxiredoxin-2 (EC 1.11.1.15) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"GO:0000187; GO:0002536; GO:0004601; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0008430; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042743; GO:0042744; GO:0042981; GO:0043209; GO:0043524; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001237; GO:2001240";"activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]"
comp7519_c0_seq1;GAXK01100028.1;P48767;1.86E-29;NAC1_FELCA;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; sodium ion transmembrane transport [GO:0035725]";"GO:0005432; GO:0005509; GO:0005516; GO:0007154; GO:0016021; GO:0031226; GO:0035725; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; sodium ion transmembrane transport [GO:0035725]";"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]";"calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]"
comp751914_c0_seq1;GAXK01122838.1;Q9V576;4.22E-38;WUN_DROME;Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen);"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]; defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"GO:0005887; GO:0005918; GO:0006644; GO:0007280; GO:0007424; GO:0008195; GO:0008354; GO:0009880; GO:0016791; GO:0019991; GO:0035233; GO:0035234; GO:0042577; GO:0042803; GO:0045177; GO:0045824; GO:0046839; GO:0050829";"defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; embryonic pattern specification [GO:0009880]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; pole cell migration [GO:0007280]; septate junction assembly [GO:0019991]";"apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; septate junction [GO:0005918]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; protein homodimerization activity [GO:0042803]"
comp7519327_c0_seq1;GAXK01193362.1;O50314;1.82E-20;BCHH_CHLP8;Magnesium-chelatase subunit H (EC 6.6.1.1) (Mg-protoporphyrin IX chelatase subunit H);"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]; light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";"GO:0005524; GO:0015979; GO:0016851; GO:0036070";"light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";;"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]"
comp751994_c0_seq1;GAXK01122809.1;Q9Y6C5;6.38E-08;PTC2_HUMAN;Protein patched homolog 2 (PTC2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0045879; GO:0097108";"cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]"
comp75211_c0_seq1;GAXK01047707.1;Q5ZL23;3.00E-73;AB1IP_CHICK;Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; signal transduction [GO:0007165]";"GO:0005829; GO:0005856; GO:0005886; GO:0007165";signal transduction [GO:0007165];"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";
comp7521320_c0_seq1;GAXK01054274.1;Q9FHF1;6.84E-16;AB7B_ARATH;ABC transporter B family member 7 (ABC transporter ABCB.7) (AtABCB7) (Multidrug resistance protein 7) (P-glycoprotein 7);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0005886; GO:0009536; GO:0016021; GO:0016887; GO:0042626";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp7522528_c0_seq1;GAXK01049153.1;Q8YSQ6;9.25E-37;TMBP_NOSS1;Monocarboxylate 2-oxoacid-binding periplasmic protein all3028 (Extracellular solute-binding protein) (Extracytoplasmic solute receptor protein all3028) (TRAP transporter monocarboxylate 2-oxoacid-binding subunit P);"periplasmic space [GO:0042597]; tripartite ATP-independent periplasmic transporter complex [GO:0031317]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; organic acid transmembrane transporter activity [GO:0005342]; protein homodimerization activity [GO:0042803]; organic acid transport [GO:0015849]";"GO:0005342; GO:0015849; GO:0031317; GO:0042597; GO:0042803; GO:0043177; GO:0046872";organic acid transport [GO:0015849];"periplasmic space [GO:0042597]; tripartite ATP-independent periplasmic transporter complex [GO:0031317]";"metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; organic acid transmembrane transporter activity [GO:0005342]; protein homodimerization activity [GO:0042803]"
comp7522559_c0_seq1;GAXK01049137.1;B9JSR6;6.18E-54;XYLA_AGRVS;Xylose isomerase (EC 5.3.1.5);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732]";"GO:0000287; GO:0005737; GO:0009045; GO:0042732";D-xylose metabolic process [GO:0042732];cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]"
comp7523774_c0_seq1;GAXK01049145.1;Q92841;2.87E-39;DDX17_HUMAN;Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]";"GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014";"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]"
comp7523801_c0_seq1;GAXK01049135.1;Q55BJ6;1.59E-14;PLBLB_DICDI;Phospholipase B-like protein B (EC 3.1.1.-);"extracellular region [GO:0005576]; phospholipase activity [GO:0004620]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylinositol catabolic process [GO:0031161]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0005576; GO:0009395; GO:0031161; GO:0046338";"phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylinositol catabolic process [GO:0031161]; phospholipid catabolic process [GO:0009395]";extracellular region [GO:0005576];phospholipase activity [GO:0004620]
comp7524733_c0_seq1;GAXK01057165.1;P11147;4.18E-38;HSP7D_DROME;Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"GO:0000398; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0016887; GO:0030707; GO:0031072; GO:0034605; GO:0034620; GO:0035967; GO:0042026; GO:0042623; GO:0044183; GO:0048471; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0097753; GO:0098793; GO:0106161";"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to heat [GO:0034605]; cellular response to topologically incorrect protein [GO:0035967]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane bending [GO:0097753]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; positive regulation of small RNA loading onto RISC [GO:0106161]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp752474_c0_seq1;GAXK01196203.1;Q24372;9.33E-35;LACH_DROME;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0061343";"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]";"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]";protein homodimerization activity [GO:0042803]
comp752482_c1_seq1;GAXK01196169.1;Q9N4B8;1.20E-39;NHR41_CAEEL;Nuclear hormone receptor family member nhr-41;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0048856";"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"
comp75254_c2_seq1;GAXK01047738.1;Q6NRP2;3.39E-90;PSME4_XENLA;Proteasome activator complex subunit 4 (Proteasome activator PA200);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]";"GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]";"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]";"lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]"
comp7526_c3_seq1;GAXK01101226.1;Q5RCD9;6.08E-11;ZSCA2_PONAB;Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp7526102_c0_seq1;GAXK01139910.1;Q86CS2;9.40E-11;ATG1_DICDI;Serine/threonine-protein kinase atg1 (EC 2.7.11.1) (Autophagy-related protein 1);"Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagic cell death [GO:0048102]; autophagosome assembly [GO:0000045]; autophagosome organization [GO:1905037]; cellular response to nitrogen starvation [GO:0006995]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; exit from host cell [GO:0035891]; macroautophagy [GO:0016236]; necrotic cell death [GO:0070265]; positive regulation of catalytic activity [GO:0043085]; protein autophosphorylation [GO:0046777]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]; response to yeast [GO:0001878]; sorocarp development [GO:0030587]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"GO:0000045; GO:0000407; GO:0001878; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006995; GO:0009617; GO:0010506; GO:0015031; GO:0016020; GO:0016236; GO:0030435; GO:0030587; GO:0031288; GO:0034045; GO:0035891; GO:0042742; GO:0043085; GO:0046777; GO:0048102; GO:0050830; GO:0070265; GO:1905037; GO:1990316";"autophagic cell death [GO:0048102]; autophagosome assembly [GO:0000045]; autophagosome organization [GO:1905037]; cellular response to nitrogen starvation [GO:0006995]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; exit from host cell [GO:0035891]; macroautophagy [GO:0016236]; necrotic cell death [GO:0070265]; positive regulation of catalytic activity [GO:0043085]; protein autophosphorylation [GO:0046777]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]; response to yeast [GO:0001878]; sorocarp development [GO:0030587]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]";"Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp752646_c1_seq1;GAXK01196205.1;Q5ZIR1;7.71E-37;SHLB1_CHICK;Endophilin-B1 (SH3 domain-containing GRB2-like protein B1);"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915]";"GO:0000139; GO:0005741; GO:0006915; GO:0008289";apoptotic process [GO:0006915];"Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]";lipid binding [GO:0008289]
comp75265_c1_seq1;GAXK01047383.1;Q9VVH9;5.66E-76;SO74D_DROME;Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D);"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702";"ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]";"integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]";"active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]"
comp752719_c0_seq1;GAXK01196180.1;Q9P227;2.89E-13;RHG23_HUMAN;Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005829; GO:0007165; GO:0051056; GO:0070062";"regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";GTPase activator activity [GO:0005096]
comp7527412_c0_seq1;GAXK01139904.1;O97125;1.20E-20;HSP68_DROME;Heat shock protein 68;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0008340; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042594; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp7527637_c0_seq1;GAXK01139908.1;Q86GC8;2.77E-40;ACES_CULPI;Acetylcholinesterase (AChE) (EC 3.1.1.7);"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]";"GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202";neurotransmitter catabolic process [GO:0042135];"cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]";acetylcholinesterase activity [GO:0003990]
comp7528282_c0_seq1;GAXK01132153.1;P49655;2.69E-18;KCJ10_RAT;ATP-sensitive inward rectifier potassium channel 10 (ATP-sensitive inward rectifier potassium channel KAB-2) (BIR10) (Brain-specific inwardly rectifying K(+) channel 1) (BIRK1) (Inward rectifier K(+) channel Kir4.1) (Potassium channel, inwardly rectifying subfamily J member 10);"apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; signaling receptor binding [GO:0005102]; inflammatory response [GO:0006954]; L-glutamate import [GO:0051938]; membrane hyperpolarization [GO:0060081]; optic nerve development [GO:0021554]; potassium ion import across plasma membrane [GO:1990573]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to blue light [GO:0009637]; response to glucocorticoid [GO:0051384]; response to mineralocorticoid [GO:0051385]";"GO:0005102; GO:0005242; GO:0005524; GO:0005902; GO:0006954; GO:0009637; GO:0016021; GO:0016323; GO:0016324; GO:0021554; GO:0034765; GO:0042802; GO:0051289; GO:0051384; GO:0051385; GO:0051930; GO:0051938; GO:0060081; GO:0097449; GO:1990573";"inflammatory response [GO:0006954]; L-glutamate import [GO:0051938]; membrane hyperpolarization [GO:0060081]; optic nerve development [GO:0021554]; potassium ion import across plasma membrane [GO:1990573]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to blue light [GO:0009637]; response to glucocorticoid [GO:0051384]; response to mineralocorticoid [GO:0051385]";"apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; signaling receptor binding [GO:0005102]"
comp7528341_c0_seq1;GAXK01132169.1;Q23858;7.68E-21;CALR_DICDI;Calreticulin;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006911; GO:0030246; GO:0030968; GO:0045335; GO:0051082; GO:0051707";"endoplasmic reticulum unfolded protein response [GO:0030968]; phagocytosis, engulfment [GO:0006911]; protein folding [GO:0006457]; response to other organism [GO:0051707]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; phagocytic vesicle [GO:0045335]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp7529273_c0_seq1;GAXK01132166.1;P25489;3.54E-11;AT1A1_CATCO;Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0042383; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp75293_c0_seq1;GAXK01047709.1;Q29P71;0;MYO7A_DROPS;Myosin-VIIa (Protein crinkled);"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"GO:0003774; GO:0005524; GO:0005737; GO:0005902; GO:0007015; GO:0007605; GO:0008407; GO:0008586; GO:0030048; GO:0030898; GO:0031477; GO:0032027; GO:0032529; GO:0035182; GO:0035293; GO:0035317; GO:0045179; GO:0045180; GO:0045296; GO:0048800; GO:0051015; GO:0070825";"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; follicle cell microvillus organization [GO:0032529]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; sensory perception of sound [GO:0007605]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; female germline ring canal outer rim [GO:0035182]; micropyle [GO:0070825]; microvillus [GO:0005902]; myosin VII complex [GO:0031477]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]"
comp7529747_c0_seq1;GAXK01132161.1;Q9PDX7;8.91E-14;A2MG_XYLFA;Alpha-2-macroglobulin;"plasma membrane [GO:0005886]; endopeptidase inhibitor activity [GO:0004866]";"GO:0004866; GO:0005886";;plasma membrane [GO:0005886];endopeptidase inhibitor activity [GO:0004866]
comp753_c0_seq1;GAXK01168697.1;Q5REN2;4.23E-135;PSA1_PONAB;Proteasome subunit alpha type-1 (EC 3.4.25.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002376; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773";"immune system process [GO:0002376]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]";threonine-type endopeptidase activity [GO:0004298]
comp7530_c0_seq1;GAXK01100720.1;A8XV95;3.44E-60;GELS1_CAEBR;Gelsolin-like protein 1;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament depolymerization [GO:0030042]; actin filament severing [GO:0051014]; barbed-end actin filament capping [GO:0051016]; positive regulation of synapse pruning [GO:1905808]";"GO:0003785; GO:0005546; GO:0005737; GO:0005856; GO:0030042; GO:0051014; GO:0051015; GO:0051016; GO:1905808";"actin filament depolymerization [GO:0030042]; actin filament severing [GO:0051014]; barbed-end actin filament capping [GO:0051016]; positive regulation of synapse pruning [GO:1905808]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
comp753022_c0_seq1;GAXK01196277.1;O89094;5.05E-08;CASPE_MOUSE;"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008233; GO:0008630; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]"
comp753033_c1_seq1;GAXK01196273.1;Q7PPU9;8.14E-25;BND7A_ANOGA;Band 7 protein AGAP004871;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp753135_c0_seq1;GAXK01196184.1;Q63564;6.07E-09;SV2B_RAT;Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B);"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter uptake [GO:0001504]";"GO:0001504; GO:0001669; GO:0005887; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030054; GO:0030285; GO:0030672; GO:0043005; GO:0043195";"chemical synaptic transmission [GO:0007268]; neurotransmitter uptake [GO:0001504]";"acrosomal vesicle [GO:0001669]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";transmembrane transporter activity [GO:0022857]
comp7532104_c0_seq1;GAXK01137128.1;Q8TE73;7.23E-25;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7532571_c0_seq1;GAXK01137136.1;P60039;5.15E-47;RL73_ARATH;60S ribosomal protein L7-3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp7533_c0_seq1;GAXK01100801.1;Q7TNS2;3.71E-25;MIC10_MOUSE;MICOS complex subunit Mic10 (Mitochondrial inner membrane organizing system protein 1);"MICOS complex [GO:0061617]; mitochondrion [GO:0005739]";"GO:0005739; GO:0061617";;"MICOS complex [GO:0061617]; mitochondrion [GO:0005739]";
comp7533220_c0_seq1;GAXK01137134.1;P36928;8.01E-09;YEGD_ECOLI;Uncharacterized chaperone protein YegD;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp7533844_c0_seq1;GAXK01137124.1;Q9M9W1;1.25E-20;RL222_ARATH;60S ribosomal protein L22-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7533974_c0_seq1;GAXK01137141.1;Q7LHG5;1.47E-07;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp753410_c0_seq1;GAXK01196266.1;P23607;6.37E-17;ZFA_MOUSE;Zinc finger autosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7534110_c0_seq1;GAXK01022633.1;P31009;9.21E-56;RS2_DROME;40S ribosomal protein S2 (Protein strings of pearls);"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";"GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0007275; GO:0022626; GO:0022627; GO:0048477";"cytoplasmic translation [GO:0002181]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp753452_c0_seq1;GAXK01196280.1;P17789;4.56E-21;TTKB_DROME;Protein tramtrack, beta isoform (Repressor protein fushi tarazu) (Tramtrack p69);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000978; GO:0000980; GO:0001227; GO:0003682; GO:0005634; GO:0005700; GO:0006357; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0035001; GO:0035147; GO:0035151; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045467; GO:0045892; GO:0045944; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688; GO:1990841";"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; myoblast fate specification [GO:0048626]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; R7 cell development [GO:0045467]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; tracheal outgrowth, open tracheal system [GO:0007426]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp7534614_c0_seq1;GAXK01022639.1;P09201;4.88E-41;F16P_YEAST;Fructose-1,6-bisphosphatase (FBPase) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; periplasmic space [GO:0042597]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; reactive oxygen species metabolic process [GO:0072593]; sucrose biosynthetic process [GO:0005986]";"GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030388; GO:0042132; GO:0042597; GO:0046872; GO:0072593";"fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; reactive oxygen species metabolic process [GO:0072593]; sucrose biosynthetic process [GO:0005986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; periplasmic space [GO:0042597]";"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]"
comp75348_c0_seq1;GAXK01047503.1;Q9Y5Q9;1.47E-142;TF3C3_HUMAN;General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma);"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III transcription regulator recruiting activity [GO:0001004]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"GO:0000127; GO:0001004; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006383; GO:0031965; GO:0042791; GO:0042797";"5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]";"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIC complex [GO:0000127]";"DNA binding [GO:0003677]; RNA polymerase III transcription regulator recruiting activity [GO:0001004]"
comp753501_c0_seq1;GAXK01196175.1;A9V2C1;5.21E-92;NHAAB_MONBE;Probable nitrile hydratase (NHase) (Nitrilase) (EC 4.2.1.84);"indole-3-acetonitrile nitrile hydratase activity [GO:0080109]; transition metal ion binding [GO:0046914]; nitrogen compound metabolic process [GO:0006807]";"GO:0006807; GO:0046914; GO:0080109";nitrogen compound metabolic process [GO:0006807];;"indole-3-acetonitrile nitrile hydratase activity [GO:0080109]; transition metal ion binding [GO:0046914]"
comp753523_c0_seq1;GAXK01196282.1;P36609;2.05E-37;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7535642_c0_seq1;GAXK01022628.1;Q91YT7;1.72E-18;YTHD2_MOUSE;YTH domain-containing family protein 2;"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; P-body [GO:0000932]; N6-methyladenosine-containing RNA binding [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]";"GO:0000932; GO:0001556; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0006402; GO:0036464; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247";"embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; P-body [GO:0000932]";N6-methyladenosine-containing RNA binding [GO:1990247]
comp753565_c0_seq1;GAXK01196182.1;Q7SXT7;1.49E-07;ZC21A_DANRE;Zinc finger C2HC domain-containing protein 1A;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp7536550_c0_seq1;;P54910;2.08E-26;TRBE_RHIRD;Conjugal transfer protein TrbE;"ATP binding [GO:0005524]; conjugation [GO:0000746]";"GO:0000746; GO:0005524";conjugation [GO:0000746];;ATP binding [GO:0005524]
comp753672_c0_seq1;GAXK01196185.1;B4GVM9;1.08E-173;NAAT1_DROPE;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp753698_c0_seq1;GAXK01196208.1;Q8NB50;1.60E-16;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp7537397_c0_seq1;GAXK01150467.1;Q03529;4.07E-18;SCS7_YEAST;Ceramide very long chain fatty acid hydroxylase SCS7 (Ceramide VLCFA hydroxylase SCS7) (4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase SCS7) (EC 1.14.18.6) (Dihydroceramide fatty acyl 2-hydroxylase SCS7) (EC 1.14.18.7) (Sphingolipid alpha-hydroxylase) (Suppressor of calcium sensitivity 7);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; fatty acid alpha-hydroxylase activity [GO:0080132]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; inositol phosphoceramide metabolic process [GO:0006673]";"GO:0005506; GO:0005783; GO:0005789; GO:0006631; GO:0006633; GO:0006673; GO:0008270; GO:0016021; GO:0020037; GO:0046513; GO:0080132";"ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; inositol phosphoceramide metabolic process [GO:0006673]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"fatty acid alpha-hydroxylase activity [GO:0080132]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]"
comp753831_c0_seq1;GAXK01196181.1;Q5VTD9;5.91E-52;GFI1B_HUMAN;Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML);"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000981; GO:0001085; GO:0003677; GO:0005634; GO:0005667; GO:0006325; GO:0007275; GO:0016363; GO:0046872; GO:2000134";"chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]"
comp7539_c0_seq1;GAXK01100047.1;Q5DC69;1.20E-35;CH10_SCHJA;10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein folding [GO:0006457]";"GO:0005524; GO:0005759; GO:0006457";protein folding [GO:0006457];mitochondrial matrix [GO:0005759];ATP binding [GO:0005524]
comp754007_c0_seq1;GAXK01041958.1;P24392;6.41E-32;PEX2_RAT;Peroxisome biogenesis factor 2 (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1);"Cdc73/Paf1 complex [GO:0016593]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038]";"GO:0000038; GO:0000122; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0016020; GO:0016558; GO:0016593; GO:0031648; GO:0046872; GO:0048147; GO:0050680";"fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038]";"Cdc73/Paf1 complex [GO:0016593]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";metal ion binding [GO:0046872]
comp7540284_c0_seq1;GAXK01078246.1;Q9JLF1;8.59E-10;GBRT_MOUSE;Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp754056_c0_seq1;GAXK01041961.1;O46470;2.33E-162;RGS7_BOVIN;Regulator of G-protein signaling 7 (RGS7);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]";"GO:0005096; GO:0005829; GO:0005886; GO:0007186; GO:0009968; GO:0031681; GO:0035556";"G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]"
comp75406_c0_seq1;GAXK01047404.1;Q8NBS9;5.08E-23;TXND5_HUMAN;Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46);"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"GO:0005576; GO:0005783; GO:0005788; GO:0016853; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0045454; GO:0070062";"apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]";"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]";isomerase activity [GO:0016853]
comp754065_c1_seq1;GAXK01041959.1;Q8VIG1;1.49E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp75424_c0_seq1;GAXK01047847.1;A7SMW7;3.86E-152;L2HDH_NEMVE;L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2);"mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]";"GO:0003973; GO:0005739; GO:0047545";;mitochondrion [GO:0005739];"(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]"
comp7543198_c0_seq1;GAXK01120467.1;Q8SWR3;3.27E-10;SPR_DROME;Sex peptide receptor;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042";"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled peptide receptor activity [GO:0008528]
comp7543310_c0_seq1;GAXK01120471.1;Q90419;1.55E-08;TWHH_DANRE;"Tiggy-winkle hedgehog protein (TWHH) (Sonic hedgehog protein B) (SHHB) [Cleaved into: Tiggy-winkle hedgehog protein N-product; Tiggy-winkle hedgehog protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0030182; GO:0030900; GO:0042063; GO:0048663; GO:0048702; GO:0048703; GO:0048709; GO:0055002; GO:0060956";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp754338_c0_seq1;GAXK01041955.1;Q9CZ62;4.58E-64;CEP97_MOUSE;Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2);"centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; protein-containing complex [GO:0032991]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]";"GO:0005813; GO:0005815; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018";"cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]";"centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; protein-containing complex [GO:0032991]";
comp75435_c3_seq1;GAXK01047376.1;Q9P2K3;2.03E-98;RCOR3_HUMAN;REST corepressor 3;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]";"GO:0000981; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0008134; GO:0017053; GO:0044212";;"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp7544_c0_seq1;GAXK01100296.1;Q5ZJR3;3.38E-68;OSTC_CHICK;Oligosaccharyltransferase complex subunit OSTC;"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008250; GO:0016021";protein glycosylation [GO:0006486];"integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]";
comp7545185_c0_seq1;GAXK01024239.1;Q43092;2.73E-18;SSG1_PEA;Granule-bound starch synthase 1, chloroplastic/amyloplastic (EC 2.4.1.242) (Granule-bound starch synthase I) (GBSS-I);"amyloplast [GO:0009501]; chloroplast [GO:0009507]; ADP-glucose-starch glucosyltransferase activity [GO:0102502]; glycogen (starch) synthase activity [GO:0004373]; starch biosynthetic process [GO:0019252]";"GO:0004373; GO:0009501; GO:0009507; GO:0019252; GO:0102502";starch biosynthetic process [GO:0019252];"amyloplast [GO:0009501]; chloroplast [GO:0009507]";"ADP-glucose-starch glucosyltransferase activity [GO:0102502]; glycogen (starch) synthase activity [GO:0004373]"
comp754540_c0_seq1;GAXK01041973.1;Q8BV66;3.31E-14;IFI44_MOUSE;Interferon-induced protein 44 (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp7545605_c0_seq1;GAXK01024251.1;Q9M0E2;1.73E-25;RL282_ARATH;60S ribosomal protein L28-2;"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005886; GO:0006412; GO:0009506; GO:0022625";translation [GO:0006412];"cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";structural constituent of ribosome [GO:0003735]
comp7545881_c0_seq1;GAXK01024240.1;Q8CD54;3.50E-21;PIEZ2_MOUSE;Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]";"GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260";"cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]"
comp7545951_c0_seq1;GAXK01024252.1;Q60HH4;2.11E-10;ASAH1_MACFA;"Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]";"GO:0005615; GO:0005764; GO:0017040; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121";"cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]";"extracellular space [GO:0005615]; lysosome [GO:0005764]";"ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]"
comp7546008_c0_seq1;GAXK01049542.1;Q12766;1.42E-07;HMGX3_HUMAN;HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF);"nucleus [GO:0005634]; DNA binding [GO:0003677]";"GO:0003677; GO:0005634";;nucleus [GO:0005634];DNA binding [GO:0003677]
comp7548027_c0_seq1;GAXK01192810.1;P36609;4.73E-18;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7548238_c0_seq1;GAXK01192811.1;Q96JB1;1.14E-40;DYH8_HUMAN;Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8);"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060285";"cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp754834_c0_seq1;GAXK01041968.1;Q9HCD6;0;TANC2_HUMAN;Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2);"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0098978; GO:0099092";in utero embryonic development [GO:0001701];"glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]";
comp754892_c0_seq1;GAXK01042016.1;Q811D2;9.06E-14;ANR26_MOUSE;Ankyrin repeat domain-containing protein 26;"centrosome [GO:0005813]; cytosol [GO:0005829]; glucose homeostasis [GO:0042593]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; regulation of fatty acid metabolic process [GO:0019217]; regulation of feeding behavior [GO:0060259]; regulation of lipid metabolic process [GO:0019216]";"GO:0005813; GO:0005829; GO:0019216; GO:0019217; GO:0040015; GO:0042593; GO:0045599; GO:0046621; GO:0046627; GO:0060259; GO:0070373";"glucose homeostasis [GO:0042593]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; regulation of fatty acid metabolic process [GO:0019217]; regulation of feeding behavior [GO:0060259]; regulation of lipid metabolic process [GO:0019216]";"centrosome [GO:0005813]; cytosol [GO:0005829]";
comp7549106_c0_seq1;GAXK01192803.1;P02299;2.97E-64;H3_DROME;Histone H3;"nuclear chromatin [GO:0000790]; nuclear nucleosome [GO:0000788]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]";"GO:0000786; GO:0000788; GO:0000790; GO:0005634; GO:0005700; GO:0006334; GO:0031492; GO:0035059; GO:0046982";nucleosome assembly [GO:0006334];"nuclear chromatin [GO:0000790]; nuclear nucleosome [GO:0000788]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]";"nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]"
comp7549717_c0_seq1;GAXK01192812.1;Q6H5U3;2.52E-10;DES1L_ORYSJ;Sphingolipid delta(4)-desaturase DES1-like (EC 1.14.19.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]";"GO:0005789; GO:0006633; GO:0016021; GO:0042284; GO:0046513";"ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";sphingolipid delta-4 desaturase activity [GO:0042284]
comp7551225_c0_seq1;GAXK01046417.1;A0M8T5;2.75E-13;CTTB2_FELCA;Cortactin-binding protein 2 (CortBP2);"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";"GO:0005938; GO:0043197";;"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";
comp7551563_c0_seq1;GAXK01046424.1;Q61555;4.20E-22;FBN2_MOUSE;Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide];"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023";"bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]";"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]";"calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
comp755235_c0_seq1;GAXK01041953.1;P23074;1.49E-15;POL_SFV1;"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]";"aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp75524_c0_seq1;GAXK01047402.1;Q7KRI2;2.07E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7552405_c0_seq1;GAXK01115489.1;O05399;2.41E-26;YRHG_BACSU;Uncharacterized transporter YrhG;"integral component of plasma membrane [GO:0005887]; formate transmembrane transporter activity [GO:0015499]; formate transport [GO:0015724]";"GO:0005887; GO:0015499; GO:0015724";formate transport [GO:0015724];integral component of plasma membrane [GO:0005887];formate transmembrane transporter activity [GO:0015499]
comp755259_c0_seq1;GAXK01041981.1;Q9NA51;3.61E-12;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp7552960_c0_seq1;GAXK01115497.1;Q92154;4.56E-07;SMP_COTJA;Schwann cell myelin protein (Siglec-4b);"integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]";"GO:0007155; GO:0016021; GO:0030246";cell adhesion [GO:0007155];integral component of membrane [GO:0016021];carbohydrate binding [GO:0030246]
comp7554100_c0_seq1;GAXK01095982.1;Q59J82;1.22E-21;FAD3E_MORAP;Acyl-lipid omega-3 desaturase (cytochrome b5), endoplasmic reticulum (EC 1.14.19.25) (Omega-3 fatty acid desaturase 3, endoplasmic reticulum);"integral component of membrane [GO:0016021]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; alpha-linolenic acid metabolic process [GO:0036109]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0006636; GO:0016021; GO:0016717; GO:0036109";"alpha-linolenic acid metabolic process [GO:0036109]; unsaturated fatty acid biosynthetic process [GO:0006636]";integral component of membrane [GO:0016021];oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]
comp755424_c0_seq1;GAXK01041962.1;Q5E9P6;1.18E-47;BSCL2_BOVIN;Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog);"integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]";"GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995";"fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]";integral component of endoplasmic reticulum membrane [GO:0030176];
comp75548_c15_seq1;GAXK01047350.1;Q24332;5.15E-82;NT56_DROVI;Lethal(2)neighbour of Tid protein (NOT58);"integral component of endoplasmic reticulum membrane [GO:0030176]; mannosyltransferase activity [GO:0000030]; multicellular organism development [GO:0007275]";"GO:0000030; GO:0007275; GO:0030176";multicellular organism development [GO:0007275];integral component of endoplasmic reticulum membrane [GO:0030176];mannosyltransferase activity [GO:0000030]
comp7555268_c0_seq1;GAXK01095974.1;P76079;1.07E-25;PAAC_ECOLI;1,2-phenylacetyl-CoA epoxidase, subunit C (1,2-phenylacetyl-CoA epoxidase, structural subunit beta) (1,2-phenylacetyl-CoA monooxygenase, subunit C);"cytosol [GO:0005829]; phenylacetate catabolic process [GO:0010124]";"GO:0005829; GO:0010124";phenylacetate catabolic process [GO:0010124];cytosol [GO:0005829];
comp7556_c0_seq1;GAXK01100723.1;P55833;2.01E-42;RS27_HOMAM;40S ribosomal protein S27;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp7556006_c0_seq1;GAXK01154251.1;P23536;4.92E-46;PT1_CUPNH;Phosphoenolpyruvate-protein phosphotransferase (EC 2.7.3.9) (Phosphotransferase system, enzyme I);"cytoplasm [GO:0005737]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphoenolpyruvate-protein phosphotransferase activity [GO:0008965]; phosphoenolpyruvate-dependent sugar phosphotransferase system [GO:0009401]";"GO:0005737; GO:0008965; GO:0009401; GO:0016301; GO:0046872";phosphoenolpyruvate-dependent sugar phosphotransferase system [GO:0009401];cytoplasm [GO:0005737];"kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphoenolpyruvate-protein phosphotransferase activity [GO:0008965]"
comp7556738_c0_seq1;GAXK01154255.1;Q7LHG5;1.72E-16;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp7556785_c0_seq1;GAXK01154248.1;P16100;1.42E-69;IDH_AZOVI;Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (Oxalosuccinate decarboxylase);"cytoplasm [GO:0005737]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004450; GO:0005737; GO:0006097; GO:0006099; GO:0046872";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";cytoplasm [GO:0005737];"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]"
comp7558003_c0_seq1;GAXK01089403.1;P26302;5.20E-50;KPPR_WHEAT;Phosphoribulokinase, chloroplastic (PRK) (PRKase) (EC 2.7.1.19) (Phosphopentokinase);"chloroplast [GO:0009507]; ATP binding [GO:0005524]; phosphoribulokinase activity [GO:0008974]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0005524; GO:0008974; GO:0009507; GO:0019253";reductive pentose-phosphate cycle [GO:0019253];chloroplast [GO:0009507];"ATP binding [GO:0005524]; phosphoribulokinase activity [GO:0008974]"
comp756001_c0_seq1;GAXK01060020.1;A3M0J3;1.20E-08;SET5_PICST;Potential protein lysine methyltransferase SET5 (EC 2.1.1.-) (SET domain-containing protein 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]";"GO:0005634; GO:0005737; GO:0008168";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";methyltransferase activity [GO:0008168]
comp75605_c1_seq1;GAXK01047867.1;Q3TLD5;1.13E-19;RMP_MOUSE;Unconventional prefoldin RPB5 interactor (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]";"GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0051219; GO:0071363; GO:0071383; GO:2001243";"cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]"
comp7561_c4_seq1;GAXK01101004.1;A0A0B4K692;0;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp756108_c0_seq1;GAXK01059993.1;P17538;1.81E-28;CTRB1_HUMAN;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp756208_c0_seq1;GAXK01060013.1;P84339;1.32E-13;CALM_AGABI;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7562662_c0_seq1;GAXK01044918.1;O42479;3.12E-18;HEMH_CHICK;Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783]";"GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006783; GO:0046872; GO:0051537";heme biosynthetic process [GO:0006783];"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]"
comp7562727_c0_seq1;GAXK01044914.1;Q50KB1;1.06E-14;SEP2_EMIHU;Protein disulfide-isomerase-like protein EhSep2;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein disulfide isomerase activity [GO:0003756]
comp7564_c0_seq1;GAXK01100107.1;Q7Z5L0;1.68E-08;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp7564225_c0_seq1;GAXK01112284.1;Q54FB7;6.67E-28;XDH_DICDI;Xanthine dehydrogenase (XD) (EC 1.17.1.4);"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949";xanthine catabolic process [GO:0009115];peroxisome [GO:0005777];"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]"
comp7565641_c0_seq1;GAXK01112291.1;P16326;3.71E-12;FLGL_SALTY;Flagellar hook-associated protein 3 (HAP3) (Hook-filament junction protein);"bacterial-type flagellum hook [GO:0009424]; extracellular region [GO:0005576]; structural molecule activity [GO:0005198]; bacterial-type flagellum-dependent cell motility [GO:0071973]";"GO:0005198; GO:0005576; GO:0009424; GO:0071973";bacterial-type flagellum-dependent cell motility [GO:0071973];"bacterial-type flagellum hook [GO:0009424]; extracellular region [GO:0005576]";structural molecule activity [GO:0005198]
comp7565881_c0_seq1;GAXK01112293.1;A0ZSK4;6.82E-13;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp75664_c2_seq1;GAXK01047342.1;O74467;1.33E-14;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp75673_c0_seq1;GAXK01047375.1;P23645;2.94E-61;BIB_DROME;Neurogenic protein big brain;"adherens junction [GO:0005912]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; channel activity [GO:0015267]; cell-cell adhesion [GO:0098609]; ectoderm development [GO:0007398]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; neuron fate specification [GO:0048665]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of imaginal disc-derived wing size [GO:0044719]; transmembrane transport [GO:0055085]; water transport [GO:0006833]";"GO:0005261; GO:0005886; GO:0005912; GO:0006833; GO:0007398; GO:0007498; GO:0015267; GO:0016021; GO:0030707; GO:0031410; GO:0044719; GO:0045747; GO:0046331; GO:0048665; GO:0055085; GO:0098609";"cell-cell adhesion [GO:0098609]; ectoderm development [GO:0007398]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; neuron fate specification [GO:0048665]; ovarian follicle cell development [GO:0030707]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of imaginal disc-derived wing size [GO:0044719]; transmembrane transport [GO:0055085]; water transport [GO:0006833]";"adherens junction [GO:0005912]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cation channel activity [GO:0005261]; channel activity [GO:0015267]"
comp7567380_c0_seq1;GAXK01036255.1;Q9XA16;1.46E-23;PKNX_STRCO;Probable serine/threonine-protein kinase SCO3848 (EC 2.7.11.1);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp7567609_c0_seq1;GAXK01036252.1;P23403;3.71E-42;RS20_XENLA;40S ribosomal protein S20 (S22);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7567996_c0_seq1;GAXK01036257.1;P48057;1.52E-10;SC6A1_MUSCO;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009986; GO:0010033; GO:0014054; GO:0014074; GO:0030424; GO:0032229; GO:0042165; GO:0043005; GO:0051260; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]"
comp756832_c0_seq1;GAXK01060004.1;Q9VPF0;4.04E-44;ATK_DROME;Protein artichoke;"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271";"cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]";
comp7570744_c0_seq1;GAXK01052645.1;O01802;2.04E-40;RL7_CAEEL;60S ribosomal protein L7;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003723; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp757101_c1_seq1;GAXK01060015.1;D3ZVU1;2.30E-40;SPRTN_RAT;SprT-like domain-containing protein Spartan (Protein with SprT-like domain at the N terminus) (Spartan);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"GO:0003677; GO:0005634; GO:0005694; GO:0006974; GO:0009411; GO:0019985; GO:0031398; GO:0043130; GO:0046872; GO:0070530";"cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]"
comp75729_c24_seq1;GAXK01047934.1;Q8IN81;1.81E-13;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp75734_c0_seq1;GAXK01047858.1;P0C872;1.90E-107;JMJD7_MOUSE;Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]";"GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872";protein hydroxylation [GO:0018126];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]"
comp7575179_c0_seq1;GAXK01108543.1;P76104;3.80E-24;RLHA_ECOLI;23S rRNA 5-hydroxycytidine C2501 synthase (Large subunit ribosomal RNA hydroxylation A);"peptidase activity [GO:0008233]; rRNA processing [GO:0006364]";"GO:0006364; GO:0008233";rRNA processing [GO:0006364];;peptidase activity [GO:0008233]
comp75753_c0_seq1;GAXK01047420.1;P13607;4.03E-172;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp757543_c0_seq1;GAXK01060018.1;Q9NUA8;6.47E-18;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7576_c1_seq1;GAXK01100500.1;Q3TZZ7;4.12E-56;ESYT2_MOUSE;Extended synaptotagmin-2 (E-Syt2);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268";"endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp75777_c0_seq1;GAXK01047416.1;Q63598;0;PLST_RAT;Plastin-3 (T-plastin);"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491]";"GO:0005509; GO:0005737; GO:0005884; GO:0032420; GO:0032432; GO:0042491; GO:0051015; GO:0051017; GO:0051639";"actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491]";"actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]";"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
comp75779_c13_seq1;GAXK01047600.1;Q96GS4;1.13E-18;BORC6_HUMAN;BLOC-1-related complex subunit 6 (Lysosome-dispersing protein) (Lyspersin);"BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418]";"GO:0005765; GO:0032418; GO:0099078";lysosome localization [GO:0032418];"BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]";
comp75784_c0_seq1;GAXK01047869.1;Q96T23;8.06E-17;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp757876_c0_seq1;GAXK01060012.1;G5ED00;3.07E-07;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp7579_c7_seq1;GAXK01100847.1;Q9VKK1;2.06E-67;EDC4_DROME;Enhancer of mRNA-decapping protein 4 homolog;"P-body [GO:0000932]; cytoplasmic mRNA processing body assembly [GO:0033962]; defense response to fungus [GO:0050832]; gene silencing by miRNA [GO:0035195]; mRNA catabolic process [GO:0006402]; pole plasm oskar mRNA localization [GO:0045451]";"GO:0000932; GO:0006402; GO:0033962; GO:0035195; GO:0045451; GO:0050832";"cytoplasmic mRNA processing body assembly [GO:0033962]; defense response to fungus [GO:0050832]; gene silencing by miRNA [GO:0035195]; mRNA catabolic process [GO:0006402]; pole plasm oskar mRNA localization [GO:0045451]";P-body [GO:0000932];
comp757926_c0_seq1;GAXK01059983.1;Q07DZ5;1.22E-07;CTTB2_ORNAN;Cortactin-binding protein 2 (CortBP2);"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";"GO:0005938; GO:0043197";;"cell cortex [GO:0005938]; dendritic spine [GO:0043197]";
comp7579338_c0_seq1;GAXK01138869.1;Q8A1G0;2.98E-20;SUSA_BACTN;Neopullulanase SusA (EC 3.2.1.135) (Starch-utilization system protein A);"periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; neopullulanase activity [GO:0031216]; oligosaccharide catabolic process [GO:0009313]; starch catabolic process [GO:0005983]";"GO:0004556; GO:0005886; GO:0005983; GO:0009313; GO:0031216; GO:0042597; GO:0046872";"oligosaccharide catabolic process [GO:0009313]; starch catabolic process [GO:0005983]";"periplasmic space [GO:0042597]; plasma membrane [GO:0005886]";"alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; neopullulanase activity [GO:0031216]"
comp758144_c1_seq1;GAXK01190781.1;Q8AVN9;1.57E-08;ZN346_XENLA;Zinc finger protein 346 (Double-stranded RNA-binding protein ZFa) (DsRBP-ZFa) (ZFa) (Just another zinc finger protein) (Protein jaz);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]";"GO:0003725; GO:0005634; GO:0005737; GO:0008270";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]"
comp7581595_c0_seq1;GAXK01001711.1;Q245F2;3.44E-56;IF6_TETTS;Eukaryotic translation initiation factor 6 (eIF-6);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0003743; GO:0005730; GO:0005737; GO:0042256; GO:0042273; GO:0043022; GO:0043023";"mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]"
comp7581668_c0_seq1;GAXK01001698.1;O86564;1.41E-38;SDHL_STRCO;L-serine dehydratase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-SD);"4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]; gluconeogenesis [GO:0006094]";"GO:0003941; GO:0006094; GO:0046872; GO:0051539";gluconeogenesis [GO:0006094];;"4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]"
comp758186_c0_seq1;GAXK01190779.1;Q5G270;1.10E-14;NETR_GORGO;Neurotrypsin (EC 3.4.21.-) (Serine protease 12);"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]";"GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195";exocytosis [GO:0006887];"axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp7581871_c0_seq1;GAXK01001710.1;P54679;1.67E-26;PMA1_DICDI;Probable plasma membrane ATPase (EC 7.1.2.1) (PAT2) (Proton pump);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"GO:0005524; GO:0005886; GO:0008553; GO:0016020; GO:0016021; GO:0016887; GO:0046872; GO:0051453; GO:0120029; GO:1902600";"proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp758295_c0_seq1;GAXK01205971.1;P51590;9.40E-66;CP2J3_RAT;Cytochrome P450 2J3 (EC 1.14.14.1) (CYPIIJ3);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330";"exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp7583307_c0_seq1;GAXK01045120.1;B1Y4K8;8.64E-55;PANB_LEPCP;3-methyl-2-oxobutanoate hydroxymethyltransferase (EC 2.1.2.11) (Ketopantoate hydroxymethyltransferase) (KPHMT);"cytoplasm [GO:0005737]; 3-methyl-2-oxobutanoate hydroxymethyltransferase activity [GO:0003864]; metal ion binding [GO:0046872]; pantothenate biosynthetic process [GO:0015940]";"GO:0003864; GO:0005737; GO:0015940; GO:0046872";pantothenate biosynthetic process [GO:0015940];cytoplasm [GO:0005737];"3-methyl-2-oxobutanoate hydroxymethyltransferase activity [GO:0003864]; metal ion binding [GO:0046872]"
comp7584003_c0_seq1;GAXK01123461.1;P55143;3.51E-40;GLRX_RICCO;Glutaredoxin;"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp758418_c0_seq1;GAXK01190764.1;Q08180;3.70E-49;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp75846_c0_seq1;GAXK01047378.1;Q9VHH9;2.21E-155;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp7585_c1_seq1;GAXK01100093.1;Q9VQ93;3.78E-122;GOLP3_DROME;Golgi phosphoprotein 3 homolog sauron (Protein rotini);"cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]";"GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0017137; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307";"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]";"cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]";"phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]"
comp758582_c0_seq1;GAXK01190786.1;Q9JL89;4.25E-11;NINJ2_MOUSE;Ninjurin-2 (Nerve injury-induced protein 2);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";"GO:0007155; GO:0016021; GO:0042246";"cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]";integral component of membrane [GO:0016021];
comp7586028_c0_seq1;GAXK01108122.1;Q7PRJ0;4.06E-09;CTLH2_ANOGA;CTL-like protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp75868_c0_seq1;GAXK01047983.1;O02367;1.77E-39;CALM_CIOIN;Calmodulin (CaM) (Ci-CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7587_c0_seq1;GAXK01100290.1;O74362;3.08E-35;ESF2_SCHPO;Pre-rRNA-processing protein esf2 (18S rRNA factor 2);"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]";"GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0034462";"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp7587902_c0_seq1;GAXK01108128.1;Q6AZB8;8.09E-07;HARB1_DANRE;Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]";"GO:0004518; GO:0005634; GO:0005737; GO:0046872";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
comp7587940_c0_seq1;GAXK01108127.1;Q9I310;4.99E-24;Y1727_PSEAE;Uncharacterized signaling protein PA1727;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; diguanylate cyclase activity [GO:0052621]; cellular response to nitric oxide [GO:0071732]";"GO:0005886; GO:0016021; GO:0052621; GO:0071111; GO:0071732";cellular response to nitric oxide [GO:0071732];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; diguanylate cyclase activity [GO:0052621]"
comp758797_c1_seq1;GAXK01190785.1;P62045;1.15E-11;NR1I3_PUSSI;Nuclear receptor subfamily 1 group I member 3 (Constitutive androstane receptor) (CAR);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]";"GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0005856; GO:0008270; GO:0043565";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp758816_c0_seq1;GAXK01190770.1;P52746;4.78E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7588282_c0_seq1;GAXK01194232.1;P02941;2.65E-18;MCP2_SALTY;Methyl-accepting chemotaxis protein II (MCP-II) (Aspartate chemoreceptor protein);"integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0006935; GO:0007165";"chemotaxis [GO:0006935]; signal transduction [GO:0007165]";integral component of plasma membrane [GO:0005887];transmembrane signaling receptor activity [GO:0004888]
comp75898_c1_seq1;GAXK01048003.1;P28494;0;MA2A1_RAT;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase);"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042";"in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]";"cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"
comp7590260_c0_seq1;GAXK01164557.1;A4G4T3;7.21E-53;LPXA_HERAR;Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (UDP-N-acetylglucosamine acyltransferase) (EC 2.3.1.129);"cytoplasm [GO:0005737]; acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase activity [GO:0008780]; lipid A biosynthetic process [GO:0009245]";"GO:0005737; GO:0008780; GO:0009245";lipid A biosynthetic process [GO:0009245];cytoplasm [GO:0005737];acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase activity [GO:0008780]
comp759158_c0_seq1;GAXK01190795.1;Q59E36;5.24E-10;RCOR_DROME;REST corepressor (CoREST);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"GO:0000122; GO:0003682; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006325; GO:0008134; GO:0017053; GO:0044212; GO:0045892; GO:0061086; GO:0090309; GO:2000619";"chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]";"nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp75918_c0_seq1;GAXK01047997.1;Q792I0;8.44E-95;LIN7C_RAT;Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3);"basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]";"GO:0002011; GO:0005737; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008092; GO:0014069; GO:0015031; GO:0016323; GO:0030165; GO:0043005; GO:0045199; GO:0045202; GO:0045211; GO:0097016; GO:0097025; GO:0098793; GO:0098978; GO:1903361";"exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]";"basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]";"cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]"
comp75937_c0_seq1;GAXK01047708.1;A7RDN6;3.23E-53;RNLS_MOUSE;Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) (mMAO-C);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; cardiac left ventricle morphogenesis [GO:0003214]; dopamine metabolic process [GO:0042417]; epinephrine metabolic process [GO:0042414]; heart contraction [GO:0060047]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; phosphate ion homeostasis [GO:0055062]; regulation of systemic arterial blood pressure [GO:0003073]; response to norepinephrine [GO:0071873]; response to salt [GO:1902074]";"GO:0003073; GO:0003214; GO:0005576; GO:0005615; GO:0010459; GO:0016491; GO:0016651; GO:0042414; GO:0042415; GO:0042417; GO:0045776; GO:0051379; GO:0055062; GO:0055114; GO:0060047; GO:0070404; GO:0071873; GO:0097621; GO:1902074";"cardiac left ventricle morphogenesis [GO:0003214]; dopamine metabolic process [GO:0042417]; epinephrine metabolic process [GO:0042414]; heart contraction [GO:0060047]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; phosphate ion homeostasis [GO:0055062]; regulation of systemic arterial blood pressure [GO:0003073]; response to norepinephrine [GO:0071873]; response to salt [GO:1902074]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"
comp7594417_c0_seq1;GAXK01152572.1;Q8BW94;1.18E-22;DYH3_MOUSE;Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3);"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045503; GO:0045505; GO:0051959";"cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]";"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7594672_c0_seq1;GAXK01152570.1;A1TUY9;2.65E-67;RUVB_ACIAC;Holliday junction ATP-dependent DNA helicase RuvB (EC 3.6.4.12);"ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0006281; GO:0006310; GO:0009378; GO:0009432";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp75949_c0_seq1;GAXK01047767.1;Q8BHN5;3.95E-91;RBM45_MOUSE;RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:1990904";"cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp7596379_c0_seq1;GAXK01156021.1;P34422;7.00E-27;DPF6_CAEEL;Dipeptidyl peptidase family member 6 (EC 3.4.14.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]";"GO:0004177; GO:0005886; GO:0008236; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]"
comp7596738_c0_seq1;GAXK01156018.1;Q2SVE3;1.11E-34;SYFB_BURTA;Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]";"GO:0000049; GO:0000287; GO:0004826; GO:0005524; GO:0005737; GO:0006432";phenylalanyl-tRNA aminoacylation [GO:0006432];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]"
comp759713_c0_seq1;GAXK01190774.1;Q9V817;1.17E-15;MTH4_DROME;Probable G-protein coupled receptor Mth-like 4 (Protein methuselah-like 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594";"cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp7598149_c0_seq1;GAXK01028412.1;Q8CPT6;9.59E-10;CDR_STAES;Coenzyme A disulfide reductase (CoA-disulfide reductase) (CoADR) (EC 1.8.1.14);"cell [GO:0005623]; CoA-disulfide reductase activity [GO:0050451]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005623; GO:0045454; GO:0050451; GO:0050660; GO:0050661";cell redox homeostasis [GO:0045454];cell [GO:0005623];"CoA-disulfide reductase activity [GO:0050451]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; protein disulfide isomerase activity [GO:0003756]"
comp759828_c0_seq1;GAXK01190766.1;Q9W0A0;0;DRPR_DROME;Protein draper;"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396";"apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]";"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]";phosphatidylserine binding [GO:0001786]
comp75984_c1_seq1;GAXK01047956.1;Q5VSL9;0;STRP1_HUMAN;Striatin-interacting protein 1 (Protein FAM40A);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604]";"GO:0005634; GO:0005829; GO:0017048; GO:0019901; GO:0022604; GO:0030866; GO:0070062";"cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]"
comp75995_c0_seq1;GAXK01047536.1;A5HK05;1.95E-45;APBP2_RAT;Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2);"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]";"GO:0005634; GO:0005874; GO:0006886; GO:0030659";intracellular protein transport [GO:0006886];"cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]";
comp759986_c0_seq1;GAXK01190768.1;O43167;9.96E-15;ZBT24_HUMAN;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000981; GO:0002244; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp76_c0_seq1;GAXK01166399.1;Q6QLW4;6.41E-45;CYC_PECGU;Cytochrome c;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]";"GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469";;"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp760_c0_seq1;GAXK01165945.1;Q2F637;1.03E-151;1433Z_BOMMO;14-3-3 protein zeta;"cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]";"GO:0005737; GO:0019904";;cytoplasm [GO:0005737];protein domain specific binding [GO:0019904]
comp76005_c1_seq1;GAXK01092270.1;Q7Z4H7;1.93E-10;HAUS6_HUMAN;HAUS augmin-like complex subunit 6;"centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]";"GO:0000086; GO:0005813; GO:0005815; GO:0005819; GO:0005829; GO:0005874; GO:0007098; GO:0010389; GO:0016607; GO:0051225; GO:0051301; GO:0070652; GO:0097711";"cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]";"centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; spindle [GO:0005819]";
comp7600790_c0_seq1;GAXK01142680.1;Q6ZMR5;3.92E-10;TM11A_HUMAN;Transmembrane protease serine 11A (EC 3.4.21.-) (Airway trypsin-like protease 1) (Epidermal type-II transmembrane serine protease) (Esophageal cancer-susceptibility gene 1 protein);"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; cell cycle [GO:0007049]";"GO:0004252; GO:0005576; GO:0005887; GO:0007049";cell cycle [GO:0007049];"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]";serine-type endopeptidase activity [GO:0004252]
comp7601_c0_seq1;GAXK01100291.1;Q14657;2.61E-10;LAGE3_HUMAN;EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2);"cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]";"GO:0000408; GO:0005634; GO:0005654; GO:0005737; GO:0008033; GO:0016604; GO:0045944; GO:0070525";"positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]";"cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp7601233_c0_seq1;GAXK01142677.1;Q9M573;1.01E-41;RL31_PERFR;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7601271_c0_seq1;GAXK01142683.1;P0CT31;1.19E-60;EF1A1_DICDI;Elongation factor 1-alpha (EF-1-alpha) (50 kDa actin-binding protein) (ABP-50);"cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; actin filament bundle assembly [GO:0051017]; response to alkaline pH [GO:0010446]; response to bacterium [GO:0009617]; response to reactive oxygen species [GO:0000302]; translation [GO:0006412]; translational elongation [GO:0006414]";"GO:0000302; GO:0003746; GO:0003785; GO:0003924; GO:0005525; GO:0005829; GO:0005938; GO:0006412; GO:0006414; GO:0009617; GO:0010446; GO:0030027; GO:0030175; GO:0031012; GO:0031143; GO:0045335; GO:0051015; GO:0051017";"actin filament bundle assembly [GO:0051017]; response to alkaline pH [GO:0010446]; response to bacterium [GO:0009617]; response to reactive oxygen species [GO:0000302]; translation [GO:0006412]; translational elongation [GO:0006414]";"cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; pseudopodium [GO:0031143]";"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp7602_c0_seq1;GAXK01100102.1;P61962;0;DCAF7_HUMAN;DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008";"multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";
comp7602631_c0_seq1;GAXK01005287.1;O18868;2.02E-13;KCNB1_PIG;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (Voltage-gated potassium channel subunit Kv2.1);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016021; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671";"action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]"
comp76033_c0_seq1;GAXK01092051.1;P83501;7.78E-35;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp760334_c0_seq1;GAXK01123293.1;Q8INF0;0;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp7603747_c0_seq1;GAXK01005291.1;Q962R9;1.39E-36;RS10_SPOFR;40S ribosomal protein S10;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp7603806_c0_seq1;GAXK01005296.1;Q9P3A7;3.55E-55;CDC48_SCHPO;Cell division cycle protein 48 (EC 3.6.4.6) (Transitional endoplasmic reticulum ATPase homolog);"Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Hrd1p ubiquitin ligase complex [GO:0000836]; mitotic spindle midzone [GO:1990023]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RQC complex [GO:1990112]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein binding, bridging [GO:0030674]; autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; establishment of endoplasmic reticulum localization involved in endoplasmic reticulum polarization at cell division site [GO:0061166]; macroautophagy [GO:0016236]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle disassembly [GO:0051228]; protein localization to Golgi apparatus [GO:0034067]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000790; GO:0000836; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0016236; GO:0016887; GO:0030433; GO:0030674; GO:0030970; GO:0031593; GO:0034067; GO:0034098; GO:0035103; GO:0036266; GO:0051228; GO:0051306; GO:0061166; GO:0071712; GO:0097352; GO:1990023; GO:1990112; GO:1990116";"autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; establishment of endoplasmic reticulum localization involved in endoplasmic reticulum polarization at cell division site [GO:0061166]; macroautophagy [GO:0016236]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle disassembly [GO:0051228]; protein localization to Golgi apparatus [GO:0034067]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Hrd1p ubiquitin ligase complex [GO:0000836]; mitotic spindle midzone [GO:1990023]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RQC complex [GO:1990112]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein binding, bridging [GO:0030674]"
comp760417_c0_seq1;GAXK01123288.1;P31319;4.11E-22;KAPR_APLCA;cAMP-dependent protein kinase regulatory subunit (N4 subunit of protein kinase A);"cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]";"GO:0005952; GO:0008603; GO:0030552";;cAMP-dependent protein kinase complex [GO:0005952];"cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp760517_c0_seq1;GAXK01205617.1;Q5ZJ60;2.15E-36;HIBCH_CHICK;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp760537_c0_seq1;GAXK01123253.1;Q5R1W1;4.33E-119;SEPT7_PANTR;Septin-7 (CDC10 protein homolog) (Fragment);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0060271; GO:0061640";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp7605446_c0_seq1;GAXK01011095.1;P00390;2.76E-34;GSHR_HUMAN;Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7);"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; nucleobase-containing small molecule interconversion [GO:0015949]";"GO:0004362; GO:0005739; GO:0005759; GO:0005829; GO:0006749; GO:0009055; GO:0009897; GO:0015949; GO:0034599; GO:0045454; GO:0050660; GO:0050661; GO:0070062";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; nucleobase-containing small molecule interconversion [GO:0015949]";"cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]"
comp760572_c0_seq1;GAXK01123258.1;Q8IUH5;6.07E-35;ZDH17_HUMAN;Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17);"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]";"GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231";"lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]";"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]";"identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp7605983_c0_seq1;GAXK01011096.1;Q9FR62;1.64E-13;P23A_BRANA;Co-chaperone protein p23-1 (Bnp23-1);"chaperone complex [GO:0101031]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]";"GO:0009408; GO:0051085; GO:0051087; GO:0051879; GO:0101031";"chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]";chaperone complex [GO:0101031];"chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]"
comp7607564_c0_seq1;GAXK01143155.1;A2QC74;3.78E-13;DBP2_ASPNC;ATP-dependent RNA helicase dbp2 (EC 3.6.4.13);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]";"GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp760839_c0_seq1;GAXK01123278.1;Q75S51;9.08E-09;PA2B4_BUNCA;Basic phospholipase A2 beta-bungarotoxin A4 chain (Beta-BuTX A4 chain) (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; toxin activity [GO:0090729]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";"GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0050482; GO:0090729; GO:0102567; GO:0102568";"arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; toxin activity [GO:0090729]"
comp7610_c2_seq1;GAXK01100435.1;P51452;6.23E-30;DUS3_HUMAN;Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR);"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782";"cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]";"cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]"
comp7610209_c0_seq1;GAXK01136031.1;P45337;7.61E-12;QSEB_HAEIN;Transcriptional regulatory protein QseB;"cytosol [GO:0005829]; protein-DNA complex [GO:0032993]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; phosphorelay response regulator activity [GO:0000156]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000156; GO:0000976; GO:0001216; GO:0003700; GO:0005829; GO:0032993";;"cytosol [GO:0005829]; protein-DNA complex [GO:0032993]";"DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; phosphorelay response regulator activity [GO:0000156]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp76109_c2_seq1;GAXK01092561.1;Q9QZD5;7.12E-92;RAE2_MOUSE;Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0017137; GO:0018344";"intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]";"GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp761101_c1_seq1;GAXK01123249.1;Q8T674;5.57E-110;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp7611807_c0_seq1;GAXK01136035.1;Q9Y2H6;8.58E-17;FND3A_HUMAN;Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts);"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"GO:0000139; GO:0001669; GO:0003723; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0016021; GO:0060009; GO:0098609";"cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]";"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vesicle membrane [GO:0012506]";RNA binding [GO:0003723]
comp7612319_c0_seq1;GAXK01093079.1;P92981;1.13E-10;APR2_ARATH;5'-adenylylsulfate reductase 2, chloroplastic (EC 1.8.4.9) (3'-phosphoadenosine-5'-phosphosulfate reductase homolog 43) (PAPS reductase homolog 43) (Prh-43) (Adenosine 5'-phosphosulfate 5'-adenylylsulfate sulfotransferase 2) (APS sulfotransferase 2) (Thioredoxin-independent APS reductase 2);"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; adenylyl-sulfate reductase (glutathione) activity [GO:0033741]; adenylyl-sulfate reductase activity [GO:0009973]; phosphoadenylyl-sulfate reductase (thioredoxin) activity [GO:0004604]; cell redox homeostasis [GO:0045454]; cysteine biosynthetic process [GO:0019344]; sulfate assimilation [GO:0000103]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]";"GO:0000103; GO:0004604; GO:0009507; GO:0009570; GO:0009973; GO:0019344; GO:0019379; GO:0033741; GO:0045454";"cell redox homeostasis [GO:0045454]; cysteine biosynthetic process [GO:0019344]; sulfate assimilation [GO:0000103]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]";"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]";"adenylyl-sulfate reductase (glutathione) activity [GO:0033741]; adenylyl-sulfate reductase activity [GO:0009973]; phosphoadenylyl-sulfate reductase (thioredoxin) activity [GO:0004604]"
comp7612586_c0_seq1;GAXK01093081.1;P0A9Q3;1.25E-21;ARCA_ECO57;Aerobic respiration control protein ArcA;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0005737; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp7614219_c0_seq1;GAXK01071223.1;Q91ZX7;2.33E-07;LRP1_MOUSE;"Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]";"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]";"GO:0002020; GO:0002265; GO:0003279; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005887; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048471; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060548; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:1900149; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905167; GO:2000587";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]";"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]";"alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]"
comp7614246_c0_seq1;GAXK01071225.1;Q1ZXG4;1.16E-33;PRLA_DICDI;Proliferation-associated protein A;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005730; GO:0005737; GO:0045335";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]";nucleic acid binding [GO:0003676]
comp761504_c2_seq1;GAXK01123234.1;Q86WI1;0;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp76154_c1_seq1;GAXK01092153.1;P80147;1.15E-177;GABT_PIG;4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT);"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]";"GO:0003867; GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537";"behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]";"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; 4-aminobutyrate transaminase activity [GO:0003867]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]"
comp761581_c0_seq1;GAXK01123250.1;Q26474;6.70E-28;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp761623_c0_seq1;GAXK01123291.1;P21369;2.10E-33;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp7617607_c0_seq1;GAXK01102378.1;Q94464;9.69E-21;DYNA_DICDI;Dynamin-A;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]";"GO:0000266; GO:0003374; GO:0003924; GO:0005522; GO:0005525; GO:0005543; GO:0005737; GO:0006907; GO:0006909; GO:0006997; GO:0007005; GO:0007015; GO:0007032; GO:0007163; GO:0008017; GO:0016020; GO:0031288; GO:0031966; GO:0032154; GO:0042802; GO:0044656; GO:0045335; GO:0048312; GO:0061025; GO:0061952; GO:0090383; GO:0097204; GO:1900756; GO:1905345";"actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]";"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]"
comp76178_c1_seq1;GAXK01092020.1;D8Q9M3;3.74E-45;AMYG_SCHCM;Glucoamylase ARB_02327-1 (EC 3.2.1.3) (1,4-alpha-D-glucan glucohydrolase) (Glucan 1,4-alpha-glucosidase) (allergen Sch c 1);"extracellular region [GO:0005576]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004339; GO:0005576; GO:2001070";polysaccharide catabolic process [GO:0000272];extracellular region [GO:0005576];"glucan 1,4-alpha-glucosidase activity [GO:0004339]; starch binding [GO:2001070]"
comp7618009_c0_seq1;GAXK01038912.1;Q54BT3;1.58E-16;ABCB2_DICDI;ABC transporter B family member 2 (ABC transporter ABCB.2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp7618013_c0_seq1;GAXK01038905.1;P20163;3.87E-42;BIBH_CAEEL;Endoplasmic reticulum chaperone BiP homolog (Heat shock 70 kDa protein D) (EC 3.6.4.10);"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA polymerase II transcription factor binding [GO:0001085]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0001085; GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0005791; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA polymerase II transcription factor binding [GO:0001085]; unfolded protein binding [GO:0051082]"
comp7618586_c0_seq1;GAXK01038917.1;P41129;9.86E-33;RL132_BRANA;60S ribosomal protein L13-2 (Cold-induced protein C24B);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp761868_c1_seq1;GAXK01123242.1;Q64449;5.21E-29;MRC2_MOUSE;C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]";"GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0016021; GO:0030246; GO:0030574";"collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]"
comp76196_c0_seq1;GAXK01092100.1;Q8BN59;1.78E-18;LARP6_MOUSE;La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]";"GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904";"positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]";"mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]"
comp76199_c1_seq1;GAXK01091984.1;Q5RBN9;8.88E-77;TAD2B_PONAB;Transcriptional adapter 2-beta;"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003677; GO:0003713; GO:0005634; GO:0006357; GO:0008270; GO:0035065";"regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]"
comp7619914_c0_seq1;GAXK01038913.1;P82600;2.28E-09;PERC_AEDAE;Chorion peroxidase (EC 1.11.1.7);"extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0020037; GO:0042743; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]";extracellular region [GO:0005576];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp762002_c1_seq1;GAXK01099703.1;O08914;1.41E-78;FAAH1_MOUSE;Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Oleamide hydrolase 1);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]";"GO:0000139; GO:0004040; GO:0005543; GO:0005789; GO:0008289; GO:0009062; GO:0016021; GO:0016788; GO:0017064; GO:0031090; GO:0042802; GO:0042803; GO:0047372; GO:0052651; GO:0102077; GO:0103073";"fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]";"acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]"
comp762047_c0_seq1;GAXK01099716.1;Q9VW15;4.24E-66;ASH1_DROME;Histone-lysine N-methyltransferase ash1 (EC 2.1.1.43) (Absent small and homeotic disks protein 1) (Lysine N-methyltransferase 2H);"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000785; GO:0001700; GO:0003682; GO:0005634; GO:0005700; GO:0006355; GO:0010452; GO:0010628; GO:0016571; GO:0018991; GO:0032991; GO:0034770; GO:0035035; GO:0035097; GO:0042054; GO:0042800; GO:0042802; GO:0046872; GO:0046975; GO:0048096; GO:0048477; GO:0051567; GO:0051568; GO:0061086; GO:0097676";"chromatin-mediated maintenance of transcription [GO:0048096]; embryonic development via the syncytial blastoderm [GO:0001700]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; histone H3-K9 methylation [GO:0051567]; histone H4-K20 methylation [GO:0034770]; histone methylation [GO:0016571]; negative regulation of histone H3-K27 methylation [GO:0061086]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp7620931_c0_seq1;GAXK01119340.1;Q56JY1;2.11E-27;RL35A_BOVIN;60S ribosomal protein L35a;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";cytosolic large ribosomal subunit [GO:0022625];"structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp7621446_c0_seq1;GAXK01119345.1;Q1HRT4;3.20E-21;RL38_AEDAE;60S ribosomal protein L38;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7622664_c0_seq1;GAXK01203721.1;P34730;2.01E-41;BMH2_YEAST;Protein BMH2;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA replication origin binding [GO:0003688]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; ascospore formation [GO:0030437]; DNA damage checkpoint [GO:0000077]; DNA replication initiation [GO:0006270]; fungal-type cell wall chitin biosynthetic process [GO:0034221]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; pseudohyphal growth [GO:0007124]; Ras protein signal transduction [GO:0007265]; regulation of glycogen metabolic process [GO:0070873]; signal transduction involved in filamentous growth [GO:0001402]";"GO:0000077; GO:0001402; GO:0003688; GO:0005634; GO:0005737; GO:0005886; GO:0006267; GO:0006270; GO:0007124; GO:0007265; GO:0019904; GO:0030437; GO:0034221; GO:0043066; GO:0050815; GO:0070873; GO:1904667";"ascospore formation [GO:0030437]; DNA damage checkpoint [GO:0000077]; DNA replication initiation [GO:0006270]; fungal-type cell wall chitin biosynthetic process [GO:0034221]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; pseudohyphal growth [GO:0007124]; Ras protein signal transduction [GO:0007265]; regulation of glycogen metabolic process [GO:0070873]; signal transduction involved in filamentous growth [GO:0001402]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA replication origin binding [GO:0003688]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]"
comp7622709_c0_seq1;GAXK01203726.1;Q7CEG6;2.88E-41;CLPB_BRUSU;Chaperone protein ClpB;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein metabolic process [GO:0019538]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0009408; GO:0019538; GO:0042026";"protein metabolic process [GO:0019538]; protein refolding [GO:0042026]; response to heat [GO:0009408]";cytoplasm [GO:0005737];ATP binding [GO:0005524]
comp7623_c0_seq1;GAXK01100034.1;Q1HRV8;9.29E-78;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp7624083_c0_seq1;GAXK01076014.1;F5L9G2;7.40E-07;DHPH_CALTT;Phenylalanine dehydrogenase (PheDH) (EC 1.4.1.20);"nucleotide binding [GO:0000166]; phenylalanine dehydrogenase activity [GO:0050175]; L-phenylalanine biosynthetic process [GO:0009094]";"GO:0000166; GO:0009094; GO:0050175";L-phenylalanine biosynthetic process [GO:0009094];;"nucleotide binding [GO:0000166]; phenylalanine dehydrogenase activity [GO:0050175]"
comp7625096_c0_seq1;GAXK01076011.1;Q39230;4.30E-108;SYSC_ARATH;Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plastid [GO:0009536]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"GO:0004828; GO:0005524; GO:0005737; GO:0005829; GO:0006434; GO:0009536; GO:0046686; GO:0097056";"response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plastid [GO:0009536]";"ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]"
comp76256_c0_seq1;GAXK01092171.1;P18747;4.02E-08;ZO28_XENLA;Oocyte zinc finger protein XlCOF28 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7625802_c0_seq1;GAXK01076018.1;O04619;1.03E-24;ADNT1_ARATH;Mitochondrial adenine nucleotide transporter ADNT1 (Adenine nucleotide transporter 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]";"GO:0005743; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";transmembrane transporter activity [GO:0022857]
comp762723_c0_seq1;GAXK01099711.1;Q09788;1.43E-09;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp7628178_c0_seq1;GAXK01138620.1;P0DJ19;2.11E-31;RL27_TETTH;60S ribosomal protein L27;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7628738_c0_seq1;GAXK01138629.1;Q75HE6;2.96E-27;MTHR_ORYSJ;Probable methylenetetrahydrofolate reductase (EC 1.5.1.20);"cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";"GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949";"methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";cytosol [GO:0005829];"FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]"
comp762874_c0_seq1;GAXK01099678.1;Q9ESC1;3.50E-09;AGRL4_RAT;Adhesion G protein-coupled receptor L4 (EGF,latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein);"cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0031410; GO:0046983";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]";"cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]"
comp762926_c0_seq1;GAXK01099698.1;Q1ZXJ0;1.92E-101;CLCD_DICDI;Chloride channel protein D;"chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; regulation of ion transmembrane transport [GO:0034765]; sorocarp development [GO:0030587]";"GO:0005247; GO:0015108; GO:0022857; GO:0030587; GO:0034707; GO:0034765; GO:0043231";"regulation of ion transmembrane transport [GO:0034765]; sorocarp development [GO:0030587]";"chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]";"chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]"
comp7629782_c0_seq1;GAXK01138616.1;Q9W1B0;4.69E-11;GEK_DROME;Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1);"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]";"GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872";"actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]";"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp763075_c0_seq1;GAXK01099664.1;P73392;3.70E-20;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp763103_c0_seq1;GAXK01099726.1;Q9UDV7;2.53E-13;ZN282_HUMAN;Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0045892";"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp7631163_c0_seq1;GAXK01061069.1;Q8ZRP0;1.52E-34;BAMA_SALTY;Outer membrane protein assembly factor BamA;"Bam protein complex [GO:1990063]; integral component of membrane [GO:0016021]; Gram-negative-bacterium-type cell outer membrane assembly [GO:0043165]; protein insertion into membrane [GO:0051205]";"GO:0016021; GO:0043165; GO:0051205; GO:1990063";"Gram-negative-bacterium-type cell outer membrane assembly [GO:0043165]; protein insertion into membrane [GO:0051205]";"Bam protein complex [GO:1990063]; integral component of membrane [GO:0016021]";
comp763231_c0_seq1;GAXK01099719.1;Q8MJU1;2.36E-29;CASP3_FELCA;"Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]";"cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";"GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0097153; GO:0097199; GO:1902004";"apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]";cytoplasm [GO:0005737];"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]"
comp763252_c0_seq1;GAXK01099722.1;Q9XTJ4;9.38E-14;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp763321_c1_seq1;GAXK01099724.1;Q0IIY2;1.80E-36;WSCD1_XENTR;WSC domain-containing protein 1;"integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]";"GO:0008146; GO:0016021";;integral component of membrane [GO:0016021];sulfotransferase activity [GO:0008146]
comp7633946_c0_seq1;GAXK01176801.1;P14540;4.28E-47;ALF_YEAST;Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0004332; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0008270; GO:0009277";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]"
comp7634340_c0_seq1;GAXK01005828.1;Q9JZP1;1.13E-61;UVRA_NEIMB;UvrABC system protein A (UvrA protein) (Excinuclease ABC subunit A);"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0005737; GO:0006289; GO:0008270; GO:0009380; GO:0009381; GO:0009432; GO:0016887";"nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]"
comp76355_c1_seq1;GAXK01092149.1;O75897;2.55E-46;ST1C4_HUMAN;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2);"cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";"GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]";cytosol [GO:0005829];"aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
comp7635908_c0_seq1;GAXK01005833.1;Q9JJZ9;5.56E-28;CNGB3_MOUSE;Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3) (CNG channel beta-3) (Cyclic nucleotide-gated channel subunit CNG6);"photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; cation transport [GO:0006812]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0001750; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0030553; GO:0050896; GO:1902495";"cation transport [GO:0006812]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]";"cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]"
comp7636168_c0_seq1;GAXK01149970.1;O31250;6.40E-31;ALKB_ACIAD;Alkane 1-monooxygenase (EC 1.14.15.3) (Alkane hydroxylase) (AHs) (Terminal alkane hydroxylase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid omega-hydroxylase activity [GO:0052869]; metal ion binding [GO:0046872]; alkane catabolic process [GO:0043448]; lipid metabolic process [GO:0006629]";"GO:0005886; GO:0006629; GO:0016021; GO:0018685; GO:0043448; GO:0046872; GO:0052869";"alkane catabolic process [GO:0043448]; lipid metabolic process [GO:0006629]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid omega-hydroxylase activity [GO:0052869]; metal ion binding [GO:0046872]"
comp7636328_c0_seq1;GAXK01149977.1;O75096;1.13E-08;LRP4_HUMAN;Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp7636382_c0_seq1;GAXK01149983.1;B4F7B7;1.11E-16;DUS15_RAT;Dual specificity protein phosphatase 15 (EC 3.1.3.16) (EC 3.1.3.48);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000122; GO:0004725; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0042127; GO:0046330; GO:0070374";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp7636537_c0_seq1;GAXK01149982.1;P17326;2.16E-19;AT1A_ARTSF;Sodium/potassium-transporting ATPase subunit alpha-A (Na(+)/K(+) ATPase alpha-A subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]";"GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp7636548_c0_seq1;GAXK01149976.1;P36627;2.89E-13;BYR3_SCHPO;Cellular nucleic acid-binding protein homolog;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation activator activity [GO:0008494]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]";"GO:0003677; GO:0003727; GO:0003729; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0008494; GO:0045182; GO:2000767";positive regulation of cytoplasmic translation [GO:2000767];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation activator activity [GO:0008494]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]"
comp7637009_c0_seq1;GAXK01149971.1;Q5ZJG3;9.58E-41;BT3L4_CHICK;Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4);;;;;
comp7637642_c0_seq1;GAXK01149980.1;Q7ZV55;3.20E-45;EIF3I_DANRE;Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (eIF-3-beta) (eIF3 p36);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; liver development [GO:0001889]; sprouting angiogenesis [GO:0002040]; translational initiation [GO:0006413]";"GO:0001732; GO:0001889; GO:0002040; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; liver development [GO:0001889]; sprouting angiogenesis [GO:0002040]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp76387_c2_seq1;GAXK01092101.1;P55162;0;HEM_DROME;Membrane-associated protein Hem (dHem-2);"integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"GO:0000902; GO:0001764; GO:0005886; GO:0007010; GO:0007409; GO:0007417; GO:0007520; GO:0007528; GO:0008360; GO:0008407; GO:0016021; GO:0016477; GO:0030031; GO:0030036; GO:0030866; GO:0031209; GO:0031594; GO:0033627; GO:0048812; GO:0050807";"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]";"integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]";
comp7638969_c0_seq1;GAXK01203450.1;A8IB25;1.45E-48;RSSA_CHLRE;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp7639753_c0_seq1;GAXK01203451.1;P18172;6.11E-22;DHGL_DROPS;Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein];"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]";"GO:0005576; GO:0016614; GO:0050660";;extracellular region [GO:0005576];"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
comp763992_c0_seq1;GAXK01099693.1;Q6GQ39;2.12E-54;TM135_XENLA;Transmembrane protein 135 (Peroxisomal membrane protein 52) (PMP52);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; regulation of mitochondrial fission [GO:0090140]";"GO:0005739; GO:0005778; GO:0016021; GO:0031966; GO:0090140";regulation of mitochondrial fission [GO:0090140];"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]";
comp76412_c1_seq1;GAXK01092398.1;Q5TM63;1.56E-41;ATAT_MACMU;Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog);"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; spindle [GO:0005819]; coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]";"GO:0004468; GO:0005737; GO:0005819; GO:0005874; GO:0005905; GO:0005925; GO:0019799; GO:0030424; GO:0048666; GO:0050662; GO:0070507; GO:0071929";"alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]";"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; spindle [GO:0005819]";"coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]"
comp764151_c0_seq1;GAXK01051146.1;P24367;9.61E-54;PPIB_CHICK;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"GO:0000413; GO:0003755; GO:0005788; GO:0016018; GO:0032991; GO:0042026; GO:0042470; GO:0051082; GO:0061077; GO:1904027";"chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]";"endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp764176_c0_seq1;GAXK01051133.1;Q05192;2.28E-14;FTF1B_DROME;Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"GO:0000976; GO:0000978; GO:0003682; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0009755; GO:0009888; GO:0035211; GO:0045944; GO:0060968; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp7641816_c0_seq1;GAXK01054926.1;A7S8T5;1.38E-08;CCD42_NEMVE;Coiled-coil domain-containing protein 42 homolog;;;;;
comp7641940_c0_seq1;GAXK01054929.1;Q8PBK7;1.43E-53;GCSP_XANCP;Glycine dehydrogenase (decarboxylating) (EC 1.4.4.2) (Glycine cleavage system P-protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring));"cytosol [GO:0005829]; glycine cleavage complex [GO:0005960]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; pyridoxal phosphate binding [GO:0030170]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"GO:0004375; GO:0005829; GO:0005960; GO:0016594; GO:0019464; GO:0030170";glycine decarboxylation via glycine cleavage system [GO:0019464];"cytosol [GO:0005829]; glycine cleavage complex [GO:0005960]";"glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; pyridoxal phosphate binding [GO:0030170]"
comp764218_c0_seq1;GAXK01051159.1;Q9ZR37;7.83E-10;DUS1_ARATH;Dual specificity protein phosphatase 1 (AtDsPTP1) (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005516; GO:0005634; GO:0005737; GO:0006470; GO:0008138";protein dephosphorylation [GO:0006470];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"calmodulin binding [GO:0005516]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp764232_c0_seq1;GAXK01051114.1;Q3TDE8;9.90E-16;ZN691_MOUSE;Zinc finger protein 691;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp7643456_c0_seq1;GAXK01117734.1;O62515;3.68E-13;PAHX_CAEEL;Probable phytanoyl-CoA dioxygenase (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH);"L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; phytanoyl-CoA dioxygenase activity [GO:0048244]; fatty acid alpha-oxidation [GO:0001561]";"GO:0001561; GO:0031418; GO:0046872; GO:0048244";fatty acid alpha-oxidation [GO:0001561];;"L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; phytanoyl-CoA dioxygenase activity [GO:0048244]"
comp76447_c0_seq1;GAXK01091924.1;Q5TM59;1.51E-116;GNL1_MACMU;Guanine nucleotide-binding protein-like 1;GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp764633_c0_seq1;GAXK01051143.1;Q7XBS0;6.55E-78;DUR3_ORYSJ;Urea-proton symporter DUR3 (OsDUR3) (High-affinity urea active transporter DUR3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; urea transmembrane transport [GO:0071918]";"GO:0005886; GO:0015204; GO:0015293; GO:0016021; GO:0071918";urea transmembrane transport [GO:0071918];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]"
comp764679_c1_seq1;GAXK01051162.1;P42335;2.09E-101;IP3KB_RAT;Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]";"GO:0000165; GO:0001932; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005829; GO:0007166; GO:0008440; GO:0016020; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0071277";"cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]"
comp764707_c0_seq1;GAXK01051176.1;P93748;1.43E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp76472_c0_seq1;GAXK01091931.1;Q9W092;5.07E-17;CHIT2_DROME;Probable chitinase 2 (EC 3.2.1.14);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060";"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp764750_c1_seq1;GAXK01051172.1;Q9NZC4;2.91E-13;EHF_HUMAN;ETS homologous factor (hEHF) (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3) (ESE-3);"Golgi apparatus [GO:0005794]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0006366; GO:0007275; GO:0008283; GO:0030154; GO:0030855; GO:0045893; GO:0045944; GO:0050673";"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp7648077_c0_seq1;GAXK01002627.1;P14611;1.44E-92;THIL_CUPNH;Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase);"cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]";"GO:0003985; GO:0005737; GO:0042619";poly-hydroxybutyrate biosynthetic process [GO:0042619];cytoplasm [GO:0005737];acetyl-CoA C-acetyltransferase activity [GO:0003985]
comp764812_c0_seq1;GAXK01051147.1;Q2M3R5;9.95E-11;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp7648687_c0_seq1;GAXK01002631.1;P23538;1.31E-71;PPSA_ECOLI;Phosphoenolpyruvate synthase (PEP synthase) (EC 2.7.9.2) (Pyruvate, water dikinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; pyruvate, water dikinase activity [GO:0008986]; gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]";"GO:0000287; GO:0005524; GO:0005829; GO:0006090; GO:0006094; GO:0008986";"gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]";cytosol [GO:0005829];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; pyruvate, water dikinase activity [GO:0008986]"
comp7649_c4_seq1;GAXK01101120.1;Q2MHN3;7.69E-87;ZFHX2_MOUSE;Zinc finger homeobox protein 2 (Zinc finger homeodomain protein 5);"nucleus [GO:0005634]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sensory perception of pain [GO:0051930]";"GO:0000122; GO:0000978; GO:0005634; GO:0008270; GO:0030534; GO:0044212; GO:0045893; GO:0051930";"adult behavior [GO:0030534]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sensory perception of pain [GO:0051930]";nucleus [GO:0005634];"RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp76494_c0_seq1;GAXK01092073.1;Q9MA15;1.39E-94;AB1K3_ARATH;Protein ACTIVITY OF BC1 COMPLEX KINASE 3, chloroplastic (ABC1-LIKE KINASE 3) (EC 2.7.-.-) (EC 2.7.11.1) (Protein REPRESSOR OF BDR1);"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; plastoglobule [GO:0010287]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; cellular response to nitrogen starvation [GO:0006995]; chlorophyll catabolic process [GO:0015996]; chloroplast organization [GO:0009658]; plastoglobule organization [GO:0080177]; protein stabilization [GO:0050821]; regulation of tocopherol cyclase activity [GO:1902171]; response to high light intensity [GO:0009644]; response to photooxidative stress [GO:0080183]; response to red light [GO:0010114]; response to water deprivation [GO:0009414]";"GO:0004672; GO:0005524; GO:0005739; GO:0006995; GO:0009414; GO:0009507; GO:0009644; GO:0009658; GO:0010114; GO:0010287; GO:0015996; GO:0050821; GO:0080177; GO:0080183; GO:1902171";"cellular response to nitrogen starvation [GO:0006995]; chlorophyll catabolic process [GO:0015996]; chloroplast organization [GO:0009658]; plastoglobule organization [GO:0080177]; protein stabilization [GO:0050821]; regulation of tocopherol cyclase activity [GO:1902171]; response to high light intensity [GO:0009644]; response to photooxidative stress [GO:0080183]; response to red light [GO:0010114]; response to water deprivation [GO:0009414]";"chloroplast [GO:0009507]; mitochondrion [GO:0005739]; plastoglobule [GO:0010287]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp7649999_c0_seq1;GAXK01002626.1;A1W4L8;1.42E-67;PNP_ACISJ;Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]";"GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402";"mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]";cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]"
comp7650108_c0_seq1;GAXK01194410.1;O86428;1.16E-48;ILVE_PSEAE;Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42);"cytosol [GO:0005829]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; isoleucine biosynthetic process [GO:0009097]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";"GO:0004084; GO:0005829; GO:0009097; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656";"isoleucine biosynthetic process [GO:0009097]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]";cytosol [GO:0005829];"branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]"
comp765016_c0_seq1;GAXK01051174.1;O02367;1.88E-34;CALM_CIOIN;Calmodulin (CaM) (Ci-CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7650904_c0_seq1;GAXK01194405.1;A0A0H2ZDT7;3.52E-33;FLDP_PSEAB;Flavodoxin FldP;"FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]";"GO:0010181; GO:0016491";;;"FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]"
comp7652067_c0_seq1;GAXK01039676.1;P49205;1.40E-32;RS171_ARATH;40S ribosomal protein S17-1;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0006412; GO:0022627";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]";structural constituent of ribosome [GO:0003735]
comp765224_c1_seq1;GAXK01051164.1;C4N147;1.67E-14;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp765338_c0_seq1;GAXK01051151.1;Q5E6F9;8.00E-10;PANP_ALIF1;Aspartate 1-decarboxylase (EC 4.1.1.11);"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; pantothenate biosynthetic process [GO:0015940]";"GO:0004068; GO:0015940; GO:0030170";pantothenate biosynthetic process [GO:0015940];;"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]"
comp7653435_c0_seq1;GAXK01039672.1;Q24186;4.76E-34;RS5A_DROME;40S ribosomal protein S5a;"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0019843; GO:0022626; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp765410_c0_seq1;GAXK01051144.1;O02466;8.38E-40;ILPR_BRALA;"Insulin-like peptide receptor (ILP receptor) (EC 2.7.10.1) [Cleaved into: Insulin-like peptide receptor alpha chain; Insulin-like peptide receptor beta chain]";"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0043548; GO:0043560; GO:0046777; GO:0046872";"protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp7655206_c0_seq1;GAXK01087437.1;A8IB25;2.58E-52;RSSA_CHLRE;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022627";"cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp7656_c2_seq1;GAXK01100752.1;Q96QU8;0;XPO6_HUMAN;Exportin-6 (Exp6) (Ran-binding protein 20);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]";"GO:0005049; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991";protein export from nucleus [GO:0006611];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]"
comp7656999_c0_seq1;GAXK01136092.1;P61276;3.53E-09;CATK_MACFA;Cathepsin K (EC 3.4.22.38);"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037";"bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]";"collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]"
comp76570_c0_seq1;GAXK01091976.1;Q9VFB2;1.66E-41;RT10_DROME;28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt);"mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]";"GO:0003735; GO:0005763; GO:0006412; GO:0032543";"mitochondrial translation [GO:0032543]; translation [GO:0006412]";mitochondrial small ribosomal subunit [GO:0005763];structural constituent of ribosome [GO:0003735]
comp76571_c1_seq1;GAXK01092131.1;Q8VCW8;0;ACSF2_MOUSE;Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]";"GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760";fatty acid metabolic process [GO:0006631];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]"
comp765846_c0_seq1;GAXK01051141.1;Q98867;3.06E-09;THAA_DANRE;Thyroid hormone receptor alpha-A (zTRalpha-A) (Nuclear receptor subfamily 1 group A member 1-A) (Thyroid hormone receptor alpha-1) (TRalpha-1);"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; type I pneumocyte differentiation [GO:0060509]; ventricular system development [GO:0021591]";"GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0002154; GO:0003707; GO:0004879; GO:0005634; GO:0006355; GO:0007275; GO:0008134; GO:0008270; GO:0009725; GO:0009755; GO:0009887; GO:0021591; GO:0030154; GO:0030374; GO:0030878; GO:0033993; GO:0038023; GO:0045892; GO:0045893; GO:0045944; GO:0060509; GO:0090575";"animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; response to lipid [GO:0033993]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; type I pneumocyte differentiation [GO:0060509]; ventricular system development [GO:0021591]";"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp7658861_c0_seq1;GAXK01072624.1;Q94694;1.93E-24;RAP1_PHYPO;Ras-related protein Rap-1 (Pprap1);"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486]";"GO:0003924; GO:0005525; GO:0005886; GO:0032486";Rap protein signal transduction [GO:0032486];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp7659586_c0_seq1;GAXK01072616.1;P27659;6.91E-51;RL3_MOUSE;60S ribosomal protein L3 (J1 protein);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0005730; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0032991; GO:0045202; GO:0071353";"cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp766_c25_seq1;GAXK01166292.1;P68365;0;TBA1C_CRIGR;Tubulin alpha-1C chain (Alpha-tubulin 3) (Alpha-tubulin III) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain];"cytoplasmic microtubule [GO:0005881]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017";microtubule-based process [GO:0007017];cytoplasmic microtubule [GO:0005881];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp7660776_c0_seq1;GAXK01086509.1;Q6P2Q9;9.88E-09;PRP8_HUMAN;Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220);"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"GO:0000244; GO:0000375; GO:0000386; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157";"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]";"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]"
comp766098_c0_seq1;GAXK01056905.1;Q09855;2.11E-16;POF11_SCHPO;F-box/WD repeat-containing protein pof11 (Meiotically up-regulated gene 156 protein);"cytosol [GO:0005829]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; protein binding, bridging [GO:0030674]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; meiotic cell cycle [GO:0051321]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0000462; GO:0005829; GO:0019005; GO:0030674; GO:0031146; GO:0032040; GO:0034388; GO:0051321";"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; meiotic cell cycle [GO:0051321]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"cytosol [GO:0005829]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]";protein binding, bridging [GO:0030674]
comp76622_c0_seq1;GAXK01092219.1;Q99MB4;3.59E-122;CBWD1_RAT;COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1);ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp766278_c0_seq1;GAXK01056863.1;Q7KRI2;8.02E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp766286_c1_seq1;GAXK01056907.1;Q18297;1.72E-25;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp7664_c0_seq1;GAXK01100259.1;P55795;1.02E-54;HNRH2_HUMAN;Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed];"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0014069; GO:0016020; GO:0016070; GO:1990904";"mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]";RNA binding [GO:0003723]
comp7664088_c0_seq1;GAXK01008571.1;Q7YQC6;1.35E-24;HSP71_CANLF;Heat shock 70 kDa protein 1;"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006986; GO:0016887; GO:0031072; GO:0031625; GO:0032436; GO:0032991; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090063; GO:1901673; GO:1990904";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp76652_c1_seq1;GAXK01091957.1;Q5XGI0;1.09E-135;PRPS2_XENTR;Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II);"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp766527_c0_seq1;GAXK01056865.1;Q9VZW5;9.35E-22;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp7666647_c0_seq1;GAXK01170900.1;Q9Y6R4;7.01E-15;M3K4_HUMAN;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0000186; GO:0001890; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0031098; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355";"activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp766759_c0_seq1;GAXK01056876.1;Q9VZW5;3.69E-07;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp7668363_c0_seq1;GAXK01162740.1;P18418;3.63E-63;CALR_RAT;Calreticulin (CALBP) (CRP55) (Calcium-binding protein 3) (CABP3) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP);"acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; androgen receptor binding [GO:0050681]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; peptide binding [GO:0042277]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cardiac muscle cell differentiation [GO:0055007]; cellular response to lithium ion [GO:0071285]; cellular response to organic substance [GO:0071310]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"GO:0000122; GO:0001669; GO:0002502; GO:0003729; GO:0005178; GO:0005506; GO:0005509; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0005790; GO:0005794; GO:0005829; GO:0005844; GO:0006457; GO:0006611; GO:0007283; GO:0008284; GO:0009897; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0016529; GO:0017148; GO:0030246; GO:0030866; GO:0030968; GO:0031625; GO:0032355; GO:0032991; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042493; GO:0042562; GO:0042824; GO:0043231; GO:0044322; GO:0045665; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0062023; GO:0071157; GO:0071285; GO:0071310; GO:0090398; GO:1900026; GO:1901164; GO:1901224; GO:2000510";"cardiac muscle cell differentiation [GO:0055007]; cellular response to lithium ion [GO:0071285]; cellular response to organic substance [GO:0071310]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]";"acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]";"androgen receptor binding [GO:0050681]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; peptide binding [GO:0042277]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]"
comp7668567_c0_seq1;GAXK01162742.1;P0DJ60;5.08E-24;RL19_TETTS;60S ribosomal protein L19;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0022625";translation [GO:0006412];cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7668635_c0_seq1;GAXK01162741.1;P34114;1.50E-41;PHS2_DICDI;Glycogen phosphorylase 2 (GP2) (EC 2.4.1.1);"cytoplasm [GO:0005737]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; response to ammonia [GO:1903717]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]";"GO:0005737; GO:0005980; GO:0008184; GO:0030170; GO:0042803; GO:0051591; GO:0102250; GO:0102499; GO:1903013; GO:1903717";"glycogen catabolic process [GO:0005980]; response to ammonia [GO:1903717]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]";cytoplasm [GO:0005737];"glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]"
comp766964_c0_seq1;GAXK01205367.1;O54750;9.80E-86;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp7670265_c0_seq1;GAXK01081739.1;Q8TDC3;4.30E-13;BRSK1_HUMAN;Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1);"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle clustering [GO:2000807]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007095; GO:0007269; GO:0007409; GO:0008021; GO:0008306; GO:0009411; GO:0010975; GO:0019901; GO:0030010; GO:0030054; GO:0030182; GO:0035556; GO:0043015; GO:0048156; GO:0048167; GO:0048786; GO:0050321; GO:0050770; GO:0051298; GO:0090176; GO:0099504; GO:0150034; GO:2000807";"associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle clustering [GO:2000807]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]";"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]";"ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]"
comp7670446_c0_seq1;GAXK01081744.1;Q9N293;1.48E-09;B3GT5_GORGO;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp7671_c1_seq1;GAXK01204954.1;Q93112;5.15E-63;GST1C_ANOGA;Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta);"cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]";"GO:0004364; GO:0005737; GO:0006749; GO:0018833";glutathione metabolic process [GO:0006749];cytoplasm [GO:0005737];"DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]"
comp7671565_c0_seq1;GAXK01081745.1;Q9XBL8;2.53E-18;RUBR_ANAVT;Rubredoxin (Rd);"iron ion binding [GO:0005506]; oxidation-reduction process [GO:0055114]";"GO:0005506; GO:0055114";oxidation-reduction process [GO:0055114];;iron ion binding [GO:0005506]
comp7671600_c0_seq1;GAXK01081741.1;Q9STL4;4.05E-16;CEP2_ARATH;KDEL-tailed cysteine endopeptidase CEP2 (EC 3.4.22.-);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp76720_c0_seq1;GAXK01091926.1;Q9VAI1;2.17E-55;CIA30_DROME;Complex I intermediate-associated protein 30, mitochondrial;"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]; unfolded protein binding [GO:0051082]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to starvation [GO:0042594]";"GO:0001666; GO:0005739; GO:0005747; GO:0006119; GO:0006120; GO:0007005; GO:0009408; GO:0032981; GO:0042594; GO:0051082; GO:0055093; GO:1990204";"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to starvation [GO:0042594]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]";unfolded protein binding [GO:0051082]
comp7673048_c0_seq1;GAXK01013163.1;B9K8S7;2.47E-45;ASSY_THENN;Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase);"cytoplasm [GO:0005737]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]";"GO:0004055; GO:0005524; GO:0005737; GO:0006526";arginine biosynthetic process [GO:0006526];cytoplasm [GO:0005737];"argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]"
comp7675_c0_seq1;GAXK01101282.1;Q5XGU5;4.73E-34;DNJ6B_XENLA;DnaJ homolog subfamily B member 6-B;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp767531_c0_seq1;GAXK01056848.1;Q1HRV8;1.07E-56;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp7676_c0_seq1;GAXK01101190.1;O17389;1.60E-17;TYB_CAEEL;Thymosin beta (Tetrathymosin beta);"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]";"GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054";actin filament organization [GO:0007015];"cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]";actin monomer binding [GO:0003785]
comp767627_c0_seq1;GAXK01056884.1;Q96IR2;1.31E-17;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp767712_c1_seq1;GAXK01056866.1;Q5R6Q7;1.39E-21;SNX16_PONAB;Sorting nexin-16;"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]";"GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0045022";"early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]";"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]";phosphatidylinositol binding [GO:0035091]
comp76772_c1_seq1;GAXK01092177.1;O61735;8.58E-127;CLOCK_DROME;Circadian locomoter output cycles protein kaput (dCLOCK) (dPAS1);"CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; behavioral response to cocaine [GO:0048148]; circadian regulation of gene expression [GO:0032922]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to light stimulus [GO:0009416]; response to temperature stimulus [GO:0009266]; rhythmic behavior [GO:0007622]";"GO:0000122; GO:0003053; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007622; GO:0007623; GO:0008062; GO:0008134; GO:0009266; GO:0009416; GO:0009649; GO:0032922; GO:0043066; GO:0045187; GO:0045475; GO:0045893; GO:0045944; GO:0046982; GO:0048148; GO:1990513";"behavioral response to cocaine [GO:0048148]; circadian regulation of gene expression [GO:0032922]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to light stimulus [GO:0009416]; response to temperature stimulus [GO:0009266]; rhythmic behavior [GO:0007622]";"CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]"
comp7677944_c0_seq1;GAXK01004550.1;A2SIR5;3.04E-66;DNAJ_METPP;Chaperone protein DnaJ;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082";"DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
comp76782_c1_seq1;GAXK01092201.1;Q8JG30;3.68E-40;ST1B1_CHICK;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]";"GO:0005737; GO:0008146; GO:0008202";steroid metabolic process [GO:0008202];cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp767859_c0_seq1;GAXK01056846.1;Q7TQP6;9.89E-12;TNI3K_RAT;Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase);"cytoplasm [GO:0005737]; I band [GO:0031674]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]";"GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0007519; GO:0031432; GO:0031674; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:1903779";"bundle of His cell to Purkinje myocyte communication [GO:0086069]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; I band [GO:0031674]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]"
comp767930_c0_seq1;GAXK01056896.1;B5D5N9;6.94E-148;CTR2_RAT;Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; arginine transport [GO:0015809]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"GO:0000064; GO:0002537; GO:0005886; GO:0006809; GO:0015181; GO:0015189; GO:0015809; GO:0016021; GO:0030054; GO:0042116; GO:0043030; GO:0050727; GO:0061459; GO:0097638; GO:1903352";"arginine transport [GO:0015809]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]"
comp76799_c0_seq1;GAXK01092402.1;B5X8M4;3.14E-45;BRCC3_SALSA;Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36);"BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0007049; GO:0008237; GO:0010212; GO:0031593; GO:0036459; GO:0045739; GO:0046872; GO:0051301; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0072425";"cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]";"BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]";"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp768026_c0_seq1;GAXK01179883.1;Q03923;2.12E-38;ZNF85_HUMAN;Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]";"GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"
comp7680547_c0_seq1;GAXK01088871.1;Q9XGL4;2.20E-38;RL31_CYAPA;60S ribosomal protein L31;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp76809_c2_seq1;GAXK01092202.1;P19967;2.92E-64;CYB5R_DROME;Cytochrome b5-related protein (Protein TU-36B);"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; lipid metabolic process [GO:0006629]";"GO:0005739; GO:0006629; GO:0016021; GO:0016491; GO:0020037; GO:0046872";lipid metabolic process [GO:0006629];"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp7681508_c0_seq1;GAXK01088870.1;Q5PQQ6;2.33E-07;DRC9_RAT;Dynein regulatory complex protein 9 (IQ domain-containing protein G);"cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]";"GO:0002177; GO:0005516; GO:0005737; GO:0007286; GO:0007288; GO:0031514; GO:0036126; GO:0044782";"cilium organization [GO:0044782]; spermatid development [GO:0007286]; sperm axoneme assembly [GO:0007288]";"cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]";calmodulin binding [GO:0005516]
comp76817_c1_seq1;GAXK01092220.1;Q6NRK3;1.40E-08;SWAHB_XENLA;Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B);;;;;
comp768407_c0_seq1;GAXK01179845.1;P67862;2.24E-07;TXVE_PROFL;Snake venom vascular endothelial growth factor toxin (svVEGF) (VEGF-F);"extracellular region [GO:0005576]; membrane [GO:0016020]; growth factor activity [GO:0008083]; toxin activity [GO:0090729]";"GO:0005576; GO:0008083; GO:0016020; GO:0090729";;"extracellular region [GO:0005576]; membrane [GO:0016020]";"growth factor activity [GO:0008083]; toxin activity [GO:0090729]"
comp7684460_c0_seq1;GAXK01004248.1;Q03206;1.41E-15;RAC1_CAEEL;Ras-related protein ced-10 (CErac1) (Cell death protein 10) (Cell-corpse engulfment protein ced-10) (Ras-related protein rac-1);"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of cell migration [GO:0030334]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000132; GO:0001764; GO:0002119; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007264; GO:0007266; GO:0007369; GO:0008045; GO:0009898; GO:0010171; GO:0010172; GO:0016021; GO:0016477; GO:0019901; GO:0030036; GO:0030334; GO:0031103; GO:0031410; GO:0032228; GO:0033563; GO:0042995; GO:0043025; GO:0043652; GO:0045138; GO:0048598; GO:0048812; GO:0048846; GO:0050764; GO:0070986; GO:0097628; GO:1901076; GO:1903356";"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of cell migration [GO:0030334]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp7685545_c0_seq1;GAXK01004253.1;P11471;6.03E-22;PSBP_CHLRE;Oxygen-evolving enhancer protein 2, chloroplastic (OEE2);"chloroplast thylakoid membrane [GO:0009535]; extrinsic component of membrane [GO:0019898]; photosystem II oxygen evolving complex [GO:0009654]; calcium ion binding [GO:0005509]; photosynthesis [GO:0015979]";"GO:0005509; GO:0009535; GO:0009654; GO:0015979; GO:0019898";photosynthesis [GO:0015979];"chloroplast thylakoid membrane [GO:0009535]; extrinsic component of membrane [GO:0019898]; photosystem II oxygen evolving complex [GO:0009654]";calcium ion binding [GO:0005509]
comp768555_c0_seq1;GAXK01179882.1;P97500;1.15E-33;MYT1L_MOUSE;Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1);"chromosome [GO:0005694]; nucleus [GO:0005634]; cobalt ion binding [GO:0050897]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0001227; GO:0001228; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897";"negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"cobalt ion binding [GO:0050897]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]"
comp768607_c0_seq1;GAXK01179876.1;Q09003;2.51E-11;COIL_XENLA;Coilin (Sphere organelles protein SPH-1) (Sphere protein 1);sphere organelle [GO:0071601];GO:0071601;;sphere organelle [GO:0071601];
comp76878_c0_seq1;GAXK01092399.1;Q01781;0;SAHH_PETCR;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp768806_c0_seq1;GAXK01179859.1;P05661;8.55E-18;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp7688291_c0_seq1;GAXK01039763.1;Q7SYU0;6.29E-31;RS8_XENLA;40S ribosomal protein S8;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp768870_c0_seq1;GAXK01179831.1;Q96C11;3.70E-156;FGGY_HUMAN;FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-);"cell [GO:0005623]; D-ribulokinase activity [GO:0019150]; carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]";"GO:0005623; GO:0019150; GO:0019321; GO:0046835; GO:0070050";"carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]";cell [GO:0005623];D-ribulokinase activity [GO:0019150]
comp7689_c2_seq1;GAXK01100516.1;P15771;2.73E-16;NUCL_CHICK;Nucleolin (Protein C23);"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723]";"GO:0003677; GO:0003723; GO:0005730; GO:1990904";;"nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]"
comp768913_c0_seq2;GAXK01179839.1;P47736;7.86E-62;RPGP1_HUMAN;Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1);"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0000139; GO:0003924; GO:0005096; GO:0005829; GO:0007165; GO:0007411; GO:0016020; GO:0017016; GO:0042803; GO:0043087; GO:0043547; GO:0051056; GO:1903697";"axon guidance [GO:0007411]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]";"GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]"
comp7689345_c0_seq1;GAXK01039762.1;Q8HZM5;6.66E-45;GLNA_CANLF;Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]";"GO:0001525; GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006542; GO:0010594; GO:0018345; GO:0019706; GO:0046872; GO:1903670";"angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp76897_c1_seq1;GAXK01092521.1;Q8R1G2;1.16E-12;CMBL_MOUSE;Carboxymethylenebutenolidase homolog (EC 3.1.-.-);"cytosol [GO:0005829]; hydrolase activity [GO:0016787]";"GO:0005829; GO:0016787";;cytosol [GO:0005829];hydrolase activity [GO:0016787]
comp7690190_c0_seq1;GAXK01050767.1;Q0V8B6;5.56E-11;TPP1_BOVIN;Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I);"lysosome [GO:0005764]; melanosome [GO:0042470]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; bone resorption [GO:0045453]; central nervous system development [GO:0007417]; nervous system development [GO:0007399]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005764; GO:0006508; GO:0007399; GO:0007417; GO:0008240; GO:0042470; GO:0043171; GO:0045453; GO:0046872";"bone resorption [GO:0045453]; central nervous system development [GO:0007417]; nervous system development [GO:0007399]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"lysosome [GO:0005764]; melanosome [GO:0042470]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]"
comp76909_c4_seq1;GAXK01091960.1;Q3SXY7;9.22E-27;LRIT3_HUMAN;Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3;"dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005789; GO:0007601; GO:0016021; GO:0030425; GO:0040036; GO:0043204; GO:0050896";"regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]";
comp7691_c1_seq1;GAXK01100571.1;Q99437;2.43E-67;VATO_HUMAN;V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit) (hATPL);"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]";"GO:0005215; GO:0005774; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0030670; GO:0033179; GO:0033572; GO:0034220; GO:0046961; GO:0090383; GO:1902600";"insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]";"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]";"proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"
comp769103_c0_seq1;GAXK01179848.1;Q4G0Z9;8.49E-17;MCMD2_HUMAN;Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2);"MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; double-strand break repair involved in meiotic recombination [GO:1990918]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0007130; GO:0007283; GO:0042140; GO:0042555; GO:0048477; GO:1990918";"DNA replication initiation [GO:0006270]; double-strand break repair involved in meiotic recombination [GO:1990918]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp769185_c0_seq1;GAXK01179880.1;Q2PYN8;1.98E-33;LBX1_XENLA;Transcription factor LBX1 (Ladybird homeobox protein homolog 1);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007517; GO:0030154; GO:0043565; GO:0051450";"cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp7692_c1_seq1;GAXK01100724.1;Q556Y2;9.37E-67;ORN_DICDI;Probable oligoribonuclease (EC 3.1.-.-) (RNA exonuclease 2 homolog);"mitochondrion [GO:0005739]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; RNA metabolic process [GO:0016070]";"GO:0000175; GO:0003676; GO:0005739; GO:0008408; GO:0016070";RNA metabolic process [GO:0016070];mitochondrion [GO:0005739];"3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]"
comp7692723_c0_seq1;GAXK01064359.1;P39623;1.09E-08;SPSC_BACSU;Spore coat polysaccharide biosynthesis protein SpsC;"pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; polysaccharide biosynthetic process [GO:0000271]";"GO:0000271; GO:0008483; GO:0030170";polysaccharide biosynthetic process [GO:0000271];;"pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp7693259_c0_seq1;GAXK01064367.1;Q9XZT6;5.28E-10;DNK_DROME;Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897";"DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]"
comp7693697_c0_seq1;GAXK01064358.1;P05444;6.38E-74;CLPA_RHOBL;ClpA homolog protein;"ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein metabolic process [GO:0019538]; protein unfolding [GO:0043335]";"GO:0005524; GO:0016887; GO:0019538; GO:0043335";"protein metabolic process [GO:0019538]; protein unfolding [GO:0043335]";;"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp7694_c0_seq1;GAXK01100292.1;Q5R4B3;0;ERF3B_PONAB;Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (Eukaryotic peptide chain release factor subunit 3b) (eRF3b) (G1 to S phase transition protein 2 homolog);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell cycle [GO:0007049]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]";"GO:0000184; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0007049";"cell cycle [GO:0007049]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]";cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp76945_c0_seq1;GAXK01092060.1;A6NFY7;2.07E-23;SDHF1_HUMAN;Succinate dehydrogenase assembly factor 1, mitochondrial (SDH assembly factor 1) (SDHAF1) (LYR motif-containing protein 8);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex II assembly [GO:0034553]";"GO:0005739; GO:0005759; GO:0034553";mitochondrial respiratory chain complex II assembly [GO:0034553];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";
comp769489_c0_seq1;GAXK01179847.1;Q9TXD8;2.47E-27;ISOHC_AGEAP;Venom peptide isomerase heavy chain (EC 5.-.-.-);"extracellular region [GO:0005576]; isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0016853";;extracellular region [GO:0005576];"isomerase activity [GO:0016853]; serine-type endopeptidase activity [GO:0004252]"
comp7695119_c0_seq1;GAXK01123085.1;P37094;2.02E-81;PILF_NEIGO;Type IV pilus assembly protein PilF;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pilus assembly [GO:0009297]; protein transport [GO:0015031]";"GO:0005524; GO:0005737; GO:0009297; GO:0015031; GO:0016887";"pilus assembly [GO:0009297]; protein transport [GO:0015031]";cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp7696_c1_seq1;GAXK01100460.1;P91926;0;AP2A_DROME;AP-2 complex subunit alpha (Alpha-adaptin);"AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; clathrin adaptor activity [GO:0035615]; asymmetric cell division [GO:0008356]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; mitotic cleavage furrow ingression [GO:1990386]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]";"GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0008104; GO:0008356; GO:0010508; GO:0015031; GO:0030100; GO:0030122; GO:0030707; GO:0035615; GO:0045807; GO:0048488; GO:0048489; GO:0072583; GO:0098793; GO:1990386";"asymmetric cell division [GO:0008356]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; mitotic cleavage furrow ingression [GO:1990386]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]";"AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]";clathrin adaptor activity [GO:0035615]
comp7696204_c0_seq1;GAXK01181787.1;A0DTY1;9.46E-26;PP2C4_PARTE;Probable protein phosphatase 2C 4 (PP2C 4) (EC 3.1.3.16);"membrane [GO:0016020]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]";"GO:0004722; GO:0004724; GO:0016020; GO:0046872";;membrane [GO:0016020];"magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp769657_c0_seq1;GAXK01179840.1;Q6GN42;3.88E-124;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp769671_c0_seq1;GAXK01179885.1;O94806;7.33E-27;KPCD3_HUMAN;Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700";"protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]";"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp7698501_c0_seq1;GAXK01035454.1;Q56242;8.22E-12;UVRA_THET8;UvrABC system protein A (UvrA protein) (Excinuclease ABC subunit A);"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0005737; GO:0006289; GO:0008270; GO:0009380; GO:0009381; GO:0009432; GO:0016887";"nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432]";"cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; zinc ion binding [GO:0008270]"
comp77_c0_seq1;GAXK01166333.1;B0FWD1;8.25E-109;COX3_AEDAE;Cytochrome c oxidase subunit 3 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide III);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; aerobic electron transport chain [GO:0019646]";"GO:0004129; GO:0005743; GO:0016021; GO:0019646";aerobic electron transport chain [GO:0019646];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";cytochrome-c oxidase activity [GO:0004129]
comp7700358_c0_seq1;GAXK01198008.1;P55215;3.38E-18;CASP2_RAT;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; neural retina development [GO:0003407]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"GO:0001554; GO:0003407; GO:0005634; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0012501; GO:0016020; GO:0016485; GO:0019904; GO:0035234; GO:0042802; GO:0043525; GO:0071260; GO:0097153; GO:0097192; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; neural retina development [GO:0003407]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein processing [GO:0016485]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp77005_c0_seq1;GAXK01092564.1;Q5NVS7;5.81E-21;CAN1_PONAB;Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Micromolar-calpain) (muCANP);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; self proteolysis [GO:0097264]";"GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0006508; GO:0050790; GO:0097264";"proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; self proteolysis [GO:0097264]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]"
comp770161_c0_seq1;GAXK01108350.1;Q28IX8;5.85E-38;TBA_XENTR;Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp77025_c0_seq1;GAXK01091940.1;O00845;3.89E-19;PPIA_PARPR;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0006457";protein folding [GO:0006457];;peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp77029_c0_seq1;GAXK01091923.1;Q96QE2;3.50E-122;MYCT_HUMAN;Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]";"GO:0005366; GO:0005886; GO:0005887; GO:0015798";myo-inositol transport [GO:0015798];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";myo-inositol:proton symporter activity [GO:0005366]
comp7703_c2_seq1;GAXK01100051.1;Q31125;6.65E-66;S39A7_MOUSE;Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]";"GO:0005385; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006882; GO:0016021; GO:0071577";"cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]";zinc ion transmembrane transporter activity [GO:0005385]
comp770362_c0_seq1;GAXK01108303.1;Q62765;5.94E-108;NLGN1_RAT;Neuroligin-1 (Neuroligin I);"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuronal ion channel clustering [GO:0045161]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein homooligomerization [GO:0051260]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of presynapse organization [GO:0099174]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]";"GO:0002087; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0030054; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0043197; GO:0043198; GO:0045161; GO:0045184; GO:0045202; GO:0045664; GO:0046983; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050808; GO:0050839; GO:0051260; GO:0051290; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098698; GO:0098793; GO:0098942; GO:0098978; GO:0099060; GO:0099174; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809";"AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuronal ion channel clustering [GO:0045161]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein homooligomerization [GO:0051260]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of presynapse organization [GO:0099174]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]";"cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp770451_c0_seq1;GAXK01108268.1;Q9UJU3;3.08E-14;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7705474_c0_seq1;GAXK01034630.1;Q59601;3.48E-18;PLSC_NEIGO;1-acyl-sn-glycerol-3-phosphate acyltransferase (1-AGP acyltransferase) (1-AGPAT) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase) (LPAAT);"plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0003841; GO:0005886; GO:0016024";CDP-diacylglycerol biosynthetic process [GO:0016024];plasma membrane [GO:0005886];1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]
comp77058_c0_seq1;GAXK01092666.1;Q0IES8;0;MAB21_AEDAE;Protein mab-21;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp77063_c1_seq1;GAXK01092242.1;Q3LXA3;2.76E-123;TKFC_HUMAN;"Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]";"GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0019563; GO:0034012; GO:0039534; GO:0044262; GO:0045087; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062";"carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]"
comp770634_c0_seq1;GAXK01108344.1;P23787;1.77E-96;TERA_XENLA;Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0018279; GO:0019985; GO:0030433; GO:0032510; GO:0034214; GO:0034605; GO:0035617; GO:0035861; GO:0036503; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]"
comp7707543_c0_seq1;GAXK01145917.1;P14350;2.15E-10;POL_FOAMV;"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0042802; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]";"host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]";"aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp77094_c1_seq1;GAXK01091956.1;Q4VBS4;3.35E-90;MAP12_DANRE;Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D);"mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]";"GO:0005739; GO:0046872; GO:0070006; GO:0070084";protein initiator methionine removal [GO:0070084];mitochondrion [GO:0005739];"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp77104_c4_seq1;GAXK01092205.1;Q5RKH6;2.33E-41;OS9_RAT;Protein OS-9;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:1904153";"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"carbohydrate binding [GO:0030246]; protease binding [GO:0002020]"
comp7711135_c0_seq1;GAXK01007351.1;Q9VBZ5;1.58E-15;YTHDF_DROME;YTH domain-containing family protein;"cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]";"GO:0005737; GO:0036002; GO:1990247";;cytoplasm [GO:0005737];"N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]"
comp7712_c0_seq1;GAXK01101052.1;O55029;0;COPB2_MOUSE;Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102);"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]";"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]";"protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]"
comp7712072_c0_seq1;GAXK01084987.1;Q9LF61;4.46E-09;XPT_ARATH;Xylulose 5-phosphate/phosphate translocator, chloroplastic (Xul-5-P/phosphate translocator);"chloroplast envelope [GO:0009941]; chloroplast membrane [GO:0031969]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plastid [GO:0009536]; antiporter activity [GO:0015297]; phosphoglycerate transmembrane transporter activity [GO:0015120]; transmembrane transporter activity [GO:0022857]; triose-phosphate transmembrane transporter activity [GO:0071917]; phosphoglycerate transmembrane transport [GO:0015713]; triose phosphate transmembrane transport [GO:0035436]";"GO:0005794; GO:0009536; GO:0009941; GO:0015120; GO:0015297; GO:0015713; GO:0016021; GO:0022857; GO:0031969; GO:0035436; GO:0071917";"phosphoglycerate transmembrane transport [GO:0015713]; triose phosphate transmembrane transport [GO:0035436]";"chloroplast envelope [GO:0009941]; chloroplast membrane [GO:0031969]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plastid [GO:0009536]";"antiporter activity [GO:0015297]; phosphoglycerate transmembrane transporter activity [GO:0015120]; transmembrane transporter activity [GO:0022857]; triose-phosphate transmembrane transporter activity [GO:0071917]"
comp77122_c11_seq1;GAXK01091998.1;Q28Z18;8.09E-174;SETB1_DROPS;Histone-lysine N-methyltransferase eggless (EC 2.1.1.43) (SETDB1 homolog);"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038";"multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]"
comp771292_c0_seq1;GAXK01108286.1;P28175;7.68E-25;LFC_TACTR;"Limulus clotting factor C (FC) (EC 3.4.21.84) [Cleaved into: Limulus clotting factor C heavy chain; Limulus clotting factor C light chain; Limulus clotting factor C chain A; Limulus clotting factor C chain B]";"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]; cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]";"GO:0004252; GO:0005576; GO:0007155; GO:0030246; GO:0042381";"cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]";extracellular region [GO:0005576];"carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]"
comp7714425_c0_seq1;GAXK01120230.1;O24111;1.21E-59;RS5_NICPL;40S ribosomal protein S5 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7714900_c0_seq1;GAXK01120240.1;O76190;3.17E-11;RL5_BOMMO;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp7715553_c0_seq1;GAXK01120239.1;P63688;3.93E-09;CTPF_MYCBO;Probable cation-transporting ATPase F (EC 3.6.3.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0005524; GO:0005886; GO:0016021; GO:0016787; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp771580_c0_seq1;GAXK01108307.1;Q6ZMW2;2.16E-23;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp771642_c1_seq1;GAXK01108298.1;O64425;1.13E-08;RMA1_ARATH;E3 ubiquitin-protein ligase RMA1 (EC 2.3.2.27) (Protein RING membrane-anchor 1) (RING-type E3 ubiquitin transferase RMA1);"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0032527; GO:0036513; GO:0044390; GO:0046872; GO:0061630; GO:0071712";"ER-associated misfolded protein catabolic process [GO:0071712]; protein exit from endoplasmic reticulum [GO:0032527]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp77166_c0_seq1;GAXK01092077.1;Q7KRI2;1.25E-33;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7716897_c0_seq1;GAXK01037334.1;P42974;1.06E-47;DHNA_BACSU;NADH dehydrogenase (EC 1.6.99.3) (Alkyl hydroperoxide reductase);"plasma membrane [GO:0005886]; alkyl hydroperoxide reductase activity [GO:0008785]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0003954; GO:0005886; GO:0008785; GO:0009055; GO:0015035; GO:0045454; GO:0050660; GO:0051287";"cell redox homeostasis [GO:0045454]; response to reactive oxygen species [GO:0000302]";plasma membrane [GO:0005886];"alkyl hydroperoxide reductase activity [GO:0008785]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; protein disulfide oxidoreductase activity [GO:0015035]"
comp771697_c0_seq1;GAXK01108261.1;P52746;2.68E-26;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp77171_c2_seq1;GAXK01092500.1;O61585;4.98E-132;KTNB1_STRPU;Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]";"GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007019; GO:0007049; GO:0008017; GO:0008352; GO:0051013; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]";microtubule binding [GO:0008017]
comp771736_c0_seq1;GAXK01108301.1;Q9WTP3;2.89E-07;SPDEF_MOUSE;SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000981; GO:0005634; GO:0006357; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576";"cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp7717477_c0_seq1;GAXK01037337.1;Q9UQE7;1.56E-14;SMC3_HUMAN;Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide) (hCAP);"basement membrane [GO:0005604]; chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; interaction with symbiont [GO:0051702]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of DNA replication [GO:0006275]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"GO:0000278; GO:0000775; GO:0000785; GO:0000800; GO:0003682; GO:0003777; GO:0005524; GO:0005604; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006275; GO:0006281; GO:0007062; GO:0008278; GO:0016363; GO:0019827; GO:0030893; GO:0032876; GO:0034991; GO:0036033; GO:0044791; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0051702; GO:0070840; GO:0097431; GO:1901673";"cell division [GO:0051301]; DNA repair [GO:0006281]; interaction with symbiont [GO:0051702]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of DNA replication [GO:0006275]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]";"basement membrane [GO:0005604]; chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]"
comp7717489_c0_seq1;GAXK01037333.1;Q3SX45;6.71E-08;ASB2_BOVIN;Ankyrin repeat and SOCS box protein 2 (ASB-2);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp77188_c9_seq1;GAXK01092606.1;Q32NH8;2.64E-133;PLCD4_XENLA;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4);"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0007340; GO:0016020; GO:0016042; GO:0035556; GO:0046488";"acrosome reaction [GO:0007340]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]";"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]";"calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]"
comp772086_c0_seq1;GAXK01049511.1;Q9VN12;1.84E-75;NCKXH_DROME;Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp772104_c0_seq1;GAXK01049506.1;P10074;8.76E-09;TZAP_HUMAN;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0000981; GO:0003691; GO:0003700; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp7722769_c0_seq1;GAXK01164483.1;P35316;3.29E-25;ATC_ARTSF;Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump);"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]";"GO:0005388; GO:0005524; GO:0016021; GO:0033017";;"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"
comp7723_c0_seq1;GAXK01100104.1;Q6QEF8;9.15E-171;CORO6_HUMAN;Coronin-6 (Coronin-like protein E) (Clipin-E);"actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477]";"GO:0007015; GO:0016477; GO:0051015";"actin filament organization [GO:0007015]; cell migration [GO:0016477]";;actin filament binding [GO:0051015]
comp7723120_c0_seq1;GAXK01164490.1;Q9BGI3;1.52E-41;PRDX2_BOVIN;Peroxiredoxin-2 (EC 1.11.1.15);"cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";"GO:0000187; GO:0002536; GO:0005829; GO:0006979; GO:0008379; GO:0010310; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0042098; GO:0042744; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001240";"activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]";cytosol [GO:0005829];thioredoxin peroxidase activity [GO:0008379]
comp7723636_c0_seq1;GAXK01164484.1;Q3J170;3.27E-23;RCEH_RHOS4;Reaction center protein H chain (Photosynthetic reaction center H subunit);"integral component of membrane [GO:0016021]; plasma membrane light-harvesting complex [GO:0030077]; plasma membrane-derived chromatophore membrane [GO:0042717]; bacteriochlorophyll binding [GO:0042314]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]; photosynthesis, light reaction [GO:0019684]; protein-chromophore linkage [GO:0018298]";"GO:0016021; GO:0018298; GO:0019684; GO:0030077; GO:0042314; GO:0042717; GO:0045156";"photosynthesis, light reaction [GO:0019684]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane-derived chromatophore membrane [GO:0042717]; plasma membrane light-harvesting complex [GO:0030077]";"bacteriochlorophyll binding [GO:0042314]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]"
comp77238_c0_seq1;GAXK01091981.1;E1C3S7;4.64E-12;TDRD7_CHICK;Tudor domain-containing protein 7;"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"GO:0002089; GO:0003729; GO:0005737; GO:0007283; GO:0010608; GO:0035770; GO:0070306";"lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]";mRNA binding [GO:0003729]
comp772556_c0_seq1;GAXK01049480.1;Q7KRI2;4.96E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7726893_c0_seq1;GAXK01068624.1;Q7LHG5;5.54E-08;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp7726934_c0_seq1;GAXK01068636.1;Q96IR2;1.60E-10;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7727509_c0_seq1;GAXK01068627.1;Q4KTD9;2.75E-52;RS3A_SUBDO;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp7728_c0_seq1;GAXK01100536.1;B0XK69;1.19E-38;SDHF2_CULQU;Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]";"GO:0005739; GO:0005759; GO:0006121; GO:0018293";"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";
comp772832_c0_seq1;GAXK01049495.1;Q9VYB7;1.53E-137;TPST_DROME;Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase) (TPST);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0009306; GO:0016021";"peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp772959_c1_seq1;GAXK01049483.1;O35379;0;MRP1_MOUSE;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"GO:0005324; GO:0005524; GO:0005737; GO:0005774; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0046618; GO:0046624; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215";"cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp7731354_c0_seq1;GAXK01022572.1;A6ZM04;2.33E-14;PIF1_YEAS7;ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (Petite integration frequency protein 1) (Telomere stability protein 1);"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; telomerase inhibitor activity [GO:0010521]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; telomere maintenance [GO:0000723]";"GO:0000002; GO:0000723; GO:0003678; GO:0005524; GO:0005730; GO:0005743; GO:0006281; GO:0006310; GO:0010521; GO:0032211; GO:0051880";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; telomere maintenance [GO:0000723]";"mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; telomerase inhibitor activity [GO:0010521]"
comp7731594_c0_seq1;GAXK01022569.1;O48557;1.10E-47;RL17_MAIZE;60S ribosomal protein L17;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp7731694_c0_seq1;GAXK01022575.1;Q09575;5.01E-08;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp77318_c0_seq1;GAXK01092174.1;Q60LV4;1.19E-25;MYO3_CAEBR;Myosin-3 (Myosin heavy chain A) (MHC A);"A band [GO:0031672]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; locomotory behavior [GO:0007626]";"GO:0003774; GO:0005524; GO:0007626; GO:0031672; GO:0032982; GO:0051015";locomotory behavior [GO:0007626];"A band [GO:0031672]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp7732020_c0_seq1;GAXK01153619.1;Q75HE6;3.86E-51;MTHR_ORYSJ;Probable methylenetetrahydrofolate reductase (EC 1.5.1.20);"cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";"GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949";"methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]";cytosol [GO:0005829];"FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]"
comp7732472_c0_seq1;GAXK01153620.1;Q29458;6.66E-17;LIPG_BOVIN;Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Pregastric esterase) (PGE);"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0016298; GO:0043231; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]";"lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]"
comp773326_c0_seq1;GAXK01049484.1;Q8K1Y2;1.80E-161;KPCD3_MOUSE;Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (nPKC-nu);"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase D signaling [GO:0089700]";"GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0016020; GO:0016301; GO:0046872; GO:0089700";protein kinase D signaling [GO:0089700];"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]"
comp773352_c0_seq1;GAXK01049500.1;Q91502;3.18E-88;SC6A8_TORMA;Creatine transporter;"integral component of membrane [GO:0016021]; neurotransmitter:sodium symporter activity [GO:0005328]";"GO:0005328; GO:0016021";;integral component of membrane [GO:0016021];neurotransmitter:sodium symporter activity [GO:0005328]
comp77336_c0_seq1;GAXK01092302.1;P0DPW5;5.00E-11;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp77343_c0_seq1;GAXK01092170.1;Q969J3;1.66E-25;BORC5_HUMAN;BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein) (Myrlysin);"BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intrinsic component of membrane [GO:0031224]; synaptic vesicle membrane [GO:0030672]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]";"GO:0030672; GO:0031224; GO:0032418; GO:0072384; GO:0098574; GO:0099078; GO:1903744";"lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]";"BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intrinsic component of membrane [GO:0031224]; synaptic vesicle membrane [GO:0030672]";
comp773470_c0_seq1;GAXK01049502.1;Q6PFJ9;8.02E-51;ARI1_DANRE;E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase arih1);"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0032436; GO:0061630; GO:0097413";"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp773521_c0_seq1;GAXK01049498.1;Q14591;1.26E-12;ZN271_HUMAN;Deleted.;;;;;
comp7735389_c0_seq1;GAXK01035677.1;A5F9G0;1.50E-07;IRGA_VIBC3;Iron-regulated outer membrane virulence protein;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]";"GO:0006811; GO:0009279; GO:0009405; GO:0016021; GO:0055072";"ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]";"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";
comp773561_c0_seq1;GAXK01049508.1;Q54U44;1.08E-90;ABCCC_DICDI;ABC transporter C family member 12 (ABC transporter ABCC.12);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp77368_c0_seq1;GAXK01092557.1;P08111;4.03E-68;L2GL_DROME;Lethal(2) giant larvae protein;"apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin binding [GO:0017022]; myosin II binding [GO:0045159]; protein kinase inhibitor activity [GO:0004860]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; actin cytoskeleton organization [GO:0030036]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; cell competition in a multicellular organism [GO:0035212]; chitin-based larval cuticle pattern formation [GO:0035293]; cortical actin cytoskeleton organization [GO:0030866]; dorsal closure [GO:0007391]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization [GO:0045184]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; localization within membrane [GO:0051668]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein kinase activity [GO:0006469]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton organization [GO:0016325]; protein localization to cell cortex [GO:0072697]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of intracellular mRNA localization [GO:1904580]; regulation of Notch signaling pathway [GO:0008593]; salivary gland histolysis [GO:0035070]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; septate junction assembly [GO:0019991]; symmetric cell division [GO:0098725]; synaptic vesicle priming [GO:0016082]";"GO:0000132; GO:0000149; GO:0001738; GO:0004860; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0005938; GO:0006469; GO:0007269; GO:0007314; GO:0007391; GO:0007399; GO:0007406; GO:0007423; GO:0008021; GO:0008360; GO:0008593; GO:0016082; GO:0016323; GO:0016325; GO:0016327; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0016360; GO:0017022; GO:0017137; GO:0019905; GO:0019991; GO:0030036; GO:0030863; GO:0030864; GO:0030866; GO:0031012; GO:0032878; GO:0035070; GO:0035072; GO:0035212; GO:0035293; GO:0045159; GO:0045167; GO:0045175; GO:0045176; GO:0045184; GO:0045196; GO:0045197; GO:0045200; GO:0045571; GO:0045746; GO:0048730; GO:0051294; GO:0051668; GO:0051726; GO:0055059; GO:0072697; GO:0090163; GO:0098725; GO:1904580";"actin cytoskeleton organization [GO:0030036]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; cell competition in a multicellular organism [GO:0035212]; chitin-based larval cuticle pattern formation [GO:0035293]; cortical actin cytoskeleton organization [GO:0030866]; dorsal closure [GO:0007391]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; epidermis morphogenesis [GO:0048730]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization [GO:0045184]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; localization within membrane [GO:0051668]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein kinase activity [GO:0006469]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton organization [GO:0016325]; protein localization to cell cortex [GO:0072697]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of intracellular mRNA localization [GO:1904580]; regulation of Notch signaling pathway [GO:0008593]; salivary gland histolysis [GO:0035070]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; septate junction assembly [GO:0019991]; symmetric cell division [GO:0098725]; synaptic vesicle priming [GO:0016082]";"apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; synaptic vesicle [GO:0008021]";"GTPase activator activity [GO:0005096]; myosin binding [GO:0017022]; myosin II binding [GO:0045159]; protein kinase inhibitor activity [GO:0004860]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp77370_c0_seq1;GAXK01091930.1;P09052;3.48E-39;VASA1_DROME;ATP-dependent RNA helicase vasa (EC 3.6.4.13) (Antigen Mab46F11);"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007275; GO:0007276; GO:0008104; GO:0030154; GO:0043073; GO:0043186; GO:0048477; GO:0061803";"cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; protein localization [GO:0008104]";"cytoplasm [GO:0005737]; germ cell nucleus [GO:0043073]; nucleus [GO:0005634]; P granule [GO:0043186]; posterior cell cortex [GO:0061803]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp774037_c1_seq1;GAXK01110715.1;Q01611;2.44E-13;ZFY1_XENLA;Zinc finger Y-chromosomal protein 1 (ZFY-1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7741_c0_seq1;GAXK01101311.1;B5X4E0;8.32E-103;CALUB_SALSA;Calumenin-B;"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470";;"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]";calcium ion binding [GO:0005509]
comp774451_c0_seq1;GAXK01110794.1;Q24799;4.33E-08;MYPH_ECHGR;Myophilin;;;;;
comp7745121_c0_seq1;GAXK01009990.1;Q62273;3.99E-18;S26A2_MOUSE;Sulfate transporter (Diastrophic dysplasia protein homolog) (ST-OB) (Solute carrier family 26 member 2);"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]; sulfate transport [GO:0008272]";"GO:0001503; GO:0005887; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016324; GO:0019531; GO:0031528; GO:1902358";"ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]; sulfate transport [GO:0008272]";"apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]";"anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp774513_c0_seq1;GAXK01110778.1;Q503V1;3.89E-32;CYBR1_DANRE;Cytochrome b reductase 1 (EC 1.-.-.-);"brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; response to iron ion [GO:0010039]";"GO:0000293; GO:0005765; GO:0010039; GO:0016021; GO:0016491; GO:0031526; GO:0046872";response to iron ion [GO:0010039];"brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]";"ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp774526_c1_seq1;GAXK01110747.1;Q5MYW4;4.71E-22;ZN667_RAT;Zinc finger protein 667 (Myocardial ischemic preconditioning up-regulated protein 1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7746031_c0_seq1;GAXK01075985.1;Q19266;1.80E-40;KPC3_CAEEL;Protein kinase C-like 3 (EC 2.7.11.13) (Atypical protein kinase C-3) (aPKC3);"apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; defense response to fungus [GO:0050832]; embryo development ending in birth or egg hatching [GO:0009792]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein localization [GO:0008104]; response to wounding [GO:0009611]; single fertilization [GO:0007338]";"GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0005938; GO:0007163; GO:0007338; GO:0007369; GO:0007506; GO:0008104; GO:0008406; GO:0009611; GO:0009792; GO:0016020; GO:0016324; GO:0018105; GO:0019904; GO:0030154; GO:0030864; GO:0035556; GO:0046872; GO:0050832";"cell differentiation [GO:0030154]; defense response to fungus [GO:0050832]; embryo development ending in birth or egg hatching [GO:0009792]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein localization [GO:0008104]; response to wounding [GO:0009611]; single fertilization [GO:0007338]";"apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp774637_c0_seq1;GAXK01110729.1;Q7KRI2;2.22E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp774867_c0_seq1;GAXK01110746.1;Q96N38;9.60E-09;ZN714_HUMAN;Zinc finger protein 714;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp774883_c1_seq1;GAXK01110732.1;Q8BGM5;1.11E-71;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp77490_c0_seq1;GAXK01092161.1;Q8VHU4;4.01E-175;ELP1_RAT;Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein);"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activity [GO:0004672]; I-kappaB phosphorylation [GO:0007252]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0004672; GO:0005524; GO:0005737; GO:0006357; GO:0007252; GO:0008023; GO:0008607; GO:0030335; GO:0033588";"I-kappaB phosphorylation [GO:0007252]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]";"ATP binding [GO:0005524]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activity [GO:0004672]"
comp774946_c0_seq1;GAXK01110750.1;Q868T3;4.54E-123;CCAPR_DROME;Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]";"GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990";"ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]"
comp7749642_c0_seq1;GAXK01157447.1;P16423;4.07E-09;POLR_DROME;"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0046872";;;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp77500_c1_seq1;GAXK01092237.1;Q32KI9;1.54E-81;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp775056_c1_seq1;GAXK01110696.1;Q6P418;1.38E-44;REP3A_XENLA;Receptor expression-enhancing protein 3-A;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"GO:0005789; GO:0005874; GO:0006998; GO:0007084; GO:0016021; GO:0051301";"cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]";
comp77507_c0_seq1;GAXK01092348.1;Q6ZM63;1.08E-110;GPN3_DANRE;GPN-loop GTPase 3 (ATP-binding domain 1 family member C);"GTP binding [GO:0005525]; GTPase activity [GO:0003924]";"GO:0003924; GO:0005525";;;"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp7751149_c0_seq1;GAXK01027598.1;P07486;1.76E-50;G3P1_DROME;Glyceraldehyde-3-phosphate dehydrogenase 1 (EC 1.2.1.12) (Glyceraldehyde-3-phosphate dehydrogenase I) (GAPDH I);"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; somatic muscle development [GO:0007525]";"GO:0004365; GO:0005829; GO:0006006; GO:0006096; GO:0007520; GO:0007525; GO:0030018; GO:0031430; GO:0035605; GO:0050661; GO:0051287";"glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; somatic muscle development [GO:0007525]";"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]";"glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]"
comp775153_c0_seq1;GAXK01110783.1;Q9SB68;4.13E-53;ADPRM_ARATH;Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase);"ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; metal ion binding [GO:0046872]";"GO:0046872; GO:0047631; GO:0047734";;;"ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; metal ion binding [GO:0046872]"
comp7751828_c0_seq1;GAXK01027603.1;Q6P8Y1;3.57E-53;CAPSL_MOUSE;Calcyphosin-like protein;"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0005737";;cytoplasm [GO:0005737];calcium ion binding [GO:0005509]
comp7752_c0_seq1;GAXK01100127.1;Q80W54;5.99E-171;FACE1_MOUSE;CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog);"integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription, DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]";"GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0006281; GO:0006325; GO:0006355; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043969; GO:0043979; GO:0044029; GO:0044030; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0048739; GO:0050688; GO:0050905; GO:0051276; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:0090239; GO:1903025; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772";"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription, DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]";"integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]";"double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp77526_c0_seq1;GAXK01091975.1;O94905;2.30E-30;ERLN2_HUMAN;Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; SREBP signaling pathway [GO:0032933]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0008203; GO:0015485; GO:0016021; GO:0030433; GO:0031625; GO:0032933; GO:0032991; GO:0045121; GO:0045541; GO:0045717; GO:0055085";"cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; SREBP signaling pathway [GO:0032933]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp7752647_c0_seq1;GAXK01080566.1;P56333;4.03E-40;IF5A1_SOLTU;Eukaryotic translation initiation factor 5A-1/2 (eIF-5A-1/2) (eIF-4D);"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003743; GO:0003746; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";;"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]"
comp77535_c1_seq1;GAXK01092175.1;Q9VN03;0;SUV3_DROME;ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13);"mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]";"GO:0000963; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005739; GO:0005759; GO:0006401; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222";"DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]";"mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]"
comp7754127_c0_seq1;GAXK01156623.1;Q58010;1.09E-07;ACD_METJA;Acetate--CoA ligase [ADP-forming] (EC 6.2.1.13) (ADP-forming acetyl coenzyme A synthetase) (ACS);"acetate-CoA ligase (ADP-forming) activity [GO:0043758]; ATP binding [GO:0005524]; cofactor binding [GO:0048037]";"GO:0005524; GO:0043758; GO:0048037";;;"acetate-CoA ligase (ADP-forming) activity [GO:0043758]; ATP binding [GO:0005524]; cofactor binding [GO:0048037]"
comp775439_c1_seq1;GAXK01110707.1;P63014;8.36E-34;PRRX1_RAT;Paired mesoderm homeobox protein 1 (Paired-related homeobox protein 1) (PRX-1) (rHox);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron projection regeneration [GO:0070570]; roof of mouth development [GO:0060021]";"GO:0000122; GO:0000978; GO:0001227; GO:0002053; GO:0003713; GO:0005654; GO:0005829; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0045944; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0070570; GO:0071837; GO:0097150";"artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; neuron fate determination [GO:0048664]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron projection regeneration [GO:0070570]; roof of mouth development [GO:0060021]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]"
comp77561_c0_seq1;GAXK01092400.1;Q9VHH9;1.18E-08;JHD1_DROME;JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1);"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544";"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]";"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]";"DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]"
comp7758983_c0_seq1;GAXK01012900.1;O66392;4.25E-23;PHAC_AZOC5;Poly(3-hydroxyalkanoate) polymerase subunit PhaC (PHA polymerase) (EC 2.3.1.-) (PHB synthase subunit PhaC) (Poly(3-hydroxybutyrate) polymerase subunit PhaC) (PHB polymerase) (Poly-beta-hydroxybutyrate polymerase) (Polyhydroxyalkanoic acid synthase subunit PhaC) (PHA synthase);"cytoplasm [GO:0005737]; transferase activity, transferring acyl groups [GO:0016746]; poly-hydroxybutyrate biosynthetic process [GO:0042619]";"GO:0005737; GO:0016746; GO:0042619";poly-hydroxybutyrate biosynthetic process [GO:0042619];cytoplasm [GO:0005737];transferase activity, transferring acyl groups [GO:0016746]
comp77598_c0_seq1;GAXK01092254.1;Q4UMH6;2.07E-14;Y381_RICFE;Putative ankyrin repeat protein RF_0381;guanosine tetraphosphate metabolic process [GO:0015969];GO:0015969;guanosine tetraphosphate metabolic process [GO:0015969];;
comp77607_c0_seq1;GAXK01092495.1;Q6GNG3;2.90E-82;TMX3_XENLA;Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005789; GO:0016021; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";protein disulfide isomerase activity [GO:0003756]
comp77611_c2_seq1;GAXK01091912.1;Q502K1;3.77E-83;EXOG_DANRE;Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; exodeoxyribonuclease activity [GO:0004529]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]";"GO:0000014; GO:0000737; GO:0003676; GO:0004519; GO:0004521; GO:0004529; GO:0005739; GO:0005743; GO:0006309; GO:0008409; GO:0046872";"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; exodeoxyribonuclease activity [GO:0004529]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]"
comp77628_c0_seq1;GAXK01092510.1;Q9H0H0;0;INT2_HUMAN;Integrator complex subunit 2 (Int2);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795";"snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp7763_c0_seq1;GAXK01100816.1;Q6DEB1;0;AT2L1_XENLA;Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1);"mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]";"GO:0005739; GO:0008483; GO:0030170; GO:0050459";;mitochondrion [GO:0005739];"ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]"
comp7764_c1_seq1;GAXK01100261.1;Q20719;8.31E-110;NDUV2_CAEEL;Probable NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2);"mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0005747; GO:0006120; GO:0008137; GO:0046872; GO:0051537";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];mitochondrial respiratory chain complex I [GO:0005747];"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp776431_c1_seq1;GAXK01145419.1;Q1ENI8;8.19E-63;PXDN_CAEEL;Peroxidasin homolog (EC 1.11.1.7);"basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679";"embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]";"basement membrane [GO:0005604]; extracellular space [GO:0005615]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp77654_c0_seq1;GAXK01092015.1;P04920;2.40E-64;B3A2_HUMAN;Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]";"GO:0005452; GO:0005886; GO:0005887; GO:0005925; GO:0006820; GO:0007283; GO:0008509; GO:0015301; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0048565; GO:0051453";"anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]"
comp77660_c0_seq1;GAXK01091928.1;Q8N1M1;3.09E-36;BEST3_HUMAN;Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3);"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]";"GO:0005254; GO:0005886; GO:0034707; GO:0043271";negative regulation of ion transport [GO:0043271];"chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp776699_c0_seq1;GAXK01145395.1;P02550;3.27E-33;TBA1A_PIG;Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";"microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp7768247_c0_seq1;GAXK01159680.1;Q2KI69;3.01E-16;KCIP4_BOVIN;Kv channel-interacting protein 4 (KChIP4);"plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005244; GO:0005267; GO:0005509; GO:0005886; GO:0034765";regulation of ion transmembrane transport [GO:0034765];plasma membrane [GO:0005886];"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]"
comp776938_c0_seq1;GAXK01145390.1;P08548;1.63E-32;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp77698_c0_seq1;GAXK01092318.1;Q96MW5;3.66E-57;COG8_HUMAN;Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]";
comp777_c0_seq1;GAXK01168998.1;Q8K3J1;9.16E-93;NDUS8_MOUSE;NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]";"GO:0005739; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0032981; GO:0046872; GO:0051539";"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]";"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp7770584_c0_seq1;GAXK01055802.1;B9MDD6;3.83E-20;ENGB_ACIET;Probable GTP-binding protein EngB;"GTP binding [GO:0005525]; metal ion binding [GO:0046872]; division septum assembly [GO:0000917]";"GO:0000917; GO:0005525; GO:0046872";division septum assembly [GO:0000917];;"GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp7771_c0_seq1;GAXK01101008.1;Q13435;0;SF3B2_HUMAN;Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (Spliceosome-associated protein 145) (SAP 145);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; viral process [GO:0016032]";"GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016032; GO:0016607; GO:0071005; GO:0071013";"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; viral process [GO:0016032]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]";RNA binding [GO:0003723]
comp77712_c0_seq1;GAXK01092072.1;Q9D8Z1;8.19E-74;ASCC1_MOUSE;Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50);"neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003723; GO:0005634; GO:0005667; GO:0006281; GO:0006355; GO:0016607; GO:0031594";"DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]";"neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";RNA binding [GO:0003723]
comp7771293_c0_seq1;GAXK01055800.1;Q8TE73;1.06E-41;DYH5_HUMAN;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]"
comp7771469_c0_seq1;GAXK01055804.1;A8GII5;9.90E-21;LPLT_SERP5;Lysophospholipid transporter LplT;"integral component of plasma membrane [GO:0005887]; lysophospholipid:sodium symporter activity [GO:0051978]";"GO:0005887; GO:0051978";;integral component of plasma membrane [GO:0005887];lysophospholipid:sodium symporter activity [GO:0051978]
comp77726_c2_seq1;GAXK01092241.1;Q9NH49;1.71E-61;KARG_CALSI;Arginine kinase (AK) (EC 2.7.3.3);"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]";"GO:0004054; GO:0004111; GO:0005524; GO:0046314";phosphocreatine biosynthetic process [GO:0046314];;"arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
comp7773935_c0_seq1;GAXK01190573.1;Q8I7C3;4.21E-19;LASP1_DROME;LIM and SH3 domain protein Lasp;"A band [GO:0031672]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; sperm individualization complex [GO:0070864]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; sperm individualization [GO:0007291]; spermatogenesis [GO:0007283]";"GO:0003779; GO:0005829; GO:0005925; GO:0007279; GO:0007283; GO:0007291; GO:0014881; GO:0030018; GO:0031672; GO:0045214; GO:0045856; GO:0046872; GO:0051015; GO:0070864; GO:0071689";"muscle thin filament assembly [GO:0071689]; pole cell formation [GO:0007279]; positive regulation of pole plasm oskar mRNA localization [GO:0045856]; regulation of myofibril size [GO:0014881]; sarcomere organization [GO:0045214]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]";"A band [GO:0031672]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; sperm individualization complex [GO:0070864]; Z disc [GO:0030018]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp77752_c4_seq1;GAXK01092449.1;Q8TEM1;8.93E-37;PO210_HUMAN;Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa);"endoplasmic reticulum membrane [GO:0005789]; host cell [GO:0043657]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein dimerization activity [GO:0046983]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0005635; GO:0005643; GO:0005789; GO:0006110; GO:0006406; GO:0006409; GO:0016020; GO:0016021; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043657; GO:0046983; GO:0060964; GO:0075733; GO:1900034";"intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"endoplasmic reticulum membrane [GO:0005789]; host cell [GO:0043657]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]";protein dimerization activity [GO:0046983]
comp77770_c0_seq1;GAXK01091950.1;Q8MV48;1.29E-151;GALT7_DROME;N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp777726_c0_seq1;GAXK01145499.1;H3BUK9;1.58E-08;POTB2_HUMAN;POTE ankyrin domain family member B2;;;;;
comp77777_c6_seq1;GAXK01091947.1;Q9V3A6;1.24E-149;ERO1L_DROME;Ero1-like protein (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductin-1-like protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]";"GO:0003756; GO:0005783; GO:0005789; GO:0015035; GO:0016491; GO:0016671; GO:0034975; GO:0051085";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]";"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"
comp777773_c0_seq1;GAXK01145389.1;Q70JS2;1.23E-60;KELC_ANOST;Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp7777866_c0_seq1;GAXK01004766.1;O94889;2.04E-07;KLH18_HUMAN;Kelch-like protein 18;;;;;
comp7778104_c0_seq1;GAXK01157202.1;Q5PGP4;3.96E-10;GSIB_SALPA;Glutathione-binding protein GsiB;"ATP-binding cassette (ABC) transporter complex [GO:0043190]; periplasmic space [GO:0042597]; transmembrane transport [GO:0055085]";"GO:0042597; GO:0043190; GO:0055085";transmembrane transport [GO:0055085];"ATP-binding cassette (ABC) transporter complex [GO:0043190]; periplasmic space [GO:0042597]";
comp7778748_c0_seq1;GAXK01157206.1;O48917;3.88E-17;SQD1_ARATH;UDP-sulfoquinovose synthase, chloroplastic (EC 3.13.1.1) (Sulfite:UDP-glucose sulfotransferase) (Sulfolipid biosynthesis protein);"chloroplast [GO:0009507]; plasma membrane [GO:0005886]; coenzyme binding [GO:0050662]; sulfotransferase activity [GO:0008146]; UDPsulfoquinovose synthase activity [GO:0046507]; zinc ion binding [GO:0008270]; cellular response to phosphate starvation [GO:0016036]; glycolipid biosynthetic process [GO:0009247]";"GO:0005886; GO:0008146; GO:0008270; GO:0009247; GO:0009507; GO:0016036; GO:0046507; GO:0050662";"cellular response to phosphate starvation [GO:0016036]; glycolipid biosynthetic process [GO:0009247]";"chloroplast [GO:0009507]; plasma membrane [GO:0005886]";"coenzyme binding [GO:0050662]; sulfotransferase activity [GO:0008146]; UDPsulfoquinovose synthase activity [GO:0046507]; zinc ion binding [GO:0008270]"
comp7779_c1_seq1;GAXK01101256.1;Q9VSA3;0;ACADM_DROME;Probable medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty acid catabolic process [GO:0051793]";"GO:0003995; GO:0005739; GO:0005759; GO:0006635; GO:0050660; GO:0051793; GO:0070991";"fatty acid beta-oxidation [GO:0006635]; medium-chain fatty acid catabolic process [GO:0051793]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]"
comp7779673_c0_seq1;GAXK01157208.1;Q9D4B2;3.66E-13;TTC25_MOUSE;Tetratricopeptide repeat protein 25 (TPR repeat protein 25);"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"GO:0005737; GO:0005856; GO:0005929";;"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";
comp777996_c0_seq1;GAXK01145526.1;P42787;4.47E-70;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp77807_c0_seq1;GAXK01092350.1;O17444;0;VACHT_DROME;Vesicular acetylcholine transporter (VAChT);"AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; integral component of plasma membrane [GO:0005887]; terminal bouton [GO:0043195]; acetylcholine transmembrane transporter activity [GO:0005277]; xenobiotic transmembrane transporter activity [GO:0042910]";"GO:0005277; GO:0005887; GO:0030121; GO:0030122; GO:0042910; GO:0043195";;"AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; integral component of plasma membrane [GO:0005887]; terminal bouton [GO:0043195]";"acetylcholine transmembrane transporter activity [GO:0005277]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp778170_c0_seq1;GAXK01197720.1;O16025;5.73E-140;AOSL_PLEHO;"Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (EC 4.2.1.92) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]";"GO:0004096; GO:0005506; GO:0005737; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677; GO:0047987";"arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]"
comp778224_c0_seq1;GAXK01197706.1;P0DPW5;4.55E-07;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp7782270_c0_seq1;GAXK01174439.1;O89094;4.22E-10;CASPE_MOUSE;"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008233; GO:0008630; GO:0045095; GO:0070268; GO:0097153";"apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]"
comp77825_c2_seq1;GAXK01092265.1;O13157;3.92E-12;GFRA2_CHICK;GDNF family receptor alpha-2 (GDNF receptor alpha-2) (GDNFR-alpha-2) (GFR-alpha-2) (GDNF receptor beta) (GDNFR-beta) (Neurturin receptor alpha) (NRTNR-alpha) (NTNR-alpha);"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; nervous system development [GO:0007399]";"GO:0007399; GO:0009897; GO:0016167; GO:0031225; GO:0043235";nervous system development [GO:0007399];"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235]";glial cell-derived neurotrophic factor receptor activity [GO:0016167]
comp778252_c1_seq1;GAXK01197689.1;P91766;8.70E-179;ACH1_MANSE;Acetylcholine receptor subunit alpha-like (MARA1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]";"GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211";;"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp7783517_c0_seq1;GAXK01174451.1;Q96JL9;1.82E-13;ZN333_HUMAN;Zinc finger protein 333;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7784_c0_seq1;GAXK01100458.1;A7RRJ0;0;FEN1_NEMVE;Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1);"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]";"GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137; GO:0048256";"base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]";"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp7785807_c0_seq1;GAXK01141795.1;P36182;2.70E-55;HSP82_TOBAC;Heat shock protein 82 (Fragment);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005737; GO:0006457; GO:0051082";protein folding [GO:0006457];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp7786172_c0_seq1;GAXK01123525.1;A4G2T5;1.12E-35;RS16_HERAR;30S ribosomal protein S16;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp778928_c0_seq1;GAXK01197718.1;P10076;3.84E-24;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp779025_c1_seq1;GAXK01197693.1;Q9Y3Q0;1.06E-158;NALD2_HUMAN;N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]";"GO:0004180; GO:0005886; GO:0006508; GO:0008236; GO:0008237; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129";"cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]"
comp7790727_c0_seq1;GAXK01062836.1;Q4KTE2;1.08E-75;RSSA_SUBDO;40S ribosomal protein SA;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0006412; GO:0022627";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp7791647_c0_seq1;GAXK01062839.1;Q9VXD9;6.62E-11;MTH1_DROME;Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252";"actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp779272_c1_seq1;GAXK01197710.1;A4IFG2;1.11E-13;BTBD9_BOVIN;BTB/POZ domain-containing protein 9;"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";"GO:0008344; GO:0048512";"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]";;
comp779427_c0_seq1;GAXK01197713.1;Q2PYN8;1.59E-30;LBX1_XENLA;Transcription factor LBX1 (Ladybird homeobox protein homolog 1);"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007517; GO:0030154; GO:0043565; GO:0051450";"cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp7794811_c0_seq1;GAXK01099466.1;P81549;2.06E-09;BFRD_BORPE;Probable TonB-dependent receptor BfrD (Virulence-associated outer membrane protein Vir-90);"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; siderophore uptake transmembrane transporter activity [GO:0015344]; signaling receptor activity [GO:0038023]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]";"GO:0009279; GO:0009405; GO:0015344; GO:0016021; GO:0038023; GO:0055072";"iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]";"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";"siderophore uptake transmembrane transporter activity [GO:0015344]; signaling receptor activity [GO:0038023]"
comp7795077_c0_seq1;GAXK01099457.1;Q9TUG3;7.70E-21;HSP72_CAPHI;Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 3) (HSP70.3);"CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; response to cold [GO:0009409]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]";"GO:0005524; GO:0005737; GO:0007283; GO:0009408; GO:0009409; GO:0030154; GO:0036128; GO:0072687";"cell differentiation [GO:0030154]; response to cold [GO:0009409]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]";"CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]";ATP binding [GO:0005524]
comp7796183_c0_seq1;GAXK01118600.1;B2T1M5;2.24E-39;GATB_PARPJ;Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B (Asp/Glu-ADT subunit B) (EC 6.3.5.-);"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; translation [GO:0006412]";"GO:0005524; GO:0006412; GO:0050567";translation [GO:0006412];;"ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]"
comp77963_c1_seq1;GAXK01091951.1;G5EBI4;1.03E-62;CEEH1_CAEEL;Epoxide hydrolase 1 (EC 3.3.2.10);"integral component of membrane [GO:0016021]; epoxide hydrolase activity [GO:0004301]; cellular lipid metabolic process [GO:0044255]";"GO:0004301; GO:0016021; GO:0044255";cellular lipid metabolic process [GO:0044255];integral component of membrane [GO:0016021];epoxide hydrolase activity [GO:0004301]
comp779641_c0_seq1;GAXK01197714.1;B2FQP3;1.16E-16;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp77972_c3_seq1;GAXK01091932.1;P15364;2.96E-28;AMAL_DROME;Protein amalgam;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";"GO:0005886; GO:0031225";;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp77976_c1_seq1;GAXK01092444.1;Q7KRI2;5.18E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7798664_c0_seq1;GAXK01086316.1;Q7TXJ4;2.65E-35;RNTF_MYCBO;PGL/p-HBAD biosynthesis rhamnosyltransferase (EC 2.4.1.-);transferase activity, transferring hexosyl groups [GO:0016758];GO:0016758;;;transferase activity, transferring hexosyl groups [GO:0016758]
comp77991_c0_seq1;GAXK01092050.1;Q5E9N9;3.76E-108;APEX2_BOVIN;DNA-(apurinic or apyrimidinic site) lyase 2 (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]";"GO:0003677; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008270; GO:0008311; GO:0140078";"base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]"
comp7799582_c0_seq1;GAXK01086319.1;P20825;1.05E-07;POL2_DROME;"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074";DNA integration [GO:0015074];;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp78_c0_seq1;GAXK01169007.1;Q4LAY1;1.99E-28;RS29_SCALT;40S ribosomal protein S29;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0008270; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";"structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]"
comp780019_c0_seq1;GAXK01039127.1;Q9W0T5;3.92E-09;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp78005_c0_seq1;GAXK01085558.1;Q9ULK4;0;MED23_HUMAN;Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130);"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003713; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592";"positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]";transcription coactivator activity [GO:0003713]
comp780131_c0_seq1;GAXK01039091.1;Q8L7L1;5.40E-42;SPHK1_ARATH;Sphingosine kinase 1 (EC 2.7.1.91);"plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]; cellular response to abscisic acid stimulus [GO:0071215]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]";"GO:0003951; GO:0005524; GO:0005773; GO:0006665; GO:0008481; GO:0009705; GO:0009737; GO:0009845; GO:0017050; GO:0071215";"cellular response to abscisic acid stimulus [GO:0071215]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]";"plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]";"ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]"
comp780147_c0_seq1;GAXK01039076.1;P40859;7.28E-08;MSOX_BACB0;Monomeric sarcosine oxidase (MSOX) (EC 1.5.3.1);"cytoplasm [GO:0005737]; sarcosine oxidase activity [GO:0008115]; tetrahydrofolate metabolic process [GO:0046653]";"GO:0005737; GO:0008115; GO:0046653";tetrahydrofolate metabolic process [GO:0046653];cytoplasm [GO:0005737];sarcosine oxidase activity [GO:0008115]
comp7801677_c0_seq1;GAXK01087439.1;Q84K47;2.44E-33;AB2A_ARATH;ABC transporter A family member 2 (ABC transporter ABCA.2) (AtABCA2) (ABC2 homolog 1);"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]";"GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231";lipid transport [GO:0006869];"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]"
comp78033_c2_seq1;GAXK01085480.1;Q28D99;2.22E-149;GADL1_XENTR;Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1) (Fragment);"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]";"GO:0004068; GO:0004782; GO:0019752; GO:0030170";carboxylic acid metabolic process [GO:0019752];;"aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]"
comp7803717_c0_seq1;GAXK01104256.1;A2SLF1;1.40E-45;RS3_METPP;30S ribosomal protein S3;"small ribosomal subunit [GO:0015935]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0006412; GO:0015935; GO:0019843";translation [GO:0006412];small ribosomal subunit [GO:0015935];"mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp780431_c0_seq1;GAXK01039098.1;Q9NR45;3.51E-52;SIAS_HUMAN;Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]";"GO:0005737; GO:0005829; GO:0006055; GO:0008781; GO:0016051; GO:0047444; GO:0050462; GO:0070062";"carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]"
comp780461_c1_seq1;GAXK01039093.1;Q7KRI2;1.16E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7805707_c0_seq1;GAXK01131042.1;Q00246;4.25E-09;RHO4_YEAST;GTP-binding protein RHO4;"cell cortex [GO:0005938]; cell division site [GO:0032153]; cell periphery [GO:0071944]; cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; incipient cellular bud site [GO:0000131]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; maintenance of cell polarity [GO:0030011]; positive regulation of formin-nucleated actin cable assembly [GO:0090338]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of formin-nucleated actin cable assembly [GO:0090337]; Rho protein signal transduction [GO:0007266]";"GO:0000131; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005886; GO:0005935; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0019901; GO:0030011; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017; GO:0071944; GO:0090337; GO:0090338";"actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; maintenance of cell polarity [GO:0030011]; positive regulation of formin-nucleated actin cable assembly [GO:0090338]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of formin-nucleated actin cable assembly [GO:0090337]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell division site [GO:0032153]; cell periphery [GO:0071944]; cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; incipient cellular bud site [GO:0000131]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp780577_c0_seq1;GAXK01039088.1;Q86YE8;1.24E-08;ZN573_HUMAN;Zinc finger protein 573;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7807369_c0_seq1;GAXK01115218.1;Q21565;2.25E-10;AMT3_CAEEL;Putative ammonium transporter 3;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp780833_c0_seq1;GAXK01039116.1;Q6ZN57;2.82E-39;ZFP2_HUMAN;Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7808600_c0_seq1;GAXK01062226.1;Q8TE57;4.95E-07;ATS16_HUMAN;A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]";"GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017";"branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp780862_c0_seq1;GAXK01039115.1;Q03720;9.04E-52;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp780888_c2_seq1;GAXK01039105.1;Q27367;7.23E-27;CRQ_DROME;Protein croquemort (d-CD36);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"GO:0002433; GO:0005044; GO:0005886; GO:0006909; GO:0006911; GO:0006915; GO:0006955; GO:0016021; GO:0042116; GO:0048102; GO:0050764; GO:0090382";"apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; immune response [GO:0006955]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; phagosome maturation [GO:0090382]; regulation of phagocytosis [GO:0050764]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";scavenger receptor activity [GO:0005044]
comp7809_c0_seq1;GAXK01100251.1;P12075;1.51E-11;COX5B_RAT;Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb) (Cytochrome c oxidase subunit VIA*);"mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; response to hormone [GO:0009725]; response to peptide hormone [GO:0043434]";"GO:0004129; GO:0005743; GO:0006123; GO:0009725; GO:0042776; GO:0043434; GO:0046872";"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; response to hormone [GO:0009725]; response to peptide hormone [GO:0043434]";mitochondrial inner membrane [GO:0005743];"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp78114_c0_seq1;GAXK01085557.1;Q964R0;2.81E-70;CP6K1_BLAGE;Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp781442_c0_seq1;GAXK01039124.1;Q95LI3;6.03E-20;ZFY_BOVIN;Zinc finger Y-chromosomal protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp781557_c0_seq1;GAXK01039075.1;Q6XPS3;1.65E-64;TPTE2_HUMAN;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]";"GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314";phosphatidylinositol biosynthetic process [GO:0006661];"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp78166_c0_seq1;GAXK01085460.1;P70110;2.77E-28;CD36_MESAU;Platelet glycoprotein 4 (Glycoprotein IIIb) (GPIIIB) (PAS IV) (PAS-4) (Platelet glycoprotein IV) (GPIV) (CD antigen CD36);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; amyloid fibril formation [GO:1990000]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol import [GO:0070508]; energy homeostasis [GO:0097009]; immune response [GO:0006955]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; long-chain fatty acid import into cell [GO:0044539]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; receptor internalization [GO:0031623]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; sensory perception of taste [GO:0050909]; triglyceride transport [GO:0034197]";"GO:0005794; GO:0006955; GO:0007155; GO:0007166; GO:0007204; GO:0016020; GO:0016021; GO:0016324; GO:0030299; GO:0031526; GO:0031623; GO:0033993; GO:0034197; GO:0044539; GO:0045121; GO:0050702; GO:0050892; GO:0050909; GO:0070374; GO:0070508; GO:0070542; GO:0070543; GO:0071404; GO:0071726; GO:0097009; GO:1900227; GO:1990000";"amyloid fibril formation [GO:1990000]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol import [GO:0070508]; energy homeostasis [GO:0097009]; immune response [GO:0006955]; interleukin-1 beta secretion [GO:0050702]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; long-chain fatty acid import into cell [GO:0044539]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; receptor internalization [GO:0031623]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; sensory perception of taste [GO:0050909]; triglyceride transport [GO:0034197]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]";
comp7817058_c0_seq1;GAXK01155377.1;O73888;2.34E-16;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp781868_c0_seq1;GAXK01039122.1;Q8IUS5;1.03E-17;EPHX4_HUMAN;Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein);"integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]";"GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];hydrolase activity [GO:0016787]
comp781936_c0_seq1;GAXK01039090.1;Q6P2X9;5.10E-39;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp7819554_c0_seq1;GAXK01062461.1;Q8I7P9;1.04E-10;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp78198_c0_seq1;GAXK01085960.1;O18638;2.47E-41;OAF_DROVI;Out at first protein;multicellular organism development [GO:0007275];GO:0007275;multicellular organism development [GO:0007275];;
comp7820178_c0_seq1;GAXK01045137.1;P05661;5.85E-44;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp7821475_c0_seq1;GAXK01045127.1;Q8I7P9;2.05E-09;POL5_DROME;"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";"GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074";"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]";nucleus [GO:0005634];"endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]"
comp78216_c0_seq1;GAXK01085429.1;A0JM59;4.56E-15;UBP20_XENTR;Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0036459; GO:0048471; GO:0070536; GO:0071108";"endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]"
comp782232_c0_seq1;GAXK01061132.1;Q6YCH1;3.92E-16;TDPZ5_MOUSE;TD and POZ domain-containing protein 5;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp782295_c1_seq1;GAXK01061137.1;Q26261;4.97E-11;UNC5_CAEEL;Netrin receptor unc-5 (Uncoordinated protein 5);"integral component of plasma membrane [GO:0005887]; netrin receptor activity [GO:0005042]; protein tyrosine kinase binding [GO:1990782]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral axon guidance [GO:0033563]; gonad morphogenesis [GO:0035262]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; positive regulation of anterior/posterior axon guidance [GO:1905488]; positive regulation of axon extension [GO:0045773]; positive regulation of locomotion [GO:0040017]; ventral cord development [GO:0007419]";"GO:0005042; GO:0005887; GO:0007419; GO:0008045; GO:0008078; GO:0033563; GO:0035262; GO:0038007; GO:0040017; GO:0045138; GO:0045773; GO:0071679; GO:1905488; GO:1990782";"commissural neuron axon guidance [GO:0071679]; dorsal/ventral axon guidance [GO:0033563]; gonad morphogenesis [GO:0035262]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; positive regulation of anterior/posterior axon guidance [GO:1905488]; positive regulation of axon extension [GO:0045773]; positive regulation of locomotion [GO:0040017]; ventral cord development [GO:0007419]";integral component of plasma membrane [GO:0005887];"netrin receptor activity [GO:0005042]; protein tyrosine kinase binding [GO:1990782]"
comp7822951_c0_seq1;GAXK01077024.1;Q8YFI5;1.92E-27;NHAA_BRUME;Na(+)/H(+) antiporter NhaA (Sodium/proton antiporter NhaA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]; regulation of pH [GO:0006885]";"GO:0005886; GO:0006885; GO:0008233; GO:0015081; GO:0015297; GO:0016021";regulation of pH [GO:0006885];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]"
comp7823885_c0_seq1;GAXK01077023.1;Q127X9;1.75E-29;NUOH_POLSJ;NADH-quinone oxidoreductase subunit H (EC 7.1.1.-) (NADH dehydrogenase I subunit H) (NDH-1 subunit H);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; quinone binding [GO:0048038]";"GO:0005886; GO:0016021; GO:0016655; GO:0048038";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; quinone binding [GO:0048038]"
comp782397_c0_seq1;GAXK01061136.1;B8VIW9;3.07E-15;FP_ACRMI;Fibronectin type III domain-containing protein (Neuroglian-like protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp782412_c0_seq1;GAXK01061145.1;Q17328;4.67E-12;GLUCB_CAEEL;Glutamate-gated chloride channel subunit beta (Glu-Cl subunit beta) (Avermectin-sensitive glutamate-gated chloride channel subunit);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp78245_c1_seq1;GAXK01085814.1;P18726;1.30E-10;ZG5A_XENLA;Gastrula zinc finger protein XlCGF51.1A (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7825868_c0_seq1;GAXK01010846.1;P42593;2.46E-40;FADH_ECOLI;2,4-dienoyl-CoA reductase (DCR) (EC 1.3.1.34) (2,4-dienoyl-coenzyme A reductase [NADPH]);"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FAD binding [GO:0071949]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway [GO:0033543]";"GO:0008670; GO:0010181; GO:0033543; GO:0046872; GO:0051539; GO:0071949";fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway [GO:0033543];;"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FAD binding [GO:0071949]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]"
comp782611_c2_seq1;GAXK01061168.1;Q08DG8;2.57E-27;ZN135_BOVIN;Zinc finger protein 135;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0007010; GO:0022604; GO:0046872";"cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp78284_c0_seq1;GAXK01086074.1;Q5ND52;3.62E-31;MRM3_MOUSE;rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1);"mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]";"GO:0003723; GO:0005739; GO:0070039";;mitochondrion [GO:0005739];"RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]"
comp782895_c0_seq1;GAXK01061127.1;Q09388;1.36E-53;ACM2_CAEEL;Muscarinic acetylcholine receptor gar-2 (G-protein-linked acetylcholine receptor 2);"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004930; GO:0004993; GO:0005887; GO:0007186; GO:0007187; GO:0007213; GO:0007268; GO:0007271; GO:0016907; GO:0030424; GO:0030425; GO:0030594; GO:0032223; GO:0042493";"chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]";"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]";"G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]"
comp782896_c0_seq1;GAXK01061121.1;Q9UL36;1.79E-08;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp7828985_c0_seq1;GAXK01120447.1;P85828;2.65E-14;PROH3_APIME;Prohormone-3 [Cleaved into: Brain peptide ITGQGNRIF];integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp7829_c6_seq1;GAXK01100547.1;P20483;6.63E-44;MPIP_DROME;M-phase inducer phosphatase (EC 3.1.3.48) (Cdc25-like protein) (Protein string);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; G2/M transition of mitotic cell cycle [GO:0000086]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; histoblast morphogenesis [GO:0007488]; negative regulation of cell size [GO:0045792]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; protein dephosphorylation [GO:0006470]; regulation of cell diameter [GO:0060305]; regulation of mitotic cell cycle [GO:0007346]";"GO:0000086; GO:0004725; GO:0005634; GO:0005694; GO:0005737; GO:0006470; GO:0007030; GO:0007099; GO:0007346; GO:0007369; GO:0007488; GO:0008283; GO:0008284; GO:0010971; GO:0045792; GO:0045930; GO:0045931; GO:0045977; GO:0051301; GO:0060305; GO:0110032";"cell division [GO:0051301]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; G2/M transition of mitotic cell cycle [GO:0000086]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; histoblast morphogenesis [GO:0007488]; negative regulation of cell size [GO:0045792]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; protein dephosphorylation [GO:0006470]; regulation of cell diameter [GO:0060305]; regulation of mitotic cell cycle [GO:0007346]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein tyrosine phosphatase activity [GO:0004725]
comp7830_c2_seq1;GAXK01101112.1;Q4R550;0;SYCC_MACFA;Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]";"GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872";cysteinyl-tRNA aminoacylation [GO:0006423];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]"
comp783134_c0_seq1;GAXK01061142.1;Q26366;1.99E-14;VG_DROME;Protein vestigial;"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compound eye morphogenesis [GO:0001745]; determination of muscle attachment site [GO:0016204]; DNA replication [GO:0006260]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; haltere development [GO:0007482]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of mitotic cell cycle [GO:0007346]; somatic muscle development [GO:0007525]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc proximal/distal pattern formation [GO:0007473]";"GO:0001745; GO:0003677; GO:0005634; GO:0006260; GO:0007049; GO:0007346; GO:0007451; GO:0007472; GO:0007473; GO:0007476; GO:0007480; GO:0007482; GO:0007525; GO:0008022; GO:0016204; GO:0035220; GO:0042127; GO:0044719; GO:0045944; GO:0048190; GO:0090254";"cell cycle [GO:0007049]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compound eye morphogenesis [GO:0001745]; determination of muscle attachment site [GO:0016204]; DNA replication [GO:0006260]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; haltere development [GO:0007482]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of mitotic cell cycle [GO:0007346]; somatic muscle development [GO:0007525]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc morphogenesis [GO:0007472]; wing disc proximal/distal pattern formation [GO:0007473]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]"
comp7831815_c0_seq1;GAXK01015004.1;Q06572;1.54E-32;AVP_HORVU;Pyrophosphate-energized vacuolar membrane proton pump (EC 7.1.3.1) (Pyrophosphate-energized inorganic pyrophosphatase) (H(+)-PPase);"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]";"GO:0004427; GO:0005774; GO:0009678; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]";"inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"
comp783456_c0_seq1;GAXK01061166.1;Q09927;4.75E-32;ACA1_SCHPO;N-acetyltransferase aca1 (EC 2.3.1.271) ((S)-1-pyrroline-5-carboxylate acetyltransferase) (L-azetidine-2-carboxylate acetyltransferase) (AZC acetyltransferase);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; azetidine-2-carboxylic acid acetyltransferase activity [GO:0046941]; arginine biosynthetic process [GO:0006526]; proline catabolic process [GO:0006562]";"GO:0005634; GO:0005739; GO:0005829; GO:0006526; GO:0006562; GO:0046941";"arginine biosynthetic process [GO:0006526]; proline catabolic process [GO:0006562]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";azetidine-2-carboxylic acid acetyltransferase activity [GO:0046941]
comp78358_c0_seq1;GAXK01085433.1;P59110;1.95E-55;SENP1_MOUSE;Sentrin-specific protease 1 (EC 3.4.22.-) (SUMO-1 protease 2) (SuPr-2) (Sentrin/SUMO-specific protease SENP1);"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"GO:0005634; GO:0005737; GO:0005925; GO:0006919; GO:0007275; GO:0010724; GO:0016926; GO:0031965; GO:0032435; GO:0045944; GO:0070140; GO:0097190";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; regulation of definitive erythrocyte differentiation [GO:0010724]";"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";SUMO-specific isopeptidase activity [GO:0070140]
comp783713_c0_seq1;GAXK01061120.1;Q7KRI2;1.02E-30;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp78372_c0_seq1;GAXK01085734.1;Q56NL1;6.94E-179;ACE2_PAGLA;Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) [Cleaved into: Processed angiotensin-converting enzyme 2];"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]";"GO:0001618; GO:0004180; GO:0005576; GO:0005737; GO:0005886; GO:0008237; GO:0008241; GO:0009986; GO:0016021; GO:0046872";;"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]"
comp78380_c1_seq1;GAXK01086075.1;Q7Z6E9;4.68E-50;RBBP6_HUMAN;E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis);"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0001701; GO:0003723; GO:0004842; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]";"protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7839_c3_seq1;GAXK01100700.1;P51958;1.52E-161;CDK1_CARAU;Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase);"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0007049; GO:0008353; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp7840_c1_seq1;GAXK01100248.1;O75112;2.18E-11;LDB3_HUMAN;LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein);"cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]";"GO:0001725; GO:0003779; GO:0005080; GO:0005856; GO:0005913; GO:0007507; GO:0008092; GO:0030018; GO:0030036; GO:0031143; GO:0031941; GO:0045214; GO:0046872; GO:0048471; GO:0051371; GO:0061061";"actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]";"cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]";"actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]"
comp78400_c0_seq1;GAXK01085562.1;Q86XE5;5.19E-119;HOGA1_HUMAN;4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase) (Protein 569272);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; protein homodimerization activity [GO:0042803]; 4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866]";"GO:0005739; GO:0005759; GO:0008700; GO:0009436; GO:0019470; GO:0033609; GO:0042803; GO:0042866; GO:0046487";"4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; protein homodimerization activity [GO:0042803]"
comp7840150_c0_seq1;GAXK01000619.1;P0AE47;7.52E-45;YTFL_ECO57;UPF0053 inner membrane protein YtfL;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]";"GO:0005886; GO:0016021; GO:0050660";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";flavin adenine dinucleotide binding [GO:0050660]
comp784041_c0_seq1;GAXK01162862.1;Q9XZP2;8.61E-19;CALM2_BRAFL;Calmodulin-2 (CaM 2);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp7840698_c0_seq1;GAXK01000624.1;Q9C912;3.95E-24;R35A3_ARATH;60S ribosomal protein L35a-3;"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005739; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]";structural constituent of ribosome [GO:0003735]
comp7841724_c0_seq1;GAXK01000612.1;Q9HGT6;2.00E-10;SYSC_CANAL;Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";"GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0097056";"selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]"
comp7841892_c0_seq1;GAXK01000614.1;P64760;3.45E-35;Y930_MYCBO;Uncharacterized protein Mb0930;"N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0070290";;;"N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]"
comp7841983_c0_seq1;GAXK01000615.1;B1Y8I0;2.72E-68;RL16_LEPCP;50S ribosomal protein L16;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]";"GO:0000049; GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]"
comp78427_c0_seq1;GAXK01085405.1;Q8K0C9;0;GMDS_MOUSE;GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD);"cytoplasm [GO:0005737]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]";"GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401";"'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]";cytoplasm [GO:0005737];"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"
comp78440_c0_seq1;GAXK01085933.1;Q26474;3.45E-84;LACH_SCHAM;Lachesin;"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]";"GO:0005886; GO:0007155; GO:0031225";cell adhesion [GO:0007155];"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]";
comp784473_c0_seq1;GAXK01162852.1;A1L272;4.95E-46;S29A4_DANRE;Equilibrative nucleoside transporter 4 (Solute carrier family 29 member 4);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monoamine transmembrane transporter activity [GO:0008504]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005886; GO:0008504; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"monoamine transmembrane transporter activity [GO:0008504]; nucleoside transmembrane transporter activity [GO:0005337]"
comp78449_c0_seq1;GAXK01085323.1;Q6P828;8.83E-12;LITAF_XENTR;Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog);"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0000139; GO:0003677; GO:0005634; GO:0008270; GO:0009898; GO:0098559; GO:0098560; GO:0098574";;"cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp7844941_c0_seq1;GAXK01084356.1;O32271;8.68E-41;TUAD_BACSU;UDP-glucose 6-dehydrogenase TuaD (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Teichuronic acid biosynthesis protein TuaD);"cytoplasm [GO:0005737]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; cell wall organization [GO:0071555]; polysaccharide biosynthetic process [GO:0000271]; UDP-glucuronate biosynthetic process [GO:0006065]";"GO:0000271; GO:0003979; GO:0005737; GO:0006065; GO:0051287; GO:0071555";"cell wall organization [GO:0071555]; polysaccharide biosynthetic process [GO:0000271]; UDP-glucuronate biosynthetic process [GO:0006065]";cytoplasm [GO:0005737];"NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]"
comp7845451_c0_seq1;GAXK01084354.1;P69680;1.21E-22;AMTB_ECO57;Ammonia channel (Ammonia transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]";"GO:0005886; GO:0008519; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ammonium transmembrane transporter activity [GO:0008519]
comp784610_c0_seq1;GAXK01162831.1;O60906;8.14E-13;NSMA_HUMAN;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase);"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"GO:0004767; GO:0005886; GO:0005887; GO:0005901; GO:0006684; GO:0006685; GO:0006687; GO:0009612; GO:0035556; GO:0046513; GO:0046872; GO:2000304";"ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; intracellular signal transduction [GO:0035556]; positive regulation of ceramide biosynthetic process [GO:2000304]; response to mechanical stimulus [GO:0009612]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]";"caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp78463_c2_seq1;GAXK01085754.1;P51123;0;TAF1_DROME;Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (TAFII250) (TBP-associated factor 230 kDa) (p230) (Transcription initiation factor TFIID 230 kDa subunit) (TAFII-230);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H3-K14 specific) [GO:0036408]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; DNA-templated transcription, initiation [GO:0006352]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006352; GO:0006367; GO:0006468; GO:0007049; GO:0008134; GO:0010485; GO:0017025; GO:0035102; GO:0036408; GO:0043565; GO:0043967; GO:0044154; GO:0045944; GO:0051123; GO:0060261";"cell cycle [GO:0007049]; DNA-templated transcription, initiation [GO:0006352]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; transcription factor TFIID complex [GO:0005669]";"ATP binding [GO:0005524]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H3-K14 specific) [GO:0036408]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"
comp784683_c2_seq1;GAXK01162861.1;Q2KI24;1.79E-56;MTHSD_BOVIN;Methenyltetrahydrofolate synthase domain-containing protein;"cytoplasm [GO:0005737]; RNA binding [GO:0003723]";"GO:0003723; GO:0005737";;cytoplasm [GO:0005737];RNA binding [GO:0003723]
comp78469_c0_seq1;GAXK01205420.1;Q3T149;1.11E-18;HSPB1_BOVIN;Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27);"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]";"GO:0001932; GO:0005080; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0008426; GO:0009615; GO:0030018; GO:0032731; GO:0035556; GO:0038033; GO:0042535; GO:0042802; GO:0042803; GO:0043122; GO:0043536; GO:0044183; GO:0045766; GO:0061077; GO:0099641; GO:1902176; GO:1904115";"anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]";"axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; Z disc [GO:0030018]";"identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]"
comp7847261_c0_seq1;GAXK01123090.1;Q9VUL9;1.31E-18;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp78475_c3_seq1;GAXK01085425.1;Q803C9;1.98E-151;PTSS1_DANRE;Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]";"GO:0005789; GO:0006659; GO:0016021; GO:0016740";phosphatidylserine biosynthetic process [GO:0006659];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";transferase activity [GO:0016740]
comp7847675_c0_seq1;GAXK01123092.1;Q9NBX4;6.59E-12;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp78486_c0_seq1;GAXK01085452.1;Q9BWX1;1.17E-29;PHF7_HUMAN;PHD finger protein 7 (Testis development protein NYD-SP6);"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]";"GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872";;"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";metal ion binding [GO:0046872]
comp7848654_c0_seq1;GAXK01176818.1;Q55434;5.88E-29;PHY2_SYNY3;Phytochrome-like protein cph2 (Bacteriophytochrome cph2);"red or far-red light photoreceptor activity [GO:0009883]; detection of visible light [GO:0009584]; protein-chromophore linkage [GO:0018298]; red, far-red light phototransduction [GO:0009585]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0006355; GO:0009584; GO:0009585; GO:0009883; GO:0018298";"detection of visible light [GO:0009584]; protein-chromophore linkage [GO:0018298]; red, far-red light phototransduction [GO:0009585]; regulation of transcription, DNA-templated [GO:0006355]";;red or far-red light photoreceptor activity [GO:0009883]
comp784910_c0_seq1;GAXK01162833.1;P19019;5.41E-40;GBRB3_CHICK;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007605; GO:0022851; GO:0030054; GO:0030659; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043524; GO:0045202; GO:0045211; GO:0050877; GO:0060021; GO:0060080; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098982; GO:1902711; GO:1904315; GO:1904862";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp784995_c0_seq1;GAXK01162868.1;P27165;3.89E-100;CALM_PHYIN;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp785118_c3_seq1;GAXK01162892.1;Q8WVM7;0;STAG1_HUMAN;Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1);"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; cell division [GO:0051301]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]";"GO:0000775; GO:0000785; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0097431; GO:1901673";"cell division [GO:0051301]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]";"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]"
comp78514_c0_seq1;GAXK01085795.1;Q9DAZ9;1.09E-36;ANCHR_MOUSE;Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19);"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]";"GO:0005737; GO:0005813; GO:0009838; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0046872; GO:0051301; GO:0090543";"abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]";"centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]";"metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp7852309_c0_seq1;GAXK01128880.1;Q9LRB8;2.59E-08;RL36_ULVCO;60S ribosomal protein L36;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7855461_c0_seq1;GAXK01195730.1;Q9SF40;1.08E-24;RL4A_ARATH;60S ribosomal protein L4-1 (L1);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp78557_c4_seq1;GAXK01085475.1;Q61194;0;P3C2A_MOUSE;Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Cpk-m) (Phosphoinositide 3-kinase-C2-alpha) (p170);"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; macroautophagy [GO:0016236]; negative regulation of zinc ion transmembrane transport [GO:0071583]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]";"GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005942; GO:0006887; GO:0006897; GO:0009267; GO:0014065; GO:0016020; GO:0016236; GO:0016303; GO:0016477; GO:0030136; GO:0031982; GO:0035005; GO:0035091; GO:0036092; GO:0046854; GO:0048015; GO:0071583; GO:0090050; GO:1905037";"autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; macroautophagy [GO:0016236]; negative regulation of zinc ion transmembrane transport [GO:0071583]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]";"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]"
comp7855785_c0_seq1;GAXK01195727.1;Q5BL35;5.06E-09;SPOLA_DANRE;Speckle-type POZ protein-like A (HIB homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp78584_c0_seq1;GAXK01085961.1;P15624;3.28E-16;SYFB_YEAST;Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS);"cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]";"GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328";phenylalanyl-tRNA aminoacylation [GO:0006432];"cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]"
comp78599_c1_seq1;GAXK01085423.1;P40855;1.40E-27;PEX19_HUMAN;Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein);"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085]";"GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016021; GO:0016557; GO:0016559; GO:0031526; GO:0032991; GO:0036105; GO:0045046; GO:0047485; GO:0050821; GO:0051117; GO:0055085; GO:0061077; GO:0072321; GO:0072663; GO:1900131";"chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085]";"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]";"ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]"
comp7860_c1_seq1;GAXK01101249.1;P91778;9.19E-127;AMY_PECMA;Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase);"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]";"GO:0004556; GO:0005975; GO:0046872; GO:0103025";carbohydrate metabolic process [GO:0005975];;"alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]"
comp786038_c0_seq1;GAXK01150424.1;Q96MU6;4.10E-18;ZN778_HUMAN;Zinc finger protein 778;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp78609_c0_seq1;GAXK01085197.1;Q2TAP8;1.68E-13;CHCH7_XENLA;Coiled-coil-helix-coiled-coil-helix domain-containing protein 7;mitochondrial intermembrane space [GO:0005758];GO:0005758;;mitochondrial intermembrane space [GO:0005758];
comp786134_c0_seq1;GAXK01150459.1;Q9FKD5;3.18E-09;SINL9_ARATH;Putative E3 ubiquitin-protein ligase SINA-like 9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINA-like 9) (Seven in absentia-like protein 9);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp7864_c0_seq1;GAXK01101219.1;Q9N2W7;1.73E-34;NDUAC_CAEEL;Probable NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (NADH-ubiquinone oxidoreductase 17.0 kDa subunit);"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979]";"GO:0005739; GO:0005747; GO:0006979; GO:0008137; GO:0009055";response to oxidative stress [GO:0006979];"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"
comp786450_c0_seq1;GAXK01150419.1;P16662;7.51E-51;UD2B7_HUMAN;UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; lipid metabolic process [GO:0006629]";"GO:0005789; GO:0006629; GO:0008194; GO:0008209; GO:0015020; GO:0016020; GO:0016021; GO:0043231; GO:0052695";"androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; lipid metabolic process [GO:0006629]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]";"glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]"
comp786467_c0_seq1;GAXK01150398.1;Q7TSU7;7.02E-17;KIRR2_MOUSE;Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2);"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; identical protein binding [GO:0042802]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"GO:0001933; GO:0005886; GO:0005911; GO:0016021; GO:0036057; GO:0042802; GO:0098609";"cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]";"cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";identical protein binding [GO:0042802]
comp78649_c2_seq1;GAXK01085627.1;Q80ZI6;2.64E-105;LRSM1_MOUSE;E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]";"GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786";"autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp7865_c1_seq1;GAXK01100293.1;Q9D8N6;1.12E-22;LIN37_MOUSE;Protein lin-37 homolog (Antolefinin) (Antolefinine);"Myb complex [GO:0031523]; transcriptional repressor complex [GO:0017053]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0017053; GO:0031523";negative regulation of transcription by RNA polymerase II [GO:0000122];"Myb complex [GO:0031523]; transcriptional repressor complex [GO:0017053]";
comp78650_c1_seq1;GAXK01085805.1;Q8R239;6.88E-07;TM268_MOUSE;Transmembrane protein 268;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp7865326_c0_seq1;GAXK01015276.1;Q6VZZ7;5.27E-07;OPN5_MOUSE;Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin);"integral component of plasma membrane [GO:0005887]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0005502; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of plasma membrane [GO:0005887];"11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]"
comp786584_c0_seq1;GAXK01150406.1;Q9HFY6;1.53E-09;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp786609_c0_seq1;GAXK01150452.1;P81018;1.55E-13;LADD_ONCMY;Ladderlectin;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]";"GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0008061; GO:0030246; GO:0044194";;"brush border [GO:0005903]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]"
comp78666_c2_seq1;GAXK01085602.1;Q3UQ28;2.77E-61;PXDN_MOUSE;Peroxidasin homolog (EC 1.11.1.7);"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023";"collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]";"bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp78671_c1_seq1;GAXK01085426.1;Q8MIR0;1.19E-141;TDH_PIG;L-threonine 3-dehydrogenase, mitochondrial (EC 1.1.1.103);"mitochondrion [GO:0005739]; coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]";"GO:0005739; GO:0006567; GO:0008743; GO:0019518; GO:0042802; GO:0050662";"L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]";mitochondrion [GO:0005739];"coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]"
comp78675_c0_seq1;GAXK01085427.1;Q5U3A7;0;OPA1_DANRE;Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1];"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; chordate embryonic development [GO:0043009]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; ventricular cardiac muscle cell development [GO:0055015]";"GO:0000266; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0006915; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0031966; GO:0043009; GO:0046039; GO:0055015; GO:0061025; GO:0070300; GO:0070584; GO:0097749; GO:1901612";"apoptotic process [GO:0006915]; chordate embryonic development [GO:0043009]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; ventricular cardiac muscle cell development [GO:0055015]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"cardiolipin binding [GO:1901612]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]"
comp7867892_c0_seq1;GAXK01056433.1;A6Q3P4;3.79E-56;KDSB_NITSB;3-deoxy-manno-octulosonate cytidylyltransferase (EC 2.7.7.38) (CMP-2-keto-3-deoxyoctulosonic acid synthase) (CKS) (CMP-KDO synthase);"cytoplasm [GO:0005737]; 3-deoxy-manno-octulosonate cytidylyltransferase activity [GO:0008690]; CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process [GO:0033468]; lipopolysaccharide biosynthetic process [GO:0009103]";"GO:0005737; GO:0008690; GO:0009103; GO:0033468";"CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process [GO:0033468]; lipopolysaccharide biosynthetic process [GO:0009103]";cytoplasm [GO:0005737];3-deoxy-manno-octulosonate cytidylyltransferase activity [GO:0008690]
comp78687_c0_seq1;GAXK01085482.1;Q7Z569;1.72E-135;BRAP_HUMAN;BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]";"GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630";"MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]";"identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp78688_c0_seq1;GAXK01085459.1;A2VDV9;1.51E-19;SMIM8_BOVIN;Small integral membrane protein 8;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp786893_c0_seq1;GAXK01150422.1;O15442;6.76E-67;MPPD1_HUMAN;Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp7869257_c0_seq1;GAXK01099649.1;A2SI71;5.82E-51;COBQ_METPP;Cobyric acid synthase;"ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; catalytic activity [GO:0003824]; cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541]";"GO:0003824; GO:0006541; GO:0009236; GO:0015420";"cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541]";;"ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; catalytic activity [GO:0003824]"
comp7869357_c0_seq1;GAXK01099652.1;P52738;4.48E-07;ZN140_HUMAN;Zinc finger protein 140;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0043565; GO:0046872";negative regulation of transcription by RNA polymerase II [GO:0000122];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp78698_c0_seq1;GAXK01085642.1;Q02960;2.88E-25;MIF_CHICK;Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase);"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; MHC class II protein binding [GO:0042289]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]";"GO:0001516; GO:0002020; GO:0002906; GO:0004167; GO:0005125; GO:0005126; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0006954; GO:0007166; GO:0007569; GO:0008283; GO:0009986; GO:0010629; GO:0010739; GO:0010760; GO:0030330; GO:0030890; GO:0031666; GO:0032269; GO:0032760; GO:0033033; GO:0033138; GO:0042056; GO:0042289; GO:0042802; GO:0043406; GO:0043518; GO:0045087; GO:0048146; GO:0050178; GO:0050715; GO:0050731; GO:0061078; GO:0061081; GO:0070207; GO:0070374; GO:0071157; GO:0090238; GO:0090344; GO:1902166; GO:2000343";"cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]";"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; MHC class II protein binding [GO:0042289]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]"
comp7869911_c0_seq1;GAXK01099653.1;Q5RJI5;5.08E-17;BRSK1_MOUSE;Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B);"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]";"GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007095; GO:0007269; GO:0007409; GO:0008021; GO:0008306; GO:0009411; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030054; GO:0030182; GO:0035556; GO:0043015; GO:0048167; GO:0048812; GO:0050321; GO:0050770; GO:0051298; GO:0090176; GO:0099504; GO:0150034";"associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]";"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]";"ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp7869917_c0_seq1;GAXK01099654.1;Q6J4K2;6.76E-11;NCLX_HUMAN;Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1);"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803]; calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; ion transport [GO:0006811]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]";"GO:0005432; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0015368; GO:0030061; GO:0032592; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256";"calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; ion transport [GO:0006811]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]";"integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]";"calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803]"
comp787064_c0_seq1;GAXK01150382.1;Q8TCB0;6.19E-15;IFI44_HUMAN;Interferon-induced protein 44 (p44) (Microtubule-associated protein 44);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";"GO:0005737; GO:0006955; GO:0009615; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]";cytoplasm [GO:0005737];
comp787162_c0_seq1;GAXK01150397.1;A8MUP2;9.84E-21;CSKMT_HUMAN;Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CS-KMT) (EC 2.1.1.-) (Methyltransferase-like protein 12, mitochondrial);"mitochondrion [GO:0005739]; lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";"GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]";mitochondrion [GO:0005739];"lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp7872_c0_seq1;GAXK01101266.1;P36609;9.53E-74;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp78727_c0_seq1;GAXK01085415.1;Q9N293;6.01E-21;B3GT5_GORGO;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp7873417_c0_seq1;GAXK01012905.1;Q94HW2;2.60E-11;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp787350_c0_seq1;GAXK01150387.1;Q6R5J2;4.56E-65;DISP1_DANRE;Protein dispatched homolog 1 (Protein chameleon);"integral component of membrane [GO:0016021]; adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]";"GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016021; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839";"adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]";integral component of membrane [GO:0016021];
comp7873509_c0_seq1;GAXK01012904.1;P09481;2.75E-07;ACHA3_CHICK;Neuronal acetylcholine receptor subunit alpha-3;"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]";"GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084";"behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission involved in micturition [GO:0060084]";"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]"
comp787488_c0_seq1;GAXK01150460.1;P20350;1.46E-39;RHOM_DROME;Protein rhomboid (EC 3.4.21.105) (Protein veinlet);"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0006508; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0038005; GO:0042058; GO:0042327; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317; GO:0098609";"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; peptide bond cleavage involved in epidermal growth factor receptor ligand maturation [GO:0038005]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]";serine-type endopeptidase activity [GO:0004252]
comp78749_c0_seq1;GAXK01085421.1;Q5ZJU5;4.83E-09;NUSAP_CHICK;Nucleolar and spindle-associated protein 1 (NuSAP);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]";"GO:0000281; GO:0003677; GO:0005730; GO:0005737; GO:0005874; GO:0007076; GO:0008017; GO:0040001; GO:0072686";"establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; microtubule binding [GO:0008017]"
comp7875_c0_seq1;GAXK01100726.1;Q4V842;5.60E-45;GPTC4_XENLA;G patch domain-containing protein 4;nucleic acid binding [GO:0003676];GO:0003676;;;nucleic acid binding [GO:0003676]
comp7875074_c0_seq1;GAXK01107795.1;Q478Z5;2.12E-21;RDGC_DECAR;Recombination-associated protein RdgC;"cytoplasm [GO:0005737]; nucleoid [GO:0009295]; DNA recombination [GO:0006310]";"GO:0005737; GO:0006310; GO:0009295";DNA recombination [GO:0006310];"cytoplasm [GO:0005737]; nucleoid [GO:0009295]";
comp787600_c2_seq1;GAXK01150454.1;Q29RM3;5.49E-45;REEP5_BOVIN;Receptor expression-enhancing protein 5;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";"GO:0016021; GO:0071782";;"endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]";
comp7876028_c0_seq1;GAXK01102372.1;B3EWY9;3.17E-14;MLP_ACRMI;Mucin-like protein (Fragment);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]";"GO:0005509; GO:0007160; GO:0016021";cell-matrix adhesion [GO:0007160];integral component of membrane [GO:0016021];calcium ion binding [GO:0005509]
comp7876372_c0_seq1;GAXK01102373.1;P22271;1.49E-20;PROF1_PHYPO;Profilin-A;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]";"GO:0003779; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";actin binding [GO:0003779]
comp7876414_c0_seq1;GAXK01102367.1;Q68EK2;5.87E-13;CALRL_DANRE;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064";"angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";calcitonin receptor activity [GO:0004948]
comp787652_c0_seq1;GAXK01150388.1;Q8VIG1;7.26E-09;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp7876773_c0_seq1;GAXK01102374.1;P00793;4.56E-09;PEPA_CHICK;Pepsin A (EC 3.4.23.1);"aspartic-type endopeptidase activity [GO:0004190]; digestion [GO:0007586]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";"GO:0004190; GO:0006508; GO:0007586; GO:0030163";"digestion [GO:0007586]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]";;aspartic-type endopeptidase activity [GO:0004190]
comp7876851_c0_seq1;GAXK01102371.1;Q01484;7.65E-14;ANK2_HUMAN;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]";"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp78776_c7_seq1;GAXK01085212.1;Q9NB71;5.26E-34;HIW_DROME;E3 ubiquitin-protein ligase highwire (EC 2.3.2.-) (Protein pam/highwire/rpm-1);"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; locomotion [GO:0040011]; long-term memory [GO:0007616]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; response to axon injury [GO:0048678]; synapse organization [GO:0050808]";"GO:0004842; GO:0005634; GO:0005886; GO:0006914; GO:0007616; GO:0007628; GO:0008270; GO:0008582; GO:0010629; GO:0016567; GO:0030054; GO:0030424; GO:0030514; GO:0031410; GO:0040011; GO:0045202; GO:0045886; GO:0048678; GO:0050808; GO:2000331";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; locomotion [GO:0040011]; long-term memory [GO:0007616]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; response to axon injury [GO:0048678]; synapse organization [GO:0050808]";"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7878579_c0_seq1;GAXK01162419.1;Q55707;1.04E-14;Y617_SYNY3;Uncharacterized protein sll0617;;;;;
comp7878693_c0_seq1;GAXK01162420.1;Q9LZH9;1.40E-50;RL7A2_ARATH;60S ribosomal protein L7a-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]";"GO:0000470; GO:0003723; GO:0003735; GO:0005774; GO:0005829; GO:0022625; GO:0022626; GO:0042788";maturation of LSU-rRNA [GO:0000470];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp7878862_c0_seq1;GAXK01162421.1;P43899;1.84E-26;HEMW_HAEIN;Heme chaperone HemW (Oxygen-independent coproporphyrinogen-III oxidase-like protein HI_0463);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]";"GO:0004109; GO:0005737; GO:0006779; GO:0046872; GO:0051539";porphyrin-containing compound biosynthetic process [GO:0006779];cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]"
comp78794_c1_seq1;GAXK01085403.1;Q9VEC1;0;MED17_DROME;Mediator of RNA polymerase II transcription subunit 17 (Mediator complex subunit 17) (dMED17) (dTRAP80);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; transcription coregulator activity [GO:0003712]; cellular process [GO:0009987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0003712; GO:0005634; GO:0006357; GO:0006366; GO:0006367; GO:0009987; GO:0016592; GO:0031618; GO:0033613; GO:0045498; GO:0045944; GO:0070847";"cellular process [GO:0009987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]";"activating transcription factor binding [GO:0033613]; transcription coregulator activity [GO:0003712]"
comp7879650_c0_seq1;GAXK01162428.1;Q57242;5.60E-21;UUP1_HAEIN;ABC transporter ATP-binding protein uup-1;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0003677; GO:0004832; GO:0005524; GO:0005737; GO:0006438; GO:0016887";valyl-tRNA aminoacylation [GO:0006438];cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]"
comp78801_c0_seq1;GAXK01085417.1;Q62277;2.03E-46;SYPH_MOUSE;Synaptophysin (BM89 antigen) (Major synaptic vesicle protein p38);"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; cellular response to organic substance [GO:0071310]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle endocytosis [GO:0048488]";"GO:0000149; GO:0006897; GO:0007268; GO:0008021; GO:0014069; GO:0015485; GO:0016020; GO:0017075; GO:0019904; GO:0030054; GO:0030285; GO:0030672; GO:0031594; GO:0032991; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0043229; GO:0044306; GO:0044309; GO:0044877; GO:0045202; GO:0048169; GO:0048172; GO:0048471; GO:0048488; GO:0048786; GO:0060076; GO:0071310; GO:0098685; GO:2000300; GO:2000474";"cellular response to organic substance [GO:0071310]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle endocytosis [GO:0048488]";"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; SH2 domain binding [GO:0042169]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]"
comp788079_c0_seq1;GAXK01165132.1;Q24331;1.48E-10;TID_DROVI;Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID58);"mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; response to heat [GO:0009408]";"GO:0005524; GO:0005741; GO:0006457; GO:0007275; GO:0009408; GO:0031072; GO:0046872; GO:0051082";"multicellular organism development [GO:0007275]; protein folding [GO:0006457]; response to heat [GO:0009408]";mitochondrial outer membrane [GO:0005741];"ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp7881936_c0_seq1;GAXK01089874.1;P52746;1.05E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7882213_c0_seq1;GAXK01058252.1;P0CQ59;1.30E-22;RS3A_CRYNB;40S ribosomal protein S1;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp788256_c0_seq1;GAXK01165147.1;C9JN71;5.48E-12;ZN878_HUMAN;Zinc finger protein 878;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp78829_c0_seq1;GAXK01204851.1;O35711;4.56E-104;LIPB2_MOUSE;Liprin-beta-2 (Coiled-coil-like protein 1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2) (PTPRF-interacting protein-binding protein 2);"presynapse [GO:0098793]; identical protein binding [GO:0042802]";"GO:0042802; GO:0098793";;presynapse [GO:0098793];identical protein binding [GO:0042802]
comp78843_c0_seq1;GAXK01085749.1;P59889;4.16E-30;S39A1_DANRE;Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577";"zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]"
comp788504_c0_seq1;GAXK01165176.1;Q9NPC7;1.28E-11;MYNN_HUMAN;Myoneurin (Zinc finger and BTB domain-containing protein 31);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";"GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0008270; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]"
comp7885413_c0_seq1;GAXK01075741.1;P34662;3.68E-35;RL35_CAEEL;60S ribosomal protein L35;"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";"GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp7885461_c0_seq1;GAXK01075733.1;Q9UNQ0;8.23E-23;ABCG2_HUMAN;ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification [GO:1990748]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]; urate metabolic process [GO:0046415]";"GO:0005524; GO:0005634; GO:0005886; GO:0006879; GO:0008559; GO:0016021; GO:0016887; GO:0031966; GO:0042626; GO:0042802; GO:0042803; GO:0046415; GO:0055085; GO:1990748";"cellular detoxification [GO:1990748]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]; urate metabolic process [GO:0046415]";"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
comp788603_c1_seq1;GAXK01165152.1;O69060;6.26E-08;HTXA_PSEST;Probable alpha-ketoglutarate-dependent hypophosphite dioxygenase (EC 1.-.-.-);dioxygenase activity [GO:0051213];GO:0051213;;;dioxygenase activity [GO:0051213]
comp7887339_c0_seq1;GAXK01085184.1;B7YZU2;1.65E-13;LINT_DROME;Serine protease lint (EC 3.4.21.-) (Lumens interrupted);"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595";"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]";"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp7887431_c0_seq1;GAXK01085181.1;Q9I0K9;1.51E-42;PUR8_PSEAE;Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase);"cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]";"GO:0004018; GO:0005829; GO:0006189; GO:0044208; GO:0070626";"'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]";cytosol [GO:0005829];"(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]"
comp789002_c2_seq1;GAXK01165153.1;Q1RJR6;6.71E-11;Y317_RICBR;Putative ankyrin repeat protein RBE_0317;;;;;
comp789121_c0_seq1;GAXK01165148.1;B1AT66;3.43E-34;MOT7_MOUSE;Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6);"integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];integral component of plasma membrane [GO:0005887];"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp7891230_c0_seq1;GAXK01091656.1;O61370;4.80E-07;NACH_DROAN;Sodium channel protein Nach;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp78922_c0_seq1;GAXK01085757.1;Q60929;3.29E-50;MEF2A_MOUSE;Myocyte-specific enhancer factor 2A;"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005]";"GO:0000002; GO:0000122; GO:0000165; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001085; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006355; GO:0006915; GO:0010613; GO:0019901; GO:0033613; GO:0035035; GO:0042826; GO:0043565; GO:0045893; GO:0045944; GO:0046326; GO:0046332; GO:0046982; GO:0048311; GO:0048813; GO:0055005; GO:0061337; GO:0070375; GO:0071277";"apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp78930_c2_seq1;GAXK01085597.1;Q9VHX7;1.13E-65;ELOVL_DROME;Elongation of very long chain fatty acids protein (EC 2.3.1.199) (Elongation of very long chain fatty acids elongase) (Very-long-chain 3-oxoacyl-CoA synthase);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0001676; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0030497; GO:0034625; GO:0034626; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp789336_c0_seq1;GAXK01165164.1;P48733;1.08E-10;UROM_BOVIN;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]";"GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016323; GO:0016324; GO:0031225; GO:0060170";;"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]";calcium ion binding [GO:0005509]
comp78934_c0_seq1;GAXK01085751.1;Q9UBU6;4.12E-24;FA8A1_HUMAN;Protein FAM8A1 (Autosomal highly conserved protein);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp7893988_c0_seq1;GAXK01188820.1;P93847;1.13E-52;RL10_SOLME;60S ribosomal protein L10 (EQM);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp7894195_c0_seq1;GAXK01123716.1;P57630;2.71E-12;HFLC_BUCAI;Protein HflC;"integral component of membrane [GO:0016021]; regulation of peptidase activity [GO:0052547]";"GO:0016021; GO:0052547";regulation of peptidase activity [GO:0052547];integral component of membrane [GO:0016021];
comp78942_c0_seq1;GAXK01085802.1;Q8CGZ0;1.21E-43;CHERP_MOUSE;Calcium homeostasis endoplasmic reticulum protein (SR-related CTD-associated factor 6);"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396]";"GO:0003723; GO:0005737; GO:0006396; GO:0006874; GO:0008285; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886";"cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]";"ion channel binding [GO:0044325]; RNA binding [GO:0003723]"
comp789426_c0_seq1;GAXK01165191.1;Q29RZ4;1.76E-16;ZNF2_BOVIN;Zinc finger protein 2;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7896544_c0_seq1;GAXK01059381.1;P42810;8.92E-21;Y4667_PSEAE;TPR repeat-containing protein PA4667;;;;;
comp7896854_c0_seq1;GAXK01059394.1;Q27597;1.07E-49;NCPR_DROME;NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4);"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cuticle hydrocarbon biosynthetic process [GO:0006723]; response to hormone [GO:0009725]";"GO:0003958; GO:0005789; GO:0005829; GO:0006723; GO:0009725; GO:0010181; GO:0012505; GO:0016021; GO:0016491; GO:0050660; GO:0050661";"cuticle hydrocarbon biosynthetic process [GO:0006723]; response to hormone [GO:0009725]";"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]"
comp7896985_c0_seq1;GAXK01059385.1;C5CTM8;1.19E-25;UPPP_VARPS;Undecaprenyl-diphosphatase (EC 3.6.1.27) (Bacitracin resistance protein) (Undecaprenyl pyrophosphate phosphatase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; undecaprenyl-diphosphatase activity [GO:0050380]; cell wall organization [GO:0071555]; dephosphorylation [GO:0016311]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"GO:0005886; GO:0008360; GO:0009252; GO:0016021; GO:0016311; GO:0046677; GO:0050380; GO:0071555";"cell wall organization [GO:0071555]; dephosphorylation [GO:0016311]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";undecaprenyl-diphosphatase activity [GO:0050380]
comp7897045_c0_seq1;GAXK01059376.1;P29267;2.01E-78;HOXA_CUPNH;Hydrogenase transcriptional regulatory protein HoxA;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0005524; GO:0005737; GO:0006355; GO:0008134; GO:0043565";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp7897212_c0_seq1;GAXK01059390.1;Q9YE02;3.07E-16;SPEE_AERPE;Polyamine aminopropyltransferase (Putrescine aminopropyltransferase) (PAPT) (Spermidine synthase) (SPDS) (SPDSY) (EC 2.5.1.16);"cytoplasm [GO:0005737]; spermidine synthase activity [GO:0004766]; spermidine biosynthetic process [GO:0008295]";"GO:0004766; GO:0005737; GO:0008295";spermidine biosynthetic process [GO:0008295];cytoplasm [GO:0005737];spermidine synthase activity [GO:0004766]
comp789737_c1_seq1;GAXK01165131.1;Q5I597;2.06E-175;BHMT1_BOVIN;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]";"GO:0005829; GO:0006579; GO:0008270; GO:0047150; GO:0070062; GO:0071267";"amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]"
comp789824_c0_seq1;GAXK01165179.1;O46040;5.14E-22;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp7898406_c0_seq1;GAXK01174088.1;Q8I6K0;1.44E-09;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp789847_c0_seq1;GAXK01165167.1;Q9VZW5;2.26E-11;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp7899644_c0_seq1;GAXK01174093.1;P80971;2.97E-18;COX42_THUOB;Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (EC 1.9.3.1) (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2);"mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005743";;mitochondrial inner membrane [GO:0005743];cytochrome-c oxidase activity [GO:0004129]
comp789976_c0_seq1;GAXK01165134.1;Q09476;1.54E-19;PXL1_CAEEL;Paxillin homolog 1;"adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; M band [GO:0031430]; plasma membrane [GO:0005886]; podosome [GO:0002102]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]; muscle structure development [GO:0061061]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]";"GO:0002102; GO:0002119; GO:0003712; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0017166; GO:0031430; GO:0042995; GO:0043050; GO:0046872; GO:0055120; GO:0061061";"muscle structure development [GO:0061061]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]";"adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; M band [GO:0031430]; plasma membrane [GO:0005886]; podosome [GO:0002102]; striated muscle dense body [GO:0055120]";"metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]"
comp7900488_c0_seq1;GAXK01077802.1;P21629;3.25E-25;BRAF_PSEAE;High-affinity branched-chain amino acid transport ATP-binding protein BraF;"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-valine transmembrane transporter activity [GO:0005304]; D-alanine transport [GO:0042941]; L-alanine transport [GO:0015808]; L-isoleucine import across plasma membrane [GO:1903806]; L-valine import across plasma membrane [GO:1903805]; leucine import across plasma membrane [GO:0098713]";"GO:0005304; GO:0005524; GO:0005886; GO:0015188; GO:0015190; GO:0015192; GO:0015808; GO:0016887; GO:0042941; GO:0098713; GO:1903805; GO:1903806";"D-alanine transport [GO:0042941]; L-alanine transport [GO:0015808]; leucine import across plasma membrane [GO:0098713]; L-isoleucine import across plasma membrane [GO:1903806]; L-valine import across plasma membrane [GO:1903805]";plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-valine transmembrane transporter activity [GO:0005304]"
comp7901388_c0_seq1;GAXK01077789.1;Q9SL76;1.45E-20;P2C19_ARATH;"Protein phosphatase 2C and cyclic nucleotide-binding/kinase domain-containing protein [Includes: Probable protein phosphatase 2C 19 (AtPP2C19) (EC 3.1.3.16); Probable inactive cyclic nucleotide-dependent protein kinase At2g20050]";"cAMP-dependent protein kinase complex [GO:0005952]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]";"GO:0004691; GO:0004721; GO:0005524; GO:0005739; GO:0005886; GO:0005952; GO:0007165; GO:0018105; GO:0046872";"peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]";"cAMP-dependent protein kinase complex [GO:0005952]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]"
comp790248_c0_seq1;GAXK01151334.1;B7TB45;8.47E-09;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp7903_c0_seq1;GAXK01100621.1;O60925;1.60E-31;PFD1_HUMAN;Prefoldin subunit 1;"prefoldin complex [GO:0016272]; DNA-binding transcription factor activity [GO:0003700]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]";"GO:0003700; GO:0016272; GO:0044183; GO:0051082";;prefoldin complex [GO:0016272];"DNA-binding transcription factor activity [GO:0003700]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp7903694_c0_seq1;GAXK01028551.1;O02495;9.71E-20;SYB1_CAEEL;Synaptobrevin-1 (Synaptobrevin-related protein 1);"axon [GO:0030424]; cell junction [GO:0030054]; cortical granule [GO:0060473]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; defecation [GO:0030421]; nematode larval development [GO:0002119]; regulation of hindgut contraction [GO:0043134]; regulation of pharyngeal pumping [GO:0043051]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle exocytosis [GO:0016079]";"GO:0002119; GO:0005886; GO:0007271; GO:0008021; GO:0016021; GO:0016079; GO:0030054; GO:0030421; GO:0030424; GO:0030672; GO:0043005; GO:0043051; GO:0043134; GO:0048786; GO:0060473";"defecation [GO:0030421]; nematode larval development [GO:0002119]; regulation of hindgut contraction [GO:0043134]; regulation of pharyngeal pumping [GO:0043051]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle exocytosis [GO:0016079]";"axon [GO:0030424]; cell junction [GO:0030054]; cortical granule [GO:0060473]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]";
comp79049_c1_seq1;GAXK01085756.1;Q9T034;8.06E-42;SYFA_ARATH;Phenylalanine--tRNA ligase alpha subunit, cytoplasmic (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]";"GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006432; GO:0009328";phenylalanyl-tRNA aminoacylation [GO:0006432];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]"
comp7904958_c0_seq1;GAXK01175124.1;O06581;5.09E-45;PRPR_MYCTU;HTH-type transcriptional regulator PrpR (Propionate regulator) (PRPR);"DNA binding [GO:0003677]; cholesterol metabolic process [GO:0008203]; propionate metabolic process, methylcitrate cycle [GO:0019679]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0003677; GO:0006355; GO:0008203; GO:0019679; GO:0052572";"cholesterol metabolic process [GO:0008203]; propionate metabolic process, methylcitrate cycle [GO:0019679]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]";;DNA binding [GO:0003677]
comp7905_c0_seq1;GAXK01100246.1;B3MTS7;4.38E-37;DDRGK_DROAN;DDRGK domain-containing protein 1;;;;;
comp790515_c0_seq1;GAXK01151347.1;A7MBJ2;2.13E-31;SENP7_BOVIN;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp7907_c5_seq1;GAXK01101323.1;P34519;2.30E-94;TXTP_CAEEL;Putative tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial citrate transmembrane transport [GO:0006843]";"GO:0005743; GO:0006843; GO:0016021";mitochondrial citrate transmembrane transport [GO:0006843];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp7908289_c0_seq1;GAXK01091899.1;Q9JP87;4.35E-31;CARA_RUBGI;Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase glutamine chain);"ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]";"GO:0004088; GO:0005524; GO:0006207; GO:0006526; GO:0006541; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]";;"ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]"
comp790849_c0_seq1;GAXK01151280.1;P16303;1.50E-29;CES1D_RAT;Carboxylesterase 1D (Carboxyesterase ES-10) (Carboxylesterase 3) (EC 3.1.1.1) (EC 3.1.1.67) (ES-HVEL) (Fatty acid ethyl ester synthase) (FAEE synthase) (Liver carboxylesterase 10) (pI 6.1 esterase);"cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acylglycerol catabolic process [GO:0046464]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0005811; GO:0005829; GO:0016042; GO:0030339; GO:0046464; GO:0052689; GO:0080030";"acylglycerol catabolic process [GO:0046464]; lipid catabolic process [GO:0016042]";"cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]";"carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"
comp7908755_c0_seq1;GAXK01091900.1;P32899;2.39E-24;IMP3_YEAST;U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (Interacting with MPP10 protein 3);"90S preribosome [GO:0030686]; Mpp10 complex [GO:0034457]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]";"GO:0005654; GO:0006364; GO:0019843; GO:0030515; GO:0030686; GO:0031167; GO:0032040; GO:0034457; GO:0042274";"ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]";"90S preribosome [GO:0030686]; Mpp10 complex [GO:0034457]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";"rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]"
comp7909106_c0_seq1;GAXK01091901.1;Q8CEL2;1.51E-10;CFA61_MOUSE;Cilia- and flagella-associated protein 61;"axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782]";"GO:0003341; GO:0005930; GO:0031514; GO:0044782";"cilium movement [GO:0003341]; cilium organization [GO:0044782]";"axoneme [GO:0005930]; motile cilium [GO:0031514]";
comp791_c1_seq1;GAXK01170565.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp791064_c1_seq1;GAXK01151336.1;P39087;0;GRIK2_MOUSE;Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098978; GO:0099507; GO:1904315";"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"
comp7910785_c0_seq1;GAXK01072463.1;P0AD57;1.25E-40;ISPB_ECOLI;Octaprenyl diphosphate synthase (EC 2.5.1.90) (All-trans-octaprenyl-diphosphate synthase) (Octaprenyl pyrophosphate synthase) (OPP synthase);"cytosol [GO:0005829]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; polyprenol biosynthetic process [GO:0016094]; ubiquinone biosynthetic process [GO:0006744]";"GO:0004659; GO:0005829; GO:0006744; GO:0016094; GO:0042802; GO:0046872";"polyprenol biosynthetic process [GO:0016094]; ubiquinone biosynthetic process [GO:0006744]";cytosol [GO:0005829];"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]"
comp7911_c0_seq1;GAXK01100561.1;Q9Y5Z4;1.85E-18;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp791216_c0_seq1;GAXK01151356.1;P87149;1.80E-19;MRS2_SCHPO;Mitochondrial inner membrane magnesium transporter mrs2 (RNA-splicing protein mrs2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"GO:0005739; GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016";"magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";magnesium ion transmembrane transporter activity [GO:0015095]
comp79122_c0_seq1;GAXK01085473.1;Q99583;1.51E-18;MNT_HUMAN;Max-binding protein MNT (Class D basic helix-loop-helix protein 3) (bHLHd3) (Myc antagonist MNT) (Protein ROX);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cell aging [GO:0007569]; multicellular organism development [GO:0007275]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006366; GO:0007275; GO:0007569; GO:0008285; GO:0046983; GO:0051726; GO:2001234";"cell aging [GO:0007569]; multicellular organism development [GO:0007275]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; transcription by RNA polymerase II [GO:0006366]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp79123_c0_seq1;GAXK01085456.1;Q1L908;9.61E-68;MSTO1_DANRE;Protein misato homolog 1;"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]";"GO:0000002; GO:0000070; GO:0005737; GO:0005741; GO:0048311; GO:0090307";"mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]";"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]";
comp79124_c4_seq1;GAXK01085980.1;P14629;7.63E-66;ERCC5_XENLA;DNA repair protein complementing XP-G cells homolog (EC 3.1.-.-) (Xeroderma pigmentosum group G-complementing protein homolog);"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; nucleotide-excision repair [GO:0006289]";"GO:0003697; GO:0004519; GO:0005634; GO:0006289; GO:0046872";nucleotide-excision repair [GO:0006289];nucleus [GO:0005634];"endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]"
comp7914049_c0_seq1;GAXK01063889.1;Q6R7M4;1.95E-23;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp791435_c0_seq1;GAXK01151297.1;Q11011;6.50E-10;PSA_MOUSE;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp7915_c0_seq1;GAXK01100295.1;Q9VHS8;0;IF4A3_DROME;Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]";"GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0006325; GO:0008380; GO:0010628; GO:0045451; GO:0045495; GO:0051028; GO:0071011; GO:0071013; GO:1903040";"chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]";"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp791614_c0_seq1;GAXK01151294.1;A1A4N1;4.42E-39;S29A3_BOVIN;Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0016021; GO:0031902";;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";nucleoside transmembrane transporter activity [GO:0005337]
comp79165_c1_seq1;GAXK01085448.1;Q08623;5.19E-64;HDHD1_HUMAN;Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase);"cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]";"GO:0000287; GO:0005829; GO:0009117; GO:0043097; GO:1990738";"nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]";cytosol [GO:0005829];"magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]"
comp7917_c0_seq1;GAXK01100122.1;Q2KHZ4;2.47E-40;MIA40_BOVIN;Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; peptidyl-cysteine oxidation [GO:0018171]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]";"GO:0005739; GO:0005758; GO:0015035; GO:0018171; GO:0022417; GO:0045041; GO:0051084";"'de novo' posttranslational protein folding [GO:0051084]; peptidyl-cysteine oxidation [GO:0018171]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";protein disulfide oxidoreductase activity [GO:0015035]
comp79170_c0_seq1;GAXK01085811.1;Q8BJM3;2.36E-26;R3HCL_MOUSE;Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88 homolog) (R3H and coiled-coil domain-containing protein 1-like);exon-exon junction complex [GO:0035145];GO:0035145;;exon-exon junction complex [GO:0035145];
comp791765_c0_seq1;GAXK01151352.1;Q75NA5;1.33E-51;GBRB_MUSDO;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta) (MdRdl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"GO:0001505; GO:0004890; GO:0005230; GO:0005254; GO:0006836; GO:0007214; GO:0008503; GO:0030054; GO:0030285; GO:0034707; GO:0045211";"gamma-aminobutyric acid signaling pathway [GO:0007214]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter levels [GO:0001505]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of synaptic vesicle membrane [GO:0030285]; postsynaptic membrane [GO:0045211]";"benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp791842_c1_seq1;GAXK01151298.1;Q96IR2;2.46E-31;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7919182_c0_seq1;GAXK01173341.1;A4VRT4;2.25E-48;GCSP_PSEU5;Glycine dehydrogenase (decarboxylating) (EC 1.4.4.2) (Glycine cleavage system P-protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring));"glycine dehydrogenase (decarboxylating) activity [GO:0004375]; glycine decarboxylation via glycine cleavage system [GO:0019464]";"GO:0004375; GO:0019464";glycine decarboxylation via glycine cleavage system [GO:0019464];;glycine dehydrogenase (decarboxylating) activity [GO:0004375]
comp791958_c0_seq1;GAXK01205829.1;Q9IA20;1.00E-42;HXA2_HETFR;Homeobox protein Hox-A2;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]";"GO:0003700; GO:0005634; GO:0007275; GO:0043565";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp7920580_c0_seq1;GAXK01154784.1;Q04850;1.40E-19;NTRY_AZOC5;Nitrogen regulation protein NtrY (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; nitrogen fixation [GO:0009399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000155; GO:0005524; GO:0005886; GO:0006355; GO:0009399; GO:0016021";"nitrogen fixation [GO:0009399]; regulation of transcription, DNA-templated [GO:0006355]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp79212_c1_seq1;GAXK01086073.1;Q9V730;0;EXT1_DROME;Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007411; GO:0008354; GO:0008375; GO:0008589; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016055; GO:0016757; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263";"axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp7921242_c0_seq1;GAXK01154779.1;P21187;2.90E-38;PABP_DROME;Polyadenylate-binding protein (PABP) (Poly(A)-binding protein);"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of neuron death [GO:1901215]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]";"GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007112; GO:0007140; GO:0007268; GO:0007283; GO:0007289; GO:0008143; GO:0008266; GO:0009953; GO:0010494; GO:0045314; GO:0045727; GO:0048477; GO:0048599; GO:0071011; GO:0071013; GO:1901215; GO:1990904";"chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of neuron death [GO:1901215]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]";"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]"
comp7921361_c0_seq1;GAXK01154781.1;Q9JJZ5;3.19E-18;EGFL6_MOUSE;Epidermal growth factor-like protein 6 (EGF-like protein 6) (MAM and EGF domains-containing gene protein) (Protein W80);"basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]";"GO:0005178; GO:0005509; GO:0005604; GO:0007155; GO:0007275; GO:0010811; GO:0016020; GO:0030154; GO:0030198; GO:0031012";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]";"basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; integrin binding [GO:0005178]"
comp792291_c0_seq1;GAXK01084546.1;Q6DCX5;4.03E-12;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp7923181_c0_seq1;GAXK01189323.1;Q24F59;2.29E-18;RL36_TETTS;60S ribosomal protein L36;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp79240_c4_seq1;GAXK01085454.1;Q4R907;5.01E-86;CB042_MACFA;Uncharacterized protein C2orf42 homolog;;;;;
comp79249_c4_seq1;GAXK01085815.1;Q9NA51;5.56E-12;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp7925464_c0_seq1;GAXK01052712.1;Q8S3N1;2.40E-08;SINA5_ARATH;E3 ubiquitin-protein ligase SINAT5 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT5) (Seven in absentia homolog 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp792564_c0_seq1;GAXK01084493.1;P07706;3.87E-106;NU5M_DROYA;NADH-ubiquinone oxidoreductase chain 5 (EC 7.1.1.2) (NADH dehydrogenase subunit 5);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773]";"GO:0005743; GO:0008137; GO:0016021; GO:0042773; GO:0070469";ATP synthesis coupled electron transport [GO:0042773];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp792649_c0_seq1;GAXK01084497.1;Q6ZMW2;2.77E-40;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp79285_c0_seq1;GAXK01085410.1;Q99MZ3;7.14E-22;MLXPL_MOUSE;Carbohydrate-responsive element-binding protein (ChREBP) (MLX interactor) (MLX-interacting protein-like) (Williams-Beuren syndrome chromosomal region 14 protein homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]";"GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006357; GO:0008134; GO:0008284; GO:0009749; GO:0010255; GO:0019901; GO:0033137; GO:0035538; GO:0042593; GO:0043565; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0071157; GO:0071333; GO:0090324; GO:0097009";"cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp792974_c0_seq1;GAXK01084539.1;O43916;5.01E-23;CHST1_HUMAN;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp793_c9_seq2;GAXK01169755.1;P21797;5.59E-33;TNNC1_BALNU;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp7930_c0_seq1;GAXK01101298.1;Q66KB9;7.71E-43;BL1S2_XENTR;Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2);"axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]; gamma-tubulin binding [GO:0043015]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455]";"GO:0000930; GO:0005765; GO:0008089; GO:0016197; GO:0031083; GO:0031175; GO:0032418; GO:0043015; GO:0045746; GO:0048490; GO:0099078; GO:1902038; GO:1904115; GO:1905455; GO:1905457";"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455]";"axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]";gamma-tubulin binding [GO:0043015]
comp7930111_c0_seq1;GAXK01090558.1;Q96321;4.37E-42;IMPA1_ARATH;Importin subunit alpha-1 (IMPa-1) (Karyopherin subunit alpha-1) (KAP-alpha-1);"cell wall [GO:0005618]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]";"GO:0005618; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0061608";"NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]";"cell wall [GO:0005618]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]"
comp79306_c1_seq1;GAXK01085976.1;Q6DHN0;1.32E-16;TMM53_DANRE;Transmembrane protein 53;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp7931067_c0_seq1;GAXK01090557.1;A1A967;5.36E-21;GSIA_ECOK1;Glutathione import ATP-binding protein GsiA (EC 7.4.2.10);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptide transport [GO:0015833]";"GO:0005524; GO:0005886; GO:0015833; GO:0016887";peptide transport [GO:0015833];plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp793195_c0_seq1;GAXK01084544.1;B1WB06;1.11E-09;MET24_XENTR;Methyltransferase-like protein 24 (EC 2.1.1.-);"extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]";"GO:0005576; GO:0008168";;extracellular region [GO:0005576];methyltransferase activity [GO:0008168]
comp7932900_c0_seq1;GAXK01193724.1;Q6NCS7;1.42E-61;ASSY_RHOPA;Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase);"cytoplasm [GO:0005737]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; arginine biosynthetic process [GO:0006526]";"GO:0004055; GO:0005524; GO:0005737; GO:0006526; GO:0042803";arginine biosynthetic process [GO:0006526];cytoplasm [GO:0005737];"argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]"
comp7933_c2_seq1;GAXK01100996.1;P54385;0;DHE3_DROME;Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0019551; GO:0042802";"glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp7933154_c0_seq1;GAXK01193721.1;P51422;2.72E-43;R35A4_ARATH;60S ribosomal protein L35a-4;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003735; GO:0005829; GO:0022625; GO:0022626; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]";structural constituent of ribosome [GO:0003735]
comp7933610_c0_seq1;GAXK01193720.1;A9BP42;4.36E-59;UBIB_DELAS;Probable protein kinase UbiB (EC 2.7.-.-) (Ubiquinone biosynthesis protein UbiB);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]";"GO:0004672; GO:0005524; GO:0005886; GO:0006744; GO:0010795; GO:0016021";"regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]"
comp79338_c12_seq1;GAXK01085717.1;Q9CQV3;5.94E-40;SPB11_MOUSE;Serpin B11;"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]";"GO:0004867; GO:0005615; GO:0005737; GO:0010951";negative regulation of endopeptidase activity [GO:0010951];"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp793413_c4_seq1;GAXK01204849.1;P91645;1.22E-85;CAC1A_DROME;Voltage-dependent calcium channel type A subunit alpha-1 (Protein cacophony) (Protein nightblind A) (Protein no-on-transient B) (Dmca1A);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; adult locomotory behavior [GO:0008344]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; detection of light stimulus involved in visual perception [GO:0050908]; epithelial fluid transport [GO:0042045]; exocytosis [GO:0006887]; male courtship behavior, veined wing generated song production [GO:0045433]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neurotransmitter secretion [GO:0007269]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of neurotransmitter secretion [GO:0046928]; visual behavior [GO:0007632]";"GO:0002027; GO:0005245; GO:0005509; GO:0005891; GO:0006816; GO:0006887; GO:0006914; GO:0007268; GO:0007269; GO:0007602; GO:0007619; GO:0007632; GO:0008331; GO:0008332; GO:0008344; GO:0010524; GO:0016057; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0031594; GO:0034765; GO:0042045; GO:0045433; GO:0045887; GO:0046928; GO:0048786; GO:0050908; GO:0070050; GO:0070509; GO:0070588; GO:0097352";"adult locomotory behavior [GO:0008344]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; detection of light stimulus involved in visual perception [GO:0050908]; epithelial fluid transport [GO:0042045]; exocytosis [GO:0006887]; male courtship behavior, veined wing generated song production [GO:0045433]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neurotransmitter secretion [GO:0007269]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential in photoreceptor cell [GO:0016057]; regulation of neurotransmitter secretion [GO:0046928]; visual behavior [GO:0007632]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; voltage-gated calcium channel complex [GO:0005891]";"calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]"
comp79350_c0_seq1;GAXK01085364.1;O73874;1.01E-21;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp793619_c0_seq1;GAXK01084475.1;P11480;1.56E-10;TBAE_PHYPO;Tubulin alpha-2B chain (Tubulin alpha-E chain);"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp7937480_c0_seq1;GAXK01120881.1;Q54N49;7.40E-57;INO1_DICDI;Inositol-3-phosphate synthase (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (IPS) (MI-1-P synthase) (MIP synthase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; autophagy [GO:0006914]; cell-substrate adhesion [GO:0031589]; inositol biosynthetic process [GO:0006021]; mitotic cytokinesis [GO:0000281]; phospholipid biosynthetic process [GO:0008654]; regulation of phospholipid metabolic process [GO:1903725]";"GO:0000281; GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0006914; GO:0008654; GO:0031589; GO:1903725";"autophagy [GO:0006914]; cell-substrate adhesion [GO:0031589]; inositol biosynthetic process [GO:0006021]; mitotic cytokinesis [GO:0000281]; phospholipid biosynthetic process [GO:0008654]; regulation of phospholipid metabolic process [GO:1903725]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";inositol-3-phosphate synthase activity [GO:0004512]
comp79381_c0_seq1;GAXK01085589.1;P08836;4.31E-106;FPPS_CHICK;Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase);"cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]";"GO:0004161; GO:0004337; GO:0005737; GO:0006695; GO:0033384; GO:0045337; GO:0046872";"cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]";cytoplasm [GO:0005737];"dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]"
comp7938493_c0_seq1;GAXK01128563.1;A4XHV2;1.45E-32;LIPA_CALS8;Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]";"GO:0005737; GO:0009249; GO:0016992; GO:0046872; GO:0051539";protein lipoylation [GO:0009249];cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]"
comp793865_c0_seq1;GAXK01084483.1;Q9NXL6;5.41E-58;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp79388_c3_seq1;GAXK01085827.1;Q9UJX4;3.10E-62;APC5_HUMAN;Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5);"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin protein ligase activity [GO:0061630]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0061630; GO:0070979; GO:1901990";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]";"anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"protein phosphatase binding [GO:0019903]; ubiquitin protein ligase activity [GO:0061630]"
comp7939674_c0_seq1;GAXK01128562.1;Q0AJ13;3.41E-58;DGTL1_NITEC;Deoxyguanosinetriphosphate triphosphohydrolase-like protein;triphosphoric monoester hydrolase activity [GO:0016793];GO:0016793;;;triphosphoric monoester hydrolase activity [GO:0016793]
comp79397_c1_seq1;GAXK01085420.1;Q8VCE1;3.39E-50;DJC28_MOUSE;DnaJ homolog subfamily C member 28;"Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0006890; GO:0007030; GO:0017119; GO:0048213";"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";Golgi transport complex [GO:0017119];
comp79411_c0_seq1;GAXK01085328.1;Q6DCX3;4.77E-71;KCD15_XENLA;BTB/POZ domain-containing protein kctd15 (Potassium channel tetramerization domain-containing protein 15);"multicellular organism development [GO:0007275]; protein homooligomerization [GO:0051260]";"GO:0007275; GO:0051260";"multicellular organism development [GO:0007275]; protein homooligomerization [GO:0051260]";;
comp7941563_c0_seq1;GAXK01016730.1;Q805R1;2.07E-24;GCNT3_BHV4L;Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M);"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; protein glycosylation [GO:0006486]";"GO:0003829; GO:0006486; GO:0008109; GO:0016021; GO:0044178; GO:0047225";protein glycosylation [GO:0006486];"host cell Golgi membrane [GO:0044178]; integral component of membrane [GO:0016021]";"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"
comp7941611_c0_seq1;GAXK01016738.1;Q5ZWR1;8.49E-50;COPA_LEGPH;Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]";"GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872";copper ion transport [GO:0006825];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp794225_c0_seq1;GAXK01154474.1;P21369;7.57E-30;PNCA_ECOLI;Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-);"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]";"GO:0008936; GO:0019365; GO:0046872";pyridine nucleotide salvage [GO:0019365];;"metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]"
comp794376_c0_seq1;GAXK01154455.1;Q8BKE6;3.41E-11;CP20A_MOUSE;Cytochrome P450 20A1 (EC 1.14.-.-);"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037";;integral component of membrane [GO:0016021];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp7944705_c0_seq1;GAXK01075991.1;Q94HW2;7.67E-07;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp794615_c0_seq1;GAXK01154449.1;A4IHB9;7.83E-79;SL9B2_XENTR;Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2);"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]";"GO:0005886; GO:0010008; GO:0015385; GO:0016021; GO:0030054; GO:0030317; GO:0030672; GO:0031966";flagellated sperm motility [GO:0030317];"cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";sodium:proton antiporter activity [GO:0015385]
comp794681_c0_seq1;GAXK01154469.1;P52746;2.53E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7947_c1_seq1;GAXK01100336.1;Q8CDN6;1.70E-59;TXNL1_MOUSE;Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]";"GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036; GO:0045454";cell redox homeostasis [GO:0045454];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";disulfide oxidoreductase activity [GO:0015036]
comp79472_c1_seq1;GAXK01085946.1;Q5D1D6;8.35E-89;GBP1_CHLAE;Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1);"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607";"defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]";"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp794729_c0_seq1;GAXK01154453.1;Q6ZNA1;2.94E-15;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp79479_c1_seq1;GAXK01085412.1;B3DLF3;1.53E-12;LYRM2_XENTR;LYR motif-containing protein 2;;;;;
comp79484_c0_seq1;GAXK01085813.1;P21816;1.06E-56;CDO1_RAT;Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I);"cytosol [GO:0005829]; cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; cysteine metabolic process [GO:0006534]; L-cysteine catabolic process [GO:0019448]; L-cysteine metabolic process [GO:0046439]; lactation [GO:0007595]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to organonitrogen compound [GO:0010243]; taurine biosynthetic process [GO:0042412]";"GO:0005829; GO:0006534; GO:0007595; GO:0008198; GO:0010243; GO:0016702; GO:0017172; GO:0019448; GO:0033762; GO:0042412; GO:0043200; GO:0045471; GO:0046439; GO:0051384; GO:0051591";"cysteine metabolic process [GO:0006534]; lactation [GO:0007595]; L-cysteine catabolic process [GO:0019448]; L-cysteine metabolic process [GO:0046439]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to organonitrogen compound [GO:0010243]; taurine biosynthetic process [GO:0042412]";cytosol [GO:0005829];"cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp794840_c1_seq1;GAXK01154478.1;Q6ZMG9;1.98E-16;CERS6_HUMAN;Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"GO:0000981; GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0050291";"ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]"
comp79489_c0_seq1;GAXK01085312.1;O60312;0;AT10A_HUMAN;Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]";"GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0008360; GO:0016021; GO:0034220; GO:0045332; GO:0140326";"ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp795039_c0_seq1;GAXK01154396.1;P14381;5.14E-47;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp7950763_c0_seq1;GAXK01074602.1;P07584;8.16E-12;ASTA_ASTAS;Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase);"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360";"cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]";"cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp79513_c0_seq1;GAXK01085409.1;Q9EQC0;3.12E-12;CHST1_MOUSE;Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130";"galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]"
comp79518_c4_seq1;GAXK01085825.1;P97789;0;XRN1_MOUSE;5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]";"GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503";"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]"
comp7954_c1_seq1;GAXK01101285.1;P41252;0;SYIC_HUMAN;Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS);"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062";"isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]";"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]";"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]"
comp795526_c0_seq1;GAXK01154392.1;P70496;0;PLD1_RAT;Phospholipase D1 (PLD 1) (rPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; vesicle [GO:0031982]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell migration [GO:0030335]; regulation of microvillus assembly [GO:0032534]; response to peptide hormone [GO:0043434]";"GO:0000139; GO:0004630; GO:0005789; GO:0005794; GO:0006654; GO:0008654; GO:0009395; GO:0030027; GO:0030335; GO:0031902; GO:0031982; GO:0031985; GO:0032534; GO:0035091; GO:0043231; GO:0043434; GO:0045202; GO:0048017; GO:0048471; GO:0048870; GO:0070290";"cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell migration [GO:0030335]; regulation of microvillus assembly [GO:0032534]; response to peptide hormone [GO:0043434]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; vesicle [GO:0031982]";"N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]"
comp7955300_c0_seq1;GAXK01034095.1;Q39565;4.13E-31;DYHB_CHLRE;Dynein beta chain, flagellar outer arm;"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]";"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp79554_c3_seq1;GAXK01085202.1;E6ZHJ8;7.42E-15;FXL15_DICLA;F-box/LRR-repeat protein 15;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0000086; GO:0005737; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp79557_c4_seq1;GAXK01085304.1;Q9JJY4;3.42E-108;DDX20_MOUSE;Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) (Regulator of steroidogenic factor 1) (ROSF-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcriptional repressor complex [GO:0017053]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000122; GO:0000387; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005829; GO:0008285; GO:0017053; GO:0019904; GO:0030674; GO:0032797; GO:0034719; GO:0042826; GO:0043065; GO:0045892; GO:0048477; GO:0050810; GO:0070491; GO:0090571; GO:0097504";"negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcriptional repressor complex [GO:0017053]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp7957185_c0_seq1;GAXK01172645.1;Q9LQK7;3.44E-10;AB7I_ARATH;Protein ABCI7, chloroplastic (ABC transporter I family member 7) (ABC transporter ABCI.7) (AtABCI7) (Non-intrinsic ABC protein 6) (Plastid SufD-like protein);"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]; embryo development ending in seed dormancy [GO:0009793]; iron-sulfur cluster assembly [GO:0016226]; thylakoid membrane organization [GO:0010027]";"GO:0009507; GO:0009536; GO:0009570; GO:0009793; GO:0010027; GO:0016226";"embryo development ending in seed dormancy [GO:0009793]; iron-sulfur cluster assembly [GO:0016226]; thylakoid membrane organization [GO:0010027]";"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]";
comp7958_c0_seq1;GAXK01101024.1;P06576;4.91E-55;ATPB_HUMAN;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta);"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transmembrane transporter activity [GO:0022857]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0007005; GO:0009986; GO:0016020; GO:0022857; GO:0031966; GO:0042288; GO:0042407; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600";"angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]";"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; transmembrane transporter activity [GO:0022857]"
comp79592_c0_seq1;GAXK01085810.1;P29617;1.15E-76;PROS_DROME;Homeobox protein prospero;"apical cortex [GO:0045179]; basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; brain development [GO:0007420]; cell dedifferentiation [GO:0043697]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; compound eye cone cell fate commitment [GO:0042676]; courtship behavior [GO:0007619]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; eye photoreceptor cell differentiation [GO:0001754]; G1 to G0 transition [GO:0070314]; ganglion mother cell fate determination [GO:0007402]; glial cell differentiation [GO:0010001]; male courtship behavior [GO:0008049]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; R7 cell fate commitment [GO:0007465]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to nucleus [GO:1900180]; regulation of R7 cell differentiation [GO:0045676]; regulation of retinal cone cell fate specification [GO:0042673]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of taste [GO:0050909]; synapse assembly [GO:0007416]; ventral cord development [GO:0007419]";"GO:0000122; GO:0001227; GO:0001708; GO:0001754; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0005886; GO:0005938; GO:0006355; GO:0007399; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007416; GO:0007417; GO:0007419; GO:0007420; GO:0007422; GO:0007423; GO:0007465; GO:0007619; GO:0008049; GO:0008104; GO:0008285; GO:0008356; GO:0010001; GO:0010468; GO:0010628; GO:0010629; GO:0014016; GO:0042673; GO:0042676; GO:0043565; GO:0043697; GO:0045165; GO:0045178; GO:0045179; GO:0045180; GO:0045664; GO:0045676; GO:0045944; GO:0048813; GO:0050771; GO:0050909; GO:0051090; GO:0055059; GO:0055060; GO:0060385; GO:0061564; GO:0070314; GO:0070983; GO:1900180; GO:1902692";"asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; brain development [GO:0007420]; cell dedifferentiation [GO:0043697]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; compound eye cone cell fate commitment [GO:0042676]; courtship behavior [GO:0007619]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; eye photoreceptor cell differentiation [GO:0001754]; G1 to G0 transition [GO:0070314]; ganglion mother cell fate determination [GO:0007402]; glial cell differentiation [GO:0010001]; male courtship behavior [GO:0008049]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; R7 cell fate commitment [GO:0007465]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to nucleus [GO:1900180]; regulation of R7 cell differentiation [GO:0045676]; regulation of retinal cone cell fate specification [GO:0042673]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of taste [GO:0050909]; synapse assembly [GO:0007416]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]"
comp796_c0_seq1;GAXK01166403.1;Q969S3;1.68E-74;ZN622_HUMAN;Zinc finger protein 622 (Zinc finger-like protein 9);"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000981; GO:0003723; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0022625; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330";"intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp796036_c0_seq1;GAXK01022430.1;P10076;6.80E-57;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp796078_c0_seq1;GAXK01022525.1;P18722;7.39E-12;ZG46_XENLA;Gastrula zinc finger protein XlCGF46.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7961451_c0_seq1;GAXK01098750.1;Q39709;1.40E-23;FCP_ISOGA;Fucoxanthin-chlorophyll a-c binding protein, chloroplastic (FCP);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp7963898_c0_seq1;GAXK01108911.1;Q5E8M6;4.00E-11;COABC_ALIF1;"Coenzyme A biosynthesis bifunctional protein CoaBC (DNA/pantothenate metabolism flavoprotein) [Includes: Phosphopantothenoylcysteine decarboxylase (PPCDC) (EC 4.1.1.36) (CoaC); Phosphopantothenate--cysteine ligase (EC 6.3.2.5) (CoaB) (PPC synthetase) (PPCS) (Phosphopantothenoylcysteine synthase)]";"FMN binding [GO:0010181]; metal ion binding [GO:0046872]; phosphopantothenate--cysteine ligase activity [GO:0004632]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]; pantothenate catabolic process [GO:0015941]";"GO:0004632; GO:0004633; GO:0010181; GO:0015937; GO:0015941; GO:0046872";"coenzyme A biosynthetic process [GO:0015937]; pantothenate catabolic process [GO:0015941]";;"FMN binding [GO:0010181]; metal ion binding [GO:0046872]; phosphopantothenate--cysteine ligase activity [GO:0004632]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]"
comp796420_c0_seq1;GAXK01022433.1;Q26492;1.63E-09;ITPL_SCHGR;Ion transport peptide-like;"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]";"GO:0005184; GO:0005576";;extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp796550_c0_seq1;GAXK01022436.1;Q6ZMW2;2.83E-28;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp796593_c0_seq1;GAXK01022527.1;P0DSI3;4.32E-18;VA3_DINQU;Venom allergen 3 homolog (Cysteine-rich venom protein) (CRVP);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp7966_c0_seq1;GAXK01100073.1;Q99PT1;4.90E-57;GDIR1_MOUSE;Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (GDI-1) (Rho-GDI alpha);"cytosol [GO:0005829]; extracellular space [GO:0005615]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202]; fatty acid binding [GO:0005504]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; Rho GTPase binding [GO:0017048]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; negative regulation of cell migration [GO:0030336]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001772; GO:0005094; GO:0005096; GO:0005504; GO:0005615; GO:0005634; GO:0005829; GO:0007266; GO:0008360; GO:0016020; GO:0017048; GO:0019901; GO:0030336; GO:0032880; GO:0035023; GO:0045202; GO:0048365; GO:0051879; GO:0071260; GO:0071407; GO:0071461; GO:0071526; GO:2000249";"cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to redox state [GO:0071461]; negative regulation of cell migration [GO:0030336]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202]";"fatty acid binding [GO:0005504]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; Rho GTPase binding [GO:0017048]"
comp7966241_c0_seq1;GAXK01186705.1;P38379;6.20E-43;SC61A_PYRSA;Protein transport protein Sec61 subunit alpha;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]";"GO:0005789; GO:0015031; GO:0016021";protein transport [GO:0015031];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp79665_c3_seq1;GAXK01085416.1;Q8VDD9;3.44E-153;PHIP_MOUSE;PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (Neuronal differentiation-related protein) (NDRP) (WD repeat-containing protein 11);"nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]; cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of growth [GO:0040008]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001932; GO:0005158; GO:0005634; GO:0006357; GO:0006606; GO:0007010; GO:0008284; GO:0008286; GO:0008360; GO:0010800; GO:0022604; GO:0033138; GO:0040008; GO:0043066; GO:0043568; GO:0045840; GO:0045893; GO:0045944; GO:0070577; GO:2001237";"cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of growth [GO:0040008]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]"
comp79677_c1_seq1;GAXK01085791.1;O08876;6.22E-33;KLF10_RAT;Krueppel-like factor 10 (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1) (Zinc finger transcription factor homolog CPG20);"nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; bone mineralization [GO:0030282]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0005634; GO:0006357; GO:0007623; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0046872; GO:1901653";"bone mineralization [GO:0030282]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]";nucleus [GO:0005634];"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp796773_c0_seq1;GAXK01022511.1;Q9UJU3;2.16E-17;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp7967835_c0_seq1;GAXK01186703.1;O18276;1.33E-14;GBRB_CAEEL;Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp796814_c0_seq1;GAXK01022521.1;Q8JG30;4.96E-43;ST1B1_CHICK;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]";"GO:0005737; GO:0008146; GO:0008202";steroid metabolic process [GO:0008202];cytoplasm [GO:0005737];sulfotransferase activity [GO:0008146]
comp79683_c1_seq1;GAXK01085792.1;Q6GPH4;1.80E-26;XAF1_HUMAN;XIAP-associated factor 1 (BIRC4-binding protein);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337]";"GO:0005634; GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0035456; GO:0060337";"apoptotic process [GO:0006915]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";zinc ion binding [GO:0008270]
comp79706_c0_seq1;GAXK01085959.1;Q27712;1.78E-50;CP2L1_PANAR;Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1);"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]";"GO:0005506; GO:0005789; GO:0020037; GO:0070330";;endoplasmic reticulum membrane [GO:0005789];"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp797084_c0_seq1;GAXK01022529.1;Q8WTS6;1.82E-28;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp797089_c0_seq1;GAXK01022514.1;P16066;0;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp797091_c0_seq1;GAXK01022471.1;Q9U3P2;1.61E-14;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp797198_c0_seq1;GAXK01022508.1;P70196;1.74E-73;TRAF6_MOUSE;TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6);"CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]";"GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002726; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032743; GO:0032991; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043123; GO:0043422; GO:0043507; GO:0045084; GO:0045410; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051023; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:1901224; GO:1904996; GO:2000679";"activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; interleukin-1-mediated signaling pathway [GO:0070498]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]";"CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp7972031_c0_seq1;GAXK01054659.1;Q57242;4.96E-63;UUP1_HAEIN;ABC transporter ATP-binding protein uup-1;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]";"GO:0003677; GO:0004832; GO:0005524; GO:0005737; GO:0006438; GO:0016887";valyl-tRNA aminoacylation [GO:0006438];cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; valine-tRNA ligase activity [GO:0004832]"
comp7974114_c0_seq1;GAXK01057695.1;Q9JI18;7.03E-08;LRP1B_MOUSE;Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701]";"GO:0001701; GO:0005041; GO:0005509; GO:0016020; GO:0016021; GO:0043235; GO:0050750";in utero embryonic development [GO:0001701];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]";"calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]"
comp7975217_c0_seq1;GAXK01057691.1;P03360;6.07E-11;POL_AVIRE;"Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";"GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";;"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp7975840_c0_seq1;GAXK01057696.1;P36267;3.16E-60;GGT_PSEUA;"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]";"periplasmic space [GO:0042597]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]";"GO:0006750; GO:0006751; GO:0036374; GO:0042597; GO:0102953; GO:0103068";"glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]";periplasmic space [GO:0042597];"glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]"
comp79763_c2_seq1;GAXK01085806.1;Q7KRI2;4.56E-34;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp79768_c0_seq1;GAXK01085414.1;O02776;3.33E-146;PARG_BOVIN;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"GO:0004649; GO:0005634; GO:0005737; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";poly(ADP-ribose) glycohydrolase activity [GO:0004649]
comp79779_c15_seq1;GAXK01085921.1;Q9Y490;4.35E-146;TLN1_HUMAN;Talin-1;"cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]";"GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005925; GO:0006936; GO:0007016; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527";"cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]";"cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]"
comp79784_c2_seq1;GAXK01085550.1;A0ZSK4;1.21E-32;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp7979102_c0_seq1;GAXK01028220.1;P22608;7.84E-55;PILB_PSEAE;Type 4 fimbrial assembly protein PilB;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cell motility [GO:0048870]; protein transport [GO:0015031]; type IV pilus biogenesis [GO:0043683]; type IV pilus-dependent motility [GO:0043107]";"GO:0005524; GO:0005737; GO:0005886; GO:0015031; GO:0016887; GO:0043107; GO:0043683; GO:0048870";"cell motility [GO:0048870]; protein transport [GO:0015031]; type IV pilus biogenesis [GO:0043683]; type IV pilus-dependent motility [GO:0043107]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp7979428_c0_seq1;GAXK01028218.1;Q9VYB7;3.53E-37;TPST_DROME;Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase) (TPST);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"GO:0000139; GO:0005794; GO:0006478; GO:0008476; GO:0009306; GO:0016021";"peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";protein-tyrosine sulfotransferase activity [GO:0008476]
comp798040_c0_seq1;GAXK01050823.1;Q9Z0Z7;9.99E-33;KLF5_MOUSE;Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of cardiac vascular smooth muscle cell differentiation [GO:2000723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle tissue regeneration [GO:0043403]";"GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008134; GO:0008284; GO:0010468; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0035914; GO:0043231; GO:0043403; GO:0043426; GO:0043565; GO:0045600; GO:0045893; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0071407; GO:0099156; GO:1901653; GO:1902895; GO:1990830; GO:2000723";"angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of cardiac vascular smooth muscle cell differentiation [GO:2000723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of gene expression [GO:0010468]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle tissue regeneration [GO:0043403]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp798044_c0_seq1;GAXK01050828.1;Q6NT16;7.35E-27;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp798052_c0_seq1;GAXK01050833.1;P15594;1.40E-07;RTP2_TRYBG;Retrotransposable element SLACS 132 kDa protein (ORF2) [Includes: Reverse transcriptase (EC 2.7.7.49)];RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp7980729_c0_seq1;GAXK01197025.1;Q9XHM1;3.34E-17;EIF3C_MEDTR;Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";"translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp798187_c0_seq1;GAXK01050783.1;P50219;3.16E-25;MNX1_HUMAN;Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]";"GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0006959; GO:0009653; GO:0021520; GO:0031018; GO:0043565; GO:0048812";"anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]";"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp7982844_c0_seq1;GAXK01179702.1;A4FBM5;2.99E-35;PGK_SACEN;Phosphoglycerate kinase (EC 2.7.2.3);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]";"GO:0004618; GO:0005524; GO:0005737; GO:0006096";glycolytic process [GO:0006096];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]"
comp7984_c0_seq1;GAXK01100253.1;O14327;1.54E-07;PAB2_SCHPO;Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Poly(A)-binding protein II) (PABII);"cytoplasm [GO:0005737]; Mmi1 nuclear focus [GO:1990251]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; poly(A) binding [GO:0008143]; mRNA catabolic process [GO:0006402]";"GO:0000790; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005844; GO:0006402; GO:0008143; GO:0016604; GO:1990251";mRNA catabolic process [GO:0006402];"cytoplasm [GO:0005737]; Mmi1 nuclear focus [GO:1990251]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]";poly(A) binding [GO:0008143]
comp7984017_c0_seq1;GAXK01088427.1;Q5ZJ60;1.57E-13;HIBCH_CHICK;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H);"mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";"GO:0003860; GO:0005739; GO:0006574; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; valine catabolic process [GO:0006574]";mitochondrion [GO:0005739];3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]
comp7985299_c0_seq1;GAXK01088424.1;P31252;1.17E-19;UBE13_WHEAT;Ubiquitin-activating enzyme E1 3 (EC 6.2.1.45);"ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]";"GO:0004839; GO:0005524";;;"ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]"
comp79854_c0_seq1;GAXK01085477.1;B4LY58;1.36E-08;HTRA2_DROVI;Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2);"integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]";"GO:0004252; GO:0005758; GO:0006915; GO:0016021; GO:0031966";apoptotic process [GO:0006915];"integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]";serine-type endopeptidase activity [GO:0004252]
comp79862_c0_seq1;GAXK01085565.1;Q9H0H5;1.01E-10;RGAP1_HUMAN;Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4);"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019886; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0035556; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149";"actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]";"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]";"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]"
comp798631_c0_seq1;GAXK01050831.1;Q7KRI2;8.69E-13;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp79875_c1_seq1;GAXK01085801.1;Q58FK9;2.24E-151;KAT3_RAT;Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]";"GO:0005737; GO:0005739; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0047315; GO:0047804; GO:0070189";"biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]"
comp7988_c0_seq1;GAXK01100306.1;Q15185;1.76E-15;TEBP_HUMAN;Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23);"chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]; chaperone binding [GO:0051087]; DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; xenobiotic metabolic process [GO:0006805]";"GO:0000723; GO:0000781; GO:0001516; GO:0003720; GO:0005634; GO:0005654; GO:0005697; GO:0005737; GO:0005829; GO:0006457; GO:0006805; GO:0007004; GO:0007165; GO:0019371; GO:0032991; GO:0042327; GO:0050220; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0051131; GO:0051879; GO:0051973; GO:0070182; GO:0101031; GO:1900034; GO:1905323";"chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; xenobiotic metabolic process [GO:0006805]";"chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]";"chaperone binding [GO:0051087]; DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082]"
comp798803_c0_seq1;GAXK01050841.1;O46040;3.56E-14;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp7988279_c0_seq1;GAXK01086596.1;Q6C5H4;1.46E-24;GSHR_YARLI;Glutathione reductase (GR) (GRase) (EC 1.8.1.7);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]";"GO:0004362; GO:0005739; GO:0005829; GO:0006749; GO:0009055; GO:0034599; GO:0045454; GO:0050660; GO:0050661";"cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]"
comp799005_c0_seq1;GAXK01050816.1;Q6Y288;1.64E-34;B3GLT_HUMAN;Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066";"fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp7990231_c0_seq1;;P55395;1.65E-19;TRBB_SINFN;Probable conjugal transfer protein TrbB;"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; conjugation [GO:0000746]";"GO:0000746; GO:0005524; GO:0005737";conjugation [GO:0000746];cytoplasm [GO:0005737];ATP binding [GO:0005524]
comp7991133_c0_seq1;GAXK01098996.1;Q64424;8.13E-18;LIPR2_MYOCO;Pancreatic lipase-related protein 2 (PL-RP2) (EC 3.1.1.26) (EC 3.1.1.3) (Galactolipase);"extracellular space [GO:0005615]; 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; galactolipid catabolic process [GO:0019376]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0009395; GO:0019376; GO:0047372; GO:0047714; GO:0102549";"galactolipid catabolic process [GO:0019376]; phospholipid catabolic process [GO:0009395]";extracellular space [GO:0005615];"1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]"
comp7991259_c0_seq1;GAXK01098995.1;P42435;2.81E-21;NASD_BACSU;Nitrite reductase [NAD(P)H] (EC 1.7.1.4);"4 iron, 4 sulfur cluster binding [GO:0051539]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitrite reductase [NAD(P)H] activity [GO:0008942]; nitrate assimilation [GO:0042128]";"GO:0008942; GO:0020037; GO:0042128; GO:0046872; GO:0050660; GO:0050661; GO:0051539";nitrate assimilation [GO:0042128];;"4 iron, 4 sulfur cluster binding [GO:0051539]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitrite reductase [NAD(P)H] activity [GO:0008942]"
comp799203_c0_seq1;GAXK01050819.1;Q7KRI2;8.11E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp7992776_c0_seq1;GAXK01050982.1;P60039;1.23E-49;RL73_ARATH;60S ribosomal protein L7-3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003735; GO:0022625";maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp7993206_c0_seq1;GAXK01050975.1;Q220R4;1.12E-11;RUVA_RHOFT;Holliday junction ATP-dependent DNA helicase RuvA (EC 3.6.4.12);"Holliday junction helicase complex [GO:0009379]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0006281; GO:0006310; GO:0009378; GO:0009379; GO:0009432";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";Holliday junction helicase complex [GO:0009379];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp7994_c0_seq1;GAXK01100124.1;Q9JJ80;5.32E-119;RPF2_MOUSE;Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog);"nucleolus [GO:0005730]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0000027; GO:0000463; GO:0000981; GO:0005634; GO:0005730; GO:0008097; GO:0042273; GO:1901796; GO:1902570";"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
comp79948_c0_seq1;GAXK01085971.1;Q0EEE2;4.07E-95;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp7996075_c0_seq1;GAXK01067230.1;Q8G6P9;1.81E-23;PKNB_BIFLO;Probable serine/threonine-protein kinase PknB (EC 2.7.11.1);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp7997_c0_seq1;GAXK01100235.1;Q8BTQ0;8.06E-83;PCGF3_MOUSE;Polycomb group RING finger protein 3 (RING finger protein 3A);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]";"GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0060819";"histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp799735_c0_seq1;GAXK01050817.1;P02595;1.42E-11;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp79980_c0_seq1;GAXK01085803.1;Q9JIP7;6.24E-131;S15A1_MOUSE;Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) (Proton-coupled dipeptide cotransporter);"brush border [GO:0005903]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"GO:0005427; GO:0005887; GO:0005903; GO:0006857; GO:0015031; GO:0015333; GO:0016020; GO:0016021; GO:0016248; GO:0035673; GO:0051956; GO:0071916; GO:1904680";"negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]";"brush border [GO:0005903]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide:proton symporter activity [GO:0015333]; peptide transmembrane transporter activity [GO:1904680]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]"
comp79981_c1_seq1;GAXK01085458.1;Q9Z2G9;1.84E-53;HTAI2_MOUSE;Oxidoreductase HTATIP2 (EC 1.1.1.-);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]";"GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170; GO:0051287";"angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]";"NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]"
comp799820_c0_seq1;GAXK01050835.1;Q7ZYC4;4.67E-50;ACBG2_XENLA;Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15);"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391";;cytoplasm [GO:0005737];"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp79985_c1_seq1;GAXK01085601.1;Q24180;2.55E-07;DEAF1_DROME;Deformed epidermal autoregulatory factor 1 (Protein DEAF-1);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776";"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp799944_c0_seq1;GAXK01050818.1;Q08BL7;8.03E-80;GLCTK_DANRE;Glycerate kinase (EC 2.7.1.31);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]; protein phosphorylation [GO:0006468]";"GO:0005524; GO:0005737; GO:0006468; GO:0008887";protein phosphorylation [GO:0006468];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]"
comp799998_c1_seq1;GAXK01050827.1;Q18297;8.05E-58;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp8_c1_seq1;GAXK01169633.1;P02993;0;EF1A_ARTSA;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp80_c0_seq1;GAXK01168683.1;Q6EV23;4.17E-88;RS23_PAPDA;40S ribosomal protein S23;"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788";cytoplasmic translation [GO:0002181];"cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]";structural constituent of ribosome [GO:0003735]
comp800038_c0_seq1;GAXK01195864.1;Q6DJM2;1.95E-39;TAM41_XENLA;Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41);"extrinsic component of mitochondrial inner membrane [GO:0031314]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]";"GO:0004605; GO:0016024; GO:0031314; GO:0032049";"cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]";extrinsic component of mitochondrial inner membrane [GO:0031314];phosphatidate cytidylyltransferase activity [GO:0004605]
comp8001046_c0_seq1;GAXK01151397.1;Q54YD2;2.52E-20;Y8295_DICDI;Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0278295;"sterol binding [GO:0032934]; sterol transport [GO:0015918]";"GO:0015918; GO:0032934";sterol transport [GO:0015918];;sterol binding [GO:0032934]
comp800347_c0_seq1;GAXK01195821.1;P17141;7.23E-24;ZFP37_MOUSE;Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007281; GO:0007283; GO:0008270";"germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp80035_c1_seq1;GAXK01019161.1;Q5RA23;1.91E-12;NFYC_PONAB;Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC);"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0003677; GO:0005634; GO:0046982";;nucleus [GO:0005634];"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp80036_c0_seq1;GAXK01019334.1;Q9GRW0;3.93E-75;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp8003777_c0_seq1;GAXK01180181.1;P0AA16;5.98E-19;OMPR_ECOLI;Transcriptional regulatory protein OmpR;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay response regulator activity [GO:0000156]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000156; GO:0000160; GO:0003677; GO:0005737; GO:0045893";"phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]";cytoplasm [GO:0005737];"DNA binding [GO:0003677]; phosphorelay response regulator activity [GO:0000156]"
comp800389_c0_seq1;GAXK01195863.1;B9FKW9;1.39E-09;CDPKE_ORYSJ;Calcium-dependent protein kinase 14 (OsCDPK14) (OsCPK14) (EC 2.7.11.1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0009738; GO:0009931; GO:0016020; GO:0018105; GO:0035556; GO:0046777";"abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]";"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]"
comp800528_c0_seq1;GAXK01195841.1;Q8WX94;2.50E-14;NALP7_HUMAN;NACHT, LRR and PYD domains-containing protein 7 (Nucleotide-binding oligomerization domain protein 12) (PYRIN-containing APAF1-like protein 3);"aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; interleukin-1 binding [GO:0019966]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of aspartic-type peptidase activity [GO:1905246]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of protein processing [GO:0010955]; positive regulation of interleukin-1 beta secretion [GO:0050718]";"GO:0005524; GO:0010955; GO:0019828; GO:0019966; GO:0050713; GO:0050718; GO:0071222; GO:0071347; GO:0089720; GO:1900016; GO:1905246";"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of aspartic-type peptidase activity [GO:1905246]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of protein processing [GO:0010955]; positive regulation of interleukin-1 beta secretion [GO:0050718]";;"aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; interleukin-1 binding [GO:0019966]"
comp8005340_c0_seq1;GAXK01161089.1;Q6PEH9;2.72E-09;S39AA_DANRE;Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10);"integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; response to zinc ion [GO:0010043]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005887; GO:0006829; GO:0006882; GO:0010043; GO:0055113; GO:0071578";"cellular zinc ion homeostasis [GO:0006882]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; response to zinc ion [GO:0010043]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]";integral component of plasma membrane [GO:0005887];zinc ion transmembrane transporter activity [GO:0005385]
comp8005853_c0_seq1;GAXK01161086.1;O22254;9.76E-34;RL181_ARATH;Putative 60S ribosomal protein L18-1;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8006_c1_seq1;GAXK01014637.1;P13808;0;B3A2_MOUSE;Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; anion:anion antiporter activity [GO:0015301]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; regulation of intracellular pH [GO:0051453]";"GO:0005452; GO:0005887; GO:0006821; GO:0015108; GO:0015301; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0051453";"bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; regulation of intracellular pH [GO:0051453]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"anion:anion antiporter activity [GO:0015301]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]"
comp80084_c0_seq1;GAXK01019364.1;Q9CQW7;9.23E-30;COA8_MOUSE;Cytochrome c oxidase assembly factor 8 (COA8) (Apoptogenic protein 1, mitochondrial) (APOP-1);"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein stabilization [GO:0050821]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0005739; GO:0033617; GO:0034393; GO:0043280; GO:0050821; GO:0090200; GO:0097193; GO:0099617; GO:1903427; GO:1904960";"intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein stabilization [GO:0050821]; response to reactive oxygen species [GO:0000302]";"matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739]";
comp8009_c0_seq1;GAXK01013395.1;P05661;1.33E-124;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp800924_c0_seq1;GAXK01195808.1;O46040;5.70E-32;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp800964_c1_seq1;GAXK01195861.1;P52746;2.81E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp801_c0_seq1;GAXK01170546.1;O76217;7.98E-08;PE1_ANOGA;Peritrophin-1 (AgAper-1) (Peritrophic matrix protein 1) (Peritrophin A);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];chitin binding [GO:0008061]
comp8010_c12_seq1;GAXK01014860.1;P48053;1.49E-92;YPD1_CAEEL;Uncharacterized protein C05D11.1;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0046872";;;"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp80100_c2_seq1;GAXK01019189.1;Q23498;6.93E-32;ASM2_CAEEL;Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Acid sphingomyelinase 2);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005576; GO:0005615; GO:0005764; GO:0006685; GO:0008081; GO:0016798; GO:0046513; GO:0046872; GO:0061750";"ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]";"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]"
comp801183_c0_seq1;GAXK01205992.1;Q9VUF8;1.23E-105;CP314_DROME;Ecdysone 20-monooxygenase (E20MO) (EC 1.14.99.22) (CYPCCCXIVA1) (Cytochrome P450 314a1, mitochondrial) (Protein shade);"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ecdysone 20-monooxygenase activity [GO:0004501]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysteroid biosynthetic process [GO:0045456]; growth of a germarium-derived egg chamber [GO:0007295]; head involution [GO:0008258]; midgut development [GO:0007494]; pupation [GO:0035074]";"GO:0004501; GO:0005506; GO:0005739; GO:0007295; GO:0007298; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0016491; GO:0020037; GO:0031966; GO:0035074; GO:0045456";"border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; dorsal closure [GO:0007391]; ecdysteroid biosynthetic process [GO:0045456]; growth of a germarium-derived egg chamber [GO:0007295]; head involution [GO:0008258]; midgut development [GO:0007494]; pupation [GO:0035074]";"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"ecdysone 20-monooxygenase activity [GO:0004501]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"
comp801309_c0_seq1;GAXK01195833.1;Q9SEE4;5.33E-12;PIRL_SOLLC;Pirin-like protein;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp80138_c3_seq1;GAXK01019122.1;Q6F7T9;6.66E-76;ALMA_ACIAD;Probable FAD-binding monooxygenase AlmA (EC 1.14.13.-);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; alkane catabolic process [GO:0043448]";"GO:0004499; GO:0005886; GO:0016021; GO:0043448; GO:0050660; GO:0050661";alkane catabolic process [GO:0043448];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
comp8014_c0_seq1;GAXK01013958.1;Q6IFY7;3.22E-39;RTN1A_XENLA;Reticulon-1-A (RTN1.1) (xRTN1) (XRTN1-C.1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"GO:0005634; GO:0005789; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";
comp80145_c0_seq1;GAXK01019497.1;Q7TPD0;0;INT3_MOUSE;Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A);"cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]";"GO:0005634; GO:0005730; GO:0005737; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0016180; GO:0032039; GO:0070876";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]";"cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SOSS complex [GO:0070876]";
comp801508_c0_seq1;GAXK01195877.1;Q8BG19;6.12E-144;TMTC4_MOUSE;Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]";"GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269";protein O-linked mannosylation [GO:0035269];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp801511_c0_seq1;GAXK01195817.1;Q55874;3.82E-07;Y103_SYNY3;Uncharacterized protein sll0103;;;;;
comp8016_c1_seq1;GAXK01014144.1;P29742;0;CLH_DROME;Clathrin heavy chain;"cell cortex [GO:0005938]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; dsRNA transport [GO:0033227]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; receptor-mediated endocytosis [GO:0006898]; regulation of growth [GO:0040008]; regulation of tube length, open tracheal system [GO:0035159]; secretory granule organization [GO:0033363]; sperm individualization [GO:0007291]; synaptic vesicle exocytosis [GO:0016079]";"GO:0005198; GO:0005802; GO:0005886; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0006898; GO:0007268; GO:0007291; GO:0008103; GO:0010508; GO:0016079; GO:0030130; GO:0030132; GO:0030136; GO:0030141; GO:0030198; GO:0031410; GO:0032051; GO:0033227; GO:0033363; GO:0035002; GO:0035159; GO:0040008; GO:0045334; GO:0045451; GO:0045807; GO:0046667; GO:0048471; GO:0048749; GO:0071439; GO:0098793";"chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; compound eye retinal cell programmed cell death [GO:0046667]; dsRNA transport [GO:0033227]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular protein transport [GO:0006886]; liquid clearance, open tracheal system [GO:0035002]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of autophagy [GO:0010508]; positive regulation of endocytosis [GO:0045807]; receptor-mediated endocytosis [GO:0006898]; regulation of growth [GO:0040008]; regulation of tube length, open tracheal system [GO:0035159]; secretory granule organization [GO:0033363]; sperm individualization [GO:0007291]; synaptic vesicle exocytosis [GO:0016079]";"cell cortex [GO:0005938]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]";"clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]"
comp801638_c0_seq1;GAXK01195807.1;Q2LE78;3.36E-08;BTBD6_XENLA;BTB/POZ domain-containing protein 6;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp8017_c0_seq1;GAXK01014143.1;Q04832;2.26E-13;HEXP_LEIMA;DNA-binding protein HEXBP (Hexamer-binding protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0005634; GO:0008270";;nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp801721_c0_seq1;GAXK01195869.1;Q9U3P2;4.10E-19;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp801791_c0_seq1;GAXK01195845.1;Q14982;1.72E-26;OPCM_HUMAN;Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1);"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"GO:0005576; GO:0005886; GO:0007155; GO:0008038; GO:0031225";"cell adhesion [GO:0007155]; neuron recognition [GO:0008038]";"anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]";
comp8018_c1_seq1;GAXK01013953.1;Q6P1L6;2.60E-09;ZN343_HUMAN;Zinc finger protein 343;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8018006_c0_seq1;GAXK01076225.1;P36609;7.76E-12;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp8018542_c0_seq1;GAXK01076228.1;Q9P784;2.45E-42;RL4B_SCHPO;60S ribosomal protein L4-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp801855_c1_seq1;GAXK01195831.1;P36537;1.09E-52;UDB10_HUMAN;UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]";"GO:0005789; GO:0006629; GO:0008194; GO:0016021; GO:0016758; GO:0043231";lipid metabolic process [GO:0006629];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]"
comp80192_c0_seq1;GAXK01019525.1;Q6ZNH5;1.20E-08;ZN497_HUMAN;Zinc finger protein 497;"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp80196_c0_seq1;GAXK01019613.1;P51487;7.69E-49;ARRB_CALVI;Phosrestin-1 (Arrestin-2) (Arrestin-B) (Phosrestin I);"signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0007165; GO:0007601";"signal transduction [GO:0007165]; visual perception [GO:0007601]";;
comp80205_c4_seq1;GAXK01019355.1;Q4SS66;4.24E-18;TRBP2_TETNG;RISC-loading complex subunit tarbp2;"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"GO:0003725; GO:0005737; GO:0006417; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0035197; GO:0035198; GO:0035280; GO:0042803; GO:0046782; GO:0070578; GO:0070883; GO:0090065; GO:1903798";"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]";"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]"
comp80212_c0_seq1;GAXK01019132.1;Q03755;1.35E-07;CUT1_CAEEL;Cuticlin-1;"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; structural constituent of cuticle [GO:0042302]";"GO:0042302; GO:0060102";;collagen and cuticulin-based cuticle extracellular matrix [GO:0060102];structural constituent of cuticle [GO:0042302]
comp802212_c0_seq1;GAXK01046627.1;P78563;4.07E-12;RED1_HUMAN;Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0044387; GO:0045070; GO:0045087; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049";"adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp802323_c0_seq1;GAXK01046659.1;P15620;2.82E-27;ZN271_MOUSE;Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";"GO:0000976; GO:0002437; GO:0002829; GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872";"cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp8027444_c0_seq1;GAXK01180436.1;Q16974;6.49E-23;KPC1_APLCA;Calcium-dependent protein kinase C (EC 2.7.11.13) (APL I);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]";"GO:0004697; GO:0005524; GO:0005737; GO:0008270; GO:0035556";intracellular signal transduction [GO:0035556];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]"
comp80276_c0_seq1;GAXK01019350.1;Q62296;0;TEAD4_MOUSE;Transcriptional enhancer factor TEF-3 (ETF-related factor 2) (ETFR-2) (TEA domain family member 4) (TEAD-4) (TEF-1-related factor 1) (TEF-1-related factor FR-19) (RTEF-1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; embryo implantation [GO:0007566]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; trophectodermal cell fate commitment [GO:0001830]";"GO:0000978; GO:0001085; GO:0001228; GO:0001701; GO:0001708; GO:0001825; GO:0001830; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0007566; GO:0032993; GO:0035329; GO:0043565; GO:0044212; GO:0045165; GO:0045944; GO:1902459";"blastocyst formation [GO:0001825]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; embryo implantation [GO:0007566]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; trophectodermal cell fate commitment [GO:0001830]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp8028020_c0_seq1;GAXK01155858.1;G5E8K5;1.15E-16;ANK3_MOUSE;Ankyrin-3 (ANK-3) (Ankyrin-G);"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259";"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]";"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]"
comp802808_c0_seq1;GAXK01046633.1;P81139;1.51E-28;LIPR2_CAVPO;Pancreatic lipase-related protein 2 (PL-RP2) (EC 3.1.1.26) (EC 3.1.1.3) (GPL) (Galactolipase);"extracellular space [GO:0005615]; 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0009395; GO:0019376; GO:0047372; GO:0047714; GO:0102549";"galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]";extracellular space [GO:0005615];"1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]"
comp8028675_c0_seq1;GAXK01204897.1;Q87GB7;4.45E-56;MALF_VIBPA;Maltose/maltodextrin transport system permease protein MalF;"ATP-binding cassette (ABC) transporter complex [GO:0043190]; carbohydrate transport [GO:0008643]; transmembrane transport [GO:0055085]";"GO:0008643; GO:0043190; GO:0055085";"carbohydrate transport [GO:0008643]; transmembrane transport [GO:0055085]";ATP-binding cassette (ABC) transporter complex [GO:0043190];
comp8029004_c0_seq1;GAXK01155856.1;Q9T0F4;2.30E-07;IAN13_ARATH;Immune-associated nucleotide-binding protein 13 (AtIAN13) (AIG1-like protein);GTP binding [GO:0005525];GO:0005525;;;GTP binding [GO:0005525]
comp80298_c0_seq1;GAXK01019187.1;Q9M2E2;6.55E-22;SDR1_ARATH;(+)-neomenthol dehydrogenase (EC 1.1.1.-) (EC 1.1.1.208) (Menthone:neomenthol reductase) (Short-chain dehydrogenase/reductase 1) (AtSDR1);"cytoplasm [GO:0005737]; (+)-neomenthol dehydrogenase activity [GO:0047501]; defense response [GO:0006952]; oxidation-reduction process [GO:0055114]";"GO:0005737; GO:0006952; GO:0047501; GO:0055114";"defense response [GO:0006952]; oxidation-reduction process [GO:0055114]";cytoplasm [GO:0005737];(+)-neomenthol dehydrogenase activity [GO:0047501]
comp802986_c0_seq1;GAXK01046648.1;Q61830;1.17E-09;MRC1_MOUSE;Macrophage mannose receptor 1 (MMR) (CD antigen CD206);"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353";"cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]";"cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]"
comp80299_c1_seq1;GAXK01019585.1;Q5RBU8;2.60E-10;ROA2_PONAB;Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1);"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006406; GO:0031053; GO:0035198; GO:0043047; GO:0070062; GO:1990247; GO:1990428; GO:1990904";"miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]";"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]";"miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]"
comp803_c0_seq1;GAXK01170073.1;Q6PBH5;1.28E-08;NDUA4_DANRE;Cytochrome c oxidase subunit NDUFA4;"mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";"GO:0005751; GO:0022900; GO:1902600";"electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600]";mitochondrial respiratory chain complex IV [GO:0005751];
comp8031007_c0_seq1;GAXK01003868.1;P74292;2.28E-37;NADE_SYNY3;Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; NAD biosynthetic process [GO:0009435]";"GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0008795; GO:0009435";NAD biosynthetic process [GO:0009435];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]"
comp80312_c0_seq1;GAXK01019602.1;Q9VAT2;9.16E-92;DCA10_DROME;DDB1- and CUL4-associated factor 10 homolog (WD repeat-containing protein 32 homolog);Cul4-RING E3 ubiquitin ligase complex [GO:0080008];GO:0080008;;Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
comp8032496_c0_seq1;GAXK01063496.1;P36508;1.82E-07;ZNF76_HUMAN;Zinc finger protein 76 (Zinc finger protein 523);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]";"GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp803254_c0_seq1;GAXK01046618.1;Q86MW9;5.41E-08;SINA_SCHMA;E3 ubiquitin-protein ligase sina (EC 2.3.2.27) (RING-type E3 ubiquitin transferase sina) (Seven in absentia homolog) (SmSINA);"nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp803277_c0_seq1;GAXK01046643.1;Q8BUZ1;1.93E-21;ABRA_MOUSE;Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030016; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp803287_c0_seq1;GAXK01046619.1;Q9N003;2.21E-15;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp803353_c0_seq1;GAXK01046655.1;Q27802;0;DYHC2_TRIGR;Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B);"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]";"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0030030; GO:0030286";"cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]"
comp8034_c6_seq1;GAXK01013357.1;P51987;1.18E-28;CCNB_HYDVD;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp80348_c0_seq1;GAXK01019607.1;Q9D9I4;3.34E-83;TBC20_MOUSE;TBC1 domain family member 20;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; acrosome assembly [GO:0001675]; camera-type eye development [GO:0043010]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; male gonad development [GO:0008584]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of GTPase activity [GO:0043547]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; virion assembly [GO:0019068]";"GO:0001675; GO:0002088; GO:0005096; GO:0005783; GO:0005789; GO:0006888; GO:0007030; GO:0007283; GO:0008584; GO:0017137; GO:0019068; GO:0030173; GO:0031965; GO:0034389; GO:0043010; GO:0043547; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953";"acrosome assembly [GO:0001675]; camera-type eye development [GO:0043010]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; male gonad development [GO:0008584]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of GTPase activity [GO:0043547]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; virion assembly [GO:0019068]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp803540_c0_seq1;GAXK01046637.1;Q54P79;9.69E-89;4CL3_DICDI;Probable 4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp80358_c1_seq1;GAXK01019567.1;P54185;3.88E-11;OBA5_DROME;Putative odorant-binding protein A5 (Antennal protein 5);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp803669_c0_seq1;GAXK01046620.1;A3KPN8;7.27E-72;TTC38_DANRE;Tetratricopeptide repeat protein 38 (TPR repeat protein 38);;;;;
comp803884_c0_seq1;GAXK01046653.1;P10076;4.78E-17;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp804_c1_seq1;GAXK01166407.1;Q9W385;4.73E-28;FRDA_DROME;Frataxin homolog, mitochondrial (Dfh) (EC 1.16.3.1);"axon cytoplasm [GO:1904115]; L-cysteine desulfurase complex [GO:1990221]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; cellular iron ion homeostasis [GO:0006879]; determination of adult lifespan [GO:0008340]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; lipid catabolic process [GO:0016042]; mitochondrion organization [GO:0007005]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; positive regulation of heart contraction [GO:0045823]; positive regulation of oxidative phosphorylation [GO:1903862]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to oxidative stress [GO:0006979]; steroid biosynthetic process [GO:0006694]";"GO:0004322; GO:0005739; GO:0006694; GO:0006783; GO:0006811; GO:0006879; GO:0006979; GO:0007005; GO:0008198; GO:0008199; GO:0008340; GO:0008344; GO:0010039; GO:0016042; GO:0016226; GO:0018283; GO:0019896; GO:0034986; GO:0042542; GO:0045823; GO:0045998; GO:0051537; GO:0051881; GO:1903862; GO:1904115; GO:1990221";"adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; cellular iron ion homeostasis [GO:0006879]; determination of adult lifespan [GO:0008340]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; lipid catabolic process [GO:0016042]; mitochondrion organization [GO:0007005]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; positive regulation of heart contraction [GO:0045823]; positive regulation of oxidative phosphorylation [GO:1903862]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to oxidative stress [GO:0006979]; steroid biosynthetic process [GO:0006694]";"axon cytoplasm [GO:1904115]; L-cysteine desulfurase complex [GO:1990221]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]"
comp80402_c0_seq1;GAXK01019361.1;Q28CN3;3.63E-123;UBP33_XENTR;Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0036459; GO:0048471; GO:0051298; GO:0070536; GO:0071108";"axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]"
comp80403_c0_seq1;GAXK01019542.1;Q7L0Q8;7.68E-79;RHOU_HUMAN;Rho-related GTP-binding protein RhoU (CDC42-like GTPase 1) (GTP-binding protein-like 1) (Rho GTPase-like protein ARHU) (Ryu GTPase) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1);"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell projection assembly [GO:0030031]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006897; GO:0007010; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016601; GO:0019221; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0042995; GO:0046872; GO:0051056; GO:1903955";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell projection assembly [GO:0030031]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]";"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]"
comp80429_c1_seq1;GAXK01019303.1;P58200;1.11E-19;VTI1B_RAT;Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1);"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]";"GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0008021; GO:0012507; GO:0016021; GO:0031201; GO:0031901; GO:0031902; GO:0042147; GO:0043025; GO:0048280; GO:0055038";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]";"SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp8044243_c0_seq1;GAXK01041308.1;Q9VZW5;9.24E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp80448_c1_seq1;GAXK01019271.1;Q9UNX4;0;WDR3_HUMAN;WD repeat-containing protein 3;"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388";rRNA processing [GO:0006364];"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]";RNA binding [GO:0003723]
comp8045665_c0_seq1;GAXK01041303.1;Q1LN82;1.58E-57;F16A2_CUPMC;Fructose-1,6-bisphosphatase class 1 2 (FBPase class 1 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase class 1 2);"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]; gluconeogenesis [GO:0006094]";"GO:0000287; GO:0005737; GO:0006094; GO:0042132";gluconeogenesis [GO:0006094];cytoplasm [GO:0005737];"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]"
comp80461_c0_seq1;GAXK01019346.1;Q58EL2;2.74E-15;TM35A_DANRE;Transmembrane protein 35A;"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021; GO:0031410";;"cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp804650_c0_seq1;GAXK01155254.1;Q9XYN1;5.49E-49;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp80474_c1_seq1;GAXK01019552.1;Q9V6L0;3.10E-83;KDM4B_DROME;Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B);"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544";"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]";"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]"
comp8049925_c0_seq1;GAXK01189331.1;O35156;2.48E-17;UGPA_CRIGR;UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase);"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; UDP-glucose metabolic process [GO:0006011]";"GO:0003983; GO:0005737; GO:0006011; GO:0042802; GO:0046872";UDP-glucose metabolic process [GO:0006011];cytoplasm [GO:0005737];"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]"
comp8050899_c0_seq1;GAXK01119335.1;Q9Y8H5;5.69E-37;FAD12_MORAP;Delta(12) fatty acid desaturase (EC 1.14.19.6) (Delta-12 fatty acid desaturase);"integral component of membrane [GO:0016021]; Delta12-fatty-acid desaturase activity [GO:0102985]; oxidoreductase activity [GO:0016491]; fatty acid biosynthetic process [GO:0006633]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0006633; GO:0006636; GO:0016021; GO:0016491; GO:0102985";"fatty acid biosynthetic process [GO:0006633]; unsaturated fatty acid biosynthetic process [GO:0006636]";integral component of membrane [GO:0016021];"Delta12-fatty-acid desaturase activity [GO:0102985]; oxidoreductase activity [GO:0016491]"
comp8051061_c0_seq1;GAXK01119337.1;Q02212;4.00E-46;COX2_PHYME;Cytochrome c oxidase subunit 2 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide II);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]";"GO:0004129; GO:0005507; GO:0005743; GO:0016021; GO:0070469";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]";"copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]"
comp80512_c0_seq1;GAXK01019593.1;Q8K2V1;1.73E-97;PP4R1_MOUSE;Serine/threonine-protein phosphatase 4 regulatory subunit 1;"protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";"GO:0006470; GO:0007165; GO:0019888; GO:0030289";"protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]";protein phosphatase 4 complex [GO:0030289];protein phosphatase regulator activity [GO:0019888]
comp805216_c0_seq1;GAXK01155231.1;Q96JB3;1.57E-15;HIC2_HUMAN;Hypermethylated in cancer 2 protein (Hic-2) (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0008022; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp805354_c0_seq1;GAXK01155212.1;Q86B87;6.03E-08;MMD4_DROME;Modifier of mdg4;"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; germ cell migration [GO:0008354]; male meiosis chromosome segregation [GO:0007060]; male meiosis I [GO:0007141]; meiotic chromosome condensation [GO:0010032]; oogenesis [GO:0048477]; regulation of chromatin assembly or disassembly [GO:0001672]";"GO:0000785; GO:0001672; GO:0003677; GO:0003682; GO:0005634; GO:0005700; GO:0005704; GO:0006325; GO:0006915; GO:0007060; GO:0007141; GO:0008354; GO:0010032; GO:0031208; GO:0042803; GO:0046872; GO:0048477";"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; germ cell migration [GO:0008354]; male meiosis chromosome segregation [GO:0007060]; male meiosis I [GO:0007141]; meiotic chromosome condensation [GO:0010032]; oogenesis [GO:0048477]; regulation of chromatin assembly or disassembly [GO:0001672]";"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8054699_c0_seq1;GAXK01145809.1;P52206;7.28E-64;GNA11_CANLF;Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Fragment);"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]";"GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0007188; GO:0031683; GO:0031826; GO:0046872; GO:0060158";"action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]";"cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]"
comp80551_c0_seq1;GAXK01019580.1;O43169;4.05E-33;CYB5B_HUMAN;Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"GO:0005741; GO:0006805; GO:0016020; GO:0016021; GO:0020037; GO:0046872; GO:0055114";"oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp8056_c3_seq1;GAXK01014080.1;Q99MD6;0;TRXR3_MOUSE;Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"GO:0001825; GO:0004791; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006749; GO:0007283; GO:0009055; GO:0015035; GO:0030154; GO:0045454; GO:0050660";"blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]"
comp80563_c0_seq1;GAXK01019313.1;Q7KRI2;6.26E-31;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp805682_c0_seq1;GAXK01155214.1;Q8NF99;1.15E-07;ZN397_HUMAN;Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0003700; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0015630; GO:0042803; GO:0045892; GO:0046872; GO:0046982";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp8059623_c0_seq1;GAXK01089411.1;P43156;4.76E-20;CYSP_HEMSP;Thiol protease SEN102 (EC 3.4.22.-);"endoplasmic reticulum lumen [GO:0005788]; cysteine-type peptidase activity [GO:0008234]";"GO:0005788; GO:0008234";;endoplasmic reticulum lumen [GO:0005788];cysteine-type peptidase activity [GO:0008234]
comp8061193_c0_seq1;GAXK01072930.1;Q68Y21;3.44E-07;GRID2_DANRE;Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005886; GO:0008066; GO:0016021; GO:0030054; GO:0035249; GO:0045211; GO:0050804; GO:1904315";"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp8061528_c0_seq1;GAXK01072924.1;P96793;3.76E-08;XYLQ_LACPE;Alpha-xylosidase XylQ (EC 3.2.1.177);"cytoplasmic side of plasma membrane [GO:0009898]; alpha-D-xyloside xylohydrolase [GO:0061634]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]";"GO:0005975; GO:0009898; GO:0030246; GO:0061634";carbohydrate metabolic process [GO:0005975];cytoplasmic side of plasma membrane [GO:0009898];"alpha-D-xyloside xylohydrolase [GO:0061634]; carbohydrate binding [GO:0030246]"
comp806182_c0_seq1;GAXK01073911.1;P52746;1.23E-14;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp806236_c0_seq1;GAXK01073932.1;Q7KRI2;3.29E-25;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp806282_c0_seq1;GAXK01073921.1;Q9NY64;5.15E-24;GTR8_HUMAN;Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1);"clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; carbohydrate:proton symporter activity [GO:0005351]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]";"GO:0001666; GO:0005351; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659";"carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]";"clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]";"carbohydrate:proton symporter activity [GO:0005351]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]"
comp806473_c0_seq1;GAXK01073908.1;O70302;1.41E-13;CIDEA_MOUSE;Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A);"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell death [GO:0008219]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]";"GO:0001659; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0006629; GO:0006915; GO:0008219; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0035634; GO:0042803; GO:0050710; GO:0050995; GO:0120163; GO:1900118; GO:1902510";"apoptotic process [GO:0006915]; cell death [GO:0008219]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]";"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";protein homodimerization activity [GO:0042803]
comp8065023_c0_seq1;GAXK01064853.1;Q9ZU75;1.98E-15;UB12L_ARATH;Probable NEDD8-conjugating enzyme Ubc12-like (EC 2.3.2.-) (RUB1 carrier protein 2) (RUB1-conjugating enzyme 2);"ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; protein neddylation [GO:0045116]";"GO:0005524; GO:0019788; GO:0045116";protein neddylation [GO:0045116];;"ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]"
comp80655_c0_seq1;GAXK01019610.1;O15118;4.00E-42;NPC1_HUMAN;NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein);"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103";"adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]";"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]";"cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
comp806562_c1_seq1;GAXK01073969.1;Q02401;1.33E-150;LPH_RAT;"Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; transferase activity [GO:0016740]; carbohydrate metabolic process [GO:0005975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]";"GO:0000016; GO:0001666; GO:0005903; GO:0005975; GO:0007584; GO:0008422; GO:0009725; GO:0009744; GO:0010033; GO:0010040; GO:0010045; GO:0010288; GO:0016021; GO:0016324; GO:0016740; GO:0017042; GO:0042493; GO:0042594; GO:0043627; GO:0045471";"carbohydrate metabolic process [GO:0005975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of membrane [GO:0016021]";"beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; transferase activity [GO:0016740]"
comp806632_c0_seq1;GAXK01073967.1;O02485;4.87E-88;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp8066665_c0_seq1;GAXK01148962.1;Q9FT72;1.40E-40;RQL3_ARATH;ATP-dependent DNA helicase Q-like 3 (EC 3.6.4.12) (RecQ-like protein 3) (AtRecQ3) (AtRecQl3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138; GO:0046872";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]"
comp80681_c0_seq1;GAXK01019308.1;O94876;4.61E-24;TMCC1_HUMAN;Transmembrane and coiled-coil domains protein 1;"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0016021; GO:0016197; GO:0042803; GO:0046982; GO:0051260; GO:0051291; GO:0090148; GO:0097750; GO:0140284; GO:0140285";"endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]";"protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp806817_c0_seq1;GAXK01073958.1;P27473;1.93E-34;IFI44_PANTR;Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein);"cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]";"GO:0005737; GO:0006955; GO:0009617";"immune response [GO:0006955]; response to bacterium [GO:0009617]";cytoplasm [GO:0005737];
comp8068544_c0_seq1;GAXK01160874.1;D3GS80;2.04E-46;LFHA_ECO44;Putative flagellar export/assembly protein LfhA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bacterial-type flagellum assembly [GO:0044780]; protein secretion [GO:0009306]";"GO:0005886; GO:0009306; GO:0016021; GO:0044780";"bacterial-type flagellum assembly [GO:0044780]; protein secretion [GO:0009306]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp807105_c0_seq1;GAXK01073954.1;P0DPW5;8.76E-08;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp8071155_c0_seq1;;O07137;3.69E-07;ECHA8_MYCLE;Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17);"enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]";"GO:0004300; GO:0006631";fatty acid metabolic process [GO:0006631];;enoyl-CoA hydratase activity [GO:0004300]
comp807146_c0_seq1;GAXK01073913.1;Q9CXE0;7.19E-19;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp80717_c0_seq1;GAXK01019343.1;Q8BK64;1.21E-46;AHSA1_MOUSE;Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]";"GO:0001671; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879";"positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";"ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]"
comp8072_c6_seq1;GAXK01014599.1;Q9NJG9;9.78E-11;SUZ12_DROME;Polycomb protein Su(z)12 (Suppressor 12 of zeste protein);"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"GO:0000790; GO:0003677; GO:0005634; GO:0016458; GO:0016571; GO:0016586; GO:0022008; GO:0031490; GO:0034968; GO:0035097; GO:0035098; GO:0045892; GO:0046872; GO:0070734; GO:2001229";"gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]";"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8072601_c0_seq1;GAXK01164385.1;Q504A5;6.33E-21;TPMT_DANRE;Probable thiopurine S-methyltransferase (Thiopurine methyltransferase) (EC 2.1.1.67);"cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]";"GO:0005737; GO:0008119";;cytoplasm [GO:0005737];thiopurine S-methyltransferase activity [GO:0008119]
comp807399_c0_seq1;GAXK01073965.1;Q22328;2.65E-123;LEV9_CAEEL;Protein lev-9;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase inhibitor activity [GO:0030414]";"GO:0005615; GO:0030054; GO:0030414; GO:0045202";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";peptidase inhibitor activity [GO:0030414]
comp80740_c2_seq1;GAXK01019297.1;Q9VD83;1.97E-58;BURS_DROME;Bursicon (Bursicon subunit alpha) (Cuticle-tanning hormone);"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]; terminal bouton [GO:0043195]; hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; border follicle cell delamination [GO:0030709]; border follicle cell migration [GO:0007298]; chitin-based cuticle sclerotization [GO:0007593]; cuticle pigmentation [GO:0048067]; intestinal stem cell homeostasis [GO:0036335]";"GO:0005179; GO:0005576; GO:0007298; GO:0007593; GO:0030709; GO:0031395; GO:0036335; GO:0043195; GO:0046982; GO:0048067";"border follicle cell delamination [GO:0030709]; border follicle cell migration [GO:0007298]; chitin-based cuticle sclerotization [GO:0007593]; cuticle pigmentation [GO:0048067]; intestinal stem cell homeostasis [GO:0036335]";"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]; terminal bouton [GO:0043195]";"hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]"
comp8075198_c0_seq1;GAXK01038658.1;Q6ZNG9;1.71E-19;KRBA2_HUMAN;KRAB-A domain-containing protein 2;"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0015074";"DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]";;nucleic acid binding [GO:0003676]
comp807575_c0_seq1;GAXK01073933.1;B1AWL2;6.05E-08;ZN462_MOUSE;Zinc finger protein 462 (Zinc finger PBX1-interacting protein) (ZFPIP);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872";"chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp8076517_c0_seq1;GAXK01152674.1;A6RZS5;7.82E-26;RS3A_BOTFB;40S ribosomal protein S1;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp80767_c0_seq1;GAXK01019524.1;O34499;1.29E-43;6PGL_BACSU;6-phosphogluconolactonase (EC 3.1.1.31);"cytosol [GO:0005829]; 6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0005829; GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";cytosol [GO:0005829];6-phosphogluconolactonase activity [GO:0017057]
comp8077150_c0_seq1;GAXK01152673.1;P18694;1.16E-62;HSP72_USTMA;Heat shock 70 kDa protein 2;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp8077694_c0_seq1;GAXK01152672.1;A2SKU1;2.24E-46;PTH_METPP;Peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29);"cytoplasm [GO:0005737]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation [GO:0006412]";"GO:0004045; GO:0005737; GO:0006412";translation [GO:0006412];cytoplasm [GO:0005737];aminoacyl-tRNA hydrolase activity [GO:0004045]
comp807816_c0_seq1;GAXK01073970.1;A2AJ76;5.33E-18;HMCN2_MOUSE;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp8078726_c0_seq1;GAXK01196621.1;A0R4C9;2.25E-38;THTR_MYCS2;Putative thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese-like protein);thiosulfate sulfurtransferase activity [GO:0004792];GO:0004792;;;thiosulfate sulfurtransferase activity [GO:0004792]
comp808_c0_seq1;GAXK01169097.1;P02362;6.25E-48;RS7_XENLA;40S ribosomal protein S7 (40S ribosomal protein S8);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8081894_c0_seq1;GAXK01092952.1;Q02540;3.53E-38;COPR_PSEUB;Transcriptional activator protein CopR;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0005737; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp8082537_c0_seq1;GAXK01009532.1;Q2HJ94;5.98E-21;DNJA2_BOVIN;DnaJ homolog subfamily A member 2;"cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"GO:0001671; GO:0005524; GO:0005829; GO:0009408; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087";"protein refolding [GO:0042026]; response to heat [GO:0009408]";"cytosol [GO:0005829]; membrane [GO:0016020]";"ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp8083768_c0_seq1;GAXK01009535.1;Q9UYU5;1.37E-13;CDR_PYRAB;Coenzyme A disulfide reductase (CoA-disulfide reductase) (CoADR) (EC 1.8.1.14);"cell [GO:0005623]; CoA-disulfide reductase activity [GO:0050451]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005623; GO:0045454; GO:0050451; GO:0050660; GO:0050661";cell redox homeostasis [GO:0045454];cell [GO:0005623];"CoA-disulfide reductase activity [GO:0050451]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; protein disulfide isomerase activity [GO:0003756]"
comp8084_c1_seq1;GAXK01013957.1;Q5ZLM0;5.60E-174;CDC73_CHICK;Parafibromin (Cell division cycle protein 73 homolog);"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134";"cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]";RNA polymerase II complex binding [GO:0000993]
comp80844_c0_seq1;GAXK01019496.1;Q32P12;1.92E-08;CQ053_MOUSE;Uncharacterized protein C17orf53 homolog;;;;;
comp8084676_c0_seq1;GAXK01123468.1;P94177;6.49E-09;CZCA_ALCSC;Cation efflux system protein CzcA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; response to cadmium ion [GO:0046686]";"GO:0005886; GO:0008324; GO:0016021; GO:0046686";response to cadmium ion [GO:0046686];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp808743_c1_seq1;GAXK01063259.1;A6H782;1.11E-104;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp809044_c0_seq1;GAXK01063317.1;D3Z5L6;3.65E-36;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp80908_c1_seq1;GAXK01019590.1;Q8QFR2;2.78E-23;HIRA_XENLA;Protein HIRA;"nucleus [GO:0005634]; DNA replication-independent nucleosome assembly [GO:0006336]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0005634; GO:0006336; GO:0006351; GO:0006355";"DNA replication-independent nucleosome assembly [GO:0006336]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];
comp80911_c2_seq1;GAXK01019341.1;Q15637;3.45E-78;SF01_HUMAN;Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0016604; GO:0030238; GO:0030575; GO:0033327; GO:0042802; GO:0045131; GO:0048662; GO:0050810";"Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]";"identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp8092258_c0_seq1;GAXK01200019.1;Q9UFB7;4.15E-07;ZBT47_HUMAN;Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0046872";cellular response to DNA damage stimulus [GO:0006974];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8092431_c0_seq1;GAXK01200015.1;A9BUJ5;5.31E-77;HSLV_DELAS;ATP-dependent protease subunit HslV (EC 3.4.25.2);"HslUV protease complex [GO:0009376]; proteasome core complex [GO:0005839]; metal ion binding [GO:0046872]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004298; GO:0005839; GO:0009376; GO:0046872; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"HslUV protease complex [GO:0009376]; proteasome core complex [GO:0005839]";"metal ion binding [GO:0046872]; threonine-type endopeptidase activity [GO:0004298]"
comp809303_c1_seq1;GAXK01063269.1;Q8C827;3.05E-21;ZFP62_MOUSE;Zinc finger protein 62 (Zfp-62) (ZT3);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp8094_c0_seq1;GAXK01014239.1;P82119;9.86E-08;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp80941_c0_seq1;GAXK01019506.1;P31396;2.66E-29;HR3_DROME;Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4);"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]";"GO:0000122; GO:0000977; GO:0003707; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944";"metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]";nucleus [GO:0005634];"nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp809649_c0_seq1;GAXK01063311.1;B7Z6K7;1.39E-14;ZN814_HUMAN;Zinc finger protein 814;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp809664_c3_seq1;GAXK01063278.1;D2KBH9;3.90E-27;NAS8_STECR;Zinc metalloproteinase nas-8 (EC 3.4.24.21) (Nematode astacin 8) (Sc-AST);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]";"GO:0004222; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp809722_c1_seq1;GAXK01063287.1;Q6DHG0;6.33E-22;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp8098_c2_seq1;GAXK01014016.1;A6NMX2;1.94E-58;I4E1B_HUMAN;Eukaryotic translation initiation factor 4E type 1B;"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]";"GO:0000340; GO:0003743; GO:0005845; GO:0016281";;"eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]";"RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]"
comp809882_c0_seq1;GAXK01063279.1;Q8T674;3.27E-47;ABCGK_DICDI;ABC transporter G family member 20 (ABC transporter ABCG.20);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0016887; GO:0042626; GO:0043190";;ATP-binding cassette (ABC) transporter complex [GO:0043190];"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp81_c0_seq1;GAXK01168417.1;O61462;4.21E-39;RL37A_CRYST;60S ribosomal protein L37a;"ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0046872";translation [GO:0006412];ribosome [GO:0005840];"metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]"
comp810_c1_seq1;GAXK01170195.1;P05661;2.18E-21;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp810257_c0_seq1;GAXK01072951.1;A2RUV5;6.69E-129;HFM1_XENTR;Probable ATP-dependent DNA helicase HFM1 (EC 3.6.4.12);"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; resolution of meiotic recombination intermediates [GO:0000712]";"GO:0000712; GO:0003676; GO:0003678; GO:0005524";resolution of meiotic recombination intermediates [GO:0000712];;"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]"
comp810460_c0_seq1;GAXK01072949.1;P56597;4.66E-47;NDK5_HUMAN;Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5);"extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]";"GO:0003351; GO:0004550; GO:0005576; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0060271; GO:1902176";"cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]";"extracellular region [GO:0005576]; sperm flagellum [GO:0036126]";nucleoside diphosphate kinase activity [GO:0004550]
comp810559_c0_seq1;GAXK01072946.1;Q864R9;4.71E-26;MRP1_MACFA;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]";"GO:0005524; GO:0005886; GO:0008559; GO:0015431; GO:0016021; GO:0016887; GO:0042493; GO:0042910; GO:0050729; GO:0071716; GO:0140359";"leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp810776_c1_seq1;GAXK01073013.1;O74467;1.05E-12;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp81103_c0_seq1;GAXK01019205.1;Q9NUP7;1.01E-80;TRM13_HUMAN;tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76);"metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methylation [GO:0030488]";"GO:0030488; GO:0046872; GO:0106050";tRNA methylation [GO:0030488];;"metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]"
comp81107_c0_seq1;GAXK01019501.1;Q3ZAU7;2.97E-12;CENPL_RAT;Centromere protein L (CENP-L);"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]";"GO:0000775; GO:0005634";;"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]";
comp811141_c0_seq1;GAXK01072982.1;Q5BKE0;1.01E-38;TAF9_RAT;Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32);"MLL1 complex [GO:0071339]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to L-glutamate [GO:1902065]; transcription by RNA polymerase II [GO:0006366]";"GO:0000124; GO:0005669; GO:0006352; GO:0006366; GO:0008134; GO:0043966; GO:0044212; GO:0045944; GO:0046982; GO:0071339; GO:1902065";"DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to L-glutamate [GO:1902065]; transcription by RNA polymerase II [GO:0006366]";"MLL1 complex [GO:0071339]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]";"protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp811242_c0_seq1;GAXK01072937.1;Q92482;4.18E-10;AQP3_HUMAN;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"GO:0002684; GO:0003091; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323; GO:0032526; GO:0033280; GO:0042476; GO:0045616; GO:0051592; GO:0070295; GO:0071456; GO:0090650";"cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; regulation of keratinocyte differentiation [GO:0045616]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; response to calcium ion [GO:0051592]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp81141_c1_seq1;GAXK01019640.1;O97562;4.55E-97;UCP2_PIG;Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]";"GO:0005743; GO:0009409; GO:0016021; GO:0017077; GO:1990542; GO:1990845";"adaptive thermogenesis [GO:1990845]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";oxidative phosphorylation uncoupler activity [GO:0017077]
comp81153_c3_seq1;GAXK01019582.1;P57093;2.94E-125;PAHX_RAT;Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]";"GO:0001561; GO:0005739; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031418; GO:0048244; GO:0097089";"2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]"
comp811658_c0_seq1;GAXK01072936.1;Q6YCH2;5.32E-18;TDPZ4_MOUSE;TD and POZ domain-containing protein 4;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0030162; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp81173_c4_seq1;GAXK01019312.1;Q7SYN4;4.98E-67;5NT3_DANRE;Cytosolic 5'-nucleotidase 3 (EC 3.1.3.5) (Cytosolic 5'-nucleotidase III) (cN-III);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740]; nucleotide metabolic process [GO:0009117]";"GO:0000166; GO:0000287; GO:0005737; GO:0008253; GO:0009117; GO:0016740";nucleotide metabolic process [GO:0009117];cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740]"
comp81177_c1_seq1;GAXK01204941.1;Q9VHD2;1.45E-77;MAAI2_DROME;Probable maleylacetoacetate isomerase 2 (MAAI 2) (EC 5.2.1.2) (Glutathione S-transferase zeta 2) (EC 2.5.1.18);"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0004364; GO:0005737; GO:0005739; GO:0006559; GO:0006572; GO:0006749; GO:0016034";"glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]";"glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]"
comp81178_c0_seq1;GAXK01019298.1;P29747;2.51E-24;CREBA_DROME;Cyclic AMP response element-binding protein A (cAMP response element-binding protein A) (dCREB-A) (Box B-binding factor 2) (BBF-2);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; sequence-specific DNA binding [GO:0043565]; chitin-based larval cuticle pattern formation [GO:0035293]; dorsal/ventral pattern formation [GO:0009953]; larval chitin-based cuticle development [GO:0008363]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]";"GO:0001158; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0007431; GO:0007435; GO:0008363; GO:0009953; GO:0035293; GO:0035497; GO:0043565; GO:0045893; GO:0045944";"chitin-based larval cuticle pattern formation [GO:0035293]; dorsal/ventral pattern formation [GO:0009953]; larval chitin-based cuticle development [GO:0008363]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; sequence-specific DNA binding [GO:0043565]"
comp811858_c0_seq1;GAXK01073003.1;P35035;7.75E-54;TRY1_ANOGA;Trypsin-1 (EC 3.4.21.4) (Antryp1);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp81194_c4_seq1;GAXK01019519.1;Q5VT25;0;MRCKA_HUMAN;Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha);"actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]";"GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0070062";"actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]";"actomyosin [GO:0042641]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]";"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp8120_c2_seq1;GAXK01014014.1;Q9VWA1;7.86E-22;CLC_DROME;Clathrin light chain (dClc);"cell cortex [GO:0005938]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; structural molecule activity [GO:0005198]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"GO:0005198; GO:0005737; GO:0005886; GO:0005938; GO:0006886; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0032050; GO:0048268; GO:0071439; GO:0072583; GO:0072686; GO:0099631";"clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]";"cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; synaptic vesicle membrane [GO:0030672]";"clathrin heavy chain binding [GO:0032050]; structural molecule activity [GO:0005198]"
comp81221_c0_seq1;GAXK01019512.1;Q8R1R3;1.77E-18;STAR7_MOUSE;StAR-related lipid transfer protein 7, mitochondrial (START domain-containing protein 7) (StARD7);"mitochondrion [GO:0005739]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914]";"GO:0005548; GO:0005739; GO:0008289; GO:0015914";phospholipid transport [GO:0015914];mitochondrion [GO:0005739];"lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]"
comp8122153_c0_seq1;GAXK01172650.1;Q02541;8.07E-26;COPS_PSEUB;Sensor protein CopS (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]";"GO:0000155; GO:0005524; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp81223_c0_seq1;GAXK01205088.1;O54750;9.32E-82;CP2J6_MOUSE;Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469";"arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]";"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"
comp812250_c0_seq1;GAXK01008983.1;Q6PFQ7;4.09E-18;RASL2_MOUSE;Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580]";"GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046580; GO:0046872; GO:0071277";"cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]"
comp8122528_c0_seq1;GAXK01172649.1;Q9CQ26;5.85E-19;STABP_MOUSE;STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM);"cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; mitotic cytokinesis [GO:0000281]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"GO:0000281; GO:0004843; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0008237; GO:0014067; GO:0016020; GO:0016579; GO:0019904; GO:0032154; GO:0043524; GO:0046580; GO:0046872; GO:0061578; GO:0070536";"mitotic cytokinesis [GO:0000281]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]";"cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp812286_c0_seq1;GAXK01008982.1;P24339;2.37E-30;CUT7_SCHPO;Kinesin-like protein cut7 (Cell untimely torn protein 7);"condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity [GO:1990939]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle pole body separation [GO:0000073]";"GO:0000073; GO:0000778; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0005876; GO:0007018; GO:0008017; GO:0008569; GO:0008574; GO:0015630; GO:0016887; GO:0044732; GO:0051256; GO:0051301; GO:0072687; GO:0090307; GO:0099606; GO:1990023; GO:1990939";"cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle pole body separation [GO:0000073]";"condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity [GO:1990939]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp81235_c1_seq1;GAXK01019591.1;Q7Z9I2;1.64E-20;YCP9_SCHPO;Uncharacterized oxidoreductase C663.09c (EC 1.-.-.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]";"GO:0005634; GO:0005829; GO:0016491; GO:0110095";cellular detoxification of aldehyde [GO:0110095];"cytosol [GO:0005829]; nucleus [GO:0005634]";oxidoreductase activity [GO:0016491]
comp8123588_c0_seq1;GAXK01172652.1;O74423;9.29E-08;ENT1_SCHPO;Epsin-1;"actin cortical patch [GO:0030479]; membrane [GO:0016020]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin binding [GO:0043130]; actin cortical patch assembly [GO:0000147]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]";"GO:0000147; GO:0005546; GO:0006897; GO:0007015; GO:0016020; GO:0030276; GO:0030479; GO:0043130";"actin cortical patch assembly [GO:0000147]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]";"actin cortical patch [GO:0030479]; membrane [GO:0016020]";"clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin binding [GO:0043130]"
comp812417_c0_seq1;GAXK01009016.1;Q02156;2.36E-176;KPCE_HUMAN;Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon);"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"GO:0002281; GO:0003785; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030168; GO:0030546; GO:0030838; GO:0031397; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043278; GO:0043410; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:1903078; GO:2000650; GO:2001031";"apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]";"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]"
comp8126356_c0_seq1;GAXK01029084.1;Q54KA7;8.30E-18;SECG_DICDI;Ankyrin repeat, PH and SEC7 domain containing protein secG;"cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327";"actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]";"cytosol [GO:0005829]; lysosome [GO:0005764]";ARF guanyl-nucleotide exchange factor activity [GO:0005086]
comp81273_c5_seq1;GAXK01019344.1;Q08379;2.83E-10;GOGA2_HUMAN;Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95);"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0048208; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307; GO:1904668";"asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]";"cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]";"cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]"
comp812809_c0_seq1;GAXK01008988.1;P10076;1.55E-07;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp81283_c0_seq1;GAXK01019543.1;P22673;1.37E-92;URIC_DROPS;Uricase (EC 1.7.3.3) (Urate oxidase);"peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";"GO:0004846; GO:0005777; GO:0006144; GO:0019628";"purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]";peroxisome [GO:0005777];urate oxidase activity [GO:0004846]
comp81332_c0_seq1;GAXK01019221.1;P11420;3.39E-26;DA_DROME;Protein daughterless;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0061101; GO:0061382";"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp813567_c0_seq1;GAXK01009002.1;Q9W5U2;1.45E-31;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp8135766_c0_seq1;GAXK01037288.1;Q48815;6.76E-38;HELA_LEGPN;Protein HelA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]";"GO:0005886; GO:0008324; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp813668_c0_seq1;GAXK01009018.1;P53440;1.48E-08;CALMF_NAEGR;Calmodulin, flagellar (CAM-1);"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722; GO:0031514";calcium-mediated signaling [GO:0019722];motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp81377_c0_seq1;GAXK01019601.1;Q3TWN3;4.03E-42;CNNM2_MOUSE;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (mACDP2) (Cyclin-M2);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]";"GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0043231";"magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]"
comp81387_c1_seq1;GAXK01019558.1;P62184;2.01E-50;CALM_RENRE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8142182_c0_seq1;GAXK01046433.1;Q16587;9.48E-09;ZNF74_HUMAN;Zinc finger protein 74 (Zinc finger protein 520) (hZNF7);"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003723; GO:0005654; GO:0006355; GO:0007275; GO:0015629; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp814309_c1_seq1;GAXK01122505.1;Q8K2G4;0;BBS7_MOUSE;Bardet-Biedl syndrome 7 protein homolog (BBS2-like protein 1);"axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; RNA polymerase II repressing transcription factor binding [GO:0001103]; brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular transport [GO:0046907]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]";"GO:0001103; GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0046907; GO:0060170; GO:0060173; GO:0060271; GO:1903929; GO:1905515";"brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular transport [GO:0046907]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]";"axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]";RNA polymerase II repressing transcription factor binding [GO:0001103]
comp8143336_c0_seq1;GAXK01046434.1;B4EJ37;8.81E-42;METE_BURCJ;5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14) (Cobalamin-independent methionine synthase) (Methionine synthase, vitamin-B12 independent isozyme);"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]";"GO:0003871; GO:0008270; GO:0009086";methionine biosynthetic process [GO:0009086];;"5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]"
comp8143474_c0_seq1;GAXK01046432.1;O44006;6.05E-37;KPYK_EIMTE;Pyruvate kinase (PK) (EC 2.7.1.40);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]";"GO:0000287; GO:0004743; GO:0005524; GO:0016301; GO:0030955";;;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]"
comp814357_c0_seq1;GAXK01122491.1;A2CG49;4.97E-12;KALRN_MOUSE;Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain);"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274";"adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp8144_c2_seq1;GAXK01014905.1;Q25504;1.07E-10;CU16_MANSE;Larval cuticle protein 16/17;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp81442_c1_seq1;GAXK01019272.1;Q54DV3;2.39E-67;Y2016_DICDI;von Willebrand factor A domain-containing protein DDB_G0292016;;;;;
comp814445_c0_seq1;GAXK01122506.1;Q8I6K0;9.50E-27;PPAF3_HOLDI;"Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]";"extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp81474_c1_seq1;GAXK01019180.1;P26342;1.60E-16;TGBR3_RAT;Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of cellular component movement [GO:0051271]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein-containing complex assembly [GO:0065003]; regulation of protein binding [GO:0043393]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; signal transduction [GO:0007165]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0001666; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005887; GO:0006955; GO:0007165; GO:0007179; GO:0007181; GO:0008201; GO:0009897; GO:0015026; GO:0016021; GO:0017134; GO:0030509; GO:0030511; GO:0030512; GO:0031012; GO:0031100; GO:0032354; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0043235; GO:0043393; GO:0046332; GO:0048185; GO:0050431; GO:0051271; GO:0060317; GO:0060389; GO:0062023; GO:0065003; GO:0070123";"animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of cellular component movement [GO:0051271]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein-containing complex assembly [GO:0065003]; regulation of protein binding [GO:0043393]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; signal transduction [GO:0007165]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]";"activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]"
comp814851_c0_seq1;GAXK01122475.1;Q9NA51;1.18E-13;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp81499_c0_seq1;GAXK01019472.1;Q96ST3;0;SIN3A_HUMAN;Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a);"chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]";"GO:0000122; GO:0000776; GO:0000785; GO:0000976; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678";"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]";"chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]";"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; protein-containing complex binding [GO:0044877]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp815166_c0_seq1;GAXK01122488.1;Q09225;5.50E-59;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp81524_c0_seq1;GAXK01019539.1;Q9W0K7;1.76E-18;BAB1_DROME;Protein bric-a-brac 1;"nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";"GO:0003680; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092";"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; transcription, DNA-templated [GO:0006351]";nucleus [GO:0005634];"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]"
comp8153_c6_seq1;GAXK01013805.1;Q6P7N4;3.85E-39;HMCES_XENTR;Abasic site processing protein HMCES (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (Putative endonuclease HMCES) (EC 3.1.25.-) (SRAP domain-containing protein 1);"replication fork [GO:0005657]; endonuclease activity [GO:0004519]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003697; GO:0004519; GO:0005657; GO:0006974; GO:0008233";cellular response to DNA damage stimulus [GO:0006974];replication fork [GO:0005657];"endonuclease activity [GO:0004519]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]"
comp815410_c1_seq1;GAXK01122503.1;Q9Y5Y6;1.37E-38;ST14_HUMAN;Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein);"basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cornification [GO:0070268]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]";"GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016323; GO:0019897; GO:0030216; GO:0060672; GO:0070268";"cornification [GO:0070268]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]";"basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp8157499_c0_seq1;GAXK01156900.1;A4G431;5.69E-21;NADA_HERAR;Quinolinate synthase A (EC 2.5.1.72);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; quinolinate synthetase A activity [GO:0008987]; NAD biosynthetic process [GO:0009435]";"GO:0005737; GO:0008987; GO:0009435; GO:0046872; GO:0051539";NAD biosynthetic process [GO:0009435];cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; quinolinate synthetase A activity [GO:0008987]"
comp8158101_c0_seq1;GAXK01197909.1;B4F6U4;4.59E-08;PRD10_XENTR;PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0046872";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
comp81595_c20_seq1;GAXK01019247.1;Q5NVA9;9.68E-31;EME1_PONAB;Crossover junction endonuclease EME1 (EC 3.1.22.-);"Holliday junction resolvase complex [GO:0048476]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; response to intra-S DNA damage checkpoint signaling [GO:0072429]";"GO:0003677; GO:0004519; GO:0005720; GO:0005730; GO:0006281; GO:0006310; GO:0046872; GO:0048476; GO:0072429";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; response to intra-S DNA damage checkpoint signaling [GO:0072429]";"Holliday junction resolvase complex [GO:0048476]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]";"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]"
comp8162654_c0_seq1;GAXK01095801.1;O95625;7.13E-07;ZBT11_HUMAN;Zinc finger and BTB domain-containing protein 11;"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0046872";;nucleoplasm [GO:0005654];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp816298_c0_seq1;GAXK01140373.1;Q9JME2;2.96E-20;CHSTB_MOUSE;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216";"carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp816381_c0_seq1;GAXK01140400.1;Q9Y149;9.61E-07;MED15_DROME;Mediator of RNA polymerase II transcription subunit 15 (Mediator complex subunit 15) (dARC105);"mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; ovarian follicle cell development [GO:0030707]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0003712; GO:0005634; GO:0006357; GO:0006366; GO:0016592; GO:0030707";"ovarian follicle cell development [GO:0030707]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"mediator complex [GO:0016592]; nucleus [GO:0005634]";transcription coregulator activity [GO:0003712]
comp81639_c0_seq1;GAXK01019498.1;Q8N2Y8;2.67E-13;RUSC2_HUMAN;Iporin (Interacting protein of Rab1) (RUN and SH3 domain-containing protein 2);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Rab GTPase binding [GO:0017137]";"GO:0005829; GO:0017137; GO:0031410; GO:0070062";;"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";Rab GTPase binding [GO:0017137]
comp8166506_c0_seq1;GAXK01196593.1;Q6B9X6;5.74E-21;VWKA_DICDI;Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase);"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177";"contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]";"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp81676_c1_seq1;GAXK01019106.1;Q5UQ60;5.61E-12;YL662_MIMIV;Uncharacterized protein L662;;;;;
comp8168_c0_seq1;GAXK01014670.1;P24862;4.05E-107;CCNB_PATVU;G2/mitotic-specific cyclin-B;"nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005634; GO:0007049; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";nucleus [GO:0005634];
comp81682_c0_seq1;GAXK01019500.1;Q8CFH6;7.78E-163;SIK2_MOUSE;Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2);"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]";"GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008286; GO:0031588; GO:0032007; GO:0035556; GO:0042149; GO:0046626; GO:0046777";"cellular response to glucose starvation [GO:0042149]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]";"cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp816842_c0_seq1;GAXK01140424.1;Q7T3A4;5.61E-25;RAB13_DANRE;Ras-related protein Rab-13;"bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; trans-Golgi network to recycling endosome transport [GO:0044795]";"GO:0001525; GO:0003924; GO:0005525; GO:0005802; GO:0005886; GO:0005923; GO:0006886; GO:0010737; GO:0016328; GO:0030027; GO:0030139; GO:0030659; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032482; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0044795; GO:0055037; GO:0055038; GO:0070830; GO:0072659; GO:1902463";"angiogenesis [GO:0001525]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; trans-Golgi network to recycling endosome transport [GO:0044795]";"bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp81689_c0_seq1;GAXK01019216.1;Q6PLK3;1.97E-26;AOFB_PIG;Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]";"GO:0005741; GO:0016021; GO:0016491";;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";oxidoreductase activity [GO:0016491]
comp8169_c1_seq1;GAXK01014671.1;Q5RAP8;1.42E-32;TSN31_PONAB;Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence homolog);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp8169234_c0_seq1;GAXK01140816.1;Q0EEE2;3.50E-11;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp81703_c1_seq1;GAXK01019573.1;P90543;3.43E-42;H3_EUPCR;Histone H3;"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]";"GO:0000786; GO:0003677; GO:0005634; GO:0046982";;"nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp817069_c0_seq1;GAXK01140429.1;O60308;7.17E-46;CE104_HUMAN;Centrosomal protein of 104 kDa (Cep104);"centriole [GO:0005814]; cilium [GO:0005929]; spindle pole [GO:0000922]; glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]";"GO:0000922; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596";;"centriole [GO:0005814]; cilium [GO:0005929]; spindle pole [GO:0000922]";"glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]"
comp81717_c0_seq1;GAXK01019612.1;Q4KLF3;1.43E-87;KTI12_XENLA;Protein KTI12 homolog;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp81722_c0_seq1;GAXK01019133.1;Q9CR35;2.23E-39;CTRB1_MOUSE;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]";"GO:0004252; GO:0005615; GO:0005737; GO:0005764; GO:0006508; GO:0007586; GO:0008233; GO:0030163; GO:0034097; GO:0043065";"digestion [GO:0007586]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]";"peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
comp817222_c0_seq1;GAXK01140387.1;Q5W1J5;1.71E-30;FOXP1_XENLA;Forkhead box protein P1 (XlFoxP1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0042803; GO:0043565; GO:0045892; GO:0046872; GO:0046982";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]"
comp817230_c0_seq1;GAXK01140375.1;P05789;1.30E-15;EREB_ECOLX;Erythromycin esterase type II (EC 3.1.1.-);"carboxylic ester hydrolase activity [GO:0052689]; response to antibiotic [GO:0046677]";"GO:0046677; GO:0052689";response to antibiotic [GO:0046677];;carboxylic ester hydrolase activity [GO:0052689]
comp81729_c0_seq1;GAXK01019108.1;Q9QXX8;1.59E-12;NUFP1_MOUSE;Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1);"cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]";"GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005726; GO:0005730; GO:0008023; GO:0016363; GO:0022626; GO:0030515; GO:0030674; GO:0032991; GO:0042802; GO:0045202; GO:0045944; GO:0046872; GO:0048786; GO:0051117; GO:0051259; GO:0070761";"box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]";"cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023]";"ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]"
comp81743_c0_seq1;GAXK01019548.1;Q5RCI9;7.40E-19;PCNP_PONAB;PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein);"nucleus [GO:0005634]; cell cycle [GO:0007049]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0007049; GO:0016567";"cell cycle [GO:0007049]; protein ubiquitination [GO:0016567]";nucleus [GO:0005634];
comp81746_c0_seq1;GAXK01019186.1;A1Z7A6;0;ASAP_DROME;ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein;"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]";"GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386";"compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]"
comp8175006_c0_seq1;GAXK01155880.1;Q6VTH5;5.73E-09;RSPH1_CYPCA;Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0005737; GO:0005856; GO:0007275; GO:0007283; GO:0030154; GO:0031514; GO:0051321";"cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";
comp81761_c0_seq1;GAXK01019470.1;O43679;7.51E-88;LDB2_HUMAN;LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1);"cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0001102; GO:0001942; GO:0003712; GO:0005634; GO:0005667; GO:0005730; GO:0005886; GO:0007275; GO:0010669; GO:0019899; GO:0030274; GO:0030334; GO:0031252; GO:0035019; GO:0043549; GO:0044089; GO:0045892; GO:0045944";"epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019]";"cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]";"enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]"
comp81770_c0_seq1;GAXK01205087.1;Q16539;0;MK14_HUMAN;Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to organic substance [GO:0071310]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 secretion [GO:2001184]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000077; GO:0000187; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001890; GO:0002062; GO:0002741; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006357; GO:0006915; GO:0006935; GO:0007165; GO:0007166; GO:0007178; GO:0007265; GO:0007519; GO:0010468; GO:0010628; GO:0010759; GO:0010831; GO:0016607; GO:0018105; GO:0019395; GO:0019899; GO:0019903; GO:0030278; GO:0030316; GO:0031281; GO:0031663; GO:0032495; GO:0034774; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0043312; GO:0045648; GO:0045663; GO:0045944; GO:0046326; GO:0048010; GO:0048273; GO:0051090; GO:0051146; GO:0051149; GO:0051525; GO:0060045; GO:0070935; GO:0071222; GO:0071223; GO:0071310; GO:0071356; GO:0071479; GO:0090090; GO:0090336; GO:0090400; GO:0098586; GO:0098978; GO:0099179; GO:1900015; GO:1901741; GO:1901796; GO:1904813; GO:1905050; GO:2000379; GO:2001184";"3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to organic substance [GO:0071310]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 secretion [GO:2001184]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]"
comp8177335_c0_seq1;GAXK01078183.1;P48608;3.68E-16;DIA_DROME;Protein diaphanous;"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005912; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036";"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]";"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]";"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"
comp817742_c1_seq1;GAXK01140351.1;A2ASQ1;4.61E-31;AGRIN_MOUSE;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]";"acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp817914_c0_seq1;GAXK01140365.1;Q9VAS7;3.32E-35;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp8181296_c0_seq1;GAXK01087942.1;P41797;4.43E-33;HSP71_CANAL;Heat shock protein SSA1;"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal biofilm matrix [GO:0062040]; fungal-type cell wall [GO:0009277]; hyphal cell wall [GO:0030446]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; yeast-form cell wall [GO:0030445]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; antimicrobial humoral response [GO:0019730]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; entry into host cell [GO:0030260]; induction by symbiont of host defense response [GO:0044416]; interaction with host [GO:0051701]; protein refolding [GO:0042026]; response to toxic substance [GO:0009636]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; vesicle-mediated transport [GO:0016192]";"GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006616; GO:0006986; GO:0009277; GO:0009636; GO:0009986; GO:0016192; GO:0016887; GO:0019730; GO:0030260; GO:0030445; GO:0030446; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042277; GO:0042623; GO:0044183; GO:0044416; GO:0051082; GO:0051085; GO:0051701; GO:0051787; GO:0062040";"antimicrobial humoral response [GO:0019730]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; entry into host cell [GO:0030260]; induction by symbiont of host defense response [GO:0044416]; interaction with host [GO:0051701]; protein refolding [GO:0042026]; response to toxic substance [GO:0009636]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; vesicle-mediated transport [GO:0016192]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal biofilm matrix [GO:0062040]; fungal-type cell wall [GO:0009277]; hyphal cell wall [GO:0030446]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; yeast-form cell wall [GO:0030445]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp8183_c1_seq1;GAXK01013459.1;Q6XHI1;9.05E-15;THIO2_DROYA;Thioredoxin-2 (Trx-2);"cell [GO:0005623]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"GO:0005623; GO:0006662; GO:0015035; GO:0045454";"cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";cell [GO:0005623];protein disulfide oxidoreductase activity [GO:0015035]
comp818374_c0_seq1;GAXK01196542.1;Q32M78;5.44E-24;ZN699_HUMAN;Zinc finger protein 699 (Hangover homolog);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp81838_c1_seq1;GAXK01019207.1;Q566Y1;1.92E-63;ELP4_DANRE;Elongator complex protein 4 (ELP4);"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; RNA polymerase II complex binding [GO:0000993]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]";"GO:0000993; GO:0002098; GO:0005737; GO:0006357; GO:0008023; GO:0008607; GO:0033588";"regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]";"phosphorylase kinase regulator activity [GO:0008607]; RNA polymerase II complex binding [GO:0000993]"
comp81848_c9_seq1;GAXK01019326.1;P97503;1.70E-08;NKX32_MOUSE;Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ development [GO:0048513]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; digestive system development [GO:0055123]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]";"GO:0000122; GO:0000978; GO:0001227; GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0043565; GO:0045944; GO:0048513; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0055123; GO:0060576";"animal organ development [GO:0048513]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; digestive system development [GO:0055123]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp818487_c0_seq1;GAXK01196526.1;Q8I6K1;4.02E-42;PPO1_HOLDI;Phenoloxidase 1 (EC 1.14.18.-) (Prophenoloxidase-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";"GO:0004497; GO:0005576; GO:0042438; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
comp8185_c1_seq1;GAXK01013519.1;Q10567;0;AP1B1_HUMAN;AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit);"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005765; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019886; GO:0019901; GO:0030131; GO:0030276; GO:0030659; GO:0030665; GO:0032588; GO:0043231; GO:0050690";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]";"clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]";"clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]"
comp81856_c0_seq1;GAXK01019314.1;P55853;1.37E-21;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp8186_c0_seq1;GAXK01204940.1;P42860;3.83E-38;GSTT1_LUCCU;Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta);glutathione transferase activity [GO:0004364];GO:0004364;;;glutathione transferase activity [GO:0004364]
comp818722_c0_seq1;GAXK01196539.1;Q15937;3.13E-16;ZNF79_HUMAN;Zinc finger protein 79 (ZNFpT7);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp81873_c0_seq1;GAXK01019427.1;Q6PDN3;2.10E-42;MYLK_MOUSE;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cardiovascular system development [GO:0072358]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]";"GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005911; GO:0006939; GO:0014820; GO:0015629; GO:0019899; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0035690; GO:0035865; GO:0046872; GO:0051928; GO:0060414; GO:0071277; GO:0071476; GO:0072358; GO:0090303";"aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cardiovascular system development [GO:0072358]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]";"actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]"
comp81875_c7_seq1;GAXK01019630.1;Q14139;5.64E-134;UBE4A_HUMAN;Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0030433; GO:0034450";"protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";ubiquitin-ubiquitin ligase activity [GO:0034450]
comp818843_c0_seq1;GAXK01196549.1;Q8BJ51;1.81E-87;MFS11_MOUSE;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp81888_c7_seq1;GAXK01019167.1;Q9NX74;2.56E-56;DUS2L_HUMAN;tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.91) (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8) (URLC8) (tRNA-dihydrouridine synthase 2-like) (hDUS2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]";"GO:0002943; GO:0003725; GO:0004860; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264";"negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";"double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; tRNA dihydrouridine synthase activity [GO:0017150]"
comp8188976_c0_seq1;GAXK01021732.1;P18737;1.02E-12;ZG8_XENLA;Gastrula zinc finger protein XlCGF8.2DB (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp81893_c2_seq1;GAXK01019639.1;D3ZZL9;1.98E-31;GCC2_RAT;GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]";"GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0070861; GO:0071955; GO:0090161";"Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]";
comp818954_c0_seq1;GAXK01196525.1;P17141;4.51E-21;ZFP37_MOUSE;Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007281; GO:0007283; GO:0008270";"germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp8189684_c0_seq1;GAXK01021731.1;Q90YQ0;9.40E-40;RS24_ICTPU;40S ribosomal protein S24;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp81942_c1_seq1;GAXK01019311.1;Q99873;6.00E-50;ANM1_HUMAN;Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006479; GO:0006977; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008469; GO:0016274; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0031175; GO:0034709; GO:0034969; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:1900745; GO:1904047";"cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]"
comp819502_c0_seq1;GAXK01196541.1;Q9H165;3.69E-22;BC11A_HUMAN;B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173";"cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp819557_c0_seq1;GAXK01196561.1;Q291H8;2.79E-21;TRET1_DROPS;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp81958_c1_seq1;GAXK01019547.1;Q8YFI5;6.13E-55;NHAA_BRUME;Na(+)/H(+) antiporter NhaA (Sodium/proton antiporter NhaA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]; regulation of pH [GO:0006885]";"GO:0005886; GO:0006885; GO:0008233; GO:0015081; GO:0015297; GO:0016021";regulation of pH [GO:0006885];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]"
comp8197944_c0_seq1;GAXK01023695.1;A6H603;1.75E-25;NWD1_MOUSE;NACHT domain- and WD repeat-containing protein 1;"cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";"GO:0005524; GO:0005829; GO:0010628; GO:0032088";"negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]";cytosol [GO:0005829];ATP binding [GO:0005524]
comp81980_c0_seq1;GAXK01019109.1;Q01433;0;AMPD2_HUMAN;AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L);"cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]";"GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009";"AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]";cytosol [GO:0005829];"AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]"
comp819997_c0_seq1;GAXK01196554.1;Q9XYN1;1.29E-46;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp820009_c1_seq1;GAXK01038965.1;O15068;9.51E-53;MCF2L_HUMAN;Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"GO:0005089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0012505; GO:0031234; GO:0035023; GO:0035025; GO:0035091; GO:0035556; GO:0043065; GO:0051056";"G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]";"phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp820015_c1_seq1;GAXK01038941.1;P52746;5.29E-30;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp820230_c1_seq1;GAXK01038960.1;Q6P1S6;3.85E-09;MTPN_XENTR;Myotrophin;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp8202968_c0_seq1;GAXK01090194.1;Q9XHS0;7.39E-42;RS12_HORVU;40S ribosomal protein S12;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8204661_c0_seq1;GAXK01061757.1;P41376;2.22E-52;IF4A1_ARATH;Eukaryotic initiation factor 4A-1 (eIF-4A-1) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1) (DEAD-box ATP-dependent RNA helicase 4) (AtRH04);"cytoplasmic stress granule [GO:0010494]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]";"GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0010494";cytoplasmic translational initiation [GO:0002183];cytoplasmic stress granule [GO:0010494];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp820490_c0_seq1;GAXK01038934.1;B0WC46;9.72E-08;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp82079_c0_seq1;GAXK01033087.1;Q9BYB0;1.26E-115;SHAN3_HUMAN;SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2);"cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex adaptor activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]";"GO:0000165; GO:0003779; GO:0005829; GO:0007411; GO:0007416; GO:0007612; GO:0007613; GO:0008022; GO:0008270; GO:0014069; GO:0017124; GO:0021773; GO:0030054; GO:0030159; GO:0030160; GO:0030425; GO:0030534; GO:0031234; GO:0032232; GO:0035176; GO:0035255; GO:0042297; GO:0043005; GO:0043197; GO:0043621; GO:0044309; GO:0045211; GO:0045794; GO:0048170; GO:0048854; GO:0051124; GO:0051835; GO:0051968; GO:0060170; GO:0060291; GO:0060997; GO:0060999; GO:0061001; GO:0071625; GO:0097107; GO:0097110; GO:0097113; GO:0097114; GO:0097117; GO:1900271; GO:1900273; GO:1900451; GO:1900452; GO:2000311; GO:2000463; GO:2000969";"adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]";"cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex adaptor activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]"
comp8209_c2_seq1;GAXK01014022.1;Q9JMJ2;3.01E-55;FBXW4_MOUSE;F-box/WD repeat-containing protein 4 (F-box and WD-40 domain-containing protein 4) (Protein hagoromo);"SCF ubiquitin ligase complex [GO:0019005]; cartilage development [GO:0051216]; embryonic digit morphogenesis [GO:0042733]; limb development [GO:0060173]; positive regulation of mesenchymal cell proliferation [GO:0002053]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";"GO:0002053; GO:0016055; GO:0019005; GO:0031146; GO:0042733; GO:0051216; GO:0060173";"cartilage development [GO:0051216]; embryonic digit morphogenesis [GO:0042733]; limb development [GO:0060173]; positive regulation of mesenchymal cell proliferation [GO:0002053]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055]";SCF ubiquitin ligase complex [GO:0019005];
comp82096_c2_seq1;GAXK01033644.1;B2GUY0;0;MA1B1_RAT;Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0006486; GO:0006491; GO:0016020; GO:0016021; GO:0030433; GO:0036509; GO:0044322; GO:1904382";"mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
comp821007_c0_seq1;GAXK01038927.1;Q8BGC3;8.74E-30;MOT12_MOUSE;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp82103_c6_seq1;GAXK01033837.1;Q5U367;0;PLOD3_RAT;"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]";"GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070831";"basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]";"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]"
comp8210724_c0_seq1;GAXK01057706.1;Q8WN93;1.94E-12;CALRL_PIG;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell surface receptor signaling pathway [GO:0007166]";"GO:0001525; GO:0001605; GO:0001635; GO:0004948; GO:0005886; GO:0007166; GO:0007189; GO:0016021; GO:1990408; GO:1990410";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell surface receptor signaling pathway [GO:0007166]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]"
comp821112_c0_seq1;GAXK01038959.1;P52746;7.24E-08;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp82117_c0_seq1;GAXK01033282.1;P49138;2.87E-10;MAPK2_MOUSE;MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mRNA stabilization [GO:0048255]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0002224; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0042535; GO:0044351; GO:0046777; GO:0048010; GO:0048255; GO:0048839; GO:0051019; GO:0070935";"3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mRNA stabilization [GO:0048255]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]"
comp821245_c0_seq1;GAXK01038967.1;P56721;5.18E-24;COLL_DROME;Transcription factor collier (Transcription factor knot);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";"GO:0001228; GO:0001700; GO:0003677; GO:0005634; GO:0006355; GO:0007350; GO:0007367; GO:0007419; GO:0007474; GO:0007476; GO:0007526; GO:0009608; GO:0010468; GO:0016204; GO:0035203; GO:0035287; GO:0035288; GO:0035289; GO:0035291; GO:0042694; GO:0045087; GO:0045944; GO:0046872; GO:0046983; GO:0048813; GO:0048814";"anterior head segmentation [GO:0035288]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of muscle attachment site [GO:0016204]; embryonic development via the syncytial blastoderm [GO:0001700]; head segmentation [GO:0035287]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; muscle cell fate specification [GO:0042694]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression [GO:0010468]; regulation of lamellocyte differentiation [GO:0035203]; regulation of transcription, DNA-templated [GO:0006355]; response to symbiont [GO:0009608]; segment polarity determination [GO:0007367]; specification of segmental identity, intercalary segment [GO:0035291]; ventral cord development [GO:0007419]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp82125_c2_seq1;GAXK01033565.1;Q8IN81;8.32E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp82126_c3_seq1;GAXK01033429.1;Q9Y4D8;0;HECD4_HUMAN;Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4);"integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]";"GO:0004842; GO:0006006; GO:0016021; GO:0042593";"glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]";integral component of membrane [GO:0016021];ubiquitin-protein transferase activity [GO:0004842]
comp82130_c1_seq1;GAXK01033581.1;E2AX35;1.27E-90;PROH4_CAMFO;IDLSRF-like peptide;"extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]";"GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];
comp82145_c2_seq1;GAXK01033184.1;P06797;3.64E-72;CATL1_MOUSE;"Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) (p39 cysteine proteinase) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"GO:0004175; GO:0004177; GO:0004197; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016540; GO:0016807; GO:0021675; GO:0030984; GO:0031069; GO:0031410; GO:0034698; GO:0042277; GO:0042393; GO:0043005; GO:0043204; GO:0044877; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0062023";"autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]";"aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]"
comp82158_c0_seq1;GAXK01033483.1;Q2PFW9;2.15E-70;NOVA1_MACFA;RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1);"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]";"GO:0000398; GO:0003723; GO:0005634";mRNA splicing, via spliceosome [GO:0000398];nucleus [GO:0005634];RNA binding [GO:0003723]
comp82159_c0_seq1;GAXK01033830.1;P02730;4.62E-48;B3AT_HUMAN;Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233);"basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]";"GO:0005452; GO:0005886; GO:0005887; GO:0006096; GO:0006820; GO:0006821; GO:0006873; GO:0007596; GO:0008509; GO:0009898; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0017121; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042803; GO:0043495; GO:0045852; GO:0048821; GO:0051453; GO:0070062; GO:0072562; GO:0072659";"anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]";"basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]"
comp821669_c0_seq1;GAXK01038938.1;P18725;2.37E-10;ZG5_XENLA;Gastrula zinc finger protein 5-1 (XlCGF5.1);"metal ion binding [GO:0046872]; RNA binding [GO:0003723]";"GO:0003723; GO:0046872";;;"metal ion binding [GO:0046872]; RNA binding [GO:0003723]"
comp82179_c0_seq1;GAXK01033103.1;Q00871;3.48E-60;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp82181_c0_seq1;GAXK01033831.1;P12815;1.99E-47;PDCD6_MOUSE;Programmed cell death protein 6 (ALG-257) (Apoptosis-linked gene 2 protein) (ALG-2) (PMP41);"COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein binding, bridging [GO:0030674]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]";"GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0060090; GO:0070971; GO:1902527";"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]";"COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein binding, bridging [GO:0030674]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]"
comp82185_c0_seq1;GAXK01033391.1;A0MTA1;1.32E-112;APEX1_DANRE;DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (zAP1);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]";"GO:0001947; GO:0003677; GO:0003723; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0006284; GO:0008311; GO:0010628; GO:0016607; GO:0043066; GO:0046872; GO:0055114; GO:0060047; GO:0080111; GO:0140078";"base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]";"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]"
comp8219_c0_seq1;GAXK01014503.1;Q94514;5.62E-45;COX5A_DROME;Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va);"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of cell cycle [GO:0045787]";"GO:0004129; GO:0005739; GO:0005751; GO:0006123; GO:0007406; GO:0045787; GO:0046872";"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of cell cycle [GO:0045787]";"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]";"cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]"
comp82206_c1_seq1;GAXK01033471.1;Q9NL98;3.62E-29;PRDX_ASCSU;Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase);"cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005623; GO:0006979; GO:0008379; GO:0016209; GO:0045454";"cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]";cell [GO:0005623];"antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]"
comp822125_c0_seq1;GAXK01157539.1;P00920;1.55E-17;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp82222_c2_seq1;GAXK01033481.1;P97629;1.79E-84;LCAP_RAT;Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (GP160) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) (Vesicle protein of 165 kDa) (Vp165);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; insulin-responsive compartment [GO:0032593]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuropeptide catabolic process [GO:0010813]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; proteolysis [GO:0006508]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to hormone [GO:0009725]";"GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0009725; GO:0009986; GO:0010813; GO:0016021; GO:0031982; GO:0032593; GO:0042277; GO:0043025; GO:0043171; GO:0043229; GO:0043231; GO:0045777; GO:0048169; GO:0048471; GO:0070006; GO:0120163";"negative regulation of cold-induced thermogenesis [GO:0120163]; neuropeptide catabolic process [GO:0010813]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; proteolysis [GO:0006508]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to hormone [GO:0009725]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; insulin-responsive compartment [GO:0032593]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp822251_c0_seq1;GAXK01157571.1;Q9JL56;8.62E-43;GDE1_MOUSE;Glycerophosphodiester phosphodiesterase 1 (EC 3.1.4.-) (EC 3.1.4.44) (Membrane-interacting protein of RGS16);"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0005887; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0016021; GO:0030659; GO:0046872; GO:0047395; GO:0070291";"G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]";"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]"
comp8223_c0_seq1;GAXK01014755.1;Q6DDF0;1.34E-132;WDR37_XENLA;WD repeat-containing protein 37;;;;;
comp8223579_c0_seq1;GAXK01040867.1;Q9FVQ1;7.07E-21;NUCL1_ARATH;Nucleolin 1 (Protein NUCLEOLIN LIKE 1) (AtNUC-L1) (Protein PARALLEL 1) (AtPARL1);"90S preribosome [GO:0030686]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; cotyledon vascular tissue pattern formation [GO:0010588]; endonucleolytic cleavage involved in rRNA processing [GO:0000478]; leaf development [GO:0048366]; leaf vascular tissue pattern formation [GO:0010305]; petal vascular tissue pattern formation [GO:0080056]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; root development [GO:0048364]; rRNA processing [GO:0006364]; sepal vascular tissue pattern formation [GO:0080057]; shoot system development [GO:0048367]";"GO:0000478; GO:0003677; GO:0003729; GO:0005634; GO:0005730; GO:0005739; GO:0006364; GO:0010305; GO:0010588; GO:0019843; GO:0030686; GO:0042254; GO:0042274; GO:0048364; GO:0048366; GO:0048367; GO:0080056; GO:0080057";"cotyledon vascular tissue pattern formation [GO:0010588]; endonucleolytic cleavage involved in rRNA processing [GO:0000478]; leaf development [GO:0048366]; leaf vascular tissue pattern formation [GO:0010305]; petal vascular tissue pattern formation [GO:0080056]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; root development [GO:0048364]; rRNA processing [GO:0006364]; sepal vascular tissue pattern formation [GO:0080057]; shoot system development [GO:0048367]";"90S preribosome [GO:0030686]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]"
comp82239_c0_seq1;GAXK01033278.1;Q7KMJ6;1.15E-49;NITO_DROME;RNA-binding protein spenito;"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737";"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]";"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";RNA binding [GO:0003723]
comp822456_c0_seq1;GAXK01157541.1;Q3SYV7;9.65E-29;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp82246_c0_seq1;GAXK01033502.1;A0JN41;4.10E-30;CAH10_BOVIN;Carbonic anhydrase-related protein 10;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0008270";;;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp822527_c2_seq1;GAXK01157564.1;Q95NI4;2.16E-11;CALM_HALOK;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp82267_c1_seq1;GAXK01033839.1;Q2T9T9;5.46E-08;FBXW9_BOVIN;F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9);"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]";"GO:0030687; GO:0070545";;"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]";
comp8227707_c0_seq1;GAXK01162591.1;Q8XWD0;5.48E-38;XERD_RALSO;Tyrosine recombinase XerD;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; tyrosine-based site-specific recombinase activity [GO:0009037]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0005737; GO:0006313; GO:0007049; GO:0007059; GO:0009037; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; transposition, DNA-mediated [GO:0006313]";cytoplasm [GO:0005737];"DNA binding [GO:0003677]; tyrosine-based site-specific recombinase activity [GO:0009037]"
comp822808_c1_seq1;GAXK01157570.1;P82198;9.22E-20;BGH3_MOUSE;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp8228110_c0_seq1;GAXK01084307.1;Q9WU02;1.39E-11;V1BR_MOUSE;Vasopressin V1b receptor (V1bR) (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; vasopressin receptor activity [GO:0005000]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]";"GO:0001992; GO:0005000; GO:0005886; GO:0005887; GO:0007186; GO:0016021; GO:0017046; GO:0032870; GO:0042803; GO:0045907";"cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; vasopressin receptor activity [GO:0005000]"
comp82300_c1_seq1;GAXK01033405.1;Q9VFP2;3.01E-22;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp82308_c0_seq1;GAXK01033287.1;Q9W1L5;6.55E-79;PAL2_DROME;Peptidyl-alpha-hydroxyglycine alpha-amidating lyase 2 (EC 4.3.2.5) (Peptidylamidoglycolate lyase 2) (dPAL2);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; cellular metabolic process [GO:0044237]; peptide amidation [GO:0001519]";"GO:0001519; GO:0004504; GO:0004598; GO:0005576; GO:0044237; GO:0046872";"cellular metabolic process [GO:0044237]; peptide amidation [GO:0001519]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp82324_c0_seq1;GAXK01033390.1;Q17103;6.33E-08;MYC_ASTRU;Myc protein (c-myc) (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]";"GO:0000981; GO:0003677; GO:0005634; GO:0046983";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]"
comp823546_c0_seq1;GAXK01157584.1;P52569;1.30E-171;CTR2_HUMAN;Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"GO:0000064; GO:0002537; GO:0005886; GO:0005887; GO:0006809; GO:0006865; GO:0015171; GO:0015174; GO:0015181; GO:0015189; GO:0030054; GO:0042116; GO:0043030; GO:0050727; GO:0061459; GO:0097638; GO:1903352";"amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]"
comp8235735_c0_seq1;GAXK01092981.1;Q43298;1.22E-79;CH62_MAIZE;Chaperonin CPN60-2, mitochondrial (HSP60-2);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]";"GO:0005524; GO:0005739; GO:0005829; GO:0006458; GO:0007005; GO:0042026; GO:0045041; GO:0051082";"'de novo' protein folding [GO:0006458]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp823741_c0_seq1;GAXK01157559.1;Q4VBD9;2.52E-17;GZF1_MOUSE;GDNF-inducible zinc finger protein 1 (Zinc finger protein 336);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0001658; GO:0003700; GO:0005634; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872";"branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp82381_c0_seq1;GAXK01033394.1;A1ZAU8;7.10E-80;PTRO_DROME;Patronin (Short spindle protein 4);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]";"GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0045167; GO:0051011; GO:0061867";"asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]";"calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]"
comp823830_c0_seq1;GAXK01157560.1;Q6IV72;5.42E-08;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp824021_c1_seq1;GAXK01173922.1;A4QP81;1.30E-07;FRRS1_DANRE;Putative ferric-chelate reductase 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491";;integral component of membrane [GO:0016021];oxidoreductase activity [GO:0016491]
comp824145_c0_seq1;GAXK01173966.1;Q9HFY6;1.59E-37;CALM_BLAEM;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8242298_c0_seq1;GAXK01202685.1;O31249;2.19E-10;ALKR_ACIAD;HTH-type transcriptional regulator AlkR;"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; alkane catabolic process [GO:0043448]";"GO:0003700; GO:0043448; GO:0043565";alkane catabolic process [GO:0043448];;"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp824262_c0_seq1;GAXK01173949.1;Q5F362;3.42E-47;CC50A_CHICK;Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A);"apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; phospholipid translocation [GO:0045332]";"GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0016324; GO:0030658; GO:0045332";phospholipid translocation [GO:0045332];"apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]";
comp82443_c3_seq1;GAXK01033085.1;P63300;2.48E-25;SELW_MOUSE;Selenoprotein W (SelW);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; response to selenium ion [GO:0010269]";"GO:0005737; GO:0005829; GO:0005886; GO:0010269; GO:0016209; GO:0016491";response to selenium ion [GO:0010269];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]"
comp8245956_c0_seq1;GAXK01010193.1;B4LG38;1.30E-07;UBP36_DROVI;Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Protein scrawny) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36);"nucleolus [GO:0005730]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005730; GO:0006511; GO:0016242; GO:0016579; GO:0030718; GO:0035019; GO:0036459";"germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleolus [GO:0005730];thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
comp824691_c0_seq1;GAXK01173970.1;Q9JJX6;9.15E-80;P2RX4_MOUSE;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor);"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; drug binding [GO:0008144]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; vasodilation [GO:0042311]";"GO:0001614; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005639; GO:0005886; GO:0005887; GO:0006809; GO:0006812; GO:0006816; GO:0007165; GO:0008144; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0016021; GO:0019228; GO:0019233; GO:0030054; GO:0030424; GO:0030425; GO:0033198; GO:0034220; GO:0034405; GO:0035381; GO:0035590; GO:0042311; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045177; GO:0045202; GO:0045296; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0055117; GO:0055119; GO:0060079; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904141; GO:2001028";"apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; vasodilation [GO:0042311]";"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; drug binding [GO:0008144]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]"
comp82475_c1_seq1;GAXK01033829.1;A1L0Z4;1.88E-47;TBCC1_XENTR;TBCC domain-containing protein 1;"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; cell morphogenesis [GO:0000902]";"GO:0000902; GO:0000922; GO:0005737; GO:0005815";cell morphogenesis [GO:0000902];"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";
comp8247737_c0_seq1;GAXK01126090.1;O23755;1.15E-37;EF2_BETVU;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp824869_c0_seq1;GAXK01173931.1;Q96IR2;7.54E-31;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8249_c0_seq1;GAXK01013470.1;O76080;4.34E-22;ZFAN5_HUMAN;AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0005737; GO:0008270";;cytoplasm [GO:0005737];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp824919_c1_seq1;GAXK01173930.1;Q9NFP5;7.28E-08;SH3BG_DROME;SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein);SH3 domain binding [GO:0017124];GO:0017124;;;SH3 domain binding [GO:0017124]
comp825047_c0_seq1;GAXK01173961.1;O64571;2.20E-09;UBA1C_ARATH;UBP1-associated proteins 1C;"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]";"GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0008270; GO:1990904";mRNA processing [GO:0006397];"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
comp825123_c0_seq1;GAXK01173919.1;P73392;2.95E-12;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp82516_c0_seq1;GAXK01033274.1;Q6DCV0;2.37E-137;WIPI4_XENLA;WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45);"phagophore assembly site [GO:0000407]; phosphatidylinositol phosphate binding [GO:1901981]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]";"GO:0000045; GO:0000407; GO:0009267; GO:1901981";"autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]";phagophore assembly site [GO:0000407];phosphatidylinositol phosphate binding [GO:1901981]
comp82519_c1_seq1;GAXK01033412.1;P0C1J6;7.35E-36;FKBP4_RHIO9;FK506-binding protein 4 (EC 5.2.1.8) (Histone proline isomerase) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005634";;nucleus [GO:0005634];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp8253_c2_seq1;GAXK01013668.1;Q3T0Q8;6.67E-32;UT14A_BOVIN;U3 small nucleolar RNA-associated protein 14 homolog A;"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]";"GO:0005730; GO:0006364; GO:0032040";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]";
comp825376_c1_seq1;GAXK01173926.1;Q9M2P4;4.79E-14;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp8253862_c0_seq1;GAXK01101857.1;Q8R2R1;1.28E-30;POMT1_MOUSE;Protein O-mannosyl-transferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1);"acrosomal vesicle [GO:0001669]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; extracellular matrix organization [GO:0030198]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked mannosylation [GO:0035269]";"GO:0000030; GO:0001669; GO:0004169; GO:0005789; GO:0016021; GO:0016529; GO:0030198; GO:0035269; GO:1904100";"extracellular matrix organization [GO:0030198]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked mannosylation [GO:0035269]";"acrosomal vesicle [GO:0001669]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]";"dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]"
comp82544_c0_seq1;GAXK01033249.1;Q2PFX0;2.08E-85;ATE1_MACFA;Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]";"GO:0004057; GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";arginyltransferase activity [GO:0004057]
comp8254712_c0_seq1;GAXK01141968.1;P17970;5.74E-23;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp825494_c0_seq1;GAXK01173973.1;O43167;1.28E-10;ZBT24_HUMAN;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000981; GO:0002244; GO:0003700; GO:0005654; GO:0044212; GO:0045944; GO:0046872";"hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleoplasm [GO:0005654];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp8255_c1_seq1;GAXK01014830.1;Q13823;0;NOG2_HUMAN;Nucleolar GTP-binding protein 2 (Autoantigen NGP-1);"membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]";"GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254";ribosome biogenesis [GO:0042254];"membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]"
comp82552_c3_seq1;GAXK01033329.1;Q15031;0;SYLM_HUMAN;Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006429; GO:0032543";"leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]"
comp8256_c0_seq1;GAXK01013390.1;Q5ZIW2;2.66E-73;CNO10_CHICK;CCR4-NOT transcription complex subunit 10;"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]";"GO:0005634; GO:0005737; GO:0006402; GO:0017148; GO:0030014; GO:0031047";"gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]";"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp82568_c0_seq1;GAXK01033188.1;Q2HJ10;2.17E-115;ZNT2_MOUSE;Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2);"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0005385; GO:0005737; GO:0005770; GO:0005774; GO:0005886; GO:0006829; GO:0010043; GO:0016021; GO:0031410; GO:0043231; GO:0061088; GO:0061090; GO:0071577";"positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";zinc ion transmembrane transporter activity [GO:0005385]
comp82579_c0_seq1;GAXK01033578.1;P25169;8.76E-75;AT1B1_ARTSF;Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit);"sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";"GO:0005890; GO:0006813; GO:0006814";"potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]";sodium:potassium-exchanging ATPase complex [GO:0005890];
comp8258_c0_seq1;GAXK01014820.1;Q93092;3.25E-146;TALDO_MOUSE;Transaldolase (EC 2.2.1.2);"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]";"GO:0004801; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0030246; GO:0043231; GO:0048029";"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]";"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]"
comp82582_c0_seq1;GAXK01033102.1;P36898;0;BMR1B_MOUSE;Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (Activin receptor-like kinase 6) (ALK-6) (Serine/threonine-protein kinase receptor R6) (SKR6) (CD antigen CDw293);"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"GO:0001501; GO:0001502; GO:0001550; GO:0001654; GO:0002062; GO:0002063; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0006703; GO:0006954; GO:0007178; GO:0007179; GO:0007389; GO:0009953; GO:0019838; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0035108; GO:0042698; GO:0043010; GO:0043025; GO:0043235; GO:0045597; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:1902043; GO:1902731";"BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"
comp82583_c0_seq1;GAXK01033280.1;P81127;1.95E-52;SNAG_BOVIN;Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma);"SNARE complex [GO:0031201]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005483; GO:0005774; GO:0006886; GO:0016192; GO:0019905; GO:0031201";"intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"SNARE complex [GO:0031201]; vacuolar membrane [GO:0005774]";"soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp8259650_c0_seq1;GAXK01190435.1;P17612;1.46E-23;KAPCA_HUMAN;cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11);"acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; G2/M transition of mitotic cell cycle [GO:0000086]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; sperm capacitation [GO:0048240]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"GO:0000086; GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0002223; GO:0003091; GO:0004672; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0007165; GO:0007596; GO:0010389; GO:0010737; GO:0010881; GO:0016020; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034199; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045171; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070613; GO:0071158; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097711; GO:1901621; GO:1903779; GO:2000810";"activation of protein kinase A activity [GO:0034199]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; G2/M transition of mitotic cell cycle [GO:0000086]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; sperm capacitation [GO:0048240]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]";"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]"
comp826129_c0_seq1;GAXK01071830.1;P24046;1.97E-18;GBRR1_HUMAN;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098978; GO:0098982; GO:0099507; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp8262_c1_seq1;GAXK01013292.1;Q9I8E6;0;COPG2_TAKRU;Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP);"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005198; GO:0006886; GO:0016192; GO:0030126";"intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]";structural molecule activity [GO:0005198]
comp82621_c0_seq1;GAXK01033525.1;Q5R4W8;2.05E-07;ZN346_PONAB;Zinc finger protein 346;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]";"GO:0003725; GO:0005634; GO:0005730; GO:0005737; GO:0008270";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]"
comp82623_c1_seq1;GAXK01033616.1;A4IF62;0;RPC1_BOVIN;DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A);"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0046872; GO:0051607";"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]";"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]"
comp826244_c0_seq1;GAXK01071818.1;Q49SH1;5.68E-15;NCKX5_DANRE;Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Protein golden) (Solute carrier family 24 member 5);"integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; melanocyte differentiation [GO:0030318]; response to stimulus [GO:0050896]";"GO:0005262; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0050896; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; melanocyte differentiation [GO:0030318]; response to stimulus [GO:0050896]";"integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp82634_c0_seq1;GAXK01033132.1;Q9VZH2;2.68E-143;MAS_DROME;Protein masquerade;"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007417; GO:0007422; GO:0010976; GO:0016203; GO:0030424; GO:0043025; GO:0061564; GO:0106030";"axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]";"axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";
comp82638_c3_seq1;GAXK01033192.1;Q6TCH7;4.98E-55;PAQR3_HUMAN;Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]";"GO:0000139; GO:0000165; GO:0001933; GO:0005794; GO:0010977; GO:0016021; GO:0033137; GO:0034067; GO:0038023; GO:0043407";"MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp826429_c1_seq1;GAXK01071790.1;O75030;2.27E-26;MITF_HUMAN;Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0010628; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141";"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp82655_c0_seq1;GAXK01033254.1;Q9CXE0;3.86E-12;PRDM5_MOUSE;PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5);"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000278; GO:0000978; GO:0001227; GO:0005634; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp826567_c0_seq1;GAXK01071774.1;Q7Z2Y8;4.49E-18;GVIN1_HUMAN;Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp826635_c0_seq1;GAXK01071795.1;Q00577;1.09E-27;PURA_HUMAN;Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha);"dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; postsynapse [GO:0098794]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000784; GO:0000900; GO:0000977; GO:0000981; GO:0001227; GO:0003690; GO:0003691; GO:0003697; GO:0003723; GO:0005634; GO:0005662; GO:0006268; GO:0006270; GO:0007399; GO:0008134; GO:0008284; GO:0030154; GO:0032422; GO:0032839; GO:0043025; GO:0043565; GO:0046332; GO:0046651; GO:0050673; GO:0098794; GO:0098963; GO:0098978";"cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]";"dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; postsynapse [GO:0098794]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"
comp82690_c0_seq1;GAXK01033232.1;P60762;1.45E-40;MO4L1_MOUSE;Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Testis-expressed gene 189 protein) (Transcription factor-like protein MRG15);"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"GO:0000123; GO:0000724; GO:0003682; GO:0006338; GO:0006342; GO:0008283; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0047485";"cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]";"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]";"chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]"
comp82710_c0_seq1;GAXK01033289.1;Q27052;6.16E-13;FCA1_TRYRA;Flagellar calcium-binding protein;"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp82715_c2_seq1;GAXK01033393.1;A3KPA3;6.21E-82;NAA60_DANRE;N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF);"Golgi membrane [GO:0000139]; H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]";"GO:0000139; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0043966; GO:0043967";"cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]";Golgi membrane [GO:0000139];"H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]"
comp8271652_c0_seq1;GAXK01150270.1;C0LGH8;1.28E-11;Y1634_ARATH;Probable LRR receptor-like serine/threonine-protein kinase At1g63430 (EC 2.7.11.1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp8271824_c0_seq1;GAXK01150269.1;Q8FHF4;5.76E-16;HIPA_ECOL6;Serine/threonine-protein kinase toxin HipA (Ser/Thr-protein kinase HipA) (EC 2.7.11.1) (Toxin HipA);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp8271954_c0_seq1;GAXK01150265.1;P54932;6.70E-29;RDXB_RHOS4;Protein RdxB;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]";"GO:0005886; GO:0016021; GO:0046872; GO:0051539; GO:0055114";oxidation-reduction process [GO:0055114];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"
comp82724_c2_seq1;GAXK01033279.1;Q4PEQ5;8.01E-86;MCA1_USTMA;Metacaspase-1 (EC 3.4.22.-);"cytosol [GO:0005829]; nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; apoptotic process [GO:0006915]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"GO:0004198; GO:0005634; GO:0005829; GO:0006515; GO:0006915";"apoptotic process [GO:0006915]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]";"cytosol [GO:0005829]; nucleus [GO:0005634]";calcium-dependent cysteine-type endopeptidase activity [GO:0004198]
comp82731_c0_seq1;GAXK01033284.1;Q9V7U0;5.73E-08;RESIL_DROME;Pro-resilin;"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]";"GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302";chitin-based cuticle development [GO:0040003];"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]";"chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]"
comp82744_c0_seq1;GAXK01033582.1;Q3SZL5;9.04E-07;PIGS_BOVIN;GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein);"GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]";"GO:0016255; GO:0042765";attachment of GPI anchor to protein [GO:0016255];GPI-anchor transamidase complex [GO:0042765];
comp82753_c1_seq1;GAXK01033272.1;D3ZSI8;6.33E-32;PI51A_RAT;Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha);"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"GO:0005524; GO:0005829; GO:0005847; GO:0006661; GO:0010761; GO:0016308; GO:0016607; GO:0019900; GO:0030027; GO:0031532; GO:0032587; GO:0048041; GO:0060326; GO:0072659; GO:0090630; GO:0097178";"actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178]";"cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]";"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]"
comp827756_c3_seq1;GAXK01071808.1;Q66KG0;1.32E-17;S22AG_XENLA;Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2);"integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]";"GO:0006811; GO:0016021; GO:0022857";ion transport [GO:0006811];integral component of membrane [GO:0016021];transmembrane transporter activity [GO:0022857]
comp82794_c0_seq1;GAXK01033504.1;Q9GPJ1;1.35E-21;SKEL2_DROME;Protein Skeletor, isoforms D/E;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";structural molecule activity [GO:0005198]
comp82797_c0_seq1;GAXK01033597.1;E1B932;9.55E-08;KLH12_BOVIN;Kelch-like protein 12;"COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0005815; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0042802; GO:0048208";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]";identical protein binding [GO:0042802]
comp8279715_c0_seq1;GAXK01060709.1;P51615;3.94E-19;MAOX_VITVI;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40);"cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]";"GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287";;cytoplasm [GO:0005737];"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp828034_c0_seq1;GAXK01028469.1;Q7Z0G7;1.53E-51;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp828116_c0_seq1;GAXK01028502.1;Q99PV8;1.87E-28;BC11B_MOUSE;B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (mRit1);"neuron projection [GO:0043005]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006355; GO:0007409; GO:0008285; GO:0009791; GO:0010468; GO:0010837; GO:0019216; GO:0021773; GO:0021902; GO:0021953; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043066; GO:0043368; GO:0043565; GO:0043588; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0071678; GO:0097535";"alpha-beta T cell differentiation [GO:0046632]; axonogenesis [GO:0007409]; central nervous system neuron differentiation [GO:0021953]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; skin development [GO:0043588]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymus development [GO:0048538]";"neuron projection [GO:0043005]; nucleus [GO:0005634]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp8281655_c0_seq1;GAXK01196627.1;Q9UL36;7.36E-07;ZN236_HUMAN;Zinc finger protein 236;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333";"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp82824_c0_seq1;GAXK01033515.1;Q9VJ79;0;PDE11_DROME;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";"GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555";"cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"
comp828264_c0_seq1;GAXK01028509.1;A0JNA8;1.19E-27;PAXI1_BOVIN;PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein);"chromosome [GO:0005694]; nuclear matrix [GO:0016363]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of DNA-binding transcription factor activity [GO:0043433]";"GO:0005694; GO:0006281; GO:0006310; GO:0016363; GO:0043433";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of DNA-binding transcription factor activity [GO:0043433]";"chromosome [GO:0005694]; nuclear matrix [GO:0016363]";
comp8283714_c0_seq1;GAXK01039664.1;P21329;1.64E-12;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp8284_c0_seq1;GAXK01013484.1;Q9VYD7;1.76E-32;TIM9_DROME;Mitochondrial import inner membrane translocase subunit Tim9;"TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein targeting to mitochondrion [GO:0006626]";"GO:0005744; GO:0006626; GO:0015450; GO:0046872";protein targeting to mitochondrion [GO:0006626];TIM23 mitochondrial import inner membrane translocase complex [GO:0005744];"metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]"
comp82841_c2_seq1;GAXK01033283.1;Q5M7T9;6.16E-172;THNS2_RAT;Threonine synthase-like 2 (TSH2) (EC 4.2.3.-);"pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; threonine synthase activity [GO:0004795]; 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071]; threonine biosynthetic process [GO:0009088]";"GO:0004795; GO:0009071; GO:0009088; GO:0016311; GO:0030170; GO:0046360; GO:0070905";"2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071]; threonine biosynthetic process [GO:0009088]";;"pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; threonine synthase activity [GO:0004795]"
comp82848_c1_seq1;GAXK01033482.1;Q8IZN3;6.78E-60;ZDH14_HUMAN;Probable palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14) (DHHC-14);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706";"peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp82855_c0_seq1;GAXK01033104.1;P56223;5.06E-42;PO6F1_RAT;POU domain, class 6, transcription factor 1 (Brain-specific homeobox/POU domain protein 5) (Brain-5) (Brn-5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp8285710_c0_seq1;GAXK01197147.1;P44303;7.36E-31;AROG_HAEIN;Phospho-2-dehydro-3-deoxyheptonate aldolase (EC 2.5.1.54) (3-deoxy-D-arabino-heptulosonate 7-phosphate synthase) (DAHP synthase) (Phospho-2-keto-3-deoxyheptonate aldolase);"cytoplasm [GO:0005737]; 3-deoxy-7-phosphoheptulonate synthase activity [GO:0003849]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]";"GO:0003849; GO:0005737; GO:0009073; GO:0009423";"aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]";cytoplasm [GO:0005737];3-deoxy-7-phosphoheptulonate synthase activity [GO:0003849]
comp8286001_c0_seq1;GAXK01070289.1;Q9VZW5;1.01E-08;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp828609_c0_seq1;GAXK01028475.1;Q9CPW0;3.30E-09;CNTP2_MOUSE;Contactin-associated protein-like 2 (Cell recognition molecule Caspr2);"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]";"GO:0002020; GO:0005769; GO:0005794; GO:0005886; GO:0007155; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019899; GO:0021761; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0033270; GO:0035176; GO:0042297; GO:0043025; GO:0044224; GO:0044325; GO:0045163; GO:0048812; GO:0071205; GO:0071625; GO:0097060";"adult behavior [GO:0030534]; cell adhesion [GO:0007155]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]; vocal learning [GO:0042297]";"axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]";"enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protease binding [GO:0002020]"
comp8287091_c0_seq1;GAXK01070293.1;Q9VKY2;6.32E-09;CAND1_DROME;Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1);"nucleus [GO:0005634]; negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";"GO:0005634; GO:0010265; GO:0016567; GO:0031647; GO:2000435";"negative regulation of protein neddylation [GO:2000435]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; SCF complex assembly [GO:0010265]";nucleus [GO:0005634];
comp82877_c0_seq1;GAXK01033114.1;Q8N1F8;1.10E-19;S11IP_HUMAN;Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosomal membrane [GO:0005765]; protein kinase binding [GO:0019901]; neutrophil degranulation [GO:0043312]; protein localization [GO:0008104]";"GO:0005576; GO:0005737; GO:0005765; GO:0008104; GO:0019901; GO:0035578; GO:0043312";"neutrophil degranulation [GO:0043312]; protein localization [GO:0008104]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosomal membrane [GO:0005765]";protein kinase binding [GO:0019901]
comp828773_c0_seq1;GAXK01028488.1;Q5BKW9;1.45E-70;ASGL1_DANRE;"Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain]";"cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345]";"GO:0001917; GO:0004067; GO:0005737; GO:0008798; GO:0033345";asparagine catabolic process via L-aspartate [GO:0033345];"cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]";"asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]"
comp8288836_c0_seq1;GAXK01056221.1;P91443;3.16E-09;HUM6_CAEEL;Unconventional myosin heavy chain 6;"cytoplasm [GO:0005737]; myosin VI complex [GO:0031476]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; transcription factor binding [GO:0008134]; signal transduction [GO:0007165]";"GO:0003774; GO:0005524; GO:0005737; GO:0007165; GO:0008134; GO:0031476; GO:0051015";signal transduction [GO:0007165];"cytoplasm [GO:0005737]; myosin VI complex [GO:0031476]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; transcription factor binding [GO:0008134]"
comp829087_c0_seq1;GAXK01028473.1;Q9HBE1;2.78E-10;PATZ1_HUMAN;POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872";"male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp829263_c0_seq1;GAXK01028444.1;P61214;6.42E-67;ARL4A_RAT;ADP-ribosylation factor-like protein 4A;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873";"brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp8292742_c0_seq1;GAXK01052795.1;P27708;1.99E-36;PYR1_HUMAN;"CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]";"GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]";"aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]"
comp82933_c0_seq1;GAXK01033832.1;Q0EEE2;6.18E-146;PTHD3_MOUSE;Patched domain-containing protein 3 (RND-type protein RNDEu-3);"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";"GO:0016021; GO:0097225";;"integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]";
comp829380_c0_seq1;GAXK01028467.1;O44252;1.89E-11;ROST_DROME;Protein rolling stone;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"GO:0007275; GO:0007520; GO:0016020; GO:0016021";"multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp8295421_c0_seq1;GAXK01153774.1;Q46845;4.03E-13;YGHU_ECOLI;Disulfide-bond oxidoreductase YghU (EC 1.8.4.-) (GSH-dependent disulfide-bond oxidoreductase YghU) (GST N2-2) (Organic hydroperoxidase) (EC 1.11.1.-);"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]";"GO:0004601; GO:0015036";;;"disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]"
comp829557_c0_seq1;GAXK01028466.1;Q61166;3.04E-50;MARE1_MOUSE;Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1);"cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"GO:0005794; GO:0005813; GO:0005815; GO:0005874; GO:0005881; GO:0005925; GO:0008017; GO:0015630; GO:0016477; GO:0019901; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0042802; GO:0042995; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721";"cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]";"cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; spindle midzone [GO:0051233]";"identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]"
comp829570_c0_seq1;GAXK01028448.1;Q3SIB2;5.81E-16;RNH_THIDA;Ribonuclease H (RNase H) (EC 3.1.26.4);"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; RNA catabolic process [GO:0006401]";"GO:0000287; GO:0003676; GO:0004523; GO:0005737; GO:0006401";RNA catabolic process [GO:0006401];cytoplasm [GO:0005737];"magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
comp8296981_c0_seq1;GAXK01042109.1;P16423;3.57E-12;POLR_DROME;"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0046872";;;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp829716_c0_seq1;GAXK01028496.1;Q9UTM9;8.36E-11;FAP2_SCHPO;L-saccharopine oxidase (EC 1.5.3.18);"cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; flavin adenine dinucleotide binding [GO:0050660]; saccharopine oxidase activity [GO:0051698]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process [GO:0019477]";"GO:0005576; GO:0005634; GO:0005829; GO:0008115; GO:0019477; GO:0050660; GO:0051698";L-lysine catabolic process [GO:0019477];"cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]";"flavin adenine dinucleotide binding [GO:0050660]; saccharopine oxidase activity [GO:0051698]; sarcosine oxidase activity [GO:0008115]"
comp82975_c1_seq1;GAXK01033516.1;Q5ZJR8;4.31E-80;ELOV6_CHICK;Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp829787_c0_seq1;GAXK01028450.1;F1MN90;2.38E-08;CIDEC_BOVIN;Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0034389; GO:0097194";"execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";
comp8299855_c0_seq1;GAXK01071110.1;P11352;1.36E-23;GPX1_MOUSE;Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Selenium-dependent glutathione peroxidase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; SH3 domain binding [GO:0017124]; angiogenesis involved in wound healing [GO:0060055]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]";"GO:0000302; GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006641; GO:0006749; GO:0006979; GO:0007605; GO:0008283; GO:0009410; GO:0009609; GO:0009611; GO:0009636; GO:0009650; GO:0010269; GO:0010332; GO:0014902; GO:0017124; GO:0018158; GO:0033194; GO:0033599; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0048741; GO:0051450; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:0097413; GO:1902042; GO:1902176";"angiogenesis involved in wound healing [GO:0060055]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; SH3 domain binding [GO:0017124]"
comp83036_c1_seq1;GAXK01033532.1;P13607;0;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp83047_c0_seq1;GAXK01033580.1;P42639;1.04E-19;TPM1_PIG;Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1);"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]";"GO:0005737; GO:0005884; GO:0007015; GO:0015629; GO:0042802; GO:0042803; GO:0046982; GO:0051015; GO:0060048";"actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]";"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp8305_c0_seq1;GAXK01013634.1;F1PT61;4.66E-13;MYH16_CANLF;Myosin-16 (Myosin heavy chain 16);"myofibril [GO:0030016]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]";"GO:0003774; GO:0005524; GO:0016459; GO:0030016; GO:0051015";;"myofibril [GO:0030016]; myosin complex [GO:0016459]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
comp83050_c1_seq1;GAXK01033469.1;Q26061;2.93E-44;FRI_PACLE;Ferritin (EC 1.16.3.1);"cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";"GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199";"cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]";cytoplasm [GO:0005737];"ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]"
comp830506_c0_seq1;GAXK01190249.1;Q9VNM1;3.37E-21;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp83053_c0_seq1;GAXK01204946.1;O73888;1.86E-34;HPGDS_CHICK;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase);"cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";"GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0006693; GO:0006749; GO:0042803; GO:2000255";"glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]";cytoplasm [GO:0005737];"calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]"
comp830551_c1_seq1;GAXK01190235.1;C9WMM5;1.58E-97;VCP_APIME;Venom serine carboxypeptidase (EC 3.4.16.5) (allergen Api m 9);"extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]";"GO:0004185; GO:0005576";;extracellular region [GO:0005576];serine-type carboxypeptidase activity [GO:0004185]
comp830565_c0_seq1;GAXK01190208.1;P58242;3.84E-44;ASM3B_MOUSE;Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-);"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0045824; GO:0046466; GO:0050728";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp830689_c0_seq1;GAXK01190261.1;Q7ZV79;1.38E-91;UCK2B_DANRE;Uridine-cytidine kinase 2-B (UCK 2-B) (EC 2.7.1.48) (Cytidine monophosphokinase 2-B) (Uridine monophosphokinase 2-B);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp830854_c0_seq1;GAXK01190257.1;P62184;6.92E-47;CALM_RENRE;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp830883_c2_seq1;GAXK01190280.1;B3A0N5;4.50E-125;APY_TABYA;Apyrase (EC 3.6.1.5) (ATP-diphosphatase) (ADPase) (ATP-diphosphohydrolase) (Adenosine diphosphatase) (allergen Tab y 1);"extracellular region [GO:0005576]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; nucleotide catabolic process [GO:0009166]";"GO:0005524; GO:0005576; GO:0009166; GO:0016788; GO:0046872; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491";nucleotide catabolic process [GO:0009166];extracellular region [GO:0005576];"8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]"
comp831_c0_seq1;GAXK01169003.1;O16797;9.96E-80;RL3_DROME;60S ribosomal protein L3;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp83109_c0_seq1;GAXK01033183.1;Q7T2D4;1.76E-92;ERGI2_DANRE;Endoplasmic reticulum-Golgi intermediate compartment protein 2;"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]";
comp8310930_c0_seq1;GAXK01038343.1;Q8BWJ3;5.65E-41;KPB2_MOUSE;Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit);"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"GO:0003824; GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468";"glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]";"phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]"
comp83124_c0_seq1;GAXK01033576.1;Q811D0;0;DLG1_MOUSE;Disks large homolog 1 (Embryo-dlg/synapse-associated protein 97) (E-dlg/SAP97) (Synapse-associated protein 97) (SAP-97) (SAP97);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microvillus [GO:0005902]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; T-tubule [GO:0030315]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization [GO:0032880]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; tissue morphogenesis [GO:0048729]; ureteric bud development [GO:0001657]";"GO:0000122; GO:0001657; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0002369; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0005911; GO:0005913; GO:0005923; GO:0007015; GO:0007268; GO:0008022; GO:0008104; GO:0008284; GO:0008360; GO:0009898; GO:0009925; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019894; GO:0019900; GO:0019901; GO:0019902; GO:0030054; GO:0030165; GO:0030315; GO:0030425; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0032880; GO:0033268; GO:0033270; GO:0034629; GO:0035255; GO:0035748; GO:0040018; GO:0042110; GO:0042130; GO:0042391; GO:0042734; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045202; GO:0045930; GO:0048471; GO:0048608; GO:0048639; GO:0048704; GO:0048729; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099092; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764";"actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization [GO:0032880]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; tissue morphogenesis [GO:0048729]; ureteric bud development [GO:0001657]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microvillus [GO:0005902]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; T-tubule [GO:0030315]";"ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]"
comp8313848_c0_seq1;GAXK01057957.1;Q29GB8;6.73E-11;NAAT1_DROPS;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp83151_c2_seq1;GAXK01033503.1;P0A0W2;9.64E-12;FKBP_NEIMB;FK506-binding protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";"GO:0000413; GO:0003755; GO:0005737; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]";cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp831643_c0_seq1;GAXK01190247.1;A4QP81;8.62E-14;FRRS1_DANRE;Putative ferric-chelate reductase 1 (EC 1.-.-.-);"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]";"GO:0016021; GO:0016491";;integral component of membrane [GO:0016021];oxidoreductase activity [GO:0016491]
comp83170_c1_seq1;GAXK01033210.1;Q17RR3;2.20E-13;LIPR3_HUMAN;Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3);"extracellular space [GO:0005615]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005615; GO:0016042; GO:0016298";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];"lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]"
comp83175_c3_seq1;GAXK01033133.1;O35547;1.83E-167;ACSL4_RAT;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005811; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0031957; GO:0031966; GO:0032024; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp83179_c1_seq1;GAXK01033095.1;Q86X02;5.08E-17;CDR2L_HUMAN;Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen);;;;;
comp83180_c4_seq1;GAXK01033300.1;Q91XA9;1.01E-98;CHIA_MOUSE;Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (YNL);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]";"GO:0000272; GO:0001878; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0006955; GO:0008061; GO:0019900; GO:0052356; GO:0090197";"apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"chitinase activity [GO:0004568]; chitin binding [GO:0008061]; kinase binding [GO:0019900]"
comp831949_c0_seq1;GAXK01190192.1;P55853;2.54E-16;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp832_c1_seq1;GAXK01170554.1;B4GDM5;4.91E-137;EIF3M_DROPE;Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Transport and Golgi organization protein 7) (Tango-7);"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; Golgi apparatus [GO:0005794]; investment cone [GO:0070865]; caspase binding [GO:0089720]; translation initiation factor activity [GO:0003743]; activation of cysteine-type endopeptidase activity [GO:0097202]; formation of cytoplasmic translation initiation complex [GO:0001732]; Golgi organization [GO:0007030]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; protein secretion [GO:0009306]; sperm individualization [GO:0007291]";"GO:0001732; GO:0003743; GO:0005794; GO:0005829; GO:0007030; GO:0007291; GO:0009306; GO:0016282; GO:0033290; GO:0070865; GO:0071541; GO:0089720; GO:0097202; GO:2001272";"activation of cysteine-type endopeptidase activity [GO:0097202]; formation of cytoplasmic translation initiation complex [GO:0001732]; Golgi organization [GO:0007030]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; protein secretion [GO:0009306]; sperm individualization [GO:0007291]";"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; Golgi apparatus [GO:0005794]; investment cone [GO:0070865]";"caspase binding [GO:0089720]; translation initiation factor activity [GO:0003743]"
comp8320354_c0_seq1;GAXK01128974.1;P21329;1.57E-08;RTJK_DROFU;RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase);RNA-directed DNA polymerase activity [GO:0003964];GO:0003964;;;RNA-directed DNA polymerase activity [GO:0003964]
comp832043_c0_seq1;GAXK01139833.1;O43451;0;MGA_HUMAN;"Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983]";"GO:0003824; GO:0004339; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016160; GO:0016324; GO:0030246; GO:0032450; GO:0043312; GO:0044245; GO:0070062; GO:0070821; GO:0101003";"neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]";"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]"
comp832244_c0_seq1;GAXK01139808.1;A1TC01;1.32E-12;GPGP_MYCVP;Glucosyl-3-phosphoglycerate phosphatase (EC 3.1.3.85);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp83225_c0_seq1;GAXK01033614.1;Q5LJZ2;5.76E-101;SET1_DROME;Histone-lysine N-methyltransferase SETD1 (EC 2.1.1.43);"euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"GO:0000791; GO:0003723; GO:0005700; GO:0035327; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0080182";"histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]";"euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]";"histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]"
comp832558_c0_seq1;GAXK01139845.1;A8MQ14;1.04E-10;ZN850_HUMAN;Zinc finger protein 850;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp832560_c0_seq1;GAXK01139811.1;Q64104;1.31E-38;NR2E1_MOUSE;Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (mTll);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of cellular component organization [GO:0051128]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601]";"GO:0000122; GO:0000977; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005654; GO:0006357; GO:0007420; GO:0007601; GO:0008270; GO:0008284; GO:0008347; GO:0019899; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0021987; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043010; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0048856; GO:0051128; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:2000178; GO:2000179; GO:2000648";"aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of cellular component organization [GO:0051128]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp8326_c2_seq1;GAXK01014047.1;A0JNA3;0;IMDH1_BOVIN;Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]";"GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872";"GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp83262_c4_seq1;GAXK01033648.1;Q6IDD9;2.49E-83;SARM1_DROME;Sterile alpha and TIR motif-containing protein 1 (Tir-1 homolog) (dSarm);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214";"innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";signaling adaptor activity [GO:0035591]
comp83264_c4_seq1;GAXK01033314.1;O13134;1.00E-169;S4A4_AMBTI;Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0005452; GO:0006814; GO:0015293; GO:0016021; GO:0016323";sodium ion transport [GO:0006814];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]"
comp832815_c0_seq1;GAXK01139818.1;Q08731;4.25E-13;LIT2_MOUSE;Lithostathine-2 (Islet of Langerhans regenerating protein 2) (REG-2) (Pancreatic stone protein 2) (PSP) (Pancreatic thread protein 2) (PTP);"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; transmembrane signaling receptor activity [GO:0004888]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in other organism [GO:0044278]; myelination [GO:0042552]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434]; suckling behavior [GO:0001967]";"GO:0001967; GO:0004888; GO:0005615; GO:0008284; GO:0042552; GO:0042834; GO:0043434; GO:0044278; GO:0061844; GO:0062023; GO:0070492";"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in other organism [GO:0044278]; myelination [GO:0042552]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434]; suckling behavior [GO:0001967]";"collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]";"oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; transmembrane signaling receptor activity [GO:0004888]"
comp83284_c4_seq1;GAXK01033207.1;O08586;2.78E-87;PTEN_MOUSE;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog);"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]";"GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008284; GO:0008285; GO:0009749; GO:0009898; GO:0010043; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032869; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045475; GO:0045666; GO:0045736; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:1901017; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990090; GO:1990314; GO:1990381; GO:1990782; GO:2000060; GO:2000134; GO:2000272; GO:2000463; GO:2000808; GO:2001235";"adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; neuron projection development [GO:0031175]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]";"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]";"anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]"
comp832856_c0_seq1;GAXK01139832.1;C0HL12;5.92E-08;AGRB1_RAT;"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]";"dendritic spine [GO:0043197]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; phagocytic cup [GO:0001891]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]";"GO:0001891; GO:0004930; GO:0005576; GO:0005925; GO:0006909; GO:0007166; GO:0007399; GO:0007517; GO:0014069; GO:0016525; GO:0043197; GO:0045087; GO:0051963; GO:0098974; GO:0098978; GO:0099055";"cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]";"dendritic spine [GO:0043197]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; phagocytic cup [GO:0001891]; postsynaptic density [GO:0014069]";G protein-coupled receptor activity [GO:0004930]
comp833133_c0_seq1;GAXK01139849.1;Q02280;0;KCNAE_DROME;Potassium voltage-gated channel protein eag (Ether-a-go-go protein);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805; GO:1903818";"behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ion channel binding [GO:0044325]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp8332_c2_seq1;GAXK01013956.1;Q8K363;0;DDX18_MOUSE;ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18);"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0071392";"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"chromosome [GO:0005694]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp8335_c0_seq1;GAXK01013440.1;D3ZTX0;7.34E-78;TMED7_RAT;Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27);"COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0016021; GO:0030134; GO:0030663; GO:0033116";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]";"COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";
comp83382_c0_seq1;GAXK01033301.1;P57722;1.87E-62;PCBP3_MOUSE;Poly(rC)-binding protein 3 (Alpha-CP3);"cytoplasm [GO:0005737]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001227; GO:0003690; GO:0003723; GO:0005737; GO:1990829";negative regulation of transcription by RNA polymerase II [GO:0000122];cytoplasm [GO:0005737];"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp8339076_c0_seq1;GAXK01001614.1;P10040;8.74E-10;CRB_DROME;Protein crumbs (95F);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]";"GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007163; GO:0007219; GO:0007391; GO:0007399; GO:0007424; GO:0007435; GO:0007443; GO:0008284; GO:0016021; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032435; GO:0032880; GO:0033157; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036";"adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]";"calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]"
comp83396_c0_seq1;GAXK01033298.1;O46102;1.69E-63;PAPD1_DROME;Poly(A) RNA polymerase, mitochondrial (DmMTPAP) (EC 2.7.7.19);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; tRNA stabilization [GO:0036416]";"GO:0003723; GO:0005524; GO:0005739; GO:0006378; GO:0036416; GO:0046872; GO:0097222; GO:1990817";"mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; tRNA stabilization [GO:0036416]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]"
comp8339975_c0_seq1;GAXK01001617.1;P0AEQ2;8.34E-27;GLCG_ECOL6;Protein GlcG;;;;;
comp834009_c0_seq1;GAXK01002736.1;A1ZBD6;1.40E-117;MCTP_DROME;Multiple C2 and transmembrane domain-containing protein;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"GO:0005509; GO:0005789; GO:0016021; GO:0046928; GO:0048168";"regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";calcium ion binding [GO:0005509]
comp834063_c0_seq1;GAXK01002747.1;Q90419;2.43E-15;TWHH_DANRE;"Tiggy-winkle hedgehog protein (TWHH) (Sonic hedgehog protein B) (SHHB) [Cleaved into: Tiggy-winkle hedgehog protein N-product; Tiggy-winkle hedgehog protein C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0030182; GO:0030900; GO:0042063; GO:0048663; GO:0048702; GO:0048703; GO:0048709; GO:0055002; GO:0060956";"cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; endocardial cell differentiation [GO:0060956]; forebrain development [GO:0030900]; gliogenesis [GO:0042063]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte differentiation [GO:0048709]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; striated muscle cell development [GO:0055002]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]"
comp834126_c0_seq1;GAXK01002733.1;P57727;3.52E-18;TMPS3_HUMAN;Transmembrane protease serine 3 (EC 3.4.21.-) (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"GO:0004252; GO:0005044; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0016021; GO:0017080; GO:0043025";"cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]"
comp83423_c1_seq1;GAXK01033514.1;A8MTT3;9.08E-09;CEBOS_HUMAN;Protein CEBPZOS (CEBPZ antisense RNA 1) (CEBPZ opposite strand);"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]";"GO:0016021; GO:0031966";;"integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]";
comp834324_c0_seq1;GAXK01002818.1;Q01603;2.61E-129;PERO_DROME;Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase);"chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872";"eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]";"chorion [GO:0042600]; extracellular region [GO:0005576]";"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp834342_c1_seq1;GAXK01002809.1;P18735;7.32E-17;ZG7_XENLA;Gastrula zinc finger protein XlCGF7.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp83439_c0_seq1;GAXK01033131.1;Q6NYI0;2.11E-13;HERP2_DANRE;Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein;"integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]";"GO:0016021; GO:0030968";endoplasmic reticulum unfolded protein response [GO:0030968];integral component of membrane [GO:0016021];
comp834515_c0_seq1;GAXK01002811.1;Q08180;8.25E-92;ICCR_DROME;Irregular chiasm C-roughest protein (Protein IRREC);"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"GO:0001745; GO:0005886; GO:0005913; GO:0007156; GO:0007520; GO:0016021; GO:0016202; GO:0016324; GO:0030165; GO:0042802; GO:0045177; GO:0046666; GO:0046667; GO:0048749";"compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myoblast fusion [GO:0007520]; regulation of striated muscle tissue development [GO:0016202]; retinal cell programmed cell death [GO:0046666]";"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]"
comp83458_c1_seq1;GAXK01033255.1;B0R0T1;0;VWA8_DANRE;von Willebrand factor A domain-containing protein 8;"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]";"GO:0005524; GO:0005739; GO:0016887";;mitochondrion [GO:0005739];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp8347609_c0_seq1;GAXK01044930.1;P48613;4.40E-09;TIPE_DROME;Protein tipE (Temperature-induced paralytic E);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]; cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433";"cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"sodium channel regulator activity [GO:0017080]; voltage-gated sodium channel activity [GO:0005248]"
comp83478_c20_seq1;GAXK01033452.1;G5EBI4;1.00E-76;CEEH1_CAEEL;Epoxide hydrolase 1 (EC 3.3.2.10);"integral component of membrane [GO:0016021]; epoxide hydrolase activity [GO:0004301]; cellular lipid metabolic process [GO:0044255]";"GO:0004301; GO:0016021; GO:0044255";cellular lipid metabolic process [GO:0044255];integral component of membrane [GO:0016021];epoxide hydrolase activity [GO:0004301]
comp8349_c1_seq1;GAXK01013597.1;P81900;7.08E-111;KAPR2_DROME;cAMP-dependent protein kinase type II regulatory subunit;"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; axon guidance [GO:0007411]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular response to ethanol [GO:0071361]; cGMP-mediated signaling [GO:0019934]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; rhythmic behavior [GO:0007622]";"GO:0005737; GO:0005829; GO:0005886; GO:0005952; GO:0007411; GO:0007622; GO:0007623; GO:0008603; GO:0019934; GO:0030552; GO:0045475; GO:0047555; GO:0048148; GO:0048149; GO:0071361";"axon guidance [GO:0007411]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular response to ethanol [GO:0071361]; cGMP-mediated signaling [GO:0019934]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; rhythmic behavior [GO:0007622]";"cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]"
comp834932_c0_seq1;GAXK01002755.1;G5ED00;2.69E-13;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp834960_c0_seq1;GAXK01002754.1;Q9NRC8;2.51E-14;SIR7_HUMAN;NAD-dependent protein deacetylase sirtuin-7 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7);"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"GO:0000122; GO:0003682; GO:0004407; GO:0005634; GO:0005724; GO:0005730; GO:0005731; GO:0005737; GO:0007072; GO:0009303; GO:0046872; GO:0070403; GO:0070932; GO:0097372";"histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]";"cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]"
comp8349849_c0_seq1;GAXK01185104.1;Q7SDU2;3.30E-16;RL24_NEUCR;60S ribosomal protein L24;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp83520_c0_seq1;GAXK01033859.1;A1Z6E0;1.88E-14;GUS_DROME;Protein gustavus;"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449";"cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]";"cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]";
comp83535_c0_seq1;GAXK01033295.1;Q06985;3.29E-20;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp835422_c0_seq1;GAXK01002823.1;Q148C8;3.49E-07;MIEN1_BOVIN;Migration and invasion enhancer 1;"cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491]; response to selenium ion [GO:0010269]";"GO:0005829; GO:0006915; GO:0010269; GO:0030335; GO:0031235; GO:0043066; GO:0051491";"apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491]; response to selenium ion [GO:0010269]";"cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]";
comp83575_c0_seq1;GAXK01033428.1;Q8SX68;8.36E-47;Y0915_DROME;Uncharacterized protein CG10915;;;;;
comp83578_c0_seq1;GAXK01033853.1;Q23551;4.24E-42;UNC22_CAEEL;Twitchin (EC 2.7.11.1) (Uncoordinated protein 22);"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688";"adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]";"A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]"
comp835900_c1_seq1;GAXK01002732.1;Q6VVW5;1.86E-66;ANPRB_MOUSE;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp83597_c9_seq1;GAXK01033324.1;P49815;2.82E-82;TSC2_HUMAN;Tuberin (Tuberous sclerosis 2 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]";"GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0014069; GO:0016020; GO:0016032; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525";"anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]";"GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]"
comp83602_c0_seq1;GAXK01033113.1;Q4V8U5;2.26E-81;ANO10_DANRE;Anoctamin-10 (Transmembrane protein 16K);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp8361124_c0_seq1;GAXK01173763.1;P22225;1.76E-54;PFR1_TRYBB;69 kDa paraflagellar rod protein (69 kDa PFR protein) (PFR-A/PFR-B);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calmodulin binding [GO:0005516]";"GO:0005516; GO:0005737; GO:0005856; GO:0031514";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]";calmodulin binding [GO:0005516]
comp83619_c2_seq1;GAXK01033119.1;P35502;1.32E-67;ESTF_MYZPE;Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase);methyl indole-3-acetate esterase activity [GO:0080030];GO:0080030;;;methyl indole-3-acetate esterase activity [GO:0080030]
comp836246_c0_seq1;GAXK01203666.1;Q7ZSX3;1.01E-38;PTF1A_DANRE;Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]";"GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048699";"amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]"
comp83640_c0_seq1;GAXK01033484.1;Q02748;9.83E-57;IF4A_DROME;Eukaryotic initiation factor 4A (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; translational initiation [GO:0006413]";"GO:0000278; GO:0000381; GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0005829; GO:0006413; GO:0007279; GO:0010494; GO:0016281; GO:0030514; GO:0030718; GO:0032436; GO:0043186; GO:0046332; GO:0048132; GO:0048477";"cytoplasmic translational initiation [GO:0002183]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; oogenesis [GO:0048477]; pole cell formation [GO:0007279]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; translational initiation [GO:0006413]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; P granule [GO:0043186]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; translation initiation factor activity [GO:0003743]"
comp836475_c0_seq1;GAXK01203677.1;Q494W8;3.10E-07;CRFM7_HUMAN;CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10);"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0004888; GO:0005230; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp836602_c0_seq1;GAXK01203699.1;P18715;6.87E-22;ZG26_XENLA;Gastrula zinc finger protein XlCGF26.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp83669_c0_seq1;GAXK01033234.1;Q9NL83;3.22E-31;ORCKA_PROCL;"Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]";"extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]";"GO:0005184; GO:0005576; GO:0007218";neuropeptide signaling pathway [GO:0007218];extracellular region [GO:0005576];neuropeptide hormone activity [GO:0005184]
comp837_c2_seq1;GAXK01169215.1;P60517;4.43E-73;GBRAP_RAT;Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein);"actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]";"GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225";"autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]";"actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]";"beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]"
comp8370_c18_seq1;GAXK01014402.1;Q5RBR8;1.08E-26;IF4H_PONAB;Eukaryotic translation initiation factor 4H (eIF-4H);"perinuclear region of cytoplasm [GO:0048471]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0048471";;perinuclear region of cytoplasm [GO:0048471];translation initiation factor activity [GO:0003743]
comp837053_c0_seq1;GAXK01203690.1;B3FWS5;3.37E-11;HPM9_HYPSB;FAD-linked oxidoreductase hmp9 (EC 1.-.-.-) (Hypothemycin biosynthesis cluster protein hpm9);"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]";"GO:0016491; GO:0071949";;;"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp837192_c1_seq1;GAXK01203672.1;Q8BML1;3.52E-129;MICA2_MOUSE;[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2) (mMical2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";"GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp837285_c4_seq1;GAXK01203686.1;P04069;3.60E-61;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp8376_c2_seq1;GAXK01013263.1;Q8CHU3;5.84E-96;EPN2_MOUSE;Epsin-2 (EPS-15-interacting protein 2) (Intersectin-EH-binding protein 2) (Ibp2);"clathrin coat of endocytic vesicle [GO:0030128]; intracellular membrane-bounded organelle [GO:0043231]; lipid binding [GO:0008289]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]";"GO:0001701; GO:0006897; GO:0007219; GO:0008289; GO:0030100; GO:0030128; GO:0030948; GO:0043231; GO:0045747; GO:0048568; GO:1903671";"embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]";"clathrin coat of endocytic vesicle [GO:0030128]; intracellular membrane-bounded organelle [GO:0043231]";lipid binding [GO:0008289]
comp83762_c0_seq1;GAXK01033852.1;Q6DC53;8.92E-57;CTU2_DANRE;Cytoplasmic tRNA 2-thiolation protein 2;"cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";"GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0034227";"protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]";cytosol [GO:0005829];"nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]"
comp837726_c0_seq1;GAXK01203682.1;P0C548;9.01E-69;PLPL2_RAT;Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0055088";"lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]";triglyceride lipase activity [GO:0004806]
comp8377726_c0_seq1;GAXK01180442.1;Q3SZ90;1.01E-44;RL13A_BOVIN;60S ribosomal protein L13a;"cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194";"negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp83780_c0_seq1;GAXK01033577.1;Q7KRI2;8.34E-15;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp83804_c0_seq1;GAXK01033467.1;P49880;5.02E-130;ECR_AEDAE;Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (AaEcR) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1);"nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565";ecdysone receptor-mediated signaling pathway [GO:0035076];nucleus [GO:0005634];"ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp83808_c0_seq1;GAXK01033130.1;A0JMD2;4.32E-108;LST2_DANRE;Lateral signaling target protein 2 homolog (Zinc finger FYVE domain-containing protein 28);"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]";"GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872";"negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]";"metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
comp838106_c0_seq1;GAXK01149772.1;B0VXV1;4.58E-11;SL2_SISCA;Snaclec 2 (C-type lectin isoform 2);"extracellular region [GO:0005576]; toxin activity [GO:0090729]";"GO:0005576; GO:0090729";;extracellular region [GO:0005576];toxin activity [GO:0090729]
comp83833_c0_seq1;GAXK01033086.1;Q5ZIA0;1.85E-72;MET16_CHICK;RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346);"nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]";"GO:0001734; GO:0003723; GO:0005634; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049; GO:1905869";"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]";nucleus [GO:0005634];"23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]"
comp83848_c1_seq1;GAXK01033508.1;O60341;0;KDM1A_HUMAN;Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2);"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]";"GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042162; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0044212; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:2000179; GO:2000648";"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]";"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]";"androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp83857_c1_seq1;GAXK01033603.1;Q8GAV9;1.91E-38;CPNA_COMS9;Cyclopentanol dehydrogenase (EC 1.1.1.163);"cyclopentanol dehydrogenase activity [GO:0055041]; cyclopentanol catabolic process [GO:0033022]";"GO:0033022; GO:0055041";cyclopentanol catabolic process [GO:0033022];;cyclopentanol dehydrogenase activity [GO:0055041]
comp838577_c0_seq1;GAXK01149789.1;P54350;2.67E-40;WEE1_DROME;Wee1-like protein kinase (Dwee1) (EC 2.7.10.2);"nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";"GO:0000287; GO:0001700; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0006468; GO:0007093; GO:0018108; GO:0045736; GO:0051225; GO:0051299; GO:0051301; GO:0051642";"cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]";nucleus [GO:0005634];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]"
comp838642_c2_seq1;GAXK01149806.1;Q80SU7;3.46E-07;GVIN1_MOUSE;Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]";"GO:0005525; GO:0005634; GO:0005829";;"cytosol [GO:0005829]; nucleus [GO:0005634]";GTP binding [GO:0005525]
comp8387_c0_seq1;GAXK01013618.1;P38117;2.26E-105;ETFB_HUMAN;Electron transfer flavoprotein subunit beta (Beta-ETF);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]";"GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539";"fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";electron transfer activity [GO:0009055]
comp838897_c0_seq1;GAXK01149824.1;Q4R766;2.25E-33;ABD12_MACFA;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]";"GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0016021; GO:0046464; GO:0047372; GO:0052651";"acylglycerol catabolic process [GO:0046464]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]"
comp838918_c0_seq1;GAXK01149826.1;P0DPW5;2.29E-12;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp83906_c0_seq1;GAXK01033857.1;Q8K4K6;2.25E-133;PANK1_MOUSE;Pantothenate kinase 1 (mPank) (mPank1) (EC 2.7.1.33) (Pantothenic acid kinase 1);"cell periphery [GO:0071944]; clathrin coat [GO:0030118]; cytosol [GO:0005829]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]";"GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0030118; GO:0042803; GO:0055037; GO:0071944; GO:1905502";"coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]";"cell periphery [GO:0071944]; clathrin coat [GO:0030118]; cytosol [GO:0005829]; nucleus [GO:0005634]; recycling endosome [GO:0055037]";"acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]"
comp83909_c0_seq1;GAXK01033836.1;A7GCK7;1.18E-92;PSUG_CLOBL;Pseudouridine-5'-phosphate glycosidase (PsiMP glycosidase) (EC 4.2.1.70);"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridylate synthase activity [GO:0004730]; nucleobase catabolic process [GO:0046113]";"GO:0004730; GO:0016798; GO:0046113; GO:0046872";nucleobase catabolic process [GO:0046113];;"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridylate synthase activity [GO:0004730]"
comp8391_c0_seq1;GAXK01014825.1;Q08473;1.12E-43;SQD_DROME;RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40);"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003680; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0035925; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837; GO:1990904";"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]";"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]";"AT DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"
comp839121_c1_seq1;GAXK01149813.1;Q18192;2.05E-13;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp8393730_c0_seq1;GAXK01034101.1;B9M9W3;1.10E-71;MNMG_ACIET;tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A);"cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]";"GO:0002098; GO:0005737; GO:0050660";tRNA wobble uridine modification [GO:0002098];cytoplasm [GO:0005737];flavin adenine dinucleotide binding [GO:0050660]
comp8393994_c0_seq1;GAXK01034100.1;P07274;6.43E-15;PROF_YEAST;Profilin;"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; proline-rich region binding [GO:0070064]; intracellular transport [GO:0046907]; mitotic actomyosin contractile ring assembly [GO:1903475]; positive regulation of formin-nucleated actin cable assembly [GO:0090338]; sequestering of actin monomers [GO:0042989]";"GO:0003785; GO:0005546; GO:0005829; GO:0005856; GO:0005938; GO:0019897; GO:0042989; GO:0046907; GO:0070064; GO:0090338; GO:1903475";"intracellular transport [GO:0046907]; mitotic actomyosin contractile ring assembly [GO:1903475]; positive regulation of formin-nucleated actin cable assembly [GO:0090338]; sequestering of actin monomers [GO:0042989]";"cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]";"actin monomer binding [GO:0003785]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; proline-rich region binding [GO:0070064]"
comp83941_c8_seq1;GAXK01033193.1;P51659;0;DHB4_HUMAN;"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]";"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]";"GO:0000038; GO:0001649; GO:0003857; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009";"alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]";"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"
comp8394761_c0_seq1;GAXK01157213.1;P0AD15;9.10E-15;BTSS_ECOL6;Sensor histidine kinase BtsS (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; cell wall organization [GO:0071555]";"GO:0000155; GO:0005524; GO:0005886; GO:0016021; GO:0071555";cell wall organization [GO:0071555];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp8395445_c0_seq1;GAXK01157215.1;Q9P769;1.19E-36;RL10B_SCHPO;60S ribosomal protein L10-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"GO:0000027; GO:0002181; GO:0003735; GO:0005829; GO:0022625; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp839600_c0_seq1;GAXK01149799.1;Q6DFU2;3.81E-12;NS1BP_XENLA;Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0005856";;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";
comp839818_c0_seq1;GAXK01149792.1;Q32L31;3.09E-08;HMGB3_BOVIN;High mobility group protein B3;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000400; GO:0000790; GO:0003690; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0032392; GO:0045087; GO:0045089; GO:0045944";"chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]";"DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; transcription factor binding [GO:0008134]"
comp839832_c0_seq1;GAXK01149770.1;P52192;6.18E-47;IRK1_CAEEL;Inward rectifier potassium channel irk-1;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"GO:0005242; GO:0008277; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0043204; GO:0046662; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of ion transmembrane transport [GO:0034765]; regulation of oviposition [GO:0046662]";"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]";inward rectifier potassium channel activity [GO:0005242]
comp83996_c9_seq1;GAXK01033136.1;P0DKX0;3.79E-19;ZN728_HUMAN;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp83999_c6_seq1;GAXK01033696.1;Q8IYB9;3.23E-29;ZN595_HUMAN;Zinc finger protein 595;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp84_c0_seq1;GAXK01168768.1;Q90YR7;1.90E-102;RS7_ICTPU;40S ribosomal protein S7;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726";"chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]";ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp84000_c0_seq1;GAXK01055189.1;Q9VN27;6.50E-72;LIPT2_DROME;Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase);"mitochondrion [GO:0005739]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; protein lipoylation [GO:0009249]";"GO:0005739; GO:0009249; GO:0033819; GO:0102555";protein lipoylation [GO:0009249];mitochondrion [GO:0005739];"lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]"
comp840124_c0_seq1;GAXK01148889.1;P18741;9.54E-10;ZO15_XENLA;Oocyte zinc finger protein XlCOF15 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp84016_c1_seq1;GAXK01055183.1;Q96KQ7;2.10E-11;EHMT2_HUMAN;Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a);"nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]; regulation of signal transduction by p53 class mediator [GO:1901796]";"GO:0000122; GO:0000790; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0008270; GO:0009267; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0046974; GO:0046976; GO:0070317; GO:0070742; GO:1901796; GO:1990841";"cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]; regulation of signal transduction by p53 class mediator [GO:1901796]";"nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]"
comp84027_c0_seq1;GAXK01055247.1;P36609;9.15E-34;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp840273_c0_seq1;GAXK01148854.1;Q22328;7.16E-121;LEV9_CAEEL;Protein lev-9;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase inhibitor activity [GO:0030414]";"GO:0005615; GO:0030054; GO:0030414; GO:0045202";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]";peptidase inhibitor activity [GO:0030414]
comp8403288_c0_seq1;GAXK01099314.1;Q9V427;1.15E-54;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp840610_c0_seq1;GAXK01148882.1;Q05481;1.75E-15;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp84063_c0_seq1;GAXK01055327.1;Q7KRI2;4.99E-35;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp840740_c0_seq1;GAXK01148891.1;Q63870;1.32E-16;CO7A1_MOUSE;Collagen alpha-1(VII) chain (Long-chain collagen) (LC collagen);"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]";"GO:0003429; GO:0004867; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0007155; GO:0031012; GO:0042802; GO:0062023";"cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp8407751_c0_seq1;GAXK01064340.1;Q50KB1;9.52E-35;SEP2_EMIHU;Protein disulfide-isomerase-like protein EhSep2;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";protein disulfide isomerase activity [GO:0003756]
comp84091_c0_seq1;GAXK01055325.1;Q86YQ8;4.83E-172;CPNE8_HUMAN;Copine-8 (Copine VIII);"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]";"GO:0005544; GO:0005886; GO:0070062; GO:0071277";cellular response to calcium ion [GO:0071277];"extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]";calcium-dependent phospholipid binding [GO:0005544]
comp840927_c0_seq1;GAXK01148879.1;Q63406;6.29E-64;MCF2L_RAT;Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene);"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"GO:0005089; GO:0005737; GO:0005886; GO:0008289; GO:0019898; GO:0035025; GO:0035556";"intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]";"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]";"lipid binding [GO:0008289]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp8410462_c0_seq1;GAXK01008538.1;P26162;3.45E-65;BCHH_RHOCB;Magnesium-chelatase subunit H (EC 6.6.1.1) (Mg-protoporphyrin IX chelatase subunit H);"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]; light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";"GO:0005524; GO:0015979; GO:0016851; GO:0036070";"light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis [GO:0015979]";;"ATP binding [GO:0005524]; magnesium chelatase activity [GO:0016851]"
comp84110_c5_seq1;GAXK01055050.1;P54132;6.29E-175;BLM_HUMAN;Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0032508; GO:0036310; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1901796; GO:1905773";"cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]";"3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]"
comp84125_c0_seq1;GAXK01055088.1;Q8L765;5.69E-07;BPM1_ARATH;BTB/POZ and MATH domain-containing protein 1 (Protein BTB-POZ AND MATH DOMAIN 1) (AtBPM1);"nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";"GO:0005634; GO:0006970; GO:0016567; GO:0042631; GO:0042802; GO:0071472";"cellular response to salt stress [GO:0071472]; cellular response to water deprivation [GO:0042631]; protein ubiquitination [GO:0016567]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];identical protein binding [GO:0042802]
comp84127_c2_seq1;GAXK01055252.1;Q8TF45;4.42E-17;ZN418_HUMAN;Zinc finger protein 418;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp841300_c0_seq1;GAXK01148881.1;Q9D2V8;1.77E-24;MFS10_MOUSE;Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein);"brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nuclear inner membrane [GO:0005637]; organic anion transmembrane transporter activity [GO:0008514]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]";"GO:0005637; GO:0005887; GO:0006915; GO:0008514; GO:0030659; GO:0031526; GO:0043252";"apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]";"brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nuclear inner membrane [GO:0005637]";organic anion transmembrane transporter activity [GO:0008514]
comp8417336_c0_seq1;GAXK01089521.1;P9WL97;3.94E-16;Y2567_MYCTU;Uncharacterized protein Rv2567;plasma membrane [GO:0005886];GO:0005886;;plasma membrane [GO:0005886];
comp84190_c2_seq1;GAXK01055506.1;O95198;4.49E-16;KLHL2_HUMAN;Kelch-like protein 2 (Actin-binding protein Mayven);"actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0043687";"post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]";"actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]";"actin binding [GO:0003779]; identical protein binding [GO:0042802]"
comp84195_c0_seq1;GAXK01055095.1;Q9H3J6;3.79E-18;CL065_HUMAN;Probable peptide chain release factor C12orf65, mitochondrial;"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; translation release factor activity [GO:0003747]";"GO:0003747; GO:0005739; GO:0005762";;"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";translation release factor activity [GO:0003747]
comp842170_c1_seq1;GAXK01104368.1;Q8WV74;4.14E-31;NUDT8_HUMAN;Nucleoside diphosphate-linked moiety X motif 8 (Nudix motif 8) (EC 3.6.1.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp84221_c0_seq1;GAXK01055505.1;Q7KRI2;2.52E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp842215_c0_seq1;GAXK01104364.1;Q93794;3.37E-07;SEL10_CAEEL;F-box/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor/enhancer of lin-12 protein 10);"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cell differentiation [GO:0030154]; female sex differentiation [GO:0046660]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0005730; GO:0005737; GO:0007219; GO:0008593; GO:0010826; GO:0019901; GO:0030154; GO:0030424; GO:0031647; GO:0040028; GO:0042803; GO:0045746; GO:0046660";"cell differentiation [GO:0030154]; female sex differentiation [GO:0046660]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]; ribosomal large subunit assembly [GO:0000027]";"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]";"protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"
comp84249_c1_seq1;GAXK01055031.1;O13737;5.94E-22;YDR2_SCHPO;Uncharacterized endoplasmic reticulum membrane protein C16E8.02;"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid alpha-oxygenase activity [GO:0102672]; sphingoid catabolic process [GO:0046521]";"GO:0005783; GO:0030176; GO:0046521; GO:0102672";sphingoid catabolic process [GO:0046521];"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";fatty acid alpha-oxygenase activity [GO:0102672]
comp842691_c1_seq1;GAXK01104353.1;Q18192;3.40E-11;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp84271_c1_seq1;GAXK01055062.1;Q8IN81;7.11E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp8428252_c0_seq1;GAXK01042405.1;Q2N9A7;7.37E-51;EFG_ERYLH;Elongation factor G (EF-G);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp8429_c0_seq1;GAXK01014334.1;Q2KIK3;2.74E-12;SIM14_BOVIN;Small integral membrane protein 14;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; blastocyst hatching [GO:0001835]";"GO:0001835; GO:0005783; GO:0005789; GO:0016021";blastocyst hatching [GO:0001835];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp8429914_c0_seq1;GAXK01042407.1;B8B9K6;1.06E-29;R10A_ORYSI;60S ribosomal protein L10a;"large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp843_c1_seq1;GAXK01166393.1;Q9W0E3;5.81E-163;IML1_DROME;GATOR complex protein Iml1 (Increased minichromosome loss 1);"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]";"GO:0005096; GO:0005765; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130";"cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]";"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]";GTPase activator activity [GO:0005096]
comp84304_c1_seq1;GAXK01055271.1;Q08DK0;3.44E-90;TM129_BOVIN;E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0030970; GO:0046872; GO:0061630";"protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp84321_c0_seq1;GAXK01055126.1;Q7KRI2;1.18E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8434_c2_seq1;GAXK01013355.1;P49841;0;GSK3B_HUMAN;Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1);"axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dendrite development [GO:2000171]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of synaptic vesicle exocytosis [GO:2000300]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]";"GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000171; GO:2000300; GO:2000466";"beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dendrite development [GO:2000171]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synaptic vesicle exocytosis [GO:2000300]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]";"axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]";"ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]"
comp843430_c1_seq1;GAXK01104341.1;Q9D6P8;5.22E-46;CALL3_MOUSE;Calmodulin-like protein 3;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8435591_c0_seq1;GAXK01025877.1;Q9SMV7;5.83E-34;MSH7_ARATH;DNA mismatch repair protein MSH7 (AtMSH7) (MutS protein homolog 7);"mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]";"GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0008094; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910";"interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]";"mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]";"ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]"
comp84365_c1_seq1;GAXK01055215.1;Q0V9T6;7.75E-42;BICL1_XENTR;BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107";"Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]"
comp8437_c0_seq1;GAXK01014015.1;Q3SWT4;3.01E-66;IWS1_RAT;Protein IWS1 homolog (IWS1-like protein);"nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]";"GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253";"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]";nucleus [GO:0005634];
comp843735_c0_seq1;GAXK01104348.1;P42519;2.66E-11;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp8437729_c0_seq1;GAXK01012913.1;Q9GPE9;2.31E-51;ATPB_TRYBB;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta);"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp8438881_c0_seq1;GAXK01030543.1;Q129L9;8.36E-36;PYRD_POLSJ;Dihydroorotate dehydrogenase (quinone) (EC 1.3.5.2) (DHOdehase) (DHOD) (DHODase) (Dihydroorotate oxidase);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]";"GO:0004152; GO:0005737; GO:0005886; GO:0006207; GO:0044205";"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";dihydroorotate dehydrogenase activity [GO:0004152]
comp844002_c0_seq2;GAXK01053481.1;E2AZE8;2.14E-12;DIUX_CAMFO;Diuretic hormone class 2 (DH(31)) (Diuretic peptide) (DP);"extracellular region [GO:0005576]; diuretic hormone activity [GO:0008613]; body fluid secretion [GO:0007589]";"GO:0005576; GO:0007589; GO:0008613";body fluid secretion [GO:0007589];extracellular region [GO:0005576];diuretic hormone activity [GO:0008613]
comp84402_c2_seq1;GAXK01055503.1;P11420;9.70E-33;DA_DROME;Protein daughterless;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007422; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0061101; GO:0061382";"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp844092_c1_seq1;GAXK01053506.1;P10072;3.13E-27;ZN875_HUMAN;Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0046872";"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8441_c0_seq1;GAXK01013639.1;Q567Z6;4.62E-37;CRIPT_DANRE;Cysteine-rich PDZ-binding protein (Cysteine-rich interactor of PDZ three) (Cysteine-rich interactor of PDZ3);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; cytoplasmic microtubule organization [GO:0031122]";"GO:0005737; GO:0008017; GO:0030165; GO:0030425; GO:0031122";cytoplasmic microtubule organization [GO:0031122];"cytoplasm [GO:0005737]; dendrite [GO:0030425]";"microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]"
comp844192_c0_seq2;GAXK01053497.1;Q7Z0G7;6.61E-19;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp8442_c0_seq1;GAXK01013667.1;O75832;2.28E-45;PSD10_HUMAN;26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK));"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]";transcription factor binding [GO:0008134]
comp84420_c0_seq1;GAXK01054983.1;Q5R991;4.75E-78;AVL9_PONAB;Late secretory pathway protein AVL9 homolog;"integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477]";"GO:0016021; GO:0016477; GO:0055037";cell migration [GO:0016477];"integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]";
comp84427_c0_seq1;GAXK01055089.1;Q6R7M4;5.01E-77;C15A1_DIPPU;Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1);"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]";"GO:0005506; GO:0006718; GO:0016709; GO:0020037";juvenile hormone biosynthetic process [GO:0006718];;"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp844327_c0_seq1;GAXK01053482.1;P0DPW5;1.55E-09;TX11A_CORWE;U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp8444223_c0_seq1;GAXK01044922.1;Q7ZV90;6.53E-07;PIF1_DANRE;ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1);"mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]";"GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0032508; GO:0043139";"DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]"
comp84459_c0_seq1;GAXK01055125.1;Q9N0P9;2.76E-85;PIM1_BOVIN;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0008134; GO:0008283; GO:0030145; GO:0043024; GO:0043066; GO:0043433; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp84464_c0_seq1;GAXK01054984.1;Q95VA8;2.97E-38;TPM_TRISP;Tropomyosin;;;;;
comp844643_c0_seq1;GAXK01053483.1;Q7KRI2;2.44E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8447_c0_seq1;GAXK01013943.1;Q6DIR8;3.51E-14;PALD_XENTR;Paladin;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]";"GO:0004722; GO:0004725; GO:0005737; GO:0005829";;"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"
comp8448257_c0_seq1;GAXK01164554.1;Q14DK5;1.63E-09;HIPL1_MOUSE;HHIP-like protein 1;"extracellular region [GO:0005576]; membrane [GO:0016020]; catalytic activity [GO:0003824]; scavenger receptor activity [GO:0005044]";"GO:0003824; GO:0005044; GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";"catalytic activity [GO:0003824]; scavenger receptor activity [GO:0005044]"
comp84483_c0_seq1;GAXK01055198.1;Q96T23;4.74E-09;RSF1_HUMAN;Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex);"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]";"GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434";"CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]";"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]";"histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]"
comp84504_c0_seq1;GAXK01055080.1;Q5M9B1;2.39E-59;SPSB3_XENLA;SPRY domain-containing SOCS box protein 3 (SSB-3);protein ubiquitination [GO:0016567];GO:0016567;protein ubiquitination [GO:0016567];;
comp845090_c0_seq1;GAXK01053487.1;D3Z5L6;1.65E-21;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp84516_c0_seq1;GAXK01055558.1;Q5GLH2;2.55E-97;TRIB2_BOVIN;Tribbles homolog 2 (TRB-2);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 biosynthetic process [GO:0045081]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]";"GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0008134; GO:0031434; GO:0031625; GO:0032436; GO:0043405; GO:0045081; GO:0045599; GO:0055106";"negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 biosynthetic process [GO:0045081]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]"
comp845187_c0_seq1;GAXK01053475.1;A2ANX9;2.14E-10;ZN711_MOUSE;Zinc finger protein 711;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0043565; GO:0045893; GO:0046872";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp845196_c0_seq1;GAXK01053471.1;A1A4N1;1.64E-53;S29A3_BOVIN;Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0016021; GO:0031902";;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";nucleoside transmembrane transporter activity [GO:0005337]
comp845233_c0_seq1;GAXK01053472.1;P93748;3.59E-13;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp8453_c0_seq1;GAXK01013629.1;Q01728;3.28E-53;NAC1_RAT;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1);"cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; calcium ion export [GO:1901660]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of sodium ion transport [GO:0002028]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0001666; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0007584; GO:0009749; GO:0010763; GO:0010881; GO:0014704; GO:0021537; GO:0030018; GO:0030315; GO:0030501; GO:0030506; GO:0031226; GO:0033198; GO:0034614; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042493; GO:0042542; GO:0042995; GO:0043197; GO:0043198; GO:0045211; GO:0051924; GO:0060402; GO:0070509; GO:0070588; GO:0071320; GO:0071456; GO:0086064; GO:0098719; GO:0098735; GO:0099055; GO:0099580; GO:1901660; GO:1905060";"calcium ion export [GO:1901660]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of sodium ion transport [GO:0002028]; response to ATP [GO:0033198]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell projection [GO:0042995]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]"
comp84534_c2_seq1;GAXK01055061.1;Q24174;1.32E-52;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp8454636_c0_seq1;GAXK01123721.1;Q25074;6.74E-16;AQP_HAEIX;Aquaporin (BfWC1) (Water channel 1);"integral component of membrane [GO:0016021]; channel activity [GO:0015267]";"GO:0015267; GO:0016021";;integral component of membrane [GO:0016021];channel activity [GO:0015267]
comp84555_c0_seq1;GAXK01055302.1;Q5EA28;1.07E-08;CXXC1_BOVIN;CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1);"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005829; GO:0008270; GO:0016363; GO:0016607; GO:0042800; GO:0045322; GO:0045893; GO:0048188";positive regulation of transcription, DNA-templated [GO:0045893];"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]";"histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]"
comp845703_c0_seq1;GAXK01053504.1;P17970;1.64E-87;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp8457292_c0_seq1;GAXK01077742.1;A9RVK2;3.90E-10;M3K1B_PHYPA;Mitogen-activated protein kinase kinase kinase 1b (PpMEKK1b) (EC 2.7.11.25) (MAP kinase kinase kinase 1b);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; defense response [GO:0006952]; response to chitin [GO:0010200]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005886; GO:0006952; GO:0010200; GO:0023014; GO:0031098; GO:0032147";"activation of protein kinase activity [GO:0032147]; defense response [GO:0006952]; response to chitin [GO:0010200]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]"
comp845757_c0_seq1;GAXK01053457.1;P47236;4.65E-81;PAX1_CHICK;Paired box protein Pax-1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sclerotome development [GO:0061056]";"GO:0003677; GO:0003700; GO:0005634; GO:0061056";sclerotome development [GO:0061056];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp8458_c0_seq1;GAXK01014323.1;P04813;5.22E-49;CTR2_CANLF;"Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C]";"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586";digestion [GO:0007586];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp845941_c0_seq1;GAXK01053477.1;Q9NZI2;1.02E-55;KCIP1_HUMAN;Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein);"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0061337; GO:1901379";"cardiac conduction [GO:0061337]; regulation of potassium ion transmembrane transport [GO:1901379]";"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]"
comp8460_c2_seq1;GAXK01013424.1;Q8BH95;2.85E-127;ECHM_MOUSE;Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]";"GO:0004300; GO:0005739; GO:0005759; GO:0006635";fatty acid beta-oxidation [GO:0006635];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";enoyl-CoA hydratase activity [GO:0004300]
comp8460085_c0_seq1;GAXK01087554.1;Q9NBX4;2.41E-07;RTXE_DROME;Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase);"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]";"GO:0003964; GO:0006313";transposition, DNA-mediated [GO:0006313];;RNA-directed DNA polymerase activity [GO:0003964]
comp84605_c0_seq1;GAXK01055129.1;O46040;6.97E-13;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp84606_c0_seq1;GAXK01055497.1;Q9D6Y9;0;GLGB_MOUSE;1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme);"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]";"GO:0003844; GO:0004553; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0102752";"carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]";;"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp846187_c1_seq1;GAXK01077390.1;P91685;1.21E-08;GRM_DROME;Metabotropic glutamate receptor (DmGluRA);"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553";"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]";"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]";"cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]"
comp846343_c0_seq1;GAXK01077357.1;Q9VZW5;4.24E-09;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp846351_c0_seq1;GAXK01077383.1;Q8BL86;5.01E-45;MBLC2_MOUSE;Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp8463947_c0_seq1;GAXK01131235.1;O08564;1.54E-13;PLPP1_RAT;Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a);"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";"GO:0005887; GO:0006644; GO:0008195; GO:0016020; GO:0016791; GO:0042577; GO:0046839";"phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]"
comp846431_c1_seq1;GAXK01077403.1;B0WC46;7.33E-27;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp846495_c0_seq1;GAXK01077385.1;P22770;5.90E-23;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp84650_c2_seq1;GAXK01055014.1;P35503;3.12E-38;UD13_HUMAN;UDP-glucuronosyltransferase 1-3 (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]";"GO:0001972; GO:0005783; GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0019899; GO:0042573; GO:0042803; GO:0043231; GO:0045922; GO:0046982; GO:0052695; GO:0052696; GO:0052697; GO:1904224; GO:2001030";"cellular glucuronidation [GO:0052695]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]";"enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; UDP-glycosyltransferase activity [GO:0008194]"
comp846523_c0_seq1;GAXK01077381.1;Q8AW42;2.59E-58;S39AD_DANRE;Zinc transporter ZIP13 (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"GO:0000139; GO:0005385; GO:0006829; GO:0006882; GO:0016021; GO:0071577";"cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";zinc ion transmembrane transporter activity [GO:0005385]
comp8465680_c0_seq1;GAXK01028070.1;P43295;7.08E-10;RD19B_ARATH;Probable cysteine protease RD19B (EC 3.4.22.-) (RD19-like protein 1) (Thiol protease A1494);"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0000323; GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]";cysteine-type endopeptidase activity [GO:0004197]
comp846729_c0_seq1;GAXK01077411.1;P50572;2.84E-23;GBRR1_RAT;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA receptor activity [GO:0016917]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0007601; GO:0016917; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0046982; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; GABA receptor activity [GO:0016917]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp84673_c0_seq1;GAXK01055323.1;Q13360;2.81E-13;ZN177_HUMAN;Zinc finger protein 177;"blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0003677; GO:0005634; GO:0046872; GO:0072562";negative regulation of transcription by RNA polymerase II [GO:0000122];"blood microparticle [GO:0072562]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp84674_c0_seq1;GAXK01055169.1;Q9ESJ1;2.41E-53;CABL1_MOUSE;CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1);"cytosol [GO:0005829]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726]";"GO:0000082; GO:0005654; GO:0005829; GO:0007399; GO:0030426; GO:0051301; GO:0051726";"cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726]";"cytosol [GO:0005829]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]";
comp8469476_c0_seq1;GAXK01073709.1;P70473;2.86E-27;AMACR_RAT;Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]";"GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008410";"bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]";"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";"alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]"
comp847007_c0_seq1;GAXK01077375.1;Q32KH7;5.33E-49;ARSI_CANLF;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp8470366_c0_seq1;GAXK01093148.1;Q30D77;4.31E-09;COOA1_MOUSE;Collagen alpha-1(XXIV) chain;"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]";"GO:0002244; GO:0005201; GO:0005581; GO:0005615; GO:0030198; GO:0031012; GO:0062023";"extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]";"collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";extracellular matrix structural constituent [GO:0005201]
comp847417_c0_seq1;GAXK01077374.1;O73874;1.15E-12;EFNB2_DANRE;Ephrin-B2a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920";"angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";ephrin receptor binding [GO:0046875]
comp84757_c0_seq1;GAXK01055071.1;Q9W0E8;8.99E-165;ZER1_DROME;Protein zer-1 homolog (Zyg-11 homolog B-like protein);Cul2-RING ubiquitin ligase complex [GO:0031462];GO:0031462;;Cul2-RING ubiquitin ligase complex [GO:0031462];
comp84765_c1_seq1;GAXK01055566.1;Q810B6;0;ANFY1_MOUSE;Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif);"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0017137; GO:0030904; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0090160; GO:1901981";"endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]";"metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]"
comp847679_c0_seq1;GAXK01077404.1;Q9UG56;3.82E-57;PISD_HUMAN;"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0016540; GO:0031305";"phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]";"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";phosphatidylserine decarboxylase activity [GO:0004609]
comp847778_c0_seq1;GAXK01077353.1;Q8BGQ2;1.37E-07;CSRN2_MOUSE;Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0019902; GO:0043565; GO:0045944";"apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]"
comp847908_c0_seq1;GAXK01077359.1;P17972;0;KCNAW_DROME;Potassium voltage-gated channel protein Shaw (Shaw2);"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]";"axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]"
comp8480126_c0_seq1;GAXK01180832.1;P55935;2.64E-51;RS9_DROME;40S ribosomal protein S9;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]";"GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0019843; GO:0022626; GO:0022627; GO:0045903";"cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp848013_c0_seq1;GAXK01182726.1;B0WC46;3.81E-55;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp848166_c0_seq1;GAXK01182704.1;Q6INV8;1.46E-16;Z652B_XENLA;Zinc finger protein 652-B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp848399_c0_seq1;GAXK01182697.1;Q5ZU30;7.75E-10;SETA_LEGPH;"Subversion of eukaryotic traffic protein A (Effector protein SetA) (Subversion of eukaryotic vesicle trafficking A) [Includes: Glucosyltransferase (EC 2.4.1.-); Phosphatidylinositol-3-phosphate-binding domain (PtdIns(3)P-binding domain)]";"extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]; pathogenesis [GO:0009405]";"GO:0005576; GO:0009405; GO:0016757";pathogenesis [GO:0009405];extracellular region [GO:0005576];transferase activity, transferring glycosyl groups [GO:0016757]
comp84845_c1_seq1;GAXK01055078.1;P54277;6.51E-52;PMS1_HUMAN;PMS1 protein homolog 1 (DNA mismatch repair protein PMS1);"mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]";"GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0032389; GO:0042493";"mismatch repair [GO:0006298]; response to drug [GO:0042493]";"mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleus [GO:0005634]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]"
comp848521_c0_seq1;GAXK01182789.1;Q7T0S7;1.17E-18;CFA36_XENLA;Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104);"cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]";"GO:0005634; GO:0005737; GO:0031514";;"cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]";
comp848534_c0_seq1;GAXK01182718.1;O77633;1.30E-19;ADA10_PIG;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005798; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030307; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945";"cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]";"adherens junction [GO:0005912]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp8487_c2_seq1;GAXK01014596.1;Q9V9S8;1.07E-154;HEMH_DROME;Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"GO:0004325; GO:0005739; GO:0005743; GO:0006782; GO:0006783; GO:0046872; GO:0051537";"heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]"
comp849038_c0_seq1;GAXK01182719.1;Q9NUB1;6.00E-17;ACS2L_HUMAN;Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17);"mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]";"GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218";"acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]";mitochondrial matrix [GO:0005759];"acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]"
comp849065_c0_seq1;GAXK01182769.1;Q8BQS5;5.59E-61;PAQR2_MOUSE;Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II);"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]";"GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009755; GO:0016021; GO:0019395; GO:0030308; GO:0031226; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0046326; GO:0046872; GO:0046982; GO:0055100; GO:0061042; GO:0097003; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]";"integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]";"adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]"
comp84907_c0_seq1;GAXK01055045.1;Q74FW6;1.47E-55;TSAL_GEOSL;L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine/serine ammonia-lyase);"L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567]";"GO:0003941; GO:0004794; GO:0006565; GO:0006567; GO:0009097; GO:0030170";"isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567]";;"L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]"
comp849138_c0_seq1;GAXK01182731.1;Q6IR74;2.55E-87;CTL1_XENLA;Choline transporter-like protein 1 (Solute carrier family 44 member 1);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp849170_c0_seq1;GAXK01182707.1;Q96MF7;7.51E-11;NSE2_HUMAN;E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (hMMS21) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog);"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016604; GO:0016605; GO:0019789; GO:0030915; GO:0034184; GO:0045842; GO:0051301; GO:0090398";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";"SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]"
comp849362_c0_seq1;GAXK01182783.1;Q96IR2;3.06E-16;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp849481_c0_seq1;GAXK01182775.1;Q9Y5R2;3.42E-74;MMP24_HUMAN;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp84965_c1_seq1;GAXK01055190.1;B4IXJ2;2.14E-38;CUE_DROGR;Protein cueball;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]";"GO:0005886; GO:0007283; GO:0016021; GO:0048477";"oogenesis [GO:0048477]; spermatogenesis [GO:0007283]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp84970_c2_seq1;GAXK01055118.1;Q9V4P1;9.52E-104;ANLN_DROME;Anillin (Actin-binding protein 8) (ABP8) (Protein scraps);"actomyosin contractile ring [GO:0005826]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; male germline ring canal [GO:0035323]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; GTP-Rho binding [GO:0017049]; microtubule binding [GO:0008017]; myosin binding [GO:0017022]; actomyosin contractile ring assembly [GO:0000915]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; cortical cytoskeleton organization [GO:0030865]; intercellular bridge organization [GO:0043063]; maintenance of actomyosin contractile ring localization [GO:0032189]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]";"GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005737; GO:0005826; GO:0007009; GO:0007112; GO:0007279; GO:0007349; GO:0007423; GO:0008017; GO:0008104; GO:0008356; GO:0017022; GO:0017049; GO:0030726; GO:0030865; GO:0031106; GO:0032154; GO:0032189; GO:0032465; GO:0035323; GO:0043063; GO:0045035; GO:0045172; GO:0048477; GO:0051015; GO:0070938; GO:1904498";"actomyosin contractile ring assembly [GO:0000915]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; cortical cytoskeleton organization [GO:0030865]; intercellular bridge organization [GO:0043063]; maintenance of actomyosin contractile ring localization [GO:0032189]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]";"actomyosin contractile ring [GO:0005826]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; male germline ring canal [GO:0035323]; nucleus [GO:0005634]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; GTP-Rho binding [GO:0017049]; microtubule binding [GO:0008017]; myosin binding [GO:0017022]"
comp849732_c1_seq1;GAXK01182706.1;P16924;6.64E-25;P4HA1_CHICK;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp84986_c1_seq1;GAXK01055042.1;O15550;3.26E-161;KDM6A_HUMAN;Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein);"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]";"GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358";"canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]";"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp84999_c3_seq1;GAXK01055034.1;Q9PUQ1;3.66E-08;ETV4_DANRE;ETS translocation variant 4 (Polyomavirus enhancer activator 3 homolog) (Protein PEA3);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; embryo development ending in birth or egg hatching [GO:0009792]; limb morphogenesis [GO:0035108]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; pronephros development [GO:0048793]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0009792; GO:0030154; GO:0035108; GO:0035778; GO:0043565; GO:0045893; GO:0048793";"cell differentiation [GO:0030154]; embryo development ending in birth or egg hatching [GO:0009792]; limb morphogenesis [GO:0035108]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; pronephros development [GO:0048793]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp85_c0_seq1;GAXK01168226.1;Q962R9;1.49E-71;RS10_SPOFR;40S ribosomal protein S10;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp850052_c0_seq1;GAXK01109068.1;B0BLW3;1.19E-25;LGR4_XENTR;Leucine-rich repeat-containing G-protein coupled receptor 4;"integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; rhythmic process [GO:0048511]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]";"GO:0001649; GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0007283; GO:0008528; GO:0009755; GO:0016055; GO:0016500; GO:0030282; GO:0034122; GO:0042802; GO:0046849; GO:0048511; GO:0050710; GO:0090263";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; rhythmic process [GO:0048511]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]";integral component of plasma membrane [GO:0005887];"G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]"
comp8501_c0_seq1;GAXK01013610.1;Q03958;1.20E-26;PFD6_MOUSE;Prefoldin subunit 6 (Protein Ke2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]";"GO:0005634; GO:0005737; GO:0006457; GO:0016272; GO:0051082; GO:0051087; GO:0051131";"chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]";"chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp8503430_c0_seq1;GAXK01038163.1;Q9DG68;2.55E-41;RLA0_RANSY;60S acidic ribosomal protein P0 (60S ribosomal protein L10E);"ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]";"GO:0005840; GO:0042254";ribosome biogenesis [GO:0042254];ribosome [GO:0005840];
comp850347_c0_seq1;GAXK01109107.1;Q7KRI2;2.34E-21;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8503579_c0_seq1;GAXK01038162.1;P19198;3.61E-09;CAP1_DICDI;cAMP-binding protein 1 (CABP-1);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cAMP binding [GO:0030552]";"GO:0005634; GO:0005737; GO:0009986; GO:0030552";;"cell surface [GO:0009986]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";cAMP binding [GO:0030552]
comp850374_c1_seq1;GAXK01109095.1;Q9XYD3;4.06E-07;HBL1_CAEEL;Hunchback-like protein;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; oviposition [GO:0018991]; protein metabolic process [GO:0019538]; regulation of development, heterochronic [GO:0040034]";"GO:0000122; GO:0000977; GO:0000981; GO:0002119; GO:0005634; GO:0009792; GO:0018991; GO:0019538; GO:0040034; GO:0046872";"embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; oviposition [GO:0018991]; protein metabolic process [GO:0019538]; regulation of development, heterochronic [GO:0040034]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp850398_c0_seq1;GAXK01109058.1;Q9GTD4;1.20E-12;NHR71_CAEEL;Nuclear hormone receptor family member nhr-71;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp850468_c0_seq1;GAXK01109092.1;Q73B49;5.70E-81;HMP_BACC1;Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17);"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";"GO:0005344; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046872; GO:0051409; GO:0071949";"response to nitrosative stress [GO:0051409]; response to toxic substance [GO:0009636]";;"FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]"
comp8505_c1_seq1;GAXK01014103.1;Q5ZK33;3.68E-101;LETM1_CHICK;Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]";"GO:0005509; GO:0005743; GO:0006851; GO:0015369; GO:0016021; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093";"calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"calcium:proton antiporter activity [GO:0015369]; calcium ion binding [GO:0005509]; ribosome binding [GO:0043022]"
comp85055_c0_seq1;GAXK01055082.1;Q6GN42;9.45E-170;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp85066_c0_seq1;GAXK01055246.1;Q6DHL5;4.99E-78;LRC57_DANRE;Leucine-rich repeat-containing protein 57;;;;;
comp8507204_c0_seq1;GAXK01095984.1;P22805;2.90E-25;BIOA_LYSSH;Adenosylmethionine-8-amino-7-oxononanoate aminotransferase (EC 2.6.1.62) (7,8-diamino-pelargonic acid aminotransferase) (DAPA AT) (DAPA aminotransferase) (7,8-diaminononanoate synthase) (DANS) (Diaminopelargonic acid synthase);"cytoplasm [GO:0005737]; adenosylmethionine-8-amino-7-oxononanoate transaminase activity [GO:0004015]; pyridoxal phosphate binding [GO:0030170]; biotin biosynthetic process [GO:0009102]";"GO:0004015; GO:0005737; GO:0009102; GO:0030170";biotin biosynthetic process [GO:0009102];cytoplasm [GO:0005737];"adenosylmethionine-8-amino-7-oxononanoate transaminase activity [GO:0004015]; pyridoxal phosphate binding [GO:0030170]"
comp85084_c5_seq1;GAXK01055184.1;P37662;7.08E-07;YHJX_ECOLI;Uncharacterized MFS-type transporter YhjX;"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; cellular response to nutrient levels [GO:0031669]";"GO:0005886; GO:0005887; GO:0022857; GO:0031669";cellular response to nutrient levels [GO:0031669];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp850856_c0_seq1;GAXK01109091.1;Q8RZB5;5.36E-10;CML10_ORYSJ;Probable calcium-binding protein CML10 (Calmodulin-like protein 10);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp85101_c1_seq1;GAXK01055245.1;O75629;3.87E-55;CREG1_HUMAN;Protein CREG1 (Cellular repressor of E1A-stimulated genes 1);"azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription factor complex [GO:0005667]; cofactor binding [GO:0048037]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003714; GO:0005576; GO:0005615; GO:0005667; GO:0006357; GO:0007275; GO:0008134; GO:0035578; GO:0040008; GO:0043312; GO:0048037; GO:0070062";"multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]";"azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription factor complex [GO:0005667]";"cofactor binding [GO:0048037]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp8510227_c0_seq1;GAXK01141971.1;Q2RSB4;8.23E-47;PNTB_RHORT;NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]";"GO:0005886; GO:0008750; GO:0016021; GO:0050661";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]"
comp851057_c0_seq1;GAXK01109081.1;Q9VXY2;0;MADD_DROME;MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor);"integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]";"GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0043025; GO:0043195; GO:0048789; GO:0051726; GO:0098527; GO:1902041";"activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]";"integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]";Rab guanyl-nucleotide exchange factor activity [GO:0017112]
comp851507_c0_seq1;GAXK01109071.1;Q5DW34;3.22E-23;EHMT1_MOUSE;Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Lysine N-methyltransferase 1D);"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0060992; GO:0070742; GO:0120162";"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992]";"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]"
comp8517_c0_seq1;GAXK01014322.1;P08985;1.39E-75;H2AV_DROME;Histone H2A.v (H2A.F/Z) (H2A.Z);"chromosome [GO:0005694]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; male germ-line stem cell population maintenance [GO:0036098]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; somatic stem cell population maintenance [GO:0035019]";"GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0005694; GO:0005700; GO:0005701; GO:0006281; GO:0006325; GO:0007275; GO:0035019; GO:0035861; GO:0036098; GO:0044877; GO:0046982; GO:0071168";"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; male germ-line stem cell population maintenance [GO:0036098]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; somatic stem cell population maintenance [GO:0035019]";"chromosome [GO:0005694]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; site of double-strand break [GO:0035861]";"DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]"
comp85183_c1_seq1;GAXK01055567.1;Q4V7D6;6.72E-101;NIF3L_RAT;NIF3-like protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]";"GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:1903507";"negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";
comp85199_c0_seq1;GAXK01055133.1;Q9V4A7;0;PLXB_DROME;Plexin-B;"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; negative regulation of Rac protein signal transduction [GO:0035021]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]";"GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0035021; GO:0035025; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287";"axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; negative regulation of Rac protein signal transduction [GO:0035021]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]";"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]";semaphorin receptor activity [GO:0017154]
comp8521569_c0_seq1;GAXK01109965.1;Q8SPI0;7.18E-12;APOD_MACFA;Apolipoprotein D (Apo-D) (ApoD);"cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405";"aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]";"cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]";cholesterol binding [GO:0015485]
comp852302_c0_seq1;GAXK01062575.1;A8K7I4;3.05E-09;CLCA1_HUMAN;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0034220; GO:0042589; GO:0046872; GO:0071456";"calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]";"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp85251_c2_seq1;GAXK01055217.1;E9Q309;1.02E-17;CE350_MOUSE;Centrosome-associated protein 350 (Cep350);"cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]";"GO:0005634; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0034453; GO:0042995";microtubule anchoring [GO:0034453];"cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]";microtubule binding [GO:0008017]
comp852564_c0_seq1;GAXK01062561.1;P69527;3.19E-96;AMPO_RAT;Aminopeptidase O (AP-O) (EC 3.4.11.-);"nucleolus [GO:0005730]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]";"GO:0004177; GO:0005730; GO:0008237; GO:0008270; GO:0070006";;nucleolus [GO:0005730];"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
comp85262_c1_seq1;GAXK01055477.1;O46040;2.04E-19;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp8526737_c0_seq1;GAXK01128035.1;Q3SZI8;6.49E-67;IVD_BOVIN;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]";"GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0050660";leucine catabolic process [GO:0006552];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]"
comp8530_c2_seq1;GAXK01013761.1;Q68FN9;1.94E-23;FAKD3_RAT;FAST kinase domain-containing protein 3, mitochondrial;"mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein kinase activity [GO:0004672]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]";"GO:0004672; GO:0005634; GO:0005739; GO:0033617; GO:0044528; GO:0070131";"mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]";"mitochondrion [GO:0005739]; nucleus [GO:0005634]";protein kinase activity [GO:0004672]
comp85305_c0_seq1;GAXK01055442.1;Q9U969;0;SWS_DROME;Neuropathy target esterase sws (Swiss cheese) (DSWS) (EC 3.1.1.5);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; protein kinase A catalytic subunit binding [GO:0034236]; ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]";"GO:0004622; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006643; GO:0006644; GO:0007272; GO:0007608; GO:0016021; GO:0016042; GO:0034236; GO:0034349; GO:0045494; GO:0046470; GO:0051402; GO:0061024; GO:0072657; GO:2000480";"ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"lysophospholipase activity [GO:0004622]; protein kinase A catalytic subunit binding [GO:0034236]"
comp853109_c0_seq1;GAXK01062563.1;Q6P4Q7;7.99E-27;CNNM4_HUMAN;Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4);"basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0030425; GO:0032991; GO:0043025; GO:0050896; GO:0055065; GO:0070166";"enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]";"basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]"
comp853142_c0_seq1;GAXK01062562.1;Q6WV17;5.85E-129;GALT5_DROME;Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5);"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]";"endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp8532926_c0_seq1;GAXK01025819.1;Q9U639;2.25E-96;HSP7D_MANSE;Heat shock 70 kDa protein cognate 4 (Hsc 70-4);"nucleus [GO:0005634]; ATP binding [GO:0005524]";"GO:0005524; GO:0005634";;nucleus [GO:0005634];ATP binding [GO:0005524]
comp8533089_c0_seq1;GAXK01025820.1;Q2RSB3;2.72E-27;PNTAB_RHORT;NAD(P) transhydrogenase subunit alpha part 2 (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha 2) (Proton-translocating transhydrogenase component 2) (Pyridine nucleotide transhydrogenase subunit alpha 2) (dII);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp85331_c0_seq1;GAXK01055150.1;W4VS53;3.68E-37;CRVP_TRILK;CRISP/Allergen/PR-1 (Cap-1);extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp853598_c1_seq1;GAXK01062573.1;P19217;7.88E-36;ST1E1_BOVIN;Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring);"cytosol [GO:0005829]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; estrogen metabolic process [GO:0008210]";"GO:0004304; GO:0005496; GO:0005829; GO:0008210; GO:0050294";estrogen metabolic process [GO:0008210];cytosol [GO:0005829];"estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]"
comp8536318_c0_seq1;GAXK01045220.1;P42722;1.87E-25;CFXR_CUPNH;HTH-type transcriptional regulator CfxR (RuBisCO operon transcriptional regulator);"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700";;;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp85392_c2_seq1;GAXK01055105.1;P17010;4.72E-09;ZFX_HUMAN;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]";"GO:0000981; GO:0003677; GO:0003713; GO:0005654; GO:0005730; GO:0046872";;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]"
comp8540094_c0_seq1;GAXK01136087.1;Q08972;2.30E-36;NEW1_YEAST;[NU+] prion formation protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0016887; GO:0016973; GO:0042274";"poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]"
comp85401_c0_seq1;GAXK01055028.1;E9Q784;1.24E-07;ZC3HD_MOUSE;Zinc finger CCCH domain-containing protein 13;"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; metal ion binding [GO:0046872]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380]";"GO:0005654; GO:0006397; GO:0007275; GO:0008380; GO:0016607; GO:0036396; GO:0046872; GO:0080009; GO:2000036";"mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380]";"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]";metal ion binding [GO:0046872]
comp85402_c0_seq1;GAXK01055021.1;Q5ZKW0;6.41E-108;MTU1_CHICK;Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14);"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA wobble position uridine thiolation [GO:0002143]";"GO:0000049; GO:0002143; GO:0005524; GO:0005654; GO:0005739; GO:0016783";tRNA wobble position uridine thiolation [GO:0002143];"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]"
comp854358_c0_seq1;GAXK01200111.1;Q9PU85;1.11E-80;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp854457_c0_seq1;GAXK01200098.1;Q9CWR2;2.67E-20;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp854461_c0_seq1;GAXK01200115.1;P05661;2.55E-10;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp854499_c0_seq1;GAXK01200089.1;P41823;1.20E-22;SY65_APLCA;Synaptotagmin-1 (Synaptotagmin I) (p65);"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"GO:0000149; GO:0005509; GO:0005544; GO:0016079; GO:0030054; GO:0030285; GO:0045955";"negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]";"cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; SNARE binding [GO:0000149]"
comp85472_c3_seq1;GAXK01055479.1;Q93075;2.14E-49;TATD2_HUMAN;Putative deoxyribonuclease TATDN2 (EC 3.1.21.-);"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]";"GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0016888; GO:0036498; GO:0046872";IRE1-mediated unfolded protein response [GO:0036498];"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
comp85473_c9_seq1;GAXK01055276.1;P10351;0;XDH_DROME;Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus);"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0006144; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0043546; GO:0048072; GO:0050660; GO:0051537; GO:0071949";"arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]";"cytosol [GO:0005829]; peroxisome [GO:0005777]";"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"
comp854733_c0_seq1;GAXK01200101.1;Q1HRV8;2.08E-16;ELVL1_AEDAE;Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004);"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]";"GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756";fatty acid biosynthetic process [GO:0006633];integral component of endoplasmic reticulum membrane [GO:0030176];"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp854871_c0_seq1;GAXK01200074.1;O08705;1.94E-12;NTCP_MOUSE;Sodium/bile acid cotransporter (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; bile acid transmembrane transporter activity [GO:0015125]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]";"GO:0008508; GO:0015125; GO:0015721; GO:0016020; GO:0016021; GO:0016323";bile acid and bile salt transport [GO:0015721];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"bile acid:sodium symporter activity [GO:0008508]; bile acid transmembrane transporter activity [GO:0015125]"
comp85488_c1_seq1;GAXK01055199.1;Q9XTM1;0;EXOC5_DROME;Exocyst complex component 5 (Exocyst complex component Sec10);"exocyst [GO:0000145]; presynapse [GO:0098793]; beta-catenin binding [GO:0008013]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]";"GO:0000145; GO:0006887; GO:0006893; GO:0007269; GO:0008013; GO:0015031; GO:0016080; GO:0016081; GO:0016192; GO:0090522; GO:0098793";"exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]; vesicle tethering involved in exocytosis [GO:0090522]";"exocyst [GO:0000145]; presynapse [GO:0098793]";beta-catenin binding [GO:0008013]
comp854977_c0_seq2;GAXK01200094.1;Q20065;3.33E-47;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp85502_c0_seq1;GAXK01055491.1;P33434;2.32E-15;MMP2_MOUSE;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) [Cleaved into: PEX];"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of innate immune response [GO:0045089]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; skeletal system morphogenesis [GO:0048705]; tissue remodeling [GO:0048771]";"GO:0001525; GO:0001541; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004222; GO:0004252; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0006508; GO:0006979; GO:0007162; GO:0007507; GO:0007566; GO:0007568; GO:0008233; GO:0008237; GO:0008270; GO:0009612; GO:0014012; GO:0016477; GO:0030017; GO:0030198; GO:0030335; GO:0030574; GO:0031012; GO:0034614; GO:0035987; GO:0042493; GO:0042542; GO:0043065; GO:0043627; GO:0045089; GO:0045906; GO:0048661; GO:0048705; GO:0048771; GO:0060325; GO:0060346; GO:0060740; GO:0071230; GO:0071392; GO:1904645; GO:1904707";"aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of innate immune response [GO:0045089]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; skeletal system morphogenesis [GO:0048705]; tissue remodeling [GO:0048771]";"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp85506_c0_seq1;GAXK01054999.1;Q5VZK9;0;CARL1_HUMAN;F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A);"cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]";"GO:0005634; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813";"actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]";"cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";protein-containing complex binding [GO:0044877]
comp855122_c0_seq1;GAXK01200119.1;P78317;1.50E-13;RNF4_HUMAN;E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0008134; GO:0008270; GO:0016605; GO:0030374; GO:0030521; GO:0031491; GO:0032184; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0070534; GO:0070936; GO:0070979; GO:0085020; GO:0090169; GO:0090234";"androgen receptor signaling pathway [GO:0030521]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]";"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp855444_c1_seq1;GAXK01200072.1;Q9Y4D2;1.22E-10;DGLA_HUMAN;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp8554948_c0_seq1;GAXK01075751.1;Q9JP92;4.93E-28;SURE_RUBGI;5'-nucleotidase SurE (EC 3.1.3.5) (Nucleoside 5'-monophosphate phosphohydrolase);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]";"GO:0000166; GO:0005737; GO:0008253; GO:0046872";;cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp8556994_c0_seq1;GAXK01016256.1;P42893;7.59E-08;ECE1_RAT;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);"cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]";"GO:0001666; GO:0001921; GO:0004222; GO:0005769; GO:0005886; GO:0006508; GO:0006915; GO:0008217; GO:0009897; GO:0010613; GO:0016020; GO:0016021; GO:0016485; GO:0030141; GO:0031410; GO:0031982; GO:0035994; GO:0042493; GO:0042803; GO:0043950; GO:0045745; GO:0046686; GO:0046872; GO:0070372; GO:0097746";"apoptotic process [GO:0006915]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]";"cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]"
comp85587_c2_seq1;GAXK01055478.1;Q14679;7.93E-145;TTLL4_HUMAN;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp85602_c1_seq1;GAXK01055273.1;Q7PMT1;5.56E-156;EXD_ANOGA;Homeobox protein extradenticle;"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565";"eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp85603_c5_seq1;GAXK01055011.1;Q6ZNA1;3.01E-36;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp85612_c0_seq1;GAXK01055210.1;Q5XIV0;6.61E-129;TET5C_RAT;Terminal nucleotidyltransferase 5C (EC 2.7.7.19);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]";"GO:0001701; GO:0003723; GO:0005634; GO:0005737; GO:0048255; GO:1990817";"in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]"
comp85622_c7_seq1;GAXK01055365.1;Q96N67;0;DOCK7_HUMAN;Dedicator of cytokinesis protein 7;"axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]";"GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:0120163; GO:1904754";"activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]";"axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]";"guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]"
comp8563_c0_seq1;GAXK01014010.1;Q8IY33;4.88E-39;MILK2_HUMAN;MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2);"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0001725; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:1903955";"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]";"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]";"actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]"
comp856343_c0_seq1;GAXK01189234.1;Q0V9T6;8.72E-34;BICL1_XENTR;BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107";"Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]";"dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]"
comp856527_c0_seq1;GAXK01189256.1;Q96AQ7;8.00E-07;CIDEC_HUMAN;Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0006915; GO:0034389; GO:0097194";"apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]";
comp856633_c0_seq1;GAXK01189294.1;P69526;2.88E-24;TMPS9_RAT;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp856656_c0_seq1;GAXK01189243.1;Q6P6J4;2.35E-67;ALKB2_MOUSE;DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2);"microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; DNA dealkylation involved in DNA repair [GO:0006307]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; oxidative DNA demethylation [GO:0035511]";"GO:0005634; GO:0005654; GO:0006307; GO:0008198; GO:0015630; GO:0016706; GO:0035511; GO:0043734; GO:0051747; GO:0090305; GO:0103053";"DNA dealkylation involved in DNA repair [GO:0006307]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; oxidative DNA demethylation [GO:0035511]";"microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]"
comp856797_c0_seq1;GAXK01189308.1;P00443;1.81E-31;SODC_HORSE;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; reactive oxygen species metabolic process [GO:0072593]; removal of superoxide radicals [GO:0019430]";"GO:0004784; GO:0005507; GO:0005634; GO:0005739; GO:0005829; GO:0019430; GO:0072593";"reactive oxygen species metabolic process [GO:0072593]; removal of superoxide radicals [GO:0019430]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]"
comp856997_c0_seq1;GAXK01189312.1;O46107;6.07E-26;LIP1_DROME;Lipase 1 (DmLip1) (EC 3.1.1.-);"extracellular region [GO:0005576]; lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0007586; GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]";extracellular region [GO:0005576];lipase activity [GO:0016298]
comp857131_c0_seq1;GAXK01189281.1;Q9LZX1;9.89E-08;LOR15_ARATH;Protein LURP-one-related 15;"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein domain specific binding [GO:0019904]";"GO:0005829; GO:0005886; GO:0019904";;"cytosol [GO:0005829]; plasma membrane [GO:0005886]";protein domain specific binding [GO:0019904]
comp857185_c0_seq1;GAXK01189288.1;A9ZSY2;2.10E-66;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp857234_c0_seq1;GAXK01189246.1;Q9H0B6;8.98E-17;KLC2_HUMAN;Kinesin light chain 2 (KLC 2);"cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0003777; GO:0005654; GO:0005739; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0006890; GO:0007018; GO:0016020; GO:0016938; GO:0019886; GO:0019894; GO:0032991; GO:0045296";"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; microtubule motor activity [GO:0003777]"
comp857270_c1_seq1;GAXK01189263.1;Q2V2M9;3.41E-67;FHOD3_HUMAN;FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2);"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003";"actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]";"striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp85756_c1_seq1;GAXK01055112.1;Q14849;1.07E-66;STAR3_HUMAN;StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein) (MLN 64) (Protein CAB1) (START domain-containing protein 3) (StARD3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044]";"GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0006629; GO:0006700; GO:0006701; GO:0006839; GO:0008202; GO:0008203; GO:0015485; GO:0016021; GO:0030301; GO:0031902; GO:0042803; GO:0044232; GO:0099044; GO:0120020; GO:0140284";"C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; organelle membrane contact site [GO:0044232]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803]"
comp857726_c0_seq1;GAXK01189244.1;Q9N003;1.23E-19;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp85778_c1_seq1;GAXK01055204.1;Q8N988;1.93E-18;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp857780_c0_seq1;GAXK01189255.1;A1ZAI5;1.34E-142;FACR1_DROME;Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84);"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965";"ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]";"integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]"
comp858_c0_seq1;GAXK01170185.1;Q9CQC9;1.80E-98;SAR1B_MOUSE;GTP-binding protein SAR1b;"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]";"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp8580_c0_seq1;GAXK01014715.1;O14359;2.19E-14;YB4E_SCHPO;Uncharacterized AIM2 family protein C30D10.14;"cytosol [GO:0005829]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]";"GO:0005634; GO:0005829; GO:0016787";;"cytosol [GO:0005829]; nucleus [GO:0005634]";hydrolase activity [GO:0016787]
comp85814_c2_seq1;GAXK01055072.1;Q9I3H5;1.09E-80;BVMO_PSEAE;Baeyer-Villiger monooxygenase (BVMO) (EC 1.14.13.-);"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidation-reduction process [GO:0055114]";"GO:0004499; GO:0016709; GO:0050660; GO:0050661; GO:0055114";oxidation-reduction process [GO:0055114];;"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp858174_c0_seq1;GAXK01038048.1;Q5VU57;1.05E-151;CBPC6_HUMAN;Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607";"C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]";"metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]"
comp85839_c0_seq1;GAXK01055407.1;Q28824;3.67E-120;MYLK_BOVIN;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp8584118_c0_seq1;GAXK01152713.1;Q14678;1.37E-12;KANK1_HUMAN;KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005634; GO:0005737; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393";"actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]";beta-catenin binding [GO:0008013]
comp858430_c0_seq1;GAXK01038090.1;Q54IT3;9.06E-71;AOFA_DICDI;Probable flavin-containing monoamine oxidase A (EC 1.4.3.4);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp858528_c0_seq1;GAXK01038074.1;Q7ZVG6;1.70E-13;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp8585715_c0_seq1;GAXK01152715.1;Q10101;5.34E-31;RS7_SCHPO;40S ribosomal protein S7;"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0022627; GO:0032040; GO:0042254; GO:0042274";"cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]";"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]";structural constituent of ribosome [GO:0003735]
comp85867_c0_seq1;GAXK01055324.1;P52227;1.97E-09;THIO_CHLCV;Thioredoxin (Trx);"cell [GO:0005623]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";"GO:0005623; GO:0006662; GO:0015035; GO:0045454";"cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]";cell [GO:0005623];protein disulfide oxidoreductase activity [GO:0015035]
comp858785_c0_seq1;GAXK01038086.1;O70444;8.28E-65;PIM3_RAT;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";"GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0016572; GO:0043066; GO:0046777; GO:0061179";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp85885_c6_seq1;GAXK01055548.1;O95985;0;TOP3B_HUMAN;DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1);"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]";"GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059";"chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]";"condensed chromosome [GO:0000793]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]"
comp858861_c1_seq1;GAXK01038058.1;P11584;2.19E-163;ITBX_DROME;Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129";"actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]";"integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]"
comp85899_c1_seq1;GAXK01055510.1;Q80TA1;3.46E-104;EPT1_MOUSE;Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phosphatidylethanolamine biosynthetic process [GO:0006646]";"GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0016780; GO:0046872";phosphatidylethanolamine biosynthetic process [GO:0006646];"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]";"ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
comp859_c0_seq1;GAXK01168202.1;Q66KC4;8.18E-161;HSDL2_XENTR;Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-);"peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]";"GO:0005777; GO:0016491";;peroxisome [GO:0005777];oxidoreductase activity [GO:0016491]
comp859092_c0_seq1;GAXK01038041.1;Q9M7R0;1.55E-11;ALL8_OLEEU;Calcium-binding allergen Ole e 8 (PCA18/PCA23) (allergen Ole e 8);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp859184_c0_seq1;GAXK01038042.1;G5EBU4;9.63E-07;ZAG1_CAEEL;Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";"GO:0000122; GO:0005634; GO:0007411; GO:0043565; GO:0045773; GO:0046872";"axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp859195_c0_seq1;GAXK01038069.1;Q1ECV4;4.93E-135;TTLL3_DANRE;Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3);"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; tubulin-glycine ligase activity [GO:0070738]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; protein polyglycylation [GO:0018094]";"GO:0003341; GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0035082; GO:0060271; GO:0070735; GO:0070736; GO:0070738";"axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; protein polyglycylation [GO:0018094]";"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]";"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; tubulin-glycine ligase activity [GO:0070738]"
comp85924_c0_seq1;GAXK01055206.1;Q8IN81;6.70E-15;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp85931_c0_seq1;GAXK01055275.1;Q9Y5Z4;5.86E-10;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp859328_c0_seq1;GAXK01038050.1;Q5F4B8;5.27E-10;S46A3_CHICK;Solute carrier family 46 member 3;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp859338_c0_seq1;GAXK01038106.1;Q9H165;6.19E-38;BC11A_HUMAN;B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173";"cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp85942_c2_seq1;GAXK01055269.1;Q3ZC98;1.39E-141;NUP85_BOVIN;Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85);"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0000777; GO:0005819; GO:0005829; GO:0006406; GO:0006606; GO:0017056; GO:0030032; GO:0031080; GO:0031965; GO:0045893; GO:0048246; GO:0072006";"lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; spindle [GO:0005819]";structural constituent of nuclear pore [GO:0017056]
comp859454_c0_seq1;GAXK01038020.1;Q86VQ0;1.50E-11;LCA5_HUMAN;Lebercilin (Leber congenital amaurosis 5 protein);"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]";"GO:0005929; GO:0005930; GO:0032391; GO:0036064; GO:0042073; GO:0044877; GO:0045494";"intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]";"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]";protein-containing complex binding [GO:0044877]
comp85949_c1_seq1;GAXK01055098.1;P05661;2.88E-40;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp859884_c0_seq1;GAXK01038055.1;P10076;1.67E-29;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp86_c0_seq1;GAXK01169718.1;Q8NFU1;6.94E-109;BEST2_HUMAN;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0034707; GO:0051899";"membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp860_c1_seq1;GAXK01168999.1;Q1LZ95;2.27E-70;IDI1_BOVIN;Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1);"peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]";"GO:0004452; GO:0005777; GO:0006695; GO:0009240; GO:0016787; GO:0046872; GO:0050992";"cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]";peroxisome [GO:0005777];"hydrolase activity [GO:0016787]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872]"
comp86000_c0_seq1;GAXK01202490.1;Q29558;4.00E-80;MAOX_PIG;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1) (Fragment);"cytosol [GO:0005829]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; response to hormone [GO:0009725]";"GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008948; GO:0009725; GO:0030145; GO:0051287";"malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; response to hormone [GO:0009725]";"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp860022_c0_seq1;GAXK01121049.1;Q9NTW7;8.48E-18;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp860062_c0_seq1;GAXK01121063.1;Q9NXL6;1.50E-40;SIDT1_HUMAN;SID1 transmembrane family member 1;"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033";"dsRNA transport [GO:0033227]; RNA transport [GO:0050658]";"integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]";"double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
comp860189_c0_seq1;GAXK01121060.1;Q22633;6.70E-23;HPPD_CAEEL;4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"GO:0000139; GO:0003868; GO:0005789; GO:0006559; GO:0006572; GO:0046872";"L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]";"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";"4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]"
comp860259_c0_seq1;GAXK01121065.1;Q60519;2.31E-07;SEM5B_MOUSE;Semaphorin-5B (Semaphorin-G) (Sema G);"integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";"GO:0001755; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485; GO:1990138";"axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]";integral component of membrane [GO:0016021];"chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]"
comp86035_c0_seq1;GAXK01202440.1;Q8CBH5;5.38E-123;MFSD6_MOUSE;Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"GO:0002250; GO:0005886; GO:0016021; GO:0032393; GO:0042288; GO:0042590";"adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]"
comp86044_c2_seq1;GAXK01202314.1;Q6DCF2;3.79E-41;MMS19_XENLA;MMS19 nucleotide excision repair protein homolog (MMS19-like protein);"CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"GO:0005634; GO:0005737; GO:0005819; GO:0006259; GO:0006281; GO:0006974; GO:0016226; GO:0097361; GO:0097428; GO:1905168";"cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]";"CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]";
comp8605_c0_seq1;GAXK01013514.1;Q04753;1.03E-31;ICLN_RAT;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000387; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715";"cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]";"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]";
comp86054_c0_seq1;GAXK01202045.1;Q93XW5;3.93E-37;NSP5_ARATH;Nitrile-specifier protein 5 (AtNSP5);"cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536]; enzyme regulator activity [GO:0030234]; glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028]";"GO:0005634; GO:0005829; GO:0009536; GO:0019762; GO:0030234; GO:0080028";"glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536]";enzyme regulator activity [GO:0030234]
comp860559_c0_seq1;GAXK01121053.1;P48987;2.58E-08;ATO_DROME;Protein atonal;"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; optic lobe placode development [GO:0001748]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate commitment [GO:0007460]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]";"GO:0001746; GO:0001748; GO:0003677; GO:0005634; GO:0007399; GO:0007420; GO:0007423; GO:0007438; GO:0007455; GO:0007460; GO:0007605; GO:0008038; GO:0016360; GO:0045165; GO:0045433; GO:0045944; GO:0046982; GO:0048800; GO:0048801";"antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; optic lobe placode development [GO:0001748]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate commitment [GO:0007460]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]";nucleus [GO:0005634];"DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
comp86071_c11_seq1;GAXK01202363.1;Q9HAZ2;4.95E-12;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp86072_c11_seq1;GAXK01202047.1;F1QDI9;3.97E-53;MCM9_DANRE;DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9);"MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]";"GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006974; GO:0042555; GO:0097362";"cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]";"MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]"
comp860906_c0_seq1;GAXK01121072.1;P58462;4.66E-21;FOXP1_MOUSE;Forkhead box protein P1 (Forkhead-related transcription factor 1);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle cell differentiation [GO:0055007]; cardiovascular system development [GO:0072358]; cellular response to ionomycin [GO:1904637]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; innate vocalization behavior [GO:0098582]; interleukin-21 secretion [GO:0072619]; lung development [GO:0030324]; lung secretory cell differentiation [GO:0061140]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; motor neuron axon guidance [GO:0008045]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of lung goblet cell differentiation [GO:1901250]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pre-B cell differentiation [GO:0002329]; regulation of action potential [GO:0098900]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of defense response to bacterium [GO:1900424]; regulation of lung goblet cell differentiation [GO:1901249]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]; ventral spinal cord development [GO:0021517]";"GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001701; GO:0002053; GO:0002329; GO:0002639; GO:0002903; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007507; GO:0007519; GO:0008045; GO:0008134; GO:0010595; GO:0021517; GO:0021756; GO:0030316; GO:0030324; GO:0032496; GO:0032680; GO:0033152; GO:0033574; GO:0035926; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042803; GO:0043621; GO:0044212; GO:0045214; GO:0045655; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046982; GO:0048661; GO:0048745; GO:0050679; GO:0055007; GO:0060043; GO:0060766; GO:0061052; GO:0061140; GO:0061470; GO:0071356; GO:0072358; GO:0072619; GO:0098582; GO:0098900; GO:1900424; GO:1901249; GO:1901250; GO:1901256; GO:1904637; GO:1905206";"cardiac muscle cell differentiation [GO:0055007]; cardiovascular system development [GO:0072358]; cellular response to ionomycin [GO:1904637]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate vocalization behavior [GO:0098582]; interleukin-21 secretion [GO:0072619]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lung secretory cell differentiation [GO:0061140]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; motor neuron axon guidance [GO:0008045]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of lung goblet cell differentiation [GO:1901250]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-B cell differentiation [GO:0002329]; regulation of action potential [GO:0098900]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of defense response to bacterium [GO:1900424]; regulation of lung goblet cell differentiation [GO:1901249]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]; ventral spinal cord development [GO:0021517]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
comp861122_c0_seq1;GAXK01121059.1;Q8TDR0;4.54E-36;MIPT3_HUMAN;TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3) (MIP-T3);"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of type I interferon production [GO:0032480]; neural tube patterning [GO:0021532]; post-anal tail morphogenesis [GO:0036342]; regulation of microtubule cytoskeleton organization [GO:0070507]";"GO:0001738; GO:0001822; GO:0001933; GO:0005813; GO:0005929; GO:0005930; GO:0008017; GO:0021532; GO:0030992; GO:0031076; GO:0031333; GO:0032480; GO:0032688; GO:0035050; GO:0035735; GO:0035869; GO:0036064; GO:0036342; GO:0042073; GO:0042733; GO:0050687; GO:0060271; GO:0070507; GO:0097542; GO:0097546; GO:1901621";"cilium assembly [GO:0060271]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of type I interferon production [GO:0032480]; neural tube patterning [GO:0021532]; post-anal tail morphogenesis [GO:0036342]; regulation of microtubule cytoskeleton organization [GO:0070507]";"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]";microtubule binding [GO:0008017]
comp86127_c0_seq1;GAXK01201813.1;A1CRI1;2.01E-95;XYL1_ASPCL;Probable NAD(P)H-dependent D-xylose reductase xyl1 (XR) (EC 1.1.1.307);"oxidoreductase activity [GO:0016491]; D-xylose catabolic process [GO:0042843]";"GO:0016491; GO:0042843";D-xylose catabolic process [GO:0042843];;oxidoreductase activity [GO:0016491]
comp86128_c1_seq1;GAXK01201622.1;Q5E983;4.81E-12;EF1B_BOVIN;Elongation factor 1-beta (EF-1-beta);"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]";"GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414";translational elongation [GO:0006414];"cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]";"guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]"
comp8613_c1_seq1;GAXK01013635.1;Q9VAS7;6.67E-111;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp86180_c1_seq1;GAXK01201741.1;Q9V9A7;1.86E-107;MCCB_DROME;Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta);"methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]";"GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202";"leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]";"methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]"
comp861938_c0_seq1;GAXK01121073.1;P20693;5.48E-21;FCER2_MOUSE;Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23);"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770";"positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]";"external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]"
comp862_c0_seq1;GAXK01168234.1;P16381;0;DDX3L_MOUSE;Putative ATP-dependent RNA helicase Pl10 (EC 3.6.4.13);"nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007275; GO:0007276; GO:0007283; GO:0030154; GO:0043186";"cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]";"nucleus [GO:0005634]; P granule [GO:0043186]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp86201_c2_seq1;GAXK01201834.1;Q9H2X3;1.03E-10;CLC4M_HUMAN;C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0006897; GO:0007159; GO:0009988; GO:0016020; GO:0019048; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046790; GO:0046872; GO:0046968; GO:0048306; GO:0075733";"adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]"
comp862308_c1_seq1;GAXK01187075.1;Q86SQ4;8.82E-23;AGRG6_HUMAN;"Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]";"GO:0004930; GO:0005518; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0014037; GO:0016021; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]"
comp862498_c0_seq1;GAXK01187060.1;Q15842;8.28E-31;KCNJ8_HUMAN;ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1);"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0008076; GO:0015272; GO:0034765; GO:0098915; GO:1902282; GO:1990573";"membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]";"plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]"
comp86255_c0_seq1;GAXK01202419.1;Q7Z410;9.18E-16;TMPS9_HUMAN;"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]";"integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005887";;integral component of plasma membrane [GO:0005887];serine-type endopeptidase activity [GO:0004252]
comp86267_c0_seq1;GAXK01201851.1;P05661;6.77E-16;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp862680_c0_seq1;GAXK01187043.1;P06276;7.62E-10;CHLE_HUMAN;Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase);"blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]";"GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005641; GO:0005788; GO:0007612; GO:0008285; GO:0014016; GO:0016020; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0072562";"choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]";"blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]";"acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]"
comp86269_c5_seq1;GAXK01201853.1;Q868Z9;1.33E-70;PPN_DROME;Papilin;"basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";"GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198";"extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]";basement membrane [GO:0005604];"extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]"
comp8626956_c0_seq1;GAXK01137636.1;P08548;3.60E-08;LIN1_NYCCO;LINE-1 reverse transcriptase homolog (EC 2.7.7.49);"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]";"GO:0003964; GO:0046872";;;"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]"
comp86272_c0_seq1;GAXK01206002.1;A7YVD7;4.59E-67;NDUF6_BOVIN;NADH dehydrogenase (ubiquinone) complex I, assembly factor 6;"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005739; GO:0005743; GO:0032981";mitochondrial respiratory chain complex I assembly [GO:0032981];"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp86274_c3_seq1;GAXK01202415.1;Q80ZD3;3.04E-114;S2611_MOUSE;Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]";"GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231";sulfate transport [GO:0008272];"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]"
comp86280_c0_seq1;GAXK01201596.1;Q6GNV7;3.18E-22;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp8629_c0_seq1;GAXK01013356.1;O44081;0;DKC1_DROME;H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Nucleolar protein AT band 60B) (Protein minifly);"box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; box H/ACA snoRNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]";"GO:0000495; GO:0001522; GO:0003723; GO:0005730; GO:0006364; GO:0007281; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0035220; GO:0042254; GO:1990481";"box H/ACA snoRNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]";"box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]";"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp8630709_c0_seq1;GAXK01057115.1;Q7TS63;2.68E-08;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp863074_c0_seq1;GAXK01187057.1;P52746;1.44E-14;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8631_c3_seq1;GAXK01014289.1;Q7Z6Z7;0;HUWE1_HUMAN;E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043312; GO:0061630; GO:0070062; GO:1903955; GO:1904813";"base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]";"DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp86311_c0_seq1;GAXK01202278.1;Q28619;4.06E-21;NHRF1_RABIT;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0005737; GO:0005902; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0030175; GO:0031528; GO:0032782; GO:0034635; GO:0045859; GO:0051898; GO:0060090; GO:0070293; GO:0071944; GO:0097225; GO:0097291; GO:2000146";"bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]";"chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]"
comp8632262_c0_seq1;GAXK01099753.1;Q03720;2.51E-12;SLO_DROME;Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0015271; GO:0016020; GO:0016021; GO:0034765; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074";"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]"
comp8635517_c0_seq1;GAXK01189809.1;Q81LW0;1.83E-28;SODM1_BACAN;Superoxide dismutase [Mn] 1 (EC 1.15.1.1);"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; removal of superoxide radicals [GO:0019430]";"GO:0004784; GO:0019430; GO:0046872";removal of superoxide radicals [GO:0019430];;"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp863689_c0_seq1;GAXK01187051.1;Q9UJU3;2.89E-17;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8637544_c0_seq1;GAXK01077030.1;Q5JVG2;9.48E-14;ZN484_HUMAN;Zinc finger protein 484;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp863759_c0_seq1;GAXK01187040.1;D3Z5L6;6.45E-20;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp863867_c0_seq1;GAXK01187089.1;P28476;1.64E-24;GBRR2_HUMAN;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp86388_c1_seq1;GAXK01201963.1;Q9S777;2.95E-08;4CL3_ARATH;4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 3) (At4CL3) (4-coumaroyl-CoA synthase 3);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]; pollen exine formation [GO:0010584]";"GO:0005524; GO:0009698; GO:0010584; GO:0016207";"phenylpropanoid metabolic process [GO:0009698]; pollen exine formation [GO:0010584]";;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp863980_c0_seq1;GAXK01187041.1;Q539E5;1.15E-13;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp863981_c0_seq1;GAXK01187077.1;Q8I6K1;2.23E-103;PPO1_HOLDI;Phenoloxidase 1 (EC 1.14.18.-) (Prophenoloxidase-I);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";"GO:0004497; GO:0005576; GO:0042438; GO:0045087; GO:0046872";"innate immune response [GO:0045087]; melanin biosynthetic process [GO:0042438]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
comp8639848_c0_seq1;GAXK01091906.1;C5DXN2;3.17E-13;AIM41_ZYGRC;Altered inheritance of mitochondria protein 41, mitochondrial;"mitochondrion [GO:0005739]; carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO:0016884]";"GO:0005739; GO:0016884";;mitochondrion [GO:0005739];carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO:0016884]
comp8640310_c0_seq1;GAXK01038628.1;Q55G75;3.74E-09;Y7786_DICDI;PH domain-containing protein DDB_G0267786;;;;;
comp86423_c0_seq1;GAXK01202469.1;Q8VIG1;2.40E-18;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp864278_c0_seq1;GAXK01012412.1;Q9GUM2;2.00E-61;BRE4_CAEEL;Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT);"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";"GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872";"carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]";integral component of membrane [GO:0016021];"acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"
comp864468_c2_seq1;GAXK01012375.1;Q9V778;0;ADAS_DROME;Alkyldihydroxyacetonephosphate synthase (Alkyl-DHAP synthase) (EC 2.5.1.26) (Alkylglycerone-phosphate synthase);"peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]";"GO:0005777; GO:0008609; GO:0008610; GO:0008611; GO:0016491; GO:0071949";"ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]";peroxisome [GO:0005777];"alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]"
comp86450_c4_seq1;GAXK01201594.1;A6H619;1.73E-25;PHRF1_MOUSE;PHD and RING finger domain-containing protein 1;"metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]";"GO:0006366; GO:0006397; GO:0019904; GO:0046872; GO:0070063";"mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]";;"metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]"
comp86466_c2_seq1;GAXK01201848.1;Q6H8Q1;6.27E-79;ABLM2_HUMAN;Actin-binding LIM protein 2 (abLIM-2) (Actin-binding LIM protein family member 2);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]";"GO:0005737; GO:0006351; GO:0015629; GO:0030032; GO:0030036; GO:0046872; GO:0051015";"actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]";"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]"
comp864691_c0_seq1;GAXK01012397.1;B4PZQ4;6.47E-28;NAAT1_DROYA;Sodium-dependent nutrient amino acid transporter 1;"integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";"GO:0005283; GO:0005328; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943";"D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]";integral component of plasma membrane [GO:0005887];"amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]"
comp864715_c0_seq1;GAXK01012379.1;Q6DCX5;1.29E-11;PCFT_XENLA;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp864747_c1_seq1;GAXK01012408.1;G3M4F8;5.60E-29;OCTB2_CHISP;Octopamine receptor beta-2R (CsOA2B2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]";"GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016021; GO:0071418; GO:0071927; GO:0071928";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]"
comp864839_c0_seq1;GAXK01012434.1;Q99N23;2.75E-44;CAH15_MOUSE;Carbonic anhydrase 15 (EC 4.2.1.1) (Carbonate dehydratase XV) (Carbonic anhydrase XV) (CA-XV);"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; membrane [GO:0016020]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]";"GO:0004089; GO:0005576; GO:0008270; GO:0016020; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; membrane [GO:0016020]";"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp864934_c0_seq1;GAXK01012410.1;O77408;6.56E-78;OAR1_LYMST;Octopamine receptor 1 (OA1);"integral component of plasma membrane [GO:0005887]; G protein-coupled acetylcholine receptor activity [GO:0016907]";"GO:0005887; GO:0016907";;integral component of plasma membrane [GO:0005887];G protein-coupled acetylcholine receptor activity [GO:0016907]
comp8649884_c0_seq1;GAXK01148279.1;P76071;5.81E-45;INSH5_ECOLI;Transposase InsH for insertion sequence element IS5Y;"cytosol [GO:0005829]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0005829; GO:0006313; GO:0045893";"positive regulation of transcription, DNA-templated [GO:0045893]; transposition, DNA-mediated [GO:0006313]";cytosol [GO:0005829];"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp8650_c0_seq1;GAXK01014056.1;Q5R6X7;2.73E-61;CBX3_PONAB;Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma);"chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"GO:0000779; GO:0000785; GO:0005635; GO:0005719; GO:0005720; GO:0005819; GO:0006325; GO:0006974; GO:0019904; GO:0031618; GO:0042802; GO:0045892; GO:0048511; GO:0090734; GO:1990226";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]";"chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; site of DNA damage [GO:0090734]; spindle [GO:0005819]";"histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp865037_c0_seq1;GAXK01012401.1;Q08705;4.00E-08;CTCF_CHICK;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp86520_c0_seq1;GAXK01201579.1;P81225;3.91E-12;CU21_LOCMI;Cuticle protein 21 (LM-ACP 21);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp86522_c1_seq1;GAXK01201623.1;Q9V427;1.72E-65;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp8655821_c0_seq1;GAXK01117985.1;Q7VZ66;1.91E-71;PSTB_BORPE;Phosphate import ATP-binding protein PstB (EC 7.3.2.1) (ABC phosphate transporter) (Phosphate-transporting ATPase);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; inorganic phosphate transmembrane transporter activity [GO:0005315]";"GO:0005315; GO:0005524; GO:0005886; GO:0015415; GO:0016887";;plasma membrane [GO:0005886];"ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; ATP binding [GO:0005524]; inorganic phosphate transmembrane transporter activity [GO:0005315]"
comp865660_c0_seq1;GAXK01012372.1;A0PJX2;2.29E-30;TLDC2_HUMAN;TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2);;;;;
comp86572_c1_seq1;GAXK01202235.1;Q7KRI2;2.41E-31;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp86583_c0_seq1;GAXK01202229.1;Q5R7X2;6.78E-169;SR140_PONAB;U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140);"nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396]";"GO:0003723; GO:0005634; GO:0006396";RNA processing [GO:0006396];nucleus [GO:0005634];RNA binding [GO:0003723]
comp86592_c0_seq1;GAXK01201564.1;Q9VMM6;2.23E-27;OBSTE_DROME;Protein obstructor-E;"extracellular matrix [GO:0031012]; chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin metabolic process [GO:0006030]; chitin-based cuticle development [GO:0040003]";"GO:0006030; GO:0008010; GO:0008011; GO:0008061; GO:0031012; GO:0040003";"chitin-based cuticle development [GO:0040003]; chitin metabolic process [GO:0006030]";extracellular matrix [GO:0031012];"chitin binding [GO:0008061]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp866169_c0_seq1;GAXK01055957.1;Q61315;4.36E-80;APC_MOUSE;Adenomatous polyposis coli protein (Protein APC) (mAPC);"adherens junction [GO:0005912]; axon [GO:0030424]; axonal growth cone [GO:0044295]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell body fiber [GO:0070852]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; Scrib-APC-beta-catenin complex [GO:0034750]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell cycle arrest [GO:0007050]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; establishment or maintenance of cell polarity [GO:0007163]; hair follicle development [GO:0001942]; insulin receptor signaling pathway [GO:0008286]; kidney development [GO:0001822]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint [GO:0007094]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of molecular function [GO:0044092]; negative regulation of odontogenesis [GO:0042483]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuron projection development [GO:0031175]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; protein homooligomerization [GO:0051260]; protein-containing complex assembly [GO:0065003]; proximal/distal pattern formation [GO:0009954]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation [GO:0030856]; regulation of glutamate metabolic process [GO:2000211]; regulation of microtubule-based process [GO:0032886]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; retina development in camera-type eye [GO:0060041]; skin development [GO:0043588]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; Wnt signaling pathway [GO:0016055]";"GO:0000122; GO:0000281; GO:0000776; GO:0001708; GO:0001822; GO:0001942; GO:0002020; GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0005938; GO:0006974; GO:0007026; GO:0007050; GO:0007091; GO:0007094; GO:0007163; GO:0007389; GO:0007409; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0009798; GO:0009952; GO:0009953; GO:0009954; GO:0010942; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019827; GO:0019887; GO:0019901; GO:0030027; GO:0030178; GO:0030334; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0030856; GO:0030858; GO:0030877; GO:0031116; GO:0031122; GO:0031175; GO:0031253; GO:0031274; GO:0031625; GO:0031965; GO:0032587; GO:0032886; GO:0032991; GO:0033077; GO:0034750; GO:0035019; GO:0042483; GO:0042802; GO:0042995; GO:0043025; GO:0043065; GO:0043066; GO:0043409; GO:0043588; GO:0044092; GO:0044295; GO:0044306; GO:0044336; GO:0044337; GO:0044877; GO:0045295; GO:0045595; GO:0045597; GO:0045667; GO:0045670; GO:0045732; GO:0045736; GO:0045785; GO:0046716; GO:0048471; GO:0048538; GO:0050680; GO:0051010; GO:0051171; GO:0051260; GO:0051276; GO:0051726; GO:0051781; GO:0051988; GO:0060041; GO:0060044; GO:0060070; GO:0060770; GO:0065003; GO:0070840; GO:0070852; GO:0090090; GO:0120162; GO:1904781; GO:2000211";"anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell cycle arrest [GO:0007050]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; establishment or maintenance of cell polarity [GO:0007163]; hair follicle development [GO:0001942]; insulin receptor signaling pathway [GO:0008286]; kidney development [GO:0001822]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint [GO:0007094]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of molecular function [GO:0044092]; negative regulation of odontogenesis [GO:0042483]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuron projection development [GO:0031175]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; protein-containing complex assembly [GO:0065003]; protein homooligomerization [GO:0051260]; proximal/distal pattern formation [GO:0009954]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation [GO:0030856]; regulation of glutamate metabolic process [GO:2000211]; regulation of microtubule-based process [GO:0032886]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; retina development in camera-type eye [GO:0060041]; skin development [GO:0043588]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; Wnt signaling pathway [GO:0016055]";"adherens junction [GO:0005912]; axon [GO:0030424]; axonal growth cone [GO:0044295]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell body fiber [GO:0070852]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; Scrib-APC-beta-catenin complex [GO:0034750]";"beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]"
comp866323_c0_seq1;GAXK01055938.1;P22815;1.79E-15;BOSS_DROME;Protein bride of sevenless;"integral component of plasma membrane [GO:0005887]; rhabdomere microvillus membrane [GO:0035997]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; receptor ligand activity [GO:0048018]; sevenless binding [GO:0005118]; glucose homeostasis [GO:0042593]; lipid homeostasis [GO:0055088]; R7 cell fate commitment [GO:0007465]; R8 cell-mediated photoreceptor organization [GO:0045470]; response to glucose [GO:0009749]; sevenless signaling pathway [GO:0045500]; visual perception [GO:0007601]";"GO:0004930; GO:0005118; GO:0005887; GO:0007465; GO:0007601; GO:0008066; GO:0009749; GO:0035997; GO:0042593; GO:0045470; GO:0045500; GO:0048018; GO:0055088";"glucose homeostasis [GO:0042593]; lipid homeostasis [GO:0055088]; R7 cell fate commitment [GO:0007465]; R8 cell-mediated photoreceptor organization [GO:0045470]; response to glucose [GO:0009749]; sevenless signaling pathway [GO:0045500]; visual perception [GO:0007601]";"integral component of plasma membrane [GO:0005887]; rhabdomere microvillus membrane [GO:0035997]";"glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; receptor ligand activity [GO:0048018]; sevenless binding [GO:0005118]"
comp86636_c9_seq1;GAXK01201764.1;O00748;7.25E-63;EST2_HUMAN;Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]";"GO:0005615; GO:0005783; GO:0005788; GO:0006693; GO:0006805; GO:0009056; GO:0047374; GO:0052689; GO:0080030";"catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]";"carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]"
comp866485_c0_seq1;GAXK01055946.1;Q6IV72;2.14E-10;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp866781_c0_seq1;GAXK01055989.1;Q2TBF2;1.60E-18;WSCD2_HUMAN;WSC domain-containing protein 2;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp866827_c1_seq1;GAXK01055947.1;Q9Y4D2;1.09E-09;DGLA_HUMAN;Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator);"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055";"arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]";"integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]";"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp86684_c0_seq1;GAXK01202202.1;P13607;5.46E-166;ATNA_DROME;Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha);"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573";"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]";"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]";"ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]"
comp86696_c7_seq1;GAXK01201738.1;Q499B3;8.91E-103;KANL3_DANRE;KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog);"histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleus [GO:0005634]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"GO:0000123; GO:0005634; GO:0043981; GO:0043982; GO:0043984; GO:0044545";"histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]";"histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleus [GO:0005634]";
comp867_c1_seq1;GAXK01169410.1;O54981;6.92E-119;STIP1_CRIGR;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop);"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"GO:0005634; GO:0005737";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp867052_c0_seq1;GAXK01055945.1;P02594;6.41E-44;CALM_ELEEL;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8670700_c0_seq1;GAXK01053921.1;Q143F8;7.89E-63;GLK_PARXL;"Bifunctional protein glk [Includes: Glucokinase (EC 2.7.1.2) (Glucose kinase); Putative HTH-type transcriptional regulator]";"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; glycolytic process [GO:0006096]";"GO:0003677; GO:0003700; GO:0004340; GO:0005524; GO:0005536; GO:0005737; GO:0006096";glycolytic process [GO:0006096];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]"
comp86721_c1_seq1;GAXK01201913.1;Q9NRZ5;3.23E-78;PLCD_HUMAN;1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0016746";"CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"
comp86724_c1_seq1;GAXK01202420.1;Q78KK3;3.03E-60;S22AI_MOUSE;Solute carrier family 22 member 18 (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Multi-membrane-spanning polyspecific transporter) (Organic cation transporter-like protein 2) (ORCTL-2);"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; organic anion transmembrane transporter activity [GO:0008514]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; anion transport [GO:0006820]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]";"GO:0005635; GO:0005737; GO:0005887; GO:0006820; GO:0008514; GO:0015293; GO:0016324; GO:0022857; GO:0031625; GO:0042908; GO:1990961";"anion transport [GO:0006820]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]";"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]";"organic anion transmembrane transporter activity [GO:0008514]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]"
comp86726_c0_seq1;GAXK01201903.1;O17040;3.50E-59;HACD_CAEEL;Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase hpo-8 (EC 4.2.1.134) (Probable 3-hydroxyacyl-CoA dehydratase);"integral component of membrane [GO:0016021]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0016021; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345";"fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";integral component of membrane [GO:0016021];"3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]"
comp86727_c0_seq1;GAXK01201976.1;Q4V8S3;3.72E-18;TM242_DANRE;Transmembrane protein 242;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp86769_c0_seq1;GAXK01202468.1;Q9BY78;6.19E-12;RNF26_HUMAN;E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]";"GO:0005789; GO:0007032; GO:0008270; GO:0016021; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719";"endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp86776_c0_seq1;GAXK01201812.1;Q08832;0;GBRB3_DROME;Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902711";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]"
comp867812_c0_seq1;GAXK01055988.1;A8J4S9;1.08E-129;TREA_APIME;Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase);"integral component of membrane [GO:0016021]; alpha,alpha-trehalase activity [GO:0004555]; trehalose metabolic process [GO:0005991]";"GO:0004555; GO:0005991; GO:0016021";trehalose metabolic process [GO:0005991];integral component of membrane [GO:0016021];alpha,alpha-trehalase activity [GO:0004555]
comp867858_c0_seq1;GAXK01055929.1;E9QAG8;2.55E-22;ZN431_MOUSE;Zinc finger protein 431 (Zinc finger protein 932);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872";"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp867919_c0_seq1;GAXK01055944.1;Q9NUA8;4.13E-12;ZBT40_HUMAN;Zinc finger and BTB domain-containing protein 40;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";"GO:0003677; GO:0005634; GO:0006974; GO:0030282; GO:0046872";"bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8679653_c0_seq1;GAXK01152583.1;P80871;7.59E-11;GS14_BACSU;General stress protein 14 (GSP14) (EC 1.6.99.-);"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; positive regulation of ion transmembrane transporter activity [GO:0032414]";"GO:0003955; GO:0009055; GO:0010181; GO:0032414";positive regulation of ion transmembrane transporter activity [GO:0032414];;"electron transfer activity [GO:0009055]; FMN binding [GO:0010181]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]"
comp868_c0_seq1;GAXK01168710.1;Q6DRC4;9.95E-95;EIF3G_DANRE;Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp86803_c0_seq1;GAXK01201731.1;Q6FSC1;1.47E-19;FKBP2_CANGA;FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]";"GO:0003755; GO:0005528; GO:0005783; GO:0016020";;"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]";"FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp868143_c0_seq1;GAXK01055654.1;Q8WTS6;9.95E-40;SETD7_HUMAN;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9);"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828";"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]";"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp86823_c0_seq1;GAXK01201751.1;Q92047;3.21E-84;PIMT_DANRE;Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase);"cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]";"GO:0004719; GO:0005737";;cytoplasm [GO:0005737];protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]
comp8685_c3_seq1;GAXK01013586.1;O43776;0;SYNC_HUMAN;Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421]; tRNA aminoacylation for protein translation [GO:0006418]";"GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0070062";"asparaginyl-tRNA aminoacylation [GO:0006421]; tRNA aminoacylation for protein translation [GO:0006418]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]"
comp868538_c0_seq1;GAXK01055679.1;Q5R1P3;2.35E-67;NMDE2_CANLF;Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"GO:0004972; GO:0005886; GO:0005887; GO:0008270; GO:0014069; GO:0016595; GO:0017146; GO:0022849; GO:0030054; GO:0051290; GO:0060079; GO:0060291; GO:0097553; GO:0098839";"calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]";"glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]"
comp86863_c0_seq1;GAXK01202488.1;Q28658;2.18E-07;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp86864_c1_seq1;GAXK01201914.1;Q9H7F0;0;AT133_HUMAN;Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1);"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"GO:0005524; GO:0005623; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872";"cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]";"cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp8687_c24_seq1;GAXK01014001.1;Q7KRI2;1.82E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp86870_c0_seq1;GAXK01201791.1;Q4AEI0;5.32E-70;GPX2_PONPY;Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI);"cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]";"GO:0004602; GO:0005737; GO:0006979";response to oxidative stress [GO:0006979];cytoplasm [GO:0005737];glutathione peroxidase activity [GO:0004602]
comp86879_c0_seq1;GAXK01201977.1;P11536;3.89E-57;E74EB_DROME;Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]";"GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0008219; GO:0030154; GO:0035071; GO:0040034; GO:0043565; GO:0045944; GO:0048477";"autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp86888_c0_seq1;GAXK01201924.1;Q9BT30;1.16E-46;ALKB7_HUMAN;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) (Spermatogenesis cell proliferation-related protein) (Spermatogenesis-associated protein 11);"mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]";"GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445";"cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]";mitochondrial matrix [GO:0005759];"dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
comp86909_c2_seq2;GAXK01202294.1;O15943;0;CADN_DROME;Neural-cadherin (Cadherin-N) (dN-cadherin);"axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]";"GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0008013; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609";"axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]";"axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]"
comp86940_c5_seq1;GAXK01201907.1;Q29KT5;2.99E-18;SPIR_DROPS;Protein spire;"cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0003779; GO:0005856; GO:0005886; GO:0007275; GO:0015031; GO:0016192; GO:0030659; GO:0045010; GO:0048471";"actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";actin binding [GO:0003779]
comp869424_c0_seq1;GAXK01055668.1;P51547;1.76E-32;SODE_HAECO;Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005615; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp8695439_c0_seq1;GAXK01200071.1;Q9SP37;1.59E-44;SAHH_LUPLU;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase);"adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0006730";one-carbon metabolic process [GO:0006730];;adenosylhomocysteinase activity [GO:0004013]
comp86970_c1_seq1;GAXK01201792.1;P27779;5.21E-09;CUP7_DROME;Pupal cuticle protein Edg-78E;"extracellular matrix [GO:0031012]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]; chitin-based cuticle development [GO:0040003]";"GO:0008010; GO:0008011; GO:0031012; GO:0040003";chitin-based cuticle development [GO:0040003];extracellular matrix [GO:0031012];"structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of pupal chitin-based cuticle [GO:0008011]"
comp86975_c0_seq1;GAXK01201729.1;Q5BJI7;5.11E-15;SMY2A_DANRE;N-lysine methyltransferase SMYD2-A (EC 2.1.1.-) (Histone methyltransferase SMYD2-A) (EC 2.1.1.43) (SET and MYND domain-containing protein 2A);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; caudal fin development [GO:0033336]; heart contraction [GO:0060047]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of sarcomere organization [GO:0060297]; skeletal muscle tissue development [GO:0007519]";"GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0007519; GO:0008285; GO:0016279; GO:0018026; GO:0018027; GO:0033336; GO:0043516; GO:0046872; GO:0046975; GO:0060047; GO:0060297";"caudal fin development [GO:0033336]; heart contraction [GO:0060047]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of sarcomere organization [GO:0060297]; skeletal muscle tissue development [GO:0007519]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]"
comp86976_c4_seq1;GAXK01202401.1;P17139;4.82E-167;CO4A1_CAEEL;Collagen alpha-1(IV) chain;"basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]";"GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0005615; GO:0007517; GO:0009792; GO:0030198; GO:0031012; GO:0038063; GO:0048680; GO:0050714";"collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]";"basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";extracellular matrix structural constituent [GO:0005201]
comp86983_c5_seq1;GAXK01201917.1;Q10570;0;CPSF1_HUMAN;Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit);"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789";"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]";"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]"
comp869892_c0_seq1;GAXK01055688.1;A9JRD8;3.57E-21;BTB6A_DANRE;BTB/POZ domain-containing protein 6-A;"cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]; regulation of neurogenesis [GO:0050767]";"GO:0005634; GO:0005829; GO:0022008; GO:0050767";"neurogenesis [GO:0022008]; regulation of neurogenesis [GO:0050767]";"cytosol [GO:0005829]; nucleus [GO:0005634]";
comp86992_c0_seq1;GAXK01201922.1;Q5RFU0;4.25E-81;SIAE_PONAB;Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase);"lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]";"GO:0001681; GO:0005764";;lysosome [GO:0005764];sialate O-acetylesterase activity [GO:0001681]
comp869955_c0_seq1;GAXK01055667.1;Q9R1A7;7.60E-07;NR1I2_RAT;Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor);"intermediate filament cytoskeleton [GO:0045111]; nuclear body [GO:0016604]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; drug export [GO:0046618]; exogenous drug catabolic process [GO:0042738]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]";"GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0006805; GO:0007275; GO:0008134; GO:0008144; GO:0008270; GO:0016604; GO:0030154; GO:0030374; GO:0038023; GO:0042738; GO:0042908; GO:0045111; GO:0045892; GO:0045893; GO:0045944; GO:0046618; GO:0090575";"cell differentiation [GO:0030154]; drug export [GO:0046618]; exogenous drug catabolic process [GO:0042738]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]";"intermediate filament cytoskeleton [GO:0045111]; nuclear body [GO:0016604]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp869970_c1_seq1;GAXK01055674.1;P15330;1.18E-36;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp869985_c0_seq1;GAXK01055687.1;P63016;2.94E-12;PAX6_RAT;Paired box protein Pax-6 (Oculorhombin);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cellular response to drug [GO:0035690]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to prostaglandin E stimulus [GO:0071380]; central nervous system development [GO:0007417]; cerebellum development [GO:0021549]; epithelial cell development [GO:0002064]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; learned vocalization behavior or vocal learning [GO:0098598]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell death [GO:0010942]; positive regulation of cell fate specification [GO:0042660]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; response to ethanol [GO:0045471]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; sensory neuron migration [GO:1904937]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]";"GO:0000790; GO:0000978; GO:0000981; GO:0001755; GO:0001764; GO:0002064; GO:0003309; GO:0003310; GO:0003322; GO:0003680; GO:0003690; GO:0003700; GO:0005634; GO:0006366; GO:0007417; GO:0007420; GO:0010628; GO:0010942; GO:0010975; GO:0021510; GO:0021549; GO:0021593; GO:0021772; GO:0022027; GO:0030902; GO:0032869; GO:0035690; GO:0042660; GO:0043565; GO:0044344; GO:0045471; GO:0045664; GO:0045893; GO:0048708; GO:0050767; GO:0060041; GO:0061034; GO:0061351; GO:0070094; GO:0071333; GO:0071380; GO:0098598; GO:0120008; GO:1901142; GO:1904798; GO:1904937; GO:2001224";"astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cellular response to drug [GO:0035690]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to prostaglandin E stimulus [GO:0071380]; central nervous system development [GO:0007417]; cerebellum development [GO:0021549]; epithelial cell development [GO:0002064]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; learned vocalization behavior or vocal learning [GO:0098598]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell death [GO:0010942]; positive regulation of cell fate specification [GO:0042660]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; response to ethanol [GO:0045471]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; sensory neuron migration [GO:1904937]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
comp87_c0_seq1;GAXK01169487.1;O95478;2.39E-144;NSA2_HUMAN;Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1);"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005730; GO:0006364; GO:0030687";rRNA processing [GO:0006364];"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]";RNA binding [GO:0003723]
comp8701_c0_seq1;GAXK01014620.1;Q9UPR5;9.02E-30;NAC2_HUMAN;Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2);"basolateral plasma membrane [GO:0016323]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of cardiac conduction [GO:1903779]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; sodium ion transmembrane transport [GO:0035725]";"GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0016323; GO:0035725; GO:0043197; GO:0043204; GO:0046872; GO:0048172; GO:0060291; GO:0070588; GO:1903779";"calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of cardiac conduction [GO:1903779]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; sodium ion transmembrane transport [GO:0035725]";"basolateral plasma membrane [GO:0016323]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";"calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp870106_c0_seq1;GAXK01088599.1;P05656;1.41E-107;SACC_BACSU;Levanase (EC 3.2.1.80) (Beta-D-fructofuranosidase) (Exo-beta-D-fructosidase) (Exo-levanase);"extracellular region [GO:0005576]; beta-fructofuranosidase activity [GO:0004564]; fructan beta-fructosidase activity [GO:0051669]; sucrose alpha-glucosidase activity [GO:0004575]; sucrose catabolic process [GO:0005987]";"GO:0004564; GO:0004575; GO:0005576; GO:0005987; GO:0051669";sucrose catabolic process [GO:0005987];extracellular region [GO:0005576];"beta-fructofuranosidase activity [GO:0004564]; fructan beta-fructosidase activity [GO:0051669]; sucrose alpha-glucosidase activity [GO:0004575]"
comp870141_c0_seq1;GAXK01088643.1;Q86BJ3;1.72E-74;PIPE_DROME;Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005";"dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]";sulfotransferase activity [GO:0008146]
comp87028_c0_seq1;GAXK01202436.1;Q80UN1;7.70E-16;KCTD9_MOUSE;BTB/POZ domain-containing protein KCTD9;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602";"intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]";;"cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]"
comp87029_c2_seq1;GAXK01202288.1;Q9UKU7;0;ACAD8_HUMAN;Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8);"mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]";"GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660";"branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]";mitochondrial matrix [GO:0005759];"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]"
comp870479_c0_seq1;GAXK01088645.1;P10076;4.16E-26;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8705_c2_seq1;GAXK01014684.1;Q8VE97;1.58E-39;SRSF4_MOUSE;Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4);"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"GO:0000381; GO:0002244; GO:0003723; GO:0005634; GO:0016607; GO:0045292; GO:0048025; GO:1990825";"hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]";"nuclear speck [GO:0016607]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]"
comp870528_c0_seq1;GAXK01088569.1;Q9UJU3;1.25E-37;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8706_c0_seq1;GAXK01014175.1;Q7JVR7;1.44E-08;CSN9_DROME;COP9 signalosome complex subunit 9 homolog;"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to UV [GO:0034644]; negative regulation of protein neddylation [GO:2000435]; positive regulation of cell population proliferation [GO:0008284]";"GO:0000790; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0008284; GO:0034644; GO:2000435";"cellular response to UV [GO:0034644]; negative regulation of protein neddylation [GO:2000435]; positive regulation of cell population proliferation [GO:0008284]";"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp870782_c0_seq1;GAXK01088601.1;A7Y7X5;4.58E-08;ZN711_DANRE;Zinc finger protein 711 (Vitelline envelope protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0005634; GO:0005737; GO:0043565; GO:0045893; GO:0046872; GO:0060388";positive regulation of transcription, DNA-templated [GO:0045893];"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]";"metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp870831_c0_seq1;GAXK01088565.1;Q95JP0;2.36E-24;WDR63_MACFA;WD repeat-containing protein 63;;;;;
comp87100_c0_seq1;GAXK01202417.1;Q8JIY1;2.06E-14;ADA10_XENLA;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872";"membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]"
comp871053_c0_seq1;GAXK01088572.1;Q99J59;3.64E-11;TSN1_MOUSE;Tetraspanin-1 (Tspan-1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]";"GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0008283; GO:0016020; GO:0016477; GO:0030054; GO:0031982; GO:0043231; GO:0045807; GO:0048471; GO:0050821";"cell migration [GO:0016477]; cell population proliferation [GO:0008283]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";
comp871083_c0_seq1;GAXK01088597.1;Q9I7U4;3.78E-51;TITIN_DROME;Titin (D-Titin) (Kettin);"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301";"cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]";"condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]";"actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]"
comp871193_c0_seq1;GAXK01088621.1;O46043;2.93E-18;PARG_DROME;Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; Cajal body organization [GO:0030576]; carbohydrate metabolic process [GO:0005975]; chromatin silencing [GO:0006342]; female germ-line stem cell population maintenance [GO:0036099]; maintenance of protein location in nucleus [GO:0051457]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone acetylation [GO:0035065]; regulation of RNA splicing [GO:0043484]; response to heat [GO:0009408]";"GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005975; GO:0006282; GO:0006342; GO:0009225; GO:0009408; GO:0030576; GO:0035065; GO:0036099; GO:0043484; GO:0051457; GO:1990966";"ATP generation from poly-ADP-D-ribose [GO:1990966]; Cajal body organization [GO:0030576]; carbohydrate metabolic process [GO:0005975]; chromatin silencing [GO:0006342]; female germ-line stem cell population maintenance [GO:0036099]; maintenance of protein location in nucleus [GO:0051457]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone acetylation [GO:0035065]; regulation of RNA splicing [GO:0043484]; response to heat [GO:0009408]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";poly(ADP-ribose) glycohydrolase activity [GO:0004649]
comp8712_c0_seq1;GAXK01014052.1;Q9NHD5;7.47E-87;SAN_DROME;Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0016573; GO:0031248; GO:0031415";"histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]";"N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]"
comp87120_c0_seq1;GAXK01201852.1;Q9XZ71;7.44E-81;TNNT_PERAM;Troponin T (TnT);"troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]";"GO:0005861; GO:0006937";regulation of muscle contraction [GO:0006937];troponin complex [GO:0005861];
comp871251_c1_seq1;GAXK01088594.1;Q9D700;1.06E-24;DUS26_MOUSE;Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP3);"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA polymerase II activating transcription factor binding [GO:0001102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; protein dephosphorylation [GO:0006470]";"GO:0000122; GO:0001102; GO:0002039; GO:0004647; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0006470; GO:0008138; GO:0044387; GO:0045785; GO:0070373; GO:1902310";"negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; protein dephosphorylation [GO:0006470]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA polymerase II activating transcription factor binding [GO:0001102]"
comp87139_c2_seq1;GAXK01202279.1;Q5EA49;8.89E-08;MIS12_BOVIN;Protein MIS12 homolog;"MIS12/MIND type complex [GO:0000444]; nuclear MIS12/MIND complex [GO:0000818]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; protein localization to kinetochore [GO:0034501]";"GO:0000070; GO:0000444; GO:0000818; GO:0034501; GO:0051301; GO:0051315; GO:0051382";"attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; protein localization to kinetochore [GO:0034501]";"MIS12/MIND type complex [GO:0000444]; nuclear MIS12/MIND complex [GO:0000818]";
comp8716462_c0_seq1;GAXK01030546.1;Q94HW2;6.66E-16;POLR1_ARATH;"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]";"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]";"GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]";;"aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]"
comp871953_c0_seq1;GAXK01088578.1;O73693;2.65E-20;EGR1_TAEGU;Early growth response protein 1 (EGR-1) (Zinc finger protein ZENK) (Fragment);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein sumoylation [GO:0033233]; response to auditory stimulus [GO:0010996]; transcription by RNA polymerase II [GO:0006366]";"GO:0000976; GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0008270; GO:0010385; GO:0010996; GO:0032922; GO:0033233; GO:0035035; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0070498; GO:0098759; GO:1990841";"cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein sumoylation [GO:0033233]; response to auditory stimulus [GO:0010996]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp872031_c0_seq1;GAXK01083452.1;Q9VZW5;5.50E-20;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp87216_c0_seq1;GAXK01201742.1;Q9W517;3.59E-105;WAPL_DROME;Protein wings apart-like (Protein parallel sister chromatids);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin organization [GO:0006325]; meiotic chromosome segregation [GO:0045132]; mitotic cohesin unloading [GO:0061781]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; sister chromatid cohesion [GO:0007062]";"GO:0005634; GO:0005700; GO:0006325; GO:0007062; GO:0045132; GO:0060623; GO:0061781; GO:0071922";"chromatin organization [GO:0006325]; meiotic chromosome segregation [GO:0045132]; mitotic cohesin unloading [GO:0061781]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; sister chromatid cohesion [GO:0007062]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";
comp87225_c0_seq1;GAXK01202442.1;Q59DX8;6.32E-21;NAA80_DROME;N-alpha-acetyltransferase 80 (DmNAA80) (EC 2.3.1.-);"cytoplasm [GO:0005737]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]";"GO:0004596; GO:0005737; GO:0006473; GO:0008080; GO:0017190; GO:0018002; GO:1905502";"N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]";cytoplasm [GO:0005737];"acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]"
comp872338_c0_seq1;GAXK01083409.1;P10076;2.74E-40;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8724_c1_seq1;GAXK01014709.1;Q21738;9.00E-10;PAXT1_CAEEL;Partner of xrn-2 protein 1;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]";"GO:0005634; GO:0005654; GO:0005730; GO:0006397";mRNA processing [GO:0006397];"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp87245_c0_seq1;GAXK01201618.1;Q8NE00;1.31E-156;TM104_HUMAN;Transmembrane protein 104;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp872598_c0_seq1;GAXK01083410.1;Q9NTW7;1.11E-77;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp872602_c0_seq1;GAXK01083456.1;O88956;3.20E-33;PLPP1_CAVPO;Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidate phosphatase activity [GO:0008195]; lipid metabolic process [GO:0006629]";"GO:0005886; GO:0006629; GO:0008195; GO:0016020; GO:0016021";lipid metabolic process [GO:0006629];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";phosphatidate phosphatase activity [GO:0008195]
comp872753_c0_seq1;GAXK01083402.1;P0DOV5;3.38E-16;SQD_PSEPU;Sulfoquinovose 1-dehydrogenase (SQ dehydrogenase) (EC 1.1.1.390);oxidoreductase activity [GO:0016491];GO:0016491;;;oxidoreductase activity [GO:0016491]
comp872770_c0_seq1;GAXK01083429.1;P13582;1.07E-20;EAST_DROME;Serine protease easter (EC 3.4.21.-);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; perivitelline space [GO:0098595]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; Toll signaling pathway [GO:0008063]; ventral furrow formation [GO:0007370]";"GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007311; GO:0007370; GO:0008063; GO:0009950; GO:0009953; GO:0045752; GO:0046872; GO:0098595";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; maternal specification of dorsal/ventral axis, oocyte, germ-line encoded [GO:0007311]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]; Toll signaling pathway [GO:0008063]; ventral furrow formation [GO:0007370]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; perivitelline space [GO:0098595]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp872785_c0_seq1;GAXK01083427.1;Q91VC9;1.66E-22;GHITM_MOUSE;Growth hormone-inducible transmembrane protein (Mitochondrial morphology and cristae structure 1) (MICS1);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]";"GO:0005739; GO:0005743; GO:0006915; GO:0016021";apoptotic process [GO:0006915];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";
comp87280_c0_seq1;GAXK01201906.1;Q3UMM4;7.26E-180;CDK10_MOUSE;Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10);"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]";"GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:1902018";"cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]"
comp872812_c0_seq1;GAXK01083397.1;Q7Z6K4;7.27E-07;NRARP_HUMAN;Notch-regulated ankyrin repeat-containing protein;"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";"GO:0000122; GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:1902367";"blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; somite rostral/caudal axis specification [GO:0032525]";;
comp87285_c1_seq1;GAXK01201637.1;Q9KS29;2.26E-39;TTCA_VIBCH;tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA thio-modification [GO:0034227]";"GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539";tRNA thio-modification [GO:0034227];cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]"
comp872898_c0_seq1;GAXK01083401.1;Q6IDD9;3.24E-38;SARM1_DROME;Sterile alpha and TIR motif-containing protein 1 (Tir-1 homolog) (dSarm);"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214";"innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]";"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]";signaling adaptor activity [GO:0035591]
comp872908_c0_seq1;GAXK01083439.1;P89116;4.43E-21;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp872974_c0_seq1;GAXK01083403.1;Q29013;3.28E-19;PO2F2_PIG;POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2) (Oct-2) (Octamer-binding transcription factor 2) (OTF-2);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]";"GO:0003700; GO:0005634; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp873011_c0_seq1;GAXK01083455.1;Q09506;1.09E-34;YQI7_CAEEL;Uncharacterized protein C45G9.7;;;;;
comp87304_c1_seq1;GAXK01206005.1;P70711;1.95E-42;U2D2B_RAT;Ubiquitin-conjugating enzyme E2 D2B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D2B) (Ubiquitin carrier protein D2B) (Ubiquitin-conjugating enzyme E2(17)KB 2B) (Ubiquitin-conjugating enzyme E2-17 kDa 2B) (Ubiquitin-protein ligase D2B);"ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to arsenite(3-) [GO:1903841]; cellular response to cadmium ion [GO:0071276]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0005524; GO:0006511; GO:0031625; GO:0061631; GO:0070936; GO:0070979; GO:0071276; GO:1903841";"cellular response to arsenite(3-) [GO:1903841]; cellular response to cadmium ion [GO:0071276]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]";ubiquitin ligase complex [GO:0000151];"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]"
comp8730546_c0_seq1;GAXK01079872.1;P24577;7.46E-23;YI71_BURM1;Insertion element IS407 uncharacterized 31.7 kDa protein (ORF1);"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]";"GO:0003676; GO:0015074";DNA integration [GO:0015074];;nucleic acid binding [GO:0003676]
comp873128_c0_seq1;GAXK01083424.1;P35675;2.66E-12;YGAE_ERWAM;Uncharacterized protein in galE 3'region (Fragment);;;;;
comp8731282_c0_seq1;GAXK01079881.1;E9PYY5;8.37E-18;WDR78_MOUSE;WD repeat-containing protein 78;"axonemal dynein complex [GO:0005858]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018]";"GO:0002244; GO:0003341; GO:0005858; GO:0007018; GO:0045503; GO:0045504";"cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018]";axonemal dynein complex [GO:0005858];"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]"
comp8731345_c0_seq1;GAXK01079883.1;Q54F46;7.42E-07;WARA_DICDI;Homeobox protein Wariai (Homeobox protein 1) (DdHbx-1);"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; negative regulation of sorocarp stalk cell differentiation [GO:0031286]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0007275; GO:0009653; GO:0031286; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; multicellular organism development [GO:0007275]; negative regulation of sorocarp stalk cell differentiation [GO:0031286]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];sequence-specific DNA binding [GO:0043565]
comp8731953_c0_seq1;GAXK01079873.1;B1Y3P5;1.20E-42;FPG_LEPCP;Formamidopyrimidine-DNA glycosylase (Fapy-DNA glycosylase) (EC 3.2.2.23) (DNA-(apurinic or apyrimidinic site) lyase MutM) (AP lyase MutM) (EC 4.2.99.18);"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";"GO:0003684; GO:0006284; GO:0006289; GO:0008270; GO:0008534; GO:0140078";"base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]";;"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; zinc ion binding [GO:0008270]"
comp873201_c0_seq1;GAXK01083428.1;Q4V8A1;3.59E-42;PCT2B_RAT;Lysophosphatidylcholine acyltransferase 2B (EC 2.3.1.-) (Acyltransferase-like 1-B);"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]";"GO:0005509; GO:0008654; GO:0016021; GO:0016746";phospholipid biosynthetic process [GO:0008654];integral component of membrane [GO:0016021];"calcium ion binding [GO:0005509]; transferase activity, transferring acyl groups [GO:0016746]"
comp8733475_c0_seq1;GAXK01089883.1;Q9M888;1.05E-48;TCPZA_ARATH;T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A);"chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]";"GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0046686; GO:0051082";"protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]";"chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp87339_c1_seq1;GAXK01202450.1;O75694;9.81E-148;NU155_HUMAN;Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155);"host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"GO:0000972; GO:0005635; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034";"atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]";"host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]";structural constituent of nuclear pore [GO:0017056]
comp8734_c0_seq1;GAXK01013949.1;P54397;2.57E-38;FKB39_DROME;39 kDa FK506-binding nuclear protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase);"heterochromatin [GO:0000792]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; juvenile hormone response element binding [GO:0070594]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; juvenile hormone mediated signaling pathway [GO:0035626]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]";"GO:0000792; GO:0003755; GO:0005528; GO:0005634; GO:0010507; GO:0016242; GO:0035626; GO:0070594";"juvenile hormone mediated signaling pathway [GO:0035626]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]";"heterochromatin [GO:0000792]; nucleus [GO:0005634]";"FK506 binding [GO:0005528]; juvenile hormone response element binding [GO:0070594]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp87341_c1_seq1;GAXK01202292.1;Q5M7W7;3.48E-124;SYPM_RAT;Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]";"GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433";prolyl-tRNA aminoacylation [GO:0006433];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]"
comp87348_c5_seq1;GAXK01202213.1;Q8N0N3;6.18E-61;BGBP_PENMO;Beta-1,3-glucan-binding protein (GBP);"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";"GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087";"carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]";extracellular region [GO:0005576];"(1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"
comp8735969_c0_seq1;GAXK01197501.1;P15112;9.63E-80;EF2_DICDI;Elongation factor 2 (EF-2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006414; GO:0009617; GO:0030587; GO:0031012; GO:0043022; GO:0045335; GO:1990904";"response to bacterium [GO:0009617]; sorocarp development [GO:0030587]; translational elongation [GO:0006414]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; ribonucleoprotein complex [GO:1990904]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp87365_c0_seq1;GAXK01201923.1;Q6RUV5;9.35E-101;RAC1_RAT;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1);"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0006935; GO:0007015; GO:0007266; GO:0008045; GO:0008283; GO:0008361; GO:0010592; GO:0016020; GO:0016477; GO:0016601; GO:0017137; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030334; GO:0031116; GO:0031410; GO:0031996; GO:0032587; GO:0032707; GO:0034446; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048012; GO:0048870; GO:0051022; GO:0051117; GO:0051496; GO:0051668; GO:0051894; GO:0055038; GO:0060263; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098978; GO:1900026; GO:1902622";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"ATPase binding [GO:0051117]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]"
comp8737_c0_seq1;GAXK01013436.1;Q5U4Z8;1.55E-11;RM20_XENLA;39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20);"mitochondrial large ribosomal subunit [GO:0005762]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005762; GO:0006412; GO:0019843";translation [GO:0006412];mitochondrial large ribosomal subunit [GO:0005762];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp87371_c0_seq1;GAXK01201576.1;Q9Y0H4;0;SUDX_DROME;E3 ubiquitin-protein ligase Su(dx) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Su(dx)) (Protein suppressor of deltex);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; WW domain binding [GO:0050699]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000209; GO:0004842; GO:0005112; GO:0005737; GO:0005938; GO:0006511; GO:0007219; GO:0008586; GO:0008587; GO:0016348; GO:0016567; GO:0019915; GO:0031623; GO:0032880; GO:0035209; GO:0043161; GO:0045732; GO:0045746; GO:0045879; GO:0048190; GO:0050699; GO:0061630";"imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]";"Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; WW domain binding [GO:0050699]"
comp8737114_c0_seq1;GAXK01069229.1;P59815;1.39E-33;RLUB_SHIFL;Ribosomal large subunit pseudouridine synthase B (EC 5.4.99.22) (23S rRNA pseudouridine(2605) synthase) (rRNA pseudouridylate synthase B) (rRNA-uridine isomerase B);"RNA binding [GO:0003723]; rRNA pseudouridine synthase activity [GO:0120159]; pseudouridine synthesis [GO:0001522]; rRNA processing [GO:0006364]";"GO:0001522; GO:0003723; GO:0006364; GO:0120159";"pseudouridine synthesis [GO:0001522]; rRNA processing [GO:0006364]";;"RNA binding [GO:0003723]; rRNA pseudouridine synthase activity [GO:0120159]"
comp873774_c1_seq1;GAXK01083434.1;Q05481;1.96E-29;ZNF91_HUMAN;Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";"GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895";"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]"
comp8738206_c0_seq1;GAXK01063394.1;Q9ULH0;1.77E-16;KDIS_HUMAN;Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090";"activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]";"PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]"
comp873892_c0_seq1;GAXK01083446.1;Q8IRC7;2.23E-08;AWH_DROME;LIM/homeobox protein Awh (Protein arrowhead);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007444; GO:0010468; GO:0030182; GO:0045944; GO:0046872; GO:0048749";"compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp873904_c1_seq1;GAXK01083414.1;O46040;2.81E-21;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp873985_c0_seq1;GAXK01083408.1;Q7T2H2;2.60E-10;FGRL1_CHICK;Fibroblast growth factor receptor-like 1;"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030133; GO:0044291; GO:0051260; GO:0060412; GO:0098742";"cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]";"cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]"
comp874056_c0_seq1;GAXK01205648.1;Q9V5L3;6.27E-86;C49A1_DROME;Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016491; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp8741_c1_seq1;GAXK01013631.1;P86704;1.67E-19;TPM_PANBO;Tropomyosin (allergen Pan b 1);;;;;
comp874130_c1_seq1;GAXK01127974.1;Q9VUL9;2.19E-147;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp874246_c0_seq1;GAXK01127969.1;Q4VSI4;2.62E-81;UBP7_RAT;Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (rHAUSP) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription factor binding [GO:0008134]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006283; GO:0006511; GO:0007275; GO:0008134; GO:0010216; GO:0016579; GO:0016605; GO:0031647; GO:0035616; GO:0042752; GO:0042803; GO:0043065; GO:0048511; GO:0050821; GO:0051090; GO:0101005; GO:1901537; GO:1990380";"histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]";"cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; protein homodimerization activity [GO:0042803]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription factor binding [GO:0008134]; ubiquitinyl hydrolase activity [GO:0101005]"
comp8742530_c0_seq1;GAXK01180681.1;P54744;9.27E-28;PKNB_MYCLE;Serine/threonine-protein kinase PknB (EC 2.7.11.1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0005886; GO:0016021; GO:0046872";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]"
comp8742664_c0_seq1;GAXK01180684.1;P23847;4.12E-26;DPPA_ECOLI;Periplasmic dipeptide transport protein (Dipeptide-binding protein) (DBP);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288]; dipeptide transmembrane transporter activity [GO:0071916]; heme binding [GO:0020037]; peptide binding [GO:0042277]; chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"GO:0006935; GO:0015031; GO:0020037; GO:0030288; GO:0042277; GO:0042938; GO:0043190; GO:0061077; GO:0071916";"chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288]";"dipeptide transmembrane transporter activity [GO:0071916]; heme binding [GO:0020037]; peptide binding [GO:0042277]"
comp87440_c0_seq1;GAXK01201826.1;Q99973;1.03E-135;TEP1_HUMAN;Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904";telomere maintenance via recombination [GO:0000722];"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]";"ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]"
comp874495_c0_seq1;GAXK01127947.1;P83088;2.03E-43;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp8745192_c0_seq1;GAXK01009734.1;A2SG87;7.56E-86;RIMO_METPP;Ribosomal protein S12 methylthiotransferase RimO (S12 MTTase) (S12 methylthiotransferase) (EC 2.8.4.4) (Ribosomal protein S12 (aspartate-C(3))-methylthiotransferase) (Ribosome maturation factor RimO);"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; protein methylthiotransferase activity [GO:0103039]; peptidyl-L-beta-methylthioaspartic acid biosynthetic process from peptidyl-aspartic acid [GO:0018339]; tRNA modification [GO:0006400]";"GO:0005737; GO:0006400; GO:0018339; GO:0046872; GO:0051539; GO:0103039";"peptidyl-L-beta-methylthioaspartic acid biosynthetic process from peptidyl-aspartic acid [GO:0018339]; tRNA modification [GO:0006400]";cytoplasm [GO:0005737];"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; protein methylthiotransferase activity [GO:0103039]"
comp8745811_c0_seq1;GAXK01009733.1;P00582;1.14E-69;DPO1_ECOLI;DNA polymerase I (POL I) (EC 2.7.7.7);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]";"GO:0003677; GO:0003887; GO:0005737; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006284; GO:0008408; GO:0008409";"base-excision repair [GO:0006284]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]";"3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]"
comp8747756_c0_seq1;GAXK01062363.1;Q9JP92;5.78E-26;SURE_RUBGI;5'-nucleotidase SurE (EC 3.1.3.5) (Nucleoside 5'-monophosphate phosphohydrolase);"cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]";"GO:0000166; GO:0005737; GO:0008253; GO:0046872";;cytoplasm [GO:0005737];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp8748408_c0_seq1;GAXK01204913.1;Q8XZ28;2.24E-11;IF3_RALSO;Translation initiation factor IF-3;"cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0005737";;cytoplasm [GO:0005737];translation initiation factor activity [GO:0003743]
comp8748644_c0_seq1;GAXK01179898.1;Q3IPX0;1.32E-07;DNLI_NATPD;DNA ligase (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP]);"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";"GO:0003677; GO:0003910; GO:0005524; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]"
comp8749735_c0_seq1;GAXK01179889.1;P77338;2.43E-12;MSCK_ECOLI;Mechanosensitive channel MscK (Potassium efflux system KefA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular water homeostasis [GO:0009992]; potassium ion transport [GO:0006813]; transmembrane transport [GO:0055085]";"GO:0005886; GO:0006813; GO:0009992; GO:0016021; GO:0055085";"cellular water homeostasis [GO:0009992]; potassium ion transport [GO:0006813]; transmembrane transport [GO:0055085]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp875080_c0_seq1;GAXK01127927.1;P33727;5.64E-97;ARSB_FELCA;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);"cell surface [GO:0009986]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"GO:0003943; GO:0005764; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580";"colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]";"cell surface [GO:0009986]; lysosome [GO:0005764]";"metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]"
comp8751562_c0_seq1;GAXK01001891.1;Q9SGA6;1.16E-49;RS191_ARATH;40S ribosomal protein S19-1;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003735; GO:0005618; GO:0005829; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";"ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";structural constituent of ribosome [GO:0003735]
comp8752_c0_seq1;GAXK01013517.1;P21797;4.51E-39;TNNC1_BALNU;Troponin C, isoform 1;calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp87535_c0_seq1;GAXK01202290.1;P15372;5.62E-136;ARRA_DROME;Phosrestin-2 (Arrestin-1) (Arrestin-A) (Phosrestin II);"cytoplasm [GO:0005737]; rhabdomere [GO:0016028]; G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; deactivation of rhodopsin mediated signaling [GO:0016059]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; metarhodopsin inactivation [GO:0016060]; photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0001664; GO:0002031; GO:0002032; GO:0002046; GO:0005737; GO:0006897; GO:0007165; GO:0007601; GO:0007608; GO:0016028; GO:0016059; GO:0016060; GO:0045494";"deactivation of rhodopsin mediated signaling [GO:0016059]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; metarhodopsin inactivation [GO:0016060]; photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cytoplasm [GO:0005737]; rhabdomere [GO:0016028]";"G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]"
comp875372_c0_seq1;GAXK01127960.1;P00748;3.20E-45;FA12_HUMAN;"Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2)]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]";"GO:0002353; GO:0002542; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005791; GO:0005886; GO:0006508; GO:0007597; GO:0010756; GO:0016485; GO:0016540; GO:0030194; GO:0031638; GO:0042730; GO:0045087; GO:0051787; GO:0051788; GO:0051919; GO:0062023; GO:0070062";"blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]";"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]";"calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]"
comp8753748_c0_seq1;GAXK01180444.1;P0ACR6;1.42E-15;YEIE_ECO57;Uncharacterized HTH-type transcriptional regulator YeiE;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700";;;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp875394_c0_seq1;GAXK01127936.1;Q5ZLG9;8.13E-138;WDR59_CHICK;GATOR complex protein WDR59;"GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"GO:0005765; GO:0032008; GO:0034198; GO:0061700";"cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]";"GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]";
comp8754536_c0_seq1;GAXK01024705.1;P55037;1.75E-75;GLTB_SYNY3;Ferredoxin-dependent glutamate synthase 1 (EC 1.4.7.1) (Fd-GOGAT);"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; metal ion binding [GO:0046872]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";"GO:0006537; GO:0016041; GO:0019676; GO:0046872; GO:0051538; GO:0097054";"ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";;"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; metal ion binding [GO:0046872]"
comp87548_c2_seq1;GAXK01202480.1;Q6DFF9;0;MABP1_XENLA;Mitogen-activated protein kinase-binding protein 1;;;;;
comp8754959_c0_seq1;GAXK01024707.1;P19824;6.88E-29;KPPR_CHLRE;Phosphoribulokinase, chloroplastic (PRK) (PRKase) (EC 2.7.1.19) (Phosphopentokinase);"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]; stromule [GO:0010319]; supramolecular complex [GO:0099080]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; phosphoribulokinase activity [GO:0008974]; protein homodimerization activity [GO:0042803]; defense response to bacterium [GO:0042742]; reductive pentose-phosphate cycle [GO:0019253]; response to cold [GO:0009409]";"GO:0005524; GO:0008974; GO:0009409; GO:0009507; GO:0009535; GO:0009570; GO:0009941; GO:0010319; GO:0019253; GO:0019899; GO:0042742; GO:0042803; GO:0048046; GO:0097718; GO:0099080";"defense response to bacterium [GO:0042742]; reductive pentose-phosphate cycle [GO:0019253]; response to cold [GO:0009409]";"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]; stromule [GO:0010319]; supramolecular complex [GO:0099080]";"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; phosphoribulokinase activity [GO:0008974]; protein homodimerization activity [GO:0042803]"
comp875507_c0_seq1;GAXK01127940.1;Q3SZK8;2.04E-20;NHRF1_BOVIN;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0003096; GO:0005737; GO:0005902; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0043621; GO:0044062; GO:0045198; GO:0045859; GO:0045930; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0060088; GO:0060090; GO:0060158; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0097225; GO:0097291; GO:2000146; GO:2001244";"actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]";"beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]"
comp875523_c0_seq1;GAXK01127961.1;Q1H9T6;2.77E-28;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp875548_c0_seq1;GAXK01127922.1;P25304;1.13E-73;AGRIN_RAT;"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"GO:0001932; GO:0001934; GO:0002162; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0007268; GO:0007411; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030054; GO:0031012; GO:0033691; GO:0035374; GO:0036122; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0045202; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0070507; GO:0071340; GO:0098978; GO:1902667";"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]";"axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]";"BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]"
comp8756_c2_seq1;GAXK01013508.1;Q7ZVK3;2.53E-113;SIR2_DANRE;NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2);"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]";"GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777";"cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]";"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]";"histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]"
comp875610_c1_seq1;GAXK01127916.1;O74467;2.88E-16;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp875635_c1_seq1;GAXK01127967.1;Q920M9;1.03E-12;SIAH1_RAT;E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a);"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244";"cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]";"beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]";"disordered domain specific binding [GO:0097718]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp8756379_c0_seq1;GAXK01197201.1;P49362;4.07E-35;GCSPB_FLAPR;Glycine dehydrogenase (decarboxylating) B, mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein B) (Glycine decarboxylase B) (Glycine dehydrogenase (aminomethyl-transferring) B);"mitochondrion [GO:0005739]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; glycine catabolic process [GO:0006546]";"GO:0004375; GO:0005739; GO:0006546";glycine catabolic process [GO:0006546];mitochondrion [GO:0005739];glycine dehydrogenase (decarboxylating) activity [GO:0004375]
comp8757657_c0_seq1;GAXK01197198.1;A8GHR1;4.39E-37;MDTD_SERP5;Putative multidrug resistance protein MdtD;"integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]";"GO:0005887; GO:0022857";;integral component of plasma membrane [GO:0005887];transmembrane transporter activity [GO:0022857]
comp8759442_c0_seq1;GAXK01186709.1;P77806;4.22E-43;YBDL_ECOLI;Methionine aminotransferase (EC 2.6.1.88) (Methionine-oxo-acid transaminase);"cytoplasm [GO:0005737]; methionine-oxo-acid transaminase activity [GO:0010326]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]";"GO:0005737; GO:0009058; GO:0010326; GO:0030170";biosynthetic process [GO:0009058];cytoplasm [GO:0005737];"methionine-oxo-acid transaminase activity [GO:0010326]; pyridoxal phosphate binding [GO:0030170]"
comp8759623_c0_seq1;GAXK01186710.1;P10718;1.16E-15;RCEM_RHORU;Reaction center protein M chain (Photosynthetic reaction center M subunit);"integral component of membrane [GO:0016021]; plasma membrane light-harvesting complex [GO:0030077]; plasma membrane-derived chromatophore membrane [GO:0042717]; bacteriochlorophyll binding [GO:0042314]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]; metal ion binding [GO:0046872]; photosynthetic electron transport in photosystem II [GO:0009772]; protein-chromophore linkage [GO:0018298]";"GO:0009772; GO:0016021; GO:0018298; GO:0030077; GO:0042314; GO:0042717; GO:0045156; GO:0046872";"photosynthetic electron transport in photosystem II [GO:0009772]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane-derived chromatophore membrane [GO:0042717]; plasma membrane light-harvesting complex [GO:0030077]";"bacteriochlorophyll binding [GO:0042314]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]; metal ion binding [GO:0046872]"
comp8760028_c0_seq1;GAXK01137142.1;A4WFX7;2.39E-12;UBID_ENT38;3-octaprenyl-4-hydroxybenzoate carboxy-lyase (EC 4.1.1.98) (Polyprenyl p-hydroxybenzoate decarboxylase);"plasma membrane [GO:0005886]; 3-octaprenyl-4-hydroxybenzoate carboxy-lyase activity [GO:0008694]; metal ion binding [GO:0046872]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005886; GO:0006744; GO:0008694; GO:0046872";ubiquinone biosynthetic process [GO:0006744];plasma membrane [GO:0005886];"3-octaprenyl-4-hydroxybenzoate carboxy-lyase activity [GO:0008694]; metal ion binding [GO:0046872]"
comp8760569_c0_seq1;GAXK01137150.1;A5U6W6;3.70E-29;GLTR2_MYCTA;PGL/p-HBAD biosynthesis glycosyltransferase MRA_2985 (EC 2.4.1.-);transferase activity, transferring hexosyl groups [GO:0016758];GO:0016758;;;transferase activity, transferring hexosyl groups [GO:0016758]
comp87607_c0_seq1;GAXK01206003.1;Q5RJU3;3.27E-23;CC103_XENTR;Coiled-coil domain-containing protein 103;"extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; inner dynein arm assembly [GO:0036159]";"GO:0003351; GO:0005576; GO:0007368; GO:0031514; GO:0036157; GO:0036159";"determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; inner dynein arm assembly [GO:0036159]";"extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]";
comp8760717_c0_seq1;GAXK01137147.1;Q8NKF4;9.21E-36;RL3_ASPFU;60S ribosomal protein L3 (allergen Asp f 23);"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003735; GO:0006412; GO:0022625";"ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp8761390_c0_seq1;GAXK01137148.1;Q44586;2.31E-14;NCCA_ALCXX;Nickel-cobalt-cadmium resistance protein NccA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; response to cadmium ion [GO:0046686]";"GO:0005886; GO:0008324; GO:0016021; GO:0046686";response to cadmium ion [GO:0046686];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp8761571_c0_seq1;GAXK01137144.1;Q5GCA5;1.24E-75;CCOP_RUBGE;Cbb3-type cytochrome c oxidase subunit CcoP (Cbb3-Cox subunit CcoP) (C-type cytochrome CcoP) (Cyt c(P)) (Cytochrome c oxidase subunit III);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; ion transport [GO:0006811]; oxidative phosphorylation [GO:0006119]";"GO:0005506; GO:0005886; GO:0006119; GO:0006811; GO:0009055; GO:0016021; GO:0020037; GO:0070469";"ion transport [GO:0006811]; oxidative phosphorylation [GO:0006119]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; respirasome [GO:0070469]";"electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"
comp8761874_c0_seq1;GAXK01137149.1;A2SE03;1.95E-38;HIS1_METPP;ATP phosphoribosyltransferase (ATP-PRT) (ATP-PRTase) (EC 2.4.2.17);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]; histidine biosynthetic process [GO:0000105]";"GO:0000105; GO:0003879; GO:0005524; GO:0005737";histidine biosynthetic process [GO:0000105];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]"
comp87634_c0_seq1;GAXK01202424.1;P10077;1.38E-24;ZFP27_MOUSE;Zinc finger protein 27 (Zfp-27) (Protein mKR4);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8764_c1_seq1;GAXK01013930.1;Q6CTH3;3.67E-17;TCTP_KLULA;Translationally-controlled tumor protein homolog (TCTP);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; cellular response to oxidative stress [GO:0034599]; cytoplasmic translation [GO:0002181]; negative regulation of microtubule depolymerization [GO:0007026]";"GO:0002181; GO:0005739; GO:0005829; GO:0005874; GO:0007026; GO:0010494; GO:0034599";"cellular response to oxidative stress [GO:0034599]; cytoplasmic translation [GO:0002181]; negative regulation of microtubule depolymerization [GO:0007026]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]";
comp8766421_c0_seq1;GAXK01003098.1;Q9AFF7;6.41E-36;PRRB_PRB02;Blue-light absorbing proteorhodopsin (BPR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005886; GO:0007602; GO:0009881; GO:0010461; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"light-activated ion channel activity [GO:0010461]; photoreceptor activity [GO:0009881]"
comp87665_c0_seq1;GAXK01202443.1;Q05319;1.60E-43;STUB_DROME;"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017";"actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";serine-type endopeptidase activity [GO:0004252]
comp87666_c0_seq1;GAXK01201784.1;P19222;1.31E-84;CBPA2_RAT;Carboxypeptidase A2 (EC 3.4.17.15);"extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]";"GO:0004181; GO:0005615; GO:0006508; GO:0008270";proteolysis [GO:0006508];extracellular space [GO:0005615];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp8766869_c0_seq1;GAXK01003104.1;A2SCE2;2.39E-48;PROA_METPP;Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase) (GSA dehydrogenase);"cytoplasm [GO:0005737]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; NADP binding [GO:0050661]; L-proline biosynthetic process [GO:0055129]";"GO:0004350; GO:0005737; GO:0050661; GO:0055129";L-proline biosynthetic process [GO:0055129];cytoplasm [GO:0005737];"glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; NADP binding [GO:0050661]"
comp8767133_c0_seq1;GAXK01003108.1;Q55DV9;3.02E-47;CGL_DICDI;Cystathionine gamma-lyase (EC 4.4.1.1) (Gamma-cystathionase);"cytoplasm [GO:0005737]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; transsulfuration [GO:0019346]";"GO:0004123; GO:0005737; GO:0006534; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146";"cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; transsulfuration [GO:0019346]";cytoplasm [GO:0005737];"carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]"
comp87673_c0_seq1;GAXK01201783.1;Q5RJV0;1.23E-26;COQ9_XENTR;Ubiquinone biosynthesis protein COQ9, mitochondrial;"mitochondrial inner membrane [GO:0005743]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; ubiquinone biosynthetic process [GO:0006744]";"GO:0005743; GO:0006744; GO:0008289; GO:0042803";ubiquinone biosynthetic process [GO:0006744];mitochondrial inner membrane [GO:0005743];"lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]"
comp8767608_c0_seq1;GAXK01003105.1;O50655;2.02E-09;XERD_SELRU;Integrase/recombinase xerD homolog;"DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";"GO:0003677; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0075713";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]";;DNA binding [GO:0003677]
comp876763_c2_seq1;GAXK01069373.1;A0ZSK4;1.04E-09;STXB_SYNVE;Neoverrucotoxin subunit beta (NeoVTX subunit beta);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp876898_c0_seq1;GAXK01069415.1;Q6D7C2;4.74E-15;6PGL_PECAS;6-phosphogluconolactonase (6-P-gluconolactonase) (EC 3.1.1.31);"6-phosphogluconolactonase activity [GO:0017057]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";"GO:0006006; GO:0006098; GO:0017057";"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]";;6-phosphogluconolactonase activity [GO:0017057]
comp8769273_c0_seq1;GAXK01061927.1;Q8MZS4;7.53E-19;PHYSA_PHYPO;"Physarolisin (EC 3.4.21.103) (Physaropepsin) [Cleaved into: Physarolisin heavy chain; Physarolisin light chain]";"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0046872";;;"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp87700_c0_seq1;GAXK01202206.1;Q08D64;0;ABCB6_XENTR;ATP-binding cassette sub-family B member 6, mitochondrial;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]";"GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0016887; GO:0042626";;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp877143_c0_seq1;GAXK01069424.1;Q8K2J9;6.03E-15;BTBD6_MOUSE;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp87733_c0_seq1;GAXK01202418.1;Q8IN81;2.04E-21;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp87735_c4_seq1;GAXK01202319.1;Q5FVC7;2.48E-120;ACAP2_RAT;Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2);"endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]";"GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090";"cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]";endosome membrane [GO:0010008];"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
comp8774793_c0_seq1;GAXK01048368.1;A1VRB4;3.94E-52;SYC_POLNA;Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; zinc ion binding [GO:0008270]; cysteinyl-tRNA aminoacylation [GO:0006423]";"GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0008270";cysteinyl-tRNA aminoacylation [GO:0006423];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; zinc ion binding [GO:0008270]"
comp8775752_c0_seq1;GAXK01048371.1;Q9JU03;8.90E-43;SUHB_NEIMA;Inositol-1-monophosphatase (I-1-Pase) (IMPase) (Inositol-1-phosphatase) (EC 3.1.3.25);"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]";"GO:0008934; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833";"inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]";;"inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]"
comp8776535_c0_seq1;GAXK01179698.1;Q28I38;1.13E-14;DJB14_XENTR;DnaJ homolog subfamily B member 14;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005783; GO:0005789; GO:0016021; GO:0030433; GO:0030544; GO:0034622; GO:0051085; GO:0071218";"cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";Hsp70 protein binding [GO:0030544]
comp8777491_c0_seq1;GAXK01179694.1;Q42971;7.72E-28;ENO_ORYSJ;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase) (OSE1);"phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0006096";glycolytic process [GO:0006096];phosphopyruvate hydratase complex [GO:0000015];"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp877760_c0_seq1;GAXK01069419.1;Q6P2X9;2.27E-17;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp87779_c1_seq1;GAXK01202492.1;P35037;4.21E-32;TRY3_ANOGA;Trypsin-3 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp87784_c1_seq1;GAXK01201804.1;Q96KG9;0;SCYL1_HUMAN;N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase);"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0016020; GO:0030126; GO:0045296";retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890];"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]"
comp8779208_c0_seq1;GAXK01170626.1;Q9LUQ6;3.48E-25;RL192_ARATH;60S ribosomal protein L19-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp8779685_c0_seq1;GAXK01170627.1;B0KSA5;1.24E-16;DXR_PSEPG;1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXP reductoisomerase) (EC 1.1.1.267) (1-deoxyxylulose-5-phosphate reductoisomerase) (2-C-methyl-D-erythritol 4-phosphate synthase);"1-deoxy-D-xylulose-5-phosphate reductoisomerase activity [GO:0030604]; metal ion binding [GO:0046872]; NADPH binding [GO:0070402]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]";"GO:0016114; GO:0019288; GO:0030604; GO:0046872; GO:0070402";"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]";;"1-deoxy-D-xylulose-5-phosphate reductoisomerase activity [GO:0030604]; metal ion binding [GO:0046872]; NADPH binding [GO:0070402]"
comp877997_c0_seq1;GAXK01069376.1;Q2T9K2;2.51E-109;AP2E_XENLA;Transcription factor AP-2-epsilon (AP-2-epsilon);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700; GO:0005634";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp878074_c1_seq1;GAXK01139428.1;Q8SWR2;6.08E-19;BICRD_DROME;Bicaudal D-related protein homolog (BICD-related protein homolog);;;;;
comp87808_c0_seq1;GAXK01201904.1;Q9UGQ2;3.76E-28;FLOWR_HUMAN;Calcium channel flower homolog (Calcium channel flower domain-containing protein 1);"integral component of membrane [GO:0016021]; vesicle-mediated transport [GO:0016192]";"GO:0016021; GO:0016192";vesicle-mediated transport [GO:0016192];integral component of membrane [GO:0016021];
comp8780814_c0_seq1;GAXK01140113.1;O48557;2.97E-43;RL17_MAIZE;60S ribosomal protein L17;"cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];structural constituent of ribosome [GO:0003735]
comp8782_c2_seq1;GAXK01013346.1;O88544;0;CSN4_MOUSE;COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4);"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]";"GO:0000338; GO:0005829; GO:0008021; GO:0008180; GO:0016607; GO:0030054";protein deneddylation [GO:0000338];"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]";
comp87829_c1_seq1;GAXK01202273.1;Q28D84;5.07E-88;EZH2_XENTR;Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.43) (Enhancer of zeste homolog 2);"ESC/E(Z) complex [GO:0035098]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; negative regulation of gene expression, epigenetic [GO:0045814]; rhythmic process [GO:0048511]";"GO:0018024; GO:0035098; GO:0045814; GO:0048511; GO:1990841";"negative regulation of gene expression, epigenetic [GO:0045814]; rhythmic process [GO:0048511]";ESC/E(Z) complex [GO:0035098];"histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]"
comp878305_c0_seq1;GAXK01139406.1;E7EYQ9;9.85E-21;TM216_DANRE;Transmembrane protein 216;"ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]";"GO:0005737; GO:0005856; GO:0016021; GO:0035869; GO:0060271; GO:1905515";"cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]";"ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]";
comp878308_c1_seq1;GAXK01139431.1;P35917;1.52E-44;VGFR3_MOUSE;Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4);"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]";"GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007585; GO:0008284; GO:0010575; GO:0010595; GO:0014068; GO:0018108; GO:0019838; GO:0019903; GO:0030307; GO:0035924; GO:0036328; GO:0038084; GO:0038085; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037";"blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]";"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]; VEGF-C-activated receptor activity [GO:0036328]"
comp8783355_c0_seq1;GAXK01061635.1;F4KIB2;1.48E-15;TMN8_ARATH;Transmembrane 9 superfamily member 8 (Endomembrane protein 1) (Transmembrane nine protein 8) (AtTMN8);"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type cell wall [GO:0009505]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]; protein localization to membrane [GO:0072657]";"GO:0000139; GO:0005768; GO:0005774; GO:0005794; GO:0005802; GO:0009505; GO:0010008; GO:0016020; GO:0016021; GO:0072657";protein localization to membrane [GO:0072657];"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type cell wall [GO:0009505]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]";
comp8784_c0_seq1;GAXK01013278.1;C4N147;5.55E-28;FABP1_DORPE;Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1);"cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]";"GO:0005737; GO:0008289; GO:0016020";;"cytoplasm [GO:0005737]; membrane [GO:0016020]";lipid binding [GO:0008289]
comp8784564_c0_seq1;GAXK01109578.1;Q12DU4;8.38E-17;UREE_POLSJ;Urease accessory protein UreE;"cytoplasm [GO:0005737]; nickel cation binding [GO:0016151]; unfolded protein binding [GO:0051082]; enzyme active site formation [GO:0018307]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003]; urea metabolic process [GO:0019627]";"GO:0005737; GO:0006457; GO:0016151; GO:0018307; GO:0019627; GO:0051082; GO:0065003";"enzyme active site formation [GO:0018307]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; urea metabolic process [GO:0019627]";cytoplasm [GO:0005737];"nickel cation binding [GO:0016151]; unfolded protein binding [GO:0051082]"
comp87847_c0_seq1;GAXK01202237.1;A7YY55;2.64E-71;HACD3_BOVIN;Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Protein-tyrosine phosphatase-like A domain-containing protein 1);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0007249; GO:0007254; GO:0007266; GO:0016021; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345";"fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]";"3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]"
comp8784804_c0_seq1;GAXK01109572.1;M1BJF6;1.83E-10;JOKA2_SOLTU;Protein JOKA2 (Protein NBR1 homolog);"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; defense response [GO:0006952]; protein transport [GO:0015031]";"GO:0005776; GO:0006914; GO:0006952; GO:0008270; GO:0015031; GO:0031410";"autophagy [GO:0006914]; defense response [GO:0006952]; protein transport [GO:0015031]";"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]";zinc ion binding [GO:0008270]
comp8784863_c0_seq1;GAXK01109570.1;Q4P184;5.37E-46;FAL1_USTMA;ATP-dependent RNA helicase FAL1 (EC 3.6.4.13);"catalytic step 2 spliceosome [GO:0071013]; FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]";"GO:0000462; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0030688; GO:0071013; GO:0097078";maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];"catalytic step 2 spliceosome [GO:0071013]; FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp8786830_c0_seq1;GAXK01074610.1;Q8T5Z4;2.91E-40;RS19_BRABE;40S ribosomal protein S19;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8787146_c0_seq1;GAXK01074615.1;A1TUG3;8.01E-53;SAHH_ACIAC;Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase);"cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]";"GO:0004013; GO:0005737; GO:0006730";one-carbon metabolic process [GO:0006730];cytoplasm [GO:0005737];adenosylhomocysteinase activity [GO:0004013]
comp87882_c0_seq1;GAXK01201818.1;Q924A2;1.11E-41;CIC_MOUSE;Protein capicua homolog;"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]";"GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286";"brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; social behavior [GO:0035176]";"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]"
comp87899_c1_seq1;GAXK01202208.1;P54886;0;P5CS_HUMAN;"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]";"GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0005829; GO:0006536; GO:0006561; GO:0006592; GO:0008652; GO:0019240; GO:0042802; GO:0055129";"cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]";"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]"
comp879_c0_seq1;GAXK01168706.1;Q1HPS0;5.20E-20;MLR_BOMMO;Myosin regulatory light chain 2 (MLC-2);"myosin complex [GO:0016459]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016459";;myosin complex [GO:0016459];calcium ion binding [GO:0005509]
comp8790633_c0_seq1;GAXK01150904.1;A1TR37;4.74E-40;RL35_ACIAC;50S ribosomal protein L35;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8791019_c0_seq1;GAXK01150906.1;Q19013;7.33E-29;GLS2_CAEEL;Putative glutaminase 2 (GLS) (EC 3.5.1.2) (L-glutamine amidohydrolase);"mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";"GO:0004359; GO:0005739; GO:0006537; GO:0006543";"glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]";mitochondrion [GO:0005739];glutaminase activity [GO:0004359]
comp879170_c0_seq1;GAXK01139419.1;Q9VUL9;1.03E-60;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp8792235_c0_seq1;GAXK01054918.1;P54209;1.83E-11;ATC1_DUNBI;Cation-transporting ATPase CA1 (EC 3.6.3.-);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; hydrolase activity [GO:0016787]";"GO:0005388; GO:0005524; GO:0016021; GO:0016787";;integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; hydrolase activity [GO:0016787]"
comp8792386_c0_seq1;GAXK01054917.1;Q8VHE6;1.07E-09;DYH5_MOUSE;Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5);"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045505; GO:0051959; GO:0060271; GO:0097729";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]";"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp87926_c0_seq1;GAXK01201583.1;P08253;5.22E-08;MMP2_HUMAN;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX];"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"GO:0001525; GO:0001666; GO:0001955; GO:0001957; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007566; GO:0008237; GO:0008270; GO:0019221; GO:0022617; GO:0030017; GO:0030198; GO:0030574; GO:0034614; GO:0035987; GO:0044267; GO:0048013; GO:0048771; GO:0060325; GO:0060346; GO:0062023; GO:0071230; GO:1904645; GO:1904707";"angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]";"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";"metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
comp8793820_c0_seq1;GAXK01054921.1;P49669;7.19E-27;RL4_TRYBB;60S ribosomal protein L4 (L1);"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp8793877_c0_seq1;GAXK01054915.1;P51410;3.16E-37;RL9_MOUSE;60S ribosomal protein L9;"cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"GO:0002181; GO:0003735; GO:0006412; GO:0019843; GO:0022625; GO:0045202";"cytoplasmic translation [GO:0002181]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp87940_c1_seq1;GAXK01201838.1;Q8TCT0;1.88E-97;CERK1_HUMAN;Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4);"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]";"GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006687; GO:0016021; GO:0102773";"ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]";"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]"
comp87952_c2_seq1;GAXK01201978.1;P58365;6.57E-65;CAD23_RAT;Cadherin-23 (Otocadherin);"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605]";"GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007605; GO:0007626; GO:0016021; GO:0032420; GO:0045177; GO:0047485; GO:0060122; GO:0098609";"cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605]";"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]";"calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]"
comp8796331_c0_seq1;GAXK01131292.1;P0A122;4.11E-45;FER1_PSEPK;Ferredoxin 1;"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]";"GO:0009055; GO:0046872; GO:0051538; GO:0051539";;;"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"
comp87967_c1_seq1;GAXK01202233.1;Q8T8R1;2.07E-14;Y3800_DROME;CCHC-type zinc finger protein CG3800;"cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]";"GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767";positive regulation of cytoplasmic translation [GO:2000767];cytoplasm [GO:0005737];"mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]"
comp8796964_c0_seq1;GAXK01131294.1;Q3J4D7;1.19E-53;MCM_RHOS4;Methylmalonyl-CoA mutase (MCM) (EC 5.4.99.2);"cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]";"GO:0004494; GO:0031419; GO:0046872";;;"cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]"
comp8797470_c0_seq1;GAXK01131295.1;Q88N32;3.66E-07;TTGC_PSEPK;Probable efflux pump outer membrane protein TtgC;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; efflux transmembrane transporter activity [GO:0015562]";"GO:0009279; GO:0015562; GO:0016021";;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";efflux transmembrane transporter activity [GO:0015562]
comp8797995_c0_seq1;GAXK01131297.1;P48159;1.69E-54;RL23_DROME;60S ribosomal protein L23 (L17A);"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]"
comp87980_c0_seq1;GAXK01202458.1;Q62371;7.99E-61;DDR2_MOUSE;Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b);"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"GO:0001503; GO:0001952; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0007160; GO:0007169; GO:0008284; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030154; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091; GO:1903053";"biomineral tissue development [GO:0031214]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix organization [GO:1903053]; regulation of tissue remodeling [GO:0034103]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]";"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp8798945_c0_seq1;GAXK01072659.1;A4G1P5;4.61E-41;TRPD_HERAR;Anthranilate phosphoribosyltransferase (EC 2.4.2.18);"anthranilate phosphoribosyltransferase activity [GO:0004048]; magnesium ion binding [GO:0000287]; tryptophan biosynthetic process [GO:0000162]";"GO:0000162; GO:0000287; GO:0004048";tryptophan biosynthetic process [GO:0000162];;"anthranilate phosphoribosyltransferase activity [GO:0004048]; magnesium ion binding [GO:0000287]"
comp8798971_c0_seq1;GAXK01072669.1;O15460;6.60E-09;P4HA2_HUMAN;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0016702; GO:0018401; GO:0031418; GO:0043231";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]";"electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp8799205_c0_seq1;GAXK01072672.1;P52746;3.24E-09;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp88_c2_seq1;GAXK01166597.1;Q04451;0;SYG_BOMMO;Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]";"GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0016740; GO:0046983";"diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]"
comp8800137_c0_seq1;GAXK01095826.1;Q42262;3.37E-27;RS3A2_ARATH;40S ribosomal protein S3a-2;"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp8801829_c0_seq1;GAXK01095833.1;Q64542;3.31E-34;AT2B4_RAT;Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);"basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of presynaptic active zone membrane [GO:0099059]; neuron projection [GO:0043005]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; calcium ion export [GO:1901660]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]";"GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0006357; GO:0006816; GO:0006874; GO:0007283; GO:0010751; GO:0014832; GO:0016323; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0033138; GO:0036487; GO:0043005; GO:0045019; GO:0046872; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097228; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:1900082; GO:1901660; GO:1902806; GO:1903243; GO:1903249; GO:1905145; GO:2000481";"calcium ion export [GO:1901660]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]";"basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of presynaptic active zone membrane [GO:0099059]; neuron projection [GO:0043005]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]"
comp8802669_c0_seq1;GAXK01123731.1;A3C4S4;2.16E-38;GME1_ORYSJ;GDP-mannose 3,5-epimerase 1 (GDP-Man 3,5-epimerase 1) (EC 5.1.3.18) (OsGME-1);"GDP-mannose 3,5-epimerase activity [GO:0047918]; NAD binding [GO:0051287]; L-ascorbic acid biosynthetic process [GO:0019853]";"GO:0019853; GO:0047918; GO:0051287";L-ascorbic acid biosynthetic process [GO:0019853];;"GDP-mannose 3,5-epimerase activity [GO:0047918]; NAD binding [GO:0051287]"
comp880386_c0_seq1;GAXK01008586.1;Q2UPB6;2.06E-08;ACLN_ASPOR;Aspirochlorine biosynthesis protein N;;;;;
comp880406_c0_seq1;GAXK01008585.1;Q86UY8;1.13E-127;NT5D3_HUMAN;5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase);"receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]";"GO:0008253; GO:0043235; GO:0046872";;receptor complex [GO:0043235];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]"
comp8806358_c0_seq1;GAXK01029620.1;P72161;2.92E-13;PBP5_PSEAE;D-alanyl-D-alanine endopeptidase (DD-endopeptidase) (EC 3.4.21.-) (Penicillin-binding protein 5) (PBP-5);"periplasmic space [GO:0042597]; endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0004175; GO:0008360; GO:0009002; GO:0009252; GO:0042597; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";periplasmic space [GO:0042597];"endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]"
comp8807485_c0_seq1;GAXK01029625.1;P38754;3.77E-29;RL14B_YEAST;60S ribosomal protein L14-B (Large ribosomal subunit protein eL14-B);"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";"GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273";"cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp8807733_c0_seq1;GAXK01029629.1;Q91X83;6.91E-44;METK1_MOUSE;S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1);"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; ADP binding [GO:0043531]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; S-adenosylmethionine biosynthetic process [GO:0006556]";"GO:0000287; GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0009087; GO:0016363; GO:0016597; GO:0042802; GO:0042803; GO:0043531; GO:0046983; GO:0051260; GO:0051262; GO:0051289";"methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; S-adenosylmethionine biosynthetic process [GO:0006556]";"cytosol [GO:0005829]; nuclear matrix [GO:0016363]";"ADP binding [GO:0043531]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]"
comp8808_c0_seq1;GAXK01014187.1;P53568;1.27E-15;CEBPG_MOUSE;CCAAT/enhancer-binding protein gamma (C/EBP gamma) (Granulocyte colony-stimulating factor promoter element 1-binding protein) (GPE1-BP) (GPE1-binding protein) (Immunoglobulin enhancer-binding protein 1) (IG/EBP-1);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II proximal promoter sequence-specific DNA binding, bending [GO:0044377]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; B cell differentiation [GO:0030183]; chromatin remodeling [GO:0006338]; enucleate erythrocyte differentiation [GO:0043353]; immune response [GO:0006955]; liver development [GO:0001889]; mRNA metabolic process [GO:0016071]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; nucleosome disassembly [GO:0006337]; positive regulation of DNA repair [GO:0045739]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000978; GO:0001228; GO:0001889; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0006955; GO:0008134; GO:0016071; GO:0030183; GO:0042267; GO:0042803; GO:0043353; GO:0043433; GO:0043565; GO:0044377; GO:0045078; GO:0045739; GO:0045944; GO:0046982";"B cell differentiation [GO:0030183]; chromatin remodeling [GO:0006338]; enucleate erythrocyte differentiation [GO:0043353]; immune response [GO:0006955]; liver development [GO:0001889]; mRNA metabolic process [GO:0016071]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; nucleosome disassembly [GO:0006337]; positive regulation of DNA repair [GO:0045739]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II proximal promoter sequence-specific DNA binding, bending [GO:0044377]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"
comp880806_c0_seq1;GAXK01008607.1;A0ZT93;3.97E-08;ISP2_BRASG;Type-2 ice-structuring protein (Type II antifreeze protein) (lpAFP);"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp88087_c1_seq1;GAXK01195114.1;Q66GV0;8.98E-53;MPV17_XENLA;Protein Mpv17;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";"GO:0005743; GO:0016021";;"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";
comp880884_c1_seq1;GAXK01008610.1;O46108;3.47E-34;LIP3_DROME;Lipase 3 (DmLip3) (EC 3.1.1.-);"lipase activity [GO:0016298]; cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";"GO:0016042; GO:0016298; GO:0044255";"cellular lipid metabolic process [GO:0044255]; lipid catabolic process [GO:0016042]";;lipase activity [GO:0016298]
comp8809128_c0_seq1;GAXK01109185.1;Q54UJ0;8.34E-32;PSD12_DICDI;26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55);"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0005737; GO:0008541; GO:0031595; GO:0043161";proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome regulatory particle, lid subcomplex [GO:0008541]";
comp881031_c1_seq1;GAXK01008633.1;Q62559;0;IFT52_MOUSE;Intraflagellar transport protein 52 homolog (Protein NGD5);"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]";"GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515";"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]";"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]";
comp8810523_c0_seq1;GAXK01126224.1;Q7Z5L0;4.17E-13;VMO1_HUMAN;Vitelline membrane outer layer protein 1 homolog;extracellular exosome [GO:0070062];GO:0070062;;extracellular exosome [GO:0070062];
comp88114_c0_seq1;GAXK01195225.1;O17482;0;TIM_DROVI;Protein timeless;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511]";"GO:0005634; GO:0048471; GO:0048511";rhythmic process [GO:0048511];"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";
comp88122_c0_seq1;GAXK01195073.1;A8MW92;2.46E-22;P20L1_HUMAN;PHD finger protein 20-like protein 1;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];metal ion binding [GO:0046872]
comp88126_c1_seq1;GAXK01195047.1;Q8BW70;2.82E-32;UBP38_MOUSE;Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38);"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp8812807_c0_seq1;GAXK01123004.1;A2SFB4;1.11E-49;TIG_METPP;Trigger factor (TF) (EC 5.2.1.8) (PPIase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein folding [GO:0006457]; protein transport [GO:0015031]";"GO:0003755; GO:0005737; GO:0006457; GO:0007049; GO:0015031; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein folding [GO:0006457]; protein transport [GO:0015031]";cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp88132_c0_seq1;GAXK01194973.1;P0CJ78;8.08E-07;ZN865_HUMAN;Zinc finger protein 865;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8814_c1_seq1;GAXK01013397.1;Q6PC19;6.13E-67;SSU72_DANRE;RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16);"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]";"GO:0005737; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940";"dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]";"cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]";RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]
comp8815_c0_seq1;GAXK01013501.1;Q7TQ20;3.55E-129;DNJC2_RAT;DnaJ homolog subfamily C member 2 (Gliosarcoma-related antigen MIDA1) (Zuotin-related factor 1);"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003677; GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0030308; GO:0042393; GO:0045893; GO:0061649";"chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription, DNA-templated [GO:0045893]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]"
comp88152_c3_seq1;GAXK01195116.1;Q9U3P2;2.67E-18;SYG2_CAEEL;Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839";"cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]"
comp8816463_c0_seq1;GAXK01107839.1;Q91611;1.36E-12;DHHB_XENLA;"Desert hedgehog protein B (Desert hedgehog protein 2) (DHH-2) (Hedgehog protein 4) (X-HH4) [Cleaved into: Desert hedgehog protein B N-product; Desert hedgehog protein B C-product]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0046872";"cell-cell signaling [GO:0007267]; multicellular organism development [GO:0007275]";"extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; peptidase activity [GO:0008233]"
comp8817_c0_seq1;GAXK01013656.1;Q14181;1.34E-90;DPOA2_HUMAN;DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit);"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"GO:0000082; GO:0003677; GO:0003887; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006270; GO:0032201; GO:0046982";"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]";"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]"
comp8817014_c0_seq1;GAXK01107838.1;P21822;5.18E-18;MCPS_KLEAK;Methyl-accepting chemotaxis serine transducer;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"GO:0004888; GO:0005886; GO:0006935; GO:0007165; GO:0016021";"chemotaxis [GO:0006935]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane signaling receptor activity [GO:0004888]
comp88174_c0_seq1;GAXK01195066.1;Q5U249;2.89E-110;ELYS_XENLA;Protein ELYS (Protein MEL-28) (xELYS);"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]";"GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028";"mRNA transport [GO:0051028]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp88177_c0_seq1;GAXK01195226.1;P29227;8.01E-10;HP1_DROVI;Heterochromatin protein 1 (HP1);"condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; polytene chromosome, telomeric region [GO:0035012]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; establishment of chromatin silencing [GO:0006343]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]";"GO:0000182; GO:0000278; GO:0000723; GO:0000780; GO:0000791; GO:0003682; GO:0003696; GO:0003723; GO:0005701; GO:0005703; GO:0005704; GO:0005705; GO:0005720; GO:0005721; GO:0006343; GO:0030544; GO:0030674; GO:0031507; GO:0033697; GO:0034773; GO:0035012; GO:0042981; GO:0044877; GO:0061408; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646";"establishment of chromatin silencing [GO:0006343]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]";"condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome, telomeric region [GO:0035012]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]";"chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein binding, bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]"
comp881801_c0_seq1;GAXK01008616.1;Q4V348;2.04E-18;Z658B_HUMAN;Zinc finger protein 658B;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8818157_c0_seq1;GAXK01090160.1;Q74CR0;4.71E-21;GPMA_GEOSL;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11);"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";"GO:0006094; GO:0006096; GO:0046538";"gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]";;2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]
comp881817_c1_seq1;GAXK01008612.1;Q08380;3.18E-11;LG3BP_HUMAN;Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K);"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; platelet degranulation [GO:0002576]; signal transduction [GO:0007165]";"GO:0002576; GO:0005044; GO:0005576; GO:0005615; GO:0006968; GO:0007155; GO:0007165; GO:0016020; GO:0031089; GO:0062023; GO:0070062; GO:0072562";"cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; platelet degranulation [GO:0002576]; signal transduction [GO:0007165]";"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]";scavenger receptor activity [GO:0005044]
comp88184_c0_seq1;GAXK01195058.1;Q2PZI1;0;D19L1_HUMAN;Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]";"GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406";protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406];"integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]";mannosyltransferase activity [GO:0000030]
comp881920_c0_seq1;GAXK01008634.1;Q9PVG3;3.15E-19;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp8819601_c0_seq1;GAXK01090155.1;P76502;3.91E-08;SIXA_ECOLI;Phosphohistidine phosphatase SixA (EC 3.1.3.-) (RX6);"cytoplasm [GO:0005737]; protein histidine phosphatase activity [GO:0101006]; cellular protein modification process [GO:0006464]";"GO:0005737; GO:0006464; GO:0101006";cellular protein modification process [GO:0006464];cytoplasm [GO:0005737];protein histidine phosphatase activity [GO:0101006]
comp88202_c1_seq1;GAXK01194983.1;Q0IIV2;3.38E-114;RHBG_XENTR;Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0016323; GO:0030659; GO:0072488";ammonium transmembrane transport [GO:0072488];"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]";ammonium transmembrane transporter activity [GO:0008519]
comp8820200_c0_seq1;GAXK01162355.1;G5EDN0;1.55E-11;ACC3_CAEEL;Acetylcholine-gated chloride channel subunit acc-3;"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]"
comp882124_c0_seq1;GAXK01153011.1;Q5ZHN4;4.17E-93;XRP2_CHICK;Protein XRP2;"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]";"GO:0000287; GO:0000902; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005814; GO:0005886; GO:0006892; GO:0016604; GO:0031410; GO:0036064; GO:1990075";"cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]";"GTPase activator activity [GO:0005096]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]"
comp882126_c0_seq1;GAXK01152994.1;Q6GLT8;5.05E-102;FAHD2_XENLA;Fumarylacetoacetate hydrolase domain-containing protein 2 (EC 3.-.-.-);"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]";"GO:0016787; GO:0046872";;;"hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]"
comp8821821_c0_seq1;GAXK01162351.1;P93343;3.94E-34;1433C_TOBAC;14-3-3-like protein C (14-3-3-like protein B);protein domain specific binding [GO:0019904];GO:0019904;;;protein domain specific binding [GO:0019904]
comp8822118_c0_seq1;GAXK01179976.1;Q9XF19;6.20E-17;AB21I_ARATH;ABC transporter I family member 21 (ABC transporter ABCI.21) (AtABCI21) (GCN-related protein 1) (Non-intrinsic ABC protein 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to far red light [GO:0010218]; response to red light [GO:0010114]";"GO:0005524; GO:0005737; GO:0010114; GO:0010218; GO:0016887";"response to far red light [GO:0010218]; response to red light [GO:0010114]";cytoplasm [GO:0005737];"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp8822671_c0_seq1;GAXK01179982.1;P37624;9.74E-30;RBBA_ECOLI;Ribosome-associated ATPase (Ribosomal bound ATPase);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell pole [GO:0060187]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ribosomal small subunit binding [GO:0043024]; positive regulation of translation [GO:0045727]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005886; GO:0016020; GO:0016887; GO:0022627; GO:0042623; GO:0043024; GO:0043190; GO:0045727; GO:0055085; GO:0060187";"positive regulation of translation [GO:0045727]; transmembrane transport [GO:0055085]";"ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell pole [GO:0060187]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; ribosomal small subunit binding [GO:0043024]"
comp88228_c0_seq1;GAXK01195222.1;Q8MIR4;1.07E-103;COASY_PIG;"Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]";"GO:0004140; GO:0004595; GO:0005524; GO:0005654; GO:0005759; GO:0005829; GO:0015937";coenzyme A biosynthetic process [GO:0015937];"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]";"ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]"
comp8823086_c0_seq1;GAXK01179980.1;A2SFP5;7.07E-17;Y1422_METPP;UPF0761 membrane protein Mpe_A1422;integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp8824499_c0_seq1;GAXK01083325.1;Q75AP7;1.20E-53;RL2_ASHGO;60S ribosomal protein L2;"cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0019843; GO:0022625";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp882638_c0_seq1;GAXK01152964.1;Q2QL80;7.96E-21;CAV2_DIDVI;Caveolin-2;"caveola [GO:0005901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; D1 dopamine receptor binding [GO:0031748]; caveola assembly [GO:0070836]; endoplasmic reticulum organization [GO:0007029]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; skeletal muscle fiber development [GO:0048741]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000139; GO:0001937; GO:0005634; GO:0005901; GO:0006906; GO:0007005; GO:0007029; GO:0031234; GO:0031748; GO:0048278; GO:0048471; GO:0048741; GO:0060161; GO:0070836";"caveola assembly [GO:0070836]; endoplasmic reticulum organization [GO:0007029]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; skeletal muscle fiber development [GO:0048741]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"caveola [GO:0005901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";D1 dopamine receptor binding [GO:0031748]
comp8826794_c0_seq1;GAXK01146627.1;B4SLL0;4.16E-08;ASPN_STRM5;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp8827_c0_seq1;GAXK01013344.1;P61023;1.61E-62;CHP1_RAT;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015630; GO:0017156; GO:0019722; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071468; GO:0090314; GO:1901214";"calcium-ion regulated exocytosis [GO:0017156]; calcium-mediated signaling [GO:0019722]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]"
comp882710_c0_seq1;GAXK01153018.1;P80303;6.35E-15;NUCB2_HUMAN;Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; negative regulation of appetite [GO:0032099]";"GO:0003677; GO:0005509; GO:0005615; GO:0005640; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0032099; GO:0070062";negative regulation of appetite [GO:0032099];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]";"calcium ion binding [GO:0005509]; DNA binding [GO:0003677]"
comp8827697_c0_seq1;GAXK01205817.1;Q9SJ44;4.68E-46;UEV1C_ARATH;Ubiquitin-conjugating enzyme E2 variant 1C (Ubc enzyme variant 1C) (Protein MMS ZWEI HOMOLOG 3);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]";"GO:0005634; GO:0005783; GO:0005829; GO:0006301; GO:0031372; GO:0061631; GO:0070534";"postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]";ubiquitin conjugating enzyme activity [GO:0061631]
comp882773_c0_seq1;GAXK01153015.1;Q7KRI2;2.20E-16;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8827927_c0_seq1;GAXK01146628.1;P00515;4.68E-09;KAP2_BOVIN;cAMP-dependent protein kinase type II-alpha regulatory subunit;"axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; cGMP-mediated signaling [GO:0019934]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]";"GO:0004862; GO:0005813; GO:0005829; GO:0005930; GO:0005952; GO:0008603; GO:0019904; GO:0019934; GO:0030552; GO:0031588; GO:0031625; GO:0034236; GO:0044853; GO:0047555; GO:2000480";"cGMP-mediated signaling [GO:0019934]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]";"axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]"
comp8831911_c0_seq1;GAXK01120886.1;P45206;4.10E-24;SSPB_HAEIN;Stringent starvation protein B homolog (Adapter protein SspB) (Specificity-enhancing factor SspB);"cytosol [GO:0005829]; ribosome [GO:0005840]; positive regulation of protein catabolic process [GO:0045732]";"GO:0005829; GO:0005840; GO:0045732";positive regulation of protein catabolic process [GO:0045732];"cytosol [GO:0005829]; ribosome [GO:0005840]";
comp8832400_c0_seq1;GAXK01180829.1;Q9GZS0;2.51E-11;DNAI2_HUMAN;Dynein intermediate chain 2, axonemal (Axonemal dynein intermediate chain 2);"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271";"cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]";"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]";"dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]"
comp88325_c0_seq1;GAXK01194994.1;Q9D531;3.11E-40;NXNL2_MOUSE;Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2);"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";"GO:0007601; GO:0007608; GO:0045494";"photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]";;
comp8832817_c0_seq1;GAXK01180827.1;Q9WUK7;4.46E-09;OPN3_MOUSE;Opsin-3 (Encephalopsin) (Panopsin);"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0001750; GO:0005887; GO:0007186; GO:0007602; GO:0008020; GO:0018298; GO:0071482";"cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]";G protein-coupled photoreceptor activity [GO:0008020]
comp883317_c1_seq1;GAXK01153017.1;Q18297;5.73E-12;TRPA1_CAEEL;Transient receptor potential cation channel subfamily A member 1 homolog;"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]";"GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730";response to stimulus [GO:0050896];"integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]";ion channel activity [GO:0005216]
comp8833531_c0_seq1;GAXK01180825.1;Q8XD86;3.17E-32;RECG_ECO57;ATP-dependent DNA helicase RecG (EC 3.6.4.12);"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]";"GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]";;"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
comp883398_c0_seq1;GAXK01152968.1;Q0VGE8;1.64E-17;ZN816_HUMAN;Zinc finger protein 816;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp883473_c0_seq1;GAXK01153012.1;Q6ZG77;1.47E-72;DCDA_ORYSJ;Probable diaminopimelate decarboxylase, chloroplastic (DAP decarboxylase) (DAPDC) (EC 4.1.1.20);"chloroplast [GO:0009507]; diaminopimelate decarboxylase activity [GO:0008836]; lysine biosynthetic process via diaminopimelate [GO:0009089]";"GO:0008836; GO:0009089; GO:0009507";lysine biosynthetic process via diaminopimelate [GO:0009089];chloroplast [GO:0009507];diaminopimelate decarboxylase activity [GO:0008836]
comp8835928_c0_seq1;GAXK01173866.1;Q04770;4.55E-15;CDK2_ENTHI;Cell division protein kinase 2 homolog (EC 2.7.11.22);"transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0004693; GO:0005524; GO:0007049; GO:0008353; GO:0051301; GO:0070985";"cell cycle [GO:0007049]; cell division [GO:0051301]";transcription factor TFIIK complex [GO:0070985];"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp8836846_c0_seq1;GAXK01000240.1;O61370;8.67E-08;NACH_DROAN;Sodium channel protein Nach;"integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; liquid clearance, open tracheal system [GO:0035002]";"GO:0005272; GO:0016021; GO:0035002";liquid clearance, open tracheal system [GO:0035002];integral component of membrane [GO:0016021];sodium channel activity [GO:0005272]
comp88376_c0_seq1;GAXK01195213.1;Q3SZI7;5.81E-155;COG6_BOVIN;Conserved oligomeric Golgi complex subunit 6 (COG complex subunit 6) (Component of oligomeric Golgi complex 6);"Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"GO:0000139; GO:0006891; GO:0015031; GO:0017119; GO:0070085";"glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]";"Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]";
comp88379_c2_seq1;GAXK01194982.1;Q07536;1.18E-119;MMSA_BOVIN;Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1);"mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";"GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859";"thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]";mitochondrion [GO:0005739];"fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
comp8837934_c0_seq1;GAXK01000241.1;A2SGT2;2.57E-30;DNLJ_METPP;DNA ligase (EC 6.5.1.2) (Polydeoxyribonucleotide synthase [NAD(+)]);"DNA binding [GO:0003677]; DNA ligase (NAD+) activity [GO:0003911]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260]";"GO:0003677; GO:0003911; GO:0006260; GO:0006281; GO:0046872";"DNA repair [GO:0006281]; DNA replication [GO:0006260]";;"DNA binding [GO:0003677]; DNA ligase (NAD+) activity [GO:0003911]; metal ion binding [GO:0046872]"
comp8838982_c0_seq1;GAXK01005120.1;Q0ZAH7;7.14E-14;KEFB_ALKAM;Putative K(+) efflux antiporter KefB;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; solute:proton antiporter activity [GO:0015299]; potassium ion transport [GO:0006813]";"GO:0005886; GO:0006813; GO:0015299; GO:0016021";potassium ion transport [GO:0006813];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";solute:proton antiporter activity [GO:0015299]
comp883946_c0_seq1;GAXK01152983.1;Q5R1W1;1.32E-36;SEPT7_PANTR;Septin-7 (CDC10 protein homolog) (Fragment);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0060271; GO:0061640";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp884133_c0_seq1;GAXK01157398.1;O75995;1.80E-27;SASH3_HUMAN;SAM and SH3 domain-containing protein 3 (SH3 protein expressed in lymphocytes homolog);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042102; GO:0043372; GO:0046622; GO:0048873";"homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp8841718_c0_seq1;GAXK01081465.1;Q8LDP4;2.41E-18;CP19D_ARATH;Peptidyl-prolyl cis-trans isomerase CYP19-4 (PPIase CYP19-4) (EC 5.2.1.8) (Cyclophilin of 19 kDa 4) (Cyclophilin-5) (Rotamase CYP19-4);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi stack [GO:0005795]; membrane [GO:0016020]; multivesicular body [GO:0005771]; peroxisome [GO:0005777]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; regulation of protein refolding [GO:0061083]";"GO:0003755; GO:0005576; GO:0005768; GO:0005771; GO:0005777; GO:0005783; GO:0005795; GO:0005802; GO:0005829; GO:0016018; GO:0016020; GO:0042026; GO:0051082; GO:0061083; GO:0099503";"protein refolding [GO:0042026]; regulation of protein refolding [GO:0061083]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi stack [GO:0005795]; membrane [GO:0016020]; multivesicular body [GO:0005771]; peroxisome [GO:0005777]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]";"cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]"
comp88419_c1_seq1;GAXK01195108.1;Q9JJ93;3.86E-12;CN119_MOUSE;Uncharacterized protein C14orf119 homolog;"cytosol [GO:0005829]; mitochondrion [GO:0005739]";"GO:0005739; GO:0005829";;"cytosol [GO:0005829]; mitochondrion [GO:0005739]";
comp8842_c0_seq1;GAXK01013518.1;Q9Y5Z4;3.49E-13;HEBP2_HUMAN;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062";"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]";"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]";heme binding [GO:0020037]
comp8842620_c0_seq1;GAXK01137991.1;P00784;7.39E-37;PAPA1_CARPA;Papain (EC 3.4.22.2) (Papaya proteinase I) (PPI) (allergen Car p 1);"cysteine-type peptidase activity [GO:0008234]; serpin family protein binding [GO:0097655]";"GO:0008234; GO:0097655";;;"cysteine-type peptidase activity [GO:0008234]; serpin family protein binding [GO:0097655]"
comp884400_c0_seq1;GAXK01157383.1;O96102;3.75E-28;CALM_PHYPO;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8844034_c0_seq1;GAXK01120858.1;A4SWL6;1.98E-33;MSRA_POLAQ;Peptide methionine sulfoxide reductase MsrA (Protein-methionine-S-oxide reductase) (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase);"peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]";"GO:0006464; GO:0008113";cellular protein modification process [GO:0006464];;peptide-methionine (S)-S-oxide reductase activity [GO:0008113]
comp8844502_c0_seq1;GAXK01120862.1;P47207;3.42E-56;TCPB_CAEEL;T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta);"chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]";"GO:0005524; GO:0005832; GO:0006457; GO:0051082";protein folding [GO:0006457];chaperonin-containing T-complex [GO:0005832];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp8845_c0_seq1;GAXK01014057.1;Q5UPJ3;2.24E-07;YL116_MIMIV;Uncharacterized protein L116;;;;;
comp8846559_c0_seq1;GAXK01205411.1;Q9VYX7;2.49E-22;PGPSA_DROME;Peptidoglycan-recognition protein SA (EC 3.4.17.13) (Protein semmelweis);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; muramyl dipeptide binding [GO:0032500]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; signaling pattern recognition receptor activity [GO:0008329]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; response to peptidoglycan [GO:0032494]";"GO:0005576; GO:0005615; GO:0006965; GO:0008233; GO:0008270; GO:0008329; GO:0008745; GO:0009253; GO:0016019; GO:0019730; GO:0032494; GO:0032500; GO:0032827; GO:0038187; GO:0042834; GO:0045087; GO:0045752; GO:0050830";"antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of Toll signaling pathway [GO:0045752]; response to peptidoglycan [GO:0032494]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";"muramyl dipeptide binding [GO:0032500]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; signaling pattern recognition receptor activity [GO:0008329]; zinc ion binding [GO:0008270]"
comp884703_c0_seq1;GAXK01157423.1;Q6RUV5;3.19E-54;RAC1_RAT;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1);"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0006935; GO:0007015; GO:0007266; GO:0008045; GO:0008283; GO:0008361; GO:0010592; GO:0016020; GO:0016477; GO:0016601; GO:0017137; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030334; GO:0031116; GO:0031410; GO:0031996; GO:0032587; GO:0032707; GO:0034446; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048012; GO:0048870; GO:0051022; GO:0051117; GO:0051496; GO:0051668; GO:0051894; GO:0055038; GO:0060263; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098978; GO:1900026; GO:1902622";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]";"actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]";"ATPase binding [GO:0051117]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]"
comp8848116_c0_seq1;GAXK01181144.1;P0CT77;8.06E-60;RL11A_SCHPO;60S ribosomal protein L11-A;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0019843; GO:0022625; GO:0022627; GO:0042254";"cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp8848308_c0_seq1;GAXK01181140.1;P72943;1.83E-21;RSMB_SYNY3;Probable ribosomal RNA small subunit methyltransferase B (EC 2.1.1.176) (16S rRNA m5C967 methyltransferase) (rRNA (cytosine-C(5)-)-methyltransferase RsmB);"cytosol [GO:0005829]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; regulation of transcription, DNA-templated [GO:0006355]; rRNA base methylation [GO:0070475]";"GO:0003723; GO:0005829; GO:0006355; GO:0009383; GO:0070475";"regulation of transcription, DNA-templated [GO:0006355]; rRNA base methylation [GO:0070475]";cytosol [GO:0005829];"RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]"
comp8848519_c0_seq1;GAXK01181143.1;P14381;2.39E-14;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp885_c0_seq1;GAXK01169397.1;Q2F637;1.29E-147;1433Z_BOMMO;14-3-3 protein zeta;"cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]";"GO:0005737; GO:0019904";;cytoplasm [GO:0005737];protein domain specific binding [GO:0019904]
comp885061_c0_seq1;GAXK01157442.1;Q13105;1.10E-10;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp885075_c0_seq1;GAXK01157388.1;B5AJT4;9.65E-20;VMP03_EULPE;Venom metalloproteinase 3 (EpMP3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]";"GO:0004222; GO:0005576; GO:0046872; GO:0090729";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]"
comp885185_c0_seq1;GAXK01157382.1;Q60934;3.31E-77;GRIK1_MOUSE;Glutamate receptor ionotropic, kainate 1 (GluK1) (Glutamate receptor 5) (GluR-5) (GluR5);"cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]; terminal bouton [GO:0043195]; drug binding [GO:0008144]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; voltage-gated cation channel activity [GO:0022843]; adult behavior [GO:0030534]; behavioral response to pain [GO:0048266]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; ionotropic glutamate receptor signaling pathway [GO:0035235]; membrane depolarization [GO:0051899]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nervous system development [GO:0007399]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0004970; GO:0005234; GO:0005886; GO:0007399; GO:0008066; GO:0008144; GO:0008328; GO:0014054; GO:0014069; GO:0015277; GO:0016020; GO:0016595; GO:0022843; GO:0030054; GO:0030425; GO:0030534; GO:0032229; GO:0032230; GO:0032983; GO:0035235; GO:0035249; GO:0042391; GO:0042734; GO:0042803; GO:0043025; GO:0043195; GO:0043235; GO:0045202; GO:0045211; GO:0048169; GO:0048172; GO:0048266; GO:0050804; GO:0051899; GO:0051967; GO:0060079; GO:0060080; GO:0098978; GO:0099056; GO:1904315";"adult behavior [GO:0030534]; behavioral response to pain [GO:0048266]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; ionotropic glutamate receptor signaling pathway [GO:0035235]; membrane depolarization [GO:0051899]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nervous system development [GO:0007399]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; synapse [GO:0045202]; terminal bouton [GO:0043195]";"drug binding [GO:0008144]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; voltage-gated cation channel activity [GO:0022843]"
comp88523_c0_seq1;GAXK01194673.1;P0CG00;4.25E-17;ZSA5D_HUMAN;Putative zinc finger and SCAN domain-containing protein 5D (Zinc finger and SCAN domain-containing protein 5D pseudogene);"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp88524_c0_seq1;GAXK01194961.1;Q9U2X0;1.90E-88;ANM1_CAEEL;Protein arginine N-methyltransferase 1 (EC 2.1.1.319);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; determination of adult lifespan [GO:0008340]; heat acclimation [GO:0010286]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of dauer entry [GO:1905909]; regulation of gene expression [GO:0010468]; regulation of lipid storage [GO:0010883]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; response to UV [GO:0009411]";"GO:0001933; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006355; GO:0006979; GO:0008340; GO:0008469; GO:0009411; GO:0010286; GO:0010468; GO:0010628; GO:0010883; GO:0016274; GO:0016571; GO:0019919; GO:0032091; GO:0034969; GO:0035241; GO:0035242; GO:0035246; GO:0042594; GO:1900182; GO:1904047; GO:1905909";"determination of adult lifespan [GO:0008340]; heat acclimation [GO:0010286]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of dauer entry [GO:1905909]; regulation of gene expression [GO:0010468]; regulation of lipid storage [GO:0010883]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; response to UV [GO:0009411]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]";"histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]"
comp885246_c0_seq1;GAXK01157443.1;Q9VJS7;6.68E-24;PBURS_DROME;Partner of bursicon (Bursicon subunit beta);"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; protein heterodimerization activity [GO:0046982]; chitin-based cuticle sclerotization [GO:0007593]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of establishment of planar polarity [GO:0090175]";"GO:0001664; GO:0005184; GO:0005576; GO:0007186; GO:0007593; GO:0018990; GO:0031395; GO:0046982; GO:0071855; GO:0090175";"chitin-based cuticle sclerotization [GO:0007593]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of establishment of planar polarity [GO:0090175]";"bursicon neuropeptide hormone complex [GO:0031395]; extracellular region [GO:0005576]";"G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; protein heterodimerization activity [GO:0046982]"
comp8853100_c0_seq1;GAXK01092739.1;O62738;4.67E-33;RS4X_MONDO;40S ribosomal protein S4, X isoform;"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:0022627; GO:1990904";translation [GO:0006412];"cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]";"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp8854694_c0_seq1;GAXK01153780.1;O62739;7.38E-58;RS4Y1_MONDO;40S ribosomal protein S4, Y isoform 1;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0019843; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp8856_c0_seq1;GAXK01014347.1;E0VI98;1.02E-35;RU1C_PEDHC;U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C);"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000243; GO:0000387; GO:0000395; GO:0003729; GO:0005685; GO:0008270; GO:0030619; GO:0071004";"mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]";"commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]";"mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]"
comp8856757_c0_seq1;GAXK01133565.1;Q86B05;7.28E-59;RLP24_DICDI;Probable ribosome biogenesis protein RLP24;"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0022625; GO:0042273; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]";"cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]";"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp88570_c2_seq1;GAXK01195080.1;Q9VZW5;1.32E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp88572_c1_seq1;GAXK01195275.1;Q66HF8;0;AL1B1_RAT;Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase family 1 member B1);"mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; ethanol catabolic process [GO:0006068]";"GO:0004029; GO:0005759; GO:0006068; GO:0043878";ethanol catabolic process [GO:0006068];mitochondrial matrix [GO:0005759];"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]"
comp88575_c1_seq1;GAXK01194957.1;Q9NW07;6.41E-33;ZN358_HUMAN;Zinc finger protein 358;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";"GO:0003677; GO:0005634; GO:0019827; GO:0021915; GO:0035115; GO:0046872";"embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; stem cell population maintenance [GO:0019827]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp885849_c0_seq1;GAXK01157432.1;Q701R1;4.10E-64;SIAT2_XENTR;Beta-galactoside alpha-2,6-sialyltransferase 2 (Alpha 2,6-ST 2) (EC 2.4.99.1) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 2) (ST6Gal II) (ST6GalII) (Sialyltransferase 2);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein glycosylation [GO:0006486]";"GO:0003835; GO:0006486; GO:0016021; GO:0032580";protein glycosylation [GO:0006486];"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]
comp8860529_c0_seq1;GAXK01184964.1;Q9SR22;9.09E-09;PAE5_ARATH;Pectin acetylesterase 5 (EC 3.1.1.-);"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; pectin acetylesterase activity [GO:0052793]; cell wall organization [GO:0071555]";"GO:0005576; GO:0009505; GO:0052793; GO:0071555";cell wall organization [GO:0071555];"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]";pectin acetylesterase activity [GO:0052793]
comp886087_c0_seq1;GAXK01200978.1;P16573;7.97E-08;CEAM1_RAT;Carcinoembryonic antigen-related cell adhesion molecule 1 (ATP-dependent taurocolate-carrier protein) (Cell-CAM 105) (C-CAM 105) (Ecto-ATPase) (GP110) (pp120) (CD antigen CD66a);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of vasculogenesis [GO:2001214]; protein homotrimerization [GO:0070207]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]";"GO:0001558; GO:0001568; GO:0001915; GO:0002859; GO:0005516; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006469; GO:0007155; GO:0007156; GO:0007165; GO:0009925; GO:0009986; GO:0010594; GO:0014066; GO:0015125; GO:0015721; GO:0016324; GO:0016328; GO:0019901; GO:0030054; GO:0030133; GO:0030334; GO:0030853; GO:0031528; GO:0032692; GO:0032869; GO:0035726; GO:0038016; GO:0038158; GO:0042058; GO:0042803; GO:0043116; GO:0043318; GO:0043406; GO:0044319; GO:0045601; GO:0045717; GO:0046983; GO:0050860; GO:0051055; GO:0060312; GO:0070207; GO:0070372; GO:0090331; GO:0098742; GO:1901143; GO:1903385; GO:1903387; GO:1903670; GO:2000346; GO:2001214";"bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of vasculogenesis [GO:2001214]; protein homotrimerization [GO:0070207]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]";"bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"
comp886130_c1_seq1;GAXK01201031.1;G5ED00;6.93E-13;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp8863_c6_seq1;GAXK01013935.1;Q8C1A5;0;THOP1_MOUSE;Thimet oligopeptidase (EC 3.4.24.15);"mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";"GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0046872";"intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]";mitochondrial intermembrane space [GO:0005758];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]"
comp8863273_c0_seq1;;P54910;8.52E-20;TRBE_RHIRD;Conjugal transfer protein TrbE;"ATP binding [GO:0005524]; conjugation [GO:0000746]";"GO:0000746; GO:0005524";conjugation [GO:0000746];;ATP binding [GO:0005524]
comp8863446_c0_seq1;GAXK01177499.1;Q6DFV8;8.58E-10;VWDE_MOUSE;von Willebrand factor D and EGF domain-containing protein;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp88648_c1_seq1;GAXK01194943.1;O08888;1.86E-141;PTSS2_CRIGR;Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]";"GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740";phosphatidylserine biosynthetic process [GO:0006659];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";transferase activity [GO:0016740]
comp88651_c0_seq1;GAXK01195244.1;P16264;6.22E-23;SPER_STRPU;Egg peptide speract receptor;"integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]";"GO:0005044; GO:0016021";;integral component of membrane [GO:0016021];scavenger receptor activity [GO:0005044]
comp88655_c2_seq1;GAXK01194610.1;Q7Z3D4;4.51E-10;LYSM3_HUMAN;LysM and putative peptidoglycan-binding domain-containing protein 3;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp886594_c0_seq1;GAXK01201020.1;O54963;4.39E-11;REST_RAT;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008285; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp88678_c0_seq1;GAXK01194992.1;Q9VVE2;4.42E-71;ROGDI_DROME;Protein rogdi;"nuclear envelope [GO:0005635]; nucleus [GO:0005634]; RAVE complex [GO:0043291]; behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]";"GO:0005634; GO:0005635; GO:0007035; GO:0032502; GO:0043291; GO:0048149";"behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]";"nuclear envelope [GO:0005635]; nucleus [GO:0005634]; RAVE complex [GO:0043291]";
comp8867837_c0_seq1;GAXK01034580.1;Q5HUM7;6.77E-60;PCKA_CAMJR;Phosphoenolpyruvate carboxykinase (ATP) (PCK) (PEP carboxykinase) (PEPCK) (EC 4.1.1.49);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (ATP) activity [GO:0004612]; gluconeogenesis [GO:0006094]";"GO:0004612; GO:0005524; GO:0005737; GO:0006094; GO:0046872";gluconeogenesis [GO:0006094];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (ATP) activity [GO:0004612]"
comp886818_c0_seq1;GAXK01201029.1;P34410;1.23E-14;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp887047_c0_seq1;GAXK01200988.1;Q6ZNA1;3.66E-16;ZN836_HUMAN;Zinc finger protein 836;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp887072_c0_seq1;GAXK01204934.1;Q86Y13;9.27E-07;DZIP3_HUMAN;E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630";protein polyubiquitination [GO:0000209];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp88717_c0_seq1;GAXK01194993.1;Q8C0J2;2.64E-122;A16L1_MOUSE;Autophagy-related protein 16-1 (APG16-like 1);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]";"GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0010508; GO:0015031; GO:0034045; GO:0034497; GO:0039689; GO:0042802; GO:0051020; GO:0061739; GO:0098792";"autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]";"GTPase binding [GO:0051020]; identical protein binding [GO:0042802]"
comp8872_c11_seq1;GAXK01014547.1;O75533;0;SF3B1_HUMAN;Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155);"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013";"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]";"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp887302_c0_seq1;GAXK01200980.1;Q9W0T5;2.43E-32;PYX_DROME;Transient receptor potential channel pyrexia;"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060; GO:0051290";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; response to heat [GO:0009408]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]"
comp8873156_c0_seq1;GAXK01108254.1;Q9QZP2;1.31E-07;PRDM4_RAT;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0003700; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0031670; GO:0043565; GO:0046872; GO:0071363; GO:1990226; GO:2000177; GO:2000736";"cellular response to growth factor stimulus [GO:0071363]; cellular response to nutrient [GO:0031670]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp887316_c1_seq1;GAXK01201036.1;G5EBR3;2.62E-17;GLUCL_CAEEL;Glutamate-gated chloride channel alpha (Avermectin-sensitive glutamate-gated chloride channel GluCl alpha) (GluCl alpha);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0008068; GO:0016595; GO:0030054; GO:0031987; GO:0034220; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051259; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; locomotion involved in locomotory behavior [GO:0031987]; nervous system process [GO:0050877]; protein complex oligomerization [GO:0051259]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]"
comp887335_c0_seq1;GAXK01201030.1;P48637;8.98E-58;GSHB_HUMAN;Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]";"GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006750; GO:0006979; GO:0007399; GO:0007568; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686; GO:0070062";"aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
comp8873928_c0_seq1;GAXK01108257.1;Q55434;1.88E-09;PHY2_SYNY3;Phytochrome-like protein cph2 (Bacteriophytochrome cph2);"red or far-red light photoreceptor activity [GO:0009883]; detection of visible light [GO:0009584]; protein-chromophore linkage [GO:0018298]; red, far-red light phototransduction [GO:0009585]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0006355; GO:0009584; GO:0009585; GO:0009883; GO:0018298";"detection of visible light [GO:0009584]; protein-chromophore linkage [GO:0018298]; red, far-red light phototransduction [GO:0009585]; regulation of transcription, DNA-templated [GO:0006355]";;red or far-red light photoreceptor activity [GO:0009883]
comp887410_c0_seq1;GAXK01200984.1;Q76KX8;7.20E-10;ZN534_HUMAN;Zinc finger protein 534 (KRAB domain only protein 3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp887497_c0_seq1;GAXK01201003.1;Q76CA2;3.31E-08;ACTP2_MONPT;Echotoxin-2 (Echt 2);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp8875160_c0_seq1;GAXK01091660.1;A5UXG2;4.38E-24;TRPA_ROSS1;Tryptophan synthase alpha chain (EC 4.2.1.20);tryptophan synthase activity [GO:0004834];GO:0004834;;;tryptophan synthase activity [GO:0004834]
comp887536_c0_seq1;GAXK01200999.1;B4KR21;9.52E-25;QVR_DROMO;Protein quiver (Protein sleepless);"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818";"negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]";"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]";GPI anchor binding [GO:0034235]
comp8875399_c0_seq1;GAXK01091658.1;Q9KBU2;5.59E-22;LUTA_BACHD;Lactate utilization protein A;lactate metabolic process [GO:0006089];GO:0006089;lactate metabolic process [GO:0006089];;
comp8875728_c0_seq1;GAXK01091659.1;Q13U06;8.14E-48;ZAPD_PARXL;Cell division protein ZapD (Z ring-associated protein D);"cytoplasm [GO:0005737]; division septum assembly [GO:0000917]; FtsZ-dependent cytokinesis [GO:0043093]";"GO:0000917; GO:0005737; GO:0043093";"division septum assembly [GO:0000917]; FtsZ-dependent cytokinesis [GO:0043093]";cytoplasm [GO:0005737];
comp8876093_c0_seq1;GAXK01197905.1;P50974;3.25E-47;NUOM_RHOCA;NADH-quinone oxidoreductase subunit M (EC 7.1.1.-) (NADH dehydrogenase I subunit M) (NDH-1 subunit M);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]";"GO:0005886; GO:0006120; GO:0008137; GO:0016021; GO:0048038";mitochondrial electron transport, NADH to ubiquinone [GO:0006120];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"
comp88782_c5_seq1;GAXK01194606.1;A2VD13;2.27E-60;PTCD1_RAT;Pentatricopeptide repeat-containing protein 1, mitochondrial;"mitochondrial matrix [GO:0005759]; tRNA binding [GO:0000049]; tRNA 3'-end processing [GO:0042780]";"GO:0000049; GO:0005759; GO:0042780";tRNA 3'-end processing [GO:0042780];mitochondrial matrix [GO:0005759];tRNA binding [GO:0000049]
comp887915_c0_seq1;GAXK01201026.1;P97500;9.37E-42;MYT1L_MOUSE;Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1);"chromosome [GO:0005694]; nucleus [GO:0005634]; cobalt ion binding [GO:0050897]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000122; GO:0000977; GO:0001227; GO:0001228; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897";"negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"cobalt ion binding [GO:0050897]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]"
comp8879158_c0_seq1;GAXK01058383.1;Q43157;2.77E-47;RPE_SPIOL;Ribulose-phosphate 3-epimerase, chloroplastic (EC 5.1.3.1) (Pentose-5-phosphate 3-epimerase) (PPE) (R5P3E) (RPE);"chloroplast thylakoid membrane [GO:0009535]; metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]";"GO:0004750; GO:0006098; GO:0009535; GO:0019253; GO:0046872";"pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]";chloroplast thylakoid membrane [GO:0009535];"metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]"
comp8879689_c0_seq1;GAXK01058389.1;P76462;1.30E-10;YFAP_ECOLI;Uncharacterized protein YfaP;;;;;
comp88805_c1_seq1;GAXK01195276.1;A6H782;3.86E-85;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp888057_c1_seq1;GAXK01107676.1;P16066;2.80E-82;ANPRA_HUMAN;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779";"body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]";"ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]"
comp8880600_c0_seq1;GAXK01144216.1;P31906;8.19E-29;HYPE_BRADU;Carbamoyl dehydratase HypE (EC 4.2.1.-) (Hydrogenase maturation factor HypE);lyase activity [GO:0016829];GO:0016829;;;lyase activity [GO:0016829]
comp8881671_c0_seq1;GAXK01144215.1;Q7VUH1;5.98E-57;KPRS_BORPE;Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";"GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301";"5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]"
comp888338_c0_seq1;GAXK01107671.1;P55786;1.80E-35;PSA_HUMAN;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp88847_c0_seq1;GAXK01195227.1;A8XKT0;1.64E-133;KYNU_CAEBR;Kynureninase (EC 3.7.1.3) (Abnormal fluorescence under UV illumination) (L-kynurenine hydrolase);"cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053";"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441]";cytoplasm [GO:0005737];"kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]"
comp8885131_c0_seq1;GAXK01140827.1;O94609;9.87E-12;UBA1_SCHPO;Ubiquitin-activating enzyme E1 1 (EC 6.2.1.45) (Poly(A)+ RNA transport protein 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000287; GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446";"cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; ubiquitin activating enzyme activity [GO:0004839]"
comp888845_c0_seq1;GAXK01107673.1;P52746;1.08E-19;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8888558_c0_seq1;GAXK01086974.1;Q7VYQ1;3.32E-78;QUEH_BORPE;Epoxyqueuosine reductase QueH (EC 1.17.99.6) (Queuosine biosynthesis protein QueH);"4 iron, 4 sulfur cluster binding [GO:0051539]; epoxyqueuosine reductase activity [GO:0052693]; metal ion binding [GO:0046872]; queuosine biosynthetic process [GO:0008616]; tRNA processing [GO:0008033]";"GO:0008033; GO:0008616; GO:0046872; GO:0051539; GO:0052693";"queuosine biosynthetic process [GO:0008616]; tRNA processing [GO:0008033]";;"4 iron, 4 sulfur cluster binding [GO:0051539]; epoxyqueuosine reductase activity [GO:0052693]; metal ion binding [GO:0046872]"
comp888901_c0_seq1;GAXK01107694.1;Q13887;6.47E-47;KLF5_HUMAN;Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2);"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0006366; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0071407; GO:0099156; GO:1901653; GO:1902895; GO:1990830";"angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]";"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp8891400_c0_seq1;GAXK01149967.1;Q7TS63;4.60E-09;ZFAT_MOUSE;Zinc finger protein ZFAT (Zinc finger protein 406);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712";"hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp889229_c0_seq1;GAXK01107691.1;P13678;9.83E-154;KPC3_DROME;Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F);"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";"GO:0004674; GO:0004697; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872";"dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]";plasma membrane [GO:0005886];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]"
comp88933_c3_seq1;GAXK01195235.1;Q9BDJ4;3.39E-11;LIPH_RABIT;Lipase member H (EC 3.1.1.-) (Lacrimal lipase);"extracellular region [GO:0005576]; membrane [GO:0016020]; carboxylic ester hydrolase activity [GO:0052689]; lipid catabolic process [GO:0016042]";"GO:0005576; GO:0016020; GO:0016042; GO:0052689";lipid catabolic process [GO:0016042];"extracellular region [GO:0005576]; membrane [GO:0016020]";carboxylic ester hydrolase activity [GO:0052689]
comp889372_c0_seq1;GAXK01107685.1;O35206;1.91E-26;COFA1_MOUSE;Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)];"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]";"GO:0005201; GO:0005581; GO:0005604; GO:0005615; GO:0007155; GO:0030198; GO:0031012; GO:0062023";"cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]";extracellular matrix structural constituent [GO:0005201]
comp88939_c5_seq1;GAXK01194683.1;Q95V25;0;SLO1_CAEEL;Calcium-activated potassium channel slo-1 (BK channel) (Maxi K channel) (MaxiK) (Slo homolog) (Slowpoke protein 1);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]; behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"GO:0005249; GO:0005886; GO:0006813; GO:0015269; GO:0015271; GO:0016021; GO:0030054; GO:0031430; GO:0034765; GO:0040011; GO:0042391; GO:0042493; GO:0043050; GO:0045202; GO:0045211; GO:0045214; GO:0046928; GO:0048149; GO:0050804; GO:0055120; GO:0060072";"behavioral response to ethanol [GO:0048149]; locomotion [GO:0040011]; modulation of chemical synaptic transmission [GO:0050804]; pharyngeal pumping [GO:0043050]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; response to drug [GO:0042493]; sarcomere organization [GO:0045214]";"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; M band [GO:0031430]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; striated muscle dense body [GO:0055120]; synapse [GO:0045202]";"calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated potassium channel activity [GO:0005249]"
comp8894129_c0_seq1;GAXK01034113.1;P41406;5.62E-07;ENVZ_SALTI;Osmolarity sensor protein EnvZ (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]";"GO:0000155; GO:0005524; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp8894385_c0_seq1;GAXK01034110.1;A1VRU2;4.28E-23;ACP_POLNA;Acyl carrier protein (ACP);"cytoplasm [GO:0005737]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]";"GO:0000036; GO:0005737; GO:0031177";;cytoplasm [GO:0005737];"acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]"
comp88948_c0_seq1;GAXK01194671.1;Q8GZ43;4.65E-08;YZR3_ARATH;RanBP2-type zinc finger protein At1g67325;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]";"GO:0003729; GO:0046872";;;"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp88972_c0_seq1;GAXK01194598.1;Q8TC21;2.26E-28;ZN596_HUMAN;Zinc finger protein 596;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp88995_c2_seq1;GAXK01195249.1;B2D0J5;3.66E-70;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp8899571_c0_seq1;GAXK01134995.1;Q7QH73;1.37E-17;PERC_ANOGA;Chorion peroxidase (EC 1.11.1.7);"extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";"GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477";"hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]";extracellular region [GO:0005576];"heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
comp89_c0_seq1;GAXK01165827.1;Q8WQI7;1.17E-79;RL18A_SPOFR;60S ribosomal protein L18a;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp89007_c1_seq1;GAXK01195149.1;Q6DC93;8.90E-46;PEF1_DANRE;Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1);"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]";"GO:0000139; GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0048208; GO:0060090; GO:1902527";"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]";"COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]";"calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]"
comp8902_c0_seq1;GAXK01013632.1;P05661;2.03E-70;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp890201_c0_seq1;GAXK01089314.1;Q8CEE6;2.48E-43;PASK_MOUSE;PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009";"energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]"
comp890433_c0_seq1;GAXK01089303.1;Q4VIT4;1.11E-69;PDIA3_CHLAE;Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]";"GO:0003756; GO:0005783; GO:0005788; GO:0042470; GO:0045454";cell redox homeostasis [GO:0045454];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]";protein disulfide isomerase activity [GO:0003756]
comp8905_c1_seq1;GAXK01013276.1;Q95RI5;2.07E-71;FAXC_DROME;Failed axon connections;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"GO:0005737; GO:0005886; GO:0007409; GO:0036099";"axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";
comp890506_c0_seq1;GAXK01089365.1;Q5E9S3;7.22E-10;TCF21_BOVIN;Transcription factor 21 (TCF-21);"nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]";"GO:0000122; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001944; GO:0005634; GO:0007530; GO:0014707; GO:0030855; GO:0032835; GO:0042826; GO:0043425; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0050681; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0070888; GO:0072162; GO:0072277";"branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]";nucleus [GO:0005634];"androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]"
comp890550_c0_seq1;GAXK01089306.1;O88368;8.59E-19;MITF_RAT;Microphthalmia-associated transcription factor;"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"GO:0000122; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0006351; GO:0006357; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144";"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]"
comp8905957_c0_seq1;GAXK01140698.1;B1XYF6;2.34E-36;RISB_LEPCP;6,7-dimethyl-8-ribityllumazine synthase (DMRL synthase) (LS) (Lumazine synthase) (EC 2.5.1.78);"riboflavin synthase complex [GO:0009349]; 6,7-dimethyl-8-ribityllumazine synthase activity [GO:0000906]; riboflavin biosynthetic process [GO:0009231]";"GO:0000906; GO:0009231; GO:0009349";riboflavin biosynthetic process [GO:0009231];riboflavin synthase complex [GO:0009349];6,7-dimethyl-8-ribityllumazine synthase activity [GO:0000906]
comp890668_c0_seq1;GAXK01089372.1;P15304;4.48E-56;LIPS_RAT;Hormone-sensitive lipase (HSL) (EC 3.1.1.79);"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acylglycerol lipase activity [GO:0047372]; hormone-sensitive lipase activity [GO:0033878]; hydrolase activity, acting on ester bonds [GO:0016788]; rRNA primary transcript binding [GO:0042134]; cholesterol metabolic process [GO:0008203]; female pregnancy [GO:0007565]; lipid catabolic process [GO:0016042]; response to drug [GO:0042493]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]";"GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0007565; GO:0008203; GO:0016042; GO:0016788; GO:0019433; GO:0033878; GO:0042134; GO:0042493; GO:0047372";"cholesterol metabolic process [GO:0008203]; female pregnancy [GO:0007565]; lipid catabolic process [GO:0016042]; response to drug [GO:0042493]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]";"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"acylglycerol lipase activity [GO:0047372]; hormone-sensitive lipase activity [GO:0033878]; hydrolase activity, acting on ester bonds [GO:0016788]; rRNA primary transcript binding [GO:0042134]"
comp8906752_c0_seq1;GAXK01033984.1;Q9W2X7;1.73E-38;YPL1_DROME;Protein yippee-like CG15309;metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp8907717_c0_seq1;GAXK01033983.1;A2SF93;1.33E-57;GLMM_METPP;Phosphoglucosamine mutase (EC 5.4.2.10);"magnesium ion binding [GO:0000287]; phosphoglucosamine mutase activity [GO:0008966]; carbohydrate metabolic process [GO:0005975]";"GO:0000287; GO:0005975; GO:0008966";carbohydrate metabolic process [GO:0005975];;"magnesium ion binding [GO:0000287]; phosphoglucosamine mutase activity [GO:0008966]"
comp8907776_c0_seq1;GAXK01033982.1;Q9HWS0;2.92E-36;CDPD1_PSEAE;Cyclic di-GMP phosphodiesterase PA4108 (EC 3.1.4.-);"cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; metal ion binding [GO:0046872]; positive regulation of cell motility [GO:2000147]; regulation of single-species biofilm formation on inanimate substrate [GO:1900231]";"GO:0046872; GO:0071111; GO:1900231; GO:2000147";"positive regulation of cell motility [GO:2000147]; regulation of single-species biofilm formation on inanimate substrate [GO:1900231]";;"cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; metal ion binding [GO:0046872]"
comp890784_c2_seq1;GAXK01089340.1;A0JNH6;7.31E-13;C102A_BOVIN;Coiled-coil domain-containing protein 102A;"myosin complex [GO:0016459]; motor activity [GO:0003774]";"GO:0003774; GO:0016459";;myosin complex [GO:0016459];motor activity [GO:0003774]
comp8908_c0_seq1;GAXK01013385.1;P23128;0;DDX6_DROME;ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]";"GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0030707; GO:0033962; GO:0034063; GO:0035195; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:1905618; GO:1990120; GO:1990124; GO:2000766";"cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P-body [GO:0000932]; P granule [GO:0043186]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp89082_c0_seq1;GAXK01195079.1;A6QLK2;1.28E-45;SOSB1_BOVIN;SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1);"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic cell cycle checkpoint [GO:0007093]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212]";"GO:0000724; GO:0000784; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070182; GO:0070200; GO:0070876; GO:0098505; GO:1904355";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic cell cycle checkpoint [GO:0007093]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212]";"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]";"DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]"
comp891_c0_seq1;GAXK01168690.1;O01814;6.89E-25;FABP5_CAEEL;Fatty acid-binding protein homolog 5;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504]";"GO:0005504; GO:0005634; GO:0048471";;"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";fatty acid binding [GO:0005504]
comp8910878_c0_seq1;;O78427;8.72E-74;PSBD_GUITH;Photosystem II D2 protein (PSII D2 protein) (EC 1.10.3.9) (Photosystem Q(A) protein);"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]; iron ion binding [GO:0005506]; photosynthetic electron transport in photosystem II [GO:0009772]; protein-chromophore linkage [GO:0018298]";"GO:0005506; GO:0009523; GO:0009535; GO:0009772; GO:0016021; GO:0016168; GO:0018298; GO:0045156";"photosynthetic electron transport in photosystem II [GO:0009772]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem II [GO:0009523]";"chlorophyll binding [GO:0016168]; electron transporter, transferring electrons within the cyclic electron transport pathway of photosynthesis activity [GO:0045156]; iron ion binding [GO:0005506]"
comp8911_c0_seq1;GAXK01014505.1;Q9UMY4;9.38E-84;SNX12_HUMAN;Sorting nexin-12;"early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]";"GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0016020; GO:0019899; GO:0030100; GO:0035091; GO:0042177; GO:0051224; GO:2000642";"negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]";"early endosome [GO:0005769]; membrane [GO:0016020]";"enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]"
comp8911520_c0_seq1;GAXK01149961.1;Q9BUQ8;3.99E-71;DDX23_HUMAN;Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"GO:0000354; GO:0000375; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0070062; GO:0071013";"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]";"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp89120_c0_seq1;GAXK01195037.1;P11049;1.75E-09;CD37_HUMAN;Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37);"extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"GO:0001772; GO:0005887; GO:0016020; GO:0070062";;"extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp89129_c3_seq1;GAXK01195268.1;P49283;6.34E-160;MVL_DROME;Protein Malvolio;"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838";"copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]";"apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]"
comp89145_c0_seq1;GAXK01194628.1;Q28570;2.93E-13;THA_SHEEP;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]";"GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0008270; GO:0043565; GO:0070324";;"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]"
comp89152_c2_seq1;GAXK01195077.1;P51570;1.70E-125;GALK1_HUMAN;Galactokinase (EC 2.7.1.6) (Galactose kinase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]";"GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0033499; GO:0061623; GO:0070062";"galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]";"ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]"
comp89157_c0_seq1;GAXK01195072.1;P11121;6.41E-13;CALM_PYUSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp891675_c0_seq1;GAXK01089349.1;Q9GV27;6.11E-29;EIF3H_BOMMO;Eukaryotic translation initiation factor 3 subunit H (eIF3h);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]";"GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290";formation of cytoplasmic translation initiation complex [GO:0001732];"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp891786_c2_seq1;GAXK01089366.1;P36513;5.76E-39;UDB14_RABIT;UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]";"GO:0005789; GO:0015020; GO:0016021";;"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";glucuronosyltransferase activity [GO:0015020]
comp8918275_c0_seq1;GAXK01075995.1;Q67ZM4;4.58E-15;ADF7_ARATH;Actin-depolymerizing factor 7 (ADF-7) (AtADF7);"actin filament [GO:0005884]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]";"GO:0003779; GO:0005737; GO:0005884; GO:0030042";actin filament depolymerization [GO:0030042];"actin filament [GO:0005884]; cytoplasm [GO:0005737]";actin binding [GO:0003779]
comp891836_c0_seq1;GAXK01089316.1;D3ZKX9;5.22E-34;LOXE3_RAT;Hydroperoxide isomerase ALOXE3 (EC 5.4.4.7) (Epidermis-type lipoxygenase 3) (Epidermal LOX-3) (e-LOX-3) (eLOX-3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152);"cytoplasm [GO:0005737]; hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]";"GO:0005506; GO:0005737; GO:0006665; GO:0016702; GO:0016829; GO:0019233; GO:0019369; GO:0019372; GO:0035357; GO:0043651; GO:0045444; GO:0046513; GO:0051120; GO:0051122; GO:0061436";"arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]";cytoplasm [GO:0005737];"hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp89184_c0_seq1;GAXK01194956.1;P51521;6.56E-77;OVO_DROME;Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)];"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896";"adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp89199_c0_seq1;GAXK01194612.1;Q9PVZ4;0;INSR_XENLA;"Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; insulin receptor signaling pathway [GO:0008286]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";"GO:0004713; GO:0004714; GO:0005009; GO:0005524; GO:0005886; GO:0005887; GO:0007275; GO:0008286; GO:0016020; GO:0042169; GO:0043548; GO:0043559; GO:0043560; GO:0046777; GO:0051290; GO:0051425";"insulin receptor signaling pathway [GO:0008286]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]";"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
comp892011_c0_seq1;GAXK01070142.1;Q8N1G0;8.07E-25;ZN687_HUMAN;Zinc finger protein 687;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005654; GO:0005829; GO:0046872";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8920309_c0_seq1;GAXK01028337.1;Q08DV6;2.40E-11;ASB3_BOVIN;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp892063_c0_seq1;GAXK01070109.1;Q9PJJ8;4.76E-11;UHPT_CHLMU;Probable hexose phosphate transport protein;"integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]";"GO:0005887; GO:0008643; GO:0022857";carbohydrate transport [GO:0008643];integral component of plasma membrane [GO:0005887];transmembrane transporter activity [GO:0022857]
comp8923134_c0_seq1;GAXK01120479.1;Q41969;4.03E-20;IF2B_ARATH;Eukaryotic translation initiation factor 2 subunit beta (eIF2-beta) (Protein EMBRYO DEFECTIVE 1401);"eukaryotic translation initiation factor 2 complex [GO:0005850]; plasma membrane [GO:0005886]; plastid [GO:0009536]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]";"GO:0001731; GO:0001732; GO:0003729; GO:0003743; GO:0005850; GO:0005886; GO:0009536; GO:0031369; GO:0046872";"formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]";"eukaryotic translation initiation factor 2 complex [GO:0005850]; plasma membrane [GO:0005886]; plastid [GO:0009536]";"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp892388_c0_seq1;GAXK01070174.1;Q3TZZ7;5.79E-34;ESYT2_MOUSE;Extended synaptotagmin-2 (E-Syt2);"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268";"endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]";"endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]"
comp89241_c1_seq1;GAXK01194975.1;Q6DHG0;1.45E-56;SETD7_DANRE;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003007; GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"heart morphogenesis [GO:0003007]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp8925253_c0_seq1;GAXK01128656.1;O13439;2.37E-55;ACEA_COPCI;Isocitrate lyase (ICL) (Isocitrase) (Isocitratase) (EC 4.1.3.1) (Methylisocitrate lyase) (MICA) (EC 4.1.3.30) (Threo-D(S)-isocitrate glyoxylate-lyase);"glyoxysome [GO:0009514]; isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]; methylisocitrate lyase activity [GO:0046421]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004451; GO:0006097; GO:0006099; GO:0009514; GO:0046421; GO:0046872";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";glyoxysome [GO:0009514];"isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]; methylisocitrate lyase activity [GO:0046421]"
comp892858_c0_seq1;GAXK01070164.1;Q9GRW0;6.12E-44;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp89286_c0_seq1;GAXK01195248.1;Q8T9B6;4.70E-27;MESD_DROME;LDLR chaperone boca;"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]";"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";identical protein binding [GO:0042802]
comp8929325_c0_seq1;GAXK01042683.1;Q3J4E3;9.56E-27;PCCB_RHOS4;Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase);"ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]";"GO:0004658; GO:0005524";;;"ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]"
comp89309_c0_seq1;GAXK01194623.1;Q3TD49;1.64E-90;SPP2B_MOUSE;Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-);"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]";"GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556";"membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]";"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"
comp89326_c0_seq1;GAXK01195273.1;Q8BHY3;0;ANO1_MOUSE;Anoctamin-1 (Transmembrane protein 16A);"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]";"GO:0005227; GO:0005229; GO:0005247; GO:0005254; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007200; GO:0009897; GO:0015111; GO:0015705; GO:0016324; GO:0034605; GO:0034707; GO:0035774; GO:0042391; GO:0042803; GO:0046982; GO:0050965; GO:0060438; GO:1902476";"cation transport [GO:0006812]; cellular response to heat [GO:0034605]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]";"apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]"
comp8933137_c0_seq1;GAXK01010971.1;Q479P5;8.96E-17;YACG_DECAR;DNA gyrase inhibitor YacG;"DNA topoisomerase (ATP-hydrolyzing) inhibitor activity [GO:0008657]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0006355; GO:0008270; GO:0008657";regulation of transcription, DNA-templated [GO:0006355];;"DNA topoisomerase (ATP-hydrolyzing) inhibitor activity [GO:0008657]; zinc ion binding [GO:0008270]"
comp89334_c0_seq1;GAXK01195172.1;Q9C0H5;2.07E-81;RHG39_HUMAN;Rho GTPase-activating protein 39;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173";"postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]";GTPase activator activity [GO:0005096]
comp89338_c0_seq1;GAXK01195002.1;Q19204;1.32E-36;ADT2_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-2 (ADAMTS adt-2) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";"GO:0004222; GO:0005576; GO:0008340; GO:0008361; GO:0030199; GO:0040018; GO:0046872";"collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]";extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp89339_c1_seq1;GAXK01195059.1;P56671;6.16E-11;MAZ_MOUSE;Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000978; GO:0000981; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0006367; GO:0006369; GO:0008284; GO:0010628; GO:0014068; GO:0030335; GO:0045893; GO:0045944; GO:0046872; GO:0051897; GO:2001234";"negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp89343_c0_seq1;GAXK01194672.1;P54629;3.68E-22;TRYU_DROER;Trypsin eta (EC 3.4.21.4);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615";;extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp89349_c1_seq1;GAXK01194977.1;Q92540;2.02E-84;SMG7_HUMAN;Protein SMG7 (EST1-like protein C) (SMG-7 homolog) (hSMG-7);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]";"GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0007004; GO:0032210; GO:0035303; GO:0042162; GO:0045111; GO:0051721; GO:0070034";"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]";"protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]"
comp8935159_c0_seq1;GAXK01195470.1;P23438;7.19E-49;SSRB_CANLF;Translocon-associated protein subunit beta (TRAP-beta) (Glycoprotein 25H) (gp25H) (Signal sequence receptor subunit beta) (SSR-beta);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"GO:0005783; GO:0005789; GO:0016021";;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp893532_c0_seq1;GAXK01070107.1;Q5ZIN0;2.27E-40;ABD12_CHICK;Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-);"AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0047372; GO:0050727; GO:0052651";"acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]";"AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]"
comp8936_c3_seq1;GAXK01014023.1;P32007;2.46E-118;ADT3_BOVIN;ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]";"GO:0005471; GO:0005743; GO:0006915; GO:0016021";apoptotic process [GO:0006915];"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]";ATP:ADP antiporter activity [GO:0005471]
comp8936240_c0_seq1;GAXK01080833.1;P62755;2.85E-48;RS6_RAT;40S ribosomal protein S6;"cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0003729; GO:0003735; GO:0006412; GO:0022627; GO:0032868; GO:0042593; GO:0071361; GO:1903347";"cellular response to ethanol [GO:0071361]; glucose homeostasis [GO:0042593]; negative regulation of bicellular tight junction assembly [GO:1903347]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp8936459_c0_seq1;GAXK01080837.1;P14381;2.43E-10;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp893840_c0_seq1;GAXK01070134.1;Q63ZR5;5.13E-152;RHN2B_XENLA;Rhophilin-2-B (GTP-Rho-binding protein 2-B);"perinuclear region of cytoplasm [GO:0048471]; signal transduction [GO:0007165]";"GO:0007165; GO:0048471";signal transduction [GO:0007165];perinuclear region of cytoplasm [GO:0048471];
comp8938479_c0_seq1;GAXK01013261.1;P13800;5.44E-19;DEGU_BACSU;Transcriptional regulatory protein DegU (Protease production enhancer protein);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000160; GO:0003677; GO:0005737; GO:0006355";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp89387_c1_seq1;GAXK01194991.1;Q5ZJY5;4.10E-87;SMC5_CHICK;Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5);"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000724; GO:0000781; GO:0005524; GO:0005634; GO:0007062; GO:0016605; GO:0030915; GO:0034184; GO:0051301; GO:0090398";"cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp8941849_c0_seq1;GAXK01110616.1;Q9LK36;4.76E-38;SAHH2_ARATH;Adenosylhomocysteinase 2 (AdoHcyase 2) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase 1) (SAH hydrolase 2);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";"GO:0004013; GO:0005773; GO:0005829; GO:0005886; GO:0006730; GO:0033353";"one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuole [GO:0005773]";adenosylhomocysteinase activity [GO:0004013]
comp894247_c0_seq1;GAXK01113595.1;A7RWP6;2.17E-17;EIF3E_NEMVE;Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540";"formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]";translation initiation factor activity [GO:0003743]
comp8942495_c0_seq1;GAXK01021314.1;Q6N9K2;4.07E-45;BCHB_RHOPA;Light-independent protochlorophyllide reductase subunit B (DPOR subunit B) (LI-POR subunit B) (EC 1.3.7.7);"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on iron-sulfur proteins as donors [GO:0016730]; oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor [GO:0016636]; light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis, dark reaction [GO:0019685]";"GO:0005524; GO:0016636; GO:0016730; GO:0019685; GO:0036070; GO:0046872; GO:0051539";"light-independent bacteriochlorophyll biosynthetic process [GO:0036070]; photosynthesis, dark reaction [GO:0019685]";;"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on iron-sulfur proteins as donors [GO:0016730]; oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor [GO:0016636]"
comp8943016_c0_seq1;GAXK01021315.1;P12613;4.28E-21;TCPA_DROME;T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1);"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]";"GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0030707; GO:0051082";"ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]";"chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp8944942_c0_seq1;GAXK01058462.1;P23847;6.15E-18;DPPA_ECOLI;Periplasmic dipeptide transport protein (Dipeptide-binding protein) (DBP);"ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288]; dipeptide transmembrane transporter activity [GO:0071916]; heme binding [GO:0020037]; peptide binding [GO:0042277]; chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"GO:0006935; GO:0015031; GO:0020037; GO:0030288; GO:0042277; GO:0042938; GO:0043190; GO:0061077; GO:0071916";"chaperone-mediated protein folding [GO:0061077]; chemotaxis [GO:0006935]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]";"ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288]";"dipeptide transmembrane transporter activity [GO:0071916]; heme binding [GO:0020037]; peptide binding [GO:0042277]"
comp894514_c0_seq1;GAXK01113605.1;Q06985;1.97E-08;SIA1B_MOUSE;E3 ubiquitin-protein ligase SIAH1B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1B) (Seven in absentia homolog 1b) (Siah-1b) (Siah1b);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp894573_c0_seq1;GAXK01113591.1;P86905;1.64E-10;SNMP1_APIME;Sensory neuron membrane protein 1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";"GO:0005886; GO:0007608; GO:0016021; GO:0050896";"response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp89460_c1_seq1;GAXK01195105.1;P27393;6.17E-154;CO4A2_ASCSU;Collagen alpha-2(IV) chain;"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]";"GO:0005201; GO:0005581; GO:0005604";;"basement membrane [GO:0005604]; collagen trimer [GO:0005581]";extracellular matrix structural constituent [GO:0005201]
comp8949161_c0_seq1;GAXK01034217.1;Q2YL86;7.70E-15;LIVB4_BRUA2;Leu/Ile/Val-binding protein homolog 4;amino acid transport [GO:0006865];GO:0006865;amino acid transport [GO:0006865];;
comp8950797_c0_seq1;GAXK01154896.1;Q41094;1.06E-16;FCPF_PHATR;Fucoxanthin-chlorophyll a-c binding protein F, chloroplastic;"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]; chlorophyll binding [GO:0016168]; photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"GO:0009523; GO:0009535; GO:0009765; GO:0016021; GO:0016168; GO:0018298; GO:0030076";"photosynthesis, light harvesting [GO:0009765]; protein-chromophore linkage [GO:0018298]";"chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; light-harvesting complex [GO:0030076]; photosystem II [GO:0009523]";chlorophyll binding [GO:0016168]
comp89522_c3_seq1;GAXK01195214.1;P49754;0;VPS41_HUMAN;Vacuolar protein sorting-associated protein 41 homolog (S53);"AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]";"GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006886; GO:0006914; GO:0008017; GO:0008333; GO:0010008; GO:0015630; GO:0016020; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042144; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774";"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]";"AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]"
comp8953263_c0_seq1;GAXK01107894.1;Q08972;4.15E-37;NEW1_YEAST;[NU+] prion formation protein 1;"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0016887; GO:0016973; GO:0042274";"poly(A)+ mRNA export from nucleus [GO:0016973]; ribosomal small subunit biogenesis [GO:0042274]";"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]"
comp89547_c0_seq1;GAXK01195208.1;Q8VBW5;5.89E-22;BBX_MOUSE;HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348]";"GO:0003677; GO:0005654; GO:0005829; GO:0060348";bone development [GO:0060348];"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";DNA binding [GO:0003677]
comp8955634_c0_seq1;;A7ZWZ1;2.13E-13;BGAL_ECOHS;Beta-galactosidase (Beta-gal) (EC 3.2.1.23) (Lactase);"beta-galactosidase complex [GO:0009341]; beta-galactosidase activity [GO:0004565]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975]";"GO:0000287; GO:0004565; GO:0005975; GO:0009341; GO:0030246";carbohydrate metabolic process [GO:0005975];beta-galactosidase complex [GO:0009341];"beta-galactosidase activity [GO:0004565]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]"
comp8956020_c0_seq1;GAXK01087621.1;P13471;6.01E-41;RS14_RAT;40S ribosomal protein S14;"cytosolic small ribosomal subunit [GO:0022627]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";"GO:0000028; GO:0000462; GO:0003723; GO:0003735; GO:0006412; GO:0022627; GO:0030490; GO:0048027; GO:0070181";"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]"
comp895648_c0_seq1;GAXK01113600.1;Q9H2X3;6.31E-10;CLC4M_HUMAN;C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0006897; GO:0007159; GO:0009988; GO:0016020; GO:0019048; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046790; GO:0046872; GO:0046968; GO:0048306; GO:0075733";"adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]";"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";"calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]"
comp895672_c0_seq1;GAXK01113587.1;Q5R5X9;5.48E-33;SMYD4_PONAB;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp895756_c0_seq1;GAXK01113569.1;P54985;9.75E-66;PPIA_BLAGE;Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase);"cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]";"GO:0003755; GO:0005737; GO:0006457";protein folding [GO:0006457];cytoplasm [GO:0005737];peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
comp8958383_c0_seq1;GAXK01118645.1;O14966;2.24E-11;RAB7L_HUMAN;Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29);"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0032482; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1903441; GO:1905279; GO:1990967";"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]";"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]";"dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]"
comp89603_c0_seq1;GAXK01194611.1;Q9GQM9;3.42E-26;CP6L1_BLAGE;Cytochrome P450 6l1 (EC 1.14.-.-) (CYPVIL1);"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]";"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037";;endoplasmic reticulum membrane [GO:0005789];"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
comp89604_c0_seq1;GAXK01194675.1;Q8IN81;3.05E-23;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp8960752_c0_seq1;GAXK01185309.1;Q1ZXG4;4.05E-32;PRLA_DICDI;Proliferation-associated protein A;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005730; GO:0005737; GO:0045335";;"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; phagocytic vesicle [GO:0045335]";nucleic acid binding [GO:0003676]
comp89612_c1_seq1;GAXK01194614.1;Q9U6A0;0;NCKX_DROME;Sodium/potassium/calcium exchanger Nckx30C (Na(+)/K(+)/Ca(2+)-exchange protein Nckx30C);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]";"GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0048749; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp8961663_c0_seq1;GAXK01185308.1;P31570;8.39E-09;BTUR_SALTY;Corrinoid adenosyltransferase (EC 2.5.1.17) (Cob(II)alamin adenosyltransferase) (Cob(II)yrinic acid a,c-diamide adenosyltransferase) (Cobinamide/cobalamin adenosyltransferase);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin biosynthetic process [GO:0009236]; porphyrin-containing compound biosynthetic process [GO:0006779]";"GO:0005524; GO:0005737; GO:0006779; GO:0008817; GO:0009236";"cobalamin biosynthetic process [GO:0009236]; porphyrin-containing compound biosynthetic process [GO:0006779]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]"
comp89617_c0_seq1;GAXK01194680.1;Q94887;0;NRX4_DROME;Neurexin-4 (Neurexin IV);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"GO:0003015; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0007163; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016080; GO:0016081; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105";"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]";
comp896268_c0_seq1;GAXK01040761.1;Q8IN81;3.61E-14;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp896397_c0_seq1;GAXK01040757.1;Q9XWZ2;1.28E-73;ACD11_CAEEL;Acyl-CoA dehydrogenase family member 11 (EC 1.3.99.-);"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; fatty acid metabolic process [GO:0006631]";"GO:0000166; GO:0006631; GO:0016627";fatty acid metabolic process [GO:0006631];;"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp89640_c1_seq1;GAXK01194677.1;B3EWZ5;5.23E-84;MLRP1_ACRMI;MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment);"extracellular region [GO:0005576]; membrane [GO:0016020]";"GO:0005576; GO:0016020";;"extracellular region [GO:0005576]; membrane [GO:0016020]";
comp89647_c0_seq1;GAXK01195076.1;O83142;3.56E-18;5NTD_TREPA;Probable 5'-nucleotidase (EC 3.1.3.5);"plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]";"GO:0000166; GO:0005886; GO:0008253; GO:0009166; GO:0046872";nucleotide catabolic process [GO:0009166];plasma membrane [GO:0005886];"5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"
comp8965691_c0_seq1;GAXK01091626.1;Q9SCC7;1.23E-101;CBBX_GUITH;Protein cbbX homolog, chloroplastic;"chloroplast [GO:0009507]; ATP binding [GO:0005524]";"GO:0005524; GO:0009507";;chloroplast [GO:0009507];ATP binding [GO:0005524]
comp896572_c0_seq1;GAXK01040743.1;Q16181;1.17E-17;SEPT7_HUMAN;Septin-7 (CDC10 protein homolog);"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134";"cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]";"axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]";"cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]"
comp89664_c1_seq1;GAXK01195074.1;P25722;3.70E-99;HS2ST_DROME;Heparin sulfate O-sulfotransferase (EC 2.8.2.-);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; open tracheal system development [GO:0007424]; signal transduction [GO:0007165]";"GO:0000139; GO:0004394; GO:0007165; GO:0007424; GO:0008146; GO:0015012; GO:0015014; GO:0015015; GO:0016021";"heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; open tracheal system development [GO:0007424]; signal transduction [GO:0007165]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]"
comp89672_c1_seq1;GAXK01194622.1;P18737;2.77E-16;ZG8_XENLA;Gastrula zinc finger protein XlCGF8.2DB (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp896734_c0_seq1;GAXK01040738.1;Q9VI25;1.51E-28;NCDN_DROME;Neurochondrin homolog (dNeurochondrin);"dendrite [GO:0030425]; neuronal cell body [GO:0043025]; muscle system process [GO:0003012]";"GO:0003012; GO:0030425; GO:0043025";muscle system process [GO:0003012];"dendrite [GO:0030425]; neuronal cell body [GO:0043025]";
comp8967754_c0_seq1;GAXK01049205.1;Q8U3Y2;8.53E-35;GYAR_PYRFU;Glyoxylate reductase (EC 1.1.1.26);"cytoplasm [GO:0005737]; glyoxylate reductase activity [GO:0047964]; NAD binding [GO:0051287]";"GO:0005737; GO:0047964; GO:0051287";;cytoplasm [GO:0005737];"glyoxylate reductase activity [GO:0047964]; NAD binding [GO:0051287]"
comp8968848_c0_seq1;GAXK01045233.1;P42593;1.72E-24;FADH_ECOLI;2,4-dienoyl-CoA reductase (DCR) (EC 1.3.1.34) (2,4-dienoyl-coenzyme A reductase [NADPH]);"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FAD binding [GO:0071949]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway [GO:0033543]";"GO:0008670; GO:0010181; GO:0033543; GO:0046872; GO:0051539; GO:0071949";fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway [GO:0033543];;"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FAD binding [GO:0071949]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]"
comp897039_c0_seq1;GAXK01040751.1;Q32PH1;4.15E-29;CDCA7_BOVIN;Cell division cycle-associated protein 7;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006915; GO:0042127";"apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp897196_c1_seq1;GAXK01040747.1;Q6ZMW2;1.01E-16;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp897242_c0_seq1;GAXK01040741.1;Q5GH73;2.02E-19;XKR6_HUMAN;XK-related protein 6;"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742";"apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]";
comp8973_c0_seq1;GAXK01013928.1;Q03755;8.72E-09;CUT1_CAEEL;Cuticlin-1;"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; structural constituent of cuticle [GO:0042302]";"GO:0042302; GO:0060102";;collagen and cuticulin-based cuticle extracellular matrix [GO:0060102];structural constituent of cuticle [GO:0042302]
comp897451_c0_seq1;GAXK01040708.1;Q90678;2.88E-66;PAFA_CHICK;Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase);"extracellular space [GO:0005615]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]";"GO:0003847; GO:0005615; GO:0016042";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]
comp89746_c1_seq1;GAXK01194955.1;Q9Y227;2.70E-131;ENTP4_HUMAN;Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.6) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase);"cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; uridine-diphosphatase activity [GO:0045134]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256]";"GO:0000139; GO:0006256; GO:0030173; GO:0031410; GO:0034656; GO:0045134; GO:0097637";"nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256]";"cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]";uridine-diphosphatase activity [GO:0045134]
comp8976448_c0_seq1;GAXK01143161.1;P75936;2.94E-13;FLGD_ECOLI;Basal-body rod modification protein FlgD;"cytosol [GO:0005829]; bacterial-type flagellum organization [GO:0044781]";"GO:0005829; GO:0044781";bacterial-type flagellum organization [GO:0044781];cytosol [GO:0005829];
comp8977072_c0_seq1;GAXK01143157.1;Q54KE6;1.87E-19;MCCA_DICDI;Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]";"GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0046872";leucine catabolic process [GO:0006552];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]"
comp897755_c0_seq1;GAXK01040710.1;Q2EI21;1.08E-07;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp897775_c0_seq1;GAXK01040758.1;Q02361;2.17E-60;FD3_DROME;Fork head domain-containing protein FD3;"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0009653; GO:0030154; GO:0043565";"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp897833_c0_seq1;GAXK01040765.1;Q9VFP2;2.03E-14;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp897904_c0_seq1;GAXK01040766.1;P24044;7.63E-50;CALM_PLAFA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp8979279_c0_seq1;GAXK01025766.1;P37279;2.80E-26;ATCS_SYNE7;Probable copper-transporting ATPase PacS (EC 7.2.2.8);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]";"GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872";copper ion transport [GO:0006825];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp8979978_c0_seq1;GAXK01025770.1;P43510;2.39E-10;CPR6_CAEEL;Cathepsin B-like cysteine proteinase 6 (EC 3.4.22.-) (Cysteine protease-related 6);"extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]";"GO:0004197; GO:0005615; GO:0005764; GO:0051603";proteolysis involved in cellular protein catabolic process [GO:0051603];"extracellular space [GO:0005615]; lysosome [GO:0005764]";cysteine-type endopeptidase activity [GO:0004197]
comp8979995_c0_seq1;GAXK01025768.1;P17708;7.01E-23;DCAM_RAT;"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]";"cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]; polyamine metabolic process [GO:0006595]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; S-adenosylmethionine metabolic process [GO:0046500]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";"GO:0004014; GO:0005829; GO:0006557; GO:0006595; GO:0006597; GO:0008295; GO:0019810; GO:0046500";"polyamine metabolic process [GO:0006595]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; S-adenosylmethionine metabolic process [GO:0046500]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]";cytosol [GO:0005829];"adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]"
comp8980744_c0_seq1;GAXK01204969.1;P46595;1.87E-66;UBC4_SCHPO;Ubiquitin-conjugating enzyme E2 4 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein 4) (Ubiquitin-protein ligase 4);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0031146; GO:0031625; GO:0035103; GO:0043224; GO:0045842; GO:0060049; GO:0061631";"positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]"
comp898082_c1_seq1;GAXK01182094.1;Q32KI9;9.13E-60;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp898190_c0_seq1;GAXK01182089.1;Q99LI5;9.51E-07;ZN281_MOUSE;Zinc finger protein 281;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]";"GO:0000122; GO:0000978; GO:0000980; GO:0001227; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0010172; GO:0010629; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048863";"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell differentiation [GO:0048863]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp898203_c0_seq1;GAXK01182124.1;Q6V5K9;2.95E-19;ZN474_MOUSE;Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP);metal ion binding [GO:0046872];GO:0046872;;;metal ion binding [GO:0046872]
comp89832_c2_seq1;GAXK01195102.1;Q9U2C4;4.70E-135;GALT9_CAEEL;Probable N-acetylgalactosaminyltransferase 9 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9) (pp-GaNTase 9);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005794; GO:0006486; GO:0016021; GO:0016757; GO:0030246; GO:0046872";protein glycosylation [GO:0006486];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp8983758_c0_seq1;GAXK01115649.1;C5CNB3;4.91E-33;ATPA_VARPS;ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha);"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]";"GO:0005524; GO:0005886; GO:0015986; GO:0045261; GO:0046933";ATP synthesis coupled proton transport [GO:0015986];"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]";"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp89845_c0_seq1;GAXK01205975.1;Q94517;0;HDAC1_DROME;Histone deacetylase Rpd3 (HD) (dRPD3) (EC 3.5.1.98);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; blastoderm segmentation [GO:0007350]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; dendrite guidance [GO:0070983]; determination of adult lifespan [GO:0008340]; gene silencing [GO:0016458]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of axonogenesis [GO:0050771]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone methylation [GO:0031061]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone acetylation [GO:0035065]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000118; GO:0000122; GO:0000785; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005700; GO:0005705; GO:0005737; GO:0006325; GO:0006342; GO:0006355; GO:0007350; GO:0008134; GO:0008340; GO:0010629; GO:0016458; GO:0016575; GO:0016580; GO:0016581; GO:0017053; GO:0030261; GO:0031061; GO:0031523; GO:0032041; GO:0035065; GO:0035098; GO:0045664; GO:0045879; GO:0045892; GO:0045944; GO:0048477; GO:0050771; GO:0061086; GO:0070822; GO:0070932; GO:0070933; GO:0070983; GO:1902692; GO:2001229";"blastoderm segmentation [GO:0007350]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; dendrite guidance [GO:0070983]; determination of adult lifespan [GO:0008340]; gene silencing [GO:0016458]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of axonogenesis [GO:0050771]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone methylation [GO:0031061]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone acetylation [GO:0035065]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]";"histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"
comp8986786_c0_seq1;GAXK01131472.1;Q7SDU2;6.50E-29;RL24_NEUCR;60S ribosomal protein L24;"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";"GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:1902626";"assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]";cytosolic large ribosomal subunit [GO:0022625];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp8986956_c0_seq1;GAXK01131475.1;Q9WX37;2.27E-17;RBPE_NOSS1;Putative RNA-binding protein RbpE;RNA binding [GO:0003723];GO:0003723;;;RNA binding [GO:0003723]
comp898773_c0_seq1;GAXK01182102.1;A3QMC6;1.18E-22;ERLN_CAEEL;Erlin (Endoplasmic reticulum lipid raft-associated protein 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; SREBP signaling pathway [GO:0032933]";"GO:0005789; GO:0015485; GO:0016021; GO:0031625; GO:0032933; GO:0032991";SREBP signaling pathway [GO:0032933];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp8988281_c0_seq1;GAXK01136672.1;P31902;9.36E-09;HYPB_CUPNH;Hydrogenase maturation factor HypB;"GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nickel cation binding [GO:0016151]; protein maturation [GO:0051604]";"GO:0005525; GO:0016151; GO:0016787; GO:0051604";protein maturation [GO:0051604];;"GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nickel cation binding [GO:0016151]"
comp898898_c0_seq1;GAXK01182109.1;Q96PE6;3.16E-13;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp8989300_c0_seq1;GAXK01136669.1;O24573;2.50E-29;RLA0_MAIZE;60S acidic ribosomal protein P0;"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";"GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0034059; GO:0044877; GO:0070180";"cytoplasmic translation [GO:0002181]; response to anoxia [GO:0034059]; ribosomal large subunit assembly [GO:0000027]";cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]"
comp8989534_c0_seq1;GAXK01136664.1;P35332;1.03E-15;HPCL4_RAT;Hippocalcin-like protein 4 (Neural visinin-like protein 2) (NVL-2) (NVP-2) (Visinin-like protein 2) (VILIP-2);"calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165]";"GO:0005246; GO:0005509; GO:0007165; GO:0008022; GO:0019904";signal transduction [GO:0007165];;"calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]"
comp89897_c0_seq1;GAXK01195269.1;Q149F1;3.57E-70;RUSD2_MOUSE;RNA pseudouridylate synthase domain-containing protein 2;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]";"GO:0001522; GO:0003723; GO:0009982";pseudouridine synthesis [GO:0001522];;"pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]"
comp899_c0_seq1;GAXK01166364.1;Q5ZIM5;8.93E-180;MAP1_CHICK;Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]";"GO:0005737; GO:0046872; GO:0070006; GO:0070084";protein initiator methionine removal [GO:0070084];cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]"
comp899134_c0_seq1;GAXK01182132.1;O01812;7.48E-10;FABP6_CAEEL;Fatty acid-binding protein homolog 6;lipid binding [GO:0008289];GO:0008289;;;lipid binding [GO:0008289]
comp89936_c1_seq1;GAXK01194609.1;Q7KRI2;9.82E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp8994119_c0_seq1;GAXK01204662.1;P55143;1.99E-18;GLRX_RICCO;Glutaredoxin;"cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]";"GO:0005737; GO:0009055; GO:0015035; GO:0045454";cell redox homeostasis [GO:0045454];cytoplasm [GO:0005737];"electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]"
comp89956_c3_seq1;GAXK01195242.1;Q8TCF1;6.59E-45;ZFAN1_HUMAN;AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1);"cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]";"GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843";"cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]";cytoplasmic stress granule [GO:0010494];"proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]"
comp899636_c1_seq1;GAXK01182134.1;A8QZJ5;1.64E-19;MCTX1_MILDI;Millepora cytotoxin-1 (MCTx-1);"extracellular region [GO:0005576]; nematocyst [GO:0042151]";"GO:0005576; GO:0042151";;"extracellular region [GO:0005576]; nematocyst [GO:0042151]";
comp899854_c1_seq1;GAXK01182085.1;Q6NPT7;9.03E-10;HRD1B_ARATH;ERAD-associated E3 ubiquitin-protein ligase HRD1B (AtHrd1B) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase HRD1B);"Derlin-1 retrotranslocation complex [GO:0036513]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein K48-linked ubiquitination [GO:0070936]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005886; GO:0006511; GO:0016021; GO:0030433; GO:0030968; GO:0030970; GO:0036513; GO:0046872; GO:0051082; GO:0061630; GO:0070936; GO:1990381";"endoplasmic reticulum unfolded protein response [GO:0030968]; protein K48-linked ubiquitination [GO:0070936]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Derlin-1 retrotranslocation complex [GO:0036513]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]"
comp89995_c0_seq1;GAXK01194676.1;Q5RDY1;9.53E-53;NPL_PONAB;N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase);"cytoplasm [GO:0005737]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]";"GO:0005737; GO:0005975; GO:0008747; GO:0019262";"carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]";cytoplasm [GO:0005737];N-acetylneuraminate lyase activity [GO:0008747]
comp9_c0_seq1;GAXK01168977.1;Q15369;5.72E-59;ELOC_HUMAN;Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1);"cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0006368; GO:0006511; GO:0016032; GO:0016567; GO:0032968; GO:0043687; GO:0061418; GO:0070449";"positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]";"cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]";
comp900276_c0_seq1;GAXK01056690.1;O62836;4.72E-22;ZFX_BOVIN;Zinc finger X-chromosomal protein;"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"GO:0001541; GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746";"fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9003516_c0_seq1;GAXK01034366.1;Q43935;1.64E-35;CATF_ACIAD;Beta-ketoadipyl-CoA thiolase (EC 2.3.1.174) (3-oxoadipyl-CoA thiolase);"3-oxoadipyl-CoA thiolase activity [GO:0033812]; 3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]";"GO:0019619; GO:0033812; GO:0042952";"3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]";;3-oxoadipyl-CoA thiolase activity [GO:0033812]
comp900364_c0_seq1;GAXK01056684.1;P83088;3.95E-52;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp900561_c0_seq1;GAXK01056725.1;B1WBP0;8.71E-34;MPPD2_RAT;Metallophosphoesterase MPPED2 (EC 3.1.-.-) (239FB) (Fetal brain protein 239 homolog) (Metallophosphoesterase domain-containing protein 2);"AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]";"GO:0008081; GO:0016208; GO:0019002; GO:0030145";;;"AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]"
comp90059_c0_seq1;GAXK01002451.1;Q9NRK6;0;ABCBA_HUMAN;ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2);"integral component of membrane [GO:0016021]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; mitochondrial transport [GO:0006839]";"GO:0005524; GO:0005743; GO:0006839; GO:0016021; GO:0016887; GO:0032592; GO:0042626; GO:0042803";mitochondrial transport [GO:0006839];"integral component of membrane [GO:0016021]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]"
comp900597_c1_seq1;GAXK01056738.1;P21521;1.77E-16;SY65_DROME;Synaptotagmin 1 (p65);"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073";"calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]";"axon [GO:0030424]; cell junction [GO:0030054]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp900791_c0_seq1;GAXK01056685.1;Q6DGN0;4.99E-31;RERGL_DANRE;Ras-related and estrogen-regulated growth inhibitor-like protein (RERG/Ras-like protein);"membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]";"GO:0003924; GO:0005525; GO:0007165; GO:0016020";signal transduction [GO:0007165];membrane [GO:0016020];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp9008_c1_seq1;GAXK01013516.1;O54698;3.96E-66;S29A1_RAT;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"GO:0005337; GO:0005886; GO:0005887; GO:0007595; GO:0015858; GO:0015862; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794";"cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]";nucleoside transmembrane transporter activity [GO:0005337]
comp900941_c0_seq1;GAXK01056688.1;P23696;2.11E-179;PP2A_DROME;Serine/threonine-protein phosphatase PP2A (EC 3.1.3.16) (Protein microtubule star);"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; protein serine/threonine phosphatase activity [GO:0004722]; asymmetric neuroblast division [GO:0055059]; autophagy [GO:0006914]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; circadian rhythm [GO:0007623]; establishment of epithelial cell polarity [GO:0090162]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; R7 cell fate commitment [GO:0007465]; response to light stimulus [GO:0009416]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0000159; GO:0000226; GO:0000278; GO:0001933; GO:0004722; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0006470; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0007099; GO:0007406; GO:0007465; GO:0007623; GO:0009416; GO:0019208; GO:0035331; GO:0045879; GO:0045880; GO:0046627; GO:0046872; GO:0048190; GO:0048477; GO:0051225; GO:0051898; GO:0055059; GO:0090162; GO:0090263";"asymmetric neuroblast division [GO:0055059]; autophagy [GO:0006914]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; circadian rhythm [GO:0007623]; establishment of epithelial cell polarity [GO:0090162]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; R7 cell fate commitment [GO:0007465]; response to light stimulus [GO:0009416]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]; wing disc dorsal/ventral pattern formation [GO:0048190]";"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]";"metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; protein serine/threonine phosphatase activity [GO:0004722]"
comp900942_c0_seq1;GAXK01056727.1;A9Y006;2.57E-45;AQP3_PIG;Aquaporin-3 (Aquaglyceroporin-3);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transport [GO:0015793]; water transport [GO:0006833]";"GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323";"glycerol transport [GO:0015793]; water transport [GO:0006833]";"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]";"glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
comp90098_c0_seq1;GAXK01002447.1;Q24180;3.44E-07;DEAF1_DROME;Deformed epidermal autoregulatory factor 1 (Protein DEAF-1);"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776";"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleus [GO:0005634]; polytene chromosome [GO:0005700]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp90106_c0_seq1;GAXK01002445.1;Q5U2Q3;6.67E-102;CK054_RAT;Ester hydrolase C11orf54 homolog (EC 3.1.-.-);"nuclear body [GO:0016604]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]";"GO:0008270; GO:0016604; GO:0016788";;nuclear body [GO:0016604];"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
comp9012094_c0_seq1;GAXK01153980.1;P41116;1.43E-45;RL8_XENLA;60S ribosomal protein L8;"large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934; GO:0019843";translation [GO:0006412];large ribosomal subunit [GO:0015934];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp9012112_c0_seq1;GAXK01153985.1;Q9HYT3;2.30E-07;Y3311_PSEAE;Uncharacterized signaling protein PA3311;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; cellular response to nitric oxide [GO:0071732]";"GO:0005886; GO:0016021; GO:0071111; GO:0071732";cellular response to nitric oxide [GO:0071732];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]
comp90132_c2_seq1;GAXK01002404.1;E1BBQ2;4.82E-13;GP158_BOVIN;Probable G-protein coupled receptor 158;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659]";"GO:0004930; GO:0005886; GO:0016021; GO:0072659";protein localization to plasma membrane [GO:0072659];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp901323_c0_seq1;GAXK01056679.1;O75596;4.41E-11;CLC3A_HUMAN;C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin);"extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; ossification [GO:0001503]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001503; GO:0005615; GO:0030246";"ossification [GO:0001503]; skeletal system development [GO:0001501]";extracellular space [GO:0005615];carbohydrate binding [GO:0030246]
comp901358_c0_seq1;GAXK01056683.1;Q68DY1;6.47E-10;ZN626_HUMAN;Zinc finger protein 626;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9015281_c0_seq1;GAXK01028432.1;Q9VNM1;2.98E-19;NPFR_DROME;Neuropeptide F receptor (DmNPFR1);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834";"endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]"
comp9015353_c0_seq1;GAXK01028425.1;Q56897;3.74E-19;TRA8_YEREN;Transposase for insertion sequence element IS1328;"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]";"GO:0003677; GO:0004803; GO:0006313";transposition, DNA-mediated [GO:0006313];;"DNA binding [GO:0003677]; transposase activity [GO:0004803]"
comp9016585_c0_seq1;GAXK01136899.1;P94177;2.58E-55;CZCA_ALCSC;Cation efflux system protein CzcA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; response to cadmium ion [GO:0046686]";"GO:0005886; GO:0008324; GO:0016021; GO:0046686";response to cadmium ion [GO:0046686];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp90180_c2_seq1;GAXK01002343.1;Q925Q9;3.16E-15;SH3K1_RAT;SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes);"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of apoptotic process [GO:0042981]; regulation of cell shape [GO:0008360]";"GO:0005737; GO:0005856; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0042981; GO:0043005; GO:0045202";"actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; regulation of apoptotic process [GO:0042981]; regulation of cell shape [GO:0008360]";"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]";"SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]"
comp901808_c0_seq1;GAXK01056675.1;A4FUH1;7.11E-21;TOR2A_BOVIN;Torsin-2A (Torsin family 2 member A);"endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260]";"GO:0005524; GO:0005635; GO:0005788; GO:0016887; GO:0051085; GO:0051260";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260]";"endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]"
comp90218_c10_seq1;GAXK01002492.1;Q69ZL1;1.68E-137;FGD6_MOUSE;FYVE, RhoGEF and PH domain-containing protein 6;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0005089; GO:0005737; GO:0005856; GO:0035023; GO:0043087; GO:0046872";"regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]";"metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp902289_c0_seq1;GAXK01036584.1;A5E8F3;1.35E-18;Y150_BRASB;UPF0314 protein BBta_0150;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp9024_c0_seq1;GAXK01014142.1;Q5F3A1;5.02E-24;SEC62_CHICK;Translocation protein SEC62 (Translocation protein 1) (TP-1);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; posttranslational protein targeting to membrane, translocation [GO:0031204]";"GO:0005783; GO:0016020; GO:0030176; GO:0031204";posttranslational protein targeting to membrane, translocation [GO:0031204];"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]";
comp902484_c0_seq1;GAXK01036596.1;Q539E5;2.67E-31;APX1_HYDVD;Putative ascorbate peroxidase (EC 1.11.1.11) (HvAPX1);"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0016688; GO:0020037; GO:0042744; GO:0046872";"hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]";;"heme binding [GO:0020037]; L-ascorbate peroxidase activity [GO:0016688]; metal ion binding [GO:0046872]"
comp9026_c1_seq1;GAXK01014768.1;P55016;0;S12A1_RAT;Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) (BSC1) (Kidney-specific Na-K-Cl symporter);"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006884; GO:0008511; GO:0009986; GO:0015081; GO:0015378; GO:0015379; GO:0016021; GO:0016101; GO:0016324; GO:0032978; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070294; GO:1902476; GO:1990573";"cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; diterpenoid metabolic process [GO:0016101]; ion transmembrane transport [GO:0034220]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein insertion into membrane from inner side [GO:0032978]; renal sodium ion absorption [GO:0070294]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"potassium:chloride symporter activity [GO:0015379]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]"
comp902876_c3_seq1;GAXK01036569.1;Q99JD2;2.67E-24;TEKT1_RAT;Tektin-1;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]";"GO:0005737; GO:0005874; GO:0015630; GO:0031514; GO:0060271; GO:0060294";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]";
comp902890_c0_seq1;GAXK01036614.1;Q7KRI2;1.34E-17;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp9030_c0_seq1;GAXK01014063.1;E9NA96;2.04E-106;IR25A_DROME;Ionotropic receptor 25a;"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]; AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"GO:0004971; GO:0005886; GO:0005929; GO:0007610; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0032281; GO:0043204; GO:0048511; GO:0050907; GO:0050911; GO:0071683";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]";"AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]"
comp90302_c1_seq1;GAXK01002215.1;Q86TI0;4.63E-98;TBCD1_HUMAN;TBC1 domain family member 1;"cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; regulation of protein localization [GO:0032880]";"GO:0005096; GO:0005634; GO:0005829; GO:0006886; GO:0017137; GO:0032880; GO:0061024; GO:0090630";"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; regulation of protein localization [GO:0032880]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]"
comp9031_c0_seq1;GAXK01013657.1;Q5RAS8;4.69E-11;TM199_PONAB;Transmembrane protein 199;"COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0005764; GO:0005783; GO:0005789; GO:0006879; GO:0007042; GO:0016021; GO:0016471; GO:0030663; GO:0033116; GO:0036295; GO:0070072; GO:1905146";"cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";
comp90310_c0_seq1;GAXK01002388.1;Q6Y288;7.64E-82;B3GLT_HUMAN;Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066";"fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp903297_c0_seq1;GAXK01036582.1;O88870;3.72E-26;BEST1_MOUSE;Bestrophin-1 (Vitelliform macular dystrophy protein 2 homolog);"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"GO:0005254; GO:0006821; GO:0016323; GO:0030321; GO:0034707; GO:0042802; GO:0050908; GO:0051924";"chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]";"basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]";"chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]"
comp9035854_c0_seq1;GAXK01102317.1;P94177;8.42E-16;CZCA_ALCSC;Cation efflux system protein CzcA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; response to cadmium ion [GO:0046686]";"GO:0005886; GO:0008324; GO:0016021; GO:0046686";response to cadmium ion [GO:0046686];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp9035856_c0_seq1;GAXK01102320.1;P11718;2.98E-20;ATXA_LEIDO;Probable proton ATPase 1A (EC 7.1.2.1) (LdH1A);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]";"GO:0005524; GO:0008553; GO:0016021; GO:0046872; GO:0120029";proton export across plasma membrane [GO:0120029];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp90369_c0_seq1;GAXK01002525.1;Q8IN81;8.12E-09;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp903751_c0_seq1;GAXK01036597.1;A4IG42;1.56E-14;TCAF_DANRE;TRPM8 channel-associated factor homolog;"plasma membrane [GO:0005886]; ion channel binding [GO:0044325]; positive regulation of protein targeting to membrane [GO:0090314]";"GO:0005886; GO:0044325; GO:0090314";positive regulation of protein targeting to membrane [GO:0090314];plasma membrane [GO:0005886];ion channel binding [GO:0044325]
comp903841_c0_seq1;GAXK01036608.1;Q868T3;4.60E-120;CCAPR_DROME;Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]";"GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990";"ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]"
comp9040016_c0_seq1;GAXK01119122.1;P45337;9.62E-30;QSEB_HAEIN;Transcriptional regulatory protein QseB;"cytosol [GO:0005829]; protein-DNA complex [GO:0032993]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; phosphorelay response regulator activity [GO:0000156]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000156; GO:0000976; GO:0001216; GO:0003700; GO:0005829; GO:0032993";;"cytosol [GO:0005829]; protein-DNA complex [GO:0032993]";"DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; phosphorelay response regulator activity [GO:0000156]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp9041_c1_seq1;GAXK01014770.1;Q13610;4.84E-101;PWP1_HUMAN;Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502);"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]";"GO:0005634; GO:0005694; GO:0005730; GO:0005794; GO:0006351; GO:0033140; GO:0034773; GO:0042254; GO:1901838; GO:1990889; GO:2000738";"histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]";"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]";H4K20me3 modified histone binding [GO:1990889]
comp90414_c1_seq1;GAXK01002314.1;Q8BMG7;7.22E-33;RBGPR_MOUSE;Rab3 GTPase-activating protein non-catalytic subunit (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]";"GO:0005096; GO:0005829; GO:0005886; GO:0017112; GO:0017137; GO:0030234; GO:0032991; GO:0043087; GO:0046982; GO:0097051; GO:1903061; GO:1903373; GO:2000786";"establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp90422_c1_seq1;GAXK01002459.1;Q92611;0;EDEM1_HUMAN;ER degradation-enhancing alpha-mannosidase-like protein 1;"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]";"GO:0004571; GO:0005509; GO:0005783; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382";"IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]";"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"
comp9044336_c0_seq1;GAXK01129144.1;P29557;4.91E-08;IF4E1_WHEAT;Eukaryotic translation initiation factor 4E-1 (eIF-4E-1) (eIF4E-1) (eIF-4F 25 kDa subunit) (eIF-4F p26 subunit) (mRNA cap-binding protein);"cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]";"GO:0003743; GO:0005737";;cytoplasm [GO:0005737];translation initiation factor activity [GO:0003743]
comp904525_c0_seq1;GAXK01154078.1;A8X679;4.59E-11;SIAH1_CAEBR;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp904583_c0_seq1;GAXK01154043.1;Q5ZJA3;7.30E-17;CDR2_CHICK;Cerebellar degeneration-related protein 2;cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp9047005_c0_seq1;GAXK01089288.1;Q18DH5;2.08E-13;BACRM_HALWD;Bacteriorhodopsin-II-like protein (Bacteriorhodopsin-II) (Middle rhodopsin) (HwMR);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"GO:0005216; GO:0005886; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ion channel activity [GO:0005216]; photoreceptor activity [GO:0009881]"
comp904816_c0_seq1;GAXK01154053.1;Q95NT6;5.27E-28;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp90486_c0_seq1;GAXK01002392.1;B2FQP3;5.26E-12;ASPN_STRMK;Peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) (Endopeptidase Asp-N);"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0008237; GO:0046872";;;"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp90511_c1_seq1;GAXK01002226.1;Q8BQM9;0;MD12L_MOUSE;Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein);"mediator complex [GO:0016592]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0003713; GO:0005634; GO:0006357; GO:0008013; GO:0008134; GO:0016592";regulation of transcription by RNA polymerase II [GO:0006357];"mediator complex [GO:0016592]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"
comp90513_c0_seq1;GAXK01002452.1;P38166;2.10E-17;SFT2_YEAST;Protein transport protein SFT2;"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000138; GO:0000139; GO:0005829; GO:0015031; GO:0016021; GO:0042147";"protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]";
comp9052187_c0_seq1;GAXK01086978.1;P21865;9.87E-48;KDPD_ECOLI;Sensor protein KdpD (EC 2.7.13.3);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155]; transcription factor binding [GO:0008134]; cellular response to extracellular stimulus [GO:0031668]; cellular response to salt stress [GO:0071472]; detection of chemical stimulus [GO:0009593]; protein autophosphorylation [GO:0046777]; signal transduction by protein phosphorylation [GO:0023014]";"GO:0000155; GO:0005524; GO:0005886; GO:0005887; GO:0008134; GO:0009593; GO:0016791; GO:0023014; GO:0031668; GO:0046777; GO:0071472";"cellular response to extracellular stimulus [GO:0031668]; cellular response to salt stress [GO:0071472]; detection of chemical stimulus [GO:0009593]; protein autophosphorylation [GO:0046777]; signal transduction by protein phosphorylation [GO:0023014]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155]; transcription factor binding [GO:0008134]"
comp9052300_c0_seq1;GAXK01086975.1;Q99315;1.53E-07;YG31B_YEAST;"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp905291_c0_seq1;GAXK01154081.1;Q96MF2;1.75E-11;STAC3_HUMAN;SH3 and cysteine-rich domain-containing protein 3;"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741]";"GO:0003009; GO:0005654; GO:0005829; GO:0005891; GO:0007274; GO:0030315; GO:0031234; GO:0035556; GO:0042802; GO:0046872; GO:0048741; GO:1901387; GO:1903078";"intracellular signal transduction [GO:0035556]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741]";"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]";"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp905568_c1_seq1;GAXK01154059.1;Q32KI9;5.91E-113;ARSI_MOUSE;Arylsulfatase I (ASI) (EC 3.1.6.-);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0005576; GO:0005783; GO:0008484; GO:0046872";;"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]";"metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp905571_c0_seq1;GAXK01154058.1;Q8BHA1;9.85E-24;LRC24_MOUSE;Leucine-rich repeat-containing protein 24;"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]";"GO:0005615; GO:0016021; GO:0031012; GO:0051965";positive regulation of synapse assembly [GO:0051965];"extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";
comp905649_c0_seq1;GAXK01154064.1;Q6P9S0;9.65E-15;MTSS2_MOUSE;Protein MTSS 2 (MTSS1-like protein);"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"GO:0001726; GO:0003785; GO:0005096; GO:0005546; GO:0005886; GO:0007009; GO:0030027; GO:0030864; GO:0032587; GO:0036120; GO:0048365; GO:0061024; GO:0090630; GO:0097178; GO:0097581";"activation of GTPase activity [GO:0090630]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]";"cortical actin cytoskeleton [GO:0030864]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]";"actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rac GTPase binding [GO:0048365]"
comp9058_c4_seq1;GAXK01014627.1;Q91642;4.25E-90;PEPE_XENLA;Alpha-aspartyl dipeptidase (EC 3.4.13.21) (Asp-specific dipeptidase) (Dipeptidase E);"cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]";"GO:0005737; GO:0008236; GO:0016805";;cytoplasm [GO:0005737];"dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]"
comp90587_c0_seq1;GAXK01002317.1;Q9M2P4;5.97E-14;SINA2_ARATH;E3 ubiquitin-protein ligase SINAT2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT2) (Seven in absentia homolog 2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp9058740_c0_seq1;GAXK01009920.1;Q59967;1.81E-28;SRPH_SYNE7;Serine acetyltransferase, plasmid (SAT) (EC 2.3.1.30);"cytoplasm [GO:0005737]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process from serine [GO:0006535]";"GO:0005737; GO:0006535; GO:0009001";cysteine biosynthetic process from serine [GO:0006535];cytoplasm [GO:0005737];serine O-acetyltransferase activity [GO:0009001]
comp9058901_c0_seq1;GAXK01009919.1;P34552;4.86E-13;ALXA_CAEEL;Apoptosis-linked gene 2-interacting protein X 1 (Prion-like-(Q/N-rich) domain-bearing protein 58) (Protein YNK1);"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]; Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"GO:0005112; GO:0005771; GO:0007032; GO:0008022; GO:0016323; GO:0031410; GO:0032456; GO:0033365; GO:0042176; GO:0043226; GO:0055037";"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; protein localization to organelle [GO:0033365]; regulation of protein catabolic process [GO:0042176]";"basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; multivesicular body [GO:0005771]; organelle [GO:0043226]; recycling endosome [GO:0055037]";"Notch binding [GO:0005112]; protein C-terminus binding [GO:0008022]"
comp9059_c0_seq1;GAXK01014818.1;Q8MQI6;3.61E-43;ELOF1_DROME;Transcription elongation factor 1 homolog;"transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368]";"GO:0000993; GO:0006368; GO:0008023; GO:0046872; GO:0048096";"chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368]";transcription elongation factor complex [GO:0008023];"metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]"
comp905991_c0_seq1;GAXK01154076.1;P83088;1.16E-45;FUCTC_DROME;Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920";"fucosylation [GO:0036065]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]";"alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]"
comp9060638_c0_seq1;GAXK01042687.1;P55908;1.54E-31;YCGA_BACSU;Uncharacterized protein YcgA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp90614_c0_seq1;GAXK01002079.1;Q96NG8;7.27E-18;ZN582_HUMAN;Zinc finger protein 582;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9061564_c0_seq1;GAXK01042686.1;Q54MJ7;1.28E-13;ALAM_DICDI;Probable alanine aminotransferase, mitochondrial (ALT) (EC 2.6.1.2) (Glutamate pyruvate transaminase) (GPT) (Glutamic--alanine transaminase) (Glutamic--pyruvic transaminase);"mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]";"GO:0004021; GO:0005759; GO:0009058; GO:0030170; GO:0042853";"biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]";mitochondrial matrix [GO:0005759];"L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
comp9062253_c0_seq1;GAXK01057710.1;Q9ZZY5;3.99E-16;COX3_HIPAM;Cytochrome c oxidase subunit 3 (Cytochrome c oxidase polypeptide III);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; aerobic electron transport chain [GO:0019646]; respiratory chain complex IV assembly [GO:0008535]";"GO:0004129; GO:0005743; GO:0008535; GO:0016021; GO:0019646; GO:0045277";"aerobic electron transport chain [GO:0019646]; respiratory chain complex IV assembly [GO:0008535]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]";cytochrome-c oxidase activity [GO:0004129]
comp90626_c1_seq1;GAXK01002522.1;P00765;2.22E-41;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp906378_c0_seq1;GAXK01060395.1;Q9HCG1;1.49E-118;ZN160_HUMAN;Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; hemopoiesis [GO:0030097]";"GO:0000981; GO:0003677; GO:0005634; GO:0030097; GO:0046872";hemopoiesis [GO:0030097];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp906491_c0_seq1;GAXK01060402.1;Q93243;7.28E-20;NAS37_CAEEL;Zinc metalloproteinase nas-37 (EC 3.4.24.-) (Nematode astacin 37);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";"GO:0004222; GO:0005576; GO:0008270; GO:0018996; GO:0040002; GO:0042395";"collagen and cuticulin-based cuticle development [GO:0040002]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp906595_c0_seq1;GAXK01060391.1;Q6P560;2.15E-29;ZN182_MOUSE;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp906720_c0_seq1;GAXK01060383.1;Q61313;1.09E-113;AP2B_MOUSE;Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta);"nucleus [GO:0005634]; chromatin binding [GO:0003682]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonia homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; sensory organ development [GO:0007423]; skin development [GO:0043588]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]";"GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001822; GO:0003091; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0006006; GO:0006355; GO:0006357; GO:0006366; GO:0007423; GO:0008284; GO:0008285; GO:0010842; GO:0010960; GO:0030510; GO:0035136; GO:0035137; GO:0035810; GO:0035909; GO:0042493; GO:0042593; GO:0042803; GO:0043027; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0046983; GO:0048485; GO:0050796; GO:0055062; GO:0055074; GO:0055075; GO:0055078; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:0097275; GO:0097276; GO:0097277";"aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonia homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of insulin secretion [GO:0050796]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; sensory organ development [GO:0007423]; skin development [GO:0043588]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"chromatin binding [GO:0003682]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
comp9067525_c0_seq1;GAXK01123570.1;D9IA43;8.00E-42;CCON1_PSEST;Cbb3-type cytochrome c oxidase subunit CcoN1 (EC 1.9.3.1) (Cytochrome CBB3 subunit CcoN1);"cytochrome complex [GO:0070069]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane respirasome [GO:0070470]; plasma membrane respiratory chain complex IV [GO:0045278]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]; electron transporter, transferring electrons within cytochrome c oxidase complex activity [GO:0045154]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; oxygen binding [GO:0019825]; aerobic electron transport chain [GO:0019646]; aerobic respiration, using ferrous ions as electron donor [GO:0019411]; electron transport coupled proton transport [GO:0015990]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; proton transmembrane transport [GO:1902600]";"GO:0004129; GO:0005506; GO:0005507; GO:0005886; GO:0005887; GO:0006119; GO:0015990; GO:0016705; GO:0019411; GO:0019646; GO:0019825; GO:0020037; GO:0045154; GO:0045278; GO:0055114; GO:0070069; GO:0070470; GO:1902600";"aerobic electron transport chain [GO:0019646]; aerobic respiration, using ferrous ions as electron donor [GO:0019411]; electron transport coupled proton transport [GO:0015990]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; proton transmembrane transport [GO:1902600]";"cytochrome complex [GO:0070069]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane respirasome [GO:0070470]; plasma membrane respiratory chain complex IV [GO:0045278]";"copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]; electron transporter, transferring electrons within cytochrome c oxidase complex activity [GO:0045154]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; oxygen binding [GO:0019825]"
comp90683_c2_seq1;GAXK01002519.1;Q7JR49;1.26E-09;VAS1_DROME;V-type proton ATPase subunit S1 (Vacuolar H(+) ATPase AC45 accessory subunit);"integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; hydrolase activity [GO:0016787]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0016021; GO:0016471; GO:0016787; GO:0030641; GO:0033180; GO:0033181; GO:0046933; GO:0046961; GO:0070072; GO:1902600";"proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]";"hydrolase activity [GO:0016787]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp9069447_c0_seq1;GAXK01010765.1;O59804;3.24E-25;CH10_SCHPO;10 kDa heat shock protein, mitochondrial (HSP10) (10 kDa chaperonin);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]";"GO:0005524; GO:0005739; GO:0005759; GO:0006457; GO:0030150; GO:0046872; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp906951_c0_seq1;GAXK01060389.1;Q6NT16;2.47E-39;S18B1_HUMAN;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp9070350_c0_seq1;GAXK01101848.1;Q4U2R1;2.16E-12;HERC2_MOUSE;E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2);"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]";"centriole [GO:0005814]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]";"SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp90706_c1_seq1;GAXK01002246.1;Q9GRW0;3.85E-78;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp907100_c1_seq1;GAXK01060379.1;O02827;2.34E-52;MYLK_SHEEP;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] (Fragment);"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp907366_c0_seq1;GAXK01060382.1;A6H782;3.88E-28;TEKT3_BOVIN;Tektin-3;"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp90737_c0_seq1;GAXK01002162.1;Q9VZZ9;6.62E-31;DOS_DROME;Protein daughter of sevenless;"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification, embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293]";"GO:0005737; GO:0005886; GO:0007465; GO:0008293; GO:0008595; GO:0019730; GO:0042169; GO:0042461; GO:0045500; GO:0046578";"anterior/posterior axis specification, embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";SH2 domain binding [GO:0042169]
comp907436_c0_seq1;GAXK01060415.1;Q9V427;4.18E-37;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp90746_c3_seq1;GAXK01002089.1;O14841;8.48E-120;OPLA_HUMAN;5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase);"cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]";"GO:0005524; GO:0005829; GO:0006749; GO:0006750; GO:0017168";"glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]";cytosol [GO:0005829];"5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]"
comp9075597_c0_seq1;GAXK01200460.1;P36967;4.35E-22;SUCA_DICDI;Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (p36);"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"GO:0000166; GO:0004550; GO:0004775; GO:0004776; GO:0005739; GO:0005829; GO:0006099; GO:0006104; GO:0006105; GO:0009142; GO:0016020; GO:0048037";"nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]";"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]";"cofactor binding [GO:0048037]; nucleoside diphosphate kinase activity [GO:0004550]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]"
comp907628_c0_seq1;GAXK01060411.1;Q3SYV7;3.62E-18;ZN345_BOVIN;Zinc finger protein 345;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9076548_c0_seq1;GAXK01182007.1;P50257;1.61E-19;EF1AS_PORPU;Elongation factor 1-alpha S (EF-1-alpha S) (Sporophyte-specific EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp9079074_c0_seq1;GAXK01072935.1;Q93714;7.78E-19;IDH3A_CAEEL;Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha);"mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp9080_c0_seq1;GAXK01013627.1;P47193;1.66E-27;VAMP2_XENLA;Vesicle-associated membrane protein 2 (VAMP-2) (SYBII) (Synaptobrevin-2);"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192]";"GO:0005886; GO:0016021; GO:0016192; GO:0030054; GO:0030672; GO:0043005";vesicle-mediated transport [GO:0016192];"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";
comp90801_c6_seq1;GAXK01002450.1;O02485;5.24E-45;YDJ1_CAEEL;Uncharacterized protein ZK1073.1;;;;;
comp90805_c2_seq1;GAXK01002153.1;Q8CG46;2.21E-159;SMC5_MOUSE;Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453);"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"GO:0000722; GO:0000724; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0030054; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0051301; GO:0051984; GO:0090398";"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]";"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]";ATP binding [GO:0005524]
comp908170_c0_seq1;GAXK01035305.1;O76083;4.54E-99;PDE9A_HUMAN;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35);"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]";"GO:0004114; GO:0005783; GO:0005794; GO:0005829; GO:0007165; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471";"cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]";"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp908246_c0_seq1;GAXK01035291.1;B2D0J5;1.13E-55;EST6_APIME;Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8);"extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]";"GO:0005576; GO:0080030";;extracellular region [GO:0005576];methyl indole-3-acetate esterase activity [GO:0080030]
comp908278_c0_seq1;GAXK01035322.1;P10078;2.81E-16;ZFP28_MOUSE;Zinc finger protein 28 (Zfp-28) (Protein mKR5);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9083_c0_seq1;GAXK01013959.1;P30419;0;NMT1_HUMAN;Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400]";"GO:0001701; GO:0004379; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006499; GO:0018008; GO:0019107; GO:0019898; GO:0022400; GO:0042180; GO:1900740";"cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]";"glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]"
comp9083208_c0_seq1;GAXK01042114.1;Q57B99;1.64E-16;LIVB1_BRUAB;Leu/Ile/Val-binding protein homolog 1;amino acid transport [GO:0006865];GO:0006865;amino acid transport [GO:0006865];;
comp908322_c0_seq1;GAXK01035301.1;Q9XTJ4;1.28E-11;NHR3_CAEEL;Nuclear hormone receptor family member nhr-3;"RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";"GO:0000976; GO:0003682; GO:0004879; GO:0008270; GO:0009755; GO:0009888; GO:0045944; GO:0090575";"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]";RNA polymerase II transcription factor complex [GO:0090575];"chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp908348_c0_seq1;GAXK01035303.1;Q8BGN2;1.39E-10;CD033_MOUSE;UPF0462 protein C4orf33 homolog;;;;;
comp90850_c1_seq1;GAXK01002454.1;Q3T1G7;4.71E-102;COG7_RAT;Conserved oligomeric Golgi complex subunit 7 (COG complex subunit 7) (Component of oligomeric Golgi complex 7);"Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0000139; GO:0005730; GO:0006486; GO:0006886; GO:0006890; GO:0007030; GO:0017119; GO:0034067; GO:0050821";"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]";
comp908530_c1_seq1;GAXK01035290.1;O57460;5.74E-09;TLL1_DANRE;Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein);"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";"GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264";"blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]";extracellular region [GO:0005576];"calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
comp9085929_c0_seq1;GAXK01196166.1;P0AAA7;1.69E-20;WZXE_ECOLI;Lipid III flippase;"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enterobacterial common antigen biosynthetic process [GO:0009246]";"GO:0005886; GO:0005887; GO:0009246";enterobacterial common antigen biosynthetic process [GO:0009246];"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";
comp908614_c0_seq1;GAXK01035292.1;Q24498;4.66E-87;RYR_DROME;Ryanodine receptor (Ryanodine receptor 44F);"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"GO:0005219; GO:0005509; GO:0005790; GO:0005886; GO:0006816; GO:0006936; GO:0007275; GO:0016021; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0035206; GO:0042383; GO:0048763; GO:0051209; GO:0060047; GO:0072347";"calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]";"calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]";"calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]"
comp908697_c0_seq1;GAXK01035307.1;O60500;1.30E-18;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp90875_c0_seq1;GAXK01002405.1;P48810;2.34E-25;RB87F_DROME;Heterogeneous nuclear ribonucleoprotein 87F (HRP36.1 protein) (Protein P11);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594]";"GO:0000278; GO:0000381; GO:0000785; GO:0000792; GO:0001745; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0008585; GO:0009408; GO:0035062; GO:0042594; GO:0043565; GO:1990904";"compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]"
comp90876_c1_seq1;GAXK01002273.1;Q0V8F1;0;CORO7_BOVIN;Coronin-7 (Crn7);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"GO:0000139; GO:0003779; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0015031; GO:0030041; GO:0031410; GO:0051015";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]";"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp908889_c0_seq1;GAXK01035331.1;O60683;5.63E-43;PEX10_HUMAN;Peroxisome biogenesis factor 10 (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (RING finger protein 69);"cell [GO:0005623]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]";"GO:0005623; GO:0005777; GO:0005778; GO:0005779; GO:0006625; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:0016567; GO:0046872";"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]";"cell [GO:0005623]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]";"metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]"
comp908933_c0_seq1;GAXK01035293.1;Q6P2X9;9.75E-25;MOT12_XENTR;Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);"integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";"GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881";"creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]";integral component of plasma membrane [GO:0005887];"creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp908936_c0_seq1;GAXK01035282.1;P22770;4.15E-23;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp90944_c0_seq1;GAXK01002375.1;Q8IWV8;0;UBR2_HUMAN;E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596";"cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp90954_c0_seq1;GAXK01002183.1;P18850;1.38E-36;ATF6A_HUMAN;Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha];"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0000139; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003700; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0006457; GO:0007165; GO:0007601; GO:0016020; GO:0030176; GO:0030968; GO:0031625; GO:0035497; GO:0036500; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:1903893; GO:1990440";"ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"
comp9095771_c0_seq1;GAXK01054337.1;P0AG25;4.32E-12;SPOT_ECO57;Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase (EC 3.1.7.2) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase);"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; guanosine tetraphosphate biosynthetic process [GO:0015970]";"GO:0008893; GO:0015970";guanosine tetraphosphate biosynthetic process [GO:0015970];;guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]
comp9096_c0_seq1;GAXK01013594.1;O35459;2.79E-105;ECH1_MOUSE;Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-);"mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]";"GO:0005739; GO:0005777; GO:0006635; GO:0051750";fatty acid beta-oxidation [GO:0006635];"mitochondrion [GO:0005739]; peroxisome [GO:0005777]";delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]
comp9096130_c0_seq1;GAXK01073906.1;P36871;2.56E-35;PGM1_HUMAN;Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]";"GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0015629; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813";"galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]";"magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]"
comp9097076_c0_seq1;GAXK01073907.1;P39812;4.23E-31;GLTA_BACSU;Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (NADPH-GOGAT);"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";"GO:0004355; GO:0006537; GO:0019676; GO:0046872; GO:0051538; GO:0097054";"ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]";;"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"
comp9098_c2_seq1;GAXK01013299.1;Q8BKZ9;4.38E-100;ODPX_MOUSE;Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (Lipoyl-containing pyruvate dehydrogenase complex component X);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]";"GO:0005739; GO:0005759; GO:0016746; GO:0034604; GO:0045254; GO:0061732";mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732];"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]";"pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]"
comp909867_c0_seq1;GAXK01035321.1;P18713;1.92E-08;ZG17_XENLA;Gastrula zinc finger protein XlCGF17.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp909974_c0_seq1;GAXK01035308.1;Q5F3V0;3.44E-08;SMYD4_CHICK;SET and MYND domain-containing protein 4 (EC 2.1.1.-);"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]";"GO:0008168; GO:0046872";;;"metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
comp90998_c2_seq1;GAXK01002140.1;Q86WA6;3.76E-75;BPHL_HUMAN;Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA);"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; alpha-amino-acid esterase activity [GO:0047658]; cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]";"GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0047658";"cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]";"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";alpha-amino-acid esterase activity [GO:0047658]
comp91_c0_seq1;GAXK01166119.1;P91913;7.33E-17;RLA1_CAEEL;60S acidic ribosomal protein P1 (Ribosomal protein large subunit P1);"cytosolic large ribosomal subunit [GO:0022625]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";"GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021";"cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]";cytosolic large ribosomal subunit [GO:0022625];"protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]"
comp910_c0_seq1;GAXK01169406.1;P17220;2.56E-143;PSA2_RAT;Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"GO:0000932; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp9101092_c0_seq1;GAXK01013154.1;Q6DFB9;1.83E-28;V26BB_XENLA;Vacuolar protein sorting-associated protein 26B-B (Vesicle protein sorting 26B-B);"endosome [GO:0005768]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]";"GO:0005768; GO:0006886; GO:0016020";intracellular protein transport [GO:0006886];"endosome [GO:0005768]; membrane [GO:0016020]";
comp910168_c0_seq1;GAXK01192262.1;Q6IV72;1.88E-22;ZN425_HUMAN;Zinc finger protein 425;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9102150_c0_seq1;GAXK01015240.1;Q9LVQ8;4.18E-15;P2C80_ARATH;Probable protein phosphatase 2C 80 (AtPP2C80) (EC 3.1.3.16);"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]";"GO:0004721; GO:0009507; GO:0009570; GO:0046872";;"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]";"metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]"
comp910282_c0_seq1;GAXK01192264.1;O17185;5.14E-81;SUP9_CAEEL;Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38);"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"GO:0005267; GO:0005887; GO:0006813; GO:0006937; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]";"potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]"
comp910289_c0_seq1;GAXK01192281.1;O61366;3.15E-152;GPRS_DROME;Serine-enriched protein;;;;;
comp910389_c0_seq1;GAXK01192283.1;Q1H9T6;3.87E-23;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp910522_c0_seq1;GAXK01192266.1;P02595;3.28E-19;CALM_PATSP;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp9106_c0_seq1;GAXK01013495.1;Q3Y8M6;1.71E-63;TPM_PENAT;Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102);"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]";"GO:0006937; GO:0019863; GO:0042803";regulation of muscle contraction [GO:0006937];;"IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]"
comp91071_c2_seq1;GAXK01002176.1;E9NA96;0;IR25A_DROME;Ionotropic receptor 25a;"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]; AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"GO:0004971; GO:0005886; GO:0005929; GO:0007610; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0032281; GO:0043204; GO:0048511; GO:0050907; GO:0050911; GO:0071683";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; rhythmic process [GO:0048511]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]";"AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sensory dendrite [GO:0071683]";"AMPA glutamate receptor activity [GO:0004971]; coreceptor activity [GO:0015026]; ligand-gated ion channel activity [GO:0015276]"
comp9107890_c0_seq1;GAXK01144565.1;O77229;7.94E-55;CATA_DICDI;Catalase-A (EC 1.11.1.6);"peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to methanol [GO:0033986]; response to oxidative stress [GO:0006979]";"GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0033986; GO:0042542; GO:0042744; GO:0045335; GO:0046872; GO:1904643";"hydrogen peroxide catabolic process [GO:0042744]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to methanol [GO:0033986]; response to oxidative stress [GO:0006979]";"peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]";"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
comp91081_c0_seq1;GAXK01002322.1;Q9BX70;0;BTBD2_HUMAN;BTB/POZ domain-containing protein 2;"cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]";"GO:0000932; GO:0005829; GO:0022008";neurogenesis [GO:0022008];"cytosol [GO:0005829]; P-body [GO:0000932]";
comp911240_c0_seq1;GAXK01192273.1;Q3MI00;3.04E-27;DNJB1_BOVIN;DnaJ homolog subfamily B member 1;"cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"GO:0000122; GO:0001671; GO:0003714; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]";"cytosol [GO:0005829]; nucleolus [GO:0005730]";"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]"
comp91126_c1_seq1;GAXK01002327.1;Q0VEE6;1.32E-10;ZN800_MOUSE;Zinc finger protein 800;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9113299_c0_seq1;GAXK01059886.1;Q71VT6;2.38E-25;SERC_LISMF;Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT);"cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]";"GO:0004648; GO:0005737; GO:0006564; GO:0008615; GO:0030170";"L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]";cytoplasm [GO:0005737];"O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]"
comp911499_c0_seq1;GAXK01192278.1;Q9H9D4;1.70E-11;ZN408_HUMAN;Zinc finger protein 408 (PR domain zinc finger protein 17);"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0042802; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
comp91156_c0_seq1;GAXK01002319.1;B5X2B8;6.48E-63;ERAL1_SALSA;GTPase Era, mitochondrial (ERA-like protein 1);"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028]";"GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024";ribosomal small subunit assembly [GO:0000028];"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]";"GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]"
comp911682_c0_seq1;GAXK01192261.1;P30531;1.15E-93;SC6A1_HUMAN;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056";"chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]";"axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]"
comp9117634_c0_seq1;GAXK01009996.1;P89116;1.13E-28;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp9119283_c0_seq1;GAXK01171190.1;Q91757;2.54E-35;GSK3B_XENLA;Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Xgsk-3 protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007399; GO:0016055; GO:0030154; GO:0045892; GO:0048511; GO:0050321; GO:0090090";"cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp911931_c0_seq1;GAXK01192290.1;Q8BUZ1;3.14E-21;ABRA_MOUSE;Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS);"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]";"GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030016; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091";"positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]";"actin cytoskeleton [GO:0015629]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]";actin binding [GO:0003779]
comp9120724_c0_seq1;GAXK01000871.1;Q51487;1.66E-10;OPRM_PSEAE;Outer membrane protein OprM;"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; efflux transmembrane transporter activity [GO:0015562]; xenobiotic transmembrane transporter activity [GO:0042910]; response to antibiotic [GO:0046677]";"GO:0009279; GO:0015562; GO:0016021; GO:0042910; GO:0046677";response to antibiotic [GO:0046677];"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]";"efflux transmembrane transporter activity [GO:0015562]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp91209_c0_seq1;GAXK01002248.1;A1L1K4;5.78E-16;C42S2_RAT;CDC42 small effector protein 2;"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; Rho GTPase binding [GO:0017048]; phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966]";"GO:0001891; GO:0005737; GO:0005856; GO:0005886; GO:0006909; GO:0008360; GO:0009966; GO:0017048; GO:0035023; GO:0042995";"phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966]";"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]";Rho GTPase binding [GO:0017048]
comp9121591_c0_seq1;GAXK01000876.1;Q6Q477;3.61E-34;AT2B4_MOUSE;Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10);"basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; calcium ion export [GO:1901660]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]";"GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0006357; GO:0006816; GO:0006874; GO:0007283; GO:0010751; GO:0014832; GO:0016020; GO:0016323; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0033138; GO:0036126; GO:0036487; GO:0042383; GO:0043005; GO:0045019; GO:0046872; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097228; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:1900082; GO:1901660; GO:1902806; GO:1903243; GO:1903249; GO:1905145; GO:2000481";"calcium ion export [GO:1901660]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; urinary bladder smooth muscle contraction [GO:0014832]";"basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]"
comp9123_c6_seq1;GAXK01014106.1;Q9JMC3;1.59E-22;DNJA4_MOUSE;DnaJ homolog subfamily A member 4 (MmDjA4);"cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"GO:0005524; GO:0005829; GO:0009408; GO:0010596; GO:0010628; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0090084";"negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]";"cytosol [GO:0005829]; membrane [GO:0016020]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]"
comp91234_c3_seq1;GAXK01002324.1;Q63150;2.14E-139;DPYS_RAT;Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase);"cytosol [GO:0005829]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]";"GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0051219; GO:0051260; GO:0051289";"beta-alanine metabolic process [GO:0019482]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]";cytosol [GO:0005829];"amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]"
comp91240_c1_seq1;GAXK01002320.1;Q9C585;4.62E-27;UBP8_ARATH;Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (AtUBP8) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8);"thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0006511; GO:0016579; GO:0036459";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";;thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
comp912430_c0_seq1;GAXK01192727.1;Q54II4;4.04E-09;RT4I1_DICDI;Reticulon-4-interacting protein 1 homolog, mitochondrial;"mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]";"GO:0005739; GO:0016491";;mitochondrion [GO:0005739];oxidoreductase activity [GO:0016491]
comp9124822_c0_seq1;GAXK01202711.1;E9JFX9;1.28E-59;DMOA_HYPSL;Dimethyl-sulfide monooxygenase (EC 1.14.13.131) (Dimethylsulfide monooxygenase large subunit);dimethyl sulfide monooxygenase activity [GO:0018633];GO:0018633;;;dimethyl sulfide monooxygenase activity [GO:0018633]
comp912504_c0_seq1;GAXK01192791.1;Q8L7L1;1.26E-41;SPHK1_ARATH;Sphingosine kinase 1 (EC 2.7.1.91);"plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]; cellular response to abscisic acid stimulus [GO:0071215]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]";"GO:0003951; GO:0005524; GO:0005773; GO:0006665; GO:0008481; GO:0009705; GO:0009737; GO:0009845; GO:0017050; GO:0071215";"cellular response to abscisic acid stimulus [GO:0071215]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]";"plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]";"ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]"
comp912592_c0_seq1;GAXK01192768.1;O54728;1.22E-81;PLB1_RAT;"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568";"lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; retinol metabolic process [GO:0042572]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]";"lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]"
comp912687_c0_seq1;GAXK01192787.1;Q14593;1.59E-18;ZN273_HUMAN;Zinc finger protein 273 (Zinc finger protein HZF9);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp91273_c2_seq1;GAXK01002242.1;Q6IR70;5.41E-20;PPR21_XENLA;Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1);early endosome [GO:0005769];GO:0005769;;early endosome [GO:0005769];
comp912782_c0_seq1;GAXK01192761.1;Q9VU52;5.83E-07;SNKY_DROME;Protein sneaky;"acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; zinc ion binding [GO:0008270]; fertilization, exchange of chromosomal proteins [GO:0035042]; sperm chromatin decondensation [GO:0035041]; sperm plasma membrane disassembly [GO:0035045]";"GO:0001669; GO:0002080; GO:0008270; GO:0016021; GO:0035041; GO:0035042; GO:0035045";"fertilization, exchange of chromosomal proteins [GO:0035042]; sperm chromatin decondensation [GO:0035041]; sperm plasma membrane disassembly [GO:0035045]";"acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]";zinc ion binding [GO:0008270]
comp91283_c0_seq1;GAXK01002349.1;Q09990;4.80E-10;LIN23_CAEEL;F-box/WD repeat-containing protein lin-23 (Abnormal cell lineage protein 23);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007049; GO:0008013; GO:0008285; GO:0010826; GO:0019902; GO:0031647; GO:0046983; GO:0048812; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; neuron projection morphogenesis [GO:0048812]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"beta-catenin binding [GO:0008013]; phosphatase binding [GO:0019902]; protein dimerization activity [GO:0046983]"
comp912941_c0_seq1;GAXK01192732.1;Q9VN45;5.51E-30;SPART_DROME;Protein spartin;"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030054; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301";"cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]";"cell junction [GO:0030054]; early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";Rab GTPase binding [GO:0017137]
comp913_c1_seq1;GAXK01168216.1;Q5TTG1;0;VATA_ANOGA;V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha);"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]";"GO:0005524; GO:0005774; GO:0005886; GO:0033180; GO:0046034; GO:0046961";ATP metabolic process [GO:0046034];"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]";"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
comp9130394_c0_seq1;GAXK01042650.1;A8EV17;6.21E-24;PDXH_ARCB4;Pyridoxine/pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5) (PNP/PMP oxidase) (PNPOx) (Pyridoxal 5'-phosphate synthase);"FMN binding [GO:0010181]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxine biosynthetic process [GO:0008615]";"GO:0004733; GO:0008615; GO:0010181";pyridoxine biosynthetic process [GO:0008615];;"FMN binding [GO:0010181]; pyridoxamine-phosphate oxidase activity [GO:0004733]"
comp9130612_c0_seq1;GAXK01042648.1;P26300;4.18E-43;ENO_SOLLC;Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase);"phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]";"GO:0000015; GO:0000287; GO:0004634; GO:0006096";glycolytic process [GO:0006096];phosphopyruvate hydratase complex [GO:0000015];"magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
comp91309_c3_seq1;GAXK01002270.1;Q8VI56;4.79E-49;LRP4_MOUSE;Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan);"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395";"amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]";"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]";"apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp9132504_c0_seq1;GAXK01064681.1;Q9JXZ2;8.14E-72;DPO3A_NEIMB;DNA polymerase III subunit alpha (EC 2.7.7.7);"cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; nucleic acid binding [GO:0003676]; DNA replication [GO:0006260]";"GO:0003676; GO:0003887; GO:0005737; GO:0006260; GO:0008408";DNA replication [GO:0006260];cytoplasm [GO:0005737];"3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; nucleic acid binding [GO:0003676]"
comp913345_c0_seq1;GAXK01192772.1;Q9Y473;8.76E-14;ZN175_HUMAN;Zinc finger protein 175 (Zinc finger protein OTK18);"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0005829; GO:0045111; GO:0045944; GO:0046872; GO:0051607";"defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]";"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp913499_c0_seq1;GAXK01192785.1;P17970;3.35E-40;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp913506_c0_seq1;GAXK01192726.1;P36609;8.50E-51;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp91355_c0_seq1;GAXK01002389.1;O96005;2.32E-24;CLPT1_HUMAN;Cleft lip and palate transmembrane protein 1;"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]";"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]";
comp9136752_c0_seq1;GAXK01038401.1;A9H863;9.33E-53;HUTH_GLUDA;Histidine ammonia-lyase (Histidase) (EC 4.3.1.3);"cytoplasm [GO:0005737]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";"GO:0004397; GO:0005737; GO:0019556; GO:0019557";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]";cytoplasm [GO:0005737];histidine ammonia-lyase activity [GO:0004397]
comp9137_c2_seq1;GAXK01014758.1;O43818;5.31E-126;U3IP2_HUMAN;U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K);"box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364]";"GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0031428; GO:0032040; GO:0034511";rRNA processing [GO:0006364];"box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]";"RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]"
comp9138173_c0_seq1;GAXK01027177.1;Q4KTI3;2.95E-54;RL5_SUBDO;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp9139971_c0_seq1;GAXK01027179.1;P45455;2.12E-70;RPE_SERMA;Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Pentose-5-phosphate 3-epimerase) (PPE) (R5P3E);"metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]";"GO:0004750; GO:0005975; GO:0006098; GO:0046872";"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]";;"metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]"
comp914073_c0_seq1;GAXK01180128.1;Q4V7Q8;8.70E-09;TM220_XENLA;Transmembrane protein 220;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp914086_c0_seq1;GAXK01180121.1;Q7Z0G7;7.23E-32;SETD7_HALRO;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (SET domain-containing protein 7);"chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0005634; GO:0005694; GO:0006355; GO:0016279; GO:0018024; GO:0018026; GO:0018027";"peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome [GO:0005694]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp9141600_c0_seq1;GAXK01063761.1;P12522;4.47E-31;ATXB_LEIDO;Probable proton ATPase 1B (EC 7.1.2.1) (LdH1B);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]";"GO:0005524; GO:0008553; GO:0016021; GO:0120029";proton export across plasma membrane [GO:0120029];integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"
comp9141663_c0_seq1;GAXK01063763.1;Q54QR2;1.57E-61;PSB7_DICDI;Proteasome subunit beta type-7 (EC 3.4.25.1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]";"GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0006508; GO:0010498; GO:0010499; GO:0019774; GO:0043161";"proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]";"endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]"
comp914282_c0_seq1;GAXK01180088.1;Q9U3S9;3.20E-34;NAS6_CAEEL;Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6);"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";"GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465";"pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]";extracellular region [GO:0005576];"metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp9143886_c0_seq1;GAXK01038164.1;Q59098;1.40E-32;ODP2_CUPNH;Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (E2);"pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096]";"GO:0004742; GO:0006096; GO:0045254";glycolytic process [GO:0006096];pyruvate dehydrogenase complex [GO:0045254];dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]
comp91446_c1_seq1;GAXK01002272.1;Q5T6L9;1.52E-47;EMARD_HUMAN;Endoplasmic reticulum membrane-associated RNA degradation protein (ER membrane-associated RNA degradation protein);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275]";"GO:0005789; GO:0007275; GO:0016021";multicellular organism development [GO:0007275];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";
comp91449_c0_seq1;GAXK01002170.1;Q7KRI2;9.07E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp9144984_c0_seq1;GAXK01151206.1;P36609;3.27E-12;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp91451_c0_seq1;GAXK01002105.1;Q5R5K4;1.06E-25;SNP29_PONAB;Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29);"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; SNARE complex [GO:0031201]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; protein transport [GO:0015031]";"GO:0000139; GO:0000421; GO:0005654; GO:0005776; GO:0005813; GO:0005829; GO:0015031; GO:0016240; GO:0020018; GO:0031201; GO:0031410; GO:0060271; GO:0097352";"autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; protein transport [GO:0015031]";"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; SNARE complex [GO:0031201]";
comp91457_c0_seq1;GAXK01002381.1;G5EBF1;1.08E-171;SAX3_CAEEL;Protein sax-3 (Sensory axon guidance 3);"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; axon guidance receptor activity [GO:0008046]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374]";"GO:0001764; GO:0005829; GO:0005887; GO:0008046; GO:0033563; GO:0035385; GO:0097374; GO:1905489";"dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374]";"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]";axon guidance receptor activity [GO:0008046]
comp91458_c6_seq1;GAXK01002100.1;P41636;2.71E-106;4CL_PINTA;4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase);"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]";"GO:0005524; GO:0009698; GO:0016207";phenylpropanoid metabolic process [GO:0009698];;"4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]"
comp91464_c0_seq1;GAXK01002015.1;Q6PFX9;1.59E-09;TNKS1_MOUSE;Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1);"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404";"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]";"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]"
comp9147221_c0_seq1;GAXK01143517.1;Q12AE4;2.03E-17;MSRB_POLSJ;Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase);"peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]";"GO:0006979; GO:0008270; GO:0030091; GO:0033743";"protein repair [GO:0030091]; response to oxidative stress [GO:0006979]";;"peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]"
comp9147760_c0_seq1;GAXK01143522.1;A1VNR3;9.04E-61;F16A2_POLNA;Fructose-1,6-bisphosphatase class 1 2 (FBPase class 1 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase class 1 2);"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]; gluconeogenesis [GO:0006094]";"GO:0000287; GO:0005737; GO:0006094; GO:0042132";gluconeogenesis [GO:0006094];cytoplasm [GO:0005737];"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]"
comp9147821_c0_seq1;GAXK01143519.1;P81926;1.49E-37;SODC_HALRO;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1);"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]";"GO:0004784; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
comp914971_c0_seq1;GAXK01180150.1;P58283;4.97E-31;RN216_MOUSE;E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1);"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546";"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]";"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]";"metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
comp91501_c0_seq1;GAXK01002165.1;P42519;6.64E-15;STAR_DROME;Protein Star;"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038";"behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]";
comp91505_c0_seq1;GAXK01002524.1;Q8BHG2;4.77E-62;CZIB_MOUSE;CXXC motif containing zinc binding protein (UPF0587 protein C1orf123 homolog);zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp91506_c0_seq1;GAXK01002016.1;Q8BVH9;8.89E-99;METL6_MOUSE;tRNA N(3)-methylcytidine methyltransferase METTL6 (EC 2.1.1.-) (Methyltransferase-like protein 6);"tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA C5-cytosine methylation [GO:0002946]";"GO:0002946; GO:0016428";tRNA C5-cytosine methylation [GO:0002946];;tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]
comp915083_c0_seq1;GAXK01180117.1;A5A4K9;6.20E-18;GHSR_RABIT;Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]";"GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963";"actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]";"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]";"growth hormone-releasing hormone receptor activity [GO:0016520]; growth hormone secretagogue receptor activity [GO:0001616]"
comp9151590_c0_seq1;GAXK01089527.1;Q642H9;1.79E-36;RS4X_DANRE;40S ribosomal protein S4, X isoform;"cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0007420; GO:0019843; GO:0022627; GO:0043009";"brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412]";cytosolic small ribosomal subunit [GO:0022627];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp9152029_c0_seq1;GAXK01045093.1;Q8ZRJ7;7.07E-45;FADE_SALTY;Acyl-coenzyme A dehydrogenase (ACDH) (Acyl-CoA dehydrogenase) (EC 1.3.8.7) (EC 1.3.8.8) (Medium-/long-chain fatty acyl-CoA dehydrogenase);"plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]";"GO:0003995; GO:0005886; GO:0033539; GO:0050660; GO:0052890";fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539];plasma membrane [GO:0005886];"acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO:0052890]"
comp915210_c0_seq1;GAXK01180079.1;O18391;2.51E-40;KRAK_DROME;Probable serine hydrolase (EC 3.1.-.-) (Kraken protein);"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]; digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";"GO:0007275; GO:0007586; GO:0009636; GO:0017171; GO:0052689";"digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]";;"carboxylic ester hydrolase activity [GO:0052689]; serine hydrolase activity [GO:0017171]"
comp91530_c1_seq1;GAXK01002342.1;Q8YFI5;6.82E-50;NHAA_BRUME;Na(+)/H(+) antiporter NhaA (Sodium/proton antiporter NhaA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]; regulation of pH [GO:0006885]";"GO:0005886; GO:0006885; GO:0008233; GO:0015081; GO:0015297; GO:0016021";regulation of pH [GO:0006885];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"antiporter activity [GO:0015297]; peptidase activity [GO:0008233]; sodium ion transmembrane transporter activity [GO:0015081]"
comp915320_c0_seq1;GAXK01180104.1;O55171;1.08E-39;ACOT2_RAT;Acyl-coenzyme A thioesterase 2, mitochondrial (Acyl-CoA thioesterase 2) (EC 3.1.2.2) (ARTISt/p43) (Acyl coenzyme A thioester hydrolase) (MTE-I) (Very-long-chain acyl-CoA thioesterase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; response to drug [GO:0042493]; response to epidermal growth factor [GO:0070849]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; very long-chain fatty acid catabolic process [GO:0042760]";"GO:0001666; GO:0005739; GO:0005759; GO:0006631; GO:0006637; GO:0009725; GO:0016290; GO:0031667; GO:0042493; GO:0042760; GO:0047617; GO:0052689; GO:0070849; GO:0102991";"acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; response to drug [GO:0042493]; response to epidermal growth factor [GO:0070849]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; very long-chain fatty acid catabolic process [GO:0042760]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]"
comp915352_c0_seq1;GAXK01180137.1;Q9CWR2;5.90E-08;SMYD3_MOUSE;Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549";"cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp915503_c0_seq1;GAXK01180122.1;B7Z0W9;2.81E-26;OTOP_DROME;Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]";"GO:0005886; GO:0015252; GO:0016021; GO:1902600";proton transmembrane transport [GO:1902600];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";proton channel activity [GO:0015252]
comp9157278_c0_seq1;GAXK01015558.1;P0ADX3;1.03E-08;YHFA_ECO57;Protein YhfA;;;;;
comp915817_c3_seq1;GAXK01180141.1;Q96IR2;1.27E-40;ZN845_HUMAN;Zinc finger protein 845;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp91592_c0_seq1;GAXK01002580.1;Q6DI40;1.16E-43;TTC33_DANRE;Tetratricopeptide repeat protein 33 (TPR repeat protein 33);;;;;
comp91607_c3_seq1;GAXK01002237.1;Q6PB75;1.03E-64;PAPD7_MOUSE;Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-);"Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; snoRNA polyadenylation [GO:0071050]";"GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006397; GO:0031499; GO:0031965; GO:0042493; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870";"histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; snoRNA polyadenylation [GO:0071050]";"Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]";"ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]"
comp916194_c1_seq1;GAXK01127325.1;P55042;1.16E-23;RAD_HUMAN;GTP-binding protein RAD (RAD1) (Ras associated with diabetes);"plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007264; GO:1901842";"negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]";plasma membrane [GO:0005886];"calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp91626_c1_seq1;GAXK01002276.1;Q6IR42;1.71E-22;ZCPW1_MOUSE;Zinc finger CW-type PWWP domain protein 1;zinc ion binding [GO:0008270];GO:0008270;;;zinc ion binding [GO:0008270]
comp916276_c0_seq1;GAXK01127327.1;Q10739;3.30E-72;MMP14_RAT;Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT-MMP) (MT1-MMP) (MT1MMP);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638]";"GO:0001501; GO:0001503; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004222; GO:0005178; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0009725; GO:0010831; GO:0010954; GO:0014070; GO:0016021; GO:0030198; GO:0030307; GO:0030324; GO:0030574; GO:0031012; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0051895; GO:0060322; GO:0070006; GO:0097094; GO:1903076; GO:1905523; GO:1990834";"angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp9162780_c0_seq1;GAXK01001207.1;A0A0H3AJF5;1.29E-17;MNEA_VIBC3;Putative manganese exporter (Manganese exporter A);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion transport [GO:0006811]";"GO:0005886; GO:0006811; GO:0016021";ion transport [GO:0006811];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp916676_c0_seq1;GAXK01127322.1;Q60821;1.76E-32;ZBT17_MOUSE;Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13);"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp9167044_c0_seq1;GAXK01138632.1;Q881J7;4.49E-10;LOVHK_PSESM;"Blue-light-activated protein [Includes: Blue-light-activated histidine kinase (EC 2.7.13.3) (PS-LOV-histidine kinase) (PS-LOV-HK); Response regulator]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; photoreceptor activity [GO:0009881]; pathogenesis [GO:0009405]; protein-chromophore linkage [GO:0018298]";"GO:0000155; GO:0005524; GO:0009405; GO:0009881; GO:0018298";"pathogenesis [GO:0009405]; protein-chromophore linkage [GO:0018298]";;"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; photoreceptor activity [GO:0009881]"
comp91677_c0_seq1;GAXK01002278.1;P04920;3.17E-67;B3A2_HUMAN;Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]";"GO:0005452; GO:0005886; GO:0005887; GO:0005925; GO:0006820; GO:0007283; GO:0008509; GO:0015301; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0048565; GO:0051453";"anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]";"anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]"
comp916855_c0_seq1;GAXK01127305.1;Q2KI83;6.45E-14;DJC17_BOVIN;DnaJ homolog subfamily C member 17;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]";"GO:0000122; GO:0003723; GO:0005634; GO:0005737; GO:1901998";"negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp9170_c2_seq1;GAXK01014333.1;Q9NFP5;7.12E-24;SH3BG_DROME;SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein);SH3 domain binding [GO:0017124];GO:0017124;;;SH3 domain binding [GO:0017124]
comp91713_c1_seq1;GAXK01002315.1;Q8N961;0;ABTB2_HUMAN;Ankyrin repeat and BTB/POZ domain-containing protein 2;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; cellular response to toxic substance [GO:0097237]";"GO:0005634; GO:0005654; GO:0046982; GO:0097237";cellular response to toxic substance [GO:0097237];"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";protein heterodimerization activity [GO:0046982]
comp917139_c0_seq1;GAXK01127278.1;Q6PB93;2.28E-110;GALT2_MOUSE;Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form];"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]";"GO:0002378; GO:0004653; GO:0005615; GO:0005794; GO:0005795; GO:0005796; GO:0006493; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471";"immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]";"extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
comp9173055_c0_seq1;GAXK01204709.1;Q09575;1.54E-10;YRD6_CAEEL;Uncharacterized protein K02A2.6;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]";"GO:0003676; GO:0008270; GO:0015074";DNA integration [GO:0015074];;"nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
comp91733_c5_seq1;GAXK01002418.1;Q92072;0;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp917490_c0_seq1;GAXK01127301.1;B1A193;8.62E-08;RASFA_XENLA;Ras association domain-containing protein 10;"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0050769; GO:2000179";"positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165]";"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]";
comp91776_c0_seq1;GAXK01002247.1;P55786;1.28E-134;PSA_HUMAN;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp917922_c0_seq2;GAXK01127307.1;Q9GZM7;1.60E-69;TINAL_HUMAN;Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP);"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cysteine-type peptidase activity [GO:0008234]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; endosomal transport [GO:0016197]; immune response [GO:0006955]";"GO:0005044; GO:0005201; GO:0005576; GO:0005615; GO:0005737; GO:0006955; GO:0007155; GO:0008234; GO:0016197; GO:0030247; GO:0043236; GO:0062023; GO:0070062";"cell adhesion [GO:0007155]; endosomal transport [GO:0016197]; immune response [GO:0006955]";"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";"cysteine-type peptidase activity [GO:0008234]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]"
comp91802_c0_seq1;GAXK01002326.1;A8Y9I2;1.93E-26;NINAB_GALME;Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B);"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]";"GO:0004497; GO:0016702; GO:0042572; GO:0046872";retinol metabolic process [GO:0042572];;"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp918076_c0_seq1;GAXK01087764.1;Q9C0G0;2.10E-09;ZN407_HUMAN;Zinc finger protein 407;"nucleus [GO:0005634]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]; regulation of gene expression [GO:0010468]";"GO:0000979; GO:0005634; GO:0008270; GO:0010468";regulation of gene expression [GO:0010468];nucleus [GO:0005634];"RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; zinc ion binding [GO:0008270]"
comp91813_c1_seq1;GAXK01002268.1;Q27955;2.70E-96;KCAB2_BOVIN;Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2);"axon [GO:0030424]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; postsynaptic density [GO:0014069]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; hematopoietic progenitor cell differentiation [GO:0002244]; NADPH oxidation [GO:0070995]; neuromuscular process [GO:0050905]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]";"GO:0002244; GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0008076; GO:0014069; GO:0015459; GO:0016020; GO:0030054; GO:0030424; GO:0031234; GO:0034705; GO:0043005; GO:0043679; GO:0044224; GO:0050905; GO:0055114; GO:0070995; GO:1901379; GO:1990031; GO:2000008";"hematopoietic progenitor cell differentiation [GO:0002244]; NADPH oxidation [GO:0070995]; neuromuscular process [GO:0050905]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]";"axon [GO:0030424]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; postsynaptic density [GO:0014069]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]";"aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]"
comp91820_c0_seq1;GAXK01002147.1;Q70HJ4;1.21E-13;PGLR2_ASPAC;Probable endopolygalacturonase II (EPG-II) (EC 3.2.1.15) (Pectinase 2) (Polygalacturonase II) (PG-II) (Polygalacturonase X2);"extracellular region [GO:0005576]; polygalacturonase activity [GO:0004650]; cell wall organization [GO:0071555]; pectin catabolic process [GO:0045490]";"GO:0004650; GO:0005576; GO:0045490; GO:0071555";"cell wall organization [GO:0071555]; pectin catabolic process [GO:0045490]";extracellular region [GO:0005576];polygalacturonase activity [GO:0004650]
comp918396_c0_seq1;GAXK01087763.1;P18746;3.05E-08;ZO26_XENLA;Oocyte zinc finger protein XlCOF26 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9184335_c0_seq1;GAXK01170868.1;I1RNL0;4.31E-24;C9MT2_GIBZE;Sphingolipid C9-methyltransferase 2 (C-9-MT2) (EC 2.1.1.317);"integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168]; lipid biosynthetic process [GO:0008610]; sphingolipid metabolic process [GO:0006665]";"GO:0006665; GO:0008168; GO:0008610; GO:0016021";"lipid biosynthetic process [GO:0008610]; sphingolipid metabolic process [GO:0006665]";integral component of membrane [GO:0016021];methyltransferase activity [GO:0008168]
comp918464_c2_seq1;GAXK01087768.1;Q965X6;6.19E-09;SIAH1_CAEEL;E3 ubiquitin-protein ligase siah-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0061630";"multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp9184710_c0_seq1;GAXK01170872.1;Q54XM6;1.56E-32;ETFD_DICDI;Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase);"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]";"GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539";respiratory electron transport chain [GO:0022904];integral component of mitochondrial inner membrane [GO:0031305];"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"
comp9184735_c0_seq1;GAXK01170873.1;P48159;3.94E-43;RL23_DROME;60S ribosomal protein L23 (L17A);"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180";cytoplasmic translation [GO:0002181];cytosolic large ribosomal subunit [GO:0022625];"large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]"
comp9186215_c0_seq1;GAXK01186697.1;P83401;3.74E-38;AL7A1_DICDI;Putative aldehyde dehydrogenase family 7 member A1 homolog (EC 1.2.1.3) (Antiquitin-1);"extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; cellular aldehyde metabolic process [GO:0006081]";"GO:0004029; GO:0006081; GO:0031012; GO:0043878; GO:0045335";cellular aldehyde metabolic process [GO:0006081];"extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335]";"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]"
comp9186689_c0_seq1;GAXK01186700.1;P55552;3.14E-15;Y4LL_SINFN;Uncharacterized protein y4lL;;;;;
comp91884_c0_seq1;GAXK01002148.1;Q8WUR0;3.41E-11;CS012_MOUSE;Protein C19orf12 homolog;"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitochondrial calcium ion homeostasis [GO:0051560]; response to oxidative stress [GO:0006979]";"GO:0005739; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0006979; GO:0016021; GO:0031966; GO:0051560";"apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitochondrial calcium ion homeostasis [GO:0051560]; response to oxidative stress [GO:0006979]";"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";
comp9189_c1_seq1;GAXK01014901.1;O75132;1.90E-07;ZBED4_HUMAN;Zinc finger BED domain-containing protein 4;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]";"GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0046872; GO:0046983";;"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]"
comp9189282_c0_seq1;GAXK01143163.1;A2SE03;1.51E-29;HIS1_METPP;ATP phosphoribosyltransferase (ATP-PRT) (ATP-PRTase) (EC 2.4.2.17);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]; histidine biosynthetic process [GO:0000105]";"GO:0000105; GO:0003879; GO:0005524; GO:0005737";histidine biosynthetic process [GO:0000105];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]"
comp91894_c0_seq1;GAXK01002267.1;Q5I0K7;2.78E-32;ALG13_RAT;UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1);"endoplasmic reticulum [GO:0005783]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]";"GO:0004577; GO:0005783; GO:0006488";dolichol-linked oligosaccharide biosynthetic process [GO:0006488];endoplasmic reticulum [GO:0005783];N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]
comp9189546_c0_seq1;GAXK01143168.1;O32178;3.13E-39;FADN_BACSU;Probable 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35);"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; fatty acid beta-oxidation [GO:0006635]";"GO:0003857; GO:0006635";fatty acid beta-oxidation [GO:0006635];;3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]
comp9189640_c0_seq1;GAXK01143166.1;Q8T9W4;2.77E-23;ABCB3_DICDI;ABC transporter B family member 3 (ABC transporter ABCB.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cAMP transport [GO:0070730]; sorocarp development [GO:0030587]";"GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0030587; GO:0042626; GO:0070730";"cAMP transport [GO:0070730]; sorocarp development [GO:0030587]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp918979_c0_seq1;GAXK01087741.1;P53355;8.70E-14;DAPK1_HUMAN;Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1);"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]";"GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310";"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]";"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]"
comp919_c0_seq1;GAXK01169939.1;Q24407;1.06E-26;ATP5J_DROME;ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6);"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"GO:0000276; GO:0005739; GO:0005753; GO:0005756; GO:0015078; GO:0015986; GO:1902600";"ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]";"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]";proton transmembrane transporter activity [GO:0015078]
comp919000_c0_seq1;GAXK01087792.1;Q2YDJ8;3.80E-08;KMT5A_BOVIN;N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.43) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8);"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"GO:0000122; GO:0002039; GO:0003714; GO:0005634; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]";"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]"
comp91901_c3_seq1;GAXK01002109.1;A5D9A7;4.19E-35;CYAC3_BOVIN;Cytochrome b ascorbate-dependent protein 3 (EC 1.-.-.-) (Cytochrome b561 family member A3);"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]";"GO:0005765; GO:0016021; GO:0016491; GO:0031902; GO:0046872";;"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]";"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
comp91924_c1_seq1;GAXK01002384.1;P53777;8.29E-22;MLP1_DROME;Muscle LIM protein 1;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0046872; GO:0060537";"actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]";"actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
comp9192511_c0_seq1;GAXK01162829.1;Q56FG6;4.65E-45;RL5_LYSTE;60S ribosomal protein L5;"nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005634; GO:0005840; GO:0006412; GO:0008097";translation [GO:0006412];"nucleus [GO:0005634]; ribosome [GO:0005840]";"5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]"
comp919355_c0_seq1;GAXK01087828.1;B6CZ45;7.04E-31;LRC51_MACMU;Leucine-rich repeat-containing protein 51 (Protein LRTOMT1);cytoplasm [GO:0005737];GO:0005737;;cytoplasm [GO:0005737];
comp91936_c2_seq1;GAXK01002463.1;Q8MQJ9;3.42E-50;BRAT_DROME;Brain tumor protein;"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"GO:0000209; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007411; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0043161; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061630; GO:0099738; GO:1900242; GO:1902692";"asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]";"apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]";"mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp91939_c1_seq1;GAXK01002108.1;Q7KRI2;7.61E-22;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp919400_c0_seq1;GAXK01087738.1;A6NN14;7.22E-19;ZN729_HUMAN;Zinc finger protein 729;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp919440_c0_seq1;GAXK01087803.1;Q9M8L2;1.40E-07;FBK30_ARATH;F-box/kelch-repeat protein At1g80440;"cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; negative regulation of cytokinin-activated signaling pathway [GO:0080037]; regulation of phenylpropanoid metabolic process [GO:2000762]";"GO:0005829; GO:0019005; GO:0080037; GO:2000762";"negative regulation of cytokinin-activated signaling pathway [GO:0080037]; regulation of phenylpropanoid metabolic process [GO:2000762]";"cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]";
comp919476_c0_seq1;GAXK01087826.1;Q7KRI2;5.42E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp91954_c0_seq1;GAXK01002181.1;Q9HAZ2;3.04E-08;PRD16_HUMAN;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp919686_c0_seq1;GAXK01087773.1;Q5ZJG8;6.48E-40;HSDL1_CHICK;Hydroxysteroid dehydrogenase-like protein 1 (EC 1.1.1.-);"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"GO:0005739; GO:0005783; GO:0006694; GO:0016491; GO:0030497";"fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]";"endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]";oxidoreductase activity [GO:0016491]
comp9197042_c0_seq1;GAXK01092959.1;Q75KR1;4.30E-53;PPDK2_ORYSJ;Pyruvate, phosphate dikinase 2 (EC 2.7.9.1) (Pyruvate, orthophosphate dikinase 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]; pyruvate metabolic process [GO:0006090]";"GO:0005524; GO:0005737; GO:0006090; GO:0016301; GO:0046872; GO:0050242";pyruvate metabolic process [GO:0006090];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pyruvate, phosphate dikinase activity [GO:0050242]"
comp92_c0_seq1;GAXK01170082.1;Q8TGM6;1.03E-12;TAR1_YEAST;Protein TAR1 (Transcript antisense to ribosomal RNA protein 1);"mitochondrion [GO:0005739]; regulation of cellular respiration [GO:0043457]";"GO:0005739; GO:0043457";regulation of cellular respiration [GO:0043457];mitochondrion [GO:0005739];
comp9200_c0_seq1;GAXK01014254.1;Q3SZF2;7.06E-49;ARF4_BOVIN;ADP-ribosylation factor 4;"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]";"GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0006890; GO:0006893; GO:0016192";"Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]";GTP binding [GO:0005525]
comp9200360_c0_seq1;GAXK01114337.1;P47203;4.70E-50;FTSA_PSEAE;Cell division protein FtsA;"cell division site [GO:0032153]; cytoplasmic side of plasma membrane [GO:0009898]; cell division [GO:0051301]; FtsZ-dependent cytokinesis [GO:0043093]";"GO:0009898; GO:0032153; GO:0043093; GO:0051301";"cell division [GO:0051301]; FtsZ-dependent cytokinesis [GO:0043093]";"cell division site [GO:0032153]; cytoplasmic side of plasma membrane [GO:0009898]";
comp920066_c0_seq1;GAXK01184979.1;Q7KRI2;1.53E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp92015_c0_seq1;GAXK01134524.1;Q86UE3;6.55E-09;ZN546_HUMAN;Zinc finger protein 546 (Zinc finger protein 49);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp920181_c0_seq1;GAXK01184971.1;Q3ZCX4;2.84E-19;ZN568_HUMAN;Zinc finger protein 568;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669";"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp920280_c0_seq1;GAXK01184990.1;Q9V427;1.38E-40;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp92029_c1_seq1;GAXK01134378.1;Q9GRW0;5.65E-31;PPAF2_HOLDI;"Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]";"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]";"GO:0004252; GO:0005576; GO:0045087; GO:0046872";innate immune response [GO:0045087];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp920462_c1_seq1;GAXK01184996.1;Q8NBN7;7.96E-61;RDH13_HUMAN;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3);"mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";mitochondrial inner membrane [GO:0005743];NADP-retinol dehydrogenase activity [GO:0052650]
comp92047_c0_seq1;GAXK01134568.1;P57790;6.56E-16;KEAP1_RAT;Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2);"cell-cell adherens junction [GO:0005913]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; transcription factor binding [GO:0008134]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of gene expression [GO:0010629]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein complex oligomerization [GO:0051259]; protein ubiquitination [GO:0016567]; response to immobilization stress [GO:0035902]; response to metal ion [GO:0010038]; response to thyroid hormone [GO:0097066]; selenium compound metabolic process [GO:0001887]";"GO:0001887; GO:0005634; GO:0005737; GO:0005913; GO:0005925; GO:0008134; GO:0010038; GO:0010499; GO:0010629; GO:0016567; GO:0031463; GO:0035902; GO:0042994; GO:0051259; GO:0071407; GO:0097066";"cellular response to organic cyclic compound [GO:0071407]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of gene expression [GO:0010629]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein complex oligomerization [GO:0051259]; protein ubiquitination [GO:0016567]; response to immobilization stress [GO:0035902]; response to metal ion [GO:0010038]; response to thyroid hormone [GO:0097066]; selenium compound metabolic process [GO:0001887]";"cell-cell adherens junction [GO:0005913]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]";transcription factor binding [GO:0008134]
comp9204938_c0_seq1;GAXK01046562.1;Q02NB5;6.30E-21;IDH_PSEAB;Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase);"extracellular region [GO:0005576]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004450; GO:0005576; GO:0006097; GO:0006099; GO:0051287";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";extracellular region [GO:0005576];"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp92050_c0_seq1;GAXK01134335.1;Q9VWP4;3.55E-178;SUOX_DROME;Probable sulfite oxidase, mitochondrial (EC 1.8.3.1);"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";"GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0042128; GO:0043546";"nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]";"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]";"heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]"
comp92059_c0_seq1;GAXK01134654.1;P42283;3.27E-07;LOLA1_DROME;Longitudinals lacking protein, isoform G;"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0019730; GO:0035167; GO:0044719; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813";"antimicrobial humoral response [GO:0019730]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp9207873_c0_seq1;GAXK01113877.1;Q17GM7;4.58E-84;CISY1_AEDAE;Probable citrate synthase 1, mitochondrial (EC 2.3.3.16);"mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";"GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101";"carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]";mitochondrial matrix [GO:0005759];citrate (Si)-synthase activity [GO:0004108]
comp920878_c0_seq1;GAXK01184982.1;Q6GNV7;1.27E-28;DIRC2_XENLA;Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog);"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]";"GO:0005765; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]";
comp9209048_c0_seq1;GAXK01062396.1;O74538;6.05E-37;RL27B_SCHPO;60S ribosomal protein L27-B;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]";"GO:0002181; GO:0003735; GO:0005829; GO:0022625";cytoplasmic translation [GO:0002181];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]";structural constituent of ribosome [GO:0003735]
comp921_c10_seq1;GAXK01165798.1;Q8CI04;0;COG3_MOUSE;Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3);"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0033365; GO:0050821";"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]";"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]";
comp921041_c0_seq1;GAXK01184968.1;Q5RFR0;8.96E-27;TTPAL_PONAB;Alpha-tocopherol transfer protein-like;;;;;
comp9211_c0_seq1;GAXK01014110.1;Q9JMB0;7.00E-21;GKAP1_MOUSE;G kinase-anchoring protein 1 (cGMP-dependent protein kinase-anchoring protein of 42 kDa);"Golgi apparatus [GO:0005794]; identical protein binding [GO:0042802]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165]";"GO:0005794; GO:0007165; GO:0007199; GO:0042802; GO:0046628";"G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165]";Golgi apparatus [GO:0005794];identical protein binding [GO:0042802]
comp921111_c0_seq1;GAXK01184978.1;P23381;6.15E-45;SYWC_HUMAN;"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062";"angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]"
comp921143_c0_seq1;GAXK01185016.1;Q6JEL3;4.02E-07;KLH10_RAT;Kelch-like protein 10;"cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";"GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873";"cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]";cytoplasm [GO:0005737];
comp921198_c1_seq1;GAXK01185006.1;Q32LN0;3.00E-08;EHF_BOVIN;ETS homologous factor (ETS domain-containing transcription factor);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000981; GO:0005634; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0043565; GO:0050673";"cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp921267_c0_seq1;GAXK01184984.1;Q6GR09;1.50E-12;SPOPL_XENLA;Speckle-type POZ protein-like;"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0016567; GO:0031397; GO:0031463; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]";
comp92156_c2_seq1;GAXK01134642.1;P26221;1.09E-118;GUN4_THEFU;Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4);"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]";"GO:0008810; GO:0030245; GO:0030248";cellulose catabolic process [GO:0030245];;"cellulase activity [GO:0008810]; cellulose binding [GO:0030248]"
comp92157_c2_seq1;GAXK01134501.1;Q0IUU4;9.66E-17;CML2_ORYSJ;Putative calmodulin-like protein 2;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp921587_c0_seq1;GAXK01184977.1;P73392;3.42E-11;Y1735_SYNY3;Uncharacterized protein sll1735;extracellular space [GO:0005615];GO:0005615;;extracellular space [GO:0005615];
comp9216259_c0_seq1;GAXK01194564.1;Q9FJ47;3.95E-34;SAG12_ARATH;Senescence-specific cysteine protease SAG12 (EC 3.4.22.-) (Cysteine proteinase SAG12) (Protein SENESCENCE-ASSOCIATED GENE 12);"extracellular space [GO:0005615]; lysosome [GO:0005764]; senescence-associated vacuole [GO:0010282]; cysteine-type endopeptidase activity [GO:0004197]; aging [GO:0007568]; defense response to fungus, incompatible interaction [GO:0009817]; floral organ senescence [GO:0080187]; leaf senescence [GO:0010150]; plant-type hypersensitive response [GO:0009626]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to auxin [GO:0009733]; response to cytokinin [GO:0009735]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to sucrose [GO:0009744]; response to UV-B [GO:0010224]; stress response to copper ion [GO:1990169]";"GO:0004197; GO:0005615; GO:0005764; GO:0007568; GO:0009626; GO:0009733; GO:0009735; GO:0009744; GO:0009749; GO:0009750; GO:0009817; GO:0010150; GO:0010224; GO:0010282; GO:0010623; GO:0051603; GO:0080187; GO:1990169";"aging [GO:0007568]; defense response to fungus, incompatible interaction [GO:0009817]; floral organ senescence [GO:0080187]; leaf senescence [GO:0010150]; plant-type hypersensitive response [GO:0009626]; programmed cell death involved in cell development [GO:0010623]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to auxin [GO:0009733]; response to cytokinin [GO:0009735]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to sucrose [GO:0009744]; response to UV-B [GO:0010224]; stress response to copper ion [GO:1990169]";"extracellular space [GO:0005615]; lysosome [GO:0005764]; senescence-associated vacuole [GO:0010282]";cysteine-type endopeptidase activity [GO:0004197]
comp9217514_c0_seq1;GAXK01194563.1;A4SZM1;5.26E-35;SYQ_POLAQ;Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; glutaminyl-tRNA aminoacylation [GO:0006425]; glutamyl-tRNA aminoacylation [GO:0006424]";"GO:0004819; GO:0005524; GO:0005737; GO:0006424; GO:0006425";"glutaminyl-tRNA aminoacylation [GO:0006425]; glutamyl-tRNA aminoacylation [GO:0006424]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]"
comp921762_c0_seq1;GAXK01185014.1;A0A0B4K692;1.72E-67;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp92183_c0_seq1;GAXK01134492.1;Q9ESG9;1.49E-77;PMYT1_MOUSE;Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; meiotic cell cycle [GO:0051321]; negative regulation of phosphatase activity [GO:0010923]";"GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0010923; GO:0016301; GO:0046872; GO:0051321";"meiotic cell cycle [GO:0051321]; negative regulation of phosphatase activity [GO:0010923]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp9219095_c0_seq1;GAXK01044602.1;Q9FVT2;5.79E-12;EF1G2_ARATH;Probable elongation factor 1-gamma 2 (EF-1-gamma 2) (eEF-1B gamma 2);"cell wall [GO:0005618]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; copper ion binding [GO:0005507]; translation elongation factor activity [GO:0003746]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]";"GO:0003746; GO:0005507; GO:0005618; GO:0005634; GO:0005773; GO:0005829; GO:0005886; GO:0009506; GO:0010043; GO:0046686";"response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]";"cell wall [GO:0005618]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]";"copper ion binding [GO:0005507]; translation elongation factor activity [GO:0003746]"
comp921929_c0_seq1;GAXK01185013.1;Q9QXL2;1.65E-10;KI21A_MOUSE;Kinesin-like protein KIF21A;"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]";"GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425";microtubule-based movement [GO:0007018];"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp92193_c0_seq1;GAXK01134211.1;Q8BMC4;2.26E-49;NOP9_MOUSE;Nucleolar protein 9 (Pumilio domain-containing protein NOP9);RNA binding [GO:0003723];GO:0003723;;;RNA binding [GO:0003723]
comp9220_c0_seq1;GAXK01014506.1;Q5RBA5;1.00E-22;SQSTM_PONAB;Sequestosome-1 (Ubiquitin-binding protein p62);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"GO:0000932; GO:0002376; GO:0005080; GO:0005764; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0035973; GO:0042169; GO:0043122; GO:0043130; GO:0061912; GO:0070530; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp9221244_c0_seq1;GAXK01200021.1;O70340;3.82E-07;NPTX2_MOUSE;Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II);"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"GO:0005576; GO:0005886; GO:0008306; GO:0009898; GO:0030175; GO:0030246; GO:0030425; GO:0030426; GO:0031175; GO:0043025; GO:0046872; GO:0098892; GO:0098962; GO:0098978; GO:0099645";"associative learning [GO:0008306]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]";"cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]"
comp922176_c0_seq1;GAXK01072398.1;P24524;6.71E-59;GLRA3_RAT;Glycine receptor subunit alpha-3;"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099060; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]"
comp9222_c1_seq1;GAXK01013483.1;Q3B726;7.72E-22;RPA43_HUMAN;DNA-directed RNA polymerase I subunit RPA43 (Twist neighbor protein);"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"GO:0003899; GO:0005654; GO:0005736; GO:0006361; GO:0006362; GO:0006363; GO:0045815; GO:1990830";"cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of gene expression, epigenetic [GO:0045815]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]";"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]";DNA-directed 5'-3' RNA polymerase activity [GO:0003899]
comp922209_c0_seq1;GAXK01072260.1;P43080;1.95E-09;GUC1A_HUMAN;Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A);"photoreceptor disc membrane [GO:0097381]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase regulator activity [GO:0030249]; cellular response to calcium ion [GO:0071277]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0005509; GO:0007165; GO:0007601; GO:0008048; GO:0022400; GO:0030249; GO:0031284; GO:0071277; GO:0097381";"cellular response to calcium ion [GO:0071277]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]";photoreceptor disc membrane [GO:0097381];"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase regulator activity [GO:0030249]"
comp922233_c0_seq1;GAXK01072383.1;P17970;0;KCNAB_DROME;Potassium voltage-gated channel protein Shab;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0007268; GO:0008016; GO:0008076; GO:0008345; GO:0016021; GO:0034765; GO:0045938; GO:0051260; GO:0060025; GO:0071805";"action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; larval locomotory behavior [GO:0008345]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
comp9222624_c0_seq1;GAXK01072655.1;O94523;1.19E-34;ACO1_SCHPO;Probable acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; iron ion binding [GO:0005506]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]";"GO:0004768; GO:0005506; GO:0005783; GO:0005789; GO:0006636; GO:0030176; GO:0031227";unsaturated fatty acid biosynthetic process [GO:0006636];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]";"iron ion binding [GO:0005506]; stearoyl-CoA 9-desaturase activity [GO:0004768]"
comp9225_c1_seq1;GAXK01013488.1;Q9QY36;3.52E-91;NAA10_MOUSE;N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit Naa10);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; protein acetylation [GO:0006473]";"GO:0004596; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006473; GO:0006474; GO:0008080; GO:0017198; GO:0018002; GO:0031415; GO:0043022; GO:1990189; GO:1990190; GO:2000719";"negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; protein acetylation [GO:0006473]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]";"N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]"
comp922534_c2_seq1;GAXK01072343.1;G5ED00;5.76E-09;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp922697_c0_seq1;GAXK01072376.1;Q9UJU3;1.26E-15;ZN112_HUMAN;Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9227_c1_seq1;GAXK01014321.1;Q9W2N0;4.27E-141;CAPZA_DROME;F-actin-capping protein subunit alpha;"actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]";"GO:0000902; GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030036; GO:0030479; GO:0030837; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0071203";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]";"actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]";"actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]"
comp922707_c2_seq1;GAXK01072424.1;P91119;0;PDE5_CAEEL;Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17);"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";"GO:0004114; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555";"chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]";;"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"
comp922777_c0_seq1;GAXK01072382.1;Q7UM18;2.79E-07;Y9128_RHOBA;UPF0314 protein RB9128;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp922840_c0_seq1;GAXK01072378.1;Q08890;8.21E-96;IDS_MOUSE;Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase);"lysosome [GO:0005764]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]";"GO:0004423; GO:0005764; GO:0008484; GO:0046872";;lysosome [GO:0005764];"iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]"
comp92296_c4_seq1;GAXK01134326.1;Q5VT52;9.22E-18;RPRD2_HUMAN;Regulation of nuclear pre-mRNA domain-containing protein 2;"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; snRNA transcription by RNA polymerase II [GO:0042795]";"GO:0000993; GO:0005654; GO:0016591; GO:0031124; GO:0042795";"mRNA 3'-end processing [GO:0031124]; snRNA transcription by RNA polymerase II [GO:0042795]";"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]";RNA polymerase II complex binding [GO:0000993]
comp9230_c0_seq1;GAXK01013630.1;Q9BQR3;3.01E-35;PRS27_HUMAN;Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin);"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005576; GO:0019897; GO:0046658";;"anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]";serine-type endopeptidase activity [GO:0004252]
comp923057_c0_seq1;GAXK01072353.1;Q8Q0U0;1.74E-20;Y045_METMA;Putative ankyrin repeat protein MM_0045;;;;;
comp923072_c0_seq1;GAXK01072412.1;P36609;7.44E-28;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp92308_c0_seq1;GAXK01134419.1;O60784;6.25E-24;TOM1_HUMAN;Target of Myb protein 1;"azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; clathrin binding [GO:0030276]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]";"GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0015031; GO:0016020; GO:0016197; GO:0030276; GO:0035577; GO:0035579; GO:0043312; GO:0070062";"endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]";"azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]";clathrin binding [GO:0030276]
comp9231_c1_seq1;GAXK01014904.1;Q8MR62;3.06E-79;VIAF1_DROME;Viral IAP-associated factor homolog;"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]";"GO:0005737; GO:0006915; GO:0043281";"apoptotic process [GO:0006915]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]";cytoplasm [GO:0005737];
comp923140_c0_seq1;GAXK01072386.1;E9PTT0;6.84E-10;ZDH17_RAT;Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 17);"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953";"lipoprotein transport [GO:0042953]; protein palmitoylation [GO:0018345]";"aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]";"identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]"
comp9232756_c0_seq1;GAXK01082831.1;P18907;9.05E-10;AT1A1_HORSE;Sodium/potassium-transporting ATPase subunit alpha-1 (Sodium pump subunit alpha-1) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha-1 subunit);"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]";"GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006883; GO:0008217; GO:0014069; GO:0016021; GO:0016323; GO:0016324; GO:0016791; GO:0030007; GO:0030315; GO:0031947; GO:0036376; GO:0042493; GO:0045822; GO:0045823; GO:0045989; GO:0046872; GO:0051087; GO:0071383; GO:0086009; GO:1902600; GO:1903416; GO:1990239; GO:1990573";"cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]";"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]";"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]"
comp923281_c1_seq1;GAXK01072270.1;Q5R8K7;8.41E-51;PGPS1_PONAB;CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]";"GO:0005524; GO:0005739; GO:0008444; GO:0032049";cardiolipin biosynthetic process [GO:0032049];mitochondrion [GO:0005739];"ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]"
comp923481_c0_seq1;GAXK01072350.1;Q16983;2.56E-56;DIHR_ACHDO;Diuretic hormone receptor (DH-R);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0008036; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"diuretic hormone receptor activity [GO:0008036]; G protein-coupled receptor activity [GO:0004930]"
comp9235612_c0_seq1;GAXK01150124.1;P0DJ54;3.80E-18;RL24_TETTS;60S ribosomal protein L24;ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp92366_c2_seq1;GAXK01134629.1;Q7Z401;0;MYCPP_HUMAN;C-myc promoter-binding protein (DENN domain-containing protein 4A);"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0017112";regulation of transcription, DNA-templated [GO:0006355];"cytosol [GO:0005829]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]"
comp92367_c0_seq1;GAXK01134503.1;Q4R4R4;3.91E-40;PRAF3_MACFA;PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5);"cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]";"GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0016021";negative regulation of L-glutamate import across plasma membrane [GO:0002037];"cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp9238_c0_seq1;GAXK01014680.1;Q91V16;5.32E-17;ETFR1_MOUSE;Electron transfer flavoprotein regulatory factor 1 (Growth hormone-inducible soluble protein) (LYR motif-containing protein 5);"mitochondrion [GO:0005739]; respiratory electron transport chain [GO:0022904]";"GO:0005739; GO:0022904";respiratory electron transport chain [GO:0022904];mitochondrion [GO:0005739];
comp9238121_c0_seq1;GAXK01170968.1;P93099;4.47E-23;RL13A_CYAPA;60S ribosomal protein L13a;"large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0015934";translation [GO:0006412];large ribosomal subunit [GO:0015934];structural constituent of ribosome [GO:0003735]
comp92388_c0_seq1;GAXK01134452.1;P57721;3.35E-52;PCBP3_HUMAN;Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]";"GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829";mRNA metabolic process [GO:0016071];"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]"
comp92404_c1_seq1;GAXK01134420.1;Q5ZI67;5.01E-145;NHLC2_CHICK;NHL repeat-containing protein 2;"cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; cell redox homeostasis [GO:0045454]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]";"GO:0000209; GO:0005829; GO:0043161; GO:0045454; GO:0061630";"cell redox homeostasis [GO:0045454]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]";cytosol [GO:0005829];ubiquitin protein ligase activity [GO:0061630]
comp924102_c0_seq1;GAXK01002965.1;Q6GLE8;3.08E-21;LRC28_XENTR;Leucine-rich repeat-containing protein 28;;;;;
comp92415_c0_seq1;GAXK01134359.1;O73692;6.93E-16;EGR1_COTJA;Early growth response protein 1 (EGR-1) (Zinc finger protein ZENK) (Fragment);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein sumoylation [GO:0033233]; transcription by RNA polymerase II [GO:0006366]";"GO:0000976; GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0008270; GO:0010385; GO:0032922; GO:0033233; GO:0035035; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0070498; GO:0098759; GO:1990841";"cellular response to interleukin-8 [GO:0098759]; circadian regulation of gene expression [GO:0032922]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein sumoylation [GO:0033233]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp92424_c3_seq1;GAXK01134658.1;Q9NX07;1.35E-46;TSAP1_HUMAN;tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; selenocysteine incorporation [GO:0001514]";"GO:0001514; GO:0003723; GO:0005634; GO:0005737";selenocysteine incorporation [GO:0001514];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";RNA binding [GO:0003723]
comp9245878_c0_seq1;GAXK01025897.1;P69104;1.50E-29;GBLP_TRYBR;Guanine nucleotide-binding protein subunit beta-like protein (Activated protein kinase C receptor homolog) (Track);ribosome [GO:0005840];GO:0005840;;ribosome [GO:0005840];
comp924602_c0_seq1;GAXK01002907.1;O97596;5.01E-27;S20A1_FELCA;Sodium-dependent phosphate transporter 1 (Feline leukemia virus subtype-B receptor) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1);"integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005887; GO:0015319; GO:0035435";phosphate ion transmembrane transport [GO:0035435];integral component of plasma membrane [GO:0005887];"inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]"
comp924611_c0_seq1;GAXK01002900.1;Q98989;4.02E-54;STXA_SYNHO;Stonustoxin subunit alpha (SNTX subunit alpha) (DELTA-synanceitoxin-Sh1a) (DELTA-SYTX-Sh1a) (Trachynilysin subunit alpha) (TLY subunit alpha);"extracellular region [GO:0005576]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]";"GO:0005576; GO:0044179; GO:0090729";hemolysis in other organism [GO:0044179];extracellular region [GO:0005576];toxin activity [GO:0090729]
comp924654_c0_seq1;GAXK01002944.1;Q9NA51;2.14E-14;NHR5_CAEEL;Nuclear hormone receptor family member nhr-5;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]";"GO:0003700; GO:0005634; GO:0008270; GO:0043565";;nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"
comp92474_c0_seq1;GAXK01134657.1;P54190;7.24E-09;TES26_TOXCA;26 kDa secreted antigen (Toxocara excretory-secretory antigen 26) (TES-26);"extracellular region [GO:0005576]; lipid binding [GO:0008289]";"GO:0005576; GO:0008289";;extracellular region [GO:0005576];lipid binding [GO:0008289]
comp9247592_c0_seq1;GAXK01192958.1;P44450;2.98E-45;FDXH_HAEIN;Formate dehydrogenase iron-sulfur subunit (Formate dehydrogenase subunit beta) (FDH subunit beta);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; cellular respiration [GO:0045333]; formate oxidation [GO:0015944]";"GO:0005886; GO:0015944; GO:0016021; GO:0045333; GO:0046872; GO:0051539";"cellular respiration [GO:0045333]; formate oxidation [GO:0015944]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"
comp924785_c0_seq1;GAXK01002939.1;Q8NHY6;8.01E-18;ZFP28_HUMAN;Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9248077_c0_seq1;GAXK01192244.1;Q9SF40;6.30E-25;RL4A_ARATH;60S ribosomal protein L4-1 (L1);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp92493_c0_seq1;GAXK01134377.1;Q8BIZ6;8.63E-61;SNIP1_MOUSE;Smad nuclear-interacting protein 1;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA binding [GO:0003729]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mRNA splicing, via spliceosome [GO:0000398]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007249; GO:0035196; GO:0071005";"I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mRNA splicing, via spliceosome [GO:0000398]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]";mRNA binding [GO:0003729]
comp925022_c1_seq1;GAXK01002911.1;A7MBD8;8.25E-118;SC5AC_BOVIN;Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324";sodium ion transport [GO:0006814];"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";"lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]"
comp92508_c2_seq1;GAXK01134661.1;Q9HC07;3.47E-22;TM165_HUMAN;Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL);"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0016021; GO:0031901; GO:0031902; GO:0032472; GO:0032588; GO:0035751; GO:0043231";"cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]";"early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]";
comp92521_c0_seq1;GAXK01134333.1;Q8CEF9;6.70E-79;T132C_MOUSE;Transmembrane protein 132C;"integral component of membrane [GO:0016021]; negative regulation of phosphatase activity [GO:0010923]";"GO:0010923; GO:0016021";negative regulation of phosphatase activity [GO:0010923];integral component of membrane [GO:0016021];
comp9252401_c0_seq1;GAXK01102464.1;Q9R1A9;1.77E-16;TREX2_MOUSE;Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2);"nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";"GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803";"DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]";nucleus [GO:0005634];"3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]"
comp92537_c1_seq1;GAXK01134396.1;P98198;3.56E-141;AT8B2_HUMAN;Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326";"Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp925377_c0_seq1;GAXK01002935.1;Q5SV42;2.98E-25;ILEUC_MOUSE;Leukocyte elastase inhibitor C (Serine protease inhibitor EIC) (Serpin B1c);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta secretion [GO:0050713]";"GO:0004867; GO:0005615; GO:0005737; GO:0010951; GO:0050713";"negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta secretion [GO:0050713]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase inhibitor activity [GO:0004867]
comp925442_c0_seq1;GAXK01002964.1;P36609;2.82E-19;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp925772_c0_seq2;GAXK01002915.1;P04630;1.21E-30;CALL_CAEEL;Calmodulin-like protein;"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp925894_c0_seq1;GAXK01002946.1;Q54DY9;5.57E-17;BCS1B_DICDI;Probable mitochondrial chaperone BCS1-B (BCS1-like protein 2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005524; GO:0005739; GO:0005743; GO:0008320; GO:0016021; GO:0034551; GO:0051131";"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]"
comp926268_c0_seq1;GAXK01152011.1;P22648;3.04E-34;FAS2_SCHAM;Fasciclin-2 (Fasciclin II) (FAS II);"integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";"GO:0007155; GO:0007399; GO:0016021; GO:0030154";"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]";integral component of membrane [GO:0016021];
comp926363_c0_seq1;GAXK01151995.1;Q1H9T6;1.01E-07;TZAP_MOUSE;Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872";"positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp926415_c0_seq1;GAXK01152036.1;Q9NPF2;7.16E-14;CHSTB_HUMAN;Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659";"carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
comp92652_c1_seq1;GAXK01134628.1;Q24325;0;TAF2_DROME;Transcription initiation factor TFIID subunit 2 (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150);"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000979; GO:0003682; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0008237; GO:0008270; GO:0017025; GO:0044212; GO:0045944; GO:0051123; GO:0060261";"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]";"chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp92656_c0_seq1;GAXK01134617.1;Q2T9V8;7.46E-52;DTD1_BOVIN;D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase) (EC 3.1.1.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399]";"GO:0000049; GO:0002161; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500";"DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"aminoacyl-tRNA editing activity [GO:0002161]; DNA binding [GO:0003677]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]"
comp926599_c0_seq1;GAXK01152043.1;Q8N988;1.07E-16;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp926702_c0_seq1;GAXK01152044.1;O60488;7.29E-132;ACSL4_HUMAN;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4);"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391";"dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]";"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]"
comp926771_c0_seq1;GAXK01151990.1;Q3T906;3.05E-112;GNPTA_HUMAN;"N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]";"GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835";"carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"
comp9267911_c0_seq1;GAXK01009999.1;Q60049;1.56E-07;NOX_THET8;NADH dehydrogenase (EC 1.6.99.3) (H(2)O(2)-forming NADH oxidase) (NADH:oxygen oxidoreductase);NADH dehydrogenase activity [GO:0003954];GO:0003954;;;NADH dehydrogenase activity [GO:0003954]
comp9268171_c0_seq1;GAXK01127254.1;P26683;1.28E-23;SIGA_NOSS1;RNA polymerase sigma factor SigA (Sigma-A);"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]; transcription initiation from bacterial-type RNA polymerase promoter [GO:0001123]";"GO:0001123; GO:0003677; GO:0003700; GO:0005737; GO:0016987";transcription initiation from bacterial-type RNA polymerase promoter [GO:0001123];cytoplasm [GO:0005737];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sigma factor activity [GO:0016987]"
comp9270_c1_seq1;GAXK01013842.1;P51892;0;DNLI1_XENLA;DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1);"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";"GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897";"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]";nucleus [GO:0005634];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]"
comp92702_c2_seq1;GAXK01134348.1;Q9XYN1;2.75E-99;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp927180_c0_seq1;GAXK01152028.1;Q9Y2C3;4.08E-26;B3GT5_HUMAN;Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0008376; GO:0008499; GO:0009312; GO:0016021";"oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
comp9273_c0_seq1;GAXK01013638.1;P04069;1.15E-97;CBPB_ASTAS;Carboxypeptidase B (EC 3.4.17.2);"extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]";"GO:0004181; GO:0005576; GO:0008270";;extracellular region [GO:0005576];"metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]"
comp9273246_c0_seq1;GAXK01173311.1;Q6NVF4;7.81E-16;HELB_MOUSE;DNA helicase B (EC 3.6.4.12);"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA-dependent DNA replication [GO:0006261]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005662; GO:0005737; GO:0006260; GO:0006261; GO:0006269; GO:0006974; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042";"cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]";"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]"
comp927325_c0_seq1;GAXK01152041.1;Q9N2A3;1.56E-91;ACM3_GORGO;Muscarinic acetylcholine receptor M3;"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; acetylcholine binding [GO:0042166]; adrenergic receptor activity [GO:0004935]; G protein-coupled acetylcholine receptor activity [GO:0016907]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; positive regulation of smooth muscle contraction [GO:0045987]; saliva secretion [GO:0046541]";"GO:0004935; GO:0005887; GO:0007188; GO:0007213; GO:0016323; GO:0016907; GO:0030054; GO:0042166; GO:0045211; GO:0045987; GO:0046541; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; positive regulation of smooth muscle contraction [GO:0045987]; saliva secretion [GO:0046541]";"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]";"acetylcholine binding [GO:0042166]; adrenergic receptor activity [GO:0004935]; G protein-coupled acetylcholine receptor activity [GO:0016907]"
comp927410_c0_seq1;GAXK01152038.1;P86854;4.06E-15;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp927414_c0_seq1;GAXK01152005.1;Q7KRI2;1.66E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp927419_c0_seq1;GAXK01151988.1;D3Z5L6;8.37E-27;S18B1_MOUSE;MFS-type transporter SLC18B1 (Solute carrier family 18 member B1);"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp927511_c0_seq1;GAXK01204892.1;Q03012;1.02E-08;SPP1_YEAST;COMPASS component SPP1 (Complex proteins associated with SET1 protein SPP1) (Set1C component SPP1) (Suppressor of PRP protein 1);"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin silencing at telomere [GO:0006348]; histone H3-K4 methylation [GO:0051568]; regulation of meiotic DNA double-strand break formation [GO:1903341]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000781; GO:0003682; GO:0005634; GO:0005829; GO:0006348; GO:0006355; GO:0035064; GO:0046872; GO:0048188; GO:0051568; GO:1903341";"chromatin silencing at telomere [GO:0006348]; histone H3-K4 methylation [GO:0051568]; regulation of meiotic DNA double-strand break formation [GO:1903341]; regulation of transcription, DNA-templated [GO:0006355]";"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]";"chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp927562_c0_seq1;GAXK01152025.1;P89116;2.78E-34;CASP1_SPOFR;"Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]";"cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]";"GO:0004197; GO:0006915";apoptotic process [GO:0006915];;cysteine-type endopeptidase activity [GO:0004197]
comp9276785_c0_seq1;GAXK01076088.1;P0A0Z5;3.10E-21;PBPA_NEIMA;"Penicillin-binding protein 1A (PBP-1a) (PBP1a) [Includes: Penicillin-insensitive transglycosylase (EC 2.4.1.129) (Peptidoglycan TGase); Penicillin-sensitive transpeptidase (EC 3.4.16.4) (DD-transpeptidase)]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"GO:0005886; GO:0008360; GO:0008658; GO:0008955; GO:0009002; GO:0009252; GO:0016021; GO:0046677; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]"
comp927817_c0_seq1;GAXK01152099.1;Q3U4H6;2.00E-13;HEXD_MOUSE;Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase);"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]";"GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561";carbohydrate metabolic process [GO:0005975];"cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]";"beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]"
comp927900_c0_seq1;GAXK01152051.1;Q92072;8.68E-110;DNMT1_CHICK;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT);"nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";"GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841";"DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]";nucleus [GO:0005634];"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]"
comp927962_c0_seq1;GAXK01152094.1;Q90703;5.85E-98;NOS2_CHICK;Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (Macrophage NOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2);"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0031284; GO:0032310; GO:0032496; GO:0042742; GO:0045776; GO:0046872; GO:0050660; GO:0050661; GO:0072604; GO:0072606; GO:1900015";"arginine catabolic process [GO:0006527]; defense response to bacterium [GO:0042742]; interleukin-6 secretion [GO:0072604]; interleukin-8 secretion [GO:0072606]; negative regulation of blood pressure [GO:0045776]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; prostaglandin secretion [GO:0032310]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]";"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]";"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]"
comp92798_c0_seq1;GAXK01134449.1;Q8NB14;6.07E-38;UBP38_HUMAN;Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38);"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0006511; GO:0016579";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";;"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp92799_c0_seq1;GAXK01134416.1;Q5ZI03;7.41E-30;CIR1_CHICK;Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor);"centrosome [GO:0005813]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]";"GO:0003714; GO:0005813; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0044877; GO:0045892";"mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]";"centrosome [GO:0005813]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]";"protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]"
comp9281978_c0_seq1;GAXK01003893.1;P41561;1.45E-65;IDH2_COLMA;Isocitrate dehydrogenase [NADP] 2 (EC 1.1.1.42) (IDH-II) (IDP-2) (NADP(+)-specific ICDH 2) (Oxalosuccinate decarboxylase 2);"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";"GO:0004450; GO:0006097; GO:0006099; GO:0046872";"glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]";;"isocitrate dehydrogenase (NADP+) activity [GO:0004450]; metal ion binding [GO:0046872]"
comp92820_c1_seq1;GAXK01134297.1;O75417;0;DPOLQ_HUMAN;DNA polymerase theta (EC 2.7.7.7) (DNA polymerase eta);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"GO:0000724; GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0017116; GO:0042802; GO:0051260; GO:0051575; GO:0097681; GO:2000042";"base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]"
comp928222_c0_seq1;GAXK01059736.1;Q6XD76;1.64E-10;ASCL4_HUMAN;Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44);"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]";"GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0008134; GO:0043588; GO:0045944; GO:0046983; GO:0090575";"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]";"nuclear chromatin [GO:0000790]; RNA polymerase II transcription factor complex [GO:0090575]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]"
comp9284188_c0_seq1;GAXK01009740.1;A6SWY0;2.44E-11;COBT_JANMA;Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (NN:DBI PRT) (EC 2.4.2.21) (N(1)-alpha-phosphoribosyltransferase);"nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity [GO:0008939]; cobalamin biosynthetic process [GO:0009236]; nucleoside biosynthetic process [GO:0009163]";"GO:0008939; GO:0009163; GO:0009236";"cobalamin biosynthetic process [GO:0009236]; nucleoside biosynthetic process [GO:0009163]";;nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity [GO:0008939]
comp928420_c1_seq1;GAXK01059704.1;P22770;2.36E-24;ACHA7_CHICK;Neuronal acetylcholine receptor subunit alpha-7;"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"GO:0000187; GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890";"activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]";"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
comp9285_c0_seq1;GAXK01014013.1;B3MF39;1.06E-18;EIF3J_DROAN;Eukaryotic translation initiation factor 3 subunit J (eIF3j);"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]";"GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0033290";"formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]";"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]";translation initiation factor activity [GO:0003743]
comp92860_c0_seq1;GAXK01134459.1;Q9NR83;1.13E-12;S2A4R_HUMAN;SLC2A4 regulator (GLUT4 enhancer factor) (GEF) (Huntington disease gene regulatory region-binding protein 1) (HDBP-1);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0016607; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp92866_c1_seq1;GAXK01134382.1;Q9H6P5;1.85E-38;TASP1_HUMAN;"Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]";"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]";"GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604";"positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]";cytoplasm [GO:0005737];"identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]"
comp9288758_c0_seq1;GAXK01101841.1;P24657;7.56E-19;RNTR_HYPRU;Ribonuclease Trv (RNase Trv) (EC 4.6.1.19);"lyase activity [GO:0016829]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]";"GO:0003723; GO:0016829; GO:0033897";;;"lyase activity [GO:0016829]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]"
comp9288992_c0_seq1;GAXK01101843.1;P54811;7.48E-17;TERA1_CAEEL;Transitional endoplasmic reticulum ATPase homolog 1 (EC 3.6.4.6) (Cell division cycle-related protein 48.1) (p97/CDC48 homolog 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of protein localization to chromatin [GO:1905634]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008340; GO:0009792; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0032436; GO:0034098; GO:0042802; GO:0044877; GO:0045977; GO:0048471; GO:0051228; GO:0071712; GO:0097352; GO:1905634";"autophagosome maturation [GO:0097352]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of protein localization to chromatin [GO:1905634]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]"
comp9289_c0_seq1;GAXK01014757.1;P12007;0;IVD_RAT;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; protein homooligomerization [GO:0051260]";"GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0008470; GO:0031966; GO:0033539; GO:0050660; GO:0051260";"fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; protein homooligomerization [GO:0051260]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]"
comp92890_c0_seq1;GAXK01134307.1;Q02157;1.27E-45;LIPP_RABIT;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004806; GO:0005576; GO:0016042; GO:0046872";lipid catabolic process [GO:0016042];extracellular region [GO:0005576];"metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
comp9289239_c0_seq1;GAXK01101845.1;P37899;6.04E-28;HSP70_PYRSA;Heat shock 70 kDa protein;ATP binding [GO:0005524];GO:0005524;;;ATP binding [GO:0005524]
comp92894_c5_seq1;GAXK01134569.1;A0A0B4K692;0;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp92895_c0_seq1;GAXK01134542.1;Q91VJ5;2.66E-18;PQBP1_MOUSE;Polyglutamine-binding protein 1 (PQBP-1) (38 kDa nuclear protein containing a WW domain) (Npw38) (Polyglutamine tract-binding protein 1);"centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; protein C-terminus binding [GO:0008022]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]";"GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0008022; GO:0010494; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598; GO:0097546; GO:1902857";"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]";"centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; protein C-terminus binding [GO:0008022]; ribonucleoprotein complex binding [GO:0043021]"
comp929483_c0_seq1;GAXK01059684.1;Q08ER8;2.12E-37;ZN543_HUMAN;Zinc finger protein 543;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp929551_c0_seq1;GAXK01059698.1;Q80V63;8.20E-10;PRDM4_MOUSE;PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4);"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005123; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010629; GO:0030308; GO:0031490; GO:0035097; GO:0043565; GO:0045944; GO:0046872; GO:1990226; GO:2000177; GO:2000736";"negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of stem cell differentiation [GO:2000736]; transcription by RNA polymerase II [GO:0006366]";"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]";"chromatin DNA binding [GO:0031490]; death receptor binding [GO:0005123]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp929592_c0_seq1;GAXK01059691.1;Q86VH2;1.12E-53;KIF27_HUMAN;Kinesin-like protein KIF27;"cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]";"GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271";"cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp9298_c0_seq1;GAXK01013493.1;Q9VM71;0;XRN2_DROME;5'-3' exoribonuclease 2 homolog (EC 3.1.13.-) (Ribonucleic acid-trafficking protein 1) (dRAT1);"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]";"GO:0000738; GO:0003676; GO:0004534; GO:0005634; GO:0006353; GO:0006397; GO:0008409; GO:0046872";"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]";nucleus [GO:0005634];"5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp929885_c0_seq1;GAXK01059735.1;Q5WRU0;1.61E-20;OIG4_CAEEL;Immunoglobulin domain-containing protein oig-4;"cell junction [GO:0030054]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]";"GO:0005615; GO:0030054; GO:0031594";;"cell junction [GO:0030054]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]";
comp93000_c0_seq1;GAXK01134355.1;Q04688;1.13E-46;ELG_DROME;DNA-binding protein Ets97D (D-elg);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000820; GO:0000981; GO:0005634; GO:0006357; GO:0009267; GO:0010821; GO:0030154; GO:0043565; GO:0045944; GO:1903862";"cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
comp93015_c0_seq1;GAXK01134497.1;Q9Y2H8;1.56E-12;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp930316_c0_seq1;GAXK01151919.1;Q58EG2;7.69E-09;ERLN1_DANRE;Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0031625; GO:0032933";"cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]";"cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]"
comp930321_c0_seq1;GAXK01151964.1;Q99MV7;1.04E-14;RNF17_MOUSE;RING finger protein 17 (Mad member-interacting protein 2) (Mmip-2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]";"GO:0005634; GO:0005737; GO:0007275; GO:0007286; GO:0042803; GO:0046872";"multicellular organism development [GO:0007275]; spermatid development [GO:0007286]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
comp9303318_c0_seq1;GAXK01078187.1;P27489;7.70E-09;CB23_SOLLC;Chlorophyll a-b binding protein 13, chloroplastic (LHCII type III CAB-13);"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; plastoglobule [GO:0010287]; chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]; photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"GO:0009416; GO:0009522; GO:0009523; GO:0009535; GO:0009768; GO:0009941; GO:0010287; GO:0016021; GO:0016168; GO:0018298; GO:0046872";"photosynthesis, light harvesting in photosystem I [GO:0009768]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]";"chloroplast envelope [GO:0009941]; chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; photosystem I [GO:0009522]; photosystem II [GO:0009523]; plastoglobule [GO:0010287]";"chlorophyll binding [GO:0016168]; metal ion binding [GO:0046872]"
comp93036_c4_seq1;GAXK01134582.1;Q8BZG5;9.12E-78;RRNAD_MOUSE;Protein RRNAD1;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp9306_c3_seq1;GAXK01013445.1;P97807;0;FUMH_MOUSE;Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) (EF-3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]";"GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0120162; GO:2001034";"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]";"fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]"
comp93088_c0_seq1;GAXK01134296.1;Q13439;2.26E-18;GOGA4_HUMAN;Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0016192; GO:0043001; GO:0043231; GO:0045773; GO:0051020; GO:0070062";"Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]";GTPase binding [GO:0051020]
comp93089_c0_seq1;GAXK01134454.1;P97440;7.59E-17;SLBP_MOUSE;Histone RNA hairpin-binding protein (Histone stem-loop-binding protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell cycle phase transition [GO:0044770]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]; nuclear DNA replication [GO:0033260]";"GO:0003729; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006398; GO:0033260; GO:0042802; GO:0044770; GO:0051028; GO:0071204; GO:0071207; GO:1990904";"cell cycle phase transition [GO:0044770]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]; nuclear DNA replication [GO:0033260]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]"
comp9309020_c0_seq1;GAXK01114671.1;Q8R5F3;1.19E-19;OARD1_MOUSE;ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293";"cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]";"ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]"
comp93097_c0_seq1;GAXK01205796.1;Q03685;0;BIP5_TOBAC;Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5);"endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]";"GO:0005524; GO:0005788";;endoplasmic reticulum lumen [GO:0005788];ATP binding [GO:0005524]
comp931109_c0_seq1;GAXK01151944.1;Q05546;3.33E-09;TENR_RAT;Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin);"extracellular matrix [GO:0031012]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perisynaptic extracellular matrix [GO:0098966]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]";"GO:0005178; GO:0007155; GO:0007162; GO:0007399; GO:0031012; GO:0050767; GO:0098686; GO:0098966";"cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]";"extracellular matrix [GO:0031012]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perisynaptic extracellular matrix [GO:0098966]";integrin binding [GO:0005178]
comp93115_c0_seq1;GAXK01134655.1;Q8JFP1;2.20E-13;IF4A2_CHICK;Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2);"cytoplasmic stress granule [GO:0010494]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]";"GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0010494";cytoplasmic translational initiation [GO:0002183];cytoplasmic stress granule [GO:0010494];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]"
comp931187_c0_seq1;GAXK01151922.1;Q24799;1.03E-13;MYPH_ECHGR;Myophilin;;;;;
comp9312942_c0_seq1;GAXK01086593.1;P0CH36;4.75E-28;ADHC1_MYCS2;NADP-dependent alcohol dehydrogenase C 1 (Ms-ADHC 1) (EC 1.1.1.2);"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]";"GO:0008106; GO:0008270";;;"alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270]"
comp931416_c0_seq1;GAXK01151963.1;Q8VIG1;7.35E-09;REST_MOUSE;RE1-silencing transcription factor (Neural-restrictive silencer factor);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001228; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042803; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044212; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0051260; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798";"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp93156_c0_seq1;GAXK01134367.1;F1NPQ2;8.65E-37;MINP1_CHICK;Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Band 17) (Histidine phosphatase of the endoplasmic reticulum 1) (HiPER1);"endoplasmic reticulum lumen [GO:0005788]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]";"GO:0003993; GO:0005788; GO:0034417; GO:0052745; GO:0052826";;endoplasmic reticulum lumen [GO:0005788];"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]"
comp93159_c0_seq1;GAXK01134565.1;Q5SPB6;9.37E-51;CHAC1_DANRE;Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Cation transport regulator-like protein 1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]; apoptotic process [GO:0006915]; glutathione catabolic process [GO:0006751]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]";"GO:0003839; GO:0005112; GO:0005737; GO:0005802; GO:0005829; GO:0006751; GO:0006915; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061928";"apoptotic process [GO:0006915]; glutathione catabolic process [GO:0006751]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802]";"gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]"
comp9316563_c0_seq1;GAXK01195732.1;A6X7E7;1.28E-14;RFNT_OCHA4;Riboflavin transporter RfnT;"integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085]";"GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];
comp9317819_c0_seq1;GAXK01195731.1;P46791;4.61E-56;RS2_CRIGR;40S ribosomal protein S2 (Fragment);"small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003723; GO:0003735; GO:0006412; GO:0015935";translation [GO:0006412];small ribosomal subunit [GO:0015935];"RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
comp9319496_c0_seq1;GAXK01055692.1;Q9SF40;5.84E-62;RL4A_ARATH;60S ribosomal protein L4-1 (L1);"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788";translation [GO:0006412];"cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuole [GO:0005773]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp932_c0_seq1;GAXK01169096.1;O54842;1.96E-10;NUPR1_RAT;Nuclear protein 1 (Protein p8);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506]; regulation of response to endoplasmic reticulum stress [GO:1905897]";"GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0008285; GO:0010506; GO:0010507; GO:0010667; GO:0010698; GO:0043066; GO:0043433; GO:0043525; GO:0045786; GO:0045820; GO:0048471; GO:0050680; GO:0062099; GO:0150078; GO:1901800; GO:1902902; GO:1903862; GO:1904036; GO:1904691; GO:1905897; GO:2001244";"negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed necrotic cell death [GO:0062099]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506]; regulation of response to endoplasmic reticulum stress [GO:1905897]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]";"acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]"
comp9321361_c0_seq1;GAXK01004822.1;Q3J4E3;9.40E-66;PCCB_RHOS4;Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase);"ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]";"GO:0004658; GO:0005524";;;"ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]"
comp932224_c0_seq1;GAXK01029855.1;Q9VCG3;1.44E-13;OPA32_DROME;Putative OPA3-like protein CG13603;"mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]";"GO:0005739; GO:0019216";regulation of lipid metabolic process [GO:0019216];mitochondrion [GO:0005739];
comp932398_c0_seq1;GAXK01029770.1;P46197;8.82E-45;ANPRB_BOVIN;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0016941; GO:0017046; GO:0022414; GO:0035556; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194";"bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]"
comp932453_c0_seq1;GAXK01029851.1;Q8N6F8;1.64E-19;MET27_HUMAN;Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein);;;;;
comp93246_c0_seq1;GAXK01134496.1;Q5T1M5;1.69E-52;FKB15_HUMAN;FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL);"early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923]";"GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0010923; GO:0016020; GO:0030426";"endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923]";"early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]";"actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]"
comp93256_c0_seq1;GAXK01134659.1;Q8IV50;1.04E-09;LYSM2_HUMAN;LysM and putative peptidoglycan-binding domain-containing protein 2;;;;;
comp932744_c0_seq1;GAXK01029780.1;P52746;2.73E-16;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp932815_c0_seq1;GAXK01029862.1;G3V893;4.60E-07;ZN335_RAT;Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";"GO:0000979; GO:0002052; GO:0005634; GO:0007420; GO:0010468; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0050671; GO:0050769; GO:0080182; GO:2000327";"brain development [GO:0007420]; histone H3-K4 trimethylation [GO:0080182]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]"
comp932886_c0_seq1;GAXK01029817.1;Q9Y2K2;3.25E-113;SIK3_HUMAN;Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]";"GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:1904263; GO:1904515";"intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]"
comp9329281_c0_seq1;GAXK01028228.1;P14381;1.30E-08;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp932952_c1_seq1;GAXK01029875.1;A2CE44;9.34E-63;ZXDB_MOUSE;Zinc finger X-linked protein ZXDB;"nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003676; GO:0003700; GO:0005634; GO:0045893; GO:0046872; GO:0070742";positive regulation of transcription, DNA-templated [GO:0045893];nucleus [GO:0005634];"C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp932958_c0_seq1;GAXK01029812.1;Q811F1;7.02E-11;ZBT41_MOUSE;Zinc finger and BTB domain-containing protein 41;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9332_c4_seq1;GAXK01014181.1;P97440;5.47E-17;SLBP_MOUSE;Histone RNA hairpin-binding protein (Histone stem-loop-binding protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell cycle phase transition [GO:0044770]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]; nuclear DNA replication [GO:0033260]";"GO:0003729; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006398; GO:0033260; GO:0042802; GO:0044770; GO:0051028; GO:0071204; GO:0071207; GO:1990904";"cell cycle phase transition [GO:0044770]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]; nuclear DNA replication [GO:0033260]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]"
comp9333220_c0_seq1;GAXK01133781.1;P14381;1.58E-10;YTX2_XENLA;Transposon TX1 uncharacterized 149 kDa protein (ORF 2);;;;;
comp93349_c1_seq1;GAXK01134541.1;Q64520;3.60E-74;KGUA_MOUSE;Guanylate kinase (EC 2.7.4.8) (GMP kinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";"GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939";"ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]";cytosol [GO:0005829];"ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]"
comp933499_c0_seq1;GAXK01029775.1;Q01842;8.19E-10;POK_DROME;Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"GO:0000122; GO:0000980; GO:0000981; GO:0001012; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090175; GO:1903688; GO:2000051";"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp933549_c0_seq1;GAXK01029772.1;Q9D1D1;1.04E-39;TSN11_MOUSE;Tetraspanin-11 (Tspan-11);integral component of plasma membrane [GO:0005887];GO:0005887;;integral component of plasma membrane [GO:0005887];
comp933788_c0_seq1;GAXK01029863.1;O15973;1.11E-29;OPSD1_MIZYE;Rhodopsin, GQ-coupled (GQ-rhodopsin);"integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";"GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298";"phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]";integral component of membrane [GO:0016021];"G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]"
comp933889_c0_seq1;GAXK01029868.1;P53041;4.54E-78;PPP5_HUMAN;Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT);"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]";"GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051291; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324";"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]";"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]"
comp933967_c0_seq1;GAXK01029842.1;Q8WU39;6.13E-20;MZB1_HUMAN;Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7) (MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein);"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626]";"GO:0002642; GO:0005576; GO:0005737; GO:0005788; GO:0006915; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626";"apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626]";"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]";
comp9340_c1_seq1;GAXK01014051.1;Q7ZWF0;0;RAE1L_DANRE;mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41);"cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]";"GO:0000972; GO:0003723; GO:0005643; GO:0005737; GO:0006406; GO:0007049; GO:0043130; GO:0051301; GO:0060236; GO:0097431";"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]";"cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]";"RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"
comp93406_c4_seq1;GAXK01134428.1;Q91DM0;3.15E-07;POLG_PVCV1;"Genome polyprotein [Includes: Aspartic protease (PR) (EC 3.4.23.-); Reverse transcriptase (RT) (EC 2.7.7.49) (EC 2.7.7.7)]";"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; transport of virus in host, cell to cell [GO:0046740]";"GO:0003677; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0046740";transport of virus in host, cell to cell [GO:0046740];;"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]"
comp934080_c0_seq1;GAXK01157303.1;P0DKX0;8.66E-37;ZN728_HUMAN;Zinc finger protein 728;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003676; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];;"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp93427_c0_seq1;GAXK01134376.1;Q5BK48;4.35E-108;TTC5_RAT;Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Strap);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006281; GO:0045944";"DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";"chromatin binding [GO:0003682]; DNA binding [GO:0003677]"
comp934463_c0_seq1;GAXK01157331.1;Q8K1X4;1.91E-12;NCKPL_MOUSE;Nck-associated protein 1-like (Hematopoietic protein 1);"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]";"GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0006935; GO:0016021; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070358; GO:0090023";"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]";"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]";"GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]"
comp934474_c0_seq1;GAXK01157271.1;Q6TCG8;2.80E-22;PAQR3_MOUSE;Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]";"GO:0000139; GO:0001933; GO:0005794; GO:0010977; GO:0016021; GO:0033137; GO:0034067; GO:0038023; GO:0043407";"negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp93449_c4_seq1;GAXK01134293.1;Q8BMS4;1.27E-72;COQ3_MOUSE;Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114);"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity [GO:1990886]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]";"GO:0004395; GO:0005739; GO:0006071; GO:0006744; GO:0008171; GO:0008425; GO:0008689; GO:0010795; GO:0031314; GO:0032259; GO:1990886";"glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]";"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]";"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity [GO:1990886]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]"
comp93452_c1_seq1;GAXK01134373.1;O88444;0;ADCY1_MOUSE;Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase);"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]";"GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007190; GO:0007409; GO:0007420; GO:0007616; GO:0007623; GO:0008294; GO:0010226; GO:0014069; GO:0019933; GO:0032793; GO:0042752; GO:0045121; GO:0046872; GO:0050804; GO:0071277; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300";"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]";"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"
comp934543_c0_seq1;GAXK01157269.1;Q9VIS1;5.86E-40;CDGAP_DROME;GTPase-activating protein CdGAPr (d-CdGAPr);"GTPase activator activity [GO:0005096]; retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005096; GO:0007264; GO:0031290";"retinal ganglion cell axon guidance [GO:0031290]; small GTPase mediated signal transduction [GO:0007264]";;GTPase activator activity [GO:0005096]
comp934757_c0_seq1;GAXK01157286.1;Q28615;2.77E-07;S13A2_RABIT;Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter);"integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]";"GO:0006814; GO:0015293; GO:0016021";sodium ion transport [GO:0006814];integral component of membrane [GO:0016021];symporter activity [GO:0015293]
comp93477_c0_seq1;GAXK01134663.1;Q5ZMS2;1.84E-71;PA1B2_CHICK;Platelet-activating factor acetylhydrolase IB subunit beta (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta);"cytoplasm [GO:0005737]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]";"GO:0003847; GO:0005737; GO:0007420; GO:0016042; GO:0047179";"brain development [GO:0007420]; lipid catabolic process [GO:0016042]";cytoplasm [GO:0005737];"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]"
comp935353_c1_seq1;GAXK01157317.1;Q9R1D1;2.76E-12;CTCF_RAT;Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog);"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"GO:0000775; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0008285; GO:0044212; GO:0045944; GO:0046872; GO:0071459; GO:1902895";"chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]";"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]"
comp9354576_c0_seq1;GAXK01042047.1;A5DZS4;1.00E-09;MCA1_LODEL;Metacaspase-1 (EC 3.4.22.-);"cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]";"GO:0006915; GO:0008234";apoptotic process [GO:0006915];;cysteine-type peptidase activity [GO:0008234]
comp935668_c0_seq1;GAXK01157322.1;Q96RI1;9.82E-16;NR1H4_HUMAN;Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14);"nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; bile acid binding [GO:0032052]; bile acid receptor activity [GO:0038181]; chenodeoxycholic acid binding [GO:1902122]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; cell differentiation [GO:0030154]; cell-cell junction assembly [GO:0007043]; cellular glucose homeostasis [GO:0001678]; cellular response to fatty acid [GO:0071398]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organonitrogen compound [GO:0071417]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; defense response to bacterium [GO:0042742]; fatty acid homeostasis [GO:0055089]; histone H3-R17 methylation [GO:0034971]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17 secretion [GO:0072615]; intracellular bile acid receptor signaling pathway [GO:0038185]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor secretion [GO:1904468]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nitrogen catabolite activation of transcription from RNA polymerase II promoter [GO:0001080]; Notch signaling pathway [GO:0007219]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of ammonia assimilation cycle [GO:2001250]; positive regulation of glutamate metabolic process [GO:2000213]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phosphatidic acid biosynthetic process [GO:1905695]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of cholesterol metabolic process [GO:0090181]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of transcription, DNA-templated [GO:0006355]; regulation of urea metabolic process [GO:0034255]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000980; GO:0000981; GO:0001080; GO:0001228; GO:0001678; GO:0003700; GO:0003707; GO:0003713; GO:0003714; GO:0004879; GO:0005634; GO:0005654; GO:0005719; GO:0006355; GO:0006367; GO:0006629; GO:0006954; GO:0007043; GO:0007219; GO:0007275; GO:0008134; GO:0008206; GO:0008270; GO:0010804; GO:0010988; GO:0015721; GO:0016922; GO:0030154; GO:0030374; GO:0030522; GO:0032052; GO:0032088; GO:0032692; GO:0032703; GO:0032715; GO:0034142; GO:0034162; GO:0034255; GO:0034971; GO:0035356; GO:0035774; GO:0038023; GO:0038181; GO:0038183; GO:0038185; GO:0042632; GO:0042742; GO:0043066; GO:0043124; GO:0043565; GO:0045087; GO:0045944; GO:0046628; GO:0046965; GO:0050728; GO:0055088; GO:0055089; GO:0061178; GO:0070857; GO:0070858; GO:0071222; GO:0071398; GO:0071417; GO:0071638; GO:0072615; GO:0090181; GO:0090575; GO:1902122; GO:1902714; GO:1904179; GO:1904468; GO:1905695; GO:2000213; GO:2001250";"bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; cell-cell junction assembly [GO:0007043]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to fatty acid [GO:0071398]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organonitrogen compound [GO:0071417]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; defense response to bacterium [GO:0042742]; fatty acid homeostasis [GO:0055089]; histone H3-R17 methylation [GO:0034971]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17 secretion [GO:0072615]; intracellular bile acid receptor signaling pathway [GO:0038185]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nitrogen catabolite activation of transcription from RNA polymerase II promoter [GO:0001080]; Notch signaling pathway [GO:0007219]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of ammonia assimilation cycle [GO:2001250]; positive regulation of glutamate metabolic process [GO:2000213]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phosphatidic acid biosynthetic process [GO:1905695]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of cholesterol metabolic process [GO:0090181]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of transcription, DNA-templated [GO:0006355]; regulation of urea metabolic process [GO:0034255]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; transcription initiation from RNA polymerase II promoter [GO:0006367]";"nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]";"bile acid binding [GO:0032052]; bile acid receptor activity [GO:0038181]; chenodeoxycholic acid binding [GO:1902122]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"
comp9357215_c0_seq1;GAXK01008665.1;P68434;1.04E-10;ERG3_MYCBO;C-5 sterol desaturase (EC 1.3.-.-) (Sterol-C5-desaturase);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol biosynthetic process [GO:0016126]";"GO:0005506; GO:0005886; GO:0016021; GO:0016126; GO:0016491";sterol biosynthetic process [GO:0016126];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"
comp9358_c0_seq1;GAXK01014410.1;P55326;1.33E-11;YZG1_CAEEL;Uncharacterized protein F13E6.1;;;;;
comp93585_c0_seq1;GAXK01134653.1;A8CEP3;1.08E-33;CALM_SACJA;Calmodulin (CaM);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp936_c1_seq1;GAXK01168416.1;A7RP64;2.22E-113;PNO1_NEMVE;RNA-binding protein pno1;"nucleolus [GO:0005730]; RNA binding [GO:0003723]";"GO:0003723; GO:0005730";;nucleolus [GO:0005730];RNA binding [GO:0003723]
comp93612_c0_seq1;GAXK01134368.1;Q96RW7;2.48E-34;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp93616_c0_seq1;GAXK01134487.1;Q61827;1.34E-12;MAFK_MOUSE;Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit);"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000976; GO:0000978; GO:0001221; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007399; GO:0043565; GO:0071535";"negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]";"nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp93619_c0_seq2;GAXK01134386.1;Q7Z4N8;5.77E-47;P4HA3_HUMAN;Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp936226_c0_seq1;GAXK01193508.1;Q9BXF9;1.60E-79;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp936280_c0_seq1;GAXK01193502.1;P20273;4.48E-10;CD22_HUMAN;B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22);"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776]";"GO:0001791; GO:0005102; GO:0005737; GO:0005769; GO:0005886; GO:0007155; GO:0009986; GO:0016021; GO:0019903; GO:0030100; GO:0030246; GO:0030888; GO:0032809; GO:0033691; GO:0042113; GO:0042609; GO:0050776; GO:0050849; GO:0050859; GO:0051025; GO:0055037; GO:0070062";"B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776]";"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]"
comp93630_c0_seq1;GAXK01134311.1;Q96G23;4.39E-87;CERS2_HUMAN;Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (SP260) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Tumor metastasis-suppressor gene 1 protein);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]";"GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0031965; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045";"ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]";"DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]"
comp936349_c0_seq1;GAXK01193501.1;P41383;2.71E-59;TBA2_PATVU;Tubulin alpha-2/alpha-4 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp9366714_c0_seq1;GAXK01177736.1;Q9W770;2.70E-09;SPON1_CHICK;Spondin-1 (F-spondin);"extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]";"GO:0007155; GO:0031012; GO:0046872";cell adhesion [GO:0007155];extracellular matrix [GO:0031012];metal ion binding [GO:0046872]
comp93669_c0_seq1;GAXK01134630.1;P52824;2.76E-178;DGKQ_HUMAN;Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]";"GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030168; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:1900242; GO:1903432; GO:2000064; GO:2000182";"cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]";"activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]"
comp9368927_c0_seq1;GAXK01152149.1;Q2L224;1.09E-11;RF2_BORA1;Peptide chain release factor 2 (RF-2);"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]";"GO:0005737; GO:0016149";;cytoplasm [GO:0005737];translation release factor activity, codon specific [GO:0016149]
comp937_c1_seq1;GAXK01170551.1;P35998;0;PRS7_HUMAN;26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1);"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0001649; GO:0002223; GO:0002479; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0017025; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0036402; GO:0036464; GO:0038061; GO:0038095; GO:0043161; GO:0043197; GO:0043312; GO:0043488; GO:0043687; GO:0045899; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]";"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]"
comp93720_c0_seq1;GAXK01134417.1;O15976;6.89E-93;GNAO_MIZYE;Guanine nucleotide-binding protein G(o) subunit alpha;"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]";"GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872";adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188];;"G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
comp93721_c1_seq1;GAXK01134403.1;Q96EY1;1.14E-68;DNJA3_HUMAN;DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137";"activation-induced cell death of T cells [GO:0006924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]";"ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]"
comp937409_c0_seq1;GAXK01193523.1;Q9XWZ2;3.44E-80;ACD11_CAEEL;Acyl-CoA dehydrogenase family member 11 (EC 1.3.99.-);"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; fatty acid metabolic process [GO:0006631]";"GO:0000166; GO:0006631; GO:0016627";fatty acid metabolic process [GO:0006631];;"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
comp93742_c0_seq1;GAXK01134405.1;Q7KRI2;9.79E-26;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp937454_c0_seq1;GAXK01193477.1;Q63ZR5;3.33E-138;RHN2B_XENLA;Rhophilin-2-B (GTP-Rho-binding protein 2-B);"perinuclear region of cytoplasm [GO:0048471]; signal transduction [GO:0007165]";"GO:0007165; GO:0048471";signal transduction [GO:0007165];perinuclear region of cytoplasm [GO:0048471];
comp9376990_c0_seq1;GAXK01164599.1;Q86LG1;7.79E-12;PPK28_DROME;Pickpocket protein 28 (PPK28);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium channel activity [GO:0005272]; cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"GO:0005272; GO:0005886; GO:0006814; GO:0009415; GO:0016021; GO:0035002; GO:0042756; GO:0071462";"cellular response to water stimulus [GO:0071462]; drinking behavior [GO:0042756]; liquid clearance, open tracheal system [GO:0035002]; response to water [GO:0009415]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";sodium channel activity [GO:0005272]
comp93772_c0_seq1;GAXK01134641.1;Q3UDE2;0;TTL12_MOUSE;Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]; cellular protein modification process [GO:0006464]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]";"GO:0005524; GO:0005737; GO:0006464; GO:0007346; GO:0015631; GO:0060339; GO:1990889";"cellular protein modification process [GO:0006464]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]"
comp93798_c2_seq1;GAXK01134668.1;Q5R5S1;1.60E-95;FBX21_PONAB;F-box only protein 21;DNA binding [GO:0003677];GO:0003677;;;DNA binding [GO:0003677]
comp938_c0_seq1;GAXK01166405.1;P90789;8.66E-13;NDUB7_CAEEL;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7;"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]";"GO:0005743; GO:0005758; GO:0008137; GO:0070469";;"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]";NADH dehydrogenase (ubiquinone) activity [GO:0008137]
comp938009_c1_seq1;GAXK01008856.1;Q9JI93;1.46E-24;A4GAT_RAT;Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"GO:0000139; GO:0001576; GO:0007009; GO:0008378; GO:0015643; GO:0016021; GO:0050512";"globoside biosynthetic process [GO:0001576]; plasma membrane organization [GO:0007009]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]"
comp93814_c1_seq1;GAXK01134458.1;Q80Y17;2.15E-129;L2GL1_MOUSE;Lethal(2) giant larvae protein homolog 1 (LLGL) (Mgl-1) (Mlgl);"axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; maintenance of apical/basal cell polarity [GO:0035090]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]";"GO:0000137; GO:0005096; GO:0005737; GO:0005856; GO:0005886; GO:0006887; GO:0006893; GO:0007409; GO:0007420; GO:0008593; GO:0016323; GO:0017137; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031901; GO:0032588; GO:0032878; GO:0035090; GO:0035748; GO:0045159; GO:0051294; GO:0065003";"axonogenesis [GO:0007409]; brain development [GO:0007420]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; maintenance of apical/basal cell polarity [GO:0035090]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]";"axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]";"GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]"
comp938254_c0_seq1;GAXK01008857.1;O94812;6.19E-131;BAIP3_HUMAN;BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3);"cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]";"GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502";"dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]";"cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]";"calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
comp938417_c0_seq1;GAXK01008849.1;Q14590;6.31E-77;ZN235_HUMAN;Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp93881_c4_seq1;GAXK01134213.1;Q06210;1.14E-18;GFPT1_HUMAN;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1);"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367";"circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"cytosol [GO:0005829]; extracellular exosome [GO:0070062]";"carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]"
comp93897_c0_seq1;GAXK01134423.1;Q92485;5.03E-75;ASM3B_HUMAN;Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-);"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062";"inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]";"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]";"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"
comp938990_c0_seq1;GAXK01008817.1;Q9PU85;4.40E-97;PIM3_COTJA;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]";"GO:0004674; GO:0005524; GO:0005737; GO:0043066";negative regulation of apoptotic process [GO:0043066];cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp939116_c0_seq1;GAXK01008797.1;O43345;5.06E-13;ZN208_HUMAN;Zinc finger protein 208 (Zinc finger protein 91-like);"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp93933_c0_seq1;GAXK01134413.1;Q03755;4.36E-10;CUT1_CAEEL;Cuticlin-1;"collagen and cuticulin-based cuticle extracellular matrix [GO:0060102]; structural constituent of cuticle [GO:0042302]";"GO:0042302; GO:0060102";;collagen and cuticulin-based cuticle extracellular matrix [GO:0060102];structural constituent of cuticle [GO:0042302]
comp939336_c0_seq1;GAXK01008795.1;Q8R431;5.84E-52;MGLL_RAT;Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL);"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0097756";"acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]";"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; membrane [GO:0016020]; synapse [GO:0045202]";"acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]"
comp93950_c0_seq1;GAXK01134401.1;Q8BMK1;3.99E-116;METL2_MOUSE;tRNA N(3)-methylcytidine methyltransferase METTL2 (EC 2.1.1.-) (Methyltransferase-like protein 2);"tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]";"GO:0002946; GO:0016427; GO:0016428; GO:0030488; GO:0052735";"tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]";;"tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]"
comp93956_c2_seq1;GAXK01134337.1;Q967D7;0;TUTL_DROME;Protein turtle;"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632";"adult locomotory behavior [GO:0008344]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]";"axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";cell-cell adhesion mediator activity [GO:0098632]
comp939685_c0_seq1;GAXK01008863.1;Q55A09;1.02E-29;Y9963_DICDI;Probable serine/threonine-protein kinase DDB_G0272254 (EC 2.7.11.1);"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524; GO:0016021";;integral component of membrane [GO:0016021];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp9397_c2_seq1;GAXK01013590.1;P00920;2.82E-42;CAH2_MOUSE;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II);"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:2001150; GO:2001225";"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]";"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]";"arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp93984_c0_seq1;GAXK01134560.1;Q64373;8.33E-12;B2CL1_MOUSE;Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X);"Bcl-2 family protein complex [GO:0097136]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process in bone marrow cell [GO:0071839]; cell population proliferation [GO:0008283]; cellular process regulating host cell cycle in response to virus [GO:0060154]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of long-term synaptic depression [GO:1900452]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; response to ischemia [GO:0002931]; response to radiation [GO:0009314]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; suppression by virus of host apoptotic process [GO:0019050]; synaptic vesicle recycling via endosome [GO:0036466]";"GO:0001541; GO:0001701; GO:0001836; GO:0002931; GO:0005737; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0007093; GO:0007281; GO:0007283; GO:0008134; GO:0008283; GO:0008284; GO:0008584; GO:0008630; GO:0009314; GO:0009566; GO:0009615; GO:0016020; GO:0016021; GO:0019050; GO:0019901; GO:0030054; GO:0030276; GO:0030672; GO:0031965; GO:0031966; GO:0032465; GO:0034097; GO:0036466; GO:0040008; GO:0042802; GO:0042803; GO:0042981; GO:0043027; GO:0043065; GO:0043066; GO:0043524; GO:0044877; GO:0046898; GO:0046902; GO:0046982; GO:0051020; GO:0051400; GO:0051402; GO:0051434; GO:0051881; GO:0060154; GO:0070584; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097136; GO:0097192; GO:0097284; GO:0097371; GO:0098793; GO:1900118; GO:1900244; GO:1900452; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000302; GO:2000809; GO:2000811; GO:2001171; GO:2001243";"apoptotic process in bone marrow cell [GO:0071839]; cell population proliferation [GO:0008283]; cellular process regulating host cell cycle in response to virus [GO:0060154]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of long-term synaptic depression [GO:1900452]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; response to ischemia [GO:0002931]; response to radiation [GO:0009314]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; suppression by virus of host apoptotic process [GO:0019050]; synaptic vesicle recycling via endosome [GO:0036466]";"Bcl-2 family protein complex [GO:0097136]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]";"BH3 domain binding [GO:0051434]; BH domain binding [GO:0051400]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]"
comp93992_c0_seq1;GAXK01134400.1;O75582;0;KS6A5_HUMAN;Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"GO:0000287; GO:0001818; GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007173; GO:0007411; GO:0016572; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0043990; GO:0045892; GO:0045944; GO:0051092; GO:0070498";"axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp94_c0_seq1;GAXK01168259.1;Q24756;3.77E-23;MLC1_DROVI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp940_c0_seq1;GAXK01168689.1;P25843;3.12E-43;PROF_DROME;Profilin (Protein chickadee);"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007411; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491";"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]";"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]";actin monomer binding [GO:0003785]
comp94026_c4_seq1;GAXK01113371.1;Q12797;4.61E-28;ASPH_HUMAN;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase);"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779";"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]";"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]";"calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]"
comp940464_c0_seq1;GAXK01041260.1;P11309;1.24E-14;PIM1_HUMAN;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan metabolic process [GO:0030212]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007275; GO:0008134; GO:0008283; GO:0019221; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:1902033; GO:1905062";"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan metabolic process [GO:0030212]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; vitamin D receptor signaling pathway [GO:0070561]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]"
comp940580_c0_seq1;GAXK01041265.1;Q27433;2.68E-07;MEC2_CAEEL;Mechanosensory protein 2;"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792";"detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]";"integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]";cholesterol binding [GO:0015485]
comp9406_c0_seq1;GAXK01014824.1;O77735;4.28E-59;SCAM1_PIG;Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; exocytosis [GO:0006887]; protein transport [GO:0015031]";"GO:0000139; GO:0005794; GO:0005802; GO:0006887; GO:0015031; GO:0016021; GO:0030672; GO:0032588; GO:0042589; GO:0055038";"exocytosis [GO:0006887]; protein transport [GO:0015031]";"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]";
comp940699_c0_seq1;GAXK01041257.1;Q1LYE3;5.05E-44;ZN143_DANRE;Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor);"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0000977; GO:0000981; GO:0005634; GO:0007417; GO:0045893; GO:0046872";"central nervous system development [GO:0007417]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp94071_c0_seq1;GAXK01113540.1;P26967;3.32E-08;CU20_TENMO;Adult-specific cuticular protein ACP-20;structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp94081_c0_seq1;GAXK01113085.1;Q99578;1.15E-71;RIT2_HUMAN;GTP-binding protein Rit2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2);"cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003682; GO:0003924; GO:0005516; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045944; GO:0050848; GO:0097447";"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]";"cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]"
comp94084_c2_seq1;GAXK01113458.1;Q9W440;2.04E-31;THEM6_DROME;Protein THEM6;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp940848_c0_seq1;GAXK01041253.1;O14628;7.66E-21;ZN195_HUMAN;Zinc finger protein 195;"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0008270";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp94096_c0_seq1;GAXK01112984.1;P14404;3.72E-07;MECOM_MOUSE;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein homolog);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"GO:0000977; GO:0001228; GO:0001701; GO:0001780; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0006954; GO:0009617; GO:0009791; GO:0016607; GO:0030154; GO:0030900; GO:0035115; GO:0035116; GO:0042127; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0060039; GO:0070828; GO:0071425; GO:0072197; GO:0090336; GO:0098727";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; inflammatory response [GO:0006954]; in utero embryonic development [GO:0001701]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp94105_c5_seq1;GAXK01113027.1;Q3UG20;1.20E-22;KMT2E_MOUSE;Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]; enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]";"GO:0000785; GO:0002446; GO:0003713; GO:0005634; GO:0005737; GO:0005815; GO:0006306; GO:0007050; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0035327; GO:0042119; GO:0042800; GO:0045893; GO:0046872; GO:0048384; GO:1900087; GO:1905437";"cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]";"enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]"
comp9411_c0_seq1;GAXK01014759.1;E2RKN8;4.17E-30;TM258_CANLF;Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258);"integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; protein N-linked glycosylation [GO:0006487]";"GO:0006487; GO:0016021; GO:0034998";protein N-linked glycosylation [GO:0006487];"integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]";
comp9411129_c0_seq1;GAXK01005816.1;Q9XA16;4.95E-12;PKNX_STRCO;Probable serine/threonine-protein kinase SCO3848 (EC 2.7.11.1);"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]";"GO:0004674; GO:0005524";;;"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]"
comp9411345_c0_seq1;GAXK01005818.1;Q9LUQ6;5.28E-20;RL192_ARATH;60S ribosomal protein L19-2;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003729; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0022625";translation [GO:0006412];"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp94125_c0_seq1;GAXK01113460.1;Q8C208;1.96E-07;IKZF4_MOUSE;Zinc finger protein Eos (Ikaros family zinc finger protein 4);"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"GO:0003700; GO:0005654; GO:0008270; GO:0016604; GO:0019904; GO:0032991; GO:0042803; GO:0043425; GO:0043565; GO:0044212; GO:0045892; GO:0045944; GO:0046982; GO:0051260; GO:0051291";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]";"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]"
comp94129_c0_seq1;GAXK01113293.1;Q28955;1.79E-65;NTAN1_PIG;Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0008418";ubiquitin-dependent protein catabolic process [GO:0006511];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";protein-N-terminal asparagine amidohydrolase activity [GO:0008418]
comp9414_c1_seq1;GAXK01014678.1;P79345;5.14E-15;NPC2_BOVIN;NPC intracellular cholesterol transporter 2 (EPV20) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog);"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0030301; GO:0032367; GO:0032934; GO:0033344; GO:0120020";"cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]";"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]";"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]"
comp94147_c0_seq1;GAXK01113493.1;Q9VGY6;2.04E-165;SKEL1_DROME;Protein Skeletor, isoforms B/C;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"GO:0004500; GO:0005198; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321";"catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]";"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]";"dopamine beta-monooxygenase activity [GO:0004500]; structural molecule activity [GO:0005198]"
comp94167_c0_seq1;GAXK01113043.1;Q8K430;1.08E-102;KLH17_RAT;Kelch-like protein 17 (Actinfilin);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0030054; GO:0031208; GO:0032839; GO:0043025; GO:0045211; GO:0051015; GO:0060090";"actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]";"actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]"
comp9418_c0_seq1;GAXK01013779.1;A2VDT1;1.45E-48;TP4A3_BOVIN;Protein tyrosine phosphatase type IVA 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a3);"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; endothelial cell migration [GO:0043542]";"GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0008138; GO:0043542";endothelial cell migration [GO:0043542];"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"
comp94217_c2_seq1;GAXK01113179.1;Q24546;2.97E-124;SYN_DROME;"Synapsin [Cleaved into: Synapsin-1 (Syn1) (Syn1-S); Synapsin-2 (Syn2)]";"cell junction [GO:0030054]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; male courtship behavior [GO:0008049]; memory [GO:0007613]; neurotransmitter secretion [GO:0007269]; olfactory learning [GO:0008355]; optomotor response [GO:0071632]; response to heat [GO:0009408]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle exocytosis [GO:0016079]; terminal button organization [GO:0072553]";"GO:0005524; GO:0007269; GO:0007613; GO:0008049; GO:0008306; GO:0008355; GO:0009408; GO:0016079; GO:0030054; GO:0030672; GO:0043195; GO:0048149; GO:0051124; GO:0071632; GO:0072553";"associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; male courtship behavior [GO:0008049]; memory [GO:0007613]; neurotransmitter secretion [GO:0007269]; olfactory learning [GO:0008355]; optomotor response [GO:0071632]; response to heat [GO:0009408]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle exocytosis [GO:0016079]; terminal button organization [GO:0072553]";"cell junction [GO:0030054]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]";ATP binding [GO:0005524]
comp94224_c1_seq1;GAXK01112983.1;Q63151;3.39E-23;ACSL3_RAT;Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Brain acyl-CoA synthetase II) (Long-chain acyl-CoA synthetase 3) (LACS 3);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247";"brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]";"acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]"
comp94230_c1_seq1;GAXK01113547.1;Q96RW7;1.20E-19;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp942506_c0_seq1;GAXK01056069.1;Q15937;1.65E-47;ZNF79_HUMAN;Zinc finger protein 79 (ZNFpT7);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp94299_c0_seq1;GAXK01113227.1;Q8BZQ7;1.08E-170;ANC2_MOUSE;Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2);"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005680; GO:0006511; GO:0007049; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0070979; GO:0090129";"cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]";"anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp94301_c1_seq1;GAXK01112966.1;Q7K4B3;9.45E-115;ELP2_DROME;Probable elongator complex protein 2 (ELP2) (Stat3-interacting protein homolog);"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"GO:0000502; GO:0002098; GO:0005737; GO:0006368; GO:0008023; GO:0033588; GO:0043248; GO:0061133";"proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]";"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]";endopeptidase activator activity [GO:0061133]
comp9430477_c0_seq1;GAXK01034582.1;Q5UP73;3.14E-08;YR614_MIMIV;Putative band 7 family protein R614;membrane [GO:0016020];GO:0016020;;membrane [GO:0016020];
comp943124_c0_seq1;GAXK01056051.1;O54803;3.60E-20;P2RX6_MOUSE;P2X purinoceptor 6 (P2X6) (ATP receptor) (P2XM) (Purinergic receptor) (Purinergic receptor P2X-like 1);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; purinergic nucleotide receptor activity [GO:0001614]; cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to ATP [GO:0033198]";"GO:0001614; GO:0004931; GO:0005524; GO:0005639; GO:0005737; GO:0005887; GO:0006812; GO:0014069; GO:0016020; GO:0016021; GO:0030054; GO:0033198; GO:0034220; GO:0035381; GO:0042802; GO:0043025; GO:0043197; GO:0051260; GO:0051291; GO:0098688; GO:0098978; GO:0099060";"cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to ATP [GO:0033198]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; ATP-gated ion channel activity [GO:0035381]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; purinergic nucleotide receptor activity [GO:0001614]"
comp943186_c0_seq1;GAXK01056062.1;Q6GN42;2.10E-20;CTL4_XENLA;Choline transporter-like protein 4 (Solute carrier family 44 member 4);"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526";"acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]";"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]";choline transmembrane transporter activity [GO:0015220]
comp943196_c0_seq1;GAXK01056061.1;P55853;3.59E-23;SUMO_CAEEL;Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965";"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]";"identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]"
comp943333_c1_seq1;GAXK01056055.1;Q9WV76;5.53E-32;AP4B1_MOUSE;AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin);"AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; intracellular protein transport [GO:0006886]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]";"GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0061938";"intracellular protein transport [GO:0006886]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]";"AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]";clathrin binding [GO:0030276]
comp9434_c2_seq1;GAXK01014021.1;Q5RGB8;3.81E-09;KLH26_DANRE;Kelch-like protein 26;;;;;
comp94353_c0_seq1;GAXK01113555.1;Q5DWG1;8.63E-46;CRJ35_CRYJA;Pathogenesis-related thaumatin-like protein 3.5 (allergen Cry j 3.5);"defense response [GO:0006952]; response to abscisic acid [GO:0009737]; response to biotic stimulus [GO:0009607]";"GO:0006952; GO:0009607; GO:0009737";"defense response [GO:0006952]; response to abscisic acid [GO:0009737]; response to biotic stimulus [GO:0009607]";;
comp94362_c0_seq1;GAXK01113430.1;Q6DC58;7.13E-08;TM223_DANRE;Transmembrane protein 223;"integral component of membrane [GO:0016021]; nervous system development [GO:0007399]";"GO:0007399; GO:0016021";nervous system development [GO:0007399];integral component of membrane [GO:0016021];
comp94366_c1_seq1;GAXK01113464.1;Q9V831;3.47E-89;APC10_DROME;Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10);"anaphase-promoting complex [GO:0005680]; ubiquitin protein ligase activity [GO:0061630]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; protein K11-linked ubiquitination [GO:0070979]; regulation of stem cell differentiation [GO:2000736]";"GO:0000278; GO:0005680; GO:0007113; GO:0031145; GO:0051301; GO:0061630; GO:0070979; GO:2000736";"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; protein K11-linked ubiquitination [GO:0070979]; regulation of stem cell differentiation [GO:2000736]";anaphase-promoting complex [GO:0005680];ubiquitin protein ligase activity [GO:0061630]
comp9439_c0_seq1;GAXK01014677.1;Q27889;0;PP2B2_DROME;Serine/threonine-protein phosphatase 2B catalytic subunit 2 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A2 subunit);"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; female meiotic nuclear division [GO:0007143]; meiotic cell cycle [GO:0051321]; protein dephosphorylation [GO:0006470]; regulation of embryonic development [GO:0045995]; sleep [GO:0030431]; wing disc development [GO:0035220]";"GO:0004722; GO:0004723; GO:0005516; GO:0005737; GO:0005955; GO:0006470; GO:0007143; GO:0030431; GO:0033192; GO:0035220; GO:0045995; GO:0046872; GO:0051321; GO:0097720";"calcineurin-mediated signaling [GO:0097720]; female meiotic nuclear division [GO:0007143]; meiotic cell cycle [GO:0051321]; protein dephosphorylation [GO:0006470]; regulation of embryonic development [GO:0045995]; sleep [GO:0030431]; wing disc development [GO:0035220]";"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]";"calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]"
comp9440017_c0_seq1;GAXK01180425.1;Q01908;2.65E-10;ATPG1_ARATH;ATP synthase gamma chain 1, chloroplastic (F-ATPase gamma subunit 1);"chloroplast [GO:0009507]; chloroplast ATP synthase complex [GO:0009544]; chloroplast envelope [GO:0009941]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; thylakoid [GO:0009579]; enzyme regulator activity [GO:0030234]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; photosynthetic electron transport in photosystem II [GO:0009772]";"GO:0000275; GO:0005829; GO:0006754; GO:0009507; GO:0009534; GO:0009535; GO:0009544; GO:0009579; GO:0009772; GO:0009941; GO:0015986; GO:0030234; GO:0046933";"ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; photosynthetic electron transport in photosystem II [GO:0009772]";"chloroplast [GO:0009507]; chloroplast ATP synthase complex [GO:0009544]; chloroplast envelope [GO:0009941]; chloroplast thylakoid [GO:0009534]; chloroplast thylakoid membrane [GO:0009535]; cytosol [GO:0005829]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; thylakoid [GO:0009579]";"enzyme regulator activity [GO:0030234]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"
comp9442_c1_seq1;GAXK01013482.1;Q8WQA4;1.94E-51;EXC4_CAEEL;Chloride intracellular channel exc-4 (Excretory canal abnormal protein 4);"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150]";"GO:0002064; GO:0005244; GO:0005254; GO:0005634; GO:0005764; GO:0005887; GO:0016324; GO:0034707; GO:0034765; GO:0035150; GO:0043296";"epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150]";"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]";"chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]"
comp944389_c0_seq1;GAXK01149088.1;Q7KRI2;1.51E-08;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp94449_c3_seq1;GAXK01113468.1;A0JJX5;7.71E-17;SYT4_ARATH;Synaptotagmin-4 (NTMC2T2.2) (Synaptotagmin D);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; lipid transport [GO:0006869]";"GO:0005783; GO:0006869; GO:0008289; GO:0016021; GO:0046872";lipid transport [GO:0006869];"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"lipid binding [GO:0008289]; metal ion binding [GO:0046872]"
comp94451_c2_seq1;GAXK01113193.1;O75460;8.24E-146;ERN1_HUMAN;"Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]";"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]";"GO:0000287; GO:0001935; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006402; GO:0006468; GO:0007050; GO:0007257; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630";"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]";"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]";"ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]"
comp94452_c2_seq1;GAXK01112981.1;Q6ZMB0;1.74E-25;B3GN6_HUMAN;Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0008376; GO:0008378; GO:0008532; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016269; GO:0030311; GO:0047223; GO:0047224";"glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]"
comp9446428_c0_seq1;GAXK01075863.1;P36415;2.24E-54;HS7C1_DICDI;Heat shock cognate 70 kDa protein 1 (HSC70-1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006986; GO:0016887; GO:0031012; GO:0031072; GO:0031982; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0044183; GO:0045335; GO:0051082; GO:0051085; GO:0051787";"cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]";"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]"
comp944661_c1_seq1;GAXK01149032.1;P98149;5.12E-16;DIF_DROME;Dorsal-related immunity factor Dif;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; salivary gland histolysis [GO:0035070]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002804; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0010628; GO:0034097; GO:0035070; GO:0035206; GO:0038061; GO:0045087; GO:0045944; GO:0048935; GO:0050830; GO:0050832";"defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; salivary gland histolysis [GO:0035070]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp944846_c1_seq1;GAXK01149046.1;Q8VII8;2.51E-14;MCR_MOUSE;Mineralocorticoid receptor (MR) (Nuclear receptor subfamily 3 group C member 2);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; receptor complex [GO:0043235]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular sodium ion homeostasis [GO:0006883]; excretion [GO:0007588]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cell population proliferation [GO:0042127]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic vesicle exocytosis [GO:2000300]";"GO:0003690; GO:0003700; GO:0003707; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0006883; GO:0007588; GO:0008270; GO:0042127; GO:0042803; GO:0043235; GO:0043565; GO:0046982; GO:0060078; GO:0098831; GO:0098978; GO:0098982; GO:0099092; GO:1901224; GO:2000300";"cellular sodium ion homeostasis [GO:0006883]; excretion [GO:0007588]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cell population proliferation [GO:0042127]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic vesicle exocytosis [GO:2000300]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; receptor complex [GO:0043235]";"DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp945020_c0_seq1;GAXK01149092.1;Q6PC64;9.44E-73;ELOV6_DANRE;Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6);"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756";"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]";"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]";"3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]"
comp94536_c0_seq1;GAXK01113461.1;P98199;0;AT8B2_MOUSE;Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2);"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]";"GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005886; GO:0007030; GO:0016021; GO:0045332; GO:0140326";"Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]";"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]"
comp945400_c0_seq1;GAXK01149027.1;A8MUV8;8.11E-18;ZN727_HUMAN;Putative zinc finger protein 727 (Zinc finger protein 727 pseudogene);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp94548_c1_seq1;GAXK01113152.1;Q8LIY8;4.01E-27;CCD8B_ORYSJ;Carotenoid cleavage dioxygenase 8 homolog B, chloroplastic (OsCCD8b) (EC 1.13.11.69) (EC 1.13.11.70) (Protein DWARF-10) (Protein MAX4 homolog);"chloroplast [GO:0009507]; 9-cis-10'-apo-beta-carotenal cleavage oxygenase activity [GO:0102396]; all-trans-beta-apo-10'-carotenal cleavage oxygenase activity [GO:0102251]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; carotene catabolic process [GO:0016121]; secondary shoot formation [GO:0010223]; strigolactone biosynthetic process [GO:1901601]";"GO:0009507; GO:0010223; GO:0010436; GO:0016121; GO:0016702; GO:0046872; GO:0102251; GO:0102396; GO:1901601";"carotene catabolic process [GO:0016121]; secondary shoot formation [GO:0010223]; strigolactone biosynthetic process [GO:1901601]";chloroplast [GO:0009507];"9-cis-10'-apo-beta-carotenal cleavage oxygenase activity [GO:0102396]; all-trans-beta-apo-10'-carotenal cleavage oxygenase activity [GO:0102251]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp9455_c0_seq1;GAXK01013393.1;P05661;9.32E-60;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp945553_c0_seq1;GAXK01149093.1;Q99M85;6.85E-25;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp945636_c0_seq1;GAXK01149049.1;A6QLU5;1.07E-24;ZN184_BOVIN;Zinc finger protein 184;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp945685_c0_seq1;GAXK01149059.1;Q8C8R3;8.71E-13;ANK2_MOUSE;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin);"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259";"atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]";"A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]";"ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]"
comp94578_c2_seq1;GAXK01113545.1;Q4R0J7;8.94E-41;ARD1_UROFA;D-arabinitol dehydrogenase 1 (EC 1.1.1.287) (NADP-dependent D-arabitol dehydrogenase);"cell projection [GO:0042995]; D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity [GO:0033709]; D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity [GO:0052677]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]";"GO:0005975; GO:0008270; GO:0009405; GO:0033709; GO:0042995; GO:0052677; GO:0055114";"carbohydrate metabolic process [GO:0005975]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]";cell projection [GO:0042995];"D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity [GO:0033709]; D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity [GO:0052677]; zinc ion binding [GO:0008270]"
comp945954_c0_seq1;GAXK01149036.1;O60551;9.53E-100;NMT2_HUMAN;Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]";"GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0019898; GO:0022400; GO:0043657; GO:0075733";"intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]";glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]
comp945980_c0_seq1;GAXK01149048.1;P55965;4.63E-89;BYN_DROME;T-related protein (Trp) (Protein brachyenteron);"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; hindgut morphogenesis [GO:0007442]; Malpighian tubule morphogenesis [GO:0007443]; mesoderm formation [GO:0001707]; mesoderm migration involved in gastrulation [GO:0007509]; midgut development [GO:0007494]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pole cell migration [GO:0007280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somitogenesis [GO:0001756]";"GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001102; GO:0001228; GO:0001707; GO:0001708; GO:0001709; GO:0001756; GO:0003007; GO:0003677; GO:0005634; GO:0007280; GO:0007442; GO:0007443; GO:0007494; GO:0007509; GO:0042803; GO:0045944";"cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; hindgut morphogenesis [GO:0007442]; Malpighian tubule morphogenesis [GO:0007443]; mesoderm formation [GO:0001707]; mesoderm migration involved in gastrulation [GO:0007509]; midgut development [GO:0007494]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pole cell migration [GO:0007280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somitogenesis [GO:0001756]";"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp94604_c4_seq1;GAXK01113307.1;P98160;4.50E-52;PGBM_HUMAN;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016477; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0034446; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907";"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]";"amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]"
comp946102_c0_seq1;GAXK01022877.1;Q587J7;1.28E-13;TDR12_HUMAN;Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12);"PET complex [GO:1990923]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";"GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007275; GO:0007283; GO:0009566; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:1990923";"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]";PET complex [GO:1990923];"ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]"
comp946481_c0_seq1;GAXK01022843.1;Q0JNL7;5.75E-30;CALM3_ORYSJ;Calmodulin-3 (CaM-3);"calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0019722";calcium-mediated signaling [GO:0019722];;calcium ion binding [GO:0005509]
comp946630_c0_seq1;GAXK01022838.1;O76082;1.12E-47;S22A5_HUMAN;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]";"GO:0005524; GO:0005886; GO:0006814; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0015893; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0052106; GO:0060731; GO:0070062; GO:0070715; GO:1902603";"carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; drug transport [GO:0015893]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
comp9466545_c0_seq1;GAXK01024997.1;A7AMD1;6.50E-25;RS3A_BABBO;40S ribosomal protein S3a;"cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0006412; GO:0022627";translation [GO:0006412];cytosolic small ribosomal subunit [GO:0022627];structural constituent of ribosome [GO:0003735]
comp94673_c0_seq1;GAXK01113531.1;O15085;5.10E-68;ARHGB_HUMAN;Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]";"GO:0001558; GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0006941; GO:0007186; GO:0007266; GO:0016020; GO:0030010; GO:0030036; GO:0035023; GO:0043065; GO:0045893; GO:0051056";"actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]";"G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp94682_c0_seq1;GAXK01113055.1;G5ECS8;4.42E-35;ADT1_CAEEL;A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-);"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]";"GO:0004222; GO:0005576; GO:0046872";;extracellular region [GO:0005576];"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
comp9469051_c0_seq1;GAXK01054342.1;P39376;4.83E-09;YJIE_ECOLI;HTH-type transcriptional regulator YjiE (Hypochlorite-response regulator protein YjiE) (Quorum-sensing regulator protein D);"bacterial-type RNA polymerase regulatory region DNA binding [GO:0001017]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";"GO:0000976; GO:0001017; GO:0003700; GO:0006351; GO:0006355; GO:0042802";"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]";;"bacterial-type RNA polymerase regulatory region DNA binding [GO:0001017]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp9473470_c0_seq1;GAXK01136871.1;P15253;3.12E-50;CALR_RABIT;Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP);"sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821]";"GO:0005509; GO:0006457; GO:0016529; GO:0030246; GO:0033018; GO:0050821; GO:0051082";"protein folding [GO:0006457]; protein stabilization [GO:0050821]";"sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]";"calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]"
comp9476_c12_seq1;GAXK01013796.1;Q6DEW6;1.99E-77;REXO4_XENTR;RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein);"nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364]";"GO:0000726; GO:0000737; GO:0000738; GO:0003676; GO:0004527; GO:0005634; GO:0006364; GO:0008408; GO:0045944";"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364]";nucleus [GO:0005634];"3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]"
comp947797_c0_seq1;GAXK01022885.1;Q7ZVG6;3.13E-09;SIAH1_DANRE;E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1);"cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630";"multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; nucleus [GO:0005634]";"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp94787_c0_seq1;GAXK01113083.1;Q24174;3.46E-19;ABRU_DROME;Protein abrupt (Protein clueless);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";"GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0044719; GO:0046872; GO:0048813";"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp947912_c0_seq1;GAXK01022852.1;P91622;2.52E-51;PDK_DROME;[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";"GO:0004672; GO:0004740; GO:0005524; GO:0005759; GO:0006006; GO:0006090";"glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]";mitochondrial matrix [GO:0005759];"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp9481727_c0_seq1;GAXK01196102.1;P97364;2.82E-40;SPS2_MOUSE;Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";"GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0016260; GO:0070329";"selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]"
comp94824_c1_seq1;GAXK01113431.1;G5ED00;1.32E-07;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp948403_c0_seq1;GAXK01080867.1;Q52KB5;3.95E-09;ZBT24_DANRE;Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp94842_c1_seq1;GAXK01113535.1;A3KQ55;1.60E-69;MEPCE_DANRE;7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3);"O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]";"GO:0001510; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031";"RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]";;"O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]"
comp948476_c0_seq1;GAXK01080863.1;A1YF12;6.92E-64;ZNF16_GORGO;Zinc finger protein 16;"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0003700; GO:0005634; GO:0005730; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0043565; GO:0045648; GO:0045654; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989";"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleolus [GO:0005730]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
comp9486_c0_seq1;GAXK01014019.1;Q5FW12;1.85E-56;TIPRL_XENTR;TIP41-like protein;"cytosol [GO:0005829]; chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]";"GO:0005829; GO:0007165; GO:0031929; GO:0043009; GO:0043066; GO:0043666";"chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]";cytosol [GO:0005829];
comp948748_c0_seq1;GAXK01080860.1;Q3T0Y3;1.53E-42;ST1B1_BOVIN;Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-);"cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";"GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923";"3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]";cytoplasm [GO:0005737];aryl sulfotransferase activity [GO:0004062]
comp94875_c0_seq1;GAXK01113292.1;Q9VHJ6;5.83E-16;ICH_DROME;Ichor;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";"GO:0000122; GO:0003677; GO:0005634; GO:0010628; GO:0035149; GO:0045944; GO:0046872; GO:0060439; GO:1901148";"gene expression involved in extracellular matrix organization [GO:1901148]; lumen formation, open tracheal system [GO:0035149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; trachea morphogenesis [GO:0060439]";nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9488881_c0_seq1;GAXK01047263.1;Q8ISP0;1.25E-42;RS18_BRABE;40S ribosomal protein S18;"ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412; GO:0019843";translation [GO:0006412];ribosome [GO:0005840];"rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]"
comp949_c0_seq1;GAXK01169973.1;Q3T145;3.59E-134;MDHC_BOVIN;Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase);"cytosol [GO:0005829]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]";"GO:0005829; GO:0005975; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060";"carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]";cytosol [GO:0005829];L-malate dehydrogenase activity [GO:0030060]
comp9494357_c0_seq1;GAXK01001619.1;Q8XDR6;2.31E-57;LCFA_ECO57;Long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) (Long-chain acyl-CoA synthetase) (Acyl-CoA synthetase);"membrane [GO:0016020]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]";"GO:0003996; GO:0004467; GO:0005524; GO:0016020; GO:0102391";;membrane [GO:0016020];"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]"
comp9498912_c0_seq1;GAXK01016551.1;Q9FWX7;7.29E-10;AB11B_ARATH;ABC transporter B family member 11 (ABC transporter ABCB.11) (AtABCB11) (Multidrug resistance protein 8) (P-glycoprotein 11);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; auxin efflux transmembrane transporter activity [GO:0010329]; basipetal auxin transport [GO:0010540]";"GO:0005524; GO:0005576; GO:0005886; GO:0009506; GO:0010329; GO:0010540; GO:0016021; GO:0016887; GO:0042626";basipetal auxin transport [GO:0010540];"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; auxin efflux transmembrane transporter activity [GO:0010329]"
comp950_c0_seq1;GAXK01170219.1;P82119;2.56E-12;CUO6_BLACR;Cuticle protein 6 (BcNCP14.9);structural constituent of cuticle [GO:0042302];GO:0042302;;;structural constituent of cuticle [GO:0042302]
comp950275_c0_seq1;GAXK01109441.1;Q6DH86;7.45E-17;C149B_DANRE;Coiled-coil domain-containing protein 149-B;;;;;
comp950517_c0_seq1;GAXK01109443.1;Q2EI21;5.08E-10;RESTA_XENLA;RE1-silencing transcription factor A (Neural-restrictive silencer factor A);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp95063_c3_seq1;GAXK01113377.1;Q9UPU5;3.55E-140;UBP24_HUMAN;Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0006511; GO:0016579; GO:0036459";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp950671_c0_seq1;GAXK01109461.1;O16098;4.80E-82;MAL1_DROVI;Maltase 1 (EC 3.2.1.20);"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]";"GO:0004558; GO:0032450";;;"alpha-1,4-glucosidase activity [GO:0004558]; maltose alpha-glucosidase activity [GO:0032450]"
comp950714_c0_seq1;GAXK01109466.1;Q9VZW5;3.11E-16;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp950840_c0_seq1;GAXK01109448.1;O60500;3.41E-16;NPHN_HUMAN;Nephrin (Renal glomerulus-specific cell adhesion receptor);"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015";"cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]";"cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]";myosin binding [GO:0017022]
comp95094_c0_seq1;GAXK01112967.1;Q4WNA2;2.61E-09;CBHA_ASPFU;Probable 1,4-beta-D-glucan cellobiohydrolase A (EC 3.2.1.91) (Beta-glucancellobiohydrolase A) (Cellobiohydrolase D) (Exocellobiohydrolase A) (Exoglucanase A);"extracellular region [GO:0005576]; cellulose 1,4-beta-cellobiosidase activity [GO:0016162]; cellulose catabolic process [GO:0030245]";"GO:0005576; GO:0016162; GO:0030245";cellulose catabolic process [GO:0030245];extracellular region [GO:0005576];cellulose 1,4-beta-cellobiosidase activity [GO:0016162]
comp95099_c0_seq1;GAXK01113462.1;Q9VVX5;1.01E-90;MBOA5_DROME;Lysophospholipid acyltransferase 5 (LPLAT 5) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) (Protein nessy);"integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; lysophospholipid acyltransferase activity [GO:0071617]; germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]";"GO:0007009; GO:0007291; GO:0008354; GO:0008654; GO:0016020; GO:0016021; GO:0030258; GO:0047184; GO:0071617";"germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phospholipid biosynthetic process [GO:0008654]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; lysophospholipid acyltransferase activity [GO:0071617]"
comp951049_c0_seq1;GAXK01109447.1;G5ED00;1.03E-10;ZIG8_CAEEL;Zwei Ig domain protein zig-8 (2 Ig domain protein zig-8);"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]; synapse organization [GO:0050808]";"GO:0005576; GO:0032589; GO:0050808";synapse organization [GO:0050808];"extracellular region [GO:0005576]; neuron projection membrane [GO:0032589]";
comp9510581_c0_seq1;GAXK01172425.1;Q9SLA2;4.33E-36;VATO2_ARATH;V-type proton ATPase subunit c''2 (V-ATPase subunit c''2) (Vacuolar H(+)-ATPase subunit c'' isoform 2) (Vacuolar proton pump subunit c''2);"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuole [GO:0005773]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]";"GO:0000139; GO:0005773; GO:0005789; GO:0016021; GO:0033179; GO:0046961";;"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuole [GO:0005773]";proton-transporting ATPase activity, rotational mechanism [GO:0046961]
comp951061_c1_seq1;GAXK01109485.1;Q96RW7;3.25E-20;HMCN1_HUMAN;Hemicentin-1 (Fibulin-6) (FIBL-6);"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062";"cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]";"basement membrane [GO:0005604]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]";"calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
comp9510757_c0_seq1;GAXK01172426.1;P0AFK1;1.30E-31;PMBA_ECO57;Metalloprotease PmbA (EC 3.4.-.-);"cytoplasm [GO:0005737]; metallopeptidase activity [GO:0008237]";"GO:0005737; GO:0008237";;cytoplasm [GO:0005737];metallopeptidase activity [GO:0008237]
comp951145_c0_seq1;GAXK01109476.1;P06867;6.56E-16;PLMN_PIG;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]";"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance [GO:0052213]; tissue remodeling [GO:0048771]";"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771; GO:0052213";"blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance [GO:0052213]; tissue remodeling [GO:0048771]";extracellular region [GO:0005576];serine-type endopeptidase activity [GO:0004252]
comp95139_c2_seq1;GAXK01113264.1;P49869;2.04E-137;HR38_DROME;Probable nuclear hormone receptor HR38 (dHR38) (Nuclear receptor subfamily 4 group A member 4);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; core promoter binding [GO:0001047]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]";"GO:0000977; GO:0000978; GO:0001047; GO:0003707; GO:0004879; GO:0005102; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0035259; GO:0042335; GO:0043565; GO:0045944; GO:0046982; GO:0048082; GO:0071376";"cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"core promoter binding [GO:0001047]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp951621_c1_seq1;GAXK01109465.1;Q6INE5;2.93E-15;RHG19_XENLA;Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19);"GTPase activator activity [GO:0005096]; signal transduction [GO:0007165]";"GO:0005096; GO:0007165";signal transduction [GO:0007165];;GTPase activator activity [GO:0005096]
comp951898_c0_seq1;GAXK01109486.1;P18722;9.07E-19;ZG46_XENLA;Gastrula zinc finger protein XlCGF46.1 (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp952154_c0_seq1;GAXK01081819.1;P33085;2.60E-29;SHAKB_DROME;Innexin shaking-B (Protein passover);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085";"cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]";"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]"
comp95216_c0_seq1;GAXK01113154.1;Q7T330;6.10E-13;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp95226_c0_seq1;GAXK01113294.1;Q14119;1.86E-07;VEZF1_HUMAN;Vascular endothelial zinc finger 1 (Putative transcription factor DB1) (Zinc finger protein 161);"nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; angiogenesis [GO:0001525]; cellular defense response [GO:0006968]; endothelial cell development [GO:0001885]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";"GO:0000977; GO:0001228; GO:0001525; GO:0001885; GO:0005654; GO:0006357; GO:0006366; GO:0006968; GO:0045603; GO:0045944; GO:0046872";"angiogenesis [GO:0001525]; cellular defense response [GO:0006968]; endothelial cell development [GO:0001885]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]";nucleoplasm [GO:0005654];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp95230_c1_seq1;GAXK01113025.1;O94673;3.25E-33;YG75_SCHPO;Uncharacterized membrane protein C776.05;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158";phosphatidylcholine biosynthetic process [GO:0006656];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";glycero-3-phosphocholine acyltransferase activity [GO:0106158]
comp952306_c0_seq1;GAXK01081776.1;Q8BGD7;4.83E-47;NPAS4_MOUSE;Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (HLH-PAS transcription factor NXF) (Limbic-enhanced PAS protein) (LE-PAS);"nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]";"GO:0000978; GO:0000981; GO:0001012; GO:0001228; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0045893; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862";"cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]";"nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]"
comp952338_c1_seq1;GAXK01081827.1;Q20065;1.65E-30;P4HA2_CAEEL;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114";"macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp9524_c0_seq1;GAXK01013461.1;P97493;3.65E-33;THIOM_MOUSE;Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2);"dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]";"GO:0001666; GO:0005730; GO:0005739; GO:0006662; GO:0006979; GO:0008113; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678";"cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]";"dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]";"peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein disulfide oxidoreductase activity [GO:0015035]"
comp952603_c0_seq1;GAXK01081765.1;Q28658;3.72E-11;SPRR3_RABIT;Small proline-rich protein 3 (Cornifin beta);"cytoplasm [GO:0005737]; keratinization [GO:0031424]";"GO:0005737; GO:0031424";keratinization [GO:0031424];cytoplasm [GO:0005737];
comp95293_c0_seq1;GAXK01113116.1;Q8JH47;0;CDK8_DANRE;Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit cdk8) (Mediator of RNA polymerase II transcription subunit cdk8);"mediator complex [GO:0016592]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; protein phosphorylation [GO:0006468]";"GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0008353; GO:0016592";protein phosphorylation [GO:0006468];"mediator complex [GO:0016592]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"
comp95294_c5_seq1;GAXK01113295.1;Q9NYT6;5.01E-18;ZN226_HUMAN;Zinc finger protein 226;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp953054_c0_seq1;GAXK01081802.1;Q9N003;3.10E-24;ZN425_MACFA;Zinc finger protein 425 (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0005737; GO:0045892; GO:0046872";negative regulation of transcription, DNA-templated [GO:0045892];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp953224_c0_seq1;GAXK01081781.1;Q8N1C3;2.42E-52;GBRG1_HUMAN;Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"GO:0004890; GO:0005237; GO:0005254; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:1902476; GO:1902711; GO:1904315";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; GABA receptor binding [GO:0050811]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp953262_c0_seq1;GAXK01081763.1;P00770;1.15E-19;MCPT2_RAT;Mast cell protease 2 (rMCP-2) (EC 3.4.21.-) (Group-specific protease) (Mast cell protease II) (rMCP-II);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005615; GO:0005737";;"cytoplasm [GO:0005737]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp953444_c0_seq1;GAXK01081773.1;Q8BJ51;1.27E-95;MFS11_MOUSE;UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp953473_c0_seq1;GAXK01081767.1;P83501;6.84E-21;MSTAB_DROME;SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp95359_c1_seq1;GAXK01113349.1;B0WC46;5.86E-66;TRET1_CULQU;Facilitated trehalose transporter Tret1;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp9536_c0_seq1;GAXK01013944.1;Q9NRX2;5.78E-13;RM17_HUMAN;39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019904; GO:0070125; GO:0070126";"mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]";"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]";"protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]"
comp95363_c1_seq1;GAXK01113082.1;P51174;9.45E-159;ACADL_MOUSE;Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8);"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]";"GO:0000062; GO:0001659; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0051289; GO:0055114; GO:0090181; GO:0120162";"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]";"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]";"fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]"
comp95366_c0_seq1;GAXK01113539.1;Q3SZK8;3.44E-26;NHRF1_BOVIN;Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1);"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"GO:0001726; GO:0003096; GO:0005737; GO:0005902; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0043621; GO:0044062; GO:0045198; GO:0045859; GO:0045930; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0060088; GO:0060090; GO:0060158; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0097225; GO:0097291; GO:2000146; GO:2001244";"actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; microvillus assembly [GO:0030033]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]";"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]";"beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; growth factor receptor binding [GO:0070851]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]"
comp953694_c1_seq1;GAXK01081809.1;Q60560;9.26E-147;SMBP2_MESAU;DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Immunoglobulin mu-binding protein 2) (Insulin II gene enhancer-binding protein) (RIPE3B-binding complex 3B2 p110 subunit) (RIP-1);"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; protein homooligomerization [GO:0051260]";"GO:0000049; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0030424; GO:0032574; GO:0043022; GO:0043139; GO:0043621; GO:0051260";protein homooligomerization [GO:0051260];"axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]"
comp9537_c0_seq1;GAXK01014713.1;P0DPW4;5.00E-11;TX11A_ETHRU;U-scoloptoxin(01)-Er1a (U-SLPTX(01)-Er1a);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; toxin activity [GO:0090729]; chitin metabolic process [GO:0006030]";"GO:0005576; GO:0006030; GO:0008061; GO:0090729";chitin metabolic process [GO:0006030];extracellular region [GO:0005576];"chitin binding [GO:0008061]; toxin activity [GO:0090729]"
comp953745_c0_seq1;GAXK01081799.1;Q4R6J4;2.43E-07;ZN684_MACFA;Zinc finger protein 684;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9538950_c0_seq1;GAXK01105293.1;Q5ZWR1;1.88E-12;COPA_LEGPH;Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]";"GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872";copper ion transport [GO:0006825];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp953897_c0_seq1;GAXK01081779.1;F1NHE9;2.54E-39;KCJ12_CHICK;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12);"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573";"potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]";"integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]";inward rectifier potassium channel activity [GO:0005242]
comp953957_c0_seq1;GAXK01081783.1;O42329;1.69E-25;GNRR2_CLAGA;Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]";"GO:0004930; GO:0005886; GO:0016021; GO:0016500";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
comp95405_c0_seq1;GAXK01113156.1;P26016;0;FUR11_DROME;Furin-like protease 1, isoforms 1/1-X/2 (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1);"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688";"glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]";"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]";serine-type endopeptidase activity [GO:0004252]
comp954299_c0_seq1;GAXK01141821.1;Q2QL79;2.06E-22;CAV1_DIDVI;Caveolin-1;"caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]";"GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836";"caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]";"caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]";
comp954386_c0_seq1;GAXK01141824.1;Q8BZ64;2.31E-45;TECT1_MOUSE;Tectonic-1;"ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; membrane [GO:0016020]; MKS complex [GO:0036038]; central nervous system interneuron axonogenesis [GO:0021956]; cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; in utero embryonic development [GO:0001701]; neural tube formation [GO:0001841]; protein localization to ciliary transition zone [GO:1904491]; regulation of smoothened signaling pathway [GO:0008589]; somatic motor neuron differentiation [GO:0021523]; telencephalon development [GO:0021537]";"GO:0001701; GO:0001841; GO:0005615; GO:0005737; GO:0005856; GO:0008589; GO:0016020; GO:0021523; GO:0021537; GO:0021904; GO:0021956; GO:0035869; GO:0036038; GO:0060271; GO:1904491";"central nervous system interneuron axonogenesis [GO:0021956]; cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; in utero embryonic development [GO:0001701]; neural tube formation [GO:0001841]; protein localization to ciliary transition zone [GO:1904491]; regulation of smoothened signaling pathway [GO:0008589]; somatic motor neuron differentiation [GO:0021523]; telencephalon development [GO:0021537]";"ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; membrane [GO:0016020]; MKS complex [GO:0036038]";
comp95442_c0_seq1;GAXK01113166.1;P93748;4.22E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp954581_c0_seq1;GAXK01141817.1;P23416;1.49E-45;GLRA2_HUMAN;Glycine receptor subunit alpha-2;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp95459_c0_seq1;GAXK01113494.1;Q96II8;1.66E-60;LRCH3_HUMAN;DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; septin cytoskeleton organization [GO:0032185]";"GO:0005576; GO:0005737; GO:0005829; GO:0032185";septin cytoskeleton organization [GO:0032185];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]";
comp95468_c1_seq1;GAXK01112985.1;Q5M8S7;2.99E-14;NIPA_XENTR;NIPA-like protein (Zinc finger C3HC-type protein 1-like);"nucleus [GO:0005634]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0007049; GO:0008270; GO:0016567; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]";nucleus [GO:0005634];zinc ion binding [GO:0008270]
comp95486_c3_seq1;GAXK01113204.1;Q3UNX5;0;ACSM3_MOUSE;Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]";"GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218";"acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]"
comp95488_c1_seq1;GAXK01113066.1;A4IGK4;7.74E-53;RBM5_XENTR;RNA-binding protein 5 (RNA-binding motif protein 5);"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]";"GO:0000245; GO:0000381; GO:0003729; GO:0005634; GO:0005681; GO:0043065; GO:0046872";"positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]";"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]";"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"
comp955041_c0_seq1;GAXK01141844.1;Q80WQ4;6.91E-56;TRM9B_MOUSE;Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; tRNA methyltransferase activity [GO:0008175]; tRNA wobble uridine modification [GO:0002098]";"GO:0000049; GO:0002098; GO:0005634; GO:0005737; GO:0008175; GO:0016300; GO:0016706";tRNA wobble uridine modification [GO:0002098];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; tRNA methyltransferase activity [GO:0008175]"
comp95512_c0_seq1;GAXK01113002.1;B8M9K0;4.26E-14;TROPI_TALSN;Hydrolase tropI (EC 3.1.1.-) (Tropolone synthesis protein I);hydrolase activity [GO:0016787];GO:0016787;;;hydrolase activity [GO:0016787]
comp955146_c0_seq1;GAXK01141825.1;Q80V23;4.83E-15;ZNF32_MOUSE;Zinc finger protein 32 (Zinc finger protein 637);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp955594_c0_seq1;GAXK01141835.1;Q16TM5;1.91E-23;BND7A_AEDAE;Band 7 protein AAEL010189;integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp9556_c0_seq1;GAXK01014686.1;P24733;2.66E-35;MYS_ARGIR;Myosin heavy chain, striated muscle;"myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp95560_c0_seq1;GAXK01113165.1;P79293;6.13E-43;MYH7_PIG;Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta);"myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]";"GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0030017; GO:0032982; GO:0051015";;"myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]"
comp95570_c1_seq1;GAXK01113029.1;P35038;5.12E-39;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp955854_c0_seq1;GAXK01141834.1;Q9CYL5;1.27E-09;GAPR1_MOUSE;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2);"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374";"positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]";"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]";protein homodimerization activity [GO:0042803]
comp955863_c0_seq1;GAXK01141840.1;Q27052;9.00E-14;FCA1_TRYRA;Flagellar calcium-binding protein;"motile cilium [GO:0031514]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0031514";;motile cilium [GO:0031514];calcium ion binding [GO:0005509]
comp95594_c0_seq1;GAXK01113147.1;Q5R632;1.19E-20;HPCL1_PONAB;Hippocalcin-like protein 1;"membrane [GO:0016020]; calcium ion binding [GO:0005509]";"GO:0005509; GO:0016020";;membrane [GO:0016020];calcium ion binding [GO:0005509]
comp95601_c0_seq1;GAXK01112975.1;Q13946;7.17E-96;PDE7A_HUMAN;High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22);"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";"GO:0004115; GO:0005829; GO:0006198; GO:0007186; GO:0046872";"cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]";cytosol [GO:0005829];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]"
comp95614_c1_seq1;GAXK01113525.1;A2AVA0;2.50E-22;SVEP1_MOUSE;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]";"GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020";cell adhesion [GO:0007155];"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]"
comp95642_c1_seq1;GAXK01112968.1;Q9XYN1;4.84E-124;INX2_SCHAM;Innexin inx2 (Innexin-2) (G-Inx2);"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]";"GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021";ion transport [GO:0006811];"gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp95643_c2_seq1;GAXK01113285.1;Q6GQ44;6.72E-33;TFIP8_XENLA;Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8);"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065]";"GO:0005737; GO:0043027; GO:0043065";positive regulation of apoptotic process [GO:0043065];cytoplasm [GO:0005737];cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]
comp9566077_c0_seq1;GAXK01199989.1;Q43127;5.36E-27;GLNA2_ARATH;Glutamine synthetase, chloroplastic/mitochondrial (EC 6.3.1.2) (GS2) (Glutamate--ammonia ligase);"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; plastid [GO:0009536]; thylakoid [GO:0009579]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; aging [GO:0007568]; ammonia assimilation cycle [GO:0019676]; glutamine biosynthetic process [GO:0006542]; response to cadmium ion [GO:0046686]";"GO:0004356; GO:0005524; GO:0005739; GO:0006542; GO:0007568; GO:0009507; GO:0009535; GO:0009536; GO:0009570; GO:0009579; GO:0009941; GO:0019676; GO:0022626; GO:0046686; GO:0048046";"aging [GO:0007568]; ammonia assimilation cycle [GO:0019676]; glutamine biosynthetic process [GO:0006542]; response to cadmium ion [GO:0046686]";"apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; chloroplast thylakoid membrane [GO:0009535]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; plastid [GO:0009536]; thylakoid [GO:0009579]";"ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]"
comp9568470_c0_seq1;GAXK01162921.1;P0AEB4;1.30E-16;DACA_ECO57;D-alanyl-D-alanine carboxypeptidase DacA (DD-carboxypeptidase) (DD-peptidase) (EC 3.4.16.4) (Penicillin-binding protein 5) (PBP-5);"plasma membrane [GO:0005886]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";"GO:0005886; GO:0008360; GO:0009002; GO:0009252; GO:0071555";"cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]";plasma membrane [GO:0005886];serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]
comp956874_c0_seq1;GAXK01179591.1;P52746;4.64E-17;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp956975_c0_seq1;GAXK01179599.1;Q99MD6;1.02E-19;TRXR3_MOUSE;Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"GO:0001825; GO:0004791; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006749; GO:0007283; GO:0009055; GO:0015035; GO:0030154; GO:0045454; GO:0050660";"blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]";"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]"
comp957041_c0_seq1;GAXK01179563.1;A7MBJ2;1.65E-16;SENP7_BOVIN;Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]";"GO:0005634; GO:0005737; GO:0016926; GO:0070139";protein desumoylation [GO:0016926];"cytoplasm [GO:0005737]; nucleus [GO:0005634]";SUMO-specific endopeptidase activity [GO:0070139]
comp95725_c0_seq1;GAXK01113102.1;Q9Y169;4.12E-162;EXT2_DROME;Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Protein sister of tout-velu);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]";"GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007275; GO:0008375; GO:0015012; GO:0015014; GO:0016021; GO:0016055; GO:0016757; GO:0030206; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263";"chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; Wnt signaling pathway [GO:0016055]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]"
comp957258_c0_seq1;GAXK01179566.1;Q5RD64;1.60E-25;CNTP2_PONAB;Contactin-associated protein-like 2;"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]; cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"GO:0007155; GO:0016021; GO:0033010; GO:0044224; GO:0048812; GO:0071205";"cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]";"integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]";
comp957446_c0_seq1;GAXK01179571.1;Q9Y257;1.03E-08;KCNK6_HUMAN;Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion leak channel activity [GO:0022841]; cardiac conduction [GO:0061337]; negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322]";"GO:0003085; GO:0005242; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0022841; GO:0030322; GO:0034765; GO:0060075; GO:0061337; GO:0071805";"cardiac conduction [GO:0061337]; negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]";"inward rectifier potassium channel activity [GO:0005242]; potassium ion leak channel activity [GO:0022841]"
comp957639_c0_seq1;GAXK01179580.1;Q95NT6;1.44E-18;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp95765_c0_seq1;GAXK01113081.1;Q8R5C8;2.27E-24;ZMY11_MOUSE;Zinc finger MYND domain-containing protein 11;"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]";"GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0008270; GO:0034243; GO:0035064; GO:0042393; GO:0043124; GO:0046329; GO:0051607; GO:2001237";"chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]"
comp95795_c6_seq1;GAXK01113543.1;Q9VFB7;0;TPC10_DROME;Trafficking protein particle complex subunit 10 (Shal Interactor of Di-Leucine Motif) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1);"cytosol [GO:0005829]; dendrite [GO:0030425]; perikaryon [GO:0043204]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of GTPase activity [GO:0043087]";"GO:0005829; GO:0006891; GO:0030008; GO:0030425; GO:0034498; GO:0043087; GO:0043204; GO:1990071";"early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of GTPase activity [GO:0043087]";"cytosol [GO:0005829]; dendrite [GO:0030425]; perikaryon [GO:0043204]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]";
comp958342_c0_seq1;GAXK01038248.1;P05661;1.75E-104;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp9585211_c0_seq1;GAXK01093111.1;Q87L95;2.05E-25;METH_VIBPA;Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS);"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]";"GO:0008270; GO:0008705; GO:0031419; GO:0042558";pteridine-containing compound metabolic process [GO:0042558];;"cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]"
comp95867_c0_seq1;GAXK01113000.1;P22125;1.36E-53;RAB1_DIPOM;Ras-related protein ORAB-1;"plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]";"GO:0003924; GO:0005525; GO:0005886; GO:0015031";protein transport [GO:0015031];plasma membrane [GO:0005886];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp958982_c0_seq1;GAXK01038263.1;Q8NFZ3;2.64E-102;NLGNY_HUMAN;Neuroligin-4, Y-linked (Neuroligin Y);"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0014069; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054";"learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]";"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]";"cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]"
comp958990_c0_seq1;GAXK01038249.1;Q9P2C4;5.41E-87;TM181_HUMAN;Transmembrane protein 181;"integral component of membrane [GO:0016021]; toxic substance binding [GO:0015643]; pathogenesis [GO:0009405]";"GO:0009405; GO:0015643; GO:0016021";pathogenesis [GO:0009405];integral component of membrane [GO:0016021];toxic substance binding [GO:0015643]
comp959_c0_seq1;GAXK01170143.1;Q5DC69;1.40E-25;CH10_SCHJA;10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10);"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein folding [GO:0006457]";"GO:0005524; GO:0005759; GO:0006457";protein folding [GO:0006457];mitochondrial matrix [GO:0005759];ATP binding [GO:0005524]
comp95935_c10_seq1;GAXK01113518.1;C5H5C4;1.64E-17;NOT1A_DANRE;Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98);"extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";"GO:0005576; GO:0006507; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699";"anterior/posterior pattern specification [GO:0009952]; GPI anchor release [GO:0006507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]";extracellular region [GO:0005576];palmitoleyl hydrolase activity [GO:1990699]
comp95945_c0_seq1;GAXK01113306.1;Q9YH58;0;FTCD_CHICK;"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]";"centriole [GO:0005814]; Golgi apparatus [GO:0005794]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]";"GO:0005542; GO:0005794; GO:0005814; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0035999";"histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]";"centriole [GO:0005814]; Golgi apparatus [GO:0005794]";"folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]"
comp959487_c0_seq1;GAXK01038298.1;Q0V9W6;1.54E-09;BTBD6_XENTR;BTB/POZ domain-containing protein 6;"cytosol [GO:0005829]; neurogenesis [GO:0022008]";"GO:0005829; GO:0022008";neurogenesis [GO:0022008];cytosol [GO:0005829];
comp95954_c0_seq1;GAXK01112998.1;Q8MJJ7;1.31E-87;DCPS_BOVIN;m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]";"GO:0000290; GO:0000340; GO:0000932; GO:0005634; GO:0005737; GO:0036245; GO:0043069; GO:0045292; GO:0050072";"cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]";"m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]"
comp959669_c0_seq1;GAXK01038294.1;P52740;1.84E-23;ZN132_HUMAN;Zinc finger protein 132;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp959705_c0_seq1;GAXK01038257.1;A8WIP6;6.71E-140;CDK20_DANRE;Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20);"cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]";"GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007049; GO:0007275; GO:0051301; GO:0060271";"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]"
comp95998_c1_seq1;GAXK01113020.1;Q05823;2.71E-10;RN5A_HUMAN;2-5A-dependent ribonuclease (2-5A-dependent RNase) (EC 3.1.26.-) (Ribonuclease 4) (Ribonuclease L) (RNase L);"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; rRNA processing [GO:0006364]; type I interferon signaling pathway [GO:0060337]";"GO:0003723; GO:0004521; GO:0004672; GO:0005524; GO:0005759; GO:0005829; GO:0006364; GO:0006397; GO:0006468; GO:0016363; GO:0019843; GO:0042802; GO:0043021; GO:0043488; GO:0045071; GO:0045444; GO:0045944; GO:0046326; GO:0046872; GO:0051607; GO:0060337; GO:0060338";"defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; rRNA processing [GO:0006364]; type I interferon signaling pathway [GO:0060337]";"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]";"ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]"
comp95999_c0_seq1;GAXK01113424.1;Q1PRL4;8.78E-12;LIN41_CHICK;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);"P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";"GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177";"fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]";P-body [GO:0000932];"miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp96_c0_seq1;GAXK01169693.1;Q56FC8;1.95E-39;RL38_LYSTE;60S ribosomal protein L38;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp960_c1_seq1;GAXK01169535.1;P07201;8.83E-174;RIR2_SPISO;Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit) (p41);"ribonucleoside-diphosphate reductase complex [GO:0005971]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]";"GO:0004748; GO:0005971; GO:0006260; GO:0009263; GO:0046872";"deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]";ribonucleoside-diphosphate reductase complex [GO:0005971];"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"
comp960035_c0_seq1;GAXK01088829.1;P95470;1.42E-39;ARBA_CELJU;Extracellular exo-alpha-(1->5)-L-arabinofuranosidase ArbA (ABF) (EC 3.2.1.55) (Extracellular arabinan exo-alpha-(1->5)-L-arabinosidase ArbA) (Arabinosidase);"extracellular region [GO:0005576]; alpha-L-arabinofuranosidase activity [GO:0046556]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]; arabinan catabolic process [GO:0031222]";"GO:0005576; GO:0031222; GO:0046556; GO:0046558; GO:0046872";arabinan catabolic process [GO:0031222];extracellular region [GO:0005576];"alpha-L-arabinofuranosidase activity [GO:0046556]; arabinan endo-1,5-alpha-L-arabinosidase activity [GO:0046558]; metal ion binding [GO:0046872]"
comp960096_c2_seq1;GAXK01088855.1;Q6IP59;8.37E-35;CTL2_XENLA;Choline transporter-like protein 2 (Solute carrier family 44 member 2);integral component of membrane [GO:0016021];GO:0016021;;integral component of membrane [GO:0016021];
comp96011_c0_seq1;GAXK01149160.1;Q9Y226;3.56E-47;S22AD_HUMAN;Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3);"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; organic cation transmembrane transporter activity [GO:0015101]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinate transport [GO:2001142]; organic cation transport [GO:0015695]; urate transport [GO:0015747]";"GO:0005886; GO:0005887; GO:0015101; GO:0015695; GO:0015747; GO:0016324; GO:0034356; GO:0070062; GO:0090416; GO:2001142";"NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinate transport [GO:2001142]; organic cation transport [GO:0015695]; urate transport [GO:0015747]";"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"nicotinate transmembrane transporter activity [GO:0090416]; organic cation transmembrane transporter activity [GO:0015101]"
comp9601615_c0_seq1;GAXK01055774.1;E6ZHJ8;3.25E-10;FXL15_DICLA;F-box/LRR-repeat protein 15;"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"GO:0000086; GO:0005737; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146";"bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]";"cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]";
comp960218_c0_seq1;GAXK01088848.1;O74467;3.84E-18;SET5_SCHPO;SET domain-containing protein 5 (EC 2.1.1.43);"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]";"GO:0000790; GO:0005634; GO:0005829; GO:0016279; GO:0018024; GO:0034968";histone lysine methylation [GO:0034968];"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]";"histone-lysine N-methyltransferase activity [GO:0018024]; protein-lysine N-methyltransferase activity [GO:0016279]"
comp9602978_c0_seq1;GAXK01060133.1;Q8RXK6;2.95E-50;RH8_ARATH;DEAD-box ATP-dependent RNA helicase 8 (EC 3.6.4.13);"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]; viral process [GO:0016032]";"GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005829; GO:0006397; GO:0006417; GO:0010494; GO:0016032; GO:0033962; GO:0034063; GO:0051028";"cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]; viral process [GO:0016032]";"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]";"ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp9603_c2_seq1;GAXK01014053.1;P11884;0;ALDH2_RAT;Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; ethanol catabolic process [GO:0006068]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; response to estradiol [GO:0032355]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]";"GO:0001889; GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0032355; GO:0032496; GO:0032570; GO:0032870; GO:0033574; GO:0035094; GO:0042802; GO:0043066; GO:0043878; GO:0055093; GO:0070404; GO:0071398";"cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; ethanol catabolic process [GO:0006068]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; response to estradiol [GO:0032355]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]"
comp96050_c0_seq1;GAXK01149418.1;Q9ULJ8;1.69E-57;NEB1_HUMAN;Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A);"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"GO:0005737; GO:0005829; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030054; GO:0030175; GO:0030425; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042803; GO:0043025; GO:0044325; GO:0044326; GO:0045860; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761";"actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]";"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]";"actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]"
comp96051_c0_seq1;GAXK01149360.1;P36609;1.14E-32;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp960691_c0_seq1;GAXK01088824.1;P0C2W5;1.86E-13;GBRB2_BOVIN;Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (Fragment);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030054; GO:0030659; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0071420; GO:1902476; GO:1902711; GO:1904862";"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]"
comp960792_c0_seq1;GAXK01088828.1;Q9Y2H8;2.52E-11;ZN510_HUMAN;Zinc finger protein 510;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp96088_c0_seq1;GAXK01149299.1;Q922H2;2.79E-131;PDK3_MOUSE;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377";"cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]";"ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]"
comp96119_c0_seq1;GAXK01149177.1;Q7ZWS1;0;DUS3L_XENLA;tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like);"flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]";"GO:0017150; GO:0046872; GO:0050660";;;"flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]"
comp9613_c0_seq1;GAXK01014109.1;Q26636;9.56E-148;CATL_SARPE;"Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]";"lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";"GO:0005764; GO:0007275; GO:0008234; GO:0030154";"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]";lysosome [GO:0005764];cysteine-type peptidase activity [GO:0008234]
comp96147_c0_seq1;GAXK01149229.1;Q96FG2;3.09E-50;ELMD3_HUMAN;ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1) (RNA-binding motif protein 29) (RNA-binding protein 29);"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547]";"GO:0005737; GO:0005856; GO:0032420; GO:0043547; GO:0060091";positive regulation of GTPase activity [GO:0043547];"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]";
comp96150_c0_seq1;GAXK01149331.1;Q70CQ2;0;UBP34_HUMAN;Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34);"cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";"GO:0004197; GO:0004843; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0031647; GO:0036459; GO:0071108; GO:0090263";"positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]";cytosol [GO:0005829];"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]"
comp9616_c1_seq1;GAXK01014112.1;Q7SYL3;9.84E-12;SIAH2_DANRE;E3 ubiquitin-protein ligase Siah2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2-like) (Siah-2);"nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0006511; GO:0007093; GO:0007275; GO:0008270; GO:0031624; GO:0042752; GO:0043161; GO:0048511; GO:0061630";"mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]";nucleus [GO:0005634];"ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
comp96160_c0_seq1;GAXK01149136.1;Q9U6L4;1.20E-46;TTY1_DROME;Protein tweety (Dttyh1);"chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320]; chloride transport [GO:0006821]";"GO:0005229; GO:0005254; GO:0005886; GO:0006821; GO:0016021; GO:0034707; GO:0072320";chloride transport [GO:0006821];"chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320]"
comp961622_c0_seq1;GAXK01088825.1;A2A935;4.25E-09;PRD16_MOUSE;Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.43) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1);"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162";"brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]";"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]"
comp96164_c2_seq1;GAXK01149175.1;Q8N7N5;4.00E-130;DCAF8_MOUSE;DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A);"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]";"GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016567; GO:0080008";protein ubiquitination [GO:0016567];"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";
comp9617_c0_seq1;GAXK01013434.1;Q9V427;5.41E-28;INX2_DROME;Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33);"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"GO:0005243; GO:0005737; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098";"cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; spermatogenesis [GO:0007283]";"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]";gap junction channel activity [GO:0005243]
comp961716_c0_seq1;GAXK01088844.1;Q80UG8;1.81E-15;TTLL4_MOUSE;Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4);"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739";"peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]";"cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]";"ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]"
comp9618_c0_seq1;GAXK01013443.1;Q3SZ40;3.15E-167;DDX56_BOVIN;Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (DEAD box protein 56);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp9618278_c0_seq1;GAXK01042073.1;P31018;1.84E-23;EF1A_ENTHI;Elongation factor 1-alpha (EF-1-alpha);"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]";"GO:0003746; GO:0003924; GO:0005525; GO:0005737";;cytoplasm [GO:0005737];"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]"
comp961865_c0_seq1;GAXK01088827.1;Q13105;1.26E-23;ZBT17_HUMAN;Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60);"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0000978; GO:0000981; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158";"ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]";"core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"
comp9618955_c0_seq1;GAXK01042074.1;Q16651;4.97E-10;PRSS8_HUMAN;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]; cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0008236; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0046658; GO:0070062; GO:0070268";"cornification [GO:0070268]; positive regulation of sodium ion transport [GO:0010765]";"anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]"
comp96192_c6_seq1;GAXK01149539.1;D4A1F2;5.79E-124;MICA2_RAT;[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2);"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";"GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949";"actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]";nucleus [GO:0005634];"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
comp961989_c0_seq1;GAXK01088840.1;P26433;9.07E-90;SL9A3_RAT;Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3);"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; circadian rhythm [GO:0007623]; potassium ion transmembrane transport [GO:0071805]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sodium ion transport [GO:0002028]; response to glucocorticoid [GO:0051384]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"GO:0002028; GO:0005886; GO:0005903; GO:0006814; GO:0006885; GO:0006898; GO:0007623; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0051384; GO:0051453; GO:0071805; GO:0098719";"circadian rhythm [GO:0007623]; potassium ion transmembrane transport [GO:0071805]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sodium ion transport [GO:0002028]; response to glucocorticoid [GO:0051384]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]";"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]"
comp96211_c1_seq1;GAXK01149366.1;Q9VGG5;0;CAD87_DROME;Cadherin-87A;"integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";"GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016339; GO:0044331";"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]";integral component of plasma membrane [GO:0005887];calcium ion binding [GO:0005509]
comp962306_c0_seq1;GAXK01102176.1;Q9SZJ2;1.98E-13;GRDP2_ARATH;Glycine-rich domain-containing protein 2 (AtGRDP2);"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";"GO:0009734; GO:0010928; GO:0071470; GO:2000028";"auxin-activated signaling pathway [GO:0009734]; cellular response to osmotic stress [GO:0071470]; regulation of auxin mediated signaling pathway [GO:0010928]; regulation of photoperiodism, flowering [GO:2000028]";;
comp962317_c0_seq1;GAXK01102135.1;Q9VZW5;1.35E-14;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp962331_c0_seq1;GAXK01102143.1;A1A4N1;7.58E-48;S29A3_BOVIN;Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3);"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]";"GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0016021; GO:0031902";;"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]";nucleoside transmembrane transporter activity [GO:0005337]
comp96244_c2_seq1;GAXK01149180.1;Q9W770;3.22E-89;SPON1_CHICK;Spondin-1 (F-spondin);"extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]";"GO:0007155; GO:0031012; GO:0046872";cell adhesion [GO:0007155];extracellular matrix [GO:0031012];metal ion binding [GO:0046872]
comp9625_c0_seq1;GAXK01014174.1;Q99JY0;0;ECHB_MOUSE;Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)];"endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]";"GO:0000062; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0042645; GO:0044877; GO:0050633; GO:0051287";fatty acid beta-oxidation [GO:0006635];"endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]"
comp96272_c0_seq1;GAXK01149525.1;P0AF49;6.46E-41;YJBQ_ECO57;UPF0047 protein YjbQ;;;;;
comp962792_c0_seq1;GAXK01102132.1;P52746;2.09E-11;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9630_c0_seq1;GAXK01013464.1;P38040;1.75E-14;GBG1_DROME;Guanine nucleotide-binding protein subunit gamma-1;"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343";"apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]";"G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]";"G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]"
comp9631_c0_seq1;GAXK01013489.1;O18404;6.71E-121;HCD2_DROME;3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH);"cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202]";"GO:0003857; GO:0004303; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030283; GO:0030678; GO:0035410; GO:0047015; GO:0047022; GO:0047035; GO:0090502; GO:0090646";"acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202]";"cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]";"3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]"
comp963171_c0_seq1;GAXK01102131.1;Q6Q4H1;5.73E-26;JMJD6_HYDVU;Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-) (Phosphatidylserine receptor);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";"GO:0005634; GO:0006325; GO:0018395; GO:0046872; GO:0070815";"chromatin organization [GO:0006325]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]"
comp963312_c0_seq1;GAXK01102186.1;Q13003;1.67E-43;GRIK3_HUMAN;Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7);"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315";"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]";"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]";"adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp9634_c1_seq1;GAXK01013442.1;P21127;4.67E-169;CD11B_HUMAN;Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000278; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0050684";"apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]"
comp963517_c0_seq1;GAXK01102183.1;Q27IV2;9.48E-11;SHRM3_XENLA;Protein Shroom3 (Shroom-like protein);"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"GO:0000902; GO:0001843; GO:0002064; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005912; GO:0007389; GO:0008360; GO:0016324; GO:0043482; GO:0045176; GO:0051015";"apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]";"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]"
comp963550_c0_seq1;GAXK01102189.1;Q9VN12;2.14E-27;NCKXH_DROME;Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588";"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"
comp963627_c0_seq1;GAXK01102117.1;Q8NB50;1.59E-15;ZFP62_HUMAN;Zinc finger protein 62 homolog (Zfp-62);"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]";"GO:0003676; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp96369_c1_seq1;GAXK01149392.1;O35717;1.40E-22;SOCS2_MOUSE;Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2);"cytoplasm [GO:0005737]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of multicellular organism growth [GO:0040014]; response to estradiol [GO:0032355]";"GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005942; GO:0007595; GO:0008269; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0040014; GO:0040015; GO:0045666; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0060396; GO:0060749";"cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of multicellular organism growth [GO:0040014]; response to estradiol [GO:0032355]";"cytoplasm [GO:0005737]; phosphatidylinositol 3-kinase complex [GO:0005942]";"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]"
comp96383_c1_seq1;GAXK01149301.1;P16554;3.82E-79;NUMB_DROME;Protein numb;"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007400; GO:0007405; GO:0007406; GO:0007417; GO:0007507; GO:0007622; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045165; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692";"asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]";"basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";"ATP binding [GO:0005524]; Notch binding [GO:0005112]"
comp96445_c0_seq1;GAXK01149420.1;Q6NZL6;4.55E-48;TONSL_MOUSE;Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2);"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]";"GO:0000724; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0042393; GO:0043596";"double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]";"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]";histone binding [GO:0042393]
comp964632_c0_seq1;GAXK01180483.1;P98074;5.19E-50;ENTK_PIG;"Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic mini chain; Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]";"integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]";"GO:0004252; GO:0005044; GO:0016020; GO:0016021";;"integral component of membrane [GO:0016021]; membrane [GO:0016020]";"scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp96464_c0_seq1;GAXK01149311.1;Q7KRI2;1.34E-19;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp964671_c0_seq1;GAXK01180497.1;P10665;2.26E-58;KS6AA_XENLA;Ribosomal protein S6 kinase 2 alpha (EC 2.7.11.1) (MAP kinase-activated protein kinase 1) (MAPK-activated protein kinase 1) (MAPKAP kinase 1) (MAPKAPK-1) (Ribosomal protein S6 kinase II alpha) (S6KII-alpha) (p90-RSK);"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]";"GO:0000287; GO:0004674; GO:0005524; GO:0035556";intracellular signal transduction [GO:0035556];;"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]"
comp9647_c0_seq1;GAXK01014071.1;Q5ZIH9;7.36E-34;CC174_CHICK;Coiled-coil domain-containing protein 174;nucleus [GO:0005634];GO:0005634;;nucleus [GO:0005634];
comp964826_c0_seq1;GAXK01180496.1;Q5R5U3;9.43E-70;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp9651_c1_seq1;GAXK01013426.1;Q96T88;0;UHRF1_HUMAN;E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Inverted CCAAT box-binding protein of 90 kDa) (Nuclear protein 95) (Nuclear zinc finger protein Np95) (HuNp95) (hNp95) (RING finger protein 106) (RING-type E3 ubiquitin transferase UHRF1) (Transcription factor ICBP90) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (hUHRF1) (Ubiquitin-like-containing PHD and RING finger domains protein 1);"euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; nucleosomal histone binding [GO:0031493]; proximal promoter sequence-specific DNA binding [GO:0000987]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0000987; GO:0004842; GO:0005634; GO:0005657; GO:0005720; GO:0006281; GO:0006511; GO:0007049; GO:0008270; GO:0008327; GO:0010216; GO:0010390; GO:0016363; GO:0016567; GO:0016574; GO:0031493; GO:0032270; GO:0035064; GO:0042393; GO:0042802; GO:0044729; GO:0045944; GO:0050678; GO:0051865; GO:0061630; GO:2000373";"cell cycle [GO:0007049]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511]";"euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; replication fork [GO:0005657]";"hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]; nucleosomal histone binding [GO:0031493]; proximal promoter sequence-specific DNA binding [GO:0000987]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
comp965192_c0_seq1;GAXK01180488.1;P35243;9.15E-27;RECO_HUMAN;Recoverin (Cancer-associated retinopathy protein) (Protein CAR);"dendrite [GO:0030425]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; phototransduction [GO:0007602]; regulation of calcium ion transport [GO:0051924]; signal transduction [GO:0007165]; visual perception [GO:0007601]";"GO:0005509; GO:0007165; GO:0007601; GO:0007602; GO:0008048; GO:0030425; GO:0051924";"phototransduction [GO:0007602]; regulation of calcium ion transport [GO:0051924]; signal transduction [GO:0007165]; visual perception [GO:0007601]";dendrite [GO:0030425];"calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]"
comp96544_c2_seq1;GAXK01149453.1;Q80Y56;8.31E-71;RBNS5_MOUSE;Rabenosyn-5 (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20);"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Rab GTPase binding [GO:0017137]; early endosome to Golgi transport [GO:0034498]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358]";"GO:0003676; GO:0005829; GO:0005886; GO:0015031; GO:0017137; GO:0031901; GO:0034498; GO:0043231; GO:0046872; GO:0090160; GO:1903358";"early endosome to Golgi transport [GO:0034498]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358]";"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Rab GTPase binding [GO:0017137]"
comp965958_c0_seq1;GAXK01180500.1;Q95NT6;1.19E-15;MTH2_DROYA;G-protein coupled receptor Mth2 (Protein methuselah-2);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";G protein-coupled receptor activity [GO:0004930]
comp966037_c1_seq1;GAXK01029007.1;A0NLY7;1.13E-22;ISAHY_LABAI;Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b);"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]";"GO:0004061; GO:0016812; GO:0019441; GO:0030145";tryptophan catabolic process to kynurenine [GO:0019441];;"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]"
comp966051_c0_seq1;GAXK01028998.1;Q502B3;4.68E-24;B3GL2_DANRE;UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (Beta-1,3-GalNAc-T2) (EC 2.4.1.313) (Beta-1,3-N-acetylgalactosaminyltransferase II);"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; galactosyltransferase activity [GO:0008378]; muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]";"GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006493; GO:0008375; GO:0008376; GO:0008378; GO:0016021; GO:0048747";"muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]";"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; galactosyltransferase activity [GO:0008378]"
comp966088_c0_seq1;GAXK01029014.1;Q3TMW1;3.44E-09;C102A_MOUSE;Coiled-coil domain-containing protein 102A;"myosin complex [GO:0016459]; motor activity [GO:0003774]";"GO:0003774; GO:0016459";;myosin complex [GO:0016459];motor activity [GO:0003774]
comp9661_c0_seq1;GAXK01013457.1;Q5R587;6.11E-131;RPAB1_PONAB;DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog);"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]";"GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366";transcription by RNA polymerase II [GO:0006366];"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]";"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]"
comp96616_c2_seq1;GAXK01149570.1;Q1LUA6;2.19E-88;TRIO_DANRE;Triple functional domain protein (EC 2.7.11.1);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";"GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0035023";"axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp96617_c1_seq1;GAXK01149485.1;Q9VEN1;4.14E-33;FLNA_DROME;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1);"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495";"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]";"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]";actin binding [GO:0003779]
comp966265_c0_seq1;GAXK01029000.1;P34410;4.46E-33;TWK7_CAEEL;TWiK family of potassium channels protein 7;"integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";"GO:0005887; GO:0022841; GO:0030322; GO:0071805";"potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]";integral component of plasma membrane [GO:0005887];potassium ion leak channel activity [GO:0022841]
comp9663643_c0_seq1;GAXK01203522.1;B1Y8E1;4.40E-53;RUVA_LEPCP;Holliday junction ATP-dependent DNA helicase RuvA (EC 3.6.4.12);"Holliday junction helicase complex [GO:0009379]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";"GO:0003677; GO:0005524; GO:0006281; GO:0006310; GO:0009378; GO:0009379; GO:0009432";"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432]";Holliday junction helicase complex [GO:0009379];"ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]"
comp96669_c0_seq1;GAXK01149401.1;Q5I7T1;3.81E-88;AG10B_HUMAN;Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-B) (Asparagine-linked glycosylation protein 10 homolog B) (Potassium channel regulator 1);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; transferase activity [GO:0016740]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]";"GO:0004583; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006488; GO:0016021; GO:0016740; GO:0060050; GO:0106073; GO:1901980";"dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; transferase activity [GO:0016740]"
comp966691_c0_seq1;GAXK01029006.1;Q91WG0;5.00E-51;EST2C_MOUSE;Acylcarnitine hydrolase (ACH M1) (EC 3.1.1.28) (Carboxylesterase 2) (CES 2) (Peroxisome proliferator-inducible acylcarnitine hydrolase);"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]";"GO:0005615; GO:0005783; GO:0043231; GO:0047619; GO:0052689";;"endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]";"acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]"
comp96677_c1_seq1;GAXK01149327.1;Q27567;5.59E-58;GPDA_DROEZ;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8);"glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]";"GO:0004367; GO:0005975; GO:0006650; GO:0009331; GO:0042803; GO:0046168; GO:0051287";"carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]";glycerol-3-phosphate dehydrogenase complex [GO:0009331];"glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]"
comp966812_c0_seq1;GAXK01029010.1;Q8C6G1;8.14E-31;CF410_MOUSE;Cilia- and flagella-associated protein 410;"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"GO:0001750; GO:0005737; GO:0005739; GO:0005886; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0042769; GO:0060271; GO:0097733";"cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]";"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]";
comp966953_c0_seq1;GAXK01029012.1;Q09225;5.09E-44;NRF6_CAEEL;Nose resistant to fluoxetine protein 6 (Protein nrf-6);"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";"GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747";"lipid transport [GO:0006869]; multicellular organism development [GO:0007275]";integral component of membrane [GO:0016021];"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
comp96724_c1_seq1;GAXK01149300.1;Q7Z2K6;0;ERMP1_HUMAN;Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]";"GO:0005789; GO:0006508; GO:0008237; GO:0016020; GO:0016021; GO:0046872";proteolysis [GO:0006508];"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp967377_c0_seq1;GAXK01029004.1;Q7KM13;9.76E-36;HEY_DROME;Hairy/enhancer-of-split related with YRPW motif protein;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0046983; GO:0048664; GO:0050767";"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp967429_c0_seq1;GAXK01029009.1;P0C7V5;8.05E-13;ZN812_HUMAN;Deleted.;;;;;
comp967462_c0_seq1;GAXK01028997.1;O18326;6.10E-11;HUNB_BOMMO;Protein hunchback (Fragment);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";"GO:0000981; GO:0003677; GO:0005634; GO:0035282; GO:0040034; GO:0046872";"regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp96749_c1_seq1;GAXK01149149.1;Q6S004;4.62E-15;KIF6_DICDI;Kinesin-related protein 6 (Kinesin family member 6) (Kinesin-13);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]";"GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016887";"microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
comp9675_c0_seq1;GAXK01013593.1;Q58CP0;1.61E-132;IDH3G_BOVIN;Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";"GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287";"isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]"
comp96759_c0_seq1;GAXK01149399.1;P48148;5.94E-104;RHO1_DROME;Ras-like GTP-binding protein Rho1;"apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059";"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]";"apical cortex [GO:0045179]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]";"actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]"
comp967681_c0_seq1;GAXK01029026.1;P58526;1.05E-11;MTOX_YERPE;N-methyl-L-tryptophan oxidase (MTOX) (EC 1.5.3.-);"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; N-methyl-L-amino-acid oxidase activity [GO:0050131]; sarcosine oxidase activity [GO:0008115]";"GO:0005829; GO:0008115; GO:0050131; GO:0050660";;cytosol [GO:0005829];"flavin adenine dinucleotide binding [GO:0050660]; N-methyl-L-amino-acid oxidase activity [GO:0050131]; sarcosine oxidase activity [GO:0008115]"
comp967747_c0_seq1;GAXK01029022.1;Q6P560;6.08E-42;ZN182_MOUSE;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9679_c0_seq1;GAXK01013437.1;P87362;3.35E-169;BLMH_CHICK;Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40) (Aminopeptidase H);"cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]";"GO:0004177; GO:0004197; GO:0005737; GO:0008234; GO:0009636; GO:0042493; GO:0042802; GO:0043418";"homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]";cytoplasm [GO:0005737];"aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]"
comp96790_c8_seq1;GAXK01149435.1;Q8BGQ2;1.70E-21;CSRN2_MOUSE;Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase II [GO:0045944]";"GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0019902; GO:0043565; GO:0045944";"apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of transcription by RNA polymerase II [GO:0045944]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]"
comp96811_c0_seq1;GAXK01149257.1;Q16798;1.01E-36;MAON_HUMAN;NADP-dependent malic enzyme, mitochondrial (NADP-ME) (EC 1.1.1.40) (Malic enzyme 3);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cofactor binding [GO:0048037]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]";"GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006108; GO:0008948; GO:0009060; GO:0046872; GO:0048037; GO:0051287; GO:0055114; GO:0072592";"aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"cofactor binding [GO:0048037]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]"
comp968184_c0_seq1;GAXK01105104.1;Q28BL7;1.76E-32;PO2F1_XENTR;POU domain, class 2, transcription factor 1 (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007219; GO:0042981; GO:0043565; GO:0045893; GO:0045944; GO:0060019";"Notch signaling pathway [GO:0007219]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]";"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp968265_c0_seq1;GAXK01105110.1;Q3KRE6;7.76E-48;KLDC2_RAT;Kelch domain-containing protein 2;"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";"GO:0005634; GO:0016604; GO:0031965";;"nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]";
comp968597_c0_seq1;GAXK01105100.1;Q9UK10;2.00E-26;ZN225_HUMAN;Zinc finger protein 225;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9686_c0_seq1;GAXK01014721.1;Q9U4L6;3.25E-117;TO401_DROME;Mitochondrial import receptor subunit TOM40 homolog 1 (dtom40) (Male sterile protein 15) (Translocase of outer membrane 40 kDa subunit homolog 1);"mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320]; cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]";"GO:0005739; GO:0005742; GO:0006626; GO:0006811; GO:0008320; GO:0015288; GO:0015450; GO:0030150; GO:0046930; GO:0071456";"cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]";"mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]";"porin activity [GO:0015288]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]"
comp96884_c1_seq1;GAXK01149447.1;Q6AXQ5;4.73E-96;PDE12_RAT;2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]";"GO:0000175; GO:0000288; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0046872";"mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]"
comp96918_c0_seq1;GAXK01149597.1;Q92544;1.15E-49;TM9S4_HUMAN;Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1);"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010";"cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]";"early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]";
comp96957_c1_seq1;GAXK01149362.1;Q7RTY0;3.48E-39;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp96962_c0_seq1;GAXK01149501.1;Q55DL2;2.81E-48;MET18_DICDI;Histidine protein methyltransferase 1 homolog (Protein METTL18 homolog) (EC 2.1.1.-);methyltransferase activity [GO:0008168];GO:0008168;;;methyltransferase activity [GO:0008168]
comp96980_c0_seq1;GAXK01149324.1;Q1QBB9;1.47E-32;DHMA_PSYCK;Haloalkane dehalogenase (EC 3.8.1.5);haloalkane dehalogenase activity [GO:0018786];GO:0018786;;;haloalkane dehalogenase activity [GO:0018786]
comp969905_c0_seq1;GAXK01105072.1;Q9Y5R2;5.20E-42;MMP24_HUMAN;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24];"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742";"cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]";"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]";"cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
comp97000_c4_seq1;GAXK01149271.1;Q13351;8.28E-17;KLF1_HUMAN;Krueppel-like factor 1 (Erythroid krueppel-like transcription factor) (EKLF);"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0030218; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0060135; GO:1901653";"cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]";"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]"
comp9700407_c0_seq1;GAXK01139459.1;Q59699;6.53E-26;HYDA_PSEPU;D-hydantoinase/dihydropyrimidinase (DHPase) (EC 3.5.2.2);"cytoplasm [GO:0005737]; dihydropyrimidinase activity [GO:0004157]; metal ion binding [GO:0046872]";"GO:0004157; GO:0005737; GO:0046872";;cytoplasm [GO:0005737];"dihydropyrimidinase activity [GO:0004157]; metal ion binding [GO:0046872]"
comp970072_c0_seq1;GAXK01189141.1;P45844;0;ABCG1_HUMAN;ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog);"endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; detection of hormone stimulus [GO:0009720]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]";"GO:0000139; GO:0005524; GO:0005543; GO:0005548; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009720; GO:0009897; GO:0010033; GO:0010745; GO:0010872; GO:0010875; GO:0010887; GO:0015485; GO:0016021; GO:0016887; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042626; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0046983; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0120020; GO:1902004";"amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; detection of hormone stimulus [GO:0009720]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]";"endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]"
comp970163_c0_seq1;GAXK01189107.1;P35038;8.77E-40;TRY4_ANOGA;Trypsin-4 (EC 3.4.21.4);"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; digestion [GO:0007586]";"GO:0004252; GO:0005576; GO:0007586; GO:0008236";digestion [GO:0007586];extracellular region [GO:0005576];"serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]"
comp97019_c0_seq1;GAXK01149524.1;Q86UE3;7.54E-31;ZN546_HUMAN;Zinc finger protein 546 (Zinc finger protein 49);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp97026_c0_seq1;GAXK01149223.1;Q62073;1.41E-07;M3K7_MOUSE;Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"GO:0000165; GO:0000287; GO:0001525; GO:0001841; GO:0004674; GO:0004708; GO:0004709; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007179; GO:0007252; GO:0007254; GO:0014069; GO:0016239; GO:0018107; GO:0030971; GO:0043123; GO:0043276; GO:0043507; GO:0046330; GO:0060546; GO:0097110; GO:1902443; GO:2000377; GO:2000378; GO:2001234";"angiogenesis [GO:0001525]; anoikis [GO:0043276]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; transforming growth factor beta receptor signaling pathway [GO:0007179]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]";"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
comp97057_c0_seq1;GAXK01149144.1;Q3V0C5;2.75E-120;UBP48_MOUSE;Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific-processing protease 48);"cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0004197; GO:0004843; GO:0005654; GO:0005739; GO:0005829; GO:0006511; GO:0016579; GO:0045121; GO:0045211";"protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211]";"cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]"
comp9706622_c0_seq1;GAXK01010285.1;D4AUF1;3.36E-08;WSCD1_ARTBC;WSC domain-containing protein ARB_07867;extracellular region [GO:0005576];GO:0005576;;extracellular region [GO:0005576];
comp970756_c0_seq1;GAXK01189114.1;Q18192;1.30E-11;NHR31_CAEEL;Nuclear hormone receptor family member nhr-31;"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";"GO:0003700; GO:0003707; GO:0005634; GO:0006970; GO:0008270; GO:0009792; GO:0009886; GO:0043565";"embryo development ending in birth or egg hatching [GO:0009792]; post-embryonic animal morphogenesis [GO:0009886]; response to osmotic stress [GO:0006970]";nucleus [GO:0005634];"DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp9708659_c0_seq1;GAXK01004241.1;Q08DV6;6.14E-16;ASB3_BOVIN;Ankyrin repeat and SOCS box protein 3 (ASB-3);"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";"GO:0016567; GO:0035556";"intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]";;
comp97103_c0_seq1;GAXK01149251.1;Q7RTY0;4.01E-34;MOT13_HUMAN;Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13);"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]";"GO:0000139; GO:0005794; GO:0005887; GO:0008028; GO:0015293; GO:0015718";monocarboxylic acid transport [GO:0015718];"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]";"monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
comp971089_c0_seq1;GAXK01189108.1;D3Z813;1.76E-114;S38AB_RAT;Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11);"integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";"GO:0003333; GO:0006814; GO:0015171; GO:0016021";"amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]";integral component of membrane [GO:0016021];amino acid transmembrane transporter activity [GO:0015171]
comp971169_c0_seq1;GAXK01189113.1;Q8INF0;0;GCY8E_DROME;Soluble guanylate cyclase 88E (EC 4.6.1.2);"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";"GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026";"cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]";guanylate cyclase complex, soluble [GO:0008074];"carbon monoxide binding [GO:0070025]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
comp9712_c5_seq1;GAXK01014127.1;P51400;2.73E-115;RED1_RAT;Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase);"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]";"GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0030336; GO:0042803; GO:0044387; GO:0045070; GO:0046872; GO:0050685; GO:0051726";"adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]";"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
comp971394_c0_seq1;GAXK01189139.1;Q8N988;1.53E-07;ZN557_HUMAN;Zinc finger protein 557;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9715_c0_seq1;GAXK01013343.1;Q08DB5;1.05E-99;STX5_BOVIN;Syntaxin-5;"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0047485; GO:0048278; GO:0090166; GO:1903358";"early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]";"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]";"protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]"
comp97165_c1_seq1;GAXK01149598.1;Q9BV94;0;EDEM2_HUMAN;ER degradation-enhancing alpha-mannosidase-like protein 2;"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]";"GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0006986; GO:0016020; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904382";"mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]";"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"
comp9716606_c0_seq1;GAXK01179975.1;P52076;9.37E-10;QSEB_ECOLI;Transcriptional regulatory protein QseB;"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; transcription, DNA-templated [GO:0006351]";"GO:0000160; GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0010038";"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; transcription, DNA-templated [GO:0006351]";cytoplasm [GO:0005737];DNA binding [GO:0003677]
comp97188_c0_seq1;GAXK01149222.1;Q5VZY2;2.78E-54;PLPP4_HUMAN;Phospholipid phosphatase 4 (EC 3.1.3.4) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A);"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; blastocyst hatching [GO:0001835]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";"GO:0001835; GO:0005886; GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0038096; GO:0042802; GO:0046839";"blastocyst hatching [GO:0001835]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]";"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]"
comp9720_c1_seq1;GAXK01013951.1;P06603;1.61E-138;TBA1_DROME;Tubulin alpha-1 chain;"astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]";"GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0019730; GO:0032418; GO:0048471";"antimicrobial humoral response [GO:0019730]; lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]";"astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp972252_c0_seq1;GAXK01069204.1;Q63344;1.45E-09;MOT2_RAT;Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7);"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]";"GO:0005737; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035873; GO:0035879; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098978; GO:0099061; GO:1901475";"lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]";"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]"
comp972255_c0_seq1;GAXK01069220.1;Q2M3R5;5.53E-20;S35G1_HUMAN;Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20);"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]";"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp97242_c0_seq1;GAXK01149263.1;Q5R9W4;9.82E-125;OSBL9_PONAB;Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9);"Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; lipid transport [GO:0006869]";"GO:0005794; GO:0006869; GO:0008289; GO:0031902";lipid transport [GO:0006869];"Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]";lipid binding [GO:0008289]
comp972443_c0_seq1;GAXK01069208.1;Q2KIT4;1.50E-20;DNJB4_BOVIN;DnaJ homolog subfamily B member 4;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0051082; GO:0051085; GO:0051087";"chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
comp972630_c0_seq1;GAXK01069221.1;A0A126GUP6;9.95E-36;MP1_DROME;Melanization protease 1 (EC 3.4.21.-);"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";"GO:0004175; GO:0004252; GO:0006508; GO:0009620; GO:0035006; GO:0046872";"melanization defense response [GO:0035006]; proteolysis [GO:0006508]; response to fungus [GO:0009620]";;"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp97264_c0_seq1;GAXK01149365.1;Q9QXV3;7.49E-33;ING1_MOUSE;Inhibitor of growth protein 1;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]";"GO:0005634; GO:0006606; GO:0007049; GO:0008285; GO:0010941; GO:0035064; GO:0045893; GO:0046872";"cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]";nucleus [GO:0005634];"metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
comp9727_c3_seq1;GAXK01013952.1;Q5ZMM1;1.39E-168;RIOX1_CHICK;Ribosomal oxygenase 1 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66);"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0016706; GO:0032453; GO:0034720; GO:0045668; GO:0045892; GO:0051864; GO:0070544";"histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]";"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]"
comp97270_c1_seq1;GAXK01149307.1;Q9UKV8;0;AGO2_HUMAN;Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer);"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904";"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]";"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]";"core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"
comp97289_c0_seq1;GAXK01149336.1;Q2YD98;1.96E-33;UVSSA_HUMAN;UV-stimulated scaffold protein A;"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase II complex binding [GO:0000993]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]";"GO:0000993; GO:0005654; GO:0005694; GO:0006283; GO:0009411; GO:0016567";"protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]";"chromosome [GO:0005694]; nucleoplasm [GO:0005654]";RNA polymerase II complex binding [GO:0000993]
comp97297_c0_seq1;GAXK01149527.1;B0BNE5;5.12E-97;ESTD_RAT;S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D);"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]";"GO:0005829; GO:0018738; GO:0031410; GO:0046294; GO:0052689";formaldehyde catabolic process [GO:0046294];"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]";"carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]"
comp973100_c0_seq1;GAXK01069206.1;B3MFV7;8.45E-32;LPHN_DROAN;Latrophilin Cirl;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]";"GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246";cell surface receptor signaling pathway [GO:0007166];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]"
comp973220_c0_seq1;GAXK01069210.1;Q12901;1.56E-07;ZN155_HUMAN;Zinc finger protein 155;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]";"GO:0003677; GO:0003700; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp97348_c0_seq1;GAXK01205826.1;P15330;8.64E-118;DORS_DROME;Embryonic polarity protein dorsal;"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212";"dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]";"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp97362_c0_seq1;GAXK01149424.1;Q9PVG3;3.45E-12;RESTB_XENLA;RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"GO:0000381; GO:0000981; GO:0001666; GO:0003676; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872";"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp97366_c8_seq1;GAXK01149195.1;P0DN66;1.25E-21;ACTP1_CINAN;Tereporin-Ca1 (Actinoporin-like protein) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"GO:0005576; GO:0006811; GO:0016021; GO:0044179; GO:0044218; GO:0090729";"hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]";"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp973734_c0_seq1;GAXK01069202.1;P05434;1.82E-14;CATR_CHLRE;Caltractin (20 kDa calcium-binding protein) (Centrin);"inner dynein arm [GO:0036156]; calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]; cell cycle [GO:0007049]; cell division [GO:0051301]";"GO:0005509; GO:0007049; GO:0036156; GO:0045504; GO:0051301";"cell cycle [GO:0007049]; cell division [GO:0051301]";inner dynein arm [GO:0036156];"calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]"
comp9738364_c0_seq1;GAXK01195681.1;Q8GZ26;1.94E-32;BRN2L_ARATH;RNA-binding protein BRN2 (Protein BRUNO-LIKE 2) (AtBRN2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; flower development [GO:0009908]; mRNA catabolic process [GO:0006402]; photoperiodism, flowering [GO:0048573]; regulation of photoperiodism, flowering [GO:2000028]";"GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0009908; GO:0048573; GO:1990904; GO:2000028";"flower development [GO:0009908]; mRNA catabolic process [GO:0006402]; photoperiodism, flowering [GO:0048573]; regulation of photoperiodism, flowering [GO:2000028]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]";"mRNA binding [GO:0003729]; RNA binding [GO:0003723]"
comp9738375_c0_seq1;GAXK01195682.1;Q9VDH6;6.28E-11;IR93A_DROME;Ionotropic receptor 93a;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"GO:0005886; GO:0007610; GO:0008066; GO:0015276; GO:0016021; GO:0035249; GO:0045211; GO:0050804; GO:0050907; GO:1904315";"behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]";"glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
comp97431_c1_seq1;GAXK01149258.1;Q90655;4.35E-29;AKR_CHICK;Homeobox protein AKR (Avian knotted-related protein);"nucleus [GO:0005634]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0003677; GO:0005634; GO:0045892";negative regulation of transcription, DNA-templated [GO:0045892];nucleus [GO:0005634];DNA binding [GO:0003677]
comp97459_c0_seq1;GAXK01149309.1;Q99M85;1.13E-79;SCRT1_MOUSE;Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt);"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222";"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]";"nuclear body [GO:0016604]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp97477_c0_seq1;GAXK01149522.1;Q6DIB4;3.02E-57;NOL4L_MOUSE;Nucleolar protein 4-like;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"GO:0005654; GO:0005829";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";
comp975006_c0_seq1;GAXK01081090.1;P80960;1.43E-28;HCY2A_RAPVE;Hemocyanin type 2 unit a (Hemocyanin RHSS2 subunit) (Hemocyanin Rta) (Hemocyanin heavy structural subunit) (RtH2-a);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]";"GO:0005344; GO:0005615; GO:0016491; GO:0046872";;extracellular space [GO:0005615];"metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]"
comp975011_c0_seq1;GAXK01081101.1;P23612;1.09E-104;SYWC_RABIT;"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]";"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"GO:0001525; GO:0004830; GO:0005524; GO:0005737; GO:0006436";"angiogenesis [GO:0001525]; tryptophanyl-tRNA aminoacylation [GO:0006436]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]"
comp975211_c0_seq1;GAXK01081097.1;O46040;1.02E-19;MSTAA_DROME;SET domain-containing protein SmydA-8, isoform A (EC 2.1.1.-);"nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";"GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826";"histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]";nuclear chromatin [GO:0000790];"histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
comp97527_c0_seq1;GAXK01149221.1;Q80Z37;2.07E-46;TOPRS_MOUSE;E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3);"centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0032391; GO:0034504; GO:0036064; GO:0042127; GO:0042771; GO:0043161; GO:0044547; GO:0045893; GO:0046872; GO:0051443; GO:0051457; GO:0061630; GO:0070936";"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; ubiquitin-dependent protein catabolic process [GO:0006511]";"centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]";"antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp97539_c3_seq1;GAXK01149530.1;Q6F754;1.54E-83;GBTR_ACIAD;Glycine betaine transporter;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; nitrogen compound transport [GO:0071705]";"GO:0005886; GO:0016021; GO:0022857; GO:0071705";nitrogen compound transport [GO:0071705];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp9754404_c0_seq1;GAXK01067229.1;P29013;5.73E-47;YCGB_ECOLI;Uncharacterized protein YcgB;cellular response to DNA damage stimulus [GO:0006974];GO:0006974;cellular response to DNA damage stimulus [GO:0006974];;
comp975666_c0_seq1;GAXK01081107.1;Q5F364;8.86E-45;MRP1_CHICK;Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter);"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]";"GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085";transmembrane transport [GO:0055085];"basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]";"ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]"
comp975856_c0_seq1;GAXK01081088.1;Q64237;8.67E-127;DOPO_MOUSE;Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase];"apical part of cell [GO:0045177]; axon [GO:0030424]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; varicosity [GO:0043196]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine metabolic process [GO:0046333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; visual learning [GO:0008542]";"GO:0001816; GO:0001974; GO:0001975; GO:0002443; GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005783; GO:0005815; GO:0006589; GO:0007613; GO:0007626; GO:0008306; GO:0008542; GO:0016021; GO:0016715; GO:0030424; GO:0030425; GO:0030658; GO:0030667; GO:0031410; GO:0031418; GO:0034466; GO:0034774; GO:0042127; GO:0042309; GO:0042420; GO:0042421; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0043025; GO:0043195; GO:0043196; GO:0043231; GO:0045177; GO:0045202; GO:0045907; GO:0046333; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:2001236";"associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine metabolic process [GO:0046333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; visual learning [GO:0008542]";"apical part of cell [GO:0045177]; axon [GO:0030424]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; varicosity [GO:0043196]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp97588_c0_seq1;GAXK01149297.1;Q9DGG6;3.52E-114;ADCY9_CHICK;Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]";"GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880";"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"
comp97591_c0_seq1;GAXK01149397.1;Q7KTX8;2.78E-156;MED13_DROME;Mediator of RNA polymerase II transcription subunit 13 (Mediator complex subunit 13) (Mediator complex subunit Skuld) (Protein blind spot) (Protein poils aux pattes) (dTRAP240);"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg segmentation [GO:0036011]; larval somatic muscle development [GO:0007526]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wing disc dorsal/ventral pattern formation [GO:0048190]";"GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0007526; GO:0016592; GO:0022416; GO:0036011; GO:0045165; GO:0045498; GO:0048190; GO:0048749; GO:0070847; GO:0090263";"cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg segmentation [GO:0036011]; larval somatic muscle development [GO:0007526]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wing disc dorsal/ventral pattern formation [GO:0048190]";"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";transcription coregulator activity [GO:0003712]
comp9759207_c0_seq1;GAXK01077784.1;Q9ZD61;1.17E-51;ISCU_RICPR;Iron-sulfur cluster assembly scaffold protein IscU (Sulfur acceptor protein IscU);"iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]";"GO:0005506; GO:0016226; GO:0051536";iron-sulfur cluster assembly [GO:0016226];;"iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]"
comp976_c2_seq1;GAXK01168756.1;P23787;0;TERA_XENLA;Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP);"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0018279; GO:0019985; GO:0030433; GO:0032510; GO:0034214; GO:0034605; GO:0035617; GO:0035861; GO:0036503; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843";"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]";"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]"
comp9764305_c0_seq1;GAXK01029259.1;P45778;2.16E-10;GSPD_AERSA;Secretin ExeD (General secretion pathway protein D) (Type II secretion system protein D) (T2SS protein D);"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; type II protein secretion system complex [GO:0015627]; protein secretion by the type II secretion system [GO:0015628]";"GO:0009279; GO:0015627; GO:0015628; GO:0016021";protein secretion by the type II secretion system [GO:0015628];"cell outer membrane [GO:0009279]; integral component of membrane [GO:0016021]; type II protein secretion system complex [GO:0015627]";
comp976516_c0_seq1;GAXK01023743.1;Q16YG0;2.48E-76;CDC42_AEDAE;Cdc42 homolog;"adherens junction [GO:0005912]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]";"GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0007264; GO:0007275; GO:0045185; GO:0045860";"maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]";"adherens junction [GO:0005912]; plasma membrane [GO:0005886]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp97658_c1_seq1;GAXK01149145.1;Q7KRI2;1.18E-27;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp9765870_c0_seq1;GAXK01029258.1;Q9Y244;5.81E-07;POMP_HUMAN;Proteasome maturation protein (Proteassemblin) (Protein UMP1 homolog) (hUMP1) (Voltage-gated K channel beta subunit 4.1);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; organelle membrane [GO:0031090]; proteasome assembly [GO:0043248]";"GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0016607; GO:0031090; GO:0043248";proteasome assembly [GO:0043248];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; organelle membrane [GO:0031090]";
comp97660_c2_seq1;GAXK01149243.1;Q54DY9;1.01E-29;BCS1B_DICDI;Probable mitochondrial chaperone BCS1-B (BCS1-like protein 2);"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"GO:0005524; GO:0005739; GO:0005743; GO:0008320; GO:0016021; GO:0034551; GO:0051131";"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial respiratory chain complex III assembly [GO:0034551]";"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; protein transmembrane transporter activity [GO:0008320]"
comp976681_c0_seq1;GAXK01023766.1;Q13332;5.45E-08;PTPRS_HUMAN;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma);"axon [GO:0030424]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]";"GO:0004721; GO:0004725; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0010977; GO:0021510; GO:0021549; GO:0021766; GO:0021987; GO:0022038; GO:0030054; GO:0030285; GO:0030424; GO:0030517; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0050804; GO:0061000; GO:0070062; GO:0090557; GO:0098685; GO:0098978; GO:0099056; GO:0099061; GO:0099151; GO:0099560";"cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]";"axon [GO:0030424]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]";"chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]"
comp9768894_c0_seq1;GAXK01146701.1;P48027;1.11E-21;GACS_PSESY;Sensor protein GacS (EC 2.7.13.3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]";"GO:0000155; GO:0005524; GO:0005886; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]"
comp97693_c0_seq1;GAXK01149400.1;Q9VH19;0;LMLN_DROME;Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin);"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"GO:0004222; GO:0005737; GO:0006338; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0031252; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:1902769";"brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]";"cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]";"metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]"
comp97705_c0_seq1;GAXK01205824.1;Q8K1J6;1.10E-132;TRNT1_MOUSE;CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]";"GO:0000049; GO:0001680; GO:0005524; GO:0005739; GO:0008033; GO:0009022; GO:0052927; GO:0052928; GO:0052929; GO:1990180";"mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]";mitochondrion [GO:0005739];"ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; ATP binding [GO:0005524]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]"
comp97712_c1_seq1;GAXK01149512.1;Q90744;1.39E-149;NAGAB_CHICK;Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B);"cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477";"glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]";"cytoplasm [GO:0005737]; lysosome [GO:0005764]";"alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]"
comp977420_c0_seq1;GAXK01023760.1;P23381;7.82E-28;SYWC_HUMAN;"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062";"angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]";"ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]"
comp97746_c1_seq1;GAXK01149599.1;Q09788;4.81E-13;ASL1_SCHPO;Alkali-sensitive linkage protein 1;"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; fungal-type cell wall polysaccharide metabolic process [GO:0071966]";"GO:0004553; GO:0005576; GO:0005783; GO:0005794; GO:0009277; GO:0010339; GO:0071966";fungal-type cell wall polysaccharide metabolic process [GO:0071966];"endoplasmic reticulum [GO:0005783]; external side of cell wall [GO:0010339]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; Golgi apparatus [GO:0005794]";hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp977665_c0_seq1;GAXK01023742.1;Q9NRA2;3.00E-19;S17A5_HUMAN;Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter);"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672";"amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]";"cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]";"carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]"
comp97768_c0_seq1;GAXK01149528.1;Q7ZYJ9;2.12E-120;AASDB_XENLA;Alanyl-tRNA editing protein Aarsd1-B (Alanyl-tRNA synthetase domain-containing protein 1-B);"cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; alanyl-tRNA aminoacylation [GO:0006419]";"GO:0003676; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0046872";alanyl-tRNA aminoacylation [GO:0006419];cytoplasm [GO:0005737];"alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
comp9779_c0_seq1;GAXK01013450.1;Q9WTY4;6.53E-34;AQP5_MOUSE;Aquaporin-5 (AQP-5);"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; water channel activity [GO:0015250]; camera-type eye morphogenesis [GO:0048593]; carbon dioxide transport [GO:0015670]; cellular hypotonic response [GO:0071476]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; protein homotetramerization [GO:0051289]; saliva secretion [GO:0046541]; water transport [GO:0006833]";"GO:0005783; GO:0005886; GO:0005887; GO:0005902; GO:0006833; GO:0009925; GO:0015250; GO:0015670; GO:0016021; GO:0016324; GO:0030157; GO:0030659; GO:0042476; GO:0042802; GO:0046541; GO:0048593; GO:0051289; GO:0071476";"camera-type eye morphogenesis [GO:0048593]; carbon dioxide transport [GO:0015670]; cellular hypotonic response [GO:0071476]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; protein homotetramerization [GO:0051289]; saliva secretion [GO:0046541]; water transport [GO:0006833]";"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]";"identical protein binding [GO:0042802]; water channel activity [GO:0015250]"
comp97791_c0_seq1;GAXK01149515.1;P97570;4.41E-167;PLPL9_RAT;85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9);"cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]";"GO:0001934; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005743; GO:0005815; GO:0005829; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016042; GO:0017171; GO:0019731; GO:0019901; GO:0032049; GO:0034976; GO:0035774; GO:0043008; GO:0045921; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102567; GO:0102568; GO:1901339; GO:2000304";"antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]";"cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";"ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"
comp978000_c0_seq1;GAXK01095082.1;Q8BGM5;4.33E-46;BEST2_MOUSE;Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1);"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476";"chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]";"chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]";chloride channel activity [GO:0005254]
comp97801_c0_seq1;GAXK01149213.1;Q90678;4.41E-39;PAFA_CHICK;Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase);"extracellular space [GO:0005615]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]";"GO:0003847; GO:0005615; GO:0016042";lipid catabolic process [GO:0016042];extracellular space [GO:0005615];1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]
comp978013_c0_seq1;GAXK01095098.1;Q29J90;2.57E-49;MOODY_DROPS;G-protein coupled receptor moody;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857";"axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]";"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]";G protein-coupled receptor activity [GO:0004930]
comp978048_c0_seq1;GAXK01095093.1;Q7KRI2;2.65E-20;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp97819_c0_seq1;GAXK01149452.1;Q0IID7;1.17E-80;DUS10_BOVIN;Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]";"GO:0000188; GO:0002819; GO:0004725; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0008432; GO:0010633; GO:0016607; GO:0017017; GO:0032496; GO:0033549; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264";"inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]";"JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]"
comp978194_c0_seq1;GAXK01095052.1;Q91159;1.15E-17;LYSC_OPIHO;Lysozyme C (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C);"extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";"GO:0003796; GO:0005576; GO:0008152; GO:0019835; GO:0042742";"cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]";extracellular region [GO:0005576];lysozyme activity [GO:0003796]
comp97862_c0_seq1;GAXK01149455.1;Q6AZN6;1.48E-176;PK3C3_XENLA;Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3);"midbody [GO:0030496]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465]";"GO:0005524; GO:0006914; GO:0007049; GO:0016303; GO:0030496; GO:0032465; GO:0048015; GO:0051301";"autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465]";midbody [GO:0030496];"1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]"
comp978640_c0_seq1;GAXK01095103.1;Q53LP3;2.23E-11;SWAHC_HUMAN;Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C);;;;;
comp978667_c0_seq1;GAXK01095066.1;P21279;1.05E-84;GNAQ_MOUSE;Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q);"caveola [GO:0005901]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic development [GO:0009791]; protein heterotrimerization [GO:0070208]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]";"GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0005834; GO:0005886; GO:0005901; GO:0006469; GO:0007186; GO:0007188; GO:0007189; GO:0007200; GO:0007202; GO:0007215; GO:0007507; GO:0009791; GO:0016020; GO:0016322; GO:0021884; GO:0030425; GO:0031683; GO:0031826; GO:0031965; GO:0032991; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0048661; GO:0050821; GO:0060158; GO:0060828; GO:0070208";"action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; forebrain neuron development [GO:0021884]; glutamate receptor signaling pathway [GO:0007215]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic development [GO:0009791]; protein heterotrimerization [GO:0070208]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]";"caveola [GO:0005901]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; type 2A serotonin receptor binding [GO:0031826]"
comp9787325_c0_seq1;GAXK01180775.1;B4E8V9;4.83E-23;CYSB_BURCJ;HTH-type transcriptional regulator CysB;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]";"GO:0003677; GO:0003700";;;"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]"
comp978785_c0_seq1;GAXK01095062.1;Q9VBY8;3.38E-130;UN13B_DROME;Protein unc-13 homolog 4B (Protein Staccato);"cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]; branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082]";"GO:0005764; GO:0005770; GO:0005856; GO:0007269; GO:0008021; GO:0016082; GO:0030175; GO:0035147; GO:0099503";"branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082]";"cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]";
comp97902_c0_seq1;GAXK01149147.1;P24823;1.49E-109;PPBN_MOUSE;Alkaline phosphatase, germ cell type (EC 3.1.3.1) (Alkaline phosphatase 5) (Alkaline phosphatase, placental-like) (Embryonic alkaline phosphatase) (EAP) (Embryonic-type alkaline phosphatase);"anchored component of membrane [GO:0031225]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]";"GO:0004035; GO:0005886; GO:0030016; GO:0031225; GO:0046872";;"anchored component of membrane [GO:0031225]; myofibril [GO:0030016]; plasma membrane [GO:0005886]";"alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]"
comp97913_c1_seq1;GAXK01149370.1;O08762;3.49E-11;NETR_MOUSE;Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12);"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202";"exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]";"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]";"peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]"
comp97915_c0_seq1;GAXK01149348.1;Q659A1;9.37E-08;ICE2_HUMAN;Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2);"Cajal body [GO:0015030]; cytosol [GO:0005829]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]";"GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035327; GO:0035363; GO:0042795; GO:0042796; GO:0045945";"positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]";"Cajal body [GO:0015030]; cytosol [GO:0005829]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]";
comp97918_c0_seq1;GAXK01149179.1;Q4V7W5;8.70E-21;PHC2_XENLA;Polyhomeotic-like protein 2;"PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]";"GO:0003677; GO:0007275; GO:0008270; GO:0031519; GO:0035102";multicellular organism development [GO:0007275];"PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]";"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp9792_c0_seq1;GAXK01013460.1;Q7Y1W9;7.42E-29;SAP9_ORYSJ;Zinc finger A20 and AN1 domain-containing stress-associated protein 9 (OsSAP9);"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]";"GO:0003677; GO:0008270";;;"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
comp979250_c0_seq1;GAXK01095081.1;Q5R476;5.82E-12;RN111_PONAB;E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (RING-type E3 ubiquitin transferase Arkadia);"cytoplasm [GO:0005737]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"GO:0005737; GO:0006281; GO:0007275; GO:0016567; GO:0016605; GO:0016740; GO:0032184; GO:0046872";"DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]";"cytoplasm [GO:0005737]; PML body [GO:0016605]";"metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; transferase activity [GO:0016740]"
comp97933_c0_seq1;GAXK01149402.1;Q8NCC3;1.60E-81;PAG15_HUMAN;Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2);"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006672; GO:0008374; GO:0009062; GO:0016020; GO:0034638; GO:0043231; GO:0046338; GO:0047499; GO:0070062";"ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]";"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]";"calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]"
comp97953_c0_seq1;GAXK01149340.1;Q04499;0;PROD_DROME;Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Protein sluggish-A);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"GO:0004657; GO:0005739; GO:0005759; GO:0006537; GO:0006562; GO:0007626; GO:0010133; GO:0042331; GO:0071949";"glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]"
comp9796_c5_seq1;GAXK01014344.1;Q9V0N0;8.29E-44;PANE_PYRAB;Putative 2-dehydropantoate 2-reductase (EC 1.1.1.169) (Ketopantoate reductase) (KPA reductase) (KPR);"cytoplasm [GO:0005737]; 2-dehydropantoate 2-reductase activity [GO:0008677]; pantothenate biosynthetic process [GO:0015940]";"GO:0005737; GO:0008677; GO:0015940";pantothenate biosynthetic process [GO:0015940];cytoplasm [GO:0005737];2-dehydropantoate 2-reductase activity [GO:0008677]
comp979627_c0_seq1;GAXK01095074.1;P14404;3.41E-07;MECOM_MOUSE;Histone-lysine N-methyltransferase MECOM (EC 2.1.1.43) (Ecotropic virus integration site 1 protein) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein homolog);"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"GO:0000977; GO:0001228; GO:0001701; GO:0001780; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0006954; GO:0009617; GO:0009791; GO:0016607; GO:0030154; GO:0030900; GO:0035115; GO:0035116; GO:0042127; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0060039; GO:0070828; GO:0071425; GO:0072197; GO:0090336; GO:0098727";"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; forebrain development [GO:0030900]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; inflammatory response [GO:0006954]; in utero embryonic development [GO:0001701]; maintenance of cell number [GO:0098727]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil homeostasis [GO:0001780]; pericardium development [GO:0060039]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617]; ureter morphogenesis [GO:0072197]";"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp9797_c0_seq1;GAXK01013275.1;P54385;0;DHE3_DROME;Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0019551; GO:0042802";"glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp979741_c0_seq1;GAXK01095061.1;Q3U4G3;1.95E-21;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp98_c0_seq1;GAXK01168670.1;Q94613;5.55E-62;RS19_MYAAR;40S ribosomal protein S19;"ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005840; GO:0006412";translation [GO:0006412];ribosome [GO:0005840];structural constituent of ribosome [GO:0003735]
comp980030_c1_seq1;GAXK01015882.1;A8MT65;1.42E-19;ZN891_HUMAN;Zinc finger protein 891;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp98005_c0_seq1;GAXK01076501.1;Q01664;1.47E-36;TFAP4_HUMAN;Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41);"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000790; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005739; GO:0006357; GO:0006978; GO:0008285; GO:0017053; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0044212; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071157; GO:0071549; GO:1901990; GO:2001269";"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]";"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]"
comp980188_c0_seq1;GAXK01015902.1;A0A0B4K692;1.87E-82;NEP2_DROME;Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form];"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]";"GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872";"proteolysis [GO:0006508]; sperm competition [GO:0046692]";"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
comp98023_c0_seq1;GAXK01076372.1;Q7TQK0;5.04E-107;CCNT2_MOUSE;Cyclin-T2 (CycT2);"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]";"GO:0001223; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006351; GO:0006357; GO:0007049; GO:0007519; GO:0008024; GO:0016538; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322";"cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]";"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";"7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]"
comp98030_c3_seq1;GAXK01076714.1;C0HLA0;9.82E-42;GH5FP_CHAOB;Glycosyl hydrolase 5 family protein (EC 3.2.1.-) (allergen Cha o 3);"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]";"GO:0004553; GO:0005975";carbohydrate metabolic process [GO:0005975];;hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]
comp98041_c1_seq1;GAXK01076371.1;Q8BGG7;5.93E-118;UBS3B_MOUSE;Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]";"GO:0004725; GO:0005634; GO:0005737; GO:0006469; GO:0009968; GO:0016791; GO:0030168; GO:0031625; GO:0035335; GO:0038063; GO:0038065; GO:0042802; GO:0043393; GO:0045670; GO:0045671; GO:0045779; GO:0051219; GO:0051279; GO:0070527; GO:0090331";"collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]"
comp9805_c1_seq1;GAXK01013778.1;Q5M939;7.32E-110;HAT1_RAT;Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1);"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; response to nutrient [GO:0007584]";"GO:0000781; GO:0000790; GO:0005654; GO:0006335; GO:0006336; GO:0006348; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043967";"chromatin silencing at telomere [GO:0006348]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; response to nutrient [GO:0007584]";"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]";"H4 histone acetyltransferase activity [GO:0010485]; histone binding [GO:0042393]"
comp980666_c0_seq1;GAXK01015898.1;A9ZSY2;6.17E-65;TRET1_APILI;Facilitated trehalose transporter Tret1 (AmTRET1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp980687_c0_seq1;GAXK01015879.1;Q9VT04;7.48E-38;PATH_DROME;Proton-coupled amino acid transporter-like protein pathetic;"axon [GO:0030424]; dendrite [GO:0030425]; endolysosome [GO:0036019]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transmembrane transport [GO:0003333]; dendrite extension [GO:0097484]; dendrite morphogenesis [GO:0048813]; regulation of cell projection size [GO:0032536]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing size [GO:0044719]";"GO:0003333; GO:0005765; GO:0005886; GO:0015171; GO:0016021; GO:0030424; GO:0030425; GO:0031902; GO:0032536; GO:0036019; GO:0040008; GO:0043025; GO:0043204; GO:0044719; GO:0048813; GO:0097484";"amino acid transmembrane transport [GO:0003333]; dendrite extension [GO:0097484]; dendrite morphogenesis [GO:0048813]; regulation of cell projection size [GO:0032536]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing size [GO:0044719]";"axon [GO:0030424]; dendrite [GO:0030425]; endolysosome [GO:0036019]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]";amino acid transmembrane transporter activity [GO:0015171]
comp9807350_c0_seq1;GAXK01119420.1;P10076;4.90E-09;ZFP26_MOUSE;Zinc finger protein 26 (Zfp-26) (Protein mKR3);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp98082_c0_seq1;GAXK01076616.1;O18531;9.55E-91;ECR_LUCCU;Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1);"nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]";"GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565";ecdysone receptor-mediated signaling pathway [GO:0035076];nucleus [GO:0005634];"ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
comp980850_c1_seq1;GAXK01015870.1;O01404;3.81E-45;PHM_DROME;Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3);"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0005615; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719";"memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]";"copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]"
comp98089_c1_seq1;GAXK01076654.1;Q5M7F6;1.21E-82;WDR92_XENLA;WD repeat-containing protein 92;apoptotic process [GO:0006915];GO:0006915;apoptotic process [GO:0006915];;
comp981_c1_seq1;GAXK01165940.1;Q24654;9.65E-54;MLC1_DROSI;Myosin light chain alkali;"muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]";"GO:0005509; GO:0005859; GO:0007498";mesoderm development [GO:0007498];muscle myosin complex [GO:0005859];calcium ion binding [GO:0005509]
comp981184_c0_seq1;GAXK01015869.1;Q6VFT6;5.61E-34;FOXL2_PIG;Forkhead box protein L2;"intercellular bridge [GO:0045171]; nucleus [GO:0005634]; cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; ubiquitin conjugating enzyme binding [GO:0031624]; anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]";"GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0043280; GO:0043565; GO:0045171; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014";"anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]";"intercellular bridge [GO:0045171]; nucleus [GO:0005634]";"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; ubiquitin conjugating enzyme binding [GO:0031624]"
comp9815_c0_seq1;GAXK01013471.1;Q91YN5;0;UAP1_MOUSE;"UDP-N-acetylhexosamine pyrophosphorylase [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23)]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006047; GO:0006048; GO:0030246; GO:0042802";"UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]";"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]";"carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]"
comp981529_c0_seq1;GAXK01015872.1;Q5R9S8;1.74E-18;TMM43_PONAB;Transmembrane protein 43 (Protein LUMA);"endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; protein self-association [GO:0043621]; nuclear membrane organization [GO:0071763]";"GO:0005639; GO:0005788; GO:0005794; GO:0043621; GO:0071763";nuclear membrane organization [GO:0071763];"endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]";protein self-association [GO:0043621]
comp98167_c1_seq1;GAXK01076675.1;A2AG06;4.59E-28;MEIOC_MOUSE;Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192";"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";
comp981693_c1_seq1;GAXK01015899.1;P42787;6.31E-66;CBPD_DROME;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver);"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"GO:0001933; GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471";"imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]";"endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]";"carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]"
comp981767_c0_seq1;GAXK01015883.1;Q68F62;1.01E-22;MP17L_XENLA;Mpv17-like protein;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";"GO:0005778; GO:0016021";;"integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]";
comp981783_c0_seq1;GAXK01015907.1;Q8NET6;2.60E-20;CHSTD_HUMAN;Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3);"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756";"carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";"chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
comp981829_c0_seq1;GAXK01015906.1;Q4V8E5;2.62E-60;MFSD3_RAT;Major facilitator superfamily domain-containing protein 3;"integral component of plasma membrane [GO:0005887]; solute:proton symporter activity [GO:0015295]";"GO:0005887; GO:0015295";;integral component of plasma membrane [GO:0005887];solute:proton symporter activity [GO:0015295]
comp98184_c0_seq1;GAXK01076568.1;O42260;9.88E-38;GEMI2_XENLA;Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1);"cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]";"GO:0000245; GO:0000387; GO:0005681; GO:0005829; GO:0032797; GO:0034719; GO:0097504";"spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]";"cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]";
comp9823_c8_seq1;GAXK01014241.1;P27701;3.61E-14;CD82_HUMAN;CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82);"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"GO:0005886; GO:0005887; GO:0070062";;"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";
comp98234_c0_seq1;GAXK01076750.1;P00765;8.55E-60;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp982516_c1_seq1;GAXK01163748.1;Q96PE6;3.64E-18;ZIM3_HUMAN;Zinc finger imprinted 3 (Zinc finger protein 657);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9826_c0_seq1;GAXK01014070.1;P0C6T1;6.79E-26;CTF8_RAT;Chromosome transmission fidelity protein 8 homolog;"Ctf18 RFC-like complex [GO:0031390]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"GO:0003689; GO:0005634; GO:0006260; GO:0007064; GO:0017116; GO:0031390; GO:1900264";"DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]";"Ctf18 RFC-like complex [GO:0031390]; nucleus [GO:0005634]";"DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]"
comp982623_c0_seq1;GAXK01163784.1;Q9NS85;8.55E-56;CAH10_HUMAN;Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X) (Cerebral protein 15);"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; brain development [GO:0007420]";"GO:0004089; GO:0007420; GO:0008270";brain development [GO:0007420];;"carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
comp982771_c1_seq1;GAXK01163755.1;A7MCT6;1.12E-13;EKI2_MOUSE;Ethanolamine kinase 2 (EKI 2) (EC 2.7.1.82) (Ethanolamine kinase-like protein);"ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; CDP-choline pathway [GO:0006657]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310]; placenta development [GO:0001890]; post-embryonic development [GO:0009791]";"GO:0001701; GO:0001890; GO:0004305; GO:0005524; GO:0006646; GO:0006657; GO:0009791; GO:0016310; GO:0035264";"CDP-choline pathway [GO:0006657]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310]; placenta development [GO:0001890]; post-embryonic development [GO:0009791]";;"ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]"
comp9828_c1_seq1;GAXK01014634.1;Q5RBA5;4.67E-20;SQSTM_PONAB;Sequestosome-1 (Ubiquitin-binding protein p62);"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"GO:0000932; GO:0002376; GO:0005080; GO:0005764; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0035973; GO:0042169; GO:0043122; GO:0043130; GO:0061912; GO:0070530; GO:1905719";"aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; selective autophagy [GO:0061912]";"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; P-body [GO:0000932]; PML body [GO:0016605]; sarcomere [GO:0030017]";"K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]"
comp982882_c0_seq1;GAXK01163737.1;Q5ZLK5;7.99E-31;P4HA2_CHICK;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]";"GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418";peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401];"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]";"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
comp98296_c0_seq1;GAXK01076573.1;Q9NWZ3;4.68E-16;IRAK4_HUMAN;Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]";"GO:0000287; GO:0001816; GO:0002224; GO:0002446; GO:0002755; GO:0004672; GO:0004674; GO:0005149; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007254; GO:0010008; GO:0019221; GO:0034162; GO:0035556; GO:0043123; GO:0045087; GO:0048661; GO:0051092; GO:0070498; GO:1990266";"cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]";"ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp9831_c0_seq1;GAXK01013945.1;Q05975;6.72E-134;RAB2_LYMST;Ras-related protein Rab-2;"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0015031; GO:0016192; GO:0033116";"protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]";"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp983148_c0_seq1;GAXK01163757.1;Q9VVI3;6.00E-71;NEDD4_DROME;E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4);"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:1905062; GO:1905306; GO:2000650";"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]";"myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp98323_c0_seq1;GAXK01076491.1;P60330;1.31E-49;ESPL1_MOUSE;Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase);"centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]";"GO:0000070; GO:0000212; GO:0000278; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0007059; GO:0007127; GO:0008233; GO:0008234; GO:0045143; GO:0051307; GO:0072686";"chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]";"centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]"
comp983643_c0_seq1;GAXK01163768.1;Q86WI1;7.00E-49;PKHL1_HUMAN;Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1);"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]";"GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023";immune response [GO:0006955];"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]";signaling receptor activity [GO:0038023]
comp98366_c0_seq1;GAXK01076804.1;P52403;4.36E-31;CHI1_SOLTU;Endochitinase 1 (EC 3.2.1.14) (Fragment);"vacuole [GO:0005773]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005773; GO:0006032; GO:0006952; GO:0008061; GO:0016998";"cell wall macromolecule catabolic process [GO:0016998]; chitin catabolic process [GO:0006032]; defense response [GO:0006952]; polysaccharide catabolic process [GO:0000272]";vacuole [GO:0005773];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp9837_c0_seq1;GAXK01014156.1;Q8BW74;9.71E-38;HLF_MOUSE;Hepatic leukemia factor;"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]";"GO:0000977; GO:0001228; GO:0005634; GO:0035914; GO:0043565; GO:0045944; GO:0048511";"positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]";nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
comp98370_c4_seq1;GAXK01076621.1;Q9NJG9;6.50E-08;SUZ12_DROME;Polycomb protein Su(z)12 (Suppressor 12 of zeste protein);"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"GO:0000790; GO:0003677; GO:0005634; GO:0016458; GO:0016571; GO:0016586; GO:0022008; GO:0031490; GO:0034968; GO:0035097; GO:0035098; GO:0045892; GO:0046872; GO:0070734; GO:2001229";"gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of response to gamma radiation [GO:2001229]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]";"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]";"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp9838_c1_seq1;GAXK01014504.1;Q3ZC84;0;CNDP2_BOVIN;Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2);"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0004180; GO:0005654; GO:0005829; GO:0008237; GO:0046872; GO:0102008; GO:0103046";;"cytosol [GO:0005829]; nucleoplasm [GO:0005654]";"alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp983880_c0_seq1;GAXK01163745.1;Q6GPI1;2.89E-44;CTRB2_HUMAN;"Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"GO:0004252; GO:0005576; GO:0005615; GO:0007586; GO:0009235; GO:0022617";"cobalamin metabolic process [GO:0009235]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]";"extracellular region [GO:0005576]; extracellular space [GO:0005615]";serine-type endopeptidase activity [GO:0004252]
comp984116_c0_seq1;GAXK01075826.1;P37276;3.11E-19;DYHC_DROME;Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC);"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity, coupled [GO:0042623]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0042623; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045503; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904";"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]";"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]";"ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"
comp984124_c0_seq1;GAXK01075752.1;A5DIX5;1.13E-14;ROK1_PICGU;ATP-dependent RNA helicase ROK1 (EC 3.6.4.13);"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]";"GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364";rRNA processing [GO:0006364];nucleolus [GO:0005730];"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
comp984177_c0_seq1;GAXK01075794.1;P38672;5.74E-57;IF5A_NEUCR;Eukaryotic translation initiation factor 5A (eIF-5A) (eIF-4D);"cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";"GO:0003746; GO:0005737; GO:0006452; GO:0043022; GO:0045901; GO:0045905";"positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]";cytoplasm [GO:0005737];"ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]"
comp9843403_c0_seq1;GAXK01146870.1;P22118;1.13E-23;GYRB_NEIGO;DNA gyrase subunit B (EC 5.6.2.2);"chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]; DNA-dependent DNA replication [GO:0006261]";"GO:0003677; GO:0003918; GO:0005524; GO:0005694; GO:0005737; GO:0006261; GO:0006265; GO:0046872";"DNA-dependent DNA replication [GO:0006261]; DNA topological change [GO:0006265]";"chromosome [GO:0005694]; cytoplasm [GO:0005737]";"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"
comp984994_c1_seq1;GAXK01075831.1;Q8CEE7;1.74E-26;RDH13_MOUSE;Retinol dehydrogenase 13 (EC 1.1.1.300);"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650";"eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]";"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]";NADP-retinol dehydrogenase activity [GO:0052650]
comp98509_c0_seq1;GAXK01076613.1;P49455;4.30E-10;TPM4_DROME;Tropomyosin-1, isoforms 33/34 (Tropomyosin II);"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; P granule [GO:0043186]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; kinesin binding [GO:0019894]; actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]";"GO:0003779; GO:0005829; GO:0005884; GO:0006936; GO:0007015; GO:0007315; GO:0010591; GO:0019894; GO:0030017; GO:0043149; GO:0043186; GO:0045451; GO:0048477; GO:0048813; GO:0051015; GO:0055093; GO:0070865";"actin filament organization [GO:0007015]; dendrite morphogenesis [GO:0048813]; muscle contraction [GO:0006936]; oogenesis [GO:0048477]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of lamellipodium assembly [GO:0010591]; response to hyperoxia [GO:0055093]; stress fiber assembly [GO:0043149]";"actin filament [GO:0005884]; cytosol [GO:0005829]; investment cone [GO:0070865]; P granule [GO:0043186]; sarcomere [GO:0030017]";"actin binding [GO:0003779]; actin filament binding [GO:0051015]; kinesin binding [GO:0019894]"
comp985313_c0_seq1;GAXK01075807.1;Q9NTW7;1.97E-14;ZF64B_HUMAN;Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp985374_c0_seq1;GAXK01075835.1;Q5SW96;1.67E-39;ARH_HUMAN;Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein);"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030665; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0061024; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602";"amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]";"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]";"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex adaptor activity [GO:0030159]; signaling adaptor activity [GO:0035591]"
comp9854846_c0_seq1;GAXK01152147.1;Q6DTN4;2.39E-18;HYUC_RHIML;N-carbamoyl-L-amino-acid hydrolase (EC 3.5.1.87) (Hydantoin utilization protein C) (L-N-carbamoylase);"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; N-carbamoyl-L-amino-acid hydrolase activity [GO:0050538]; cellular amino acid biosynthetic process [GO:0008652]";"GO:0008652; GO:0016813; GO:0046872; GO:0050538";cellular amino acid biosynthetic process [GO:0008652];;"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; N-carbamoyl-L-amino-acid hydrolase activity [GO:0050538]"
comp98564_c0_seq1;GAXK01076539.1;Q5E9T4;1.27E-46;TPK1_BOVIN;Thiamin pyrophosphokinase 1 (EC 2.7.6.2) (Thiamine pyrophosphokinase 1);"ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]";"GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975";"thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]";;"ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]"
comp98566_c0_seq1;GAXK01076653.1;Q6GLN5;4.91E-20;NFIP1_XENLA;NEDD4 family-interacting protein 1;"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion transport [GO:0030001]; vacuolar transport [GO:0007034]";"GO:0000139; GO:0007034; GO:0016021; GO:0030001";"metal ion transport [GO:0030001]; vacuolar transport [GO:0007034]";"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]";
comp98567_c0_seq1;GAXK01076634.1;Q9NRR4;0;RNC_HUMAN;Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241);"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]";"GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628";"defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]";"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]";"DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]"
comp98569_c0_seq1;GAXK01076890.1;Q8IZU9;8.07E-28;KIRR3_HUMAN;Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3];"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102";"glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]";"axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp9858_c0_seq1;GAXK01013448.1;Q66S13;5.85E-07;NATT4_THANI;Natterin-4 (EC 3.4.-.-);"extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; toxin activity [GO:0090729]";"GO:0005576; GO:0016787; GO:0090729";;extracellular region [GO:0005576];"hydrolase activity [GO:0016787]; toxin activity [GO:0090729]"
comp985865_c0_seq1;GAXK01075788.1;P08953;2.50E-26;TOLL_DROME;Protein toll;"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]";"GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875";"antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]";"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]";"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]"
comp98592_c1_seq1;GAXK01076662.1;Q9BKZ9;4.46E-88;FEH1_CAEEL;Protein Fe65 homolog;"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005856; GO:0006355; GO:0007631; GO:0008134; GO:0009792";"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]";"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]";"amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]"
comp985938_c1_seq1;GAXK01075822.1;A5LGM7;1.81E-80;TRET1_POLVA;Facilitated trehalose transporter Tret1 (PvTret1);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]";"GO:0005886; GO:0015574; GO:0015771; GO:0016021";trehalose transport [GO:0015771];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";trehalose transmembrane transporter activity [GO:0015574]
comp985994_c0_seq1;GAXK01075836.1;A2CEA7;3.45E-179;RGRF2_DANRE;Ras-specific guanine nucleotide-releasing factor 2 (Ras-GRF2) (Ras guanine nucleotide exchange factor 2);"endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]";"GO:0005089; GO:0005516; GO:0005789; GO:0005886; GO:0007264; GO:0035023";"regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]";"endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]";"calmodulin binding [GO:0005516]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]"
comp9859965_c0_seq1;GAXK01197934.1;P18163;1.72E-35;ACSL1_RAT;Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) (Phytanate--CoA ligase) (EC 6.2.1.24);"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acetate-CoA ligase activity [GO:0003987]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"GO:0000038; GO:0001676; GO:0003987; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0010033; GO:0014070; GO:0015908; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0042493; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162";"adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]";"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]";"acetate-CoA ligase activity [GO:0003987]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]"
comp98613_c0_seq1;GAXK01076671.1;P11481;3.61E-65;TBA1_VOLCA;Tubulin alpha-1/alpha-2 chain;"cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]";"GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017";microtubule-based process [GO:0007017];"cytoplasm [GO:0005737]; microtubule [GO:0005874]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]"
comp98622_c0_seq1;GAXK01076749.1;Q8MQH7;1.51E-64;DRI_STRPU;Protein dead ringer homolog (Deadringer-like protein) (Spdeadringer) (Spdri);"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]";"GO:0000977; GO:0001228; GO:0005634; GO:0007275";multicellular organism development [GO:0007275];nucleus [GO:0005634];"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
comp98644_c2_seq1;GAXK01076893.1;P35832;1.91E-178;PTP99_DROME;Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424";"axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp986726_c0_seq1;GAXK01120312.1;Q90694;3.18E-76;CDC42_CHICK;Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein);"adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; maintenance of protein location [GO:0045185]; modification of synaptic structure [GO:0099563]; negative regulation of protein complex assembly [GO:0031333]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; Rho protein signal transduction [GO:0007266]";"GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0019901; GO:0030031; GO:0030036; GO:0030175; GO:0030496; GO:0031274; GO:0031333; GO:0032467; GO:0032488; GO:0032956; GO:0034329; GO:0042995; GO:0043005; GO:0043197; GO:0043552; GO:0045185; GO:0045198; GO:0045860; GO:0046847; GO:0051233; GO:0051489; GO:0051988; GO:0060997; GO:0072686; GO:0099563";"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; maintenance of protein location [GO:0045185]; modification of synaptic structure [GO:0099563]; negative regulation of protein complex assembly [GO:0031333]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; Rho protein signal transduction [GO:0007266]";"adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]"
comp986856_c0_seq1;GAXK01120317.1;P52746;5.68E-09;ZN142_HUMAN;Zinc finger protein 142;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]";"GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp986907_c0_seq1;GAXK01120302.1;Q9VAS7;1.07E-35;INX3_DROME;Innexin inx3 (Innexin-3);"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328";"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction, visible light [GO:0007603]";"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]";gap junction channel activity [GO:0005243]
comp98692_c0_seq1;GAXK01076720.1;Q6ULP2;6.94E-08;AFTIN_HUMAN;Aftiphilin;"AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; intracellular transport [GO:0046907]; protein transport [GO:0015031]";"GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0015031; GO:0030121; GO:0030276; GO:0032588; GO:0043231; GO:0046907";"intracellular transport [GO:0046907]; protein transport [GO:0015031]";"AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]";clathrin binding [GO:0030276]
comp987_c1_seq1;GAXK01166404.1;Q32PI6;2.03E-74;RM04_BOVIN;39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4);"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]";"GO:0003735; GO:0005743; GO:0005762; GO:0006412";translation [GO:0006412];"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]";structural constituent of ribosome [GO:0003735]
comp98702_c0_seq1;GAXK01076658.1;O95671;2.87E-51;ASML_HUMAN;"Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]";"cytosol [GO:0005829]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; nucleotide metabolic process [GO:0009117]";"GO:0005829; GO:0008171; GO:0009117; GO:0035529; GO:0047429";nucleotide metabolic process [GO:0009117];cytosol [GO:0005829];"NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]"
comp98723_c0_seq1;GAXK01076618.1;O82147;3.04E-109;SPDE_COFAR;Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase);"spermidine synthase activity [GO:0004766]; spermidine biosynthetic process [GO:0008295]";"GO:0004766; GO:0008295";spermidine biosynthetic process [GO:0008295];;spermidine synthase activity [GO:0004766]
comp98730_c3_seq1;GAXK01076757.1;Q9TUB5;3.87E-33;CLCA1_PIG;Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (pCLCA1);"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]";"GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872";calcium ion transport [GO:0006816];"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]";"intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp9873877_c0_seq1;GAXK01040886.1;Q7LHG5;7.28E-08;YI31B_YEAST;"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197";"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]";"aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]"
comp987554_c0_seq1;GAXK01120289.1;Q4VUF1;9.90E-26;FOXL2_ELLLU;Forkhead box protein L2;"nucleus [GO:0005634]; cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; extraocular skeletal muscle development [GO:0002074]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of transcription, DNA-templated [GO:0045893]";"GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0006309; GO:0030154; GO:0043028; GO:0043065; GO:0043280; GO:0043565; GO:0045893";"apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; extraocular skeletal muscle development [GO:0002074]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of transcription, DNA-templated [GO:0045893]";nucleus [GO:0005634];"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]"
comp9875664_c0_seq1;GAXK01016552.1;P73079;1.12E-16;Y2042_SYNY3;Uncharacterized protein slr2042;"cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; transcription factor binding [GO:0008134]";"GO:0004177; GO:0005829; GO:0008134; GO:0008237";;cytosol [GO:0005829];"aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; transcription factor binding [GO:0008134]"
comp987643_c0_seq1;GAXK01120266.1;Q99PJ0;2.35E-08;NTRI_MOUSE;Neurotrimin;"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"GO:0005615; GO:0005886; GO:0007155; GO:0009986; GO:0010977; GO:0030424; GO:0031225; GO:0048471; GO:0060076";"cell adhesion [GO:0007155]; negative regulation of neuron projection development [GO:0010977]";"anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]";
comp98767_c10_seq1;GAXK01076784.1;P16620;4.82E-76;PTP69_DROME;Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP);"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]";"GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007415; GO:0008045; GO:0016021; GO:0016201; GO:0030424; GO:0035335; GO:0048813; GO:0097155";"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]";"axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
comp987853_c0_seq1;GAXK01120311.1;Q66J52;1.17E-53;S226B_XENLA;Solute carrier family 22 member 6-B (Organic cation transporter 1-B) (Renal organic anion transporter 1-B) (ROAT1-B);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]";"GO:0005886; GO:0016021; GO:0022857";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp98787_c0_seq1;GAXK01076537.1;Q2KI84;0;SYHC_BOVIN;Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]";"GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802";"histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]"
comp9879_c0_seq1;GAXK01014681.1;P46935;0;NEDD4_MOUSE;E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4);"cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; development involved in symbiotic interaction [GO:0044111]; endocardial cushion development [GO:0003197]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; transmission of virus [GO:0019089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"GO:0000122; GO:0000151; GO:0000209; GO:0000785; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006511; GO:0006513; GO:0006622; GO:0007528; GO:0008022; GO:0010766; GO:0010768; GO:0014068; GO:0016020; GO:0016567; GO:0019089; GO:0019871; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0035255; GO:0042110; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045121; GO:0045732; GO:0046824; GO:0048471; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0061630; GO:0070063; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:1901016; GO:2000650";"adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; development involved in symbiotic interaction [GO:0044111]; endocardial cushion development [GO:0003197]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; transmission of virus [GO:0019089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]";"cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]";"beta-2 adrenergic receptor binding [GO:0031698]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"
comp987938_c0_seq1;GAXK01120319.1;Q3TUF7;4.07E-46;YETS2_MOUSE;YEATS domain-containing protein 2;"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]";"GO:0000122; GO:0005634; GO:0005671; GO:0017025; GO:0042393; GO:0043966; GO:0045892; GO:0072686; GO:0140030";"histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]";"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]";"histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]"
comp987971_c1_seq1;GAXK01120272.1;Q09101;2.86E-76;HIG_DROME;Locomotion-related protein Hikaru genki;"neuronal cell body [GO:0043025]; synaptic cleft [GO:0043083]; synaptic target recognition [GO:0008039]";"GO:0008039; GO:0043025; GO:0043083";synaptic target recognition [GO:0008039];"neuronal cell body [GO:0043025]; synaptic cleft [GO:0043083]";
comp9880_c1_seq1;GAXK01014636.1;P08059;0;G6PI_PIG;Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI);"cytosol [GO:0005829]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]";"GO:0004347; GO:0005125; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016866; GO:0048029; GO:0051156";"gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]";"cytosol [GO:0005829]; extracellular space [GO:0005615]";"cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]"
comp988157_c0_seq1;GAXK01064906.1;Q8BHJ5;2.57E-36;TBL1R_MOUSE;F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1);"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"GO:0000118; GO:0000122; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263";"adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]";"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]";"beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]"
comp988159_c0_seq1;GAXK01064950.1;Q66HB3;0;IFT80_RAT;Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56);"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; smoothened signaling pathway [GO:0007224]";"GO:0001649; GO:0002062; GO:0005737; GO:0005813; GO:0005929; GO:0007224; GO:0030992; GO:0050680; GO:0060271; GO:0060349; GO:1905515; GO:2000051";"bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; smoothened signaling pathway [GO:0007224]";"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]";
comp98832_c1_seq1;GAXK01076500.1;Q6DFC2;8.12E-08;CCD77_XENLA;Coiled-coil domain-containing protein 77;;;;;
comp98849_c0_seq1;GAXK01076667.1;Q52I78;3.36E-164;NAMPT_PIG;Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin);"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]";"GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0047280";"circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]";"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]";"cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]"
comp988516_c0_seq1;GAXK01064910.1;Q5EA79;5.72E-81;GALM_BOVIN;Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase);"cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";"GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499";"galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]";cytoplasm [GO:0005737];"aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]"
comp988603_c0_seq1;GAXK01064897.1;Q7ZWG6;1.28E-08;PCFT_DANRE;Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1);"integral component of plasma membrane [GO:0005887]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]";"GO:0005542; GO:0005887; GO:0055085";transmembrane transport [GO:0055085];integral component of plasma membrane [GO:0005887];folic acid binding [GO:0005542]
comp9893_c0_seq1;GAXK01013367.1;A8WQK3;6.29E-27;ACH1_CAEBR;Acetylcholine receptor subunit alpha-type acr-16;"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877";"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
comp98932_c0_seq1;GAXK01076661.1;Q92539;1.25E-39;LPIN2_HUMAN;Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2);"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944";"cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]";"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]";"phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]"
comp989413_c0_seq1;GAXK01064907.1;Q6ZS10;2.05E-20;CL17A_HUMAN;C-type lectin domain family 17, member A (Prolectin);"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]";"GO:0005537; GO:0009986; GO:0016021; GO:0042806; GO:0046872";;"cell surface [GO:0009986]; integral component of membrane [GO:0016021]";"fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]"
comp989454_c0_seq1;GAXK01064916.1;Q64176;2.59E-71;EST1E_MOUSE;Carboxylesterase 1E (EC 3.1.1.1) (Egasyn) (Liver carboxylesterase 22) (Es-22) (Esterase-22);"endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; palmitoyl-CoA hydrolase activity [GO:0016290]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]";"GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0016042; GO:0016290; GO:0052689; GO:0080030";lipid catabolic process [GO:0016042];"endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]";"carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; palmitoyl-CoA hydrolase activity [GO:0016290]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"
comp98954_c1_seq1;GAXK01076723.1;P97390;9.24E-174;VPS45_MOUSE;Vacuolar protein sorting-associated protein 45 (mVps45);"endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]";"GO:0000139; GO:0005794; GO:0006904; GO:0008021; GO:0010008; GO:0015031; GO:0016021";"protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]";"endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]";
comp98966_c0_seq1;GAXK01076492.1;Q75VN4;6.77E-32;H2B_RHASC;Histone H2B;"extracellular region [GO:0005576]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]";"GO:0000786; GO:0003677; GO:0005576; GO:0005634; GO:0044877; GO:0046982; GO:0050829; GO:0050830";"defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]";"extracellular region [GO:0005576]; nucleosome [GO:0000786]; nucleus [GO:0005634]";"DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]"
comp98968_c0_seq1;GAXK01076798.1;Q0VA04;6.71E-92;SMG8_XENTR;Protein smg8 (Protein smg-8 homolog);"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]";"GO:0000184; GO:0045859";"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]";;
comp98975_c1_seq1;GAXK01076569.1;Q7KRI2;1.35E-12;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp9897545_c0_seq1;GAXK01091506.1;Q8VEM8;2.28E-28;MPCP_MOUSE;Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3);"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]";"GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877";phosphate ion transmembrane transport [GO:0035435];"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]";"inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]"
comp98976_c0_seq1;GAXK01076373.1;P93748;1.08E-15;SINA1_ARATH;Putative E3 ubiquitin-protein ligase SINAT1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT1) (Seven in absentia homolog 1);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740; GO:2000785";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp9898_c3_seq1;GAXK01014682.1;Q86T96;1.40E-11;RN180_HUMAN;E3 ubiquitin-protein ligase RNF180 (EC 2.3.2.27) (RING finger protein 180) (RING-type E3 ubiquitin transferase RNF180);"integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear envelope [GO:0005635]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; adult behavior [GO:0030534]; norepinephrine metabolic process [GO:0042415]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; regulation of catalytic activity [GO:0050790]; serotonin metabolic process [GO:0042428]";"GO:0000209; GO:0005635; GO:0016021; GO:0030534; GO:0031227; GO:0031398; GO:0031624; GO:0032436; GO:0042415; GO:0042428; GO:0046872; GO:0050790; GO:0061630";"adult behavior [GO:0030534]; norepinephrine metabolic process [GO:0042415]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; regulation of catalytic activity [GO:0050790]; serotonin metabolic process [GO:0042428]";"integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear envelope [GO:0005635]";"metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]"
comp989985_c0_seq1;GAXK01064908.1;Q0IIJ3;7.02E-12;WASF1_BOVIN;Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1);"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; pronucleus [GO:0045120]; synapse [GO:0045202]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; pronuclear migration [GO:0035046]; receptor-mediated endocytosis [GO:0006898]";"GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0005925; GO:0005938; GO:0006898; GO:0030036; GO:0032154; GO:0034237; GO:0035046; GO:0045120; GO:0045202; GO:0071933; GO:1990416; GO:2000601";"actin cytoskeleton organization [GO:0030036]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; pronuclear migration [GO:0035046]; receptor-mediated endocytosis [GO:0006898]";"cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; pronucleus [GO:0045120]; synapse [GO:0045202]";"actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]"
comp99_c2_seq1;GAXK01166070.1;Q7ZWA3;1.71E-09;RBMX_DANRE;RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G);"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"GO:0000381; GO:0000398; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005719; GO:0006366; GO:0006509; GO:0007275; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347";"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]";"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]";"chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp990085_c0_seq1;GAXK01190463.1;P82198;7.52E-11;BGH3_MOUSE;Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3);"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023";"angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]";"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]";"cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]"
comp9901_c0_seq1;GAXK01014054.1;O08838;4.27E-53;AMPH_RAT;Amphiphysin;"axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of synaptic vesicle membrane [GO:0098850]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; synaptic vesicle endocytosis [GO:0048488]";"GO:0005543; GO:0005856; GO:0005886; GO:0008021; GO:0008022; GO:0030054; GO:0043195; GO:0043547; GO:0043679; GO:0044877; GO:0045807; GO:0046982; GO:0048488; GO:0098850";"positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; synaptic vesicle endocytosis [GO:0048488]";"axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of synaptic vesicle membrane [GO:0098850]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]";"phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]"
comp9902_c1_seq1;GAXK01013449.1;P54385;0;DHE3_DROME;Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0019551; GO:0042802";"glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]"
comp99021_c0_seq1;GAXK01076657.1;Q80T79;3.44E-69;CSMD3_MOUSE;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]";"GO:0005886; GO:0016021; GO:0050773";regulation of dendrite development [GO:0050773];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";
comp990230_c1_seq1;GAXK01190453.1;Q7KRI2;1.95E-28;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp990238_c0_seq1;GAXK01190497.1;Q3U4G3;2.36E-34;XXLT1_MOUSE;Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase);"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]";"GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252";O-glycan processing [GO:0016266];integral component of endoplasmic reticulum membrane [GO:0030176];"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]"
comp9903_c0_seq1;GAXK01013588.1;O77460;2.30E-115;IPYR_DROME;Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; regulation of hemocyte proliferation [GO:0035206]; transcription, DNA-templated [GO:0006351]";"GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0006338; GO:0006351; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766";"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; regulation of hemocyte proliferation [GO:0035206]; transcription, DNA-templated [GO:0006351]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NURF complex [GO:0016589]";"inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]"
comp990332_c0_seq1;GAXK01205968.1;Q6CVH3;2.79E-16;NHP6_KLULA;Non-histone chromosomal protein 6;"chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]";"GO:0003677; GO:0005634; GO:0005694; GO:0006281";DNA repair [GO:0006281];"chromosome [GO:0005694]; nucleus [GO:0005634]";DNA binding [GO:0003677]
comp990473_c0_seq1;GAXK01190460.1;Q9VZW5;1.31E-20;FMAR_DROME;FMRFamide receptor (DFR) (DrmFMRFa-R);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021";"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]";"G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]"
comp9907_c0_seq1;GAXK01014130.1;P00636;1.93E-141;F16P1_PIG;Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]";"GO:0000122; GO:0001085; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0051289; GO:0071286";"cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]";"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]"
comp990714_c0_seq1;GAXK01190448.1;P27323;1.89E-93;HS901_ARATH;Heat shock protein 90-1 (AtHSP90.1) (AtHsp90-1) (Heat shock protein 81-1) (Hsp81-1) (Heat shock protein 83);"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";"GO:0005524; GO:0005737; GO:0009816; GO:0051082; GO:0061077";"chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]";cytoplasm [GO:0005737];"ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]"
comp990749_c0_seq1;GAXK01190454.1;Q5R1P3;3.99E-122;NMDE2_CANLF;Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B);"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"GO:0004972; GO:0005886; GO:0005887; GO:0008270; GO:0014069; GO:0016595; GO:0017146; GO:0022849; GO:0030054; GO:0051290; GO:0060079; GO:0060291; GO:0097553; GO:0098839";"calcium ion transmembrane import into cytosol [GO:0097553]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein heterotetramerization [GO:0051290]";"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]";"glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270]"
comp99078_c0_seq1;GAXK01076428.1;Q9W3F7;5.69E-112;MIGA_DROME;Mitoguardin;"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; photoreceptor cell maintenance [GO:0045494]; regulation of mitochondrial fusion [GO:0010635]";"GO:0005739; GO:0005741; GO:0008053; GO:0010635; GO:0016021; GO:0045494; GO:0070584";"mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; photoreceptor cell maintenance [GO:0045494]; regulation of mitochondrial fusion [GO:0010635]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]";
comp99105_c0_seq1;GAXK01076652.1;Q28DT3;9.71E-23;PLD6_XENTR;Mitochondrial cardiolipin hydrolase (EC 3.1.-.-) (Choline phosphatase 6) (Mitochondrial phospholipase) (MitoPLD) (Phosphatidylcholine-hydrolyzing phospholipase D6) (Phospholipase D6) (PLD 6);"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cardiolipin hydrolase activity [GO:0035755]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; DNA methylation involved in gamete generation [GO:0043046]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]";"GO:0004519; GO:0005741; GO:0007286; GO:0008053; GO:0016021; GO:0016042; GO:0030719; GO:0034587; GO:0035755; GO:0042803; GO:0043046; GO:0046872; GO:0051321";"DNA methylation involved in gamete generation [GO:0043046]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]";"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]";"cardiolipin hydrolase activity [GO:0035755]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
comp991087_c0_seq1;GAXK01190496.1;Q9VFP2;1.18E-08;RDX_DROME;Protein roadkill (Hh-induced MATH and BTB domain-containing protein);"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044";"establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]";"identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"
comp9911_c0_seq1;GAXK01014502.1;P70549;3.68E-29;NAC3_RAT;Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3);"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031594; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034";"calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]";"cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]";"calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]"
comp991144_c0_seq1;GAXK01190500.1;Q00871;4.81E-40;CTRB1_PENVA;Chymotrypsin BI (EC 3.4.21.1);"extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]";"GO:0004252; GO:0005615; GO:0030574";collagen catabolic process [GO:0030574];extracellular space [GO:0005615];serine-type endopeptidase activity [GO:0004252]
comp99115_c0_seq1;GAXK01076747.1;Q8BGA7;2.79E-12;CG026_MOUSE;Uncharacterized protein C7orf26 homolog;;;;;
comp99121_c0_seq1;GAXK01076633.1;Q9VC99;5.38E-76;UCK_DROME;Uridine-cytidine kinase (UCK) (EC 2.7.1.48) (Cytidine monophosphokinase) (Uridine monophosphokinase);"cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";"GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211";"CTP salvage [GO:0044211]; UMP salvage [GO:0044206]";cytosol [GO:0005829];"ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]"
comp9912390_c0_seq1;GAXK01054220.1;O74904;3.14E-11;RL35_SCHPO;60S ribosomal protein L35;"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"GO:0000463; GO:0002181; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0022625";"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]";"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]";"mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]"
comp99126_c0_seq1;GAXK01076488.1;P53611;4.54E-160;PGTB2_HUMAN;Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta);"cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; regulation of apoptotic process [GO:0042981]; visual perception [GO:0007601]";"GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006464; GO:0007601; GO:0008270; GO:0017137; GO:0018342; GO:0018344; GO:0042981; GO:0043687";"cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; regulation of apoptotic process [GO:0042981]; visual perception [GO:0007601]";"cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]";"Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]"
comp991328_c1_seq1;GAXK01190508.1;P34529;2.97E-67;DCR1_CAEEL;Endoribonuclease dcr-1 (EC 3.1.26.-) [Cleaved into: Death-promoting deoxyribonuclease (tDCR-1) (EC 3.1.21.-)];"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; dsRNA processing [GO:0031050]; gonad morphogenesis [GO:0035262]; nematode larval development [GO:0002119]; olfactory learning [GO:0008355]; positive regulation of primary miRNA processing [GO:2000636]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of development, heterochronic [GO:0040034]; reproduction [GO:0000003]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]";"GO:0000003; GO:0000737; GO:0002119; GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006309; GO:0006401; GO:0008355; GO:0016075; GO:0016442; GO:0030422; GO:0031050; GO:0031054; GO:0035262; GO:0040034; GO:0046872; GO:2000636";"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; dsRNA processing [GO:0031050]; gonad morphogenesis [GO:0035262]; nematode larval development [GO:0002119]; olfactory learning [GO:0008355]; positive regulation of primary miRNA processing [GO:2000636]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of development, heterochronic [GO:0040034]; reproduction [GO:0000003]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]";"ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]"
comp991450_c0_seq1;GAXK01190495.1;Q5R5U3;3.31E-34;ZN271_PONAB;Zinc finger protein 271;"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]";"GO:0000976; GO:0005634; GO:0046872";;nucleus [GO:0005634];"metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"
comp991571_c0_seq1;GAXK01190471.1;Q9XZC0;3.81E-08;LCTA_LATTR;Alpha-latrocrustotoxin-Lt1a (Alpha-LCT-Lt1a) (Alpha-latrocrustotoxin) (Alpha-LCT) (Crusta1) (Fragment);"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; exocytosis [GO:0006887]";"GO:0005576; GO:0006887; GO:0016021; GO:0044218; GO:0090729";exocytosis [GO:0006887];"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]";toxin activity [GO:0090729]
comp991572_c0_seq1;GAXK01190498.1;B7TB45;1.45E-08;SPZ2_DROME;Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2);"extracellular region [GO:0005576]; growth factor activity [GO:0008083]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";"GO:0005121; GO:0005576; GO:0007399; GO:0007411; GO:0008045; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087";"axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]";extracellular region [GO:0005576];"growth factor activity [GO:0008083]; Toll binding [GO:0005121]"
comp991639_c0_seq1;GAXK01190534.1;Q9CXI3;1.69E-93;MOXD1_MOUSE;DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016020; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421";"dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]";"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]";"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"
comp991765_c0_seq1;GAXK01190555.1;Q9VIP7;6.57E-82;ACASE_DROME;Alkaline ceramidase (AlkCDase) (EC 3.5.1.23) (Alkaline N-acylsphingosine amidohydrolase) (Alkaline acylsphingosine deacylase) (Protein brainwashing);"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]; brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"GO:0005783; GO:0006665; GO:0007420; GO:0016021; GO:0017040; GO:0019216; GO:0046514; GO:0046872; GO:0102121";"brain development [GO:0007420]; ceramide catabolic process [GO:0046514]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]";"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]";"ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]"
comp9919_c0_seq1;GAXK01013486.1;Q9Y5V0;1.61E-09;ZN706_HUMAN;Zinc finger protein 706;"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455";"negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";metal ion binding [GO:0046872]
comp992001_c0_seq1;GAXK01010299.1;Q6PGF2;1.64E-10;MORN4_MOUSE;MORN repeat-containing protein 4;"cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678]";"GO:0005737; GO:0032426; GO:0032433; GO:0048678";response to axon injury [GO:0048678];"cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]";
comp992012_c0_seq1;GAXK01010297.1;F7B645;5.47E-65;TM231_XENTR;Transmembrane protein 231;"ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]";"GO:0007224; GO:0016021; GO:0032880; GO:0035869; GO:0036038; GO:0060170; GO:0060271";"cilium assembly [GO:0060271]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]";"ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]";
comp992092_c0_seq1;GAXK01010312.1;Q801G1;4.58E-46;ARHA_XENLA;Low density lipoprotein receptor adapter protein 1-A (Autosomal recessive hypercholesterolemia protein homolog alpha) (ARH alpha) (xARH alpha) (Phosphotyrosine-binding protein) (Xcat4);"cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]";"GO:0005737; GO:0006897; GO:0008203";"cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]";cytoplasm [GO:0005737];
comp99221_c0_seq1;GAXK01076626.1;Q8VC51;6.51E-67;TCAB1_MOUSE;Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog);"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]; chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]; Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]";"GO:0000781; GO:0003723; GO:0005654; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0016604; GO:0030576; GO:0031625; GO:0032203; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0051973; GO:0070034; GO:0090666; GO:0090671; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034";"Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]";"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]";"chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]"
comp992272_c0_seq1;GAXK01010286.1;P42575;4.88E-34;CASP2_HUMAN;"Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0008630; GO:0016020; GO:0016485; GO:0019899; GO:0019904; GO:0035234; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097194; GO:0097200; GO:2001235";"aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]";"cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]"
comp99238_c0_seq1;GAXK01076642.1;Q9VQQ9;9.75E-168;EXOC2_DROME;Exocyst complex component 2 (Exocyst complex component Sec5);"annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; Rab GTPase binding [GO:0017137]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]";"GO:0000145; GO:0000281; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0017137; GO:0030136; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0060074; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0098793";"border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]";"annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]";Rab GTPase binding [GO:0017137]
comp99248_c0_seq1;GAXK01076502.1;Q8S3N1;2.64E-18;SINA5_ARATH;E3 ubiquitin-protein ligase SINAT5 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SINAT5) (Seven in absentia homolog 5);"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0016740";"multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; nucleus [GO:0005634]";"transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
comp992503_c0_seq1;GAXK01010309.1;Q96K58;3.50E-20;ZN668_HUMAN;Zinc finger protein 668;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]";"GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]"
comp99255_c1_seq1;GAXK01076374.1;Q9W5U2;2.56E-34;CHI10_DROME;Probable chitinase 10 (EC 3.2.1.14) (Probable chitinase 1) (Probable chitinase 3);"extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";"GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061";"chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]";extracellular region [GO:0005576];"chitinase activity [GO:0004568]; chitin binding [GO:0008061]"
comp99269_c1_seq1;GAXK01076755.1;Q5YW75;4.24E-08;ECTD_NOCFA;Ectoine dioxygenase (EC 1.14.11.55) (Ectoine hydroxylase);"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; ectoine catabolic process [GO:0042400]";"GO:0005506; GO:0016706; GO:0042400";ectoine catabolic process [GO:0042400];;"2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]"
comp99291_c1_seq1;GAXK01076551.1;P70388;3.24E-84;RAD50_MOUSE;DNA repair protein RAD50 (mRad50) (EC 3.6.-.-);"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; protein heterooligomerization [GO:0051291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]";"GO:0000019; GO:0000722; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003690; GO:0003691; GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007346; GO:0016233; GO:0016234; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0043047; GO:0045120; GO:0046597; GO:0046872; GO:0048471; GO:0051276; GO:0051291; GO:0051880; GO:0070192; GO:0090305; GO:1904354";"cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; protein heterooligomerization [GO:0051291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]";"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]";"adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]"
comp993178_c0_seq1;GAXK01010294.1;P00760;3.48E-49;TRY1_BOVIN;"Cationic trypsin (EC 3.4.21.4) (Beta-trypsin) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]; digestion [GO:0007586]; proteolysis [GO:0006508]";"GO:0004175; GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872; GO:0046982; GO:0097180; GO:0097655";"digestion [GO:0007586]; proteolysis [GO:0006508]";"extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]";"endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655]"
comp99349_c2_seq1;GAXK01076805.1;Q80XP9;1.73E-154;WNK3_MOUSE;Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3);"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]";"GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0010765; GO:0010766; GO:0010800; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090188; GO:0090279; GO:1903078; GO:1903288; GO:2000651";"intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]";"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]";"ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"
comp993653_c0_seq1;GAXK01010296.1;A6NNF4;7.61E-35;ZN726_HUMAN;Zinc finger protein 726;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp993717_c0_seq1;GAXK01010321.1;Q9H223;1.28E-138;EHD4_HUMAN;EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4);"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; cellular response to growth factor stimulus [GO:0071363]; endocytic recycling [GO:0032456]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; regulation of endocytosis [GO:0030100]";"GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005783; GO:0005886; GO:0006907; GO:0016020; GO:0030100; GO:0031901; GO:0032456; GO:0045296; GO:0048471; GO:0050731; GO:0051260; GO:0055038; GO:0070062; GO:0071363";"cellular response to growth factor stimulus [GO:0071363]; endocytic recycling [GO:0032456]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; regulation of endocytosis [GO:0030100]";"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]";"ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]"
comp9938395_c0_seq1;GAXK01115326.1;Q48815;6.05E-09;HELA_LEGPN;Protein HelA;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]";"GO:0005886; GO:0008324; GO:0016021";;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";cation transmembrane transporter activity [GO:0008324]
comp993968_c0_seq1;GAXK01010317.1;P87110;4.05E-07;ITR2_SCHPO;Myo-inositol transporter 2;"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol import across plasma membrane [GO:1904679]";"GO:0005366; GO:0005783; GO:0005887; GO:1904679";myo-inositol import across plasma membrane [GO:1904679];"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]";myo-inositol:proton symporter activity [GO:0005366]
comp99408_c0_seq1;GAXK01076682.1;Q5R863;4.05E-28;GPAM1_PONAB;GPALPP motifs-containing protein 1;;;;;
comp99449_c0_seq1;GAXK01076498.1;Q5U243;4.53E-109;CLIP3_XENLA;CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein) (CLIP-170-related 59 kDa protein) (CLIPR-59);Golgi stack [GO:0005795];GO:0005795;;Golgi stack [GO:0005795];
comp9945_c0_seq1;GAXK01014819.1;Q9P0L0;6.08E-67;VAPA_HUMAN;Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33);"azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]";"GO:0000139; GO:0005783; GO:0005789; GO:0005886; GO:0005923; GO:0006888; GO:0008017; GO:0008219; GO:0015630; GO:0016021; GO:0019904; GO:0030148; GO:0031175; GO:0031965; GO:0031982; GO:0033149; GO:0035577; GO:0043123; GO:0043312; GO:0044791; GO:0044828; GO:0044829; GO:0045296; GO:0046982; GO:0061025; GO:0070972; GO:0090114";"cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]";"azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]";"cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]"
comp994577_c0_seq1;GAXK01045703.1;Q9US12;5.65E-12;YK66_SCHPO;Putative zinc metalloproteinase C607.06c (EC 3.4.24.-);"cell division site [GO:0032153]; cytosol [GO:0005829]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]";"GO:0005634; GO:0005829; GO:0008237; GO:0030246; GO:0032153; GO:0046872";;"cell division site [GO:0032153]; cytosol [GO:0005829]; nucleus [GO:0005634]";"carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]"
comp994752_c0_seq1;GAXK01045675.1;P55786;2.55E-84;PSA_HUMAN;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955";"cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]";"aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
comp99477_c0_seq1;GAXK01076631.1;Q8IVS2;4.99E-91;FABD_HUMAN;Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase);"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; fatty acid synthase activity [GO:0004312]; RNA binding [GO:0003723]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]";"GO:0003723; GO:0004312; GO:0004314; GO:0005739; GO:0005759; GO:0006633; GO:0006635";"fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]";"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]";"[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; fatty acid synthase activity [GO:0004312]; RNA binding [GO:0003723]"
comp994822_c0_seq1;GAXK01045678.1;Q23983;1.49E-103;SNAP_DROME;Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein);"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"GO:0000149; GO:0000281; GO:0001671; GO:0001745; GO:0005483; GO:0005737; GO:0005774; GO:0006886; GO:0006891; GO:0007268; GO:0007269; GO:0007274; GO:0016020; GO:0016082; GO:0019905; GO:0031201; GO:0031410; GO:0031629; GO:0035494; GO:0043195; GO:0043679; GO:0048526";"chemical synaptic transmission [GO:0007268]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing expansion [GO:0048526]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; SNARE complex disassembly [GO:0035494]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]";"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]";"ATPase activator activity [GO:0001671]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]"
comp99517_c0_seq1;GAXK01076549.1;Q9NDJ2;4.88E-38;DOM_DROME;Helicase domino (EC 3.6.4.-);"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]";"GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983; GO:2000637";"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]";"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]";"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]"
comp9953_c3_seq1;GAXK01013348.1;Q9W590;7.82E-154;LSG1_DROME;Large subunit GTPase 1 homolog (EC 3.6.1.-) (Nucleostemin-3);"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; regulation of growth [GO:0040008]; regulation of insulin receptor signaling pathway [GO:0046626]; ribosomal subunit export from nucleus [GO:0000054]";"GO:0000054; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0007275; GO:0015030; GO:0040008; GO:0046626; GO:0051168";"multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; regulation of growth [GO:0040008]; regulation of insulin receptor signaling pathway [GO:0046626]; ribosomal subunit export from nucleus [GO:0000054]";"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]";"GTPase activity [GO:0003924]; GTP binding [GO:0005525]"
comp995558_c0_seq1;GAXK01045690.1;Q9UBS8;1.66E-28;RNF14_HUMAN;E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630";"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]";"androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]"
comp995559_c0_seq1;GAXK01045682.1;Q94900;2.72E-20;GLUCL_DROME;Glutamate-gated chloride channel (DrosGluCl);"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476";"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; transmembrane signaling receptor activity [GO:0004888]"
comp995719_c0_seq1;GAXK01045686.1;Q04637;4.44E-27;IF4G1_HUMAN;Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220);"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]; viral process [GO:0016032]";"GO:0000184; GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010507; GO:0010801; GO:0010942; GO:0016020; GO:0016032; GO:0016281; GO:0030307; GO:0031369; GO:0031669; GO:0032270; GO:0032502; GO:0033138; GO:0034645; GO:0042802; GO:0043488; GO:0045666; GO:0060090; GO:0060964; GO:0080135; GO:0097009; GO:1900087; GO:1901215; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696";"behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]; viral process [GO:0016032]";"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]";"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"
comp995914_c0_seq1;GAXK01045684.1;Q5R9S5;6.74E-08;ZN182_PONAB;Zinc finger protein 182 (Zinc finger protein 21);"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp99595_c0_seq1;GAXK01076718.1;Q5M965;1.47E-115;THG1_RAT;Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (tRNA-histidine guanylyltransferase);"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; tRNA guanylyltransferase activity [GO:0008193]; protein homotetramerization [GO:0051289]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]";"GO:0000287; GO:0005524; GO:0005525; GO:0005739; GO:0006400; GO:0008033; GO:0008193; GO:0042802; GO:0051289";"protein homotetramerization [GO:0051289]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]";mitochondrion [GO:0005739];"ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; tRNA guanylyltransferase activity [GO:0008193]"
comp996_c1_seq1;GAXK01166050.1;Q0MQD0;5.91E-09;NDUB3_PONPY;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit);"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"GO:0005747; GO:0016021; GO:0022900; GO:0032981";"electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]";"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]";
comp996004_c0_seq1;GAXK01072195.1;Q9JLC8;2.58E-80;SACS_MOUSE;Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29);"cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]";"GO:0005737; GO:0050750";;cytoplasm [GO:0005737];low-density lipoprotein particle receptor binding [GO:0050750]
comp9960047_c0_seq1;GAXK01127253.1;P45335;1.68E-31;Y1706_HAEIN;Uncharacterized transporter HI_1706;"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; nitrogen compound transport [GO:0071705]";"GO:0005886; GO:0016021; GO:0022857; GO:0071705";nitrogen compound transport [GO:0071705];"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";transmembrane transporter activity [GO:0022857]
comp996240_c0_seq1;GAXK01072246.1;Q9NFP5;5.09E-20;SH3BG_DROME;SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein);SH3 domain binding [GO:0017124];GO:0017124;;;SH3 domain binding [GO:0017124]
comp996434_c0_seq1;GAXK01072174.1;P12252;1.51E-12;PDE4B_DROME;cAMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce);"nucleus [GO:0005634]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; reproduction [GO:0000003]; short-term memory [GO:0007614]; thermosensory behavior [GO:0040040]";"GO:0000003; GO:0001661; GO:0004115; GO:0005634; GO:0006198; GO:0007268; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045475; GO:0046872; GO:0046958; GO:0048149; GO:0048675";"anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; reproduction [GO:0000003]; short-term memory [GO:0007614]; thermosensory behavior [GO:0040040]";nucleus [GO:0005634];"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]"
comp996482_c0_seq1;GAXK01072156.1;Q8IN81;4.95E-08;FRU_DROME;Sex determination protein fruitless;"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";"GO:0002118; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007275; GO:0007417; GO:0007517; GO:0007530; GO:0007617; GO:0007620; GO:0008049; GO:0016199; GO:0016543; GO:0016544; GO:0016545; GO:0021954; GO:0044719; GO:0045433; GO:0046661; GO:0046872; GO:0048047; GO:0048065; GO:0048813; GO:0060179";"aggressive behavior [GO:0002118]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; copulation [GO:0007620]; dendrite morphogenesis [GO:0048813]; male courtship behavior [GO:0008049]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, tapping to detect pheromone [GO:0016544]; male courtship behavior, veined wing extension [GO:0048065]; male courtship behavior, veined wing generated song production [GO:0045433]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; male sex differentiation [GO:0046661]; mating behavior [GO:0007617]; mating behavior, sex discrimination [GO:0048047]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination [GO:0007530]";nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]"
comp996491_c0_seq1;GAXK01072191.1;P36609;2.66E-35;NCS2_CAEEL;Neuronal calcium sensor 2 (NCS-2);calcium ion binding [GO:0005509];GO:0005509;;;calcium ion binding [GO:0005509]
comp996604_c0_seq1;GAXK01072161.1;O02827;4.06E-66;MYLK_SHEEP;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] (Fragment);"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]";"GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872";;"cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]";"actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]"
comp996664_c0_seq1;GAXK01072157.1;Q9VUL9;5.24E-119;FUCTA_DROME;Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase);"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]";"GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920";"fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]";"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]";"1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]"
comp99669_c0_seq1;GAXK01076719.1;Q5BJP5;3.37E-15;TM230_RAT;Transmembrane protein 230;"autophagosome [GO:0005776]; cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; synaptic vesicle transport [GO:0048489]";"GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005802; GO:0008021; GO:0016021; GO:0030054; GO:0048489; GO:0055037";synaptic vesicle transport [GO:0048489];"autophagosome [GO:0005776]; cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]";
comp99678_c0_seq1;GAXK01076370.1;Q9BXF9;2.50E-115;TEKT3_HUMAN;Tektin-3;"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"GO:0002080; GO:0002081; GO:0005634; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0070062";"cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]";"acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]";
comp99718_c2_seq1;GAXK01076801.1;P54145;1.51E-74;AMT1_CAEEL;Putative ammonium transporter 1;"integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]";"GO:0005887; GO:0008519; GO:0072488";ammonium transmembrane transport [GO:0072488];integral component of plasma membrane [GO:0005887];ammonium transmembrane transporter activity [GO:0008519]
comp99744_c1_seq1;GAXK01076891.1;P00765;5.09E-41;TRYP_ASTAS;Trypsin-1 (EC 3.4.21.4) (Trypsin I);"extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]";"GO:0004252; GO:0005615; GO:0007586; GO:0046872";digestion [GO:0007586];extracellular space [GO:0005615];"metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
comp997485_c0_seq1;GAXK01072172.1;P17035;6.17E-22;ZNF28_HUMAN;Zinc finger protein 28 (Zinc finger protein KOX24);"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]";"GO:0000981; GO:0003677; GO:0005634; GO:0046872";;nucleus [GO:0005634];"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
comp99776_c0_seq1;GAXK01076615.1;P05661;0;MYSA_DROME;Myosin heavy chain, muscle;"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689";"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]";"A band [GO:0031672]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]";"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]"
comp99806_c0_seq1;GAXK01076469.1;Q7KRI2;4.42E-24;LOLAL_DROME;Longitudinals lacking protein-like (Lola-like protein) (Protein Batman);"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944";"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]";"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]";"DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]"
comp998075_c0_seq1;GAXK01123391.1;O93430;1.90E-22;GLRA1_DANRE;Glycine receptor subunit alphaZ1;"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"GO:0004888; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007417; GO:0008270; GO:0016021; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0034220; GO:0034707; GO:0042391; GO:0042803; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0045664; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476";"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]";"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]";"extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
comp998079_c1_seq2;GAXK01123433.1;Q6IQ16;9.27E-16;SPOPL_HUMAN;Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161";"negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp998135_c1_seq1;GAXK01123406.1;A2AJ76;3.83E-07;HMCN2_MOUSE;Hemicentin-2;"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]";"GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023";response to stimulus [GO:0050896];"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]";calcium ion binding [GO:0005509]
comp998142_c0_seq1;GAXK01123393.1;A8Y9I2;5.59E-10;NINAB_GALME;Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B);"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]";"GO:0004497; GO:0016702; GO:0042572; GO:0046872";retinol metabolic process [GO:0042572];;"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"
comp998157_c0_seq1;GAXK01123381.1;F1Q575;3.54E-93;NNRD_DANRE;ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (NAD(P)HX dehydratase);"ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; nicotinamide nucleotide metabolic process [GO:0046496]";"GO:0005524; GO:0046496; GO:0047453; GO:0052855";nicotinamide nucleotide metabolic process [GO:0046496];;"ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]"
comp998215_c0_seq1;GAXK01123440.1;P08442;3.09E-14;Y1184_SYNP6;Uncharacterized protein syc1184_c;;;;;
comp998331_c0_seq1;GAXK01123439.1;P11799;5.45E-09;MYLK_CHICK;Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form];"cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin light chain kinase activity [GO:0004687]; structural constituent of muscle [GO:0008307]; cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"GO:0004687; GO:0005516; GO:0005524; GO:0005829; GO:0005865; GO:0006936; GO:0008307; GO:0016020; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0045214; GO:0046872; GO:0048739; GO:0051015; GO:0051371; GO:0055003; GO:0055008; GO:0071688";"cardiac muscle fiber development [GO:0048739]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle myosin thick filament assembly [GO:0071688]";"cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]";"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin light chain kinase activity [GO:0004687]; structural constituent of muscle [GO:0008307]"
comp99852_c2_seq1;GAXK01076685.1;Q00719;7.61E-25;MDMC_STRMY;O-methyltransferase MdmC (EC 2.1.1.-);"metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; antibiotic biosynthetic process [GO:0017000]";"GO:0008171; GO:0017000; GO:0046872";antibiotic biosynthetic process [GO:0017000];;"metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]"
comp998543_c0_seq1;GAXK01123380.1;Q497K5;2.80E-10;ARRD5_MOUSE;Arrestin domain-containing protein 5;;;;;
comp99877_c0_seq1;GAXK01076645.1;Q8I4E2;1.66E-42;LST4_CAEEL;Sorting nexin lst-4 (Lateral signaling target protein 4);"cytoplasm [GO:0005737]; early phagosome [GO:0032009]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTPase binding [GO:0051020]; phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein self-association [GO:0043621]; execution phase of apoptosis [GO:0097194]; mitotic cell cycle [GO:0000278]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome maturation involved in apoptotic cell clearance [GO:0090386]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein transport [GO:0015031]";"GO:0000278; GO:0005546; GO:0005547; GO:0005737; GO:0015031; GO:0019902; GO:0030670; GO:0032009; GO:0035091; GO:0043621; GO:0045335; GO:0051020; GO:0090386; GO:0090387; GO:0090389; GO:0097194";"execution phase of apoptosis [GO:0097194]; mitotic cell cycle [GO:0000278]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; phagosome maturation involved in apoptotic cell clearance [GO:0090386]; protein transport [GO:0015031]";"cytoplasm [GO:0005737]; early phagosome [GO:0032009]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]";"GTPase binding [GO:0051020]; phosphatase binding [GO:0019902]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol binding [GO:0035091]; protein self-association [GO:0043621]"
comp998880_c0_seq1;GAXK01123379.1;Q7Z020;1.61E-16;TRPA1_DROME;Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1);"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016021; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604";"calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]";"cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]";"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]"
comp998995_c0_seq1;GAXK01123368.1;P14735;2.61E-159;IDE_HUMAN;Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin);"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006625; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032461; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0045861; GO:0050435; GO:0051260; GO:0051289; GO:0051291; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715";"amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]";"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]";"amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"
comp99905_c0_seq1;GAXK01076632.1;P86854;3.95E-07;PLCL_MYTGA;Perlucin-like protein;"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]";"GO:0005576; GO:0030246";;extracellular region [GO:0005576];carbohydrate binding [GO:0030246]
comp99912_c0_seq1;GAXK01076753.1;P49657;0;MNB_DROME;Serine/threonine-protein kinase minibrain (EC 2.7.12.1);"nucleus [GO:0005634]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription coactivator activity [GO:0003713]; circadian rhythm [GO:0007623]; learning or memory [GO:0007611]; negative regulation of cell cycle [GO:0045786]; negative regulation of hippo signaling [GO:0035331]; nervous system development [GO:0007399]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of feeding behavior [GO:2000253]; positive regulation of growth [GO:0045927]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; visual behavior [GO:0007632]";"GO:0003713; GO:0004674; GO:0004712; GO:0004860; GO:0005524; GO:0005634; GO:0007399; GO:0007611; GO:0007623; GO:0007632; GO:0008355; GO:0018105; GO:0018107; GO:0035331; GO:0043195; GO:0045666; GO:0045786; GO:0045887; GO:0045893; GO:0045927; GO:0046777; GO:1900244; GO:2000253";"circadian rhythm [GO:0007623]; learning or memory [GO:0007611]; negative regulation of cell cycle [GO:0045786]; negative regulation of hippo signaling [GO:0035331]; nervous system development [GO:0007399]; olfactory learning [GO:0008355]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of feeding behavior [GO:2000253]; positive regulation of growth [GO:0045927]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; visual behavior [GO:0007632]";"nucleus [GO:0005634]; terminal bouton [GO:0043195]";"ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
comp999159_c0_seq1;GAXK01123367.1;A6QP79;2.19E-07;COL12_BOVIN;Collectin-12 (Collectin placenta protein 1) (CL-P1);"collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]";"GO:0004888; GO:0005581; GO:0006910; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0071360";"cellular response to exogenous dsRNA [GO:0071360]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]";"collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]";"carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]"
comp999384_c1_seq1;GAXK01123396.1;Q0IQB6;3.13E-23;CML3_ORYSJ;Calmodulin-like protein 3;"membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]";"GO:0005509; GO:0016020; GO:0019722";calcium-mediated signaling [GO:0019722];membrane [GO:0016020];calcium ion binding [GO:0005509]
comp99952_c0_seq1;GAXK01076558.1;Q6NTN5;0;MTMRD_XENLA;Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2);"cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]";"GO:0005085; GO:0005737; GO:0006914; GO:0016020; GO:0019208; GO:0043087";"autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]";"cytoplasm [GO:0005737]; membrane [GO:0016020]";"guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]"
comp99975_c0_seq1;GAXK01076724.1;Q6ZMW2;1.42E-34;ZN782_HUMAN;Zinc finger protein 782;"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]";"GO:0003677; GO:0005634; GO:0006355; GO:0046872";regulation of transcription, DNA-templated [GO:0006355];nucleus [GO:0005634];"DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
comp999876_c0_seq1;GAXK01123438.1;Q7T330;2.62E-15;SPOP_DANRE;Speckle-type POZ protein (HIB homolog 1) (SPOP1);"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"GO:0005634; GO:0005737; GO:0006511; GO:0016567; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161";"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511]";"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]";ubiquitin protein ligase binding [GO:0031625]
comp999997_c0_seq1;GAXK01123374.1;Q9H2J7;7.62E-33;S6A15_HUMAN;Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Sodium-coupled branched-chain amino-acid transporter 1) (Solute carrier family 6 member 15) (Transporter v7-3);"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; proline:sodium symporter activity [GO:0005298]; amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]";"GO:0005298; GO:0005326; GO:0005328; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015804; GO:0015820; GO:0015824; GO:0016021";"amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]";"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]";"amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter:sodium symporter activity [GO:0005328]; neurotransmitter transmembrane transporter activity [GO:0005326]; proline:sodium symporter activity [GO:0005298]"